data_2nr2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2nr2 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.5 ttp . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 113.994 1.109 . . . . 1.39 113.994 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -105.36 140.03 39.1 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.306 -3.371 . . . . 2.2 113.49 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 pt -125.88 153.02 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 114.933 -1.03 . . . . 1.32 109.672 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -99.88 135.54 41.15 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.802 2.041 . . . . 2.2 109.247 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.7 t -114.81 104.07 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 104.32 -2.474 . . . . 1.23 104.32 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -82.16 126.05 31.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.31 2.005 . . . . 2.51 111.962 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.3 p -83.94 -169.05 2.39 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 117.171 -3.455 . . . . 1.41 113.019 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.8 tp -73.46 -57.93 3.66 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.844 1.783 . . . . 2.95 113.103 170.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.4 p -67.86 -22.9 65.1 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.256 -3.402 . . . . 2.52 118.191 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.93 22.36 1.03 Allowed Glycine 0 N--CA 1.429 -1.774 0 C-N-CA 125.848 1.689 . . . . 1.5 115.111 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.499 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 74.3 tttt -88.31 131.02 34.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.031 2.133 . . . . 1.79 105.985 177.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -109.59 124.39 51.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 123.603 2.911 . . . . 1.38 104.382 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.413 HD12 HG22 ' A' ' 13' ' ' ILE . 43.1 mt -111.72 128.23 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 107.436 -1.32 . . . . 2.03 107.436 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.8 m -102.83 115.83 31.36 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.11 -0.994 . . . . 1.61 108.928 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -105.49 157.28 17.48 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.971 -1.081 . . . . 2.15 111.568 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.39 110.82 21.46 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.358 2.263 . . . . 1.98 106.524 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.0 m -118.84 159.02 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 126.791 2.557 . . . . 1.52 109.01 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -89.82 146.3 35.09 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-O 111.762 -3.97 . . . . 2.35 106.769 160.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -73.47 -5.61 17.4 Favored 'Trans proline' 0 N--CA 1.433 -2.05 0 CA-C-N 127.547 3.731 . . . . 1.31 115.142 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 m -90.08 7.58 37.03 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 125.228 1.58 . . . . 1.71 109.444 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -85.19 144.14 28.34 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.19 1.922 . . . . 1.69 116.19 172.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.6 p -82.9 160.5 22.11 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.323 -2.736 . . . . 1.33 115.657 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.454 15.5 mm -57.79 -38.99 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 123.419 1.581 . . . . 1.32 115.252 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -47.49 -45.05 25.88 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.357 1.984 . . . . 1.62 116.357 161.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -72.58 -20.8 61.25 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 126.533 1.933 . . . . 2.13 113.4 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.23 -39.37 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.99 -2.319 . . . . 1.23 108.394 172.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -66.05 -41.69 90.5 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.974 -2.329 . . . . 1.97 110.183 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.75 -43.79 66.02 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.956 -2.34 . . . . 1.19 116.033 173.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -61.7 -32.15 72.34 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 125.966 2.041 . . . . 1.92 113.593 170.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -81.81 -32.13 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 118.018 -2.927 . . . . 1.94 115.093 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -56.2 -38.71 71.36 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.868 1.794 . . . . 1.9 113.879 166.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -64.56 -50.39 67.47 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.903 2.881 . . . . 1.55 111.101 167.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -71.5 -62.84 1.26 Allowed 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 126.827 2.051 . . . . 2.95 111.569 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.499 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 45.6 mm-40 -101.25 -35.31 9.31 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 118.45 -2.656 . . . . 1.48 115.81 -170.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.93 11.06 29.07 Favored Glycine 0 N--CA 1.43 -1.751 0 CA-C-O 124.106 1.948 . . . . 1.12 113.188 175.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.5 mm -76.1 125.97 87.31 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-O 114.418 -2.706 . . . . 2.07 112.842 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.0 154.35 74.39 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 CA-C-N 128.252 3.983 . . . . 1.39 118.169 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -74.08 -9.6 22.17 Favored 'Trans proline' 0 C--N 1.299 -2.066 0 CA-C-N 123.844 2.409 . . . . 1.68 116.52 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -59.99 -44.38 94.56 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 118.378 -0.82 . . . . 2.25 111.254 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -79.6 -29.56 41.21 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.228 0.955 . . . . 2.44 110.604 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -66.66 107.68 2.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 121.044 3.72 . . . . 1.32 121.044 -172.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 mtt180 -101.38 139.31 37.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.075 -3.516 . . . . 3.19 110.478 171.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.6 mt -113.3 141.25 47.23 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.677 -2.514 . . . . 1.75 111.891 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mm -128.72 137.58 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 115.184 -2.341 . . . . 1.98 110.899 172.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.485 ' CE2' HG12 ' A' ' 61' ' ' ILE 0.293 10.9 t80 -115.67 -54.62 2.5 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.068 1.48 . . . . 1.94 107.766 176.098 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -121.46 -75.96 0.59 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 115.276 1.584 . . . . 1.67 115.276 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.96 -44.14 0.28 Allowed Glycine 0 N--CA 1.429 -1.767 0 O-C-N 119.412 -2.055 . . . . 1.3 114.166 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 mttm -91.93 151.37 20.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 120.784 2.292 . . . . 2.89 114.459 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -83.56 121.91 27.85 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 111.959 -2.382 . . . . 2.89 111.732 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mt -78.21 132.16 37.45 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.501 -1.681 . . . . 1.34 114.197 -162.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -87.62 155.87 19.75 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 115.986 -1.959 . . . . 1.94 115.002 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -66.77 -48.21 69.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.199 2.6 . . . . 1.56 116.099 -172.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.97 38.85 1.12 Allowed Glycine 0 N--CA 1.43 -1.737 1 N-CA-C 124.923 4.729 . . . . 0.97 124.923 174.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -139.59 150.65 45.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.099 -2.412 . . . . 3.07 109.337 171.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 p -91.28 158.81 16.36 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 111.901 -2.409 . . . . 1.34 113.437 -177.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 mt -48.93 -48.73 42.54 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.875 -4.265 . . . . 1.63 107.763 170.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.4 p -56.44 -39.57 73.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.874 2.546 . . . . 1.51 117.874 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -53.56 -57.36 11.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.884 -2.385 . . . . 1.9 112.807 171.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -63.49 -16.16 59.87 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 128.124 2.57 . . . . 0.97 115.149 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.2 t30 69.23 51.56 0.51 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.356 2.662 . . . . 2.35 112.593 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.506 HG23 HD13 ' A' ' 67' ' ' LEU . 34.6 mt -91.73 122.88 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 118.245 -2.784 . . . . 1.39 108.06 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -89.48 -167.6 1.91 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 125.192 1.557 . . . . 2.58 109.682 -174.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.296 40.2 tttm -75.7 138.16 41.13 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.478 -2.045 . . . . 2.58 105.478 172.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 55.3 51.88 12.36 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 130.925 3.69 . . . . 1.71 109.607 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.6 m -103.02 149.87 24.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.159 -2.163 . . . . 1.34 105.159 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.0 m -100.65 118.3 36.51 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 123.138 1.447 . . . . 1.36 112.613 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.506 HD13 HG23 ' A' ' 61' ' ' ILE . 9.4 mp -102.2 148.19 25.73 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 105.782 -1.933 . . . . 2.03 105.782 170.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -99.38 130.12 45.63 Favored 'General case' 0 N--CA 1.43 -1.429 1 C-N-CA 131.932 4.093 . . . . 2.31 110.96 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.2 tp -108.86 116.06 31.27 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 115.075 -2.65 . . . . 1.72 105.964 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.6 t -99.92 130.92 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 108.516 -0.92 . . . . 1.8 108.516 173.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.7 mt . . . . . 0 N--CA 1.43 -1.465 0 C-N-CA 129.232 3.013 . . . . 3.26 108.371 175.514 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.3 ttp . . . . . 0 CA--C 1.489 -1.376 0 CA-C-O 121.788 0.804 . . . . 1.39 111.326 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -96.06 140.75 30.34 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.327 -1.483 . . . . 2.2 113.769 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.6 pt -139.34 165.14 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 125.994 2.807 . . . . 1.32 105.823 171.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -124.64 140.86 52.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 112.715 -2.038 . . . . 2.2 111.08 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -109.67 120.83 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 O-C-N 120.307 -1.495 . . . . 1.23 113.05 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -94.75 137.92 33.23 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.195 -3.441 . . . . 2.51 112.126 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.258 74.8 p -81.32 -165.02 0.85 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.626 2.631 . . . . 1.41 110.815 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.8 tp -77.19 -44.69 29.22 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.083 -2.886 . . . . 2.95 113.835 169.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.49 -53.63 7.4 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.503 1.62 . . . . 2.52 107.863 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.82 21.71 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.706 1 O-C-N 115.673 -4.392 . . . . 1.5 113.018 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -85.9 139.75 30.97 Favored 'General case' 0 N--CA 1.431 -1.412 1 CA-C-N 125.283 4.541 . . . . 1.79 106.546 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 38.2 m -101.8 114.15 27.96 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.995 1.318 . . . . 1.38 110.345 171.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.0 mt -96.21 122.9 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 117.033 -3.542 . . . . 2.03 110.192 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.3 m -87.21 125.55 34.25 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.186 -1.571 . . . . 1.61 110.73 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.1 mt -126.69 152.46 46.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.615 -1.303 . . . . 2.15 112.084 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -123.36 105.57 9.94 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 111.781 -2.463 . . . . 1.98 110.07 173.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.1 m -121.64 -167.83 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 102.107 -3.294 . . . . 1.52 102.107 -176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -122.07 162.42 37.39 Favored Pre-proline 0 N--CA 1.431 -1.388 0 C-N-CA 126.982 2.113 . . . . 2.35 106.477 167.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -83.81 -14.65 7.49 Favored 'Trans proline' 0 N--CA 1.433 -2.064 0 CA-C-O 116.845 -1.398 . . . . 1.31 108.83 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.3 p -80.94 0.99 32.98 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 124.345 1.028 . . . . 1.71 112.648 171.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -83.54 157.03 22.5 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 125.466 2.555 . . . . 1.69 111.772 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.9 p -88.6 163.35 15.88 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 112.939 -1.937 . . . . 1.33 112.169 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.0 mm -63.29 -34.37 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-O 115.31 -2.281 . . . . 1.32 110.037 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -55.48 -46.94 76.83 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 122.215 2.279 . . . . 1.62 114.788 170.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -56.03 -37.73 69.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.267 1.58 . . . . 2.13 115.267 174.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -62.44 -40.46 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 119.7 -1.875 . . . . 1.23 113.864 172.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -61.85 -28.66 69.65 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.477 -1.39 . . . . 1.97 113.803 173.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.82 -28.11 61.46 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.3 2.24 . . . . 1.19 110.156 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -74.12 -36.13 64.17 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.907 -3.621 . . . . 1.92 111.162 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.6 mt -70.61 -39.9 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 123.157 1.456 . . . . 1.94 113.648 175.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -53.03 -38.7 62.62 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.079 -2.263 . . . . 1.9 115.779 169.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -68.88 -46.66 67.83 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.488 -2.008 . . . . 1.55 113.839 173.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -80.04 -55.78 4.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.58 1.552 . . . . 2.95 114.783 -174.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -94.06 -45.51 7.54 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 127.864 3.697 . . . . 1.48 110.928 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.27 56.34 0.7 Allowed Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 111.888 -2.415 . . . . 1.12 111.211 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.5 mt -124.86 127.78 25.04 Favored Pre-proline 0 N--CA 1.43 -1.434 0 N-CA-C 103.268 -2.864 . . . . 2.07 103.268 -167.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.28 32.2 Cg_exo -66.07 138.55 52.56 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 124.625 3.55 . . . . 1.39 109.314 -171.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -64.86 -14.19 43.66 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-O 114.219 -2.492 . . . . 1.68 114.321 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -74.04 -16.34 61.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 122.455 2.389 . . . . 2.25 114.427 164.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -92.06 4.2 53.6 Favored 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 118.756 -2.465 . . . . 2.44 112.168 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -113.48 101.01 8.96 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 127.832 3.682 . . . . 1.32 119.009 -172.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -94.06 122.67 36.8 Favored 'General case' 0 N--CA 1.431 -1.409 1 O-C-N 115.266 -4.646 . . . . 3.19 110.435 173.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.2 mt -112.11 124.81 53.22 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.706 -1.59 . . . . 1.75 106.706 -170.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mm -111.0 144.48 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 129.345 3.058 . . . . 1.98 108.912 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -143.0 116.46 9.11 Favored 'General case' 0 N--CA 1.43 -1.442 1 N-CA-C 97.629 -4.952 . . . . 1.94 97.629 175.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 42.83 39.64 1.79 Allowed 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.1 -3.5 . . . . 1.67 120.349 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.21 -25.98 26.26 Favored Glycine 0 N--CA 1.431 -1.657 0 O-C-N 118.042 -2.911 . . . . 1.3 111.039 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -77.35 130.9 37.74 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.74 -3.8 . . . . 2.89 106.378 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -91.6 135.65 33.71 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.297 1.046 . . . . 2.89 112.764 165.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.1 mt -97.81 144.03 27.82 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.069 -2.269 . . . . 1.34 113.29 -166.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -86.45 147.33 26.04 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 119.533 -1.98 . . . . 1.94 115.563 174.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -55.88 -64.26 0.91 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 118.504 2.779 . . . . 1.56 118.504 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.51 22.1 9.5 Favored Glycine 0 N--CA 1.431 -1.693 1 N-CA-C 123.162 4.025 . . . . 0.97 123.162 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -86.14 156.27 20.42 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.92 2.888 . . . . 3.07 109.624 161.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.405 ' HG1' ' CG ' ' A' ' 58' ' ' ASP 0.251 40.5 p -95.44 157.5 15.87 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 126.563 3.077 . . . . 1.34 112.426 177.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.8 mt -63.38 -31.85 73.11 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 117.422 -3.299 . . . . 1.63 111.769 168.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.4 t -67.61 -40.21 84.71 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.914 -4.241 . . . . 1.51 113.718 174.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.405 ' CG ' ' HG1' ' A' ' 55' ' ' THR . 28.6 m-20 -46.67 -53.61 11.3 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 116.743 2.127 . . . . 1.9 116.743 169.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.337 86.1 m-85 -60.21 -34.87 74.25 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 118.033 2.605 . . . . 0.97 118.033 175.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.294 67.1 m-80 91.84 66.19 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.66 2.384 . . . . 2.35 106.04 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.3 mt -108.68 118.01 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 125.441 2.543 . . . . 1.39 109.654 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -100.75 -179.66 4.14 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 109.94 -3.3 . . . . 2.58 107.27 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -56.93 149.68 18.25 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.89 2.182 . . . . 2.58 116.89 174.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 64.3 26.4 13.67 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 128.966 2.907 . . . . 1.71 110.478 170.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 m -81.7 136.96 35.46 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 116.404 -1.76 . . . . 1.34 107.839 -173.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.6 m -101.95 112.63 25.34 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 101.056 -3.683 . . . . 1.36 101.056 -172.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mp -103.05 156.91 17.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.71 3.204 . . . . 2.03 109.136 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -113.92 144.06 43.68 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 123.867 0.867 . . . . 2.31 109.326 -174.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.7 tp -115.42 111.68 21.17 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 130.593 3.557 . . . . 1.72 114.271 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.5 t -103.22 125.42 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 1 C-N-CA 132.41 4.284 . . . . 1.8 110.946 173.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 N--CA 1.43 -1.441 0 CA-C-O 124.731 2.205 . . . . 3.26 113.792 -179.721 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttp . . . . . 0 CA--C 1.49 -1.343 0 CA-C-O 124.335 2.017 . . . . 1.39 110.789 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -76.54 123.96 26.86 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.508 -3.245 . . . . 2.2 117.176 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -138.22 152.15 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 O-C-N 120.305 -1.497 . . . . 1.32 107.103 174.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -108.61 141.18 40.93 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 128.195 2.598 . . . . 2.2 111.616 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.503 HG21 HD13 ' A' ' 30' ' ' ILE . 17.5 t -121.9 128.76 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 114.242 -2.79 . . . . 1.23 107.883 171.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -120.49 133.28 55.43 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 124.535 3.334 . . . . 2.51 111.472 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.448 HG21 HD21 ' A' ' 69' ' ' LEU . 27.2 p -70.88 175.35 5.14 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.514 -1.366 . . . . 1.41 112.293 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.0 tp -65.57 -41.85 92.44 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 126.194 1.798 . . . . 2.95 115.193 169.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.5 m -66.49 -47.44 73.02 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.908 1.337 . . . . 2.52 108.197 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.38 42.79 0.11 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 117.957 -2.964 . . . . 1.5 114.029 169.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.539 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 53.7 tttt -97.18 117.66 31.89 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 115.565 -2.159 . . . . 1.79 108.024 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.5 m -92.14 125.74 36.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 122.396 2.362 . . . . 1.38 113.268 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mt -112.94 126.5 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 100.524 -3.88 . . . . 2.03 100.524 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.1 m -101.39 125.51 48.04 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 119.971 -1.705 . . . . 1.61 111.301 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.9 mt -126.2 159.42 33.03 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.453 2.073 . . . . 2.15 107.074 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -119.25 138.61 52.87 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 111.722 -2.49 . . . . 1.98 104.292 170.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.273 17.3 m -145.3 164.26 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 104.713 -2.329 . . . . 1.52 104.713 -176.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -98.8 145.02 29.23 Favored Pre-proline 0 N--CA 1.43 -1.468 0 O-C-N 125.828 1.955 . . . . 2.35 107.363 160.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.37 -14.27 31.0 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 CA-C-N 122.898 2.071 . . . . 1.31 112.017 -169.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.339 6.2 t -87.29 -7.66 57.59 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 125.181 3.628 . . . . 1.71 110.692 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -74.59 151.44 39.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.086 -2.259 . . . . 1.69 111.977 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.253 77.1 p -74.16 170.03 16.36 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 117.348 -3.345 . . . . 1.33 117.096 -172.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.5 mm -77.1 -38.14 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 103.755 -2.684 . . . . 1.32 103.755 173.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -42.12 -53.15 4.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.17 2.588 . . . . 1.62 113.427 161.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -59.87 -44.5 94.13 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.222 1.409 . . . . 2.13 112.779 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.6 t -64.49 -42.92 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 120.505 -1.372 . . . . 1.23 110.673 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -58.54 -40.91 84.32 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.575 1.95 . . . . 1.97 113.223 172.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.3 -37.06 84.1 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.188 -3.445 . . . . 1.19 110.246 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -67.43 -39.83 85.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.277 2.325 . . . . 1.92 117.277 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.503 HD13 HG21 ' A' ' 5' ' ' VAL . 9.9 mt -62.47 -48.02 90.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-O 127.066 3.317 . . . . 1.94 113.342 169.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -48.51 -39.66 24.04 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 113.923 -5.485 . . . . 1.9 115.678 167.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -59.56 -45.11 92.78 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.883 -3.011 . . . . 1.55 113.272 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -82.66 -83.18 0.13 Allowed 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.432 -1.321 . . . . 2.95 107.432 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.539 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS 0.297 58.1 mm-40 -76.25 -28.19 57.01 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.6 -3.812 . . . . 1.48 114.654 -166.014 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.31 -8.19 22.74 Favored Glycine 0 N--CA 1.431 -1.652 0 O-C-N 120.718 -1.239 . . . . 1.12 112.693 167.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.1 mt -62.19 115.29 15.12 Favored Pre-proline 0 N--CA 1.43 -1.462 0 N-CA-C 116.993 2.22 . . . . 2.07 116.993 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -67.61 148.43 78.19 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 N-CA-C 119.573 2.874 . . . . 1.39 119.573 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -61.78 -32.91 86.21 Favored 'Trans proline' 0 N--CA 1.433 -2.038 1 C-N-CA 125.876 4.384 . . . . 1.68 113.068 -173.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -62.05 -30.89 71.29 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.769 1.766 . . . . 2.25 115.769 171.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -86.32 -24.68 25.79 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.797 1.639 . . . . 2.44 112.053 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -81.77 117.65 22.24 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 104.35 -2.463 . . . . 1.32 104.35 -176.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -109.19 124.97 51.71 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 103.845 -2.65 . . . . 3.19 103.845 169.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.8 mt -119.47 125.07 48.01 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 106.248 -1.76 . . . . 1.75 106.248 -172.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.8 mm -114.55 117.38 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 C-N-CA 127.905 2.482 . . . . 1.98 114.879 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -102.95 108.18 19.27 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.357 -1.349 . . . . 1.94 107.357 173.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.4 -98.78 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.517 -1.989 . . . . 1.67 110.397 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.91 30.62 3.34 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-O 125.38 2.655 . . . . 1.3 113.273 173.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -118.58 131.0 56.2 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.727 -2.043 . . . . 2.89 112.007 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -96.06 114.8 26.54 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.802 1.641 . . . . 2.89 108.994 171.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 mt -83.13 138.78 33.53 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.776 -3.078 . . . . 1.34 111.414 -166.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -92.08 138.77 31.26 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.32 -1.487 . . . . 1.94 108.691 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.39 -46.83 83.0 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.148 2.579 . . . . 1.56 115.547 -173.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.13 -5.23 58.29 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 120.51 2.964 . . . . 0.97 120.51 176.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 -88.99 169.8 11.22 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.137 -3.567 . . . . 3.07 111.283 162.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.7 p -92.81 171.2 9.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.582 2.067 . . . . 1.34 116.582 169.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 mt -59.18 -42.52 91.04 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 115.921 -1.99 . . . . 1.63 113.616 165.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.0 t -63.14 -36.46 83.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 125.497 1.748 . . . . 1.51 112.848 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -57.06 -35.28 69.15 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 117.855 2.539 . . . . 1.9 117.855 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -90.87 -0.58 57.76 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 125.767 1.627 . . . . 0.97 110.206 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 67.68 26.1 7.98 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 121.895 2.134 . . . . 2.35 112.679 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.7 mt -68.41 123.08 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 128.529 2.732 . . . . 1.39 106.253 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -124.5 -168.83 1.87 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.944 -2.973 . . . . 2.58 107.139 -171.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -53.31 134.8 39.58 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.363 3.465 . . . . 2.58 112.534 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.536 21.5 pt-20 64.65 15.96 10.04 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 129.214 3.005 . . . . 1.71 114.032 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.256 18.2 m -73.3 138.58 45.53 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.515 -3.241 . . . . 1.34 108.456 -173.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.7 m -109.62 98.2 7.61 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 127.924 3.265 . . . . 1.36 114.603 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.1 mp -74.48 148.78 40.7 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 112.334 -2.212 . . . . 2.03 109.716 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -112.27 115.46 28.82 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.615 -2.553 . . . . 2.31 109.423 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.448 HD21 HG21 ' A' ' 7' ' ' THR . 33.9 tp -101.7 113.97 27.61 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.477 1.608 . . . . 1.72 112.749 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -108.11 146.74 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 113.764 -1.562 . . . . 1.8 112.298 173.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.0 tp . . . . . 0 N--CA 1.43 -1.47 0 O-C-N 119.384 -2.072 . . . . 3.26 111.231 -176.401 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 ptt? . . . . . 0 CA--C 1.491 -1.316 0 CA-C-O 123.706 1.717 . . . . 1.39 111.274 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -100.76 133.41 45.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 126.859 3.219 . . . . 2.2 109.953 -174.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.2 pt -123.44 155.36 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 118.01 -2.931 . . . . 1.32 105.86 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -119.81 124.3 45.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.982 1.849 . . . . 2.2 110.26 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 t -100.56 95.74 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 126.846 3.212 . . . . 1.23 114.838 173.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -75.1 124.33 26.82 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.19 -2.194 . . . . 2.51 109.708 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.1 p -100.21 178.25 4.83 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 112.933 0.716 . . . . 1.41 112.933 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.5 tp -64.57 -64.29 0.91 Allowed 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 118.368 -2.708 . . . . 2.95 112.876 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.454 22.9 p -63.27 -36.83 84.98 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 119.502 3.149 . . . . 2.52 119.502 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.22 -52.82 0.12 Allowed Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 115.015 -3.469 . . . . 1.5 114.3 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -60.6 132.39 53.75 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 124.669 2.176 . . . . 1.79 116.412 -168.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.1 m -99.76 112.91 25.12 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.067 -3.521 . . . . 1.38 104.529 168.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mt -90.81 119.66 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 120.211 -0.595 . . . . 2.03 110.973 -173.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.6 m -85.69 112.17 20.78 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.048 -2.282 . . . . 1.61 108.222 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.4 mt -116.03 116.27 27.6 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 125.335 1.647 . . . . 2.15 112.724 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -84.93 124.09 31.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.502 -3.874 . . . . 1.98 115.778 167.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.03 163.15 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 125.779 2.704 . . . . 1.52 109.147 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -97.88 152.13 37.93 Favored Pre-proline 0 N--CA 1.431 -1.391 1 O-C-N 114.493 -5.13 . . . . 2.35 104.757 164.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -73.39 -3.07 13.06 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 125.273 3.982 . . . . 1.31 120.995 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.8 m -97.35 -4.82 37.79 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.539 -1.976 . . . . 1.71 109.227 172.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -71.44 146.22 48.78 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.756 -2.465 . . . . 1.69 111.16 173.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.4 p -79.59 154.67 28.57 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 118.757 2.873 . . . . 1.33 118.757 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.9 mm -57.7 -37.27 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 121.977 2.171 . . . . 1.32 113.125 175.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.436 30.6 tt0 -38.65 -52.43 1.66 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 119.497 3.147 . . . . 1.62 119.497 165.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -56.9 -45.06 82.85 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.166 1.913 . . . . 2.13 116.166 172.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.4 t -59.29 -43.4 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-O 124.771 2.224 . . . . 1.23 115.189 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -62.21 -45.97 90.96 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.947 2.499 . . . . 1.97 108.518 172.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.56 -30.5 69.82 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.618 2.822 . . . . 1.19 118.618 172.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -80.81 -29.38 36.0 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 116.235 -4.041 . . . . 1.92 106.627 172.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.1 mt -72.45 -34.4 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 116.503 -3.873 . . . . 1.94 112.621 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -52.1 -50.94 60.62 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 116.889 -3.632 . . . . 1.9 112.958 162.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -53.48 -45.31 69.54 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 128.238 2.615 . . . . 1.55 114.188 171.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -72.96 -70.12 0.38 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.053 -2.905 . . . . 2.95 111.214 -174.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -93.36 -43.61 8.69 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 128.455 2.702 . . . . 1.48 110.951 -165.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.18 50.37 2.25 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 125.862 1.696 . . . . 1.12 114.814 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.5 mt -118.05 137.99 25.04 Favored Pre-proline 0 N--CA 1.43 -1.463 1 N-CA-C 98.105 -4.776 . . . . 2.07 98.105 -176.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -65.35 154.79 71.99 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 C-N-CA 124.244 3.296 . . . . 1.39 115.783 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.55 -10.9 24.1 Favored 'Trans proline' 0 N--CA 1.434 -1.979 0 CA-C-O 114.047 -2.564 . . . . 1.68 117.107 -174.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.31 -50.54 38.28 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.729 2.518 . . . . 2.25 114.393 169.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -60.71 -33.78 73.39 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 128.197 2.599 . . . . 2.44 106.467 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -74.07 128.43 35.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 114.494 -2.669 . . . . 1.32 107.477 -170.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -111.53 115.26 28.89 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 127.093 2.745 . . . . 3.19 105.312 166.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.7 mt -97.14 129.49 44.52 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 120.543 -0.463 . . . . 1.75 112.226 173.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.59 138.83 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 128.118 2.567 . . . . 1.98 113.3 175.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -127.51 87.6 2.65 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.445 -2.035 . . . . 1.94 113.347 172.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.388 . . 84.97 -73.52 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.676 1.99 . . . . 1.67 108.444 -175.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.02 -21.48 0.28 Allowed Glycine 0 N--CA 1.431 -1.7 0 N-CA-C 109.439 -1.464 . . . . 1.3 109.439 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -80.02 128.22 33.23 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.309 1.444 . . . . 2.89 109.681 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -87.49 126.33 34.84 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 102.195 -3.261 . . . . 2.89 102.195 170.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.9 mt -89.19 127.37 35.74 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.847 1.308 . . . . 1.34 111.208 -164.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -77.17 142.25 39.73 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.153 -2.842 . . . . 1.94 115.664 174.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -56.68 -55.59 32.14 Favored 'General case' 0 N--CA 1.43 -1.456 1 C-N-CA 132.623 4.369 . . . . 1.56 115.402 -170.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.23 14.19 29.28 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 128.933 3.158 . . . . 0.97 112.773 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -109.51 164.45 12.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.326 3.563 . . . . 3.07 110.926 168.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.3 p -90.77 152.98 20.58 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 126.162 2.887 . . . . 1.34 115.109 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mt -56.4 -45.93 80.38 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.538 -3.226 . . . . 1.63 118.142 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.0 p -68.63 -13.4 62.33 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 118.095 2.628 . . . . 1.51 118.095 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -75.64 -34.28 60.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.291 -1.374 . . . . 1.9 107.291 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -85.35 1.83 46.85 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 117.581 -1.199 . . . . 0.97 111.787 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 65.83 36.77 5.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.563 2.745 . . . . 2.35 112.031 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.6 mt -87.64 121.45 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.149 -3.469 . . . . 1.39 111.532 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -122.11 -168.17 1.67 Allowed 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 105.829 -1.915 . . . . 2.58 105.829 -173.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -56.25 140.5 44.53 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 116.128 1.899 . . . . 2.58 116.128 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.307 98.5 mt-10 69.8 15.56 7.94 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 112.768 -2.015 . . . . 1.71 114.098 176.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.329 44.8 m -78.75 156.64 28.76 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 121.72 2.055 . . . . 1.34 111.107 -177.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.8 m -102.57 126.65 49.71 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 112.57 -2.105 . . . . 1.36 106.852 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -116.68 150.78 37.61 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 104.26 -2.496 . . . . 2.03 104.26 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -116.64 112.02 20.68 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 126.495 1.918 . . . . 2.31 106.403 -171.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.9 tp -98.22 122.18 41.06 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.103 -1.814 . . . . 1.72 106.103 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.74 150.93 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 113.368 -1.742 . . . . 1.8 107.466 173.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.3 mt . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 117.811 2.523 . . . . 3.26 117.811 -175.1 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.49 -1.336 0 N-CA-C 111.807 0.299 . . . . 1.39 111.807 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -97.48 136.67 37.57 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 124.012 0.82 . . . . 2.2 110.557 -172.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.2 pt -130.17 160.62 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 105.088 -2.19 . . . . 1.32 105.088 172.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -118.01 150.09 39.87 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 120.54 1.518 . . . . 2.2 109.826 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 96.4 t -132.47 122.87 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 105.913 -1.884 . . . . 1.23 105.913 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -97.31 147.83 23.75 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.863 1.792 . . . . 2.51 107.446 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.441 8.9 p -101.92 175.39 5.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.498 -3.876 . . . . 1.41 112.007 174.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.0 tp -58.34 -58.39 8.72 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.629 -1.919 . . . . 2.95 114.772 169.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.277 62.5 p -78.35 -14.53 59.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 119.26 3.059 . . . . 2.52 119.26 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.63 17.01 2.18 Favored Glycine 0 N--CA 1.429 -1.796 0 CA-C-O 115.003 -3.11 . . . . 1.5 117.905 173.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -94.8 122.07 37.05 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 101.699 -3.445 . . . . 1.79 101.699 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.265 10.7 m -92.59 116.19 28.78 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.462 -3.273 . . . . 1.38 111.06 169.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -102.22 135.47 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 118.335 -2.728 . . . . 2.03 117.206 172.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.2 m -103.62 137.74 41.25 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 101.367 -3.568 . . . . 1.61 101.367 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.4 mt -129.24 142.65 50.79 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 120.847 1.658 . . . . 2.15 111.704 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -101.57 117.4 34.84 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.852 2.861 . . . . 1.98 103.791 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -134.28 164.41 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 101.823 -3.399 . . . . 1.52 101.823 -172.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -109.16 159.56 30.76 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-N 110.169 -3.196 . . . . 2.35 107.402 166.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -81.24 -11.75 11.92 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 CA-C-N 124.734 2.727 . . . . 1.31 109.677 -172.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.1 m -86.83 -7.98 57.74 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 116.09 -4.132 . . . . 1.71 110.536 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -66.45 148.82 51.32 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 128.813 2.845 . . . . 1.69 107.848 170.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.1 p -93.12 -173.45 3.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.486 1.291 . . . . 1.33 114.486 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.6 mm -79.54 -37.88 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 125.431 1.492 . . . . 1.32 107.784 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -51.15 -48.24 61.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.599 1.96 . . . . 1.62 116.047 166.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -58.0 -48.99 78.38 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 122.821 1.296 . . . . 2.13 112.34 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.9 t -56.31 -52.5 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 114.785 1.402 . . . . 1.23 114.785 174.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HZ2' ' CG ' ' A' ' 52' ' ' ASP . 46.3 mtmt -62.16 -22.56 65.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 128.22 3.867 . . . . 1.97 114.516 174.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.14 -35.9 61.62 Favored 'General case' 0 N--CA 1.429 -1.5 1 O-C-N 113.04 -6.037 . . . . 1.19 112.596 171.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -68.9 -30.88 69.45 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.972 -2.33 . . . . 1.92 108.945 171.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.0 mt -69.73 -31.69 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 1 O-C-N 112.779 -6.201 . . . . 1.94 112.474 176.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -64.37 -42.09 96.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.865 -1.772 . . . . 1.9 108.654 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -52.8 -49.66 65.18 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 114.611 1.337 . . . . 1.55 114.611 169.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -70.56 -73.7 0.16 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.822 -2.424 . . . . 2.95 115.797 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -90.95 -28.98 17.7 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.443 2.297 . . . . 1.48 113.898 -169.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.06 54.62 1.98 Allowed Glycine 0 N--CA 1.43 -1.732 1 O-C-N 115.244 -4.66 . . . . 1.12 114.614 173.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.4 mt -118.27 132.36 23.8 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 104.888 -2.264 . . . . 2.07 104.888 -173.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -63.17 150.84 87.47 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 O-C-N 114.09 -3.689 . . . . 1.39 117.132 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -67.75 -15.51 44.41 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 C-N-CA 124.376 3.384 . . . . 1.68 112.935 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.63 -30.97 61.83 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.831 2.53 . . . . 2.25 117.831 173.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -92.27 -26.65 18.05 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 123.419 1.58 . . . . 2.44 111.607 -172.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.431 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 66.0 mt-30 -75.44 112.1 11.41 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.763 1.625 . . . . 1.32 112.846 -175.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -103.59 119.6 39.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.693 -3.754 . . . . 3.19 105.798 168.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.9 mt -96.16 129.73 43.39 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.852 -1.976 . . . . 1.75 107.051 173.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mm -104.68 135.68 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 128.679 2.792 . . . . 1.98 108.663 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -154.97 127.25 7.79 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 114.384 1.253 . . . . 1.94 114.384 170.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.43 27.8 3.87 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 115.935 1.828 . . . . 1.67 115.935 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.37 -12.32 61.68 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 115.992 1.157 . . . . 1.3 115.992 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -135.45 143.81 46.1 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.465 1.602 . . . . 2.89 114.578 -167.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -71.61 149.13 45.9 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 118.771 -2.456 . . . . 2.89 114.44 171.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.308 55.1 mt -113.67 147.99 37.14 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 122.18 0.991 . . . . 1.34 113.106 -165.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -75.89 152.6 37.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 113.807 1.039 . . . . 1.94 113.807 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.444 ' CG ' ' HZ2' ' A' ' 27' ' ' LYS 0.351 0.9 OUTLIER -73.95 -51.07 17.23 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 116.099 1.888 . . . . 1.56 116.099 -169.843 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.34 32.77 3.03 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 119.678 2.631 . . . . 0.97 119.678 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -95.22 155.51 16.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.974 -3.074 . . . . 3.07 110.756 162.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.275 14.3 p -87.2 165.76 15.46 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 126.426 3.013 . . . . 1.34 111.163 175.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 37.6 mt -78.93 -20.51 49.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.823 -3.048 . . . . 1.63 109.698 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -70.96 -29.04 64.94 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 127.511 2.324 . . . . 1.51 112.375 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -68.28 -35.64 78.16 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.279 1.832 . . . . 1.9 114.628 170.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -95.43 7.79 45.17 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.156 1.383 . . . . 0.97 109.709 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.2 m120 45.47 39.9 5.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.266 3.027 . . . . 2.35 114.687 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mt -78.02 105.44 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 105.667 -1.975 . . . . 1.39 105.667 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -78.08 -169.42 1.58 Allowed 'General case' 0 N--CA 1.43 -1.466 1 C-N-CA 131.964 4.106 . . . . 2.58 113.186 175.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -76.34 157.15 32.71 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.996 -2.94 . . . . 2.58 113.821 172.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.289 52.9 mt-10 68.35 22.8 7.85 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 111.852 -2.431 . . . . 1.71 111.949 171.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.0 m -86.14 125.8 33.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.059 2.944 . . . . 1.34 111.417 -174.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.6 m -92.14 120.27 32.57 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.96 -3.587 . . . . 1.36 106.218 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 9.3 mp -103.67 137.51 41.62 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 104.609 -2.367 . . . . 2.03 104.609 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -107.79 137.85 45.07 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 123.641 2.928 . . . . 2.31 115.008 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.4 tt -98.35 108.59 21.32 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.412 2.053 . . . . 1.72 111.422 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -110.9 130.2 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 C-N-CA 129.483 3.113 . . . . 1.8 111.612 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.6 mt . . . . . 0 N--CA 1.43 -1.473 0 O-C-N 116.333 -3.979 . . . . 3.26 115.46 -179.154 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptt? . . . . . 0 CA--C 1.489 -1.367 1 CA-C-O 109.231 -5.176 . . . . 1.39 110.82 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -117.56 145.05 44.53 Favored 'General case' 0 N--CA 1.43 -1.45 2 O-C-N 130.148 4.655 . . . . 2.2 122.534 174.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.336 15.5 pt -128.21 153.82 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 125.741 1.901 . . . . 1.32 109.176 175.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -112.15 121.07 43.93 Favored 'General case' 0 N--CA 1.429 -1.484 1 N-CA-C 99.583 -4.228 . . . . 2.2 99.583 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.497 HG23 HD13 ' A' ' 15' ' ' LEU . 71.2 t -113.51 112.12 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-O 124.973 2.32 . . . . 1.23 105.389 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -88.52 145.51 25.69 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.549 -3.219 . . . . 2.51 115.474 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.318 22.1 p -93.58 162.62 13.88 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.094 2.158 . . . . 1.41 108.762 177.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.37 -29.07 70.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.185 2.194 . . . . 2.95 111.552 176.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.315 28.4 p -83.25 -45.4 13.88 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 126.51 3.052 . . . . 2.52 113.145 -176.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.64 23.79 0.06 OUTLIER Glycine 0 N--CA 1.429 -1.773 1 O-C-N 114.769 -4.957 . . . . 1.5 116.653 172.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -103.67 135.86 44.45 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 103.603 -2.74 . . . . 1.79 103.603 -172.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.0 m -97.41 112.6 24.37 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 115.537 -2.173 . . . . 1.38 109.774 169.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -95.24 120.26 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 123.525 2.875 . . . . 2.03 105.188 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.4 m -92.37 124.7 36.62 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 105.271 -2.122 . . . . 1.61 105.271 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.497 HD13 HG23 ' A' ' 5' ' ' VAL . 46.1 mt -119.67 130.14 54.9 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.471 1.508 . . . . 2.15 111.573 -174.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -85.05 126.5 33.62 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 104.907 -2.257 . . . . 1.98 104.907 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.8 m -143.48 167.34 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 126.8 2.04 . . . . 1.52 112.479 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -120.9 160.67 43.84 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-O 115.231 -2.319 . . . . 2.35 112.329 163.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -60.12 -25.12 79.04 Favored 'Trans proline' 0 N--CA 1.433 -2.056 2 CA-C-N 128.948 4.231 . . . . 1.31 113.597 -176.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m -74.7 -20.9 59.67 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.277 2.231 . . . . 1.71 113.32 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -62.44 141.79 58.19 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.942 -2.973 . . . . 1.69 110.998 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.483 HG22 HG21 ' A' ' 55' ' ' THR . 72.3 p -82.6 167.09 18.65 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.528 -1.669 . . . . 1.33 108.235 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.5 mm -66.28 -33.6 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 116.22 -1.848 . . . . 1.32 109.781 172.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -54.39 -33.31 59.03 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.658 2.096 . . . . 1.62 116.658 166.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -73.23 -35.19 66.22 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 120.881 1.673 . . . . 2.13 109.947 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.18 -51.66 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 125.016 1.326 . . . . 1.23 110.038 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -66.69 -25.87 66.76 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 117.58 -1.648 . . . . 1.97 115.141 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.91 -35.48 72.29 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.667 -2.52 . . . . 1.19 114.599 172.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -64.49 -29.87 70.9 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.447 -2.658 . . . . 1.92 113.001 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.03 -36.57 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 119.553 -1.967 . . . . 1.94 111.069 170.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -67.71 -41.32 83.77 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.947 -1.721 . . . . 1.9 109.488 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.56 -53.01 63.01 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.671 -1.893 . . . . 1.55 111.931 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -69.99 -59.63 2.8 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 123.646 1.688 . . . . 2.95 112.164 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -103.24 -28.85 11.64 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 118.815 -2.428 . . . . 1.48 110.312 -160.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.7 40.67 5.57 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 122.257 2.299 . . . . 1.12 115.579 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.7 mm -115.1 118.51 40.15 Favored Pre-proline 0 N--CA 1.43 -1.469 0 N-CA-C 104.445 -2.428 . . . . 2.07 104.445 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -74.5 144.81 32.68 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 124.196 2.534 . . . . 1.39 114.089 -175.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.96 -20.84 44.36 Favored 'Trans proline' 0 N--CA 1.433 -2.041 1 C-N-CA 125.923 4.416 . . . . 1.68 114.183 -175.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -48.48 -53.07 19.38 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.482 1.611 . . . . 2.25 111.331 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -78.18 -24.76 47.08 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 119.273 3.064 . . . . 2.44 119.273 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -66.5 141.49 57.86 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.83 -1.794 . . . . 1.32 112.928 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -135.38 124.47 24.37 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.684 -2.51 . . . . 3.19 110.245 171.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.288 0.3 OUTLIER -92.51 123.94 36.18 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 120.726 1.603 . . . . 1.75 112.163 175.277 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.1 mm -107.33 128.87 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-O 122.273 1.035 . . . . 1.98 108.704 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.411 ' HB3' HD22 ' A' ' 50' ' ' LEU . 76.4 t80 -140.4 128.5 22.23 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.626 -1.296 . . . . 1.94 112.074 169.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.29 17.21 2.72 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 111.509 -2.587 . . . . 1.67 112.567 -174.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.31 -7.92 56.76 Favored Glycine 0 N--CA 1.43 -1.743 1 CA-C-O 111.724 -4.931 . . . . 1.3 115.41 -170.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -102.16 131.4 48.69 Favored 'General case' 0 N--CA 1.43 -1.443 1 CA-C-N 125.342 4.571 . . . . 2.89 112.057 177.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -79.09 125.31 29.25 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 125.714 2.673 . . . . 2.89 105.926 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.411 HD22 ' HB3' ' A' ' 45' ' ' PHE 0.288 12.5 mt -84.77 129.9 34.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.004 -1.907 . . . . 1.34 109.091 -171.392 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -88.72 143.85 26.65 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 116.642 2.09 . . . . 1.94 116.642 -176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.67 -36.92 85.82 Favored 'General case' 0 N--CA 1.431 -1.419 1 N-CA-C 122.967 4.432 . . . . 1.56 122.967 -169.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.92 10.25 63.41 Favored Glycine 0 N--CA 1.43 -1.726 1 O-C-N 115.626 -4.421 . . . . 0.97 117.952 169.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.25 24.1 mtt180 -107.47 152.07 24.71 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.126 1.917 . . . . 3.07 110.347 172.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.483 HG21 HG22 ' A' ' 22' ' ' THR . 7.0 p -92.75 167.2 12.03 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 126.5 3.048 . . . . 1.34 118.895 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.1 mt -63.02 -22.96 67.22 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 116.114 -4.116 . . . . 1.63 118.382 170.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.3 t -79.75 -31.99 41.0 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.146 1.927 . . . . 1.51 114.128 171.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -60.13 -35.77 76.01 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.205 -2.184 . . . . 1.9 112.7 172.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.406 ' HB2' HD12 ' A' ' 61' ' ' ILE . 78.7 m-85 -94.78 18.81 11.02 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 123.666 2.939 . . . . 0.97 111.194 170.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.56 3.1 p-10 43.61 48.04 6.4 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 129.547 3.139 . . . . 2.35 118.336 -177.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.406 HD12 ' HB2' ' A' ' 59' ' ' TYR . 47.7 mt -90.17 115.93 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 118.627 -2.546 . . . . 1.39 115.898 -178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -100.37 -176.5 3.23 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 131.583 3.953 . . . . 2.58 107.808 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -58.7 158.93 7.25 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.388 -2.695 . . . . 2.58 114.812 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 71.92 27.65 2.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.397 1.879 . . . . 1.71 110.671 168.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.2 m -96.1 135.86 37.33 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 125.683 2.659 . . . . 1.34 114.07 -173.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.3 m -94.67 108.93 20.91 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 113.541 -5.724 . . . . 1.36 105.248 -173.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 mp -97.73 159.0 15.2 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 127.278 3.418 . . . . 2.03 106.512 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -133.69 121.46 21.99 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.564 -2.585 . . . . 2.31 104.631 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.3 tp -89.52 132.14 35.21 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.299 -1.741 . . . . 1.72 106.299 -176.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -116.37 135.39 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 1 N-CA-C 99.32 -4.326 . . . . 1.8 99.32 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.6 mt . . . . . 0 N--CA 1.43 -1.466 0 O-C-N 119.811 -1.805 . . . . 3.26 109.182 -178.262 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 ttp . . . . . 0 CA--C 1.489 -1.376 0 CA-C-O 115.842 -2.028 . . . . 1.39 109.883 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -91.96 123.4 35.3 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 124.699 1.249 . . . . 2.2 110.939 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -124.9 159.51 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.455 -1.403 . . . . 1.32 110.855 172.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -108.12 128.21 54.48 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.729 0.811 . . . . 2.2 110.663 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.3 t -105.93 108.41 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 C-N-CA 128.722 2.809 . . . . 1.23 106.926 171.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -104.48 132.04 51.18 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 127.669 3.604 . . . . 2.51 110.332 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.8 p -100.28 164.36 11.98 Favored 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 115.603 -4.436 . . . . 1.41 107.818 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.1 mt -84.51 -3.8 58.6 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 109.339 -0.615 . . . . 2.95 109.339 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.3 p -90.11 -29.88 18.03 Favored 'General case' 0 N--CA 1.429 -1.505 1 O-C-N 116.191 -4.068 . . . . 2.52 111.333 -175.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.2 54.07 0.17 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 124.725 2.292 . . . . 1.5 115.317 175.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.488 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 76.6 tttt -153.68 138.43 17.03 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 115.028 -2.415 . . . . 1.79 107.461 -173.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.3 m -136.58 131.05 33.26 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 127.806 3.191 . . . . 1.38 103.616 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 pt -127.01 153.76 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 123.789 1.757 . . . . 2.03 108.506 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.6 m -109.62 109.19 19.87 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 112.871 -1.968 . . . . 1.61 111.743 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.251 41.3 mt -89.09 153.31 21.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.87 2.748 . . . . 2.15 106.278 175.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -126.59 113.46 16.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.888 -2.382 . . . . 1.98 107.342 174.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 m -130.09 -164.31 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 127.576 2.35 . . . . 1.52 108.14 -173.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -129.12 171.0 9.48 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 126.159 2.162 . . . . 2.35 107.588 163.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -70.61 -17.48 33.7 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 CA-C-O 123.254 1.272 . . . . 1.31 110.882 -173.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.15 2.57 53.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.145 1.165 . . . . 1.71 114.145 176.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.37 141.11 43.35 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.667 -2.52 . . . . 1.69 109.94 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 21.9 p -75.14 163.99 26.96 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.773 2.829 . . . . 1.33 109.605 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 51' ' ' GLU . 39.1 mm -67.39 -33.73 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 124.092 1.901 . . . . 1.32 110.245 175.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -51.73 -45.94 63.82 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.981 -2.324 . . . . 1.62 116.822 163.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -67.07 -29.05 68.71 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 118.312 2.708 . . . . 2.13 118.312 173.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.0 t -74.31 -44.9 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 127.419 2.287 . . . . 1.23 108.892 176.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -62.86 -38.88 92.6 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 126.989 2.116 . . . . 1.97 112.864 174.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.83 -32.75 72.67 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.557 1.543 . . . . 1.19 113.313 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -61.37 -55.14 34.92 Favored 'General case' 0 N--CA 1.428 -1.532 0 O-C-N 118.201 -2.812 . . . . 1.92 111.989 165.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -53.7 -39.98 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 117.802 -3.061 . . . . 1.94 114.642 173.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -58.94 -38.99 80.29 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.868 1.318 . . . . 1.9 114.237 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -69.89 -55.03 10.79 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.151 -0.968 . . . . 1.55 110.67 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -65.89 -75.67 0.09 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.709 -3.12 . . . . 2.95 106.718 -175.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.488 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 71.5 mm-40 -78.5 -25.7 45.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.306 2.242 . . . . 1.48 113.356 -163.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.99 12.11 55.69 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 116.332 -2.371 . . . . 1.12 110.303 168.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.7 mt -88.84 126.33 59.8 Favored Pre-proline 0 N--CA 1.43 -1.454 0 CA-C-N 122.738 3.269 . . . . 2.07 108.453 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -68.21 160.31 49.44 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 124.082 3.188 . . . . 1.39 109.894 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.61 -7.64 13.61 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 115.105 -2.796 . . . . 1.68 116.277 -171.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -82.77 -22.25 34.37 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.767 -1.833 . . . . 2.25 108.267 175.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -80.6 -21.36 41.67 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.726 -2.484 . . . . 2.44 113.432 -175.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -113.65 137.44 51.6 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 118.131 0.423 . . . . 1.32 109.958 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -120.04 133.44 55.53 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.251 -1.531 . . . . 3.19 108.446 171.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.1 mt -105.31 121.35 43.69 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.393 2.997 . . . . 1.75 108.175 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.4 mm -111.3 131.0 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 116.555 -3.841 . . . . 1.98 107.194 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -124.26 118.57 27.09 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 105.114 -2.18 . . . . 1.94 105.114 170.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.304 . . 64.76 -89.23 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 130.154 3.382 . . . . 1.67 111.218 -171.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.76 -21.15 3.98 Favored Glycine 0 N--CA 1.429 -1.794 0 C-N-CA 127.025 2.25 . . . . 1.3 117.903 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.253 29.5 mttm -104.93 132.53 51.06 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 127.313 2.245 . . . . 2.89 114.777 -172.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -75.94 145.1 40.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.878 -1.056 . . . . 2.89 111.92 170.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 mt -98.06 143.5 28.55 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 125.478 1.736 . . . . 1.34 112.989 -172.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.414 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 40.3 tp10 -95.95 135.84 37.17 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.883 -2.386 . . . . 1.94 116.068 -176.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -47.24 -66.4 0.41 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 120.163 3.394 . . . . 1.56 120.163 -173.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.15 52.67 2.59 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 118.724 2.25 . . . . 0.97 118.724 169.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 22' ' ' THR . 40.0 mmt180 -134.95 157.86 45.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 116.408 -1.758 . . . . 3.07 107.964 172.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.287 6.5 p -88.65 172.92 8.92 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.486 1.612 . . . . 1.34 114.9 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.5 mt -72.46 -38.38 68.26 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 116.222 -4.049 . . . . 1.63 111.919 168.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.1 t -57.49 -38.96 75.42 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 129.486 3.114 . . . . 1.51 112.951 173.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -59.64 -32.85 70.83 Favored 'General case' 0 N--CA 1.43 -1.471 1 O-C-N 115.439 -4.538 . . . . 1.9 112.348 174.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -96.19 9.1 42.06 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 126.134 2.873 . . . . 0.97 112.412 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.6 m120 49.21 47.14 22.45 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 129.729 3.212 . . . . 2.35 109.327 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.1 mt -91.6 114.65 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 124.083 1.897 . . . . 1.39 109.722 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -97.05 -172.31 2.42 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.696 -1.594 . . . . 2.58 106.696 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -65.97 143.8 57.16 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.571 2.129 . . . . 2.58 113.77 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.279 70.5 mt-10 71.09 18.62 5.8 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 116.905 -3.622 . . . . 1.71 114.774 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.3 m -79.33 139.76 37.7 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.161 2.185 . . . . 1.34 115.513 -175.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.6 m -90.74 101.39 14.14 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 124.329 2.014 . . . . 1.36 115.416 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.6 143.96 34.27 Favored 'General case' 0 N--CA 1.429 -1.505 1 O-C-N 114.468 -5.145 . . . . 2.03 108.153 165.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -108.2 115.69 30.59 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.088 -3.508 . . . . 2.31 111.457 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tt -91.6 119.87 31.88 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 126.303 2.252 . . . . 1.72 111.429 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.88 147.39 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 126.403 3.001 . . . . 1.8 103.122 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.7 mt . . . . . 0 N--CA 1.429 -1.488 1 O-C-N 115.811 -4.306 . . . . 3.26 112.782 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 121.675 0.75 . . . . 1.39 112.74 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -107.79 135.69 48.78 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.331 -3.355 . . . . 2.2 111.42 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.1 pt -130.69 171.59 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 O-C-N 120.5 -1.375 . . . . 1.32 110.051 173.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -120.4 148.39 43.84 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 124.765 1.226 . . . . 2.2 113.749 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.413 HG21 ' HB2' ' A' ' 67' ' ' LEU . 68.6 t -133.91 124.36 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 N-CA-C 104.775 -2.306 . . . . 1.23 104.775 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 tptt -92.27 135.83 33.69 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 109.659 -3.428 . . . . 2.51 114.954 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.289 38.0 p -83.24 -171.52 3.62 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.315 3.436 . . . . 1.41 110.58 -174.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.22 -49.65 73.35 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 125.325 2.488 . . . . 2.95 113.333 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.7 p -88.25 -43.4 11.61 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.591 -1.64 . . . . 2.52 113.522 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.04 -3.94 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.762 0 O-C-N 116.981 -3.574 . . . . 1.5 121.158 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.433 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 27.8 ttpt -71.59 133.8 45.98 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 120.535 2.167 . . . . 1.79 114.016 -173.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.4 m -90.88 110.61 21.84 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 117.969 -1.493 . . . . 1.38 109.151 176.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 mt -93.41 135.54 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 125.234 1.414 . . . . 2.03 107.324 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.3 m -102.51 127.51 49.54 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.259 1.424 . . . . 1.61 111.295 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.5 mt -124.57 156.39 37.46 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 107.293 -1.373 . . . . 2.15 107.293 -177.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -104.57 123.11 46.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.149 2.18 . . . . 1.98 114.296 167.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.1 m -141.15 161.46 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 124.614 3.37 . . . . 1.52 103.227 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -111.86 157.28 39.99 Favored Pre-proline 0 N--CA 1.43 -1.466 0 N-CA-C 103.725 -2.694 . . . . 2.35 103.725 166.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.13 -9.83 19.29 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 C-N-CA 124.009 3.139 . . . . 1.31 111.686 -171.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.0 p -83.68 -9.93 58.52 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 114.807 -2.52 . . . . 1.71 112.426 171.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -67.44 145.62 54.82 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 124.353 3.251 . . . . 1.69 111.403 174.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.1 p -88.12 158.82 18.45 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 113.231 -5.918 . . . . 1.33 110.844 178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.4 mm -59.83 -32.33 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 119.786 3.254 . . . . 1.32 119.786 174.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -50.74 -47.56 59.36 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.264 1.95 . . . . 1.62 116.264 159.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -60.65 -38.22 84.13 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 125.51 1.524 . . . . 2.13 112.148 174.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.63 -43.61 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 124.798 1.239 . . . . 1.23 108.984 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HZ3' ' CG ' ' A' ' 52' ' ' ASP . 93.2 mttt -62.04 -33.03 73.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 118.434 2.753 . . . . 1.97 118.434 169.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.82 -33.65 76.35 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.349 1.46 . . . . 1.19 114.615 173.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -74.17 -18.13 60.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.287 3.035 . . . . 1.92 111.593 171.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.0 mt -82.46 -32.05 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 116.932 -3.605 . . . . 1.94 105.854 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -67.73 -33.97 75.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.458 -3.276 . . . . 1.9 113.245 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -56.77 -45.16 82.28 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.199 -1.563 . . . . 1.55 112.86 166.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -74.92 -67.82 0.61 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.945 -1.097 . . . . 2.95 112.721 -176.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.433 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 40.4 mm-40 -84.75 -45.76 12.07 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.679 2.791 . . . . 1.48 111.619 -167.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.97 -7.2 17.14 Favored Glycine 0 N--CA 1.429 -1.824 0 CA-C-O 123.228 1.46 . . . . 1.12 111.988 175.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.419 HD11 HD21 ' A' ' 71' ' ' LEU . 72.1 mt -71.99 122.81 88.31 Favored Pre-proline 0 N--CA 1.431 -1.418 0 C-N-CA 126.947 2.099 . . . . 2.07 110.597 -172.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.9 145.38 68.1 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 125.092 3.861 . . . . 1.39 112.06 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -63.32 -27.72 71.76 Favored 'Trans proline' 0 C--N 1.3 -2.006 1 C-N-CA 125.567 4.178 . . . . 1.68 111.425 -174.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -53.07 -50.81 63.62 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 122.612 2.46 . . . . 2.25 111.64 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -68.86 -26.92 65.38 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.541 2.336 . . . . 2.44 114.108 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -71.83 153.45 41.92 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.046 -2.909 . . . . 1.32 116.343 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -141.46 120.8 13.11 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.083 2.153 . . . . 3.19 106.421 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.1 mt -105.61 137.36 43.58 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 121.139 1.79 . . . . 1.75 111.542 174.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 mp -123.37 136.58 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 127.904 3.252 . . . . 1.98 110.784 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -156.31 131.28 9.13 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 115.743 -4.348 . . . . 1.94 112.747 174.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.447 . . 67.99 35.56 3.7 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.765 2.826 . . . . 1.67 116.563 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.04 -28.68 4.04 Favored Glycine 0 N--CA 1.431 -1.684 0 CA-C-O 124.745 2.303 . . . . 1.3 112.205 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -90.04 165.34 14.08 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.707 -3.819 . . . . 2.89 111.944 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -108.79 137.63 46.41 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 103.523 -2.769 . . . . 2.89 103.523 172.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.3 mt -78.9 153.27 30.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.15 -2.844 . . . . 1.34 112.605 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.318 10.0 tp10 -98.77 141.91 30.97 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.337 -1.477 . . . . 1.94 109.968 171.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.444 ' CG ' ' HZ3' ' A' ' 27' ' ' LYS . 2.4 m-20 -63.59 -57.35 10.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.256 2.455 . . . . 1.56 117.485 -166.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.81 39.68 2.85 Favored Glycine 0 N--CA 1.43 -1.762 1 O-C-N 114.254 -5.279 . . . . 0.97 118.949 165.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -113.63 160.83 18.16 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.001 1.72 . . . . 3.07 107.751 166.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.4 p -106.36 161.62 14.4 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.479 1.609 . . . . 1.34 113.694 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.45 -37.67 86.79 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.16 2.184 . . . . 1.63 113.881 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 t -63.82 -39.25 93.78 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 113.341 -3.219 . . . . 1.51 113.654 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.257 9.7 t70 -49.18 -71.03 0.07 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 127.89 3.244 . . . . 1.9 109.985 173.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -50.84 -27.33 7.14 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 130.051 3.34 . . . . 0.97 119.541 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m120 79.3 47.06 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 129.855 3.262 . . . . 2.35 114.487 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.2 mt -99.86 126.65 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 124.724 2.202 . . . . 1.39 108.372 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -102.09 -173.56 2.37 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 116.254 -4.028 . . . . 2.58 111.746 -173.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -68.43 149.62 49.1 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.964 2.316 . . . . 2.58 116.942 169.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 59.98 26.68 15.99 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.459 3.103 . . . . 1.71 113.262 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -88.74 131.87 34.85 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 128.814 2.845 . . . . 1.34 106.43 -174.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.7 m -99.8 111.86 24.15 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 105.446 -2.057 . . . . 1.36 105.446 -174.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.413 ' HB2' HG21 ' A' ' 5' ' ' VAL . 7.6 mp -83.09 159.93 22.01 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 106.307 -1.738 . . . . 2.03 106.307 168.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -110.86 132.4 54.23 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 117.498 -1.239 . . . . 2.31 110.049 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -98.6 132.52 43.94 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 103.225 -2.879 . . . . 1.72 103.225 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.2 t -126.12 156.81 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 129.952 3.301 . . . . 1.8 103.839 174.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.419 HD21 HD11 ' A' ' 36' ' ' ILE . 88.2 mt . . . . . 0 N--CA 1.43 -1.446 0 CA-C-O 125.525 2.583 . . . . 3.26 107.258 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.417 ' SD ' ' HG3' ' A' ' 19' ' ' PRO . 5.6 ttt . . . . . 0 CA--C 1.491 -1.32 0 CA-C-O 121.045 0.45 . . . . 1.39 111.65 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -87.15 134.75 33.49 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.701 -2.499 . . . . 2.2 109.493 -172.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 pt -131.8 169.62 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 121.545 1.975 . . . . 1.32 108.017 174.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -121.56 157.58 30.42 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.88 -1.763 . . . . 2.2 107.558 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.7 t -123.17 132.74 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 125.657 1.848 . . . . 1.23 109.328 163.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.401 ' HB2' ' CG2' ' A' ' 66' ' ' THR . 26.3 tptt -98.98 134.79 41.31 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.359 -2.713 . . . . 2.51 107.856 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.6 p -85.95 -166.29 1.49 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.793 1.758 . . . . 1.41 114.962 176.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.9 mt -74.22 -47.5 34.91 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.704 -1.135 . . . . 2.95 112.171 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 p -77.61 -29.88 52.08 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 114.87 1.433 . . . . 2.52 114.87 -174.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.31 11.39 0.66 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 125.371 1.462 . . . . 1.5 115.3 172.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -81.42 140.82 34.44 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.806 -1.997 . . . . 1.79 107.626 -172.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.9 m -97.96 107.94 20.53 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.98 -1.464 . . . . 1.38 109.805 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -82.7 122.36 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 119.969 1.259 . . . . 2.03 108.563 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.2 m -95.0 114.22 26.0 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.925 -1.109 . . . . 1.61 113.786 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mp -116.33 160.45 20.49 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.358 1.614 . . . . 2.15 115.358 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.261 7.0 pt-20 -128.74 124.9 36.74 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 117.013 -1.875 . . . . 1.98 112.418 177.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 m -129.2 -167.42 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 113.765 -1.562 . . . . 1.52 110.454 -176.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -136.76 173.89 5.05 Favored Pre-proline 0 N--CA 1.431 -1.399 0 O-C-N 117.386 -3.321 . . . . 2.35 103.446 162.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.417 ' HG3' ' SD ' ' A' ' 1' ' ' MET . 92.5 Cg_exo -80.57 -8.36 13.64 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 CA-C-N 123.393 2.248 . . . . 1.31 117.751 -170.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.274 21.0 m -87.9 -19.85 26.77 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 126.812 2.57 . . . . 1.71 114.567 174.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -62.02 152.48 32.35 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.972 -2.955 . . . . 1.69 113.314 174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 31.9 p -90.11 168.99 11.54 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.662 -2.523 . . . . 1.33 117.507 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.5 mm -64.92 -36.3 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 120.307 -1.496 . . . . 1.32 109.979 171.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -57.41 -30.5 65.01 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.498 2.719 . . . . 1.62 113.495 168.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -73.66 -32.71 64.14 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 114.338 -5.226 . . . . 2.13 111.235 176.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.6 t -63.11 -49.68 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.026 2.13 . . . . 1.23 111.688 174.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HD3' ' HB3' ' A' ' 38' ' ' PRO . 55.9 mttt -58.56 -39.58 80.67 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 127.855 3.222 . . . . 1.97 114.083 176.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.71 -33.47 75.71 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 118.52 2.785 . . . . 1.19 118.52 173.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -75.0 -35.57 62.01 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 125.077 1.485 . . . . 1.92 111.464 170.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.68 -39.54 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 1 O-C-N 115.69 -4.381 . . . . 1.94 112.449 166.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -63.84 -41.47 97.81 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.614 -3.804 . . . . 1.9 113.833 172.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -55.37 -69.25 0.14 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 115.821 1.785 . . . . 1.55 115.821 170.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -68.44 -59.81 2.89 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.611 -3.806 . . . . 2.95 113.875 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -83.53 -43.24 15.95 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.208 -2.807 . . . . 1.48 111.196 -163.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.7 30.28 3.56 Favored Glycine 0 N--CA 1.43 -1.76 0 CA-C-O 124.386 2.103 . . . . 1.12 111.894 169.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 88.1 mt -105.95 134.77 19.59 Favored Pre-proline 0 N--CA 1.431 -1.41 0 O-C-N 117.661 -3.259 . . . . 2.07 104.876 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -72.98 158.66 49.38 Favored 'Trans proline' 0 C--N 1.3 -2.003 1 CA-C-N 129.411 4.397 . . . . 1.39 113.699 174.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 70.4 Cg_exo -73.44 -19.7 21.65 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 CA-C-O 114.455 -2.394 . . . . 1.68 117.939 -175.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -72.19 -12.08 61.02 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 127.334 2.896 . . . . 2.25 111.39 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -100.27 -15.83 17.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 116.239 -1.839 . . . . 2.44 112.226 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -88.37 139.49 30.43 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 130.031 3.333 . . . . 1.32 111.296 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -123.23 120.73 34.02 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 128.854 2.862 . . . . 3.19 107.583 165.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.5 mt -103.01 130.67 50.19 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 124.877 2.275 . . . . 1.75 108.92 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.7 mm -117.12 139.77 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 125.068 2.366 . . . . 1.98 107.287 -172.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -146.62 148.81 32.47 Favored 'General case' 0 N--CA 1.429 -1.497 1 O-C-N 113.693 -5.629 . . . . 1.94 108.157 168.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.66 30.3 8.54 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.217 1.932 . . . . 1.67 116.217 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.67 -29.8 5.64 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 124.887 1.232 . . . . 1.3 115.039 -173.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -82.1 142.96 31.82 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 128.706 2.802 . . . . 2.89 114.787 -174.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -90.56 132.46 35.7 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.006 1.73 . . . . 2.89 108.382 168.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mt -86.74 146.89 26.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.892 1.677 . . . . 1.34 111.845 -172.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -92.42 154.7 18.35 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 123.324 1.535 . . . . 1.94 111.043 171.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.64 -66.37 0.6 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 112.987 -1.915 . . . . 1.56 113.619 -163.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.31 64.48 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.723 0 O-C-N 118.763 -2.46 . . . . 0.97 113.916 162.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -140.94 151.04 43.89 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.228 -1.767 . . . . 3.07 106.228 168.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.25 18.5 p -85.14 169.83 13.49 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 121.747 2.067 . . . . 1.34 111.146 -178.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mt -69.83 -43.98 70.86 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 123.959 1.837 . . . . 1.63 113.859 173.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.1 t -57.89 -38.63 76.14 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.615 2.366 . . . . 1.51 114.271 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -57.36 -43.85 83.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.907 -1.746 . . . . 1.9 114.115 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -85.58 3.41 40.78 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.991 2.329 . . . . 0.97 114.033 172.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.4 m120 59.75 37.85 21.9 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.801 -3.062 . . . . 2.35 113.798 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.0 mt -74.15 116.4 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 125.527 1.531 . . . . 1.39 108.496 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -89.3 -174.62 4.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 117.364 2.357 . . . . 2.58 117.364 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -60.17 133.07 55.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.285 -2.134 . . . . 2.58 115.677 169.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.41 50.1 mt-10 64.33 41.96 5.56 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.684 -1.26 . . . . 1.71 112.678 174.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.257 62.6 m -106.55 163.81 12.58 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 103.25 -2.87 . . . . 1.34 103.25 -175.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 6' ' ' LYS . 89.5 m -128.79 124.31 35.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.608 3.099 . . . . 1.36 109.39 -176.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.3 mt -91.49 162.46 14.54 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 110.385 -3.098 . . . . 2.03 108.926 172.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -127.57 119.88 26.97 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 117.351 -1.74 . . . . 2.31 109.596 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.1 tp -75.78 125.44 29.07 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.957 1.836 . . . . 1.72 115.957 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 t -123.59 148.36 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 103.277 -2.86 . . . . 1.8 103.277 171.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.7 mt . . . . . 0 N--CA 1.431 -1.422 0 CA-C-O 124.397 2.046 . . . . 3.26 110.603 -178.822 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 CA--C 1.491 -1.313 0 CA-C-O 124.834 2.254 . . . . 1.39 114.101 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -74.11 132.37 42.21 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 128.85 2.86 . . . . 2.2 107.971 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.0 pt -136.86 152.32 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 125.983 1.713 . . . . 1.32 109.452 171.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -117.26 148.23 41.85 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.269 -2.144 . . . . 2.2 115.809 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -125.11 107.46 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 104.673 -2.343 . . . . 1.23 104.673 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 tttp -91.3 132.52 36.1 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.59 -1.944 . . . . 2.51 110.681 176.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.3 p -87.49 176.21 7.59 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.609 2.448 . . . . 1.41 117.609 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.2 mt -60.99 -29.63 69.8 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.143 -3.473 . . . . 2.95 119.946 166.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 p -83.79 -87.4 0.11 Allowed 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 113.702 -1.59 . . . . 2.52 107.279 -175.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.74 48.74 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.732 0 O-C-N 118.911 -2.368 . . . . 1.5 107.956 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -128.24 135.32 49.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.512 2.325 . . . . 1.79 107.478 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.6 m -118.32 119.68 35.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.937 2.304 . . . . 1.38 105.857 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.1 mt -91.99 113.97 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 O-C-N 117.513 -3.242 . . . . 2.03 103.354 -172.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.3 m -86.5 113.33 22.34 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.022 -3.549 . . . . 1.61 109.157 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.6 mt -111.56 171.19 7.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 114.946 1.461 . . . . 2.15 114.946 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -125.48 121.87 34.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.101 -3.5 . . . . 1.98 115.609 168.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -130.23 175.67 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 118.987 -2.32 . . . . 1.52 106.942 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.451 ' HG3' ' H ' ' A' ' 20' ' ' SER . 11.6 pt-20 -104.21 157.36 34.2 Favored Pre-proline 0 N--CA 1.431 -1.419 0 O-C-N 118.72 -2.487 . . . . 2.35 116.061 160.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -64.33 -9.1 18.7 Favored 'Trans proline' 0 N--CA 1.434 -2.012 2 CA-C-N 129.141 4.3 . . . . 1.31 114.443 -175.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.451 ' H ' ' HG3' ' A' ' 18' ' ' GLU 0.257 15.0 m -94.42 11.51 30.39 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 123.578 2.899 . . . . 1.71 117.481 171.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.98 138.54 36.07 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.97 -2.331 . . . . 1.69 115.221 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 p -76.07 159.4 30.81 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 114.325 1.231 . . . . 1.33 114.325 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.2 mm -68.13 -36.75 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 127.456 2.302 . . . . 1.32 107.762 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -59.36 -33.45 71.18 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.668 1.729 . . . . 1.62 115.668 165.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -69.6 -39.09 77.48 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.076 -3.515 . . . . 2.13 118.94 171.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.38 -39.8 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 126.346 2.974 . . . . 1.23 113.329 167.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -63.3 -37.59 87.86 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 116.251 -4.031 . . . . 1.97 112.459 -176.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.49 -19.04 63.74 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 128.284 2.634 . . . . 1.19 112.63 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -84.79 -30.91 24.22 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 117.66 -3.15 . . . . 1.92 110.365 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.4 mt -73.65 -35.84 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 123.831 1.777 . . . . 1.94 109.479 172.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -56.4 -50.76 70.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.547 -3.846 . . . . 1.9 111.397 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -53.89 -42.63 68.87 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 128.98 2.912 . . . . 1.55 112.144 174.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -83.2 -60.04 2.27 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.921 -2.987 . . . . 2.95 111.854 -174.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -97.66 -16.81 19.81 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 122.349 2.34 . . . . 1.48 112.243 -169.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.78 30.19 24.42 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 108.087 -2.005 . . . . 1.12 108.087 171.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.6 mt -102.23 133.7 20.46 Favored Pre-proline 0 N--CA 1.431 -1.401 0 N-CA-C 104.838 -2.282 . . . . 2.07 104.838 -174.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -76.07 161.87 35.09 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 O-C-N 115.105 -3.156 . . . . 1.39 114.21 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -70.76 -25.2 24.23 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 C-N-CA 122.867 2.378 . . . . 1.68 114.559 -170.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -74.03 -26.45 60.42 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.439 1.59 . . . . 2.25 112.247 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -84.31 -12.03 55.34 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.371 -1.456 . . . . 2.44 113.684 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -91.01 122.22 33.48 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 122.178 0.989 . . . . 1.32 110.849 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -101.06 102.64 13.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.603 1.192 . . . . 3.19 112.152 166.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.0 mt -84.73 125.43 32.54 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 115.925 1.824 . . . . 1.75 115.925 171.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.61 125.48 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 127.979 2.512 . . . . 1.98 108.461 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -132.52 126.9 33.97 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.96 -1.088 . . . . 1.94 110.572 173.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.21 -40.19 0.24 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.264 2.626 . . . . 1.67 116.56 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.44 -7.46 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.668 0 C-N-CA 128.812 3.101 . . . . 1.3 111.286 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -94.34 132.37 39.01 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 126.42 1.888 . . . . 2.89 110.82 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -87.75 148.24 24.82 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 107.347 -1.353 . . . . 2.89 107.347 172.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.35 6.9 mt -107.26 120.65 42.71 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.916 2.886 . . . . 1.34 110.41 -159.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -88.32 136.95 32.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 129.027 3.954 . . . . 1.94 111.912 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -57.47 -59.94 4.4 Favored 'General case' 0 N--CA 1.431 -1.422 2 C-N-CA 134.983 5.313 . . . . 1.56 116.131 -168.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.11 29.11 2.81 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 119.687 -1.883 . . . . 0.97 115.998 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -105.47 156.12 18.51 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.283 -2.304 . . . . 3.07 108.489 165.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.3 p -93.05 170.35 9.72 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 119.918 -1.738 . . . . 1.34 109.267 172.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.0 mt -56.94 -41.49 78.34 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.711 2.805 . . . . 1.63 115.337 167.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.9 t -64.6 -32.15 73.68 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 128.504 2.722 . . . . 1.51 115.289 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -81.88 -21.02 37.69 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.378 2.671 . . . . 1.9 112.27 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -98.01 -11.96 22.44 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.595 -1.261 . . . . 0.97 107.595 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 67.63 42.92 1.95 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 128.122 3.82 . . . . 2.35 111.242 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.9 mt -89.75 114.05 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 126.836 3.208 . . . . 1.39 113.627 172.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -101.84 -165.93 1.24 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.524 -1.985 . . . . 2.58 105.777 -172.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.473 ' HG3' ' HG2' ' A' ' 64' ' ' GLU . 16.0 pttp -73.47 166.06 23.92 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 118.742 2.867 . . . . 2.58 118.742 178.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.473 ' HG2' ' HG3' ' A' ' 63' ' ' LYS 0.554 13.5 pt-20 63.53 18.07 10.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.758 -2.464 . . . . 1.71 115.976 176.295 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.7 p -90.82 151.14 21.29 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.735 -1.575 . . . . 1.34 109.36 -175.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.0 m -118.74 92.84 3.91 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.465 1.602 . . . . 1.36 112.249 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.0 mt -75.0 136.79 41.25 Favored 'General case' 0 N--CA 1.43 -1.475 1 C-N-CA 132.851 4.46 . . . . 2.03 109.473 174.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -107.04 132.06 53.38 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.469 -2.019 . . . . 2.31 111.562 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.4 tp -113.15 112.54 23.97 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 128.273 3.892 . . . . 1.72 106.831 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.3 t -107.66 146.15 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 129.256 3.022 . . . . 1.8 105.357 174.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tm? . . . . . 0 N--CA 1.43 -1.435 0 N-CA-C 106.12 -1.807 . . . . 3.26 106.12 177.483 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 CA--C 1.49 -1.329 0 N-CA-C 114.211 1.189 . . . . 1.39 114.211 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.385 2.4 mp0 -94.27 130.89 40.37 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 116.518 -1.706 . . . . 2.2 113.96 -174.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.2 pt -123.35 159.61 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 119.266 0.939 . . . . 1.32 110.828 172.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -111.75 135.73 51.96 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.527 -2.608 . . . . 2.2 112.688 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.01 125.11 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 119.509 -1.994 . . . . 1.23 106.308 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -102.9 148.55 25.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.105 2.128 . . . . 2.51 112.916 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.261 6.4 p -98.55 159.05 15.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 125.377 1.673 . . . . 1.41 114.546 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.1 mt -49.82 -38.63 35.56 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.543 -2.598 . . . . 2.95 117.619 171.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.0 p -83.63 -12.33 56.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.481 2.562 . . . . 2.52 112.313 -171.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.42 7.09 26.7 Favored Glycine 0 N--CA 1.43 -1.754 0 CA-C-N 112.426 -2.17 . . . . 1.5 116.722 174.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.419 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 73.8 tttt -80.46 144.18 32.79 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 123.205 3.502 . . . . 1.79 109.053 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.9 m -125.94 94.44 4.11 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 106.982 -1.488 . . . . 1.38 106.982 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.4 4.4 pt -76.53 142.41 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 128.374 2.67 . . . . 2.03 112.427 174.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -108.32 129.7 55.22 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.545 -2.391 . . . . 1.61 104.545 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.8 mt -117.0 165.11 13.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 126.425 2.328 . . . . 2.15 107.307 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.296 66.1 tt0 -116.1 121.54 42.46 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.519 -2.613 . . . . 1.98 106.352 178.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.423 HG13 ' HE3' ' A' ' 29' ' ' LYS . 21.8 m -132.34 168.83 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 116.516 -1.707 . . . . 1.52 115.396 176.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -116.54 160.04 37.84 Favored Pre-proline 0 N--CA 1.43 -1.448 0 O-C-N 127.56 3.037 . . . . 2.35 107.21 167.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -65.42 -25.78 55.82 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 123.714 2.943 . . . . 1.31 112.62 -177.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 m -81.75 3.93 23.87 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 117.361 2.356 . . . . 1.71 117.361 172.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.58 137.56 40.87 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.543 -1.973 . . . . 1.69 109.673 173.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 p -73.92 157.3 36.52 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.96 -2.962 . . . . 1.33 112.523 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.7 mm -56.45 -32.66 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 123.984 1.849 . . . . 1.32 114.493 170.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -59.28 -44.1 92.48 Favored 'General case' 0 N--CA 1.43 -1.469 1 O-C-N 115.718 -4.364 . . . . 1.62 110.399 165.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -66.66 -32.09 73.18 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 116.978 -3.576 . . . . 2.13 110.344 175.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.4 t -66.09 -51.25 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 121.125 1.784 . . . . 1.23 107.811 175.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -59.4 -33.26 71.0 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.118 -3.489 . . . . 1.97 112.076 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.33 -19.31 65.9 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 116.648 2.092 . . . . 1.19 116.648 171.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HE3' HG13 ' A' ' 17' ' ' VAL . 39.8 mttm -85.2 -18.81 32.95 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 123.488 2.858 . . . . 1.92 107.155 176.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.9 mt -87.46 -24.43 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 108.129 -1.063 . . . . 1.94 108.129 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -65.66 -44.05 87.47 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.464 2.764 . . . . 1.9 118.464 166.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -60.13 -62.2 2.04 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 113.701 -1.59 . . . . 1.55 110.37 168.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -69.58 -63.99 0.97 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.62 2.082 . . . . 2.95 116.62 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.419 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 56.4 mm-40 -87.41 -33.38 19.11 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.613 2.149 . . . . 1.48 114.944 -170.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.68 34.18 2.11 Favored Glycine 0 N--CA 1.43 -1.743 0 O-C-N 118.767 -2.458 . . . . 1.12 113.744 169.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.2 mt -108.8 123.11 38.05 Favored Pre-proline 0 N--CA 1.431 -1.424 0 O-C-N 119.884 -1.95 . . . . 2.07 105.786 -170.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -68.63 145.42 63.74 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 114.746 -3.344 . . . . 1.39 112.711 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.254 18.0 Cg_exo -66.18 -28.1 48.42 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 124.474 3.449 . . . . 1.68 117.295 -171.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.254 8.8 p-10 -56.94 -31.99 65.53 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.307 -3.995 . . . . 2.25 116.091 168.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -78.13 -25.38 47.36 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.725 2.01 . . . . 2.44 113.182 -176.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -90.91 147.9 22.82 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.767 1.627 . . . . 1.32 112.614 -173.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.272 91.8 mtt180 -122.71 146.75 47.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.982 -1.699 . . . . 3.19 108.131 162.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.0 mt -121.7 114.74 21.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.965 -1.71 . . . . 1.75 111.002 172.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.9 mt -104.22 116.2 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 117.771 -1.109 . . . . 1.98 111.312 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -112.9 131.79 55.58 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.009 -1.849 . . . . 1.94 106.009 170.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 82.48 -43.29 0.13 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.064 1.346 . . . . 1.67 111.189 172.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.28 -5.63 0.18 Allowed Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 114.423 -3.431 . . . . 1.3 107.05 -173.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -123.82 143.71 50.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 121.762 2.781 . . . . 2.89 113.258 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -69.17 138.85 54.46 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.026 -2.921 . . . . 2.89 115.407 173.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.7 mt -98.87 122.39 42.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.32 2.009 . . . . 1.34 105.848 -175.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -71.6 120.63 17.46 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 123.852 1.786 . . . . 1.94 115.111 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -44.78 -53.78 7.04 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.999 2.519 . . . . 1.56 114.536 -171.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.05 39.67 1.85 Allowed Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 118.471 2.149 . . . . 0.97 118.471 173.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -124.94 167.95 13.97 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 116.664 -3.844 . . . . 3.07 106.601 168.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.6 p -97.03 175.64 6.25 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.916 1.821 . . . . 1.34 115.916 169.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.5 mt -73.16 -22.65 60.46 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 127.037 3.303 . . . . 1.63 110.161 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -78.21 -41.33 34.8 Favored 'General case' 0 N--CA 1.43 -1.453 2 C-N-CA 133.464 4.706 . . . . 1.51 116.346 175.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -63.16 -32.68 74.12 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.801 1.762 . . . . 1.9 111.516 168.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -92.93 -0.45 57.22 Favored 'General case' 0 N--CA 1.431 -1.398 1 O-C-N 116.063 -4.148 . . . . 0.97 112.884 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 48.43 53.87 11.33 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.49 2.033 . . . . 2.35 116.49 -174.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.5 mt -97.06 129.42 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 129.155 2.982 . . . . 1.39 108.377 175.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -103.29 -167.97 1.45 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 115.536 1.68 . . . . 2.58 115.536 -172.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -55.63 139.53 44.21 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.022 1.119 . . . . 2.58 114.022 160.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.279 93.0 mt-10 60.0 52.22 5.35 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 120.097 3.369 . . . . 1.71 120.097 173.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.1 p -103.53 135.28 45.42 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.531 3.532 . . . . 1.34 109.399 -175.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 m -96.54 107.42 19.84 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 104.816 -2.29 . . . . 1.36 104.816 -176.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.0 mt -93.99 145.94 24.29 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 126.623 3.106 . . . . 2.03 104.122 170.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -111.15 118.93 37.33 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 112.996 -1.911 . . . . 2.31 107.766 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.0 tp -86.09 118.43 25.56 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.252 1.501 . . . . 1.72 109.003 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.13 129.74 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 124.862 2.267 . . . . 1.8 107.781 172.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.3 mt . . . . . 0 N--CA 1.43 -1.449 1 O-C-N 113.831 -5.543 . . . . 3.26 109.105 -178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.342 0 N-CA-C 117.298 2.333 . . . . 1.39 117.298 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -93.19 115.39 28.01 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 119.991 3.33 . . . . 2.2 119.991 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.9 pt -113.17 163.09 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-N 122.904 2.593 . . . . 1.32 109.842 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.298 79.6 m-85 -121.01 134.22 55.29 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.07 -1.456 . . . . 2.2 107.07 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.2 t -119.16 130.24 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 119.578 -1.951 . . . . 1.23 110.021 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -95.26 119.8 34.4 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.646 3.178 . . . . 2.51 106.511 -173.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -86.84 -173.71 4.6 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 115.914 -1.993 . . . . 1.41 108.204 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.7 mt -87.01 -29.27 22.1 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.423 2.689 . . . . 2.95 108.901 173.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -77.52 -7.71 56.69 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.618 2.451 . . . . 2.52 117.618 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.28 5.56 37.25 Favored Glycine 0 N--CA 1.43 -1.745 0 CA-C-O 124.183 1.991 . . . . 1.5 112.578 174.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.598 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 38.4 ttpt -96.22 144.63 26.25 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.968 -2.489 . . . . 1.79 110.605 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -106.22 115.54 30.4 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 106.025 -1.843 . . . . 1.38 106.025 173.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -91.6 126.45 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 125.753 2.692 . . . . 2.03 107.606 173.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.5 m -96.94 113.59 25.14 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 116.536 -3.853 . . . . 1.61 111.051 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.0 mt -120.29 154.42 34.99 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 114.208 1.188 . . . . 2.15 114.208 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.477 ' O ' ' HE3' ' A' ' 29' ' ' LYS . 29.7 mt-10 -109.72 145.22 36.95 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.646 -0.872 . . . . 1.98 108.646 172.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -152.22 156.31 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 126.17 1.788 . . . . 1.52 108.874 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -95.51 154.13 39.35 Favored Pre-proline 0 N--CA 1.43 -1.465 0 CA-C-O 114.364 -2.732 . . . . 2.35 108.561 171.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.426 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 57.5 Cg_endo -74.31 -11.87 22.93 Favored 'Trans proline' 0 N--CA 1.433 -2.03 0 CA-C-N 126.902 3.501 . . . . 1.31 112.218 -172.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -78.96 4.78 13.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.946 2.499 . . . . 1.71 112.596 173.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -93.56 151.76 19.48 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 126.957 2.103 . . . . 1.69 115.584 173.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.5 p -82.55 161.07 22.43 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.24 -2.788 . . . . 1.33 115.933 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mm -60.8 -34.82 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.079 -2.888 . . . . 1.32 115.387 170.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -48.27 -36.29 13.78 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 120.402 3.482 . . . . 1.62 120.402 158.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -62.0 -33.37 74.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.715 -2.491 . . . . 2.13 113.955 175.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.91 -41.25 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 127.159 2.183 . . . . 1.23 112.752 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -67.54 -34.23 76.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 113.878 -1.51 . . . . 1.97 112.32 174.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.6 -41.32 98.34 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.773 -1.829 . . . . 1.19 115.814 170.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HE3' ' O ' ' A' ' 16' ' ' GLU . 58.9 mttm -62.59 -38.26 89.46 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.1 -2.25 . . . . 1.92 114.367 168.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.41 92.7 mt -62.23 -35.52 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-O 126.888 3.233 . . . . 1.94 113.836 174.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -66.56 -31.54 72.31 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.23 -2.169 . . . . 1.9 115.057 174.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -73.22 -53.78 10.07 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.236 -1.024 . . . . 1.55 108.236 171.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -65.41 -50.23 66.25 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.917 1.451 . . . . 2.95 114.917 -174.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.598 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 37.0 mm-40 -108.19 -48.95 3.27 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 126.269 1.828 . . . . 1.48 113.405 -172.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.27 16.66 3.83 Favored Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 119.445 -1.36 . . . . 1.12 114.863 175.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.422 HG22 HD22 ' A' ' 71' ' ' LEU . 3.5 mt -88.88 131.01 42.7 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 115.495 -2.193 . . . . 2.07 110.052 -174.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -69.21 161.68 44.85 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 CA-C-N 126.453 3.34 . . . . 1.39 117.924 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.96 -1.86 8.78 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 CA-C-N 122.574 1.955 . . . . 1.68 113.287 -167.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -84.47 -26.27 28.32 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 116.137 -4.102 . . . . 2.25 111.998 176.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -83.92 -34.49 24.48 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.676 -2.515 . . . . 2.44 111.006 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -76.42 121.0 22.43 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 117.8 2.519 . . . . 1.32 117.8 -175.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.6 mtt85 -103.0 164.51 11.57 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 125.574 1.796 . . . . 3.19 106.365 167.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.1 mp -129.85 134.02 47.28 Favored 'General case' 0 CA--C 1.489 -1.387 0 O-C-N 117.636 -3.165 . . . . 1.75 112.026 170.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.2 mt -125.21 124.92 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 CA-C-O 128.564 4.03 . . . . 1.98 109.524 177.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -127.99 139.74 52.39 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 115.379 -4.576 . . . . 1.94 107.072 171.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.302 . . 52.35 25.83 3.71 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.632 2.773 . . . . 1.67 115.764 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.99 13.1 72.62 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-O 114.17 -3.572 . . . . 1.3 110.906 -176.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -125.17 129.66 50.58 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.639 2.22 . . . . 2.89 105.211 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.288 16.7 tt0 -83.33 125.56 31.77 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.153 2.981 . . . . 2.89 111.022 173.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.4 mt -79.26 164.47 24.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.294 -1.775 . . . . 1.34 112.58 -167.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -95.3 153.36 17.71 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.622 -1.992 . . . . 1.94 105.622 175.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -79.76 -50.69 10.19 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.665 -1.272 . . . . 1.56 111.943 -167.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.62 60.23 3.62 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 120.562 2.985 . . . . 0.97 120.562 171.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -126.19 166.96 16.1 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 104.86 -2.274 . . . . 3.07 104.86 165.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.3 p -97.8 162.0 13.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.872 -2.64 . . . . 1.34 103.872 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 5.0 mt -63.99 -27.94 69.47 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 112.762 -2.017 . . . . 1.63 115.794 174.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.9 t -59.89 -45.78 91.44 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.817 2.447 . . . . 1.51 109.001 176.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -55.46 -31.93 62.36 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.867 -2.396 . . . . 1.9 116.257 175.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -85.2 -0.42 54.56 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.195 1.798 . . . . 0.97 112.029 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.289 18.7 m120 49.26 50.91 17.25 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.935 -3.603 . . . . 2.35 115.512 -171.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.274 83.7 mt -93.38 125.02 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 127.545 2.338 . . . . 1.39 105.308 -173.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -105.77 -175.96 2.94 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.556 3.142 . . . . 2.58 107.411 -172.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -72.21 159.31 34.31 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.417 -1.427 . . . . 2.58 110.141 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 59.53 48.53 9.58 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.685 1.994 . . . . 1.71 112.828 174.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.6 m -111.85 137.57 49.63 Favored 'General case' 0 N--CA 1.429 -1.476 1 N-CA-C 99.314 -4.328 . . . . 1.34 99.314 -169.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.6 m -102.53 108.51 19.84 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.608 1.963 . . . . 1.36 109.861 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.8 mt -105.01 148.77 26.38 Favored 'General case' 0 CA--C 1.489 -1.39 0 CA-C-O 123.559 1.647 . . . . 2.03 113.897 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -102.39 132.35 48.45 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.204 -3.435 . . . . 2.31 109.764 -173.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.1 tp -91.66 119.36 31.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.224 -2.797 . . . . 1.72 109.507 175.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.21 137.26 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 O-C-N 118.11 -2.869 . . . . 1.8 107.041 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.422 HD22 HG22 ' A' ' 36' ' ' ILE . 96.8 mt . . . . . 0 N--CA 1.431 -1.399 0 C-N-CA 116.804 -1.958 . . . . 3.26 110.769 172.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 115.436 1.643 . . . . 1.39 115.436 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -83.83 148.04 27.22 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 114.806 -2.521 . . . . 2.2 109.561 -176.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -142.43 168.43 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 1 O-C-N 130.8 5.062 . . . . 1.32 107.97 170.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -117.88 156.68 28.01 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 114.455 1.28 . . . . 2.2 114.455 171.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.9 t -134.36 128.04 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 101.381 -3.563 . . . . 1.23 101.381 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -98.92 106.88 19.19 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.905 2.187 . . . . 2.51 116.905 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.262 4.8 p -58.13 165.43 1.93 Allowed 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 125.508 1.523 . . . . 1.41 112.571 176.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.3 94.7 mt -60.18 -54.89 40.42 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 130.867 3.667 . . . . 2.95 110.995 176.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 p -76.8 -12.23 59.95 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 117.84 -3.038 . . . . 2.52 113.264 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.65 2.21 5.36 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 122.285 2.311 . . . . 1.5 113.448 166.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -77.02 143.23 39.49 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 116.241 -4.093 . . . . 1.79 114.027 -175.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.0 m -85.44 125.92 33.39 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.144 0.977 . . . . 1.38 112.446 166.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.3 mt -100.51 112.89 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 104.999 -2.223 . . . . 2.03 104.999 171.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 m -87.99 145.49 25.98 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 116.031 -2.267 . . . . 1.61 108.479 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.3 mt -141.17 174.89 10.1 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 120.427 1.467 . . . . 2.15 109.308 175.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -126.18 119.66 28.08 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.682 1.993 . . . . 1.98 110.288 167.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 m -121.19 153.49 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 126.447 1.899 . . . . 1.52 110.702 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.278 17.7 mm-40 -101.84 175.84 2.13 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-N 125.2 3.636 . . . . 2.35 110.957 155.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -74.76 -20.17 17.74 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 121.23 1.475 . . . . 1.31 110.106 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.8 m -76.21 -8.93 58.13 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 120.328 3.455 . . . . 1.71 120.328 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -80.45 142.5 34.23 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 116.772 -3.705 . . . . 1.69 110.198 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 38.4 p -82.99 179.98 7.61 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 123.275 1.512 . . . . 1.33 111.703 -176.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.9 mm -82.62 -31.12 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 116.657 -3.777 . . . . 1.32 109.201 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -63.41 -28.76 70.2 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.18 -2.2 . . . . 1.62 115.404 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -66.71 -46.08 76.67 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.005 1.722 . . . . 2.13 113.414 172.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.2 t -62.67 -42.11 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 119.148 -2.22 . . . . 1.23 109.554 176.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -71.46 -8.31 53.06 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 118.222 2.675 . . . . 1.97 118.222 169.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.03 -39.76 19.22 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.369 1.08 . . . . 1.19 112.828 169.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -59.24 -40.84 87.18 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.324 1.85 . . . . 1.92 111.186 174.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.7 mt -74.67 -26.35 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 115.588 1.699 . . . . 1.94 115.588 170.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -62.18 -39.23 92.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.481 -2.012 . . . . 1.9 113.49 167.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -55.8 -47.66 76.74 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 116.277 1.955 . . . . 1.55 116.277 165.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -90.06 -51.42 5.47 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 115.735 1.754 . . . . 2.95 115.735 -167.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -98.54 -39.44 8.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 106.038 -1.838 . . . . 1.48 106.038 -171.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.47 18.16 6.29 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 120.933 3.133 . . . . 1.12 120.933 174.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.2 mt -103.71 120.75 50.47 Favored Pre-proline 0 N--CA 1.43 -1.437 1 C-N-CA 134.775 5.23 . . . . 2.07 108.374 -163.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -57.28 137.17 80.43 Favored 'Trans proline' 0 C--N 1.299 -2.052 2 C-N-CA 125.726 4.284 . . . . 1.39 116.749 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -67.59 -12.58 36.12 Favored 'Trans proline' 0 N--CA 1.434 -2.027 0 CA-C-N 127.978 3.885 . . . . 1.68 120.197 -172.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -78.41 -16.1 57.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.633 1.973 . . . . 2.25 112.483 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -92.01 -37.41 12.84 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.407 -2.058 . . . . 2.44 110.979 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -69.47 126.99 31.43 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.68 2.392 . . . . 1.32 112.051 -171.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.447 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 29.9 mtt180 -103.99 126.73 51.33 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 120.303 -1.498 . . . . 3.19 110.952 158.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.0 mt -104.84 118.12 35.75 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.356 -2.715 . . . . 1.75 106.427 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 49' ' ' GLN . 18.5 mm -112.8 141.44 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.669 1.988 . . . . 1.98 105.831 -174.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -154.8 124.26 6.45 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.535 -1.654 . . . . 1.94 106.535 169.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.47 37.83 2.55 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 126.703 2.502 . . . . 1.67 110.383 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.13 -23.51 4.5 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 118.031 -2.033 . . . . 1.3 116.131 -175.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -87.23 142.07 28.17 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.554 -1.556 . . . . 2.89 114.831 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.409 ' HA ' HD12 ' A' ' 44' ' ' ILE . 35.0 tt0 -87.0 135.03 33.42 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.354 -2.716 . . . . 2.89 108.864 172.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.6 mt -93.09 128.77 39.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.887 -1.133 . . . . 1.34 112.54 -175.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -84.32 132.01 34.65 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 117.604 2.446 . . . . 1.94 117.604 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -40.53 -67.93 0.21 Allowed 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 121.22 3.785 . . . . 1.56 121.22 -165.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.25 58.03 5.05 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 118.011 1.964 . . . . 0.97 118.011 171.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -129.09 157.85 40.6 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 103.562 -2.755 . . . . 3.07 103.562 168.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 68.2 p -98.92 167.51 10.7 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.955 -1.716 . . . . 1.34 113.603 175.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.87 -24.81 66.94 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.993 -1.692 . . . . 1.63 115.305 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.5 t -69.4 -39.7 77.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.586 1.954 . . . . 1.51 109.654 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -55.28 -40.01 70.53 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 115.446 1.647 . . . . 1.9 115.446 171.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -88.67 -2.03 58.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.046 1.738 . . . . 0.97 113.296 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 59.08 50.75 7.77 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 123.14 1.448 . . . . 2.35 110.853 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.7 mm -85.97 126.66 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-O 125.687 2.66 . . . . 1.39 105.699 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -91.92 174.21 7.45 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.572 -2.58 . . . . 2.58 113.476 -176.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.3 pttt -70.13 147.02 50.43 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.164 1.459 . . . . 2.58 113.65 173.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.322 41.1 mt-10 61.97 35.58 16.08 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 119.139 -2.225 . . . . 1.71 114.674 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 t -102.62 149.42 24.45 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 124.326 1.05 . . . . 1.34 110.505 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.5 m -96.95 110.68 23.16 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.058 2.543 . . . . 1.36 113.031 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.8 mt -90.03 153.13 20.8 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 118.065 -1.454 . . . . 2.03 109.966 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -104.19 123.82 48.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.125 1.44 . . . . 2.31 112.599 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.1 tp -94.46 128.79 41.25 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.126 -4.109 . . . . 1.72 108.282 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 89.0 t -120.87 154.21 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 102.239 -3.245 . . . . 1.8 102.239 172.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 N--CA 1.429 -1.515 0 O-C-N 120.594 -1.316 . . . . 3.26 108.587 -175.784 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 CA--C 1.491 -1.324 0 CA-C-O 118.376 -0.821 . . . . 1.39 112.089 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -99.27 126.98 45.21 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.727 0.775 . . . . 2.2 111.232 -176.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.6 pt -114.69 164.45 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 105.663 -1.977 . . . . 1.32 105.663 173.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -119.2 135.01 54.88 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 105.26 -2.126 . . . . 2.2 105.26 -175.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.5 t -117.79 118.22 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 102.98 -2.97 . . . . 1.23 102.98 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -108.98 135.92 49.36 Favored 'General case' 0 N--CA 1.429 -1.485 2 O-C-N 115.639 -4.413 . . . . 2.51 108.05 175.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.1 p -87.32 -177.05 5.86 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 125.119 2.39 . . . . 1.41 115.752 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.78 -30.31 64.0 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 124.733 2.206 . . . . 2.95 114.794 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p -77.94 -51.04 11.02 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 114.549 -5.094 . . . . 2.52 110.526 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.61 35.68 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.748 0 O-C-N 118.552 -2.593 . . . . 1.5 111.777 173.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -102.42 108.46 19.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.931 -2.248 . . . . 1.79 104.931 -170.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.9 m -83.7 114.9 21.9 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.535 2.734 . . . . 1.38 106.694 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.4 mt -101.54 146.43 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 100.522 -3.881 . . . . 2.03 100.522 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.7 m -118.21 130.82 56.3 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.851 2.739 . . . . 1.61 103.853 174.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.3 mt -125.75 139.98 53.07 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 113.275 -1.784 . . . . 2.15 108.283 -177.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.27 48.0 mt-10 -103.32 129.91 50.47 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 123.929 1.823 . . . . 1.98 111.341 170.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 m -137.31 166.22 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 113.929 -1.487 . . . . 1.52 110.669 -169.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -105.55 167.23 10.03 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 119.25 -2.156 . . . . 2.35 109.679 161.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -70.89 -13.1 31.6 Favored 'Trans proline' 0 N--CA 1.434 -1.99 0 N-CA-C 118.999 2.653 . . . . 1.31 118.999 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.8 p -93.11 4.22 54.38 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.499 1.92 . . . . 1.71 115.5 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -80.2 144.27 33.09 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 126.378 2.99 . . . . 1.69 111.929 170.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.3 p -80.27 158.62 26.12 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 128.335 2.654 . . . . 1.33 108.108 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.452 ' HA ' HD13 ' A' ' 23' ' ' ILE . 26.6 mm -64.99 -36.75 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 103.031 -2.951 . . . . 1.32 103.031 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -55.16 -46.26 75.73 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.353 -3.342 . . . . 1.62 117.259 170.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -64.28 -37.98 89.43 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 115.785 1.772 . . . . 2.13 115.785 171.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.5 t -53.2 -44.55 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 118.418 -2.676 . . . . 1.23 114.684 167.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 34.0 mtpt -62.56 -46.63 87.48 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.318 -1.489 . . . . 1.97 114.57 173.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.1 -37.4 69.32 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.782 1.633 . . . . 1.19 112.281 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -68.37 -31.2 70.4 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 117.052 -1.451 . . . . 1.92 112.865 173.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.1 mt -68.68 -41.69 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 120.153 1.342 . . . . 1.94 108.337 173.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -53.57 -45.47 69.93 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 117.575 -3.203 . . . . 1.9 114.148 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.27 20.9 t70 -55.49 -68.06 0.23 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.074 -1.642 . . . . 1.55 109.761 167.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -59.82 -55.4 34.68 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 119.436 3.124 . . . . 2.95 119.436 -173.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -95.03 -51.23 4.74 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.092 2.557 . . . . 1.48 113.449 -169.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.56 24.7 2.81 Favored Glycine 0 N--CA 1.43 -1.733 0 CA-C-O 116.942 -2.032 . . . . 1.12 115.771 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.9 mm -103.62 135.12 19.42 Favored Pre-proline 0 N--CA 1.429 -1.484 0 CA-C-N 121.63 2.715 . . . . 2.07 108.777 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -67.48 137.64 43.53 Favored 'Trans proline' 0 C--N 1.3 -1.998 3 C-N-CA 126.452 4.768 . . . . 1.39 115.355 178.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -59.14 -21.13 57.93 Favored 'Trans proline' 0 C--N 1.299 -2.047 1 C-N-CA 129.349 6.699 . . . . 1.68 111.461 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -62.59 -39.11 92.68 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 126.299 2.952 . . . . 2.25 114.292 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -77.75 -30.68 51.66 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 114.613 -5.054 . . . . 2.44 110.026 -173.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -79.44 151.02 31.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.703 -1.248 . . . . 1.32 112.495 -164.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -139.82 156.09 46.92 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 106.341 -1.725 . . . . 3.19 106.341 168.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.461 HD21 ' HA ' ' A' ' 69' ' ' LEU . 42.1 mt -136.59 126.43 25.74 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 118.86 0.754 . . . . 1.75 111.322 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.8 mm -104.62 145.93 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 O-C-N 126.471 2.357 . . . . 1.98 106.257 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -134.42 126.45 29.55 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 116.893 -3.629 . . . . 1.94 102.288 165.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.22 -55.9 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.45 1 C-N-CA 135.027 5.331 . . . . 1.67 118.945 -175.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.85 -16.8 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.723 0 O-C-N 120.132 -1.605 . . . . 1.3 113.757 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -95.29 162.36 13.71 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.542 1.537 . . . . 2.89 111.063 -178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -116.58 126.33 53.13 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.623 1.569 . . . . 2.89 107.139 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.445 HD13 HD11 ' A' ' 23' ' ' ILE . 20.3 mt -90.42 132.3 35.7 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 125.706 1.879 . . . . 1.34 108.748 -162.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -60.12 143.76 51.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.181 -2.825 . . . . 1.94 113.074 172.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -70.21 -43.21 71.14 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 112.899 -6.126 . . . . 1.56 113.92 -169.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.62 53.25 1.29 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 125.949 2.971 . . . . 0.97 109.718 174.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.5 mtt-85 -120.87 155.21 34.64 Favored 'General case' 0 N--CA 1.43 -1.468 1 N-CA-C 100.069 -4.049 . . . . 3.07 100.069 165.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.4 p -90.56 167.41 12.58 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 124.68 1.237 . . . . 1.34 113.346 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 mt -65.22 -42.93 92.97 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 127.299 2.874 . . . . 1.63 112.735 169.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.2 t -59.0 -40.11 83.91 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 120.041 1.291 . . . . 1.51 114.34 175.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.1 -40.96 95.71 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.726 2.121 . . . . 1.9 116.726 175.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -79.04 -10.1 59.73 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.77 1.294 . . . . 0.97 113.661 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.9 m120 68.33 40.19 2.11 Favored 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 135.507 5.523 . . . . 2.35 114.661 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.9 mt -72.33 139.6 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 127.328 2.251 . . . . 1.39 106.974 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -119.21 -178.48 3.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.942 2.306 . . . . 2.58 106.857 -175.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -65.43 147.66 53.04 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.117 2.389 . . . . 2.58 116.125 167.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.272 34.8 mt-10 70.31 21.57 5.73 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.673 1.989 . . . . 1.71 113.852 173.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -92.92 141.15 28.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.621 1.677 . . . . 1.34 108.778 -175.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.2 m -96.22 100.56 12.19 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 129.266 3.026 . . . . 1.36 112.721 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.326 18.6 mt -83.13 150.88 25.99 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 128.421 3.962 . . . . 2.03 103.699 170.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -106.92 98.93 8.53 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 110.365 -3.107 . . . . 2.31 116.919 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.461 ' HA ' HD21 ' A' ' 43' ' ' LEU . 24.9 tp -63.65 116.69 5.91 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 116.914 2.19 . . . . 1.72 116.914 169.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.9 m -131.69 -178.78 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 102.779 -3.045 . . . . 1.8 102.779 175.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.9 mt . . . . . 0 N--CA 1.43 -1.46 0 N-CA-C 105.256 -2.127 . . . . 3.26 105.256 179.044 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.344 0 CA-C-O 118.34 -0.838 . . . . 1.39 111.149 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -95.66 131.4 41.94 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 116.302 1.964 . . . . 2.2 116.302 -171.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.9 pt -126.92 165.93 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 115.093 -2.385 . . . . 1.32 111.742 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -125.88 127.68 46.41 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 125.946 2.029 . . . . 2.2 106.321 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.9 t -112.83 111.9 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 CA-C-N 115.503 -0.771 . . . . 1.23 109.633 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -93.63 135.67 34.68 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 116.852 -3.655 . . . . 2.51 111.496 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.3 p -84.2 -167.64 1.84 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.844 -1.785 . . . . 1.41 109.559 173.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.0 mt -91.96 -23.48 19.56 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.107 -2.245 . . . . 2.95 112.226 171.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.1 p -80.96 -47.64 13.38 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.035 1.124 . . . . 2.52 114.035 -173.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.17 25.3 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 116.615 -2.707 . . . . 1.5 111.686 176.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -118.47 124.45 47.64 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.492 -0.929 . . . . 1.79 108.492 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -102.41 118.56 37.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 124.579 1.175 . . . . 1.38 110.231 167.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mt -105.22 129.45 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 127.832 2.453 . . . . 2.03 110.128 -170.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.4 m -99.34 110.06 22.61 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 127.427 2.954 . . . . 1.61 108.318 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.1 mt -121.49 147.07 46.26 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.059 2.838 . . . . 2.15 109.728 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -99.3 125.71 44.99 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.509 -3.869 . . . . 1.98 114.495 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 m -124.9 150.38 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 117.8 -3.063 . . . . 1.52 106.134 -176.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -86.21 140.23 34.49 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 112.907 -3.425 . . . . 2.35 113.018 166.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -77.44 5.14 5.35 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 CA-C-N 126.878 3.492 . . . . 1.31 112.69 -166.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 p -106.17 9.63 32.17 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.939 -2.976 . . . . 1.71 111.841 173.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -91.23 157.26 17.27 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 124.64 2.162 . . . . 1.69 110.253 171.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 26' ' ' VAL . 43.9 p -83.37 165.7 19.04 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.679 -2.513 . . . . 1.33 107.392 -175.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.412 11.3 mm -68.42 -37.49 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 C-N-CA 128.101 2.56 . . . . 1.32 110.51 176.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -56.96 -34.1 67.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 126.789 3.185 . . . . 1.62 115.966 169.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -83.05 -26.42 31.17 Favored 'General case' 0 N--CA 1.432 -1.374 1 O-C-N 111.808 -6.807 . . . . 2.13 113.405 177.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 22' ' ' THR . 44.3 t -52.66 -44.61 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.384 1.873 . . . . 1.23 113.436 165.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.462 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 43.7 mtmt -67.38 -40.28 85.69 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.973 -2.329 . . . . 1.97 111.371 175.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.43 76.58 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.321 2.01 . . . . 1.19 113.808 175.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -64.66 -46.76 81.08 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 118.93 -2.356 . . . . 1.92 116.522 163.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.6 mt -61.51 -26.96 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 117.299 -3.376 . . . . 1.94 114.588 167.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -67.43 -45.47 75.98 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.851 -3.655 . . . . 1.9 109.905 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.26 -36.94 76.43 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 118.796 -2.44 . . . . 1.55 106.338 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -76.02 -55.94 5.13 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 123.585 2.902 . . . . 2.95 113.073 -171.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -112.32 -15.9 13.06 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 126.097 2.123 . . . . 1.48 115.146 -164.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.79 21.2 40.61 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-O 123.048 1.36 . . . . 1.12 115.375 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 mt -101.55 131.98 22.33 Favored Pre-proline 0 N--CA 1.43 -1.467 0 O-C-N 121.013 -1.287 . . . . 2.07 111.059 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -70.47 145.0 51.84 Favored 'Trans proline' 0 C--N 1.3 -2.003 1 C-N-CA 126.302 4.668 . . . . 1.39 115.27 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -72.58 -6.52 19.2 Favored 'Trans proline' 0 N--CA 1.433 -2.03 1 C-N-CA 127.45 5.434 . . . . 1.68 117.21 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.98 -39.45 30.08 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.851 -1.781 . . . . 2.25 108.669 169.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -73.65 -36.46 65.39 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 125.163 1.539 . . . . 2.44 113.422 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.462 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 74.3 mt-30 -74.04 135.06 43.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.322 1.23 . . . . 1.32 114.322 -175.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.481 ' HB3' HG21 ' A' ' 70' ' ' VAL . 43.1 ttt180 -122.13 117.68 26.84 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 114.859 -2.496 . . . . 3.19 107.901 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.1 mt -100.77 125.55 47.26 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 125.291 2.472 . . . . 1.75 105.935 -176.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.1 mt -106.05 142.71 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 1 O-C-N 115.903 -4.248 . . . . 1.98 101.904 176.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -153.8 133.56 13.03 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 127.486 3.517 . . . . 1.94 106.252 172.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.22 -57.99 0.28 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.064 2.546 . . . . 1.67 115.244 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -159.84 -18.59 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 108.616 -1.794 . . . . 1.3 108.616 -173.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -134.88 163.41 29.88 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.317 -3.461 . . . . 2.89 112.223 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.3 pm0 -71.16 152.7 43.14 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 117.81 -1.091 . . . . 2.89 111.885 170.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.2 mt -97.89 172.57 7.57 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.894 2.134 . . . . 1.34 114.538 -171.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -104.68 153.57 21.09 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.037 -2.914 . . . . 1.94 110.591 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -89.47 -52.05 5.23 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.284 -2.76 . . . . 1.56 109.085 -163.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.84 46.1 1.7 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 117.233 1.653 . . . . 0.97 117.233 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.353 17.7 mmt180 -128.22 165.92 19.56 Favored 'General case' 0 CA--C 1.489 -1.38 0 O-C-N 119.499 -2.177 . . . . 3.07 106.643 168.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.288 27.2 p -99.36 170.55 8.56 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.233 1.568 . . . . 1.34 115.233 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.532 ' HA ' HD13 ' A' ' 61' ' ' ILE . 11.3 mt -63.15 -40.32 97.22 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 127.2 2.2 . . . . 1.63 107.926 171.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 m -65.47 -48.85 71.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.634 3.174 . . . . 1.51 110.891 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -52.49 -41.82 63.72 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.427 1.584 . . . . 1.9 114.334 174.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -82.33 -7.23 59.63 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.424 -2.047 . . . . 0.97 114.062 175.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.1 t30 56.44 43.83 25.37 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.414 3.485 . . . . 2.35 112.535 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.532 HD13 ' HA ' ' A' ' 56' ' ' LEU . 62.9 mt -75.59 109.87 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-N 111.927 -2.397 . . . . 1.39 113.1 177.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -82.78 -178.19 7.01 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 120.435 -1.416 . . . . 2.58 107.855 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -66.5 149.3 50.64 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 125.083 1.353 . . . . 2.58 111.075 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 69.09 33.75 3.28 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 131.557 3.943 . . . . 1.71 107.668 168.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m -96.42 139.6 32.29 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 121.507 1.958 . . . . 1.34 111.713 -176.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 m -99.98 115.96 30.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.43 1.468 . . . . 1.36 110.939 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mp -104.47 155.33 18.89 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 112.194 -2.276 . . . . 2.03 106.29 173.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -107.34 122.92 47.55 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.885 3.274 . . . . 2.31 113.666 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.9 tp -101.42 102.09 12.82 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.243 -3.411 . . . . 1.72 106.06 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.481 HG21 ' HB3' ' A' ' 42' ' ' ARG . 10.4 m -111.96 -177.05 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 126.685 2.491 . . . . 1.8 105.686 172.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.373 18.0 mt . . . . . 0 N--CA 1.43 -1.473 0 C-N-CA 119.473 -0.891 . . . . 3.26 109.319 -176.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ptt? . . . . . 0 CA--C 1.49 -1.341 0 CA-C-O 124.85 2.262 . . . . 1.39 110.814 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -109.81 123.75 50.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 112.496 -2.138 . . . . 2.2 111.779 -173.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 pp -123.83 162.1 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 129.932 3.293 . . . . 1.32 111.344 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -123.52 136.76 54.74 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 122.782 1.277 . . . . 2.2 107.812 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.4 t -110.34 124.64 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-N 112.053 -2.34 . . . . 1.23 110.346 174.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 mmtt -95.9 117.53 30.77 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.35 1.06 . . . . 2.51 109.617 174.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.2 p -77.65 -177.55 4.87 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.359 2.028 . . . . 1.41 109.556 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.7 tp -58.49 -50.76 72.56 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 114.656 -5.028 . . . . 2.95 116.736 174.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.7 p -68.86 -6.31 26.32 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 111.624 -2.535 . . . . 2.52 114.763 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.17 9.68 44.25 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 117.518 -3.239 . . . . 1.5 110.434 173.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -84.03 126.87 33.47 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 107.503 -1.295 . . . . 1.79 107.503 -171.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 m -93.72 121.71 35.44 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.259 -0.882 . . . . 1.38 112.368 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.0 mt -115.13 126.53 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 107.055 -1.461 . . . . 2.03 107.055 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.8 m -102.36 121.72 42.86 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.604 -1.31 . . . . 1.61 113.529 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.0 mt -115.52 155.13 28.09 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.351 -2.718 . . . . 2.15 110.517 -174.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -110.18 109.32 19.78 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 125.051 1.469 . . . . 1.98 110.306 171.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -123.64 173.41 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 126.192 1.797 . . . . 1.52 109.876 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -115.68 157.27 44.86 Favored Pre-proline 0 N--CA 1.429 -1.494 0 CA-C-O 115.18 -2.343 . . . . 2.35 113.42 166.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.23 2.26 8.7 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 C-N-CA 124.441 3.427 . . . . 1.31 115.472 -176.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.6 p -95.61 -25.71 16.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.086 1.513 . . . . 1.71 115.086 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -69.72 154.8 41.47 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.163 2.985 . . . . 1.69 112.607 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.269 71.7 p -81.77 149.16 28.54 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 112.281 -2.236 . . . . 1.33 112.91 -175.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -52.85 -44.01 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 117.592 -1.194 . . . . 1.32 112.676 171.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -43.39 -50.96 6.72 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.427 2.691 . . . . 1.62 111.501 162.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -66.35 -36.89 84.02 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 115.999 1.851 . . . . 2.13 115.999 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.24 -45.93 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-O 125.901 2.762 . . . . 1.23 113.779 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.2 mtmt -53.24 -31.25 42.5 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.395 -2.066 . . . . 1.97 115.445 166.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.88 -20.64 60.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 120.015 -0.674 . . . . 1.19 112.366 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -70.37 -38.29 74.71 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.98 -2.325 . . . . 1.92 114.428 173.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.6 mt -68.98 -31.95 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 127.085 2.154 . . . . 1.94 111.977 169.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -65.89 -52.85 46.54 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 115.654 -4.404 . . . . 1.9 110.102 174.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -56.77 -47.68 79.56 Favored 'General case' 0 N--CA 1.431 -1.391 1 O-C-N 114.511 -5.118 . . . . 1.55 108.767 170.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -65.99 -63.32 1.11 Allowed 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 123.315 2.779 . . . . 2.95 117.244 -176.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -93.46 -43.61 8.65 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.666 -1.896 . . . . 1.48 111.631 -174.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.05 81.06 1.5 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 125.899 2.944 . . . . 1.12 106.357 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.7 mt -155.78 126.44 3.47 Favored Pre-proline 0 N--CA 1.43 -1.472 1 N-CA-C 99.03 -4.433 . . . . 2.07 99.03 -170.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -70.0 148.7 64.09 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 CA-C-N 122.725 2.009 . . . . 1.39 112.247 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.335 36.2 Cg_endo -67.64 -20.87 46.37 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 CA-C-N 125.994 3.177 . . . . 1.68 115.697 -175.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -63.79 -31.35 72.5 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 129.832 3.253 . . . . 2.25 113.733 175.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -89.06 -16.99 30.23 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 119.532 -1.98 . . . . 2.44 106.934 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -88.37 124.64 34.13 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.117 -4.739 . . . . 1.32 111.621 -176.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -116.72 133.74 55.65 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.537 -0.912 . . . . 3.19 108.537 171.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.4 mt -112.06 125.34 53.99 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 126.23 2.919 . . . . 1.75 108.861 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.6 mt -111.1 145.61 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 127.485 2.314 . . . . 1.98 104.778 176.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -150.71 135.62 17.5 Favored 'General case' 0 N--CA 1.43 -1.448 1 N-CA-C 99.878 -4.119 . . . . 1.94 99.878 178.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.24 47.6 21.97 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.893 2.758 . . . . 1.67 114.02 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.74 -2.34 54.79 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 127.633 2.54 . . . . 1.3 116.017 175.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm -123.75 143.82 50.06 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.524 -2.163 . . . . 2.89 114.249 -174.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -66.37 127.18 31.24 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 111.411 -2.631 . . . . 2.89 114.906 171.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 mt -92.27 119.89 32.3 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 110.258 -3.156 . . . . 1.34 108.389 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -77.38 151.12 34.98 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 117.127 -1.415 . . . . 1.94 113.375 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -72.35 -53.48 12.23 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.932 2.197 . . . . 1.56 116.932 -169.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.73 29.33 0.62 Allowed Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 120.266 2.866 . . . . 0.97 120.266 169.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -118.17 174.98 5.9 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 120.213 2.007 . . . . 3.07 108.327 170.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.4 p -104.08 179.19 4.34 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 126.099 2.856 . . . . 1.34 111.624 175.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.8 mt -71.4 -33.89 69.87 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 116.464 -3.898 . . . . 1.63 113.213 171.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -57.25 -44.83 84.21 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 125.269 2.461 . . . . 1.51 110.159 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -54.95 -33.52 62.4 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.332 -2.73 . . . . 1.9 117.218 176.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -101.05 -2.41 31.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.165 -1.584 . . . . 0.97 109.148 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.257 6.6 m120 64.39 55.17 1.43 Allowed 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 116.825 2.157 . . . . 2.35 116.825 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.5 mt -100.16 132.27 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 110.568 -3.014 . . . . 1.39 107.5 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -115.65 -164.16 0.94 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 123.469 0.707 . . . . 2.58 111.621 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -67.6 153.36 43.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.952 2.501 . . . . 2.58 108.531 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 54.47 26.96 7.67 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.478 2.711 . . . . 1.71 117.089 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.252 47.2 m -94.08 144.85 25.12 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.358 -1.464 . . . . 1.34 109.971 -173.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.4 m -102.41 103.53 13.93 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 126.549 1.94 . . . . 1.36 111.661 -171.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 mt -84.22 160.52 20.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.322 1.849 . . . . 2.03 111.758 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -123.43 123.96 41.83 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.529 -2.607 . . . . 2.31 104.114 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.1 tp -95.63 120.93 36.74 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.295 2.638 . . . . 1.72 109.318 176.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.296 14.1 m -116.94 163.13 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 127.899 2.48 . . . . 1.8 111.425 168.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.3 mt . . . . . 0 N--CA 1.431 -1.421 0 C-N-CA 117.48 -1.688 . . . . 3.26 111.914 179.852 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 tmm? . . . . . 0 CA--C 1.491 -1.299 0 CA-C-O 116.791 -1.576 . . . . 1.39 114.134 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -91.64 115.38 28.0 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.827 2.558 . . . . 2.2 113.149 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.9 pt -104.88 152.57 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 124.376 2.036 . . . . 1.32 113.015 165.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -111.46 113.74 26.39 Favored 'General case' 0 N--CA 1.429 -1.49 1 O-C-N 114.825 -4.922 . . . . 2.2 108.697 -174.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.7 t -98.13 106.5 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-O 124.082 1.896 . . . . 1.23 106.067 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -94.62 121.3 36.04 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.791 -2.443 . . . . 2.51 112.779 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 p -89.24 163.82 15.22 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.543 -1.348 . . . . 1.41 108.203 174.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.9 tp -44.8 -56.88 4.11 Favored 'General case' 0 N--CA 1.43 -1.433 1 C-N-CA 133.229 4.611 . . . . 2.95 110.842 174.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.7 p -72.59 -19.73 61.42 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 113.061 -1.881 . . . . 2.52 115.275 -174.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.4 -14.86 4.22 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 117.293 -1.837 . . . . 1.5 116.689 166.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.479 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 79.1 tttt -75.04 133.21 41.67 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 120.343 2.072 . . . . 1.79 108.748 -168.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -105.15 118.89 37.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.028 -0.73 . . . . 1.38 109.028 172.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.12 112.31 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-O 126.112 2.863 . . . . 2.03 105.226 -178.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.7 m -88.72 131.52 34.99 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.186 -2.821 . . . . 1.61 106.862 -176.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.4 mt -135.32 131.21 36.18 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 124.642 1.213 . . . . 2.15 109.788 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -88.48 94.13 9.77 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.007 -2.308 . . . . 1.98 112.481 176.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.284 30.9 m -110.79 178.35 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 105.493 -2.04 . . . . 1.52 105.493 -177.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.487 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 22.7 mm-40 -122.34 155.5 61.88 Favored Pre-proline 0 N--CA 1.431 -1.412 0 O-C-N 119.532 -1.98 . . . . 2.35 109.786 161.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 94.3 Cg_endo -72.32 -23.09 21.09 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 C-N-CA 124.126 3.217 . . . . 1.31 112.975 -166.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.1 m -74.32 -11.21 60.2 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 116.17 1.915 . . . . 1.71 116.17 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -81.73 159.48 23.87 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 119.359 3.096 . . . . 1.69 119.359 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.257 7.3 p -78.07 147.71 34.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 119.067 2.988 . . . . 1.33 119.067 -177.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.1 mm -53.68 -38.36 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 123.86 3.027 . . . . 1.32 115.849 173.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -45.85 -38.12 6.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.86 2.911 . . . . 1.62 118.86 162.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -85.4 -23.7 27.84 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.86 -1.775 . . . . 2.13 113.719 175.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.94 -48.01 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 118.583 -2.573 . . . . 1.23 109.581 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -47.7 -37.4 13.01 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.761 3.245 . . . . 1.97 119.761 174.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.08 -33.12 71.5 Favored 'General case' 0 N--CA 1.43 -1.43 2 C-N-CA 133.53 4.732 . . . . 1.19 110.731 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -62.28 -26.42 68.4 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.133 3.012 . . . . 1.92 119.133 173.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.7 mt -82.67 -16.41 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 126.541 2.401 . . . . 1.94 114.292 175.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -82.17 -49.53 10.03 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.793 -1.929 . . . . 1.9 105.793 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -48.86 -61.28 2.13 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.874 2.47 . . . . 1.55 111.305 167.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -76.88 -62.57 1.6 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.968 -1.708 . . . . 2.95 112.959 -167.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.479 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 46.6 tp10 -98.5 -42.77 7.15 Favored 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 115.247 -4.658 . . . . 1.48 110.806 -166.892 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.34 20.47 2.19 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 121.891 3.516 . . . . 1.12 121.891 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.1 mm -99.82 118.86 61.08 Favored Pre-proline 0 N--CA 1.43 -1.471 0 C-N-CA 126.337 1.855 . . . . 2.07 109.75 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -69.3 157.44 61.27 Favored 'Trans proline' 0 C--N 1.299 -2.064 0 CA-C-N 123.116 2.148 . . . . 1.39 115.795 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -73.15 -16.14 25.36 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 C-N-CA 124.343 3.362 . . . . 1.68 112.717 -173.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -85.87 -34.54 20.97 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.898 2.479 . . . . 2.25 112.409 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -79.44 3.66 17.86 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.332 2.653 . . . . 2.44 111.269 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -122.92 147.72 46.27 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 120.799 3.629 . . . . 1.32 120.799 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -125.19 129.21 49.65 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 124.011 3.096 . . . . 3.19 103.613 176.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.4 mt -105.92 132.91 51.45 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.128 -4.732 . . . . 1.75 109.274 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.4 mt -119.7 135.36 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 106.366 -1.716 . . . . 1.98 106.366 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -124.31 131.95 53.54 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.844 2.458 . . . . 1.94 104.434 169.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.16 -57.59 0.52 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.889 2.876 . . . . 1.67 113.799 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -169.09 -32.45 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.749 0 CA-C-O 125.67 2.816 . . . . 1.3 115.439 -173.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -95.79 162.78 13.45 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.645 -2.679 . . . . 2.89 114.078 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -90.3 145.45 24.97 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 121.514 3.894 . . . . 2.89 121.514 173.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.6 mt -92.33 128.28 38.12 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 124.505 2.098 . . . . 1.34 112.605 -170.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -75.96 134.93 40.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 130.257 3.423 . . . . 1.94 110.144 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.55 -49.93 74.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.417 2.687 . . . . 1.56 115.206 -172.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.31 34.59 3.93 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 119.681 2.633 . . . . 0.97 119.681 173.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -103.83 166.13 10.61 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 114.549 -2.861 . . . . 3.07 106.789 167.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.8 p -89.97 159.82 16.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.974 -2.953 . . . . 1.34 110.127 169.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.299 81.0 mt -60.16 -33.27 71.95 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.688 1.736 . . . . 1.63 115.688 168.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.6 t -76.76 -20.78 56.09 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.457 -3.277 . . . . 1.51 115.804 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.88 -36.14 82.94 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.486 1.115 . . . . 1.9 109.326 169.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -82.54 3.21 29.45 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.553 -1.967 . . . . 0.97 112.733 172.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.312 21.7 m120 51.92 34.75 14.2 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.594 -2.566 . . . . 2.35 115.822 -176.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.4 mt -68.81 105.52 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 120.581 -1.324 . . . . 1.39 109.009 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -97.23 167.25 11.15 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 128.437 2.695 . . . . 2.58 107.953 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -62.42 145.77 53.18 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 118.215 -2.803 . . . . 2.58 118.059 175.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.33 29.3 mt-10 71.37 28.7 2.89 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 113.156 -1.838 . . . . 1.71 112.149 -172.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 m -84.42 141.44 30.83 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 121.032 1.742 . . . . 1.34 115.242 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.3 m -94.87 109.03 21.06 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.967 -1.494 . . . . 1.36 106.967 -171.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.7 mt -95.04 130.59 41.66 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.979 2.172 . . . . 2.03 106.628 171.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.272 32.1 m80 -100.33 114.1 27.34 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.032 -1.47 . . . . 2.31 107.032 -175.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -87.71 110.12 20.2 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.017 1.727 . . . . 1.72 112.266 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.7 t -98.62 133.92 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 1 N-CA-C 99.212 -4.366 . . . . 1.8 99.212 169.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.265 13.5 tp . . . . . 0 N--CA 1.43 -1.449 0 O-C-N 119.25 -2.156 . . . . 3.26 107.983 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 CA--C 1.491 -1.299 0 CA-C-O 118.176 -0.916 . . . . 1.39 111.647 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -107.03 137.81 44.39 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.127 3.371 . . . . 2.2 106.103 -178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 pt -131.2 167.45 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.604 -3.185 . . . . 1.32 104.863 168.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.252 63.4 m-85 -121.88 125.18 45.84 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.469 1.108 . . . . 2.2 108.658 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.79 112.07 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 112.693 0.627 . . . . 1.23 112.693 172.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.4 ttmm -102.42 142.77 33.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.463 -1.31 . . . . 2.51 107.463 -172.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.1 p -93.06 167.21 11.94 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 127.392 3.472 . . . . 1.41 112.975 165.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.257 21.0 tp -71.89 -25.58 61.98 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.242 -3.411 . . . . 2.95 114.382 175.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.8 p -88.24 -36.7 16.6 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.344 -2.097 . . . . 2.52 112.631 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.66 8.95 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 116.768 -2.634 . . . . 1.5 118.933 166.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -104.48 133.28 49.61 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 122.721 3.26 . . . . 1.79 109.923 -171.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.1 m -117.22 112.74 21.23 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 118.514 -1.275 . . . . 1.38 112.635 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.31 19.7 pt -97.02 136.0 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 124.178 1.942 . . . . 2.03 111.882 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.1 m -97.65 126.75 43.15 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 116.931 -3.606 . . . . 1.61 108.415 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.3 mt -131.41 141.48 49.85 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 127.4 3.476 . . . . 2.15 109.632 -173.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -97.54 118.67 34.56 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 113.562 -5.711 . . . . 1.98 109.59 171.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.97 174.99 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 119.859 -1.775 . . . . 1.52 109.138 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -116.02 147.96 40.37 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-O 116.342 -1.789 . . . . 2.35 107.084 157.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.03 -18.06 35.98 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-O 113.741 -2.691 . . . . 1.31 109.557 -174.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.2 p -71.0 -9.47 58.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 122.892 2.587 . . . . 1.71 115.057 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -80.02 166.66 21.33 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 114.629 -5.044 . . . . 1.69 110.37 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.5 p -93.82 152.0 19.21 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 121.903 0.858 . . . . 1.33 110.699 -177.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.445 HD11 ' HB3' ' A' ' 50' ' ' LEU . 4.1 mt -59.65 -36.39 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 115.913 1.82 . . . . 1.32 115.913 173.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -44.18 -56.32 4.17 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 126.304 1.842 . . . . 1.62 115.357 162.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -61.54 -39.16 90.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 112.87 -3.443 . . . . 2.13 111.683 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.3 t -63.12 -38.63 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 122.247 2.294 . . . . 1.23 108.05 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -71.45 -26.77 62.87 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.81 2.893 . . . . 1.97 118.81 171.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.98 -24.5 65.15 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.897 -2.377 . . . . 1.19 111.107 168.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -70.23 -37.33 74.97 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.119 -2.238 . . . . 1.92 112.561 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.3 mt -58.55 -35.41 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 128.787 2.835 . . . . 1.94 109.903 167.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -65.24 -42.72 93.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.175 -2.345 . . . . 1.9 113.862 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -63.71 -32.07 73.44 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 126.515 2.384 . . . . 1.55 114.82 165.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -88.41 -65.84 0.98 Allowed 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.115 -2.24 . . . . 2.95 110.224 -167.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -99.42 -24.39 14.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.246 1.818 . . . . 1.48 110.863 -169.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.43 43.67 2.91 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-O 125.298 2.61 . . . . 1.12 111.066 170.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.3 mt -120.74 129.49 25.29 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 120.288 -1.713 . . . . 2.07 106.542 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -71.61 150.69 57.44 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-N 124.82 2.757 . . . . 1.39 109.725 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -72.89 -12.29 26.13 Favored 'Trans proline' 0 C--N 1.298 -2.08 0 C-N-CA 122.511 2.141 . . . . 1.68 116.948 -173.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -81.12 -32.08 33.97 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 114.375 -5.203 . . . . 2.25 105.579 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -79.66 6.03 11.72 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 114.445 1.276 . . . . 2.44 114.445 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -149.51 147.42 28.18 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.804 -2.435 . . . . 1.32 114.253 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.277 60.2 mtt180 -129.78 162.12 29.16 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.051 -2.906 . . . . 3.19 108.563 171.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.9 mt -120.32 148.75 43.33 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 119.28 -2.138 . . . . 1.75 109.633 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.7 mt -127.61 129.04 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 124.87 2.271 . . . . 1.98 109.006 -172.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.434 ' CE1' ' HB3' ' A' ' 65' ' ' SER . 43.2 t80 -118.08 125.72 50.86 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 104.785 -2.302 . . . . 1.94 104.785 170.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.268 . . 79.84 -54.26 0.39 Allowed 'General case' 0 N--CA 1.428 -1.535 0 O-C-N 118.446 -2.659 . . . . 1.67 111.876 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.72 -24.32 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.675 0 O-C-N 118.119 -2.863 . . . . 1.3 115.099 -170.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -97.35 141.35 30.55 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.337 -1.684 . . . . 2.89 107.524 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -76.77 120.3 21.73 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.464 3.106 . . . . 2.89 111.649 177.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.445 ' HB3' HD11 ' A' ' 23' ' ' ILE . 43.2 mt -80.85 144.99 31.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.095 -1.628 . . . . 1.34 109.656 -166.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -74.87 121.5 21.95 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.716 2.406 . . . . 1.94 112.117 175.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -65.05 -29.36 70.25 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 113.382 -1.735 . . . . 1.56 112.463 -171.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.16 33.15 4.6 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 120.79 3.076 . . . . 0.97 120.79 168.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.9 mtt-85 -132.67 176.07 8.77 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 101.037 -3.69 . . . . 3.07 101.037 166.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.6 p -108.63 175.33 5.51 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.299 1.439 . . . . 1.34 109.962 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.6 mt -68.3 -23.7 64.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.539 1.681 . . . . 1.63 115.539 173.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 t -65.25 -40.09 93.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.678 2.791 . . . . 1.51 111.486 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -70.62 -21.89 62.59 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.262 1.578 . . . . 1.9 115.262 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -96.39 -3.24 43.99 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.81 -3.056 . . . . 0.97 108.582 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 58.84 40.88 22.3 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 127.575 2.35 . . . . 2.35 112.987 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.9 mt -80.53 127.08 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 1 O-C-N 131.022 5.201 . . . . 1.39 104.949 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -93.71 -174.85 3.58 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 128.079 2.552 . . . . 2.58 111.243 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.7 pttp -72.35 151.27 42.8 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.432 -1.258 . . . . 2.58 111.536 174.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.375 11.7 mt-10 56.65 42.23 27.28 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.443 2.757 . . . . 1.71 118.443 176.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.434 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 74.5 m -100.65 143.53 30.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.593 -2.743 . . . . 1.34 103.593 -175.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -103.04 110.4 22.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 125.183 2.421 . . . . 1.36 108.202 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -96.04 115.33 27.27 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.074 3.35 . . . . 2.03 112.538 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -86.71 121.37 29.12 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.445 -2.035 . . . . 2.31 115.977 -171.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.2 tt -89.39 138.34 31.53 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.355 -2.716 . . . . 1.72 108.764 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -125.45 162.75 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 O-C-N 128.408 3.568 . . . . 1.8 111.702 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.6 mt . . . . . 0 N--CA 1.431 -1.408 0 CA-C-O 124.031 1.872 . . . . 3.26 109.45 -179.801 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ptt? . . . . . 0 CA--C 1.489 -1.373 0 CA-C-O 123.198 1.475 . . . . 1.39 109.361 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -118.03 139.42 51.22 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.618 -3.176 . . . . 2.2 108.621 -176.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.422 HD13 HD23 ' A' ' 67' ' ' LEU . 22.1 pt -125.13 144.6 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 CA-C-O 115.826 -2.035 . . . . 1.32 106.251 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -102.31 101.02 11.24 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 126.419 2.324 . . . . 2.2 108.705 -174.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.451 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 21.7 t -82.2 110.99 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 116.699 -3.751 . . . . 1.23 106.779 175.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -98.58 136.38 38.76 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 109.247 -0.649 . . . . 2.51 109.247 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 p -90.81 -155.42 0.39 Allowed 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.704 1.602 . . . . 1.41 108.15 175.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.4 mt -103.47 -60.78 1.51 Allowed 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 113.739 -3.029 . . . . 2.95 110.428 175.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 p -51.37 -41.68 60.82 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 133.894 6.996 . . . . 2.52 116.672 -174.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.46 -19.77 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 126.262 3.146 . . . . 1.5 120.398 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -71.67 151.48 43.64 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.169 -2.371 . . . . 1.79 110.805 -174.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.4 m -130.32 110.23 11.36 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.147 1.779 . . . . 1.38 110.635 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.451 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 4.8 mm -85.92 101.75 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 115.539 -2.172 . . . . 2.03 105.752 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.8 m -78.42 89.63 4.41 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 125.489 1.743 . . . . 1.61 111.119 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.413 HD11 HG13 ' A' ' 26' ' ' VAL . 26.8 mt -85.3 124.15 31.6 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.592 -3.193 . . . . 2.15 113.207 178.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -71.48 114.87 10.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 125.493 1.746 . . . . 1.98 112.431 161.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 m -134.18 165.43 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 120.253 -1.529 . . . . 1.52 108.851 -176.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -104.91 156.41 36.06 Favored Pre-proline 0 N--CA 1.429 -1.488 0 CA-C-O 116.401 -1.762 . . . . 2.35 106.879 167.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -79.5 -11.9 14.13 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 CA-C-N 126.047 3.195 . . . . 1.31 106.22 -170.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.9 p -73.35 -21.8 60.45 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.898 2.555 . . . . 1.71 117.898 173.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -63.54 147.18 52.1 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 125.441 1.713 . . . . 1.69 112.159 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.8 p -83.6 168.74 16.08 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.662 -1.274 . . . . 1.33 110.51 170.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.485 HG23 HD12 ' A' ' 43' ' ' LEU . 24.1 mm -68.77 -30.06 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 128.684 2.794 . . . . 1.32 108.91 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -48.8 -47.78 41.89 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.301 1.84 . . . . 1.62 113.73 166.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -63.87 -41.49 97.75 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.959 2.504 . . . . 2.13 111.516 173.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.413 HG13 HD11 ' A' ' 15' ' ' LEU . 53.9 t -67.75 -45.0 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 1 O-C-N 116.231 -4.043 . . . . 1.23 112.807 179.817 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -68.66 -22.32 64.39 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.274 1.511 . . . . 1.97 114.034 175.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.32 83.42 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.35 -3.969 . . . . 1.19 117.356 170.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -64.01 -29.49 70.64 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.285 -2.134 . . . . 1.92 113.991 165.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.3 76.7 mt -72.89 -40.08 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 117.042 -3.536 . . . . 1.94 111.108 176.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -64.47 -46.86 81.26 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.819 2.048 . . . . 1.9 111.474 173.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.07 -54.38 25.38 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.434 -2.666 . . . . 1.55 116.974 167.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -73.61 -68.58 0.49 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.529 2.048 . . . . 2.95 116.529 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -84.19 -23.23 30.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.362 -1.29 . . . . 1.48 113.557 -167.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.25 24.56 14.21 Favored Glycine 0 N--CA 1.429 -1.769 1 CA-C-O 128.144 4.191 . . . . 1.12 114.301 170.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.412 HD11 HD23 ' A' ' 71' ' ' LEU . 8.7 mt -105.37 133.71 20.03 Favored Pre-proline 0 N--CA 1.429 -1.482 0 O-C-N 116.758 -3.789 . . . . 2.07 106.622 -170.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -65.55 146.6 85.14 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 CA-C-O 114.733 -2.278 . . . . 1.39 115.304 172.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -81.16 -9.49 12.76 Favored 'Trans proline' 0 N--CA 1.433 -2.058 0 CA-C-N 125.928 3.153 . . . . 1.68 108.462 -171.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -71.19 -23.79 62.1 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.482 -2.011 . . . . 2.25 111.344 168.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -92.15 -22.53 19.81 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 120.351 1.432 . . . . 2.44 107.848 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.307 74.5 mt-30 -79.31 152.66 30.37 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 125.324 2.488 . . . . 1.32 110.449 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.434 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 72.0 mtt180 -125.45 138.29 54.0 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.063 -4.148 . . . . 3.19 108.756 158.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.485 HD12 HG23 ' A' ' 23' ' ' ILE . 23.9 mt -116.47 111.56 20.17 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.424 -3.298 . . . . 1.75 104.405 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.6 mm -98.25 141.73 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 103.824 -2.658 . . . . 1.98 103.824 174.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -115.6 -109.44 0.36 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 114.877 -2.487 . . . . 1.94 109.372 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.99 -32.15 16.04 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 124.418 3.281 . . . . 1.67 112.912 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.81 -41.23 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 127.756 2.598 . . . . 1.3 114.086 -175.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -80.69 136.02 36.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.706 2.669 . . . . 2.89 110.56 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -89.95 95.53 10.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.704 2.802 . . . . 2.89 108.208 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 mt -57.01 140.93 47.49 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.988 -2.32 . . . . 1.34 115.32 -164.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.257 42.4 mt-10 -83.14 150.19 26.41 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.456 -1.402 . . . . 1.94 114.721 173.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -65.71 -52.3 52.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.235 2.309 . . . . 1.56 117.235 -169.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.15 56.97 1.76 Allowed Glycine 0 N--CA 1.43 -1.758 0 CA-C-N 108.533 -3.939 . . . . 0.97 113.6 173.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.0 mmt-85 -132.45 168.54 18.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 129.162 3.507 . . . . 3.07 105.34 163.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -107.18 164.83 11.83 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.439 -1.71 . . . . 1.34 113.487 173.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.8 mt -66.53 -24.68 66.41 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.504 -1.373 . . . . 1.63 113.609 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.3 t -64.59 -39.79 94.36 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 128.749 2.82 . . . . 1.51 111.063 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -66.55 -31.39 72.08 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.082 -2.886 . . . . 1.9 116.211 173.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -90.5 2.65 55.52 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 115.439 1.644 . . . . 0.97 115.439 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 69.35 27.15 5.12 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 117.452 -1.261 . . . . 2.35 109.872 178.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.4 mt -79.65 128.02 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 126.149 2.88 . . . . 1.39 110.848 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -130.82 171.51 13.06 Favored 'General case' 0 N--CA 1.429 -1.494 1 O-C-N 115.043 -4.786 . . . . 2.58 108.469 -167.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -54.16 130.74 39.43 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.818 2.723 . . . . 2.58 115.641 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 65.94 34.9 6.81 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 130.032 3.333 . . . . 1.71 112.116 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.6 t -90.91 141.48 28.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.965 1.364 . . . . 1.34 112.217 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.0 m -83.99 111.85 19.64 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.989 1.716 . . . . 1.36 114.464 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.422 HD23 HD13 ' A' ' 3' ' ' ILE . 6.8 mp -108.45 166.44 10.77 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.715 2.006 . . . . 2.03 112.058 177.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -123.21 132.16 53.94 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.328 -4.608 . . . . 2.31 110.879 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.0 tp -98.89 108.79 21.57 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.65 1.214 . . . . 1.72 108.484 174.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.434 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 15.5 t -105.88 143.12 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 128.926 2.891 . . . . 1.8 108.015 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.412 HD23 HD11 ' A' ' 36' ' ' ILE . 84.8 mt . . . . . 0 N--CA 1.43 -1.473 0 CA-C-N 125.986 3.993 . . . . 3.26 108.848 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ptt? . . . . . 0 CA--C 1.491 -1.314 0 CA-C-O 122.655 1.217 . . . . 1.39 112.804 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -96.0 139.97 31.42 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 107.45 -1.315 . . . . 2.2 107.45 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.256 16.3 pt -132.08 169.49 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 107.312 -1.366 . . . . 1.32 107.312 172.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -134.07 142.61 47.62 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.132 0.967 . . . . 2.2 113.02 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.57 134.13 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 O-C-N 118.837 -2.415 . . . . 1.23 110.416 168.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -96.79 149.11 22.21 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 117.419 -1.276 . . . . 2.51 109.63 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.321 4.8 p -103.85 -166.35 1.25 Allowed 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.501 2.375 . . . . 1.41 114.928 176.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.2 tp -76.18 -57.93 3.58 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 114.839 1.422 . . . . 2.95 114.839 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.2 p -70.5 -32.8 70.43 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 116.871 2.175 . . . . 2.52 116.871 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.07 58.32 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 118.757 -1.687 . . . . 1.5 115.597 172.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -118.18 138.2 52.47 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 121.109 2.455 . . . . 1.79 107.775 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.5 m -100.6 117.33 34.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 104.889 -2.263 . . . . 1.38 104.889 174.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.6 mt -96.47 116.54 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 106.219 -1.771 . . . . 2.03 106.219 174.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.406 3.6 m -83.08 121.53 27.16 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 126.039 1.736 . . . . 1.61 113.551 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.5 mt -123.03 143.16 50.13 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.635 -1.915 . . . . 2.15 112.201 -175.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -104.07 141.99 35.25 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 104.49 -2.411 . . . . 1.98 104.49 170.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.3 m -161.07 161.9 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 106.966 -1.494 . . . . 1.52 106.966 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.52 162.44 19.71 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-O 115.828 -2.034 . . . . 2.35 106.868 157.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 97.5 Cg_endo -74.33 -1.79 11.47 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 CA-C-N 124.592 2.676 . . . . 1.31 113.714 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.1 m -90.72 -2.51 57.81 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 115.359 1.615 . . . . 1.71 115.359 171.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -66.73 131.07 45.18 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.146 2.403 . . . . 1.69 107.121 168.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 17.6 p -68.47 175.16 3.56 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 112.954 -1.93 . . . . 1.33 112.205 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.5 mm -74.66 -35.48 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 116.528 -3.858 . . . . 1.32 108.018 176.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -54.3 -46.66 72.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.213 -3.43 . . . . 1.62 115.351 165.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -56.86 -37.16 70.93 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 125.577 2.608 . . . . 2.13 112.79 171.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.56 -39.8 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 116.463 -3.898 . . . . 1.23 114.34 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -65.88 -33.3 75.52 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 117.621 2.452 . . . . 1.97 117.621 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.68 -23.75 61.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 111.598 -2.546 . . . . 1.19 110.691 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -75.72 -29.64 59.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 122.579 2.445 . . . . 1.92 113.564 168.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.6 mt -66.44 -42.29 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.908 -1.745 . . . . 1.94 110.195 171.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -58.54 -38.36 77.61 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.314 -3.366 . . . . 1.9 118.216 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -59.96 -32.83 71.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.989 2.218 . . . . 1.55 116.989 172.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.327 53.8 mmtt -89.15 -48.74 7.19 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.924 -3.61 . . . . 2.95 110.009 -174.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -112.39 -19.16 12.27 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 123.096 1.426 . . . . 1.48 114.164 -165.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.33 9.42 79.55 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 118.984 -2.323 . . . . 1.12 113.907 167.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.5 mt -81.58 133.26 53.04 Favored Pre-proline 0 N--CA 1.43 -1.457 0 O-C-N 120.951 -1.323 . . . . 2.07 112.237 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -69.17 148.78 69.63 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 CA-C-N 122.517 1.935 . . . . 1.39 113.681 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -71.14 -25.03 22.87 Favored 'Trans proline' 0 C--N 1.301 -1.953 1 C-N-CA 125.893 4.395 . . . . 1.68 115.211 -170.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -70.65 -27.13 63.81 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 128.348 2.659 . . . . 2.25 113.881 175.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -91.77 -1.94 57.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.432 2.293 . . . . 2.44 110.472 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -100.86 135.19 42.69 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.658 -1.901 . . . . 1.32 109.813 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 62.4 mtm180 -117.87 114.28 23.0 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.585 2.448 . . . . 3.19 110.191 173.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.6 mt -100.32 129.17 46.28 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 120.762 1.619 . . . . 1.75 110.515 -176.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.8 mm -110.77 128.17 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 125.638 1.575 . . . . 1.98 108.639 177.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CZ ' HG12 ' A' ' 61' ' ' ILE . 41.3 t80 -109.12 102.72 11.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.145 1.45 . . . . 1.94 107.155 170.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.312 . . 65.41 -63.62 0.2 Allowed 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.064 -2.897 . . . . 1.67 118.084 -173.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -162.6 -5.85 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.709 0 O-C-N 118.194 -2.816 . . . . 1.3 111.914 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -95.38 143.08 27.03 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 125.843 1.555 . . . . 2.89 107.609 173.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -93.59 143.55 26.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.944 2.783 . . . . 2.89 111.37 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.0 mt -94.76 132.05 39.94 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 113.857 -5.527 . . . . 1.34 108.217 -167.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -83.81 139.24 32.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.395 1.478 . . . . 1.94 109.292 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.287 8.5 m-20 -62.95 -50.11 72.09 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.499 -3.251 . . . . 1.56 119.701 -171.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.23 9.44 63.92 Favored Glycine 0 N--CA 1.43 -1.704 1 N-CA-C 123.183 4.033 . . . . 0.97 123.183 174.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 22' ' ' THR . 7.8 mtt180 -78.39 161.23 27.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 113.621 0.971 . . . . 3.07 113.621 168.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.1 p -89.39 164.9 14.67 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 118.955 2.946 . . . . 1.34 118.955 164.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 89.5 mt -64.32 -36.56 84.51 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.599 -3.188 . . . . 1.63 116.86 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.2 p -58.41 -29.0 65.74 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 128.1 2.56 . . . . 1.51 113.362 166.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -59.6 -47.5 85.35 Favored 'General case' 0 N--CA 1.43 -1.431 1 CA-C-N 127.312 4.596 . . . . 1.9 110.892 173.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -83.36 0.98 43.56 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.123 3.369 . . . . 0.97 114.056 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.3 m120 58.32 45.85 16.4 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.996 2.221 . . . . 2.35 116.996 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.419 HG12 ' CZ ' ' A' ' 45' ' ' PHE . 65.4 mt -87.76 118.04 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 104.765 -2.309 . . . . 1.39 104.765 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -85.23 -163.21 0.81 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.737 -2.477 . . . . 2.58 109.029 -174.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 pttt -74.43 147.02 42.39 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.085 -2.259 . . . . 2.58 110.217 174.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 62.73 48.74 4.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.172 0.986 . . . . 1.71 109.622 170.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.1 m -108.59 141.29 40.73 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.853 -1.779 . . . . 1.34 110.203 -169.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.8 m -103.81 108.68 20.1 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 125.568 2.604 . . . . 1.36 108.656 -172.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mp -96.52 163.88 12.85 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 112.425 -2.17 . . . . 2.03 107.875 171.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -118.05 140.28 49.98 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.197 1.799 . . . . 2.31 111.937 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.7 tp -108.97 120.59 42.99 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.399 -3.313 . . . . 1.72 109.667 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.4 t -116.93 150.31 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 105.418 -2.067 . . . . 1.8 105.418 174.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 N--CA 1.43 -1.472 0 O-C-N 117.09 -3.506 . . . . 3.26 113.211 -177.049 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 ttp . . . . . 0 CA--C 1.49 -1.33 0 N-CA-C 116.563 2.061 . . . . 1.39 116.563 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -92.84 123.74 36.33 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.233 -2.792 . . . . 2.2 108.46 -170.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.335 50.4 pt -116.22 137.66 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.495 1.918 . . . . 1.32 112.73 176.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -104.83 100.05 9.69 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 116.58 2.067 . . . . 2.2 116.58 -176.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.3 t -84.53 96.9 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 124.537 2.113 . . . . 1.23 111.89 178.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -95.74 122.75 38.85 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.48 1.61 . . . . 2.51 109.423 -174.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.29 20.2 p -89.99 167.27 12.92 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.787 2.035 . . . . 1.41 114.19 -176.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.8 tp -66.24 -32.19 73.46 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 126.009 2.814 . . . . 2.95 115.455 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.6 p -77.44 -48.24 17.67 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.428 1.891 . . . . 2.52 111.854 -178.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.3 -1.21 0.53 Allowed Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 117.174 1.63 . . . . 1.5 117.174 173.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -78.11 139.66 39.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 119.372 1.586 . . . . 1.79 109.133 -177.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -104.17 112.09 24.95 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.644 -2.535 . . . . 1.38 105.435 169.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -93.06 105.51 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 103.413 -2.81 . . . . 2.03 103.413 178.141 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -84.74 107.08 16.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.006 2.224 . . . . 1.61 117.006 177.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.2 mt -105.27 136.72 44.27 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 121.122 1.783 . . . . 2.15 107.518 -175.076 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -87.99 90.9 8.57 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 124.154 1.931 . . . . 1.98 108.625 168.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.21 176.27 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 128.571 2.749 . . . . 1.52 109.11 -176.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -117.88 151.37 48.68 Favored Pre-proline 0 N--CA 1.431 -1.413 0 O-C-N 124.917 1.386 . . . . 2.35 108.638 161.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -74.26 -11.96 23.06 Favored 'Trans proline' 0 N--CA 1.434 -2.004 1 O-C-N 112.794 -4.371 . . . . 1.31 115.208 -170.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.4 p -81.98 -15.35 54.04 Favored 'General case' 0 N--CA 1.429 -1.476 1 C-N-CA 132.297 4.239 . . . . 1.71 110.315 174.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -68.62 153.38 43.88 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 120.756 1.616 . . . . 1.69 110.942 172.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 25.2 p -87.6 166.87 14.4 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.353 1.861 . . . . 1.33 108.93 -179.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.2 mm -71.61 -36.0 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 124.455 2.074 . . . . 1.32 113.188 175.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -38.82 -42.97 0.88 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.853 -3.03 . . . . 1.62 117.047 159.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -76.94 -38.18 53.86 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.226 -2.796 . . . . 2.13 108.489 179.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.9 t -55.89 -39.09 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 127.354 2.261 . . . . 1.23 114.269 172.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -81.05 -19.34 44.0 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.612 -2.555 . . . . 1.97 115.88 173.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.07 -38.59 63.88 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 122.819 1.295 . . . . 1.19 109.486 174.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -63.24 -29.29 70.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.633 -2.542 . . . . 1.92 113.864 174.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.3 mt -77.88 -24.34 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 116.661 2.097 . . . . 1.94 116.661 169.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -76.42 -30.48 57.46 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.27 -3.394 . . . . 1.9 110.025 173.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -76.5 -43.33 40.02 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.805 1.288 . . . . 1.55 112.129 173.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -77.4 -69.36 0.54 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.347 -2.096 . . . . 2.95 114.506 -173.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -80.46 -51.17 9.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.677 -1.147 . . . . 1.48 113.153 -172.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.09 43.03 1.13 Allowed Glycine 0 N--CA 1.429 -1.796 0 O-C-N 125.508 1.755 . . . . 1.12 111.232 175.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.3 mt -104.3 132.99 20.45 Favored Pre-proline 0 N--CA 1.431 -1.386 0 C-N-CA 125.557 1.543 . . . . 2.07 107.377 -178.16 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -70.85 138.96 35.42 Favored 'Trans proline' 0 N--CA 1.433 -2.067 1 C-N-CA 126.054 4.502 . . . . 1.39 111.54 -178.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -71.52 -19.47 28.33 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 O-C-N 117.924 -1.671 . . . . 1.68 112.434 -169.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -62.4 -35.02 77.9 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 114.83 1.418 . . . . 2.25 114.83 165.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -87.57 -13.93 41.55 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 124.037 0.935 . . . . 2.44 112.628 -179.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.329 71.3 mt-30 -84.78 113.01 21.02 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 120.957 1.708 . . . . 1.32 107.701 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -92.34 134.5 34.86 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 116.676 -1.63 . . . . 3.19 106.712 165.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.8 mt -127.79 125.42 39.81 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 102.629 -3.1 . . . . 1.75 102.629 177.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -115.13 137.3 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 115.947 -1.978 . . . . 1.98 105.788 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -124.06 107.4 11.25 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.227 2.285 . . . . 1.94 107.628 171.172 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.363 . . 74.55 -77.07 0.06 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.517 2.58 . . . . 1.67 114.922 -173.414 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.3 -0.67 0.24 Allowed Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 129.917 3.627 . . . . 1.3 115.42 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -111.56 114.01 26.8 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 124.663 1.185 . . . . 2.89 110.565 -179.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -81.13 127.94 33.19 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 124.56 1.144 . . . . 2.89 111.885 176.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.481 HD23 ' CD2' ' A' ' 59' ' ' TYR . 69.7 mt -79.82 120.36 23.97 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 120.338 3.458 . . . . 1.34 120.338 -162.569 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.288 37.1 mt-10 -78.22 138.63 38.74 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.216 -2.177 . . . . 1.94 113.758 -176.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.66 -45.33 92.36 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 112.616 -2.084 . . . . 1.56 113.072 -171.477 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.59 25.14 9.88 Favored Glycine 0 N--CA 1.43 -1.713 0 C-N-CA 125.763 1.649 . . . . 0.97 116.601 175.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -112.7 166.36 11.43 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.99 1.852 . . . . 3.07 110.309 165.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 12.2 p -101.28 169.17 9.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.134 -2.854 . . . . 1.34 106.424 176.369 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.44 HD22 HD13 ' A' ' 61' ' ' ILE . 62.6 mt -65.95 -38.19 87.96 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.576 2.608 . . . . 1.63 112.304 172.185 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.0 p -60.34 -41.1 92.89 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.923 -4.236 . . . . 1.51 116.067 -178.134 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -53.47 -49.7 66.88 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 117.715 2.487 . . . . 1.9 117.715 169.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.481 ' CD2' HD23 ' A' ' 50' ' ' LEU . 59.9 m-85 -67.26 -10.41 50.44 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.659 2.466 . . . . 0.97 117.659 173.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.309 64.8 t30 73.93 47.62 0.15 Allowed 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.573 -2.58 . . . . 2.35 105.167 -177.402 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.44 HD13 HD22 ' A' ' 56' ' ' LEU . 87.6 mt -100.59 119.82 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 102.829 -3.026 . . . . 1.39 102.829 177.261 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -115.09 -167.8 1.29 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 114.219 -1.355 . . . . 2.58 112.274 -176.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -60.27 138.86 57.87 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.611 2.448 . . . . 2.58 117.611 169.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.432 20.8 mt-10 69.19 22.97 6.54 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.007 2.225 . . . . 1.71 117.007 174.299 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.4 m -83.16 141.06 32.22 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.209 2.604 . . . . 1.34 113.913 -175.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.4 m -94.65 116.1 28.34 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.3 -3.375 . . . . 1.36 107.464 -174.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -109.68 128.38 55.22 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 104.87 -2.27 . . . . 2.03 104.87 174.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -88.8 121.53 31.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 114.531 -2.652 . . . . 2.31 115.085 -177.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.8 tp -89.14 120.27 30.38 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 123.827 3.012 . . . . 1.72 114.376 175.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.45 169.23 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 120.651 -1.281 . . . . 1.8 107.852 172.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 N--CA 1.43 -1.462 0 O-C-N 117.89 -3.007 . . . . 3.26 107.528 177.783 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.316 0 N-CA-C 114.325 1.231 . . . . 1.39 114.325 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.267 0.7 OUTLIER -97.39 131.96 43.56 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.023 1.49 . . . . 2.2 115.023 -175.607 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -112.5 145.14 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 117.896 -3.002 . . . . 1.32 110.131 172.114 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -109.87 112.83 25.1 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 103.984 -2.599 . . . . 2.2 103.984 -173.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.52 103.1 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 104.071 -2.566 . . . . 1.23 104.071 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -102.76 131.11 49.83 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 112.58 0.585 . . . . 2.51 112.58 -179.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.4 p -93.16 176.81 6.27 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 128.155 3.409 . . . . 1.41 119.39 -177.157 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.3 tp -67.03 -37.57 84.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 124.92 3.509 . . . . 2.95 112.047 170.206 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.8 p -78.87 6.63 8.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 129.926 3.29 . . . . 2.52 111.313 -171.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.68 5.25 57.76 Favored Glycine 0 N--CA 1.43 -1.716 0 CA-C-N 125.001 3.546 . . . . 1.5 113.671 169.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -93.99 133.66 37.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.317 2.247 . . . . 1.79 115.719 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.5 m -108.39 117.18 33.48 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.277 -1.009 . . . . 1.38 108.277 171.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 mt -105.02 113.7 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 101.238 -3.615 . . . . 2.03 101.238 -179.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.4 m -101.19 117.33 34.79 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 120.819 1.645 . . . . 1.61 107.426 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.7 mt -102.06 151.38 22.23 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.985 3.314 . . . . 2.15 114.677 178.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -105.48 104.72 14.5 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 121.636 3.939 . . . . 1.98 121.636 168.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.3 m -119.91 168.36 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 112.452 -2.158 . . . . 1.52 109.528 -177.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -105.44 159.88 27.96 Favored Pre-proline 0 N--CA 1.431 -1.409 0 C-N-CA 125.713 1.605 . . . . 2.35 108.772 164.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.89 -18.44 16.88 Favored 'Trans proline' 0 N--CA 1.435 -1.967 0 O-C-N 115.767 -2.807 . . . . 1.31 113.537 -170.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.4 m -86.67 2.72 47.51 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.438 -2.039 . . . . 1.71 115.989 174.482 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -79.27 148.13 32.27 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 127.463 2.305 . . . . 1.69 109.766 172.124 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.5 p -76.99 161.04 28.67 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 127.147 2.179 . . . . 1.33 116.197 175.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.8 mm -71.56 -31.36 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 125.738 1.615 . . . . 1.32 111.944 173.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -50.87 -46.65 60.44 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.142 2.401 . . . . 1.62 114.562 162.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.282 6.3 t-20 -63.4 -45.13 92.45 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 116.226 -4.046 . . . . 2.13 114.949 176.755 . . . . . . . . 3 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -48.11 -38.81 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 127.893 2.477 . . . . 1.23 115.816 168.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -66.82 -34.58 78.13 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.392 -2.692 . . . . 1.97 113.603 173.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.0 -32.43 61.65 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.583 -2.573 . . . . 1.19 112.345 176.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -58.5 -38.73 78.26 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 120.688 1.585 . . . . 1.92 115.199 165.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.7 mt -71.55 -37.34 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 130.766 3.626 . . . . 1.94 111.902 177.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -59.81 -47.43 85.73 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 129.027 2.931 . . . . 1.9 109.364 169.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.4 -54.9 41.41 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.613 2.625 . . . . 1.55 115.127 171.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -72.49 -67.51 0.55 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.712 -3.118 . . . . 2.95 112.696 -175.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -77.53 -55.37 5.43 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 120.035 -1.666 . . . . 1.48 114.639 -174.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.94 25.98 0.65 Allowed Glycine 0 N--CA 1.43 -1.716 0 O-C-N 118.136 -2.853 . . . . 1.12 110.326 174.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.0 mt -99.95 140.09 21.26 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-N 123.344 3.572 . . . . 2.07 105.365 -167.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -66.85 159.04 53.47 Favored 'Trans proline' 0 N--CA 1.433 -2.066 0 CA-C-N 125.128 2.867 . . . . 1.39 111.053 176.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -78.23 -3.52 13.49 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 CA-C-N 122.635 1.977 . . . . 1.68 111.907 -175.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.271 96.0 m-20 -88.22 -29.65 20.3 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 125.813 2.72 . . . . 2.25 112.727 174.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -84.51 16.04 3.38 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 116.351 1.982 . . . . 2.44 116.351 -179.079 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -126.08 129.72 49.69 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.93 1.292 . . . . 1.32 109.78 -176.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -118.7 134.78 54.88 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.443 2.697 . . . . 3.19 108.973 167.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.5 mt -120.01 123.98 44.78 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 113.715 -1.584 . . . . 1.75 114.303 178.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.497 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 23.7 mm -99.9 145.59 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 101.397 -3.557 . . . . 1.98 101.397 175.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -139.16 123.82 18.49 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 101.404 -3.554 . . . . 1.94 101.404 168.153 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.07 -68.59 0.21 Allowed 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 127.487 2.992 . . . . 1.67 112.402 -172.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.25 -32.03 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 114.412 -1.267 . . . . 1.3 115.117 -179.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.276 12.4 ptpt -74.93 151.15 38.9 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.174 1.175 . . . . 2.89 114.174 177.443 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -87.16 105.34 17.13 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 131.066 3.746 . . . . 2.89 113.326 174.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.454 HD22 ' CD2' ' A' ' 59' ' ' TYR . 61.9 mt -66.77 158.37 30.51 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.074 -2.266 . . . . 1.34 109.536 -161.285 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -91.27 156.18 18.0 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 124.855 2.264 . . . . 1.94 108.862 170.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -74.53 -66.37 0.75 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.504 -1.997 . . . . 1.56 114.186 -178.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.46 50.21 1.69 Allowed Glycine 0 N--CA 1.43 -1.761 0 O-C-N 118.057 -2.902 . . . . 0.97 115.177 168.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -122.7 160.38 25.99 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.346 -1.679 . . . . 3.07 106.962 159.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.2 p -85.68 169.17 13.72 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.675 -1.891 . . . . 1.34 113.325 176.132 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.1 mt -66.05 -33.12 75.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.844 2.458 . . . . 1.63 115.185 171.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.7 p -70.25 -32.91 70.96 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.408 -2.682 . . . . 1.51 114.784 176.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -67.59 -27.46 66.94 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.721 1.608 . . . . 1.9 115.252 177.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.454 ' CD2' HD22 ' A' ' 50' ' ' LEU . 59.8 m-85 -89.15 -14.8 35.33 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.074 2.25 . . . . 0.97 117.074 170.045 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.3 22.1 m120 75.77 45.68 0.12 Allowed 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.016 2.969 . . . . 2.35 119.016 -174.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.1 mt -91.32 107.9 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 129.833 3.253 . . . . 1.39 107.576 172.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -99.73 -165.11 1.19 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.53 1.932 . . . . 2.58 108.359 179.279 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -56.7 144.41 32.58 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.35 -2.719 . . . . 2.58 114.887 170.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 68.46 17.98 9.04 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.269 2.462 . . . . 1.71 114.97 171.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.7 m -80.89 131.43 35.36 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 125.675 2.655 . . . . 1.34 110.938 -169.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.0 m -80.61 110.38 16.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.758 -1.565 . . . . 1.36 115.109 176.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.46 155.17 17.98 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.476 2.71 . . . . 2.03 106.148 172.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.497 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 60.8 m80 -119.14 109.63 16.11 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.44 -2.037 . . . . 2.31 112.722 -170.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.1 tp -93.48 112.3 24.17 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 125.125 1.516 . . . . 1.72 112.338 -172.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.68 125.5 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 127.921 2.488 . . . . 1.8 110.266 179.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.8 tp . . . . . 0 N--CA 1.43 -1.46 0 O-C-N 117.679 -3.138 . . . . 3.26 106.623 -175.133 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptt? . . . . . 0 CA--C 1.489 -1.398 0 CA-C-O 126.429 3.014 . . . . 1.39 113.551 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -89.03 125.4 34.99 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.444 -1.707 . . . . 2.2 110.888 -174.506 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 pt -121.05 146.61 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 104.773 -2.306 . . . . 1.32 104.773 166.33 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -97.17 134.69 40.16 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 131.618 3.967 . . . . 2.2 103.677 -179.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.5 t -130.4 106.18 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 124.488 2.09 . . . . 1.23 106.947 172.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -96.65 142.93 28.1 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.185 1.469 . . . . 2.51 112.914 -176.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.1 p -82.02 179.32 7.86 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 118.339 -2.725 . . . . 1.41 114.345 175.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.7 tp -81.08 -30.73 34.65 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.661 2.384 . . . . 2.95 107.12 175.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -75.01 -44.91 45.39 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.614 -3.804 . . . . 2.52 112.36 -170.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.98 -3.59 0.16 Allowed Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 117.577 -2.249 . . . . 1.5 114.732 173.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.498 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 52.2 pttt -110.99 138.89 46.84 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 114.574 1.324 . . . . 1.79 114.574 -172.245 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -102.21 128.86 48.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 115.138 -2.363 . . . . 1.38 112.936 177.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.294 30.6 pt -107.14 145.8 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 106.773 -1.566 . . . . 2.03 106.773 176.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.9 m -97.51 134.4 40.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 111.802 -2.454 . . . . 1.61 112.639 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.64 142.43 50.66 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.701 1.715 . . . . 2.15 109.728 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -108.75 122.79 47.89 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 116.479 -3.888 . . . . 1.98 109.012 169.015 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.6 m -136.29 154.54 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 125.38 1.472 . . . . 1.52 107.887 -171.135 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -95.26 152.63 39.52 Favored Pre-proline 0 N--CA 1.43 -1.437 0 C-N-CA 130.896 3.679 . . . . 2.35 108.397 160.117 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -76.27 -7.28 17.9 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 C-N-CA 123.769 2.979 . . . . 1.31 111.322 -174.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.5 m -94.91 0.51 54.8 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.125 1.77 . . . . 1.71 111.524 175.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.53 142.65 38.94 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.178 -2.826 . . . . 1.69 108.794 174.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 p -84.58 173.29 10.9 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 124.498 1.119 . . . . 1.33 113.393 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.2 mm -65.29 -36.41 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 118.766 -2.459 . . . . 1.32 112.682 170.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.307 3.1 mp0 -54.11 -48.49 70.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.874 -2.391 . . . . 1.62 116.084 165.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -63.24 -36.13 82.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 112.628 0.603 . . . . 2.13 112.628 175.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.9 t -62.11 -52.13 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 126.681 1.992 . . . . 1.23 111.932 175.404 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -57.71 -40.39 79.44 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.848 1.259 . . . . 1.97 111.82 176.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.312 . . -50.9 -38.93 52.87 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 120.458 3.503 . . . . 1.19 120.458 167.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -74.65 -24.1 58.77 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.424 -2.048 . . . . 1.92 115.277 177.034 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.9 mt -78.51 -35.65 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 129.313 3.045 . . . . 1.94 106.012 177.034 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -75.98 -36.56 59.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.823 -1.798 . . . . 1.9 111.972 -179.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -55.56 -48.04 75.41 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 128.55 2.74 . . . . 1.55 108.625 174.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -87.66 -59.49 2.23 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.125 -2.234 . . . . 2.95 114.478 -177.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.498 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 68.2 mm-40 -86.55 -25.4 25.06 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 115.11 1.522 . . . . 1.48 115.11 -172.043 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.14 26.55 33.63 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 119.441 -1.361 . . . . 1.12 113.156 175.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.7 mt -96.05 115.67 65.72 Favored Pre-proline 0 N--CA 1.43 -1.454 1 CA-C-O 111.631 -4.033 . . . . 2.07 110.103 -177.179 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.29 164.81 34.47 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 CA-C-N 126.975 3.527 . . . . 1.39 115.142 -177.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -65.37 -34.27 44.63 Favored 'Trans proline' 0 N--CA 1.434 -1.982 0 CA-C-O 115.833 -1.82 . . . . 1.68 116.717 -165.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -45.46 -38.74 6.44 Favored 'General case' 0 N--CA 1.43 -1.461 1 C-N-CA 132.382 4.273 . . . . 2.25 116.171 170.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -96.94 2.27 51.4 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.608 2.363 . . . . 2.44 113.856 -176.466 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -88.1 99.61 12.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 116.751 -3.718 . . . . 1.32 107.811 -173.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -90.66 112.02 23.59 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 118.384 -2.697 . . . . 3.19 109.88 163.247 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.8 mt -105.3 129.84 53.56 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.154 1.781 . . . . 1.75 109.805 175.087 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.9 129.27 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 127.571 2.348 . . . . 1.98 109.136 177.201 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.437 ' HB3' HD21 ' A' ' 50' ' ' LEU . 73.1 t80 -123.14 114.29 20.12 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 104.438 -2.43 . . . . 1.94 104.438 171.478 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.37 -110.48 0.54 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 110.224 -3.171 . . . . 1.67 112.545 -170.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.13 4.27 35.59 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 126.492 1.996 . . . . 1.3 114.204 177.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -105.76 129.1 54.03 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.91 1.684 . . . . 2.89 114.739 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -82.5 126.6 32.43 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 126.558 1.943 . . . . 2.89 109.129 170.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.469 HD23 ' CE2' ' A' ' 59' ' ' TYR . 18.3 mt -79.5 128.89 33.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.501 1.92 . . . . 1.34 109.756 -173.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -112.68 179.13 4.06 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.207 2.432 . . . . 1.94 110.874 178.261 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -79.77 151.87 30.12 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 117.197 -1.801 . . . . 1.56 112.763 -171.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.71 -0.57 81.47 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 119.524 -1.985 . . . . 0.97 116.914 170.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -87.54 159.42 18.62 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 125.575 1.397 . . . . 3.07 110.505 169.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.266 70.4 p -100.08 167.52 10.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.937 2.303 . . . . 1.34 112.397 173.357 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.21 -29.75 70.85 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 117.086 -3.509 . . . . 1.63 112.221 164.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 t -68.8 -30.95 69.63 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.156 -1.59 . . . . 1.51 112.111 178.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -62.84 -50.34 71.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 114.904 1.446 . . . . 1.9 114.904 172.351 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.469 ' CE2' HD23 ' A' ' 50' ' ' LEU . 85.0 m-85 -81.87 11.9 4.55 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 115.927 -1.987 . . . . 0.97 111.788 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 m120 56.96 46.08 20.1 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 125.559 2.6 . . . . 2.35 115.04 178.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.3 mt -91.82 122.61 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 112.354 -2.203 . . . . 1.39 110.154 178.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -108.58 173.53 6.28 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 127.176 2.797 . . . . 2.58 109.477 -173.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -59.53 142.7 52.06 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.482 1.66 . . . . 2.58 115.482 173.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 5.7 tt0 75.71 15.2 2.64 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 126.271 2.939 . . . . 1.71 116.32 174.07 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 m -77.35 139.97 39.86 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 113.605 -1.634 . . . . 1.34 108.048 -175.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -109.51 90.94 3.45 Favored 'General case' 0 N--CA 1.429 -1.497 1 O-C-N 116.016 -4.177 . . . . 1.36 114.772 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -65.45 153.13 42.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.904 2.288 . . . . 2.03 112.82 173.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -105.53 101.51 11.03 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 115.815 -4.303 . . . . 2.31 109.326 -178.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.0 tp -91.89 108.74 20.14 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 121.018 1.736 . . . . 1.72 110.116 173.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -98.69 129.98 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 1 C-N-CA 134.069 4.947 . . . . 1.8 106.804 173.479 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.4 tp . . . . . 0 N--CA 1.43 -1.45 0 CA-C-N 111.911 -2.404 . . . . 3.26 112.861 174.179 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptt? . . . . . 0 CA--C 1.49 -1.34 0 N-CA-C 113.533 0.938 . . . . 1.39 113.533 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -105.38 124.33 49.37 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.371 3.068 . . . . 2.2 112.688 -175.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.1 pt -123.8 155.36 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 C-N-CA 129.349 3.06 . . . . 1.32 110.645 175.166 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -114.42 132.8 56.12 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 112.305 -2.225 . . . . 2.2 112.007 -171.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.86 97.22 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 103.192 -2.892 . . . . 1.23 103.192 178.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -90.62 141.09 29.14 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.529 -1.982 . . . . 2.51 112.403 174.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.7 p -107.31 165.39 11.42 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 120.126 1.33 . . . . 1.41 110.406 176.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.3 tp -52.7 -36.18 56.84 Favored 'General case' 0 N--CA 1.43 -1.435 1 C-N-CA 134.79 5.236 . . . . 2.95 116.974 177.65 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.4 p -90.08 -19.81 23.91 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.789 -3.07 . . . . 2.52 111.195 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.56 12.38 2.5 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 118.878 -2.389 . . . . 1.5 114.592 169.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 28.7 ttpt -94.21 135.4 35.64 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 119.809 1.805 . . . . 1.79 110.433 -176.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.1 m -115.41 108.7 16.85 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.625 -4.422 . . . . 1.38 108.506 178.45 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -81.48 124.01 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.455 2.302 . . . . 2.03 108.594 175.076 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.6 m -101.32 98.27 8.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.435 -2.666 . . . . 1.61 108.518 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 mt -100.07 139.91 35.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 127.821 3.676 . . . . 2.15 108.829 179.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -96.35 132.1 42.19 Favored 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 114.532 -5.105 . . . . 1.98 107.882 172.494 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.82 168.33 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 126.886 2.074 . . . . 1.52 109.763 179.007 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -105.43 160.61 25.44 Favored Pre-proline 0 N--CA 1.429 -1.477 0 O-C-N 119.457 -2.027 . . . . 2.35 105.927 165.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -79.59 -16.6 11.69 Favored 'Trans proline' 0 N--CA 1.434 -2.004 1 CA-C-N 129.395 4.391 . . . . 1.31 112.027 -168.437 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.8 p -85.32 2.9 42.14 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.681 -2.512 . . . . 1.71 116.272 173.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -71.12 140.04 50.48 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 125.44 1.713 . . . . 1.69 109.98 173.3 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.434 HG21 HG23 ' A' ' 55' ' ' THR 0.444 42.7 p -84.46 161.02 20.45 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.848 -1.782 . . . . 1.33 110.646 -178.624 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.9 mm -52.98 -27.86 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 C-N-CA 126.46 1.904 . . . . 1.32 115.124 170.471 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -57.65 -44.87 85.95 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.292 2.637 . . . . 1.62 115.687 167.278 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -65.13 -37.35 87.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.787 2.708 . . . . 2.13 115.598 178.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.3 t -72.75 -47.63 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 112.333 -2.212 . . . . 1.23 115.086 177.517 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -65.75 -17.05 64.35 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 114.581 1.326 . . . . 1.97 114.581 169.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.28 -41.28 17.02 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 119.958 1.253 . . . . 1.19 108.198 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -59.64 -31.83 69.89 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.143 1.905 . . . . 1.92 116.143 170.413 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.77 -49.73 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.453 1.597 . . . . 1.94 114.706 170.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -59.56 -37.51 78.65 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 113.662 0.986 . . . . 1.9 113.662 177.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.7 -37.95 77.21 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.62 -3.175 . . . . 1.55 113.684 176.357 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -92.56 -59.64 2.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.265 1.983 . . . . 2.95 114.364 -177.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.409 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 49.1 mm-40 -84.97 -27.45 26.49 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 118.622 -2.549 . . . . 1.48 113.074 -169.309 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.32 24.43 26.56 Favored Glycine 0 N--CA 1.431 -1.684 0 CA-C-O 124.497 2.165 . . . . 1.12 109.423 169.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.3 mt -91.82 112.79 56.41 Favored Pre-proline 0 N--CA 1.431 -1.411 0 CA-C-N 113.225 -1.487 . . . . 2.07 110.461 -171.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.255 18.4 Cg_exo -55.37 139.68 81.75 Favored 'Trans proline' 0 N--CA 1.433 -2.058 1 N-CA-C 123.69 4.458 . . . . 1.39 123.69 174.821 . . . . . . . . 3 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -62.01 -22.26 73.91 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 C-N-CA 123.659 2.906 . . . . 1.68 111.013 -175.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.63 -31.32 71.92 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.883 1.801 . . . . 2.25 110.864 173.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -88.09 -14.84 37.81 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 116.413 -3.929 . . . . 2.44 115.562 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -78.98 98.94 6.62 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 112.139 -2.301 . . . . 1.32 106.659 -173.102 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -102.8 107.48 18.36 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.097 -2.927 . . . . 3.19 103.097 169.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.4 mt -105.28 148.12 27.35 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 114.597 -2.841 . . . . 1.75 105.049 -175.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 mm -125.1 131.78 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 109.38 -0.6 . . . . 1.98 109.38 -179.258 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -122.23 108.79 13.69 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.888 -2.382 . . . . 1.94 104.799 168.432 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.87 -92.67 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.18 2.192 . . . . 1.67 110.01 179.051 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.4 -26.69 4.74 Favored Glycine 0 N--CA 1.429 -1.811 0 CA-C-N 113.68 -1.6 . . . . 1.3 109.974 -173.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.383 51.2 mttm -99.07 134.97 41.15 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.018 -3.048 . . . . 2.89 118.26 -176.304 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -90.08 116.04 27.8 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 105.836 -1.912 . . . . 2.89 105.836 176.206 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.3 118.97 10.09 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 123.607 1.67 . . . . 1.34 111.521 -169.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.12 154.13 20.41 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 116.531 -3.856 . . . . 1.94 110.682 -179.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -68.98 152.73 44.89 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.59 -1.943 . . . . 1.56 114.178 -173.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.47 10.55 85.65 Favored Glycine 0 N--CA 1.43 -1.709 0 O-C-N 119.454 -2.029 . . . . 0.97 112.57 173.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -104.24 171.3 7.41 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.992 2.33 . . . . 3.07 110.245 170.253 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.434 HG23 HG21 ' A' ' 22' ' ' THR . 69.1 p -106.32 -174.09 2.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.524 -3.86 . . . . 1.34 104.876 174.324 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.8 mt -83.02 -35.56 25.69 Favored 'General case' 0 N--CA 1.431 -1.423 1 C-N-CA 133.367 4.667 . . . . 1.63 110.477 174.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -70.41 -25.88 63.42 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.221 -3.425 . . . . 1.51 114.938 175.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -59.9 -34.06 72.67 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.894 -3.004 . . . . 1.9 111.81 168.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -92.76 11.53 26.59 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 121.42 1.918 . . . . 0.97 111.177 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.33 10.9 m120 53.26 36.29 22.28 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 127.47 2.308 . . . . 2.35 116.34 -175.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.4 mt -85.9 129.2 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 127.625 2.37 . . . . 1.39 108.464 -176.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -123.66 -167.01 1.55 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.253 -2.779 . . . . 2.58 110.91 -173.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -58.44 141.42 51.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.651 0.982 . . . . 2.58 113.651 178.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 69.28 33.71 3.17 Favored 'General case' 0 N--CA 1.43 -1.465 1 C-N-CA 132.199 4.199 . . . . 1.71 109.316 175.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 m -101.24 142.93 31.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 123.075 2.671 . . . . 1.34 107.562 -172.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.3 m -102.4 102.74 13.1 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 116.083 -1.913 . . . . 1.36 110.65 -171.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.317 57.6 mt -78.69 147.37 33.52 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.767 -1.197 . . . . 2.03 107.767 169.26 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -101.73 128.12 48.2 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.998 -1.064 . . . . 2.31 109.006 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.2 tt -93.61 104.33 16.45 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 118.661 -2.525 . . . . 1.72 110.391 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.0 t -107.67 129.48 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 O-C-N 117.157 -3.464 . . . . 1.8 109.408 -179.09 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.4 mt . . . . . 0 N--CA 1.43 -1.444 0 O-C-N 118.201 -2.812 . . . . 3.26 111.651 -177.88 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.351 19.0 ptt? . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 118.131 -0.938 . . . . 1.39 111.139 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -100.69 132.9 45.85 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 125.965 1.706 . . . . 2.2 106.972 -171.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.04 157.5 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 115.181 -2.342 . . . . 1.32 109.525 166.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -107.59 143.95 35.31 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.161 1.458 . . . . 2.2 111.782 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 t -123.44 124.44 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 105.583 -2.006 . . . . 1.23 105.583 171.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -114.69 135.89 53.66 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 117.15 2.278 . . . . 2.51 117.15 178.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.515 21.3 p -69.59 -175.59 0.88 Allowed 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.82 2.247 . . . . 1.41 113.707 179.386 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.3 mt -89.99 -33.67 16.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.482 -3.261 . . . . 2.95 113.913 165.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 p -74.49 -56.08 5.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.865 -1.772 . . . . 2.52 114.606 -176.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.07 31.16 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 119.997 2.759 . . . . 1.5 119.997 174.412 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -121.8 128.48 51.74 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.507 2.099 . . . . 1.79 111.423 -175.467 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.278 32.3 m -103.5 130.55 50.9 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.271 -2.143 . . . . 1.38 111.541 172.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -100.67 149.83 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 129.682 3.193 . . . . 2.03 107.912 176.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.5 m -123.46 131.17 53.56 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 122.22 2.282 . . . . 1.61 105.468 172.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.8 mt -119.4 128.57 54.17 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 116.047 -1.93 . . . . 2.15 114.048 -179.6 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -80.0 112.43 17.29 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 115.138 1.533 . . . . 1.98 115.138 165.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.86 174.93 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.578 -2.576 . . . . 1.52 104.701 -171.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -124.02 171.67 6.76 Favored Pre-proline 0 N--CA 1.43 -1.475 0 CA-C-O 114.233 -2.794 . . . . 2.35 104.979 165.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -76.11 -7.75 18.34 Favored 'Trans proline' 0 N--CA 1.434 -1.996 1 CA-C-N 130.02 4.614 . . . . 1.31 114.093 -177.369 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.5 p -83.24 -15.92 48.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 129.922 3.289 . . . . 1.71 109.959 179.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.69 139.96 58.24 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 114.542 1.312 . . . . 1.69 114.542 174.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 p -85.3 164.45 18.0 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 118.109 -2.869 . . . . 1.33 115.929 172.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.4 mm -64.56 -24.92 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 119.152 -2.218 . . . . 1.32 115.611 173.269 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -74.98 -31.7 61.51 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 116.053 -1.927 . . . . 1.62 114.901 165.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -66.68 -41.23 88.45 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 120.4 1.455 . . . . 2.13 110.194 174.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.68 -48.43 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 114.29 -2.767 . . . . 1.23 111.135 174.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -54.86 -45.2 74.55 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 122.144 2.247 . . . . 1.97 114.002 176.219 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.05 -41.16 87.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.174 1.916 . . . . 1.19 116.174 168.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -61.06 -41.36 96.47 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.292 2.237 . . . . 1.92 110.435 173.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.4 mt -64.37 -32.91 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 121.096 1.771 . . . . 1.94 114.474 169.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -62.69 -43.07 99.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.431 1.092 . . . . 1.9 112.503 175.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -56.1 -42.5 76.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.391 -2.693 . . . . 1.55 113.567 174.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -74.99 -66.64 0.73 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.626 1.343 . . . . 2.95 114.626 -178.117 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -95.29 -21.23 18.55 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.241 2.617 . . . . 1.48 115.389 -166.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.37 1.78 68.74 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 127.954 3.284 . . . . 1.12 113.704 175.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 mt -72.1 126.63 91.14 Favored Pre-proline 0 N--CA 1.429 -1.481 0 C-N-CA 125.538 1.535 . . . . 2.07 113.44 -177.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -72.67 150.62 50.92 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 O-C-N 113.651 -3.921 . . . . 1.39 116.341 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -63.59 -32.16 69.8 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 CA-C-N 124.045 2.48 . . . . 1.68 111.48 -171.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -57.61 -29.7 64.73 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 114.939 -4.851 . . . . 2.25 114.775 176.594 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -90.73 -21.0 21.79 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 119.108 -1.037 . . . . 2.44 111.138 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.279 57.9 mt-30 -78.68 140.0 38.42 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 120.328 -1.483 . . . . 1.32 114.134 -174.623 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -126.44 126.44 43.8 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.771 1.748 . . . . 3.19 106.741 170.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.305 29.3 mt -98.21 111.74 23.96 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 118.868 -2.395 . . . . 1.75 111.203 178.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mm -105.95 121.02 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 124.327 1.051 . . . . 1.98 111.846 -178.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -114.36 98.31 6.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 129.06 2.944 . . . . 1.94 112.638 168.135 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.409 ' HB3' ' H ' ' A' ' 47' ' ' GLY . . . 62.1 -106.22 0.21 Allowed 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.335 -2.728 . . . . 1.67 113.837 -179.702 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 46' ' ' ALA . . . -94.94 -12.44 55.37 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 128.704 3.05 . . . . 1.3 112.867 -179.28 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -114.06 149.3 35.68 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 123.28 3.54 . . . . 2.89 106.403 -173.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -106.83 142.87 35.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 100.673 -3.825 . . . . 2.89 100.673 169.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 mt -103.24 130.19 50.41 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 116.434 -2.106 . . . . 1.34 111.655 -172.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -81.19 141.32 34.3 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 118.028 2.603 . . . . 1.94 118.028 -174.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -60.66 132.0 52.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.609 1.818 . . . . 1.56 108.94 -176.127 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.02 -19.13 44.52 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 126.159 1.838 . . . . 0.97 116.149 171.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.8 mtt180 -82.24 164.9 20.88 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 123.094 1.426 . . . . 3.07 113.5 170.25 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.2 p -87.99 162.99 16.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.487 3.041 . . . . 1.34 112.707 174.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.6 mt -61.11 -26.46 67.69 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 114.218 -5.301 . . . . 1.63 119.552 167.457 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.7 t -67.08 -35.03 78.94 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 112.925 -1.943 . . . . 1.51 112.729 176.242 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -56.7 -41.99 78.33 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.812 -3.055 . . . . 1.9 112.402 175.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -88.96 4.46 48.03 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 119.284 -2.135 . . . . 0.97 112.584 177.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.1 m120 58.33 47.34 14.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.801 2.889 . . . . 2.35 118.801 -178.227 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mt -96.17 130.05 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 124.789 1.306 . . . . 1.39 108.69 -178.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -114.23 -159.62 0.7 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 115.504 -2.479 . . . . 2.58 105.734 176.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -56.0 153.45 8.82 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 115.551 -4.468 . . . . 2.58 116.925 171.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 55.23 33.18 20.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.341 2.972 . . . . 1.71 110.987 173.213 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 m -89.52 143.08 27.1 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 113.962 -5.461 . . . . 1.34 110.584 -179.614 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.2 m -96.02 113.08 24.66 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.282 -2.118 . . . . 1.36 105.282 178.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mp -104.57 169.82 8.24 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 104.263 -2.495 . . . . 2.03 104.263 165.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -125.84 139.21 53.67 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 127.831 3.207 . . . . 2.31 112.827 -172.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.0 tp -98.67 123.38 42.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.789 -2.444 . . . . 1.72 112.038 177.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.16 162.25 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.849 -2.278 . . . . 1.8 104.849 174.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.5 mt . . . . . 0 N--CA 1.429 -1.486 0 CA-C-O 125.085 2.374 . . . . 3.26 109.947 -179.478 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ttp . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 123.506 1.622 . . . . 1.39 113.285 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -83.15 130.11 35.08 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 115.41 -4.556 . . . . 2.2 114.049 -178.28 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -126.17 161.83 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 115.704 -2.094 . . . . 1.32 108.516 168.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -112.76 137.61 50.81 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 104.865 -2.272 . . . . 2.2 104.865 -177.192 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 t -107.46 120.59 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 114.106 -1.406 . . . . 1.23 108.015 173.249 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -96.01 115.45 27.45 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.828 -2.42 . . . . 2.51 111.381 179.327 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.9 p -80.42 175.14 10.92 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 115.982 -4.199 . . . . 1.41 116.223 173.491 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.0 mt -80.5 -24.55 39.32 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.672 -1.232 . . . . 2.95 107.672 176.586 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.3 p -70.93 -39.93 72.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.332 -2.73 . . . . 2.52 108.96 175.508 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.86 50.63 0.55 Allowed Glycine 0 N--CA 1.429 -1.827 0 C-N-CA 126.36 1.933 . . . . 1.5 113.708 -177.568 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -124.21 136.93 54.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 101.556 -3.498 . . . . 1.79 101.556 -179.116 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.4 m -100.22 116.74 32.93 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.777 -3.077 . . . . 1.38 104.767 178.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mt -99.15 141.26 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 104.821 -2.288 . . . . 2.03 104.821 178.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.5 m -109.88 108.2 18.4 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 103.893 -2.632 . . . . 1.61 103.893 -175.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.8 mt -102.74 160.59 14.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.415 -2.678 . . . . 2.15 108.46 177.699 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -119.69 107.19 12.92 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 130.553 3.541 . . . . 1.98 107.919 172.227 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.267 23.2 m -121.58 -171.61 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.696 1.598 . . . . 1.52 109.391 -174.107 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -143.84 179.89 1.09 Allowed Pre-proline 0 N--CA 1.43 -1.428 0 C-N-CA 126.114 1.765 . . . . 2.35 112.672 167.769 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -76.5 -28.0 7.18 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 125.317 2.935 . . . . 1.31 115.669 -176.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 p -77.8 -20.33 53.43 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.062 2.545 . . . . 1.71 113.43 -177.68 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.34 139.86 41.51 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 122.989 2.631 . . . . 1.69 112.813 172.531 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.1 p -84.17 175.37 9.51 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 124.295 1.038 . . . . 1.33 112.073 174.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 33.6 mm -74.8 -34.35 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-O 116.241 -1.838 . . . . 1.32 107.573 177.831 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -49.32 -41.7 39.28 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 129.008 2.923 . . . . 1.62 113.131 166.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -78.19 -28.61 48.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.394 -2.066 . . . . 2.13 113.075 177.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.39 -43.16 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 125.223 1.409 . . . . 1.23 107.459 171.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -55.06 -39.86 69.69 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 123.179 2.718 . . . . 1.97 113.178 169.11 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.61 -40.08 76.84 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 126.925 2.09 . . . . 1.19 110.774 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -68.51 -23.28 64.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.353 -2.092 . . . . 1.92 113.109 176.177 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.4 mt -82.81 -28.1 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 117.208 -1.797 . . . . 1.94 110.896 172.615 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -63.33 -44.52 94.7 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.976 -1.702 . . . . 1.9 110.98 177.373 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -56.28 -50.06 72.46 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.809 2.043 . . . . 1.55 111.225 173.193 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -66.08 -59.81 3.43 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 118.951 2.945 . . . . 2.95 118.951 -178.581 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -108.84 -25.58 10.71 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 128.828 2.851 . . . . 1.48 113.544 -165.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.02 47.91 7.31 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 123.908 0.755 . . . . 1.12 112.626 -177.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.9 mt -104.82 114.39 63.91 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 105.663 -1.977 . . . . 2.07 105.663 177.115 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -55.83 151.45 40.43 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 123.456 2.771 . . . . 1.39 116.154 175.396 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -70.51 -22.81 28.15 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 126.099 3.214 . . . . 1.68 119.904 -173.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.59 -17.94 62.9 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.459 1.903 . . . . 2.25 110.977 171.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -79.51 -29.44 41.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 121.162 1.801 . . . . 2.44 109.472 175.704 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.427 ' HG2' HD13 ' A' ' 69' ' ' LEU . 76.2 mt-30 -84.51 140.08 31.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 118.744 2.868 . . . . 1.32 118.744 -167.803 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -129.99 116.61 18.83 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 104.65 -2.352 . . . . 3.19 104.65 167.412 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.8 mt -96.04 105.65 17.71 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.071 2.549 . . . . 1.75 114.58 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.5 mm -98.04 134.94 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 106.24 -1.763 . . . . 1.98 106.24 -172.692 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.411 ' HB3' HD21 ' A' ' 50' ' ' LEU . 68.5 t80 -130.08 95.14 3.86 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 116.089 -2.244 . . . . 1.94 107.277 171.305 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 74.33 -107.38 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.325 1.85 . . . . 1.67 111.098 -173.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.79 -12.5 24.2 Favored Glycine 0 N--CA 1.429 -1.768 0 O-C-N 118.482 -2.636 . . . . 1.3 109.029 -175.43 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -100.08 134.17 43.39 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.213 -1.757 . . . . 2.89 110.032 -174.51 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -84.37 132.87 34.55 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 103.146 -2.909 . . . . 2.89 103.146 167.383 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' A' ' 45' ' ' PHE . 14.1 mt -88.5 136.58 32.92 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.911 -2.368 . . . . 1.34 113.75 -179.101 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -73.52 138.65 45.15 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 126.134 2.146 . . . . 1.94 111.731 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.473 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 7.8 m-20 -62.96 -39.72 95.52 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 117.599 2.444 . . . . 1.56 117.599 -166.761 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.21 16.43 55.83 Favored Glycine 0 N--CA 1.43 -1.708 0 O-C-N 117.575 -3.203 . . . . 0.97 111.779 175.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -95.34 174.4 7.05 Favored 'General case' 0 N--CA 1.429 -1.5 1 CA-C-N 125.407 4.604 . . . . 3.07 108.93 167.224 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.1 p -107.84 176.66 5.07 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 115.397 -2.521 . . . . 1.34 113.979 177.19 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.8 mt -57.91 -46.44 84.98 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 126.773 3.178 . . . . 1.63 113.162 169.627 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 t -62.27 -37.28 84.86 Favored 'General case' 0 N--CA 1.43 -1.435 1 CA-C-N 108.005 -4.18 . . . . 1.51 116.54 178.669 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -62.07 -36.4 81.55 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 120.389 1.45 . . . . 1.9 114.801 176.451 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -89.9 0.92 56.78 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 116.795 2.146 . . . . 0.97 116.795 177.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 m120 74.5 24.79 1.71 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.713 3.205 . . . . 2.35 114.849 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.3 mt -68.94 112.71 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 115.244 1.572 . . . . 1.39 115.244 174.577 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -107.04 -165.54 1.08 Allowed 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 125.007 1.323 . . . . 2.58 112.081 -177.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -67.72 153.23 44.17 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.483 1.66 . . . . 2.58 115.483 177.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 60.83 24.31 14.26 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 128.283 2.633 . . . . 1.71 116.056 179.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.3 m -89.3 148.34 23.61 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.056 -2.278 . . . . 1.34 110.404 -170.722 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.8 m -111.82 110.11 20.29 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.065 -2.897 . . . . 1.36 110.664 -173.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.3 mp -90.23 151.89 21.32 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 100.792 -3.781 . . . . 2.03 100.792 172.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -116.36 123.08 46.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.463 -2.023 . . . . 2.31 110.8 175.227 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.427 HD13 ' HG2' ' A' ' 41' ' ' GLN . 45.9 tp -95.04 101.97 13.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.653 -2.067 . . . . 1.72 108.651 -174.507 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.6 t -102.41 138.38 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 105.669 -1.975 . . . . 1.8 105.669 178.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.3 mt . . . . . 0 N--CA 1.43 -1.442 0 CA-C-O 123.432 1.587 . . . . 3.26 107.702 -179.73 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptt? . . . . . 0 CA--C 1.49 -1.364 0 CA-C-O 118.977 -0.535 . . . . 1.39 111.39 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -98.57 121.59 40.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.28 1.038 . . . . 2.2 109.442 -175.244 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.0 pt -119.44 155.04 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 123.317 1.532 . . . . 1.32 109.433 174.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -113.78 126.03 54.76 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.732 -1.855 . . . . 2.2 112.712 -179.127 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.451 HG21 HD12 ' A' ' 30' ' ' ILE . 40.5 t -104.88 114.25 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 105.259 -2.126 . . . . 1.23 105.259 178.601 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -103.74 121.5 43.13 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 129.232 3.013 . . . . 2.51 107.682 -175.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 p -86.49 -179.24 6.6 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 127.93 3.729 . . . . 1.41 117.797 179.248 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.2 mt -83.06 -29.22 28.99 Favored 'General case' 0 N--CA 1.429 -1.505 1 O-C-N 110.91 -7.369 . . . . 2.95 111.913 168.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.9 p -64.7 -41.3 96.11 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 117.035 -3.54 . . . . 2.52 110.141 171.443 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.08 4.88 3.19 Favored Glycine 0 N--CA 1.431 -1.692 0 O-C-N 119.962 -1.711 . . . . 1.5 114.248 173.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -75.9 122.28 23.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 125.959 1.704 . . . . 1.79 111.23 -171.547 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.307 23.8 m -80.15 88.25 5.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.842 -3.661 . . . . 1.38 114.056 167.106 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.5 mt -82.71 130.34 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 103.067 -2.938 . . . . 2.03 103.067 -176.834 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.3 m -101.89 117.48 34.93 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.957 3.303 . . . . 1.61 107.196 -174.287 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.5 mt -131.21 152.43 50.5 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 124.925 3.511 . . . . 2.15 111.642 -178.396 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -106.64 105.13 15.01 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 126.586 1.955 . . . . 1.98 113.285 175.289 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 m -118.09 174.45 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 126.476 1.91 . . . . 1.52 107.615 -175.446 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -126.43 165.62 26.91 Favored Pre-proline 0 N--CA 1.431 -1.39 0 O-C-N 118.638 -2.538 . . . . 2.35 106.203 166.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -75.77 -22.57 13.38 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 CA-C-N 124.639 2.693 . . . . 1.31 114.581 -171.305 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.0 m -85.44 15.49 4.43 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 116.354 -2.138 . . . . 1.71 112.591 174.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -91.39 167.35 12.34 Favored 'General case' 0 N--CA 1.431 -1.425 1 O-C-N 116.141 -4.1 . . . . 1.69 109.48 169.025 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 36.4 p -104.0 174.57 5.82 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.704 -1.135 . . . . 1.33 108.339 -175.382 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.9 mm -74.76 -31.71 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 127.854 2.462 . . . . 1.32 107.958 175.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -57.72 -40.5 79.7 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.633 1.716 . . . . 1.62 115.633 169.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -65.29 -48.77 71.99 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 124.23 1.967 . . . . 2.13 111.881 171.472 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.28 47.5 t -54.17 -41.71 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 117.19 -3.444 . . . . 1.23 115.333 172.455 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -59.26 -46.72 87.75 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 118.046 2.61 . . . . 1.97 118.046 167.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.01 -38.93 80.36 Favored 'General case' 0 N--CA 1.432 -1.369 1 C-N-CA 131.714 4.006 . . . . 1.19 114.037 172.845 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.23 -42.93 99.29 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.908 1.683 . . . . 1.92 113.148 167.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.451 HD12 HG21 ' A' ' 5' ' ' VAL . 65.8 mt -69.16 -32.32 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 125.945 1.698 . . . . 1.94 110.109 179.14 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -69.92 -47.92 60.54 Favored 'General case' 0 N--CA 1.431 -1.404 1 O-C-N 115.853 -4.279 . . . . 1.9 114.248 175.013 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.27 16.4 t70 -44.53 -59.48 2.43 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 130.53 3.532 . . . . 1.55 110.132 166.297 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -67.81 -53.34 27.79 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.942 2.097 . . . . 2.95 112.557 -172.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -102.06 -75.04 0.61 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.76 3.171 . . . . 1.48 112.184 -170.185 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.66 22.84 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.714 0 CA-C-O 124.309 2.061 . . . . 1.12 115.101 177.709 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mt -97.79 128.64 33.49 Favored Pre-proline 0 N--CA 1.43 -1.434 0 O-C-N 117.95 -3.088 . . . . 2.07 117.281 -172.319 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -63.03 137.88 64.55 Favored 'Trans proline' 0 N--CA 1.433 -2.032 0 O-C-N 114.65 -3.395 . . . . 1.39 113.309 178.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -59.92 -17.72 45.72 Favored 'Trans proline' 0 N--CA 1.434 -2.009 1 C-N-CA 125.474 4.116 . . . . 1.68 115.135 178.747 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -75.33 -28.42 59.64 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.028 -2.295 . . . . 2.25 112.289 169.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -82.01 -26.0 34.21 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.781 -2.449 . . . . 2.44 110.196 -173.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -87.58 124.22 33.27 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.451 -2.031 . . . . 1.32 114.475 -174.157 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -113.07 115.4 28.28 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 124.329 2.014 . . . . 3.19 109.291 170.098 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.252 4.2 mm? -95.97 116.34 28.79 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 125.544 2.592 . . . . 1.75 112.215 178.962 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.3 mm -98.23 122.85 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 1 O-C-N 114.918 -4.864 . . . . 1.98 108.655 178.956 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -138.22 142.32 39.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 116.755 -3.715 . . . . 1.94 103.143 168.245 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.317 . . 62.53 22.37 13.24 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.352 2.352 . . . . 1.67 117.352 177.609 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.04 -14.56 43.16 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 116.947 -3.595 . . . . 1.3 114.229 -175.104 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -100.2 161.36 13.66 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 128.479 2.712 . . . . 2.89 111.707 176.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -94.92 140.84 29.37 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 117.535 -3.228 . . . . 2.89 114.854 169.962 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.323 19.7 mt -80.04 135.61 36.4 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 126.426 3.012 . . . . 1.34 113.252 -176.48 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -89.02 144.15 26.35 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.976 -3.577 . . . . 1.94 115.47 175.348 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.269 16.5 m-20 -53.59 -65.78 0.51 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.715 -2.49 . . . . 1.56 116.281 -170.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.3 58.79 2.81 Favored Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 127.186 2.327 . . . . 0.97 116.816 167.196 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -139.37 144.98 38.43 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 102.734 -3.062 . . . . 3.07 102.734 166.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 60.8 p -79.72 160.98 26.03 Favored 'General case' 0 N--CA 1.429 -1.477 1 CA-C-O 128.785 4.136 . . . . 1.34 114.643 170.937 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.1 mt -71.28 -32.61 68.88 Favored 'General case' 0 N--CA 1.431 -1.391 1 O-C-N 114.351 -5.218 . . . . 1.63 107.066 -176.263 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.8 p -64.76 -35.97 82.8 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.489 2.403 . . . . 1.51 117.489 171.575 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.252 7.9 t70 -60.54 -44.5 96.02 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.048 2.832 . . . . 1.9 113.653 171.726 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -74.64 -22.62 58.82 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 117.788 -3.07 . . . . 0.97 113.936 176.412 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.322 63.6 m-80 68.24 54.32 0.57 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 126.083 2.849 . . . . 2.35 111.597 -178.629 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.9 mm -98.64 124.92 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 102.333 -3.21 . . . . 1.39 102.333 174.226 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -105.28 -174.99 2.67 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.529 -0.732 . . . . 2.58 110.183 -175.45 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -65.12 149.67 49.49 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 116.289 1.959 . . . . 2.58 116.289 169.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 77.11 11.42 2.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.87 1.268 . . . . 1.71 113.674 172.111 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.346 5.4 t -78.55 134.84 37.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.971 3.708 . . . . 1.34 120.909 -174.112 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.9 m -101.2 106.47 17.7 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.928 1.694 . . . . 1.36 108.918 -177.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.6 mt -88.8 138.56 31.3 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 118.561 -1.255 . . . . 2.03 108.496 170.073 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -94.56 125.36 39.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 123.958 1.837 . . . . 2.31 113.312 -176.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.7 tp -103.46 126.78 50.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.468 -3.27 . . . . 1.72 111.446 -173.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.3 t -118.16 147.07 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 102.258 -3.238 . . . . 1.8 102.258 173.143 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.5 mt . . . . . 0 N--CA 1.43 -1.439 0 CA-C-N 113.031 -1.895 . . . . 3.26 110.029 179.081 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 ptt? . . . . . 0 CA--C 1.49 -1.364 0 CA-C-O 124.246 1.974 . . . . 1.39 110.713 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -111.79 132.78 54.44 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 117.829 -3.044 . . . . 2.2 115.553 -171.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.2 pt -135.88 161.83 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 105.592 -2.003 . . . . 1.32 105.592 176.17 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -119.32 145.92 45.73 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 123.611 1.672 . . . . 2.2 109.847 -179.184 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.5 t -119.37 123.62 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 114.528 -1.214 . . . . 1.23 112.464 176.207 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -93.67 111.97 23.76 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 119.339 -0.945 . . . . 2.51 110.665 177.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.2 p -69.52 169.37 12.7 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.559 -1.963 . . . . 1.41 115.224 176.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.39 -25.87 61.66 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 118.552 -2.592 . . . . 2.95 112.723 178.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.9 p -74.6 -22.18 59.09 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 128.012 2.525 . . . . 2.52 115.175 177.317 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.76 52.53 2.43 Favored Glycine 0 N--CA 1.43 -1.712 0 C-N-CA 130.35 3.833 . . . . 1.5 111.71 175.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -116.68 140.88 48.91 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 102.432 -3.173 . . . . 1.79 102.432 -178.497 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.5 m -107.38 117.75 34.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 101.579 -3.489 . . . . 1.38 101.579 167.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.2 pt -96.04 166.83 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 118.131 -2.855 . . . . 2.03 105.258 173.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.0 m -122.28 141.41 51.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 116.712 -1.613 . . . . 1.61 107.925 175.228 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.403 HD21 ' HG2' ' A' ' 29' ' ' LYS . 13.0 mt -129.81 158.41 39.51 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 127.842 2.457 . . . . 2.15 110.29 173.603 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -111.99 136.53 51.21 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 106.45 -1.685 . . . . 1.98 106.45 167.546 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.7 m -136.17 166.11 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 125.553 1.541 . . . . 1.52 113.976 178.017 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -104.78 156.55 35.8 Favored Pre-proline 0 N--CA 1.43 -1.437 0 O-C-N 120.403 -1.436 . . . . 2.35 109.819 155.531 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -80.34 -5.53 13.51 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 O-C-N 114.624 -3.408 . . . . 1.31 109.908 -171.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.284 67.9 m -77.13 -17.77 58.38 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 116.951 -1.499 . . . . 1.71 110.028 171.135 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -60.98 134.47 57.13 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 120.681 1.582 . . . . 1.69 112.843 173.451 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.7 p -71.58 159.68 34.02 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.286 1.517 . . . . 1.33 109.614 176.714 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.0 mm -69.87 -38.54 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 124.633 2.159 . . . . 1.32 111.285 -176.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -48.13 -42.63 29.78 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 128.794 2.837 . . . . 1.62 115.389 162.626 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -67.12 -32.79 74.16 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.201 -1.562 . . . . 2.13 109.194 178.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.4 t -71.3 -29.14 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 O-C-N 118.386 -2.696 . . . . 1.23 113.614 174.346 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -75.25 -35.76 61.36 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.23 -0.919 . . . . 1.97 108.787 176.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.05 -44.33 74.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.681 1.993 . . . . 1.19 111.788 170.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.403 ' HG2' HD21 ' A' ' 15' ' ' LEU . 23.3 ttmt -58.45 -49.22 78.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 116.836 2.161 . . . . 1.92 116.836 173.424 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.418 3.3 mt -58.27 -37.38 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 118.383 2.734 . . . . 1.94 118.383 170.668 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -63.71 -39.79 95.17 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 118.663 -1.215 . . . . 1.9 113.623 173.11 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -59.67 -58.92 6.49 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.935 1.694 . . . . 1.55 110.555 171.636 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -57.51 -65.66 0.59 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 125.919 1.687 . . . . 2.95 115.288 -179.304 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -106.72 -3.1 20.9 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 129.152 2.981 . . . . 1.48 111.971 -167.161 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.6 54.25 8.87 Favored Glycine 0 N--CA 1.431 -1.696 1 O-C-N 114.469 -5.144 . . . . 1.12 119.29 173.449 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.9 mt -132.27 135.29 26.15 Favored Pre-proline 0 N--CA 1.43 -1.439 0 N-CA-C 102.096 -3.298 . . . . 2.07 102.096 -174.527 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.69 152.27 58.8 Favored 'Trans proline' 0 N--CA 1.434 -2.005 2 C-N-CA 126.379 4.719 . . . . 1.39 108.664 177.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.44 -20.93 54.18 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 122.473 2.115 . . . . 1.68 111.449 -177.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -54.45 -50.02 68.69 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 131.497 3.919 . . . . 2.25 111.513 176.592 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -73.55 -35.06 65.44 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.307 -1.315 . . . . 2.44 112.293 177.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -71.67 123.75 23.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.939 2.199 . . . . 1.32 116.939 -172.663 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -113.38 126.05 54.93 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 122.771 2.532 . . . . 3.19 109.481 166.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.3 mt -97.76 132.69 43.16 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.721 -1.237 . . . . 1.75 112.803 178.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 mt -119.48 146.44 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 2 C-N-CA 135.113 5.365 . . . . 1.98 104.8 179.86 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.304 68.4 t80 -151.26 128.88 11.48 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 102.631 -3.099 . . . . 1.94 102.631 173.382 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.354 . . 52.1 42.56 30.62 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 121.471 3.878 . . . . 1.67 121.471 -178.368 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.38 -30.7 5.49 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-N 120.54 1.518 . . . . 1.3 116.329 179.472 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.331 16.3 pttm -94.55 148.38 22.31 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 129.934 3.294 . . . . 2.89 112.009 178.147 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -87.58 148.98 24.62 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 127.353 3.454 . . . . 2.89 112.8 169.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.445 HD22 ' CD2' ' A' ' 59' ' ' TYR . 55.8 mt -108.45 134.78 50.76 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.36 -2.2 . . . . 1.34 105.333 -175.478 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -88.57 153.72 20.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 126.281 1.832 . . . . 1.94 113.717 178.015 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -63.41 -55.27 25.74 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 117.228 2.307 . . . . 1.56 117.228 -169.527 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.03 62.11 4.59 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 125.825 2.903 . . . . 0.97 119.831 173.517 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.5 mmt-85 -140.5 171.5 14.04 Favored 'General case' 0 N--CA 1.429 -1.479 1 N-CA-C 99.238 -4.356 . . . . 3.07 99.238 171.641 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.8 p -111.36 168.62 9.38 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.747 -1.845 . . . . 1.34 115.476 166.359 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mt -64.11 -37.33 87.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 116.528 -3.858 . . . . 1.63 107.158 174.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -65.69 -34.91 79.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 125.973 3.988 . . . . 1.51 116.751 178.356 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -57.35 -45.63 84.16 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 117.322 2.342 . . . . 1.9 117.322 167.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.445 ' CD2' HD22 ' A' ' 50' ' ' LEU . 43.0 m-85 -87.14 -2.09 58.37 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.462 2.023 . . . . 0.97 116.462 174.586 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 54.63 74.98 0.32 Allowed 'General case' 0 N--CA 1.43 -1.43 1 C-N-CA 132.075 4.15 . . . . 2.35 110.83 -179.465 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.8 mt -116.99 113.41 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 103.005 -2.961 . . . . 1.39 103.005 -177.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -86.48 177.06 7.53 Favored 'General case' 0 N--CA 1.43 -1.452 1 CA-C-O 128.93 4.205 . . . . 2.58 107.908 -174.527 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -63.25 144.74 56.68 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 110.906 -2.861 . . . . 2.58 116.527 172.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.314 43.0 mt-10 73.83 26.05 1.87 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.811 3.196 . . . . 1.71 112.886 173.934 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.284 70.0 m -96.26 151.74 19.23 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.721 -3.112 . . . . 1.34 105.445 -177.196 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.0 m -109.44 120.08 41.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 120.959 1.709 . . . . 1.36 111.236 176.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mt -95.72 136.0 36.69 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 125.569 1.547 . . . . 2.03 109.973 176.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -98.64 118.53 35.56 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.435 -1.415 . . . . 2.31 112.806 -175.299 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.3 tp -99.55 118.01 35.19 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.21 2.204 . . . . 1.72 111.926 178.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.23 165.22 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 105.614 -1.995 . . . . 1.8 105.614 172.61 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.6 mt . . . . . 0 N--CA 1.43 -1.435 0 N-CA-C 114.436 1.273 . . . . 3.26 114.436 -176.122 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.315 0 N-CA-C 114.134 1.161 . . . . 1.39 114.134 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -86.62 146.23 26.41 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 123.301 1.524 . . . . 2.2 110.425 -176.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.5 pt -139.46 150.03 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 128.254 2.621 . . . . 1.32 109.483 174.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -103.53 118.28 36.37 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.452 -1.704 . . . . 2.2 111.753 177.18 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.3 t -94.31 110.7 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 117.735 -1.126 . . . . 1.23 109.047 170.341 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.3 tttp -110.17 139.25 45.52 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 122.574 2.443 . . . . 2.51 112.296 -176.529 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.493 HG22 HD21 ' A' ' 69' ' ' LEU 0.358 58.0 p -85.05 165.67 17.32 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.859 -1.519 . . . . 1.41 108.793 -178.193 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.1 mt -78.23 -19.31 54.02 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 123.96 1.838 . . . . 2.95 112.157 170.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.06 -45.04 13.48 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 114.058 -1.428 . . . . 2.52 107.88 -173.702 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.47 1.31 0.21 Allowed Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 120.262 2.865 . . . . 1.5 120.262 167.249 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -86.55 146.78 26.23 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 119.256 1.528 . . . . 1.79 113.555 -176.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.4 m -114.04 110.49 20.12 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.957 2.789 . . . . 1.38 109.195 171.005 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.5 mt -91.83 109.65 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 124.513 2.102 . . . . 2.03 106.403 177.32 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 m -83.44 115.04 21.88 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.69 -3.756 . . . . 1.61 106.085 176.063 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mp -108.39 156.51 19.34 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 129.089 2.956 . . . . 2.15 109.856 175.138 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -118.61 131.73 56.19 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.149 -2.219 . . . . 1.98 111.184 166.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -138.67 171.36 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 125.807 1.643 . . . . 1.52 113.233 -175.462 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -102.54 156.1 35.69 Favored Pre-proline 0 N--CA 1.429 -1.48 0 N-CA-C 103.738 -2.69 . . . . 2.35 103.738 166.717 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.9 0.98 9.39 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 124.002 3.135 . . . . 1.31 109.891 179.835 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.4 p -84.03 -18.57 36.61 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.545 -1.972 . . . . 1.71 112.151 171.155 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -66.31 140.9 58.14 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 125.451 2.548 . . . . 1.69 110.917 173.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 3.0 p -80.34 163.97 23.49 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 114.95 -2.452 . . . . 1.33 116.055 179.003 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.405 HG13 ' HB3' ' A' ' 50' ' ' LEU . 19.4 mm -64.16 -36.49 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 123.412 2.824 . . . . 1.32 110.735 176.837 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -58.05 -32.84 68.4 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.86 1.664 . . . . 1.62 113.257 168.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.383 20.0 t-20 -64.18 -39.73 94.6 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.476 2.084 . . . . 2.13 114.322 174.184 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.5 t -64.55 -46.34 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 124.781 2.229 . . . . 1.23 113.761 174.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -66.63 -25.22 66.49 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 125.57 2.605 . . . . 1.97 117.139 -179.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.37 -43.25 81.87 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.569 3.556 . . . . 1.19 109.115 174.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -63.3 -39.17 93.82 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 116.02 -4.175 . . . . 1.92 113.789 173.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.8 mt -69.79 -30.29 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-O 122.837 1.304 . . . . 1.94 111.625 173.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -75.15 -41.98 57.11 Favored 'General case' 0 N--CA 1.431 -1.401 1 O-C-N 113.66 -5.65 . . . . 1.9 106.757 175.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -54.62 -46.98 73.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.713 2.673 . . . . 1.55 118.191 168.207 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.282 26.4 tttp -89.49 -43.4 10.86 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 117.168 -3.457 . . . . 2.95 117.301 -174.008 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -101.57 -35.89 8.97 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 126.755 2.534 . . . . 1.48 108.919 -172.378 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.23 56.25 1.22 Allowed Glycine 0 N--CA 1.431 -1.663 0 C-N-CA 117.926 -2.083 . . . . 1.12 113.508 176.094 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.7 mt -134.31 130.62 20.22 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 103.436 -2.801 . . . . 2.07 103.436 -175.49 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -66.85 154.01 76.0 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 CA-C-N 124.387 2.603 . . . . 1.39 116.714 177.664 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -59.33 -31.96 95.89 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 124.051 3.167 . . . . 1.68 110.13 -176.528 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -55.22 -57.95 9.69 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 126.023 2.821 . . . . 2.25 114.741 177.043 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -61.64 -26.88 68.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.298 2.639 . . . . 2.44 110.395 -177.661 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.272 75.2 mt-30 -96.06 131.13 42.79 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.015 1.388 . . . . 1.32 107.41 -173.642 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -118.83 131.87 56.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.107 -1.406 . . . . 3.19 109.954 167.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 tp -110.06 119.88 40.68 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 104.679 -2.341 . . . . 1.75 104.679 179.123 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.308 1.7 mt -104.95 143.02 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 128.046 2.539 . . . . 1.98 115.106 179.23 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -155.85 123.08 5.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 125.37 3.713 . . . . 1.94 102.642 179.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.257 . . 62.97 30.1 16.43 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.445 2.387 . . . . 1.67 117.445 169.314 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.29 -22.82 32.82 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 125.294 1.621 . . . . 1.3 116.108 -174.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -99.36 130.97 45.68 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 118.174 -1.41 . . . . 2.89 114.033 -176.749 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -75.1 130.42 39.24 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 117.254 -1.778 . . . . 2.89 112.988 173.688 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.477 HD22 ' CE2' ' A' ' 59' ' ' TYR . 42.1 mt -76.53 140.95 41.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.699 2.481 . . . . 1.34 117.699 -170.83 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -82.78 135.6 34.93 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.631 -3.168 . . . . 1.94 110.59 177.609 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -54.99 -64.99 0.66 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.766 2.426 . . . . 1.56 112.435 -171.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.26 54.54 3.95 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 119.643 -1.91 . . . . 0.97 113.352 172.076 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.9 tpp85 -131.29 161.99 31.06 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 115.296 -2.288 . . . . 3.07 111.126 161.059 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 63.9 p -96.52 155.83 16.6 Favored 'General case' 0 N--CA 1.43 -1.456 1 CA-C-N 127.759 4.799 . . . . 1.34 112.445 178.554 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.1 mt -57.78 -24.24 56.19 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.146 1.778 . . . . 1.63 113.941 173.601 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.7 p -78.4 -27.93 46.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.099 -2.876 . . . . 1.51 115.499 177.404 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -67.73 -34.71 77.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.827 -3.046 . . . . 1.9 115.787 172.332 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.477 ' CE2' HD22 ' A' ' 50' ' ' LEU . 12.7 m-85 -85.94 -8.88 57.71 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.476 1.11 . . . . 0.97 109.381 175.249 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 59.0 54.13 5.19 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.528 -1.983 . . . . 2.35 112.438 178.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.1 mt -85.8 114.47 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 126.727 3.156 . . . . 1.39 108.227 174.299 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.283 83.6 mt-30 -91.18 177.6 6.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.369 -3.332 . . . . 2.58 111.409 178.339 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -72.65 160.8 31.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 115.724 -2.391 . . . . 2.58 113.563 178.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.433 30.5 mt-10 64.51 32.33 11.79 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 110.582 -3.008 . . . . 1.71 116.005 176.765 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.9 t -100.2 128.65 46.23 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 112.973 -1.921 . . . . 1.34 110.586 -166.26 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.37 2.4 m -75.87 93.74 3.24 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 121.88 2.127 . . . . 1.36 116.313 178.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 60.0 mt -81.39 156.8 25.25 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 130.663 3.585 . . . . 2.03 103.282 174.053 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -125.5 121.34 33.45 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 120.56 1.527 . . . . 2.31 113.035 -174.092 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.493 HD21 HG22 ' A' ' 7' ' ' THR . 5.1 tp -96.64 110.69 23.07 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 105.812 -1.921 . . . . 1.72 105.812 -178.765 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -107.04 138.81 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 122.863 1.316 . . . . 1.8 111.457 172.474 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.4 mt . . . . . 0 N--CA 1.431 -1.414 0 O-C-N 120.46 -1.4 . . . . 3.26 113.117 -177.191 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 CA--C 1.491 -1.321 0 CA-C-O 118.985 -0.531 . . . . 1.39 110.664 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -84.95 134.24 34.25 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.49 1.116 . . . . 2.2 112.898 -178.551 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.5 pt -131.83 159.84 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 123.643 1.687 . . . . 1.32 109.666 166.453 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -120.84 149.53 42.44 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 102.492 -3.151 . . . . 2.2 102.492 -173.544 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.4 t -136.2 119.07 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.494 -1.379 . . . . 1.23 109.427 174.409 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -92.23 127.36 37.68 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.816 -1.084 . . . . 2.51 112.079 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.2 p -83.63 165.03 19.33 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.171 1.463 . . . . 1.41 112.111 -178.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.68 -31.42 72.63 Favored 'General case' 0 N--CA 1.429 -1.512 1 O-C-N 116.053 -4.154 . . . . 2.95 114.723 167.324 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.0 p -71.62 -48.64 46.68 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 124.285 0.991 . . . . 2.52 111.626 -175.217 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.52 41.64 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 119.273 -1.442 . . . . 1.5 110.674 -179.21 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.452 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU 0.29 33.7 ttpt -133.57 149.89 51.65 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.07 -2.43 . . . . 1.79 106.775 179.969 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.9 m -95.41 113.94 25.66 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.161 2.584 . . . . 1.38 114.674 167.234 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 mt -82.39 119.25 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 117.645 -3.16 . . . . 2.03 110.305 172.215 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.8 m -104.32 111.27 23.84 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.874 -2.391 . . . . 1.61 107.896 178.093 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.8 mt -110.1 156.06 21.08 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 119.395 3.109 . . . . 2.15 119.395 -177.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 tp10 -103.39 107.23 17.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.206 -1.559 . . . . 1.98 113.307 168.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.7 m -121.17 164.77 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 115.879 -2.01 . . . . 1.52 112.944 174.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -111.69 169.51 6.25 Favored Pre-proline 0 N--CA 1.43 -1.439 0 O-C-N 125.055 1.472 . . . . 2.35 109.993 163.381 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -77.38 -20.59 12.38 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 C-N-CA 122.808 2.339 . . . . 1.31 116.103 -174.122 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.7 m -82.99 3.26 30.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.8 1.64 . . . . 1.71 111.473 174.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -82.5 147.13 28.86 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.185 -2.822 . . . . 1.69 111.266 172.796 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.1 p -75.86 164.48 26.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.291 2.701 . . . . 1.33 118.291 174.215 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.4 mm -74.94 -29.12 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 118.279 -2.763 . . . . 1.32 110.687 178.402 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -53.37 -39.65 64.36 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 126.037 1.735 . . . . 1.62 112.529 163.708 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -60.1 -47.89 84.0 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.548 2.339 . . . . 2.13 114.793 173.206 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.7 t -60.61 -48.78 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 130.144 3.378 . . . . 1.23 112.237 177.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -60.09 -38.36 82.7 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 124.543 2.116 . . . . 1.97 115.083 173.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.85 -31.98 71.32 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 119.198 -2.189 . . . . 1.19 115.767 176.237 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -71.29 -37.44 71.86 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.498 2.094 . . . . 1.92 110.866 170.582 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.0 mt -67.14 -41.77 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 116.639 -3.788 . . . . 1.94 110.984 172.29 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -51.77 -33.06 33.47 Favored 'General case' 0 N--CA 1.43 -1.466 1 N-CA-C 122.31 4.189 . . . . 1.9 122.31 169.757 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -63.51 -42.18 98.49 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 117.04 -1.457 . . . . 1.55 110.057 174.132 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -85.13 -50.9 7.03 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 125.894 1.996 . . . . 2.95 110.414 -172.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.452 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 70.3 mm-40 -94.35 -27.18 16.22 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 113.567 0.951 . . . . 1.48 113.567 -168.517 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.31 -23.29 29.03 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-O 126.223 3.124 . . . . 1.12 113.759 168.025 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.2 mt -63.77 123.0 80.1 Favored Pre-proline 0 N--CA 1.431 -1.41 0 C-N-CA 128.461 2.704 . . . . 2.07 114.498 -172.691 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.35 158.35 36.92 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 CA-C-N 126.387 3.317 . . . . 1.39 111.536 -172.025 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.91 -31.51 73.78 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 123.359 2.706 . . . . 1.68 116.597 -174.017 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -55.37 -42.87 74.54 Favored 'General case' 0 N--CA 1.43 -1.457 1 CA-C-O 129.263 4.363 . . . . 2.25 117.761 174.019 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -88.15 -25.54 22.91 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.94 -4.225 . . . . 2.44 112.503 -177.635 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -64.73 134.3 53.9 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.931 -1.731 . . . . 1.32 110.068 179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -126.21 140.92 52.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.173 -2.829 . . . . 3.19 106.151 165.324 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.9 mt -121.95 114.93 21.68 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.689 -2.05 . . . . 1.75 110.553 -178.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 mt -104.23 127.04 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 117.63 -3.168 . . . . 1.98 110.612 178.421 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -136.02 120.34 17.95 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.12 2.568 . . . . 1.94 107.196 176.317 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.313 . . 76.68 6.7 3.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.983 -1.698 . . . . 1.67 114.915 -177.438 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.78 -10.56 74.31 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 117.796 -3.065 . . . . 1.3 111.83 -175.267 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -92.17 146.42 23.73 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 105.978 -1.86 . . . . 2.89 105.978 170.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -94.43 141.89 28.06 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.162 1.385 . . . . 2.89 111.376 170.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -105.52 123.62 48.2 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 119.245 0.93 . . . . 1.34 109.196 -166.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -69.1 144.1 54.02 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.145 1.778 . . . . 1.94 111.85 174.509 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -60.6 -63.12 1.41 Allowed 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 130.975 3.71 . . . . 1.56 115.742 -169.179 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.75 23.12 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.714 1 C-N-CA 131.056 4.169 . . . . 0.97 121.317 170.85 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.296 65.1 mtt180 -123.61 162.91 22.06 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.053 -2.439 . . . . 3.07 111.598 165.467 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.0 p -84.12 154.44 23.15 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 125.543 2.592 . . . . 1.34 113.579 168.694 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mt -51.3 -34.12 31.84 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.759 -4.338 . . . . 1.63 113.883 175.529 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.7 p -79.44 -12.21 59.89 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 117.583 2.438 . . . . 1.51 117.583 179.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.85 -51.49 47.71 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 127.033 3.301 . . . . 1.9 108.481 171.247 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -66.75 -21.18 66.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.963 -2.961 . . . . 0.97 117.137 172.751 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.26 2.5 m-80 70.34 47.28 0.54 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.963 3.305 . . . . 2.35 111.997 -177.279 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.2 mm -78.72 113.63 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 117.907 -2.996 . . . . 1.39 106.695 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -97.89 175.15 6.25 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 126.049 1.739 . . . . 2.58 112.847 -177.644 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -59.62 132.75 54.93 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 114.59 1.33 . . . . 2.58 114.59 172.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.401 48.4 mt-10 85.57 17.01 0.13 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.554 1.645 . . . . 1.71 111.664 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.277 6.8 m -81.47 129.88 34.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.053 -2.28 . . . . 1.34 113.362 -173.928 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.8 m -103.45 106.4 16.91 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 127.923 3.265 . . . . 1.36 109.892 -175.617 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mt -87.07 155.62 20.07 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 126.045 2.831 . . . . 2.03 111.907 172.151 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -118.9 120.84 38.5 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 115.86 -2.019 . . . . 2.31 111.457 -179.103 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.8 tp -82.82 133.68 35.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.144 1.778 . . . . 1.72 107.652 179.007 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.08 157.66 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 102.527 -3.138 . . . . 1.8 102.527 175.483 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.5 mt . . . . . 0 N--CA 1.43 -1.456 0 CA-C-O 126.228 2.918 . . . . 3.26 111.061 -169.49 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.434 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 26.2 ptt? . . . . . 0 CA--C 1.49 -1.345 0 N-CA-C 106.879 -1.526 . . . . 1.39 106.879 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -104.04 124.96 49.99 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 118.695 -2.503 . . . . 2.2 108.695 -173.554 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.9 pt -116.2 160.9 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 118.163 -2.835 . . . . 1.32 109.177 170.176 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -103.61 134.57 46.72 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 125.967 1.707 . . . . 2.2 111.057 176.475 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.2 t -112.59 125.99 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 103.939 -2.615 . . . . 1.23 103.939 172.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -103.18 144.51 31.23 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.032 -3.543 . . . . 2.51 112.438 169.543 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.5 p -93.99 -177.51 4.35 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 124.7 1.25 . . . . 1.41 114.082 -178.839 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.434 HD13 ' H ' ' A' ' 71' ' ' LEU . 46.4 mt -72.29 -27.58 62.55 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 116.442 -1.742 . . . . 2.95 113.088 174.167 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 p -88.13 -62.41 1.5 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.914 1.34 . . . . 2.52 111.672 -172.169 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.86 36.61 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.7 0 CA-C-N 113.721 -1.581 . . . . 1.5 110.153 177.492 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -99.0 148.19 24.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 106.233 -1.766 . . . . 1.79 106.233 -179.468 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.6 m -114.04 127.28 55.87 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 122.373 2.351 . . . . 1.38 106.966 169.158 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mt -108.53 133.3 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.507 -1.996 . . . . 2.03 110.707 173.475 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.0 m -93.88 112.88 24.8 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.325 1.85 . . . . 1.61 109.705 174.101 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -110.29 143.64 40.18 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 121.607 2.003 . . . . 2.15 112.711 174.659 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 1' ' ' MET . 33.1 mt-10 -114.11 115.11 27.01 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.709 -2.495 . . . . 1.98 110.178 175.199 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.77 177.36 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 127.324 2.25 . . . . 1.52 108.871 -176.521 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -120.11 155.65 55.46 Favored Pre-proline 0 N--CA 1.43 -1.443 0 O-C-N 119.079 -2.263 . . . . 2.35 105.903 162.067 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -73.57 -10.41 23.62 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 124.351 2.59 . . . . 1.31 114.376 -170.232 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.273 48.9 m -87.19 -0.8 57.26 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 127.403 2.939 . . . . 1.71 112.556 175.098 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -68.58 150.28 48.2 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 117.044 -1.455 . . . . 1.69 109.583 179.128 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.3 p -87.59 170.94 10.86 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 125.522 2.582 . . . . 1.33 109.476 176.815 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.407 7.4 mm -61.36 -48.31 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 111.295 -2.684 . . . . 1.32 112.627 173.908 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -41.8 -51.43 4.23 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 119.97 3.322 . . . . 1.62 119.97 164.506 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -61.48 -24.6 66.69 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 119.055 2.983 . . . . 2.13 119.055 174.873 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.0 t -75.65 -39.42 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 125.465 2.555 . . . . 1.23 108.988 175.718 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.3 51.5 mtmt -65.24 -36.71 84.97 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.773 -1.83 . . . . 1.97 111.557 177.784 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.19 -24.1 66.56 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 128.32 2.648 . . . . 1.19 113.965 175.966 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -78.16 -38.63 43.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 126.838 2.586 . . . . 1.92 112.951 170.503 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.363 68.8 mt -65.84 -42.99 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-O 126.391 2.996 . . . . 1.94 111.915 172.304 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.427 ' CD ' ' HD3' ' A' ' 38' ' ' PRO . 65.2 tt0 -57.79 -55.03 40.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 111.474 -2.603 . . . . 1.9 111.011 172.555 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.298 33.5 t70 -29.13 -56.64 0.14 Allowed 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 119.727 3.232 . . . . 1.55 119.727 170.898 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -81.45 -53.16 6.53 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 117.563 2.431 . . . . 2.95 117.563 -178.798 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -92.72 -22.62 19.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.178 -2.826 . . . . 1.48 106.525 -163.854 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.56 10.58 59.04 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 130.239 3.78 . . . . 1.12 114.701 177.042 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.5 mt -86.73 125.09 68.13 Favored Pre-proline 0 N--CA 1.43 -1.463 0 O-C-N 116.495 -3.944 . . . . 2.07 109.305 -174.231 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -64.24 149.67 89.79 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 N-CA-C 120.86 3.369 . . . . 1.39 120.86 176.741 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' CD ' ' A' ' 31' ' ' GLN . 47.5 Cg_exo -69.32 -14.9 38.27 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 CA-C-N 124.966 2.809 . . . . 1.68 117.808 -175.714 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -83.09 -10.65 58.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.704 1.593 . . . . 2.25 110.784 176.714 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.16 -15.74 23.09 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.299 -1.501 . . . . 2.44 108.843 -179.664 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -93.44 124.32 37.35 Favored 'General case' 0 N--CA 1.43 -1.465 1 CA-C-O 129.352 4.406 . . . . 1.32 110.529 -179.324 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -106.65 110.07 22.15 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 114.009 -5.432 . . . . 3.19 104.205 169.963 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.6 mt -89.77 124.66 34.84 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 115.518 -2.182 . . . . 1.75 107.48 172.836 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.4 mt -121.62 136.76 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 128.005 3.316 . . . . 1.98 106.747 -178.255 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -147.44 123.7 10.89 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.718 -1.583 . . . . 1.94 108.245 -176.349 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.304 . . 82.35 -51.09 0.21 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 114.654 1.353 . . . . 1.67 114.654 173.365 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.61 -34.84 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 128.179 2.799 . . . . 1.3 113.739 -178.405 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -89.29 164.11 15.07 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 126.228 2.918 . . . . 2.89 112.24 -179.695 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -98.23 133.45 42.64 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.592 -1.943 . . . . 2.89 110.727 171.09 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.2 mt -88.71 129.56 35.51 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 118.774 -2.454 . . . . 1.34 114.827 -167.356 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.341 26.9 mt-10 -65.0 131.53 46.84 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.727 -1.858 . . . . 1.94 115.571 174.381 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -43.58 -63.75 0.78 Allowed 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 131.188 3.795 . . . . 1.56 114.716 -171.609 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.22 61.15 1.88 Allowed Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 112.364 -2.198 . . . . 0.97 117.323 174.202 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 -126.03 172.85 9.62 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.36 -2.089 . . . . 3.07 105.36 156.393 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.0 p -97.78 177.94 5.3 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 117.315 2.339 . . . . 1.34 117.315 169.557 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.8 mt -77.3 -32.28 55.29 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.247 -2.158 . . . . 1.63 109.77 173.702 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -66.6 -37.02 84.02 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 123.814 3.006 . . . . 1.51 114.136 171.484 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -54.24 -64.1 0.94 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 131.668 3.987 . . . . 1.9 115.022 169.921 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -62.99 -14.15 44.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.913 1.819 . . . . 0.97 115.913 173.901 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.345 29.0 m120 78.02 36.83 0.23 Allowed 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 116.794 -1.574 . . . . 2.35 114.79 179.329 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.9 mt -96.22 125.54 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 122.182 2.264 . . . . 1.39 110.96 -177.147 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -98.34 -179.91 4.51 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 118.095 2.628 . . . . 2.58 118.095 -171.498 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.304 21.7 pttp -65.87 145.83 55.46 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 118.749 -1.18 . . . . 2.58 109.328 170.373 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.269 19.4 mt-10 69.99 20.13 6.66 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 126.227 2.204 . . . . 1.71 113.142 171.815 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.2 m -87.13 148.13 25.34 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 118.027 -2.92 . . . . 1.34 111.239 179.668 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.6 m -92.89 98.4 11.35 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.829 2.159 . . . . 1.36 116.829 -177.31 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -84.82 145.53 27.81 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 113.987 -5.446 . . . . 2.03 113.744 172.072 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -117.03 119.5 35.47 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 118.918 -2.364 . . . . 2.31 109.702 -176.043 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.0 tp -84.88 102.44 13.11 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.967 3.307 . . . . 1.72 109.625 178.092 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.32 98.7 t -94.02 130.48 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 130.513 3.525 . . . . 1.8 107.28 170.814 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.434 ' H ' HD13 ' A' ' 8' ' ' LEU . 66.4 mt . . . . . 0 N--CA 1.429 -1.487 0 O-C-N 117.441 -3.287 . . . . 3.26 108.589 179.106 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttp . . . . . 0 CA--C 1.491 -1.324 0 CA-C-O 124.177 1.942 . . . . 1.39 114.399 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -106.25 141.41 37.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.808 -3.057 . . . . 2.2 111.692 -176.05 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 pt -127.35 173.16 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 131.566 3.947 . . . . 1.32 113.337 175.691 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -135.32 126.02 27.2 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.569 -2.582 . . . . 2.2 105.953 -178.544 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -115.24 118.74 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 106.25 -1.759 . . . . 1.23 106.25 173.443 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -100.28 145.24 28.35 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 118.202 -1.399 . . . . 2.51 111.525 175.383 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.2 p -101.2 160.53 14.32 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 128.931 2.892 . . . . 1.41 112.766 179.939 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 mt -71.14 -28.72 64.48 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.718 -1.864 . . . . 2.95 112.862 175.053 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 t -72.76 -38.6 67.28 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 121.744 2.066 . . . . 2.52 110.142 -177.782 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.27 -10.42 0.54 Allowed Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 125.347 1.451 . . . . 1.5 112.918 166.039 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -80.02 135.02 36.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.75 2.02 . . . . 1.79 113.735 -167.731 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.2 m -108.0 117.38 33.97 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.855 2.462 . . . . 1.38 109.484 176.204 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 mt -104.8 105.61 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 113.361 0.874 . . . . 2.03 113.361 178.332 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.8 m -79.31 118.19 21.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.347 -3.345 . . . . 1.61 108.819 -178.762 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.8 mt -120.78 153.58 36.86 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 116.803 -3.686 . . . . 2.15 111.605 -179.8 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -116.33 120.37 38.68 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.059 2.544 . . . . 1.98 110.256 168.382 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -131.92 167.82 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 105.894 -1.891 . . . . 1.52 105.894 -170.575 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -109.45 147.91 37.0 Favored Pre-proline 0 N--CA 1.43 -1.45 0 O-C-N 118.485 -2.635 . . . . 2.35 109.831 160.653 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.254 2.2 Cg_endo -57.11 -18.6 29.78 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 N-CA-C 120.619 3.277 . . . . 1.31 120.619 -173.18 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.9 m -91.05 3.64 54.2 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 125.92 1.688 . . . . 1.71 112.37 -178.709 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -71.78 161.73 30.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.481 2.312 . . . . 1.69 108.54 172.405 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.7 p -98.37 163.8 12.55 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 123.306 1.527 . . . . 1.33 107.657 178.471 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mm -54.38 -41.18 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 118.32 -2.738 . . . . 1.32 114.031 174.25 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.328 16.6 tt0 -54.86 -32.18 60.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.057 -2.277 . . . . 1.62 117.09 166.955 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -64.81 -38.49 91.17 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 129.483 3.113 . . . . 2.13 111.75 176.494 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.3 t -69.18 -40.68 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 119.523 -1.985 . . . . 1.23 107.629 179.254 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.547 ' HD3' ' HB2' ' A' ' 41' ' ' GLN . 74.1 mttt -61.19 -35.64 77.69 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.042 -2.911 . . . . 1.97 114.906 170.734 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.16 -25.21 65.15 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 114.539 -2.864 . . . . 1.19 118.701 177.963 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -67.92 -35.53 78.6 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 130.383 3.473 . . . . 1.92 107.201 168.654 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mt -74.07 -39.36 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 1 O-C-N 116.083 -4.136 . . . . 1.94 108.671 178.953 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -64.29 -37.12 86.35 Favored 'General case' 0 N--CA 1.428 -1.547 0 O-C-N 117.12 -3.488 . . . . 1.9 111.556 178.766 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -69.85 -43.6 71.58 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.417 1.103 . . . . 1.55 112.72 172.517 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -72.73 -48.19 40.73 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 120.399 3.481 . . . . 2.95 120.399 178.943 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -108.66 -30.85 7.99 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.467 -2.645 . . . . 1.48 112.489 -165.715 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.67 37.24 5.58 Favored Glycine 0 N--CA 1.43 -1.702 0 O-C-N 118.917 -2.364 . . . . 1.12 116.133 176.467 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.3 mt -113.89 126.18 28.42 Favored Pre-proline 0 N--CA 1.431 -1.412 0 CA-C-O 111.83 -3.938 . . . . 2.07 105.368 177.622 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.84 151.06 35.45 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-N 126.379 3.314 . . . . 1.39 110.77 -176.095 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -55.87 -31.85 82.83 Favored 'Trans proline' 0 N--CA 1.433 -2.047 1 C-N-CA 126.121 4.547 . . . . 1.68 112.806 -178.897 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -41.78 -49.11 4.38 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 113.229 -3.272 . . . . 2.25 117.372 165.935 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -80.55 -20.82 42.58 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 122.664 2.484 . . . . 2.44 117.279 177.514 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.547 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 72.1 mt-30 -76.82 130.86 38.21 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.999 1.32 . . . . 1.32 111.868 -172.086 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.0 mtt180 -120.33 131.01 54.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.432 -2.668 . . . . 3.19 108.561 169.653 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.7 mt -107.55 130.52 54.86 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 120.521 1.51 . . . . 1.75 110.795 179.663 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -105.03 127.92 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 125.742 1.617 . . . . 1.98 113.046 178.373 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -152.2 141.91 21.88 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.494 -2.78 . . . . 1.94 103.494 173.163 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.27 . . 64.71 14.38 9.06 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.124 2.392 . . . . 1.67 115.024 -179.013 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.49 18.51 75.71 Favored Glycine 0 N--CA 1.431 -1.674 0 O-C-N 117.511 -3.243 . . . . 1.3 118.23 179.295 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -126.18 150.18 48.5 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.277 3.031 . . . . 2.89 111.047 176.503 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -80.15 132.75 35.97 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 121.646 2.021 . . . . 2.89 112.129 169.705 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.3 mt -88.45 135.77 33.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.453 -3.904 . . . . 1.34 114.297 -173.248 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.93 125.84 27.58 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.034 2.934 . . . . 1.94 108.739 -179.76 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.32 1.0 OUTLIER -47.23 -47.4 24.57 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 120.829 3.64 . . . . 1.56 120.829 -174.12 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.84 32.11 7.18 Favored Glycine 0 N--CA 1.43 -1.712 0 CA-C-O 125.652 2.807 . . . . 0.97 118.795 -179.834 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -101.98 157.87 16.56 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.404 -3.409 . . . . 3.07 108.951 159.685 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -85.09 168.17 15.11 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.59 -1.186 . . . . 1.34 110.048 -179.337 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.6 mt -69.64 -41.01 76.16 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 124.86 1.35 . . . . 1.63 109.869 179.289 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.264 48.3 p -58.99 -18.75 37.05 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 117.32 2.341 . . . . 1.51 117.32 175.8 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -69.79 -45.04 68.86 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.657 2.383 . . . . 1.9 111.567 173.023 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -83.5 2.96 34.35 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.399 -2.688 . . . . 0.97 113.309 174.19 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.4 m120 57.56 49.02 13.34 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 129.11 2.964 . . . . 2.35 117.203 177.394 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -85.14 114.29 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 128.564 2.746 . . . . 1.39 111.791 -175.96 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -93.14 -173.73 3.34 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.005 2.336 . . . . 2.58 112.633 -176.488 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -62.54 137.72 58.32 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 112.574 -2.103 . . . . 2.58 113.456 176.673 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 64.15 29.7 13.93 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 114.029 1.122 . . . . 1.71 114.029 170.143 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.6 m -81.43 143.24 32.26 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 123.288 1.518 . . . . 1.34 114.368 -178.753 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 m -99.16 117.06 32.79 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.58 -2.575 . . . . 1.36 111.382 -179.62 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -104.24 160.23 15.05 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.088 2.555 . . . . 2.03 106.261 174.439 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -124.94 135.56 52.95 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.211 -1.774 . . . . 2.31 106.211 -176.824 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.1 tp -99.57 128.75 45.68 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 105.449 -2.056 . . . . 1.72 105.449 -176.411 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.3 m -122.0 170.13 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 104.037 -2.579 . . . . 1.8 104.037 168.771 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 N--CA 1.43 -1.429 0 CA-C-O 117.469 -1.253 . . . . 3.26 111.4 177.39 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tmm? . . . . . 0 CA--C 1.49 -1.352 0 CA-C-O 121.05 0.452 . . . . 1.39 110.579 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -108.72 129.31 55.36 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 117.228 2.307 . . . . 2.2 117.228 -177.537 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -129.28 170.62 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 106.28 -1.748 . . . . 1.32 106.28 175.544 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -121.94 140.15 52.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.921 -2.252 . . . . 2.2 104.921 -177.203 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.449 HG22 ' HB2' ' A' ' 67' ' ' LEU . 92.6 t -123.96 131.51 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 118.069 -2.894 . . . . 1.23 106.771 170.52 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -88.68 118.81 28.62 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.857 2.063 . . . . 2.51 115.352 171.454 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.5 p -83.49 176.06 9.34 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.238 -3.414 . . . . 1.41 111.619 173.775 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.3 mt -78.9 -17.17 56.0 Favored 'General case' 0 N--CA 1.43 -1.432 1 CA-C-O 129.617 4.532 . . . . 2.95 116.066 -179.762 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 p -95.27 -56.74 2.62 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.367 -3.333 . . . . 2.52 107.119 -170.601 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.4 23.65 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.728 0 CA-C-O 114.969 -3.128 . . . . 1.5 115.453 176.124 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.549 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 82.3 tttt -109.68 139.82 44.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 121.67 2.735 . . . . 1.79 108.467 -173.255 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.1 m -106.84 124.33 49.46 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 100.61 -3.848 . . . . 1.38 100.61 175.577 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.7 mt -94.62 123.14 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 N-CA-C 104.776 -2.305 . . . . 2.03 104.776 179.553 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.3 m -90.21 106.7 18.66 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.529 2.331 . . . . 1.61 109.369 176.617 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.3 mt -103.83 128.62 51.27 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.715 1.721 . . . . 2.15 108.396 -176.811 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -90.6 116.32 28.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.807 -3.058 . . . . 1.98 111.803 165.993 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.2 m -130.22 159.59 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.731 -2.481 . . . . 1.52 111.108 -171.358 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -99.68 146.07 31.21 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 118.591 -2.568 . . . . 2.35 108.209 170.875 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -73.44 -17.44 23.81 Favored 'Trans proline' 0 C--N 1.299 -2.059 0 CA-C-N 127.744 3.802 . . . . 1.31 113.52 -177.547 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -77.34 -2.55 35.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 123.206 2.73 . . . . 1.71 111.479 172.431 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -73.97 139.65 44.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 122.415 2.37 . . . . 1.69 109.03 178.588 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 p -74.51 158.65 33.41 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 111.015 -2.811 . . . . 1.33 110.847 170.257 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.6 mm -61.78 -30.98 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 125.062 1.476 . . . . 1.32 113.388 174.484 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -52.0 -33.33 37.76 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.51 3.124 . . . . 1.62 116.162 165.766 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -85.45 -29.62 24.19 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.301 -2.749 . . . . 2.13 108.699 176.258 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.1 t -70.2 -42.1 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 117.126 -3.483 . . . . 1.23 110.898 178.886 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -63.3 -27.57 69.42 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.347 2.659 . . . . 1.97 113.14 170.194 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.43 -21.64 41.96 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 123.373 1.559 . . . . 1.19 110.933 175.504 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -75.56 -30.16 59.59 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.749 -3.094 . . . . 1.92 114.574 170.054 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.8 mt -66.88 -38.19 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 O-C-N 120.383 -1.448 . . . . 1.94 109.401 169.905 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.425 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 14.4 tt0 -57.43 -58.43 8.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.506 0.67 . . . . 1.9 112.624 170.819 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -47.61 -49.78 26.06 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.854 2.062 . . . . 1.55 110.438 178.638 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -65.13 -66.26 0.57 Allowed 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.969 2.908 . . . . 2.95 112.06 -176.375 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.549 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 29.1 mm-40 -95.62 -53.75 3.61 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 127.86 2.464 . . . . 1.48 113.351 -164.056 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.98 -43.6 0.6 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 106.693 -2.563 . . . . 1.12 106.693 -179.365 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.407 HG13 ' H ' ' A' ' 36' ' ' ILE . 7.8 mt -40.69 115.2 1.19 Allowed Pre-proline 0 N--CA 1.43 -1.452 1 N-CA-C 123.715 4.709 . . . . 2.07 123.715 -171.479 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -69.38 157.58 60.61 Favored 'Trans proline' 0 C--N 1.3 -1.993 2 CA-C-N 129.712 4.504 . . . . 1.39 108.448 -174.444 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.425 ' HD3' ' HB2' ' A' ' 31' ' ' GLN . 38.0 Cg_exo -65.65 -23.79 56.19 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 N-CA-C 117.522 2.085 . . . . 1.68 117.522 177.099 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.3 -12.98 47.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.624 -3.173 . . . . 2.25 118.46 174.873 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -97.39 -22.4 16.63 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 124.044 0.938 . . . . 2.44 108.977 -178.546 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -90.46 136.2 33.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 118.687 2.847 . . . . 1.32 118.687 -168.246 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -126.03 118.33 25.11 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.329 -2.1 . . . . 3.19 105.329 169.955 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.3 mt -96.94 122.34 39.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 123.962 0.905 . . . . 1.75 111.462 177.88 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.9 mm -105.58 141.6 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 128.326 2.651 . . . . 1.98 104.183 -176.961 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -140.71 132.74 27.82 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 116.82 -3.675 . . . . 1.94 103.622 168.054 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.42 . . 56.13 32.48 20.2 Favored 'General case' 0 N--CA 1.429 -1.48 1 CA-C-O 132.335 5.826 . . . . 1.67 121.617 174.25 . . . . . . . . 3 2 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.99 -15.21 39.34 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 108.461 -3.972 . . . . 1.3 109.793 179.206 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -87.16 129.49 34.92 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 128.549 2.74 . . . . 2.89 116.931 -178.106 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -74.4 114.91 13.33 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 128.692 2.797 . . . . 2.89 112.43 173.022 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.1 mt -85.58 147.65 26.31 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 115.922 1.823 . . . . 1.34 115.922 -174.273 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -93.16 138.38 31.63 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.592 -0.892 . . . . 1.94 108.592 179.937 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -66.79 -41.48 87.54 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 118.479 0.581 . . . . 1.56 112.028 -165.623 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.95 47.51 3.39 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 118.454 2.142 . . . . 0.97 118.454 176.498 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -134.49 171.65 14.01 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 102.312 -3.218 . . . . 3.07 102.312 171.409 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.2 p -113.81 177.83 4.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 125.275 2.464 . . . . 1.34 116.799 178.818 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.55 HD23 HD11 ' A' ' 61' ' ' ILE . 84.8 mt -66.91 -42.24 85.77 Favored 'General case' 0 N--CA 1.43 -1.427 1 C-N-CA 131.816 4.046 . . . . 1.63 109.084 173.9 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 t -59.56 -32.97 70.84 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 116.277 -4.014 . . . . 1.51 111.704 173.698 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.271 54.3 m-20 -81.39 -39.91 24.27 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.127 1.899 . . . . 1.9 116.127 179.629 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -84.05 -3.72 58.25 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.31 1.596 . . . . 0.97 115.31 176.72 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 74.12 36.72 0.66 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.079 2.552 . . . . 2.35 114.101 -177.744 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.55 HD11 HD23 ' A' ' 56' ' ' LEU . 11.7 mt -88.16 118.28 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 1 O-C-N 115.581 -4.449 . . . . 1.39 106.68 179.713 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -115.12 -164.9 0.97 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.272 -1.517 . . . . 2.58 115.023 -171.01 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -57.69 127.59 32.78 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 117.708 2.485 . . . . 2.58 117.708 174.927 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 69.69 34.57 2.65 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.449 3.023 . . . . 1.71 113.668 172.854 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m -88.1 129.57 35.26 Favored 'General case' 0 N--CA 1.429 -1.491 1 O-C-N 114.076 -5.39 . . . . 1.34 115.584 -177.955 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.0 m -85.09 88.68 7.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 118.533 2.79 . . . . 1.36 118.533 -175.671 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.461 HD12 HG22 ' A' ' 61' ' ' ILE . 10.3 mp -77.69 158.75 29.54 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 124.031 1.872 . . . . 2.03 107.147 179.332 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -119.62 140.88 49.9 Favored 'General case' 0 N--CA 1.43 -1.429 1 O-C-N 115.282 -4.636 . . . . 2.31 110.707 -179.746 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 tp -115.11 107.24 15.07 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 114.525 1.306 . . . . 1.72 114.525 -178.256 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.8 t -100.9 114.8 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 118.965 -2.335 . . . . 1.8 106.206 175.995 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.5 mt . . . . . 0 N--CA 1.43 -1.444 0 CA-C-O 124.362 2.029 . . . . 3.26 108.696 177.138 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.514 ' HG3' HG21 ' A' ' 17' ' ' VAL . 12.4 ptm . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 116.972 2.212 . . . . 1.39 116.972 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -108.66 163.74 12.98 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 127.464 2.306 . . . . 2.2 105.285 -179.593 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.7 pt -142.72 163.29 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 126.96 2.104 . . . . 1.32 106.085 168.865 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -126.03 110.14 13.22 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 124.517 1.135 . . . . 2.2 111.635 178.105 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.2 t -93.93 118.62 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 106.92 -1.511 . . . . 1.23 106.92 178.48 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -103.86 128.11 51.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.394 1.077 . . . . 2.51 109.619 177.236 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.5 p -85.21 165.7 17.16 Favored 'General case' 0 N--CA 1.429 -1.505 1 CA-C-O 128.979 4.228 . . . . 1.41 109.972 173.404 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.9 mt -59.35 -46.68 87.96 Favored 'General case' 0 N--CA 1.429 -1.502 1 O-C-N 115.269 -4.644 . . . . 2.95 113.113 166.153 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 p -55.99 -34.68 65.99 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 125.383 1.473 . . . . 2.52 111.952 -177.666 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.5 27.72 1.28 Allowed Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 117.718 -1.601 . . . . 1.5 112.533 174.55 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.466 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 71.6 tttt -106.83 151.46 25.17 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 117.242 -1.783 . . . . 1.79 110.028 -176.83 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.0 m -125.73 117.88 24.39 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.27 3.414 . . . . 1.38 108.343 174.055 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.365 11.5 pt -106.1 137.65 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.605 -2.56 . . . . 2.03 105.785 174.306 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.5 m -104.03 107.35 18.21 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.306 -1.316 . . . . 1.61 109.948 173.731 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.4 mt -102.52 149.6 24.23 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.262 2.225 . . . . 2.15 109.882 -175.8 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -103.25 132.12 49.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.176 -3.453 . . . . 1.98 110.979 177.479 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.514 HG21 ' HG3' ' A' ' 1' ' ' MET . 12.6 m -137.43 160.96 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 104.97 -2.233 . . . . 1.52 104.97 -169.078 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -107.5 155.97 38.66 Favored Pre-proline 0 N--CA 1.431 -1.392 0 O-C-N 120.484 -1.385 . . . . 2.35 108.872 166.352 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.67 -27.53 38.35 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 C-N-CA 124.274 3.316 . . . . 1.31 113.24 -166.715 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.6 m -92.17 3.74 54.69 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 116.014 -1.946 . . . . 1.71 113.626 -179.796 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -59.14 145.91 40.72 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 120.206 1.366 . . . . 1.69 113.284 171.824 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -79.73 159.45 26.61 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 104.873 -2.269 . . . . 1.33 104.873 175.462 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.3 mm -65.45 -37.81 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 119.399 -2.063 . . . . 1.32 110.159 177.095 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -49.49 -41.49 40.83 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 130.21 3.404 . . . . 1.62 117.69 164.571 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -77.64 -3.79 42.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 124.149 0.905 . . . . 2.13 113.184 174.79 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.04 -36.81 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 105.159 -2.163 . . . . 1.23 105.159 175.948 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -61.07 -38.17 85.28 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.496 2.093 . . . . 1.97 109.919 175.405 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.42 -36.3 68.8 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.402 -2.686 . . . . 1.19 117.856 167.029 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -69.0 -33.63 73.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.3 -4.0 . . . . 1.92 112.886 172.071 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.0 mt -66.16 -34.77 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 114.225 -2.798 . . . . 1.94 113.974 172.589 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -68.11 -39.24 82.82 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 122.359 2.345 . . . . 1.9 107.07 178.51 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -62.57 -47.06 85.5 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.468 -2.02 . . . . 1.55 110.246 178.718 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -75.52 -63.0 1.38 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.287 -2.133 . . . . 2.95 116.549 -177.389 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.466 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 29.2 mm-40 -94.41 -47.92 6.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.252 1.821 . . . . 1.48 115.432 -173.478 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.31 -2.4 6.19 Favored Glycine 0 N--CA 1.431 -1.698 0 CA-C-O 127.651 3.917 . . . . 1.12 112.862 174.523 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.2 mt -71.29 131.69 86.58 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 117.464 -3.374 . . . . 2.07 111.016 -175.085 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -88.26 165.71 6.79 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 125.249 2.911 . . . . 1.39 110.371 -176.889 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.42 -14.76 28.02 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 C-N-CA 122.037 1.825 . . . . 1.68 115.265 -173.341 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -61.36 -36.64 80.75 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.882 3.273 . . . . 2.25 112.479 172.356 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.439 ' HB3' HD13 ' A' ' 71' ' ' LEU . 78.8 mt-30 -106.07 -9.83 16.81 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 126.5 1.92 . . . . 2.44 110.095 -172.474 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -82.27 103.34 11.79 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.258 -2.151 . . . . 1.32 112.213 -175.19 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -114.71 137.41 51.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.514 2.578 . . . . 3.19 105.392 164.851 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 mt -108.66 134.42 51.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.391 -3.943 . . . . 1.75 112.24 172.132 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 93.3 mt -116.44 128.92 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 125.923 2.773 . . . . 1.98 107.172 177.712 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -137.19 142.19 42.13 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.506 -2.622 . . . . 1.94 106.455 173.754 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.26 13.9 3.33 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.294 2.638 . . . . 1.67 117.121 -176.706 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.01 -16.85 57.95 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-O 122.78 1.211 . . . . 1.3 112.384 -178.324 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -101.47 154.22 19.02 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.759 -3.789 . . . . 2.89 108.631 -178.892 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -82.19 132.69 35.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 124.999 1.437 . . . . 2.89 111.674 170.265 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 mt -89.27 140.79 29.13 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 122.041 2.2 . . . . 1.34 114.301 -176.184 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -81.91 142.91 32.06 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 128.032 2.533 . . . . 1.94 110.943 178.265 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.02 -56.31 22.58 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.916 2.086 . . . . 1.56 113.352 -174.531 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.37 37.58 2.59 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 116.021 -2.544 . . . . 0.97 114.359 176.51 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -114.91 164.36 14.25 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.192 -1.781 . . . . 3.07 106.192 166.922 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -114.0 167.18 10.88 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.169 -2.207 . . . . 1.34 112.702 -176.932 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.9 mp -64.25 -42.12 96.65 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.514 2.726 . . . . 1.63 111.672 177.482 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.1 p -70.02 -37.46 75.64 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 117.81 -1.09 . . . . 1.51 113.081 -179.629 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.19 -40.76 98.44 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.004 1.722 . . . . 1.9 115.627 174.198 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -75.21 -16.47 60.48 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.987 -3.57 . . . . 0.97 107.557 177.398 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 70.97 48.64 0.38 Allowed 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.542 1.137 . . . . 2.35 112.421 -174.361 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.8 mt -86.5 107.88 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 113.56 -1.654 . . . . 1.39 110.216 175.831 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -95.38 -160.76 0.81 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.058 2.543 . . . . 2.58 112.071 -174.967 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -76.21 138.37 40.6 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 116.997 -3.564 . . . . 2.58 111.762 174.565 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.309 5.4 tt0 71.37 69.81 0.17 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 127.866 3.229 . . . . 1.71 110.991 174.529 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.397 55.2 m -116.01 144.61 43.86 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.423 -2.673 . . . . 1.34 109.287 -174.817 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.4 m -104.07 102.72 12.47 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.94 -1.504 . . . . 1.36 106.94 175.375 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.0 mt -91.31 123.93 35.12 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.518 -2.614 . . . . 2.03 108.023 170.757 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -92.65 109.14 20.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.645 0.778 . . . . 2.31 110.59 -178.093 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 tp -91.07 113.77 26.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.321 1.534 . . . . 1.72 112.378 -179.752 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.4 m -102.78 160.63 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 124.808 2.242 . . . . 1.8 106.43 178.548 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.439 HD13 ' HB3' ' A' ' 40' ' ' GLN . 20.6 tp . . . . . 0 N--CA 1.43 -1.435 0 CA-C-N 113.837 -1.529 . . . . 3.26 114.24 176.397 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptt? . . . . . 0 CA--C 1.49 -1.349 1 CA-C-O 129.473 4.463 . . . . 1.39 110.689 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -91.03 146.75 23.59 Favored 'General case' 0 N--CA 1.431 -1.41 1 O-C-N 113.862 -5.524 . . . . 2.2 110.089 -176.555 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.329 13.9 pt -135.97 153.0 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 129.346 3.058 . . . . 1.32 109.109 178.526 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -112.95 141.98 46.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 126.459 3.028 . . . . 2.2 107.755 176.096 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -134.56 122.02 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 118.263 -2.773 . . . . 1.23 107.842 170.238 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -96.23 137.26 35.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.771 -1.559 . . . . 2.51 111.027 175.41 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.289 44.8 p -77.15 172.67 12.88 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 126.27 2.938 . . . . 1.41 110.363 175.035 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 tp -64.17 -51.34 64.28 Favored 'General case' 0 N--CA 1.429 -1.494 1 O-C-N 115.849 -4.282 . . . . 2.95 113.622 174.965 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.379 75.4 p -61.06 -41.7 97.09 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.563 1.69 . . . . 2.52 115.563 174.552 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.34 9.97 0.2 Allowed Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 116.945 1.538 . . . . 1.5 116.945 175.005 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.565 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 84.5 tttt -84.37 118.5 24.27 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.427 -2.219 . . . . 1.79 114.165 -174.353 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.6 m -93.47 126.77 38.79 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 121.785 2.084 . . . . 1.38 109.415 179.485 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mt -116.87 111.73 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 127.179 2.192 . . . . 2.03 113.153 -178.191 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.1 m -81.2 121.31 25.99 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 126.519 1.928 . . . . 1.61 107.596 177.087 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.5 mt -124.9 146.86 49.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 100.712 -3.81 . . . . 2.15 100.712 -179.475 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -106.18 122.68 46.69 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 118.393 -2.692 . . . . 1.98 108.371 169.909 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.9 m -129.74 152.04 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 126.584 3.087 . . . . 1.52 107.247 -172.99 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -94.1 151.05 39.35 Favored Pre-proline 0 N--CA 1.429 -1.507 1 O-C-N 114.869 -4.894 . . . . 2.35 106.254 156.273 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -76.53 -6.68 17.24 Favored 'Trans proline' 0 N--CA 1.433 -2.05 0 CA-C-N 125.72 3.078 . . . . 1.31 113.525 -174.756 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -87.01 -3.02 59.05 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 125.632 1.833 . . . . 1.71 111.913 -178.466 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -76.37 156.63 33.09 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 129.515 3.126 . . . . 1.69 109.334 171.383 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.5 p -84.98 166.61 16.61 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.402 -2.686 . . . . 1.33 111.794 177.529 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.22 -42.81 97.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 126.419 1.888 . . . . 1.32 109.395 174.939 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -46.35 -44.28 16.77 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.624 3.194 . . . . 1.62 119.624 164.812 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -67.17 -32.97 74.43 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.306 1.595 . . . . 2.13 115.306 173.522 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.3 t -64.15 -39.05 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 126.933 3.254 . . . . 1.23 111.966 169.771 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -59.15 -44.05 92.09 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.324 -2.735 . . . . 1.97 115.268 173.876 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.3 -33.0 65.13 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.056 -2.278 . . . . 1.19 111.401 173.788 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -76.54 -26.39 55.13 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 115.342 1.608 . . . . 1.92 115.342 173.96 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.7 mt -70.96 -28.25 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 119.739 -1.851 . . . . 1.94 114.558 169.146 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -70.92 -33.55 70.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.81 3.244 . . . . 1.9 108.111 179.559 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -74.95 -34.26 62.03 Favored 'General case' 0 N--CA 1.431 -1.408 1 C-N-CA 132.998 4.519 . . . . 1.55 112.356 175.47 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.9 mmtm -89.33 -64.72 1.1 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 127.959 3.742 . . . . 2.95 110.099 -171.078 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.565 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 22.6 mm-40 -93.93 -42.08 9.26 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.04 -2.287 . . . . 1.48 113.621 -170.533 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.73 5.74 21.93 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 121.254 3.261 . . . . 1.12 121.254 175.638 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.1 mt -74.92 129.69 82.68 Favored Pre-proline 0 N--CA 1.431 -1.414 0 C-N-CA 128.747 2.819 . . . . 2.07 110.436 -178.186 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -77.3 141.93 20.84 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 126.077 3.206 . . . . 1.39 111.998 -177.244 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.27 -17.53 33.28 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 N-CA-C 118.739 2.554 . . . . 1.68 118.739 -173.061 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -79.04 -23.2 44.43 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 114.863 1.431 . . . . 2.25 114.863 171.349 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -88.66 -13.75 39.06 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.351 -2.093 . . . . 2.44 108.111 176.765 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.329 69.2 mt-30 -98.12 143.76 28.31 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 121.163 1.802 . . . . 1.32 110.9 -174.316 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -135.87 135.79 40.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 121.398 0.618 . . . . 3.19 111.037 171.301 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.0 mt -102.84 134.75 45.72 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 117.254 -3.404 . . . . 1.75 115.702 172.139 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.3 mt -118.53 130.28 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 114.724 -1.125 . . . . 1.98 108.322 -179.484 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -136.29 123.15 21.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.139 -2.85 . . . . 1.94 118.009 176.167 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.54 40.44 23.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.046 1.738 . . . . 1.67 110.631 -171.445 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.92 -8.45 50.5 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-O 114.465 -3.408 . . . . 1.3 114.922 179.537 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -85.39 135.5 33.85 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 120.002 1.901 . . . . 2.89 110.706 175.348 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -84.69 120.69 26.69 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.748 2.689 . . . . 2.89 108.475 164.927 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.1 mt -80.25 107.99 13.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 118.204 2.668 . . . . 1.34 118.204 -173.726 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.269 33.2 mt-10 -52.9 121.98 8.36 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 121.525 3.898 . . . . 1.94 121.525 170.434 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.12 -57.82 1.25 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 131.158 3.783 . . . . 1.56 115.756 -174.075 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.89 39.19 2.84 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 127.73 2.586 . . . . 0.97 116.613 175.186 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -121.35 172.37 8.08 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.081 1.896 . . . . 3.07 106.142 167.385 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.301 62.2 p -87.83 176.67 7.27 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 118.944 -2.348 . . . . 1.34 113.959 168.663 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.4 mt -80.53 -25.78 38.47 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.446 1.899 . . . . 1.63 109.409 165.771 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.56 -39.55 62.21 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 107.657 -1.238 . . . . 1.51 107.657 -170.641 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -43.61 -57.79 2.98 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 126.783 2.033 . . . . 1.9 116.078 169.351 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -71.49 -1.31 12.87 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 119.279 3.066 . . . . 0.97 119.279 -178.588 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.396 23.1 m120 62.2 49.9 4.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 131.003 3.721 . . . . 2.35 113.083 -170.198 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.4 mt -87.64 137.31 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 123.508 2.867 . . . . 1.39 109.247 174.988 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -122.51 -176.56 3.41 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.833 2.254 . . . . 2.58 110.528 -175.762 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 ptmm? -62.59 139.55 58.63 Favored 'General case' 0 N--CA 1.429 -1.487 1 O-C-N 116.206 -4.059 . . . . 2.58 111.898 -177.513 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 62.61 31.52 16.79 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.856 2.862 . . . . 1.71 109.15 175.307 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 t -95.01 137.45 34.05 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.458 -2.651 . . . . 1.34 109.994 -179.897 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.2 m -88.07 121.58 30.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 126.929 2.643 . . . . 1.36 112.035 -177.767 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 72.2 mt -105.28 152.79 22.46 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 128.631 2.772 . . . . 2.03 105.871 176.9 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -101.82 125.32 48.47 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.439 -2.663 . . . . 2.31 107.261 -177.48 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.2 tp -96.93 126.28 41.96 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 124.296 3.225 . . . . 1.72 110.949 178.131 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.9 m -131.1 176.98 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 118.366 -2.709 . . . . 1.8 111.162 172.012 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 N--CA 1.43 -1.46 0 O-C-N 119.724 -1.86 . . . . 3.26 114.064 178.431 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 112.157 0.429 . . . . 1.39 112.157 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -108.96 140.73 42.07 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.316 -2.74 . . . . 2.2 105.678 177.588 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.4 pt -128.86 153.17 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 106.486 -1.672 . . . . 1.32 106.486 173.477 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -109.75 105.82 15.21 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.501 -2.0 . . . . 2.2 115.226 179.188 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.0 t -94.58 115.95 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 117.801 -3.062 . . . . 1.23 105.762 176.565 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -95.39 156.91 16.12 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.689 2.185 . . . . 2.51 108.013 175.502 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.2 p -105.06 -171.61 1.95 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.994 1.318 . . . . 1.41 110.252 -178.404 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.9 mt -85.88 -36.84 19.71 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 115.701 -4.375 . . . . 2.95 114.242 172.477 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.251 38.6 p -80.06 -54.84 5.41 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.589 -2.004 . . . . 2.52 105.589 -175.339 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.02 23.77 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 120.241 2.856 . . . . 1.5 120.241 171.541 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -88.18 135.83 33.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 117.684 -1.15 . . . . 1.79 111.058 -179.917 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.8 m -109.79 111.65 23.23 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.359 -1.349 . . . . 1.38 107.359 169.851 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 mt -92.3 105.54 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 104.835 -2.283 . . . . 2.03 104.835 -177.315 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.8 m -85.36 107.6 17.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.673 -3.142 . . . . 1.61 106.174 178.159 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.8 mt -101.13 144.17 30.35 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 114.318 1.229 . . . . 2.15 114.318 -177.973 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -101.05 118.88 37.88 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.678 2.656 . . . . 1.98 110.875 174.952 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 m -130.26 158.57 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 123.863 1.792 . . . . 1.52 110.614 -172.412 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -113.26 170.73 4.99 Favored Pre-proline 0 N--CA 1.43 -1.45 0 O-C-N 117.772 -3.08 . . . . 2.35 105.408 159.358 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -87.21 -9.55 6.05 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 C-N-CA 122.342 2.028 . . . . 1.31 114.006 -167.836 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.261 81.5 p -85.04 0.85 50.14 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 131.284 3.833 . . . . 1.71 116.079 173.445 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -86.7 145.33 26.72 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.673 -3.142 . . . . 1.69 111.552 169.098 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.5 p -59.75 155.41 16.04 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.718 2.199 . . . . 1.33 112.559 168.979 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.455 HG21 HD12 ' A' ' 43' ' ' LEU 0.253 3.3 mt -63.19 -37.13 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 119.654 -1.904 . . . . 1.32 112.551 170.332 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -53.09 -40.55 64.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.075 1.509 . . . . 1.62 115.075 165.655 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -61.02 -32.98 72.57 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 118.275 2.695 . . . . 2.13 118.275 174.186 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.318 45.6 t -71.2 -35.85 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 122.387 1.089 . . . . 1.23 110.196 -178.42 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -70.08 -24.37 63.22 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 132.042 4.137 . . . . 1.97 113.593 174.442 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.56 -33.99 62.82 Favored 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 116.298 -4.001 . . . . 1.19 111.644 174.941 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -69.1 -25.93 64.66 Favored 'General case' 0 N--CA 1.431 -1.395 1 O-C-N 114.972 -4.83 . . . . 1.92 115.522 178.429 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 mt -68.01 -39.64 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 1 C-N-CA 132.499 4.32 . . . . 1.94 112.397 170.594 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.11 -36.68 77.99 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.718 2.488 . . . . 1.9 117.718 178.332 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.03 -57.9 10.88 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 116.544 -1.693 . . . . 1.55 114.127 163.242 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -62.78 -61.84 2.13 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 118.284 2.698 . . . . 2.95 118.284 -177.722 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -93.79 -32.34 14.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.9 -3.0 . . . . 1.48 109.584 -171.81 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.88 16.78 22.86 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 116.92 -2.562 . . . . 1.12 115.629 172.699 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.4 mt -90.58 131.96 36.54 Favored Pre-proline 0 N--CA 1.43 -1.455 1 CA-C-O 110.889 -4.386 . . . . 2.07 110.66 179.237 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -57.68 146.67 83.96 Favored 'Trans proline' 0 C--N 1.299 -2.056 0 CA-C-N 127.664 3.773 . . . . 1.39 116.954 171.767 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.66 -13.38 13.28 Favored 'Trans proline' 0 N--CA 1.434 -2.027 1 C-N-CA 125.674 4.249 . . . . 1.68 113.985 -175.077 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.391 9.6 p-10 -62.83 -31.78 72.86 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 119.724 1.147 . . . . 2.25 113.708 166.325 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -80.75 -26.89 37.03 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 123.813 1.768 . . . . 2.44 113.284 -176.398 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -84.67 142.78 29.65 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 111.711 -2.495 . . . . 1.32 111.252 -173.651 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -143.35 142.6 31.35 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.921 -1.49 . . . . 3.19 111.845 171.644 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.455 HD12 HG21 ' A' ' 23' ' ' ILE . 97.6 mt -105.19 146.63 28.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.92 2.295 . . . . 1.75 106.387 -178.38 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 mt -118.76 138.93 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 128.582 2.753 . . . . 1.98 104.51 174.29 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -144.58 120.44 10.6 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 124.971 2.32 . . . . 1.94 104.789 177.109 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.38 13.58 5.52 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 127.865 2.466 . . . . 1.67 114.912 175.435 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.29 -22.57 38.58 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 127.487 2.47 . . . . 1.3 113.991 -171.571 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -80.57 134.96 36.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 126.548 3.07 . . . . 2.89 111.676 -177.267 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -77.8 128.79 34.57 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 117.195 -3.441 . . . . 2.89 111.942 176.778 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.6 mt -92.97 142.65 27.07 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.188 -2.195 . . . . 1.34 113.438 -172.356 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -79.86 148.01 31.5 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.077 2.951 . . . . 1.94 110.849 175.242 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -89.18 -34.27 16.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.167 1.914 . . . . 1.56 116.167 -168.468 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.36 21.03 6.42 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 128.488 2.947 . . . . 0.97 117.698 171.979 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -105.55 178.2 4.63 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 119.698 1.749 . . . . 3.07 108.187 169.311 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -108.84 -172.94 2.15 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 124.905 2.288 . . . . 1.34 107.274 167.164 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.6 mt -66.06 -43.87 86.2 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 128.436 3.97 . . . . 1.63 112.889 171.089 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.4 m -53.27 -25.97 16.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.179 -3.451 . . . . 1.51 118.291 -179.734 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -78.37 -44.83 23.99 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.115 2.966 . . . . 1.9 111.841 177.386 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -80.76 9.87 5.7 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 129.949 3.3 . . . . 0.97 114.648 174.949 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.27 10.2 p30 47.93 39.8 11.68 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 129.044 2.938 . . . . 2.35 114.176 -178.888 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.304 12.7 mt -77.92 127.56 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 116.856 -3.652 . . . . 1.39 109.555 179.966 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 -107.58 -178.37 3.61 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 125.655 2.645 . . . . 2.58 106.369 178.427 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -64.22 159.22 21.19 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 115.74 -4.35 . . . . 2.58 110.467 -177.484 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.421 19.9 mt-10 59.41 41.53 19.34 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 116.966 -3.583 . . . . 1.71 112.657 169.389 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.2 p -106.36 135.14 48.38 Favored 'General case' 0 N--CA 1.431 -1.397 1 O-C-N 114.857 -4.902 . . . . 1.34 109.9 -173.373 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.5 m -86.44 116.55 24.66 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.477 -2.64 . . . . 1.36 107.163 175.808 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.6 mp -109.45 160.57 16.09 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 112.862 -1.972 . . . . 2.03 110.29 172.594 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -127.39 139.53 52.78 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.949 -2.344 . . . . 2.31 112.046 -176.681 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.6 tp -103.46 127.13 50.91 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 130.695 3.598 . . . . 1.72 109.16 -177.495 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.0 m -135.15 163.95 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 O-C-N 116.351 -3.968 . . . . 1.8 110.557 166.476 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.6 mt . . . . . 0 N--CA 1.43 -1.466 0 CA-C-O 117.024 -1.465 . . . . 3.26 113.278 170.77 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 CA--C 1.49 -1.36 0 CA-C-O 125.998 2.809 . . . . 1.39 103.709 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -90.28 125.75 35.61 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.969 -3.582 . . . . 2.2 109.432 -179.328 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -127.65 150.49 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 118.926 -1.109 . . . . 1.32 109.092 170.148 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.262 33.3 m-85 -115.03 121.86 44.4 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 124.28 1.99 . . . . 2.2 112.314 -172.027 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -103.12 107.97 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 119.677 -1.889 . . . . 1.23 110.903 178.309 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -85.61 158.66 20.05 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 118.806 -2.434 . . . . 2.51 107.474 177.781 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.3 p -108.43 -167.52 1.24 Allowed 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 106.824 -1.547 . . . . 1.41 106.824 175.3 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.6 mt -88.69 -30.75 18.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 119.865 1.211 . . . . 2.95 109.171 178.592 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.9 p -70.57 -27.65 64.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.055 -2.278 . . . . 2.52 106.542 -179.478 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.34 18.66 6.13 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-O 122.432 1.018 . . . . 1.5 115.592 173.362 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -82.63 117.86 22.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 117.041 -1.457 . . . . 1.79 113.375 -177.463 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.288 89.2 m -85.35 115.41 23.08 Favored 'General case' 0 N--CA 1.431 -1.389 1 CA-C-N 126.202 4.092 . . . . 1.38 114.115 175.396 . . . . . . . . 3 2 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.2 mt -100.56 107.31 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 1 O-C-N 114.963 -4.836 . . . . 2.03 110.6 178.629 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.7 m -80.68 116.3 20.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.954 -2.341 . . . . 1.61 114.057 175.562 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.9 mt -107.6 127.98 54.12 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.55 -1.969 . . . . 2.15 107.717 178.009 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -96.15 99.83 11.53 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.376 -2.702 . . . . 1.98 104.619 170.69 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.3 m -112.38 164.63 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 105.681 -1.97 . . . . 1.52 105.681 -176.406 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -104.78 163.73 16.61 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 105.618 -1.993 . . . . 2.35 105.618 165.663 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -86.82 -8.93 6.72 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 O-C-N 113.932 -3.773 . . . . 1.31 108.759 -166.402 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.25 4.9 p -90.72 1.14 57.12 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 119.763 -0.775 . . . . 1.71 111.674 177.149 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.27 36.2 m-20 -63.01 148.7 46.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 129.694 3.198 . . . . 1.69 108.737 172.173 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 23.5 p -97.99 163.87 12.59 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 118.846 -2.409 . . . . 1.33 112.632 173.893 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.298 24.1 mm -63.41 -34.98 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 120.062 1.301 . . . . 1.32 111.099 -179.581 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -48.77 -39.95 27.04 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 117.948 -2.97 . . . . 1.62 115.243 160.279 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -75.84 -48.65 20.66 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.508 -2.62 . . . . 2.13 107.905 -176.741 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.6 t -49.1 -54.25 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.989 2.916 . . . . 1.23 116.334 172.56 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -50.97 -32.75 22.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.427 -1.421 . . . . 1.97 113.876 175.983 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.88 -40.02 91.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.181 3.372 . . . . 1.19 114.068 178.789 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -58.79 -40.94 85.49 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.78 -3.075 . . . . 1.92 112.378 176.245 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.4 mt -70.5 -31.6 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 116.487 -3.883 . . . . 1.94 112.061 176.139 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -69.13 -33.39 73.38 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 119.434 -2.041 . . . . 1.9 111.453 171.929 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.355 17.5 t70 -77.13 -44.3 30.87 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.43 2.011 . . . . 1.55 116.43 167.814 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -65.33 -60.56 2.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.194 -3.441 . . . . 2.95 111.092 -171.099 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -105.13 -37.16 7.02 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 124.283 1.992 . . . . 1.48 109.355 -166.251 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.92 38.39 2.35 Favored Glycine 0 N--CA 1.43 -1.752 0 O-C-N 117.56 -3.213 . . . . 1.12 111.575 168.752 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.414 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 37.5 mt -111.08 122.23 38.48 Favored Pre-proline 0 N--CA 1.43 -1.465 0 O-C-N 118.577 -2.719 . . . . 2.07 106.395 -174.441 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 36' ' ' ILE . 18.5 Cg_endo -57.76 141.73 95.79 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 O-C-N 115.65 -2.868 . . . . 1.39 116.819 175.448 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -64.83 -32.96 54.87 Favored 'Trans proline' 0 N--CA 1.433 -2.03 1 C-N-CA 127.54 5.493 . . . . 1.68 111.797 -174.136 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -51.14 -39.35 56.09 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 129.871 3.268 . . . . 2.25 113.996 168.158 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -82.19 -5.22 58.33 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.11 1.909 . . . . 2.44 112.688 178.248 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -99.6 113.76 26.38 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 116.333 -3.98 . . . . 1.32 108.27 -166.933 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -89.29 123.02 33.11 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 125.31 2.481 . . . . 3.19 104.823 163.017 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.2 mt -109.29 119.67 40.2 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.039 -5.413 . . . . 1.75 105.267 175.385 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.3 mm -108.51 133.16 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 128.306 2.643 . . . . 1.98 113.037 179.57 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -130.93 114.31 15.09 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 129.298 4.124 . . . . 1.94 111.05 174.074 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.01 -92.14 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.162 2.185 . . . . 1.67 113.306 -178.437 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.79 23.0 4.01 Favored Glycine 0 N--CA 1.431 -1.696 0 C-N-CA 127.676 2.56 . . . . 1.3 112.536 174.106 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.9 mmtt -123.33 129.95 52.04 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.09 -1.829 . . . . 2.89 110.212 -179.36 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -87.55 125.13 34.15 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 117.185 -3.447 . . . . 2.89 105.274 172.014 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 99.3 mt -82.11 126.69 32.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.082 -1.636 . . . . 1.34 111.906 -162.104 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -76.13 147.97 38.16 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.644 -2.535 . . . . 1.94 111.938 168.772 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.276 42.6 m-20 -61.11 -65.65 0.66 Allowed 'General case' 0 N--CA 1.431 -1.419 1 N-CA-C 123.201 4.519 . . . . 1.56 123.201 -171.271 . . . . . . . . 3 2 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.82 32.92 3.36 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 122.045 3.578 . . . . 0.97 122.045 178.886 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.7 mtt-85 -102.7 153.65 19.93 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 103.697 -2.705 . . . . 3.07 103.697 169.875 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.268 8.1 p -77.43 153.56 33.48 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 131.043 3.737 . . . . 1.34 110.328 171.733 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 mt -59.74 -42.15 92.52 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.017 -0.992 . . . . 1.63 111.847 172.118 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.6 p -56.81 -36.56 70.06 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.564 2.346 . . . . 1.51 111.725 179.067 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -66.41 -45.7 79.04 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.871 1.669 . . . . 1.9 111.7 -177.197 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -72.19 -9.16 58.08 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 116.966 2.21 . . . . 0.97 116.966 170.62 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 61.46 53.01 3.51 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.496 1.518 . . . . 2.35 112.504 -177.68 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.8 mt -89.05 113.78 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 130.791 3.637 . . . . 1.39 105.038 176.079 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -99.52 -169.9 1.82 Allowed 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.301 1.593 . . . . 2.58 115.301 178.504 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -66.32 141.25 58.06 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.765 1.745 . . . . 2.58 110.791 176.38 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 67.23 24.98 9.01 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 112.437 -2.165 . . . . 1.71 113.272 172.918 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.3 m -75.58 144.6 41.75 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.855 1.312 . . . . 1.34 112.732 -175.874 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 m -97.57 123.46 41.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 118.071 -1.451 . . . . 1.36 108.518 -176.081 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 mp -122.26 163.38 19.74 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 104.508 -2.404 . . . . 2.03 104.508 178.195 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.263 43.6 m80 -134.63 112.03 10.49 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.46 2.552 . . . . 2.31 110.822 -172.302 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.05 122.74 22.26 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.695 2.398 . . . . 1.72 111.605 175.397 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.5 t -123.01 136.27 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 102.506 -3.146 . . . . 1.8 102.506 175.202 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.7 tp . . . . . 0 N--CA 1.429 -1.487 1 O-C-N 114.822 -4.924 . . . . 3.26 111.027 -174.45 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 ptt? . . . . . 0 CA--C 1.491 -1.325 0 N-CA-C 118.225 2.676 . . . . 1.39 118.225 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.257 7.1 tt0 -117.83 123.27 45.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.677 2.791 . . . . 2.2 114.206 -178.498 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.4 pt -127.94 160.47 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 117.774 -3.079 . . . . 1.32 106.922 174.457 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -118.71 132.79 56.16 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.38 3.472 . . . . 2.2 106.231 -173.355 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 t -122.97 125.59 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 123.447 0.699 . . . . 1.23 110.772 170.851 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.344 19.4 mttm -103.05 145.41 29.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.967 2.794 . . . . 2.51 115.067 179.598 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.301 22.9 p -91.45 168.68 11.37 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.722 -4.362 . . . . 1.41 116.291 173.653 . . . . . . . . 3 2 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.342 31.6 tp -59.31 -56.65 19.4 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.673 2.101 . . . . 2.95 116.673 169.603 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 p -61.89 -60.85 3.03 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 114.35 -1.295 . . . . 2.52 112.002 -176.075 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.86 30.53 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 117.964 -2.065 . . . . 1.5 117.214 173.105 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.432 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 95.0 mttt -111.36 146.3 37.35 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.696 -2.061 . . . . 1.79 111.305 -178.509 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.8 m -112.69 104.61 12.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 104.065 -2.568 . . . . 1.38 104.065 167.602 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.2 mt -91.0 123.53 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 122.213 1.006 . . . . 2.03 108.379 -176.447 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 m -94.31 120.89 35.21 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 118.488 -2.632 . . . . 1.61 109.318 -179.957 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.6 mt -113.14 143.51 44.25 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 126.929 3.252 . . . . 2.15 112.215 179.551 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -86.2 112.35 21.26 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 111.805 -2.452 . . . . 1.98 107.004 171.237 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.13 149.86 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.989 1.716 . . . . 1.52 114.922 -177.613 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -108.79 149.54 39.65 Favored Pre-proline 0 N--CA 1.43 -1.438 0 N-CA-C 103.651 -2.722 . . . . 2.35 103.651 172.418 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -63.94 -19.7 67.0 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 123.428 2.752 . . . . 1.31 113.178 -173.84 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.4 p -80.73 -16.77 53.04 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 130.08 3.352 . . . . 1.71 110.683 -177.51 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -60.24 145.63 46.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 116.779 -1.968 . . . . 1.69 113.892 172.428 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.9 p -80.25 162.62 24.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.537 2.113 . . . . 1.33 108.905 176.461 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.3 mm -64.87 -30.5 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 126.833 3.206 . . . . 1.32 112.016 177.125 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.6 -39.17 91.27 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 114.693 -5.004 . . . . 1.62 112.217 167.059 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.253 15.8 m-80 -70.39 -32.73 70.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 119.892 1.224 . . . . 2.13 112.552 171.683 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.35 43.4 t -53.57 -48.67 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 1 O-C-N 114.287 -5.258 . . . . 1.23 112.72 167.825 . . . . . . . . 3 2 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -56.06 -41.25 74.78 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.187 1.921 . . . . 1.97 116.187 174.531 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.3 -31.74 72.96 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.431 1.493 . . . . 1.19 112.637 172.275 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -66.22 -38.59 88.3 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 127.494 3.521 . . . . 1.92 115.673 176.119 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.7 mt -73.07 -36.99 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 117.636 -3.165 . . . . 1.94 107.596 172.911 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.428 ' HG3' ' HD3' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -62.64 -35.2 78.85 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 123.851 3.023 . . . . 1.9 113.844 179.431 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.45 -54.72 24.39 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.461 1.904 . . . . 1.55 109.726 175.188 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.5 mmtt -57.83 -77.64 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.479 3.038 . . . . 2.95 115.638 -179.08 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.432 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 34.0 tp10 -101.68 -20.78 14.85 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.166 -3.458 . . . . 1.48 110.142 -161.895 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.77 53.81 2.48 Favored Glycine 0 N--CA 1.431 -1.682 0 O-C-N 120.412 -1.43 . . . . 1.12 115.165 172.524 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.1 mt -108.05 117.04 55.99 Favored Pre-proline 0 N--CA 1.43 -1.436 0 CA-C-O 113.51 -3.138 . . . . 2.07 110.153 -175.773 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -67.32 127.24 16.26 Favored 'Trans proline' 0 C--N 1.299 -2.054 0 CA-C-N 126.241 3.265 . . . . 1.39 117.292 -179.654 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.428 ' HD3' ' HG3' ' A' ' 31' ' ' GLN . 27.5 Cg_exo -59.49 -31.13 94.15 Favored 'Trans proline' 0 N--CA 1.434 -2.016 1 C-N-CA 127.527 5.485 . . . . 1.68 118.406 -172.402 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -64.9 -24.68 67.6 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.753 2.821 . . . . 2.25 108.445 178.721 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -94.02 12.71 25.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.912 -2.368 . . . . 2.44 116.53 173.733 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.275 9.6 mt-30 -115.29 147.21 40.69 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.217 2.437 . . . . 1.32 110.675 -178.893 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.6 ptt85 -135.02 134.65 40.66 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 112.907 -1.951 . . . . 3.19 106.048 163.853 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.3 mt -103.69 133.48 48.63 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 119.823 1.192 . . . . 1.75 113.203 179.64 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.4 mm -118.64 145.49 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 125.059 2.361 . . . . 1.98 108.553 177.9 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -134.54 108.79 8.29 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.013 -2.93 . . . . 1.94 103.92 172.295 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.519 . . 72.77 -97.33 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 116.666 2.099 . . . . 1.67 116.666 -176.961 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.9 17.52 1.97 Allowed Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 127.603 2.525 . . . . 1.3 108.532 -175.639 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.2 mttm -106.49 144.79 32.66 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.204 -2.35 . . . . 2.89 110.06 170.664 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -107.75 129.29 55.05 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.587 3.089 . . . . 2.89 115.345 169.649 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.7 mt -97.19 122.84 40.66 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.394 -3.941 . . . . 1.34 104.433 -160.342 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -77.09 138.66 39.67 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 117.633 -3.167 . . . . 1.94 111.72 172.397 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -54.91 -41.14 70.6 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 130.489 3.515 . . . . 1.56 115.978 -170.131 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.38 31.24 6.9 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 126.537 2.018 . . . . 0.97 115.051 174.935 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.87 165.28 11.83 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.224 -1.399 . . . . 3.07 107.224 166.426 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 5.4 p -95.62 171.52 8.62 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 119.034 2.976 . . . . 1.34 119.034 169.179 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -59.35 -39.1 82.16 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 121.59 1.995 . . . . 1.63 112.171 169.772 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 t -64.3 -37.86 88.98 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 116.944 2.202 . . . . 1.51 116.944 -179.151 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -61.19 -21.59 63.96 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.657 -1.902 . . . . 1.9 113.851 174.071 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -109.52 12.35 24.48 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.659 2.936 . . . . 0.97 115.685 -178.962 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.401 6.4 t-20 62.6 39.24 11.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.683 2.793 . . . . 2.35 116.71 -177.093 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.7 mt -90.84 105.5 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 112.661 -2.063 . . . . 1.39 112.556 178.046 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -98.9 -171.59 2.13 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 122.23 2.286 . . . . 2.58 107.111 -174.551 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.253 21.8 pttp -61.54 149.01 40.26 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 126.698 1.999 . . . . 2.58 115.604 176.354 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.317 36.1 mt-10 67.19 13.18 9.32 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.804 1.779 . . . . 1.71 115.804 175.123 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.6 m -66.44 148.74 51.45 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.477 -2.014 . . . . 1.34 112.271 -177.835 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.6 m -103.45 97.92 7.9 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.808 1.766 . . . . 1.36 115.494 173.751 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 mp -87.26 152.43 22.31 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.526 -1.984 . . . . 2.03 113.993 -178.924 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.6 m170 -120.79 129.07 53.44 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.158 -1.589 . . . . 2.31 109.87 -173.788 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.4 tp -95.34 128.82 42.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.576 -1.327 . . . . 1.72 114.374 -176.175 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.4 159.0 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 124.163 1.935 . . . . 1.8 113.669 177.371 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 tp . . . . . 0 N--CA 1.43 -1.433 0 O-C-N 120.786 -1.196 . . . . 3.26 110.852 -174.439 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.2 ttp . . . . . 0 CA--C 1.49 -1.355 0 CA-C-O 116.443 -1.741 . . . . 1.39 109.537 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -96.13 134.29 39.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.114 1.779 . . . . 2.2 109.064 176.69 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 pt -130.22 162.58 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 106.289 -1.745 . . . . 1.32 106.289 163.566 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -115.01 143.32 45.37 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.038 -1.664 . . . . 2.2 113.952 178.088 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.3 t -113.73 120.29 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 118.098 -2.876 . . . . 1.23 104.05 171.106 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -107.78 119.38 39.27 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 126.973 2.109 . . . . 2.51 106.641 177.547 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.3 p -84.13 163.55 19.73 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 121.165 -0.959 . . . . 1.41 111.724 -176.746 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.4 tp -39.56 -43.05 1.24 Allowed 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 118.713 2.857 . . . . 2.95 118.713 172.755 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.5 p -81.2 -24.86 37.16 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.892 1.995 . . . . 2.52 108.419 -176.7 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.44 31.24 3.3 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-O 125.402 2.668 . . . . 1.5 115.245 178.843 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -92.78 124.48 36.81 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.636 -2.685 . . . . 1.79 106.723 178.548 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -109.49 111.73 23.43 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.722 2.677 . . . . 1.38 112.026 175.315 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.262 36.1 pt -100.24 132.57 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 1 CA-C-O 128.847 4.165 . . . . 2.03 106.752 -178.691 . . . . . . . . 3 2 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 95.9 m -90.5 122.11 33.04 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.04 -2.913 . . . . 1.61 110.834 177.584 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.46 142.55 35.94 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.436 2.294 . . . . 2.15 112.675 176.547 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -110.57 118.61 36.68 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.548 2.339 . . . . 1.98 109.667 169.339 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.437 HG23 HD11 ' A' ' 56' ' ' LEU . 15.9 m -132.89 159.92 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 C-N-CA 124.016 0.926 . . . . 1.52 112.006 -178.676 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -92.05 156.26 42.36 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-O 116.424 -1.751 . . . . 2.35 112.693 159.57 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -73.11 -9.13 23.1 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 CA-C-N 126.139 3.228 . . . . 1.31 111.477 -177.285 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.4 m -79.04 -19.15 52.14 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 129.772 3.229 . . . . 1.71 108.545 177.934 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -61.04 137.45 58.23 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.488 2.774 . . . . 1.69 118.488 177.076 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.9 p -86.59 171.42 11.04 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 111.74 0.274 . . . . 1.33 111.74 177.193 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.0 mm -68.71 -33.79 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 114.588 1.329 . . . . 1.32 114.588 175.796 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -53.15 -43.44 67.0 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 117.551 2.426 . . . . 1.62 117.551 161.085 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -62.55 -42.53 99.59 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 120.553 1.524 . . . . 2.13 110.615 171.365 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 t -57.02 -48.84 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.449 1.5 . . . . 1.23 111.553 172.915 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -56.7 -34.53 67.52 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 116.953 -3.592 . . . . 1.97 117.627 172.977 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.85 -42.68 81.01 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 125.674 2.654 . . . . 1.19 112.922 176.819 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.27 13.6 mttm -60.02 -34.54 73.5 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 130.382 3.473 . . . . 1.92 115.174 173.584 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.0 mt -74.02 -35.44 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 129.395 3.078 . . . . 1.94 108.13 174.9 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -63.34 -32.03 73.35 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 119.705 3.224 . . . . 1.9 119.705 173.854 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -76.31 -20.41 57.31 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.631 1.973 . . . . 1.55 113.702 169.138 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -84.0 -47.44 10.97 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.657 -2.527 . . . . 2.95 109.942 177.42 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -131.86 -31.69 1.5 Allowed 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 118.453 2.76 . . . . 1.48 118.453 -167.421 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.57 60.99 1.07 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 104.248 -3.541 . . . . 1.12 104.248 169.997 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.1 mt -129.52 115.15 18.25 Favored Pre-proline 0 N--CA 1.43 -1.463 0 N-CA-C 104.699 -2.334 . . . . 2.07 104.699 178.077 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -70.57 160.2 50.27 Favored 'Trans proline' 0 N--CA 1.433 -2.053 1 CA-C-N 129.081 4.279 . . . . 1.39 116.19 -173.347 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.64 -35.13 99.08 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-N 123.682 2.351 . . . . 1.68 116.965 -176.551 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -55.7 -37.0 67.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.986 1.476 . . . . 2.25 114.986 171.635 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -84.32 -12.41 54.64 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 119.56 1.073 . . . . 2.44 111.657 -175.7 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -83.85 115.98 22.52 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.875 -1.528 . . . . 1.32 106.875 -178.561 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -109.2 95.41 5.62 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.525 1.766 . . . . 3.19 107.623 168.266 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.3 mt -87.57 132.53 34.02 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.184 -1.413 . . . . 1.75 107.184 -174.282 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.5 mm -117.19 133.83 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 126.77 2.028 . . . . 1.98 106.166 178.95 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -112.34 108.24 17.35 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.977 -1.86 . . . . 1.94 105.977 165.055 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.13 -83.31 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.924 2.89 . . . . 1.67 109.645 -177.474 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.15 -27.3 2.07 Favored Glycine 0 N--CA 1.43 -1.74 0 O-C-N 118.822 -2.424 . . . . 1.3 116.082 -176.019 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -95.59 155.23 16.83 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 126.353 2.978 . . . . 2.89 113.262 -178.572 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -93.91 129.09 40.48 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.77 -3.081 . . . . 2.89 107.764 178.766 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.2 mt -80.49 140.57 35.83 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.026 1.393 . . . . 1.34 112.469 -170.373 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -88.54 159.25 18.01 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.282 -4.011 . . . . 1.94 110.703 170.613 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.16 -50.79 15.16 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 127.207 2.203 . . . . 1.56 114.575 -171.264 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.83 62.82 0.78 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 119.058 -2.276 . . . . 0.97 117.14 171.499 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.25 31.4 mmt180 -122.66 153.62 39.12 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.956 -2.239 . . . . 3.07 104.956 164.728 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.1 p -89.62 171.94 9.31 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 119.488 1.04 . . . . 1.34 109.963 174.232 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.437 HD11 HG23 ' A' ' 17' ' ' VAL . 29.6 mt -81.18 -29.31 34.67 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.29 -0.881 . . . . 1.63 108.781 175.757 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 t -68.86 -35.76 77.3 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.101 -2.249 . . . . 1.51 112.272 179.053 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.84 -28.27 69.44 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.212 -2.805 . . . . 1.9 112.748 176.385 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -81.59 -13.12 58.4 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.162 -4.086 . . . . 0.97 115.432 179.578 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 77.81 26.75 0.62 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 126.609 2.443 . . . . 2.35 111.152 178.688 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.8 mt -70.0 113.2 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 127.205 3.383 . . . . 1.39 114.79 -179.26 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -95.03 171.97 8.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 114.932 -2.707 . . . . 2.58 110.911 -178.329 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -62.64 145.9 53.43 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.297 -2.752 . . . . 2.58 110.062 176.769 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 58.37 38.53 25.82 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 125.663 2.649 . . . . 1.71 112.379 175.462 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.2 t -98.97 141.79 31.29 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 104.082 -2.562 . . . . 1.34 104.082 179.51 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -96.57 121.11 38.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 127.404 2.282 . . . . 1.36 110.34 178.185 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -101.85 158.89 15.8 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 102.307 -3.22 . . . . 2.03 102.307 174.912 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -114.42 127.79 56.01 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.033 1.733 . . . . 2.31 114.348 -176.19 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.2 tt -108.48 123.77 49.4 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 106.635 -1.616 . . . . 1.72 106.635 -178.278 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 t -104.37 142.94 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 104.92 -2.252 . . . . 1.8 104.92 173.702 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.455 HD11 ' HA ' ' A' ' 71' ' ' LEU . 7.9 tp . . . . . 0 N--CA 1.43 -1.443 0 CA-C-O 116.375 -1.774 . . . . 3.26 110.939 174.334 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 124.2 1.952 . . . . 1.39 108.461 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -104.65 132.13 51.25 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.135 -1.603 . . . . 2.2 108.301 -174.981 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.4 pt -127.38 140.89 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 126.027 2.822 . . . . 1.32 107.526 175.333 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -101.75 131.69 47.89 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.397 -2.064 . . . . 2.2 111.3 -178.939 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.3 t -109.41 111.52 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 116.876 -3.64 . . . . 1.23 108.789 177.965 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.5 mtpt -93.36 139.29 30.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.612 -3.18 . . . . 2.51 106.93 175.912 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p -93.25 164.94 13.04 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 116.918 -1.515 . . . . 1.41 112.301 179.904 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.9 tp -65.87 -30.88 71.56 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.246 3.403 . . . . 2.95 113.379 166.339 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.315 70.2 p -61.61 -38.4 87.46 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.124 -4.11 . . . . 2.52 114.271 -178.815 . . . . . . . . 3 2 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.87 24.42 1.69 Allowed Glycine 0 N--CA 1.43 -1.726 1 C-N-CA 131.031 4.158 . . . . 1.5 114.416 174.191 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -101.6 153.15 20.01 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.054 -1.461 . . . . 1.79 107.054 -177.994 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -108.6 110.47 21.94 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 113.078 -1.874 . . . . 1.38 109.99 168.079 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 mt -92.35 119.91 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 121.129 1.786 . . . . 2.03 115.122 177.362 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.259 8.7 m -89.37 130.06 35.8 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 116.741 -3.725 . . . . 1.61 106.894 179.079 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.0 mt -133.08 156.41 47.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 118.605 -1.238 . . . . 2.15 107.967 177.898 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -112.74 129.37 56.44 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 117.52 -1.228 . . . . 1.98 109.594 165.833 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 m -127.31 177.55 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 126.645 1.978 . . . . 1.52 114.89 177.872 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -120.11 161.64 37.6 Favored Pre-proline 0 N--CA 1.43 -1.432 0 CA-C-O 115.119 -2.372 . . . . 2.35 110.878 164.261 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.256 33.8 Cg_endo -74.81 -12.63 21.95 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 C-N-CA 122.987 2.458 . . . . 1.31 112.649 -176.744 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.255 70.0 m -92.4 9.7 33.09 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.75 2.82 . . . . 1.71 111.724 173.253 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -84.96 139.0 32.14 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 121.67 2.032 . . . . 1.69 109.906 176.864 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.5 p -84.43 156.42 21.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.305 2.955 . . . . 1.33 112.342 176.113 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mm -64.48 -20.71 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 O-C-N 116.372 -3.955 . . . . 1.32 115.086 176.464 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -56.92 -51.87 67.43 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.367 2.508 . . . . 1.62 117.162 163.079 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -60.45 -31.99 70.96 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 111.048 -2.796 . . . . 2.13 116.571 170.535 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.2 t -65.78 -32.89 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 124.098 3.135 . . . . 1.23 112.202 175.804 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -71.71 -27.48 63.05 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.335 1.854 . . . . 1.97 112.082 175.882 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.04 -21.67 58.9 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.803 -2.436 . . . . 1.19 114.82 173.365 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -78.3 -30.5 48.4 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.608 -3.183 . . . . 1.92 108.206 178.584 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.4 mt -68.54 -33.3 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 129.309 3.044 . . . . 1.94 110.189 168.838 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -66.93 -29.47 69.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.712 -3.117 . . . . 1.9 113.885 167.324 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -74.58 -58.22 3.43 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 120.986 1.721 . . . . 1.55 110.464 172.162 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.2 tptt -57.79 -55.86 29.46 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.574 2.435 . . . . 2.95 117.574 -172.915 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -110.84 -36.43 5.69 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.473 2.082 . . . . 1.48 108.756 -164.905 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.85 66.34 1.0 Allowed Glycine 0 N--CA 1.429 -1.788 0 O-C-N 119.576 -1.953 . . . . 1.12 110.583 169.979 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.6 mt -126.93 130.12 23.86 Favored Pre-proline 0 N--CA 1.429 -1.488 0 CA-C-O 114.452 -2.689 . . . . 2.07 105.552 -178.341 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -62.11 150.42 86.68 Favored 'Trans proline' 0 N--CA 1.433 -2.056 0 C-N-CA 124.167 3.245 . . . . 1.39 111.582 178.82 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -87.13 -0.22 7.69 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 CA-C-N 120.853 1.341 . . . . 1.68 110.319 -162.535 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -71.47 -46.83 58.87 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.372 2.269 . . . . 2.25 112.719 170.719 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -69.41 -19.52 63.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.805 2.842 . . . . 2.44 115.599 -175.055 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -86.83 139.43 30.68 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 124.126 1.917 . . . . 1.32 111.053 -168.82 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.9 mtt180 -131.38 134.07 45.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.731 -3.731 . . . . 3.19 104.19 170.556 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.3 mt -114.21 117.03 30.04 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 114.038 -5.414 . . . . 1.75 112.826 175.296 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 mm -99.3 138.28 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 128.489 3.618 . . . . 1.98 114.439 178.684 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -129.5 96.27 4.23 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 120.836 1.653 . . . . 1.94 109.208 170.358 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.26 26.45 2.7 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 111.854 -3.927 . . . . 1.67 117.246 -179.608 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.39 -24.18 23.04 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 122.991 2.632 . . . . 1.3 112.731 -174.408 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -96.56 132.43 42.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.718 -2.636 . . . . 2.89 106.709 175.351 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.79 131.3 35.26 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.893 -2.379 . . . . 2.89 111.784 166.327 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.0 mt -79.01 128.85 33.78 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.033 1.333 . . . . 1.34 108.689 -173.088 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -80.26 138.93 36.86 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 121.564 1.984 . . . . 1.94 111.034 176.437 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.85 -55.38 14.46 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.525 3.157 . . . . 1.56 119.525 -173.254 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.23 39.96 2.12 Favored Glycine 0 N--CA 1.43 -1.733 0 O-C-N 124.662 1.226 . . . . 0.97 115.889 173.059 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.422 HH21 ' CG ' ' A' ' 58' ' ' ASP . 44.1 mmm-85 -117.73 161.07 20.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 124.814 0.949 . . . . 3.07 112.151 158.168 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -96.52 172.38 7.96 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 115.574 1.694 . . . . 1.34 115.574 173.301 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.1 mt -77.26 -25.4 51.44 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.014 1.116 . . . . 1.63 114.014 176.859 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.8 t -78.8 -33.43 46.26 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.106 -1.442 . . . . 1.51 107.106 -179.495 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.422 ' CG ' HH21 ' A' ' 54' ' ' ARG . 38.1 t0 -61.44 -52.82 62.97 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.365 2.666 . . . . 1.9 112.023 178.183 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -74.42 -7.49 53.11 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 126.813 3.197 . . . . 0.97 117.882 177.993 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.3 m120 62.8 46.15 5.29 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.2 -2.812 . . . . 2.35 115.509 179.702 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.4 mt -96.25 124.24 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 103.729 -2.693 . . . . 1.39 103.729 -177.699 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -112.44 -176.2 2.86 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 118.364 -1.334 . . . . 2.58 112.147 -175.055 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -55.06 137.52 46.23 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 126.768 3.175 . . . . 2.58 110.092 174.812 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 57.3 mt-10 76.3 12.98 2.6 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 126.116 2.865 . . . . 1.71 113.534 170.46 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -79.39 133.22 36.57 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 117.593 -3.192 . . . . 1.34 107.475 -170.813 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.1 m -86.07 113.79 22.42 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.85 -3.656 . . . . 1.36 113.848 178.58 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -92.46 160.4 15.09 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.625 -1.922 . . . . 2.03 110.895 174.271 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -129.32 123.16 31.1 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.438 2.066 . . . . 2.31 108.351 -175.243 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.5 tp -93.65 125.23 38.15 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 130.892 3.677 . . . . 1.72 108.317 176.59 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.14 159.34 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 104.126 -2.546 . . . . 1.8 104.126 167.201 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.4 mt . . . . . 0 N--CA 1.429 -1.485 0 CA-C-O 122.653 1.216 . . . . 3.26 108.042 -179.668 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptt? . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 123.259 1.504 . . . . 1.39 109.188 . . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -101.23 129.44 47.17 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.848 1.659 . . . . 2.2 111.038 -172.304 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.1 pt -125.44 174.48 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.775 -2.453 . . . . 1.32 110.007 176.196 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -119.77 140.91 50.01 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 116.055 1.872 . . . . 2.2 116.055 179.767 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.7 t -124.96 119.63 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 124.196 1.951 . . . . 1.23 105.898 171.606 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -95.44 127.32 41.38 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.627 -3.795 . . . . 2.51 111.68 179.441 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.0 p -73.39 -168.92 0.58 Allowed 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 125.031 2.348 . . . . 1.41 110.953 -176.069 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.424 HD11 ' H ' ' A' ' 71' ' ' LEU . 86.1 mt -86.9 -38.6 16.56 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 111.825 -2.443 . . . . 2.95 111.597 171.492 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.9 p -65.44 -27.35 68.46 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.427 1.891 . . . . 2.52 112.885 -175.9 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.57 22.97 5.25 Favored Glycine 0 N--CA 1.431 -1.669 0 O-C-N 118.151 -2.843 . . . . 1.5 119.108 177.845 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -108.04 138.53 44.14 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 105.602 -1.999 . . . . 1.79 105.602 -175.348 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.0 m -92.91 111.08 22.57 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.595 2.758 . . . . 1.38 108.044 177.149 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -89.85 137.16 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 116.48 -3.888 . . . . 2.03 105.075 -179.268 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.1 m -100.34 129.5 46.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.599 1.959 . . . . 1.61 110.36 -178.653 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.4 mt -129.36 155.38 45.75 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 119.651 1.114 . . . . 2.15 112.673 -175.923 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -116.22 112.25 21.35 Favored 'General case' 0 N--CA 1.429 -1.477 1 O-C-N 115.186 -4.696 . . . . 1.98 105.792 173.253 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.5 m -126.37 155.48 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 110.974 -2.83 . . . . 1.52 112.101 -179.0 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -103.28 159.5 29.1 Favored Pre-proline 0 N--CA 1.431 -1.392 1 O-C-N 114.639 -5.038 . . . . 2.35 109.644 165.485 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.66 -20.78 46.34 Favored 'Trans proline' 0 C--N 1.299 -2.039 1 O-C-N 113.297 -4.107 . . . . 1.31 115.455 -170.993 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 p -84.76 4.52 32.48 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.133 2.173 . . . . 1.71 112.121 175.543 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -75.58 138.2 41.3 Favored 'General case' 0 N--CA 1.431 -1.419 1 O-C-N 115.496 -4.502 . . . . 1.69 106.424 170.473 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.6 p -87.02 159.76 18.85 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 125.935 2.022 . . . . 1.33 108.074 -179.225 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.7 mm -60.24 -37.02 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 124.168 0.987 . . . . 1.32 109.692 177.415 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.302 25.5 tt0 -47.12 -50.59 19.91 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.664 1.986 . . . . 1.62 113.385 164.465 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -68.86 -32.74 72.64 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 125.934 2.021 . . . . 2.13 109.745 -179.706 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.55 -38.94 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 120.642 1.565 . . . . 1.23 113.315 175.105 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -61.56 -38.67 88.34 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 122.605 1.193 . . . . 1.97 112.83 169.701 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.65 -25.86 57.22 Favored 'General case' 0 N--CA 1.43 -1.428 1 CA-C-O 129.274 4.368 . . . . 1.19 113.694 179.332 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -72.63 -34.05 67.06 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 114.856 -4.903 . . . . 1.92 111.647 171.703 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.253 97.1 mt -64.73 -48.57 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 O-C-N 120.015 -1.678 . . . . 1.94 109.401 171.126 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -56.63 -42.83 79.51 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 116.446 -3.909 . . . . 1.9 113.265 177.145 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -53.95 -47.26 71.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.815 3.197 . . . . 1.55 117.079 166.522 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.265 14.2 tppt? -73.24 -53.49 10.75 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.04 2.352 . . . . 2.95 114.144 -171.844 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -111.42 -30.1 7.53 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.738 -3.101 . . . . 1.48 109.993 -171.431 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.28 38.36 4.56 Favored Glycine 0 N--CA 1.429 -1.787 0 C-N-CA 125.465 1.507 . . . . 1.12 114.056 -179.586 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.4 mt -97.77 130.38 29.13 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-O 114.749 -2.548 . . . . 2.07 112.117 179.509 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -66.18 154.0 75.86 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 CA-C-N 125.356 2.948 . . . . 1.39 113.487 -173.475 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -65.62 -23.32 56.94 Favored 'Trans proline' 0 N--CA 1.432 -2.094 1 CA-C-N 129.094 4.283 . . . . 1.68 116.373 -177.668 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -69.0 -34.62 75.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.77 -2.456 . . . . 2.25 115.546 178.06 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -73.75 -12.79 60.82 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 124.38 1.05 . . . . 2.44 111.279 179.597 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -98.64 118.06 34.5 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 118.214 -2.804 . . . . 1.32 112.572 -167.951 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -106.51 114.64 28.87 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 126.259 2.224 . . . . 3.19 106.378 170.674 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.1 mt -98.03 109.42 22.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.99 1.853 . . . . 1.75 113.607 175.343 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.3 mt -100.48 112.2 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 128.356 2.662 . . . . 1.98 112.617 180.0 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -105.67 123.76 48.46 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.5 -2.625 . . . . 1.94 107.446 172.008 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.362 . . 69.46 -63.81 0.36 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.128 2.171 . . . . 1.67 110.694 -176.459 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 48' ' ' LYS . . . -166.59 -16.81 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.791 0 N-CA-C 106.122 -2.791 . . . . 1.3 106.122 179.378 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.4 ' H ' ' H ' ' A' ' 47' ' ' GLY . 28.5 ttmt -83.6 125.1 31.46 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.611 3.164 . . . . 2.89 106.848 -172.557 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.3 17.4 tt0 -83.96 115.48 22.33 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.176 1.547 . . . . 2.89 115.176 175.849 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.8 mt -75.58 133.85 40.84 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.173 1.789 . . . . 1.34 112.047 -171.018 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -87.15 151.43 23.21 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 127.859 2.464 . . . . 1.94 115.719 172.743 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -66.24 -44.65 83.12 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 128.364 2.665 . . . . 1.56 113.434 -160.147 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.15 51.25 1.29 Allowed Glycine 0 N--CA 1.43 -1.705 0 O-C-N 118.813 -2.43 . . . . 0.97 110.866 176.332 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -123.56 161.88 24.06 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.889 -1.948 . . . . 3.07 107.377 162.582 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.7 p -107.89 172.61 6.73 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.084 -2.26 . . . . 1.34 110.741 179.693 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.532 HD23 HD11 ' A' ' 61' ' ' ILE . 20.8 mt -62.17 -38.41 88.95 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 126.758 2.536 . . . . 1.63 114.077 172.855 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -66.52 -30.8 71.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.916 2.486 . . . . 1.51 115.256 174.284 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -71.49 -43.9 65.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.752 -3.093 . . . . 1.9 111.393 171.222 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -91.55 8.26 37.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 124.964 1.415 . . . . 0.97 114.154 -177.877 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 47.23 49.24 15.54 Favored 'General case' 0 N--CA 1.43 -1.438 1 C-N-CA 132.459 4.304 . . . . 2.35 116.613 -179.462 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.532 HD11 HD23 ' A' ' 56' ' ' LEU . 76.8 mt -89.81 115.04 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 114.191 -2.814 . . . . 1.39 105.48 176.912 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -107.22 -166.66 1.18 Allowed 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 126.291 2.244 . . . . 2.58 112.88 -175.754 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -63.27 144.87 56.57 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 125.128 1.517 . . . . 2.58 113.586 -179.682 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.294 32.2 mt-10 67.28 15.13 9.91 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.629 1.971 . . . . 1.71 114.686 -179.766 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 t -90.17 135.94 33.35 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 123.537 1.636 . . . . 1.34 111.07 -173.903 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.2 m -96.09 113.84 25.49 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.821 3.648 . . . . 1.36 112.213 -172.397 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.432 HD22 HG23 ' A' ' 61' ' ' ILE . 10.5 mt -95.98 152.85 18.14 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 115.604 -4.435 . . . . 2.03 108.883 169.762 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -112.2 119.36 38.11 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 115.873 -2.331 . . . . 2.31 109.463 -174.488 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.6 tp -86.45 116.55 24.67 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.346 1.858 . . . . 1.72 111.454 -178.87 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.8 t -111.73 119.87 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 115.167 -2.349 . . . . 1.8 109.402 177.502 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.424 ' H ' HD11 ' A' ' 8' ' ' LEU 0.296 93.3 mt . . . . . 0 N--CA 1.431 -1.405 0 CA-C-N 121.211 1.823 . . . . 3.26 108.85 -173.482 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 CA--C 1.49 -1.327 0 N-CA-C 104.728 -2.323 . . . . 1.39 104.728 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -100.96 128.68 46.88 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.574 -1.954 . . . . 2.2 110.418 -173.675 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.8 pt -137.04 155.75 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 O-C-N 117.315 -3.365 . . . . 1.32 106.709 172.493 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -103.06 140.43 37.32 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.393 1.877 . . . . 2.2 106.716 -175.921 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.8 t -120.73 109.84 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 118.711 -2.493 . . . . 1.23 106.299 171.591 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.7 tttt -96.12 128.75 43.3 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 118.001 2.593 . . . . 2.51 118.001 -178.55 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.7 p -86.12 176.25 8.09 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 115.166 1.543 . . . . 1.41 115.166 174.07 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.8 mt -74.47 -22.85 58.89 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.699 -1.876 . . . . 2.95 115.558 172.76 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 p -67.34 -25.97 66.26 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.808 2.043 . . . . 2.52 113.103 176.602 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.27 28.61 5.74 Favored Glycine 0 N--CA 1.429 -1.803 0 C-N-CA 128.6 3.0 . . . . 1.5 114.29 179.743 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -111.55 141.13 45.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.895 3.712 . . . . 1.79 112.476 -173.014 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.2 m -96.34 116.68 29.43 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 127.891 3.71 . . . . 1.38 116.907 176.084 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mt -96.86 125.35 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 1 O-C-N 114.042 -5.411 . . . . 2.03 110.556 168.299 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.1 m -97.66 118.58 34.51 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 124.903 2.287 . . . . 1.61 106.039 -174.49 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.1 mt -105.48 145.6 30.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.506 -3.871 . . . . 2.15 111.279 -178.163 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -103.79 126.05 50.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.469 1.604 . . . . 1.98 107.219 167.987 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 m -144.43 161.67 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 117.249 -3.407 . . . . 1.52 112.481 -176.006 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -99.33 155.01 37.0 Favored Pre-proline 0 N--CA 1.431 -1.421 0 O-C-N 119.132 -2.23 . . . . 2.35 106.462 157.737 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -72.8 -9.65 24.02 Favored 'Trans proline' 0 N--CA 1.433 -2.064 0 C-N-CA 124.625 3.55 . . . . 1.31 111.755 173.907 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.5 m -87.93 0.71 55.53 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 131.109 3.763 . . . . 1.71 114.584 173.303 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -94.08 143.58 26.24 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 117.729 -3.107 . . . . 1.69 107.809 -179.315 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p -80.58 164.02 23.23 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 128.117 3.818 . . . . 1.33 110.165 176.973 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mm -59.22 -33.83 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 112.264 -2.244 . . . . 1.32 112.295 175.598 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -59.81 -30.99 69.3 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.585 -1.947 . . . . 1.62 111.627 175.733 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -74.9 -39.12 61.65 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.974 -3.579 . . . . 2.13 111.771 175.9 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.283 57.3 t -57.09 -60.48 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 O-C-N 118.07 -2.894 . . . . 1.23 110.233 172.368 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -53.51 -41.6 66.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 120.579 3.548 . . . . 1.97 120.579 177.318 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.14 -40.71 94.87 Favored 'General case' 0 CA--C 1.489 -1.394 0 O-C-N 119.412 -2.055 . . . . 1.19 111.794 169.932 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -63.95 -32.29 73.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.397 3.11 . . . . 1.92 119.397 170.488 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.2 mt -68.56 -39.04 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 O-C-N 124.871 1.357 . . . . 1.94 108.669 170.585 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -61.31 -43.92 98.07 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.12 2.39 . . . . 1.9 115.881 176.097 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.56 -46.2 91.06 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.122 -2.861 . . . . 1.55 113.933 174.105 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -68.41 -54.84 14.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.873 -3.642 . . . . 2.95 113.738 -179.828 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -104.78 -35.24 7.83 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.928 2.299 . . . . 1.48 116.82 -165.412 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.88 36.66 5.71 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-O 117.236 -1.869 . . . . 1.12 113.236 -179.645 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.8 mt -104.02 119.01 55.69 Favored Pre-proline 0 CA--C 1.489 -1.398 0 CA-C-O 113.78 -3.009 . . . . 2.07 103.585 -176.605 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.25 9.2 Cg_exo -62.81 161.68 28.08 Favored 'Trans proline' 0 N--CA 1.433 -2.031 1 C-N-CA 125.988 4.458 . . . . 1.39 116.611 176.147 . . . . . . . . 3 2 . 1 . 042 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.45 -25.13 11.47 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 CA-C-N 124.941 2.8 . . . . 1.68 117.904 -170.097 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -60.99 -49.13 78.69 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 125.968 2.794 . . . . 2.25 113.098 -179.416 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -62.26 -31.81 72.43 Favored 'General case' 0 N--CA 1.43 -1.45 1 C-N-CA 133.812 4.845 . . . . 2.44 112.727 176.225 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -75.73 130.81 39.26 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 117.736 -3.103 . . . . 1.32 114.413 -174.909 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -120.57 106.68 12.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.73 -1.211 . . . . 3.19 107.73 175.431 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.4 mt -91.41 129.65 37.37 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.17 2.588 . . . . 1.75 109.838 179.147 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 mt -121.79 146.26 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 127.013 2.125 . . . . 1.98 107.939 177.808 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.419 ' HB3' HD21 ' A' ' 50' ' ' LEU . 20.7 t80 -135.7 117.49 15.1 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 105.129 -2.174 . . . . 1.94 105.129 171.615 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.98 -68.88 0.12 Allowed 'General case' 0 N--CA 1.43 -1.464 1 C-N-CA 132.015 4.126 . . . . 1.67 107.612 179.943 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.4 14.11 0.45 Allowed Glycine 0 N--CA 1.43 -1.728 0 O-C-N 117.364 -3.335 . . . . 1.3 113.983 176.967 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -121.53 128.18 51.76 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 123.562 1.649 . . . . 2.89 108.208 -178.686 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -72.0 126.63 30.26 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.399 2.523 . . . . 2.89 109.234 169.47 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.419 HD21 ' HB3' ' A' ' 45' ' ' PHE . 31.4 mt -83.27 145.43 29.11 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.261 -1.791 . . . . 1.34 107.464 -171.262 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -106.91 155.82 19.36 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-O 123.985 1.85 . . . . 1.94 113.327 -179.018 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -52.44 -60.28 3.42 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 121.12 3.748 . . . . 1.56 121.12 -168.071 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.9 37.69 2.68 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 129.82 3.581 . . . . 0.97 112.956 174.085 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -120.25 153.54 36.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 116.67 -1.634 . . . . 3.07 107.649 170.759 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.4 p -88.18 168.43 12.76 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 125.364 1.665 . . . . 1.34 113.72 164.918 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.7 mt -74.22 -27.78 60.95 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 116.183 -1.865 . . . . 1.63 109.659 178.031 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.1 p -64.66 -31.65 72.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 126.246 2.216 . . . . 1.51 115.115 174.582 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -55.05 -41.7 71.79 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 127.819 3.676 . . . . 1.9 114.772 171.306 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -84.16 -1.39 54.96 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 117.594 -3.191 . . . . 0.97 116.852 176.946 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.299 7.5 m120 65.85 40.96 4.0 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 125.854 2.74 . . . . 2.35 115.93 -176.927 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.6 mt -92.43 121.36 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 126.701 3.143 . . . . 1.39 111.032 177.969 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -110.64 179.34 4.1 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 111.374 -2.648 . . . . 2.58 108.71 -176.065 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -63.52 156.49 26.22 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 124.767 1.227 . . . . 2.58 113.961 179.22 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.451 65.6 mt-10 79.44 -4.03 2.05 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.323 -2.11 . . . . 1.71 113.485 172.793 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.298 49.7 m -73.14 154.08 40.49 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 117.699 2.481 . . . . 1.34 117.699 -174.578 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.7 m -112.73 124.02 51.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.58 -1.637 . . . . 1.36 106.58 178.247 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.2 mt -103.81 164.25 11.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.869 -1.16 . . . . 2.03 107.869 168.932 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.0 m170 -113.97 129.68 56.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 116.555 -1.688 . . . . 2.31 111.887 -176.902 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.7 tp -117.34 115.6 25.55 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 102.219 -3.252 . . . . 1.72 102.219 -176.125 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.6 m -115.33 159.76 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 127.33 3.443 . . . . 1.8 102.747 173.909 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.43 -1.445 1 O-C-N 111.015 -7.303 . . . . 3.26 109.562 173.764 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.253 6.2 ptt? . . . . . 0 CA--C 1.49 -1.342 0 N-CA-C 113.775 1.028 . . . . 1.39 113.775 . . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.264 34.5 mt-30 -115.18 147.69 39.98 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 116.155 -4.091 . . . . 2.2 110.916 177.08 . . . . . . . . 3 2 . 1 . 043 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.8 pt -134.35 156.67 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 116.904 -3.623 . . . . 1.32 103.436 177.518 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -116.65 139.06 50.95 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.156 -1.59 . . . . 2.2 110.738 178.221 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.0 t -120.43 116.41 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-O 116.98 -1.486 . . . . 1.23 108.553 177.471 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -100.21 139.44 35.87 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 117.081 -1.848 . . . . 2.51 114.707 177.469 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 p -83.49 157.67 22.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.614 2.766 . . . . 1.41 113.234 174.205 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.1 tp -49.12 -41.1 34.79 Favored 'General case' 0 N--CA 1.43 -1.466 2 O-C-N 114.045 -5.41 . . . . 2.95 110.855 166.46 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.1 p -67.83 -28.26 67.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.948 1.832 . . . . 2.52 115.948 179.385 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.11 31.19 3.16 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 125.238 2.577 . . . . 1.5 113.849 173.454 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -109.6 133.39 53.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.743 -3.21 . . . . 1.79 104.181 -176.628 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.4 m -99.51 119.06 37.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.301 -3.374 . . . . 1.38 106.69 175.735 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mt -97.01 98.42 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.823 2.049 . . . . 2.03 106.836 175.997 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.6 m -87.35 125.86 34.51 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 125.401 2.524 . . . . 1.61 107.942 177.851 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.4 mt -116.94 162.59 17.52 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.542 -2.599 . . . . 2.15 107.272 -173.641 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -121.12 112.68 18.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.759 -2.463 . . . . 1.98 110.402 179.718 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -132.45 164.47 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 125.479 1.512 . . . . 1.52 114.356 -176.816 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -111.86 155.68 42.85 Favored Pre-proline 0 N--CA 1.43 -1.438 1 CA-C-O 110.828 -4.415 . . . . 2.35 104.471 164.806 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -69.92 -4.78 14.83 Favored 'Trans proline' 0 C--N 1.3 -2.023 1 CA-C-N 129.049 4.268 . . . . 1.31 114.808 -175.272 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 p -86.09 6.89 26.97 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.662 2.785 . . . . 1.71 111.633 170.714 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.5 133.33 47.56 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.973 -0.751 . . . . 1.69 108.973 169.008 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.7 p -79.96 167.63 20.24 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.731 -2.322 . . . . 1.33 104.731 177.412 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.3 mm -81.5 -21.64 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 117.536 -3.227 . . . . 1.32 109.302 176.849 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -55.1 -49.67 71.11 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 122.02 2.191 . . . . 1.62 109.59 161.348 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -59.14 -59.39 5.54 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 114.578 1.325 . . . . 2.13 114.578 -179.617 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.2 t -45.1 -43.9 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 127.067 2.147 . . . . 1.23 114.483 172.167 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.49 ' HD2' ' HB2' ' A' ' 41' ' ' GLN 0.349 36.2 mtmt -60.17 -38.95 84.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 118.716 2.858 . . . . 1.97 118.716 171.491 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.57 -19.89 61.41 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.002 2.334 . . . . 1.19 117.024 179.584 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -78.71 -16.33 57.39 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 119.311 -2.118 . . . . 1.92 112.144 171.516 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.332 73.0 mt -78.32 -44.56 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 128.368 3.937 . . . . 1.94 108.751 172.179 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -57.4 -45.24 84.74 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 110.842 -2.89 . . . . 1.9 117.483 172.098 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -45.42 -45.25 12.68 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.872 1.669 . . . . 1.55 114.366 166.761 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -82.38 -68.8 0.67 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.364 -0.834 . . . . 2.95 111.741 -171.33 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -93.99 -20.75 19.69 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 125.789 1.931 . . . . 1.48 113.946 -169.667 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.23 -0.62 64.03 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 118.355 2.102 . . . . 1.12 118.355 175.753 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.9 mt -70.8 122.58 87.23 Favored Pre-proline 0 N--CA 1.429 -1.484 0 CA-C-O 113.955 -2.926 . . . . 2.07 105.303 -178.311 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.37 146.11 61.55 Favored 'Trans proline' 0 N--CA 1.433 -2.033 1 CA-C-O 106.609 -5.663 . . . . 1.39 116.565 177.873 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -55.63 -13.49 8.23 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 128.013 3.898 . . . . 1.68 122.196 -177.847 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -57.04 -41.54 78.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.991 2.517 . . . . 2.25 113.259 176.975 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.281 68.9 mt-30 -84.77 -27.0 27.18 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 126.331 1.852 . . . . 2.44 108.993 -170.437 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.49 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 61.1 mt-30 -71.23 139.92 50.24 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.509 2.781 . . . . 1.32 118.509 -171.496 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -133.83 129.24 36.21 Favored 'General case' 0 N--CA 1.43 -1.435 1 N-CA-C 99.126 -4.398 . . . . 3.19 99.126 172.493 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.9 mt -111.24 107.92 17.38 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 112.189 -2.278 . . . . 1.75 106.889 177.426 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 mm -97.26 133.98 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 115.003 -0.999 . . . . 1.98 108.699 176.227 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -122.32 100.6 7.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 101.772 -3.418 . . . . 1.94 101.772 176.794 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 81.65 -100.92 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 105.259 -2.126 . . . . 1.67 105.259 172.61 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.31 -10.16 7.49 Favored Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 107.033 -2.427 . . . . 1.3 107.033 179.284 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -100.94 148.32 25.14 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 119.96 1.88 . . . . 2.89 108.916 -173.478 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -105.4 129.04 53.8 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.795 -2.002 . . . . 2.89 113.661 178.284 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.4 mt -92.72 146.47 23.63 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 116.933 -1.508 . . . . 1.34 109.818 -167.058 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.1 148.94 21.69 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 128.786 3.804 . . . . 1.94 117.667 174.778 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.65 -59.73 4.76 Favored 'General case' 0 CA--C 1.488 -1.41 1 C-N-CA 133.241 4.617 . . . . 1.56 113.295 -169.527 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.66 46.7 3.49 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 119.508 -1.995 . . . . 0.97 116.515 175.458 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -127.75 -179.8 5.13 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 120.553 2.177 . . . . 3.07 112.043 166.805 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.2 p -104.53 172.47 6.77 Favored 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 116.011 -4.181 . . . . 1.34 117.835 178.715 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.5 mt -66.32 -29.63 69.87 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.704 -2.497 . . . . 1.63 111.006 173.105 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -71.69 -29.31 64.44 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 130.019 3.328 . . . . 1.51 117.453 178.367 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.327 23.6 m-20 -63.65 -36.58 84.29 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 119.231 -0.988 . . . . 1.9 112.709 170.118 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -93.42 12.85 23.49 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 117.166 2.284 . . . . 0.97 117.166 -174.996 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 50.08 32.62 6.02 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 118.137 2.643 . . . . 2.35 118.137 -175.304 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.8 mt -89.88 111.59 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 125.11 1.364 . . . . 1.39 110.498 -178.352 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -100.99 -165.68 1.23 Allowed 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 113.868 -1.514 . . . . 2.58 109.286 -173.768 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.5 pttp -68.78 149.81 48.58 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.534 2.111 . . . . 2.58 112.548 179.667 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.281 10.8 mt-10 66.66 30.13 8.39 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 125.619 2.628 . . . . 1.71 116.259 172.71 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.1 m -89.29 135.7 33.43 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.869 -2.394 . . . . 1.34 107.926 -170.697 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.6 m -105.06 106.36 16.81 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.913 -2.367 . . . . 1.36 108.818 -177.006 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -96.61 167.28 11.23 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.448 -2.032 . . . . 2.03 109.586 171.842 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -118.86 121.8 40.84 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 113.662 -1.608 . . . . 2.31 111.138 -170.338 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.9 tp -88.31 121.85 31.16 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.816 -1.549 . . . . 1.72 106.816 -177.449 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.6 t -114.26 124.51 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 106.487 -1.671 . . . . 1.8 106.487 179.308 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.0 mt . . . . . 0 N--CA 1.429 -1.479 0 O-C-N 116.366 -3.959 . . . . 3.26 111.763 179.673 . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptt? . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 121.808 0.813 . . . . 1.39 109.507 . . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -104.57 120.24 40.84 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 113.129 -3.32 . . . . 2.2 108.717 -175.829 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.265 9.2 pt -116.74 174.01 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 127.007 2.692 . . . . 1.32 114.281 171.365 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -125.68 140.22 52.89 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.897 2.879 . . . . 2.2 106.71 -178.278 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.8 t -129.07 114.81 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.499 -2.001 . . . . 1.23 107.051 171.405 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -86.23 143.14 28.1 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.678 0.751 . . . . 2.51 111.339 -176.129 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.3 p -88.01 169.36 12.04 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.043 -2.286 . . . . 1.41 111.995 176.408 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.8 mt -56.42 -33.71 66.09 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 114.001 -5.437 . . . . 2.95 113.023 172.609 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.2 p -90.18 -34.9 15.66 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 114.835 1.42 . . . . 2.52 114.835 -172.69 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.71 -17.01 0.4 Allowed Glycine 0 N--CA 1.429 -1.771 0 C-N-CA 116.27 -2.872 . . . . 1.5 112.15 177.46 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.523 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 32.5 ttpt -84.84 147.91 26.56 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 124.743 2.211 . . . . 1.79 111.326 -170.743 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.6 m -115.65 128.22 55.76 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.745 -3.722 . . . . 1.38 108.752 178.905 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 mt -95.32 137.92 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 119.662 -1.899 . . . . 2.03 107.02 177.055 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.7 m -95.31 111.43 23.29 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.526 -1.984 . . . . 1.61 112.945 175.623 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.7 mt -115.42 148.87 38.86 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.01 -1.681 . . . . 2.15 111.891 -177.831 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -115.29 109.78 18.45 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 103.449 -2.797 . . . . 1.98 103.449 179.49 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.6 m -120.78 170.2 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 124.993 2.33 . . . . 1.52 105.075 177.36 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -126.75 155.4 75.21 Favored Pre-proline 0 N--CA 1.43 -1.429 0 N-CA-C 104.814 -2.291 . . . . 2.35 104.814 168.818 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.45 -29.34 39.36 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 N-CA-C 120.924 3.394 . . . . 1.31 120.924 -176.679 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 m -76.13 4.37 8.7 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.424 2.379 . . . . 1.71 117.424 177.176 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -85.1 148.74 25.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 125.74 1.9 . . . . 1.69 114.878 177.637 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.3 p -90.1 169.96 10.73 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.35 -2.094 . . . . 1.33 114.225 175.595 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.8 mm -63.64 -41.31 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 1 O-C-N 115.867 -4.27 . . . . 1.32 114.462 176.255 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.382 76.8 tt0 -35.75 -55.73 0.71 Allowed 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 118.624 2.824 . . . . 1.62 118.624 155.583 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -56.83 -28.15 61.13 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.734 -1.854 . . . . 2.13 115.718 176.187 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.2 t -69.98 -42.63 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 117.988 -2.945 . . . . 1.23 108.998 175.208 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -56.29 -39.53 72.84 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.437 -2.039 . . . . 1.97 116.404 171.777 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.0 -49.48 72.3 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.073 -2.892 . . . . 1.19 115.659 174.469 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -52.83 -45.11 67.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.248 1.419 . . . . 1.92 113.131 170.715 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.4 mt -69.29 -30.9 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 O-C-N 115.722 -4.361 . . . . 1.94 112.169 175.125 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.31 -40.04 71.06 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.119 -1.613 . . . . 1.9 111.041 173.369 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.02 -54.7 44.12 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 123.358 1.551 . . . . 1.55 112.304 170.117 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -72.94 -57.89 3.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 116.55 -3.844 . . . . 2.95 115.628 -174.617 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.523 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 20.1 mm-40 -94.28 -27.33 16.19 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.364 1.987 . . . . 1.48 116.364 -174.188 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.35 23.67 21.17 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 117.47 1.748 . . . . 1.12 117.47 178.614 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.1 mt -89.77 138.84 27.77 Favored Pre-proline 0 N--CA 1.431 -1.402 0 O-C-N 118.188 -2.948 . . . . 2.07 103.827 -173.194 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.57 151.37 64.38 Favored 'Trans proline' 0 C--N 1.299 -2.052 1 CA-C-N 130.675 4.848 . . . . 1.39 111.712 176.761 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -73.03 -19.0 23.55 Favored 'Trans proline' 0 C--N 1.3 -2.004 3 C-N-CA 126.53 4.82 . . . . 1.68 115.676 -176.729 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.27 -39.03 66.5 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 115.686 1.736 . . . . 2.25 115.686 177.421 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -89.71 -18.61 26.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.342 -1.355 . . . . 2.44 107.342 -173.071 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -78.35 100.2 6.67 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 117.728 2.492 . . . . 1.32 117.728 -167.639 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -97.85 122.99 41.61 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 119.292 0.951 . . . . 3.19 110.867 171.009 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.1 mt -92.76 105.72 17.81 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.214 2.911 . . . . 1.75 112.896 179.146 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mm -90.66 130.57 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 128.615 2.766 . . . . 1.98 109.783 -177.521 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -138.89 114.8 10.08 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 106.344 -1.724 . . . . 1.94 106.344 176.364 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.458 . . 68.16 24.98 7.45 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.098 -1.626 . . . . 1.67 113.405 173.605 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.24 -24.87 28.33 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 117.827 -1.54 . . . . 1.3 112.151 -173.189 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.5 tttt -106.44 128.99 54.49 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 122.239 3.02 . . . . 2.89 112.618 -179.685 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -78.48 138.22 38.33 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 112.124 -2.307 . . . . 2.89 112.865 168.964 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.1 mt -93.38 137.89 32.24 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 129.305 3.042 . . . . 1.34 108.959 -166.816 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -68.37 144.8 54.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.995 1.85 . . . . 1.94 115.995 173.11 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.15 -38.81 82.53 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 118.751 2.871 . . . . 1.56 118.751 -165.799 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.39 23.47 31.83 Favored Glycine 0 N--CA 1.43 -1.753 0 O-C-N 119.147 -2.221 . . . . 0.97 115.788 173.486 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -99.07 143.82 28.91 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 118.562 1.181 . . . . 3.07 109.104 166.416 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.251 72.1 p -80.9 162.57 23.87 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 126.277 2.235 . . . . 1.34 112.857 -179.76 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.9 -24.26 67.75 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.307 -2.746 . . . . 1.63 110.467 172.622 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.6 t -88.02 -11.08 48.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.936 -1.728 . . . . 1.51 110.431 -176.997 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -75.8 -42.75 49.1 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.659 -1.9 . . . . 1.9 109.526 173.08 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -79.63 -0.05 32.19 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.41 2.374 . . . . 0.97 117.41 176.13 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 64.01 39.76 7.68 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 115.733 1.753 . . . . 2.35 115.733 -179.48 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.1 mm -75.43 118.4 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 119.273 -2.142 . . . . 1.39 110.081 178.085 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -91.84 172.71 8.29 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.322 2.487 . . . . 2.58 114.394 177.373 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -66.98 140.28 57.72 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.451 -3.28 . . . . 2.58 107.607 179.635 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.386 6.3 tt0 85.71 12.7 0.2 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.812 1.645 . . . . 1.71 113.365 177.2 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.8 m -80.15 152.55 29.18 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 116.856 -3.652 . . . . 1.34 112.52 -172.687 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.83 115.48 30.17 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.76 2.219 . . . . 1.36 109.599 -178.006 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -102.52 163.19 12.37 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 114.118 -5.364 . . . . 2.03 104.86 174.183 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -122.67 123.46 41.18 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.866 1.666 . . . . 2.31 109.942 176.496 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.1 tp -84.8 122.14 28.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.719 1.608 . . . . 1.72 114.144 179.067 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.1 t -117.82 138.47 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 102.156 -3.276 . . . . 1.8 102.156 177.737 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.0 mt . . . . . 0 N--CA 1.43 -1.438 0 CA-C-O 123.057 1.408 . . . . 3.26 108.495 -177.156 . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 3.3 ptt? . . . . . 0 CA--C 1.491 -1.32 0 N-CA-C 116.566 2.061 . . . . 1.39 116.566 . . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -103.05 112.52 25.41 Favored 'General case' 0 N--CA 1.429 -1.486 1 O-C-N 116.03 -4.169 . . . . 2.2 107.153 -168.571 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.3 pt -117.71 154.07 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 117.333 -1.318 . . . . 1.32 111.425 169.724 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -118.0 134.63 54.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 125.589 1.805 . . . . 2.2 113.815 -179.195 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -104.14 127.16 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 104.509 -2.404 . . . . 1.23 104.509 173.851 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -104.1 147.69 27.13 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.806 -1.553 . . . . 2.51 106.806 176.208 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.337 7.8 p -97.8 154.09 17.85 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 128.228 3.455 . . . . 1.41 113.378 174.119 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.5 mt -55.14 -36.85 66.23 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.87 2.468 . . . . 2.95 113.389 168.044 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.6 p -78.25 -47.31 18.2 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.592 -1.942 . . . . 2.52 112.489 -173.567 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.85 25.6 0.06 OUTLIER Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 117.3 1.68 . . . . 1.5 117.3 167.916 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.485 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 34.9 ttpt -103.74 153.24 20.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 116.121 -1.895 . . . . 1.79 111.668 -179.115 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.3 m -116.24 124.59 50.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 106.716 -1.587 . . . . 1.38 106.716 173.67 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.8 mt -99.08 117.65 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 123.413 2.824 . . . . 2.03 104.042 179.768 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.0 m -98.18 112.58 24.5 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.971 -2.956 . . . . 1.61 107.958 -176.107 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.8 mt -96.6 143.98 27.07 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.766 -1.209 . . . . 2.15 109.491 -174.384 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -98.41 119.17 36.64 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 126.284 2.24 . . . . 1.98 106.727 166.211 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.15 172.27 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 CA-C-N 121.231 1.832 . . . . 1.52 110.433 -175.823 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -126.2 152.53 73.67 Favored Pre-proline 0 N--CA 1.429 -1.483 0 C-N-CA 127.873 2.469 . . . . 2.35 107.246 172.409 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -75.69 -26.63 9.67 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 N-CA-C 107.056 -1.94 . . . . 1.31 107.056 -170.626 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.8 p -78.9 -5.76 54.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.672 -2.517 . . . . 1.71 115.557 -179.241 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -70.0 157.87 36.7 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 124.197 0.935 . . . . 1.69 111.852 168.945 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.7 p -88.75 166.72 13.85 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.649 2.092 . . . . 1.33 116.649 175.373 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.5 mm -67.13 -38.88 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.39 -2.069 . . . . 1.32 107.588 175.017 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -49.07 -44.82 42.24 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 118.31 -2.744 . . . . 1.62 114.077 167.676 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -64.71 -22.33 66.96 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.898 2.079 . . . . 2.13 111.8 175.956 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.36 98.5 t -73.67 -39.53 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 124.055 1.883 . . . . 1.23 110.792 176.543 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.443 ' HB3' ' HA ' ' A' ' 38' ' ' PRO . 87.6 mttt -70.88 -38.95 73.08 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.91 2.484 . . . . 1.97 110.487 178.449 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.46 -38.16 63.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.692 2.797 . . . . 1.19 114.193 169.853 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -77.23 -38.36 51.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.815 -1.803 . . . . 1.92 112.109 177.164 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.1 mt -61.08 -36.55 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 124.451 1.101 . . . . 1.94 111.42 172.219 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -65.51 -38.2 88.99 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 123.743 1.735 . . . . 1.9 110.936 178.777 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.53 -41.1 98.64 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 117.822 -3.049 . . . . 1.55 113.023 176.6 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -81.59 -59.09 2.73 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 116.423 -1.751 . . . . 2.95 112.064 -176.766 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.485 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 68.5 mm-40 -98.72 -39.17 8.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.989 2.515 . . . . 1.48 114.119 -164.825 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.21 26.59 7.31 Favored Glycine 0 N--CA 1.431 -1.693 0 O-C-N 125.733 1.896 . . . . 1.12 111.753 173.503 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.2 mt -102.31 128.39 28.44 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 118.712 -2.64 . . . . 2.07 105.923 -176.809 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.305 80.1 Cg_endo -68.54 158.48 57.52 Favored 'Trans proline' 0 C--N 1.299 -2.051 2 C-N-CA 128.958 6.438 . . . . 1.39 112.75 -175.937 . . . . . . . . 3 2 . 1 . 045 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 29.4 Cg_exo -66.52 -31.68 41.12 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 CA-C-N 124.389 2.603 . . . . 1.68 112.364 -178.514 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -50.14 -47.55 54.13 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.755 2.872 . . . . 2.25 118.755 175.271 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -70.27 -19.77 63.09 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.32 2.341 . . . . 2.44 117.32 176.199 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -96.41 135.97 37.55 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 120.011 1.278 . . . . 1.32 110.398 -173.484 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -128.01 124.23 36.65 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 100.817 -3.771 . . . . 3.19 100.817 173.279 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.8 mt -104.88 129.51 53.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.451 -2.159 . . . . 1.75 110.735 178.21 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.5 mm -108.59 129.21 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 125.588 2.613 . . . . 1.98 110.198 178.473 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -130.15 130.82 45.25 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.939 -2.976 . . . . 1.94 109.502 172.068 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.255 . . 67.51 -75.23 0.06 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.21 1.481 . . . . 1.67 109.089 -173.08 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.38 -7.9 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 129.912 3.625 . . . . 1.3 112.3 -175.937 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -81.3 130.85 35.2 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.569 -1.548 . . . . 2.89 112.427 -177.467 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -91.2 106.87 18.82 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 114.905 -4.872 . . . . 2.89 104.003 169.671 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.4 mt -71.21 133.17 45.93 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 117.316 2.339 . . . . 1.34 117.316 -169.583 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -83.87 141.97 30.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 111.562 -2.563 . . . . 1.94 114.031 -178.795 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.6 -65.68 0.64 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.469 -2.644 . . . . 1.56 117.989 -161.573 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.3 54.26 4.92 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-O 126.339 3.189 . . . . 0.97 117.33 168.701 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -117.14 146.69 43.02 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 111.585 -2.307 . . . . 3.07 108.987 159.657 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.6 p -72.79 152.93 41.33 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.905 1.446 . . . . 1.34 114.905 169.351 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.6 mt -59.72 -36.8 77.31 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.708 2.803 . . . . 1.63 108.161 175.109 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.263 1.7 t -71.38 -26.11 62.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 127.333 2.896 . . . . 1.51 112.836 175.078 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -67.88 -47.57 68.48 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 123.805 3.002 . . . . 1.9 111.183 168.74 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -69.8 -23.15 63.29 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.732 -1.855 . . . . 0.97 114.692 176.963 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.7 t30 73.79 53.11 0.11 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 127.414 2.286 . . . . 2.35 109.668 -171.672 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.8 mt -95.91 119.79 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 103.524 -2.769 . . . . 1.39 103.524 174.163 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -105.18 -178.06 3.54 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.282 -2.136 . . . . 2.58 111.869 -179.038 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.362 14.1 ptmt -49.18 137.42 13.77 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 127.326 2.25 . . . . 2.58 115.668 172.852 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 77.91 11.31 2.0 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.714 1.605 . . . . 1.71 114.421 173.163 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.3 m -82.59 147.19 28.74 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 124.395 1.059 . . . . 1.34 113.188 -175.165 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.5 m -105.19 116.48 32.02 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.732 2.206 . . . . 1.36 110.625 179.635 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.8 mt -88.4 141.46 28.52 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.323 -2.736 . . . . 2.03 110.804 172.15 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -100.69 123.61 45.14 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.714 1.721 . . . . 2.31 107.448 173.75 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.8 tp -85.89 111.99 20.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.916 1.686 . . . . 1.72 113.745 176.86 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.7 t -111.51 134.3 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 2 CA-C-O 129.965 4.698 . . . . 1.8 99.757 178.947 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.6 mt . . . . . 0 N--CA 1.43 -1.473 0 O-C-N 118.023 -2.923 . . . . 3.26 115.687 -177.549 . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 CA--C 1.489 -1.371 0 CA-C-O 117.439 -1.267 . . . . 1.39 111.138 . . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -94.7 134.57 37.15 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.774 1.75 . . . . 2.2 111.374 -171.633 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -120.61 136.6 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.855 -3.028 . . . . 1.32 106.26 169.037 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -101.66 90.66 4.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 125.312 2.482 . . . . 2.2 111.701 -173.443 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.99 100.08 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.49 1 O-C-N 112.216 -6.553 . . . . 1.23 113.367 177.238 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -96.12 134.89 38.64 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.84 -1.163 . . . . 2.51 110.568 178.452 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.5 p -84.52 -178.78 6.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 131.049 3.74 . . . . 1.41 116.102 174.612 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.3 tp -79.01 -26.58 43.24 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.97 -4.206 . . . . 2.95 116.336 171.395 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.5 p -77.32 -34.01 55.41 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.253 2.93 . . . . 2.52 114.335 -179.167 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.32 4.16 2.6 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 119.27 -2.144 . . . . 1.5 111.455 174.464 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -82.4 122.74 28.39 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.82 -1.988 . . . . 1.79 111.531 -176.174 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 m -99.26 112.23 24.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.394 -2.691 . . . . 1.38 113.362 170.041 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.52 117.63 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 120.021 -1.674 . . . . 2.03 106.59 171.049 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.6 m -99.07 98.04 9.11 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.495 -1.669 . . . . 1.61 106.495 -178.362 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.1 mt -76.51 126.09 30.37 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.436 1.894 . . . . 2.15 111.294 -176.928 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -81.26 104.07 11.47 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.904 -2.997 . . . . 1.98 113.363 166.662 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 m -110.49 171.62 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 123.983 0.913 . . . . 1.52 111.596 -179.739 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -123.32 169.73 9.6 Favored Pre-proline 0 N--CA 1.43 -1.472 0 CA-C-O 116.278 -1.82 . . . . 2.35 107.387 158.22 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -78.66 -16.08 13.3 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 124.127 2.51 . . . . 1.31 112.719 -167.905 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.83 -19.21 65.8 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 114.886 -2.483 . . . . 1.71 113.886 174.537 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -72.18 143.63 48.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 125.189 1.555 . . . . 1.69 113.073 -174.863 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 p -86.89 167.42 14.34 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.568 -1.958 . . . . 1.33 113.361 178.798 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.427 HG22 HD13 ' A' ' 43' ' ' LEU . 42.4 mm -64.08 -37.16 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.536 -1.353 . . . . 1.32 111.84 172.962 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -53.03 -42.18 65.43 Favored 'General case' 0 N--CA 1.429 -1.492 1 O-C-N 115.458 -4.526 . . . . 1.62 114.866 163.639 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -72.72 -32.94 66.09 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.407 -2.683 . . . . 2.13 111.756 -178.621 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.56 -50.38 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 119.019 -2.3 . . . . 1.23 109.927 171.724 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -66.82 -18.59 65.45 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.142 1.377 . . . . 1.97 111.168 -179.227 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.0 -35.51 31.86 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 113.292 0.849 . . . . 1.19 113.292 169.816 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -63.46 -52.47 61.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.153 -2.217 . . . . 1.92 108.542 171.203 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.8 mt -53.92 -32.54 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 123.96 3.073 . . . . 1.94 117.397 174.83 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -71.1 -40.06 71.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.088 -2.883 . . . . 1.9 114.901 173.568 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.64 -56.85 16.16 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.09 -2.881 . . . . 1.55 107.428 168.836 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -71.22 -56.48 5.97 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.485 1.291 . . . . 2.95 114.485 -170.103 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -96.15 -24.79 16.12 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.151 2.58 . . . . 1.48 112.11 -168.972 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.55 37.53 13.99 Favored Glycine 0 N--CA 1.43 -1.751 0 CA-C-O 127.6 3.889 . . . . 1.12 113.71 173.853 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.7 mt -108.86 132.72 21.0 Favored Pre-proline 0 N--CA 1.429 -1.494 1 O-C-N 116.262 -4.081 . . . . 2.07 108.268 -178.539 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -68.51 142.88 55.29 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 C-N-CA 125.05 3.833 . . . . 1.39 120.817 -179.574 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.47 -9.11 21.32 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 123.731 2.954 . . . . 1.68 117.745 -171.376 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.74 -23.39 36.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.906 1.683 . . . . 2.25 112.697 166.85 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -86.15 -41.08 15.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 129.122 2.969 . . . . 2.44 111.123 -177.762 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.257 58.0 mt-30 -70.0 134.54 48.42 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 111.056 -2.793 . . . . 1.32 113.168 179.978 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -133.11 120.13 20.85 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.322 1.601 . . . . 3.19 115.322 175.074 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.427 HD13 HG22 ' A' ' 23' ' ' ILE . 46.6 mt -100.02 117.42 34.25 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 121.223 -0.923 . . . . 1.75 111.167 -177.214 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 80.8 mt -110.33 129.19 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 126.964 2.106 . . . . 1.98 108.097 179.472 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -142.83 137.52 29.68 Favored 'General case' 0 N--CA 1.43 -1.463 1 N-CA-C 99.092 -4.41 . . . . 1.94 99.092 173.002 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.16 33.4 23.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 117.078 2.251 . . . . 1.67 117.078 175.695 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.57 9.18 73.53 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 116.198 -2.906 . . . . 1.3 115.459 -174.023 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -121.33 137.9 54.49 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.694 2.187 . . . . 2.89 109.732 -176.459 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -89.37 118.22 28.88 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 127.261 3.41 . . . . 2.89 102.155 179.281 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.1 mt -87.22 152.59 22.18 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.771 -3.706 . . . . 1.34 112.82 -170.715 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -97.4 163.9 12.68 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.104 -3.498 . . . . 1.94 109.535 179.633 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -72.88 -69.04 0.44 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.458 2.303 . . . . 1.56 114.168 -168.314 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.08 59.77 2.25 Favored Glycine 0 N--CA 1.43 -1.728 1 C-N-CA 131.455 4.359 . . . . 0.97 110.76 176.919 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.5 mmt-85 -142.74 148.46 37.28 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.073 -1.825 . . . . 3.07 106.073 169.7 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.6 p -86.43 170.24 12.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.217 -3.427 . . . . 1.34 108.617 178.72 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 31.3 mt -65.89 -39.1 90.32 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.794 2.838 . . . . 1.63 110.648 169.078 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 t -64.88 -37.03 86.26 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.825 -3.047 . . . . 1.51 114.966 177.726 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -60.48 -40.67 92.14 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 115.925 1.824 . . . . 1.9 115.925 177.486 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -77.25 -9.92 59.1 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.797 2.839 . . . . 0.97 114.246 171.809 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.258 9.6 t30 63.18 48.39 3.73 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 125.787 2.708 . . . . 2.35 113.368 -176.698 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.1 mt -96.47 100.24 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 1 C-N-CA 132.25 4.22 . . . . 1.39 104.843 179.352 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -90.75 -174.45 4.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 121.959 2.163 . . . . 2.58 106.591 -175.955 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -62.37 151.66 36.2 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.58 -1.646 . . . . 2.58 109.76 173.088 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.344 43.7 mt-10 67.4 21.88 9.57 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 128.983 2.913 . . . . 1.71 111.078 171.106 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.1 m -85.59 136.7 33.28 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 115.617 -2.135 . . . . 1.34 112.64 -178.396 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.0 m -90.72 111.13 22.36 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 120.234 1.379 . . . . 1.36 108.623 -178.764 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.3 mt -88.91 137.67 32.11 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.259 -3.4 . . . . 2.03 107.313 173.326 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -94.06 116.65 29.1 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.78 -2.45 . . . . 2.31 106.527 -174.046 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.1 tp -99.63 108.68 21.12 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.749 -1.844 . . . . 1.72 110.005 -176.909 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.3 t -98.52 132.73 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 131.262 3.825 . . . . 1.8 107.691 178.307 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.8 mt . . . . . 0 N--CA 1.43 -1.44 0 CA-C-O 127.458 3.504 . . . . 3.26 105.354 177.565 . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ptt? . . . . . 0 CA--C 1.489 -1.392 0 CA-C-O 121.792 0.806 . . . . 1.39 111.739 . . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -110.81 142.21 43.12 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.645 -1.909 . . . . 2.2 110.301 -169.694 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.2 pt -136.64 146.2 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 129.073 2.949 . . . . 1.32 109.809 178.42 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -105.29 109.55 21.58 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 113.384 -1.735 . . . . 2.2 112.933 -178.497 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -100.49 103.06 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 117.601 -3.187 . . . . 1.23 108.703 176.227 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -91.76 131.57 37.03 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.73 -1.605 . . . . 2.51 113.049 176.486 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.351 0.0 OUTLIER -98.4 168.83 9.96 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.455 2.302 . . . . 1.41 109.32 -177.976 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.5 mt -67.67 -35.29 78.58 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 126.404 2.315 . . . . 2.95 112.686 -175.611 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.319 17.8 p -71.31 -35.66 71.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.893 1.679 . . . . 2.52 109.197 -176.388 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.29 -12.68 1.83 Allowed Glycine 0 N--CA 1.429 -1.805 0 O-C-N 118.949 -2.344 . . . . 1.5 115.758 178.031 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -80.29 134.45 36.08 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 124.946 2.308 . . . . 1.79 114.064 -175.654 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -99.82 127.3 45.99 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.197 -2.19 . . . . 1.38 109.518 173.813 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 mt -102.48 117.61 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 118.136 -2.853 . . . . 2.03 108.66 174.699 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.1 m -95.92 117.69 31.1 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 119.534 -0.866 . . . . 1.61 109.194 178.629 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.5 mt -119.21 150.27 40.35 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 121.212 -0.93 . . . . 2.15 112.627 177.371 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -101.07 139.91 36.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 127.762 3.164 . . . . 1.98 108.547 167.657 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.9 m -150.93 170.47 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 C-N-CA 129.969 3.307 . . . . 1.52 112.981 -178.383 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -108.47 156.9 37.84 Favored Pre-proline 0 CA--C 1.489 -1.383 0 CA-C-O 114.071 -2.871 . . . . 2.35 110.264 167.054 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -67.84 -21.27 44.51 Favored 'Trans proline' 0 N--CA 1.433 -2.065 0 C-N-CA 124.525 3.483 . . . . 1.31 111.827 -174.643 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.2 p -71.4 -6.64 41.74 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 130.511 3.525 . . . . 1.71 115.944 169.713 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.74 156.19 30.75 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.473 -2.017 . . . . 1.69 112.928 176.021 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.6 p -92.64 169.63 10.36 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.085 1.754 . . . . 1.33 113.128 176.512 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.5 mm -66.93 -30.97 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.806 -2.434 . . . . 1.32 114.975 173.579 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -57.25 -40.44 77.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.883 -3.01 . . . . 1.62 112.176 168.827 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -69.42 -23.65 63.73 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 113.217 0.821 . . . . 2.13 113.217 177.912 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.9 t -79.69 -46.54 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 119.647 -1.908 . . . . 1.23 113.48 176.38 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -68.85 -23.6 64.26 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 125.761 2.696 . . . . 1.97 115.017 176.614 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.84 -19.75 57.15 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.24 -3.412 . . . . 1.19 111.105 173.561 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -84.64 -34.85 22.99 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.173 2.416 . . . . 1.92 110.3 -179.838 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.7 mt -75.95 -22.13 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 117.965 -2.96 . . . . 1.94 107.767 175.822 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -70.23 -37.27 74.95 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 117.968 -2.958 . . . . 1.9 110.883 170.818 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.97 -59.33 3.58 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 120.467 -1.396 . . . . 1.55 110.873 172.438 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.256 32.6 tttp -59.18 -58.83 6.93 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.266 2.626 . . . . 2.95 111.25 -172.266 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -92.99 -74.7 0.51 Allowed 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.4 1.88 . . . . 1.48 109.612 -174.065 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 156.6 -14.23 0.35 Allowed Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 125.31 3.687 . . . . 1.12 110.274 177.186 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.6 mt -57.59 119.41 32.61 Favored Pre-proline 0 N--CA 1.43 -1.433 0 C-N-CA 128.929 2.892 . . . . 2.07 113.476 -172.891 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -60.22 147.09 94.85 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 CA-C-N 125.168 2.882 . . . . 1.39 117.534 171.789 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.304 73.6 Cg_endo -72.35 -18.25 26.57 Favored 'Trans proline' 0 N--CA 1.433 -2.031 1 C-N-CA 126.691 4.927 . . . . 1.68 114.615 -172.327 . . . . . . . . 3 2 . 1 . 047 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -73.36 -22.03 60.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 124.176 3.171 . . . . 2.25 109.373 174.799 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -87.4 -18.38 30.13 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.918 -2.364 . . . . 2.44 110.0 -178.724 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -96.12 116.27 28.72 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.726 -1.953 . . . . 1.32 105.726 -172.043 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -103.57 119.79 39.59 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 131.472 3.909 . . . . 3.19 107.851 168.695 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.5 mt -109.53 120.82 43.67 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.047 1.403 . . . . 1.75 110.916 179.631 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 mt -104.98 126.81 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 O-C-N 119.871 -1.768 . . . . 1.98 109.843 -179.614 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.441 ' CE2' HG12 ' A' ' 61' ' ' ILE . 49.3 t80 -134.12 127.79 32.82 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 116.881 -3.637 . . . . 1.94 112.936 173.762 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 35.39 38.75 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.843 1.657 . . . . 1.67 114.508 -171.51 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.27 -43.12 1.76 Allowed Glycine 0 N--CA 1.431 -1.699 0 O-C-N 118.012 -2.93 . . . . 1.3 113.096 175.752 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -72.46 144.03 48.22 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 119.374 1.587 . . . . 2.89 113.522 176.47 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.445 1.1 mp0 -99.14 112.8 24.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.325 -2.109 . . . . 2.89 112.101 169.742 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.8 mt -78.27 139.28 38.89 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 116.715 -3.741 . . . . 1.34 113.964 -158.393 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -82.05 141.8 32.87 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.747 2.419 . . . . 1.94 109.673 178.262 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.31 -48.46 71.32 Favored 'General case' 0 N--CA 1.43 -1.433 1 N-CA-C 121.91 4.041 . . . . 1.56 121.91 -173.378 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.92 63.25 1.52 Allowed Glycine 0 N--CA 1.431 -1.649 0 O-C-N 118.378 -2.701 . . . . 0.97 114.216 171.228 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -129.65 150.39 50.99 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.371 3.069 . . . . 3.07 105.932 167.62 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.7 p -87.41 170.15 11.63 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 119.071 -1.052 . . . . 1.34 110.048 177.662 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.6 mt -70.67 -30.11 66.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.591 1.956 . . . . 1.63 107.943 173.39 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.3 p -73.03 -43.0 62.56 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 116.241 -4.037 . . . . 1.51 118.036 175.382 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -44.05 -60.45 1.86 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.256 2.222 . . . . 1.9 116.584 167.058 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -73.25 3.78 5.34 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.424 -1.262 . . . . 0.97 112.054 179.61 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.2 t30 52.76 48.76 21.77 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.612 3.165 . . . . 2.35 114.654 -175.308 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.441 HG12 ' CE2' ' A' ' 45' ' ' PHE . 19.5 mt -94.92 124.74 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 116.528 -3.857 . . . . 1.39 108.281 175.785 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -114.33 -162.64 0.82 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 116.794 -3.691 . . . . 2.58 105.809 -165.299 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HE2' ' HB2' ' A' ' 63' ' ' LYS . 12.8 ptmm? -67.87 139.59 56.51 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 124.935 2.302 . . . . 2.58 113.371 167.347 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.438 84.5 mt-10 70.81 38.3 1.22 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.912 -2.368 . . . . 1.71 111.191 171.043 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 m -95.53 115.24 27.16 Favored 'General case' 0 N--CA 1.43 -1.453 1 C-N-CA 133.734 4.813 . . . . 1.34 107.779 -170.31 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.256 87.5 m -80.46 102.47 9.7 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.723 -1.236 . . . . 1.36 114.263 175.414 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.308 8.8 mt -89.21 135.61 33.48 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-O 123.904 1.812 . . . . 2.03 107.494 174.033 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -97.39 104.98 17.05 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.084 1.354 . . . . 2.31 107.586 -174.276 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.362 16.6 tp -76.43 115.42 16.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.371 -3.331 . . . . 1.72 114.335 174.906 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.0 t -108.48 128.77 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 115.554 -2.165 . . . . 1.8 106.508 172.212 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.8 mt . . . . . 0 N--CA 1.429 -1.486 0 CA-C-N 123.968 3.076 . . . . 3.26 109.019 176.285 . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 ptt? . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 117.878 -1.058 . . . . 1.39 112.834 . . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -86.4 129.43 34.86 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 120.878 1.672 . . . . 2.2 112.013 -179.881 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.261 32.5 pt -130.91 150.68 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.129 -3.482 . . . . 1.32 108.642 175.459 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -110.88 142.73 42.55 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 117.897 -3.002 . . . . 2.2 104.819 -178.653 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.4 t -124.1 108.49 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 107.082 -1.451 . . . . 1.23 107.082 172.748 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -98.28 132.1 44.05 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.89 -2.381 . . . . 2.51 110.633 -178.872 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 p -86.53 177.48 7.38 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.805 2.241 . . . . 1.41 113.682 178.797 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.317 43.0 mt -83.2 -38.99 21.56 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 119.153 -2.217 . . . . 2.95 109.828 170.073 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 p -63.71 -52.28 61.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.452 3.101 . . . . 2.52 113.963 179.69 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.84 11.31 0.04 OUTLIER Glycine 0 N--CA 1.429 -1.783 0 O-C-N 118.465 -2.647 . . . . 1.5 118.008 -175.136 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -115.59 150.95 35.83 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 105.824 -1.917 . . . . 1.79 105.824 -167.445 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.3 m -122.29 111.23 16.66 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 116.393 -1.765 . . . . 1.38 109.377 166.963 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -91.58 121.79 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 123.605 2.911 . . . . 2.03 109.952 177.622 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 m -87.55 114.18 23.92 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 127.189 3.376 . . . . 1.61 113.286 173.008 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.42 HD23 ' HB3' ' A' ' 29' ' ' LYS . 13.4 mt -110.8 154.74 23.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.918 -2.989 . . . . 2.15 112.88 -179.712 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -110.09 123.14 49.17 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 124.259 1.981 . . . . 1.98 108.028 166.283 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.96 170.59 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 118.672 -2.517 . . . . 1.52 107.116 -174.528 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -118.91 154.65 53.12 Favored Pre-proline 0 N--CA 1.43 -1.463 0 O-C-N 119.151 -2.218 . . . . 2.35 105.825 165.331 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -68.17 -16.54 44.53 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 O-C-N 114.683 -3.377 . . . . 1.31 114.276 -175.253 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.4 m -91.15 12.03 21.35 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 114.045 -5.409 . . . . 1.71 113.378 175.836 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -88.54 144.86 26.06 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 113.31 -3.356 . . . . 1.69 108.463 179.707 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.278 53.7 p -71.28 153.24 42.55 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.473 1.909 . . . . 1.33 109.758 -179.945 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.6 mm -54.09 -40.58 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 118.403 -2.685 . . . . 1.32 114.598 168.645 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -42.59 -46.29 4.88 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 117.675 2.472 . . . . 1.62 117.675 164.983 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.61 -46.03 84.38 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 111.625 -2.534 . . . . 2.13 112.478 178.151 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.6 t -59.01 -44.32 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 C-N-CA 126.743 2.017 . . . . 1.23 106.155 178.034 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.254 84.2 mttt -60.8 -42.61 97.97 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 116.203 -4.061 . . . . 1.97 114.124 177.473 . . . . . . . . 3 2 . 1 . 048 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.34 -20.68 62.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.448 -3.283 . . . . 1.19 116.379 175.091 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.42 ' HB3' HD23 ' A' ' 15' ' ' LEU . 9.4 mttm -72.68 -45.24 59.83 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.095 1.758 . . . . 1.92 112.359 170.442 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -48.69 -43.91 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.532 1.533 . . . . 1.94 112.756 163.264 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -66.05 -43.38 87.65 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.855 -3.653 . . . . 1.9 112.622 -179.537 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -53.77 -49.59 67.91 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.323 1.449 . . . . 1.55 110.339 168.26 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -80.97 -54.79 5.27 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.071 -2.893 . . . . 2.95 112.627 -174.815 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -99.62 -26.62 14.02 Favored 'General case' 0 N--CA 1.431 -1.401 1 O-C-N 112.694 -6.254 . . . . 1.48 109.03 -168.309 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.2 17.4 40.23 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 117.918 -2.989 . . . . 1.12 115.158 179.929 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.8 mt -84.83 123.28 74.17 Favored Pre-proline 0 N--CA 1.43 -1.471 0 CA-C-O 113.678 -3.058 . . . . 2.07 107.972 -177.404 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -69.81 144.4 53.61 Favored 'Trans proline' 0 N--CA 1.433 -2.037 1 CA-C-N 129.548 4.446 . . . . 1.39 114.205 -178.142 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_exo -62.08 -20.05 68.42 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 N-CA-C 121.185 3.494 . . . . 1.68 121.185 -165.425 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -66.79 -28.17 68.17 Favored 'General case' 0 N--CA 1.429 -1.49 1 O-C-N 129.998 4.561 . . . . 2.25 111.773 173.542 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -85.62 -24.59 27.05 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 116.296 -1.812 . . . . 2.44 110.457 -176.412 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.251 60.1 mt-30 -79.49 129.8 34.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 127.899 3.249 . . . . 1.32 110.959 -169.107 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -115.1 129.87 56.79 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.457 -2.053 . . . . 3.19 105.457 168.993 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.3 mt -114.1 126.96 55.68 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.139 -2.85 . . . . 1.75 111.093 179.647 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -117.73 124.23 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-O 126.969 3.271 . . . . 1.98 111.245 -175.47 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -135.66 139.3 43.63 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 115.965 -4.21 . . . . 1.94 109.049 172.192 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.362 . . 58.68 25.21 13.05 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 123.779 2.991 . . . . 1.67 115.673 173.469 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.11 2.92 90.7 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 117.077 1.591 . . . . 1.3 117.077 -177.055 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -113.26 157.21 22.05 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.382 2.273 . . . . 2.89 115.61 176.773 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -97.54 139.66 33.12 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.431 -2.668 . . . . 2.89 109.674 173.079 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.3 mt -102.2 120.66 40.82 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.978 -2.951 . . . . 1.34 111.329 -170.362 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -67.28 148.01 52.25 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.191 1.552 . . . . 1.94 115.191 175.283 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.65 -47.11 76.67 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 120.75 3.611 . . . . 1.56 120.75 -174.37 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.39 18.01 21.03 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 115.372 -2.904 . . . . 0.97 118.766 173.684 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -102.79 156.74 17.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.77 2.785 . . . . 3.07 110.974 171.643 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.1 p -88.55 169.65 11.55 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 123.329 1.538 . . . . 1.34 115.008 172.817 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.333 77.3 mt -69.22 -23.96 63.95 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 116.011 -4.181 . . . . 1.63 110.809 170.713 . . . . . . . . 3 2 . 1 . 048 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -65.72 -36.4 83.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.8 2.44 . . . . 1.51 115.489 171.806 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -65.41 -38.59 90.38 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.698 1.599 . . . . 1.9 113.911 173.881 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -78.9 -25.28 43.79 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 115.328 -2.272 . . . . 0.97 113.901 175.323 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.279 1.9 m-80 70.8 58.46 0.21 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.107 1.763 . . . . 2.35 109.909 -171.299 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 mt -105.25 117.12 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 105.022 -2.214 . . . . 1.39 105.022 174.034 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -84.83 -175.16 5.65 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 124.837 2.256 . . . . 2.58 111.374 -169.216 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -20.98 -87.87 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.422 1 C-N-CA 134.351 5.06 . . . . 2.58 118.208 169.086 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -103.17 69.3 1.01 Allowed 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 122.408 2.367 . . . . 1.71 116.226 -179.97 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.3 m -91.85 152.38 20.12 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 114.797 -1.092 . . . . 1.34 112.762 -179.99 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.5 m -113.52 115.69 28.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.136 1.374 . . . . 1.36 109.851 174.024 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.3 mt -96.93 156.63 16.27 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.545 1.938 . . . . 2.03 110.83 -179.674 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -110.9 129.65 55.81 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 100.991 -3.707 . . . . 2.31 100.991 -175.815 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.0 tp -102.53 113.89 27.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 125.328 1.643 . . . . 1.72 108.441 178.509 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.96 148.79 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 125.497 2.57 . . . . 1.8 109.464 172.845 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.9 mt . . . . . 0 N--CA 1.43 -1.464 1 O-C-N 115.728 -4.358 . . . . 3.26 111.985 -177.708 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 ptt? . . . . . 0 CA--C 1.491 -1.316 0 N-CA-C 116.773 2.138 . . . . 1.39 116.773 . . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -87.62 121.17 29.72 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 122.566 2.439 . . . . 2.2 110.489 178.904 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 pt -108.42 153.09 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 127.699 2.4 . . . . 1.32 108.577 173.777 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -104.18 131.08 51.85 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.868 -1.16 . . . . 2.2 107.868 -179.744 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.5 t -121.01 121.47 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 104.481 -2.414 . . . . 1.23 104.481 168.054 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -100.25 128.18 46.37 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 126.632 1.973 . . . . 2.51 111.727 -176.971 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.353 30.5 p -77.41 -164.07 0.44 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.602 1.668 . . . . 1.41 114.42 179.201 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.308 10.3 mt -90.97 -40.6 11.59 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.704 -1.872 . . . . 2.95 112.911 169.159 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.0 p -64.75 -37.09 86.42 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.548 -2.595 . . . . 2.52 107.616 -176.409 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.35 51.97 0.31 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 128.067 2.746 . . . . 1.5 111.312 175.92 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.523 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 83.1 tttt -114.1 130.27 56.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 101.972 -3.344 . . . . 1.79 101.972 177.425 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.3 m -102.67 103.76 14.05 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 118.016 -2.927 . . . . 1.38 110.399 177.146 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.81 136.51 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 118.755 -2.465 . . . . 2.03 108.418 179.541 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.7 m -103.29 111.93 24.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 118.733 -0.651 . . . . 1.61 109.265 179.602 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.38 142.23 28.01 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 127.992 3.307 . . . . 2.15 109.253 -178.97 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -105.81 116.28 31.67 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 123.395 1.569 . . . . 1.98 113.044 164.407 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.78 179.46 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.039 -1.437 . . . . 1.52 109.635 -178.808 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.433 ' O ' HD13 ' A' ' 56' ' ' LEU . 89.8 mt-10 -115.89 163.35 21.46 Favored Pre-proline 0 N--CA 1.432 -1.373 0 O-C-N 117.1 -3.5 . . . . 2.35 107.888 164.189 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -70.51 -14.46 33.73 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 C-N-CA 122.603 2.202 . . . . 1.31 112.444 -177.688 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.0 p -90.6 -0.99 57.88 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.165 2.186 . . . . 1.71 112.675 179.335 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -75.89 137.51 40.46 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.602 -1.936 . . . . 1.69 112.321 174.284 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 17.2 p -78.87 170.84 16.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.902 1.81 . . . . 1.33 111.625 174.297 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.284 3.5 mp -64.43 -41.07 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.267 -3.396 . . . . 1.32 112.721 168.106 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -43.5 -50.97 6.96 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 117.133 2.271 . . . . 1.62 117.133 163.694 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -67.01 -34.58 78.04 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.234 -2.166 . . . . 2.13 110.743 179.11 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.25 -42.1 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 118.253 2.686 . . . . 1.23 118.253 170.548 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.526 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 40.1 mtmt -71.86 -34.96 69.65 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 117.621 -3.175 . . . . 1.97 117.091 174.337 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.39 -28.38 63.99 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.733 2.413 . . . . 1.19 113.116 179.254 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -71.53 -37.89 71.11 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.689 2.395 . . . . 1.92 110.345 168.616 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.1 mt -68.31 -38.81 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 125.282 1.433 . . . . 1.94 107.996 175.872 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.342 40.3 tt0 -56.44 -41.8 77.04 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 128.788 2.835 . . . . 1.9 114.057 171.035 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -60.51 -41.73 94.95 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 118.236 2.68 . . . . 1.55 118.236 162.013 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -76.28 -52.4 10.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.719 -3.113 . . . . 2.95 116.431 -173.748 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.523 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 54.9 mm-40 -100.31 -26.77 13.79 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.714 2.406 . . . . 1.48 111.152 -168.585 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.75 13.88 56.04 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 118.12 -2.862 . . . . 1.12 117.289 176.048 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.9 mt -98.7 117.86 63.89 Favored Pre-proline 0 N--CA 1.43 -1.431 0 C-N-CA 127.439 2.295 . . . . 2.07 110.094 -170.799 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.39 152.71 70.94 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 CA-C-N 125.273 2.919 . . . . 1.39 116.932 -178.593 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -81.8 8.73 4.28 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 CA-C-O 113.582 -2.757 . . . . 1.68 107.919 -165.808 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -73.37 -44.13 59.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 125.272 3.669 . . . . 2.25 113.167 168.939 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -72.61 -26.36 61.66 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.783 2.833 . . . . 2.44 107.926 -172.466 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.526 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 73.3 mt-30 -87.25 133.18 33.7 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 123.455 0.702 . . . . 1.32 111.518 -165.932 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -124.6 146.89 48.81 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.182 2.593 . . . . 3.19 105.167 166.01 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.5 mt -129.33 128.06 42.36 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 129.168 2.987 . . . . 1.75 105.933 -177.709 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -121.01 115.66 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 105.339 -2.097 . . . . 1.98 105.339 -178.165 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.262 23.8 t80 -101.45 117.37 34.8 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.736 -1.852 . . . . 1.94 106.397 171.127 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.54 -46.31 0.62 Allowed 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.45 2.7 . . . . 1.67 114.806 -177.086 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.04 -32.81 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 126.938 2.209 . . . . 1.3 110.186 -171.712 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.27 52.8 mttm -73.29 125.96 29.01 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 126.657 2.034 . . . . 2.89 114.685 175.272 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -82.79 136.36 34.69 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 128.382 3.944 . . . . 2.89 112.825 172.309 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.4 mt -99.89 132.53 45.19 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.125 -2.86 . . . . 1.34 111.628 -165.171 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -79.17 141.28 37.35 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 122.175 0.988 . . . . 1.94 112.426 174.728 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.82 -57.74 8.45 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 126.031 2.824 . . . . 1.56 116.273 -174.135 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.43 16.43 13.84 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 122.6 3.8 . . . . 0.97 122.6 174.502 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 -85.41 163.87 18.25 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.8 1.8 . . . . 3.07 111.14 161.17 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.7 p -89.66 169.66 11.13 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 115.365 1.617 . . . . 1.34 115.365 165.287 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 18' ' ' GLU . 58.5 mt -64.6 -47.8 77.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 129.086 2.954 . . . . 1.63 108.666 172.147 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.7 m -57.65 -37.06 72.72 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.038 -2.289 . . . . 1.51 114.481 175.675 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -62.79 -54.37 39.99 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 129.764 3.226 . . . . 1.9 115.913 175.365 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -64.42 -12.38 42.65 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.564 -2.16 . . . . 0.97 116.294 169.404 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.2 m120 69.67 56.24 0.35 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 126.615 2.447 . . . . 2.35 113.175 -179.583 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 56' ' ' LEU . 65.9 mt -95.66 128.44 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 128.885 2.874 . . . . 1.39 106.433 -176.731 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -75.76 159.42 31.07 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 125.708 1.603 . . . . 2.58 109.875 -171.943 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -52.27 -35.26 49.57 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 120.448 3.499 . . . . 2.58 120.448 167.519 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -128.39 86.44 2.46 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 130.086 4.616 . . . . 1.71 105.011 174.437 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.44 172.76 11.2 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 117.895 -1.05 . . . . 1.34 110.997 -176.697 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.4 m -130.48 125.79 35.27 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 117.807 -1.092 . . . . 1.36 108.727 176.381 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 mt -104.12 145.64 29.89 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 128.773 2.829 . . . . 2.03 111.671 170.492 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -106.15 122.13 45.56 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.171 -1.58 . . . . 2.31 111.416 -172.277 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 tp -90.22 118.69 29.93 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.208 -1.775 . . . . 1.72 106.208 -173.574 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.5 t -119.29 148.9 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 103.69 -2.707 . . . . 1.8 103.69 173.722 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 N--CA 1.431 -1.422 0 O-C-N 125.933 2.02 . . . . 3.26 108.401 -175.459 . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.368 0 CA-C-O 125.902 2.763 . . . . 1.39 115.991 . . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -82.21 99.19 9.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.174 -3.454 . . . . 2.2 107.851 172.029 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -92.92 134.42 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 120.7 -1.25 . . . . 1.32 113.827 168.944 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -94.77 109.45 21.41 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 129.554 3.142 . . . . 2.2 111.328 -176.497 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 t -90.18 102.54 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 123.747 0.819 . . . . 1.23 111.963 173.352 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -75.87 140.57 42.28 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.137 2.399 . . . . 2.51 108.838 172.869 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 p -108.94 162.39 14.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.809 -1.807 . . . . 1.41 108.424 176.786 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.506 HD12 HG13 ' A' ' 70' ' ' VAL . 5.2 mt -69.63 -32.76 71.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 128.278 3.894 . . . . 2.95 112.531 177.951 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.0 p -70.86 -35.73 72.52 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 130.405 3.482 . . . . 2.52 115.975 -174.707 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.58 15.66 0.95 Allowed Glycine 0 N--CA 1.431 -1.692 0 CA-C-O 116.954 -2.025 . . . . 1.5 117.263 170.468 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.449 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 17.7 ptpt -116.87 172.28 7.36 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 120.333 2.066 . . . . 1.79 110.141 -178.26 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.4 m -123.87 106.6 10.58 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 128.134 2.574 . . . . 1.38 113.392 177.259 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -90.58 107.65 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 117.272 -1.347 . . . . 2.03 109.878 178.731 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.3 m -98.63 101.02 12.32 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.852 2.739 . . . . 1.61 106.907 -175.374 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.2 mt -102.15 141.62 34.7 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.284 -1.78 . . . . 2.15 111.658 -179.149 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -89.09 115.96 27.01 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.918 2.192 . . . . 1.98 116.918 163.599 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.1 m -127.32 170.26 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 128.79 2.836 . . . . 1.52 110.274 176.959 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -124.17 165.32 24.78 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 127.355 2.262 . . . . 2.35 109.527 167.417 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -69.1 -28.73 28.06 Favored 'Trans proline' 0 N--CA 1.434 -2.012 1 O-C-N 113.487 -4.007 . . . . 1.31 113.468 -168.062 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.7 m -83.93 6.07 23.1 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 114.565 -2.854 . . . . 1.71 111.2 -177.692 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -72.86 142.67 47.96 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.405 2.526 . . . . 1.69 108.168 173.432 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 38.2 p -84.41 164.83 18.65 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.668 -2.52 . . . . 1.33 109.249 -178.619 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.335 1.4 mp -70.25 -29.4 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.192 -2.193 . . . . 1.32 112.128 176.718 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -53.31 -46.68 69.52 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.797 -1.19 . . . . 1.62 113.536 165.649 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -62.05 -38.41 88.66 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 116.875 2.176 . . . . 2.13 116.875 177.496 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.1 -46.73 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 131.163 3.785 . . . . 1.23 111.294 173.028 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -65.63 -35.86 82.02 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.282 1.433 . . . . 1.97 111.127 179.043 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.24 74.7 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 115.739 -2.077 . . . . 1.19 113.775 174.446 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -72.79 -20.49 61.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.442 2.756 . . . . 1.92 118.442 175.327 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.0 mt -79.57 -34.13 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.98 2.112 . . . . 1.94 111.475 173.44 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -53.79 -41.88 67.71 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.494 -2.629 . . . . 1.9 112.687 175.09 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -67.49 -55.45 13.5 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.164 2.283 . . . . 1.55 117.164 170.028 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -66.46 -71.71 0.19 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.152 -2.218 . . . . 2.95 112.743 -174.461 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.449 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 59.1 mm-40 -74.19 -38.23 63.7 Favored 'General case' 0 N--CA 1.428 -1.527 0 O-C-N 118.095 -2.878 . . . . 1.48 113.535 -174.734 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.63 32.69 7.13 Favored Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 126.031 3.017 . . . . 1.12 113.267 -179.372 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.4 mt -101.11 125.14 39.1 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-N 111.144 -2.528 . . . . 2.07 107.812 -179.916 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -66.51 163.5 32.34 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 CA-C-O 112.374 -3.261 . . . . 1.39 114.773 -178.735 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -77.7 -16.52 14.7 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 CA-C-N 122.759 2.021 . . . . 1.68 113.444 -177.941 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -68.14 -35.83 78.71 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.77 -2.456 . . . . 2.25 109.935 168.54 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -76.82 -16.79 59.34 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.165 1.386 . . . . 2.44 114.62 -178.214 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -93.31 120.88 34.1 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.635 -3.79 . . . . 1.32 110.161 -173.31 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -103.58 116.27 32.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.503 -2.776 . . . . 3.19 103.503 167.842 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.5 mt -104.98 112.51 25.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 102.159 -3.274 . . . . 1.75 102.159 177.807 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.6 mm -103.23 137.39 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 105.45 -2.055 . . . . 1.98 105.45 177.379 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -129.33 109.34 11.02 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 103.749 -2.686 . . . . 1.94 103.749 176.855 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.402 . . 74.71 -86.58 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.144 -2.223 . . . . 1.67 112.37 177.855 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.28 1.09 1.85 Allowed Glycine 0 N--CA 1.43 -1.765 0 O-C-N 118.929 -2.357 . . . . 1.3 113.914 179.8 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -115.39 141.58 47.85 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 109.468 -0.567 . . . . 2.89 109.468 -178.707 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -86.06 134.25 33.84 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.742 2.417 . . . . 2.89 109.335 173.002 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.7 mt -85.14 121.81 28.43 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.63 2.826 . . . . 1.34 118.63 -179.601 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -81.5 142.19 33.13 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 116.336 1.976 . . . . 1.94 116.336 173.884 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.28 -54.53 19.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.224 1.409 . . . . 1.56 114.579 -167.81 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.0 15.89 2.96 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 120.043 2.777 . . . . 0.97 120.043 172.851 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.486 HH21 ' CG ' ' A' ' 58' ' ' ASP . 79.0 mtp180 -102.83 156.4 17.68 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 121.225 2.512 . . . . 3.07 107.772 165.722 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 16.7 p -82.59 161.73 22.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.321 2.249 . . . . 1.34 114.462 175.874 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -65.48 -28.72 69.41 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.403 2.001 . . . . 1.63 116.403 167.216 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.0 p -74.44 -21.92 59.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 117.08 2.252 . . . . 1.51 117.08 173.052 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.486 ' CG ' HH21 ' A' ' 54' ' ' ARG . 48.6 t0 -67.26 -40.97 86.28 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 118.296 -0.859 . . . . 1.9 110.999 172.346 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -77.53 -17.77 57.62 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 114.911 -2.471 . . . . 0.97 115.17 169.286 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 73.34 34.55 0.99 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.497 2.57 . . . . 2.35 116.367 -179.997 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.5 mt -65.38 124.58 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 116.384 -3.947 . . . . 1.39 115.528 179.618 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -61.43 164.55 5.57 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 119.987 3.328 . . . . 2.58 119.987 -178.082 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -60.08 -61.16 2.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.698 -3.126 . . . . 2.58 110.421 174.178 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -93.35 81.28 4.42 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 116.521 -2.071 . . . . 1.71 113.579 172.784 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.282 19.1 m -108.83 139.72 43.27 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 118.962 2.949 . . . . 1.34 118.962 -178.835 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.2 m -115.08 130.01 56.83 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.164 -1.421 . . . . 1.36 107.164 178.641 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -115.17 168.72 9.69 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 116.513 -1.708 . . . . 2.03 111.245 -179.345 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -122.88 122.84 39.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.29 1.436 . . . . 2.31 112.92 -179.22 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 tp -94.77 101.21 13.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.243 -1.536 . . . . 1.72 111.77 177.34 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.506 HG13 HD12 ' A' ' 8' ' ' LEU . 2.8 t -88.45 128.92 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 104.344 -2.465 . . . . 1.8 104.344 173.217 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.8 tp . . . . . 0 N--CA 1.43 -1.434 0 CA-C-O 115.585 -2.15 . . . . 3.26 113.074 175.185 . . . . . . . . 0 0 . 1 . 051 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 ptt? . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 123.773 1.749 . . . . 1.39 110.914 . . . . . . . . . 0 0 . 1 . 051 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -88.11 107.24 18.66 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 113.773 -5.579 . . . . 2.2 115.316 -178.687 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.3 pt -111.83 164.28 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 117.743 -3.098 . . . . 1.32 109.257 178.564 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -120.39 125.89 49.12 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 116.766 -3.709 . . . . 2.2 112.128 178.703 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 t -109.78 111.4 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 1 O-C-N 113.228 -5.92 . . . . 1.23 109.116 167.686 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -71.68 140.4 49.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.268 2.937 . . . . 2.51 111.124 175.097 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.1 p -87.93 177.75 6.88 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 113.25 -5.906 . . . . 1.41 110.769 169.744 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 tp -79.49 -51.28 9.54 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.334 -1.478 . . . . 2.95 108.422 179.631 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.1 p -65.7 -58.02 6.68 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.758 2.133 . . . . 2.52 116.758 -174.385 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.43 39.99 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.67 0 CA-C-O 115.054 -3.081 . . . . 1.5 110.546 -179.918 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.433 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 65.3 tttt -135.94 156.72 48.34 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 124.192 3.996 . . . . 1.79 110.571 -175.092 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.2 m -127.29 111.51 14.0 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 130.346 3.458 . . . . 1.38 107.514 177.814 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mt -88.28 118.92 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 123.924 3.056 . . . . 2.03 104.566 -177.94 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.9 m -98.73 122.09 41.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.224 -1.398 . . . . 1.61 107.224 178.229 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.8 mt -123.93 154.28 39.98 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 113.534 0.938 . . . . 2.15 113.534 -176.461 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -110.01 111.57 23.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 104.449 -2.426 . . . . 1.98 104.449 171.287 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.25 170.31 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 C-N-CA 127.443 2.297 . . . . 1.52 106.961 -179.91 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -117.97 156.59 49.99 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 105.209 -2.145 . . . . 2.35 105.209 167.035 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -68.49 -16.28 42.77 Favored 'Trans proline' 0 C--N 1.299 -2.069 0 N-CA-C 116.386 1.648 . . . . 1.31 116.386 -177.786 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.2 m -85.02 -11.51 55.24 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-O 115.731 -2.08 . . . . 1.71 110.763 179.699 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.07 139.51 54.83 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 126.262 1.825 . . . . 1.69 109.691 173.379 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.36 35.8 p -71.25 150.89 44.8 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 128.552 2.741 . . . . 1.33 110.021 176.091 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.423 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 20.5 mt -62.1 -35.1 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 104.869 -2.271 . . . . 1.32 104.869 178.795 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.291 30.1 tt0 -52.95 -46.39 68.15 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 116.262 -4.024 . . . . 1.62 118.548 165.812 . . . . . . . . 3 2 . 1 . 051 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.338 83.9 m-20 -61.77 -35.62 78.67 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.439 1.496 . . . . 2.13 113.95 173.613 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.5 t -68.94 -36.21 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 123.482 1.611 . . . . 1.23 112.01 175.101 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 18.7 mtmt -59.04 -30.44 68.04 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 119.125 -2.234 . . . . 1.97 115.252 163.84 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.21 -38.6 63.54 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 114.634 -5.042 . . . . 1.19 111.591 172.62 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.277 12.4 ttmm -57.32 -39.37 75.69 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.092 -2.88 . . . . 1.92 116.064 166.751 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.0 mt -57.34 -39.96 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 125.132 3.606 . . . . 1.94 114.57 166.945 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -66.85 -39.9 87.75 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.898 -1.751 . . . . 1.9 111.315 177.257 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -52.95 -43.51 66.38 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.579 2.066 . . . . 1.55 116.579 172.292 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -87.02 -47.57 8.83 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.664 -1.273 . . . . 2.95 113.289 -175.801 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.433 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 40.5 mm-40 -99.97 -55.68 2.57 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 116.941 -1.504 . . . . 1.48 107.214 -167.259 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.36 52.26 0.83 Allowed Glycine 0 N--CA 1.431 -1.695 0 CA-C-N 120.719 1.6 . . . . 1.12 112.607 -176.479 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.42 HD12 HD21 ' A' ' 71' ' ' LEU . 11.4 mt -130.74 126.29 21.79 Favored Pre-proline 0 N--CA 1.429 -1.48 0 N-CA-C 101.4 -3.556 . . . . 2.07 101.4 177.817 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -60.8 140.75 92.27 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 CA-C-O 111.082 -3.799 . . . . 1.39 111.648 -177.698 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -55.05 -23.8 37.17 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-N 124.925 2.795 . . . . 1.68 117.929 175.416 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -68.89 -23.13 64.16 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.309 1.226 . . . . 2.25 114.309 173.849 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -81.74 -20.96 38.23 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.877 1.323 . . . . 2.44 109.293 176.612 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -97.4 136.7 37.47 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.113 -2.867 . . . . 1.32 118.256 -173.849 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -123.77 108.09 12.14 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.185 -2.28 . . . . 3.19 111.533 173.595 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.5 mt -71.5 138.93 49.32 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 123.739 1.733 . . . . 1.75 112.053 176.903 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.316 47.0 mm -127.44 146.85 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 106.252 -1.759 . . . . 1.98 106.252 179.488 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -143.39 133.3 24.06 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.642 -1.911 . . . . 1.94 109.864 177.49 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.69 -83.91 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.412 2.285 . . . . 1.67 111.683 174.544 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -156.03 16.88 0.45 Allowed Glycine 0 N--CA 1.43 -1.759 0 O-C-N 125.647 1.842 . . . . 1.3 109.164 -178.215 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -126.7 167.0 16.33 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 126.077 2.846 . . . . 2.89 109.336 -177.984 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -93.0 162.68 13.95 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 114.607 -5.058 . . . . 2.89 105.874 170.521 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 98.0 mt -109.64 148.06 31.98 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.519 -3.238 . . . . 1.34 109.345 179.011 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -96.68 144.64 26.51 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.511 1.924 . . . . 1.94 110.909 171.681 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -85.88 -40.0 16.42 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 116.153 1.908 . . . . 1.56 116.153 -162.936 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.86 47.22 3.67 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-N 122.823 2.556 . . . . 0.97 113.657 171.505 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -131.84 164.28 26.4 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 104.175 -2.528 . . . . 3.07 104.175 170.353 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.363 20.4 p -90.93 174.74 7.27 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 118.717 -2.489 . . . . 1.34 115.147 -178.777 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.2 mt -73.04 -23.98 60.65 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.239 -1.538 . . . . 1.63 110.025 171.874 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -85.57 -41.12 15.55 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.69 1.367 . . . . 1.51 114.69 -177.27 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -53.05 -46.67 68.62 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.875 2.47 . . . . 1.9 111.815 168.881 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -75.06 -9.24 58.35 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 117.64 -3.162 . . . . 0.97 113.769 175.991 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.295 35.2 t-20 59.8 47.91 9.7 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 124.236 1.97 . . . . 2.35 114.896 -177.217 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.5 mm -74.75 130.91 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 128.102 2.561 . . . . 1.39 108.812 178.292 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -69.63 171.07 9.55 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.424 -3.298 . . . . 2.58 115.894 -176.691 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -57.36 -56.12 26.01 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 116.295 -4.003 . . . . 2.58 110.2 172.308 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -103.35 92.55 4.54 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.574 1.15 . . . . 1.71 109.389 171.733 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.3 t -115.14 144.69 43.28 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.644 2.09 . . . . 1.34 116.644 176.397 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.2 m -102.95 102.17 12.21 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.495 1.918 . . . . 1.36 110.875 179.695 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -106.69 172.88 6.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.893 -1.754 . . . . 2.03 109.304 178.292 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -123.7 137.35 54.72 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 118.151 2.648 . . . . 2.31 118.151 178.453 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.5 tp -95.64 118.69 32.8 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 112.744 -2.025 . . . . 1.72 111.282 177.064 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.2 t -122.53 121.67 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 125.862 1.665 . . . . 1.8 112.999 174.854 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.42 HD21 HD12 ' A' ' 36' ' ' ILE . 12.1 mt . . . . . 0 N--CA 1.431 -1.388 0 CA-C-O 126.974 3.273 . . . . 3.26 115.61 178.792 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ttp . . . . . 0 CA--C 1.49 -1.335 0 N-CA-C 118.428 2.751 . . . . 1.39 118.428 . . . . . . . . . 0 0 . 1 . 052 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -75.05 124.49 27.08 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 115.078 1.51 . . . . 2.2 115.078 -177.991 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.1 pt -136.14 159.0 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 117.248 -3.408 . . . . 1.32 103.218 175.752 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -116.64 149.5 39.64 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 124.477 1.111 . . . . 2.2 108.607 176.65 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.71 113.31 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-N 111.298 -2.683 . . . . 1.23 107.854 170.458 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -101.68 132.03 47.6 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 103.516 -2.772 . . . . 2.51 103.516 -176.048 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.1 p -86.48 165.86 15.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.986 -3.571 . . . . 1.41 113.508 173.66 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.9 mt -81.95 -29.77 32.04 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.841 -2.412 . . . . 2.95 108.78 174.097 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.9 p -68.1 -48.24 66.03 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 125.185 1.553 . . . . 2.52 111.692 -174.85 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.34 44.63 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.772 0 CA-C-N 119.523 1.056 . . . . 1.5 114.815 168.014 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.455 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 30.5 mtmt -143.43 147.17 34.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.684 2.183 . . . . 1.79 110.061 -162.53 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.3 m -112.84 135.04 54.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.48 -2.638 . . . . 1.38 105.038 171.427 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mt -111.57 107.54 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 126.585 1.954 . . . . 2.03 105.916 176.433 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.3 m -89.74 115.94 27.47 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.656 1.693 . . . . 1.61 108.789 -178.16 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.8 mt -115.31 154.99 28.13 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 125.421 2.534 . . . . 2.15 106.974 -170.348 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -112.06 117.68 33.33 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 115.382 -2.247 . . . . 1.98 108.044 166.191 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.0 m -129.73 177.47 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 101.859 -3.385 . . . . 1.52 101.859 -178.869 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -111.79 154.23 44.12 Favored Pre-proline 0 N--CA 1.43 -1.462 1 C-N-CA 133.196 4.598 . . . . 2.35 107.603 164.305 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -77.89 -5.46 15.3 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 125.078 3.852 . . . . 1.31 110.733 -172.404 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 m -101.57 3.25 39.83 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 123.529 1.633 . . . . 1.71 108.008 -175.53 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -81.91 149.84 28.04 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.394 1.257 . . . . 1.69 114.394 170.945 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 p -75.66 159.43 31.17 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 123.777 0.831 . . . . 1.33 111.075 -177.835 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.413 HG21 ' HB2' ' A' ' 50' ' ' LEU . 27.1 mm -67.65 -26.51 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.559 -1.338 . . . . 1.32 108.53 173.454 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -62.03 -34.61 76.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.143 1.792 . . . . 1.62 112.639 168.821 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -65.68 -40.8 92.72 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.748 1.619 . . . . 2.13 108.652 -179.08 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.7 t -64.8 -37.63 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-O 122.382 1.087 . . . . 1.23 113.278 175.947 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -59.97 -40.23 88.37 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 118.395 2.739 . . . . 1.97 118.395 166.292 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.56 -36.86 85.58 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.548 -1.97 . . . . 1.19 113.417 176.16 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -59.85 -48.01 83.41 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.577 -1.952 . . . . 1.92 114.805 170.628 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.8 mt -64.91 -32.81 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 119.22 -2.175 . . . . 1.94 112.976 172.029 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -62.98 -38.94 93.15 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.221 -1.55 . . . . 1.9 115.123 169.388 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -62.12 -44.06 97.47 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 123.423 1.582 . . . . 1.55 112.214 172.186 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -66.83 -55.79 13.26 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.572 -2.58 . . . . 2.95 116.002 178.555 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.455 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 63.4 mm-40 -100.03 -55.84 2.53 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.848 2.859 . . . . 1.48 108.952 -166.713 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.22 -9.56 9.51 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-O 123.443 1.579 . . . . 1.12 113.633 -176.154 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.9 mt -72.44 126.4 90.94 Favored Pre-proline 0 N--CA 1.43 -1.452 0 O-C-N 116.779 -3.777 . . . . 2.07 102.287 -175.635 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.85 161.38 46.27 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.667 2.245 . . . . 1.39 112.511 175.105 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -70.05 -12.17 31.84 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 C-N-CA 121.745 1.63 . . . . 1.68 113.477 -172.593 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -75.67 -27.08 58.17 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.422 2.058 . . . . 2.25 109.63 176.436 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -90.61 -20.07 22.98 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.091 -2.881 . . . . 2.44 108.022 -174.979 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -85.78 124.94 32.85 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.595 3.183 . . . . 1.32 119.595 178.911 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.4 ttm105 -109.31 118.71 37.4 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.467 -2.02 . . . . 3.19 110.538 171.654 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.267 66.9 mt -99.06 105.32 17.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 109.257 -0.645 . . . . 1.75 109.257 -178.944 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.7 mt -93.75 118.81 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-N 113.719 -1.582 . . . . 1.98 108.59 -179.343 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -138.54 138.26 37.83 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.158 -1.589 . . . . 1.94 110.772 173.865 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.16 41.61 26.86 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.053 2.941 . . . . 1.67 113.527 173.417 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.63 -18.01 22.21 Favored Glycine 0 N--CA 1.429 -1.789 1 CA-C-O 112.334 -4.592 . . . . 1.3 113.16 -179.832 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 172.3 7.3 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 123.534 3.667 . . . . 2.89 113.595 -178.544 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -104.57 134.84 47.06 Favored 'General case' 0 N--CA 1.431 -1.401 1 O-C-N 115.353 -4.592 . . . . 2.89 109.03 173.863 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.413 ' HB2' HG21 ' A' ' 23' ' ' ILE . 25.4 mt -76.3 155.05 34.59 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 123.842 1.782 . . . . 1.34 114.737 -173.661 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -98.85 141.99 30.94 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 124.78 2.229 . . . . 1.94 107.211 178.737 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -75.81 -41.93 51.34 Favored 'General case' 0 N--CA 1.43 -1.454 1 N-CA-C 124.093 4.849 . . . . 1.56 124.093 -167.018 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.04 0.5 89.02 Favored Glycine 0 N--CA 1.431 -1.665 0 O-C-N 116.563 -3.836 . . . . 0.97 110.856 170.232 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -71.55 151.22 44.03 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 122.465 3.132 . . . . 3.07 111.538 169.542 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.7 p -97.83 167.55 10.86 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.101 1.905 . . . . 1.34 111.684 -177.199 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.5 mt -69.37 -25.41 64.16 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.407 -3.308 . . . . 1.63 111.29 178.038 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.2 t -70.81 -39.56 73.01 Favored 'General case' 0 N--CA 1.431 -1.406 1 C-N-CA 132.845 4.458 . . . . 1.51 112.816 175.7 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -57.92 -34.61 70.05 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 124.858 2.266 . . . . 1.9 113.913 172.826 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -94.53 0.09 55.01 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 114.309 -5.244 . . . . 0.97 112.03 -178.208 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.0 m120 58.66 47.52 12.96 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 119.865 3.283 . . . . 2.35 119.865 -175.15 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.0 mt -83.21 105.91 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 126.336 1.854 . . . . 1.39 109.886 171.28 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -121.9 -48.23 2.14 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 124.213 1.958 . . . . 2.58 112.332 -179.246 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.2 mmtt -78.34 -173.95 3.52 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 112.739 -2.028 . . . . 2.58 115.728 176.907 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -71.44 69.79 0.6 Allowed 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 129.964 3.306 . . . . 1.71 112.796 177.267 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -90.59 158.4 16.99 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.511 3.124 . . . . 1.34 111.639 -175.364 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.8 m -118.66 118.36 31.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 104.496 -2.409 . . . . 1.36 104.496 -173.843 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.1 mt -94.57 148.61 22.08 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 103.33 -2.841 . . . . 2.03 103.33 172.105 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -108.63 112.87 25.44 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 126.032 2.825 . . . . 2.31 106.026 -176.489 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.0 tp -89.65 122.26 32.61 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.993 -3.567 . . . . 1.72 113.507 179.264 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.33 3.2 t -125.52 145.85 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 114.23 -1.35 . . . . 1.8 108.148 -177.067 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.8 tp . . . . . 0 N--CA 1.429 -1.491 0 C-N-CA 130.853 3.661 . . . . 3.26 106.567 -179.954 . . . . . . . . 0 0 . 1 . 053 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ptt? . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 123.816 1.77 . . . . 1.39 107.903 . . . . . . . . . 0 0 . 1 . 053 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -93.44 136.51 33.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 117.067 -3.521 . . . . 2.2 111.523 -179.252 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.2 pt -131.7 161.79 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 117.005 -3.559 . . . . 1.32 104.707 173.771 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -122.04 141.94 50.85 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.767 -1.561 . . . . 2.2 107.888 -170.615 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 t -117.21 120.66 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 103.311 -2.848 . . . . 1.23 103.311 175.748 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -95.81 130.38 42.76 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 119.067 -1.053 . . . . 2.51 108.28 175.409 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.9 p -84.2 -176.13 6.11 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.708 -2.495 . . . . 1.41 115.199 176.788 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mt -68.55 -41.16 80.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 119.805 1.184 . . . . 2.95 109.328 172.086 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -72.59 -13.92 61.5 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 127.972 2.509 . . . . 2.52 107.824 -178.764 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.28 30.53 9.17 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 120.734 1.606 . . . . 1.5 113.577 175.857 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -95.71 134.1 39.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 117.908 -3.113 . . . . 1.79 107.286 -171.412 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.1 m -86.66 90.45 8.27 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 118.537 2.791 . . . . 1.38 118.537 175.449 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.7 mm -79.77 112.01 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 126.977 2.673 . . . . 2.03 109.542 176.204 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.5 m -103.67 113.83 27.65 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 123.279 2.763 . . . . 1.61 109.854 179.788 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -106.63 143.39 34.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.137 -1.602 . . . . 2.15 109.325 -179.511 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -93.3 123.89 36.9 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 104.037 -2.579 . . . . 1.98 104.037 170.246 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 m -133.76 160.44 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-O 115.471 -2.204 . . . . 1.52 108.468 -175.716 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -109.25 160.59 27.03 Favored Pre-proline 0 N--CA 1.43 -1.466 0 N-CA-C 104.899 -2.26 . . . . 2.35 104.899 160.259 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.74 -14.3 24.37 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 C-N-CA 121.788 1.659 . . . . 1.31 113.887 -179.0 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.1 p -75.59 -25.76 57.29 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 114.0 1.111 . . . . 1.71 114.0 173.481 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -62.67 160.53 13.96 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.976 -1.703 . . . . 1.69 114.549 -179.524 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.334 20.4 p -93.67 166.62 12.13 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.939 2.94 . . . . 1.33 118.939 -179.828 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.6 mm -71.3 -34.1 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.311 1.445 . . . . 1.32 111.152 177.386 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -60.04 -34.75 73.82 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.156 2.28 . . . . 1.62 117.156 165.999 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -71.69 -40.42 69.57 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.745 -1.847 . . . . 2.13 113.783 173.67 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.8 t -60.3 -38.81 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 123.709 0.804 . . . . 1.23 111.728 174.228 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -60.74 -40.51 92.69 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.545 -3.222 . . . . 1.97 114.725 164.618 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.75 -33.62 76.29 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.412 1.577 . . . . 1.19 113.634 173.413 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -56.67 -46.89 80.84 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.997 -2.939 . . . . 1.92 117.461 173.22 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.8 mt -67.85 -39.09 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 125.422 2.534 . . . . 1.94 114.333 173.826 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -57.63 -37.93 74.15 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.16 -4.713 . . . . 1.9 111.991 172.256 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -67.05 -35.98 81.04 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.349 2.976 . . . . 1.55 114.045 177.535 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -82.82 -44.49 15.44 Favored 'General case' 0 N--CA 1.429 -1.499 1 O-C-N 115.389 -4.57 . . . . 2.95 108.614 -176.554 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -125.92 -17.13 5.44 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 122.045 2.202 . . . . 1.48 113.186 -166.866 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.05 27.97 7.54 Favored Glycine 0 N--CA 1.43 -1.713 0 CA-C-N 120.861 1.664 . . . . 1.12 113.703 173.171 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.6 mt -99.81 120.4 57.31 Favored Pre-proline 0 N--CA 1.43 -1.467 0 O-C-N 120.014 -1.874 . . . . 2.07 109.104 -172.0 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.74 136.25 61.13 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 C-N-CA 124.899 3.733 . . . . 1.39 112.252 179.624 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -55.94 -15.46 13.58 Favored 'Trans proline' 0 C--N 1.3 -2.008 1 C-N-CA 126.399 4.733 . . . . 1.68 118.219 -177.181 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -76.07 -26.41 56.5 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.735 0.779 . . . . 2.25 111.527 173.748 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -85.2 -30.03 24.23 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.391 2.043 . . . . 2.44 107.63 -177.79 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -74.71 118.18 17.39 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.783 -4.323 . . . . 1.32 112.092 -176.807 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.1 ttm-85 -121.7 116.33 24.33 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.685 -1.969 . . . . 3.19 105.685 170.56 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.5 mt -99.52 130.38 45.77 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.183 -1.043 . . . . 1.75 108.183 -179.772 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.3 mt -113.71 119.54 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 126.818 2.047 . . . . 1.98 112.085 174.715 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.488 ' HB3' HD22 ' A' ' 50' ' ' LEU . 51.6 t80 -114.72 132.11 56.54 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 102.865 -3.013 . . . . 1.94 102.865 174.653 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.39 -94.43 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.417 1 C-N-CA 132.138 4.175 . . . . 1.67 110.079 177.015 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.66 8.61 7.75 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 129.003 3.192 . . . . 1.3 113.059 176.217 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -106.04 137.9 43.16 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 129.5 3.12 . . . . 2.89 111.179 -178.527 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -103.47 113.92 27.79 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 125.543 2.592 . . . . 2.89 106.927 169.863 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.488 HD22 ' HB3' ' A' ' 45' ' ' PHE . 13.6 mt -67.75 126.15 28.48 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.358 -3.338 . . . . 1.34 113.67 -170.707 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -91.06 134.29 34.63 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 114.645 1.35 . . . . 1.94 114.645 174.446 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -47.1 -52.39 15.42 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 119.893 3.294 . . . . 1.56 119.893 -171.785 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.23 68.78 0.96 Allowed Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 113.962 -3.688 . . . . 0.97 111.668 174.86 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.253 84.1 mmt-85 -139.55 164.74 29.11 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 102.53 -3.137 . . . . 3.07 102.53 167.851 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.9 p -93.54 166.34 12.3 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.188 2.423 . . . . 1.34 108.086 173.828 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 mt -59.91 -40.33 88.44 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.444 2.698 . . . . 1.63 108.961 171.079 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.2 t -54.88 -48.61 72.75 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.285 2.234 . . . . 1.51 113.465 176.158 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -50.77 -34.1 25.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 118.595 2.813 . . . . 1.9 118.595 170.791 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -90.48 1.19 56.91 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.151 1.38 . . . . 0.97 110.253 178.203 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.257 4.3 m120 52.08 43.56 30.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.093 2.557 . . . . 2.35 115.157 -174.231 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.436 HD12 HD22 ' A' ' 67' ' ' LEU . 27.4 mt -91.49 115.01 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 127.177 3.37 . . . . 1.39 113.487 177.574 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -95.47 -177.02 3.94 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.213 -2.804 . . . . 2.58 114.805 -176.214 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -62.62 152.45 35.1 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 115.049 -4.782 . . . . 2.58 116.722 169.723 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.331 31.4 mt-10 66.47 18.36 10.81 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.112 -2.243 . . . . 1.71 113.203 174.371 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.3 p -89.96 165.12 14.26 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 127.382 3.468 . . . . 1.34 111.517 -172.87 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.1 m -120.92 108.74 14.26 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 113.337 -5.852 . . . . 1.36 113.177 -177.807 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.436 HD22 HD12 ' A' ' 61' ' ' ILE . 31.0 mt -81.75 137.51 35.34 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 124.905 1.282 . . . . 2.03 113.238 166.794 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -98.33 115.25 28.03 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.904 -0.497 . . . . 2.31 110.323 -177.826 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.9 tp -93.72 112.37 24.23 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 126.197 2.186 . . . . 1.72 106.874 -177.12 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.27 143.42 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 128.468 2.707 . . . . 1.8 104.204 174.972 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.6 mt . . . . . 0 N--CA 1.43 -1.446 0 O-C-N 121.112 -0.992 . . . . 3.26 108.658 175.367 . . . . . . . . 0 0 . 1 . 054 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 108.268 -1.012 . . . . 1.39 108.268 . . . . . . . . . 0 0 . 1 . 054 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -100.62 130.13 46.64 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 115.698 -2.096 . . . . 2.2 112.199 179.766 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.3 pt -129.03 159.33 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 120.099 1.318 . . . . 1.32 107.948 171.798 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -106.81 143.35 35.03 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.341 -1.754 . . . . 2.2 110.456 -176.516 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.2 t -119.35 120.04 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 129.43 3.092 . . . . 1.23 108.328 177.715 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.0 mttp -105.28 141.54 36.63 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 116.06 1.874 . . . . 2.51 116.06 169.87 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 p -95.76 177.72 5.69 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.513 2.325 . . . . 1.41 113.195 177.929 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.6 tp -57.74 -45.74 85.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.052 0.941 . . . . 2.95 113.279 178.278 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.2 p -78.01 -14.13 59.62 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.022 2.344 . . . . 2.52 112.879 -175.148 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.15 30.3 4.82 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 117.148 -3.47 . . . . 1.5 114.997 172.882 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -91.91 111.3 22.78 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.049 -1.575 . . . . 1.79 108.782 -176.317 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 m -83.8 115.24 22.14 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.92 -2.988 . . . . 1.38 109.152 177.201 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.9 mt -101.33 126.73 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 106.85 -1.537 . . . . 2.03 106.85 175.297 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.6 m -104.55 125.39 50.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 102.587 -3.116 . . . . 1.61 102.587 -170.338 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.2 mt -128.35 150.73 49.96 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 126.706 2.002 . . . . 2.15 109.239 -173.83 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -115.93 131.5 56.92 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.844 -0.616 . . . . 1.98 112.074 170.245 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.3 m -144.29 165.78 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 125.363 1.665 . . . . 1.52 108.919 -174.433 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -101.07 153.02 37.99 Favored Pre-proline 0 N--CA 1.43 -1.475 0 O-C-N 117.63 -3.169 . . . . 2.35 111.442 165.294 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -67.74 -13.52 38.95 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 CA-C-N 126.932 3.511 . . . . 1.31 115.795 -173.437 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.1 p -84.22 0.86 47.18 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 131.553 3.941 . . . . 1.71 116.059 171.494 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -76.46 136.45 39.4 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 118.892 -2.38 . . . . 1.69 113.407 170.558 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 p -70.13 152.96 43.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.526 -3.233 . . . . 1.33 108.125 179.419 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.6 mm -57.53 -23.1 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 118.039 2.607 . . . . 1.32 118.039 167.858 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -53.74 -43.65 69.3 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.267 -3.396 . . . . 1.62 115.346 159.443 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.4 m-20 -66.54 -28.94 68.94 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.526 2.584 . . . . 2.13 117.746 177.686 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.3 -41.7 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 113.809 -1.541 . . . . 1.23 111.258 171.017 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.68 -33.8 69.14 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 126.512 1.925 . . . . 1.97 112.628 174.615 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.52 -44.25 84.94 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.051 2.14 . . . . 1.19 111.497 170.02 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -61.49 -38.49 87.5 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.692 2.397 . . . . 1.92 110.937 172.222 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.7 mt -70.48 -37.32 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 O-C-N 117.954 -2.966 . . . . 1.94 115.205 170.336 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -52.92 -46.51 68.11 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.632 2.634 . . . . 1.9 110.991 172.388 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -55.03 -59.76 4.3 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 116.181 -4.075 . . . . 1.55 114.713 172.913 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -69.65 -60.23 2.45 Favored 'General case' 0 N--CA 1.43 -1.461 1 CA-C-O 129.579 4.514 . . . . 2.95 110.592 -174.635 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -80.36 -59.93 2.51 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.672 -4.392 . . . . 1.48 114.046 -172.96 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.57 -16.23 6.26 Favored Glycine 0 N--CA 1.431 -1.695 0 CA-C-O 115.427 -2.874 . . . . 1.12 109.105 -179.483 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.408 ' H ' HG13 ' A' ' 36' ' ' ILE . 19.9 mt -60.92 122.09 66.64 Favored Pre-proline 0 N--CA 1.431 -1.38 0 C-N-CA 126.877 2.071 . . . . 2.07 112.826 -170.363 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.67 142.98 99.3 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 N-CA-C 119.236 2.744 . . . . 1.39 119.236 -176.33 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -80.49 -9.92 13.46 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 115.82 -2.779 . . . . 1.68 115.072 -166.604 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.55 -14.99 57.75 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.116 2.566 . . . . 2.25 113.469 167.635 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -94.68 -32.31 13.43 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.509 -3.245 . . . . 2.44 110.364 178.522 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -62.93 145.29 55.57 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 113.407 -1.724 . . . . 1.32 113.432 179.521 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.442 ' HB2' HG23 ' A' ' 70' ' ' VAL . 92.5 mtt180 -134.91 130.31 35.69 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.534 -2.604 . . . . 3.19 106.127 164.154 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.4 mt -100.4 131.55 46.26 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.944 2.307 . . . . 1.75 108.21 172.902 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.4 mt -120.24 139.98 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 112.081 -2.327 . . . . 1.98 107.111 176.056 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -135.28 134.43 39.93 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 102.447 -3.168 . . . . 1.94 102.447 168.187 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.83 -68.5 0.22 Allowed 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.196 2.903 . . . . 1.67 113.511 177.171 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.69 -47.26 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.763 0 CA-C-O 127.433 3.796 . . . . 1.3 113.702 -174.692 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -73.85 138.86 44.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 127.59 3.567 . . . . 2.89 113.549 -178.021 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -73.58 124.33 25.7 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.905 -2.997 . . . . 2.89 115.032 166.771 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.6 mt -85.51 161.58 19.3 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.955 -1.716 . . . . 1.34 115.1 -178.016 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.282 27.8 mt-10 -104.77 143.45 33.1 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 120.554 3.538 . . . . 1.94 120.554 174.084 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -67.23 -43.57 81.63 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 116.338 -3.976 . . . . 1.56 116.304 -170.182 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.98 15.91 0.65 Allowed Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 130.437 3.875 . . . . 0.97 114.86 173.947 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -120.71 170.93 8.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.13 1.965 . . . . 3.07 111.738 166.557 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.3 p -107.21 177.51 4.83 Favored 'General case' 0 N--CA 1.429 -1.514 1 CA-C-O 128.554 4.026 . . . . 1.34 111.687 176.374 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.7 mt -70.32 -31.75 69.2 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.444 -2.66 . . . . 1.63 108.329 176.377 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -66.7 -41.05 88.63 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.964 -2.335 . . . . 1.51 115.126 -177.823 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -49.61 -45.98 48.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.077 2.151 . . . . 1.9 110.907 173.638 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -85.25 -0.67 55.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.027 2.346 . . . . 0.97 116.272 -178.174 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 56.78 37.42 28.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.04 2.936 . . . . 2.35 115.921 -178.527 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.2 mt -70.39 116.53 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 C-N-CA 128.681 2.792 . . . . 1.39 111.564 173.769 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -89.98 178.01 6.32 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.055 2.142 . . . . 2.58 108.411 174.21 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -67.51 152.89 44.88 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.12 1.914 . . . . 2.58 112.623 177.519 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.268 51.4 mt-10 67.31 27.43 8.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.989 -1.069 . . . . 1.71 113.68 169.434 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.9 m -98.91 144.49 28.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.684 3.194 . . . . 1.34 108.196 -175.253 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.6 m -108.93 120.79 43.56 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.143 -2.848 . . . . 1.36 109.393 -172.29 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -93.07 162.91 13.85 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.416 -1.327 . . . . 2.03 107.416 177.692 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -119.77 132.83 55.73 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.149 1.38 . . . . 2.31 112.968 -179.601 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.0 tp -118.5 116.57 26.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.529 -1.982 . . . . 1.72 109.854 -174.854 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' A' ' 42' ' ' ARG . 3.2 m -117.66 170.36 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 123.351 1.548 . . . . 1.8 110.902 172.516 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.1 mt . . . . . 0 N--CA 1.431 -1.423 0 CA-C-O 124.029 1.871 . . . . 3.26 115.072 174.11 . . . . . . . . 0 0 . 1 . 055 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.49 -1.361 0 CA-C-O 123.375 1.559 . . . . 1.39 109.497 . . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -104.96 142.32 34.99 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.555 -1.341 . . . . 2.2 109.446 -172.335 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.0 pt -131.81 155.05 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 124.723 1.209 . . . . 1.32 107.997 174.557 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.271 64.2 m-85 -108.33 125.27 51.51 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 112.957 0.725 . . . . 2.2 112.957 177.8 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -105.67 122.77 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 119.03 0.832 . . . . 1.23 109.625 173.257 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -94.61 124.57 38.73 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 128.712 2.805 . . . . 2.51 109.707 175.913 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.8 p -77.56 -173.52 2.99 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 127.627 2.371 . . . . 1.41 105.583 -178.55 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.7 mt -59.86 -48.11 83.0 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 129.802 3.241 . . . . 2.95 117.859 169.564 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.1 p -79.36 -15.43 57.91 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.626 3.571 . . . . 2.52 110.627 -179.202 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.14 44.53 5.62 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 126.914 2.197 . . . . 1.5 114.031 176.067 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -95.4 151.52 19.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 104.697 -2.334 . . . . 1.79 104.697 174.788 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.2 m -101.21 112.36 24.83 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 125.764 1.915 . . . . 1.38 112.08 179.795 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 mm -94.76 124.62 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 103.018 -2.956 . . . . 2.03 103.018 172.032 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.7 m -106.44 115.41 30.16 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.337 -3.352 . . . . 1.61 114.678 -178.999 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.259 34.6 mt -112.71 135.5 53.38 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.87 -2.394 . . . . 2.15 110.895 -175.957 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -75.8 116.39 16.45 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.142 -1.429 . . . . 1.98 107.142 161.085 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -127.85 175.74 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.241 1.417 . . . . 1.52 109.76 174.339 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -118.23 156.71 50.4 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-O 124.614 2.15 . . . . 2.35 109.629 167.064 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -71.79 -20.14 26.55 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 O-C-N 113.246 -4.134 . . . . 1.31 111.767 -175.72 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 p -87.36 3.58 46.39 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 130.788 3.635 . . . . 1.71 115.831 175.732 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -83.63 149.21 26.68 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.497 -2.627 . . . . 1.69 106.168 177.36 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.2 p -90.8 168.21 11.9 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 118.006 -0.997 . . . . 1.33 108.464 -177.789 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.417 HG22 HD12 ' A' ' 43' ' ' LEU 0.324 40.9 mm -65.78 -24.61 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 N-CA-C 114.494 1.294 . . . . 1.32 114.494 173.937 . . . . . . . . 3 3 . 1 . 055 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -69.07 -30.41 68.73 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 113.772 -3.013 . . . . 1.62 116.278 163.62 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -76.37 -25.66 54.85 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.207 1.821 . . . . 2.13 108.602 170.687 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.7 -50.25 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 121.879 2.127 . . . . 1.23 114.565 170.822 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -65.72 -34.67 78.73 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 118.454 2.761 . . . . 1.97 118.454 179.75 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.05 -38.87 73.85 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 114.177 -2.821 . . . . 1.19 111.736 168.555 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -66.59 -35.72 80.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 120.709 1.595 . . . . 1.92 114.013 174.28 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 53.8 mt -73.58 -24.28 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 119.777 -1.827 . . . . 1.94 114.803 173.159 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -75.73 -29.98 59.08 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.076 1.762 . . . . 1.9 111.773 172.066 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -72.1 -46.27 57.36 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.468 1.127 . . . . 1.55 112.996 175.831 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -65.17 -75.44 0.09 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 126.176 1.791 . . . . 2.95 111.935 -178.913 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -86.91 -42.31 13.29 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.588 2.355 . . . . 1.48 114.813 -169.532 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.96 31.67 2.22 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 118.277 -1.916 . . . . 1.12 111.948 174.574 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.8 mt -102.09 124.4 40.11 Favored Pre-proline 0 N--CA 1.43 -1.426 0 CA-C-O 114.6 -2.619 . . . . 2.07 113.436 -175.509 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -60.79 138.7 81.03 Favored 'Trans proline' 0 N--CA 1.433 -2.064 0 CA-C-O 114.05 -2.562 . . . . 1.39 114.38 -176.715 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -62.83 -29.17 76.34 Favored 'Trans proline' 0 N--CA 1.434 -2.009 1 C-N-CA 127.49 5.46 . . . . 1.68 114.273 -171.947 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -62.76 -28.95 70.33 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.849 -2.407 . . . . 2.25 112.056 173.057 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -76.36 -13.18 60.15 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 116.785 2.143 . . . . 2.44 116.785 179.092 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -95.39 117.18 29.89 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.013 -3.555 . . . . 1.32 115.26 -172.361 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -107.27 127.09 53.24 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 127.2 2.2 . . . . 3.19 107.946 169.343 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.417 HD12 HG22 ' A' ' 23' ' ' ILE 0.284 65.6 mt -109.49 138.69 45.48 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 105.263 -2.125 . . . . 1.75 105.263 -175.788 . . . . . . . . 3 3 . 1 . 055 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.7 mm -122.37 126.23 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 109.74 -3.391 . . . . 1.98 107.325 179.801 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -120.46 108.93 14.7 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.652 -1.981 . . . . 1.94 105.652 172.317 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.92 -73.22 0.09 Allowed 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 126.526 1.93 . . . . 1.67 109.106 -179.443 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -160.73 7.84 0.11 Allowed Glycine 0 N--CA 1.43 -1.709 0 CA-C-O 124.898 2.388 . . . . 1.3 114.915 -174.039 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -105.78 128.61 53.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 111.585 -2.307 . . . . 2.89 105.842 177.311 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -79.47 138.89 37.72 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.176 -0.952 . . . . 2.89 109.573 170.499 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.3 mt -101.73 126.44 48.59 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 121.649 2.022 . . . . 1.34 111.967 -165.966 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -88.56 156.3 19.14 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.285 -1.746 . . . . 1.94 106.285 178.73 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -76.04 -40.2 53.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 118.748 2.869 . . . . 1.56 118.748 -168.613 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.25 22.85 9.11 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 117.798 -3.064 . . . . 0.97 112.868 177.559 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -108.13 164.37 12.36 Favored 'General case' 0 N--CA 1.431 -1.397 1 O-C-N 116.294 -4.062 . . . . 3.07 106.918 164.786 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.0 p -101.1 168.78 9.37 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.989 2.116 . . . . 1.34 111.662 179.129 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -58.5 -42.86 88.59 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 112.119 -2.31 . . . . 1.63 110.275 169.926 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.388 5.6 t -64.03 -33.39 75.64 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.499 1.954 . . . . 1.51 112.973 -179.013 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -61.18 -34.42 75.04 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 119.834 3.272 . . . . 1.9 119.834 175.016 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -90.74 10.72 24.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 111.957 -2.383 . . . . 0.97 114.169 174.934 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.279 46.7 m-80 65.09 21.45 12.21 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 113.379 -5.825 . . . . 2.35 115.263 -178.878 . . . . . . . . 3 2 . 1 . 055 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.0 mt -75.9 106.74 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 124.777 1.231 . . . . 1.39 112.298 -178.326 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -98.45 -164.91 1.18 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.264 2.226 . . . . 2.58 106.465 -169.655 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.264 44.8 mttp -72.25 141.21 48.94 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.641 -2.537 . . . . 2.58 110.867 173.826 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.254 31.9 mt-10 74.32 15.48 3.53 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 125.956 2.035 . . . . 1.71 112.872 172.192 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.32 50.1 m -84.16 145.79 28.2 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.162 -3.461 . . . . 1.34 110.819 -172.165 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.0 m -97.35 118.9 34.86 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.161 2.184 . . . . 1.36 106.14 -175.552 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.3 mp -107.06 145.51 32.31 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.225 2.61 . . . . 2.03 111.854 171.902 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -119.36 139.28 52.23 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.455 -2.054 . . . . 2.31 105.455 -174.989 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tt -107.67 124.48 50.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 113.82 -1.536 . . . . 1.72 107.979 -173.948 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.2 t -116.68 132.53 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 CA-C-O 129.171 4.32 . . . . 1.8 105.035 174.345 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.431 -1.423 0 O-C-N 116.633 -3.792 . . . . 3.26 108.994 175.746 . . . . . . . . 0 0 . 1 . 056 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 CA--C 1.49 -1.327 0 CA-C-O 122.367 1.08 . . . . 1.39 110.552 . . . . . . . . . 0 0 . 1 . 056 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -111.65 136.91 50.23 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 117.477 -1.249 . . . . 2.2 109.831 -169.467 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.6 pt -135.56 159.39 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 122.489 2.404 . . . . 1.32 105.806 171.526 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -109.49 145.1 36.81 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.372 2.269 . . . . 2.2 107.781 -173.616 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.3 t -124.64 132.53 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.206 -1.776 . . . . 1.23 106.206 168.613 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 mmtm -97.09 143.59 27.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 104.975 -2.231 . . . . 2.51 104.975 169.472 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.7 p -90.36 -165.04 1.26 Allowed 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 130.272 3.429 . . . . 1.41 111.192 176.128 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.353 0.6 OUTLIER -64.63 -46.98 80.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 130.298 3.439 . . . . 2.95 113.042 175.992 . . . . . . . . 3 3 . 1 . 056 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.3 p -92.84 -37.34 12.35 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 126.381 2.991 . . . . 2.52 115.634 -178.6 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.05 -2.52 1.01 Allowed Glycine 0 N--CA 1.43 -1.721 0 O-C-N 116.301 -3.999 . . . . 1.5 117.701 178.215 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -74.92 120.97 21.19 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 122.7 3.25 . . . . 1.79 105.022 -166.905 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.7 m -71.17 117.23 12.42 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 126.56 2.413 . . . . 1.38 113.91 176.591 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.3 mm -98.84 138.68 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 117.08 -1.848 . . . . 2.03 107.78 173.522 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.4 m -106.3 112.81 25.99 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.702 2.001 . . . . 1.61 111.911 179.692 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.7 mt -108.57 144.26 36.5 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 116.177 -4.077 . . . . 2.15 115.268 175.141 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -90.85 123.71 34.6 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.172 1.789 . . . . 1.98 107.85 166.858 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 m -138.53 154.0 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 121.605 0.717 . . . . 1.52 109.639 -179.165 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -101.55 162.36 20.69 Favored Pre-proline 0 N--CA 1.429 -1.489 0 CA-C-O 115.597 -2.144 . . . . 2.35 109.603 167.365 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -81.7 -8.05 12.43 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 125.846 3.124 . . . . 1.31 112.089 178.694 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 p -81.13 -15.68 55.18 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.613 -0.721 . . . . 1.71 111.902 176.165 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -61.77 143.71 55.85 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 124.964 2.316 . . . . 1.69 115.376 178.933 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.0 p -90.58 165.25 13.86 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 115.759 -4.338 . . . . 1.33 108.664 178.5 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.5 mm -71.98 -22.03 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-O 122.76 1.266 . . . . 1.32 109.961 -178.933 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -61.48 -35.36 77.44 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.075 -2.891 . . . . 1.62 118.07 160.681 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -76.53 -30.87 57.33 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 116.83 -3.669 . . . . 2.13 111.697 172.634 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.98 -41.92 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 O-C-N 120.156 -1.59 . . . . 1.23 111.809 179.982 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -61.35 -41.3 96.82 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.118 -2.239 . . . . 1.97 111.783 176.888 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.71 -39.6 81.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 126.538 2.399 . . . . 1.19 111.731 178.871 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.265 51.8 mttm -57.82 -53.94 52.48 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.102 -2.248 . . . . 1.92 110.333 173.465 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.253 64.8 mt -52.15 -41.4 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 130.122 3.369 . . . . 1.94 109.241 178.309 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -66.52 -50.82 61.93 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 130.261 3.424 . . . . 1.9 111.372 174.975 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -49.28 -45.54 45.17 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 124.13 3.15 . . . . 1.55 114.009 169.423 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -75.46 -66.56 0.76 Allowed 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 127.607 2.363 . . . . 2.95 114.137 -177.52 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -96.47 -18.46 19.84 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 117.508 2.41 . . . . 1.48 117.508 -173.042 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.51 46.84 5.36 Favored Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 118.696 2.238 . . . . 1.12 118.696 -177.731 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.46 HD11 HD22 ' A' ' 69' ' ' LEU . 55.8 mt -119.14 129.09 25.58 Favored Pre-proline 0 N--CA 1.43 -1.465 0 CA-C-O 111.704 -3.998 . . . . 2.07 106.376 -174.14 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -64.1 152.14 82.34 Favored 'Trans proline' 0 N--CA 1.433 -2.059 0 CA-C-O 112.132 -3.362 . . . . 1.39 119.896 172.122 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -81.4 -23.53 5.01 Favored 'Trans proline' 0 N--CA 1.433 -2.046 0 CA-C-N 127.253 3.626 . . . . 1.68 112.466 -166.484 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -56.43 -31.67 64.15 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.448 2.699 . . . . 2.25 110.663 175.126 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -93.52 6.97 46.44 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 111.184 -2.735 . . . . 2.44 108.44 -170.09 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -122.11 126.67 48.88 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 122.536 2.426 . . . . 1.32 109.4 -174.285 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -109.47 150.27 28.36 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 116.856 -1.545 . . . . 3.19 110.117 158.975 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.4 mt -125.8 136.06 52.7 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 107.468 -1.308 . . . . 1.75 107.468 176.295 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.9 mm -112.43 124.44 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 128.054 2.541 . . . . 1.98 111.397 -178.787 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -114.31 128.09 56.18 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 122.517 2.417 . . . . 1.94 108.901 168.673 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.66 -85.06 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.56 1.544 . . . . 1.67 110.125 -171.574 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -164.19 43.55 0.31 Allowed Glycine 0 N--CA 1.429 -1.78 0 O-C-N 121.091 -1.006 . . . . 1.3 111.929 178.079 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -135.26 135.83 41.2 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.16 2.184 . . . . 2.89 110.253 -179.768 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -89.32 116.08 27.27 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 114.505 1.298 . . . . 2.89 114.505 175.886 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.5 mt -67.88 160.51 28.3 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.981 2.324 . . . . 1.34 113.308 -168.447 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -103.98 135.11 46.11 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.863 -2.426 . . . . 1.94 109.868 172.519 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.261 2.9 m-20 -56.17 -49.38 74.16 Favored 'General case' 0 N--CA 1.43 -1.439 1 C-N-CA 132.311 4.244 . . . . 1.56 113.528 -172.913 . . . . . . . . 3 2 . 1 . 056 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.2 50.63 2.76 Favored Glycine 0 N--CA 1.43 -1.767 0 N-CA-C 119.689 2.636 . . . . 0.97 119.689 171.226 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -124.03 164.1 20.06 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.233 1.968 . . . . 3.07 106.136 163.062 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.6 p -106.12 164.01 12.33 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.211 -2.268 . . . . 1.34 113.859 175.117 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.4 mt -50.08 -37.52 34.13 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.712 -3.742 . . . . 1.63 114.518 168.566 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -64.25 -26.33 68.45 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.257 2.317 . . . . 1.51 117.257 176.703 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -70.15 -51.4 31.62 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.387 1.475 . . . . 1.9 108.036 177.805 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -76.89 2.7 13.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.057 2.143 . . . . 0.97 113.05 179.753 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.508 1.1 m-80 60.42 39.62 18.28 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.334 1.646 . . . . 2.35 114.096 179.778 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.4 mt -90.85 118.87 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 126.054 2.835 . . . . 1.39 113.241 -177.267 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -101.5 -167.37 1.41 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.159 -3.463 . . . . 2.58 113.8 -177.068 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.256 13.7 ptmt -58.5 153.97 14.95 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.851 -2.405 . . . . 2.58 116.329 174.759 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 49.0 42.49 20.87 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 129.745 3.218 . . . . 1.71 113.741 173.149 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.6 m -92.47 142.72 27.1 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 130.749 3.619 . . . . 1.34 105.535 -179.095 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.2 m -104.73 117.41 34.02 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.142 -2.17 . . . . 1.36 105.142 -175.012 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -98.34 162.91 12.93 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 131.521 3.928 . . . . 2.03 110.045 171.05 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -123.08 126.36 46.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.083 -3.511 . . . . 2.31 111.472 -178.939 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.46 HD22 HD11 ' A' ' 36' ' ' ILE . 52.4 tp -95.9 113.92 25.59 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 107.07 -1.455 . . . . 1.72 107.07 -176.415 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.0 t -104.58 143.66 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 101.197 -3.631 . . . . 1.8 101.197 176.526 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.4 mt . . . . . 0 N--CA 1.43 -1.446 0 C-N-CA 113.181 -3.408 . . . . 3.26 110.927 -179.925 . . . . . . . . 0 0 . 1 . 057 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 116.883 -1.532 . . . . 1.39 111.724 . . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -97.17 140.67 31.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 127.273 3.416 . . . . 2.2 109.416 -174.66 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.0 pt -123.44 160.73 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 124.814 2.245 . . . . 1.32 110.996 171.323 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -108.91 143.08 38.62 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.234 -4.041 . . . . 2.2 111.419 -179.265 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.8 t -110.91 123.79 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.243 -3.411 . . . . 1.23 108.043 174.199 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 11' ' ' LYS . 73.9 tttt -119.45 138.89 52.83 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.033 1.397 . . . . 2.51 108.563 -178.618 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.0 p -103.69 168.98 8.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.438 -1.414 . . . . 1.41 108.176 -178.067 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.2 tp -66.34 -42.46 88.11 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.955 1.302 . . . . 2.95 112.285 172.464 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.6 p -76.89 -18.52 58.27 Favored 'General case' 0 N--CA 1.43 -1.463 1 CA-C-O 128.968 4.223 . . . . 2.52 110.064 -171.35 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.15 26.95 1.28 Allowed Glycine 0 N--CA 1.43 -1.727 1 O-C-N 116.004 -4.185 . . . . 1.5 118.002 166.285 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 63.4 tttt -91.98 133.87 35.32 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 117.258 -1.353 . . . . 1.79 110.241 -179.814 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m -122.43 105.94 10.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 125.627 1.83 . . . . 1.38 115.762 168.966 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 pt -114.79 164.92 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 125.92 2.771 . . . . 2.03 105.191 179.778 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.7 m -112.37 135.18 53.37 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.875 -3.015 . . . . 1.61 112.544 -178.37 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.8 mt -115.78 154.74 29.09 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.888 -1.758 . . . . 2.15 109.887 172.393 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -112.73 120.52 41.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.333 -1.48 . . . . 1.98 110.864 167.273 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.4 m -125.28 175.11 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 124.354 2.026 . . . . 1.52 108.427 178.508 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -114.29 171.96 3.98 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 104.7 -2.333 . . . . 2.35 104.7 164.075 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -83.38 -9.51 10.29 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 N-CA-C 107.174 -1.895 . . . . 1.31 107.174 -176.314 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.4 m -95.82 6.35 49.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.608 1.963 . . . . 1.71 115.415 173.48 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -77.09 153.8 33.96 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 104.727 -2.323 . . . . 1.69 104.727 170.296 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.5 p -86.95 162.1 17.87 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 116.158 -4.089 . . . . 1.33 110.218 168.904 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.306 23.1 mm -65.97 -38.89 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 118.159 -2.838 . . . . 1.32 111.31 179.17 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -50.79 -38.12 46.38 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 127.182 3.373 . . . . 1.62 117.597 166.941 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -75.07 -26.38 59.31 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.519 3.128 . . . . 2.13 110.915 172.792 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.38 -34.33 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 123.334 2.788 . . . . 1.23 109.547 170.831 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -70.49 -36.52 73.88 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.528 -1.983 . . . . 1.97 113.838 175.982 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.84 76.91 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 115.724 1.75 . . . . 1.19 115.724 173.278 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -58.26 -37.36 74.8 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.981 2.113 . . . . 1.92 111.964 175.018 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.3 mt -75.94 -29.12 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 1 O-C-N 115.676 -4.39 . . . . 1.94 110.357 174.717 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -69.05 -42.3 76.46 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 116.797 -3.689 . . . . 1.9 115.155 168.885 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.337 23.2 t70 -55.03 -49.18 72.2 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.238 -2.164 . . . . 1.55 112.396 168.811 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -70.49 -69.04 0.38 Allowed 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.011 -1.681 . . . . 2.95 113.753 -177.388 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -91.44 -48.71 6.73 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 112.287 -2.233 . . . . 1.48 110.187 -167.387 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.1 32.63 3.21 Favored Glycine 0 N--CA 1.429 -1.773 0 CA-C-O 125.183 2.546 . . . . 1.12 114.837 -179.037 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.8 mt -92.65 129.22 41.14 Favored Pre-proline 0 N--CA 1.43 -1.444 0 N-CA-C 102.49 -3.152 . . . . 2.07 102.49 -177.222 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -76.74 139.37 19.86 Favored 'Trans proline' 0 N--CA 1.433 -2.053 0 CA-C-O 114.156 -2.518 . . . . 1.39 112.737 -178.954 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -68.57 0.04 5.31 Favored 'Trans proline' 0 N--CA 1.433 -2.058 1 C-N-CA 125.624 4.216 . . . . 1.68 112.014 -169.501 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -64.92 -42.81 94.4 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.806 1.289 . . . . 2.25 113.097 166.36 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -75.49 -27.07 58.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.132 2.396 . . . . 2.44 111.034 -176.243 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -81.88 122.26 27.51 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 119.995 3.331 . . . . 1.32 119.995 -169.088 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -116.41 136.68 52.78 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 131.242 3.817 . . . . 3.19 108.976 170.453 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.9 mt -120.13 113.58 20.68 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.425 -4.547 . . . . 1.75 113.513 178.392 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.1 mm -102.19 143.01 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 126.889 3.233 . . . . 1.98 105.765 173.425 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.416 ' HB3' HD23 ' A' ' 50' ' ' LEU . 59.1 t80 -132.66 125.3 30.02 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 115.3 -4.625 . . . . 1.94 110.111 162.866 . . . . . . . . 3 3 . 1 . 057 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.43 ' HB1' ' H ' ' A' ' 47' ' ' GLY . . . 61.63 -95.15 0.05 OUTLIER 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 124.171 1.938 . . . . 1.67 112.615 -172.428 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.43 ' H ' ' HB1' ' A' ' 46' ' ' ALA . . . -138.74 20.16 3.1 Favored Glycine 0 N--CA 1.43 -1.757 0 O-C-N 119.208 -2.182 . . . . 1.3 111.3 176.352 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -111.85 135.35 52.59 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 128.675 2.79 . . . . 2.89 109.887 175.752 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -86.76 101.01 12.91 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 129.667 3.187 . . . . 2.89 109.591 168.921 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.416 HD23 ' HB3' ' A' ' 45' ' ' PHE . 21.1 mt -72.11 122.08 20.36 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.397 2.679 . . . . 1.34 112.781 -169.194 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -75.11 133.55 41.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 116.414 2.005 . . . . 1.94 116.414 174.786 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -45.52 -55.1 6.59 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 131.252 3.821 . . . . 1.56 116.298 -174.484 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.68 9.61 58.73 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 118.171 2.028 . . . . 0.97 118.171 173.491 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -91.58 165.51 13.3 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 121.836 2.818 . . . . 3.07 109.496 164.712 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.268 30.3 p -94.02 177.64 5.91 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.785 -1.197 . . . . 1.34 113.059 178.411 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mt -75.03 -27.95 60.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.65 2.643 . . . . 1.63 115.289 171.635 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.4 t -68.07 -39.94 82.83 Favored 'General case' 0 N--CA 1.429 -1.481 1 C-N-CA 132.575 4.35 . . . . 1.51 117.13 175.588 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.288 2.5 m-20 -55.52 -46.91 76.96 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.741 2.816 . . . . 1.9 109.567 175.955 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -83.34 -1.07 52.43 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 126.549 1.94 . . . . 0.97 116.105 176.155 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 63.26 47.34 4.09 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 128.877 2.871 . . . . 2.35 112.36 175.503 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.8 mt -85.52 130.25 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 127.676 2.39 . . . . 1.39 110.799 178.762 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -115.84 175.37 5.57 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 116.267 -4.021 . . . . 2.58 112.061 -173.632 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -50.38 146.65 5.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.899 -2.376 . . . . 2.58 114.423 169.116 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 63.43 23.02 13.52 Favored 'General case' 0 N--CA 1.43 -1.461 2 C-N-CA 132.773 4.429 . . . . 1.71 111.757 176.927 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -91.15 155.21 18.79 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 116.927 -3.608 . . . . 1.34 107.034 -178.588 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.4 m -103.41 116.12 31.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.123 -1.399 . . . . 1.36 112.062 -177.753 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -97.11 136.15 38.06 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 102.65 -3.093 . . . . 2.03 102.65 172.848 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -101.72 101.82 12.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.521 1.928 . . . . 2.31 110.377 -175.233 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.1 tp -80.18 124.85 29.15 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 125.93 2.019 . . . . 1.72 110.323 -179.242 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.9 t -126.58 124.14 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.183 -1.826 . . . . 1.8 107.249 -169.471 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.3 mt . . . . . 0 N--CA 1.43 -1.443 0 C-N-CA 117.943 -1.503 . . . . 3.26 114.709 -177.484 . . . . . . . . 0 0 . 1 . 058 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 123.649 1.69 . . . . 1.39 110.639 . . . . . . . . . 0 0 . 1 . 058 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -85.19 121.68 28.29 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.05 -2.906 . . . . 2.2 109.691 -176.817 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -118.83 171.59 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 125.392 2.52 . . . . 1.32 107.848 168.272 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -129.42 129.68 45.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 111.706 -2.497 . . . . 2.2 111.808 179.938 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.6 t -110.94 115.96 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 113.254 -1.794 . . . . 1.23 107.113 169.497 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -97.19 140.98 30.87 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 125.125 2.393 . . . . 2.51 107.786 175.464 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.0 p -82.17 178.64 8.16 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.973 -1.704 . . . . 1.41 114.494 179.796 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.2 tp -54.33 -47.0 73.01 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 116.169 -4.082 . . . . 2.95 112.423 167.556 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 p -71.65 -26.89 62.73 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.729 -3.732 . . . . 2.52 111.374 -178.424 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.1 26.93 6.09 Favored Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 126.491 1.996 . . . . 1.5 112.033 -178.02 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -83.19 128.38 34.44 Favored 'General case' 0 N--CA 1.43 -1.474 2 O-C-N 116.287 -4.067 . . . . 1.79 108.386 176.441 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -99.02 113.29 25.4 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 128.333 3.921 . . . . 1.38 109.979 -176.377 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mt -91.95 126.71 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 111.11 -2.768 . . . . 2.03 108.996 176.111 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.6 t -98.89 143.31 29.34 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 119.95 1.25 . . . . 1.61 111.174 172.958 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.9 mt -136.97 158.1 45.24 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.587 2.755 . . . . 2.15 108.592 -177.828 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -111.33 121.1 44.36 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.479 -1.388 . . . . 1.98 107.819 166.057 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.03 159.32 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 126.491 3.043 . . . . 1.52 106.488 -172.724 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -112.01 149.17 40.47 Favored Pre-proline 0 N--CA 1.43 -1.475 1 O-C-N 116.067 -4.145 . . . . 2.35 108.186 165.239 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -72.31 -9.42 24.28 Favored 'Trans proline' 0 C--N 1.299 -2.031 2 O-C-N 112.925 -4.303 . . . . 1.31 115.671 -173.526 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.7 p -89.03 2.98 53.2 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 111.656 -2.52 . . . . 1.71 111.364 177.795 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -78.3 157.95 29.03 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.65 2.092 . . . . 1.69 116.65 172.864 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -95.87 160.12 14.63 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.015 2.816 . . . . 1.33 110.184 169.844 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 mm -54.83 -32.03 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 117.447 -3.283 . . . . 1.32 115.561 166.385 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -51.29 -59.86 3.75 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 116.692 2.108 . . . . 1.62 116.692 160.901 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -54.26 -37.44 64.7 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 117.768 2.507 . . . . 2.13 117.768 174.476 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.4 t -56.54 -42.34 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 126.86 2.064 . . . . 1.23 115.1 167.46 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -68.82 -24.2 64.35 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 115.577 1.695 . . . . 1.97 115.577 174.915 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.34 83.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 116.795 -1.574 . . . . 1.19 112.901 166.349 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -68.23 -35.45 77.96 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 128.726 3.766 . . . . 1.92 115.999 -179.573 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.2 mt -79.98 -32.25 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 C-N-CA 128.634 2.773 . . . . 1.94 113.535 170.931 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -62.96 -51.53 66.53 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 115.781 -4.324 . . . . 1.9 114.058 167.155 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -52.18 -43.85 64.36 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.34 1.978 . . . . 1.55 116.34 169.145 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -84.83 -63.82 1.27 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.066 -1.646 . . . . 2.95 113.944 -177.898 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -96.62 -39.19 9.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.752 2.215 . . . . 1.48 115.86 -174.151 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.61 44.92 2.4 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 116.79 -3.694 . . . . 1.12 113.626 169.604 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.7 mt -103.95 130.84 22.67 Favored Pre-proline 0 N--CA 1.43 -1.451 1 N-CA-C 99.775 -4.157 . . . . 2.07 99.775 -174.489 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -54.16 135.15 63.54 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-O 112.205 -3.331 . . . . 1.39 116.058 -179.571 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.64 -26.12 63.33 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 CA-C-N 127.052 3.554 . . . . 1.68 119.863 -178.988 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -68.67 -37.29 79.5 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.378 -1.283 . . . . 2.25 113.727 177.634 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -73.1 -27.48 61.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.609 -3.182 . . . . 2.44 115.105 178.307 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -68.49 129.49 40.08 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.377 3.473 . . . . 1.32 120.377 177.526 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -127.92 114.99 17.87 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.66 1.984 . . . . 3.19 111.715 168.9 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.71 130.16 34.59 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 125.881 1.988 . . . . 1.75 108.248 176.949 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.1 mm -127.41 123.3 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 125.985 2.053 . . . . 1.98 108.131 177.101 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -123.3 124.06 42.14 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.648 1.69 . . . . 1.94 108.945 171.948 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.89 -92.85 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.503 2.721 . . . . 1.67 116.05 -172.886 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.31 -38.18 1.68 Allowed Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 126.462 1.982 . . . . 1.3 113.505 -177.854 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -82.39 146.83 29.13 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 129.897 3.279 . . . . 2.89 116.039 -172.304 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -92.49 141.09 28.89 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 118.966 -2.334 . . . . 2.89 108.953 171.801 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.7 mt -98.4 128.43 44.78 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 104.418 -2.438 . . . . 1.34 104.418 -168.922 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.55 140.63 32.14 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.672 2.389 . . . . 1.94 112.936 173.396 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -56.57 -54.44 45.88 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.34 3.089 . . . . 1.56 119.34 -172.179 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.02 8.44 63.33 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 115.278 -2.957 . . . . 0.97 117.505 175.106 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -78.88 158.21 28.14 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 122.732 3.266 . . . . 3.07 115.124 163.041 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.7 p -89.4 156.59 18.58 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 122.758 2.526 . . . . 1.34 113.351 173.141 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.0 mt -53.8 -36.86 62.92 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.104 -0.953 . . . . 1.63 111.675 166.361 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -54.19 -48.05 71.39 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.232 -2.168 . . . . 1.51 113.863 -178.841 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -45.69 -43.93 13.07 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 119.984 3.327 . . . . 1.9 119.984 171.786 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -96.75 3.54 52.29 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.203 2.601 . . . . 0.97 111.176 178.944 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.4 m120 54.88 47.29 22.6 Favored 'General case' 0 N--CA 1.431 -1.384 0 O-C-N 119.32 -2.113 . . . . 2.35 112.862 -176.092 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.3 mt -80.5 117.5 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 122.184 2.265 . . . . 1.39 110.274 177.481 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -110.32 176.86 4.89 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 120.13 1.332 . . . . 2.58 108.423 -168.43 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.377 45.5 pttt -54.27 128.46 31.4 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 131.555 3.942 . . . . 2.58 115.172 174.191 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 64.17 48.18 3.02 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 128.021 2.528 . . . . 1.71 109.269 175.758 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.2 p -92.12 173.45 7.83 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.806 -3.059 . . . . 1.34 113.35 178.117 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.1 m -120.88 114.86 22.18 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.281 -2.137 . . . . 1.36 112.317 173.201 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -105.11 155.1 19.32 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.062 1.745 . . . . 2.03 108.522 175.575 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -118.42 130.64 56.09 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 126.543 2.402 . . . . 2.31 105.179 -174.763 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.2 tp -99.38 117.77 34.53 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.411 1.084 . . . . 1.72 112.981 175.524 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.8 t -102.97 129.85 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-O 123.896 1.808 . . . . 1.8 109.134 172.6 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.4 mt . . . . . 0 N--CA 1.43 -1.471 0 O-C-N 117.939 -2.976 . . . . 3.26 108.522 178.087 . . . . . . . . 0 0 . 1 . 059 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 CA--C 1.491 -1.319 0 CA-C-O 122.992 1.377 . . . . 1.39 113.882 . . . . . . . . . 0 0 . 1 . 059 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -85.9 135.18 33.79 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.21 1.804 . . . . 2.2 110.175 -174.565 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 pt -135.97 161.01 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 120.003 -1.686 . . . . 1.32 111.815 174.199 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -118.04 141.43 48.47 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.161 -2.212 . . . . 2.2 107.819 -179.268 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 t -116.88 130.11 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 126.064 2.102 . . . . 1.23 107.185 173.566 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -115.06 123.44 49.02 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.133 -3.479 . . . . 2.51 113.722 179.02 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.3 p -68.0 171.22 7.08 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 124.522 2.106 . . . . 1.41 112.038 178.161 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 tp -71.77 -27.37 62.91 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 117.912 -2.993 . . . . 2.95 110.403 174.622 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 p -73.6 -30.32 62.92 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.758 -3.714 . . . . 2.52 106.46 178.546 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.26 -21.22 2.96 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 125.289 3.677 . . . . 1.5 113.041 -179.433 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -57.11 117.41 4.0 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 126.874 2.07 . . . . 1.79 114.185 -177.159 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.8 m -107.64 114.82 29.06 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.169 -1.789 . . . . 1.38 106.169 -179.798 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.9 pt -104.61 161.64 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 125.839 1.962 . . . . 2.03 105.883 -178.162 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -117.24 121.13 40.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.711 2.004 . . . . 1.61 108.861 -174.48 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.6 mt -122.99 164.42 18.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 126.289 2.947 . . . . 2.15 110.974 -177.657 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -129.0 132.4 47.52 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 116.406 -3.934 . . . . 1.98 110.884 174.828 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.7 m -137.59 -175.45 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-O 128.377 3.942 . . . . 1.52 112.047 -179.818 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -122.88 147.32 50.83 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-N 112.157 -2.292 . . . . 2.35 110.572 166.084 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -65.6 -20.09 60.07 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 O-C-N 114.036 -3.718 . . . . 1.31 115.276 -178.783 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.6 p -70.64 -21.92 62.57 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 117.45 -3.281 . . . . 1.71 112.154 177.862 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -62.86 146.7 52.16 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.994 2.961 . . . . 1.69 118.994 178.395 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.8 p -85.58 151.64 23.76 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 124.895 1.278 . . . . 1.33 108.191 177.358 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.2 mm -54.0 -41.34 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 129.225 3.01 . . . . 1.32 113.063 -179.884 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -44.56 -53.17 7.36 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 118.612 2.819 . . . . 1.62 118.612 161.777 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -50.8 -32.15 19.15 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 126.537 1.935 . . . . 2.13 113.693 174.096 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.9 t -77.44 -42.7 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 107.243 -1.391 . . . . 1.23 107.243 -177.305 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.402 ' HA ' HD12 ' A' ' 30' ' ' ILE . 40.8 mtmt -60.16 -42.3 94.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 120.393 1.451 . . . . 1.97 112.79 174.744 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.85 -20.53 65.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.594 1.558 . . . . 1.19 110.227 177.915 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -80.11 -40.79 26.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.969 2.319 . . . . 1.92 112.878 174.545 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 27' ' ' LYS . 33.2 mt -51.52 -42.57 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.551 -2.593 . . . . 1.94 113.65 165.68 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -54.17 -47.76 71.64 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.339 2.656 . . . . 1.9 113.613 177.559 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -56.71 -42.51 79.3 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.816 2.046 . . . . 1.55 115.058 170.884 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -74.26 -48.56 27.9 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.671 1.988 . . . . 2.95 114.654 -179.213 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -115.85 -15.09 11.3 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 123.911 1.815 . . . . 1.48 114.264 -171.061 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.17 21.67 32.1 Favored Glycine 0 N--CA 1.429 -1.789 1 O-C-N 113.848 -5.533 . . . . 1.12 113.012 171.394 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 mt -98.69 124.02 47.67 Favored Pre-proline 0 N--CA 1.431 -1.42 0 O-C-N 120.626 -1.514 . . . . 2.07 107.009 -175.328 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -67.97 152.54 76.77 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 C-N-CA 124.302 3.335 . . . . 1.39 113.779 178.043 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -82.47 -15.84 8.45 Favored 'Trans proline' 0 N--CA 1.433 -2.052 0 C-N-CA 123.704 2.936 . . . . 1.68 113.321 -163.304 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -72.7 -27.76 62.26 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 129.981 4.551 . . . . 2.25 113.889 175.333 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -82.03 -20.54 38.13 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.046 2.355 . . . . 2.44 112.522 179.132 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.276 76.8 mt-30 -97.11 145.39 26.04 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 127.805 3.669 . . . . 1.32 109.786 -171.867 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -139.18 122.58 17.18 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.101 -2.249 . . . . 3.19 113.903 172.539 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.2 mt -92.44 120.85 33.34 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.414 -1.428 . . . . 1.75 112.866 -176.299 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.5 mt -112.7 130.15 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 129.981 3.313 . . . . 1.98 107.92 -175.537 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -138.3 135.15 35.16 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.744 -1.222 . . . . 1.94 110.206 177.872 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.01 46.96 25.71 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.824 3.202 . . . . 1.67 116.675 179.592 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.17 -44.28 3.35 Favored Glycine 0 N--CA 1.43 -1.717 0 O-C-N 118.617 -2.552 . . . . 1.3 117.479 -177.147 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -86.67 159.5 19.17 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 118.89 1.345 . . . . 2.89 114.498 -176.228 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -83.54 135.01 34.8 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.411 -0.813 . . . . 2.89 109.501 174.497 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 mt -87.7 148.1 24.92 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.759 -1.2 . . . . 1.34 107.759 -179.011 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -99.69 134.54 42.44 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.26 -2.775 . . . . 1.94 110.027 -179.619 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -68.36 -25.86 65.29 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 117.692 2.478 . . . . 1.56 117.692 -167.626 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.05 14.76 64.13 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 115.617 -3.183 . . . . 0.97 117.662 169.091 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -96.84 176.51 5.95 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.991 1.377 . . . . 3.07 108.157 170.005 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.5 p -102.6 -174.72 2.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 116.328 -3.982 . . . . 1.34 117.182 177.648 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.259 60.2 mt -77.33 -38.54 50.17 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.632 -2.542 . . . . 1.63 111.255 174.301 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.1 p -72.28 -15.12 61.9 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 128.369 3.543 . . . . 1.51 118.387 179.012 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -66.09 -29.66 70.02 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.127 -1.608 . . . . 1.9 113.672 168.921 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -102.96 6.46 38.92 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 122.851 1.31 . . . . 0.97 109.83 -177.231 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.8 m120 55.45 35.41 25.01 Favored 'General case' 0 N--CA 1.431 -1.38 1 O-C-N 116.279 -4.013 . . . . 2.35 114.746 -173.507 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.9 mt -68.72 118.03 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.943 1.297 . . . . 1.39 113.475 175.073 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -115.55 -175.85 2.8 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 130.97 3.708 . . . . 2.58 112.859 -178.864 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -67.07 139.12 57.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.247 2.927 . . . . 2.58 110.894 -176.224 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.446 25.3 mt-10 85.38 9.07 0.35 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 111.439 -2.619 . . . . 1.71 116.015 176.652 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.0 m -74.23 133.43 42.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.859 -1.776 . . . . 1.34 114.371 -173.282 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.5 m -99.99 109.99 22.32 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 104.651 -2.351 . . . . 1.36 104.651 -169.595 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.19 151.47 19.44 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.274 2.23 . . . . 2.03 109.134 172.306 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -109.34 108.18 18.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 123.598 1.666 . . . . 2.31 112.228 -179.06 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.4 tp -85.08 120.38 26.52 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.516 2.103 . . . . 1.72 109.412 178.178 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.366 31.3 m -114.67 148.25 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 117.17 -3.456 . . . . 1.8 112.611 171.702 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.286 62.1 mt . . . . . 0 N--CA 1.43 -1.455 0 CA-C-O 125.986 2.803 . . . . 3.26 108.829 -179.076 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.295 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.359 0 CA-C-O 125.099 2.381 . . . . 1.39 115.096 . . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -87.78 128.5 35.32 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.46 -3.9 . . . . 2.2 111.475 179.317 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.7 pt -126.66 172.96 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 117.07 -3.519 . . . . 1.32 106.603 169.612 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -127.17 135.65 50.99 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 123.519 0.728 . . . . 2.2 110.861 -176.864 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.2 t -117.37 117.94 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 101.342 -3.577 . . . . 1.23 101.342 176.774 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.7 tttp -101.73 148.2 25.56 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.625 -3.797 . . . . 2.51 113.54 174.84 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 p -97.28 171.59 8.33 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.542 2.591 . . . . 1.41 108.751 176.946 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.6 mt -83.47 -4.79 58.84 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.811 -2.43 . . . . 2.95 114.205 172.544 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.2 p -88.83 -30.44 18.94 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 115.723 -2.084 . . . . 2.52 105.467 178.947 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.11 -2.17 10.69 Favored Glycine 0 N--CA 1.43 -1.754 1 O-C-N 129.471 4.232 . . . . 1.5 115.89 170.941 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -72.47 140.61 48.36 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.859 -1.163 . . . . 1.79 107.859 -176.421 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.6 m -108.3 124.58 50.55 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.848 -2.649 . . . . 1.38 103.848 177.419 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.3 mm -101.55 116.81 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 119.237 -2.165 . . . . 2.03 109.769 176.209 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.2 m -92.85 120.8 33.57 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 121.351 1.887 . . . . 1.61 107.891 -179.162 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.4 mt -125.88 127.23 45.7 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.048 2.939 . . . . 2.15 110.261 -173.731 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -86.29 114.26 22.95 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 126.72 2.513 . . . . 1.98 113.075 166.409 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.1 m -129.28 167.11 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 118.044 -2.91 . . . . 1.52 109.103 -179.407 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.271 69.1 mm-40 -110.4 156.08 40.93 Favored Pre-proline 0 N--CA 1.431 -1.408 0 CA-C-O 117.839 -1.077 . . . . 2.35 108.573 164.851 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -71.08 -8.22 23.09 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 CA-C-N 123.217 2.185 . . . . 1.31 113.853 -175.175 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.1 p -81.49 -24.91 36.41 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.049 2.94 . . . . 1.71 113.284 178.535 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -66.74 154.55 40.44 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 117.687 -1.149 . . . . 1.69 111.985 178.97 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 19.0 p -87.13 175.94 7.83 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 106.303 -1.74 . . . . 1.33 106.303 -177.872 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.4 mm -73.31 -33.96 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 C-N-CA 123.889 0.876 . . . . 1.32 111.792 175.848 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -46.2 -41.14 12.35 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.678 3.191 . . . . 1.62 113.751 167.41 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -73.39 -22.13 60.33 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 115.513 -4.492 . . . . 2.13 114.205 179.275 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -74.51 -47.02 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 113.709 -1.587 . . . . 1.23 109.047 175.589 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -52.69 -27.77 18.89 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 128.419 3.574 . . . . 1.97 119.817 167.116 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.21 -37.38 57.84 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.461 -3.899 . . . . 1.19 110.781 172.54 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -70.22 -39.83 74.88 Favored 'General case' 0 N--CA 1.43 -1.444 2 O-C-N 111.372 -7.08 . . . . 1.92 110.68 177.269 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 53.5 mt -59.28 -42.29 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 1 O-C-N 115.989 -4.194 . . . . 1.94 111.05 173.038 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -65.55 -46.5 79.3 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.215 -3.428 . . . . 1.9 107.671 177.755 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -55.15 -64.99 0.66 Allowed 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.081 -4.762 . . . . 1.55 117.003 169.91 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -61.37 -57.18 13.32 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.226 -2.796 . . . . 2.95 113.215 -176.021 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -100.93 -46.1 5.22 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.957 2.903 . . . . 1.48 111.315 -165.639 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.01 22.75 5.18 Favored Glycine 0 N--CA 1.429 -1.79 0 O-C-N 116.649 -3.782 . . . . 1.12 113.781 170.61 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.9 mt -92.43 128.24 45.44 Favored Pre-proline 0 N--CA 1.432 -1.374 0 N-CA-C 101.666 -3.457 . . . . 2.07 101.666 -173.11 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -71.26 155.78 60.12 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 CA-C-O 112.67 -3.137 . . . . 1.39 114.961 175.681 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -65.61 -24.15 56.05 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 CA-C-N 124.861 2.772 . . . . 1.68 118.274 -179.163 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.83 -33.85 76.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.548 2.055 . . . . 2.25 116.548 172.866 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -83.41 -35.28 25.16 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 126.321 2.962 . . . . 2.44 112.603 -177.916 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -79.05 130.09 35.15 Favored 'General case' 0 N--CA 1.429 -1.482 1 O-C-N 115.575 -4.453 . . . . 1.32 111.816 -176.103 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -123.91 129.73 51.44 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.696 1.599 . . . . 3.19 106.686 166.776 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 mt -96.19 139.42 32.36 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 124.657 1.223 . . . . 1.75 113.595 173.692 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.469 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 60.1 mt -114.63 138.5 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.899 -3.0 . . . . 1.98 107.607 174.141 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -147.13 136.74 22.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.797 -3.064 . . . . 1.94 112.062 169.46 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.374 . . 63.53 -2.21 0.51 Allowed 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 116.677 2.103 . . . . 1.67 116.677 -178.426 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.21 -11.28 33.84 Favored Glycine 0 N--CA 1.429 -1.776 0 CA-C-O 126.648 3.36 . . . . 1.3 113.52 -173.862 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -90.23 128.98 36.53 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 117.592 -3.299 . . . . 2.89 108.795 -179.548 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -77.03 126.44 30.97 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.084 -3.51 . . . . 2.89 108.099 171.565 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.289 26.5 mt -79.17 127.96 32.7 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 118.136 2.643 . . . . 1.34 118.136 -170.519 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -83.43 149.49 26.64 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.584 2.068 . . . . 1.94 116.584 174.441 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.76 -36.11 72.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.142 2.577 . . . . 1.56 114.15 -171.782 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.46 10.59 68.81 Favored Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 114.572 -3.68 . . . . 0.97 119.141 171.233 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -80.06 154.3 28.21 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 126.594 1.996 . . . . 3.07 113.225 170.701 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 32.5 p -82.77 164.32 20.7 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 124.886 2.279 . . . . 1.34 111.098 167.902 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mt -75.43 -29.04 59.59 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 116.791 -3.693 . . . . 1.63 112.481 173.098 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 p -62.92 -40.6 98.1 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.39 -2.069 . . . . 1.51 112.491 173.9 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.278 2.0 t70 -53.62 -40.87 66.11 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 118.535 2.791 . . . . 1.9 118.535 172.833 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -79.66 -9.07 59.58 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 126.009 2.068 . . . . 0.97 116.077 172.184 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.4 m120 70.8 65.82 0.18 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 130.1 3.36 . . . . 2.35 108.557 -177.521 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.5 mt -108.78 124.18 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 O-C-N 117.068 -3.52 . . . . 1.39 111.009 -178.145 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -107.42 -173.83 2.38 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.53 1.532 . . . . 2.58 115.032 -178.045 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -70.87 145.83 49.99 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 119.086 -2.259 . . . . 2.58 113.006 176.709 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.35 31.7 mt-10 78.4 15.05 1.33 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.297 2.639 . . . . 1.71 112.333 165.847 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.5 m -86.61 146.0 26.51 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.314 -2.221 . . . . 1.34 110.265 -169.42 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.7 m -93.79 110.41 22.06 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.547 1.976 . . . . 1.36 116.007 179.406 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -87.29 151.52 23.06 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.497 -2.002 . . . . 2.03 110.184 172.511 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.469 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 39.7 m80 -109.57 100.8 9.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.785 -1.822 . . . . 2.31 114.62 -179.562 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.259 36.0 tp -84.96 115.73 22.97 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.386 -2.071 . . . . 1.72 108.489 -173.122 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 m -107.74 153.16 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 126.238 1.815 . . . . 1.8 110.792 174.817 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.1 mt . . . . . 0 N--CA 1.43 -1.474 0 O-C-N 118.802 -2.436 . . . . 3.26 107.788 179.281 . . . . . . . . 0 0 . 1 . 061 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 ptt? . . . . . 0 CA--C 1.491 -1.294 0 N-CA-C 115.138 1.533 . . . . 1.39 115.138 . . . . . . . . . 0 0 . 1 . 061 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -87.45 135.12 33.46 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 124.835 1.334 . . . . 2.2 110.435 179.439 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -126.66 138.39 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 105.894 -1.891 . . . . 1.32 105.894 175.073 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -104.19 77.03 1.38 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.791 -1.095 . . . . 2.2 108.91 -176.105 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 t -63.42 105.29 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 116.213 1.931 . . . . 1.23 116.213 168.95 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.257 35.7 tptt -90.46 139.8 30.33 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 124.151 1.929 . . . . 2.51 112.652 179.095 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.3 p -91.17 -179.39 5.42 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.556 -1.965 . . . . 1.41 108.513 179.544 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.4 tp -66.23 -50.88 62.28 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 123.218 1.485 . . . . 2.95 113.903 179.997 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 p -74.69 -22.07 59.06 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.113 1.523 . . . . 2.52 115.113 -172.577 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.05 -2.53 2.96 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 117.679 -2.201 . . . . 1.5 114.817 172.49 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -78.86 131.09 36.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.165 -2.962 . . . . 1.79 112.146 -175.18 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.271 85.8 m -98.83 118.1 34.82 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.147 -2.221 . . . . 1.38 108.97 175.452 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.1 mm -102.39 118.68 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 125.175 1.547 . . . . 2.03 110.201 179.698 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.2 m -81.02 98.33 7.91 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.447 -1.251 . . . . 1.61 110.549 174.862 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.3 tp -100.69 158.08 16.21 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.016 -2.303 . . . . 2.15 110.118 -176.394 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -121.55 118.74 30.03 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.284 -1.006 . . . . 1.98 108.284 174.956 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 m -135.58 176.67 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 107.619 -1.252 . . . . 1.52 107.619 -177.581 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -124.25 166.7 18.2 Favored Pre-proline 0 N--CA 1.429 -1.482 0 O-C-N 118.547 -2.596 . . . . 2.35 109.644 170.275 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.359 14.5 Cg_endo -75.68 -16.27 18.83 Favored 'Trans proline' 0 C--N 1.299 -2.075 0 O-C-N 114.7 -3.368 . . . . 1.31 114.502 -175.99 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.9 p -90.87 2.57 56.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.206 -2.184 . . . . 1.71 107.334 -178.804 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -80.51 142.59 34.04 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.923 -1.736 . . . . 1.69 113.544 179.433 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.6 p -85.71 164.71 17.47 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 117.029 2.233 . . . . 1.33 117.029 177.783 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.9 mm -76.48 -31.06 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 101.738 -3.43 . . . . 1.32 101.738 -172.979 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -49.76 -47.01 51.21 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 115.641 1.719 . . . . 1.62 115.641 167.298 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -76.72 -30.82 56.81 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 115.87 -2.014 . . . . 2.13 112.533 177.328 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.31 -29.7 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 121.592 1.996 . . . . 1.23 114.463 177.551 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -74.55 -35.39 63.08 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 117.607 -1.187 . . . . 1.97 109.213 171.232 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -36.93 83.99 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 123.389 2.813 . . . . 1.19 112.619 171.007 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.6 mttm -63.94 -47.38 80.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 126.842 2.589 . . . . 1.92 114.804 170.364 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.9 mt -61.48 -36.38 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 1 O-C-N 114.462 -5.149 . . . . 1.94 109.756 171.066 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -57.52 -54.27 48.71 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 117.14 -3.475 . . . . 1.9 113.152 172.734 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -52.75 -44.64 66.61 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.767 -1.208 . . . . 1.55 111.98 171.92 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -65.18 -57.41 8.6 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 127.612 2.365 . . . . 2.95 110.464 -173.369 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -105.75 -47.64 3.84 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 118.128 -2.857 . . . . 1.48 115.705 -169.611 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.42 4.63 8.96 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 119.547 -1.971 . . . . 1.12 114.17 -176.445 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.9 mt -83.5 127.37 68.48 Favored Pre-proline 0 N--CA 1.43 -1.462 0 O-C-N 119.026 -2.455 . . . . 2.07 110.478 -176.108 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -73.35 146.57 40.27 Favored 'Trans proline' 0 C--N 1.3 -2.014 2 O-C-N 110.895 -5.371 . . . . 1.39 113.389 179.135 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.06 -5.69 16.4 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 C-N-CA 126.107 4.538 . . . . 1.68 116.672 -176.931 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.53 -37.61 84.38 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.815 2.245 . . . . 2.25 110.782 169.343 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -85.17 -31.9 22.99 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 115.937 -1.982 . . . . 2.44 115.022 -177.411 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.359 46.7 mt-30 -67.58 113.47 5.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.388 2.675 . . . . 1.32 117.698 -172.089 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -122.01 115.47 22.58 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.327 -2.733 . . . . 3.19 109.551 172.765 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.9 mt -96.53 143.11 27.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.51 -1.369 . . . . 1.75 110.256 179.427 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.2 mm -124.6 148.64 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 102.679 -3.082 . . . . 1.98 102.679 175.423 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.455 ' HB3' HD22 ' A' ' 50' ' ' LEU . 69.4 t80 -139.53 112.86 8.27 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 101.156 -3.646 . . . . 1.94 101.156 173.982 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.96 28.76 14.49 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 126.286 2.241 . . . . 1.67 114.119 172.662 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.91 -17.1 56.68 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 124.938 1.256 . . . . 1.3 114.31 -175.168 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.316 34.7 ttmt -87.63 122.51 31.41 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.766 -2.608 . . . . 2.89 115.756 178.417 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -64.46 138.12 58.24 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 118.193 2.664 . . . . 2.89 118.193 171.718 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.455 HD22 ' HB3' ' A' ' 45' ' ' PHE . 39.7 mt -95.9 113.2 24.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.951 -1.022 . . . . 1.34 111.126 -172.326 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -77.5 142.56 39.03 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.873 -1.158 . . . . 1.94 107.873 -178.973 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -56.96 -65.47 0.61 Allowed 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 119.29 3.071 . . . . 1.56 119.29 -168.723 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.1 25.5 0.15 Allowed Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 119.38 2.512 . . . . 0.97 119.38 171.943 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -105.97 158.0 17.1 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 119.773 1.786 . . . . 3.07 109.926 164.821 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.7 p -84.91 169.1 14.41 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 112.735 -2.03 . . . . 1.34 111.602 170.708 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.482 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 94.0 mt -66.02 -37.16 85.18 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 127.384 2.274 . . . . 1.63 111.739 171.543 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.9 p -69.39 -10.4 57.79 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 129.23 3.012 . . . . 1.51 115.016 173.806 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.99 -48.21 31.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.876 1.67 . . . . 1.9 110.362 169.84 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -85.63 -1.11 56.8 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 130.476 3.51 . . . . 0.97 113.775 -177.924 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.0 m120 57.21 54.32 6.9 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.604 2.361 . . . . 2.35 116.646 179.517 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.482 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 88.9 mt -100.27 109.8 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 126.846 2.058 . . . . 1.39 108.797 -179.194 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -93.74 -178.62 4.74 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.052 2.358 . . . . 2.58 110.422 -178.902 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -58.28 140.18 53.77 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.108 -3.495 . . . . 2.58 119.885 175.735 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.327 12.7 mt-10 67.98 40.56 2.26 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 123.778 0.674 . . . . 1.71 110.557 174.913 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 p -96.22 155.43 16.76 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 126.667 1.987 . . . . 1.34 108.547 176.106 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.4 m -104.68 85.75 2.37 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.689 -2.337 . . . . 1.36 104.689 -177.079 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -63.6 159.78 18.15 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 114.539 -5.1 . . . . 2.03 113.884 169.01 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -118.2 129.86 55.75 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.39 2.043 . . . . 2.31 108.584 -178.96 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.6 tp -116.67 131.27 56.99 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 116.065 -4.147 . . . . 1.72 113.242 175.351 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 m -135.1 167.9 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 103.437 -2.801 . . . . 1.8 103.437 175.727 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 66.4 mt . . . . . 0 N--CA 1.43 -1.428 0 CA-C-O 126.446 3.022 . . . . 3.26 113.958 179.596 . . . . . . . . 0 0 . 1 . 062 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 ttp . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 117.484 2.401 . . . . 1.39 117.484 . . . . . . . . . 0 0 . 1 . 062 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -100.03 124.01 44.91 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 124.53 1.144 . . . . 2.2 110.852 -176.337 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.1 pt -129.11 157.89 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 105.571 -2.011 . . . . 1.32 105.571 172.003 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -108.79 134.67 51.17 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.023 1.729 . . . . 2.2 112.117 -174.854 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.532 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 42.1 t -111.85 115.01 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 122.15 0.976 . . . . 1.23 108.852 173.612 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -96.57 149.94 21.2 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.948 -2.345 . . . . 2.51 107.544 176.979 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.6 p -109.78 -149.21 0.44 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 116.275 -1.821 . . . . 1.41 107.462 176.464 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.2 tp -91.77 -58.12 2.52 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-N 122.809 2.55 . . . . 2.95 110.92 167.121 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.4 p -127.19 133.83 50.23 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 113.755 -3.022 . . . . 2.52 117.946 178.877 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.21 -116.97 2.71 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 103.307 -3.917 . . . . 1.5 103.307 173.983 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -119.67 164.62 15.62 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 121.831 -0.805 . . . . 1.79 108.87 -170.17 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.5 m -88.65 120.26 29.88 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 125.853 1.97 . . . . 1.38 109.652 168.958 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 15.6 mt -79.9 122.62 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-N 122.122 2.237 . . . . 2.03 114.983 -179.627 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.8 m -78.83 100.95 7.39 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.767 -1.833 . . . . 1.61 109.973 176.882 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tp -102.8 119.52 38.98 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 113.709 1.003 . . . . 2.15 113.709 -178.302 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -91.71 126.3 36.74 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.396 2.522 . . . . 1.98 112.983 168.574 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -142.89 171.46 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 1 C-N-CA 131.737 4.015 . . . . 1.52 110.868 -174.331 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -114.24 169.14 6.9 Favored Pre-proline 0 N--CA 1.43 -1.462 0 C-N-CA 129.163 2.985 . . . . 2.35 106.737 166.428 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -73.16 -18.11 24.01 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 N-CA-C 120.11 3.081 . . . . 1.31 120.11 -177.1 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.4 m -84.69 10.15 12.02 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 112.036 -2.347 . . . . 1.71 116.171 174.574 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.69 130.49 35.08 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 116.688 -3.757 . . . . 1.69 106.007 177.464 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.9 p -71.05 163.59 27.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.712 2.196 . . . . 1.33 108.493 171.18 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.474 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 49.1 mm -66.41 -34.07 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 113.625 -3.083 . . . . 1.32 105.381 175.951 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -61.65 -40.02 93.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 122.883 2.583 . . . . 1.62 116.207 171.731 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -69.59 -41.02 76.32 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 125.144 1.528 . . . . 2.13 112.476 177.653 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.5 t -49.85 -50.12 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 120.858 -1.151 . . . . 1.23 113.569 169.872 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -58.77 -37.32 76.02 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.152 -1.592 . . . . 1.97 113.735 170.319 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.59 -37.84 85.75 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.648 -2.533 . . . . 1.19 108.908 178.945 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -69.32 -38.29 78.14 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 129.087 2.955 . . . . 1.92 112.813 179.303 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.8 mt -69.1 -28.66 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 117.431 -3.293 . . . . 1.94 110.959 170.99 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -66.31 -47.19 74.36 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.519 1.528 . . . . 1.9 110.761 172.235 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -64.3 -28.81 69.97 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 114.519 1.303 . . . . 1.55 114.519 173.058 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -87.89 -46.89 9.01 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.087 -2.258 . . . . 2.95 115.12 -173.839 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -113.58 -29.35 7.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.056 1.742 . . . . 1.48 115.262 -175.486 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.19 4.03 38.42 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 119.305 -2.122 . . . . 1.12 118.165 175.074 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.9 mt -85.06 132.48 45.46 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 119.262 1.531 . . . . 2.07 110.771 -173.934 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -61.32 144.04 98.31 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 C-N-CA 123.464 2.776 . . . . 1.39 116.72 -179.721 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -59.43 -32.52 96.59 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 123.379 2.719 . . . . 1.68 114.141 -178.627 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -63.24 -18.11 63.19 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.928 2.936 . . . . 2.25 118.928 171.59 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -91.89 -23.19 19.71 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 116.295 -1.812 . . . . 2.44 107.1 -177.162 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -89.49 141.09 28.89 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 117.406 2.373 . . . . 1.32 117.406 -172.932 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -123.23 137.72 54.81 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.486 -2.008 . . . . 3.19 110.143 163.496 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.2 mt -112.25 140.0 47.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.882 -1.896 . . . . 1.75 105.882 179.742 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.7 mm -120.92 127.58 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 130.108 3.363 . . . . 1.98 108.668 177.985 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -139.27 126.02 20.77 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 104.721 -2.325 . . . . 1.94 104.721 172.16 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.97 41.27 10.65 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 121.037 3.717 . . . . 1.67 121.037 173.921 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.1 -17.59 58.43 Favored Glycine 0 N--CA 1.43 -1.71 0 O-C-N 117.659 -3.151 . . . . 1.3 113.267 -178.772 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -108.81 135.5 49.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.477 -2.778 . . . . 2.89 115.279 -178.866 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -87.6 127.06 35.27 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.114 0.959 . . . . 2.89 109.248 170.805 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.418 HD21 ' CD2' ' A' ' 59' ' ' TYR . 37.0 mt -89.41 144.99 25.63 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 126.576 3.084 . . . . 1.34 112.325 -163.638 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -95.09 125.16 39.56 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.428 -3.295 . . . . 1.94 114.806 -179.781 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.474 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 5.9 m-20 -48.05 -49.86 29.96 Favored 'General case' 0 N--CA 1.429 -1.491 1 C-N-CA 132.406 4.282 . . . . 1.56 119.766 -169.006 . . . . . . . . 3 3 . 1 . 062 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.42 46.2 3.18 Favored Glycine 0 N--CA 1.431 -1.673 0 CA-C-O 114.538 -3.368 . . . . 0.97 119.174 168.354 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -125.32 152.72 44.33 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.593 -2.743 . . . . 3.07 103.593 165.659 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.8 p -94.84 159.75 14.9 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.547 3.654 . . . . 1.34 116.039 176.857 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.6 mt -55.21 -40.49 70.84 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 115.682 1.734 . . . . 1.63 115.682 175.483 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 p -73.43 -9.28 58.53 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.181 -3.449 . . . . 1.51 118.41 179.506 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -93.21 -31.9 14.57 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 114.648 -2.596 . . . . 1.9 107.354 174.585 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.418 ' CD2' HD21 ' A' ' 50' ' ' LEU . 25.7 m-85 -80.0 -5.51 55.87 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 125.892 1.995 . . . . 0.97 106.937 177.049 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 56.18 71.74 0.54 Allowed 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 115.053 -4.78 . . . . 2.35 111.813 -175.38 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.1 mt -115.87 111.9 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 105.001 -2.222 . . . . 1.39 105.001 178.619 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -95.34 -175.08 3.38 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.431 3.015 . . . . 2.58 109.621 -174.232 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -57.73 140.23 51.94 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 111.471 -2.604 . . . . 2.58 112.116 177.162 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.338 51.0 mt-10 69.38 20.85 7.17 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 125.214 1.406 . . . . 1.71 113.309 174.486 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.2 m -85.4 147.72 26.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 121.617 -0.677 . . . . 1.34 112.032 -172.459 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.2 m -104.5 111.07 23.6 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.052 -1.655 . . . . 1.36 112.921 -175.509 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -93.8 147.4 23.09 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.45 -1.406 . . . . 2.03 110.9 174.456 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -113.96 128.1 56.25 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.102 -2.874 . . . . 2.31 110.404 -177.367 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.0 tp -102.49 124.48 48.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 124.834 1.334 . . . . 1.72 112.995 -172.059 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.255 6.2 m -138.3 133.37 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.606 2.763 . . . . 1.8 107.662 -175.408 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 N--CA 1.43 -1.456 0 CA-C-O 125.144 2.402 . . . . 3.26 117.412 -175.995 . . . . . . . . 0 0 . 1 . 063 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ttp . . . . . 0 CA--C 1.49 -1.347 0 CA-C-O 116.447 -1.74 . . . . 1.39 107.145 . . . . . . . . . 0 0 . 1 . 063 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -116.55 128.91 55.85 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 124.665 1.228 . . . . 2.2 112.323 171.869 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.6 pt -121.06 173.55 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 119.116 -2.24 . . . . 1.32 107.648 169.521 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -128.3 150.93 49.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.98 -2.23 . . . . 2.2 104.98 -179.328 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.6 t -138.8 112.64 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 126.515 3.055 . . . . 1.23 112.627 174.469 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -89.51 153.25 20.95 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 111.072 -2.786 . . . . 2.51 115.509 -176.831 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 t -127.68 -160.55 1.02 Allowed 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 124.483 2.087 . . . . 1.41 107.853 170.864 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.8 mt -81.19 -85.53 0.1 Allowed 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 114.563 -5.086 . . . . 2.95 113.74 175.383 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.1 p -80.71 -41.34 23.8 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 128.764 2.826 . . . . 2.52 117.287 179.239 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.36 -168.31 11.16 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 118.696 -2.503 . . . . 1.5 118.622 176.181 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -60.34 151.31 28.1 Favored 'General case' 0 N--CA 1.43 -1.461 1 C-N-CA 131.735 4.014 . . . . 1.79 114.068 -172.808 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.8 m -98.18 117.23 32.09 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.453 -2.655 . . . . 1.38 104.216 163.659 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 pt -99.86 153.91 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 116.76 -3.713 . . . . 2.03 108.168 179.991 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.7 m -107.55 126.32 52.39 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 104.404 -2.443 . . . . 1.61 104.404 175.852 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.45 HD12 HG12 ' A' ' 30' ' ' ILE . 95.2 mt -117.38 129.04 55.61 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 123.388 1.566 . . . . 2.15 110.519 -179.263 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -96.73 125.99 41.57 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 116.641 -3.787 . . . . 1.98 104.343 174.305 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.25 27.4 m -136.8 170.42 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 129.264 3.025 . . . . 1.52 111.191 -170.871 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -109.7 156.0 40.47 Favored Pre-proline 0 N--CA 1.43 -1.442 0 CA-C-N 124.384 3.266 . . . . 2.35 107.324 166.728 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.86 -16.52 29.46 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 124.991 3.794 . . . . 1.31 114.787 -168.197 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.3 m -107.34 17.5 22.75 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 120.219 1.372 . . . . 1.71 110.21 177.574 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -73.75 151.09 40.74 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.306 -3.371 . . . . 1.69 113.164 171.053 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -91.53 160.07 15.6 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.913 1.816 . . . . 1.33 113.31 -178.525 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.315 26.0 mm -56.51 -37.9 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 116.381 1.993 . . . . 1.32 116.381 176.069 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -52.54 -43.39 65.13 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.844 2.165 . . . . 1.62 116.844 170.206 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -76.93 -42.4 39.51 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.229 -2.794 . . . . 2.13 108.346 -177.949 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.0 t -57.06 -45.62 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 118.177 2.658 . . . . 1.23 118.177 169.619 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -56.25 -40.71 74.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.021 1.328 . . . . 1.97 112.988 170.116 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.55 -33.55 75.27 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.779 2.432 . . . . 1.19 113.346 175.501 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -67.93 -40.19 83.37 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.474 2.709 . . . . 1.92 106.926 170.369 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.45 HG12 HD12 ' A' ' 15' ' ' LEU . 79.5 mt -62.31 -40.89 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 123.448 2.84 . . . . 1.94 113.117 173.092 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -55.64 -48.88 74.23 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.842 2.457 . . . . 1.9 114.503 170.503 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -58.03 -46.55 85.15 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.61 2.078 . . . . 1.55 116.61 170.853 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -76.71 -58.87 3.03 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 117.889 -3.007 . . . . 2.95 114.611 -177.353 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -88.51 -47.15 8.53 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.257 -1.527 . . . . 1.48 110.531 -170.294 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.85 34.84 1.95 Allowed Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 124.006 1.892 . . . . 1.12 113.72 177.367 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 mt -108.75 128.55 25.33 Favored Pre-proline 0 N--CA 1.431 -1.418 0 O-C-N 120.512 -1.581 . . . . 2.07 111.027 -176.935 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -63.36 141.13 80.2 Favored 'Trans proline' 0 N--CA 1.434 -1.98 0 CA-C-N 125.305 2.93 . . . . 1.39 114.111 173.694 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -75.07 -1.8 11.72 Favored 'Trans proline' 0 C--N 1.3 -1.994 1 C-N-CA 127.188 5.259 . . . . 1.68 113.904 -174.868 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -76.13 -34.2 59.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.905 2.482 . . . . 2.25 109.076 171.381 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -82.01 -25.97 34.25 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.056 2.36 . . . . 2.44 110.108 -175.591 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -82.22 125.02 30.44 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.766 2.698 . . . . 1.32 111.038 -171.746 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -114.99 98.07 6.6 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 109.335 -3.575 . . . . 3.19 109.694 167.837 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.3 mt -79.28 125.47 29.53 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 119.244 -2.16 . . . . 1.75 113.114 176.024 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.9 mm -112.92 123.33 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 O-C-N 119.469 -2.019 . . . . 1.98 106.04 176.18 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -91.03 -73.76 0.52 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 117.56 -1.656 . . . . 1.94 111.88 168.911 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.72 -69.32 0.65 Allowed 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 128.147 2.579 . . . . 1.67 114.035 179.895 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.47 17.48 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.72 1 O-C-N 112.9 -6.125 . . . . 1.3 115.914 -177.006 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -141.85 162.9 34.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 112.509 -1.845 . . . . 2.89 107.694 178.418 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -64.31 168.34 5.74 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 118.175 2.657 . . . . 2.89 118.175 168.146 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.404 HD23 ' CD2' ' A' ' 59' ' ' TYR . 91.4 mt -123.22 128.18 49.66 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.188 -2.195 . . . . 1.34 107.252 -172.622 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -90.06 152.86 20.96 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.796 1.776 . . . . 1.94 115.796 179.565 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.93 -37.82 79.13 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 129.731 3.212 . . . . 1.56 115.379 -165.375 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.88 43.84 1.8 Allowed Glycine 0 N--CA 1.43 -1.721 1 CA-C-O 113.096 -4.169 . . . . 0.97 109.616 169.913 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -122.12 162.0 22.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.524 3.162 . . . . 3.07 104.758 166.088 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.256 20.7 p -95.79 168.41 10.67 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 113.34 -1.755 . . . . 1.34 113.824 -177.551 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -56.96 -46.98 81.76 Favored 'General case' 0 N--CA 1.43 -1.468 1 C-N-CA 132.298 4.239 . . . . 1.63 115.768 168.666 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 t -60.94 -37.85 83.8 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 117.221 2.304 . . . . 1.51 117.221 173.73 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.276 11.7 t0 -46.19 -60.65 2.17 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 129.624 3.169 . . . . 1.9 111.869 178.171 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.404 ' CD2' HD23 ' A' ' 50' ' ' LEU . 60.6 m-85 -79.68 -1.66 39.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 112.57 -2.105 . . . . 0.97 116.397 -175.368 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.357 33.1 m120 73.89 52.22 0.11 Allowed 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 127.857 2.463 . . . . 2.35 114.176 -178.825 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.1 mt -96.31 117.44 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 103.901 -2.629 . . . . 1.39 103.901 -177.944 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -113.45 178.51 4.25 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 125.058 2.361 . . . . 2.58 111.578 -173.395 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -64.87 129.1 38.48 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 114.918 -4.864 . . . . 2.58 110.844 172.714 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.313 18.1 mt-10 80.03 36.18 0.13 Allowed 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 123.509 1.623 . . . . 1.71 114.558 178.108 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -107.18 125.18 50.78 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.203 2.201 . . . . 1.34 114.808 -176.205 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.9 m -97.32 117.69 32.11 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 121.323 -0.861 . . . . 1.36 111.029 -177.867 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 mp -101.88 164.7 11.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.479 1.133 . . . . 2.03 109.536 179.361 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -119.69 113.13 20.19 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 116.992 -1.48 . . . . 2.31 111.856 -176.496 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -80.55 131.97 35.6 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 124.654 1.221 . . . . 1.72 108.328 176.197 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.5 t -113.0 129.36 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 105.572 -2.01 . . . . 1.8 105.572 166.274 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 N--CA 1.431 -1.397 0 N-CA-C 108.555 -0.906 . . . . 3.26 108.555 179.644 . . . . . . . . 0 0 . 1 . 064 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ptt? . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 115.963 1.838 . . . . 1.39 115.963 . . . . . . . . . 0 0 . 1 . 064 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -102.91 127.71 50.01 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 114.923 -2.465 . . . . 2.2 112.592 -175.968 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.4 pt -124.54 176.53 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 123.104 2.683 . . . . 1.32 109.303 176.246 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -120.51 152.72 37.66 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.496 -2.627 . . . . 2.2 111.078 172.992 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.9 t -135.67 124.39 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 105.627 -1.99 . . . . 1.23 105.627 173.72 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -106.69 133.4 51.41 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 114.203 1.186 . . . . 2.51 114.203 175.67 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -95.99 165.39 12.29 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.669 1.588 . . . . 1.41 111.559 -179.588 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.258 43.2 mt -72.28 -28.58 63.19 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 118.037 2.606 . . . . 2.95 118.037 175.939 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 p -76.71 -26.98 55.27 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 126.805 2.042 . . . . 2.52 109.095 -179.362 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.6 46.46 0.48 Allowed Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 129.61 3.481 . . . . 1.5 114.951 167.07 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -109.82 133.83 52.72 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.707 3.203 . . . . 1.79 106.448 177.091 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 m -117.02 106.97 13.97 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 124.192 0.933 . . . . 1.38 109.34 167.521 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mt -85.49 136.95 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.358 1.863 . . . . 2.03 113.919 179.042 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.9 m -95.72 117.37 30.38 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 114.921 -2.466 . . . . 1.61 105.56 176.581 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.3 mt -129.08 137.83 51.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 124.651 3.387 . . . . 2.15 111.175 178.512 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -99.48 128.8 45.62 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 126.739 3.161 . . . . 1.98 110.082 172.379 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.69 172.76 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 101.922 -3.362 . . . . 1.52 101.922 -174.426 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -117.9 155.92 50.53 Favored Pre-proline 0 N--CA 1.43 -1.451 0 N-CA-C 104.276 -2.49 . . . . 2.35 104.276 163.392 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -73.73 -7.22 19.84 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 N-CA-C 115.702 1.385 . . . . 1.31 115.702 -170.414 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.1 p -97.57 -0.75 45.27 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 126.199 1.799 . . . . 1.71 109.188 178.179 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -76.89 148.88 36.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.482 -2.636 . . . . 1.69 108.287 173.785 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 26' ' ' VAL . 72.5 p -85.91 165.13 17.02 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.938 2.495 . . . . 1.33 116.722 176.092 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.9 mm -70.27 -28.74 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 117.435 -3.291 . . . . 1.32 114.776 -178.146 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.25 75.3 tt0 -56.7 -46.56 81.15 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.015 1.388 . . . . 1.62 114.622 167.925 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -67.27 -37.32 83.27 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.362 -2.711 . . . . 2.13 110.798 179.688 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 22' ' ' THR . 98.9 t -66.72 -46.66 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 119.77 -1.831 . . . . 1.23 109.109 178.161 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -60.52 -39.22 87.03 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.903 -1.044 . . . . 1.97 112.446 174.724 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.46 -15.16 62.36 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 116.972 2.212 . . . . 1.19 116.972 175.532 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -85.3 -33.75 22.04 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.152 1.781 . . . . 1.92 114.316 177.735 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.3 mt -66.99 -47.43 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 1 C-N-CA 131.702 4.001 . . . . 1.94 106.718 166.634 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -47.8 -55.58 9.36 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 121.266 3.802 . . . . 1.9 121.266 173.534 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -34.21 -59.85 0.42 Allowed 'General case' 0 N--CA 1.431 -1.41 1 C-N-CA 131.777 4.031 . . . . 1.55 112.928 164.605 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -66.39 -57.61 7.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 118.488 2.773 . . . . 2.95 118.488 179.817 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -82.81 -45.64 14.07 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 130.411 3.484 . . . . 1.48 110.874 -171.093 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.18 47.27 1.74 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 107.6 -2.2 . . . . 1.12 107.6 174.178 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.7 mt -120.33 129.15 25.47 Favored Pre-proline 0 N--CA 1.431 -1.413 0 C-N-CA 127.504 2.322 . . . . 2.07 107.825 -169.143 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -72.65 145.69 42.1 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 114.007 -3.733 . . . . 1.39 112.375 175.691 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -65.18 -13.88 42.17 Favored 'Trans proline' 0 N--CA 1.433 -2.062 0 CA-C-N 126.668 3.417 . . . . 1.68 118.463 -177.392 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -56.24 -44.39 79.59 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 124.818 2.246 . . . . 2.25 114.227 175.088 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -90.27 -6.36 55.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 110.535 -3.03 . . . . 2.44 114.09 -177.678 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -103.77 139.63 38.73 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.353 -2.462 . . . . 1.32 104.353 -177.501 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -130.88 145.48 52.02 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.141 1.924 . . . . 3.19 108.711 167.962 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 mt -107.47 130.34 54.85 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.727 -1.583 . . . . 1.75 106.727 178.931 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 7.1 mm -112.28 140.14 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 105.293 -2.114 . . . . 1.98 105.293 177.925 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.408 ' HB2' HD23 ' A' ' 67' ' ' LEU . 52.7 t80 -155.07 126.99 7.58 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 125.07 2.367 . . . . 1.94 108.512 175.275 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.358 . . 61.86 34.05 17.27 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 127.747 3.641 . . . . 1.67 118.722 -175.885 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.31 -18.1 11.48 Favored Glycine 0 N--CA 1.429 -1.804 0 O-C-N 118.442 -2.661 . . . . 1.3 114.375 -178.495 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.263 30.0 mtmt -95.77 148.7 22.31 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.607 -3.29 . . . . 2.89 110.278 -177.393 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -88.09 122.1 31.27 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.26 2.225 . . . . 2.89 107.791 172.67 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.2 mt -74.04 162.07 29.4 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 110.06 -3.245 . . . . 1.34 112.433 -176.803 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -109.12 159.18 17.09 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.511 -3.243 . . . . 1.94 106.386 172.869 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.56 -58.56 3.22 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.829 2.852 . . . . 1.56 116.246 -169.93 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.94 43.13 2.59 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 127.356 2.407 . . . . 0.97 113.74 172.999 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -120.87 148.3 44.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.535 -3.332 . . . . 3.07 103.991 164.135 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -76.69 163.44 26.83 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 118.204 2.668 . . . . 1.34 118.204 170.609 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mt -55.55 -44.53 76.87 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.983 2.913 . . . . 1.63 109.9 170.461 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 p -59.44 -32.11 69.91 Favored 'General case' 0 N--CA 1.431 -1.412 1 O-C-N 129.813 4.446 . . . . 1.51 116.563 174.675 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -69.08 -34.8 75.71 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.609 1.671 . . . . 1.9 112.63 172.62 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -82.97 0.1 46.18 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.898 -3.626 . . . . 0.97 117.684 177.709 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.4 t30 48.96 43.7 22.0 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 131.661 3.984 . . . . 2.35 115.104 -176.535 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.2 mt -82.33 130.46 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 112.845 -1.98 . . . . 1.39 111.959 179.91 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -127.14 178.47 6.0 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 120.089 -1.632 . . . . 2.58 109.798 -173.446 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -57.56 154.72 10.8 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 115.412 1.634 . . . . 2.58 115.412 -178.281 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 61.33 11.02 3.39 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 126.277 1.831 . . . . 1.71 112.461 171.456 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.0 t -89.51 131.07 35.72 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 104.962 -2.236 . . . . 1.34 104.962 -174.069 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.0 m -96.32 114.14 25.79 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 102.761 -3.051 . . . . 1.36 102.761 -174.413 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.408 HD23 ' HB2' ' A' ' 45' ' ' PHE . 11.2 mt -90.96 161.93 14.95 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.21 -2.806 . . . . 2.03 111.673 167.648 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.407 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 80.6 m80 -112.58 127.03 55.97 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 117.564 -1.208 . . . . 2.31 113.3 -177.54 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.4 tp -93.79 134.63 35.93 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 124.639 1.175 . . . . 1.72 110.635 176.805 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.0 m -129.92 156.47 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 103.823 -2.658 . . . . 1.8 103.823 174.503 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 N--CA 1.431 -1.415 0 CA-C-O 125.059 2.361 . . . . 3.26 113.108 -179.755 . . . . . . . . 0 0 . 1 . 065 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ptt? . . . . . 0 CA--C 1.49 -1.347 0 CA-C-O 123.032 1.396 . . . . 1.39 114.107 . . . . . . . . . 0 0 . 1 . 065 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -94.27 133.52 37.72 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 115.876 1.806 . . . . 2.2 115.876 -174.303 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.9 pt -127.44 153.78 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 120.727 -1.233 . . . . 1.32 109.627 173.993 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.304 58.2 m-85 -112.74 119.1 36.91 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 125.237 1.586 . . . . 2.2 113.099 -179.858 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.5 t -105.53 120.03 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 116.043 -2.263 . . . . 1.23 113.536 177.094 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -88.36 116.99 26.97 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.872 -2.392 . . . . 2.51 114.477 178.318 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.295 19.9 p -72.84 168.2 19.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.001 1.72 . . . . 1.41 112.988 178.774 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.433 HD23 HG11 ' A' ' 70' ' ' VAL 0.291 19.0 mt -66.15 -45.64 80.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.416 1.462 . . . . 2.95 113.862 173.981 . . . . . . . . 3 3 . 1 . 065 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -65.14 -67.24 0.45 Allowed 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 117.379 2.362 . . . . 2.52 117.379 176.555 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.75 22.57 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 117.967 -2.063 . . . . 1.5 115.502 177.893 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -106.37 130.48 54.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.44 -1.319 . . . . 1.79 107.44 -176.831 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.9 m -99.34 107.69 20.02 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 105.722 -1.955 . . . . 1.38 105.722 172.165 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.1 mt -78.57 119.27 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 118.948 -2.345 . . . . 2.03 110.661 -179.967 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.6 m -83.1 117.98 23.24 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.394 -1.442 . . . . 1.61 108.736 174.163 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.2 mt -111.79 164.15 13.38 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 118.841 0.746 . . . . 2.15 111.58 179.136 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.75 129.54 56.38 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.351 1.06 . . . . 1.98 109.05 167.539 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.09 161.53 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 104.307 -2.479 . . . . 1.52 104.307 178.046 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -106.71 137.43 19.47 Favored Pre-proline 0 N--CA 1.43 -1.437 0 C-N-CA 128.172 2.589 . . . . 2.35 108.647 163.162 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -68.0 -8.42 22.6 Favored 'Trans proline' 0 N--CA 1.433 -2.04 0 C-N-CA 122.672 2.248 . . . . 1.31 114.586 -174.023 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.6 p -101.35 10.59 40.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.458 2.39 . . . . 1.71 111.697 175.676 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -91.35 165.06 13.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.503 1.62 . . . . 1.69 108.692 -176.7 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -90.4 161.2 15.68 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.777 -4.327 . . . . 1.33 110.093 -178.56 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.3 mt -72.22 -34.29 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.438 -2.663 . . . . 1.32 115.703 -177.156 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -52.47 -45.14 65.97 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.418 2.377 . . . . 1.62 117.418 157.14 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -58.29 -38.73 77.62 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 116.364 -3.96 . . . . 2.13 110.919 175.093 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.74 -49.2 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 122.828 1.299 . . . . 1.23 112.217 170.75 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -55.81 -39.58 71.53 Favored 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 115.786 -4.321 . . . . 1.97 114.658 175.945 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.258 . . -55.86 -31.23 62.59 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.334 2.654 . . . . 1.19 113.2 168.562 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -65.69 -36.25 83.08 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 116.51 -3.868 . . . . 1.92 114.797 173.839 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.0 mt -66.47 -34.41 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 114.932 1.456 . . . . 1.94 114.932 170.266 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -59.86 -38.94 83.58 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 130.106 3.362 . . . . 1.9 109.255 178.148 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -50.42 -46.64 56.56 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 119.452 3.13 . . . . 1.55 119.452 163.837 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -80.54 -45.65 17.08 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 124.884 1.274 . . . . 2.95 111.747 -177.728 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -100.89 -44.29 5.81 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.738 -1.208 . . . . 1.48 107.738 -166.923 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.37 16.99 47.91 Favored Glycine 0 N--CA 1.43 -1.707 0 O-C-N 118.296 -2.752 . . . . 1.12 114.725 177.742 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.1 mt -98.26 127.46 36.4 Favored Pre-proline 0 N--CA 1.43 -1.461 1 C-N-CA 132.235 4.214 . . . . 2.07 104.114 174.583 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.91 151.57 81.97 Favored 'Trans proline' 0 N--CA 1.432 -2.093 1 O-C-N 112.363 -4.599 . . . . 1.39 114.289 -177.928 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.2 -19.29 20.11 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 CA-C-N 124.288 2.567 . . . . 1.68 112.28 -169.633 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -57.84 -30.27 65.63 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 120.615 1.552 . . . . 2.25 114.103 168.033 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.272 10.6 tt0 -77.17 -33.36 56.48 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 118.044 -2.91 . . . . 2.44 112.809 178.799 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -80.57 148.18 30.46 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 117.391 2.367 . . . . 1.32 117.391 -172.97 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -146.64 139.41 25.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.662 -1.607 . . . . 3.19 106.662 173.736 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.1 mt -105.06 145.15 30.89 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.067 -3.521 . . . . 1.75 109.694 -178.634 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.5 mm -119.76 140.67 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 105.456 -2.053 . . . . 1.98 105.456 -178.322 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -147.57 135.04 20.79 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.985 -1.697 . . . . 1.94 110.401 170.919 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.87 8.46 0.16 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 130.213 3.405 . . . . 1.67 116.532 -177.158 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.36 -25.79 9.01 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 129.684 3.516 . . . . 1.3 113.738 -174.498 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -79.61 146.52 32.5 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 121.202 2.501 . . . . 2.89 111.147 179.01 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -89.47 123.46 33.61 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 101.259 -3.608 . . . . 2.89 101.259 172.648 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.7 mt -85.42 145.41 27.46 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 105.709 -1.96 . . . . 1.34 105.709 -172.208 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -79.56 154.88 28.46 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 115.886 1.81 . . . . 1.94 115.886 173.8 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -82.74 -47.36 12.05 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.43 -3.294 . . . . 1.56 117.595 -171.359 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.21 57.34 1.73 Allowed Glycine 0 N--CA 1.43 -1.737 1 O-C-N 116.286 -4.009 . . . . 0.97 111.447 178.432 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.0 ttt85 -138.08 164.37 29.27 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.815 -1.92 . . . . 3.07 105.815 171.822 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.7 p -101.76 153.84 19.44 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 116.495 2.035 . . . . 1.34 116.495 175.366 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.8 mt -53.0 -47.34 68.35 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 126.293 2.949 . . . . 1.63 113.996 177.948 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.4 p -60.86 -24.65 66.07 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.061 -4.15 . . . . 1.51 120.384 174.38 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.28 -30.18 70.55 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 123.147 2.703 . . . . 1.9 114.798 172.946 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -86.87 -12.79 46.76 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.733 2.813 . . . . 0.97 114.646 177.611 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 66.47 45.03 2.21 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.472 -1.695 . . . . 2.35 114.582 -174.311 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.9 mt -98.32 106.71 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 128.327 3.917 . . . . 1.39 110.298 179.01 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -89.45 171.8 9.46 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 110.718 -2.947 . . . . 2.58 116.321 -170.933 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -52.53 137.7 29.55 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.536 1.935 . . . . 2.58 112.403 170.168 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.275 37.0 mt-10 56.4 41.56 28.76 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 119.926 3.306 . . . . 1.71 119.926 178.65 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.8 m -98.62 156.45 16.81 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.184 2.193 . . . . 1.34 110.166 -179.592 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.4 m -106.95 106.48 17.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.914 2.769 . . . . 1.36 111.746 -175.329 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -94.82 164.36 12.96 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.351 2.024 . . . . 2.03 109.298 176.343 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -137.5 122.08 18.5 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 126.235 2.921 . . . . 2.31 107.6 -179.386 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.5 tp -87.92 133.8 33.85 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 111.455 -2.611 . . . . 1.72 117.067 178.185 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.433 HG11 HD23 ' A' ' 8' ' ' LEU . 28.6 m -130.02 173.23 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.184 -2.822 . . . . 1.8 106.008 173.487 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.7 mt . . . . . 0 N--CA 1.429 -1.49 0 O-C-N 118.422 -2.673 . . . . 3.26 108.846 -173.954 . . . . . . . . 0 0 . 1 . 066 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 CA--C 1.49 -1.361 0 N-CA-C 120.207 3.41 . . . . 1.39 120.207 . . . . . . . . . 0 0 . 1 . 066 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -96.62 140.17 31.62 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 105.82 -1.919 . . . . 2.2 105.82 179.862 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.7 pt -136.43 165.16 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 129.928 3.291 . . . . 1.32 108.868 167.877 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -118.95 132.75 56.09 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.28 -2.138 . . . . 2.2 115.476 -175.812 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.7 t -118.29 121.64 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 1 O-C-N 116.056 -4.152 . . . . 1.23 112.825 176.634 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -91.15 128.11 36.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 118.456 2.762 . . . . 2.51 118.456 178.455 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.4 p -79.53 -177.83 6.01 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.069 2.366 . . . . 1.41 113.232 -177.293 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.3 mt -68.04 -43.6 78.34 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 113.939 -1.482 . . . . 2.95 113.203 166.506 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.6 p -73.89 -21.0 60.24 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 123.005 1.383 . . . . 2.52 108.919 -175.861 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.38 23.68 4.38 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 116.539 -3.851 . . . . 1.5 113.281 171.047 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -82.87 136.25 34.67 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 112.664 -3.541 . . . . 1.79 113.059 -176.932 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.4 m -95.69 118.86 33.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 123.916 3.053 . . . . 1.38 109.343 170.588 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.1 mt -90.74 123.58 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 130.509 3.524 . . . . 2.03 108.119 174.766 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 m -97.6 112.26 24.2 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 116.666 -3.771 . . . . 1.61 107.048 -179.67 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.417 HD21 ' HE3' ' A' ' 33' ' ' LYS . 55.4 mt -126.75 152.73 46.47 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.425 1.09 . . . . 2.15 113.469 -178.619 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -107.26 146.47 31.42 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.74 -1.207 . . . . 1.98 107.74 172.046 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 m -149.25 178.4 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 102.236 -3.246 . . . . 1.52 102.236 -177.479 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -138.55 157.57 71.95 Favored Pre-proline 0 N--CA 1.43 -1.47 0 CA-C-O 124.076 1.893 . . . . 2.35 106.196 158.996 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 47.6 Cg_exo -52.92 -23.7 22.03 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 124.943 3.762 . . . . 1.31 118.019 -175.221 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.1 m -79.26 -13.15 59.86 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 120.179 1.354 . . . . 1.71 114.107 178.775 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -72.57 153.87 41.07 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 112.73 0.641 . . . . 1.69 112.73 -179.943 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.2 p -87.41 167.42 14.03 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 126.403 3.001 . . . . 1.33 109.906 174.742 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.7 mm -70.58 -34.19 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 1 O-C-N 116.236 -4.04 . . . . 1.32 109.107 174.202 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.313 29.1 tt0 -51.89 -44.32 63.71 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 116.872 2.175 . . . . 1.62 116.872 168.088 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -71.15 -9.28 57.81 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 119.549 3.166 . . . . 2.13 119.549 179.642 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -87.12 -38.98 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 C-N-CA 126.208 1.803 . . . . 1.23 108.205 167.384 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -75.53 -24.28 56.74 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 117.462 2.393 . . . . 1.97 117.462 177.853 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.07 -45.24 89.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.822 2.449 . . . . 1.19 108.259 165.335 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -57.74 -31.95 66.97 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 118.01 2.596 . . . . 1.92 118.01 164.3 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.8 mt -78.14 -20.79 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 118.816 -2.428 . . . . 1.94 115.859 177.742 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -59.99 -30.13 68.92 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.891 -1.755 . . . . 1.9 112.725 165.606 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -74.06 -51.18 16.57 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.435 -2.041 . . . . 1.55 114.844 168.634 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HE3' HD21 ' A' ' 15' ' ' LEU . 50.0 mmtt -56.48 -55.34 34.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.675 -1.148 . . . . 2.95 111.573 -172.474 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -107.65 -57.71 2.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 126.134 2.147 . . . . 1.48 113.468 -173.188 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.16 9.5 2.12 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 127.05 2.719 . . . . 1.12 116.135 173.849 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.8 mt -88.96 139.19 29.0 Favored Pre-proline 0 N--CA 1.43 -1.467 1 CA-C-O 111.678 -4.01 . . . . 2.07 111.379 -174.665 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -77.81 151.53 28.11 Favored 'Trans proline' 0 C--N 1.3 -2.0 1 CA-C-N 133.151 5.732 . . . . 1.39 110.936 -171.945 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.45 -17.04 43.9 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 O-C-N 125.453 2.291 . . . . 1.68 112.641 -176.011 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -54.41 -59.95 3.99 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 114.807 -2.52 . . . . 2.25 110.998 167.628 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -70.39 -17.33 63.03 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.394 3.878 . . . . 2.44 117.55 -176.525 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -95.8 147.18 23.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.431 -0.793 . . . . 1.32 111.912 -178.984 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -136.59 139.56 42.21 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.604 -3.185 . . . . 3.19 113.186 170.674 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.8 mt -96.49 143.44 27.5 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.065 -3.522 . . . . 1.75 118.901 174.371 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.8 mt -119.53 139.84 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 102.409 -3.182 . . . . 1.98 102.409 179.317 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -145.58 120.57 10.03 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 101.47 -3.53 . . . . 1.94 101.47 168.673 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.8 52.08 1.71 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 120.05 3.352 . . . . 1.67 120.05 173.874 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.75 2.59 6.38 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 129.094 3.235 . . . . 1.3 116.939 177.818 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -120.93 152.9 37.94 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.609 -2.701 . . . . 2.89 109.56 174.873 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -84.96 138.33 32.55 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.337 2.494 . . . . 2.89 109.119 174.629 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.3 mt -94.69 145.21 25.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.239 2.216 . . . . 1.34 109.153 -175.913 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -85.97 142.67 28.63 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.932 -2.355 . . . . 1.94 113.869 170.432 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -59.05 -58.62 7.84 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.821 3.649 . . . . 1.56 112.64 -175.227 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.23 39.39 3.05 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 127.826 2.632 . . . . 0.97 115.301 172.474 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.7 mmm-85 -110.35 150.62 28.52 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.811 2.719 . . . . 3.07 107.333 155.232 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.1 p -76.28 155.98 33.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.322 -3.361 . . . . 1.34 109.841 172.632 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.418 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 46.8 mt -60.36 -39.4 87.05 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 114.309 1.225 . . . . 1.63 114.309 172.093 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.288 82.7 p -50.62 -42.4 56.03 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.306 -3.371 . . . . 1.51 112.504 175.347 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -56.49 -42.17 77.86 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.537 -3.227 . . . . 1.9 111.804 176.175 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -87.12 -13.57 43.8 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 114.5 -2.667 . . . . 0.97 112.769 177.125 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 70.23 24.71 4.77 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.704 2.669 . . . . 2.35 117.05 -178.971 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.0 mt -70.37 112.54 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 113.064 -1.88 . . . . 1.39 111.531 179.061 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -87.95 179.52 6.42 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.123 -1.611 . . . . 2.58 108.658 178.209 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -55.7 142.25 34.93 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 130.911 3.684 . . . . 2.58 117.796 173.251 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.46 37.6 mt-10 77.21 10.84 2.4 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.499 -2.001 . . . . 1.71 113.769 170.029 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.1 m -75.08 146.13 41.72 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.648 3.179 . . . . 1.34 111.717 177.773 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.2 m -111.02 113.22 25.6 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 125.323 2.487 . . . . 1.36 105.241 -179.294 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.4 mt -96.73 127.19 42.48 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 125.968 1.707 . . . . 2.03 111.39 175.883 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -84.89 136.84 33.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.987 -1.695 . . . . 2.31 109.842 -177.4 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tp -104.75 121.01 42.72 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.457 2.348 . . . . 1.72 105.26 178.792 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 m -123.65 163.95 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 119.59 -1.944 . . . . 1.8 106.299 172.847 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.6 mt . . . . . 0 N--CA 1.431 -1.397 0 O-C-N 119.389 -2.07 . . . . 3.26 112.019 176.281 . . . . . . . . 0 0 . 1 . 067 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 ptt? . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 114.284 1.216 . . . . 1.39 114.284 . . . . . . . . . 0 0 . 1 . 067 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -112.77 122.94 49.14 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 125.828 1.955 . . . . 2.2 112.229 -171.052 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.4 HG21 ' H ' ' A' ' 65' ' ' SER . 5.7 pt -113.07 157.61 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 126.324 2.265 . . . . 1.32 116.175 167.348 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -103.66 125.39 50.13 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.672 1.589 . . . . 2.2 110.165 -174.818 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 t -103.0 125.61 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.109 -2.245 . . . . 1.23 110.974 173.887 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -93.4 118.05 30.83 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.679 2.487 . . . . 2.51 113.009 176.097 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -94.84 171.53 8.72 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.566 -1.959 . . . . 1.41 109.749 -174.421 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.4 mt -83.19 -5.59 59.18 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 117.713 2.486 . . . . 2.95 117.713 171.613 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -88.64 -32.57 17.98 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 104.941 -2.244 . . . . 2.52 104.941 179.88 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.8 37.61 1.04 Allowed Glycine 0 N--CA 1.429 -1.777 0 C-N-CA 126.56 2.028 . . . . 1.5 110.853 -179.952 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -106.7 144.92 32.66 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.764 -1.433 . . . . 1.79 109.798 -179.94 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.5 m -104.84 114.41 28.61 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.564 2.746 . . . . 1.38 108.002 168.462 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.4 mt -109.96 116.66 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 118.55 -2.594 . . . . 2.03 105.062 -168.712 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 m -89.84 97.07 10.98 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.387 1.875 . . . . 1.61 109.944 179.005 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.2 mt -96.5 131.78 42.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 112.531 -2.122 . . . . 2.15 116.383 177.632 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -88.23 111.22 21.4 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.967 2.907 . . . . 1.98 109.787 172.461 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.54 158.26 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 116.565 -3.835 . . . . 1.52 104.447 -172.543 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -103.01 161.23 23.74 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 117.348 -1.311 . . . . 2.35 111.716 169.064 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -75.67 -11.95 20.27 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 CA-C-N 121.008 1.396 . . . . 1.31 113.731 -168.252 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.4 p -85.75 -6.3 59.13 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 125.611 1.819 . . . . 1.71 110.733 175.785 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -76.46 149.69 36.77 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 123.851 1.786 . . . . 1.69 109.138 172.574 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.299 63.3 p -90.17 166.54 13.32 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.881 2.277 . . . . 1.33 108.967 -179.578 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.441 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 19.8 mm -63.79 -36.69 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 111.933 -2.394 . . . . 1.32 110.1 179.956 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -53.14 -42.12 65.76 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 121.509 3.892 . . . . 1.62 121.509 163.142 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 -59.97 -27.51 66.89 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.406 2.373 . . . . 2.13 117.406 173.302 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.9 t -72.23 -47.14 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 C-N-CA 127.112 2.165 . . . . 1.23 114.331 169.302 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -60.37 -29.4 68.9 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 113.972 -1.467 . . . . 1.97 112.593 172.5 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.26 -25.58 65.25 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 116.002 -4.186 . . . . 1.19 117.295 -179.556 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -76.77 -35.1 57.93 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 127.156 2.182 . . . . 1.92 109.533 179.471 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.4 mt -71.64 -32.96 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 126.311 1.845 . . . . 1.94 108.88 174.344 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -62.84 -45.42 92.67 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.736 -4.353 . . . . 1.9 111.887 173.376 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -50.73 -60.91 2.56 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 116.206 1.928 . . . . 1.55 116.206 168.063 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -65.14 -62.28 1.64 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.067 2.547 . . . . 2.95 111.45 -174.472 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -105.41 -38.39 6.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.458 -1.401 . . . . 1.48 109.933 -160.596 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.7 -11.2 7.49 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 117.575 -3.203 . . . . 1.12 114.063 168.152 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.0 mt -67.1 124.18 88.21 Favored Pre-proline 0 N--CA 1.429 -1.497 0 O-C-N 119.814 -1.992 . . . . 2.07 108.549 -174.451 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.83 145.05 35.75 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 CA-C-N 120.847 1.338 . . . . 1.39 109.578 172.976 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.03 -0.39 3.99 Favored 'Trans proline' 0 C--N 1.3 -2.009 1 C-N-CA 127.634 5.556 . . . . 1.68 115.975 -169.732 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -91.36 -13.91 31.64 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.117 1.78 . . . . 2.25 113.028 169.99 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -87.94 -45.65 10.06 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 121.47 1.941 . . . . 2.44 111.793 178.815 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -79.33 126.69 31.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.375 2.512 . . . . 1.32 110.963 -176.384 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -113.35 151.15 31.61 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 117.538 -3.226 . . . . 3.19 107.683 171.537 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.1 mt -114.58 120.53 40.49 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 126.223 2.202 . . . . 1.75 111.676 176.817 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.269 82.7 mt -105.49 132.32 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 N-CA-C 115.195 1.554 . . . . 1.98 115.195 175.734 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -148.18 126.36 12.17 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 119.008 -2.308 . . . . 1.94 112.57 173.916 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.17 21.56 7.15 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.874 1.805 . . . . 1.67 115.874 -175.645 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.7 8.48 77.04 Favored Glycine 0 N--CA 1.429 -1.774 1 C-N-CA 131.967 4.603 . . . . 1.3 113.575 -173.451 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -101.38 128.99 47.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.858 -1.534 . . . . 2.89 106.858 179.14 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -74.21 112.03 9.95 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 127.893 2.477 . . . . 2.89 114.02 170.365 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 mt -83.11 124.27 30.32 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 117.741 -1.584 . . . . 1.34 114.725 -163.317 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -75.73 135.36 40.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.344 -3.347 . . . . 1.94 110.849 -178.976 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.441 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -63.05 -45.17 93.5 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 109.144 -3.662 . . . . 1.56 115.941 -168.317 . . . . . . . . 3 3 . 1 . 067 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.18 29.82 1.63 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 118.246 2.058 . . . . 0.97 118.246 166.703 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.5 mtp180 -120.53 158.16 27.89 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 124.21 1.957 . . . . 3.07 111.72 163.452 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.3 p -89.16 168.58 12.18 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 124.216 1.96 . . . . 1.34 114.312 171.585 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.331 8.4 mt -66.7 -38.52 86.9 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 110.845 -2.888 . . . . 1.63 105.25 174.603 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -68.09 -32.53 72.91 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.896 -3.002 . . . . 1.51 111.919 -179.021 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.32 38.0 t0 -63.08 -47.73 81.63 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.484 2.031 . . . . 1.9 116.484 174.219 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -73.86 -9.47 58.68 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.444 -3.91 . . . . 0.97 114.97 168.777 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.4 t30 66.63 58.37 0.64 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.662 2.385 . . . . 2.35 113.804 -178.883 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mt -100.67 120.78 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 126.253 1.821 . . . . 1.39 110.087 -178.15 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.23 174.78 5.98 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.539 1.638 . . . . 2.58 111.792 -174.521 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -53.66 148.51 9.62 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.876 -3.64 . . . . 2.58 114.959 169.199 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.251 86.3 mt-10 67.79 25.18 8.03 Favored 'General case' 0 N--CA 1.431 -1.378 1 C-N-CA 132.699 4.4 . . . . 1.71 110.372 178.495 . . . . . . . . 3 2 . 1 . 067 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.4 ' H ' HG21 ' A' ' 3' ' ' ILE . 69.0 m -75.86 143.9 41.52 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.58 2.61 . . . . 1.34 110.481 -177.496 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.6 m -100.64 97.16 7.86 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.949 -3.594 . . . . 1.36 110.209 -179.519 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.4 mt -91.64 128.76 37.59 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 126.033 2.083 . . . . 2.03 111.54 -178.676 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -89.09 116.12 27.13 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.93 -3.606 . . . . 2.31 113.09 177.34 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 tt -97.54 123.05 41.28 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 104.935 -2.246 . . . . 1.72 104.935 -177.737 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.52 176.41 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 O-C-N 118.686 -2.508 . . . . 1.8 106.135 174.677 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 N--CA 1.431 -1.39 0 CA-C-O 125.121 2.391 . . . . 3.26 105.58 173.385 . . . . . . . . 0 0 . 1 . 068 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 CA--C 1.49 -1.338 0 CA-C-O 118.662 -0.685 . . . . 1.39 112.825 . . . . . . . . . 0 0 . 1 . 068 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -97.96 148.74 23.16 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 120.316 1.416 . . . . 2.2 112.784 -176.492 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.0 pt -130.51 169.05 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.896 -2.377 . . . . 1.32 106.647 171.85 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -112.82 125.93 54.88 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.862 1.43 . . . . 2.2 114.862 179.585 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 t -114.76 116.64 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 126.782 3.182 . . . . 1.23 110.26 173.922 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -92.1 119.03 31.4 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 111.202 -2.726 . . . . 2.51 112.057 179.093 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.1 p -75.1 179.41 5.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.885 2.074 . . . . 1.41 111.488 -178.815 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.4 mt -60.59 -41.15 94.12 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.991 -1.068 . . . . 2.95 113.321 177.384 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.5 p -84.85 -38.21 19.76 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 115.491 -2.195 . . . . 2.52 116.9 178.434 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.92 29.57 0.22 Allowed Glycine 0 N--CA 1.429 -1.826 0 O-C-N 126.991 2.682 . . . . 1.5 111.91 175.571 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -86.76 131.49 34.12 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 119.99 1.895 . . . . 1.79 110.03 175.466 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.5 m -90.93 112.15 23.9 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 117.694 -1.603 . . . . 1.38 109.312 177.188 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.3 mm -95.43 117.21 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 102.666 -3.087 . . . . 2.03 102.666 178.72 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.7 m -100.32 105.13 16.63 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.176 -1.787 . . . . 1.61 106.176 -178.049 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' A' ' 29' ' ' LYS . 24.4 mt -103.12 146.24 28.69 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 118.592 -0.718 . . . . 2.15 109.881 -177.835 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -92.4 139.15 30.89 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 106.407 -1.701 . . . . 1.98 106.407 170.232 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.6 m -142.98 -177.58 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 100.204 -3.999 . . . . 1.52 100.204 -176.831 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -125.94 161.04 53.77 Favored Pre-proline 0 N--CA 1.43 -1.456 0 C-N-CA 128.28 2.632 . . . . 2.35 105.486 169.196 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -62.74 -21.99 73.51 Favored 'Trans proline' 0 C--N 1.3 -2.009 1 C-N-CA 127.832 5.688 . . . . 1.31 111.115 174.792 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 p -83.56 -5.59 59.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 125.898 1.999 . . . . 1.71 113.13 179.936 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -81.29 142.41 33.14 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 120.906 1.685 . . . . 1.69 112.533 179.18 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.2 p -87.88 165.28 15.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 128.143 3.402 . . . . 1.33 113.925 175.376 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.458 HG13 ' HB3' ' A' ' 50' ' ' LEU . 20.2 mm -62.67 -37.19 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 124.697 1.199 . . . . 1.32 111.643 177.957 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -54.94 -42.39 72.22 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 118.656 2.836 . . . . 1.62 118.656 168.515 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -62.88 -36.46 83.37 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 116.873 -3.642 . . . . 2.13 111.774 -178.998 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 30' ' ' ILE . 88.3 t -59.83 -48.29 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 C-N-CA 128.84 2.856 . . . . 1.23 114.112 171.229 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -55.85 -43.68 77.31 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 115.242 1.571 . . . . 1.97 115.242 169.689 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.62 -36.69 85.06 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.585 -3.197 . . . . 1.19 115.939 172.467 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.457 ' HB3' HD21 ' A' ' 15' ' ' LEU 0.281 41.2 mttm -54.42 -53.87 48.3 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.425 1.89 . . . . 1.92 112.566 167.867 . . . . . . . . 3 3 . 1 . 068 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 26' ' ' VAL . 71.9 mt -59.14 -34.79 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 O-C-N 118.198 -2.814 . . . . 1.94 117.751 176.373 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -69.14 -37.25 78.2 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 113.008 -1.906 . . . . 1.9 110.576 178.05 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -65.52 -41.85 92.65 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.988 2.327 . . . . 1.55 115.861 167.661 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -58.97 -82.12 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 125.779 2.704 . . . . 2.95 115.704 -177.73 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -95.56 -23.25 17.16 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.633 2.773 . . . . 1.48 112.939 -171.596 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.14 46.25 3.9 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 117.577 -2.249 . . . . 1.12 113.549 176.165 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.4 mt -105.38 132.09 21.18 Favored Pre-proline 0 N--CA 1.429 -1.475 0 CA-C-O 114.337 -2.744 . . . . 2.07 104.448 178.911 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -67.75 140.55 51.53 Favored 'Trans proline' 0 N--CA 1.434 -1.999 0 CA-C-N 125.439 2.978 . . . . 1.39 117.773 -178.402 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -75.27 -10.59 20.83 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 N-CA-C 120.835 3.359 . . . . 1.68 120.835 -174.173 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -88.7 17.77 5.25 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.35 1.46 . . . . 2.25 108.587 168.507 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -115.24 -31.68 5.91 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.927 -2.983 . . . . 2.44 107.167 -177.686 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -84.09 121.89 28.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 131.457 3.903 . . . . 1.32 117.315 -165.751 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -116.72 122.15 43.66 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.862 1.665 . . . . 3.19 107.545 -179.19 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -95.45 117.7 30.85 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 116.099 -1.905 . . . . 1.75 108.575 -178.427 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.406 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 30.0 mm -101.62 125.11 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 129.308 3.043 . . . . 1.98 111.294 176.888 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -150.9 115.59 5.2 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 127.892 3.71 . . . . 1.94 106.886 174.694 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 46.34 0.77 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 109.098 -3.683 . . . . 1.67 113.939 178.872 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.02 -16.29 0.88 Allowed Glycine 0 N--CA 1.43 -1.712 0 CA-C-O 116.558 -2.246 . . . . 1.3 118.398 -171.189 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -101.5 157.13 17.04 Favored 'General case' 0 N--CA 1.43 -1.464 1 CA-C-N 125.797 4.799 . . . . 2.89 103.326 -175.047 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -95.44 141.86 28.49 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.517 2.103 . . . . 2.89 106.3 172.779 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.458 ' HB3' HG13 ' A' ' 23' ' ' ILE . 81.7 mt -89.84 136.58 32.96 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.65 -2.531 . . . . 1.34 116.658 -169.909 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -65.29 133.05 50.6 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 120.999 3.703 . . . . 1.94 120.999 175.501 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -60.07 -49.67 76.75 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.759 2.695 . . . . 1.56 114.436 -170.567 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.76 45.61 1.41 Allowed Glycine 0 N--CA 1.43 -1.733 0 CA-C-N 111.374 -2.648 . . . . 0.97 116.653 179.303 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.422 ' HD3' ' CE2' ' A' ' 59' ' ' TYR . 62.3 ttt180 -130.54 127.41 39.05 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 128.271 2.983 . . . . 3.07 112.769 169.576 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.375 2.6 p -63.04 167.04 5.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 121.038 3.718 . . . . 1.34 121.038 173.738 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.4 mt -74.0 -43.28 58.59 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.662 -1.899 . . . . 1.63 110.935 176.464 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 t -60.59 -42.26 96.38 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 122.491 1.139 . . . . 1.51 114.035 176.053 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -56.03 -38.21 70.25 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 121.055 3.724 . . . . 1.9 121.055 173.575 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.422 ' CE2' ' HD3' ' A' ' 54' ' ' ARG . 21.8 m-85 -80.99 -15.87 55.0 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.282 -2.137 . . . . 0.97 111.158 175.242 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.3 m120 77.94 34.63 0.31 Allowed 'General case' 0 N--CA 1.43 -1.462 1 C-N-CA 132.998 4.519 . . . . 2.35 114.067 -177.732 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -89.69 117.48 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 130.295 3.438 . . . . 1.39 114.901 176.61 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -110.34 -178.23 3.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.031 1.872 . . . . 2.58 108.536 -174.869 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -59.11 153.5 17.88 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.4 -3.313 . . . . 2.58 116.251 179.128 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.3 32.2 mt-10 65.11 31.45 10.99 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 125.223 1.409 . . . . 1.71 110.817 175.115 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.2 t -96.67 152.06 19.02 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 104.06 -2.57 . . . . 1.34 104.06 -175.458 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.3 m -109.95 109.53 20.17 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.781 -1.824 . . . . 1.36 113.84 178.515 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.1 mt -106.39 145.33 31.86 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 128.943 2.897 . . . . 2.03 109.384 176.407 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 96.9 m-70 -109.41 127.52 54.44 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 114.239 -2.791 . . . . 2.31 112.72 -175.207 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.3 tp -93.81 120.89 34.67 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 123.444 2.838 . . . . 1.72 113.0 -175.517 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.9 t -110.62 149.42 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 108.101 -1.074 . . . . 1.8 108.101 175.923 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.2 mt . . . . . 0 N--CA 1.429 -1.478 0 CA-C-O 123.161 1.458 . . . . 3.26 114.531 -179.624 . . . . . . . . 0 0 . 1 . 069 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 CA--C 1.49 -1.331 0 CA-C-O 123.532 1.634 . . . . 1.39 113.204 . . . . . . . . . 0 0 . 1 . 069 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -106.29 125.48 51.05 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.886 -2.384 . . . . 2.2 111.088 -173.702 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.1 pt -120.82 165.58 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 106.266 -1.753 . . . . 1.32 106.266 169.584 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -120.11 139.54 52.43 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.27 -2.769 . . . . 2.2 114.814 -177.02 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.1 t -124.22 125.85 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 118.456 -2.652 . . . . 1.23 108.58 174.029 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -90.6 122.92 33.82 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.798 -4.314 . . . . 2.51 109.695 176.567 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.0 p -91.0 167.32 12.48 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 126.905 2.082 . . . . 1.41 114.828 -179.758 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.3 mt -69.64 -36.8 76.41 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 113.961 1.097 . . . . 2.95 113.961 179.607 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.2 p -74.39 -67.63 0.6 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 130.637 3.575 . . . . 2.52 111.808 -176.881 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.95 62.78 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.638 0 CA-C-O 115.37 -2.906 . . . . 1.5 117.596 171.644 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -150.71 139.16 20.47 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 125.725 2.679 . . . . 1.79 113.818 179.91 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.7 m -102.6 97.42 7.62 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 103.861 -2.644 . . . . 1.38 103.861 174.994 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 mt -65.21 121.57 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 116.763 2.135 . . . . 2.03 116.763 176.184 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.4 m -84.94 105.94 16.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 122.572 2.442 . . . . 1.61 110.119 177.235 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.4 mt -101.11 133.77 45.13 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 123.44 1.591 . . . . 2.15 110.193 178.875 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -98.12 110.85 23.36 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 114.652 1.353 . . . . 1.98 114.652 166.909 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.458 HG22 HD11 ' A' ' 56' ' ' LEU . 8.9 m -127.08 176.36 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 128.169 2.588 . . . . 1.52 108.896 -174.8 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -116.18 163.76 20.42 Favored Pre-proline 0 N--CA 1.43 -1.455 0 C-N-CA 127.861 2.465 . . . . 2.35 106.56 161.777 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -84.58 -6.91 9.82 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 O-C-N 116.569 -2.385 . . . . 1.31 109.751 -166.474 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.4 m -93.23 -6.28 48.0 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.501 2.037 . . . . 1.71 116.501 174.626 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -69.18 147.17 51.71 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 118.801 -1.16 . . . . 1.69 109.639 174.523 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 75.7 p -82.88 175.51 10.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.432 -2.043 . . . . 1.33 112.128 -178.72 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.8 mm -70.24 -42.89 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-O 123.918 1.818 . . . . 1.32 109.316 173.646 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -47.03 -47.77 22.29 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 119.022 2.971 . . . . 1.62 119.022 162.706 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -65.75 -38.18 88.38 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 116.174 -4.079 . . . . 2.13 114.132 174.958 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.42 HG21 HD13 ' A' ' 56' ' ' LEU . 53.5 t -62.52 -39.31 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 126.758 3.171 . . . . 1.23 111.103 176.012 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -65.99 -33.43 75.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.586 -2.571 . . . . 1.97 114.094 174.131 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.59 -34.1 77.13 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.308 2.255 . . . . 1.19 115.004 173.739 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -74.67 -16.28 60.77 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.309 -2.744 . . . . 1.92 114.811 174.995 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.3 mt -87.0 -36.17 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 127.102 3.334 . . . . 1.94 107.487 171.657 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.97 -38.52 88.77 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.203 -2.811 . . . . 1.9 109.099 -178.274 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -55.93 -48.08 76.36 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.913 -2.992 . . . . 1.55 115.647 170.469 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -79.37 -52.16 8.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.141 -1.6 . . . . 2.95 113.446 -176.243 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -112.44 -8.84 13.87 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.83 1.3 . . . . 1.48 110.386 -161.67 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.98 21.72 60.68 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 118.223 -2.798 . . . . 1.12 113.995 173.601 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mt -83.7 123.38 76.31 Favored Pre-proline 0 N--CA 1.431 -1.386 0 CA-C-O 112.655 -3.545 . . . . 2.07 115.342 -174.555 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -65.81 136.45 45.5 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 CA-C-N 127.199 3.607 . . . . 1.39 116.269 -179.69 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -60.71 -23.0 75.09 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 N-CA-C 117.383 2.032 . . . . 1.68 117.383 -177.286 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.17 -19.5 61.1 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.233 2.213 . . . . 2.25 109.9 177.716 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -92.22 -39.84 11.32 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 130.271 3.428 . . . . 2.44 109.963 -170.654 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -74.45 123.77 25.32 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 113.458 -1.701 . . . . 1.32 113.863 -171.216 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -117.61 123.48 46.28 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 124.379 1.049 . . . . 3.19 109.216 167.792 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.5 mt -105.49 131.34 53.02 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.117 2.389 . . . . 1.75 106.264 -175.965 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.2 mm -116.9 145.57 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 120.349 -1.469 . . . . 1.98 113.49 -178.888 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -161.06 105.07 1.32 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.686 1.736 . . . . 1.94 115.686 174.821 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.468 . . 61.68 32.37 18.41 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 118.003 2.594 . . . . 1.67 118.003 -179.87 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.48 -15.55 45.86 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 119.163 0.892 . . . . 1.3 112.173 -177.497 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -102.46 124.71 48.51 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.732 -2.628 . . . . 2.89 115.277 174.694 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -81.3 145.97 30.63 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 102.714 -3.069 . . . . 2.89 102.714 165.129 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.3 mt -101.75 123.33 45.54 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 114.809 1.411 . . . . 1.34 114.809 -172.954 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.56 157.49 18.59 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 116.489 -2.085 . . . . 1.94 115.174 175.289 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.26 -63.55 1.19 Allowed 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 118.509 2.781 . . . . 1.56 118.509 -165.106 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.68 30.83 4.07 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 116.943 1.537 . . . . 0.97 116.943 176.418 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.7 mmt-85 -99.21 159.0 15.3 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 119.052 -1.059 . . . . 3.07 110.046 162.384 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.8 p -97.19 162.87 13.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.692 -3.755 . . . . 1.34 114.163 178.949 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.458 HD11 HG22 ' A' ' 17' ' ' VAL . 62.5 mt -58.24 -14.82 8.0 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 126.367 2.984 . . . . 1.63 113.864 170.436 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 t -85.12 -42.34 14.87 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.388 -2.695 . . . . 1.51 116.089 172.543 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -63.82 -39.48 94.34 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 127.833 2.453 . . . . 1.9 110.929 175.426 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -80.0 -8.7 59.49 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.784 2.034 . . . . 0.97 110.925 174.923 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.337 57.1 m-80 54.44 45.43 27.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.196 3.406 . . . . 2.35 120.196 -175.979 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.4 mm -78.68 123.99 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 126.132 1.773 . . . . 1.39 113.159 174.65 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -101.89 175.88 5.4 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 114.58 1.326 . . . . 2.58 114.58 -172.333 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -70.45 129.85 40.34 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 126.691 3.139 . . . . 2.58 112.537 -179.603 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.477 7.0 mt-10 67.7 35.99 3.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 125.499 2.571 . . . . 1.71 112.551 -179.858 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.301 4.4 t -94.63 126.94 40.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 109.559 -3.473 . . . . 1.34 110.29 -176.537 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.7 m -96.14 119.55 34.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.948 -1.72 . . . . 1.36 111.061 -169.845 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.5 mt -97.75 148.02 23.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 129.01 2.924 . . . . 2.03 108.745 175.249 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -106.71 137.42 44.76 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.744 -4.348 . . . . 2.31 106.264 178.566 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.5 tp -108.73 121.03 44.19 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.754 -3.091 . . . . 1.72 110.526 -178.106 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.0 t -109.85 153.6 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 130.969 3.707 . . . . 1.8 107.707 178.991 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.429 -1.496 0 O-C-N 119.079 -2.263 . . . . 3.26 115.251 178.427 . . . . . . . . 0 0 . 1 . 070 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 ptt? . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 115.09 1.515 . . . . 1.39 115.09 . . . . . . . . . 0 0 . 1 . 070 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -101.86 133.87 45.93 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.056 -1.652 . . . . 2.2 113.973 -172.652 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -130.77 159.93 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 104.321 -2.474 . . . . 1.32 104.321 174.275 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -119.55 120.87 38.0 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.065 2.946 . . . . 2.2 110.053 -174.111 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.404 ' CG1' ' HB2' ' A' ' 69' ' ' LEU . 94.9 t -105.69 115.19 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 119.889 -1.757 . . . . 1.23 110.439 172.979 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -96.37 134.21 39.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 103.639 -2.726 . . . . 2.51 103.639 179.626 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.269 28.0 p -80.86 169.85 17.04 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 118.044 -2.91 . . . . 1.41 112.665 171.813 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.4 mt -54.81 -49.64 70.52 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.961 3.305 . . . . 2.95 116.951 167.916 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.49 -62.26 1.47 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.408 3.004 . . . . 2.52 107.993 -172.029 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.78 12.27 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 116.929 -2.558 . . . . 1.5 116.78 179.618 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.416 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 86.4 mttt -101.01 154.43 18.71 Favored 'General case' 0 N--CA 1.429 -1.504 1 CA-C-N 126.147 4.974 . . . . 1.79 106.895 -169.148 . . . . . . . . 3 3 . 1 . 070 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -113.04 108.91 17.97 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.426 -1.421 . . . . 1.38 108.928 167.063 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.9 mt -88.36 124.5 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 105.823 -1.918 . . . . 2.03 105.823 177.999 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.0 m -91.44 130.52 37.27 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 104.721 -2.325 . . . . 1.61 104.721 179.298 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mt -118.56 155.4 30.97 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 112.969 0.729 . . . . 2.15 112.969 179.685 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -113.03 130.14 56.25 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 100.596 -3.853 . . . . 1.98 100.596 167.765 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.1 m -143.95 156.35 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 126.39 1.876 . . . . 1.52 107.506 -176.805 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 36.1 mm-40 -114.21 154.46 46.26 Favored Pre-proline 0 N--CA 1.431 -1.416 0 C-N-CA 126.141 1.776 . . . . 2.35 110.036 168.042 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 53.4 Cg_exo -73.72 -25.7 14.4 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 CA-C-N 125.672 3.062 . . . . 1.31 117.195 -165.355 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -91.24 4.58 51.95 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 122.575 1.179 . . . . 1.71 113.657 177.984 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -64.77 149.43 49.3 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 115.018 -2.673 . . . . 1.69 112.649 165.995 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.319 21.6 p -87.03 169.45 12.41 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 116.049 -2.26 . . . . 1.33 112.743 177.656 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.91 -37.06 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 113.16 0.8 . . . . 1.32 113.16 171.185 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -57.42 -37.57 72.97 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.656 -3.152 . . . . 1.62 110.663 172.059 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -75.42 -28.12 59.27 Favored 'General case' 0 N--CA 1.43 -1.473 1 O-C-N 115.174 -4.704 . . . . 2.13 111.448 -179.217 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.9 t -71.07 -39.51 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.122 1.369 . . . . 1.23 112.474 172.239 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -63.83 -39.91 95.34 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 118.958 0.799 . . . . 1.97 111.97 170.966 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.14 68.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 119.977 3.325 . . . . 1.19 119.977 172.068 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -63.35 -35.44 80.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 115.32 -2.276 . . . . 1.92 112.91 165.856 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.3 mt -73.8 -40.17 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 123.138 2.699 . . . . 1.94 110.608 171.112 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -51.47 -45.89 62.92 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.671 2.788 . . . . 1.9 117.28 176.425 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -60.57 -28.83 68.77 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.433 -2.667 . . . . 1.55 116.279 174.957 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -94.93 -61.83 1.42 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 104.893 -2.262 . . . . 2.95 104.893 -173.139 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.416 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 42.1 mm-40 -98.87 -8.43 25.71 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 118.894 -2.378 . . . . 1.48 113.486 -169.744 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.76 5.64 89.68 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 118.389 -2.694 . . . . 1.12 113.365 174.695 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.1 mt -88.02 131.75 41.99 Favored Pre-proline 0 N--CA 1.429 -1.505 0 CA-C-N 121.523 2.662 . . . . 2.07 111.742 -175.086 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -64.58 146.57 89.29 Favored 'Trans proline' 0 C--N 1.3 -1.993 1 CA-C-N 129.058 4.271 . . . . 1.39 118.274 -177.359 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -68.33 -11.86 33.23 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 C-N-CA 123.029 2.486 . . . . 1.68 113.696 -177.581 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -77.87 -24.98 48.32 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.787 -3.696 . . . . 2.25 110.757 170.787 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -83.16 -39.71 20.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 116.352 -2.139 . . . . 2.44 108.49 176.67 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -63.93 125.8 25.6 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 126.611 1.965 . . . . 1.32 113.604 -172.171 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -118.9 118.52 31.75 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.158 -2.839 . . . . 3.19 108.19 170.708 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.6 mt -98.4 128.81 44.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.139 -2.225 . . . . 1.75 112.243 -174.788 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mm -110.05 137.57 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 125.386 1.474 . . . . 1.98 107.543 -179.812 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -146.61 144.59 29.64 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 125.963 1.705 . . . . 1.94 108.392 165.806 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.24 -107.53 0.15 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 123.832 0.707 . . . . 1.67 112.014 172.496 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.2 18.11 4.75 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 108.134 -1.987 . . . . 1.3 108.134 177.333 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -133.45 149.28 51.78 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.606 1.669 . . . . 2.89 114.455 177.114 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -93.67 130.65 39.54 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.238 -4.039 . . . . 2.89 103.831 174.271 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.336 79.4 mt -87.24 138.06 31.81 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.589 -1.944 . . . . 1.34 113.743 -168.485 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -85.8 164.08 17.77 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 117.85 -3.031 . . . . 1.94 111.671 -179.4 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -67.44 -62.89 1.2 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.315 -3.99 . . . . 1.56 118.931 -170.45 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.93 40.17 0.82 Allowed Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 129.495 3.426 . . . . 0.97 114.03 172.04 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -119.51 158.9 25.34 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.484 3.142 . . . . 3.07 105.605 168.179 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.4 p -100.09 164.17 12.1 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 125.76 1.912 . . . . 1.34 115.356 176.714 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.18 -43.95 97.68 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 117.851 -3.031 . . . . 1.63 109.947 178.667 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.0 m -53.6 -49.51 67.65 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.424 -3.297 . . . . 1.51 116.405 170.759 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -51.82 -39.29 58.54 Favored 'General case' 0 N--CA 1.429 -1.475 1 O-C-N 116.225 -4.047 . . . . 1.9 114.764 172.317 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -85.87 -13.01 49.24 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.325 1.972 . . . . 0.97 116.325 177.006 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.416 27.9 m120 75.03 23.39 1.65 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 124.163 1.935 . . . . 2.35 115.712 -177.772 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.9 mt -77.07 102.06 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 118.34 -2.725 . . . . 1.39 111.77 179.112 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -90.53 -178.99 5.46 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 125.814 2.721 . . . . 2.58 110.398 -176.389 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.4 pttp -66.46 151.69 46.68 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.163 -3.461 . . . . 2.58 113.007 174.396 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.522 90.5 mt-10 90.71 -15.55 0.22 Allowed 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.995 2.918 . . . . 1.71 115.356 -179.102 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.6 m -68.54 137.38 54.3 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.643 2.831 . . . . 1.34 118.643 -171.244 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.5 m -96.6 109.18 21.84 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 119.795 -1.816 . . . . 1.36 113.533 -179.468 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -92.79 163.66 13.64 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.74 3.15 . . . . 2.03 109.92 174.43 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.279 39.1 m80 -124.56 119.82 30.17 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.35 -1.295 . . . . 2.31 107.678 -173.347 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.404 ' HB2' ' CG1' ' A' ' 5' ' ' VAL 0.263 3.4 tt -91.71 104.67 17.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.496 -3.253 . . . . 1.72 115.567 -177.05 . . . . . . . . 3 3 . 1 . 070 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.2 t -93.44 144.46 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 105.674 -1.973 . . . . 1.8 105.674 177.529 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.3 mt . . . . . 0 N--CA 1.431 -1.424 0 CA-C-O 125.601 2.62 . . . . 3.26 111.766 177.623 . . . . . . . . 0 0 . 1 . 071 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptt? . . . . . 0 CA--C 1.49 -1.354 0 N-CA-C 107.393 -1.336 . . . . 1.39 107.393 . . . . . . . . . 0 0 . 1 . 071 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -94.23 126.92 39.77 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 114.134 1.161 . . . . 2.2 114.134 178.649 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.422 HG12 HG22 ' A' ' 17' ' ' VAL . 42.5 pt -115.91 163.08 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 107.628 -1.249 . . . . 1.32 107.628 165.886 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -125.05 132.65 53.16 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.984 -1.073 . . . . 2.2 108.111 -178.196 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.5 t -109.45 130.47 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 105.246 -2.131 . . . . 1.23 105.246 174.736 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -118.31 136.1 53.91 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.826 -2.421 . . . . 2.51 108.258 173.581 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.6 p -87.75 174.02 8.64 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 116.393 -3.942 . . . . 1.41 109.554 177.021 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 70' ' ' VAL . 5.2 mt -73.43 -23.85 60.17 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 127.677 3.608 . . . . 2.95 117.802 172.193 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 p -88.98 -12.91 40.16 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.517 -3.239 . . . . 2.52 107.786 -175.08 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.4 32.53 3.93 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 115.519 0.968 . . . . 1.5 115.519 167.922 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -113.14 137.9 50.75 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 114.279 -2.968 . . . . 1.79 103.493 -178.228 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.271 32.9 m -109.01 125.2 51.82 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.484 2.088 . . . . 1.38 110.783 -179.129 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.7 mt -109.52 121.97 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.828 -3.045 . . . . 2.03 109.629 179.347 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.3 m -95.84 119.4 34.27 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 114.604 -5.06 . . . . 1.61 110.734 176.966 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.7 mt -126.99 138.97 53.35 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 116.953 -3.592 . . . . 2.15 117.49 -176.27 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -97.83 108.8 21.59 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.709 2.003 . . . . 1.98 109.683 178.781 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.422 HG22 HG12 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -120.11 157.23 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 128.283 2.633 . . . . 1.52 108.908 178.514 . . . . . . . . 3 3 . 1 . 071 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -98.06 148.79 34.98 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-O 115.069 -2.396 . . . . 2.35 113.108 156.522 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.88 -13.77 34.83 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 125.29 3.993 . . . . 1.31 113.112 -172.459 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m -74.08 -25.76 60.0 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.705 1.878 . . . . 1.71 106.1 174.354 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -67.19 140.34 57.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.513 -2.617 . . . . 1.69 116.166 -179.828 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.499 HG21 HG22 ' A' ' 55' ' ' THR . 50.7 p -83.28 161.16 21.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 111.397 -2.638 . . . . 1.33 113.094 -172.398 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.465 HG22 ' HE3' ' A' ' 27' ' ' LYS . 29.7 mm -59.09 -46.8 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 1 C-N-CA 134.742 5.217 . . . . 1.32 109.505 176.065 . . . . . . . . 3 3 . 1 . 071 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -47.8 -40.08 19.99 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 127.084 2.154 . . . . 1.62 114.283 163.124 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -76.56 -24.64 53.57 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.765 -3.084 . . . . 2.13 116.71 176.304 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.3 t -74.63 -40.43 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 124.151 0.98 . . . . 1.23 111.733 173.996 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HE3' HG22 ' A' ' 23' ' ' ILE . 91.3 mttt -61.38 -29.23 69.79 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.193 1.797 . . . . 1.97 113.249 173.357 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.22 -33.72 76.39 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.513 -1.992 . . . . 1.19 111.095 175.747 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.271 56.2 mttm -61.74 -43.05 99.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.475 -2.641 . . . . 1.92 114.985 176.287 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.0 mt -70.3 -33.87 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 C-N-CA 127.874 2.469 . . . . 1.94 109.364 175.402 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -64.14 -50.59 67.62 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 116.554 -3.841 . . . . 1.9 112.624 179.805 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -54.04 -49.7 68.38 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.293 2.637 . . . . 1.55 111.403 171.668 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -79.63 -61.23 2.06 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.55 2.426 . . . . 2.95 117.55 -178.478 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -87.3 -29.17 21.81 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.056 2.243 . . . . 1.48 117.056 -167.31 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.07 13.8 14.88 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 119.55 -1.309 . . . . 1.12 113.677 171.823 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.9 mt -96.14 119.67 64.08 Favored Pre-proline 0 N--CA 1.43 -1.434 1 CA-C-O 111.533 -4.079 . . . . 2.07 107.001 -171.053 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -70.57 159.11 53.89 Favored 'Trans proline' 0 N--CA 1.433 -2.035 1 CA-C-N 129.31 4.361 . . . . 1.39 113.831 172.996 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -68.37 -26.37 35.08 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 C-N-CA 122.784 2.323 . . . . 1.68 113.759 -173.131 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -56.47 -33.34 65.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.985 2.514 . . . . 2.25 110.151 174.108 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -98.65 19.79 14.07 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.248 1.944 . . . . 2.44 116.248 175.972 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -127.44 113.15 15.81 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.985 -1.117 . . . . 1.32 107.985 -175.501 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.428 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 14.0 tpp180 -110.28 127.74 55.16 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.797 -0.816 . . . . 3.19 108.797 173.857 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.5 mt -110.3 143.01 41.14 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 112.791 -3.48 . . . . 1.75 114.566 179.419 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.2 mt -128.65 143.24 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 129.031 3.957 . . . . 1.98 105.165 -174.28 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -155.1 136.3 13.95 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.162 -2.211 . . . . 1.94 105.779 168.912 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.251 . . 61.81 26.17 15.84 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 118.556 2.798 . . . . 1.67 118.556 175.837 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.2 -14.13 63.12 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-O 117.557 -1.691 . . . . 1.3 110.604 -173.867 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -97.66 126.95 43.26 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 125.602 1.413 . . . . 2.89 112.794 -171.599 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -80.67 112.31 17.92 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 124.811 2.243 . . . . 2.89 106.448 170.54 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.5 mt -74.67 124.85 27.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.92 2.888 . . . . 1.34 115.664 -176.222 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -87.68 142.11 28.08 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 118.733 2.864 . . . . 1.94 118.733 178.772 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -46.83 -66.77 0.36 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.948 2.499 . . . . 1.56 117.692 -173.072 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.56 35.87 0.84 Allowed Glycine 0 N--CA 1.43 -1.723 0 CA-C-O 125.033 2.463 . . . . 0.97 116.871 171.023 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -115.81 175.64 5.44 Favored 'General case' 0 N--CA 1.429 -1.507 1 O-C-N 113.785 -5.538 . . . . 3.07 107.956 166.299 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.499 HG22 HG21 ' A' ' 22' ' ' THR . 60.0 p -106.95 -174.68 2.59 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.515 -1.99 . . . . 1.34 110.759 175.665 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mt -80.91 -37.01 30.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.877 2.071 . . . . 1.63 108.995 176.449 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.8 t -57.14 -48.4 78.78 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 128.235 3.459 . . . . 1.51 110.884 174.538 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -49.62 -29.7 7.62 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.203 3.038 . . . . 1.9 119.203 175.665 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -111.33 1.55 17.15 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.621 -1.299 . . . . 0.97 109.315 -179.577 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 61.77 40.05 13.36 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.954 2.902 . . . . 2.35 109.324 -178.176 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.9 mt -78.59 114.82 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 124.257 1.98 . . . . 1.39 107.489 172.852 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.403 ' HB3' ' H ' ' A' ' 63' ' ' LYS . 35.5 mt-30 -108.59 -158.58 0.65 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.049 -2.907 . . . . 2.58 115.608 -179.325 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 62' ' ' GLN 0.273 25.3 pttt -74.67 138.74 43.04 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.72 -2.487 . . . . 2.58 113.822 -179.235 . . . . . . . . 3 3 . 1 . 071 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 71.87 31.2 2.13 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 124.723 2.201 . . . . 1.71 114.821 178.852 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.3 m -86.59 121.46 29.15 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 113.161 -1.836 . . . . 1.34 115.138 -178.786 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.1 m -92.88 120.48 33.27 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 118.0 -2.937 . . . . 1.36 107.382 176.028 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.1 mt -94.35 147.8 22.86 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.159 -1.837 . . . . 2.03 107.582 171.832 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -92.35 123.6 35.79 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.85 2.46 . . . . 2.31 108.34 176.941 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.47 117.54 31.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 122.257 2.299 . . . . 1.72 107.601 175.244 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 78.0 t -106.61 129.91 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 130.77 3.628 . . . . 1.8 102.672 -176.191 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.43 -1.443 0 O-C-N 118.446 -2.659 . . . . 3.26 114.129 171.266 . . . . . . . . 0 0 . 1 . 072 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ptt? . . . . . 0 CA--C 1.491 -1.323 0 N-CA-C 116.767 2.136 . . . . 1.39 116.767 . . . . . . . . . 0 0 . 1 . 072 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.293 19.6 mt-30 -107.47 129.52 54.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 103.941 -2.615 . . . . 2.2 103.941 -176.717 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.9 pt -113.79 153.89 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 117.524 -1.226 . . . . 1.32 110.795 165.623 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -107.02 147.64 29.68 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 122.389 1.09 . . . . 2.2 112.528 174.879 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.2 t -124.05 128.22 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.828 2.051 . . . . 1.23 108.105 176.488 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -107.31 144.93 33.45 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.319 -2.113 . . . . 2.51 106.432 178.822 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 p -89.19 -168.17 2.09 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.291 2.7 . . . . 1.41 118.291 179.796 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 mt -65.87 -52.89 46.35 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.956 1.703 . . . . 2.95 111.721 174.696 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.4 p -70.77 -52.59 19.69 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.081 -2.262 . . . . 2.52 115.428 -178.235 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.27 50.49 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 104.529 -3.428 . . . . 1.5 104.529 171.626 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -107.29 147.88 29.69 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.522 -2.752 . . . . 1.79 107.303 175.598 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.0 m -102.21 136.19 42.48 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 103.131 -2.915 . . . . 1.38 103.131 179.034 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.2 mt -122.75 120.75 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-O 125.371 2.51 . . . . 2.03 108.297 176.659 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.1 m -92.75 125.5 37.4 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.391 -2.693 . . . . 1.61 106.398 177.393 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 68.5 mt -116.03 142.4 46.85 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 129.1 4.0 . . . . 2.15 112.657 170.452 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -98.73 123.73 43.13 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 120.656 1.571 . . . . 1.98 109.259 172.026 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.413 HG11 HG22 ' A' ' 26' ' ' VAL . 27.8 m -139.67 171.71 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 O-C-N 118.486 -2.634 . . . . 1.52 106.659 -177.788 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -121.47 162.15 37.66 Favored Pre-proline 0 N--CA 1.43 -1.468 0 N-CA-C 103.21 -2.885 . . . . 2.35 103.21 156.773 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -76.39 -3.4 13.77 Favored 'Trans proline' 0 N--CA 1.434 -1.971 0 C-N-CA 124.595 3.53 . . . . 1.31 111.192 -168.819 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.1 m -86.84 -5.25 59.16 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.614 3.102 . . . . 1.71 113.084 178.543 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -78.79 147.36 33.33 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.873 -3.642 . . . . 1.69 116.919 175.996 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 35.1 p -72.46 158.96 34.76 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 118.183 -0.913 . . . . 1.33 112.814 177.701 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.6 mm -67.87 -31.37 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 126.852 2.595 . . . . 1.32 112.813 173.713 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -60.47 -30.98 70.02 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.352 -2.718 . . . . 1.62 114.353 170.966 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -76.74 -35.82 57.52 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.846 -1.784 . . . . 2.13 109.41 176.037 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.413 HG22 HG11 ' A' ' 17' ' ' VAL . 92.9 t -69.82 -34.21 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 119.105 -2.247 . . . . 1.23 113.099 178.294 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -69.85 -18.18 63.42 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.114 -2.241 . . . . 1.97 115.869 170.783 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.07 -19.47 43.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.303 1.441 . . . . 1.19 112.474 -179.585 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -78.68 -33.4 47.02 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.171 1.788 . . . . 1.92 111.469 172.173 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.3 mt -76.53 -24.08 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 107.603 -1.258 . . . . 1.94 107.603 173.707 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -67.14 -32.08 72.95 Favored 'General case' 0 N--CA 1.429 -1.491 2 O-C-N 114.999 -4.813 . . . . 1.9 115.89 175.042 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -73.59 -31.12 63.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.836 -1.165 . . . . 1.55 112.09 166.795 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -83.66 -72.86 0.44 Allowed 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.45 -2.056 . . . . 2.95 105.45 -170.321 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -93.86 -7.62 42.7 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 115.574 1.694 . . . . 1.48 115.574 -167.309 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.76 16.22 77.98 Favored Glycine 0 N--CA 1.429 -1.782 0 O-C-N 117.679 -3.138 . . . . 1.12 115.74 176.729 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.1 mt -89.03 128.44 51.88 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 116.99 -3.653 . . . . 2.07 104.369 -178.977 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -70.15 142.31 45.88 Favored 'Trans proline' 0 N--CA 1.433 -2.044 0 CA-C-N 126.671 3.418 . . . . 1.39 114.565 179.311 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -58.1 -17.28 30.94 Favored 'Trans proline' 0 N--CA 1.434 -2.022 1 C-N-CA 126.345 4.696 . . . . 1.68 115.905 -176.942 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -75.82 -18.98 59.28 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.346 2.339 . . . . 2.25 116.33 170.337 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -97.37 2.37 50.44 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 121.272 1.851 . . . . 2.44 115.94 179.885 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -105.79 139.75 39.88 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 111.058 -2.792 . . . . 1.32 111.408 -172.225 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -132.73 122.5 24.67 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.174 2.19 . . . . 3.19 112.536 167.59 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.2 mt -88.11 138.86 31.07 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 106.459 -1.682 . . . . 1.75 106.459 174.082 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mt -119.96 132.68 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 127.424 2.29 . . . . 1.98 105.209 178.344 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -155.16 123.1 5.78 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.165 2.257 . . . . 1.94 110.39 170.54 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.284 . . 75.41 37.01 0.46 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.623 3.569 . . . . 1.67 114.152 176.449 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.05 -24.05 6.43 Favored Glycine 0 N--CA 1.43 -1.749 0 CA-C-O 115.777 -2.679 . . . . 1.3 112.412 -173.929 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -102.94 148.1 26.08 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 120.66 2.23 . . . . 2.89 112.102 -175.834 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -88.15 150.46 23.32 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 122.068 0.937 . . . . 2.89 109.542 171.926 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.1 mt -97.02 133.42 41.72 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.251 1.82 . . . . 1.34 108.715 -169.561 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -80.73 146.09 31.21 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.393 -1.276 . . . . 1.94 109.754 177.166 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -65.39 -59.21 4.26 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.211 -3.43 . . . . 1.56 120.092 -169.542 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.98 32.06 1.51 Allowed Glycine 0 N--CA 1.431 -1.692 0 CA-C-N 111.479 -2.601 . . . . 0.97 119.171 173.079 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 22' ' ' THR . 30.8 mmt180 -105.12 176.69 5.08 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 104.2 -2.518 . . . . 3.07 104.2 164.676 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.3 p -107.26 167.22 10.07 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 112.612 -2.085 . . . . 1.34 112.022 171.462 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.9 mt -67.07 -38.31 85.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.058 2.837 . . . . 1.63 113.637 175.678 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.9 t -69.01 -19.2 64.12 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 119.666 3.21 . . . . 1.51 119.666 173.842 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -58.7 -51.99 67.6 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 114.875 -2.488 . . . . 1.9 104.658 172.844 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -81.69 -8.57 59.72 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 129.404 3.081 . . . . 0.97 113.488 -176.053 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 m120 59.98 56.68 3.32 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 116.589 -3.819 . . . . 2.35 117.677 -173.461 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.2 mt -96.54 117.71 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 104.968 -2.234 . . . . 1.39 104.968 -178.284 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -97.71 -176.57 3.51 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.037 -2.289 . . . . 2.58 105.755 -171.85 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.5 pttt -65.85 151.69 46.11 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.644 2.64 . . . . 2.58 116.471 174.521 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 60.98 15.26 5.95 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 131.654 3.981 . . . . 1.71 114.213 176.02 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 t -76.16 150.22 37.19 Favored 'General case' 0 N--CA 1.429 -1.486 1 C-N-CA 132.318 4.247 . . . . 1.34 109.134 -177.541 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.6 m -103.49 105.47 15.74 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.587 -3.196 . . . . 1.36 113.19 -179.417 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -82.77 168.38 17.24 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 106.126 -1.805 . . . . 2.03 106.126 170.902 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -121.56 135.57 55.0 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.31 -2.744 . . . . 2.31 108.867 -179.271 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.4 tp -109.16 117.37 33.95 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.08 2.848 . . . . 1.72 111.386 -177.594 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 t -105.96 146.28 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 1 O-C-N 115.932 -4.23 . . . . 1.8 112.22 174.474 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.9 mt . . . . . 0 N--CA 1.43 -1.452 0 N-CA-C 117.847 2.536 . . . . 3.26 117.847 178.512 . . . . . . . . 0 0 . 1 . 073 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.269 0.7 OUTLIER . . . . . 0 CA--C 1.491 -1.312 0 N-CA-C 104.38 -2.452 . . . . 1.39 104.38 . . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -89.86 127.73 36.05 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 117.263 -1.351 . . . . 2.2 107.557 -179.114 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.3 pt -115.11 138.83 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 122.105 2.23 . . . . 1.32 106.658 165.764 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -97.88 118.23 33.98 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.13 0.972 . . . . 2.2 109.794 -178.008 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.5 t -99.56 124.38 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.613 1.965 . . . . 1.23 106.289 174.069 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -117.62 126.92 53.38 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 125.189 1.396 . . . . 2.51 110.155 -175.395 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.289 7.3 p -74.49 176.01 7.23 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 128.485 2.714 . . . . 1.41 117.344 -179.364 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.9 tp -67.99 -56.11 10.19 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.95 1.705 . . . . 2.95 113.219 166.224 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 p -62.52 -53.02 61.01 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 118.462 2.764 . . . . 2.52 118.462 -176.378 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.79 30.09 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 119.122 2.409 . . . . 1.5 119.122 176.87 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -103.58 138.48 40.2 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 119.061 1.43 . . . . 1.79 107.89 176.697 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.1 m -105.09 118.93 37.78 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.194 -2.15 . . . . 1.38 105.194 169.019 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.6 mt -101.49 115.22 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 106.741 -1.577 . . . . 2.03 106.741 176.592 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.9 m -96.52 124.35 40.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 120.804 1.638 . . . . 1.61 112.493 176.004 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.268 84.0 mt -116.03 127.71 55.12 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 127.959 3.743 . . . . 2.15 109.688 -173.217 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -80.02 108.21 13.43 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.1 -3.5 . . . . 1.98 114.68 168.723 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.87 160.87 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 125.373 1.469 . . . . 1.52 111.982 -179.082 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -97.46 161.44 25.96 Favored Pre-proline 0 N--CA 1.431 -1.388 0 C-N-CA 127.794 2.437 . . . . 2.35 107.065 159.852 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -71.14 -15.77 31.98 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 C-N-CA 124.164 3.243 . . . . 1.31 112.29 179.064 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 p -83.38 -2.6 56.16 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.347 1.459 . . . . 1.71 112.503 174.746 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -77.82 140.89 39.44 Favored 'General case' 0 N--CA 1.431 -1.4 1 O-C-N 116.216 -4.053 . . . . 1.69 110.579 169.805 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.361 22.9 p -81.05 176.23 9.99 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 110.759 -2.928 . . . . 1.33 114.892 179.717 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.402 HD12 HD12 ' A' ' 50' ' ' LEU . 44.2 mm -85.76 -20.77 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 CA-C-N 121.252 1.842 . . . . 1.32 108.526 175.581 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -56.01 -38.27 70.28 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.103 2.561 . . . . 1.62 113.058 165.37 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -71.88 -33.23 68.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.05 2.14 . . . . 2.13 114.961 176.348 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.327 79.1 t -65.33 -48.23 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 C-N-CA 128.065 2.546 . . . . 1.23 110.067 173.841 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -69.96 -26.81 64.28 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.945 -2.347 . . . . 1.97 115.552 174.703 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.75 -37.07 83.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.282 -2.761 . . . . 1.19 113.37 171.445 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.1 mttm -65.37 -51.61 59.26 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.91 -1.744 . . . . 1.92 114.356 176.2 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.7 mt -51.81 -37.43 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 128.064 3.792 . . . . 1.94 113.549 170.723 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -63.24 -44.56 94.86 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 114.748 -4.97 . . . . 1.9 118.308 170.001 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -55.57 -49.55 72.41 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 114.736 1.384 . . . . 1.55 114.736 167.831 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -74.71 -65.58 0.85 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.763 -2.017 . . . . 2.95 107.572 -170.075 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.261 13.8 mm-40 -85.21 -51.75 6.39 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.87 1.804 . . . . 1.48 115.87 -171.119 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.91 9.51 5.2 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 117.628 1.811 . . . . 1.12 117.628 -178.706 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.0 mt -87.82 135.35 33.86 Favored Pre-proline 0 N--CA 1.429 -1.5 0 CA-C-O 113.967 -2.92 . . . . 2.07 112.018 -173.224 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -78.32 157.71 29.51 Favored 'Trans proline' 0 N--CA 1.434 -1.991 0 CA-C-N 124.632 2.69 . . . . 1.39 108.71 -178.944 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -64.02 -17.09 58.45 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 125.08 3.854 . . . . 1.68 114.257 -178.235 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -67.21 -49.17 65.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 129.879 3.272 . . . . 2.25 111.868 175.768 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -70.95 -31.67 68.32 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.647 -2.533 . . . . 2.44 110.495 -175.951 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -80.01 120.12 23.76 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 130.025 3.33 . . . . 1.32 113.902 -175.095 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -113.63 123.67 50.48 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.221 -2.14 . . . . 3.19 105.221 167.507 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -108.34 126.3 52.69 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 102.984 -2.969 . . . . 1.75 102.984 178.822 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.253 37.8 mm -112.71 154.21 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 131.549 3.94 . . . . 1.98 106.255 177.592 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -114.4 -94.01 0.48 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.535 -3.228 . . . . 1.94 102.744 175.307 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.38 -65.78 0.98 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 119.656 -0.818 . . . . 1.67 109.95 177.254 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.63 -13.43 0.73 Allowed Glycine 0 N--CA 1.429 -1.802 0 O-C-N 117.534 -3.229 . . . . 1.3 114.789 -173.705 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -105.95 150.44 25.67 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.828 2.051 . . . . 2.89 110.988 175.789 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -77.16 138.3 39.4 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 130.83 3.652 . . . . 2.89 110.033 178.774 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.402 HD12 HD12 ' A' ' 23' ' ' ILE . 80.4 mt -82.9 160.14 22.18 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.138 -1.601 . . . . 1.34 113.796 -176.478 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -102.99 151.51 22.39 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.981 1.712 . . . . 1.94 109.967 176.755 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.377 30.1 m-20 -75.02 -63.29 1.3 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 112.988 0.736 . . . . 1.56 112.988 -167.294 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.45 55.97 4.72 Favored Glycine 0 N--CA 1.431 -1.665 0 O-C-N 118.631 -2.543 . . . . 0.97 112.3 178.641 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -120.58 161.08 21.94 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 102.62 -3.104 . . . . 3.07 102.62 162.259 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -90.67 164.19 14.25 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.351 2.5 . . . . 1.34 109.23 168.251 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.9 mt -59.03 -34.43 71.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.658 2.783 . . . . 1.63 115.15 167.309 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.8 p -70.99 -21.51 62.3 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 114.606 1.335 . . . . 1.51 114.606 179.221 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -69.99 -34.54 73.47 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.8 2.84 . . . . 1.9 108.969 175.69 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -96.74 15.88 20.67 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.182 2.896 . . . . 0.97 112.964 176.458 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 m120 57.29 25.19 10.84 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 111.298 -2.683 . . . . 2.35 116.97 174.028 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.8 mt -81.63 98.97 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 106.043 -1.836 . . . . 1.39 106.043 178.629 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -112.92 -39.06 4.34 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.795 2.838 . . . . 2.58 104.569 -174.83 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -101.16 171.83 7.38 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.324 1.601 . . . . 2.58 115.324 167.294 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -45.11 103.05 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 129.953 3.301 . . . . 1.71 116.12 168.581 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.6 m -123.13 159.53 28.37 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.469 -4.519 . . . . 1.34 116.75 -175.952 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.2 m -101.88 126.79 48.85 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.843 -1.786 . . . . 1.36 111.822 -175.552 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mp -107.56 142.6 37.22 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.847 3.659 . . . . 2.03 112.327 176.814 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -116.03 117.69 30.8 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.634 -1.917 . . . . 2.31 109.404 -175.469 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.1 tp -87.62 123.43 32.47 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.971 1.367 . . . . 1.72 111.057 -176.894 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.0 t -122.84 136.66 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.181 -2.2 . . . . 1.8 108.488 176.416 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.1 mt . . . . . 0 N--CA 1.43 -1.448 0 O-C-N 118.37 -2.706 . . . . 3.26 113.007 -174.165 . . . . . . . . 0 0 . 1 . 074 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.351 0 CA-C-O 116.147 -1.882 . . . . 1.39 113.619 . . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -119.22 125.92 50.3 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 120.403 1.456 . . . . 2.2 112.87 -178.028 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.9 pt -121.95 162.75 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 125.89 2.757 . . . . 1.32 107.241 170.582 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -103.89 149.04 25.45 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.5 2.32 . . . . 2.2 110.737 178.064 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.283 49.4 t -119.0 121.97 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 126.792 2.558 . . . . 1.23 106.071 171.067 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.7 tttt -101.9 140.13 36.6 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 126.53 2.394 . . . . 2.51 112.88 177.708 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.443 HG22 HD22 ' A' ' 69' ' ' LEU . 54.9 p -96.97 173.67 7.16 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.327 -2.733 . . . . 1.41 108.092 174.328 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.8 mt -56.61 -57.62 11.6 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.692 -1.88 . . . . 2.95 112.649 167.279 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.1 p -61.46 -30.69 70.75 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 117.66 2.467 . . . . 2.52 117.66 -179.244 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.87 15.91 1.31 Allowed Glycine 0 N--CA 1.429 -1.817 0 CA-C-O 114.784 -3.231 . . . . 1.5 114.715 170.004 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.432 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 26.0 tttt -90.13 115.23 27.22 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 122.768 3.284 . . . . 1.79 106.874 -173.573 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 m -87.16 115.35 24.49 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 113.926 -1.488 . . . . 1.38 113.543 175.454 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mt -103.07 127.46 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 116.533 2.049 . . . . 2.03 116.533 176.302 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.4 m -89.09 105.58 17.88 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 116.687 -3.758 . . . . 1.61 111.456 -174.974 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.9 mt -112.38 127.6 56.06 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 125.186 2.422 . . . . 2.15 110.378 178.537 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -92.74 117.14 29.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.543 3.068 . . . . 1.98 108.422 170.47 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 m -127.1 178.32 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 111.962 -2.381 . . . . 1.52 112.5 -179.444 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -105.38 154.14 39.21 Favored Pre-proline 0 N--CA 1.43 -1.441 0 C-N-CA 126.963 2.105 . . . . 2.35 109.846 165.241 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.11 -14.2 23.45 Favored 'Trans proline' 0 C--N 1.299 -2.028 1 CA-C-N 128.307 4.003 . . . . 1.31 107.157 -177.462 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 m -86.69 -4.88 59.23 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 115.08 1.511 . . . . 1.71 115.08 177.728 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -64.09 146.8 53.56 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.15 -2.219 . . . . 1.69 112.451 174.259 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.8 p -89.77 161.86 15.82 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 119.731 -1.855 . . . . 1.33 112.793 172.963 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.7 mm -58.51 -22.64 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.287 -3.383 . . . . 1.32 117.772 174.679 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.09 -59.13 5.54 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 117.857 -3.027 . . . . 1.62 110.985 161.745 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -51.98 -50.24 61.66 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.077 2.151 . . . . 2.13 111.687 176.616 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -61.51 -49.4 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 119.816 -1.802 . . . . 1.23 111.88 -177.9 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -68.53 -19.7 64.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 124.064 3.12 . . . . 1.97 112.238 175.585 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.12 -27.3 63.48 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.394 -2.066 . . . . 1.19 109.293 173.923 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -68.12 -48.18 66.13 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.835 2.054 . . . . 1.92 110.628 171.823 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mt -59.91 -36.06 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 113.794 1.035 . . . . 1.94 113.794 173.033 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -60.22 -43.65 95.84 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.633 -3.167 . . . . 1.9 114.496 175.121 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -47.06 -58.91 3.51 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.635 -3.791 . . . . 1.55 115.758 166.861 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -71.29 -53.56 13.84 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.707 -1.87 . . . . 2.95 113.257 -176.57 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.432 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 46.8 mm-40 -92.4 -58.89 2.23 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 125.002 1.439 . . . . 1.48 108.385 -167.091 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.53 -0.16 2.74 Favored Glycine 0 N--CA 1.429 -1.782 0 O-C-N 119.698 -1.877 . . . . 1.12 111.72 176.191 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.0 mt -74.46 128.78 85.24 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 114.094 -2.86 . . . . 2.07 113.29 -169.277 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -63.61 151.04 86.92 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 CA-C-N 122.618 1.971 . . . . 1.39 113.856 175.037 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.29 -4.46 15.1 Favored 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 124.188 3.259 . . . . 1.68 118.704 -178.883 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -80.55 -29.53 37.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 126.264 2.228 . . . . 2.25 114.799 170.751 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -79.37 -40.26 30.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.723 2.202 . . . . 2.44 111.784 177.593 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -70.04 95.94 1.01 Allowed 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 114.743 -4.973 . . . . 1.32 115.616 -171.186 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -90.66 132.22 35.9 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 118.526 -2.609 . . . . 3.19 107.589 172.219 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.5 mt -111.06 120.4 42.24 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.813 1.768 . . . . 1.75 110.589 178.449 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.9 mt -102.83 128.64 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 120.476 -1.39 . . . . 1.98 108.919 172.936 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -82.14 -76.85 0.24 Allowed 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.13 2.395 . . . . 1.94 108.673 174.245 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -96.04 -60.07 1.71 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.53 1.532 . . . . 1.67 110.565 -179.004 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.91 -48.01 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.806 0 CA-C-O 122.379 0.989 . . . . 1.3 112.377 -172.522 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -81.09 141.98 33.76 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.246 -1.149 . . . . 2.89 111.037 179.927 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 pm0 -77.38 152.19 34.51 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 117.285 -1.766 . . . . 2.89 111.915 176.761 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.0 mt -98.39 136.96 37.8 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 116.649 -2.02 . . . . 1.34 113.929 -167.047 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.03 144.71 48.71 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.538 2.335 . . . . 1.94 115.499 172.461 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -64.55 -56.19 15.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.805 3.642 . . . . 1.56 114.752 -175.578 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.47 64.37 3.99 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 121.072 3.189 . . . . 0.97 121.072 170.31 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -135.35 158.39 44.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.17 1.788 . . . . 3.07 106.651 161.651 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.259 17.0 p -80.72 164.94 22.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 117.659 2.466 . . . . 1.34 117.659 174.478 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.2 mt -64.56 -33.8 76.76 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.388 -2.07 . . . . 1.63 113.118 175.791 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 t -68.79 -31.37 70.34 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.079 2.152 . . . . 1.51 116.337 177.096 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -57.24 -37.07 71.74 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 120.86 -1.15 . . . . 1.9 111.774 171.369 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -77.59 3.81 12.83 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 118.305 2.706 . . . . 0.97 118.305 174.63 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.66 17.3 m-80 81.76 12.01 0.69 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.034 2.605 . . . . 2.35 118.034 178.686 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.2 mt -91.51 102.84 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 118.949 -2.344 . . . . 1.39 111.827 178.135 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -106.49 -26.21 11.52 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.739 1.615 . . . . 2.58 108.294 -171.555 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.5 tttp -137.66 -91.99 0.22 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 117.317 2.339 . . . . 2.58 117.317 175.918 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.14 126.09 49.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 121.284 -0.885 . . . . 1.71 111.518 -176.125 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.3 t -146.8 145.48 29.92 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.587 -1.188 . . . . 1.34 114.09 -173.714 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.9 m -118.43 109.09 15.83 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.714 -3.116 . . . . 1.36 103.673 179.752 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.6 mt -93.36 154.87 17.72 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.23 -2.137 . . . . 2.03 105.23 173.336 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -118.49 117.05 27.98 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.394 1.092 . . . . 2.31 113.472 -175.258 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.443 HD22 HG22 ' A' ' 7' ' ' THR . 36.3 tp -79.59 94.62 5.69 Favored 'General case' 0 N--CA 1.43 -1.428 1 C-N-CA 132.904 4.481 . . . . 1.72 107.974 -171.728 . . . . . . . . 3 3 . 1 . 074 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.27 121.44 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 C-N-CA 127.981 2.512 . . . . 1.8 108.613 175.716 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 N--CA 1.429 -1.48 0 CA-C-O 116.499 -1.715 . . . . 3.26 111.665 176.61 . . . . . . . . 0 0 . 1 . 075 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.491 -1.311 0 CA-C-O 118.621 -0.704 . . . . 1.39 110.359 . . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -100.56 122.37 43.14 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 119.57 1.077 . . . . 2.2 112.678 177.176 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.258 21.6 pt -106.97 147.57 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 118.188 -2.82 . . . . 1.32 109.551 -179.341 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -105.17 117.94 35.28 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 117.746 -3.096 . . . . 2.2 107.412 -177.683 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.3 t -99.55 96.41 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 120.09 -1.631 . . . . 1.23 108.825 173.219 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -78.99 112.23 15.98 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.762 2.425 . . . . 2.51 107.051 176.409 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.8 p -75.99 166.45 23.48 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 116.315 1.969 . . . . 1.41 116.315 -179.382 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.8 tp -54.54 -39.86 68.1 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 127.393 2.277 . . . . 2.95 110.336 161.753 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.0 p -75.82 -30.17 58.92 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.114 -1.616 . . . . 2.52 111.64 -178.985 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.32 38.78 1.59 Allowed Glycine 0 N--CA 1.43 -1.721 0 CA-C-O 124.385 2.103 . . . . 1.5 113.657 177.571 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -120.53 121.26 38.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 104.671 -2.344 . . . . 1.79 104.671 178.132 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.284 85.6 m -73.0 101.95 3.36 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 112.849 -1.978 . . . . 1.38 112.909 171.16 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 mt -96.62 128.34 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 105.33 -2.1 . . . . 2.03 105.33 -179.08 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.8 m -99.73 119.47 38.19 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.133 -1.062 . . . . 1.61 108.133 175.185 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.8 mt -120.29 128.93 53.75 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 127.837 2.455 . . . . 2.15 109.586 176.207 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -74.48 131.69 41.24 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.713 3.227 . . . . 1.98 119.713 162.939 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.2 m -139.26 176.69 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.718 -1.239 . . . . 1.52 113.62 174.193 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -101.84 163.33 18.0 Favored Pre-proline 0 N--CA 1.429 -1.494 0 O-C-N 116.98 -3.575 . . . . 2.35 104.781 160.123 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -77.83 -10.36 16.89 Favored 'Trans proline' 0 N--CA 1.433 -2.043 0 O-C-N 116.802 -2.262 . . . . 1.31 109.325 -179.582 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -79.9 -12.26 59.75 Favored 'General case' 0 N--CA 1.428 -1.531 1 O-C-N 116.002 -4.187 . . . . 1.71 116.882 174.55 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -76.16 151.59 36.91 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.559 1.647 . . . . 1.69 114.3 176.516 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.2 p -80.77 161.25 24.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.908 -1.745 . . . . 1.33 114.13 -177.79 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.0 mt -70.99 -35.99 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 120.428 -1.42 . . . . 1.32 109.374 174.35 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -49.31 -38.81 29.0 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.463 2.705 . . . . 1.62 112.374 162.255 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -70.79 -52.14 22.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.905 -2.997 . . . . 2.13 105.41 179.142 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.284 42.2 t -47.68 -57.56 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-N 121.797 2.09 . . . . 1.23 115.446 166.945 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -60.28 -31.19 70.0 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.103 -3.498 . . . . 1.97 112.307 179.094 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.7 -27.76 58.36 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 124.482 3.31 . . . . 1.19 111.343 -179.404 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.268 35.1 mttm -74.97 -26.84 59.88 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.592 2.757 . . . . 1.92 111.169 173.394 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.2 mt -69.41 -45.53 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 C-N-CA 128.9 2.88 . . . . 1.94 104.911 171.862 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -58.05 -39.35 78.23 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.484 2.313 . . . . 1.9 113.265 176.595 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.53 -56.07 21.44 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 127.203 3.382 . . . . 1.55 111.676 173.265 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -80.81 -58.84 2.91 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.604 -3.81 . . . . 2.95 113.332 -174.038 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -83.62 -50.61 8.04 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.595 -3.191 . . . . 1.48 111.786 -172.535 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.64 73.04 1.27 Allowed Glycine 0 N--CA 1.43 -1.701 0 CA-C-O 125.649 2.805 . . . . 1.12 110.203 179.963 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.9 mt -132.72 128.77 21.0 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-O 113.435 -3.174 . . . . 2.07 103.347 178.341 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -64.54 160.55 39.24 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 125.742 3.087 . . . . 1.39 117.115 179.944 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.01 -26.65 12.82 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 123.058 2.128 . . . . 1.68 111.018 -174.552 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.18 -39.15 81.63 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 117.882 -1.056 . . . . 2.25 112.766 171.203 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -83.78 -1.89 55.2 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 123.011 2.641 . . . . 2.44 112.593 -179.849 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -93.06 122.75 35.74 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 120.938 1.699 . . . . 1.32 108.712 -176.032 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -115.3 114.78 25.63 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 114.347 -1.297 . . . . 3.19 108.035 165.607 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.5 mt -98.63 122.59 42.03 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 123.774 1.749 . . . . 1.75 107.57 -179.264 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.3 mm -106.2 139.24 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 118.614 -2.554 . . . . 1.98 104.708 179.314 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -103.43 -92.67 0.34 Allowed 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 119.61 -1.931 . . . . 1.94 110.234 173.992 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.96 -84.29 0.51 Allowed 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.843 -1.91 . . . . 1.67 105.843 179.844 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.74 7.59 22.05 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 126.809 2.568 . . . . 1.3 112.361 -170.352 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -139.38 155.99 47.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.167 -1.784 . . . . 2.89 110.438 178.28 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -83.23 148.58 27.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.814 -1.178 . . . . 2.89 111.756 166.76 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.1 mt -86.75 131.14 34.21 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 119.26 -2.15 . . . . 1.34 110.806 -176.486 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -84.82 136.88 33.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.417 2.687 . . . . 1.94 110.405 175.016 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.39 -51.56 59.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.366 -3.334 . . . . 1.56 114.398 -167.088 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.61 26.38 2.71 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 123.293 2.769 . . . . 0.97 115.387 171.87 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -105.46 171.69 7.19 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.489 1.138 . . . . 3.07 110.813 165.539 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.6 p -98.82 172.43 7.45 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 127.852 3.691 . . . . 1.34 111.365 167.701 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.6 mt -64.0 -44.45 92.58 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 111.99 -2.368 . . . . 1.63 109.779 171.397 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 t -57.88 -37.45 73.98 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 116.851 2.167 . . . . 1.51 116.851 176.879 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -53.36 -21.66 6.14 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.741 -2.474 . . . . 1.9 113.497 175.687 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -112.27 22.14 15.04 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.5 -2.625 . . . . 0.97 113.206 177.334 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.504 1.0 OUTLIER 61.37 31.95 19.16 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 119.705 3.224 . . . . 2.35 119.705 177.968 . . . . . . . . 3 3 . 1 . 075 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.317 57.4 mt -86.2 125.8 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 118.322 -2.736 . . . . 1.39 105.009 177.968 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -148.77 -51.06 0.16 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.792 -2.442 . . . . 2.58 110.08 -170.831 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.492 ' HG3' ' H ' ' A' ' 64' ' ' GLU . 11.4 tptp -79.47 -173.17 3.6 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 113.633 0.975 . . . . 2.58 113.633 169.352 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.492 ' H ' ' HG3' ' A' ' 63' ' ' LYS . 15.1 mp0 -73.05 95.88 2.09 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.123 2.392 . . . . 1.71 116.304 175.84 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.5 m -94.27 160.12 14.82 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 120.922 3.675 . . . . 1.34 120.922 -169.991 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.9 m -106.92 119.19 38.68 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 117.185 -1.388 . . . . 1.36 110.104 177.91 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -105.32 160.95 14.72 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 125.651 1.844 . . . . 2.03 106.61 168.471 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -127.08 124.47 39.31 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.273 -2.142 . . . . 2.31 108.864 -177.946 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.4 tp -99.55 112.17 24.42 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.059 1.344 . . . . 1.72 110.63 -174.42 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.1 t -97.6 120.56 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 C-N-CA 130.497 3.519 . . . . 1.8 112.737 174.018 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.4 mt . . . . . 0 N--CA 1.43 -1.437 0 C-N-CA 118.21 -1.396 . . . . 3.26 107.758 -177.787 . . . . . . . . 0 0 . 1 . 076 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ttp . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 118.662 2.838 . . . . 1.39 118.662 . . . . . . . . . 0 0 . 1 . 076 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -97.71 112.91 24.61 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.138 1.923 . . . . 2.2 109.623 -178.172 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 pt -109.14 146.77 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.038 -2.914 . . . . 1.32 109.368 175.083 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -106.32 124.06 49.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.091 2.956 . . . . 2.2 113.38 175.33 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.3 t -105.45 113.58 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 114.76 -1.109 . . . . 1.23 111.375 178.819 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -85.95 135.56 33.62 Favored 'General case' 0 N--CA 1.431 -1.423 2 O-C-N 113.041 -6.037 . . . . 2.51 115.826 179.038 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 p -99.1 173.11 6.97 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.653 -1.28 . . . . 1.41 109.708 178.797 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 tt -56.14 -49.14 74.77 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.22 1.008 . . . . 2.95 111.576 174.686 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -77.29 4.33 10.91 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.04 -2.287 . . . . 2.52 115.261 -177.425 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.16 17.63 46.17 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 119.497 2.559 . . . . 1.5 119.497 177.523 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -99.63 145.55 27.45 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 120.413 2.106 . . . . 1.79 109.939 -177.767 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.3 m -105.43 126.55 52.25 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.755 -1.216 . . . . 1.38 108.019 -173.036 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.9 mt -100.9 107.1 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.814 -3.054 . . . . 2.03 106.265 178.645 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 m -91.19 126.34 36.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.1 1.905 . . . . 1.61 108.021 -175.444 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.0 mt -126.63 160.75 29.81 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.867 2.867 . . . . 2.15 109.241 -178.473 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.342 43.6 mt-10 -122.85 115.62 22.29 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 125.658 2.647 . . . . 1.98 108.922 170.094 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.21 163.6 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 117.242 -3.411 . . . . 1.52 113.619 -178.591 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -98.2 145.45 29.85 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-O 116.634 -1.65 . . . . 2.35 112.816 162.735 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 21.1 Cg_exo -63.91 -9.87 20.67 Favored 'Trans proline' 0 N--CA 1.434 -1.999 2 CA-C-N 129.993 4.605 . . . . 1.31 114.149 -179.495 . . . . . . . . 3 3 . 1 . 076 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.6 p -84.57 -0.2 52.36 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 127.189 3.376 . . . . 1.71 116.099 173.526 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -80.67 156.01 26.53 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.816 -2.428 . . . . 1.69 106.356 176.0 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 p -104.37 165.77 10.84 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.52 -1.218 . . . . 1.33 113.245 176.292 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -58.43 -41.4 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.183 2.193 . . . . 1.32 112.496 176.695 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -44.17 -60.59 1.82 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.491 3.145 . . . . 1.62 119.491 162.024 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -58.96 -33.31 70.5 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 115.059 1.503 . . . . 2.13 115.059 177.85 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.23 -47.83 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 131.626 3.97 . . . . 1.23 115.406 172.478 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.33 27.1 mtmt -69.45 -32.43 71.37 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 111.561 -2.563 . . . . 1.97 110.944 177.946 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.66 -26.32 65.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.255 1.822 . . . . 1.19 113.537 171.79 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -75.97 -42.71 47.58 Favored 'General case' 0 N--CA 1.431 -1.411 1 C-N-CA 131.972 4.109 . . . . 1.92 108.427 -179.859 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt -61.08 -36.0 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 1 O-C-N 116.207 -4.058 . . . . 1.94 113.524 169.068 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -62.44 -37.54 86.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.052 2.541 . . . . 1.9 111.88 172.54 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.6 -52.18 41.48 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 119.548 3.166 . . . . 1.55 119.548 166.928 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -69.4 -51.5 35.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.662 1.185 . . . . 2.95 112.193 -176.546 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -110.34 -25.38 10.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.161 1.784 . . . . 1.48 112.159 -169.453 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.26 39.94 5.26 Favored Glycine 0 N--CA 1.429 -1.773 0 O-C-N 118.363 -2.711 . . . . 1.12 115.255 175.985 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.5 mt -117.97 126.65 27.14 Favored Pre-proline 0 N--CA 1.429 -1.483 0 CA-C-O 116.836 -1.554 . . . . 2.07 111.775 -174.111 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -63.78 145.39 90.78 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 CA-C-N 127.145 3.588 . . . . 1.39 116.932 178.283 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -66.72 -25.23 46.59 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 CA-C-N 120.686 1.281 . . . . 1.68 113.279 -175.137 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -70.78 -13.8 62.19 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 120.398 3.481 . . . . 2.25 120.398 177.476 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -84.76 -36.88 21.46 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 127.866 3.229 . . . . 2.44 108.165 174.043 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -76.91 108.88 10.27 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.067 2.365 . . . . 1.32 113.422 -173.378 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -102.19 114.76 29.18 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 114.611 -5.055 . . . . 3.19 110.756 162.725 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.432 HD22 HD13 ' A' ' 69' ' ' LEU . 64.9 mt -100.53 123.43 44.74 Favored 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 116.035 -4.166 . . . . 1.75 111.922 -177.687 . . . . . . . . 3 3 . 1 . 076 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 49' ' ' GLN . 33.9 mm -109.4 136.33 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 112.255 -2.248 . . . . 1.98 110.635 -177.654 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -99.42 -88.05 0.35 Allowed 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.742 -1.849 . . . . 1.94 109.571 172.404 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -113.02 -8.63 13.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 126.595 3.093 . . . . 1.67 113.151 -176.186 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.14 -40.04 0.17 Allowed Glycine 0 N--CA 1.429 -1.816 1 N-CA-C 102.958 -4.057 . . . . 1.3 102.958 -178.37 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -75.96 150.57 37.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.47 1.605 . . . . 2.89 114.39 175.424 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.403 ' HA ' HD13 ' A' ' 44' ' ' ILE . 59.3 tt0 -84.25 134.06 34.55 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.858 -3.026 . . . . 2.89 107.532 170.67 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.2 mt -82.38 124.94 30.47 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 129.208 4.068 . . . . 1.34 105.448 -173.715 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -80.25 140.86 36.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.364 3.468 . . . . 1.94 120.364 174.082 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.94 -62.82 1.39 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 116.479 2.029 . . . . 1.56 116.479 -170.723 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.1 56.68 4.97 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 118.512 2.165 . . . . 0.97 118.512 173.056 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.266 50.5 mmt-85 -133.35 151.57 51.86 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 107.623 -1.251 . . . . 3.07 107.623 169.108 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.43 ' HG1' ' CG ' ' A' ' 58' ' ' ASP 0.263 4.5 p -74.2 169.04 18.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 127.027 3.299 . . . . 1.34 118.141 174.172 . . . . . . . . 3 3 . 1 . 076 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 94.3 mt -74.4 -34.93 63.42 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.536 -4.477 . . . . 1.63 113.279 173.764 . . . . . . . . 3 3 . 1 . 076 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -66.52 -49.19 67.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.127 -2.76 . . . . 1.51 108.891 178.529 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.43 ' CG ' ' HG1' ' A' ' 55' ' ' THR . 48.0 m-20 -42.1 -45.16 3.89 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 120.258 3.429 . . . . 1.9 120.258 173.788 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -82.25 -20.81 36.86 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 115.988 1.847 . . . . 0.97 115.988 179.472 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 80.26 50.16 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 128.001 2.521 . . . . 2.35 111.057 -175.022 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.2 mt -93.2 115.94 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 124.809 1.244 . . . . 1.39 109.519 170.814 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -108.18 -174.86 2.62 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.991 2.116 . . . . 2.58 111.577 -167.197 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -65.58 -34.75 78.96 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.819 1.295 . . . . 2.58 112.821 172.066 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.258 13.5 pt-20 -77.04 -12.14 59.9 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.067 -2.896 . . . . 1.71 115.957 178.455 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.314 19.0 m -82.01 139.86 34.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 114.827 1.417 . . . . 1.34 114.827 -167.437 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.4 m -107.11 124.15 49.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.218 1.807 . . . . 1.36 111.609 -179.495 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.6 mp -96.85 149.5 21.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 123.198 2.726 . . . . 2.03 106.269 178.13 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.402 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 57.9 m80 -110.34 131.05 55.4 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.48 1.609 . . . . 2.31 113.413 176.735 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.432 HD13 HD22 ' A' ' 43' ' ' LEU . 51.8 tp -110.14 135.57 50.72 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 125.527 2.584 . . . . 1.72 105.658 -174.93 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.1 t -125.54 123.85 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.082 -2.562 . . . . 1.8 104.082 175.826 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 N--CA 1.43 -1.465 0 O-C-N 120.77 -1.206 . . . . 3.26 111.821 177.623 . . . . . . . . 0 0 . 1 . 077 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ttp . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 116.743 -1.599 . . . . 1.39 112.034 . . . . . . . . . 0 0 . 1 . 077 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -93.5 111.62 23.33 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 115.316 -2.278 . . . . 2.2 111.185 -177.274 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.7 pt -106.47 167.98 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-O 125.992 2.806 . . . . 1.32 107.824 172.872 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -126.1 114.8 18.87 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.403 2.049 . . . . 2.2 113.129 -176.727 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.0 t -107.6 113.59 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 116.404 -3.935 . . . . 1.23 102.174 -179.002 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -82.74 143.93 30.55 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 116.103 -4.123 . . . . 2.51 116.49 177.166 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.2 p -93.85 158.46 15.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.558 1.943 . . . . 1.41 116.126 176.179 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.435 ' HA ' HD22 ' A' ' 8' ' ' LEU 0.25 80.1 mt -64.44 -32.53 74.2 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.246 1.818 . . . . 2.95 114.648 175.906 . . . . . . . . 3 3 . 1 . 077 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.7 p -71.61 -44.31 64.64 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.542 -1.349 . . . . 2.52 112.172 178.33 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.79 -33.75 0.44 Allowed Glycine 0 N--CA 1.43 -1.762 0 CA-C-O 125.516 2.731 . . . . 1.5 115.072 172.036 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.362 0.0 OUTLIER -70.9 153.41 42.72 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 110.879 -2.661 . . . . 1.79 115.434 -176.285 . . . . . . . . 3 3 . 1 . 077 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.9 m -103.21 136.38 43.11 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.051 -1.655 . . . . 1.38 110.432 177.642 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 69.7 mt -98.78 115.48 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 116.517 -1.706 . . . . 2.03 108.768 177.597 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 m -92.44 110.83 22.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.242 1.817 . . . . 1.61 111.767 179.95 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.9 mt -112.89 133.85 54.67 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 125.332 2.491 . . . . 2.15 110.803 -174.742 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -91.0 113.15 25.34 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 116.28 -4.012 . . . . 1.98 109.64 168.255 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.7 163.14 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 113.502 -1.681 . . . . 1.52 108.688 -177.378 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -104.55 131.0 22.26 Favored Pre-proline 0 N--CA 1.43 -1.434 0 O-C-N 125.792 1.933 . . . . 2.35 106.102 163.449 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.71 -14.04 24.77 Favored 'Trans proline' 0 C--N 1.3 -1.993 1 C-N-CA 127.827 5.684 . . . . 1.31 114.788 -178.542 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -85.96 -17.04 36.46 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.895 2.878 . . . . 1.71 114.858 -179.771 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -68.17 144.46 54.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 116.997 -1.478 . . . . 1.69 113.704 176.007 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.3 p -76.61 164.11 26.23 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 122.959 2.618 . . . . 1.33 110.332 -178.266 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 50' ' ' LEU . 52.0 mt -67.86 -35.38 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 118.158 -2.838 . . . . 1.32 114.594 176.165 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -47.89 -37.65 14.59 Favored 'General case' 0 N--CA 1.431 -1.409 1 O-C-N 115.665 -4.397 . . . . 1.62 116.873 156.659 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -78.97 -30.22 44.35 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.43 -2.669 . . . . 2.13 111.087 177.094 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.7 t -61.83 -52.98 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 O-C-N 119.554 -1.966 . . . . 1.23 113.305 170.961 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -50.05 -40.73 45.97 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 127.892 3.245 . . . . 1.97 114.771 176.457 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.97 -37.37 68.96 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.839 -1.163 . . . . 1.19 112.432 173.388 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -70.16 -24.92 63.23 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 118.801 2.889 . . . . 1.92 118.801 174.548 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.8 mt -77.33 -42.37 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 129.051 2.94 . . . . 1.94 104.38 179.693 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -61.38 -47.9 83.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.418 -1.426 . . . . 1.9 110.585 179.947 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -41.71 -48.68 4.22 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 118.076 2.621 . . . . 1.55 118.076 170.329 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -79.0 -60.76 2.25 Favored 'General case' 0 N--CA 1.432 -1.372 0 O-C-N 119.192 -2.193 . . . . 2.95 108.607 -174.031 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -101.85 -17.37 16.22 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 119.862 1.21 . . . . 1.48 111.535 -163.922 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.98 46.89 5.77 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 123.844 1.802 . . . . 1.12 116.852 173.444 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.4 mt -129.3 129.1 23.27 Favored Pre-proline 0 N--CA 1.431 -1.395 0 O-C-N 120.211 -1.758 . . . . 2.07 112.162 -174.112 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -62.72 162.16 26.01 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 O-C-N 114.574 -3.435 . . . . 1.39 120.881 -177.278 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.7 -14.92 19.51 Favored 'Trans proline' 0 N--CA 1.433 -2.038 0 CA-C-N 127.825 3.83 . . . . 1.68 112.824 -178.398 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -60.47 -46.21 90.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.919 2.488 . . . . 2.25 109.398 173.41 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -83.77 -27.57 28.77 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 123.503 0.721 . . . . 2.44 112.473 -174.417 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -76.87 108.32 9.83 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.344 2.021 . . . . 1.32 110.731 -177.582 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -93.8 119.13 32.36 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.971 -3.581 . . . . 3.19 104.564 167.542 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.3 mt -98.41 138.38 35.73 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.278 -2.139 . . . . 1.75 108.688 174.277 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.41 134.1 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 101.735 -3.432 . . . . 1.98 101.735 -178.404 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -98.11 -107.23 0.18 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.187 -1.571 . . . . 1.94 109.736 170.171 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.66 -51.38 5.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.079 -2.263 . . . . 1.67 110.752 177.582 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.25 -40.17 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 128.955 3.169 . . . . 1.3 106.343 -171.074 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -74.5 146.77 42.44 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 112.878 0.696 . . . . 2.89 112.878 178.348 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.276 3.6 mp0 -97.92 145.65 26.25 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 100.308 -3.96 . . . . 2.89 100.308 171.879 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.403 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 78.8 mt -99.75 121.02 40.65 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 127.733 3.635 . . . . 1.34 108.437 -169.496 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -71.35 129.15 38.12 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.519 -2.613 . . . . 1.94 114.189 170.638 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.41 -48.04 47.46 Favored 'General case' 0 N--CA 1.431 -1.417 1 C-N-CA 131.966 4.106 . . . . 1.56 117.412 -175.071 . . . . . . . . 3 3 . 1 . 077 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.62 -9.58 62.19 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 119.157 2.423 . . . . 0.97 119.157 176.663 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -90.39 177.02 6.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 118.386 1.093 . . . . 3.07 109.247 179.412 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.5 p -108.23 164.36 12.38 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.184 1.393 . . . . 1.34 108.46 173.873 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.0 mt -58.4 -33.24 69.42 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.478 1.511 . . . . 1.63 111.421 171.629 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -64.27 -34.72 78.78 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 118.788 2.884 . . . . 1.51 118.788 176.728 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.284 64.6 m-20 -67.47 -29.79 69.33 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.42 -2.675 . . . . 1.9 111.785 178.429 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -92.53 -7.16 48.07 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 130.402 3.481 . . . . 0.97 112.088 178.664 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.268 71.6 m-80 61.96 60.82 1.47 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.213 1.482 . . . . 2.35 110.06 176.479 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.282 12.8 mt -83.69 130.43 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 128.054 2.542 . . . . 1.39 109.665 173.431 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -100.7 178.38 4.72 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 117.576 -1.202 . . . . 2.58 114.003 -171.453 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HG2' ' HZ1' ' A' ' 63' ' ' LYS . 41.3 tttm -44.19 -80.86 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.248 2.219 . . . . 2.58 116.684 173.627 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.341 0.8 OUTLIER -93.05 58.29 2.91 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 123.214 1.483 . . . . 1.71 113.622 -177.666 . . . . . . . . 3 3 . 1 . 077 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 p -92.3 139.87 30.17 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.952 2.501 . . . . 1.34 113.514 -175.039 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.4 m -109.79 124.12 50.74 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 104.122 -2.547 . . . . 1.36 104.122 -176.223 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -97.91 170.33 9.03 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 126.531 3.063 . . . . 2.03 104.815 172.361 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -120.76 125.51 47.77 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 118.037 -2.914 . . . . 2.31 105.09 -177.998 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.0 tp -95.17 107.16 19.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.471 2.081 . . . . 1.72 111.608 169.069 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -112.49 150.3 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 118.609 -2.557 . . . . 1.8 107.819 173.964 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.5 mt . . . . . 0 N--CA 1.43 -1.43 0 O-C-N 118.6 -2.563 . . . . 3.26 111.516 -178.788 . . . . . . . . 0 0 . 1 . 078 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tmm? . . . . . 0 CA--C 1.491 -1.32 0 N-CA-C 105.25 -2.13 . . . . 1.39 105.25 . . . . . . . . . 0 0 . 1 . 078 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.83 131.64 36.56 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.095 -3.503 . . . . 2.2 113.372 179.762 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.49 HD13 HG21 ' A' ' 17' ' ' VAL . 28.2 pt -116.48 148.15 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 129.245 3.018 . . . . 1.32 105.305 174.867 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -104.42 131.11 52.14 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.24 -1.538 . . . . 2.2 107.275 -179.546 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.0 t -109.79 118.66 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 105.185 -2.154 . . . . 1.23 105.185 177.083 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -105.08 130.39 53.28 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.475 -1.391 . . . . 2.51 110.066 176.277 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.8 p -69.93 167.02 18.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.549 2.118 . . . . 1.41 113.71 176.883 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.2 tp -56.01 -46.18 78.84 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 112.122 -2.308 . . . . 2.95 114.11 173.427 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 p -81.22 -21.15 39.75 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.299 2.333 . . . . 2.52 117.299 -176.248 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.76 1.69 4.1 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 122.686 3.834 . . . . 1.5 122.686 177.78 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -88.25 131.27 34.84 Favored 'General case' 0 N--CA 1.431 -1.397 1 O-C-N 115.855 -4.321 . . . . 1.79 109.978 -174.306 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.5 m -119.53 112.99 20.04 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 120.171 1.35 . . . . 1.38 113.384 179.626 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.9 pt -101.78 151.94 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 125.691 1.869 . . . . 2.03 107.61 -177.476 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.1 m -116.68 118.68 33.25 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 126.61 2.444 . . . . 1.61 110.012 -175.122 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.418 ' HB2' HG13 ' A' ' 3' ' ' ILE . 72.7 mt -102.96 149.22 24.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.518 -3.239 . . . . 2.15 107.247 177.977 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -102.48 123.36 46.1 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.225 -1.398 . . . . 1.98 107.225 165.762 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.49 HG21 HD13 ' A' ' 3' ' ' ILE . 21.3 m -131.77 147.66 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 106.67 -1.604 . . . . 1.52 106.67 -176.558 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -87.01 129.68 51.12 Favored Pre-proline 0 N--CA 1.429 -1.523 1 CA-C-O 111.438 -4.125 . . . . 2.35 110.132 163.875 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.31 -1.94 12.06 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 CA-C-N 127.809 3.825 . . . . 1.31 115.517 -166.246 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.2 m -84.19 2.66 38.72 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 116.301 -3.999 . . . . 1.71 116.513 172.917 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -81.36 163.32 22.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.514 -3.241 . . . . 1.69 113.174 174.952 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -90.98 157.95 16.99 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 125.729 2.68 . . . . 1.33 112.73 -178.538 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.44 -37.67 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.004 -2.935 . . . . 1.32 115.814 171.22 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -48.27 -41.21 27.22 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.647 -3.158 . . . . 1.62 117.879 167.811 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -73.8 -33.56 64.26 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.406 1.262 . . . . 2.13 114.406 172.568 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.5 -40.26 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 116.791 -3.693 . . . . 1.23 111.572 174.665 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -66.32 -35.74 81.14 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.288 -2.132 . . . . 1.97 110.115 177.58 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.439 . . -69.62 -27.02 64.72 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.883 2.473 . . . . 1.19 116.148 173.369 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -75.09 -34.84 61.8 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 120.702 -1.249 . . . . 1.92 111.698 172.391 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.1 mt -69.0 -33.73 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 117.425 -1.274 . . . . 1.94 112.666 168.38 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -65.2 -35.21 80.35 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.435 -1.32 . . . . 1.9 107.435 176.53 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.32 -26.9 68.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.041 2.237 . . . . 1.55 117.041 173.892 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -99.37 -69.71 0.76 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.522 1.629 . . . . 2.95 113.332 -172.734 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -84.8 -25.36 28.21 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.058 -2.901 . . . . 1.48 105.475 -169.314 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.88 58.88 2.56 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 107.928 -2.069 . . . . 1.12 107.928 178.948 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.3 mt -115.25 120.31 36.9 Favored Pre-proline 0 N--CA 1.43 -1.443 1 CA-C-O 110.705 -4.474 . . . . 2.07 107.411 -179.25 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -63.56 143.95 88.86 Favored 'Trans proline' 0 N--CA 1.434 -2.028 1 CA-C-N 128.555 4.091 . . . . 1.39 116.801 177.681 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -68.87 -18.37 41.33 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 CA-C-N 125.763 3.094 . . . . 1.68 115.015 -172.925 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.257 11.3 p-10 -77.51 -18.67 56.83 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 127.69 3.614 . . . . 2.25 113.729 178.413 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -90.32 -16.51 29.1 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 114.903 -4.873 . . . . 2.44 110.524 178.831 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -87.46 131.07 34.46 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 126.088 2.852 . . . . 1.32 116.638 -177.614 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -111.85 114.38 27.29 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.171 2.988 . . . . 3.19 111.304 172.361 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 39.5 mt -104.5 126.01 51.2 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 118.455 -2.653 . . . . 1.75 108.253 178.106 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.8 mt -119.72 153.76 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 N-CA-C 101.28 -3.6 . . . . 1.98 101.28 -179.185 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.414 ' CE2' HG12 ' A' ' 61' ' ' ILE 0.429 26.7 t80 -126.03 -73.15 0.63 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 119.052 -1.059 . . . . 1.94 112.738 167.964 . . . . . . . . 3 3 . 1 . 078 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.11 -40.12 8.57 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 114.115 -2.85 . . . . 1.67 115.29 178.768 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.89 -52.69 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 108.452 -1.859 . . . . 1.3 108.452 -175.873 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -89.12 163.46 15.45 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 122.084 2.942 . . . . 2.89 112.787 177.677 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -68.63 147.98 51.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 125.623 1.827 . . . . 2.89 112.053 170.669 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.1 mt -84.64 144.73 28.41 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 115.925 -1.988 . . . . 1.34 107.481 -175.436 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -90.97 155.38 18.76 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 125.799 3.908 . . . . 1.94 109.372 178.252 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -65.44 -57.85 7.27 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.87 3.268 . . . . 1.56 112.858 -172.81 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.67 62.62 1.64 Allowed Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 121.385 3.314 . . . . 0.97 121.385 168.506 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 ttm-85 -139.92 163.26 33.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 113.545 -1.328 . . . . 3.07 107.442 164.938 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.254 24.4 p -91.75 172.41 8.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.269 1.985 . . . . 1.34 112.149 -174.93 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.55 -46.0 64.38 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.322 -1.763 . . . . 1.63 111.065 168.594 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.273 1.2 t -63.51 -17.2 62.51 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.127 2.171 . . . . 1.51 114.747 175.733 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -77.73 -36.08 51.23 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 115.596 1.702 . . . . 1.9 115.596 170.268 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -87.22 7.08 29.98 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.289 1.995 . . . . 0.97 112.233 173.08 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 m120 44.06 59.83 3.02 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.887 3.675 . . . . 2.35 115.86 -174.649 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.414 HG12 ' CE2' ' A' ' 45' ' ' PHE . 46.8 mt -87.07 106.98 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 119.411 -2.055 . . . . 1.39 105.811 179.294 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -104.03 -170.31 1.76 Allowed 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 116.269 -0.423 . . . . 2.58 110.364 -179.97 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -27.99 137.46 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 130.16 3.384 . . . . 2.58 118.934 169.124 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 48.42 56.2 7.83 Favored 'General case' 0 N--CA 1.431 -1.385 1 C-N-CA 132.402 4.281 . . . . 1.71 114.948 176.679 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.4 m -116.91 135.45 53.71 Favored 'General case' 0 N--CA 1.432 -1.37 0 O-C-N 119.756 -1.84 . . . . 1.34 113.859 -173.938 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.2 m -102.35 99.87 9.98 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.195 2.998 . . . . 1.36 109.299 -176.471 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.61 135.35 48.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 116.339 -1.791 . . . . 2.03 111.968 169.465 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.6 m170 -91.11 100.37 13.22 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 127.864 2.466 . . . . 2.31 113.15 -176.898 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.2 tp -91.48 135.6 33.73 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 126.9 2.625 . . . . 1.72 114.083 177.681 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.6 t -135.16 120.46 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 129.841 3.256 . . . . 1.8 109.37 170.63 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.0 pp . . . . . 0 N--CA 1.429 -1.489 0 CA-C-N 124.366 3.257 . . . . 3.26 107.526 172.264 . . . . . . . . 0 0 . 1 . 079 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ptt? . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 114.363 1.246 . . . . 1.39 114.363 . . . . . . . . . 0 0 . 1 . 079 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -89.05 127.82 35.71 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.281 -2.762 . . . . 2.2 107.456 -175.778 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.8 pt -114.73 162.53 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 115.254 1.575 . . . . 1.32 115.254 171.67 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.532 ' CE2' ' HB3' ' A' ' 64' ' ' GLU . 36.1 m-85 -116.15 121.34 41.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.538 -3.226 . . . . 2.2 110.962 -175.883 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.0 t -103.2 124.45 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 1 O-C-N 116.009 -4.182 . . . . 1.23 110.592 176.49 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -99.62 135.98 40.23 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.38 1.446 . . . . 2.51 109.407 179.744 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.1 p -88.17 -175.49 5.07 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 117.235 -1.364 . . . . 1.41 113.665 176.053 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.3 mt -62.47 -52.52 63.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 124.724 1.265 . . . . 2.95 112.308 170.232 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.5 p -74.53 -12.98 60.61 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 115.591 -2.147 . . . . 2.52 110.472 -178.327 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.54 9.23 25.53 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 122.14 3.616 . . . . 1.5 122.14 173.291 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.49 140.87 54.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.493 2.092 . . . . 1.79 107.659 -177.006 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.7 m -108.33 104.83 14.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.498 -3.251 . . . . 1.38 112.458 177.128 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.7 mt -98.12 120.57 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 125.046 1.466 . . . . 2.03 107.8 -176.13 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 m -90.99 115.92 28.38 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 127.332 2.895 . . . . 1.61 108.708 178.357 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 mt -123.35 137.45 54.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.26 1.824 . . . . 2.15 107.83 -178.261 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.89 130.93 35.33 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 101.997 -3.335 . . . . 1.98 101.997 170.146 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -138.27 158.78 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 126.022 2.82 . . . . 1.52 108.968 174.472 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -102.6 153.35 38.23 Favored Pre-proline 0 N--CA 1.43 -1.433 1 O-C-N 115.211 -4.681 . . . . 2.35 107.034 161.105 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.406 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 38.3 Cg_endo -76.67 -7.66 17.74 Favored 'Trans proline' 0 N--CA 1.433 -2.037 1 CA-C-N 128.475 4.063 . . . . 1.31 112.567 -167.753 . . . . . . . . 3 3 . 1 . 079 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -80.95 -8.92 59.87 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 126.037 1.735 . . . . 1.71 108.776 -179.01 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -66.7 141.17 57.86 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.661 1.984 . . . . 1.69 113.063 171.001 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 82.3 p -82.66 168.01 17.69 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.875 -2.391 . . . . 1.33 114.557 173.435 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 14.1 mm -64.41 -32.31 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 117.795 -3.065 . . . . 1.32 112.437 173.107 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -58.65 -39.35 80.35 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 115.957 -4.214 . . . . 1.62 115.02 169.539 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -63.48 -43.44 97.28 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 127.837 2.455 . . . . 2.13 111.728 174.874 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.6 t -61.81 -47.05 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 126.814 2.046 . . . . 1.23 110.554 175.255 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -62.68 -30.61 71.52 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 119.559 3.17 . . . . 1.97 119.559 170.838 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.76 -28.66 61.79 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 123.075 1.416 . . . . 1.19 112.836 175.819 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.289 18.5 ttmm -80.18 -36.45 34.99 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 129.551 3.14 . . . . 1.92 114.041 173.317 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.443 68.7 mt -62.68 -44.75 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 127.796 2.438 . . . . 1.94 112.368 168.093 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -55.92 -52.19 65.0 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.518 -3.239 . . . . 1.9 114.251 169.872 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -60.58 -42.95 97.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.625 2.083 . . . . 1.55 116.625 175.058 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -86.22 -50.16 7.18 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.776 1.274 . . . . 2.95 110.516 -173.435 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -94.82 -41.97 8.95 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 116.643 -3.786 . . . . 1.48 114.003 -171.691 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.94 22.65 6.81 Favored Glycine 0 N--CA 1.431 -1.699 0 CA-C-O 124.279 2.044 . . . . 1.12 111.836 174.02 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.4 mt -94.89 131.9 29.43 Favored Pre-proline 0 N--CA 1.43 -1.442 0 O-C-N 118.891 -2.535 . . . . 2.07 104.856 -173.168 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -64.72 144.62 84.5 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 C-N-CA 124.685 3.59 . . . . 1.39 119.293 -179.931 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -71.65 -15.46 30.38 Favored 'Trans proline' 0 N--CA 1.433 -2.085 0 C-N-CA 114.745 -3.036 . . . . 1.68 113.757 -172.124 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -65.43 -25.29 67.46 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 118.395 2.739 . . . . 2.25 118.395 175.261 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -96.68 -25.22 15.63 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 116.13 -4.106 . . . . 2.44 105.472 -172.044 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -75.38 103.42 5.51 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.396 -3.94 . . . . 1.32 114.533 -177.382 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -94.77 129.57 41.66 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.425 -2.047 . . . . 3.19 109.203 165.605 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 42.9 mt -115.08 127.32 55.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.5 -2.0 . . . . 1.75 108.694 -179.494 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.442 HD12 ' HA ' ' A' ' 49' ' ' GLN . 9.5 mm -116.31 155.37 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 127.994 2.518 . . . . 1.98 104.597 173.958 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -104.73 -83.32 0.5 Allowed 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.88 -2.637 . . . . 1.94 103.88 174.218 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.99 -43.69 6.6 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 113.95 -1.477 . . . . 1.67 110.787 179.199 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -173.81 -16.9 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 127.254 2.359 . . . . 1.3 114.23 -179.007 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -82.2 124.73 30.17 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 102.758 -3.053 . . . . 2.89 102.758 178.864 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.442 ' HA ' HD12 ' A' ' 44' ' ' ILE . 1.0 OUTLIER -64.04 130.69 45.03 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.349 -2.719 . . . . 2.89 112.166 173.73 . . . . . . . . 3 3 . 1 . 079 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.1 mt -87.41 132.32 34.02 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.108 -2.87 . . . . 1.34 107.432 -175.094 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -94.25 138.18 32.55 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 117.704 -1.141 . . . . 1.94 113.122 177.75 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.446 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 2.4 m-20 -50.6 -56.07 13.44 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 130.866 3.666 . . . . 1.56 113.339 -166.813 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.85 52.98 4.48 Favored Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 118.024 1.969 . . . . 0.97 118.024 172.963 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.0 mmt-85 -126.94 159.23 34.65 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 105.942 -1.873 . . . . 3.07 105.942 165.438 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.299 35.6 p -89.7 170.78 10.16 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.566 -2.583 . . . . 1.34 113.277 175.808 . . . . . . . . 3 3 . 1 . 079 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 3.5 mt -73.3 -32.55 64.69 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 106.416 -1.698 . . . . 1.63 106.416 173.381 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -64.38 -43.56 94.12 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 117.079 -1.439 . . . . 1.51 110.195 177.959 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -46.02 -45.79 16.13 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 122.383 2.356 . . . . 1.9 113.801 173.791 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -82.42 6.68 16.43 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.338 -1.476 . . . . 0.97 114.946 178.45 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.4 m120 61.79 37.96 15.18 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 131.25 3.82 . . . . 2.35 116.684 176.09 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -86.65 128.01 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 127.043 2.137 . . . . 1.39 105.761 -177.57 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -142.94 -47.31 0.31 Allowed 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.243 -1.536 . . . . 2.58 113.333 -172.318 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -88.6 -162.36 0.84 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.333 1.453 . . . . 2.58 114.465 179.917 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.532 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 24.8 mt-10 -84.51 75.45 10.27 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.002 -2.937 . . . . 1.71 111.74 179.598 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 m -82.42 144.09 30.73 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 119.985 3.328 . . . . 1.34 119.985 -175.834 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.3 m -91.7 106.47 18.5 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.2 -1.364 . . . . 1.36 111.44 179.63 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -85.26 154.96 21.59 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 128.317 3.913 . . . . 2.03 105.963 166.126 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.433 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 69.9 m80 -115.17 119.04 35.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 111.791 -2.458 . . . . 2.31 106.637 -176.525 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.5 tp -105.08 99.7 9.31 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 105.118 -2.178 . . . . 1.72 105.118 178.096 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.6 t -86.88 125.39 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 113.478 -1.692 . . . . 1.8 111.017 171.283 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.3 mt . . . . . 0 N--CA 1.43 -1.468 0 O-C-N 119.191 -2.193 . . . . 3.26 114.635 -179.111 . . . . . . . . 0 0 . 1 . 080 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.329 0 CA-C-O 119.556 -0.259 . . . . 1.39 111.252 . . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -114.0 113.26 24.54 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 101.531 -3.507 . . . . 2.2 101.531 -174.581 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.7 pt -92.52 166.66 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 122.601 2.455 . . . . 1.32 111.835 170.611 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -122.61 94.12 4.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.895 1.678 . . . . 2.2 110.831 176.142 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.4 t -77.05 115.11 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 O-C-N 118.035 -2.915 . . . . 1.23 113.557 174.742 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -94.84 128.89 41.91 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 117.083 -1.847 . . . . 2.51 113.74 -178.288 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 p -85.67 173.24 10.26 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 124.463 2.078 . . . . 1.41 109.914 177.126 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 mt -79.96 -33.97 39.13 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.242 -2.786 . . . . 2.95 108.406 172.845 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.9 p -71.77 -35.06 69.94 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 123.769 2.986 . . . . 2.52 113.568 179.898 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.81 8.41 0.92 Allowed Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 119.162 2.425 . . . . 1.5 119.162 176.957 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.0 tptt -96.94 144.55 26.75 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.898 -1.519 . . . . 1.79 106.898 -172.309 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.4 m -111.73 108.25 17.62 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.318 -2.845 . . . . 1.38 103.318 174.241 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.9 mt -82.27 111.1 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 113.526 -1.67 . . . . 2.03 108.276 179.472 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.5 m -85.23 106.84 16.95 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.194 1.398 . . . . 1.61 112.665 -178.756 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.4 mt -123.36 133.28 54.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 124.833 1.333 . . . . 2.15 107.871 -172.849 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -94.21 133.59 37.57 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.748 -1.845 . . . . 1.98 110.672 162.902 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.3 m -133.3 173.54 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 125.964 2.792 . . . . 1.52 108.997 176.744 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.267 39.5 mt-10 -123.42 167.08 15.79 Favored Pre-proline 0 N--CA 1.43 -1.451 0 N-CA-C 103.595 -2.743 . . . . 2.35 103.595 162.911 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -69.06 -11.54 32.0 Favored 'Trans proline' 0 N--CA 1.433 -2.065 0 N-CA-C 117.184 1.955 . . . . 1.31 117.184 179.395 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -79.27 -11.73 59.95 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 129.066 2.946 . . . . 1.71 112.07 179.001 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -74.76 141.22 44.42 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.16 -1.588 . . . . 1.69 113.098 175.425 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.2 p -84.46 164.35 18.89 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.865 -1.772 . . . . 1.33 107.957 174.875 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.275 1.9 mp -69.95 -27.77 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 119.232 -2.168 . . . . 1.32 113.429 178.86 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -53.34 -46.72 69.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.07 -2.269 . . . . 1.62 114.69 164.436 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -53.3 -40.8 65.04 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.532 -3.23 . . . . 2.13 113.714 172.633 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.06 -42.0 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 O-C-N 121.045 -1.034 . . . . 1.23 111.682 177.546 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -59.56 -36.89 77.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.057 -2.277 . . . . 1.97 115.03 173.634 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.17 73.64 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.052 2.095 . . . . 1.19 115.034 174.883 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -72.81 -37.19 67.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 131.418 3.887 . . . . 1.92 112.748 173.823 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.6 mt -73.6 -28.02 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 117.825 -3.047 . . . . 1.94 109.106 170.596 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -71.2 -35.22 71.47 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.859 -1.776 . . . . 1.9 110.228 176.613 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -69.64 -57.39 5.22 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.098 2.559 . . . . 1.55 109.066 176.41 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.254 22.6 mmtt -57.58 -73.44 0.07 Allowed 'General case' 0 CA--C 1.489 -1.384 0 C-N-CA 131.068 3.747 . . . . 2.95 115.104 178.449 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.276 47.0 mm-40 -88.73 -41.14 12.74 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.727 -2.483 . . . . 1.48 114.52 -168.105 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.62 34.43 2.86 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 126.421 1.962 . . . . 1.12 111.427 173.97 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.8 mm -92.93 135.31 26.15 Favored Pre-proline 0 N--CA 1.429 -1.488 0 CA-C-O 112.456 -3.64 . . . . 2.07 109.52 -177.586 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -75.48 136.02 18.93 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 CA-C-N 127.342 3.658 . . . . 1.39 112.638 176.75 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -60.9 -21.14 69.89 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 C-N-CA 123.574 2.85 . . . . 1.68 116.909 -173.629 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.55 -28.68 68.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 130.094 3.358 . . . . 2.25 113.135 172.814 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -80.98 -34.82 32.77 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 131.066 3.746 . . . . 2.44 113.663 -177.518 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -88.59 115.47 26.14 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 116.266 1.95 . . . . 1.32 116.266 -163.587 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -95.71 120.04 35.27 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.898 -2.376 . . . . 3.19 110.092 173.46 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.264 68.0 mt -97.43 99.17 10.6 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.132 1.787 . . . . 1.75 113.109 175.835 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mm -95.05 130.65 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 128.857 2.863 . . . . 1.98 107.432 -174.788 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -111.7 -80.96 0.59 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 105.326 -2.102 . . . . 1.94 105.326 174.889 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.99 -95.67 0.35 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.777 -2.452 . . . . 1.67 111.016 -179.168 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.58 -4.12 54.91 Favored Glycine 0 N--CA 1.429 -1.772 0 O-C-N 119.551 -1.968 . . . . 1.3 113.634 -178.977 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -133.25 153.87 51.18 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.178 -2.366 . . . . 2.89 113.458 -177.581 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -82.31 141.41 32.91 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.045 -3.535 . . . . 2.89 109.483 162.948 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.8 mt -75.68 141.1 42.81 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.631 -2.543 . . . . 1.34 106.157 -178.909 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -86.42 137.34 32.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.204 -3.435 . . . . 1.94 115.077 176.773 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -53.03 -60.86 2.75 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 120.742 3.608 . . . . 1.56 120.742 -166.372 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.87 25.62 1.18 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 120.81 3.084 . . . . 0.97 120.81 170.128 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -113.87 159.82 19.43 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 127.325 2.427 . . . . 3.07 106.241 173.161 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.1 p -87.21 156.84 19.5 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.384 2.364 . . . . 1.34 117.384 -176.462 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.8 mt -53.62 -40.24 65.6 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 118.576 -2.577 . . . . 1.63 114.064 167.824 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.1 t -56.23 -36.69 68.76 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 115.573 1.694 . . . . 1.51 115.573 174.777 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -55.31 -30.49 60.32 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 120.795 3.628 . . . . 1.9 120.795 175.015 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -96.91 -1.24 46.22 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.843 -1.526 . . . . 0.97 109.906 -179.221 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.308 33.8 m-80 64.74 67.86 0.54 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.999 2.92 . . . . 2.35 109.44 -177.978 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.4 mt -124.34 114.02 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 1 C-N-CA 132.614 4.365 . . . . 1.39 101.794 179.851 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.25 57.0 mm-40 -139.77 -25.32 0.82 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 116.448 -1.739 . . . . 2.58 109.083 -176.104 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -107.45 -173.35 2.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 129.555 3.142 . . . . 2.58 110.977 -179.481 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.51 77.5 1.44 Allowed 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.938 1.295 . . . . 1.71 113.719 177.597 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.379 54.3 p -80.06 158.56 26.43 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.046 1.339 . . . . 1.34 113.772 -170.386 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.516 HG23 ' CE1' ' A' ' 68' ' ' HIS . 2.9 m -107.96 115.46 30.17 Favored 'General case' 0 N--CA 1.431 -1.424 1 N-CA-C 99.636 -4.209 . . . . 1.36 99.636 179.097 . . . . . . . . 3 3 . 1 . 080 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mp -108.27 168.01 9.61 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 116.66 -3.775 . . . . 2.03 106.292 175.706 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.516 ' CE1' HG23 ' A' ' 66' ' ' THR . 86.3 m-70 -127.33 135.41 50.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.978 -1.701 . . . . 2.31 113.002 -178.554 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.259 42.0 tp -106.08 107.08 17.9 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.655 -2.528 . . . . 1.72 107.393 179.738 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 37.1 t -98.16 143.57 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 103.382 -2.821 . . . . 1.8 103.382 176.543 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.5 mt . . . . . 0 N--CA 1.43 -1.426 1 O-C-N 115.404 -4.56 . . . . 3.26 112.227 178.022 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ptt? . . . . . 0 CA--C 1.489 -1.387 0 CA-C-O 121.672 0.748 . . . . 1.39 112.948 . . . . . . . . . 0 0 . 1 . 081 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -95.54 137.88 33.99 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.939 -2.245 . . . . 2.2 104.939 -179.287 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.2 pt -123.14 155.95 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 124.398 2.047 . . . . 1.32 109.756 161.946 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -115.88 119.07 34.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.469 -3.269 . . . . 2.2 107.433 -172.363 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.478 HG22 ' HB2' ' A' ' 67' ' ' LEU . 40.0 t -110.83 117.89 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 119.032 -2.292 . . . . 1.23 106.028 -179.092 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -108.62 168.77 9.09 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 119.634 -0.827 . . . . 2.51 111.292 177.05 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -103.9 -165.93 1.2 Allowed 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 122.663 1.22 . . . . 1.41 109.743 173.979 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.0 tp -75.29 -49.99 17.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.136 2.174 . . . . 2.95 113.494 173.681 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.8 p -89.43 -37.68 14.64 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.122 -2.236 . . . . 2.52 114.445 -172.548 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.73 28.21 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.713 0 N-CA-C 121.981 3.552 . . . . 1.5 121.981 179.28 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -104.95 95.76 6.08 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 126.478 1.911 . . . . 1.79 114.366 -177.506 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.9 m -89.77 124.19 34.42 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 115.54 -2.464 . . . . 1.38 109.149 178.847 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 pt -119.32 128.57 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 117.688 -3.132 . . . . 2.03 107.5 172.675 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.3 m -95.76 122.94 39.07 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 116.133 -1.889 . . . . 1.61 110.016 -177.565 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.278 76.9 mt -119.89 128.17 53.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 121.925 2.148 . . . . 2.15 111.465 -177.502 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -80.03 122.23 26.49 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 125.487 1.742 . . . . 1.98 108.031 171.608 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 m -136.54 178.72 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 1 C-N-CA 131.797 4.039 . . . . 1.52 111.663 -173.963 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -125.84 162.55 44.65 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 113.046 -3.359 . . . . 2.35 107.303 166.411 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -74.16 -19.46 20.03 Favored 'Trans proline' 0 C--N 1.3 -2.013 1 CA-C-N 130.026 4.616 . . . . 1.31 111.886 -170.622 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.15 10.85 27.65 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 131.056 3.742 . . . . 1.71 110.925 -173.96 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -88.37 148.15 24.39 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.813 -3.679 . . . . 1.69 110.086 176.368 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 p -87.0 162.55 17.58 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.829 1.789 . . . . 1.33 115.829 -177.488 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.6 mm -66.47 -29.39 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 127.817 3.675 . . . . 1.32 114.859 173.389 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -58.51 -51.33 70.35 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 113.574 -5.704 . . . . 1.62 113.358 173.173 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -63.25 -40.02 96.24 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.69 1.596 . . . . 2.13 110.62 176.711 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.6 t -63.38 -33.91 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 117.729 -3.107 . . . . 1.23 116.077 176.455 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.451 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 37.4 mtmt -65.33 -32.18 73.7 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.17 -4.081 . . . . 1.97 111.8 174.386 . . . . . . . . 3 3 . 1 . 081 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.14 -23.35 62.99 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.191 1.796 . . . . 1.19 113.271 172.914 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -76.45 -41.18 48.28 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 126.307 2.955 . . . . 1.92 115.366 170.908 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.9 -35.13 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 118.608 -2.558 . . . . 1.94 109.672 171.139 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -62.81 -54.48 38.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.169 -3.457 . . . . 1.9 110.782 177.343 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -40.17 -52.44 2.59 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 125.619 1.567 . . . . 1.55 113.642 170.362 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -72.15 -67.05 0.57 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 115.958 1.836 . . . . 2.95 115.958 -176.818 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -101.38 -21.19 14.89 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.788 2.709 . . . . 1.48 113.829 -167.08 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.64 7.85 50.24 Favored Glycine 0 N--CA 1.43 -1.715 0 O-C-N 119.138 -2.226 . . . . 1.12 114.426 168.321 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.7 mt -81.46 117.8 69.65 Favored Pre-proline 0 N--CA 1.43 -1.433 0 N-CA-C 103.469 -2.789 . . . . 2.07 103.469 -166.614 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.91 137.28 61.73 Favored 'Trans proline' 0 N--CA 1.433 -2.066 0 C-N-CA 121.871 1.714 . . . . 1.39 114.231 -176.505 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -63.23 -8.82 15.35 Favored 'Trans proline' 0 N--CA 1.434 -1.999 0 N-CA-C 122.05 3.827 . . . . 1.68 122.05 -172.301 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -81.75 -14.35 56.58 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 119.929 -0.709 . . . . 2.25 112.0 168.668 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -90.77 -27.09 19.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.912 2.885 . . . . 2.44 110.38 -175.601 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.451 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 76.2 mt-30 -75.66 128.35 35.02 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 126.294 2.246 . . . . 1.32 114.76 -176.423 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -116.82 100.78 8.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.53 -3.856 . . . . 3.19 101.167 175.176 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.4 mt -91.11 125.6 35.94 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 103.796 -2.668 . . . . 1.75 103.796 177.822 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 mm -120.76 130.97 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 103.888 -2.634 . . . . 1.98 103.888 178.907 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -84.32 -75.44 0.34 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 118.117 -0.945 . . . . 1.94 109.979 170.164 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.0 -77.63 0.59 Allowed 'General case' 0 N--CA 1.43 -1.429 2 O-C-N 115.822 -4.299 . . . . 1.67 104.909 173.589 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.8 -25.26 3.4 Favored Glycine 0 N--CA 1.429 -1.779 0 O-C-N 118.564 -2.585 . . . . 1.3 113.646 -177.971 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -84.43 138.08 33.03 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.835 -2.568 . . . . 2.89 117.503 176.66 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -71.0 142.37 50.96 Favored 'General case' 0 N--CA 1.431 -1.405 1 O-C-N 115.932 -4.23 . . . . 2.89 111.362 174.422 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.8 mt -90.98 141.85 28.4 Favored 'General case' 0 N--CA 1.429 -1.495 1 O-C-N 115.983 -4.198 . . . . 1.34 109.988 -175.835 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -92.66 145.08 24.7 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 125.44 1.713 . . . . 1.94 111.935 -178.069 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.74 -63.36 1.33 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.383 2.04 . . . . 1.56 112.591 -167.619 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.4 39.37 2.49 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 116.745 -3.722 . . . . 0.97 116.106 177.184 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -115.56 159.38 21.33 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 121.511 2.656 . . . . 3.07 107.381 166.399 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.319 33.5 p -84.46 156.45 21.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 126.898 3.237 . . . . 1.34 110.754 176.777 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.1 mt -68.5 -25.94 65.21 Favored 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 111.544 -6.972 . . . . 1.63 115.287 171.776 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -66.65 -32.98 74.65 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.113 -3.492 . . . . 1.51 110.014 172.538 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -64.04 -34.08 77.2 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.075 -1.641 . . . . 1.9 114.47 171.382 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -89.42 -3.44 58.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.146 1.339 . . . . 0.97 111.892 177.025 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.6 m120 55.12 50.0 16.22 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 127.415 2.286 . . . . 2.35 115.948 -174.964 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.9 mt -77.88 126.99 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 113.161 -1.836 . . . . 1.39 108.6 178.474 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -102.46 175.35 5.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.111 1.764 . . . . 2.58 110.825 -176.28 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -72.97 -8.95 58.03 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 119.308 3.077 . . . . 2.58 119.308 177.604 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -106.85 7.48 30.19 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 125.707 1.879 . . . . 1.71 109.739 177.202 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 m -84.36 144.75 28.62 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.872 -1.768 . . . . 1.34 112.766 -171.635 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.3 m -110.32 120.04 41.14 Favored 'General case' 0 N--CA 1.431 -1.384 1 C-N-CA 133.065 4.546 . . . . 1.36 104.516 -177.007 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.478 ' HB2' HG22 ' A' ' 5' ' ' VAL . 7.9 mp -104.77 158.73 16.32 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.374 -2.825 . . . . 2.03 103.374 174.519 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -121.04 124.89 45.92 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.115 1.766 . . . . 2.31 109.413 -176.505 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.1 tp -105.7 99.73 9.32 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.897 1.681 . . . . 1.72 107.058 -177.812 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.7 152.04 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 105.682 -1.97 . . . . 1.8 105.682 171.247 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 N--CA 1.43 -1.474 0 O-C-N 119.164 -2.21 . . . . 3.26 107.001 176.377 . . . . . . . . 0 0 . 1 . 082 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 ptt? . . . . . 0 CA--C 1.489 -1.37 0 CA-C-O 124.694 2.188 . . . . 1.39 115.184 . . . . . . . . . 0 0 . 1 . 082 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -94.25 125.0 38.62 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.673 -2.517 . . . . 2.2 110.772 -179.715 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.6 pt -124.89 163.79 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 124.902 1.281 . . . . 1.32 112.339 171.696 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -114.42 159.18 20.59 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.137 2.875 . . . . 2.2 107.43 -178.248 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.0 t -143.05 134.34 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 102.539 -3.134 . . . . 1.23 102.539 177.283 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -113.73 131.78 56.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.856 1.312 . . . . 2.51 109.324 177.856 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.5 p -87.26 164.77 16.12 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 126.122 2.867 . . . . 1.41 107.801 179.845 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.1 mt -52.36 -56.71 13.09 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 116.173 -4.08 . . . . 2.95 114.696 170.647 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.4 p -69.51 -14.07 62.67 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.202 2.601 . . . . 2.52 114.142 -173.367 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.38 32.18 1.69 Allowed Glycine 0 N--CA 1.43 -1.745 1 N-CA-C 123.26 4.064 . . . . 1.5 123.26 169.246 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -111.6 148.43 33.33 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 115.217 -2.325 . . . . 1.79 114.955 -178.414 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.1 m -98.95 127.0 44.77 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 120.636 1.562 . . . . 1.38 108.067 175.712 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -103.73 123.6 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 125.991 2.805 . . . . 2.03 106.665 175.57 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.9 m -97.86 128.55 44.55 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.494 -3.879 . . . . 1.61 103.971 -178.096 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -125.61 133.08 52.36 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 121.688 2.04 . . . . 2.15 115.897 178.75 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -80.54 104.0 10.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 113.369 0.878 . . . . 1.98 113.369 162.318 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -114.9 154.1 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 119.211 -2.18 . . . . 1.52 109.583 177.967 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -113.86 151.39 44.7 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 102.923 -2.991 . . . . 2.35 102.923 164.261 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -68.29 -4.17 12.26 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-O 116.907 -1.372 . . . . 1.31 114.911 -173.39 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.2 p -93.11 -5.09 51.07 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.497 3.119 . . . . 1.71 113.065 -179.547 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -79.93 138.39 37.1 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.864 2.066 . . . . 1.69 108.132 174.599 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 39.3 p -76.22 173.78 10.95 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 128.392 3.949 . . . . 1.33 108.443 176.803 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.463 HG22 ' HE3' ' A' ' 27' ' ' LYS . 31.0 mm -74.67 -27.45 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 1 O-C-N 113.348 -5.845 . . . . 1.32 106.925 175.037 . . . . . . . . 3 3 . 1 . 082 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -65.6 -33.68 76.46 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 129.268 3.027 . . . . 1.62 111.433 172.079 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -83.96 -33.92 24.52 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.541 1.162 . . . . 2.13 111.825 172.867 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.26 29.0 t -64.62 -39.03 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 1 O-C-N 114.449 -5.157 . . . . 1.23 108.206 178.544 . . . . . . . . 3 2 . 1 . 082 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.463 ' HE3' HG22 ' A' ' 23' ' ' ILE 0.328 91.0 mttt -61.02 -47.87 84.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.23 -3.419 . . . . 1.97 113.528 173.486 . . . . . . . . 3 3 . 1 . 082 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.0 -39.65 63.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.849 -2.407 . . . . 1.19 109.648 170.961 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -61.22 -37.71 84.01 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.662 -4.398 . . . . 1.92 114.224 176.098 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.6 mt -77.7 -33.2 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 127.309 2.244 . . . . 1.94 112.101 171.851 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -60.77 -34.6 74.72 Favored 'General case' 0 N--CA 1.431 -1.384 1 O-C-N 115.647 -4.408 . . . . 1.9 118.452 171.902 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -67.83 -26.03 65.85 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 110.523 -3.035 . . . . 1.55 113.728 168.879 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -96.44 -58.52 2.04 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 104.633 -2.358 . . . . 2.95 104.633 -172.94 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -92.45 -44.38 8.69 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.776 -2.453 . . . . 1.48 115.145 -169.817 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.8 -11.0 10.24 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 119.299 -2.126 . . . . 1.12 111.402 176.718 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 36' ' ' ILE . 6.0 mt -68.64 129.12 92.75 Favored Pre-proline 0 N--CA 1.429 -1.49 0 CA-C-O 112.896 -3.43 . . . . 2.07 109.165 -174.627 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -73.87 154.95 48.64 Favored 'Trans proline' 0 N--CA 1.433 -2.049 0 CA-C-N 126.783 3.458 . . . . 1.39 109.959 -174.667 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.39 -11.27 19.05 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 123.942 3.095 . . . . 1.68 111.654 -171.779 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -53.79 -59.14 5.0 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.906 2.482 . . . . 2.25 114.768 165.417 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -66.96 -23.79 65.99 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 118.911 2.93 . . . . 2.44 118.911 -177.871 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -83.97 134.69 34.64 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.415 1.886 . . . . 1.32 113.52 -170.311 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.255 47.8 mtt180 -119.34 114.44 22.36 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.382 -1.449 . . . . 3.19 109.847 172.11 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.0 mt -95.73 137.62 34.53 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.036 -1.839 . . . . 1.75 106.036 178.247 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.4 mt -135.37 136.78 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 128.261 2.625 . . . . 1.98 109.186 179.571 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -139.08 143.93 38.53 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 121.478 -0.764 . . . . 1.94 110.941 168.696 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.344 . . 54.4 27.57 8.35 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.712 -2.493 . . . . 1.67 115.499 176.658 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.88 -7.21 35.98 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-O 119.054 -0.859 . . . . 1.3 112.649 -170.583 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -87.2 139.93 30.06 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 123.032 3.416 . . . . 2.89 111.815 173.537 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -98.09 115.49 28.36 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.493 -2.004 . . . . 2.89 109.03 174.825 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 mt -83.24 159.42 21.97 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.425 -1.261 . . . . 1.34 112.961 -173.532 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -112.47 155.17 24.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 118.486 2.773 . . . . 1.94 118.486 172.471 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.51 -54.03 38.76 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 119.483 3.142 . . . . 1.56 119.483 -167.666 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.78 63.69 4.41 Favored Glycine 0 N--CA 1.431 -1.679 0 O-C-N 119.613 -1.929 . . . . 0.97 116.387 170.952 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -139.48 155.17 47.72 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.006 -2.22 . . . . 3.07 105.006 168.121 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 40.7 p -87.81 171.34 10.46 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.68 2.181 . . . . 1.34 109.481 176.274 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.0 mt -70.46 -37.69 74.34 Favored 'General case' 0 N--CA 1.43 -1.433 1 O-C-N 116.179 -4.076 . . . . 1.63 107.448 172.529 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.8 t -52.61 -45.83 66.74 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 118.5 2.778 . . . . 1.51 118.5 173.802 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -58.34 -53.74 54.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 130.7 3.6 . . . . 1.9 112.184 173.098 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -76.67 -2.1 31.11 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.863 -3.648 . . . . 0.97 115.876 -175.461 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.269 17.6 m120 60.93 55.44 3.14 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.569 1.947 . . . . 2.35 116.036 -178.825 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.0 mt -106.76 128.01 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-O 115.586 -2.149 . . . . 1.39 108.925 174.872 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -107.39 -176.2 3.0 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 114.446 -2.692 . . . . 2.58 111.983 -170.024 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.1 ptmm? -59.14 146.48 38.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 126.706 2.504 . . . . 2.58 114.462 171.717 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.285 50.8 mt-10 69.87 20.5 6.68 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.281 1.515 . . . . 1.71 114.984 174.767 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.8 t -102.77 161.95 13.32 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 114.249 -1.341 . . . . 1.34 110.912 -171.917 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.2 m -121.18 120.12 34.31 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.629 -1.92 . . . . 1.36 114.144 -172.205 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mt -92.15 164.06 13.71 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 122.749 1.262 . . . . 2.03 110.381 172.694 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -121.96 112.29 18.11 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.819 -3.051 . . . . 2.31 112.324 -179.234 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.5 tp -87.55 122.29 31.07 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 118.211 -2.806 . . . . 1.72 113.361 179.14 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.94 168.33 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 105.145 -2.169 . . . . 1.8 105.145 175.107 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.1 mt . . . . . 0 N--CA 1.43 -1.43 1 O-C-N 116.24 -4.037 . . . . 3.26 108.782 -176.533 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 CA--C 1.491 -1.312 0 CA-C-O 127.519 3.533 . . . . 1.39 115.955 . . . . . . . . . 0 0 . 1 . 083 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -81.77 140.2 34.38 Favored 'General case' 0 N--CA 1.431 -1.407 1 O-C-N 113.473 -5.767 . . . . 2.2 110.601 -175.387 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.5 pt -131.47 159.47 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 119.818 -1.801 . . . . 1.32 106.606 177.136 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -120.08 100.12 7.01 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.949 1.833 . . . . 2.2 112.048 -175.532 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -91.09 111.99 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 103.968 -2.605 . . . . 1.23 103.968 177.195 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.254 68.2 mmtt -90.68 141.09 29.15 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.232 -2.792 . . . . 2.51 110.85 177.666 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.5 p -93.96 176.29 6.39 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 120.586 3.55 . . . . 1.41 120.586 172.229 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.6 tp -66.11 -43.83 86.07 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 126.35 1.86 . . . . 2.95 110.497 -177.559 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.8 p -78.36 -49.55 13.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.063 3.357 . . . . 2.52 120.063 -171.641 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.9 32.59 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 128.321 2.867 . . . . 1.5 120.073 174.565 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.35 149.44 31.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.373 -0.973 . . . . 1.79 108.373 178.482 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -104.59 138.06 41.5 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.667 -2.521 . . . . 1.38 106.752 171.835 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.265 3.2 mt -106.12 92.91 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 122.793 1.282 . . . . 2.03 109.391 175.177 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.8 m -78.81 116.58 19.23 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 119.97 -1.706 . . . . 1.61 109.709 174.812 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.7 mt -125.51 149.26 48.45 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 106.849 -1.537 . . . . 2.15 106.849 -179.773 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -85.2 109.81 18.58 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 127.31 2.881 . . . . 1.98 117.386 165.227 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -121.88 164.07 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 121.879 2.127 . . . . 1.52 110.008 -178.799 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -112.06 157.75 38.85 Favored Pre-proline 0 N--CA 1.43 -1.435 0 C-N-CA 125.529 1.532 . . . . 2.35 109.482 164.858 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -86.48 -0.29 8.15 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 CA-C-N 125.658 3.057 . . . . 1.31 110.902 -170.281 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.1 p -89.82 -14.82 33.62 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 129.657 3.183 . . . . 1.71 111.251 175.205 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -68.03 142.37 55.91 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 127.086 3.327 . . . . 1.69 107.816 173.934 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.2 p -79.69 160.95 26.1 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.795 -2.441 . . . . 1.33 111.429 174.003 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mm -66.58 -27.17 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 1 O-C-N 115.628 -4.42 . . . . 1.32 111.743 171.513 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -56.98 -45.57 82.85 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 129.056 2.942 . . . . 1.62 109.836 167.913 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -65.45 -52.1 55.46 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.146 2.578 . . . . 2.13 111.752 176.626 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.82 -37.36 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 128.866 2.866 . . . . 1.23 109.404 177.046 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.84 -36.42 82.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 121.292 1.86 . . . . 1.97 115.467 174.81 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -24.81 67.78 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.257 1.206 . . . . 1.19 114.257 166.406 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -82.52 -25.57 33.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.756 -3.715 . . . . 1.92 111.618 173.747 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.8 mt -77.53 -29.09 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 117.915 -2.991 . . . . 1.94 111.103 175.093 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -66.61 -43.31 85.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 127.462 2.976 . . . . 1.9 111.567 173.536 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.263 31.6 t70 -49.6 -39.77 36.64 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 116.752 2.13 . . . . 1.55 116.752 168.03 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -86.07 -61.69 1.69 Allowed 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 118.289 2.7 . . . . 2.95 118.289 -178.153 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -95.19 -11.74 27.56 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.088 1.355 . . . . 1.48 113.052 -174.083 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.65 24.77 71.63 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 117.257 -3.402 . . . . 1.12 118.334 179.696 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.5 mt -99.62 132.37 23.21 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 116.852 -3.734 . . . . 2.07 110.218 -169.848 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -72.91 152.51 52.11 Favored 'Trans proline' 0 C--N 1.299 -2.038 1 C-N-CA 125.518 4.145 . . . . 1.39 113.536 -175.255 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -66.92 -36.61 22.38 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 O-C-N 115.322 -3.041 . . . . 1.68 112.947 -175.046 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.26 -25.74 67.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 124.715 2.198 . . . . 2.25 115.774 178.405 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -91.24 -22.91 20.36 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.29 -1.506 . . . . 2.44 109.811 179.783 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -78.84 135.89 37.17 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.831 -3.043 . . . . 1.32 112.239 -177.517 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.346 38.2 ttt180 -124.25 123.51 40.39 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 116.973 -3.579 . . . . 3.19 109.288 167.948 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mt -105.63 127.17 52.9 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.672 2.177 . . . . 1.75 108.885 179.682 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.3 mm -114.37 143.17 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 131.273 3.829 . . . . 1.98 106.816 -177.683 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -131.07 100.05 5.09 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.723 -3.111 . . . . 1.94 107.973 175.998 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.351 . . 66.76 -61.53 0.32 Allowed 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 129.22 3.008 . . . . 1.67 114.856 -173.031 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.09 -24.31 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 106.538 -2.625 . . . . 1.3 106.538 -176.079 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -90.08 153.41 20.57 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.094 -2.416 . . . . 2.89 110.481 177.237 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -97.73 140.59 31.9 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 102.072 -3.307 . . . . 2.89 102.072 179.184 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.2 mt -116.47 127.08 54.25 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 115.961 -1.971 . . . . 1.34 110.767 -173.023 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -83.31 157.1 22.73 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 118.635 2.828 . . . . 1.94 118.635 -179.419 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -59.87 -63.85 1.16 Allowed 'General case' 0 N--CA 1.43 -1.444 1 N-CA-C 121.829 4.011 . . . . 1.56 121.829 -167.02 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.21 31.79 2.58 Favored Glycine 0 N--CA 1.43 -1.754 0 CA-C-N 113.572 -1.649 . . . . 0.97 117.114 172.05 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -98.25 164.77 12.17 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.486 -3.361 . . . . 3.07 109.04 159.616 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.455 11.9 p -95.69 172.83 7.8 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.65 2.38 . . . . 1.34 109.855 172.615 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.6 mp -76.01 -37.96 57.86 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.979 -1.009 . . . . 1.63 109.607 171.098 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -48.97 -50.03 37.62 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 116.588 2.07 . . . . 1.51 116.588 175.433 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -56.28 -35.44 67.49 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.352 2.661 . . . . 1.9 115.367 176.126 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -99.45 6.72 45.89 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.835 1.654 . . . . 0.97 112.849 178.342 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.9 m120 53.87 37.89 27.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.53 2.048 . . . . 2.35 116.53 -178.811 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.2 mm -82.27 114.69 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 126.691 1.996 . . . . 1.39 107.88 -173.896 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -103.61 -177.22 3.31 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.779 -2.451 . . . . 2.58 110.731 -173.61 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -58.45 146.29 35.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 127.143 2.177 . . . . 2.58 113.08 179.425 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.276 72.9 mt-10 64.03 19.42 11.75 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 128.325 3.516 . . . . 1.71 118.119 172.957 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.6 m -88.48 151.33 22.62 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.91 -1.885 . . . . 1.34 105.91 -168.778 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.0 m -90.12 110.38 21.39 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.269 2.228 . . . . 1.36 107.716 -179.364 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -102.34 155.76 18.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 102.214 -3.254 . . . . 2.03 102.214 174.055 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -129.16 128.24 43.01 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.974 -4.204 . . . . 2.31 115.34 -176.781 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.0 tp -108.34 124.21 50.0 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 124.749 1.281 . . . . 1.72 112.28 -174.686 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.431 15.6 m -118.17 -179.3 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 130.481 3.512 . . . . 1.8 108.812 170.202 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 N--CA 1.43 -1.442 0 O-C-N 116.398 -3.938 . . . . 3.26 113.099 179.038 . . . . . . . . 0 0 . 1 . 084 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 CA--C 1.489 -1.382 0 N-CA-C 115.709 1.744 . . . . 1.39 115.709 . . . . . . . . . 0 0 . 1 . 084 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -74.82 134.64 41.71 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 118.079 -0.962 . . . . 2.2 111.048 -177.683 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.5 pt -131.15 173.38 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-O 127.385 3.469 . . . . 1.32 108.341 174.769 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.251 22.9 m-85 -127.41 134.83 49.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.519 -3.238 . . . . 2.2 105.653 -171.465 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.432 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 41.3 t -116.69 114.59 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.545 -2.021 . . . . 1.23 105.545 178.554 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -107.98 137.02 46.7 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 116.18 -4.075 . . . . 2.51 109.779 178.367 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.2 p -83.69 166.77 17.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.531 -1.981 . . . . 1.41 115.157 173.167 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.8 mt -39.14 -51.9 1.9 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 120.903 3.668 . . . . 2.95 120.903 167.021 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.8 p -82.99 -32.28 27.06 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 116.697 -3.752 . . . . 2.52 110.061 -175.544 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.44 24.66 0.16 Allowed Glycine 0 N--CA 1.43 -1.717 0 O-C-N 119.407 -2.058 . . . . 1.5 116.758 172.066 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -88.41 123.18 32.71 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.207 1.504 . . . . 1.79 112.707 -175.791 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -83.93 115.84 22.49 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 120.726 3.602 . . . . 1.38 120.726 172.939 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 57.4 mt -108.24 141.08 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 124.911 1.284 . . . . 2.03 111.136 176.352 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.8 m -116.97 137.21 52.37 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.523 -1.986 . . . . 1.61 107.152 178.419 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.8 mt -135.96 144.11 45.23 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.219 1.407 . . . . 2.15 112.007 -179.435 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -93.59 115.83 28.33 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.004 0.82 . . . . 1.98 111.168 169.283 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.545 HG12 HG22 ' A' ' 26' ' ' VAL . 11.5 m -118.57 173.4 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 101.914 -3.365 . . . . 1.52 101.914 178.377 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -118.25 160.24 40.19 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 103.488 -2.782 . . . . 2.35 103.488 167.435 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -64.71 -18.28 62.1 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 C-N-CA 124.558 3.505 . . . . 1.31 117.25 -173.183 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 m -104.08 19.72 19.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 126.622 2.451 . . . . 1.71 107.563 -178.346 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -82.03 140.96 33.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 113.449 0.907 . . . . 1.69 113.449 171.168 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.264 68.2 p -80.02 156.22 27.25 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.563 2.125 . . . . 1.33 113.491 174.99 . . . . . . . . 3 3 . 1 . 084 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.3 mm -58.62 -41.12 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.663 1.585 . . . . 1.32 111.621 175.074 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -46.54 -44.72 18.14 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.701 -1.875 . . . . 1.62 114.992 168.276 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -71.21 -35.58 71.57 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 125.658 1.583 . . . . 2.13 111.276 179.678 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.545 HG22 HG12 ' A' ' 17' ' ' VAL . 5.5 t -58.38 -45.69 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 117.587 -3.196 . . . . 1.23 114.199 167.989 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -65.77 -35.49 80.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 114.169 -2.824 . . . . 1.97 111.353 170.0 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.04 -29.21 68.13 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 123.365 2.802 . . . . 1.19 111.539 175.085 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.6 mttm -65.71 -21.98 66.57 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.571 -1.331 . . . . 1.92 114.049 171.752 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.2 mm -85.94 -23.92 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 127.252 2.221 . . . . 1.94 105.911 170.073 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.484 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 50.4 tt0 -77.04 -23.03 52.11 Favored 'General case' 0 N--CA 1.429 -1.482 2 O-C-N 114.538 -5.101 . . . . 1.9 111.265 173.717 . . . . . . . . 3 3 . 1 . 084 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -74.51 -40.45 61.77 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 114.716 1.376 . . . . 1.55 114.716 167.571 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -87.35 -66.31 0.92 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 116.592 2.071 . . . . 2.95 116.592 179.093 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -82.52 -32.11 28.85 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 118.057 -1.457 . . . . 1.48 109.625 -172.101 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.75 43.05 3.45 Favored Glycine 0 N--CA 1.429 -1.776 0 O-C-N 116.78 -3.7 . . . . 1.12 114.155 -176.193 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.4 mt -120.38 136.78 25.46 Favored Pre-proline 0 N--CA 1.429 -1.5 1 N-CA-C 99.808 -4.145 . . . . 2.07 99.808 -174.721 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -67.84 152.66 77.08 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 O-C-N 115.767 -2.807 . . . . 1.39 113.845 176.798 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.484 ' HD3' ' OE1' ' A' ' 31' ' ' GLN . 63.1 Cg_endo -78.41 -12.93 15.31 Favored 'Trans proline' 0 N--CA 1.433 -2.079 0 C-N-CA 117.529 -1.181 . . . . 1.68 110.713 -173.277 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -72.6 -38.5 67.82 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.347 -2.095 . . . . 2.25 113.89 170.885 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -69.97 -25.67 63.74 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.327 -2.733 . . . . 2.44 111.085 178.308 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -89.35 143.62 26.69 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.384 2.673 . . . . 1.32 115.873 -171.817 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -132.0 150.38 52.17 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 115.709 -2.091 . . . . 3.19 107.966 167.503 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.9 mt -106.14 138.85 41.6 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 124.553 3.342 . . . . 1.75 110.017 174.355 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 mt -112.67 146.12 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-O 125.03 2.347 . . . . 1.98 106.372 172.251 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -165.36 137.08 4.09 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 127.756 3.646 . . . . 1.94 105.166 174.653 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.53 19.51 11.53 Favored 'General case' 0 N--CA 1.431 -1.4 1 O-C-N 116.052 -4.155 . . . . 1.67 113.775 -176.622 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.13 -22.8 32.61 Favored Glycine 0 N--CA 1.431 -1.669 0 O-C-N 119.177 -2.202 . . . . 1.3 113.826 -175.5 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -93.0 157.54 16.26 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 121.539 3.903 . . . . 2.89 121.539 176.403 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -94.45 133.91 37.53 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 116.973 -1.891 . . . . 2.89 111.106 174.226 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.9 mt -81.13 133.23 35.43 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.106 1.362 . . . . 1.34 113.069 -172.927 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -67.3 142.98 56.67 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.273 1.035 . . . . 1.94 109.725 170.136 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -77.0 -56.43 4.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.154 1.454 . . . . 1.56 110.381 -168.553 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.16 40.87 1.74 Allowed Glycine 0 N--CA 1.43 -1.765 1 O-C-N 116.225 -4.047 . . . . 0.97 118.198 171.33 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -117.73 161.2 20.08 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.626 -3.279 . . . . 3.07 106.555 167.745 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.5 p -86.23 177.19 7.58 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.094 -1.629 . . . . 1.34 114.233 176.11 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.0 mt -70.45 -44.69 67.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.672 -1.893 . . . . 1.63 110.4 176.106 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 t -63.01 -30.54 71.68 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.239 1.57 . . . . 1.51 115.239 -178.811 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -57.26 -46.7 82.81 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.806 2.442 . . . . 1.9 107.269 177.596 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.263 24.2 m-85 -87.15 -1.86 58.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.208 -3.432 . . . . 0.97 116.515 177.121 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 71.88 52.8 0.21 Allowed 'General case' 0 N--CA 1.43 -1.459 1 C-N-CA 133.87 4.868 . . . . 2.35 107.268 178.047 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 mt -96.7 126.27 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.123 -2.236 . . . . 1.39 107.747 -179.455 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.408 31.0 mt-30 -96.76 -167.49 1.56 Allowed 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 121.153 -0.967 . . . . 2.58 110.127 -171.582 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -75.05 151.32 38.7 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.699 1.6 . . . . 2.58 112.79 167.848 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.295 8.8 mt-10 66.6 27.31 9.59 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.579 2.351 . . . . 1.71 114.053 172.856 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.9 t -108.98 134.82 51.12 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 117.183 -3.448 . . . . 1.34 110.648 -172.961 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.9 m -82.11 104.21 12.28 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.449 2.547 . . . . 1.36 115.324 -178.346 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.6 mt -91.58 129.23 37.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.142 -2.849 . . . . 2.03 108.922 177.953 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -92.19 115.54 28.17 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.348 -2.72 . . . . 2.31 108.666 -173.22 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.4 tp -86.52 134.2 33.68 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 113.558 -3.115 . . . . 1.72 115.742 179.946 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 m -132.11 -172.63 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 127.892 3.245 . . . . 1.8 108.78 170.427 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.0 mt . . . . . 0 N--CA 1.43 -1.431 0 C-N-CA 126.317 1.847 . . . . 3.26 110.279 176.315 . . . . . . . . 0 0 . 1 . 085 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptt? . . . . . 0 CA--C 1.49 -1.328 0 N-CA-C 107.841 -1.17 . . . . 1.39 107.841 . . . . . . . . . 0 0 . 1 . 085 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -121.55 144.81 48.51 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 119.941 -0.704 . . . . 2.2 111.656 -176.02 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.2 pt -129.06 163.74 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 120.042 -1.661 . . . . 1.32 110.038 175.167 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -111.42 114.31 27.35 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.366 2.508 . . . . 2.2 108.539 -178.647 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 81.4 t -103.76 126.33 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 118.252 -2.78 . . . . 1.23 105.985 169.347 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -107.16 127.49 53.56 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 125.638 1.836 . . . . 2.51 110.385 174.109 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.3 p -81.15 170.31 16.3 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 129.805 3.242 . . . . 1.41 113.154 173.09 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.9 mt -67.2 -30.6 70.58 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.271 -2.143 . . . . 2.95 114.086 174.701 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 p -85.7 -5.42 59.26 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.556 -1.275 . . . . 2.52 107.556 -174.677 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.92 1.49 36.36 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 115.225 0.85 . . . . 1.5 115.225 170.592 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -78.64 114.57 17.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 118.54 1.17 . . . . 1.79 112.518 -178.123 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 m -79.64 130.44 35.37 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 120.708 1.595 . . . . 1.38 110.497 170.052 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mt -109.19 119.15 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 131.541 3.936 . . . . 2.03 106.554 174.528 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.2 m -92.41 95.66 9.79 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 107.143 -1.429 . . . . 1.61 107.143 178.765 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.3 mt -96.2 139.07 32.89 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 117.937 2.569 . . . . 2.15 117.937 -177.149 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -59.76 114.49 2.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 111.127 -2.761 . . . . 1.98 109.289 163.56 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.298 13.7 m -136.6 166.19 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 126.983 2.113 . . . . 1.52 109.708 173.795 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -125.28 162.42 44.18 Favored Pre-proline 0 N--CA 1.43 -1.473 0 N-CA-C 101.258 -3.608 . . . . 2.35 101.258 171.892 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -81.93 -6.55 12.29 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 O-C-N 117.739 -1.769 . . . . 1.31 107.909 -175.79 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.7 p -99.82 16.98 21.93 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.247 1.573 . . . . 1.71 115.247 176.445 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -78.14 144.29 36.54 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 129.56 3.144 . . . . 1.69 106.123 172.952 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.0 p -83.4 154.53 23.95 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.01 1.724 . . . . 1.33 111.586 175.548 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.0 mm -67.72 -36.3 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 124.897 1.373 . . . . 1.32 110.145 -179.523 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -59.95 -41.97 93.02 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.573 -1.955 . . . . 1.62 111.92 169.977 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.3 28.4 t-20 -61.55 -37.16 82.77 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.75 -3.094 . . . . 2.13 114.738 177.256 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.9 t -53.33 -51.39 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 124.522 1.138 . . . . 1.23 113.329 169.676 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -59.96 -31.86 70.27 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 114.071 1.137 . . . . 1.97 114.071 174.38 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.22 -33.45 73.32 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.168 -2.207 . . . . 1.19 113.376 170.893 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -71.2 -26.04 62.77 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 122.397 2.362 . . . . 1.92 110.247 173.544 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.3 mt -76.99 -26.54 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-N 121.28 1.855 . . . . 1.94 106.585 173.786 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -68.9 -48.51 63.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 121.194 1.816 . . . . 1.9 109.755 176.75 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -51.18 -39.08 55.63 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.071 -2.893 . . . . 1.55 113.616 174.184 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -82.92 -71.11 0.51 Allowed 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.877 2.471 . . . . 2.95 106.221 -174.978 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -100.42 -45.14 5.66 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.051 2.982 . . . . 1.48 119.051 -166.292 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.78 74.25 0.85 Allowed Glycine 0 N--CA 1.431 -1.694 0 CA-C-O 124.748 2.305 . . . . 1.12 115.946 166.37 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.89 127.24 23.94 Favored Pre-proline 0 N--CA 1.43 -1.466 0 CA-C-N 110.804 -2.698 . . . . 2.07 105.54 -178.724 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -58.42 134.92 64.48 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 CA-C-O 112.481 -3.216 . . . . 1.39 118.075 176.851 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -65.44 -14.97 47.68 Favored 'Trans proline' 0 C--N 1.299 -2.046 1 C-N-CA 126.51 4.807 . . . . 1.68 120.528 -174.407 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.85 -20.34 35.79 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.338 -2.101 . . . . 2.25 111.06 167.44 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -87.11 -29.02 22.15 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.517 1.962 . . . . 2.44 114.438 -175.476 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.329 1.5 pt20 -78.95 135.62 37.0 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 115.067 -2.397 . . . . 1.32 110.041 -176.468 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.31 65.9 mtt180 -104.15 136.44 43.77 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 128.482 3.614 . . . . 3.19 110.047 164.834 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.5 mt -108.89 132.83 53.67 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 126.67 3.128 . . . . 1.75 110.072 172.116 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 53.7 mt -119.58 142.06 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 118.822 -2.423 . . . . 1.98 106.51 -178.831 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -157.89 141.15 15.24 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 100.603 -3.851 . . . . 1.94 100.603 171.98 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.56 -44.96 0.61 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.385 3.074 . . . . 1.67 116.394 -173.948 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 166.78 -48.42 0.26 Allowed Glycine 0 N--CA 1.43 -1.731 0 CA-C-O 124.646 2.248 . . . . 1.3 109.598 -170.923 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -83.09 -179.97 7.58 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.443 2.016 . . . . 2.89 116.443 178.752 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -96.53 147.7 23.58 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.433 -2.042 . . . . 2.89 111.502 170.87 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.6 mt -94.54 134.11 37.45 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 104.583 -2.377 . . . . 1.34 104.583 -176.105 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -86.09 137.34 32.75 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.717 0.77 . . . . 1.94 111.436 176.478 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.13 -57.99 5.73 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.935 3.694 . . . . 1.56 117.746 -168.95 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.98 44.16 3.28 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 124.639 3.381 . . . . 0.97 120.041 176.318 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 -115.65 173.26 6.63 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.733 2.682 . . . . 3.07 104.479 165.685 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.7 p -108.88 173.8 6.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.534 -1.666 . . . . 1.34 112.258 176.406 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.15 -37.28 72.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 114.856 1.428 . . . . 1.63 114.856 170.062 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -57.51 -42.0 81.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.397 -2.689 . . . . 1.51 113.73 174.539 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -52.21 -41.22 62.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.185 2.661 . . . . 1.9 118.185 173.461 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -88.99 -16.06 32.64 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 128.366 2.667 . . . . 0.97 108.251 178.139 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.419 12.0 m-80 72.83 48.56 0.19 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.776 -1.203 . . . . 2.35 111.395 179.434 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.6 mt -87.92 122.22 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.97 -2.331 . . . . 1.39 107.954 -172.993 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -87.39 -177.12 5.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 117.38 -1.728 . . . . 2.58 114.373 -173.543 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.256 14.8 pttp -63.43 140.37 58.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.952 -3.593 . . . . 2.58 110.969 167.358 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 68.42 30.18 5.47 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 127.937 2.495 . . . . 1.71 111.642 177.908 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.1 m -88.02 145.24 26.08 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 119.097 -2.252 . . . . 1.34 113.278 -172.79 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.3 m -92.27 119.68 32.1 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 118.302 -2.749 . . . . 1.36 112.953 -179.923 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mt -104.95 131.36 52.55 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 119.7 -1.875 . . . . 2.03 107.718 165.3 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -94.92 135.51 36.35 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 103.701 -2.703 . . . . 2.31 103.701 -178.719 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.7 tp -106.96 123.17 47.79 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 127.226 2.211 . . . . 1.72 110.666 -172.18 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.329 0.1 OUTLIER -121.63 167.89 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.578 1.951 . . . . 1.8 112.596 176.499 . . . . . . . . 3 3 . 1 . 085 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 N--CA 1.431 -1.42 0 O-C-N 125.66 1.85 . . . . 3.26 108.697 177.979 . . . . . . . . 0 0 . 1 . 086 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 CA--C 1.491 -1.321 0 CA-C-O 116.583 -1.675 . . . . 1.39 114.993 . . . . . . . . . 0 0 . 1 . 086 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -93.35 122.81 36.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 128.69 2.796 . . . . 2.2 106.769 -177.367 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 pt -119.65 170.17 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 124.553 2.121 . . . . 1.32 108.124 169.539 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.263 72.7 m-85 -122.09 144.56 48.85 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.185 -3.447 . . . . 2.2 110.645 -179.652 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.83 128.9 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 120.482 -1.386 . . . . 1.23 108.045 173.327 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -93.28 132.36 37.54 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.753 -3.092 . . . . 2.51 108.573 171.206 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.9 p -74.16 -169.99 0.88 Allowed 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 117.338 2.347 . . . . 1.41 117.338 177.105 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.2 mt -72.69 -62.44 1.45 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.225 2.61 . . . . 2.95 106.377 173.743 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.8 p -56.76 -56.34 22.76 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 120.383 3.475 . . . . 2.52 120.383 -175.178 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.38 43.55 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.764 0 CA-C-O 119.219 -0.767 . . . . 1.5 111.35 177.968 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -126.49 155.56 42.12 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 130.279 3.432 . . . . 1.79 104.334 -179.002 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.9 m -125.32 119.05 27.3 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 104.839 -2.282 . . . . 1.38 104.839 -178.94 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -95.52 148.88 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 103.483 -2.784 . . . . 2.03 103.483 -176.421 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.3 m -117.41 117.85 30.6 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.452 2.548 . . . . 1.61 106.231 177.296 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.2 mt -116.37 138.19 51.54 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.7 -2.5 . . . . 2.15 111.179 -174.517 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.12 106.15 18.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.724 2.009 . . . . 1.98 115.143 170.713 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 m -127.87 167.79 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 125.538 2.589 . . . . 1.52 108.549 -172.937 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -110.1 161.78 23.03 Favored Pre-proline 0 N--CA 1.43 -1.453 0 O-C-N 116.584 -3.823 . . . . 2.35 108.257 162.682 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -73.06 -12.12 25.67 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-N 124.72 2.721 . . . . 1.31 113.275 -177.245 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 m -83.7 -9.14 59.05 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 115.124 -2.369 . . . . 1.71 109.339 175.523 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -74.0 155.86 38.15 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 124.391 3.269 . . . . 1.69 111.138 178.251 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.6 p -95.73 164.44 12.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.5 -1.375 . . . . 1.33 110.411 -177.19 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.6 mm -62.47 -31.11 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 124.581 1.153 . . . . 1.32 112.032 175.934 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -58.71 -47.52 84.29 Favored 'General case' 0 N--CA 1.429 -1.499 1 C-N-CA 134.097 4.959 . . . . 1.62 114.611 162.383 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.281 29.4 m120 -66.21 -37.95 86.8 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.483 -3.26 . . . . 2.13 106.93 178.947 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.4 t -71.2 -25.95 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 1 O-C-N 115.045 -4.784 . . . . 1.23 117.875 176.415 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -81.96 -32.92 30.49 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 104.635 -2.357 . . . . 1.97 104.635 178.994 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.4 68.0 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.872 -3.642 . . . . 1.19 111.407 172.715 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -67.15 -28.19 67.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 125.867 1.979 . . . . 1.92 109.921 171.595 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.1 mt -75.39 -18.04 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 116.514 -3.866 . . . . 1.94 113.93 170.138 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -68.35 -27.75 66.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 119.715 1.143 . . . . 1.9 111.694 167.667 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -68.57 -51.74 39.39 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.385 -3.322 . . . . 1.55 112.338 165.638 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.402 ' HB2' ' H ' ' A' ' 34' ' ' GLU . 38.0 mmtt -68.81 -74.81 0.12 Allowed 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.926 -2.359 . . . . 2.95 117.256 -175.603 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.402 ' H ' ' HB2' ' A' ' 33' ' ' LYS . 48.6 mm-40 -90.73 -15.24 30.58 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 124.389 1.055 . . . . 1.48 113.122 -176.6 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.38 48.47 5.94 Favored Glycine 0 N--CA 1.43 -1.723 0 C-N-CA 119.276 -1.44 . . . . 1.12 115.967 168.046 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.4 mt -125.66 140.07 35.62 Favored Pre-proline 0 N--CA 1.429 -1.488 0 C-N-CA 126.781 2.033 . . . . 2.07 107.786 -175.51 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -67.83 149.9 78.4 Favored 'Trans proline' 0 N--CA 1.433 -2.055 2 C-N-CA 125.938 4.425 . . . . 1.39 112.285 -174.381 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.472 58.0 Cg_endo -61.22 -38.35 66.87 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 CA-C-N 127.293 3.64 . . . . 1.68 119.213 -179.972 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -57.44 -36.65 71.67 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 127.003 2.69 . . . . 2.25 114.178 -179.316 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -81.22 -13.11 58.88 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.576 2.065 . . . . 2.44 116.576 -177.021 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -92.19 141.94 28.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.94 -1.725 . . . . 1.32 110.822 -175.445 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -113.52 134.78 54.5 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 125.775 1.922 . . . . 3.19 110.702 167.515 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.8 mt -116.73 111.96 20.52 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.022 -1.844 . . . . 1.75 106.022 -178.618 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.542 HD11 ' HA ' ' A' ' 49' ' ' GLN . 24.3 mm -102.46 135.58 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 118.626 -2.546 . . . . 1.98 108.063 -173.318 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -154.44 122.89 6.1 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 124.249 1.02 . . . . 1.94 111.166 171.687 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.92 46.64 4.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.801 2.239 . . . . 1.67 116.525 -177.448 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.24 -31.01 4.21 Favored Glycine 0 N--CA 1.43 -1.734 0 CA-C-N 113.875 -1.511 . . . . 1.3 114.505 175.528 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -96.68 156.74 16.22 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 124.867 2.27 . . . . 2.89 114.415 -177.299 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.542 ' HA ' HD11 ' A' ' 44' ' ' ILE . 39.3 tt0 -93.05 121.51 34.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 127.492 3.52 . . . . 2.89 109.867 175.349 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.3 mt -79.07 122.6 26.42 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 113.55 -5.719 . . . . 1.34 114.864 -172.901 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.259 53.4 mt-10 -70.59 139.67 51.49 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 121.171 3.767 . . . . 1.94 121.171 -178.222 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -52.54 -63.09 1.25 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.327 3.051 . . . . 1.56 116.74 -169.323 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.74 43.3 3.06 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 125.784 1.659 . . . . 0.97 113.12 172.296 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.5 mtt-85 -121.91 162.02 21.76 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.642 -2.681 . . . . 3.07 109.543 165.686 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.26 70.2 p -92.63 151.17 20.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.368 2.667 . . . . 1.34 110.372 178.519 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -50.96 -50.59 57.71 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 125.514 2.578 . . . . 1.63 110.9 167.438 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -48.36 -42.69 32.24 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 114.605 -5.059 . . . . 1.51 118.006 174.668 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -71.5 -16.85 62.36 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.938 2.199 . . . . 1.9 116.938 173.538 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -94.15 -2.91 51.92 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 126.167 1.787 . . . . 0.97 106.359 177.096 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.5 m120 66.03 32.3 8.44 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.922 1.689 . . . . 2.35 112.735 176.341 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.405 HD11 HD21 ' A' ' 67' ' ' LEU . 20.7 mt -91.03 121.55 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 126.842 3.211 . . . . 1.39 107.771 -177.537 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -113.1 -170.46 1.68 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.66 -3.15 . . . . 2.58 114.044 178.531 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -61.73 135.63 57.68 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 112.348 -2.206 . . . . 2.58 112.279 -179.689 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.272 12.9 mt-10 83.67 13.58 0.35 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.791 2.036 . . . . 1.71 116.086 173.119 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.8 t -88.11 145.34 25.99 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.843 2.057 . . . . 1.34 105.873 -170.364 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.2 m -108.31 110.16 21.67 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.7 -1.25 . . . . 1.36 110.497 -176.678 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.405 HD21 HD11 ' A' ' 61' ' ' ILE . 24.4 mt -90.34 150.83 21.73 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 127.424 3.488 . . . . 2.03 107.247 172.582 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -111.73 129.39 56.13 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.083 -4.761 . . . . 2.31 110.993 -179.48 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.3 tp -98.28 133.13 43.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 128.106 3.812 . . . . 1.72 101.559 -171.234 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.55 163.06 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.986 -2.946 . . . . 1.8 106.668 172.516 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.1 mt . . . . . 0 N--CA 1.431 -1.41 0 CA-C-O 125.643 2.64 . . . . 3.26 114.646 176.034 . . . . . . . . 0 0 . 1 . 087 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.429 ' HE1' HG23 ' A' ' 17' ' ' VAL . 14.2 ptt? . . . . . 0 CA--C 1.491 -1.315 0 N-CA-C 115.303 1.594 . . . . 1.39 115.303 . . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.278 4.8 pt20 -127.02 138.93 53.33 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 129.042 3.963 . . . . 2.2 112.984 175.064 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.5 pt -127.2 151.05 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 130.794 3.638 . . . . 1.32 109.989 175.987 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -98.26 136.83 37.89 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 111.898 -2.41 . . . . 2.2 110.438 -179.056 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 89.2 t -112.66 125.84 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-O 114.692 -2.575 . . . . 1.23 111.397 171.982 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -105.29 128.43 53.45 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 123.122 2.692 . . . . 2.51 113.611 176.263 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.286 3.5 p -84.56 173.91 10.42 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 120.036 3.347 . . . . 1.41 120.036 177.576 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.77 -38.08 82.93 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 130.548 3.539 . . . . 2.95 111.302 -179.821 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.7 p -74.95 -45.42 42.42 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.485 1.514 . . . . 2.52 109.713 177.408 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.25 42.67 0.31 Allowed Glycine 0 N--CA 1.43 -1.728 0 O-C-N 125.944 2.027 . . . . 1.5 110.603 169.154 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -105.69 157.98 17.04 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.076 2.15 . . . . 1.79 106.279 -173.266 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -111.25 124.53 52.4 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 121.024 1.738 . . . . 1.38 106.33 175.414 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.548 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 20.0 mt -100.04 121.51 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 100.807 -3.775 . . . . 2.03 100.807 173.795 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.0 m -104.89 114.07 28.05 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.176 2.893 . . . . 1.61 105.675 175.087 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.6 mt -101.11 145.16 29.12 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 128.171 2.588 . . . . 2.15 112.772 -177.046 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -97.18 112.69 24.37 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 117.02 -1.467 . . . . 1.98 113.892 173.475 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.455 HG11 HG23 ' A' ' 26' ' ' VAL . 34.4 m -134.8 169.93 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 116.032 1.864 . . . . 1.52 116.032 -179.815 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -114.37 160.74 31.71 Favored Pre-proline 0 N--CA 1.43 -1.449 0 O-C-N 127.968 3.293 . . . . 2.35 109.424 165.954 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.34 -10.66 29.64 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 O-C-N 114.521 -3.463 . . . . 1.31 114.792 -173.687 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.8 p -85.87 -16.18 39.45 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.792 3.808 . . . . 1.71 111.468 177.881 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -70.19 147.8 49.41 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.408 -3.308 . . . . 1.69 114.064 -175.845 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.8 p -95.67 166.24 11.92 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 116.197 -4.064 . . . . 1.33 112.494 -177.299 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.331 29.7 mm -65.42 -31.79 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 116.81 2.152 . . . . 1.32 116.81 179.203 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -46.83 -52.08 15.08 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.19 2.196 . . . . 1.62 116.608 160.965 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -70.72 -35.81 72.9 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.704 2.002 . . . . 2.13 109.11 -177.974 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.455 HG23 HG11 ' A' ' 17' ' ' VAL . 34.9 t -70.04 -49.69 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 119.044 -2.285 . . . . 1.23 111.459 -179.489 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -62.56 -27.7 69.36 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.164 -2.21 . . . . 1.97 115.749 175.984 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.58 -40.53 97.18 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 128.661 2.785 . . . . 1.19 114.422 173.67 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -62.25 -26.93 68.66 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.303 2.241 . . . . 1.92 116.565 171.629 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.9 mt -74.09 -42.89 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 126.997 2.119 . . . . 1.94 111.701 171.913 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -62.68 -34.04 76.31 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.496 -1.229 . . . . 1.9 112.519 178.36 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.24 -47.04 81.2 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.437 -2.039 . . . . 1.55 115.643 171.831 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -78.9 -59.59 2.72 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.27 -1.786 . . . . 2.95 113.725 -177.343 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -101.28 -30.84 11.28 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 128.905 2.882 . . . . 1.48 109.989 -165.258 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.74 19.86 30.56 Favored Glycine 0 N--CA 1.429 -1.77 0 O-C-N 121.098 -1.001 . . . . 1.12 113.993 170.428 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.5 mt -91.3 123.42 64.2 Favored Pre-proline 0 N--CA 1.431 -1.409 0 CA-C-O 114.466 -2.683 . . . . 2.07 110.039 178.219 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -67.66 144.08 64.67 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 124.386 3.391 . . . . 1.39 110.187 -174.009 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.77 -24.41 47.15 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 C-N-CA 125.053 3.836 . . . . 1.68 113.03 -167.831 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -68.01 -26.05 65.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.892 2.477 . . . . 2.25 109.871 178.496 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -89.32 -18.69 26.45 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 125.427 2.537 . . . . 2.44 110.894 -176.275 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -82.18 125.87 31.41 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.621 -2.55 . . . . 1.32 112.059 -177.868 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -119.54 129.38 54.65 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 104.903 -2.258 . . . . 3.19 104.903 168.759 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.1 mt -103.01 139.48 38.52 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.63 -3.169 . . . . 1.75 111.022 176.69 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 17.8 mm -121.14 146.97 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 103.154 -2.906 . . . . 1.98 103.154 176.901 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -135.94 105.21 5.99 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 101.365 -3.569 . . . . 1.94 101.365 173.208 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.309 . . 70.65 -75.13 0.08 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.921 2.088 . . . . 1.67 115.054 179.283 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.34 -4.66 0.9 Allowed Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 113.481 -1.691 . . . . 1.3 115.101 -175.385 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.27 65.6 mttm -106.82 143.2 35.26 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.765 -0.828 . . . . 2.89 108.765 -178.85 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -86.44 128.51 34.96 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 117.375 -1.298 . . . . 2.89 108.371 164.775 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.405 HD22 ' CE2' ' A' ' 59' ' ' TYR . 42.9 mt -83.66 134.92 34.76 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 116.349 1.981 . . . . 1.34 116.349 -173.815 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -75.86 147.98 38.67 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.576 1.151 . . . . 1.94 111.56 175.182 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -68.53 -38.03 80.51 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 118.559 2.8 . . . . 1.56 118.559 -171.133 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.8 28.25 14.46 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 126.078 1.799 . . . . 0.97 113.49 176.703 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -100.34 163.97 12.15 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 121.234 -1.156 . . . . 3.07 111.671 167.222 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.8 p -96.5 -172.03 2.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.516 -1.99 . . . . 1.34 111.368 175.509 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.443 HD23 HD11 ' A' ' 61' ' ' ILE . 15.3 mt -87.83 -29.25 21.08 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 119.107 -2.245 . . . . 1.63 111.436 172.362 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.282 8.2 t -63.08 -37.49 87.43 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 120.916 3.673 . . . . 1.51 120.916 171.057 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -52.97 -40.38 63.69 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 113.458 -1.701 . . . . 1.9 113.923 170.249 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.405 ' CE2' HD22 ' A' ' 50' ' ' LEU . 38.8 m-85 -93.76 -3.38 52.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.532 2.333 . . . . 0.97 112.485 -177.695 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.286 13.7 m120 66.35 33.05 7.27 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.714 1.721 . . . . 2.35 114.232 -174.046 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.443 HD11 HD23 ' A' ' 56' ' ' LEU 0.279 33.7 mt -73.59 104.19 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 114.843 -2.503 . . . . 1.39 107.837 172.91 . . . . . . . . 3 3 . 1 . 087 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -92.04 -164.04 1.12 Allowed 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 124.673 1.233 . . . . 2.58 110.101 179.772 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -72.0 156.5 39.16 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.04 1.4 . . . . 2.58 112.094 171.28 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.326 26.9 mt-10 61.26 28.7 18.2 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.033 -2.292 . . . . 1.71 115.628 175.956 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.0 t -101.18 154.89 18.36 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.951 -2.968 . . . . 1.34 109.597 -173.71 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.7 m -110.42 111.81 23.32 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.854 2.74 . . . . 1.36 112.5 -174.783 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.43 HD22 HD13 ' A' ' 61' ' ' ILE . 20.1 mt -93.02 147.52 22.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.308 -3.37 . . . . 2.03 108.008 170.526 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.468 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 5.5 m-70 -102.11 122.89 44.99 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 126.834 2.584 . . . . 2.31 104.721 -175.604 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.8 tp -93.96 137.92 32.65 Favored 'General case' 0 N--CA 1.428 -1.542 0 O-C-N 118.732 -2.48 . . . . 1.72 111.59 178.678 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 m -135.93 150.05 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 105.868 -1.901 . . . . 1.8 105.868 168.376 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.8 mt . . . . . 0 N--CA 1.43 -1.438 0 O-C-N 118.803 -2.436 . . . . 3.26 112.812 -175.054 . . . . . . . . 0 0 . 1 . 088 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ptt? . . . . . 0 CA--C 1.49 -1.357 0 CA-C-O 123.049 1.404 . . . . 1.39 114.281 . . . . . . . . . 0 0 . 1 . 088 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -77.89 124.3 27.83 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.224 3.01 . . . . 2.2 114.453 -179.402 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.277 9.8 pt -128.48 153.12 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.301 -2.749 . . . . 1.32 111.139 171.286 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -117.59 130.49 56.43 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.526 1.967 . . . . 2.2 110.666 -178.89 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.51 111.16 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 102.908 -2.997 . . . . 1.23 102.908 -179.749 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -93.13 133.4 36.34 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 124.153 1.93 . . . . 2.51 111.774 -178.231 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.307 3.9 p -102.3 161.48 13.66 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 117.376 2.362 . . . . 1.41 117.376 169.166 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.4 tp -78.78 -35.72 43.99 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 112.22 -2.264 . . . . 2.95 111.449 168.75 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.273 0.8 OUTLIER -63.91 -58.41 6.85 Favored 'General case' 0 N--CA 1.431 -1.412 1 C-N-CA 133.323 4.649 . . . . 2.52 111.716 -169.983 . . . . . . . . 4 3 . 1 . 088 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.85 -79.23 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 129.456 3.407 . . . . 1.5 120.515 176.422 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.504 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 10.5 ptpt -77.92 165.4 24.14 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 129.831 3.252 . . . . 1.79 116.197 -170.281 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.8 m -115.66 120.58 39.85 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 103.452 -2.796 . . . . 1.38 103.452 168.315 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.4 mt -89.18 107.03 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.859 2.463 . . . . 2.03 105.93 -176.522 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.7 m -82.54 100.0 9.85 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 124.282 0.989 . . . . 1.61 113.434 178.944 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.1 mt -88.13 154.52 20.39 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.7 2.19 . . . . 2.15 115.911 -179.98 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -104.27 114.78 29.24 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 102.399 -3.186 . . . . 1.98 102.399 163.616 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.8 m -117.36 177.39 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.069 -2.269 . . . . 1.52 109.426 173.081 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -115.57 156.65 45.82 Favored Pre-proline 0 N--CA 1.429 -1.476 0 N-CA-C 104.623 -2.362 . . . . 2.35 104.623 154.913 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -78.53 -9.09 16.12 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 CA-C-N 127.334 3.655 . . . . 1.31 109.197 -171.589 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.1 p -81.45 -9.65 59.67 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.884 -2.385 . . . . 1.71 113.911 174.838 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -66.82 141.85 57.55 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 125.855 1.972 . . . . 1.69 111.83 172.704 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 52.6 p -81.35 170.34 16.13 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.795 -2.441 . . . . 1.33 112.699 176.852 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.411 HG13 ' HB3' ' A' ' 50' ' ' LEU . 25.2 mm -66.01 -26.18 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 129.179 2.991 . . . . 1.32 109.37 170.563 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -70.97 -33.85 70.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.164 1.935 . . . . 1.62 115.546 173.999 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.438 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 83.5 m-20 -66.02 -43.38 87.8 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.193 2.597 . . . . 2.13 111.878 169.723 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.25 -45.21 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 115.224 1.564 . . . . 1.23 115.224 174.059 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -67.11 -36.03 81.03 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 117.348 -3.345 . . . . 1.97 113.277 169.769 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.71 -25.02 62.48 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 118.501 -2.624 . . . . 1.19 117.454 172.122 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 25' ' ' ASN 0.356 44.5 mttm -69.63 -55.14 10.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.41 -2.681 . . . . 1.92 117.247 174.537 . . . . . . . . 3 3 . 1 . 088 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.2 mt -52.62 -47.07 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 1 C-N-CA 135.202 5.401 . . . . 1.94 106.419 173.615 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -50.02 -40.82 45.84 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 120.825 3.639 . . . . 1.9 120.825 177.129 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -66.56 -43.4 85.11 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.958 -3.589 . . . . 1.55 114.807 164.444 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -70.19 -49.98 44.83 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 127.656 3.598 . . . . 2.95 110.322 -169.95 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.504 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS 0.264 28.7 mm-40 -120.3 4.72 10.76 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 111.286 -2.688 . . . . 1.48 112.726 -165.858 . . . . . . . . 3 3 . 1 . 088 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.6 0.38 47.95 Favored Glycine 0 N--CA 1.431 -1.662 0 C-N-CA 115.678 -3.153 . . . . 1.12 119.222 173.605 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.5 mt -86.42 116.29 65.34 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 103.445 -2.798 . . . . 2.07 103.445 -169.202 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.1 165.26 24.72 Favored 'Trans proline' 0 C--N 1.3 -2.016 1 C-N-CA 126.54 4.827 . . . . 1.39 115.695 176.389 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -79.38 -17.43 11.51 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 124.524 2.651 . . . . 1.68 112.994 -172.235 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -67.54 -27.49 67.0 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.373 2.035 . . . . 2.25 115.436 175.458 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -104.87 24.02 12.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.813 -2.429 . . . . 2.44 114.308 -178.032 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -123.53 119.0 28.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.987 2.515 . . . . 1.32 113.392 179.66 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.525 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 90.5 mtt-85 -113.94 120.8 41.9 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.806 1.642 . . . . 3.19 108.288 169.466 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.6 mt -104.51 126.62 51.77 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.143 -1.598 . . . . 1.75 111.219 -178.103 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mm -117.61 140.4 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 124.206 3.185 . . . . 1.98 112.755 177.131 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -152.56 132.57 13.4 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 104.752 -2.314 . . . . 1.94 104.752 175.959 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.91 21.92 11.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 115.968 -1.968 . . . . 1.67 115.178 179.64 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.66 -2.34 83.16 Favored Glycine 0 N--CA 1.431 -1.688 1 C-N-CA 132.379 4.8 . . . . 1.3 113.286 -179.38 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -101.01 137.57 39.2 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.842 0.829 . . . . 2.89 112.841 -178.983 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -70.68 127.13 31.62 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 117.194 -3.442 . . . . 2.89 115.808 166.627 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.411 ' HB3' HG13 ' A' ' 23' ' ' ILE . 36.9 mt -81.62 136.9 35.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.705 -1.872 . . . . 1.34 113.647 -176.075 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.419 ' CD ' HH21 ' A' ' 54' ' ' ARG . 19.7 tt0 -85.74 144.14 27.94 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 119.031 2.974 . . . . 1.94 119.031 172.467 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.12 -43.26 82.87 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 121.763 3.986 . . . . 1.56 121.763 -168.362 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.23 8.84 50.82 Favored Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 118.123 2.009 . . . . 0.97 118.123 170.446 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.419 HH21 ' CD ' ' A' ' 51' ' ' GLU . 84.8 mtt180 -101.59 149.55 24.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.679 1.704 . . . . 3.07 110.233 170.289 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.283 32.2 p -81.7 170.65 15.52 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.069 -2.894 . . . . 1.34 110.547 -178.211 . . . . . . . . 3 3 . 1 . 088 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.7 mt -67.8 -37.04 81.47 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 127.031 2.132 . . . . 1.63 110.062 167.672 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.382 4.9 t -59.4 -43.64 92.95 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.525 -3.234 . . . . 1.51 114.234 176.72 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -60.82 -44.63 96.64 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.113 2.863 . . . . 1.9 111.042 179.995 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -77.92 -6.76 55.37 Favored 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 114.939 -4.85 . . . . 0.97 115.883 178.416 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.304 13.1 m120 68.95 36.79 2.42 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.605 -2.559 . . . . 2.35 115.412 -178.206 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.2 mt -85.24 113.96 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 125.905 1.682 . . . . 1.39 111.968 177.635 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -103.64 -173.96 2.43 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 118.411 -1.316 . . . . 2.58 108.824 -174.933 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -53.42 147.48 10.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.419 3.009 . . . . 2.58 114.4 171.082 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 56.09 33.51 22.08 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 120.441 3.497 . . . . 1.71 120.441 -178.969 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.7 m -103.51 149.1 25.18 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.777 -1.556 . . . . 1.34 109.96 -177.151 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -103.58 112.06 24.8 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 126.132 1.773 . . . . 1.36 109.106 -170.452 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mt -90.24 140.72 29.41 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.458 -1.312 . . . . 2.03 107.458 174.15 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.375 66.9 m80 -107.28 118.1 35.82 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.665 -1.272 . . . . 2.31 108.116 178.308 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -88.02 121.44 30.43 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 121.378 -0.826 . . . . 1.72 109.761 179.875 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 59.6 t -105.69 135.46 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 104.473 -2.417 . . . . 1.8 104.473 174.242 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.428 0 N-CA-C 107.402 -1.332 . . . . 3.26 107.402 -179.5 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 CA--C 1.49 -1.34 0 N-CA-C 106.721 -1.585 . . . . 1.39 106.721 . . . . . . . . . 0 0 . 1 . 089 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -93.71 126.5 38.93 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.138 1.375 . . . . 2.2 112.692 179.698 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -127.25 166.98 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 105.002 -2.222 . . . . 1.32 105.002 167.759 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -123.27 145.05 49.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.076 2.95 . . . . 2.2 110.268 -177.716 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.2 t -124.91 124.18 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 106.691 -1.596 . . . . 1.23 106.691 173.677 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -106.41 128.59 54.16 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.601 2.36 . . . . 2.51 108.406 -178.73 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 p -87.4 179.44 6.58 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.02 2.343 . . . . 1.41 110.03 -179.399 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.331 14.2 tp -65.94 -41.95 90.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.918 2.487 . . . . 2.95 114.61 168.462 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.8 p -75.42 -38.54 59.75 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 120.817 -1.177 . . . . 2.52 108.307 -177.778 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.73 28.32 0.3 Allowed Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 123.652 0.644 . . . . 1.5 113.226 169.783 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -94.48 129.22 41.34 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.082 -2.422 . . . . 1.79 110.863 -177.134 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.8 m -116.36 90.21 3.28 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.937 2.78 . . . . 1.38 107.489 -174.345 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 pt -92.94 136.97 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 112.224 -2.262 . . . . 2.03 106.099 -178.876 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -94.86 128.37 41.57 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 130.22 3.408 . . . . 1.61 113.287 -178.801 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.9 mt -122.32 151.06 41.53 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.882 1.801 . . . . 2.15 112.88 178.184 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -114.54 112.7 23.36 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.657 1.218 . . . . 1.98 108.689 174.464 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m -118.27 175.11 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 118.715 -2.491 . . . . 1.52 111.548 -176.751 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -108.15 147.93 36.53 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-N 122.186 2.266 . . . . 2.35 106.784 160.498 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.13 -18.88 26.83 Favored 'Trans proline' 0 N--CA 1.433 -2.058 0 C-N-CA 123.718 2.945 . . . . 1.31 112.533 -174.548 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.3 p -90.57 9.92 27.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 121.725 2.057 . . . . 1.71 113.329 178.097 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -89.59 158.42 17.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.331 -3.355 . . . . 1.69 107.333 -179.865 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.6 p -80.6 171.11 15.46 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.297 1.221 . . . . 1.33 114.297 178.832 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.6 mm -69.77 -39.79 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 125.679 1.592 . . . . 1.32 108.91 175.993 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.26 86.7 tt0 -45.77 -45.75 14.84 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 117.613 2.449 . . . . 1.62 117.613 169.117 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -68.09 -35.66 78.54 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 118.058 2.614 . . . . 2.13 118.058 175.703 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.8 t -62.96 -31.22 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 112.971 0.73 . . . . 1.23 112.971 170.783 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.466 ' HZ3' ' CG ' ' A' ' 52' ' ' ASP . 78.8 mttt -71.5 -25.58 62.32 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 118.802 2.89 . . . . 1.97 118.802 167.327 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.87 -20.3 53.26 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 119.582 -1.949 . . . . 1.19 108.476 170.893 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -80.54 -23.51 39.94 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 120.419 1.463 . . . . 1.92 107.993 177.626 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.1 mt -81.85 -28.26 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.784 -2.447 . . . . 1.94 112.802 167.616 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 67.0 tt0 -65.74 -36.75 84.46 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 123.552 2.887 . . . . 1.9 113.362 173.655 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -60.05 -56.79 17.35 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 124.285 1.034 . . . . 1.55 111.781 170.118 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -77.34 -52.75 8.64 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 116.272 1.953 . . . . 2.95 116.272 -172.807 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -99.08 -25.1 14.66 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 119.348 -2.095 . . . . 1.48 108.407 -165.911 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.4 37.33 11.0 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 122.017 2.189 . . . . 1.12 113.161 175.668 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 mt -106.92 126.96 28.96 Favored Pre-proline 0 N--CA 1.43 -1.433 0 C-N-CA 127.671 2.388 . . . . 2.07 107.472 -178.752 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -68.82 150.2 73.49 Favored 'Trans proline' 0 N--CA 1.434 -1.977 0 O-C-N 115.28 -3.063 . . . . 1.39 116.585 -178.653 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -69.39 -14.5 37.37 Favored 'Trans proline' 0 N--CA 1.433 -2.061 0 CA-C-N 124.447 2.624 . . . . 1.68 117.886 -172.557 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -74.86 -34.09 62.22 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.993 1.854 . . . . 2.25 111.069 172.314 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -72.56 -28.41 62.81 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 115.165 -4.709 . . . . 2.44 114.523 -178.895 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -78.99 147.19 33.0 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.353 -1.467 . . . . 1.32 110.419 -173.382 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.277 12.1 tpt180 -133.35 120.12 20.58 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.07 -2.567 . . . . 3.19 104.07 170.773 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.2 mt -96.51 125.85 41.28 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.546 -1.346 . . . . 1.75 108.708 -177.899 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.278 6.2 mt -118.91 115.07 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 116.422 2.008 . . . . 1.98 116.422 -179.865 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -130.54 137.99 49.97 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 117.076 2.25 . . . . 1.94 117.076 164.97 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.291 . . 51.26 45.73 27.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.404 -3.31 . . . . 1.67 118.806 -175.487 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.6 -22.12 1.43 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 125.335 1.445 . . . . 1.3 113.646 -175.471 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -90.22 133.09 35.14 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 118.526 2.787 . . . . 2.89 118.526 -173.828 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -74.19 133.68 42.73 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 116.785 -3.697 . . . . 2.89 104.365 171.016 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.7 mt -91.17 123.69 34.81 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 127.07 3.319 . . . . 1.34 110.869 -175.741 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -85.19 135.5 33.92 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.165 -2.834 . . . . 1.94 116.105 175.966 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.466 ' CG ' ' HZ3' ' A' ' 27' ' ' LYS . 3.4 m-20 -57.11 -53.04 62.6 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 129.973 3.309 . . . . 1.56 117.38 -160.958 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.09 21.51 1.35 Allowed Glycine 0 N--CA 1.43 -1.737 0 O-C-N 118.952 -2.342 . . . . 0.97 115.88 170.263 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -113.79 166.28 11.72 Favored 'General case' 0 N--CA 1.43 -1.451 1 CA-C-N 124.531 4.165 . . . . 3.07 108.251 168.979 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.8 p -97.78 173.47 7.09 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 123.551 1.644 . . . . 1.34 110.061 -179.173 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.9 mt -67.77 -31.91 72.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 114.317 1.229 . . . . 1.63 114.317 177.065 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.8 t -62.18 -44.73 95.94 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.043 3.337 . . . . 1.51 113.941 178.377 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -52.86 -38.54 61.68 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 125.141 1.526 . . . . 1.9 112.112 175.571 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -91.23 -1.0 57.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.335 1.854 . . . . 0.97 111.984 178.488 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.311 3.4 m120 61.72 31.26 18.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 119.446 3.128 . . . . 2.35 119.446 -179.526 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.4 mt -88.11 110.36 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 128.7 2.8 . . . . 1.39 104.469 -173.41 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -95.82 -169.91 2.03 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 112.373 -2.194 . . . . 2.58 106.288 -174.434 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -57.83 147.9 26.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 130.239 3.416 . . . . 2.58 117.797 172.894 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 55.89 49.33 16.19 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 115.817 1.784 . . . . 1.71 115.817 178.102 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 m -117.53 147.91 42.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.774 -1.195 . . . . 1.34 107.774 -174.62 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.4 m -99.2 105.41 17.45 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.355 3.462 . . . . 1.36 111.209 177.394 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.69 132.54 39.32 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.778 1.631 . . . . 2.03 108.505 178.072 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -89.13 124.88 34.74 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.95 -4.219 . . . . 2.31 106.395 -178.734 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.8 tp -95.13 122.09 37.44 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.716 -2.49 . . . . 1.72 105.842 171.214 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.1 t -115.14 151.4 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 127.872 2.469 . . . . 1.8 108.829 168.537 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.0 mt . . . . . 0 N--CA 1.429 -1.482 0 O-C-N 117.601 -3.187 . . . . 3.26 110.659 174.637 . . . . . . . . 0 0 . 1 . 090 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 CA--C 1.491 -1.304 0 CA-C-O 121.188 0.518 . . . . 1.39 110.677 . . . . . . . . . 0 0 . 1 . 090 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -110.6 121.31 45.02 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.489 -2.632 . . . . 2.2 111.44 -179.691 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.3 pt -108.73 172.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 114.588 -1.187 . . . . 1.32 111.792 169.621 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -120.4 160.08 23.81 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.76 -0.829 . . . . 2.2 108.76 178.879 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.7 t -139.56 133.46 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 117.381 -3.325 . . . . 1.23 106.815 168.851 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -110.76 137.57 48.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.551 -3.218 . . . . 2.51 109.415 177.323 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.275 11.1 p -81.67 -169.63 2.42 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 114.824 -4.923 . . . . 1.41 115.74 176.858 . . . . . . . . 3 2 . 1 . 090 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.322 13.1 mt -77.46 -37.34 51.69 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 113.656 0.984 . . . . 2.95 113.656 174.963 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.76 -37.72 22.26 Favored 'General case' 0 N--CA 1.429 -1.504 1 C-N-CA 133.61 4.764 . . . . 2.52 110.019 -169.501 . . . . . . . . 3 3 . 1 . 090 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.67 33.66 0.64 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 115.04 -3.089 . . . . 1.5 111.842 173.175 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.446 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 46.0 tttm -97.54 137.48 36.41 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.513 2.156 . . . . 1.79 106.572 -178.953 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 m -108.27 121.42 44.86 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 118.897 -0.573 . . . . 1.38 109.9 176.687 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mt -104.77 106.87 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 125.498 1.749 . . . . 2.03 111.444 179.081 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.9 m -80.78 94.72 6.46 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 130.485 3.514 . . . . 1.61 111.67 178.024 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.8 mt -98.02 130.99 44.82 Favored 'General case' 0 N--CA 1.429 -1.482 1 O-C-N 115.781 -4.324 . . . . 2.15 112.907 -174.898 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -92.08 125.92 36.96 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.182 1.81 . . . . 1.98 107.18 174.836 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.9 m -133.89 174.95 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 107.401 -1.333 . . . . 1.52 107.401 -173.569 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -126.26 159.99 59.83 Favored Pre-proline 0 N--CA 1.43 -1.443 0 O-C-N 120.378 -1.451 . . . . 2.35 108.09 163.694 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -78.02 -10.06 16.66 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 CA-C-N 126.29 3.282 . . . . 1.31 109.919 -172.561 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.9 p -78.34 -22.54 47.85 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 130.369 3.468 . . . . 1.71 113.951 174.598 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -68.08 142.39 55.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.104 2.162 . . . . 1.69 110.655 176.21 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.9 p -78.08 164.25 25.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.659 2.171 . . . . 1.33 113.424 175.346 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -59.91 -33.18 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.515 1.926 . . . . 1.32 111.189 173.127 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -63.32 -44.48 94.83 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.582 1.553 . . . . 1.62 113.196 172.141 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -60.83 -26.45 67.35 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 115.517 -2.183 . . . . 2.13 114.083 170.037 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.338 46.6 t -84.43 -25.97 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 CA-C-N 127.243 4.565 . . . . 1.23 109.658 179.146 . . . . . . . . 3 2 . 1 . 090 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -75.74 -30.71 59.32 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.575 -3.203 . . . . 1.97 110.766 173.676 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.61 93.06 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.248 -1.532 . . . . 1.19 112.123 174.872 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -58.95 -45.44 90.46 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.436 -3.29 . . . . 1.92 111.074 174.883 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.4 mt -58.48 -33.61 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.292 -3.38 . . . . 1.94 114.652 173.229 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -70.07 -34.85 73.71 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.507 2.41 . . . . 1.9 117.507 -179.673 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -72.82 -47.74 43.75 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 125.016 2.341 . . . . 1.55 116.387 164.506 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -63.86 -65.85 0.62 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.12 -3.488 . . . . 2.95 109.639 -173.673 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.446 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 67.6 mm-40 -94.23 -51.93 4.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.439 -2.663 . . . . 1.48 110.96 -168.406 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.56 73.19 0.97 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-N 115.489 -0.778 . . . . 1.12 112.276 179.374 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 mt -138.53 117.4 9.46 Favored Pre-proline 0 N--CA 1.429 -1.487 0 N-CA-C 102.427 -3.175 . . . . 2.07 102.427 -174.695 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -57.83 143.13 96.23 Favored 'Trans proline' 0 C--N 1.299 -2.059 0 CA-C-O 112.559 -3.184 . . . . 1.39 114.219 177.838 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -62.21 -15.92 47.52 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 CA-C-N 124.961 2.807 . . . . 1.68 115.926 178.404 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -63.73 -34.99 79.1 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 124.784 2.231 . . . . 2.25 115.907 173.976 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -81.81 -21.87 37.43 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.418 -2.676 . . . . 2.44 109.705 -177.86 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -82.06 104.53 12.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.642 1.686 . . . . 1.32 114.975 -173.767 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.5 tpp85 -100.59 123.37 44.7 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 112.455 -2.157 . . . . 3.19 107.282 162.54 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.0 mt -111.43 137.1 49.65 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.758 2.694 . . . . 1.75 106.531 178.713 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.0 mt -125.36 149.77 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 117.266 -3.396 . . . . 1.98 104.211 -179.654 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.31 84.1 t80 -146.84 135.58 22.17 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 116.564 2.061 . . . . 1.94 116.564 168.541 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.59 -67.3 0.21 Allowed 'General case' 0 N--CA 1.43 -1.45 1 C-N-CA 131.942 4.097 . . . . 1.67 112.317 179.464 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.59 15.42 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.648 0 C-N-CA 128.042 2.734 . . . . 1.3 107.861 174.441 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.1 mttp -123.11 134.14 54.24 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.6 -2.117 . . . . 2.89 107.269 -176.706 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -73.17 140.48 47.05 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 116.857 -1.937 . . . . 2.89 115.237 169.003 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 mt -94.89 133.34 38.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 116.703 -3.748 . . . . 1.34 108.33 -164.558 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -96.67 118.85 34.02 Favored 'General case' 0 N--CA 1.431 -1.393 1 O-C-N 115.46 -4.525 . . . . 1.94 109.46 -176.521 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -39.88 -51.31 2.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 117.797 2.517 . . . . 1.56 117.797 -175.817 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.53 39.54 0.22 Allowed Glycine 0 N--CA 1.429 -1.787 0 C-N-CA 128.04 2.733 . . . . 0.97 114.331 170.411 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -137.1 169.49 17.7 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 119.723 1.762 . . . . 3.07 111.619 164.847 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.8 p -98.51 166.36 11.39 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.45 1.9 . . . . 1.34 115.858 175.702 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mt -62.51 -36.47 82.66 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.379 -2.076 . . . . 1.63 112.227 172.167 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -60.64 -44.98 95.75 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.687 1.995 . . . . 1.51 116.336 175.359 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -60.62 -45.82 92.59 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 119.551 1.068 . . . . 1.9 111.8 179.951 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -77.65 -8.86 58.52 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 113.52 0.933 . . . . 0.97 113.52 179.242 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.29 71.4 m-80 62.26 51.29 3.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.048 2.139 . . . . 2.35 116.691 -174.749 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.0 mt -92.7 121.99 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 101.418 -3.549 . . . . 1.39 101.418 178.069 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.6 mm-40 -110.33 -168.49 1.32 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.197 -1.564 . . . . 2.58 112.676 178.923 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -68.74 155.93 39.22 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.586 -3.196 . . . . 2.58 107.83 -179.929 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 64.2 20.59 12.24 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 112.641 -2.072 . . . . 1.71 114.724 178.433 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.278 50.6 m -84.39 148.09 26.8 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-O 114.661 -2.59 . . . . 1.34 114.51 -174.068 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.0 m -109.59 113.62 26.56 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 115.963 -2.295 . . . . 1.36 109.993 176.657 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.6 mt -84.69 155.4 21.96 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.208 -1.558 . . . . 2.03 107.417 175.732 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -107.09 109.95 21.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 118.027 -0.987 . . . . 2.31 111.932 -174.699 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 tt -80.59 112.58 18.08 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.366 1.066 . . . . 1.72 113.065 174.348 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.4 t -109.77 122.06 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 127.267 2.227 . . . . 1.8 105.382 171.622 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.9 mt . . . . . 0 N--CA 1.431 -1.391 0 N-CA-C 104.142 -2.54 . . . . 3.26 104.142 177.131 . . . . . . . . 0 0 . 1 . 091 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptt? . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 117.885 2.55 . . . . 1.39 117.885 . . . . . . . . . 0 0 . 1 . 091 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -89.29 121.35 31.48 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.997 -1.064 . . . . 2.2 111.818 -173.585 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.483 HG12 HG22 ' A' ' 17' ' ' VAL . 10.8 pt -116.46 154.7 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 101.025 -3.695 . . . . 1.32 101.025 173.265 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -113.18 151.94 30.32 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 124.783 1.233 . . . . 2.2 111.623 179.943 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.1 t -134.58 127.64 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 122.745 2.521 . . . . 1.23 105.582 175.456 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -92.86 140.6 29.33 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.716 -1.865 . . . . 2.51 110.743 -179.793 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.0 p -87.13 -177.9 6.12 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.365 -0.976 . . . . 1.41 108.365 178.133 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 tp -64.7 -46.52 82.01 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.09 -4.131 . . . . 2.95 115.346 171.126 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -77.23 -21.45 53.76 Favored 'General case' 0 N--CA 1.43 -1.433 1 O-C-N 115.988 -4.195 . . . . 2.52 117.066 178.056 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.59 37.98 0.87 Allowed Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 121.037 3.175 . . . . 1.5 121.037 174.98 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.473 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 83.1 tttt -98.31 127.05 44.06 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 102.006 -3.331 . . . . 1.79 102.006 -177.358 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.0 m -91.68 118.18 30.42 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.134 -1.604 . . . . 1.38 113.871 175.841 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.293 10.4 mt -90.92 126.46 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 103.614 -2.736 . . . . 2.03 103.614 -179.855 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.2 m -98.84 120.16 38.81 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 123.527 2.876 . . . . 1.61 107.127 173.083 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.4 mt -118.38 117.11 28.16 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 125.095 2.379 . . . . 2.15 113.996 177.856 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -79.63 97.37 6.49 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.108 -1.62 . . . . 1.98 113.36 172.258 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.483 HG22 HG12 ' A' ' 3' ' ' ILE . 27.0 m -113.84 166.72 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 128.299 2.64 . . . . 1.52 110.915 -175.669 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -107.36 163.71 16.36 Favored Pre-proline 0 N--CA 1.429 -1.5 0 O-C-N 125.017 1.448 . . . . 2.35 111.79 162.02 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.43 -19.67 10.1 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 O-C-N 113.594 -3.951 . . . . 1.31 109.877 -175.172 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 m -81.56 -3.07 52.26 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 116.616 -1.659 . . . . 1.71 114.07 -179.573 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -72.72 142.78 48.19 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.498 1.519 . . . . 1.69 112.576 176.846 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 p -81.82 165.25 21.04 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 124.606 1.191 . . . . 1.33 110.52 176.319 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.4 mm -68.79 -24.64 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 1 O-C-N 115.285 -4.634 . . . . 1.32 113.122 178.882 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -51.91 -45.84 64.38 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 129.661 3.185 . . . . 1.62 113.59 164.062 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -62.96 -36.98 85.27 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 115.624 1.713 . . . . 2.13 115.624 174.064 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.75 -48.4 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 127.177 2.191 . . . . 1.23 111.735 175.391 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.5 mttt -55.1 -34.06 63.35 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.339 1.977 . . . . 1.97 116.339 170.033 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.69 -23.79 61.71 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 116.011 1.856 . . . . 1.19 116.011 172.615 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -75.44 -33.49 60.9 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.955 2.902 . . . . 1.92 114.128 168.599 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.4 mt -76.41 -26.68 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 1 O-C-N 113.791 -5.568 . . . . 1.94 110.402 174.861 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -74.01 -25.3 59.82 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.964 -2.335 . . . . 1.9 106.475 178.808 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -86.13 -41.95 14.3 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.172 1.463 . . . . 1.55 114.483 171.122 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.3 mmtt -57.47 -65.7 0.58 Allowed 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 113.999 -5.438 . . . . 2.95 111.36 172.316 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.473 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 51.3 mm-40 -97.16 -35.53 10.75 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.023 2.529 . . . . 1.48 115.08 -168.067 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.18 44.98 3.65 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 119.896 -1.753 . . . . 1.12 114.093 179.162 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.3 mt -114.18 126.67 27.71 Favored Pre-proline 0 N--CA 1.43 -1.429 1 C-N-CA 134.79 5.236 . . . . 2.07 111.32 -178.76 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.78 156.16 43.97 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 CA-C-N 125.962 3.165 . . . . 1.39 113.442 179.372 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -65.31 -12.11 33.31 Favored 'Trans proline' 0 N--CA 1.433 -2.032 2 CA-C-N 131.235 5.048 . . . . 1.68 118.198 -173.021 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -63.95 -45.14 90.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 127.128 2.768 . . . . 2.25 113.132 175.231 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -84.37 -7.86 59.17 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.9 -3.0 . . . . 2.44 108.465 -175.831 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -92.01 129.74 37.9 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 115.71 -4.368 . . . . 1.32 109.457 -171.684 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -130.64 120.85 24.56 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 129.424 3.09 . . . . 3.19 105.925 172.511 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.5 mt -107.01 122.71 46.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.602 3.096 . . . . 1.75 113.474 -176.719 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 29.0 mm -109.9 123.32 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 111.786 -2.461 . . . . 1.98 109.087 177.549 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -101.83 111.41 23.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.53 -2.767 . . . . 1.94 103.53 167.919 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.407 ' HB3' ' H ' ' A' ' 47' ' ' GLY . . . 72.05 -93.48 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 125.48 1.738 . . . . 1.67 108.905 172.901 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 46' ' ' ALA . . . -138.37 14.04 3.48 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-O 116.208 -2.44 . . . . 1.3 114.15 176.583 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp -107.82 133.63 51.93 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 128.496 3.115 . . . . 2.89 112.858 179.904 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -86.94 115.98 24.7 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 126.018 2.818 . . . . 2.89 114.819 173.681 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.0 mt -73.79 143.88 45.81 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.898 -1.751 . . . . 1.34 112.214 -171.561 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -100.1 138.72 36.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 125.23 2.443 . . . . 1.94 115.568 174.236 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -48.46 -46.86 38.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.422 3.489 . . . . 1.56 119.847 -175.985 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.54 44.91 1.39 Allowed Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 127.105 2.288 . . . . 0.97 116.691 170.928 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.25 20.7 mmt85 -117.25 163.61 16.05 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 117.703 -3.234 . . . . 3.07 103.659 166.332 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.5 p -99.61 163.63 12.41 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.081 -3.512 . . . . 1.34 115.964 169.064 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.7 mt -57.54 -36.17 71.28 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 113.646 -1.615 . . . . 1.63 112.198 174.402 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 t -66.4 -37.75 85.94 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 116.132 1.901 . . . . 1.51 116.132 178.825 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -55.92 -32.15 63.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.37 1.868 . . . . 1.9 114.513 173.065 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -94.86 -8.01 38.54 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 122.951 1.358 . . . . 0.97 110.73 -178.936 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.8 m120 69.0 43.13 1.17 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.356 2.662 . . . . 2.35 114.668 -173.169 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.8 mt -84.9 128.82 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 126.014 2.816 . . . . 1.39 106.379 -179.127 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -109.06 179.99 4.01 Favored 'General case' 0 N--CA 1.431 -1.425 1 O-C-N 115.893 -4.255 . . . . 2.58 108.22 -176.86 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -53.73 138.76 34.57 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 130.943 3.697 . . . . 2.58 115.41 167.005 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.343 9.7 pt-20 77.04 3.2 3.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.598 2.359 . . . . 1.71 117.145 171.828 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.41 164.07 25.37 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 112.818 -1.992 . . . . 1.34 112.849 -176.661 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.3 m -120.0 121.1 38.18 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 124.34 2.019 . . . . 1.36 108.432 175.321 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.29 174.18 5.98 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 104.642 -2.355 . . . . 2.03 104.642 175.117 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.407 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 31.3 m170 -130.63 141.53 50.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.962 -1.496 . . . . 2.31 106.962 179.232 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.6 tp -112.23 110.78 21.23 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 129.993 3.317 . . . . 1.72 106.849 -174.259 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.1 t -112.83 123.05 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 C-N-CA 125.222 1.409 . . . . 1.8 109.676 176.93 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 N--CA 1.43 -1.466 0 CA-C-O 122.704 1.24 . . . . 3.26 111.63 178.036 . . . . . . . . 0 0 . 1 . 092 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ptt? . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 116.565 2.061 . . . . 1.39 116.565 . . . . . . . . . 0 0 . 1 . 092 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -106.88 123.09 47.66 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.133 -2.854 . . . . 2.2 111.887 -177.31 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.0 pt -127.19 155.61 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 112.028 -2.351 . . . . 1.32 108.535 170.05 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -124.55 137.22 54.42 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.384 1.073 . . . . 2.2 110.282 -176.014 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.1 t -116.6 101.49 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 129.422 3.089 . . . . 1.23 106.371 178.199 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -81.9 139.59 34.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.711 1.243 . . . . 2.51 112.653 178.769 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.2 p -100.43 -175.96 3.07 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 120.191 -1.568 . . . . 1.41 112.61 -179.147 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.2 mt -77.35 -43.19 33.82 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 112.82 -6.175 . . . . 2.95 111.185 178.205 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.8 p -70.05 -17.49 63.25 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.89 2.076 . . . . 2.52 111.526 -168.352 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.52 33.65 3.3 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 126.091 1.805 . . . . 1.5 116.15 170.317 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -108.56 148.44 30.29 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 103.226 -2.879 . . . . 1.79 103.226 -178.557 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 80.5 m -117.38 120.18 37.38 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 126.247 2.217 . . . . 1.38 109.007 -179.212 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.0 mm -98.72 108.7 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 126.48 3.038 . . . . 2.03 112.204 179.904 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.268 47.4 m -85.18 139.49 31.64 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.131 -3.48 . . . . 1.61 106.704 -175.377 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.442 HD12 HG11 ' A' ' 26' ' ' VAL . 23.1 mt -125.47 146.58 49.57 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.688 -2.507 . . . . 2.15 109.497 176.159 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -99.61 104.21 15.97 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 127.651 2.381 . . . . 1.98 110.726 163.95 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -124.8 176.3 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 119.069 -2.269 . . . . 1.52 111.037 177.728 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -115.47 155.65 46.92 Favored Pre-proline 0 N--CA 1.429 -1.508 0 N-CA-C 103.308 -2.849 . . . . 2.35 103.308 162.487 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -74.95 5.73 3.79 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 127.167 3.595 . . . . 1.31 112.026 -174.61 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.7 p -94.97 -8.73 36.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 130.405 3.482 . . . . 1.71 109.434 179.613 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -72.05 134.1 45.65 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.784 -2.448 . . . . 1.69 107.477 175.412 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.6 p -78.62 160.46 27.54 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 111.004 -2.816 . . . . 1.33 110.926 174.154 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -65.57 -31.39 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 117.176 -3.452 . . . . 1.32 116.246 177.692 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -40.16 -53.43 2.47 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.576 -3.828 . . . . 1.62 114.982 159.78 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -58.75 -39.29 80.51 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 125.117 2.389 . . . . 2.13 116.5 173.259 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.442 HG11 HD12 ' A' ' 15' ' ' LEU . 74.7 t -63.29 -42.57 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 129.909 3.284 . . . . 1.23 113.872 -179.346 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.28 39.0 mtmt -70.03 -33.5 72.05 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 126.469 2.355 . . . . 1.97 114.895 174.256 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.27 -34.03 76.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.221 1.563 . . . . 1.19 115.221 169.857 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -58.35 -31.41 67.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 127.986 3.755 . . . . 1.92 118.293 172.046 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.2 mt -84.41 -32.42 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 1 CA-C-N 108.299 -4.046 . . . . 1.94 110.151 179.256 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -63.63 -33.97 76.81 Favored 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 116.201 -4.062 . . . . 1.9 114.62 176.863 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -64.34 -47.09 80.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.616 1.566 . . . . 1.55 113.332 168.139 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -75.9 -62.29 1.64 Allowed 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 121.267 1.849 . . . . 2.95 114.101 -178.773 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -89.97 -18.25 26.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.952 1.251 . . . . 1.48 114.035 -171.477 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.62 13.85 46.0 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 120.469 -1.394 . . . . 1.12 111.264 167.534 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.7 mt -98.35 133.46 22.83 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 118.936 -2.508 . . . . 2.07 113.837 -173.93 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -64.65 143.61 81.59 Favored 'Trans proline' 0 N--CA 1.433 -2.045 1 N-CA-C 124.499 4.769 . . . . 1.39 124.499 170.563 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -62.69 -21.01 72.54 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 124.435 3.423 . . . . 1.68 114.772 179.807 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -63.65 -21.61 66.46 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.517 2.043 . . . . 2.25 116.517 168.381 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -94.94 -38.62 10.61 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 103.994 -2.595 . . . . 2.44 103.994 179.127 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.331 76.5 mt-30 -80.23 132.2 35.82 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 114.255 1.206 . . . . 1.32 114.255 -171.696 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -123.33 151.59 42.31 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.295 2.638 . . . . 3.19 104.822 170.219 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.2 mt -127.84 127.47 43.52 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 124.444 2.069 . . . . 1.75 106.929 176.521 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.6 mt -104.72 137.66 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 101.48 -3.526 . . . . 1.98 101.48 171.107 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.281 2.8 t80 -130.14 103.94 7.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.802 -3.061 . . . . 1.94 103.669 170.401 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.391 . . 80.58 -98.44 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 123.812 1.767 . . . . 1.67 110.844 -178.18 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.6 -5.78 3.95 Favored Glycine 0 N--CA 1.429 -1.79 1 CA-C-O 113.243 -4.087 . . . . 1.3 109.043 -176.995 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -101.77 128.61 48.03 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 122.093 2.947 . . . . 2.89 111.136 177.067 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -88.19 117.84 27.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.638 3.575 . . . . 2.89 111.286 177.803 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 mt -75.9 148.14 38.48 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.289 1.995 . . . . 1.34 113.576 -166.947 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -99.0 153.0 19.19 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 111.586 -2.552 . . . . 1.94 111.436 175.604 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.22 -54.33 8.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.466 1.507 . . . . 1.56 114.832 -168.418 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.06 47.31 3.68 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-O 114.787 -3.229 . . . . 0.97 115.672 176.104 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -130.47 158.15 40.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.756 2.278 . . . . 3.07 110.224 165.82 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.328 27.1 p -84.85 169.11 14.47 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 113.67 -5.644 . . . . 1.34 114.557 179.704 . . . . . . . . 3 2 . 1 . 092 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.7 mt -65.73 -34.08 77.36 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 113.326 0.861 . . . . 1.63 113.326 172.251 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.6 t -70.95 -25.42 62.72 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 127.416 2.287 . . . . 1.51 111.231 179.57 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -68.03 -29.31 68.27 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 117.728 -1.13 . . . . 1.9 113.298 169.427 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -96.18 18.2 14.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.578 2.351 . . . . 0.97 105.67 176.158 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.6 m120 45.07 41.19 5.34 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 129.097 2.959 . . . . 2.35 118.727 -179.763 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.9 mt -92.65 131.01 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 118.915 -2.366 . . . . 1.39 105.113 -176.864 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -148.1 -34.91 0.22 Allowed 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.259 2.457 . . . . 2.58 110.022 -175.214 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -95.96 -179.6 4.75 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 118.934 -2.354 . . . . 2.58 109.526 174.544 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -68.31 97.56 0.75 Allowed 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 124.404 2.05 . . . . 1.71 116.202 175.745 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 98.2 p -91.85 138.97 31.12 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.362 -1.29 . . . . 1.34 109.739 -167.371 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.1 m -89.57 104.07 16.66 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 115.807 -2.357 . . . . 1.36 112.894 175.483 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mp -88.54 158.1 18.41 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.482 -1.386 . . . . 2.03 107.498 176.181 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -122.87 121.94 37.44 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 118.261 -2.774 . . . . 2.31 114.81 176.331 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 tt -82.57 117.99 22.96 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 116.962 -1.895 . . . . 1.72 115.301 -178.793 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.5 t -114.96 133.67 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 CA-C-O 126.368 2.985 . . . . 1.8 112.466 175.321 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.6 mt . . . . . 0 N--CA 1.429 -1.484 0 O-C-N 116.752 -3.718 . . . . 3.26 107.735 175.87 . . . . . . . . 0 0 . 1 . 093 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 ttp . . . . . 0 CA--C 1.491 -1.318 0 N-CA-C 113.991 1.108 . . . . 1.39 113.991 . . . . . . . . . 0 0 . 1 . 093 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -106.29 95.0 5.46 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.752 -2.467 . . . . 2.2 111.004 -166.316 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.9 pt -90.44 165.58 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 125.762 1.914 . . . . 1.32 111.842 177.855 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -121.41 130.86 53.84 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.393 -1.442 . . . . 2.2 107.338 178.388 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.62 108.45 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 O-C-N 119.816 -1.802 . . . . 1.23 108.44 174.41 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -99.63 133.59 43.74 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.214 1.405 . . . . 2.51 111.059 179.707 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.9 p -101.08 163.58 12.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 115.742 1.756 . . . . 1.41 115.742 -179.31 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 tp -51.58 -49.06 62.85 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.802 3.241 . . . . 2.95 114.303 170.058 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 p -74.86 -40.01 61.23 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.702 1.715 . . . . 2.52 114.201 -165.975 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.37 15.73 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.709 0 O-C-N 118.283 -2.761 . . . . 1.5 114.134 174.323 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -108.03 134.41 50.96 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 126.02 2.819 . . . . 1.79 114.864 -178.367 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.0 m -108.66 107.15 17.51 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 130.02 3.328 . . . . 1.38 105.089 174.059 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -88.4 131.79 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 1 O-C-N 116.066 -4.146 . . . . 2.03 107.318 174.828 . . . . . . . . 3 3 . 1 . 093 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 m -100.1 103.08 14.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 100.416 -3.92 . . . . 1.61 100.416 178.523 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.9 mt -102.97 130.72 50.15 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.055 1.883 . . . . 2.15 112.347 177.398 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -97.17 113.84 25.48 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.411 -2.681 . . . . 1.98 110.689 169.024 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.55 155.76 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 107.273 -1.38 . . . . 1.52 107.273 -177.443 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.325 19.5 mm-40 -86.61 152.8 55.02 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-N 121.644 2.02 . . . . 2.35 107.026 163.669 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 51.9 Cg_exo -71.25 -16.71 31.45 Favored 'Trans proline' 0 C--N 1.3 -1.996 3 CA-C-N 129.823 4.544 . . . . 1.31 113.537 179.715 . . . . . . . . 3 3 . 1 . 093 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 m -74.95 -6.07 47.26 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 126.042 2.089 . . . . 1.71 113.312 168.652 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -74.3 153.59 39.29 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.64 -2.537 . . . . 1.69 109.276 175.997 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 p -87.28 177.03 7.27 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.196 -2.815 . . . . 1.33 115.283 178.901 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.3 mm -76.79 -32.03 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 124.997 1.319 . . . . 1.32 108.758 174.179 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -53.39 -52.81 58.12 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.89 2.476 . . . . 1.62 113.256 170.488 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -62.58 -38.59 90.71 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 114.79 -2.528 . . . . 2.13 116.234 172.426 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.06 -44.71 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 123.265 2.757 . . . . 1.23 111.706 171.587 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.411 ' HZ3' ' CG ' ' A' ' 52' ' ' ASP . 95.5 mttt -59.9 -32.79 71.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.77 -3.081 . . . . 1.97 112.181 175.482 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.57 -35.2 79.63 Favored 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.731 -4.355 . . . . 1.19 117.727 172.249 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -71.54 -27.03 62.9 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.576 -2.577 . . . . 1.92 114.281 176.053 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.3 mt -75.45 -36.82 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 117.372 -3.33 . . . . 1.94 109.103 173.67 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -63.09 -53.14 58.29 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.21 -1.556 . . . . 1.9 109.963 177.392 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -41.34 -63.5 0.69 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.688 2.847 . . . . 1.55 118.688 166.53 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -81.9 -36.47 28.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 117.08 2.252 . . . . 2.95 117.08 -166.112 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -103.09 -46.97 4.48 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.848 -1.782 . . . . 1.48 111.315 -175.223 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.96 25.36 2.31 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 123.913 0.768 . . . . 1.12 114.668 170.831 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.4 mt -107.09 127.36 28.12 Favored Pre-proline 0 N--CA 1.429 -1.493 0 O-C-N 118.575 -2.72 . . . . 2.07 109.445 -170.465 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -67.78 138.5 45.05 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 C-N-CA 123.286 2.658 . . . . 1.39 115.809 179.344 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.14 -13.63 31.28 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 CA-C-N 121.335 1.512 . . . . 1.68 115.11 -162.025 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -55.93 -27.8 53.97 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 129.509 3.124 . . . . 2.25 113.721 168.517 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -98.08 -0.14 45.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.8 -1.813 . . . . 2.44 111.149 -173.664 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -97.79 135.82 39.01 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.563 2.601 . . . . 1.32 112.646 -175.215 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -125.05 115.45 20.54 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.756 -1.84 . . . . 3.19 107.241 169.175 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mt -94.44 126.07 39.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.681 2.392 . . . . 1.75 113.807 177.888 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.3 mm -111.04 131.7 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 108.736 -0.838 . . . . 1.98 108.736 -175.913 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -123.67 87.46 2.74 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 127.124 2.17 . . . . 1.94 106.853 168.793 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.256 . . 69.18 -98.49 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.378 -2.076 . . . . 1.67 112.176 -178.441 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.06 6.65 13.13 Favored Glycine 0 N--CA 1.431 -1.653 0 O-C-N 118.352 -2.717 . . . . 1.3 111.571 177.762 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -99.36 130.25 45.63 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.91 -1.885 . . . . 2.89 105.91 178.74 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -103.4 107.25 18.01 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 111.156 -2.747 . . . . 2.89 109.597 170.268 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.3 mt -76.1 131.66 39.57 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 121.111 3.745 . . . . 1.34 121.111 -166.059 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -90.5 141.38 28.82 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 119.647 3.203 . . . . 1.94 119.647 176.536 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.411 ' CG ' ' HZ3' ' A' ' 27' ' ' LYS . 11.3 m-20 -42.96 -68.71 0.17 Allowed 'General case' 0 N--CA 1.431 -1.418 1 N-CA-C 122.337 4.199 . . . . 1.56 122.337 -171.752 . . . . . . . . 3 3 . 1 . 093 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.6 25.15 1.15 Allowed Glycine 0 N--CA 1.429 -1.774 0 C-N-CA 129.194 3.283 . . . . 0.97 119.419 171.193 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -105.99 151.95 23.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.178 -3.542 . . . . 3.07 111.845 163.659 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.7 p -76.04 171.37 14.58 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 124.781 2.229 . . . . 1.34 116.412 172.811 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 47.9 mt -73.02 -27.69 61.91 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.305 -2.122 . . . . 1.63 113.312 167.838 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.9 p -78.49 -28.39 46.35 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-O 118.148 -0.929 . . . . 1.51 110.087 -177.978 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -56.34 -59.74 4.52 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.366 1.066 . . . . 1.9 111.14 171.909 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -62.85 -28.93 70.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 126.743 2.527 . . . . 0.97 114.507 -179.063 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 82.86 51.79 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.412 1 C-N-CA 132.95 4.5 . . . . 2.35 112.048 -178.466 . . . . . . . . 3 3 . 1 . 093 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -84.09 114.7 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 108.373 -0.973 . . . . 1.39 108.373 -178.547 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -95.32 159.79 14.84 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 126.256 1.823 . . . . 2.58 114.118 -170.696 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.382 6.5 tmtm? -6.35 -81.31 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 120.233 3.419 . . . . 2.58 120.233 175.165 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -105.39 71.04 0.91 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.948 2.309 . . . . 1.71 110.962 -175.141 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.283 18.7 m -107.55 141.52 38.88 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 124.392 2.044 . . . . 1.34 107.216 -177.49 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.3 m -105.4 119.19 38.47 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.767 -1.833 . . . . 1.36 107.659 174.374 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -96.34 148.92 22.27 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.527 2.331 . . . . 2.03 107.563 174.314 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -126.15 122.33 35.38 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.148 -1.797 . . . . 2.31 106.148 -174.617 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.5 tp -82.29 135.61 35.18 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 125.062 2.363 . . . . 1.72 107.095 -176.143 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.0 t -135.17 150.21 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 1 N-CA-C 99.328 -4.323 . . . . 1.8 99.328 -179.208 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.43 -1.461 1 O-C-N 115.094 -4.754 . . . . 3.26 107.76 -176.919 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 ttp . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 109.275 -0.639 . . . . 1.39 109.275 . . . . . . . . . 0 0 . 1 . 094 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -102.68 117.6 35.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.811 -3.681 . . . . 2.2 107.85 -178.052 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.0 pt -117.12 149.54 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 125.69 2.662 . . . . 1.32 110.062 174.369 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -95.26 153.76 17.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.984 -2.322 . . . . 2.2 112.223 -177.062 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.9 t -137.37 114.24 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 117.957 -2.964 . . . . 1.23 108.286 172.464 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -86.69 122.51 30.69 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.344 2.257 . . . . 2.51 112.427 179.709 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.301 17.0 p -80.89 174.89 11.17 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.451 -0.795 . . . . 1.41 112.674 -177.378 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 tp -78.03 -25.69 48.0 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 119.176 3.028 . . . . 2.95 119.176 171.357 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.9 p -74.82 -46.55 35.89 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.736 -3.102 . . . . 2.52 112.054 -178.001 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.31 6.89 0.12 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 126.629 2.062 . . . . 1.5 110.014 174.137 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.416 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 77.9 tttt -84.0 144.68 28.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 121.415 2.608 . . . . 1.79 114.137 178.371 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.335 31.3 m -102.57 137.63 40.55 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.228 2.211 . . . . 1.38 111.452 167.306 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mt -125.04 129.54 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 1 C-N-CA 132.908 4.483 . . . . 2.03 110.361 177.082 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.6 m -101.06 117.8 35.74 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 125.615 1.822 . . . . 1.61 109.651 177.096 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -111.36 137.82 48.64 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.425 1.89 . . . . 2.15 111.166 173.763 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -90.38 134.28 34.43 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.154 -2.216 . . . . 1.98 106.305 163.711 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.7 m -142.82 161.95 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 C-N-CA 129.427 3.091 . . . . 1.52 111.789 179.503 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -98.06 149.02 35.3 Favored Pre-proline 0 N--CA 1.431 -1.417 0 O-C-N 117.328 -3.358 . . . . 2.35 108.026 165.474 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -69.82 -17.58 37.21 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 CA-C-N 128.182 3.958 . . . . 1.31 112.109 -179.183 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.0 p -77.95 -16.09 58.45 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.048 1.739 . . . . 1.71 112.984 175.784 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -66.86 134.26 51.72 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.535 -1.211 . . . . 1.69 113.213 178.757 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -69.03 168.38 13.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 115.346 1.61 . . . . 1.33 115.346 174.653 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.276 15.4 mm -76.06 -29.59 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 113.642 -1.617 . . . . 1.32 112.186 176.621 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -46.82 -48.87 20.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.641 3.176 . . . . 1.62 111.703 158.84 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -63.87 -37.22 86.59 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.296 1.438 . . . . 2.13 114.859 176.459 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.3 t -59.99 -43.06 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 118.983 -2.323 . . . . 1.23 116.535 173.593 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.411 ' HD3' ' HB2' ' A' ' 41' ' ' GLN . 74.4 mttt -71.7 -33.75 69.04 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.241 1.816 . . . . 1.97 114.528 179.741 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.22 -17.76 60.27 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.026 -2.921 . . . . 1.19 109.978 173.412 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -89.93 -12.68 38.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.967 1.841 . . . . 1.92 113.646 173.824 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.8 mt -88.32 -23.52 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 119.918 -1.739 . . . . 1.94 110.671 169.432 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -69.73 -49.42 53.42 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.314 1.845 . . . . 1.9 108.673 172.04 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.306 33.1 t70 -53.7 -62.86 1.38 Allowed 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 123.189 2.722 . . . . 1.55 116.405 164.078 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -63.21 -62.39 1.72 Allowed 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.818 -3.052 . . . . 2.95 113.995 -170.938 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.416 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 51.6 tp10 -96.02 -56.46 2.64 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.258 -2.776 . . . . 1.48 113.23 -170.935 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.91 5.49 1.03 Allowed Glycine 0 N--CA 1.431 -1.698 0 O-C-N 124.867 1.354 . . . . 1.12 114.497 170.739 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.5 mt -78.12 135.53 62.3 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-O 114.611 -2.614 . . . . 2.07 111.969 -174.578 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -77.37 153.24 31.03 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 CA-C-N 125.413 2.969 . . . . 1.39 113.469 -178.024 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -64.51 -24.66 63.34 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 CA-C-N 127.664 3.773 . . . . 1.68 115.603 -172.106 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -61.24 -33.25 73.21 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.613 -2.555 . . . . 2.25 117.254 173.792 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -76.97 -24.74 52.28 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.376 -3.327 . . . . 2.44 116.746 -178.29 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.411 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 68.0 mt-30 -80.9 107.86 14.08 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.28 2.232 . . . . 1.32 110.513 -172.468 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -103.5 119.67 39.35 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.094 -2.879 . . . . 3.19 106.577 168.713 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.7 mt -102.92 123.86 47.34 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 119.67 3.211 . . . . 1.75 119.67 -178.789 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -109.58 157.68 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 115.675 -2.107 . . . . 1.98 109.751 178.356 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -140.63 114.95 9.29 Favored 'General case' 0 N--CA 1.43 -1.453 1 N-CA-C 95.64 -5.689 . . . . 1.94 95.64 173.604 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.259 . . 55.9 -110.23 0.54 Allowed 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.299 -1.501 . . . . 1.67 114.348 -176.815 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.48 -8.71 24.55 Favored Glycine 0 N--CA 1.43 -1.738 0 CA-C-O 123.062 1.368 . . . . 1.3 112.967 -176.601 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -91.61 143.86 26.13 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.388 -3.419 . . . . 2.89 114.468 171.572 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -99.83 129.05 45.89 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.236 1.014 . . . . 2.89 108.634 170.365 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.1 mt -91.36 147.13 23.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.194 1.473 . . . . 1.34 113.234 -167.86 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -91.74 143.23 26.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.719 -1.863 . . . . 1.94 115.581 175.392 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.81 -47.68 77.16 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 118.646 2.832 . . . . 1.56 118.646 -173.504 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.55 26.04 2.75 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 122.934 3.934 . . . . 0.97 122.934 171.885 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.4 mtt-85 -111.46 146.67 36.82 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 118.813 -2.581 . . . . 3.07 110.589 169.84 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.343 43.7 p -70.98 170.9 11.8 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.638 2.637 . . . . 1.34 113.264 176.404 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mt -74.87 -27.96 60.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.318 -2.739 . . . . 1.63 109.779 168.571 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.6 t -65.75 -39.87 91.52 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 127.706 2.402 . . . . 1.51 114.752 178.977 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -51.0 -50.22 58.92 Favored 'General case' 0 N--CA 1.43 -1.452 1 CA-C-O 129.135 4.302 . . . . 1.9 112.505 174.544 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -88.15 -2.1 58.4 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.822 -3.049 . . . . 0.97 114.286 -178.904 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 63.73 55.73 1.63 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.61 1.964 . . . . 2.35 113.183 -176.381 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.1 mm -85.3 118.44 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-O 116.333 -1.794 . . . . 1.39 106.308 179.288 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -82.56 -170.52 3.0 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 128.035 3.334 . . . . 2.58 109.35 -176.69 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.28 92.4 mttt -72.61 -56.3 5.55 Favored 'General case' 0 N--CA 1.429 -1.495 1 N-CA-C 123.84 4.756 . . . . 2.58 123.84 -177.981 . . . . . . . . 3 2 . 1 . 094 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -74.3 27.14 0.08 Allowed 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.783 2.706 . . . . 1.71 115.01 -176.571 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.7 m -73.83 136.41 43.51 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.722 -4.361 . . . . 1.34 116.174 -174.859 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.8 m -112.98 108.97 18.08 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.478 2.085 . . . . 1.36 107.123 178.773 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -75.77 138.97 41.56 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 112.368 -2.197 . . . . 2.03 105.843 174.395 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -106.73 109.41 21.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.744 -3.098 . . . . 2.31 107.225 -170.339 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tp -106.48 126.0 51.7 Favored 'General case' 0 N--CA 1.43 -1.455 1 CA-C-O 128.81 4.148 . . . . 1.72 107.701 -171.69 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -112.85 138.74 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 109.353 -3.567 . . . . 1.8 105.906 -179.151 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.43 -1.467 0 C-N-CA 116.579 -2.049 . . . . 3.26 108.884 -173.899 . . . . . . . . 0 0 . 1 . 095 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ptt? . . . . . 0 CA--C 1.49 -1.356 0 CA-C-O 119.635 -0.221 . . . . 1.39 111.008 . . . . . . . . . 0 0 . 1 . 095 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -111.3 117.67 33.79 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.815 -1.178 . . . . 2.2 108.517 -176.594 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.8 pt -114.13 159.13 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 124.586 1.154 . . . . 1.32 113.054 -178.63 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -112.17 146.61 37.77 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 104.914 -2.254 . . . . 2.2 104.914 174.916 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.8 t -117.3 114.45 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 110.927 -2.851 . . . . 1.23 109.822 174.159 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -91.96 131.5 37.21 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 120.937 1.699 . . . . 2.51 110.329 175.838 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.295 39.4 p -83.12 174.13 11.09 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 126.535 3.064 . . . . 1.41 112.379 174.914 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 71' ' ' LEU . 20.3 tp -57.96 -47.32 83.28 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.488 2.566 . . . . 2.95 117.818 172.746 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.3 p -86.4 -8.0 58.0 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.241 2.216 . . . . 2.52 110.103 -173.809 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.4 30.14 5.73 Favored Glycine 0 N--CA 1.431 -1.7 1 C-N-CA 132.932 5.063 . . . . 1.5 118.84 167.613 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -106.15 133.94 50.06 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.258 -2.319 . . . . 1.79 105.54 -176.038 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.7 m -105.05 118.7 37.2 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.239 -0.891 . . . . 1.38 110.155 -173.501 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.72 129.27 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 124.783 1.233 . . . . 2.03 109.982 -176.12 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 100.0 m -88.86 122.46 32.27 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 126.813 2.571 . . . . 1.61 106.409 177.931 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.2 tp -121.63 134.69 54.99 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.379 -2.076 . . . . 2.15 108.612 -178.616 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -94.02 99.92 12.14 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 129.643 3.177 . . . . 1.98 116.561 173.197 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.2 m -115.29 149.58 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 127.712 2.405 . . . . 1.52 112.681 -175.456 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -103.81 165.84 12.75 Favored Pre-proline 0 N--CA 1.43 -1.448 0 N-CA-C 106.625 -1.62 . . . . 2.35 106.625 168.274 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -79.56 -20.01 9.7 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 123.18 2.587 . . . . 1.31 107.625 -172.597 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.8 p -84.8 0.49 50.59 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.244 -2.16 . . . . 1.71 115.974 177.039 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -70.65 151.65 44.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.816 1.246 . . . . 1.69 110.611 173.913 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 p -84.78 166.64 16.79 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.421 1.488 . . . . 1.33 111.028 171.293 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.4 mm -75.12 -35.87 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 116.645 2.091 . . . . 1.32 116.645 173.335 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -48.31 -49.45 33.93 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.053 2.983 . . . . 1.62 119.053 163.536 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -58.49 -35.73 72.66 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.861 2.064 . . . . 2.13 112.899 173.892 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 t -72.76 -38.9 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 121.09 -1.006 . . . . 1.23 112.797 177.685 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -64.02 -31.26 72.38 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.495 -3.253 . . . . 1.97 111.409 170.514 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.43 -32.04 70.75 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 119.144 0.884 . . . . 1.19 111.695 175.246 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -68.86 -45.16 71.79 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.0 1.481 . . . . 1.92 115.0 171.888 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mt -59.03 -35.41 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 125.621 2.629 . . . . 1.94 113.553 177.428 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.298 26.3 tt0 -69.15 -40.89 77.95 Favored 'General case' 0 N--CA 1.428 -1.535 0 O-C-N 116.331 -3.981 . . . . 1.9 111.475 172.67 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -56.05 -61.79 2.14 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 122.969 2.622 . . . . 1.55 114.362 167.429 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.439 12.0 ptpt -76.77 -50.77 12.75 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 114.8 1.407 . . . . 2.95 114.8 -173.706 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -97.28 -48.44 5.33 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 125.577 2.608 . . . . 1.48 112.98 -170.248 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.93 67.02 0.75 Allowed Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 119.936 2.734 . . . . 1.12 119.936 -179.336 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.3 mt -127.26 135.24 27.12 Favored Pre-proline 0 N--CA 1.43 -1.446 0 N-CA-C 100.563 -3.865 . . . . 2.07 100.563 -177.303 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -85.55 135.17 4.99 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 C-N-CA 115.047 -2.835 . . . . 1.39 111.76 -175.202 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.29 -11.68 6.56 Favored 'Trans proline' 0 C--N 1.3 -2.0 1 C-N-CA 126.233 4.622 . . . . 1.68 117.41 -172.91 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -73.83 -23.7 59.69 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.82 1.415 . . . . 2.25 114.82 169.329 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -99.85 -3.06 33.37 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.023 -2.923 . . . . 2.44 113.871 -176.379 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -101.13 97.59 8.11 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.466 -2.021 . . . . 1.32 113.782 -172.706 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.8 ttt-85 -87.82 122.14 31.1 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 115.856 -2.021 . . . . 3.19 110.263 166.737 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.8 mt -111.08 131.5 55.02 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.886 2.18 . . . . 1.75 116.886 -177.717 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.91 136.23 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 105.691 -1.966 . . . . 1.98 105.691 -177.927 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -93.1 -105.42 0.12 Allowed 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.882 -1.508 . . . . 1.94 107.644 168.847 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.83 -69.81 0.79 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 113.934 1.087 . . . . 1.67 113.934 170.174 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.79 -28.57 5.29 Favored Glycine 0 N--CA 1.429 -1.779 0 O-C-N 119.701 -1.874 . . . . 1.3 109.5 -179.275 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -95.25 142.75 27.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 120.423 2.112 . . . . 2.89 108.599 -179.404 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -95.3 135.68 36.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 128.634 2.774 . . . . 2.89 104.394 166.851 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.1 mt -86.68 115.85 24.4 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 126.287 2.242 . . . . 1.34 116.777 -168.769 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -84.8 134.4 34.31 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 125.636 2.636 . . . . 1.94 111.776 179.014 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.283 20.0 m-20 -59.75 -40.38 87.92 Favored 'General case' 0 N--CA 1.43 -1.44 2 N-CA-C 127.458 6.095 . . . . 1.56 127.458 -168.547 . . . . . . . . 3 2 . 1 . 095 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.52 56.88 1.98 Allowed Glycine 0 N--CA 1.43 -1.703 0 O-C-N 119.256 -2.153 . . . . 0.97 113.518 167.736 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -131.93 162.25 31.12 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 127.811 2.444 . . . . 3.07 108.733 172.012 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.3 p -95.53 169.71 9.85 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 121.049 1.75 . . . . 1.34 110.134 173.948 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.262 7.5 mp -59.02 -30.25 67.87 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 119.152 3.019 . . . . 1.63 119.152 161.906 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 p -74.24 -23.62 59.18 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.909 -2.994 . . . . 1.51 109.118 177.614 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -74.63 -40.65 61.37 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 129.759 3.224 . . . . 1.9 112.696 178.784 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.254 46.8 m-85 -91.62 -0.67 57.6 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 113.469 -5.769 . . . . 0.97 109.505 177.553 . . . . . . . . 3 2 . 1 . 095 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.8 m120 63.74 56.78 1.48 Allowed 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 114.233 -2.794 . . . . 2.35 109.278 -179.029 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.295 65.6 mt -84.66 126.18 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 127.886 2.474 . . . . 1.39 110.659 175.643 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -107.58 170.92 7.68 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 117.925 -1.036 . . . . 2.58 108.277 -173.473 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -71.51 -29.3 64.63 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 115.478 -2.489 . . . . 2.58 113.981 -178.963 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -80.04 10.4 4.37 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 125.603 2.621 . . . . 1.71 113.972 -179.652 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.8 m -78.84 130.94 36.24 Favored 'General case' 0 N--CA 1.431 -1.406 1 O-C-N 116.096 -4.127 . . . . 1.34 116.899 -174.631 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.8 m -106.51 115.71 30.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.937 -1.938 . . . . 1.36 111.879 170.947 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.297 8.8 mp -87.61 157.61 19.08 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.744 -1.116 . . . . 2.03 109.439 177.103 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -128.54 123.93 34.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 103.36 -2.83 . . . . 2.31 103.36 -176.088 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.305 6.8 tt -103.56 115.42 30.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.253 1.021 . . . . 1.72 111.349 179.579 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.388 4.1 m -109.66 166.71 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 118.628 -2.545 . . . . 1.8 112.446 174.283 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.403 ' HB2' HD21 ' A' ' 8' ' ' LEU . 45.4 tp . . . . . 0 N--CA 1.431 -1.404 0 N-CA-C 117.365 2.358 . . . . 3.26 117.365 -178.45 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 ptt? . . . . . 0 CA--C 1.49 -1.355 0 N-CA-C 113.268 0.84 . . . . 1.39 113.268 . . . . . . . . . 0 0 . 1 . 096 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -101.14 107.11 18.44 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 120.414 1.461 . . . . 2.2 112.021 -178.768 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.1 pt -89.62 155.9 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 C-N-CA 124.76 1.224 . . . . 1.32 111.431 176.763 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -104.88 140.99 37.32 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 123.303 1.525 . . . . 2.2 107.93 -179.894 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.6 t -124.43 114.97 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 103.584 -2.747 . . . . 1.23 103.584 174.298 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -96.59 138.14 34.62 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.828 -1.795 . . . . 2.51 111.481 -178.322 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.346 18.3 p -91.73 166.86 12.56 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 116.429 -1.748 . . . . 1.41 110.977 175.204 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.8 mt -68.95 -44.82 72.23 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 125.33 1.644 . . . . 2.95 111.182 171.784 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.1 p -62.17 -81.84 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 128.399 3.952 . . . . 2.52 113.299 -177.432 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.12 40.48 0.11 Allowed Glycine 0 N--CA 1.431 -1.692 1 O-C-N 116.299 -4.001 . . . . 1.5 119.243 174.819 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -122.87 142.39 50.84 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.069 1.435 . . . . 1.79 108.134 -177.206 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.6 m -120.63 118.66 30.72 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.759 2.423 . . . . 1.38 106.289 172.03 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mt -97.59 133.2 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-O 124.978 2.323 . . . . 2.03 105.89 178.61 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 p -107.28 92.63 4.16 Favored 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 132.496 4.318 . . . . 1.61 107.091 -177.402 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.0 mt -101.31 130.36 47.46 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 125.313 1.633 . . . . 2.15 112.353 -179.198 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -74.7 107.49 6.84 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 115.269 -2.301 . . . . 1.98 109.758 171.314 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.1 m -127.57 173.32 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 105.847 -1.908 . . . . 1.52 105.847 -173.349 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -125.77 169.57 11.21 Favored Pre-proline 0 N--CA 1.431 -1.399 0 CA-C-O 112.903 -3.427 . . . . 2.35 106.285 163.849 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -74.87 -17.95 19.48 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 C-N-CA 124.028 3.152 . . . . 1.31 111.356 -175.192 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.6 p -78.17 -8.96 58.94 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.736 2.014 . . . . 1.71 115.656 176.339 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -74.29 137.88 43.19 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.69 -3.131 . . . . 1.69 112.567 176.565 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 29.6 p -76.42 154.84 34.47 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.697 1.999 . . . . 1.33 111.354 176.072 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.0 mm -54.42 -37.08 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 125.679 1.592 . . . . 1.32 112.072 173.96 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -53.32 -45.52 69.07 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.281 2.232 . . . . 1.62 116.783 162.599 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -55.75 -42.22 75.11 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 119.09 -2.256 . . . . 2.13 115.642 171.692 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.0 t -66.33 -39.34 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 114.284 1.216 . . . . 1.23 114.284 179.204 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -63.27 -27.02 69.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.587 2.069 . . . . 1.97 116.587 168.931 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.71 -47.29 78.86 Favored 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 116.291 -4.005 . . . . 1.19 113.773 169.127 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -55.47 -49.95 71.17 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 126.431 3.015 . . . . 1.92 116.672 169.634 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.1 mt -59.11 -40.14 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 O-C-N 116.394 -3.941 . . . . 1.94 114.291 169.921 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -61.09 -39.87 91.56 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.77 -1.831 . . . . 1.9 113.058 173.444 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -62.7 -50.68 70.2 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.511 2.041 . . . . 1.55 116.511 172.711 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -67.6 -61.18 2.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.863 2.465 . . . . 2.95 109.665 -173.583 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -94.93 -56.27 2.81 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.622 -2.549 . . . . 1.48 112.837 -169.719 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.73 -1.1 2.84 Favored Glycine 0 N--CA 1.431 -1.667 0 O-C-N 119.615 -1.928 . . . . 1.12 116.155 176.111 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.1 mt -90.84 134.51 30.27 Favored Pre-proline 0 N--CA 1.429 -1.481 0 O-C-N 119.959 -1.906 . . . . 2.07 107.486 -167.269 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -61.08 153.05 67.14 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 O-C-N 115.121 -3.147 . . . . 1.39 114.943 173.5 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -73.7 -19.02 21.75 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 122.815 2.041 . . . . 1.68 110.557 -177.644 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.265 3.3 m-20 -63.42 -28.57 70.06 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.12 -2.863 . . . . 2.25 116.897 170.276 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.251 18.6 mt-30 -85.95 -23.91 26.75 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 115.164 -0.925 . . . . 2.44 111.936 -179.552 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -78.43 134.46 37.37 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 120.346 3.461 . . . . 1.32 120.346 -178.456 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -122.57 130.64 53.23 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 105.092 -2.188 . . . . 3.19 105.092 175.465 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.2 mt -114.73 147.11 40.15 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 117.238 -3.414 . . . . 1.75 113.371 175.778 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.0 mt -144.25 136.97 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 C-N-CA 128.268 2.627 . . . . 1.98 104.084 -168.674 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -117.52 123.65 46.79 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 103.289 -2.856 . . . . 1.94 103.289 170.374 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.285 . . 63.3 -89.53 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.476 -2.64 . . . . 1.67 116.75 -176.816 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.9 4.82 3.6 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 105.38 -3.088 . . . . 1.3 105.38 -177.91 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -109.12 130.03 55.48 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.029 -2.454 . . . . 2.89 115.557 -174.538 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -70.32 130.9 43.21 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.836 1.655 . . . . 2.89 110.347 171.171 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.1 mt -99.32 159.15 15.21 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 124.43 3.286 . . . . 1.34 105.094 -168.202 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.563 ' HB3' ' HG3' ' A' ' 54' ' ' ARG . 37.6 tt0 -104.25 130.2 52.05 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 125.65 1.844 . . . . 1.94 114.036 174.5 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -50.25 -50.73 49.17 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.523 3.156 . . . . 1.56 119.523 -168.848 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.6 -9.43 65.15 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 119.832 2.693 . . . . 0.97 119.832 170.68 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.563 ' HG3' ' HB3' ' A' ' 51' ' ' GLU . 37.4 mtt180 -84.92 163.22 19.1 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 115.757 -4.378 . . . . 3.07 115.066 169.687 . . . . . . . . 3 3 . 1 . 096 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 43.0 p -84.02 174.66 10.12 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 118.582 2.808 . . . . 1.34 118.582 171.825 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.83 -31.29 72.41 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 117.922 2.564 . . . . 1.63 117.922 165.892 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.5 t -77.25 -25.2 51.28 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.937 2.095 . . . . 1.51 112.927 178.79 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -65.3 -33.49 76.1 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.316 -2.115 . . . . 1.9 111.898 169.45 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -91.81 4.51 52.69 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.316 -4.615 . . . . 0.97 113.439 170.059 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.663 2.9 m120 63.46 25.83 14.64 Favored 'General case' 0 N--CA 1.43 -1.439 1 N-CA-C 124.288 4.922 . . . . 2.35 124.288 -174.862 . . . . . . . . 3 2 . 1 . 096 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.4 mt -66.84 121.87 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 128.106 2.563 . . . . 1.39 110.541 -177.252 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -89.44 174.73 7.63 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.416 2.531 . . . . 2.58 112.349 -179.518 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -42.06 -56.65 2.75 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 128.023 3.773 . . . . 2.58 118.154 174.791 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -94.61 44.29 1.11 Allowed 'General case' 0 N--CA 1.429 -1.513 1 O-C-N 113.077 -6.015 . . . . 1.71 113.445 -175.269 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.31 38.8 m -92.65 133.73 35.7 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 118.73 -2.481 . . . . 1.34 115.478 -171.716 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.3 m -104.33 105.32 15.41 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 120.694 1.588 . . . . 1.36 107.448 175.004 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -81.74 161.85 23.17 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.299 2.0 . . . . 2.03 109.385 163.67 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.261 98.8 m-70 -118.45 130.7 56.11 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 112.493 -2.139 . . . . 2.31 108.966 -178.199 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.8 tp -102.16 111.5 23.81 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 123.351 1.548 . . . . 1.72 110.228 179.295 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.289 40.0 t -109.48 129.79 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 118.218 2.673 . . . . 1.8 118.218 177.848 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.2 tp . . . . . 0 N--CA 1.43 -1.433 0 C-N-CA 115.889 -2.324 . . . . 3.26 113.741 -170.287 . . . . . . . . 0 0 . 1 . 097 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttp . . . . . 0 CA--C 1.491 -1.309 0 N-CA-C 116.139 1.904 . . . . 1.39 116.139 . . . . . . . . . 0 0 . 1 . 097 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -95.98 125.65 40.68 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 116.52 -3.863 . . . . 2.2 110.688 -174.312 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.461 HD11 HD22 ' A' ' 67' ' ' LEU . 36.6 pt -111.98 144.54 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 124.739 2.209 . . . . 1.32 110.12 169.121 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 64' ' ' GLU . 23.5 m-85 -108.34 112.67 25.24 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.131 -1.85 . . . . 2.2 110.63 -174.661 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.39 116.24 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-O 124.895 2.283 . . . . 1.23 107.262 178.564 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 tppt? -97.38 132.35 43.18 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.389 -3.945 . . . . 2.51 109.197 177.045 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.357 12.5 p -73.56 173.78 9.21 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.08 -2.262 . . . . 1.41 115.106 176.26 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.9 mt -70.92 -15.32 62.6 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.628 1.68 . . . . 2.95 114.985 172.962 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.7 p -109.24 -26.17 10.22 Favored 'General case' 0 N--CA 1.431 -1.399 1 O-C-N 116.025 -4.172 . . . . 2.52 107.264 -175.796 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.42 27.22 0.83 Allowed Glycine 0 N--CA 1.431 -1.651 0 O-C-N 118.968 -2.332 . . . . 1.5 117.12 169.383 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.509 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 34.3 ttpt -100.66 118.41 36.74 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.808 2.304 . . . . 1.79 109.919 -168.712 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.4 m -81.44 122.48 27.56 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 119.557 -0.857 . . . . 1.38 110.012 178.518 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -111.14 133.77 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 102.729 -3.063 . . . . 2.03 102.729 173.518 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.8 m -111.63 125.73 54.26 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.277 -2.764 . . . . 1.61 108.815 -172.833 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.8 mt -119.01 135.45 54.62 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 120.739 1.609 . . . . 2.15 107.817 -177.369 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -91.43 112.57 24.54 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.143 -1.428 . . . . 1.98 107.143 169.966 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.7 m -127.53 165.85 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 C-N-CA 129.008 2.923 . . . . 1.52 116.02 -178.785 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -109.27 163.32 17.28 Favored Pre-proline 0 N--CA 1.43 -1.462 0 C-N-CA 119.717 -0.793 . . . . 2.35 111.601 163.876 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -82.18 -12.35 10.58 Favored 'Trans proline' 0 C--N 1.299 -2.049 0 O-C-N 114.531 -3.458 . . . . 1.31 113.729 -172.996 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.7 m -82.36 -5.92 58.93 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 124.792 1.307 . . . . 1.71 110.457 176.177 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -85.33 146.5 26.99 Favored 'General case' 0 N--CA 1.429 -1.498 1 O-C-N 114.652 -5.03 . . . . 1.69 109.776 178.783 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -77.55 161.78 27.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 118.289 -2.757 . . . . 1.33 112.159 178.629 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mp -68.81 -31.32 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 119.469 -2.019 . . . . 1.32 108.937 -179.818 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -46.48 -40.51 12.54 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.476 -2.015 . . . . 1.62 114.1 165.65 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -70.77 -29.55 65.8 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 117.514 2.413 . . . . 2.13 117.514 174.752 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.39 -39.61 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-N 113.428 -1.714 . . . . 1.23 109.289 176.809 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.3 84.2 mttt -60.73 -34.37 74.3 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 124.277 0.985 . . . . 1.97 111.974 169.275 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.62 -44.48 96.18 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.524 -2.61 . . . . 1.19 114.676 173.235 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -66.58 -43.55 84.64 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.425 -1.716 . . . . 1.92 115.014 172.397 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.5 mt -58.12 -31.07 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 116.652 -3.78 . . . . 1.94 113.327 170.656 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -60.34 -45.64 92.72 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 116.849 2.166 . . . . 1.9 116.849 170.69 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.87 -53.86 43.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.032 2.349 . . . . 1.55 114.151 174.92 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -56.81 -75.96 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 111.502 -2.59 . . . . 2.95 113.551 177.782 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.509 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 21.2 tp10 -94.52 -21.38 18.91 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.433 3.123 . . . . 1.48 119.433 -169.068 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.75 43.38 3.63 Favored Glycine 0 N--CA 1.43 -1.755 1 O-C-N 114.802 -4.936 . . . . 1.12 113.471 175.886 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.7 mt -115.72 131.39 23.7 Favored Pre-proline 0 N--CA 1.43 -1.441 0 O-C-N 120.892 -1.357 . . . . 2.07 109.481 179.787 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -63.84 147.07 92.36 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 O-C-N 116.456 -2.444 . . . . 1.39 113.623 176.069 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.66 -22.89 64.04 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 C-N-CA 124.246 3.297 . . . . 1.68 115.991 -176.606 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.58 -24.47 65.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 128.395 2.678 . . . . 2.25 117.35 177.311 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -86.96 -33.22 19.72 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.014 -1.448 . . . . 2.44 107.257 -177.982 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -85.87 129.78 34.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.081 -1.637 . . . . 1.32 115.118 -168.642 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -115.97 142.24 47.06 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.599 1.959 . . . . 3.19 106.253 163.393 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.8 mt -117.7 125.56 50.9 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.306 -1.739 . . . . 1.75 106.306 178.89 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 39.3 mm -102.29 144.65 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 129.959 3.304 . . . . 1.98 107.259 174.222 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.315 17.4 t80 -143.0 114.83 8.18 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 105.235 -2.135 . . . . 1.94 105.235 171.57 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.5 17.73 9.03 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 127.524 3.535 . . . . 1.67 116.826 176.619 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.32 -7.55 54.31 Favored Glycine 0 N--CA 1.43 -1.712 1 O-C-N 114.323 -5.236 . . . . 1.3 111.527 -178.388 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -104.4 133.32 49.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.229 -1.748 . . . . 2.89 108.463 -175.801 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -74.42 125.64 28.97 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 112.901 -1.954 . . . . 2.89 111.372 169.033 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.1 mt -83.76 152.21 24.79 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 125.078 1.486 . . . . 1.34 108.719 -172.323 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -94.93 135.39 36.51 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 123.28 1.514 . . . . 1.94 111.073 176.074 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -54.59 -53.88 48.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 111.612 -2.54 . . . . 1.56 114.94 -171.801 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.38 63.17 2.72 Favored Glycine 0 N--CA 1.429 -1.803 0 O-C-N 119.297 -2.127 . . . . 0.97 114.554 169.347 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -133.99 158.56 43.2 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 100.794 -3.78 . . . . 3.07 100.794 161.169 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.8 p -88.41 171.01 10.44 Favored 'General case' 0 N--CA 1.43 -1.439 1 CA-C-O 129.288 4.375 . . . . 1.34 110.115 176.694 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.32 -36.78 71.71 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 112.07 -6.643 . . . . 1.63 111.467 175.597 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.4 t -51.59 -35.07 39.95 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 129.158 2.983 . . . . 1.51 113.89 179.432 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -62.75 -30.36 71.38 Favored 'General case' 0 N--CA 1.43 -1.455 1 C-N-CA 132.855 4.462 . . . . 1.9 110.384 174.332 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -99.68 167.94 10.25 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.946 -2.346 . . . . 0.97 110.264 179.772 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -89.39 62.81 6.17 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 118.982 -2.324 . . . . 2.35 110.356 -179.829 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.8 mm -80.82 128.61 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 124.454 1.102 . . . . 1.39 108.283 177.858 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -100.17 -119.49 0.16 Allowed 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.49 2.404 . . . . 2.58 117.49 -169.941 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -100.39 -59.55 1.69 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.983 0.897 . . . . 2.58 111.192 177.703 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.42 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 9.1 pt-20 -130.32 75.23 1.64 Allowed 'General case' 0 N--CA 1.429 -1.523 0 O-C-N 118.321 -2.737 . . . . 1.71 107.684 177.278 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.0 m -91.47 142.6 27.49 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.907 -2.995 . . . . 1.34 109.573 -167.336 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.0 m -98.4 126.95 44.12 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.67 1.7 . . . . 1.36 107.118 178.871 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.461 HD22 HD11 ' A' ' 3' ' ' ILE . 9.9 mp -110.15 166.18 11.16 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.659 -1.901 . . . . 2.03 107.088 176.157 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.462 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 98.4 m-70 -124.07 127.89 48.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.68 -3.762 . . . . 2.31 112.212 -170.109 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.0 tp -103.67 116.91 33.21 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 127.053 2.721 . . . . 1.72 113.022 -178.454 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.7 128.05 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 N-CA-C 105.329 -2.101 . . . . 1.8 105.329 178.351 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 N--CA 1.43 -1.466 0 O-C-N 124.2 0.937 . . . . 3.26 111.607 174.911 . . . . . . . . 0 0 . 1 . 098 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 ttp . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 120.56 0.219 . . . . 1.39 111.2 . . . . . . . . . 0 0 . 1 . 098 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -98.99 114.44 27.09 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.9 -2.259 . . . . 2.2 104.9 -170.069 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 pt -117.83 153.97 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 113.047 -1.888 . . . . 1.32 108.712 -179.722 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -118.88 113.53 21.2 Favored 'General case' 0 N--CA 1.43 -1.44 1 C-N-CA 132.556 4.342 . . . . 2.2 109.521 -175.93 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -104.23 121.49 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 100.812 -3.773 . . . . 1.23 100.812 177.364 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt -99.54 135.77 40.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.353 2.661 . . . . 2.51 110.878 177.511 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -92.64 -176.62 4.32 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.97 1.708 . . . . 1.41 112.125 173.229 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.5 mt -95.16 -11.72 27.64 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.953 2.101 . . . . 2.95 111.227 168.955 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.3 p -82.92 -46.41 12.99 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.368 2.032 . . . . 2.52 114.534 179.658 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.31 -13.5 0.29 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 117.546 -3.221 . . . . 1.5 111.141 170.976 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -86.82 128.26 35.03 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 119.902 1.851 . . . . 1.79 113.047 -165.654 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -92.52 115.64 28.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.834 -3.041 . . . . 1.38 108.353 175.037 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mt -99.08 117.25 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 1 O-C-N 115.967 -4.208 . . . . 2.03 109.455 -179.342 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.0 m -98.07 124.38 42.56 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.406 2.527 . . . . 1.61 108.459 -178.359 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.4 mt -118.99 138.33 52.89 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.348 1.61 . . . . 2.15 115.348 -179.968 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -103.46 102.37 12.28 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.69 -3.131 . . . . 1.98 109.927 175.219 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.9 m -114.75 170.78 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 128.421 2.688 . . . . 1.52 108.458 -175.296 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -118.18 157.48 48.82 Favored Pre-proline 0 N--CA 1.43 -1.459 0 O-C-N 118.393 -2.692 . . . . 2.35 107.521 163.775 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.429 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -62.7 -20.86 72.17 Favored 'Trans proline' 0 C--N 1.299 -2.055 0 C-N-CA 124.044 3.163 . . . . 1.31 115.508 -171.605 . . . . . . . . 3 3 . 1 . 098 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 m -80.91 0.93 33.1 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 118.076 2.621 . . . . 1.71 118.076 173.862 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -87.43 163.91 16.48 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 102.457 -3.164 . . . . 1.69 102.457 175.624 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.2 p -90.8 -175.26 4.32 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.132 2.396 . . . . 1.33 114.006 176.142 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.4 mm -82.63 -36.41 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 O-C-N 116.893 -3.629 . . . . 1.32 106.61 178.917 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -50.97 -45.86 61.07 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.169 2.187 . . . . 1.62 112.478 167.168 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -64.27 -38.73 92.07 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.336 2.654 . . . . 2.13 107.202 175.787 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.8 t -59.27 -48.04 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 124.264 3.211 . . . . 1.23 114.364 176.805 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.262 37.8 mtmt -64.64 -41.73 95.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.46 1.504 . . . . 1.97 112.049 174.162 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.08 -32.38 72.91 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 117.067 2.247 . . . . 1.19 117.067 176.952 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -76.46 -36.54 57.85 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 125.092 1.495 . . . . 1.92 111.694 175.437 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.2 mt -71.9 -31.29 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 116.666 -3.772 . . . . 1.94 110.089 175.557 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -59.28 -59.1 6.0 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 113.579 -3.105 . . . . 1.9 107.74 169.985 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -50.16 -52.51 34.72 Favored 'General case' 0 N--CA 1.43 -1.432 1 CA-C-N 127.925 4.875 . . . . 1.55 111.79 166.418 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -61.66 -48.48 80.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.033 -2.917 . . . . 2.95 117.61 -167.952 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.418 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 6.6 tp10 -112.59 -52.04 2.8 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 118.909 -1.116 . . . . 1.48 113.308 -168.317 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.21 36.25 0.43 Allowed Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 126.382 1.944 . . . . 1.12 114.305 178.934 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.8 mt -117.92 116.7 36.02 Favored Pre-proline 0 N--CA 1.429 -1.489 0 O-C-N 118.237 -2.919 . . . . 2.07 105.692 -171.239 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -59.93 154.0 53.51 Favored 'Trans proline' 0 C--N 1.299 -2.051 2 C-N-CA 126.67 4.913 . . . . 1.39 114.877 -179.954 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -73.36 -17.76 23.76 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 C-N-CA 124.566 3.511 . . . . 1.68 113.294 -176.55 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -84.25 -16.55 42.79 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.168 2.587 . . . . 2.25 108.986 -178.814 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.329 14.8 tt0 -97.86 -24.44 15.42 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 126.076 2.11 . . . . 2.44 109.925 -177.017 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -88.07 125.0 34.34 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 113.72 1.007 . . . . 1.32 113.72 -175.761 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -110.07 124.53 51.65 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.055 -0.72 . . . . 3.19 109.055 172.806 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.3 mt -107.84 114.83 29.04 Favored 'General case' 0 N--CA 1.429 -1.516 0 O-C-N 118.933 -2.354 . . . . 1.75 110.748 -173.102 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.7 mm -91.85 124.94 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 114.949 -1.023 . . . . 1.98 109.673 177.107 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -114.15 111.28 21.33 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.072 -1.085 . . . . 1.94 108.072 163.89 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.498 . . 68.01 -44.11 0.49 Allowed 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 127.039 3.305 . . . . 1.67 118.642 174.33 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.67 -47.66 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.738 0 O-C-N 116.798 -3.689 . . . . 1.3 108.246 -172.659 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -75.34 156.59 35.36 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 124.676 2.179 . . . . 2.89 112.319 179.612 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -104.82 135.48 46.11 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.173 -2.204 . . . . 2.89 105.718 169.131 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.8 mt -96.1 143.59 27.1 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.748 -1.845 . . . . 1.34 110.395 -169.675 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -83.67 147.44 27.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 113.312 -1.767 . . . . 1.94 115.303 172.449 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.61 -63.83 1.16 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 130.909 3.684 . . . . 1.56 113.216 -165.857 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.81 36.71 2.83 Favored Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 119.785 2.674 . . . . 0.97 119.785 171.637 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -102.73 152.43 21.24 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 120.999 0.428 . . . . 3.07 111.221 161.463 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.1 p -83.67 173.27 11.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 124.781 2.229 . . . . 1.34 109.219 171.677 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.429 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 1.2 mm? -72.7 -38.27 67.58 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.955 -2.966 . . . . 1.63 106.937 172.412 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.34 59.8 p -60.87 -24.76 66.18 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.528 1.931 . . . . 1.51 115.356 178.564 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.386 4.7 t0 -62.18 -38.4 88.91 Favored 'General case' 0 N--CA 1.429 -1.524 1 CA-C-O 129.017 4.246 . . . . 1.9 114.838 172.057 . . . . . . . . 3 2 . 1 . 098 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -97.83 171.12 8.51 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 110.894 -2.867 . . . . 0.97 111.125 -179.367 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -89.68 43.16 1.13 Allowed 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.373 -2.704 . . . . 2.35 116.325 -175.136 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.3 mm -71.59 124.73 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 118.47 2.767 . . . . 1.39 118.47 -179.371 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -85.28 173.76 10.11 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 125.014 2.34 . . . . 2.58 109.125 -177.42 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.47 -48.83 77.91 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.497 -3.252 . . . . 2.58 115.568 173.858 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.06 64.09 0.93 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.445 -3.285 . . . . 1.71 111.964 175.365 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.5 m -87.39 141.65 28.47 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 117.896 2.554 . . . . 1.34 117.896 178.551 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.1 m -102.02 122.47 44.14 Favored 'General case' 0 N--CA 1.431 -1.409 1 CA-C-N 108.097 -4.138 . . . . 1.36 105.032 176.536 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -112.88 154.72 25.89 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 101.84 -3.392 . . . . 2.03 101.84 177.218 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -126.22 117.32 22.84 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.111 -2.243 . . . . 2.31 111.594 -175.534 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.251 3.9 tt -86.38 115.57 23.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 127.252 2.221 . . . . 1.72 108.946 -179.561 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.9 t -101.56 157.41 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 1 C-N-CA 133.523 4.729 . . . . 1.8 105.346 172.087 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.6 mt . . . . . 0 N--CA 1.431 -1.422 0 O-C-N 120.659 -1.275 . . . . 3.26 108.199 173.676 . . . . . . . . 0 0 . 1 . 099 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttp . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 114.076 1.139 . . . . 1.39 114.076 . . . . . . . . . 0 0 . 1 . 099 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -96.95 104.3 16.3 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 114.976 -2.44 . . . . 2.2 109.313 -172.636 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.421 HG12 HG23 ' A' ' 17' ' ' VAL . 13.4 pt -95.47 165.39 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 127.459 2.975 . . . . 1.32 111.977 174.94 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -117.5 136.3 53.33 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.359 1.464 . . . . 2.2 112.742 176.618 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.6 t -116.19 98.58 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 131.246 3.818 . . . . 1.23 111.123 177.21 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -84.53 134.46 34.42 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 119.168 0.895 . . . . 2.51 112.935 179.396 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -83.5 -174.86 5.53 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.809 -1.087 . . . . 1.41 110.95 176.864 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.7 tp -81.75 -41.54 21.08 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.609 1.195 . . . . 2.95 112.758 171.01 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.9 p -74.39 -21.78 59.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.769 2.137 . . . . 2.52 116.769 -177.452 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.45 -0.01 1.03 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 118.415 2.126 . . . . 1.5 118.415 166.62 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.8 tttp -91.24 126.4 36.31 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.132 -1.805 . . . . 1.79 114.303 -172.957 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.5 m -95.37 109.78 21.9 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 121.398 -0.814 . . . . 1.38 110.454 176.197 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.1 mt -89.85 137.29 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 113.162 -3.304 . . . . 2.03 102.324 -174.884 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 m -110.17 129.62 55.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 126.598 2.436 . . . . 1.61 105.397 -174.508 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.2 mt -133.33 125.76 29.91 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.02 -2.3 . . . . 2.15 105.081 -171.596 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -85.74 113.61 22.06 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.433 -3.292 . . . . 1.98 107.875 173.48 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.421 HG23 HG12 ' A' ' 3' ' ' ILE . 1.9 m -123.01 172.34 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 128.031 2.532 . . . . 1.52 111.741 176.447 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -126.01 156.71 71.35 Favored Pre-proline 0 N--CA 1.431 -1.42 0 C-N-CA 124.493 1.117 . . . . 2.35 109.315 164.153 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -64.17 -8.35 16.21 Favored 'Trans proline' 0 N--CA 1.433 -2.038 0 CA-C-N 126.678 3.421 . . . . 1.31 116.551 -174.761 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 p -93.77 -1.93 54.37 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.179 1.809 . . . . 1.71 111.966 178.635 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -73.38 156.0 38.78 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.519 -1.988 . . . . 1.69 110.672 172.569 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.3 p -95.63 173.47 7.47 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 114.842 1.423 . . . . 1.33 114.842 176.872 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.9 mm -67.05 -44.79 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 116.307 -1.806 . . . . 1.32 108.479 169.418 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -52.12 -33.54 40.3 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 117.287 2.328 . . . . 1.62 117.287 169.285 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -66.79 -42.72 85.55 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.868 -3.645 . . . . 2.13 113.186 174.463 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 t -53.32 -47.88 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 115.328 1.603 . . . . 1.23 115.328 171.303 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -65.73 -31.16 72.0 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 126.578 2.423 . . . . 1.97 114.734 176.217 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -43.47 98.75 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 120.96 1.709 . . . . 1.19 110.775 176.793 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -57.03 -38.12 72.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.978 1.844 . . . . 1.92 115.978 172.2 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.5 mt -69.75 -34.35 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 113.911 1.078 . . . . 1.94 113.911 168.555 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -69.07 -34.02 74.49 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 130.14 3.376 . . . . 1.9 115.388 174.905 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.351 36.8 t70 -71.19 -41.92 69.68 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 123.977 0.911 . . . . 1.55 113.043 166.509 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -81.12 -44.94 17.19 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 117.527 2.417 . . . . 2.95 117.527 -176.557 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -109.42 -46.84 3.48 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.502 -1.295 . . . . 1.48 107.502 -165.273 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.89 36.13 2.25 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 119.055 2.382 . . . . 1.12 119.055 173.271 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.468 HD13 HD23 ' A' ' 71' ' ' LEU . 9.9 mt -111.18 136.76 20.86 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-O 116.687 -1.625 . . . . 2.07 109.981 -177.575 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -70.85 160.58 48.92 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 CA-C-N 125.08 2.85 . . . . 1.39 112.48 -175.379 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.82 -19.84 52.53 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 N-CA-C 118.1 2.308 . . . . 1.68 118.1 178.535 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -62.55 -37.48 86.32 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 119.702 3.223 . . . . 2.25 119.702 171.545 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.34 18.4 mm100 -80.23 -29.76 38.5 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 108.666 -3.879 . . . . 2.44 111.763 -173.21 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -81.8 133.15 35.31 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.064 -1.425 . . . . 1.32 108.484 -175.181 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.407 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 91.7 mtt180 -123.86 110.92 15.47 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 106.325 -1.731 . . . . 3.19 106.325 175.046 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.8 mt -99.96 118.0 35.43 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.699 2.666 . . . . 1.75 105.556 -179.008 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.8 mm -109.75 116.05 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 104.152 -2.536 . . . . 1.98 104.152 -173.244 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -121.83 110.11 15.49 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.849 -2.278 . . . . 1.94 104.849 176.147 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.27 30.87 4.11 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.627 3.171 . . . . 1.67 110.658 175.951 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.71 -33.74 5.33 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 119.867 1.212 . . . . 1.3 112.396 -175.046 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -78.29 132.94 37.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.232 1.813 . . . . 2.89 108.83 -177.972 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -91.44 122.02 33.66 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.424 2.059 . . . . 2.89 109.409 170.992 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.2 mt -70.23 136.08 49.61 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 129.553 3.141 . . . . 1.34 113.691 -174.911 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -77.88 148.42 34.62 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.202 -1.561 . . . . 1.94 114.922 174.973 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -62.95 -63.13 1.3 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.14 -2.225 . . . . 1.56 116.94 -171.943 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.5 42.7 0.24 Allowed Glycine 0 N--CA 1.43 -1.729 1 N-CA-C 123.859 4.303 . . . . 0.97 123.859 167.554 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -117.12 164.43 14.77 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 114.238 -2.791 . . . . 3.07 111.14 168.453 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.0 p -96.39 169.64 9.78 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 122.64 2.473 . . . . 1.34 110.769 169.803 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.2 mt -75.88 -23.47 55.6 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.596 -2.565 . . . . 1.63 112.976 174.916 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.4 t -71.53 -29.59 64.95 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.859 2.17 . . . . 1.51 116.859 178.709 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -58.61 -49.29 78.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 131.434 3.893 . . . . 1.9 110.991 174.236 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -80.44 164.16 23.26 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 125.664 2.65 . . . . 0.97 105.833 -177.961 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -90.92 58.18 3.72 Favored 'General case' 0 N--CA 1.43 -1.473 1 O-C-N 114.139 -5.351 . . . . 2.35 113.484 -175.877 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.4 mm -93.24 143.64 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.521 -1.218 . . . . 1.39 109.702 179.878 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -96.63 -102.65 0.17 Allowed 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.41 1.084 . . . . 2.58 108.846 -174.343 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -131.04 -73.85 0.54 Allowed 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 113.67 0.989 . . . . 2.58 113.67 -179.995 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -98.9 52.09 0.97 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.139 1.447 . . . . 1.71 111.418 177.352 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -83.46 149.3 26.73 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 128.407 2.683 . . . . 1.34 111.388 -169.561 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.7 m -101.56 122.94 44.77 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.532 -1.667 . . . . 1.36 111.79 -174.818 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -111.0 156.43 21.26 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 103.749 -2.686 . . . . 2.03 103.749 176.705 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -125.1 129.38 50.08 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 125.656 2.645 . . . . 2.31 108.213 -172.29 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.3 tp -98.62 114.16 26.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.769 -2.457 . . . . 1.72 111.52 179.909 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 71.2 t -105.71 135.67 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 C-N-CA 127.48 2.312 . . . . 1.8 105.241 174.732 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.468 HD23 HD13 ' A' ' 36' ' ' ILE . 81.5 mt . . . . . 0 N--CA 1.431 -1.413 0 O-C-N 117.465 -3.272 . . . . 3.26 112.193 175.645 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 CA--C 1.49 -1.355 0 N-CA-C 112.965 0.728 . . . . 1.39 112.965 . . . . . . . . . 0 0 . 1 . 100 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.86 134.69 36.92 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 122.793 1.283 . . . . 2.2 108.836 174.576 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.6 pt -125.76 157.51 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 105.965 -1.865 . . . . 1.32 105.965 164.023 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.45 ' HB3' ' CG2' ' A' ' 12' ' ' THR . 55.9 m-85 -113.72 114.66 26.68 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 125.661 2.648 . . . . 2.2 109.969 -178.612 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.4 t -97.45 106.06 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 113.548 -1.66 . . . . 1.23 111.568 177.303 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.278 85.9 mttt -91.77 122.72 34.58 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 116.92 -3.612 . . . . 2.51 112.044 -177.261 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.1 p -89.81 168.42 12.09 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.036 -2.915 . . . . 1.41 111.641 -179.031 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.8 mt -75.16 -36.55 61.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.957 -2.965 . . . . 2.95 114.3 176.44 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -74.83 -22.98 58.39 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 127.392 2.277 . . . . 2.52 112.416 -177.91 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.46 54.68 0.33 Allowed Glycine 0 N--CA 1.43 -1.757 0 O-C-N 119.528 -1.983 . . . . 1.5 116.191 171.709 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -141.46 140.34 33.55 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.413 -2.227 . . . . 1.79 112.642 169.689 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.45 ' CG2' ' HB3' ' A' ' 4' ' ' PHE . 32.4 m -95.8 105.37 17.37 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 111.767 -2.469 . . . . 1.38 105.294 174.438 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 80.2 mt -89.51 123.2 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.776 -2.453 . . . . 2.03 106.281 -178.025 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -95.44 122.98 38.74 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.191 1.472 . . . . 1.61 110.574 177.095 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.269 62.3 mt -111.86 142.53 44.13 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 128.943 2.897 . . . . 2.15 113.327 -175.074 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -98.75 103.72 15.7 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.163 1.459 . . . . 1.98 108.085 169.426 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.6 172.03 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 117.823 -1.551 . . . . 1.52 111.699 176.354 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -123.2 157.47 60.95 Favored Pre-proline 0 N--CA 1.43 -1.465 0 O-C-N 119.122 -2.236 . . . . 2.35 108.81 165.58 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.75 -7.74 17.7 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 CA-C-N 127.068 3.56 . . . . 1.31 112.998 -171.175 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.5 m -78.58 -25.07 45.2 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 127.303 2.877 . . . . 1.71 108.628 176.91 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -70.3 163.37 26.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.906 2.765 . . . . 1.69 111.528 -175.129 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.3 p -98.22 165.04 12.07 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.912 -1.742 . . . . 1.33 109.553 -177.034 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.8 mm -66.59 -32.24 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 126.965 2.106 . . . . 1.32 114.26 172.163 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -52.81 -35.19 56.55 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 130.986 3.714 . . . . 1.62 113.113 163.347 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -80.92 -28.3 35.86 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.555 -1.966 . . . . 2.13 113.522 176.874 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.2 t -67.92 -51.27 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 104.217 -2.512 . . . . 1.23 104.217 178.982 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -64.44 -28.76 69.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 116.66 -3.775 . . . . 1.97 113.215 179.739 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.11 -29.19 66.08 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 121.187 1.812 . . . . 1.19 114.704 175.01 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.06 -30.58 63.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.441 -1.412 . . . . 1.92 114.371 172.313 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.2 mt -65.95 -36.89 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 118.559 -2.588 . . . . 1.94 113.897 167.283 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -58.16 -47.39 83.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.014 2.926 . . . . 1.9 111.457 172.782 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -60.29 -57.14 14.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 118.906 2.928 . . . . 1.55 118.906 165.827 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -66.51 -56.82 9.07 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 128.398 3.952 . . . . 2.95 116.046 -175.912 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -96.17 -44.65 7.19 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.788 -3.695 . . . . 1.48 114.715 -170.378 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.03 32.05 2.31 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 117.44 -1.755 . . . . 1.12 113.824 176.575 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.5 mm -108.55 143.81 28.27 Favored Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 101.824 -3.399 . . . . 2.07 101.824 -174.088 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -73.11 154.47 52.27 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 N-CA-C 116.239 1.592 . . . . 1.39 116.239 174.552 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -78.29 -28.49 4.61 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 CA-C-N 120.644 1.266 . . . . 1.68 112.379 -173.766 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -59.83 -35.29 74.42 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.426 1.891 . . . . 2.25 113.404 173.535 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -81.34 -33.85 32.19 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 116.507 -3.871 . . . . 2.44 111.257 179.349 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.297 71.8 mt-30 -74.66 130.95 40.45 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 116.424 -1.75 . . . . 1.32 111.855 -175.832 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -115.62 125.1 52.49 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 121.703 2.047 . . . . 3.19 110.94 163.47 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.4 mt -99.8 127.36 45.95 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.317 -2.114 . . . . 1.75 110.766 179.169 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.9 mt -118.78 134.08 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 126.981 2.112 . . . . 1.98 108.551 -178.435 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.706 ' CD1' HD21 ' A' ' 67' ' ' LEU . 34.4 t80 -128.54 137.79 51.92 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.503 -2.406 . . . . 1.94 104.503 169.091 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 37.32 39.72 0.17 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 118.483 2.771 . . . . 1.67 118.483 -176.078 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.66 -18.0 32.28 Favored Glycine 0 N--CA 1.43 -1.713 0 N-CA-C 119.976 2.75 . . . . 1.3 119.976 -177.921 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -81.32 134.11 35.53 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.756 -2.026 . . . . 2.89 109.45 175.824 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -93.23 106.94 18.84 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 125.957 2.036 . . . . 2.89 108.848 179.182 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.4 mt -66.12 137.03 56.76 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 110.567 -3.015 . . . . 1.34 106.545 -168.542 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -84.36 159.87 20.77 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.645 2.641 . . . . 1.94 109.619 174.18 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -70.38 -55.77 8.28 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 116.383 -3.948 . . . . 1.56 114.086 -167.854 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.65 49.67 4.1 Favored Glycine 0 N--CA 1.431 -1.643 0 C-N-CA 126.348 1.928 . . . . 0.97 110.495 178.182 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 -124.47 158.74 32.12 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.773 -1.936 . . . . 3.07 105.773 164.357 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 p -89.47 163.02 15.43 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.996 1.48 . . . . 1.34 114.996 175.035 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.8 mt -66.6 -35.49 80.32 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.747 -3.095 . . . . 1.63 105.719 178.571 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 t -58.41 -34.33 70.65 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 118.367 2.729 . . . . 1.51 118.367 173.172 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -74.86 -37.41 62.21 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 113.48 -1.691 . . . . 1.9 110.286 -179.615 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -80.44 5.41 15.14 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.205 -1.56 . . . . 0.97 114.017 172.655 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.275 14.0 m-80 62.48 31.42 17.08 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.632 1.573 . . . . 2.35 113.047 179.755 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.9 mt -78.93 122.22 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 125.351 1.461 . . . . 1.39 112.32 179.904 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -96.06 177.23 5.81 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 110.402 -3.09 . . . . 2.58 114.958 -177.752 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -54.47 130.84 41.07 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 115.746 1.758 . . . . 2.58 115.746 171.229 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.361 77.5 mt-10 62.72 55.46 2.13 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.502 -1.999 . . . . 1.71 116.307 -178.046 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.3 m -104.02 151.46 23.2 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.127 2.394 . . . . 1.34 109.667 -175.173 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.0 m -102.84 113.65 27.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.085 -2.884 . . . . 1.36 105.394 177.946 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.706 HD21 ' CD1' ' A' ' 45' ' ' PHE . 31.9 mt -110.24 165.74 11.52 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 105.858 -1.904 . . . . 2.03 105.858 174.791 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -124.01 126.29 46.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.853 -1.78 . . . . 2.31 111.765 -173.732 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.0 tp -105.27 134.86 47.68 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 126.001 1.72 . . . . 1.72 111.759 -176.484 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.1 m -137.29 158.76 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 125.142 2.401 . . . . 1.8 105.007 176.131 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.1 mt . . . . . 0 N--CA 1.43 -1.452 0 O-C-N 117.906 -2.996 . . . . 3.26 115.828 -177.207 . . . . . . . . 0 0 . 1 . 101 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.6 ptt? . . . . . 0 CA--C 1.49 -1.33 0 CA-C-O 119.657 -0.211 . . . . 1.39 110.758 . . . . . . . . . 0 0 . 1 . 101 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -88.44 149.78 23.5 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 117.153 -1.403 . . . . 2.2 110.42 177.222 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -140.12 144.6 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.971 -2.233 . . . . 1.32 104.971 175.131 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -103.81 139.17 39.39 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 112.629 -3.628 . . . . 2.2 109.519 177.877 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 67' ' ' LEU . 12.6 t -113.25 109.67 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 117.983 -2.948 . . . . 1.23 109.526 167.41 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -91.04 137.94 31.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.504 -2.623 . . . . 2.51 111.179 -178.208 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.438 HG22 HD23 ' A' ' 69' ' ' LEU 0.263 67.8 p -82.34 -175.41 5.68 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 124.787 2.232 . . . . 1.41 115.323 177.707 . . . . . . . . 3 3 . 1 . 101 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.1 mt -50.31 -55.93 13.4 Favored 'General case' 0 N--CA 1.43 -1.461 2 O-C-N 114.521 -5.112 . . . . 2.95 109.426 166.044 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.253 20.4 p -72.19 -31.09 65.57 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.533 -2.604 . . . . 2.52 110.383 -175.834 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.74 25.05 1.62 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 110.773 -0.931 . . . . 1.5 110.773 172.291 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -76.53 117.64 18.38 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.041 -3.035 . . . . 1.79 109.328 -179.976 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m -74.39 90.08 2.14 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.017 2.817 . . . . 1.38 113.42 175.694 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mt -83.07 125.73 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 117.249 -3.407 . . . . 2.03 108.456 -179.718 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.3 m -101.33 128.27 47.57 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 119.487 -2.008 . . . . 1.61 113.854 177.55 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mp -128.89 154.67 46.28 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 126.0 2.063 . . . . 2.15 105.557 -175.956 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -100.7 129.29 46.58 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.245 -1.761 . . . . 1.98 106.245 171.883 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -135.46 155.88 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 O-C-N 127.904 3.252 . . . . 1.52 107.566 179.821 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -106.33 153.67 40.27 Favored Pre-proline 0 N--CA 1.43 -1.474 0 N-CA-C 102.915 -2.995 . . . . 2.35 102.915 161.897 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -70.68 -12.11 30.66 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 115.255 -3.076 . . . . 1.31 116.683 -177.356 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.8 p -90.42 7.08 40.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 117.365 -1.303 . . . . 1.71 109.685 175.039 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -81.31 146.23 30.48 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.927 2.775 . . . . 1.69 109.855 174.189 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.52 159.49 18.61 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.737 -3.102 . . . . 1.33 111.833 -174.289 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.1 mm -59.07 -43.03 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 124.472 1.109 . . . . 1.32 113.067 175.336 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -39.91 -41.66 1.21 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.725 3.602 . . . . 1.62 120.725 161.084 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -79.38 -25.1 42.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 114.721 -2.561 . . . . 2.13 111.716 173.268 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -68.37 -45.92 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 122.856 2.571 . . . . 1.23 110.668 173.417 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -58.73 -38.37 78.24 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.435 1.642 . . . . 1.97 115.435 174.18 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.27 -37.77 72.89 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.301 -2.124 . . . . 1.19 114.598 173.671 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.8 mttm -60.98 -44.77 96.88 Favored 'General case' 0 N--CA 1.431 -1.392 1 C-N-CA 131.884 4.073 . . . . 1.92 111.325 175.463 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.7 mt -66.54 -44.8 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 126.641 3.115 . . . . 1.94 114.602 172.022 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -50.27 -44.41 53.69 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.158 -2.839 . . . . 1.9 114.977 166.899 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -60.61 -59.2 5.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 115.74 -2.076 . . . . 1.55 108.6 175.544 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -68.01 -47.21 69.09 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 116.607 2.077 . . . . 2.95 116.607 -172.917 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -99.7 -46.36 5.45 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.972 2.509 . . . . 1.48 109.902 -165.58 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.92 22.59 5.9 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 126.484 2.365 . . . . 1.12 114.532 175.014 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mt -97.46 119.82 62.05 Favored Pre-proline 0 N--CA 1.43 -1.44 0 C-N-CA 125.628 1.571 . . . . 2.07 114.355 -174.432 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.74 161.01 30.9 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 116.854 -1.631 . . . . 1.39 113.728 -173.672 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -62.81 -19.68 69.2 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 123.809 3.006 . . . . 1.68 118.546 -171.186 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -67.82 -27.77 67.0 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.078 2.151 . . . . 2.25 114.194 177.338 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -94.34 -38.4 11.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.742 2.017 . . . . 2.44 113.568 -173.062 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -102.17 135.94 42.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.582 2.611 . . . . 1.32 115.156 -170.566 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -121.8 143.53 49.34 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.08 -2.263 . . . . 3.19 111.147 170.813 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -110.62 130.84 55.47 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.21 2.433 . . . . 1.75 112.313 178.72 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.0 mm -109.34 138.66 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 110.581 -3.009 . . . . 1.98 106.537 178.828 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -120.77 107.0 12.22 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.995 2.918 . . . . 1.94 109.144 163.558 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.371 . . 69.29 -93.64 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.881 3.229 . . . . 1.67 113.685 179.987 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.61 8.62 6.17 Favored Glycine 0 N--CA 1.43 -1.746 0 O-C-N 116.959 -3.588 . . . . 1.3 111.693 -177.773 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -117.65 138.54 51.9 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 119.61 -2.112 . . . . 2.89 107.462 -177.796 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -76.77 111.16 11.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 112.609 -2.087 . . . . 2.89 113.073 164.812 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.5 mt -66.25 113.89 4.92 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 118.423 0.556 . . . . 1.34 111.565 -174.418 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -76.21 129.26 36.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 127.52 3.534 . . . . 1.94 113.03 176.462 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -43.9 -53.43 6.11 Favored 'General case' 0 N--CA 1.43 -1.433 2 N-CA-C 124.061 4.837 . . . . 1.56 124.061 -173.163 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.35 43.97 3.15 Favored Glycine 0 N--CA 1.429 -1.797 0 O-C-N 119.861 -1.774 . . . . 0.97 115.338 175.996 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.311 33.6 mmt180 -118.29 171.79 7.89 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.953 2.311 . . . . 3.07 112.07 159.655 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.7 p -93.37 174.14 7.36 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.497 -2.627 . . . . 1.34 117.748 163.682 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 56' ' ' LEU . 26.8 mt -67.16 -33.89 76.39 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 130.231 3.412 . . . . 1.63 114.845 165.057 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 t -65.43 -35.28 80.44 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.86 2.864 . . . . 1.51 114.288 173.315 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -68.41 -44.33 75.26 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 117.673 -1.156 . . . . 1.9 109.899 177.293 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -82.59 3.45 28.66 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 116.196 -1.859 . . . . 0.97 113.311 176.732 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.5 t30 58.27 50.61 9.45 Favored 'General case' 0 N--CA 1.43 -1.434 1 CA-C-O 129.264 4.364 . . . . 2.35 114.564 174.85 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.251 24.6 mt -105.1 115.48 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 C-N-CA 131.87 4.068 . . . . 1.39 108.59 177.641 . . . . . . . . 3 2 . 1 . 101 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -93.46 172.68 8.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 130.798 3.639 . . . . 2.58 112.167 -176.507 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -72.04 144.83 48.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 115.546 -2.462 . . . . 2.58 114.175 169.897 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.384 54.3 mt-10 72.06 23.42 3.45 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.759 1.266 . . . . 1.71 114.153 177.275 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.281 17.4 m -88.75 153.46 21.07 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.02 -2.585 . . . . 1.34 104.02 -172.424 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.5 m -103.12 115.05 29.85 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 125.818 2.723 . . . . 1.36 106.788 -178.819 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.417 ' HB2' HG23 ' A' ' 5' ' ' VAL . 8.1 mp -103.38 164.63 11.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 103.027 -2.953 . . . . 2.03 103.027 174.11 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -131.2 138.02 49.21 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.532 -1.355 . . . . 2.31 111.918 177.981 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.438 HD23 HG22 ' A' ' 7' ' ' THR . 14.1 tp -106.93 117.78 34.96 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 129.221 3.008 . . . . 1.72 108.195 -177.849 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.7 m -115.5 175.06 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 107.119 -1.437 . . . . 1.8 107.119 165.803 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 N--CA 1.431 -1.406 0 O-C-N 120.914 -1.116 . . . . 3.26 109.412 -174.197 . . . . . . . . 0 0 . 1 . 102 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.1 ttp . . . . . 0 CA--C 1.491 -1.318 1 CA-C-O 129.664 4.554 . . . . 1.39 110.065 . . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.271 20.5 tt0 -93.81 113.44 25.48 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 114.487 -5.133 . . . . 2.2 110.305 -176.17 . . . . . . . . 3 2 . 1 . 102 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.0 pt -119.93 168.18 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.735 1.731 . . . . 1.32 107.119 170.348 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -131.4 157.61 42.99 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 103.268 -2.864 . . . . 2.2 103.268 -178.838 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.6 t -133.12 128.34 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 101.818 -3.401 . . . . 1.23 101.818 -178.34 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -119.39 119.38 33.77 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 122.591 1.186 . . . . 2.51 108.549 178.98 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.9 p -77.5 174.98 10.26 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 121.654 3.946 . . . . 1.41 121.654 -174.74 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.407 HD13 ' H ' ' A' ' 71' ' ' LEU . 85.6 mt -52.02 -52.25 52.04 Favored 'General case' 0 N--CA 1.43 -1.443 1 CA-C-O 129.104 4.288 . . . . 2.95 115.218 169.082 . . . . . . . . 3 3 . 1 . 102 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -72.2 -25.15 61.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.172 -2.83 . . . . 2.52 115.469 -178.066 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.33 19.25 4.29 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 124.778 3.444 . . . . 1.5 111.386 169.303 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.45 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 72.5 tttt -89.57 143.02 27.14 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 104.801 -2.296 . . . . 1.79 104.801 -176.638 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -110.28 119.74 40.22 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.361 1.553 . . . . 1.38 109.942 173.119 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.2 mt -98.8 122.25 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 125.631 2.634 . . . . 2.03 109.812 176.033 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.3 m -91.3 121.69 33.27 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.483 -3.26 . . . . 1.61 108.621 -179.74 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mt -116.92 163.5 16.11 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.028 -1.842 . . . . 2.15 106.028 -173.527 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -121.44 104.57 9.78 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.334 1.453 . . . . 1.98 107.305 169.983 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.11 -174.13 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 103.912 -2.625 . . . . 1.52 103.912 179.528 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -138.2 155.24 74.32 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 103.004 -2.962 . . . . 2.35 103.004 165.709 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -62.25 -11.88 24.43 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 126.529 3.368 . . . . 1.31 117.382 -173.384 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.9 m -85.22 -0.14 53.69 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.874 1.67 . . . . 1.71 113.025 -175.564 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -84.23 144.04 29.19 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 126.095 2.122 . . . . 1.69 110.735 -179.588 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.4 p -83.71 164.1 19.84 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.02 -1.9 . . . . 1.33 110.339 178.159 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.2 mm -68.32 -35.33 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 O-C-N 120.025 -1.672 . . . . 1.32 110.699 -179.912 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -45.8 -49.31 15.25 Favored 'General case' 0 N--CA 1.43 -1.446 1 C-N-CA 133.446 4.699 . . . . 1.62 110.773 163.424 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -73.78 -41.65 62.11 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.153 -2.217 . . . . 2.13 110.746 -176.486 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.1 t -61.56 -37.19 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 116.713 2.116 . . . . 1.23 116.713 170.856 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -56.88 -36.58 70.26 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 118.127 2.64 . . . . 1.97 118.127 170.762 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.56 80.78 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 118.68 -2.512 . . . . 1.19 111.196 166.437 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -68.32 -29.65 68.45 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 115.04 -4.788 . . . . 1.92 115.59 170.323 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.307 56.7 mt -70.09 -30.24 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-O 123.672 1.701 . . . . 1.94 106.816 175.281 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -69.34 -37.52 77.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.245 -1.534 . . . . 1.9 109.173 179.257 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -67.89 -54.63 17.32 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 126.876 2.61 . . . . 1.55 108.735 174.984 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -69.18 -54.63 13.82 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 118.579 -2.576 . . . . 2.95 111.833 -169.652 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.45 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 61.3 mm-40 -93.26 -59.54 2.0 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.157 -2.214 . . . . 1.48 112.31 -169.978 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.64 45.93 0.37 Allowed Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 107.03 -2.428 . . . . 1.12 107.03 176.444 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.4 mt -118.56 134.61 23.47 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 103.245 -2.872 . . . . 2.07 103.245 -176.662 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -75.12 152.05 39.73 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-O 114.939 -2.192 . . . . 1.39 116.354 -177.618 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -71.94 -14.3 29.33 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 CA-C-N 121.685 1.638 . . . . 1.68 115.769 -172.938 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.393 2.6 p30 -67.41 -48.64 66.72 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.959 1.704 . . . . 2.25 108.393 172.567 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -68.85 -16.74 63.86 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 116.35 -1.786 . . . . 2.44 113.574 -177.242 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -88.2 110.47 20.73 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 123.366 1.555 . . . . 1.32 108.347 -178.073 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -101.19 112.55 25.07 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.28 -2.118 . . . . 3.19 105.28 170.48 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.5 mt -107.79 128.56 54.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.091 -2.88 . . . . 1.75 111.647 -178.203 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 mt -107.74 136.7 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 1 C-N-CA 135.187 5.395 . . . . 1.98 105.752 -177.892 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.329 73.3 t80 -149.22 114.62 5.54 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 127.753 2.421 . . . . 1.94 105.42 173.624 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.59 30.45 15.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.863 2.465 . . . . 1.67 116.615 -178.839 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.67 -9.08 53.04 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-O 114.689 -3.284 . . . . 1.3 112.266 -176.385 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -92.11 134.3 34.97 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 115.692 -2.403 . . . . 2.89 114.305 167.868 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -86.93 123.58 32.21 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 118.956 -2.34 . . . . 2.89 109.174 173.473 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.8 mt -78.8 154.85 29.57 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.115 -2.241 . . . . 1.34 111.759 -159.29 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -91.47 150.66 21.13 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.43 -2.044 . . . . 1.94 110.468 173.898 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -71.99 -41.14 67.98 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 121.667 2.031 . . . . 1.56 115.481 -173.086 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.66 45.31 3.42 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 121.726 3.45 . . . . 0.97 121.726 170.291 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 mmt-85 -122.78 143.99 49.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 128.207 3.86 . . . . 3.07 101.473 168.748 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.312 80.8 p -82.63 167.08 18.62 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.257 -4.027 . . . . 1.34 114.591 168.543 . . . . . . . . 3 2 . 1 . 102 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -57.58 -46.68 83.69 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 126.955 2.102 . . . . 1.63 108.956 172.496 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.255 10.6 t -56.4 -38.61 71.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 130.131 3.372 . . . . 1.51 114.805 178.22 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -63.78 -61.72 2.11 Favored 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.411 -4.556 . . . . 1.9 115.172 172.766 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -64.55 -4.05 3.7 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.707 -1.87 . . . . 0.97 116.009 170.924 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.276 73.9 m-80 66.36 39.31 4.06 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.977 -2.952 . . . . 2.35 112.65 -175.701 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.0 mt -87.05 103.17 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.558 -2.589 . . . . 1.39 104.396 175.266 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -100.15 -172.42 2.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.306 1.842 . . . . 2.58 110.093 -172.454 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -58.99 140.31 55.84 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 127.613 3.578 . . . . 2.58 112.271 177.369 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 65.51 36.8 6.41 Favored 'General case' 0 N--CA 1.43 -1.438 1 C-N-CA 132.124 4.169 . . . . 1.71 112.089 175.75 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 m -88.22 159.64 18.06 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 114.473 -2.679 . . . . 1.34 111.435 -170.969 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.5 m -111.32 113.49 26.0 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 123.921 3.055 . . . . 1.36 108.645 172.887 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.3 mt -88.66 134.48 33.88 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 115.638 -2.425 . . . . 2.03 107.314 167.013 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -101.1 112.84 25.41 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.293 -3.38 . . . . 2.31 108.446 -171.952 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.4 tp -92.69 117.87 30.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.894 3.277 . . . . 1.72 119.564 -173.75 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.89 124.65 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 102.384 -3.191 . . . . 1.8 102.384 172.941 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.407 ' H ' HD13 ' A' ' 8' ' ' LEU . 19.7 tp . . . . . 0 N--CA 1.429 -1.48 0 O-C-N 116.882 -3.636 . . . . 3.26 109.012 171.51 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 ptt? . . . . . 0 CA--C 1.491 -1.313 0 N-CA-C 119.601 3.185 . . . . 1.39 119.601 . . . . . . . . . 0 0 . 1 . 103 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -95.98 139.14 32.6 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.096 -2.253 . . . . 2.2 106.889 -174.616 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.0 pt -143.03 150.35 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 122.541 2.428 . . . . 1.32 109.983 169.654 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -108.77 134.02 52.04 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.4 -1.333 . . . . 2.2 107.4 -172.08 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -120.43 122.66 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 116.08 1.882 . . . . 1.23 116.08 166.553 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -94.33 130.1 40.76 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.978 2.511 . . . . 2.51 113.365 -176.013 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.6 p -97.14 153.28 18.07 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.958 -3.589 . . . . 1.41 107.853 -178.57 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.6 mt -61.91 -23.44 66.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 130.978 3.711 . . . . 2.95 112.841 174.095 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.8 p -77.78 -52.4 8.99 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 120.001 1.273 . . . . 2.52 113.754 178.872 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.05 11.51 0.03 OUTLIER Glycine 0 N--CA 1.429 -1.785 0 O-C-N 120.633 -1.292 . . . . 1.5 114.802 169.921 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -107.29 147.83 29.75 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 117.456 -3.379 . . . . 1.79 114.707 -173.276 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.7 m -112.69 116.96 30.96 Favored 'General case' 0 N--CA 1.43 -1.469 1 O-C-N 115.453 -4.529 . . . . 1.38 108.573 173.383 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mt -86.22 128.36 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 128.983 2.913 . . . . 2.03 105.93 -179.279 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.8 m -99.91 99.91 10.76 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.327 -3.358 . . . . 1.61 107.859 174.739 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.9 mt -97.09 145.39 26.03 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 115.973 -4.204 . . . . 2.15 109.721 177.219 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -97.2 132.14 43.26 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 125.32 2.486 . . . . 1.98 114.351 159.407 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.437 HG11 ' HE3' ' A' ' 29' ' ' LYS . 17.2 m -135.48 168.75 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 113.896 -1.502 . . . . 1.52 108.181 -176.148 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -116.08 152.27 47.55 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-O 116.147 -1.882 . . . . 2.35 106.539 166.914 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -76.33 -3.89 14.38 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-N 126.691 3.425 . . . . 1.31 112.999 -172.938 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -88.78 0.34 56.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 123.895 0.878 . . . . 1.71 111.988 173.525 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -82.07 147.33 29.17 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 125.042 1.337 . . . . 1.69 110.921 178.26 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 68.0 p -87.04 160.64 18.54 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.452 1.901 . . . . 1.33 112.349 -179.161 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.0 mm -75.99 -18.66 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 124.888 2.28 . . . . 1.32 114.441 -178.029 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.33 -44.58 94.5 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.37 -3.956 . . . . 1.62 111.298 158.407 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.307 18.3 m120 -50.82 -53.58 30.9 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 123.007 2.639 . . . . 2.13 114.18 169.054 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.293 2.4 t -50.46 -43.89 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 119.272 3.064 . . . . 1.23 119.272 171.758 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -74.54 -14.57 60.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.909 3.718 . . . . 1.97 114.515 174.245 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.262 . . -74.16 -34.35 63.8 Favored 'General case' 0 N--CA 1.431 -1.405 1 O-C-N 115.05 -4.781 . . . . 1.19 112.898 169.885 . . . . . . . . 3 2 . 1 . 103 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.437 ' HE3' HG11 ' A' ' 17' ' ' VAL . 67.4 mttm -64.09 -34.12 77.31 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.223 -1.353 . . . . 1.92 111.937 176.06 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.46 36.5 mt -68.86 -38.47 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.877 1.799 . . . . 1.94 110.584 177.158 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -64.81 -40.77 95.76 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.898 -2.376 . . . . 1.9 108.696 178.001 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -60.24 -40.85 91.68 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.684 1.735 . . . . 1.55 115.684 171.715 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -76.42 -67.68 0.67 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.886 -1.134 . . . . 2.95 112.748 -176.909 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -95.95 -45.1 7.07 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 116.645 -1.645 . . . . 1.48 111.027 -172.52 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.09 43.68 0.99 Allowed Glycine 0 N--CA 1.429 -1.78 0 CA-C-O 124.677 2.265 . . . . 1.12 117.237 174.852 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 mt -108.59 134.99 20.08 Favored Pre-proline 0 N--CA 1.43 -1.434 1 CA-C-O 111.536 -4.078 . . . . 2.07 102.736 -177.663 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -63.18 153.86 71.32 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 N-CA-C 120.024 3.048 . . . . 1.39 120.024 174.715 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -73.7 -24.75 15.44 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 CA-C-N 126.677 3.42 . . . . 1.68 113.014 -176.83 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.342 10.2 p-10 -65.86 -32.34 73.8 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 121.986 2.176 . . . . 2.25 111.951 170.528 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -73.84 -24.62 59.79 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.813 -2.429 . . . . 2.44 114.354 -179.174 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -92.11 145.59 24.39 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.929 -2.982 . . . . 1.32 110.225 -173.417 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.4 mtm180 -126.81 135.05 50.5 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 117.282 -1.342 . . . . 3.19 110.843 168.836 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.7 mt -103.42 124.99 49.75 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 123.715 2.962 . . . . 1.75 109.122 177.007 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.7 mm -114.88 120.48 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 104.749 -2.315 . . . . 1.98 104.749 177.908 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.493 ' HB3' HD23 ' A' ' 50' ' ' LEU . 35.7 t80 -130.02 136.28 49.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 129.277 3.031 . . . . 1.94 108.843 169.007 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.306 . . 54.6 31.58 15.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.278 1.584 . . . . 1.67 115.278 175.466 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.48 -20.82 6.83 Favored Glycine 0 N--CA 1.429 -1.805 0 O-C-N 119.176 -2.203 . . . . 1.3 115.438 -174.849 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.0 mttt -85.6 136.68 33.29 Favored 'General case' 0 N--CA 1.43 -1.468 2 C-N-CA 133.535 4.734 . . . . 2.89 110.802 -179.211 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -86.57 128.56 34.99 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.095 -1.866 . . . . 2.89 111.345 168.941 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.493 HD23 ' HB3' ' A' ' 45' ' ' PHE . 17.4 mt -83.76 127.24 33.66 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 104.927 -2.249 . . . . 1.34 104.927 -176.224 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -82.91 137.8 34.1 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.799 -3.063 . . . . 1.94 114.325 175.116 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -37.74 -72.8 0.05 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 131.087 3.755 . . . . 1.56 117.976 -177.676 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.86 51.79 4.6 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 120.696 3.038 . . . . 0.97 120.696 176.566 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.268 10.7 mmt180 -131.34 156.32 45.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.569 -3.313 . . . . 3.07 107.324 172.121 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.253 24.7 p -80.84 169.98 16.87 Favored 'General case' 0 N--CA 1.43 -1.442 2 O-C-N 114.123 -5.361 . . . . 1.34 116.647 176.733 . . . . . . . . 4 3 . 1 . 103 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mt -63.87 -49.47 72.61 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.596 1.958 . . . . 1.63 109.186 171.663 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 t -57.29 -40.33 77.57 Favored 'General case' 0 N--CA 1.432 -1.363 0 O-C-N 118.774 -2.454 . . . . 1.51 111.632 177.137 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.4 -29.97 17.59 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 116.414 2.005 . . . . 1.9 116.414 167.876 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -99.95 7.86 44.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.069 -2.269 . . . . 0.97 115.373 171.846 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.294 7.7 m120 52.17 57.77 6.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 126.576 2.422 . . . . 2.35 117.433 -171.144 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mt -96.57 131.08 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 120.045 -1.659 . . . . 1.39 110.635 -177.876 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -97.68 -171.78 2.25 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 127.023 2.129 . . . . 2.58 114.339 -169.189 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -81.98 143.48 31.57 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.25 -1.531 . . . . 2.58 114.622 175.349 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.254 32.3 mt-10 65.43 21.32 11.86 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.426 2.01 . . . . 1.71 116.426 178.461 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.4 t -85.2 150.22 24.96 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 125.682 1.593 . . . . 1.34 112.741 -174.427 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.311 8.8 m -106.07 115.63 30.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 121.599 1.999 . . . . 1.36 113.648 -176.771 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 mt -101.36 164.15 11.92 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.105 -2.554 . . . . 2.03 104.105 173.759 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.293 74.1 m80 -123.73 135.54 53.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.833 -3.042 . . . . 2.31 107.392 178.431 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 tp -97.5 132.41 43.21 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 112.293 -2.231 . . . . 1.72 111.323 178.381 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.9 m -143.65 161.26 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 103.707 -2.701 . . . . 1.8 103.707 176.659 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.43 -1.463 0 CA-C-O 125.713 2.673 . . . . 3.26 112.846 -174.402 . . . . . . . . 0 0 . 1 . 104 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 CA--C 1.491 -1.324 0 CA-C-O 117.582 -1.199 . . . . 1.39 111.118 . . . . . . . . . 0 0 . 1 . 104 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -103.51 143.29 32.92 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 120.119 1.327 . . . . 2.2 110.979 179.837 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.9 pt -131.31 168.46 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 116.635 -1.65 . . . . 1.32 109.28 176.657 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -122.17 137.81 54.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 120.927 1.694 . . . . 2.2 113.163 177.283 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.45 HG22 ' HB2' ' A' ' 67' ' ' LEU . 4.3 t -122.22 131.3 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-O 125.842 2.734 . . . . 1.23 118.172 165.706 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -89.21 123.25 33.27 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 112.152 -2.294 . . . . 2.51 108.676 177.932 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.0 p -80.05 177.18 9.12 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.444 1.592 . . . . 1.41 112.758 169.455 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.0 mt -66.0 -46.31 78.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.299 -2.75 . . . . 2.95 113.909 176.165 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -65.04 -68.57 0.35 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.08 1.352 . . . . 2.52 108.488 179.379 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.67 -6.24 0.03 OUTLIER Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 117.454 1.742 . . . . 1.5 117.454 -176.203 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -71.62 141.73 49.96 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.304 -1.704 . . . . 1.79 114.664 -175.573 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.3 m -108.27 104.57 13.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 127.915 3.722 . . . . 1.38 111.183 172.435 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.59 115.57 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 1 O-C-N 115.874 -4.266 . . . . 2.03 109.743 179.248 . . . . . . . . 3 3 . 1 . 104 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.5 m -91.48 119.22 31.25 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.124 -2.176 . . . . 1.61 105.124 177.719 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 mt -115.42 139.51 49.96 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 125.102 2.382 . . . . 2.15 110.592 -171.378 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -87.97 120.75 29.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.201 -2.187 . . . . 1.98 108.038 174.852 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.9 177.02 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 125.741 1.901 . . . . 1.52 114.095 179.397 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -129.14 148.0 67.26 Favored Pre-proline 0 N--CA 1.43 -1.465 3 CA-C-O 108.292 -5.623 . . . . 2.35 110.668 166.82 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -61.35 -24.39 78.55 Favored 'Trans proline' 0 N--CA 1.434 -2.004 1 CA-C-N 128.843 4.194 . . . . 1.31 115.22 -174.216 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.4 p -69.75 -10.78 59.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.837 2.455 . . . . 1.71 116.072 177.045 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.305 36.4 m-20 -78.75 147.55 33.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 128.044 3.783 . . . . 1.69 108.576 -178.878 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 p -82.82 165.79 19.53 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 114.514 -2.66 . . . . 1.33 115.913 174.55 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.2 mm -66.08 -20.03 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-N 122.071 2.214 . . . . 1.32 111.18 178.289 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -64.68 -39.38 93.58 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 117.522 2.416 . . . . 1.62 117.522 169.51 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -72.74 -33.05 66.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.416 3.008 . . . . 2.13 108.665 179.591 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.6 t -69.09 -48.28 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 112.289 -2.232 . . . . 1.23 112.844 176.86 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 52.6 mtmt -55.84 -30.82 62.06 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 119.558 3.17 . . . . 1.97 119.558 160.052 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -31.96 72.76 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 124.312 3.233 . . . . 1.19 113.132 172.419 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -70.12 -29.13 66.0 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.544 -3.222 . . . . 1.92 113.342 172.562 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.9 mt -73.09 -39.17 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 120.017 -1.677 . . . . 1.94 112.544 176.255 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -58.21 -35.38 71.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 114.435 -2.698 . . . . 1.9 109.425 171.854 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -66.3 -50.66 62.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 123.355 2.798 . . . . 1.55 117.176 170.797 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -59.75 -61.01 2.94 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 116.949 -3.595 . . . . 2.95 111.616 -172.333 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -101.47 -44.9 5.47 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.449 -1.705 . . . . 1.48 108.893 -168.795 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.01 57.05 1.17 Allowed Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 118.502 -1.808 . . . . 1.12 111.383 178.821 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.0 mt -122.49 125.13 26.57 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 112.381 -3.675 . . . . 2.07 104.637 -177.58 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -57.64 138.42 86.04 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 CA-C-N 129.358 4.378 . . . . 1.39 116.708 177.276 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -54.39 -27.67 50.0 Favored 'Trans proline' 0 C--N 1.299 -2.076 1 C-N-CA 127.208 5.272 . . . . 1.68 117.414 -178.329 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -69.89 -39.41 76.26 Favored 'General case' 0 N--CA 1.431 -1.422 1 CA-C-O 111.334 -4.174 . . . . 2.25 110.086 171.663 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -61.65 -31.33 71.43 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 124.176 3.171 . . . . 2.44 114.326 177.701 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.401 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 63.0 mt-30 -78.13 135.27 37.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 120.354 3.464 . . . . 1.32 120.354 -177.447 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -135.05 146.98 49.48 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 102.512 -3.144 . . . . 3.19 102.512 173.23 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.5 mt -113.0 137.05 52.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.76 -2.462 . . . . 1.75 110.173 179.17 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.7 mm -117.47 133.9 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 124.994 2.33 . . . . 1.98 108.209 -178.551 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.416 ' HB3' HD22 ' A' ' 50' ' ' LEU . 7.7 t80 -147.47 138.02 23.32 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.29 -3.381 . . . . 1.94 112.338 169.787 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.76 43.27 30.33 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.412 3.085 . . . . 1.67 115.166 -178.525 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.55 -23.66 15.2 Favored Glycine 0 N--CA 1.429 -1.781 0 O-C-N 118.06 -2.9 . . . . 1.3 116.801 -176.373 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -119.03 166.81 12.42 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.056 -3.026 . . . . 2.89 112.841 -171.791 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.345 33.3 tt0 -98.78 153.41 18.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.126 -0.943 . . . . 2.89 112.435 178.192 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.416 HD22 ' HB3' ' A' ' 45' ' ' PHE . 8.1 mt -110.56 126.58 54.57 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.675 1.59 . . . . 1.34 110.353 -173.302 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -73.73 141.63 46.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.19 2.596 . . . . 1.94 113.725 -178.1 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -46.98 -54.44 10.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 118.476 2.769 . . . . 1.56 118.476 -177.254 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.94 5.76 61.25 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 127.265 2.853 . . . . 0.97 120.088 172.893 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -87.92 154.33 20.6 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 120.092 1.946 . . . . 3.07 106.54 171.903 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.0 p -97.79 162.09 13.43 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.094 1.902 . . . . 1.34 115.79 172.038 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.38 -20.2 65.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.901 -2.999 . . . . 1.63 114.15 174.748 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.0 p -80.28 -31.86 38.26 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.541 3.137 . . . . 1.51 110.805 178.856 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.68 -46.22 39.26 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 112.834 -3.46 . . . . 1.9 111.799 175.483 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -76.52 -18.82 58.51 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 127.117 2.76 . . . . 0.97 110.654 178.095 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.7 t30 65.96 53.88 1.07 Allowed 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 127.073 2.149 . . . . 2.35 109.599 -176.264 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 mt -84.39 106.67 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 101.192 -3.633 . . . . 1.39 101.192 172.186 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -89.26 -174.43 4.4 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 122.248 2.295 . . . . 2.58 112.017 -178.713 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -60.53 137.55 58.15 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 123.638 1.685 . . . . 2.58 114.35 174.584 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 74.42 26.75 1.49 Allowed 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 131.492 3.917 . . . . 1.71 114.476 169.627 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.89 151.93 20.31 Favored 'General case' 0 N--CA 1.429 -1.491 1 C-N-CA 131.892 4.077 . . . . 1.34 105.613 -177.22 . . . . . . . . 3 3 . 1 . 104 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.4 m -107.3 126.25 52.21 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.57 -1.956 . . . . 1.36 112.411 178.364 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.45 ' HB2' HG22 ' A' ' 5' ' ' VAL . 66.4 mt -100.07 151.9 20.85 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 126.259 2.933 . . . . 2.03 106.532 169.561 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -113.35 116.58 29.92 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 116.035 -4.166 . . . . 2.31 112.584 179.083 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.7 tp -92.58 125.93 37.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.314 2.959 . . . . 1.72 107.826 -176.906 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.7 t -118.81 147.97 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 C-N-CA 127.216 2.206 . . . . 1.8 106.255 176.64 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.9 mt . . . . . 0 N--CA 1.429 -1.494 0 O-C-N 117.797 -3.064 . . . . 3.26 114.205 175.404 . . . . . . . . 0 0 . 1 . 105 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 ptt? . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 117.633 -1.175 . . . . 1.39 113.744 . . . . . . . . . 0 0 . 1 . 105 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -90.03 140.3 29.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 123.054 2.661 . . . . 2.2 112.907 175.357 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.2 pt -130.72 161.97 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 108.066 -1.087 . . . . 1.32 108.066 166.062 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -119.62 130.13 54.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.315 3.046 . . . . 2.2 111.245 172.656 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.0 t -109.56 121.4 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 111.677 -2.511 . . . . 1.23 108.554 172.954 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -97.24 123.36 41.0 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 117.784 -3.073 . . . . 2.51 112.595 174.637 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.6 p -78.78 174.53 11.36 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.148 3.356 . . . . 1.41 115.214 170.062 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.12 -43.18 74.93 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 116.416 -3.927 . . . . 2.95 115.935 178.412 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 p -73.36 -41.22 63.69 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.119 2.568 . . . . 2.52 110.957 -177.334 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.57 8.18 0.42 Allowed Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 115.514 -3.231 . . . . 1.5 116.178 170.766 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.23 133.96 35.91 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 104.583 -2.377 . . . . 1.79 104.583 -176.137 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.6 m -98.73 123.39 42.92 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.301 -1.5 . . . . 1.38 107.156 171.274 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -100.59 95.41 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 124.437 2.065 . . . . 2.03 109.871 175.676 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.4 m -76.53 115.42 16.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 105.256 -2.127 . . . . 1.61 105.256 177.923 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.5 mt -120.24 171.69 8.32 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.001 2.12 . . . . 2.15 112.215 -176.712 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -127.61 132.39 49.79 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 105.304 -2.11 . . . . 1.98 105.304 169.505 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.8 m -140.25 169.49 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 128.286 2.634 . . . . 1.52 108.549 -178.471 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -104.81 159.93 27.69 Favored Pre-proline 0 N--CA 1.43 -1.433 0 O-C-N 119.269 -2.144 . . . . 2.35 108.774 162.897 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -70.23 -19.06 34.37 Favored 'Trans proline' 0 N--CA 1.434 -2.01 1 O-C-N 112.146 -4.713 . . . . 1.31 106.999 -174.911 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -91.57 9.01 33.91 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.474 2.398 . . . . 1.71 117.474 -176.481 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -85.66 150.19 24.79 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 113.082 0.771 . . . . 1.69 113.082 173.098 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.8 p -78.35 160.14 27.99 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 123.395 1.569 . . . . 1.33 113.176 173.559 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.456 HD13 HD22 ' A' ' 56' ' ' LEU . 43.3 mm -60.59 -33.86 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 126.615 1.966 . . . . 1.32 109.92 169.884 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.303 3.4 tt0 -47.03 -46.56 22.16 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.526 2.047 . . . . 1.62 116.526 158.766 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -75.53 -35.73 60.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 116.83 2.159 . . . . 2.13 116.83 -178.021 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.4 t -57.92 -47.18 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 111.683 -2.508 . . . . 1.23 111.374 173.417 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.286 37.6 mtmt -57.91 -29.83 65.42 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 121.692 3.96 . . . . 1.97 121.692 170.628 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.38 -33.06 62.95 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.892 -2.38 . . . . 1.19 112.872 169.645 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -61.5 -17.17 53.43 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.706 1.602 . . . . 1.92 113.735 167.677 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.9 mt -98.61 -36.15 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 125.636 2.636 . . . . 1.94 108.945 178.777 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.307 24.7 tt0 -45.18 -50.01 11.74 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 117.815 -3.053 . . . . 1.9 113.825 173.752 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.397 0.6 OUTLIER -62.01 -26.4 68.21 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.92 2.933 . . . . 1.55 118.92 174.879 . . . . . . . . 3 3 . 1 . 105 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -86.17 -78.7 0.27 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.182 2.593 . . . . 2.95 109.212 -178.61 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -89.21 -12.36 41.04 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 119.03 2.974 . . . . 1.48 119.03 -172.529 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.66 24.08 26.71 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 120.92 -1.112 . . . . 1.12 115.419 172.962 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.4 mt -104.28 133.88 19.98 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-O 112.594 -3.574 . . . . 2.07 107.765 -169.549 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -77.51 158.95 32.49 Favored 'Trans proline' 0 N--CA 1.434 -1.974 0 CA-C-N 125.037 2.835 . . . . 1.39 115.397 -179.377 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -61.92 -26.73 79.21 Favored 'Trans proline' 0 C--N 1.299 -2.03 1 C-N-CA 127.002 5.135 . . . . 1.68 117.358 -178.329 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.342 0.2 OUTLIER -61.02 -51.2 70.2 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 130.275 3.43 . . . . 2.25 110.259 179.303 . . . . . . . . 3 3 . 1 . 105 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -74.71 -43.65 54.01 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.597 -1.26 . . . . 2.44 107.597 178.284 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -60.21 137.8 58.05 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 116.792 2.145 . . . . 1.32 116.792 -174.35 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -138.17 128.68 26.37 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 125.875 1.67 . . . . 3.19 109.955 175.351 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.261 85.2 mt -95.64 135.67 37.03 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.648 1.69 . . . . 1.75 110.488 174.608 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.251 37.2 mm -123.17 120.23 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 109.565 -3.47 . . . . 1.98 106.501 173.748 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -134.62 131.81 38.26 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.615 2.626 . . . . 1.94 108.886 171.127 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.58 45.52 24.17 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.405 2.743 . . . . 1.67 118.405 179.848 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.54 -45.98 1.99 Allowed Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 120.574 -0.822 . . . . 1.3 114.895 179.456 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -82.73 149.04 27.51 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.083 2.553 . . . . 2.89 116.252 179.372 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -81.27 125.71 30.66 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 129.041 2.936 . . . . 2.89 107.988 172.464 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 mt -88.09 146.53 25.39 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.74 1.257 . . . . 1.34 109.702 -173.437 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -98.07 146.54 25.44 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 126.087 2.851 . . . . 1.94 107.41 177.207 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.7 -61.49 2.57 Favored 'General case' 0 N--CA 1.43 -1.473 1 C-N-CA 133.675 4.79 . . . . 1.56 117.042 -168.753 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.41 12.63 1.8 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 120.088 2.795 . . . . 0.97 120.088 172.985 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -106.15 159.35 16.15 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.702 1.715 . . . . 3.07 113.274 178.06 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -95.48 162.98 13.42 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.878 -4.264 . . . . 1.34 110.945 -179.639 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.456 HD22 HD13 ' A' ' 23' ' ' ILE . 66.3 mt -64.28 -43.21 95.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.957 3.303 . . . . 1.63 108.242 178.538 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 p -60.8 -34.23 74.2 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 114.479 1.288 . . . . 1.51 114.479 -179.992 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -64.09 -37.24 86.72 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 129.774 3.23 . . . . 1.9 113.807 173.04 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -92.9 7.82 42.29 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.947 -2.971 . . . . 0.97 110.97 177.639 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.2 m120 55.5 39.15 31.02 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 130.917 3.687 . . . . 2.35 114.459 -175.897 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.2 mt -82.56 115.99 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 103.999 -2.593 . . . . 1.39 103.999 179.064 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -100.99 -179.94 4.19 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.917 2.294 . . . . 2.58 110.54 -176.655 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.284 32.7 pttt -54.41 137.07 43.14 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.674 -3.141 . . . . 2.58 119.085 169.232 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.292 59.3 mt-10 71.31 24.28 3.79 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.061 1.744 . . . . 1.71 113.748 171.919 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.7 p -91.23 159.32 16.11 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.256 2.622 . . . . 1.34 115.431 -174.827 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.1 m -105.97 100.32 9.87 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.201 3.0 . . . . 1.36 114.321 176.952 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mp -97.9 146.84 25.05 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 103.31 -2.848 . . . . 2.03 103.31 170.893 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -109.31 145.65 35.64 Favored 'General case' 0 CA--C 1.489 -1.37 0 CA-C-O 114.498 -2.668 . . . . 2.31 110.299 -179.009 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.2 tp -111.7 119.88 40.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 127.347 2.904 . . . . 1.72 110.592 -173.582 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 m -113.31 151.58 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 118.968 -2.332 . . . . 1.8 111.326 172.959 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.2 mt . . . . . 0 N--CA 1.43 -1.463 0 C-N-CA 116.966 -1.894 . . . . 3.26 108.846 -179.624 . . . . . . . . 0 0 . 1 . 106 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.37 15.3 ptt? . . . . . 0 CA--C 1.489 -1.382 0 N-CA-C 115.006 1.484 . . . . 1.39 115.006 . . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -97.74 130.07 44.73 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 117.168 -1.813 . . . . 2.2 111.79 179.799 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.2 pt -121.15 169.06 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 103.247 -2.872 . . . . 1.32 103.247 175.953 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -128.4 126.39 40.53 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.691 -1.226 . . . . 2.2 107.691 -171.442 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.0 t -107.91 121.96 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 114.494 -1.23 . . . . 1.23 108.406 172.462 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -99.04 126.88 44.86 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.313 1.445 . . . . 2.51 108.902 175.903 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 p -69.69 -178.63 1.53 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.643 2.09 . . . . 1.41 116.643 175.024 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.7 tp -74.73 -38.55 62.25 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.943 -1.098 . . . . 2.95 112.126 173.529 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.2 p -79.33 -53.25 7.11 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.987 2.588 . . . . 2.52 117.987 176.697 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.99 7.89 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.778 0 CA-C-N 125.772 3.897 . . . . 1.5 115.096 179.988 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -99.77 139.6 35.19 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 115.198 -2.601 . . . . 1.79 113.695 -175.603 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.4 m -103.28 128.19 50.39 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 116.53 -2.068 . . . . 1.38 105.534 174.787 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.4 mt -116.32 123.98 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.661 2.784 . . . . 2.03 111.265 -177.72 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.8 m -96.64 126.41 41.79 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 105.847 -1.908 . . . . 1.61 105.847 -174.891 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -121.35 120.31 34.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.399 2.28 . . . . 2.15 111.222 -178.056 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -82.48 111.65 18.69 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.114 1.765 . . . . 1.98 108.16 172.667 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.263 23.8 m -134.97 -178.43 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 O-C-N 120.163 -1.586 . . . . 1.52 107.25 177.579 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -117.31 174.68 2.38 Favored Pre-proline 0 N--CA 1.43 -1.451 0 O-C-N 117.237 -3.414 . . . . 2.35 108.304 163.817 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -77.56 -19.04 13.28 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 117.377 -1.96 . . . . 1.31 113.215 -175.124 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.333 4.5 m -82.94 3.95 27.79 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 122.755 2.525 . . . . 1.71 115.387 176.816 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.269 2.8 m-20 -72.59 153.74 41.12 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 115.917 1.821 . . . . 1.69 115.917 172.114 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.5 p -89.85 153.86 20.32 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 117.481 -3.262 . . . . 1.33 111.424 -179.61 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.5 mm -47.63 -49.01 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 118.832 -2.417 . . . . 1.32 116.497 172.354 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -45.31 -35.71 3.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 117.101 2.26 . . . . 1.62 117.101 167.828 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -65.48 -32.42 74.01 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 122.02 2.191 . . . . 2.13 114.515 174.836 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.9 t -75.75 -40.19 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 120.112 -1.618 . . . . 1.23 109.772 -174.93 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -59.37 -32.07 69.8 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 113.251 -1.795 . . . . 1.97 114.957 167.556 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.17 84.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 114.98 -2.438 . . . . 1.19 112.905 171.748 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -70.2 -22.16 62.96 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 127.635 3.084 . . . . 1.92 115.023 -179.648 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.1 mm -79.38 -35.66 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 127.262 2.225 . . . . 1.94 109.513 175.446 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.35 8.7 tt0 -58.39 -48.78 79.54 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 126.539 2.399 . . . . 1.9 113.459 172.867 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -54.05 -53.04 58.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 111.647 -2.524 . . . . 1.55 113.145 168.949 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -87.53 -49.21 7.34 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.488 -3.258 . . . . 2.95 114.102 -167.522 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -96.36 -44.45 7.22 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 113.472 -1.695 . . . . 1.48 113.832 -172.202 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.74 -28.28 3.98 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 117.226 1.65 . . . . 1.12 117.226 169.56 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 mp -57.45 138.17 81.43 Favored Pre-proline 0 N--CA 1.429 -1.496 0 N-CA-C 115.754 1.761 . . . . 2.07 115.754 -174.57 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -59.92 134.39 56.49 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 C-N-CA 123.872 3.048 . . . . 1.39 114.445 174.772 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -73.95 -16.75 22.93 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-O 112.004 -3.415 . . . . 1.68 112.74 -169.72 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.03 -38.33 90.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.596 2.617 . . . . 2.25 111.616 171.584 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -78.4 -18.29 55.23 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.765 -2.459 . . . . 2.44 114.739 178.521 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -88.66 138.64 31.24 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.781 2.229 . . . . 1.32 116.09 177.766 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -121.77 158.04 29.68 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.908 -3.62 . . . . 3.19 110.976 165.408 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.276 12.8 mt -119.26 125.16 48.47 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 126.285 1.834 . . . . 1.75 111.387 179.324 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.1 mt -113.08 136.88 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 106.932 -1.507 . . . . 1.98 106.932 -174.149 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -142.04 129.59 21.4 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.588 -1.32 . . . . 1.94 111.106 173.214 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.43 18.3 6.72 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 130.322 3.449 . . . . 1.67 116.334 -179.288 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.54 -3.76 57.89 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 126.561 2.029 . . . . 1.3 115.049 -175.624 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -108.0 133.3 52.51 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 126.421 3.01 . . . . 2.89 113.785 177.215 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -77.41 127.62 32.85 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.251 -4.031 . . . . 2.89 104.735 172.564 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.5 mt -89.61 147.33 23.98 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.283 -2.136 . . . . 1.34 116.73 -173.927 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -82.83 132.87 35.15 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.366 2.031 . . . . 1.94 112.572 171.435 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -60.9 -51.45 69.23 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 111.008 -2.814 . . . . 1.56 115.213 -172.671 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.19 46.95 3.62 Favored Glycine 0 N--CA 1.43 -1.747 0 CA-C-O 118.347 -1.252 . . . . 0.97 114.293 173.726 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -128.21 155.6 44.26 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.085 2.154 . . . . 3.07 113.152 168.8 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.342 70.1 p -82.04 164.01 21.7 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 121.692 2.042 . . . . 1.34 111.116 173.951 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mt -70.41 -26.98 63.93 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 111.302 -2.681 . . . . 1.63 111.698 170.314 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.254 23.2 t -65.74 -46.28 79.45 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 115.572 -2.156 . . . . 1.51 111.681 171.515 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -52.27 -28.36 18.56 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 117.999 2.592 . . . . 1.9 117.999 176.397 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -93.39 -11.46 32.19 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 117.593 -3.192 . . . . 0.97 111.31 -179.693 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.1 m120 67.23 50.5 0.98 Allowed 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 128.728 2.811 . . . . 2.35 113.308 -175.087 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.8 mt -95.46 110.54 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 1 CA-C-O 128.857 4.17 . . . . 1.39 107.674 177.366 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -89.84 -173.15 3.8 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 114.081 -5.387 . . . . 2.58 112.563 -179.589 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -61.73 166.48 4.3 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.118 -2.239 . . . . 2.58 111.329 175.1 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 49.79 28.82 2.9 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 118.471 2.767 . . . . 1.71 118.471 172.703 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.9 p -90.88 147.33 23.23 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.074 2.55 . . . . 1.34 113.054 -174.848 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.9 m -107.98 98.6 8.15 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 115.305 1.594 . . . . 1.36 115.305 -179.205 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.297 2.7 mp -84.01 156.22 22.38 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 129.176 2.99 . . . . 2.03 107.945 175.123 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -126.05 120.23 29.69 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 118.281 -1.368 . . . . 2.31 109.873 -176.614 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.9 tp -84.58 130.81 34.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.903 -2.373 . . . . 1.72 107.636 -179.879 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.5 m -125.04 140.47 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 126.388 2.994 . . . . 1.8 113.066 166.065 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.335 4.9 mt . . . . . 0 N--CA 1.43 -1.446 0 O-C-N 118.023 -2.923 . . . . 3.26 112.553 176.919 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptt? . . . . . 0 CA--C 1.491 -1.319 0 CA-C-O 117.99 -1.005 . . . . 1.39 111.215 . . . . . . . . . 0 0 . 1 . 107 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -115.42 135.05 54.51 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 127.476 2.985 . . . . 2.2 109.275 175.997 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt -117.25 163.54 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 106.832 -1.544 . . . . 1.32 106.832 171.25 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -109.53 136.08 49.49 Favored 'General case' 0 N--CA 1.431 -1.409 1 C-N-CA 132.429 4.292 . . . . 2.2 109.703 174.998 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.9 t -130.01 123.46 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 O-C-N 118.099 -2.876 . . . . 1.23 104.861 178.769 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -98.03 139.49 33.77 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.299 -3.376 . . . . 2.51 112.391 176.531 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.323 32.7 p -82.59 -171.67 3.62 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.831 -1.168 . . . . 1.41 111.676 176.319 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt -61.71 -47.77 83.78 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.389 -1.444 . . . . 2.95 112.544 172.14 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.3 p -81.02 -22.84 39.06 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.969 -1.707 . . . . 2.52 109.1 -178.672 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.93 23.89 4.46 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 118.969 2.347 . . . . 1.5 118.969 172.375 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -77.73 134.4 38.1 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 120.054 1.927 . . . . 1.79 108.276 179.039 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.9 m -91.66 110.75 22.08 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.409 -2.057 . . . . 1.38 109.31 -173.272 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mt -100.86 125.91 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 125.742 1.617 . . . . 2.03 106.723 178.153 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.0 m -103.79 121.42 42.99 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.781 2.032 . . . . 1.61 108.207 179.613 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.5 mt -120.45 125.01 46.85 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.774 -2.454 . . . . 2.15 117.268 -178.621 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -70.69 117.56 12.36 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 124.774 1.296 . . . . 1.98 110.235 170.461 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.0 m -142.84 171.97 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 126.2 2.905 . . . . 1.52 109.064 178.231 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -118.58 158.62 46.7 Favored Pre-proline 0 N--CA 1.43 -1.428 1 O-C-N 114.087 -5.383 . . . . 2.35 106.484 163.509 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.08 -14.1 26.06 Favored 'Trans proline' 0 C--N 1.299 -2.048 1 C-N-CA 125.581 4.188 . . . . 1.31 110.235 -171.379 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 m -90.25 8.21 34.33 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 122.125 2.239 . . . . 1.71 110.24 177.773 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.35 147.03 28.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.593 -2.567 . . . . 1.69 110.285 171.388 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.0 p -86.71 161.35 18.47 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.663 -1.606 . . . . 1.33 106.663 -177.395 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.3 26.1 mm -64.98 -29.32 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 O-C-N 116.205 -4.06 . . . . 1.32 110.991 -178.374 . . . . . . . . 3 2 . 1 . 107 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -52.98 -47.49 68.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 129.009 2.924 . . . . 1.62 111.773 167.963 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.258 26.3 t30 -71.31 -32.85 69.1 Favored 'General case' 0 N--CA 1.431 -1.41 1 O-C-N 116.229 -4.044 . . . . 2.13 112.997 177.789 . . . . . . . . 3 2 . 1 . 107 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.0 t -63.15 -45.09 99.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 1 O-C-N 113.509 -5.744 . . . . 1.23 113.931 174.482 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.5 mttt -60.37 -38.71 84.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 128.006 3.316 . . . . 1.97 117.267 167.859 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.51 -41.6 85.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 123.901 1.81 . . . . 1.19 113.335 172.442 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -68.33 -29.46 68.21 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.545 -3.222 . . . . 1.92 117.156 171.107 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.8 mt -71.98 -43.92 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-N 120.898 1.681 . . . . 1.94 110.602 172.487 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -49.34 -45.84 46.13 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.575 2.35 . . . . 1.9 115.375 170.951 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -51.58 -46.53 63.53 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.751 2.215 . . . . 1.55 115.023 175.342 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 tttp -85.03 -57.73 2.98 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.681 -3.137 . . . . 2.95 113.008 -174.767 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -89.12 -46.81 8.54 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 129.824 3.25 . . . . 1.48 114.636 -168.274 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.88 27.08 3.35 Favored Glycine 0 N--CA 1.429 -1.798 1 O-C-N 114.637 -5.04 . . . . 1.12 110.455 169.981 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.0 mt -104.97 124.24 37.31 Favored Pre-proline 0 N--CA 1.429 -1.484 0 CA-C-O 113.883 -2.96 . . . . 2.07 107.087 -178.256 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -64.39 164.51 22.95 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 CA-C-N 127.969 3.882 . . . . 1.39 118.413 174.677 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -65.33 -26.65 55.91 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 123.815 3.01 . . . . 1.68 118.593 -176.847 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -55.96 -43.34 77.44 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 127.344 2.902 . . . . 2.25 113.062 173.774 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -85.38 -1.51 57.09 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 113.147 -1.842 . . . . 2.44 114.321 -170.317 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -107.6 103.62 12.97 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.146 1.378 . . . . 1.32 112.451 -171.946 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.257 72.6 mtt180 -96.39 116.74 29.53 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.286 -2.759 . . . . 3.19 107.849 167.74 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.1 mt -99.46 126.86 45.46 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.583 -3.198 . . . . 1.75 105.089 177.559 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -114.31 143.36 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 125.298 2.475 . . . . 1.98 107.966 176.481 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.514 ' C ' ' H ' ' A' ' 47' ' ' GLY . 34.9 t80 -141.2 127.37 19.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.346 -3.971 . . . . 1.94 108.888 171.964 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 75.93 -27.39 0.18 Allowed 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 127.953 2.501 . . . . 1.67 109.624 174.155 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 143.48 -13.02 2.25 Favored Glycine 0 N--CA 1.431 -1.694 0 CA-C-O 125.162 2.535 . . . . 1.3 113.55 -175.887 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -86.22 137.1 32.89 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 111.806 -2.197 . . . . 2.89 109.473 178.781 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -77.59 109.66 11.75 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.796 3.638 . . . . 2.89 110.508 169.092 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.8 mt -68.46 130.97 44.44 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 114.858 1.429 . . . . 1.34 114.858 -177.393 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -89.8 144.52 25.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.654 1.582 . . . . 1.94 113.285 177.891 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -60.87 -54.87 39.81 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.718 -3.114 . . . . 1.56 115.862 -171.933 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.42 28.86 0.85 Allowed Glycine 0 N--CA 1.43 -1.763 1 N-CA-C 123.754 4.262 . . . . 0.97 123.754 171.357 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -127.87 160.01 33.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.548 -1.56 . . . . 3.07 112.139 173.01 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.26 44.2 p -89.15 167.07 13.41 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.356 1.551 . . . . 1.34 109.974 -177.703 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mt -64.81 -34.73 79.06 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 113.892 -1.503 . . . . 1.63 109.854 169.938 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.9 t -61.16 -41.81 97.43 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 122.598 1.189 . . . . 1.51 109.613 179.397 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -55.23 -41.87 72.63 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.569 -2.582 . . . . 1.9 117.56 176.309 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -84.9 -6.69 59.34 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 117.75 2.5 . . . . 0.97 117.75 -179.441 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.318 35.9 m120 68.62 50.57 0.67 Allowed 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 119.399 1.0 . . . . 2.35 111.999 -176.204 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.6 mt -103.44 108.73 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 121.704 0.764 . . . . 1.39 111.451 172.838 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -93.78 -175.8 3.85 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.297 2.639 . . . . 2.58 107.627 177.886 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -68.59 149.35 49.28 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 125.932 2.777 . . . . 2.58 113.747 171.275 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.429 75.3 mt-10 64.97 22.39 12.44 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 109.99 -3.277 . . . . 1.71 115.375 174.687 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.5 m -92.23 156.42 17.31 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.776 -3.077 . . . . 1.34 110.812 -176.883 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.2 m -106.89 110.19 22.28 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 126.521 2.388 . . . . 1.36 108.211 -173.005 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -93.22 141.33 28.54 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.59 1.556 . . . . 2.03 106.869 172.31 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -101.9 117.99 35.99 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.015 -2.928 . . . . 2.31 106.773 -177.902 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.8 tp -93.1 121.4 34.42 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.697 -2.502 . . . . 1.72 111.163 173.868 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.1 t -111.36 140.77 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 O-C-N 117.8 -3.062 . . . . 1.8 108.084 177.561 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.5 tp . . . . . 0 N--CA 1.43 -1.474 0 N-CA-C 116.39 1.996 . . . . 3.26 116.39 174.567 . . . . . . . . 0 0 . 1 . 108 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ptt? . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 106.733 -1.58 . . . . 1.39 106.733 . . . . . . . . . 0 0 . 1 . 108 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.1 pm0 -107.15 131.6 53.96 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 114.28 1.215 . . . . 2.2 114.28 -178.863 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 pt -121.32 152.7 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 105.867 -1.901 . . . . 1.32 105.867 169.67 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.252 75.0 m-85 -113.89 135.34 54.08 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.035 -1.439 . . . . 2.2 108.88 -176.58 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.0 t -118.07 107.47 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 123.191 1.472 . . . . 1.23 111.405 178.709 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -89.02 138.23 31.59 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 118.239 -2.788 . . . . 2.51 118.278 174.686 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.329 27.8 p -94.81 154.35 17.3 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 110.725 -2.943 . . . . 1.41 110.013 178.309 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.282 43.1 mt -65.6 -41.64 92.57 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 131.012 3.725 . . . . 2.95 107.611 178.367 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 p -67.57 -46.17 73.45 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.138 1.375 . . . . 2.52 114.001 -176.7 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.05 50.57 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 125.406 1.479 . . . . 1.5 114.953 166.417 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -127.87 137.94 52.51 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.505 2.574 . . . . 1.79 107.652 -179.798 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.0 m -103.07 110.89 22.99 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 120.192 -1.567 . . . . 1.38 111.634 167.492 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.9 mm -97.54 112.72 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 104.545 -2.391 . . . . 2.03 104.545 -179.475 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.7 m -87.58 104.0 16.09 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.795 -1.191 . . . . 1.61 110.067 176.922 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.0 mt -101.54 134.76 44.16 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 105.598 -2.001 . . . . 2.15 105.598 -170.646 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -81.72 99.37 8.9 Favored 'General case' 0 N--CA 1.429 -1.492 1 O-C-N 116.116 -4.115 . . . . 1.98 116.395 165.233 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.5 m -109.22 -177.66 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.457 1 O-C-N 116.295 -4.003 . . . . 1.52 109.964 -179.693 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -124.11 158.5 60.42 Favored Pre-proline 0 N--CA 1.431 -1.417 0 CA-C-O 114.885 -2.483 . . . . 2.35 105.823 161.55 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -79.03 -6.82 15.18 Favored 'Trans proline' 0 N--CA 1.434 -2.019 1 CA-C-N 129.825 4.544 . . . . 1.31 111.894 -173.347 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.275 1.0 OUTLIER -82.79 2.2 35.22 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 116.448 2.018 . . . . 1.71 116.448 172.01 . . . . . . . . 3 3 . 1 . 108 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -78.02 134.63 37.76 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 116.566 2.062 . . . . 1.69 116.566 172.552 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.7 p -73.63 157.93 35.71 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.139 2.4 . . . . 1.33 110.134 174.569 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.266 35.4 mm -68.64 -37.31 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 112.392 -2.186 . . . . 1.32 110.075 -177.545 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -44.67 -46.53 10.3 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 128.329 2.652 . . . . 1.62 112.463 162.762 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -74.51 -38.63 62.79 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.748 2.69 . . . . 2.13 117.015 -179.679 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.7 t -65.11 -37.86 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 O-C-N 115.188 -4.695 . . . . 1.23 110.196 175.2 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -60.89 -29.72 69.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.838 -2.414 . . . . 1.97 115.334 172.34 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.48 -32.86 66.56 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.097 1.359 . . . . 1.19 112.162 174.325 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.28 0.4 OUTLIER -64.82 -32.95 74.89 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 130.371 3.469 . . . . 1.92 112.822 171.724 . . . . . . . . 3 3 . 1 . 108 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.3 mt -70.82 -41.15 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.579 2.351 . . . . 1.94 108.761 167.495 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.369 13.6 tt0 -57.83 -45.5 86.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 127.754 3.645 . . . . 1.9 117.259 170.065 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -52.45 -56.88 12.05 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.41 -3.306 . . . . 1.55 116.004 170.772 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -78.17 -51.12 10.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.92 -2.362 . . . . 2.95 113.074 -177.992 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -93.91 -62.19 1.4 Allowed 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.982 -2.949 . . . . 1.48 110.386 -170.973 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.15 53.68 0.35 Allowed Glycine 0 N--CA 1.431 -1.663 1 O-C-N 114.13 -5.356 . . . . 1.12 114.829 -179.489 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.9 mt -123.11 127.97 25.48 Favored Pre-proline 0 N--CA 1.43 -1.432 1 N-CA-C 99.661 -4.2 . . . . 2.07 99.661 -177.172 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.02 135.18 39.73 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 C-N-CA 123.022 2.482 . . . . 1.39 112.022 -179.319 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -46.47 -21.51 1.33 Allowed 'Trans proline' 0 N--CA 1.434 -1.999 1 C-N-CA 128.968 6.445 . . . . 1.68 121.96 179.612 . . . . . . . . 3 3 . 1 . 108 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -72.87 -50.41 24.06 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.881 2.472 . . . . 2.25 110.334 177.416 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -77.66 -7.22 56.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.551 3.072 . . . . 2.44 108.51 -172.977 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -91.72 124.02 35.55 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.387 -3.321 . . . . 1.32 113.424 -178.705 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -121.18 147.93 44.92 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.565 2.126 . . . . 3.19 105.467 169.008 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.262 29.5 mt -127.07 133.95 50.36 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 117.912 -1.515 . . . . 1.75 107.013 178.587 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.5 mt -106.39 147.98 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 127.948 3.28 . . . . 1.98 107.569 171.57 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -128.59 107.3 9.59 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.416 -2.068 . . . . 1.94 105.416 177.164 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.43 -42.13 0.49 Allowed 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 132.225 4.21 . . . . 1.67 113.216 177.38 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -172.23 -25.44 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 127.747 2.594 . . . . 1.3 109.435 -176.811 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -104.43 147.77 27.18 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.278 1.539 . . . . 2.89 113.48 -175.489 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -81.59 140.63 34.35 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.012 -1.449 . . . . 2.89 113.232 172.266 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.5 mt -98.44 144.76 27.45 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.378 1.561 . . . . 1.34 113.482 -177.883 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -99.04 144.82 27.75 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.601 -2.562 . . . . 1.94 108.277 170.501 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.92 -43.93 94.45 Favored 'General case' 0 CA--C 1.489 -1.391 1 C-N-CA 137.864 6.465 . . . . 1.56 114.513 -167.668 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.31 22.87 13.54 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 129.14 3.257 . . . . 0.97 111.847 168.605 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -98.57 168.34 10.23 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.812 2.244 . . . . 3.07 109.25 161.234 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.3 p -102.68 173.09 6.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.586 -2.571 . . . . 1.34 111.27 170.741 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.321 16.7 mt -76.68 -31.51 57.31 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.442 -2.036 . . . . 1.63 106.579 176.951 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 t -64.05 -41.77 97.27 Favored 'General case' 0 CA--C 1.489 -1.39 0 C-N-CA 124.796 1.238 . . . . 1.51 111.093 179.703 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -56.14 -41.01 74.7 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.843 2.164 . . . . 1.9 116.843 174.552 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -87.67 7.36 30.35 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.004 2.122 . . . . 0.97 112.781 179.456 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.277 35.0 m120 56.67 40.49 29.23 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.721 -2.487 . . . . 2.35 115.455 -179.855 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.2 mt -79.03 108.18 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 124.082 1.896 . . . . 1.39 112.116 171.916 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -95.01 -175.27 3.48 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.927 -1.733 . . . . 2.58 113.009 179.131 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -69.02 146.36 52.76 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 115.858 -2.02 . . . . 2.58 114.901 170.774 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 69.57 42.94 1.06 Allowed 'General case' 0 N--CA 1.431 -1.409 1 CA-C-O 130.943 5.163 . . . . 1.71 108.193 177.372 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.256 37.9 m -107.11 129.48 54.82 Favored 'General case' 0 N--CA 1.431 -1.411 1 O-C-N 113.693 -5.629 . . . . 1.34 115.809 176.943 . . . . . . . . 3 2 . 1 . 108 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.3 m -88.33 126.12 35.03 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 125.686 1.866 . . . . 1.36 111.815 177.53 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -112.57 151.7 29.75 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.67 2.788 . . . . 2.03 108.271 173.607 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -110.26 113.45 26.13 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.224 1.935 . . . . 2.31 116.224 -174.967 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.3 tp -82.21 112.97 19.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.203 -2.811 . . . . 1.72 113.39 -178.64 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.39 112.56 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 125.04 2.352 . . . . 1.8 112.593 179.408 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.7 tp . . . . . 0 N--CA 1.43 -1.426 0 O-C-N 118.935 -2.353 . . . . 3.26 107.644 -175.301 . . . . . . . . 0 0 . 1 . 109 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.324 0 N-CA-C 107.442 -1.318 . . . . 1.39 107.442 . . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -99.16 144.45 28.28 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.288 1.994 . . . . 2.2 108.857 -173.913 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 pt -118.7 145.52 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 120.201 -1.562 . . . . 1.32 110.818 169.946 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -100.86 104.13 15.34 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.714 -0.676 . . . . 2.2 110.965 -179.567 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.423 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 32.8 t -88.29 117.62 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.446 -2.034 . . . . 1.23 107.299 174.651 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -101.88 145.12 29.66 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 125.288 1.618 . . . . 2.51 107.264 -179.529 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -103.9 -166.54 1.26 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.582 2.134 . . . . 1.41 112.186 178.532 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.5 tp -61.14 -51.29 69.68 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.539 -4.476 . . . . 2.95 114.15 176.233 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 p -72.24 -24.69 61.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.443 -3.286 . . . . 2.52 110.458 178.523 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.25 38.1 2.73 Favored Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 115.043 -3.087 . . . . 1.5 112.167 179.261 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -95.67 130.06 42.67 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 121.492 2.646 . . . . 1.79 110.956 -178.74 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.1 m -80.0 120.74 24.6 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.091 2.956 . . . . 1.38 112.786 178.972 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.423 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 3.2 mt -107.8 118.1 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 101.786 -3.413 . . . . 2.03 101.786 171.523 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.6 m -102.0 113.33 26.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 123.723 2.965 . . . . 1.61 107.462 -172.23 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.8 mt -108.58 137.05 47.17 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.231 -0.918 . . . . 2.15 110.924 177.543 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -80.94 112.86 18.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.872 1.269 . . . . 1.98 110.635 165.516 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -121.48 171.86 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 116.648 2.092 . . . . 1.52 116.648 174.866 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -106.14 158.05 33.44 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 104.115 -2.55 . . . . 2.35 104.115 164.712 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -82.51 4.61 6.95 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 O-C-N 114.656 -3.391 . . . . 1.31 109.095 179.926 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.6 p -92.66 -13.61 29.25 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.329 1.452 . . . . 1.71 114.561 175.661 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -66.67 135.88 54.72 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 126.109 2.861 . . . . 1.69 109.041 -179.416 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.263 23.8 p -68.96 158.33 34.91 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 116.451 -3.906 . . . . 1.33 113.534 177.881 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.401 7.9 mm -55.85 -41.77 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 124.623 2.154 . . . . 1.32 116.416 171.953 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -56.53 -39.65 73.72 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 119.546 3.165 . . . . 1.62 119.546 167.933 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -29.21 64.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.552 2.056 . . . . 2.13 116.552 172.321 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.44 -37.09 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 130.373 3.469 . . . . 1.23 109.635 168.732 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -81.44 -18.74 44.29 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 122.538 1.161 . . . . 1.97 109.793 -179.427 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.38 -17.34 58.28 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.651 -1.906 . . . . 1.19 111.532 168.242 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -83.64 -30.61 26.74 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 119.831 -1.793 . . . . 1.92 111.522 173.22 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.258 13.6 mt -73.01 -26.56 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 117.167 -3.458 . . . . 1.94 113.213 171.561 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -70.65 -51.36 28.46 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.492 3.517 . . . . 1.9 109.446 174.305 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -50.28 -45.16 54.22 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.608 2.763 . . . . 1.55 117.005 165.708 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -81.59 -60.15 2.36 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 113.869 1.063 . . . . 2.95 113.869 -179.646 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -95.13 -48.35 5.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.041 1.497 . . . . 1.48 115.041 -171.396 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.07 -2.0 6.25 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-O 124.222 2.012 . . . . 1.12 114.614 169.922 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.7 mt -74.03 117.61 62.76 Favored Pre-proline 0 N--CA 1.431 -1.409 0 C-N-CA 127.899 2.48 . . . . 2.07 105.039 -174.732 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -69.14 166.88 25.29 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 CA-C-O 111.815 -3.494 . . . . 1.39 117.074 178.03 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -66.19 -32.72 41.98 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 N-CA-C 120.133 3.09 . . . . 1.68 120.133 -174.64 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.379 38.0 m-20 -47.95 -36.63 12.83 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.974 2.109 . . . . 2.25 113.173 169.102 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -98.59 -4.74 33.35 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.964 -0.46 . . . . 2.44 111.802 -172.172 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -97.58 126.17 42.73 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.459 -2.025 . . . . 1.32 110.839 -179.685 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -106.83 116.82 32.59 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.08 2.152 . . . . 3.19 108.826 168.691 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.5 mt -104.84 115.73 30.79 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.8 -1.188 . . . . 1.75 112.037 -179.086 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.9 mm -110.65 126.17 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 127.129 2.172 . . . . 1.98 116.589 -179.779 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.43 ' HB3' HD22 ' A' ' 50' ' ' LEU . 64.3 t80 -127.92 104.0 7.56 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 104.792 -2.299 . . . . 1.94 104.792 174.97 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.284 . . 61.88 -117.03 0.62 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 110.641 -2.982 . . . . 1.67 110.976 -179.655 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.08 -27.12 29.28 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 119.876 -1.765 . . . . 1.3 110.634 -168.513 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -96.28 139.55 32.26 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 126.86 2.153 . . . . 2.89 115.36 -179.224 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -90.46 127.73 36.3 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 111.919 -2.4 . . . . 2.89 105.836 173.408 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.43 HD22 ' HB3' ' A' ' 45' ' ' PHE . 37.4 mt -83.85 117.17 23.13 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.363 -1.461 . . . . 1.34 112.445 -171.424 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -68.7 139.7 55.4 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 119.936 3.31 . . . . 1.94 119.936 172.381 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.52 -59.43 4.84 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 118.566 2.802 . . . . 1.56 118.566 -174.611 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.76 60.19 4.83 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-N 113.118 -1.855 . . . . 0.97 114.805 172.362 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -136.8 178.48 7.04 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.418 2.532 . . . . 3.07 106.038 164.521 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.6 p -110.38 176.6 4.98 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 116.604 -3.81 . . . . 1.34 106.961 170.241 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.6 mt -75.2 -33.92 61.46 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.32 -2.737 . . . . 1.63 109.024 177.302 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.6 t -56.01 -44.24 78.47 Favored 'General case' 0 N--CA 1.43 -1.436 1 C-N-CA 134.34 5.056 . . . . 1.51 109.685 176.84 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.251 33.6 m-20 -57.27 -39.79 76.36 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.542 -3.849 . . . . 1.9 118.25 175.653 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -96.67 -2.25 45.02 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 127.469 2.308 . . . . 0.97 112.76 179.476 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.9 m120 58.21 42.53 21.84 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.916 2.886 . . . . 2.35 118.713 -179.165 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.1 mt -94.36 114.38 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 119.439 -2.038 . . . . 1.39 108.596 -179.695 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -101.13 -172.77 2.23 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.742 2.417 . . . . 2.58 112.776 -179.85 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -45.56 151.55 0.39 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.492 -3.88 . . . . 2.58 120.577 174.056 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 50.96 34.93 11.45 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.694 1.368 . . . . 1.71 114.694 174.548 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.0 m -91.84 137.38 32.41 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.697 -1.592 . . . . 1.34 109.294 -176.257 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.2 m -86.7 111.45 20.69 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 124.981 1.425 . . . . 1.36 110.831 177.003 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -92.13 163.97 13.75 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 117.461 -3.274 . . . . 2.03 107.428 171.405 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -128.95 116.28 19.13 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 124.232 1.968 . . . . 2.31 110.031 179.93 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.7 tp -82.36 110.26 17.35 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.677 3.214 . . . . 1.72 119.677 174.548 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.6 t -113.19 142.8 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.686 -1.227 . . . . 1.8 107.686 -178.919 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.9 tp . . . . . 0 N--CA 1.429 -1.48 0 CA-C-N 122.919 2.6 . . . . 3.26 108.851 178.37 . . . . . . . . 0 0 . 1 . 110 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 114.307 1.225 . . . . 1.39 114.307 . . . . . . . . . 0 0 . 1 . 110 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -93.31 130.16 39.16 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.646 -2.534 . . . . 2.2 112.898 -175.967 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.5 pt -129.85 149.64 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 128.561 3.663 . . . . 1.32 110.614 176.149 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -109.0 130.69 55.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 113.052 -1.886 . . . . 2.2 107.854 -176.106 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.48 130.58 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 103.076 -2.935 . . . . 1.23 103.076 173.589 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -110.24 146.13 36.14 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 116.21 -4.056 . . . . 2.51 115.691 174.137 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.251 2.9 p -104.34 171.63 7.23 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 119.727 1.149 . . . . 1.41 108.4 173.704 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.9 mt -73.41 -40.26 64.42 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 117.242 -3.411 . . . . 2.95 114.962 174.592 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.0 p -80.72 -37.29 30.86 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.62 2.452 . . . . 2.52 117.62 -175.549 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.57 -55.14 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 116.252 -2.88 . . . . 1.5 119.801 174.973 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -54.18 129.62 35.52 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 121.102 3.742 . . . . 1.79 121.102 -178.311 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.7 m -112.6 115.23 28.27 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 104.498 -2.408 . . . . 1.38 104.498 168.261 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mt -95.03 129.06 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 107.474 -1.306 . . . . 2.03 107.474 -173.005 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.9 m -89.23 111.09 21.8 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.879 2.276 . . . . 1.61 106.634 172.832 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.8 mt -111.44 141.48 44.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 117.408 2.373 . . . . 2.15 117.408 174.527 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -103.37 115.94 31.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 130.64 3.576 . . . . 1.98 109.283 168.251 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.0 m -131.45 155.89 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.223 1.809 . . . . 1.52 112.994 -176.938 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -97.02 142.58 24.75 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-O 112.675 -3.536 . . . . 2.35 117.07 164.356 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.407 ' HA ' ' HB2' ' A' ' 56' ' ' LEU 0.267 18.8 Cg_endo -70.7 -24.68 25.11 Favored 'Trans proline' 0 C--N 1.299 -2.055 2 C-N-CA 127.502 5.468 . . . . 1.31 111.705 -170.373 . . . . . . . . 4 3 . 1 . 110 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.329 25.5 m -84.56 8.13 17.73 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 114.216 1.191 . . . . 1.71 114.216 173.916 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -78.13 149.0 33.89 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.992 2.517 . . . . 1.69 104.859 174.637 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.2 p -74.36 163.83 27.33 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.516 2.413 . . . . 1.33 117.516 169.907 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.416 HG22 ' HE3' ' A' ' 27' ' ' LYS . 18.2 mm -66.26 -36.22 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 121.673 2.033 . . . . 1.32 110.264 171.027 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -52.27 -43.55 64.47 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.391 -2.693 . . . . 1.62 116.709 171.839 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -57.44 -46.49 83.54 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.323 -2.11 . . . . 2.13 113.006 171.765 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.63 -39.23 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 120.408 1.458 . . . . 1.23 113.18 177.106 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HE3' HG22 ' A' ' 23' ' ' ILE . 97.4 mttt -64.03 -33.0 74.75 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.113 1.153 . . . . 1.97 114.113 173.295 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.25 -27.8 66.66 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.476 1.11 . . . . 1.19 112.548 175.001 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -81.61 -26.34 34.95 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.699 -2.5 . . . . 1.92 109.221 176.913 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.4 mt -75.02 -30.44 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 122.213 2.278 . . . . 1.94 109.485 174.918 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -57.13 -48.81 77.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 130.17 3.388 . . . . 1.9 108.74 169.44 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.29 4.4 t70 -52.29 -58.63 6.05 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.015 1.726 . . . . 1.55 111.478 171.227 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -75.93 -62.47 1.58 Allowed 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 116.02 -4.175 . . . . 2.95 113.296 -172.553 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -96.37 -20.27 18.59 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 116.513 2.042 . . . . 1.48 116.513 -170.221 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.68 20.73 21.07 Favored Glycine 0 N--CA 1.429 -1.803 0 CA-C-O 125.24 2.578 . . . . 1.12 114.736 169.91 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.95 127.46 36.96 Favored Pre-proline 0 N--CA 1.43 -1.445 1 O-C-N 115.801 -4.353 . . . . 2.07 107.707 -174.385 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -64.61 147.76 90.21 Favored 'Trans proline' 0 C--N 1.3 -2.016 1 CA-C-N 129.276 4.349 . . . . 1.39 115.017 -178.966 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -62.07 -12.43 26.38 Favored 'Trans proline' 0 N--CA 1.433 -2.049 0 C-N-CA 124.386 3.391 . . . . 1.68 111.672 -178.778 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -73.68 -30.4 62.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 124.629 3.377 . . . . 2.25 115.253 172.382 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -78.66 -32.49 47.2 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 119.181 -2.2 . . . . 2.44 115.498 -176.47 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -71.2 124.52 24.68 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 124.499 1.124 . . . . 1.32 111.326 -172.129 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -120.93 109.78 15.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 114.785 -1.098 . . . . 3.19 109.82 167.537 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.8 mt -90.3 124.43 34.89 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 106.224 -1.769 . . . . 1.75 106.224 -175.997 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 9.0 mm -102.6 121.1 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 129.685 3.194 . . . . 1.98 113.582 172.107 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -136.49 136.13 39.16 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.902 -1.749 . . . . 1.94 108.773 171.756 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.12 27.01 7.12 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 120.101 3.371 . . . . 1.67 120.101 -178.963 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.73 5.53 84.0 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 119.025 -1.56 . . . . 1.3 116.713 -175.05 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -114.48 143.03 45.6 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.246 1.819 . . . . 2.89 113.818 -178.609 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -97.45 116.18 29.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.674 -1.232 . . . . 2.89 107.674 176.898 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.49 120.91 25.1 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.679 -2.513 . . . . 1.34 108.498 -164.491 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -66.69 157.61 32.2 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 113.849 1.055 . . . . 1.94 113.849 173.659 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -69.72 -55.53 9.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 114.398 1.258 . . . . 1.56 114.398 -176.305 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.27 46.8 2.81 Favored Glycine 0 N--CA 1.43 -1.766 0 CA-C-N 120.202 1.365 . . . . 0.97 115.075 173.538 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -112.88 156.39 23.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 119.913 -1.934 . . . . 3.07 108.212 162.778 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.2 p -99.13 168.78 9.85 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 115.428 -4.545 . . . . 1.34 113.185 169.32 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 6.6 mt -63.81 -37.58 87.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 125.273 1.608 . . . . 1.63 112.367 173.291 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.6 t -71.89 -36.43 70.04 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 122.229 1.014 . . . . 1.51 113.355 -179.943 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -54.6 -36.73 64.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.5 3.519 . . . . 1.9 120.5 168.284 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -92.02 9.52 32.91 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.087 -1.449 . . . . 0.97 107.087 -179.964 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 46.42 44.03 12.49 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 117.068 2.247 . . . . 2.35 117.068 -169.65 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.4 mt -86.4 121.04 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 106.5 -1.667 . . . . 1.39 106.5 175.988 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -104.71 179.31 4.31 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 123.296 1.522 . . . . 2.58 107.67 179.632 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -48.84 155.01 0.63 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 117.584 2.439 . . . . 2.58 117.584 173.064 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.305 20.0 mt-10 62.46 25.47 15.18 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 119.068 2.988 . . . . 1.71 119.068 172.075 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -93.25 145.64 24.29 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.721 1.608 . . . . 1.34 113.213 -173.178 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.253 3.2 m -94.02 104.29 16.34 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.3 -4.0 . . . . 1.36 113.666 176.229 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -89.25 142.69 27.43 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 124.394 1.059 . . . . 2.03 109.638 172.645 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.405 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 51.9 m80 -105.05 119.66 39.58 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 116.448 -3.908 . . . . 2.31 108.607 -178.89 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.7 tp -91.54 129.86 37.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.951 -3.593 . . . . 1.72 106.374 177.359 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.14 148.45 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 128.125 2.57 . . . . 1.8 106.376 174.297 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 71.2 mt . . . . . 0 N--CA 1.43 -1.449 1 O-C-N 115.913 -4.242 . . . . 3.26 110.442 175.651 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ptt? . . . . . 0 CA--C 1.49 -1.338 0 N-CA-C 109.758 -0.46 . . . . 1.39 109.758 . . . . . . . . . 0 0 . 1 . 111 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -99.43 126.55 45.36 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.49 2.716 . . . . 2.2 111.005 -177.007 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.4 pt -116.85 142.19 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 118.386 -2.696 . . . . 1.32 106.245 168.648 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -100.3 106.33 17.96 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.444 2.698 . . . . 2.2 109.205 -178.16 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.0 t -101.66 112.14 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 O-C-N 117.403 -3.311 . . . . 1.23 106.986 173.354 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.5 mttm -89.98 146.93 24.01 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.89 -3.006 . . . . 2.51 113.375 177.964 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.2 p -98.69 172.05 7.72 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.472 3.034 . . . . 1.41 108.097 172.651 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.6 mt -73.39 -26.47 61.0 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.666 -2.061 . . . . 2.95 113.67 166.181 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.9 p -71.94 -69.95 0.36 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.069 2.248 . . . . 2.52 117.069 -175.67 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.02 12.67 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.809 0 CA-C-O 115.619 -2.767 . . . . 1.5 111.859 176.738 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.429 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 74.7 tttt -108.09 126.91 53.3 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 120.461 2.131 . . . . 1.79 113.225 -177.423 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.2 m -103.78 103.44 13.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.927 -2.249 . . . . 1.38 104.927 173.219 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -82.85 113.93 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 O-C-N 117.129 -3.482 . . . . 2.03 110.912 177.446 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.5 m -79.76 116.25 19.82 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.902 -2.374 . . . . 1.61 105.545 172.647 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.5 mt -114.2 134.43 54.92 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.169 -1.419 . . . . 2.15 107.169 176.185 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -86.75 106.99 18.05 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.174 2.99 . . . . 1.98 114.07 167.719 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.74 165.42 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 112.981 -1.918 . . . . 1.52 109.571 -177.552 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -109.53 155.18 41.73 Favored Pre-proline 0 N--CA 1.429 -1.485 0 N-CA-C 109.38 -0.6 . . . . 2.35 109.38 162.421 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -73.56 -11.87 24.5 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 O-C-N 117.134 -2.087 . . . . 1.31 111.326 -173.01 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.6 p -89.13 0.21 56.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.943 2.897 . . . . 1.71 113.475 178.353 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -76.22 150.12 37.12 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 126.121 2.867 . . . . 1.69 114.456 170.361 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.3 p -85.11 153.12 22.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.232 -2.167 . . . . 1.33 112.567 176.081 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.2 mm -65.45 -36.15 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 120.512 1.506 . . . . 1.32 114.071 -178.954 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -58.28 -39.98 80.69 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.069 -2.269 . . . . 1.62 116.923 173.669 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.323 70.1 m-80 -66.03 -26.04 67.33 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 116.1 1.889 . . . . 2.13 116.1 170.524 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -72.04 -33.3 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-N 120.135 1.334 . . . . 1.23 111.854 170.838 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -83.14 -20.34 34.95 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.381 -2.699 . . . . 1.97 111.175 177.842 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.67 67.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 121.197 1.817 . . . . 1.19 114.012 171.476 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -72.32 -48.86 38.83 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 125.452 1.72 . . . . 1.92 111.261 175.277 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.5 mt -60.79 -33.25 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 125.695 1.598 . . . . 1.94 111.258 176.284 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -64.66 -60.04 3.58 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.644 1.212 . . . . 1.9 110.659 177.624 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -42.43 -56.67 2.93 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 115.368 1.618 . . . . 1.55 115.368 174.698 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -67.69 -59.91 2.95 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 113.977 1.103 . . . . 2.95 113.977 177.359 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.429 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 13.1 mm-40 -92.37 -58.52 2.35 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.354 -1.466 . . . . 1.48 111.66 -166.414 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.16 16.69 0.64 Allowed Glycine 0 N--CA 1.43 -1.746 0 O-C-N 119.814 -1.804 . . . . 1.12 115.579 175.049 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -96.59 133.76 24.21 Favored Pre-proline 0 N--CA 1.43 -1.464 0 C-N-CA 119.291 -0.964 . . . . 2.07 110.903 -175.31 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.39 149.16 91.9 Favored 'Trans proline' 0 N--CA 1.435 -1.965 0 CA-C-N 125.036 2.834 . . . . 1.39 112.933 176.004 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -80.08 -11.25 13.62 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-O 115.702 -1.874 . . . . 1.68 108.9 -168.653 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -77.99 -24.49 48.0 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.871 2.123 . . . . 2.25 114.999 166.914 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -84.35 -34.28 23.68 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 124.244 1.973 . . . . 2.44 109.952 -177.773 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -72.38 100.06 2.58 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.437 -3.29 . . . . 1.32 112.069 179.797 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -86.65 135.37 33.43 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 121.558 1.981 . . . . 3.19 108.05 166.393 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.274 80.0 mt -104.17 125.82 50.78 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.631 3.586 . . . . 1.75 108.226 175.572 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.492 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 29.8 mm -103.13 140.93 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 118.976 -2.327 . . . . 1.98 110.358 171.699 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -130.14 107.98 9.72 Favored 'General case' 0 N--CA 1.429 -1.479 1 N-CA-C 98.835 -4.505 . . . . 1.94 98.835 170.506 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.07 -84.89 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.246 1.818 . . . . 1.67 115.14 179.87 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.01 13.25 0.74 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 130.473 3.892 . . . . 1.3 111.338 -175.583 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -109.6 151.36 26.93 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 121.189 2.495 . . . . 2.89 104.439 168.268 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -94.42 132.81 38.67 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 130.031 3.332 . . . . 2.89 102.726 171.071 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.9 mt -91.38 133.2 35.65 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.481 -2.012 . . . . 1.34 107.011 -170.387 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.402 ' HB2' ' HG2' ' A' ' 54' ' ' ARG . 31.1 mt-10 -71.88 151.73 43.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.19 -3.443 . . . . 1.94 108.605 171.572 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.25 -40.81 36.06 Favored 'General case' 0 N--CA 1.429 -1.523 0 O-C-N 116.865 -3.647 . . . . 1.56 110.137 -168.81 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.04 45.45 3.42 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 118.193 -2.817 . . . . 0.97 117.149 172.265 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.402 ' HG2' ' HB2' ' A' ' 51' ' ' GLU . 37.7 mmt180 -116.25 167.5 10.96 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 118.417 -0.802 . . . . 3.07 109.778 163.007 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.6 p -96.9 175.84 6.19 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 127.398 3.475 . . . . 1.34 108.286 167.941 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.8 mt -72.45 -43.75 63.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.742 -3.099 . . . . 1.63 108.607 176.514 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.2 p -72.9 1.41 8.77 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 119.969 3.322 . . . . 1.51 119.969 179.301 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -82.45 -40.59 20.95 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.47 -2.644 . . . . 1.9 112.27 169.593 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -77.87 -7.3 56.51 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.072 2.549 . . . . 0.97 110.621 172.161 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.312 42.8 m-80 68.46 33.32 4.11 Favored 'General case' 0 N--CA 1.428 -1.539 0 O-C-N 116.669 -3.769 . . . . 2.35 115.829 -177.273 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.6 mt -81.31 125.29 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 CA-C-N 114.011 -1.45 . . . . 1.39 111.657 -179.573 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -108.1 -164.11 0.94 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 121.28 3.808 . . . . 2.58 121.28 -176.535 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -74.4 146.63 42.78 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 120.438 -1.414 . . . . 2.58 112.853 171.946 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.261 43.4 mt-10 68.59 18.17 8.89 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 126.901 2.08 . . . . 1.71 115.436 178.182 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -77.04 124.66 28.12 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.413 2.685 . . . . 1.34 113.482 -174.749 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.29 3.8 m -80.97 105.16 11.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 127.418 2.287 . . . . 1.36 115.143 175.845 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -103.52 166.76 10.23 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 125.58 2.61 . . . . 2.03 106.044 175.249 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.492 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 73.6 m80 -128.72 133.1 48.05 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.829 -4.295 . . . . 2.31 110.108 -172.12 . . . . . . . . 3 3 . 1 . 111 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.6 tp -99.29 129.72 45.53 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.217 -0.927 . . . . 1.72 112.551 -176.368 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -131.05 123.4 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 122.074 2.216 . . . . 1.8 112.26 175.743 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.7 mt . . . . . 0 N--CA 1.43 -1.462 0 N-CA-C 117.65 2.463 . . . . 3.26 117.65 -178.397 . . . . . . . . 0 0 . 1 . 112 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.414 ' HE1' ' HB3' ' A' ' 19' ' ' PRO . 7.0 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 113.311 0.856 . . . . 1.39 113.311 . . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -91.7 142.7 27.33 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.826 -1.916 . . . . 2.2 105.826 -178.046 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.0 pt -132.01 176.69 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 105.166 -2.161 . . . . 1.32 105.166 167.701 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -127.13 130.14 49.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.402 1.573 . . . . 2.2 109.079 176.299 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -109.49 110.09 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 126.231 2.919 . . . . 1.23 104.481 175.158 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 12' ' ' THR 0.27 23.7 ttmm -103.98 142.55 34.24 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 114.843 -4.911 . . . . 2.51 109.656 -178.422 . . . . . . . . 4 3 . 1 . 112 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.7 p -91.76 142.52 27.5 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 114.284 -2.77 . . . . 1.41 111.885 179.668 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.3 tp -59.97 -37.78 80.61 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.605 2.362 . . . . 2.95 109.532 165.711 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.9 -27.01 57.51 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 122.754 2.525 . . . . 2.52 110.192 -178.357 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.07 -77.38 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.739 1 N-CA-C 123.187 4.035 . . . . 1.5 123.187 176.297 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -72.59 157.51 37.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 129.266 3.568 . . . . 1.79 117.881 -174.694 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 3.3 m -105.11 133.88 49.15 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.944 2.497 . . . . 1.38 107.713 162.499 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 pt -113.18 143.88 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 101.584 -3.487 . . . . 2.03 101.584 176.319 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.3 m -99.85 128.65 45.93 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 114.753 -4.967 . . . . 1.61 104.159 174.397 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.7 mt -114.87 148.86 38.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.145 -3.472 . . . . 2.15 102.892 178.542 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -109.44 122.07 46.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.635 -1.987 . . . . 1.98 105.635 171.164 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.79 175.16 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-O 121.862 0.839 . . . . 1.52 111.136 -176.984 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.268 81.3 mt-10 -112.77 167.04 9.8 Favored Pre-proline 0 N--CA 1.431 -1.403 0 O-C-N 117.614 -3.178 . . . . 2.35 110.268 168.222 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.414 ' HB3' ' HE1' ' A' ' 1' ' ' MET . 59.4 Cg_endo -88.43 -8.75 5.27 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 CA-C-N 124.692 2.711 . . . . 1.31 110.513 -169.739 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 p -81.63 1.16 35.26 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 128.146 2.578 . . . . 1.71 115.897 172.958 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -77.52 137.74 38.79 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.058 -0.974 . . . . 1.69 108.507 175.25 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.3 p -79.29 156.36 28.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 128.198 2.599 . . . . 1.33 108.873 172.69 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.352 8.0 mm -61.64 -45.44 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 128.062 2.545 . . . . 1.32 114.764 -177.856 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.299 31.8 tt0 -48.83 -39.55 25.99 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 116.313 1.968 . . . . 1.62 116.313 167.292 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -73.55 -28.26 61.77 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 124.326 1.05 . . . . 2.13 111.575 179.793 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.2 t -69.06 -46.42 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 125.502 1.521 . . . . 1.23 109.262 171.297 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -62.21 -16.07 50.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 117.984 2.587 . . . . 1.97 117.984 176.878 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.82 -35.63 38.06 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 127.582 2.353 . . . . 1.19 109.574 171.465 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -70.02 -33.4 71.95 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.413 -1.429 . . . . 1.92 110.28 172.653 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.25 42.4 mt -63.63 -37.3 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 116.465 -3.897 . . . . 1.94 115.541 168.903 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.416 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 50.2 tt0 -69.62 -31.59 69.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 117.315 -1.326 . . . . 1.9 114.444 170.806 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.52 -45.48 65.47 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.393 1.451 . . . . 1.55 109.551 172.241 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -78.02 -64.78 1.08 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.049 -2.282 . . . . 2.95 114.41 -171.007 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.287 21.7 mm-40 -93.54 -45.78 7.59 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.716 1.246 . . . . 1.48 109.851 -172.745 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.88 64.15 0.34 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 106.067 -2.813 . . . . 1.12 106.067 167.069 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.416 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 8.8 mt -120.37 127.9 26.08 Favored Pre-proline 0 N--CA 1.43 -1.433 0 O-C-N 126.837 2.14 . . . . 2.07 111.448 -177.977 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -63.0 129.64 26.53 Favored 'Trans proline' 0 C--N 1.3 -2.023 1 CA-C-O 110.002 -4.249 . . . . 1.39 121.654 179.797 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -33.16 87.19 Favored 'Trans proline' 0 N--CA 1.434 -2.006 1 CA-C-N 129.243 4.337 . . . . 1.68 121.947 -175.142 . . . . . . . . 3 3 . 1 . 112 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -60.77 -37.81 83.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 125.243 3.656 . . . . 2.25 114.21 174.099 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -71.62 -28.05 63.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.107 -1.442 . . . . 2.44 107.107 -172.862 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -79.96 119.48 22.86 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.401 1.91 . . . . 1.32 115.382 -170.092 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.496 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 92.6 mtt180 -103.81 112.14 24.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 114.171 1.174 . . . . 3.19 114.171 166.821 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.6 mt -94.5 119.14 32.74 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.635 -3.166 . . . . 1.75 110.863 177.165 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.21 130.91 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 122.074 2.216 . . . . 1.98 108.152 174.484 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -118.3 114.94 23.72 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 102.953 -2.98 . . . . 1.94 102.953 171.445 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.383 . . 77.62 -63.9 0.32 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 125.961 2.791 . . . . 1.67 116.296 179.409 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.3 -60.66 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 127.213 2.339 . . . . 1.3 117.263 -172.55 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -68.26 125.41 26.31 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.971 2.908 . . . . 2.89 111.687 172.964 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -71.88 143.17 49.47 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 112.82 -1.991 . . . . 2.89 109.728 173.882 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.2 mt -80.05 128.57 33.65 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.875 1.67 . . . . 1.34 110.79 -178.04 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -86.07 148.31 25.77 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.445 -0.785 . . . . 1.94 109.107 176.002 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -59.41 -47.68 84.54 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 127.481 3.515 . . . . 1.56 117.16 -171.431 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.18 39.47 2.88 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 117.717 -3.114 . . . . 0.97 120.34 170.39 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.353 14.5 mmt180 -116.47 173.39 6.64 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 119.395 -0.922 . . . . 3.07 109.86 163.541 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.5 p -96.84 165.96 11.86 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 115.587 1.699 . . . . 1.34 115.587 168.754 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.0 mt -67.78 -32.55 73.2 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 123.04 1.4 . . . . 1.63 111.901 171.2 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.3 p -67.21 -16.19 64.15 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.256 -2.777 . . . . 1.51 112.895 174.909 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -69.81 -41.25 75.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 122.014 2.188 . . . . 1.9 115.236 177.467 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -90.35 -9.62 47.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.762 2.425 . . . . 0.97 109.724 -179.497 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.287 41.8 m-80 58.76 50.47 8.7 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 117.441 2.386 . . . . 2.35 117.441 -176.461 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.494 HG23 HD13 ' A' ' 67' ' ' LEU . 71.9 mt -86.42 118.2 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 126.409 3.004 . . . . 1.39 113.145 170.085 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -98.92 -178.16 3.86 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.638 -2.539 . . . . 2.58 111.277 -179.011 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -54.32 144.4 20.6 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.584 -2.573 . . . . 2.58 117.385 173.596 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.314 22.5 mt-10 66.66 27.39 9.44 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.737 -2.477 . . . . 1.71 117.068 174.825 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -101.09 153.46 19.55 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.232 -1.349 . . . . 1.34 108.877 -174.52 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.6 m -111.17 117.17 32.5 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.681 -3.137 . . . . 1.36 106.605 -175.125 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.494 HD13 HG23 ' A' ' 61' ' ' ILE . 7.7 mp -100.73 135.6 41.91 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.225 2.21 . . . . 2.03 106.047 176.798 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -99.57 117.44 33.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.403 -2.061 . . . . 2.31 110.178 -176.707 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.8 tp -86.96 119.44 27.17 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.465 3.506 . . . . 1.72 111.4 176.952 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 44.7 t -107.63 151.33 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 115.208 -2.33 . . . . 1.8 106.623 174.718 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 N--CA 1.43 -1.45 0 C-N-CA 115.26 -2.576 . . . . 3.26 107.465 179.667 . . . . . . . . 0 0 . 1 . 113 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 ttp . . . . . 0 CA--C 1.491 -1.318 0 CA-C-O 115.598 -2.144 . . . . 1.39 110.758 . . . . . . . . . 0 0 . 1 . 113 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.485 HE21 HG21 ' A' ' 14' ' ' THR . 29.0 mt-30 -90.9 132.36 35.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.766 2.53 . . . . 2.2 112.547 -178.36 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.1 pt -111.68 149.18 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 122.077 2.217 . . . . 1.32 110.543 172.282 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -108.95 115.52 30.24 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.919 -1.882 . . . . 2.2 105.919 178.694 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.5 t -100.34 120.0 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 115.179 -2.343 . . . . 1.23 105.017 175.885 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.251 89.1 mttt -101.79 130.59 48.26 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 116.893 -1.527 . . . . 2.51 106.892 176.489 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.2 p -82.57 170.62 14.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 120.418 1.463 . . . . 1.41 111.621 176.039 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.2 tp -79.62 -28.02 40.97 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 125.712 2.673 . . . . 2.95 111.535 170.277 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.296 38.9 p -75.5 -50.1 16.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.339 -3.35 . . . . 2.52 113.38 -177.195 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.15 32.2 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 122.75 3.86 . . . . 1.5 122.75 167.182 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -135.71 147.45 48.49 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 121.405 2.603 . . . . 1.79 112.043 -175.059 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.8 m -97.09 122.8 40.5 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.882 -1.508 . . . . 1.38 107.956 173.265 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.9 mt -117.28 115.93 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 103.939 -2.615 . . . . 2.03 103.939 -175.155 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.485 HG21 HE21 ' A' ' 2' ' ' GLN . 47.4 m -94.72 104.6 16.52 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.961 1.362 . . . . 1.61 114.226 179.52 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.6 mt -97.27 140.43 31.75 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 119.113 -2.242 . . . . 2.15 111.116 -176.425 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -91.3 115.43 28.02 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 115.538 -4.476 . . . . 1.98 113.236 165.118 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -133.3 152.61 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 126.773 2.546 . . . . 1.52 107.762 -179.189 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -90.71 153.67 45.62 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 115.859 -2.02 . . . . 2.35 110.843 163.452 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -84.07 0.91 9.07 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 CA-C-N 126.07 3.204 . . . . 1.31 116.473 -171.749 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.8 p -85.94 -14.79 43.66 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.614 3.166 . . . . 1.71 111.051 174.612 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.284 18.7 m-20 -82.34 156.02 24.46 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.102 2.161 . . . . 1.69 112.359 177.823 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 60.0 p -78.07 171.15 15.45 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 127.284 3.421 . . . . 1.33 116.759 175.35 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.468 HD13 ' HG ' ' A' ' 56' ' ' LEU . 14.4 mm -74.76 -27.75 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 1 O-C-N 114.968 -4.833 . . . . 1.32 111.524 174.415 . . . . . . . . 3 3 . 1 . 113 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -54.43 -41.34 69.25 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 125.652 1.581 . . . . 1.62 108.964 165.536 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.263 18.1 t-20 -60.71 -44.3 96.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 124.483 2.087 . . . . 2.13 113.423 175.539 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.08 -50.13 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 113.143 -1.844 . . . . 1.23 111.53 174.194 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.471 ' HZ2' ' CG ' ' A' ' 52' ' ' ASP . 94.0 mttt -64.64 -41.57 96.05 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.332 2.345 . . . . 1.97 117.332 174.588 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.99 -45.15 41.84 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.158 2.183 . . . . 1.19 115.431 168.375 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -62.72 -39.61 94.61 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 116.182 1.919 . . . . 1.92 116.182 170.652 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.257 21.2 mt -63.51 -25.82 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 C-N-CA 125.296 1.438 . . . . 1.94 112.57 173.155 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -77.61 -35.55 52.64 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.561 -0.745 . . . . 1.9 112.58 174.307 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.36 -44.14 95.85 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.139 1.447 . . . . 1.55 113.378 167.975 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -73.29 -66.65 0.66 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 119.783 3.253 . . . . 2.95 119.783 -176.821 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -95.14 -48.6 5.87 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 128.377 2.671 . . . . 1.48 110.348 -174.725 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.91 -10.82 6.64 Favored Glycine 0 N--CA 1.43 -1.757 0 O-C-N 127.049 2.718 . . . . 1.12 117.104 173.362 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mm -71.68 132.19 85.48 Favored Pre-proline 0 N--CA 1.43 -1.428 0 O-C-N 119.367 -2.255 . . . . 2.07 109.178 -173.271 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.36 151.61 76.04 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 O-C-N 117.343 -1.978 . . . . 1.39 115.117 178.802 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.79 -25.49 74.74 Favored 'Trans proline' 0 N--CA 1.433 -2.035 1 C-N-CA 126.68 4.92 . . . . 1.68 112.703 -173.525 . . . . . . . . 3 3 . 1 . 113 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.85 -42.54 98.01 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 129.446 3.098 . . . . 2.25 108.38 -179.296 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -78.97 -22.72 45.21 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 117.469 2.396 . . . . 2.44 117.469 -177.998 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -85.89 129.0 34.96 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.205 1.479 . . . . 1.32 110.221 -169.567 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -116.29 117.33 29.71 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 125.156 2.407 . . . . 3.19 110.103 173.289 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.6 mt -96.27 128.16 42.93 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 114.336 -5.227 . . . . 1.75 105.936 179.098 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.3 mm -107.26 141.36 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 103.095 -2.928 . . . . 1.98 103.095 178.649 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.296 26.1 t80 -140.58 109.46 6.04 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.53 1.932 . . . . 1.94 108.137 176.894 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.371 . . 64.8 -75.46 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.51 2.324 . . . . 1.67 112.079 -172.101 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -137.44 -34.97 0.19 Allowed Glycine 0 N--CA 1.429 -1.824 0 O-C-N 123.999 0.812 . . . . 1.3 114.686 178.847 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -89.44 150.78 22.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.221 1.934 . . . . 2.89 116.221 -176.077 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -84.71 127.34 34.05 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 111.903 -2.408 . . . . 2.89 112.183 174.552 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.1 mt -81.91 148.44 28.75 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 121.057 1.753 . . . . 1.34 112.492 -168.548 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -98.27 148.67 23.39 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 118.605 -1.238 . . . . 1.94 113.697 179.765 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.471 ' CG ' ' HZ2' ' A' ' 27' ' ' LYS . 4.6 m-20 -60.69 -66.62 0.5 Allowed 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 116.197 -4.064 . . . . 1.56 117.288 -170.962 . . . . . . . . 3 3 . 1 . 113 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.27 32.25 0.32 Allowed Glycine 0 N--CA 1.432 -1.632 0 N-CA-C 122.607 3.803 . . . . 0.97 122.607 172.977 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -115.24 161.97 17.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.469 -2.049 . . . . 3.07 105.469 166.026 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 26.7 p -81.23 158.65 24.77 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.707 -1.871 . . . . 1.34 113.767 175.279 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.468 ' HG ' HD13 ' A' ' 23' ' ' ILE . 5.1 mt -65.78 -24.8 67.01 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.277 2.231 . . . . 1.63 114.591 175.757 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.4 p -83.46 -11.28 57.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.9 2.48 . . . . 1.51 111.467 178.667 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -61.85 -55.83 25.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.483 3.113 . . . . 1.9 108.089 167.26 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -76.81 -13.59 60.0 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 130.13 4.643 . . . . 0.97 113.713 -176.236 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 57.23 64.67 1.55 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 116.678 2.103 . . . . 2.35 116.678 -176.059 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.8 mm -78.54 104.53 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 105.549 -2.019 . . . . 1.39 105.549 174.892 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -73.32 169.94 16.07 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.056 1.342 . . . . 2.58 112.64 175.418 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -55.66 136.3 50.68 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.188 -3.445 . . . . 2.58 112.822 163.115 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 70.3 38.83 1.35 Allowed 'General case' 0 N--CA 1.429 -1.49 1 C-N-CA 135.946 5.698 . . . . 1.71 112.686 175.65 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.6 m -90.73 142.26 27.94 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 116.657 2.095 . . . . 1.34 116.657 -172.595 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.7 m -100.25 116.61 32.65 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 126.169 2.168 . . . . 1.36 107.224 -178.399 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -100.62 152.67 20.16 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.352 1.549 . . . . 2.03 111.362 168.875 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -120.93 130.53 53.9 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.086 -2.259 . . . . 2.31 107.511 -174.218 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 tp -112.14 118.2 34.7 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 116.574 2.064 . . . . 1.72 116.574 177.924 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.6 m -112.77 172.08 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 103.325 -2.843 . . . . 1.8 103.325 173.1 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.255 10.8 mt . . . . . 0 N--CA 1.43 -1.464 0 CA-C-N 113.857 -1.52 . . . . 3.26 112.428 178.111 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 ptt? . . . . . 0 CA--C 1.489 -1.372 0 CA-C-O 116.273 -1.822 . . . . 1.39 111.64 . . . . . . . . . 0 0 . 1 . 114 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -99.6 138.85 36.11 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 125.214 1.571 . . . . 2.2 109.824 -173.49 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.5 pt -123.28 160.81 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 128.37 3.938 . . . . 1.32 108.281 173.641 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -119.07 133.22 55.93 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 115.195 -4.69 . . . . 2.2 106.61 -176.556 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.97 119.48 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 106.204 -1.776 . . . . 1.23 106.204 175.973 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -106.34 133.94 50.25 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 115.79 -4.318 . . . . 2.51 111.354 178.568 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.1 p -89.19 178.99 6.22 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.452 -2.03 . . . . 1.41 115.599 -174.144 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.451 HD11 ' H ' ' A' ' 71' ' ' LEU . 5.8 mt -78.11 -22.42 48.94 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 121.727 2.058 . . . . 2.95 109.985 173.379 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.3 p -80.54 -36.27 33.3 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.357 -2.714 . . . . 2.52 109.666 -178.921 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.67 53.82 0.66 Allowed Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 130.088 3.709 . . . . 1.5 119.824 175.957 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.415 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 68.2 tttt -122.74 137.24 54.98 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.102 3.361 . . . . 1.79 105.005 -176.696 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.8 m -105.68 121.54 44.21 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-O 124.42 2.057 . . . . 1.38 108.46 179.823 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.5 mt -99.32 140.5 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.357 -2.714 . . . . 2.03 107.882 174.852 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.8 m -106.75 98.61 8.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.096 -2.252 . . . . 1.61 110.835 -178.606 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.7 mt -95.18 140.84 29.53 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 121.521 1.964 . . . . 2.15 112.933 179.942 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -97.29 134.41 40.62 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.989 -2.319 . . . . 1.98 109.16 169.772 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 m -138.87 156.66 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 127.042 2.137 . . . . 1.52 107.063 -174.141 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -106.37 160.75 25.11 Favored Pre-proline 0 N--CA 1.43 -1.446 0 O-C-N 118.197 -2.815 . . . . 2.35 107.317 162.671 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -71.25 -7.85 22.19 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 CA-C-N 124.394 2.605 . . . . 1.31 112.235 -172.136 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.3 p -93.89 -14.37 26.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.037 2.135 . . . . 1.71 111.894 -174.141 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -65.39 149.29 50.26 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 130.16 3.384 . . . . 1.69 105.635 174.246 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.428 HG21 HG21 ' A' ' 55' ' ' THR . 68.6 p -96.44 170.93 8.89 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 117.235 -1.364 . . . . 1.33 111.097 178.568 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.7 mm -62.16 -32.6 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.413 0 C-N-CA 126.658 1.983 . . . . 1.32 111.366 170.508 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.295 35.5 tt0 -54.15 -51.35 64.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.581 3.552 . . . . 1.62 108.86 169.453 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -57.22 -37.69 72.63 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.557 -2.59 . . . . 2.13 114.918 174.354 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.3 t -62.79 -44.82 99.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 114.803 1.408 . . . . 1.23 114.803 175.091 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -65.86 -30.2 70.78 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 129.539 3.136 . . . . 1.97 113.465 173.451 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.19 83.18 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.864 -3.648 . . . . 1.19 111.101 179.738 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -61.96 -42.37 99.04 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.529 -3.232 . . . . 1.92 115.203 174.0 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.1 mt -72.95 -23.75 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 123.439 1.59 . . . . 1.94 110.513 175.995 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -70.12 -35.01 73.8 Favored 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 114.517 -5.114 . . . . 1.9 112.623 169.559 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.69 -48.7 78.16 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.783 2.706 . . . . 1.55 112.558 175.412 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -82.55 -63.04 1.45 Allowed 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 114.406 -5.184 . . . . 2.95 114.88 -178.975 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.415 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 43.3 mm-40 -85.49 -15.4 42.95 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.948 -3.595 . . . . 1.48 116.918 -168.658 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.37 31.45 54.61 Favored Glycine 0 N--CA 1.429 -1.776 0 O-C-N 119.725 -1.859 . . . . 1.12 114.617 176.543 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mt -101.25 135.43 19.89 Favored Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 108.452 -0.944 . . . . 2.07 108.452 -173.702 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -68.1 151.26 77.44 Favored 'Trans proline' 0 N--CA 1.433 -2.03 0 CA-C-N 123.884 2.423 . . . . 1.39 111.608 179.901 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -73.17 -20.63 21.27 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-N 126.515 3.362 . . . . 1.68 111.242 -173.478 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -65.7 -29.99 70.61 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 126.191 2.9 . . . . 2.25 112.805 174.463 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -81.74 -25.7 35.15 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 114.667 -5.021 . . . . 2.44 107.944 -177.566 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -82.92 119.3 24.24 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.839 -2.413 . . . . 1.32 110.991 -169.775 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.358 80.2 mtp180 -108.18 124.98 51.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.519 -1.219 . . . . 3.19 110.229 163.942 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -107.2 116.73 32.44 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.431 2.539 . . . . 1.75 104.554 -177.771 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.3 mt -111.44 137.28 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 O-C-N 119.939 -1.726 . . . . 1.98 112.982 176.552 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -148.98 132.67 16.87 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 124.15 0.98 . . . . 1.94 111.089 174.249 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.354 . . 49.38 25.03 1.18 Allowed 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 120.256 3.428 . . . . 1.67 120.256 171.199 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.11 7.55 26.73 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 121.477 -0.765 . . . . 1.3 114.591 -177.881 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -149.0 153.53 38.06 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.442 -2.799 . . . . 2.89 110.632 -176.813 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -96.64 128.34 43.48 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 113.912 -1.495 . . . . 2.89 111.662 171.224 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.2 mt -81.49 121.21 25.99 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.648 2.468 . . . . 1.34 115.691 -174.593 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -73.72 137.32 43.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.094 2.627 . . . . 1.94 118.094 177.098 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -40.27 -64.49 0.5 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 131.431 3.892 . . . . 1.56 117.397 -171.319 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.31 16.64 12.5 Favored Glycine 0 N--CA 1.429 -1.798 1 CA-C-O 112.011 -4.772 . . . . 0.97 118.745 175.275 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.0 mtt180 -95.46 161.56 14.02 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 121.155 2.478 . . . . 3.07 110.163 171.632 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.428 HG21 HG21 ' A' ' 22' ' ' THR . 19.3 p -97.56 170.63 8.9 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 117.179 -1.809 . . . . 1.34 114.596 172.94 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.85 -39.79 82.36 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.274 -2.239 . . . . 1.63 111.828 176.506 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.3 t -61.75 -44.24 97.29 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 130.118 3.367 . . . . 1.51 113.56 175.067 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -59.57 -24.83 64.08 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 115.224 1.565 . . . . 1.9 115.224 174.201 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -106.36 9.45 31.85 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.069 -2.895 . . . . 0.97 112.601 175.08 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.6 m120 44.68 62.77 1.93 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 128.163 2.585 . . . . 2.35 114.155 -177.579 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.7 mt -108.35 127.55 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 129.398 3.079 . . . . 1.39 107.183 176.511 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -106.71 -174.11 2.46 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.541 2.336 . . . . 2.58 110.979 -172.978 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.2 ptmm? -61.2 148.16 41.81 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 114.73 1.382 . . . . 2.58 114.73 174.811 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 62.75 37.89 12.21 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 126.51 3.053 . . . . 1.71 112.921 169.957 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.7 m -84.03 133.06 34.68 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.924 2.297 . . . . 1.34 110.665 178.079 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.7 m -93.39 104.82 16.95 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.202 -2.186 . . . . 1.36 109.3 176.344 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.6 mt -88.1 147.38 24.97 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 123.184 0.593 . . . . 2.03 110.066 174.296 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -97.68 121.52 39.69 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 116.917 -1.516 . . . . 2.31 113.815 173.622 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.9 tp -91.01 111.97 23.66 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.591 2.756 . . . . 1.72 108.491 175.942 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.7 t -112.11 141.83 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 114.579 -1.192 . . . . 1.8 109.151 172.156 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.451 ' H ' HD11 ' A' ' 8' ' ' LEU . 64.4 mt . . . . . 0 N--CA 1.429 -1.504 0 N-CA-C 119.61 3.189 . . . . 3.26 119.61 179.639 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ptt? . . . . . 0 CA--C 1.489 -1.371 0 N-CA-C 112.624 0.601 . . . . 1.39 112.624 . . . . . . . . . 0 0 . 1 . 115 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.338 0.0 OUTLIER -97.83 133.72 41.95 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.129 -1.607 . . . . 2.2 111.446 179.286 . . . . . . . . 3 3 . 1 . 115 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.3 pt -115.74 158.88 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 103.637 -2.727 . . . . 1.32 103.637 169.74 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -112.34 137.89 49.85 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.452 2.701 . . . . 2.2 107.302 178.92 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.447 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 55.9 t -118.15 123.15 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 102.226 -3.25 . . . . 1.23 102.226 174.291 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.7 tppt? -100.36 126.96 46.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 126.144 2.878 . . . . 2.51 105.33 175.687 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 p -78.3 -162.91 0.39 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 120.253 3.427 . . . . 1.41 120.253 173.463 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 mt -88.31 -34.73 17.56 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 117.294 -1.336 . . . . 2.95 112.831 173.66 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 p -68.38 -32.74 73.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 127.536 2.334 . . . . 2.52 106.999 173.266 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.67 35.29 2.26 Favored Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 127.592 2.52 . . . . 1.5 107.744 168.367 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -80.57 134.36 35.91 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.258 -2.867 . . . . 1.79 103.258 178.876 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.9 m -95.02 91.49 6.39 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.855 -1.521 . . . . 1.38 114.341 175.042 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.447 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 13.4 mt -88.38 119.13 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 123.848 1.785 . . . . 2.03 106.714 -175.449 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.1 m -90.44 126.88 36.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.062 -2.273 . . . . 1.61 110.37 -177.268 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.5 mt -128.18 134.12 49.0 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.221 -3.424 . . . . 2.15 106.246 -175.238 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -98.15 132.24 43.84 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.615 -1.624 . . . . 1.98 106.615 171.87 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 m -140.61 164.79 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 126.962 2.105 . . . . 1.52 109.621 -173.938 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -109.58 151.92 42.5 Favored Pre-proline 0 N--CA 1.43 -1.454 0 CA-C-O 114.486 -2.673 . . . . 2.35 112.651 160.373 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -70.52 -14.93 34.14 Favored 'Trans proline' 0 N--CA 1.433 -2.058 0 C-N-CA 125.09 3.86 . . . . 1.31 109.715 -165.29 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.1 m -82.93 -9.95 59.05 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 122.346 2.339 . . . . 1.71 108.974 176.919 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -66.74 142.5 57.37 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.443 3.497 . . . . 1.69 112.43 172.732 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 p -83.19 171.58 13.51 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 113.121 -5.987 . . . . 1.33 110.142 -174.632 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.1 mm -75.57 -30.55 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 122.949 1.357 . . . . 1.32 109.783 179.098 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.253 38.2 tt0 -45.34 -42.85 10.38 Favored 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 117.977 -2.952 . . . . 1.62 117.49 157.925 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -68.35 -38.52 81.55 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 125.336 1.648 . . . . 2.13 110.968 176.49 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.1 t -62.67 -35.28 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 125.156 2.408 . . . . 1.23 115.094 177.844 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -68.31 -38.42 81.58 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.163 -1.586 . . . . 1.97 115.093 166.269 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.68 -22.42 66.63 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 118.465 2.765 . . . . 1.19 118.465 169.796 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -84.45 -29.48 26.06 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.675 -1.891 . . . . 1.92 111.901 173.947 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.8 mt -70.49 -38.06 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 124.164 1.935 . . . . 1.94 114.752 170.662 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.435 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 10.8 tt0 -65.51 -42.53 91.96 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 128.208 2.603 . . . . 1.9 109.66 171.926 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -58.09 -52.48 65.35 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.348 -3.345 . . . . 1.55 113.116 172.469 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -64.09 -66.32 0.56 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.618 3.58 . . . . 2.95 111.818 -176.179 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -89.84 -44.59 9.84 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 110.654 -2.976 . . . . 1.48 112.956 -172.119 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 113.42 0.69 24.89 Favored Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 117.649 1.82 . . . . 1.12 117.649 -177.899 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 mt -68.49 121.26 80.08 Favored Pre-proline 0 N--CA 1.429 -1.488 0 O-C-N 118.77 -2.606 . . . . 2.07 107.003 -176.549 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -67.88 164.68 30.7 Favored 'Trans proline' 0 N--CA 1.434 -1.989 1 C-N-CA 125.739 4.293 . . . . 1.39 112.126 -176.459 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -67.45 -34.16 27.2 Favored 'Trans proline' 0 N--CA 1.433 -2.05 1 C-N-CA 125.758 4.305 . . . . 1.68 113.173 -175.223 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -44.17 -48.94 9.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 126.604 3.097 . . . . 2.25 114.211 173.762 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -83.98 -17.0 41.99 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.146 -2.846 . . . . 2.44 115.951 -170.93 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -85.49 134.29 34.05 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.439 1.896 . . . . 1.32 111.218 -168.875 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -121.14 114.64 21.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 130.388 3.475 . . . . 3.19 108.606 167.467 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.4 mt -88.9 116.97 27.57 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.627 -1.921 . . . . 1.75 112.578 173.866 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.6 mm -106.4 141.1 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 102.652 -3.092 . . . . 1.98 102.652 -178.431 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -132.24 97.58 4.16 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 100.378 -3.934 . . . . 1.94 100.378 174.976 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.36 . . 79.5 -86.62 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.096 2.159 . . . . 1.67 106.858 -179.309 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.57 -6.55 1.8 Allowed Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 128.668 3.032 . . . . 1.3 111.179 -178.017 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -92.87 131.1 38.2 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.403 2.681 . . . . 2.89 109.135 -177.114 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -81.66 114.59 20.44 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 112.364 -2.198 . . . . 2.89 110.776 175.234 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.8 mt -83.23 148.62 27.3 Favored 'General case' 0 N--CA 1.431 -1.407 1 O-C-N 115.198 -4.689 . . . . 1.34 112.267 -174.521 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -100.3 149.36 23.68 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.499 1.919 . . . . 1.94 113.291 172.852 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -61.67 -61.15 2.72 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 130.49 3.516 . . . . 1.56 112.222 -169.525 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.82 20.52 0.2 Allowed Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 122.285 3.674 . . . . 0.97 122.285 171.705 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -107.67 154.13 21.92 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.135 -1.803 . . . . 3.07 113.042 167.02 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.426 ' HG1' ' CG ' ' A' ' 58' ' ' ASP . 43.3 p -94.21 168.45 10.91 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.805 2.891 . . . . 1.34 118.805 177.999 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 56.4 mt -62.77 -43.05 99.82 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.887 -1.758 . . . . 1.63 109.916 174.316 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 t -55.36 -43.66 75.27 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 120.342 3.46 . . . . 1.51 120.342 174.719 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.426 ' CG ' ' HG1' ' A' ' 55' ' ' THR . 80.9 m-20 -54.45 -42.2 70.34 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 128.287 2.635 . . . . 1.9 110.87 177.687 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -95.03 11.39 32.2 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 115.289 1.589 . . . . 0.97 115.289 -178.65 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 52.45 50.0 19.22 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 129.038 2.935 . . . . 2.35 110.98 -177.798 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.412 HD12 HG22 ' A' ' 61' ' ' ILE . 96.0 mt -91.94 114.19 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 N-CA-C 106.621 -1.622 . . . . 1.39 106.621 -179.068 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -94.16 -170.67 2.35 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 125.197 2.427 . . . . 2.58 109.494 -177.153 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.321 17.8 pttp -67.39 150.82 48.44 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 111.695 -2.502 . . . . 2.58 117.416 168.769 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.343 17.2 mt-10 68.38 9.52 7.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.942 2.201 . . . . 1.71 116.942 170.156 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.3 t -94.36 138.76 31.94 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 131.034 3.734 . . . . 1.34 107.855 -175.82 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.2 m -85.99 122.95 30.74 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 115.969 1.84 . . . . 1.36 115.969 179.225 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mp -99.78 157.45 16.49 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 101.472 -3.529 . . . . 2.03 101.472 169.674 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -121.04 117.27 26.81 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 113.995 1.109 . . . . 2.31 113.995 179.956 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.7 tp -88.85 110.37 21.0 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.413 2.054 . . . . 1.72 113.185 -178.713 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.7 t -107.04 147.82 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 117.981 -2.949 . . . . 1.8 106.124 171.605 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.0 mt . . . . . 0 N--CA 1.43 -1.435 0 O-C-N 119.159 -2.213 . . . . 3.26 109.437 -179.532 . . . . . . . . 0 0 . 1 . 116 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 119.322 -0.37 . . . . 1.39 110.208 . . . . . . . . . 0 0 . 1 . 116 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -102.7 132.42 48.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.66 -2.525 . . . . 2.2 106.83 -179.249 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.0 pt -132.42 167.02 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-O 116.376 -1.773 . . . . 1.32 108.001 173.923 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -124.1 149.08 46.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 122.349 2.34 . . . . 2.2 115.282 176.75 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 t -128.42 119.48 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 102.858 -3.016 . . . . 1.23 102.858 171.024 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -109.82 129.1 55.67 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 111.329 -2.669 . . . . 2.51 109.595 176.258 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 p -89.89 -173.87 4.05 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 126.546 3.069 . . . . 1.41 109.205 178.555 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.6 mt -91.48 3.66 54.43 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.678 -3.764 . . . . 2.95 117.739 169.51 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.2 p -76.6 -31.14 57.27 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.861 2.465 . . . . 2.52 108.578 177.899 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.22 -29.35 3.69 Favored Glycine 0 N--CA 1.43 -1.739 1 N-CA-C 102.78 -4.128 . . . . 1.5 102.78 179.904 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -63.58 131.21 47.33 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.406 2.002 . . . . 1.79 116.406 -170.898 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.9 m -102.1 117.48 34.89 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.345 -1.298 . . . . 1.38 108.895 169.112 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.283 7.7 mt -103.83 109.69 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 129.047 2.939 . . . . 2.03 106.243 -177.2 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.6 m -83.36 131.6 35.05 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.479 1.133 . . . . 1.61 110.21 177.559 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.3 mt -134.06 140.56 46.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.037 -2.289 . . . . 2.15 108.61 -175.759 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -84.3 124.14 30.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.487 2.715 . . . . 1.98 108.583 174.175 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.344 4.1 m -134.42 149.3 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 O-C-N 118.353 -2.717 . . . . 1.52 113.258 -176.423 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -95.73 141.72 23.57 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 115.233 -2.318 . . . . 2.35 105.331 165.291 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -81.98 -15.54 9.22 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 CA-C-N 126.484 3.351 . . . . 1.31 111.512 -167.899 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.8 m -71.56 -11.78 61.03 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 120.734 -1.229 . . . . 1.71 114.08 174.948 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -67.49 159.04 30.47 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.471 2.082 . . . . 1.69 112.235 177.455 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.6 p -87.12 177.37 7.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.323 -2.736 . . . . 1.33 109.1 -177.699 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.1 mt -84.12 -24.0 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 1 O-C-N 114.307 -5.246 . . . . 1.32 114.899 171.671 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.08 -28.39 69.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.153 1.908 . . . . 1.62 116.153 163.049 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -73.29 -36.27 66.26 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 121.221 1.828 . . . . 2.13 111.888 173.889 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.8 t -63.01 -48.8 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 128.504 2.722 . . . . 1.23 114.243 176.421 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -57.91 -33.96 69.32 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.633 2.086 . . . . 1.97 116.633 176.353 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.21 -24.16 67.75 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.227 1.936 . . . . 1.19 116.227 169.827 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -72.86 -31.66 64.89 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 126.397 2.999 . . . . 1.92 116.355 172.947 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.5 mm -68.37 -27.95 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 O-C-N 117.678 -3.139 . . . . 1.94 106.702 169.758 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.402 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 41.6 tt0 -71.49 -39.0 71.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.924 -2.36 . . . . 1.9 112.277 172.283 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -63.04 -41.43 99.51 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 118.227 2.677 . . . . 1.55 118.227 171.603 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -83.96 -58.16 2.9 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.824 2.05 . . . . 2.95 111.941 -174.878 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -97.99 -42.64 7.42 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.491 1.516 . . . . 1.48 109.698 -173.905 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 94.62 57.33 1.27 Allowed Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 128.142 2.782 . . . . 1.12 111.899 179.387 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.1 mt -115.23 122.31 33.47 Favored Pre-proline 0 N--CA 1.431 -1.423 0 N-CA-C 101.927 -3.36 . . . . 2.07 101.927 -177.957 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -66.94 149.29 82.99 Favored 'Trans proline' 0 C--N 1.3 -2.024 1 CA-C-O 108.871 -4.72 . . . . 1.39 108.283 -174.134 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -66.48 -8.54 21.13 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 CA-C-N 127.15 3.589 . . . . 1.68 116.496 -174.645 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.95 -35.16 62.14 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.234 1.969 . . . . 2.25 115.134 175.771 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -81.11 -15.68 55.24 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.214 -3.429 . . . . 2.44 111.753 -177.573 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -70.65 116.49 11.02 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.649 1.98 . . . . 1.32 112.875 -175.202 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -106.35 124.84 50.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.885 -3.009 . . . . 3.19 105.537 175.561 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.0 tp -112.46 125.58 54.38 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 123.987 1.851 . . . . 1.75 107.085 -175.674 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.1 mm -114.74 125.99 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 O-C-N 120.283 -1.511 . . . . 1.98 110.01 -175.733 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -138.22 118.73 13.86 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.987 -1.857 . . . . 1.94 105.987 171.512 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.6 35.99 1.75 Allowed 'General case' 0 N--CA 1.431 -1.421 1 CA-C-O 129.417 4.437 . . . . 1.67 115.946 175.195 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.29 -21.47 28.28 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 110.423 -3.081 . . . . 1.3 115.052 -175.925 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -100.43 148.38 24.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.138 2.273 . . . . 2.89 117.138 -178.524 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -76.49 119.33 20.19 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 129.901 3.281 . . . . 2.89 109.43 169.819 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.5 HD22 ' CG ' ' A' ' 59' ' ' TYR . 20.5 mt -85.92 147.04 26.43 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.675 2.179 . . . . 1.34 116.85 -177.073 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -92.21 136.65 33.02 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 117.382 -3.324 . . . . 1.94 115.087 176.297 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -66.1 -42.54 89.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.884 -3.01 . . . . 1.56 116.258 -173.19 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.88 -13.95 62.39 Favored Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 125.32 1.438 . . . . 0.97 116.673 169.317 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -77.99 160.55 28.1 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 121.027 2.414 . . . . 3.07 112.306 174.115 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.261 60.8 p -91.15 159.5 16.05 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 116.41 -3.931 . . . . 1.34 110.805 177.331 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.511 HD21 HD12 ' A' ' 61' ' ' ILE . 6.1 mt -70.05 -26.25 63.94 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.285 -1.78 . . . . 1.63 110.095 179.852 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.5 p -77.07 -30.85 55.66 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.079 2.552 . . . . 1.51 111.799 176.527 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.284 3.5 t70 -60.89 -43.18 98.83 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.051 -3.53 . . . . 1.9 114.31 172.35 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.5 ' CG ' HD22 ' A' ' 50' ' ' LEU . 35.6 m-85 -85.27 -6.0 59.28 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 116.743 -1.599 . . . . 0.97 113.293 170.734 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.37 55.6 t30 68.9 50.54 0.61 Allowed 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 123.455 2.843 . . . . 2.35 113.11 175.79 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.511 HD12 HD21 ' A' ' 56' ' ' LEU . 68.2 mt -100.42 124.11 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 105.605 -1.998 . . . . 1.39 105.605 176.169 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -110.82 -173.1 2.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 129.337 3.055 . . . . 2.58 113.504 -177.832 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.314 26.2 tttm -46.4 124.05 5.43 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.961 2.505 . . . . 2.58 112.726 174.568 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.399 44.1 mt-10 61.9 43.16 9.53 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.235 3.014 . . . . 1.71 117.522 174.203 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 t -99.36 153.41 19.0 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.527 2.108 . . . . 1.34 109.876 -175.424 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.287 11.8 m -97.25 107.41 19.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.721 -1.862 . . . . 1.36 113.81 178.465 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.8 mt -88.34 139.8 30.12 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.414 -1.328 . . . . 2.03 107.414 170.196 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -107.38 133.55 51.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 124.628 1.205 . . . . 2.31 109.069 -177.972 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.329 36.9 tp -111.33 121.1 44.36 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 127.161 2.788 . . . . 1.72 109.473 -178.802 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.9 m -117.78 164.99 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 116.923 -1.513 . . . . 1.8 111.03 168.787 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.6 mt . . . . . 0 N--CA 1.431 -1.402 0 CA-C-N 122.223 2.283 . . . . 3.26 113.972 176.19 . . . . . . . . 0 0 . 1 . 117 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 114.926 1.454 . . . . 1.39 114.926 . . . . . . . . . 0 0 . 1 . 117 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -101.39 112.77 25.39 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.226 1.81 . . . . 2.2 107.537 -179.504 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -100.42 174.43 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 127.168 2.187 . . . . 1.32 114.183 166.908 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -123.83 141.37 52.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.969 -2.332 . . . . 2.2 110.869 -175.0 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.0 t -106.03 119.37 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 118.026 -2.921 . . . . 1.23 112.372 166.676 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -98.37 119.14 36.54 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 116.468 -3.895 . . . . 2.51 108.716 176.723 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p -73.57 173.26 9.96 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.601 -3.187 . . . . 1.41 119.599 174.036 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.2 mt -53.41 -54.06 42.28 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 118.157 2.651 . . . . 2.95 118.157 170.401 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.4 p -69.23 -24.59 64.03 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 126.393 2.308 . . . . 2.52 111.015 -177.748 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.21 38.07 0.97 Allowed Glycine 0 N--CA 1.43 -1.712 0 O-C-N 119.526 -1.984 . . . . 1.5 112.707 170.25 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -109.98 131.07 55.39 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.867 -3.137 . . . . 1.79 107.023 -173.149 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -89.68 106.62 18.58 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.857 2.063 . . . . 1.38 114.316 177.841 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.4 mt -104.99 120.37 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 103.502 -2.777 . . . . 2.03 103.502 -178.128 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -86.33 132.95 33.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.761 -1.109 . . . . 1.61 111.978 178.971 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.3 mt -136.53 132.9 35.87 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 115.208 -2.33 . . . . 2.15 114.893 -175.698 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -84.39 114.32 21.81 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 131.258 3.823 . . . . 1.98 111.48 173.974 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.403 HG13 HG22 ' A' ' 26' ' ' VAL . 5.5 m -140.77 167.1 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-O 125.097 2.38 . . . . 1.52 106.131 178.763 . . . . . . . . 2 2 . 1 . 117 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -121.07 158.28 53.08 Favored Pre-proline 0 N--CA 1.431 -1.425 0 O-C-N 118.518 -2.613 . . . . 2.35 111.571 168.26 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -59.14 -16.53 33.95 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 O-C-N 111.538 -5.032 . . . . 1.31 116.41 -176.45 . . . . . . . . 2 2 . 1 . 117 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.7 p -79.14 -5.29 53.82 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.086 1.513 . . . . 1.71 115.086 171.691 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.27 46.5 m-20 -76.93 142.62 40.0 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.779 -1.201 . . . . 1.69 109.743 -178.395 . . . . . . . . 2 2 . 1 . 117 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.3 p -86.35 161.08 18.89 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.073 -1.084 . . . . 1.33 108.073 179.761 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.8 mm -58.03 -42.24 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 122.324 1.059 . . . . 1.32 110.727 176.291 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -37.66 -54.01 1.21 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 119.142 3.015 . . . . 1.62 119.142 160.864 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -55.77 -41.9 74.72 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.591 2.756 . . . . 2.13 113.315 176.905 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.403 HG22 HG13 ' A' ' 17' ' ' VAL . 39.6 t -61.66 -50.96 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 126.282 1.833 . . . . 1.23 111.742 173.55 . . . . . . . . 2 2 . 1 . 117 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.4 mttt -61.47 -27.9 68.9 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.458 -3.276 . . . . 1.97 118.237 175.248 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.53 -27.57 64.27 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.56 2.124 . . . . 1.19 113.943 178.0 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -76.47 -36.51 57.82 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.803 -2.436 . . . . 1.92 112.479 176.044 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.56 -30.05 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.908 -1.496 . . . . 1.94 114.808 161.574 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -68.6 -33.36 73.91 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.448 1.476 . . . . 1.9 113.627 179.003 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -78.3 -53.85 6.85 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 117.235 -1.786 . . . . 1.55 115.092 166.354 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -59.19 -43.51 92.19 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 115.153 -2.356 . . . . 2.95 117.309 -174.925 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -108.14 -26.65 10.51 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 126.702 2.501 . . . . 1.48 110.524 -172.713 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.52 48.89 3.83 Favored Glycine 0 N--CA 1.43 -1.767 0 O-C-N 119.987 -1.695 . . . . 1.12 111.914 171.212 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.4 mt -128.57 125.37 23.11 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-O 115.622 -2.133 . . . . 2.07 109.822 -177.876 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -66.85 148.76 82.92 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-N 125.484 2.994 . . . . 1.39 114.094 178.16 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -69.33 -14.1 36.85 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 N-CA-C 116.63 1.742 . . . . 1.68 116.63 -170.933 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.56 -29.67 70.75 Favored 'General case' 0 N--CA 1.43 -1.449 1 C-N-CA 132.514 4.326 . . . . 2.25 109.029 169.788 . . . . . . . . 2 2 . 1 . 117 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -90.87 -31.1 16.56 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.482 1.66 . . . . 2.44 115.482 -178.697 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.281 77.4 mt-30 -81.08 134.3 35.63 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.856 -1.164 . . . . 1.32 107.856 -175.012 . . . . . . . . 2 2 . 1 . 117 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -121.15 133.4 55.2 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.914 -2.991 . . . . 3.19 105.98 168.898 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.2 mt -98.01 126.49 43.46 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 105.781 -1.933 . . . . 1.75 105.781 -177.905 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 mm -110.84 138.86 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-N 122.466 2.393 . . . . 1.98 104.616 -178.407 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.444 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 81.0 t80 -144.48 130.15 19.11 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 106.376 -1.713 . . . . 1.94 106.376 163.49 . . . . . . . . 2 2 . 1 . 117 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.05 24.78 14.86 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 120.381 3.474 . . . . 1.67 120.381 177.771 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.86 -18.51 57.39 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 115.72 -2.711 . . . . 1.3 108.439 -179.785 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 41.0 pttt -101.22 156.72 17.27 Favored 'General case' 0 N--CA 1.431 -1.422 1 CA-C-N 124.847 4.323 . . . . 2.89 111.028 177.382 . . . . . . . . 3 3 . 1 . 117 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.291 39.9 tt0 -96.74 144.57 26.61 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.858 2.742 . . . . 2.89 107.95 175.185 . . . . . . . . 2 2 . 1 . 117 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.6 mt -92.45 148.09 22.38 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.472 -3.268 . . . . 1.34 109.129 -178.727 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -92.93 144.45 25.25 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 130.611 3.564 . . . . 1.94 112.813 -179.522 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -63.64 -54.91 28.34 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.284 -3.385 . . . . 1.56 115.665 -167.479 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.86 42.36 3.05 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-O 123.299 1.5 . . . . 0.97 115.51 173.036 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -110.43 152.95 25.69 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.362 -2.257 . . . . 3.07 105.253 165.281 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.7 p -103.1 158.82 16.04 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.86 2.064 . . . . 1.34 108.256 -177.99 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.0 mt -65.44 -28.31 69.14 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 128.484 2.714 . . . . 1.63 108.378 176.042 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 p -64.59 -40.99 96.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.285 2.634 . . . . 1.51 115.461 171.874 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -65.24 -35.24 80.43 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 124.235 0.959 . . . . 1.9 113.411 176.623 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -85.43 3.1 41.67 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.336 1.606 . . . . 0.97 115.336 179.595 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.0 m120 56.02 32.27 19.62 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 110.698 -2.956 . . . . 2.35 117.895 -174.232 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.6 mm -72.17 130.02 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 1 O-C-N 115.325 -4.609 . . . . 1.39 116.582 176.594 . . . . . . . . 2 2 . 1 . 117 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -117.61 174.81 5.95 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 128.115 2.566 . . . . 2.58 107.049 -168.106 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -54.32 152.8 5.96 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.058 1.503 . . . . 2.58 115.058 172.858 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.37 35.0 mt-10 73.55 14.03 4.37 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 125.554 2.597 . . . . 1.71 115.282 172.112 . . . . . . . . 2 2 . 1 . 117 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.327 27.3 m -78.51 124.39 28.1 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 116.303 1.964 . . . . 1.34 116.303 -175.019 . . . . . . . . 2 2 . 1 . 117 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.6 m -89.59 99.87 12.78 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 118.134 2.642 . . . . 1.36 118.134 177.913 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.5 mt -86.52 139.06 31.23 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.302 -2.481 . . . . 2.03 104.302 176.547 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -97.29 141.5 30.32 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.747 -3.096 . . . . 2.31 108.832 174.685 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.0 tp -106.62 125.62 51.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.11 1.909 . . . . 1.72 111.382 179.954 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.12 163.89 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 105.063 -2.199 . . . . 1.8 105.063 174.695 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.9 mt . . . . . 0 N--CA 1.43 -1.436 0 N-CA-C 101.799 -3.408 . . . . 3.26 101.799 -176.672 . . . . . . . . 0 0 . 1 . 118 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 ttp . . . . . 0 CA--C 1.491 -1.326 0 CA-C-O 118.61 -0.709 . . . . 1.39 112.597 . . . . . . . . . 0 0 . 1 . 118 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -94.31 133.54 37.75 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.562 -2.586 . . . . 2.2 111.716 178.576 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -123.37 159.34 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.269 2.628 . . . . 1.32 106.859 175.278 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.297 44.3 m-85 -128.96 121.71 28.6 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 123.887 1.803 . . . . 2.2 110.679 -177.604 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.52 105.01 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 125.851 2.739 . . . . 1.23 110.757 175.308 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -88.13 138.59 31.31 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.547 -3.221 . . . . 2.51 110.066 176.241 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.9 p -90.52 -177.67 5.11 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 127.989 3.306 . . . . 1.41 116.18 -174.405 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.7 mt -82.74 -26.18 32.16 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.564 -1.96 . . . . 2.95 113.169 163.674 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.1 p -64.35 -62.58 1.52 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.507 1.923 . . . . 2.52 114.758 -174.262 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.49 31.61 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.757 0 N-CA-C 105.234 -3.147 . . . . 1.5 105.234 174.826 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -117.61 128.42 54.92 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 123.618 1.675 . . . . 1.79 109.025 -172.493 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.6 m -107.08 102.32 11.67 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 104.526 -2.398 . . . . 1.38 104.526 176.412 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.8 pt -91.27 133.06 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 120.778 1.626 . . . . 2.03 109.998 176.924 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.9 m -91.53 151.19 20.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 121.183 -0.948 . . . . 1.61 108.565 175.544 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.1 mt -144.31 139.39 28.52 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.106 -1.813 . . . . 2.15 106.106 176.48 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -78.0 116.19 18.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.101 1.519 . . . . 1.98 115.101 165.085 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.277 11.3 m -127.75 151.22 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 127.672 2.389 . . . . 1.52 106.839 178.49 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -94.87 161.96 26.8 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 118.107 -2.871 . . . . 2.35 112.622 157.828 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -73.45 -20.95 20.21 Favored 'Trans proline' 0 N--CA 1.433 -2.072 0 CA-C-N 126.69 3.425 . . . . 1.31 115.743 -174.895 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 p -72.59 5.32 3.14 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.488 3.915 . . . . 1.71 114.039 169.011 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -95.82 135.16 37.9 Favored 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 117.775 -3.078 . . . . 1.69 112.909 -179.604 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 26.6 p -67.79 173.98 3.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.21 -2.268 . . . . 1.33 114.225 177.414 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.6 mm -84.88 -29.7 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 118.143 -2.848 . . . . 1.32 105.156 176.861 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -48.95 -48.34 43.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.228 -2.795 . . . . 1.62 116.55 163.622 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -51.87 -50.27 61.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.861 -2.399 . . . . 2.13 115.148 167.369 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.2 t -55.97 -42.75 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 114.73 -2.557 . . . . 1.23 115.246 177.409 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -64.15 -41.11 97.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 125.101 2.382 . . . . 1.97 116.337 174.896 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.85 -43.73 81.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.51 3.124 . . . . 1.19 115.893 166.983 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -58.86 -33.29 70.29 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 116.248 -4.033 . . . . 1.92 113.835 170.616 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.9 mt -78.79 -31.09 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 112.907 -1.951 . . . . 1.94 108.969 176.521 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -71.15 -40.35 71.4 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 115.53 1.678 . . . . 1.9 115.53 177.868 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -58.01 -52.11 66.88 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.932 1.456 . . . . 1.55 114.932 168.001 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.2 tttp -70.23 -71.66 0.23 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.579 2.751 . . . . 2.95 113.361 -172.374 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -90.58 -34.24 15.57 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.048 -1.658 . . . . 1.48 111.616 -162.798 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.47 5.55 22.59 Favored Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 105.089 -3.204 . . . . 1.12 105.089 175.593 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.9 mt -80.17 122.37 82.86 Favored Pre-proline 0 N--CA 1.431 -1.41 0 CA-C-N 119.087 1.443 . . . . 2.07 108.475 -175.799 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -68.31 150.75 76.52 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 C-N-CA 124.58 3.52 . . . . 1.39 110.653 -175.883 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.263 39.0 Cg_endo -62.91 -43.8 18.61 Favored 'Trans proline' 0 N--CA 1.433 -2.039 1 C-N-CA 126.963 5.109 . . . . 1.68 116.469 -168.904 . . . . . . . . 3 2 . 1 . 118 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -55.86 -26.56 47.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 121.792 3.997 . . . . 2.25 121.792 171.945 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -71.17 -34.89 71.36 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.585 1.954 . . . . 2.44 110.691 -179.322 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -70.62 97.71 1.38 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.165 2.283 . . . . 1.32 117.165 -175.299 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -87.44 126.14 34.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 118.341 -0.838 . . . . 3.19 108.96 161.957 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.0 mt -117.8 119.54 35.2 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 121.478 1.945 . . . . 1.75 108.431 -178.639 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.476 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 27.4 mt -108.3 128.94 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 128.53 2.732 . . . . 1.98 113.818 -172.426 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.417 ' CZ ' HG12 ' A' ' 61' ' ' ILE 0.288 72.1 t80 -144.95 110.92 5.46 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 105.581 -2.007 . . . . 1.94 105.581 178.648 . . . . . . . . 3 3 . 1 . 118 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.82 45.25 7.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.867 1.802 . . . . 1.67 115.867 178.974 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.02 -4.85 36.25 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 120.681 3.032 . . . . 1.3 120.681 -171.534 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -96.3 119.72 35.31 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 130.155 4.091 . . . . 2.89 115.642 177.441 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -79.76 110.29 14.97 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 114.922 -4.861 . . . . 2.89 109.593 168.899 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.2 mt -82.12 146.35 29.66 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.041 -2.287 . . . . 1.34 110.827 -163.765 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -85.3 145.22 27.63 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.836 2.055 . . . . 1.94 114.004 173.536 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.39 -59.07 4.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.594 2.072 . . . . 1.56 116.594 -168.703 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.64 49.82 3.7 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-O 123.943 1.857 . . . . 0.97 116.905 173.744 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -118.25 156.48 28.75 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 101.489 -3.522 . . . . 3.07 101.489 165.443 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 16.9 p -100.07 162.48 12.95 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.686 -3.133 . . . . 1.34 112.784 174.005 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.4 mt -54.87 -48.27 73.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.777 2.831 . . . . 1.63 109.2 174.813 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 p -60.72 -37.92 83.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.07 2.148 . . . . 1.51 113.856 179.085 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -61.31 -33.93 74.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 122.637 2.471 . . . . 1.9 113.375 174.276 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -85.96 -14.34 44.94 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 127.002 2.121 . . . . 0.97 114.055 178.836 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.6 m120 66.84 50.34 1.11 Allowed 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 124.242 1.972 . . . . 2.35 111.739 -177.661 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.417 HG12 ' CZ ' ' A' ' 45' ' ' PHE . 70.8 mt -95.78 128.71 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 119.951 -1.718 . . . . 1.39 108.457 174.629 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -100.1 175.98 5.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 112.159 -2.291 . . . . 2.58 111.07 -174.171 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -46.37 137.43 6.43 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.819 -3.05 . . . . 2.58 117.639 166.811 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.253 73.8 mt-10 69.57 14.04 8.27 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.287 -2.758 . . . . 1.71 117.682 175.455 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 m -76.1 148.95 37.53 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 120.438 -1.414 . . . . 1.34 112.826 -175.364 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.1 m -97.28 119.0 34.98 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 126.177 2.173 . . . . 1.36 111.258 -179.365 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.3 mt -103.8 136.68 43.03 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.053 -1.655 . . . . 2.03 107.851 170.235 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.476 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 63.5 m80 -91.64 107.5 19.25 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.298 2.332 . . . . 2.31 117.298 174.181 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.2 tp -88.09 117.04 26.7 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 124.835 1.254 . . . . 1.72 110.184 -179.334 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.2 t -120.84 143.25 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 126.493 3.044 . . . . 1.8 103.723 178.431 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 N--CA 1.43 -1.456 0 O-C-N 118.149 -2.845 . . . . 3.26 109.126 -175.422 . . . . . . . . 0 0 . 1 . 119 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.27 0.2 OUTLIER . . . . . 0 CA--C 1.491 -1.321 0 N-CA-C 107.138 -1.43 . . . . 1.39 107.138 . . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -115.38 119.96 38.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.765 2.026 . . . . 2.2 109.359 -178.41 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 pt -120.74 158.44 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 122.031 0.919 . . . . 1.32 112.716 -179.905 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -114.37 148.14 38.1 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.878 -2.389 . . . . 2.2 106.299 176.028 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.4 t -124.16 121.86 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 129.385 3.074 . . . . 1.23 105.51 173.118 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -107.16 137.69 44.75 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.305 2.642 . . . . 2.51 112.342 177.004 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.6 p -95.65 -176.83 3.86 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 123.376 1.56 . . . . 1.41 114.329 179.935 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.374 66.4 tp -57.54 -45.81 84.62 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 116.01 -4.181 . . . . 2.95 113.11 172.222 . . . . . . . . 3 2 . 1 . 119 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.5 p -80.11 -35.56 36.65 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 121.579 1.99 . . . . 2.52 111.844 -175.555 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.07 7.16 1.36 Allowed Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 119.524 1.057 . . . . 1.5 113.498 178.14 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.3 mtpt -76.6 130.65 38.15 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.676 -2.661 . . . . 1.79 111.65 -176.555 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.0 m -97.96 113.57 25.44 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 125.22 2.438 . . . . 1.38 113.203 -179.184 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.0 mt -92.4 95.15 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 119.101 -2.249 . . . . 2.03 110.369 178.327 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.6 m -81.48 118.82 23.03 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 120.473 1.488 . . . . 1.61 110.432 175.324 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.4 mt -119.85 153.64 35.51 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.567 -2.382 . . . . 2.15 104.567 178.275 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -110.44 120.17 41.57 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 111.558 -2.565 . . . . 1.98 107.493 174.25 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.87 -176.76 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.457 -2.652 . . . . 1.52 106.287 175.2 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -105.48 163.06 17.88 Favored Pre-proline 0 N--CA 1.431 -1.408 0 O-C-N 116.631 -3.793 . . . . 2.35 104.64 169.693 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -71.1 -14.74 32.03 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 124.012 2.468 . . . . 1.31 112.82 179.055 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.263 18.9 m -92.76 5.82 49.77 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 123.766 2.985 . . . . 1.71 111.572 -179.64 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -82.4 151.09 26.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 127.892 3.71 . . . . 1.69 108.706 176.445 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -79.49 170.57 16.38 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 113.586 -5.696 . . . . 1.33 113.596 179.322 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.41 -30.57 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-N 113.561 -1.654 . . . . 1.32 110.873 178.572 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -54.82 -41.55 70.81 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.922 2.089 . . . . 1.62 113.724 169.36 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -61.9 -45.5 93.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.248 1.944 . . . . 2.13 116.248 171.252 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 56.4 t -51.51 -48.85 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 128.583 2.753 . . . . 1.23 107.896 175.445 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -67.42 -36.12 80.61 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 122.402 2.365 . . . . 1.97 117.384 175.197 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.02 -32.48 73.85 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 116.037 -4.164 . . . . 1.19 118.402 169.008 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -67.19 -31.05 71.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 112.483 -2.144 . . . . 1.92 114.839 170.142 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.293 57.3 mt -68.31 -25.43 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 CA-C-O 125.969 2.795 . . . . 1.94 113.683 172.339 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -85.47 -27.51 25.63 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.84 -4.287 . . . . 1.9 106.835 -174.32 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -78.09 -38.14 44.88 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 114.095 -3.042 . . . . 1.55 111.032 168.92 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -65.08 -61.46 2.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 112.986 0.736 . . . . 2.95 112.986 -172.243 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -106.09 -52.64 2.77 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.209 3.004 . . . . 1.48 108.969 -167.403 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.93 -15.8 5.86 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 119.096 2.398 . . . . 1.12 119.096 176.491 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mt -65.1 131.83 95.24 Favored Pre-proline 0 N--CA 1.43 -1.469 0 CA-C-O 116.499 -1.715 . . . . 2.07 110.337 -175.156 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.93 155.36 43.25 Favored 'Trans proline' 0 N--CA 1.433 -2.038 0 C-N-CA 125.219 3.946 . . . . 1.39 112.814 -177.136 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -63.84 -27.41 67.4 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 123.663 2.909 . . . . 1.68 119.056 -174.364 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.272 2.6 m-20 -62.08 -32.46 73.01 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.072 1.415 . . . . 2.25 113.39 177.268 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -87.81 -16.91 32.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.159 1.457 . . . . 2.44 114.085 -171.436 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -87.31 127.17 35.19 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 117.148 -1.406 . . . . 1.32 109.698 -174.909 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -118.44 128.18 54.37 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.441 -1.689 . . . . 3.19 106.441 170.421 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.2 mt -95.05 136.76 34.98 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.103 -2.873 . . . . 1.75 112.678 174.565 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 73.0 mt -125.38 117.92 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 124.415 2.055 . . . . 1.98 110.775 178.401 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -109.0 107.82 18.32 Favored 'General case' 0 N--CA 1.43 -1.439 1 N-CA-C 99.77 -4.159 . . . . 1.94 99.77 -178.534 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.88 -74.32 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.477 2.311 . . . . 1.67 113.716 -172.555 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.92 6.11 1.13 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 105.709 -2.956 . . . . 1.3 105.709 178.095 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -94.98 119.04 32.82 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.327 -3.455 . . . . 2.89 110.17 177.747 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -89.08 121.64 31.61 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.862 -2.399 . . . . 2.89 108.642 175.599 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.0 mt -80.08 164.67 23.19 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.158 -1.383 . . . . 1.34 111.599 -164.131 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -115.66 137.05 52.46 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 127.012 3.291 . . . . 1.94 111.396 174.552 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.28 -40.77 97.35 Favored 'General case' 0 N--CA 1.429 -1.483 1 N-CA-C 122.274 4.175 . . . . 1.56 122.274 -166.842 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.42 30.44 5.25 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 118.079 1.991 . . . . 0.97 118.079 171.385 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -105.86 162.61 13.41 Favored 'General case' 0 N--CA 1.43 -1.439 1 CA-C-O 130.099 4.762 . . . . 3.07 107.959 163.073 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.0 p -84.25 163.82 19.44 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 113.02 -6.05 . . . . 1.34 109.648 172.279 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.2 mt -64.76 -42.7 94.92 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 121.0 -1.063 . . . . 1.63 109.086 172.432 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.3 p -66.32 -21.56 66.26 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.406 -3.309 . . . . 1.51 115.092 -179.22 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -59.34 -17.69 31.82 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 118.123 2.638 . . . . 1.9 118.123 167.017 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -115.79 11.22 15.56 Favored 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 114.561 -5.087 . . . . 0.97 109.189 178.835 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.334 1.3 t-20 67.01 33.97 5.42 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.568 1.947 . . . . 2.35 114.111 179.044 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.4 mt -92.03 126.37 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 104.759 -2.311 . . . . 1.39 104.759 -174.688 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -125.17 -171.46 2.37 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 119.488 1.04 . . . . 2.58 109.458 -169.25 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -52.68 141.7 20.26 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 118.452 -2.655 . . . . 2.58 112.842 165.722 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.316 4.2 mt-10 60.71 36.46 19.44 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.298 2.873 . . . . 1.71 115.926 175.066 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.4 t -109.49 140.82 42.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 111.562 -2.563 . . . . 1.34 106.74 -167.107 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.3 m -114.18 120.37 40.27 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.782 -1.192 . . . . 1.36 107.782 -167.759 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.7 mt -100.52 161.58 13.51 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.518 2.727 . . . . 2.03 111.186 173.795 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -123.79 109.65 13.92 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.122 2.169 . . . . 2.31 111.196 -177.616 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.9 tp -92.12 122.87 35.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 111.812 -2.449 . . . . 1.72 108.073 -175.008 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.327 4.7 m -118.4 141.03 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 118.802 -2.436 . . . . 1.8 110.953 175.63 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.9 mt . . . . . 0 N--CA 1.431 -1.414 0 O-C-N 117.926 -2.984 . . . . 3.26 110.145 177.226 . . . . . . . . 0 0 . 1 . 120 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 ptt? . . . . . 0 CA--C 1.491 -1.301 0 CA-C-O 120.957 0.408 . . . . 1.39 110.23 . . . . . . . . . 0 0 . 1 . 120 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -107.65 147.38 30.77 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.537 -0.727 . . . . 2.2 112.3 -176.681 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.3 pt -134.09 152.41 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 124.174 1.94 . . . . 1.32 106.385 172.935 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -109.7 134.37 52.05 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 127.019 2.128 . . . . 2.2 114.298 178.619 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -114.14 109.57 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 118.015 -2.928 . . . . 1.23 106.062 178.338 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 6' ' ' LYS . 17.9 tptm -93.61 131.38 38.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.219 -1.551 . . . . 2.51 111.83 178.673 . . . . . . . . 2 2 . 1 . 120 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.1 p -89.07 -178.67 5.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.211 -2.806 . . . . 1.41 113.782 -178.428 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.263 35.4 tp -85.31 -33.47 22.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 119.292 -2.13 . . . . 2.95 108.198 171.85 . . . . . . . . 2 2 . 1 . 120 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.259 59.9 p -68.33 -34.32 75.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.678 -1.889 . . . . 2.52 109.015 -174.095 . . . . . . . . 2 2 . 1 . 120 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.0 44.54 0.44 Allowed Glycine 0 N--CA 1.431 -1.673 0 CA-C-O 115.376 -2.902 . . . . 1.5 113.513 178.378 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -127.55 148.69 50.34 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 114.076 -2.868 . . . . 1.79 110.853 -177.838 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.8 m -122.89 121.76 36.97 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 124.69 3.405 . . . . 1.38 103.626 177.126 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mt -98.13 124.54 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 1 O-C-N 115.971 -4.206 . . . . 2.03 104.355 179.1 . . . . . . . . 2 2 . 1 . 120 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.0 m -101.29 118.2 36.51 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.261 -2.15 . . . . 1.61 107.876 179.912 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.7 mt -117.46 162.3 18.18 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.5 -2.625 . . . . 2.15 109.683 178.3 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -101.26 136.11 41.64 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 127.144 2.777 . . . . 1.98 112.656 166.545 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -142.36 171.26 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 128.085 2.554 . . . . 1.52 107.48 -176.236 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -118.53 148.22 43.65 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 101.904 -3.369 . . . . 2.35 101.904 163.139 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.97 -6.12 17.39 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 O-C-N 115.809 -2.785 . . . . 1.31 118.35 178.07 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.8 p -80.57 -5.77 57.28 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.475 2.71 . . . . 1.71 112.401 169.131 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -70.01 143.17 52.65 Favored 'General case' 0 N--CA 1.431 -1.413 1 CA-C-O 128.515 4.007 . . . . 1.69 111.706 171.129 . . . . . . . . 2 2 . 1 . 120 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.395 53.6 p -75.09 157.05 35.38 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.02 -2.925 . . . . 1.33 112.848 176.493 . . . . . . . . 3 3 . 1 . 120 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.9 mm -71.53 -29.97 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 122.95 1.357 . . . . 1.32 109.634 179.131 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -46.57 -57.9 4.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.561 3.077 . . . . 1.62 115.538 164.661 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -54.48 -34.24 61.22 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 119.849 3.277 . . . . 2.13 119.849 178.017 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 68.9 t -71.05 -35.73 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 112.185 -2.28 . . . . 1.23 111.208 176.109 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -72.96 -34.11 66.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.011 -2.931 . . . . 1.97 113.456 171.76 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.98 -32.63 74.22 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 117.992 -2.943 . . . . 1.19 113.067 174.335 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt -72.42 -33.55 67.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 123.35 1.547 . . . . 1.92 114.853 174.279 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.2 mt -72.39 -29.99 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 120.399 -1.438 . . . . 1.94 108.309 176.26 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.46 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 7.7 tt0 -64.0 -51.28 64.99 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.809 1.644 . . . . 1.9 112.549 171.803 . . . . . . . . 2 2 . 1 . 120 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -60.75 -39.47 88.85 Favored 'General case' 0 N--CA 1.432 -1.368 0 O-C-N 120.121 -1.612 . . . . 1.55 113.509 175.549 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.6 tptt -67.83 -56.44 9.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.427 -1.421 . . . . 2.95 114.781 -173.818 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.307 71.4 mm-40 -113.71 -15.23 12.49 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 115.755 1.761 . . . . 1.48 115.755 -171.995 . . . . . . . . 2 2 . 1 . 120 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.21 64.31 1.6 Allowed Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 125.169 1.366 . . . . 1.12 110.338 171.303 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.46 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 16.9 mt -141.53 117.07 7.13 Favored Pre-proline 0 N--CA 1.429 -1.485 0 N-CA-C 101.947 -3.353 . . . . 2.07 101.947 -176.436 . . . . . . . . 2 2 . 1 . 120 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -58.01 153.64 43.79 Favored 'Trans proline' 0 C--N 1.3 -2.002 1 C-N-CA 128.218 5.945 . . . . 1.39 111.93 178.149 . . . . . . . . 2 2 . 1 . 120 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -71.73 -27.75 17.84 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 CA-C-N 125.454 2.984 . . . . 1.68 115.37 -171.825 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -61.36 -31.62 71.5 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.354 3.062 . . . . 2.25 113.912 178.007 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -92.57 -10.36 37.84 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 116.462 -3.899 . . . . 2.44 105.546 -172.332 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -92.87 132.47 36.98 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 124.062 3.119 . . . . 1.32 109.818 -172.041 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -103.52 125.56 50.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.762 -1.837 . . . . 3.19 109.369 163.811 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.6 mt -113.81 118.51 34.47 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.64 -2.537 . . . . 1.75 109.388 179.16 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.436 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 5.1 mt -110.83 125.36 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 126.824 2.049 . . . . 1.98 109.794 -177.446 . . . . . . . . 2 2 . 1 . 120 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -125.23 130.78 52.76 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.17 -1.789 . . . . 1.94 106.17 168.403 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.78 -76.44 0.07 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.804 1.242 . . . . 1.67 112.0 179.259 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -177.4 33.8 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.649 0 O-C-N 117.258 -3.401 . . . . 1.3 104.809 -175.482 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.32 122.29 16.69 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.644 1.978 . . . . 2.89 107.277 179.444 . . . . . . . . 2 2 . 1 . 120 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -70.85 143.14 51.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.425 -2.672 . . . . 2.89 107.228 166.186 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.1 mt -99.97 139.99 34.83 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 125.268 1.605 . . . . 1.34 110.183 -173.107 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -83.05 161.64 21.63 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 117.767 -1.111 . . . . 1.94 108.886 176.44 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -73.49 -57.15 4.2 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 129.03 2.932 . . . . 1.56 117.131 -169.237 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.04 54.47 3.64 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 126.607 3.337 . . . . 0.97 120.048 172.631 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.253 79.2 mmt-85 -122.58 169.18 11.29 Favored 'General case' 0 N--CA 1.43 -1.444 1 C-N-CA 132.122 4.169 . . . . 3.07 103.306 169.257 . . . . . . . . 3 2 . 1 . 120 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 62.5 p -109.29 -179.72 3.92 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.409 -3.932 . . . . 1.34 108.464 170.561 . . . . . . . . 2 2 . 1 . 120 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 79.8 mt -72.64 -33.67 66.77 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 130.825 3.65 . . . . 1.63 109.738 172.295 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.4 t -73.9 -37.74 64.57 Favored 'General case' 0 N--CA 1.43 -1.468 1 C-N-CA 131.976 4.111 . . . . 1.51 110.688 -176.214 . . . . . . . . 2 2 . 1 . 120 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -64.08 -38.14 89.98 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 113.209 -1.814 . . . . 1.9 113.956 173.509 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -84.0 -2.83 57.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 113.945 -2.931 . . . . 0.97 112.47 170.463 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.417 8.1 t-20 56.9 46.34 19.8 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 121.24 1.836 . . . . 2.35 114.245 -177.043 . . . . . . . . 2 2 . 1 . 120 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.2 mt -88.18 107.31 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 130.713 3.605 . . . . 1.39 108.212 176.621 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -79.33 -175.88 4.92 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.567 -2.583 . . . . 2.58 111.556 -177.131 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -72.88 149.1 43.78 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 118.382 -2.699 . . . . 2.58 108.305 172.98 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 71.51 18.32 5.46 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 126.615 3.102 . . . . 1.71 116.88 174.915 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -83.33 151.64 25.46 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.289 -3.382 . . . . 1.34 117.223 178.951 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.6 m -108.89 110.29 21.58 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.753 -1.203 . . . . 1.36 107.753 -173.604 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.7 mt -87.94 147.58 24.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 102.162 -3.273 . . . . 2.03 102.162 170.878 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.436 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 67.7 m80 -108.41 112.87 25.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.382 -1.34 . . . . 2.31 107.382 -175.761 . . . . . . . . 2 2 . 1 . 120 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.7 tp -87.68 112.0 21.89 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.898 -2.376 . . . . 1.72 110.226 -178.81 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.7 t -111.13 120.23 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 103.055 -2.943 . . . . 1.8 103.055 178.368 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 123.732 1.73 . . . . 3.26 114.435 -178.312 . . . . . . . . 0 0 . 1 . 121 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 CA--C 1.49 -1.329 0 CA-C-O 125.53 2.586 . . . . 1.39 113.826 . . . . . . . . . 0 0 . 1 . 121 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -115.59 108.82 16.92 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.881 -2.387 . . . . 2.2 106.272 -173.861 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.3 pt -114.08 164.49 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 105.733 -1.951 . . . . 1.32 105.733 171.942 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -124.35 151.68 44.05 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.573 -2.01 . . . . 2.2 105.573 -172.09 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 t -134.1 118.52 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 102.86 -3.015 . . . . 1.23 102.86 174.545 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -90.83 141.4 28.85 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.434 -1.321 . . . . 2.51 107.434 171.055 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.2 p -91.49 -162.46 0.92 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.803 2.841 . . . . 1.41 111.45 -178.715 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.5 mt -83.2 -30.89 27.39 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 126.138 2.875 . . . . 2.95 110.132 178.493 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.8 p -82.09 -60.73 2.12 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 113.977 -5.452 . . . . 2.52 110.01 -171.615 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.93 31.41 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 125.03 1.3 . . . . 1.5 111.101 175.101 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -103.76 134.81 46.45 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.949 -4.265 . . . . 1.79 104.676 -174.609 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 m -80.98 119.63 23.75 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 112.779 -2.01 . . . . 1.38 109.908 167.675 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 mt -94.84 117.51 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 104.168 -2.531 . . . . 2.03 104.168 172.468 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.266 99.3 m -86.42 122.0 29.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 124.98 1.312 . . . . 1.61 109.683 179.227 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.3 mt -129.3 112.66 14.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 126.554 3.073 . . . . 2.15 109.146 -174.026 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -79.63 120.79 24.45 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 110.668 -2.969 . . . . 1.98 113.393 174.561 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.1 162.43 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 113.427 -1.715 . . . . 1.52 108.487 -175.235 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -118.54 170.53 6.32 Favored Pre-proline 0 N--CA 1.43 -1.435 0 O-C-N 116.836 -3.665 . . . . 2.35 108.85 168.13 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -62.9 -18.86 66.98 Favored 'Trans proline' 0 C--N 1.3 -1.982 1 C-N-CA 125.42 4.08 . . . . 1.31 120.813 -173.109 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.7 m -95.49 16.19 17.69 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 118.448 2.759 . . . . 1.71 118.448 171.049 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -77.25 148.45 35.77 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 124.746 2.212 . . . . 1.69 106.966 167.421 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.4 p -97.73 -168.26 1.65 Allowed 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.028 -4.795 . . . . 1.33 114.109 175.791 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.3 mm -89.1 -30.3 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 119.631 -1.918 . . . . 1.32 110.488 175.114 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -59.41 -32.19 69.95 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 128.0 2.52 . . . . 1.62 114.038 167.118 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.265 71.1 m-20 -64.23 -44.41 91.95 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 130.411 3.484 . . . . 2.13 115.348 161.709 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.9 t -65.91 -33.37 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 114.268 -2.973 . . . . 1.23 117.683 175.305 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.275 53.1 mtmt -73.11 -36.55 66.78 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.261 2.625 . . . . 1.97 109.227 -176.73 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.11 -32.84 71.06 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.631 -2.543 . . . . 1.19 111.197 174.569 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -74.95 -25.35 58.81 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 116.367 -3.958 . . . . 1.92 115.747 176.206 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.4 mt -80.83 -27.53 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 C-N-CA 117.181 -1.808 . . . . 1.94 113.88 172.933 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -64.09 -36.4 83.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.625 1.97 . . . . 1.9 114.351 169.997 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -60.54 -65.07 0.75 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 128.978 3.924 . . . . 1.55 109.786 167.859 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -67.6 -54.07 22.81 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 115.384 1.624 . . . . 2.95 115.384 -172.343 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -113.08 -25.1 9.1 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.951 -2.343 . . . . 1.48 115.001 -164.646 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.69 50.27 2.75 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 118.06 -2.019 . . . . 1.12 116.115 168.651 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.5 mt -120.72 128.4 25.8 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 130.389 3.476 . . . . 2.07 105.021 -178.623 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -63.98 146.73 91.6 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 124.403 3.402 . . . . 1.39 115.839 177.183 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -73.71 -9.05 22.25 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 124.356 3.37 . . . . 1.68 113.315 -171.268 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -87.86 -17.43 31.47 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 115.948 -2.301 . . . . 2.25 112.522 170.404 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -78.97 -25.21 43.48 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 120.179 1.354 . . . . 2.44 114.39 178.587 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -82.22 103.19 11.64 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.37 1.468 . . . . 1.32 113.131 -170.469 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -90.89 118.33 30.2 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.934 -2.354 . . . . 3.19 112.677 170.553 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.9 mt -103.06 114.07 28.05 Favored 'General case' 0 N--CA 1.431 -1.392 1 CA-C-N 126.431 4.196 . . . . 1.75 113.698 -178.151 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.459 HG12 HG23 ' A' ' 70' ' ' VAL . 23.8 mm -97.32 138.71 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 117.062 -1.447 . . . . 1.98 109.622 -177.13 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -157.35 129.46 7.2 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.596 -1.631 . . . . 1.94 106.596 176.251 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.06 9.12 2.91 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.181 1.792 . . . . 1.67 114.187 -174.483 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.57 -28.66 9.3 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 117.641 -1.644 . . . . 1.3 116.865 -176.092 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -96.47 153.8 17.63 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.417 2.377 . . . . 2.89 117.417 179.405 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -82.77 103.72 12.47 Favored 'General case' 0 N--CA 1.43 -1.433 1 C-N-CA 134.336 5.054 . . . . 2.89 112.911 178.017 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.9 mt -69.9 141.89 53.07 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.736 3.16 . . . . 1.34 115.219 -174.979 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.259 34.7 mt-10 -80.41 141.82 34.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.191 2.596 . . . . 1.94 114.381 176.831 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -53.03 -65.15 0.61 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 120.771 3.619 . . . . 1.56 120.771 -177.524 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.25 49.22 3.48 Favored Glycine 0 N--CA 1.43 -1.751 0 O-C-N 127.293 2.871 . . . . 0.97 111.807 178.799 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -118.86 147.63 43.75 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.544 -2.739 . . . . 3.07 104.825 168.873 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -79.66 173.4 12.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 117.125 -1.83 . . . . 1.34 115.16 175.74 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.29 -20.5 60.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.612 -2.555 . . . . 1.63 111.89 172.048 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 t -70.04 -49.03 55.38 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.207 -2.808 . . . . 1.51 110.952 177.6 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -57.04 -36.38 70.42 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.764 1.626 . . . . 1.9 114.02 175.824 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -92.83 5.73 50.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.097 2.159 . . . . 0.97 115.336 177.671 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.447 26.4 m120 44.82 43.25 6.79 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.247 2.619 . . . . 2.35 117.842 -176.796 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.8 mt -81.71 128.27 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 104.914 -2.254 . . . . 1.39 104.914 -176.339 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.268 10.2 mt-30 -105.85 179.94 4.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 127.774 3.171 . . . . 2.58 111.505 -174.155 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 pttp -69.02 129.02 38.73 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 124.807 1.243 . . . . 2.58 112.42 170.168 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 87.24 10.02 0.16 Allowed 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 126.837 2.055 . . . . 1.71 111.611 177.4 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.6 t -85.07 134.83 34.19 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 114.534 -5.104 . . . . 1.34 111.601 -173.542 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.8 m -99.97 120.93 40.57 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 123.697 1.713 . . . . 1.36 110.615 -177.811 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.0 mt -95.84 169.5 9.96 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.619 -1.628 . . . . 2.03 111.354 172.175 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -126.52 110.71 13.56 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.567 -1.958 . . . . 2.31 113.634 -173.281 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.7 tp -87.37 112.23 21.91 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.203 -1.56 . . . . 1.72 108.783 -175.824 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.459 HG23 HG12 ' A' ' 44' ' ' ILE . 49.4 t -107.46 131.36 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 129.519 3.128 . . . . 1.8 112.068 170.881 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.6 mt . . . . . 0 N--CA 1.431 -1.381 0 O-C-N 120.056 -1.653 . . . . 3.26 111.289 -176.886 . . . . . . . . 0 0 . 1 . 122 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 CA--C 1.491 -1.315 0 CA-C-O 118.85 -0.595 . . . . 1.39 110.761 . . . . . . . . . 0 0 . 1 . 122 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -97.25 118.96 34.86 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 113.633 0.975 . . . . 2.2 113.633 -169.553 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.8 pt -125.59 169.62 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 120.504 1.502 . . . . 1.32 112.725 172.404 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -120.87 154.02 36.39 Favored 'General case' 0 N--CA 1.431 -1.407 1 O-C-N 114.913 -4.867 . . . . 2.2 110.628 -178.211 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.3 t -125.39 135.25 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 103.237 -2.875 . . . . 1.23 103.237 172.901 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -114.22 143.38 44.92 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.837 -3.039 . . . . 2.51 107.579 176.803 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -96.75 170.08 9.43 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.414 1.486 . . . . 1.41 114.566 176.552 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.3 mt -55.7 -45.53 77.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.554 -2.591 . . . . 2.95 110.246 174.355 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 p -73.64 -57.46 3.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 116.66 -1.638 . . . . 2.52 111.936 -177.001 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.11 19.25 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.7 0 CA-C-O 125.549 2.75 . . . . 1.5 117.485 179.156 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -102.99 122.33 44.39 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 111.659 -2.27 . . . . 1.79 109.004 -168.707 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.0 m -95.6 124.62 39.71 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.395 2.521 . . . . 1.38 110.96 177.305 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 mm -100.44 129.7 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 115.034 -2.412 . . . . 2.03 106.824 -179.097 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.4 m -89.72 104.84 17.36 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 124.133 3.152 . . . . 1.61 108.319 179.49 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.4 mt -108.73 146.52 33.39 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 125.455 3.752 . . . . 2.15 120.975 -178.845 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -98.33 131.83 44.31 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 114.245 -1.343 . . . . 1.98 109.44 169.682 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.7 m -144.5 162.47 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 1 C-N-CA 132.127 4.171 . . . . 1.52 108.214 177.831 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -114.13 150.8 44.22 Favored Pre-proline 0 N--CA 1.429 -1.477 0 C-N-CA 126.487 1.915 . . . . 2.35 108.452 166.428 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -62.47 -21.92 73.38 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-O 125.182 2.076 . . . . 1.31 114.59 -168.104 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.8 p -83.26 0.1 47.1 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.273 3.429 . . . . 1.71 111.193 178.923 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -79.99 151.97 29.71 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 115.974 -4.204 . . . . 1.69 105.473 172.525 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 35.0 p -93.57 173.48 7.67 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 112.721 -2.036 . . . . 1.33 113.372 177.865 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.415 HG21 ' HG3' ' A' ' 27' ' ' LYS . 42.2 mm -72.05 -33.13 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 O-C-N 120.542 -1.349 . . . . 1.32 108.276 -179.076 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -55.45 -44.96 76.85 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 125.516 2.579 . . . . 1.62 115.806 167.004 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 -60.09 -42.47 94.69 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 116.075 -4.141 . . . . 2.13 112.595 176.488 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.9 t -69.78 -42.04 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 C-N-CA 129.485 3.114 . . . . 1.23 109.737 172.152 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HG3' HG21 ' A' ' 23' ' ' ILE . 75.3 mttt -64.85 -37.44 87.65 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 125.825 3.92 . . . . 1.97 112.267 -178.668 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.5 -31.59 56.29 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 119.926 3.306 . . . . 1.19 119.926 169.739 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.265 15.9 tppt? -80.15 -35.04 37.16 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 121.543 0.687 . . . . 1.92 111.977 174.087 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.8 mt -60.81 -42.49 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.371 -1.455 . . . . 1.94 114.289 171.215 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -56.11 -39.5 72.27 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.878 2.871 . . . . 1.9 111.622 173.845 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -70.57 -45.47 65.35 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 124.71 1.256 . . . . 1.55 113.718 176.698 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -70.67 -51.69 26.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 115.04 1.496 . . . . 2.95 115.04 -176.643 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -104.48 -14.14 15.8 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.682 1.993 . . . . 1.48 113.903 -168.66 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.21 49.23 34.22 Favored Glycine 0 N--CA 1.431 -1.648 0 O-C-N 118.238 -2.789 . . . . 1.12 112.987 175.438 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.415 HG21 ' HG3' ' A' ' 41' ' ' GLN . 56.9 mt -125.25 126.38 25.14 Favored Pre-proline 0 N--CA 1.429 -1.478 0 N-CA-C 105.047 -2.205 . . . . 2.07 105.047 178.735 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -66.84 150.29 83.24 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 125.237 3.958 . . . . 1.39 111.79 179.983 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -60.08 -31.51 93.47 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 C-N-CA 125.169 3.913 . . . . 1.68 114.721 -173.689 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -56.96 -41.4 78.27 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 130.33 3.452 . . . . 2.25 110.096 176.285 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -89.19 2.72 53.8 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.601 -1.312 . . . . 2.44 113.714 -178.307 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.415 ' HG3' HG21 ' A' ' 36' ' ' ILE . 73.5 mt-30 -90.01 116.51 28.1 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.429 2.692 . . . . 1.32 116.678 -173.697 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -111.96 109.03 18.58 Favored 'General case' 0 N--CA 1.429 -1.5 1 O-C-N 115.623 -4.423 . . . . 3.19 111.777 169.2 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.8 mt -89.4 122.04 32.23 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.943 -1.723 . . . . 1.75 108.537 -178.879 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.3 mm -111.47 123.43 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 126.941 3.258 . . . . 1.98 111.474 177.316 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.276 69.6 t80 -132.31 134.7 45.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 116.531 -3.856 . . . . 1.94 104.533 173.104 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.99 28.22 0.59 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 119.77 3.248 . . . . 1.67 119.77 -177.62 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.8 -12.1 69.83 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 126.033 1.778 . . . . 1.3 111.598 -177.757 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -86.59 145.04 26.91 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.621 -1.517 . . . . 2.89 114.396 -179.347 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -87.09 109.76 19.64 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.033 -2.292 . . . . 2.89 109.615 171.893 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.7 mt -71.16 133.14 45.96 Favored 'General case' 0 N--CA 1.431 -1.423 1 CA-C-O 128.778 4.132 . . . . 1.34 109.303 -170.017 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -89.94 135.69 33.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.363 -3.961 . . . . 1.94 118.123 -179.791 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -55.05 -54.22 45.83 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 116.864 -3.648 . . . . 1.56 119.332 -168.492 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.55 23.27 16.74 Favored Glycine 0 N--CA 1.429 -1.785 0 CA-C-O 118.424 -1.209 . . . . 0.97 112.026 177.298 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.4 mtt-85 -104.27 161.56 13.94 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 121.679 2.74 . . . . 3.07 108.624 165.981 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.1 p -97.89 156.63 16.51 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.557 2.743 . . . . 1.34 112.993 178.005 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.3 mt -58.86 -32.48 69.48 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.243 2.449 . . . . 1.63 114.878 179.712 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.5 p -69.03 -26.65 65.1 Favored 'General case' 0 N--CA 1.429 -1.52 0 O-C-N 116.627 -3.795 . . . . 1.51 117.558 176.376 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -68.61 -37.18 79.58 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.53 -1.981 . . . . 1.9 110.628 174.974 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -82.0 -13.57 57.21 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 115.262 -2.304 . . . . 0.97 106.779 -178.403 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.3 m120 65.82 56.44 0.89 Allowed 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 126.295 2.247 . . . . 2.35 108.437 -177.174 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.8 mt -99.32 136.17 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 103.922 -2.622 . . . . 1.39 103.922 179.545 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -109.69 178.16 4.51 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 126.318 2.961 . . . . 2.58 109.932 -178.799 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -60.8 152.32 27.38 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 112.4 -2.182 . . . . 2.58 116.212 167.778 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.277 53.4 mt-10 67.04 11.99 8.71 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 114.937 1.458 . . . . 1.71 114.937 -177.899 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -89.16 150.0 22.89 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.067 2.365 . . . . 1.34 109.485 -175.883 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.1 m -104.38 120.28 40.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.175 -1.578 . . . . 1.36 111.757 -176.918 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.3 mt -89.51 135.7 33.45 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.695 -1.878 . . . . 2.03 112.399 172.988 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -105.53 122.5 46.13 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.581 -2.574 . . . . 2.31 104.998 -174.792 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.0 tp -93.63 108.51 20.22 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.445 2.298 . . . . 1.72 110.803 -177.084 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.278 28.8 t -98.88 140.29 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 128.179 3.847 . . . . 1.8 105.07 173.216 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 N--CA 1.431 -1.388 0 O-C-N 118.621 -2.55 . . . . 3.26 106.756 170.643 . . . . . . . . 0 0 . 1 . 123 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.4 ttp . . . . . 0 CA--C 1.489 -1.388 0 CA-C-O 117.375 -1.298 . . . . 1.39 109.681 . . . . . . . . . 0 0 . 1 . 123 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -87.8 133.05 33.95 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 120.314 1.415 . . . . 2.2 114.681 -178.704 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pt -138.98 164.54 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 118.582 -2.574 . . . . 1.32 109.332 174.443 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -113.21 146.71 38.84 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 127.053 2.141 . . . . 2.2 110.852 -177.397 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.1 t -126.98 105.61 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 105.886 -1.894 . . . . 1.23 105.886 175.076 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -84.03 120.96 26.76 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 131.631 3.972 . . . . 2.51 115.293 173.761 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.2 p -104.41 -121.96 0.21 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.677 1.362 . . . . 1.41 114.677 -174.163 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.0 tp -159.98 -63.53 0.07 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 103.284 -2.858 . . . . 2.95 103.284 173.585 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.5 p -97.14 93.94 6.84 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 120.418 1.463 . . . . 2.52 111.901 -178.215 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.49 -146.93 17.63 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 127.842 2.639 . . . . 1.5 110.415 176.96 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -90.88 168.33 11.78 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 122.545 1.164 . . . . 1.79 112.154 -174.853 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -102.61 116.91 33.54 Favored 'General case' 0 N--CA 1.431 -1.383 1 N-CA-C 99.382 -4.303 . . . . 1.38 99.382 175.65 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.28 16.4 pt -84.33 152.17 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 128.097 2.559 . . . . 2.03 112.578 178.159 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 m -116.77 128.67 55.52 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 128.345 2.658 . . . . 1.61 106.263 176.617 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.6 mt -122.06 157.43 31.43 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.393 -2.692 . . . . 2.15 108.447 179.663 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -107.65 120.88 43.45 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.019 -2.301 . . . . 1.98 104.983 170.996 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.1 m -131.03 172.55 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 125.435 1.494 . . . . 1.52 109.806 -175.263 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -112.94 152.7 45.1 Favored Pre-proline 0 N--CA 1.43 -1.441 0 CA-C-O 116.304 -1.808 . . . . 2.35 111.136 164.911 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.76 -22.32 32.26 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 126.335 3.298 . . . . 1.31 114.118 -176.345 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.0 m -72.45 -12.88 61.28 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 116.137 -1.887 . . . . 1.71 110.251 176.073 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -66.08 135.54 54.76 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 123.4 2.818 . . . . 1.69 117.842 177.276 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.5 p -69.83 160.91 30.89 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 117.547 -3.221 . . . . 1.33 112.873 176.795 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 mm -66.58 -42.28 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 128.025 2.53 . . . . 1.32 108.279 175.366 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -45.93 -49.62 15.52 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.084 2.624 . . . . 1.62 118.084 161.275 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -68.31 -45.53 72.72 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 127.547 3.029 . . . . 2.13 111.447 178.997 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.5 t -59.02 -30.1 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 115.209 1.559 . . . . 1.23 115.209 173.936 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -68.38 -35.56 77.88 Favored 'General case' 0 N--CA 1.43 -1.475 1 O-C-N 113.871 -5.518 . . . . 1.97 111.671 169.657 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.2 -46.76 82.6 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 124.106 1.908 . . . . 1.19 115.506 169.6 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -47.98 -49.84 29.41 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 127.0 2.12 . . . . 1.92 109.046 169.727 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.2 mt -62.63 -30.34 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 123.653 2.933 . . . . 1.94 116.856 175.462 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -68.48 -34.64 76.29 Favored 'General case' 0 N--CA 1.431 -1.414 1 CA-C-O 128.821 4.153 . . . . 1.9 114.52 -174.181 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -61.74 -41.41 97.62 Favored 'General case' 0 N--CA 1.432 -1.369 2 O-C-N 115.043 -4.786 . . . . 1.55 112.178 172.286 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -91.74 -65.65 0.99 Allowed 'General case' 0 N--CA 1.429 -1.495 1 O-C-N 115.556 -4.465 . . . . 2.95 107.467 -172.801 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -88.36 -17.77 29.85 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 126.111 2.862 . . . . 1.48 116.158 -165.241 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.75 34.31 28.12 Favored Glycine 0 N--CA 1.43 -1.747 0 O-C-N 117.648 -3.158 . . . . 1.12 116.248 176.629 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.8 mt -107.85 121.92 42.49 Favored Pre-proline 0 N--CA 1.429 -1.492 0 N-CA-C 107.011 -1.477 . . . . 2.07 107.011 -178.354 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.288 52.8 Cg_exo -51.36 146.8 23.54 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-O 113.875 -2.635 . . . . 1.39 116.357 175.78 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -68.67 -23.1 36.68 Favored 'Trans proline' 0 C--N 1.299 -2.058 1 C-N-CA 125.761 4.307 . . . . 1.68 110.249 -175.623 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -84.44 -18.48 35.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.555 2.428 . . . . 2.25 117.555 176.573 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -88.34 -24.15 23.21 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 115.465 1.654 . . . . 2.44 115.465 -177.59 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -100.57 139.25 36.52 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.568 1.547 . . . . 1.32 112.528 -177.201 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -118.4 133.14 56.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 107.89 -1.152 . . . . 3.19 107.89 175.172 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.6 mt -99.5 127.0 45.54 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.733 1.606 . . . . 1.75 114.762 -179.441 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.0 mm -107.86 138.41 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 1 O-C-N 130.357 4.786 . . . . 1.98 107.121 -177.09 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -145.72 140.05 26.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.441 -3.912 . . . . 1.94 102.274 171.552 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.301 . . 62.5 -96.13 0.05 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.604 1.561 . . . . 1.67 109.079 -174.66 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.61 24.59 1.2 Allowed Glycine 0 N--CA 1.429 -1.817 0 O-C-N 127.744 3.153 . . . . 1.3 110.217 -179.291 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -121.34 147.87 45.11 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.2 1.8 . . . . 2.89 107.793 -177.37 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -95.98 130.97 42.82 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.897 -1.956 . . . . 2.89 107.58 173.306 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mt -96.15 124.79 40.29 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.805 3.261 . . . . 1.34 119.805 -172.813 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -66.14 132.75 49.2 Favored 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 132.549 4.34 . . . . 1.94 114.024 177.429 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -63.64 -32.87 74.48 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.297 -3.377 . . . . 1.56 114.737 -169.239 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.84 25.71 7.28 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 116.374 -3.953 . . . . 0.97 115.362 173.662 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -121.47 168.28 11.88 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 120.766 2.283 . . . . 3.07 111.134 173.614 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 p -104.83 154.6 19.83 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.185 1.469 . . . . 1.34 111.262 -178.39 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.8 mt -51.48 -37.96 51.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.046 1.879 . . . . 1.63 113.268 173.444 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -59.16 -50.1 75.33 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.48 -3.263 . . . . 1.51 117.057 171.391 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -43.04 -47.72 5.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.986 -3.571 . . . . 1.9 113.882 168.046 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -77.97 -13.61 59.82 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 117.762 2.504 . . . . 0.97 117.762 177.415 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.5 m120 69.08 63.9 0.29 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.631 1.972 . . . . 2.35 112.723 178.523 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.4 mt -98.33 137.1 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 117.43 -3.293 . . . . 1.39 106.837 176.22 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -117.58 -179.47 3.74 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 106.32 -1.733 . . . . 2.58 106.32 -174.659 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -71.3 140.45 50.31 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 126.77 2.544 . . . . 2.58 115.363 176.712 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 22.9 mt-10 70.83 46.53 0.49 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 126.133 2.873 . . . . 1.71 114.099 177.308 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.3 m -109.42 135.46 50.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 112.076 -2.329 . . . . 1.34 113.298 -173.643 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.3 m -92.47 99.81 12.48 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.788 -3.07 . . . . 1.36 112.392 -173.985 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mp -81.95 146.35 29.82 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.168 -1.79 . . . . 2.03 106.168 176.344 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -107.91 138.44 44.16 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.934 -1.506 . . . . 2.31 106.934 -175.363 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 tt -106.56 122.07 45.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 119.983 1.265 . . . . 1.72 111.435 -177.606 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.6 m -107.84 122.45 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 104.922 -2.251 . . . . 1.8 104.922 175.5 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 N--CA 1.429 -1.479 0 C-N-CA 128.707 2.803 . . . . 3.26 116.863 -173.385 . . . . . . . . 0 0 . 1 . 124 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.3 ttp . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 117.391 2.367 . . . . 1.39 117.391 . . . . . . . . . 0 0 . 1 . 124 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -109.58 113.48 26.3 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.492 1.293 . . . . 2.2 114.492 -173.499 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.3 pt -111.41 171.15 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 119.597 -1.94 . . . . 1.32 110.062 174.246 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -124.65 122.67 38.17 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.869 2.068 . . . . 2.2 108.07 -176.617 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.6 t -104.41 114.17 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 118.549 -2.594 . . . . 1.23 110.091 171.169 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -93.37 158.22 15.84 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.06 -3.525 . . . . 2.51 108.909 178.063 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.9 p -119.27 172.91 7.27 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.533 -3.23 . . . . 1.41 114.369 -178.945 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.2 tp -72.55 -47.3 49.3 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.572 1.653 . . . . 2.95 110.97 178.647 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.9 p -73.65 -30.67 63.07 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.479 -1.388 . . . . 2.52 113.271 -176.398 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.07 2.07 0.65 Allowed Glycine 0 N--CA 1.43 -1.724 0 O-C-N 117.021 -3.55 . . . . 1.5 117.203 176.995 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -91.28 149.84 21.58 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 122.667 3.234 . . . . 1.79 108.57 -179.664 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.2 m -134.95 112.8 10.92 Favored 'General case' 0 N--CA 1.431 -1.398 1 N-CA-C 100.138 -4.023 . . . . 1.38 100.138 -179.806 . . . . . . . . 2 2 . 1 . 124 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 mt -106.31 113.35 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 129.741 3.217 . . . . 2.03 114.231 -171.682 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.6 m -74.75 114.98 13.81 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.662 -2.524 . . . . 1.61 115.542 173.445 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.1 mt -113.66 129.11 56.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.515 1.507 . . . . 2.15 109.088 -176.791 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -97.72 113.86 25.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.618 -1.301 . . . . 1.98 111.714 174.704 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -116.5 166.62 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 126.395 2.309 . . . . 1.52 110.569 -170.599 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -112.19 155.34 43.66 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 113.252 -3.261 . . . . 2.35 105.69 164.641 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.9 -21.73 63.81 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 CA-C-N 124.207 2.538 . . . . 1.31 117.433 -175.957 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.5 p -73.89 -17.31 61.06 Favored 'General case' 0 N--CA 1.431 -1.41 1 C-N-CA 134.307 5.043 . . . . 1.71 118.927 173.024 . . . . . . . . 2 2 . 1 . 124 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -69.14 143.47 54.11 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 125.475 2.56 . . . . 1.69 109.301 174.083 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 3.3 p -94.74 164.12 13.07 Favored 'General case' 0 N--CA 1.431 -1.408 1 O-C-N 116.197 -4.064 . . . . 1.33 105.154 -177.43 . . . . . . . . 3 3 . 1 . 124 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.1 mm -56.27 -42.91 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 126.666 2.479 . . . . 1.32 111.605 176.651 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -46.77 -50.55 18.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 116.213 1.931 . . . . 1.62 116.213 164.559 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -74.02 -24.97 59.63 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 121.919 2.145 . . . . 2.13 111.166 178.45 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.2 t -74.06 -33.27 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 116.867 -3.646 . . . . 1.23 111.322 176.44 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -71.16 -28.84 64.55 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.347 -3.971 . . . . 1.97 109.231 172.366 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.57 -28.13 69.66 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 115.914 -4.241 . . . . 1.19 117.377 168.192 . . . . . . . . 2 2 . 1 . 124 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -74.16 -30.87 62.47 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 122.593 2.452 . . . . 1.92 109.021 -178.134 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.0 mt -67.69 -35.71 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 O-C-N 127.216 2.822 . . . . 1.94 114.813 172.284 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -73.33 -15.8 61.38 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 118.993 2.96 . . . . 1.9 118.993 178.157 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -69.07 -43.0 75.48 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.436 1.273 . . . . 1.55 114.436 162.721 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -73.06 -61.07 1.94 Allowed 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 126.893 3.235 . . . . 2.95 112.348 -175.405 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -100.15 -30.34 11.99 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.133 -2.854 . . . . 1.48 110.16 -164.564 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.43 33.11 7.75 Favored Glycine 0 N--CA 1.431 -1.674 0 O-C-N 128.116 3.385 . . . . 1.12 115.729 173.239 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.3 mt -106.05 129.21 24.93 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 116.566 -1.683 . . . . 2.07 107.291 -177.975 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -62.82 142.65 89.57 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 124.405 3.404 . . . . 1.39 119.747 175.98 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.28 -17.65 35.07 Favored 'Trans proline' 0 C--N 1.299 -2.057 0 N-CA-C 118.445 2.441 . . . . 1.68 118.445 -178.111 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -68.15 -24.87 65.04 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.72 -1.237 . . . . 2.25 113.728 173.144 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -93.69 -18.11 22.48 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.746 1.736 . . . . 2.44 111.184 -179.493 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -95.02 154.15 17.3 Favored 'General case' 0 N--CA 1.431 -1.378 0 O-C-N 118.419 -2.676 . . . . 1.32 110.82 -176.264 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -141.32 151.35 43.53 Favored 'General case' 0 N--CA 1.43 -1.465 1 C-N-CA 133.284 4.633 . . . . 3.19 113.257 171.136 . . . . . . . . 2 2 . 1 . 124 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.5 mt -115.99 132.61 56.6 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.211 -2.806 . . . . 1.75 111.035 177.404 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.1 mt -109.73 123.1 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.354 -1.35 . . . . 1.98 107.354 -178.529 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -145.72 140.92 27.57 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.382 -2.699 . . . . 1.94 103.976 175.712 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.85 14.21 7.99 Favored 'General case' 0 N--CA 1.43 -1.434 1 C-N-CA 131.717 4.007 . . . . 1.67 114.53 -176.555 . . . . . . . . 2 2 . 1 . 124 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.95 -30.39 10.52 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 125.74 1.638 . . . . 1.3 115.441 -171.796 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -101.25 156.16 17.6 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 120.73 2.265 . . . . 2.89 115.422 -177.974 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -72.29 135.62 46.02 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 116.897 -1.525 . . . . 2.89 113.416 167.797 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.6 mt -89.05 145.57 25.39 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.102 2.228 . . . . 1.34 112.716 -176.119 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -72.55 139.24 47.4 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.203 -2.186 . . . . 1.94 111.549 173.418 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -66.99 -56.25 10.96 Favored 'General case' 0 N--CA 1.431 -1.409 1 C-N-CA 131.826 4.05 . . . . 1.56 119.49 -168.519 . . . . . . . . 2 2 . 1 . 124 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.6 37.14 2.78 Favored Glycine 0 N--CA 1.43 -1.757 0 O-C-N 117.936 -2.977 . . . . 0.97 116.775 175.564 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 22' ' ' THR . 83.3 mtt-85 -114.13 160.49 18.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.866 -2.549 . . . . 3.07 108.576 171.266 . . . . . . . . 2 2 . 1 . 124 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.452 54.7 p -87.49 146.27 25.89 Favored 'General case' 0 N--CA 1.43 -1.47 1 C-N-CA 132.103 4.161 . . . . 1.34 111.571 179.711 . . . . . . . . 4 3 . 1 . 124 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mt -55.46 -34.87 64.9 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 114.694 1.368 . . . . 1.63 114.694 172.026 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 p -64.11 -33.81 76.62 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.238 3.015 . . . . 1.51 112.975 178.567 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -66.62 -37.12 84.19 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 125.047 1.339 . . . . 1.9 113.74 178.226 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -85.92 -5.13 59.28 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.06 1.344 . . . . 0.97 110.038 175.152 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.4 t30 60.74 38.45 18.25 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 127.053 3.311 . . . . 2.35 116.257 179.139 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.0 mt -74.82 125.24 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 O-C-N 116.892 -3.63 . . . . 1.39 109.611 -177.405 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -99.19 -175.84 3.14 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.217 -2.802 . . . . 2.58 111.854 -176.982 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -70.68 160.67 32.18 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 124.116 1.912 . . . . 2.58 111.233 177.165 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.384 16.4 mt-10 44.83 48.54 9.1 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 118.133 2.642 . . . . 1.71 118.133 179.626 . . . . . . . . 2 2 . 1 . 124 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.6 m -107.28 144.05 34.66 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 127.34 2.9 . . . . 1.34 106.028 -175.941 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.6 m -108.75 103.81 12.96 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.586 -1.188 . . . . 1.36 108.118 -178.205 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mp -87.62 158.51 18.85 Favored 'General case' 0 N--CA 1.429 -1.475 1 C-N-CA 132.52 4.328 . . . . 2.03 106.377 173.339 . . . . . . . . 2 2 . 1 . 124 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -121.28 142.89 49.51 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 102.079 -3.304 . . . . 2.31 102.079 -174.085 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.5 tp -97.99 129.35 44.87 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 114.669 -2.586 . . . . 1.72 108.975 -179.784 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 m -129.72 168.05 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 121.642 2.019 . . . . 1.8 106.632 171.092 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.43 -1.456 0 O-C-N 119.384 -2.073 . . . . 3.26 106.772 -177.147 . . . . . . . . 0 0 . 1 . 125 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptt? . . . . . 0 CA--C 1.489 -1.389 0 N-CA-C 108.363 -0.977 . . . . 1.39 108.363 . . . . . . . . . 0 0 . 1 . 125 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -102.39 131.58 48.94 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.009 2.124 . . . . 2.2 112.365 -172.147 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.412 HD13 HG22 ' A' ' 17' ' ' VAL . 23.1 pt -139.07 157.17 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-O 125.606 2.622 . . . . 1.32 106.625 176.651 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -109.01 121.7 45.69 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.834 -2.416 . . . . 2.2 112.764 -176.954 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.1 t -96.85 103.42 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 116.854 -3.654 . . . . 1.23 107.166 175.073 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -76.43 136.43 39.44 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 118.567 2.803 . . . . 2.51 118.567 168.272 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -83.33 169.96 15.08 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.065 -4.147 . . . . 1.41 109.847 177.622 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.2 mt -60.71 -42.64 97.64 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.419 -2.676 . . . . 2.95 115.455 170.324 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -75.44 -51.2 13.61 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 127.145 2.778 . . . . 2.52 116.148 -176.706 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.21 -44.84 0.19 Allowed Glycine 0 N--CA 1.431 -1.695 0 CA-C-O 113.956 -3.691 . . . . 1.5 114.161 -177.845 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -53.51 136.18 38.7 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 122.62 3.21 . . . . 1.79 118.625 -177.445 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.266 88.5 m -107.72 98.7 8.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.79 1.757 . . . . 1.38 107.818 178.4 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -80.72 98.64 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 125.695 2.664 . . . . 2.03 110.195 177.231 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.5 m -82.12 122.85 28.38 Favored 'General case' 0 N--CA 1.429 -1.498 1 O-C-N 115.153 -4.717 . . . . 1.61 110.722 178.269 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.5 mt -122.28 144.32 49.07 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.175 1.917 . . . . 2.15 116.175 -178.494 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -103.86 124.83 49.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 116.42 -2.112 . . . . 1.98 108.749 174.905 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.412 HG22 HD13 ' A' ' 3' ' ' ILE . 20.8 m -140.98 165.08 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.041 -1.662 . . . . 1.52 108.094 -171.122 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.293 4.6 mm-40 -102.75 150.19 37.49 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-O 114.538 -2.649 . . . . 2.35 110.518 163.578 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -75.96 -14.9 18.95 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 125.877 3.135 . . . . 1.31 109.12 -171.963 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.1 p -81.18 -1.31 44.16 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 123.836 1.779 . . . . 1.71 114.129 174.202 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -75.02 147.92 40.31 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 118.315 -2.74 . . . . 1.69 113.021 172.309 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.0 p -85.82 176.42 8.12 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 124.287 1.994 . . . . 1.33 112.894 -175.349 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.408 HG23 ' HB2' ' A' ' 50' ' ' LEU 0.252 20.8 mm -76.85 -37.23 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 116.345 -3.972 . . . . 1.32 106.278 177.832 . . . . . . . . 3 3 . 1 . 125 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -53.33 -36.36 61.2 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.282 -3.386 . . . . 1.62 112.027 169.027 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -74.83 -46.08 38.96 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 120.629 1.559 . . . . 2.13 112.281 177.365 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.1 t -57.3 -43.26 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 C-N-CA 128.829 2.852 . . . . 1.23 112.02 175.538 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -70.26 -34.26 72.6 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.661 2.467 . . . . 1.97 117.661 171.509 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.94 89.29 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.598 -1.939 . . . . 1.19 106.855 178.057 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -57.97 -41.52 83.1 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 119.292 3.071 . . . . 1.92 119.292 167.567 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.268 65.3 mt -63.22 -35.91 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.242 -2.786 . . . . 1.94 113.66 170.635 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -61.37 -41.26 96.81 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 130.747 3.619 . . . . 1.9 109.389 172.074 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -58.15 -57.53 12.45 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 114.45 1.278 . . . . 1.55 114.45 177.195 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -73.13 -63.59 1.15 Allowed 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 117.731 2.493 . . . . 2.95 117.731 -174.284 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -101.35 -19.06 15.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.071 -1.643 . . . . 1.48 111.566 -168.529 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.76 30.3 6.88 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 118.215 2.046 . . . . 1.12 118.215 173.696 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.9 mt -106.15 119.2 52.86 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-N 121.35 2.575 . . . . 2.07 109.104 -176.018 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -56.28 145.89 75.19 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 CA-C-N 127.263 3.629 . . . . 1.39 114.363 174.946 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -82.72 -5.31 11.56 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 124.499 3.466 . . . . 1.68 108.493 -166.214 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -80.93 -23.74 38.67 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.516 1.507 . . . . 2.25 111.384 176.389 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -90.07 -12.75 37.56 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.051 -2.281 . . . . 2.44 111.657 -178.192 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -87.21 123.49 32.28 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 130.167 3.387 . . . . 1.32 111.647 -174.682 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -123.47 114.13 19.69 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-O 125.107 2.384 . . . . 3.19 109.472 161.777 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.9 mt -87.18 138.6 31.35 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 124.346 2.022 . . . . 1.75 106.486 -178.553 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.6 mt -135.37 128.54 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 128.006 2.523 . . . . 1.98 110.209 -178.54 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -127.17 115.32 18.92 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 115.291 -4.631 . . . . 1.94 104.603 177.931 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 73.15 -58.52 0.6 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.729 2.812 . . . . 1.67 110.605 177.082 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -162.66 -13.73 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 O-C-N 120.502 -1.374 . . . . 1.3 111.849 -178.365 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -98.62 134.0 42.17 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.127 -1.536 . . . . 2.89 109.502 -177.163 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -73.27 140.61 46.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.838 2.055 . . . . 2.89 108.856 166.828 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.408 ' HB2' HG23 ' A' ' 23' ' ' ILE . 16.0 mt -97.56 123.28 41.39 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.204 -1.776 . . . . 1.34 106.204 -170.853 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -91.46 145.68 24.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.747 -2.471 . . . . 1.94 110.26 178.955 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -43.26 -57.59 2.92 Favored 'General case' 0 N--CA 1.43 -1.439 1 C-N-CA 131.993 4.117 . . . . 1.56 119.818 -175.757 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.15 7.29 8.13 Favored Glycine 0 N--CA 1.43 -1.728 1 N-CA-C 123.149 4.02 . . . . 0.97 123.149 168.524 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -98.23 167.07 11.09 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 120.656 2.228 . . . . 3.07 112.158 167.738 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.341 18.6 p -109.81 166.61 10.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.828 2.159 . . . . 1.34 116.828 -179.137 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.6 mt -61.98 -35.36 78.28 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.029 2.347 . . . . 1.63 111.62 172.21 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.8 t -75.84 -33.03 60.02 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.601 -2.562 . . . . 1.51 113.477 -179.997 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -56.42 -46.4 80.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.834 2.054 . . . . 1.9 114.116 166.248 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -84.77 -9.22 58.4 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 121.817 2.099 . . . . 0.97 112.756 -179.617 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.522 12.8 m120 81.68 46.52 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 125.867 1.667 . . . . 2.35 113.591 175.403 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.1 mt -96.8 118.81 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 113.495 -1.684 . . . . 1.39 114.012 179.931 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -115.1 -179.02 3.51 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 106.319 -1.734 . . . . 2.58 106.319 -174.964 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -62.05 151.87 34.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 127.801 2.441 . . . . 2.58 114.405 -178.675 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 66.2 29.55 9.66 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.797 2.237 . . . . 1.71 110.746 177.495 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.6 p -106.71 150.95 25.75 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 113.982 -5.449 . . . . 1.34 109.298 -176.158 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.4 m -103.14 122.18 44.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.329 2.49 . . . . 1.36 109.668 179.713 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -110.57 145.21 38.22 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 118.615 -2.553 . . . . 2.03 105.539 176.559 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -100.67 136.12 41.03 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 118.58 -2.575 . . . . 2.31 107.189 179.859 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.5 tp -113.96 123.96 50.99 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.961 -1.712 . . . . 1.72 108.21 174.691 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.8 t -105.85 134.51 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 103.083 -2.932 . . . . 1.8 103.083 176.04 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.8 tp . . . . . 0 N--CA 1.43 -1.448 0 CA-C-O 125.339 2.495 . . . . 3.26 111.985 174.825 . . . . . . . . 0 0 . 1 . 126 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.4 ttp . . . . . 0 CA--C 1.49 -1.335 0 CA-C-O 117.396 -1.288 . . . . 1.39 110.935 . . . . . . . . . 0 0 . 1 . 126 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -81.34 133.1 35.37 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 120.405 1.457 . . . . 2.2 111.21 -179.136 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 pt -140.25 162.73 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 123.981 1.848 . . . . 1.32 108.072 173.565 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -120.66 133.31 55.37 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 102.226 -3.25 . . . . 2.2 102.226 -177.148 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.0 t -109.48 123.83 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 127.994 2.517 . . . . 1.23 104.831 167.829 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -101.06 124.16 46.34 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.787 -1.821 . . . . 2.51 111.43 176.74 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -85.84 151.81 23.5 Favored 'General case' 0 N--CA 1.431 -1.41 1 O-C-N 115.448 -4.533 . . . . 1.41 114.041 175.032 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.5 tp -34.56 -54.1 0.54 Allowed 'General case' 0 N--CA 1.43 -1.434 1 C-N-CA 133.018 4.527 . . . . 2.95 115.404 169.83 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.4 p -81.88 -31.78 31.32 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 125.872 1.982 . . . . 2.52 110.644 -170.93 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.78 17.28 0.11 Allowed Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 118.444 -1.836 . . . . 1.5 117.048 178.862 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.407 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 73.8 tttt -114.79 141.91 47.23 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 115.68 -4.423 . . . . 1.79 105.404 -177.685 . . . . . . . . 3 3 . 1 . 126 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.5 m -105.77 124.79 50.13 Favored 'General case' 0 N--CA 1.429 -1.522 0 O-C-N 123.358 0.411 . . . . 1.38 109.944 173.473 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mt -93.46 116.09 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 125.577 2.608 . . . . 2.03 105.933 179.889 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.2 m -92.26 102.45 14.95 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 115.507 -4.495 . . . . 1.61 107.323 174.72 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.5 mt -90.96 160.21 15.77 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.526 -1.359 . . . . 2.15 110.54 178.616 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -125.3 114.06 18.41 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 119.854 -1.779 . . . . 1.98 108.008 165.715 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.01 -176.2 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 119.205 -2.185 . . . . 1.52 110.382 -173.318 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -107.08 149.12 38.22 Favored Pre-proline 0 N--CA 1.43 -1.432 0 CA-C-O 114.096 -2.859 . . . . 2.35 109.622 167.145 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.39 -24.15 19.68 Favored 'Trans proline' 0 N--CA 1.433 -2.054 1 CA-C-N 128.661 4.129 . . . . 1.31 111.807 -171.561 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.8 m -102.03 16.29 26.47 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 126.318 2.261 . . . . 1.71 116.873 -179.352 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.83 157.56 25.68 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.306 1.527 . . . . 1.69 112.446 173.227 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.8 p -86.68 162.58 17.84 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.51 3.052 . . . . 1.33 116.204 -176.903 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mm -70.45 -38.96 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 1 O-C-N 115.124 -4.735 . . . . 1.32 107.512 -179.289 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -47.58 -54.11 12.7 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.346 3.058 . . . . 1.62 111.592 167.937 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -62.22 -36.98 83.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.945 2.898 . . . . 2.13 118.178 171.375 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.372 4.2 t -63.3 -39.31 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 116.57 -3.831 . . . . 1.23 112.52 174.847 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -65.91 -32.39 73.87 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.844 2.165 . . . . 1.97 116.844 172.089 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.82 -31.62 72.36 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.636 -1.915 . . . . 1.19 114.1 170.472 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -68.24 -26.88 65.91 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.276 1.988 . . . . 1.92 115.217 170.199 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.4 mt -75.2 -28.25 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 117.385 -3.322 . . . . 1.94 114.174 170.489 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -70.81 -38.39 73.29 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.352 2.501 . . . . 1.9 115.062 170.3 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.83 -36.84 85.23 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 116.748 -3.72 . . . . 1.55 111.917 172.513 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -85.35 -53.39 5.25 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.478 1.609 . . . . 2.95 110.919 -176.69 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.407 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 65.8 mm-40 -100.73 -43.98 5.96 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.882 -3.011 . . . . 1.48 117.141 -174.069 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.66 -0.73 18.03 Favored Glycine 0 N--CA 1.429 -1.806 0 CA-C-O 117.01 -1.994 . . . . 1.12 111.599 178.194 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.0 mt -70.22 130.72 89.23 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-N 121.099 2.45 . . . . 2.07 112.733 -178.805 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -76.32 154.3 36.29 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 O-C-N 115.556 -2.918 . . . . 1.39 116.023 174.788 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -71.8 -6.81 19.89 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 124.009 3.139 . . . . 1.68 113.039 -169.13 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -67.58 -35.03 78.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.345 3.058 . . . . 2.25 109.132 175.116 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -85.28 -22.32 28.64 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.384 -1.448 . . . . 2.44 113.396 178.708 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -83.19 119.16 24.19 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.028 -2.92 . . . . 1.32 117.622 -168.654 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.425 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 51.4 ttt180 -107.83 118.78 37.63 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 105.297 -2.112 . . . . 3.19 105.297 172.758 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.5 mt -113.73 122.51 47.33 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 116.375 -1.774 . . . . 1.75 108.671 -177.092 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.3 mt -120.19 136.2 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 124.574 2.13 . . . . 1.98 107.702 177.483 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -130.4 112.2 13.03 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.056 1.884 . . . . 1.94 109.496 171.45 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.65 -72.58 0.09 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.468 2.307 . . . . 1.67 114.021 177.968 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.7 -62.18 0.19 Allowed Glycine 0 N--CA 1.43 -1.751 0 O-C-N 120.835 -1.165 . . . . 1.3 112.675 -178.28 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -79.85 153.51 29.04 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 115.085 1.513 . . . . 2.89 115.085 -173.455 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -82.95 137.66 34.11 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.321 -2.737 . . . . 2.89 111.052 171.503 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.8 mt -84.87 121.57 27.92 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.488 -2.007 . . . . 1.34 114.835 -169.217 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.316 10.7 pt-20 -78.63 173.25 12.62 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 118.463 -2.648 . . . . 1.94 115.669 175.152 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -68.08 -58.68 4.09 Favored 'General case' 0 N--CA 1.429 -1.478 1 N-CA-C 125.054 5.205 . . . . 1.56 125.054 -177.023 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.65 56.59 1.37 Allowed Glycine 0 N--CA 1.43 -1.711 0 O-C-N 118.502 -2.624 . . . . 0.97 111.143 170.81 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -123.24 168.65 12.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.224 -2.139 . . . . 3.07 105.224 160.722 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.0 p -101.65 169.29 8.93 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.469 -1.394 . . . . 1.34 112.279 179.494 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mt -54.61 -44.9 73.51 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 114.717 1.377 . . . . 1.63 114.717 166.98 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.262 41.7 p -67.88 -24.38 65.22 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.258 2.623 . . . . 1.51 115.078 -176.651 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -70.59 -25.18 62.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.124 2.869 . . . . 1.9 115.793 176.195 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -95.81 -6.71 38.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.123 -2.308 . . . . 0.97 114.18 175.157 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.26 7.6 t30 76.53 43.16 0.15 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.864 -2.397 . . . . 2.35 110.166 179.56 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.7 mt -91.91 107.3 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.733 -1.229 . . . . 1.39 108.261 177.325 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -101.08 -170.82 1.89 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 126.184 2.897 . . . . 2.58 107.749 -174.304 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -63.69 141.91 58.59 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 111.318 -2.674 . . . . 2.58 110.693 171.822 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 69.05 20.84 7.59 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 110.734 -2.939 . . . . 1.71 116.877 177.008 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.6 m -88.88 159.37 17.72 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 116.165 1.913 . . . . 1.34 116.165 -170.899 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.2 m -101.32 115.79 31.3 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 117.007 -3.558 . . . . 1.36 110.49 -178.97 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -105.37 146.82 28.92 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.674 -1.232 . . . . 2.03 107.674 171.181 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -101.58 130.63 47.94 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 116.132 -1.89 . . . . 2.31 110.736 177.05 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.1 tp -115.12 108.29 16.44 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.205 1.366 . . . . 1.72 107.551 177.172 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 74.6 t -96.2 130.19 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 119.131 -2.23 . . . . 1.8 105.784 171.801 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 N--CA 1.428 -1.543 0 CA-C-N 120.275 1.398 . . . . 3.26 111.087 178.896 . . . . . . . . 0 0 . 1 . 127 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 ptt? . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 104.575 -2.379 . . . . 1.39 104.575 . . . . . . . . . 0 0 . 1 . 127 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -119.08 154.54 33.02 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 124.53 3.332 . . . . 2.2 106.291 175.994 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -136.37 167.36 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 105.425 -2.065 . . . . 1.32 105.425 167.491 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -120.96 125.84 48.44 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.046 2.138 . . . . 2.2 108.129 -176.835 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.6 t -104.45 130.72 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.708 -3.12 . . . . 1.23 105.283 170.751 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.287 12.4 ttpt -127.03 122.08 33.39 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 129.715 4.384 . . . . 2.51 119.645 -177.12 . . . . . . . . 3 2 . 1 . 127 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 p -70.89 161.73 30.53 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 112.671 -2.059 . . . . 1.41 115.106 177.963 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.7 tp -54.31 -48.34 71.44 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.783 2.433 . . . . 2.95 115.465 174.058 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.31 -31.95 70.76 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.522 2.729 . . . . 2.52 115.582 -177.728 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.94 27.68 0.7 Allowed Glycine 0 N--CA 1.429 -1.775 0 CA-C-O 117.641 -1.644 . . . . 1.5 109.817 176.1 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.45 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 78.4 tttt -97.46 122.98 41.15 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.449 3.125 . . . . 1.79 108.318 -178.093 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.4 m -96.45 117.48 30.97 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 127.309 3.433 . . . . 1.38 107.156 172.661 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.8 mt -93.6 122.05 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 117.668 -3.145 . . . . 2.03 102.529 174.944 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -108.91 106.5 16.5 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 123.657 1.694 . . . . 1.61 109.943 174.256 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.4 mt -102.6 152.58 21.01 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 116.475 -3.89 . . . . 2.15 109.445 -178.033 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.68 130.44 42.58 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.382 -1.449 . . . . 1.98 110.869 169.299 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.66 163.01 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 114.196 -1.365 . . . . 1.52 110.232 -173.969 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -104.06 151.25 38.94 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 117.963 -2.961 . . . . 2.35 112.427 158.476 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -75.99 -7.29 18.16 Favored 'Trans proline' 0 N--CA 1.434 -1.998 1 CA-C-N 129.621 4.472 . . . . 1.31 117.359 -176.262 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.3 m -82.34 -9.95 59.27 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 128.36 2.664 . . . . 1.71 113.515 173.565 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -76.27 158.2 31.81 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 116.195 -2.202 . . . . 1.69 109.774 177.918 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.2 p -87.36 158.46 19.02 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 116.304 1.964 . . . . 1.33 116.304 177.307 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.0 mp -55.13 -46.02 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 118.402 -0.808 . . . . 1.32 111.428 172.187 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.264 42.9 tt0 -41.39 -44.41 2.81 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 120.11 3.374 . . . . 1.62 120.11 163.586 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -83.36 -34.26 25.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.346 -3.346 . . . . 2.13 110.524 -177.077 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.0 t -62.44 -37.82 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 O-C-N 117.016 -3.553 . . . . 1.23 108.076 170.727 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -67.17 -24.63 65.89 Favored 'General case' 0 N--CA 1.431 -1.412 1 CA-C-O 128.715 4.102 . . . . 1.97 119.518 175.64 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.6 -16.39 62.62 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 117.974 -2.954 . . . . 1.19 113.403 169.105 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -87.48 -30.94 20.27 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 116.008 -4.182 . . . . 1.92 112.429 179.01 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.287 51.3 mt -66.16 -19.01 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-O 124.519 2.104 . . . . 1.94 108.518 173.155 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -75.05 -43.97 50.35 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.681 -2.512 . . . . 1.9 112.295 178.458 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -65.81 -53.8 35.29 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.668 1.187 . . . . 1.55 110.143 168.948 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -59.89 -69.71 0.2 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.209 1.48 . . . . 2.95 112.64 -173.179 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.45 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 21.9 mm-40 -90.13 -40.82 12.0 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 128.672 2.789 . . . . 1.48 113.517 -166.848 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.22 31.6 3.75 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 116.244 -2.884 . . . . 1.12 111.849 172.53 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.1 mt -113.17 119.11 43.04 Favored Pre-proline 0 N--CA 1.429 -1.48 0 C-N-CA 126.939 2.096 . . . . 2.07 109.816 -177.001 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -63.1 156.24 56.26 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 125.276 3.984 . . . . 1.39 116.48 175.754 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.88 -21.05 16.55 Favored 'Trans proline' 0 N--CA 1.433 -2.072 0 CA-C-N 128.114 3.934 . . . . 1.68 115.945 -170.171 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.17 -34.08 69.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.777 2.431 . . . . 2.25 115.691 167.369 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -84.8 -1.9 56.99 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 125.743 2.687 . . . . 2.44 112.974 177.952 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -114.87 129.05 56.63 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 115.342 -4.599 . . . . 1.32 111.26 -171.895 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -129.04 134.81 48.27 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 104.638 -2.356 . . . . 3.19 104.638 171.562 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.3 mt -107.38 129.04 54.96 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 128.14 2.576 . . . . 1.75 108.39 -177.77 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.7 mm -105.99 125.44 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 131.282 3.833 . . . . 1.98 102.915 -174.433 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -116.56 110.79 19.02 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 120.651 1.569 . . . . 1.94 107.069 170.53 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.36 -101.61 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 104.826 -2.287 . . . . 1.67 104.826 177.467 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.63 2.98 15.4 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 125.881 1.988 . . . . 1.3 113.831 -179.578 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -115.45 157.07 24.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.214 1.483 . . . . 2.89 109.274 -179.096 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -94.02 144.42 25.48 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.766 -2.679 . . . . 2.89 103.766 179.512 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.8 mt -97.12 140.4 31.69 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.769 -3.082 . . . . 1.34 109.983 -175.441 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -79.39 149.02 31.77 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.294 -1.504 . . . . 1.94 113.184 172.923 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -76.81 -37.12 56.33 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 115.655 1.724 . . . . 1.56 115.655 -173.231 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.43 44.71 2.6 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-O 116.655 -2.192 . . . . 0.97 108.0 179.55 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -126.93 160.05 32.2 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 121.315 2.558 . . . . 3.07 106.07 168.343 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -84.19 175.62 9.33 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 126.553 3.073 . . . . 1.34 112.506 169.448 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.7 mt -71.54 -42.42 67.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.929 -3.607 . . . . 1.63 110.064 171.381 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 m -60.19 -38.85 84.52 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 128.823 2.849 . . . . 1.51 114.094 171.875 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -52.59 -36.6 56.45 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.973 2.953 . . . . 1.9 118.973 171.425 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -90.53 3.05 55.1 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 116.505 2.039 . . . . 0.97 116.505 176.442 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 64.31 27.33 13.77 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.751 2.42 . . . . 2.35 114.64 -173.944 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.257 75.7 mt -69.82 140.8 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 118.943 -2.348 . . . . 1.39 108.185 178.027 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -111.41 175.6 5.36 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.475 -2.016 . . . . 2.58 111.777 -174.441 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -64.0 148.28 50.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.411 -1.431 . . . . 2.58 111.713 166.15 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.338 35.9 mt-10 77.13 21.24 1.12 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.425 -2.047 . . . . 1.71 113.41 169.175 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.95 140.91 30.02 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.982 3.313 . . . . 1.34 112.949 -173.622 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.8 m -89.62 114.83 26.49 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.911 2.884 . . . . 1.36 111.746 -178.856 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -113.52 151.8 31.06 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.851 -3.031 . . . . 2.03 104.789 175.246 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -107.57 123.75 48.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 123.505 1.621 . . . . 2.31 109.854 -169.748 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.5 tp -90.96 110.63 21.88 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.148 -2.845 . . . . 1.72 113.275 -178.034 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.9 t -105.08 128.9 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 1 N-CA-C 99.468 -4.271 . . . . 1.8 99.468 176.67 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.0 tp . . . . . 0 N--CA 1.431 -1.409 0 CA-C-N 113.357 -1.747 . . . . 3.26 109.337 177.147 . . . . . . . . 0 0 . 1 . 128 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 CA--C 1.489 -1.37 0 CA-C-O 122.74 1.257 . . . . 1.39 113.344 . . . . . . . . . 0 0 . 1 . 128 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -114.58 130.03 56.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 115.738 1.755 . . . . 2.2 115.738 -171.508 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.7 pt -120.46 151.67 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-O 115.244 -2.313 . . . . 1.32 111.686 177.693 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -110.66 118.83 37.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.674 -1.973 . . . . 2.2 105.674 -174.298 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.35 116.04 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 O-C-N 118.926 -2.359 . . . . 1.23 111.052 171.983 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.314 42.1 mtpt -104.32 136.3 44.17 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 127.997 3.76 . . . . 2.51 117.599 178.325 . . . . . . . . 2 2 . 1 . 128 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 p -89.82 156.15 18.69 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.522 -2.611 . . . . 1.41 111.07 172.857 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.5 mt -63.6 -44.5 93.82 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.266 -3.396 . . . . 2.95 112.267 168.141 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.337 69.4 p -65.22 -38.47 90.5 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 116.453 -1.737 . . . . 2.52 114.009 -169.7 . . . . . . . . 2 2 . 1 . 128 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.13 1.88 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 123.358 2.799 . . . . 1.5 116.009 167.802 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -98.68 144.82 27.53 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.304 3.052 . . . . 1.79 111.064 -179.587 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -131.07 139.69 49.93 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 118.028 -2.92 . . . . 1.38 106.51 168.084 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.412 HG22 HD12 ' A' ' 13' ' ' ILE . 28.4 pt -130.4 150.99 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 130.098 3.359 . . . . 2.03 106.558 179.165 . . . . . . . . 2 2 . 1 . 128 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 m -107.05 127.15 53.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.946 -1.479 . . . . 1.61 108.022 175.247 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.3 mt -106.8 137.0 45.66 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 125.088 2.375 . . . . 2.15 109.81 169.754 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -89.99 126.47 35.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 128.414 3.959 . . . . 1.98 107.831 162.035 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -132.09 152.33 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 109.585 -3.461 . . . . 1.52 113.358 -173.186 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -99.99 146.18 31.47 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-O 114.776 -2.535 . . . . 2.35 106.459 168.083 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -80.42 -4.8 13.21 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 CA-C-N 128.087 3.924 . . . . 1.31 106.661 -171.302 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.4 p -85.56 -17.63 35.75 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 120.0 -1.687 . . . . 1.71 111.851 175.659 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -61.44 136.26 57.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.826 -2.421 . . . . 1.69 111.733 174.992 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.7 p -78.26 162.23 26.69 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.588 -3.195 . . . . 1.33 112.473 178.655 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.4 mm -64.35 -44.23 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-N 113.09 -1.868 . . . . 1.32 112.093 172.283 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.434 76.2 tt0 -35.26 -58.66 0.55 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.349 -3.344 . . . . 1.62 117.1 158.914 . . . . . . . . 2 2 . 1 . 128 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -68.75 -34.27 75.32 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.018 -3.551 . . . . 2.13 116.253 -177.967 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.7 t -55.3 -44.6 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 118.143 -2.848 . . . . 1.23 116.907 164.518 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 43.3 mtmt -54.18 -49.82 68.44 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.045 3.338 . . . . 1.97 110.018 175.704 . . . . . . . . 2 2 . 1 . 128 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.95 -26.67 67.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.875 -3.016 . . . . 1.19 112.898 178.706 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -67.83 -35.34 78.42 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.218 -2.801 . . . . 1.92 111.604 173.115 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.465 HD12 HG21 ' A' ' 30' ' ' ILE . 35.7 mt -71.36 -26.7 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 117.851 -1.54 . . . . 1.94 112.246 172.934 . . . . . . . . 2 2 . 1 . 128 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -68.15 -37.96 81.6 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 118.854 -0.593 . . . . 1.9 110.889 -179.646 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -58.29 -44.62 88.58 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 123.45 1.595 . . . . 1.55 111.463 175.819 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -84.49 -80.55 0.2 Allowed 'General case' 0 N--CA 1.43 -1.446 1 C-N-CA 132.043 4.137 . . . . 2.95 114.302 -171.197 . . . . . . . . 2 2 . 1 . 128 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -78.4 -27.13 46.69 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 123.742 1.734 . . . . 1.48 110.295 -171.965 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.23 28.63 16.89 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 118.73 -2.481 . . . . 1.12 108.262 170.395 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.9 mt -94.66 123.98 56.38 Favored Pre-proline 0 N--CA 1.431 -1.421 0 N-CA-C 103.98 -2.6 . . . . 2.07 103.98 179.961 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -62.13 145.64 96.33 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 C-N-CA 116.272 -2.018 . . . . 1.39 114.249 175.685 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 88.4 Cg_exo -66.32 -22.36 53.09 Favored 'Trans proline' 0 N--CA 1.433 -2.038 1 C-N-CA 126.201 4.6 . . . . 1.68 112.751 -175.653 . . . . . . . . 3 3 . 1 . 128 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -60.3 -31.98 70.77 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 131.544 3.938 . . . . 2.25 111.375 171.264 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -97.31 1.81 49.94 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 112.76 -2.018 . . . . 2.44 112.245 -178.617 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -100.56 100.14 10.83 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.659 -2.526 . . . . 1.32 111.793 -177.331 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -96.2 95.19 7.96 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.808 -1.807 . . . . 3.19 110.371 168.489 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.1 mt -72.73 127.34 32.26 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.448 1.499 . . . . 1.75 112.891 179.358 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.9 mm -118.36 135.51 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 123.483 2.856 . . . . 1.98 109.598 175.636 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -122.42 101.23 7.38 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.958 -2.339 . . . . 1.94 107.148 175.95 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.3 . . 78.04 -91.72 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.906 1.282 . . . . 1.67 109.935 179.027 . . . . . . . . 2 2 . 1 . 128 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.18 21.09 2.63 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 104.595 -3.402 . . . . 1.3 104.595 -177.567 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -112.08 120.74 42.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.051 -1.852 . . . . 2.89 111.666 178.562 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -76.22 113.7 14.07 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.637 2.375 . . . . 2.89 108.563 166.416 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.6 mt -90.82 146.06 24.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.154 2.407 . . . . 1.34 109.329 -164.04 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -83.98 164.68 19.19 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.258 1.823 . . . . 1.94 112.284 175.281 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -89.32 -53.02 4.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 116.391 -3.943 . . . . 1.56 114.048 -167.691 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.84 18.58 4.81 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 120.118 2.807 . . . . 0.97 120.118 176.046 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.285 0.0 OUTLIER -79.43 152.3 30.39 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.731 1.752 . . . . 3.07 115.731 168.596 . . . . . . . . 3 3 . 1 . 128 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.9 p -89.37 170.48 10.52 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.558 -1.201 . . . . 1.34 111.513 168.523 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.8 mt -75.6 -32.09 60.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.457 -2.027 . . . . 1.63 109.138 177.374 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.294 1.1 t -62.89 -49.4 74.99 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.728 1.611 . . . . 1.51 109.619 -179.199 . . . . . . . . 2 2 . 1 . 128 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -47.2 -50.59 20.54 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.511 2.324 . . . . 1.9 111.776 172.225 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -76.71 -6.53 52.55 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 119.637 3.199 . . . . 0.97 119.637 176.118 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 65.41 41.17 4.37 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.521 2.045 . . . . 2.35 116.521 -179.693 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.8 mt -95.05 114.89 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 101.71 -3.441 . . . . 1.39 101.71 179.146 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -102.26 -175.6 2.88 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.345 -1.298 . . . . 2.58 107.878 -178.072 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -61.03 142.91 56.26 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 117.448 2.388 . . . . 2.58 117.448 169.711 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.379 13.8 mt-10 75.17 19.71 2.22 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 129.965 4.541 . . . . 1.71 118.411 177.569 . . . . . . . . 3 2 . 1 . 128 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 m -92.74 153.52 18.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.538 2.399 . . . . 1.34 105.669 -173.445 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.8 m -106.09 103.52 13.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 131.207 3.803 . . . . 1.36 111.101 -176.358 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -94.47 168.52 10.82 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 105.045 -2.206 . . . . 2.03 105.045 174.405 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.97 162.84 32.17 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 105.499 -2.037 . . . . 2.31 105.499 -174.258 . . . . . . . . 2 2 . 1 . 128 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.265 0.5 OUTLIER -144.77 121.91 11.47 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.983 -1.858 . . . . 1.72 105.983 -172.805 . . . . . . . . 3 3 . 1 . 128 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -115.69 125.65 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 129.416 3.086 . . . . 1.8 106.85 178.713 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.1 mt . . . . . 0 N--CA 1.431 -1.411 0 O-C-N 119.594 -1.941 . . . . 3.26 114.783 -175.649 . . . . . . . . 0 0 . 1 . 129 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.7 ttp . . . . . 0 CA--C 1.491 -1.318 0 N-CA-C 118.974 2.953 . . . . 1.39 118.974 . . . . . . . . . 0 0 . 1 . 129 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.11 127.12 35.41 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 119.417 -2.052 . . . . 2.2 115.091 174.045 . . . . . . . . 2 2 . 1 . 129 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 pt -122.06 163.92 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.612 2.365 . . . . 1.32 114.598 166.534 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -112.0 123.62 50.65 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 116.108 -4.12 . . . . 2.2 113.835 176.169 . . . . . . . . 2 2 . 1 . 129 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.8 t -110.41 113.15 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 118.622 -2.549 . . . . 1.23 108.502 171.052 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -86.37 139.92 30.51 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.894 -1.503 . . . . 2.51 110.503 -178.719 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 p -100.25 175.37 5.74 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.453 2.073 . . . . 1.41 110.412 174.815 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.6 mt -80.56 -25.19 38.74 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 114.876 -4.89 . . . . 2.95 108.892 171.599 . . . . . . . . 2 2 . 1 . 129 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 p -65.88 -46.09 79.67 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.275 -3.39 . . . . 2.52 113.717 -176.092 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.2 6.56 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 112.134 -2.303 . . . . 1.5 117.345 173.765 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -98.85 150.62 21.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 128.157 3.837 . . . . 1.79 114.187 -173.199 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.2 m -114.98 90.93 3.46 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.722 -3.111 . . . . 1.38 105.578 169.822 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mt -80.9 111.15 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 O-C-N 120.805 -1.184 . . . . 2.03 109.36 -179.807 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.4 m -77.17 107.22 9.4 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.144 -2.223 . . . . 1.61 109.584 170.936 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.6 mt -103.64 148.6 25.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 126.764 3.173 . . . . 2.15 104.912 173.828 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -120.44 129.35 53.85 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.172 2.189 . . . . 1.98 113.1 166.703 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.0 m -143.02 174.07 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.486 -2.413 . . . . 1.52 104.486 -178.937 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -96.82 154.03 38.46 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 104.699 -2.334 . . . . 2.35 104.699 165.06 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -73.79 -15.56 23.92 Favored 'Trans proline' 0 C--N 1.3 -2.003 1 C-N-CA 125.871 4.381 . . . . 1.31 112.239 -176.252 . . . . . . . . 2 2 . 1 . 129 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.1 p -94.34 5.57 51.37 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.758 -3.089 . . . . 1.71 115.236 172.225 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -71.39 154.91 41.21 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.85 -1.157 . . . . 1.69 110.426 168.112 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.7 p -92.12 159.5 15.64 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.185 -1.043 . . . . 1.33 108.185 176.752 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -63.53 -16.49 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.463 1.905 . . . . 1.32 113.27 -179.543 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -62.93 -32.58 73.91 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.316 1.846 . . . . 1.62 115.781 166.68 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -72.78 -35.99 67.52 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.887 2.075 . . . . 2.13 111.788 168.765 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.9 t -57.53 -51.53 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 118.945 -2.347 . . . . 1.23 114.381 169.66 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -65.38 -35.99 82.64 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 129.152 2.981 . . . . 1.97 111.339 176.363 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.37 -45.54 69.26 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 116.045 1.868 . . . . 1.19 116.045 174.021 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -74.58 -28.56 60.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.599 1.559 . . . . 1.92 110.256 -179.837 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.6 mt -78.82 -29.17 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 1 O-C-N 115.457 -4.527 . . . . 1.94 114.083 172.669 . . . . . . . . 2 2 . 1 . 129 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -67.31 -32.29 73.17 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.523 -3.236 . . . . 1.9 113.061 170.022 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -61.0 -49.11 78.77 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.247 2.314 . . . . 1.55 117.247 169.666 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -89.23 -43.99 10.6 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.123 2.268 . . . . 2.95 117.123 -176.897 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -99.66 -36.87 9.35 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.434 -2.666 . . . . 1.48 113.182 -172.289 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.83 68.09 1.3 Allowed Glycine 0 N--CA 1.43 -1.704 0 CA-C-N 110.81 -2.905 . . . . 1.12 111.775 172.144 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 mt -126.85 119.2 22.49 Favored Pre-proline 0 N--CA 1.429 -1.508 0 O-C-N 126.637 2.022 . . . . 2.07 108.343 174.32 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -55.87 145.48 72.83 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-O 113.104 -2.956 . . . . 1.39 117.637 176.174 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -58.66 -22.52 61.12 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 123.418 2.746 . . . . 1.68 115.142 -175.025 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.02 -43.15 99.46 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 131.109 3.764 . . . . 2.25 109.357 173.887 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -83.79 -14.79 50.57 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 117.152 2.279 . . . . 2.44 117.152 -176.962 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -85.45 104.57 15.36 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 118.871 -2.393 . . . . 1.32 113.131 -175.726 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -96.23 101.04 12.63 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 106.327 -1.731 . . . . 3.19 106.327 175.16 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.4 mt -87.16 125.43 34.16 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.965 -2.334 . . . . 1.75 116.554 173.387 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.5 mm -108.57 106.36 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 118.853 -2.404 . . . . 1.98 109.114 178.226 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -92.99 91.97 7.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 118.977 -1.089 . . . . 1.94 110.578 171.149 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.49 -65.93 0.25 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.719 2.408 . . . . 1.67 112.811 -172.657 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.91 -14.82 0.4 Allowed Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 126.718 2.104 . . . . 1.3 112.923 -178.954 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -90.59 129.03 36.76 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 115.299 -2.56 . . . . 2.89 109.926 -176.83 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -83.17 117.24 22.77 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.302 -2.124 . . . . 2.89 112.309 165.934 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.7 mt -79.05 163.53 25.08 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 120.925 -1.109 . . . . 1.34 109.586 -166.181 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -125.64 128.53 47.99 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.329 1.852 . . . . 1.94 108.793 176.354 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.345 30.4 m-20 -45.62 -50.61 13.15 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.079 2.952 . . . . 1.56 115.489 -174.795 . . . . . . . . 2 2 . 1 . 129 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.15 20.59 15.7 Favored Glycine 0 N--CA 1.43 -1.765 1 O-C-N 115.535 -4.478 . . . . 0.97 114.343 175.675 . . . . . . . . 2 2 . 1 . 129 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -107.22 142.89 36.24 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 116.147 -4.149 . . . . 3.07 105.723 168.692 . . . . . . . . 2 2 . 1 . 129 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.5 p -70.09 168.51 15.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.949 -1.023 . . . . 1.34 113.136 175.803 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.415 ' HG ' HD12 ' A' ' 61' ' ' ILE . 6.3 mp -67.09 -42.32 84.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.683 1.993 . . . . 1.63 112.984 173.73 . . . . . . . . 2 2 . 1 . 129 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.2 p -52.79 -26.57 14.75 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 131.515 3.926 . . . . 1.51 112.216 179.455 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -75.77 -51.45 12.62 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-O 126.571 3.081 . . . . 1.9 116.922 175.697 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.272 35.3 m-85 -83.31 9.32 11.12 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.831 -3.043 . . . . 0.97 114.691 174.119 . . . . . . . . 2 2 . 1 . 129 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.7 t30 47.31 59.18 4.24 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 118.801 2.889 . . . . 2.35 118.801 -176.379 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 ' HG ' ' A' ' 56' ' ' LEU . 78.8 mt -93.95 122.3 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 104.489 -2.411 . . . . 1.39 104.489 179.523 . . . . . . . . 2 2 . 1 . 129 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -121.35 -160.99 0.88 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 122.217 2.28 . . . . 2.58 111.742 -173.12 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.462 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 77.5 tttt -59.44 136.06 57.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 119.173 3.027 . . . . 2.58 119.173 175.649 . . . . . . . . 2 2 . 1 . 129 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.462 ' HG3' ' HG2' ' A' ' 63' ' ' LYS 0.295 42.8 mt-10 64.04 25.65 13.86 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.206 -2.184 . . . . 1.71 114.738 172.914 . . . . . . . . 3 3 . 1 . 129 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.7 m -75.18 137.55 41.37 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 128.005 2.522 . . . . 1.34 114.817 179.862 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.2 m -91.66 104.79 17.22 Favored 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 127.105 2.753 . . . . 1.36 114.62 -176.632 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -92.62 128.6 38.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 116.785 -1.579 . . . . 2.03 111.588 171.551 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -96.47 114.73 26.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 104.407 -2.442 . . . . 2.31 104.407 -177.803 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.4 tp -92.38 120.55 33.01 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.584 -3.197 . . . . 1.72 106.91 -177.424 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.84 153.74 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 126.251 2.22 . . . . 1.8 106.159 174.956 . . . . . . . . 1 1 . 1 . 129 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.9 tp . . . . . 0 N--CA 1.43 -1.468 0 C-N-CA 116.056 -2.258 . . . . 3.26 105.586 175.978 . . . . . . . . 0 0 . 1 . 130 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ttt . . . . . 0 CA--C 1.49 -1.35 0 CA-C-O 117.206 -1.378 . . . . 1.39 109.387 . . . . . . . . . 0 0 . 1 . 130 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -86.33 135.17 33.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 115.895 -2.002 . . . . 2.2 113.301 -171.833 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 pt -129.91 153.06 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 122.105 2.23 . . . . 1.32 107.238 170.577 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.331 11.6 m-85 -115.82 122.62 45.94 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 116.876 -1.93 . . . . 2.2 110.974 177.298 . . . . . . . . 2 2 . 1 . 130 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.05 108.48 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 117.749 -3.094 . . . . 1.23 111.548 177.463 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -87.79 120.43 29.1 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.931 1.825 . . . . 2.51 108.537 -173.487 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.2 p -79.4 169.37 18.18 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 115.484 -4.51 . . . . 1.41 113.165 174.686 . . . . . . . . 2 2 . 1 . 130 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.3 mt -73.79 -26.35 60.58 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.004 -3.56 . . . . 2.95 112.222 164.851 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.5 p -75.25 -34.16 61.38 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 124.216 1.006 . . . . 2.52 111.824 -171.197 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.97 -8.0 2.44 Favored Glycine 0 N--CA 1.431 -1.678 0 CA-C-O 115.829 -2.651 . . . . 1.5 116.635 177.384 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -97.89 136.29 38.4 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 126.318 1.834 . . . . 1.79 109.983 -174.122 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -111.94 96.14 5.88 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.433 1.111 . . . . 1.38 109.363 169.759 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.7 pt -91.85 125.31 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 113.852 -1.522 . . . . 2.03 113.366 -175.149 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.8 m -91.22 109.6 20.87 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.424 -2.673 . . . . 1.61 105.443 -171.734 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.7 mt -93.34 153.16 18.7 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.371 -2.705 . . . . 2.15 108.306 176.826 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -92.78 121.56 34.28 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.524 1.929 . . . . 1.98 113.219 165.396 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.9 m -137.26 173.21 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 123.634 1.683 . . . . 1.52 108.082 176.741 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -121.8 154.97 60.77 Favored Pre-proline 0 N--CA 1.43 -1.439 0 O-C-N 117.999 -2.938 . . . . 2.35 108.529 162.869 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.287 40.1 Cg_endo -64.4 -18.6 63.63 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 C-N-CA 123.133 2.555 . . . . 1.31 117.493 -172.611 . . . . . . . . 2 2 . 1 . 130 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.2 m -89.31 7.78 33.85 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.397 2.046 . . . . 1.71 115.596 178.58 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -81.05 146.68 30.51 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 130.037 3.335 . . . . 1.69 108.238 173.984 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.308 30.3 p -75.39 164.83 26.0 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 118.324 -1.351 . . . . 1.33 113.073 172.986 . . . . . . . . 2 2 . 1 . 130 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.438 HD11 HG21 ' A' ' 23' ' ' ILE . 63.5 mt -78.97 -35.7 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 108.063 -1.088 . . . . 1.32 108.063 178.859 . . . . . . . . 2 2 . 1 . 130 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -47.07 -41.68 17.43 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.918 2.192 . . . . 1.62 116.918 162.796 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -64.95 -38.31 90.53 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.671 -4.393 . . . . 2.13 112.235 175.41 . . . . . . . . 2 2 . 1 . 130 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 68.3 t -69.49 -28.21 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 114.703 1.372 . . . . 1.23 114.703 174.489 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -69.8 -30.24 67.72 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.712 -2.492 . . . . 1.97 112.117 169.247 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.47 -27.23 65.05 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.56 -1.963 . . . . 1.19 110.909 174.418 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? -72.61 -35.86 67.95 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 120.748 1.613 . . . . 1.92 111.399 172.745 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.9 mt -60.54 -46.22 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 O-C-N 116.381 -3.949 . . . . 1.94 112.486 167.515 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -57.26 -45.73 83.73 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 117.968 -2.957 . . . . 1.9 116.449 175.016 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -45.31 -40.87 8.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 125.455 2.55 . . . . 1.55 114.804 166.907 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -87.5 -59.24 2.3 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.691 -3.13 . . . . 2.95 114.824 -173.966 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -97.4 -25.59 15.16 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.954 1.835 . . . . 1.48 109.009 -165.921 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.29 52.77 4.11 Favored Glycine 0 N--CA 1.429 -1.809 1 O-C-N 115.136 -4.727 . . . . 1.12 116.287 -178.175 . . . . . . . . 2 2 . 1 . 130 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.2 mt -130.57 109.81 16.07 Favored Pre-proline 0 N--CA 1.429 -1.505 0 CA-C-N 112.223 -1.988 . . . . 2.07 109.738 -176.81 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -60.59 139.09 84.12 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 N-CA-C 120.948 3.403 . . . . 1.39 120.948 -179.919 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.85 -27.92 29.16 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 C-N-CA 124.948 3.765 . . . . 1.68 117.088 -176.197 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.58 -34.63 72.95 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 123.211 2.732 . . . . 2.25 115.954 171.488 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -80.0 4.32 17.36 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 113.639 -3.077 . . . . 2.44 108.899 -175.057 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -141.98 150.6 41.59 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 125.118 3.599 . . . . 1.32 108.897 -176.832 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -130.46 149.91 51.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.195 -2.816 . . . . 3.19 105.317 168.601 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.3 mt -106.47 149.74 26.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.951 2.159 . . . . 1.75 112.657 174.859 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.489 HD11 HG21 ' A' ' 70' ' ' VAL . 9.5 mt -128.52 132.79 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 108.452 -0.944 . . . . 1.98 108.452 178.911 . . . . . . . . 2 2 . 1 . 130 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.264 50.4 t80 -117.07 121.05 40.21 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.537 1.637 . . . . 1.94 106.705 178.358 . . . . . . . . 2 2 . 1 . 130 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.52 -82.27 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.001 -3.562 . . . . 1.67 113.479 174.826 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.77 -26.02 1.47 Allowed Glycine 0 N--CA 1.43 -1.731 0 CA-C-N 122.356 2.344 . . . . 1.3 113.459 176.181 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -100.49 150.2 22.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.991 3.757 . . . . 2.89 117.466 178.875 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -74.48 133.51 42.34 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.982 -2.949 . . . . 2.89 112.718 172.601 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.0 mt -84.4 126.07 32.9 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.939 -2.975 . . . . 1.34 115.27 -171.856 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.18 125.57 24.94 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 125.953 2.787 . . . . 1.94 109.18 173.919 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -63.59 -45.7 89.2 Favored 'General case' 0 N--CA 1.429 -1.491 1 O-C-N 114.466 -5.146 . . . . 1.56 116.957 -172.81 . . . . . . . . 2 2 . 1 . 130 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.22 33.57 3.37 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-O 124.799 2.333 . . . . 0.97 118.504 177.226 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -110.83 167.14 10.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.878 -2.542 . . . . 3.07 112.134 167.071 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.9 p -87.4 176.83 7.32 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.802 2.841 . . . . 1.34 111.898 170.761 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.5 mt -82.25 -41.39 20.27 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 127.135 2.174 . . . . 1.63 108.645 -178.72 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.0 p -59.35 -41.56 89.51 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 129.205 3.002 . . . . 1.51 111.353 176.189 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -48.72 -52.01 25.81 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 128.704 2.802 . . . . 1.9 112.626 172.725 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -86.81 -3.69 59.09 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 115.606 1.706 . . . . 0.97 115.606 179.584 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.6 m120 73.47 37.87 0.68 Allowed 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.696 -1.138 . . . . 2.35 112.167 177.036 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.3 mt -84.97 129.08 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 119.713 -1.867 . . . . 1.39 113.17 173.614 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -116.53 -175.83 2.84 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.996 2.808 . . . . 2.58 113.2 -176.361 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -40.66 121.63 1.5 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 112.214 -2.266 . . . . 2.58 116.06 172.949 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 59.89 50.86 6.44 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 119.261 3.06 . . . . 1.71 119.261 179.06 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.1 m -89.79 133.92 34.46 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 116.479 -1.724 . . . . 1.34 112.207 -178.721 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.4 m -81.48 109.08 15.61 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 126.986 2.678 . . . . 1.36 110.538 179.087 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.58 169.71 8.36 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.465 1.939 . . . . 2.03 110.247 176.652 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -125.3 146.64 49.47 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.217 1.007 . . . . 2.31 108.887 -176.372 . . . . . . . . 1 1 . 1 . 130 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.99 132.11 56.1 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 115.008 -2.425 . . . . 1.72 107.723 172.916 . . . . . . . . 2 2 . 1 . 130 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.489 HG21 HD11 ' A' ' 44' ' ' ILE . 27.6 m -121.26 164.24 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 121.889 2.131 . . . . 1.8 114.797 171.526 . . . . . . . . 2 2 . 1 . 130 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.2 tp . . . . . 0 N--CA 1.431 -1.417 0 O-C-N 118.076 -2.89 . . . . 3.26 110.899 -179.484 . . . . . . . . 0 0 . 1 . 131 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.6 ttp . . . . . 0 CA--C 1.49 -1.354 0 CA-C-O 125.828 2.728 . . . . 1.39 109.936 . . . . . . . . . 0 0 . 1 . 131 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -69.56 127.98 34.88 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 115.409 -2.234 . . . . 2.2 112.559 178.167 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.318 7.4 pt -133.27 150.03 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 107.151 -1.426 . . . . 1.32 107.151 172.511 . . . . . . . . 2 2 . 1 . 131 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -118.74 118.7 32.31 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.798 2.237 . . . . 2.2 112.942 -176.099 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -102.7 112.21 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.786 -3.071 . . . . 1.23 108.489 -179.993 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -96.1 138.31 33.9 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.021 -3.549 . . . . 2.51 111.334 177.699 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 p -89.25 -176.4 5.09 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 122.789 1.28 . . . . 1.41 112.602 178.551 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.4 tp -86.03 -34.59 20.72 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.2 -2.188 . . . . 2.95 110.311 170.4 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.7 p -56.6 -57.28 13.07 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.145 2.578 . . . . 2.52 113.327 -178.753 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.36 24.32 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.701 0 O-C-N 117.816 -3.052 . . . . 1.5 114.254 171.745 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -106.92 146.43 31.02 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.729 2.411 . . . . 1.79 105.705 -178.001 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.7 m -116.98 97.38 5.92 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.537 3.135 . . . . 1.38 103.054 171.154 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -80.41 116.77 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 106.44 -1.689 . . . . 2.03 106.44 -176.785 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 m -88.07 114.76 25.0 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.597 -4.439 . . . . 1.61 109.613 175.21 . . . . . . . . 2 2 . 1 . 131 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.8 mt -113.75 161.43 17.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 128.128 3.392 . . . . 2.15 108.829 178.127 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -118.01 112.66 20.56 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.386 2.993 . . . . 1.98 108.256 170.313 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.6 m -107.48 160.14 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.191 -2.818 . . . . 1.52 112.954 176.529 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -105.2 143.32 26.51 Favored Pre-proline 0 N--CA 1.43 -1.43 0 O-C-N 118.925 -2.359 . . . . 2.35 107.923 164.705 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -76.51 -13.53 18.33 Favored 'Trans proline' 0 C--N 1.299 -2.044 1 C-N-CA 127.476 5.45 . . . . 1.31 116.079 -166.118 . . . . . . . . 2 2 . 1 . 131 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -85.79 -2.16 57.95 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 121.413 1.915 . . . . 1.71 109.175 176.889 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -73.73 159.72 32.57 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 120.344 3.461 . . . . 1.69 120.344 169.68 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.3 p -79.75 163.53 24.4 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.869 -1.77 . . . . 1.33 114.988 177.521 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.7 mm -73.04 -25.23 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 118.344 -1.343 . . . . 1.32 111.421 177.307 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -50.93 -36.67 39.76 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.752 -2.467 . . . . 1.62 116.566 162.818 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -69.05 -24.67 64.2 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.671 2.789 . . . . 2.13 109.104 -177.825 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.34 -59.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 104.539 -2.393 . . . . 1.23 104.539 175.699 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -49.76 -38.57 34.52 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.123 2.569 . . . . 1.97 113.512 173.441 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.89 -30.93 71.22 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 123.097 2.68 . . . . 1.19 114.893 178.78 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -71.75 -29.12 64.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.865 -1.147 . . . . 1.92 112.477 175.202 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.5 mt -73.06 -33.28 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-O 125.912 2.768 . . . . 1.94 111.685 171.157 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -73.81 -41.93 61.65 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.113 -3.492 . . . . 1.9 105.927 177.04 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -61.64 -36.51 80.99 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.649 -2.532 . . . . 1.55 115.923 174.645 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -84.18 -51.22 7.21 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.04 -3.538 . . . . 2.95 113.085 -175.082 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -104.68 -36.83 7.31 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.271 -2.143 . . . . 1.48 114.574 -169.994 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.05 16.83 17.8 Favored Glycine 0 N--CA 1.429 -1.81 0 C-N-CA 115.381 -3.295 . . . . 1.12 110.249 175.263 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.9 mt -95.92 134.84 23.34 Favored Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 102.44 -3.17 . . . . 2.07 102.44 -175.073 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.459 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 17.2 Cg_exo -67.05 156.9 64.3 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 125.924 3.152 . . . . 1.39 114.904 174.558 . . . . . . . . 2 2 . 1 . 131 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -85.9 -14.96 4.99 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 CA-C-N 124.728 2.724 . . . . 1.68 115.586 -174.16 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -67.25 -29.96 69.72 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 114.808 -2.52 . . . . 2.25 108.954 169.044 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -83.05 -19.9 35.99 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 123.238 2.745 . . . . 2.44 113.183 -176.856 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 37' ' ' PRO . 77.7 mt-30 -87.8 107.59 18.73 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.7 2.0 . . . . 1.32 110.264 -170.709 . . . . . . . . 2 2 . 1 . 131 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -99.08 122.84 42.85 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.446 -1.687 . . . . 3.19 106.446 171.525 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.4 mt -104.0 127.31 51.55 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 124.846 1.341 . . . . 1.75 110.568 176.417 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.1 mt -115.16 115.4 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 119.388 -2.07 . . . . 1.98 108.314 179.847 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -104.07 102.76 12.5 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 113.456 -1.702 . . . . 1.94 107.477 175.002 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.02 -94.05 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.189 1.796 . . . . 1.67 110.353 -178.478 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.4 -19.08 6.35 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 128.25 2.833 . . . . 1.3 114.406 -177.443 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -98.55 137.08 37.72 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 125.946 2.784 . . . . 2.89 105.304 -175.876 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.4 113.97 26.26 Favored 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 119.224 -2.173 . . . . 2.89 107.168 172.972 . . . . . . . . 2 2 . 1 . 131 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.4 mt -77.36 144.43 37.98 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 121.524 1.966 . . . . 1.34 115.195 -163.134 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -90.24 150.39 21.98 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.878 2.471 . . . . 1.94 113.812 173.018 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -70.47 -59.77 2.66 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.755 2.422 . . . . 1.56 115.543 -168.086 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.92 22.55 0.9 Allowed Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 122.155 3.622 . . . . 0.97 122.155 169.987 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -97.91 162.72 13.1 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.137 -2.978 . . . . 3.07 109.06 168.633 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.6 p -100.12 176.79 5.28 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 124.007 3.094 . . . . 1.34 112.712 178.094 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 mt -65.75 -34.47 78.25 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.34 -2.1 . . . . 1.63 109.133 172.961 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -57.82 -42.78 84.99 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.814 1.783 . . . . 1.51 115.814 174.318 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -71.64 -30.32 65.62 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.609 -3.182 . . . . 1.9 115.129 -177.272 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -93.11 2.62 56.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 119.132 0.878 . . . . 0.97 113.063 176.017 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.9 m120 51.17 70.76 0.5 Allowed 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 130.705 3.602 . . . . 2.35 113.06 -176.009 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.6 mt -104.84 120.48 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 118.715 -2.491 . . . . 1.39 111.654 -179.344 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -110.85 176.53 4.99 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 111.053 -2.794 . . . . 2.58 115.743 -176.618 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -51.79 118.43 3.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 120.028 3.344 . . . . 2.58 120.028 173.74 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.386 26.2 mt-10 84.56 35.75 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.302 2.001 . . . . 1.71 111.657 171.109 . . . . . . . . 2 2 . 1 . 131 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.8 m -89.64 146.62 24.42 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.618 -2.552 . . . . 1.34 114.145 -174.633 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.3 m -108.1 107.96 18.84 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.672 -1.268 . . . . 1.36 112.341 -177.637 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -103.39 143.6 32.47 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 103.466 -2.79 . . . . 2.03 103.466 178.964 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.294 62.3 m80 -104.5 131.64 51.65 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 104.754 -2.313 . . . . 2.31 104.754 -177.095 . . . . . . . . 2 2 . 1 . 131 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.5 tp -95.83 110.56 22.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.943 2.306 . . . . 1.72 108.112 178.899 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 t -110.74 131.91 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 119.108 -2.245 . . . . 1.8 107.855 172.345 . . . . . . . . 1 1 . 1 . 131 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.0 mt . . . . . 0 N--CA 1.43 -1.439 0 CA-C-N 115.153 -0.93 . . . . 3.26 112.329 176.035 . . . . . . . . 0 0 . 1 . 132 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 ptt? . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 111.909 0.337 . . . . 1.39 111.909 . . . . . . . . . 0 0 . 1 . 132 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -98.59 144.16 28.19 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 126.569 3.08 . . . . 2.2 106.144 -178.518 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.7 pt -130.62 152.91 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 1 N-CA-C 99.206 -4.368 . . . . 1.32 99.206 178.136 . . . . . . . . 2 2 . 1 . 132 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -109.79 126.29 53.62 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.532 -2.605 . . . . 2.2 110.496 179.666 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.422 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 72.4 t -96.26 115.7 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 120.599 -1.313 . . . . 1.23 108.147 168.952 . . . . . . . . 2 2 . 1 . 132 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -91.77 137.95 31.95 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 106.044 -1.836 . . . . 2.51 106.044 177.162 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -87.82 -164.59 1.13 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.68 -1.263 . . . . 1.41 113.348 178.627 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.9 mt -82.09 -39.03 23.98 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 124.344 1.027 . . . . 2.95 110.359 176.216 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.289 44.9 p -75.41 -10.96 59.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.701 2.4 . . . . 2.52 108.946 -177.329 . . . . . . . . 2 2 . 1 . 132 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.28 39.42 5.69 Favored Glycine 0 N--CA 1.431 -1.664 1 C-N-CA 135.1 6.095 . . . . 1.5 114.094 172.473 . . . . . . . . 2 2 . 1 . 132 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -90.05 132.4 35.41 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.099 1.95 . . . . 1.79 106.788 -171.309 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.8 m -88.87 111.43 22.06 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.18 -2.2 . . . . 1.38 108.357 -174.627 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.422 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 31.8 mt -104.47 115.49 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 115.569 1.692 . . . . 2.03 115.569 176.429 . . . . . . . . 2 2 . 1 . 132 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 m -81.66 115.85 21.12 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 120.719 -1.238 . . . . 1.61 110.585 -179.129 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.0 mt -121.67 147.89 45.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 115.249 -2.31 . . . . 2.15 111.902 177.625 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -99.69 119.31 37.91 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 120.877 1.671 . . . . 1.98 115.48 171.63 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.82 167.75 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 130.403 3.481 . . . . 1.52 108.779 -177.598 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -118.62 167.44 11.63 Favored Pre-proline 0 N--CA 1.43 -1.47 0 O-C-N 118.477 -2.639 . . . . 2.35 106.953 162.41 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -67.54 -16.54 47.37 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 CA-C-N 125.248 2.91 . . . . 1.31 115.532 -170.654 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -74.86 -15.59 60.71 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 131.265 3.826 . . . . 1.71 117.905 174.41 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -69.66 138.34 52.93 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.061 -2.275 . . . . 1.69 115.09 171.024 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.1 p -79.16 179.52 7.32 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.187 -1.824 . . . . 1.33 114.76 -175.842 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -78.42 -33.75 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 118.934 -2.354 . . . . 1.32 110.799 176.513 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -49.9 -41.96 46.96 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.74 -3.1 . . . . 1.62 116.856 159.182 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.263 40.6 m-20 -76.48 -32.77 58.55 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 112.9 -3.429 . . . . 2.13 113.212 177.677 . . . . . . . . 2 2 . 1 . 132 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.9 t -66.44 -50.5 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 126.954 2.659 . . . . 1.23 113.363 167.855 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.6 mtmt -60.01 -31.17 69.69 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.078 -2.889 . . . . 1.97 116.601 169.109 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.78 -45.38 78.2 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.781 2.141 . . . . 1.19 116.781 170.307 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -65.71 -41.25 92.52 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.383 -3.948 . . . . 1.92 115.374 179.481 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.6 mm -56.83 -40.51 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.147 1.779 . . . . 1.94 113.685 166.773 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -59.81 -55.5 33.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.577 1.951 . . . . 1.9 115.168 171.693 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -46.82 -57.37 4.97 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 130.271 3.428 . . . . 1.55 112.528 175.26 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -85.89 -62.14 1.59 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.371 1.868 . . . . 2.95 112.525 -166.847 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -76.68 -23.01 53.2 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.406 2.002 . . . . 1.48 116.406 -175.459 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.59 20.11 38.72 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 118.556 2.182 . . . . 1.12 118.556 172.876 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.1 mt -101.51 134.79 20.04 Favored Pre-proline 0 N--CA 1.43 -1.465 0 CA-C-O 113.491 -3.147 . . . . 2.07 116.75 -174.564 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -64.52 132.56 33.7 Favored 'Trans proline' 0 C--N 1.3 -2.009 1 C-N-CA 126.319 4.679 . . . . 1.39 116.819 -179.046 . . . . . . . . 2 2 . 1 . 132 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -63.36 -14.71 43.83 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 CA-C-N 127.792 3.819 . . . . 1.68 116.467 -179.026 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -60.31 -27.91 67.69 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 117.758 2.503 . . . . 2.25 117.758 168.615 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -93.12 -29.52 15.72 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.599 -1.313 . . . . 2.44 108.669 -176.951 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -72.77 126.33 29.65 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 126.341 2.972 . . . . 1.32 112.972 -171.759 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -126.78 146.94 50.05 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 111.52 -2.582 . . . . 3.19 109.478 167.328 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 mt -117.28 127.64 54.28 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 114.158 1.17 . . . . 1.75 114.158 175.429 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mm -119.52 126.72 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 118.848 -2.407 . . . . 1.98 106.151 -175.999 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.471 ' CD2' HG12 ' A' ' 61' ' ' ILE . 49.0 t80 -137.79 121.17 17.06 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.865 -3.022 . . . . 1.94 103.328 176.038 . . . . . . . . 2 2 . 1 . 132 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.25 . . 43.51 62.54 1.85 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.216 3.006 . . . . 1.67 113.35 179.942 . . . . . . . . 2 2 . 1 . 132 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.72 -31.96 2.7 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 120.346 2.898 . . . . 1.3 120.346 177.863 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -89.79 127.02 35.9 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.568 1.947 . . . . 2.89 114.261 -178.31 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -73.68 116.38 14.2 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 115.708 -2.091 . . . . 2.89 108.521 173.156 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 mt -76.96 136.43 38.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 116.761 2.134 . . . . 1.34 116.761 -168.648 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -87.73 139.35 30.62 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 121.376 3.843 . . . . 1.94 121.376 179.826 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -47.01 -55.33 8.37 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 121.25 3.796 . . . . 1.56 121.25 -166.403 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.05 35.5 4.74 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 125.94 1.733 . . . . 0.97 116.902 179.433 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.3 mtt-85 -114.47 172.6 6.92 Favored 'General case' 0 N--CA 1.429 -1.482 1 O-C-N 116.0 -4.235 . . . . 3.07 100.864 168.496 . . . . . . . . 2 2 . 1 . 132 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -104.73 170.0 8.13 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.061 3.344 . . . . 1.34 114.282 179.07 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.8 mt -60.75 -41.62 95.77 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.813 1.412 . . . . 1.63 114.813 169.247 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.0 t -64.41 -28.26 69.56 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.575 2.131 . . . . 1.51 116.259 -178.46 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -59.17 -37.51 77.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.772 -3.705 . . . . 1.9 110.741 173.563 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -94.51 1.2 55.72 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.678 -1.264 . . . . 0.97 109.873 -179.301 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.303 32.8 m120 53.82 51.3 15.14 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 126.946 2.098 . . . . 2.35 111.032 -177.716 . . . . . . . . 2 2 . 1 . 132 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.471 HG12 ' CD2' ' A' ' 45' ' ' PHE . 76.8 mt -94.36 107.96 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 104.906 -2.257 . . . . 1.39 104.906 179.985 . . . . . . . . 2 2 . 1 . 132 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -81.79 -171.72 3.5 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 125.864 2.745 . . . . 2.58 111.773 -179.69 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -70.04 165.53 21.66 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 113.437 -5.789 . . . . 2.58 111.319 168.298 . . . . . . . . 2 2 . 1 . 132 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 63.57 22.96 13.41 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.239 1.971 . . . . 1.71 110.801 177.127 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -98.86 125.57 44.29 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 125.434 1.494 . . . . 1.34 107.285 -170.693 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.1 m -93.55 113.95 26.19 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 122.165 0.983 . . . . 1.36 111.029 -178.121 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -101.71 129.5 47.89 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 129.327 3.051 . . . . 2.03 113.06 -179.633 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -86.82 111.44 20.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 127.331 3.443 . . . . 2.31 111.652 -171.352 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 tp -87.68 111.39 21.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 116.874 -3.641 . . . . 1.72 108.564 -177.918 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 37.7 t -106.16 120.66 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 128.209 2.604 . . . . 1.8 109.098 -177.191 . . . . . . . . 1 1 . 1 . 132 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.9 mt . . . . . 0 N--CA 1.429 -1.477 0 C-N-CA 125.823 1.649 . . . . 3.26 106.82 -179.523 . . . . . . . . 0 0 . 1 . 133 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.516 ' HE3' HD11 ' A' ' 56' ' ' LEU . 11.6 ptt? . . . . . 0 CA--C 1.49 -1.352 0 CA-C-O 122.833 1.301 . . . . 1.39 114.384 . . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -108.86 130.31 55.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.54 -3.85 . . . . 2.2 107.148 -168.644 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -128.7 163.84 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 127.396 2.278 . . . . 1.32 110.711 173.728 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -123.33 129.26 51.07 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 112.714 -2.039 . . . . 2.2 113.717 179.91 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -111.96 118.61 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 118.917 -1.113 . . . . 1.23 108.607 172.191 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -89.28 134.25 34.13 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.073 -2.267 . . . . 2.51 113.74 171.089 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.4 p -85.82 167.73 14.92 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.833 2.16 . . . . 1.41 116.833 177.916 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.2 mt -69.07 -40.41 78.5 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 127.145 3.355 . . . . 2.95 109.793 175.348 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.274 17.2 p -57.1 -60.68 3.24 Favored 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 114.878 -4.889 . . . . 2.52 119.021 174.85 . . . . . . . . 3 2 . 1 . 133 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.67 6.33 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.768 0 CA-C-N 119.879 1.218 . . . . 1.5 112.642 177.811 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.2 ttpt -95.63 142.63 27.72 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 121.55 2.675 . . . . 1.79 109.769 -174.937 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.0 m -112.3 120.91 43.35 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.616 -1.624 . . . . 1.38 106.616 174.496 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 mt -102.09 123.91 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 116.494 -1.717 . . . . 2.03 106.933 -177.676 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.1 m -90.37 119.6 30.8 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 124.763 1.29 . . . . 1.61 111.002 175.726 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.0 mt -111.76 137.22 49.98 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 115.358 1.614 . . . . 2.15 115.358 178.713 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -91.49 119.63 31.61 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 117.95 2.574 . . . . 1.98 117.95 165.586 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.8 m -139.3 -178.25 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.414 1 N-CA-C 99.64 -4.207 . . . . 1.52 99.64 -175.303 . . . . . . . . 2 2 . 1 . 133 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -123.29 159.81 53.02 Favored Pre-proline 0 N--CA 1.43 -1.43 1 O-C-N 115.779 -4.326 . . . . 2.35 104.456 163.234 . . . . . . . . 2 2 . 1 . 133 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.47 -7.96 22.34 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 125.026 3.817 . . . . 1.31 112.802 -173.273 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.2 p -80.52 -7.1 59.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.541 2.736 . . . . 1.71 114.528 171.405 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -83.4 145.04 29.22 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.965 -2.334 . . . . 1.69 109.997 175.875 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.35 41.4 p -75.17 154.75 37.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 118.282 2.697 . . . . 1.33 118.282 176.143 . . . . . . . . 2 2 . 1 . 133 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.6 mm -58.36 -29.78 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 127.07 2.148 . . . . 1.32 113.765 171.486 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.62 -32.87 74.68 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.197 2.599 . . . . 1.62 110.815 167.465 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -72.53 -28.66 62.99 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 126.078 1.751 . . . . 2.13 111.541 179.758 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.42 -50.23 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 131.39 3.876 . . . . 1.23 110.605 168.496 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HZ1' ' CG ' ' A' ' 52' ' ' ASP . 87.2 mttt -69.18 -27.64 65.69 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 115.361 1.615 . . . . 1.97 115.361 173.045 . . . . . . . . 2 2 . 1 . 133 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.25 . . -72.79 -39.36 66.77 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.411 -1.431 . . . . 1.19 109.328 -178.945 . . . . . . . . 2 2 . 1 . 133 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -66.49 -39.61 88.82 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.326 3.05 . . . . 1.92 112.62 169.445 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.63 -30.85 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 117.674 -3.141 . . . . 1.94 114.796 169.478 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -65.09 -60.86 2.56 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.814 -1.804 . . . . 1.9 109.444 174.053 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -45.7 -39.57 8.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.929 2.937 . . . . 1.55 118.929 172.02 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -91.81 -63.2 1.28 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.582 2.753 . . . . 2.95 107.481 -172.282 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -93.11 -17.79 23.37 Favored 'General case' 0 N--CA 1.429 -1.521 0 O-C-N 117.272 -3.393 . . . . 1.48 115.541 -169.233 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.55 -4.84 62.06 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 108.712 -1.755 . . . . 1.12 108.712 170.793 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.2 mt -75.06 133.84 75.09 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 125.077 1.351 . . . . 2.07 112.785 -176.879 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -75.9 138.29 20.77 Favored 'Trans proline' 0 N--CA 1.433 -2.043 0 CA-C-O 114.122 -2.532 . . . . 1.39 115.766 -178.597 . . . . . . . . 2 2 . 1 . 133 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -64.67 -24.66 62.23 Favored 'Trans proline' 0 N--CA 1.433 -2.031 1 C-N-CA 125.996 4.464 . . . . 1.68 118.572 -172.176 . . . . . . . . 2 2 . 1 . 133 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -55.76 -36.05 66.88 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.212 3.445 . . . . 2.25 116.176 173.299 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -79.9 -11.89 59.78 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.025 1.73 . . . . 2.44 109.928 -178.842 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -86.58 121.21 28.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 118.737 2.865 . . . . 1.32 118.737 -169.172 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -110.44 110.55 21.34 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.211 1.368 . . . . 3.19 111.678 172.458 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.2 mt -97.93 119.43 36.53 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 123.675 2.943 . . . . 1.75 109.7 -176.001 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 29.6 mm -108.45 137.8 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 119.175 -2.203 . . . . 1.98 110.96 178.301 . . . . . . . . 2 2 . 1 . 133 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.422 ' HB2' HD13 ' A' ' 67' ' ' LEU . 87.4 t80 -130.06 121.67 26.87 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 104.604 -2.369 . . . . 1.94 104.604 173.121 . . . . . . . . 2 2 . 1 . 133 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.26 -100.47 0.06 Allowed 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 120.909 -1.12 . . . . 1.67 110.129 -178.793 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.69 10.39 6.75 Favored Glycine 0 N--CA 1.429 -1.817 0 C-N-CA 126.176 1.846 . . . . 1.3 115.348 174.186 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -110.38 137.66 47.8 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.729 -1.235 . . . . 2.89 112.72 -173.857 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -95.24 129.13 42.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 126.643 2.464 . . . . 2.89 109.421 176.826 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.2 mt -100.35 136.86 39.59 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 117.263 2.32 . . . . 1.34 117.263 -166.804 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -79.54 138.74 37.6 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.79 -2.444 . . . . 1.94 116.614 -178.164 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.469 ' CG ' ' HZ1' ' A' ' 27' ' ' LYS . 1.1 m-20 -60.97 -47.18 87.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.367 -2.708 . . . . 1.56 114.78 -168.869 . . . . . . . . 2 2 . 1 . 133 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.76 35.86 3.45 Favored Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 119.677 2.631 . . . . 0.97 119.677 173.058 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -114.97 160.51 19.48 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 123.102 1.429 . . . . 3.07 108.463 163.152 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.4 p -100.58 171.4 7.75 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.006 -3.559 . . . . 1.34 117.235 177.953 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.516 HD11 ' HE3' ' A' ' 1' ' ' MET . 3.2 mt -64.71 -23.61 67.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.712 1.72 . . . . 1.63 113.088 172.25 . . . . . . . . 2 2 . 1 . 133 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.271 19.2 t -60.4 -59.59 5.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.266 3.426 . . . . 1.51 116.111 174.993 . . . . . . . . 2 2 . 1 . 133 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -39.29 -41.27 0.87 Allowed 'General case' 0 N--CA 1.43 -1.458 1 C-N-CA 132.928 4.491 . . . . 1.9 118.74 165.632 . . . . . . . . 2 2 . 1 . 133 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -97.57 9.84 41.42 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 112.508 -3.615 . . . . 0.97 116.436 175.214 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.1 t30 52.84 51.22 16.36 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 131.213 5.321 . . . . 2.35 115.44 -175.486 . . . . . . . . 2 2 . 1 . 133 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.0 mt -101.79 116.94 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 125.574 2.607 . . . . 1.39 111.011 177.394 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -100.86 -153.59 0.45 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.15 -1.594 . . . . 2.58 109.824 -173.277 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -74.31 142.5 45.18 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 128.157 2.583 . . . . 2.58 116.422 175.74 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.252 49.0 mt-10 68.89 33.88 3.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.937 2.095 . . . . 1.71 108.072 176.782 . . . . . . . . 2 2 . 1 . 133 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.0 m -91.67 137.03 32.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 130.004 3.322 . . . . 1.34 113.969 -175.465 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.1 m -107.94 117.26 33.65 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 126.673 1.989 . . . . 1.36 114.962 -174.125 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.422 HD13 ' HB2' ' A' ' 45' ' ' PHE . 2.2 mm? -103.64 156.86 17.47 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 125.629 1.571 . . . . 2.03 108.332 177.08 . . . . . . . . 2 2 . 1 . 133 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.446 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 74.2 m80 -117.37 123.14 45.74 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 125.546 2.594 . . . . 2.31 108.13 -178.661 . . . . . . . . 2 2 . 1 . 133 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.2 tp -97.13 93.4 6.54 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.633 -2.542 . . . . 1.72 112.433 -179.916 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.5 t -91.46 136.27 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 127.831 2.452 . . . . 1.8 106.154 174.569 . . . . . . . . 1 1 . 1 . 133 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.5 mt . . . . . 0 N--CA 1.429 -1.501 0 CA-C-O 124.506 2.098 . . . . 3.26 111.198 178.582 . . . . . . . . 0 0 . 1 . 134 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.263 16.0 ptt? . . . . . 0 CA--C 1.49 -1.333 0 N-CA-C 114.366 1.247 . . . . 1.39 114.366 . . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -106.78 135.35 48.46 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 116.088 1.884 . . . . 2.2 116.088 -177.109 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.1 pt -120.42 165.11 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 101.514 -3.514 . . . . 1.32 101.514 176.657 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -116.83 147.53 42.04 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 121.989 0.9 . . . . 2.2 111.74 -179.732 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.347 65.0 t -123.34 113.79 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-O 123.703 1.716 . . . . 1.23 107.802 174.856 . . . . . . . . 2 2 . 1 . 134 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.458 ' HD2' HG23 ' A' ' 66' ' ' THR . 6.6 tttp -99.2 130.48 45.5 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.737 -2.477 . . . . 2.51 108.545 -178.618 . . . . . . . . 2 2 . 1 . 134 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.7 p -98.65 175.82 5.86 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.93 -1.731 . . . . 1.41 111.847 176.502 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.7 tp -77.32 -31.71 54.78 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 118.211 -1.396 . . . . 2.95 111.097 169.798 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.8 p -59.62 -27.31 66.21 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 131.62 3.968 . . . . 2.52 115.679 -177.425 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.01 56.6 0.62 Allowed Glycine 0 N--CA 1.43 -1.766 1 C-N-CA 135.417 6.246 . . . . 1.5 104.909 165.608 . . . . . . . . 2 2 . 1 . 134 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -125.73 141.96 51.75 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.306 -2.879 . . . . 1.79 107.807 177.642 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 100.0 m -120.53 112.69 19.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.556 -1.276 . . . . 1.38 107.556 175.921 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.3 mt -93.97 141.07 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 118.212 -2.805 . . . . 2.03 106.838 -178.634 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -104.42 117.74 34.9 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 124.551 2.12 . . . . 1.61 107.868 177.585 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.9 mt -116.06 128.7 55.9 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 111.75 -2.477 . . . . 2.15 107.735 -178.878 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -87.47 117.01 25.97 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 104.598 -2.371 . . . . 1.98 104.598 175.763 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.26 159.34 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 125.213 1.57 . . . . 1.52 107.591 -174.766 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 26.1 mt-10 -106.34 165.04 13.68 Favored Pre-proline 0 N--CA 1.429 -1.484 0 C-N-CA 125.502 1.521 . . . . 2.35 108.208 165.226 . . . . . . . . 2 2 . 1 . 134 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 95.7 Cg_exo -72.76 -22.38 20.44 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 125.073 3.849 . . . . 1.31 115.381 -173.18 . . . . . . . . 2 2 . 1 . 134 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.8 m -88.88 -1.33 58.04 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.796 -0.638 . . . . 1.71 112.32 -179.833 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -74.32 140.7 45.05 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.023 -2.923 . . . . 1.69 112.935 -179.318 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.0 p -76.5 162.39 27.85 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.772 -4.33 . . . . 1.33 113.499 177.873 . . . . . . . . 2 2 . 1 . 134 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mm -64.86 -29.05 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.29 -2.756 . . . . 1.32 114.325 175.48 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -61.28 -31.75 71.58 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 116.943 2.201 . . . . 1.62 116.943 164.921 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -75.43 -39.85 58.4 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.915 -1.116 . . . . 2.13 109.212 -179.344 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.0 t -63.67 -39.89 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 117.398 2.37 . . . . 1.23 117.398 171.535 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.257 66.4 mttt -61.22 -40.45 94.04 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 124.649 2.166 . . . . 1.97 114.934 172.529 . . . . . . . . 2 2 . 1 . 134 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.37 -39.77 67.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.974 -3.579 . . . . 1.19 113.6 172.506 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -68.76 -28.66 66.99 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 120.75 1.614 . . . . 1.92 109.855 172.519 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.1 mt -70.87 -24.8 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 116.95 -3.594 . . . . 1.94 115.402 174.381 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -62.11 -30.15 70.81 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.035 -2.916 . . . . 1.9 112.392 173.254 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -71.83 -20.04 61.89 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.896 -2.378 . . . . 1.55 113.205 175.801 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -103.11 -59.43 1.71 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.506 -1.664 . . . . 2.95 106.506 -173.907 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -105.57 -10.2 16.99 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.249 -1.341 . . . . 1.48 111.401 -164.45 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 56.3 54.0 38.97 Favored Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 125.757 1.646 . . . . 1.12 112.801 175.906 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.0 mt -118.49 127.55 26.5 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 127.236 2.214 . . . . 2.07 105.433 178.586 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -75.6 163.91 33.19 Favored 'Trans proline' 0 N--CA 1.432 -2.124 2 O-C-N 112.669 -4.438 . . . . 1.39 115.553 179.499 . . . . . . . . 2 2 . 1 . 134 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -70.63 -12.23 30.93 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 CA-C-N 123.622 2.329 . . . . 1.68 117.053 -177.238 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -75.2 -16.25 60.5 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 115.603 -4.436 . . . . 2.25 112.533 172.642 . . . . . . . . 2 2 . 1 . 134 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -90.26 -10.68 43.34 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 119.668 1.122 . . . . 2.44 109.773 -177.071 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -103.32 132.04 49.9 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 123.931 1.824 . . . . 1.32 106.1 -160.301 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -121.41 111.25 17.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 114.207 -1.361 . . . . 3.19 112.428 168.506 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.3 mt -90.13 132.37 35.48 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.552 -1.967 . . . . 1.75 115.751 179.362 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 mm -123.73 124.82 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-O 126.316 2.96 . . . . 1.98 112.331 -179.587 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.41 ' HB2' HD23 ' A' ' 67' ' ' LEU . 37.0 t80 -124.48 108.16 11.84 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 127.612 2.365 . . . . 1.94 108.529 177.15 . . . . . . . . 2 2 . 1 . 134 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.53 -74.3 0.09 Allowed 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 110.592 -3.003 . . . . 1.67 114.066 -178.056 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -147.67 -10.98 0.17 Allowed Glycine 0 N--CA 1.431 -1.679 1 C-N-CA 131.178 4.228 . . . . 1.3 114.631 -177.886 . . . . . . . . 2 2 . 1 . 134 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -94.93 122.43 37.56 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.515 -2.756 . . . . 2.89 113.909 -173.032 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -73.26 117.96 15.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.751 1.62 . . . . 2.89 111.273 168.76 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.8 mt -92.17 128.68 38.1 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 123.429 2.831 . . . . 1.34 113.186 -171.842 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -73.8 146.64 44.07 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.415 1.579 . . . . 1.94 112.963 178.956 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -66.1 -50.1 65.22 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.817 -2.427 . . . . 1.56 115.554 -170.288 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.92 52.85 1.93 Allowed Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 117.234 -2.412 . . . . 0.97 118.082 168.527 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -114.55 161.64 17.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.848 -1.908 . . . . 3.07 105.848 161.553 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.3 p -108.05 175.6 5.42 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 116.749 2.129 . . . . 1.34 116.749 178.11 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.3 mt -65.49 -31.62 72.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.158 2.885 . . . . 1.63 114.563 172.301 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 t -63.06 -44.41 95.89 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.879 -3.638 . . . . 1.51 118.011 171.511 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -64.74 -37.2 86.81 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 129.602 3.161 . . . . 1.9 110.269 -175.597 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -98.4 -10.16 24.13 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.788 2.835 . . . . 0.97 110.085 -174.305 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.1 m120 60.66 54.89 3.5 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 128.487 3.994 . . . . 2.35 113.003 178.715 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.9 mt -106.59 101.35 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-N 108.768 -3.833 . . . . 1.39 106.644 179.607 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -104.01 174.49 5.85 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 129.988 3.315 . . . . 2.58 111.583 -167.012 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -55.67 138.81 46.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.815 -3.053 . . . . 2.58 114.486 179.813 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 67.71 39.07 2.8 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 129.837 3.255 . . . . 1.71 112.783 -178.89 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.3 t -109.9 137.28 47.9 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.22 -1.77 . . . . 1.34 106.22 -169.494 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.458 HG23 ' HD2' ' A' ' 6' ' ' LYS . 44.6 m -96.81 110.0 22.57 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 129.148 2.979 . . . . 1.36 114.114 -176.031 . . . . . . . . 2 2 . 1 . 134 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.41 HD23 ' HB2' ' A' ' 45' ' ' PHE . 13.1 mt -95.06 147.28 23.59 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 127.647 2.379 . . . . 2.03 107.742 169.342 . . . . . . . . 2 2 . 1 . 134 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -109.31 123.43 49.28 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 103.735 -2.691 . . . . 2.31 103.735 -173.207 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.6 tp -81.9 107.23 14.45 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.246 -2.784 . . . . 1.72 109.011 173.706 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.4 t -98.37 144.69 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 127.923 3.264 . . . . 1.8 104.692 167.809 . . . . . . . . 1 1 . 1 . 134 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 N--CA 1.431 -1.407 0 O-C-N 117.841 -3.037 . . . . 3.26 110.593 178.755 . . . . . . . . 0 0 . 1 . 135 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ptt? . . . . . 0 CA--C 1.489 -1.381 0 N-CA-C 112.017 0.377 . . . . 1.39 112.017 . . . . . . . . . 0 0 . 1 . 135 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -92.0 136.16 33.38 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.191 -2.193 . . . . 2.2 115.964 173.659 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.373 27.5 pt -116.61 161.66 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-O 114.541 -2.647 . . . . 1.32 112.378 165.839 . . . . . . . . 2 2 . 1 . 135 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -120.13 143.52 48.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 121.383 1.901 . . . . 2.2 110.91 177.226 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.83 127.55 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 112.33 -2.213 . . . . 1.23 108.198 175.654 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -97.4 138.83 34.26 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.343 -1.725 . . . . 2.51 106.343 177.256 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 p -97.57 -179.45 4.47 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 127.609 3.576 . . . . 1.41 110.867 173.027 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.8 mt -77.79 -51.33 10.68 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.208 -4.683 . . . . 2.95 112.624 175.315 . . . . . . . . 2 2 . 1 . 135 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.0 p -56.83 -43.87 81.48 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.464 2.024 . . . . 2.52 116.464 177.602 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.08 61.08 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 127.106 2.289 . . . . 1.5 111.118 177.978 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.38 156.48 48.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 103.1 -2.926 . . . . 1.79 103.1 178.38 . . . . . . . . 2 2 . 1 . 135 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.9 m -133.04 121.81 23.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.715 2.674 . . . . 1.38 110.805 -176.95 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mt -102.23 115.27 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 118.627 -2.546 . . . . 2.03 106.896 -175.998 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.2 m -93.19 115.73 28.34 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.163 -1.586 . . . . 1.61 106.784 174.867 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.3 mt -117.63 147.87 42.47 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 125.726 2.679 . . . . 2.15 112.022 -178.787 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -90.61 121.13 32.26 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.378 1.871 . . . . 1.98 110.525 177.346 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.6 m -140.99 167.38 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 116.534 -1.698 . . . . 1.52 111.829 -176.735 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -118.86 173.46 3.4 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-N 122.739 2.518 . . . . 2.35 114.182 156.96 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -75.7 -11.31 20.24 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 115.224 -2.717 . . . . 1.31 118.861 -179.479 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.6 m -79.57 -3.02 45.06 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.359 1.064 . . . . 1.71 112.062 170.493 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -81.33 151.57 27.95 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.517 -1.99 . . . . 1.69 107.884 178.781 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.269 17.3 p -92.52 164.03 13.6 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 115.088 1.514 . . . . 1.33 115.088 178.796 . . . . . . . . 2 2 . 1 . 135 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.9 mm -63.33 -22.38 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 116.267 1.951 . . . . 1.32 116.267 171.999 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -66.72 -45.34 79.01 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.149 3.379 . . . . 1.62 111.764 166.114 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -56.89 -38.16 72.39 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.343 -2.098 . . . . 2.13 114.504 178.133 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.1 t -66.26 -36.03 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 127.914 2.485 . . . . 1.23 114.245 174.979 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -67.4 -39.56 85.58 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.97 2.952 . . . . 1.97 118.97 173.582 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.28 -36.55 66.25 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 116.847 2.166 . . . . 1.19 116.847 170.547 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -60.42 -40.25 90.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.913 1.285 . . . . 1.92 114.224 170.048 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.3 mt -76.4 -31.42 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.438 1.495 . . . . 1.94 108.654 179.367 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -67.26 -43.55 81.59 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.171 -2.205 . . . . 1.9 113.904 174.851 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -58.13 -65.57 0.62 Allowed 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 130.386 3.474 . . . . 1.55 110.805 168.783 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -56.63 -53.55 56.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.926 3.306 . . . . 2.95 119.926 -175.252 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -120.87 -3.63 9.68 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.681 -1.6 . . . . 1.48 112.826 -164.845 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.83 -6.34 81.95 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 118.493 2.157 . . . . 1.12 118.493 169.527 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.7 mp -73.97 113.63 25.1 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 118.288 -2.889 . . . . 2.07 115.451 -170.665 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -60.23 146.44 96.39 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 124.974 3.783 . . . . 1.39 114.009 179.718 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -58.18 -24.91 69.26 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 C-N-CA 123.437 2.758 . . . . 1.68 117.224 -177.534 . . . . . . . . 2 2 . 1 . 135 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -70.8 -26.2 63.21 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 130.176 4.672 . . . . 2.25 112.702 179.296 . . . . . . . . 2 2 . 1 . 135 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -89.89 -16.26 30.4 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.21 -3.431 . . . . 2.44 112.492 -174.974 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -87.25 126.87 35.09 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 117.313 2.338 . . . . 1.32 117.313 -177.759 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -120.74 126.27 49.73 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.127 2.571 . . . . 3.19 108.099 164.883 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.435 HD23 HD11 ' A' ' 69' ' ' LEU . 90.9 mt -109.51 115.03 29.17 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.774 -3.079 . . . . 1.75 109.391 -174.993 . . . . . . . . 2 2 . 1 . 135 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.418 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 31.3 mm -101.18 134.72 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 125.943 1.697 . . . . 1.98 108.581 -177.028 . . . . . . . . 2 2 . 1 . 135 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.415 ' HB3' HD12 ' A' ' 50' ' ' LEU . 89.2 t80 -154.42 126.54 7.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.565 -2.383 . . . . 1.94 104.565 174.976 . . . . . . . . 2 2 . 1 . 135 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.52 45.12 16.85 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 125.958 2.789 . . . . 1.67 113.788 -177.264 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.49 2.27 20.08 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 111.97 -2.377 . . . . 1.3 118.737 -173.506 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -103.88 125.9 50.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.283 -3.481 . . . . 2.89 107.19 -175.523 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -74.0 122.01 21.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.083 -2.261 . . . . 2.89 107.258 163.707 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 45' ' ' PHE . 19.9 mt -78.24 127.02 31.64 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 130.459 3.504 . . . . 1.34 116.855 -177.396 . . . . . . . . 2 2 . 1 . 135 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -89.29 130.55 35.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 116.421 2.008 . . . . 1.94 116.421 173.871 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.53 -61.41 1.7 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 130.275 3.43 . . . . 1.56 115.898 -170.269 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.68 23.8 3.45 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 123.066 3.986 . . . . 0.97 123.066 173.199 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -99.73 165.44 11.59 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.363 1.465 . . . . 3.07 107.347 163.862 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.391 18.6 p -92.6 171.19 9.17 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 117.09 2.256 . . . . 1.34 117.09 177.097 . . . . . . . . 2 2 . 1 . 135 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.72 -33.79 64.52 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 114.897 -2.478 . . . . 1.63 107.374 170.987 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -73.46 -35.68 65.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.42 1.888 . . . . 1.51 107.94 -175.256 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.39 3.0 t0 -63.32 -53.98 44.25 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.941 1.353 . . . . 1.9 111.859 171.005 . . . . . . . . 2 2 . 1 . 135 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -73.19 -7.98 53.79 Favored 'General case' 0 N--CA 1.43 -1.454 2 O-C-N 115.318 -4.613 . . . . 0.97 122.295 177.112 . . . . . . . . 2 2 . 1 . 135 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.0 m120 70.2 56.42 0.29 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.568 1.692 . . . . 2.35 115.568 179.137 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.1 mt -104.71 108.29 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 128.097 3.373 . . . . 1.39 109.008 177.485 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -87.95 -175.39 5.09 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 125.265 2.46 . . . . 2.58 109.49 177.807 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -63.2 131.0 47.0 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 115.276 -4.64 . . . . 2.58 115.62 174.522 . . . . . . . . 2 2 . 1 . 135 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.662 17.9 mt-10 97.69 -5.31 0.05 Allowed 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 124.622 1.201 . . . . 1.71 112.284 174.315 . . . . . . . . 2 2 . 1 . 135 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -66.71 122.69 18.2 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.807 2.043 . . . . 1.34 115.455 -176.265 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.5 m -91.2 115.59 28.14 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 103.803 -2.666 . . . . 1.36 103.803 -178.682 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.4 mt -79.34 139.74 37.7 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.079 2.952 . . . . 2.03 112.245 165.343 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.418 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 42.6 m80 -108.7 117.08 33.25 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.95 -2.969 . . . . 2.31 114.702 -179.059 . . . . . . . . 2 2 . 1 . 135 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.435 HD11 HD23 ' A' ' 43' ' ' LEU . 23.9 tp -83.17 115.14 21.79 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 128.577 2.751 . . . . 1.72 111.746 -174.916 . . . . . . . . 2 2 . 1 . 135 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.2 t -104.25 133.27 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 105.354 -2.091 . . . . 1.8 105.354 174.498 . . . . . . . . 1 1 . 1 . 135 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 N--CA 1.431 -1.408 0 O-C-N 125.345 1.653 . . . . 3.26 110.036 -178.231 . . . . . . . . 0 0 . 1 . 136 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 ptt? . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 122.104 0.954 . . . . 1.39 109.965 . . . . . . . . . 0 0 . 1 . 136 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -103.08 144.02 31.83 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.336 -1.302 . . . . 2.2 107.966 -177.381 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.2 pt -132.35 159.68 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 C-N-CA 127.341 2.256 . . . . 1.32 107.182 175.71 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -103.39 153.09 20.85 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 128.581 2.753 . . . . 2.2 111.574 178.752 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.5 t -137.7 104.68 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 106.636 -1.616 . . . . 1.23 106.636 177.546 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -90.59 117.62 29.4 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 127.062 3.315 . . . . 2.51 111.13 -179.791 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.1 p -80.22 174.5 11.53 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.137 -3.477 . . . . 1.41 115.567 179.303 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.2 mt -61.47 -52.74 63.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 124.875 1.359 . . . . 2.95 111.573 170.235 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.276 72.6 p -66.5 -38.17 86.65 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 119.465 -2.022 . . . . 2.52 115.625 -173.189 . . . . . . . . 2 2 . 1 . 136 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.75 52.12 0.17 Allowed Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 125.542 1.544 . . . . 1.5 116.49 173.578 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -119.3 149.27 42.06 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 103.475 -2.787 . . . . 1.79 103.475 174.773 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.3 m -119.28 115.05 23.36 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 125.497 1.748 . . . . 1.38 106.636 174.633 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mt -95.69 135.63 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.189 -2.195 . . . . 2.03 105.33 179.744 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.8 m -96.14 129.52 43.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.961 -2.977 . . . . 1.61 102.961 172.122 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.0 mt -124.29 133.89 53.36 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.104 -1.813 . . . . 2.15 106.104 -179.102 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -92.3 107.24 19.07 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.07 -2.268 . . . . 1.98 111.098 169.413 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 m -113.67 179.04 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 C-N-CA 127.734 2.414 . . . . 1.52 114.113 174.669 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -125.73 154.75 73.2 Favored Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 103.84 -2.652 . . . . 2.35 103.84 166.317 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.294 25.6 Cg_endo -66.74 -30.73 41.04 Favored 'Trans proline' 0 N--CA 1.434 -2.001 1 C-N-CA 125.577 4.185 . . . . 1.31 110.234 -172.031 . . . . . . . . 3 2 . 1 . 136 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.2 p -64.51 -16.94 63.39 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.552 3.141 . . . . 1.71 116.646 173.549 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -70.07 142.47 52.66 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.376 -2.077 . . . . 1.69 109.39 177.137 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.0 p -78.26 164.56 24.79 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 126.247 2.217 . . . . 1.33 112.941 174.237 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.4 mm -65.2 -32.6 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 117.142 2.275 . . . . 1.32 117.142 174.114 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -50.03 -49.88 49.44 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 126.386 2.993 . . . . 1.62 109.688 164.533 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -65.36 -37.21 86.35 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.407 -2.683 . . . . 2.13 116.295 -178.127 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.4 t -67.53 -27.89 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 121.254 1.843 . . . . 1.23 108.221 174.812 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -75.0 -27.32 60.09 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 121.005 1.729 . . . . 1.97 112.526 178.343 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.18 -31.74 69.35 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 117.3 -1.333 . . . . 1.19 111.457 173.844 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -69.05 -35.64 76.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.515 2.726 . . . . 1.92 109.914 175.033 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.8 mt -69.03 -43.66 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-N 113.789 -1.55 . . . . 1.94 111.359 171.134 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -62.68 -38.07 88.92 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.103 -2.248 . . . . 1.9 113.389 179.206 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -49.67 -49.5 47.2 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 130.272 3.429 . . . . 1.55 114.474 168.943 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -87.96 -58.45 2.56 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.106 -3.496 . . . . 2.95 117.002 -179.557 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -81.88 -43.97 17.47 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.695 1.712 . . . . 1.48 112.546 -166.086 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.1 63.35 1.14 Allowed Glycine 0 N--CA 1.431 -1.689 0 CA-C-N 111.946 -2.388 . . . . 1.12 112.586 176.001 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.2 mt -129.81 117.9 18.52 Favored Pre-proline 0 N--CA 1.429 -1.505 0 CA-C-O 115.789 -2.053 . . . . 2.07 106.074 -177.599 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -67.4 140.63 53.35 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 CA-C-N 127.493 3.712 . . . . 1.39 112.114 -179.904 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -51.9 -20.17 9.57 Favored 'Trans proline' 0 N--CA 1.433 -2.073 1 N-CA-C 122.719 4.084 . . . . 1.68 122.719 -175.958 . . . . . . . . 3 3 . 1 . 136 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.96 -39.55 72.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.805 2.842 . . . . 2.25 111.02 172.523 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -75.75 -36.0 60.01 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 116.706 -3.746 . . . . 2.44 111.496 179.878 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -93.52 142.45 27.33 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 119.951 -1.718 . . . . 1.32 107.036 -166.136 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -124.13 151.54 43.82 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.993 -1.692 . . . . 3.19 106.535 166.599 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.6 mt -121.64 123.9 43.02 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.084 1.421 . . . . 1.75 108.868 -179.559 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.4 mt -105.53 128.43 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 129.719 3.208 . . . . 1.98 110.664 -176.101 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.495 ' C ' ' H ' ' A' ' 47' ' ' GLY . 2.4 t80 -139.13 133.11 31.04 Favored 'General case' 0 N--CA 1.43 -1.473 1 N-CA-C 99.256 -4.35 . . . . 1.94 99.256 179.835 . . . . . . . . 3 3 . 1 . 136 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.57 -36.01 0.18 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 131.418 3.887 . . . . 1.67 113.557 179.504 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.495 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 164.91 -26.06 0.18 Allowed Glycine 0 N--CA 1.429 -1.781 0 O-C-N 116.964 -3.585 . . . . 1.3 111.245 178.297 . . . . . . . . 2 2 . 1 . 136 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -83.22 137.67 33.92 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.703 2.668 . . . . 2.89 111.611 -178.974 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 pm0 -92.4 126.99 37.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.26 -2.15 . . . . 2.89 109.514 177.019 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.293 34.8 mt -81.87 122.84 28.24 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.378 2.513 . . . . 1.34 109.899 -161.683 . . . . . . . . 2 2 . 1 . 136 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -77.99 130.64 36.75 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 116.801 -3.687 . . . . 1.94 108.119 178.601 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -46.57 -48.18 19.58 Favored 'General case' 0 N--CA 1.43 -1.472 1 C-N-CA 132.34 4.256 . . . . 1.56 115.028 -173.34 . . . . . . . . 2 2 . 1 . 136 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.65 49.61 3.89 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 128.425 2.917 . . . . 0.97 116.077 172.983 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -135.78 172.86 12.39 Favored 'General case' 0 N--CA 1.43 -1.464 1 N-CA-C 97.606 -4.961 . . . . 3.07 97.606 169.47 . . . . . . . . 2 2 . 1 . 136 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.5 p -99.14 169.21 9.56 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.232 -1.804 . . . . 1.34 114.56 170.3 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.5 mt -76.02 -21.68 56.59 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 112.324 -2.216 . . . . 1.63 109.161 176.907 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 t -73.86 -39.78 63.73 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.893 -0.594 . . . . 1.51 109.798 176.862 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -54.84 -40.8 69.98 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 120.442 3.497 . . . . 1.9 120.442 174.508 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -78.84 -15.03 58.89 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 128.121 2.568 . . . . 0.97 116.992 175.966 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 m120 68.74 51.54 0.59 Allowed 'General case' 0 N--CA 1.43 -1.445 1 C-N-CA 132.932 4.493 . . . . 2.35 113.88 -178.311 . . . . . . . . 2 2 . 1 . 136 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mp -82.15 116.86 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 117.39 -3.318 . . . . 1.39 108.976 175.516 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -95.95 165.07 12.44 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 111.884 -2.417 . . . . 2.58 115.531 177.309 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -53.49 135.23 40.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.359 -1.291 . . . . 2.58 113.576 176.269 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 63.84 34.29 11.96 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 118.674 2.842 . . . . 1.71 118.674 178.241 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.7 m -92.12 154.46 18.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.1 2.16 . . . . 1.34 114.277 -177.314 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.0 m -102.36 114.14 28.07 Favored 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 117.516 -3.24 . . . . 1.36 116.348 -179.957 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -87.15 147.7 25.51 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.651 -0.656 . . . . 2.03 109.855 165.806 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -114.92 120.77 41.06 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 123.797 0.839 . . . . 2.31 109.137 -178.692 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.4 tp -97.69 129.16 44.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.932 -2.355 . . . . 1.72 109.472 -175.565 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.83 164.52 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 129.887 3.275 . . . . 1.8 105.555 177.796 . . . . . . . . 1 1 . 1 . 136 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.7 mt . . . . . 0 N--CA 1.429 -1.501 0 O-C-N 116.794 -3.691 . . . . 3.26 109.364 179.553 . . . . . . . . 0 0 . 1 . 137 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 ptt? . . . . . 0 CA--C 1.49 -1.339 0 CA-C-O 115.847 -2.025 . . . . 1.39 116.247 . . . . . . . . . 0 0 . 1 . 137 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.62 138.13 34.66 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 122.809 2.55 . . . . 2.2 109.978 -179.096 . . . . . . . . 2 2 . 1 . 137 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.8 pt -124.33 170.85 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 104.232 -2.507 . . . . 1.32 104.232 167.991 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -119.1 147.25 44.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.811 3.245 . . . . 2.2 107.051 -176.586 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.5 t -133.93 138.08 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 102.832 -3.025 . . . . 1.23 102.832 170.755 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -110.6 130.31 55.6 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.082 2.153 . . . . 2.51 107.328 177.768 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -81.8 -176.73 6.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 123.898 0.749 . . . . 1.41 111.966 174.977 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.7 mt -58.49 -47.51 83.84 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.171 2.988 . . . . 2.95 112.331 179.494 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.0 p -89.04 -35.73 16.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.161 -2.837 . . . . 2.52 106.529 -172.338 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.74 5.54 0.25 Allowed Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 119.938 2.735 . . . . 1.5 119.938 -178.497 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.1 ttpt -85.17 126.03 33.31 Favored 'General case' 0 N--CA 1.43 -1.443 2 O-C-N 113.803 -5.528 . . . . 1.79 108.895 -174.482 . . . . . . . . 2 2 . 1 . 137 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.293 66.0 m -83.77 114.9 21.94 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.058 2.361 . . . . 1.38 109.362 173.966 . . . . . . . . 2 2 . 1 . 137 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mt -98.25 116.7 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 124.553 2.121 . . . . 2.03 105.654 177.051 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.6 m -86.59 105.89 17.18 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.812 -3.055 . . . . 1.61 116.436 173.371 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.0 mt -113.41 115.99 28.93 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 117.199 -1.381 . . . . 2.15 113.319 -179.495 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.368 0.8 OUTLIER -67.94 111.71 4.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.811 1.291 . . . . 1.98 111.211 171.081 . . . . . . . . 3 3 . 1 . 137 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 m -117.0 169.81 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 117.039 -3.538 . . . . 1.52 112.678 179.334 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -112.82 165.57 12.83 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-N 121.512 1.96 . . . . 2.35 108.382 160.25 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -66.47 -28.31 46.01 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 CA-C-N 124.27 2.561 . . . . 1.31 114.313 -172.587 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.293 24.0 p -77.65 1.01 21.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 130.953 3.701 . . . . 1.71 119.475 177.143 . . . . . . . . 2 2 . 1 . 137 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -80.78 143.49 32.83 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.254 -1.529 . . . . 1.69 107.654 175.377 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.3 p -75.56 167.79 21.24 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.439 -0.578 . . . . 1.33 109.439 179.174 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -68.4 -37.18 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.672 -1.893 . . . . 1.32 115.158 175.849 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -49.74 -43.68 48.07 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 112.164 -2.289 . . . . 1.62 114.141 162.817 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -72.42 -28.42 62.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.852 -1.155 . . . . 2.13 113.868 176.104 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.7 t -71.56 -35.42 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 117.366 -3.334 . . . . 1.23 112.042 170.556 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -68.91 -35.66 77.1 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 124.45 1.094 . . . . 1.97 109.146 172.704 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.27 -40.65 96.94 Favored 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 118.78 -2.45 . . . . 1.19 112.97 172.485 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -61.09 -42.35 98.35 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 119.031 -2.293 . . . . 1.92 115.542 171.003 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.0 mt -58.89 -36.29 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 119.077 -2.264 . . . . 1.94 112.796 167.583 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -61.44 -40.21 93.65 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.49 -1.381 . . . . 1.9 113.501 176.44 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.45 -40.37 94.23 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 119.697 3.221 . . . . 1.55 119.697 162.931 . . . . . . . . 2 2 . 1 . 137 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt -78.68 -68.2 0.67 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.167 2.187 . . . . 2.95 107.935 -176.88 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -101.44 -19.19 15.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 116.857 -1.937 . . . . 1.48 111.238 -169.364 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.57 9.84 45.71 Favored Glycine 0 N--CA 1.431 -1.679 0 CA-C-O 114.748 -3.251 . . . . 1.12 115.877 176.156 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.1 mt -85.97 128.39 58.33 Favored Pre-proline 0 N--CA 1.429 -1.49 1 CA-C-O 110.901 -4.38 . . . . 2.07 106.797 -178.953 . . . . . . . . 2 2 . 1 . 137 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -80.65 153.12 20.11 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 CA-C-N 127.561 3.736 . . . . 1.39 110.671 -179.03 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.64 -19.95 41.24 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 124.829 3.686 . . . . 1.68 111.84 -165.768 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -68.16 -39.52 82.56 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 124.283 1.992 . . . . 2.25 116.276 173.009 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -73.04 -43.62 61.77 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 131.221 3.808 . . . . 2.44 115.119 174.091 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -60.75 137.22 58.22 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.584 -2.573 . . . . 1.32 111.094 -174.591 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -116.51 142.78 46.43 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 125.021 3.555 . . . . 3.19 107.402 167.294 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.43 HD11 HD13 ' A' ' 67' ' ' LEU . 74.9 mt -127.52 119.67 26.56 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.251 -2.129 . . . . 1.75 105.251 178.297 . . . . . . . . 2 2 . 1 . 137 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 mt -111.55 132.9 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 129.093 2.957 . . . . 1.98 110.672 -179.995 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -139.23 141.04 37.89 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.394 -2.076 . . . . 1.94 105.394 170.413 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.43 20.71 0.32 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.123 -2.861 . . . . 1.67 117.712 177.667 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.59 6.19 80.78 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 116.807 -3.683 . . . . 1.3 113.287 179.677 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -98.09 121.71 40.35 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 115.382 -2.247 . . . . 2.89 110.841 174.795 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -77.68 125.13 28.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.506 2.323 . . . . 2.89 105.897 171.945 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.288 22.2 mt -79.99 136.41 36.6 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.908 1.814 . . . . 1.34 112.402 -167.684 . . . . . . . . 2 2 . 1 . 137 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.32 46.1 mt-10 -81.19 129.65 34.68 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.113 -3.492 . . . . 1.94 113.574 173.039 . . . . . . . . 2 2 . 1 . 137 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -59.83 -46.05 90.46 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.807 2.521 . . . . 1.56 117.807 -172.211 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.9 49.02 2.25 Favored Glycine 0 N--CA 1.43 -1.704 1 O-C-N 113.098 -6.001 . . . . 0.97 110.149 173.14 . . . . . . . . 2 2 . 1 . 137 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -119.5 176.25 5.45 Favored 'General case' 0 N--CA 1.429 -1.477 1 O-C-N 116.232 -4.099 . . . . 3.07 105.388 161.561 . . . . . . . . 2 2 . 1 . 137 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.3 p -104.29 -175.54 2.82 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 117.904 -1.518 . . . . 1.34 114.245 175.385 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.0 mt -77.97 -29.27 49.65 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.783 -1.198 . . . . 1.63 110.818 173.888 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.9 t -73.58 -29.47 62.43 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.576 -1.328 . . . . 1.51 113.261 176.584 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -58.88 -28.91 66.6 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.833 2.901 . . . . 1.9 118.833 172.252 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.356 26.6 m-85 -100.18 8.96 43.47 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 115.671 1.73 . . . . 0.97 115.671 173.022 . . . . . . . . 2 2 . 1 . 137 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.7 m120 46.69 64.14 1.64 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.553 2.341 . . . . 2.35 113.019 -173.514 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.4 mt -104.5 121.87 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 103.213 -2.884 . . . . 1.39 103.213 177.218 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -96.84 -172.66 2.52 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.994 2.118 . . . . 2.58 106.494 -168.681 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.17 153.61 40.64 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 116.49 -2.084 . . . . 2.58 110.685 173.131 . . . . . . . . 2 2 . 1 . 137 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.301 41.5 mt-10 59.53 46.65 11.86 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 115.117 1.525 . . . . 1.71 115.117 177.729 . . . . . . . . 2 2 . 1 . 137 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -104.17 142.94 33.63 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 131.469 3.908 . . . . 1.34 106.305 178.75 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.4 m -108.77 118.02 35.71 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.176 1.941 . . . . 1.36 106.76 -179.832 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.43 HD13 HD11 ' A' ' 43' ' ' LEU . 74.4 mt -92.44 146.53 23.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 113.202 -1.817 . . . . 2.03 110.242 167.381 . . . . . . . . 2 2 . 1 . 137 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -105.33 115.45 30.27 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.691 2.186 . . . . 2.31 107.036 -179.771 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 tt -88.22 116.3 26.32 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 111.863 -2.426 . . . . 1.72 110.844 -179.625 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.9 t -119.75 -178.51 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.259 -2.126 . . . . 1.8 105.259 176.795 . . . . . . . . 1 1 . 1 . 137 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.0 mt . . . . . 0 N--CA 1.43 -1.458 0 O-C-N 117.173 -3.454 . . . . 3.26 113.354 177.889 . . . . . . . . 0 0 . 1 . 138 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ptt? . . . . . 0 CA--C 1.49 -1.344 0 N-CA-C 115.568 1.692 . . . . 1.39 115.568 . . . . . . . . . 0 0 . 1 . 138 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -99.16 142.45 30.63 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.173 -2.158 . . . . 2.2 105.173 179.508 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.458 HG13 ' HB2' ' A' ' 15' ' ' LEU . 3.1 pt -117.6 165.08 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 106.569 -1.641 . . . . 1.32 106.569 169.282 . . . . . . . . 2 2 . 1 . 138 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -118.35 121.14 39.66 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.559 -1.338 . . . . 2.2 108.49 179.053 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.3 t -103.37 138.76 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 104.685 -2.339 . . . . 1.23 104.685 171.369 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -111.94 143.58 42.68 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 113.427 -3.178 . . . . 2.51 112.248 173.228 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.5 p -88.61 -172.41 3.73 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.452 3.595 . . . . 1.41 112.915 179.243 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.1 mt -54.14 -38.83 65.91 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 127.028 3.299 . . . . 2.95 116.169 167.282 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -88.81 -35.58 16.53 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 114.297 -5.252 . . . . 2.52 113.002 179.842 . . . . . . . . 2 2 . 1 . 138 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.92 27.37 0.94 Allowed Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 117.745 -1.586 . . . . 1.5 114.541 -179.804 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.8 124.9 29.04 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 120.73 2.265 . . . . 1.79 109.784 -173.929 . . . . . . . . 2 2 . 1 . 138 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.528 1.7 m -78.64 118.63 20.93 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 113.835 -5.54 . . . . 1.38 118.25 176.98 . . . . . . . . 3 2 . 1 . 138 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mt -106.04 121.36 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 125.736 1.615 . . . . 2.03 110.099 172.873 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.251 6.4 m -92.51 108.93 20.34 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 116.854 2.168 . . . . 1.61 116.854 179.55 . . . . . . . . 2 2 . 1 . 138 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.458 ' HB2' HG13 ' A' ' 3' ' ' ILE . 21.5 mt -113.9 130.64 56.48 Favored 'General case' 0 N--CA 1.431 -1.409 1 O-C-N 115.141 -4.724 . . . . 2.15 110.651 -173.627 . . . . . . . . 3 3 . 1 . 138 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -84.81 101.06 11.97 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 116.688 -3.757 . . . . 1.98 111.184 169.61 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.411 HG21 HG12 ' A' ' 3' ' ' ILE . 15.0 m -114.18 164.26 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 121.154 -0.967 . . . . 1.52 110.089 -179.064 . . . . . . . . 2 2 . 1 . 138 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -102.14 161.4 23.51 Favored Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 127.395 2.278 . . . . 2.35 104.941 159.058 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -77.16 -7.65 17.25 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 CA-C-N 122.655 1.984 . . . . 1.31 107.523 -179.616 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 m -79.31 -14.92 58.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.692 1.597 . . . . 1.71 111.825 177.174 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -65.99 144.8 56.52 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.923 2.297 . . . . 1.69 105.948 -179.888 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.4 p -89.34 158.28 17.85 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.415 -1.72 . . . . 1.33 112.937 176.972 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.433 HD11 ' O ' ' A' ' 54' ' ' ARG 0.332 2.8 mp -53.53 -43.74 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 116.323 -3.985 . . . . 1.32 115.305 169.8 . . . . . . . . 3 3 . 1 . 138 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -41.18 -59.96 1.37 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.189 2.196 . . . . 1.62 114.941 165.888 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -72.24 -24.54 61.39 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 120.322 3.453 . . . . 2.13 120.322 -175.624 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -61.18 -32.22 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 120.361 -1.462 . . . . 1.23 113.198 168.777 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -60.06 -43.46 95.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 117.68 -1.152 . . . . 1.97 110.987 177.602 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.78 -27.06 63.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 125.008 1.443 . . . . 1.19 109.027 177.895 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -66.46 -30.8 71.22 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 118.273 -2.767 . . . . 1.92 110.64 173.535 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.6 mt -65.87 -31.42 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 129.686 3.194 . . . . 1.94 109.732 169.494 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.328 52.9 tt0 -69.33 -33.63 73.42 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.024 -2.922 . . . . 1.9 116.91 175.694 . . . . . . . . 2 2 . 1 . 138 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.261 11.9 m-20 -67.81 -36.87 81.17 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.422 2.289 . . . . 1.55 112.196 168.918 . . . . . . . . 2 2 . 1 . 138 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -76.49 -77.28 0.14 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.831 1.252 . . . . 2.95 110.995 -178.494 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -88.17 -66.92 0.87 Allowed 'General case' 0 N--CA 1.429 -1.487 1 C-N-CA 133.316 4.646 . . . . 1.48 114.743 -166.561 . . . . . . . . 2 2 . 1 . 138 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.76 29.66 0.74 Allowed Glycine 0 N--CA 1.43 -1.714 0 O-C-N 126.973 2.671 . . . . 1.12 110.599 166.932 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.6 mt -89.44 126.12 59.35 Favored Pre-proline 0 N--CA 1.43 -1.459 1 O-C-N 115.738 -4.39 . . . . 2.07 109.192 -179.448 . . . . . . . . 2 2 . 1 . 138 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -54.37 129.28 33.86 Favored 'Trans proline' 0 C--N 1.299 -2.035 1 C-N-CA 125.611 4.207 . . . . 1.39 116.274 175.674 . . . . . . . . 3 3 . 1 . 138 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -59.96 -14.24 26.87 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 CA-C-N 124.324 2.58 . . . . 1.68 116.511 -173.38 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -65.28 -21.92 66.79 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 128.826 2.851 . . . . 2.25 118.581 170.608 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -102.41 -9.4 20.32 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-O 116.406 -1.759 . . . . 2.44 108.715 -172.712 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -89.38 133.49 34.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.742 2.417 . . . . 1.32 114.993 -170.39 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -132.96 145.09 50.58 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.435 2.064 . . . . 3.19 106.906 169.621 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.5 mt -122.15 143.45 49.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.414 -2.054 . . . . 1.75 114.616 -177.992 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.5 mt -118.83 129.5 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 130.166 3.386 . . . . 1.98 108.887 -179.699 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -130.28 127.3 39.25 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.199 1.8 . . . . 1.94 109.816 167.641 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.85 12.8 0.93 Allowed 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.212 2.301 . . . . 1.67 117.212 -178.379 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.49 0.19 29.35 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 118.136 -2.852 . . . . 1.3 116.837 -174.388 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.307 64.5 mttt -114.62 137.18 52.2 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.748 1.737 . . . . 2.89 114.622 179.671 . . . . . . . . 2 2 . 1 . 138 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -86.01 138.5 31.92 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 117.188 -1.805 . . . . 2.89 107.845 174.192 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.7 mt -88.98 138.74 31.13 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.151 2.278 . . . . 1.34 117.151 -171.654 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -73.11 147.71 44.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 124.107 0.879 . . . . 1.94 113.356 169.932 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.72 -53.96 13.61 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.473 -2.017 . . . . 1.56 111.731 -168.532 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.87 44.1 2.93 Favored Glycine 0 N--CA 1.431 -1.666 0 O-C-N 126.702 2.501 . . . . 0.97 115.372 172.121 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.433 ' O ' HD11 ' A' ' 23' ' ' ILE . 18.0 mmt180 -116.91 165.37 13.41 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 125.43 2.538 . . . . 3.07 104.447 163.616 . . . . . . . . 2 2 . 1 . 138 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.9 p -96.66 163.76 12.88 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 112.89 -1.959 . . . . 1.34 110.605 172.873 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.2 mt -57.39 -40.43 78.2 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 127.345 2.258 . . . . 1.63 111.161 170.518 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.9 t -64.92 -40.94 95.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 126.646 2.466 . . . . 1.51 114.374 -179.174 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -56.0 -40.83 73.93 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.124 -3.485 . . . . 1.9 119.409 176.822 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -84.91 3.82 36.36 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 112.882 -1.963 . . . . 0.97 110.938 170.851 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.421 26.4 m120 62.49 38.64 12.5 Favored 'General case' 0 N--CA 1.43 -1.454 1 N-CA-C 121.957 4.058 . . . . 2.35 121.957 -174.382 . . . . . . . . 3 2 . 1 . 138 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.1 mt -93.65 123.65 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 117.281 -3.387 . . . . 1.39 109.107 -175.044 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -107.69 -172.48 2.08 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.178 1.353 . . . . 2.58 111.009 -172.577 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -56.16 144.35 29.91 Favored 'General case' 0 N--CA 1.428 -1.526 0 O-C-N 126.65 2.469 . . . . 2.58 113.658 168.315 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.294 35.5 mt-10 57.23 32.34 21.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.525 3.13 . . . . 1.71 117.052 173.226 . . . . . . . . 2 2 . 1 . 138 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 t -96.14 133.86 39.91 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.719 3.208 . . . . 1.34 109.996 -174.237 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.15 116.57 21.12 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 118.119 2.637 . . . . 1.36 118.119 177.344 . . . . . . . . 2 2 . 1 . 138 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.263 54.3 mt -101.46 140.24 36.03 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.847 -3.033 . . . . 2.03 106.291 173.542 . . . . . . . . 2 2 . 1 . 138 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -104.14 121.22 42.78 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 116.081 -1.914 . . . . 2.31 110.934 -174.556 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.3 tp -89.89 128.52 36.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.869 1.795 . . . . 1.72 115.365 178.48 . . . . . . . . 1 1 . 1 . 138 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.4 m -127.09 151.71 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 1 CA-C-O 128.827 4.156 . . . . 1.8 104.86 176.778 . . . . . . . . 2 2 . 1 . 138 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.8 mt . . . . . 0 N--CA 1.43 -1.465 1 O-C-N 116.188 -4.07 . . . . 3.26 111.481 -167.571 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.294 45.1 ttp . . . . . 0 CA--C 1.491 -1.327 0 N-CA-C 113.749 1.018 . . . . 1.39 113.749 . . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -100.73 123.47 44.98 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 119.491 -0.883 . . . . 2.2 111.541 -177.499 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 pt -120.93 163.65 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.311 -0.996 . . . . 1.32 108.311 174.258 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -119.95 143.03 48.22 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 130.937 3.695 . . . . 2.2 109.738 -177.924 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.298 43.5 t -116.84 115.07 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 116.915 -3.616 . . . . 1.23 113.651 171.734 . . . . . . . . 2 2 . 1 . 139 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -95.53 143.8 26.54 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 115.949 -1.977 . . . . 2.51 108.374 -176.54 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.7 p -101.37 179.75 4.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 126.748 3.166 . . . . 1.41 112.213 173.058 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.3 mt -79.77 -10.42 59.78 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 111.607 -6.933 . . . . 2.95 115.062 173.218 . . . . . . . . 2 2 . 1 . 139 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.257 28.8 p -86.51 -51.64 6.06 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 126.321 2.962 . . . . 2.52 110.914 178.002 . . . . . . . . 2 2 . 1 . 139 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.7 -2.19 0.45 Allowed Glycine 0 N--CA 1.43 -1.705 0 O-C-N 118.198 -2.814 . . . . 1.5 112.343 177.891 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -78.19 142.58 37.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 123.078 3.439 . . . . 1.79 110.672 -179.627 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.6 m -107.95 132.88 53.03 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 123.863 1.792 . . . . 1.38 107.503 171.797 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -109.93 149.16 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 102.454 -3.165 . . . . 2.03 102.454 177.212 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.3 m -123.4 125.11 44.37 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.487 -3.883 . . . . 1.61 100.645 -177.256 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -126.51 159.11 34.35 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.357 2.263 . . . . 2.15 106.011 176.244 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -120.92 125.91 48.65 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.939 3.295 . . . . 1.98 108.576 169.839 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 m -132.28 158.41 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 129.843 3.257 . . . . 1.52 105.315 -173.059 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -114.38 141.13 26.03 Favored Pre-proline 0 N--CA 1.429 -1.476 0 N-CA-C 102.409 -3.182 . . . . 2.35 102.409 167.365 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -61.96 -7.52 9.83 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 C-N-CA 124.511 3.474 . . . . 1.31 116.169 -171.295 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 p -73.36 -14.71 61.33 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.161 2.984 . . . . 1.71 112.104 172.977 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -75.34 145.36 41.79 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 117.354 -3.341 . . . . 1.69 111.652 179.538 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 60.9 p -89.83 179.19 6.05 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.875 -1.141 . . . . 1.33 113.477 178.31 . . . . . . . . 2 2 . 1 . 139 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.3 mm -79.67 -22.59 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 121.289 1.859 . . . . 1.32 107.162 175.453 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -70.83 -31.4 68.12 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.052 2.141 . . . . 1.62 110.499 170.233 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -77.18 -35.42 55.84 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.65 2.38 . . . . 2.13 111.788 173.493 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.0 t -55.44 -55.11 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-N 123.819 3.009 . . . . 1.23 112.32 167.043 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -50.44 -39.2 47.03 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 126.298 2.249 . . . . 1.97 116.078 173.939 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.83 -35.82 80.94 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.075 1.75 . . . . 1.19 111.139 173.499 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -74.54 -22.8 58.83 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 115.825 -2.35 . . . . 1.92 111.429 174.062 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.287 55.5 mt -70.96 -30.48 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.389 -2.07 . . . . 1.94 111.931 171.572 . . . . . . . . 2 2 . 1 . 139 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -65.4 -38.09 88.91 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.768 -1.56 . . . . 1.9 110.306 175.481 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.57 -59.9 2.8 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 115.22 -4.675 . . . . 1.55 112.497 168.951 . . . . . . . . 2 2 . 1 . 139 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -60.75 -58.4 8.61 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.767 1.627 . . . . 2.95 112.367 -172.737 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -95.34 -56.21 2.79 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.917 -2.364 . . . . 1.48 109.611 -170.542 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.94 4.48 7.22 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 105.146 -3.182 . . . . 1.12 105.146 176.779 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mt -74.16 129.51 84.35 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 114.32 -2.753 . . . . 2.07 105.826 -173.878 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -70.58 154.23 64.62 Favored 'Trans proline' 0 N--CA 1.434 -2.009 0 C-N-CA 115.388 -2.608 . . . . 1.39 116.888 178.006 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.59 -4.88 13.83 Favored 'Trans proline' 0 C--N 1.3 -2.015 1 C-N-CA 125.544 4.162 . . . . 1.68 108.068 -172.647 . . . . . . . . 2 2 . 1 . 139 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -77.45 -40.09 44.46 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 125.669 3.849 . . . . 2.25 111.55 169.334 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -60.07 -28.62 67.95 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.668 2.47 . . . . 2.44 117.668 -178.981 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -89.47 151.77 21.82 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.182 1.944 . . . . 1.32 115.396 -178.223 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.28 83.9 mtt180 -135.8 139.8 43.77 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 101.258 -3.608 . . . . 3.19 101.258 170.104 . . . . . . . . 2 2 . 1 . 139 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 39.0 mt -122.14 128.6 51.46 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 124.67 3.396 . . . . 1.75 105.793 -178.682 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 mm -119.06 139.02 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 114.704 -2.57 . . . . 1.98 107.57 -178.888 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -131.53 126.51 35.09 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 115.921 -1.99 . . . . 1.94 106.358 171.964 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 82.23 -71.95 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 126.874 2.609 . . . . 1.67 106.188 -177.83 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.18 -26.57 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.659 0 C-N-CA 126.112 1.815 . . . . 1.3 114.206 -171.491 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -85.55 160.35 19.68 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.241 1.941 . . . . 2.89 116.241 172.809 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.277 49.2 tt0 -90.76 137.43 32.36 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.24 3.052 . . . . 2.89 119.24 170.324 . . . . . . . . 2 2 . 1 . 139 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.0 mt -94.45 127.73 40.55 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.082 -3.511 . . . . 1.34 109.274 -169.472 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -75.9 158.81 31.61 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 118.225 2.676 . . . . 1.94 118.225 179.885 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -63.44 -59.82 4.16 Favored 'General case' 0 N--CA 1.43 -1.473 1 N-CA-C 122.879 4.4 . . . . 1.56 122.879 -168.018 . . . . . . . . 2 2 . 1 . 139 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.44 23.51 8.44 Favored Glycine 0 N--CA 1.429 -1.795 0 CA-C-O 116.094 -2.503 . . . . 0.97 113.836 178.75 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -98.22 154.19 17.95 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 122.787 3.294 . . . . 3.07 109.106 168.35 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 31.1 p -85.7 177.3 7.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.873 -2.392 . . . . 1.34 115.591 171.356 . . . . . . . . 2 2 . 1 . 139 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.27 -40.89 90.41 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 111.667 -2.515 . . . . 1.63 111.297 173.225 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.4 m -70.9 -25.79 62.94 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.567 3.547 . . . . 1.51 112.307 178.435 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -66.69 -55.6 14.43 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 120.762 1.619 . . . . 1.9 113.182 170.773 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -75.42 3.69 8.72 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 120.544 3.535 . . . . 0.97 120.544 173.685 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 54.43 46.78 24.3 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.023 -2.298 . . . . 2.35 117.011 178.704 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.4 mt -97.06 103.92 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 104.867 -2.271 . . . . 1.39 104.867 -179.556 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -104.67 -172.79 2.16 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 125.4 2.524 . . . . 2.58 109.296 -172.862 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -53.5 139.82 30.0 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.127 -2.858 . . . . 2.58 112.958 -179.863 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.374 30.7 mt-10 59.77 21.9 10.74 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 130.945 3.698 . . . . 1.71 113.871 -179.057 . . . . . . . . 2 2 . 1 . 139 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.11 143.32 27.14 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.152 1.908 . . . . 1.34 116.152 -176.989 . . . . . . . . 2 2 . 1 . 139 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.7 m -106.67 121.08 43.64 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 123.769 0.668 . . . . 1.36 112.552 -171.441 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.2 mt -95.41 164.64 12.73 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 106.694 -1.595 . . . . 2.03 106.694 173.063 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -115.48 116.64 28.54 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.486 1.915 . . . . 2.31 110.733 -179.58 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.5 tp -92.76 125.6 37.45 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.682 1.706 . . . . 1.72 112.889 179.683 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.1 t -120.08 126.08 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 101.89 -3.374 . . . . 1.8 101.89 178.252 . . . . . . . . 1 1 . 1 . 139 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.8 mt . . . . . 0 N--CA 1.431 -1.417 0 CA-C-O 126.229 2.918 . . . . 3.26 113.709 178.394 . . . . . . . . 0 0 . 1 . 140 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptt? . . . . . 0 CA--C 1.49 -1.355 0 N-CA-C 118.619 2.822 . . . . 1.39 118.619 . . . . . . . . . 0 0 . 1 . 140 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -85.78 146.83 26.6 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 117.823 -1.551 . . . . 2.2 110.191 179.722 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.2 pt -140.76 158.41 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 101.07 -3.678 . . . . 1.32 101.07 175.722 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -112.15 115.89 29.58 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 113.619 -1.628 . . . . 2.2 111.047 -176.816 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -85.84 113.69 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 118.942 -2.349 . . . . 1.23 107.749 171.594 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -104.06 122.23 44.85 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.13 -3.481 . . . . 2.51 111.868 177.688 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.448 HG23 HD23 ' A' ' 69' ' ' LEU . 27.2 p -83.47 158.05 22.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 123.481 1.61 . . . . 1.41 112.902 174.767 . . . . . . . . 2 2 . 1 . 140 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.6 mt -88.52 -23.92 23.06 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.606 -4.434 . . . . 2.95 109.173 176.36 . . . . . . . . 2 2 . 1 . 140 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -61.37 -37.89 85.0 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.199 -3.438 . . . . 2.52 110.699 174.415 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.23 -58.09 0.38 Allowed Glycine 0 N--CA 1.43 -1.76 0 O-C-N 121.75 -0.594 . . . . 1.5 112.896 176.272 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.261 19.3 ptmt -61.69 150.34 36.93 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.567 -3.314 . . . . 1.79 116.312 -170.675 . . . . . . . . 2 2 . 1 . 140 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.3 m -114.66 123.55 49.57 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.488 1.515 . . . . 1.38 108.237 169.811 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.2 mt -114.41 126.97 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.211 -3.43 . . . . 2.03 110.821 179.766 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.6 m -89.49 109.81 20.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.611 -2.556 . . . . 1.61 108.514 -177.256 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -107.12 157.51 17.8 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.92 -1.881 . . . . 2.15 105.92 179.629 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -106.68 133.6 51.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.069 1.748 . . . . 1.98 108.296 171.199 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.1 m -145.23 160.81 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 117.274 -1.346 . . . . 1.52 107.881 -178.484 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -95.98 155.59 38.12 Favored Pre-proline 0 N--CA 1.43 -1.462 0 N-CA-C 106.225 -1.768 . . . . 2.35 106.225 168.308 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.265 39.7 Cg_exo -66.28 -13.99 42.27 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 123.129 2.552 . . . . 1.31 115.456 -176.371 . . . . . . . . 2 2 . 1 . 140 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -111.2 25.59 11.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 122.658 1.218 . . . . 1.71 108.538 -179.751 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -84.17 137.14 33.67 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 116.841 -3.662 . . . . 1.69 104.613 174.388 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.335 80.4 p -67.05 165.21 16.2 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 117.773 2.509 . . . . 1.33 117.773 176.627 . . . . . . . . 3 3 . 1 . 140 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.2 mm -67.95 -38.05 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 116.966 -3.584 . . . . 1.32 109.517 175.269 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -46.87 -42.21 17.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 128.651 2.781 . . . . 1.62 113.688 168.596 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -80.08 -29.13 39.05 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.449 -2.657 . . . . 2.13 110.771 -178.268 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.274 12.0 t -67.81 -41.15 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 119.764 -1.835 . . . . 1.23 113.239 167.606 . . . . . . . . 2 2 . 1 . 140 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -65.04 -26.5 68.29 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.552 -2.593 . . . . 1.97 116.463 170.771 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.23 -31.2 68.51 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.429 -3.294 . . . . 1.19 112.51 172.184 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -73.45 -37.31 65.86 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 123.686 0.616 . . . . 1.92 111.651 174.584 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.5 mt -65.3 -35.09 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-O 124.442 2.068 . . . . 1.94 112.064 175.322 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -61.45 -41.82 97.8 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.045 3.738 . . . . 1.9 112.493 -178.783 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -68.47 -32.74 72.96 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 126.759 2.537 . . . . 1.55 115.347 167.943 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -79.13 -60.09 2.51 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 119.17 0.896 . . . . 2.95 112.497 -179.415 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -102.71 -20.84 14.22 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 118.246 -2.784 . . . . 1.48 112.545 -167.388 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.2 30.49 10.9 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 117.59 -2.243 . . . . 1.12 112.643 178.73 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.8 mt -109.56 111.49 59.34 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 116.544 -1.694 . . . . 2.07 108.435 -178.589 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -61.77 153.1 70.04 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 122.973 2.449 . . . . 1.39 113.362 179.816 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -70.96 -15.14 32.63 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-N 126.631 3.404 . . . . 1.68 118.961 -177.005 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -51.83 -46.0 64.17 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 126.301 2.251 . . . . 2.25 113.784 170.48 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -76.97 -5.43 48.58 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 116.988 -1.482 . . . . 2.44 111.424 -177.701 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -99.26 126.42 45.09 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 120.013 1.279 . . . . 1.32 109.842 -172.374 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -116.8 130.84 56.96 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 128.626 2.77 . . . . 3.19 104.443 164.508 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -107.54 132.43 53.26 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.309 -2.744 . . . . 1.75 111.669 173.74 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 49' ' ' GLN . 29.4 mm -109.63 141.96 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 119.881 -1.762 . . . . 1.98 108.74 179.556 . . . . . . . . 2 2 . 1 . 140 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -140.7 117.66 11.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.575 -1.268 . . . . 1.94 107.575 170.636 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.377 . . 72.98 -44.19 0.59 Allowed 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 129.594 3.157 . . . . 1.67 112.048 -175.827 . . . . . . . . 2 2 . 1 . 140 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 173.38 -42.45 0.15 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 128.039 2.733 . . . . 1.3 115.253 -171.947 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -74.13 157.5 35.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 118.584 -1.246 . . . . 2.89 110.262 178.663 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.41 ' HA ' HD12 ' A' ' 44' ' ' ILE . 53.5 mt-30 -87.58 143.59 27.12 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 126.319 1.848 . . . . 2.89 110.283 176.273 . . . . . . . . 2 2 . 1 . 140 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.3 mt -93.64 151.79 19.43 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 116.288 -4.008 . . . . 1.34 112.216 -176.655 . . . . . . . . 2 2 . 1 . 140 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -93.49 147.66 22.77 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 104.403 -2.443 . . . . 1.94 104.403 174.05 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -66.37 -52.68 44.39 Favored 'General case' 0 N--CA 1.43 -1.426 1 CA-C-O 128.599 4.047 . . . . 1.56 116.194 -170.938 . . . . . . . . 2 2 . 1 . 140 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.61 48.34 3.66 Favored Glycine 0 N--CA 1.43 -1.743 1 O-C-N 114.511 -5.118 . . . . 0.97 111.838 173.962 . . . . . . . . 2 2 . 1 . 140 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -130.67 161.84 30.74 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.547 -2.737 . . . . 3.07 105.742 162.071 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 14.0 p -95.7 179.72 5.02 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 117.036 -1.866 . . . . 1.34 110.076 -173.174 . . . . . . . . 2 2 . 1 . 140 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.9 mt -72.24 -41.68 66.54 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 116.783 -1.579 . . . . 1.63 113.082 172.378 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 t -68.34 -11.96 60.34 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 121.769 2.077 . . . . 1.51 114.869 172.617 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -79.92 -29.44 39.77 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 125.445 3.748 . . . . 1.9 110.405 177.826 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -90.68 -6.04 55.02 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.056 -3.528 . . . . 0.97 112.304 174.258 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 75.7 34.19 0.59 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.684 3.74 . . . . 2.35 113.174 175.889 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.7 mt -74.7 107.66 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 127.476 2.31 . . . . 1.39 111.917 175.685 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -84.74 178.51 7.62 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 126.728 2.517 . . . . 2.58 110.509 177.624 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -62.05 146.94 48.82 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 115.031 1.493 . . . . 2.58 115.031 172.451 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 64.29 39.41 7.32 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 122.827 1.299 . . . . 1.71 111.477 173.144 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 t -113.94 147.56 38.34 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.806 -1.543 . . . . 1.34 112.949 -173.806 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.2 m -93.96 130.14 40.18 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.726 -1.858 . . . . 1.36 113.777 178.446 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.7 mt -115.01 132.92 56.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.918 -1.882 . . . . 2.03 105.918 173.808 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -94.05 125.34 38.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.756 3.169 . . . . 2.31 111.278 -174.469 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.448 HD23 HG23 ' A' ' 7' ' ' THR . 11.8 tp -92.94 116.1 28.73 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 113.345 -5.847 . . . . 1.72 110.57 176.735 . . . . . . . . 3 3 . 1 . 140 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.0 t -111.77 126.03 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 128.474 2.709 . . . . 1.8 106.332 179.23 . . . . . . . . 1 1 . 1 . 140 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 N--CA 1.43 -1.444 0 O-C-N 118.216 -2.802 . . . . 3.26 107.015 178.948 . . . . . . . . 0 0 . 1 . 141 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 ttp . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 123.405 1.574 . . . . 1.39 109.537 . . . . . . . . . 0 0 . 1 . 141 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -91.53 144.43 25.56 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.235 -4.666 . . . . 2.2 106.781 178.357 . . . . . . . . 2 2 . 1 . 141 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.3 pt -140.12 175.35 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 124.195 1.95 . . . . 1.32 106.974 169.008 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -116.29 143.54 45.4 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 104.736 -2.32 . . . . 2.2 104.736 176.557 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.92 117.74 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 1 O-C-N 129.425 4.203 . . . . 1.23 103.805 167.315 . . . . . . . . 2 2 . 1 . 141 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -105.75 141.3 37.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.411 -2.68 . . . . 2.51 114.13 173.582 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.1 p -84.25 171.34 12.83 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.35 -1.468 . . . . 1.41 112.658 177.058 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.258 13.1 tp -57.53 -44.09 84.84 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.754 2.822 . . . . 2.95 114.854 168.142 . . . . . . . . 2 2 . 1 . 141 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 p -75.83 -65.58 0.89 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.752 1.621 . . . . 2.52 112.844 -173.72 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.09 53.28 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.696 0 CA-C-O 117.574 -1.681 . . . . 1.5 116.585 175.599 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -128.6 124.52 36.07 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.29 -1.744 . . . . 1.79 106.29 -179.374 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.9 m -104.14 133.86 48.36 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 102.906 -2.998 . . . . 1.38 102.906 -178.778 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.8 mt -106.85 135.01 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 103.182 -2.896 . . . . 2.03 103.182 178.703 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.9 m -97.35 122.71 40.7 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.158 -2.214 . . . . 1.61 106.821 178.351 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.8 tp -129.02 124.18 34.28 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 117.217 2.303 . . . . 2.15 117.217 -175.379 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -79.86 124.63 28.82 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 117.166 -1.397 . . . . 1.98 107.443 174.47 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.0 m -134.77 177.57 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 128.668 2.787 . . . . 1.52 106.655 178.95 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -123.36 166.57 17.81 Favored Pre-proline 0 N--CA 1.43 -1.448 0 C-N-CA 127.187 2.195 . . . . 2.35 106.735 163.092 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -82.2 -17.31 7.95 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 122.915 2.41 . . . . 1.31 109.681 -174.37 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 m -90.35 5.19 48.4 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.255 -2.153 . . . . 1.71 110.318 178.156 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -84.2 158.55 21.26 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.112 -1.81 . . . . 1.69 106.112 177.324 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -92.78 163.94 13.54 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 123.579 1.657 . . . . 1.33 110.202 178.767 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mp -68.08 -34.82 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 127.272 3.415 . . . . 1.32 116.363 174.548 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -53.36 -44.07 68.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.724 -2.485 . . . . 1.62 117.59 161.699 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -66.37 -31.97 73.07 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.583 1.953 . . . . 2.13 109.801 175.847 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.51 -47.98 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 117.848 -3.032 . . . . 1.23 113.497 175.899 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.302 95.8 mttt -49.63 -40.82 40.64 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 130.275 3.43 . . . . 1.97 115.229 167.664 . . . . . . . . 2 2 . 1 . 141 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.89 -39.66 87.54 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.941 1.696 . . . . 1.19 113.494 177.923 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -66.03 -29.78 70.2 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 118.346 2.721 . . . . 1.92 118.346 167.929 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.1 mt -76.02 -33.65 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 118.496 -2.627 . . . . 1.94 114.827 171.841 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -69.6 -33.4 72.64 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.268 -1.333 . . . . 1.9 109.951 172.931 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.3 -59.54 4.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.078 1.751 . . . . 1.55 110.069 170.37 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -65.62 -60.52 2.83 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 130.463 3.505 . . . . 2.95 112.029 -168.478 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -102.85 -53.15 2.91 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.623 -3.173 . . . . 1.48 111.885 -175.521 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.05 38.02 0.4 Allowed Glycine 0 N--CA 1.43 -1.721 0 O-C-N 120.466 -1.396 . . . . 1.12 115.309 172.325 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.7 mt -110.24 126.43 28.95 Favored Pre-proline 0 N--CA 1.43 -1.435 0 C-N-CA 126.26 1.824 . . . . 2.07 108.695 -174.974 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.47 143.54 97.45 Favored 'Trans proline' 0 N--CA 1.434 -2.006 1 O-C-N 112.743 -4.398 . . . . 1.39 115.701 -178.411 . . . . . . . . 2 2 . 1 . 141 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -67.61 -14.15 41.17 Favored 'Trans proline' 0 N--CA 1.434 -2.029 0 N-CA-C 118.897 2.614 . . . . 1.68 118.897 -173.179 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -79.78 -36.71 36.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 125.37 1.669 . . . . 2.25 107.951 179.364 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -74.98 -30.2 61.12 Favored 'General case' 0 N--CA 1.431 -1.402 1 C-N-CA 133.634 4.773 . . . . 2.44 111.363 -169.035 . . . . . . . . 2 2 . 1 . 141 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -87.92 134.14 33.77 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.566 -2.584 . . . . 1.32 112.519 -173.41 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -112.71 142.84 44.86 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 116.74 -3.725 . . . . 3.19 107.012 168.408 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.3 mt -119.86 116.49 25.95 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 118.896 -2.378 . . . . 1.75 113.393 174.958 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.3 mt -88.87 137.01 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 127.875 2.47 . . . . 1.98 110.967 -178.901 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -154.9 131.18 10.36 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.685 2.184 . . . . 1.94 105.439 173.286 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.74 -64.75 0.1 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 119.395 3.109 . . . . 1.67 119.395 178.998 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -158.34 11.47 0.22 Allowed Glycine 0 N--CA 1.43 -1.703 0 CA-C-O 122.776 1.209 . . . . 1.3 112.914 177.835 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.5 pttt -144.94 177.23 8.9 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 111.964 -2.118 . . . . 2.89 111.486 -174.411 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -110.39 157.3 19.69 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.533 1.933 . . . . 2.89 108.707 171.982 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.6 mt -102.86 137.7 40.71 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 117.953 -1.022 . . . . 1.34 113.02 -173.837 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.506 ' HB2' ' HG2' ' A' ' 54' ' ' ARG . 49.8 mt-10 -75.44 141.82 43.09 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.89 2.876 . . . . 1.94 111.003 177.512 . . . . . . . . 2 2 . 1 . 141 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -69.21 -53.07 21.84 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 123.3 2.773 . . . . 1.56 116.005 -162.977 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.95 42.04 3.12 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 119.078 -2.264 . . . . 0.97 114.714 175.121 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.506 ' HG2' ' HB2' ' A' ' 51' ' ' GLU . 28.6 mmt180 -112.14 161.31 16.67 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 121.415 2.607 . . . . 3.07 104.142 166.766 . . . . . . . . 2 2 . 1 . 141 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.1 p -90.9 162.26 14.86 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 116.807 -3.683 . . . . 1.34 111.546 178.879 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.2 mt -63.86 -33.13 75.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.488 2.315 . . . . 1.63 110.573 169.566 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.5 p -63.57 -53.6 49.21 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.369 -2.707 . . . . 1.51 114.978 179.339 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -56.16 -34.19 65.92 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.424 -1.262 . . . . 1.9 114.385 173.875 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -82.01 -4.17 56.14 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.906 -1.121 . . . . 0.97 112.571 -176.896 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.261 19.4 m-80 58.42 41.89 22.13 Favored 'General case' 0 N--CA 1.431 -1.415 1 C-N-CA 133.043 4.537 . . . . 2.35 115.861 -174.418 . . . . . . . . 3 2 . 1 . 141 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.1 mt -85.32 122.51 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 117.607 -3.183 . . . . 1.39 112.576 178.188 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -97.54 -174.04 2.81 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 125.404 2.526 . . . . 2.58 113.251 -175.141 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -59.52 131.82 52.11 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 127.348 3.452 . . . . 2.58 116.702 170.82 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.308 13.6 mt-10 73.02 31.46 1.48 Allowed 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 127.04 3.305 . . . . 1.71 114.127 173.797 . . . . . . . . 2 2 . 1 . 141 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.5 m -88.84 160.98 16.97 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 118.523 -2.611 . . . . 1.34 108.68 -173.48 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.253 4.3 m -114.38 114.16 25.51 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 116.41 -3.931 . . . . 1.36 112.307 -178.424 . . . . . . . . 2 2 . 1 . 141 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.9 mt -93.87 128.24 40.05 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 129.909 3.284 . . . . 2.03 108.158 170.337 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -111.51 116.81 31.49 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 126.128 2.871 . . . . 2.31 115.184 -175.85 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.9 tp -84.53 116.98 23.42 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.852 -2.405 . . . . 1.72 113.852 -173.622 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.4 m -122.0 161.24 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 114.415 -1.266 . . . . 1.8 111.082 168.7 . . . . . . . . 1 1 . 1 . 141 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.4 mt . . . . . 0 N--CA 1.429 -1.487 0 O-C-N 120.055 -1.653 . . . . 3.26 107.598 178.981 . . . . . . . . 0 0 . 1 . 142 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 ptt? . . . . . 0 CA--C 1.489 -1.373 0 N-CA-C 113.809 1.04 . . . . 1.39 113.809 . . . . . . . . . 0 0 . 1 . 142 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -88.52 127.92 35.54 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.466 -1.396 . . . . 2.2 109.379 -176.449 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.8 pt -121.97 161.07 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 104.891 -2.262 . . . . 1.32 104.891 164.798 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -120.69 137.01 54.69 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.182 2.193 . . . . 2.2 106.865 176.449 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -119.07 125.31 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 128.281 2.632 . . . . 1.23 110.253 173.402 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -99.48 141.9 31.66 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.515 -1.991 . . . . 2.51 113.894 -178.215 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 p -102.19 175.63 5.46 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 121.165 1.802 . . . . 1.41 109.908 179.136 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.2 tp -44.6 -47.76 10.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.461 1.652 . . . . 2.95 115.461 167.996 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.8 p -80.55 -0.56 38.23 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 123.547 0.739 . . . . 2.52 112.401 -178.662 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.8 25.57 57.95 Favored Glycine 0 N--CA 1.43 -1.76 1 C-N-CA 134.18 5.657 . . . . 1.5 112.533 178.651 . . . . . . . . 2 2 . 1 . 142 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -71.01 127.1 31.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.862 -1.533 . . . . 1.79 106.862 -173.145 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.1 m -84.79 122.23 28.83 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 113.076 -3.45 . . . . 1.38 114.55 173.957 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.0 mt -98.99 119.64 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 105.323 -2.103 . . . . 2.03 105.323 173.086 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.5 m -90.63 111.47 22.81 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.312 2.258 . . . . 1.61 113.148 -178.986 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.0 mt -116.28 155.1 28.98 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 120.254 1.388 . . . . 2.15 111.45 -174.882 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -107.34 114.58 28.7 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 128.396 2.678 . . . . 1.98 105.134 172.377 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -124.68 164.12 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 118.185 -2.822 . . . . 1.52 106.831 179.117 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -102.84 147.84 34.68 Favored Pre-proline 0 N--CA 1.43 -1.453 1 C-N-CA 133.06 4.544 . . . . 2.35 114.308 159.792 . . . . . . . . 2 2 . 1 . 142 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -77.58 -12.67 16.72 Favored 'Trans proline' 0 C--N 1.3 -2.008 1 CA-C-N 129.347 4.374 . . . . 1.31 110.929 -166.521 . . . . . . . . 2 2 . 1 . 142 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 p -88.88 -0.51 57.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 115.311 -2.281 . . . . 1.71 113.295 178.342 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -74.31 149.67 40.54 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 125.276 1.61 . . . . 1.69 114.6 177.233 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.259 57.8 p -85.04 157.33 20.77 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 125.632 2.634 . . . . 1.33 110.153 -178.505 . . . . . . . . 2 2 . 1 . 142 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.3 mm -67.72 -32.03 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.492 -2.63 . . . . 1.32 109.783 175.665 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -61.89 -32.72 73.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.224 2.21 . . . . 1.62 116.096 165.086 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -81.17 -29.47 34.66 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 122.428 2.376 . . . . 2.13 113.162 176.023 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.8 -32.2 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.401 -1.333 . . . . 1.23 107.401 174.488 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HZ3' ' CG ' ' A' ' 52' ' ' ASP 0.319 48.8 mttt -51.69 -41.29 61.33 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 118.889 2.922 . . . . 1.97 118.889 172.95 . . . . . . . . 3 3 . 1 . 142 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.1 -40.73 59.11 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 117.512 2.412 . . . . 1.19 117.512 166.179 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -68.7 -48.99 62.47 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.405 2.526 . . . . 1.92 114.228 -178.933 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.415 ' H ' HG13 ' A' ' 30' ' ' ILE . 4.2 mt -54.74 -39.67 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 O-C-N 118.144 -2.848 . . . . 1.94 117.714 166.621 . . . . . . . . 2 2 . 1 . 142 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -68.52 -32.11 71.84 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.032 -2.917 . . . . 1.9 112.152 -179.801 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -59.93 -38.17 81.6 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.167 -2.833 . . . . 1.55 114.76 168.411 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -75.13 -66.24 0.78 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 127.586 2.354 . . . . 2.95 109.676 -178.761 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -106.41 -20.88 13.24 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 128.403 2.681 . . . . 1.48 111.824 -159.988 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.31 -2.27 70.89 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 121.773 3.469 . . . . 1.12 121.773 177.901 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.8 mt -68.93 129.37 92.34 Favored Pre-proline 0 N--CA 1.431 -1.41 0 C-N-CA 127.473 2.309 . . . . 2.07 113.561 -179.584 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.251 0.3 OUTLIER -72.52 143.74 38.97 Favored 'Trans proline' 0 C--N 1.299 -2.042 1 C-N-CA 125.496 4.131 . . . . 1.39 112.995 -173.285 . . . . . . . . 4 3 . 1 . 142 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.53 -11.95 33.79 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 121.813 1.683 . . . . 1.68 114.151 -178.53 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.48 -31.86 67.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.832 -1.168 . . . . 2.25 112.054 173.99 . . . . . . . . 2 2 . 1 . 142 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -96.88 -22.19 17.04 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 125.227 1.58 . . . . 2.44 113.903 -173.373 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -75.86 122.65 24.43 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 123.674 1.702 . . . . 1.32 111.921 178.705 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -121.99 143.76 49.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 117.721 -3.112 . . . . 3.19 106.134 168.653 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.45 150.53 29.73 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.181 -3.449 . . . . 1.75 110.999 178.972 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mt -129.69 140.04 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 N-CA-C 97.291 -5.077 . . . . 1.98 97.291 -179.583 . . . . . . . . 2 2 . 1 . 142 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -154.98 137.78 15.33 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.793 2.437 . . . . 1.94 105.448 169.492 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.406 . . 74.46 -49.52 0.67 Allowed 'General case' 0 N--CA 1.431 -1.385 1 C-N-CA 134.917 5.287 . . . . 1.67 115.425 178.999 . . . . . . . . 3 2 . 1 . 142 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -173.43 -23.92 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 106.095 -2.802 . . . . 1.3 106.095 -177.497 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -118.53 158.3 25.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.626 2.631 . . . . 2.89 113.281 -170.819 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -71.66 126.29 29.3 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.7 -1.963 . . . . 2.89 105.7 169.715 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.1 mt -82.97 141.66 31.96 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.861 2.464 . . . . 1.34 108.887 -175.962 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -81.42 152.69 27.3 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.491 -4.506 . . . . 1.94 106.589 171.889 . . . . . . . . 2 2 . 1 . 142 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.414 ' CG ' ' HZ3' ' A' ' 27' ' ' LYS . 11.9 m-20 -77.59 -57.22 3.93 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.287 -1.779 . . . . 1.56 111.654 -167.843 . . . . . . . . 2 2 . 1 . 142 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.34 17.59 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.752 0 CA-C-O 114.002 -3.666 . . . . 0.97 120.37 168.689 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -110.21 175.15 5.54 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 123.609 3.704 . . . . 3.07 105.122 176.307 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.0 p -102.41 171.9 7.19 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 128.242 3.877 . . . . 1.34 117.012 171.003 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.2 mt -65.32 -33.18 75.37 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 112.241 -2.254 . . . . 1.63 112.923 173.848 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 m -64.23 -36.25 83.47 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.142 2.645 . . . . 1.51 118.142 177.099 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -56.88 -42.89 80.62 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.493 2.717 . . . . 1.9 109.045 173.097 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -93.4 3.81 54.99 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.175 -3.453 . . . . 0.97 116.981 -177.905 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.321 69.9 m-80 71.48 29.96 2.58 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 125.936 2.779 . . . . 2.35 112.162 171.313 . . . . . . . . 2 2 . 1 . 142 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.3 mt -80.97 119.71 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 111.842 -2.436 . . . . 1.39 110.408 -178.071 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -115.59 -176.58 2.96 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.324 -3.36 . . . . 2.58 107.322 -173.386 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -64.2 153.49 37.79 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 117.728 -3.108 . . . . 2.58 117.433 177.322 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 64.0 20.27 12.12 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 130.506 3.522 . . . . 1.71 113.157 168.578 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.2 m -88.79 160.28 17.35 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 115.356 -2.259 . . . . 1.34 113.69 -172.286 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.0 m -101.92 95.93 6.71 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 115.573 -2.156 . . . . 1.36 111.163 -172.389 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -91.4 163.38 14.21 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 124.355 3.252 . . . . 2.03 106.819 179.373 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -123.04 152.31 41.1 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 124.584 2.135 . . . . 2.31 113.465 -178.173 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.6 tp -127.93 136.96 52.06 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.888 -1.758 . . . . 1.72 108.393 -176.694 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.4 m -135.14 156.76 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 104.003 -2.592 . . . . 1.8 104.003 178.94 . . . . . . . . 1 1 . 1 . 142 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.3 mt . . . . . 0 N--CA 1.43 -1.472 0 CA-C-O 122.928 1.347 . . . . 3.26 113.71 179.357 . . . . . . . . 0 0 . 1 . 143 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.368 0 N-CA-C 112.64 0.608 . . . . 1.39 112.64 . . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.04 146.72 23.51 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.8 -1.813 . . . . 2.2 110.467 179.078 . . . . . . . . 2 2 . 1 . 143 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 pt -127.99 170.03 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 103.997 -2.594 . . . . 1.32 103.997 168.147 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -124.28 142.22 51.43 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.505 -3.247 . . . . 2.2 106.327 -178.809 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.1 t -130.79 118.98 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-O 116.953 -1.499 . . . . 1.23 107.211 179.741 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -97.29 133.3 42.1 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 125.957 2.036 . . . . 2.51 112.782 176.859 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.9 p -74.29 -161.78 0.13 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.527 -2.608 . . . . 1.41 117.697 171.665 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.5 mt -71.0 -63.95 1.0 Allowed 'General case' 0 N--CA 1.429 -1.492 2 C-N-CA 134.428 5.091 . . . . 2.95 113.111 174.606 . . . . . . . . 2 2 . 1 . 143 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.5 p -69.09 -47.18 65.88 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 118.921 -2.362 . . . . 2.52 116.31 -176.405 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.06 1.22 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 121.594 3.398 . . . . 1.5 121.594 177.458 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.454 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 73.2 tttt -86.47 126.21 34.26 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 118.51 -2.759 . . . . 1.79 111.103 -173.494 . . . . . . . . 2 2 . 1 . 143 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.259 80.1 m -102.89 116.84 33.33 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 105.101 -2.185 . . . . 1.38 105.101 174.947 . . . . . . . . 2 2 . 1 . 143 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.5 pt -99.68 148.94 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 122.543 1.163 . . . . 2.03 111.101 173.102 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.251 37.5 m -106.66 101.97 11.38 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 127.05 2.14 . . . . 1.61 109.161 178.147 . . . . . . . . 2 2 . 1 . 143 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.6 mt -96.98 140.26 31.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 113.809 1.04 . . . . 2.15 113.809 179.376 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -104.13 130.92 51.87 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 126.247 2.927 . . . . 1.98 110.96 172.643 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.6 m -135.24 158.92 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 118.292 -2.755 . . . . 1.52 110.096 -169.49 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -103.93 147.0 33.61 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 106.337 -1.727 . . . . 2.35 106.337 160.397 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.364 43.9 Cg_endo -72.07 -0.89 9.21 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 124.937 2.799 . . . . 1.31 117.548 -176.554 . . . . . . . . 2 2 . 1 . 143 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.6 p -108.59 2.06 21.8 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.792 2.437 . . . . 1.71 106.146 -176.2 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.76 139.96 43.71 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 119.815 1.189 . . . . 1.69 113.514 171.393 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 p -79.11 167.36 21.15 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.227 2.441 . . . . 1.33 106.74 -179.046 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.2 mm -66.68 -33.6 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 115.358 -2.258 . . . . 1.32 111.104 176.624 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -54.46 -46.43 73.32 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 126.01 2.069 . . . . 1.62 111.79 171.593 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -70.24 -42.11 72.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 112.877 -3.44 . . . . 2.13 115.278 174.825 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.1 t -52.47 -32.76 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 122.266 2.303 . . . . 1.23 112.894 168.71 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -73.11 -31.49 64.36 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.407 -3.308 . . . . 1.97 113.447 178.454 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.27 -33.81 75.34 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.282 1.433 . . . . 1.19 110.683 167.432 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -73.23 -34.8 66.1 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.119 -4.113 . . . . 1.92 113.55 176.563 . . . . . . . . 2 2 . 1 . 143 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 99.6 mt -67.75 -31.02 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 127.777 2.431 . . . . 1.94 106.252 172.638 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -39.36 80.02 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 120.468 1.485 . . . . 1.9 114.014 174.214 . . . . . . . . 2 2 . 1 . 143 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -69.79 -47.12 64.06 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 116.77 -1.586 . . . . 1.55 108.846 175.633 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -75.82 -56.38 4.73 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 125.827 1.651 . . . . 2.95 114.237 -174.442 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.454 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 27.1 mm-40 -103.3 -25.09 13.45 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 117.428 -3.295 . . . . 1.48 110.603 -165.045 . . . . . . . . 2 2 . 1 . 143 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.41 32.95 8.98 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 115.769 -2.684 . . . . 1.12 111.796 -179.893 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mt -110.44 123.1 36.67 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 113.016 -3.373 . . . . 2.07 105.881 -176.403 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -62.16 144.82 96.23 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 124.072 3.181 . . . . 1.39 117.805 177.196 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -72.75 -2.04 11.29 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 123.821 3.014 . . . . 1.68 116.134 -170.193 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -73.06 -43.64 61.67 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.686 2.394 . . . . 2.25 109.276 169.076 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.292 31.1 mt-30 -66.35 -55.57 15.29 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.179 -1.576 . . . . 2.44 110.915 -172.667 . . . . . . . . 2 2 . 1 . 143 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.408 70.7 mt-30 -63.89 130.18 43.08 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 128.919 2.888 . . . . 1.32 112.595 -175.874 . . . . . . . . 2 2 . 1 . 143 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.43 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 13.2 tpp180 -120.31 115.63 23.95 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 103.25 -2.87 . . . . 3.19 103.25 174.026 . . . . . . . . 2 2 . 1 . 143 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.2 mt -97.91 142.52 29.54 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.317 -1.734 . . . . 1.75 106.317 179.557 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.7 mt -136.85 144.88 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 100.597 -3.853 . . . . 1.98 100.597 177.291 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -127.9 104.8 8.01 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 124.389 2.042 . . . . 1.94 106.944 173.736 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.3 . . 71.27 -75.28 0.08 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 112.454 -2.157 . . . . 1.67 113.747 -179.694 . . . . . . . . 2 2 . 1 . 143 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.75 -17.48 1.06 Allowed Glycine 0 N--CA 1.43 -1.71 0 CA-C-O 114.351 -3.472 . . . . 1.3 113.844 174.787 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -96.64 131.3 43.44 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 105.914 -1.884 . . . . 2.89 105.914 -174.378 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -83.28 132.51 35.03 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 131.369 3.867 . . . . 2.89 105.226 172.56 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.286 56.1 mt -85.93 146.37 26.73 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 115.585 -2.15 . . . . 1.34 105.782 -170.556 . . . . . . . . 2 2 . 1 . 143 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.467 ' HB2' ' HG2' ' A' ' 54' ' ' ARG . 45.0 mt-10 -109.15 165.29 11.72 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 125.631 3.832 . . . . 1.94 104.433 169.919 . . . . . . . . 2 2 . 1 . 143 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -76.77 -44.3 33.49 Favored 'General case' 0 N--CA 1.43 -1.434 2 C-N-CA 133.1 4.56 . . . . 1.56 122.423 -171.444 . . . . . . . . 2 2 . 1 . 143 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.68 43.13 2.76 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 126.428 1.966 . . . . 0.97 113.487 169.404 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.467 ' HG2' ' HB2' ' A' ' 51' ' ' GLU . 32.5 mmt180 -122.18 152.91 39.46 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.444 2.297 . . . . 3.07 111.231 170.491 . . . . . . . . 2 2 . 1 . 143 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.6 p -95.91 168.68 10.49 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 127.899 3.249 . . . . 1.34 112.221 177.934 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.3 mt -69.95 -33.12 71.69 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 116.735 -3.728 . . . . 1.63 109.837 176.952 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.2 t -68.86 -36.59 78.32 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.435 -3.29 . . . . 1.51 112.213 178.753 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -51.59 -49.5 62.0 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.233 -2.792 . . . . 1.9 112.504 176.391 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -87.53 -4.95 58.97 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 115.785 -4.322 . . . . 0.97 111.087 -179.163 . . . . . . . . 2 2 . 1 . 143 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.3 t30 54.26 53.45 10.93 Favored 'General case' 0 N--CA 1.43 -1.467 1 C-N-CA 132.597 4.359 . . . . 2.35 117.392 176.754 . . . . . . . . 2 2 . 1 . 143 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.0 mt -73.42 126.18 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 126.783 3.182 . . . . 1.39 112.559 -175.617 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -92.66 171.34 9.07 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 114.884 -4.885 . . . . 2.58 114.182 -176.603 . . . . . . . . 2 2 . 1 . 143 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -64.09 143.26 58.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 118.27 -2.769 . . . . 2.58 109.048 174.727 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 55.92 19.2 3.44 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 118.389 2.737 . . . . 1.71 118.389 -178.593 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -74.96 147.32 40.97 Favored 'General case' 0 N--CA 1.428 -1.54 0 O-C-N 120.028 -1.67 . . . . 1.34 106.941 -173.947 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.7 m -93.41 113.28 25.39 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.628 -1.92 . . . . 1.36 106.425 -176.981 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 mp -110.59 156.69 20.59 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 123.125 2.693 . . . . 2.03 104.041 175.558 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -106.35 144.14 33.46 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.136 -2.852 . . . . 2.31 110.155 -179.622 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.6 tp -128.01 115.9 19.21 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 102.947 -2.983 . . . . 1.72 102.947 179.369 . . . . . . . . 1 1 . 1 . 143 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 3.9 t -93.89 138.22 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 119.18 -2.2 . . . . 1.8 106.218 177.334 . . . . . . . . 2 2 . 1 . 143 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.43 -1.442 0 CA-C-O 123.814 1.768 . . . . 3.26 113.51 -175.474 . . . . . . . . 0 0 . 1 . 144 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 CA--C 1.489 -1.375 0 CA-C-O 123.218 1.485 . . . . 1.39 110.811 . . . . . . . . . 0 0 . 1 . 144 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -100.93 94.17 5.89 Favored 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 115.028 -4.795 . . . . 2.2 106.864 -173.984 . . . . . . . . 2 2 . 1 . 144 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.266 18.9 pt -85.35 149.84 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 1 O-C-N 129.244 4.09 . . . . 1.32 114.227 172.913 . . . . . . . . 3 2 . 1 . 144 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -107.75 108.13 19.21 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.09 2.556 . . . . 2.2 114.707 -179.358 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -94.55 116.27 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-N 119.91 1.232 . . . . 1.23 110.073 176.232 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -95.74 129.86 42.83 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 124.941 2.305 . . . . 2.51 110.232 176.357 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.0 p -74.03 -173.78 1.7 Allowed 'General case' 0 N--CA 1.431 -1.393 1 O-C-N 114.808 -4.932 . . . . 1.41 112.829 166.486 . . . . . . . . 2 2 . 1 . 144 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.1 mt -81.12 -49.53 10.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 125.959 2.037 . . . . 2.95 116.421 170.271 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 p -63.56 -56.02 19.21 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.858 -4.276 . . . . 2.52 111.87 -173.392 . . . . . . . . 2 2 . 1 . 144 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.22 53.7 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 116.778 -2.63 . . . . 1.5 111.745 173.098 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -136.7 125.16 23.48 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 121.491 2.646 . . . . 1.79 104.566 -174.193 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.8 m -107.04 113.35 26.77 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 118.668 -2.52 . . . . 1.38 114.431 175.876 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.6 mt -96.49 125.71 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 122.784 1.278 . . . . 2.03 111.96 -176.043 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 m -89.84 119.03 29.87 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.05 -2.906 . . . . 1.61 111.244 177.768 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.404 HD23 ' HG2' ' A' ' 29' ' ' LYS . 62.8 mt -116.53 153.07 32.85 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.309 -1.494 . . . . 2.15 109.013 -179.324 . . . . . . . . 2 2 . 1 . 144 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -109.29 130.7 55.49 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.262 -3.399 . . . . 1.98 107.561 172.198 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -144.42 173.61 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 123.31 1.529 . . . . 1.52 109.685 179.709 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -106.44 159.68 28.91 Favored Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 105.244 -2.132 . . . . 2.35 105.244 167.164 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -84.5 -11.33 8.27 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 O-C-N 113.87 -3.805 . . . . 1.31 106.486 -173.71 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.9 p -93.32 -3.37 53.59 Favored 'General case' 0 N--CA 1.43 -1.439 1 C-N-CA 131.769 4.028 . . . . 1.71 110.818 -174.154 . . . . . . . . 2 2 . 1 . 144 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -73.76 152.05 40.45 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.253 2.221 . . . . 1.69 107.22 177.269 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.6 p -86.35 156.5 20.19 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 116.906 -3.621 . . . . 1.33 106.73 175.09 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 mm -44.23 -48.55 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 1 C-N-CA 131.764 4.026 . . . . 1.32 112.12 174.842 . . . . . . . . 2 2 . 1 . 144 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -35.46 -57.72 0.61 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 119.019 2.97 . . . . 1.62 119.019 166.831 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -71.16 -27.77 63.78 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 113.367 -1.742 . . . . 2.13 113.848 179.461 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.37 -48.54 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 125.862 2.744 . . . . 1.23 114.085 170.868 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -60.22 -37.36 80.06 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.904 -3.623 . . . . 1.97 115.239 175.879 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.45 -14.35 61.23 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.304 -2.747 . . . . 1.19 112.694 179.509 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HG2' HD23 ' A' ' 15' ' ' LEU . 10.5 ttmt -74.18 -41.61 61.18 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.097 -1.627 . . . . 1.92 114.233 170.261 . . . . . . . . 2 2 . 1 . 144 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.3 mt -58.51 -46.29 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 123.234 1.492 . . . . 1.94 111.439 166.741 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -49.03 -42.83 39.6 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 125.194 2.426 . . . . 1.9 112.856 171.738 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.53 -58.91 6.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.869 -3.644 . . . . 1.55 113.787 168.827 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.9 tptt -68.82 -62.04 1.55 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.541 2.336 . . . . 2.95 113.429 -170.079 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -87.22 -45.2 10.85 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 128.061 2.545 . . . . 1.48 113.142 -168.57 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.11 39.89 3.91 Favored Glycine 0 N--CA 1.43 -1.751 0 CA-C-N 112.659 -2.064 . . . . 1.12 114.92 177.691 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.3 mt -106.7 134.16 19.95 Favored Pre-proline 0 N--CA 1.43 -1.466 0 C-N-CA 126.374 1.87 . . . . 2.07 107.01 -178.043 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.69 143.44 99.41 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-O 113.684 -2.715 . . . . 1.39 117.513 175.692 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -80.84 -2.31 11.75 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 126.497 3.356 . . . . 1.68 112.012 -168.331 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.74 -26.21 32.13 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 124.829 2.252 . . . . 2.25 111.66 170.393 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -84.86 -20.26 31.09 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.235 -2.791 . . . . 2.44 114.773 -176.065 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -85.85 117.93 25.02 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 114.944 -1.025 . . . . 1.32 111.266 -176.221 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.8 mtt-85 -113.22 116.01 29.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.669 -1.269 . . . . 3.19 108.706 169.772 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.5 mt -88.41 136.84 32.79 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.858 -1.151 . . . . 1.75 112.559 176.181 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -113.49 117.63 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 O-C-N 117.682 -3.136 . . . . 1.98 104.886 179.904 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -107.21 123.13 47.84 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 116.675 -3.766 . . . . 1.94 108.05 165.916 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.305 . . 64.29 -82.84 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 131.314 3.846 . . . . 1.67 114.215 -173.991 . . . . . . . . 2 2 . 1 . 144 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.66 3.06 2.03 Favored Glycine 0 N--CA 1.43 -1.719 0 O-C-N 116.65 -3.781 . . . . 1.3 105.466 -176.919 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -127.0 141.72 51.72 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 115.658 -4.436 . . . . 2.89 113.913 178.454 . . . . . . . . 2 2 . 1 . 144 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -65.38 142.98 58.03 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.246 2.219 . . . . 2.89 113.589 171.439 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.6 mt -96.36 123.46 40.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.765 -3.084 . . . . 1.34 113.493 -176.519 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -81.47 144.26 31.49 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 130.012 3.325 . . . . 1.94 112.959 -178.54 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.6 150.72 28.0 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.453 2.701 . . . . 1.56 107.385 -169.113 . . . . . . . . 2 2 . 1 . 144 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.97 -4.44 78.28 Favored Glycine 0 N--CA 1.429 -1.77 0 O-C-N 119.454 -2.029 . . . . 0.97 109.409 174.194 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -97.34 172.34 7.84 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.087 2.286 . . . . 3.07 110.392 171.433 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.6 p -110.83 174.32 5.91 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.504 -1.372 . . . . 1.34 112.57 173.282 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.1 mt -52.16 -34.67 46.0 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.844 2.458 . . . . 1.63 112.427 170.185 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.1 m -75.11 -34.56 61.72 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.701 2.501 . . . . 1.51 114.179 -172.579 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -51.31 -34.68 34.4 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 119.985 3.328 . . . . 1.9 119.985 170.442 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -92.56 -5.91 50.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 109.712 -3.404 . . . . 0.97 114.195 178.892 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.25 8.9 m120 64.92 50.3 1.96 Allowed 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.057 -2.902 . . . . 2.35 113.516 179.583 . . . . . . . . 2 2 . 1 . 144 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.8 mt -92.64 107.84 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 126.004 2.811 . . . . 1.39 110.903 178.409 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -89.49 172.61 8.86 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.207 -2.269 . . . . 2.58 106.231 -171.288 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -14.42 -89.35 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.007 3.323 . . . . 2.58 119.613 167.473 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -91.44 74.95 6.01 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.537 -4.477 . . . . 1.71 114.309 179.028 . . . . . . . . 2 2 . 1 . 144 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -94.41 144.85 25.21 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.89 -4.256 . . . . 1.34 119.657 177.024 . . . . . . . . 2 2 . 1 . 144 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.1 m -101.13 110.11 22.09 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.284 3.434 . . . . 1.36 106.472 -177.026 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -108.81 152.37 24.98 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.695 -1.965 . . . . 2.03 105.695 -177.672 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -116.53 133.24 56.25 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.618 -4.426 . . . . 2.31 110.0 -179.788 . . . . . . . . 2 2 . 1 . 144 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.0 tp -107.75 115.42 30.11 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 115.183 -2.341 . . . . 1.72 110.905 -174.173 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -111.75 146.93 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 126.059 2.837 . . . . 1.8 106.373 173.967 . . . . . . . . 1 1 . 1 . 144 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.0 tp . . . . . 0 N--CA 1.431 -1.422 0 O-C-N 119.935 -1.728 . . . . 3.26 111.877 -174.124 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.5 ttp . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 113.994 1.109 . . . . 1.39 113.994 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -105.36 140.03 39.1 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.306 -3.371 . . . . 2.2 113.49 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 pt -125.88 153.02 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 114.933 -1.03 . . . . 1.32 109.672 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -99.88 135.54 41.15 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.802 2.041 . . . . 2.2 109.247 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.7 t -114.81 104.07 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 104.32 -2.474 . . . . 1.23 104.32 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -82.16 126.05 31.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.31 2.005 . . . . 2.51 111.962 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.3 p -83.94 -169.05 2.39 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 117.171 -3.455 . . . . 1.41 113.019 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.8 tp -73.46 -57.93 3.66 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.844 1.783 . . . . 2.95 113.103 170.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.4 p -67.86 -22.9 65.1 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.256 -3.402 . . . . 2.52 118.191 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.93 22.36 1.03 Allowed Glycine 0 N--CA 1.429 -1.774 0 C-N-CA 125.848 1.689 . . . . 1.5 115.111 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.499 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 74.3 tttt -88.31 131.02 34.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.031 2.133 . . . . 1.79 105.985 177.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -109.59 124.39 51.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 123.603 2.911 . . . . 1.38 104.382 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.413 HD12 HG22 ' A' ' 13' ' ' ILE . 43.1 mt -111.72 128.23 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 107.436 -1.32 . . . . 2.03 107.436 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.8 m -102.83 115.83 31.36 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.11 -0.994 . . . . 1.61 108.928 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -105.49 157.28 17.48 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.971 -1.081 . . . . 2.15 111.568 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.39 110.82 21.46 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.358 2.263 . . . . 1.98 106.524 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.0 m -118.84 159.02 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 126.791 2.557 . . . . 1.52 109.01 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -89.82 146.3 35.09 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-O 111.762 -3.97 . . . . 2.35 106.769 160.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -73.47 -5.61 17.4 Favored 'Trans proline' 0 N--CA 1.433 -2.05 0 CA-C-N 127.547 3.731 . . . . 1.31 115.142 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 m -90.08 7.58 37.03 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 125.228 1.58 . . . . 1.71 109.444 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -85.19 144.14 28.34 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.19 1.922 . . . . 1.69 116.19 172.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.6 p -82.9 160.5 22.11 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.323 -2.736 . . . . 1.33 115.657 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.454 15.5 mm -57.79 -38.99 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 123.419 1.581 . . . . 1.32 115.252 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -47.49 -45.05 25.88 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.357 1.984 . . . . 1.62 116.357 161.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -72.58 -20.8 61.25 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 126.533 1.933 . . . . 2.13 113.4 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.23 -39.37 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.99 -2.319 . . . . 1.23 108.394 172.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -66.05 -41.69 90.5 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.974 -2.329 . . . . 1.97 110.183 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.75 -43.79 66.02 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.956 -2.34 . . . . 1.19 116.033 173.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -61.7 -32.15 72.34 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 125.966 2.041 . . . . 1.92 113.593 170.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -81.81 -32.13 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 118.018 -2.927 . . . . 1.94 115.093 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -56.2 -38.71 71.36 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.868 1.794 . . . . 1.9 113.879 166.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -64.56 -50.39 67.47 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.903 2.881 . . . . 1.55 111.101 167.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -71.5 -62.84 1.26 Allowed 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 126.827 2.051 . . . . 2.95 111.569 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.499 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 45.6 mm-40 -101.25 -35.31 9.31 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 118.45 -2.656 . . . . 1.48 115.81 -170.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.93 11.06 29.07 Favored Glycine 0 N--CA 1.43 -1.751 0 CA-C-O 124.106 1.948 . . . . 1.12 113.188 175.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.5 mm -76.1 125.97 87.31 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-O 114.418 -2.706 . . . . 2.07 112.842 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.0 154.35 74.39 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 CA-C-N 128.252 3.983 . . . . 1.39 118.169 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -74.08 -9.6 22.17 Favored 'Trans proline' 0 C--N 1.299 -2.066 0 CA-C-N 123.844 2.409 . . . . 1.68 116.52 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -59.99 -44.38 94.56 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 118.378 -0.82 . . . . 2.25 111.254 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -79.6 -29.56 41.21 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.228 0.955 . . . . 2.44 110.604 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -66.66 107.68 2.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 121.044 3.72 . . . . 1.32 121.044 -172.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 mtt180 -101.38 139.31 37.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.075 -3.516 . . . . 3.19 110.478 171.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.6 mt -113.3 141.25 47.23 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.677 -2.514 . . . . 1.75 111.891 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mm -128.72 137.58 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 115.184 -2.341 . . . . 1.98 110.899 172.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.485 ' CE2' HG12 ' A' ' 61' ' ' ILE 0.293 10.9 t80 -115.67 -54.62 2.5 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.068 1.48 . . . . 1.94 107.766 176.098 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -121.46 -75.96 0.59 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 115.276 1.584 . . . . 1.67 115.276 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.96 -44.14 0.28 Allowed Glycine 0 N--CA 1.429 -1.767 0 O-C-N 119.412 -2.055 . . . . 1.3 114.166 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 mttm -91.93 151.37 20.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 120.784 2.292 . . . . 2.89 114.459 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -83.56 121.91 27.85 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 111.959 -2.382 . . . . 2.89 111.732 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mt -78.21 132.16 37.45 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.501 -1.681 . . . . 1.34 114.197 -162.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -87.62 155.87 19.75 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 115.986 -1.959 . . . . 1.94 115.002 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -66.77 -48.21 69.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.199 2.6 . . . . 1.56 116.099 -172.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.97 38.85 1.12 Allowed Glycine 0 N--CA 1.43 -1.737 1 N-CA-C 124.923 4.729 . . . . 0.97 124.923 174.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -139.59 150.65 45.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.099 -2.412 . . . . 3.07 109.337 171.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 p -91.28 158.81 16.36 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 111.901 -2.409 . . . . 1.34 113.437 -177.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 mt -48.93 -48.73 42.54 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.875 -4.265 . . . . 1.63 107.763 170.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.4 p -56.44 -39.57 73.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.874 2.546 . . . . 1.51 117.874 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -53.56 -57.36 11.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.884 -2.385 . . . . 1.9 112.807 171.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -63.49 -16.16 59.87 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 128.124 2.57 . . . . 0.97 115.149 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.2 t30 69.23 51.56 0.51 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.356 2.662 . . . . 2.35 112.593 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.506 HG23 HD13 ' A' ' 67' ' ' LEU . 34.6 mt -91.73 122.88 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 118.245 -2.784 . . . . 1.39 108.06 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -89.48 -167.6 1.91 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 125.192 1.557 . . . . 2.58 109.682 -174.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.296 40.2 tttm -75.7 138.16 41.13 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.478 -2.045 . . . . 2.58 105.478 172.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 55.3 51.88 12.36 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 130.925 3.69 . . . . 1.71 109.607 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.6 m -103.02 149.87 24.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.159 -2.163 . . . . 1.34 105.159 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.0 m -100.65 118.3 36.51 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 123.138 1.447 . . . . 1.36 112.613 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.506 HD13 HG23 ' A' ' 61' ' ' ILE . 9.4 mp -102.2 148.19 25.73 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 105.782 -1.933 . . . . 2.03 105.782 170.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -99.38 130.12 45.63 Favored 'General case' 0 N--CA 1.43 -1.429 1 C-N-CA 131.932 4.093 . . . . 2.31 110.96 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.2 tp -108.86 116.06 31.27 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 115.075 -2.65 . . . . 1.72 105.964 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.6 t -99.92 130.92 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 108.516 -0.92 . . . . 1.8 108.516 173.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.7 mt -90.06 111.85 23.09 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 129.232 3.013 . . . . 3.26 108.371 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -70.41 128.22 35.42 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 125.386 2.517 . . . . 4.12 111.085 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.4 mt -101.1 -70.09 0.75 Allowed 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.759 -3.088 . . . . 3.54 108.023 163.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -116.46 -58.97 2.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.137 -2.542 . . . . 7.32 104.137 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.55 119.4 0.56 Allowed Glycine 0 N--CA 1.43 -1.706 0 O-C-N 128.499 3.624 . . . . 3.73 116.723 -162.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.705 0 C-N-CA 126.564 2.031 . . . . 3.87 108.642 -178.453 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.3 ttp . . . . . 0 CA--C 1.489 -1.376 0 CA-C-O 121.788 0.804 . . . . 1.39 111.326 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -96.06 140.75 30.34 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.327 -1.483 . . . . 2.2 113.769 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.6 pt -139.34 165.14 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 125.994 2.807 . . . . 1.32 105.823 171.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -124.64 140.86 52.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 112.715 -2.038 . . . . 2.2 111.08 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -109.67 120.83 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 O-C-N 120.307 -1.495 . . . . 1.23 113.05 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -94.75 137.92 33.23 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.195 -3.441 . . . . 2.51 112.126 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.258 74.8 p -81.32 -165.02 0.85 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.626 2.631 . . . . 1.41 110.815 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.8 tp -77.19 -44.69 29.22 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.083 -2.886 . . . . 2.95 113.835 169.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.49 -53.63 7.4 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.503 1.62 . . . . 2.52 107.863 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.82 21.71 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.706 1 O-C-N 115.673 -4.392 . . . . 1.5 113.018 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -85.9 139.75 30.97 Favored 'General case' 0 N--CA 1.431 -1.412 1 CA-C-N 125.283 4.541 . . . . 1.79 106.546 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 38.2 m -101.8 114.15 27.96 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.995 1.318 . . . . 1.38 110.345 171.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.0 mt -96.21 122.9 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 117.033 -3.542 . . . . 2.03 110.192 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.3 m -87.21 125.55 34.25 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.186 -1.571 . . . . 1.61 110.73 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.1 mt -126.69 152.46 46.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.615 -1.303 . . . . 2.15 112.084 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -123.36 105.57 9.94 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 111.781 -2.463 . . . . 1.98 110.07 173.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.1 m -121.64 -167.83 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 102.107 -3.294 . . . . 1.52 102.107 -176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -122.07 162.42 37.39 Favored Pre-proline 0 N--CA 1.431 -1.388 0 C-N-CA 126.982 2.113 . . . . 2.35 106.477 167.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -83.81 -14.65 7.49 Favored 'Trans proline' 0 N--CA 1.433 -2.064 0 CA-C-O 116.845 -1.398 . . . . 1.31 108.83 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.3 p -80.94 0.99 32.98 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 124.345 1.028 . . . . 1.71 112.648 171.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -83.54 157.03 22.5 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 125.466 2.555 . . . . 1.69 111.772 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.9 p -88.6 163.35 15.88 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 112.939 -1.937 . . . . 1.33 112.169 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.0 mm -63.29 -34.37 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-O 115.31 -2.281 . . . . 1.32 110.037 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -55.48 -46.94 76.83 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 122.215 2.279 . . . . 1.62 114.788 170.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -56.03 -37.73 69.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.267 1.58 . . . . 2.13 115.267 174.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -62.44 -40.46 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 119.7 -1.875 . . . . 1.23 113.864 172.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -61.85 -28.66 69.65 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.477 -1.39 . . . . 1.97 113.803 173.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.82 -28.11 61.46 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.3 2.24 . . . . 1.19 110.156 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -74.12 -36.13 64.17 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.907 -3.621 . . . . 1.92 111.162 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.6 mt -70.61 -39.9 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 123.157 1.456 . . . . 1.94 113.648 175.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -53.03 -38.7 62.62 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.079 -2.263 . . . . 1.9 115.779 169.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -68.88 -46.66 67.83 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.488 -2.008 . . . . 1.55 113.839 173.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -80.04 -55.78 4.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.58 1.552 . . . . 2.95 114.783 -174.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -94.06 -45.51 7.54 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 127.864 3.697 . . . . 1.48 110.928 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.27 56.34 0.7 Allowed Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 111.888 -2.415 . . . . 1.12 111.211 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.5 mt -124.86 127.78 25.04 Favored Pre-proline 0 N--CA 1.43 -1.434 0 N-CA-C 103.268 -2.864 . . . . 2.07 103.268 -167.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.28 32.2 Cg_exo -66.07 138.55 52.56 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 124.625 3.55 . . . . 1.39 109.314 -171.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -64.86 -14.19 43.66 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-O 114.219 -2.492 . . . . 1.68 114.321 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -74.04 -16.34 61.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 122.455 2.389 . . . . 2.25 114.427 164.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -92.06 4.2 53.6 Favored 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 118.756 -2.465 . . . . 2.44 112.168 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -113.48 101.01 8.96 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 127.832 3.682 . . . . 1.32 119.009 -172.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -94.06 122.67 36.8 Favored 'General case' 0 N--CA 1.431 -1.409 1 O-C-N 115.266 -4.646 . . . . 3.19 110.435 173.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.2 mt -112.11 124.81 53.22 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.706 -1.59 . . . . 1.75 106.706 -170.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mm -111.0 144.48 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 129.345 3.058 . . . . 1.98 108.912 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -143.0 116.46 9.11 Favored 'General case' 0 N--CA 1.43 -1.442 1 N-CA-C 97.629 -4.952 . . . . 1.94 97.629 175.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 42.83 39.64 1.79 Allowed 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.1 -3.5 . . . . 1.67 120.349 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.21 -25.98 26.26 Favored Glycine 0 N--CA 1.431 -1.657 0 O-C-N 118.042 -2.911 . . . . 1.3 111.039 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -77.35 130.9 37.74 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.74 -3.8 . . . . 2.89 106.378 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -91.6 135.65 33.71 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.297 1.046 . . . . 2.89 112.764 165.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.1 mt -97.81 144.03 27.82 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.069 -2.269 . . . . 1.34 113.29 -166.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -86.45 147.33 26.04 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 119.533 -1.98 . . . . 1.94 115.563 174.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -55.88 -64.26 0.91 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 118.504 2.779 . . . . 1.56 118.504 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.51 22.1 9.5 Favored Glycine 0 N--CA 1.431 -1.693 1 N-CA-C 123.162 4.025 . . . . 0.97 123.162 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -86.14 156.27 20.42 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.92 2.888 . . . . 3.07 109.624 161.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.405 ' HG1' ' CG ' ' A' ' 58' ' ' ASP 0.251 40.5 p -95.44 157.5 15.87 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 126.563 3.077 . . . . 1.34 112.426 177.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.8 mt -63.38 -31.85 73.11 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 117.422 -3.299 . . . . 1.63 111.769 168.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.4 t -67.61 -40.21 84.71 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.914 -4.241 . . . . 1.51 113.718 174.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.405 ' CG ' ' HG1' ' A' ' 55' ' ' THR . 28.6 m-20 -46.67 -53.61 11.3 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 116.743 2.127 . . . . 1.9 116.743 169.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.337 86.1 m-85 -60.21 -34.87 74.25 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 118.033 2.605 . . . . 0.97 118.033 175.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.294 67.1 m-80 91.84 66.19 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.66 2.384 . . . . 2.35 106.04 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.3 mt -108.68 118.01 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 125.441 2.543 . . . . 1.39 109.654 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -100.75 -179.66 4.14 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 109.94 -3.3 . . . . 2.58 107.27 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -56.93 149.68 18.25 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.89 2.182 . . . . 2.58 116.89 174.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 64.3 26.4 13.67 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 128.966 2.907 . . . . 1.71 110.478 170.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 m -81.7 136.96 35.46 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 116.404 -1.76 . . . . 1.34 107.839 -173.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.6 m -101.95 112.63 25.34 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 101.056 -3.683 . . . . 1.36 101.056 -172.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mp -103.05 156.91 17.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.71 3.204 . . . . 2.03 109.136 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -113.92 144.06 43.68 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 123.867 0.867 . . . . 2.31 109.326 -174.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.7 tp -115.42 111.68 21.17 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 130.593 3.557 . . . . 1.72 114.271 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.5 t -103.22 125.42 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 1 C-N-CA 132.41 4.284 . . . . 1.8 110.946 173.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 tp -77.53 132.2 38.25 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.731 2.205 . . . . 3.26 113.792 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -117.01 92.9 3.99 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 116.909 -3.62 . . . . 4.12 113.954 175.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.1 mt -80.58 -179.13 7.05 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.365 2.031 . . . . 3.54 111.134 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -69.67 -44.57 70.22 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.251 -1.531 . . . . 7.32 112.004 172.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.93 49.36 0.88 Allowed Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 127.297 2.38 . . . . 3.73 109.121 -163.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.755 0 CA-C-O 123.892 1.829 . . . . 3.87 111.321 174.291 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttp . . . . . 0 CA--C 1.49 -1.343 0 CA-C-O 124.335 2.017 . . . . 1.39 110.789 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -76.54 123.96 26.86 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.508 -3.245 . . . . 2.2 117.176 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -138.22 152.15 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 O-C-N 120.305 -1.497 . . . . 1.32 107.103 174.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -108.61 141.18 40.93 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 128.195 2.598 . . . . 2.2 111.616 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.503 HG21 HD13 ' A' ' 30' ' ' ILE . 17.5 t -121.9 128.76 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 114.242 -2.79 . . . . 1.23 107.883 171.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -120.49 133.28 55.43 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 124.535 3.334 . . . . 2.51 111.472 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.448 HG21 HD21 ' A' ' 69' ' ' LEU . 27.2 p -70.88 175.35 5.14 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.514 -1.366 . . . . 1.41 112.293 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.0 tp -65.57 -41.85 92.44 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 126.194 1.798 . . . . 2.95 115.193 169.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.5 m -66.49 -47.44 73.02 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.908 1.337 . . . . 2.52 108.197 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.38 42.79 0.11 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 117.957 -2.964 . . . . 1.5 114.029 169.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.539 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 53.7 tttt -97.18 117.66 31.89 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 115.565 -2.159 . . . . 1.79 108.024 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.5 m -92.14 125.74 36.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 122.396 2.362 . . . . 1.38 113.268 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mt -112.94 126.5 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 100.524 -3.88 . . . . 2.03 100.524 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.1 m -101.39 125.51 48.04 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 119.971 -1.705 . . . . 1.61 111.301 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.9 mt -126.2 159.42 33.03 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.453 2.073 . . . . 2.15 107.074 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -119.25 138.61 52.87 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 111.722 -2.49 . . . . 1.98 104.292 170.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.273 17.3 m -145.3 164.26 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 104.713 -2.329 . . . . 1.52 104.713 -176.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -98.8 145.02 29.23 Favored Pre-proline 0 N--CA 1.43 -1.468 0 O-C-N 125.828 1.955 . . . . 2.35 107.363 160.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.37 -14.27 31.0 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 CA-C-N 122.898 2.071 . . . . 1.31 112.017 -169.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.339 6.2 t -87.29 -7.66 57.59 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 125.181 3.628 . . . . 1.71 110.692 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -74.59 151.44 39.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.086 -2.259 . . . . 1.69 111.977 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.253 77.1 p -74.16 170.03 16.36 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 117.348 -3.345 . . . . 1.33 117.096 -172.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.5 mm -77.1 -38.14 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 103.755 -2.684 . . . . 1.32 103.755 173.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -42.12 -53.15 4.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.17 2.588 . . . . 1.62 113.427 161.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -59.87 -44.5 94.13 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.222 1.409 . . . . 2.13 112.779 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.6 t -64.49 -42.92 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 120.505 -1.372 . . . . 1.23 110.673 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -58.54 -40.91 84.32 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.575 1.95 . . . . 1.97 113.223 172.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.3 -37.06 84.1 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.188 -3.445 . . . . 1.19 110.246 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -67.43 -39.83 85.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.277 2.325 . . . . 1.92 117.277 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.503 HD13 HG21 ' A' ' 5' ' ' VAL . 9.9 mt -62.47 -48.02 90.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-O 127.066 3.317 . . . . 1.94 113.342 169.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -48.51 -39.66 24.04 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 113.923 -5.485 . . . . 1.9 115.678 167.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -59.56 -45.11 92.78 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.883 -3.011 . . . . 1.55 113.272 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -82.66 -83.18 0.13 Allowed 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.432 -1.321 . . . . 2.95 107.432 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.539 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS 0.297 58.1 mm-40 -76.25 -28.19 57.01 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.6 -3.812 . . . . 1.48 114.654 -166.014 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.31 -8.19 22.74 Favored Glycine 0 N--CA 1.431 -1.652 0 O-C-N 120.718 -1.239 . . . . 1.12 112.693 167.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.1 mt -62.19 115.29 15.12 Favored Pre-proline 0 N--CA 1.43 -1.462 0 N-CA-C 116.993 2.22 . . . . 2.07 116.993 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -67.61 148.43 78.19 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 N-CA-C 119.573 2.874 . . . . 1.39 119.573 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -61.78 -32.91 86.21 Favored 'Trans proline' 0 N--CA 1.433 -2.038 1 C-N-CA 125.876 4.384 . . . . 1.68 113.068 -173.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -62.05 -30.89 71.29 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.769 1.766 . . . . 2.25 115.769 171.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -86.32 -24.68 25.79 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.797 1.639 . . . . 2.44 112.053 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -81.77 117.65 22.24 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 104.35 -2.463 . . . . 1.32 104.35 -176.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -109.19 124.97 51.71 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 103.845 -2.65 . . . . 3.19 103.845 169.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.8 mt -119.47 125.07 48.01 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 106.248 -1.76 . . . . 1.75 106.248 -172.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.8 mm -114.55 117.38 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 C-N-CA 127.905 2.482 . . . . 1.98 114.879 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -102.95 108.18 19.27 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.357 -1.349 . . . . 1.94 107.357 173.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.4 -98.78 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.517 -1.989 . . . . 1.67 110.397 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.91 30.62 3.34 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-O 125.38 2.655 . . . . 1.3 113.273 173.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -118.58 131.0 56.2 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.727 -2.043 . . . . 2.89 112.007 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -96.06 114.8 26.54 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.802 1.641 . . . . 2.89 108.994 171.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 mt -83.13 138.78 33.53 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.776 -3.078 . . . . 1.34 111.414 -166.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -92.08 138.77 31.26 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.32 -1.487 . . . . 1.94 108.691 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.39 -46.83 83.0 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.148 2.579 . . . . 1.56 115.547 -173.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.13 -5.23 58.29 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 120.51 2.964 . . . . 0.97 120.51 176.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 -88.99 169.8 11.22 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.137 -3.567 . . . . 3.07 111.283 162.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.7 p -92.81 171.2 9.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.582 2.067 . . . . 1.34 116.582 169.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 mt -59.18 -42.52 91.04 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 115.921 -1.99 . . . . 1.63 113.616 165.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.0 t -63.14 -36.46 83.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 125.497 1.748 . . . . 1.51 112.848 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -57.06 -35.28 69.15 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 117.855 2.539 . . . . 1.9 117.855 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -90.87 -0.58 57.76 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 125.767 1.627 . . . . 0.97 110.206 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 67.68 26.1 7.98 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 121.895 2.134 . . . . 2.35 112.679 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.7 mt -68.41 123.08 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 128.529 2.732 . . . . 1.39 106.253 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -124.5 -168.83 1.87 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.944 -2.973 . . . . 2.58 107.139 -171.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -53.31 134.8 39.58 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.363 3.465 . . . . 2.58 112.534 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.536 21.5 pt-20 64.65 15.96 10.04 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 129.214 3.005 . . . . 1.71 114.032 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.256 18.2 m -73.3 138.58 45.53 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.515 -3.241 . . . . 1.34 108.456 -173.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.7 m -109.62 98.2 7.61 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 127.924 3.265 . . . . 1.36 114.603 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.1 mp -74.48 148.78 40.7 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 112.334 -2.212 . . . . 2.03 109.716 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -112.27 115.46 28.82 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.615 -2.553 . . . . 2.31 109.423 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.448 HD21 HG21 ' A' ' 7' ' ' THR . 33.9 tp -101.7 113.97 27.61 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.477 1.608 . . . . 1.72 112.749 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -108.11 146.74 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 113.764 -1.562 . . . . 1.8 112.298 173.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.0 tp -97.41 113.23 24.86 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.384 -2.072 . . . . 3.26 111.231 -176.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -79.54 116.98 20.07 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 130.509 3.524 . . . . 4.12 111.525 173.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.3 mt -95.72 164.92 12.56 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 125.772 1.92 . . . . 3.54 115.709 167.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 -69.44 -53.61 18.43 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.646 -3.159 . . . . 7.32 109.491 173.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.86 61.76 0.56 Allowed Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 125.561 2.756 . . . . 3.73 107.666 -169.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.805 0 O-C-N 116.925 -3.691 . . . . 3.87 107.834 174.694 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 ptt? . . . . . 0 CA--C 1.491 -1.316 0 CA-C-O 123.706 1.717 . . . . 1.39 111.274 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -100.76 133.41 45.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 126.859 3.219 . . . . 2.2 109.953 -174.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.2 pt -123.44 155.36 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 118.01 -2.931 . . . . 1.32 105.86 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -119.81 124.3 45.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.982 1.849 . . . . 2.2 110.26 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 t -100.56 95.74 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 126.846 3.212 . . . . 1.23 114.838 173.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -75.1 124.33 26.82 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.19 -2.194 . . . . 2.51 109.708 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.1 p -100.21 178.25 4.83 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 112.933 0.716 . . . . 1.41 112.933 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.5 tp -64.57 -64.29 0.91 Allowed 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 118.368 -2.708 . . . . 2.95 112.876 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.454 22.9 p -63.27 -36.83 84.98 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 119.502 3.149 . . . . 2.52 119.502 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.22 -52.82 0.12 Allowed Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 115.015 -3.469 . . . . 1.5 114.3 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -60.6 132.39 53.75 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 124.669 2.176 . . . . 1.79 116.412 -168.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.1 m -99.76 112.91 25.12 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.067 -3.521 . . . . 1.38 104.529 168.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mt -90.81 119.66 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 120.211 -0.595 . . . . 2.03 110.973 -173.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.6 m -85.69 112.17 20.78 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.048 -2.282 . . . . 1.61 108.222 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.4 mt -116.03 116.27 27.6 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 125.335 1.647 . . . . 2.15 112.724 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -84.93 124.09 31.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.502 -3.874 . . . . 1.98 115.778 167.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.03 163.15 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 125.779 2.704 . . . . 1.52 109.147 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -97.88 152.13 37.93 Favored Pre-proline 0 N--CA 1.431 -1.391 1 O-C-N 114.493 -5.13 . . . . 2.35 104.757 164.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -73.39 -3.07 13.06 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 125.273 3.982 . . . . 1.31 120.995 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.8 m -97.35 -4.82 37.79 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.539 -1.976 . . . . 1.71 109.227 172.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -71.44 146.22 48.78 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.756 -2.465 . . . . 1.69 111.16 173.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.4 p -79.59 154.67 28.57 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 118.757 2.873 . . . . 1.33 118.757 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.9 mm -57.7 -37.27 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 121.977 2.171 . . . . 1.32 113.125 175.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.436 30.6 tt0 -38.65 -52.43 1.66 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 119.497 3.147 . . . . 1.62 119.497 165.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -56.9 -45.06 82.85 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.166 1.913 . . . . 2.13 116.166 172.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.4 t -59.29 -43.4 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-O 124.771 2.224 . . . . 1.23 115.189 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -62.21 -45.97 90.96 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.947 2.499 . . . . 1.97 108.518 172.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.56 -30.5 69.82 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.618 2.822 . . . . 1.19 118.618 172.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -80.81 -29.38 36.0 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 116.235 -4.041 . . . . 1.92 106.627 172.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.1 mt -72.45 -34.4 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 116.503 -3.873 . . . . 1.94 112.621 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -52.1 -50.94 60.62 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 116.889 -3.632 . . . . 1.9 112.958 162.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -53.48 -45.31 69.54 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 128.238 2.615 . . . . 1.55 114.188 171.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -72.96 -70.12 0.38 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.053 -2.905 . . . . 2.95 111.214 -174.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -93.36 -43.61 8.69 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 128.455 2.702 . . . . 1.48 110.951 -165.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.18 50.37 2.25 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 125.862 1.696 . . . . 1.12 114.814 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.5 mt -118.05 137.99 25.04 Favored Pre-proline 0 N--CA 1.43 -1.463 1 N-CA-C 98.105 -4.776 . . . . 2.07 98.105 -176.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -65.35 154.79 71.99 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 C-N-CA 124.244 3.296 . . . . 1.39 115.783 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.55 -10.9 24.1 Favored 'Trans proline' 0 N--CA 1.434 -1.979 0 CA-C-O 114.047 -2.564 . . . . 1.68 117.107 -174.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.31 -50.54 38.28 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.729 2.518 . . . . 2.25 114.393 169.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -60.71 -33.78 73.39 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 128.197 2.599 . . . . 2.44 106.467 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -74.07 128.43 35.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 114.494 -2.669 . . . . 1.32 107.477 -170.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -111.53 115.26 28.89 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 127.093 2.745 . . . . 3.19 105.312 166.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.7 mt -97.14 129.49 44.52 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 120.543 -0.463 . . . . 1.75 112.226 173.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.59 138.83 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 128.118 2.567 . . . . 1.98 113.3 175.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -127.51 87.6 2.65 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.445 -2.035 . . . . 1.94 113.347 172.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.388 . . 84.97 -73.52 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.676 1.99 . . . . 1.67 108.444 -175.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.02 -21.48 0.28 Allowed Glycine 0 N--CA 1.431 -1.7 0 N-CA-C 109.439 -1.464 . . . . 1.3 109.439 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -80.02 128.22 33.23 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.309 1.444 . . . . 2.89 109.681 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -87.49 126.33 34.84 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 102.195 -3.261 . . . . 2.89 102.195 170.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.9 mt -89.19 127.37 35.74 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.847 1.308 . . . . 1.34 111.208 -164.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -77.17 142.25 39.73 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.153 -2.842 . . . . 1.94 115.664 174.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -56.68 -55.59 32.14 Favored 'General case' 0 N--CA 1.43 -1.456 1 C-N-CA 132.623 4.369 . . . . 1.56 115.402 -170.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.23 14.19 29.28 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 128.933 3.158 . . . . 0.97 112.773 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -109.51 164.45 12.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.326 3.563 . . . . 3.07 110.926 168.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.3 p -90.77 152.98 20.58 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 126.162 2.887 . . . . 1.34 115.109 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mt -56.4 -45.93 80.38 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.538 -3.226 . . . . 1.63 118.142 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.0 p -68.63 -13.4 62.33 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 118.095 2.628 . . . . 1.51 118.095 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -75.64 -34.28 60.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.291 -1.374 . . . . 1.9 107.291 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -85.35 1.83 46.85 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 117.581 -1.199 . . . . 0.97 111.787 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 65.83 36.77 5.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.563 2.745 . . . . 2.35 112.031 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.6 mt -87.64 121.45 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.149 -3.469 . . . . 1.39 111.532 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -122.11 -168.17 1.67 Allowed 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 105.829 -1.915 . . . . 2.58 105.829 -173.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -56.25 140.5 44.53 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 116.128 1.899 . . . . 2.58 116.128 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.307 98.5 mt-10 69.8 15.56 7.94 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 112.768 -2.015 . . . . 1.71 114.098 176.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.329 44.8 m -78.75 156.64 28.76 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 121.72 2.055 . . . . 1.34 111.107 -177.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.8 m -102.57 126.65 49.71 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 112.57 -2.105 . . . . 1.36 106.852 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -116.68 150.78 37.61 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 104.26 -2.496 . . . . 2.03 104.26 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -116.64 112.02 20.68 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 126.495 1.918 . . . . 2.31 106.403 -171.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.9 tp -98.22 122.18 41.06 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.103 -1.814 . . . . 1.72 106.103 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 m -126.74 150.93 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 113.368 -1.742 . . . . 1.8 107.466 173.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.3 mt -99.32 142.61 30.58 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 117.811 2.523 . . . . 3.26 117.811 -175.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.7 ttt-85 -110.9 77.5 1.04 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 103.587 -2.746 . . . . 4.12 103.587 172.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.0 mt -75.63 171.14 14.83 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 115.943 1.831 . . . . 3.54 115.943 168.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.7 ptt-85 -84.52 155.53 22.1 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 114.547 -2.861 . . . . 7.32 112.456 169.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.71 -43.5 1.2 Allowed Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 109.123 -1.591 . . . . 3.73 109.123 -168.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.756 0 CA-C-O 117.539 -1.701 . . . . 3.87 114.898 174.306 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.49 -1.336 0 N-CA-C 111.807 0.299 . . . . 1.39 111.807 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -97.48 136.67 37.57 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 124.012 0.82 . . . . 2.2 110.557 -172.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.2 pt -130.17 160.62 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 105.088 -2.19 . . . . 1.32 105.088 172.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -118.01 150.09 39.87 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 120.54 1.518 . . . . 2.2 109.826 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 96.4 t -132.47 122.87 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 105.913 -1.884 . . . . 1.23 105.913 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -97.31 147.83 23.75 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.863 1.792 . . . . 2.51 107.446 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.441 8.9 p -101.92 175.39 5.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.498 -3.876 . . . . 1.41 112.007 174.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.0 tp -58.34 -58.39 8.72 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.629 -1.919 . . . . 2.95 114.772 169.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.277 62.5 p -78.35 -14.53 59.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 119.26 3.059 . . . . 2.52 119.26 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.63 17.01 2.18 Favored Glycine 0 N--CA 1.429 -1.796 0 CA-C-O 115.003 -3.11 . . . . 1.5 117.905 173.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -94.8 122.07 37.05 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 101.699 -3.445 . . . . 1.79 101.699 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.265 10.7 m -92.59 116.19 28.78 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.462 -3.273 . . . . 1.38 111.06 169.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -102.22 135.47 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 118.335 -2.728 . . . . 2.03 117.206 172.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.2 m -103.62 137.74 41.25 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 101.367 -3.568 . . . . 1.61 101.367 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.4 mt -129.24 142.65 50.79 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 120.847 1.658 . . . . 2.15 111.704 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -101.57 117.4 34.84 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.852 2.861 . . . . 1.98 103.791 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -134.28 164.41 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 101.823 -3.399 . . . . 1.52 101.823 -172.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -109.16 159.56 30.76 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-N 110.169 -3.196 . . . . 2.35 107.402 166.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -81.24 -11.75 11.92 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 CA-C-N 124.734 2.727 . . . . 1.31 109.677 -172.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.1 m -86.83 -7.98 57.74 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 116.09 -4.132 . . . . 1.71 110.536 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -66.45 148.82 51.32 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 128.813 2.845 . . . . 1.69 107.848 170.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.1 p -93.12 -173.45 3.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.486 1.291 . . . . 1.33 114.486 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.6 mm -79.54 -37.88 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 125.431 1.492 . . . . 1.32 107.784 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -51.15 -48.24 61.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.599 1.96 . . . . 1.62 116.047 166.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -58.0 -48.99 78.38 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 122.821 1.296 . . . . 2.13 112.34 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.9 t -56.31 -52.5 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 114.785 1.402 . . . . 1.23 114.785 174.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HZ2' ' CG ' ' A' ' 52' ' ' ASP . 46.3 mtmt -62.16 -22.56 65.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 128.22 3.867 . . . . 1.97 114.516 174.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.14 -35.9 61.62 Favored 'General case' 0 N--CA 1.429 -1.5 1 O-C-N 113.04 -6.037 . . . . 1.19 112.596 171.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -68.9 -30.88 69.45 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.972 -2.33 . . . . 1.92 108.945 171.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.0 mt -69.73 -31.69 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 1 O-C-N 112.779 -6.201 . . . . 1.94 112.474 176.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -64.37 -42.09 96.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.865 -1.772 . . . . 1.9 108.654 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -52.8 -49.66 65.18 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 114.611 1.337 . . . . 1.55 114.611 169.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -70.56 -73.7 0.16 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.822 -2.424 . . . . 2.95 115.797 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -90.95 -28.98 17.7 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.443 2.297 . . . . 1.48 113.898 -169.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.06 54.62 1.98 Allowed Glycine 0 N--CA 1.43 -1.732 1 O-C-N 115.244 -4.66 . . . . 1.12 114.614 173.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.4 mt -118.27 132.36 23.8 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 104.888 -2.264 . . . . 2.07 104.888 -173.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -63.17 150.84 87.47 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 O-C-N 114.09 -3.689 . . . . 1.39 117.132 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -67.75 -15.51 44.41 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 C-N-CA 124.376 3.384 . . . . 1.68 112.935 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.63 -30.97 61.83 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.831 2.53 . . . . 2.25 117.831 173.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -92.27 -26.65 18.05 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 123.419 1.58 . . . . 2.44 111.607 -172.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.431 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 66.0 mt-30 -75.44 112.1 11.41 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.763 1.625 . . . . 1.32 112.846 -175.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -103.59 119.6 39.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.693 -3.754 . . . . 3.19 105.798 168.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.9 mt -96.16 129.73 43.39 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.852 -1.976 . . . . 1.75 107.051 173.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mm -104.68 135.68 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 128.679 2.792 . . . . 1.98 108.663 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -154.97 127.25 7.79 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 114.384 1.253 . . . . 1.94 114.384 170.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.43 27.8 3.87 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 115.935 1.828 . . . . 1.67 115.935 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.37 -12.32 61.68 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 115.992 1.157 . . . . 1.3 115.992 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -135.45 143.81 46.1 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.465 1.602 . . . . 2.89 114.578 -167.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -71.61 149.13 45.9 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 118.771 -2.456 . . . . 2.89 114.44 171.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.308 55.1 mt -113.67 147.99 37.14 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 122.18 0.991 . . . . 1.34 113.106 -165.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -75.89 152.6 37.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 113.807 1.039 . . . . 1.94 113.807 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.444 ' CG ' ' HZ2' ' A' ' 27' ' ' LYS 0.351 0.9 OUTLIER -73.95 -51.07 17.23 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 116.099 1.888 . . . . 1.56 116.099 -169.843 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.34 32.77 3.03 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 119.678 2.631 . . . . 0.97 119.678 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -95.22 155.51 16.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.974 -3.074 . . . . 3.07 110.756 162.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.275 14.3 p -87.2 165.76 15.46 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 126.426 3.013 . . . . 1.34 111.163 175.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 37.6 mt -78.93 -20.51 49.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.823 -3.048 . . . . 1.63 109.698 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -70.96 -29.04 64.94 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 127.511 2.324 . . . . 1.51 112.375 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -68.28 -35.64 78.16 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.279 1.832 . . . . 1.9 114.628 170.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -95.43 7.79 45.17 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.156 1.383 . . . . 0.97 109.709 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.2 m120 45.47 39.9 5.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.266 3.027 . . . . 2.35 114.687 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mt -78.02 105.44 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 105.667 -1.975 . . . . 1.39 105.667 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -78.08 -169.42 1.58 Allowed 'General case' 0 N--CA 1.43 -1.466 1 C-N-CA 131.964 4.106 . . . . 2.58 113.186 175.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -76.34 157.15 32.71 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.996 -2.94 . . . . 2.58 113.821 172.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.289 52.9 mt-10 68.35 22.8 7.85 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 111.852 -2.431 . . . . 1.71 111.949 171.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.0 m -86.14 125.8 33.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.059 2.944 . . . . 1.34 111.417 -174.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.6 m -92.14 120.27 32.57 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.96 -3.587 . . . . 1.36 106.218 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 9.3 mp -103.67 137.51 41.62 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 104.609 -2.367 . . . . 2.03 104.609 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -107.79 137.85 45.07 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 123.641 2.928 . . . . 2.31 115.008 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.4 tt -98.35 108.59 21.32 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.412 2.053 . . . . 1.72 111.422 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -110.9 130.2 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 C-N-CA 129.483 3.113 . . . . 1.8 111.612 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.6 mt -83.33 138.81 33.38 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 116.333 -3.979 . . . . 3.26 115.46 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -95.49 94.24 7.67 Favored 'General case' 0 N--CA 1.43 -1.475 1 N-CA-C 98.343 -4.688 . . . . 4.12 98.343 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.1 mt -81.53 154.76 26.09 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.215 -2.803 . . . . 3.54 117.833 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.255 68.9 mtt180 -74.68 147.02 41.85 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.741 2.497 . . . . 7.32 117.741 175.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 135.71 -75.78 0.4 Allowed Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 104.979 -3.249 . . . . 3.73 104.979 -167.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.795 0 N-CA-C 108.924 -1.67 . . . . 3.87 108.924 -174.661 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptt? . . . . . 0 CA--C 1.489 -1.367 1 CA-C-O 109.231 -5.176 . . . . 1.39 110.82 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -117.56 145.05 44.53 Favored 'General case' 0 N--CA 1.43 -1.45 2 O-C-N 130.148 4.655 . . . . 2.2 122.534 174.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.336 15.5 pt -128.21 153.82 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 125.741 1.901 . . . . 1.32 109.176 175.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -112.15 121.07 43.93 Favored 'General case' 0 N--CA 1.429 -1.484 1 N-CA-C 99.583 -4.228 . . . . 2.2 99.583 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.497 HG23 HD13 ' A' ' 15' ' ' LEU . 71.2 t -113.51 112.12 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-O 124.973 2.32 . . . . 1.23 105.389 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -88.52 145.51 25.69 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.549 -3.219 . . . . 2.51 115.474 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.318 22.1 p -93.58 162.62 13.88 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.094 2.158 . . . . 1.41 108.762 177.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.37 -29.07 70.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.185 2.194 . . . . 2.95 111.552 176.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.315 28.4 p -83.25 -45.4 13.88 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 126.51 3.052 . . . . 2.52 113.145 -176.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.64 23.79 0.06 OUTLIER Glycine 0 N--CA 1.429 -1.773 1 O-C-N 114.769 -4.957 . . . . 1.5 116.653 172.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -103.67 135.86 44.45 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 103.603 -2.74 . . . . 1.79 103.603 -172.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.0 m -97.41 112.6 24.37 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 115.537 -2.173 . . . . 1.38 109.774 169.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -95.24 120.26 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 123.525 2.875 . . . . 2.03 105.188 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.4 m -92.37 124.7 36.62 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 105.271 -2.122 . . . . 1.61 105.271 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.497 HD13 HG23 ' A' ' 5' ' ' VAL . 46.1 mt -119.67 130.14 54.9 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.471 1.508 . . . . 2.15 111.573 -174.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -85.05 126.5 33.62 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 104.907 -2.257 . . . . 1.98 104.907 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.8 m -143.48 167.34 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 126.8 2.04 . . . . 1.52 112.479 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -120.9 160.67 43.84 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-O 115.231 -2.319 . . . . 2.35 112.329 163.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -60.12 -25.12 79.04 Favored 'Trans proline' 0 N--CA 1.433 -2.056 2 CA-C-N 128.948 4.231 . . . . 1.31 113.597 -176.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m -74.7 -20.9 59.67 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.277 2.231 . . . . 1.71 113.32 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -62.44 141.79 58.19 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.942 -2.973 . . . . 1.69 110.998 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.483 HG22 HG21 ' A' ' 55' ' ' THR . 72.3 p -82.6 167.09 18.65 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.528 -1.669 . . . . 1.33 108.235 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.5 mm -66.28 -33.6 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 116.22 -1.848 . . . . 1.32 109.781 172.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -54.39 -33.31 59.03 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.658 2.096 . . . . 1.62 116.658 166.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -73.23 -35.19 66.22 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 120.881 1.673 . . . . 2.13 109.947 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.18 -51.66 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 125.016 1.326 . . . . 1.23 110.038 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -66.69 -25.87 66.76 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 117.58 -1.648 . . . . 1.97 115.141 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.91 -35.48 72.29 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.667 -2.52 . . . . 1.19 114.599 172.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -64.49 -29.87 70.9 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.447 -2.658 . . . . 1.92 113.001 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.03 -36.57 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 119.553 -1.967 . . . . 1.94 111.069 170.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -67.71 -41.32 83.77 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.947 -1.721 . . . . 1.9 109.488 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.56 -53.01 63.01 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.671 -1.893 . . . . 1.55 111.931 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -69.99 -59.63 2.8 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 123.646 1.688 . . . . 2.95 112.164 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -103.24 -28.85 11.64 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 118.815 -2.428 . . . . 1.48 110.312 -160.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.7 40.67 5.57 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 122.257 2.299 . . . . 1.12 115.579 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.7 mm -115.1 118.51 40.15 Favored Pre-proline 0 N--CA 1.43 -1.469 0 N-CA-C 104.445 -2.428 . . . . 2.07 104.445 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -74.5 144.81 32.68 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 124.196 2.534 . . . . 1.39 114.089 -175.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.96 -20.84 44.36 Favored 'Trans proline' 0 N--CA 1.433 -2.041 1 C-N-CA 125.923 4.416 . . . . 1.68 114.183 -175.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -48.48 -53.07 19.38 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.482 1.611 . . . . 2.25 111.331 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -78.18 -24.76 47.08 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 119.273 3.064 . . . . 2.44 119.273 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -66.5 141.49 57.86 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.83 -1.794 . . . . 1.32 112.928 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -135.38 124.47 24.37 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.684 -2.51 . . . . 3.19 110.245 171.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.288 0.3 OUTLIER -92.51 123.94 36.18 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 120.726 1.603 . . . . 1.75 112.163 175.277 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.1 mm -107.33 128.87 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-O 122.273 1.035 . . . . 1.98 108.704 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.411 ' HB3' HD22 ' A' ' 50' ' ' LEU . 76.4 t80 -140.4 128.5 22.23 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.626 -1.296 . . . . 1.94 112.074 169.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.29 17.21 2.72 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 111.509 -2.587 . . . . 1.67 112.567 -174.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.31 -7.92 56.76 Favored Glycine 0 N--CA 1.43 -1.743 1 CA-C-O 111.724 -4.931 . . . . 1.3 115.41 -170.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -102.16 131.4 48.69 Favored 'General case' 0 N--CA 1.43 -1.443 1 CA-C-N 125.342 4.571 . . . . 2.89 112.057 177.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -79.09 125.31 29.25 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 125.714 2.673 . . . . 2.89 105.926 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.411 HD22 ' HB3' ' A' ' 45' ' ' PHE 0.288 12.5 mt -84.77 129.9 34.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.004 -1.907 . . . . 1.34 109.091 -171.392 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -88.72 143.85 26.65 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 116.642 2.09 . . . . 1.94 116.642 -176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.67 -36.92 85.82 Favored 'General case' 0 N--CA 1.431 -1.419 1 N-CA-C 122.967 4.432 . . . . 1.56 122.967 -169.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.92 10.25 63.41 Favored Glycine 0 N--CA 1.43 -1.726 1 O-C-N 115.626 -4.421 . . . . 0.97 117.952 169.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.25 24.1 mtt180 -107.47 152.07 24.71 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.126 1.917 . . . . 3.07 110.347 172.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.483 HG21 HG22 ' A' ' 22' ' ' THR . 7.0 p -92.75 167.2 12.03 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 126.5 3.048 . . . . 1.34 118.895 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.1 mt -63.02 -22.96 67.22 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 116.114 -4.116 . . . . 1.63 118.382 170.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.3 t -79.75 -31.99 41.0 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.146 1.927 . . . . 1.51 114.128 171.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -60.13 -35.77 76.01 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.205 -2.184 . . . . 1.9 112.7 172.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.406 ' HB2' HD12 ' A' ' 61' ' ' ILE . 78.7 m-85 -94.78 18.81 11.02 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 123.666 2.939 . . . . 0.97 111.194 170.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.56 3.1 p-10 43.61 48.04 6.4 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 129.547 3.139 . . . . 2.35 118.336 -177.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.406 HD12 ' HB2' ' A' ' 59' ' ' TYR . 47.7 mt -90.17 115.93 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 118.627 -2.546 . . . . 1.39 115.898 -178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -100.37 -176.5 3.23 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 131.583 3.953 . . . . 2.58 107.808 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -58.7 158.93 7.25 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.388 -2.695 . . . . 2.58 114.812 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 71.92 27.65 2.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.397 1.879 . . . . 1.71 110.671 168.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.2 m -96.1 135.86 37.33 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 125.683 2.659 . . . . 1.34 114.07 -173.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.3 m -94.67 108.93 20.91 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 113.541 -5.724 . . . . 1.36 105.248 -173.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 mp -97.73 159.0 15.2 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 127.278 3.418 . . . . 2.03 106.512 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -133.69 121.46 21.99 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.564 -2.585 . . . . 2.31 104.631 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.3 tp -89.52 132.14 35.21 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.299 -1.741 . . . . 1.72 106.299 -176.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -116.37 135.39 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 1 N-CA-C 99.32 -4.326 . . . . 1.8 99.32 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.6 mt -114.11 98.99 7.3 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.811 -1.805 . . . . 3.26 109.182 -178.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -97.7 75.44 2.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.168 -1.79 . . . . 4.12 106.168 -174.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.7 tp -94.81 -70.94 0.69 Allowed 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 109.899 -3.319 . . . . 3.54 108.839 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -74.75 -44.37 50.06 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 113.034 -1.894 . . . . 7.32 111.34 172.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.28 20.16 57.53 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 120.199 2.84 . . . . 3.73 120.199 -163.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.796 1 N-CA-C 102.622 -4.191 . . . . 3.87 102.622 -171.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 ttp . . . . . 0 CA--C 1.489 -1.376 0 CA-C-O 115.842 -2.028 . . . . 1.39 109.883 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -91.96 123.4 35.3 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 124.699 1.249 . . . . 2.2 110.939 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -124.9 159.51 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.455 -1.403 . . . . 1.32 110.855 172.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -108.12 128.21 54.48 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.729 0.811 . . . . 2.2 110.663 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.3 t -105.93 108.41 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 C-N-CA 128.722 2.809 . . . . 1.23 106.926 171.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -104.48 132.04 51.18 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 127.669 3.604 . . . . 2.51 110.332 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.8 p -100.28 164.36 11.98 Favored 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 115.603 -4.436 . . . . 1.41 107.818 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.1 mt -84.51 -3.8 58.6 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 109.339 -0.615 . . . . 2.95 109.339 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.3 p -90.11 -29.88 18.03 Favored 'General case' 0 N--CA 1.429 -1.505 1 O-C-N 116.191 -4.068 . . . . 2.52 111.333 -175.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.2 54.07 0.17 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 124.725 2.292 . . . . 1.5 115.317 175.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.488 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 76.6 tttt -153.68 138.43 17.03 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 115.028 -2.415 . . . . 1.79 107.461 -173.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.3 m -136.58 131.05 33.26 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 127.806 3.191 . . . . 1.38 103.616 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 pt -127.01 153.76 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 123.789 1.757 . . . . 2.03 108.506 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.6 m -109.62 109.19 19.87 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 112.871 -1.968 . . . . 1.61 111.743 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.251 41.3 mt -89.09 153.31 21.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.87 2.748 . . . . 2.15 106.278 175.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -126.59 113.46 16.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.888 -2.382 . . . . 1.98 107.342 174.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 m -130.09 -164.31 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 127.576 2.35 . . . . 1.52 108.14 -173.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -129.12 171.0 9.48 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 126.159 2.162 . . . . 2.35 107.588 163.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -70.61 -17.48 33.7 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 CA-C-O 123.254 1.272 . . . . 1.31 110.882 -173.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.15 2.57 53.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.145 1.165 . . . . 1.71 114.145 176.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.37 141.11 43.35 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.667 -2.52 . . . . 1.69 109.94 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 21.9 p -75.14 163.99 26.96 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.773 2.829 . . . . 1.33 109.605 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 51' ' ' GLU . 39.1 mm -67.39 -33.73 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 124.092 1.901 . . . . 1.32 110.245 175.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -51.73 -45.94 63.82 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.981 -2.324 . . . . 1.62 116.822 163.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -67.07 -29.05 68.71 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 118.312 2.708 . . . . 2.13 118.312 173.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.0 t -74.31 -44.9 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 127.419 2.287 . . . . 1.23 108.892 176.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -62.86 -38.88 92.6 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 126.989 2.116 . . . . 1.97 112.864 174.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.83 -32.75 72.67 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.557 1.543 . . . . 1.19 113.313 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -61.37 -55.14 34.92 Favored 'General case' 0 N--CA 1.428 -1.532 0 O-C-N 118.201 -2.812 . . . . 1.92 111.989 165.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -53.7 -39.98 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 117.802 -3.061 . . . . 1.94 114.642 173.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -58.94 -38.99 80.29 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.868 1.318 . . . . 1.9 114.237 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -69.89 -55.03 10.79 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.151 -0.968 . . . . 1.55 110.67 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -65.89 -75.67 0.09 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.709 -3.12 . . . . 2.95 106.718 -175.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.488 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 71.5 mm-40 -78.5 -25.7 45.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.306 2.242 . . . . 1.48 113.356 -163.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.99 12.11 55.69 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 116.332 -2.371 . . . . 1.12 110.303 168.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.7 mt -88.84 126.33 59.8 Favored Pre-proline 0 N--CA 1.43 -1.454 0 CA-C-N 122.738 3.269 . . . . 2.07 108.453 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -68.21 160.31 49.44 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 124.082 3.188 . . . . 1.39 109.894 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.61 -7.64 13.61 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 115.105 -2.796 . . . . 1.68 116.277 -171.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -82.77 -22.25 34.37 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.767 -1.833 . . . . 2.25 108.267 175.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -80.6 -21.36 41.67 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.726 -2.484 . . . . 2.44 113.432 -175.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -113.65 137.44 51.6 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 118.131 0.423 . . . . 1.32 109.958 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -120.04 133.44 55.53 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.251 -1.531 . . . . 3.19 108.446 171.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.1 mt -105.31 121.35 43.69 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.393 2.997 . . . . 1.75 108.175 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.4 mm -111.3 131.0 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 116.555 -3.841 . . . . 1.98 107.194 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -124.26 118.57 27.09 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 105.114 -2.18 . . . . 1.94 105.114 170.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.304 . . 64.76 -89.23 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 130.154 3.382 . . . . 1.67 111.218 -171.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.76 -21.15 3.98 Favored Glycine 0 N--CA 1.429 -1.794 0 C-N-CA 127.025 2.25 . . . . 1.3 117.903 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.253 29.5 mttm -104.93 132.53 51.06 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 127.313 2.245 . . . . 2.89 114.777 -172.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -75.94 145.1 40.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.878 -1.056 . . . . 2.89 111.92 170.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 mt -98.06 143.5 28.55 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 125.478 1.736 . . . . 1.34 112.989 -172.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.414 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 40.3 tp10 -95.95 135.84 37.17 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.883 -2.386 . . . . 1.94 116.068 -176.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -47.24 -66.4 0.41 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 120.163 3.394 . . . . 1.56 120.163 -173.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.15 52.67 2.59 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 118.724 2.25 . . . . 0.97 118.724 169.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 22' ' ' THR . 40.0 mmt180 -134.95 157.86 45.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 116.408 -1.758 . . . . 3.07 107.964 172.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.287 6.5 p -88.65 172.92 8.92 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.486 1.612 . . . . 1.34 114.9 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.5 mt -72.46 -38.38 68.26 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 116.222 -4.049 . . . . 1.63 111.919 168.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.1 t -57.49 -38.96 75.42 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 129.486 3.114 . . . . 1.51 112.951 173.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -59.64 -32.85 70.83 Favored 'General case' 0 N--CA 1.43 -1.471 1 O-C-N 115.439 -4.538 . . . . 1.9 112.348 174.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -96.19 9.1 42.06 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 126.134 2.873 . . . . 0.97 112.412 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.6 m120 49.21 47.14 22.45 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 129.729 3.212 . . . . 2.35 109.327 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.1 mt -91.6 114.65 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 124.083 1.897 . . . . 1.39 109.722 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -97.05 -172.31 2.42 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.696 -1.594 . . . . 2.58 106.696 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -65.97 143.8 57.16 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.571 2.129 . . . . 2.58 113.77 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.279 70.5 mt-10 71.09 18.62 5.8 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 116.905 -3.622 . . . . 1.71 114.774 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.3 m -79.33 139.76 37.7 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.161 2.185 . . . . 1.34 115.513 -175.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.6 m -90.74 101.39 14.14 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 124.329 2.014 . . . . 1.36 115.416 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.6 143.96 34.27 Favored 'General case' 0 N--CA 1.429 -1.505 1 O-C-N 114.468 -5.145 . . . . 2.03 108.153 165.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -108.2 115.69 30.59 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.088 -3.508 . . . . 2.31 111.457 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tt -91.6 119.87 31.88 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 126.303 2.252 . . . . 1.72 111.429 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.88 147.39 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 126.403 3.001 . . . . 1.8 103.122 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.7 mt -103.46 156.93 17.39 Favored 'General case' 0 N--CA 1.429 -1.488 1 O-C-N 115.811 -4.306 . . . . 3.26 112.782 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -76.37 87.86 3.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 124.856 2.265 . . . . 4.12 106.913 -170.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.6 mt -118.43 -59.0 1.93 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.068 -2.895 . . . . 3.54 106.774 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -73.72 150.58 41.1 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 130.796 3.639 . . . . 7.32 111.352 166.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -52.47 -59.26 9.29 Favored Glycine 0 N--CA 1.43 -1.761 1 C-N-CA 131.571 4.415 . . . . 3.73 111.814 -169.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.732 0 N-CA-C 116.254 1.262 . . . . 3.87 116.254 -175.83 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 121.675 0.75 . . . . 1.39 112.74 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -107.79 135.69 48.78 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.331 -3.355 . . . . 2.2 111.42 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.1 pt -130.69 171.59 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 O-C-N 120.5 -1.375 . . . . 1.32 110.051 173.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -120.4 148.39 43.84 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 124.765 1.226 . . . . 2.2 113.749 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.413 HG21 ' HB2' ' A' ' 67' ' ' LEU . 68.6 t -133.91 124.36 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 N-CA-C 104.775 -2.306 . . . . 1.23 104.775 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 tptt -92.27 135.83 33.69 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 109.659 -3.428 . . . . 2.51 114.954 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.289 38.0 p -83.24 -171.52 3.62 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.315 3.436 . . . . 1.41 110.58 -174.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.22 -49.65 73.35 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 125.325 2.488 . . . . 2.95 113.333 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.7 p -88.25 -43.4 11.61 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.591 -1.64 . . . . 2.52 113.522 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.04 -3.94 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.762 0 O-C-N 116.981 -3.574 . . . . 1.5 121.158 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.433 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 27.8 ttpt -71.59 133.8 45.98 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 120.535 2.167 . . . . 1.79 114.016 -173.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.4 m -90.88 110.61 21.84 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 117.969 -1.493 . . . . 1.38 109.151 176.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 mt -93.41 135.54 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 125.234 1.414 . . . . 2.03 107.324 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.3 m -102.51 127.51 49.54 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.259 1.424 . . . . 1.61 111.295 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.5 mt -124.57 156.39 37.46 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 107.293 -1.373 . . . . 2.15 107.293 -177.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -104.57 123.11 46.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.149 2.18 . . . . 1.98 114.296 167.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.1 m -141.15 161.46 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 124.614 3.37 . . . . 1.52 103.227 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -111.86 157.28 39.99 Favored Pre-proline 0 N--CA 1.43 -1.466 0 N-CA-C 103.725 -2.694 . . . . 2.35 103.725 166.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.13 -9.83 19.29 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 C-N-CA 124.009 3.139 . . . . 1.31 111.686 -171.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.0 p -83.68 -9.93 58.52 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 114.807 -2.52 . . . . 1.71 112.426 171.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -67.44 145.62 54.82 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 124.353 3.251 . . . . 1.69 111.403 174.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.1 p -88.12 158.82 18.45 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 113.231 -5.918 . . . . 1.33 110.844 178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.4 mm -59.83 -32.33 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 119.786 3.254 . . . . 1.32 119.786 174.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -50.74 -47.56 59.36 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.264 1.95 . . . . 1.62 116.264 159.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -60.65 -38.22 84.13 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 125.51 1.524 . . . . 2.13 112.148 174.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.63 -43.61 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 124.798 1.239 . . . . 1.23 108.984 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HZ3' ' CG ' ' A' ' 52' ' ' ASP . 93.2 mttt -62.04 -33.03 73.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 118.434 2.753 . . . . 1.97 118.434 169.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.82 -33.65 76.35 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.349 1.46 . . . . 1.19 114.615 173.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -74.17 -18.13 60.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.287 3.035 . . . . 1.92 111.593 171.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.0 mt -82.46 -32.05 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 116.932 -3.605 . . . . 1.94 105.854 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -67.73 -33.97 75.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.458 -3.276 . . . . 1.9 113.245 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -56.77 -45.16 82.28 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.199 -1.563 . . . . 1.55 112.86 166.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -74.92 -67.82 0.61 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.945 -1.097 . . . . 2.95 112.721 -176.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.433 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 40.4 mm-40 -84.75 -45.76 12.07 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.679 2.791 . . . . 1.48 111.619 -167.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.97 -7.2 17.14 Favored Glycine 0 N--CA 1.429 -1.824 0 CA-C-O 123.228 1.46 . . . . 1.12 111.988 175.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.419 HD11 HD21 ' A' ' 71' ' ' LEU . 72.1 mt -71.99 122.81 88.31 Favored Pre-proline 0 N--CA 1.431 -1.418 0 C-N-CA 126.947 2.099 . . . . 2.07 110.597 -172.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.9 145.38 68.1 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 125.092 3.861 . . . . 1.39 112.06 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -63.32 -27.72 71.76 Favored 'Trans proline' 0 C--N 1.3 -2.006 1 C-N-CA 125.567 4.178 . . . . 1.68 111.425 -174.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -53.07 -50.81 63.62 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 122.612 2.46 . . . . 2.25 111.64 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -68.86 -26.92 65.38 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.541 2.336 . . . . 2.44 114.108 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -71.83 153.45 41.92 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.046 -2.909 . . . . 1.32 116.343 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -141.46 120.8 13.11 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.083 2.153 . . . . 3.19 106.421 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.1 mt -105.61 137.36 43.58 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 121.139 1.79 . . . . 1.75 111.542 174.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 mp -123.37 136.58 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 127.904 3.252 . . . . 1.98 110.784 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -156.31 131.28 9.13 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 115.743 -4.348 . . . . 1.94 112.747 174.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.447 . . 67.99 35.56 3.7 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.765 2.826 . . . . 1.67 116.563 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.04 -28.68 4.04 Favored Glycine 0 N--CA 1.431 -1.684 0 CA-C-O 124.745 2.303 . . . . 1.3 112.205 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -90.04 165.34 14.08 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.707 -3.819 . . . . 2.89 111.944 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -108.79 137.63 46.41 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 103.523 -2.769 . . . . 2.89 103.523 172.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.3 mt -78.9 153.27 30.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.15 -2.844 . . . . 1.34 112.605 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.318 10.0 tp10 -98.77 141.91 30.97 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.337 -1.477 . . . . 1.94 109.968 171.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.444 ' CG ' ' HZ3' ' A' ' 27' ' ' LYS . 2.4 m-20 -63.59 -57.35 10.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.256 2.455 . . . . 1.56 117.485 -166.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.81 39.68 2.85 Favored Glycine 0 N--CA 1.43 -1.762 1 O-C-N 114.254 -5.279 . . . . 0.97 118.949 165.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -113.63 160.83 18.16 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.001 1.72 . . . . 3.07 107.751 166.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.4 p -106.36 161.62 14.4 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.479 1.609 . . . . 1.34 113.694 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.45 -37.67 86.79 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.16 2.184 . . . . 1.63 113.881 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 t -63.82 -39.25 93.78 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 113.341 -3.219 . . . . 1.51 113.654 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.257 9.7 t70 -49.18 -71.03 0.07 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 127.89 3.244 . . . . 1.9 109.985 173.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -50.84 -27.33 7.14 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 130.051 3.34 . . . . 0.97 119.541 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m120 79.3 47.06 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 129.855 3.262 . . . . 2.35 114.487 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.2 mt -99.86 126.65 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 124.724 2.202 . . . . 1.39 108.372 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -102.09 -173.56 2.37 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 116.254 -4.028 . . . . 2.58 111.746 -173.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -68.43 149.62 49.1 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.964 2.316 . . . . 2.58 116.942 169.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 59.98 26.68 15.99 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.459 3.103 . . . . 1.71 113.262 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -88.74 131.87 34.85 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 128.814 2.845 . . . . 1.34 106.43 -174.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.7 m -99.8 111.86 24.15 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 105.446 -2.057 . . . . 1.36 105.446 -174.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.413 ' HB2' HG21 ' A' ' 5' ' ' VAL . 7.6 mp -83.09 159.93 22.01 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 106.307 -1.738 . . . . 2.03 106.307 168.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -110.86 132.4 54.23 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 117.498 -1.239 . . . . 2.31 110.049 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -98.6 132.52 43.94 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 103.225 -2.879 . . . . 1.72 103.225 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.2 t -126.12 156.81 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 129.952 3.301 . . . . 1.8 103.839 174.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.419 HD21 HD11 ' A' ' 36' ' ' ILE . 88.2 mt -126.39 176.09 7.38 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.525 2.583 . . . . 3.26 107.258 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -53.9 -58.57 6.8 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 128.593 2.757 . . . . 4.12 110.756 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.7 mt -86.74 131.6 34.09 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 131.288 3.835 . . . . 3.54 109.879 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -86.13 -82.47 0.2 Allowed 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 113.786 -1.552 . . . . 7.32 111.661 170.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.26 -61.03 1.87 Allowed Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 108.218 -1.953 . . . . 3.73 108.218 -164.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.757 0 N-CA-C 107.218 -2.353 . . . . 3.87 107.218 179.477 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.417 ' SD ' ' HG3' ' A' ' 19' ' ' PRO . 5.6 ttt . . . . . 0 CA--C 1.491 -1.32 0 CA-C-O 121.045 0.45 . . . . 1.39 111.65 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -87.15 134.75 33.49 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.701 -2.499 . . . . 2.2 109.493 -172.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 pt -131.8 169.62 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 121.545 1.975 . . . . 1.32 108.017 174.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -121.56 157.58 30.42 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.88 -1.763 . . . . 2.2 107.558 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.7 t -123.17 132.74 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 125.657 1.848 . . . . 1.23 109.328 163.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.401 ' HB2' ' CG2' ' A' ' 66' ' ' THR . 26.3 tptt -98.98 134.79 41.31 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.359 -2.713 . . . . 2.51 107.856 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.6 p -85.95 -166.29 1.49 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.793 1.758 . . . . 1.41 114.962 176.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.9 mt -74.22 -47.5 34.91 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.704 -1.135 . . . . 2.95 112.171 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 p -77.61 -29.88 52.08 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 114.87 1.433 . . . . 2.52 114.87 -174.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.31 11.39 0.66 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 125.371 1.462 . . . . 1.5 115.3 172.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -81.42 140.82 34.44 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.806 -1.997 . . . . 1.79 107.626 -172.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.9 m -97.96 107.94 20.53 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.98 -1.464 . . . . 1.38 109.805 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -82.7 122.36 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 119.969 1.259 . . . . 2.03 108.563 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.2 m -95.0 114.22 26.0 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.925 -1.109 . . . . 1.61 113.786 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mp -116.33 160.45 20.49 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.358 1.614 . . . . 2.15 115.358 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.261 7.0 pt-20 -128.74 124.9 36.74 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 117.013 -1.875 . . . . 1.98 112.418 177.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 m -129.2 -167.42 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 113.765 -1.562 . . . . 1.52 110.454 -176.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -136.76 173.89 5.05 Favored Pre-proline 0 N--CA 1.431 -1.399 0 O-C-N 117.386 -3.321 . . . . 2.35 103.446 162.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.417 ' HG3' ' SD ' ' A' ' 1' ' ' MET . 92.5 Cg_exo -80.57 -8.36 13.64 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 CA-C-N 123.393 2.248 . . . . 1.31 117.751 -170.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.274 21.0 m -87.9 -19.85 26.77 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 126.812 2.57 . . . . 1.71 114.567 174.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -62.02 152.48 32.35 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.972 -2.955 . . . . 1.69 113.314 174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 31.9 p -90.11 168.99 11.54 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.662 -2.523 . . . . 1.33 117.507 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.5 mm -64.92 -36.3 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 120.307 -1.496 . . . . 1.32 109.979 171.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -57.41 -30.5 65.01 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.498 2.719 . . . . 1.62 113.495 168.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -73.66 -32.71 64.14 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 114.338 -5.226 . . . . 2.13 111.235 176.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.6 t -63.11 -49.68 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.026 2.13 . . . . 1.23 111.688 174.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HD3' ' HB3' ' A' ' 38' ' ' PRO . 55.9 mttt -58.56 -39.58 80.67 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 127.855 3.222 . . . . 1.97 114.083 176.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.71 -33.47 75.71 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 118.52 2.785 . . . . 1.19 118.52 173.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -75.0 -35.57 62.01 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 125.077 1.485 . . . . 1.92 111.464 170.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.68 -39.54 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 1 O-C-N 115.69 -4.381 . . . . 1.94 112.449 166.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -63.84 -41.47 97.81 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.614 -3.804 . . . . 1.9 113.833 172.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -55.37 -69.25 0.14 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 115.821 1.785 . . . . 1.55 115.821 170.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -68.44 -59.81 2.89 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.611 -3.806 . . . . 2.95 113.875 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -83.53 -43.24 15.95 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.208 -2.807 . . . . 1.48 111.196 -163.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.7 30.28 3.56 Favored Glycine 0 N--CA 1.43 -1.76 0 CA-C-O 124.386 2.103 . . . . 1.12 111.894 169.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 88.1 mt -105.95 134.77 19.59 Favored Pre-proline 0 N--CA 1.431 -1.41 0 O-C-N 117.661 -3.259 . . . . 2.07 104.876 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -72.98 158.66 49.38 Favored 'Trans proline' 0 C--N 1.3 -2.003 1 CA-C-N 129.411 4.397 . . . . 1.39 113.699 174.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 70.4 Cg_exo -73.44 -19.7 21.65 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 CA-C-O 114.455 -2.394 . . . . 1.68 117.939 -175.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -72.19 -12.08 61.02 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 127.334 2.896 . . . . 2.25 111.39 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -100.27 -15.83 17.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 116.239 -1.839 . . . . 2.44 112.226 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -88.37 139.49 30.43 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 130.031 3.333 . . . . 1.32 111.296 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -123.23 120.73 34.02 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 128.854 2.862 . . . . 3.19 107.583 165.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.5 mt -103.01 130.67 50.19 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 124.877 2.275 . . . . 1.75 108.92 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.7 mm -117.12 139.77 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 125.068 2.366 . . . . 1.98 107.287 -172.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -146.62 148.81 32.47 Favored 'General case' 0 N--CA 1.429 -1.497 1 O-C-N 113.693 -5.629 . . . . 1.94 108.157 168.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.66 30.3 8.54 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.217 1.932 . . . . 1.67 116.217 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.67 -29.8 5.64 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 124.887 1.232 . . . . 1.3 115.039 -173.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -82.1 142.96 31.82 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 128.706 2.802 . . . . 2.89 114.787 -174.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -90.56 132.46 35.7 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.006 1.73 . . . . 2.89 108.382 168.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mt -86.74 146.89 26.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.892 1.677 . . . . 1.34 111.845 -172.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -92.42 154.7 18.35 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 123.324 1.535 . . . . 1.94 111.043 171.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.64 -66.37 0.6 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 112.987 -1.915 . . . . 1.56 113.619 -163.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.31 64.48 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.723 0 O-C-N 118.763 -2.46 . . . . 0.97 113.916 162.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -140.94 151.04 43.89 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.228 -1.767 . . . . 3.07 106.228 168.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.25 18.5 p -85.14 169.83 13.49 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 121.747 2.067 . . . . 1.34 111.146 -178.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mt -69.83 -43.98 70.86 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 123.959 1.837 . . . . 1.63 113.859 173.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.1 t -57.89 -38.63 76.14 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.615 2.366 . . . . 1.51 114.271 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -57.36 -43.85 83.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.907 -1.746 . . . . 1.9 114.115 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -85.58 3.41 40.78 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.991 2.329 . . . . 0.97 114.033 172.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.4 m120 59.75 37.85 21.9 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.801 -3.062 . . . . 2.35 113.798 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.0 mt -74.15 116.4 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 125.527 1.531 . . . . 1.39 108.496 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -89.3 -174.62 4.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 117.364 2.357 . . . . 2.58 117.364 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -60.17 133.07 55.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.285 -2.134 . . . . 2.58 115.677 169.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.41 50.1 mt-10 64.33 41.96 5.56 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.684 -1.26 . . . . 1.71 112.678 174.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.257 62.6 m -106.55 163.81 12.58 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 103.25 -2.87 . . . . 1.34 103.25 -175.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 6' ' ' LYS . 89.5 m -128.79 124.31 35.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.608 3.099 . . . . 1.36 109.39 -176.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.3 mt -91.49 162.46 14.54 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 110.385 -3.098 . . . . 2.03 108.926 172.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -127.57 119.88 26.97 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 117.351 -1.74 . . . . 2.31 109.596 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.1 tp -75.78 125.44 29.07 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.957 1.836 . . . . 1.72 115.957 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 t -123.59 148.36 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 103.277 -2.86 . . . . 1.8 103.277 171.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.7 mt -121.53 147.01 46.36 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 124.397 2.046 . . . . 3.26 110.603 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -68.81 -51.12 44.16 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 112.485 -2.143 . . . . 4.12 116.415 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.3 mt -106.12 -158.66 0.67 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.071 -1.825 . . . . 3.54 106.071 175.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -89.14 147.57 24.13 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 117.473 -1.691 . . . . 7.32 108.208 167.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.81 87.62 0.37 Allowed Glycine 0 N--CA 1.429 -1.768 0 O-C-N 119.301 -2.124 . . . . 3.73 112.09 -172.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.732 0 CA-C-O 126.312 3.173 . . . . 3.87 115.152 177.508 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 CA--C 1.491 -1.313 0 CA-C-O 124.834 2.254 . . . . 1.39 114.101 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -74.11 132.37 42.21 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 128.85 2.86 . . . . 2.2 107.971 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.0 pt -136.86 152.32 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 125.983 1.713 . . . . 1.32 109.452 171.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -117.26 148.23 41.85 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.269 -2.144 . . . . 2.2 115.809 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -125.11 107.46 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 104.673 -2.343 . . . . 1.23 104.673 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 tttp -91.3 132.52 36.1 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.59 -1.944 . . . . 2.51 110.681 176.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.3 p -87.49 176.21 7.59 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.609 2.448 . . . . 1.41 117.609 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.2 mt -60.99 -29.63 69.8 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.143 -3.473 . . . . 2.95 119.946 166.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 p -83.79 -87.4 0.11 Allowed 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 113.702 -1.59 . . . . 2.52 107.279 -175.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.74 48.74 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.732 0 O-C-N 118.911 -2.368 . . . . 1.5 107.956 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -128.24 135.32 49.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.512 2.325 . . . . 1.79 107.478 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.6 m -118.32 119.68 35.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.937 2.304 . . . . 1.38 105.857 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.1 mt -91.99 113.97 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 O-C-N 117.513 -3.242 . . . . 2.03 103.354 -172.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.3 m -86.5 113.33 22.34 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.022 -3.549 . . . . 1.61 109.157 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.6 mt -111.56 171.19 7.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 114.946 1.461 . . . . 2.15 114.946 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -125.48 121.87 34.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.101 -3.5 . . . . 1.98 115.609 168.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -130.23 175.67 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 118.987 -2.32 . . . . 1.52 106.942 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.451 ' HG3' ' H ' ' A' ' 20' ' ' SER . 11.6 pt-20 -104.21 157.36 34.2 Favored Pre-proline 0 N--CA 1.431 -1.419 0 O-C-N 118.72 -2.487 . . . . 2.35 116.061 160.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -64.33 -9.1 18.7 Favored 'Trans proline' 0 N--CA 1.434 -2.012 2 CA-C-N 129.141 4.3 . . . . 1.31 114.443 -175.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.451 ' H ' ' HG3' ' A' ' 18' ' ' GLU 0.257 15.0 m -94.42 11.51 30.39 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 123.578 2.899 . . . . 1.71 117.481 171.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.98 138.54 36.07 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.97 -2.331 . . . . 1.69 115.221 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 p -76.07 159.4 30.81 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 114.325 1.231 . . . . 1.33 114.325 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.2 mm -68.13 -36.75 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 127.456 2.302 . . . . 1.32 107.762 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -59.36 -33.45 71.18 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.668 1.729 . . . . 1.62 115.668 165.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -69.6 -39.09 77.48 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.076 -3.515 . . . . 2.13 118.94 171.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.38 -39.8 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 126.346 2.974 . . . . 1.23 113.329 167.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -63.3 -37.59 87.86 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 116.251 -4.031 . . . . 1.97 112.459 -176.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.49 -19.04 63.74 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 128.284 2.634 . . . . 1.19 112.63 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -84.79 -30.91 24.22 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 117.66 -3.15 . . . . 1.92 110.365 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.4 mt -73.65 -35.84 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 123.831 1.777 . . . . 1.94 109.479 172.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -56.4 -50.76 70.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.547 -3.846 . . . . 1.9 111.397 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -53.89 -42.63 68.87 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 128.98 2.912 . . . . 1.55 112.144 174.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -83.2 -60.04 2.27 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.921 -2.987 . . . . 2.95 111.854 -174.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -97.66 -16.81 19.81 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 122.349 2.34 . . . . 1.48 112.243 -169.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.78 30.19 24.42 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 108.087 -2.005 . . . . 1.12 108.087 171.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.6 mt -102.23 133.7 20.46 Favored Pre-proline 0 N--CA 1.431 -1.401 0 N-CA-C 104.838 -2.282 . . . . 2.07 104.838 -174.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -76.07 161.87 35.09 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 O-C-N 115.105 -3.156 . . . . 1.39 114.21 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -70.76 -25.2 24.23 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 C-N-CA 122.867 2.378 . . . . 1.68 114.559 -170.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -74.03 -26.45 60.42 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.439 1.59 . . . . 2.25 112.247 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -84.31 -12.03 55.34 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.371 -1.456 . . . . 2.44 113.684 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -91.01 122.22 33.48 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 122.178 0.989 . . . . 1.32 110.849 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -101.06 102.64 13.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.603 1.192 . . . . 3.19 112.152 166.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.0 mt -84.73 125.43 32.54 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 115.925 1.824 . . . . 1.75 115.925 171.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.61 125.48 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 127.979 2.512 . . . . 1.98 108.461 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -132.52 126.9 33.97 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.96 -1.088 . . . . 1.94 110.572 173.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.21 -40.19 0.24 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.264 2.626 . . . . 1.67 116.56 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.44 -7.46 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.668 0 C-N-CA 128.812 3.101 . . . . 1.3 111.286 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -94.34 132.37 39.01 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 126.42 1.888 . . . . 2.89 110.82 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -87.75 148.24 24.82 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 107.347 -1.353 . . . . 2.89 107.347 172.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.35 6.9 mt -107.26 120.65 42.71 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.916 2.886 . . . . 1.34 110.41 -159.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -88.32 136.95 32.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 129.027 3.954 . . . . 1.94 111.912 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -57.47 -59.94 4.4 Favored 'General case' 0 N--CA 1.431 -1.422 2 C-N-CA 134.983 5.313 . . . . 1.56 116.131 -168.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.11 29.11 2.81 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 119.687 -1.883 . . . . 0.97 115.998 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -105.47 156.12 18.51 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.283 -2.304 . . . . 3.07 108.489 165.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.3 p -93.05 170.35 9.72 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 119.918 -1.738 . . . . 1.34 109.267 172.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.0 mt -56.94 -41.49 78.34 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.711 2.805 . . . . 1.63 115.337 167.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.9 t -64.6 -32.15 73.68 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 128.504 2.722 . . . . 1.51 115.289 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -81.88 -21.02 37.69 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.378 2.671 . . . . 1.9 112.27 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -98.01 -11.96 22.44 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.595 -1.261 . . . . 0.97 107.595 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 67.63 42.92 1.95 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 128.122 3.82 . . . . 2.35 111.242 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.9 mt -89.75 114.05 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 126.836 3.208 . . . . 1.39 113.627 172.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -101.84 -165.93 1.24 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.524 -1.985 . . . . 2.58 105.777 -172.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.473 ' HG3' ' HG2' ' A' ' 64' ' ' GLU . 16.0 pttp -73.47 166.06 23.92 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 118.742 2.867 . . . . 2.58 118.742 178.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.473 ' HG2' ' HG3' ' A' ' 63' ' ' LYS 0.554 13.5 pt-20 63.53 18.07 10.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.758 -2.464 . . . . 1.71 115.976 176.295 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.7 p -90.82 151.14 21.29 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.735 -1.575 . . . . 1.34 109.36 -175.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.0 m -118.74 92.84 3.91 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.465 1.602 . . . . 1.36 112.249 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.0 mt -75.0 136.79 41.25 Favored 'General case' 0 N--CA 1.43 -1.475 1 C-N-CA 132.851 4.46 . . . . 2.03 109.473 174.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -107.04 132.06 53.38 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.469 -2.019 . . . . 2.31 111.562 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.4 tp -113.15 112.54 23.97 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 128.273 3.892 . . . . 1.72 106.831 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.3 t -107.66 146.15 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 129.256 3.022 . . . . 1.8 105.357 174.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -88.29 127.84 35.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.12 -1.807 . . . . 3.26 106.12 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -73.69 110.2 7.79 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 126.958 2.103 . . . . 4.12 112.95 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.4 mt -87.52 164.0 16.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.116 1.913 . . . . 3.54 114.99 173.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -70.0 103.09 2.16 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 111.907 -2.406 . . . . 7.32 116.771 172.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 150.51 -115.79 0.73 Allowed Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 116.271 1.269 . . . . 3.73 116.271 -166.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.793 0 CA-C-O 126.416 3.231 . . . . 3.87 109.949 -179.498 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 CA--C 1.49 -1.329 0 N-CA-C 114.211 1.189 . . . . 1.39 114.211 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.385 2.4 mp0 -94.27 130.89 40.37 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 116.518 -1.706 . . . . 2.2 113.96 -174.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.2 pt -123.35 159.61 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 119.266 0.939 . . . . 1.32 110.828 172.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -111.75 135.73 51.96 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.527 -2.608 . . . . 2.2 112.688 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.01 125.11 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 119.509 -1.994 . . . . 1.23 106.308 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -102.9 148.55 25.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.105 2.128 . . . . 2.51 112.916 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.261 6.4 p -98.55 159.05 15.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 125.377 1.673 . . . . 1.41 114.546 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.1 mt -49.82 -38.63 35.56 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.543 -2.598 . . . . 2.95 117.619 171.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.0 p -83.63 -12.33 56.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.481 2.562 . . . . 2.52 112.313 -171.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.42 7.09 26.7 Favored Glycine 0 N--CA 1.43 -1.754 0 CA-C-N 112.426 -2.17 . . . . 1.5 116.722 174.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.419 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 73.8 tttt -80.46 144.18 32.79 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 123.205 3.502 . . . . 1.79 109.053 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.9 m -125.94 94.44 4.11 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 106.982 -1.488 . . . . 1.38 106.982 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.4 4.4 pt -76.53 142.41 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 128.374 2.67 . . . . 2.03 112.427 174.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -108.32 129.7 55.22 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.545 -2.391 . . . . 1.61 104.545 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.8 mt -117.0 165.11 13.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 126.425 2.328 . . . . 2.15 107.307 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.296 66.1 tt0 -116.1 121.54 42.46 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.519 -2.613 . . . . 1.98 106.352 178.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.423 HG13 ' HE3' ' A' ' 29' ' ' LYS . 21.8 m -132.34 168.83 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 116.516 -1.707 . . . . 1.52 115.396 176.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -116.54 160.04 37.84 Favored Pre-proline 0 N--CA 1.43 -1.448 0 O-C-N 127.56 3.037 . . . . 2.35 107.21 167.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -65.42 -25.78 55.82 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 123.714 2.943 . . . . 1.31 112.62 -177.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 m -81.75 3.93 23.87 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 117.361 2.356 . . . . 1.71 117.361 172.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.58 137.56 40.87 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.543 -1.973 . . . . 1.69 109.673 173.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 p -73.92 157.3 36.52 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.96 -2.962 . . . . 1.33 112.523 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.7 mm -56.45 -32.66 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 123.984 1.849 . . . . 1.32 114.493 170.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -59.28 -44.1 92.48 Favored 'General case' 0 N--CA 1.43 -1.469 1 O-C-N 115.718 -4.364 . . . . 1.62 110.399 165.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -66.66 -32.09 73.18 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 116.978 -3.576 . . . . 2.13 110.344 175.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.4 t -66.09 -51.25 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 121.125 1.784 . . . . 1.23 107.811 175.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -59.4 -33.26 71.0 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.118 -3.489 . . . . 1.97 112.076 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.33 -19.31 65.9 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 116.648 2.092 . . . . 1.19 116.648 171.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HE3' HG13 ' A' ' 17' ' ' VAL . 39.8 mttm -85.2 -18.81 32.95 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 123.488 2.858 . . . . 1.92 107.155 176.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.9 mt -87.46 -24.43 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 108.129 -1.063 . . . . 1.94 108.129 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -65.66 -44.05 87.47 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.464 2.764 . . . . 1.9 118.464 166.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -60.13 -62.2 2.04 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 113.701 -1.59 . . . . 1.55 110.37 168.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -69.58 -63.99 0.97 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.62 2.082 . . . . 2.95 116.62 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.419 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 56.4 mm-40 -87.41 -33.38 19.11 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.613 2.149 . . . . 1.48 114.944 -170.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.68 34.18 2.11 Favored Glycine 0 N--CA 1.43 -1.743 0 O-C-N 118.767 -2.458 . . . . 1.12 113.744 169.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.2 mt -108.8 123.11 38.05 Favored Pre-proline 0 N--CA 1.431 -1.424 0 O-C-N 119.884 -1.95 . . . . 2.07 105.786 -170.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -68.63 145.42 63.74 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 114.746 -3.344 . . . . 1.39 112.711 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.254 18.0 Cg_exo -66.18 -28.1 48.42 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 124.474 3.449 . . . . 1.68 117.295 -171.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.254 8.8 p-10 -56.94 -31.99 65.53 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.307 -3.995 . . . . 2.25 116.091 168.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -78.13 -25.38 47.36 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.725 2.01 . . . . 2.44 113.182 -176.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -90.91 147.9 22.82 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.767 1.627 . . . . 1.32 112.614 -173.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.272 91.8 mtt180 -122.71 146.75 47.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.982 -1.699 . . . . 3.19 108.131 162.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.0 mt -121.7 114.74 21.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.965 -1.71 . . . . 1.75 111.002 172.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.9 mt -104.22 116.2 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 117.771 -1.109 . . . . 1.98 111.312 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -112.9 131.79 55.58 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.009 -1.849 . . . . 1.94 106.009 170.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 82.48 -43.29 0.13 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.064 1.346 . . . . 1.67 111.189 172.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.28 -5.63 0.18 Allowed Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 114.423 -3.431 . . . . 1.3 107.05 -173.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -123.82 143.71 50.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 121.762 2.781 . . . . 2.89 113.258 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -69.17 138.85 54.46 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.026 -2.921 . . . . 2.89 115.407 173.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.7 mt -98.87 122.39 42.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.32 2.009 . . . . 1.34 105.848 -175.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -71.6 120.63 17.46 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 123.852 1.786 . . . . 1.94 115.111 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -44.78 -53.78 7.04 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.999 2.519 . . . . 1.56 114.536 -171.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.05 39.67 1.85 Allowed Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 118.471 2.149 . . . . 0.97 118.471 173.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -124.94 167.95 13.97 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 116.664 -3.844 . . . . 3.07 106.601 168.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.6 p -97.03 175.64 6.25 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.916 1.821 . . . . 1.34 115.916 169.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.5 mt -73.16 -22.65 60.46 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 127.037 3.303 . . . . 1.63 110.161 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -78.21 -41.33 34.8 Favored 'General case' 0 N--CA 1.43 -1.453 2 C-N-CA 133.464 4.706 . . . . 1.51 116.346 175.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -63.16 -32.68 74.12 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.801 1.762 . . . . 1.9 111.516 168.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -92.93 -0.45 57.22 Favored 'General case' 0 N--CA 1.431 -1.398 1 O-C-N 116.063 -4.148 . . . . 0.97 112.884 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 48.43 53.87 11.33 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.49 2.033 . . . . 2.35 116.49 -174.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.5 mt -97.06 129.42 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 129.155 2.982 . . . . 1.39 108.377 175.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -103.29 -167.97 1.45 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 115.536 1.68 . . . . 2.58 115.536 -172.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -55.63 139.53 44.21 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.022 1.119 . . . . 2.58 114.022 160.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.279 93.0 mt-10 60.0 52.22 5.35 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 120.097 3.369 . . . . 1.71 120.097 173.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.1 p -103.53 135.28 45.42 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.531 3.532 . . . . 1.34 109.399 -175.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 m -96.54 107.42 19.84 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 104.816 -2.29 . . . . 1.36 104.816 -176.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.0 mt -93.99 145.94 24.29 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 126.623 3.106 . . . . 2.03 104.122 170.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -111.15 118.93 37.33 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 112.996 -1.911 . . . . 2.31 107.766 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.0 tp -86.09 118.43 25.56 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.252 1.501 . . . . 1.72 109.003 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.13 129.74 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 124.862 2.267 . . . . 1.8 107.781 172.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.3 mt -104.94 149.76 25.46 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 113.831 -5.543 . . . . 3.26 109.105 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -75.54 165.37 25.2 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 117.298 -1.761 . . . . 4.12 109.835 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.9 mt -73.89 145.51 44.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.223 2.916 . . . . 3.54 112.682 168.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -83.32 -158.44 0.29 Allowed 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.715 -2.491 . . . . 7.32 117.362 170.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.57 77.79 0.49 Allowed Glycine 0 N--CA 1.431 -1.696 0 O-C-N 120.774 -1.204 . . . . 3.73 112.077 -168.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.818 0 O-C-N 119.522 -2.163 . . . . 3.87 115.343 178.226 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.342 0 N-CA-C 117.298 2.333 . . . . 1.39 117.298 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -93.19 115.39 28.01 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 119.991 3.33 . . . . 2.2 119.991 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.9 pt -113.17 163.09 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-N 122.904 2.593 . . . . 1.32 109.842 173.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.298 79.6 m-85 -121.01 134.22 55.29 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.07 -1.456 . . . . 2.2 107.07 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.2 t -119.16 130.24 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 119.578 -1.951 . . . . 1.23 110.021 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -95.26 119.8 34.4 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.646 3.178 . . . . 2.51 106.511 -173.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -86.84 -173.71 4.6 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 115.914 -1.993 . . . . 1.41 108.204 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.7 mt -87.01 -29.27 22.1 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.423 2.689 . . . . 2.95 108.901 173.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -77.52 -7.71 56.69 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.618 2.451 . . . . 2.52 117.618 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.28 5.56 37.25 Favored Glycine 0 N--CA 1.43 -1.745 0 CA-C-O 124.183 1.991 . . . . 1.5 112.578 174.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.598 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 38.4 ttpt -96.22 144.63 26.25 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.968 -2.489 . . . . 1.79 110.605 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -106.22 115.54 30.4 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 106.025 -1.843 . . . . 1.38 106.025 173.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -91.6 126.45 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 125.753 2.692 . . . . 2.03 107.606 173.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.5 m -96.94 113.59 25.14 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 116.536 -3.853 . . . . 1.61 111.051 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.0 mt -120.29 154.42 34.99 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 114.208 1.188 . . . . 2.15 114.208 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.477 ' O ' ' HE3' ' A' ' 29' ' ' LYS . 29.7 mt-10 -109.72 145.22 36.95 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.646 -0.872 . . . . 1.98 108.646 172.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -152.22 156.31 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 126.17 1.788 . . . . 1.52 108.874 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -95.51 154.13 39.35 Favored Pre-proline 0 N--CA 1.43 -1.465 0 CA-C-O 114.364 -2.732 . . . . 2.35 108.561 171.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.426 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 57.5 Cg_endo -74.31 -11.87 22.93 Favored 'Trans proline' 0 N--CA 1.433 -2.03 0 CA-C-N 126.902 3.501 . . . . 1.31 112.218 -172.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -78.96 4.78 13.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.946 2.499 . . . . 1.71 112.596 173.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -93.56 151.76 19.48 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 126.957 2.103 . . . . 1.69 115.584 173.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.5 p -82.55 161.07 22.43 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.24 -2.788 . . . . 1.33 115.933 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mm -60.8 -34.82 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.079 -2.888 . . . . 1.32 115.387 170.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -48.27 -36.29 13.78 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 120.402 3.482 . . . . 1.62 120.402 158.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -62.0 -33.37 74.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.715 -2.491 . . . . 2.13 113.955 175.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.91 -41.25 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 127.159 2.183 . . . . 1.23 112.752 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -67.54 -34.23 76.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 113.878 -1.51 . . . . 1.97 112.32 174.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.6 -41.32 98.34 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.773 -1.829 . . . . 1.19 115.814 170.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HE3' ' O ' ' A' ' 16' ' ' GLU . 58.9 mttm -62.59 -38.26 89.46 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.1 -2.25 . . . . 1.92 114.367 168.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.41 92.7 mt -62.23 -35.52 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-O 126.888 3.233 . . . . 1.94 113.836 174.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -66.56 -31.54 72.31 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.23 -2.169 . . . . 1.9 115.057 174.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -73.22 -53.78 10.07 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.236 -1.024 . . . . 1.55 108.236 171.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -65.41 -50.23 66.25 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.917 1.451 . . . . 2.95 114.917 -174.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.598 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 37.0 mm-40 -108.19 -48.95 3.27 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 126.269 1.828 . . . . 1.48 113.405 -172.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.27 16.66 3.83 Favored Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 119.445 -1.36 . . . . 1.12 114.863 175.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.422 HG22 HD22 ' A' ' 71' ' ' LEU . 3.5 mt -88.88 131.01 42.7 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 115.495 -2.193 . . . . 2.07 110.052 -174.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -69.21 161.68 44.85 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 CA-C-N 126.453 3.34 . . . . 1.39 117.924 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.96 -1.86 8.78 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 CA-C-N 122.574 1.955 . . . . 1.68 113.287 -167.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -84.47 -26.27 28.32 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 116.137 -4.102 . . . . 2.25 111.998 176.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -83.92 -34.49 24.48 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.676 -2.515 . . . . 2.44 111.006 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -76.42 121.0 22.43 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 117.8 2.519 . . . . 1.32 117.8 -175.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.6 mtt85 -103.0 164.51 11.57 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 125.574 1.796 . . . . 3.19 106.365 167.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.1 mp -129.85 134.02 47.28 Favored 'General case' 0 CA--C 1.489 -1.387 0 O-C-N 117.636 -3.165 . . . . 1.75 112.026 170.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.2 mt -125.21 124.92 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 CA-C-O 128.564 4.03 . . . . 1.98 109.524 177.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -127.99 139.74 52.39 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 115.379 -4.576 . . . . 1.94 107.072 171.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.302 . . 52.35 25.83 3.71 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.632 2.773 . . . . 1.67 115.764 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.99 13.1 72.62 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-O 114.17 -3.572 . . . . 1.3 110.906 -176.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -125.17 129.66 50.58 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.639 2.22 . . . . 2.89 105.211 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.288 16.7 tt0 -83.33 125.56 31.77 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.153 2.981 . . . . 2.89 111.022 173.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.4 mt -79.26 164.47 24.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.294 -1.775 . . . . 1.34 112.58 -167.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -95.3 153.36 17.71 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.622 -1.992 . . . . 1.94 105.622 175.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -79.76 -50.69 10.19 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.665 -1.272 . . . . 1.56 111.943 -167.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.62 60.23 3.62 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 120.562 2.985 . . . . 0.97 120.562 171.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -126.19 166.96 16.1 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 104.86 -2.274 . . . . 3.07 104.86 165.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.3 p -97.8 162.0 13.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.872 -2.64 . . . . 1.34 103.872 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 5.0 mt -63.99 -27.94 69.47 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 112.762 -2.017 . . . . 1.63 115.794 174.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.9 t -59.89 -45.78 91.44 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.817 2.447 . . . . 1.51 109.001 176.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -55.46 -31.93 62.36 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.867 -2.396 . . . . 1.9 116.257 175.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -85.2 -0.42 54.56 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.195 1.798 . . . . 0.97 112.029 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.289 18.7 m120 49.26 50.91 17.25 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.935 -3.603 . . . . 2.35 115.512 -171.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.274 83.7 mt -93.38 125.02 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 127.545 2.338 . . . . 1.39 105.308 -173.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -105.77 -175.96 2.94 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.556 3.142 . . . . 2.58 107.411 -172.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -72.21 159.31 34.31 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.417 -1.427 . . . . 2.58 110.141 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 59.53 48.53 9.58 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.685 1.994 . . . . 1.71 112.828 174.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.6 m -111.85 137.57 49.63 Favored 'General case' 0 N--CA 1.429 -1.476 1 N-CA-C 99.314 -4.328 . . . . 1.34 99.314 -169.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.6 m -102.53 108.51 19.84 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.608 1.963 . . . . 1.36 109.861 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.8 mt -105.01 148.77 26.38 Favored 'General case' 0 CA--C 1.489 -1.39 0 CA-C-O 123.559 1.647 . . . . 2.03 113.897 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -102.39 132.35 48.45 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.204 -3.435 . . . . 2.31 109.764 -173.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.1 tp -91.66 119.36 31.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.224 -2.797 . . . . 1.72 109.507 175.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.21 137.26 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 O-C-N 118.11 -2.869 . . . . 1.8 107.041 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.422 HD22 HG22 ' A' ' 36' ' ' ILE . 96.8 mt -119.97 -165.51 1.18 Allowed 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 116.804 -1.958 . . . . 3.26 110.769 172.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.4 mmt-85 -90.98 -67.05 0.88 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.744 2.688 . . . . 4.12 105.294 170.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.6 mt -125.08 156.32 38.43 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.571 -1.956 . . . . 3.54 111.22 172.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -78.04 157.93 29.4 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.306 2.642 . . . . 7.32 108.286 171.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.15 -121.49 1.69 Allowed Glycine 0 N--CA 1.429 -1.795 0 O-C-N 118.028 -2.92 . . . . 3.73 109.296 -171.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.745 0 O-C-N 120.075 -1.838 . . . . 3.87 117.628 -179.558 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 115.436 1.643 . . . . 1.39 115.436 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -83.83 148.04 27.22 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 114.806 -2.521 . . . . 2.2 109.561 -176.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -142.43 168.43 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 1 O-C-N 130.8 5.062 . . . . 1.32 107.97 170.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -117.88 156.68 28.01 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 114.455 1.28 . . . . 2.2 114.455 171.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.9 t -134.36 128.04 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 101.381 -3.563 . . . . 1.23 101.381 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -98.92 106.88 19.19 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.905 2.187 . . . . 2.51 116.905 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.262 4.8 p -58.13 165.43 1.93 Allowed 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 125.508 1.523 . . . . 1.41 112.571 176.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.3 94.7 mt -60.18 -54.89 40.42 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 130.867 3.667 . . . . 2.95 110.995 176.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 p -76.8 -12.23 59.95 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 117.84 -3.038 . . . . 2.52 113.264 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.65 2.21 5.36 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 122.285 2.311 . . . . 1.5 113.448 166.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -77.02 143.23 39.49 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 116.241 -4.093 . . . . 1.79 114.027 -175.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.0 m -85.44 125.92 33.39 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.144 0.977 . . . . 1.38 112.446 166.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.3 mt -100.51 112.89 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 104.999 -2.223 . . . . 2.03 104.999 171.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 m -87.99 145.49 25.98 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 116.031 -2.267 . . . . 1.61 108.479 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.3 mt -141.17 174.89 10.1 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 120.427 1.467 . . . . 2.15 109.308 175.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -126.18 119.66 28.08 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.682 1.993 . . . . 1.98 110.288 167.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 m -121.19 153.49 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 126.447 1.899 . . . . 1.52 110.702 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.278 17.7 mm-40 -101.84 175.84 2.13 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-N 125.2 3.636 . . . . 2.35 110.957 155.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -74.76 -20.17 17.74 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 121.23 1.475 . . . . 1.31 110.106 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.8 m -76.21 -8.93 58.13 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 120.328 3.455 . . . . 1.71 120.328 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -80.45 142.5 34.23 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 116.772 -3.705 . . . . 1.69 110.198 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 38.4 p -82.99 179.98 7.61 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 123.275 1.512 . . . . 1.33 111.703 -176.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.9 mm -82.62 -31.12 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 116.657 -3.777 . . . . 1.32 109.201 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -63.41 -28.76 70.2 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.18 -2.2 . . . . 1.62 115.404 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -66.71 -46.08 76.67 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.005 1.722 . . . . 2.13 113.414 172.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.2 t -62.67 -42.11 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 119.148 -2.22 . . . . 1.23 109.554 176.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -71.46 -8.31 53.06 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 118.222 2.675 . . . . 1.97 118.222 169.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.03 -39.76 19.22 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.369 1.08 . . . . 1.19 112.828 169.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -59.24 -40.84 87.18 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.324 1.85 . . . . 1.92 111.186 174.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.7 mt -74.67 -26.35 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 115.588 1.699 . . . . 1.94 115.588 170.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -62.18 -39.23 92.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.481 -2.012 . . . . 1.9 113.49 167.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -55.8 -47.66 76.74 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 116.277 1.955 . . . . 1.55 116.277 165.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -90.06 -51.42 5.47 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 115.735 1.754 . . . . 2.95 115.735 -167.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -98.54 -39.44 8.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 106.038 -1.838 . . . . 1.48 106.038 -171.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.47 18.16 6.29 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 120.933 3.133 . . . . 1.12 120.933 174.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.2 mt -103.71 120.75 50.47 Favored Pre-proline 0 N--CA 1.43 -1.437 1 C-N-CA 134.775 5.23 . . . . 2.07 108.374 -163.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -57.28 137.17 80.43 Favored 'Trans proline' 0 C--N 1.299 -2.052 2 C-N-CA 125.726 4.284 . . . . 1.39 116.749 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -67.59 -12.58 36.12 Favored 'Trans proline' 0 N--CA 1.434 -2.027 0 CA-C-N 127.978 3.885 . . . . 1.68 120.197 -172.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -78.41 -16.1 57.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.633 1.973 . . . . 2.25 112.483 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -92.01 -37.41 12.84 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.407 -2.058 . . . . 2.44 110.979 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -69.47 126.99 31.43 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.68 2.392 . . . . 1.32 112.051 -171.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.447 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 29.9 mtt180 -103.99 126.73 51.33 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 120.303 -1.498 . . . . 3.19 110.952 158.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.0 mt -104.84 118.12 35.75 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.356 -2.715 . . . . 1.75 106.427 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 49' ' ' GLN . 18.5 mm -112.8 141.44 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.669 1.988 . . . . 1.98 105.831 -174.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -154.8 124.26 6.45 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.535 -1.654 . . . . 1.94 106.535 169.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.47 37.83 2.55 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 126.703 2.502 . . . . 1.67 110.383 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.13 -23.51 4.5 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 118.031 -2.033 . . . . 1.3 116.131 -175.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -87.23 142.07 28.17 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.554 -1.556 . . . . 2.89 114.831 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.409 ' HA ' HD12 ' A' ' 44' ' ' ILE . 35.0 tt0 -87.0 135.03 33.42 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.354 -2.716 . . . . 2.89 108.864 172.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.6 mt -93.09 128.77 39.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.887 -1.133 . . . . 1.34 112.54 -175.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -84.32 132.01 34.65 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 117.604 2.446 . . . . 1.94 117.604 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -40.53 -67.93 0.21 Allowed 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 121.22 3.785 . . . . 1.56 121.22 -165.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.25 58.03 5.05 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 118.011 1.964 . . . . 0.97 118.011 171.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -129.09 157.85 40.6 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 103.562 -2.755 . . . . 3.07 103.562 168.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 68.2 p -98.92 167.51 10.7 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.955 -1.716 . . . . 1.34 113.603 175.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.87 -24.81 66.94 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.993 -1.692 . . . . 1.63 115.305 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.5 t -69.4 -39.7 77.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.586 1.954 . . . . 1.51 109.654 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -55.28 -40.01 70.53 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 115.446 1.647 . . . . 1.9 115.446 171.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -88.67 -2.03 58.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.046 1.738 . . . . 0.97 113.296 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 59.08 50.75 7.77 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 123.14 1.448 . . . . 2.35 110.853 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.7 mm -85.97 126.66 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-O 125.687 2.66 . . . . 1.39 105.699 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -91.92 174.21 7.45 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.572 -2.58 . . . . 2.58 113.476 -176.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.3 pttt -70.13 147.02 50.43 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.164 1.459 . . . . 2.58 113.65 173.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.322 41.1 mt-10 61.97 35.58 16.08 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 119.139 -2.225 . . . . 1.71 114.674 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 t -102.62 149.42 24.45 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 124.326 1.05 . . . . 1.34 110.505 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.5 m -96.95 110.68 23.16 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.058 2.543 . . . . 1.36 113.031 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.8 mt -90.03 153.13 20.8 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 118.065 -1.454 . . . . 2.03 109.966 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -104.19 123.82 48.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.125 1.44 . . . . 2.31 112.599 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.1 tp -94.46 128.79 41.25 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.126 -4.109 . . . . 1.72 108.282 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 89.0 t -120.87 154.21 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 102.239 -3.245 . . . . 1.8 102.239 172.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.0 mt -130.53 155.7 46.05 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 120.594 -1.316 . . . . 3.26 108.587 -175.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.4 ttp180 -70.8 -48.84 52.08 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 130.386 3.474 . . . . 4.12 110.34 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 55.7 mt -90.56 160.39 15.97 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.535 1.636 . . . . 3.54 110.967 170.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.329 1.0 OUTLIER -90.61 -40.97 11.61 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 116.545 -3.847 . . . . 7.32 113.08 169.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.17 -59.28 1.39 Allowed Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 125.891 1.71 . . . . 3.73 111.219 -163.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.744 1 CA-C-O 112.0 -4.778 . . . . 3.87 112.951 175.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 CA--C 1.491 -1.324 0 CA-C-O 118.376 -0.821 . . . . 1.39 112.089 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -99.27 126.98 45.21 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.727 0.775 . . . . 2.2 111.232 -176.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.6 pt -114.69 164.45 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 105.663 -1.977 . . . . 1.32 105.663 173.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -119.2 135.01 54.88 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 105.26 -2.126 . . . . 2.2 105.26 -175.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.5 t -117.79 118.22 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 102.98 -2.97 . . . . 1.23 102.98 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -108.98 135.92 49.36 Favored 'General case' 0 N--CA 1.429 -1.485 2 O-C-N 115.639 -4.413 . . . . 2.51 108.05 175.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.1 p -87.32 -177.05 5.86 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 125.119 2.39 . . . . 1.41 115.752 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.78 -30.31 64.0 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 124.733 2.206 . . . . 2.95 114.794 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p -77.94 -51.04 11.02 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 114.549 -5.094 . . . . 2.52 110.526 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.61 35.68 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.748 0 O-C-N 118.552 -2.593 . . . . 1.5 111.777 173.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -102.42 108.46 19.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.931 -2.248 . . . . 1.79 104.931 -170.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.9 m -83.7 114.9 21.9 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.535 2.734 . . . . 1.38 106.694 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.4 mt -101.54 146.43 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 100.522 -3.881 . . . . 2.03 100.522 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.7 m -118.21 130.82 56.3 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.851 2.739 . . . . 1.61 103.853 174.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.3 mt -125.75 139.98 53.07 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 113.275 -1.784 . . . . 2.15 108.283 -177.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.27 48.0 mt-10 -103.32 129.91 50.47 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 123.929 1.823 . . . . 1.98 111.341 170.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 m -137.31 166.22 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 113.929 -1.487 . . . . 1.52 110.669 -169.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -105.55 167.23 10.03 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 119.25 -2.156 . . . . 2.35 109.679 161.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -70.89 -13.1 31.6 Favored 'Trans proline' 0 N--CA 1.434 -1.99 0 N-CA-C 118.999 2.653 . . . . 1.31 118.999 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.8 p -93.11 4.22 54.38 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.499 1.92 . . . . 1.71 115.5 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -80.2 144.27 33.09 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 126.378 2.99 . . . . 1.69 111.929 170.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.3 p -80.27 158.62 26.12 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 128.335 2.654 . . . . 1.33 108.108 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.452 ' HA ' HD13 ' A' ' 23' ' ' ILE . 26.6 mm -64.99 -36.75 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 103.031 -2.951 . . . . 1.32 103.031 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -55.16 -46.26 75.73 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.353 -3.342 . . . . 1.62 117.259 170.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -64.28 -37.98 89.43 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 115.785 1.772 . . . . 2.13 115.785 171.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.5 t -53.2 -44.55 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 118.418 -2.676 . . . . 1.23 114.684 167.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 34.0 mtpt -62.56 -46.63 87.48 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.318 -1.489 . . . . 1.97 114.57 173.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.1 -37.4 69.32 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.782 1.633 . . . . 1.19 112.281 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -68.37 -31.2 70.4 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 117.052 -1.451 . . . . 1.92 112.865 173.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.1 mt -68.68 -41.69 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 120.153 1.342 . . . . 1.94 108.337 173.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -53.57 -45.47 69.93 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 117.575 -3.203 . . . . 1.9 114.148 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.27 20.9 t70 -55.49 -68.06 0.23 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.074 -1.642 . . . . 1.55 109.761 167.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -59.82 -55.4 34.68 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 119.436 3.124 . . . . 2.95 119.436 -173.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -95.03 -51.23 4.74 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.092 2.557 . . . . 1.48 113.449 -169.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.56 24.7 2.81 Favored Glycine 0 N--CA 1.43 -1.733 0 CA-C-O 116.942 -2.032 . . . . 1.12 115.771 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.9 mm -103.62 135.12 19.42 Favored Pre-proline 0 N--CA 1.429 -1.484 0 CA-C-N 121.63 2.715 . . . . 2.07 108.777 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -67.48 137.64 43.53 Favored 'Trans proline' 0 C--N 1.3 -1.998 3 C-N-CA 126.452 4.768 . . . . 1.39 115.355 178.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -59.14 -21.13 57.93 Favored 'Trans proline' 0 C--N 1.299 -2.047 1 C-N-CA 129.349 6.699 . . . . 1.68 111.461 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -62.59 -39.11 92.68 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 126.299 2.952 . . . . 2.25 114.292 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -77.75 -30.68 51.66 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 114.613 -5.054 . . . . 2.44 110.026 -173.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -79.44 151.02 31.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.703 -1.248 . . . . 1.32 112.495 -164.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -139.82 156.09 46.92 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 106.341 -1.725 . . . . 3.19 106.341 168.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.461 HD21 ' HA ' ' A' ' 69' ' ' LEU . 42.1 mt -136.59 126.43 25.74 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 118.86 0.754 . . . . 1.75 111.322 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.8 mm -104.62 145.93 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 O-C-N 126.471 2.357 . . . . 1.98 106.257 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -134.42 126.45 29.55 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 116.893 -3.629 . . . . 1.94 102.288 165.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.22 -55.9 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.45 1 C-N-CA 135.027 5.331 . . . . 1.67 118.945 -175.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.85 -16.8 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.723 0 O-C-N 120.132 -1.605 . . . . 1.3 113.757 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -95.29 162.36 13.71 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.542 1.537 . . . . 2.89 111.063 -178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -116.58 126.33 53.13 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.623 1.569 . . . . 2.89 107.139 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.445 HD13 HD11 ' A' ' 23' ' ' ILE . 20.3 mt -90.42 132.3 35.7 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 125.706 1.879 . . . . 1.34 108.748 -162.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -60.12 143.76 51.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.181 -2.825 . . . . 1.94 113.074 172.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -70.21 -43.21 71.14 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 112.899 -6.126 . . . . 1.56 113.92 -169.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.62 53.25 1.29 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 125.949 2.971 . . . . 0.97 109.718 174.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.5 mtt-85 -120.87 155.21 34.64 Favored 'General case' 0 N--CA 1.43 -1.468 1 N-CA-C 100.069 -4.049 . . . . 3.07 100.069 165.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.4 p -90.56 167.41 12.58 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 124.68 1.237 . . . . 1.34 113.346 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 mt -65.22 -42.93 92.97 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 127.299 2.874 . . . . 1.63 112.735 169.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.2 t -59.0 -40.11 83.91 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 120.041 1.291 . . . . 1.51 114.34 175.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.1 -40.96 95.71 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.726 2.121 . . . . 1.9 116.726 175.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -79.04 -10.1 59.73 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.77 1.294 . . . . 0.97 113.661 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.9 m120 68.33 40.19 2.11 Favored 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 135.507 5.523 . . . . 2.35 114.661 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.9 mt -72.33 139.6 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 127.328 2.251 . . . . 1.39 106.974 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -119.21 -178.48 3.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.942 2.306 . . . . 2.58 106.857 -175.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -65.43 147.66 53.04 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.117 2.389 . . . . 2.58 116.125 167.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.272 34.8 mt-10 70.31 21.57 5.73 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.673 1.989 . . . . 1.71 113.852 173.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -92.92 141.15 28.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.621 1.677 . . . . 1.34 108.778 -175.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.2 m -96.22 100.56 12.19 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 129.266 3.026 . . . . 1.36 112.721 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.326 18.6 mt -83.13 150.88 25.99 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 128.421 3.962 . . . . 2.03 103.699 170.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -106.92 98.93 8.53 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 110.365 -3.107 . . . . 2.31 116.919 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.461 ' HA ' HD21 ' A' ' 43' ' ' LEU . 24.9 tp -63.65 116.69 5.91 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 116.914 2.19 . . . . 1.72 116.914 169.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.9 m -131.69 -178.78 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 102.779 -3.045 . . . . 1.8 102.779 175.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.9 mt -118.37 174.41 6.26 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 105.256 -2.127 . . . . 3.26 105.256 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.293 12.4 ptt180 -51.58 -48.7 63.06 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.756 1.762 . . . . 4.12 115.756 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.1 mt -79.57 120.47 23.97 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 129.285 3.034 . . . . 3.54 110.677 173.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -71.09 122.5 20.2 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.86 2.118 . . . . 7.32 106.161 170.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.53 108.85 0.3 Allowed Glycine 0 N--CA 1.429 -1.805 0 O-C-N 120.32 -1.488 . . . . 3.73 110.784 -166.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.755 0 N-CA-C 110.439 -1.064 . . . . 3.87 110.439 176.734 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.344 0 CA-C-O 118.34 -0.838 . . . . 1.39 111.149 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -95.66 131.4 41.94 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 116.302 1.964 . . . . 2.2 116.302 -171.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.9 pt -126.92 165.93 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 115.093 -2.385 . . . . 1.32 111.742 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -125.88 127.68 46.41 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 125.946 2.029 . . . . 2.2 106.321 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.9 t -112.83 111.9 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 CA-C-N 115.503 -0.771 . . . . 1.23 109.633 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -93.63 135.67 34.68 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 116.852 -3.655 . . . . 2.51 111.496 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.3 p -84.2 -167.64 1.84 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.844 -1.785 . . . . 1.41 109.559 173.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.0 mt -91.96 -23.48 19.56 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.107 -2.245 . . . . 2.95 112.226 171.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.1 p -80.96 -47.64 13.38 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.035 1.124 . . . . 2.52 114.035 -173.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.17 25.3 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 116.615 -2.707 . . . . 1.5 111.686 176.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -118.47 124.45 47.64 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.492 -0.929 . . . . 1.79 108.492 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -102.41 118.56 37.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 124.579 1.175 . . . . 1.38 110.231 167.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mt -105.22 129.45 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 127.832 2.453 . . . . 2.03 110.128 -170.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.4 m -99.34 110.06 22.61 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 127.427 2.954 . . . . 1.61 108.318 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.1 mt -121.49 147.07 46.26 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.059 2.838 . . . . 2.15 109.728 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -99.3 125.71 44.99 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.509 -3.869 . . . . 1.98 114.495 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 m -124.9 150.38 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 117.8 -3.063 . . . . 1.52 106.134 -176.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -86.21 140.23 34.49 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 112.907 -3.425 . . . . 2.35 113.018 166.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -77.44 5.14 5.35 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 CA-C-N 126.878 3.492 . . . . 1.31 112.69 -166.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 p -106.17 9.63 32.17 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.939 -2.976 . . . . 1.71 111.841 173.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -91.23 157.26 17.27 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 124.64 2.162 . . . . 1.69 110.253 171.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 26' ' ' VAL . 43.9 p -83.37 165.7 19.04 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.679 -2.513 . . . . 1.33 107.392 -175.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.412 11.3 mm -68.42 -37.49 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 C-N-CA 128.101 2.56 . . . . 1.32 110.51 176.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -56.96 -34.1 67.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 126.789 3.185 . . . . 1.62 115.966 169.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -83.05 -26.42 31.17 Favored 'General case' 0 N--CA 1.432 -1.374 1 O-C-N 111.808 -6.807 . . . . 2.13 113.405 177.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 22' ' ' THR . 44.3 t -52.66 -44.61 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.384 1.873 . . . . 1.23 113.436 165.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.462 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 43.7 mtmt -67.38 -40.28 85.69 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.973 -2.329 . . . . 1.97 111.371 175.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.43 76.58 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.321 2.01 . . . . 1.19 113.808 175.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -64.66 -46.76 81.08 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 118.93 -2.356 . . . . 1.92 116.522 163.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.6 mt -61.51 -26.96 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 117.299 -3.376 . . . . 1.94 114.588 167.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -67.43 -45.47 75.98 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.851 -3.655 . . . . 1.9 109.905 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.26 -36.94 76.43 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 118.796 -2.44 . . . . 1.55 106.338 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -76.02 -55.94 5.13 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 123.585 2.902 . . . . 2.95 113.073 -171.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -112.32 -15.9 13.06 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 126.097 2.123 . . . . 1.48 115.146 -164.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.79 21.2 40.61 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-O 123.048 1.36 . . . . 1.12 115.375 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 mt -101.55 131.98 22.33 Favored Pre-proline 0 N--CA 1.43 -1.467 0 O-C-N 121.013 -1.287 . . . . 2.07 111.059 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -70.47 145.0 51.84 Favored 'Trans proline' 0 C--N 1.3 -2.003 1 C-N-CA 126.302 4.668 . . . . 1.39 115.27 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -72.58 -6.52 19.2 Favored 'Trans proline' 0 N--CA 1.433 -2.03 1 C-N-CA 127.45 5.434 . . . . 1.68 117.21 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.98 -39.45 30.08 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.851 -1.781 . . . . 2.25 108.669 169.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -73.65 -36.46 65.39 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 125.163 1.539 . . . . 2.44 113.422 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.462 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 74.3 mt-30 -74.04 135.06 43.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.322 1.23 . . . . 1.32 114.322 -175.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.481 ' HB3' HG21 ' A' ' 70' ' ' VAL . 43.1 ttt180 -122.13 117.68 26.84 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 114.859 -2.496 . . . . 3.19 107.901 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.1 mt -100.77 125.55 47.26 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 125.291 2.472 . . . . 1.75 105.935 -176.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.1 mt -106.05 142.71 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 1 O-C-N 115.903 -4.248 . . . . 1.98 101.904 176.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -153.8 133.56 13.03 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 127.486 3.517 . . . . 1.94 106.252 172.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.22 -57.99 0.28 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.064 2.546 . . . . 1.67 115.244 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -159.84 -18.59 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 108.616 -1.794 . . . . 1.3 108.616 -173.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -134.88 163.41 29.88 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.317 -3.461 . . . . 2.89 112.223 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.3 pm0 -71.16 152.7 43.14 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 117.81 -1.091 . . . . 2.89 111.885 170.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.2 mt -97.89 172.57 7.57 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.894 2.134 . . . . 1.34 114.538 -171.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -104.68 153.57 21.09 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.037 -2.914 . . . . 1.94 110.591 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -89.47 -52.05 5.23 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.284 -2.76 . . . . 1.56 109.085 -163.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.84 46.1 1.7 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 117.233 1.653 . . . . 0.97 117.233 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.353 17.7 mmt180 -128.22 165.92 19.56 Favored 'General case' 0 CA--C 1.489 -1.38 0 O-C-N 119.499 -2.177 . . . . 3.07 106.643 168.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.288 27.2 p -99.36 170.55 8.56 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.233 1.568 . . . . 1.34 115.233 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.532 ' HA ' HD13 ' A' ' 61' ' ' ILE . 11.3 mt -63.15 -40.32 97.22 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 127.2 2.2 . . . . 1.63 107.926 171.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 m -65.47 -48.85 71.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.634 3.174 . . . . 1.51 110.891 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -52.49 -41.82 63.72 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.427 1.584 . . . . 1.9 114.334 174.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -82.33 -7.23 59.63 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.424 -2.047 . . . . 0.97 114.062 175.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.1 t30 56.44 43.83 25.37 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.414 3.485 . . . . 2.35 112.535 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.532 HD13 ' HA ' ' A' ' 56' ' ' LEU . 62.9 mt -75.59 109.87 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-N 111.927 -2.397 . . . . 1.39 113.1 177.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -82.78 -178.19 7.01 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 120.435 -1.416 . . . . 2.58 107.855 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -66.5 149.3 50.64 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 125.083 1.353 . . . . 2.58 111.075 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 69.09 33.75 3.28 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 131.557 3.943 . . . . 1.71 107.668 168.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m -96.42 139.6 32.29 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 121.507 1.958 . . . . 1.34 111.713 -176.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 m -99.98 115.96 30.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.43 1.468 . . . . 1.36 110.939 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mp -104.47 155.33 18.89 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 112.194 -2.276 . . . . 2.03 106.29 173.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -107.34 122.92 47.55 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.885 3.274 . . . . 2.31 113.666 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.9 tp -101.42 102.09 12.82 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.243 -3.411 . . . . 1.72 106.06 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.481 HG21 ' HB3' ' A' ' 42' ' ' ARG . 10.4 m -111.96 -177.05 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 126.685 2.491 . . . . 1.8 105.686 172.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.373 18.0 mt -128.47 178.38 6.33 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 119.473 -0.891 . . . . 3.26 109.319 -176.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.1 ptm85 -116.04 160.85 19.73 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 102.549 -3.13 . . . . 4.12 102.549 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.5 mt -76.12 168.55 19.84 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.716 -3.115 . . . . 3.54 105.906 172.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -86.1 126.37 34.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.641 1.576 . . . . 7.32 112.637 166.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 135.61 2.69 2.82 Favored Glycine 0 N--CA 1.429 -1.804 0 O-C-N 126.321 2.263 . . . . 3.73 113.601 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.751 0 N-CA-C 107.683 -2.167 . . . . 3.87 107.683 -173.72 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ptt? . . . . . 0 CA--C 1.49 -1.341 0 CA-C-O 124.85 2.262 . . . . 1.39 110.814 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -109.81 123.75 50.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 112.496 -2.138 . . . . 2.2 111.779 -173.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 pp -123.83 162.1 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 129.932 3.293 . . . . 1.32 111.344 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -123.52 136.76 54.74 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 122.782 1.277 . . . . 2.2 107.812 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.4 t -110.34 124.64 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-N 112.053 -2.34 . . . . 1.23 110.346 174.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 mmtt -95.9 117.53 30.77 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.35 1.06 . . . . 2.51 109.617 174.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.2 p -77.65 -177.55 4.87 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.359 2.028 . . . . 1.41 109.556 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.7 tp -58.49 -50.76 72.56 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 114.656 -5.028 . . . . 2.95 116.736 174.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.7 p -68.86 -6.31 26.32 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 111.624 -2.535 . . . . 2.52 114.763 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.17 9.68 44.25 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 117.518 -3.239 . . . . 1.5 110.434 173.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -84.03 126.87 33.47 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 107.503 -1.295 . . . . 1.79 107.503 -171.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 m -93.72 121.71 35.44 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.259 -0.882 . . . . 1.38 112.368 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.0 mt -115.13 126.53 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 107.055 -1.461 . . . . 2.03 107.055 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.8 m -102.36 121.72 42.86 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.604 -1.31 . . . . 1.61 113.529 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.0 mt -115.52 155.13 28.09 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.351 -2.718 . . . . 2.15 110.517 -174.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -110.18 109.32 19.78 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 125.051 1.469 . . . . 1.98 110.306 171.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -123.64 173.41 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 126.192 1.797 . . . . 1.52 109.876 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -115.68 157.27 44.86 Favored Pre-proline 0 N--CA 1.429 -1.494 0 CA-C-O 115.18 -2.343 . . . . 2.35 113.42 166.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.23 2.26 8.7 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 C-N-CA 124.441 3.427 . . . . 1.31 115.472 -176.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.6 p -95.61 -25.71 16.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.086 1.513 . . . . 1.71 115.086 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -69.72 154.8 41.47 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.163 2.985 . . . . 1.69 112.607 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.269 71.7 p -81.77 149.16 28.54 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 112.281 -2.236 . . . . 1.33 112.91 -175.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -52.85 -44.01 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 117.592 -1.194 . . . . 1.32 112.676 171.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -43.39 -50.96 6.72 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.427 2.691 . . . . 1.62 111.501 162.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -66.35 -36.89 84.02 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 115.999 1.851 . . . . 2.13 115.999 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.24 -45.93 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-O 125.901 2.762 . . . . 1.23 113.779 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.2 mtmt -53.24 -31.25 42.5 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.395 -2.066 . . . . 1.97 115.445 166.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.88 -20.64 60.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 120.015 -0.674 . . . . 1.19 112.366 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -70.37 -38.29 74.71 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.98 -2.325 . . . . 1.92 114.428 173.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.6 mt -68.98 -31.95 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 127.085 2.154 . . . . 1.94 111.977 169.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -65.89 -52.85 46.54 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 115.654 -4.404 . . . . 1.9 110.102 174.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -56.77 -47.68 79.56 Favored 'General case' 0 N--CA 1.431 -1.391 1 O-C-N 114.511 -5.118 . . . . 1.55 108.767 170.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -65.99 -63.32 1.11 Allowed 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 123.315 2.779 . . . . 2.95 117.244 -176.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -93.46 -43.61 8.65 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.666 -1.896 . . . . 1.48 111.631 -174.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.05 81.06 1.5 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 125.899 2.944 . . . . 1.12 106.357 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.7 mt -155.78 126.44 3.47 Favored Pre-proline 0 N--CA 1.43 -1.472 1 N-CA-C 99.03 -4.433 . . . . 2.07 99.03 -170.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -70.0 148.7 64.09 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 CA-C-N 122.725 2.009 . . . . 1.39 112.247 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.335 36.2 Cg_endo -67.64 -20.87 46.37 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 CA-C-N 125.994 3.177 . . . . 1.68 115.697 -175.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -63.79 -31.35 72.5 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 129.832 3.253 . . . . 2.25 113.733 175.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -89.06 -16.99 30.23 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 119.532 -1.98 . . . . 2.44 106.934 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -88.37 124.64 34.13 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.117 -4.739 . . . . 1.32 111.621 -176.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -116.72 133.74 55.65 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.537 -0.912 . . . . 3.19 108.537 171.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.4 mt -112.06 125.34 53.99 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 126.23 2.919 . . . . 1.75 108.861 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.6 mt -111.1 145.61 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 127.485 2.314 . . . . 1.98 104.778 176.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -150.71 135.62 17.5 Favored 'General case' 0 N--CA 1.43 -1.448 1 N-CA-C 99.878 -4.119 . . . . 1.94 99.878 178.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.24 47.6 21.97 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.893 2.758 . . . . 1.67 114.02 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.74 -2.34 54.79 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 127.633 2.54 . . . . 1.3 116.017 175.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm -123.75 143.82 50.06 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.524 -2.163 . . . . 2.89 114.249 -174.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -66.37 127.18 31.24 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 111.411 -2.631 . . . . 2.89 114.906 171.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 mt -92.27 119.89 32.3 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 110.258 -3.156 . . . . 1.34 108.389 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -77.38 151.12 34.98 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 117.127 -1.415 . . . . 1.94 113.375 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -72.35 -53.48 12.23 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.932 2.197 . . . . 1.56 116.932 -169.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.73 29.33 0.62 Allowed Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 120.266 2.866 . . . . 0.97 120.266 169.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -118.17 174.98 5.9 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 120.213 2.007 . . . . 3.07 108.327 170.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.4 p -104.08 179.19 4.34 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 126.099 2.856 . . . . 1.34 111.624 175.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.8 mt -71.4 -33.89 69.87 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 116.464 -3.898 . . . . 1.63 113.213 171.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -57.25 -44.83 84.21 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 125.269 2.461 . . . . 1.51 110.159 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -54.95 -33.52 62.4 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.332 -2.73 . . . . 1.9 117.218 176.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -101.05 -2.41 31.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.165 -1.584 . . . . 0.97 109.148 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.257 6.6 m120 64.39 55.17 1.43 Allowed 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 116.825 2.157 . . . . 2.35 116.825 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.5 mt -100.16 132.27 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 110.568 -3.014 . . . . 1.39 107.5 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -115.65 -164.16 0.94 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 123.469 0.707 . . . . 2.58 111.621 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -67.6 153.36 43.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.952 2.501 . . . . 2.58 108.531 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 54.47 26.96 7.67 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.478 2.711 . . . . 1.71 117.089 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.252 47.2 m -94.08 144.85 25.12 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.358 -1.464 . . . . 1.34 109.971 -173.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.4 m -102.41 103.53 13.93 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 126.549 1.94 . . . . 1.36 111.661 -171.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 mt -84.22 160.52 20.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.322 1.849 . . . . 2.03 111.758 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -123.43 123.96 41.83 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.529 -2.607 . . . . 2.31 104.114 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.1 tp -95.63 120.93 36.74 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.295 2.638 . . . . 1.72 109.318 176.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.296 14.1 m -116.94 163.13 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 127.899 2.48 . . . . 1.8 111.425 168.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.3 mt -115.81 134.29 55.15 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 117.48 -1.688 . . . . 3.26 111.914 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -90.34 100.48 13.31 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-O 126.005 2.812 . . . . 4.12 116.593 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.7 mt -117.29 170.97 8.28 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 123.957 1.837 . . . . 3.54 110.343 166.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -85.47 158.67 20.13 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 113.653 -1.612 . . . . 7.32 111.126 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.58 47.96 6.52 Favored Glycine 0 N--CA 1.43 -1.745 0 CA-C-O 116.815 -2.103 . . . . 3.73 116.892 -166.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.767 0 CA-C-N 121.617 2.708 . . . . 3.87 106.502 -177.404 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 tmm? . . . . . 0 CA--C 1.491 -1.299 0 CA-C-O 116.791 -1.576 . . . . 1.39 114.134 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -91.64 115.38 28.0 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.827 2.558 . . . . 2.2 113.149 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.9 pt -104.88 152.57 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 124.376 2.036 . . . . 1.32 113.015 165.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -111.46 113.74 26.39 Favored 'General case' 0 N--CA 1.429 -1.49 1 O-C-N 114.825 -4.922 . . . . 2.2 108.697 -174.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.7 t -98.13 106.5 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-O 124.082 1.896 . . . . 1.23 106.067 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -94.62 121.3 36.04 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.791 -2.443 . . . . 2.51 112.779 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 p -89.24 163.82 15.22 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.543 -1.348 . . . . 1.41 108.203 174.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.9 tp -44.8 -56.88 4.11 Favored 'General case' 0 N--CA 1.43 -1.433 1 C-N-CA 133.229 4.611 . . . . 2.95 110.842 174.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.7 p -72.59 -19.73 61.42 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 113.061 -1.881 . . . . 2.52 115.275 -174.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.4 -14.86 4.22 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 117.293 -1.837 . . . . 1.5 116.689 166.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.479 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 79.1 tttt -75.04 133.21 41.67 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 120.343 2.072 . . . . 1.79 108.748 -168.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -105.15 118.89 37.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.028 -0.73 . . . . 1.38 109.028 172.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.12 112.31 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-O 126.112 2.863 . . . . 2.03 105.226 -178.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.7 m -88.72 131.52 34.99 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.186 -2.821 . . . . 1.61 106.862 -176.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.4 mt -135.32 131.21 36.18 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 124.642 1.213 . . . . 2.15 109.788 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -88.48 94.13 9.77 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.007 -2.308 . . . . 1.98 112.481 176.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.284 30.9 m -110.79 178.35 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 105.493 -2.04 . . . . 1.52 105.493 -177.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.487 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 22.7 mm-40 -122.34 155.5 61.88 Favored Pre-proline 0 N--CA 1.431 -1.412 0 O-C-N 119.532 -1.98 . . . . 2.35 109.786 161.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 94.3 Cg_endo -72.32 -23.09 21.09 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 C-N-CA 124.126 3.217 . . . . 1.31 112.975 -166.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.1 m -74.32 -11.21 60.2 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 116.17 1.915 . . . . 1.71 116.17 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -81.73 159.48 23.87 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 119.359 3.096 . . . . 1.69 119.359 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.257 7.3 p -78.07 147.71 34.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 119.067 2.988 . . . . 1.33 119.067 -177.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.1 mm -53.68 -38.36 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 123.86 3.027 . . . . 1.32 115.849 173.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -45.85 -38.12 6.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.86 2.911 . . . . 1.62 118.86 162.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -85.4 -23.7 27.84 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.86 -1.775 . . . . 2.13 113.719 175.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.94 -48.01 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 118.583 -2.573 . . . . 1.23 109.581 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -47.7 -37.4 13.01 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.761 3.245 . . . . 1.97 119.761 174.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.08 -33.12 71.5 Favored 'General case' 0 N--CA 1.43 -1.43 2 C-N-CA 133.53 4.732 . . . . 1.19 110.731 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -62.28 -26.42 68.4 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.133 3.012 . . . . 1.92 119.133 173.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.7 mt -82.67 -16.41 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 126.541 2.401 . . . . 1.94 114.292 175.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -82.17 -49.53 10.03 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.793 -1.929 . . . . 1.9 105.793 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -48.86 -61.28 2.13 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.874 2.47 . . . . 1.55 111.305 167.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -76.88 -62.57 1.6 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.968 -1.708 . . . . 2.95 112.959 -167.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.479 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 46.6 tp10 -98.5 -42.77 7.15 Favored 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 115.247 -4.658 . . . . 1.48 110.806 -166.892 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.34 20.47 2.19 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 121.891 3.516 . . . . 1.12 121.891 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.1 mm -99.82 118.86 61.08 Favored Pre-proline 0 N--CA 1.43 -1.471 0 C-N-CA 126.337 1.855 . . . . 2.07 109.75 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -69.3 157.44 61.27 Favored 'Trans proline' 0 C--N 1.299 -2.064 0 CA-C-N 123.116 2.148 . . . . 1.39 115.795 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -73.15 -16.14 25.36 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 C-N-CA 124.343 3.362 . . . . 1.68 112.717 -173.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -85.87 -34.54 20.97 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.898 2.479 . . . . 2.25 112.409 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -79.44 3.66 17.86 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.332 2.653 . . . . 2.44 111.269 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -122.92 147.72 46.27 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 120.799 3.629 . . . . 1.32 120.799 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -125.19 129.21 49.65 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 124.011 3.096 . . . . 3.19 103.613 176.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.4 mt -105.92 132.91 51.45 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.128 -4.732 . . . . 1.75 109.274 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.4 mt -119.7 135.36 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 106.366 -1.716 . . . . 1.98 106.366 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -124.31 131.95 53.54 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.844 2.458 . . . . 1.94 104.434 169.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.16 -57.59 0.52 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.889 2.876 . . . . 1.67 113.799 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -169.09 -32.45 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.749 0 CA-C-O 125.67 2.816 . . . . 1.3 115.439 -173.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -95.79 162.78 13.45 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.645 -2.679 . . . . 2.89 114.078 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -90.3 145.45 24.97 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 121.514 3.894 . . . . 2.89 121.514 173.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.6 mt -92.33 128.28 38.12 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 124.505 2.098 . . . . 1.34 112.605 -170.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -75.96 134.93 40.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 130.257 3.423 . . . . 1.94 110.144 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.55 -49.93 74.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.417 2.687 . . . . 1.56 115.206 -172.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.31 34.59 3.93 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 119.681 2.633 . . . . 0.97 119.681 173.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -103.83 166.13 10.61 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 114.549 -2.861 . . . . 3.07 106.789 167.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.8 p -89.97 159.82 16.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.974 -2.953 . . . . 1.34 110.127 169.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.299 81.0 mt -60.16 -33.27 71.95 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.688 1.736 . . . . 1.63 115.688 168.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.6 t -76.76 -20.78 56.09 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.457 -3.277 . . . . 1.51 115.804 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.88 -36.14 82.94 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.486 1.115 . . . . 1.9 109.326 169.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -82.54 3.21 29.45 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.553 -1.967 . . . . 0.97 112.733 172.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.312 21.7 m120 51.92 34.75 14.2 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.594 -2.566 . . . . 2.35 115.822 -176.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.4 mt -68.81 105.52 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 120.581 -1.324 . . . . 1.39 109.009 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -97.23 167.25 11.15 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 128.437 2.695 . . . . 2.58 107.953 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -62.42 145.77 53.18 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 118.215 -2.803 . . . . 2.58 118.059 175.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.33 29.3 mt-10 71.37 28.7 2.89 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 113.156 -1.838 . . . . 1.71 112.149 -172.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 m -84.42 141.44 30.83 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 121.032 1.742 . . . . 1.34 115.242 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.3 m -94.87 109.03 21.06 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.967 -1.494 . . . . 1.36 106.967 -171.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.7 mt -95.04 130.59 41.66 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.979 2.172 . . . . 2.03 106.628 171.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.272 32.1 m80 -100.33 114.1 27.34 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.032 -1.47 . . . . 2.31 107.032 -175.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -87.71 110.12 20.2 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.017 1.727 . . . . 1.72 112.266 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.7 t -98.62 133.92 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 1 N-CA-C 99.212 -4.366 . . . . 1.8 99.212 169.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.265 13.5 tp -94.04 127.35 39.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.25 -2.156 . . . . 3.26 107.983 177.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -95.77 124.25 39.7 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.292 -2.13 . . . . 4.12 111.023 -173.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.2 tp -99.36 -68.55 0.8 Allowed 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 122.843 1.306 . . . . 3.54 109.68 170.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.0 ttm105 -103.69 -82.13 0.5 Allowed 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.838 -2.414 . . . . 7.32 109.829 175.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.29 38.33 0.23 Allowed Glycine 0 N--CA 1.43 -1.735 1 O-C-N 114.675 -5.016 . . . . 3.73 110.696 -166.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.764 0 N-CA-C 107.424 -2.27 . . . . 3.87 107.424 -175.414 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 CA--C 1.491 -1.299 0 CA-C-O 118.176 -0.916 . . . . 1.39 111.647 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -107.03 137.81 44.39 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.127 3.371 . . . . 2.2 106.103 -178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 pt -131.2 167.45 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.604 -3.185 . . . . 1.32 104.863 168.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.252 63.4 m-85 -121.88 125.18 45.84 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.469 1.108 . . . . 2.2 108.658 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.79 112.07 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 112.693 0.627 . . . . 1.23 112.693 172.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.4 ttmm -102.42 142.77 33.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.463 -1.31 . . . . 2.51 107.463 -172.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.1 p -93.06 167.21 11.94 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 127.392 3.472 . . . . 1.41 112.975 165.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.257 21.0 tp -71.89 -25.58 61.98 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.242 -3.411 . . . . 2.95 114.382 175.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.8 p -88.24 -36.7 16.6 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.344 -2.097 . . . . 2.52 112.631 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.66 8.95 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 116.768 -2.634 . . . . 1.5 118.933 166.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -104.48 133.28 49.61 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 122.721 3.26 . . . . 1.79 109.923 -171.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.1 m -117.22 112.74 21.23 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 118.514 -1.275 . . . . 1.38 112.635 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.31 19.7 pt -97.02 136.0 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 124.178 1.942 . . . . 2.03 111.882 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.1 m -97.65 126.75 43.15 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 116.931 -3.606 . . . . 1.61 108.415 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.3 mt -131.41 141.48 49.85 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 127.4 3.476 . . . . 2.15 109.632 -173.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -97.54 118.67 34.56 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 113.562 -5.711 . . . . 1.98 109.59 171.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.97 174.99 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 119.859 -1.775 . . . . 1.52 109.138 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -116.02 147.96 40.37 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-O 116.342 -1.789 . . . . 2.35 107.084 157.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.03 -18.06 35.98 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-O 113.741 -2.691 . . . . 1.31 109.557 -174.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.2 p -71.0 -9.47 58.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 122.892 2.587 . . . . 1.71 115.057 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -80.02 166.66 21.33 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 114.629 -5.044 . . . . 1.69 110.37 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.5 p -93.82 152.0 19.21 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 121.903 0.858 . . . . 1.33 110.699 -177.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.445 HD11 ' HB3' ' A' ' 50' ' ' LEU . 4.1 mt -59.65 -36.39 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 115.913 1.82 . . . . 1.32 115.913 173.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -44.18 -56.32 4.17 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 126.304 1.842 . . . . 1.62 115.357 162.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -61.54 -39.16 90.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 112.87 -3.443 . . . . 2.13 111.683 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.3 t -63.12 -38.63 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 122.247 2.294 . . . . 1.23 108.05 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -71.45 -26.77 62.87 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.81 2.893 . . . . 1.97 118.81 171.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.98 -24.5 65.15 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.897 -2.377 . . . . 1.19 111.107 168.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -70.23 -37.33 74.97 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.119 -2.238 . . . . 1.92 112.561 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.3 mt -58.55 -35.41 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 128.787 2.835 . . . . 1.94 109.903 167.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -65.24 -42.72 93.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.175 -2.345 . . . . 1.9 113.862 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -63.71 -32.07 73.44 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 126.515 2.384 . . . . 1.55 114.82 165.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -88.41 -65.84 0.98 Allowed 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.115 -2.24 . . . . 2.95 110.224 -167.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -99.42 -24.39 14.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.246 1.818 . . . . 1.48 110.863 -169.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.43 43.67 2.91 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-O 125.298 2.61 . . . . 1.12 111.066 170.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.3 mt -120.74 129.49 25.29 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 120.288 -1.713 . . . . 2.07 106.542 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -71.61 150.69 57.44 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-N 124.82 2.757 . . . . 1.39 109.725 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -72.89 -12.29 26.13 Favored 'Trans proline' 0 C--N 1.298 -2.08 0 C-N-CA 122.511 2.141 . . . . 1.68 116.948 -173.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -81.12 -32.08 33.97 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 114.375 -5.203 . . . . 2.25 105.579 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -79.66 6.03 11.72 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 114.445 1.276 . . . . 2.44 114.445 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -149.51 147.42 28.18 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.804 -2.435 . . . . 1.32 114.253 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.277 60.2 mtt180 -129.78 162.12 29.16 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.051 -2.906 . . . . 3.19 108.563 171.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.9 mt -120.32 148.75 43.33 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 119.28 -2.138 . . . . 1.75 109.633 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.7 mt -127.61 129.04 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 124.87 2.271 . . . . 1.98 109.006 -172.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.434 ' CE1' ' HB3' ' A' ' 65' ' ' SER . 43.2 t80 -118.08 125.72 50.86 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 104.785 -2.302 . . . . 1.94 104.785 170.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.268 . . 79.84 -54.26 0.39 Allowed 'General case' 0 N--CA 1.428 -1.535 0 O-C-N 118.446 -2.659 . . . . 1.67 111.876 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.72 -24.32 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.675 0 O-C-N 118.119 -2.863 . . . . 1.3 115.099 -170.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -97.35 141.35 30.55 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.337 -1.684 . . . . 2.89 107.524 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -76.77 120.3 21.73 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.464 3.106 . . . . 2.89 111.649 177.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.445 ' HB3' HD11 ' A' ' 23' ' ' ILE . 43.2 mt -80.85 144.99 31.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.095 -1.628 . . . . 1.34 109.656 -166.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -74.87 121.5 21.95 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.716 2.406 . . . . 1.94 112.117 175.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -65.05 -29.36 70.25 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 113.382 -1.735 . . . . 1.56 112.463 -171.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.16 33.15 4.6 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 120.79 3.076 . . . . 0.97 120.79 168.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.9 mtt-85 -132.67 176.07 8.77 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 101.037 -3.69 . . . . 3.07 101.037 166.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.6 p -108.63 175.33 5.51 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.299 1.439 . . . . 1.34 109.962 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.6 mt -68.3 -23.7 64.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.539 1.681 . . . . 1.63 115.539 173.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 t -65.25 -40.09 93.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.678 2.791 . . . . 1.51 111.486 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -70.62 -21.89 62.59 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.262 1.578 . . . . 1.9 115.262 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -96.39 -3.24 43.99 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.81 -3.056 . . . . 0.97 108.582 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 58.84 40.88 22.3 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 127.575 2.35 . . . . 2.35 112.987 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.9 mt -80.53 127.08 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 1 O-C-N 131.022 5.201 . . . . 1.39 104.949 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -93.71 -174.85 3.58 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 128.079 2.552 . . . . 2.58 111.243 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.7 pttp -72.35 151.27 42.8 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.432 -1.258 . . . . 2.58 111.536 174.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.375 11.7 mt-10 56.65 42.23 27.28 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.443 2.757 . . . . 1.71 118.443 176.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.434 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 74.5 m -100.65 143.53 30.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.593 -2.743 . . . . 1.34 103.593 -175.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -103.04 110.4 22.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 125.183 2.421 . . . . 1.36 108.202 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -96.04 115.33 27.27 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.074 3.35 . . . . 2.03 112.538 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -86.71 121.37 29.12 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.445 -2.035 . . . . 2.31 115.977 -171.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.2 tt -89.39 138.34 31.53 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.355 -2.716 . . . . 1.72 108.764 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -125.45 162.75 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 O-C-N 128.408 3.568 . . . . 1.8 111.702 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.6 mt -100.09 152.51 20.15 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 124.031 1.872 . . . . 3.26 109.45 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.9 ttt-85 -137.1 140.91 42.26 Favored 'General case' 0 N--CA 1.43 -1.473 1 CA-C-O 128.864 4.173 . . . . 4.12 117.382 -177.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.412 ' HA ' HD22 ' A' ' 73' ' ' LEU . 31.7 mt -99.35 157.01 16.7 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.654 -3.779 . . . . 3.54 107.215 175.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -77.26 94.77 4.2 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.715 2.806 . . . . 7.32 111.652 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.68 -149.95 19.02 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 107.519 -2.232 . . . . 3.73 107.519 -170.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.782 0 O-C-N 118.43 -2.806 . . . . 3.87 110.654 -177.275 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ptt? . . . . . 0 CA--C 1.489 -1.373 0 CA-C-O 123.198 1.475 . . . . 1.39 109.361 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -118.03 139.42 51.22 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.618 -3.176 . . . . 2.2 108.621 -176.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.422 HD13 HD23 ' A' ' 67' ' ' LEU . 22.1 pt -125.13 144.6 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 CA-C-O 115.826 -2.035 . . . . 1.32 106.251 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -102.31 101.02 11.24 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 126.419 2.324 . . . . 2.2 108.705 -174.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.451 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 21.7 t -82.2 110.99 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 116.699 -3.751 . . . . 1.23 106.779 175.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -98.58 136.38 38.76 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 109.247 -0.649 . . . . 2.51 109.247 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 p -90.81 -155.42 0.39 Allowed 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.704 1.602 . . . . 1.41 108.15 175.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.4 mt -103.47 -60.78 1.51 Allowed 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 113.739 -3.029 . . . . 2.95 110.428 175.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 p -51.37 -41.68 60.82 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 133.894 6.996 . . . . 2.52 116.672 -174.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.46 -19.77 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 126.262 3.146 . . . . 1.5 120.398 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -71.67 151.48 43.64 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.169 -2.371 . . . . 1.79 110.805 -174.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.4 m -130.32 110.23 11.36 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.147 1.779 . . . . 1.38 110.635 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.451 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 4.8 mm -85.92 101.75 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 115.539 -2.172 . . . . 2.03 105.752 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.8 m -78.42 89.63 4.41 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 125.489 1.743 . . . . 1.61 111.119 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.413 HD11 HG13 ' A' ' 26' ' ' VAL . 26.8 mt -85.3 124.15 31.6 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.592 -3.193 . . . . 2.15 113.207 178.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -71.48 114.87 10.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 125.493 1.746 . . . . 1.98 112.431 161.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 m -134.18 165.43 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 120.253 -1.529 . . . . 1.52 108.851 -176.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -104.91 156.41 36.06 Favored Pre-proline 0 N--CA 1.429 -1.488 0 CA-C-O 116.401 -1.762 . . . . 2.35 106.879 167.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -79.5 -11.9 14.13 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 CA-C-N 126.047 3.195 . . . . 1.31 106.22 -170.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.9 p -73.35 -21.8 60.45 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.898 2.555 . . . . 1.71 117.898 173.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -63.54 147.18 52.1 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 125.441 1.713 . . . . 1.69 112.159 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.8 p -83.6 168.74 16.08 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.662 -1.274 . . . . 1.33 110.51 170.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.485 HG23 HD12 ' A' ' 43' ' ' LEU . 24.1 mm -68.77 -30.06 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 128.684 2.794 . . . . 1.32 108.91 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -48.8 -47.78 41.89 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.301 1.84 . . . . 1.62 113.73 166.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -63.87 -41.49 97.75 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.959 2.504 . . . . 2.13 111.516 173.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.413 HG13 HD11 ' A' ' 15' ' ' LEU . 53.9 t -67.75 -45.0 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 1 O-C-N 116.231 -4.043 . . . . 1.23 112.807 179.817 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -68.66 -22.32 64.39 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.274 1.511 . . . . 1.97 114.034 175.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.32 83.42 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.35 -3.969 . . . . 1.19 117.356 170.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -64.01 -29.49 70.64 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.285 -2.134 . . . . 1.92 113.991 165.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.3 76.7 mt -72.89 -40.08 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 117.042 -3.536 . . . . 1.94 111.108 176.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -64.47 -46.86 81.26 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.819 2.048 . . . . 1.9 111.474 173.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.07 -54.38 25.38 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.434 -2.666 . . . . 1.55 116.974 167.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -73.61 -68.58 0.49 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.529 2.048 . . . . 2.95 116.529 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -84.19 -23.23 30.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.362 -1.29 . . . . 1.48 113.557 -167.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.25 24.56 14.21 Favored Glycine 0 N--CA 1.429 -1.769 1 CA-C-O 128.144 4.191 . . . . 1.12 114.301 170.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.412 HD11 HD23 ' A' ' 71' ' ' LEU . 8.7 mt -105.37 133.71 20.03 Favored Pre-proline 0 N--CA 1.429 -1.482 0 O-C-N 116.758 -3.789 . . . . 2.07 106.622 -170.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -65.55 146.6 85.14 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 CA-C-O 114.733 -2.278 . . . . 1.39 115.304 172.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -81.16 -9.49 12.76 Favored 'Trans proline' 0 N--CA 1.433 -2.058 0 CA-C-N 125.928 3.153 . . . . 1.68 108.462 -171.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -71.19 -23.79 62.1 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.482 -2.011 . . . . 2.25 111.344 168.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -92.15 -22.53 19.81 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 120.351 1.432 . . . . 2.44 107.848 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.307 74.5 mt-30 -79.31 152.66 30.37 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 125.324 2.488 . . . . 1.32 110.449 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.434 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 72.0 mtt180 -125.45 138.29 54.0 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.063 -4.148 . . . . 3.19 108.756 158.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.485 HD12 HG23 ' A' ' 23' ' ' ILE . 23.9 mt -116.47 111.56 20.17 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.424 -3.298 . . . . 1.75 104.405 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.6 mm -98.25 141.73 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 103.824 -2.658 . . . . 1.98 103.824 174.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -115.6 -109.44 0.36 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 114.877 -2.487 . . . . 1.94 109.372 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.99 -32.15 16.04 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 124.418 3.281 . . . . 1.67 112.912 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.81 -41.23 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 127.756 2.598 . . . . 1.3 114.086 -175.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -80.69 136.02 36.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.706 2.669 . . . . 2.89 110.56 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -89.95 95.53 10.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.704 2.802 . . . . 2.89 108.208 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 mt -57.01 140.93 47.49 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.988 -2.32 . . . . 1.34 115.32 -164.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.257 42.4 mt-10 -83.14 150.19 26.41 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.456 -1.402 . . . . 1.94 114.721 173.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -65.71 -52.3 52.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.235 2.309 . . . . 1.56 117.235 -169.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.15 56.97 1.76 Allowed Glycine 0 N--CA 1.43 -1.758 0 CA-C-N 108.533 -3.939 . . . . 0.97 113.6 173.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.0 mmt-85 -132.45 168.54 18.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 129.162 3.507 . . . . 3.07 105.34 163.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -107.18 164.83 11.83 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.439 -1.71 . . . . 1.34 113.487 173.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.8 mt -66.53 -24.68 66.41 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.504 -1.373 . . . . 1.63 113.609 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.3 t -64.59 -39.79 94.36 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 128.749 2.82 . . . . 1.51 111.063 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -66.55 -31.39 72.08 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.082 -2.886 . . . . 1.9 116.211 173.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -90.5 2.65 55.52 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 115.439 1.644 . . . . 0.97 115.439 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 69.35 27.15 5.12 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 117.452 -1.261 . . . . 2.35 109.872 178.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.4 mt -79.65 128.02 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 126.149 2.88 . . . . 1.39 110.848 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -130.82 171.51 13.06 Favored 'General case' 0 N--CA 1.429 -1.494 1 O-C-N 115.043 -4.786 . . . . 2.58 108.469 -167.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -54.16 130.74 39.43 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.818 2.723 . . . . 2.58 115.641 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 65.94 34.9 6.81 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 130.032 3.333 . . . . 1.71 112.116 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.6 t -90.91 141.48 28.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.965 1.364 . . . . 1.34 112.217 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.0 m -83.99 111.85 19.64 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.989 1.716 . . . . 1.36 114.464 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.422 HD23 HD13 ' A' ' 3' ' ' ILE . 6.8 mp -108.45 166.44 10.77 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.715 2.006 . . . . 2.03 112.058 177.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -123.21 132.16 53.94 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.328 -4.608 . . . . 2.31 110.879 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.0 tp -98.89 108.79 21.57 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.65 1.214 . . . . 1.72 108.484 174.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.434 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 15.5 t -105.88 143.12 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 128.926 2.891 . . . . 1.8 108.015 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.412 HD23 HD11 ' A' ' 36' ' ' ILE . 84.8 mt -123.14 147.37 46.87 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 125.986 3.993 . . . . 3.26 108.848 -178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.7 mtp180 -95.74 -169.15 1.89 Allowed 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 126.689 3.138 . . . . 4.12 103.8 173.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.2 mt -106.13 -56.09 2.23 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 111.315 -2.675 . . . . 3.54 110.57 168.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.61 172.38 13.1 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 114.153 -2.832 . . . . 7.32 108.02 171.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.86 -169.3 42.54 Favored Glycine 0 N--CA 1.43 -1.747 0 CA-C-N 121.376 1.898 . . . . 3.73 113.318 -171.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.808 0 CA-C-O 115.495 -2.836 . . . . 3.87 107.219 -177.681 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ptt? . . . . . 0 CA--C 1.491 -1.314 0 CA-C-O 122.655 1.217 . . . . 1.39 112.804 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -96.0 139.97 31.42 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 107.45 -1.315 . . . . 2.2 107.45 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.256 16.3 pt -132.08 169.49 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 107.312 -1.366 . . . . 1.32 107.312 172.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -134.07 142.61 47.62 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.132 0.967 . . . . 2.2 113.02 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.57 134.13 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 O-C-N 118.837 -2.415 . . . . 1.23 110.416 168.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -96.79 149.11 22.21 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 117.419 -1.276 . . . . 2.51 109.63 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.321 4.8 p -103.85 -166.35 1.25 Allowed 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.501 2.375 . . . . 1.41 114.928 176.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.2 tp -76.18 -57.93 3.58 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 114.839 1.422 . . . . 2.95 114.839 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.2 p -70.5 -32.8 70.43 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 116.871 2.175 . . . . 2.52 116.871 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.07 58.32 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 118.757 -1.687 . . . . 1.5 115.597 172.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -118.18 138.2 52.47 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 121.109 2.455 . . . . 1.79 107.775 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.5 m -100.6 117.33 34.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 104.889 -2.263 . . . . 1.38 104.889 174.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.6 mt -96.47 116.54 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 106.219 -1.771 . . . . 2.03 106.219 174.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.406 3.6 m -83.08 121.53 27.16 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 126.039 1.736 . . . . 1.61 113.551 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.5 mt -123.03 143.16 50.13 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.635 -1.915 . . . . 2.15 112.201 -175.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -104.07 141.99 35.25 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 104.49 -2.411 . . . . 1.98 104.49 170.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.3 m -161.07 161.9 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 106.966 -1.494 . . . . 1.52 106.966 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.52 162.44 19.71 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-O 115.828 -2.034 . . . . 2.35 106.868 157.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 97.5 Cg_endo -74.33 -1.79 11.47 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 CA-C-N 124.592 2.676 . . . . 1.31 113.714 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.1 m -90.72 -2.51 57.81 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 115.359 1.615 . . . . 1.71 115.359 171.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -66.73 131.07 45.18 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.146 2.403 . . . . 1.69 107.121 168.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 17.6 p -68.47 175.16 3.56 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 112.954 -1.93 . . . . 1.33 112.205 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.5 mm -74.66 -35.48 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 116.528 -3.858 . . . . 1.32 108.018 176.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -54.3 -46.66 72.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.213 -3.43 . . . . 1.62 115.351 165.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -56.86 -37.16 70.93 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 125.577 2.608 . . . . 2.13 112.79 171.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.56 -39.8 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 116.463 -3.898 . . . . 1.23 114.34 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -65.88 -33.3 75.52 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 117.621 2.452 . . . . 1.97 117.621 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.68 -23.75 61.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 111.598 -2.546 . . . . 1.19 110.691 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -75.72 -29.64 59.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 122.579 2.445 . . . . 1.92 113.564 168.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.6 mt -66.44 -42.29 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.908 -1.745 . . . . 1.94 110.195 171.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -58.54 -38.36 77.61 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.314 -3.366 . . . . 1.9 118.216 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -59.96 -32.83 71.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.989 2.218 . . . . 1.55 116.989 172.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.327 53.8 mmtt -89.15 -48.74 7.19 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.924 -3.61 . . . . 2.95 110.009 -174.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -112.39 -19.16 12.27 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 123.096 1.426 . . . . 1.48 114.164 -165.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.33 9.42 79.55 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 118.984 -2.323 . . . . 1.12 113.907 167.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.5 mt -81.58 133.26 53.04 Favored Pre-proline 0 N--CA 1.43 -1.457 0 O-C-N 120.951 -1.323 . . . . 2.07 112.237 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -69.17 148.78 69.63 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 CA-C-N 122.517 1.935 . . . . 1.39 113.681 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -71.14 -25.03 22.87 Favored 'Trans proline' 0 C--N 1.301 -1.953 1 C-N-CA 125.893 4.395 . . . . 1.68 115.211 -170.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -70.65 -27.13 63.81 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 128.348 2.659 . . . . 2.25 113.881 175.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -91.77 -1.94 57.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.432 2.293 . . . . 2.44 110.472 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -100.86 135.19 42.69 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.658 -1.901 . . . . 1.32 109.813 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 62.4 mtm180 -117.87 114.28 23.0 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.585 2.448 . . . . 3.19 110.191 173.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.6 mt -100.32 129.17 46.28 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 120.762 1.619 . . . . 1.75 110.515 -176.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.8 mm -110.77 128.17 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 125.638 1.575 . . . . 1.98 108.639 177.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CZ ' HG12 ' A' ' 61' ' ' ILE . 41.3 t80 -109.12 102.72 11.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.145 1.45 . . . . 1.94 107.155 170.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.312 . . 65.41 -63.62 0.2 Allowed 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.064 -2.897 . . . . 1.67 118.084 -173.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -162.6 -5.85 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.709 0 O-C-N 118.194 -2.816 . . . . 1.3 111.914 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -95.38 143.08 27.03 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 125.843 1.555 . . . . 2.89 107.609 173.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -93.59 143.55 26.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.944 2.783 . . . . 2.89 111.37 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.0 mt -94.76 132.05 39.94 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 113.857 -5.527 . . . . 1.34 108.217 -167.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -83.81 139.24 32.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.395 1.478 . . . . 1.94 109.292 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.287 8.5 m-20 -62.95 -50.11 72.09 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.499 -3.251 . . . . 1.56 119.701 -171.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.23 9.44 63.92 Favored Glycine 0 N--CA 1.43 -1.704 1 N-CA-C 123.183 4.033 . . . . 0.97 123.183 174.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 22' ' ' THR . 7.8 mtt180 -78.39 161.23 27.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 113.621 0.971 . . . . 3.07 113.621 168.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.1 p -89.39 164.9 14.67 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 118.955 2.946 . . . . 1.34 118.955 164.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 89.5 mt -64.32 -36.56 84.51 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.599 -3.188 . . . . 1.63 116.86 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.2 p -58.41 -29.0 65.74 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 128.1 2.56 . . . . 1.51 113.362 166.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -59.6 -47.5 85.35 Favored 'General case' 0 N--CA 1.43 -1.431 1 CA-C-N 127.312 4.596 . . . . 1.9 110.892 173.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -83.36 0.98 43.56 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.123 3.369 . . . . 0.97 114.056 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.3 m120 58.32 45.85 16.4 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.996 2.221 . . . . 2.35 116.996 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.419 HG12 ' CZ ' ' A' ' 45' ' ' PHE . 65.4 mt -87.76 118.04 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 104.765 -2.309 . . . . 1.39 104.765 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -85.23 -163.21 0.81 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.737 -2.477 . . . . 2.58 109.029 -174.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 pttt -74.43 147.02 42.39 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.085 -2.259 . . . . 2.58 110.217 174.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 62.73 48.74 4.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.172 0.986 . . . . 1.71 109.622 170.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.1 m -108.59 141.29 40.73 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.853 -1.779 . . . . 1.34 110.203 -169.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.8 m -103.81 108.68 20.1 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 125.568 2.604 . . . . 1.36 108.656 -172.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mp -96.52 163.88 12.85 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 112.425 -2.17 . . . . 2.03 107.875 171.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -118.05 140.28 49.98 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.197 1.799 . . . . 2.31 111.937 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.7 tp -108.97 120.59 42.99 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.399 -3.313 . . . . 1.72 109.667 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.4 t -116.93 150.31 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 105.418 -2.067 . . . . 1.8 105.418 174.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.6 155.88 17.82 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.09 -3.506 . . . . 3.26 113.211 -177.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -136.81 127.97 27.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 116.903 -1.523 . . . . 4.12 112.031 -177.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 tp -98.64 -65.2 0.98 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.75 2.02 . . . . 3.54 111.314 169.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -146.63 -104.22 0.1 Allowed 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.521 1.153 . . . . 7.32 111.811 170.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.58 64.41 1.55 Allowed Glycine 0 N--CA 1.429 -1.797 0 O-C-N 118.394 -2.691 . . . . 3.73 116.942 -167.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.727 0 N-CA-C 106.825 -2.51 . . . . 3.87 106.825 176.678 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 ttp . . . . . 0 CA--C 1.49 -1.33 0 N-CA-C 116.563 2.061 . . . . 1.39 116.563 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -92.84 123.74 36.33 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.233 -2.792 . . . . 2.2 108.46 -170.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.335 50.4 pt -116.22 137.66 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.495 1.918 . . . . 1.32 112.73 176.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -104.83 100.05 9.69 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 116.58 2.067 . . . . 2.2 116.58 -176.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.3 t -84.53 96.9 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 124.537 2.113 . . . . 1.23 111.89 178.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -95.74 122.75 38.85 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.48 1.61 . . . . 2.51 109.423 -174.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.29 20.2 p -89.99 167.27 12.92 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.787 2.035 . . . . 1.41 114.19 -176.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.8 tp -66.24 -32.19 73.46 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 126.009 2.814 . . . . 2.95 115.455 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.6 p -77.44 -48.24 17.67 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.428 1.891 . . . . 2.52 111.854 -178.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.3 -1.21 0.53 Allowed Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 117.174 1.63 . . . . 1.5 117.174 173.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -78.11 139.66 39.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 119.372 1.586 . . . . 1.79 109.133 -177.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -104.17 112.09 24.95 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.644 -2.535 . . . . 1.38 105.435 169.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -93.06 105.51 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 103.413 -2.81 . . . . 2.03 103.413 178.141 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -84.74 107.08 16.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.006 2.224 . . . . 1.61 117.006 177.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.2 mt -105.27 136.72 44.27 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 121.122 1.783 . . . . 2.15 107.518 -175.076 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -87.99 90.9 8.57 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 124.154 1.931 . . . . 1.98 108.625 168.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.21 176.27 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 128.571 2.749 . . . . 1.52 109.11 -176.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -117.88 151.37 48.68 Favored Pre-proline 0 N--CA 1.431 -1.413 0 O-C-N 124.917 1.386 . . . . 2.35 108.638 161.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -74.26 -11.96 23.06 Favored 'Trans proline' 0 N--CA 1.434 -2.004 1 O-C-N 112.794 -4.371 . . . . 1.31 115.208 -170.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.4 p -81.98 -15.35 54.04 Favored 'General case' 0 N--CA 1.429 -1.476 1 C-N-CA 132.297 4.239 . . . . 1.71 110.315 174.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -68.62 153.38 43.88 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 120.756 1.616 . . . . 1.69 110.942 172.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 25.2 p -87.6 166.87 14.4 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.353 1.861 . . . . 1.33 108.93 -179.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.2 mm -71.61 -36.0 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 124.455 2.074 . . . . 1.32 113.188 175.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -38.82 -42.97 0.88 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.853 -3.03 . . . . 1.62 117.047 159.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -76.94 -38.18 53.86 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.226 -2.796 . . . . 2.13 108.489 179.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.9 t -55.89 -39.09 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 127.354 2.261 . . . . 1.23 114.269 172.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -81.05 -19.34 44.0 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.612 -2.555 . . . . 1.97 115.88 173.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.07 -38.59 63.88 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 122.819 1.295 . . . . 1.19 109.486 174.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -63.24 -29.29 70.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.633 -2.542 . . . . 1.92 113.864 174.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.3 mt -77.88 -24.34 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 116.661 2.097 . . . . 1.94 116.661 169.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -76.42 -30.48 57.46 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.27 -3.394 . . . . 1.9 110.025 173.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -76.5 -43.33 40.02 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.805 1.288 . . . . 1.55 112.129 173.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -77.4 -69.36 0.54 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.347 -2.096 . . . . 2.95 114.506 -173.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -80.46 -51.17 9.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.677 -1.147 . . . . 1.48 113.153 -172.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.09 43.03 1.13 Allowed Glycine 0 N--CA 1.429 -1.796 0 O-C-N 125.508 1.755 . . . . 1.12 111.232 175.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.3 mt -104.3 132.99 20.45 Favored Pre-proline 0 N--CA 1.431 -1.386 0 C-N-CA 125.557 1.543 . . . . 2.07 107.377 -178.16 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -70.85 138.96 35.42 Favored 'Trans proline' 0 N--CA 1.433 -2.067 1 C-N-CA 126.054 4.502 . . . . 1.39 111.54 -178.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -71.52 -19.47 28.33 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 O-C-N 117.924 -1.671 . . . . 1.68 112.434 -169.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -62.4 -35.02 77.9 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 114.83 1.418 . . . . 2.25 114.83 165.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -87.57 -13.93 41.55 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 124.037 0.935 . . . . 2.44 112.628 -179.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.329 71.3 mt-30 -84.78 113.01 21.02 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 120.957 1.708 . . . . 1.32 107.701 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -92.34 134.5 34.86 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 116.676 -1.63 . . . . 3.19 106.712 165.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.8 mt -127.79 125.42 39.81 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 102.629 -3.1 . . . . 1.75 102.629 177.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -115.13 137.3 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 115.947 -1.978 . . . . 1.98 105.788 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -124.06 107.4 11.25 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.227 2.285 . . . . 1.94 107.628 171.172 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.363 . . 74.55 -77.07 0.06 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.517 2.58 . . . . 1.67 114.922 -173.414 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.3 -0.67 0.24 Allowed Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 129.917 3.627 . . . . 1.3 115.42 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -111.56 114.01 26.8 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 124.663 1.185 . . . . 2.89 110.565 -179.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -81.13 127.94 33.19 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 124.56 1.144 . . . . 2.89 111.885 176.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.481 HD23 ' CD2' ' A' ' 59' ' ' TYR . 69.7 mt -79.82 120.36 23.97 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 120.338 3.458 . . . . 1.34 120.338 -162.569 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.288 37.1 mt-10 -78.22 138.63 38.74 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.216 -2.177 . . . . 1.94 113.758 -176.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.66 -45.33 92.36 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 112.616 -2.084 . . . . 1.56 113.072 -171.477 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.59 25.14 9.88 Favored Glycine 0 N--CA 1.43 -1.713 0 C-N-CA 125.763 1.649 . . . . 0.97 116.601 175.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -112.7 166.36 11.43 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.99 1.852 . . . . 3.07 110.309 165.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 12.2 p -101.28 169.17 9.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.134 -2.854 . . . . 1.34 106.424 176.369 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.44 HD22 HD13 ' A' ' 61' ' ' ILE . 62.6 mt -65.95 -38.19 87.96 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.576 2.608 . . . . 1.63 112.304 172.185 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.0 p -60.34 -41.1 92.89 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.923 -4.236 . . . . 1.51 116.067 -178.134 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -53.47 -49.7 66.88 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 117.715 2.487 . . . . 1.9 117.715 169.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.481 ' CD2' HD23 ' A' ' 50' ' ' LEU . 59.9 m-85 -67.26 -10.41 50.44 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.659 2.466 . . . . 0.97 117.659 173.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.309 64.8 t30 73.93 47.62 0.15 Allowed 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.573 -2.58 . . . . 2.35 105.167 -177.402 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.44 HD13 HD22 ' A' ' 56' ' ' LEU . 87.6 mt -100.59 119.82 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 102.829 -3.026 . . . . 1.39 102.829 177.261 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -115.09 -167.8 1.29 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 114.219 -1.355 . . . . 2.58 112.274 -176.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -60.27 138.86 57.87 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.611 2.448 . . . . 2.58 117.611 169.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.432 20.8 mt-10 69.19 22.97 6.54 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.007 2.225 . . . . 1.71 117.007 174.299 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.4 m -83.16 141.06 32.22 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.209 2.604 . . . . 1.34 113.913 -175.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.4 m -94.65 116.1 28.34 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.3 -3.375 . . . . 1.36 107.464 -174.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -109.68 128.38 55.22 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 104.87 -2.27 . . . . 2.03 104.87 174.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -88.8 121.53 31.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 114.531 -2.652 . . . . 2.31 115.085 -177.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.8 tp -89.14 120.27 30.38 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 123.827 3.012 . . . . 1.72 114.376 175.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.45 169.23 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 120.651 -1.281 . . . . 1.8 107.852 172.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.3 mt -112.05 159.36 18.54 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.89 -3.007 . . . . 3.26 107.528 177.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -128.9 156.22 44.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.344 -0.844 . . . . 4.12 109.212 175.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.9 mt -86.17 -107.65 0.06 Allowed 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.395 -1.44 . . . . 3.54 108.337 170.305 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -78.97 -55.63 4.99 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 128.046 3.784 . . . . 7.32 110.189 172.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.8 142.67 9.94 Favored Glycine 0 N--CA 1.429 -1.802 1 O-C-N 116.285 -4.009 . . . . 3.73 106.71 -168.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.805 0 N-CA-C 106.585 -2.606 . . . . 3.87 106.585 176.075 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.316 0 N-CA-C 114.325 1.231 . . . . 1.39 114.325 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.267 0.7 OUTLIER -97.39 131.96 43.56 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.023 1.49 . . . . 2.2 115.023 -175.607 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -112.5 145.14 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 117.896 -3.002 . . . . 1.32 110.131 172.114 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -109.87 112.83 25.1 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 103.984 -2.599 . . . . 2.2 103.984 -173.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.52 103.1 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 104.071 -2.566 . . . . 1.23 104.071 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -102.76 131.11 49.83 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 112.58 0.585 . . . . 2.51 112.58 -179.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.4 p -93.16 176.81 6.27 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 128.155 3.409 . . . . 1.41 119.39 -177.157 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.3 tp -67.03 -37.57 84.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 124.92 3.509 . . . . 2.95 112.047 170.206 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.8 p -78.87 6.63 8.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 129.926 3.29 . . . . 2.52 111.313 -171.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.68 5.25 57.76 Favored Glycine 0 N--CA 1.43 -1.716 0 CA-C-N 125.001 3.546 . . . . 1.5 113.671 169.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -93.99 133.66 37.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.317 2.247 . . . . 1.79 115.719 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.5 m -108.39 117.18 33.48 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.277 -1.009 . . . . 1.38 108.277 171.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 mt -105.02 113.7 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 101.238 -3.615 . . . . 2.03 101.238 -179.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.4 m -101.19 117.33 34.79 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 120.819 1.645 . . . . 1.61 107.426 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.7 mt -102.06 151.38 22.23 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.985 3.314 . . . . 2.15 114.677 178.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -105.48 104.72 14.5 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 121.636 3.939 . . . . 1.98 121.636 168.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.3 m -119.91 168.36 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 112.452 -2.158 . . . . 1.52 109.528 -177.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -105.44 159.88 27.96 Favored Pre-proline 0 N--CA 1.431 -1.409 0 C-N-CA 125.713 1.605 . . . . 2.35 108.772 164.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.89 -18.44 16.88 Favored 'Trans proline' 0 N--CA 1.435 -1.967 0 O-C-N 115.767 -2.807 . . . . 1.31 113.537 -170.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.4 m -86.67 2.72 47.51 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.438 -2.039 . . . . 1.71 115.989 174.482 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -79.27 148.13 32.27 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 127.463 2.305 . . . . 1.69 109.766 172.124 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.5 p -76.99 161.04 28.67 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 127.147 2.179 . . . . 1.33 116.197 175.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.8 mm -71.56 -31.36 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 125.738 1.615 . . . . 1.32 111.944 173.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -50.87 -46.65 60.44 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.142 2.401 . . . . 1.62 114.562 162.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.282 6.3 t-20 -63.4 -45.13 92.45 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 116.226 -4.046 . . . . 2.13 114.949 176.755 . . . . . . . . 3 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -48.11 -38.81 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 127.893 2.477 . . . . 1.23 115.816 168.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -66.82 -34.58 78.13 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.392 -2.692 . . . . 1.97 113.603 173.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.0 -32.43 61.65 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.583 -2.573 . . . . 1.19 112.345 176.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -58.5 -38.73 78.26 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 120.688 1.585 . . . . 1.92 115.199 165.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.7 mt -71.55 -37.34 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 130.766 3.626 . . . . 1.94 111.902 177.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -59.81 -47.43 85.73 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 129.027 2.931 . . . . 1.9 109.364 169.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.4 -54.9 41.41 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.613 2.625 . . . . 1.55 115.127 171.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -72.49 -67.51 0.55 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.712 -3.118 . . . . 2.95 112.696 -175.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -77.53 -55.37 5.43 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 120.035 -1.666 . . . . 1.48 114.639 -174.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.94 25.98 0.65 Allowed Glycine 0 N--CA 1.43 -1.716 0 O-C-N 118.136 -2.853 . . . . 1.12 110.326 174.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.0 mt -99.95 140.09 21.26 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-N 123.344 3.572 . . . . 2.07 105.365 -167.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -66.85 159.04 53.47 Favored 'Trans proline' 0 N--CA 1.433 -2.066 0 CA-C-N 125.128 2.867 . . . . 1.39 111.053 176.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -78.23 -3.52 13.49 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 CA-C-N 122.635 1.977 . . . . 1.68 111.907 -175.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.271 96.0 m-20 -88.22 -29.65 20.3 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 125.813 2.72 . . . . 2.25 112.727 174.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -84.51 16.04 3.38 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 116.351 1.982 . . . . 2.44 116.351 -179.079 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -126.08 129.72 49.69 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.93 1.292 . . . . 1.32 109.78 -176.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -118.7 134.78 54.88 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.443 2.697 . . . . 3.19 108.973 167.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.5 mt -120.01 123.98 44.78 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 113.715 -1.584 . . . . 1.75 114.303 178.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.497 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 23.7 mm -99.9 145.59 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 101.397 -3.557 . . . . 1.98 101.397 175.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -139.16 123.82 18.49 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 101.404 -3.554 . . . . 1.94 101.404 168.153 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.07 -68.59 0.21 Allowed 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 127.487 2.992 . . . . 1.67 112.402 -172.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.25 -32.03 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 114.412 -1.267 . . . . 1.3 115.117 -179.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.276 12.4 ptpt -74.93 151.15 38.9 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.174 1.175 . . . . 2.89 114.174 177.443 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -87.16 105.34 17.13 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 131.066 3.746 . . . . 2.89 113.326 174.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.454 HD22 ' CD2' ' A' ' 59' ' ' TYR . 61.9 mt -66.77 158.37 30.51 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.074 -2.266 . . . . 1.34 109.536 -161.285 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -91.27 156.18 18.0 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 124.855 2.264 . . . . 1.94 108.862 170.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -74.53 -66.37 0.75 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.504 -1.997 . . . . 1.56 114.186 -178.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.46 50.21 1.69 Allowed Glycine 0 N--CA 1.43 -1.761 0 O-C-N 118.057 -2.902 . . . . 0.97 115.177 168.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -122.7 160.38 25.99 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.346 -1.679 . . . . 3.07 106.962 159.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.2 p -85.68 169.17 13.72 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.675 -1.891 . . . . 1.34 113.325 176.132 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.1 mt -66.05 -33.12 75.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.844 2.458 . . . . 1.63 115.185 171.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.7 p -70.25 -32.91 70.96 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.408 -2.682 . . . . 1.51 114.784 176.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -67.59 -27.46 66.94 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.721 1.608 . . . . 1.9 115.252 177.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.454 ' CD2' HD22 ' A' ' 50' ' ' LEU . 59.8 m-85 -89.15 -14.8 35.33 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.074 2.25 . . . . 0.97 117.074 170.045 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.3 22.1 m120 75.77 45.68 0.12 Allowed 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.016 2.969 . . . . 2.35 119.016 -174.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.1 mt -91.32 107.9 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 129.833 3.253 . . . . 1.39 107.576 172.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -99.73 -165.11 1.19 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.53 1.932 . . . . 2.58 108.359 179.279 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -56.7 144.41 32.58 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.35 -2.719 . . . . 2.58 114.887 170.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 68.46 17.98 9.04 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.269 2.462 . . . . 1.71 114.97 171.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.7 m -80.89 131.43 35.36 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 125.675 2.655 . . . . 1.34 110.938 -169.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.0 m -80.61 110.38 16.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.758 -1.565 . . . . 1.36 115.109 176.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.46 155.17 17.98 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.476 2.71 . . . . 2.03 106.148 172.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.497 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 60.8 m80 -119.14 109.63 16.11 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.44 -2.037 . . . . 2.31 112.722 -170.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.1 tp -93.48 112.3 24.17 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 125.125 1.516 . . . . 1.72 112.338 -172.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.68 125.5 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 127.921 2.488 . . . . 1.8 110.266 179.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.8 tp -88.54 138.58 31.3 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.679 -3.138 . . . . 3.26 106.623 -175.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -106.24 102.4 11.81 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.28 -3.388 . . . . 4.12 105.974 -179.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.9 mt -80.52 153.46 28.12 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.614 -2.554 . . . . 3.54 114.21 171.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.78 108.57 18.77 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.478 -2.639 . . . . 7.32 107.296 168.676 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.93 41.82 0.03 OUTLIER Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 116.734 -2.651 . . . . 3.73 108.957 -171.209 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.734 0 N-CA-C 108.258 -1.937 . . . . 3.87 108.258 -178.017 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptt? . . . . . 0 CA--C 1.489 -1.398 0 CA-C-O 126.429 3.014 . . . . 1.39 113.551 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -89.03 125.4 34.99 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.444 -1.707 . . . . 2.2 110.888 -174.506 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 pt -121.05 146.61 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 104.773 -2.306 . . . . 1.32 104.773 166.33 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -97.17 134.69 40.16 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 131.618 3.967 . . . . 2.2 103.677 -179.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.5 t -130.4 106.18 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 124.488 2.09 . . . . 1.23 106.947 172.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -96.65 142.93 28.1 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.185 1.469 . . . . 2.51 112.914 -176.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.1 p -82.02 179.32 7.86 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 118.339 -2.725 . . . . 1.41 114.345 175.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.7 tp -81.08 -30.73 34.65 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.661 2.384 . . . . 2.95 107.12 175.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -75.01 -44.91 45.39 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.614 -3.804 . . . . 2.52 112.36 -170.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.98 -3.59 0.16 Allowed Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 117.577 -2.249 . . . . 1.5 114.732 173.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.498 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 52.2 pttt -110.99 138.89 46.84 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 114.574 1.324 . . . . 1.79 114.574 -172.245 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -102.21 128.86 48.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 115.138 -2.363 . . . . 1.38 112.936 177.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.294 30.6 pt -107.14 145.8 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 106.773 -1.566 . . . . 2.03 106.773 176.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.9 m -97.51 134.4 40.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 111.802 -2.454 . . . . 1.61 112.639 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.64 142.43 50.66 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.701 1.715 . . . . 2.15 109.728 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -108.75 122.79 47.89 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 116.479 -3.888 . . . . 1.98 109.012 169.015 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.6 m -136.29 154.54 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 125.38 1.472 . . . . 1.52 107.887 -171.135 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -95.26 152.63 39.52 Favored Pre-proline 0 N--CA 1.43 -1.437 0 C-N-CA 130.896 3.679 . . . . 2.35 108.397 160.117 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -76.27 -7.28 17.9 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 C-N-CA 123.769 2.979 . . . . 1.31 111.322 -174.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.5 m -94.91 0.51 54.8 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.125 1.77 . . . . 1.71 111.524 175.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.53 142.65 38.94 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.178 -2.826 . . . . 1.69 108.794 174.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 p -84.58 173.29 10.9 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 124.498 1.119 . . . . 1.33 113.393 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.2 mm -65.29 -36.41 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 118.766 -2.459 . . . . 1.32 112.682 170.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.307 3.1 mp0 -54.11 -48.49 70.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.874 -2.391 . . . . 1.62 116.084 165.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -63.24 -36.13 82.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 112.628 0.603 . . . . 2.13 112.628 175.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.9 t -62.11 -52.13 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 126.681 1.992 . . . . 1.23 111.932 175.404 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -57.71 -40.39 79.44 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.848 1.259 . . . . 1.97 111.82 176.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.312 . . -50.9 -38.93 52.87 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 120.458 3.503 . . . . 1.19 120.458 167.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -74.65 -24.1 58.77 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.424 -2.048 . . . . 1.92 115.277 177.034 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.9 mt -78.51 -35.65 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 129.313 3.045 . . . . 1.94 106.012 177.034 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -75.98 -36.56 59.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.823 -1.798 . . . . 1.9 111.972 -179.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -55.56 -48.04 75.41 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 128.55 2.74 . . . . 1.55 108.625 174.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -87.66 -59.49 2.23 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.125 -2.234 . . . . 2.95 114.478 -177.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.498 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 68.2 mm-40 -86.55 -25.4 25.06 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 115.11 1.522 . . . . 1.48 115.11 -172.043 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.14 26.55 33.63 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 119.441 -1.361 . . . . 1.12 113.156 175.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.7 mt -96.05 115.67 65.72 Favored Pre-proline 0 N--CA 1.43 -1.454 1 CA-C-O 111.631 -4.033 . . . . 2.07 110.103 -177.179 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.29 164.81 34.47 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 CA-C-N 126.975 3.527 . . . . 1.39 115.142 -177.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -65.37 -34.27 44.63 Favored 'Trans proline' 0 N--CA 1.434 -1.982 0 CA-C-O 115.833 -1.82 . . . . 1.68 116.717 -165.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -45.46 -38.74 6.44 Favored 'General case' 0 N--CA 1.43 -1.461 1 C-N-CA 132.382 4.273 . . . . 2.25 116.171 170.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -96.94 2.27 51.4 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.608 2.363 . . . . 2.44 113.856 -176.466 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -88.1 99.61 12.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 116.751 -3.718 . . . . 1.32 107.811 -173.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -90.66 112.02 23.59 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 118.384 -2.697 . . . . 3.19 109.88 163.247 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.8 mt -105.3 129.84 53.56 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.154 1.781 . . . . 1.75 109.805 175.087 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.9 129.27 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 127.571 2.348 . . . . 1.98 109.136 177.201 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.437 ' HB3' HD21 ' A' ' 50' ' ' LEU . 73.1 t80 -123.14 114.29 20.12 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 104.438 -2.43 . . . . 1.94 104.438 171.478 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.37 -110.48 0.54 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 110.224 -3.171 . . . . 1.67 112.545 -170.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.13 4.27 35.59 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 126.492 1.996 . . . . 1.3 114.204 177.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -105.76 129.1 54.03 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.91 1.684 . . . . 2.89 114.739 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -82.5 126.6 32.43 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 126.558 1.943 . . . . 2.89 109.129 170.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.469 HD23 ' CE2' ' A' ' 59' ' ' TYR . 18.3 mt -79.5 128.89 33.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.501 1.92 . . . . 1.34 109.756 -173.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -112.68 179.13 4.06 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.207 2.432 . . . . 1.94 110.874 178.261 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -79.77 151.87 30.12 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 117.197 -1.801 . . . . 1.56 112.763 -171.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.71 -0.57 81.47 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 119.524 -1.985 . . . . 0.97 116.914 170.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -87.54 159.42 18.62 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 125.575 1.397 . . . . 3.07 110.505 169.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.266 70.4 p -100.08 167.52 10.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.937 2.303 . . . . 1.34 112.397 173.357 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.21 -29.75 70.85 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 117.086 -3.509 . . . . 1.63 112.221 164.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 t -68.8 -30.95 69.63 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.156 -1.59 . . . . 1.51 112.111 178.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -62.84 -50.34 71.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 114.904 1.446 . . . . 1.9 114.904 172.351 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.469 ' CE2' HD23 ' A' ' 50' ' ' LEU . 85.0 m-85 -81.87 11.9 4.55 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 115.927 -1.987 . . . . 0.97 111.788 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 m120 56.96 46.08 20.1 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 125.559 2.6 . . . . 2.35 115.04 178.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.3 mt -91.82 122.61 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 112.354 -2.203 . . . . 1.39 110.154 178.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -108.58 173.53 6.28 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 127.176 2.797 . . . . 2.58 109.477 -173.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -59.53 142.7 52.06 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.482 1.66 . . . . 2.58 115.482 173.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 5.7 tt0 75.71 15.2 2.64 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 126.271 2.939 . . . . 1.71 116.32 174.07 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 m -77.35 139.97 39.86 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 113.605 -1.634 . . . . 1.34 108.048 -175.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -109.51 90.94 3.45 Favored 'General case' 0 N--CA 1.429 -1.497 1 O-C-N 116.016 -4.177 . . . . 1.36 114.772 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -65.45 153.13 42.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.904 2.288 . . . . 2.03 112.82 173.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -105.53 101.51 11.03 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 115.815 -4.303 . . . . 2.31 109.326 -178.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.0 tp -91.89 108.74 20.14 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 121.018 1.736 . . . . 1.72 110.116 173.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -98.69 129.98 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 1 C-N-CA 134.069 4.947 . . . . 1.8 106.804 173.479 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.4 tp -102.42 116.71 33.19 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 111.911 -2.404 . . . . 3.26 112.861 174.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.86 159.33 15.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.772 2.138 . . . . 4.12 116.772 176.56 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.9 mt -81.17 -100.22 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.443 2.544 . . . . 3.54 110.776 171.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -87.17 168.19 13.46 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 115.858 -4.276 . . . . 7.32 111.061 172.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.07 166.76 38.08 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 106.43 -2.668 . . . . 3.73 106.43 -168.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.744 1 CA-C-O 113.232 -4.094 . . . . 3.87 106.312 178.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptt? . . . . . 0 CA--C 1.49 -1.34 0 N-CA-C 113.533 0.938 . . . . 1.39 113.533 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -105.38 124.33 49.37 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.371 3.068 . . . . 2.2 112.688 -175.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.1 pt -123.8 155.36 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 C-N-CA 129.349 3.06 . . . . 1.32 110.645 175.166 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -114.42 132.8 56.12 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 112.305 -2.225 . . . . 2.2 112.007 -171.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.86 97.22 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 103.192 -2.892 . . . . 1.23 103.192 178.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -90.62 141.09 29.14 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.529 -1.982 . . . . 2.51 112.403 174.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.7 p -107.31 165.39 11.42 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 120.126 1.33 . . . . 1.41 110.406 176.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.3 tp -52.7 -36.18 56.84 Favored 'General case' 0 N--CA 1.43 -1.435 1 C-N-CA 134.79 5.236 . . . . 2.95 116.974 177.65 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.4 p -90.08 -19.81 23.91 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.789 -3.07 . . . . 2.52 111.195 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.56 12.38 2.5 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 118.878 -2.389 . . . . 1.5 114.592 169.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 28.7 ttpt -94.21 135.4 35.64 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 119.809 1.805 . . . . 1.79 110.433 -176.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.1 m -115.41 108.7 16.85 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.625 -4.422 . . . . 1.38 108.506 178.45 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -81.48 124.01 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.455 2.302 . . . . 2.03 108.594 175.076 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.6 m -101.32 98.27 8.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.435 -2.666 . . . . 1.61 108.518 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 mt -100.07 139.91 35.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 127.821 3.676 . . . . 2.15 108.829 179.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -96.35 132.1 42.19 Favored 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 114.532 -5.105 . . . . 1.98 107.882 172.494 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.82 168.33 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 126.886 2.074 . . . . 1.52 109.763 179.007 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -105.43 160.61 25.44 Favored Pre-proline 0 N--CA 1.429 -1.477 0 O-C-N 119.457 -2.027 . . . . 2.35 105.927 165.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -79.59 -16.6 11.69 Favored 'Trans proline' 0 N--CA 1.434 -2.004 1 CA-C-N 129.395 4.391 . . . . 1.31 112.027 -168.437 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.8 p -85.32 2.9 42.14 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.681 -2.512 . . . . 1.71 116.272 173.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -71.12 140.04 50.48 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 125.44 1.713 . . . . 1.69 109.98 173.3 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.434 HG21 HG23 ' A' ' 55' ' ' THR 0.444 42.7 p -84.46 161.02 20.45 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.848 -1.782 . . . . 1.33 110.646 -178.624 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.9 mm -52.98 -27.86 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 C-N-CA 126.46 1.904 . . . . 1.32 115.124 170.471 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -57.65 -44.87 85.95 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.292 2.637 . . . . 1.62 115.687 167.278 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -65.13 -37.35 87.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.787 2.708 . . . . 2.13 115.598 178.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.3 t -72.75 -47.63 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 112.333 -2.212 . . . . 1.23 115.086 177.517 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -65.75 -17.05 64.35 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 114.581 1.326 . . . . 1.97 114.581 169.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.28 -41.28 17.02 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 119.958 1.253 . . . . 1.19 108.198 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -59.64 -31.83 69.89 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.143 1.905 . . . . 1.92 116.143 170.413 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.77 -49.73 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.453 1.597 . . . . 1.94 114.706 170.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -59.56 -37.51 78.65 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 113.662 0.986 . . . . 1.9 113.662 177.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.7 -37.95 77.21 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.62 -3.175 . . . . 1.55 113.684 176.357 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -92.56 -59.64 2.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.265 1.983 . . . . 2.95 114.364 -177.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.409 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 49.1 mm-40 -84.97 -27.45 26.49 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 118.622 -2.549 . . . . 1.48 113.074 -169.309 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.32 24.43 26.56 Favored Glycine 0 N--CA 1.431 -1.684 0 CA-C-O 124.497 2.165 . . . . 1.12 109.423 169.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.3 mt -91.82 112.79 56.41 Favored Pre-proline 0 N--CA 1.431 -1.411 0 CA-C-N 113.225 -1.487 . . . . 2.07 110.461 -171.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.255 18.4 Cg_exo -55.37 139.68 81.75 Favored 'Trans proline' 0 N--CA 1.433 -2.058 1 N-CA-C 123.69 4.458 . . . . 1.39 123.69 174.821 . . . . . . . . 3 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -62.01 -22.26 73.91 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 C-N-CA 123.659 2.906 . . . . 1.68 111.013 -175.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.63 -31.32 71.92 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.883 1.801 . . . . 2.25 110.864 173.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -88.09 -14.84 37.81 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 116.413 -3.929 . . . . 2.44 115.562 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -78.98 98.94 6.62 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 112.139 -2.301 . . . . 1.32 106.659 -173.102 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -102.8 107.48 18.36 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.097 -2.927 . . . . 3.19 103.097 169.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.4 mt -105.28 148.12 27.35 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 114.597 -2.841 . . . . 1.75 105.049 -175.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 mm -125.1 131.78 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 109.38 -0.6 . . . . 1.98 109.38 -179.258 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -122.23 108.79 13.69 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.888 -2.382 . . . . 1.94 104.799 168.432 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.87 -92.67 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.18 2.192 . . . . 1.67 110.01 179.051 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.4 -26.69 4.74 Favored Glycine 0 N--CA 1.429 -1.811 0 CA-C-N 113.68 -1.6 . . . . 1.3 109.974 -173.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.383 51.2 mttm -99.07 134.97 41.15 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.018 -3.048 . . . . 2.89 118.26 -176.304 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -90.08 116.04 27.8 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 105.836 -1.912 . . . . 2.89 105.836 176.206 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.3 118.97 10.09 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 123.607 1.67 . . . . 1.34 111.521 -169.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.12 154.13 20.41 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 116.531 -3.856 . . . . 1.94 110.682 -179.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -68.98 152.73 44.89 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.59 -1.943 . . . . 1.56 114.178 -173.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.47 10.55 85.65 Favored Glycine 0 N--CA 1.43 -1.709 0 O-C-N 119.454 -2.029 . . . . 0.97 112.57 173.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -104.24 171.3 7.41 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.992 2.33 . . . . 3.07 110.245 170.253 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.434 HG23 HG21 ' A' ' 22' ' ' THR . 69.1 p -106.32 -174.09 2.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.524 -3.86 . . . . 1.34 104.876 174.324 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.8 mt -83.02 -35.56 25.69 Favored 'General case' 0 N--CA 1.431 -1.423 1 C-N-CA 133.367 4.667 . . . . 1.63 110.477 174.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -70.41 -25.88 63.42 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.221 -3.425 . . . . 1.51 114.938 175.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -59.9 -34.06 72.67 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.894 -3.004 . . . . 1.9 111.81 168.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -92.76 11.53 26.59 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 121.42 1.918 . . . . 0.97 111.177 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.33 10.9 m120 53.26 36.29 22.28 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 127.47 2.308 . . . . 2.35 116.34 -175.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.4 mt -85.9 129.2 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 127.625 2.37 . . . . 1.39 108.464 -176.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -123.66 -167.01 1.55 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.253 -2.779 . . . . 2.58 110.91 -173.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -58.44 141.42 51.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.651 0.982 . . . . 2.58 113.651 178.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 69.28 33.71 3.17 Favored 'General case' 0 N--CA 1.43 -1.465 1 C-N-CA 132.199 4.199 . . . . 1.71 109.316 175.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 m -101.24 142.93 31.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 123.075 2.671 . . . . 1.34 107.562 -172.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.3 m -102.4 102.74 13.1 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 116.083 -1.913 . . . . 1.36 110.65 -171.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.317 57.6 mt -78.69 147.37 33.52 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.767 -1.197 . . . . 2.03 107.767 169.26 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -101.73 128.12 48.2 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.998 -1.064 . . . . 2.31 109.006 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.2 tt -93.61 104.33 16.45 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 118.661 -2.525 . . . . 1.72 110.391 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.0 t -107.67 129.48 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 O-C-N 117.157 -3.464 . . . . 1.8 109.408 -179.09 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.4 mt -97.82 125.37 42.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.201 -2.812 . . . . 3.26 111.651 -177.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -87.17 130.02 34.71 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.665 3.586 . . . . 4.12 108.074 178.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.4 tp -97.43 -62.92 1.18 Allowed 'General case' 0 N--CA 1.432 -1.361 0 CA-C-O 123.917 1.818 . . . . 3.54 111.439 174.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -137.99 146.66 43.39 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 111.901 -2.409 . . . . 7.32 111.593 175.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.56 179.6 29.12 Favored Glycine 0 N--CA 1.43 -1.723 0 O-C-N 119.106 -2.246 . . . . 3.73 110.815 -168.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.747 1 O-C-N 115.97 -4.253 . . . . 3.87 120.793 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.351 19.0 ptt? . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 118.131 -0.938 . . . . 1.39 111.139 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -100.69 132.9 45.85 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 125.965 1.706 . . . . 2.2 106.972 -171.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.04 157.5 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 115.181 -2.342 . . . . 1.32 109.525 166.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -107.59 143.95 35.31 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.161 1.458 . . . . 2.2 111.782 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 t -123.44 124.44 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 105.583 -2.006 . . . . 1.23 105.583 171.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -114.69 135.89 53.66 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 117.15 2.278 . . . . 2.51 117.15 178.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.515 21.3 p -69.59 -175.59 0.88 Allowed 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.82 2.247 . . . . 1.41 113.707 179.386 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.3 mt -89.99 -33.67 16.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.482 -3.261 . . . . 2.95 113.913 165.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 p -74.49 -56.08 5.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.865 -1.772 . . . . 2.52 114.606 -176.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.07 31.16 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 119.997 2.759 . . . . 1.5 119.997 174.412 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -121.8 128.48 51.74 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.507 2.099 . . . . 1.79 111.423 -175.467 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.278 32.3 m -103.5 130.55 50.9 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.271 -2.143 . . . . 1.38 111.541 172.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -100.67 149.83 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 129.682 3.193 . . . . 2.03 107.912 176.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.5 m -123.46 131.17 53.56 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 122.22 2.282 . . . . 1.61 105.468 172.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.8 mt -119.4 128.57 54.17 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 116.047 -1.93 . . . . 2.15 114.048 -179.6 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -80.0 112.43 17.29 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 115.138 1.533 . . . . 1.98 115.138 165.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.86 174.93 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.578 -2.576 . . . . 1.52 104.701 -171.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -124.02 171.67 6.76 Favored Pre-proline 0 N--CA 1.43 -1.475 0 CA-C-O 114.233 -2.794 . . . . 2.35 104.979 165.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -76.11 -7.75 18.34 Favored 'Trans proline' 0 N--CA 1.434 -1.996 1 CA-C-N 130.02 4.614 . . . . 1.31 114.093 -177.369 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.5 p -83.24 -15.92 48.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 129.922 3.289 . . . . 1.71 109.959 179.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.69 139.96 58.24 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 114.542 1.312 . . . . 1.69 114.542 174.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 p -85.3 164.45 18.0 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 118.109 -2.869 . . . . 1.33 115.929 172.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.4 mm -64.56 -24.92 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 119.152 -2.218 . . . . 1.32 115.611 173.269 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -74.98 -31.7 61.51 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 116.053 -1.927 . . . . 1.62 114.901 165.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -66.68 -41.23 88.45 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 120.4 1.455 . . . . 2.13 110.194 174.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.68 -48.43 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 114.29 -2.767 . . . . 1.23 111.135 174.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -54.86 -45.2 74.55 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 122.144 2.247 . . . . 1.97 114.002 176.219 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.05 -41.16 87.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.174 1.916 . . . . 1.19 116.174 168.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -61.06 -41.36 96.47 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.292 2.237 . . . . 1.92 110.435 173.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.4 mt -64.37 -32.91 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 121.096 1.771 . . . . 1.94 114.474 169.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -62.69 -43.07 99.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.431 1.092 . . . . 1.9 112.503 175.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -56.1 -42.5 76.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.391 -2.693 . . . . 1.55 113.567 174.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -74.99 -66.64 0.73 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.626 1.343 . . . . 2.95 114.626 -178.117 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -95.29 -21.23 18.55 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.241 2.617 . . . . 1.48 115.389 -166.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.37 1.78 68.74 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 127.954 3.284 . . . . 1.12 113.704 175.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 mt -72.1 126.63 91.14 Favored Pre-proline 0 N--CA 1.429 -1.481 0 C-N-CA 125.538 1.535 . . . . 2.07 113.44 -177.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -72.67 150.62 50.92 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 O-C-N 113.651 -3.921 . . . . 1.39 116.341 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -63.59 -32.16 69.8 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 CA-C-N 124.045 2.48 . . . . 1.68 111.48 -171.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -57.61 -29.7 64.73 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 114.939 -4.851 . . . . 2.25 114.775 176.594 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -90.73 -21.0 21.79 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 119.108 -1.037 . . . . 2.44 111.138 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.279 57.9 mt-30 -78.68 140.0 38.42 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 120.328 -1.483 . . . . 1.32 114.134 -174.623 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -126.44 126.44 43.8 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.771 1.748 . . . . 3.19 106.741 170.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.305 29.3 mt -98.21 111.74 23.96 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 118.868 -2.395 . . . . 1.75 111.203 178.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mm -105.95 121.02 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 124.327 1.051 . . . . 1.98 111.846 -178.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -114.36 98.31 6.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 129.06 2.944 . . . . 1.94 112.638 168.135 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.409 ' HB3' ' H ' ' A' ' 47' ' ' GLY . . . 62.1 -106.22 0.21 Allowed 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.335 -2.728 . . . . 1.67 113.837 -179.702 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 46' ' ' ALA . . . -94.94 -12.44 55.37 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 128.704 3.05 . . . . 1.3 112.867 -179.28 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -114.06 149.3 35.68 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 123.28 3.54 . . . . 2.89 106.403 -173.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -106.83 142.87 35.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 100.673 -3.825 . . . . 2.89 100.673 169.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 mt -103.24 130.19 50.41 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 116.434 -2.106 . . . . 1.34 111.655 -172.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -81.19 141.32 34.3 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 118.028 2.603 . . . . 1.94 118.028 -174.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -60.66 132.0 52.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.609 1.818 . . . . 1.56 108.94 -176.127 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.02 -19.13 44.52 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 126.159 1.838 . . . . 0.97 116.149 171.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.8 mtt180 -82.24 164.9 20.88 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 123.094 1.426 . . . . 3.07 113.5 170.25 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.2 p -87.99 162.99 16.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.487 3.041 . . . . 1.34 112.707 174.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.6 mt -61.11 -26.46 67.69 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 114.218 -5.301 . . . . 1.63 119.552 167.457 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.7 t -67.08 -35.03 78.94 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 112.925 -1.943 . . . . 1.51 112.729 176.242 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -56.7 -41.99 78.33 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.812 -3.055 . . . . 1.9 112.402 175.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -88.96 4.46 48.03 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 119.284 -2.135 . . . . 0.97 112.584 177.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.1 m120 58.33 47.34 14.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.801 2.889 . . . . 2.35 118.801 -178.227 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mt -96.17 130.05 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 124.789 1.306 . . . . 1.39 108.69 -178.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -114.23 -159.62 0.7 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 115.504 -2.479 . . . . 2.58 105.734 176.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -56.0 153.45 8.82 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 115.551 -4.468 . . . . 2.58 116.925 171.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 55.23 33.18 20.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.341 2.972 . . . . 1.71 110.987 173.213 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 m -89.52 143.08 27.1 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 113.962 -5.461 . . . . 1.34 110.584 -179.614 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.2 m -96.02 113.08 24.66 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.282 -2.118 . . . . 1.36 105.282 178.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mp -104.57 169.82 8.24 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 104.263 -2.495 . . . . 2.03 104.263 165.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -125.84 139.21 53.67 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 127.831 3.207 . . . . 2.31 112.827 -172.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.0 tp -98.67 123.38 42.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.789 -2.444 . . . . 1.72 112.038 177.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.16 162.25 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.849 -2.278 . . . . 1.8 104.849 174.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.5 mt -129.03 147.03 50.86 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.085 2.374 . . . . 3.26 109.947 -179.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.286 68.3 ttt180 -82.92 140.22 32.95 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 110.313 -3.13 . . . . 4.12 109.87 179.213 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.9 mt -106.78 74.26 0.99 Allowed 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.781 -3.075 . . . . 3.54 114.963 178.617 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -64.28 -31.92 73.31 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.49 -2.006 . . . . 7.32 112.437 169.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.81 -44.63 1.62 Allowed Glycine 0 N--CA 1.43 -1.706 0 O-C-N 117.74 -3.1 . . . . 3.73 114.556 -175.223 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.782 0 N-CA-C 107.641 -2.184 . . . . 3.87 107.641 -176.48 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ttp . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 123.506 1.622 . . . . 1.39 113.285 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -83.15 130.11 35.08 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 115.41 -4.556 . . . . 2.2 114.049 -178.28 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -126.17 161.83 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 115.704 -2.094 . . . . 1.32 108.516 168.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -112.76 137.61 50.81 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 104.865 -2.272 . . . . 2.2 104.865 -177.192 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 t -107.46 120.59 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 114.106 -1.406 . . . . 1.23 108.015 173.249 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -96.01 115.45 27.45 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.828 -2.42 . . . . 2.51 111.381 179.327 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.9 p -80.42 175.14 10.92 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 115.982 -4.199 . . . . 1.41 116.223 173.491 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.0 mt -80.5 -24.55 39.32 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.672 -1.232 . . . . 2.95 107.672 176.586 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.3 p -70.93 -39.93 72.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.332 -2.73 . . . . 2.52 108.96 175.508 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.86 50.63 0.55 Allowed Glycine 0 N--CA 1.429 -1.827 0 C-N-CA 126.36 1.933 . . . . 1.5 113.708 -177.568 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -124.21 136.93 54.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 101.556 -3.498 . . . . 1.79 101.556 -179.116 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.4 m -100.22 116.74 32.93 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.777 -3.077 . . . . 1.38 104.767 178.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mt -99.15 141.26 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 104.821 -2.288 . . . . 2.03 104.821 178.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.5 m -109.88 108.2 18.4 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 103.893 -2.632 . . . . 1.61 103.893 -175.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.8 mt -102.74 160.59 14.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.415 -2.678 . . . . 2.15 108.46 177.699 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -119.69 107.19 12.92 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 130.553 3.541 . . . . 1.98 107.919 172.227 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.267 23.2 m -121.58 -171.61 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.696 1.598 . . . . 1.52 109.391 -174.107 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -143.84 179.89 1.09 Allowed Pre-proline 0 N--CA 1.43 -1.428 0 C-N-CA 126.114 1.765 . . . . 2.35 112.672 167.769 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -76.5 -28.0 7.18 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 125.317 2.935 . . . . 1.31 115.669 -176.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 p -77.8 -20.33 53.43 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.062 2.545 . . . . 1.71 113.43 -177.68 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.34 139.86 41.51 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 122.989 2.631 . . . . 1.69 112.813 172.531 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.1 p -84.17 175.37 9.51 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 124.295 1.038 . . . . 1.33 112.073 174.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 33.6 mm -74.8 -34.35 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-O 116.241 -1.838 . . . . 1.32 107.573 177.831 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -49.32 -41.7 39.28 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 129.008 2.923 . . . . 1.62 113.131 166.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -78.19 -28.61 48.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.394 -2.066 . . . . 2.13 113.075 177.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.39 -43.16 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 125.223 1.409 . . . . 1.23 107.459 171.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -55.06 -39.86 69.69 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 123.179 2.718 . . . . 1.97 113.178 169.11 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.61 -40.08 76.84 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 126.925 2.09 . . . . 1.19 110.774 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -68.51 -23.28 64.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.353 -2.092 . . . . 1.92 113.109 176.177 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.4 mt -82.81 -28.1 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 117.208 -1.797 . . . . 1.94 110.896 172.615 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -63.33 -44.52 94.7 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.976 -1.702 . . . . 1.9 110.98 177.373 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -56.28 -50.06 72.46 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.809 2.043 . . . . 1.55 111.225 173.193 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -66.08 -59.81 3.43 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 118.951 2.945 . . . . 2.95 118.951 -178.581 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -108.84 -25.58 10.71 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 128.828 2.851 . . . . 1.48 113.544 -165.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.02 47.91 7.31 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 123.908 0.755 . . . . 1.12 112.626 -177.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.9 mt -104.82 114.39 63.91 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 105.663 -1.977 . . . . 2.07 105.663 177.115 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -55.83 151.45 40.43 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 123.456 2.771 . . . . 1.39 116.154 175.396 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -70.51 -22.81 28.15 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 126.099 3.214 . . . . 1.68 119.904 -173.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.59 -17.94 62.9 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.459 1.903 . . . . 2.25 110.977 171.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -79.51 -29.44 41.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 121.162 1.801 . . . . 2.44 109.472 175.704 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.427 ' HG2' HD13 ' A' ' 69' ' ' LEU . 76.2 mt-30 -84.51 140.08 31.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 118.744 2.868 . . . . 1.32 118.744 -167.803 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -129.99 116.61 18.83 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 104.65 -2.352 . . . . 3.19 104.65 167.412 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.8 mt -96.04 105.65 17.71 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.071 2.549 . . . . 1.75 114.58 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.5 mm -98.04 134.94 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 106.24 -1.763 . . . . 1.98 106.24 -172.692 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.411 ' HB3' HD21 ' A' ' 50' ' ' LEU . 68.5 t80 -130.08 95.14 3.86 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 116.089 -2.244 . . . . 1.94 107.277 171.305 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 74.33 -107.38 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.325 1.85 . . . . 1.67 111.098 -173.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.79 -12.5 24.2 Favored Glycine 0 N--CA 1.429 -1.768 0 O-C-N 118.482 -2.636 . . . . 1.3 109.029 -175.43 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -100.08 134.17 43.39 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.213 -1.757 . . . . 2.89 110.032 -174.51 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -84.37 132.87 34.55 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 103.146 -2.909 . . . . 2.89 103.146 167.383 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' A' ' 45' ' ' PHE . 14.1 mt -88.5 136.58 32.92 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.911 -2.368 . . . . 1.34 113.75 -179.101 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -73.52 138.65 45.15 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 126.134 2.146 . . . . 1.94 111.731 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.473 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 7.8 m-20 -62.96 -39.72 95.52 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 117.599 2.444 . . . . 1.56 117.599 -166.761 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.21 16.43 55.83 Favored Glycine 0 N--CA 1.43 -1.708 0 O-C-N 117.575 -3.203 . . . . 0.97 111.779 175.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -95.34 174.4 7.05 Favored 'General case' 0 N--CA 1.429 -1.5 1 CA-C-N 125.407 4.604 . . . . 3.07 108.93 167.224 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.1 p -107.84 176.66 5.07 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 115.397 -2.521 . . . . 1.34 113.979 177.19 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.8 mt -57.91 -46.44 84.98 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 126.773 3.178 . . . . 1.63 113.162 169.627 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 t -62.27 -37.28 84.86 Favored 'General case' 0 N--CA 1.43 -1.435 1 CA-C-N 108.005 -4.18 . . . . 1.51 116.54 178.669 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -62.07 -36.4 81.55 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 120.389 1.45 . . . . 1.9 114.801 176.451 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -89.9 0.92 56.78 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 116.795 2.146 . . . . 0.97 116.795 177.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 m120 74.5 24.79 1.71 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.713 3.205 . . . . 2.35 114.849 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.3 mt -68.94 112.71 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 115.244 1.572 . . . . 1.39 115.244 174.577 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -107.04 -165.54 1.08 Allowed 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 125.007 1.323 . . . . 2.58 112.081 -177.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -67.72 153.23 44.17 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.483 1.66 . . . . 2.58 115.483 177.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 60.83 24.31 14.26 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 128.283 2.633 . . . . 1.71 116.056 179.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.3 m -89.3 148.34 23.61 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.056 -2.278 . . . . 1.34 110.404 -170.722 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.8 m -111.82 110.11 20.29 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.065 -2.897 . . . . 1.36 110.664 -173.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.3 mp -90.23 151.89 21.32 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 100.792 -3.781 . . . . 2.03 100.792 172.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -116.36 123.08 46.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.463 -2.023 . . . . 2.31 110.8 175.227 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.427 HD13 ' HG2' ' A' ' 41' ' ' GLN . 45.9 tp -95.04 101.97 13.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.653 -2.067 . . . . 1.72 108.651 -174.507 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.6 t -102.41 138.38 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 105.669 -1.975 . . . . 1.8 105.669 178.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.3 mt -116.48 164.16 14.99 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.432 1.587 . . . . 3.26 107.702 -179.73 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -87.5 150.46 23.72 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 111.094 -2.776 . . . . 4.12 110.243 174.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.0 mt -48.04 120.65 3.64 Favored 'General case' 0 N--CA 1.43 -1.442 1 N-CA-C 123.149 4.5 . . . . 3.54 123.149 177.816 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.436 ' HB3' ' H ' ' A' ' 75' ' ' GLY . 26.3 ttt180 -106.2 -79.31 0.57 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.317 2.008 . . . . 7.32 115.28 170.734 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.436 ' H ' ' HB3' ' A' ' 74' ' ' ARG . . . 142.99 82.25 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 103.951 -3.66 . . . . 3.73 103.951 -167.321 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.753 0 CA-C-N 120.283 2.041 . . . . 3.87 110.319 -171.078 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptt? . . . . . 0 CA--C 1.49 -1.364 0 CA-C-O 118.977 -0.535 . . . . 1.39 111.39 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -98.57 121.59 40.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.28 1.038 . . . . 2.2 109.442 -175.244 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.0 pt -119.44 155.04 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 123.317 1.532 . . . . 1.32 109.433 174.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -113.78 126.03 54.76 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.732 -1.855 . . . . 2.2 112.712 -179.127 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.451 HG21 HD12 ' A' ' 30' ' ' ILE . 40.5 t -104.88 114.25 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 105.259 -2.126 . . . . 1.23 105.259 178.601 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -103.74 121.5 43.13 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 129.232 3.013 . . . . 2.51 107.682 -175.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 p -86.49 -179.24 6.6 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 127.93 3.729 . . . . 1.41 117.797 179.248 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.2 mt -83.06 -29.22 28.99 Favored 'General case' 0 N--CA 1.429 -1.505 1 O-C-N 110.91 -7.369 . . . . 2.95 111.913 168.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.9 p -64.7 -41.3 96.11 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 117.035 -3.54 . . . . 2.52 110.141 171.443 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.08 4.88 3.19 Favored Glycine 0 N--CA 1.431 -1.692 0 O-C-N 119.962 -1.711 . . . . 1.5 114.248 173.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -75.9 122.28 23.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 125.959 1.704 . . . . 1.79 111.23 -171.547 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.307 23.8 m -80.15 88.25 5.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.842 -3.661 . . . . 1.38 114.056 167.106 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.5 mt -82.71 130.34 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 103.067 -2.938 . . . . 2.03 103.067 -176.834 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.3 m -101.89 117.48 34.93 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.957 3.303 . . . . 1.61 107.196 -174.287 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.5 mt -131.21 152.43 50.5 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 124.925 3.511 . . . . 2.15 111.642 -178.396 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -106.64 105.13 15.01 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 126.586 1.955 . . . . 1.98 113.285 175.289 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 m -118.09 174.45 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 126.476 1.91 . . . . 1.52 107.615 -175.446 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -126.43 165.62 26.91 Favored Pre-proline 0 N--CA 1.431 -1.39 0 O-C-N 118.638 -2.538 . . . . 2.35 106.203 166.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -75.77 -22.57 13.38 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 CA-C-N 124.639 2.693 . . . . 1.31 114.581 -171.305 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.0 m -85.44 15.49 4.43 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 116.354 -2.138 . . . . 1.71 112.591 174.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -91.39 167.35 12.34 Favored 'General case' 0 N--CA 1.431 -1.425 1 O-C-N 116.141 -4.1 . . . . 1.69 109.48 169.025 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 36.4 p -104.0 174.57 5.82 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.704 -1.135 . . . . 1.33 108.339 -175.382 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.9 mm -74.76 -31.71 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 127.854 2.462 . . . . 1.32 107.958 175.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -57.72 -40.5 79.7 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.633 1.716 . . . . 1.62 115.633 169.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -65.29 -48.77 71.99 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 124.23 1.967 . . . . 2.13 111.881 171.472 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.28 47.5 t -54.17 -41.71 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 117.19 -3.444 . . . . 1.23 115.333 172.455 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -59.26 -46.72 87.75 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 118.046 2.61 . . . . 1.97 118.046 167.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.01 -38.93 80.36 Favored 'General case' 0 N--CA 1.432 -1.369 1 C-N-CA 131.714 4.006 . . . . 1.19 114.037 172.845 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.23 -42.93 99.29 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.908 1.683 . . . . 1.92 113.148 167.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.451 HD12 HG21 ' A' ' 5' ' ' VAL . 65.8 mt -69.16 -32.32 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 125.945 1.698 . . . . 1.94 110.109 179.14 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -69.92 -47.92 60.54 Favored 'General case' 0 N--CA 1.431 -1.404 1 O-C-N 115.853 -4.279 . . . . 1.9 114.248 175.013 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.27 16.4 t70 -44.53 -59.48 2.43 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 130.53 3.532 . . . . 1.55 110.132 166.297 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -67.81 -53.34 27.79 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.942 2.097 . . . . 2.95 112.557 -172.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -102.06 -75.04 0.61 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.76 3.171 . . . . 1.48 112.184 -170.185 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.66 22.84 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.714 0 CA-C-O 124.309 2.061 . . . . 1.12 115.101 177.709 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mt -97.79 128.64 33.49 Favored Pre-proline 0 N--CA 1.43 -1.434 0 O-C-N 117.95 -3.088 . . . . 2.07 117.281 -172.319 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -63.03 137.88 64.55 Favored 'Trans proline' 0 N--CA 1.433 -2.032 0 O-C-N 114.65 -3.395 . . . . 1.39 113.309 178.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -59.92 -17.72 45.72 Favored 'Trans proline' 0 N--CA 1.434 -2.009 1 C-N-CA 125.474 4.116 . . . . 1.68 115.135 178.747 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -75.33 -28.42 59.64 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.028 -2.295 . . . . 2.25 112.289 169.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -82.01 -26.0 34.21 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.781 -2.449 . . . . 2.44 110.196 -173.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -87.58 124.22 33.27 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.451 -2.031 . . . . 1.32 114.475 -174.157 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -113.07 115.4 28.28 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 124.329 2.014 . . . . 3.19 109.291 170.098 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.252 4.2 mm? -95.97 116.34 28.79 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 125.544 2.592 . . . . 1.75 112.215 178.962 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.3 mm -98.23 122.85 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 1 O-C-N 114.918 -4.864 . . . . 1.98 108.655 178.956 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -138.22 142.32 39.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 116.755 -3.715 . . . . 1.94 103.143 168.245 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.317 . . 62.53 22.37 13.24 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.352 2.352 . . . . 1.67 117.352 177.609 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.04 -14.56 43.16 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 116.947 -3.595 . . . . 1.3 114.229 -175.104 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -100.2 161.36 13.66 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 128.479 2.712 . . . . 2.89 111.707 176.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -94.92 140.84 29.37 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 117.535 -3.228 . . . . 2.89 114.854 169.962 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.323 19.7 mt -80.04 135.61 36.4 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 126.426 3.012 . . . . 1.34 113.252 -176.48 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -89.02 144.15 26.35 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.976 -3.577 . . . . 1.94 115.47 175.348 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.269 16.5 m-20 -53.59 -65.78 0.51 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.715 -2.49 . . . . 1.56 116.281 -170.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.3 58.79 2.81 Favored Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 127.186 2.327 . . . . 0.97 116.816 167.196 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -139.37 144.98 38.43 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 102.734 -3.062 . . . . 3.07 102.734 166.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 60.8 p -79.72 160.98 26.03 Favored 'General case' 0 N--CA 1.429 -1.477 1 CA-C-O 128.785 4.136 . . . . 1.34 114.643 170.937 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.1 mt -71.28 -32.61 68.88 Favored 'General case' 0 N--CA 1.431 -1.391 1 O-C-N 114.351 -5.218 . . . . 1.63 107.066 -176.263 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.8 p -64.76 -35.97 82.8 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.489 2.403 . . . . 1.51 117.489 171.575 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.252 7.9 t70 -60.54 -44.5 96.02 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.048 2.832 . . . . 1.9 113.653 171.726 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -74.64 -22.62 58.82 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 117.788 -3.07 . . . . 0.97 113.936 176.412 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.322 63.6 m-80 68.24 54.32 0.57 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 126.083 2.849 . . . . 2.35 111.597 -178.629 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.9 mm -98.64 124.92 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 102.333 -3.21 . . . . 1.39 102.333 174.226 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -105.28 -174.99 2.67 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.529 -0.732 . . . . 2.58 110.183 -175.45 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -65.12 149.67 49.49 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 116.289 1.959 . . . . 2.58 116.289 169.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 77.11 11.42 2.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.87 1.268 . . . . 1.71 113.674 172.111 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.346 5.4 t -78.55 134.84 37.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.971 3.708 . . . . 1.34 120.909 -174.112 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.9 m -101.2 106.47 17.7 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.928 1.694 . . . . 1.36 108.918 -177.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.6 mt -88.8 138.56 31.3 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 118.561 -1.255 . . . . 2.03 108.496 170.073 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -94.56 125.36 39.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 123.958 1.837 . . . . 2.31 113.312 -176.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.7 tp -103.46 126.78 50.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.468 -3.27 . . . . 1.72 111.446 -173.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.3 t -118.16 147.07 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 102.258 -3.238 . . . . 1.8 102.258 173.143 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.5 mt -111.07 137.59 48.54 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 113.031 -1.895 . . . . 3.26 110.029 179.081 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -94.2 86.94 5.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.267 2.227 . . . . 4.12 106.805 179.495 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.2 mt -89.83 158.9 17.27 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 125.807 2.718 . . . . 3.54 110.473 176.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -97.02 148.49 22.94 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.867 -3.645 . . . . 7.32 108.1 171.502 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.92 -86.65 0.45 Allowed Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 108.293 -1.923 . . . . 3.73 108.293 -166.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.733 0 CA-C-N 110.562 -2.819 . . . . 3.87 108.082 -173.418 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 ptt? . . . . . 0 CA--C 1.49 -1.364 0 CA-C-O 124.246 1.974 . . . . 1.39 110.713 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -111.79 132.78 54.44 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 117.829 -3.044 . . . . 2.2 115.553 -171.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.2 pt -135.88 161.83 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 105.592 -2.003 . . . . 1.32 105.592 176.17 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -119.32 145.92 45.73 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 123.611 1.672 . . . . 2.2 109.847 -179.184 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.5 t -119.37 123.62 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 114.528 -1.214 . . . . 1.23 112.464 176.207 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -93.67 111.97 23.76 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 119.339 -0.945 . . . . 2.51 110.665 177.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.2 p -69.52 169.37 12.7 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.559 -1.963 . . . . 1.41 115.224 176.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.39 -25.87 61.66 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 118.552 -2.592 . . . . 2.95 112.723 178.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.9 p -74.6 -22.18 59.09 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 128.012 2.525 . . . . 2.52 115.175 177.317 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.76 52.53 2.43 Favored Glycine 0 N--CA 1.43 -1.712 0 C-N-CA 130.35 3.833 . . . . 1.5 111.71 175.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -116.68 140.88 48.91 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 102.432 -3.173 . . . . 1.79 102.432 -178.497 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.5 m -107.38 117.75 34.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 101.579 -3.489 . . . . 1.38 101.579 167.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.2 pt -96.04 166.83 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 118.131 -2.855 . . . . 2.03 105.258 173.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.0 m -122.28 141.41 51.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 116.712 -1.613 . . . . 1.61 107.925 175.228 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.403 HD21 ' HG2' ' A' ' 29' ' ' LYS . 13.0 mt -129.81 158.41 39.51 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 127.842 2.457 . . . . 2.15 110.29 173.603 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -111.99 136.53 51.21 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 106.45 -1.685 . . . . 1.98 106.45 167.546 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.7 m -136.17 166.11 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 125.553 1.541 . . . . 1.52 113.976 178.017 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -104.78 156.55 35.8 Favored Pre-proline 0 N--CA 1.43 -1.437 0 O-C-N 120.403 -1.436 . . . . 2.35 109.819 155.531 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -80.34 -5.53 13.51 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 O-C-N 114.624 -3.408 . . . . 1.31 109.908 -171.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.284 67.9 m -77.13 -17.77 58.38 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 116.951 -1.499 . . . . 1.71 110.028 171.135 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -60.98 134.47 57.13 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 120.681 1.582 . . . . 1.69 112.843 173.451 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.7 p -71.58 159.68 34.02 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.286 1.517 . . . . 1.33 109.614 176.714 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.0 mm -69.87 -38.54 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 124.633 2.159 . . . . 1.32 111.285 -176.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -48.13 -42.63 29.78 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 128.794 2.837 . . . . 1.62 115.389 162.626 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -67.12 -32.79 74.16 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.201 -1.562 . . . . 2.13 109.194 178.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.4 t -71.3 -29.14 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 O-C-N 118.386 -2.696 . . . . 1.23 113.614 174.346 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -75.25 -35.76 61.36 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.23 -0.919 . . . . 1.97 108.787 176.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.05 -44.33 74.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.681 1.993 . . . . 1.19 111.788 170.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.403 ' HG2' HD21 ' A' ' 15' ' ' LEU . 23.3 ttmt -58.45 -49.22 78.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 116.836 2.161 . . . . 1.92 116.836 173.424 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.418 3.3 mt -58.27 -37.38 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 118.383 2.734 . . . . 1.94 118.383 170.668 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -63.71 -39.79 95.17 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 118.663 -1.215 . . . . 1.9 113.623 173.11 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -59.67 -58.92 6.49 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.935 1.694 . . . . 1.55 110.555 171.636 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -57.51 -65.66 0.59 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 125.919 1.687 . . . . 2.95 115.288 -179.304 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -106.72 -3.1 20.9 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 129.152 2.981 . . . . 1.48 111.971 -167.161 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.6 54.25 8.87 Favored Glycine 0 N--CA 1.431 -1.696 1 O-C-N 114.469 -5.144 . . . . 1.12 119.29 173.449 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.9 mt -132.27 135.29 26.15 Favored Pre-proline 0 N--CA 1.43 -1.439 0 N-CA-C 102.096 -3.298 . . . . 2.07 102.096 -174.527 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.69 152.27 58.8 Favored 'Trans proline' 0 N--CA 1.434 -2.005 2 C-N-CA 126.379 4.719 . . . . 1.39 108.664 177.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.44 -20.93 54.18 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 122.473 2.115 . . . . 1.68 111.449 -177.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -54.45 -50.02 68.69 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 131.497 3.919 . . . . 2.25 111.513 176.592 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -73.55 -35.06 65.44 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.307 -1.315 . . . . 2.44 112.293 177.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -71.67 123.75 23.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.939 2.199 . . . . 1.32 116.939 -172.663 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -113.38 126.05 54.93 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 122.771 2.532 . . . . 3.19 109.481 166.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.3 mt -97.76 132.69 43.16 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.721 -1.237 . . . . 1.75 112.803 178.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 mt -119.48 146.44 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 2 C-N-CA 135.113 5.365 . . . . 1.98 104.8 179.86 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.304 68.4 t80 -151.26 128.88 11.48 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 102.631 -3.099 . . . . 1.94 102.631 173.382 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.354 . . 52.1 42.56 30.62 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 121.471 3.878 . . . . 1.67 121.471 -178.368 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.38 -30.7 5.49 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-N 120.54 1.518 . . . . 1.3 116.329 179.472 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.331 16.3 pttm -94.55 148.38 22.31 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 129.934 3.294 . . . . 2.89 112.009 178.147 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -87.58 148.98 24.62 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 127.353 3.454 . . . . 2.89 112.8 169.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.445 HD22 ' CD2' ' A' ' 59' ' ' TYR . 55.8 mt -108.45 134.78 50.76 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.36 -2.2 . . . . 1.34 105.333 -175.478 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -88.57 153.72 20.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 126.281 1.832 . . . . 1.94 113.717 178.015 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -63.41 -55.27 25.74 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 117.228 2.307 . . . . 1.56 117.228 -169.527 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.03 62.11 4.59 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 125.825 2.903 . . . . 0.97 119.831 173.517 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.5 mmt-85 -140.5 171.5 14.04 Favored 'General case' 0 N--CA 1.429 -1.479 1 N-CA-C 99.238 -4.356 . . . . 3.07 99.238 171.641 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.8 p -111.36 168.62 9.38 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.747 -1.845 . . . . 1.34 115.476 166.359 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mt -64.11 -37.33 87.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 116.528 -3.858 . . . . 1.63 107.158 174.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -65.69 -34.91 79.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 125.973 3.988 . . . . 1.51 116.751 178.356 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -57.35 -45.63 84.16 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 117.322 2.342 . . . . 1.9 117.322 167.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.445 ' CD2' HD22 ' A' ' 50' ' ' LEU . 43.0 m-85 -87.14 -2.09 58.37 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.462 2.023 . . . . 0.97 116.462 174.586 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 54.63 74.98 0.32 Allowed 'General case' 0 N--CA 1.43 -1.43 1 C-N-CA 132.075 4.15 . . . . 2.35 110.83 -179.465 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.8 mt -116.99 113.41 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 103.005 -2.961 . . . . 1.39 103.005 -177.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -86.48 177.06 7.53 Favored 'General case' 0 N--CA 1.43 -1.452 1 CA-C-O 128.93 4.205 . . . . 2.58 107.908 -174.527 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -63.25 144.74 56.68 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 110.906 -2.861 . . . . 2.58 116.527 172.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.314 43.0 mt-10 73.83 26.05 1.87 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.811 3.196 . . . . 1.71 112.886 173.934 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.284 70.0 m -96.26 151.74 19.23 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.721 -3.112 . . . . 1.34 105.445 -177.196 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.0 m -109.44 120.08 41.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 120.959 1.709 . . . . 1.36 111.236 176.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mt -95.72 136.0 36.69 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 125.569 1.547 . . . . 2.03 109.973 176.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -98.64 118.53 35.56 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.435 -1.415 . . . . 2.31 112.806 -175.299 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.3 tp -99.55 118.01 35.19 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.21 2.204 . . . . 1.72 111.926 178.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.23 165.22 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 105.614 -1.995 . . . . 1.8 105.614 172.61 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.6 mt -97.34 153.01 18.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 114.436 1.273 . . . . 3.26 114.436 -176.122 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -103.73 115.24 30.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 116.632 -1.652 . . . . 4.12 113.326 176.383 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.5 mt -87.54 62.32 7.03 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 121.904 2.138 . . . . 3.54 116.125 173.208 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -73.12 138.35 45.73 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.059 2.544 . . . . 7.32 111.14 171.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.13 60.52 0.48 Allowed Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 104.235 -3.546 . . . . 3.73 104.235 -173.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.794 0 N-CA-C 107.481 -2.248 . . . . 3.87 107.481 178.122 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.315 0 N-CA-C 114.134 1.161 . . . . 1.39 114.134 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -86.62 146.23 26.41 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 123.301 1.524 . . . . 2.2 110.425 -176.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.5 pt -139.46 150.03 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 128.254 2.621 . . . . 1.32 109.483 174.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -103.53 118.28 36.37 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.452 -1.704 . . . . 2.2 111.753 177.18 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.3 t -94.31 110.7 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 117.735 -1.126 . . . . 1.23 109.047 170.341 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.3 tttp -110.17 139.25 45.52 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 122.574 2.443 . . . . 2.51 112.296 -176.529 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.493 HG22 HD21 ' A' ' 69' ' ' LEU 0.358 58.0 p -85.05 165.67 17.32 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.859 -1.519 . . . . 1.41 108.793 -178.193 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.1 mt -78.23 -19.31 54.02 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 123.96 1.838 . . . . 2.95 112.157 170.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.06 -45.04 13.48 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 114.058 -1.428 . . . . 2.52 107.88 -173.702 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.47 1.31 0.21 Allowed Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 120.262 2.865 . . . . 1.5 120.262 167.249 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -86.55 146.78 26.23 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 119.256 1.528 . . . . 1.79 113.555 -176.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.4 m -114.04 110.49 20.12 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.957 2.789 . . . . 1.38 109.195 171.005 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.5 mt -91.83 109.65 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 124.513 2.102 . . . . 2.03 106.403 177.32 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 m -83.44 115.04 21.88 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.69 -3.756 . . . . 1.61 106.085 176.063 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mp -108.39 156.51 19.34 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 129.089 2.956 . . . . 2.15 109.856 175.138 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -118.61 131.73 56.19 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.149 -2.219 . . . . 1.98 111.184 166.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -138.67 171.36 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 125.807 1.643 . . . . 1.52 113.233 -175.462 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -102.54 156.1 35.69 Favored Pre-proline 0 N--CA 1.429 -1.48 0 N-CA-C 103.738 -2.69 . . . . 2.35 103.738 166.717 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.9 0.98 9.39 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 124.002 3.135 . . . . 1.31 109.891 179.835 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.4 p -84.03 -18.57 36.61 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.545 -1.972 . . . . 1.71 112.151 171.155 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -66.31 140.9 58.14 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 125.451 2.548 . . . . 1.69 110.917 173.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 3.0 p -80.34 163.97 23.49 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 114.95 -2.452 . . . . 1.33 116.055 179.003 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.405 HG13 ' HB3' ' A' ' 50' ' ' LEU . 19.4 mm -64.16 -36.49 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 123.412 2.824 . . . . 1.32 110.735 176.837 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -58.05 -32.84 68.4 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.86 1.664 . . . . 1.62 113.257 168.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.383 20.0 t-20 -64.18 -39.73 94.6 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.476 2.084 . . . . 2.13 114.322 174.184 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.5 t -64.55 -46.34 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 124.781 2.229 . . . . 1.23 113.761 174.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -66.63 -25.22 66.49 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 125.57 2.605 . . . . 1.97 117.139 -179.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.37 -43.25 81.87 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.569 3.556 . . . . 1.19 109.115 174.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -63.3 -39.17 93.82 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 116.02 -4.175 . . . . 1.92 113.789 173.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.8 mt -69.79 -30.29 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-O 122.837 1.304 . . . . 1.94 111.625 173.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -75.15 -41.98 57.11 Favored 'General case' 0 N--CA 1.431 -1.401 1 O-C-N 113.66 -5.65 . . . . 1.9 106.757 175.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -54.62 -46.98 73.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.713 2.673 . . . . 1.55 118.191 168.207 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.282 26.4 tttp -89.49 -43.4 10.86 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 117.168 -3.457 . . . . 2.95 117.301 -174.008 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -101.57 -35.89 8.97 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 126.755 2.534 . . . . 1.48 108.919 -172.378 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.23 56.25 1.22 Allowed Glycine 0 N--CA 1.431 -1.663 0 C-N-CA 117.926 -2.083 . . . . 1.12 113.508 176.094 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.7 mt -134.31 130.62 20.22 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 103.436 -2.801 . . . . 2.07 103.436 -175.49 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -66.85 154.01 76.0 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 CA-C-N 124.387 2.603 . . . . 1.39 116.714 177.664 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -59.33 -31.96 95.89 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 124.051 3.167 . . . . 1.68 110.13 -176.528 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -55.22 -57.95 9.69 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 126.023 2.821 . . . . 2.25 114.741 177.043 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -61.64 -26.88 68.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.298 2.639 . . . . 2.44 110.395 -177.661 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.272 75.2 mt-30 -96.06 131.13 42.79 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.015 1.388 . . . . 1.32 107.41 -173.642 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -118.83 131.87 56.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.107 -1.406 . . . . 3.19 109.954 167.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 tp -110.06 119.88 40.68 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 104.679 -2.341 . . . . 1.75 104.679 179.123 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.308 1.7 mt -104.95 143.02 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 128.046 2.539 . . . . 1.98 115.106 179.23 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -155.85 123.08 5.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 125.37 3.713 . . . . 1.94 102.642 179.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.257 . . 62.97 30.1 16.43 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.445 2.387 . . . . 1.67 117.445 169.314 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.29 -22.82 32.82 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 125.294 1.621 . . . . 1.3 116.108 -174.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -99.36 130.97 45.68 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 118.174 -1.41 . . . . 2.89 114.033 -176.749 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -75.1 130.42 39.24 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 117.254 -1.778 . . . . 2.89 112.988 173.688 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.477 HD22 ' CE2' ' A' ' 59' ' ' TYR . 42.1 mt -76.53 140.95 41.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.699 2.481 . . . . 1.34 117.699 -170.83 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -82.78 135.6 34.93 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.631 -3.168 . . . . 1.94 110.59 177.609 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -54.99 -64.99 0.66 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.766 2.426 . . . . 1.56 112.435 -171.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.26 54.54 3.95 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 119.643 -1.91 . . . . 0.97 113.352 172.076 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.9 tpp85 -131.29 161.99 31.06 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 115.296 -2.288 . . . . 3.07 111.126 161.059 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 63.9 p -96.52 155.83 16.6 Favored 'General case' 0 N--CA 1.43 -1.456 1 CA-C-N 127.759 4.799 . . . . 1.34 112.445 178.554 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.1 mt -57.78 -24.24 56.19 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.146 1.778 . . . . 1.63 113.941 173.601 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.7 p -78.4 -27.93 46.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.099 -2.876 . . . . 1.51 115.499 177.404 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -67.73 -34.71 77.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.827 -3.046 . . . . 1.9 115.787 172.332 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.477 ' CE2' HD22 ' A' ' 50' ' ' LEU . 12.7 m-85 -85.94 -8.88 57.71 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.476 1.11 . . . . 0.97 109.381 175.249 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 59.0 54.13 5.19 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.528 -1.983 . . . . 2.35 112.438 178.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.1 mt -85.8 114.47 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 126.727 3.156 . . . . 1.39 108.227 174.299 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.283 83.6 mt-30 -91.18 177.6 6.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.369 -3.332 . . . . 2.58 111.409 178.339 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -72.65 160.8 31.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 115.724 -2.391 . . . . 2.58 113.563 178.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.433 30.5 mt-10 64.51 32.33 11.79 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 110.582 -3.008 . . . . 1.71 116.005 176.765 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.9 t -100.2 128.65 46.23 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 112.973 -1.921 . . . . 1.34 110.586 -166.26 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.37 2.4 m -75.87 93.74 3.24 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 121.88 2.127 . . . . 1.36 116.313 178.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 60.0 mt -81.39 156.8 25.25 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 130.663 3.585 . . . . 2.03 103.282 174.053 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -125.5 121.34 33.45 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 120.56 1.527 . . . . 2.31 113.035 -174.092 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.493 HD21 HG22 ' A' ' 7' ' ' THR . 5.1 tp -96.64 110.69 23.07 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 105.812 -1.921 . . . . 1.72 105.812 -178.765 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -107.04 138.81 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 122.863 1.316 . . . . 1.8 111.457 172.474 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.4 mt -107.64 144.38 34.78 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.46 -1.4 . . . . 3.26 113.117 -177.191 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -88.08 72.01 9.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 104.798 -2.297 . . . . 4.12 104.798 173.802 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.9 mt -61.21 142.47 56.75 Favored 'General case' 0 N--CA 1.43 -1.445 1 C-N-CA 132.41 4.284 . . . . 3.54 108.625 177.413 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.262 32.8 ttm180 -73.09 118.94 16.66 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 116.147 -1.883 . . . . 7.32 112.891 172.445 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.46 -83.18 0.16 Allowed Glycine 0 N--CA 1.43 -1.701 0 CA-C-O 123.115 1.397 . . . . 3.73 110.145 179.25 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.72 0 C-N-CA 129.246 3.308 . . . . 3.87 110.678 -176.604 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 CA--C 1.491 -1.321 0 CA-C-O 118.985 -0.531 . . . . 1.39 110.664 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -84.95 134.24 34.25 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.49 1.116 . . . . 2.2 112.898 -178.551 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.5 pt -131.83 159.84 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 123.643 1.687 . . . . 1.32 109.666 166.453 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -120.84 149.53 42.44 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 102.492 -3.151 . . . . 2.2 102.492 -173.544 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.4 t -136.2 119.07 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.494 -1.379 . . . . 1.23 109.427 174.409 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -92.23 127.36 37.68 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.816 -1.084 . . . . 2.51 112.079 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.2 p -83.63 165.03 19.33 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.171 1.463 . . . . 1.41 112.111 -178.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.68 -31.42 72.63 Favored 'General case' 0 N--CA 1.429 -1.512 1 O-C-N 116.053 -4.154 . . . . 2.95 114.723 167.324 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.0 p -71.62 -48.64 46.68 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 124.285 0.991 . . . . 2.52 111.626 -175.217 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.52 41.64 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 119.273 -1.442 . . . . 1.5 110.674 -179.21 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU 0.29 33.7 ttpt -133.57 149.89 51.65 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.07 -2.43 . . . . 1.79 106.775 179.969 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.9 m -95.41 113.94 25.66 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.161 2.584 . . . . 1.38 114.674 167.234 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 mt -82.39 119.25 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 117.645 -3.16 . . . . 2.03 110.305 172.215 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.8 m -104.32 111.27 23.84 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.874 -2.391 . . . . 1.61 107.896 178.093 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.8 mt -110.1 156.06 21.08 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 119.395 3.109 . . . . 2.15 119.395 -177.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 tp10 -103.39 107.23 17.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.206 -1.559 . . . . 1.98 113.307 168.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.7 m -121.17 164.77 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 115.879 -2.01 . . . . 1.52 112.944 174.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -111.69 169.51 6.25 Favored Pre-proline 0 N--CA 1.43 -1.439 0 O-C-N 125.055 1.472 . . . . 2.35 109.993 163.381 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -77.38 -20.59 12.38 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 C-N-CA 122.808 2.339 . . . . 1.31 116.103 -174.122 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.7 m -82.99 3.26 30.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.8 1.64 . . . . 1.71 111.473 174.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -82.5 147.13 28.86 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.185 -2.822 . . . . 1.69 111.266 172.796 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.1 p -75.86 164.48 26.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.291 2.701 . . . . 1.33 118.291 174.215 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.4 mm -74.94 -29.12 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 118.279 -2.763 . . . . 1.32 110.687 178.402 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -53.37 -39.65 64.36 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 126.037 1.735 . . . . 1.62 112.529 163.708 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -60.1 -47.89 84.0 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.548 2.339 . . . . 2.13 114.793 173.206 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.7 t -60.61 -48.78 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 130.144 3.378 . . . . 1.23 112.237 177.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -60.09 -38.36 82.7 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 124.543 2.116 . . . . 1.97 115.083 173.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.85 -31.98 71.32 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 119.198 -2.189 . . . . 1.19 115.767 176.237 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -71.29 -37.44 71.86 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.498 2.094 . . . . 1.92 110.866 170.582 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.0 mt -67.14 -41.77 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 116.639 -3.788 . . . . 1.94 110.984 172.29 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -51.77 -33.06 33.47 Favored 'General case' 0 N--CA 1.43 -1.466 1 N-CA-C 122.31 4.189 . . . . 1.9 122.31 169.757 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -63.51 -42.18 98.49 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 117.04 -1.457 . . . . 1.55 110.057 174.132 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -85.13 -50.9 7.03 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 125.894 1.996 . . . . 2.95 110.414 -172.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.452 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 70.3 mm-40 -94.35 -27.18 16.22 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 113.567 0.951 . . . . 1.48 113.567 -168.517 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.31 -23.29 29.03 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-O 126.223 3.124 . . . . 1.12 113.759 168.025 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.2 mt -63.77 123.0 80.1 Favored Pre-proline 0 N--CA 1.431 -1.41 0 C-N-CA 128.461 2.704 . . . . 2.07 114.498 -172.691 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.35 158.35 36.92 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 CA-C-N 126.387 3.317 . . . . 1.39 111.536 -172.025 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -54.91 -31.51 73.78 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 123.359 2.706 . . . . 1.68 116.597 -174.017 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -55.37 -42.87 74.54 Favored 'General case' 0 N--CA 1.43 -1.457 1 CA-C-O 129.263 4.363 . . . . 2.25 117.761 174.019 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -88.15 -25.54 22.91 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.94 -4.225 . . . . 2.44 112.503 -177.635 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -64.73 134.3 53.9 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.931 -1.731 . . . . 1.32 110.068 179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -126.21 140.92 52.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.173 -2.829 . . . . 3.19 106.151 165.324 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.9 mt -121.95 114.93 21.68 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.689 -2.05 . . . . 1.75 110.553 -178.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 mt -104.23 127.04 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 117.63 -3.168 . . . . 1.98 110.612 178.421 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -136.02 120.34 17.95 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.12 2.568 . . . . 1.94 107.196 176.317 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.313 . . 76.68 6.7 3.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.983 -1.698 . . . . 1.67 114.915 -177.438 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.78 -10.56 74.31 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 117.796 -3.065 . . . . 1.3 111.83 -175.267 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -92.17 146.42 23.73 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 105.978 -1.86 . . . . 2.89 105.978 170.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -94.43 141.89 28.06 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.162 1.385 . . . . 2.89 111.376 170.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -105.52 123.62 48.2 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 119.245 0.93 . . . . 1.34 109.196 -166.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -69.1 144.1 54.02 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.145 1.778 . . . . 1.94 111.85 174.509 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -60.6 -63.12 1.41 Allowed 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 130.975 3.71 . . . . 1.56 115.742 -169.179 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.75 23.12 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.714 1 C-N-CA 131.056 4.169 . . . . 0.97 121.317 170.85 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.296 65.1 mtt180 -123.61 162.91 22.06 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.053 -2.439 . . . . 3.07 111.598 165.467 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.0 p -84.12 154.44 23.15 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 125.543 2.592 . . . . 1.34 113.579 168.694 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mt -51.3 -34.12 31.84 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.759 -4.338 . . . . 1.63 113.883 175.529 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.7 p -79.44 -12.21 59.89 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 117.583 2.438 . . . . 1.51 117.583 179.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.85 -51.49 47.71 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 127.033 3.301 . . . . 1.9 108.481 171.247 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -66.75 -21.18 66.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.963 -2.961 . . . . 0.97 117.137 172.751 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.26 2.5 m-80 70.34 47.28 0.54 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.963 3.305 . . . . 2.35 111.997 -177.279 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.2 mm -78.72 113.63 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 117.907 -2.996 . . . . 1.39 106.695 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -97.89 175.15 6.25 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 126.049 1.739 . . . . 2.58 112.847 -177.644 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -59.62 132.75 54.93 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 114.59 1.33 . . . . 2.58 114.59 172.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.401 48.4 mt-10 85.57 17.01 0.13 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.554 1.645 . . . . 1.71 111.664 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.277 6.8 m -81.47 129.88 34.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.053 -2.28 . . . . 1.34 113.362 -173.928 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.8 m -103.45 106.4 16.91 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 127.923 3.265 . . . . 1.36 109.892 -175.617 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mt -87.07 155.62 20.07 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 126.045 2.831 . . . . 2.03 111.907 172.151 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -118.9 120.84 38.5 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 115.86 -2.019 . . . . 2.31 111.457 -179.103 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.8 tp -82.82 133.68 35.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.144 1.778 . . . . 1.72 107.652 179.007 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.08 157.66 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 102.527 -3.138 . . . . 1.8 102.527 175.483 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.5 mt -122.65 141.2 52.0 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.228 2.918 . . . . 3.26 111.061 -169.49 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -95.39 89.09 5.32 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 128.063 3.792 . . . . 4.12 109.472 -171.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.9 mt -59.89 172.71 0.7 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 111.911 -2.404 . . . . 3.54 112.032 169.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -81.13 143.09 32.66 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 117.67 2.47 . . . . 7.32 117.67 168.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.47 -32.61 0.22 Allowed Glycine 0 N--CA 1.43 -1.75 0 O-C-N 116.785 -3.697 . . . . 3.73 110.758 -170.225 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.698 0 N-CA-C 104.647 -3.381 . . . . 3.87 104.647 -174.986 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.434 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 26.2 ptt? . . . . . 0 CA--C 1.49 -1.345 0 N-CA-C 106.879 -1.526 . . . . 1.39 106.879 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -104.04 124.96 49.99 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 118.695 -2.503 . . . . 2.2 108.695 -173.554 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.9 pt -116.2 160.9 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 118.163 -2.835 . . . . 1.32 109.177 170.176 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -103.61 134.57 46.72 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 125.967 1.707 . . . . 2.2 111.057 176.475 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.2 t -112.59 125.99 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 103.939 -2.615 . . . . 1.23 103.939 172.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -103.18 144.51 31.23 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.032 -3.543 . . . . 2.51 112.438 169.543 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.5 p -93.99 -177.51 4.35 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 124.7 1.25 . . . . 1.41 114.082 -178.839 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.434 HD13 ' H ' ' A' ' 71' ' ' LEU . 46.4 mt -72.29 -27.58 62.55 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 116.442 -1.742 . . . . 2.95 113.088 174.167 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 p -88.13 -62.41 1.5 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.914 1.34 . . . . 2.52 111.672 -172.169 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.86 36.61 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.7 0 CA-C-N 113.721 -1.581 . . . . 1.5 110.153 177.492 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -99.0 148.19 24.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 106.233 -1.766 . . . . 1.79 106.233 -179.468 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.6 m -114.04 127.28 55.87 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 122.373 2.351 . . . . 1.38 106.966 169.158 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mt -108.53 133.3 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.507 -1.996 . . . . 2.03 110.707 173.475 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.0 m -93.88 112.88 24.8 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.325 1.85 . . . . 1.61 109.705 174.101 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -110.29 143.64 40.18 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 121.607 2.003 . . . . 2.15 112.711 174.659 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 1' ' ' MET . 33.1 mt-10 -114.11 115.11 27.01 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.709 -2.495 . . . . 1.98 110.178 175.199 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.77 177.36 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 127.324 2.25 . . . . 1.52 108.871 -176.521 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -120.11 155.65 55.46 Favored Pre-proline 0 N--CA 1.43 -1.443 0 O-C-N 119.079 -2.263 . . . . 2.35 105.903 162.067 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -73.57 -10.41 23.62 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 124.351 2.59 . . . . 1.31 114.376 -170.232 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.273 48.9 m -87.19 -0.8 57.26 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 127.403 2.939 . . . . 1.71 112.556 175.098 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -68.58 150.28 48.2 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 117.044 -1.455 . . . . 1.69 109.583 179.128 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.3 p -87.59 170.94 10.86 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 125.522 2.582 . . . . 1.33 109.476 176.815 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.407 7.4 mm -61.36 -48.31 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 111.295 -2.684 . . . . 1.32 112.627 173.908 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -41.8 -51.43 4.23 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 119.97 3.322 . . . . 1.62 119.97 164.506 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -61.48 -24.6 66.69 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 119.055 2.983 . . . . 2.13 119.055 174.873 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.0 t -75.65 -39.42 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 125.465 2.555 . . . . 1.23 108.988 175.718 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.3 51.5 mtmt -65.24 -36.71 84.97 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.773 -1.83 . . . . 1.97 111.557 177.784 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.19 -24.1 66.56 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 128.32 2.648 . . . . 1.19 113.965 175.966 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -78.16 -38.63 43.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 126.838 2.586 . . . . 1.92 112.951 170.503 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.363 68.8 mt -65.84 -42.99 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-O 126.391 2.996 . . . . 1.94 111.915 172.304 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.427 ' CD ' ' HD3' ' A' ' 38' ' ' PRO . 65.2 tt0 -57.79 -55.03 40.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 111.474 -2.603 . . . . 1.9 111.011 172.555 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.298 33.5 t70 -29.13 -56.64 0.14 Allowed 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 119.727 3.232 . . . . 1.55 119.727 170.898 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -81.45 -53.16 6.53 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 117.563 2.431 . . . . 2.95 117.563 -178.798 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -92.72 -22.62 19.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.178 -2.826 . . . . 1.48 106.525 -163.854 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.56 10.58 59.04 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 130.239 3.78 . . . . 1.12 114.701 177.042 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.5 mt -86.73 125.09 68.13 Favored Pre-proline 0 N--CA 1.43 -1.463 0 O-C-N 116.495 -3.944 . . . . 2.07 109.305 -174.231 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_exo -64.24 149.67 89.79 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 N-CA-C 120.86 3.369 . . . . 1.39 120.86 176.741 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' CD ' ' A' ' 31' ' ' GLN . 47.5 Cg_exo -69.32 -14.9 38.27 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 CA-C-N 124.966 2.809 . . . . 1.68 117.808 -175.714 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -83.09 -10.65 58.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.704 1.593 . . . . 2.25 110.784 176.714 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.16 -15.74 23.09 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.299 -1.501 . . . . 2.44 108.843 -179.664 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -93.44 124.32 37.35 Favored 'General case' 0 N--CA 1.43 -1.465 1 CA-C-O 129.352 4.406 . . . . 1.32 110.529 -179.324 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -106.65 110.07 22.15 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 114.009 -5.432 . . . . 3.19 104.205 169.963 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.6 mt -89.77 124.66 34.84 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 115.518 -2.182 . . . . 1.75 107.48 172.836 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.4 mt -121.62 136.76 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 128.005 3.316 . . . . 1.98 106.747 -178.255 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -147.44 123.7 10.89 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.718 -1.583 . . . . 1.94 108.245 -176.349 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.304 . . 82.35 -51.09 0.21 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 114.654 1.353 . . . . 1.67 114.654 173.365 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.61 -34.84 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 128.179 2.799 . . . . 1.3 113.739 -178.405 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -89.29 164.11 15.07 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 126.228 2.918 . . . . 2.89 112.24 -179.695 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -98.23 133.45 42.64 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.592 -1.943 . . . . 2.89 110.727 171.09 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.2 mt -88.71 129.56 35.51 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 118.774 -2.454 . . . . 1.34 114.827 -167.356 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.341 26.9 mt-10 -65.0 131.53 46.84 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.727 -1.858 . . . . 1.94 115.571 174.381 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -43.58 -63.75 0.78 Allowed 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 131.188 3.795 . . . . 1.56 114.716 -171.609 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.22 61.15 1.88 Allowed Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 112.364 -2.198 . . . . 0.97 117.323 174.202 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 -126.03 172.85 9.62 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.36 -2.089 . . . . 3.07 105.36 156.393 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.0 p -97.78 177.94 5.3 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 117.315 2.339 . . . . 1.34 117.315 169.557 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.8 mt -77.3 -32.28 55.29 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.247 -2.158 . . . . 1.63 109.77 173.702 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -66.6 -37.02 84.02 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 123.814 3.006 . . . . 1.51 114.136 171.484 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -54.24 -64.1 0.94 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 131.668 3.987 . . . . 1.9 115.022 169.921 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -62.99 -14.15 44.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.913 1.819 . . . . 0.97 115.913 173.901 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.345 29.0 m120 78.02 36.83 0.23 Allowed 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 116.794 -1.574 . . . . 2.35 114.79 179.329 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.9 mt -96.22 125.54 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 122.182 2.264 . . . . 1.39 110.96 -177.147 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -98.34 -179.91 4.51 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 118.095 2.628 . . . . 2.58 118.095 -171.498 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.304 21.7 pttp -65.87 145.83 55.46 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 118.749 -1.18 . . . . 2.58 109.328 170.373 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.269 19.4 mt-10 69.99 20.13 6.66 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 126.227 2.204 . . . . 1.71 113.142 171.815 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.2 m -87.13 148.13 25.34 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 118.027 -2.92 . . . . 1.34 111.239 179.668 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.6 m -92.89 98.4 11.35 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.829 2.159 . . . . 1.36 116.829 -177.31 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -84.82 145.53 27.81 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 113.987 -5.446 . . . . 2.03 113.744 172.072 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -117.03 119.5 35.47 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 118.918 -2.364 . . . . 2.31 109.702 -176.043 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.0 tp -84.88 102.44 13.11 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.967 3.307 . . . . 1.72 109.625 178.092 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.32 98.7 t -94.02 130.48 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 130.513 3.525 . . . . 1.8 107.28 170.814 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.434 ' H ' HD13 ' A' ' 8' ' ' LEU . 66.4 mt -100.13 141.38 33.05 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.441 -3.287 . . . . 3.26 108.589 179.106 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -74.8 -39.81 61.5 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.628 -3.17 . . . . 4.12 114.333 176.578 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.273 17.1 mt -109.82 -163.24 0.85 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.247 3.019 . . . . 3.54 111.637 164.057 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -64.94 137.89 58.02 Favored 'General case' 0 N--CA 1.43 -1.44 2 CA-C-O 129.388 4.423 . . . . 7.32 107.897 165.364 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.78 36.46 0.19 Allowed Glycine 0 N--CA 1.43 -1.707 1 O-C-N 115.27 -4.644 . . . . 3.73 113.626 -175.834 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.788 0 CA-C-O 125.85 2.916 . . . . 3.87 113.922 179.693 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttp . . . . . 0 CA--C 1.491 -1.324 0 CA-C-O 124.177 1.942 . . . . 1.39 114.399 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -106.25 141.41 37.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.808 -3.057 . . . . 2.2 111.692 -176.05 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 pt -127.35 173.16 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 131.566 3.947 . . . . 1.32 113.337 175.691 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -135.32 126.02 27.2 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.569 -2.582 . . . . 2.2 105.953 -178.544 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -115.24 118.74 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 106.25 -1.759 . . . . 1.23 106.25 173.443 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -100.28 145.24 28.35 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 118.202 -1.399 . . . . 2.51 111.525 175.383 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.2 p -101.2 160.53 14.32 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 128.931 2.892 . . . . 1.41 112.766 179.939 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 mt -71.14 -28.72 64.48 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.718 -1.864 . . . . 2.95 112.862 175.053 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 t -72.76 -38.6 67.28 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 121.744 2.066 . . . . 2.52 110.142 -177.782 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.27 -10.42 0.54 Allowed Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 125.347 1.451 . . . . 1.5 112.918 166.039 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -80.02 135.02 36.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.75 2.02 . . . . 1.79 113.735 -167.731 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.2 m -108.0 117.38 33.97 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.855 2.462 . . . . 1.38 109.484 176.204 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 mt -104.8 105.61 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 113.361 0.874 . . . . 2.03 113.361 178.332 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.8 m -79.31 118.19 21.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.347 -3.345 . . . . 1.61 108.819 -178.762 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.8 mt -120.78 153.58 36.86 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 116.803 -3.686 . . . . 2.15 111.605 -179.8 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -116.33 120.37 38.68 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.059 2.544 . . . . 1.98 110.256 168.382 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -131.92 167.82 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 105.894 -1.891 . . . . 1.52 105.894 -170.575 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -109.45 147.91 37.0 Favored Pre-proline 0 N--CA 1.43 -1.45 0 O-C-N 118.485 -2.635 . . . . 2.35 109.831 160.653 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.254 2.2 Cg_endo -57.11 -18.6 29.78 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 N-CA-C 120.619 3.277 . . . . 1.31 120.619 -173.18 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.9 m -91.05 3.64 54.2 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 125.92 1.688 . . . . 1.71 112.37 -178.709 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -71.78 161.73 30.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.481 2.312 . . . . 1.69 108.54 172.405 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.7 p -98.37 163.8 12.55 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 123.306 1.527 . . . . 1.33 107.657 178.471 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mm -54.38 -41.18 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 118.32 -2.738 . . . . 1.32 114.031 174.25 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.328 16.6 tt0 -54.86 -32.18 60.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.057 -2.277 . . . . 1.62 117.09 166.955 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -64.81 -38.49 91.17 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 129.483 3.113 . . . . 2.13 111.75 176.494 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.3 t -69.18 -40.68 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 119.523 -1.985 . . . . 1.23 107.629 179.254 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.547 ' HD3' ' HB2' ' A' ' 41' ' ' GLN . 74.1 mttt -61.19 -35.64 77.69 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.042 -2.911 . . . . 1.97 114.906 170.734 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.16 -25.21 65.15 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 114.539 -2.864 . . . . 1.19 118.701 177.963 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -67.92 -35.53 78.6 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 130.383 3.473 . . . . 1.92 107.201 168.654 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mt -74.07 -39.36 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 1 O-C-N 116.083 -4.136 . . . . 1.94 108.671 178.953 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -64.29 -37.12 86.35 Favored 'General case' 0 N--CA 1.428 -1.547 0 O-C-N 117.12 -3.488 . . . . 1.9 111.556 178.766 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -69.85 -43.6 71.58 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.417 1.103 . . . . 1.55 112.72 172.517 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -72.73 -48.19 40.73 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 120.399 3.481 . . . . 2.95 120.399 178.943 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -108.66 -30.85 7.99 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.467 -2.645 . . . . 1.48 112.489 -165.715 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.67 37.24 5.58 Favored Glycine 0 N--CA 1.43 -1.702 0 O-C-N 118.917 -2.364 . . . . 1.12 116.133 176.467 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.3 mt -113.89 126.18 28.42 Favored Pre-proline 0 N--CA 1.431 -1.412 0 CA-C-O 111.83 -3.938 . . . . 2.07 105.368 177.622 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.84 151.06 35.45 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-N 126.379 3.314 . . . . 1.39 110.77 -176.095 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -55.87 -31.85 82.83 Favored 'Trans proline' 0 N--CA 1.433 -2.047 1 C-N-CA 126.121 4.547 . . . . 1.68 112.806 -178.897 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -41.78 -49.11 4.38 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 113.229 -3.272 . . . . 2.25 117.372 165.935 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -80.55 -20.82 42.58 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 122.664 2.484 . . . . 2.44 117.279 177.514 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.547 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 72.1 mt-30 -76.82 130.86 38.21 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.999 1.32 . . . . 1.32 111.868 -172.086 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.0 mtt180 -120.33 131.01 54.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.432 -2.668 . . . . 3.19 108.561 169.653 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.7 mt -107.55 130.52 54.86 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 120.521 1.51 . . . . 1.75 110.795 179.663 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -105.03 127.92 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 125.742 1.617 . . . . 1.98 113.046 178.373 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -152.2 141.91 21.88 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.494 -2.78 . . . . 1.94 103.494 173.163 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.27 . . 64.71 14.38 9.06 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.124 2.392 . . . . 1.67 115.024 -179.013 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.49 18.51 75.71 Favored Glycine 0 N--CA 1.431 -1.674 0 O-C-N 117.511 -3.243 . . . . 1.3 118.23 179.295 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -126.18 150.18 48.5 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.277 3.031 . . . . 2.89 111.047 176.503 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -80.15 132.75 35.97 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 121.646 2.021 . . . . 2.89 112.129 169.705 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.3 mt -88.45 135.77 33.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.453 -3.904 . . . . 1.34 114.297 -173.248 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.93 125.84 27.58 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.034 2.934 . . . . 1.94 108.739 -179.76 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.32 1.0 OUTLIER -47.23 -47.4 24.57 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 120.829 3.64 . . . . 1.56 120.829 -174.12 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.84 32.11 7.18 Favored Glycine 0 N--CA 1.43 -1.712 0 CA-C-O 125.652 2.807 . . . . 0.97 118.795 -179.834 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -101.98 157.87 16.56 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.404 -3.409 . . . . 3.07 108.951 159.685 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -85.09 168.17 15.11 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.59 -1.186 . . . . 1.34 110.048 -179.337 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.6 mt -69.64 -41.01 76.16 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 124.86 1.35 . . . . 1.63 109.869 179.289 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.264 48.3 p -58.99 -18.75 37.05 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 117.32 2.341 . . . . 1.51 117.32 175.8 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -69.79 -45.04 68.86 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.657 2.383 . . . . 1.9 111.567 173.023 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -83.5 2.96 34.35 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.399 -2.688 . . . . 0.97 113.309 174.19 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.4 m120 57.56 49.02 13.34 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 129.11 2.964 . . . . 2.35 117.203 177.394 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -85.14 114.29 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 128.564 2.746 . . . . 1.39 111.791 -175.96 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -93.14 -173.73 3.34 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.005 2.336 . . . . 2.58 112.633 -176.488 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -62.54 137.72 58.32 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 112.574 -2.103 . . . . 2.58 113.456 176.673 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 64.15 29.7 13.93 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 114.029 1.122 . . . . 1.71 114.029 170.143 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.6 m -81.43 143.24 32.26 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 123.288 1.518 . . . . 1.34 114.368 -178.753 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 m -99.16 117.06 32.79 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.58 -2.575 . . . . 1.36 111.382 -179.62 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -104.24 160.23 15.05 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.088 2.555 . . . . 2.03 106.261 174.439 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -124.94 135.56 52.95 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.211 -1.774 . . . . 2.31 106.211 -176.824 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.1 tp -99.57 128.75 45.68 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 105.449 -2.056 . . . . 1.72 105.449 -176.411 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.3 m -122.0 170.13 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 104.037 -2.579 . . . . 1.8 104.037 168.771 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.5 mt -122.44 153.51 39.0 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 117.469 -1.253 . . . . 3.26 111.4 177.39 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.274 49.1 ttp180 -60.95 123.63 18.15 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 127.412 2.945 . . . . 4.12 115.454 175.019 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.4 mt -99.87 -172.83 2.31 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 123.94 0.896 . . . . 3.54 112.822 177.495 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -88.14 86.48 7.1 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.392 2.677 . . . . 7.32 113.608 169.012 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.09 -110.56 0.41 Allowed Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 110.731 -0.948 . . . . 3.73 110.731 -169.818 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.774 0 CA-C-O 115.443 -2.865 . . . . 3.87 111.836 -174.454 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tmm? . . . . . 0 CA--C 1.49 -1.352 0 CA-C-O 121.05 0.452 . . . . 1.39 110.579 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -108.72 129.31 55.36 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 117.228 2.307 . . . . 2.2 117.228 -177.537 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -129.28 170.62 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 106.28 -1.748 . . . . 1.32 106.28 175.544 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -121.94 140.15 52.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.921 -2.252 . . . . 2.2 104.921 -177.203 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.449 HG22 ' HB2' ' A' ' 67' ' ' LEU . 92.6 t -123.96 131.51 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 118.069 -2.894 . . . . 1.23 106.771 170.52 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -88.68 118.81 28.62 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.857 2.063 . . . . 2.51 115.352 171.454 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.5 p -83.49 176.06 9.34 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.238 -3.414 . . . . 1.41 111.619 173.775 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.3 mt -78.9 -17.17 56.0 Favored 'General case' 0 N--CA 1.43 -1.432 1 CA-C-O 129.617 4.532 . . . . 2.95 116.066 -179.762 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 p -95.27 -56.74 2.62 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.367 -3.333 . . . . 2.52 107.119 -170.601 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.4 23.65 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.728 0 CA-C-O 114.969 -3.128 . . . . 1.5 115.453 176.124 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.549 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 82.3 tttt -109.68 139.82 44.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 121.67 2.735 . . . . 1.79 108.467 -173.255 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.1 m -106.84 124.33 49.46 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 100.61 -3.848 . . . . 1.38 100.61 175.577 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.7 mt -94.62 123.14 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 N-CA-C 104.776 -2.305 . . . . 2.03 104.776 179.553 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.3 m -90.21 106.7 18.66 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.529 2.331 . . . . 1.61 109.369 176.617 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.3 mt -103.83 128.62 51.27 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.715 1.721 . . . . 2.15 108.396 -176.811 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -90.6 116.32 28.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.807 -3.058 . . . . 1.98 111.803 165.993 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.2 m -130.22 159.59 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.731 -2.481 . . . . 1.52 111.108 -171.358 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -99.68 146.07 31.21 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 118.591 -2.568 . . . . 2.35 108.209 170.875 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -73.44 -17.44 23.81 Favored 'Trans proline' 0 C--N 1.299 -2.059 0 CA-C-N 127.744 3.802 . . . . 1.31 113.52 -177.547 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -77.34 -2.55 35.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 123.206 2.73 . . . . 1.71 111.479 172.431 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -73.97 139.65 44.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 122.415 2.37 . . . . 1.69 109.03 178.588 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 p -74.51 158.65 33.41 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 111.015 -2.811 . . . . 1.33 110.847 170.257 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.6 mm -61.78 -30.98 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 125.062 1.476 . . . . 1.32 113.388 174.484 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -52.0 -33.33 37.76 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.51 3.124 . . . . 1.62 116.162 165.766 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -85.45 -29.62 24.19 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.301 -2.749 . . . . 2.13 108.699 176.258 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.1 t -70.2 -42.1 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 117.126 -3.483 . . . . 1.23 110.898 178.886 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -63.3 -27.57 69.42 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.347 2.659 . . . . 1.97 113.14 170.194 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.43 -21.64 41.96 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 123.373 1.559 . . . . 1.19 110.933 175.504 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -75.56 -30.16 59.59 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.749 -3.094 . . . . 1.92 114.574 170.054 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.8 mt -66.88 -38.19 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 O-C-N 120.383 -1.448 . . . . 1.94 109.401 169.905 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.425 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 14.4 tt0 -57.43 -58.43 8.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.506 0.67 . . . . 1.9 112.624 170.819 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -47.61 -49.78 26.06 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.854 2.062 . . . . 1.55 110.438 178.638 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -65.13 -66.26 0.57 Allowed 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.969 2.908 . . . . 2.95 112.06 -176.375 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.549 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 29.1 mm-40 -95.62 -53.75 3.61 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 127.86 2.464 . . . . 1.48 113.351 -164.056 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.98 -43.6 0.6 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 106.693 -2.563 . . . . 1.12 106.693 -179.365 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.407 HG13 ' H ' ' A' ' 36' ' ' ILE . 7.8 mt -40.69 115.2 1.19 Allowed Pre-proline 0 N--CA 1.43 -1.452 1 N-CA-C 123.715 4.709 . . . . 2.07 123.715 -171.479 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -69.38 157.58 60.61 Favored 'Trans proline' 0 C--N 1.3 -1.993 2 CA-C-N 129.712 4.504 . . . . 1.39 108.448 -174.444 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.425 ' HD3' ' HB2' ' A' ' 31' ' ' GLN . 38.0 Cg_exo -65.65 -23.79 56.19 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 N-CA-C 117.522 2.085 . . . . 1.68 117.522 177.099 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.3 -12.98 47.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.624 -3.173 . . . . 2.25 118.46 174.873 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -97.39 -22.4 16.63 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 124.044 0.938 . . . . 2.44 108.977 -178.546 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -90.46 136.2 33.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 118.687 2.847 . . . . 1.32 118.687 -168.246 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -126.03 118.33 25.11 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.329 -2.1 . . . . 3.19 105.329 169.955 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.3 mt -96.94 122.34 39.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 123.962 0.905 . . . . 1.75 111.462 177.88 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.9 mm -105.58 141.6 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 128.326 2.651 . . . . 1.98 104.183 -176.961 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -140.71 132.74 27.82 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 116.82 -3.675 . . . . 1.94 103.622 168.054 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.42 . . 56.13 32.48 20.2 Favored 'General case' 0 N--CA 1.429 -1.48 1 CA-C-O 132.335 5.826 . . . . 1.67 121.617 174.25 . . . . . . . . 3 2 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.99 -15.21 39.34 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 108.461 -3.972 . . . . 1.3 109.793 179.206 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -87.16 129.49 34.92 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 128.549 2.74 . . . . 2.89 116.931 -178.106 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -74.4 114.91 13.33 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 128.692 2.797 . . . . 2.89 112.43 173.022 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.1 mt -85.58 147.65 26.31 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 115.922 1.823 . . . . 1.34 115.922 -174.273 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -93.16 138.38 31.63 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.592 -0.892 . . . . 1.94 108.592 179.937 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -66.79 -41.48 87.54 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 118.479 0.581 . . . . 1.56 112.028 -165.623 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.95 47.51 3.39 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 118.454 2.142 . . . . 0.97 118.454 176.498 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -134.49 171.65 14.01 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 102.312 -3.218 . . . . 3.07 102.312 171.409 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.2 p -113.81 177.83 4.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 125.275 2.464 . . . . 1.34 116.799 178.818 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.55 HD23 HD11 ' A' ' 61' ' ' ILE . 84.8 mt -66.91 -42.24 85.77 Favored 'General case' 0 N--CA 1.43 -1.427 1 C-N-CA 131.816 4.046 . . . . 1.63 109.084 173.9 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 t -59.56 -32.97 70.84 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 116.277 -4.014 . . . . 1.51 111.704 173.698 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.271 54.3 m-20 -81.39 -39.91 24.27 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.127 1.899 . . . . 1.9 116.127 179.629 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -84.05 -3.72 58.25 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.31 1.596 . . . . 0.97 115.31 176.72 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 74.12 36.72 0.66 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.079 2.552 . . . . 2.35 114.101 -177.744 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.55 HD11 HD23 ' A' ' 56' ' ' LEU . 11.7 mt -88.16 118.28 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 1 O-C-N 115.581 -4.449 . . . . 1.39 106.68 179.713 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -115.12 -164.9 0.97 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.272 -1.517 . . . . 2.58 115.023 -171.01 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -57.69 127.59 32.78 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 117.708 2.485 . . . . 2.58 117.708 174.927 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 69.69 34.57 2.65 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.449 3.023 . . . . 1.71 113.668 172.854 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m -88.1 129.57 35.26 Favored 'General case' 0 N--CA 1.429 -1.491 1 O-C-N 114.076 -5.39 . . . . 1.34 115.584 -177.955 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.0 m -85.09 88.68 7.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 118.533 2.79 . . . . 1.36 118.533 -175.671 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.461 HD12 HG22 ' A' ' 61' ' ' ILE . 10.3 mp -77.69 158.75 29.54 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 124.031 1.872 . . . . 2.03 107.147 179.332 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -119.62 140.88 49.9 Favored 'General case' 0 N--CA 1.43 -1.429 1 O-C-N 115.282 -4.636 . . . . 2.31 110.707 -179.746 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 tp -115.11 107.24 15.07 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 114.525 1.306 . . . . 1.72 114.525 -178.256 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.8 t -100.9 114.8 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 118.965 -2.335 . . . . 1.8 106.206 175.995 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.5 mt -97.57 158.2 15.61 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.362 2.029 . . . . 3.26 108.696 177.138 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -100.37 159.5 15.08 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.872 2.469 . . . . 4.12 106.582 -174.906 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.4 mt -81.67 85.13 6.62 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 121.839 -0.538 . . . . 3.54 111.135 168.749 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.4 ttt85 -82.8 -63.58 1.34 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.693 1.738 . . . . 7.32 115.693 169.562 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.94 -97.41 0.2 Allowed Glycine 0 N--CA 1.431 -1.692 0 O-C-N 118.675 -2.516 . . . . 3.73 113.316 -169.105 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.767 0 N-CA-C 107.914 -2.074 . . . . 3.87 107.914 -177.654 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.514 ' HG3' HG21 ' A' ' 17' ' ' VAL . 12.4 ptm . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 116.972 2.212 . . . . 1.39 116.972 . . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -108.66 163.74 12.98 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 127.464 2.306 . . . . 2.2 105.285 -179.593 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.7 pt -142.72 163.29 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 126.96 2.104 . . . . 1.32 106.085 168.865 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -126.03 110.14 13.22 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 124.517 1.135 . . . . 2.2 111.635 178.105 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.2 t -93.93 118.62 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 106.92 -1.511 . . . . 1.23 106.92 178.48 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -103.86 128.11 51.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.394 1.077 . . . . 2.51 109.619 177.236 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.5 p -85.21 165.7 17.16 Favored 'General case' 0 N--CA 1.429 -1.505 1 CA-C-O 128.979 4.228 . . . . 1.41 109.972 173.404 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.9 mt -59.35 -46.68 87.96 Favored 'General case' 0 N--CA 1.429 -1.502 1 O-C-N 115.269 -4.644 . . . . 2.95 113.113 166.153 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 p -55.99 -34.68 65.99 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 125.383 1.473 . . . . 2.52 111.952 -177.666 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.5 27.72 1.28 Allowed Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 117.718 -1.601 . . . . 1.5 112.533 174.55 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.466 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 71.6 tttt -106.83 151.46 25.17 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 117.242 -1.783 . . . . 1.79 110.028 -176.83 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.0 m -125.73 117.88 24.39 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.27 3.414 . . . . 1.38 108.343 174.055 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.365 11.5 pt -106.1 137.65 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.605 -2.56 . . . . 2.03 105.785 174.306 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.5 m -104.03 107.35 18.21 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.306 -1.316 . . . . 1.61 109.948 173.731 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.4 mt -102.52 149.6 24.23 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.262 2.225 . . . . 2.15 109.882 -175.8 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -103.25 132.12 49.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.176 -3.453 . . . . 1.98 110.979 177.479 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.514 HG21 ' HG3' ' A' ' 1' ' ' MET . 12.6 m -137.43 160.96 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 104.97 -2.233 . . . . 1.52 104.97 -169.078 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -107.5 155.97 38.66 Favored Pre-proline 0 N--CA 1.431 -1.392 0 O-C-N 120.484 -1.385 . . . . 2.35 108.872 166.352 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.67 -27.53 38.35 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 C-N-CA 124.274 3.316 . . . . 1.31 113.24 -166.715 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.6 m -92.17 3.74 54.69 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 116.014 -1.946 . . . . 1.71 113.626 -179.796 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -59.14 145.91 40.72 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 120.206 1.366 . . . . 1.69 113.284 171.824 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -79.73 159.45 26.61 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 104.873 -2.269 . . . . 1.33 104.873 175.462 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.3 mm -65.45 -37.81 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 119.399 -2.063 . . . . 1.32 110.159 177.095 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -49.49 -41.49 40.83 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 130.21 3.404 . . . . 1.62 117.69 164.571 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -77.64 -3.79 42.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 124.149 0.905 . . . . 2.13 113.184 174.79 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.04 -36.81 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 105.159 -2.163 . . . . 1.23 105.159 175.948 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -61.07 -38.17 85.28 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.496 2.093 . . . . 1.97 109.919 175.405 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.42 -36.3 68.8 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.402 -2.686 . . . . 1.19 117.856 167.029 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -69.0 -33.63 73.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.3 -4.0 . . . . 1.92 112.886 172.071 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.0 mt -66.16 -34.77 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 114.225 -2.798 . . . . 1.94 113.974 172.589 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -68.11 -39.24 82.82 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 122.359 2.345 . . . . 1.9 107.07 178.51 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -62.57 -47.06 85.5 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.468 -2.02 . . . . 1.55 110.246 178.718 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -75.52 -63.0 1.38 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.287 -2.133 . . . . 2.95 116.549 -177.389 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.466 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 29.2 mm-40 -94.41 -47.92 6.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.252 1.821 . . . . 1.48 115.432 -173.478 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.31 -2.4 6.19 Favored Glycine 0 N--CA 1.431 -1.698 0 CA-C-O 127.651 3.917 . . . . 1.12 112.862 174.523 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.2 mt -71.29 131.69 86.58 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 117.464 -3.374 . . . . 2.07 111.016 -175.085 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -88.26 165.71 6.79 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 125.249 2.911 . . . . 1.39 110.371 -176.889 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.42 -14.76 28.02 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 C-N-CA 122.037 1.825 . . . . 1.68 115.265 -173.341 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -61.36 -36.64 80.75 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.882 3.273 . . . . 2.25 112.479 172.356 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.439 ' HB3' HD13 ' A' ' 71' ' ' LEU . 78.8 mt-30 -106.07 -9.83 16.81 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 126.5 1.92 . . . . 2.44 110.095 -172.474 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -82.27 103.34 11.79 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.258 -2.151 . . . . 1.32 112.213 -175.19 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -114.71 137.41 51.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.514 2.578 . . . . 3.19 105.392 164.851 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 mt -108.66 134.42 51.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.391 -3.943 . . . . 1.75 112.24 172.132 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 93.3 mt -116.44 128.92 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 125.923 2.773 . . . . 1.98 107.172 177.712 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -137.19 142.19 42.13 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.506 -2.622 . . . . 1.94 106.455 173.754 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.26 13.9 3.33 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.294 2.638 . . . . 1.67 117.121 -176.706 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.01 -16.85 57.95 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-O 122.78 1.211 . . . . 1.3 112.384 -178.324 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -101.47 154.22 19.02 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.759 -3.789 . . . . 2.89 108.631 -178.892 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -82.19 132.69 35.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 124.999 1.437 . . . . 2.89 111.674 170.265 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 mt -89.27 140.79 29.13 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 122.041 2.2 . . . . 1.34 114.301 -176.184 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -81.91 142.91 32.06 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 128.032 2.533 . . . . 1.94 110.943 178.265 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.02 -56.31 22.58 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.916 2.086 . . . . 1.56 113.352 -174.531 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.37 37.58 2.59 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 116.021 -2.544 . . . . 0.97 114.359 176.51 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -114.91 164.36 14.25 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.192 -1.781 . . . . 3.07 106.192 166.922 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -114.0 167.18 10.88 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.169 -2.207 . . . . 1.34 112.702 -176.932 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.9 mp -64.25 -42.12 96.65 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.514 2.726 . . . . 1.63 111.672 177.482 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.1 p -70.02 -37.46 75.64 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 117.81 -1.09 . . . . 1.51 113.081 -179.629 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.19 -40.76 98.44 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.004 1.722 . . . . 1.9 115.627 174.198 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -75.21 -16.47 60.48 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.987 -3.57 . . . . 0.97 107.557 177.398 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 70.97 48.64 0.38 Allowed 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.542 1.137 . . . . 2.35 112.421 -174.361 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.8 mt -86.5 107.88 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 113.56 -1.654 . . . . 1.39 110.216 175.831 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -95.38 -160.76 0.81 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.058 2.543 . . . . 2.58 112.071 -174.967 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -76.21 138.37 40.6 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 116.997 -3.564 . . . . 2.58 111.762 174.565 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.309 5.4 tt0 71.37 69.81 0.17 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 127.866 3.229 . . . . 1.71 110.991 174.529 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.397 55.2 m -116.01 144.61 43.86 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.423 -2.673 . . . . 1.34 109.287 -174.817 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.4 m -104.07 102.72 12.47 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.94 -1.504 . . . . 1.36 106.94 175.375 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.0 mt -91.31 123.93 35.12 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.518 -2.614 . . . . 2.03 108.023 170.757 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -92.65 109.14 20.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.645 0.778 . . . . 2.31 110.59 -178.093 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 tp -91.07 113.77 26.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.321 1.534 . . . . 1.72 112.378 -179.752 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.4 m -102.78 160.63 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 124.808 2.242 . . . . 1.8 106.43 178.548 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.439 HD13 ' HB3' ' A' ' 40' ' ' GLN . 20.6 tp -96.05 115.81 28.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.837 -1.529 . . . . 3.26 114.24 176.397 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -95.94 121.9 38.17 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 105.018 -2.216 . . . . 4.12 105.018 -179.732 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.4 mt -96.28 175.91 6.26 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.26 -0.882 . . . . 3.54 112.416 172.289 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -84.7 106.05 15.95 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.413 2.054 . . . . 7.32 114.175 174.586 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.31 -165.27 37.84 Favored Glycine 0 N--CA 1.43 -1.738 0 O-C-N 119.445 -2.035 . . . . 3.73 113.706 -166.228 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.772 0 CA-C-O 115.597 -2.78 . . . . 3.87 109.993 -176.036 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptt? . . . . . 0 CA--C 1.49 -1.349 1 CA-C-O 129.473 4.463 . . . . 1.39 110.689 . . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -91.03 146.75 23.59 Favored 'General case' 0 N--CA 1.431 -1.41 1 O-C-N 113.862 -5.524 . . . . 2.2 110.089 -176.555 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.329 13.9 pt -135.97 153.0 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 129.346 3.058 . . . . 1.32 109.109 178.526 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -112.95 141.98 46.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 126.459 3.028 . . . . 2.2 107.755 176.096 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -134.56 122.02 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 118.263 -2.773 . . . . 1.23 107.842 170.238 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -96.23 137.26 35.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.771 -1.559 . . . . 2.51 111.027 175.41 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.289 44.8 p -77.15 172.67 12.88 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 126.27 2.938 . . . . 1.41 110.363 175.035 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 tp -64.17 -51.34 64.28 Favored 'General case' 0 N--CA 1.429 -1.494 1 O-C-N 115.849 -4.282 . . . . 2.95 113.622 174.965 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.379 75.4 p -61.06 -41.7 97.09 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.563 1.69 . . . . 2.52 115.563 174.552 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.34 9.97 0.2 Allowed Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 116.945 1.538 . . . . 1.5 116.945 175.005 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.565 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 84.5 tttt -84.37 118.5 24.27 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.427 -2.219 . . . . 1.79 114.165 -174.353 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.6 m -93.47 126.77 38.79 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 121.785 2.084 . . . . 1.38 109.415 179.485 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mt -116.87 111.73 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 127.179 2.192 . . . . 2.03 113.153 -178.191 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.1 m -81.2 121.31 25.99 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 126.519 1.928 . . . . 1.61 107.596 177.087 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.5 mt -124.9 146.86 49.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 100.712 -3.81 . . . . 2.15 100.712 -179.475 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -106.18 122.68 46.69 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 118.393 -2.692 . . . . 1.98 108.371 169.909 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.9 m -129.74 152.04 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 126.584 3.087 . . . . 1.52 107.247 -172.99 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -94.1 151.05 39.35 Favored Pre-proline 0 N--CA 1.429 -1.507 1 O-C-N 114.869 -4.894 . . . . 2.35 106.254 156.273 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -76.53 -6.68 17.24 Favored 'Trans proline' 0 N--CA 1.433 -2.05 0 CA-C-N 125.72 3.078 . . . . 1.31 113.525 -174.756 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -87.01 -3.02 59.05 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 125.632 1.833 . . . . 1.71 111.913 -178.466 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -76.37 156.63 33.09 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 129.515 3.126 . . . . 1.69 109.334 171.383 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.5 p -84.98 166.61 16.61 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.402 -2.686 . . . . 1.33 111.794 177.529 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.22 -42.81 97.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 126.419 1.888 . . . . 1.32 109.395 174.939 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -46.35 -44.28 16.77 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.624 3.194 . . . . 1.62 119.624 164.812 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -67.17 -32.97 74.43 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.306 1.595 . . . . 2.13 115.306 173.522 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.3 t -64.15 -39.05 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 126.933 3.254 . . . . 1.23 111.966 169.771 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -59.15 -44.05 92.09 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.324 -2.735 . . . . 1.97 115.268 173.876 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.3 -33.0 65.13 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.056 -2.278 . . . . 1.19 111.401 173.788 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -76.54 -26.39 55.13 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 115.342 1.608 . . . . 1.92 115.342 173.96 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.7 mt -70.96 -28.25 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 119.739 -1.851 . . . . 1.94 114.558 169.146 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -70.92 -33.55 70.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.81 3.244 . . . . 1.9 108.111 179.559 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -74.95 -34.26 62.03 Favored 'General case' 0 N--CA 1.431 -1.408 1 C-N-CA 132.998 4.519 . . . . 1.55 112.356 175.47 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.9 mmtm -89.33 -64.72 1.1 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 127.959 3.742 . . . . 2.95 110.099 -171.078 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.565 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 22.6 mm-40 -93.93 -42.08 9.26 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.04 -2.287 . . . . 1.48 113.621 -170.533 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.73 5.74 21.93 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 121.254 3.261 . . . . 1.12 121.254 175.638 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.1 mt -74.92 129.69 82.68 Favored Pre-proline 0 N--CA 1.431 -1.414 0 C-N-CA 128.747 2.819 . . . . 2.07 110.436 -178.186 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -77.3 141.93 20.84 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 126.077 3.206 . . . . 1.39 111.998 -177.244 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.27 -17.53 33.28 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 N-CA-C 118.739 2.554 . . . . 1.68 118.739 -173.061 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -79.04 -23.2 44.43 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 114.863 1.431 . . . . 2.25 114.863 171.349 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -88.66 -13.75 39.06 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.351 -2.093 . . . . 2.44 108.111 176.765 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.329 69.2 mt-30 -98.12 143.76 28.31 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 121.163 1.802 . . . . 1.32 110.9 -174.316 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -135.87 135.79 40.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 121.398 0.618 . . . . 3.19 111.037 171.301 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.0 mt -102.84 134.75 45.72 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 117.254 -3.404 . . . . 1.75 115.702 172.139 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.3 mt -118.53 130.28 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 114.724 -1.125 . . . . 1.98 108.322 -179.484 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -136.29 123.15 21.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.139 -2.85 . . . . 1.94 118.009 176.167 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.54 40.44 23.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.046 1.738 . . . . 1.67 110.631 -171.445 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.92 -8.45 50.5 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-O 114.465 -3.408 . . . . 1.3 114.922 179.537 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -85.39 135.5 33.85 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 120.002 1.901 . . . . 2.89 110.706 175.348 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -84.69 120.69 26.69 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.748 2.689 . . . . 2.89 108.475 164.927 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.1 mt -80.25 107.99 13.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 118.204 2.668 . . . . 1.34 118.204 -173.726 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.269 33.2 mt-10 -52.9 121.98 8.36 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 121.525 3.898 . . . . 1.94 121.525 170.434 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.12 -57.82 1.25 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 131.158 3.783 . . . . 1.56 115.756 -174.075 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.89 39.19 2.84 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 127.73 2.586 . . . . 0.97 116.613 175.186 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -121.35 172.37 8.08 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.081 1.896 . . . . 3.07 106.142 167.385 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.301 62.2 p -87.83 176.67 7.27 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 118.944 -2.348 . . . . 1.34 113.959 168.663 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.4 mt -80.53 -25.78 38.47 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.446 1.899 . . . . 1.63 109.409 165.771 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.56 -39.55 62.21 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 107.657 -1.238 . . . . 1.51 107.657 -170.641 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -43.61 -57.79 2.98 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 126.783 2.033 . . . . 1.9 116.078 169.351 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -71.49 -1.31 12.87 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 119.279 3.066 . . . . 0.97 119.279 -178.588 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.396 23.1 m120 62.2 49.9 4.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 131.003 3.721 . . . . 2.35 113.083 -170.198 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.4 mt -87.64 137.31 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 123.508 2.867 . . . . 1.39 109.247 174.988 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -122.51 -176.56 3.41 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.833 2.254 . . . . 2.58 110.528 -175.762 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 ptmm? -62.59 139.55 58.63 Favored 'General case' 0 N--CA 1.429 -1.487 1 O-C-N 116.206 -4.059 . . . . 2.58 111.898 -177.513 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 62.61 31.52 16.79 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.856 2.862 . . . . 1.71 109.15 175.307 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 t -95.01 137.45 34.05 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.458 -2.651 . . . . 1.34 109.994 -179.897 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.2 m -88.07 121.58 30.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 126.929 2.643 . . . . 1.36 112.035 -177.767 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 72.2 mt -105.28 152.79 22.46 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 128.631 2.772 . . . . 2.03 105.871 176.9 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -101.82 125.32 48.47 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.439 -2.663 . . . . 2.31 107.261 -177.48 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.2 tp -96.93 126.28 41.96 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 124.296 3.225 . . . . 1.72 110.949 178.131 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.9 m -131.1 176.98 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 118.366 -2.709 . . . . 1.8 111.162 172.012 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 67.7 mt -101.39 133.49 45.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.724 -1.86 . . . . 3.26 114.064 178.431 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.3 ttt-85 -86.56 75.93 9.65 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 126.501 1.92 . . . . 4.12 110.805 170.613 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.9 mt -81.95 163.19 22.36 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 113.627 -1.624 . . . . 3.54 110.781 -178.27 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -73.04 -178.5 2.85 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 127.359 2.264 . . . . 7.32 116.683 174.464 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.24 40.65 9.02 Favored Glycine 0 N--CA 1.432 -1.619 0 N-CA-C 120.03 2.772 . . . . 3.73 120.03 -170.286 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.773 0 C-N-CA 116.604 -2.713 . . . . 3.87 111.608 -175.488 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 112.157 0.429 . . . . 1.39 112.157 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -108.96 140.73 42.07 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.316 -2.74 . . . . 2.2 105.678 177.588 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.4 pt -128.86 153.17 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 106.486 -1.672 . . . . 1.32 106.486 173.477 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -109.75 105.82 15.21 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.501 -2.0 . . . . 2.2 115.226 179.188 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.0 t -94.58 115.95 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 117.801 -3.062 . . . . 1.23 105.762 176.565 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -95.39 156.91 16.12 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.689 2.185 . . . . 2.51 108.013 175.502 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.2 p -105.06 -171.61 1.95 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.994 1.318 . . . . 1.41 110.252 -178.404 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.9 mt -85.88 -36.84 19.71 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 115.701 -4.375 . . . . 2.95 114.242 172.477 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.251 38.6 p -80.06 -54.84 5.41 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.589 -2.004 . . . . 2.52 105.589 -175.339 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.02 23.77 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 120.241 2.856 . . . . 1.5 120.241 171.541 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -88.18 135.83 33.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 117.684 -1.15 . . . . 1.79 111.058 -179.917 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.8 m -109.79 111.65 23.23 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.359 -1.349 . . . . 1.38 107.359 169.851 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 mt -92.3 105.54 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 104.835 -2.283 . . . . 2.03 104.835 -177.315 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.8 m -85.36 107.6 17.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.673 -3.142 . . . . 1.61 106.174 178.159 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.8 mt -101.13 144.17 30.35 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 114.318 1.229 . . . . 2.15 114.318 -177.973 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -101.05 118.88 37.88 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.678 2.656 . . . . 1.98 110.875 174.952 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 m -130.26 158.57 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 123.863 1.792 . . . . 1.52 110.614 -172.412 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -113.26 170.73 4.99 Favored Pre-proline 0 N--CA 1.43 -1.45 0 O-C-N 117.772 -3.08 . . . . 2.35 105.408 159.358 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -87.21 -9.55 6.05 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 C-N-CA 122.342 2.028 . . . . 1.31 114.006 -167.836 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.261 81.5 p -85.04 0.85 50.14 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 131.284 3.833 . . . . 1.71 116.079 173.445 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -86.7 145.33 26.72 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.673 -3.142 . . . . 1.69 111.552 169.098 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.5 p -59.75 155.41 16.04 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.718 2.199 . . . . 1.33 112.559 168.979 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.455 HG21 HD12 ' A' ' 43' ' ' LEU 0.253 3.3 mt -63.19 -37.13 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 119.654 -1.904 . . . . 1.32 112.551 170.332 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -53.09 -40.55 64.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.075 1.509 . . . . 1.62 115.075 165.655 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -61.02 -32.98 72.57 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 118.275 2.695 . . . . 2.13 118.275 174.186 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.318 45.6 t -71.2 -35.85 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 122.387 1.089 . . . . 1.23 110.196 -178.42 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -70.08 -24.37 63.22 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 132.042 4.137 . . . . 1.97 113.593 174.442 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.56 -33.99 62.82 Favored 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 116.298 -4.001 . . . . 1.19 111.644 174.941 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -69.1 -25.93 64.66 Favored 'General case' 0 N--CA 1.431 -1.395 1 O-C-N 114.972 -4.83 . . . . 1.92 115.522 178.429 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 mt -68.01 -39.64 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 1 C-N-CA 132.499 4.32 . . . . 1.94 112.397 170.594 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.11 -36.68 77.99 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.718 2.488 . . . . 1.9 117.718 178.332 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.03 -57.9 10.88 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 116.544 -1.693 . . . . 1.55 114.127 163.242 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -62.78 -61.84 2.13 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 118.284 2.698 . . . . 2.95 118.284 -177.722 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -93.79 -32.34 14.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.9 -3.0 . . . . 1.48 109.584 -171.81 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.88 16.78 22.86 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 116.92 -2.562 . . . . 1.12 115.629 172.699 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.4 mt -90.58 131.96 36.54 Favored Pre-proline 0 N--CA 1.43 -1.455 1 CA-C-O 110.889 -4.386 . . . . 2.07 110.66 179.237 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -57.68 146.67 83.96 Favored 'Trans proline' 0 C--N 1.299 -2.056 0 CA-C-N 127.664 3.773 . . . . 1.39 116.954 171.767 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.66 -13.38 13.28 Favored 'Trans proline' 0 N--CA 1.434 -2.027 1 C-N-CA 125.674 4.249 . . . . 1.68 113.985 -175.077 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.391 9.6 p-10 -62.83 -31.78 72.86 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 119.724 1.147 . . . . 2.25 113.708 166.325 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -80.75 -26.89 37.03 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 123.813 1.768 . . . . 2.44 113.284 -176.398 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -84.67 142.78 29.65 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 111.711 -2.495 . . . . 1.32 111.252 -173.651 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -143.35 142.6 31.35 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.921 -1.49 . . . . 3.19 111.845 171.644 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.455 HD12 HG21 ' A' ' 23' ' ' ILE . 97.6 mt -105.19 146.63 28.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.92 2.295 . . . . 1.75 106.387 -178.38 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 mt -118.76 138.93 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 128.582 2.753 . . . . 1.98 104.51 174.29 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -144.58 120.44 10.6 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 124.971 2.32 . . . . 1.94 104.789 177.109 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.38 13.58 5.52 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 127.865 2.466 . . . . 1.67 114.912 175.435 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.29 -22.57 38.58 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 127.487 2.47 . . . . 1.3 113.991 -171.571 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -80.57 134.96 36.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 126.548 3.07 . . . . 2.89 111.676 -177.267 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -77.8 128.79 34.57 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 117.195 -3.441 . . . . 2.89 111.942 176.778 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.6 mt -92.97 142.65 27.07 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.188 -2.195 . . . . 1.34 113.438 -172.356 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -79.86 148.01 31.5 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.077 2.951 . . . . 1.94 110.849 175.242 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -89.18 -34.27 16.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.167 1.914 . . . . 1.56 116.167 -168.468 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.36 21.03 6.42 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 128.488 2.947 . . . . 0.97 117.698 171.979 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -105.55 178.2 4.63 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 119.698 1.749 . . . . 3.07 108.187 169.311 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -108.84 -172.94 2.15 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 124.905 2.288 . . . . 1.34 107.274 167.164 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.6 mt -66.06 -43.87 86.2 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 128.436 3.97 . . . . 1.63 112.889 171.089 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.4 m -53.27 -25.97 16.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.179 -3.451 . . . . 1.51 118.291 -179.734 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -78.37 -44.83 23.99 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.115 2.966 . . . . 1.9 111.841 177.386 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -80.76 9.87 5.7 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 129.949 3.3 . . . . 0.97 114.648 174.949 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.27 10.2 p30 47.93 39.8 11.68 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 129.044 2.938 . . . . 2.35 114.176 -178.888 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.304 12.7 mt -77.92 127.56 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 116.856 -3.652 . . . . 1.39 109.555 179.966 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 -107.58 -178.37 3.61 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 125.655 2.645 . . . . 2.58 106.369 178.427 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -64.22 159.22 21.19 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 115.74 -4.35 . . . . 2.58 110.467 -177.484 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.421 19.9 mt-10 59.41 41.53 19.34 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 116.966 -3.583 . . . . 1.71 112.657 169.389 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.2 p -106.36 135.14 48.38 Favored 'General case' 0 N--CA 1.431 -1.397 1 O-C-N 114.857 -4.902 . . . . 1.34 109.9 -173.373 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.5 m -86.44 116.55 24.66 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.477 -2.64 . . . . 1.36 107.163 175.808 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.6 mp -109.45 160.57 16.09 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 112.862 -1.972 . . . . 2.03 110.29 172.594 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -127.39 139.53 52.78 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.949 -2.344 . . . . 2.31 112.046 -176.681 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.6 tp -103.46 127.13 50.91 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 130.695 3.598 . . . . 1.72 109.16 -177.495 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.0 m -135.15 163.95 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 O-C-N 116.351 -3.968 . . . . 1.8 110.557 166.476 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.6 mt -98.07 158.69 15.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 117.024 -1.465 . . . . 3.26 113.278 170.77 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -80.45 142.48 34.25 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 117.125 2.269 . . . . 4.12 117.125 -178.5 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.5 mt -88.4 112.81 23.33 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 104.692 -2.336 . . . . 3.54 104.692 172.95 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -81.46 120.45 25.02 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 114.146 -5.346 . . . . 7.32 110.65 173.827 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.1 -128.72 1.1 Allowed Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 107.131 -2.388 . . . . 3.73 107.131 -173.543 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.778 0 C-N-CA 128.153 2.787 . . . . 3.87 111.496 -178.262 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 CA--C 1.49 -1.36 0 CA-C-O 125.998 2.809 . . . . 1.39 103.709 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -90.28 125.75 35.61 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.969 -3.582 . . . . 2.2 109.432 -179.328 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -127.65 150.49 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 118.926 -1.109 . . . . 1.32 109.092 170.148 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.262 33.3 m-85 -115.03 121.86 44.4 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 124.28 1.99 . . . . 2.2 112.314 -172.027 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -103.12 107.97 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 119.677 -1.889 . . . . 1.23 110.903 178.309 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -85.61 158.66 20.05 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 118.806 -2.434 . . . . 2.51 107.474 177.781 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.3 p -108.43 -167.52 1.24 Allowed 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 106.824 -1.547 . . . . 1.41 106.824 175.3 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.6 mt -88.69 -30.75 18.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 119.865 1.211 . . . . 2.95 109.171 178.592 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.9 p -70.57 -27.65 64.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.055 -2.278 . . . . 2.52 106.542 -179.478 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.34 18.66 6.13 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-O 122.432 1.018 . . . . 1.5 115.592 173.362 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -82.63 117.86 22.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 117.041 -1.457 . . . . 1.79 113.375 -177.463 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.288 89.2 m -85.35 115.41 23.08 Favored 'General case' 0 N--CA 1.431 -1.389 1 CA-C-N 126.202 4.092 . . . . 1.38 114.115 175.396 . . . . . . . . 3 2 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.2 mt -100.56 107.31 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 1 O-C-N 114.963 -4.836 . . . . 2.03 110.6 178.629 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.7 m -80.68 116.3 20.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.954 -2.341 . . . . 1.61 114.057 175.562 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.9 mt -107.6 127.98 54.12 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.55 -1.969 . . . . 2.15 107.717 178.009 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -96.15 99.83 11.53 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.376 -2.702 . . . . 1.98 104.619 170.69 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.3 m -112.38 164.63 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 105.681 -1.97 . . . . 1.52 105.681 -176.406 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -104.78 163.73 16.61 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 105.618 -1.993 . . . . 2.35 105.618 165.663 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -86.82 -8.93 6.72 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 O-C-N 113.932 -3.773 . . . . 1.31 108.759 -166.402 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.25 4.9 p -90.72 1.14 57.12 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 119.763 -0.775 . . . . 1.71 111.674 177.149 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.27 36.2 m-20 -63.01 148.7 46.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 129.694 3.198 . . . . 1.69 108.737 172.173 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 23.5 p -97.99 163.87 12.59 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 118.846 -2.409 . . . . 1.33 112.632 173.893 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.298 24.1 mm -63.41 -34.98 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 120.062 1.301 . . . . 1.32 111.099 -179.581 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -48.77 -39.95 27.04 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 117.948 -2.97 . . . . 1.62 115.243 160.279 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -75.84 -48.65 20.66 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.508 -2.62 . . . . 2.13 107.905 -176.741 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.6 t -49.1 -54.25 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.989 2.916 . . . . 1.23 116.334 172.56 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -50.97 -32.75 22.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.427 -1.421 . . . . 1.97 113.876 175.983 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.88 -40.02 91.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.181 3.372 . . . . 1.19 114.068 178.789 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -58.79 -40.94 85.49 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.78 -3.075 . . . . 1.92 112.378 176.245 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.4 mt -70.5 -31.6 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 116.487 -3.883 . . . . 1.94 112.061 176.139 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -69.13 -33.39 73.38 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 119.434 -2.041 . . . . 1.9 111.453 171.929 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.355 17.5 t70 -77.13 -44.3 30.87 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.43 2.011 . . . . 1.55 116.43 167.814 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -65.33 -60.56 2.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.194 -3.441 . . . . 2.95 111.092 -171.099 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -105.13 -37.16 7.02 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 124.283 1.992 . . . . 1.48 109.355 -166.251 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.92 38.39 2.35 Favored Glycine 0 N--CA 1.43 -1.752 0 O-C-N 117.56 -3.213 . . . . 1.12 111.575 168.752 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.414 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 37.5 mt -111.08 122.23 38.48 Favored Pre-proline 0 N--CA 1.43 -1.465 0 O-C-N 118.577 -2.719 . . . . 2.07 106.395 -174.441 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 36' ' ' ILE . 18.5 Cg_endo -57.76 141.73 95.79 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 O-C-N 115.65 -2.868 . . . . 1.39 116.819 175.448 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -64.83 -32.96 54.87 Favored 'Trans proline' 0 N--CA 1.433 -2.03 1 C-N-CA 127.54 5.493 . . . . 1.68 111.797 -174.136 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -51.14 -39.35 56.09 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 129.871 3.268 . . . . 2.25 113.996 168.158 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -82.19 -5.22 58.33 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.11 1.909 . . . . 2.44 112.688 178.248 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -99.6 113.76 26.38 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 116.333 -3.98 . . . . 1.32 108.27 -166.933 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -89.29 123.02 33.11 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 125.31 2.481 . . . . 3.19 104.823 163.017 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.2 mt -109.29 119.67 40.2 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.039 -5.413 . . . . 1.75 105.267 175.385 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.3 mm -108.51 133.16 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 128.306 2.643 . . . . 1.98 113.037 179.57 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -130.93 114.31 15.09 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 129.298 4.124 . . . . 1.94 111.05 174.074 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.01 -92.14 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.162 2.185 . . . . 1.67 113.306 -178.437 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.79 23.0 4.01 Favored Glycine 0 N--CA 1.431 -1.696 0 C-N-CA 127.676 2.56 . . . . 1.3 112.536 174.106 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.9 mmtt -123.33 129.95 52.04 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.09 -1.829 . . . . 2.89 110.212 -179.36 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -87.55 125.13 34.15 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 117.185 -3.447 . . . . 2.89 105.274 172.014 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 99.3 mt -82.11 126.69 32.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.082 -1.636 . . . . 1.34 111.906 -162.104 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -76.13 147.97 38.16 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.644 -2.535 . . . . 1.94 111.938 168.772 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.276 42.6 m-20 -61.11 -65.65 0.66 Allowed 'General case' 0 N--CA 1.431 -1.419 1 N-CA-C 123.201 4.519 . . . . 1.56 123.201 -171.271 . . . . . . . . 3 2 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.82 32.92 3.36 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 122.045 3.578 . . . . 0.97 122.045 178.886 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.7 mtt-85 -102.7 153.65 19.93 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 103.697 -2.705 . . . . 3.07 103.697 169.875 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.268 8.1 p -77.43 153.56 33.48 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 131.043 3.737 . . . . 1.34 110.328 171.733 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 mt -59.74 -42.15 92.52 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.017 -0.992 . . . . 1.63 111.847 172.118 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.6 p -56.81 -36.56 70.06 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.564 2.346 . . . . 1.51 111.725 179.067 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -66.41 -45.7 79.04 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.871 1.669 . . . . 1.9 111.7 -177.197 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -72.19 -9.16 58.08 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 116.966 2.21 . . . . 0.97 116.966 170.62 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 61.46 53.01 3.51 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.496 1.518 . . . . 2.35 112.504 -177.68 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.8 mt -89.05 113.78 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 130.791 3.637 . . . . 1.39 105.038 176.079 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -99.52 -169.9 1.82 Allowed 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.301 1.593 . . . . 2.58 115.301 178.504 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -66.32 141.25 58.06 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.765 1.745 . . . . 2.58 110.791 176.38 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 67.23 24.98 9.01 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 112.437 -2.165 . . . . 1.71 113.272 172.918 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.3 m -75.58 144.6 41.75 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.855 1.312 . . . . 1.34 112.732 -175.874 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 m -97.57 123.46 41.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 118.071 -1.451 . . . . 1.36 108.518 -176.081 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 mp -122.26 163.38 19.74 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 104.508 -2.404 . . . . 2.03 104.508 178.195 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.263 43.6 m80 -134.63 112.03 10.49 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.46 2.552 . . . . 2.31 110.822 -172.302 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.05 122.74 22.26 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.695 2.398 . . . . 1.72 111.605 175.397 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.5 t -123.01 136.27 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 102.506 -3.146 . . . . 1.8 102.506 175.202 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.7 tp -98.35 125.68 43.58 Favored 'General case' 0 N--CA 1.429 -1.487 1 O-C-N 114.822 -4.924 . . . . 3.26 111.027 -174.45 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -84.5 117.11 23.48 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.18 1.792 . . . . 4.12 109.225 176.075 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.6 mt -83.07 -166.45 1.35 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.988 1.715 . . . . 3.54 112.223 168.712 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -83.81 176.19 9.11 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.825 1.774 . . . . 7.32 112.506 172.127 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.93 42.77 96.72 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 118.125 2.01 . . . . 3.73 118.125 -167.291 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.83 0 O-C-N 119.908 -1.936 . . . . 3.87 109.24 172.188 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 ptt? . . . . . 0 CA--C 1.491 -1.325 0 N-CA-C 118.225 2.676 . . . . 1.39 118.225 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.257 7.1 tt0 -117.83 123.27 45.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.677 2.791 . . . . 2.2 114.206 -178.498 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.4 pt -127.94 160.47 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 117.774 -3.079 . . . . 1.32 106.922 174.457 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -118.71 132.79 56.16 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.38 3.472 . . . . 2.2 106.231 -173.355 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 t -122.97 125.59 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 123.447 0.699 . . . . 1.23 110.772 170.851 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.344 19.4 mttm -103.05 145.41 29.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.967 2.794 . . . . 2.51 115.067 179.598 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.301 22.9 p -91.45 168.68 11.37 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.722 -4.362 . . . . 1.41 116.291 173.653 . . . . . . . . 3 2 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.342 31.6 tp -59.31 -56.65 19.4 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.673 2.101 . . . . 2.95 116.673 169.603 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 p -61.89 -60.85 3.03 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 114.35 -1.295 . . . . 2.52 112.002 -176.075 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.86 30.53 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 117.964 -2.065 . . . . 1.5 117.214 173.105 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.432 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 95.0 mttt -111.36 146.3 37.35 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.696 -2.061 . . . . 1.79 111.305 -178.509 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.8 m -112.69 104.61 12.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 104.065 -2.568 . . . . 1.38 104.065 167.602 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.2 mt -91.0 123.53 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 122.213 1.006 . . . . 2.03 108.379 -176.447 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 m -94.31 120.89 35.21 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 118.488 -2.632 . . . . 1.61 109.318 -179.957 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.6 mt -113.14 143.51 44.25 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 126.929 3.252 . . . . 2.15 112.215 179.551 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -86.2 112.35 21.26 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 111.805 -2.452 . . . . 1.98 107.004 171.237 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.13 149.86 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.989 1.716 . . . . 1.52 114.922 -177.613 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -108.79 149.54 39.65 Favored Pre-proline 0 N--CA 1.43 -1.438 0 N-CA-C 103.651 -2.722 . . . . 2.35 103.651 172.418 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -63.94 -19.7 67.0 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 123.428 2.752 . . . . 1.31 113.178 -173.84 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.4 p -80.73 -16.77 53.04 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 130.08 3.352 . . . . 1.71 110.683 -177.51 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -60.24 145.63 46.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 116.779 -1.968 . . . . 1.69 113.892 172.428 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.9 p -80.25 162.62 24.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.537 2.113 . . . . 1.33 108.905 176.461 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.3 mm -64.87 -30.5 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 126.833 3.206 . . . . 1.32 112.016 177.125 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.6 -39.17 91.27 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 114.693 -5.004 . . . . 1.62 112.217 167.059 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.253 15.8 m-80 -70.39 -32.73 70.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 119.892 1.224 . . . . 2.13 112.552 171.683 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.35 43.4 t -53.57 -48.67 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 1 O-C-N 114.287 -5.258 . . . . 1.23 112.72 167.825 . . . . . . . . 3 2 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -56.06 -41.25 74.78 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.187 1.921 . . . . 1.97 116.187 174.531 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.3 -31.74 72.96 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.431 1.493 . . . . 1.19 112.637 172.275 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -66.22 -38.59 88.3 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 127.494 3.521 . . . . 1.92 115.673 176.119 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.7 mt -73.07 -36.99 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 117.636 -3.165 . . . . 1.94 107.596 172.911 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.428 ' HG3' ' HD3' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -62.64 -35.2 78.85 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 123.851 3.023 . . . . 1.9 113.844 179.431 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.45 -54.72 24.39 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.461 1.904 . . . . 1.55 109.726 175.188 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.5 mmtt -57.83 -77.64 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.479 3.038 . . . . 2.95 115.638 -179.08 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.432 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 34.0 tp10 -101.68 -20.78 14.85 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.166 -3.458 . . . . 1.48 110.142 -161.895 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.77 53.81 2.48 Favored Glycine 0 N--CA 1.431 -1.682 0 O-C-N 120.412 -1.43 . . . . 1.12 115.165 172.524 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.1 mt -108.05 117.04 55.99 Favored Pre-proline 0 N--CA 1.43 -1.436 0 CA-C-O 113.51 -3.138 . . . . 2.07 110.153 -175.773 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -67.32 127.24 16.26 Favored 'Trans proline' 0 C--N 1.299 -2.054 0 CA-C-N 126.241 3.265 . . . . 1.39 117.292 -179.654 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.428 ' HD3' ' HG3' ' A' ' 31' ' ' GLN . 27.5 Cg_exo -59.49 -31.13 94.15 Favored 'Trans proline' 0 N--CA 1.434 -2.016 1 C-N-CA 127.527 5.485 . . . . 1.68 118.406 -172.402 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -64.9 -24.68 67.6 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.753 2.821 . . . . 2.25 108.445 178.721 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -94.02 12.71 25.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.912 -2.368 . . . . 2.44 116.53 173.733 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.275 9.6 mt-30 -115.29 147.21 40.69 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.217 2.437 . . . . 1.32 110.675 -178.893 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.6 ptt85 -135.02 134.65 40.66 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 112.907 -1.951 . . . . 3.19 106.048 163.853 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 44.3 mt -103.69 133.48 48.63 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 119.823 1.192 . . . . 1.75 113.203 179.64 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.4 mm -118.64 145.49 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 125.059 2.361 . . . . 1.98 108.553 177.9 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -134.54 108.79 8.29 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.013 -2.93 . . . . 1.94 103.92 172.295 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.519 . . 72.77 -97.33 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 116.666 2.099 . . . . 1.67 116.666 -176.961 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.9 17.52 1.97 Allowed Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 127.603 2.525 . . . . 1.3 108.532 -175.639 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.2 mttm -106.49 144.79 32.66 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.204 -2.35 . . . . 2.89 110.06 170.664 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -107.75 129.29 55.05 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.587 3.089 . . . . 2.89 115.345 169.649 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.7 mt -97.19 122.84 40.66 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.394 -3.941 . . . . 1.34 104.433 -160.342 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -77.09 138.66 39.67 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 117.633 -3.167 . . . . 1.94 111.72 172.397 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -54.91 -41.14 70.6 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 130.489 3.515 . . . . 1.56 115.978 -170.131 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.38 31.24 6.9 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 126.537 2.018 . . . . 0.97 115.051 174.935 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.87 165.28 11.83 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.224 -1.399 . . . . 3.07 107.224 166.426 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 5.4 p -95.62 171.52 8.62 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 119.034 2.976 . . . . 1.34 119.034 169.179 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -59.35 -39.1 82.16 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 121.59 1.995 . . . . 1.63 112.171 169.772 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 t -64.3 -37.86 88.98 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 116.944 2.202 . . . . 1.51 116.944 -179.151 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -61.19 -21.59 63.96 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.657 -1.902 . . . . 1.9 113.851 174.071 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -109.52 12.35 24.48 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.659 2.936 . . . . 0.97 115.685 -178.962 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.401 6.4 t-20 62.6 39.24 11.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.683 2.793 . . . . 2.35 116.71 -177.093 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.7 mt -90.84 105.5 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 112.661 -2.063 . . . . 1.39 112.556 178.046 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -98.9 -171.59 2.13 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 122.23 2.286 . . . . 2.58 107.111 -174.551 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.253 21.8 pttp -61.54 149.01 40.26 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 126.698 1.999 . . . . 2.58 115.604 176.354 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.317 36.1 mt-10 67.19 13.18 9.32 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.804 1.779 . . . . 1.71 115.804 175.123 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.6 m -66.44 148.74 51.45 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.477 -2.014 . . . . 1.34 112.271 -177.835 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.6 m -103.45 97.92 7.9 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.808 1.766 . . . . 1.36 115.494 173.751 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 mp -87.26 152.43 22.31 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.526 -1.984 . . . . 2.03 113.993 -178.924 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.6 m170 -120.79 129.07 53.44 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.158 -1.589 . . . . 2.31 109.87 -173.788 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.4 tp -95.34 128.82 42.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.576 -1.327 . . . . 1.72 114.374 -176.175 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.4 159.0 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 124.163 1.935 . . . . 1.8 113.669 177.371 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 tp -88.55 138.71 31.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.786 -1.196 . . . . 3.26 110.852 -174.439 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -99.21 139.68 34.5 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.854 3.216 . . . . 4.12 106.186 178.407 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.7 mt -131.15 112.75 13.12 Favored 'General case' 0 N--CA 1.43 -1.428 1 N-CA-C 98.629 -4.582 . . . . 3.54 98.629 173.026 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -82.46 147.03 28.95 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.786 2.143 . . . . 7.32 116.786 168.771 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.86 -76.79 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 108.384 -1.886 . . . . 3.73 108.384 -168.528 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.761 0 C-N-CA 118.767 -1.682 . . . . 3.87 115.006 177.104 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.2 ttp . . . . . 0 CA--C 1.49 -1.355 0 CA-C-O 116.443 -1.741 . . . . 1.39 109.537 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -96.13 134.29 39.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.114 1.779 . . . . 2.2 109.064 176.69 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 pt -130.22 162.58 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 106.289 -1.745 . . . . 1.32 106.289 163.566 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -115.01 143.32 45.37 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.038 -1.664 . . . . 2.2 113.952 178.088 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.3 t -113.73 120.29 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 118.098 -2.876 . . . . 1.23 104.05 171.106 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -107.78 119.38 39.27 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 126.973 2.109 . . . . 2.51 106.641 177.547 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.3 p -84.13 163.55 19.73 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 121.165 -0.959 . . . . 1.41 111.724 -176.746 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.4 tp -39.56 -43.05 1.24 Allowed 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 118.713 2.857 . . . . 2.95 118.713 172.755 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.5 p -81.2 -24.86 37.16 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.892 1.995 . . . . 2.52 108.419 -176.7 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.44 31.24 3.3 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-O 125.402 2.668 . . . . 1.5 115.245 178.843 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -92.78 124.48 36.81 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.636 -2.685 . . . . 1.79 106.723 178.548 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -109.49 111.73 23.43 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.722 2.677 . . . . 1.38 112.026 175.315 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.262 36.1 pt -100.24 132.57 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 1 CA-C-O 128.847 4.165 . . . . 2.03 106.752 -178.691 . . . . . . . . 3 2 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 95.9 m -90.5 122.11 33.04 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.04 -2.913 . . . . 1.61 110.834 177.584 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.46 142.55 35.94 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.436 2.294 . . . . 2.15 112.675 176.547 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -110.57 118.61 36.68 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.548 2.339 . . . . 1.98 109.667 169.339 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.437 HG23 HD11 ' A' ' 56' ' ' LEU . 15.9 m -132.89 159.92 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 C-N-CA 124.016 0.926 . . . . 1.52 112.006 -178.676 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -92.05 156.26 42.36 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-O 116.424 -1.751 . . . . 2.35 112.693 159.57 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -73.11 -9.13 23.1 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 CA-C-N 126.139 3.228 . . . . 1.31 111.477 -177.285 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.4 m -79.04 -19.15 52.14 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 129.772 3.229 . . . . 1.71 108.545 177.934 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -61.04 137.45 58.23 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.488 2.774 . . . . 1.69 118.488 177.076 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.9 p -86.59 171.42 11.04 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 111.74 0.274 . . . . 1.33 111.74 177.193 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.0 mm -68.71 -33.79 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 114.588 1.329 . . . . 1.32 114.588 175.796 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -53.15 -43.44 67.0 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 117.551 2.426 . . . . 1.62 117.551 161.085 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -62.55 -42.53 99.59 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 120.553 1.524 . . . . 2.13 110.615 171.365 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 t -57.02 -48.84 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.449 1.5 . . . . 1.23 111.553 172.915 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -56.7 -34.53 67.52 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 116.953 -3.592 . . . . 1.97 117.627 172.977 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.85 -42.68 81.01 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 125.674 2.654 . . . . 1.19 112.922 176.819 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.27 13.6 mttm -60.02 -34.54 73.5 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 130.382 3.473 . . . . 1.92 115.174 173.584 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.0 mt -74.02 -35.44 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 129.395 3.078 . . . . 1.94 108.13 174.9 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -63.34 -32.03 73.35 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 119.705 3.224 . . . . 1.9 119.705 173.854 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -76.31 -20.41 57.31 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.631 1.973 . . . . 1.55 113.702 169.138 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -84.0 -47.44 10.97 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.657 -2.527 . . . . 2.95 109.942 177.42 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -131.86 -31.69 1.5 Allowed 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 118.453 2.76 . . . . 1.48 118.453 -167.421 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.57 60.99 1.07 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 104.248 -3.541 . . . . 1.12 104.248 169.997 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.1 mt -129.52 115.15 18.25 Favored Pre-proline 0 N--CA 1.43 -1.463 0 N-CA-C 104.699 -2.334 . . . . 2.07 104.699 178.077 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -70.57 160.2 50.27 Favored 'Trans proline' 0 N--CA 1.433 -2.053 1 CA-C-N 129.081 4.279 . . . . 1.39 116.19 -173.347 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.64 -35.13 99.08 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-N 123.682 2.351 . . . . 1.68 116.965 -176.551 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -55.7 -37.0 67.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.986 1.476 . . . . 2.25 114.986 171.635 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -84.32 -12.41 54.64 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 119.56 1.073 . . . . 2.44 111.657 -175.7 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -83.85 115.98 22.52 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.875 -1.528 . . . . 1.32 106.875 -178.561 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -109.2 95.41 5.62 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.525 1.766 . . . . 3.19 107.623 168.266 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.3 mt -87.57 132.53 34.02 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.184 -1.413 . . . . 1.75 107.184 -174.282 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.5 mm -117.19 133.83 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 126.77 2.028 . . . . 1.98 106.166 178.95 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -112.34 108.24 17.35 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.977 -1.86 . . . . 1.94 105.977 165.055 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.13 -83.31 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.924 2.89 . . . . 1.67 109.645 -177.474 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.15 -27.3 2.07 Favored Glycine 0 N--CA 1.43 -1.74 0 O-C-N 118.822 -2.424 . . . . 1.3 116.082 -176.019 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -95.59 155.23 16.83 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 126.353 2.978 . . . . 2.89 113.262 -178.572 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -93.91 129.09 40.48 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.77 -3.081 . . . . 2.89 107.764 178.766 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.2 mt -80.49 140.57 35.83 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.026 1.393 . . . . 1.34 112.469 -170.373 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -88.54 159.25 18.01 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.282 -4.011 . . . . 1.94 110.703 170.613 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.16 -50.79 15.16 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 127.207 2.203 . . . . 1.56 114.575 -171.264 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.83 62.82 0.78 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 119.058 -2.276 . . . . 0.97 117.14 171.499 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.25 31.4 mmt180 -122.66 153.62 39.12 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.956 -2.239 . . . . 3.07 104.956 164.728 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.1 p -89.62 171.94 9.31 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 119.488 1.04 . . . . 1.34 109.963 174.232 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.437 HD11 HG23 ' A' ' 17' ' ' VAL . 29.6 mt -81.18 -29.31 34.67 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.29 -0.881 . . . . 1.63 108.781 175.757 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 t -68.86 -35.76 77.3 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.101 -2.249 . . . . 1.51 112.272 179.053 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.84 -28.27 69.44 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.212 -2.805 . . . . 1.9 112.748 176.385 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -81.59 -13.12 58.4 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.162 -4.086 . . . . 0.97 115.432 179.578 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 77.81 26.75 0.62 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 126.609 2.443 . . . . 2.35 111.152 178.688 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.8 mt -70.0 113.2 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 127.205 3.383 . . . . 1.39 114.79 -179.26 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -95.03 171.97 8.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 114.932 -2.707 . . . . 2.58 110.911 -178.329 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -62.64 145.9 53.43 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.297 -2.752 . . . . 2.58 110.062 176.769 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 58.37 38.53 25.82 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 125.663 2.649 . . . . 1.71 112.379 175.462 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.2 t -98.97 141.79 31.29 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 104.082 -2.562 . . . . 1.34 104.082 179.51 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -96.57 121.11 38.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 127.404 2.282 . . . . 1.36 110.34 178.185 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -101.85 158.89 15.8 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 102.307 -3.22 . . . . 2.03 102.307 174.912 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -114.42 127.79 56.01 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.033 1.733 . . . . 2.31 114.348 -176.19 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.2 tt -108.48 123.77 49.4 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 106.635 -1.616 . . . . 1.72 106.635 -178.278 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 t -104.37 142.94 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 104.92 -2.252 . . . . 1.8 104.92 173.702 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.455 HD11 ' HA ' ' A' ' 71' ' ' LEU . 7.9 tp -83.46 111.11 18.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.375 -1.774 . . . . 3.26 110.939 174.334 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -76.58 98.86 4.8 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 130.644 3.578 . . . . 4.12 108.26 168.726 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.7 tp -93.18 82.26 4.54 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 127.739 3.637 . . . . 3.54 111.478 170.738 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -75.66 -64.76 1.01 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.312 -2.742 . . . . 7.32 111.328 172.828 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.56 144.27 4.37 Favored Glycine 0 N--CA 1.431 -1.691 0 O-C-N 119.25 -2.156 . . . . 3.73 107.77 -168.123 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.776 0 CA-C-O 117.102 -1.944 . . . . 3.87 113.959 174.52 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 124.2 1.952 . . . . 1.39 108.461 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -104.65 132.13 51.25 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.135 -1.603 . . . . 2.2 108.301 -174.981 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.4 pt -127.38 140.89 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 126.027 2.822 . . . . 1.32 107.526 175.333 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -101.75 131.69 47.89 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.397 -2.064 . . . . 2.2 111.3 -178.939 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.3 t -109.41 111.52 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 116.876 -3.64 . . . . 1.23 108.789 177.965 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.5 mtpt -93.36 139.29 30.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.612 -3.18 . . . . 2.51 106.93 175.912 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p -93.25 164.94 13.04 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 116.918 -1.515 . . . . 1.41 112.301 179.904 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.9 tp -65.87 -30.88 71.56 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.246 3.403 . . . . 2.95 113.379 166.339 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.315 70.2 p -61.61 -38.4 87.46 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.124 -4.11 . . . . 2.52 114.271 -178.815 . . . . . . . . 3 2 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.87 24.42 1.69 Allowed Glycine 0 N--CA 1.43 -1.726 1 C-N-CA 131.031 4.158 . . . . 1.5 114.416 174.191 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -101.6 153.15 20.01 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.054 -1.461 . . . . 1.79 107.054 -177.994 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -108.6 110.47 21.94 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 113.078 -1.874 . . . . 1.38 109.99 168.079 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 mt -92.35 119.91 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 121.129 1.786 . . . . 2.03 115.122 177.362 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.259 8.7 m -89.37 130.06 35.8 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 116.741 -3.725 . . . . 1.61 106.894 179.079 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.0 mt -133.08 156.41 47.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 118.605 -1.238 . . . . 2.15 107.967 177.898 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -112.74 129.37 56.44 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 117.52 -1.228 . . . . 1.98 109.594 165.833 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 m -127.31 177.55 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 126.645 1.978 . . . . 1.52 114.89 177.872 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -120.11 161.64 37.6 Favored Pre-proline 0 N--CA 1.43 -1.432 0 CA-C-O 115.119 -2.372 . . . . 2.35 110.878 164.261 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.256 33.8 Cg_endo -74.81 -12.63 21.95 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 C-N-CA 122.987 2.458 . . . . 1.31 112.649 -176.744 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.255 70.0 m -92.4 9.7 33.09 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.75 2.82 . . . . 1.71 111.724 173.253 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -84.96 139.0 32.14 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 121.67 2.032 . . . . 1.69 109.906 176.864 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.5 p -84.43 156.42 21.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.305 2.955 . . . . 1.33 112.342 176.113 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mm -64.48 -20.71 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 O-C-N 116.372 -3.955 . . . . 1.32 115.086 176.464 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -56.92 -51.87 67.43 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.367 2.508 . . . . 1.62 117.162 163.079 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -60.45 -31.99 70.96 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 111.048 -2.796 . . . . 2.13 116.571 170.535 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.2 t -65.78 -32.89 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 124.098 3.135 . . . . 1.23 112.202 175.804 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -71.71 -27.48 63.05 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.335 1.854 . . . . 1.97 112.082 175.882 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.04 -21.67 58.9 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.803 -2.436 . . . . 1.19 114.82 173.365 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -78.3 -30.5 48.4 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.608 -3.183 . . . . 1.92 108.206 178.584 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.4 mt -68.54 -33.3 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 129.309 3.044 . . . . 1.94 110.189 168.838 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -66.93 -29.47 69.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.712 -3.117 . . . . 1.9 113.885 167.324 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -74.58 -58.22 3.43 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 120.986 1.721 . . . . 1.55 110.464 172.162 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.2 tptt -57.79 -55.86 29.46 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.574 2.435 . . . . 2.95 117.574 -172.915 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -110.84 -36.43 5.69 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.473 2.082 . . . . 1.48 108.756 -164.905 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.85 66.34 1.0 Allowed Glycine 0 N--CA 1.429 -1.788 0 O-C-N 119.576 -1.953 . . . . 1.12 110.583 169.979 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.6 mt -126.93 130.12 23.86 Favored Pre-proline 0 N--CA 1.429 -1.488 0 CA-C-O 114.452 -2.689 . . . . 2.07 105.552 -178.341 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -62.11 150.42 86.68 Favored 'Trans proline' 0 N--CA 1.433 -2.056 0 C-N-CA 124.167 3.245 . . . . 1.39 111.582 178.82 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -87.13 -0.22 7.69 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 CA-C-N 120.853 1.341 . . . . 1.68 110.319 -162.535 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -71.47 -46.83 58.87 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.372 2.269 . . . . 2.25 112.719 170.719 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -69.41 -19.52 63.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.805 2.842 . . . . 2.44 115.599 -175.055 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -86.83 139.43 30.68 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 124.126 1.917 . . . . 1.32 111.053 -168.82 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.9 mtt180 -131.38 134.07 45.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.731 -3.731 . . . . 3.19 104.19 170.556 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.3 mt -114.21 117.03 30.04 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 114.038 -5.414 . . . . 1.75 112.826 175.296 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 mm -99.3 138.28 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 128.489 3.618 . . . . 1.98 114.439 178.684 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -129.5 96.27 4.23 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 120.836 1.653 . . . . 1.94 109.208 170.358 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.26 26.45 2.7 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 111.854 -3.927 . . . . 1.67 117.246 -179.608 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.39 -24.18 23.04 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 122.991 2.632 . . . . 1.3 112.731 -174.408 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -96.56 132.43 42.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.718 -2.636 . . . . 2.89 106.709 175.351 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.79 131.3 35.26 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.893 -2.379 . . . . 2.89 111.784 166.327 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.0 mt -79.01 128.85 33.78 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.033 1.333 . . . . 1.34 108.689 -173.088 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -80.26 138.93 36.86 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 121.564 1.984 . . . . 1.94 111.034 176.437 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.85 -55.38 14.46 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.525 3.157 . . . . 1.56 119.525 -173.254 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.23 39.96 2.12 Favored Glycine 0 N--CA 1.43 -1.733 0 O-C-N 124.662 1.226 . . . . 0.97 115.889 173.059 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.422 HH21 ' CG ' ' A' ' 58' ' ' ASP . 44.1 mmm-85 -117.73 161.07 20.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 124.814 0.949 . . . . 3.07 112.151 158.168 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -96.52 172.38 7.96 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 115.574 1.694 . . . . 1.34 115.574 173.301 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.1 mt -77.26 -25.4 51.44 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.014 1.116 . . . . 1.63 114.014 176.859 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.8 t -78.8 -33.43 46.26 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.106 -1.442 . . . . 1.51 107.106 -179.495 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.422 ' CG ' HH21 ' A' ' 54' ' ' ARG . 38.1 t0 -61.44 -52.82 62.97 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.365 2.666 . . . . 1.9 112.023 178.183 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -74.42 -7.49 53.11 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 126.813 3.197 . . . . 0.97 117.882 177.993 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.3 m120 62.8 46.15 5.29 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.2 -2.812 . . . . 2.35 115.509 179.702 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.4 mt -96.25 124.24 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 103.729 -2.693 . . . . 1.39 103.729 -177.699 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -112.44 -176.2 2.86 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 118.364 -1.334 . . . . 2.58 112.147 -175.055 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -55.06 137.52 46.23 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 126.768 3.175 . . . . 2.58 110.092 174.812 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 57.3 mt-10 76.3 12.98 2.6 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 126.116 2.865 . . . . 1.71 113.534 170.46 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -79.39 133.22 36.57 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 117.593 -3.192 . . . . 1.34 107.475 -170.813 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.1 m -86.07 113.79 22.42 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.85 -3.656 . . . . 1.36 113.848 178.58 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -92.46 160.4 15.09 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.625 -1.922 . . . . 2.03 110.895 174.271 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -129.32 123.16 31.1 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.438 2.066 . . . . 2.31 108.351 -175.243 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.5 tp -93.65 125.23 38.15 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 130.892 3.677 . . . . 1.72 108.317 176.59 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.14 159.34 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 104.126 -2.546 . . . . 1.8 104.126 167.201 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.4 mt -115.97 138.89 50.78 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 122.653 1.216 . . . . 3.26 108.042 -179.668 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 ttt-85 -100.2 130.32 46.32 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 104.538 -2.394 . . . . 4.12 104.538 -179.554 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.6 tp -115.13 -54.78 2.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.931 -1.137 . . . . 3.54 107.931 171.723 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -103.66 -42.01 5.77 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 118.495 -2.628 . . . . 7.32 108.353 176.928 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.77 -138.02 3.63 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-O 124.735 2.297 . . . . 3.73 113.266 -173.771 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.763 0 O-C-N 119.192 -2.358 . . . . 3.87 109.041 176.959 . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptt? . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 123.259 1.504 . . . . 1.39 109.188 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -101.23 129.44 47.17 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.848 1.659 . . . . 2.2 111.038 -172.304 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.1 pt -125.44 174.48 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.775 -2.453 . . . . 1.32 110.007 176.196 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -119.77 140.91 50.01 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 116.055 1.872 . . . . 2.2 116.055 179.767 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.7 t -124.96 119.63 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 124.196 1.951 . . . . 1.23 105.898 171.606 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -95.44 127.32 41.38 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.627 -3.795 . . . . 2.51 111.68 179.441 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.0 p -73.39 -168.92 0.58 Allowed 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 125.031 2.348 . . . . 1.41 110.953 -176.069 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.424 HD11 ' H ' ' A' ' 71' ' ' LEU . 86.1 mt -86.9 -38.6 16.56 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 111.825 -2.443 . . . . 2.95 111.597 171.492 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.9 p -65.44 -27.35 68.46 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.427 1.891 . . . . 2.52 112.885 -175.9 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.57 22.97 5.25 Favored Glycine 0 N--CA 1.431 -1.669 0 O-C-N 118.151 -2.843 . . . . 1.5 119.108 177.845 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -108.04 138.53 44.14 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 105.602 -1.999 . . . . 1.79 105.602 -175.348 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.0 m -92.91 111.08 22.57 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.595 2.758 . . . . 1.38 108.044 177.149 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -89.85 137.16 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 116.48 -3.888 . . . . 2.03 105.075 -179.268 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.1 m -100.34 129.5 46.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.599 1.959 . . . . 1.61 110.36 -178.653 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.4 mt -129.36 155.38 45.75 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 119.651 1.114 . . . . 2.15 112.673 -175.923 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -116.22 112.25 21.35 Favored 'General case' 0 N--CA 1.429 -1.477 1 O-C-N 115.186 -4.696 . . . . 1.98 105.792 173.253 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.5 m -126.37 155.48 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 110.974 -2.83 . . . . 1.52 112.101 -179.0 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -103.28 159.5 29.1 Favored Pre-proline 0 N--CA 1.431 -1.392 1 O-C-N 114.639 -5.038 . . . . 2.35 109.644 165.485 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.66 -20.78 46.34 Favored 'Trans proline' 0 C--N 1.299 -2.039 1 O-C-N 113.297 -4.107 . . . . 1.31 115.455 -170.993 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 p -84.76 4.52 32.48 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.133 2.173 . . . . 1.71 112.121 175.543 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -75.58 138.2 41.3 Favored 'General case' 0 N--CA 1.431 -1.419 1 O-C-N 115.496 -4.502 . . . . 1.69 106.424 170.473 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.6 p -87.02 159.76 18.85 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 125.935 2.022 . . . . 1.33 108.074 -179.225 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.7 mm -60.24 -37.02 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 124.168 0.987 . . . . 1.32 109.692 177.415 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.302 25.5 tt0 -47.12 -50.59 19.91 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.664 1.986 . . . . 1.62 113.385 164.465 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -68.86 -32.74 72.64 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 125.934 2.021 . . . . 2.13 109.745 -179.706 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.55 -38.94 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 120.642 1.565 . . . . 1.23 113.315 175.105 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -61.56 -38.67 88.34 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 122.605 1.193 . . . . 1.97 112.83 169.701 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.65 -25.86 57.22 Favored 'General case' 0 N--CA 1.43 -1.428 1 CA-C-O 129.274 4.368 . . . . 1.19 113.694 179.332 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -72.63 -34.05 67.06 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 114.856 -4.903 . . . . 1.92 111.647 171.703 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.253 97.1 mt -64.73 -48.57 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 O-C-N 120.015 -1.678 . . . . 1.94 109.401 171.126 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -56.63 -42.83 79.51 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 116.446 -3.909 . . . . 1.9 113.265 177.145 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -53.95 -47.26 71.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.815 3.197 . . . . 1.55 117.079 166.522 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.265 14.2 tppt? -73.24 -53.49 10.75 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.04 2.352 . . . . 2.95 114.144 -171.844 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -111.42 -30.1 7.53 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.738 -3.101 . . . . 1.48 109.993 -171.431 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.28 38.36 4.56 Favored Glycine 0 N--CA 1.429 -1.787 0 C-N-CA 125.465 1.507 . . . . 1.12 114.056 -179.586 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.4 mt -97.77 130.38 29.13 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-O 114.749 -2.548 . . . . 2.07 112.117 179.509 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -66.18 154.0 75.86 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 CA-C-N 125.356 2.948 . . . . 1.39 113.487 -173.475 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -65.62 -23.32 56.94 Favored 'Trans proline' 0 N--CA 1.432 -2.094 1 CA-C-N 129.094 4.283 . . . . 1.68 116.373 -177.668 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -69.0 -34.62 75.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.77 -2.456 . . . . 2.25 115.546 178.06 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -73.75 -12.79 60.82 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 124.38 1.05 . . . . 2.44 111.279 179.597 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -98.64 118.06 34.5 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 118.214 -2.804 . . . . 1.32 112.572 -167.951 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -106.51 114.64 28.87 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 126.259 2.224 . . . . 3.19 106.378 170.674 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.1 mt -98.03 109.42 22.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.99 1.853 . . . . 1.75 113.607 175.343 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.3 mt -100.48 112.2 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 128.356 2.662 . . . . 1.98 112.617 180.0 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -105.67 123.76 48.46 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.5 -2.625 . . . . 1.94 107.446 172.008 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.362 . . 69.46 -63.81 0.36 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.128 2.171 . . . . 1.67 110.694 -176.459 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 48' ' ' LYS . . . -166.59 -16.81 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.791 0 N-CA-C 106.122 -2.791 . . . . 1.3 106.122 179.378 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.4 ' H ' ' H ' ' A' ' 47' ' ' GLY . 28.5 ttmt -83.6 125.1 31.46 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.611 3.164 . . . . 2.89 106.848 -172.557 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.3 17.4 tt0 -83.96 115.48 22.33 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.176 1.547 . . . . 2.89 115.176 175.849 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.8 mt -75.58 133.85 40.84 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.173 1.789 . . . . 1.34 112.047 -171.018 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -87.15 151.43 23.21 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 127.859 2.464 . . . . 1.94 115.719 172.743 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -66.24 -44.65 83.12 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 128.364 2.665 . . . . 1.56 113.434 -160.147 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.15 51.25 1.29 Allowed Glycine 0 N--CA 1.43 -1.705 0 O-C-N 118.813 -2.43 . . . . 0.97 110.866 176.332 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -123.56 161.88 24.06 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.889 -1.948 . . . . 3.07 107.377 162.582 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.7 p -107.89 172.61 6.73 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.084 -2.26 . . . . 1.34 110.741 179.693 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.532 HD23 HD11 ' A' ' 61' ' ' ILE . 20.8 mt -62.17 -38.41 88.95 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 126.758 2.536 . . . . 1.63 114.077 172.855 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -66.52 -30.8 71.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.916 2.486 . . . . 1.51 115.256 174.284 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -71.49 -43.9 65.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.752 -3.093 . . . . 1.9 111.393 171.222 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -91.55 8.26 37.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 124.964 1.415 . . . . 0.97 114.154 -177.877 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 47.23 49.24 15.54 Favored 'General case' 0 N--CA 1.43 -1.438 1 C-N-CA 132.459 4.304 . . . . 2.35 116.613 -179.462 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.532 HD11 HD23 ' A' ' 56' ' ' LEU . 76.8 mt -89.81 115.04 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 114.191 -2.814 . . . . 1.39 105.48 176.912 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -107.22 -166.66 1.18 Allowed 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 126.291 2.244 . . . . 2.58 112.88 -175.754 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -63.27 144.87 56.57 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 125.128 1.517 . . . . 2.58 113.586 -179.682 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.294 32.2 mt-10 67.28 15.13 9.91 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.629 1.971 . . . . 1.71 114.686 -179.766 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 t -90.17 135.94 33.35 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 123.537 1.636 . . . . 1.34 111.07 -173.903 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.2 m -96.09 113.84 25.49 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.821 3.648 . . . . 1.36 112.213 -172.397 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.432 HD22 HG23 ' A' ' 61' ' ' ILE . 10.5 mt -95.98 152.85 18.14 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 115.604 -4.435 . . . . 2.03 108.883 169.762 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -112.2 119.36 38.11 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 115.873 -2.331 . . . . 2.31 109.463 -174.488 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.6 tp -86.45 116.55 24.67 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.346 1.858 . . . . 1.72 111.454 -178.87 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.8 t -111.73 119.87 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 115.167 -2.349 . . . . 1.8 109.402 177.502 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.424 ' H ' HD11 ' A' ' 8' ' ' LEU 0.296 93.3 mt -79.96 137.13 36.79 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 121.211 1.823 . . . . 3.26 108.85 -173.482 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -99.46 79.36 2.28 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.335 1.54 . . . . 4.12 109.364 174.715 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.5 mt -88.99 -103.59 0.09 Allowed 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.305 -1.771 . . . . 3.54 113.006 175.994 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.273 46.5 mtt85 -127.28 145.06 50.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 105.931 -1.877 . . . . 7.32 105.931 170.15 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.41 -91.88 0.15 Allowed Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 108.0 -2.04 . . . . 3.73 108.0 -167.982 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.774 0 N-CA-C 105.146 -3.182 . . . . 3.87 105.146 -178.837 . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 CA--C 1.49 -1.327 0 N-CA-C 104.728 -2.323 . . . . 1.39 104.728 . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -100.96 128.68 46.88 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.574 -1.954 . . . . 2.2 110.418 -173.675 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.8 pt -137.04 155.75 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 O-C-N 117.315 -3.365 . . . . 1.32 106.709 172.493 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -103.06 140.43 37.32 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.393 1.877 . . . . 2.2 106.716 -175.921 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.8 t -120.73 109.84 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 118.711 -2.493 . . . . 1.23 106.299 171.591 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.7 tttt -96.12 128.75 43.3 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 118.001 2.593 . . . . 2.51 118.001 -178.55 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.7 p -86.12 176.25 8.09 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 115.166 1.543 . . . . 1.41 115.166 174.07 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.8 mt -74.47 -22.85 58.89 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.699 -1.876 . . . . 2.95 115.558 172.76 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 p -67.34 -25.97 66.26 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.808 2.043 . . . . 2.52 113.103 176.602 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.27 28.61 5.74 Favored Glycine 0 N--CA 1.429 -1.803 0 C-N-CA 128.6 3.0 . . . . 1.5 114.29 179.743 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -111.55 141.13 45.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.895 3.712 . . . . 1.79 112.476 -173.014 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.2 m -96.34 116.68 29.43 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 127.891 3.71 . . . . 1.38 116.907 176.084 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mt -96.86 125.35 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 1 O-C-N 114.042 -5.411 . . . . 2.03 110.556 168.299 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.1 m -97.66 118.58 34.51 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 124.903 2.287 . . . . 1.61 106.039 -174.49 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.1 mt -105.48 145.6 30.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.506 -3.871 . . . . 2.15 111.279 -178.163 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -103.79 126.05 50.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.469 1.604 . . . . 1.98 107.219 167.987 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 m -144.43 161.67 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 117.249 -3.407 . . . . 1.52 112.481 -176.006 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -99.33 155.01 37.0 Favored Pre-proline 0 N--CA 1.431 -1.421 0 O-C-N 119.132 -2.23 . . . . 2.35 106.462 157.737 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -72.8 -9.65 24.02 Favored 'Trans proline' 0 N--CA 1.433 -2.064 0 C-N-CA 124.625 3.55 . . . . 1.31 111.755 173.907 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.5 m -87.93 0.71 55.53 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 131.109 3.763 . . . . 1.71 114.584 173.303 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -94.08 143.58 26.24 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 117.729 -3.107 . . . . 1.69 107.809 -179.315 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p -80.58 164.02 23.23 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 128.117 3.818 . . . . 1.33 110.165 176.973 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mm -59.22 -33.83 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 112.264 -2.244 . . . . 1.32 112.295 175.598 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -59.81 -30.99 69.3 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.585 -1.947 . . . . 1.62 111.627 175.733 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -74.9 -39.12 61.65 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.974 -3.579 . . . . 2.13 111.771 175.9 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.283 57.3 t -57.09 -60.48 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 O-C-N 118.07 -2.894 . . . . 1.23 110.233 172.368 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -53.51 -41.6 66.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 120.579 3.548 . . . . 1.97 120.579 177.318 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.14 -40.71 94.87 Favored 'General case' 0 CA--C 1.489 -1.394 0 O-C-N 119.412 -2.055 . . . . 1.19 111.794 169.932 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -63.95 -32.29 73.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.397 3.11 . . . . 1.92 119.397 170.488 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.2 mt -68.56 -39.04 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 O-C-N 124.871 1.357 . . . . 1.94 108.669 170.585 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -61.31 -43.92 98.07 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.12 2.39 . . . . 1.9 115.881 176.097 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.56 -46.2 91.06 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.122 -2.861 . . . . 1.55 113.933 174.105 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -68.41 -54.84 14.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.873 -3.642 . . . . 2.95 113.738 -179.828 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -104.78 -35.24 7.83 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.928 2.299 . . . . 1.48 116.82 -165.412 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.88 36.66 5.71 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-O 117.236 -1.869 . . . . 1.12 113.236 -179.645 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.8 mt -104.02 119.01 55.69 Favored Pre-proline 0 CA--C 1.489 -1.398 0 CA-C-O 113.78 -3.009 . . . . 2.07 103.585 -176.605 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.25 9.2 Cg_exo -62.81 161.68 28.08 Favored 'Trans proline' 0 N--CA 1.433 -2.031 1 C-N-CA 125.988 4.458 . . . . 1.39 116.611 176.147 . . . . . . . . 3 2 . 1 . 042 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.45 -25.13 11.47 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 CA-C-N 124.941 2.8 . . . . 1.68 117.904 -170.097 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -60.99 -49.13 78.69 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 125.968 2.794 . . . . 2.25 113.098 -179.416 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -62.26 -31.81 72.43 Favored 'General case' 0 N--CA 1.43 -1.45 1 C-N-CA 133.812 4.845 . . . . 2.44 112.727 176.225 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -75.73 130.81 39.26 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 117.736 -3.103 . . . . 1.32 114.413 -174.909 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -120.57 106.68 12.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.73 -1.211 . . . . 3.19 107.73 175.431 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.4 mt -91.41 129.65 37.37 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.17 2.588 . . . . 1.75 109.838 179.147 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 mt -121.79 146.26 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 127.013 2.125 . . . . 1.98 107.939 177.808 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.419 ' HB3' HD21 ' A' ' 50' ' ' LEU . 20.7 t80 -135.7 117.49 15.1 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 105.129 -2.174 . . . . 1.94 105.129 171.615 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.98 -68.88 0.12 Allowed 'General case' 0 N--CA 1.43 -1.464 1 C-N-CA 132.015 4.126 . . . . 1.67 107.612 179.943 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.4 14.11 0.45 Allowed Glycine 0 N--CA 1.43 -1.728 0 O-C-N 117.364 -3.335 . . . . 1.3 113.983 176.967 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -121.53 128.18 51.76 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 123.562 1.649 . . . . 2.89 108.208 -178.686 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -72.0 126.63 30.26 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.399 2.523 . . . . 2.89 109.234 169.47 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.419 HD21 ' HB3' ' A' ' 45' ' ' PHE . 31.4 mt -83.27 145.43 29.11 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.261 -1.791 . . . . 1.34 107.464 -171.262 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -106.91 155.82 19.36 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-O 123.985 1.85 . . . . 1.94 113.327 -179.018 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -52.44 -60.28 3.42 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 121.12 3.748 . . . . 1.56 121.12 -168.071 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.9 37.69 2.68 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 129.82 3.581 . . . . 0.97 112.956 174.085 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -120.25 153.54 36.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 116.67 -1.634 . . . . 3.07 107.649 170.759 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.4 p -88.18 168.43 12.76 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 125.364 1.665 . . . . 1.34 113.72 164.918 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.7 mt -74.22 -27.78 60.95 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 116.183 -1.865 . . . . 1.63 109.659 178.031 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.1 p -64.66 -31.65 72.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 126.246 2.216 . . . . 1.51 115.115 174.582 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -55.05 -41.7 71.79 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 127.819 3.676 . . . . 1.9 114.772 171.306 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -84.16 -1.39 54.96 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 117.594 -3.191 . . . . 0.97 116.852 176.946 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.299 7.5 m120 65.85 40.96 4.0 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 125.854 2.74 . . . . 2.35 115.93 -176.927 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.6 mt -92.43 121.36 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 126.701 3.143 . . . . 1.39 111.032 177.969 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -110.64 179.34 4.1 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 111.374 -2.648 . . . . 2.58 108.71 -176.065 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -63.52 156.49 26.22 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 124.767 1.227 . . . . 2.58 113.961 179.22 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.451 65.6 mt-10 79.44 -4.03 2.05 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.323 -2.11 . . . . 1.71 113.485 172.793 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.298 49.7 m -73.14 154.08 40.49 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 117.699 2.481 . . . . 1.34 117.699 -174.578 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.7 m -112.73 124.02 51.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.58 -1.637 . . . . 1.36 106.58 178.247 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.2 mt -103.81 164.25 11.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.869 -1.16 . . . . 2.03 107.869 168.932 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.0 m170 -113.97 129.68 56.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 116.555 -1.688 . . . . 2.31 111.887 -176.902 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.7 tp -117.34 115.6 25.55 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 102.219 -3.252 . . . . 1.72 102.219 -176.125 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.6 m -115.33 159.76 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 127.33 3.443 . . . . 1.8 102.747 173.909 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.58 144.24 26.2 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 111.015 -7.303 . . . . 3.26 109.562 173.764 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -110.29 137.3 48.21 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 130.301 3.44 . . . . 4.12 113.83 176.445 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.3 mt -104.6 149.67 25.32 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 126.089 2.852 . . . . 3.54 109.464 171.879 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -83.46 161.19 21.37 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.429 -3.919 . . . . 7.32 116.622 169.18 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.0 -64.68 0.84 Allowed Glycine 0 N--CA 1.429 -1.79 0 C-N-CA 124.609 1.099 . . . . 3.73 111.249 -166.582 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.789 0 CA-C-O 123.193 1.44 . . . . 3.87 115.258 177.134 . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.253 6.2 ptt? . . . . . 0 CA--C 1.49 -1.342 0 N-CA-C 113.775 1.028 . . . . 1.39 113.775 . . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.264 34.5 mt-30 -115.18 147.69 39.98 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 116.155 -4.091 . . . . 2.2 110.916 177.08 . . . . . . . . 3 2 . 1 . 043 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.8 pt -134.35 156.67 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 116.904 -3.623 . . . . 1.32 103.436 177.518 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -116.65 139.06 50.95 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.156 -1.59 . . . . 2.2 110.738 178.221 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.0 t -120.43 116.41 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-O 116.98 -1.486 . . . . 1.23 108.553 177.471 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -100.21 139.44 35.87 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 117.081 -1.848 . . . . 2.51 114.707 177.469 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 p -83.49 157.67 22.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.614 2.766 . . . . 1.41 113.234 174.205 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.1 tp -49.12 -41.1 34.79 Favored 'General case' 0 N--CA 1.43 -1.466 2 O-C-N 114.045 -5.41 . . . . 2.95 110.855 166.46 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.1 p -67.83 -28.26 67.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.948 1.832 . . . . 2.52 115.948 179.385 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.11 31.19 3.16 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 125.238 2.577 . . . . 1.5 113.849 173.454 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -109.6 133.39 53.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.743 -3.21 . . . . 1.79 104.181 -176.628 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.4 m -99.51 119.06 37.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.301 -3.374 . . . . 1.38 106.69 175.735 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mt -97.01 98.42 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.823 2.049 . . . . 2.03 106.836 175.997 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.6 m -87.35 125.86 34.51 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 125.401 2.524 . . . . 1.61 107.942 177.851 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.4 mt -116.94 162.59 17.52 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.542 -2.599 . . . . 2.15 107.272 -173.641 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -121.12 112.68 18.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.759 -2.463 . . . . 1.98 110.402 179.718 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -132.45 164.47 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 125.479 1.512 . . . . 1.52 114.356 -176.816 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -111.86 155.68 42.85 Favored Pre-proline 0 N--CA 1.43 -1.438 1 CA-C-O 110.828 -4.415 . . . . 2.35 104.471 164.806 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -69.92 -4.78 14.83 Favored 'Trans proline' 0 C--N 1.3 -2.023 1 CA-C-N 129.049 4.268 . . . . 1.31 114.808 -175.272 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 p -86.09 6.89 26.97 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.662 2.785 . . . . 1.71 111.633 170.714 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.5 133.33 47.56 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.973 -0.751 . . . . 1.69 108.973 169.008 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.7 p -79.96 167.63 20.24 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.731 -2.322 . . . . 1.33 104.731 177.412 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.3 mm -81.5 -21.64 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 117.536 -3.227 . . . . 1.32 109.302 176.849 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -55.1 -49.67 71.11 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 122.02 2.191 . . . . 1.62 109.59 161.348 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -59.14 -59.39 5.54 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 114.578 1.325 . . . . 2.13 114.578 -179.617 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.2 t -45.1 -43.9 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 127.067 2.147 . . . . 1.23 114.483 172.167 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.49 ' HD2' ' HB2' ' A' ' 41' ' ' GLN 0.349 36.2 mtmt -60.17 -38.95 84.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 118.716 2.858 . . . . 1.97 118.716 171.491 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.57 -19.89 61.41 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.002 2.334 . . . . 1.19 117.024 179.584 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -78.71 -16.33 57.39 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 119.311 -2.118 . . . . 1.92 112.144 171.516 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.332 73.0 mt -78.32 -44.56 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 128.368 3.937 . . . . 1.94 108.751 172.179 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -57.4 -45.24 84.74 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 110.842 -2.89 . . . . 1.9 117.483 172.098 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -45.42 -45.25 12.68 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.872 1.669 . . . . 1.55 114.366 166.761 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -82.38 -68.8 0.67 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.364 -0.834 . . . . 2.95 111.741 -171.33 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -93.99 -20.75 19.69 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 125.789 1.931 . . . . 1.48 113.946 -169.667 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.23 -0.62 64.03 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 118.355 2.102 . . . . 1.12 118.355 175.753 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.9 mt -70.8 122.58 87.23 Favored Pre-proline 0 N--CA 1.429 -1.484 0 CA-C-O 113.955 -2.926 . . . . 2.07 105.303 -178.311 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.37 146.11 61.55 Favored 'Trans proline' 0 N--CA 1.433 -2.033 1 CA-C-O 106.609 -5.663 . . . . 1.39 116.565 177.873 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -55.63 -13.49 8.23 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 128.013 3.898 . . . . 1.68 122.196 -177.847 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -57.04 -41.54 78.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.991 2.517 . . . . 2.25 113.259 176.975 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.281 68.9 mt-30 -84.77 -27.0 27.18 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 126.331 1.852 . . . . 2.44 108.993 -170.437 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.49 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 61.1 mt-30 -71.23 139.92 50.24 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.509 2.781 . . . . 1.32 118.509 -171.496 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -133.83 129.24 36.21 Favored 'General case' 0 N--CA 1.43 -1.435 1 N-CA-C 99.126 -4.398 . . . . 3.19 99.126 172.493 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.9 mt -111.24 107.92 17.38 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 112.189 -2.278 . . . . 1.75 106.889 177.426 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 mm -97.26 133.98 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 115.003 -0.999 . . . . 1.98 108.699 176.227 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -122.32 100.6 7.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 101.772 -3.418 . . . . 1.94 101.772 176.794 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 81.65 -100.92 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 105.259 -2.126 . . . . 1.67 105.259 172.61 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.31 -10.16 7.49 Favored Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 107.033 -2.427 . . . . 1.3 107.033 179.284 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -100.94 148.32 25.14 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 119.96 1.88 . . . . 2.89 108.916 -173.478 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -105.4 129.04 53.8 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.795 -2.002 . . . . 2.89 113.661 178.284 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.4 mt -92.72 146.47 23.63 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 116.933 -1.508 . . . . 1.34 109.818 -167.058 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.1 148.94 21.69 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 128.786 3.804 . . . . 1.94 117.667 174.778 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.65 -59.73 4.76 Favored 'General case' 0 CA--C 1.488 -1.41 1 C-N-CA 133.241 4.617 . . . . 1.56 113.295 -169.527 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.66 46.7 3.49 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 119.508 -1.995 . . . . 0.97 116.515 175.458 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -127.75 -179.8 5.13 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 120.553 2.177 . . . . 3.07 112.043 166.805 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.2 p -104.53 172.47 6.77 Favored 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 116.011 -4.181 . . . . 1.34 117.835 178.715 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.5 mt -66.32 -29.63 69.87 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.704 -2.497 . . . . 1.63 111.006 173.105 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -71.69 -29.31 64.44 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 130.019 3.328 . . . . 1.51 117.453 178.367 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.327 23.6 m-20 -63.65 -36.58 84.29 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 119.231 -0.988 . . . . 1.9 112.709 170.118 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -93.42 12.85 23.49 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 117.166 2.284 . . . . 0.97 117.166 -174.996 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 50.08 32.62 6.02 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 118.137 2.643 . . . . 2.35 118.137 -175.304 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.8 mt -89.88 111.59 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 125.11 1.364 . . . . 1.39 110.498 -178.352 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -100.99 -165.68 1.23 Allowed 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 113.868 -1.514 . . . . 2.58 109.286 -173.768 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.5 pttp -68.78 149.81 48.58 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.534 2.111 . . . . 2.58 112.548 179.667 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.281 10.8 mt-10 66.66 30.13 8.39 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 125.619 2.628 . . . . 1.71 116.259 172.71 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.1 m -89.29 135.7 33.43 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.869 -2.394 . . . . 1.34 107.926 -170.697 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.6 m -105.06 106.36 16.81 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.913 -2.367 . . . . 1.36 108.818 -177.006 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -96.61 167.28 11.23 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.448 -2.032 . . . . 2.03 109.586 171.842 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -118.86 121.8 40.84 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 113.662 -1.608 . . . . 2.31 111.138 -170.338 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.9 tp -88.31 121.85 31.16 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.816 -1.549 . . . . 1.72 106.816 -177.449 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.6 t -114.26 124.51 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 106.487 -1.671 . . . . 1.8 106.487 179.308 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.0 mt -115.04 -173.86 2.39 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 116.366 -3.959 . . . . 3.26 111.763 179.673 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -95.86 -167.48 1.6 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.952 2.575 . . . . 4.12 117.952 171.263 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.9 mt -81.05 118.29 22.37 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 116.141 -1.885 . . . . 3.54 110.818 174.944 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -75.39 98.15 3.8 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 121.946 2.157 . . . . 7.32 115.845 168.504 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.95 -30.89 0.39 Allowed Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 104.985 -3.246 . . . . 3.73 104.985 -167.19 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.764 0 O-C-N 118.838 -2.566 . . . . 3.87 107.972 -173.927 . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptt? . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 121.808 0.813 . . . . 1.39 109.507 . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -104.57 120.24 40.84 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 113.129 -3.32 . . . . 2.2 108.717 -175.829 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.265 9.2 pt -116.74 174.01 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 127.007 2.692 . . . . 1.32 114.281 171.365 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -125.68 140.22 52.89 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.897 2.879 . . . . 2.2 106.71 -178.278 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.8 t -129.07 114.81 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.499 -2.001 . . . . 1.23 107.051 171.405 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -86.23 143.14 28.1 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.678 0.751 . . . . 2.51 111.339 -176.129 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.3 p -88.01 169.36 12.04 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.043 -2.286 . . . . 1.41 111.995 176.408 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.8 mt -56.42 -33.71 66.09 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 114.001 -5.437 . . . . 2.95 113.023 172.609 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.2 p -90.18 -34.9 15.66 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 114.835 1.42 . . . . 2.52 114.835 -172.69 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.71 -17.01 0.4 Allowed Glycine 0 N--CA 1.429 -1.771 0 C-N-CA 116.27 -2.872 . . . . 1.5 112.15 177.46 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.523 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 32.5 ttpt -84.84 147.91 26.56 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 124.743 2.211 . . . . 1.79 111.326 -170.743 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.6 m -115.65 128.22 55.76 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.745 -3.722 . . . . 1.38 108.752 178.905 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 mt -95.32 137.92 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 119.662 -1.899 . . . . 2.03 107.02 177.055 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.7 m -95.31 111.43 23.29 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.526 -1.984 . . . . 1.61 112.945 175.623 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.7 mt -115.42 148.87 38.86 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.01 -1.681 . . . . 2.15 111.891 -177.831 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -115.29 109.78 18.45 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 103.449 -2.797 . . . . 1.98 103.449 179.49 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.6 m -120.78 170.2 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 124.993 2.33 . . . . 1.52 105.075 177.36 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -126.75 155.4 75.21 Favored Pre-proline 0 N--CA 1.43 -1.429 0 N-CA-C 104.814 -2.291 . . . . 2.35 104.814 168.818 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.45 -29.34 39.36 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 N-CA-C 120.924 3.394 . . . . 1.31 120.924 -176.679 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 m -76.13 4.37 8.7 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.424 2.379 . . . . 1.71 117.424 177.176 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -85.1 148.74 25.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 125.74 1.9 . . . . 1.69 114.878 177.637 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.3 p -90.1 169.96 10.73 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.35 -2.094 . . . . 1.33 114.225 175.595 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.8 mm -63.64 -41.31 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 1 O-C-N 115.867 -4.27 . . . . 1.32 114.462 176.255 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.382 76.8 tt0 -35.75 -55.73 0.71 Allowed 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 118.624 2.824 . . . . 1.62 118.624 155.583 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -56.83 -28.15 61.13 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.734 -1.854 . . . . 2.13 115.718 176.187 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.2 t -69.98 -42.63 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 117.988 -2.945 . . . . 1.23 108.998 175.208 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -56.29 -39.53 72.84 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.437 -2.039 . . . . 1.97 116.404 171.777 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.0 -49.48 72.3 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.073 -2.892 . . . . 1.19 115.659 174.469 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -52.83 -45.11 67.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.248 1.419 . . . . 1.92 113.131 170.715 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.4 mt -69.29 -30.9 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 O-C-N 115.722 -4.361 . . . . 1.94 112.169 175.125 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.31 -40.04 71.06 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.119 -1.613 . . . . 1.9 111.041 173.369 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.02 -54.7 44.12 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 123.358 1.551 . . . . 1.55 112.304 170.117 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -72.94 -57.89 3.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 116.55 -3.844 . . . . 2.95 115.628 -174.617 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.523 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 20.1 mm-40 -94.28 -27.33 16.19 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.364 1.987 . . . . 1.48 116.364 -174.188 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.35 23.67 21.17 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 117.47 1.748 . . . . 1.12 117.47 178.614 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.1 mt -89.77 138.84 27.77 Favored Pre-proline 0 N--CA 1.431 -1.402 0 O-C-N 118.188 -2.948 . . . . 2.07 103.827 -173.194 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.57 151.37 64.38 Favored 'Trans proline' 0 C--N 1.299 -2.052 1 CA-C-N 130.675 4.848 . . . . 1.39 111.712 176.761 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -73.03 -19.0 23.55 Favored 'Trans proline' 0 C--N 1.3 -2.004 3 C-N-CA 126.53 4.82 . . . . 1.68 115.676 -176.729 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.27 -39.03 66.5 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 115.686 1.736 . . . . 2.25 115.686 177.421 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -89.71 -18.61 26.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.342 -1.355 . . . . 2.44 107.342 -173.071 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -78.35 100.2 6.67 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 117.728 2.492 . . . . 1.32 117.728 -167.639 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -97.85 122.99 41.61 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 119.292 0.951 . . . . 3.19 110.867 171.009 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.1 mt -92.76 105.72 17.81 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.214 2.911 . . . . 1.75 112.896 179.146 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mm -90.66 130.57 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 128.615 2.766 . . . . 1.98 109.783 -177.521 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -138.89 114.8 10.08 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 106.344 -1.724 . . . . 1.94 106.344 176.364 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.458 . . 68.16 24.98 7.45 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.098 -1.626 . . . . 1.67 113.405 173.605 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.24 -24.87 28.33 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 117.827 -1.54 . . . . 1.3 112.151 -173.189 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.5 tttt -106.44 128.99 54.49 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 122.239 3.02 . . . . 2.89 112.618 -179.685 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -78.48 138.22 38.33 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 112.124 -2.307 . . . . 2.89 112.865 168.964 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.1 mt -93.38 137.89 32.24 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 129.305 3.042 . . . . 1.34 108.959 -166.816 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -68.37 144.8 54.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.995 1.85 . . . . 1.94 115.995 173.11 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.15 -38.81 82.53 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 118.751 2.871 . . . . 1.56 118.751 -165.799 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.39 23.47 31.83 Favored Glycine 0 N--CA 1.43 -1.753 0 O-C-N 119.147 -2.221 . . . . 0.97 115.788 173.486 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -99.07 143.82 28.91 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 118.562 1.181 . . . . 3.07 109.104 166.416 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.251 72.1 p -80.9 162.57 23.87 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 126.277 2.235 . . . . 1.34 112.857 -179.76 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.9 -24.26 67.75 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.307 -2.746 . . . . 1.63 110.467 172.622 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.6 t -88.02 -11.08 48.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.936 -1.728 . . . . 1.51 110.431 -176.997 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -75.8 -42.75 49.1 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.659 -1.9 . . . . 1.9 109.526 173.08 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -79.63 -0.05 32.19 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.41 2.374 . . . . 0.97 117.41 176.13 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 64.01 39.76 7.68 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 115.733 1.753 . . . . 2.35 115.733 -179.48 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.1 mm -75.43 118.4 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 119.273 -2.142 . . . . 1.39 110.081 178.085 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -91.84 172.71 8.29 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.322 2.487 . . . . 2.58 114.394 177.373 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -66.98 140.28 57.72 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.451 -3.28 . . . . 2.58 107.607 179.635 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.386 6.3 tt0 85.71 12.7 0.2 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.812 1.645 . . . . 1.71 113.365 177.2 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.8 m -80.15 152.55 29.18 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 116.856 -3.652 . . . . 1.34 112.52 -172.687 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.83 115.48 30.17 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.76 2.219 . . . . 1.36 109.599 -178.006 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -102.52 163.19 12.37 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 114.118 -5.364 . . . . 2.03 104.86 174.183 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -122.67 123.46 41.18 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.866 1.666 . . . . 2.31 109.942 176.496 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.1 tp -84.8 122.14 28.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.719 1.608 . . . . 1.72 114.144 179.067 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.1 t -117.82 138.47 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 102.156 -3.276 . . . . 1.8 102.156 177.737 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.0 mt -104.3 115.17 29.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.057 1.408 . . . . 3.26 108.495 -177.156 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -65.59 148.94 50.9 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 113.083 -1.871 . . . . 4.12 107.828 -177.99 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.379 29.0 tp -91.0 119.44 31.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.647 -1.983 . . . . 3.54 105.647 173.692 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 -69.48 128.83 37.89 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 119.387 -2.07 . . . . 7.32 112.7 166.263 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.95 108.98 1.86 Allowed Glycine 0 N--CA 1.43 -1.731 0 O-C-N 123.498 0.499 . . . . 3.73 112.427 -158.378 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.733 0 C-N-CA 126.076 1.798 . . . . 3.87 113.234 -175.299 . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 3.3 ptt? . . . . . 0 CA--C 1.491 -1.32 0 N-CA-C 116.566 2.061 . . . . 1.39 116.566 . . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -103.05 112.52 25.41 Favored 'General case' 0 N--CA 1.429 -1.486 1 O-C-N 116.03 -4.169 . . . . 2.2 107.153 -168.571 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.3 pt -117.71 154.07 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 117.333 -1.318 . . . . 1.32 111.425 169.724 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -118.0 134.63 54.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 125.589 1.805 . . . . 2.2 113.815 -179.195 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -104.14 127.16 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 104.509 -2.404 . . . . 1.23 104.509 173.851 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -104.1 147.69 27.13 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.806 -1.553 . . . . 2.51 106.806 176.208 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.337 7.8 p -97.8 154.09 17.85 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 128.228 3.455 . . . . 1.41 113.378 174.119 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.5 mt -55.14 -36.85 66.23 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.87 2.468 . . . . 2.95 113.389 168.044 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.6 p -78.25 -47.31 18.2 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.592 -1.942 . . . . 2.52 112.489 -173.567 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.85 25.6 0.06 OUTLIER Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 117.3 1.68 . . . . 1.5 117.3 167.916 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.485 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 34.9 ttpt -103.74 153.24 20.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 116.121 -1.895 . . . . 1.79 111.668 -179.115 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.3 m -116.24 124.59 50.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 106.716 -1.587 . . . . 1.38 106.716 173.67 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.8 mt -99.08 117.65 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 123.413 2.824 . . . . 2.03 104.042 179.768 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.0 m -98.18 112.58 24.5 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.971 -2.956 . . . . 1.61 107.958 -176.107 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.8 mt -96.6 143.98 27.07 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.766 -1.209 . . . . 2.15 109.491 -174.384 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -98.41 119.17 36.64 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 126.284 2.24 . . . . 1.98 106.727 166.211 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.15 172.27 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 CA-C-N 121.231 1.832 . . . . 1.52 110.433 -175.823 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -126.2 152.53 73.67 Favored Pre-proline 0 N--CA 1.429 -1.483 0 C-N-CA 127.873 2.469 . . . . 2.35 107.246 172.409 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -75.69 -26.63 9.67 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 N-CA-C 107.056 -1.94 . . . . 1.31 107.056 -170.626 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.8 p -78.9 -5.76 54.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.672 -2.517 . . . . 1.71 115.557 -179.241 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -70.0 157.87 36.7 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 124.197 0.935 . . . . 1.69 111.852 168.945 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.7 p -88.75 166.72 13.85 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.649 2.092 . . . . 1.33 116.649 175.373 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.5 mm -67.13 -38.88 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.39 -2.069 . . . . 1.32 107.588 175.017 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -49.07 -44.82 42.24 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 118.31 -2.744 . . . . 1.62 114.077 167.676 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -64.71 -22.33 66.96 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.898 2.079 . . . . 2.13 111.8 175.956 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.36 98.5 t -73.67 -39.53 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 124.055 1.883 . . . . 1.23 110.792 176.543 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.443 ' HB3' ' HA ' ' A' ' 38' ' ' PRO . 87.6 mttt -70.88 -38.95 73.08 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.91 2.484 . . . . 1.97 110.487 178.449 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.46 -38.16 63.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.692 2.797 . . . . 1.19 114.193 169.853 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -77.23 -38.36 51.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.815 -1.803 . . . . 1.92 112.109 177.164 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.1 mt -61.08 -36.55 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 124.451 1.101 . . . . 1.94 111.42 172.219 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -65.51 -38.2 88.99 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 123.743 1.735 . . . . 1.9 110.936 178.777 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.53 -41.1 98.64 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 117.822 -3.049 . . . . 1.55 113.023 176.6 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -81.59 -59.09 2.73 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 116.423 -1.751 . . . . 2.95 112.064 -176.766 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.485 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 68.5 mm-40 -98.72 -39.17 8.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.989 2.515 . . . . 1.48 114.119 -164.825 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.21 26.59 7.31 Favored Glycine 0 N--CA 1.431 -1.693 0 O-C-N 125.733 1.896 . . . . 1.12 111.753 173.503 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.2 mt -102.31 128.39 28.44 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 118.712 -2.64 . . . . 2.07 105.923 -176.809 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.305 80.1 Cg_endo -68.54 158.48 57.52 Favored 'Trans proline' 0 C--N 1.299 -2.051 2 C-N-CA 128.958 6.438 . . . . 1.39 112.75 -175.937 . . . . . . . . 3 2 . 1 . 045 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 29.4 Cg_exo -66.52 -31.68 41.12 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 CA-C-N 124.389 2.603 . . . . 1.68 112.364 -178.514 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -50.14 -47.55 54.13 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.755 2.872 . . . . 2.25 118.755 175.271 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -70.27 -19.77 63.09 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.32 2.341 . . . . 2.44 117.32 176.199 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -96.41 135.97 37.55 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 120.011 1.278 . . . . 1.32 110.398 -173.484 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -128.01 124.23 36.65 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 100.817 -3.771 . . . . 3.19 100.817 173.279 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.8 mt -104.88 129.51 53.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.451 -2.159 . . . . 1.75 110.735 178.21 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.5 mm -108.59 129.21 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 125.588 2.613 . . . . 1.98 110.198 178.473 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -130.15 130.82 45.25 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.939 -2.976 . . . . 1.94 109.502 172.068 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.255 . . 67.51 -75.23 0.06 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.21 1.481 . . . . 1.67 109.089 -173.08 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.38 -7.9 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 129.912 3.625 . . . . 1.3 112.3 -175.937 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -81.3 130.85 35.2 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.569 -1.548 . . . . 2.89 112.427 -177.467 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -91.2 106.87 18.82 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 114.905 -4.872 . . . . 2.89 104.003 169.671 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.4 mt -71.21 133.17 45.93 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 117.316 2.339 . . . . 1.34 117.316 -169.583 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -83.87 141.97 30.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 111.562 -2.563 . . . . 1.94 114.031 -178.795 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.6 -65.68 0.64 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.469 -2.644 . . . . 1.56 117.989 -161.573 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.3 54.26 4.92 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-O 126.339 3.189 . . . . 0.97 117.33 168.701 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -117.14 146.69 43.02 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 111.585 -2.307 . . . . 3.07 108.987 159.657 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.6 p -72.79 152.93 41.33 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.905 1.446 . . . . 1.34 114.905 169.351 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.6 mt -59.72 -36.8 77.31 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.708 2.803 . . . . 1.63 108.161 175.109 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.263 1.7 t -71.38 -26.11 62.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 127.333 2.896 . . . . 1.51 112.836 175.078 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -67.88 -47.57 68.48 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 123.805 3.002 . . . . 1.9 111.183 168.74 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -69.8 -23.15 63.29 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.732 -1.855 . . . . 0.97 114.692 176.963 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.7 t30 73.79 53.11 0.11 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 127.414 2.286 . . . . 2.35 109.668 -171.672 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.8 mt -95.91 119.79 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 103.524 -2.769 . . . . 1.39 103.524 174.163 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -105.18 -178.06 3.54 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.282 -2.136 . . . . 2.58 111.869 -179.038 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.362 14.1 ptmt -49.18 137.42 13.77 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 127.326 2.25 . . . . 2.58 115.668 172.852 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 77.91 11.31 2.0 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.714 1.605 . . . . 1.71 114.421 173.163 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.3 m -82.59 147.19 28.74 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 124.395 1.059 . . . . 1.34 113.188 -175.165 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.5 m -105.19 116.48 32.02 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.732 2.206 . . . . 1.36 110.625 179.635 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.8 mt -88.4 141.46 28.52 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.323 -2.736 . . . . 2.03 110.804 172.15 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -100.69 123.61 45.14 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.714 1.721 . . . . 2.31 107.448 173.75 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.8 tp -85.89 111.99 20.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.916 1.686 . . . . 1.72 113.745 176.86 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.7 t -111.51 134.3 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 2 CA-C-O 129.965 4.698 . . . . 1.8 99.757 178.947 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.6 mt -116.85 133.02 56.53 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.023 -2.923 . . . . 3.26 115.687 -177.549 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -125.51 178.75 5.47 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 117.389 2.366 . . . . 4.12 117.389 178.218 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.3 mt -90.96 -58.38 2.49 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 123.596 2.907 . . . . 3.54 110.578 169.789 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -109.73 -55.36 2.45 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 126.34 2.275 . . . . 7.32 108.394 172.973 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.7 -131.11 1.97 Allowed Glycine 0 N--CA 1.432 -1.633 0 CA-C-O 117.736 -1.591 . . . . 3.73 111.612 -159.354 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.8 0 CA-C-N 118.68 1.24 . . . . 3.87 112.259 -176.346 . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 CA--C 1.489 -1.371 0 CA-C-O 117.439 -1.267 . . . . 1.39 111.138 . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -94.7 134.57 37.15 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.774 1.75 . . . . 2.2 111.374 -171.633 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -120.61 136.6 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.855 -3.028 . . . . 1.32 106.26 169.037 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -101.66 90.66 4.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 125.312 2.482 . . . . 2.2 111.701 -173.443 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.99 100.08 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.49 1 O-C-N 112.216 -6.553 . . . . 1.23 113.367 177.238 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -96.12 134.89 38.64 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.84 -1.163 . . . . 2.51 110.568 178.452 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.5 p -84.52 -178.78 6.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 131.049 3.74 . . . . 1.41 116.102 174.612 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.3 tp -79.01 -26.58 43.24 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.97 -4.206 . . . . 2.95 116.336 171.395 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.5 p -77.32 -34.01 55.41 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.253 2.93 . . . . 2.52 114.335 -179.167 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.32 4.16 2.6 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 119.27 -2.144 . . . . 1.5 111.455 174.464 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -82.4 122.74 28.39 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.82 -1.988 . . . . 1.79 111.531 -176.174 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 m -99.26 112.23 24.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.394 -2.691 . . . . 1.38 113.362 170.041 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.52 117.63 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 120.021 -1.674 . . . . 2.03 106.59 171.049 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.6 m -99.07 98.04 9.11 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.495 -1.669 . . . . 1.61 106.495 -178.362 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.1 mt -76.51 126.09 30.37 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.436 1.894 . . . . 2.15 111.294 -176.928 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -81.26 104.07 11.47 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.904 -2.997 . . . . 1.98 113.363 166.662 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 m -110.49 171.62 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 123.983 0.913 . . . . 1.52 111.596 -179.739 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -123.32 169.73 9.6 Favored Pre-proline 0 N--CA 1.43 -1.472 0 CA-C-O 116.278 -1.82 . . . . 2.35 107.387 158.22 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -78.66 -16.08 13.3 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 124.127 2.51 . . . . 1.31 112.719 -167.905 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.83 -19.21 65.8 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 114.886 -2.483 . . . . 1.71 113.886 174.537 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -72.18 143.63 48.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 125.189 1.555 . . . . 1.69 113.073 -174.863 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 p -86.89 167.42 14.34 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.568 -1.958 . . . . 1.33 113.361 178.798 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.427 HG22 HD13 ' A' ' 43' ' ' LEU . 42.4 mm -64.08 -37.16 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.536 -1.353 . . . . 1.32 111.84 172.962 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -53.03 -42.18 65.43 Favored 'General case' 0 N--CA 1.429 -1.492 1 O-C-N 115.458 -4.526 . . . . 1.62 114.866 163.639 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -72.72 -32.94 66.09 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.407 -2.683 . . . . 2.13 111.756 -178.621 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.56 -50.38 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 119.019 -2.3 . . . . 1.23 109.927 171.724 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -66.82 -18.59 65.45 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.142 1.377 . . . . 1.97 111.168 -179.227 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.0 -35.51 31.86 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 113.292 0.849 . . . . 1.19 113.292 169.816 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -63.46 -52.47 61.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.153 -2.217 . . . . 1.92 108.542 171.203 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.8 mt -53.92 -32.54 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 123.96 3.073 . . . . 1.94 117.397 174.83 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -71.1 -40.06 71.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.088 -2.883 . . . . 1.9 114.901 173.568 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.64 -56.85 16.16 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.09 -2.881 . . . . 1.55 107.428 168.836 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -71.22 -56.48 5.97 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.485 1.291 . . . . 2.95 114.485 -170.103 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -96.15 -24.79 16.12 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.151 2.58 . . . . 1.48 112.11 -168.972 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.55 37.53 13.99 Favored Glycine 0 N--CA 1.43 -1.751 0 CA-C-O 127.6 3.889 . . . . 1.12 113.71 173.853 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.7 mt -108.86 132.72 21.0 Favored Pre-proline 0 N--CA 1.429 -1.494 1 O-C-N 116.262 -4.081 . . . . 2.07 108.268 -178.539 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -68.51 142.88 55.29 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 C-N-CA 125.05 3.833 . . . . 1.39 120.817 -179.574 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.47 -9.11 21.32 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 123.731 2.954 . . . . 1.68 117.745 -171.376 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.74 -23.39 36.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.906 1.683 . . . . 2.25 112.697 166.85 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -86.15 -41.08 15.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 129.122 2.969 . . . . 2.44 111.123 -177.762 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.257 58.0 mt-30 -70.0 134.54 48.42 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 111.056 -2.793 . . . . 1.32 113.168 179.978 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -133.11 120.13 20.85 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.322 1.601 . . . . 3.19 115.322 175.074 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.427 HD13 HG22 ' A' ' 23' ' ' ILE . 46.6 mt -100.02 117.42 34.25 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 121.223 -0.923 . . . . 1.75 111.167 -177.214 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 80.8 mt -110.33 129.19 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 126.964 2.106 . . . . 1.98 108.097 179.472 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -142.83 137.52 29.68 Favored 'General case' 0 N--CA 1.43 -1.463 1 N-CA-C 99.092 -4.41 . . . . 1.94 99.092 173.002 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.16 33.4 23.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 117.078 2.251 . . . . 1.67 117.078 175.695 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.57 9.18 73.53 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 116.198 -2.906 . . . . 1.3 115.459 -174.023 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -121.33 137.9 54.49 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.694 2.187 . . . . 2.89 109.732 -176.459 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -89.37 118.22 28.88 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 127.261 3.41 . . . . 2.89 102.155 179.281 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.1 mt -87.22 152.59 22.18 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.771 -3.706 . . . . 1.34 112.82 -170.715 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -97.4 163.9 12.68 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.104 -3.498 . . . . 1.94 109.535 179.633 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -72.88 -69.04 0.44 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.458 2.303 . . . . 1.56 114.168 -168.314 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.08 59.77 2.25 Favored Glycine 0 N--CA 1.43 -1.728 1 C-N-CA 131.455 4.359 . . . . 0.97 110.76 176.919 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.5 mmt-85 -142.74 148.46 37.28 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.073 -1.825 . . . . 3.07 106.073 169.7 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.6 p -86.43 170.24 12.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.217 -3.427 . . . . 1.34 108.617 178.72 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 31.3 mt -65.89 -39.1 90.32 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.794 2.838 . . . . 1.63 110.648 169.078 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 t -64.88 -37.03 86.26 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.825 -3.047 . . . . 1.51 114.966 177.726 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -60.48 -40.67 92.14 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 115.925 1.824 . . . . 1.9 115.925 177.486 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -77.25 -9.92 59.1 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.797 2.839 . . . . 0.97 114.246 171.809 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.258 9.6 t30 63.18 48.39 3.73 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 125.787 2.708 . . . . 2.35 113.368 -176.698 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.1 mt -96.47 100.24 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 1 C-N-CA 132.25 4.22 . . . . 1.39 104.843 179.352 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -90.75 -174.45 4.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 121.959 2.163 . . . . 2.58 106.591 -175.955 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -62.37 151.66 36.2 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.58 -1.646 . . . . 2.58 109.76 173.088 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.344 43.7 mt-10 67.4 21.88 9.57 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 128.983 2.913 . . . . 1.71 111.078 171.106 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.1 m -85.59 136.7 33.28 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 115.617 -2.135 . . . . 1.34 112.64 -178.396 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.0 m -90.72 111.13 22.36 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 120.234 1.379 . . . . 1.36 108.623 -178.764 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.3 mt -88.91 137.67 32.11 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.259 -3.4 . . . . 2.03 107.313 173.326 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -94.06 116.65 29.1 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.78 -2.45 . . . . 2.31 106.527 -174.046 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.1 tp -99.63 108.68 21.12 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.749 -1.844 . . . . 1.72 110.005 -176.909 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.3 t -98.52 132.73 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 131.262 3.825 . . . . 1.8 107.691 178.307 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.8 mt -112.86 106.84 15.24 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 127.458 3.504 . . . . 3.26 105.354 177.565 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -63.84 160.69 16.9 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 115.113 -4.742 . . . . 4.12 115.23 -179.38 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.6 mt -113.09 174.36 5.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.732 2.413 . . . . 3.54 106.539 171.419 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -99.98 155.38 17.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.11 -3.494 . . . . 7.32 112.994 171.726 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.38 -91.1 0.56 Allowed Glycine 0 N--CA 1.43 -1.739 0 CA-C-O 117.315 -1.825 . . . . 3.73 112.345 -170.617 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.75 0 CA-C-N 123.804 3.802 . . . . 3.87 107.784 174.578 . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ptt? . . . . . 0 CA--C 1.489 -1.392 0 CA-C-O 121.792 0.806 . . . . 1.39 111.739 . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -110.81 142.21 43.12 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.645 -1.909 . . . . 2.2 110.301 -169.694 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.2 pt -136.64 146.2 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 129.073 2.949 . . . . 1.32 109.809 178.42 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -105.29 109.55 21.58 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 113.384 -1.735 . . . . 2.2 112.933 -178.497 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -100.49 103.06 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 117.601 -3.187 . . . . 1.23 108.703 176.227 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -91.76 131.57 37.03 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.73 -1.605 . . . . 2.51 113.049 176.486 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.351 0.0 OUTLIER -98.4 168.83 9.96 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.455 2.302 . . . . 1.41 109.32 -177.976 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.5 mt -67.67 -35.29 78.58 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 126.404 2.315 . . . . 2.95 112.686 -175.611 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.319 17.8 p -71.31 -35.66 71.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.893 1.679 . . . . 2.52 109.197 -176.388 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.29 -12.68 1.83 Allowed Glycine 0 N--CA 1.429 -1.805 0 O-C-N 118.949 -2.344 . . . . 1.5 115.758 178.031 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -80.29 134.45 36.08 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 124.946 2.308 . . . . 1.79 114.064 -175.654 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -99.82 127.3 45.99 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.197 -2.19 . . . . 1.38 109.518 173.813 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 mt -102.48 117.61 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 118.136 -2.853 . . . . 2.03 108.66 174.699 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.1 m -95.92 117.69 31.1 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 119.534 -0.866 . . . . 1.61 109.194 178.629 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.5 mt -119.21 150.27 40.35 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 121.212 -0.93 . . . . 2.15 112.627 177.371 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -101.07 139.91 36.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 127.762 3.164 . . . . 1.98 108.547 167.657 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.9 m -150.93 170.47 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 C-N-CA 129.969 3.307 . . . . 1.52 112.981 -178.383 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -108.47 156.9 37.84 Favored Pre-proline 0 CA--C 1.489 -1.383 0 CA-C-O 114.071 -2.871 . . . . 2.35 110.264 167.054 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -67.84 -21.27 44.51 Favored 'Trans proline' 0 N--CA 1.433 -2.065 0 C-N-CA 124.525 3.483 . . . . 1.31 111.827 -174.643 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.2 p -71.4 -6.64 41.74 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 130.511 3.525 . . . . 1.71 115.944 169.713 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.74 156.19 30.75 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.473 -2.017 . . . . 1.69 112.928 176.021 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.6 p -92.64 169.63 10.36 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.085 1.754 . . . . 1.33 113.128 176.512 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.5 mm -66.93 -30.97 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.806 -2.434 . . . . 1.32 114.975 173.579 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -57.25 -40.44 77.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.883 -3.01 . . . . 1.62 112.176 168.827 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -69.42 -23.65 63.73 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 113.217 0.821 . . . . 2.13 113.217 177.912 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.9 t -79.69 -46.54 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 119.647 -1.908 . . . . 1.23 113.48 176.38 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -68.85 -23.6 64.26 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 125.761 2.696 . . . . 1.97 115.017 176.614 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.84 -19.75 57.15 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.24 -3.412 . . . . 1.19 111.105 173.561 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -84.64 -34.85 22.99 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.173 2.416 . . . . 1.92 110.3 -179.838 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.7 mt -75.95 -22.13 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 117.965 -2.96 . . . . 1.94 107.767 175.822 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -70.23 -37.27 74.95 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 117.968 -2.958 . . . . 1.9 110.883 170.818 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.97 -59.33 3.58 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 120.467 -1.396 . . . . 1.55 110.873 172.438 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.256 32.6 tttp -59.18 -58.83 6.93 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.266 2.626 . . . . 2.95 111.25 -172.266 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -92.99 -74.7 0.51 Allowed 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.4 1.88 . . . . 1.48 109.612 -174.065 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 156.6 -14.23 0.35 Allowed Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 125.31 3.687 . . . . 1.12 110.274 177.186 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.6 mt -57.59 119.41 32.61 Favored Pre-proline 0 N--CA 1.43 -1.433 0 C-N-CA 128.929 2.892 . . . . 2.07 113.476 -172.891 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -60.22 147.09 94.85 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 CA-C-N 125.168 2.882 . . . . 1.39 117.534 171.789 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.304 73.6 Cg_endo -72.35 -18.25 26.57 Favored 'Trans proline' 0 N--CA 1.433 -2.031 1 C-N-CA 126.691 4.927 . . . . 1.68 114.615 -172.327 . . . . . . . . 3 2 . 1 . 047 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -73.36 -22.03 60.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 124.176 3.171 . . . . 2.25 109.373 174.799 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -87.4 -18.38 30.13 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.918 -2.364 . . . . 2.44 110.0 -178.724 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -96.12 116.27 28.72 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.726 -1.953 . . . . 1.32 105.726 -172.043 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -103.57 119.79 39.59 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 131.472 3.909 . . . . 3.19 107.851 168.695 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.5 mt -109.53 120.82 43.67 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.047 1.403 . . . . 1.75 110.916 179.631 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 mt -104.98 126.81 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 O-C-N 119.871 -1.768 . . . . 1.98 109.843 -179.614 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.441 ' CE2' HG12 ' A' ' 61' ' ' ILE . 49.3 t80 -134.12 127.79 32.82 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 116.881 -3.637 . . . . 1.94 112.936 173.762 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 35.39 38.75 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.843 1.657 . . . . 1.67 114.508 -171.51 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.27 -43.12 1.76 Allowed Glycine 0 N--CA 1.431 -1.699 0 O-C-N 118.012 -2.93 . . . . 1.3 113.096 175.752 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -72.46 144.03 48.22 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 119.374 1.587 . . . . 2.89 113.522 176.47 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.445 1.1 mp0 -99.14 112.8 24.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.325 -2.109 . . . . 2.89 112.101 169.742 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.8 mt -78.27 139.28 38.89 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 116.715 -3.741 . . . . 1.34 113.964 -158.393 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -82.05 141.8 32.87 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.747 2.419 . . . . 1.94 109.673 178.262 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.31 -48.46 71.32 Favored 'General case' 0 N--CA 1.43 -1.433 1 N-CA-C 121.91 4.041 . . . . 1.56 121.91 -173.378 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.92 63.25 1.52 Allowed Glycine 0 N--CA 1.431 -1.649 0 O-C-N 118.378 -2.701 . . . . 0.97 114.216 171.228 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -129.65 150.39 50.99 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.371 3.069 . . . . 3.07 105.932 167.62 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.7 p -87.41 170.15 11.63 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 119.071 -1.052 . . . . 1.34 110.048 177.662 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.6 mt -70.67 -30.11 66.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.591 1.956 . . . . 1.63 107.943 173.39 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.3 p -73.03 -43.0 62.56 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 116.241 -4.037 . . . . 1.51 118.036 175.382 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -44.05 -60.45 1.86 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.256 2.222 . . . . 1.9 116.584 167.058 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -73.25 3.78 5.34 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.424 -1.262 . . . . 0.97 112.054 179.61 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.2 t30 52.76 48.76 21.77 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.612 3.165 . . . . 2.35 114.654 -175.308 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.441 HG12 ' CE2' ' A' ' 45' ' ' PHE . 19.5 mt -94.92 124.74 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 116.528 -3.857 . . . . 1.39 108.281 175.785 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -114.33 -162.64 0.82 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 116.794 -3.691 . . . . 2.58 105.809 -165.299 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HE2' ' HB2' ' A' ' 63' ' ' LYS . 12.8 ptmm? -67.87 139.59 56.51 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 124.935 2.302 . . . . 2.58 113.371 167.347 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.438 84.5 mt-10 70.81 38.3 1.22 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.912 -2.368 . . . . 1.71 111.191 171.043 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 m -95.53 115.24 27.16 Favored 'General case' 0 N--CA 1.43 -1.453 1 C-N-CA 133.734 4.813 . . . . 1.34 107.779 -170.31 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.256 87.5 m -80.46 102.47 9.7 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.723 -1.236 . . . . 1.36 114.263 175.414 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.308 8.8 mt -89.21 135.61 33.48 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-O 123.904 1.812 . . . . 2.03 107.494 174.033 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -97.39 104.98 17.05 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.084 1.354 . . . . 2.31 107.586 -174.276 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.362 16.6 tp -76.43 115.42 16.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.371 -3.331 . . . . 1.72 114.335 174.906 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.0 t -108.48 128.77 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 115.554 -2.165 . . . . 1.8 106.508 172.212 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.8 mt -96.86 161.05 14.03 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 123.968 3.076 . . . . 3.26 109.019 176.285 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -95.6 98.1 10.24 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 103.089 -2.93 . . . . 4.12 103.089 174.976 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.3 mt -97.83 147.72 24.13 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 124.478 2.085 . . . . 3.54 107.881 171.632 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -86.32 123.6 31.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.052 -1.431 . . . . 7.32 109.7 171.557 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.19 -87.97 0.27 Allowed Glycine 0 N--CA 1.43 -1.747 0 CA-C-O 116.238 -2.423 . . . . 3.73 109.11 -173.969 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.74 0 CA-C-O 116.82 -2.1 . . . . 3.87 110.748 178.333 . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 ptt? . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 117.878 -1.058 . . . . 1.39 112.834 . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -86.4 129.43 34.86 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 120.878 1.672 . . . . 2.2 112.013 -179.881 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.261 32.5 pt -130.91 150.68 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.129 -3.482 . . . . 1.32 108.642 175.459 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -110.88 142.73 42.55 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 117.897 -3.002 . . . . 2.2 104.819 -178.653 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.4 t -124.1 108.49 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 107.082 -1.451 . . . . 1.23 107.082 172.748 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -98.28 132.1 44.05 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.89 -2.381 . . . . 2.51 110.633 -178.872 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 p -86.53 177.48 7.38 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.805 2.241 . . . . 1.41 113.682 178.797 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.317 43.0 mt -83.2 -38.99 21.56 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 119.153 -2.217 . . . . 2.95 109.828 170.073 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 p -63.71 -52.28 61.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.452 3.101 . . . . 2.52 113.963 179.69 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.84 11.31 0.04 OUTLIER Glycine 0 N--CA 1.429 -1.783 0 O-C-N 118.465 -2.647 . . . . 1.5 118.008 -175.136 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -115.59 150.95 35.83 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 105.824 -1.917 . . . . 1.79 105.824 -167.445 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.3 m -122.29 111.23 16.66 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 116.393 -1.765 . . . . 1.38 109.377 166.963 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -91.58 121.79 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 123.605 2.911 . . . . 2.03 109.952 177.622 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 m -87.55 114.18 23.92 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 127.189 3.376 . . . . 1.61 113.286 173.008 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.42 HD23 ' HB3' ' A' ' 29' ' ' LYS . 13.4 mt -110.8 154.74 23.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.918 -2.989 . . . . 2.15 112.88 -179.712 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -110.09 123.14 49.17 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 124.259 1.981 . . . . 1.98 108.028 166.283 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.96 170.59 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 118.672 -2.517 . . . . 1.52 107.116 -174.528 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -118.91 154.65 53.12 Favored Pre-proline 0 N--CA 1.43 -1.463 0 O-C-N 119.151 -2.218 . . . . 2.35 105.825 165.331 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -68.17 -16.54 44.53 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 O-C-N 114.683 -3.377 . . . . 1.31 114.276 -175.253 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.4 m -91.15 12.03 21.35 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 114.045 -5.409 . . . . 1.71 113.378 175.836 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -88.54 144.86 26.06 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 113.31 -3.356 . . . . 1.69 108.463 179.707 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.278 53.7 p -71.28 153.24 42.55 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.473 1.909 . . . . 1.33 109.758 -179.945 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.6 mm -54.09 -40.58 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 118.403 -2.685 . . . . 1.32 114.598 168.645 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -42.59 -46.29 4.88 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 117.675 2.472 . . . . 1.62 117.675 164.983 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.61 -46.03 84.38 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 111.625 -2.534 . . . . 2.13 112.478 178.151 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.6 t -59.01 -44.32 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 C-N-CA 126.743 2.017 . . . . 1.23 106.155 178.034 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.254 84.2 mttt -60.8 -42.61 97.97 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 116.203 -4.061 . . . . 1.97 114.124 177.473 . . . . . . . . 3 2 . 1 . 048 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.34 -20.68 62.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.448 -3.283 . . . . 1.19 116.379 175.091 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.42 ' HB3' HD23 ' A' ' 15' ' ' LEU . 9.4 mttm -72.68 -45.24 59.83 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.095 1.758 . . . . 1.92 112.359 170.442 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -48.69 -43.91 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.532 1.533 . . . . 1.94 112.756 163.264 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -66.05 -43.38 87.65 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.855 -3.653 . . . . 1.9 112.622 -179.537 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -53.77 -49.59 67.91 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.323 1.449 . . . . 1.55 110.339 168.26 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -80.97 -54.79 5.27 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.071 -2.893 . . . . 2.95 112.627 -174.815 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -99.62 -26.62 14.02 Favored 'General case' 0 N--CA 1.431 -1.401 1 O-C-N 112.694 -6.254 . . . . 1.48 109.03 -168.309 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.2 17.4 40.23 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 117.918 -2.989 . . . . 1.12 115.158 179.929 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.8 mt -84.83 123.28 74.17 Favored Pre-proline 0 N--CA 1.43 -1.471 0 CA-C-O 113.678 -3.058 . . . . 2.07 107.972 -177.404 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -69.81 144.4 53.61 Favored 'Trans proline' 0 N--CA 1.433 -2.037 1 CA-C-N 129.548 4.446 . . . . 1.39 114.205 -178.142 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_exo -62.08 -20.05 68.42 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 N-CA-C 121.185 3.494 . . . . 1.68 121.185 -165.425 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -66.79 -28.17 68.17 Favored 'General case' 0 N--CA 1.429 -1.49 1 O-C-N 129.998 4.561 . . . . 2.25 111.773 173.542 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -85.62 -24.59 27.05 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 116.296 -1.812 . . . . 2.44 110.457 -176.412 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.251 60.1 mt-30 -79.49 129.8 34.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 127.899 3.249 . . . . 1.32 110.959 -169.107 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -115.1 129.87 56.79 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.457 -2.053 . . . . 3.19 105.457 168.993 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.3 mt -114.1 126.96 55.68 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.139 -2.85 . . . . 1.75 111.093 179.647 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -117.73 124.23 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-O 126.969 3.271 . . . . 1.98 111.245 -175.47 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -135.66 139.3 43.63 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 115.965 -4.21 . . . . 1.94 109.049 172.192 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.362 . . 58.68 25.21 13.05 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 123.779 2.991 . . . . 1.67 115.673 173.469 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.11 2.92 90.7 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 117.077 1.591 . . . . 1.3 117.077 -177.055 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -113.26 157.21 22.05 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.382 2.273 . . . . 2.89 115.61 176.773 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -97.54 139.66 33.12 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.431 -2.668 . . . . 2.89 109.674 173.079 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.3 mt -102.2 120.66 40.82 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.978 -2.951 . . . . 1.34 111.329 -170.362 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -67.28 148.01 52.25 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.191 1.552 . . . . 1.94 115.191 175.283 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.65 -47.11 76.67 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 120.75 3.611 . . . . 1.56 120.75 -174.37 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.39 18.01 21.03 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 115.372 -2.904 . . . . 0.97 118.766 173.684 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -102.79 156.74 17.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.77 2.785 . . . . 3.07 110.974 171.643 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.1 p -88.55 169.65 11.55 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 123.329 1.538 . . . . 1.34 115.008 172.817 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.333 77.3 mt -69.22 -23.96 63.95 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 116.011 -4.181 . . . . 1.63 110.809 170.713 . . . . . . . . 3 2 . 1 . 048 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -65.72 -36.4 83.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.8 2.44 . . . . 1.51 115.489 171.806 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -65.41 -38.59 90.38 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.698 1.599 . . . . 1.9 113.911 173.881 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -78.9 -25.28 43.79 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 115.328 -2.272 . . . . 0.97 113.901 175.323 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.279 1.9 m-80 70.8 58.46 0.21 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.107 1.763 . . . . 2.35 109.909 -171.299 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 mt -105.25 117.12 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 105.022 -2.214 . . . . 1.39 105.022 174.034 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -84.83 -175.16 5.65 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 124.837 2.256 . . . . 2.58 111.374 -169.216 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -20.98 -87.87 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.422 1 C-N-CA 134.351 5.06 . . . . 2.58 118.208 169.086 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -103.17 69.3 1.01 Allowed 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 122.408 2.367 . . . . 1.71 116.226 -179.97 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.3 m -91.85 152.38 20.12 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 114.797 -1.092 . . . . 1.34 112.762 -179.99 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.5 m -113.52 115.69 28.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.136 1.374 . . . . 1.36 109.851 174.024 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.3 mt -96.93 156.63 16.27 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.545 1.938 . . . . 2.03 110.83 -179.674 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -110.9 129.65 55.81 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 100.991 -3.707 . . . . 2.31 100.991 -175.815 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.0 tp -102.53 113.89 27.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 125.328 1.643 . . . . 1.72 108.441 178.509 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.96 148.79 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 125.497 2.57 . . . . 1.8 109.464 172.845 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.9 mt -112.62 150.54 31.27 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.728 -4.358 . . . . 3.26 111.985 -177.708 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -78.74 162.55 26.08 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.135 -2.172 . . . . 4.12 105.135 179.533 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.3 mt -78.34 104.53 8.99 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 115.275 -2.57 . . . . 3.54 116.746 172.668 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -85.92 -55.35 3.99 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.997 -1.689 . . . . 7.32 112.333 173.738 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 143.03 -68.98 0.43 Allowed Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 117.79 -1.561 . . . . 3.73 112.593 -175.716 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.733 0 CA-C-N 123.658 3.729 . . . . 3.87 108.563 -178.205 . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 ptt? . . . . . 0 CA--C 1.491 -1.316 0 N-CA-C 116.773 2.138 . . . . 1.39 116.773 . . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -87.62 121.17 29.72 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 122.566 2.439 . . . . 2.2 110.489 178.904 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 pt -108.42 153.09 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 127.699 2.4 . . . . 1.32 108.577 173.777 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -104.18 131.08 51.85 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.868 -1.16 . . . . 2.2 107.868 -179.744 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.5 t -121.01 121.47 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 104.481 -2.414 . . . . 1.23 104.481 168.054 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -100.25 128.18 46.37 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 126.632 1.973 . . . . 2.51 111.727 -176.971 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.353 30.5 p -77.41 -164.07 0.44 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.602 1.668 . . . . 1.41 114.42 179.201 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.308 10.3 mt -90.97 -40.6 11.59 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.704 -1.872 . . . . 2.95 112.911 169.159 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.0 p -64.75 -37.09 86.42 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.548 -2.595 . . . . 2.52 107.616 -176.409 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.35 51.97 0.31 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 128.067 2.746 . . . . 1.5 111.312 175.92 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.523 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 83.1 tttt -114.1 130.27 56.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 101.972 -3.344 . . . . 1.79 101.972 177.425 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.3 m -102.67 103.76 14.05 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 118.016 -2.927 . . . . 1.38 110.399 177.146 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.81 136.51 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 118.755 -2.465 . . . . 2.03 108.418 179.541 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.7 m -103.29 111.93 24.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 118.733 -0.651 . . . . 1.61 109.265 179.602 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.38 142.23 28.01 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 127.992 3.307 . . . . 2.15 109.253 -178.97 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -105.81 116.28 31.67 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 123.395 1.569 . . . . 1.98 113.044 164.407 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.78 179.46 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.039 -1.437 . . . . 1.52 109.635 -178.808 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.433 ' O ' HD13 ' A' ' 56' ' ' LEU . 89.8 mt-10 -115.89 163.35 21.46 Favored Pre-proline 0 N--CA 1.432 -1.373 0 O-C-N 117.1 -3.5 . . . . 2.35 107.888 164.189 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -70.51 -14.46 33.73 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 C-N-CA 122.603 2.202 . . . . 1.31 112.444 -177.688 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.0 p -90.6 -0.99 57.88 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.165 2.186 . . . . 1.71 112.675 179.335 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -75.89 137.51 40.46 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.602 -1.936 . . . . 1.69 112.321 174.284 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 17.2 p -78.87 170.84 16.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.902 1.81 . . . . 1.33 111.625 174.297 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.284 3.5 mp -64.43 -41.07 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.267 -3.396 . . . . 1.32 112.721 168.106 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -43.5 -50.97 6.96 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 117.133 2.271 . . . . 1.62 117.133 163.694 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -67.01 -34.58 78.04 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.234 -2.166 . . . . 2.13 110.743 179.11 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.25 -42.1 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 118.253 2.686 . . . . 1.23 118.253 170.548 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.526 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 40.1 mtmt -71.86 -34.96 69.65 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 117.621 -3.175 . . . . 1.97 117.091 174.337 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.39 -28.38 63.99 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.733 2.413 . . . . 1.19 113.116 179.254 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -71.53 -37.89 71.11 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.689 2.395 . . . . 1.92 110.345 168.616 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.1 mt -68.31 -38.81 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 125.282 1.433 . . . . 1.94 107.996 175.872 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.342 40.3 tt0 -56.44 -41.8 77.04 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 128.788 2.835 . . . . 1.9 114.057 171.035 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -60.51 -41.73 94.95 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 118.236 2.68 . . . . 1.55 118.236 162.013 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -76.28 -52.4 10.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.719 -3.113 . . . . 2.95 116.431 -173.748 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.523 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 54.9 mm-40 -100.31 -26.77 13.79 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.714 2.406 . . . . 1.48 111.152 -168.585 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.75 13.88 56.04 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 118.12 -2.862 . . . . 1.12 117.289 176.048 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.9 mt -98.7 117.86 63.89 Favored Pre-proline 0 N--CA 1.43 -1.431 0 C-N-CA 127.439 2.295 . . . . 2.07 110.094 -170.799 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.39 152.71 70.94 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 CA-C-N 125.273 2.919 . . . . 1.39 116.932 -178.593 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -81.8 8.73 4.28 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 CA-C-O 113.582 -2.757 . . . . 1.68 107.919 -165.808 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -73.37 -44.13 59.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 125.272 3.669 . . . . 2.25 113.167 168.939 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -72.61 -26.36 61.66 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.783 2.833 . . . . 2.44 107.926 -172.466 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.526 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 73.3 mt-30 -87.25 133.18 33.7 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 123.455 0.702 . . . . 1.32 111.518 -165.932 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -124.6 146.89 48.81 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.182 2.593 . . . . 3.19 105.167 166.01 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.5 mt -129.33 128.06 42.36 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 129.168 2.987 . . . . 1.75 105.933 -177.709 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -121.01 115.66 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 105.339 -2.097 . . . . 1.98 105.339 -178.165 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.262 23.8 t80 -101.45 117.37 34.8 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.736 -1.852 . . . . 1.94 106.397 171.127 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.54 -46.31 0.62 Allowed 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.45 2.7 . . . . 1.67 114.806 -177.086 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.04 -32.81 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 126.938 2.209 . . . . 1.3 110.186 -171.712 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.27 52.8 mttm -73.29 125.96 29.01 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 126.657 2.034 . . . . 2.89 114.685 175.272 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -82.79 136.36 34.69 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 128.382 3.944 . . . . 2.89 112.825 172.309 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.4 mt -99.89 132.53 45.19 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.125 -2.86 . . . . 1.34 111.628 -165.171 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -79.17 141.28 37.35 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 122.175 0.988 . . . . 1.94 112.426 174.728 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.82 -57.74 8.45 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 126.031 2.824 . . . . 1.56 116.273 -174.135 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.43 16.43 13.84 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 122.6 3.8 . . . . 0.97 122.6 174.502 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 -85.41 163.87 18.25 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.8 1.8 . . . . 3.07 111.14 161.17 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.7 p -89.66 169.66 11.13 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 115.365 1.617 . . . . 1.34 115.365 165.287 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 18' ' ' GLU . 58.5 mt -64.6 -47.8 77.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 129.086 2.954 . . . . 1.63 108.666 172.147 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.7 m -57.65 -37.06 72.72 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.038 -2.289 . . . . 1.51 114.481 175.675 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -62.79 -54.37 39.99 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 129.764 3.226 . . . . 1.9 115.913 175.365 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -64.42 -12.38 42.65 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.564 -2.16 . . . . 0.97 116.294 169.404 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.2 m120 69.67 56.24 0.35 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 126.615 2.447 . . . . 2.35 113.175 -179.583 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 56' ' ' LEU . 65.9 mt -95.66 128.44 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 128.885 2.874 . . . . 1.39 106.433 -176.731 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -75.76 159.42 31.07 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 125.708 1.603 . . . . 2.58 109.875 -171.943 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -52.27 -35.26 49.57 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 120.448 3.499 . . . . 2.58 120.448 167.519 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -128.39 86.44 2.46 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 130.086 4.616 . . . . 1.71 105.011 174.437 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.44 172.76 11.2 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 117.895 -1.05 . . . . 1.34 110.997 -176.697 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.4 m -130.48 125.79 35.27 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 117.807 -1.092 . . . . 1.36 108.727 176.381 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 mt -104.12 145.64 29.89 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 128.773 2.829 . . . . 2.03 111.671 170.492 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -106.15 122.13 45.56 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.171 -1.58 . . . . 2.31 111.416 -172.277 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 tp -90.22 118.69 29.93 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.208 -1.775 . . . . 1.72 106.208 -173.574 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.5 t -119.29 148.9 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 103.69 -2.707 . . . . 1.8 103.69 173.722 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.9 mt -122.46 151.52 41.2 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 125.933 2.02 . . . . 3.26 108.401 -175.459 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -80.82 179.87 7.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.935 -1.876 . . . . 4.12 105.935 171.028 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.6 mt -69.73 154.88 41.36 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.214 -2.179 . . . . 3.54 110.264 164.534 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 -78.46 123.19 26.77 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.435 2.064 . . . . 7.32 113.303 -179.543 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.42 51.67 50.27 Favored Glycine 0 N--CA 1.431 -1.672 0 O-C-N 118.761 -2.462 . . . . 3.73 111.863 -166.189 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.741 0 CA-C-O 113.716 -3.824 . . . . 3.87 113.288 -178.673 . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.368 0 CA-C-O 125.902 2.763 . . . . 1.39 115.991 . . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -82.21 99.19 9.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.174 -3.454 . . . . 2.2 107.851 172.029 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -92.92 134.42 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 120.7 -1.25 . . . . 1.32 113.827 168.944 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -94.77 109.45 21.41 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 129.554 3.142 . . . . 2.2 111.328 -176.497 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 t -90.18 102.54 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 123.747 0.819 . . . . 1.23 111.963 173.352 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -75.87 140.57 42.28 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.137 2.399 . . . . 2.51 108.838 172.869 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 p -108.94 162.39 14.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.809 -1.807 . . . . 1.41 108.424 176.786 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.506 HD12 HG13 ' A' ' 70' ' ' VAL . 5.2 mt -69.63 -32.76 71.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 128.278 3.894 . . . . 2.95 112.531 177.951 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.0 p -70.86 -35.73 72.52 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 130.405 3.482 . . . . 2.52 115.975 -174.707 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.58 15.66 0.95 Allowed Glycine 0 N--CA 1.431 -1.692 0 CA-C-O 116.954 -2.025 . . . . 1.5 117.263 170.468 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.449 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 17.7 ptpt -116.87 172.28 7.36 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 120.333 2.066 . . . . 1.79 110.141 -178.26 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.4 m -123.87 106.6 10.58 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 128.134 2.574 . . . . 1.38 113.392 177.259 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -90.58 107.65 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 117.272 -1.347 . . . . 2.03 109.878 178.731 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.3 m -98.63 101.02 12.32 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.852 2.739 . . . . 1.61 106.907 -175.374 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.2 mt -102.15 141.62 34.7 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.284 -1.78 . . . . 2.15 111.658 -179.149 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -89.09 115.96 27.01 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.918 2.192 . . . . 1.98 116.918 163.599 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.1 m -127.32 170.26 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 128.79 2.836 . . . . 1.52 110.274 176.959 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -124.17 165.32 24.78 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 127.355 2.262 . . . . 2.35 109.527 167.417 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -69.1 -28.73 28.06 Favored 'Trans proline' 0 N--CA 1.434 -2.012 1 O-C-N 113.487 -4.007 . . . . 1.31 113.468 -168.062 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.7 m -83.93 6.07 23.1 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 114.565 -2.854 . . . . 1.71 111.2 -177.692 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -72.86 142.67 47.96 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.405 2.526 . . . . 1.69 108.168 173.432 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 38.2 p -84.41 164.83 18.65 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.668 -2.52 . . . . 1.33 109.249 -178.619 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.335 1.4 mp -70.25 -29.4 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.192 -2.193 . . . . 1.32 112.128 176.718 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -53.31 -46.68 69.52 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.797 -1.19 . . . . 1.62 113.536 165.649 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -62.05 -38.41 88.66 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 116.875 2.176 . . . . 2.13 116.875 177.496 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.1 -46.73 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 131.163 3.785 . . . . 1.23 111.294 173.028 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -65.63 -35.86 82.02 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.282 1.433 . . . . 1.97 111.127 179.043 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.24 74.7 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 115.739 -2.077 . . . . 1.19 113.775 174.446 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -72.79 -20.49 61.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.442 2.756 . . . . 1.92 118.442 175.327 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.0 mt -79.57 -34.13 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.98 2.112 . . . . 1.94 111.475 173.44 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -53.79 -41.88 67.71 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.494 -2.629 . . . . 1.9 112.687 175.09 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -67.49 -55.45 13.5 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.164 2.283 . . . . 1.55 117.164 170.028 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -66.46 -71.71 0.19 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.152 -2.218 . . . . 2.95 112.743 -174.461 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.449 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 59.1 mm-40 -74.19 -38.23 63.7 Favored 'General case' 0 N--CA 1.428 -1.527 0 O-C-N 118.095 -2.878 . . . . 1.48 113.535 -174.734 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.63 32.69 7.13 Favored Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 126.031 3.017 . . . . 1.12 113.267 -179.372 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.4 mt -101.11 125.14 39.1 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-N 111.144 -2.528 . . . . 2.07 107.812 -179.916 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -66.51 163.5 32.34 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 CA-C-O 112.374 -3.261 . . . . 1.39 114.773 -178.735 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -77.7 -16.52 14.7 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 CA-C-N 122.759 2.021 . . . . 1.68 113.444 -177.941 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -68.14 -35.83 78.71 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.77 -2.456 . . . . 2.25 109.935 168.54 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -76.82 -16.79 59.34 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.165 1.386 . . . . 2.44 114.62 -178.214 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -93.31 120.88 34.1 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.635 -3.79 . . . . 1.32 110.161 -173.31 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -103.58 116.27 32.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.503 -2.776 . . . . 3.19 103.503 167.842 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.5 mt -104.98 112.51 25.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 102.159 -3.274 . . . . 1.75 102.159 177.807 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.6 mm -103.23 137.39 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 105.45 -2.055 . . . . 1.98 105.45 177.379 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -129.33 109.34 11.02 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 103.749 -2.686 . . . . 1.94 103.749 176.855 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.402 . . 74.71 -86.58 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.144 -2.223 . . . . 1.67 112.37 177.855 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.28 1.09 1.85 Allowed Glycine 0 N--CA 1.43 -1.765 0 O-C-N 118.929 -2.357 . . . . 1.3 113.914 179.8 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -115.39 141.58 47.85 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 109.468 -0.567 . . . . 2.89 109.468 -178.707 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -86.06 134.25 33.84 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.742 2.417 . . . . 2.89 109.335 173.002 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.7 mt -85.14 121.81 28.43 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.63 2.826 . . . . 1.34 118.63 -179.601 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -81.5 142.19 33.13 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 116.336 1.976 . . . . 1.94 116.336 173.884 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.28 -54.53 19.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.224 1.409 . . . . 1.56 114.579 -167.81 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.0 15.89 2.96 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 120.043 2.777 . . . . 0.97 120.043 172.851 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.486 HH21 ' CG ' ' A' ' 58' ' ' ASP . 79.0 mtp180 -102.83 156.4 17.68 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 121.225 2.512 . . . . 3.07 107.772 165.722 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 16.7 p -82.59 161.73 22.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.321 2.249 . . . . 1.34 114.462 175.874 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -65.48 -28.72 69.41 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.403 2.001 . . . . 1.63 116.403 167.216 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.0 p -74.44 -21.92 59.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 117.08 2.252 . . . . 1.51 117.08 173.052 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.486 ' CG ' HH21 ' A' ' 54' ' ' ARG . 48.6 t0 -67.26 -40.97 86.28 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 118.296 -0.859 . . . . 1.9 110.999 172.346 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -77.53 -17.77 57.62 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 114.911 -2.471 . . . . 0.97 115.17 169.286 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 73.34 34.55 0.99 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.497 2.57 . . . . 2.35 116.367 -179.997 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.5 mt -65.38 124.58 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 116.384 -3.947 . . . . 1.39 115.528 179.618 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -61.43 164.55 5.57 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 119.987 3.328 . . . . 2.58 119.987 -178.082 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -60.08 -61.16 2.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.698 -3.126 . . . . 2.58 110.421 174.178 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -93.35 81.28 4.42 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 116.521 -2.071 . . . . 1.71 113.579 172.784 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.282 19.1 m -108.83 139.72 43.27 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 118.962 2.949 . . . . 1.34 118.962 -178.835 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.2 m -115.08 130.01 56.83 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.164 -1.421 . . . . 1.36 107.164 178.641 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -115.17 168.72 9.69 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 116.513 -1.708 . . . . 2.03 111.245 -179.345 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -122.88 122.84 39.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.29 1.436 . . . . 2.31 112.92 -179.22 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 tp -94.77 101.21 13.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.243 -1.536 . . . . 1.72 111.77 177.34 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.506 HG13 HD12 ' A' ' 8' ' ' LEU . 2.8 t -88.45 128.92 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 104.344 -2.465 . . . . 1.8 104.344 173.217 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.8 tp -85.13 129.19 34.85 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 115.585 -2.15 . . . . 3.26 113.074 175.185 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -92.82 143.56 26.15 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.672 -1.603 . . . . 4.12 106.672 174.52 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.7 mt -71.98 175.06 6.21 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.374 -2.704 . . . . 3.54 113.55 -175.84 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -74.36 -39.07 63.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.909 2.766 . . . . 7.32 109.622 168.95 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.47 73.87 0.45 Allowed Glycine 0 N--CA 1.43 -1.756 1 CA-C-O 129.818 5.121 . . . . 3.73 112.017 -168.538 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.825 0 CA-C-O 113.602 -3.888 . . . . 3.87 106.214 -175.915 . . . . . . . . 0 0 . 1 . 051 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 ptt? . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 123.773 1.749 . . . . 1.39 110.914 . . . . . . . . . 0 0 . 1 . 051 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -88.11 107.24 18.66 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 113.773 -5.579 . . . . 2.2 115.316 -178.687 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.3 pt -111.83 164.28 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 117.743 -3.098 . . . . 1.32 109.257 178.564 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -120.39 125.89 49.12 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 116.766 -3.709 . . . . 2.2 112.128 178.703 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 t -109.78 111.4 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 1 O-C-N 113.228 -5.92 . . . . 1.23 109.116 167.686 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -71.68 140.4 49.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.268 2.937 . . . . 2.51 111.124 175.097 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.1 p -87.93 177.75 6.88 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 113.25 -5.906 . . . . 1.41 110.769 169.744 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 tp -79.49 -51.28 9.54 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.334 -1.478 . . . . 2.95 108.422 179.631 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.1 p -65.7 -58.02 6.68 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.758 2.133 . . . . 2.52 116.758 -174.385 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.43 39.99 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.67 0 CA-C-O 115.054 -3.081 . . . . 1.5 110.546 -179.918 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.433 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 65.3 tttt -135.94 156.72 48.34 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 124.192 3.996 . . . . 1.79 110.571 -175.092 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.2 m -127.29 111.51 14.0 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 130.346 3.458 . . . . 1.38 107.514 177.814 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mt -88.28 118.92 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 123.924 3.056 . . . . 2.03 104.566 -177.94 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.9 m -98.73 122.09 41.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.224 -1.398 . . . . 1.61 107.224 178.229 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.8 mt -123.93 154.28 39.98 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 113.534 0.938 . . . . 2.15 113.534 -176.461 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -110.01 111.57 23.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 104.449 -2.426 . . . . 1.98 104.449 171.287 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.25 170.31 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 C-N-CA 127.443 2.297 . . . . 1.52 106.961 -179.91 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -117.97 156.59 49.99 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 105.209 -2.145 . . . . 2.35 105.209 167.035 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -68.49 -16.28 42.77 Favored 'Trans proline' 0 C--N 1.299 -2.069 0 N-CA-C 116.386 1.648 . . . . 1.31 116.386 -177.786 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.2 m -85.02 -11.51 55.24 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-O 115.731 -2.08 . . . . 1.71 110.763 179.699 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.07 139.51 54.83 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 126.262 1.825 . . . . 1.69 109.691 173.379 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.36 35.8 p -71.25 150.89 44.8 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 128.552 2.741 . . . . 1.33 110.021 176.091 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.423 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 20.5 mt -62.1 -35.1 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 104.869 -2.271 . . . . 1.32 104.869 178.795 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.291 30.1 tt0 -52.95 -46.39 68.15 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 116.262 -4.024 . . . . 1.62 118.548 165.812 . . . . . . . . 3 2 . 1 . 051 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.338 83.9 m-20 -61.77 -35.62 78.67 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.439 1.496 . . . . 2.13 113.95 173.613 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.5 t -68.94 -36.21 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 123.482 1.611 . . . . 1.23 112.01 175.101 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 18.7 mtmt -59.04 -30.44 68.04 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 119.125 -2.234 . . . . 1.97 115.252 163.84 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.21 -38.6 63.54 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 114.634 -5.042 . . . . 1.19 111.591 172.62 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.277 12.4 ttmm -57.32 -39.37 75.69 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.092 -2.88 . . . . 1.92 116.064 166.751 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.0 mt -57.34 -39.96 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 125.132 3.606 . . . . 1.94 114.57 166.945 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -66.85 -39.9 87.75 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.898 -1.751 . . . . 1.9 111.315 177.257 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -52.95 -43.51 66.38 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.579 2.066 . . . . 1.55 116.579 172.292 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -87.02 -47.57 8.83 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.664 -1.273 . . . . 2.95 113.289 -175.801 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.433 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 40.5 mm-40 -99.97 -55.68 2.57 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 116.941 -1.504 . . . . 1.48 107.214 -167.259 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.36 52.26 0.83 Allowed Glycine 0 N--CA 1.431 -1.695 0 CA-C-N 120.719 1.6 . . . . 1.12 112.607 -176.479 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.42 HD12 HD21 ' A' ' 71' ' ' LEU . 11.4 mt -130.74 126.29 21.79 Favored Pre-proline 0 N--CA 1.429 -1.48 0 N-CA-C 101.4 -3.556 . . . . 2.07 101.4 177.817 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -60.8 140.75 92.27 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 CA-C-O 111.082 -3.799 . . . . 1.39 111.648 -177.698 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -55.05 -23.8 37.17 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-N 124.925 2.795 . . . . 1.68 117.929 175.416 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -68.89 -23.13 64.16 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.309 1.226 . . . . 2.25 114.309 173.849 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -81.74 -20.96 38.23 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.877 1.323 . . . . 2.44 109.293 176.612 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -97.4 136.7 37.47 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.113 -2.867 . . . . 1.32 118.256 -173.849 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -123.77 108.09 12.14 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.185 -2.28 . . . . 3.19 111.533 173.595 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.5 mt -71.5 138.93 49.32 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 123.739 1.733 . . . . 1.75 112.053 176.903 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.316 47.0 mm -127.44 146.85 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 106.252 -1.759 . . . . 1.98 106.252 179.488 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -143.39 133.3 24.06 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.642 -1.911 . . . . 1.94 109.864 177.49 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.69 -83.91 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.412 2.285 . . . . 1.67 111.683 174.544 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -156.03 16.88 0.45 Allowed Glycine 0 N--CA 1.43 -1.759 0 O-C-N 125.647 1.842 . . . . 1.3 109.164 -178.215 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -126.7 167.0 16.33 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 126.077 2.846 . . . . 2.89 109.336 -177.984 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -93.0 162.68 13.95 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 114.607 -5.058 . . . . 2.89 105.874 170.521 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 98.0 mt -109.64 148.06 31.98 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.519 -3.238 . . . . 1.34 109.345 179.011 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -96.68 144.64 26.51 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.511 1.924 . . . . 1.94 110.909 171.681 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -85.88 -40.0 16.42 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 116.153 1.908 . . . . 1.56 116.153 -162.936 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.86 47.22 3.67 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-N 122.823 2.556 . . . . 0.97 113.657 171.505 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -131.84 164.28 26.4 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 104.175 -2.528 . . . . 3.07 104.175 170.353 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.363 20.4 p -90.93 174.74 7.27 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 118.717 -2.489 . . . . 1.34 115.147 -178.777 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.2 mt -73.04 -23.98 60.65 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.239 -1.538 . . . . 1.63 110.025 171.874 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -85.57 -41.12 15.55 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.69 1.367 . . . . 1.51 114.69 -177.27 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -53.05 -46.67 68.62 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.875 2.47 . . . . 1.9 111.815 168.881 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -75.06 -9.24 58.35 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 117.64 -3.162 . . . . 0.97 113.769 175.991 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.295 35.2 t-20 59.8 47.91 9.7 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 124.236 1.97 . . . . 2.35 114.896 -177.217 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.5 mm -74.75 130.91 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 128.102 2.561 . . . . 1.39 108.812 178.292 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -69.63 171.07 9.55 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.424 -3.298 . . . . 2.58 115.894 -176.691 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -57.36 -56.12 26.01 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 116.295 -4.003 . . . . 2.58 110.2 172.308 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -103.35 92.55 4.54 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.574 1.15 . . . . 1.71 109.389 171.733 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.3 t -115.14 144.69 43.28 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.644 2.09 . . . . 1.34 116.644 176.397 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.2 m -102.95 102.17 12.21 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.495 1.918 . . . . 1.36 110.875 179.695 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -106.69 172.88 6.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.893 -1.754 . . . . 2.03 109.304 178.292 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -123.7 137.35 54.72 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 118.151 2.648 . . . . 2.31 118.151 178.453 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.5 tp -95.64 118.69 32.8 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 112.744 -2.025 . . . . 1.72 111.282 177.064 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.2 t -122.53 121.67 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 125.862 1.665 . . . . 1.8 112.999 174.854 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.42 HD21 HD12 ' A' ' 36' ' ' ILE . 12.1 mt -83.05 140.95 32.4 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-O 126.974 3.273 . . . . 3.26 115.61 178.792 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -91.66 110.98 22.32 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.9 -3.625 . . . . 4.12 111.071 169.701 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.8 mt -83.28 141.09 32.09 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 105.994 -1.854 . . . . 3.54 105.994 173.252 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -74.08 146.0 43.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.743 2.127 . . . . 7.32 116.743 177.518 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.31 -78.02 0.32 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 128.958 3.17 . . . . 3.73 117.012 -168.564 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.748 0 CA-C-O 116.837 -2.091 . . . . 3.87 108.022 -178.032 . . . . . . . . 0 0 . 1 . 052 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ttp . . . . . 0 CA--C 1.49 -1.335 0 N-CA-C 118.428 2.751 . . . . 1.39 118.428 . . . . . . . . . 0 0 . 1 . 052 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -75.05 124.49 27.08 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 115.078 1.51 . . . . 2.2 115.078 -177.991 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.1 pt -136.14 159.0 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 117.248 -3.408 . . . . 1.32 103.218 175.752 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -116.64 149.5 39.64 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 124.477 1.111 . . . . 2.2 108.607 176.65 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.71 113.31 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-N 111.298 -2.683 . . . . 1.23 107.854 170.458 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -101.68 132.03 47.6 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 103.516 -2.772 . . . . 2.51 103.516 -176.048 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.1 p -86.48 165.86 15.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.986 -3.571 . . . . 1.41 113.508 173.66 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.9 mt -81.95 -29.77 32.04 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.841 -2.412 . . . . 2.95 108.78 174.097 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.9 p -68.1 -48.24 66.03 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 125.185 1.553 . . . . 2.52 111.692 -174.85 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.34 44.63 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.772 0 CA-C-N 119.523 1.056 . . . . 1.5 114.815 168.014 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.455 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 30.5 mtmt -143.43 147.17 34.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.684 2.183 . . . . 1.79 110.061 -162.53 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.3 m -112.84 135.04 54.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.48 -2.638 . . . . 1.38 105.038 171.427 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mt -111.57 107.54 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 126.585 1.954 . . . . 2.03 105.916 176.433 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.3 m -89.74 115.94 27.47 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.656 1.693 . . . . 1.61 108.789 -178.16 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.8 mt -115.31 154.99 28.13 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 125.421 2.534 . . . . 2.15 106.974 -170.348 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -112.06 117.68 33.33 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 115.382 -2.247 . . . . 1.98 108.044 166.191 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.0 m -129.73 177.47 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 101.859 -3.385 . . . . 1.52 101.859 -178.869 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -111.79 154.23 44.12 Favored Pre-proline 0 N--CA 1.43 -1.462 1 C-N-CA 133.196 4.598 . . . . 2.35 107.603 164.305 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -77.89 -5.46 15.3 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 125.078 3.852 . . . . 1.31 110.733 -172.404 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 m -101.57 3.25 39.83 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 123.529 1.633 . . . . 1.71 108.008 -175.53 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -81.91 149.84 28.04 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.394 1.257 . . . . 1.69 114.394 170.945 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 p -75.66 159.43 31.17 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 123.777 0.831 . . . . 1.33 111.075 -177.835 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.413 HG21 ' HB2' ' A' ' 50' ' ' LEU . 27.1 mm -67.65 -26.51 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.559 -1.338 . . . . 1.32 108.53 173.454 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -62.03 -34.61 76.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.143 1.792 . . . . 1.62 112.639 168.821 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -65.68 -40.8 92.72 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.748 1.619 . . . . 2.13 108.652 -179.08 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.7 t -64.8 -37.63 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-O 122.382 1.087 . . . . 1.23 113.278 175.947 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -59.97 -40.23 88.37 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 118.395 2.739 . . . . 1.97 118.395 166.292 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.56 -36.86 85.58 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.548 -1.97 . . . . 1.19 113.417 176.16 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -59.85 -48.01 83.41 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.577 -1.952 . . . . 1.92 114.805 170.628 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.8 mt -64.91 -32.81 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 119.22 -2.175 . . . . 1.94 112.976 172.029 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -62.98 -38.94 93.15 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.221 -1.55 . . . . 1.9 115.123 169.388 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -62.12 -44.06 97.47 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 123.423 1.582 . . . . 1.55 112.214 172.186 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -66.83 -55.79 13.26 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.572 -2.58 . . . . 2.95 116.002 178.555 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.455 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 63.4 mm-40 -100.03 -55.84 2.53 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.848 2.859 . . . . 1.48 108.952 -166.713 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.22 -9.56 9.51 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-O 123.443 1.579 . . . . 1.12 113.633 -176.154 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.9 mt -72.44 126.4 90.94 Favored Pre-proline 0 N--CA 1.43 -1.452 0 O-C-N 116.779 -3.777 . . . . 2.07 102.287 -175.635 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.85 161.38 46.27 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.667 2.245 . . . . 1.39 112.511 175.105 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -70.05 -12.17 31.84 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 C-N-CA 121.745 1.63 . . . . 1.68 113.477 -172.593 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -75.67 -27.08 58.17 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.422 2.058 . . . . 2.25 109.63 176.436 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -90.61 -20.07 22.98 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.091 -2.881 . . . . 2.44 108.022 -174.979 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -85.78 124.94 32.85 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.595 3.183 . . . . 1.32 119.595 178.911 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.4 ttm105 -109.31 118.71 37.4 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.467 -2.02 . . . . 3.19 110.538 171.654 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.267 66.9 mt -99.06 105.32 17.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 109.257 -0.645 . . . . 1.75 109.257 -178.944 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.7 mt -93.75 118.81 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-N 113.719 -1.582 . . . . 1.98 108.59 -179.343 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -138.54 138.26 37.83 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.158 -1.589 . . . . 1.94 110.772 173.865 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.16 41.61 26.86 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.053 2.941 . . . . 1.67 113.527 173.417 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.63 -18.01 22.21 Favored Glycine 0 N--CA 1.429 -1.789 1 CA-C-O 112.334 -4.592 . . . . 1.3 113.16 -179.832 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 172.3 7.3 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 123.534 3.667 . . . . 2.89 113.595 -178.544 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -104.57 134.84 47.06 Favored 'General case' 0 N--CA 1.431 -1.401 1 O-C-N 115.353 -4.592 . . . . 2.89 109.03 173.863 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.413 ' HB2' HG21 ' A' ' 23' ' ' ILE . 25.4 mt -76.3 155.05 34.59 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 123.842 1.782 . . . . 1.34 114.737 -173.661 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -98.85 141.99 30.94 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 124.78 2.229 . . . . 1.94 107.211 178.737 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -75.81 -41.93 51.34 Favored 'General case' 0 N--CA 1.43 -1.454 1 N-CA-C 124.093 4.849 . . . . 1.56 124.093 -167.018 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.04 0.5 89.02 Favored Glycine 0 N--CA 1.431 -1.665 0 O-C-N 116.563 -3.836 . . . . 0.97 110.856 170.232 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -71.55 151.22 44.03 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 122.465 3.132 . . . . 3.07 111.538 169.542 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.7 p -97.83 167.55 10.86 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.101 1.905 . . . . 1.34 111.684 -177.199 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.5 mt -69.37 -25.41 64.16 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.407 -3.308 . . . . 1.63 111.29 178.038 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.2 t -70.81 -39.56 73.01 Favored 'General case' 0 N--CA 1.431 -1.406 1 C-N-CA 132.845 4.458 . . . . 1.51 112.816 175.7 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -57.92 -34.61 70.05 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 124.858 2.266 . . . . 1.9 113.913 172.826 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -94.53 0.09 55.01 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 114.309 -5.244 . . . . 0.97 112.03 -178.208 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.0 m120 58.66 47.52 12.96 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 119.865 3.283 . . . . 2.35 119.865 -175.15 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.0 mt -83.21 105.91 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 126.336 1.854 . . . . 1.39 109.886 171.28 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -121.9 -48.23 2.14 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 124.213 1.958 . . . . 2.58 112.332 -179.246 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.2 mmtt -78.34 -173.95 3.52 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 112.739 -2.028 . . . . 2.58 115.728 176.907 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -71.44 69.79 0.6 Allowed 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 129.964 3.306 . . . . 1.71 112.796 177.267 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -90.59 158.4 16.99 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.511 3.124 . . . . 1.34 111.639 -175.364 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.8 m -118.66 118.36 31.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 104.496 -2.409 . . . . 1.36 104.496 -173.843 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.1 mt -94.57 148.61 22.08 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 103.33 -2.841 . . . . 2.03 103.33 172.105 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -108.63 112.87 25.44 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 126.032 2.825 . . . . 2.31 106.026 -176.489 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.0 tp -89.65 122.26 32.61 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.993 -3.567 . . . . 1.72 113.507 179.264 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.33 3.2 t -125.52 145.85 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 114.23 -1.35 . . . . 1.8 108.148 -177.067 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.8 tp -81.24 127.08 32.31 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 130.853 3.661 . . . . 3.26 106.567 -179.954 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -102.5 97.77 7.94 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.274 3.03 . . . . 4.12 112.183 176.107 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.8 mt -113.88 -92.96 0.48 Allowed 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.614 -1.929 . . . . 3.54 108.162 174.749 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.8 mtm-85 -99.22 -121.61 0.15 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.896 1.679 . . . . 7.32 113.588 168.87 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.95 112.69 3.27 Favored Glycine 0 N--CA 1.429 -1.769 1 CA-C-O 128.946 4.636 . . . . 3.73 108.953 -169.164 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.751 0 O-C-N 118.874 -2.545 . . . . 3.87 109.791 -174.128 . . . . . . . . 0 0 . 1 . 053 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ptt? . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 123.816 1.77 . . . . 1.39 107.903 . . . . . . . . . 0 0 . 1 . 053 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -93.44 136.51 33.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 117.067 -3.521 . . . . 2.2 111.523 -179.252 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.2 pt -131.7 161.79 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 117.005 -3.559 . . . . 1.32 104.707 173.771 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -122.04 141.94 50.85 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.767 -1.561 . . . . 2.2 107.888 -170.615 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 t -117.21 120.66 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 103.311 -2.848 . . . . 1.23 103.311 175.748 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -95.81 130.38 42.76 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 119.067 -1.053 . . . . 2.51 108.28 175.409 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.9 p -84.2 -176.13 6.11 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.708 -2.495 . . . . 1.41 115.199 176.788 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mt -68.55 -41.16 80.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 119.805 1.184 . . . . 2.95 109.328 172.086 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -72.59 -13.92 61.5 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 127.972 2.509 . . . . 2.52 107.824 -178.764 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.28 30.53 9.17 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 120.734 1.606 . . . . 1.5 113.577 175.857 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -95.71 134.1 39.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 117.908 -3.113 . . . . 1.79 107.286 -171.412 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.1 m -86.66 90.45 8.27 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 118.537 2.791 . . . . 1.38 118.537 175.449 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.7 mm -79.77 112.01 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 126.977 2.673 . . . . 2.03 109.542 176.204 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.5 m -103.67 113.83 27.65 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 123.279 2.763 . . . . 1.61 109.854 179.788 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -106.63 143.39 34.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.137 -1.602 . . . . 2.15 109.325 -179.511 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -93.3 123.89 36.9 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 104.037 -2.579 . . . . 1.98 104.037 170.246 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 m -133.76 160.44 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-O 115.471 -2.204 . . . . 1.52 108.468 -175.716 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -109.25 160.59 27.03 Favored Pre-proline 0 N--CA 1.43 -1.466 0 N-CA-C 104.899 -2.26 . . . . 2.35 104.899 160.259 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.74 -14.3 24.37 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 C-N-CA 121.788 1.659 . . . . 1.31 113.887 -179.0 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.1 p -75.59 -25.76 57.29 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 114.0 1.111 . . . . 1.71 114.0 173.481 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -62.67 160.53 13.96 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.976 -1.703 . . . . 1.69 114.549 -179.524 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.334 20.4 p -93.67 166.62 12.13 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.939 2.94 . . . . 1.33 118.939 -179.828 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.6 mm -71.3 -34.1 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.311 1.445 . . . . 1.32 111.152 177.386 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -60.04 -34.75 73.82 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.156 2.28 . . . . 1.62 117.156 165.999 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -71.69 -40.42 69.57 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.745 -1.847 . . . . 2.13 113.783 173.67 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.8 t -60.3 -38.81 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 123.709 0.804 . . . . 1.23 111.728 174.228 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -60.74 -40.51 92.69 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.545 -3.222 . . . . 1.97 114.725 164.618 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.75 -33.62 76.29 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.412 1.577 . . . . 1.19 113.634 173.413 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -56.67 -46.89 80.84 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.997 -2.939 . . . . 1.92 117.461 173.22 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.8 mt -67.85 -39.09 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 125.422 2.534 . . . . 1.94 114.333 173.826 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -57.63 -37.93 74.15 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.16 -4.713 . . . . 1.9 111.991 172.256 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -67.05 -35.98 81.04 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.349 2.976 . . . . 1.55 114.045 177.535 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -82.82 -44.49 15.44 Favored 'General case' 0 N--CA 1.429 -1.499 1 O-C-N 115.389 -4.57 . . . . 2.95 108.614 -176.554 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -125.92 -17.13 5.44 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 122.045 2.202 . . . . 1.48 113.186 -166.866 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.05 27.97 7.54 Favored Glycine 0 N--CA 1.43 -1.713 0 CA-C-N 120.861 1.664 . . . . 1.12 113.703 173.171 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.6 mt -99.81 120.4 57.31 Favored Pre-proline 0 N--CA 1.43 -1.467 0 O-C-N 120.014 -1.874 . . . . 2.07 109.104 -172.0 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.74 136.25 61.13 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 C-N-CA 124.899 3.733 . . . . 1.39 112.252 179.624 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -55.94 -15.46 13.58 Favored 'Trans proline' 0 C--N 1.3 -2.008 1 C-N-CA 126.399 4.733 . . . . 1.68 118.219 -177.181 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -76.07 -26.41 56.5 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.735 0.779 . . . . 2.25 111.527 173.748 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -85.2 -30.03 24.23 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.391 2.043 . . . . 2.44 107.63 -177.79 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -74.71 118.18 17.39 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.783 -4.323 . . . . 1.32 112.092 -176.807 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.1 ttm-85 -121.7 116.33 24.33 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.685 -1.969 . . . . 3.19 105.685 170.56 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.5 mt -99.52 130.38 45.77 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.183 -1.043 . . . . 1.75 108.183 -179.772 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.3 mt -113.71 119.54 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 126.818 2.047 . . . . 1.98 112.085 174.715 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.488 ' HB3' HD22 ' A' ' 50' ' ' LEU . 51.6 t80 -114.72 132.11 56.54 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 102.865 -3.013 . . . . 1.94 102.865 174.653 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.39 -94.43 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.417 1 C-N-CA 132.138 4.175 . . . . 1.67 110.079 177.015 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.66 8.61 7.75 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 129.003 3.192 . . . . 1.3 113.059 176.217 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -106.04 137.9 43.16 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 129.5 3.12 . . . . 2.89 111.179 -178.527 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -103.47 113.92 27.79 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 125.543 2.592 . . . . 2.89 106.927 169.863 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.488 HD22 ' HB3' ' A' ' 45' ' ' PHE . 13.6 mt -67.75 126.15 28.48 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.358 -3.338 . . . . 1.34 113.67 -170.707 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -91.06 134.29 34.63 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 114.645 1.35 . . . . 1.94 114.645 174.446 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -47.1 -52.39 15.42 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 119.893 3.294 . . . . 1.56 119.893 -171.785 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.23 68.78 0.96 Allowed Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 113.962 -3.688 . . . . 0.97 111.668 174.86 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.253 84.1 mmt-85 -139.55 164.74 29.11 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 102.53 -3.137 . . . . 3.07 102.53 167.851 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.9 p -93.54 166.34 12.3 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.188 2.423 . . . . 1.34 108.086 173.828 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 mt -59.91 -40.33 88.44 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.444 2.698 . . . . 1.63 108.961 171.079 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.2 t -54.88 -48.61 72.75 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.285 2.234 . . . . 1.51 113.465 176.158 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -50.77 -34.1 25.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 118.595 2.813 . . . . 1.9 118.595 170.791 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -90.48 1.19 56.91 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.151 1.38 . . . . 0.97 110.253 178.203 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.257 4.3 m120 52.08 43.56 30.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.093 2.557 . . . . 2.35 115.157 -174.231 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.436 HD12 HD22 ' A' ' 67' ' ' LEU . 27.4 mt -91.49 115.01 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 127.177 3.37 . . . . 1.39 113.487 177.574 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -95.47 -177.02 3.94 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.213 -2.804 . . . . 2.58 114.805 -176.214 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -62.62 152.45 35.1 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 115.049 -4.782 . . . . 2.58 116.722 169.723 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.331 31.4 mt-10 66.47 18.36 10.81 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.112 -2.243 . . . . 1.71 113.203 174.371 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.3 p -89.96 165.12 14.26 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 127.382 3.468 . . . . 1.34 111.517 -172.87 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.1 m -120.92 108.74 14.26 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 113.337 -5.852 . . . . 1.36 113.177 -177.807 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.436 HD22 HD12 ' A' ' 61' ' ' ILE . 31.0 mt -81.75 137.51 35.34 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 124.905 1.282 . . . . 2.03 113.238 166.794 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -98.33 115.25 28.03 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.904 -0.497 . . . . 2.31 110.323 -177.826 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.9 tp -93.72 112.37 24.23 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 126.197 2.186 . . . . 1.72 106.874 -177.12 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.27 143.42 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 128.468 2.707 . . . . 1.8 104.204 174.972 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.6 mt -103.26 113.57 27.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 121.112 -0.992 . . . . 3.26 108.658 175.367 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -78.49 146.83 34.17 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 117.715 -1.136 . . . . 4.12 109.209 -179.131 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.9 mt -102.64 166.64 10.39 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 119.638 1.108 . . . . 3.54 111.42 173.055 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -92.78 93.36 8.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.02 2.343 . . . . 7.32 113.502 176.142 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.37 -95.28 0.1 Allowed Glycine 0 N--CA 1.43 -1.707 0 O-C-N 117.747 -3.096 . . . . 3.73 109.171 -174.281 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.711 0 C-N-CA 117.66 -2.209 . . . . 3.87 111.634 175.994 . . . . . . . . 0 0 . 1 . 054 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 108.268 -1.012 . . . . 1.39 108.268 . . . . . . . . . 0 0 . 1 . 054 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -100.62 130.13 46.64 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 115.698 -2.096 . . . . 2.2 112.199 179.766 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.3 pt -129.03 159.33 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 120.099 1.318 . . . . 1.32 107.948 171.798 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -106.81 143.35 35.03 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.341 -1.754 . . . . 2.2 110.456 -176.516 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.2 t -119.35 120.04 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 129.43 3.092 . . . . 1.23 108.328 177.715 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.0 mttp -105.28 141.54 36.63 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 116.06 1.874 . . . . 2.51 116.06 169.87 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 p -95.76 177.72 5.69 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.513 2.325 . . . . 1.41 113.195 177.929 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.6 tp -57.74 -45.74 85.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.052 0.941 . . . . 2.95 113.279 178.278 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.2 p -78.01 -14.13 59.62 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.022 2.344 . . . . 2.52 112.879 -175.148 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.15 30.3 4.82 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 117.148 -3.47 . . . . 1.5 114.997 172.882 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -91.91 111.3 22.78 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.049 -1.575 . . . . 1.79 108.782 -176.317 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 m -83.8 115.24 22.14 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.92 -2.988 . . . . 1.38 109.152 177.201 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.9 mt -101.33 126.73 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 106.85 -1.537 . . . . 2.03 106.85 175.297 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.6 m -104.55 125.39 50.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 102.587 -3.116 . . . . 1.61 102.587 -170.338 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.2 mt -128.35 150.73 49.96 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 126.706 2.002 . . . . 2.15 109.239 -173.83 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -115.93 131.5 56.92 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.844 -0.616 . . . . 1.98 112.074 170.245 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.3 m -144.29 165.78 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 125.363 1.665 . . . . 1.52 108.919 -174.433 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -101.07 153.02 37.99 Favored Pre-proline 0 N--CA 1.43 -1.475 0 O-C-N 117.63 -3.169 . . . . 2.35 111.442 165.294 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -67.74 -13.52 38.95 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 CA-C-N 126.932 3.511 . . . . 1.31 115.795 -173.437 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.1 p -84.22 0.86 47.18 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 131.553 3.941 . . . . 1.71 116.059 171.494 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -76.46 136.45 39.4 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 118.892 -2.38 . . . . 1.69 113.407 170.558 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 p -70.13 152.96 43.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.526 -3.233 . . . . 1.33 108.125 179.419 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.6 mm -57.53 -23.1 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 118.039 2.607 . . . . 1.32 118.039 167.858 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -53.74 -43.65 69.3 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.267 -3.396 . . . . 1.62 115.346 159.443 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.4 m-20 -66.54 -28.94 68.94 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.526 2.584 . . . . 2.13 117.746 177.686 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.3 -41.7 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 113.809 -1.541 . . . . 1.23 111.258 171.017 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.68 -33.8 69.14 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 126.512 1.925 . . . . 1.97 112.628 174.615 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.52 -44.25 84.94 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.051 2.14 . . . . 1.19 111.497 170.02 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -61.49 -38.49 87.5 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.692 2.397 . . . . 1.92 110.937 172.222 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.7 mt -70.48 -37.32 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 O-C-N 117.954 -2.966 . . . . 1.94 115.205 170.336 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -52.92 -46.51 68.11 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.632 2.634 . . . . 1.9 110.991 172.388 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -55.03 -59.76 4.3 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 116.181 -4.075 . . . . 1.55 114.713 172.913 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -69.65 -60.23 2.45 Favored 'General case' 0 N--CA 1.43 -1.461 1 CA-C-O 129.579 4.514 . . . . 2.95 110.592 -174.635 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -80.36 -59.93 2.51 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.672 -4.392 . . . . 1.48 114.046 -172.96 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.57 -16.23 6.26 Favored Glycine 0 N--CA 1.431 -1.695 0 CA-C-O 115.427 -2.874 . . . . 1.12 109.105 -179.483 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.408 ' H ' HG13 ' A' ' 36' ' ' ILE . 19.9 mt -60.92 122.09 66.64 Favored Pre-proline 0 N--CA 1.431 -1.38 0 C-N-CA 126.877 2.071 . . . . 2.07 112.826 -170.363 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.67 142.98 99.3 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 N-CA-C 119.236 2.744 . . . . 1.39 119.236 -176.33 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -80.49 -9.92 13.46 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 115.82 -2.779 . . . . 1.68 115.072 -166.604 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.55 -14.99 57.75 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.116 2.566 . . . . 2.25 113.469 167.635 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -94.68 -32.31 13.43 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.509 -3.245 . . . . 2.44 110.364 178.522 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -62.93 145.29 55.57 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 113.407 -1.724 . . . . 1.32 113.432 179.521 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.442 ' HB2' HG23 ' A' ' 70' ' ' VAL . 92.5 mtt180 -134.91 130.31 35.69 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.534 -2.604 . . . . 3.19 106.127 164.154 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.4 mt -100.4 131.55 46.26 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.944 2.307 . . . . 1.75 108.21 172.902 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.4 mt -120.24 139.98 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 112.081 -2.327 . . . . 1.98 107.111 176.056 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -135.28 134.43 39.93 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 102.447 -3.168 . . . . 1.94 102.447 168.187 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.83 -68.5 0.22 Allowed 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.196 2.903 . . . . 1.67 113.511 177.171 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.69 -47.26 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.763 0 CA-C-O 127.433 3.796 . . . . 1.3 113.702 -174.692 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -73.85 138.86 44.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 127.59 3.567 . . . . 2.89 113.549 -178.021 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -73.58 124.33 25.7 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.905 -2.997 . . . . 2.89 115.032 166.771 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.6 mt -85.51 161.58 19.3 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.955 -1.716 . . . . 1.34 115.1 -178.016 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.282 27.8 mt-10 -104.77 143.45 33.1 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 120.554 3.538 . . . . 1.94 120.554 174.084 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -67.23 -43.57 81.63 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 116.338 -3.976 . . . . 1.56 116.304 -170.182 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.98 15.91 0.65 Allowed Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 130.437 3.875 . . . . 0.97 114.86 173.947 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -120.71 170.93 8.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.13 1.965 . . . . 3.07 111.738 166.557 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.3 p -107.21 177.51 4.83 Favored 'General case' 0 N--CA 1.429 -1.514 1 CA-C-O 128.554 4.026 . . . . 1.34 111.687 176.374 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.7 mt -70.32 -31.75 69.2 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.444 -2.66 . . . . 1.63 108.329 176.377 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -66.7 -41.05 88.63 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.964 -2.335 . . . . 1.51 115.126 -177.823 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -49.61 -45.98 48.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.077 2.151 . . . . 1.9 110.907 173.638 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -85.25 -0.67 55.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.027 2.346 . . . . 0.97 116.272 -178.174 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 56.78 37.42 28.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.04 2.936 . . . . 2.35 115.921 -178.527 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.2 mt -70.39 116.53 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 C-N-CA 128.681 2.792 . . . . 1.39 111.564 173.769 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -89.98 178.01 6.32 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.055 2.142 . . . . 2.58 108.411 174.21 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -67.51 152.89 44.88 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.12 1.914 . . . . 2.58 112.623 177.519 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.268 51.4 mt-10 67.31 27.43 8.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.989 -1.069 . . . . 1.71 113.68 169.434 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.9 m -98.91 144.49 28.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.684 3.194 . . . . 1.34 108.196 -175.253 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.6 m -108.93 120.79 43.56 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.143 -2.848 . . . . 1.36 109.393 -172.29 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -93.07 162.91 13.85 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.416 -1.327 . . . . 2.03 107.416 177.692 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -119.77 132.83 55.73 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.149 1.38 . . . . 2.31 112.968 -179.601 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.0 tp -118.5 116.57 26.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.529 -1.982 . . . . 1.72 109.854 -174.854 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' A' ' 42' ' ' ARG . 3.2 m -117.66 170.36 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 123.351 1.548 . . . . 1.8 110.902 172.516 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.1 mt -108.57 151.8 25.62 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.029 1.871 . . . . 3.26 115.072 174.11 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -78.84 140.13 38.22 Favored 'General case' 0 N--CA 1.429 -1.492 1 C-N-CA 131.852 4.061 . . . . 4.12 113.992 176.721 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.0 mt -88.76 141.32 28.61 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 124.675 2.179 . . . . 3.54 111.379 168.571 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -64.78 133.87 52.92 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 114.44 -5.162 . . . . 7.32 113.072 170.656 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 135.07 -43.56 1.25 Allowed Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 125.439 1.495 . . . . 3.73 112.982 -166.169 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.765 0 CA-C-N 119.745 1.772 . . . . 3.87 116.491 -178.307 . . . . . . . . 0 0 . 1 . 055 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.49 -1.361 0 CA-C-O 123.375 1.559 . . . . 1.39 109.497 . . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -104.96 142.32 34.99 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.555 -1.341 . . . . 2.2 109.446 -172.335 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.0 pt -131.81 155.05 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 124.723 1.209 . . . . 1.32 107.997 174.557 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.271 64.2 m-85 -108.33 125.27 51.51 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 112.957 0.725 . . . . 2.2 112.957 177.8 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -105.67 122.77 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 119.03 0.832 . . . . 1.23 109.625 173.257 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -94.61 124.57 38.73 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 128.712 2.805 . . . . 2.51 109.707 175.913 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.8 p -77.56 -173.52 2.99 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 127.627 2.371 . . . . 1.41 105.583 -178.55 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.7 mt -59.86 -48.11 83.0 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 129.802 3.241 . . . . 2.95 117.859 169.564 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.1 p -79.36 -15.43 57.91 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.626 3.571 . . . . 2.52 110.627 -179.202 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.14 44.53 5.62 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 126.914 2.197 . . . . 1.5 114.031 176.067 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -95.4 151.52 19.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 104.697 -2.334 . . . . 1.79 104.697 174.788 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.2 m -101.21 112.36 24.83 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 125.764 1.915 . . . . 1.38 112.08 179.795 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 mm -94.76 124.62 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 103.018 -2.956 . . . . 2.03 103.018 172.032 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.7 m -106.44 115.41 30.16 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.337 -3.352 . . . . 1.61 114.678 -178.999 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.259 34.6 mt -112.71 135.5 53.38 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.87 -2.394 . . . . 2.15 110.895 -175.957 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -75.8 116.39 16.45 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.142 -1.429 . . . . 1.98 107.142 161.085 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -127.85 175.74 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.241 1.417 . . . . 1.52 109.76 174.339 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -118.23 156.71 50.4 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-O 124.614 2.15 . . . . 2.35 109.629 167.064 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -71.79 -20.14 26.55 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 O-C-N 113.246 -4.134 . . . . 1.31 111.767 -175.72 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 p -87.36 3.58 46.39 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 130.788 3.635 . . . . 1.71 115.831 175.732 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -83.63 149.21 26.68 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.497 -2.627 . . . . 1.69 106.168 177.36 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.2 p -90.8 168.21 11.9 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 118.006 -0.997 . . . . 1.33 108.464 -177.789 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.417 HG22 HD12 ' A' ' 43' ' ' LEU 0.324 40.9 mm -65.78 -24.61 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 N-CA-C 114.494 1.294 . . . . 1.32 114.494 173.937 . . . . . . . . 3 3 . 1 . 055 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -69.07 -30.41 68.73 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 113.772 -3.013 . . . . 1.62 116.278 163.62 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -76.37 -25.66 54.85 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.207 1.821 . . . . 2.13 108.602 170.687 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.7 -50.25 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 121.879 2.127 . . . . 1.23 114.565 170.822 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -65.72 -34.67 78.73 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 118.454 2.761 . . . . 1.97 118.454 179.75 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.05 -38.87 73.85 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 114.177 -2.821 . . . . 1.19 111.736 168.555 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -66.59 -35.72 80.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 120.709 1.595 . . . . 1.92 114.013 174.28 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 53.8 mt -73.58 -24.28 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 119.777 -1.827 . . . . 1.94 114.803 173.159 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -75.73 -29.98 59.08 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.076 1.762 . . . . 1.9 111.773 172.066 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -72.1 -46.27 57.36 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.468 1.127 . . . . 1.55 112.996 175.831 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -65.17 -75.44 0.09 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 126.176 1.791 . . . . 2.95 111.935 -178.913 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -86.91 -42.31 13.29 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.588 2.355 . . . . 1.48 114.813 -169.532 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.96 31.67 2.22 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 118.277 -1.916 . . . . 1.12 111.948 174.574 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.8 mt -102.09 124.4 40.11 Favored Pre-proline 0 N--CA 1.43 -1.426 0 CA-C-O 114.6 -2.619 . . . . 2.07 113.436 -175.509 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -60.79 138.7 81.03 Favored 'Trans proline' 0 N--CA 1.433 -2.064 0 CA-C-O 114.05 -2.562 . . . . 1.39 114.38 -176.715 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -62.83 -29.17 76.34 Favored 'Trans proline' 0 N--CA 1.434 -2.009 1 C-N-CA 127.49 5.46 . . . . 1.68 114.273 -171.947 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -62.76 -28.95 70.33 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.849 -2.407 . . . . 2.25 112.056 173.057 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -76.36 -13.18 60.15 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 116.785 2.143 . . . . 2.44 116.785 179.092 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -95.39 117.18 29.89 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.013 -3.555 . . . . 1.32 115.26 -172.361 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -107.27 127.09 53.24 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 127.2 2.2 . . . . 3.19 107.946 169.343 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.417 HD12 HG22 ' A' ' 23' ' ' ILE 0.284 65.6 mt -109.49 138.69 45.48 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 105.263 -2.125 . . . . 1.75 105.263 -175.788 . . . . . . . . 3 3 . 1 . 055 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.7 mm -122.37 126.23 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 109.74 -3.391 . . . . 1.98 107.325 179.801 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -120.46 108.93 14.7 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.652 -1.981 . . . . 1.94 105.652 172.317 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.92 -73.22 0.09 Allowed 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 126.526 1.93 . . . . 1.67 109.106 -179.443 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -160.73 7.84 0.11 Allowed Glycine 0 N--CA 1.43 -1.709 0 CA-C-O 124.898 2.388 . . . . 1.3 114.915 -174.039 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -105.78 128.61 53.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 111.585 -2.307 . . . . 2.89 105.842 177.311 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -79.47 138.89 37.72 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.176 -0.952 . . . . 2.89 109.573 170.499 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.3 mt -101.73 126.44 48.59 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 121.649 2.022 . . . . 1.34 111.967 -165.966 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -88.56 156.3 19.14 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.285 -1.746 . . . . 1.94 106.285 178.73 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -76.04 -40.2 53.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 118.748 2.869 . . . . 1.56 118.748 -168.613 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.25 22.85 9.11 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 117.798 -3.064 . . . . 0.97 112.868 177.559 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -108.13 164.37 12.36 Favored 'General case' 0 N--CA 1.431 -1.397 1 O-C-N 116.294 -4.062 . . . . 3.07 106.918 164.786 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.0 p -101.1 168.78 9.37 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.989 2.116 . . . . 1.34 111.662 179.129 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -58.5 -42.86 88.59 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 112.119 -2.31 . . . . 1.63 110.275 169.926 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.388 5.6 t -64.03 -33.39 75.64 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.499 1.954 . . . . 1.51 112.973 -179.013 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -61.18 -34.42 75.04 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 119.834 3.272 . . . . 1.9 119.834 175.016 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -90.74 10.72 24.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 111.957 -2.383 . . . . 0.97 114.169 174.934 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.279 46.7 m-80 65.09 21.45 12.21 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 113.379 -5.825 . . . . 2.35 115.263 -178.878 . . . . . . . . 3 2 . 1 . 055 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.0 mt -75.9 106.74 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 124.777 1.231 . . . . 1.39 112.298 -178.326 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -98.45 -164.91 1.18 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.264 2.226 . . . . 2.58 106.465 -169.655 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.264 44.8 mttp -72.25 141.21 48.94 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.641 -2.537 . . . . 2.58 110.867 173.826 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.254 31.9 mt-10 74.32 15.48 3.53 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 125.956 2.035 . . . . 1.71 112.872 172.192 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.32 50.1 m -84.16 145.79 28.2 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.162 -3.461 . . . . 1.34 110.819 -172.165 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.0 m -97.35 118.9 34.86 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.161 2.184 . . . . 1.36 106.14 -175.552 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.3 mp -107.06 145.51 32.31 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.225 2.61 . . . . 2.03 111.854 171.902 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -119.36 139.28 52.23 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.455 -2.054 . . . . 2.31 105.455 -174.989 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tt -107.67 124.48 50.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 113.82 -1.536 . . . . 1.72 107.979 -173.948 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.2 t -116.68 132.53 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 CA-C-O 129.171 4.32 . . . . 1.8 105.035 174.345 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.4 mt -94.08 134.62 36.31 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 116.633 -3.792 . . . . 3.26 108.994 175.746 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -110.52 116.28 31.11 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 128.305 3.907 . . . . 4.12 113.097 174.539 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.5 mt -81.9 100.08 9.43 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.892 -2.38 . . . . 3.54 111.466 163.942 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -71.68 -48.8 45.06 Favored 'General case' 0 N--CA 1.431 -1.41 1 CA-C-O 128.515 4.007 . . . . 7.32 110.764 167.267 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -131.53 -78.62 0.17 Allowed Glycine 0 N--CA 1.431 -1.677 1 O-C-N 116.166 -4.084 . . . . 3.73 106.226 -174.694 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.753 0 CA-C-O 114.552 -3.36 . . . . 3.87 105.87 178.44 . . . . . . . . 0 0 . 1 . 056 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 CA--C 1.49 -1.327 0 CA-C-O 122.367 1.08 . . . . 1.39 110.552 . . . . . . . . . 0 0 . 1 . 056 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -111.65 136.91 50.23 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 117.477 -1.249 . . . . 2.2 109.831 -169.467 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.6 pt -135.56 159.39 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 122.489 2.404 . . . . 1.32 105.806 171.526 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -109.49 145.1 36.81 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.372 2.269 . . . . 2.2 107.781 -173.616 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.3 t -124.64 132.53 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.206 -1.776 . . . . 1.23 106.206 168.613 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 mmtm -97.09 143.59 27.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 104.975 -2.231 . . . . 2.51 104.975 169.472 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.7 p -90.36 -165.04 1.26 Allowed 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 130.272 3.429 . . . . 1.41 111.192 176.128 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.353 0.6 OUTLIER -64.63 -46.98 80.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 130.298 3.439 . . . . 2.95 113.042 175.992 . . . . . . . . 3 3 . 1 . 056 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.3 p -92.84 -37.34 12.35 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 126.381 2.991 . . . . 2.52 115.634 -178.6 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.05 -2.52 1.01 Allowed Glycine 0 N--CA 1.43 -1.721 0 O-C-N 116.301 -3.999 . . . . 1.5 117.701 178.215 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -74.92 120.97 21.19 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 122.7 3.25 . . . . 1.79 105.022 -166.905 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.7 m -71.17 117.23 12.42 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 126.56 2.413 . . . . 1.38 113.91 176.591 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.3 mm -98.84 138.68 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 117.08 -1.848 . . . . 2.03 107.78 173.522 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.4 m -106.3 112.81 25.99 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.702 2.001 . . . . 1.61 111.911 179.692 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.7 mt -108.57 144.26 36.5 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 116.177 -4.077 . . . . 2.15 115.268 175.141 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -90.85 123.71 34.6 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.172 1.789 . . . . 1.98 107.85 166.858 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 m -138.53 154.0 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 121.605 0.717 . . . . 1.52 109.639 -179.165 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -101.55 162.36 20.69 Favored Pre-proline 0 N--CA 1.429 -1.489 0 CA-C-O 115.597 -2.144 . . . . 2.35 109.603 167.365 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -81.7 -8.05 12.43 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 125.846 3.124 . . . . 1.31 112.089 178.694 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 p -81.13 -15.68 55.18 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.613 -0.721 . . . . 1.71 111.902 176.165 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -61.77 143.71 55.85 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 124.964 2.316 . . . . 1.69 115.376 178.933 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.0 p -90.58 165.25 13.86 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 115.759 -4.338 . . . . 1.33 108.664 178.5 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.5 mm -71.98 -22.03 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-O 122.76 1.266 . . . . 1.32 109.961 -178.933 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -61.48 -35.36 77.44 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.075 -2.891 . . . . 1.62 118.07 160.681 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -76.53 -30.87 57.33 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 116.83 -3.669 . . . . 2.13 111.697 172.634 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.98 -41.92 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 O-C-N 120.156 -1.59 . . . . 1.23 111.809 179.982 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -61.35 -41.3 96.82 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.118 -2.239 . . . . 1.97 111.783 176.888 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.71 -39.6 81.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 126.538 2.399 . . . . 1.19 111.731 178.871 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.265 51.8 mttm -57.82 -53.94 52.48 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.102 -2.248 . . . . 1.92 110.333 173.465 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.253 64.8 mt -52.15 -41.4 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 130.122 3.369 . . . . 1.94 109.241 178.309 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -66.52 -50.82 61.93 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 130.261 3.424 . . . . 1.9 111.372 174.975 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -49.28 -45.54 45.17 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 124.13 3.15 . . . . 1.55 114.009 169.423 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -75.46 -66.56 0.76 Allowed 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 127.607 2.363 . . . . 2.95 114.137 -177.52 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -96.47 -18.46 19.84 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 117.508 2.41 . . . . 1.48 117.508 -173.042 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.51 46.84 5.36 Favored Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 118.696 2.238 . . . . 1.12 118.696 -177.731 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.46 HD11 HD22 ' A' ' 69' ' ' LEU . 55.8 mt -119.14 129.09 25.58 Favored Pre-proline 0 N--CA 1.43 -1.465 0 CA-C-O 111.704 -3.998 . . . . 2.07 106.376 -174.14 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -64.1 152.14 82.34 Favored 'Trans proline' 0 N--CA 1.433 -2.059 0 CA-C-O 112.132 -3.362 . . . . 1.39 119.896 172.122 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -81.4 -23.53 5.01 Favored 'Trans proline' 0 N--CA 1.433 -2.046 0 CA-C-N 127.253 3.626 . . . . 1.68 112.466 -166.484 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -56.43 -31.67 64.15 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.448 2.699 . . . . 2.25 110.663 175.126 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -93.52 6.97 46.44 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 111.184 -2.735 . . . . 2.44 108.44 -170.09 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -122.11 126.67 48.88 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 122.536 2.426 . . . . 1.32 109.4 -174.285 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -109.47 150.27 28.36 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 116.856 -1.545 . . . . 3.19 110.117 158.975 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.4 mt -125.8 136.06 52.7 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 107.468 -1.308 . . . . 1.75 107.468 176.295 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.9 mm -112.43 124.44 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 128.054 2.541 . . . . 1.98 111.397 -178.787 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -114.31 128.09 56.18 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 122.517 2.417 . . . . 1.94 108.901 168.673 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.66 -85.06 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.56 1.544 . . . . 1.67 110.125 -171.574 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -164.19 43.55 0.31 Allowed Glycine 0 N--CA 1.429 -1.78 0 O-C-N 121.091 -1.006 . . . . 1.3 111.929 178.079 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -135.26 135.83 41.2 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.16 2.184 . . . . 2.89 110.253 -179.768 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -89.32 116.08 27.27 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 114.505 1.298 . . . . 2.89 114.505 175.886 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.5 mt -67.88 160.51 28.3 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.981 2.324 . . . . 1.34 113.308 -168.447 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -103.98 135.11 46.11 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.863 -2.426 . . . . 1.94 109.868 172.519 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.261 2.9 m-20 -56.17 -49.38 74.16 Favored 'General case' 0 N--CA 1.43 -1.439 1 C-N-CA 132.311 4.244 . . . . 1.56 113.528 -172.913 . . . . . . . . 3 2 . 1 . 056 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.2 50.63 2.76 Favored Glycine 0 N--CA 1.43 -1.767 0 N-CA-C 119.689 2.636 . . . . 0.97 119.689 171.226 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -124.03 164.1 20.06 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.233 1.968 . . . . 3.07 106.136 163.062 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.6 p -106.12 164.01 12.33 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.211 -2.268 . . . . 1.34 113.859 175.117 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.4 mt -50.08 -37.52 34.13 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.712 -3.742 . . . . 1.63 114.518 168.566 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -64.25 -26.33 68.45 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.257 2.317 . . . . 1.51 117.257 176.703 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -70.15 -51.4 31.62 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.387 1.475 . . . . 1.9 108.036 177.805 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -76.89 2.7 13.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.057 2.143 . . . . 0.97 113.05 179.753 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.508 1.1 m-80 60.42 39.62 18.28 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.334 1.646 . . . . 2.35 114.096 179.778 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.4 mt -90.85 118.87 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 126.054 2.835 . . . . 1.39 113.241 -177.267 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -101.5 -167.37 1.41 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.159 -3.463 . . . . 2.58 113.8 -177.068 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.256 13.7 ptmt -58.5 153.97 14.95 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.851 -2.405 . . . . 2.58 116.329 174.759 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 49.0 42.49 20.87 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 129.745 3.218 . . . . 1.71 113.741 173.149 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.6 m -92.47 142.72 27.1 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 130.749 3.619 . . . . 1.34 105.535 -179.095 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.2 m -104.73 117.41 34.02 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.142 -2.17 . . . . 1.36 105.142 -175.012 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -98.34 162.91 12.93 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 131.521 3.928 . . . . 2.03 110.045 171.05 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -123.08 126.36 46.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.083 -3.511 . . . . 2.31 111.472 -178.939 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.46 HD22 HD11 ' A' ' 36' ' ' ILE . 52.4 tp -95.9 113.92 25.59 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 107.07 -1.455 . . . . 1.72 107.07 -176.415 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.0 t -104.58 143.66 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 101.197 -3.631 . . . . 1.8 101.197 176.526 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.4 mt -106.88 135.42 48.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 113.181 -3.408 . . . . 3.26 110.927 -179.925 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -102.65 130.47 49.56 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.644 -1.285 . . . . 4.12 108.309 -179.176 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.264 0.7 OUTLIER -70.46 176.5 4.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.098 2.559 . . . . 3.54 117.737 166.24 . . . . . . . . 3 3 . 1 . 056 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -96.49 102.61 14.42 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.02 -2.925 . . . . 7.32 112.499 175.414 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.85 45.17 0.31 Allowed Glycine 0 N--CA 1.429 -1.778 0 O-C-N 118.659 -2.526 . . . . 3.73 111.045 -175.867 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.718 0 N-CA-C 107.673 -2.171 . . . . 3.87 107.673 169.961 . . . . . . . . 0 0 . 1 . 057 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 116.883 -1.532 . . . . 1.39 111.724 . . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -97.17 140.67 31.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 127.273 3.416 . . . . 2.2 109.416 -174.66 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.0 pt -123.44 160.73 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 124.814 2.245 . . . . 1.32 110.996 171.323 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -108.91 143.08 38.62 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.234 -4.041 . . . . 2.2 111.419 -179.265 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.8 t -110.91 123.79 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.243 -3.411 . . . . 1.23 108.043 174.199 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 11' ' ' LYS . 73.9 tttt -119.45 138.89 52.83 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.033 1.397 . . . . 2.51 108.563 -178.618 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.0 p -103.69 168.98 8.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.438 -1.414 . . . . 1.41 108.176 -178.067 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.2 tp -66.34 -42.46 88.11 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.955 1.302 . . . . 2.95 112.285 172.464 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.6 p -76.89 -18.52 58.27 Favored 'General case' 0 N--CA 1.43 -1.463 1 CA-C-O 128.968 4.223 . . . . 2.52 110.064 -171.35 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.15 26.95 1.28 Allowed Glycine 0 N--CA 1.43 -1.727 1 O-C-N 116.004 -4.185 . . . . 1.5 118.002 166.285 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 63.4 tttt -91.98 133.87 35.32 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 117.258 -1.353 . . . . 1.79 110.241 -179.814 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m -122.43 105.94 10.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 125.627 1.83 . . . . 1.38 115.762 168.966 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 pt -114.79 164.92 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 125.92 2.771 . . . . 2.03 105.191 179.778 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.7 m -112.37 135.18 53.37 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.875 -3.015 . . . . 1.61 112.544 -178.37 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.8 mt -115.78 154.74 29.09 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.888 -1.758 . . . . 2.15 109.887 172.393 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -112.73 120.52 41.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.333 -1.48 . . . . 1.98 110.864 167.273 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.4 m -125.28 175.11 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 124.354 2.026 . . . . 1.52 108.427 178.508 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -114.29 171.96 3.98 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 104.7 -2.333 . . . . 2.35 104.7 164.075 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -83.38 -9.51 10.29 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 N-CA-C 107.174 -1.895 . . . . 1.31 107.174 -176.314 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.4 m -95.82 6.35 49.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.608 1.963 . . . . 1.71 115.415 173.48 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -77.09 153.8 33.96 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 104.727 -2.323 . . . . 1.69 104.727 170.296 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.5 p -86.95 162.1 17.87 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 116.158 -4.089 . . . . 1.33 110.218 168.904 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.306 23.1 mm -65.97 -38.89 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 118.159 -2.838 . . . . 1.32 111.31 179.17 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -50.79 -38.12 46.38 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 127.182 3.373 . . . . 1.62 117.597 166.941 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -75.07 -26.38 59.31 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.519 3.128 . . . . 2.13 110.915 172.792 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.38 -34.33 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 123.334 2.788 . . . . 1.23 109.547 170.831 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -70.49 -36.52 73.88 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.528 -1.983 . . . . 1.97 113.838 175.982 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.84 76.91 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 115.724 1.75 . . . . 1.19 115.724 173.278 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -58.26 -37.36 74.8 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.981 2.113 . . . . 1.92 111.964 175.018 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.3 mt -75.94 -29.12 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 1 O-C-N 115.676 -4.39 . . . . 1.94 110.357 174.717 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -69.05 -42.3 76.46 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 116.797 -3.689 . . . . 1.9 115.155 168.885 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.337 23.2 t70 -55.03 -49.18 72.2 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.238 -2.164 . . . . 1.55 112.396 168.811 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -70.49 -69.04 0.38 Allowed 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.011 -1.681 . . . . 2.95 113.753 -177.388 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -91.44 -48.71 6.73 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 112.287 -2.233 . . . . 1.48 110.187 -167.387 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.1 32.63 3.21 Favored Glycine 0 N--CA 1.429 -1.773 0 CA-C-O 125.183 2.546 . . . . 1.12 114.837 -179.037 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.8 mt -92.65 129.22 41.14 Favored Pre-proline 0 N--CA 1.43 -1.444 0 N-CA-C 102.49 -3.152 . . . . 2.07 102.49 -177.222 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -76.74 139.37 19.86 Favored 'Trans proline' 0 N--CA 1.433 -2.053 0 CA-C-O 114.156 -2.518 . . . . 1.39 112.737 -178.954 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -68.57 0.04 5.31 Favored 'Trans proline' 0 N--CA 1.433 -2.058 1 C-N-CA 125.624 4.216 . . . . 1.68 112.014 -169.501 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -64.92 -42.81 94.4 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.806 1.289 . . . . 2.25 113.097 166.36 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -75.49 -27.07 58.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.132 2.396 . . . . 2.44 111.034 -176.243 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -81.88 122.26 27.51 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 119.995 3.331 . . . . 1.32 119.995 -169.088 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -116.41 136.68 52.78 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 131.242 3.817 . . . . 3.19 108.976 170.453 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.9 mt -120.13 113.58 20.68 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.425 -4.547 . . . . 1.75 113.513 178.392 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.1 mm -102.19 143.01 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 126.889 3.233 . . . . 1.98 105.765 173.425 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.416 ' HB3' HD23 ' A' ' 50' ' ' LEU . 59.1 t80 -132.66 125.3 30.02 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 115.3 -4.625 . . . . 1.94 110.111 162.866 . . . . . . . . 3 3 . 1 . 057 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.43 ' HB1' ' H ' ' A' ' 47' ' ' GLY . . . 61.63 -95.15 0.05 OUTLIER 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 124.171 1.938 . . . . 1.67 112.615 -172.428 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.43 ' H ' ' HB1' ' A' ' 46' ' ' ALA . . . -138.74 20.16 3.1 Favored Glycine 0 N--CA 1.43 -1.757 0 O-C-N 119.208 -2.182 . . . . 1.3 111.3 176.352 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -111.85 135.35 52.59 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 128.675 2.79 . . . . 2.89 109.887 175.752 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -86.76 101.01 12.91 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 129.667 3.187 . . . . 2.89 109.591 168.921 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.416 HD23 ' HB3' ' A' ' 45' ' ' PHE . 21.1 mt -72.11 122.08 20.36 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.397 2.679 . . . . 1.34 112.781 -169.194 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -75.11 133.55 41.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 116.414 2.005 . . . . 1.94 116.414 174.786 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -45.52 -55.1 6.59 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 131.252 3.821 . . . . 1.56 116.298 -174.484 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.68 9.61 58.73 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 118.171 2.028 . . . . 0.97 118.171 173.491 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -91.58 165.51 13.3 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 121.836 2.818 . . . . 3.07 109.496 164.712 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.268 30.3 p -94.02 177.64 5.91 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.785 -1.197 . . . . 1.34 113.059 178.411 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mt -75.03 -27.95 60.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.65 2.643 . . . . 1.63 115.289 171.635 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.4 t -68.07 -39.94 82.83 Favored 'General case' 0 N--CA 1.429 -1.481 1 C-N-CA 132.575 4.35 . . . . 1.51 117.13 175.588 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.288 2.5 m-20 -55.52 -46.91 76.96 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.741 2.816 . . . . 1.9 109.567 175.955 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -83.34 -1.07 52.43 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 126.549 1.94 . . . . 0.97 116.105 176.155 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 63.26 47.34 4.09 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 128.877 2.871 . . . . 2.35 112.36 175.503 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.8 mt -85.52 130.25 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 127.676 2.39 . . . . 1.39 110.799 178.762 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -115.84 175.37 5.57 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 116.267 -4.021 . . . . 2.58 112.061 -173.632 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -50.38 146.65 5.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.899 -2.376 . . . . 2.58 114.423 169.116 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 63.43 23.02 13.52 Favored 'General case' 0 N--CA 1.43 -1.461 2 C-N-CA 132.773 4.429 . . . . 1.71 111.757 176.927 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -91.15 155.21 18.79 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 116.927 -3.608 . . . . 1.34 107.034 -178.588 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.4 m -103.41 116.12 31.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.123 -1.399 . . . . 1.36 112.062 -177.753 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -97.11 136.15 38.06 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 102.65 -3.093 . . . . 2.03 102.65 172.848 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -101.72 101.82 12.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.521 1.928 . . . . 2.31 110.377 -175.233 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.1 tp -80.18 124.85 29.15 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 125.93 2.019 . . . . 1.72 110.323 -179.242 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.9 t -126.58 124.14 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.183 -1.826 . . . . 1.8 107.249 -169.471 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.3 mt -100.85 133.8 44.79 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 117.943 -1.503 . . . . 3.26 114.709 -177.484 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -82.1 79.38 8.61 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.786 2.434 . . . . 4.12 111.959 175.208 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.7 mt -94.71 -50.34 5.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 114.88 -2.486 . . . . 3.54 111.004 167.733 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.266 21.3 ttt180 -92.42 -86.44 0.24 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 125.796 1.935 . . . . 7.32 108.458 171.543 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.77 80.51 0.85 Allowed Glycine 0 N--CA 1.43 -1.755 0 O-C-N 118.861 -2.399 . . . . 3.73 114.699 -173.101 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.802 0 CA-C-O 114.001 -3.666 . . . . 3.87 107.999 174.108 . . . . . . . . 0 0 . 1 . 058 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 123.649 1.69 . . . . 1.39 110.639 . . . . . . . . . 0 0 . 1 . 058 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -85.19 121.68 28.29 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.05 -2.906 . . . . 2.2 109.691 -176.817 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -118.83 171.59 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 125.392 2.52 . . . . 1.32 107.848 168.272 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -129.42 129.68 45.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 111.706 -2.497 . . . . 2.2 111.808 179.938 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.6 t -110.94 115.96 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 113.254 -1.794 . . . . 1.23 107.113 169.497 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -97.19 140.98 30.87 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 125.125 2.393 . . . . 2.51 107.786 175.464 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.0 p -82.17 178.64 8.16 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.973 -1.704 . . . . 1.41 114.494 179.796 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.2 tp -54.33 -47.0 73.01 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 116.169 -4.082 . . . . 2.95 112.423 167.556 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 p -71.65 -26.89 62.73 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.729 -3.732 . . . . 2.52 111.374 -178.424 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.1 26.93 6.09 Favored Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 126.491 1.996 . . . . 1.5 112.033 -178.02 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -83.19 128.38 34.44 Favored 'General case' 0 N--CA 1.43 -1.474 2 O-C-N 116.287 -4.067 . . . . 1.79 108.386 176.441 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -99.02 113.29 25.4 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 128.333 3.921 . . . . 1.38 109.979 -176.377 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mt -91.95 126.71 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 111.11 -2.768 . . . . 2.03 108.996 176.111 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.6 t -98.89 143.31 29.34 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 119.95 1.25 . . . . 1.61 111.174 172.958 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.9 mt -136.97 158.1 45.24 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.587 2.755 . . . . 2.15 108.592 -177.828 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -111.33 121.1 44.36 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.479 -1.388 . . . . 1.98 107.819 166.057 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.03 159.32 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 126.491 3.043 . . . . 1.52 106.488 -172.724 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -112.01 149.17 40.47 Favored Pre-proline 0 N--CA 1.43 -1.475 1 O-C-N 116.067 -4.145 . . . . 2.35 108.186 165.239 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -72.31 -9.42 24.28 Favored 'Trans proline' 0 C--N 1.299 -2.031 2 O-C-N 112.925 -4.303 . . . . 1.31 115.671 -173.526 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.7 p -89.03 2.98 53.2 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 111.656 -2.52 . . . . 1.71 111.364 177.795 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -78.3 157.95 29.03 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.65 2.092 . . . . 1.69 116.65 172.864 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -95.87 160.12 14.63 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.015 2.816 . . . . 1.33 110.184 169.844 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 mm -54.83 -32.03 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 117.447 -3.283 . . . . 1.32 115.561 166.385 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -51.29 -59.86 3.75 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 116.692 2.108 . . . . 1.62 116.692 160.901 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -54.26 -37.44 64.7 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 117.768 2.507 . . . . 2.13 117.768 174.476 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.4 t -56.54 -42.34 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 126.86 2.064 . . . . 1.23 115.1 167.46 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -68.82 -24.2 64.35 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 115.577 1.695 . . . . 1.97 115.577 174.915 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.34 83.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 116.795 -1.574 . . . . 1.19 112.901 166.349 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -68.23 -35.45 77.96 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 128.726 3.766 . . . . 1.92 115.999 -179.573 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.2 mt -79.98 -32.25 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 C-N-CA 128.634 2.773 . . . . 1.94 113.535 170.931 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -62.96 -51.53 66.53 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 115.781 -4.324 . . . . 1.9 114.058 167.155 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -52.18 -43.85 64.36 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.34 1.978 . . . . 1.55 116.34 169.145 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -84.83 -63.82 1.27 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.066 -1.646 . . . . 2.95 113.944 -177.898 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -96.62 -39.19 9.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.752 2.215 . . . . 1.48 115.86 -174.151 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.61 44.92 2.4 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 116.79 -3.694 . . . . 1.12 113.626 169.604 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.7 mt -103.95 130.84 22.67 Favored Pre-proline 0 N--CA 1.43 -1.451 1 N-CA-C 99.775 -4.157 . . . . 2.07 99.775 -174.489 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -54.16 135.15 63.54 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-O 112.205 -3.331 . . . . 1.39 116.058 -179.571 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.64 -26.12 63.33 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 CA-C-N 127.052 3.554 . . . . 1.68 119.863 -178.988 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -68.67 -37.29 79.5 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.378 -1.283 . . . . 2.25 113.727 177.634 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -73.1 -27.48 61.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.609 -3.182 . . . . 2.44 115.105 178.307 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -68.49 129.49 40.08 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.377 3.473 . . . . 1.32 120.377 177.526 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -127.92 114.99 17.87 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.66 1.984 . . . . 3.19 111.715 168.9 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.71 130.16 34.59 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 125.881 1.988 . . . . 1.75 108.248 176.949 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.1 mm -127.41 123.3 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 125.985 2.053 . . . . 1.98 108.131 177.101 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -123.3 124.06 42.14 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.648 1.69 . . . . 1.94 108.945 171.948 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.89 -92.85 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.503 2.721 . . . . 1.67 116.05 -172.886 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.31 -38.18 1.68 Allowed Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 126.462 1.982 . . . . 1.3 113.505 -177.854 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -82.39 146.83 29.13 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 129.897 3.279 . . . . 2.89 116.039 -172.304 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -92.49 141.09 28.89 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 118.966 -2.334 . . . . 2.89 108.953 171.801 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.7 mt -98.4 128.43 44.78 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 104.418 -2.438 . . . . 1.34 104.418 -168.922 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.55 140.63 32.14 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.672 2.389 . . . . 1.94 112.936 173.396 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -56.57 -54.44 45.88 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.34 3.089 . . . . 1.56 119.34 -172.179 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.02 8.44 63.33 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 115.278 -2.957 . . . . 0.97 117.505 175.106 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -78.88 158.21 28.14 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 122.732 3.266 . . . . 3.07 115.124 163.041 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.7 p -89.4 156.59 18.58 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 122.758 2.526 . . . . 1.34 113.351 173.141 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.0 mt -53.8 -36.86 62.92 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.104 -0.953 . . . . 1.63 111.675 166.361 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -54.19 -48.05 71.39 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.232 -2.168 . . . . 1.51 113.863 -178.841 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -45.69 -43.93 13.07 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 119.984 3.327 . . . . 1.9 119.984 171.786 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -96.75 3.54 52.29 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.203 2.601 . . . . 0.97 111.176 178.944 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.4 m120 54.88 47.29 22.6 Favored 'General case' 0 N--CA 1.431 -1.384 0 O-C-N 119.32 -2.113 . . . . 2.35 112.862 -176.092 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.3 mt -80.5 117.5 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 122.184 2.265 . . . . 1.39 110.274 177.481 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -110.32 176.86 4.89 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 120.13 1.332 . . . . 2.58 108.423 -168.43 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.377 45.5 pttt -54.27 128.46 31.4 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 131.555 3.942 . . . . 2.58 115.172 174.191 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 64.17 48.18 3.02 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 128.021 2.528 . . . . 1.71 109.269 175.758 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.2 p -92.12 173.45 7.83 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.806 -3.059 . . . . 1.34 113.35 178.117 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.1 m -120.88 114.86 22.18 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.281 -2.137 . . . . 1.36 112.317 173.201 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -105.11 155.1 19.32 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.062 1.745 . . . . 2.03 108.522 175.575 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -118.42 130.64 56.09 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 126.543 2.402 . . . . 2.31 105.179 -174.763 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.2 tp -99.38 117.77 34.53 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.411 1.084 . . . . 1.72 112.981 175.524 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.8 t -102.97 129.85 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-O 123.896 1.808 . . . . 1.8 109.134 172.6 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.4 mt -105.6 105.4 15.43 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.939 -2.976 . . . . 3.26 108.522 178.087 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -77.98 127.48 32.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.179 1.392 . . . . 4.12 108.242 172.788 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.1 mt -81.69 145.25 30.63 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.616 -0.678 . . . . 3.54 110.375 170.89 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -117.8 -60.84 1.76 Allowed 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 104.57 -2.381 . . . . 7.32 104.57 175.702 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.09 -58.47 0.56 Allowed Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 127.689 2.566 . . . . 3.73 111.791 -162.36 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.742 1 N-CA-C 102.133 -4.387 . . . . 3.87 102.133 179.941 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 CA--C 1.491 -1.319 0 CA-C-O 122.992 1.377 . . . . 1.39 113.882 . . . . . . . . . 0 0 . 1 . 059 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -85.9 135.18 33.79 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.21 1.804 . . . . 2.2 110.175 -174.565 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 pt -135.97 161.01 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 120.003 -1.686 . . . . 1.32 111.815 174.199 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -118.04 141.43 48.47 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.161 -2.212 . . . . 2.2 107.819 -179.268 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 t -116.88 130.11 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 126.064 2.102 . . . . 1.23 107.185 173.566 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -115.06 123.44 49.02 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.133 -3.479 . . . . 2.51 113.722 179.02 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.3 p -68.0 171.22 7.08 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 124.522 2.106 . . . . 1.41 112.038 178.161 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 tp -71.77 -27.37 62.91 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 117.912 -2.993 . . . . 2.95 110.403 174.622 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 p -73.6 -30.32 62.92 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.758 -3.714 . . . . 2.52 106.46 178.546 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.26 -21.22 2.96 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 125.289 3.677 . . . . 1.5 113.041 -179.433 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -57.11 117.41 4.0 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 126.874 2.07 . . . . 1.79 114.185 -177.159 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.8 m -107.64 114.82 29.06 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.169 -1.789 . . . . 1.38 106.169 -179.798 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.9 pt -104.61 161.64 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 125.839 1.962 . . . . 2.03 105.883 -178.162 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -117.24 121.13 40.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.711 2.004 . . . . 1.61 108.861 -174.48 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.6 mt -122.99 164.42 18.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 126.289 2.947 . . . . 2.15 110.974 -177.657 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -129.0 132.4 47.52 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 116.406 -3.934 . . . . 1.98 110.884 174.828 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.7 m -137.59 -175.45 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-O 128.377 3.942 . . . . 1.52 112.047 -179.818 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -122.88 147.32 50.83 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-N 112.157 -2.292 . . . . 2.35 110.572 166.084 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -65.6 -20.09 60.07 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 O-C-N 114.036 -3.718 . . . . 1.31 115.276 -178.783 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.6 p -70.64 -21.92 62.57 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 117.45 -3.281 . . . . 1.71 112.154 177.862 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -62.86 146.7 52.16 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.994 2.961 . . . . 1.69 118.994 178.395 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.8 p -85.58 151.64 23.76 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 124.895 1.278 . . . . 1.33 108.191 177.358 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.2 mm -54.0 -41.34 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 129.225 3.01 . . . . 1.32 113.063 -179.884 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -44.56 -53.17 7.36 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 118.612 2.819 . . . . 1.62 118.612 161.777 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -50.8 -32.15 19.15 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 126.537 1.935 . . . . 2.13 113.693 174.096 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.9 t -77.44 -42.7 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 107.243 -1.391 . . . . 1.23 107.243 -177.305 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' HA ' HD12 ' A' ' 30' ' ' ILE . 40.8 mtmt -60.16 -42.3 94.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 120.393 1.451 . . . . 1.97 112.79 174.744 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.85 -20.53 65.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.594 1.558 . . . . 1.19 110.227 177.915 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -80.11 -40.79 26.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.969 2.319 . . . . 1.92 112.878 174.545 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 27' ' ' LYS . 33.2 mt -51.52 -42.57 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.551 -2.593 . . . . 1.94 113.65 165.68 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -54.17 -47.76 71.64 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.339 2.656 . . . . 1.9 113.613 177.559 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -56.71 -42.51 79.3 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.816 2.046 . . . . 1.55 115.058 170.884 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -74.26 -48.56 27.9 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.671 1.988 . . . . 2.95 114.654 -179.213 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -115.85 -15.09 11.3 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 123.911 1.815 . . . . 1.48 114.264 -171.061 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.17 21.67 32.1 Favored Glycine 0 N--CA 1.429 -1.789 1 O-C-N 113.848 -5.533 . . . . 1.12 113.012 171.394 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 mt -98.69 124.02 47.67 Favored Pre-proline 0 N--CA 1.431 -1.42 0 O-C-N 120.626 -1.514 . . . . 2.07 107.009 -175.328 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -67.97 152.54 76.77 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 C-N-CA 124.302 3.335 . . . . 1.39 113.779 178.043 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -82.47 -15.84 8.45 Favored 'Trans proline' 0 N--CA 1.433 -2.052 0 C-N-CA 123.704 2.936 . . . . 1.68 113.321 -163.304 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -72.7 -27.76 62.26 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 129.981 4.551 . . . . 2.25 113.889 175.333 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -82.03 -20.54 38.13 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.046 2.355 . . . . 2.44 112.522 179.132 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.276 76.8 mt-30 -97.11 145.39 26.04 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 127.805 3.669 . . . . 1.32 109.786 -171.867 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -139.18 122.58 17.18 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.101 -2.249 . . . . 3.19 113.903 172.539 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.2 mt -92.44 120.85 33.34 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.414 -1.428 . . . . 1.75 112.866 -176.299 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.5 mt -112.7 130.15 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 129.981 3.313 . . . . 1.98 107.92 -175.537 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -138.3 135.15 35.16 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.744 -1.222 . . . . 1.94 110.206 177.872 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.01 46.96 25.71 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.824 3.202 . . . . 1.67 116.675 179.592 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.17 -44.28 3.35 Favored Glycine 0 N--CA 1.43 -1.717 0 O-C-N 118.617 -2.552 . . . . 1.3 117.479 -177.147 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -86.67 159.5 19.17 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 118.89 1.345 . . . . 2.89 114.498 -176.228 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -83.54 135.01 34.8 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.411 -0.813 . . . . 2.89 109.501 174.497 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 mt -87.7 148.1 24.92 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.759 -1.2 . . . . 1.34 107.759 -179.011 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -99.69 134.54 42.44 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.26 -2.775 . . . . 1.94 110.027 -179.619 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -68.36 -25.86 65.29 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 117.692 2.478 . . . . 1.56 117.692 -167.626 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.05 14.76 64.13 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 115.617 -3.183 . . . . 0.97 117.662 169.091 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -96.84 176.51 5.95 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.991 1.377 . . . . 3.07 108.157 170.005 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.5 p -102.6 -174.72 2.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 116.328 -3.982 . . . . 1.34 117.182 177.648 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.259 60.2 mt -77.33 -38.54 50.17 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.632 -2.542 . . . . 1.63 111.255 174.301 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.1 p -72.28 -15.12 61.9 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 128.369 3.543 . . . . 1.51 118.387 179.012 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -66.09 -29.66 70.02 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.127 -1.608 . . . . 1.9 113.672 168.921 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -102.96 6.46 38.92 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 122.851 1.31 . . . . 0.97 109.83 -177.231 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.8 m120 55.45 35.41 25.01 Favored 'General case' 0 N--CA 1.431 -1.38 1 O-C-N 116.279 -4.013 . . . . 2.35 114.746 -173.507 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.9 mt -68.72 118.03 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.943 1.297 . . . . 1.39 113.475 175.073 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -115.55 -175.85 2.8 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 130.97 3.708 . . . . 2.58 112.859 -178.864 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -67.07 139.12 57.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.247 2.927 . . . . 2.58 110.894 -176.224 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.446 25.3 mt-10 85.38 9.07 0.35 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 111.439 -2.619 . . . . 1.71 116.015 176.652 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.0 m -74.23 133.43 42.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.859 -1.776 . . . . 1.34 114.371 -173.282 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.5 m -99.99 109.99 22.32 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 104.651 -2.351 . . . . 1.36 104.651 -169.595 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.19 151.47 19.44 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.274 2.23 . . . . 2.03 109.134 172.306 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -109.34 108.18 18.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 123.598 1.666 . . . . 2.31 112.228 -179.06 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.4 tp -85.08 120.38 26.52 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.516 2.103 . . . . 1.72 109.412 178.178 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.366 31.3 m -114.67 148.25 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 117.17 -3.456 . . . . 1.8 112.611 171.702 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.286 62.1 mt -109.1 132.8 53.77 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.986 2.803 . . . . 3.26 108.829 -179.076 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -137.29 73.79 1.46 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.242 -2.132 . . . . 4.12 105.242 -179.546 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 pp -84.28 162.03 20.26 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 116.635 2.087 . . . . 3.54 116.635 -178.686 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -105.75 -45.52 4.37 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 115.75 -2.072 . . . . 7.32 108.999 172.755 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.75 -98.69 0.12 Allowed Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 104.761 -3.335 . . . . 3.73 104.761 -168.248 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.751 0 O-C-N 119.459 -2.2 . . . . 3.87 113.235 177.634 . . . . . . . . 0 0 . 1 . 060 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.295 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.359 0 CA-C-O 125.099 2.381 . . . . 1.39 115.096 . . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -87.78 128.5 35.32 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.46 -3.9 . . . . 2.2 111.475 179.317 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.7 pt -126.66 172.96 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 117.07 -3.519 . . . . 1.32 106.603 169.612 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -127.17 135.65 50.99 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 123.519 0.728 . . . . 2.2 110.861 -176.864 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.2 t -117.37 117.94 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 101.342 -3.577 . . . . 1.23 101.342 176.774 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.7 tttp -101.73 148.2 25.56 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.625 -3.797 . . . . 2.51 113.54 174.84 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 p -97.28 171.59 8.33 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.542 2.591 . . . . 1.41 108.751 176.946 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.6 mt -83.47 -4.79 58.84 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.811 -2.43 . . . . 2.95 114.205 172.544 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.2 p -88.83 -30.44 18.94 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 115.723 -2.084 . . . . 2.52 105.467 178.947 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.11 -2.17 10.69 Favored Glycine 0 N--CA 1.43 -1.754 1 O-C-N 129.471 4.232 . . . . 1.5 115.89 170.941 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -72.47 140.61 48.36 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.859 -1.163 . . . . 1.79 107.859 -176.421 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.6 m -108.3 124.58 50.55 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.848 -2.649 . . . . 1.38 103.848 177.419 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.3 mm -101.55 116.81 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 119.237 -2.165 . . . . 2.03 109.769 176.209 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.2 m -92.85 120.8 33.57 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 121.351 1.887 . . . . 1.61 107.891 -179.162 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.4 mt -125.88 127.23 45.7 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.048 2.939 . . . . 2.15 110.261 -173.731 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -86.29 114.26 22.95 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 126.72 2.513 . . . . 1.98 113.075 166.409 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.1 m -129.28 167.11 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 118.044 -2.91 . . . . 1.52 109.103 -179.407 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.271 69.1 mm-40 -110.4 156.08 40.93 Favored Pre-proline 0 N--CA 1.431 -1.408 0 CA-C-O 117.839 -1.077 . . . . 2.35 108.573 164.851 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -71.08 -8.22 23.09 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 CA-C-N 123.217 2.185 . . . . 1.31 113.853 -175.175 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.1 p -81.49 -24.91 36.41 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.049 2.94 . . . . 1.71 113.284 178.535 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -66.74 154.55 40.44 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 117.687 -1.149 . . . . 1.69 111.985 178.97 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 19.0 p -87.13 175.94 7.83 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 106.303 -1.74 . . . . 1.33 106.303 -177.872 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.4 mm -73.31 -33.96 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 C-N-CA 123.889 0.876 . . . . 1.32 111.792 175.848 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -46.2 -41.14 12.35 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.678 3.191 . . . . 1.62 113.751 167.41 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -73.39 -22.13 60.33 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 115.513 -4.492 . . . . 2.13 114.205 179.275 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -74.51 -47.02 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 113.709 -1.587 . . . . 1.23 109.047 175.589 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -52.69 -27.77 18.89 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 128.419 3.574 . . . . 1.97 119.817 167.116 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.21 -37.38 57.84 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.461 -3.899 . . . . 1.19 110.781 172.54 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -70.22 -39.83 74.88 Favored 'General case' 0 N--CA 1.43 -1.444 2 O-C-N 111.372 -7.08 . . . . 1.92 110.68 177.269 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 53.5 mt -59.28 -42.29 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 1 O-C-N 115.989 -4.194 . . . . 1.94 111.05 173.038 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -65.55 -46.5 79.3 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.215 -3.428 . . . . 1.9 107.671 177.755 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -55.15 -64.99 0.66 Allowed 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.081 -4.762 . . . . 1.55 117.003 169.91 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -61.37 -57.18 13.32 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.226 -2.796 . . . . 2.95 113.215 -176.021 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -100.93 -46.1 5.22 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.957 2.903 . . . . 1.48 111.315 -165.639 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.01 22.75 5.18 Favored Glycine 0 N--CA 1.429 -1.79 0 O-C-N 116.649 -3.782 . . . . 1.12 113.781 170.61 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.9 mt -92.43 128.24 45.44 Favored Pre-proline 0 N--CA 1.432 -1.374 0 N-CA-C 101.666 -3.457 . . . . 2.07 101.666 -173.11 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -71.26 155.78 60.12 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 CA-C-O 112.67 -3.137 . . . . 1.39 114.961 175.681 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -65.61 -24.15 56.05 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 CA-C-N 124.861 2.772 . . . . 1.68 118.274 -179.163 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.83 -33.85 76.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.548 2.055 . . . . 2.25 116.548 172.866 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -83.41 -35.28 25.16 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 126.321 2.962 . . . . 2.44 112.603 -177.916 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -79.05 130.09 35.15 Favored 'General case' 0 N--CA 1.429 -1.482 1 O-C-N 115.575 -4.453 . . . . 1.32 111.816 -176.103 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -123.91 129.73 51.44 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.696 1.599 . . . . 3.19 106.686 166.776 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 mt -96.19 139.42 32.36 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 124.657 1.223 . . . . 1.75 113.595 173.692 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.469 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 60.1 mt -114.63 138.5 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.899 -3.0 . . . . 1.98 107.607 174.141 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -147.13 136.74 22.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.797 -3.064 . . . . 1.94 112.062 169.46 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.374 . . 63.53 -2.21 0.51 Allowed 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 116.677 2.103 . . . . 1.67 116.677 -178.426 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.21 -11.28 33.84 Favored Glycine 0 N--CA 1.429 -1.776 0 CA-C-O 126.648 3.36 . . . . 1.3 113.52 -173.862 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -90.23 128.98 36.53 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 117.592 -3.299 . . . . 2.89 108.795 -179.548 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -77.03 126.44 30.97 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.084 -3.51 . . . . 2.89 108.099 171.565 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.289 26.5 mt -79.17 127.96 32.7 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 118.136 2.643 . . . . 1.34 118.136 -170.519 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -83.43 149.49 26.64 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.584 2.068 . . . . 1.94 116.584 174.441 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.76 -36.11 72.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.142 2.577 . . . . 1.56 114.15 -171.782 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.46 10.59 68.81 Favored Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 114.572 -3.68 . . . . 0.97 119.141 171.233 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -80.06 154.3 28.21 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 126.594 1.996 . . . . 3.07 113.225 170.701 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 32.5 p -82.77 164.32 20.7 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 124.886 2.279 . . . . 1.34 111.098 167.902 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mt -75.43 -29.04 59.59 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 116.791 -3.693 . . . . 1.63 112.481 173.098 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 p -62.92 -40.6 98.1 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.39 -2.069 . . . . 1.51 112.491 173.9 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.278 2.0 t70 -53.62 -40.87 66.11 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 118.535 2.791 . . . . 1.9 118.535 172.833 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -79.66 -9.07 59.58 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 126.009 2.068 . . . . 0.97 116.077 172.184 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.4 m120 70.8 65.82 0.18 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 130.1 3.36 . . . . 2.35 108.557 -177.521 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.5 mt -108.78 124.18 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 O-C-N 117.068 -3.52 . . . . 1.39 111.009 -178.145 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -107.42 -173.83 2.38 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.53 1.532 . . . . 2.58 115.032 -178.045 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -70.87 145.83 49.99 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 119.086 -2.259 . . . . 2.58 113.006 176.709 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.35 31.7 mt-10 78.4 15.05 1.33 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.297 2.639 . . . . 1.71 112.333 165.847 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.5 m -86.61 146.0 26.51 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.314 -2.221 . . . . 1.34 110.265 -169.42 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.7 m -93.79 110.41 22.06 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.547 1.976 . . . . 1.36 116.007 179.406 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -87.29 151.52 23.06 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.497 -2.002 . . . . 2.03 110.184 172.511 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.469 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 39.7 m80 -109.57 100.8 9.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.785 -1.822 . . . . 2.31 114.62 -179.562 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.259 36.0 tp -84.96 115.73 22.97 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.386 -2.071 . . . . 1.72 108.489 -173.122 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 m -107.74 153.16 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 126.238 1.815 . . . . 1.8 110.792 174.817 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.1 mt -122.21 144.56 48.89 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.802 -2.436 . . . . 3.26 107.788 179.281 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.64 88.56 3.86 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 127.935 3.272 . . . . 4.12 109.068 179.747 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.6 mt -119.17 -91.27 0.56 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.999 1.32 . . . . 3.54 112.127 -177.915 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 -141.24 144.84 34.93 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.39 -1.444 . . . . 7.32 108.224 -178.674 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.17 -114.9 5.1 Favored Glycine 0 N--CA 1.429 -1.771 0 O-C-N 118.352 -2.718 . . . . 3.73 108.654 -169.828 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.754 0 CA-C-O 115.225 -2.986 . . . . 3.87 114.614 -168.994 . . . . . . . . 0 0 . 1 . 061 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 ptt? . . . . . 0 CA--C 1.491 -1.294 0 N-CA-C 115.138 1.533 . . . . 1.39 115.138 . . . . . . . . . 0 0 . 1 . 061 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -87.45 135.12 33.46 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 124.835 1.334 . . . . 2.2 110.435 179.439 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -126.66 138.39 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 105.894 -1.891 . . . . 1.32 105.894 175.073 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -104.19 77.03 1.38 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.791 -1.095 . . . . 2.2 108.91 -176.105 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 t -63.42 105.29 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 116.213 1.931 . . . . 1.23 116.213 168.95 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.257 35.7 tptt -90.46 139.8 30.33 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 124.151 1.929 . . . . 2.51 112.652 179.095 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.3 p -91.17 -179.39 5.42 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.556 -1.965 . . . . 1.41 108.513 179.544 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.4 tp -66.23 -50.88 62.28 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 123.218 1.485 . . . . 2.95 113.903 179.997 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 p -74.69 -22.07 59.06 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.113 1.523 . . . . 2.52 115.113 -172.577 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.05 -2.53 2.96 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 117.679 -2.201 . . . . 1.5 114.817 172.49 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -78.86 131.09 36.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.165 -2.962 . . . . 1.79 112.146 -175.18 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.271 85.8 m -98.83 118.1 34.82 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.147 -2.221 . . . . 1.38 108.97 175.452 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.1 mm -102.39 118.68 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 125.175 1.547 . . . . 2.03 110.201 179.698 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.2 m -81.02 98.33 7.91 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.447 -1.251 . . . . 1.61 110.549 174.862 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.3 tp -100.69 158.08 16.21 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.016 -2.303 . . . . 2.15 110.118 -176.394 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -121.55 118.74 30.03 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.284 -1.006 . . . . 1.98 108.284 174.956 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 m -135.58 176.67 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 107.619 -1.252 . . . . 1.52 107.619 -177.581 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -124.25 166.7 18.2 Favored Pre-proline 0 N--CA 1.429 -1.482 0 O-C-N 118.547 -2.596 . . . . 2.35 109.644 170.275 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.359 14.5 Cg_endo -75.68 -16.27 18.83 Favored 'Trans proline' 0 C--N 1.299 -2.075 0 O-C-N 114.7 -3.368 . . . . 1.31 114.502 -175.99 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.9 p -90.87 2.57 56.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.206 -2.184 . . . . 1.71 107.334 -178.804 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -80.51 142.59 34.04 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.923 -1.736 . . . . 1.69 113.544 179.433 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.6 p -85.71 164.71 17.47 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 117.029 2.233 . . . . 1.33 117.029 177.783 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.9 mm -76.48 -31.06 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 101.738 -3.43 . . . . 1.32 101.738 -172.979 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -49.76 -47.01 51.21 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 115.641 1.719 . . . . 1.62 115.641 167.298 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -76.72 -30.82 56.81 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 115.87 -2.014 . . . . 2.13 112.533 177.328 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.31 -29.7 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 121.592 1.996 . . . . 1.23 114.463 177.551 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -74.55 -35.39 63.08 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 117.607 -1.187 . . . . 1.97 109.213 171.232 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -36.93 83.99 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 123.389 2.813 . . . . 1.19 112.619 171.007 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.6 mttm -63.94 -47.38 80.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 126.842 2.589 . . . . 1.92 114.804 170.364 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.9 mt -61.48 -36.38 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 1 O-C-N 114.462 -5.149 . . . . 1.94 109.756 171.066 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -57.52 -54.27 48.71 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 117.14 -3.475 . . . . 1.9 113.152 172.734 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -52.75 -44.64 66.61 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.767 -1.208 . . . . 1.55 111.98 171.92 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -65.18 -57.41 8.6 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 127.612 2.365 . . . . 2.95 110.464 -173.369 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -105.75 -47.64 3.84 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 118.128 -2.857 . . . . 1.48 115.705 -169.611 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.42 4.63 8.96 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 119.547 -1.971 . . . . 1.12 114.17 -176.445 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.9 mt -83.5 127.37 68.48 Favored Pre-proline 0 N--CA 1.43 -1.462 0 O-C-N 119.026 -2.455 . . . . 2.07 110.478 -176.108 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -73.35 146.57 40.27 Favored 'Trans proline' 0 C--N 1.3 -2.014 2 O-C-N 110.895 -5.371 . . . . 1.39 113.389 179.135 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.06 -5.69 16.4 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 C-N-CA 126.107 4.538 . . . . 1.68 116.672 -176.931 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.53 -37.61 84.38 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.815 2.245 . . . . 2.25 110.782 169.343 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -85.17 -31.9 22.99 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 115.937 -1.982 . . . . 2.44 115.022 -177.411 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.359 46.7 mt-30 -67.58 113.47 5.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.388 2.675 . . . . 1.32 117.698 -172.089 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -122.01 115.47 22.58 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.327 -2.733 . . . . 3.19 109.551 172.765 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.9 mt -96.53 143.11 27.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.51 -1.369 . . . . 1.75 110.256 179.427 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.2 mm -124.6 148.64 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 102.679 -3.082 . . . . 1.98 102.679 175.423 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.455 ' HB3' HD22 ' A' ' 50' ' ' LEU . 69.4 t80 -139.53 112.86 8.27 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 101.156 -3.646 . . . . 1.94 101.156 173.982 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.96 28.76 14.49 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 126.286 2.241 . . . . 1.67 114.119 172.662 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.91 -17.1 56.68 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 124.938 1.256 . . . . 1.3 114.31 -175.168 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.316 34.7 ttmt -87.63 122.51 31.41 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.766 -2.608 . . . . 2.89 115.756 178.417 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -64.46 138.12 58.24 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 118.193 2.664 . . . . 2.89 118.193 171.718 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.455 HD22 ' HB3' ' A' ' 45' ' ' PHE . 39.7 mt -95.9 113.2 24.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.951 -1.022 . . . . 1.34 111.126 -172.326 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -77.5 142.56 39.03 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.873 -1.158 . . . . 1.94 107.873 -178.973 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -56.96 -65.47 0.61 Allowed 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 119.29 3.071 . . . . 1.56 119.29 -168.723 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.1 25.5 0.15 Allowed Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 119.38 2.512 . . . . 0.97 119.38 171.943 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -105.97 158.0 17.1 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 119.773 1.786 . . . . 3.07 109.926 164.821 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.7 p -84.91 169.1 14.41 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 112.735 -2.03 . . . . 1.34 111.602 170.708 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.482 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 94.0 mt -66.02 -37.16 85.18 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 127.384 2.274 . . . . 1.63 111.739 171.543 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.9 p -69.39 -10.4 57.79 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 129.23 3.012 . . . . 1.51 115.016 173.806 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.99 -48.21 31.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.876 1.67 . . . . 1.9 110.362 169.84 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -85.63 -1.11 56.8 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 130.476 3.51 . . . . 0.97 113.775 -177.924 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.0 m120 57.21 54.32 6.9 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.604 2.361 . . . . 2.35 116.646 179.517 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.482 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 88.9 mt -100.27 109.8 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 126.846 2.058 . . . . 1.39 108.797 -179.194 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -93.74 -178.62 4.74 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.052 2.358 . . . . 2.58 110.422 -178.902 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -58.28 140.18 53.77 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.108 -3.495 . . . . 2.58 119.885 175.735 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.327 12.7 mt-10 67.98 40.56 2.26 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 123.778 0.674 . . . . 1.71 110.557 174.913 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 p -96.22 155.43 16.76 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 126.667 1.987 . . . . 1.34 108.547 176.106 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.4 m -104.68 85.75 2.37 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.689 -2.337 . . . . 1.36 104.689 -177.079 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -63.6 159.78 18.15 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 114.539 -5.1 . . . . 2.03 113.884 169.01 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -118.2 129.86 55.75 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.39 2.043 . . . . 2.31 108.584 -178.96 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.6 tp -116.67 131.27 56.99 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 116.065 -4.147 . . . . 1.72 113.242 175.351 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 m -135.1 167.9 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 103.437 -2.801 . . . . 1.8 103.437 175.727 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 66.4 mt -121.83 155.27 35.72 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 126.446 3.022 . . . . 3.26 113.958 179.596 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -110.56 121.19 44.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 130.264 3.426 . . . . 4.12 112.862 -174.193 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.1 mt -128.24 -71.67 0.64 Allowed 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 124.984 1.428 . . . . 3.54 113.26 171.614 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.439 HH12 ' C ' ' A' ' 76' ' ' GLY . 64.9 ttp85 -72.9 140.87 47.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 117.39 2.367 . . . . 7.32 117.39 173.927 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.56 81.85 1.54 Allowed Glycine 0 N--CA 1.43 -1.702 1 O-C-N 115.975 -4.203 . . . . 3.73 114.573 -171.001 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.439 ' C ' HH12 ' A' ' 74' ' ' ARG . . . . . . . . 0 N--CA 1.43 -1.755 0 CA-C-O 114.911 -3.16 . . . . 3.87 113.794 -172.658 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 ttp . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 117.484 2.401 . . . . 1.39 117.484 . . . . . . . . . 0 0 . 1 . 062 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -100.03 124.01 44.91 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 124.53 1.144 . . . . 2.2 110.852 -176.337 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.1 pt -129.11 157.89 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 105.571 -2.011 . . . . 1.32 105.571 172.003 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -108.79 134.67 51.17 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.023 1.729 . . . . 2.2 112.117 -174.854 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.532 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 42.1 t -111.85 115.01 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 122.15 0.976 . . . . 1.23 108.852 173.612 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -96.57 149.94 21.2 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.948 -2.345 . . . . 2.51 107.544 176.979 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.6 p -109.78 -149.21 0.44 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 116.275 -1.821 . . . . 1.41 107.462 176.464 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.2 tp -91.77 -58.12 2.52 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-N 122.809 2.55 . . . . 2.95 110.92 167.121 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.4 p -127.19 133.83 50.23 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 113.755 -3.022 . . . . 2.52 117.946 178.877 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.21 -116.97 2.71 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 103.307 -3.917 . . . . 1.5 103.307 173.983 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -119.67 164.62 15.62 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 121.831 -0.805 . . . . 1.79 108.87 -170.17 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.5 m -88.65 120.26 29.88 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 125.853 1.97 . . . . 1.38 109.652 168.958 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 15.6 mt -79.9 122.62 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-N 122.122 2.237 . . . . 2.03 114.983 -179.627 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.8 m -78.83 100.95 7.39 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.767 -1.833 . . . . 1.61 109.973 176.882 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tp -102.8 119.52 38.98 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 113.709 1.003 . . . . 2.15 113.709 -178.302 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -91.71 126.3 36.74 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.396 2.522 . . . . 1.98 112.983 168.574 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -142.89 171.46 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 1 C-N-CA 131.737 4.015 . . . . 1.52 110.868 -174.331 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -114.24 169.14 6.9 Favored Pre-proline 0 N--CA 1.43 -1.462 0 C-N-CA 129.163 2.985 . . . . 2.35 106.737 166.428 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -73.16 -18.11 24.01 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 N-CA-C 120.11 3.081 . . . . 1.31 120.11 -177.1 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.4 m -84.69 10.15 12.02 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 112.036 -2.347 . . . . 1.71 116.171 174.574 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.69 130.49 35.08 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 116.688 -3.757 . . . . 1.69 106.007 177.464 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.9 p -71.05 163.59 27.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.712 2.196 . . . . 1.33 108.493 171.18 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.474 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 49.1 mm -66.41 -34.07 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 113.625 -3.083 . . . . 1.32 105.381 175.951 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -61.65 -40.02 93.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 122.883 2.583 . . . . 1.62 116.207 171.731 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -69.59 -41.02 76.32 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 125.144 1.528 . . . . 2.13 112.476 177.653 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.5 t -49.85 -50.12 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 120.858 -1.151 . . . . 1.23 113.569 169.872 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -58.77 -37.32 76.02 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.152 -1.592 . . . . 1.97 113.735 170.319 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.59 -37.84 85.75 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.648 -2.533 . . . . 1.19 108.908 178.945 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -69.32 -38.29 78.14 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 129.087 2.955 . . . . 1.92 112.813 179.303 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.8 mt -69.1 -28.66 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 117.431 -3.293 . . . . 1.94 110.959 170.99 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -66.31 -47.19 74.36 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.519 1.528 . . . . 1.9 110.761 172.235 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -64.3 -28.81 69.97 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 114.519 1.303 . . . . 1.55 114.519 173.058 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -87.89 -46.89 9.01 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.087 -2.258 . . . . 2.95 115.12 -173.839 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -113.58 -29.35 7.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.056 1.742 . . . . 1.48 115.262 -175.486 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.19 4.03 38.42 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 119.305 -2.122 . . . . 1.12 118.165 175.074 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.9 mt -85.06 132.48 45.46 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 119.262 1.531 . . . . 2.07 110.771 -173.934 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -61.32 144.04 98.31 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 C-N-CA 123.464 2.776 . . . . 1.39 116.72 -179.721 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -59.43 -32.52 96.59 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 123.379 2.719 . . . . 1.68 114.141 -178.627 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -63.24 -18.11 63.19 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.928 2.936 . . . . 2.25 118.928 171.59 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -91.89 -23.19 19.71 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 116.295 -1.812 . . . . 2.44 107.1 -177.162 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -89.49 141.09 28.89 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 117.406 2.373 . . . . 1.32 117.406 -172.932 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -123.23 137.72 54.81 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.486 -2.008 . . . . 3.19 110.143 163.496 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.2 mt -112.25 140.0 47.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.882 -1.896 . . . . 1.75 105.882 179.742 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.7 mm -120.92 127.58 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 130.108 3.363 . . . . 1.98 108.668 177.985 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -139.27 126.02 20.77 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 104.721 -2.325 . . . . 1.94 104.721 172.16 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.97 41.27 10.65 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 121.037 3.717 . . . . 1.67 121.037 173.921 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.1 -17.59 58.43 Favored Glycine 0 N--CA 1.43 -1.71 0 O-C-N 117.659 -3.151 . . . . 1.3 113.267 -178.772 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -108.81 135.5 49.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.477 -2.778 . . . . 2.89 115.279 -178.866 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -87.6 127.06 35.27 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.114 0.959 . . . . 2.89 109.248 170.805 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.418 HD21 ' CD2' ' A' ' 59' ' ' TYR . 37.0 mt -89.41 144.99 25.63 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 126.576 3.084 . . . . 1.34 112.325 -163.638 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -95.09 125.16 39.56 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.428 -3.295 . . . . 1.94 114.806 -179.781 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.474 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 5.9 m-20 -48.05 -49.86 29.96 Favored 'General case' 0 N--CA 1.429 -1.491 1 C-N-CA 132.406 4.282 . . . . 1.56 119.766 -169.006 . . . . . . . . 3 3 . 1 . 062 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.42 46.2 3.18 Favored Glycine 0 N--CA 1.431 -1.673 0 CA-C-O 114.538 -3.368 . . . . 0.97 119.174 168.354 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -125.32 152.72 44.33 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.593 -2.743 . . . . 3.07 103.593 165.659 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.8 p -94.84 159.75 14.9 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.547 3.654 . . . . 1.34 116.039 176.857 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.6 mt -55.21 -40.49 70.84 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 115.682 1.734 . . . . 1.63 115.682 175.483 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 p -73.43 -9.28 58.53 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.181 -3.449 . . . . 1.51 118.41 179.506 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -93.21 -31.9 14.57 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 114.648 -2.596 . . . . 1.9 107.354 174.585 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.418 ' CD2' HD21 ' A' ' 50' ' ' LEU . 25.7 m-85 -80.0 -5.51 55.87 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 125.892 1.995 . . . . 0.97 106.937 177.049 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 56.18 71.74 0.54 Allowed 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 115.053 -4.78 . . . . 2.35 111.813 -175.38 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.1 mt -115.87 111.9 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 105.001 -2.222 . . . . 1.39 105.001 178.619 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -95.34 -175.08 3.38 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.431 3.015 . . . . 2.58 109.621 -174.232 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -57.73 140.23 51.94 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 111.471 -2.604 . . . . 2.58 112.116 177.162 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.338 51.0 mt-10 69.38 20.85 7.17 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 125.214 1.406 . . . . 1.71 113.309 174.486 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.2 m -85.4 147.72 26.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 121.617 -0.677 . . . . 1.34 112.032 -172.459 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.2 m -104.5 111.07 23.6 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.052 -1.655 . . . . 1.36 112.921 -175.509 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -93.8 147.4 23.09 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.45 -1.406 . . . . 2.03 110.9 174.456 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -113.96 128.1 56.25 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.102 -2.874 . . . . 2.31 110.404 -177.367 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.0 tp -102.49 124.48 48.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 124.834 1.334 . . . . 1.72 112.995 -172.059 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.255 6.2 m -138.3 133.37 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.606 2.763 . . . . 1.8 107.662 -175.408 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.4 mt -98.03 159.07 15.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.144 2.402 . . . . 3.26 117.412 -175.995 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -67.76 122.37 17.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 111.962 -2.381 . . . . 4.12 114.976 -175.381 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 tp -141.95 -46.7 0.35 Allowed 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.615 -3.178 . . . . 3.54 113.299 -179.916 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.7 mtt85 -63.53 -69.34 0.28 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 116.172 -2.211 . . . . 7.32 115.503 173.711 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.66 -79.19 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 106.609 -2.596 . . . . 3.73 106.609 -164.906 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.728 0 N-CA-C 105.5 -3.04 . . . . 3.87 105.5 -172.059 . . . . . . . . 0 0 . 1 . 063 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ttp . . . . . 0 CA--C 1.49 -1.347 0 CA-C-O 116.447 -1.74 . . . . 1.39 107.145 . . . . . . . . . 0 0 . 1 . 063 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -116.55 128.91 55.85 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 124.665 1.228 . . . . 2.2 112.323 171.869 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.6 pt -121.06 173.55 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 119.116 -2.24 . . . . 1.32 107.648 169.521 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -128.3 150.93 49.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.98 -2.23 . . . . 2.2 104.98 -179.328 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.6 t -138.8 112.64 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 126.515 3.055 . . . . 1.23 112.627 174.469 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -89.51 153.25 20.95 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 111.072 -2.786 . . . . 2.51 115.509 -176.831 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 t -127.68 -160.55 1.02 Allowed 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 124.483 2.087 . . . . 1.41 107.853 170.864 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.8 mt -81.19 -85.53 0.1 Allowed 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 114.563 -5.086 . . . . 2.95 113.74 175.383 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.1 p -80.71 -41.34 23.8 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 128.764 2.826 . . . . 2.52 117.287 179.239 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.36 -168.31 11.16 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 118.696 -2.503 . . . . 1.5 118.622 176.181 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -60.34 151.31 28.1 Favored 'General case' 0 N--CA 1.43 -1.461 1 C-N-CA 131.735 4.014 . . . . 1.79 114.068 -172.808 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.8 m -98.18 117.23 32.09 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.453 -2.655 . . . . 1.38 104.216 163.659 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 pt -99.86 153.91 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 116.76 -3.713 . . . . 2.03 108.168 179.991 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.7 m -107.55 126.32 52.39 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 104.404 -2.443 . . . . 1.61 104.404 175.852 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.45 HD12 HG12 ' A' ' 30' ' ' ILE . 95.2 mt -117.38 129.04 55.61 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 123.388 1.566 . . . . 2.15 110.519 -179.263 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -96.73 125.99 41.57 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 116.641 -3.787 . . . . 1.98 104.343 174.305 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.25 27.4 m -136.8 170.42 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 129.264 3.025 . . . . 1.52 111.191 -170.871 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -109.7 156.0 40.47 Favored Pre-proline 0 N--CA 1.43 -1.442 0 CA-C-N 124.384 3.266 . . . . 2.35 107.324 166.728 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.86 -16.52 29.46 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 124.991 3.794 . . . . 1.31 114.787 -168.197 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.3 m -107.34 17.5 22.75 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 120.219 1.372 . . . . 1.71 110.21 177.574 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -73.75 151.09 40.74 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.306 -3.371 . . . . 1.69 113.164 171.053 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -91.53 160.07 15.6 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.913 1.816 . . . . 1.33 113.31 -178.525 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.315 26.0 mm -56.51 -37.9 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 116.381 1.993 . . . . 1.32 116.381 176.069 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -52.54 -43.39 65.13 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.844 2.165 . . . . 1.62 116.844 170.206 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -76.93 -42.4 39.51 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.229 -2.794 . . . . 2.13 108.346 -177.949 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.0 t -57.06 -45.62 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 118.177 2.658 . . . . 1.23 118.177 169.619 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -56.25 -40.71 74.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.021 1.328 . . . . 1.97 112.988 170.116 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.55 -33.55 75.27 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.779 2.432 . . . . 1.19 113.346 175.501 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -67.93 -40.19 83.37 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.474 2.709 . . . . 1.92 106.926 170.369 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.45 HG12 HD12 ' A' ' 15' ' ' LEU . 79.5 mt -62.31 -40.89 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 123.448 2.84 . . . . 1.94 113.117 173.092 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -55.64 -48.88 74.23 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.842 2.457 . . . . 1.9 114.503 170.503 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -58.03 -46.55 85.15 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.61 2.078 . . . . 1.55 116.61 170.853 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -76.71 -58.87 3.03 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 117.889 -3.007 . . . . 2.95 114.611 -177.353 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -88.51 -47.15 8.53 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.257 -1.527 . . . . 1.48 110.531 -170.294 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.85 34.84 1.95 Allowed Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 124.006 1.892 . . . . 1.12 113.72 177.367 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 mt -108.75 128.55 25.33 Favored Pre-proline 0 N--CA 1.431 -1.418 0 O-C-N 120.512 -1.581 . . . . 2.07 111.027 -176.935 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -63.36 141.13 80.2 Favored 'Trans proline' 0 N--CA 1.434 -1.98 0 CA-C-N 125.305 2.93 . . . . 1.39 114.111 173.694 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -75.07 -1.8 11.72 Favored 'Trans proline' 0 C--N 1.3 -1.994 1 C-N-CA 127.188 5.259 . . . . 1.68 113.904 -174.868 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -76.13 -34.2 59.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.905 2.482 . . . . 2.25 109.076 171.381 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -82.01 -25.97 34.25 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.056 2.36 . . . . 2.44 110.108 -175.591 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -82.22 125.02 30.44 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.766 2.698 . . . . 1.32 111.038 -171.746 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -114.99 98.07 6.6 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 109.335 -3.575 . . . . 3.19 109.694 167.837 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.3 mt -79.28 125.47 29.53 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 119.244 -2.16 . . . . 1.75 113.114 176.024 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.9 mm -112.92 123.33 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 O-C-N 119.469 -2.019 . . . . 1.98 106.04 176.18 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -91.03 -73.76 0.52 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 117.56 -1.656 . . . . 1.94 111.88 168.911 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.72 -69.32 0.65 Allowed 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 128.147 2.579 . . . . 1.67 114.035 179.895 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.47 17.48 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.72 1 O-C-N 112.9 -6.125 . . . . 1.3 115.914 -177.006 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -141.85 162.9 34.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 112.509 -1.845 . . . . 2.89 107.694 178.418 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -64.31 168.34 5.74 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 118.175 2.657 . . . . 2.89 118.175 168.146 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.404 HD23 ' CD2' ' A' ' 59' ' ' TYR . 91.4 mt -123.22 128.18 49.66 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.188 -2.195 . . . . 1.34 107.252 -172.622 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -90.06 152.86 20.96 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.796 1.776 . . . . 1.94 115.796 179.565 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.93 -37.82 79.13 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 129.731 3.212 . . . . 1.56 115.379 -165.375 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.88 43.84 1.8 Allowed Glycine 0 N--CA 1.43 -1.721 1 CA-C-O 113.096 -4.169 . . . . 0.97 109.616 169.913 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -122.12 162.0 22.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.524 3.162 . . . . 3.07 104.758 166.088 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.256 20.7 p -95.79 168.41 10.67 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 113.34 -1.755 . . . . 1.34 113.824 -177.551 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -56.96 -46.98 81.76 Favored 'General case' 0 N--CA 1.43 -1.468 1 C-N-CA 132.298 4.239 . . . . 1.63 115.768 168.666 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 t -60.94 -37.85 83.8 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 117.221 2.304 . . . . 1.51 117.221 173.73 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.276 11.7 t0 -46.19 -60.65 2.17 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 129.624 3.169 . . . . 1.9 111.869 178.171 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.404 ' CD2' HD23 ' A' ' 50' ' ' LEU . 60.6 m-85 -79.68 -1.66 39.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 112.57 -2.105 . . . . 0.97 116.397 -175.368 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.357 33.1 m120 73.89 52.22 0.11 Allowed 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 127.857 2.463 . . . . 2.35 114.176 -178.825 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.1 mt -96.31 117.44 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 103.901 -2.629 . . . . 1.39 103.901 -177.944 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -113.45 178.51 4.25 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 125.058 2.361 . . . . 2.58 111.578 -173.395 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -64.87 129.1 38.48 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 114.918 -4.864 . . . . 2.58 110.844 172.714 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.313 18.1 mt-10 80.03 36.18 0.13 Allowed 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 123.509 1.623 . . . . 1.71 114.558 178.108 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -107.18 125.18 50.78 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.203 2.201 . . . . 1.34 114.808 -176.205 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.9 m -97.32 117.69 32.11 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 121.323 -0.861 . . . . 1.36 111.029 -177.867 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.9 mp -101.88 164.7 11.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.479 1.133 . . . . 2.03 109.536 179.361 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -119.69 113.13 20.19 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 116.992 -1.48 . . . . 2.31 111.856 -176.496 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -80.55 131.97 35.6 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 124.654 1.221 . . . . 1.72 108.328 176.197 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.5 t -113.0 129.36 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 105.572 -2.01 . . . . 1.8 105.572 166.274 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.7 tp -97.68 107.19 19.64 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.555 -0.906 . . . . 3.26 108.555 179.644 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.53 -166.22 1.26 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.966 1.841 . . . . 4.12 108.953 179.104 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.9 mt -122.74 166.34 15.1 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 103.545 -2.761 . . . . 3.54 103.545 169.808 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -76.48 109.42 10.19 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.293 -1.504 . . . . 7.32 111.577 178.774 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.14 89.98 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.759 0 CA-C-O 125.031 2.462 . . . . 3.73 117.525 -170.496 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.717 0 CA-C-O 114.32 -3.489 . . . . 3.87 109.929 179.885 . . . . . . . . 0 0 . 1 . 064 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ptt? . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 115.963 1.838 . . . . 1.39 115.963 . . . . . . . . . 0 0 . 1 . 064 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -102.91 127.71 50.01 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 114.923 -2.465 . . . . 2.2 112.592 -175.968 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.4 pt -124.54 176.53 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 123.104 2.683 . . . . 1.32 109.303 176.246 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -120.51 152.72 37.66 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.496 -2.627 . . . . 2.2 111.078 172.992 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.9 t -135.67 124.39 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 105.627 -1.99 . . . . 1.23 105.627 173.72 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -106.69 133.4 51.41 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 114.203 1.186 . . . . 2.51 114.203 175.67 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -95.99 165.39 12.29 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.669 1.588 . . . . 1.41 111.559 -179.588 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.258 43.2 mt -72.28 -28.58 63.19 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 118.037 2.606 . . . . 2.95 118.037 175.939 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 p -76.71 -26.98 55.27 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 126.805 2.042 . . . . 2.52 109.095 -179.362 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.6 46.46 0.48 Allowed Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 129.61 3.481 . . . . 1.5 114.951 167.07 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -109.82 133.83 52.72 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.707 3.203 . . . . 1.79 106.448 177.091 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 m -117.02 106.97 13.97 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 124.192 0.933 . . . . 1.38 109.34 167.521 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mt -85.49 136.95 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.358 1.863 . . . . 2.03 113.919 179.042 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.9 m -95.72 117.37 30.38 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 114.921 -2.466 . . . . 1.61 105.56 176.581 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.3 mt -129.08 137.83 51.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 124.651 3.387 . . . . 2.15 111.175 178.512 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -99.48 128.8 45.62 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 126.739 3.161 . . . . 1.98 110.082 172.379 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.69 172.76 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 101.922 -3.362 . . . . 1.52 101.922 -174.426 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -117.9 155.92 50.53 Favored Pre-proline 0 N--CA 1.43 -1.451 0 N-CA-C 104.276 -2.49 . . . . 2.35 104.276 163.392 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -73.73 -7.22 19.84 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 N-CA-C 115.702 1.385 . . . . 1.31 115.702 -170.414 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.1 p -97.57 -0.75 45.27 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 126.199 1.799 . . . . 1.71 109.188 178.179 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -76.89 148.88 36.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.482 -2.636 . . . . 1.69 108.287 173.785 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 26' ' ' VAL . 72.5 p -85.91 165.13 17.02 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.938 2.495 . . . . 1.33 116.722 176.092 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.9 mm -70.27 -28.74 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 117.435 -3.291 . . . . 1.32 114.776 -178.146 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.25 75.3 tt0 -56.7 -46.56 81.15 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.015 1.388 . . . . 1.62 114.622 167.925 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -67.27 -37.32 83.27 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.362 -2.711 . . . . 2.13 110.798 179.688 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 22' ' ' THR . 98.9 t -66.72 -46.66 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 119.77 -1.831 . . . . 1.23 109.109 178.161 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -60.52 -39.22 87.03 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.903 -1.044 . . . . 1.97 112.446 174.724 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.46 -15.16 62.36 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 116.972 2.212 . . . . 1.19 116.972 175.532 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -85.3 -33.75 22.04 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.152 1.781 . . . . 1.92 114.316 177.735 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.3 mt -66.99 -47.43 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 1 C-N-CA 131.702 4.001 . . . . 1.94 106.718 166.634 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -47.8 -55.58 9.36 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 121.266 3.802 . . . . 1.9 121.266 173.534 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -34.21 -59.85 0.42 Allowed 'General case' 0 N--CA 1.431 -1.41 1 C-N-CA 131.777 4.031 . . . . 1.55 112.928 164.605 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -66.39 -57.61 7.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 118.488 2.773 . . . . 2.95 118.488 179.817 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -82.81 -45.64 14.07 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 130.411 3.484 . . . . 1.48 110.874 -171.093 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.18 47.27 1.74 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 107.6 -2.2 . . . . 1.12 107.6 174.178 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.7 mt -120.33 129.15 25.47 Favored Pre-proline 0 N--CA 1.431 -1.413 0 C-N-CA 127.504 2.322 . . . . 2.07 107.825 -169.143 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -72.65 145.69 42.1 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 114.007 -3.733 . . . . 1.39 112.375 175.691 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -65.18 -13.88 42.17 Favored 'Trans proline' 0 N--CA 1.433 -2.062 0 CA-C-N 126.668 3.417 . . . . 1.68 118.463 -177.392 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -56.24 -44.39 79.59 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 124.818 2.246 . . . . 2.25 114.227 175.088 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -90.27 -6.36 55.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 110.535 -3.03 . . . . 2.44 114.09 -177.678 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -103.77 139.63 38.73 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.353 -2.462 . . . . 1.32 104.353 -177.501 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -130.88 145.48 52.02 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.141 1.924 . . . . 3.19 108.711 167.962 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 mt -107.47 130.34 54.85 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.727 -1.583 . . . . 1.75 106.727 178.931 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 7.1 mm -112.28 140.14 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 105.293 -2.114 . . . . 1.98 105.293 177.925 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.408 ' HB2' HD23 ' A' ' 67' ' ' LEU . 52.7 t80 -155.07 126.99 7.58 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 125.07 2.367 . . . . 1.94 108.512 175.275 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.358 . . 61.86 34.05 17.27 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 127.747 3.641 . . . . 1.67 118.722 -175.885 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.31 -18.1 11.48 Favored Glycine 0 N--CA 1.429 -1.804 0 O-C-N 118.442 -2.661 . . . . 1.3 114.375 -178.495 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.263 30.0 mtmt -95.77 148.7 22.31 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.607 -3.29 . . . . 2.89 110.278 -177.393 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -88.09 122.1 31.27 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.26 2.225 . . . . 2.89 107.791 172.67 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.2 mt -74.04 162.07 29.4 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 110.06 -3.245 . . . . 1.34 112.433 -176.803 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -109.12 159.18 17.09 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.511 -3.243 . . . . 1.94 106.386 172.869 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.56 -58.56 3.22 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.829 2.852 . . . . 1.56 116.246 -169.93 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.94 43.13 2.59 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 127.356 2.407 . . . . 0.97 113.74 172.999 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -120.87 148.3 44.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.535 -3.332 . . . . 3.07 103.991 164.135 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -76.69 163.44 26.83 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 118.204 2.668 . . . . 1.34 118.204 170.609 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mt -55.55 -44.53 76.87 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.983 2.913 . . . . 1.63 109.9 170.461 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 p -59.44 -32.11 69.91 Favored 'General case' 0 N--CA 1.431 -1.412 1 O-C-N 129.813 4.446 . . . . 1.51 116.563 174.675 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -69.08 -34.8 75.71 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.609 1.671 . . . . 1.9 112.63 172.62 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -82.97 0.1 46.18 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.898 -3.626 . . . . 0.97 117.684 177.709 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.4 t30 48.96 43.7 22.0 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 131.661 3.984 . . . . 2.35 115.104 -176.535 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.2 mt -82.33 130.46 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 112.845 -1.98 . . . . 1.39 111.959 179.91 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -127.14 178.47 6.0 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 120.089 -1.632 . . . . 2.58 109.798 -173.446 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -57.56 154.72 10.8 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 115.412 1.634 . . . . 2.58 115.412 -178.281 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 61.33 11.02 3.39 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 126.277 1.831 . . . . 1.71 112.461 171.456 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.0 t -89.51 131.07 35.72 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 104.962 -2.236 . . . . 1.34 104.962 -174.069 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.0 m -96.32 114.14 25.79 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 102.761 -3.051 . . . . 1.36 102.761 -174.413 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.408 HD23 ' HB2' ' A' ' 45' ' ' PHE . 11.2 mt -90.96 161.93 14.95 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.21 -2.806 . . . . 2.03 111.673 167.648 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.407 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 80.6 m80 -112.58 127.03 55.97 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 117.564 -1.208 . . . . 2.31 113.3 -177.54 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.4 tp -93.79 134.63 35.93 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 124.639 1.175 . . . . 1.72 110.635 176.805 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.0 m -129.92 156.47 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 103.823 -2.658 . . . . 1.8 103.823 174.503 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.1 mt -125.56 125.97 44.06 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 125.059 2.361 . . . . 3.26 113.108 -179.755 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -80.09 -176.73 5.69 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.742 -4.349 . . . . 4.12 112.954 -175.578 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.1 mt -103.26 169.56 8.47 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.116 -3.49 . . . . 3.54 111.942 162.49 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.2 mtt180 -70.3 107.0 3.55 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 124.481 1.113 . . . . 7.32 113.065 168.167 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.91 6.4 54.21 Favored Glycine 0 N--CA 1.43 -1.71 0 CA-C-O 122.58 1.1 . . . . 3.73 112.564 -168.473 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.791 0 CA-C-O 117.267 -1.852 . . . . 3.87 113.171 177.243 . . . . . . . . 0 0 . 1 . 065 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ptt? . . . . . 0 CA--C 1.49 -1.347 0 CA-C-O 123.032 1.396 . . . . 1.39 114.107 . . . . . . . . . 0 0 . 1 . 065 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -94.27 133.52 37.72 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 115.876 1.806 . . . . 2.2 115.876 -174.303 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.9 pt -127.44 153.78 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 120.727 -1.233 . . . . 1.32 109.627 173.993 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.304 58.2 m-85 -112.74 119.1 36.91 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 125.237 1.586 . . . . 2.2 113.099 -179.858 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.5 t -105.53 120.03 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 116.043 -2.263 . . . . 1.23 113.536 177.094 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -88.36 116.99 26.97 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.872 -2.392 . . . . 2.51 114.477 178.318 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.295 19.9 p -72.84 168.2 19.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.001 1.72 . . . . 1.41 112.988 178.774 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.433 HD23 HG11 ' A' ' 70' ' ' VAL 0.291 19.0 mt -66.15 -45.64 80.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.416 1.462 . . . . 2.95 113.862 173.981 . . . . . . . . 3 3 . 1 . 065 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -65.14 -67.24 0.45 Allowed 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 117.379 2.362 . . . . 2.52 117.379 176.555 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.75 22.57 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 117.967 -2.063 . . . . 1.5 115.502 177.893 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -106.37 130.48 54.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.44 -1.319 . . . . 1.79 107.44 -176.831 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.9 m -99.34 107.69 20.02 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 105.722 -1.955 . . . . 1.38 105.722 172.165 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.1 mt -78.57 119.27 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 118.948 -2.345 . . . . 2.03 110.661 -179.967 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.6 m -83.1 117.98 23.24 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.394 -1.442 . . . . 1.61 108.736 174.163 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.2 mt -111.79 164.15 13.38 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 118.841 0.746 . . . . 2.15 111.58 179.136 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.75 129.54 56.38 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.351 1.06 . . . . 1.98 109.05 167.539 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.09 161.53 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 104.307 -2.479 . . . . 1.52 104.307 178.046 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -106.71 137.43 19.47 Favored Pre-proline 0 N--CA 1.43 -1.437 0 C-N-CA 128.172 2.589 . . . . 2.35 108.647 163.162 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -68.0 -8.42 22.6 Favored 'Trans proline' 0 N--CA 1.433 -2.04 0 C-N-CA 122.672 2.248 . . . . 1.31 114.586 -174.023 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.6 p -101.35 10.59 40.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.458 2.39 . . . . 1.71 111.697 175.676 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -91.35 165.06 13.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.503 1.62 . . . . 1.69 108.692 -176.7 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -90.4 161.2 15.68 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.777 -4.327 . . . . 1.33 110.093 -178.56 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.3 mt -72.22 -34.29 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.438 -2.663 . . . . 1.32 115.703 -177.156 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -52.47 -45.14 65.97 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.418 2.377 . . . . 1.62 117.418 157.14 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -58.29 -38.73 77.62 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 116.364 -3.96 . . . . 2.13 110.919 175.093 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.74 -49.2 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 122.828 1.299 . . . . 1.23 112.217 170.75 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -55.81 -39.58 71.53 Favored 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 115.786 -4.321 . . . . 1.97 114.658 175.945 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.258 . . -55.86 -31.23 62.59 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.334 2.654 . . . . 1.19 113.2 168.562 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -65.69 -36.25 83.08 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 116.51 -3.868 . . . . 1.92 114.797 173.839 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.0 mt -66.47 -34.41 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 114.932 1.456 . . . . 1.94 114.932 170.266 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -59.86 -38.94 83.58 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 130.106 3.362 . . . . 1.9 109.255 178.148 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -50.42 -46.64 56.56 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 119.452 3.13 . . . . 1.55 119.452 163.837 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -80.54 -45.65 17.08 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 124.884 1.274 . . . . 2.95 111.747 -177.728 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -100.89 -44.29 5.81 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.738 -1.208 . . . . 1.48 107.738 -166.923 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.37 16.99 47.91 Favored Glycine 0 N--CA 1.43 -1.707 0 O-C-N 118.296 -2.752 . . . . 1.12 114.725 177.742 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.1 mt -98.26 127.46 36.4 Favored Pre-proline 0 N--CA 1.43 -1.461 1 C-N-CA 132.235 4.214 . . . . 2.07 104.114 174.583 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.91 151.57 81.97 Favored 'Trans proline' 0 N--CA 1.432 -2.093 1 O-C-N 112.363 -4.599 . . . . 1.39 114.289 -177.928 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.2 -19.29 20.11 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 CA-C-N 124.288 2.567 . . . . 1.68 112.28 -169.633 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -57.84 -30.27 65.63 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 120.615 1.552 . . . . 2.25 114.103 168.033 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.272 10.6 tt0 -77.17 -33.36 56.48 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 118.044 -2.91 . . . . 2.44 112.809 178.799 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -80.57 148.18 30.46 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 117.391 2.367 . . . . 1.32 117.391 -172.97 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -146.64 139.41 25.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.662 -1.607 . . . . 3.19 106.662 173.736 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.1 mt -105.06 145.15 30.89 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.067 -3.521 . . . . 1.75 109.694 -178.634 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.5 mm -119.76 140.67 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 105.456 -2.053 . . . . 1.98 105.456 -178.322 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -147.57 135.04 20.79 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.985 -1.697 . . . . 1.94 110.401 170.919 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.87 8.46 0.16 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 130.213 3.405 . . . . 1.67 116.532 -177.158 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.36 -25.79 9.01 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 129.684 3.516 . . . . 1.3 113.738 -174.498 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -79.61 146.52 32.5 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 121.202 2.501 . . . . 2.89 111.147 179.01 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -89.47 123.46 33.61 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 101.259 -3.608 . . . . 2.89 101.259 172.648 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.7 mt -85.42 145.41 27.46 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 105.709 -1.96 . . . . 1.34 105.709 -172.208 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -79.56 154.88 28.46 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 115.886 1.81 . . . . 1.94 115.886 173.8 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -82.74 -47.36 12.05 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.43 -3.294 . . . . 1.56 117.595 -171.359 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.21 57.34 1.73 Allowed Glycine 0 N--CA 1.43 -1.737 1 O-C-N 116.286 -4.009 . . . . 0.97 111.447 178.432 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.0 ttt85 -138.08 164.37 29.27 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.815 -1.92 . . . . 3.07 105.815 171.822 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.7 p -101.76 153.84 19.44 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 116.495 2.035 . . . . 1.34 116.495 175.366 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.8 mt -53.0 -47.34 68.35 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 126.293 2.949 . . . . 1.63 113.996 177.948 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.4 p -60.86 -24.65 66.07 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.061 -4.15 . . . . 1.51 120.384 174.38 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.28 -30.18 70.55 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 123.147 2.703 . . . . 1.9 114.798 172.946 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -86.87 -12.79 46.76 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.733 2.813 . . . . 0.97 114.646 177.611 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 66.47 45.03 2.21 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.472 -1.695 . . . . 2.35 114.582 -174.311 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.9 mt -98.32 106.71 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 128.327 3.917 . . . . 1.39 110.298 179.01 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -89.45 171.8 9.46 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 110.718 -2.947 . . . . 2.58 116.321 -170.933 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -52.53 137.7 29.55 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.536 1.935 . . . . 2.58 112.403 170.168 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.275 37.0 mt-10 56.4 41.56 28.76 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 119.926 3.306 . . . . 1.71 119.926 178.65 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.8 m -98.62 156.45 16.81 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.184 2.193 . . . . 1.34 110.166 -179.592 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.4 m -106.95 106.48 17.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.914 2.769 . . . . 1.36 111.746 -175.329 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -94.82 164.36 12.96 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.351 2.024 . . . . 2.03 109.298 176.343 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -137.5 122.08 18.5 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 126.235 2.921 . . . . 2.31 107.6 -179.386 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.5 tp -87.92 133.8 33.85 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 111.455 -2.611 . . . . 1.72 117.067 178.185 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.433 HG11 HD23 ' A' ' 8' ' ' LEU . 28.6 m -130.02 173.23 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.184 -2.822 . . . . 1.8 106.008 173.487 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.7 mt -134.05 153.79 51.57 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.422 -2.673 . . . . 3.26 108.846 -173.954 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -61.91 113.52 2.84 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 121.693 0.758 . . . . 4.12 112.611 179.027 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.7 mt -91.18 164.68 13.82 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 127.366 3.46 . . . . 3.54 107.688 167.314 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 52.3 mtt85 -91.44 167.5 12.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.91 -2.404 . . . . 7.32 108.881 172.803 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.35 28.63 7.95 Favored Glycine 0 N--CA 1.43 -1.723 0 O-C-N 118.193 -2.817 . . . . 3.73 114.606 -166.633 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.804 1 C-N-CA 133.546 5.355 . . . . 3.87 109.619 175.962 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 CA--C 1.49 -1.361 0 N-CA-C 120.207 3.41 . . . . 1.39 120.207 . . . . . . . . . 0 0 . 1 . 066 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -96.62 140.17 31.62 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 105.82 -1.919 . . . . 2.2 105.82 179.862 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.7 pt -136.43 165.16 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 129.928 3.291 . . . . 1.32 108.868 167.877 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -118.95 132.75 56.09 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.28 -2.138 . . . . 2.2 115.476 -175.812 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.7 t -118.29 121.64 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 1 O-C-N 116.056 -4.152 . . . . 1.23 112.825 176.634 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -91.15 128.11 36.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 118.456 2.762 . . . . 2.51 118.456 178.455 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.4 p -79.53 -177.83 6.01 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.069 2.366 . . . . 1.41 113.232 -177.293 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.3 mt -68.04 -43.6 78.34 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 113.939 -1.482 . . . . 2.95 113.203 166.506 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.6 p -73.89 -21.0 60.24 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 123.005 1.383 . . . . 2.52 108.919 -175.861 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.38 23.68 4.38 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 116.539 -3.851 . . . . 1.5 113.281 171.047 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -82.87 136.25 34.67 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 112.664 -3.541 . . . . 1.79 113.059 -176.932 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.4 m -95.69 118.86 33.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 123.916 3.053 . . . . 1.38 109.343 170.588 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.1 mt -90.74 123.58 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 130.509 3.524 . . . . 2.03 108.119 174.766 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 m -97.6 112.26 24.2 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 116.666 -3.771 . . . . 1.61 107.048 -179.67 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.417 HD21 ' HE3' ' A' ' 33' ' ' LYS . 55.4 mt -126.75 152.73 46.47 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.425 1.09 . . . . 2.15 113.469 -178.619 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -107.26 146.47 31.42 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.74 -1.207 . . . . 1.98 107.74 172.046 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 m -149.25 178.4 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 102.236 -3.246 . . . . 1.52 102.236 -177.479 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -138.55 157.57 71.95 Favored Pre-proline 0 N--CA 1.43 -1.47 0 CA-C-O 124.076 1.893 . . . . 2.35 106.196 158.996 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 47.6 Cg_exo -52.92 -23.7 22.03 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 124.943 3.762 . . . . 1.31 118.019 -175.221 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.1 m -79.26 -13.15 59.86 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 120.179 1.354 . . . . 1.71 114.107 178.775 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -72.57 153.87 41.07 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 112.73 0.641 . . . . 1.69 112.73 -179.943 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.2 p -87.41 167.42 14.03 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 126.403 3.001 . . . . 1.33 109.906 174.742 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.7 mm -70.58 -34.19 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 1 O-C-N 116.236 -4.04 . . . . 1.32 109.107 174.202 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.313 29.1 tt0 -51.89 -44.32 63.71 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 116.872 2.175 . . . . 1.62 116.872 168.088 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -71.15 -9.28 57.81 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 119.549 3.166 . . . . 2.13 119.549 179.642 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -87.12 -38.98 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 C-N-CA 126.208 1.803 . . . . 1.23 108.205 167.384 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -75.53 -24.28 56.74 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 117.462 2.393 . . . . 1.97 117.462 177.853 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.07 -45.24 89.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.822 2.449 . . . . 1.19 108.259 165.335 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -57.74 -31.95 66.97 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 118.01 2.596 . . . . 1.92 118.01 164.3 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.8 mt -78.14 -20.79 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 118.816 -2.428 . . . . 1.94 115.859 177.742 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -59.99 -30.13 68.92 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.891 -1.755 . . . . 1.9 112.725 165.606 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -74.06 -51.18 16.57 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.435 -2.041 . . . . 1.55 114.844 168.634 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HE3' HD21 ' A' ' 15' ' ' LEU . 50.0 mmtt -56.48 -55.34 34.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.675 -1.148 . . . . 2.95 111.573 -172.474 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -107.65 -57.71 2.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 126.134 2.147 . . . . 1.48 113.468 -173.188 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.16 9.5 2.12 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 127.05 2.719 . . . . 1.12 116.135 173.849 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.8 mt -88.96 139.19 29.0 Favored Pre-proline 0 N--CA 1.43 -1.467 1 CA-C-O 111.678 -4.01 . . . . 2.07 111.379 -174.665 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -77.81 151.53 28.11 Favored 'Trans proline' 0 C--N 1.3 -2.0 1 CA-C-N 133.151 5.732 . . . . 1.39 110.936 -171.945 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.45 -17.04 43.9 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 O-C-N 125.453 2.291 . . . . 1.68 112.641 -176.011 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -54.41 -59.95 3.99 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 114.807 -2.52 . . . . 2.25 110.998 167.628 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -70.39 -17.33 63.03 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.394 3.878 . . . . 2.44 117.55 -176.525 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -95.8 147.18 23.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.431 -0.793 . . . . 1.32 111.912 -178.984 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -136.59 139.56 42.21 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.604 -3.185 . . . . 3.19 113.186 170.674 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.8 mt -96.49 143.44 27.5 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.065 -3.522 . . . . 1.75 118.901 174.371 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.8 mt -119.53 139.84 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 102.409 -3.182 . . . . 1.98 102.409 179.317 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -145.58 120.57 10.03 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 101.47 -3.53 . . . . 1.94 101.47 168.673 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.8 52.08 1.71 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 120.05 3.352 . . . . 1.67 120.05 173.874 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.75 2.59 6.38 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 129.094 3.235 . . . . 1.3 116.939 177.818 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -120.93 152.9 37.94 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.609 -2.701 . . . . 2.89 109.56 174.873 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -84.96 138.33 32.55 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.337 2.494 . . . . 2.89 109.119 174.629 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.3 mt -94.69 145.21 25.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.239 2.216 . . . . 1.34 109.153 -175.913 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -85.97 142.67 28.63 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.932 -2.355 . . . . 1.94 113.869 170.432 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -59.05 -58.62 7.84 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.821 3.649 . . . . 1.56 112.64 -175.227 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.23 39.39 3.05 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 127.826 2.632 . . . . 0.97 115.301 172.474 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.7 mmm-85 -110.35 150.62 28.52 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.811 2.719 . . . . 3.07 107.333 155.232 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.1 p -76.28 155.98 33.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.322 -3.361 . . . . 1.34 109.841 172.632 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.418 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 46.8 mt -60.36 -39.4 87.05 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 114.309 1.225 . . . . 1.63 114.309 172.093 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.288 82.7 p -50.62 -42.4 56.03 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.306 -3.371 . . . . 1.51 112.504 175.347 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -56.49 -42.17 77.86 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.537 -3.227 . . . . 1.9 111.804 176.175 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -87.12 -13.57 43.8 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 114.5 -2.667 . . . . 0.97 112.769 177.125 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 70.23 24.71 4.77 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.704 2.669 . . . . 2.35 117.05 -178.971 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.0 mt -70.37 112.54 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 113.064 -1.88 . . . . 1.39 111.531 179.061 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -87.95 179.52 6.42 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.123 -1.611 . . . . 2.58 108.658 178.209 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -55.7 142.25 34.93 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 130.911 3.684 . . . . 2.58 117.796 173.251 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.46 37.6 mt-10 77.21 10.84 2.4 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.499 -2.001 . . . . 1.71 113.769 170.029 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.1 m -75.08 146.13 41.72 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.648 3.179 . . . . 1.34 111.717 177.773 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.2 m -111.02 113.22 25.6 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 125.323 2.487 . . . . 1.36 105.241 -179.294 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.4 mt -96.73 127.19 42.48 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 125.968 1.707 . . . . 2.03 111.39 175.883 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -84.89 136.84 33.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.987 -1.695 . . . . 2.31 109.842 -177.4 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tp -104.75 121.01 42.72 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.457 2.348 . . . . 1.72 105.26 178.792 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 m -123.65 163.95 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 119.59 -1.944 . . . . 1.8 106.299 172.847 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.6 mt -85.67 165.88 16.62 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 119.389 -2.07 . . . . 3.26 112.019 176.281 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -76.58 83.81 3.25 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 124.952 1.301 . . . . 4.12 109.559 174.955 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.3 mt -101.6 158.1 16.34 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 111.727 -2.488 . . . . 3.54 107.835 167.333 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -103.22 162.49 12.94 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.111 1.764 . . . . 7.32 110.175 171.161 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.38 -93.57 1.9 Allowed Glycine 0 N--CA 1.43 -1.754 0 C-N-CA 128.549 2.976 . . . . 3.73 114.874 -166.66 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.762 0 O-C-N 118.624 -2.692 . . . . 3.87 115.967 174.791 . . . . . . . . 0 0 . 1 . 067 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 ptt? . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 114.284 1.216 . . . . 1.39 114.284 . . . . . . . . . 0 0 . 1 . 067 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -112.77 122.94 49.14 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 125.828 1.955 . . . . 2.2 112.229 -171.052 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.4 HG21 ' H ' ' A' ' 65' ' ' SER . 5.7 pt -113.07 157.61 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 126.324 2.265 . . . . 1.32 116.175 167.348 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -103.66 125.39 50.13 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.672 1.589 . . . . 2.2 110.165 -174.818 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 t -103.0 125.61 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.109 -2.245 . . . . 1.23 110.974 173.887 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -93.4 118.05 30.83 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.679 2.487 . . . . 2.51 113.009 176.097 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -94.84 171.53 8.72 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.566 -1.959 . . . . 1.41 109.749 -174.421 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.4 mt -83.19 -5.59 59.18 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 117.713 2.486 . . . . 2.95 117.713 171.613 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -88.64 -32.57 17.98 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 104.941 -2.244 . . . . 2.52 104.941 179.88 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.8 37.61 1.04 Allowed Glycine 0 N--CA 1.429 -1.777 0 C-N-CA 126.56 2.028 . . . . 1.5 110.853 -179.952 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -106.7 144.92 32.66 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.764 -1.433 . . . . 1.79 109.798 -179.94 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.5 m -104.84 114.41 28.61 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.564 2.746 . . . . 1.38 108.002 168.462 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.4 mt -109.96 116.66 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 118.55 -2.594 . . . . 2.03 105.062 -168.712 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 m -89.84 97.07 10.98 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.387 1.875 . . . . 1.61 109.944 179.005 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.2 mt -96.5 131.78 42.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 112.531 -2.122 . . . . 2.15 116.383 177.632 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -88.23 111.22 21.4 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.967 2.907 . . . . 1.98 109.787 172.461 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.54 158.26 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 116.565 -3.835 . . . . 1.52 104.447 -172.543 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -103.01 161.23 23.74 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 117.348 -1.311 . . . . 2.35 111.716 169.064 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -75.67 -11.95 20.27 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 CA-C-N 121.008 1.396 . . . . 1.31 113.731 -168.252 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.4 p -85.75 -6.3 59.13 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 125.611 1.819 . . . . 1.71 110.733 175.785 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -76.46 149.69 36.77 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 123.851 1.786 . . . . 1.69 109.138 172.574 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.299 63.3 p -90.17 166.54 13.32 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.881 2.277 . . . . 1.33 108.967 -179.578 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.441 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 19.8 mm -63.79 -36.69 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 111.933 -2.394 . . . . 1.32 110.1 179.956 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -53.14 -42.12 65.76 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 121.509 3.892 . . . . 1.62 121.509 163.142 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 -59.97 -27.51 66.89 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.406 2.373 . . . . 2.13 117.406 173.302 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.9 t -72.23 -47.14 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 C-N-CA 127.112 2.165 . . . . 1.23 114.331 169.302 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -60.37 -29.4 68.9 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 113.972 -1.467 . . . . 1.97 112.593 172.5 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.26 -25.58 65.25 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 116.002 -4.186 . . . . 1.19 117.295 -179.556 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -76.77 -35.1 57.93 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 127.156 2.182 . . . . 1.92 109.533 179.471 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.4 mt -71.64 -32.96 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 126.311 1.845 . . . . 1.94 108.88 174.344 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -62.84 -45.42 92.67 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.736 -4.353 . . . . 1.9 111.887 173.376 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -50.73 -60.91 2.56 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 116.206 1.928 . . . . 1.55 116.206 168.063 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -65.14 -62.28 1.64 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.067 2.547 . . . . 2.95 111.45 -174.472 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -105.41 -38.39 6.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.458 -1.401 . . . . 1.48 109.933 -160.596 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.7 -11.2 7.49 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 117.575 -3.203 . . . . 1.12 114.063 168.152 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.0 mt -67.1 124.18 88.21 Favored Pre-proline 0 N--CA 1.429 -1.497 0 O-C-N 119.814 -1.992 . . . . 2.07 108.549 -174.451 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.83 145.05 35.75 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 CA-C-N 120.847 1.338 . . . . 1.39 109.578 172.976 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.03 -0.39 3.99 Favored 'Trans proline' 0 C--N 1.3 -2.009 1 C-N-CA 127.634 5.556 . . . . 1.68 115.975 -169.732 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -91.36 -13.91 31.64 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.117 1.78 . . . . 2.25 113.028 169.99 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -87.94 -45.65 10.06 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 121.47 1.941 . . . . 2.44 111.793 178.815 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -79.33 126.69 31.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.375 2.512 . . . . 1.32 110.963 -176.384 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -113.35 151.15 31.61 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 117.538 -3.226 . . . . 3.19 107.683 171.537 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.1 mt -114.58 120.53 40.49 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 126.223 2.202 . . . . 1.75 111.676 176.817 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.269 82.7 mt -105.49 132.32 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 N-CA-C 115.195 1.554 . . . . 1.98 115.195 175.734 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -148.18 126.36 12.17 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 119.008 -2.308 . . . . 1.94 112.57 173.916 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.17 21.56 7.15 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.874 1.805 . . . . 1.67 115.874 -175.645 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.7 8.48 77.04 Favored Glycine 0 N--CA 1.429 -1.774 1 C-N-CA 131.967 4.603 . . . . 1.3 113.575 -173.451 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -101.38 128.99 47.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.858 -1.534 . . . . 2.89 106.858 179.14 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -74.21 112.03 9.95 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 127.893 2.477 . . . . 2.89 114.02 170.365 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 mt -83.11 124.27 30.32 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 117.741 -1.584 . . . . 1.34 114.725 -163.317 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -75.73 135.36 40.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.344 -3.347 . . . . 1.94 110.849 -178.976 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.441 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -63.05 -45.17 93.5 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 109.144 -3.662 . . . . 1.56 115.941 -168.317 . . . . . . . . 3 3 . 1 . 067 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.18 29.82 1.63 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 118.246 2.058 . . . . 0.97 118.246 166.703 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.5 mtp180 -120.53 158.16 27.89 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 124.21 1.957 . . . . 3.07 111.72 163.452 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.3 p -89.16 168.58 12.18 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 124.216 1.96 . . . . 1.34 114.312 171.585 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.331 8.4 mt -66.7 -38.52 86.9 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 110.845 -2.888 . . . . 1.63 105.25 174.603 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -68.09 -32.53 72.91 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.896 -3.002 . . . . 1.51 111.919 -179.021 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.32 38.0 t0 -63.08 -47.73 81.63 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.484 2.031 . . . . 1.9 116.484 174.219 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -73.86 -9.47 58.68 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.444 -3.91 . . . . 0.97 114.97 168.777 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.4 t30 66.63 58.37 0.64 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.662 2.385 . . . . 2.35 113.804 -178.883 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mt -100.67 120.78 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 126.253 1.821 . . . . 1.39 110.087 -178.15 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.23 174.78 5.98 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.539 1.638 . . . . 2.58 111.792 -174.521 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -53.66 148.51 9.62 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.876 -3.64 . . . . 2.58 114.959 169.199 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.251 86.3 mt-10 67.79 25.18 8.03 Favored 'General case' 0 N--CA 1.431 -1.378 1 C-N-CA 132.699 4.4 . . . . 1.71 110.372 178.495 . . . . . . . . 3 2 . 1 . 067 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.4 ' H ' HG21 ' A' ' 3' ' ' ILE . 69.0 m -75.86 143.9 41.52 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.58 2.61 . . . . 1.34 110.481 -177.496 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.6 m -100.64 97.16 7.86 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.949 -3.594 . . . . 1.36 110.209 -179.519 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.4 mt -91.64 128.76 37.59 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 126.033 2.083 . . . . 2.03 111.54 -178.676 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -89.09 116.12 27.13 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.93 -3.606 . . . . 2.31 113.09 177.34 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 tt -97.54 123.05 41.28 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 104.935 -2.246 . . . . 1.72 104.935 -177.737 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.52 176.41 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 O-C-N 118.686 -2.508 . . . . 1.8 106.135 174.677 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.7 mt -118.08 162.57 17.98 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 125.121 2.391 . . . . 3.26 105.58 173.385 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -57.13 159.04 4.63 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 115.971 -4.206 . . . . 4.12 114.7 173.598 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.7 mt -111.89 -146.64 0.41 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 103.091 -2.929 . . . . 3.54 103.091 169.862 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -98.38 157.95 15.88 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 129.986 3.314 . . . . 7.32 107.488 175.018 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.83 -123.04 6.01 Favored Glycine 0 N--CA 1.43 -1.738 0 CA-C-N 123.073 2.67 . . . . 3.73 117.726 -164.011 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.786 0 N-CA-C 106.98 -2.448 . . . . 3.87 106.98 -179.429 . . . . . . . . 0 0 . 1 . 068 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 CA--C 1.49 -1.338 0 CA-C-O 118.662 -0.685 . . . . 1.39 112.825 . . . . . . . . . 0 0 . 1 . 068 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -97.96 148.74 23.16 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 120.316 1.416 . . . . 2.2 112.784 -176.492 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.0 pt -130.51 169.05 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.896 -2.377 . . . . 1.32 106.647 171.85 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -112.82 125.93 54.88 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.862 1.43 . . . . 2.2 114.862 179.585 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 t -114.76 116.64 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 126.782 3.182 . . . . 1.23 110.26 173.922 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -92.1 119.03 31.4 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 111.202 -2.726 . . . . 2.51 112.057 179.093 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.1 p -75.1 179.41 5.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.885 2.074 . . . . 1.41 111.488 -178.815 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.4 mt -60.59 -41.15 94.12 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.991 -1.068 . . . . 2.95 113.321 177.384 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.5 p -84.85 -38.21 19.76 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 115.491 -2.195 . . . . 2.52 116.9 178.434 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.92 29.57 0.22 Allowed Glycine 0 N--CA 1.429 -1.826 0 O-C-N 126.991 2.682 . . . . 1.5 111.91 175.571 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -86.76 131.49 34.12 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 119.99 1.895 . . . . 1.79 110.03 175.466 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.5 m -90.93 112.15 23.9 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 117.694 -1.603 . . . . 1.38 109.312 177.188 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.3 mm -95.43 117.21 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 102.666 -3.087 . . . . 2.03 102.666 178.72 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.7 m -100.32 105.13 16.63 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.176 -1.787 . . . . 1.61 106.176 -178.049 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' A' ' 29' ' ' LYS . 24.4 mt -103.12 146.24 28.69 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 118.592 -0.718 . . . . 2.15 109.881 -177.835 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -92.4 139.15 30.89 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 106.407 -1.701 . . . . 1.98 106.407 170.232 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.6 m -142.98 -177.58 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 100.204 -3.999 . . . . 1.52 100.204 -176.831 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -125.94 161.04 53.77 Favored Pre-proline 0 N--CA 1.43 -1.456 0 C-N-CA 128.28 2.632 . . . . 2.35 105.486 169.196 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -62.74 -21.99 73.51 Favored 'Trans proline' 0 C--N 1.3 -2.009 1 C-N-CA 127.832 5.688 . . . . 1.31 111.115 174.792 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 p -83.56 -5.59 59.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 125.898 1.999 . . . . 1.71 113.13 179.936 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -81.29 142.41 33.14 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 120.906 1.685 . . . . 1.69 112.533 179.18 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.2 p -87.88 165.28 15.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 128.143 3.402 . . . . 1.33 113.925 175.376 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.458 HG13 ' HB3' ' A' ' 50' ' ' LEU . 20.2 mm -62.67 -37.19 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 124.697 1.199 . . . . 1.32 111.643 177.957 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -54.94 -42.39 72.22 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 118.656 2.836 . . . . 1.62 118.656 168.515 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -62.88 -36.46 83.37 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 116.873 -3.642 . . . . 2.13 111.774 -178.998 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 30' ' ' ILE . 88.3 t -59.83 -48.29 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 C-N-CA 128.84 2.856 . . . . 1.23 114.112 171.229 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -55.85 -43.68 77.31 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 115.242 1.571 . . . . 1.97 115.242 169.689 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.62 -36.69 85.06 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.585 -3.197 . . . . 1.19 115.939 172.467 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.457 ' HB3' HD21 ' A' ' 15' ' ' LEU 0.281 41.2 mttm -54.42 -53.87 48.3 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.425 1.89 . . . . 1.92 112.566 167.867 . . . . . . . . 3 3 . 1 . 068 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 26' ' ' VAL . 71.9 mt -59.14 -34.79 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 O-C-N 118.198 -2.814 . . . . 1.94 117.751 176.373 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -69.14 -37.25 78.2 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 113.008 -1.906 . . . . 1.9 110.576 178.05 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -65.52 -41.85 92.65 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.988 2.327 . . . . 1.55 115.861 167.661 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -58.97 -82.12 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 125.779 2.704 . . . . 2.95 115.704 -177.73 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -95.56 -23.25 17.16 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.633 2.773 . . . . 1.48 112.939 -171.596 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.14 46.25 3.9 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 117.577 -2.249 . . . . 1.12 113.549 176.165 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.4 mt -105.38 132.09 21.18 Favored Pre-proline 0 N--CA 1.429 -1.475 0 CA-C-O 114.337 -2.744 . . . . 2.07 104.448 178.911 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -67.75 140.55 51.53 Favored 'Trans proline' 0 N--CA 1.434 -1.999 0 CA-C-N 125.439 2.978 . . . . 1.39 117.773 -178.402 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -75.27 -10.59 20.83 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 N-CA-C 120.835 3.359 . . . . 1.68 120.835 -174.173 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -88.7 17.77 5.25 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.35 1.46 . . . . 2.25 108.587 168.507 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -115.24 -31.68 5.91 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.927 -2.983 . . . . 2.44 107.167 -177.686 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -84.09 121.89 28.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 131.457 3.903 . . . . 1.32 117.315 -165.751 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -116.72 122.15 43.66 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.862 1.665 . . . . 3.19 107.545 -179.19 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -95.45 117.7 30.85 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 116.099 -1.905 . . . . 1.75 108.575 -178.427 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.406 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 30.0 mm -101.62 125.11 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 129.308 3.043 . . . . 1.98 111.294 176.888 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -150.9 115.59 5.2 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 127.892 3.71 . . . . 1.94 106.886 174.694 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 46.34 0.77 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 109.098 -3.683 . . . . 1.67 113.939 178.872 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.02 -16.29 0.88 Allowed Glycine 0 N--CA 1.43 -1.712 0 CA-C-O 116.558 -2.246 . . . . 1.3 118.398 -171.189 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -101.5 157.13 17.04 Favored 'General case' 0 N--CA 1.43 -1.464 1 CA-C-N 125.797 4.799 . . . . 2.89 103.326 -175.047 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -95.44 141.86 28.49 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.517 2.103 . . . . 2.89 106.3 172.779 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.458 ' HB3' HG13 ' A' ' 23' ' ' ILE . 81.7 mt -89.84 136.58 32.96 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.65 -2.531 . . . . 1.34 116.658 -169.909 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -65.29 133.05 50.6 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 120.999 3.703 . . . . 1.94 120.999 175.501 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -60.07 -49.67 76.75 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.759 2.695 . . . . 1.56 114.436 -170.567 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.76 45.61 1.41 Allowed Glycine 0 N--CA 1.43 -1.733 0 CA-C-N 111.374 -2.648 . . . . 0.97 116.653 179.303 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.422 ' HD3' ' CE2' ' A' ' 59' ' ' TYR . 62.3 ttt180 -130.54 127.41 39.05 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 128.271 2.983 . . . . 3.07 112.769 169.576 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.375 2.6 p -63.04 167.04 5.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 121.038 3.718 . . . . 1.34 121.038 173.738 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.4 mt -74.0 -43.28 58.59 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.662 -1.899 . . . . 1.63 110.935 176.464 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 t -60.59 -42.26 96.38 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 122.491 1.139 . . . . 1.51 114.035 176.053 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -56.03 -38.21 70.25 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 121.055 3.724 . . . . 1.9 121.055 173.575 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.422 ' CE2' ' HD3' ' A' ' 54' ' ' ARG . 21.8 m-85 -80.99 -15.87 55.0 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.282 -2.137 . . . . 0.97 111.158 175.242 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.3 m120 77.94 34.63 0.31 Allowed 'General case' 0 N--CA 1.43 -1.462 1 C-N-CA 132.998 4.519 . . . . 2.35 114.067 -177.732 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -89.69 117.48 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 130.295 3.438 . . . . 1.39 114.901 176.61 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -110.34 -178.23 3.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.031 1.872 . . . . 2.58 108.536 -174.869 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -59.11 153.5 17.88 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.4 -3.313 . . . . 2.58 116.251 179.128 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.3 32.2 mt-10 65.11 31.45 10.99 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 125.223 1.409 . . . . 1.71 110.817 175.115 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.2 t -96.67 152.06 19.02 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 104.06 -2.57 . . . . 1.34 104.06 -175.458 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.3 m -109.95 109.53 20.17 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.781 -1.824 . . . . 1.36 113.84 178.515 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.1 mt -106.39 145.33 31.86 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 128.943 2.897 . . . . 2.03 109.384 176.407 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 96.9 m-70 -109.41 127.52 54.44 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 114.239 -2.791 . . . . 2.31 112.72 -175.207 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.3 tp -93.81 120.89 34.67 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 123.444 2.838 . . . . 1.72 113.0 -175.517 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.9 t -110.62 149.42 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 108.101 -1.074 . . . . 1.8 108.101 175.923 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.2 mt -123.95 131.58 53.59 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.161 1.458 . . . . 3.26 114.531 -179.624 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.317 50.5 ptt85 -72.84 161.95 30.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.937 -3.602 . . . . 4.12 113.098 -178.344 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.16 112.73 3.15 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 117.864 2.542 . . . . 3.54 117.864 170.383 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.256 31.2 ptt180 -75.24 144.82 42.39 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 125.773 1.921 . . . . 7.32 114.968 -178.479 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.55 90.17 2.09 Favored Glycine 0 N--CA 1.429 -1.793 0 O-C-N 126.579 2.425 . . . . 3.73 115.604 -161.401 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.731 0 C-N-CA 126.777 2.132 . . . . 3.87 113.419 -174.613 . . . . . . . . 0 0 . 1 . 069 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 CA--C 1.49 -1.331 0 CA-C-O 123.532 1.634 . . . . 1.39 113.204 . . . . . . . . . 0 0 . 1 . 069 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -106.29 125.48 51.05 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.886 -2.384 . . . . 2.2 111.088 -173.702 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.1 pt -120.82 165.58 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 106.266 -1.753 . . . . 1.32 106.266 169.584 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -120.11 139.54 52.43 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.27 -2.769 . . . . 2.2 114.814 -177.02 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.1 t -124.22 125.85 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 118.456 -2.652 . . . . 1.23 108.58 174.029 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -90.6 122.92 33.82 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.798 -4.314 . . . . 2.51 109.695 176.567 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.0 p -91.0 167.32 12.48 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 126.905 2.082 . . . . 1.41 114.828 -179.758 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.3 mt -69.64 -36.8 76.41 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 113.961 1.097 . . . . 2.95 113.961 179.607 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.2 p -74.39 -67.63 0.6 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 130.637 3.575 . . . . 2.52 111.808 -176.881 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.95 62.78 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.638 0 CA-C-O 115.37 -2.906 . . . . 1.5 117.596 171.644 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -150.71 139.16 20.47 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 125.725 2.679 . . . . 1.79 113.818 179.91 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.7 m -102.6 97.42 7.62 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 103.861 -2.644 . . . . 1.38 103.861 174.994 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 mt -65.21 121.57 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 116.763 2.135 . . . . 2.03 116.763 176.184 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.4 m -84.94 105.94 16.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 122.572 2.442 . . . . 1.61 110.119 177.235 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.4 mt -101.11 133.77 45.13 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 123.44 1.591 . . . . 2.15 110.193 178.875 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -98.12 110.85 23.36 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 114.652 1.353 . . . . 1.98 114.652 166.909 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.458 HG22 HD11 ' A' ' 56' ' ' LEU . 8.9 m -127.08 176.36 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 128.169 2.588 . . . . 1.52 108.896 -174.8 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -116.18 163.76 20.42 Favored Pre-proline 0 N--CA 1.43 -1.455 0 C-N-CA 127.861 2.465 . . . . 2.35 106.56 161.777 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -84.58 -6.91 9.82 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 O-C-N 116.569 -2.385 . . . . 1.31 109.751 -166.474 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.4 m -93.23 -6.28 48.0 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.501 2.037 . . . . 1.71 116.501 174.626 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -69.18 147.17 51.71 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 118.801 -1.16 . . . . 1.69 109.639 174.523 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 75.7 p -82.88 175.51 10.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.432 -2.043 . . . . 1.33 112.128 -178.72 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.8 mm -70.24 -42.89 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-O 123.918 1.818 . . . . 1.32 109.316 173.646 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -47.03 -47.77 22.29 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 119.022 2.971 . . . . 1.62 119.022 162.706 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -65.75 -38.18 88.38 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 116.174 -4.079 . . . . 2.13 114.132 174.958 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.42 HG21 HD13 ' A' ' 56' ' ' LEU . 53.5 t -62.52 -39.31 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 126.758 3.171 . . . . 1.23 111.103 176.012 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -65.99 -33.43 75.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.586 -2.571 . . . . 1.97 114.094 174.131 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.59 -34.1 77.13 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.308 2.255 . . . . 1.19 115.004 173.739 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -74.67 -16.28 60.77 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.309 -2.744 . . . . 1.92 114.811 174.995 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.3 mt -87.0 -36.17 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 127.102 3.334 . . . . 1.94 107.487 171.657 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.97 -38.52 88.77 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.203 -2.811 . . . . 1.9 109.099 -178.274 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -55.93 -48.08 76.36 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.913 -2.992 . . . . 1.55 115.647 170.469 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -79.37 -52.16 8.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.141 -1.6 . . . . 2.95 113.446 -176.243 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -112.44 -8.84 13.87 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.83 1.3 . . . . 1.48 110.386 -161.67 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.98 21.72 60.68 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 118.223 -2.798 . . . . 1.12 113.995 173.601 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mt -83.7 123.38 76.31 Favored Pre-proline 0 N--CA 1.431 -1.386 0 CA-C-O 112.655 -3.545 . . . . 2.07 115.342 -174.555 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -65.81 136.45 45.5 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 CA-C-N 127.199 3.607 . . . . 1.39 116.269 -179.69 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -60.71 -23.0 75.09 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 N-CA-C 117.383 2.032 . . . . 1.68 117.383 -177.286 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.17 -19.5 61.1 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.233 2.213 . . . . 2.25 109.9 177.716 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -92.22 -39.84 11.32 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 130.271 3.428 . . . . 2.44 109.963 -170.654 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -74.45 123.77 25.32 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 113.458 -1.701 . . . . 1.32 113.863 -171.216 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.478 HH12 ' C ' ' A' ' 76' ' ' GLY . 81.4 mtt180 -117.61 123.48 46.28 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 124.379 1.049 . . . . 3.19 109.216 167.792 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.5 mt -105.49 131.34 53.02 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.117 2.389 . . . . 1.75 106.264 -175.965 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.2 mm -116.9 145.57 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 120.349 -1.469 . . . . 1.98 113.49 -178.888 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -161.06 105.07 1.32 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.686 1.736 . . . . 1.94 115.686 174.821 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.468 . . 61.68 32.37 18.41 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 118.003 2.594 . . . . 1.67 118.003 -179.87 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.48 -15.55 45.86 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 119.163 0.892 . . . . 1.3 112.173 -177.497 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -102.46 124.71 48.51 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.732 -2.628 . . . . 2.89 115.277 174.694 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -81.3 145.97 30.63 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 102.714 -3.069 . . . . 2.89 102.714 165.129 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.3 mt -101.75 123.33 45.54 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 114.809 1.411 . . . . 1.34 114.809 -172.954 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.56 157.49 18.59 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 116.489 -2.085 . . . . 1.94 115.174 175.289 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.26 -63.55 1.19 Allowed 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 118.509 2.781 . . . . 1.56 118.509 -165.106 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.68 30.83 4.07 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 116.943 1.537 . . . . 0.97 116.943 176.418 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.7 mmt-85 -99.21 159.0 15.3 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 119.052 -1.059 . . . . 3.07 110.046 162.384 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.8 p -97.19 162.87 13.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.692 -3.755 . . . . 1.34 114.163 178.949 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.458 HD11 HG22 ' A' ' 17' ' ' VAL . 62.5 mt -58.24 -14.82 8.0 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 126.367 2.984 . . . . 1.63 113.864 170.436 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 t -85.12 -42.34 14.87 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.388 -2.695 . . . . 1.51 116.089 172.543 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -63.82 -39.48 94.34 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 127.833 2.453 . . . . 1.9 110.929 175.426 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -80.0 -8.7 59.49 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.784 2.034 . . . . 0.97 110.925 174.923 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.337 57.1 m-80 54.44 45.43 27.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.196 3.406 . . . . 2.35 120.196 -175.979 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.4 mm -78.68 123.99 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 126.132 1.773 . . . . 1.39 113.159 174.65 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -101.89 175.88 5.4 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 114.58 1.326 . . . . 2.58 114.58 -172.333 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -70.45 129.85 40.34 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 126.691 3.139 . . . . 2.58 112.537 -179.603 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.477 7.0 mt-10 67.7 35.99 3.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 125.499 2.571 . . . . 1.71 112.551 -179.858 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.301 4.4 t -94.63 126.94 40.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 109.559 -3.473 . . . . 1.34 110.29 -176.537 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.7 m -96.14 119.55 34.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.948 -1.72 . . . . 1.36 111.061 -169.845 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.5 mt -97.75 148.02 23.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 129.01 2.924 . . . . 2.03 108.745 175.249 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -106.71 137.42 44.76 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.744 -4.348 . . . . 2.31 106.264 178.566 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.5 tp -108.73 121.03 44.19 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.754 -3.091 . . . . 1.72 110.526 -178.106 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.0 t -109.85 153.6 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 130.969 3.707 . . . . 1.8 107.707 178.991 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.3 mt -125.23 157.73 35.82 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 119.079 -2.263 . . . . 3.26 115.251 178.427 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -94.16 151.92 19.12 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 115.6 -2.143 . . . . 4.12 110.113 -174.455 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.3 mt -128.28 -87.76 0.55 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.741 1.386 . . . . 3.54 114.741 177.373 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -109.86 -111.41 0.32 Allowed 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.497 2.094 . . . . 7.32 106.487 165.965 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.72 53.76 0.59 Allowed Glycine 0 N--CA 1.432 -1.626 0 O-C-N 117.741 -3.099 . . . . 3.73 108.69 -158.605 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.478 ' C ' HH12 ' A' ' 42' ' ' ARG . . . . . . . . 0 C--O 1.26 1.773 0 C-N-CA 126.948 2.213 . . . . 3.87 114.935 172.441 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 ptt? . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 115.09 1.515 . . . . 1.39 115.09 . . . . . . . . . 0 0 . 1 . 070 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -101.86 133.87 45.93 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.056 -1.652 . . . . 2.2 113.973 -172.652 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -130.77 159.93 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 104.321 -2.474 . . . . 1.32 104.321 174.275 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -119.55 120.87 38.0 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.065 2.946 . . . . 2.2 110.053 -174.111 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.404 ' CG1' ' HB2' ' A' ' 69' ' ' LEU . 94.9 t -105.69 115.19 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 119.889 -1.757 . . . . 1.23 110.439 172.979 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -96.37 134.21 39.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 103.639 -2.726 . . . . 2.51 103.639 179.626 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.269 28.0 p -80.86 169.85 17.04 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 118.044 -2.91 . . . . 1.41 112.665 171.813 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.4 mt -54.81 -49.64 70.52 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.961 3.305 . . . . 2.95 116.951 167.916 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.49 -62.26 1.47 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.408 3.004 . . . . 2.52 107.993 -172.029 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.78 12.27 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 116.929 -2.558 . . . . 1.5 116.78 179.618 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.416 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 86.4 mttt -101.01 154.43 18.71 Favored 'General case' 0 N--CA 1.429 -1.504 1 CA-C-N 126.147 4.974 . . . . 1.79 106.895 -169.148 . . . . . . . . 3 3 . 1 . 070 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -113.04 108.91 17.97 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.426 -1.421 . . . . 1.38 108.928 167.063 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.9 mt -88.36 124.5 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 105.823 -1.918 . . . . 2.03 105.823 177.999 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.0 m -91.44 130.52 37.27 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 104.721 -2.325 . . . . 1.61 104.721 179.298 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mt -118.56 155.4 30.97 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 112.969 0.729 . . . . 2.15 112.969 179.685 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -113.03 130.14 56.25 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 100.596 -3.853 . . . . 1.98 100.596 167.765 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.1 m -143.95 156.35 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 126.39 1.876 . . . . 1.52 107.506 -176.805 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 36.1 mm-40 -114.21 154.46 46.26 Favored Pre-proline 0 N--CA 1.431 -1.416 0 C-N-CA 126.141 1.776 . . . . 2.35 110.036 168.042 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 53.4 Cg_exo -73.72 -25.7 14.4 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 CA-C-N 125.672 3.062 . . . . 1.31 117.195 -165.355 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -91.24 4.58 51.95 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 122.575 1.179 . . . . 1.71 113.657 177.984 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -64.77 149.43 49.3 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 115.018 -2.673 . . . . 1.69 112.649 165.995 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.319 21.6 p -87.03 169.45 12.41 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 116.049 -2.26 . . . . 1.33 112.743 177.656 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.91 -37.06 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 113.16 0.8 . . . . 1.32 113.16 171.185 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -57.42 -37.57 72.97 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.656 -3.152 . . . . 1.62 110.663 172.059 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -75.42 -28.12 59.27 Favored 'General case' 0 N--CA 1.43 -1.473 1 O-C-N 115.174 -4.704 . . . . 2.13 111.448 -179.217 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.9 t -71.07 -39.51 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.122 1.369 . . . . 1.23 112.474 172.239 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -63.83 -39.91 95.34 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 118.958 0.799 . . . . 1.97 111.97 170.966 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.14 68.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 119.977 3.325 . . . . 1.19 119.977 172.068 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -63.35 -35.44 80.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 115.32 -2.276 . . . . 1.92 112.91 165.856 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.3 mt -73.8 -40.17 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 123.138 2.699 . . . . 1.94 110.608 171.112 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -51.47 -45.89 62.92 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.671 2.788 . . . . 1.9 117.28 176.425 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -60.57 -28.83 68.77 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.433 -2.667 . . . . 1.55 116.279 174.957 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -94.93 -61.83 1.42 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 104.893 -2.262 . . . . 2.95 104.893 -173.139 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.416 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 42.1 mm-40 -98.87 -8.43 25.71 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 118.894 -2.378 . . . . 1.48 113.486 -169.744 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.76 5.64 89.68 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 118.389 -2.694 . . . . 1.12 113.365 174.695 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.1 mt -88.02 131.75 41.99 Favored Pre-proline 0 N--CA 1.429 -1.505 0 CA-C-N 121.523 2.662 . . . . 2.07 111.742 -175.086 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -64.58 146.57 89.29 Favored 'Trans proline' 0 C--N 1.3 -1.993 1 CA-C-N 129.058 4.271 . . . . 1.39 118.274 -177.359 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -68.33 -11.86 33.23 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 C-N-CA 123.029 2.486 . . . . 1.68 113.696 -177.581 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -77.87 -24.98 48.32 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.787 -3.696 . . . . 2.25 110.757 170.787 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -83.16 -39.71 20.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 116.352 -2.139 . . . . 2.44 108.49 176.67 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -63.93 125.8 25.6 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 126.611 1.965 . . . . 1.32 113.604 -172.171 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -118.9 118.52 31.75 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.158 -2.839 . . . . 3.19 108.19 170.708 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.6 mt -98.4 128.81 44.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.139 -2.225 . . . . 1.75 112.243 -174.788 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mm -110.05 137.57 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 125.386 1.474 . . . . 1.98 107.543 -179.812 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -146.61 144.59 29.64 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 125.963 1.705 . . . . 1.94 108.392 165.806 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.24 -107.53 0.15 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 123.832 0.707 . . . . 1.67 112.014 172.496 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.2 18.11 4.75 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 108.134 -1.987 . . . . 1.3 108.134 177.333 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -133.45 149.28 51.78 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.606 1.669 . . . . 2.89 114.455 177.114 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -93.67 130.65 39.54 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.238 -4.039 . . . . 2.89 103.831 174.271 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.336 79.4 mt -87.24 138.06 31.81 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.589 -1.944 . . . . 1.34 113.743 -168.485 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -85.8 164.08 17.77 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 117.85 -3.031 . . . . 1.94 111.671 -179.4 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -67.44 -62.89 1.2 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.315 -3.99 . . . . 1.56 118.931 -170.45 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.93 40.17 0.82 Allowed Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 129.495 3.426 . . . . 0.97 114.03 172.04 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -119.51 158.9 25.34 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.484 3.142 . . . . 3.07 105.605 168.179 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.4 p -100.09 164.17 12.1 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 125.76 1.912 . . . . 1.34 115.356 176.714 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.18 -43.95 97.68 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 117.851 -3.031 . . . . 1.63 109.947 178.667 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.0 m -53.6 -49.51 67.65 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.424 -3.297 . . . . 1.51 116.405 170.759 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -51.82 -39.29 58.54 Favored 'General case' 0 N--CA 1.429 -1.475 1 O-C-N 116.225 -4.047 . . . . 1.9 114.764 172.317 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -85.87 -13.01 49.24 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.325 1.972 . . . . 0.97 116.325 177.006 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.416 27.9 m120 75.03 23.39 1.65 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 124.163 1.935 . . . . 2.35 115.712 -177.772 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.9 mt -77.07 102.06 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 118.34 -2.725 . . . . 1.39 111.77 179.112 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -90.53 -178.99 5.46 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 125.814 2.721 . . . . 2.58 110.398 -176.389 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.4 pttp -66.46 151.69 46.68 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.163 -3.461 . . . . 2.58 113.007 174.396 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.522 90.5 mt-10 90.71 -15.55 0.22 Allowed 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.995 2.918 . . . . 1.71 115.356 -179.102 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.6 m -68.54 137.38 54.3 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.643 2.831 . . . . 1.34 118.643 -171.244 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.5 m -96.6 109.18 21.84 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 119.795 -1.816 . . . . 1.36 113.533 -179.468 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -92.79 163.66 13.64 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.74 3.15 . . . . 2.03 109.92 174.43 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.279 39.1 m80 -124.56 119.82 30.17 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.35 -1.295 . . . . 2.31 107.678 -173.347 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.404 ' HB2' ' CG1' ' A' ' 5' ' ' VAL 0.263 3.4 tt -91.71 104.67 17.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.496 -3.253 . . . . 1.72 115.567 -177.05 . . . . . . . . 3 3 . 1 . 070 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.2 t -93.44 144.46 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 105.674 -1.973 . . . . 1.8 105.674 177.529 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.3 mt -117.24 145.55 43.85 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.601 2.62 . . . . 3.26 111.766 177.623 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -94.82 149.61 21.06 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 116.04 -4.163 . . . . 4.12 103.956 176.382 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.1 tp -76.56 127.65 33.22 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 130.581 3.553 . . . . 3.54 107.31 179.144 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -68.1 -84.52 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.049 -2.907 . . . . 7.32 116.324 174.466 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.82 -88.31 0.58 Allowed Glycine 0 N--CA 1.43 -1.735 1 N-CA-C 97.972 -6.051 . . . . 3.73 97.972 -173.244 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.748 0 CA-C-O 114.535 -3.369 . . . . 3.87 109.327 177.688 . . . . . . . . 0 0 . 1 . 071 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptt? . . . . . 0 CA--C 1.49 -1.354 0 N-CA-C 107.393 -1.336 . . . . 1.39 107.393 . . . . . . . . . 0 0 . 1 . 071 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -94.23 126.92 39.77 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 114.134 1.161 . . . . 2.2 114.134 178.649 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.422 HG12 HG22 ' A' ' 17' ' ' VAL . 42.5 pt -115.91 163.08 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 107.628 -1.249 . . . . 1.32 107.628 165.886 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -125.05 132.65 53.16 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.984 -1.073 . . . . 2.2 108.111 -178.196 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.5 t -109.45 130.47 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 105.246 -2.131 . . . . 1.23 105.246 174.736 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -118.31 136.1 53.91 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.826 -2.421 . . . . 2.51 108.258 173.581 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.6 p -87.75 174.02 8.64 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 116.393 -3.942 . . . . 1.41 109.554 177.021 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 70' ' ' VAL . 5.2 mt -73.43 -23.85 60.17 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 127.677 3.608 . . . . 2.95 117.802 172.193 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 p -88.98 -12.91 40.16 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.517 -3.239 . . . . 2.52 107.786 -175.08 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.4 32.53 3.93 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 115.519 0.968 . . . . 1.5 115.519 167.922 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -113.14 137.9 50.75 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 114.279 -2.968 . . . . 1.79 103.493 -178.228 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.271 32.9 m -109.01 125.2 51.82 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.484 2.088 . . . . 1.38 110.783 -179.129 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.7 mt -109.52 121.97 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.828 -3.045 . . . . 2.03 109.629 179.347 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.3 m -95.84 119.4 34.27 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 114.604 -5.06 . . . . 1.61 110.734 176.966 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.7 mt -126.99 138.97 53.35 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 116.953 -3.592 . . . . 2.15 117.49 -176.27 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -97.83 108.8 21.59 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.709 2.003 . . . . 1.98 109.683 178.781 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.422 HG22 HG12 ' A' ' 3' ' ' ILE . 0.4 OUTLIER -120.11 157.23 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 128.283 2.633 . . . . 1.52 108.908 178.514 . . . . . . . . 3 3 . 1 . 071 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -98.06 148.79 34.98 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-O 115.069 -2.396 . . . . 2.35 113.108 156.522 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.88 -13.77 34.83 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 125.29 3.993 . . . . 1.31 113.112 -172.459 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m -74.08 -25.76 60.0 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.705 1.878 . . . . 1.71 106.1 174.354 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -67.19 140.34 57.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.513 -2.617 . . . . 1.69 116.166 -179.828 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.499 HG21 HG22 ' A' ' 55' ' ' THR . 50.7 p -83.28 161.16 21.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 111.397 -2.638 . . . . 1.33 113.094 -172.398 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.465 HG22 ' HE3' ' A' ' 27' ' ' LYS . 29.7 mm -59.09 -46.8 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 1 C-N-CA 134.742 5.217 . . . . 1.32 109.505 176.065 . . . . . . . . 3 3 . 1 . 071 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -47.8 -40.08 19.99 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 127.084 2.154 . . . . 1.62 114.283 163.124 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -76.56 -24.64 53.57 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.765 -3.084 . . . . 2.13 116.71 176.304 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.3 t -74.63 -40.43 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 124.151 0.98 . . . . 1.23 111.733 173.996 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.465 ' HE3' HG22 ' A' ' 23' ' ' ILE . 91.3 mttt -61.38 -29.23 69.79 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.193 1.797 . . . . 1.97 113.249 173.357 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.22 -33.72 76.39 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.513 -1.992 . . . . 1.19 111.095 175.747 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.271 56.2 mttm -61.74 -43.05 99.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.475 -2.641 . . . . 1.92 114.985 176.287 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.0 mt -70.3 -33.87 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 C-N-CA 127.874 2.469 . . . . 1.94 109.364 175.402 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -64.14 -50.59 67.62 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 116.554 -3.841 . . . . 1.9 112.624 179.805 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -54.04 -49.7 68.38 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.293 2.637 . . . . 1.55 111.403 171.668 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -79.63 -61.23 2.06 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.55 2.426 . . . . 2.95 117.55 -178.478 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -87.3 -29.17 21.81 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.056 2.243 . . . . 1.48 117.056 -167.31 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.07 13.8 14.88 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 119.55 -1.309 . . . . 1.12 113.677 171.823 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.9 mt -96.14 119.67 64.08 Favored Pre-proline 0 N--CA 1.43 -1.434 1 CA-C-O 111.533 -4.079 . . . . 2.07 107.001 -171.053 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -70.57 159.11 53.89 Favored 'Trans proline' 0 N--CA 1.433 -2.035 1 CA-C-N 129.31 4.361 . . . . 1.39 113.831 172.996 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -68.37 -26.37 35.08 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 C-N-CA 122.784 2.323 . . . . 1.68 113.759 -173.131 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -56.47 -33.34 65.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.985 2.514 . . . . 2.25 110.151 174.108 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -98.65 19.79 14.07 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.248 1.944 . . . . 2.44 116.248 175.972 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -127.44 113.15 15.81 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.985 -1.117 . . . . 1.32 107.985 -175.501 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.428 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 14.0 tpp180 -110.28 127.74 55.16 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.797 -0.816 . . . . 3.19 108.797 173.857 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.5 mt -110.3 143.01 41.14 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 112.791 -3.48 . . . . 1.75 114.566 179.419 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.2 mt -128.65 143.24 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 129.031 3.957 . . . . 1.98 105.165 -174.28 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -155.1 136.3 13.95 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.162 -2.211 . . . . 1.94 105.779 168.912 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.251 . . 61.81 26.17 15.84 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 118.556 2.798 . . . . 1.67 118.556 175.837 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.2 -14.13 63.12 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-O 117.557 -1.691 . . . . 1.3 110.604 -173.867 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -97.66 126.95 43.26 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 125.602 1.413 . . . . 2.89 112.794 -171.599 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -80.67 112.31 17.92 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 124.811 2.243 . . . . 2.89 106.448 170.54 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.5 mt -74.67 124.85 27.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.92 2.888 . . . . 1.34 115.664 -176.222 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -87.68 142.11 28.08 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 118.733 2.864 . . . . 1.94 118.733 178.772 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -46.83 -66.77 0.36 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.948 2.499 . . . . 1.56 117.692 -173.072 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.56 35.87 0.84 Allowed Glycine 0 N--CA 1.43 -1.723 0 CA-C-O 125.033 2.463 . . . . 0.97 116.871 171.023 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -115.81 175.64 5.44 Favored 'General case' 0 N--CA 1.429 -1.507 1 O-C-N 113.785 -5.538 . . . . 3.07 107.956 166.299 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.499 HG22 HG21 ' A' ' 22' ' ' THR . 60.0 p -106.95 -174.68 2.59 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.515 -1.99 . . . . 1.34 110.759 175.665 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mt -80.91 -37.01 30.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.877 2.071 . . . . 1.63 108.995 176.449 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.8 t -57.14 -48.4 78.78 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 128.235 3.459 . . . . 1.51 110.884 174.538 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -49.62 -29.7 7.62 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.203 3.038 . . . . 1.9 119.203 175.665 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -111.33 1.55 17.15 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.621 -1.299 . . . . 0.97 109.315 -179.577 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 61.77 40.05 13.36 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.954 2.902 . . . . 2.35 109.324 -178.176 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.9 mt -78.59 114.82 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 124.257 1.98 . . . . 1.39 107.489 172.852 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.403 ' HB3' ' H ' ' A' ' 63' ' ' LYS . 35.5 mt-30 -108.59 -158.58 0.65 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.049 -2.907 . . . . 2.58 115.608 -179.325 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' H ' ' HB3' ' A' ' 62' ' ' GLN 0.273 25.3 pttt -74.67 138.74 43.04 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.72 -2.487 . . . . 2.58 113.822 -179.235 . . . . . . . . 3 3 . 1 . 071 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 71.87 31.2 2.13 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 124.723 2.201 . . . . 1.71 114.821 178.852 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.3 m -86.59 121.46 29.15 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 113.161 -1.836 . . . . 1.34 115.138 -178.786 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.1 m -92.88 120.48 33.27 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 118.0 -2.937 . . . . 1.36 107.382 176.028 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.1 mt -94.35 147.8 22.86 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.159 -1.837 . . . . 2.03 107.582 171.832 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -92.35 123.6 35.79 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.85 2.46 . . . . 2.31 108.34 176.941 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.47 117.54 31.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 122.257 2.299 . . . . 1.72 107.601 175.244 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 78.0 t -106.61 129.91 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 130.77 3.628 . . . . 1.8 102.672 -176.191 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -86.88 131.99 33.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.446 -2.659 . . . . 3.26 114.129 171.266 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -114.33 167.73 10.46 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.002 -2.311 . . . . 4.12 110.554 -175.949 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.4 mt -115.04 143.97 44.35 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 118.752 -2.467 . . . . 3.54 108.785 172.653 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -60.75 108.94 0.92 Allowed 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.662 -1.899 . . . . 7.32 115.838 173.183 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 131.53 -35.55 2.39 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.281 -1.512 . . . . 3.73 114.367 -166.225 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.796 1 O-C-N 116.348 -4.031 . . . . 3.87 111.807 -173.996 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ptt? . . . . . 0 CA--C 1.491 -1.323 0 N-CA-C 116.767 2.136 . . . . 1.39 116.767 . . . . . . . . . 0 0 . 1 . 072 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.293 19.6 mt-30 -107.47 129.52 54.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 103.941 -2.615 . . . . 2.2 103.941 -176.717 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.9 pt -113.79 153.89 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 117.524 -1.226 . . . . 1.32 110.795 165.623 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -107.02 147.64 29.68 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 122.389 1.09 . . . . 2.2 112.528 174.879 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.2 t -124.05 128.22 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.828 2.051 . . . . 1.23 108.105 176.488 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -107.31 144.93 33.45 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.319 -2.113 . . . . 2.51 106.432 178.822 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 p -89.19 -168.17 2.09 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.291 2.7 . . . . 1.41 118.291 179.796 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 mt -65.87 -52.89 46.35 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.956 1.703 . . . . 2.95 111.721 174.696 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.4 p -70.77 -52.59 19.69 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.081 -2.262 . . . . 2.52 115.428 -178.235 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.27 50.49 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 104.529 -3.428 . . . . 1.5 104.529 171.626 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -107.29 147.88 29.69 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.522 -2.752 . . . . 1.79 107.303 175.598 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.0 m -102.21 136.19 42.48 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 103.131 -2.915 . . . . 1.38 103.131 179.034 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.2 mt -122.75 120.75 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-O 125.371 2.51 . . . . 2.03 108.297 176.659 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.1 m -92.75 125.5 37.4 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.391 -2.693 . . . . 1.61 106.398 177.393 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 68.5 mt -116.03 142.4 46.85 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 129.1 4.0 . . . . 2.15 112.657 170.452 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -98.73 123.73 43.13 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 120.656 1.571 . . . . 1.98 109.259 172.026 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.413 HG11 HG22 ' A' ' 26' ' ' VAL . 27.8 m -139.67 171.71 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 O-C-N 118.486 -2.634 . . . . 1.52 106.659 -177.788 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -121.47 162.15 37.66 Favored Pre-proline 0 N--CA 1.43 -1.468 0 N-CA-C 103.21 -2.885 . . . . 2.35 103.21 156.773 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -76.39 -3.4 13.77 Favored 'Trans proline' 0 N--CA 1.434 -1.971 0 C-N-CA 124.595 3.53 . . . . 1.31 111.192 -168.819 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.1 m -86.84 -5.25 59.16 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.614 3.102 . . . . 1.71 113.084 178.543 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -78.79 147.36 33.33 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.873 -3.642 . . . . 1.69 116.919 175.996 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 35.1 p -72.46 158.96 34.76 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 118.183 -0.913 . . . . 1.33 112.814 177.701 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.6 mm -67.87 -31.37 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 126.852 2.595 . . . . 1.32 112.813 173.713 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -60.47 -30.98 70.02 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.352 -2.718 . . . . 1.62 114.353 170.966 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -76.74 -35.82 57.52 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.846 -1.784 . . . . 2.13 109.41 176.037 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.413 HG22 HG11 ' A' ' 17' ' ' VAL . 92.9 t -69.82 -34.21 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 119.105 -2.247 . . . . 1.23 113.099 178.294 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -69.85 -18.18 63.42 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.114 -2.241 . . . . 1.97 115.869 170.783 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.07 -19.47 43.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.303 1.441 . . . . 1.19 112.474 -179.585 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -78.68 -33.4 47.02 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.171 1.788 . . . . 1.92 111.469 172.173 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.3 mt -76.53 -24.08 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 107.603 -1.258 . . . . 1.94 107.603 173.707 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -67.14 -32.08 72.95 Favored 'General case' 0 N--CA 1.429 -1.491 2 O-C-N 114.999 -4.813 . . . . 1.9 115.89 175.042 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -73.59 -31.12 63.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.836 -1.165 . . . . 1.55 112.09 166.795 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -83.66 -72.86 0.44 Allowed 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.45 -2.056 . . . . 2.95 105.45 -170.321 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -93.86 -7.62 42.7 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 115.574 1.694 . . . . 1.48 115.574 -167.309 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.76 16.22 77.98 Favored Glycine 0 N--CA 1.429 -1.782 0 O-C-N 117.679 -3.138 . . . . 1.12 115.74 176.729 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.1 mt -89.03 128.44 51.88 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 116.99 -3.653 . . . . 2.07 104.369 -178.977 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -70.15 142.31 45.88 Favored 'Trans proline' 0 N--CA 1.433 -2.044 0 CA-C-N 126.671 3.418 . . . . 1.39 114.565 179.311 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -58.1 -17.28 30.94 Favored 'Trans proline' 0 N--CA 1.434 -2.022 1 C-N-CA 126.345 4.696 . . . . 1.68 115.905 -176.942 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -75.82 -18.98 59.28 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.346 2.339 . . . . 2.25 116.33 170.337 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -97.37 2.37 50.44 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 121.272 1.851 . . . . 2.44 115.94 179.885 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -105.79 139.75 39.88 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 111.058 -2.792 . . . . 1.32 111.408 -172.225 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -132.73 122.5 24.67 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.174 2.19 . . . . 3.19 112.536 167.59 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.2 mt -88.11 138.86 31.07 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 106.459 -1.682 . . . . 1.75 106.459 174.082 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mt -119.96 132.68 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 127.424 2.29 . . . . 1.98 105.209 178.344 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -155.16 123.1 5.78 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.165 2.257 . . . . 1.94 110.39 170.54 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.284 . . 75.41 37.01 0.46 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.623 3.569 . . . . 1.67 114.152 176.449 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.05 -24.05 6.43 Favored Glycine 0 N--CA 1.43 -1.749 0 CA-C-O 115.777 -2.679 . . . . 1.3 112.412 -173.929 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -102.94 148.1 26.08 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 120.66 2.23 . . . . 2.89 112.102 -175.834 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -88.15 150.46 23.32 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 122.068 0.937 . . . . 2.89 109.542 171.926 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.1 mt -97.02 133.42 41.72 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.251 1.82 . . . . 1.34 108.715 -169.561 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -80.73 146.09 31.21 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.393 -1.276 . . . . 1.94 109.754 177.166 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -65.39 -59.21 4.26 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.211 -3.43 . . . . 1.56 120.092 -169.542 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.98 32.06 1.51 Allowed Glycine 0 N--CA 1.431 -1.692 0 CA-C-N 111.479 -2.601 . . . . 0.97 119.171 173.079 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 22' ' ' THR . 30.8 mmt180 -105.12 176.69 5.08 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 104.2 -2.518 . . . . 3.07 104.2 164.676 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.3 p -107.26 167.22 10.07 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 112.612 -2.085 . . . . 1.34 112.022 171.462 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.9 mt -67.07 -38.31 85.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.058 2.837 . . . . 1.63 113.637 175.678 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.9 t -69.01 -19.2 64.12 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 119.666 3.21 . . . . 1.51 119.666 173.842 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -58.7 -51.99 67.6 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 114.875 -2.488 . . . . 1.9 104.658 172.844 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -81.69 -8.57 59.72 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 129.404 3.081 . . . . 0.97 113.488 -176.053 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 m120 59.98 56.68 3.32 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 116.589 -3.819 . . . . 2.35 117.677 -173.461 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.2 mt -96.54 117.71 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 104.968 -2.234 . . . . 1.39 104.968 -178.284 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -97.71 -176.57 3.51 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.037 -2.289 . . . . 2.58 105.755 -171.85 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.5 pttt -65.85 151.69 46.11 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.644 2.64 . . . . 2.58 116.471 174.521 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 60.98 15.26 5.95 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 131.654 3.981 . . . . 1.71 114.213 176.02 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 t -76.16 150.22 37.19 Favored 'General case' 0 N--CA 1.429 -1.486 1 C-N-CA 132.318 4.247 . . . . 1.34 109.134 -177.541 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.6 m -103.49 105.47 15.74 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.587 -3.196 . . . . 1.36 113.19 -179.417 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -82.77 168.38 17.24 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 106.126 -1.805 . . . . 2.03 106.126 170.902 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -121.56 135.57 55.0 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.31 -2.744 . . . . 2.31 108.867 -179.271 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.4 tp -109.16 117.37 33.95 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.08 2.848 . . . . 1.72 111.386 -177.594 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 t -105.96 146.28 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 1 O-C-N 115.932 -4.23 . . . . 1.8 112.22 174.474 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.9 mt -108.12 126.28 52.58 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 117.847 2.536 . . . . 3.26 117.847 178.512 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -88.03 156.41 19.31 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.341 -2.099 . . . . 4.12 107.334 176.494 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.9 tp -124.2 -84.09 0.65 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 118.33 -0.843 . . . . 3.54 111.905 178.37 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -95.84 -81.04 0.41 Allowed 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 131.59 3.956 . . . . 7.32 111.878 175.019 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.48 135.35 3.67 Favored Glycine 0 N--CA 1.431 -1.666 1 CA-C-O 111.563 -5.02 . . . . 3.73 108.525 -164.567 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.767 0 O-C-N 127.754 2.679 . . . . 3.87 111.034 179.711 . . . . . . . . 0 0 . 1 . 073 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.269 0.7 OUTLIER . . . . . 0 CA--C 1.491 -1.312 0 N-CA-C 104.38 -2.452 . . . . 1.39 104.38 . . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -89.86 127.73 36.05 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 117.263 -1.351 . . . . 2.2 107.557 -179.114 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.3 pt -115.11 138.83 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 122.105 2.23 . . . . 1.32 106.658 165.764 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -97.88 118.23 33.98 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.13 0.972 . . . . 2.2 109.794 -178.008 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.5 t -99.56 124.38 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.613 1.965 . . . . 1.23 106.289 174.069 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -117.62 126.92 53.38 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 125.189 1.396 . . . . 2.51 110.155 -175.395 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.289 7.3 p -74.49 176.01 7.23 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 128.485 2.714 . . . . 1.41 117.344 -179.364 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.9 tp -67.99 -56.11 10.19 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.95 1.705 . . . . 2.95 113.219 166.224 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 p -62.52 -53.02 61.01 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 118.462 2.764 . . . . 2.52 118.462 -176.378 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.79 30.09 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 119.122 2.409 . . . . 1.5 119.122 176.87 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -103.58 138.48 40.2 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 119.061 1.43 . . . . 1.79 107.89 176.697 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.1 m -105.09 118.93 37.78 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.194 -2.15 . . . . 1.38 105.194 169.019 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.6 mt -101.49 115.22 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 106.741 -1.577 . . . . 2.03 106.741 176.592 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.9 m -96.52 124.35 40.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 120.804 1.638 . . . . 1.61 112.493 176.004 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.268 84.0 mt -116.03 127.71 55.12 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 127.959 3.743 . . . . 2.15 109.688 -173.217 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -80.02 108.21 13.43 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.1 -3.5 . . . . 1.98 114.68 168.723 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.87 160.87 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 125.373 1.469 . . . . 1.52 111.982 -179.082 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -97.46 161.44 25.96 Favored Pre-proline 0 N--CA 1.431 -1.388 0 C-N-CA 127.794 2.437 . . . . 2.35 107.065 159.852 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -71.14 -15.77 31.98 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 C-N-CA 124.164 3.243 . . . . 1.31 112.29 179.064 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 p -83.38 -2.6 56.16 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.347 1.459 . . . . 1.71 112.503 174.746 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -77.82 140.89 39.44 Favored 'General case' 0 N--CA 1.431 -1.4 1 O-C-N 116.216 -4.053 . . . . 1.69 110.579 169.805 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.361 22.9 p -81.05 176.23 9.99 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 110.759 -2.928 . . . . 1.33 114.892 179.717 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.402 HD12 HD12 ' A' ' 50' ' ' LEU . 44.2 mm -85.76 -20.77 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 CA-C-N 121.252 1.842 . . . . 1.32 108.526 175.581 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -56.01 -38.27 70.28 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.103 2.561 . . . . 1.62 113.058 165.37 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -71.88 -33.23 68.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.05 2.14 . . . . 2.13 114.961 176.348 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.327 79.1 t -65.33 -48.23 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 C-N-CA 128.065 2.546 . . . . 1.23 110.067 173.841 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -69.96 -26.81 64.28 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.945 -2.347 . . . . 1.97 115.552 174.703 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.75 -37.07 83.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.282 -2.761 . . . . 1.19 113.37 171.445 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.1 mttm -65.37 -51.61 59.26 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.91 -1.744 . . . . 1.92 114.356 176.2 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.7 mt -51.81 -37.43 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 128.064 3.792 . . . . 1.94 113.549 170.723 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -63.24 -44.56 94.86 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 114.748 -4.97 . . . . 1.9 118.308 170.001 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -55.57 -49.55 72.41 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 114.736 1.384 . . . . 1.55 114.736 167.831 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -74.71 -65.58 0.85 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.763 -2.017 . . . . 2.95 107.572 -170.075 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.261 13.8 mm-40 -85.21 -51.75 6.39 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.87 1.804 . . . . 1.48 115.87 -171.119 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.91 9.51 5.2 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 117.628 1.811 . . . . 1.12 117.628 -178.706 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.0 mt -87.82 135.35 33.86 Favored Pre-proline 0 N--CA 1.429 -1.5 0 CA-C-O 113.967 -2.92 . . . . 2.07 112.018 -173.224 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -78.32 157.71 29.51 Favored 'Trans proline' 0 N--CA 1.434 -1.991 0 CA-C-N 124.632 2.69 . . . . 1.39 108.71 -178.944 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -64.02 -17.09 58.45 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 125.08 3.854 . . . . 1.68 114.257 -178.235 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -67.21 -49.17 65.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 129.879 3.272 . . . . 2.25 111.868 175.768 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -70.95 -31.67 68.32 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.647 -2.533 . . . . 2.44 110.495 -175.951 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -80.01 120.12 23.76 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 130.025 3.33 . . . . 1.32 113.902 -175.095 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -113.63 123.67 50.48 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.221 -2.14 . . . . 3.19 105.221 167.507 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -108.34 126.3 52.69 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 102.984 -2.969 . . . . 1.75 102.984 178.822 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.253 37.8 mm -112.71 154.21 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 131.549 3.94 . . . . 1.98 106.255 177.592 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -114.4 -94.01 0.48 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.535 -3.228 . . . . 1.94 102.744 175.307 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.38 -65.78 0.98 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 119.656 -0.818 . . . . 1.67 109.95 177.254 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.63 -13.43 0.73 Allowed Glycine 0 N--CA 1.429 -1.802 0 O-C-N 117.534 -3.229 . . . . 1.3 114.789 -173.705 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -105.95 150.44 25.67 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.828 2.051 . . . . 2.89 110.988 175.789 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -77.16 138.3 39.4 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 130.83 3.652 . . . . 2.89 110.033 178.774 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.402 HD12 HD12 ' A' ' 23' ' ' ILE . 80.4 mt -82.9 160.14 22.18 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.138 -1.601 . . . . 1.34 113.796 -176.478 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -102.99 151.51 22.39 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.981 1.712 . . . . 1.94 109.967 176.755 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.377 30.1 m-20 -75.02 -63.29 1.3 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 112.988 0.736 . . . . 1.56 112.988 -167.294 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.45 55.97 4.72 Favored Glycine 0 N--CA 1.431 -1.665 0 O-C-N 118.631 -2.543 . . . . 0.97 112.3 178.641 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -120.58 161.08 21.94 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 102.62 -3.104 . . . . 3.07 102.62 162.259 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -90.67 164.19 14.25 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.351 2.5 . . . . 1.34 109.23 168.251 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.9 mt -59.03 -34.43 71.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.658 2.783 . . . . 1.63 115.15 167.309 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.8 p -70.99 -21.51 62.3 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 114.606 1.335 . . . . 1.51 114.606 179.221 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -69.99 -34.54 73.47 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.8 2.84 . . . . 1.9 108.969 175.69 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -96.74 15.88 20.67 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.182 2.896 . . . . 0.97 112.964 176.458 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 m120 57.29 25.19 10.84 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 111.298 -2.683 . . . . 2.35 116.97 174.028 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.8 mt -81.63 98.97 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 106.043 -1.836 . . . . 1.39 106.043 178.629 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -112.92 -39.06 4.34 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.795 2.838 . . . . 2.58 104.569 -174.83 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -101.16 171.83 7.38 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.324 1.601 . . . . 2.58 115.324 167.294 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -45.11 103.05 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 129.953 3.301 . . . . 1.71 116.12 168.581 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.6 m -123.13 159.53 28.37 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.469 -4.519 . . . . 1.34 116.75 -175.952 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.2 m -101.88 126.79 48.85 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.843 -1.786 . . . . 1.36 111.822 -175.552 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mp -107.56 142.6 37.22 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.847 3.659 . . . . 2.03 112.327 176.814 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -116.03 117.69 30.8 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.634 -1.917 . . . . 2.31 109.404 -175.469 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.1 tp -87.62 123.43 32.47 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.971 1.367 . . . . 1.72 111.057 -176.894 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.0 t -122.84 136.66 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.181 -2.2 . . . . 1.8 108.488 176.416 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.1 mt -112.31 126.85 55.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.37 -2.706 . . . . 3.26 113.007 -174.165 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.2 mmt-85 -112.67 -177.38 3.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 119.558 -0.857 . . . . 4.12 109.292 172.248 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.7 mt -85.06 -39.5 17.91 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 125.722 1.609 . . . . 3.54 108.514 172.024 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.9 ttt-85 -148.03 -68.31 0.24 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.685 1.365 . . . . 7.32 114.685 168.208 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.85 -3.86 3.53 Favored Glycine 0 N--CA 1.431 -1.697 0 O-C-N 119.411 -2.055 . . . . 3.73 113.339 -171.19 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.74 0 O-C-N 117.881 -3.129 . . . . 3.87 107.025 174.927 . . . . . . . . 0 0 . 1 . 074 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.351 0 CA-C-O 116.147 -1.882 . . . . 1.39 113.619 . . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -119.22 125.92 50.3 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 120.403 1.456 . . . . 2.2 112.87 -178.028 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.9 pt -121.95 162.75 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 125.89 2.757 . . . . 1.32 107.241 170.582 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -103.89 149.04 25.45 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.5 2.32 . . . . 2.2 110.737 178.064 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.283 49.4 t -119.0 121.97 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 126.792 2.558 . . . . 1.23 106.071 171.067 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.7 tttt -101.9 140.13 36.6 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 126.53 2.394 . . . . 2.51 112.88 177.708 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.443 HG22 HD22 ' A' ' 69' ' ' LEU . 54.9 p -96.97 173.67 7.16 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.327 -2.733 . . . . 1.41 108.092 174.328 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.8 mt -56.61 -57.62 11.6 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.692 -1.88 . . . . 2.95 112.649 167.279 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.1 p -61.46 -30.69 70.75 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 117.66 2.467 . . . . 2.52 117.66 -179.244 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.87 15.91 1.31 Allowed Glycine 0 N--CA 1.429 -1.817 0 CA-C-O 114.784 -3.231 . . . . 1.5 114.715 170.004 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.432 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 26.0 tttt -90.13 115.23 27.22 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 122.768 3.284 . . . . 1.79 106.874 -173.573 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 m -87.16 115.35 24.49 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 113.926 -1.488 . . . . 1.38 113.543 175.454 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mt -103.07 127.46 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 116.533 2.049 . . . . 2.03 116.533 176.302 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.4 m -89.09 105.58 17.88 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 116.687 -3.758 . . . . 1.61 111.456 -174.974 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.9 mt -112.38 127.6 56.06 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 125.186 2.422 . . . . 2.15 110.378 178.537 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -92.74 117.14 29.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.543 3.068 . . . . 1.98 108.422 170.47 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 m -127.1 178.32 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 111.962 -2.381 . . . . 1.52 112.5 -179.444 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -105.38 154.14 39.21 Favored Pre-proline 0 N--CA 1.43 -1.441 0 C-N-CA 126.963 2.105 . . . . 2.35 109.846 165.241 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.11 -14.2 23.45 Favored 'Trans proline' 0 C--N 1.299 -2.028 1 CA-C-N 128.307 4.003 . . . . 1.31 107.157 -177.462 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 m -86.69 -4.88 59.23 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 115.08 1.511 . . . . 1.71 115.08 177.728 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -64.09 146.8 53.56 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.15 -2.219 . . . . 1.69 112.451 174.259 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.8 p -89.77 161.86 15.82 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 119.731 -1.855 . . . . 1.33 112.793 172.963 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.7 mm -58.51 -22.64 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.287 -3.383 . . . . 1.32 117.772 174.679 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.09 -59.13 5.54 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 117.857 -3.027 . . . . 1.62 110.985 161.745 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -51.98 -50.24 61.66 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.077 2.151 . . . . 2.13 111.687 176.616 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -61.51 -49.4 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 119.816 -1.802 . . . . 1.23 111.88 -177.9 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -68.53 -19.7 64.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 124.064 3.12 . . . . 1.97 112.238 175.585 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.12 -27.3 63.48 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.394 -2.066 . . . . 1.19 109.293 173.923 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -68.12 -48.18 66.13 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.835 2.054 . . . . 1.92 110.628 171.823 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mt -59.91 -36.06 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 113.794 1.035 . . . . 1.94 113.794 173.033 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -60.22 -43.65 95.84 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.633 -3.167 . . . . 1.9 114.496 175.121 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -47.06 -58.91 3.51 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.635 -3.791 . . . . 1.55 115.758 166.861 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -71.29 -53.56 13.84 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.707 -1.87 . . . . 2.95 113.257 -176.57 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.432 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 46.8 mm-40 -92.4 -58.89 2.23 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 125.002 1.439 . . . . 1.48 108.385 -167.091 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.53 -0.16 2.74 Favored Glycine 0 N--CA 1.429 -1.782 0 O-C-N 119.698 -1.877 . . . . 1.12 111.72 176.191 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.0 mt -74.46 128.78 85.24 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 114.094 -2.86 . . . . 2.07 113.29 -169.277 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -63.61 151.04 86.92 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 CA-C-N 122.618 1.971 . . . . 1.39 113.856 175.037 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.29 -4.46 15.1 Favored 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 124.188 3.259 . . . . 1.68 118.704 -178.883 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -80.55 -29.53 37.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 126.264 2.228 . . . . 2.25 114.799 170.751 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -79.37 -40.26 30.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.723 2.202 . . . . 2.44 111.784 177.593 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -70.04 95.94 1.01 Allowed 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 114.743 -4.973 . . . . 1.32 115.616 -171.186 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -90.66 132.22 35.9 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 118.526 -2.609 . . . . 3.19 107.589 172.219 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.5 mt -111.06 120.4 42.24 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.813 1.768 . . . . 1.75 110.589 178.449 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.9 mt -102.83 128.64 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 120.476 -1.39 . . . . 1.98 108.919 172.936 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -82.14 -76.85 0.24 Allowed 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.13 2.395 . . . . 1.94 108.673 174.245 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -96.04 -60.07 1.71 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.53 1.532 . . . . 1.67 110.565 -179.004 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.91 -48.01 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.806 0 CA-C-O 122.379 0.989 . . . . 1.3 112.377 -172.522 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -81.09 141.98 33.76 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.246 -1.149 . . . . 2.89 111.037 179.927 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 pm0 -77.38 152.19 34.51 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 117.285 -1.766 . . . . 2.89 111.915 176.761 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.0 mt -98.39 136.96 37.8 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 116.649 -2.02 . . . . 1.34 113.929 -167.047 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.03 144.71 48.71 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.538 2.335 . . . . 1.94 115.499 172.461 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -64.55 -56.19 15.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.805 3.642 . . . . 1.56 114.752 -175.578 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.47 64.37 3.99 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 121.072 3.189 . . . . 0.97 121.072 170.31 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -135.35 158.39 44.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.17 1.788 . . . . 3.07 106.651 161.651 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.259 17.0 p -80.72 164.94 22.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 117.659 2.466 . . . . 1.34 117.659 174.478 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.2 mt -64.56 -33.8 76.76 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.388 -2.07 . . . . 1.63 113.118 175.791 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 t -68.79 -31.37 70.34 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.079 2.152 . . . . 1.51 116.337 177.096 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -57.24 -37.07 71.74 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 120.86 -1.15 . . . . 1.9 111.774 171.369 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -77.59 3.81 12.83 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 118.305 2.706 . . . . 0.97 118.305 174.63 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.66 17.3 m-80 81.76 12.01 0.69 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.034 2.605 . . . . 2.35 118.034 178.686 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.2 mt -91.51 102.84 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 118.949 -2.344 . . . . 1.39 111.827 178.135 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -106.49 -26.21 11.52 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.739 1.615 . . . . 2.58 108.294 -171.555 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.5 tttp -137.66 -91.99 0.22 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 117.317 2.339 . . . . 2.58 117.317 175.918 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.14 126.09 49.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 121.284 -0.885 . . . . 1.71 111.518 -176.125 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.3 t -146.8 145.48 29.92 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.587 -1.188 . . . . 1.34 114.09 -173.714 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.9 m -118.43 109.09 15.83 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.714 -3.116 . . . . 1.36 103.673 179.752 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.6 mt -93.36 154.87 17.72 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.23 -2.137 . . . . 2.03 105.23 173.336 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -118.49 117.05 27.98 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.394 1.092 . . . . 2.31 113.472 -175.258 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.443 HD22 HG22 ' A' ' 7' ' ' THR . 36.3 tp -79.59 94.62 5.69 Favored 'General case' 0 N--CA 1.43 -1.428 1 C-N-CA 132.904 4.481 . . . . 1.72 107.974 -171.728 . . . . . . . . 3 3 . 1 . 074 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.27 121.44 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 C-N-CA 127.981 2.512 . . . . 1.8 108.613 175.716 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.1 mp -90.09 90.33 8.07 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 116.499 -1.715 . . . . 3.26 111.665 176.61 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -104.92 133.67 49.33 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 126.841 2.588 . . . . 4.12 106.101 177.718 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.3 mt -79.81 150.01 30.85 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 124.761 3.437 . . . . 3.54 112.954 174.685 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -59.45 168.31 1.6 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 130.188 3.395 . . . . 7.32 117.528 171.504 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 150.42 -77.22 0.23 Allowed Glycine 0 N--CA 1.43 -1.718 0 O-C-N 118.031 -2.918 . . . . 3.73 108.696 -170.704 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.774 0 N-CA-C 104.177 -3.569 . . . . 3.87 104.177 -177.214 . . . . . . . . 0 0 . 1 . 075 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.491 -1.311 0 CA-C-O 118.621 -0.704 . . . . 1.39 110.359 . . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -100.56 122.37 43.14 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 119.57 1.077 . . . . 2.2 112.678 177.176 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.258 21.6 pt -106.97 147.57 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 118.188 -2.82 . . . . 1.32 109.551 -179.341 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -105.17 117.94 35.28 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 117.746 -3.096 . . . . 2.2 107.412 -177.683 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.3 t -99.55 96.41 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 120.09 -1.631 . . . . 1.23 108.825 173.219 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -78.99 112.23 15.98 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.762 2.425 . . . . 2.51 107.051 176.409 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.8 p -75.99 166.45 23.48 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 116.315 1.969 . . . . 1.41 116.315 -179.382 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.8 tp -54.54 -39.86 68.1 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 127.393 2.277 . . . . 2.95 110.336 161.753 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.0 p -75.82 -30.17 58.92 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.114 -1.616 . . . . 2.52 111.64 -178.985 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.32 38.78 1.59 Allowed Glycine 0 N--CA 1.43 -1.721 0 CA-C-O 124.385 2.103 . . . . 1.5 113.657 177.571 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -120.53 121.26 38.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 104.671 -2.344 . . . . 1.79 104.671 178.132 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.284 85.6 m -73.0 101.95 3.36 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 112.849 -1.978 . . . . 1.38 112.909 171.16 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 mt -96.62 128.34 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 105.33 -2.1 . . . . 2.03 105.33 -179.08 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.8 m -99.73 119.47 38.19 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.133 -1.062 . . . . 1.61 108.133 175.185 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.8 mt -120.29 128.93 53.75 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 127.837 2.455 . . . . 2.15 109.586 176.207 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -74.48 131.69 41.24 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.713 3.227 . . . . 1.98 119.713 162.939 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.2 m -139.26 176.69 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.718 -1.239 . . . . 1.52 113.62 174.193 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -101.84 163.33 18.0 Favored Pre-proline 0 N--CA 1.429 -1.494 0 O-C-N 116.98 -3.575 . . . . 2.35 104.781 160.123 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -77.83 -10.36 16.89 Favored 'Trans proline' 0 N--CA 1.433 -2.043 0 O-C-N 116.802 -2.262 . . . . 1.31 109.325 -179.582 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -79.9 -12.26 59.75 Favored 'General case' 0 N--CA 1.428 -1.531 1 O-C-N 116.002 -4.187 . . . . 1.71 116.882 174.55 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -76.16 151.59 36.91 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.559 1.647 . . . . 1.69 114.3 176.516 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.2 p -80.77 161.25 24.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.908 -1.745 . . . . 1.33 114.13 -177.79 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.0 mt -70.99 -35.99 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 120.428 -1.42 . . . . 1.32 109.374 174.35 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -49.31 -38.81 29.0 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.463 2.705 . . . . 1.62 112.374 162.255 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -70.79 -52.14 22.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.905 -2.997 . . . . 2.13 105.41 179.142 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.284 42.2 t -47.68 -57.56 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-N 121.797 2.09 . . . . 1.23 115.446 166.945 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -60.28 -31.19 70.0 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.103 -3.498 . . . . 1.97 112.307 179.094 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.7 -27.76 58.36 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 124.482 3.31 . . . . 1.19 111.343 -179.404 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.268 35.1 mttm -74.97 -26.84 59.88 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.592 2.757 . . . . 1.92 111.169 173.394 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.2 mt -69.41 -45.53 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 C-N-CA 128.9 2.88 . . . . 1.94 104.911 171.862 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -58.05 -39.35 78.23 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.484 2.313 . . . . 1.9 113.265 176.595 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.53 -56.07 21.44 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 127.203 3.382 . . . . 1.55 111.676 173.265 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -80.81 -58.84 2.91 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.604 -3.81 . . . . 2.95 113.332 -174.038 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -83.62 -50.61 8.04 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.595 -3.191 . . . . 1.48 111.786 -172.535 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.64 73.04 1.27 Allowed Glycine 0 N--CA 1.43 -1.701 0 CA-C-O 125.649 2.805 . . . . 1.12 110.203 179.963 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.9 mt -132.72 128.77 21.0 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-O 113.435 -3.174 . . . . 2.07 103.347 178.341 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -64.54 160.55 39.24 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 125.742 3.087 . . . . 1.39 117.115 179.944 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.01 -26.65 12.82 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 123.058 2.128 . . . . 1.68 111.018 -174.552 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.18 -39.15 81.63 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 117.882 -1.056 . . . . 2.25 112.766 171.203 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -83.78 -1.89 55.2 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 123.011 2.641 . . . . 2.44 112.593 -179.849 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -93.06 122.75 35.74 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 120.938 1.699 . . . . 1.32 108.712 -176.032 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.499 HH22 ' C ' ' A' ' 76' ' ' GLY . 97.0 mtt180 -115.3 114.78 25.63 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 114.347 -1.297 . . . . 3.19 108.035 165.607 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.5 mt -98.63 122.59 42.03 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 123.774 1.749 . . . . 1.75 107.57 -179.264 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.3 mm -106.2 139.24 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 118.614 -2.554 . . . . 1.98 104.708 179.314 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -103.43 -92.67 0.34 Allowed 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 119.61 -1.931 . . . . 1.94 110.234 173.992 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.96 -84.29 0.51 Allowed 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.843 -1.91 . . . . 1.67 105.843 179.844 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.74 7.59 22.05 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 126.809 2.568 . . . . 1.3 112.361 -170.352 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -139.38 155.99 47.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.167 -1.784 . . . . 2.89 110.438 178.28 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -83.23 148.58 27.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.814 -1.178 . . . . 2.89 111.756 166.76 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.1 mt -86.75 131.14 34.21 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 119.26 -2.15 . . . . 1.34 110.806 -176.486 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -84.82 136.88 33.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.417 2.687 . . . . 1.94 110.405 175.016 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.39 -51.56 59.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.366 -3.334 . . . . 1.56 114.398 -167.088 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.61 26.38 2.71 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 123.293 2.769 . . . . 0.97 115.387 171.87 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -105.46 171.69 7.19 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.489 1.138 . . . . 3.07 110.813 165.539 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.6 p -98.82 172.43 7.45 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 127.852 3.691 . . . . 1.34 111.365 167.701 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.6 mt -64.0 -44.45 92.58 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 111.99 -2.368 . . . . 1.63 109.779 171.397 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 t -57.88 -37.45 73.98 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 116.851 2.167 . . . . 1.51 116.851 176.879 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -53.36 -21.66 6.14 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.741 -2.474 . . . . 1.9 113.497 175.687 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -112.27 22.14 15.04 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.5 -2.625 . . . . 0.97 113.206 177.334 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.504 1.0 OUTLIER 61.37 31.95 19.16 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 119.705 3.224 . . . . 2.35 119.705 177.968 . . . . . . . . 3 3 . 1 . 075 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.317 57.4 mt -86.2 125.8 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 118.322 -2.736 . . . . 1.39 105.009 177.968 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -148.77 -51.06 0.16 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.792 -2.442 . . . . 2.58 110.08 -170.831 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.492 ' HG3' ' H ' ' A' ' 64' ' ' GLU . 11.4 tptp -79.47 -173.17 3.6 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 113.633 0.975 . . . . 2.58 113.633 169.352 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.492 ' H ' ' HG3' ' A' ' 63' ' ' LYS . 15.1 mp0 -73.05 95.88 2.09 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.123 2.392 . . . . 1.71 116.304 175.84 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.5 m -94.27 160.12 14.82 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 120.922 3.675 . . . . 1.34 120.922 -169.991 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.9 m -106.92 119.19 38.68 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 117.185 -1.388 . . . . 1.36 110.104 177.91 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -105.32 160.95 14.72 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 125.651 1.844 . . . . 2.03 106.61 168.471 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -127.08 124.47 39.31 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.273 -2.142 . . . . 2.31 108.864 -177.946 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.4 tp -99.55 112.17 24.42 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.059 1.344 . . . . 1.72 110.63 -174.42 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.1 t -97.6 120.56 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 C-N-CA 130.497 3.519 . . . . 1.8 112.737 174.018 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.4 mt -101.09 123.43 45.24 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 118.21 -1.396 . . . . 3.26 107.758 -177.787 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -140.76 -166.25 2.11 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.725 2.202 . . . . 4.12 110.332 174.533 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 mt -90.68 151.87 21.08 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.372 -3.33 . . . . 3.54 110.4 170.422 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.254 69.5 ttt180 -101.0 138.88 37.46 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 125.506 1.754 . . . . 7.32 112.119 172.134 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.73 37.13 4.56 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 105.179 -3.168 . . . . 3.73 105.179 -166.568 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.499 ' C ' HH22 ' A' ' 42' ' ' ARG . . . . . . . . 0 C--O 1.26 1.776 0 O-C-N 116.632 -3.864 . . . . 3.87 110.057 -178.668 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ttp . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 118.662 2.838 . . . . 1.39 118.662 . . . . . . . . . 0 0 . 1 . 076 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -97.71 112.91 24.61 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.138 1.923 . . . . 2.2 109.623 -178.172 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 pt -109.14 146.77 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.038 -2.914 . . . . 1.32 109.368 175.083 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -106.32 124.06 49.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.091 2.956 . . . . 2.2 113.38 175.33 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.3 t -105.45 113.58 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 114.76 -1.109 . . . . 1.23 111.375 178.819 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -85.95 135.56 33.62 Favored 'General case' 0 N--CA 1.431 -1.423 2 O-C-N 113.041 -6.037 . . . . 2.51 115.826 179.038 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 p -99.1 173.11 6.97 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.653 -1.28 . . . . 1.41 109.708 178.797 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 tt -56.14 -49.14 74.77 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.22 1.008 . . . . 2.95 111.576 174.686 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -77.29 4.33 10.91 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.04 -2.287 . . . . 2.52 115.261 -177.425 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.16 17.63 46.17 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 119.497 2.559 . . . . 1.5 119.497 177.523 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -99.63 145.55 27.45 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 120.413 2.106 . . . . 1.79 109.939 -177.767 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.3 m -105.43 126.55 52.25 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.755 -1.216 . . . . 1.38 108.019 -173.036 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.9 mt -100.9 107.1 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.814 -3.054 . . . . 2.03 106.265 178.645 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 m -91.19 126.34 36.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.1 1.905 . . . . 1.61 108.021 -175.444 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.0 mt -126.63 160.75 29.81 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.867 2.867 . . . . 2.15 109.241 -178.473 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.342 43.6 mt-10 -122.85 115.62 22.29 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 125.658 2.647 . . . . 1.98 108.922 170.094 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.21 163.6 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 117.242 -3.411 . . . . 1.52 113.619 -178.591 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -98.2 145.45 29.85 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-O 116.634 -1.65 . . . . 2.35 112.816 162.735 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 21.1 Cg_exo -63.91 -9.87 20.67 Favored 'Trans proline' 0 N--CA 1.434 -1.999 2 CA-C-N 129.993 4.605 . . . . 1.31 114.149 -179.495 . . . . . . . . 3 3 . 1 . 076 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.6 p -84.57 -0.2 52.36 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 127.189 3.376 . . . . 1.71 116.099 173.526 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -80.67 156.01 26.53 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.816 -2.428 . . . . 1.69 106.356 176.0 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 p -104.37 165.77 10.84 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.52 -1.218 . . . . 1.33 113.245 176.292 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -58.43 -41.4 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.183 2.193 . . . . 1.32 112.496 176.695 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -44.17 -60.59 1.82 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.491 3.145 . . . . 1.62 119.491 162.024 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -58.96 -33.31 70.5 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 115.059 1.503 . . . . 2.13 115.059 177.85 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.23 -47.83 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 131.626 3.97 . . . . 1.23 115.406 172.478 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.33 27.1 mtmt -69.45 -32.43 71.37 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 111.561 -2.563 . . . . 1.97 110.944 177.946 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.66 -26.32 65.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.255 1.822 . . . . 1.19 113.537 171.79 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -75.97 -42.71 47.58 Favored 'General case' 0 N--CA 1.431 -1.411 1 C-N-CA 131.972 4.109 . . . . 1.92 108.427 -179.859 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt -61.08 -36.0 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 1 O-C-N 116.207 -4.058 . . . . 1.94 113.524 169.068 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -62.44 -37.54 86.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.052 2.541 . . . . 1.9 111.88 172.54 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.6 -52.18 41.48 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 119.548 3.166 . . . . 1.55 119.548 166.928 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -69.4 -51.5 35.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.662 1.185 . . . . 2.95 112.193 -176.546 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -110.34 -25.38 10.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.161 1.784 . . . . 1.48 112.159 -169.453 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.26 39.94 5.26 Favored Glycine 0 N--CA 1.429 -1.773 0 O-C-N 118.363 -2.711 . . . . 1.12 115.255 175.985 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.5 mt -117.97 126.65 27.14 Favored Pre-proline 0 N--CA 1.429 -1.483 0 CA-C-O 116.836 -1.554 . . . . 2.07 111.775 -174.111 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -63.78 145.39 90.78 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 CA-C-N 127.145 3.588 . . . . 1.39 116.932 178.283 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -66.72 -25.23 46.59 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 CA-C-N 120.686 1.281 . . . . 1.68 113.279 -175.137 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -70.78 -13.8 62.19 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 120.398 3.481 . . . . 2.25 120.398 177.476 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -84.76 -36.88 21.46 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 127.866 3.229 . . . . 2.44 108.165 174.043 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -76.91 108.88 10.27 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.067 2.365 . . . . 1.32 113.422 -173.378 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.2 mtt180 -102.19 114.76 29.18 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 114.611 -5.055 . . . . 3.19 110.756 162.725 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.432 HD22 HD13 ' A' ' 69' ' ' LEU . 64.9 mt -100.53 123.43 44.74 Favored 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 116.035 -4.166 . . . . 1.75 111.922 -177.687 . . . . . . . . 3 3 . 1 . 076 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 49' ' ' GLN . 33.9 mm -109.4 136.33 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 112.255 -2.248 . . . . 1.98 110.635 -177.654 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -99.42 -88.05 0.35 Allowed 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.742 -1.849 . . . . 1.94 109.571 172.404 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -113.02 -8.63 13.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 126.595 3.093 . . . . 1.67 113.151 -176.186 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.14 -40.04 0.17 Allowed Glycine 0 N--CA 1.429 -1.816 1 N-CA-C 102.958 -4.057 . . . . 1.3 102.958 -178.37 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -75.96 150.57 37.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.47 1.605 . . . . 2.89 114.39 175.424 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.403 ' HA ' HD13 ' A' ' 44' ' ' ILE . 59.3 tt0 -84.25 134.06 34.55 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.858 -3.026 . . . . 2.89 107.532 170.67 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.2 mt -82.38 124.94 30.47 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 129.208 4.068 . . . . 1.34 105.448 -173.715 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -80.25 140.86 36.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.364 3.468 . . . . 1.94 120.364 174.082 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.94 -62.82 1.39 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 116.479 2.029 . . . . 1.56 116.479 -170.723 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.1 56.68 4.97 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 118.512 2.165 . . . . 0.97 118.512 173.056 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.266 50.5 mmt-85 -133.35 151.57 51.86 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 107.623 -1.251 . . . . 3.07 107.623 169.108 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.43 ' HG1' ' CG ' ' A' ' 58' ' ' ASP 0.263 4.5 p -74.2 169.04 18.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 127.027 3.299 . . . . 1.34 118.141 174.172 . . . . . . . . 3 3 . 1 . 076 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 94.3 mt -74.4 -34.93 63.42 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.536 -4.477 . . . . 1.63 113.279 173.764 . . . . . . . . 3 3 . 1 . 076 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -66.52 -49.19 67.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.127 -2.76 . . . . 1.51 108.891 178.529 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.43 ' CG ' ' HG1' ' A' ' 55' ' ' THR . 48.0 m-20 -42.1 -45.16 3.89 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 120.258 3.429 . . . . 1.9 120.258 173.788 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -82.25 -20.81 36.86 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 115.988 1.847 . . . . 0.97 115.988 179.472 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 80.26 50.16 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 128.001 2.521 . . . . 2.35 111.057 -175.022 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.2 mt -93.2 115.94 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 124.809 1.244 . . . . 1.39 109.519 170.814 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -108.18 -174.86 2.62 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.991 2.116 . . . . 2.58 111.577 -167.197 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -65.58 -34.75 78.96 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.819 1.295 . . . . 2.58 112.821 172.066 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.258 13.5 pt-20 -77.04 -12.14 59.9 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.067 -2.896 . . . . 1.71 115.957 178.455 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.314 19.0 m -82.01 139.86 34.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 114.827 1.417 . . . . 1.34 114.827 -167.437 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.4 m -107.11 124.15 49.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.218 1.807 . . . . 1.36 111.609 -179.495 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.6 mp -96.85 149.5 21.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 123.198 2.726 . . . . 2.03 106.269 178.13 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.402 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 57.9 m80 -110.34 131.05 55.4 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.48 1.609 . . . . 2.31 113.413 176.735 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.432 HD13 HD22 ' A' ' 43' ' ' LEU . 51.8 tp -110.14 135.57 50.72 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 125.527 2.584 . . . . 1.72 105.658 -174.93 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.1 t -125.54 123.85 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.082 -2.562 . . . . 1.8 104.082 175.826 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.5 mt -103.87 124.94 49.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.77 -1.206 . . . . 3.26 111.821 177.623 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.9 mmt85 -116.82 145.82 43.29 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.348 1.059 . . . . 4.12 111.514 176.416 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.8 tp -141.97 -78.42 0.25 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 104.945 -2.243 . . . . 3.54 104.945 167.013 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.1 mtm-85 -80.25 106.87 12.59 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 118.888 -2.382 . . . . 7.32 108.932 174.929 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.57 -160.01 31.04 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-O 121.825 0.68 . . . . 3.73 113.485 -167.674 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.777 0 C-N-CA 127.875 2.655 . . . . 3.87 109.619 176.759 . . . . . . . . 0 0 . 1 . 077 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ttp . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 116.743 -1.599 . . . . 1.39 112.034 . . . . . . . . . 0 0 . 1 . 077 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -93.5 111.62 23.33 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 115.316 -2.278 . . . . 2.2 111.185 -177.274 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.7 pt -106.47 167.98 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-O 125.992 2.806 . . . . 1.32 107.824 172.872 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -126.1 114.8 18.87 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.403 2.049 . . . . 2.2 113.129 -176.727 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.0 t -107.6 113.59 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 116.404 -3.935 . . . . 1.23 102.174 -179.002 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -82.74 143.93 30.55 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 116.103 -4.123 . . . . 2.51 116.49 177.166 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.2 p -93.85 158.46 15.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.558 1.943 . . . . 1.41 116.126 176.179 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.435 ' HA ' HD22 ' A' ' 8' ' ' LEU 0.25 80.1 mt -64.44 -32.53 74.2 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.246 1.818 . . . . 2.95 114.648 175.906 . . . . . . . . 3 3 . 1 . 077 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.7 p -71.61 -44.31 64.64 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.542 -1.349 . . . . 2.52 112.172 178.33 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.79 -33.75 0.44 Allowed Glycine 0 N--CA 1.43 -1.762 0 CA-C-O 125.516 2.731 . . . . 1.5 115.072 172.036 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.362 0.0 OUTLIER -70.9 153.41 42.72 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 110.879 -2.661 . . . . 1.79 115.434 -176.285 . . . . . . . . 3 3 . 1 . 077 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.9 m -103.21 136.38 43.11 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.051 -1.655 . . . . 1.38 110.432 177.642 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 69.7 mt -98.78 115.48 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 116.517 -1.706 . . . . 2.03 108.768 177.597 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 m -92.44 110.83 22.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.242 1.817 . . . . 1.61 111.767 179.95 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.9 mt -112.89 133.85 54.67 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 125.332 2.491 . . . . 2.15 110.803 -174.742 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -91.0 113.15 25.34 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 116.28 -4.012 . . . . 1.98 109.64 168.255 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.7 163.14 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 113.502 -1.681 . . . . 1.52 108.688 -177.378 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -104.55 131.0 22.26 Favored Pre-proline 0 N--CA 1.43 -1.434 0 O-C-N 125.792 1.933 . . . . 2.35 106.102 163.449 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.71 -14.04 24.77 Favored 'Trans proline' 0 C--N 1.3 -1.993 1 C-N-CA 127.827 5.684 . . . . 1.31 114.788 -178.542 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -85.96 -17.04 36.46 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.895 2.878 . . . . 1.71 114.858 -179.771 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -68.17 144.46 54.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 116.997 -1.478 . . . . 1.69 113.704 176.007 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.3 p -76.61 164.11 26.23 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 122.959 2.618 . . . . 1.33 110.332 -178.266 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 50' ' ' LEU . 52.0 mt -67.86 -35.38 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 118.158 -2.838 . . . . 1.32 114.594 176.165 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -47.89 -37.65 14.59 Favored 'General case' 0 N--CA 1.431 -1.409 1 O-C-N 115.665 -4.397 . . . . 1.62 116.873 156.659 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -78.97 -30.22 44.35 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.43 -2.669 . . . . 2.13 111.087 177.094 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.7 t -61.83 -52.98 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 O-C-N 119.554 -1.966 . . . . 1.23 113.305 170.961 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -50.05 -40.73 45.97 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 127.892 3.245 . . . . 1.97 114.771 176.457 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.97 -37.37 68.96 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.839 -1.163 . . . . 1.19 112.432 173.388 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -70.16 -24.92 63.23 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 118.801 2.889 . . . . 1.92 118.801 174.548 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.8 mt -77.33 -42.37 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 129.051 2.94 . . . . 1.94 104.38 179.693 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -61.38 -47.9 83.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.418 -1.426 . . . . 1.9 110.585 179.947 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -41.71 -48.68 4.22 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 118.076 2.621 . . . . 1.55 118.076 170.329 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -79.0 -60.76 2.25 Favored 'General case' 0 N--CA 1.432 -1.372 0 O-C-N 119.192 -2.193 . . . . 2.95 108.607 -174.031 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -101.85 -17.37 16.22 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 119.862 1.21 . . . . 1.48 111.535 -163.922 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.98 46.89 5.77 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 123.844 1.802 . . . . 1.12 116.852 173.444 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.4 mt -129.3 129.1 23.27 Favored Pre-proline 0 N--CA 1.431 -1.395 0 O-C-N 120.211 -1.758 . . . . 2.07 112.162 -174.112 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -62.72 162.16 26.01 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 O-C-N 114.574 -3.435 . . . . 1.39 120.881 -177.278 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.7 -14.92 19.51 Favored 'Trans proline' 0 N--CA 1.433 -2.038 0 CA-C-N 127.825 3.83 . . . . 1.68 112.824 -178.398 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -60.47 -46.21 90.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.919 2.488 . . . . 2.25 109.398 173.41 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -83.77 -27.57 28.77 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 123.503 0.721 . . . . 2.44 112.473 -174.417 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -76.87 108.32 9.83 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.344 2.021 . . . . 1.32 110.731 -177.582 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -93.8 119.13 32.36 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.971 -3.581 . . . . 3.19 104.564 167.542 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.3 mt -98.41 138.38 35.73 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.278 -2.139 . . . . 1.75 108.688 174.277 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.41 134.1 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 101.735 -3.432 . . . . 1.98 101.735 -178.404 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -98.11 -107.23 0.18 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.187 -1.571 . . . . 1.94 109.736 170.171 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.66 -51.38 5.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.079 -2.263 . . . . 1.67 110.752 177.582 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.25 -40.17 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 128.955 3.169 . . . . 1.3 106.343 -171.074 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -74.5 146.77 42.44 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 112.878 0.696 . . . . 2.89 112.878 178.348 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.276 3.6 mp0 -97.92 145.65 26.25 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 100.308 -3.96 . . . . 2.89 100.308 171.879 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.403 ' HB3' ' CD1' ' A' ' 23' ' ' ILE . 78.8 mt -99.75 121.02 40.65 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 127.733 3.635 . . . . 1.34 108.437 -169.496 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -71.35 129.15 38.12 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.519 -2.613 . . . . 1.94 114.189 170.638 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.41 -48.04 47.46 Favored 'General case' 0 N--CA 1.431 -1.417 1 C-N-CA 131.966 4.106 . . . . 1.56 117.412 -175.071 . . . . . . . . 3 3 . 1 . 077 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.62 -9.58 62.19 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 119.157 2.423 . . . . 0.97 119.157 176.663 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -90.39 177.02 6.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 118.386 1.093 . . . . 3.07 109.247 179.412 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.5 p -108.23 164.36 12.38 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.184 1.393 . . . . 1.34 108.46 173.873 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.0 mt -58.4 -33.24 69.42 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.478 1.511 . . . . 1.63 111.421 171.629 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -64.27 -34.72 78.78 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 118.788 2.884 . . . . 1.51 118.788 176.728 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.284 64.6 m-20 -67.47 -29.79 69.33 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.42 -2.675 . . . . 1.9 111.785 178.429 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -92.53 -7.16 48.07 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 130.402 3.481 . . . . 0.97 112.088 178.664 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.268 71.6 m-80 61.96 60.82 1.47 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.213 1.482 . . . . 2.35 110.06 176.479 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.282 12.8 mt -83.69 130.43 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 128.054 2.542 . . . . 1.39 109.665 173.431 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -100.7 178.38 4.72 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 117.576 -1.202 . . . . 2.58 114.003 -171.453 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HG2' ' HZ1' ' A' ' 63' ' ' LYS . 41.3 tttm -44.19 -80.86 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.248 2.219 . . . . 2.58 116.684 173.627 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.341 0.8 OUTLIER -93.05 58.29 2.91 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 123.214 1.483 . . . . 1.71 113.622 -177.666 . . . . . . . . 3 3 . 1 . 077 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 p -92.3 139.87 30.17 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.952 2.501 . . . . 1.34 113.514 -175.039 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.4 m -109.79 124.12 50.74 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 104.122 -2.547 . . . . 1.36 104.122 -176.223 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -97.91 170.33 9.03 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 126.531 3.063 . . . . 2.03 104.815 172.361 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -120.76 125.51 47.77 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 118.037 -2.914 . . . . 2.31 105.09 -177.998 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.0 tp -95.17 107.16 19.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.471 2.081 . . . . 1.72 111.608 169.069 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -112.49 150.3 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 118.609 -2.557 . . . . 1.8 107.819 173.964 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.5 mt -112.03 109.88 19.87 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.6 -2.563 . . . . 3.26 111.516 -178.788 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 mmt85 -115.31 171.33 7.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 102.354 -3.202 . . . . 4.12 102.354 178.571 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.9 mt -87.82 -174.74 4.87 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.609 1.707 . . . . 3.54 115.609 174.176 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.3 ttt180 -71.01 123.92 23.18 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 125.582 2.61 . . . . 7.32 113.288 165.968 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.87 37.36 0.29 Allowed Glycine 0 N--CA 1.43 -1.711 1 O-C-N 114.372 -5.205 . . . . 3.73 111.511 -166.862 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.789 0 O-C-N 118.958 -2.495 . . . . 3.87 114.085 -177.637 . . . . . . . . 0 0 . 1 . 078 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tmm? . . . . . 0 CA--C 1.491 -1.32 0 N-CA-C 105.25 -2.13 . . . . 1.39 105.25 . . . . . . . . . 0 0 . 1 . 078 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.83 131.64 36.56 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.095 -3.503 . . . . 2.2 113.372 179.762 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.49 HD13 HG21 ' A' ' 17' ' ' VAL . 28.2 pt -116.48 148.15 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 129.245 3.018 . . . . 1.32 105.305 174.867 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -104.42 131.11 52.14 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.24 -1.538 . . . . 2.2 107.275 -179.546 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.0 t -109.79 118.66 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 105.185 -2.154 . . . . 1.23 105.185 177.083 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -105.08 130.39 53.28 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.475 -1.391 . . . . 2.51 110.066 176.277 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.8 p -69.93 167.02 18.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.549 2.118 . . . . 1.41 113.71 176.883 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.2 tp -56.01 -46.18 78.84 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 112.122 -2.308 . . . . 2.95 114.11 173.427 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 p -81.22 -21.15 39.75 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.299 2.333 . . . . 2.52 117.299 -176.248 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.76 1.69 4.1 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 122.686 3.834 . . . . 1.5 122.686 177.78 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -88.25 131.27 34.84 Favored 'General case' 0 N--CA 1.431 -1.397 1 O-C-N 115.855 -4.321 . . . . 1.79 109.978 -174.306 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.5 m -119.53 112.99 20.04 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 120.171 1.35 . . . . 1.38 113.384 179.626 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.9 pt -101.78 151.94 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 125.691 1.869 . . . . 2.03 107.61 -177.476 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.1 m -116.68 118.68 33.25 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 126.61 2.444 . . . . 1.61 110.012 -175.122 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.418 ' HB2' HG13 ' A' ' 3' ' ' ILE . 72.7 mt -102.96 149.22 24.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.518 -3.239 . . . . 2.15 107.247 177.977 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -102.48 123.36 46.1 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.225 -1.398 . . . . 1.98 107.225 165.762 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.49 HG21 HD13 ' A' ' 3' ' ' ILE . 21.3 m -131.77 147.66 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 106.67 -1.604 . . . . 1.52 106.67 -176.558 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -87.01 129.68 51.12 Favored Pre-proline 0 N--CA 1.429 -1.523 1 CA-C-O 111.438 -4.125 . . . . 2.35 110.132 163.875 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.31 -1.94 12.06 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 CA-C-N 127.809 3.825 . . . . 1.31 115.517 -166.246 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.2 m -84.19 2.66 38.72 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 116.301 -3.999 . . . . 1.71 116.513 172.917 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -81.36 163.32 22.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.514 -3.241 . . . . 1.69 113.174 174.952 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -90.98 157.95 16.99 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 125.729 2.68 . . . . 1.33 112.73 -178.538 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.44 -37.67 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.004 -2.935 . . . . 1.32 115.814 171.22 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -48.27 -41.21 27.22 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.647 -3.158 . . . . 1.62 117.879 167.811 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -73.8 -33.56 64.26 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.406 1.262 . . . . 2.13 114.406 172.568 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.5 -40.26 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 116.791 -3.693 . . . . 1.23 111.572 174.665 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -66.32 -35.74 81.14 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.288 -2.132 . . . . 1.97 110.115 177.58 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.439 . . -69.62 -27.02 64.72 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.883 2.473 . . . . 1.19 116.148 173.369 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -75.09 -34.84 61.8 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 120.702 -1.249 . . . . 1.92 111.698 172.391 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.1 mt -69.0 -33.73 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 117.425 -1.274 . . . . 1.94 112.666 168.38 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -65.2 -35.21 80.35 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.435 -1.32 . . . . 1.9 107.435 176.53 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.32 -26.9 68.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.041 2.237 . . . . 1.55 117.041 173.892 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -99.37 -69.71 0.76 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.522 1.629 . . . . 2.95 113.332 -172.734 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -84.8 -25.36 28.21 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.058 -2.901 . . . . 1.48 105.475 -169.314 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.88 58.88 2.56 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 107.928 -2.069 . . . . 1.12 107.928 178.948 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.3 mt -115.25 120.31 36.9 Favored Pre-proline 0 N--CA 1.43 -1.443 1 CA-C-O 110.705 -4.474 . . . . 2.07 107.411 -179.25 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -63.56 143.95 88.86 Favored 'Trans proline' 0 N--CA 1.434 -2.028 1 CA-C-N 128.555 4.091 . . . . 1.39 116.801 177.681 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -68.87 -18.37 41.33 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 CA-C-N 125.763 3.094 . . . . 1.68 115.015 -172.925 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.257 11.3 p-10 -77.51 -18.67 56.83 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 127.69 3.614 . . . . 2.25 113.729 178.413 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -90.32 -16.51 29.1 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 114.903 -4.873 . . . . 2.44 110.524 178.831 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -87.46 131.07 34.46 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 126.088 2.852 . . . . 1.32 116.638 -177.614 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -111.85 114.38 27.29 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.171 2.988 . . . . 3.19 111.304 172.361 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 39.5 mt -104.5 126.01 51.2 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 118.455 -2.653 . . . . 1.75 108.253 178.106 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.8 mt -119.72 153.76 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 N-CA-C 101.28 -3.6 . . . . 1.98 101.28 -179.185 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.414 ' CE2' HG12 ' A' ' 61' ' ' ILE 0.429 26.7 t80 -126.03 -73.15 0.63 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 119.052 -1.059 . . . . 1.94 112.738 167.964 . . . . . . . . 3 3 . 1 . 078 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.11 -40.12 8.57 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 114.115 -2.85 . . . . 1.67 115.29 178.768 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.89 -52.69 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 108.452 -1.859 . . . . 1.3 108.452 -175.873 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -89.12 163.46 15.45 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 122.084 2.942 . . . . 2.89 112.787 177.677 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -68.63 147.98 51.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 125.623 1.827 . . . . 2.89 112.053 170.669 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.1 mt -84.64 144.73 28.41 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 115.925 -1.988 . . . . 1.34 107.481 -175.436 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -90.97 155.38 18.76 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 125.799 3.908 . . . . 1.94 109.372 178.252 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -65.44 -57.85 7.27 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.87 3.268 . . . . 1.56 112.858 -172.81 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.67 62.62 1.64 Allowed Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 121.385 3.314 . . . . 0.97 121.385 168.506 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 ttm-85 -139.92 163.26 33.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 113.545 -1.328 . . . . 3.07 107.442 164.938 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.254 24.4 p -91.75 172.41 8.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.269 1.985 . . . . 1.34 112.149 -174.93 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.55 -46.0 64.38 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.322 -1.763 . . . . 1.63 111.065 168.594 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.273 1.2 t -63.51 -17.2 62.51 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.127 2.171 . . . . 1.51 114.747 175.733 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -77.73 -36.08 51.23 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 115.596 1.702 . . . . 1.9 115.596 170.268 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -87.22 7.08 29.98 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.289 1.995 . . . . 0.97 112.233 173.08 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 m120 44.06 59.83 3.02 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.887 3.675 . . . . 2.35 115.86 -174.649 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.414 HG12 ' CE2' ' A' ' 45' ' ' PHE . 46.8 mt -87.07 106.98 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 119.411 -2.055 . . . . 1.39 105.811 179.294 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -104.03 -170.31 1.76 Allowed 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 116.269 -0.423 . . . . 2.58 110.364 -179.97 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -27.99 137.46 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 130.16 3.384 . . . . 2.58 118.934 169.124 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 48.42 56.2 7.83 Favored 'General case' 0 N--CA 1.431 -1.385 1 C-N-CA 132.402 4.281 . . . . 1.71 114.948 176.679 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.4 m -116.91 135.45 53.71 Favored 'General case' 0 N--CA 1.432 -1.37 0 O-C-N 119.756 -1.84 . . . . 1.34 113.859 -173.938 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.2 m -102.35 99.87 9.98 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.195 2.998 . . . . 1.36 109.299 -176.471 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.61 135.35 48.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 116.339 -1.791 . . . . 2.03 111.968 169.465 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.6 m170 -91.11 100.37 13.22 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 127.864 2.466 . . . . 2.31 113.15 -176.898 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.2 tp -91.48 135.6 33.73 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 126.9 2.625 . . . . 1.72 114.083 177.681 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.6 t -135.16 120.46 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 129.841 3.256 . . . . 1.8 109.37 170.63 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.0 pp -91.56 149.22 21.77 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 124.366 3.257 . . . . 3.26 107.526 172.264 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -96.88 112.33 24.13 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 122.706 1.241 . . . . 4.12 113.235 -177.563 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 53.6 mt -71.34 172.11 9.99 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.317 1.969 . . . . 3.54 116.317 173.441 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.4 mtt85 -63.34 -80.98 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 115.274 1.583 . . . . 7.32 115.274 177.481 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.06 90.76 0.89 Allowed Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 106.858 -2.497 . . . . 3.73 106.858 -168.704 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.773 0 C-N-CA 127.419 2.437 . . . . 3.87 114.616 -175.293 . . . . . . . . 0 0 . 1 . 079 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ptt? . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 114.363 1.246 . . . . 1.39 114.363 . . . . . . . . . 0 0 . 1 . 079 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -89.05 127.82 35.71 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.281 -2.762 . . . . 2.2 107.456 -175.778 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.8 pt -114.73 162.53 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 115.254 1.575 . . . . 1.32 115.254 171.67 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.532 ' CE2' ' HB3' ' A' ' 64' ' ' GLU . 36.1 m-85 -116.15 121.34 41.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.538 -3.226 . . . . 2.2 110.962 -175.883 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.0 t -103.2 124.45 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 1 O-C-N 116.009 -4.182 . . . . 1.23 110.592 176.49 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -99.62 135.98 40.23 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.38 1.446 . . . . 2.51 109.407 179.744 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.1 p -88.17 -175.49 5.07 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 117.235 -1.364 . . . . 1.41 113.665 176.053 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.3 mt -62.47 -52.52 63.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 124.724 1.265 . . . . 2.95 112.308 170.232 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.5 p -74.53 -12.98 60.61 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 115.591 -2.147 . . . . 2.52 110.472 -178.327 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.54 9.23 25.53 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 122.14 3.616 . . . . 1.5 122.14 173.291 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.49 140.87 54.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.493 2.092 . . . . 1.79 107.659 -177.006 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.7 m -108.33 104.83 14.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.498 -3.251 . . . . 1.38 112.458 177.128 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.7 mt -98.12 120.57 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 125.046 1.466 . . . . 2.03 107.8 -176.13 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 m -90.99 115.92 28.38 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 127.332 2.895 . . . . 1.61 108.708 178.357 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 mt -123.35 137.45 54.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.26 1.824 . . . . 2.15 107.83 -178.261 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.89 130.93 35.33 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 101.997 -3.335 . . . . 1.98 101.997 170.146 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -138.27 158.78 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 126.022 2.82 . . . . 1.52 108.968 174.472 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -102.6 153.35 38.23 Favored Pre-proline 0 N--CA 1.43 -1.433 1 O-C-N 115.211 -4.681 . . . . 2.35 107.034 161.105 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.406 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 38.3 Cg_endo -76.67 -7.66 17.74 Favored 'Trans proline' 0 N--CA 1.433 -2.037 1 CA-C-N 128.475 4.063 . . . . 1.31 112.567 -167.753 . . . . . . . . 3 3 . 1 . 079 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -80.95 -8.92 59.87 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 126.037 1.735 . . . . 1.71 108.776 -179.01 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -66.7 141.17 57.86 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.661 1.984 . . . . 1.69 113.063 171.001 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 82.3 p -82.66 168.01 17.69 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.875 -2.391 . . . . 1.33 114.557 173.435 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 14.1 mm -64.41 -32.31 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 117.795 -3.065 . . . . 1.32 112.437 173.107 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -58.65 -39.35 80.35 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 115.957 -4.214 . . . . 1.62 115.02 169.539 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -63.48 -43.44 97.28 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 127.837 2.455 . . . . 2.13 111.728 174.874 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.6 t -61.81 -47.05 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 126.814 2.046 . . . . 1.23 110.554 175.255 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -62.68 -30.61 71.52 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 119.559 3.17 . . . . 1.97 119.559 170.838 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.76 -28.66 61.79 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 123.075 1.416 . . . . 1.19 112.836 175.819 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.289 18.5 ttmm -80.18 -36.45 34.99 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 129.551 3.14 . . . . 1.92 114.041 173.317 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.443 68.7 mt -62.68 -44.75 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 127.796 2.438 . . . . 1.94 112.368 168.093 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -55.92 -52.19 65.0 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.518 -3.239 . . . . 1.9 114.251 169.872 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -60.58 -42.95 97.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.625 2.083 . . . . 1.55 116.625 175.058 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -86.22 -50.16 7.18 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.776 1.274 . . . . 2.95 110.516 -173.435 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -94.82 -41.97 8.95 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 116.643 -3.786 . . . . 1.48 114.003 -171.691 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.94 22.65 6.81 Favored Glycine 0 N--CA 1.431 -1.699 0 CA-C-O 124.279 2.044 . . . . 1.12 111.836 174.02 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.4 mt -94.89 131.9 29.43 Favored Pre-proline 0 N--CA 1.43 -1.442 0 O-C-N 118.891 -2.535 . . . . 2.07 104.856 -173.168 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -64.72 144.62 84.5 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 C-N-CA 124.685 3.59 . . . . 1.39 119.293 -179.931 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -71.65 -15.46 30.38 Favored 'Trans proline' 0 N--CA 1.433 -2.085 0 C-N-CA 114.745 -3.036 . . . . 1.68 113.757 -172.124 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -65.43 -25.29 67.46 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 118.395 2.739 . . . . 2.25 118.395 175.261 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -96.68 -25.22 15.63 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 116.13 -4.106 . . . . 2.44 105.472 -172.044 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -75.38 103.42 5.51 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.396 -3.94 . . . . 1.32 114.533 -177.382 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -94.77 129.57 41.66 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.425 -2.047 . . . . 3.19 109.203 165.605 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 42.9 mt -115.08 127.32 55.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.5 -2.0 . . . . 1.75 108.694 -179.494 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.442 HD12 ' HA ' ' A' ' 49' ' ' GLN . 9.5 mm -116.31 155.37 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 127.994 2.518 . . . . 1.98 104.597 173.958 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -104.73 -83.32 0.5 Allowed 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.88 -2.637 . . . . 1.94 103.88 174.218 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.99 -43.69 6.6 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 113.95 -1.477 . . . . 1.67 110.787 179.199 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -173.81 -16.9 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 127.254 2.359 . . . . 1.3 114.23 -179.007 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -82.2 124.73 30.17 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 102.758 -3.053 . . . . 2.89 102.758 178.864 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.442 ' HA ' HD12 ' A' ' 44' ' ' ILE . 1.0 OUTLIER -64.04 130.69 45.03 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.349 -2.719 . . . . 2.89 112.166 173.73 . . . . . . . . 3 3 . 1 . 079 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.1 mt -87.41 132.32 34.02 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.108 -2.87 . . . . 1.34 107.432 -175.094 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -94.25 138.18 32.55 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 117.704 -1.141 . . . . 1.94 113.122 177.75 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.446 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 2.4 m-20 -50.6 -56.07 13.44 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 130.866 3.666 . . . . 1.56 113.339 -166.813 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.85 52.98 4.48 Favored Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 118.024 1.969 . . . . 0.97 118.024 172.963 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.0 mmt-85 -126.94 159.23 34.65 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 105.942 -1.873 . . . . 3.07 105.942 165.438 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.299 35.6 p -89.7 170.78 10.16 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.566 -2.583 . . . . 1.34 113.277 175.808 . . . . . . . . 3 3 . 1 . 079 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.406 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 3.5 mt -73.3 -32.55 64.69 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 106.416 -1.698 . . . . 1.63 106.416 173.381 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -64.38 -43.56 94.12 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 117.079 -1.439 . . . . 1.51 110.195 177.959 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -46.02 -45.79 16.13 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 122.383 2.356 . . . . 1.9 113.801 173.791 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -82.42 6.68 16.43 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.338 -1.476 . . . . 0.97 114.946 178.45 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.4 m120 61.79 37.96 15.18 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 131.25 3.82 . . . . 2.35 116.684 176.09 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -86.65 128.01 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 127.043 2.137 . . . . 1.39 105.761 -177.57 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -142.94 -47.31 0.31 Allowed 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.243 -1.536 . . . . 2.58 113.333 -172.318 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -88.6 -162.36 0.84 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.333 1.453 . . . . 2.58 114.465 179.917 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.532 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 24.8 mt-10 -84.51 75.45 10.27 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.002 -2.937 . . . . 1.71 111.74 179.598 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 m -82.42 144.09 30.73 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 119.985 3.328 . . . . 1.34 119.985 -175.834 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.3 m -91.7 106.47 18.5 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.2 -1.364 . . . . 1.36 111.44 179.63 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -85.26 154.96 21.59 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 128.317 3.913 . . . . 2.03 105.963 166.126 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.433 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 69.9 m80 -115.17 119.04 35.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 111.791 -2.458 . . . . 2.31 106.637 -176.525 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.5 tp -105.08 99.7 9.31 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 105.118 -2.178 . . . . 1.72 105.118 178.096 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.6 t -86.88 125.39 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 113.478 -1.692 . . . . 1.8 111.017 171.283 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.3 mt -92.5 119.57 32.12 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.191 -2.193 . . . . 3.26 114.635 -179.111 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -76.17 95.54 3.71 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.407 1.099 . . . . 4.12 112.432 178.602 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.0 mt -104.37 -41.38 5.78 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 116.291 -4.005 . . . . 3.54 106.57 176.257 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -77.2 -59.43 2.78 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 120.886 1.676 . . . . 7.32 114.052 173.422 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.47 -82.15 0.12 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 118.487 -2.633 . . . . 3.73 110.059 -169.579 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.699 1 C-N-CA 131.285 4.278 . . . . 3.87 113.374 173.877 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.329 0 CA-C-O 119.556 -0.259 . . . . 1.39 111.252 . . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -114.0 113.26 24.54 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 101.531 -3.507 . . . . 2.2 101.531 -174.581 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.7 pt -92.52 166.66 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 122.601 2.455 . . . . 1.32 111.835 170.611 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -122.61 94.12 4.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.895 1.678 . . . . 2.2 110.831 176.142 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.4 t -77.05 115.11 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 O-C-N 118.035 -2.915 . . . . 1.23 113.557 174.742 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -94.84 128.89 41.91 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 117.083 -1.847 . . . . 2.51 113.74 -178.288 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 p -85.67 173.24 10.26 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 124.463 2.078 . . . . 1.41 109.914 177.126 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 mt -79.96 -33.97 39.13 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.242 -2.786 . . . . 2.95 108.406 172.845 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.9 p -71.77 -35.06 69.94 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 123.769 2.986 . . . . 2.52 113.568 179.898 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.81 8.41 0.92 Allowed Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 119.162 2.425 . . . . 1.5 119.162 176.957 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.0 tptt -96.94 144.55 26.75 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.898 -1.519 . . . . 1.79 106.898 -172.309 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.4 m -111.73 108.25 17.62 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.318 -2.845 . . . . 1.38 103.318 174.241 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.9 mt -82.27 111.1 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 113.526 -1.67 . . . . 2.03 108.276 179.472 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.5 m -85.23 106.84 16.95 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.194 1.398 . . . . 1.61 112.665 -178.756 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.4 mt -123.36 133.28 54.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 124.833 1.333 . . . . 2.15 107.871 -172.849 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -94.21 133.59 37.57 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.748 -1.845 . . . . 1.98 110.672 162.902 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.3 m -133.3 173.54 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 125.964 2.792 . . . . 1.52 108.997 176.744 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.267 39.5 mt-10 -123.42 167.08 15.79 Favored Pre-proline 0 N--CA 1.43 -1.451 0 N-CA-C 103.595 -2.743 . . . . 2.35 103.595 162.911 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -69.06 -11.54 32.0 Favored 'Trans proline' 0 N--CA 1.433 -2.065 0 N-CA-C 117.184 1.955 . . . . 1.31 117.184 179.395 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -79.27 -11.73 59.95 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 129.066 2.946 . . . . 1.71 112.07 179.001 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -74.76 141.22 44.42 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.16 -1.588 . . . . 1.69 113.098 175.425 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.2 p -84.46 164.35 18.89 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.865 -1.772 . . . . 1.33 107.957 174.875 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.275 1.9 mp -69.95 -27.77 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 119.232 -2.168 . . . . 1.32 113.429 178.86 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -53.34 -46.72 69.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.07 -2.269 . . . . 1.62 114.69 164.436 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -53.3 -40.8 65.04 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.532 -3.23 . . . . 2.13 113.714 172.633 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.06 -42.0 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 O-C-N 121.045 -1.034 . . . . 1.23 111.682 177.546 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -59.56 -36.89 77.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.057 -2.277 . . . . 1.97 115.03 173.634 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.17 73.64 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.052 2.095 . . . . 1.19 115.034 174.883 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -72.81 -37.19 67.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 131.418 3.887 . . . . 1.92 112.748 173.823 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.6 mt -73.6 -28.02 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 117.825 -3.047 . . . . 1.94 109.106 170.596 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -71.2 -35.22 71.47 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.859 -1.776 . . . . 1.9 110.228 176.613 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -69.64 -57.39 5.22 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.098 2.559 . . . . 1.55 109.066 176.41 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.254 22.6 mmtt -57.58 -73.44 0.07 Allowed 'General case' 0 CA--C 1.489 -1.384 0 C-N-CA 131.068 3.747 . . . . 2.95 115.104 178.449 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.276 47.0 mm-40 -88.73 -41.14 12.74 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.727 -2.483 . . . . 1.48 114.52 -168.105 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.62 34.43 2.86 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 126.421 1.962 . . . . 1.12 111.427 173.97 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.8 mm -92.93 135.31 26.15 Favored Pre-proline 0 N--CA 1.429 -1.488 0 CA-C-O 112.456 -3.64 . . . . 2.07 109.52 -177.586 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -75.48 136.02 18.93 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 CA-C-N 127.342 3.658 . . . . 1.39 112.638 176.75 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -60.9 -21.14 69.89 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 C-N-CA 123.574 2.85 . . . . 1.68 116.909 -173.629 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.55 -28.68 68.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 130.094 3.358 . . . . 2.25 113.135 172.814 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -80.98 -34.82 32.77 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 131.066 3.746 . . . . 2.44 113.663 -177.518 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -88.59 115.47 26.14 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 116.266 1.95 . . . . 1.32 116.266 -163.587 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -95.71 120.04 35.27 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.898 -2.376 . . . . 3.19 110.092 173.46 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.264 68.0 mt -97.43 99.17 10.6 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.132 1.787 . . . . 1.75 113.109 175.835 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mm -95.05 130.65 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 128.857 2.863 . . . . 1.98 107.432 -174.788 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -111.7 -80.96 0.59 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 105.326 -2.102 . . . . 1.94 105.326 174.889 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.99 -95.67 0.35 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.777 -2.452 . . . . 1.67 111.016 -179.168 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.58 -4.12 54.91 Favored Glycine 0 N--CA 1.429 -1.772 0 O-C-N 119.551 -1.968 . . . . 1.3 113.634 -178.977 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -133.25 153.87 51.18 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.178 -2.366 . . . . 2.89 113.458 -177.581 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -82.31 141.41 32.91 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.045 -3.535 . . . . 2.89 109.483 162.948 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.8 mt -75.68 141.1 42.81 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.631 -2.543 . . . . 1.34 106.157 -178.909 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -86.42 137.34 32.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.204 -3.435 . . . . 1.94 115.077 176.773 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -53.03 -60.86 2.75 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 120.742 3.608 . . . . 1.56 120.742 -166.372 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.87 25.62 1.18 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 120.81 3.084 . . . . 0.97 120.81 170.128 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -113.87 159.82 19.43 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 127.325 2.427 . . . . 3.07 106.241 173.161 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.1 p -87.21 156.84 19.5 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.384 2.364 . . . . 1.34 117.384 -176.462 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.8 mt -53.62 -40.24 65.6 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 118.576 -2.577 . . . . 1.63 114.064 167.824 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.1 t -56.23 -36.69 68.76 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 115.573 1.694 . . . . 1.51 115.573 174.777 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -55.31 -30.49 60.32 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 120.795 3.628 . . . . 1.9 120.795 175.015 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -96.91 -1.24 46.22 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.843 -1.526 . . . . 0.97 109.906 -179.221 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.308 33.8 m-80 64.74 67.86 0.54 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.999 2.92 . . . . 2.35 109.44 -177.978 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.4 mt -124.34 114.02 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 1 C-N-CA 132.614 4.365 . . . . 1.39 101.794 179.851 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.25 57.0 mm-40 -139.77 -25.32 0.82 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 116.448 -1.739 . . . . 2.58 109.083 -176.104 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -107.45 -173.35 2.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 129.555 3.142 . . . . 2.58 110.977 -179.481 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.51 77.5 1.44 Allowed 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.938 1.295 . . . . 1.71 113.719 177.597 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.379 54.3 p -80.06 158.56 26.43 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.046 1.339 . . . . 1.34 113.772 -170.386 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.516 HG23 ' CE1' ' A' ' 68' ' ' HIS . 2.9 m -107.96 115.46 30.17 Favored 'General case' 0 N--CA 1.431 -1.424 1 N-CA-C 99.636 -4.209 . . . . 1.36 99.636 179.097 . . . . . . . . 3 3 . 1 . 080 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mp -108.27 168.01 9.61 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 116.66 -3.775 . . . . 2.03 106.292 175.706 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.516 ' CE1' HG23 ' A' ' 66' ' ' THR . 86.3 m-70 -127.33 135.41 50.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.978 -1.701 . . . . 2.31 113.002 -178.554 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.259 42.0 tp -106.08 107.08 17.9 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.655 -2.528 . . . . 1.72 107.393 179.738 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 37.1 t -98.16 143.57 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 103.382 -2.821 . . . . 1.8 103.382 176.543 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.5 mt -110.97 141.74 44.02 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.404 -4.56 . . . . 3.26 112.227 178.022 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.548 HH21 ' C ' ' A' ' 76' ' ' GLY . 76.7 mtp180 -90.06 154.66 19.63 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 124.413 1.085 . . . . 4.12 112.726 174.945 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.9 mt -98.89 161.69 13.5 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 127.137 2.175 . . . . 3.54 107.822 -178.966 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 ptt-85 -69.81 129.85 40.67 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 126.612 2.445 . . . . 7.32 115.709 166.519 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.26 60.47 3.06 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-O 117.157 -1.913 . . . . 3.73 110.819 -159.605 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.548 ' C ' HH21 ' A' ' 72' ' ' ARG . . . . . . . . 0 C--O 1.26 1.724 0 CA-C-N 118.57 1.185 . . . . 3.87 111.147 -177.428 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ptt? . . . . . 0 CA--C 1.489 -1.387 0 CA-C-O 121.672 0.748 . . . . 1.39 112.948 . . . . . . . . . 0 0 . 1 . 081 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -95.54 137.88 33.99 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.939 -2.245 . . . . 2.2 104.939 -179.287 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.2 pt -123.14 155.95 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 124.398 2.047 . . . . 1.32 109.756 161.946 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -115.88 119.07 34.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.469 -3.269 . . . . 2.2 107.433 -172.363 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.478 HG22 ' HB2' ' A' ' 67' ' ' LEU . 40.0 t -110.83 117.89 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 119.032 -2.292 . . . . 1.23 106.028 -179.092 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -108.62 168.77 9.09 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 119.634 -0.827 . . . . 2.51 111.292 177.05 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -103.9 -165.93 1.2 Allowed 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 122.663 1.22 . . . . 1.41 109.743 173.979 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.0 tp -75.29 -49.99 17.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.136 2.174 . . . . 2.95 113.494 173.681 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.8 p -89.43 -37.68 14.64 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.122 -2.236 . . . . 2.52 114.445 -172.548 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.73 28.21 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.713 0 N-CA-C 121.981 3.552 . . . . 1.5 121.981 179.28 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -104.95 95.76 6.08 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 126.478 1.911 . . . . 1.79 114.366 -177.506 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.9 m -89.77 124.19 34.42 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 115.54 -2.464 . . . . 1.38 109.149 178.847 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 pt -119.32 128.57 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 117.688 -3.132 . . . . 2.03 107.5 172.675 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.3 m -95.76 122.94 39.07 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 116.133 -1.889 . . . . 1.61 110.016 -177.565 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.278 76.9 mt -119.89 128.17 53.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 121.925 2.148 . . . . 2.15 111.465 -177.502 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -80.03 122.23 26.49 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 125.487 1.742 . . . . 1.98 108.031 171.608 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 m -136.54 178.72 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 1 C-N-CA 131.797 4.039 . . . . 1.52 111.663 -173.963 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -125.84 162.55 44.65 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 113.046 -3.359 . . . . 2.35 107.303 166.411 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -74.16 -19.46 20.03 Favored 'Trans proline' 0 C--N 1.3 -2.013 1 CA-C-N 130.026 4.616 . . . . 1.31 111.886 -170.622 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.15 10.85 27.65 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 131.056 3.742 . . . . 1.71 110.925 -173.96 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -88.37 148.15 24.39 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.813 -3.679 . . . . 1.69 110.086 176.368 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 p -87.0 162.55 17.58 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.829 1.789 . . . . 1.33 115.829 -177.488 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.6 mm -66.47 -29.39 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 127.817 3.675 . . . . 1.32 114.859 173.389 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -58.51 -51.33 70.35 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 113.574 -5.704 . . . . 1.62 113.358 173.173 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -63.25 -40.02 96.24 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.69 1.596 . . . . 2.13 110.62 176.711 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.6 t -63.38 -33.91 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 117.729 -3.107 . . . . 1.23 116.077 176.455 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.451 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 37.4 mtmt -65.33 -32.18 73.7 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.17 -4.081 . . . . 1.97 111.8 174.386 . . . . . . . . 3 3 . 1 . 081 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.14 -23.35 62.99 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.191 1.796 . . . . 1.19 113.271 172.914 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -76.45 -41.18 48.28 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 126.307 2.955 . . . . 1.92 115.366 170.908 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.9 -35.13 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 118.608 -2.558 . . . . 1.94 109.672 171.139 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -62.81 -54.48 38.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.169 -3.457 . . . . 1.9 110.782 177.343 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -40.17 -52.44 2.59 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 125.619 1.567 . . . . 1.55 113.642 170.362 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -72.15 -67.05 0.57 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 115.958 1.836 . . . . 2.95 115.958 -176.818 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -101.38 -21.19 14.89 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.788 2.709 . . . . 1.48 113.829 -167.08 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.64 7.85 50.24 Favored Glycine 0 N--CA 1.43 -1.715 0 O-C-N 119.138 -2.226 . . . . 1.12 114.426 168.321 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.7 mt -81.46 117.8 69.65 Favored Pre-proline 0 N--CA 1.43 -1.433 0 N-CA-C 103.469 -2.789 . . . . 2.07 103.469 -166.614 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.91 137.28 61.73 Favored 'Trans proline' 0 N--CA 1.433 -2.066 0 C-N-CA 121.871 1.714 . . . . 1.39 114.231 -176.505 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -63.23 -8.82 15.35 Favored 'Trans proline' 0 N--CA 1.434 -1.999 0 N-CA-C 122.05 3.827 . . . . 1.68 122.05 -172.301 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -81.75 -14.35 56.58 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 119.929 -0.709 . . . . 2.25 112.0 168.668 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -90.77 -27.09 19.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.912 2.885 . . . . 2.44 110.38 -175.601 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.451 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 76.2 mt-30 -75.66 128.35 35.02 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 126.294 2.246 . . . . 1.32 114.76 -176.423 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -116.82 100.78 8.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.53 -3.856 . . . . 3.19 101.167 175.176 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.4 mt -91.11 125.6 35.94 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 103.796 -2.668 . . . . 1.75 103.796 177.822 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 mm -120.76 130.97 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 103.888 -2.634 . . . . 1.98 103.888 178.907 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -84.32 -75.44 0.34 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 118.117 -0.945 . . . . 1.94 109.979 170.164 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.0 -77.63 0.59 Allowed 'General case' 0 N--CA 1.43 -1.429 2 O-C-N 115.822 -4.299 . . . . 1.67 104.909 173.589 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.8 -25.26 3.4 Favored Glycine 0 N--CA 1.429 -1.779 0 O-C-N 118.564 -2.585 . . . . 1.3 113.646 -177.971 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -84.43 138.08 33.03 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.835 -2.568 . . . . 2.89 117.503 176.66 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -71.0 142.37 50.96 Favored 'General case' 0 N--CA 1.431 -1.405 1 O-C-N 115.932 -4.23 . . . . 2.89 111.362 174.422 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.8 mt -90.98 141.85 28.4 Favored 'General case' 0 N--CA 1.429 -1.495 1 O-C-N 115.983 -4.198 . . . . 1.34 109.988 -175.835 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -92.66 145.08 24.7 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 125.44 1.713 . . . . 1.94 111.935 -178.069 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.74 -63.36 1.33 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.383 2.04 . . . . 1.56 112.591 -167.619 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.4 39.37 2.49 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 116.745 -3.722 . . . . 0.97 116.106 177.184 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -115.56 159.38 21.33 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 121.511 2.656 . . . . 3.07 107.381 166.399 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.319 33.5 p -84.46 156.45 21.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 126.898 3.237 . . . . 1.34 110.754 176.777 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.1 mt -68.5 -25.94 65.21 Favored 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 111.544 -6.972 . . . . 1.63 115.287 171.776 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -66.65 -32.98 74.65 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.113 -3.492 . . . . 1.51 110.014 172.538 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -64.04 -34.08 77.2 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.075 -1.641 . . . . 1.9 114.47 171.382 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -89.42 -3.44 58.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.146 1.339 . . . . 0.97 111.892 177.025 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.6 m120 55.12 50.0 16.22 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 127.415 2.286 . . . . 2.35 115.948 -174.964 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.9 mt -77.88 126.99 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 113.161 -1.836 . . . . 1.39 108.6 178.474 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -102.46 175.35 5.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.111 1.764 . . . . 2.58 110.825 -176.28 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -72.97 -8.95 58.03 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 119.308 3.077 . . . . 2.58 119.308 177.604 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -106.85 7.48 30.19 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 125.707 1.879 . . . . 1.71 109.739 177.202 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 m -84.36 144.75 28.62 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.872 -1.768 . . . . 1.34 112.766 -171.635 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.3 m -110.32 120.04 41.14 Favored 'General case' 0 N--CA 1.431 -1.384 1 C-N-CA 133.065 4.546 . . . . 1.36 104.516 -177.007 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.478 ' HB2' HG22 ' A' ' 5' ' ' VAL . 7.9 mp -104.77 158.73 16.32 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.374 -2.825 . . . . 2.03 103.374 174.519 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -121.04 124.89 45.92 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.115 1.766 . . . . 2.31 109.413 -176.505 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.1 tp -105.7 99.73 9.32 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.897 1.681 . . . . 1.72 107.058 -177.812 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.7 152.04 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 105.682 -1.97 . . . . 1.8 105.682 171.247 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.2 mt -109.36 127.99 54.77 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.164 -2.21 . . . . 3.26 107.001 176.377 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -84.89 121.14 27.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.029 2.532 . . . . 4.12 109.406 178.113 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.5 mt -66.48 144.26 56.59 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.174 -3.454 . . . . 3.54 113.244 166.309 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -76.23 110.12 10.48 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 126.44 3.019 . . . . 7.32 109.317 169.664 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.94 -51.28 0.18 Allowed Glycine 0 N--CA 1.43 -1.733 0 O-C-N 116.707 -3.746 . . . . 3.73 105.743 -173.96 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.745 0 N-CA-C 106.494 -2.642 . . . . 3.87 106.494 175.534 . . . . . . . . 0 0 . 1 . 082 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 ptt? . . . . . 0 CA--C 1.489 -1.37 0 CA-C-O 124.694 2.188 . . . . 1.39 115.184 . . . . . . . . . 0 0 . 1 . 082 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -94.25 125.0 38.62 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.673 -2.517 . . . . 2.2 110.772 -179.715 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.6 pt -124.89 163.79 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 124.902 1.281 . . . . 1.32 112.339 171.696 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -114.42 159.18 20.59 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.137 2.875 . . . . 2.2 107.43 -178.248 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.0 t -143.05 134.34 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 102.539 -3.134 . . . . 1.23 102.539 177.283 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -113.73 131.78 56.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.856 1.312 . . . . 2.51 109.324 177.856 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.5 p -87.26 164.77 16.12 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 126.122 2.867 . . . . 1.41 107.801 179.845 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.1 mt -52.36 -56.71 13.09 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 116.173 -4.08 . . . . 2.95 114.696 170.647 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.4 p -69.51 -14.07 62.67 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.202 2.601 . . . . 2.52 114.142 -173.367 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.38 32.18 1.69 Allowed Glycine 0 N--CA 1.43 -1.745 1 N-CA-C 123.26 4.064 . . . . 1.5 123.26 169.246 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -111.6 148.43 33.33 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 115.217 -2.325 . . . . 1.79 114.955 -178.414 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.1 m -98.95 127.0 44.77 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 120.636 1.562 . . . . 1.38 108.067 175.712 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -103.73 123.6 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 125.991 2.805 . . . . 2.03 106.665 175.57 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.9 m -97.86 128.55 44.55 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.494 -3.879 . . . . 1.61 103.971 -178.096 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -125.61 133.08 52.36 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 121.688 2.04 . . . . 2.15 115.897 178.75 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -80.54 104.0 10.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 113.369 0.878 . . . . 1.98 113.369 162.318 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -114.9 154.1 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 119.211 -2.18 . . . . 1.52 109.583 177.967 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -113.86 151.39 44.7 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 102.923 -2.991 . . . . 2.35 102.923 164.261 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -68.29 -4.17 12.26 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-O 116.907 -1.372 . . . . 1.31 114.911 -173.39 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.2 p -93.11 -5.09 51.07 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.497 3.119 . . . . 1.71 113.065 -179.547 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -79.93 138.39 37.1 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.864 2.066 . . . . 1.69 108.132 174.599 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 39.3 p -76.22 173.78 10.95 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 128.392 3.949 . . . . 1.33 108.443 176.803 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.463 HG22 ' HE3' ' A' ' 27' ' ' LYS . 31.0 mm -74.67 -27.45 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 1 O-C-N 113.348 -5.845 . . . . 1.32 106.925 175.037 . . . . . . . . 3 3 . 1 . 082 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -65.6 -33.68 76.46 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 129.268 3.027 . . . . 1.62 111.433 172.079 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -83.96 -33.92 24.52 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.541 1.162 . . . . 2.13 111.825 172.867 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.26 29.0 t -64.62 -39.03 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 1 O-C-N 114.449 -5.157 . . . . 1.23 108.206 178.544 . . . . . . . . 3 2 . 1 . 082 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.463 ' HE3' HG22 ' A' ' 23' ' ' ILE 0.328 91.0 mttt -61.02 -47.87 84.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.23 -3.419 . . . . 1.97 113.528 173.486 . . . . . . . . 3 3 . 1 . 082 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.0 -39.65 63.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.849 -2.407 . . . . 1.19 109.648 170.961 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -61.22 -37.71 84.01 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.662 -4.398 . . . . 1.92 114.224 176.098 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.6 mt -77.7 -33.2 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 127.309 2.244 . . . . 1.94 112.101 171.851 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -60.77 -34.6 74.72 Favored 'General case' 0 N--CA 1.431 -1.384 1 O-C-N 115.647 -4.408 . . . . 1.9 118.452 171.902 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -67.83 -26.03 65.85 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 110.523 -3.035 . . . . 1.55 113.728 168.879 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -96.44 -58.52 2.04 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 104.633 -2.358 . . . . 2.95 104.633 -172.94 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -92.45 -44.38 8.69 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.776 -2.453 . . . . 1.48 115.145 -169.817 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.8 -11.0 10.24 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 119.299 -2.126 . . . . 1.12 111.402 176.718 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 36' ' ' ILE . 6.0 mt -68.64 129.12 92.75 Favored Pre-proline 0 N--CA 1.429 -1.49 0 CA-C-O 112.896 -3.43 . . . . 2.07 109.165 -174.627 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -73.87 154.95 48.64 Favored 'Trans proline' 0 N--CA 1.433 -2.049 0 CA-C-N 126.783 3.458 . . . . 1.39 109.959 -174.667 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.39 -11.27 19.05 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 123.942 3.095 . . . . 1.68 111.654 -171.779 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -53.79 -59.14 5.0 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.906 2.482 . . . . 2.25 114.768 165.417 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -66.96 -23.79 65.99 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 118.911 2.93 . . . . 2.44 118.911 -177.871 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -83.97 134.69 34.64 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.415 1.886 . . . . 1.32 113.52 -170.311 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.255 47.8 mtt180 -119.34 114.44 22.36 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.382 -1.449 . . . . 3.19 109.847 172.11 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.0 mt -95.73 137.62 34.53 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.036 -1.839 . . . . 1.75 106.036 178.247 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.4 mt -135.37 136.78 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 128.261 2.625 . . . . 1.98 109.186 179.571 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -139.08 143.93 38.53 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 121.478 -0.764 . . . . 1.94 110.941 168.696 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.344 . . 54.4 27.57 8.35 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.712 -2.493 . . . . 1.67 115.499 176.658 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.88 -7.21 35.98 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-O 119.054 -0.859 . . . . 1.3 112.649 -170.583 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -87.2 139.93 30.06 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 123.032 3.416 . . . . 2.89 111.815 173.537 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -98.09 115.49 28.36 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.493 -2.004 . . . . 2.89 109.03 174.825 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 mt -83.24 159.42 21.97 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.425 -1.261 . . . . 1.34 112.961 -173.532 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -112.47 155.17 24.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 118.486 2.773 . . . . 1.94 118.486 172.471 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.51 -54.03 38.76 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 119.483 3.142 . . . . 1.56 119.483 -167.666 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.78 63.69 4.41 Favored Glycine 0 N--CA 1.431 -1.679 0 O-C-N 119.613 -1.929 . . . . 0.97 116.387 170.952 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -139.48 155.17 47.72 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.006 -2.22 . . . . 3.07 105.006 168.121 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 40.7 p -87.81 171.34 10.46 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.68 2.181 . . . . 1.34 109.481 176.274 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.0 mt -70.46 -37.69 74.34 Favored 'General case' 0 N--CA 1.43 -1.433 1 O-C-N 116.179 -4.076 . . . . 1.63 107.448 172.529 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.8 t -52.61 -45.83 66.74 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 118.5 2.778 . . . . 1.51 118.5 173.802 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -58.34 -53.74 54.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 130.7 3.6 . . . . 1.9 112.184 173.098 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -76.67 -2.1 31.11 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.863 -3.648 . . . . 0.97 115.876 -175.461 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.269 17.6 m120 60.93 55.44 3.14 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.569 1.947 . . . . 2.35 116.036 -178.825 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.0 mt -106.76 128.01 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-O 115.586 -2.149 . . . . 1.39 108.925 174.872 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -107.39 -176.2 3.0 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 114.446 -2.692 . . . . 2.58 111.983 -170.024 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.1 ptmm? -59.14 146.48 38.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 126.706 2.504 . . . . 2.58 114.462 171.717 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.285 50.8 mt-10 69.87 20.5 6.68 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.281 1.515 . . . . 1.71 114.984 174.767 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.8 t -102.77 161.95 13.32 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 114.249 -1.341 . . . . 1.34 110.912 -171.917 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.2 m -121.18 120.12 34.31 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.629 -1.92 . . . . 1.36 114.144 -172.205 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mt -92.15 164.06 13.71 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 122.749 1.262 . . . . 2.03 110.381 172.694 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -121.96 112.29 18.11 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.819 -3.051 . . . . 2.31 112.324 -179.234 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.5 tp -87.55 122.29 31.07 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 118.211 -2.806 . . . . 1.72 113.361 179.14 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.94 168.33 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 105.145 -2.169 . . . . 1.8 105.145 175.107 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.1 mt -122.32 169.51 10.86 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 116.24 -4.037 . . . . 3.26 108.782 -176.533 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -87.69 154.51 20.52 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.07 -1.085 . . . . 4.12 108.07 173.394 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 tt -151.88 -48.59 0.11 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 103.86 -2.645 . . . . 3.54 103.86 166.755 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -82.53 -49.44 9.89 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 120.849 1.659 . . . . 7.32 110.114 172.436 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.89 161.01 37.08 Favored Glycine 0 N--CA 1.429 -1.767 0 O-C-N 118.239 -2.788 . . . . 3.73 109.264 -168.809 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.778 0 C-N-CA 127.874 2.654 . . . . 3.87 112.236 170.812 . . . . . . . . 0 0 . 1 . 083 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 CA--C 1.491 -1.312 0 CA-C-O 127.519 3.533 . . . . 1.39 115.955 . . . . . . . . . 0 0 . 1 . 083 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -81.77 140.2 34.38 Favored 'General case' 0 N--CA 1.431 -1.407 1 O-C-N 113.473 -5.767 . . . . 2.2 110.601 -175.387 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.5 pt -131.47 159.47 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 119.818 -1.801 . . . . 1.32 106.606 177.136 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -120.08 100.12 7.01 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.949 1.833 . . . . 2.2 112.048 -175.532 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -91.09 111.99 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 103.968 -2.605 . . . . 1.23 103.968 177.195 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.254 68.2 mmtt -90.68 141.09 29.15 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.232 -2.792 . . . . 2.51 110.85 177.666 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.5 p -93.96 176.29 6.39 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 120.586 3.55 . . . . 1.41 120.586 172.229 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.6 tp -66.11 -43.83 86.07 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 126.35 1.86 . . . . 2.95 110.497 -177.559 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.8 p -78.36 -49.55 13.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.063 3.357 . . . . 2.52 120.063 -171.641 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.9 32.59 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 128.321 2.867 . . . . 1.5 120.073 174.565 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.35 149.44 31.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.373 -0.973 . . . . 1.79 108.373 178.482 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -104.59 138.06 41.5 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.667 -2.521 . . . . 1.38 106.752 171.835 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.265 3.2 mt -106.12 92.91 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 122.793 1.282 . . . . 2.03 109.391 175.177 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.8 m -78.81 116.58 19.23 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 119.97 -1.706 . . . . 1.61 109.709 174.812 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.7 mt -125.51 149.26 48.45 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 106.849 -1.537 . . . . 2.15 106.849 -179.773 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -85.2 109.81 18.58 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 127.31 2.881 . . . . 1.98 117.386 165.227 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -121.88 164.07 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 121.879 2.127 . . . . 1.52 110.008 -178.799 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -112.06 157.75 38.85 Favored Pre-proline 0 N--CA 1.43 -1.435 0 C-N-CA 125.529 1.532 . . . . 2.35 109.482 164.858 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -86.48 -0.29 8.15 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 CA-C-N 125.658 3.057 . . . . 1.31 110.902 -170.281 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.1 p -89.82 -14.82 33.62 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 129.657 3.183 . . . . 1.71 111.251 175.205 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -68.03 142.37 55.91 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 127.086 3.327 . . . . 1.69 107.816 173.934 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.2 p -79.69 160.95 26.1 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.795 -2.441 . . . . 1.33 111.429 174.003 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mm -66.58 -27.17 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 1 O-C-N 115.628 -4.42 . . . . 1.32 111.743 171.513 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -56.98 -45.57 82.85 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 129.056 2.942 . . . . 1.62 109.836 167.913 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -65.45 -52.1 55.46 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.146 2.578 . . . . 2.13 111.752 176.626 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.82 -37.36 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 128.866 2.866 . . . . 1.23 109.404 177.046 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.84 -36.42 82.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 121.292 1.86 . . . . 1.97 115.467 174.81 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -24.81 67.78 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.257 1.206 . . . . 1.19 114.257 166.406 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -82.52 -25.57 33.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.756 -3.715 . . . . 1.92 111.618 173.747 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.8 mt -77.53 -29.09 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 117.915 -2.991 . . . . 1.94 111.103 175.093 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -66.61 -43.31 85.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 127.462 2.976 . . . . 1.9 111.567 173.536 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.263 31.6 t70 -49.6 -39.77 36.64 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 116.752 2.13 . . . . 1.55 116.752 168.03 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -86.07 -61.69 1.69 Allowed 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 118.289 2.7 . . . . 2.95 118.289 -178.153 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -95.19 -11.74 27.56 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.088 1.355 . . . . 1.48 113.052 -174.083 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.65 24.77 71.63 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 117.257 -3.402 . . . . 1.12 118.334 179.696 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.5 mt -99.62 132.37 23.21 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 116.852 -3.734 . . . . 2.07 110.218 -169.848 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -72.91 152.51 52.11 Favored 'Trans proline' 0 C--N 1.299 -2.038 1 C-N-CA 125.518 4.145 . . . . 1.39 113.536 -175.255 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -66.92 -36.61 22.38 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 O-C-N 115.322 -3.041 . . . . 1.68 112.947 -175.046 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.26 -25.74 67.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 124.715 2.198 . . . . 2.25 115.774 178.405 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -91.24 -22.91 20.36 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.29 -1.506 . . . . 2.44 109.811 179.783 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -78.84 135.89 37.17 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.831 -3.043 . . . . 1.32 112.239 -177.517 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.449 ' HB2' ' HD2' ' A' ' 72' ' ' ARG 0.346 38.2 ttt180 -124.25 123.51 40.39 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 116.973 -3.579 . . . . 3.19 109.288 167.948 . . . . . . . . 3 3 . 1 . 083 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mt -105.63 127.17 52.9 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.672 2.177 . . . . 1.75 108.885 179.682 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.3 mm -114.37 143.17 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 131.273 3.829 . . . . 1.98 106.816 -177.683 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -131.07 100.05 5.09 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.723 -3.111 . . . . 1.94 107.973 175.998 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.351 . . 66.76 -61.53 0.32 Allowed 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 129.22 3.008 . . . . 1.67 114.856 -173.031 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.09 -24.31 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 106.538 -2.625 . . . . 1.3 106.538 -176.079 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -90.08 153.41 20.57 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.094 -2.416 . . . . 2.89 110.481 177.237 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -97.73 140.59 31.9 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 102.072 -3.307 . . . . 2.89 102.072 179.184 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.2 mt -116.47 127.08 54.25 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 115.961 -1.971 . . . . 1.34 110.767 -173.023 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -83.31 157.1 22.73 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 118.635 2.828 . . . . 1.94 118.635 -179.419 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -59.87 -63.85 1.16 Allowed 'General case' 0 N--CA 1.43 -1.444 1 N-CA-C 121.829 4.011 . . . . 1.56 121.829 -167.02 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.21 31.79 2.58 Favored Glycine 0 N--CA 1.43 -1.754 0 CA-C-N 113.572 -1.649 . . . . 0.97 117.114 172.05 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -98.25 164.77 12.17 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.486 -3.361 . . . . 3.07 109.04 159.616 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.455 11.9 p -95.69 172.83 7.8 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.65 2.38 . . . . 1.34 109.855 172.615 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.6 mp -76.01 -37.96 57.86 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.979 -1.009 . . . . 1.63 109.607 171.098 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -48.97 -50.03 37.62 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 116.588 2.07 . . . . 1.51 116.588 175.433 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -56.28 -35.44 67.49 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.352 2.661 . . . . 1.9 115.367 176.126 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -99.45 6.72 45.89 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.835 1.654 . . . . 0.97 112.849 178.342 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.9 m120 53.87 37.89 27.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.53 2.048 . . . . 2.35 116.53 -178.811 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.2 mm -82.27 114.69 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 126.691 1.996 . . . . 1.39 107.88 -173.896 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -103.61 -177.22 3.31 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.779 -2.451 . . . . 2.58 110.731 -173.61 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -58.45 146.29 35.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 127.143 2.177 . . . . 2.58 113.08 179.425 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.276 72.9 mt-10 64.03 19.42 11.75 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 128.325 3.516 . . . . 1.71 118.119 172.957 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.6 m -88.48 151.33 22.62 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.91 -1.885 . . . . 1.34 105.91 -168.778 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.0 m -90.12 110.38 21.39 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.269 2.228 . . . . 1.36 107.716 -179.364 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -102.34 155.76 18.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 102.214 -3.254 . . . . 2.03 102.214 174.055 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -129.16 128.24 43.01 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.974 -4.204 . . . . 2.31 115.34 -176.781 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.0 tp -108.34 124.21 50.0 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 124.749 1.281 . . . . 1.72 112.28 -174.686 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.431 15.6 m -118.17 -179.3 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 130.481 3.512 . . . . 1.8 108.812 170.202 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.1 mt -131.41 150.92 51.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.398 -3.938 . . . . 3.26 113.099 179.038 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.449 ' HD2' ' HB2' ' A' ' 42' ' ' ARG . 5.5 mpt_? -84.48 160.11 20.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 127.628 3.08 . . . . 4.12 114.076 176.645 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.8 mt -104.19 -179.38 3.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.704 -2.702 . . . . 3.54 103.704 168.499 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.8 mtt85 -79.39 155.12 28.53 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.97 -2.956 . . . . 7.32 112.774 168.825 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.93 -137.05 12.82 Favored Glycine 0 N--CA 1.43 -1.762 0 O-C-N 118.336 -2.727 . . . . 3.73 108.718 -161.746 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.825 0 C-N-CA 117.798 -2.144 . . . . 3.87 108.783 174.075 . . . . . . . . 0 0 . 1 . 084 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 CA--C 1.489 -1.382 0 N-CA-C 115.709 1.744 . . . . 1.39 115.709 . . . . . . . . . 0 0 . 1 . 084 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -74.82 134.64 41.71 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 118.079 -0.962 . . . . 2.2 111.048 -177.683 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.5 pt -131.15 173.38 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-O 127.385 3.469 . . . . 1.32 108.341 174.769 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.251 22.9 m-85 -127.41 134.83 49.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.519 -3.238 . . . . 2.2 105.653 -171.465 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.432 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 41.3 t -116.69 114.59 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.545 -2.021 . . . . 1.23 105.545 178.554 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -107.98 137.02 46.7 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 116.18 -4.075 . . . . 2.51 109.779 178.367 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.2 p -83.69 166.77 17.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.531 -1.981 . . . . 1.41 115.157 173.167 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.8 mt -39.14 -51.9 1.9 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 120.903 3.668 . . . . 2.95 120.903 167.021 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.8 p -82.99 -32.28 27.06 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 116.697 -3.752 . . . . 2.52 110.061 -175.544 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.44 24.66 0.16 Allowed Glycine 0 N--CA 1.43 -1.717 0 O-C-N 119.407 -2.058 . . . . 1.5 116.758 172.066 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -88.41 123.18 32.71 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.207 1.504 . . . . 1.79 112.707 -175.791 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -83.93 115.84 22.49 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 120.726 3.602 . . . . 1.38 120.726 172.939 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 57.4 mt -108.24 141.08 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 124.911 1.284 . . . . 2.03 111.136 176.352 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.8 m -116.97 137.21 52.37 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.523 -1.986 . . . . 1.61 107.152 178.419 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.8 mt -135.96 144.11 45.23 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.219 1.407 . . . . 2.15 112.007 -179.435 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -93.59 115.83 28.33 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.004 0.82 . . . . 1.98 111.168 169.283 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.545 HG12 HG22 ' A' ' 26' ' ' VAL . 11.5 m -118.57 173.4 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 101.914 -3.365 . . . . 1.52 101.914 178.377 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -118.25 160.24 40.19 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 103.488 -2.782 . . . . 2.35 103.488 167.435 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -64.71 -18.28 62.1 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 C-N-CA 124.558 3.505 . . . . 1.31 117.25 -173.183 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 m -104.08 19.72 19.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 126.622 2.451 . . . . 1.71 107.563 -178.346 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -82.03 140.96 33.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 113.449 0.907 . . . . 1.69 113.449 171.168 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.264 68.2 p -80.02 156.22 27.25 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.563 2.125 . . . . 1.33 113.491 174.99 . . . . . . . . 3 3 . 1 . 084 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.3 mm -58.62 -41.12 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.663 1.585 . . . . 1.32 111.621 175.074 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -46.54 -44.72 18.14 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.701 -1.875 . . . . 1.62 114.992 168.276 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -71.21 -35.58 71.57 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 125.658 1.583 . . . . 2.13 111.276 179.678 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.545 HG22 HG12 ' A' ' 17' ' ' VAL . 5.5 t -58.38 -45.69 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 117.587 -3.196 . . . . 1.23 114.199 167.989 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -65.77 -35.49 80.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 114.169 -2.824 . . . . 1.97 111.353 170.0 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.04 -29.21 68.13 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 123.365 2.802 . . . . 1.19 111.539 175.085 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.6 mttm -65.71 -21.98 66.57 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.571 -1.331 . . . . 1.92 114.049 171.752 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.2 mm -85.94 -23.92 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 127.252 2.221 . . . . 1.94 105.911 170.073 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.484 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 50.4 tt0 -77.04 -23.03 52.11 Favored 'General case' 0 N--CA 1.429 -1.482 2 O-C-N 114.538 -5.101 . . . . 1.9 111.265 173.717 . . . . . . . . 3 3 . 1 . 084 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -74.51 -40.45 61.77 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 114.716 1.376 . . . . 1.55 114.716 167.571 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -87.35 -66.31 0.92 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 116.592 2.071 . . . . 2.95 116.592 179.093 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -82.52 -32.11 28.85 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 118.057 -1.457 . . . . 1.48 109.625 -172.101 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.75 43.05 3.45 Favored Glycine 0 N--CA 1.429 -1.776 0 O-C-N 116.78 -3.7 . . . . 1.12 114.155 -176.193 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.4 mt -120.38 136.78 25.46 Favored Pre-proline 0 N--CA 1.429 -1.5 1 N-CA-C 99.808 -4.145 . . . . 2.07 99.808 -174.721 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -67.84 152.66 77.08 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 O-C-N 115.767 -2.807 . . . . 1.39 113.845 176.798 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.484 ' HD3' ' OE1' ' A' ' 31' ' ' GLN . 63.1 Cg_endo -78.41 -12.93 15.31 Favored 'Trans proline' 0 N--CA 1.433 -2.079 0 C-N-CA 117.529 -1.181 . . . . 1.68 110.713 -173.277 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -72.6 -38.5 67.82 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.347 -2.095 . . . . 2.25 113.89 170.885 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -69.97 -25.67 63.74 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.327 -2.733 . . . . 2.44 111.085 178.308 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -89.35 143.62 26.69 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.384 2.673 . . . . 1.32 115.873 -171.817 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -132.0 150.38 52.17 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 115.709 -2.091 . . . . 3.19 107.966 167.503 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.9 mt -106.14 138.85 41.6 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 124.553 3.342 . . . . 1.75 110.017 174.355 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 mt -112.67 146.12 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-O 125.03 2.347 . . . . 1.98 106.372 172.251 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -165.36 137.08 4.09 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 127.756 3.646 . . . . 1.94 105.166 174.653 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.53 19.51 11.53 Favored 'General case' 0 N--CA 1.431 -1.4 1 O-C-N 116.052 -4.155 . . . . 1.67 113.775 -176.622 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.13 -22.8 32.61 Favored Glycine 0 N--CA 1.431 -1.669 0 O-C-N 119.177 -2.202 . . . . 1.3 113.826 -175.5 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -93.0 157.54 16.26 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 121.539 3.903 . . . . 2.89 121.539 176.403 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -94.45 133.91 37.53 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 116.973 -1.891 . . . . 2.89 111.106 174.226 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.9 mt -81.13 133.23 35.43 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.106 1.362 . . . . 1.34 113.069 -172.927 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -67.3 142.98 56.67 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.273 1.035 . . . . 1.94 109.725 170.136 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -77.0 -56.43 4.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.154 1.454 . . . . 1.56 110.381 -168.553 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.16 40.87 1.74 Allowed Glycine 0 N--CA 1.43 -1.765 1 O-C-N 116.225 -4.047 . . . . 0.97 118.198 171.33 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -117.73 161.2 20.08 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.626 -3.279 . . . . 3.07 106.555 167.745 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.5 p -86.23 177.19 7.58 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.094 -1.629 . . . . 1.34 114.233 176.11 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.0 mt -70.45 -44.69 67.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.672 -1.893 . . . . 1.63 110.4 176.106 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 t -63.01 -30.54 71.68 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.239 1.57 . . . . 1.51 115.239 -178.811 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -57.26 -46.7 82.81 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.806 2.442 . . . . 1.9 107.269 177.596 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.263 24.2 m-85 -87.15 -1.86 58.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.208 -3.432 . . . . 0.97 116.515 177.121 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 71.88 52.8 0.21 Allowed 'General case' 0 N--CA 1.43 -1.459 1 C-N-CA 133.87 4.868 . . . . 2.35 107.268 178.047 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 mt -96.7 126.27 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.123 -2.236 . . . . 1.39 107.747 -179.455 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.408 31.0 mt-30 -96.76 -167.49 1.56 Allowed 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 121.153 -0.967 . . . . 2.58 110.127 -171.582 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -75.05 151.32 38.7 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.699 1.6 . . . . 2.58 112.79 167.848 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.295 8.8 mt-10 66.6 27.31 9.59 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.579 2.351 . . . . 1.71 114.053 172.856 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.9 t -108.98 134.82 51.12 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 117.183 -3.448 . . . . 1.34 110.648 -172.961 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.9 m -82.11 104.21 12.28 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.449 2.547 . . . . 1.36 115.324 -178.346 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.6 mt -91.58 129.23 37.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.142 -2.849 . . . . 2.03 108.922 177.953 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -92.19 115.54 28.17 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.348 -2.72 . . . . 2.31 108.666 -173.22 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.4 tp -86.52 134.2 33.68 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 113.558 -3.115 . . . . 1.72 115.742 179.946 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 m -132.11 -172.63 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 127.892 3.245 . . . . 1.8 108.78 170.427 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.0 mt -114.82 -179.12 3.54 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.317 1.847 . . . . 3.26 110.279 176.315 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.258 12.5 ptt180 -76.47 161.42 28.66 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 125.567 1.792 . . . . 4.12 113.853 179.874 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.1 mt -93.93 166.75 12.02 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 124.744 1.217 . . . . 3.54 110.816 166.733 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.256 26.2 mmt180 -98.69 150.9 21.31 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.071 -1.455 . . . . 7.32 107.071 170.004 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.24 -139.09 6.32 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 127.381 2.419 . . . . 3.73 111.182 -170.374 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.806 0 CA-C-O 125.46 2.7 . . . . 3.87 110.925 177.157 . . . . . . . . 0 0 . 1 . 085 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptt? . . . . . 0 CA--C 1.49 -1.328 0 N-CA-C 107.841 -1.17 . . . . 1.39 107.841 . . . . . . . . . 0 0 . 1 . 085 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -121.55 144.81 48.51 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 119.941 -0.704 . . . . 2.2 111.656 -176.02 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.2 pt -129.06 163.74 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 120.042 -1.661 . . . . 1.32 110.038 175.167 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -111.42 114.31 27.35 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.366 2.508 . . . . 2.2 108.539 -178.647 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 81.4 t -103.76 126.33 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 118.252 -2.78 . . . . 1.23 105.985 169.347 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -107.16 127.49 53.56 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 125.638 1.836 . . . . 2.51 110.385 174.109 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.3 p -81.15 170.31 16.3 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 129.805 3.242 . . . . 1.41 113.154 173.09 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.9 mt -67.2 -30.6 70.58 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.271 -2.143 . . . . 2.95 114.086 174.701 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 p -85.7 -5.42 59.26 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.556 -1.275 . . . . 2.52 107.556 -174.677 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.92 1.49 36.36 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 115.225 0.85 . . . . 1.5 115.225 170.592 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -78.64 114.57 17.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 118.54 1.17 . . . . 1.79 112.518 -178.123 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 m -79.64 130.44 35.37 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 120.708 1.595 . . . . 1.38 110.497 170.052 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mt -109.19 119.15 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 131.541 3.936 . . . . 2.03 106.554 174.528 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.2 m -92.41 95.66 9.79 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 107.143 -1.429 . . . . 1.61 107.143 178.765 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.3 mt -96.2 139.07 32.89 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 117.937 2.569 . . . . 2.15 117.937 -177.149 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -59.76 114.49 2.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 111.127 -2.761 . . . . 1.98 109.289 163.56 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.298 13.7 m -136.6 166.19 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 126.983 2.113 . . . . 1.52 109.708 173.795 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -125.28 162.42 44.18 Favored Pre-proline 0 N--CA 1.43 -1.473 0 N-CA-C 101.258 -3.608 . . . . 2.35 101.258 171.892 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -81.93 -6.55 12.29 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 O-C-N 117.739 -1.769 . . . . 1.31 107.909 -175.79 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.7 p -99.82 16.98 21.93 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.247 1.573 . . . . 1.71 115.247 176.445 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -78.14 144.29 36.54 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 129.56 3.144 . . . . 1.69 106.123 172.952 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.0 p -83.4 154.53 23.95 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.01 1.724 . . . . 1.33 111.586 175.548 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.0 mm -67.72 -36.3 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 124.897 1.373 . . . . 1.32 110.145 -179.523 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -59.95 -41.97 93.02 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.573 -1.955 . . . . 1.62 111.92 169.977 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.3 28.4 t-20 -61.55 -37.16 82.77 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.75 -3.094 . . . . 2.13 114.738 177.256 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.9 t -53.33 -51.39 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 124.522 1.138 . . . . 1.23 113.329 169.676 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -59.96 -31.86 70.27 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 114.071 1.137 . . . . 1.97 114.071 174.38 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.22 -33.45 73.32 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.168 -2.207 . . . . 1.19 113.376 170.893 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -71.2 -26.04 62.77 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 122.397 2.362 . . . . 1.92 110.247 173.544 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.3 mt -76.99 -26.54 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-N 121.28 1.855 . . . . 1.94 106.585 173.786 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -68.9 -48.51 63.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 121.194 1.816 . . . . 1.9 109.755 176.75 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -51.18 -39.08 55.63 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.071 -2.893 . . . . 1.55 113.616 174.184 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -82.92 -71.11 0.51 Allowed 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.877 2.471 . . . . 2.95 106.221 -174.978 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -100.42 -45.14 5.66 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.051 2.982 . . . . 1.48 119.051 -166.292 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.78 74.25 0.85 Allowed Glycine 0 N--CA 1.431 -1.694 0 CA-C-O 124.748 2.305 . . . . 1.12 115.946 166.37 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.89 127.24 23.94 Favored Pre-proline 0 N--CA 1.43 -1.466 0 CA-C-N 110.804 -2.698 . . . . 2.07 105.54 -178.724 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -58.42 134.92 64.48 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 CA-C-O 112.481 -3.216 . . . . 1.39 118.075 176.851 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -65.44 -14.97 47.68 Favored 'Trans proline' 0 C--N 1.299 -2.046 1 C-N-CA 126.51 4.807 . . . . 1.68 120.528 -174.407 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.85 -20.34 35.79 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.338 -2.101 . . . . 2.25 111.06 167.44 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -87.11 -29.02 22.15 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.517 1.962 . . . . 2.44 114.438 -175.476 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.329 1.5 pt20 -78.95 135.62 37.0 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 115.067 -2.397 . . . . 1.32 110.041 -176.468 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.31 65.9 mtt180 -104.15 136.44 43.77 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 128.482 3.614 . . . . 3.19 110.047 164.834 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.5 mt -108.89 132.83 53.67 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 126.67 3.128 . . . . 1.75 110.072 172.116 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 53.7 mt -119.58 142.06 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 118.822 -2.423 . . . . 1.98 106.51 -178.831 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -157.89 141.15 15.24 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 100.603 -3.851 . . . . 1.94 100.603 171.98 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.56 -44.96 0.61 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.385 3.074 . . . . 1.67 116.394 -173.948 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 166.78 -48.42 0.26 Allowed Glycine 0 N--CA 1.43 -1.731 0 CA-C-O 124.646 2.248 . . . . 1.3 109.598 -170.923 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -83.09 -179.97 7.58 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.443 2.016 . . . . 2.89 116.443 178.752 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -96.53 147.7 23.58 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.433 -2.042 . . . . 2.89 111.502 170.87 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.6 mt -94.54 134.11 37.45 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 104.583 -2.377 . . . . 1.34 104.583 -176.105 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -86.09 137.34 32.75 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.717 0.77 . . . . 1.94 111.436 176.478 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.13 -57.99 5.73 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.935 3.694 . . . . 1.56 117.746 -168.95 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.98 44.16 3.28 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 124.639 3.381 . . . . 0.97 120.041 176.318 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 -115.65 173.26 6.63 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.733 2.682 . . . . 3.07 104.479 165.685 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.7 p -108.88 173.8 6.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.534 -1.666 . . . . 1.34 112.258 176.406 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.15 -37.28 72.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 114.856 1.428 . . . . 1.63 114.856 170.062 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -57.51 -42.0 81.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.397 -2.689 . . . . 1.51 113.73 174.539 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -52.21 -41.22 62.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.185 2.661 . . . . 1.9 118.185 173.461 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -88.99 -16.06 32.64 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 128.366 2.667 . . . . 0.97 108.251 178.139 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.419 12.0 m-80 72.83 48.56 0.19 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.776 -1.203 . . . . 2.35 111.395 179.434 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.6 mt -87.92 122.22 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.97 -2.331 . . . . 1.39 107.954 -172.993 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -87.39 -177.12 5.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 117.38 -1.728 . . . . 2.58 114.373 -173.543 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.256 14.8 pttp -63.43 140.37 58.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.952 -3.593 . . . . 2.58 110.969 167.358 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 68.42 30.18 5.47 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 127.937 2.495 . . . . 1.71 111.642 177.908 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.1 m -88.02 145.24 26.08 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 119.097 -2.252 . . . . 1.34 113.278 -172.79 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.3 m -92.27 119.68 32.1 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 118.302 -2.749 . . . . 1.36 112.953 -179.923 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mt -104.95 131.36 52.55 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 119.7 -1.875 . . . . 2.03 107.718 165.3 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -94.92 135.51 36.35 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 103.701 -2.703 . . . . 2.31 103.701 -178.719 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.7 tp -106.96 123.17 47.79 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 127.226 2.211 . . . . 1.72 110.666 -172.18 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.329 0.1 OUTLIER -121.63 167.89 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.578 1.951 . . . . 1.8 112.596 176.499 . . . . . . . . 3 3 . 1 . 085 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.0 mt -127.18 140.15 52.44 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 125.66 1.85 . . . . 3.26 108.697 177.979 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -84.92 168.98 14.52 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.436 2.065 . . . . 4.12 112.505 172.353 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.8 mt -84.35 108.7 17.33 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.412 -3.305 . . . . 3.54 110.516 174.721 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -72.71 -57.62 3.97 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.842 -1.54 . . . . 7.32 106.842 168.137 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.34 88.53 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.752 1 O-C-N 116.287 -4.008 . . . . 3.73 106.265 -172.072 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.802 0 C-N-CA 116.313 -2.851 . . . . 3.87 116.327 -171.412 . . . . . . . . 0 0 . 1 . 086 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 CA--C 1.491 -1.321 0 CA-C-O 116.583 -1.675 . . . . 1.39 114.993 . . . . . . . . . 0 0 . 1 . 086 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -93.35 122.81 36.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 128.69 2.796 . . . . 2.2 106.769 -177.367 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 pt -119.65 170.17 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 124.553 2.121 . . . . 1.32 108.124 169.539 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.263 72.7 m-85 -122.09 144.56 48.85 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.185 -3.447 . . . . 2.2 110.645 -179.652 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.83 128.9 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 120.482 -1.386 . . . . 1.23 108.045 173.327 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -93.28 132.36 37.54 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.753 -3.092 . . . . 2.51 108.573 171.206 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.9 p -74.16 -169.99 0.88 Allowed 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 117.338 2.347 . . . . 1.41 117.338 177.105 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.2 mt -72.69 -62.44 1.45 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.225 2.61 . . . . 2.95 106.377 173.743 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.8 p -56.76 -56.34 22.76 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 120.383 3.475 . . . . 2.52 120.383 -175.178 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.38 43.55 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.764 0 CA-C-O 119.219 -0.767 . . . . 1.5 111.35 177.968 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -126.49 155.56 42.12 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 130.279 3.432 . . . . 1.79 104.334 -179.002 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.9 m -125.32 119.05 27.3 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 104.839 -2.282 . . . . 1.38 104.839 -178.94 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -95.52 148.88 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 103.483 -2.784 . . . . 2.03 103.483 -176.421 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.3 m -117.41 117.85 30.6 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.452 2.548 . . . . 1.61 106.231 177.296 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.2 mt -116.37 138.19 51.54 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.7 -2.5 . . . . 2.15 111.179 -174.517 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.12 106.15 18.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.724 2.009 . . . . 1.98 115.143 170.713 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 m -127.87 167.79 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 125.538 2.589 . . . . 1.52 108.549 -172.937 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -110.1 161.78 23.03 Favored Pre-proline 0 N--CA 1.43 -1.453 0 O-C-N 116.584 -3.823 . . . . 2.35 108.257 162.682 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -73.06 -12.12 25.67 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-N 124.72 2.721 . . . . 1.31 113.275 -177.245 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 m -83.7 -9.14 59.05 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 115.124 -2.369 . . . . 1.71 109.339 175.523 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -74.0 155.86 38.15 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 124.391 3.269 . . . . 1.69 111.138 178.251 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.6 p -95.73 164.44 12.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.5 -1.375 . . . . 1.33 110.411 -177.19 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.6 mm -62.47 -31.11 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 124.581 1.153 . . . . 1.32 112.032 175.934 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -58.71 -47.52 84.29 Favored 'General case' 0 N--CA 1.429 -1.499 1 C-N-CA 134.097 4.959 . . . . 1.62 114.611 162.383 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.281 29.4 m120 -66.21 -37.95 86.8 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.483 -3.26 . . . . 2.13 106.93 178.947 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.4 t -71.2 -25.95 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 1 O-C-N 115.045 -4.784 . . . . 1.23 117.875 176.415 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -81.96 -32.92 30.49 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 104.635 -2.357 . . . . 1.97 104.635 178.994 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.4 68.0 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.872 -3.642 . . . . 1.19 111.407 172.715 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -67.15 -28.19 67.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 125.867 1.979 . . . . 1.92 109.921 171.595 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.1 mt -75.39 -18.04 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 116.514 -3.866 . . . . 1.94 113.93 170.138 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -68.35 -27.75 66.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 119.715 1.143 . . . . 1.9 111.694 167.667 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -68.57 -51.74 39.39 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.385 -3.322 . . . . 1.55 112.338 165.638 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.402 ' HB2' ' H ' ' A' ' 34' ' ' GLU . 38.0 mmtt -68.81 -74.81 0.12 Allowed 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.926 -2.359 . . . . 2.95 117.256 -175.603 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.402 ' H ' ' HB2' ' A' ' 33' ' ' LYS . 48.6 mm-40 -90.73 -15.24 30.58 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 124.389 1.055 . . . . 1.48 113.122 -176.6 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.38 48.47 5.94 Favored Glycine 0 N--CA 1.43 -1.723 0 C-N-CA 119.276 -1.44 . . . . 1.12 115.967 168.046 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.4 mt -125.66 140.07 35.62 Favored Pre-proline 0 N--CA 1.429 -1.488 0 C-N-CA 126.781 2.033 . . . . 2.07 107.786 -175.51 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -67.83 149.9 78.4 Favored 'Trans proline' 0 N--CA 1.433 -2.055 2 C-N-CA 125.938 4.425 . . . . 1.39 112.285 -174.381 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.472 58.0 Cg_endo -61.22 -38.35 66.87 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 CA-C-N 127.293 3.64 . . . . 1.68 119.213 -179.972 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -57.44 -36.65 71.67 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 127.003 2.69 . . . . 2.25 114.178 -179.316 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -81.22 -13.11 58.88 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.576 2.065 . . . . 2.44 116.576 -177.021 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -92.19 141.94 28.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.94 -1.725 . . . . 1.32 110.822 -175.445 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -113.52 134.78 54.5 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 125.775 1.922 . . . . 3.19 110.702 167.515 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.8 mt -116.73 111.96 20.52 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.022 -1.844 . . . . 1.75 106.022 -178.618 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.542 HD11 ' HA ' ' A' ' 49' ' ' GLN . 24.3 mm -102.46 135.58 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 118.626 -2.546 . . . . 1.98 108.063 -173.318 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -154.44 122.89 6.1 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 124.249 1.02 . . . . 1.94 111.166 171.687 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.92 46.64 4.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.801 2.239 . . . . 1.67 116.525 -177.448 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.24 -31.01 4.21 Favored Glycine 0 N--CA 1.43 -1.734 0 CA-C-N 113.875 -1.511 . . . . 1.3 114.505 175.528 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -96.68 156.74 16.22 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 124.867 2.27 . . . . 2.89 114.415 -177.299 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.542 ' HA ' HD11 ' A' ' 44' ' ' ILE . 39.3 tt0 -93.05 121.51 34.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 127.492 3.52 . . . . 2.89 109.867 175.349 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.3 mt -79.07 122.6 26.42 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 113.55 -5.719 . . . . 1.34 114.864 -172.901 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.259 53.4 mt-10 -70.59 139.67 51.49 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 121.171 3.767 . . . . 1.94 121.171 -178.222 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -52.54 -63.09 1.25 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.327 3.051 . . . . 1.56 116.74 -169.323 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.74 43.3 3.06 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 125.784 1.659 . . . . 0.97 113.12 172.296 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.5 mtt-85 -121.91 162.02 21.76 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.642 -2.681 . . . . 3.07 109.543 165.686 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.26 70.2 p -92.63 151.17 20.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.368 2.667 . . . . 1.34 110.372 178.519 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -50.96 -50.59 57.71 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 125.514 2.578 . . . . 1.63 110.9 167.438 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -48.36 -42.69 32.24 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 114.605 -5.059 . . . . 1.51 118.006 174.668 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -71.5 -16.85 62.36 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.938 2.199 . . . . 1.9 116.938 173.538 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -94.15 -2.91 51.92 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 126.167 1.787 . . . . 0.97 106.359 177.096 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.5 m120 66.03 32.3 8.44 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.922 1.689 . . . . 2.35 112.735 176.341 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.405 HD11 HD21 ' A' ' 67' ' ' LEU . 20.7 mt -91.03 121.55 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 126.842 3.211 . . . . 1.39 107.771 -177.537 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -113.1 -170.46 1.68 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.66 -3.15 . . . . 2.58 114.044 178.531 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -61.73 135.63 57.68 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 112.348 -2.206 . . . . 2.58 112.279 -179.689 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.272 12.9 mt-10 83.67 13.58 0.35 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.791 2.036 . . . . 1.71 116.086 173.119 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.8 t -88.11 145.34 25.99 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.843 2.057 . . . . 1.34 105.873 -170.364 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.2 m -108.31 110.16 21.67 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.7 -1.25 . . . . 1.36 110.497 -176.678 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.405 HD21 HD11 ' A' ' 61' ' ' ILE . 24.4 mt -90.34 150.83 21.73 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 127.424 3.488 . . . . 2.03 107.247 172.582 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -111.73 129.39 56.13 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.083 -4.761 . . . . 2.31 110.993 -179.48 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.3 tp -98.28 133.13 43.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 128.106 3.812 . . . . 1.72 101.559 -171.234 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.55 163.06 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.986 -2.946 . . . . 1.8 106.668 172.516 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.1 mt -100.96 154.92 18.28 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 125.643 2.64 . . . . 3.26 114.646 176.034 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -65.82 -64.34 0.88 Allowed 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 116.244 -4.035 . . . . 4.12 112.71 -177.428 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.5 tp -121.14 109.9 15.55 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 126.613 1.965 . . . . 3.54 109.145 173.466 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -151.77 -59.95 0.16 Allowed 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 104.704 -2.332 . . . . 7.32 104.704 171.863 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.24 -99.65 0.15 Allowed Glycine 0 N--CA 1.43 -1.701 0 O-C-N 117.898 -3.002 . . . . 3.73 107.539 -172.515 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.773 0 C-N-CA 127.491 2.472 . . . . 3.87 109.774 -174.936 . . . . . . . . 0 0 . 1 . 087 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.429 ' HE1' HG23 ' A' ' 17' ' ' VAL . 14.2 ptt? . . . . . 0 CA--C 1.491 -1.315 0 N-CA-C 115.303 1.594 . . . . 1.39 115.303 . . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.278 4.8 pt20 -127.02 138.93 53.33 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 129.042 3.963 . . . . 2.2 112.984 175.064 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.5 pt -127.2 151.05 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 130.794 3.638 . . . . 1.32 109.989 175.987 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -98.26 136.83 37.89 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 111.898 -2.41 . . . . 2.2 110.438 -179.056 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 89.2 t -112.66 125.84 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-O 114.692 -2.575 . . . . 1.23 111.397 171.982 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -105.29 128.43 53.45 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 123.122 2.692 . . . . 2.51 113.611 176.263 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.286 3.5 p -84.56 173.91 10.42 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 120.036 3.347 . . . . 1.41 120.036 177.576 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.77 -38.08 82.93 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 130.548 3.539 . . . . 2.95 111.302 -179.821 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.7 p -74.95 -45.42 42.42 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.485 1.514 . . . . 2.52 109.713 177.408 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.25 42.67 0.31 Allowed Glycine 0 N--CA 1.43 -1.728 0 O-C-N 125.944 2.027 . . . . 1.5 110.603 169.154 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -105.69 157.98 17.04 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.076 2.15 . . . . 1.79 106.279 -173.266 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -111.25 124.53 52.4 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 121.024 1.738 . . . . 1.38 106.33 175.414 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.548 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 20.0 mt -100.04 121.51 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 100.807 -3.775 . . . . 2.03 100.807 173.795 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.0 m -104.89 114.07 28.05 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.176 2.893 . . . . 1.61 105.675 175.087 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.6 mt -101.11 145.16 29.12 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 128.171 2.588 . . . . 2.15 112.772 -177.046 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -97.18 112.69 24.37 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 117.02 -1.467 . . . . 1.98 113.892 173.475 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.455 HG11 HG23 ' A' ' 26' ' ' VAL . 34.4 m -134.8 169.93 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 116.032 1.864 . . . . 1.52 116.032 -179.815 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -114.37 160.74 31.71 Favored Pre-proline 0 N--CA 1.43 -1.449 0 O-C-N 127.968 3.293 . . . . 2.35 109.424 165.954 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.34 -10.66 29.64 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 O-C-N 114.521 -3.463 . . . . 1.31 114.792 -173.687 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.8 p -85.87 -16.18 39.45 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.792 3.808 . . . . 1.71 111.468 177.881 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -70.19 147.8 49.41 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.408 -3.308 . . . . 1.69 114.064 -175.845 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.8 p -95.67 166.24 11.92 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 116.197 -4.064 . . . . 1.33 112.494 -177.299 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.331 29.7 mm -65.42 -31.79 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 116.81 2.152 . . . . 1.32 116.81 179.203 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -46.83 -52.08 15.08 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.19 2.196 . . . . 1.62 116.608 160.965 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -70.72 -35.81 72.9 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.704 2.002 . . . . 2.13 109.11 -177.974 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.455 HG23 HG11 ' A' ' 17' ' ' VAL . 34.9 t -70.04 -49.69 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 119.044 -2.285 . . . . 1.23 111.459 -179.489 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -62.56 -27.7 69.36 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.164 -2.21 . . . . 1.97 115.749 175.984 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.58 -40.53 97.18 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 128.661 2.785 . . . . 1.19 114.422 173.67 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -62.25 -26.93 68.66 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.303 2.241 . . . . 1.92 116.565 171.629 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.9 mt -74.09 -42.89 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 126.997 2.119 . . . . 1.94 111.701 171.913 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -62.68 -34.04 76.31 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.496 -1.229 . . . . 1.9 112.519 178.36 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.24 -47.04 81.2 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.437 -2.039 . . . . 1.55 115.643 171.831 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -78.9 -59.59 2.72 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.27 -1.786 . . . . 2.95 113.725 -177.343 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -101.28 -30.84 11.28 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 128.905 2.882 . . . . 1.48 109.989 -165.258 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.74 19.86 30.56 Favored Glycine 0 N--CA 1.429 -1.77 0 O-C-N 121.098 -1.001 . . . . 1.12 113.993 170.428 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.5 mt -91.3 123.42 64.2 Favored Pre-proline 0 N--CA 1.431 -1.409 0 CA-C-O 114.466 -2.683 . . . . 2.07 110.039 178.219 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -67.66 144.08 64.67 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 124.386 3.391 . . . . 1.39 110.187 -174.009 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.77 -24.41 47.15 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 C-N-CA 125.053 3.836 . . . . 1.68 113.03 -167.831 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -68.01 -26.05 65.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.892 2.477 . . . . 2.25 109.871 178.496 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -89.32 -18.69 26.45 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 125.427 2.537 . . . . 2.44 110.894 -176.275 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -82.18 125.87 31.41 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.621 -2.55 . . . . 1.32 112.059 -177.868 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -119.54 129.38 54.65 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 104.903 -2.258 . . . . 3.19 104.903 168.759 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.1 mt -103.01 139.48 38.52 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.63 -3.169 . . . . 1.75 111.022 176.69 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 17.8 mm -121.14 146.97 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 103.154 -2.906 . . . . 1.98 103.154 176.901 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -135.94 105.21 5.99 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 101.365 -3.569 . . . . 1.94 101.365 173.208 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.309 . . 70.65 -75.13 0.08 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.921 2.088 . . . . 1.67 115.054 179.283 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.34 -4.66 0.9 Allowed Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 113.481 -1.691 . . . . 1.3 115.101 -175.385 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.27 65.6 mttm -106.82 143.2 35.26 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.765 -0.828 . . . . 2.89 108.765 -178.85 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -86.44 128.51 34.96 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 117.375 -1.298 . . . . 2.89 108.371 164.775 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.405 HD22 ' CE2' ' A' ' 59' ' ' TYR . 42.9 mt -83.66 134.92 34.76 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 116.349 1.981 . . . . 1.34 116.349 -173.815 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -75.86 147.98 38.67 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.576 1.151 . . . . 1.94 111.56 175.182 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -68.53 -38.03 80.51 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 118.559 2.8 . . . . 1.56 118.559 -171.133 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.8 28.25 14.46 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 126.078 1.799 . . . . 0.97 113.49 176.703 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -100.34 163.97 12.15 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 121.234 -1.156 . . . . 3.07 111.671 167.222 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.8 p -96.5 -172.03 2.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.516 -1.99 . . . . 1.34 111.368 175.509 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.443 HD23 HD11 ' A' ' 61' ' ' ILE . 15.3 mt -87.83 -29.25 21.08 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 119.107 -2.245 . . . . 1.63 111.436 172.362 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.282 8.2 t -63.08 -37.49 87.43 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 120.916 3.673 . . . . 1.51 120.916 171.057 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -52.97 -40.38 63.69 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 113.458 -1.701 . . . . 1.9 113.923 170.249 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.405 ' CE2' HD22 ' A' ' 50' ' ' LEU . 38.8 m-85 -93.76 -3.38 52.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.532 2.333 . . . . 0.97 112.485 -177.695 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.286 13.7 m120 66.35 33.05 7.27 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.714 1.721 . . . . 2.35 114.232 -174.046 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.443 HD11 HD23 ' A' ' 56' ' ' LEU 0.279 33.7 mt -73.59 104.19 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 114.843 -2.503 . . . . 1.39 107.837 172.91 . . . . . . . . 3 3 . 1 . 087 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -92.04 -164.04 1.12 Allowed 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 124.673 1.233 . . . . 2.58 110.101 179.772 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -72.0 156.5 39.16 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.04 1.4 . . . . 2.58 112.094 171.28 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.326 26.9 mt-10 61.26 28.7 18.2 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.033 -2.292 . . . . 1.71 115.628 175.956 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.0 t -101.18 154.89 18.36 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.951 -2.968 . . . . 1.34 109.597 -173.71 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.7 m -110.42 111.81 23.32 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.854 2.74 . . . . 1.36 112.5 -174.783 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.43 HD22 HD13 ' A' ' 61' ' ' ILE . 20.1 mt -93.02 147.52 22.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.308 -3.37 . . . . 2.03 108.008 170.526 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.468 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 5.5 m-70 -102.11 122.89 44.99 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 126.834 2.584 . . . . 2.31 104.721 -175.604 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.8 tp -93.96 137.92 32.65 Favored 'General case' 0 N--CA 1.428 -1.542 0 O-C-N 118.732 -2.48 . . . . 1.72 111.59 178.678 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 m -135.93 150.05 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 105.868 -1.901 . . . . 1.8 105.868 168.376 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.8 mt -112.64 158.68 19.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.803 -2.436 . . . . 3.26 112.812 -175.054 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -97.12 177.79 5.47 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.649 2.78 . . . . 4.12 104.381 176.702 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.2 mt -88.16 155.93 19.51 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.242 2.448 . . . . 3.54 107.791 174.171 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -83.39 159.21 21.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 112.96 -1.927 . . . . 7.32 113.953 172.311 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.6 -58.09 0.16 Allowed Glycine 0 N--CA 1.43 -1.731 0 CA-C-O 127.079 3.599 . . . . 3.73 116.137 -172.29 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.772 0 N-CA-C 104.144 -3.583 . . . . 3.87 104.144 172.412 . . . . . . . . 0 0 . 1 . 088 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ptt? . . . . . 0 CA--C 1.49 -1.357 0 CA-C-O 123.049 1.404 . . . . 1.39 114.281 . . . . . . . . . 0 0 . 1 . 088 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -77.89 124.3 27.83 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.224 3.01 . . . . 2.2 114.453 -179.402 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.277 9.8 pt -128.48 153.12 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.301 -2.749 . . . . 1.32 111.139 171.286 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -117.59 130.49 56.43 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.526 1.967 . . . . 2.2 110.666 -178.89 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.51 111.16 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 102.908 -2.997 . . . . 1.23 102.908 -179.749 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -93.13 133.4 36.34 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 124.153 1.93 . . . . 2.51 111.774 -178.231 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.307 3.9 p -102.3 161.48 13.66 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 117.376 2.362 . . . . 1.41 117.376 169.166 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.4 tp -78.78 -35.72 43.99 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 112.22 -2.264 . . . . 2.95 111.449 168.75 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.273 0.8 OUTLIER -63.91 -58.41 6.85 Favored 'General case' 0 N--CA 1.431 -1.412 1 C-N-CA 133.323 4.649 . . . . 2.52 111.716 -169.983 . . . . . . . . 4 3 . 1 . 088 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.85 -79.23 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 129.456 3.407 . . . . 1.5 120.515 176.422 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.504 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 10.5 ptpt -77.92 165.4 24.14 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 129.831 3.252 . . . . 1.79 116.197 -170.281 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.8 m -115.66 120.58 39.85 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 103.452 -2.796 . . . . 1.38 103.452 168.315 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.4 mt -89.18 107.03 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.859 2.463 . . . . 2.03 105.93 -176.522 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.7 m -82.54 100.0 9.85 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 124.282 0.989 . . . . 1.61 113.434 178.944 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.1 mt -88.13 154.52 20.39 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.7 2.19 . . . . 2.15 115.911 -179.98 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -104.27 114.78 29.24 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 102.399 -3.186 . . . . 1.98 102.399 163.616 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.8 m -117.36 177.39 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.069 -2.269 . . . . 1.52 109.426 173.081 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -115.57 156.65 45.82 Favored Pre-proline 0 N--CA 1.429 -1.476 0 N-CA-C 104.623 -2.362 . . . . 2.35 104.623 154.913 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -78.53 -9.09 16.12 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 CA-C-N 127.334 3.655 . . . . 1.31 109.197 -171.589 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.1 p -81.45 -9.65 59.67 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.884 -2.385 . . . . 1.71 113.911 174.838 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -66.82 141.85 57.55 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 125.855 1.972 . . . . 1.69 111.83 172.704 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 52.6 p -81.35 170.34 16.13 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.795 -2.441 . . . . 1.33 112.699 176.852 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.411 HG13 ' HB3' ' A' ' 50' ' ' LEU . 25.2 mm -66.01 -26.18 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 129.179 2.991 . . . . 1.32 109.37 170.563 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -70.97 -33.85 70.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.164 1.935 . . . . 1.62 115.546 173.999 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.438 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 83.5 m-20 -66.02 -43.38 87.8 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.193 2.597 . . . . 2.13 111.878 169.723 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.25 -45.21 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 115.224 1.564 . . . . 1.23 115.224 174.059 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -67.11 -36.03 81.03 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 117.348 -3.345 . . . . 1.97 113.277 169.769 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.71 -25.02 62.48 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 118.501 -2.624 . . . . 1.19 117.454 172.122 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 25' ' ' ASN 0.356 44.5 mttm -69.63 -55.14 10.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.41 -2.681 . . . . 1.92 117.247 174.537 . . . . . . . . 3 3 . 1 . 088 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.2 mt -52.62 -47.07 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 1 C-N-CA 135.202 5.401 . . . . 1.94 106.419 173.615 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -50.02 -40.82 45.84 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 120.825 3.639 . . . . 1.9 120.825 177.129 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -66.56 -43.4 85.11 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.958 -3.589 . . . . 1.55 114.807 164.444 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -70.19 -49.98 44.83 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 127.656 3.598 . . . . 2.95 110.322 -169.95 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.504 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS 0.264 28.7 mm-40 -120.3 4.72 10.76 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 111.286 -2.688 . . . . 1.48 112.726 -165.858 . . . . . . . . 3 3 . 1 . 088 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.6 0.38 47.95 Favored Glycine 0 N--CA 1.431 -1.662 0 C-N-CA 115.678 -3.153 . . . . 1.12 119.222 173.605 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.5 mt -86.42 116.29 65.34 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 103.445 -2.798 . . . . 2.07 103.445 -169.202 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.1 165.26 24.72 Favored 'Trans proline' 0 C--N 1.3 -2.016 1 C-N-CA 126.54 4.827 . . . . 1.39 115.695 176.389 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -79.38 -17.43 11.51 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 124.524 2.651 . . . . 1.68 112.994 -172.235 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -67.54 -27.49 67.0 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.373 2.035 . . . . 2.25 115.436 175.458 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -104.87 24.02 12.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.813 -2.429 . . . . 2.44 114.308 -178.032 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -123.53 119.0 28.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.987 2.515 . . . . 1.32 113.392 179.66 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.525 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 90.5 mtt-85 -113.94 120.8 41.9 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.806 1.642 . . . . 3.19 108.288 169.466 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.6 mt -104.51 126.62 51.77 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.143 -1.598 . . . . 1.75 111.219 -178.103 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mm -117.61 140.4 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 124.206 3.185 . . . . 1.98 112.755 177.131 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -152.56 132.57 13.4 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 104.752 -2.314 . . . . 1.94 104.752 175.959 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.91 21.92 11.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 115.968 -1.968 . . . . 1.67 115.178 179.64 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.66 -2.34 83.16 Favored Glycine 0 N--CA 1.431 -1.688 1 C-N-CA 132.379 4.8 . . . . 1.3 113.286 -179.38 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -101.01 137.57 39.2 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.842 0.829 . . . . 2.89 112.841 -178.983 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -70.68 127.13 31.62 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 117.194 -3.442 . . . . 2.89 115.808 166.627 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.411 ' HB3' HG13 ' A' ' 23' ' ' ILE . 36.9 mt -81.62 136.9 35.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.705 -1.872 . . . . 1.34 113.647 -176.075 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.419 ' CD ' HH21 ' A' ' 54' ' ' ARG . 19.7 tt0 -85.74 144.14 27.94 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 119.031 2.974 . . . . 1.94 119.031 172.467 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.12 -43.26 82.87 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 121.763 3.986 . . . . 1.56 121.763 -168.362 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.23 8.84 50.82 Favored Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 118.123 2.009 . . . . 0.97 118.123 170.446 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.419 HH21 ' CD ' ' A' ' 51' ' ' GLU . 84.8 mtt180 -101.59 149.55 24.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.679 1.704 . . . . 3.07 110.233 170.289 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.283 32.2 p -81.7 170.65 15.52 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.069 -2.894 . . . . 1.34 110.547 -178.211 . . . . . . . . 3 3 . 1 . 088 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.7 mt -67.8 -37.04 81.47 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 127.031 2.132 . . . . 1.63 110.062 167.672 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.382 4.9 t -59.4 -43.64 92.95 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.525 -3.234 . . . . 1.51 114.234 176.72 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -60.82 -44.63 96.64 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.113 2.863 . . . . 1.9 111.042 179.995 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -77.92 -6.76 55.37 Favored 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 114.939 -4.85 . . . . 0.97 115.883 178.416 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.304 13.1 m120 68.95 36.79 2.42 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.605 -2.559 . . . . 2.35 115.412 -178.206 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.2 mt -85.24 113.96 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 125.905 1.682 . . . . 1.39 111.968 177.635 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -103.64 -173.96 2.43 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 118.411 -1.316 . . . . 2.58 108.824 -174.933 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -53.42 147.48 10.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.419 3.009 . . . . 2.58 114.4 171.082 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 56.09 33.51 22.08 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 120.441 3.497 . . . . 1.71 120.441 -178.969 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.7 m -103.51 149.1 25.18 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.777 -1.556 . . . . 1.34 109.96 -177.151 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -103.58 112.06 24.8 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 126.132 1.773 . . . . 1.36 109.106 -170.452 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mt -90.24 140.72 29.41 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.458 -1.312 . . . . 2.03 107.458 174.15 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.375 66.9 m80 -107.28 118.1 35.82 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.665 -1.272 . . . . 2.31 108.116 178.308 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -88.02 121.44 30.43 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 121.378 -0.826 . . . . 1.72 109.761 179.875 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 59.6 t -105.69 135.46 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 104.473 -2.417 . . . . 1.8 104.473 174.242 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.69 157.75 16.01 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.402 -1.332 . . . . 3.26 107.402 -179.5 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -129.95 174.34 9.85 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.34 -1.726 . . . . 4.12 106.34 175.455 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.0 mt -105.82 157.83 17.18 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.796 2.038 . . . . 3.54 106.92 177.054 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -66.39 93.59 0.23 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.161 2.184 . . . . 7.32 110.4 165.96 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.98 100.22 1.61 Allowed Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 127.809 2.623 . . . . 3.73 113.206 -166.652 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.745 0 CA-C-O 113.701 -3.833 . . . . 3.87 116.692 -175.974 . . . . . . . . 0 0 . 1 . 089 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 CA--C 1.49 -1.34 0 N-CA-C 106.721 -1.585 . . . . 1.39 106.721 . . . . . . . . . 0 0 . 1 . 089 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -93.71 126.5 38.93 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.138 1.375 . . . . 2.2 112.692 179.698 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -127.25 166.98 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 105.002 -2.222 . . . . 1.32 105.002 167.759 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -123.27 145.05 49.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.076 2.95 . . . . 2.2 110.268 -177.716 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.2 t -124.91 124.18 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 106.691 -1.596 . . . . 1.23 106.691 173.677 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -106.41 128.59 54.16 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.601 2.36 . . . . 2.51 108.406 -178.73 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 p -87.4 179.44 6.58 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.02 2.343 . . . . 1.41 110.03 -179.399 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.331 14.2 tp -65.94 -41.95 90.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.918 2.487 . . . . 2.95 114.61 168.462 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.8 p -75.42 -38.54 59.75 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 120.817 -1.177 . . . . 2.52 108.307 -177.778 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.73 28.32 0.3 Allowed Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 123.652 0.644 . . . . 1.5 113.226 169.783 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -94.48 129.22 41.34 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.082 -2.422 . . . . 1.79 110.863 -177.134 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.8 m -116.36 90.21 3.28 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.937 2.78 . . . . 1.38 107.489 -174.345 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 pt -92.94 136.97 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 112.224 -2.262 . . . . 2.03 106.099 -178.876 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -94.86 128.37 41.57 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 130.22 3.408 . . . . 1.61 113.287 -178.801 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.9 mt -122.32 151.06 41.53 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.882 1.801 . . . . 2.15 112.88 178.184 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -114.54 112.7 23.36 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.657 1.218 . . . . 1.98 108.689 174.464 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m -118.27 175.11 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 118.715 -2.491 . . . . 1.52 111.548 -176.751 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -108.15 147.93 36.53 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-N 122.186 2.266 . . . . 2.35 106.784 160.498 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.13 -18.88 26.83 Favored 'Trans proline' 0 N--CA 1.433 -2.058 0 C-N-CA 123.718 2.945 . . . . 1.31 112.533 -174.548 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.3 p -90.57 9.92 27.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 121.725 2.057 . . . . 1.71 113.329 178.097 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -89.59 158.42 17.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.331 -3.355 . . . . 1.69 107.333 -179.865 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.6 p -80.6 171.11 15.46 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.297 1.221 . . . . 1.33 114.297 178.832 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.6 mm -69.77 -39.79 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 125.679 1.592 . . . . 1.32 108.91 175.993 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.26 86.7 tt0 -45.77 -45.75 14.84 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 117.613 2.449 . . . . 1.62 117.613 169.117 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -68.09 -35.66 78.54 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 118.058 2.614 . . . . 2.13 118.058 175.703 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.8 t -62.96 -31.22 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 112.971 0.73 . . . . 1.23 112.971 170.783 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.466 ' HZ3' ' CG ' ' A' ' 52' ' ' ASP . 78.8 mttt -71.5 -25.58 62.32 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 118.802 2.89 . . . . 1.97 118.802 167.327 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.87 -20.3 53.26 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 119.582 -1.949 . . . . 1.19 108.476 170.893 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -80.54 -23.51 39.94 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 120.419 1.463 . . . . 1.92 107.993 177.626 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.1 mt -81.85 -28.26 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.784 -2.447 . . . . 1.94 112.802 167.616 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 67.0 tt0 -65.74 -36.75 84.46 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 123.552 2.887 . . . . 1.9 113.362 173.655 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -60.05 -56.79 17.35 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 124.285 1.034 . . . . 1.55 111.781 170.118 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -77.34 -52.75 8.64 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 116.272 1.953 . . . . 2.95 116.272 -172.807 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -99.08 -25.1 14.66 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 119.348 -2.095 . . . . 1.48 108.407 -165.911 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.4 37.33 11.0 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 122.017 2.189 . . . . 1.12 113.161 175.668 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 mt -106.92 126.96 28.96 Favored Pre-proline 0 N--CA 1.43 -1.433 0 C-N-CA 127.671 2.388 . . . . 2.07 107.472 -178.752 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -68.82 150.2 73.49 Favored 'Trans proline' 0 N--CA 1.434 -1.977 0 O-C-N 115.28 -3.063 . . . . 1.39 116.585 -178.653 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -69.39 -14.5 37.37 Favored 'Trans proline' 0 N--CA 1.433 -2.061 0 CA-C-N 124.447 2.624 . . . . 1.68 117.886 -172.557 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -74.86 -34.09 62.22 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.993 1.854 . . . . 2.25 111.069 172.314 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -72.56 -28.41 62.81 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 115.165 -4.709 . . . . 2.44 114.523 -178.895 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -78.99 147.19 33.0 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.353 -1.467 . . . . 1.32 110.419 -173.382 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.277 12.1 tpt180 -133.35 120.12 20.58 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.07 -2.567 . . . . 3.19 104.07 170.773 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.2 mt -96.51 125.85 41.28 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.546 -1.346 . . . . 1.75 108.708 -177.899 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.278 6.2 mt -118.91 115.07 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 116.422 2.008 . . . . 1.98 116.422 -179.865 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -130.54 137.99 49.97 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 117.076 2.25 . . . . 1.94 117.076 164.97 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.291 . . 51.26 45.73 27.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.404 -3.31 . . . . 1.67 118.806 -175.487 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.6 -22.12 1.43 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 125.335 1.445 . . . . 1.3 113.646 -175.471 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -90.22 133.09 35.14 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 118.526 2.787 . . . . 2.89 118.526 -173.828 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -74.19 133.68 42.73 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 116.785 -3.697 . . . . 2.89 104.365 171.016 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.7 mt -91.17 123.69 34.81 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 127.07 3.319 . . . . 1.34 110.869 -175.741 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -85.19 135.5 33.92 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.165 -2.834 . . . . 1.94 116.105 175.966 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.466 ' CG ' ' HZ3' ' A' ' 27' ' ' LYS . 3.4 m-20 -57.11 -53.04 62.6 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 129.973 3.309 . . . . 1.56 117.38 -160.958 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.09 21.51 1.35 Allowed Glycine 0 N--CA 1.43 -1.737 0 O-C-N 118.952 -2.342 . . . . 0.97 115.88 170.263 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -113.79 166.28 11.72 Favored 'General case' 0 N--CA 1.43 -1.451 1 CA-C-N 124.531 4.165 . . . . 3.07 108.251 168.979 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.8 p -97.78 173.47 7.09 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 123.551 1.644 . . . . 1.34 110.061 -179.173 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.9 mt -67.77 -31.91 72.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 114.317 1.229 . . . . 1.63 114.317 177.065 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.8 t -62.18 -44.73 95.94 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.043 3.337 . . . . 1.51 113.941 178.377 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -52.86 -38.54 61.68 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 125.141 1.526 . . . . 1.9 112.112 175.571 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -91.23 -1.0 57.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.335 1.854 . . . . 0.97 111.984 178.488 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.311 3.4 m120 61.72 31.26 18.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 119.446 3.128 . . . . 2.35 119.446 -179.526 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.4 mt -88.11 110.36 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 128.7 2.8 . . . . 1.39 104.469 -173.41 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -95.82 -169.91 2.03 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 112.373 -2.194 . . . . 2.58 106.288 -174.434 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -57.83 147.9 26.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 130.239 3.416 . . . . 2.58 117.797 172.894 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 55.89 49.33 16.19 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 115.817 1.784 . . . . 1.71 115.817 178.102 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 m -117.53 147.91 42.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.774 -1.195 . . . . 1.34 107.774 -174.62 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.4 m -99.2 105.41 17.45 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.355 3.462 . . . . 1.36 111.209 177.394 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.69 132.54 39.32 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.778 1.631 . . . . 2.03 108.505 178.072 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -89.13 124.88 34.74 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.95 -4.219 . . . . 2.31 106.395 -178.734 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.8 tp -95.13 122.09 37.44 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.716 -2.49 . . . . 1.72 105.842 171.214 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.1 t -115.14 151.4 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 127.872 2.469 . . . . 1.8 108.829 168.537 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.0 mt -98.7 126.39 44.29 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.601 -3.187 . . . . 3.26 110.659 174.637 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.9 ttt85 -107.05 84.36 1.97 Allowed 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.362 2.506 . . . . 4.12 110.9 178.818 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.0 mt -87.41 -53.46 4.81 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 116.561 -3.837 . . . . 3.54 109.781 175.024 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.3 ttt-85 -107.51 -58.06 2.01 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.03 2.132 . . . . 7.32 105.555 169.987 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.25 -179.58 24.06 Favored Glycine 0 N--CA 1.429 -1.775 0 O-C-N 119.102 -2.249 . . . . 3.73 108.377 -163.025 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.721 0 C-N-CA 126.713 2.102 . . . . 3.87 109.565 177.579 . . . . . . . . 0 0 . 1 . 090 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 CA--C 1.491 -1.304 0 CA-C-O 121.188 0.518 . . . . 1.39 110.677 . . . . . . . . . 0 0 . 1 . 090 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -110.6 121.31 45.02 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.489 -2.632 . . . . 2.2 111.44 -179.691 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.3 pt -108.73 172.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 114.588 -1.187 . . . . 1.32 111.792 169.621 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -120.4 160.08 23.81 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.76 -0.829 . . . . 2.2 108.76 178.879 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.7 t -139.56 133.46 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 117.381 -3.325 . . . . 1.23 106.815 168.851 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -110.76 137.57 48.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.551 -3.218 . . . . 2.51 109.415 177.323 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.275 11.1 p -81.67 -169.63 2.42 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 114.824 -4.923 . . . . 1.41 115.74 176.858 . . . . . . . . 3 2 . 1 . 090 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.322 13.1 mt -77.46 -37.34 51.69 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 113.656 0.984 . . . . 2.95 113.656 174.963 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.76 -37.72 22.26 Favored 'General case' 0 N--CA 1.429 -1.504 1 C-N-CA 133.61 4.764 . . . . 2.52 110.019 -169.501 . . . . . . . . 3 3 . 1 . 090 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.67 33.66 0.64 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 115.04 -3.089 . . . . 1.5 111.842 173.175 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 46.0 tttm -97.54 137.48 36.41 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.513 2.156 . . . . 1.79 106.572 -178.953 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 m -108.27 121.42 44.86 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 118.897 -0.573 . . . . 1.38 109.9 176.687 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mt -104.77 106.87 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 125.498 1.749 . . . . 2.03 111.444 179.081 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.9 m -80.78 94.72 6.46 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 130.485 3.514 . . . . 1.61 111.67 178.024 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.8 mt -98.02 130.99 44.82 Favored 'General case' 0 N--CA 1.429 -1.482 1 O-C-N 115.781 -4.324 . . . . 2.15 112.907 -174.898 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -92.08 125.92 36.96 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.182 1.81 . . . . 1.98 107.18 174.836 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.9 m -133.89 174.95 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 107.401 -1.333 . . . . 1.52 107.401 -173.569 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -126.26 159.99 59.83 Favored Pre-proline 0 N--CA 1.43 -1.443 0 O-C-N 120.378 -1.451 . . . . 2.35 108.09 163.694 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -78.02 -10.06 16.66 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 CA-C-N 126.29 3.282 . . . . 1.31 109.919 -172.561 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.9 p -78.34 -22.54 47.85 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 130.369 3.468 . . . . 1.71 113.951 174.598 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -68.08 142.39 55.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.104 2.162 . . . . 1.69 110.655 176.21 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.9 p -78.08 164.25 25.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.659 2.171 . . . . 1.33 113.424 175.346 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -59.91 -33.18 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.515 1.926 . . . . 1.32 111.189 173.127 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -63.32 -44.48 94.83 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.582 1.553 . . . . 1.62 113.196 172.141 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -60.83 -26.45 67.35 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 115.517 -2.183 . . . . 2.13 114.083 170.037 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.338 46.6 t -84.43 -25.97 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 CA-C-N 127.243 4.565 . . . . 1.23 109.658 179.146 . . . . . . . . 3 2 . 1 . 090 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -75.74 -30.71 59.32 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.575 -3.203 . . . . 1.97 110.766 173.676 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.61 93.06 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.248 -1.532 . . . . 1.19 112.123 174.872 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -58.95 -45.44 90.46 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.436 -3.29 . . . . 1.92 111.074 174.883 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.4 mt -58.48 -33.61 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.292 -3.38 . . . . 1.94 114.652 173.229 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -70.07 -34.85 73.71 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.507 2.41 . . . . 1.9 117.507 -179.673 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -72.82 -47.74 43.75 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 125.016 2.341 . . . . 1.55 116.387 164.506 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -63.86 -65.85 0.62 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.12 -3.488 . . . . 2.95 109.639 -173.673 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.446 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 67.6 mm-40 -94.23 -51.93 4.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.439 -2.663 . . . . 1.48 110.96 -168.406 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.56 73.19 0.97 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-N 115.489 -0.778 . . . . 1.12 112.276 179.374 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 mt -138.53 117.4 9.46 Favored Pre-proline 0 N--CA 1.429 -1.487 0 N-CA-C 102.427 -3.175 . . . . 2.07 102.427 -174.695 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -57.83 143.13 96.23 Favored 'Trans proline' 0 C--N 1.299 -2.059 0 CA-C-O 112.559 -3.184 . . . . 1.39 114.219 177.838 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -62.21 -15.92 47.52 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 CA-C-N 124.961 2.807 . . . . 1.68 115.926 178.404 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -63.73 -34.99 79.1 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 124.784 2.231 . . . . 2.25 115.907 173.976 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -81.81 -21.87 37.43 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.418 -2.676 . . . . 2.44 109.705 -177.86 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -82.06 104.53 12.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.642 1.686 . . . . 1.32 114.975 -173.767 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.5 tpp85 -100.59 123.37 44.7 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 112.455 -2.157 . . . . 3.19 107.282 162.54 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.0 mt -111.43 137.1 49.65 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.758 2.694 . . . . 1.75 106.531 178.713 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.0 mt -125.36 149.77 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 117.266 -3.396 . . . . 1.98 104.211 -179.654 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.31 84.1 t80 -146.84 135.58 22.17 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 116.564 2.061 . . . . 1.94 116.564 168.541 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.59 -67.3 0.21 Allowed 'General case' 0 N--CA 1.43 -1.45 1 C-N-CA 131.942 4.097 . . . . 1.67 112.317 179.464 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.59 15.42 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.648 0 C-N-CA 128.042 2.734 . . . . 1.3 107.861 174.441 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.1 mttp -123.11 134.14 54.24 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.6 -2.117 . . . . 2.89 107.269 -176.706 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -73.17 140.48 47.05 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 116.857 -1.937 . . . . 2.89 115.237 169.003 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 mt -94.89 133.34 38.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 116.703 -3.748 . . . . 1.34 108.33 -164.558 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -96.67 118.85 34.02 Favored 'General case' 0 N--CA 1.431 -1.393 1 O-C-N 115.46 -4.525 . . . . 1.94 109.46 -176.521 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -39.88 -51.31 2.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 117.797 2.517 . . . . 1.56 117.797 -175.817 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.53 39.54 0.22 Allowed Glycine 0 N--CA 1.429 -1.787 0 C-N-CA 128.04 2.733 . . . . 0.97 114.331 170.411 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -137.1 169.49 17.7 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 119.723 1.762 . . . . 3.07 111.619 164.847 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.8 p -98.51 166.36 11.39 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.45 1.9 . . . . 1.34 115.858 175.702 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mt -62.51 -36.47 82.66 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.379 -2.076 . . . . 1.63 112.227 172.167 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -60.64 -44.98 95.75 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.687 1.995 . . . . 1.51 116.336 175.359 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -60.62 -45.82 92.59 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 119.551 1.068 . . . . 1.9 111.8 179.951 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -77.65 -8.86 58.52 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 113.52 0.933 . . . . 0.97 113.52 179.242 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.29 71.4 m-80 62.26 51.29 3.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.048 2.139 . . . . 2.35 116.691 -174.749 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.0 mt -92.7 121.99 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 101.418 -3.549 . . . . 1.39 101.418 178.069 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.6 mm-40 -110.33 -168.49 1.32 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.197 -1.564 . . . . 2.58 112.676 178.923 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -68.74 155.93 39.22 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.586 -3.196 . . . . 2.58 107.83 -179.929 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 64.2 20.59 12.24 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 112.641 -2.072 . . . . 1.71 114.724 178.433 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.278 50.6 m -84.39 148.09 26.8 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-O 114.661 -2.59 . . . . 1.34 114.51 -174.068 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.0 m -109.59 113.62 26.56 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 115.963 -2.295 . . . . 1.36 109.993 176.657 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.6 mt -84.69 155.4 21.96 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.208 -1.558 . . . . 2.03 107.417 175.732 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -107.09 109.95 21.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 118.027 -0.987 . . . . 2.31 111.932 -174.699 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 tt -80.59 112.58 18.08 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.366 1.066 . . . . 1.72 113.065 174.348 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.4 t -109.77 122.06 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 127.267 2.227 . . . . 1.8 105.382 171.622 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.9 mt -81.94 122.53 27.88 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 104.142 -2.54 . . . . 3.26 104.142 177.131 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -116.36 145.96 42.82 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 129.735 3.214 . . . . 4.12 107.374 -176.385 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.49 117.45 6.21 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.44 2.696 . . . . 3.54 109.526 173.797 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -59.75 158.65 9.97 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 121.264 3.801 . . . . 7.32 121.264 174.645 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.28 65.3 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.749 0 O-C-N 120.963 -1.086 . . . . 3.73 113.768 -166.953 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.789 0 C-N-CA 126.988 2.232 . . . . 3.87 111.73 -172.424 . . . . . . . . 0 0 . 1 . 091 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptt? . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 117.885 2.55 . . . . 1.39 117.885 . . . . . . . . . 0 0 . 1 . 091 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -89.29 121.35 31.48 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.997 -1.064 . . . . 2.2 111.818 -173.585 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.483 HG12 HG22 ' A' ' 17' ' ' VAL . 10.8 pt -116.46 154.7 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 101.025 -3.695 . . . . 1.32 101.025 173.265 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -113.18 151.94 30.32 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 124.783 1.233 . . . . 2.2 111.623 179.943 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.1 t -134.58 127.64 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 122.745 2.521 . . . . 1.23 105.582 175.456 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -92.86 140.6 29.33 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.716 -1.865 . . . . 2.51 110.743 -179.793 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.0 p -87.13 -177.9 6.12 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.365 -0.976 . . . . 1.41 108.365 178.133 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 tp -64.7 -46.52 82.01 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.09 -4.131 . . . . 2.95 115.346 171.126 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -77.23 -21.45 53.76 Favored 'General case' 0 N--CA 1.43 -1.433 1 O-C-N 115.988 -4.195 . . . . 2.52 117.066 178.056 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.59 37.98 0.87 Allowed Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 121.037 3.175 . . . . 1.5 121.037 174.98 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.473 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 83.1 tttt -98.31 127.05 44.06 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 102.006 -3.331 . . . . 1.79 102.006 -177.358 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.0 m -91.68 118.18 30.42 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.134 -1.604 . . . . 1.38 113.871 175.841 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.293 10.4 mt -90.92 126.46 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 103.614 -2.736 . . . . 2.03 103.614 -179.855 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.2 m -98.84 120.16 38.81 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 123.527 2.876 . . . . 1.61 107.127 173.083 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.4 mt -118.38 117.11 28.16 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 125.095 2.379 . . . . 2.15 113.996 177.856 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -79.63 97.37 6.49 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.108 -1.62 . . . . 1.98 113.36 172.258 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.483 HG22 HG12 ' A' ' 3' ' ' ILE . 27.0 m -113.84 166.72 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 128.299 2.64 . . . . 1.52 110.915 -175.669 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -107.36 163.71 16.36 Favored Pre-proline 0 N--CA 1.429 -1.5 0 O-C-N 125.017 1.448 . . . . 2.35 111.79 162.02 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.43 -19.67 10.1 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 O-C-N 113.594 -3.951 . . . . 1.31 109.877 -175.172 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 m -81.56 -3.07 52.26 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 116.616 -1.659 . . . . 1.71 114.07 -179.573 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -72.72 142.78 48.19 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.498 1.519 . . . . 1.69 112.576 176.846 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 p -81.82 165.25 21.04 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 124.606 1.191 . . . . 1.33 110.52 176.319 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.4 mm -68.79 -24.64 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 1 O-C-N 115.285 -4.634 . . . . 1.32 113.122 178.882 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -51.91 -45.84 64.38 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 129.661 3.185 . . . . 1.62 113.59 164.062 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -62.96 -36.98 85.27 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 115.624 1.713 . . . . 2.13 115.624 174.064 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.75 -48.4 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 127.177 2.191 . . . . 1.23 111.735 175.391 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.5 mttt -55.1 -34.06 63.35 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.339 1.977 . . . . 1.97 116.339 170.033 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.69 -23.79 61.71 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 116.011 1.856 . . . . 1.19 116.011 172.615 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -75.44 -33.49 60.9 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.955 2.902 . . . . 1.92 114.128 168.599 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.4 mt -76.41 -26.68 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 1 O-C-N 113.791 -5.568 . . . . 1.94 110.402 174.861 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -74.01 -25.3 59.82 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.964 -2.335 . . . . 1.9 106.475 178.808 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -86.13 -41.95 14.3 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.172 1.463 . . . . 1.55 114.483 171.122 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.3 mmtt -57.47 -65.7 0.58 Allowed 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 113.999 -5.438 . . . . 2.95 111.36 172.316 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.473 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 51.3 mm-40 -97.16 -35.53 10.75 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.023 2.529 . . . . 1.48 115.08 -168.067 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.18 44.98 3.65 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 119.896 -1.753 . . . . 1.12 114.093 179.162 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.3 mt -114.18 126.67 27.71 Favored Pre-proline 0 N--CA 1.43 -1.429 1 C-N-CA 134.79 5.236 . . . . 2.07 111.32 -178.76 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.78 156.16 43.97 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 CA-C-N 125.962 3.165 . . . . 1.39 113.442 179.372 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -65.31 -12.11 33.31 Favored 'Trans proline' 0 N--CA 1.433 -2.032 2 CA-C-N 131.235 5.048 . . . . 1.68 118.198 -173.021 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -63.95 -45.14 90.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 127.128 2.768 . . . . 2.25 113.132 175.231 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -84.37 -7.86 59.17 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.9 -3.0 . . . . 2.44 108.465 -175.831 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -92.01 129.74 37.9 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 115.71 -4.368 . . . . 1.32 109.457 -171.684 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -130.64 120.85 24.56 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 129.424 3.09 . . . . 3.19 105.925 172.511 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.5 mt -107.01 122.71 46.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.602 3.096 . . . . 1.75 113.474 -176.719 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 29.0 mm -109.9 123.32 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 111.786 -2.461 . . . . 1.98 109.087 177.549 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -101.83 111.41 23.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.53 -2.767 . . . . 1.94 103.53 167.919 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.407 ' HB3' ' H ' ' A' ' 47' ' ' GLY . . . 72.05 -93.48 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 125.48 1.738 . . . . 1.67 108.905 172.901 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 46' ' ' ALA . . . -138.37 14.04 3.48 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-O 116.208 -2.44 . . . . 1.3 114.15 176.583 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp -107.82 133.63 51.93 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 128.496 3.115 . . . . 2.89 112.858 179.904 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -86.94 115.98 24.7 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 126.018 2.818 . . . . 2.89 114.819 173.681 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.0 mt -73.79 143.88 45.81 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.898 -1.751 . . . . 1.34 112.214 -171.561 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -100.1 138.72 36.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 125.23 2.443 . . . . 1.94 115.568 174.236 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -48.46 -46.86 38.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.422 3.489 . . . . 1.56 119.847 -175.985 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.54 44.91 1.39 Allowed Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 127.105 2.288 . . . . 0.97 116.691 170.928 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.25 20.7 mmt85 -117.25 163.61 16.05 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 117.703 -3.234 . . . . 3.07 103.659 166.332 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.5 p -99.61 163.63 12.41 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.081 -3.512 . . . . 1.34 115.964 169.064 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.7 mt -57.54 -36.17 71.28 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 113.646 -1.615 . . . . 1.63 112.198 174.402 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 t -66.4 -37.75 85.94 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 116.132 1.901 . . . . 1.51 116.132 178.825 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -55.92 -32.15 63.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.37 1.868 . . . . 1.9 114.513 173.065 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -94.86 -8.01 38.54 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 122.951 1.358 . . . . 0.97 110.73 -178.936 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.8 m120 69.0 43.13 1.17 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.356 2.662 . . . . 2.35 114.668 -173.169 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.8 mt -84.9 128.82 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 126.014 2.816 . . . . 1.39 106.379 -179.127 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -109.06 179.99 4.01 Favored 'General case' 0 N--CA 1.431 -1.425 1 O-C-N 115.893 -4.255 . . . . 2.58 108.22 -176.86 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -53.73 138.76 34.57 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 130.943 3.697 . . . . 2.58 115.41 167.005 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.343 9.7 pt-20 77.04 3.2 3.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.598 2.359 . . . . 1.71 117.145 171.828 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.41 164.07 25.37 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 112.818 -1.992 . . . . 1.34 112.849 -176.661 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.3 m -120.0 121.1 38.18 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 124.34 2.019 . . . . 1.36 108.432 175.321 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.29 174.18 5.98 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 104.642 -2.355 . . . . 2.03 104.642 175.117 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.407 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 31.3 m170 -130.63 141.53 50.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.962 -1.496 . . . . 2.31 106.962 179.232 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.6 tp -112.23 110.78 21.23 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 129.993 3.317 . . . . 1.72 106.849 -174.259 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.1 t -112.83 123.05 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 C-N-CA 125.222 1.409 . . . . 1.8 109.676 176.93 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.7 mt -87.32 152.98 21.82 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.704 1.24 . . . . 3.26 111.63 178.036 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -117.92 142.17 47.63 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 129.275 3.03 . . . . 4.12 109.794 169.88 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.4 mt -96.66 -179.65 4.67 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.492 1.615 . . . . 3.54 111.515 171.894 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.1 ttm-85 -81.24 140.67 34.75 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 117.961 -1.496 . . . . 7.32 110.311 169.006 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.98 -73.26 0.25 Allowed Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 106.303 -2.719 . . . . 3.73 106.303 -174.069 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.842 0 CA-C-N 122.311 3.056 . . . . 3.87 113.829 174.845 . . . . . . . . 0 0 . 1 . 092 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ptt? . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 116.565 2.061 . . . . 1.39 116.565 . . . . . . . . . 0 0 . 1 . 092 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -106.88 123.09 47.66 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.133 -2.854 . . . . 2.2 111.887 -177.31 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.0 pt -127.19 155.61 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 112.028 -2.351 . . . . 1.32 108.535 170.05 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -124.55 137.22 54.42 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.384 1.073 . . . . 2.2 110.282 -176.014 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.1 t -116.6 101.49 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 129.422 3.089 . . . . 1.23 106.371 178.199 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -81.9 139.59 34.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.711 1.243 . . . . 2.51 112.653 178.769 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.2 p -100.43 -175.96 3.07 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 120.191 -1.568 . . . . 1.41 112.61 -179.147 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.2 mt -77.35 -43.19 33.82 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 112.82 -6.175 . . . . 2.95 111.185 178.205 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.8 p -70.05 -17.49 63.25 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.89 2.076 . . . . 2.52 111.526 -168.352 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.52 33.65 3.3 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 126.091 1.805 . . . . 1.5 116.15 170.317 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -108.56 148.44 30.29 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 103.226 -2.879 . . . . 1.79 103.226 -178.557 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 80.5 m -117.38 120.18 37.38 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 126.247 2.217 . . . . 1.38 109.007 -179.212 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.0 mm -98.72 108.7 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 126.48 3.038 . . . . 2.03 112.204 179.904 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.268 47.4 m -85.18 139.49 31.64 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.131 -3.48 . . . . 1.61 106.704 -175.377 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.442 HD12 HG11 ' A' ' 26' ' ' VAL . 23.1 mt -125.47 146.58 49.57 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.688 -2.507 . . . . 2.15 109.497 176.159 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -99.61 104.21 15.97 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 127.651 2.381 . . . . 1.98 110.726 163.95 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -124.8 176.3 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 119.069 -2.269 . . . . 1.52 111.037 177.728 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -115.47 155.65 46.92 Favored Pre-proline 0 N--CA 1.429 -1.508 0 N-CA-C 103.308 -2.849 . . . . 2.35 103.308 162.487 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -74.95 5.73 3.79 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 127.167 3.595 . . . . 1.31 112.026 -174.61 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.7 p -94.97 -8.73 36.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 130.405 3.482 . . . . 1.71 109.434 179.613 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -72.05 134.1 45.65 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.784 -2.448 . . . . 1.69 107.477 175.412 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.6 p -78.62 160.46 27.54 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 111.004 -2.816 . . . . 1.33 110.926 174.154 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -65.57 -31.39 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 117.176 -3.452 . . . . 1.32 116.246 177.692 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -40.16 -53.43 2.47 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.576 -3.828 . . . . 1.62 114.982 159.78 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -58.75 -39.29 80.51 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 125.117 2.389 . . . . 2.13 116.5 173.259 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.442 HG11 HD12 ' A' ' 15' ' ' LEU . 74.7 t -63.29 -42.57 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 129.909 3.284 . . . . 1.23 113.872 -179.346 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.28 39.0 mtmt -70.03 -33.5 72.05 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 126.469 2.355 . . . . 1.97 114.895 174.256 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.27 -34.03 76.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.221 1.563 . . . . 1.19 115.221 169.857 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -58.35 -31.41 67.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 127.986 3.755 . . . . 1.92 118.293 172.046 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.2 mt -84.41 -32.42 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 1 CA-C-N 108.299 -4.046 . . . . 1.94 110.151 179.256 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -63.63 -33.97 76.81 Favored 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 116.201 -4.062 . . . . 1.9 114.62 176.863 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -64.34 -47.09 80.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.616 1.566 . . . . 1.55 113.332 168.139 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -75.9 -62.29 1.64 Allowed 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 121.267 1.849 . . . . 2.95 114.101 -178.773 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -89.97 -18.25 26.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.952 1.251 . . . . 1.48 114.035 -171.477 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.62 13.85 46.0 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 120.469 -1.394 . . . . 1.12 111.264 167.534 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.7 mt -98.35 133.46 22.83 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 118.936 -2.508 . . . . 2.07 113.837 -173.93 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -64.65 143.61 81.59 Favored 'Trans proline' 0 N--CA 1.433 -2.045 1 N-CA-C 124.499 4.769 . . . . 1.39 124.499 170.563 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -62.69 -21.01 72.54 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 124.435 3.423 . . . . 1.68 114.772 179.807 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -63.65 -21.61 66.46 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.517 2.043 . . . . 2.25 116.517 168.381 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -94.94 -38.62 10.61 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 103.994 -2.595 . . . . 2.44 103.994 179.127 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.331 76.5 mt-30 -80.23 132.2 35.82 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 114.255 1.206 . . . . 1.32 114.255 -171.696 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -123.33 151.59 42.31 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.295 2.638 . . . . 3.19 104.822 170.219 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.2 mt -127.84 127.47 43.52 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 124.444 2.069 . . . . 1.75 106.929 176.521 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.6 mt -104.72 137.66 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 101.48 -3.526 . . . . 1.98 101.48 171.107 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.281 2.8 t80 -130.14 103.94 7.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.802 -3.061 . . . . 1.94 103.669 170.401 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.391 . . 80.58 -98.44 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 123.812 1.767 . . . . 1.67 110.844 -178.18 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.6 -5.78 3.95 Favored Glycine 0 N--CA 1.429 -1.79 1 CA-C-O 113.243 -4.087 . . . . 1.3 109.043 -176.995 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -101.77 128.61 48.03 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 122.093 2.947 . . . . 2.89 111.136 177.067 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -88.19 117.84 27.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.638 3.575 . . . . 2.89 111.286 177.803 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 mt -75.9 148.14 38.48 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.289 1.995 . . . . 1.34 113.576 -166.947 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -99.0 153.0 19.19 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 111.586 -2.552 . . . . 1.94 111.436 175.604 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.22 -54.33 8.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.466 1.507 . . . . 1.56 114.832 -168.418 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.06 47.31 3.68 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-O 114.787 -3.229 . . . . 0.97 115.672 176.104 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -130.47 158.15 40.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.756 2.278 . . . . 3.07 110.224 165.82 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.328 27.1 p -84.85 169.11 14.47 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 113.67 -5.644 . . . . 1.34 114.557 179.704 . . . . . . . . 3 2 . 1 . 092 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.7 mt -65.73 -34.08 77.36 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 113.326 0.861 . . . . 1.63 113.326 172.251 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.6 t -70.95 -25.42 62.72 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 127.416 2.287 . . . . 1.51 111.231 179.57 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -68.03 -29.31 68.27 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 117.728 -1.13 . . . . 1.9 113.298 169.427 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -96.18 18.2 14.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.578 2.351 . . . . 0.97 105.67 176.158 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.6 m120 45.07 41.19 5.34 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 129.097 2.959 . . . . 2.35 118.727 -179.763 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.9 mt -92.65 131.01 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 118.915 -2.366 . . . . 1.39 105.113 -176.864 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -148.1 -34.91 0.22 Allowed 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.259 2.457 . . . . 2.58 110.022 -175.214 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -95.96 -179.6 4.75 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 118.934 -2.354 . . . . 2.58 109.526 174.544 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -68.31 97.56 0.75 Allowed 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 124.404 2.05 . . . . 1.71 116.202 175.745 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 98.2 p -91.85 138.97 31.12 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.362 -1.29 . . . . 1.34 109.739 -167.371 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.1 m -89.57 104.07 16.66 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 115.807 -2.357 . . . . 1.36 112.894 175.483 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mp -88.54 158.1 18.41 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.482 -1.386 . . . . 2.03 107.498 176.181 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -122.87 121.94 37.44 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 118.261 -2.774 . . . . 2.31 114.81 176.331 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 tt -82.57 117.99 22.96 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 116.962 -1.895 . . . . 1.72 115.301 -178.793 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.5 t -114.96 133.67 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 CA-C-O 126.368 2.985 . . . . 1.8 112.466 175.321 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.6 mt -92.62 141.31 28.63 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.752 -3.718 . . . . 3.26 107.735 175.87 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -124.35 98.66 5.85 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 112.512 -2.131 . . . . 4.12 105.637 177.139 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.8 mt -91.78 -75.79 0.47 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 129.703 3.201 . . . . 3.54 119.466 176.773 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 53.1 ttm-85 -99.42 -64.16 1.06 Allowed 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 129.313 4.133 . . . . 7.32 106.164 175.317 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.05 111.36 0.3 Allowed Glycine 0 N--CA 1.43 -1.713 0 O-C-N 126.871 2.607 . . . . 3.73 108.602 -175.525 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.791 1 CA-C-O 112.434 -4.536 . . . . 3.87 110.503 -178.435 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 ttp . . . . . 0 CA--C 1.491 -1.318 0 N-CA-C 113.991 1.108 . . . . 1.39 113.991 . . . . . . . . . 0 0 . 1 . 093 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -106.29 95.0 5.46 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.752 -2.467 . . . . 2.2 111.004 -166.316 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.9 pt -90.44 165.58 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 125.762 1.914 . . . . 1.32 111.842 177.855 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -121.41 130.86 53.84 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.393 -1.442 . . . . 2.2 107.338 178.388 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.62 108.45 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 O-C-N 119.816 -1.802 . . . . 1.23 108.44 174.41 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -99.63 133.59 43.74 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.214 1.405 . . . . 2.51 111.059 179.707 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.9 p -101.08 163.58 12.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 115.742 1.756 . . . . 1.41 115.742 -179.31 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 tp -51.58 -49.06 62.85 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.802 3.241 . . . . 2.95 114.303 170.058 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 p -74.86 -40.01 61.23 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.702 1.715 . . . . 2.52 114.201 -165.975 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.37 15.73 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.709 0 O-C-N 118.283 -2.761 . . . . 1.5 114.134 174.323 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -108.03 134.41 50.96 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 126.02 2.819 . . . . 1.79 114.864 -178.367 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.0 m -108.66 107.15 17.51 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 130.02 3.328 . . . . 1.38 105.089 174.059 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -88.4 131.79 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 1 O-C-N 116.066 -4.146 . . . . 2.03 107.318 174.828 . . . . . . . . 3 3 . 1 . 093 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 m -100.1 103.08 14.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 100.416 -3.92 . . . . 1.61 100.416 178.523 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.9 mt -102.97 130.72 50.15 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.055 1.883 . . . . 2.15 112.347 177.398 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -97.17 113.84 25.48 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.411 -2.681 . . . . 1.98 110.689 169.024 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.55 155.76 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 107.273 -1.38 . . . . 1.52 107.273 -177.443 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.325 19.5 mm-40 -86.61 152.8 55.02 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-N 121.644 2.02 . . . . 2.35 107.026 163.669 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 51.9 Cg_exo -71.25 -16.71 31.45 Favored 'Trans proline' 0 C--N 1.3 -1.996 3 CA-C-N 129.823 4.544 . . . . 1.31 113.537 179.715 . . . . . . . . 3 3 . 1 . 093 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 m -74.95 -6.07 47.26 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 126.042 2.089 . . . . 1.71 113.312 168.652 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -74.3 153.59 39.29 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.64 -2.537 . . . . 1.69 109.276 175.997 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 p -87.28 177.03 7.27 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.196 -2.815 . . . . 1.33 115.283 178.901 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.3 mm -76.79 -32.03 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 124.997 1.319 . . . . 1.32 108.758 174.179 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -53.39 -52.81 58.12 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.89 2.476 . . . . 1.62 113.256 170.488 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -62.58 -38.59 90.71 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 114.79 -2.528 . . . . 2.13 116.234 172.426 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.06 -44.71 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 123.265 2.757 . . . . 1.23 111.706 171.587 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.411 ' HZ3' ' CG ' ' A' ' 52' ' ' ASP . 95.5 mttt -59.9 -32.79 71.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.77 -3.081 . . . . 1.97 112.181 175.482 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.57 -35.2 79.63 Favored 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.731 -4.355 . . . . 1.19 117.727 172.249 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -71.54 -27.03 62.9 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.576 -2.577 . . . . 1.92 114.281 176.053 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.3 mt -75.45 -36.82 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 117.372 -3.33 . . . . 1.94 109.103 173.67 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -63.09 -53.14 58.29 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.21 -1.556 . . . . 1.9 109.963 177.392 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -41.34 -63.5 0.69 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.688 2.847 . . . . 1.55 118.688 166.53 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -81.9 -36.47 28.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 117.08 2.252 . . . . 2.95 117.08 -166.112 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -103.09 -46.97 4.48 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.848 -1.782 . . . . 1.48 111.315 -175.223 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.96 25.36 2.31 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 123.913 0.768 . . . . 1.12 114.668 170.831 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.4 mt -107.09 127.36 28.12 Favored Pre-proline 0 N--CA 1.429 -1.493 0 O-C-N 118.575 -2.72 . . . . 2.07 109.445 -170.465 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -67.78 138.5 45.05 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 C-N-CA 123.286 2.658 . . . . 1.39 115.809 179.344 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.14 -13.63 31.28 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 CA-C-N 121.335 1.512 . . . . 1.68 115.11 -162.025 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -55.93 -27.8 53.97 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 129.509 3.124 . . . . 2.25 113.721 168.517 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -98.08 -0.14 45.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.8 -1.813 . . . . 2.44 111.149 -173.664 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -97.79 135.82 39.01 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.563 2.601 . . . . 1.32 112.646 -175.215 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -125.05 115.45 20.54 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.756 -1.84 . . . . 3.19 107.241 169.175 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mt -94.44 126.07 39.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.681 2.392 . . . . 1.75 113.807 177.888 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.3 mm -111.04 131.7 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 108.736 -0.838 . . . . 1.98 108.736 -175.913 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -123.67 87.46 2.74 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 127.124 2.17 . . . . 1.94 106.853 168.793 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.256 . . 69.18 -98.49 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.378 -2.076 . . . . 1.67 112.176 -178.441 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.06 6.65 13.13 Favored Glycine 0 N--CA 1.431 -1.653 0 O-C-N 118.352 -2.717 . . . . 1.3 111.571 177.762 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -99.36 130.25 45.63 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.91 -1.885 . . . . 2.89 105.91 178.74 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -103.4 107.25 18.01 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 111.156 -2.747 . . . . 2.89 109.597 170.268 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.3 mt -76.1 131.66 39.57 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 121.111 3.745 . . . . 1.34 121.111 -166.059 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -90.5 141.38 28.82 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 119.647 3.203 . . . . 1.94 119.647 176.536 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.411 ' CG ' ' HZ3' ' A' ' 27' ' ' LYS . 11.3 m-20 -42.96 -68.71 0.17 Allowed 'General case' 0 N--CA 1.431 -1.418 1 N-CA-C 122.337 4.199 . . . . 1.56 122.337 -171.752 . . . . . . . . 3 3 . 1 . 093 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.6 25.15 1.15 Allowed Glycine 0 N--CA 1.429 -1.774 0 C-N-CA 129.194 3.283 . . . . 0.97 119.419 171.193 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -105.99 151.95 23.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.178 -3.542 . . . . 3.07 111.845 163.659 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.7 p -76.04 171.37 14.58 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 124.781 2.229 . . . . 1.34 116.412 172.811 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 47.9 mt -73.02 -27.69 61.91 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.305 -2.122 . . . . 1.63 113.312 167.838 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.9 p -78.49 -28.39 46.35 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-O 118.148 -0.929 . . . . 1.51 110.087 -177.978 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -56.34 -59.74 4.52 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.366 1.066 . . . . 1.9 111.14 171.909 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -62.85 -28.93 70.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 126.743 2.527 . . . . 0.97 114.507 -179.063 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 82.86 51.79 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.412 1 C-N-CA 132.95 4.5 . . . . 2.35 112.048 -178.466 . . . . . . . . 3 3 . 1 . 093 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -84.09 114.7 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 108.373 -0.973 . . . . 1.39 108.373 -178.547 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -95.32 159.79 14.84 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 126.256 1.823 . . . . 2.58 114.118 -170.696 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.382 6.5 tmtm? -6.35 -81.31 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 120.233 3.419 . . . . 2.58 120.233 175.165 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -105.39 71.04 0.91 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.948 2.309 . . . . 1.71 110.962 -175.141 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.283 18.7 m -107.55 141.52 38.88 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 124.392 2.044 . . . . 1.34 107.216 -177.49 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.3 m -105.4 119.19 38.47 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.767 -1.833 . . . . 1.36 107.659 174.374 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -96.34 148.92 22.27 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.527 2.331 . . . . 2.03 107.563 174.314 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -126.15 122.33 35.38 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.148 -1.797 . . . . 2.31 106.148 -174.617 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.5 tp -82.29 135.61 35.18 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 125.062 2.363 . . . . 1.72 107.095 -176.143 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.0 t -135.17 150.21 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 1 N-CA-C 99.328 -4.323 . . . . 1.8 99.328 -179.208 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.3 mt -111.56 146.95 36.44 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 115.094 -4.754 . . . . 3.26 107.76 -176.919 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -95.28 130.8 41.9 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 110.403 -3.09 . . . . 4.12 108.709 -179.479 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.345 47.4 mt -111.54 167.52 10.26 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.366 -3.334 . . . . 3.54 109.364 168.374 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -60.99 -57.84 10.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 118.154 -0.926 . . . . 7.32 110.16 169.107 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.73 59.95 4.71 Favored Glycine 0 N--CA 1.43 -1.726 0 CA-C-N 123.62 2.918 . . . . 3.73 110.501 -168.752 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.734 0 O-C-N 120.381 -1.658 . . . . 3.87 113.767 -179.961 . . . . . . . . 0 0 . 1 . 094 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 ttp . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 109.275 -0.639 . . . . 1.39 109.275 . . . . . . . . . 0 0 . 1 . 094 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -102.68 117.6 35.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.811 -3.681 . . . . 2.2 107.85 -178.052 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.0 pt -117.12 149.54 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 125.69 2.662 . . . . 1.32 110.062 174.369 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -95.26 153.76 17.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.984 -2.322 . . . . 2.2 112.223 -177.062 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.9 t -137.37 114.24 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 117.957 -2.964 . . . . 1.23 108.286 172.464 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -86.69 122.51 30.69 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.344 2.257 . . . . 2.51 112.427 179.709 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.301 17.0 p -80.89 174.89 11.17 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.451 -0.795 . . . . 1.41 112.674 -177.378 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 tp -78.03 -25.69 48.0 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 119.176 3.028 . . . . 2.95 119.176 171.357 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.9 p -74.82 -46.55 35.89 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.736 -3.102 . . . . 2.52 112.054 -178.001 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.31 6.89 0.12 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 126.629 2.062 . . . . 1.5 110.014 174.137 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.416 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 77.9 tttt -84.0 144.68 28.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 121.415 2.608 . . . . 1.79 114.137 178.371 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.335 31.3 m -102.57 137.63 40.55 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.228 2.211 . . . . 1.38 111.452 167.306 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mt -125.04 129.54 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 1 C-N-CA 132.908 4.483 . . . . 2.03 110.361 177.082 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.6 m -101.06 117.8 35.74 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 125.615 1.822 . . . . 1.61 109.651 177.096 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -111.36 137.82 48.64 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.425 1.89 . . . . 2.15 111.166 173.763 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -90.38 134.28 34.43 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.154 -2.216 . . . . 1.98 106.305 163.711 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.7 m -142.82 161.95 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 C-N-CA 129.427 3.091 . . . . 1.52 111.789 179.503 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -98.06 149.02 35.3 Favored Pre-proline 0 N--CA 1.431 -1.417 0 O-C-N 117.328 -3.358 . . . . 2.35 108.026 165.474 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -69.82 -17.58 37.21 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 CA-C-N 128.182 3.958 . . . . 1.31 112.109 -179.183 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.0 p -77.95 -16.09 58.45 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.048 1.739 . . . . 1.71 112.984 175.784 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -66.86 134.26 51.72 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.535 -1.211 . . . . 1.69 113.213 178.757 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -69.03 168.38 13.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 115.346 1.61 . . . . 1.33 115.346 174.653 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.276 15.4 mm -76.06 -29.59 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 113.642 -1.617 . . . . 1.32 112.186 176.621 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -46.82 -48.87 20.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.641 3.176 . . . . 1.62 111.703 158.84 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -63.87 -37.22 86.59 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.296 1.438 . . . . 2.13 114.859 176.459 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.3 t -59.99 -43.06 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 118.983 -2.323 . . . . 1.23 116.535 173.593 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.411 ' HD3' ' HB2' ' A' ' 41' ' ' GLN . 74.4 mttt -71.7 -33.75 69.04 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.241 1.816 . . . . 1.97 114.528 179.741 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.22 -17.76 60.27 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.026 -2.921 . . . . 1.19 109.978 173.412 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -89.93 -12.68 38.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.967 1.841 . . . . 1.92 113.646 173.824 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.8 mt -88.32 -23.52 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 119.918 -1.739 . . . . 1.94 110.671 169.432 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -69.73 -49.42 53.42 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.314 1.845 . . . . 1.9 108.673 172.04 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.306 33.1 t70 -53.7 -62.86 1.38 Allowed 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 123.189 2.722 . . . . 1.55 116.405 164.078 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -63.21 -62.39 1.72 Allowed 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.818 -3.052 . . . . 2.95 113.995 -170.938 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.416 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 51.6 tp10 -96.02 -56.46 2.64 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.258 -2.776 . . . . 1.48 113.23 -170.935 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.91 5.49 1.03 Allowed Glycine 0 N--CA 1.431 -1.698 0 O-C-N 124.867 1.354 . . . . 1.12 114.497 170.739 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.5 mt -78.12 135.53 62.3 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-O 114.611 -2.614 . . . . 2.07 111.969 -174.578 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -77.37 153.24 31.03 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 CA-C-N 125.413 2.969 . . . . 1.39 113.469 -178.024 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -64.51 -24.66 63.34 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 CA-C-N 127.664 3.773 . . . . 1.68 115.603 -172.106 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -61.24 -33.25 73.21 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.613 -2.555 . . . . 2.25 117.254 173.792 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -76.97 -24.74 52.28 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.376 -3.327 . . . . 2.44 116.746 -178.29 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.411 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 68.0 mt-30 -80.9 107.86 14.08 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.28 2.232 . . . . 1.32 110.513 -172.468 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -103.5 119.67 39.35 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.094 -2.879 . . . . 3.19 106.577 168.713 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.7 mt -102.92 123.86 47.34 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 119.67 3.211 . . . . 1.75 119.67 -178.789 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -109.58 157.68 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 115.675 -2.107 . . . . 1.98 109.751 178.356 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -140.63 114.95 9.29 Favored 'General case' 0 N--CA 1.43 -1.453 1 N-CA-C 95.64 -5.689 . . . . 1.94 95.64 173.604 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.259 . . 55.9 -110.23 0.54 Allowed 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.299 -1.501 . . . . 1.67 114.348 -176.815 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.48 -8.71 24.55 Favored Glycine 0 N--CA 1.43 -1.738 0 CA-C-O 123.062 1.368 . . . . 1.3 112.967 -176.601 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -91.61 143.86 26.13 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.388 -3.419 . . . . 2.89 114.468 171.572 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -99.83 129.05 45.89 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.236 1.014 . . . . 2.89 108.634 170.365 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.1 mt -91.36 147.13 23.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.194 1.473 . . . . 1.34 113.234 -167.86 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -91.74 143.23 26.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.719 -1.863 . . . . 1.94 115.581 175.392 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.81 -47.68 77.16 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 118.646 2.832 . . . . 1.56 118.646 -173.504 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.55 26.04 2.75 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 122.934 3.934 . . . . 0.97 122.934 171.885 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.4 mtt-85 -111.46 146.67 36.82 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 118.813 -2.581 . . . . 3.07 110.589 169.84 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.343 43.7 p -70.98 170.9 11.8 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.638 2.637 . . . . 1.34 113.264 176.404 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mt -74.87 -27.96 60.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.318 -2.739 . . . . 1.63 109.779 168.571 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.6 t -65.75 -39.87 91.52 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 127.706 2.402 . . . . 1.51 114.752 178.977 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -51.0 -50.22 58.92 Favored 'General case' 0 N--CA 1.43 -1.452 1 CA-C-O 129.135 4.302 . . . . 1.9 112.505 174.544 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -88.15 -2.1 58.4 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.822 -3.049 . . . . 0.97 114.286 -178.904 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 63.73 55.73 1.63 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.61 1.964 . . . . 2.35 113.183 -176.381 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.1 mm -85.3 118.44 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-O 116.333 -1.794 . . . . 1.39 106.308 179.288 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -82.56 -170.52 3.0 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 128.035 3.334 . . . . 2.58 109.35 -176.69 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.28 92.4 mttt -72.61 -56.3 5.55 Favored 'General case' 0 N--CA 1.429 -1.495 1 N-CA-C 123.84 4.756 . . . . 2.58 123.84 -177.981 . . . . . . . . 3 2 . 1 . 094 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -74.3 27.14 0.08 Allowed 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.783 2.706 . . . . 1.71 115.01 -176.571 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.7 m -73.83 136.41 43.51 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.722 -4.361 . . . . 1.34 116.174 -174.859 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.8 m -112.98 108.97 18.08 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.478 2.085 . . . . 1.36 107.123 178.773 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -75.77 138.97 41.56 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 112.368 -2.197 . . . . 2.03 105.843 174.395 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -106.73 109.41 21.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.744 -3.098 . . . . 2.31 107.225 -170.339 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tp -106.48 126.0 51.7 Favored 'General case' 0 N--CA 1.43 -1.455 1 CA-C-O 128.81 4.148 . . . . 1.72 107.701 -171.69 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -112.85 138.74 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 109.353 -3.567 . . . . 1.8 105.906 -179.151 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -104.41 132.85 50.2 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 116.579 -2.049 . . . . 3.26 108.884 -173.899 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 ptt-85 -121.93 166.39 14.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 113.124 -1.853 . . . . 4.12 112.536 177.128 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.7 mt -89.42 166.56 13.63 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.053 0.93 . . . . 3.54 110.852 171.025 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -85.91 135.56 33.63 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 114.554 1.316 . . . . 7.32 114.554 174.759 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.51 -54.1 0.12 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 118.183 -2.823 . . . . 3.73 113.066 -161.596 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.784 0 CA-C-N 120.267 2.034 . . . . 3.87 114.149 175.628 . . . . . . . . 0 0 . 1 . 095 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ptt? . . . . . 0 CA--C 1.49 -1.356 0 CA-C-O 119.635 -0.221 . . . . 1.39 111.008 . . . . . . . . . 0 0 . 1 . 095 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -111.3 117.67 33.79 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.815 -1.178 . . . . 2.2 108.517 -176.594 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.8 pt -114.13 159.13 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 124.586 1.154 . . . . 1.32 113.054 -178.63 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -112.17 146.61 37.77 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 104.914 -2.254 . . . . 2.2 104.914 174.916 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.8 t -117.3 114.45 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 110.927 -2.851 . . . . 1.23 109.822 174.159 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -91.96 131.5 37.21 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 120.937 1.699 . . . . 2.51 110.329 175.838 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.295 39.4 p -83.12 174.13 11.09 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 126.535 3.064 . . . . 1.41 112.379 174.914 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 71' ' ' LEU . 20.3 tp -57.96 -47.32 83.28 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.488 2.566 . . . . 2.95 117.818 172.746 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.3 p -86.4 -8.0 58.0 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.241 2.216 . . . . 2.52 110.103 -173.809 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.4 30.14 5.73 Favored Glycine 0 N--CA 1.431 -1.7 1 C-N-CA 132.932 5.063 . . . . 1.5 118.84 167.613 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -106.15 133.94 50.06 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.258 -2.319 . . . . 1.79 105.54 -176.038 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.7 m -105.05 118.7 37.2 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.239 -0.891 . . . . 1.38 110.155 -173.501 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.72 129.27 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 124.783 1.233 . . . . 2.03 109.982 -176.12 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 100.0 m -88.86 122.46 32.27 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 126.813 2.571 . . . . 1.61 106.409 177.931 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.2 tp -121.63 134.69 54.99 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.379 -2.076 . . . . 2.15 108.612 -178.616 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -94.02 99.92 12.14 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 129.643 3.177 . . . . 1.98 116.561 173.197 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.2 m -115.29 149.58 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 127.712 2.405 . . . . 1.52 112.681 -175.456 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -103.81 165.84 12.75 Favored Pre-proline 0 N--CA 1.43 -1.448 0 N-CA-C 106.625 -1.62 . . . . 2.35 106.625 168.274 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -79.56 -20.01 9.7 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 123.18 2.587 . . . . 1.31 107.625 -172.597 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.8 p -84.8 0.49 50.59 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.244 -2.16 . . . . 1.71 115.974 177.039 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -70.65 151.65 44.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.816 1.246 . . . . 1.69 110.611 173.913 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 p -84.78 166.64 16.79 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.421 1.488 . . . . 1.33 111.028 171.293 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.4 mm -75.12 -35.87 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 116.645 2.091 . . . . 1.32 116.645 173.335 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -48.31 -49.45 33.93 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.053 2.983 . . . . 1.62 119.053 163.536 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -58.49 -35.73 72.66 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.861 2.064 . . . . 2.13 112.899 173.892 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 t -72.76 -38.9 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 121.09 -1.006 . . . . 1.23 112.797 177.685 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -64.02 -31.26 72.38 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.495 -3.253 . . . . 1.97 111.409 170.514 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.43 -32.04 70.75 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 119.144 0.884 . . . . 1.19 111.695 175.246 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -68.86 -45.16 71.79 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.0 1.481 . . . . 1.92 115.0 171.888 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mt -59.03 -35.41 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 125.621 2.629 . . . . 1.94 113.553 177.428 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.298 26.3 tt0 -69.15 -40.89 77.95 Favored 'General case' 0 N--CA 1.428 -1.535 0 O-C-N 116.331 -3.981 . . . . 1.9 111.475 172.67 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -56.05 -61.79 2.14 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 122.969 2.622 . . . . 1.55 114.362 167.429 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.439 12.0 ptpt -76.77 -50.77 12.75 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 114.8 1.407 . . . . 2.95 114.8 -173.706 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -97.28 -48.44 5.33 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 125.577 2.608 . . . . 1.48 112.98 -170.248 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.93 67.02 0.75 Allowed Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 119.936 2.734 . . . . 1.12 119.936 -179.336 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.3 mt -127.26 135.24 27.12 Favored Pre-proline 0 N--CA 1.43 -1.446 0 N-CA-C 100.563 -3.865 . . . . 2.07 100.563 -177.303 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -85.55 135.17 4.99 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 C-N-CA 115.047 -2.835 . . . . 1.39 111.76 -175.202 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.29 -11.68 6.56 Favored 'Trans proline' 0 C--N 1.3 -2.0 1 C-N-CA 126.233 4.622 . . . . 1.68 117.41 -172.91 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -73.83 -23.7 59.69 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.82 1.415 . . . . 2.25 114.82 169.329 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -99.85 -3.06 33.37 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.023 -2.923 . . . . 2.44 113.871 -176.379 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -101.13 97.59 8.11 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.466 -2.021 . . . . 1.32 113.782 -172.706 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.8 ttt-85 -87.82 122.14 31.1 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 115.856 -2.021 . . . . 3.19 110.263 166.737 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.8 mt -111.08 131.5 55.02 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.886 2.18 . . . . 1.75 116.886 -177.717 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.91 136.23 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 105.691 -1.966 . . . . 1.98 105.691 -177.927 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -93.1 -105.42 0.12 Allowed 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.882 -1.508 . . . . 1.94 107.644 168.847 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.83 -69.81 0.79 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 113.934 1.087 . . . . 1.67 113.934 170.174 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.79 -28.57 5.29 Favored Glycine 0 N--CA 1.429 -1.779 0 O-C-N 119.701 -1.874 . . . . 1.3 109.5 -179.275 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -95.25 142.75 27.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 120.423 2.112 . . . . 2.89 108.599 -179.404 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -95.3 135.68 36.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 128.634 2.774 . . . . 2.89 104.394 166.851 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.1 mt -86.68 115.85 24.4 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 126.287 2.242 . . . . 1.34 116.777 -168.769 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -84.8 134.4 34.31 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 125.636 2.636 . . . . 1.94 111.776 179.014 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.283 20.0 m-20 -59.75 -40.38 87.92 Favored 'General case' 0 N--CA 1.43 -1.44 2 N-CA-C 127.458 6.095 . . . . 1.56 127.458 -168.547 . . . . . . . . 3 2 . 1 . 095 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.52 56.88 1.98 Allowed Glycine 0 N--CA 1.43 -1.703 0 O-C-N 119.256 -2.153 . . . . 0.97 113.518 167.736 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -131.93 162.25 31.12 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 127.811 2.444 . . . . 3.07 108.733 172.012 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.3 p -95.53 169.71 9.85 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 121.049 1.75 . . . . 1.34 110.134 173.948 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.262 7.5 mp -59.02 -30.25 67.87 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 119.152 3.019 . . . . 1.63 119.152 161.906 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 p -74.24 -23.62 59.18 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.909 -2.994 . . . . 1.51 109.118 177.614 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -74.63 -40.65 61.37 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 129.759 3.224 . . . . 1.9 112.696 178.784 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.254 46.8 m-85 -91.62 -0.67 57.6 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 113.469 -5.769 . . . . 0.97 109.505 177.553 . . . . . . . . 3 2 . 1 . 095 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.8 m120 63.74 56.78 1.48 Allowed 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 114.233 -2.794 . . . . 2.35 109.278 -179.029 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.295 65.6 mt -84.66 126.18 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 127.886 2.474 . . . . 1.39 110.659 175.643 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -107.58 170.92 7.68 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 117.925 -1.036 . . . . 2.58 108.277 -173.473 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -71.51 -29.3 64.63 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 115.478 -2.489 . . . . 2.58 113.981 -178.963 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -80.04 10.4 4.37 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 125.603 2.621 . . . . 1.71 113.972 -179.652 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.8 m -78.84 130.94 36.24 Favored 'General case' 0 N--CA 1.431 -1.406 1 O-C-N 116.096 -4.127 . . . . 1.34 116.899 -174.631 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.8 m -106.51 115.71 30.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.937 -1.938 . . . . 1.36 111.879 170.947 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.297 8.8 mp -87.61 157.61 19.08 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.744 -1.116 . . . . 2.03 109.439 177.103 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -128.54 123.93 34.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 103.36 -2.83 . . . . 2.31 103.36 -176.088 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.305 6.8 tt -103.56 115.42 30.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.253 1.021 . . . . 1.72 111.349 179.579 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.388 4.1 m -109.66 166.71 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 118.628 -2.545 . . . . 1.8 112.446 174.283 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.403 ' HB2' HD21 ' A' ' 8' ' ' LEU . 45.4 tp -75.04 109.84 8.84 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 117.365 2.358 . . . . 3.26 117.365 -178.45 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.36 138.71 38.93 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 120.096 -0.642 . . . . 4.12 110.796 179.731 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 55.4 mt -112.92 166.67 11.18 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 119.767 -1.833 . . . . 3.54 110.704 -176.929 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.0 ttm-85 -79.17 139.26 38.04 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 127.372 3.463 . . . . 7.32 112.173 178.362 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.54 -112.2 0.51 Allowed Glycine 0 N--CA 1.43 -1.736 1 O-C-N 113.652 -5.655 . . . . 3.73 113.661 -165.914 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.772 0 N-CA-C 108.614 -1.795 . . . . 3.87 108.614 -172.657 . . . . . . . . 0 0 . 1 . 096 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 ptt? . . . . . 0 CA--C 1.49 -1.355 0 N-CA-C 113.268 0.84 . . . . 1.39 113.268 . . . . . . . . . 0 0 . 1 . 096 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -101.14 107.11 18.44 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 120.414 1.461 . . . . 2.2 112.021 -178.768 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.1 pt -89.62 155.9 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 C-N-CA 124.76 1.224 . . . . 1.32 111.431 176.763 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -104.88 140.99 37.32 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 123.303 1.525 . . . . 2.2 107.93 -179.894 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.6 t -124.43 114.97 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 103.584 -2.747 . . . . 1.23 103.584 174.298 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -96.59 138.14 34.62 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.828 -1.795 . . . . 2.51 111.481 -178.322 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.346 18.3 p -91.73 166.86 12.56 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 116.429 -1.748 . . . . 1.41 110.977 175.204 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.8 mt -68.95 -44.82 72.23 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 125.33 1.644 . . . . 2.95 111.182 171.784 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.1 p -62.17 -81.84 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 128.399 3.952 . . . . 2.52 113.299 -177.432 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.12 40.48 0.11 Allowed Glycine 0 N--CA 1.431 -1.692 1 O-C-N 116.299 -4.001 . . . . 1.5 119.243 174.819 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -122.87 142.39 50.84 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.069 1.435 . . . . 1.79 108.134 -177.206 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.6 m -120.63 118.66 30.72 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.759 2.423 . . . . 1.38 106.289 172.03 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mt -97.59 133.2 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-O 124.978 2.323 . . . . 2.03 105.89 178.61 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 p -107.28 92.63 4.16 Favored 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 132.496 4.318 . . . . 1.61 107.091 -177.402 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.0 mt -101.31 130.36 47.46 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 125.313 1.633 . . . . 2.15 112.353 -179.198 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -74.7 107.49 6.84 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 115.269 -2.301 . . . . 1.98 109.758 171.314 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.1 m -127.57 173.32 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 105.847 -1.908 . . . . 1.52 105.847 -173.349 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -125.77 169.57 11.21 Favored Pre-proline 0 N--CA 1.431 -1.399 0 CA-C-O 112.903 -3.427 . . . . 2.35 106.285 163.849 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -74.87 -17.95 19.48 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 C-N-CA 124.028 3.152 . . . . 1.31 111.356 -175.192 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.6 p -78.17 -8.96 58.94 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.736 2.014 . . . . 1.71 115.656 176.339 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -74.29 137.88 43.19 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.69 -3.131 . . . . 1.69 112.567 176.565 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 29.6 p -76.42 154.84 34.47 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.697 1.999 . . . . 1.33 111.354 176.072 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.0 mm -54.42 -37.08 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 125.679 1.592 . . . . 1.32 112.072 173.96 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -53.32 -45.52 69.07 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.281 2.232 . . . . 1.62 116.783 162.599 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -55.75 -42.22 75.11 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 119.09 -2.256 . . . . 2.13 115.642 171.692 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.0 t -66.33 -39.34 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 114.284 1.216 . . . . 1.23 114.284 179.204 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -63.27 -27.02 69.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.587 2.069 . . . . 1.97 116.587 168.931 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.71 -47.29 78.86 Favored 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 116.291 -4.005 . . . . 1.19 113.773 169.127 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -55.47 -49.95 71.17 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 126.431 3.015 . . . . 1.92 116.672 169.634 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.1 mt -59.11 -40.14 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 O-C-N 116.394 -3.941 . . . . 1.94 114.291 169.921 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -61.09 -39.87 91.56 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.77 -1.831 . . . . 1.9 113.058 173.444 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -62.7 -50.68 70.2 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.511 2.041 . . . . 1.55 116.511 172.711 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -67.6 -61.18 2.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.863 2.465 . . . . 2.95 109.665 -173.583 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -94.93 -56.27 2.81 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.622 -2.549 . . . . 1.48 112.837 -169.719 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.73 -1.1 2.84 Favored Glycine 0 N--CA 1.431 -1.667 0 O-C-N 119.615 -1.928 . . . . 1.12 116.155 176.111 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.1 mt -90.84 134.51 30.27 Favored Pre-proline 0 N--CA 1.429 -1.481 0 O-C-N 119.959 -1.906 . . . . 2.07 107.486 -167.269 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -61.08 153.05 67.14 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 O-C-N 115.121 -3.147 . . . . 1.39 114.943 173.5 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -73.7 -19.02 21.75 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 122.815 2.041 . . . . 1.68 110.557 -177.644 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.265 3.3 m-20 -63.42 -28.57 70.06 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.12 -2.863 . . . . 2.25 116.897 170.276 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.251 18.6 mt-30 -85.95 -23.91 26.75 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 115.164 -0.925 . . . . 2.44 111.936 -179.552 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -78.43 134.46 37.37 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 120.346 3.461 . . . . 1.32 120.346 -178.456 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -122.57 130.64 53.23 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 105.092 -2.188 . . . . 3.19 105.092 175.465 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.2 mt -114.73 147.11 40.15 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 117.238 -3.414 . . . . 1.75 113.371 175.778 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.0 mt -144.25 136.97 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 C-N-CA 128.268 2.627 . . . . 1.98 104.084 -168.674 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -117.52 123.65 46.79 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 103.289 -2.856 . . . . 1.94 103.289 170.374 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.285 . . 63.3 -89.53 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.476 -2.64 . . . . 1.67 116.75 -176.816 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.9 4.82 3.6 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 105.38 -3.088 . . . . 1.3 105.38 -177.91 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -109.12 130.03 55.48 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.029 -2.454 . . . . 2.89 115.557 -174.538 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -70.32 130.9 43.21 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.836 1.655 . . . . 2.89 110.347 171.171 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.1 mt -99.32 159.15 15.21 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 124.43 3.286 . . . . 1.34 105.094 -168.202 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.563 ' HB3' ' HG3' ' A' ' 54' ' ' ARG . 37.6 tt0 -104.25 130.2 52.05 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 125.65 1.844 . . . . 1.94 114.036 174.5 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -50.25 -50.73 49.17 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.523 3.156 . . . . 1.56 119.523 -168.848 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.6 -9.43 65.15 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 119.832 2.693 . . . . 0.97 119.832 170.68 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.563 ' HG3' ' HB3' ' A' ' 51' ' ' GLU . 37.4 mtt180 -84.92 163.22 19.1 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 115.757 -4.378 . . . . 3.07 115.066 169.687 . . . . . . . . 3 3 . 1 . 096 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 43.0 p -84.02 174.66 10.12 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 118.582 2.808 . . . . 1.34 118.582 171.825 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.83 -31.29 72.41 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 117.922 2.564 . . . . 1.63 117.922 165.892 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.5 t -77.25 -25.2 51.28 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.937 2.095 . . . . 1.51 112.927 178.79 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -65.3 -33.49 76.1 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.316 -2.115 . . . . 1.9 111.898 169.45 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -91.81 4.51 52.69 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.316 -4.615 . . . . 0.97 113.439 170.059 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.663 2.9 m120 63.46 25.83 14.64 Favored 'General case' 0 N--CA 1.43 -1.439 1 N-CA-C 124.288 4.922 . . . . 2.35 124.288 -174.862 . . . . . . . . 3 2 . 1 . 096 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.4 mt -66.84 121.87 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 128.106 2.563 . . . . 1.39 110.541 -177.252 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -89.44 174.73 7.63 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.416 2.531 . . . . 2.58 112.349 -179.518 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -42.06 -56.65 2.75 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 128.023 3.773 . . . . 2.58 118.154 174.791 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -94.61 44.29 1.11 Allowed 'General case' 0 N--CA 1.429 -1.513 1 O-C-N 113.077 -6.015 . . . . 1.71 113.445 -175.269 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.31 38.8 m -92.65 133.73 35.7 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 118.73 -2.481 . . . . 1.34 115.478 -171.716 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.3 m -104.33 105.32 15.41 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 120.694 1.588 . . . . 1.36 107.448 175.004 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -81.74 161.85 23.17 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.299 2.0 . . . . 2.03 109.385 163.67 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.261 98.8 m-70 -118.45 130.7 56.11 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 112.493 -2.139 . . . . 2.31 108.966 -178.199 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.8 tp -102.16 111.5 23.81 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 123.351 1.548 . . . . 1.72 110.228 179.295 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.289 40.0 t -109.48 129.79 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 118.218 2.673 . . . . 1.8 118.218 177.848 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.2 tp -115.01 116.44 28.46 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 115.889 -2.324 . . . . 3.26 113.741 -170.287 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.89 179.55 4.09 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 119.023 0.828 . . . . 4.12 109.803 -179.982 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.7 tp -72.4 -83.26 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.274 2.63 . . . . 3.54 114.612 173.035 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -162.37 150.42 14.4 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 101.108 -3.664 . . . . 7.32 101.108 164.313 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.95 143.58 7.78 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 104.967 -3.253 . . . . 3.73 104.967 -167.716 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.757 0 CA-C-N 123.264 3.532 . . . . 3.87 114.712 174.064 . . . . . . . . 0 0 . 1 . 097 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttp . . . . . 0 CA--C 1.491 -1.309 0 N-CA-C 116.139 1.904 . . . . 1.39 116.139 . . . . . . . . . 0 0 . 1 . 097 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -95.98 125.65 40.68 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 116.52 -3.863 . . . . 2.2 110.688 -174.312 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.461 HD11 HD22 ' A' ' 67' ' ' LEU . 36.6 pt -111.98 144.54 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 124.739 2.209 . . . . 1.32 110.12 169.121 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 64' ' ' GLU . 23.5 m-85 -108.34 112.67 25.24 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.131 -1.85 . . . . 2.2 110.63 -174.661 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.39 116.24 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-O 124.895 2.283 . . . . 1.23 107.262 178.564 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 tppt? -97.38 132.35 43.18 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.389 -3.945 . . . . 2.51 109.197 177.045 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.357 12.5 p -73.56 173.78 9.21 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.08 -2.262 . . . . 1.41 115.106 176.26 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.9 mt -70.92 -15.32 62.6 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.628 1.68 . . . . 2.95 114.985 172.962 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.7 p -109.24 -26.17 10.22 Favored 'General case' 0 N--CA 1.431 -1.399 1 O-C-N 116.025 -4.172 . . . . 2.52 107.264 -175.796 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.42 27.22 0.83 Allowed Glycine 0 N--CA 1.431 -1.651 0 O-C-N 118.968 -2.332 . . . . 1.5 117.12 169.383 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.509 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 34.3 ttpt -100.66 118.41 36.74 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.808 2.304 . . . . 1.79 109.919 -168.712 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.4 m -81.44 122.48 27.56 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 119.557 -0.857 . . . . 1.38 110.012 178.518 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -111.14 133.77 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 102.729 -3.063 . . . . 2.03 102.729 173.518 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.8 m -111.63 125.73 54.26 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.277 -2.764 . . . . 1.61 108.815 -172.833 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.8 mt -119.01 135.45 54.62 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 120.739 1.609 . . . . 2.15 107.817 -177.369 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -91.43 112.57 24.54 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.143 -1.428 . . . . 1.98 107.143 169.966 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.7 m -127.53 165.85 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 C-N-CA 129.008 2.923 . . . . 1.52 116.02 -178.785 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -109.27 163.32 17.28 Favored Pre-proline 0 N--CA 1.43 -1.462 0 C-N-CA 119.717 -0.793 . . . . 2.35 111.601 163.876 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -82.18 -12.35 10.58 Favored 'Trans proline' 0 C--N 1.299 -2.049 0 O-C-N 114.531 -3.458 . . . . 1.31 113.729 -172.996 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.7 m -82.36 -5.92 58.93 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 124.792 1.307 . . . . 1.71 110.457 176.177 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -85.33 146.5 26.99 Favored 'General case' 0 N--CA 1.429 -1.498 1 O-C-N 114.652 -5.03 . . . . 1.69 109.776 178.783 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -77.55 161.78 27.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 118.289 -2.757 . . . . 1.33 112.159 178.629 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mp -68.81 -31.32 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 119.469 -2.019 . . . . 1.32 108.937 -179.818 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -46.48 -40.51 12.54 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.476 -2.015 . . . . 1.62 114.1 165.65 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -70.77 -29.55 65.8 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 117.514 2.413 . . . . 2.13 117.514 174.752 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.39 -39.61 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-N 113.428 -1.714 . . . . 1.23 109.289 176.809 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.3 84.2 mttt -60.73 -34.37 74.3 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 124.277 0.985 . . . . 1.97 111.974 169.275 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.62 -44.48 96.18 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.524 -2.61 . . . . 1.19 114.676 173.235 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -66.58 -43.55 84.64 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.425 -1.716 . . . . 1.92 115.014 172.397 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.5 mt -58.12 -31.07 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 116.652 -3.78 . . . . 1.94 113.327 170.656 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -60.34 -45.64 92.72 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 116.849 2.166 . . . . 1.9 116.849 170.69 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.87 -53.86 43.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.032 2.349 . . . . 1.55 114.151 174.92 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -56.81 -75.96 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 111.502 -2.59 . . . . 2.95 113.551 177.782 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.509 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 21.2 tp10 -94.52 -21.38 18.91 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.433 3.123 . . . . 1.48 119.433 -169.068 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.75 43.38 3.63 Favored Glycine 0 N--CA 1.43 -1.755 1 O-C-N 114.802 -4.936 . . . . 1.12 113.471 175.886 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.7 mt -115.72 131.39 23.7 Favored Pre-proline 0 N--CA 1.43 -1.441 0 O-C-N 120.892 -1.357 . . . . 2.07 109.481 179.787 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -63.84 147.07 92.36 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 O-C-N 116.456 -2.444 . . . . 1.39 113.623 176.069 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.66 -22.89 64.04 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 C-N-CA 124.246 3.297 . . . . 1.68 115.991 -176.606 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.58 -24.47 65.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 128.395 2.678 . . . . 2.25 117.35 177.311 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -86.96 -33.22 19.72 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.014 -1.448 . . . . 2.44 107.257 -177.982 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -85.87 129.78 34.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.081 -1.637 . . . . 1.32 115.118 -168.642 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -115.97 142.24 47.06 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.599 1.959 . . . . 3.19 106.253 163.393 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.8 mt -117.7 125.56 50.9 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.306 -1.739 . . . . 1.75 106.306 178.89 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.462 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 39.3 mm -102.29 144.65 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 129.959 3.304 . . . . 1.98 107.259 174.222 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.315 17.4 t80 -143.0 114.83 8.18 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 105.235 -2.135 . . . . 1.94 105.235 171.57 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.5 17.73 9.03 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 127.524 3.535 . . . . 1.67 116.826 176.619 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.32 -7.55 54.31 Favored Glycine 0 N--CA 1.43 -1.712 1 O-C-N 114.323 -5.236 . . . . 1.3 111.527 -178.388 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -104.4 133.32 49.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.229 -1.748 . . . . 2.89 108.463 -175.801 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -74.42 125.64 28.97 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 112.901 -1.954 . . . . 2.89 111.372 169.033 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.1 mt -83.76 152.21 24.79 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 125.078 1.486 . . . . 1.34 108.719 -172.323 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -94.93 135.39 36.51 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 123.28 1.514 . . . . 1.94 111.073 176.074 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -54.59 -53.88 48.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 111.612 -2.54 . . . . 1.56 114.94 -171.801 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.38 63.17 2.72 Favored Glycine 0 N--CA 1.429 -1.803 0 O-C-N 119.297 -2.127 . . . . 0.97 114.554 169.347 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -133.99 158.56 43.2 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 100.794 -3.78 . . . . 3.07 100.794 161.169 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.8 p -88.41 171.01 10.44 Favored 'General case' 0 N--CA 1.43 -1.439 1 CA-C-O 129.288 4.375 . . . . 1.34 110.115 176.694 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.32 -36.78 71.71 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 112.07 -6.643 . . . . 1.63 111.467 175.597 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.4 t -51.59 -35.07 39.95 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 129.158 2.983 . . . . 1.51 113.89 179.432 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -62.75 -30.36 71.38 Favored 'General case' 0 N--CA 1.43 -1.455 1 C-N-CA 132.855 4.462 . . . . 1.9 110.384 174.332 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -99.68 167.94 10.25 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.946 -2.346 . . . . 0.97 110.264 179.772 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -89.39 62.81 6.17 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 118.982 -2.324 . . . . 2.35 110.356 -179.829 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.8 mm -80.82 128.61 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 124.454 1.102 . . . . 1.39 108.283 177.858 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -100.17 -119.49 0.16 Allowed 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.49 2.404 . . . . 2.58 117.49 -169.941 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -100.39 -59.55 1.69 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.983 0.897 . . . . 2.58 111.192 177.703 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.42 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 9.1 pt-20 -130.32 75.23 1.64 Allowed 'General case' 0 N--CA 1.429 -1.523 0 O-C-N 118.321 -2.737 . . . . 1.71 107.684 177.278 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.0 m -91.47 142.6 27.49 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.907 -2.995 . . . . 1.34 109.573 -167.336 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.0 m -98.4 126.95 44.12 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.67 1.7 . . . . 1.36 107.118 178.871 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.461 HD22 HD11 ' A' ' 3' ' ' ILE . 9.9 mp -110.15 166.18 11.16 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.659 -1.901 . . . . 2.03 107.088 176.157 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.462 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 98.4 m-70 -124.07 127.89 48.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.68 -3.762 . . . . 2.31 112.212 -170.109 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.0 tp -103.67 116.91 33.21 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 127.053 2.721 . . . . 1.72 113.022 -178.454 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.7 128.05 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 N-CA-C 105.329 -2.101 . . . . 1.8 105.329 178.351 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.7 mt -97.86 123.0 41.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 124.2 0.937 . . . . 3.26 111.607 174.911 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -89.25 114.01 25.32 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.636 2.375 . . . . 4.12 107.029 175.445 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.6 mt -93.09 137.9 32.03 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.945 -4.222 . . . . 3.54 108.62 171.735 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.269 48.9 mtp85 -73.25 140.83 47.14 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.853 -1.521 . . . . 7.32 110.565 168.051 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.73 -74.14 0.23 Allowed Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 105.711 -2.956 . . . . 3.73 105.711 -168.756 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.794 0 C-N-CA 127.594 2.521 . . . . 3.87 114.799 179.201 . . . . . . . . 0 0 . 1 . 098 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 ttp . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 120.56 0.219 . . . . 1.39 111.2 . . . . . . . . . 0 0 . 1 . 098 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -98.99 114.44 27.09 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.9 -2.259 . . . . 2.2 104.9 -170.069 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 pt -117.83 153.97 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 113.047 -1.888 . . . . 1.32 108.712 -179.722 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -118.88 113.53 21.2 Favored 'General case' 0 N--CA 1.43 -1.44 1 C-N-CA 132.556 4.342 . . . . 2.2 109.521 -175.93 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -104.23 121.49 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 100.812 -3.773 . . . . 1.23 100.812 177.364 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt -99.54 135.77 40.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.353 2.661 . . . . 2.51 110.878 177.511 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -92.64 -176.62 4.32 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.97 1.708 . . . . 1.41 112.125 173.229 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.5 mt -95.16 -11.72 27.64 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.953 2.101 . . . . 2.95 111.227 168.955 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.3 p -82.92 -46.41 12.99 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.368 2.032 . . . . 2.52 114.534 179.658 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.31 -13.5 0.29 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 117.546 -3.221 . . . . 1.5 111.141 170.976 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -86.82 128.26 35.03 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 119.902 1.851 . . . . 1.79 113.047 -165.654 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -92.52 115.64 28.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.834 -3.041 . . . . 1.38 108.353 175.037 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mt -99.08 117.25 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 1 O-C-N 115.967 -4.208 . . . . 2.03 109.455 -179.342 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.0 m -98.07 124.38 42.56 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.406 2.527 . . . . 1.61 108.459 -178.359 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.4 mt -118.99 138.33 52.89 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.348 1.61 . . . . 2.15 115.348 -179.968 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -103.46 102.37 12.28 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.69 -3.131 . . . . 1.98 109.927 175.219 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.9 m -114.75 170.78 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 128.421 2.688 . . . . 1.52 108.458 -175.296 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -118.18 157.48 48.82 Favored Pre-proline 0 N--CA 1.43 -1.459 0 O-C-N 118.393 -2.692 . . . . 2.35 107.521 163.775 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.429 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -62.7 -20.86 72.17 Favored 'Trans proline' 0 C--N 1.299 -2.055 0 C-N-CA 124.044 3.163 . . . . 1.31 115.508 -171.605 . . . . . . . . 3 3 . 1 . 098 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 m -80.91 0.93 33.1 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 118.076 2.621 . . . . 1.71 118.076 173.862 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -87.43 163.91 16.48 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 102.457 -3.164 . . . . 1.69 102.457 175.624 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.2 p -90.8 -175.26 4.32 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.132 2.396 . . . . 1.33 114.006 176.142 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.4 mm -82.63 -36.41 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 O-C-N 116.893 -3.629 . . . . 1.32 106.61 178.917 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -50.97 -45.86 61.07 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.169 2.187 . . . . 1.62 112.478 167.168 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -64.27 -38.73 92.07 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.336 2.654 . . . . 2.13 107.202 175.787 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.8 t -59.27 -48.04 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 124.264 3.211 . . . . 1.23 114.364 176.805 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.262 37.8 mtmt -64.64 -41.73 95.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.46 1.504 . . . . 1.97 112.049 174.162 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.08 -32.38 72.91 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 117.067 2.247 . . . . 1.19 117.067 176.952 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -76.46 -36.54 57.85 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 125.092 1.495 . . . . 1.92 111.694 175.437 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.2 mt -71.9 -31.29 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 116.666 -3.772 . . . . 1.94 110.089 175.557 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -59.28 -59.1 6.0 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 113.579 -3.105 . . . . 1.9 107.74 169.985 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -50.16 -52.51 34.72 Favored 'General case' 0 N--CA 1.43 -1.432 1 CA-C-N 127.925 4.875 . . . . 1.55 111.79 166.418 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -61.66 -48.48 80.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.033 -2.917 . . . . 2.95 117.61 -167.952 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.418 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 6.6 tp10 -112.59 -52.04 2.8 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 118.909 -1.116 . . . . 1.48 113.308 -168.317 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.21 36.25 0.43 Allowed Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 126.382 1.944 . . . . 1.12 114.305 178.934 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.8 mt -117.92 116.7 36.02 Favored Pre-proline 0 N--CA 1.429 -1.489 0 O-C-N 118.237 -2.919 . . . . 2.07 105.692 -171.239 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -59.93 154.0 53.51 Favored 'Trans proline' 0 C--N 1.299 -2.051 2 C-N-CA 126.67 4.913 . . . . 1.39 114.877 -179.954 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -73.36 -17.76 23.76 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 C-N-CA 124.566 3.511 . . . . 1.68 113.294 -176.55 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -84.25 -16.55 42.79 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.168 2.587 . . . . 2.25 108.986 -178.814 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.329 14.8 tt0 -97.86 -24.44 15.42 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 126.076 2.11 . . . . 2.44 109.925 -177.017 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -88.07 125.0 34.34 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 113.72 1.007 . . . . 1.32 113.72 -175.761 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -110.07 124.53 51.65 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.055 -0.72 . . . . 3.19 109.055 172.806 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.3 mt -107.84 114.83 29.04 Favored 'General case' 0 N--CA 1.429 -1.516 0 O-C-N 118.933 -2.354 . . . . 1.75 110.748 -173.102 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.7 mm -91.85 124.94 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 114.949 -1.023 . . . . 1.98 109.673 177.107 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -114.15 111.28 21.33 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.072 -1.085 . . . . 1.94 108.072 163.89 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.498 . . 68.01 -44.11 0.49 Allowed 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 127.039 3.305 . . . . 1.67 118.642 174.33 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.67 -47.66 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.738 0 O-C-N 116.798 -3.689 . . . . 1.3 108.246 -172.659 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -75.34 156.59 35.36 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 124.676 2.179 . . . . 2.89 112.319 179.612 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -104.82 135.48 46.11 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.173 -2.204 . . . . 2.89 105.718 169.131 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.8 mt -96.1 143.59 27.1 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.748 -1.845 . . . . 1.34 110.395 -169.675 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -83.67 147.44 27.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 113.312 -1.767 . . . . 1.94 115.303 172.449 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.61 -63.83 1.16 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 130.909 3.684 . . . . 1.56 113.216 -165.857 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.81 36.71 2.83 Favored Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 119.785 2.674 . . . . 0.97 119.785 171.637 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -102.73 152.43 21.24 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 120.999 0.428 . . . . 3.07 111.221 161.463 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.1 p -83.67 173.27 11.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 124.781 2.229 . . . . 1.34 109.219 171.677 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.429 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 1.2 mm? -72.7 -38.27 67.58 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.955 -2.966 . . . . 1.63 106.937 172.412 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.34 59.8 p -60.87 -24.76 66.18 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.528 1.931 . . . . 1.51 115.356 178.564 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.386 4.7 t0 -62.18 -38.4 88.91 Favored 'General case' 0 N--CA 1.429 -1.524 1 CA-C-O 129.017 4.246 . . . . 1.9 114.838 172.057 . . . . . . . . 3 2 . 1 . 098 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -97.83 171.12 8.51 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 110.894 -2.867 . . . . 0.97 111.125 -179.367 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -89.68 43.16 1.13 Allowed 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.373 -2.704 . . . . 2.35 116.325 -175.136 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.3 mm -71.59 124.73 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 118.47 2.767 . . . . 1.39 118.47 -179.371 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -85.28 173.76 10.11 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 125.014 2.34 . . . . 2.58 109.125 -177.42 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.47 -48.83 77.91 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.497 -3.252 . . . . 2.58 115.568 173.858 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.06 64.09 0.93 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.445 -3.285 . . . . 1.71 111.964 175.365 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.5 m -87.39 141.65 28.47 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 117.896 2.554 . . . . 1.34 117.896 178.551 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.1 m -102.02 122.47 44.14 Favored 'General case' 0 N--CA 1.431 -1.409 1 CA-C-N 108.097 -4.138 . . . . 1.36 105.032 176.536 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -112.88 154.72 25.89 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 101.84 -3.392 . . . . 2.03 101.84 177.218 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -126.22 117.32 22.84 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.111 -2.243 . . . . 2.31 111.594 -175.534 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.251 3.9 tt -86.38 115.57 23.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 127.252 2.221 . . . . 1.72 108.946 -179.561 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.9 t -101.56 157.41 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 1 C-N-CA 133.523 4.729 . . . . 1.8 105.346 172.087 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.6 mt -121.98 161.82 22.22 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.659 -1.275 . . . . 3.26 108.199 173.676 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -135.63 167.93 20.2 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 115.967 -1.968 . . . . 4.12 107.346 -175.199 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.2 mt -107.78 145.47 33.51 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 121.277 1.853 . . . . 3.54 112.052 175.857 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -84.81 147.14 26.99 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.97 1.841 . . . . 7.32 115.97 174.786 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.82 57.21 0.87 Allowed Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 105.354 -3.098 . . . . 3.73 105.354 -163.815 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.729 0 C-N-CA 128.728 3.061 . . . . 3.87 114.282 177.328 . . . . . . . . 0 0 . 1 . 099 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttp . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 114.076 1.139 . . . . 1.39 114.076 . . . . . . . . . 0 0 . 1 . 099 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -96.95 104.3 16.3 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 114.976 -2.44 . . . . 2.2 109.313 -172.636 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.421 HG12 HG23 ' A' ' 17' ' ' VAL . 13.4 pt -95.47 165.39 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 127.459 2.975 . . . . 1.32 111.977 174.94 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -117.5 136.3 53.33 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.359 1.464 . . . . 2.2 112.742 176.618 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.6 t -116.19 98.58 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 131.246 3.818 . . . . 1.23 111.123 177.21 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -84.53 134.46 34.42 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 119.168 0.895 . . . . 2.51 112.935 179.396 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -83.5 -174.86 5.53 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.809 -1.087 . . . . 1.41 110.95 176.864 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.7 tp -81.75 -41.54 21.08 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.609 1.195 . . . . 2.95 112.758 171.01 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.9 p -74.39 -21.78 59.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.769 2.137 . . . . 2.52 116.769 -177.452 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.45 -0.01 1.03 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 118.415 2.126 . . . . 1.5 118.415 166.62 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.8 tttp -91.24 126.4 36.31 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.132 -1.805 . . . . 1.79 114.303 -172.957 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.5 m -95.37 109.78 21.9 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 121.398 -0.814 . . . . 1.38 110.454 176.197 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.1 mt -89.85 137.29 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 113.162 -3.304 . . . . 2.03 102.324 -174.884 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 m -110.17 129.62 55.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 126.598 2.436 . . . . 1.61 105.397 -174.508 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.2 mt -133.33 125.76 29.91 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.02 -2.3 . . . . 2.15 105.081 -171.596 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -85.74 113.61 22.06 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.433 -3.292 . . . . 1.98 107.875 173.48 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.421 HG23 HG12 ' A' ' 3' ' ' ILE . 1.9 m -123.01 172.34 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 128.031 2.532 . . . . 1.52 111.741 176.447 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -126.01 156.71 71.35 Favored Pre-proline 0 N--CA 1.431 -1.42 0 C-N-CA 124.493 1.117 . . . . 2.35 109.315 164.153 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -64.17 -8.35 16.21 Favored 'Trans proline' 0 N--CA 1.433 -2.038 0 CA-C-N 126.678 3.421 . . . . 1.31 116.551 -174.761 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 p -93.77 -1.93 54.37 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.179 1.809 . . . . 1.71 111.966 178.635 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -73.38 156.0 38.78 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.519 -1.988 . . . . 1.69 110.672 172.569 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.3 p -95.63 173.47 7.47 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 114.842 1.423 . . . . 1.33 114.842 176.872 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.9 mm -67.05 -44.79 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 116.307 -1.806 . . . . 1.32 108.479 169.418 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -52.12 -33.54 40.3 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 117.287 2.328 . . . . 1.62 117.287 169.285 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -66.79 -42.72 85.55 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.868 -3.645 . . . . 2.13 113.186 174.463 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 t -53.32 -47.88 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 115.328 1.603 . . . . 1.23 115.328 171.303 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -65.73 -31.16 72.0 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 126.578 2.423 . . . . 1.97 114.734 176.217 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -43.47 98.75 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 120.96 1.709 . . . . 1.19 110.775 176.793 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -57.03 -38.12 72.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.978 1.844 . . . . 1.92 115.978 172.2 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.5 mt -69.75 -34.35 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 113.911 1.078 . . . . 1.94 113.911 168.555 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -69.07 -34.02 74.49 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 130.14 3.376 . . . . 1.9 115.388 174.905 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.351 36.8 t70 -71.19 -41.92 69.68 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 123.977 0.911 . . . . 1.55 113.043 166.509 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -81.12 -44.94 17.19 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 117.527 2.417 . . . . 2.95 117.527 -176.557 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -109.42 -46.84 3.48 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.502 -1.295 . . . . 1.48 107.502 -165.273 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.89 36.13 2.25 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 119.055 2.382 . . . . 1.12 119.055 173.271 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.468 HD13 HD23 ' A' ' 71' ' ' LEU . 9.9 mt -111.18 136.76 20.86 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-O 116.687 -1.625 . . . . 2.07 109.981 -177.575 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -70.85 160.58 48.92 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 CA-C-N 125.08 2.85 . . . . 1.39 112.48 -175.379 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.82 -19.84 52.53 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 N-CA-C 118.1 2.308 . . . . 1.68 118.1 178.535 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -62.55 -37.48 86.32 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 119.702 3.223 . . . . 2.25 119.702 171.545 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.34 18.4 mm100 -80.23 -29.76 38.5 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 108.666 -3.879 . . . . 2.44 111.763 -173.21 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -81.8 133.15 35.31 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.064 -1.425 . . . . 1.32 108.484 -175.181 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.407 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 91.7 mtt180 -123.86 110.92 15.47 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 106.325 -1.731 . . . . 3.19 106.325 175.046 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.8 mt -99.96 118.0 35.43 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.699 2.666 . . . . 1.75 105.556 -179.008 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.8 mm -109.75 116.05 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 104.152 -2.536 . . . . 1.98 104.152 -173.244 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -121.83 110.11 15.49 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.849 -2.278 . . . . 1.94 104.849 176.147 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.27 30.87 4.11 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.627 3.171 . . . . 1.67 110.658 175.951 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.71 -33.74 5.33 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 119.867 1.212 . . . . 1.3 112.396 -175.046 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -78.29 132.94 37.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.232 1.813 . . . . 2.89 108.83 -177.972 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -91.44 122.02 33.66 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.424 2.059 . . . . 2.89 109.409 170.992 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.2 mt -70.23 136.08 49.61 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 129.553 3.141 . . . . 1.34 113.691 -174.911 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -77.88 148.42 34.62 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.202 -1.561 . . . . 1.94 114.922 174.973 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -62.95 -63.13 1.3 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.14 -2.225 . . . . 1.56 116.94 -171.943 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.5 42.7 0.24 Allowed Glycine 0 N--CA 1.43 -1.729 1 N-CA-C 123.859 4.303 . . . . 0.97 123.859 167.554 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -117.12 164.43 14.77 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 114.238 -2.791 . . . . 3.07 111.14 168.453 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.0 p -96.39 169.64 9.78 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 122.64 2.473 . . . . 1.34 110.769 169.803 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.2 mt -75.88 -23.47 55.6 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.596 -2.565 . . . . 1.63 112.976 174.916 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.4 t -71.53 -29.59 64.95 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.859 2.17 . . . . 1.51 116.859 178.709 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -58.61 -49.29 78.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 131.434 3.893 . . . . 1.9 110.991 174.236 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -80.44 164.16 23.26 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 125.664 2.65 . . . . 0.97 105.833 -177.961 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -90.92 58.18 3.72 Favored 'General case' 0 N--CA 1.43 -1.473 1 O-C-N 114.139 -5.351 . . . . 2.35 113.484 -175.877 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.4 mm -93.24 143.64 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.521 -1.218 . . . . 1.39 109.702 179.878 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -96.63 -102.65 0.17 Allowed 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.41 1.084 . . . . 2.58 108.846 -174.343 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -131.04 -73.85 0.54 Allowed 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 113.67 0.989 . . . . 2.58 113.67 -179.995 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -98.9 52.09 0.97 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.139 1.447 . . . . 1.71 111.418 177.352 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -83.46 149.3 26.73 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 128.407 2.683 . . . . 1.34 111.388 -169.561 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.7 m -101.56 122.94 44.77 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.532 -1.667 . . . . 1.36 111.79 -174.818 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -111.0 156.43 21.26 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 103.749 -2.686 . . . . 2.03 103.749 176.705 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -125.1 129.38 50.08 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 125.656 2.645 . . . . 2.31 108.213 -172.29 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.3 tp -98.62 114.16 26.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.769 -2.457 . . . . 1.72 111.52 179.909 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 71.2 t -105.71 135.67 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 C-N-CA 127.48 2.312 . . . . 1.8 105.241 174.732 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.468 HD23 HD13 ' A' ' 36' ' ' ILE . 81.5 mt -97.59 140.95 31.24 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.465 -3.272 . . . . 3.26 112.193 175.645 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -77.44 163.73 26.1 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.55 1.94 . . . . 4.12 111.297 176.325 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 46.1 tp -70.06 119.5 14.36 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 117.876 -3.015 . . . . 3.54 110.182 179.711 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -64.6 153.75 38.35 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.748 3.619 . . . . 7.32 114.814 168.172 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.41 -65.43 0.34 Allowed Glycine 0 N--CA 1.43 -1.72 0 O-C-N 120.035 -1.666 . . . . 3.73 111.8 -165.793 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.742 0 C-N-CA 126.273 1.892 . . . . 3.87 112.693 -176.698 . . . . . . . . 0 0 . 1 . 100 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 CA--C 1.49 -1.355 0 N-CA-C 112.965 0.728 . . . . 1.39 112.965 . . . . . . . . . 0 0 . 1 . 100 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.86 134.69 36.92 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 122.793 1.283 . . . . 2.2 108.836 174.576 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.6 pt -125.76 157.51 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 105.965 -1.865 . . . . 1.32 105.965 164.023 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.45 ' HB3' ' CG2' ' A' ' 12' ' ' THR . 55.9 m-85 -113.72 114.66 26.68 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 125.661 2.648 . . . . 2.2 109.969 -178.612 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.4 t -97.45 106.06 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 113.548 -1.66 . . . . 1.23 111.568 177.303 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.278 85.9 mttt -91.77 122.72 34.58 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 116.92 -3.612 . . . . 2.51 112.044 -177.261 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.1 p -89.81 168.42 12.09 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.036 -2.915 . . . . 1.41 111.641 -179.031 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.8 mt -75.16 -36.55 61.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.957 -2.965 . . . . 2.95 114.3 176.44 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -74.83 -22.98 58.39 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 127.392 2.277 . . . . 2.52 112.416 -177.91 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.46 54.68 0.33 Allowed Glycine 0 N--CA 1.43 -1.757 0 O-C-N 119.528 -1.983 . . . . 1.5 116.191 171.709 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -141.46 140.34 33.55 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.413 -2.227 . . . . 1.79 112.642 169.689 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.45 ' CG2' ' HB3' ' A' ' 4' ' ' PHE . 32.4 m -95.8 105.37 17.37 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 111.767 -2.469 . . . . 1.38 105.294 174.438 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 80.2 mt -89.51 123.2 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.776 -2.453 . . . . 2.03 106.281 -178.025 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -95.44 122.98 38.74 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.191 1.472 . . . . 1.61 110.574 177.095 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.269 62.3 mt -111.86 142.53 44.13 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 128.943 2.897 . . . . 2.15 113.327 -175.074 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -98.75 103.72 15.7 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.163 1.459 . . . . 1.98 108.085 169.426 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.6 172.03 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 117.823 -1.551 . . . . 1.52 111.699 176.354 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -123.2 157.47 60.95 Favored Pre-proline 0 N--CA 1.43 -1.465 0 O-C-N 119.122 -2.236 . . . . 2.35 108.81 165.58 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.75 -7.74 17.7 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 CA-C-N 127.068 3.56 . . . . 1.31 112.998 -171.175 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.5 m -78.58 -25.07 45.2 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 127.303 2.877 . . . . 1.71 108.628 176.91 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -70.3 163.37 26.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.906 2.765 . . . . 1.69 111.528 -175.129 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.3 p -98.22 165.04 12.07 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.912 -1.742 . . . . 1.33 109.553 -177.034 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.8 mm -66.59 -32.24 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 126.965 2.106 . . . . 1.32 114.26 172.163 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -52.81 -35.19 56.55 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 130.986 3.714 . . . . 1.62 113.113 163.347 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -80.92 -28.3 35.86 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.555 -1.966 . . . . 2.13 113.522 176.874 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.2 t -67.92 -51.27 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 104.217 -2.512 . . . . 1.23 104.217 178.982 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -64.44 -28.76 69.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 116.66 -3.775 . . . . 1.97 113.215 179.739 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.11 -29.19 66.08 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 121.187 1.812 . . . . 1.19 114.704 175.01 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.06 -30.58 63.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.441 -1.412 . . . . 1.92 114.371 172.313 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.2 mt -65.95 -36.89 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 118.559 -2.588 . . . . 1.94 113.897 167.283 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -58.16 -47.39 83.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.014 2.926 . . . . 1.9 111.457 172.782 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -60.29 -57.14 14.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 118.906 2.928 . . . . 1.55 118.906 165.827 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -66.51 -56.82 9.07 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 128.398 3.952 . . . . 2.95 116.046 -175.912 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -96.17 -44.65 7.19 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.788 -3.695 . . . . 1.48 114.715 -170.378 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.03 32.05 2.31 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 117.44 -1.755 . . . . 1.12 113.824 176.575 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.5 mm -108.55 143.81 28.27 Favored Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 101.824 -3.399 . . . . 2.07 101.824 -174.088 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -73.11 154.47 52.27 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 N-CA-C 116.239 1.592 . . . . 1.39 116.239 174.552 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -78.29 -28.49 4.61 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 CA-C-N 120.644 1.266 . . . . 1.68 112.379 -173.766 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -59.83 -35.29 74.42 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.426 1.891 . . . . 2.25 113.404 173.535 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -81.34 -33.85 32.19 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 116.507 -3.871 . . . . 2.44 111.257 179.349 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.297 71.8 mt-30 -74.66 130.95 40.45 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 116.424 -1.75 . . . . 1.32 111.855 -175.832 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -115.62 125.1 52.49 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 121.703 2.047 . . . . 3.19 110.94 163.47 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.4 mt -99.8 127.36 45.95 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.317 -2.114 . . . . 1.75 110.766 179.169 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.9 mt -118.78 134.08 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 126.981 2.112 . . . . 1.98 108.551 -178.435 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.706 ' CD1' HD21 ' A' ' 67' ' ' LEU . 34.4 t80 -128.54 137.79 51.92 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.503 -2.406 . . . . 1.94 104.503 169.091 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 37.32 39.72 0.17 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 118.483 2.771 . . . . 1.67 118.483 -176.078 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.66 -18.0 32.28 Favored Glycine 0 N--CA 1.43 -1.713 0 N-CA-C 119.976 2.75 . . . . 1.3 119.976 -177.921 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -81.32 134.11 35.53 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.756 -2.026 . . . . 2.89 109.45 175.824 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -93.23 106.94 18.84 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 125.957 2.036 . . . . 2.89 108.848 179.182 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.4 mt -66.12 137.03 56.76 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 110.567 -3.015 . . . . 1.34 106.545 -168.542 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -84.36 159.87 20.77 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.645 2.641 . . . . 1.94 109.619 174.18 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -70.38 -55.77 8.28 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 116.383 -3.948 . . . . 1.56 114.086 -167.854 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.65 49.67 4.1 Favored Glycine 0 N--CA 1.431 -1.643 0 C-N-CA 126.348 1.928 . . . . 0.97 110.495 178.182 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 -124.47 158.74 32.12 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.773 -1.936 . . . . 3.07 105.773 164.357 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 p -89.47 163.02 15.43 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.996 1.48 . . . . 1.34 114.996 175.035 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.8 mt -66.6 -35.49 80.32 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.747 -3.095 . . . . 1.63 105.719 178.571 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 t -58.41 -34.33 70.65 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 118.367 2.729 . . . . 1.51 118.367 173.172 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -74.86 -37.41 62.21 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 113.48 -1.691 . . . . 1.9 110.286 -179.615 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -80.44 5.41 15.14 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.205 -1.56 . . . . 0.97 114.017 172.655 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.275 14.0 m-80 62.48 31.42 17.08 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.632 1.573 . . . . 2.35 113.047 179.755 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.9 mt -78.93 122.22 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 125.351 1.461 . . . . 1.39 112.32 179.904 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -96.06 177.23 5.81 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 110.402 -3.09 . . . . 2.58 114.958 -177.752 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -54.47 130.84 41.07 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 115.746 1.758 . . . . 2.58 115.746 171.229 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.361 77.5 mt-10 62.72 55.46 2.13 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.502 -1.999 . . . . 1.71 116.307 -178.046 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.3 m -104.02 151.46 23.2 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.127 2.394 . . . . 1.34 109.667 -175.173 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.0 m -102.84 113.65 27.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.085 -2.884 . . . . 1.36 105.394 177.946 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.706 HD21 ' CD1' ' A' ' 45' ' ' PHE . 31.9 mt -110.24 165.74 11.52 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 105.858 -1.904 . . . . 2.03 105.858 174.791 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -124.01 126.29 46.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.853 -1.78 . . . . 2.31 111.765 -173.732 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.0 tp -105.27 134.86 47.68 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 126.001 1.72 . . . . 1.72 111.759 -176.484 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.1 m -137.29 158.76 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 125.142 2.401 . . . . 1.8 105.007 176.131 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.1 mt -120.56 158.47 27.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.906 -2.996 . . . . 3.26 115.828 -177.207 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -89.27 138.14 31.7 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 123.644 1.688 . . . . 4.12 106.535 177.963 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.9 mt -97.08 -150.43 0.34 Allowed 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 127.687 2.395 . . . . 3.54 113.376 175.566 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -121.28 133.59 55.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 107.458 -1.312 . . . . 7.32 107.458 174.249 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.79 63.28 0.68 Allowed Glycine 0 N--CA 1.431 -1.7 0 O-C-N 120.509 -1.369 . . . . 3.73 110.054 -170.513 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.729 0 O-C-N 119.274 -2.309 . . . . 3.87 112.424 -178.412 . . . . . . . . 0 0 . 1 . 101 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.6 ptt? . . . . . 0 CA--C 1.49 -1.33 0 CA-C-O 119.657 -0.211 . . . . 1.39 110.758 . . . . . . . . . 0 0 . 1 . 101 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -88.44 149.78 23.5 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 117.153 -1.403 . . . . 2.2 110.42 177.222 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -140.12 144.6 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.971 -2.233 . . . . 1.32 104.971 175.131 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -103.81 139.17 39.39 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 112.629 -3.628 . . . . 2.2 109.519 177.877 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 67' ' ' LEU . 12.6 t -113.25 109.67 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 117.983 -2.948 . . . . 1.23 109.526 167.41 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -91.04 137.94 31.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.504 -2.623 . . . . 2.51 111.179 -178.208 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.438 HG22 HD23 ' A' ' 69' ' ' LEU 0.263 67.8 p -82.34 -175.41 5.68 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 124.787 2.232 . . . . 1.41 115.323 177.707 . . . . . . . . 3 3 . 1 . 101 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.1 mt -50.31 -55.93 13.4 Favored 'General case' 0 N--CA 1.43 -1.461 2 O-C-N 114.521 -5.112 . . . . 2.95 109.426 166.044 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.253 20.4 p -72.19 -31.09 65.57 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.533 -2.604 . . . . 2.52 110.383 -175.834 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.74 25.05 1.62 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 110.773 -0.931 . . . . 1.5 110.773 172.291 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -76.53 117.64 18.38 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.041 -3.035 . . . . 1.79 109.328 -179.976 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m -74.39 90.08 2.14 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.017 2.817 . . . . 1.38 113.42 175.694 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mt -83.07 125.73 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 117.249 -3.407 . . . . 2.03 108.456 -179.718 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.3 m -101.33 128.27 47.57 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 119.487 -2.008 . . . . 1.61 113.854 177.55 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mp -128.89 154.67 46.28 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 126.0 2.063 . . . . 2.15 105.557 -175.956 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -100.7 129.29 46.58 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.245 -1.761 . . . . 1.98 106.245 171.883 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -135.46 155.88 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 O-C-N 127.904 3.252 . . . . 1.52 107.566 179.821 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -106.33 153.67 40.27 Favored Pre-proline 0 N--CA 1.43 -1.474 0 N-CA-C 102.915 -2.995 . . . . 2.35 102.915 161.897 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -70.68 -12.11 30.66 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 115.255 -3.076 . . . . 1.31 116.683 -177.356 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.8 p -90.42 7.08 40.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 117.365 -1.303 . . . . 1.71 109.685 175.039 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -81.31 146.23 30.48 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.927 2.775 . . . . 1.69 109.855 174.189 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.52 159.49 18.61 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.737 -3.102 . . . . 1.33 111.833 -174.289 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.1 mm -59.07 -43.03 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 124.472 1.109 . . . . 1.32 113.067 175.336 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -39.91 -41.66 1.21 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.725 3.602 . . . . 1.62 120.725 161.084 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -79.38 -25.1 42.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 114.721 -2.561 . . . . 2.13 111.716 173.268 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -68.37 -45.92 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 122.856 2.571 . . . . 1.23 110.668 173.417 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -58.73 -38.37 78.24 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.435 1.642 . . . . 1.97 115.435 174.18 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.27 -37.77 72.89 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.301 -2.124 . . . . 1.19 114.598 173.671 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.8 mttm -60.98 -44.77 96.88 Favored 'General case' 0 N--CA 1.431 -1.392 1 C-N-CA 131.884 4.073 . . . . 1.92 111.325 175.463 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.7 mt -66.54 -44.8 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 126.641 3.115 . . . . 1.94 114.602 172.022 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -50.27 -44.41 53.69 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.158 -2.839 . . . . 1.9 114.977 166.899 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -60.61 -59.2 5.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 115.74 -2.076 . . . . 1.55 108.6 175.544 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -68.01 -47.21 69.09 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 116.607 2.077 . . . . 2.95 116.607 -172.917 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -99.7 -46.36 5.45 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.972 2.509 . . . . 1.48 109.902 -165.58 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.92 22.59 5.9 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 126.484 2.365 . . . . 1.12 114.532 175.014 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mt -97.46 119.82 62.05 Favored Pre-proline 0 N--CA 1.43 -1.44 0 C-N-CA 125.628 1.571 . . . . 2.07 114.355 -174.432 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.74 161.01 30.9 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 116.854 -1.631 . . . . 1.39 113.728 -173.672 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -62.81 -19.68 69.2 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 123.809 3.006 . . . . 1.68 118.546 -171.186 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -67.82 -27.77 67.0 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.078 2.151 . . . . 2.25 114.194 177.338 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -94.34 -38.4 11.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.742 2.017 . . . . 2.44 113.568 -173.062 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -102.17 135.94 42.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.582 2.611 . . . . 1.32 115.156 -170.566 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -121.8 143.53 49.34 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.08 -2.263 . . . . 3.19 111.147 170.813 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -110.62 130.84 55.47 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.21 2.433 . . . . 1.75 112.313 178.72 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.0 mm -109.34 138.66 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 110.581 -3.009 . . . . 1.98 106.537 178.828 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -120.77 107.0 12.22 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.995 2.918 . . . . 1.94 109.144 163.558 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.371 . . 69.29 -93.64 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.881 3.229 . . . . 1.67 113.685 179.987 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.61 8.62 6.17 Favored Glycine 0 N--CA 1.43 -1.746 0 O-C-N 116.959 -3.588 . . . . 1.3 111.693 -177.773 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -117.65 138.54 51.9 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 119.61 -2.112 . . . . 2.89 107.462 -177.796 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -76.77 111.16 11.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 112.609 -2.087 . . . . 2.89 113.073 164.812 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.5 mt -66.25 113.89 4.92 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 118.423 0.556 . . . . 1.34 111.565 -174.418 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -76.21 129.26 36.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 127.52 3.534 . . . . 1.94 113.03 176.462 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -43.9 -53.43 6.11 Favored 'General case' 0 N--CA 1.43 -1.433 2 N-CA-C 124.061 4.837 . . . . 1.56 124.061 -173.163 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.35 43.97 3.15 Favored Glycine 0 N--CA 1.429 -1.797 0 O-C-N 119.861 -1.774 . . . . 0.97 115.338 175.996 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.311 33.6 mmt180 -118.29 171.79 7.89 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.953 2.311 . . . . 3.07 112.07 159.655 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.7 p -93.37 174.14 7.36 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.497 -2.627 . . . . 1.34 117.748 163.682 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 56' ' ' LEU . 26.8 mt -67.16 -33.89 76.39 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 130.231 3.412 . . . . 1.63 114.845 165.057 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 t -65.43 -35.28 80.44 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.86 2.864 . . . . 1.51 114.288 173.315 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -68.41 -44.33 75.26 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 117.673 -1.156 . . . . 1.9 109.899 177.293 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -82.59 3.45 28.66 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 116.196 -1.859 . . . . 0.97 113.311 176.732 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.5 t30 58.27 50.61 9.45 Favored 'General case' 0 N--CA 1.43 -1.434 1 CA-C-O 129.264 4.364 . . . . 2.35 114.564 174.85 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.251 24.6 mt -105.1 115.48 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 C-N-CA 131.87 4.068 . . . . 1.39 108.59 177.641 . . . . . . . . 3 2 . 1 . 101 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -93.46 172.68 8.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 130.798 3.639 . . . . 2.58 112.167 -176.507 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -72.04 144.83 48.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 115.546 -2.462 . . . . 2.58 114.175 169.897 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.384 54.3 mt-10 72.06 23.42 3.45 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.759 1.266 . . . . 1.71 114.153 177.275 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.281 17.4 m -88.75 153.46 21.07 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.02 -2.585 . . . . 1.34 104.02 -172.424 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.5 m -103.12 115.05 29.85 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 125.818 2.723 . . . . 1.36 106.788 -178.819 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.417 ' HB2' HG23 ' A' ' 5' ' ' VAL . 8.1 mp -103.38 164.63 11.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 103.027 -2.953 . . . . 2.03 103.027 174.11 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -131.2 138.02 49.21 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.532 -1.355 . . . . 2.31 111.918 177.981 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.438 HD23 HG22 ' A' ' 7' ' ' THR . 14.1 tp -106.93 117.78 34.96 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 129.221 3.008 . . . . 1.72 108.195 -177.849 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.7 m -115.5 175.06 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 107.119 -1.437 . . . . 1.8 107.119 165.803 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pp -159.18 -179.04 7.64 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.914 -1.116 . . . . 3.26 109.412 -174.197 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -128.37 139.09 52.57 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 129.282 3.033 . . . . 4.12 103.901 173.37 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.5 mt -83.76 148.11 27.23 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 105.777 -1.934 . . . . 3.54 105.777 168.537 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -80.87 133.98 35.68 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.674 -1.891 . . . . 7.32 114.263 178.604 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.46 42.01 1.94 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 127.138 2.304 . . . . 3.73 113.032 -174.327 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.702 0 CA-C-N 120.553 2.176 . . . . 3.87 115.226 -177.782 . . . . . . . . 0 0 . 1 . 102 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.1 ttp . . . . . 0 CA--C 1.491 -1.318 1 CA-C-O 129.664 4.554 . . . . 1.39 110.065 . . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.271 20.5 tt0 -93.81 113.44 25.48 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 114.487 -5.133 . . . . 2.2 110.305 -176.17 . . . . . . . . 3 2 . 1 . 102 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.0 pt -119.93 168.18 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.735 1.731 . . . . 1.32 107.119 170.348 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -131.4 157.61 42.99 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 103.268 -2.864 . . . . 2.2 103.268 -178.838 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.6 t -133.12 128.34 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 101.818 -3.401 . . . . 1.23 101.818 -178.34 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -119.39 119.38 33.77 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 122.591 1.186 . . . . 2.51 108.549 178.98 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.9 p -77.5 174.98 10.26 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 121.654 3.946 . . . . 1.41 121.654 -174.74 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.407 HD13 ' H ' ' A' ' 71' ' ' LEU . 85.6 mt -52.02 -52.25 52.04 Favored 'General case' 0 N--CA 1.43 -1.443 1 CA-C-O 129.104 4.288 . . . . 2.95 115.218 169.082 . . . . . . . . 3 3 . 1 . 102 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -72.2 -25.15 61.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.172 -2.83 . . . . 2.52 115.469 -178.066 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.33 19.25 4.29 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 124.778 3.444 . . . . 1.5 111.386 169.303 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.45 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 72.5 tttt -89.57 143.02 27.14 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 104.801 -2.296 . . . . 1.79 104.801 -176.638 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -110.28 119.74 40.22 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.361 1.553 . . . . 1.38 109.942 173.119 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.2 mt -98.8 122.25 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 125.631 2.634 . . . . 2.03 109.812 176.033 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.3 m -91.3 121.69 33.27 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.483 -3.26 . . . . 1.61 108.621 -179.74 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mt -116.92 163.5 16.11 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.028 -1.842 . . . . 2.15 106.028 -173.527 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -121.44 104.57 9.78 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.334 1.453 . . . . 1.98 107.305 169.983 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.11 -174.13 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 103.912 -2.625 . . . . 1.52 103.912 179.528 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -138.2 155.24 74.32 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 103.004 -2.962 . . . . 2.35 103.004 165.709 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -62.25 -11.88 24.43 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 126.529 3.368 . . . . 1.31 117.382 -173.384 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.9 m -85.22 -0.14 53.69 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.874 1.67 . . . . 1.71 113.025 -175.564 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -84.23 144.04 29.19 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 126.095 2.122 . . . . 1.69 110.735 -179.588 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.4 p -83.71 164.1 19.84 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.02 -1.9 . . . . 1.33 110.339 178.159 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.2 mm -68.32 -35.33 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 O-C-N 120.025 -1.672 . . . . 1.32 110.699 -179.912 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -45.8 -49.31 15.25 Favored 'General case' 0 N--CA 1.43 -1.446 1 C-N-CA 133.446 4.699 . . . . 1.62 110.773 163.424 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -73.78 -41.65 62.11 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.153 -2.217 . . . . 2.13 110.746 -176.486 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.1 t -61.56 -37.19 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 116.713 2.116 . . . . 1.23 116.713 170.856 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -56.88 -36.58 70.26 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 118.127 2.64 . . . . 1.97 118.127 170.762 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.56 80.78 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 118.68 -2.512 . . . . 1.19 111.196 166.437 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -68.32 -29.65 68.45 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 115.04 -4.788 . . . . 1.92 115.59 170.323 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.307 56.7 mt -70.09 -30.24 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-O 123.672 1.701 . . . . 1.94 106.816 175.281 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -69.34 -37.52 77.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.245 -1.534 . . . . 1.9 109.173 179.257 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -67.89 -54.63 17.32 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 126.876 2.61 . . . . 1.55 108.735 174.984 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -69.18 -54.63 13.82 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 118.579 -2.576 . . . . 2.95 111.833 -169.652 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.45 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 61.3 mm-40 -93.26 -59.54 2.0 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.157 -2.214 . . . . 1.48 112.31 -169.978 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.64 45.93 0.37 Allowed Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 107.03 -2.428 . . . . 1.12 107.03 176.444 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.4 mt -118.56 134.61 23.47 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 103.245 -2.872 . . . . 2.07 103.245 -176.662 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -75.12 152.05 39.73 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-O 114.939 -2.192 . . . . 1.39 116.354 -177.618 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -71.94 -14.3 29.33 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 CA-C-N 121.685 1.638 . . . . 1.68 115.769 -172.938 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.393 2.6 p30 -67.41 -48.64 66.72 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.959 1.704 . . . . 2.25 108.393 172.567 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -68.85 -16.74 63.86 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 116.35 -1.786 . . . . 2.44 113.574 -177.242 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -88.2 110.47 20.73 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 123.366 1.555 . . . . 1.32 108.347 -178.073 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -101.19 112.55 25.07 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.28 -2.118 . . . . 3.19 105.28 170.48 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.5 mt -107.79 128.56 54.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.091 -2.88 . . . . 1.75 111.647 -178.203 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 mt -107.74 136.7 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 1 C-N-CA 135.187 5.395 . . . . 1.98 105.752 -177.892 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.329 73.3 t80 -149.22 114.62 5.54 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 127.753 2.421 . . . . 1.94 105.42 173.624 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.59 30.45 15.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.863 2.465 . . . . 1.67 116.615 -178.839 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.67 -9.08 53.04 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-O 114.689 -3.284 . . . . 1.3 112.266 -176.385 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -92.11 134.3 34.97 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 115.692 -2.403 . . . . 2.89 114.305 167.868 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -86.93 123.58 32.21 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 118.956 -2.34 . . . . 2.89 109.174 173.473 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.8 mt -78.8 154.85 29.57 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.115 -2.241 . . . . 1.34 111.759 -159.29 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -91.47 150.66 21.13 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.43 -2.044 . . . . 1.94 110.468 173.898 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -71.99 -41.14 67.98 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 121.667 2.031 . . . . 1.56 115.481 -173.086 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.66 45.31 3.42 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 121.726 3.45 . . . . 0.97 121.726 170.291 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 mmt-85 -122.78 143.99 49.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 128.207 3.86 . . . . 3.07 101.473 168.748 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.312 80.8 p -82.63 167.08 18.62 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.257 -4.027 . . . . 1.34 114.591 168.543 . . . . . . . . 3 2 . 1 . 102 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -57.58 -46.68 83.69 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 126.955 2.102 . . . . 1.63 108.956 172.496 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.255 10.6 t -56.4 -38.61 71.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 130.131 3.372 . . . . 1.51 114.805 178.22 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -63.78 -61.72 2.11 Favored 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.411 -4.556 . . . . 1.9 115.172 172.766 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -64.55 -4.05 3.7 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.707 -1.87 . . . . 0.97 116.009 170.924 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.276 73.9 m-80 66.36 39.31 4.06 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.977 -2.952 . . . . 2.35 112.65 -175.701 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.0 mt -87.05 103.17 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.558 -2.589 . . . . 1.39 104.396 175.266 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -100.15 -172.42 2.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.306 1.842 . . . . 2.58 110.093 -172.454 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -58.99 140.31 55.84 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 127.613 3.578 . . . . 2.58 112.271 177.369 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 65.51 36.8 6.41 Favored 'General case' 0 N--CA 1.43 -1.438 1 C-N-CA 132.124 4.169 . . . . 1.71 112.089 175.75 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 m -88.22 159.64 18.06 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 114.473 -2.679 . . . . 1.34 111.435 -170.969 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.5 m -111.32 113.49 26.0 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 123.921 3.055 . . . . 1.36 108.645 172.887 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.3 mt -88.66 134.48 33.88 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 115.638 -2.425 . . . . 2.03 107.314 167.013 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -101.1 112.84 25.41 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.293 -3.38 . . . . 2.31 108.446 -171.952 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.4 tp -92.69 117.87 30.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.894 3.277 . . . . 1.72 119.564 -173.75 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.89 124.65 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 102.384 -3.191 . . . . 1.8 102.384 172.941 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.407 ' H ' HD13 ' A' ' 8' ' ' LEU . 19.7 tp -87.71 128.06 35.3 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 116.882 -3.636 . . . . 3.26 109.012 171.51 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -78.81 94.26 5.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.887 -2.383 . . . . 4.12 108.632 174.543 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.442 HD22 ' H ' ' A' ' 73' ' ' LEU . 2.6 pt? -80.04 -176.64 5.62 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 127.219 2.824 . . . . 3.54 107.937 173.397 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -117.1 142.84 46.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.433 2.293 . . . . 7.32 114.998 166.235 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.35 41.86 44.03 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 120.428 -1.42 . . . . 3.73 113.424 -173.633 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.797 0 CA-C-O 113.868 -3.74 . . . . 3.87 108.55 -177.82 . . . . . . . . 0 0 . 1 . 103 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 ptt? . . . . . 0 CA--C 1.491 -1.313 0 N-CA-C 119.601 3.185 . . . . 1.39 119.601 . . . . . . . . . 0 0 . 1 . 103 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -95.98 139.14 32.6 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.096 -2.253 . . . . 2.2 106.889 -174.616 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.0 pt -143.03 150.35 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 122.541 2.428 . . . . 1.32 109.983 169.654 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -108.77 134.02 52.04 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.4 -1.333 . . . . 2.2 107.4 -172.08 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -120.43 122.66 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 116.08 1.882 . . . . 1.23 116.08 166.553 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -94.33 130.1 40.76 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.978 2.511 . . . . 2.51 113.365 -176.013 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.6 p -97.14 153.28 18.07 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.958 -3.589 . . . . 1.41 107.853 -178.57 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.6 mt -61.91 -23.44 66.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 130.978 3.711 . . . . 2.95 112.841 174.095 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.8 p -77.78 -52.4 8.99 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 120.001 1.273 . . . . 2.52 113.754 178.872 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.05 11.51 0.03 OUTLIER Glycine 0 N--CA 1.429 -1.785 0 O-C-N 120.633 -1.292 . . . . 1.5 114.802 169.921 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -107.29 147.83 29.75 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 117.456 -3.379 . . . . 1.79 114.707 -173.276 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.7 m -112.69 116.96 30.96 Favored 'General case' 0 N--CA 1.43 -1.469 1 O-C-N 115.453 -4.529 . . . . 1.38 108.573 173.383 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mt -86.22 128.36 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 128.983 2.913 . . . . 2.03 105.93 -179.279 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.8 m -99.91 99.91 10.76 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.327 -3.358 . . . . 1.61 107.859 174.739 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.9 mt -97.09 145.39 26.03 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 115.973 -4.204 . . . . 2.15 109.721 177.219 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -97.2 132.14 43.26 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 125.32 2.486 . . . . 1.98 114.351 159.407 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.437 HG11 ' HE3' ' A' ' 29' ' ' LYS . 17.2 m -135.48 168.75 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 113.896 -1.502 . . . . 1.52 108.181 -176.148 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -116.08 152.27 47.55 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-O 116.147 -1.882 . . . . 2.35 106.539 166.914 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -76.33 -3.89 14.38 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-N 126.691 3.425 . . . . 1.31 112.999 -172.938 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -88.78 0.34 56.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 123.895 0.878 . . . . 1.71 111.988 173.525 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -82.07 147.33 29.17 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 125.042 1.337 . . . . 1.69 110.921 178.26 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 68.0 p -87.04 160.64 18.54 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.452 1.901 . . . . 1.33 112.349 -179.161 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.0 mm -75.99 -18.66 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 124.888 2.28 . . . . 1.32 114.441 -178.029 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.33 -44.58 94.5 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.37 -3.956 . . . . 1.62 111.298 158.407 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.307 18.3 m120 -50.82 -53.58 30.9 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 123.007 2.639 . . . . 2.13 114.18 169.054 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.293 2.4 t -50.46 -43.89 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 119.272 3.064 . . . . 1.23 119.272 171.758 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -74.54 -14.57 60.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.909 3.718 . . . . 1.97 114.515 174.245 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.262 . . -74.16 -34.35 63.8 Favored 'General case' 0 N--CA 1.431 -1.405 1 O-C-N 115.05 -4.781 . . . . 1.19 112.898 169.885 . . . . . . . . 3 2 . 1 . 103 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.437 ' HE3' HG11 ' A' ' 17' ' ' VAL . 67.4 mttm -64.09 -34.12 77.31 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.223 -1.353 . . . . 1.92 111.937 176.06 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.46 36.5 mt -68.86 -38.47 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.877 1.799 . . . . 1.94 110.584 177.158 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -64.81 -40.77 95.76 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.898 -2.376 . . . . 1.9 108.696 178.001 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -60.24 -40.85 91.68 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.684 1.735 . . . . 1.55 115.684 171.715 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -76.42 -67.68 0.67 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.886 -1.134 . . . . 2.95 112.748 -176.909 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -95.95 -45.1 7.07 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 116.645 -1.645 . . . . 1.48 111.027 -172.52 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.09 43.68 0.99 Allowed Glycine 0 N--CA 1.429 -1.78 0 CA-C-O 124.677 2.265 . . . . 1.12 117.237 174.852 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 mt -108.59 134.99 20.08 Favored Pre-proline 0 N--CA 1.43 -1.434 1 CA-C-O 111.536 -4.078 . . . . 2.07 102.736 -177.663 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -63.18 153.86 71.32 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 N-CA-C 120.024 3.048 . . . . 1.39 120.024 174.715 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -73.7 -24.75 15.44 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 CA-C-N 126.677 3.42 . . . . 1.68 113.014 -176.83 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.342 10.2 p-10 -65.86 -32.34 73.8 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 121.986 2.176 . . . . 2.25 111.951 170.528 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -73.84 -24.62 59.79 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.813 -2.429 . . . . 2.44 114.354 -179.174 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -92.11 145.59 24.39 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.929 -2.982 . . . . 1.32 110.225 -173.417 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.4 mtm180 -126.81 135.05 50.5 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 117.282 -1.342 . . . . 3.19 110.843 168.836 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.7 mt -103.42 124.99 49.75 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 123.715 2.962 . . . . 1.75 109.122 177.007 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.7 mm -114.88 120.48 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 104.749 -2.315 . . . . 1.98 104.749 177.908 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.493 ' HB3' HD23 ' A' ' 50' ' ' LEU . 35.7 t80 -130.02 136.28 49.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 129.277 3.031 . . . . 1.94 108.843 169.007 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.306 . . 54.6 31.58 15.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.278 1.584 . . . . 1.67 115.278 175.466 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.48 -20.82 6.83 Favored Glycine 0 N--CA 1.429 -1.805 0 O-C-N 119.176 -2.203 . . . . 1.3 115.438 -174.849 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.0 mttt -85.6 136.68 33.29 Favored 'General case' 0 N--CA 1.43 -1.468 2 C-N-CA 133.535 4.734 . . . . 2.89 110.802 -179.211 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -86.57 128.56 34.99 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.095 -1.866 . . . . 2.89 111.345 168.941 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.493 HD23 ' HB3' ' A' ' 45' ' ' PHE . 17.4 mt -83.76 127.24 33.66 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 104.927 -2.249 . . . . 1.34 104.927 -176.224 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -82.91 137.8 34.1 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.799 -3.063 . . . . 1.94 114.325 175.116 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -37.74 -72.8 0.05 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 131.087 3.755 . . . . 1.56 117.976 -177.676 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.86 51.79 4.6 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 120.696 3.038 . . . . 0.97 120.696 176.566 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.268 10.7 mmt180 -131.34 156.32 45.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.569 -3.313 . . . . 3.07 107.324 172.121 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.253 24.7 p -80.84 169.98 16.87 Favored 'General case' 0 N--CA 1.43 -1.442 2 O-C-N 114.123 -5.361 . . . . 1.34 116.647 176.733 . . . . . . . . 4 3 . 1 . 103 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mt -63.87 -49.47 72.61 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.596 1.958 . . . . 1.63 109.186 171.663 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 t -57.29 -40.33 77.57 Favored 'General case' 0 N--CA 1.432 -1.363 0 O-C-N 118.774 -2.454 . . . . 1.51 111.632 177.137 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.4 -29.97 17.59 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 116.414 2.005 . . . . 1.9 116.414 167.876 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -99.95 7.86 44.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.069 -2.269 . . . . 0.97 115.373 171.846 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.294 7.7 m120 52.17 57.77 6.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 126.576 2.422 . . . . 2.35 117.433 -171.144 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mt -96.57 131.08 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 120.045 -1.659 . . . . 1.39 110.635 -177.876 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -97.68 -171.78 2.25 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 127.023 2.129 . . . . 2.58 114.339 -169.189 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -81.98 143.48 31.57 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.25 -1.531 . . . . 2.58 114.622 175.349 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.254 32.3 mt-10 65.43 21.32 11.86 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.426 2.01 . . . . 1.71 116.426 178.461 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.4 t -85.2 150.22 24.96 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 125.682 1.593 . . . . 1.34 112.741 -174.427 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.311 8.8 m -106.07 115.63 30.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 121.599 1.999 . . . . 1.36 113.648 -176.771 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 mt -101.36 164.15 11.92 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.105 -2.554 . . . . 2.03 104.105 173.759 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.293 74.1 m80 -123.73 135.54 53.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.833 -3.042 . . . . 2.31 107.392 178.431 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 tp -97.5 132.41 43.21 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 112.293 -2.231 . . . . 1.72 111.323 178.381 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.9 m -143.65 161.26 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 103.707 -2.701 . . . . 1.8 103.707 176.659 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.6 mt -95.68 166.72 11.69 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.713 2.673 . . . . 3.26 112.846 -174.402 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -71.52 132.07 44.18 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 129.006 2.922 . . . . 4.12 110.853 177.099 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.3 mt -93.52 77.73 4.38 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 127.172 2.189 . . . . 3.54 109.451 171.54 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -91.95 -58.42 2.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.284 -1.376 . . . . 7.32 107.284 174.701 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.74 -91.51 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 127.623 2.535 . . . . 3.73 112.971 -175.193 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.262 1.861 0 C-N-CA 129.774 3.559 . . . . 3.87 112.044 178.529 . . . . . . . . 0 0 . 1 . 104 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 CA--C 1.491 -1.324 0 CA-C-O 117.582 -1.199 . . . . 1.39 111.118 . . . . . . . . . 0 0 . 1 . 104 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -103.51 143.29 32.92 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 120.119 1.327 . . . . 2.2 110.979 179.837 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.9 pt -131.31 168.46 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 116.635 -1.65 . . . . 1.32 109.28 176.657 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -122.17 137.81 54.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 120.927 1.694 . . . . 2.2 113.163 177.283 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.45 HG22 ' HB2' ' A' ' 67' ' ' LEU . 4.3 t -122.22 131.3 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-O 125.842 2.734 . . . . 1.23 118.172 165.706 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -89.21 123.25 33.27 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 112.152 -2.294 . . . . 2.51 108.676 177.932 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.0 p -80.05 177.18 9.12 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.444 1.592 . . . . 1.41 112.758 169.455 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.0 mt -66.0 -46.31 78.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.299 -2.75 . . . . 2.95 113.909 176.165 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -65.04 -68.57 0.35 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.08 1.352 . . . . 2.52 108.488 179.379 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.67 -6.24 0.03 OUTLIER Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 117.454 1.742 . . . . 1.5 117.454 -176.203 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -71.62 141.73 49.96 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.304 -1.704 . . . . 1.79 114.664 -175.573 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.3 m -108.27 104.57 13.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 127.915 3.722 . . . . 1.38 111.183 172.435 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.59 115.57 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 1 O-C-N 115.874 -4.266 . . . . 2.03 109.743 179.248 . . . . . . . . 3 3 . 1 . 104 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.5 m -91.48 119.22 31.25 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.124 -2.176 . . . . 1.61 105.124 177.719 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 mt -115.42 139.51 49.96 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 125.102 2.382 . . . . 2.15 110.592 -171.378 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -87.97 120.75 29.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.201 -2.187 . . . . 1.98 108.038 174.852 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.9 177.02 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 125.741 1.901 . . . . 1.52 114.095 179.397 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -129.14 148.0 67.26 Favored Pre-proline 0 N--CA 1.43 -1.465 3 CA-C-O 108.292 -5.623 . . . . 2.35 110.668 166.82 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -61.35 -24.39 78.55 Favored 'Trans proline' 0 N--CA 1.434 -2.004 1 CA-C-N 128.843 4.194 . . . . 1.31 115.22 -174.216 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.4 p -69.75 -10.78 59.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.837 2.455 . . . . 1.71 116.072 177.045 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.305 36.4 m-20 -78.75 147.55 33.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 128.044 3.783 . . . . 1.69 108.576 -178.878 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 p -82.82 165.79 19.53 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 114.514 -2.66 . . . . 1.33 115.913 174.55 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.2 mm -66.08 -20.03 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-N 122.071 2.214 . . . . 1.32 111.18 178.289 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -64.68 -39.38 93.58 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 117.522 2.416 . . . . 1.62 117.522 169.51 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -72.74 -33.05 66.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.416 3.008 . . . . 2.13 108.665 179.591 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.6 t -69.09 -48.28 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 112.289 -2.232 . . . . 1.23 112.844 176.86 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 52.6 mtmt -55.84 -30.82 62.06 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 119.558 3.17 . . . . 1.97 119.558 160.052 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -31.96 72.76 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 124.312 3.233 . . . . 1.19 113.132 172.419 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -70.12 -29.13 66.0 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.544 -3.222 . . . . 1.92 113.342 172.562 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.9 mt -73.09 -39.17 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 120.017 -1.677 . . . . 1.94 112.544 176.255 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -58.21 -35.38 71.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 114.435 -2.698 . . . . 1.9 109.425 171.854 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -66.3 -50.66 62.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 123.355 2.798 . . . . 1.55 117.176 170.797 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -59.75 -61.01 2.94 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 116.949 -3.595 . . . . 2.95 111.616 -172.333 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -101.47 -44.9 5.47 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.449 -1.705 . . . . 1.48 108.893 -168.795 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.01 57.05 1.17 Allowed Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 118.502 -1.808 . . . . 1.12 111.383 178.821 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.0 mt -122.49 125.13 26.57 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 112.381 -3.675 . . . . 2.07 104.637 -177.58 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -57.64 138.42 86.04 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 CA-C-N 129.358 4.378 . . . . 1.39 116.708 177.276 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -54.39 -27.67 50.0 Favored 'Trans proline' 0 C--N 1.299 -2.076 1 C-N-CA 127.208 5.272 . . . . 1.68 117.414 -178.329 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -69.89 -39.41 76.26 Favored 'General case' 0 N--CA 1.431 -1.422 1 CA-C-O 111.334 -4.174 . . . . 2.25 110.086 171.663 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -61.65 -31.33 71.43 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 124.176 3.171 . . . . 2.44 114.326 177.701 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.401 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 63.0 mt-30 -78.13 135.27 37.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 120.354 3.464 . . . . 1.32 120.354 -177.447 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -135.05 146.98 49.48 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 102.512 -3.144 . . . . 3.19 102.512 173.23 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.5 mt -113.0 137.05 52.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.76 -2.462 . . . . 1.75 110.173 179.17 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.7 mm -117.47 133.9 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 124.994 2.33 . . . . 1.98 108.209 -178.551 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.416 ' HB3' HD22 ' A' ' 50' ' ' LEU . 7.7 t80 -147.47 138.02 23.32 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.29 -3.381 . . . . 1.94 112.338 169.787 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.76 43.27 30.33 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.412 3.085 . . . . 1.67 115.166 -178.525 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.55 -23.66 15.2 Favored Glycine 0 N--CA 1.429 -1.781 0 O-C-N 118.06 -2.9 . . . . 1.3 116.801 -176.373 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -119.03 166.81 12.42 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.056 -3.026 . . . . 2.89 112.841 -171.791 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.345 33.3 tt0 -98.78 153.41 18.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.126 -0.943 . . . . 2.89 112.435 178.192 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.416 HD22 ' HB3' ' A' ' 45' ' ' PHE . 8.1 mt -110.56 126.58 54.57 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.675 1.59 . . . . 1.34 110.353 -173.302 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -73.73 141.63 46.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.19 2.596 . . . . 1.94 113.725 -178.1 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -46.98 -54.44 10.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 118.476 2.769 . . . . 1.56 118.476 -177.254 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.94 5.76 61.25 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 127.265 2.853 . . . . 0.97 120.088 172.893 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -87.92 154.33 20.6 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 120.092 1.946 . . . . 3.07 106.54 171.903 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.0 p -97.79 162.09 13.43 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.094 1.902 . . . . 1.34 115.79 172.038 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.38 -20.2 65.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.901 -2.999 . . . . 1.63 114.15 174.748 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.0 p -80.28 -31.86 38.26 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.541 3.137 . . . . 1.51 110.805 178.856 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.68 -46.22 39.26 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 112.834 -3.46 . . . . 1.9 111.799 175.483 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -76.52 -18.82 58.51 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 127.117 2.76 . . . . 0.97 110.654 178.095 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.7 t30 65.96 53.88 1.07 Allowed 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 127.073 2.149 . . . . 2.35 109.599 -176.264 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 mt -84.39 106.67 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 101.192 -3.633 . . . . 1.39 101.192 172.186 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -89.26 -174.43 4.4 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 122.248 2.295 . . . . 2.58 112.017 -178.713 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -60.53 137.55 58.15 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 123.638 1.685 . . . . 2.58 114.35 174.584 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 74.42 26.75 1.49 Allowed 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 131.492 3.917 . . . . 1.71 114.476 169.627 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.89 151.93 20.31 Favored 'General case' 0 N--CA 1.429 -1.491 1 C-N-CA 131.892 4.077 . . . . 1.34 105.613 -177.22 . . . . . . . . 3 3 . 1 . 104 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.4 m -107.3 126.25 52.21 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.57 -1.956 . . . . 1.36 112.411 178.364 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.45 ' HB2' HG22 ' A' ' 5' ' ' VAL . 66.4 mt -100.07 151.9 20.85 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 126.259 2.933 . . . . 2.03 106.532 169.561 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -113.35 116.58 29.92 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 116.035 -4.166 . . . . 2.31 112.584 179.083 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.7 tp -92.58 125.93 37.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.314 2.959 . . . . 1.72 107.826 -176.906 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.7 t -118.81 147.97 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 C-N-CA 127.216 2.206 . . . . 1.8 106.255 176.64 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.9 mt -114.2 156.11 24.87 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.797 -3.064 . . . . 3.26 114.205 175.404 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -80.25 141.11 35.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.681 -3.137 . . . . 4.12 112.09 177.857 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.491 HD22 ' H ' ' A' ' 73' ' ' LEU . 0.6 OUTLIER -75.02 155.06 37.7 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.319 -2.113 . . . . 3.54 113.673 177.043 . . . . . . . . 3 3 . 1 . 104 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.7 mtm-85 -76.14 134.43 39.96 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.373 1.99 . . . . 7.32 116.373 174.871 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.58 -144.9 4.53 Favored Glycine 0 N--CA 1.431 -1.667 0 CA-C-N 123.311 2.778 . . . . 3.73 108.438 -170.013 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.827 0 N-CA-C 108.174 -1.97 . . . . 3.87 108.174 -176.329 . . . . . . . . 0 0 . 1 . 105 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 ptt? . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 117.633 -1.175 . . . . 1.39 113.744 . . . . . . . . . 0 0 . 1 . 105 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -90.03 140.3 29.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 123.054 2.661 . . . . 2.2 112.907 175.357 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.2 pt -130.72 161.97 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 108.066 -1.087 . . . . 1.32 108.066 166.062 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -119.62 130.13 54.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.315 3.046 . . . . 2.2 111.245 172.656 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.0 t -109.56 121.4 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 111.677 -2.511 . . . . 1.23 108.554 172.954 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -97.24 123.36 41.0 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 117.784 -3.073 . . . . 2.51 112.595 174.637 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.6 p -78.78 174.53 11.36 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.148 3.356 . . . . 1.41 115.214 170.062 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.12 -43.18 74.93 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 116.416 -3.927 . . . . 2.95 115.935 178.412 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 p -73.36 -41.22 63.69 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.119 2.568 . . . . 2.52 110.957 -177.334 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.57 8.18 0.42 Allowed Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 115.514 -3.231 . . . . 1.5 116.178 170.766 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.23 133.96 35.91 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 104.583 -2.377 . . . . 1.79 104.583 -176.137 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.6 m -98.73 123.39 42.92 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.301 -1.5 . . . . 1.38 107.156 171.274 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -100.59 95.41 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 124.437 2.065 . . . . 2.03 109.871 175.676 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.4 m -76.53 115.42 16.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 105.256 -2.127 . . . . 1.61 105.256 177.923 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.5 mt -120.24 171.69 8.32 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.001 2.12 . . . . 2.15 112.215 -176.712 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -127.61 132.39 49.79 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 105.304 -2.11 . . . . 1.98 105.304 169.505 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.8 m -140.25 169.49 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 128.286 2.634 . . . . 1.52 108.549 -178.471 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -104.81 159.93 27.69 Favored Pre-proline 0 N--CA 1.43 -1.433 0 O-C-N 119.269 -2.144 . . . . 2.35 108.774 162.897 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -70.23 -19.06 34.37 Favored 'Trans proline' 0 N--CA 1.434 -2.01 1 O-C-N 112.146 -4.713 . . . . 1.31 106.999 -174.911 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -91.57 9.01 33.91 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.474 2.398 . . . . 1.71 117.474 -176.481 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -85.66 150.19 24.79 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 113.082 0.771 . . . . 1.69 113.082 173.098 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.8 p -78.35 160.14 27.99 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 123.395 1.569 . . . . 1.33 113.176 173.559 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.456 HD13 HD22 ' A' ' 56' ' ' LEU . 43.3 mm -60.59 -33.86 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 126.615 1.966 . . . . 1.32 109.92 169.884 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.303 3.4 tt0 -47.03 -46.56 22.16 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.526 2.047 . . . . 1.62 116.526 158.766 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -75.53 -35.73 60.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 116.83 2.159 . . . . 2.13 116.83 -178.021 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.4 t -57.92 -47.18 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 111.683 -2.508 . . . . 1.23 111.374 173.417 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.286 37.6 mtmt -57.91 -29.83 65.42 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 121.692 3.96 . . . . 1.97 121.692 170.628 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.38 -33.06 62.95 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.892 -2.38 . . . . 1.19 112.872 169.645 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -61.5 -17.17 53.43 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.706 1.602 . . . . 1.92 113.735 167.677 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.9 mt -98.61 -36.15 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 125.636 2.636 . . . . 1.94 108.945 178.777 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.307 24.7 tt0 -45.18 -50.01 11.74 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 117.815 -3.053 . . . . 1.9 113.825 173.752 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.397 0.6 OUTLIER -62.01 -26.4 68.21 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.92 2.933 . . . . 1.55 118.92 174.879 . . . . . . . . 3 3 . 1 . 105 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -86.17 -78.7 0.27 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.182 2.593 . . . . 2.95 109.212 -178.61 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -89.21 -12.36 41.04 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 119.03 2.974 . . . . 1.48 119.03 -172.529 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.66 24.08 26.71 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 120.92 -1.112 . . . . 1.12 115.419 172.962 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.4 mt -104.28 133.88 19.98 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-O 112.594 -3.574 . . . . 2.07 107.765 -169.549 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -77.51 158.95 32.49 Favored 'Trans proline' 0 N--CA 1.434 -1.974 0 CA-C-N 125.037 2.835 . . . . 1.39 115.397 -179.377 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -61.92 -26.73 79.21 Favored 'Trans proline' 0 C--N 1.299 -2.03 1 C-N-CA 127.002 5.135 . . . . 1.68 117.358 -178.329 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.342 0.2 OUTLIER -61.02 -51.2 70.2 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 130.275 3.43 . . . . 2.25 110.259 179.303 . . . . . . . . 3 3 . 1 . 105 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -74.71 -43.65 54.01 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.597 -1.26 . . . . 2.44 107.597 178.284 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -60.21 137.8 58.05 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 116.792 2.145 . . . . 1.32 116.792 -174.35 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -138.17 128.68 26.37 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 125.875 1.67 . . . . 3.19 109.955 175.351 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.261 85.2 mt -95.64 135.67 37.03 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.648 1.69 . . . . 1.75 110.488 174.608 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.251 37.2 mm -123.17 120.23 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 109.565 -3.47 . . . . 1.98 106.501 173.748 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -134.62 131.81 38.26 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.615 2.626 . . . . 1.94 108.886 171.127 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.58 45.52 24.17 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.405 2.743 . . . . 1.67 118.405 179.848 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.54 -45.98 1.99 Allowed Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 120.574 -0.822 . . . . 1.3 114.895 179.456 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -82.73 149.04 27.51 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.083 2.553 . . . . 2.89 116.252 179.372 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -81.27 125.71 30.66 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 129.041 2.936 . . . . 2.89 107.988 172.464 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 mt -88.09 146.53 25.39 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.74 1.257 . . . . 1.34 109.702 -173.437 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -98.07 146.54 25.44 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 126.087 2.851 . . . . 1.94 107.41 177.207 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.7 -61.49 2.57 Favored 'General case' 0 N--CA 1.43 -1.473 1 C-N-CA 133.675 4.79 . . . . 1.56 117.042 -168.753 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.41 12.63 1.8 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 120.088 2.795 . . . . 0.97 120.088 172.985 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -106.15 159.35 16.15 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.702 1.715 . . . . 3.07 113.274 178.06 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -95.48 162.98 13.42 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.878 -4.264 . . . . 1.34 110.945 -179.639 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.456 HD22 HD13 ' A' ' 23' ' ' ILE . 66.3 mt -64.28 -43.21 95.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.957 3.303 . . . . 1.63 108.242 178.538 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 p -60.8 -34.23 74.2 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 114.479 1.288 . . . . 1.51 114.479 -179.992 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -64.09 -37.24 86.72 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 129.774 3.23 . . . . 1.9 113.807 173.04 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -92.9 7.82 42.29 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.947 -2.971 . . . . 0.97 110.97 177.639 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.2 m120 55.5 39.15 31.02 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 130.917 3.687 . . . . 2.35 114.459 -175.897 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.2 mt -82.56 115.99 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 103.999 -2.593 . . . . 1.39 103.999 179.064 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -100.99 -179.94 4.19 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.917 2.294 . . . . 2.58 110.54 -176.655 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.284 32.7 pttt -54.41 137.07 43.14 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.674 -3.141 . . . . 2.58 119.085 169.232 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.292 59.3 mt-10 71.31 24.28 3.79 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.061 1.744 . . . . 1.71 113.748 171.919 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.7 p -91.23 159.32 16.11 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.256 2.622 . . . . 1.34 115.431 -174.827 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.1 m -105.97 100.32 9.87 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.201 3.0 . . . . 1.36 114.321 176.952 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mp -97.9 146.84 25.05 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 103.31 -2.848 . . . . 2.03 103.31 170.893 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -109.31 145.65 35.64 Favored 'General case' 0 CA--C 1.489 -1.37 0 CA-C-O 114.498 -2.668 . . . . 2.31 110.299 -179.009 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.2 tp -111.7 119.88 40.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 127.347 2.904 . . . . 1.72 110.592 -173.582 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 m -113.31 151.58 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 118.968 -2.332 . . . . 1.8 111.326 172.959 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.2 mt -110.86 124.75 52.67 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 116.966 -1.894 . . . . 3.26 108.846 -179.624 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -60.81 142.06 56.44 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 126.817 2.573 . . . . 4.12 113.892 -176.606 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.5 mt -114.17 139.28 49.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 103.898 -2.63 . . . . 3.54 103.898 174.576 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -80.46 143.41 33.4 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.161 2.184 . . . . 7.32 108.184 175.485 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.34 -71.29 0.43 Allowed Glycine 0 N--CA 1.429 -1.784 0 CA-C-O 124.698 2.277 . . . . 3.73 108.604 -162.706 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.756 0 O-C-N 119.156 -2.379 . . . . 3.87 113.689 176.078 . . . . . . . . 0 0 . 1 . 106 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.37 15.3 ptt? . . . . . 0 CA--C 1.489 -1.382 0 N-CA-C 115.006 1.484 . . . . 1.39 115.006 . . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -97.74 130.07 44.73 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 117.168 -1.813 . . . . 2.2 111.79 179.799 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.2 pt -121.15 169.06 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 103.247 -2.872 . . . . 1.32 103.247 175.953 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -128.4 126.39 40.53 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.691 -1.226 . . . . 2.2 107.691 -171.442 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.0 t -107.91 121.96 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 114.494 -1.23 . . . . 1.23 108.406 172.462 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -99.04 126.88 44.86 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.313 1.445 . . . . 2.51 108.902 175.903 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 p -69.69 -178.63 1.53 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.643 2.09 . . . . 1.41 116.643 175.024 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.7 tp -74.73 -38.55 62.25 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.943 -1.098 . . . . 2.95 112.126 173.529 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.2 p -79.33 -53.25 7.11 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.987 2.588 . . . . 2.52 117.987 176.697 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.99 7.89 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.778 0 CA-C-N 125.772 3.897 . . . . 1.5 115.096 179.988 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -99.77 139.6 35.19 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 115.198 -2.601 . . . . 1.79 113.695 -175.603 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.4 m -103.28 128.19 50.39 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 116.53 -2.068 . . . . 1.38 105.534 174.787 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.4 mt -116.32 123.98 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.661 2.784 . . . . 2.03 111.265 -177.72 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.8 m -96.64 126.41 41.79 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 105.847 -1.908 . . . . 1.61 105.847 -174.891 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -121.35 120.31 34.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.399 2.28 . . . . 2.15 111.222 -178.056 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -82.48 111.65 18.69 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.114 1.765 . . . . 1.98 108.16 172.667 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.263 23.8 m -134.97 -178.43 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 O-C-N 120.163 -1.586 . . . . 1.52 107.25 177.579 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -117.31 174.68 2.38 Favored Pre-proline 0 N--CA 1.43 -1.451 0 O-C-N 117.237 -3.414 . . . . 2.35 108.304 163.817 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -77.56 -19.04 13.28 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 117.377 -1.96 . . . . 1.31 113.215 -175.124 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.333 4.5 m -82.94 3.95 27.79 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 122.755 2.525 . . . . 1.71 115.387 176.816 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.269 2.8 m-20 -72.59 153.74 41.12 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 115.917 1.821 . . . . 1.69 115.917 172.114 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.5 p -89.85 153.86 20.32 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 117.481 -3.262 . . . . 1.33 111.424 -179.61 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.5 mm -47.63 -49.01 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 118.832 -2.417 . . . . 1.32 116.497 172.354 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -45.31 -35.71 3.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 117.101 2.26 . . . . 1.62 117.101 167.828 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -65.48 -32.42 74.01 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 122.02 2.191 . . . . 2.13 114.515 174.836 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.9 t -75.75 -40.19 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 120.112 -1.618 . . . . 1.23 109.772 -174.93 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -59.37 -32.07 69.8 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 113.251 -1.795 . . . . 1.97 114.957 167.556 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.17 84.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 114.98 -2.438 . . . . 1.19 112.905 171.748 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -70.2 -22.16 62.96 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 127.635 3.084 . . . . 1.92 115.023 -179.648 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.1 mm -79.38 -35.66 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 127.262 2.225 . . . . 1.94 109.513 175.446 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.35 8.7 tt0 -58.39 -48.78 79.54 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 126.539 2.399 . . . . 1.9 113.459 172.867 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -54.05 -53.04 58.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 111.647 -2.524 . . . . 1.55 113.145 168.949 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -87.53 -49.21 7.34 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.488 -3.258 . . . . 2.95 114.102 -167.522 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -96.36 -44.45 7.22 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 113.472 -1.695 . . . . 1.48 113.832 -172.202 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.74 -28.28 3.98 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 117.226 1.65 . . . . 1.12 117.226 169.56 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 mp -57.45 138.17 81.43 Favored Pre-proline 0 N--CA 1.429 -1.496 0 N-CA-C 115.754 1.761 . . . . 2.07 115.754 -174.57 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -59.92 134.39 56.49 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 C-N-CA 123.872 3.048 . . . . 1.39 114.445 174.772 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -73.95 -16.75 22.93 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-O 112.004 -3.415 . . . . 1.68 112.74 -169.72 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.03 -38.33 90.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.596 2.617 . . . . 2.25 111.616 171.584 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -78.4 -18.29 55.23 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.765 -2.459 . . . . 2.44 114.739 178.521 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -88.66 138.64 31.24 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.781 2.229 . . . . 1.32 116.09 177.766 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -121.77 158.04 29.68 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.908 -3.62 . . . . 3.19 110.976 165.408 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.276 12.8 mt -119.26 125.16 48.47 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 126.285 1.834 . . . . 1.75 111.387 179.324 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.1 mt -113.08 136.88 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 106.932 -1.507 . . . . 1.98 106.932 -174.149 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -142.04 129.59 21.4 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.588 -1.32 . . . . 1.94 111.106 173.214 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.43 18.3 6.72 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 130.322 3.449 . . . . 1.67 116.334 -179.288 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.54 -3.76 57.89 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 126.561 2.029 . . . . 1.3 115.049 -175.624 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -108.0 133.3 52.51 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 126.421 3.01 . . . . 2.89 113.785 177.215 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -77.41 127.62 32.85 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.251 -4.031 . . . . 2.89 104.735 172.564 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.5 mt -89.61 147.33 23.98 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.283 -2.136 . . . . 1.34 116.73 -173.927 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -82.83 132.87 35.15 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.366 2.031 . . . . 1.94 112.572 171.435 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -60.9 -51.45 69.23 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 111.008 -2.814 . . . . 1.56 115.213 -172.671 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.19 46.95 3.62 Favored Glycine 0 N--CA 1.43 -1.747 0 CA-C-O 118.347 -1.252 . . . . 0.97 114.293 173.726 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -128.21 155.6 44.26 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.085 2.154 . . . . 3.07 113.152 168.8 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.342 70.1 p -82.04 164.01 21.7 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 121.692 2.042 . . . . 1.34 111.116 173.951 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mt -70.41 -26.98 63.93 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 111.302 -2.681 . . . . 1.63 111.698 170.314 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.254 23.2 t -65.74 -46.28 79.45 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 115.572 -2.156 . . . . 1.51 111.681 171.515 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -52.27 -28.36 18.56 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 117.999 2.592 . . . . 1.9 117.999 176.397 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -93.39 -11.46 32.19 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 117.593 -3.192 . . . . 0.97 111.31 -179.693 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.1 m120 67.23 50.5 0.98 Allowed 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 128.728 2.811 . . . . 2.35 113.308 -175.087 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.8 mt -95.46 110.54 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 1 CA-C-O 128.857 4.17 . . . . 1.39 107.674 177.366 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -89.84 -173.15 3.8 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 114.081 -5.387 . . . . 2.58 112.563 -179.589 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -61.73 166.48 4.3 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.118 -2.239 . . . . 2.58 111.329 175.1 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 49.79 28.82 2.9 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 118.471 2.767 . . . . 1.71 118.471 172.703 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.9 p -90.88 147.33 23.23 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.074 2.55 . . . . 1.34 113.054 -174.848 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.9 m -107.98 98.6 8.15 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 115.305 1.594 . . . . 1.36 115.305 -179.205 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.297 2.7 mp -84.01 156.22 22.38 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 129.176 2.99 . . . . 2.03 107.945 175.123 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -126.05 120.23 29.69 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 118.281 -1.368 . . . . 2.31 109.873 -176.614 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.9 tp -84.58 130.81 34.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.903 -2.373 . . . . 1.72 107.636 -179.879 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.5 m -125.04 140.47 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 126.388 2.994 . . . . 1.8 113.066 166.065 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.335 4.9 mt -80.32 125.98 30.58 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.023 -2.923 . . . . 3.26 112.553 176.919 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -96.88 97.68 9.48 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.616 -1.302 . . . . 4.12 111.591 176.017 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -92.46 -68.43 0.8 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 124.884 1.274 . . . . 3.54 111.075 178.032 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.9 ptt-85 -65.6 147.36 53.53 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 126.22 2.914 . . . . 7.32 106.916 -179.652 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.69 80.42 0.64 Allowed Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 116.782 -2.628 . . . . 3.73 113.001 -171.31 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.761 0 N-CA-C 107.952 -2.059 . . . . 3.87 107.952 -169.16 . . . . . . . . 0 0 . 1 . 107 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptt? . . . . . 0 CA--C 1.491 -1.319 0 CA-C-O 117.99 -1.005 . . . . 1.39 111.215 . . . . . . . . . 0 0 . 1 . 107 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -115.42 135.05 54.51 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 127.476 2.985 . . . . 2.2 109.275 175.997 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt -117.25 163.54 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 106.832 -1.544 . . . . 1.32 106.832 171.25 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -109.53 136.08 49.49 Favored 'General case' 0 N--CA 1.431 -1.409 1 C-N-CA 132.429 4.292 . . . . 2.2 109.703 174.998 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.9 t -130.01 123.46 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 O-C-N 118.099 -2.876 . . . . 1.23 104.861 178.769 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -98.03 139.49 33.77 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.299 -3.376 . . . . 2.51 112.391 176.531 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.323 32.7 p -82.59 -171.67 3.62 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.831 -1.168 . . . . 1.41 111.676 176.319 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt -61.71 -47.77 83.78 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.389 -1.444 . . . . 2.95 112.544 172.14 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.3 p -81.02 -22.84 39.06 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.969 -1.707 . . . . 2.52 109.1 -178.672 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.93 23.89 4.46 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 118.969 2.347 . . . . 1.5 118.969 172.375 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -77.73 134.4 38.1 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 120.054 1.927 . . . . 1.79 108.276 179.039 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.9 m -91.66 110.75 22.08 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.409 -2.057 . . . . 1.38 109.31 -173.272 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mt -100.86 125.91 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 125.742 1.617 . . . . 2.03 106.723 178.153 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.0 m -103.79 121.42 42.99 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.781 2.032 . . . . 1.61 108.207 179.613 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.5 mt -120.45 125.01 46.85 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.774 -2.454 . . . . 2.15 117.268 -178.621 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -70.69 117.56 12.36 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 124.774 1.296 . . . . 1.98 110.235 170.461 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.0 m -142.84 171.97 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 126.2 2.905 . . . . 1.52 109.064 178.231 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -118.58 158.62 46.7 Favored Pre-proline 0 N--CA 1.43 -1.428 1 O-C-N 114.087 -5.383 . . . . 2.35 106.484 163.509 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.08 -14.1 26.06 Favored 'Trans proline' 0 C--N 1.299 -2.048 1 C-N-CA 125.581 4.188 . . . . 1.31 110.235 -171.379 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 m -90.25 8.21 34.33 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 122.125 2.239 . . . . 1.71 110.24 177.773 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.35 147.03 28.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.593 -2.567 . . . . 1.69 110.285 171.388 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.0 p -86.71 161.35 18.47 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.663 -1.606 . . . . 1.33 106.663 -177.395 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.3 26.1 mm -64.98 -29.32 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 O-C-N 116.205 -4.06 . . . . 1.32 110.991 -178.374 . . . . . . . . 3 2 . 1 . 107 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -52.98 -47.49 68.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 129.009 2.924 . . . . 1.62 111.773 167.963 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.258 26.3 t30 -71.31 -32.85 69.1 Favored 'General case' 0 N--CA 1.431 -1.41 1 O-C-N 116.229 -4.044 . . . . 2.13 112.997 177.789 . . . . . . . . 3 2 . 1 . 107 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.0 t -63.15 -45.09 99.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 1 O-C-N 113.509 -5.744 . . . . 1.23 113.931 174.482 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.5 mttt -60.37 -38.71 84.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 128.006 3.316 . . . . 1.97 117.267 167.859 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.51 -41.6 85.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 123.901 1.81 . . . . 1.19 113.335 172.442 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -68.33 -29.46 68.21 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.545 -3.222 . . . . 1.92 117.156 171.107 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.8 mt -71.98 -43.92 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-N 120.898 1.681 . . . . 1.94 110.602 172.487 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -49.34 -45.84 46.13 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.575 2.35 . . . . 1.9 115.375 170.951 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -51.58 -46.53 63.53 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.751 2.215 . . . . 1.55 115.023 175.342 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 tttp -85.03 -57.73 2.98 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.681 -3.137 . . . . 2.95 113.008 -174.767 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -89.12 -46.81 8.54 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 129.824 3.25 . . . . 1.48 114.636 -168.274 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.88 27.08 3.35 Favored Glycine 0 N--CA 1.429 -1.798 1 O-C-N 114.637 -5.04 . . . . 1.12 110.455 169.981 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.0 mt -104.97 124.24 37.31 Favored Pre-proline 0 N--CA 1.429 -1.484 0 CA-C-O 113.883 -2.96 . . . . 2.07 107.087 -178.256 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -64.39 164.51 22.95 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 CA-C-N 127.969 3.882 . . . . 1.39 118.413 174.677 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -65.33 -26.65 55.91 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 123.815 3.01 . . . . 1.68 118.593 -176.847 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -55.96 -43.34 77.44 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 127.344 2.902 . . . . 2.25 113.062 173.774 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -85.38 -1.51 57.09 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 113.147 -1.842 . . . . 2.44 114.321 -170.317 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -107.6 103.62 12.97 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.146 1.378 . . . . 1.32 112.451 -171.946 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.431 ' HG3' ' HB2' ' A' ' 72' ' ' ARG 0.257 72.6 mtt180 -96.39 116.74 29.53 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.286 -2.759 . . . . 3.19 107.849 167.74 . . . . . . . . 3 3 . 1 . 107 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.1 mt -99.46 126.86 45.46 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.583 -3.198 . . . . 1.75 105.089 177.559 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -114.31 143.36 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 125.298 2.475 . . . . 1.98 107.966 176.481 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.514 ' C ' ' H ' ' A' ' 47' ' ' GLY . 34.9 t80 -141.2 127.37 19.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.346 -3.971 . . . . 1.94 108.888 171.964 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 75.93 -27.39 0.18 Allowed 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 127.953 2.501 . . . . 1.67 109.624 174.155 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 143.48 -13.02 2.25 Favored Glycine 0 N--CA 1.431 -1.694 0 CA-C-O 125.162 2.535 . . . . 1.3 113.55 -175.887 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -86.22 137.1 32.89 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 111.806 -2.197 . . . . 2.89 109.473 178.781 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -77.59 109.66 11.75 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.796 3.638 . . . . 2.89 110.508 169.092 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.8 mt -68.46 130.97 44.44 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 114.858 1.429 . . . . 1.34 114.858 -177.393 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -89.8 144.52 25.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.654 1.582 . . . . 1.94 113.285 177.891 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -60.87 -54.87 39.81 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.718 -3.114 . . . . 1.56 115.862 -171.933 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.42 28.86 0.85 Allowed Glycine 0 N--CA 1.43 -1.763 1 N-CA-C 123.754 4.262 . . . . 0.97 123.754 171.357 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -127.87 160.01 33.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.548 -1.56 . . . . 3.07 112.139 173.01 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.26 44.2 p -89.15 167.07 13.41 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.356 1.551 . . . . 1.34 109.974 -177.703 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mt -64.81 -34.73 79.06 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 113.892 -1.503 . . . . 1.63 109.854 169.938 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.9 t -61.16 -41.81 97.43 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 122.598 1.189 . . . . 1.51 109.613 179.397 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -55.23 -41.87 72.63 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.569 -2.582 . . . . 1.9 117.56 176.309 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -84.9 -6.69 59.34 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 117.75 2.5 . . . . 0.97 117.75 -179.441 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.318 35.9 m120 68.62 50.57 0.67 Allowed 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 119.399 1.0 . . . . 2.35 111.999 -176.204 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.6 mt -103.44 108.73 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 121.704 0.764 . . . . 1.39 111.451 172.838 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -93.78 -175.8 3.85 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.297 2.639 . . . . 2.58 107.627 177.886 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -68.59 149.35 49.28 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 125.932 2.777 . . . . 2.58 113.747 171.275 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.429 75.3 mt-10 64.97 22.39 12.44 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 109.99 -3.277 . . . . 1.71 115.375 174.687 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.5 m -92.23 156.42 17.31 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.776 -3.077 . . . . 1.34 110.812 -176.883 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.2 m -106.89 110.19 22.28 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 126.521 2.388 . . . . 1.36 108.211 -173.005 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -93.22 141.33 28.54 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.59 1.556 . . . . 2.03 106.869 172.31 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -101.9 117.99 35.99 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.015 -2.928 . . . . 2.31 106.773 -177.902 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.8 tp -93.1 121.4 34.42 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.697 -2.502 . . . . 1.72 111.163 173.868 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.1 t -111.36 140.77 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 O-C-N 117.8 -3.062 . . . . 1.8 108.084 177.561 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.5 tp -85.87 126.17 33.86 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 116.39 1.996 . . . . 3.26 116.39 174.567 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.431 ' HB2' ' HG3' ' A' ' 42' ' ' ARG . 73.7 ttt180 -91.72 115.98 28.5 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 124.631 1.172 . . . . 4.12 108.106 -174.105 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.7 mt -111.43 -146.46 0.41 Allowed 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.539 1.136 . . . . 3.54 109.884 175.017 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -109.75 123.76 50.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 115.6 1.704 . . . . 7.32 115.6 177.581 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.31 100.09 0.86 Allowed Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 122.691 3.836 . . . . 3.73 122.691 -163.297 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.765 0 CA-C-O 117.563 -1.687 . . . . 3.87 110.366 175.625 . . . . . . . . 0 0 . 1 . 108 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ptt? . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 106.733 -1.58 . . . . 1.39 106.733 . . . . . . . . . 0 0 . 1 . 108 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.1 pm0 -107.15 131.6 53.96 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 114.28 1.215 . . . . 2.2 114.28 -178.863 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 pt -121.32 152.7 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 105.867 -1.901 . . . . 1.32 105.867 169.67 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.252 75.0 m-85 -113.89 135.34 54.08 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.035 -1.439 . . . . 2.2 108.88 -176.58 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.0 t -118.07 107.47 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 123.191 1.472 . . . . 1.23 111.405 178.709 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -89.02 138.23 31.59 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 118.239 -2.788 . . . . 2.51 118.278 174.686 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.329 27.8 p -94.81 154.35 17.3 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 110.725 -2.943 . . . . 1.41 110.013 178.309 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.282 43.1 mt -65.6 -41.64 92.57 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 131.012 3.725 . . . . 2.95 107.611 178.367 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 p -67.57 -46.17 73.45 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.138 1.375 . . . . 2.52 114.001 -176.7 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.05 50.57 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 125.406 1.479 . . . . 1.5 114.953 166.417 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -127.87 137.94 52.51 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.505 2.574 . . . . 1.79 107.652 -179.798 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.0 m -103.07 110.89 22.99 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 120.192 -1.567 . . . . 1.38 111.634 167.492 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.9 mm -97.54 112.72 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 104.545 -2.391 . . . . 2.03 104.545 -179.475 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.7 m -87.58 104.0 16.09 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.795 -1.191 . . . . 1.61 110.067 176.922 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.0 mt -101.54 134.76 44.16 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 105.598 -2.001 . . . . 2.15 105.598 -170.646 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -81.72 99.37 8.9 Favored 'General case' 0 N--CA 1.429 -1.492 1 O-C-N 116.116 -4.115 . . . . 1.98 116.395 165.233 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.5 m -109.22 -177.66 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.457 1 O-C-N 116.295 -4.003 . . . . 1.52 109.964 -179.693 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -124.11 158.5 60.42 Favored Pre-proline 0 N--CA 1.431 -1.417 0 CA-C-O 114.885 -2.483 . . . . 2.35 105.823 161.55 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -79.03 -6.82 15.18 Favored 'Trans proline' 0 N--CA 1.434 -2.019 1 CA-C-N 129.825 4.544 . . . . 1.31 111.894 -173.347 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.275 1.0 OUTLIER -82.79 2.2 35.22 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 116.448 2.018 . . . . 1.71 116.448 172.01 . . . . . . . . 3 3 . 1 . 108 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -78.02 134.63 37.76 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 116.566 2.062 . . . . 1.69 116.566 172.552 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.7 p -73.63 157.93 35.71 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.139 2.4 . . . . 1.33 110.134 174.569 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.266 35.4 mm -68.64 -37.31 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 112.392 -2.186 . . . . 1.32 110.075 -177.545 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -44.67 -46.53 10.3 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 128.329 2.652 . . . . 1.62 112.463 162.762 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -74.51 -38.63 62.79 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.748 2.69 . . . . 2.13 117.015 -179.679 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.7 t -65.11 -37.86 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 O-C-N 115.188 -4.695 . . . . 1.23 110.196 175.2 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -60.89 -29.72 69.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.838 -2.414 . . . . 1.97 115.334 172.34 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.48 -32.86 66.56 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.097 1.359 . . . . 1.19 112.162 174.325 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.28 0.4 OUTLIER -64.82 -32.95 74.89 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 130.371 3.469 . . . . 1.92 112.822 171.724 . . . . . . . . 3 3 . 1 . 108 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.3 mt -70.82 -41.15 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.579 2.351 . . . . 1.94 108.761 167.495 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.369 13.6 tt0 -57.83 -45.5 86.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 127.754 3.645 . . . . 1.9 117.259 170.065 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -52.45 -56.88 12.05 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.41 -3.306 . . . . 1.55 116.004 170.772 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -78.17 -51.12 10.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.92 -2.362 . . . . 2.95 113.074 -177.992 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -93.91 -62.19 1.4 Allowed 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.982 -2.949 . . . . 1.48 110.386 -170.973 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.15 53.68 0.35 Allowed Glycine 0 N--CA 1.431 -1.663 1 O-C-N 114.13 -5.356 . . . . 1.12 114.829 -179.489 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.9 mt -123.11 127.97 25.48 Favored Pre-proline 0 N--CA 1.43 -1.432 1 N-CA-C 99.661 -4.2 . . . . 2.07 99.661 -177.172 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.02 135.18 39.73 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 C-N-CA 123.022 2.482 . . . . 1.39 112.022 -179.319 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -46.47 -21.51 1.33 Allowed 'Trans proline' 0 N--CA 1.434 -1.999 1 C-N-CA 128.968 6.445 . . . . 1.68 121.96 179.612 . . . . . . . . 3 3 . 1 . 108 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -72.87 -50.41 24.06 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.881 2.472 . . . . 2.25 110.334 177.416 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -77.66 -7.22 56.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.551 3.072 . . . . 2.44 108.51 -172.977 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -91.72 124.02 35.55 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.387 -3.321 . . . . 1.32 113.424 -178.705 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -121.18 147.93 44.92 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.565 2.126 . . . . 3.19 105.467 169.008 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.262 29.5 mt -127.07 133.95 50.36 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 117.912 -1.515 . . . . 1.75 107.013 178.587 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.5 mt -106.39 147.98 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 127.948 3.28 . . . . 1.98 107.569 171.57 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -128.59 107.3 9.59 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.416 -2.068 . . . . 1.94 105.416 177.164 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.43 -42.13 0.49 Allowed 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 132.225 4.21 . . . . 1.67 113.216 177.38 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -172.23 -25.44 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 127.747 2.594 . . . . 1.3 109.435 -176.811 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -104.43 147.77 27.18 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.278 1.539 . . . . 2.89 113.48 -175.489 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -81.59 140.63 34.35 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.012 -1.449 . . . . 2.89 113.232 172.266 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.5 mt -98.44 144.76 27.45 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.378 1.561 . . . . 1.34 113.482 -177.883 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -99.04 144.82 27.75 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.601 -2.562 . . . . 1.94 108.277 170.501 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.92 -43.93 94.45 Favored 'General case' 0 CA--C 1.489 -1.391 1 C-N-CA 137.864 6.465 . . . . 1.56 114.513 -167.668 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.31 22.87 13.54 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 129.14 3.257 . . . . 0.97 111.847 168.605 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -98.57 168.34 10.23 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.812 2.244 . . . . 3.07 109.25 161.234 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.3 p -102.68 173.09 6.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.586 -2.571 . . . . 1.34 111.27 170.741 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.321 16.7 mt -76.68 -31.51 57.31 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.442 -2.036 . . . . 1.63 106.579 176.951 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 t -64.05 -41.77 97.27 Favored 'General case' 0 CA--C 1.489 -1.39 0 C-N-CA 124.796 1.238 . . . . 1.51 111.093 179.703 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -56.14 -41.01 74.7 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.843 2.164 . . . . 1.9 116.843 174.552 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -87.67 7.36 30.35 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.004 2.122 . . . . 0.97 112.781 179.456 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.277 35.0 m120 56.67 40.49 29.23 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.721 -2.487 . . . . 2.35 115.455 -179.855 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.2 mt -79.03 108.18 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 124.082 1.896 . . . . 1.39 112.116 171.916 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -95.01 -175.27 3.48 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.927 -1.733 . . . . 2.58 113.009 179.131 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -69.02 146.36 52.76 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 115.858 -2.02 . . . . 2.58 114.901 170.774 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 69.57 42.94 1.06 Allowed 'General case' 0 N--CA 1.431 -1.409 1 CA-C-O 130.943 5.163 . . . . 1.71 108.193 177.372 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.256 37.9 m -107.11 129.48 54.82 Favored 'General case' 0 N--CA 1.431 -1.411 1 O-C-N 113.693 -5.629 . . . . 1.34 115.809 176.943 . . . . . . . . 3 2 . 1 . 108 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.3 m -88.33 126.12 35.03 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 125.686 1.866 . . . . 1.36 111.815 177.53 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -112.57 151.7 29.75 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.67 2.788 . . . . 2.03 108.271 173.607 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -110.26 113.45 26.13 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.224 1.935 . . . . 2.31 116.224 -174.967 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.3 tp -82.21 112.97 19.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.203 -2.811 . . . . 1.72 113.39 -178.64 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.39 112.56 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 125.04 2.352 . . . . 1.8 112.593 179.408 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.7 tp -86.52 122.6 30.69 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.935 -2.353 . . . . 3.26 107.644 -175.301 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.63 161.87 28.64 Favored 'General case' 0 N--CA 1.428 -1.532 0 O-C-N 127.951 3.282 . . . . 4.12 113.902 -178.679 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.2 mt -120.72 167.16 12.76 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 104.62 -2.363 . . . . 3.54 104.62 170.45 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.1 mtt-85 -71.25 141.8 50.57 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.58 3.152 . . . . 7.32 115.402 168.155 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.54 -71.13 0.43 Allowed Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 128.254 2.835 . . . . 3.73 109.366 -168.876 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.748 0 C-N-CA 114.686 -3.626 . . . . 3.87 104.368 -178.986 . . . . . . . . 0 0 . 1 . 109 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.324 0 N-CA-C 107.442 -1.318 . . . . 1.39 107.442 . . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -99.16 144.45 28.28 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.288 1.994 . . . . 2.2 108.857 -173.913 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 pt -118.7 145.52 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 120.201 -1.562 . . . . 1.32 110.818 169.946 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -100.86 104.13 15.34 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.714 -0.676 . . . . 2.2 110.965 -179.567 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.423 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 32.8 t -88.29 117.62 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.446 -2.034 . . . . 1.23 107.299 174.651 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -101.88 145.12 29.66 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 125.288 1.618 . . . . 2.51 107.264 -179.529 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -103.9 -166.54 1.26 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.582 2.134 . . . . 1.41 112.186 178.532 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.5 tp -61.14 -51.29 69.68 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.539 -4.476 . . . . 2.95 114.15 176.233 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 p -72.24 -24.69 61.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.443 -3.286 . . . . 2.52 110.458 178.523 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.25 38.1 2.73 Favored Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 115.043 -3.087 . . . . 1.5 112.167 179.261 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -95.67 130.06 42.67 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 121.492 2.646 . . . . 1.79 110.956 -178.74 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.1 m -80.0 120.74 24.6 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.091 2.956 . . . . 1.38 112.786 178.972 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.423 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 3.2 mt -107.8 118.1 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 101.786 -3.413 . . . . 2.03 101.786 171.523 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.6 m -102.0 113.33 26.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 123.723 2.965 . . . . 1.61 107.462 -172.23 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.8 mt -108.58 137.05 47.17 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.231 -0.918 . . . . 2.15 110.924 177.543 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -80.94 112.86 18.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.872 1.269 . . . . 1.98 110.635 165.516 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -121.48 171.86 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 116.648 2.092 . . . . 1.52 116.648 174.866 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -106.14 158.05 33.44 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 104.115 -2.55 . . . . 2.35 104.115 164.712 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -82.51 4.61 6.95 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 O-C-N 114.656 -3.391 . . . . 1.31 109.095 179.926 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.6 p -92.66 -13.61 29.25 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.329 1.452 . . . . 1.71 114.561 175.661 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -66.67 135.88 54.72 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 126.109 2.861 . . . . 1.69 109.041 -179.416 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.263 23.8 p -68.96 158.33 34.91 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 116.451 -3.906 . . . . 1.33 113.534 177.881 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.401 7.9 mm -55.85 -41.77 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 124.623 2.154 . . . . 1.32 116.416 171.953 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -56.53 -39.65 73.72 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 119.546 3.165 . . . . 1.62 119.546 167.933 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -29.21 64.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.552 2.056 . . . . 2.13 116.552 172.321 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.44 -37.09 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 130.373 3.469 . . . . 1.23 109.635 168.732 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -81.44 -18.74 44.29 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 122.538 1.161 . . . . 1.97 109.793 -179.427 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.38 -17.34 58.28 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.651 -1.906 . . . . 1.19 111.532 168.242 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -83.64 -30.61 26.74 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 119.831 -1.793 . . . . 1.92 111.522 173.22 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.258 13.6 mt -73.01 -26.56 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 117.167 -3.458 . . . . 1.94 113.213 171.561 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -70.65 -51.36 28.46 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.492 3.517 . . . . 1.9 109.446 174.305 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -50.28 -45.16 54.22 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.608 2.763 . . . . 1.55 117.005 165.708 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -81.59 -60.15 2.36 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 113.869 1.063 . . . . 2.95 113.869 -179.646 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -95.13 -48.35 5.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.041 1.497 . . . . 1.48 115.041 -171.396 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.07 -2.0 6.25 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-O 124.222 2.012 . . . . 1.12 114.614 169.922 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.7 mt -74.03 117.61 62.76 Favored Pre-proline 0 N--CA 1.431 -1.409 0 C-N-CA 127.899 2.48 . . . . 2.07 105.039 -174.732 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -69.14 166.88 25.29 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 CA-C-O 111.815 -3.494 . . . . 1.39 117.074 178.03 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -66.19 -32.72 41.98 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 N-CA-C 120.133 3.09 . . . . 1.68 120.133 -174.64 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.379 38.0 m-20 -47.95 -36.63 12.83 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.974 2.109 . . . . 2.25 113.173 169.102 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -98.59 -4.74 33.35 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.964 -0.46 . . . . 2.44 111.802 -172.172 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -97.58 126.17 42.73 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.459 -2.025 . . . . 1.32 110.839 -179.685 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -106.83 116.82 32.59 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.08 2.152 . . . . 3.19 108.826 168.691 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.5 mt -104.84 115.73 30.79 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.8 -1.188 . . . . 1.75 112.037 -179.086 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.9 mm -110.65 126.17 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 127.129 2.172 . . . . 1.98 116.589 -179.779 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.43 ' HB3' HD22 ' A' ' 50' ' ' LEU . 64.3 t80 -127.92 104.0 7.56 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 104.792 -2.299 . . . . 1.94 104.792 174.97 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.284 . . 61.88 -117.03 0.62 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 110.641 -2.982 . . . . 1.67 110.976 -179.655 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.08 -27.12 29.28 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 119.876 -1.765 . . . . 1.3 110.634 -168.513 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -96.28 139.55 32.26 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 126.86 2.153 . . . . 2.89 115.36 -179.224 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -90.46 127.73 36.3 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 111.919 -2.4 . . . . 2.89 105.836 173.408 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.43 HD22 ' HB3' ' A' ' 45' ' ' PHE . 37.4 mt -83.85 117.17 23.13 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.363 -1.461 . . . . 1.34 112.445 -171.424 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -68.7 139.7 55.4 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 119.936 3.31 . . . . 1.94 119.936 172.381 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.52 -59.43 4.84 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 118.566 2.802 . . . . 1.56 118.566 -174.611 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.76 60.19 4.83 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-N 113.118 -1.855 . . . . 0.97 114.805 172.362 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -136.8 178.48 7.04 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.418 2.532 . . . . 3.07 106.038 164.521 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.6 p -110.38 176.6 4.98 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 116.604 -3.81 . . . . 1.34 106.961 170.241 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.6 mt -75.2 -33.92 61.46 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.32 -2.737 . . . . 1.63 109.024 177.302 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.6 t -56.01 -44.24 78.47 Favored 'General case' 0 N--CA 1.43 -1.436 1 C-N-CA 134.34 5.056 . . . . 1.51 109.685 176.84 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.251 33.6 m-20 -57.27 -39.79 76.36 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.542 -3.849 . . . . 1.9 118.25 175.653 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -96.67 -2.25 45.02 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 127.469 2.308 . . . . 0.97 112.76 179.476 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.9 m120 58.21 42.53 21.84 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.916 2.886 . . . . 2.35 118.713 -179.165 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.1 mt -94.36 114.38 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 119.439 -2.038 . . . . 1.39 108.596 -179.695 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -101.13 -172.77 2.23 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.742 2.417 . . . . 2.58 112.776 -179.85 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -45.56 151.55 0.39 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.492 -3.88 . . . . 2.58 120.577 174.056 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 50.96 34.93 11.45 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.694 1.368 . . . . 1.71 114.694 174.548 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.0 m -91.84 137.38 32.41 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.697 -1.592 . . . . 1.34 109.294 -176.257 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.2 m -86.7 111.45 20.69 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 124.981 1.425 . . . . 1.36 110.831 177.003 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -92.13 163.97 13.75 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 117.461 -3.274 . . . . 2.03 107.428 171.405 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -128.95 116.28 19.13 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 124.232 1.968 . . . . 2.31 110.031 179.93 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.7 tp -82.36 110.26 17.35 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.677 3.214 . . . . 1.72 119.677 174.548 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.6 t -113.19 142.8 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.686 -1.227 . . . . 1.8 107.686 -178.919 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.9 tp -91.31 128.07 37.0 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 122.919 2.6 . . . . 3.26 108.851 178.37 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -96.29 135.33 38.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.426 2.69 . . . . 4.12 108.242 -178.391 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.26 0.0 OUTLIER -115.44 164.01 14.9 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 108.996 -3.729 . . . . 3.54 113.779 173.272 . . . . . . . . 3 3 . 1 . 109 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -66.11 64.59 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.043 -1.661 . . . . 7.32 114.716 163.703 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.75 90.84 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 129.751 3.548 . . . . 3.73 115.582 -161.553 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.723 1 C-N-CA 132.544 4.878 . . . . 3.87 118.103 170.884 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 114.307 1.225 . . . . 1.39 114.307 . . . . . . . . . 0 0 . 1 . 110 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -93.31 130.16 39.16 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.646 -2.534 . . . . 2.2 112.898 -175.967 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.5 pt -129.85 149.64 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 128.561 3.663 . . . . 1.32 110.614 176.149 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -109.0 130.69 55.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 113.052 -1.886 . . . . 2.2 107.854 -176.106 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.48 130.58 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 103.076 -2.935 . . . . 1.23 103.076 173.589 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -110.24 146.13 36.14 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 116.21 -4.056 . . . . 2.51 115.691 174.137 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.251 2.9 p -104.34 171.63 7.23 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 119.727 1.149 . . . . 1.41 108.4 173.704 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.9 mt -73.41 -40.26 64.42 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 117.242 -3.411 . . . . 2.95 114.962 174.592 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.0 p -80.72 -37.29 30.86 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.62 2.452 . . . . 2.52 117.62 -175.549 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.57 -55.14 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 116.252 -2.88 . . . . 1.5 119.801 174.973 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -54.18 129.62 35.52 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 121.102 3.742 . . . . 1.79 121.102 -178.311 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.7 m -112.6 115.23 28.27 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 104.498 -2.408 . . . . 1.38 104.498 168.261 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mt -95.03 129.06 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 107.474 -1.306 . . . . 2.03 107.474 -173.005 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.9 m -89.23 111.09 21.8 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.879 2.276 . . . . 1.61 106.634 172.832 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.8 mt -111.44 141.48 44.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 117.408 2.373 . . . . 2.15 117.408 174.527 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -103.37 115.94 31.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 130.64 3.576 . . . . 1.98 109.283 168.251 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.0 m -131.45 155.89 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.223 1.809 . . . . 1.52 112.994 -176.938 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -97.02 142.58 24.75 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-O 112.675 -3.536 . . . . 2.35 117.07 164.356 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.407 ' HA ' ' HB2' ' A' ' 56' ' ' LEU 0.267 18.8 Cg_endo -70.7 -24.68 25.11 Favored 'Trans proline' 0 C--N 1.299 -2.055 2 C-N-CA 127.502 5.468 . . . . 1.31 111.705 -170.373 . . . . . . . . 4 3 . 1 . 110 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.329 25.5 m -84.56 8.13 17.73 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 114.216 1.191 . . . . 1.71 114.216 173.916 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -78.13 149.0 33.89 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.992 2.517 . . . . 1.69 104.859 174.637 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.2 p -74.36 163.83 27.33 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.516 2.413 . . . . 1.33 117.516 169.907 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.416 HG22 ' HE3' ' A' ' 27' ' ' LYS . 18.2 mm -66.26 -36.22 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 121.673 2.033 . . . . 1.32 110.264 171.027 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -52.27 -43.55 64.47 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.391 -2.693 . . . . 1.62 116.709 171.839 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -57.44 -46.49 83.54 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.323 -2.11 . . . . 2.13 113.006 171.765 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.63 -39.23 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 120.408 1.458 . . . . 1.23 113.18 177.106 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HE3' HG22 ' A' ' 23' ' ' ILE . 97.4 mttt -64.03 -33.0 74.75 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.113 1.153 . . . . 1.97 114.113 173.295 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.25 -27.8 66.66 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.476 1.11 . . . . 1.19 112.548 175.001 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -81.61 -26.34 34.95 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.699 -2.5 . . . . 1.92 109.221 176.913 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.4 mt -75.02 -30.44 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 122.213 2.278 . . . . 1.94 109.485 174.918 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -57.13 -48.81 77.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 130.17 3.388 . . . . 1.9 108.74 169.44 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.29 4.4 t70 -52.29 -58.63 6.05 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.015 1.726 . . . . 1.55 111.478 171.227 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -75.93 -62.47 1.58 Allowed 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 116.02 -4.175 . . . . 2.95 113.296 -172.553 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -96.37 -20.27 18.59 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 116.513 2.042 . . . . 1.48 116.513 -170.221 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.68 20.73 21.07 Favored Glycine 0 N--CA 1.429 -1.803 0 CA-C-O 125.24 2.578 . . . . 1.12 114.736 169.91 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.95 127.46 36.96 Favored Pre-proline 0 N--CA 1.43 -1.445 1 O-C-N 115.801 -4.353 . . . . 2.07 107.707 -174.385 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -64.61 147.76 90.21 Favored 'Trans proline' 0 C--N 1.3 -2.016 1 CA-C-N 129.276 4.349 . . . . 1.39 115.017 -178.966 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -62.07 -12.43 26.38 Favored 'Trans proline' 0 N--CA 1.433 -2.049 0 C-N-CA 124.386 3.391 . . . . 1.68 111.672 -178.778 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -73.68 -30.4 62.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 124.629 3.377 . . . . 2.25 115.253 172.382 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -78.66 -32.49 47.2 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 119.181 -2.2 . . . . 2.44 115.498 -176.47 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -71.2 124.52 24.68 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 124.499 1.124 . . . . 1.32 111.326 -172.129 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -120.93 109.78 15.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 114.785 -1.098 . . . . 3.19 109.82 167.537 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.8 mt -90.3 124.43 34.89 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 106.224 -1.769 . . . . 1.75 106.224 -175.997 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 9.0 mm -102.6 121.1 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 129.685 3.194 . . . . 1.98 113.582 172.107 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -136.49 136.13 39.16 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.902 -1.749 . . . . 1.94 108.773 171.756 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.12 27.01 7.12 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 120.101 3.371 . . . . 1.67 120.101 -178.963 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.73 5.53 84.0 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 119.025 -1.56 . . . . 1.3 116.713 -175.05 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -114.48 143.03 45.6 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.246 1.819 . . . . 2.89 113.818 -178.609 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -97.45 116.18 29.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.674 -1.232 . . . . 2.89 107.674 176.898 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.49 120.91 25.1 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.679 -2.513 . . . . 1.34 108.498 -164.491 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -66.69 157.61 32.2 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 113.849 1.055 . . . . 1.94 113.849 173.659 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -69.72 -55.53 9.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 114.398 1.258 . . . . 1.56 114.398 -176.305 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.27 46.8 2.81 Favored Glycine 0 N--CA 1.43 -1.766 0 CA-C-N 120.202 1.365 . . . . 0.97 115.075 173.538 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -112.88 156.39 23.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 119.913 -1.934 . . . . 3.07 108.212 162.778 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.2 p -99.13 168.78 9.85 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 115.428 -4.545 . . . . 1.34 113.185 169.32 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 6.6 mt -63.81 -37.58 87.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 125.273 1.608 . . . . 1.63 112.367 173.291 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.6 t -71.89 -36.43 70.04 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 122.229 1.014 . . . . 1.51 113.355 -179.943 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -54.6 -36.73 64.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.5 3.519 . . . . 1.9 120.5 168.284 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -92.02 9.52 32.91 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.087 -1.449 . . . . 0.97 107.087 -179.964 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 46.42 44.03 12.49 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 117.068 2.247 . . . . 2.35 117.068 -169.65 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.4 mt -86.4 121.04 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 106.5 -1.667 . . . . 1.39 106.5 175.988 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -104.71 179.31 4.31 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 123.296 1.522 . . . . 2.58 107.67 179.632 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -48.84 155.01 0.63 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 117.584 2.439 . . . . 2.58 117.584 173.064 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.305 20.0 mt-10 62.46 25.47 15.18 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 119.068 2.988 . . . . 1.71 119.068 172.075 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -93.25 145.64 24.29 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.721 1.608 . . . . 1.34 113.213 -173.178 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.253 3.2 m -94.02 104.29 16.34 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.3 -4.0 . . . . 1.36 113.666 176.229 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -89.25 142.69 27.43 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 124.394 1.059 . . . . 2.03 109.638 172.645 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.405 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 51.9 m80 -105.05 119.66 39.58 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 116.448 -3.908 . . . . 2.31 108.607 -178.89 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.7 tp -91.54 129.86 37.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.951 -3.593 . . . . 1.72 106.374 177.359 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.14 148.45 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 128.125 2.57 . . . . 1.8 106.376 174.297 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 71.2 mt -119.72 170.35 9.29 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.913 -4.242 . . . . 3.26 110.442 175.651 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 ptt85 -90.83 111.64 23.12 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.943 -1.132 . . . . 4.12 107.943 169.57 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.5 tp -105.49 -81.08 0.54 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.913 -1.884 . . . . 3.54 105.913 166.184 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -77.21 168.58 19.81 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 127.171 2.188 . . . . 7.32 110.993 170.906 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.15 71.49 0.63 Allowed Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 107.584 -2.206 . . . . 3.73 107.584 -178.43 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.729 0 N-CA-C 107.802 -2.119 . . . . 3.87 107.802 -178.925 . . . . . . . . 0 0 . 1 . 111 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ptt? . . . . . 0 CA--C 1.49 -1.338 0 N-CA-C 109.758 -0.46 . . . . 1.39 109.758 . . . . . . . . . 0 0 . 1 . 111 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -99.43 126.55 45.36 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.49 2.716 . . . . 2.2 111.005 -177.007 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.4 pt -116.85 142.19 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 118.386 -2.696 . . . . 1.32 106.245 168.648 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -100.3 106.33 17.96 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.444 2.698 . . . . 2.2 109.205 -178.16 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.0 t -101.66 112.14 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 O-C-N 117.403 -3.311 . . . . 1.23 106.986 173.354 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.5 mttm -89.98 146.93 24.01 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.89 -3.006 . . . . 2.51 113.375 177.964 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.2 p -98.69 172.05 7.72 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.472 3.034 . . . . 1.41 108.097 172.651 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.6 mt -73.39 -26.47 61.0 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.666 -2.061 . . . . 2.95 113.67 166.181 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.9 p -71.94 -69.95 0.36 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.069 2.248 . . . . 2.52 117.069 -175.67 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.02 12.67 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.809 0 CA-C-O 115.619 -2.767 . . . . 1.5 111.859 176.738 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.429 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 74.7 tttt -108.09 126.91 53.3 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 120.461 2.131 . . . . 1.79 113.225 -177.423 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.2 m -103.78 103.44 13.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.927 -2.249 . . . . 1.38 104.927 173.219 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -82.85 113.93 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 O-C-N 117.129 -3.482 . . . . 2.03 110.912 177.446 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.5 m -79.76 116.25 19.82 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.902 -2.374 . . . . 1.61 105.545 172.647 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.5 mt -114.2 134.43 54.92 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.169 -1.419 . . . . 2.15 107.169 176.185 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -86.75 106.99 18.05 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.174 2.99 . . . . 1.98 114.07 167.719 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.74 165.42 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 112.981 -1.918 . . . . 1.52 109.571 -177.552 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -109.53 155.18 41.73 Favored Pre-proline 0 N--CA 1.429 -1.485 0 N-CA-C 109.38 -0.6 . . . . 2.35 109.38 162.421 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -73.56 -11.87 24.5 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 O-C-N 117.134 -2.087 . . . . 1.31 111.326 -173.01 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.6 p -89.13 0.21 56.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.943 2.897 . . . . 1.71 113.475 178.353 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -76.22 150.12 37.12 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 126.121 2.867 . . . . 1.69 114.456 170.361 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.3 p -85.11 153.12 22.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.232 -2.167 . . . . 1.33 112.567 176.081 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.2 mm -65.45 -36.15 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 120.512 1.506 . . . . 1.32 114.071 -178.954 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -58.28 -39.98 80.69 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.069 -2.269 . . . . 1.62 116.923 173.669 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.323 70.1 m-80 -66.03 -26.04 67.33 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 116.1 1.889 . . . . 2.13 116.1 170.524 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -72.04 -33.3 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-N 120.135 1.334 . . . . 1.23 111.854 170.838 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -83.14 -20.34 34.95 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.381 -2.699 . . . . 1.97 111.175 177.842 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.67 67.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 121.197 1.817 . . . . 1.19 114.012 171.476 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -72.32 -48.86 38.83 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 125.452 1.72 . . . . 1.92 111.261 175.277 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.5 mt -60.79 -33.25 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 125.695 1.598 . . . . 1.94 111.258 176.284 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -64.66 -60.04 3.58 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.644 1.212 . . . . 1.9 110.659 177.624 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -42.43 -56.67 2.93 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 115.368 1.618 . . . . 1.55 115.368 174.698 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -67.69 -59.91 2.95 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 113.977 1.103 . . . . 2.95 113.977 177.359 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.429 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 13.1 mm-40 -92.37 -58.52 2.35 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.354 -1.466 . . . . 1.48 111.66 -166.414 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.16 16.69 0.64 Allowed Glycine 0 N--CA 1.43 -1.746 0 O-C-N 119.814 -1.804 . . . . 1.12 115.579 175.049 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -96.59 133.76 24.21 Favored Pre-proline 0 N--CA 1.43 -1.464 0 C-N-CA 119.291 -0.964 . . . . 2.07 110.903 -175.31 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.39 149.16 91.9 Favored 'Trans proline' 0 N--CA 1.435 -1.965 0 CA-C-N 125.036 2.834 . . . . 1.39 112.933 176.004 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -80.08 -11.25 13.62 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-O 115.702 -1.874 . . . . 1.68 108.9 -168.653 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -77.99 -24.49 48.0 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.871 2.123 . . . . 2.25 114.999 166.914 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -84.35 -34.28 23.68 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 124.244 1.973 . . . . 2.44 109.952 -177.773 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -72.38 100.06 2.58 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.437 -3.29 . . . . 1.32 112.069 179.797 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -86.65 135.37 33.43 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 121.558 1.981 . . . . 3.19 108.05 166.393 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.274 80.0 mt -104.17 125.82 50.78 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.631 3.586 . . . . 1.75 108.226 175.572 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.492 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 29.8 mm -103.13 140.93 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 118.976 -2.327 . . . . 1.98 110.358 171.699 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -130.14 107.98 9.72 Favored 'General case' 0 N--CA 1.429 -1.479 1 N-CA-C 98.835 -4.505 . . . . 1.94 98.835 170.506 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.07 -84.89 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.246 1.818 . . . . 1.67 115.14 179.87 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.01 13.25 0.74 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 130.473 3.892 . . . . 1.3 111.338 -175.583 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -109.6 151.36 26.93 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 121.189 2.495 . . . . 2.89 104.439 168.268 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -94.42 132.81 38.67 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 130.031 3.332 . . . . 2.89 102.726 171.071 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.9 mt -91.38 133.2 35.65 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.481 -2.012 . . . . 1.34 107.011 -170.387 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.402 ' HB2' ' HG2' ' A' ' 54' ' ' ARG . 31.1 mt-10 -71.88 151.73 43.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.19 -3.443 . . . . 1.94 108.605 171.572 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.25 -40.81 36.06 Favored 'General case' 0 N--CA 1.429 -1.523 0 O-C-N 116.865 -3.647 . . . . 1.56 110.137 -168.81 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.04 45.45 3.42 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 118.193 -2.817 . . . . 0.97 117.149 172.265 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.402 ' HG2' ' HB2' ' A' ' 51' ' ' GLU . 37.7 mmt180 -116.25 167.5 10.96 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 118.417 -0.802 . . . . 3.07 109.778 163.007 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.6 p -96.9 175.84 6.19 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 127.398 3.475 . . . . 1.34 108.286 167.941 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.8 mt -72.45 -43.75 63.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.742 -3.099 . . . . 1.63 108.607 176.514 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.2 p -72.9 1.41 8.77 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 119.969 3.322 . . . . 1.51 119.969 179.301 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -82.45 -40.59 20.95 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.47 -2.644 . . . . 1.9 112.27 169.593 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -77.87 -7.3 56.51 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.072 2.549 . . . . 0.97 110.621 172.161 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.312 42.8 m-80 68.46 33.32 4.11 Favored 'General case' 0 N--CA 1.428 -1.539 0 O-C-N 116.669 -3.769 . . . . 2.35 115.829 -177.273 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.6 mt -81.31 125.29 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 CA-C-N 114.011 -1.45 . . . . 1.39 111.657 -179.573 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -108.1 -164.11 0.94 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 121.28 3.808 . . . . 2.58 121.28 -176.535 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -74.4 146.63 42.78 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 120.438 -1.414 . . . . 2.58 112.853 171.946 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.261 43.4 mt-10 68.59 18.17 8.89 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 126.901 2.08 . . . . 1.71 115.436 178.182 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -77.04 124.66 28.12 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.413 2.685 . . . . 1.34 113.482 -174.749 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.29 3.8 m -80.97 105.16 11.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 127.418 2.287 . . . . 1.36 115.143 175.845 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -103.52 166.76 10.23 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 125.58 2.61 . . . . 2.03 106.044 175.249 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.492 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 73.6 m80 -128.72 133.1 48.05 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.829 -4.295 . . . . 2.31 110.108 -172.12 . . . . . . . . 3 3 . 1 . 111 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.6 tp -99.29 129.72 45.53 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.217 -0.927 . . . . 1.72 112.551 -176.368 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -131.05 123.4 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 122.074 2.216 . . . . 1.8 112.26 175.743 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.7 mt -90.42 110.47 21.57 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.65 2.463 . . . . 3.26 117.65 -178.397 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -123.52 -152.74 0.52 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.667 1.987 . . . . 4.12 106.778 -179.325 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.9 mt -122.78 165.7 16.17 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.238 2.215 . . . . 3.54 109.884 170.237 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -57.21 155.42 8.74 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.29 2.329 . . . . 7.32 117.29 -178.661 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.65 -20.25 0.6 Allowed Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 116.583 -2.722 . . . . 3.73 119.307 -160.732 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.76 1 N-CA-C 101.977 -4.449 . . . . 3.87 101.977 -176.736 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.414 ' HE1' ' HB3' ' A' ' 19' ' ' PRO . 7.0 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 113.311 0.856 . . . . 1.39 113.311 . . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -91.7 142.7 27.33 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.826 -1.916 . . . . 2.2 105.826 -178.046 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.0 pt -132.01 176.69 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 105.166 -2.161 . . . . 1.32 105.166 167.701 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -127.13 130.14 49.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.402 1.573 . . . . 2.2 109.079 176.299 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -109.49 110.09 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 126.231 2.919 . . . . 1.23 104.481 175.158 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 12' ' ' THR 0.27 23.7 ttmm -103.98 142.55 34.24 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 114.843 -4.911 . . . . 2.51 109.656 -178.422 . . . . . . . . 4 3 . 1 . 112 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.7 p -91.76 142.52 27.5 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 114.284 -2.77 . . . . 1.41 111.885 179.668 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.3 tp -59.97 -37.78 80.61 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.605 2.362 . . . . 2.95 109.532 165.711 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.9 -27.01 57.51 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 122.754 2.525 . . . . 2.52 110.192 -178.357 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.07 -77.38 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.739 1 N-CA-C 123.187 4.035 . . . . 1.5 123.187 176.297 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -72.59 157.51 37.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 129.266 3.568 . . . . 1.79 117.881 -174.694 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 3.3 m -105.11 133.88 49.15 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.944 2.497 . . . . 1.38 107.713 162.499 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 pt -113.18 143.88 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 101.584 -3.487 . . . . 2.03 101.584 176.319 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.3 m -99.85 128.65 45.93 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 114.753 -4.967 . . . . 1.61 104.159 174.397 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.7 mt -114.87 148.86 38.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.145 -3.472 . . . . 2.15 102.892 178.542 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -109.44 122.07 46.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.635 -1.987 . . . . 1.98 105.635 171.164 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.79 175.16 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-O 121.862 0.839 . . . . 1.52 111.136 -176.984 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.268 81.3 mt-10 -112.77 167.04 9.8 Favored Pre-proline 0 N--CA 1.431 -1.403 0 O-C-N 117.614 -3.178 . . . . 2.35 110.268 168.222 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.414 ' HB3' ' HE1' ' A' ' 1' ' ' MET . 59.4 Cg_endo -88.43 -8.75 5.27 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 CA-C-N 124.692 2.711 . . . . 1.31 110.513 -169.739 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 p -81.63 1.16 35.26 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 128.146 2.578 . . . . 1.71 115.897 172.958 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -77.52 137.74 38.79 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.058 -0.974 . . . . 1.69 108.507 175.25 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.3 p -79.29 156.36 28.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 128.198 2.599 . . . . 1.33 108.873 172.69 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.352 8.0 mm -61.64 -45.44 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 128.062 2.545 . . . . 1.32 114.764 -177.856 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.299 31.8 tt0 -48.83 -39.55 25.99 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 116.313 1.968 . . . . 1.62 116.313 167.292 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -73.55 -28.26 61.77 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 124.326 1.05 . . . . 2.13 111.575 179.793 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.2 t -69.06 -46.42 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 125.502 1.521 . . . . 1.23 109.262 171.297 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -62.21 -16.07 50.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 117.984 2.587 . . . . 1.97 117.984 176.878 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.82 -35.63 38.06 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 127.582 2.353 . . . . 1.19 109.574 171.465 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -70.02 -33.4 71.95 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.413 -1.429 . . . . 1.92 110.28 172.653 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.25 42.4 mt -63.63 -37.3 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 116.465 -3.897 . . . . 1.94 115.541 168.903 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.416 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 50.2 tt0 -69.62 -31.59 69.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 117.315 -1.326 . . . . 1.9 114.444 170.806 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.52 -45.48 65.47 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.393 1.451 . . . . 1.55 109.551 172.241 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -78.02 -64.78 1.08 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.049 -2.282 . . . . 2.95 114.41 -171.007 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.287 21.7 mm-40 -93.54 -45.78 7.59 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.716 1.246 . . . . 1.48 109.851 -172.745 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.88 64.15 0.34 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 106.067 -2.813 . . . . 1.12 106.067 167.069 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.416 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 8.8 mt -120.37 127.9 26.08 Favored Pre-proline 0 N--CA 1.43 -1.433 0 O-C-N 126.837 2.14 . . . . 2.07 111.448 -177.977 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -63.0 129.64 26.53 Favored 'Trans proline' 0 C--N 1.3 -2.023 1 CA-C-O 110.002 -4.249 . . . . 1.39 121.654 179.797 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -33.16 87.19 Favored 'Trans proline' 0 N--CA 1.434 -2.006 1 CA-C-N 129.243 4.337 . . . . 1.68 121.947 -175.142 . . . . . . . . 3 3 . 1 . 112 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -60.77 -37.81 83.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 125.243 3.656 . . . . 2.25 114.21 174.099 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -71.62 -28.05 63.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.107 -1.442 . . . . 2.44 107.107 -172.862 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -79.96 119.48 22.86 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.401 1.91 . . . . 1.32 115.382 -170.092 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.496 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 92.6 mtt180 -103.81 112.14 24.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 114.171 1.174 . . . . 3.19 114.171 166.821 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.6 mt -94.5 119.14 32.74 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.635 -3.166 . . . . 1.75 110.863 177.165 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.21 130.91 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 122.074 2.216 . . . . 1.98 108.152 174.484 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -118.3 114.94 23.72 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 102.953 -2.98 . . . . 1.94 102.953 171.445 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.383 . . 77.62 -63.9 0.32 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 125.961 2.791 . . . . 1.67 116.296 179.409 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.3 -60.66 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 127.213 2.339 . . . . 1.3 117.263 -172.55 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -68.26 125.41 26.31 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.971 2.908 . . . . 2.89 111.687 172.964 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -71.88 143.17 49.47 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 112.82 -1.991 . . . . 2.89 109.728 173.882 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.2 mt -80.05 128.57 33.65 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.875 1.67 . . . . 1.34 110.79 -178.04 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -86.07 148.31 25.77 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.445 -0.785 . . . . 1.94 109.107 176.002 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -59.41 -47.68 84.54 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 127.481 3.515 . . . . 1.56 117.16 -171.431 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.18 39.47 2.88 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 117.717 -3.114 . . . . 0.97 120.34 170.39 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.353 14.5 mmt180 -116.47 173.39 6.64 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 119.395 -0.922 . . . . 3.07 109.86 163.541 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.5 p -96.84 165.96 11.86 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 115.587 1.699 . . . . 1.34 115.587 168.754 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.0 mt -67.78 -32.55 73.2 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 123.04 1.4 . . . . 1.63 111.901 171.2 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.3 p -67.21 -16.19 64.15 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.256 -2.777 . . . . 1.51 112.895 174.909 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -69.81 -41.25 75.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 122.014 2.188 . . . . 1.9 115.236 177.467 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -90.35 -9.62 47.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.762 2.425 . . . . 0.97 109.724 -179.497 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.287 41.8 m-80 58.76 50.47 8.7 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 117.441 2.386 . . . . 2.35 117.441 -176.461 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.494 HG23 HD13 ' A' ' 67' ' ' LEU . 71.9 mt -86.42 118.2 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 126.409 3.004 . . . . 1.39 113.145 170.085 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -98.92 -178.16 3.86 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.638 -2.539 . . . . 2.58 111.277 -179.011 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -54.32 144.4 20.6 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.584 -2.573 . . . . 2.58 117.385 173.596 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.314 22.5 mt-10 66.66 27.39 9.44 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.737 -2.477 . . . . 1.71 117.068 174.825 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -101.09 153.46 19.55 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.232 -1.349 . . . . 1.34 108.877 -174.52 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.6 m -111.17 117.17 32.5 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.681 -3.137 . . . . 1.36 106.605 -175.125 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.494 HD13 HG23 ' A' ' 61' ' ' ILE . 7.7 mp -100.73 135.6 41.91 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.225 2.21 . . . . 2.03 106.047 176.798 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -99.57 117.44 33.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.403 -2.061 . . . . 2.31 110.178 -176.707 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.8 tp -86.96 119.44 27.17 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.465 3.506 . . . . 1.72 111.4 176.952 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.496 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 44.7 t -107.63 151.33 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 115.208 -2.33 . . . . 1.8 106.623 174.718 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.0 tp -123.75 131.66 53.64 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 115.26 -2.576 . . . . 3.26 107.465 179.667 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -93.33 136.69 33.36 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 114.965 -4.835 . . . . 4.12 103.855 178.753 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.3 mt -70.24 143.19 52.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.022 2.82 . . . . 3.54 110.69 173.7 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -101.08 -44.68 5.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 112.187 -2.279 . . . . 7.32 109.84 167.884 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.69 64.8 0.7 Allowed Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 115.945 1.138 . . . . 3.73 115.945 -170.97 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.763 1 C-N-CA 132.228 4.728 . . . . 3.87 113.337 174.164 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 ttp . . . . . 0 CA--C 1.491 -1.318 0 CA-C-O 115.598 -2.144 . . . . 1.39 110.758 . . . . . . . . . 0 0 . 1 . 113 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.485 HE21 HG21 ' A' ' 14' ' ' THR . 29.0 mt-30 -90.9 132.36 35.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.766 2.53 . . . . 2.2 112.547 -178.36 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.1 pt -111.68 149.18 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 122.077 2.217 . . . . 1.32 110.543 172.282 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -108.95 115.52 30.24 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.919 -1.882 . . . . 2.2 105.919 178.694 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.5 t -100.34 120.0 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 115.179 -2.343 . . . . 1.23 105.017 175.885 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.251 89.1 mttt -101.79 130.59 48.26 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 116.893 -1.527 . . . . 2.51 106.892 176.489 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.2 p -82.57 170.62 14.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 120.418 1.463 . . . . 1.41 111.621 176.039 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.2 tp -79.62 -28.02 40.97 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 125.712 2.673 . . . . 2.95 111.535 170.277 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.296 38.9 p -75.5 -50.1 16.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.339 -3.35 . . . . 2.52 113.38 -177.195 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.15 32.2 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 122.75 3.86 . . . . 1.5 122.75 167.182 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -135.71 147.45 48.49 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 121.405 2.603 . . . . 1.79 112.043 -175.059 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.8 m -97.09 122.8 40.5 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.882 -1.508 . . . . 1.38 107.956 173.265 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.9 mt -117.28 115.93 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 103.939 -2.615 . . . . 2.03 103.939 -175.155 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.485 HG21 HE21 ' A' ' 2' ' ' GLN . 47.4 m -94.72 104.6 16.52 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.961 1.362 . . . . 1.61 114.226 179.52 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.6 mt -97.27 140.43 31.75 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 119.113 -2.242 . . . . 2.15 111.116 -176.425 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -91.3 115.43 28.02 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 115.538 -4.476 . . . . 1.98 113.236 165.118 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -133.3 152.61 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 126.773 2.546 . . . . 1.52 107.762 -179.189 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -90.71 153.67 45.62 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 115.859 -2.02 . . . . 2.35 110.843 163.452 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -84.07 0.91 9.07 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 CA-C-N 126.07 3.204 . . . . 1.31 116.473 -171.749 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.8 p -85.94 -14.79 43.66 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.614 3.166 . . . . 1.71 111.051 174.612 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.284 18.7 m-20 -82.34 156.02 24.46 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.102 2.161 . . . . 1.69 112.359 177.823 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 60.0 p -78.07 171.15 15.45 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 127.284 3.421 . . . . 1.33 116.759 175.35 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.468 HD13 ' HG ' ' A' ' 56' ' ' LEU . 14.4 mm -74.76 -27.75 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 1 O-C-N 114.968 -4.833 . . . . 1.32 111.524 174.415 . . . . . . . . 3 3 . 1 . 113 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -54.43 -41.34 69.25 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 125.652 1.581 . . . . 1.62 108.964 165.536 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.263 18.1 t-20 -60.71 -44.3 96.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 124.483 2.087 . . . . 2.13 113.423 175.539 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.08 -50.13 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 113.143 -1.844 . . . . 1.23 111.53 174.194 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.471 ' HZ2' ' CG ' ' A' ' 52' ' ' ASP . 94.0 mttt -64.64 -41.57 96.05 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.332 2.345 . . . . 1.97 117.332 174.588 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.99 -45.15 41.84 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.158 2.183 . . . . 1.19 115.431 168.375 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -62.72 -39.61 94.61 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 116.182 1.919 . . . . 1.92 116.182 170.652 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.257 21.2 mt -63.51 -25.82 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 C-N-CA 125.296 1.438 . . . . 1.94 112.57 173.155 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -77.61 -35.55 52.64 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.561 -0.745 . . . . 1.9 112.58 174.307 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.36 -44.14 95.85 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.139 1.447 . . . . 1.55 113.378 167.975 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -73.29 -66.65 0.66 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 119.783 3.253 . . . . 2.95 119.783 -176.821 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -95.14 -48.6 5.87 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 128.377 2.671 . . . . 1.48 110.348 -174.725 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.91 -10.82 6.64 Favored Glycine 0 N--CA 1.43 -1.757 0 O-C-N 127.049 2.718 . . . . 1.12 117.104 173.362 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mm -71.68 132.19 85.48 Favored Pre-proline 0 N--CA 1.43 -1.428 0 O-C-N 119.367 -2.255 . . . . 2.07 109.178 -173.271 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.36 151.61 76.04 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 O-C-N 117.343 -1.978 . . . . 1.39 115.117 178.802 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.79 -25.49 74.74 Favored 'Trans proline' 0 N--CA 1.433 -2.035 1 C-N-CA 126.68 4.92 . . . . 1.68 112.703 -173.525 . . . . . . . . 3 3 . 1 . 113 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.85 -42.54 98.01 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 129.446 3.098 . . . . 2.25 108.38 -179.296 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -78.97 -22.72 45.21 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 117.469 2.396 . . . . 2.44 117.469 -177.998 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -85.89 129.0 34.96 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.205 1.479 . . . . 1.32 110.221 -169.567 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -116.29 117.33 29.71 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 125.156 2.407 . . . . 3.19 110.103 173.289 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.6 mt -96.27 128.16 42.93 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 114.336 -5.227 . . . . 1.75 105.936 179.098 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.3 mm -107.26 141.36 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 103.095 -2.928 . . . . 1.98 103.095 178.649 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.296 26.1 t80 -140.58 109.46 6.04 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.53 1.932 . . . . 1.94 108.137 176.894 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.371 . . 64.8 -75.46 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.51 2.324 . . . . 1.67 112.079 -172.101 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -137.44 -34.97 0.19 Allowed Glycine 0 N--CA 1.429 -1.824 0 O-C-N 123.999 0.812 . . . . 1.3 114.686 178.847 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -89.44 150.78 22.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.221 1.934 . . . . 2.89 116.221 -176.077 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -84.71 127.34 34.05 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 111.903 -2.408 . . . . 2.89 112.183 174.552 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.1 mt -81.91 148.44 28.75 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 121.057 1.753 . . . . 1.34 112.492 -168.548 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -98.27 148.67 23.39 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 118.605 -1.238 . . . . 1.94 113.697 179.765 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.471 ' CG ' ' HZ2' ' A' ' 27' ' ' LYS . 4.6 m-20 -60.69 -66.62 0.5 Allowed 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 116.197 -4.064 . . . . 1.56 117.288 -170.962 . . . . . . . . 3 3 . 1 . 113 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.27 32.25 0.32 Allowed Glycine 0 N--CA 1.432 -1.632 0 N-CA-C 122.607 3.803 . . . . 0.97 122.607 172.977 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -115.24 161.97 17.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.469 -2.049 . . . . 3.07 105.469 166.026 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 26.7 p -81.23 158.65 24.77 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.707 -1.871 . . . . 1.34 113.767 175.279 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.468 ' HG ' HD13 ' A' ' 23' ' ' ILE . 5.1 mt -65.78 -24.8 67.01 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.277 2.231 . . . . 1.63 114.591 175.757 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.4 p -83.46 -11.28 57.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.9 2.48 . . . . 1.51 111.467 178.667 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -61.85 -55.83 25.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.483 3.113 . . . . 1.9 108.089 167.26 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -76.81 -13.59 60.0 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 130.13 4.643 . . . . 0.97 113.713 -176.236 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 57.23 64.67 1.55 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 116.678 2.103 . . . . 2.35 116.678 -176.059 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.8 mm -78.54 104.53 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 105.549 -2.019 . . . . 1.39 105.549 174.892 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -73.32 169.94 16.07 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.056 1.342 . . . . 2.58 112.64 175.418 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -55.66 136.3 50.68 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.188 -3.445 . . . . 2.58 112.822 163.115 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 70.3 38.83 1.35 Allowed 'General case' 0 N--CA 1.429 -1.49 1 C-N-CA 135.946 5.698 . . . . 1.71 112.686 175.65 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.6 m -90.73 142.26 27.94 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 116.657 2.095 . . . . 1.34 116.657 -172.595 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.7 m -100.25 116.61 32.65 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 126.169 2.168 . . . . 1.36 107.224 -178.399 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -100.62 152.67 20.16 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.352 1.549 . . . . 2.03 111.362 168.875 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -120.93 130.53 53.9 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.086 -2.259 . . . . 2.31 107.511 -174.218 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 tp -112.14 118.2 34.7 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 116.574 2.064 . . . . 1.72 116.574 177.924 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.6 m -112.77 172.08 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 103.325 -2.843 . . . . 1.8 103.325 173.1 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.255 10.8 mt -127.83 150.21 49.94 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 113.857 -1.52 . . . . 3.26 112.428 178.111 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -98.39 111.23 23.64 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 125.185 1.394 . . . . 4.12 107.408 178.842 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.5 mp -79.03 159.41 27.61 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 104.622 -2.362 . . . . 3.54 104.622 176.812 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.0 mtm-85 -71.59 -50.76 27.91 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.762 -1.108 . . . . 7.32 111.855 178.412 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.41 70.28 1.7 Allowed Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 108.743 -1.743 . . . . 3.73 108.743 -173.062 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.775 0 C-N-CA 116.994 -2.527 . . . . 3.87 113.759 -175.764 . . . . . . . . 0 0 . 1 . 114 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 ptt? . . . . . 0 CA--C 1.489 -1.372 0 CA-C-O 116.273 -1.822 . . . . 1.39 111.64 . . . . . . . . . 0 0 . 1 . 114 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -99.6 138.85 36.11 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 125.214 1.571 . . . . 2.2 109.824 -173.49 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.5 pt -123.28 160.81 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 128.37 3.938 . . . . 1.32 108.281 173.641 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -119.07 133.22 55.93 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 115.195 -4.69 . . . . 2.2 106.61 -176.556 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.97 119.48 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 106.204 -1.776 . . . . 1.23 106.204 175.973 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -106.34 133.94 50.25 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 115.79 -4.318 . . . . 2.51 111.354 178.568 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.1 p -89.19 178.99 6.22 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.452 -2.03 . . . . 1.41 115.599 -174.144 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.451 HD11 ' H ' ' A' ' 71' ' ' LEU . 5.8 mt -78.11 -22.42 48.94 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 121.727 2.058 . . . . 2.95 109.985 173.379 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.3 p -80.54 -36.27 33.3 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.357 -2.714 . . . . 2.52 109.666 -178.921 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.67 53.82 0.66 Allowed Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 130.088 3.709 . . . . 1.5 119.824 175.957 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.415 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 68.2 tttt -122.74 137.24 54.98 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.102 3.361 . . . . 1.79 105.005 -176.696 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.8 m -105.68 121.54 44.21 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-O 124.42 2.057 . . . . 1.38 108.46 179.823 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.5 mt -99.32 140.5 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.357 -2.714 . . . . 2.03 107.882 174.852 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.8 m -106.75 98.61 8.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.096 -2.252 . . . . 1.61 110.835 -178.606 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.7 mt -95.18 140.84 29.53 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 121.521 1.964 . . . . 2.15 112.933 179.942 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -97.29 134.41 40.62 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.989 -2.319 . . . . 1.98 109.16 169.772 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 m -138.87 156.66 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 127.042 2.137 . . . . 1.52 107.063 -174.141 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -106.37 160.75 25.11 Favored Pre-proline 0 N--CA 1.43 -1.446 0 O-C-N 118.197 -2.815 . . . . 2.35 107.317 162.671 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -71.25 -7.85 22.19 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 CA-C-N 124.394 2.605 . . . . 1.31 112.235 -172.136 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.3 p -93.89 -14.37 26.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.037 2.135 . . . . 1.71 111.894 -174.141 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -65.39 149.29 50.26 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 130.16 3.384 . . . . 1.69 105.635 174.246 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.428 HG21 HG21 ' A' ' 55' ' ' THR . 68.6 p -96.44 170.93 8.89 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 117.235 -1.364 . . . . 1.33 111.097 178.568 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.7 mm -62.16 -32.6 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.413 0 C-N-CA 126.658 1.983 . . . . 1.32 111.366 170.508 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.295 35.5 tt0 -54.15 -51.35 64.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.581 3.552 . . . . 1.62 108.86 169.453 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -57.22 -37.69 72.63 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.557 -2.59 . . . . 2.13 114.918 174.354 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.3 t -62.79 -44.82 99.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 114.803 1.408 . . . . 1.23 114.803 175.091 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -65.86 -30.2 70.78 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 129.539 3.136 . . . . 1.97 113.465 173.451 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.19 83.18 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.864 -3.648 . . . . 1.19 111.101 179.738 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -61.96 -42.37 99.04 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.529 -3.232 . . . . 1.92 115.203 174.0 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.1 mt -72.95 -23.75 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 123.439 1.59 . . . . 1.94 110.513 175.995 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -70.12 -35.01 73.8 Favored 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 114.517 -5.114 . . . . 1.9 112.623 169.559 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.69 -48.7 78.16 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.783 2.706 . . . . 1.55 112.558 175.412 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -82.55 -63.04 1.45 Allowed 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 114.406 -5.184 . . . . 2.95 114.88 -178.975 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.415 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 43.3 mm-40 -85.49 -15.4 42.95 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.948 -3.595 . . . . 1.48 116.918 -168.658 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.37 31.45 54.61 Favored Glycine 0 N--CA 1.429 -1.776 0 O-C-N 119.725 -1.859 . . . . 1.12 114.617 176.543 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mt -101.25 135.43 19.89 Favored Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 108.452 -0.944 . . . . 2.07 108.452 -173.702 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -68.1 151.26 77.44 Favored 'Trans proline' 0 N--CA 1.433 -2.03 0 CA-C-N 123.884 2.423 . . . . 1.39 111.608 179.901 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -73.17 -20.63 21.27 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-N 126.515 3.362 . . . . 1.68 111.242 -173.478 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -65.7 -29.99 70.61 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 126.191 2.9 . . . . 2.25 112.805 174.463 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -81.74 -25.7 35.15 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 114.667 -5.021 . . . . 2.44 107.944 -177.566 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -82.92 119.3 24.24 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.839 -2.413 . . . . 1.32 110.991 -169.775 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.358 80.2 mtp180 -108.18 124.98 51.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.519 -1.219 . . . . 3.19 110.229 163.942 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -107.2 116.73 32.44 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.431 2.539 . . . . 1.75 104.554 -177.771 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.3 mt -111.44 137.28 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 O-C-N 119.939 -1.726 . . . . 1.98 112.982 176.552 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -148.98 132.67 16.87 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 124.15 0.98 . . . . 1.94 111.089 174.249 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.354 . . 49.38 25.03 1.18 Allowed 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 120.256 3.428 . . . . 1.67 120.256 171.199 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.11 7.55 26.73 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 121.477 -0.765 . . . . 1.3 114.591 -177.881 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -149.0 153.53 38.06 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.442 -2.799 . . . . 2.89 110.632 -176.813 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -96.64 128.34 43.48 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 113.912 -1.495 . . . . 2.89 111.662 171.224 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.2 mt -81.49 121.21 25.99 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.648 2.468 . . . . 1.34 115.691 -174.593 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -73.72 137.32 43.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.094 2.627 . . . . 1.94 118.094 177.098 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -40.27 -64.49 0.5 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 131.431 3.892 . . . . 1.56 117.397 -171.319 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.31 16.64 12.5 Favored Glycine 0 N--CA 1.429 -1.798 1 CA-C-O 112.011 -4.772 . . . . 0.97 118.745 175.275 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.0 mtt180 -95.46 161.56 14.02 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 121.155 2.478 . . . . 3.07 110.163 171.632 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.428 HG21 HG21 ' A' ' 22' ' ' THR . 19.3 p -97.56 170.63 8.9 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 117.179 -1.809 . . . . 1.34 114.596 172.94 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.85 -39.79 82.36 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.274 -2.239 . . . . 1.63 111.828 176.506 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.3 t -61.75 -44.24 97.29 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 130.118 3.367 . . . . 1.51 113.56 175.067 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -59.57 -24.83 64.08 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 115.224 1.565 . . . . 1.9 115.224 174.201 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -106.36 9.45 31.85 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.069 -2.895 . . . . 0.97 112.601 175.08 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.6 m120 44.68 62.77 1.93 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 128.163 2.585 . . . . 2.35 114.155 -177.579 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.7 mt -108.35 127.55 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 129.398 3.079 . . . . 1.39 107.183 176.511 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -106.71 -174.11 2.46 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.541 2.336 . . . . 2.58 110.979 -172.978 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.2 ptmm? -61.2 148.16 41.81 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 114.73 1.382 . . . . 2.58 114.73 174.811 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 62.75 37.89 12.21 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 126.51 3.053 . . . . 1.71 112.921 169.957 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.7 m -84.03 133.06 34.68 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.924 2.297 . . . . 1.34 110.665 178.079 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.7 m -93.39 104.82 16.95 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.202 -2.186 . . . . 1.36 109.3 176.344 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.6 mt -88.1 147.38 24.97 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 123.184 0.593 . . . . 2.03 110.066 174.296 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -97.68 121.52 39.69 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 116.917 -1.516 . . . . 2.31 113.815 173.622 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.9 tp -91.01 111.97 23.66 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.591 2.756 . . . . 1.72 108.491 175.942 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.7 t -112.11 141.83 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 114.579 -1.192 . . . . 1.8 109.151 172.156 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.451 ' H ' HD11 ' A' ' 8' ' ' LEU . 64.4 mt -110.89 132.99 53.74 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 119.61 3.189 . . . . 3.26 119.61 179.639 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -85.39 153.65 22.38 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.391 1.476 . . . . 4.12 109.185 -178.29 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.1 tp -116.7 109.58 17.34 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.512 -1.676 . . . . 3.54 115.436 179.529 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -82.14 -53.99 5.64 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 124.873 1.269 . . . . 7.32 108.03 173.785 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 131.2 -65.82 0.59 Allowed Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 105.62 -2.992 . . . . 3.73 105.62 -166.448 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.704 0 CA-C-O 115.875 -2.625 . . . . 3.87 114.065 -179.362 . . . . . . . . 0 0 . 1 . 115 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ptt? . . . . . 0 CA--C 1.489 -1.371 0 N-CA-C 112.624 0.601 . . . . 1.39 112.624 . . . . . . . . . 0 0 . 1 . 115 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.338 0.0 OUTLIER -97.83 133.72 41.95 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.129 -1.607 . . . . 2.2 111.446 179.286 . . . . . . . . 3 3 . 1 . 115 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.3 pt -115.74 158.88 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 103.637 -2.727 . . . . 1.32 103.637 169.74 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -112.34 137.89 49.85 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.452 2.701 . . . . 2.2 107.302 178.92 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.447 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 55.9 t -118.15 123.15 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 102.226 -3.25 . . . . 1.23 102.226 174.291 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.7 tppt? -100.36 126.96 46.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 126.144 2.878 . . . . 2.51 105.33 175.687 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 p -78.3 -162.91 0.39 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 120.253 3.427 . . . . 1.41 120.253 173.463 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 mt -88.31 -34.73 17.56 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 117.294 -1.336 . . . . 2.95 112.831 173.66 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 p -68.38 -32.74 73.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 127.536 2.334 . . . . 2.52 106.999 173.266 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.67 35.29 2.26 Favored Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 127.592 2.52 . . . . 1.5 107.744 168.367 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -80.57 134.36 35.91 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.258 -2.867 . . . . 1.79 103.258 178.876 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.9 m -95.02 91.49 6.39 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.855 -1.521 . . . . 1.38 114.341 175.042 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.447 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 13.4 mt -88.38 119.13 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 123.848 1.785 . . . . 2.03 106.714 -175.449 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.1 m -90.44 126.88 36.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.062 -2.273 . . . . 1.61 110.37 -177.268 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.5 mt -128.18 134.12 49.0 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.221 -3.424 . . . . 2.15 106.246 -175.238 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -98.15 132.24 43.84 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.615 -1.624 . . . . 1.98 106.615 171.87 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 m -140.61 164.79 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 126.962 2.105 . . . . 1.52 109.621 -173.938 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -109.58 151.92 42.5 Favored Pre-proline 0 N--CA 1.43 -1.454 0 CA-C-O 114.486 -2.673 . . . . 2.35 112.651 160.373 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -70.52 -14.93 34.14 Favored 'Trans proline' 0 N--CA 1.433 -2.058 0 C-N-CA 125.09 3.86 . . . . 1.31 109.715 -165.29 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.1 m -82.93 -9.95 59.05 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 122.346 2.339 . . . . 1.71 108.974 176.919 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -66.74 142.5 57.37 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.443 3.497 . . . . 1.69 112.43 172.732 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 p -83.19 171.58 13.51 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 113.121 -5.987 . . . . 1.33 110.142 -174.632 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.1 mm -75.57 -30.55 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 122.949 1.357 . . . . 1.32 109.783 179.098 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.253 38.2 tt0 -45.34 -42.85 10.38 Favored 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 117.977 -2.952 . . . . 1.62 117.49 157.925 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -68.35 -38.52 81.55 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 125.336 1.648 . . . . 2.13 110.968 176.49 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.1 t -62.67 -35.28 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 125.156 2.408 . . . . 1.23 115.094 177.844 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -68.31 -38.42 81.58 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.163 -1.586 . . . . 1.97 115.093 166.269 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.68 -22.42 66.63 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 118.465 2.765 . . . . 1.19 118.465 169.796 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -84.45 -29.48 26.06 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.675 -1.891 . . . . 1.92 111.901 173.947 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.8 mt -70.49 -38.06 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 124.164 1.935 . . . . 1.94 114.752 170.662 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.435 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 10.8 tt0 -65.51 -42.53 91.96 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 128.208 2.603 . . . . 1.9 109.66 171.926 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -58.09 -52.48 65.35 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.348 -3.345 . . . . 1.55 113.116 172.469 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -64.09 -66.32 0.56 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.618 3.58 . . . . 2.95 111.818 -176.179 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -89.84 -44.59 9.84 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 110.654 -2.976 . . . . 1.48 112.956 -172.119 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 113.42 0.69 24.89 Favored Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 117.649 1.82 . . . . 1.12 117.649 -177.899 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 mt -68.49 121.26 80.08 Favored Pre-proline 0 N--CA 1.429 -1.488 0 O-C-N 118.77 -2.606 . . . . 2.07 107.003 -176.549 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -67.88 164.68 30.7 Favored 'Trans proline' 0 N--CA 1.434 -1.989 1 C-N-CA 125.739 4.293 . . . . 1.39 112.126 -176.459 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -67.45 -34.16 27.2 Favored 'Trans proline' 0 N--CA 1.433 -2.05 1 C-N-CA 125.758 4.305 . . . . 1.68 113.173 -175.223 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -44.17 -48.94 9.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 126.604 3.097 . . . . 2.25 114.211 173.762 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -83.98 -17.0 41.99 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.146 -2.846 . . . . 2.44 115.951 -170.93 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -85.49 134.29 34.05 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.439 1.896 . . . . 1.32 111.218 -168.875 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -121.14 114.64 21.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 130.388 3.475 . . . . 3.19 108.606 167.467 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.4 mt -88.9 116.97 27.57 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.627 -1.921 . . . . 1.75 112.578 173.866 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.6 mm -106.4 141.1 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 102.652 -3.092 . . . . 1.98 102.652 -178.431 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -132.24 97.58 4.16 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 100.378 -3.934 . . . . 1.94 100.378 174.976 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.36 . . 79.5 -86.62 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.096 2.159 . . . . 1.67 106.858 -179.309 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.57 -6.55 1.8 Allowed Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 128.668 3.032 . . . . 1.3 111.179 -178.017 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -92.87 131.1 38.2 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.403 2.681 . . . . 2.89 109.135 -177.114 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -81.66 114.59 20.44 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 112.364 -2.198 . . . . 2.89 110.776 175.234 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.8 mt -83.23 148.62 27.3 Favored 'General case' 0 N--CA 1.431 -1.407 1 O-C-N 115.198 -4.689 . . . . 1.34 112.267 -174.521 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -100.3 149.36 23.68 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.499 1.919 . . . . 1.94 113.291 172.852 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -61.67 -61.15 2.72 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 130.49 3.516 . . . . 1.56 112.222 -169.525 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.82 20.52 0.2 Allowed Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 122.285 3.674 . . . . 0.97 122.285 171.705 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -107.67 154.13 21.92 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.135 -1.803 . . . . 3.07 113.042 167.02 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.426 ' HG1' ' CG ' ' A' ' 58' ' ' ASP . 43.3 p -94.21 168.45 10.91 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.805 2.891 . . . . 1.34 118.805 177.999 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 56.4 mt -62.77 -43.05 99.82 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.887 -1.758 . . . . 1.63 109.916 174.316 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 t -55.36 -43.66 75.27 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 120.342 3.46 . . . . 1.51 120.342 174.719 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.426 ' CG ' ' HG1' ' A' ' 55' ' ' THR . 80.9 m-20 -54.45 -42.2 70.34 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 128.287 2.635 . . . . 1.9 110.87 177.687 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -95.03 11.39 32.2 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 115.289 1.589 . . . . 0.97 115.289 -178.65 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 52.45 50.0 19.22 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 129.038 2.935 . . . . 2.35 110.98 -177.798 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.412 HD12 HG22 ' A' ' 61' ' ' ILE . 96.0 mt -91.94 114.19 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 N-CA-C 106.621 -1.622 . . . . 1.39 106.621 -179.068 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -94.16 -170.67 2.35 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 125.197 2.427 . . . . 2.58 109.494 -177.153 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.321 17.8 pttp -67.39 150.82 48.44 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 111.695 -2.502 . . . . 2.58 117.416 168.769 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.343 17.2 mt-10 68.38 9.52 7.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.942 2.201 . . . . 1.71 116.942 170.156 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.3 t -94.36 138.76 31.94 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 131.034 3.734 . . . . 1.34 107.855 -175.82 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.2 m -85.99 122.95 30.74 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 115.969 1.84 . . . . 1.36 115.969 179.225 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mp -99.78 157.45 16.49 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 101.472 -3.529 . . . . 2.03 101.472 169.674 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -121.04 117.27 26.81 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 113.995 1.109 . . . . 2.31 113.995 179.956 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.7 tp -88.85 110.37 21.0 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.413 2.054 . . . . 1.72 113.185 -178.713 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.7 t -107.04 147.82 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 117.981 -2.949 . . . . 1.8 106.124 171.605 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.0 mt -109.0 154.37 22.28 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.159 -2.213 . . . . 3.26 109.437 -179.532 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -115.33 131.04 57.05 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.47 -2.018 . . . . 4.12 108.737 179.302 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.19 142.92 27.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.109 -3.495 . . . . 3.54 108.452 178.784 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -62.4 92.42 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 118.151 2.649 . . . . 7.32 118.151 174.101 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.75 59.73 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.706 0 O-C-N 119.46 -2.025 . . . . 3.73 108.831 -163.857 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.792 0 N-CA-C 119.267 2.467 . . . . 3.87 119.267 -177.378 . . . . . . . . 0 0 . 1 . 116 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 119.322 -0.37 . . . . 1.39 110.208 . . . . . . . . . 0 0 . 1 . 116 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -102.7 132.42 48.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.66 -2.525 . . . . 2.2 106.83 -179.249 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.0 pt -132.42 167.02 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-O 116.376 -1.773 . . . . 1.32 108.001 173.923 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -124.1 149.08 46.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 122.349 2.34 . . . . 2.2 115.282 176.75 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 t -128.42 119.48 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 102.858 -3.016 . . . . 1.23 102.858 171.024 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -109.82 129.1 55.67 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 111.329 -2.669 . . . . 2.51 109.595 176.258 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 p -89.89 -173.87 4.05 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 126.546 3.069 . . . . 1.41 109.205 178.555 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.6 mt -91.48 3.66 54.43 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.678 -3.764 . . . . 2.95 117.739 169.51 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.2 p -76.6 -31.14 57.27 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.861 2.465 . . . . 2.52 108.578 177.899 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.22 -29.35 3.69 Favored Glycine 0 N--CA 1.43 -1.739 1 N-CA-C 102.78 -4.128 . . . . 1.5 102.78 179.904 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -63.58 131.21 47.33 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.406 2.002 . . . . 1.79 116.406 -170.898 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.9 m -102.1 117.48 34.89 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.345 -1.298 . . . . 1.38 108.895 169.112 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.283 7.7 mt -103.83 109.69 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 129.047 2.939 . . . . 2.03 106.243 -177.2 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.6 m -83.36 131.6 35.05 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.479 1.133 . . . . 1.61 110.21 177.559 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.3 mt -134.06 140.56 46.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.037 -2.289 . . . . 2.15 108.61 -175.759 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -84.3 124.14 30.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.487 2.715 . . . . 1.98 108.583 174.175 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.344 4.1 m -134.42 149.3 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 O-C-N 118.353 -2.717 . . . . 1.52 113.258 -176.423 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -95.73 141.72 23.57 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 115.233 -2.318 . . . . 2.35 105.331 165.291 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -81.98 -15.54 9.22 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 CA-C-N 126.484 3.351 . . . . 1.31 111.512 -167.899 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.8 m -71.56 -11.78 61.03 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 120.734 -1.229 . . . . 1.71 114.08 174.948 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -67.49 159.04 30.47 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.471 2.082 . . . . 1.69 112.235 177.455 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.6 p -87.12 177.37 7.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.323 -2.736 . . . . 1.33 109.1 -177.699 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.1 mt -84.12 -24.0 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 1 O-C-N 114.307 -5.246 . . . . 1.32 114.899 171.671 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.08 -28.39 69.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.153 1.908 . . . . 1.62 116.153 163.049 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -73.29 -36.27 66.26 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 121.221 1.828 . . . . 2.13 111.888 173.889 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.8 t -63.01 -48.8 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 128.504 2.722 . . . . 1.23 114.243 176.421 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -57.91 -33.96 69.32 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.633 2.086 . . . . 1.97 116.633 176.353 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.21 -24.16 67.75 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.227 1.936 . . . . 1.19 116.227 169.827 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -72.86 -31.66 64.89 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 126.397 2.999 . . . . 1.92 116.355 172.947 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.5 mm -68.37 -27.95 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 O-C-N 117.678 -3.139 . . . . 1.94 106.702 169.758 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.402 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 41.6 tt0 -71.49 -39.0 71.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.924 -2.36 . . . . 1.9 112.277 172.283 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -63.04 -41.43 99.51 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 118.227 2.677 . . . . 1.55 118.227 171.603 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -83.96 -58.16 2.9 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.824 2.05 . . . . 2.95 111.941 -174.878 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -97.99 -42.64 7.42 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.491 1.516 . . . . 1.48 109.698 -173.905 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 94.62 57.33 1.27 Allowed Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 128.142 2.782 . . . . 1.12 111.899 179.387 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.1 mt -115.23 122.31 33.47 Favored Pre-proline 0 N--CA 1.431 -1.423 0 N-CA-C 101.927 -3.36 . . . . 2.07 101.927 -177.957 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -66.94 149.29 82.99 Favored 'Trans proline' 0 C--N 1.3 -2.024 1 CA-C-O 108.871 -4.72 . . . . 1.39 108.283 -174.134 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -66.48 -8.54 21.13 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 CA-C-N 127.15 3.589 . . . . 1.68 116.496 -174.645 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.95 -35.16 62.14 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.234 1.969 . . . . 2.25 115.134 175.771 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -81.11 -15.68 55.24 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.214 -3.429 . . . . 2.44 111.753 -177.573 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -70.65 116.49 11.02 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.649 1.98 . . . . 1.32 112.875 -175.202 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.404 HH12 ' C ' ' A' ' 76' ' ' GLY . 64.2 mtt180 -106.35 124.84 50.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.885 -3.009 . . . . 3.19 105.537 175.561 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.0 tp -112.46 125.58 54.38 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 123.987 1.851 . . . . 1.75 107.085 -175.674 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.1 mm -114.74 125.99 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 O-C-N 120.283 -1.511 . . . . 1.98 110.01 -175.733 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -138.22 118.73 13.86 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.987 -1.857 . . . . 1.94 105.987 171.512 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.6 35.99 1.75 Allowed 'General case' 0 N--CA 1.431 -1.421 1 CA-C-O 129.417 4.437 . . . . 1.67 115.946 175.195 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.29 -21.47 28.28 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 110.423 -3.081 . . . . 1.3 115.052 -175.925 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -100.43 148.38 24.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.138 2.273 . . . . 2.89 117.138 -178.524 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -76.49 119.33 20.19 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 129.901 3.281 . . . . 2.89 109.43 169.819 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.5 HD22 ' CG ' ' A' ' 59' ' ' TYR . 20.5 mt -85.92 147.04 26.43 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.675 2.179 . . . . 1.34 116.85 -177.073 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -92.21 136.65 33.02 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 117.382 -3.324 . . . . 1.94 115.087 176.297 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -66.1 -42.54 89.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.884 -3.01 . . . . 1.56 116.258 -173.19 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.88 -13.95 62.39 Favored Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 125.32 1.438 . . . . 0.97 116.673 169.317 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -77.99 160.55 28.1 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 121.027 2.414 . . . . 3.07 112.306 174.115 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.261 60.8 p -91.15 159.5 16.05 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 116.41 -3.931 . . . . 1.34 110.805 177.331 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.511 HD21 HD12 ' A' ' 61' ' ' ILE . 6.1 mt -70.05 -26.25 63.94 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.285 -1.78 . . . . 1.63 110.095 179.852 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.5 p -77.07 -30.85 55.66 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.079 2.552 . . . . 1.51 111.799 176.527 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.284 3.5 t70 -60.89 -43.18 98.83 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.051 -3.53 . . . . 1.9 114.31 172.35 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.5 ' CG ' HD22 ' A' ' 50' ' ' LEU . 35.6 m-85 -85.27 -6.0 59.28 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 116.743 -1.599 . . . . 0.97 113.293 170.734 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.37 55.6 t30 68.9 50.54 0.61 Allowed 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 123.455 2.843 . . . . 2.35 113.11 175.79 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.511 HD12 HD21 ' A' ' 56' ' ' LEU . 68.2 mt -100.42 124.11 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 105.605 -1.998 . . . . 1.39 105.605 176.169 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -110.82 -173.1 2.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 129.337 3.055 . . . . 2.58 113.504 -177.832 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.314 26.2 tttm -46.4 124.05 5.43 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.961 2.505 . . . . 2.58 112.726 174.568 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.399 44.1 mt-10 61.9 43.16 9.53 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.235 3.014 . . . . 1.71 117.522 174.203 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 t -99.36 153.41 19.0 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.527 2.108 . . . . 1.34 109.876 -175.424 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.287 11.8 m -97.25 107.41 19.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.721 -1.862 . . . . 1.36 113.81 178.465 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.8 mt -88.34 139.8 30.12 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.414 -1.328 . . . . 2.03 107.414 170.196 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -107.38 133.55 51.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 124.628 1.205 . . . . 2.31 109.069 -177.972 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.329 36.9 tp -111.33 121.1 44.36 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 127.161 2.788 . . . . 1.72 109.473 -178.802 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.9 m -117.78 164.99 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 116.923 -1.513 . . . . 1.8 111.03 168.787 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.6 mt -105.02 159.66 15.65 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 122.223 2.283 . . . . 3.26 113.972 176.19 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -73.68 136.12 43.77 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 119.8 -1.813 . . . . 4.12 114.804 -174.646 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.5 mt -112.8 154.03 26.89 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.288 2.635 . . . . 3.54 110.512 166.959 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -81.48 150.45 28.28 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 126.051 2.834 . . . . 7.32 114.716 167.734 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.75 -87.54 1.08 Allowed Glycine 0 N--CA 1.431 -1.688 0 O-C-N 118.286 -2.758 . . . . 3.73 115.539 -164.73 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.404 ' C ' HH12 ' A' ' 42' ' ' ARG . . . . . . . . 0 N--CA 1.43 -1.731 0 O-C-N 117.583 -3.304 . . . . 3.87 113.69 -179.822 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 114.926 1.454 . . . . 1.39 114.926 . . . . . . . . . 0 0 . 1 . 117 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -101.39 112.77 25.39 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.226 1.81 . . . . 2.2 107.537 -179.504 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -100.42 174.43 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 127.168 2.187 . . . . 1.32 114.183 166.908 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -123.83 141.37 52.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.969 -2.332 . . . . 2.2 110.869 -175.0 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.0 t -106.03 119.37 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 118.026 -2.921 . . . . 1.23 112.372 166.676 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -98.37 119.14 36.54 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 116.468 -3.895 . . . . 2.51 108.716 176.723 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p -73.57 173.26 9.96 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.601 -3.187 . . . . 1.41 119.599 174.036 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.2 mt -53.41 -54.06 42.28 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 118.157 2.651 . . . . 2.95 118.157 170.401 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.4 p -69.23 -24.59 64.03 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 126.393 2.308 . . . . 2.52 111.015 -177.748 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.21 38.07 0.97 Allowed Glycine 0 N--CA 1.43 -1.712 0 O-C-N 119.526 -1.984 . . . . 1.5 112.707 170.25 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -109.98 131.07 55.39 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.867 -3.137 . . . . 1.79 107.023 -173.149 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -89.68 106.62 18.58 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.857 2.063 . . . . 1.38 114.316 177.841 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.4 mt -104.99 120.37 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 103.502 -2.777 . . . . 2.03 103.502 -178.128 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -86.33 132.95 33.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.761 -1.109 . . . . 1.61 111.978 178.971 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.3 mt -136.53 132.9 35.87 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 115.208 -2.33 . . . . 2.15 114.893 -175.698 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -84.39 114.32 21.81 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 131.258 3.823 . . . . 1.98 111.48 173.974 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.403 HG13 HG22 ' A' ' 26' ' ' VAL . 5.5 m -140.77 167.1 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-O 125.097 2.38 . . . . 1.52 106.131 178.763 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -121.07 158.28 53.08 Favored Pre-proline 0 N--CA 1.431 -1.425 0 O-C-N 118.518 -2.613 . . . . 2.35 111.571 168.26 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -59.14 -16.53 33.95 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 O-C-N 111.538 -5.032 . . . . 1.31 116.41 -176.45 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.7 p -79.14 -5.29 53.82 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.086 1.513 . . . . 1.71 115.086 171.691 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.27 46.5 m-20 -76.93 142.62 40.0 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.779 -1.201 . . . . 1.69 109.743 -178.395 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.3 p -86.35 161.08 18.89 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.073 -1.084 . . . . 1.33 108.073 179.761 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.8 mm -58.03 -42.24 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 122.324 1.059 . . . . 1.32 110.727 176.291 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -37.66 -54.01 1.21 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 119.142 3.015 . . . . 1.62 119.142 160.864 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -55.77 -41.9 74.72 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.591 2.756 . . . . 2.13 113.315 176.905 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.403 HG22 HG13 ' A' ' 17' ' ' VAL . 39.6 t -61.66 -50.96 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 126.282 1.833 . . . . 1.23 111.742 173.55 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.4 mttt -61.47 -27.9 68.9 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.458 -3.276 . . . . 1.97 118.237 175.248 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.53 -27.57 64.27 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.56 2.124 . . . . 1.19 113.943 178.0 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -76.47 -36.51 57.82 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.803 -2.436 . . . . 1.92 112.479 176.044 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.56 -30.05 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.908 -1.496 . . . . 1.94 114.808 161.574 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -68.6 -33.36 73.91 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.448 1.476 . . . . 1.9 113.627 179.003 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -78.3 -53.85 6.85 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 117.235 -1.786 . . . . 1.55 115.092 166.354 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -59.19 -43.51 92.19 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 115.153 -2.356 . . . . 2.95 117.309 -174.925 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -108.14 -26.65 10.51 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 126.702 2.501 . . . . 1.48 110.524 -172.713 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.52 48.89 3.83 Favored Glycine 0 N--CA 1.43 -1.767 0 O-C-N 119.987 -1.695 . . . . 1.12 111.914 171.212 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.4 mt -128.57 125.37 23.11 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-O 115.622 -2.133 . . . . 2.07 109.822 -177.876 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -66.85 148.76 82.92 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-N 125.484 2.994 . . . . 1.39 114.094 178.16 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -69.33 -14.1 36.85 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 N-CA-C 116.63 1.742 . . . . 1.68 116.63 -170.933 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.56 -29.67 70.75 Favored 'General case' 0 N--CA 1.43 -1.449 1 C-N-CA 132.514 4.326 . . . . 2.25 109.029 169.788 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -90.87 -31.1 16.56 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.482 1.66 . . . . 2.44 115.482 -178.697 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.281 77.4 mt-30 -81.08 134.3 35.63 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.856 -1.164 . . . . 1.32 107.856 -175.012 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -121.15 133.4 55.2 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.914 -2.991 . . . . 3.19 105.98 168.898 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.2 mt -98.01 126.49 43.46 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 105.781 -1.933 . . . . 1.75 105.781 -177.905 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 mm -110.84 138.86 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-N 122.466 2.393 . . . . 1.98 104.616 -178.407 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.444 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 81.0 t80 -144.48 130.15 19.11 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 106.376 -1.713 . . . . 1.94 106.376 163.49 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.05 24.78 14.86 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 120.381 3.474 . . . . 1.67 120.381 177.771 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.86 -18.51 57.39 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 115.72 -2.711 . . . . 1.3 108.439 -179.785 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 41.0 pttt -101.22 156.72 17.27 Favored 'General case' 0 N--CA 1.431 -1.422 1 CA-C-N 124.847 4.323 . . . . 2.89 111.028 177.382 . . . . . . . . 3 3 . 1 . 117 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.291 39.9 tt0 -96.74 144.57 26.61 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.858 2.742 . . . . 2.89 107.95 175.185 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.6 mt -92.45 148.09 22.38 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.472 -3.268 . . . . 1.34 109.129 -178.727 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -92.93 144.45 25.25 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 130.611 3.564 . . . . 1.94 112.813 -179.522 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -63.64 -54.91 28.34 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.284 -3.385 . . . . 1.56 115.665 -167.479 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.86 42.36 3.05 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-O 123.299 1.5 . . . . 0.97 115.51 173.036 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -110.43 152.95 25.69 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.362 -2.257 . . . . 3.07 105.253 165.281 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.7 p -103.1 158.82 16.04 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.86 2.064 . . . . 1.34 108.256 -177.99 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.0 mt -65.44 -28.31 69.14 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 128.484 2.714 . . . . 1.63 108.378 176.042 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 p -64.59 -40.99 96.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.285 2.634 . . . . 1.51 115.461 171.874 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -65.24 -35.24 80.43 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 124.235 0.959 . . . . 1.9 113.411 176.623 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -85.43 3.1 41.67 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.336 1.606 . . . . 0.97 115.336 179.595 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.0 m120 56.02 32.27 19.62 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 110.698 -2.956 . . . . 2.35 117.895 -174.232 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.6 mm -72.17 130.02 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 1 O-C-N 115.325 -4.609 . . . . 1.39 116.582 176.594 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -117.61 174.81 5.95 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 128.115 2.566 . . . . 2.58 107.049 -168.106 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -54.32 152.8 5.96 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.058 1.503 . . . . 2.58 115.058 172.858 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.37 35.0 mt-10 73.55 14.03 4.37 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 125.554 2.597 . . . . 1.71 115.282 172.112 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.327 27.3 m -78.51 124.39 28.1 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 116.303 1.964 . . . . 1.34 116.303 -175.019 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.6 m -89.59 99.87 12.78 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 118.134 2.642 . . . . 1.36 118.134 177.913 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.5 mt -86.52 139.06 31.23 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.302 -2.481 . . . . 2.03 104.302 176.547 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -97.29 141.5 30.32 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.747 -3.096 . . . . 2.31 108.832 174.685 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.0 tp -106.62 125.62 51.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.11 1.909 . . . . 1.72 111.382 179.954 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.12 163.89 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 105.063 -2.199 . . . . 1.8 105.063 174.695 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.9 mt -127.61 129.57 47.49 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 101.799 -3.408 . . . . 3.26 101.799 -176.672 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.1 ptt85 -81.23 166.89 20.18 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.976 -2.952 . . . . 4.12 108.372 173.603 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.7 mt -84.39 157.52 21.4 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 116.336 -3.978 . . . . 3.54 107.752 170.473 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.422 HH21 ' C ' ' A' ' 76' ' ' GLY . 62.3 mtp180 -114.79 -120.87 0.3 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.559 -1.655 . . . . 7.32 110.009 -177.605 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.91 -22.69 6.02 Favored Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 106.264 -2.735 . . . . 3.73 106.264 -161.492 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.422 ' C ' HH21 ' A' ' 74' ' ' ARG . . . . . . . . 0 C--O 1.261 1.792 0 N-CA-C 107.929 -2.068 . . . . 3.87 107.929 -179.16 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 ttp . . . . . 0 CA--C 1.491 -1.326 0 CA-C-O 118.61 -0.709 . . . . 1.39 112.597 . . . . . . . . . 0 0 . 1 . 118 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -94.31 133.54 37.75 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.562 -2.586 . . . . 2.2 111.716 178.576 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -123.37 159.34 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.269 2.628 . . . . 1.32 106.859 175.278 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.297 44.3 m-85 -128.96 121.71 28.6 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 123.887 1.803 . . . . 2.2 110.679 -177.604 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.52 105.01 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 125.851 2.739 . . . . 1.23 110.757 175.308 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -88.13 138.59 31.31 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.547 -3.221 . . . . 2.51 110.066 176.241 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.9 p -90.52 -177.67 5.11 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 127.989 3.306 . . . . 1.41 116.18 -174.405 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.7 mt -82.74 -26.18 32.16 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.564 -1.96 . . . . 2.95 113.169 163.674 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.1 p -64.35 -62.58 1.52 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.507 1.923 . . . . 2.52 114.758 -174.262 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.49 31.61 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.757 0 N-CA-C 105.234 -3.147 . . . . 1.5 105.234 174.826 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -117.61 128.42 54.92 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 123.618 1.675 . . . . 1.79 109.025 -172.493 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.6 m -107.08 102.32 11.67 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 104.526 -2.398 . . . . 1.38 104.526 176.412 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.8 pt -91.27 133.06 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 120.778 1.626 . . . . 2.03 109.998 176.924 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.9 m -91.53 151.19 20.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 121.183 -0.948 . . . . 1.61 108.565 175.544 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.1 mt -144.31 139.39 28.52 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.106 -1.813 . . . . 2.15 106.106 176.48 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -78.0 116.19 18.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.101 1.519 . . . . 1.98 115.101 165.085 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.277 11.3 m -127.75 151.22 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 127.672 2.389 . . . . 1.52 106.839 178.49 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -94.87 161.96 26.8 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 118.107 -2.871 . . . . 2.35 112.622 157.828 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -73.45 -20.95 20.21 Favored 'Trans proline' 0 N--CA 1.433 -2.072 0 CA-C-N 126.69 3.425 . . . . 1.31 115.743 -174.895 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 p -72.59 5.32 3.14 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.488 3.915 . . . . 1.71 114.039 169.011 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -95.82 135.16 37.9 Favored 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 117.775 -3.078 . . . . 1.69 112.909 -179.604 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 26.6 p -67.79 173.98 3.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.21 -2.268 . . . . 1.33 114.225 177.414 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.6 mm -84.88 -29.7 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 118.143 -2.848 . . . . 1.32 105.156 176.861 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -48.95 -48.34 43.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.228 -2.795 . . . . 1.62 116.55 163.622 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -51.87 -50.27 61.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.861 -2.399 . . . . 2.13 115.148 167.369 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.2 t -55.97 -42.75 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 114.73 -2.557 . . . . 1.23 115.246 177.409 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -64.15 -41.11 97.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 125.101 2.382 . . . . 1.97 116.337 174.896 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.85 -43.73 81.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.51 3.124 . . . . 1.19 115.893 166.983 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -58.86 -33.29 70.29 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 116.248 -4.033 . . . . 1.92 113.835 170.616 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.9 mt -78.79 -31.09 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 112.907 -1.951 . . . . 1.94 108.969 176.521 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -71.15 -40.35 71.4 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 115.53 1.678 . . . . 1.9 115.53 177.868 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -58.01 -52.11 66.88 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.932 1.456 . . . . 1.55 114.932 168.001 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.2 tttp -70.23 -71.66 0.23 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.579 2.751 . . . . 2.95 113.361 -172.374 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -90.58 -34.24 15.57 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.048 -1.658 . . . . 1.48 111.616 -162.798 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.47 5.55 22.59 Favored Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 105.089 -3.204 . . . . 1.12 105.089 175.593 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.9 mt -80.17 122.37 82.86 Favored Pre-proline 0 N--CA 1.431 -1.41 0 CA-C-N 119.087 1.443 . . . . 2.07 108.475 -175.799 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -68.31 150.75 76.52 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 C-N-CA 124.58 3.52 . . . . 1.39 110.653 -175.883 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.263 39.0 Cg_endo -62.91 -43.8 18.61 Favored 'Trans proline' 0 N--CA 1.433 -2.039 1 C-N-CA 126.963 5.109 . . . . 1.68 116.469 -168.904 . . . . . . . . 3 2 . 1 . 118 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -55.86 -26.56 47.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 121.792 3.997 . . . . 2.25 121.792 171.945 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -71.17 -34.89 71.36 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.585 1.954 . . . . 2.44 110.691 -179.322 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -70.62 97.71 1.38 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.165 2.283 . . . . 1.32 117.165 -175.299 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -87.44 126.14 34.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 118.341 -0.838 . . . . 3.19 108.96 161.957 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.0 mt -117.8 119.54 35.2 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 121.478 1.945 . . . . 1.75 108.431 -178.639 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.476 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 27.4 mt -108.3 128.94 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 128.53 2.732 . . . . 1.98 113.818 -172.426 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.417 ' CZ ' HG12 ' A' ' 61' ' ' ILE 0.288 72.1 t80 -144.95 110.92 5.46 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 105.581 -2.007 . . . . 1.94 105.581 178.648 . . . . . . . . 3 3 . 1 . 118 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.82 45.25 7.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.867 1.802 . . . . 1.67 115.867 178.974 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.02 -4.85 36.25 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 120.681 3.032 . . . . 1.3 120.681 -171.534 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -96.3 119.72 35.31 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 130.155 4.091 . . . . 2.89 115.642 177.441 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -79.76 110.29 14.97 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 114.922 -4.861 . . . . 2.89 109.593 168.899 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.2 mt -82.12 146.35 29.66 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.041 -2.287 . . . . 1.34 110.827 -163.765 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -85.3 145.22 27.63 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.836 2.055 . . . . 1.94 114.004 173.536 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.39 -59.07 4.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.594 2.072 . . . . 1.56 116.594 -168.703 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.64 49.82 3.7 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-O 123.943 1.857 . . . . 0.97 116.905 173.744 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -118.25 156.48 28.75 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 101.489 -3.522 . . . . 3.07 101.489 165.443 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 16.9 p -100.07 162.48 12.95 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.686 -3.133 . . . . 1.34 112.784 174.005 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.4 mt -54.87 -48.27 73.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.777 2.831 . . . . 1.63 109.2 174.813 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 p -60.72 -37.92 83.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.07 2.148 . . . . 1.51 113.856 179.085 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -61.31 -33.93 74.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 122.637 2.471 . . . . 1.9 113.375 174.276 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -85.96 -14.34 44.94 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 127.002 2.121 . . . . 0.97 114.055 178.836 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.6 m120 66.84 50.34 1.11 Allowed 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 124.242 1.972 . . . . 2.35 111.739 -177.661 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.417 HG12 ' CZ ' ' A' ' 45' ' ' PHE . 70.8 mt -95.78 128.71 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 119.951 -1.718 . . . . 1.39 108.457 174.629 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -100.1 175.98 5.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 112.159 -2.291 . . . . 2.58 111.07 -174.171 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -46.37 137.43 6.43 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.819 -3.05 . . . . 2.58 117.639 166.811 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.253 73.8 mt-10 69.57 14.04 8.27 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.287 -2.758 . . . . 1.71 117.682 175.455 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 m -76.1 148.95 37.53 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 120.438 -1.414 . . . . 1.34 112.826 -175.364 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.1 m -97.28 119.0 34.98 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 126.177 2.173 . . . . 1.36 111.258 -179.365 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.3 mt -103.8 136.68 43.03 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.053 -1.655 . . . . 2.03 107.851 170.235 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.476 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 63.5 m80 -91.64 107.5 19.25 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.298 2.332 . . . . 2.31 117.298 174.181 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.2 tp -88.09 117.04 26.7 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 124.835 1.254 . . . . 1.72 110.184 -179.334 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.2 t -120.84 143.25 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 126.493 3.044 . . . . 1.8 103.723 178.431 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.9 mt -118.12 110.51 17.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.149 -2.845 . . . . 3.26 109.126 -175.422 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -136.66 158.77 43.68 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 105.767 -1.938 . . . . 4.12 105.767 178.745 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -64.53 137.1 57.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 125.421 1.701 . . . . 3.54 115.374 167.969 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -69.33 123.94 22.53 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.713 -0.676 . . . . 7.32 111.394 172.058 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.32 94.29 0.1 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 117.622 -1.655 . . . . 3.73 114.083 -176.857 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.79 0 CA-C-O 115.938 -2.59 . . . . 3.87 112.213 168.345 . . . . . . . . 0 0 . 1 . 119 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.27 0.2 OUTLIER . . . . . 0 CA--C 1.491 -1.321 0 N-CA-C 107.138 -1.43 . . . . 1.39 107.138 . . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -115.38 119.96 38.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.765 2.026 . . . . 2.2 109.359 -178.41 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 pt -120.74 158.44 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 122.031 0.919 . . . . 1.32 112.716 -179.905 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -114.37 148.14 38.1 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.878 -2.389 . . . . 2.2 106.299 176.028 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.4 t -124.16 121.86 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 129.385 3.074 . . . . 1.23 105.51 173.118 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -107.16 137.69 44.75 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.305 2.642 . . . . 2.51 112.342 177.004 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.6 p -95.65 -176.83 3.86 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 123.376 1.56 . . . . 1.41 114.329 179.935 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.374 66.4 tp -57.54 -45.81 84.62 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 116.01 -4.181 . . . . 2.95 113.11 172.222 . . . . . . . . 3 2 . 1 . 119 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.5 p -80.11 -35.56 36.65 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 121.579 1.99 . . . . 2.52 111.844 -175.555 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.07 7.16 1.36 Allowed Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 119.524 1.057 . . . . 1.5 113.498 178.14 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.3 mtpt -76.6 130.65 38.15 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.676 -2.661 . . . . 1.79 111.65 -176.555 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.0 m -97.96 113.57 25.44 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 125.22 2.438 . . . . 1.38 113.203 -179.184 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.0 mt -92.4 95.15 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 119.101 -2.249 . . . . 2.03 110.369 178.327 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.6 m -81.48 118.82 23.03 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 120.473 1.488 . . . . 1.61 110.432 175.324 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.4 mt -119.85 153.64 35.51 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.567 -2.382 . . . . 2.15 104.567 178.275 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -110.44 120.17 41.57 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 111.558 -2.565 . . . . 1.98 107.493 174.25 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.87 -176.76 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.457 -2.652 . . . . 1.52 106.287 175.2 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -105.48 163.06 17.88 Favored Pre-proline 0 N--CA 1.431 -1.408 0 O-C-N 116.631 -3.793 . . . . 2.35 104.64 169.693 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -71.1 -14.74 32.03 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 124.012 2.468 . . . . 1.31 112.82 179.055 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.263 18.9 m -92.76 5.82 49.77 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 123.766 2.985 . . . . 1.71 111.572 -179.64 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -82.4 151.09 26.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 127.892 3.71 . . . . 1.69 108.706 176.445 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -79.49 170.57 16.38 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 113.586 -5.696 . . . . 1.33 113.596 179.322 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.41 -30.57 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-N 113.561 -1.654 . . . . 1.32 110.873 178.572 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -54.82 -41.55 70.81 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.922 2.089 . . . . 1.62 113.724 169.36 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -61.9 -45.5 93.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.248 1.944 . . . . 2.13 116.248 171.252 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 56.4 t -51.51 -48.85 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 128.583 2.753 . . . . 1.23 107.896 175.445 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -67.42 -36.12 80.61 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 122.402 2.365 . . . . 1.97 117.384 175.197 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.02 -32.48 73.85 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 116.037 -4.164 . . . . 1.19 118.402 169.008 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -67.19 -31.05 71.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 112.483 -2.144 . . . . 1.92 114.839 170.142 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.293 57.3 mt -68.31 -25.43 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 CA-C-O 125.969 2.795 . . . . 1.94 113.683 172.339 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -85.47 -27.51 25.63 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.84 -4.287 . . . . 1.9 106.835 -174.32 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -78.09 -38.14 44.88 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 114.095 -3.042 . . . . 1.55 111.032 168.92 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -65.08 -61.46 2.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 112.986 0.736 . . . . 2.95 112.986 -172.243 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -106.09 -52.64 2.77 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.209 3.004 . . . . 1.48 108.969 -167.403 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.93 -15.8 5.86 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 119.096 2.398 . . . . 1.12 119.096 176.491 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mt -65.1 131.83 95.24 Favored Pre-proline 0 N--CA 1.43 -1.469 0 CA-C-O 116.499 -1.715 . . . . 2.07 110.337 -175.156 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.93 155.36 43.25 Favored 'Trans proline' 0 N--CA 1.433 -2.038 0 C-N-CA 125.219 3.946 . . . . 1.39 112.814 -177.136 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -63.84 -27.41 67.4 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 123.663 2.909 . . . . 1.68 119.056 -174.364 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.272 2.6 m-20 -62.08 -32.46 73.01 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.072 1.415 . . . . 2.25 113.39 177.268 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -87.81 -16.91 32.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.159 1.457 . . . . 2.44 114.085 -171.436 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -87.31 127.17 35.19 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 117.148 -1.406 . . . . 1.32 109.698 -174.909 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -118.44 128.18 54.37 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.441 -1.689 . . . . 3.19 106.441 170.421 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.2 mt -95.05 136.76 34.98 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.103 -2.873 . . . . 1.75 112.678 174.565 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 73.0 mt -125.38 117.92 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 124.415 2.055 . . . . 1.98 110.775 178.401 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -109.0 107.82 18.32 Favored 'General case' 0 N--CA 1.43 -1.439 1 N-CA-C 99.77 -4.159 . . . . 1.94 99.77 -178.534 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.88 -74.32 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.477 2.311 . . . . 1.67 113.716 -172.555 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.92 6.11 1.13 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 105.709 -2.956 . . . . 1.3 105.709 178.095 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -94.98 119.04 32.82 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.327 -3.455 . . . . 2.89 110.17 177.747 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -89.08 121.64 31.61 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.862 -2.399 . . . . 2.89 108.642 175.599 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.0 mt -80.08 164.67 23.19 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.158 -1.383 . . . . 1.34 111.599 -164.131 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -115.66 137.05 52.46 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 127.012 3.291 . . . . 1.94 111.396 174.552 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.28 -40.77 97.35 Favored 'General case' 0 N--CA 1.429 -1.483 1 N-CA-C 122.274 4.175 . . . . 1.56 122.274 -166.842 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.42 30.44 5.25 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 118.079 1.991 . . . . 0.97 118.079 171.385 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -105.86 162.61 13.41 Favored 'General case' 0 N--CA 1.43 -1.439 1 CA-C-O 130.099 4.762 . . . . 3.07 107.959 163.073 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.0 p -84.25 163.82 19.44 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 113.02 -6.05 . . . . 1.34 109.648 172.279 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.2 mt -64.76 -42.7 94.92 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 121.0 -1.063 . . . . 1.63 109.086 172.432 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.3 p -66.32 -21.56 66.26 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.406 -3.309 . . . . 1.51 115.092 -179.22 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -59.34 -17.69 31.82 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 118.123 2.638 . . . . 1.9 118.123 167.017 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -115.79 11.22 15.56 Favored 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 114.561 -5.087 . . . . 0.97 109.189 178.835 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.334 1.3 t-20 67.01 33.97 5.42 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.568 1.947 . . . . 2.35 114.111 179.044 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.4 mt -92.03 126.37 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 104.759 -2.311 . . . . 1.39 104.759 -174.688 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -125.17 -171.46 2.37 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 119.488 1.04 . . . . 2.58 109.458 -169.25 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -52.68 141.7 20.26 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 118.452 -2.655 . . . . 2.58 112.842 165.722 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.316 4.2 mt-10 60.71 36.46 19.44 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.298 2.873 . . . . 1.71 115.926 175.066 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.4 t -109.49 140.82 42.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 111.562 -2.563 . . . . 1.34 106.74 -167.107 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.3 m -114.18 120.37 40.27 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.782 -1.192 . . . . 1.36 107.782 -167.759 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.7 mt -100.52 161.58 13.51 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.518 2.727 . . . . 2.03 111.186 173.795 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -123.79 109.65 13.92 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.122 2.169 . . . . 2.31 111.196 -177.616 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.9 tp -92.12 122.87 35.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 111.812 -2.449 . . . . 1.72 108.073 -175.008 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.327 4.7 m -118.4 141.03 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 118.802 -2.436 . . . . 1.8 110.953 175.63 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.9 mt -104.37 135.09 46.47 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.926 -2.984 . . . . 3.26 110.145 177.226 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -150.13 150.13 31.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 101.095 -3.669 . . . . 4.12 101.095 -177.099 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.0 mt -68.59 132.83 47.59 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.045 -2.285 . . . . 3.54 112.015 171.767 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -65.31 123.43 19.57 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.114 0.959 . . . . 7.32 111.825 169.837 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.13 -63.94 0.31 Allowed Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 103.158 -3.977 . . . . 3.73 103.158 -171.207 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.796 0 O-C-N 120.472 -1.605 . . . . 3.87 109.622 178.942 . . . . . . . . 0 0 . 1 . 120 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 ptt? . . . . . 0 CA--C 1.491 -1.301 0 CA-C-O 120.957 0.408 . . . . 1.39 110.23 . . . . . . . . . 0 0 . 1 . 120 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -107.65 147.38 30.77 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.537 -0.727 . . . . 2.2 112.3 -176.681 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.3 pt -134.09 152.41 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 124.174 1.94 . . . . 1.32 106.385 172.935 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -109.7 134.37 52.05 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 127.019 2.128 . . . . 2.2 114.298 178.619 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -114.14 109.57 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 118.015 -2.928 . . . . 1.23 106.062 178.338 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 6' ' ' LYS . 17.9 tptm -93.61 131.38 38.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.219 -1.551 . . . . 2.51 111.83 178.673 . . . . . . . . 2 2 . 1 . 120 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.1 p -89.07 -178.67 5.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.211 -2.806 . . . . 1.41 113.782 -178.428 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.263 35.4 tp -85.31 -33.47 22.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 119.292 -2.13 . . . . 2.95 108.198 171.85 . . . . . . . . 2 2 . 1 . 120 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.259 59.9 p -68.33 -34.32 75.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.678 -1.889 . . . . 2.52 109.015 -174.095 . . . . . . . . 2 2 . 1 . 120 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.0 44.54 0.44 Allowed Glycine 0 N--CA 1.431 -1.673 0 CA-C-O 115.376 -2.902 . . . . 1.5 113.513 178.378 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -127.55 148.69 50.34 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 114.076 -2.868 . . . . 1.79 110.853 -177.838 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.8 m -122.89 121.76 36.97 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 124.69 3.405 . . . . 1.38 103.626 177.126 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mt -98.13 124.54 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 1 O-C-N 115.971 -4.206 . . . . 2.03 104.355 179.1 . . . . . . . . 2 2 . 1 . 120 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.0 m -101.29 118.2 36.51 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.261 -2.15 . . . . 1.61 107.876 179.912 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.7 mt -117.46 162.3 18.18 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.5 -2.625 . . . . 2.15 109.683 178.3 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -101.26 136.11 41.64 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 127.144 2.777 . . . . 1.98 112.656 166.545 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -142.36 171.26 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 128.085 2.554 . . . . 1.52 107.48 -176.236 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -118.53 148.22 43.65 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 101.904 -3.369 . . . . 2.35 101.904 163.139 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.97 -6.12 17.39 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 O-C-N 115.809 -2.785 . . . . 1.31 118.35 178.07 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.8 p -80.57 -5.77 57.28 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.475 2.71 . . . . 1.71 112.401 169.131 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -70.01 143.17 52.65 Favored 'General case' 0 N--CA 1.431 -1.413 1 CA-C-O 128.515 4.007 . . . . 1.69 111.706 171.129 . . . . . . . . 2 2 . 1 . 120 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.395 53.6 p -75.09 157.05 35.38 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.02 -2.925 . . . . 1.33 112.848 176.493 . . . . . . . . 3 3 . 1 . 120 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.9 mm -71.53 -29.97 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 122.95 1.357 . . . . 1.32 109.634 179.131 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -46.57 -57.9 4.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.561 3.077 . . . . 1.62 115.538 164.661 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -54.48 -34.24 61.22 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 119.849 3.277 . . . . 2.13 119.849 178.017 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 68.9 t -71.05 -35.73 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 112.185 -2.28 . . . . 1.23 111.208 176.109 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -72.96 -34.11 66.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.011 -2.931 . . . . 1.97 113.456 171.76 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.98 -32.63 74.22 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 117.992 -2.943 . . . . 1.19 113.067 174.335 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt -72.42 -33.55 67.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 123.35 1.547 . . . . 1.92 114.853 174.279 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.2 mt -72.39 -29.99 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 120.399 -1.438 . . . . 1.94 108.309 176.26 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.46 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 7.7 tt0 -64.0 -51.28 64.99 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.809 1.644 . . . . 1.9 112.549 171.803 . . . . . . . . 2 2 . 1 . 120 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -60.75 -39.47 88.85 Favored 'General case' 0 N--CA 1.432 -1.368 0 O-C-N 120.121 -1.612 . . . . 1.55 113.509 175.549 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.6 tptt -67.83 -56.44 9.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.427 -1.421 . . . . 2.95 114.781 -173.818 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.307 71.4 mm-40 -113.71 -15.23 12.49 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 115.755 1.761 . . . . 1.48 115.755 -171.995 . . . . . . . . 2 2 . 1 . 120 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.21 64.31 1.6 Allowed Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 125.169 1.366 . . . . 1.12 110.338 171.303 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.46 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 16.9 mt -141.53 117.07 7.13 Favored Pre-proline 0 N--CA 1.429 -1.485 0 N-CA-C 101.947 -3.353 . . . . 2.07 101.947 -176.436 . . . . . . . . 2 2 . 1 . 120 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -58.01 153.64 43.79 Favored 'Trans proline' 0 C--N 1.3 -2.002 1 C-N-CA 128.218 5.945 . . . . 1.39 111.93 178.149 . . . . . . . . 2 2 . 1 . 120 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -71.73 -27.75 17.84 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 CA-C-N 125.454 2.984 . . . . 1.68 115.37 -171.825 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -61.36 -31.62 71.5 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.354 3.062 . . . . 2.25 113.912 178.007 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -92.57 -10.36 37.84 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 116.462 -3.899 . . . . 2.44 105.546 -172.332 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -92.87 132.47 36.98 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 124.062 3.119 . . . . 1.32 109.818 -172.041 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -103.52 125.56 50.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.762 -1.837 . . . . 3.19 109.369 163.811 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.6 mt -113.81 118.51 34.47 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.64 -2.537 . . . . 1.75 109.388 179.16 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.436 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 5.1 mt -110.83 125.36 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 126.824 2.049 . . . . 1.98 109.794 -177.446 . . . . . . . . 2 2 . 1 . 120 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -125.23 130.78 52.76 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.17 -1.789 . . . . 1.94 106.17 168.403 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.78 -76.44 0.07 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.804 1.242 . . . . 1.67 112.0 179.259 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -177.4 33.8 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.649 0 O-C-N 117.258 -3.401 . . . . 1.3 104.809 -175.482 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.32 122.29 16.69 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.644 1.978 . . . . 2.89 107.277 179.444 . . . . . . . . 2 2 . 1 . 120 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -70.85 143.14 51.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.425 -2.672 . . . . 2.89 107.228 166.186 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.1 mt -99.97 139.99 34.83 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 125.268 1.605 . . . . 1.34 110.183 -173.107 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -83.05 161.64 21.63 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 117.767 -1.111 . . . . 1.94 108.886 176.44 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -73.49 -57.15 4.2 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 129.03 2.932 . . . . 1.56 117.131 -169.237 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.04 54.47 3.64 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 126.607 3.337 . . . . 0.97 120.048 172.631 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.253 79.2 mmt-85 -122.58 169.18 11.29 Favored 'General case' 0 N--CA 1.43 -1.444 1 C-N-CA 132.122 4.169 . . . . 3.07 103.306 169.257 . . . . . . . . 3 2 . 1 . 120 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 62.5 p -109.29 -179.72 3.92 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.409 -3.932 . . . . 1.34 108.464 170.561 . . . . . . . . 2 2 . 1 . 120 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 79.8 mt -72.64 -33.67 66.77 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 130.825 3.65 . . . . 1.63 109.738 172.295 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.4 t -73.9 -37.74 64.57 Favored 'General case' 0 N--CA 1.43 -1.468 1 C-N-CA 131.976 4.111 . . . . 1.51 110.688 -176.214 . . . . . . . . 2 2 . 1 . 120 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -64.08 -38.14 89.98 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 113.209 -1.814 . . . . 1.9 113.956 173.509 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -84.0 -2.83 57.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 113.945 -2.931 . . . . 0.97 112.47 170.463 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.417 8.1 t-20 56.9 46.34 19.8 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 121.24 1.836 . . . . 2.35 114.245 -177.043 . . . . . . . . 2 2 . 1 . 120 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.2 mt -88.18 107.31 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 130.713 3.605 . . . . 1.39 108.212 176.621 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -79.33 -175.88 4.92 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.567 -2.583 . . . . 2.58 111.556 -177.131 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -72.88 149.1 43.78 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 118.382 -2.699 . . . . 2.58 108.305 172.98 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 71.51 18.32 5.46 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 126.615 3.102 . . . . 1.71 116.88 174.915 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -83.33 151.64 25.46 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.289 -3.382 . . . . 1.34 117.223 178.951 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.6 m -108.89 110.29 21.58 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.753 -1.203 . . . . 1.36 107.753 -173.604 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.7 mt -87.94 147.58 24.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 102.162 -3.273 . . . . 2.03 102.162 170.878 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.436 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 67.7 m80 -108.41 112.87 25.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.382 -1.34 . . . . 2.31 107.382 -175.761 . . . . . . . . 2 2 . 1 . 120 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.7 tp -87.68 112.0 21.89 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.898 -2.376 . . . . 1.72 110.226 -178.81 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.7 t -111.13 120.23 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 103.055 -2.943 . . . . 1.8 103.055 178.368 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.5 mt -109.98 141.15 43.17 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.732 1.73 . . . . 3.26 114.435 -178.312 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -91.55 130.02 37.44 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.894 2.553 . . . . 4.12 117.894 -176.091 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.4 mt -83.98 153.49 23.85 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.077 -3.514 . . . . 3.54 114.399 168.85 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -93.82 160.79 14.59 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 104.244 -2.502 . . . . 7.32 104.244 179.543 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.29 -50.04 1.6 Allowed Glycine 0 N--CA 1.431 -1.689 0 CA-C-O 115.099 -3.056 . . . . 3.73 113.929 -171.321 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.737 0 CA-C-N 120.942 2.371 . . . . 3.87 114.714 178.837 . . . . . . . . 0 0 . 1 . 121 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 CA--C 1.49 -1.329 0 CA-C-O 125.53 2.586 . . . . 1.39 113.826 . . . . . . . . . 0 0 . 1 . 121 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -115.59 108.82 16.92 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.881 -2.387 . . . . 2.2 106.272 -173.861 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.3 pt -114.08 164.49 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 105.733 -1.951 . . . . 1.32 105.733 171.942 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -124.35 151.68 44.05 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.573 -2.01 . . . . 2.2 105.573 -172.09 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 t -134.1 118.52 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 102.86 -3.015 . . . . 1.23 102.86 174.545 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -90.83 141.4 28.85 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.434 -1.321 . . . . 2.51 107.434 171.055 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.2 p -91.49 -162.46 0.92 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.803 2.841 . . . . 1.41 111.45 -178.715 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.5 mt -83.2 -30.89 27.39 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 126.138 2.875 . . . . 2.95 110.132 178.493 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.8 p -82.09 -60.73 2.12 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 113.977 -5.452 . . . . 2.52 110.01 -171.615 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.93 31.41 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 125.03 1.3 . . . . 1.5 111.101 175.101 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -103.76 134.81 46.45 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.949 -4.265 . . . . 1.79 104.676 -174.609 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 m -80.98 119.63 23.75 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 112.779 -2.01 . . . . 1.38 109.908 167.675 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 mt -94.84 117.51 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 104.168 -2.531 . . . . 2.03 104.168 172.468 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.266 99.3 m -86.42 122.0 29.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 124.98 1.312 . . . . 1.61 109.683 179.227 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.3 mt -129.3 112.66 14.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 126.554 3.073 . . . . 2.15 109.146 -174.026 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -79.63 120.79 24.45 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 110.668 -2.969 . . . . 1.98 113.393 174.561 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.1 162.43 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 113.427 -1.715 . . . . 1.52 108.487 -175.235 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -118.54 170.53 6.32 Favored Pre-proline 0 N--CA 1.43 -1.435 0 O-C-N 116.836 -3.665 . . . . 2.35 108.85 168.13 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -62.9 -18.86 66.98 Favored 'Trans proline' 0 C--N 1.3 -1.982 1 C-N-CA 125.42 4.08 . . . . 1.31 120.813 -173.109 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.7 m -95.49 16.19 17.69 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 118.448 2.759 . . . . 1.71 118.448 171.049 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -77.25 148.45 35.77 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 124.746 2.212 . . . . 1.69 106.966 167.421 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.4 p -97.73 -168.26 1.65 Allowed 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.028 -4.795 . . . . 1.33 114.109 175.791 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.3 mm -89.1 -30.3 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 119.631 -1.918 . . . . 1.32 110.488 175.114 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -59.41 -32.19 69.95 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 128.0 2.52 . . . . 1.62 114.038 167.118 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.265 71.1 m-20 -64.23 -44.41 91.95 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 130.411 3.484 . . . . 2.13 115.348 161.709 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.9 t -65.91 -33.37 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 114.268 -2.973 . . . . 1.23 117.683 175.305 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.275 53.1 mtmt -73.11 -36.55 66.78 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.261 2.625 . . . . 1.97 109.227 -176.73 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.11 -32.84 71.06 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.631 -2.543 . . . . 1.19 111.197 174.569 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -74.95 -25.35 58.81 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 116.367 -3.958 . . . . 1.92 115.747 176.206 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.4 mt -80.83 -27.53 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 C-N-CA 117.181 -1.808 . . . . 1.94 113.88 172.933 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -64.09 -36.4 83.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.625 1.97 . . . . 1.9 114.351 169.997 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -60.54 -65.07 0.75 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 128.978 3.924 . . . . 1.55 109.786 167.859 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -67.6 -54.07 22.81 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 115.384 1.624 . . . . 2.95 115.384 -172.343 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -113.08 -25.1 9.1 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.951 -2.343 . . . . 1.48 115.001 -164.646 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.69 50.27 2.75 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 118.06 -2.019 . . . . 1.12 116.115 168.651 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.5 mt -120.72 128.4 25.8 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 130.389 3.476 . . . . 2.07 105.021 -178.623 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -63.98 146.73 91.6 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 124.403 3.402 . . . . 1.39 115.839 177.183 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -73.71 -9.05 22.25 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 124.356 3.37 . . . . 1.68 113.315 -171.268 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -87.86 -17.43 31.47 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 115.948 -2.301 . . . . 2.25 112.522 170.404 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -78.97 -25.21 43.48 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 120.179 1.354 . . . . 2.44 114.39 178.587 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -82.22 103.19 11.64 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.37 1.468 . . . . 1.32 113.131 -170.469 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -90.89 118.33 30.2 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.934 -2.354 . . . . 3.19 112.677 170.553 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.9 mt -103.06 114.07 28.05 Favored 'General case' 0 N--CA 1.431 -1.392 1 CA-C-N 126.431 4.196 . . . . 1.75 113.698 -178.151 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.459 HG12 HG23 ' A' ' 70' ' ' VAL . 23.8 mm -97.32 138.71 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 117.062 -1.447 . . . . 1.98 109.622 -177.13 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -157.35 129.46 7.2 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.596 -1.631 . . . . 1.94 106.596 176.251 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.06 9.12 2.91 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.181 1.792 . . . . 1.67 114.187 -174.483 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.57 -28.66 9.3 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 117.641 -1.644 . . . . 1.3 116.865 -176.092 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -96.47 153.8 17.63 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.417 2.377 . . . . 2.89 117.417 179.405 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -82.77 103.72 12.47 Favored 'General case' 0 N--CA 1.43 -1.433 1 C-N-CA 134.336 5.054 . . . . 2.89 112.911 178.017 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.9 mt -69.9 141.89 53.07 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.736 3.16 . . . . 1.34 115.219 -174.979 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.259 34.7 mt-10 -80.41 141.82 34.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.191 2.596 . . . . 1.94 114.381 176.831 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -53.03 -65.15 0.61 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 120.771 3.619 . . . . 1.56 120.771 -177.524 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.25 49.22 3.48 Favored Glycine 0 N--CA 1.43 -1.751 0 O-C-N 127.293 2.871 . . . . 0.97 111.807 178.799 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -118.86 147.63 43.75 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.544 -2.739 . . . . 3.07 104.825 168.873 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -79.66 173.4 12.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 117.125 -1.83 . . . . 1.34 115.16 175.74 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.29 -20.5 60.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.612 -2.555 . . . . 1.63 111.89 172.048 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 t -70.04 -49.03 55.38 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.207 -2.808 . . . . 1.51 110.952 177.6 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -57.04 -36.38 70.42 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.764 1.626 . . . . 1.9 114.02 175.824 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -92.83 5.73 50.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.097 2.159 . . . . 0.97 115.336 177.671 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.447 26.4 m120 44.82 43.25 6.79 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.247 2.619 . . . . 2.35 117.842 -176.796 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.8 mt -81.71 128.27 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 104.914 -2.254 . . . . 1.39 104.914 -176.339 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.268 10.2 mt-30 -105.85 179.94 4.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 127.774 3.171 . . . . 2.58 111.505 -174.155 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 pttp -69.02 129.02 38.73 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 124.807 1.243 . . . . 2.58 112.42 170.168 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 87.24 10.02 0.16 Allowed 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 126.837 2.055 . . . . 1.71 111.611 177.4 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.6 t -85.07 134.83 34.19 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 114.534 -5.104 . . . . 1.34 111.601 -173.542 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.8 m -99.97 120.93 40.57 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 123.697 1.713 . . . . 1.36 110.615 -177.811 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.0 mt -95.84 169.5 9.96 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.619 -1.628 . . . . 2.03 111.354 172.175 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -126.52 110.71 13.56 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.567 -1.958 . . . . 2.31 113.634 -173.281 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.7 tp -87.37 112.23 21.91 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.203 -1.56 . . . . 1.72 108.783 -175.824 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.459 HG23 HG12 ' A' ' 44' ' ' ILE . 49.4 t -107.46 131.36 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 129.519 3.128 . . . . 1.8 112.068 170.881 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.6 mt -109.09 176.06 5.23 Favored 'General case' 0 N--CA 1.431 -1.381 0 O-C-N 120.056 -1.653 . . . . 3.26 111.289 -176.886 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -140.2 176.99 8.3 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.433 -2.062 . . . . 4.12 105.433 -177.518 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.3 mt -103.86 159.87 15.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.764 -1.835 . . . . 3.54 113.523 167.069 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.274 25.9 ptt180 -92.93 148.05 22.33 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.18 -3.45 . . . . 7.32 114.673 176.512 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.47 -108.8 0.22 Allowed Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 118.16 -1.971 . . . . 3.73 111.701 -169.008 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.75 0 O-C-N 120.044 -1.857 . . . . 3.87 109.273 175.184 . . . . . . . . 0 0 . 1 . 122 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 CA--C 1.491 -1.315 0 CA-C-O 118.85 -0.595 . . . . 1.39 110.761 . . . . . . . . . 0 0 . 1 . 122 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -97.25 118.96 34.86 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 113.633 0.975 . . . . 2.2 113.633 -169.553 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.8 pt -125.59 169.62 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 120.504 1.502 . . . . 1.32 112.725 172.404 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -120.87 154.02 36.39 Favored 'General case' 0 N--CA 1.431 -1.407 1 O-C-N 114.913 -4.867 . . . . 2.2 110.628 -178.211 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.3 t -125.39 135.25 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 103.237 -2.875 . . . . 1.23 103.237 172.901 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -114.22 143.38 44.92 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.837 -3.039 . . . . 2.51 107.579 176.803 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -96.75 170.08 9.43 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.414 1.486 . . . . 1.41 114.566 176.552 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.3 mt -55.7 -45.53 77.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.554 -2.591 . . . . 2.95 110.246 174.355 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 p -73.64 -57.46 3.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 116.66 -1.638 . . . . 2.52 111.936 -177.001 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.11 19.25 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.7 0 CA-C-O 125.549 2.75 . . . . 1.5 117.485 179.156 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -102.99 122.33 44.39 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 111.659 -2.27 . . . . 1.79 109.004 -168.707 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.0 m -95.6 124.62 39.71 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.395 2.521 . . . . 1.38 110.96 177.305 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 mm -100.44 129.7 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 115.034 -2.412 . . . . 2.03 106.824 -179.097 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.4 m -89.72 104.84 17.36 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 124.133 3.152 . . . . 1.61 108.319 179.49 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.4 mt -108.73 146.52 33.39 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 125.455 3.752 . . . . 2.15 120.975 -178.845 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -98.33 131.83 44.31 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 114.245 -1.343 . . . . 1.98 109.44 169.682 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.7 m -144.5 162.47 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 1 C-N-CA 132.127 4.171 . . . . 1.52 108.214 177.831 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -114.13 150.8 44.22 Favored Pre-proline 0 N--CA 1.429 -1.477 0 C-N-CA 126.487 1.915 . . . . 2.35 108.452 166.428 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -62.47 -21.92 73.38 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-O 125.182 2.076 . . . . 1.31 114.59 -168.104 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.8 p -83.26 0.1 47.1 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.273 3.429 . . . . 1.71 111.193 178.923 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -79.99 151.97 29.71 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 115.974 -4.204 . . . . 1.69 105.473 172.525 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 35.0 p -93.57 173.48 7.67 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 112.721 -2.036 . . . . 1.33 113.372 177.865 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.415 HG21 ' HG3' ' A' ' 27' ' ' LYS . 42.2 mm -72.05 -33.13 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 O-C-N 120.542 -1.349 . . . . 1.32 108.276 -179.076 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -55.45 -44.96 76.85 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 125.516 2.579 . . . . 1.62 115.806 167.004 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 -60.09 -42.47 94.69 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 116.075 -4.141 . . . . 2.13 112.595 176.488 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.9 t -69.78 -42.04 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 C-N-CA 129.485 3.114 . . . . 1.23 109.737 172.152 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HG3' HG21 ' A' ' 23' ' ' ILE . 75.3 mttt -64.85 -37.44 87.65 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 125.825 3.92 . . . . 1.97 112.267 -178.668 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.5 -31.59 56.29 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 119.926 3.306 . . . . 1.19 119.926 169.739 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.265 15.9 tppt? -80.15 -35.04 37.16 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 121.543 0.687 . . . . 1.92 111.977 174.087 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.8 mt -60.81 -42.49 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.371 -1.455 . . . . 1.94 114.289 171.215 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -56.11 -39.5 72.27 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.878 2.871 . . . . 1.9 111.622 173.845 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -70.57 -45.47 65.35 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 124.71 1.256 . . . . 1.55 113.718 176.698 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -70.67 -51.69 26.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 115.04 1.496 . . . . 2.95 115.04 -176.643 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -104.48 -14.14 15.8 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.682 1.993 . . . . 1.48 113.903 -168.66 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.21 49.23 34.22 Favored Glycine 0 N--CA 1.431 -1.648 0 O-C-N 118.238 -2.789 . . . . 1.12 112.987 175.438 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.415 HG21 ' HG3' ' A' ' 41' ' ' GLN . 56.9 mt -125.25 126.38 25.14 Favored Pre-proline 0 N--CA 1.429 -1.478 0 N-CA-C 105.047 -2.205 . . . . 2.07 105.047 178.735 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -66.84 150.29 83.24 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 125.237 3.958 . . . . 1.39 111.79 179.983 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -60.08 -31.51 93.47 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 C-N-CA 125.169 3.913 . . . . 1.68 114.721 -173.689 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -56.96 -41.4 78.27 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 130.33 3.452 . . . . 2.25 110.096 176.285 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -89.19 2.72 53.8 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.601 -1.312 . . . . 2.44 113.714 -178.307 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.415 ' HG3' HG21 ' A' ' 36' ' ' ILE . 73.5 mt-30 -90.01 116.51 28.1 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.429 2.692 . . . . 1.32 116.678 -173.697 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -111.96 109.03 18.58 Favored 'General case' 0 N--CA 1.429 -1.5 1 O-C-N 115.623 -4.423 . . . . 3.19 111.777 169.2 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.8 mt -89.4 122.04 32.23 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.943 -1.723 . . . . 1.75 108.537 -178.879 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.3 mm -111.47 123.43 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 126.941 3.258 . . . . 1.98 111.474 177.316 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.276 69.6 t80 -132.31 134.7 45.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 116.531 -3.856 . . . . 1.94 104.533 173.104 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.99 28.22 0.59 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 119.77 3.248 . . . . 1.67 119.77 -177.62 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.8 -12.1 69.83 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 126.033 1.778 . . . . 1.3 111.598 -177.757 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -86.59 145.04 26.91 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.621 -1.517 . . . . 2.89 114.396 -179.347 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -87.09 109.76 19.64 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.033 -2.292 . . . . 2.89 109.615 171.893 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.7 mt -71.16 133.14 45.96 Favored 'General case' 0 N--CA 1.431 -1.423 1 CA-C-O 128.778 4.132 . . . . 1.34 109.303 -170.017 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -89.94 135.69 33.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.363 -3.961 . . . . 1.94 118.123 -179.791 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -55.05 -54.22 45.83 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 116.864 -3.648 . . . . 1.56 119.332 -168.492 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.55 23.27 16.74 Favored Glycine 0 N--CA 1.429 -1.785 0 CA-C-O 118.424 -1.209 . . . . 0.97 112.026 177.298 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.4 mtt-85 -104.27 161.56 13.94 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 121.679 2.74 . . . . 3.07 108.624 165.981 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.1 p -97.89 156.63 16.51 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.557 2.743 . . . . 1.34 112.993 178.005 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.3 mt -58.86 -32.48 69.48 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.243 2.449 . . . . 1.63 114.878 179.712 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.5 p -69.03 -26.65 65.1 Favored 'General case' 0 N--CA 1.429 -1.52 0 O-C-N 116.627 -3.795 . . . . 1.51 117.558 176.376 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -68.61 -37.18 79.58 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.53 -1.981 . . . . 1.9 110.628 174.974 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -82.0 -13.57 57.21 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 115.262 -2.304 . . . . 0.97 106.779 -178.403 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.3 m120 65.82 56.44 0.89 Allowed 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 126.295 2.247 . . . . 2.35 108.437 -177.174 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.8 mt -99.32 136.17 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 103.922 -2.622 . . . . 1.39 103.922 179.545 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -109.69 178.16 4.51 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 126.318 2.961 . . . . 2.58 109.932 -178.799 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -60.8 152.32 27.38 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 112.4 -2.182 . . . . 2.58 116.212 167.778 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.277 53.4 mt-10 67.04 11.99 8.71 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 114.937 1.458 . . . . 1.71 114.937 -177.899 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -89.16 150.0 22.89 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.067 2.365 . . . . 1.34 109.485 -175.883 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.1 m -104.38 120.28 40.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.175 -1.578 . . . . 1.36 111.757 -176.918 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.3 mt -89.51 135.7 33.45 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.695 -1.878 . . . . 2.03 112.399 172.988 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -105.53 122.5 46.13 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.581 -2.574 . . . . 2.31 104.998 -174.792 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.0 tp -93.63 108.51 20.22 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.445 2.298 . . . . 1.72 110.803 -177.084 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.278 28.8 t -98.88 140.29 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 128.179 3.847 . . . . 1.8 105.07 173.216 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.0 mt -87.72 134.23 33.7 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 118.621 -2.55 . . . . 3.26 106.756 170.643 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -90.41 117.07 28.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.369 1.868 . . . . 4.12 110.692 178.347 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.0 mt -95.17 112.2 23.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 127.059 2.725 . . . . 3.54 107.855 173.769 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.319 13.7 ptm180 -63.89 161.27 15.88 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 117.568 2.432 . . . . 7.32 117.568 177.023 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -143.29 35.28 1.67 Allowed Glycine 0 N--CA 1.43 -1.731 0 CA-C-O 118.156 -1.358 . . . . 3.73 110.508 -170.482 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.754 0 CA-C-O 123.966 1.87 . . . . 3.87 111.868 -175.09 . . . . . . . . 0 0 . 1 . 123 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.4 ttp . . . . . 0 CA--C 1.489 -1.388 0 CA-C-O 117.375 -1.298 . . . . 1.39 109.681 . . . . . . . . . 0 0 . 1 . 123 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -87.8 133.05 33.95 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 120.314 1.415 . . . . 2.2 114.681 -178.704 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pt -138.98 164.54 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 118.582 -2.574 . . . . 1.32 109.332 174.443 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -113.21 146.71 38.84 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 127.053 2.141 . . . . 2.2 110.852 -177.397 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.1 t -126.98 105.61 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 105.886 -1.894 . . . . 1.23 105.886 175.076 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -84.03 120.96 26.76 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 131.631 3.972 . . . . 2.51 115.293 173.761 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.2 p -104.41 -121.96 0.21 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.677 1.362 . . . . 1.41 114.677 -174.163 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.0 tp -159.98 -63.53 0.07 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 103.284 -2.858 . . . . 2.95 103.284 173.585 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.5 p -97.14 93.94 6.84 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 120.418 1.463 . . . . 2.52 111.901 -178.215 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.49 -146.93 17.63 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 127.842 2.639 . . . . 1.5 110.415 176.96 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -90.88 168.33 11.78 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 122.545 1.164 . . . . 1.79 112.154 -174.853 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -102.61 116.91 33.54 Favored 'General case' 0 N--CA 1.431 -1.383 1 N-CA-C 99.382 -4.303 . . . . 1.38 99.382 175.65 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.28 16.4 pt -84.33 152.17 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 128.097 2.559 . . . . 2.03 112.578 178.159 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 m -116.77 128.67 55.52 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 128.345 2.658 . . . . 1.61 106.263 176.617 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.6 mt -122.06 157.43 31.43 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.393 -2.692 . . . . 2.15 108.447 179.663 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -107.65 120.88 43.45 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.019 -2.301 . . . . 1.98 104.983 170.996 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.1 m -131.03 172.55 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 125.435 1.494 . . . . 1.52 109.806 -175.263 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -112.94 152.7 45.1 Favored Pre-proline 0 N--CA 1.43 -1.441 0 CA-C-O 116.304 -1.808 . . . . 2.35 111.136 164.911 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.76 -22.32 32.26 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 126.335 3.298 . . . . 1.31 114.118 -176.345 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.0 m -72.45 -12.88 61.28 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 116.137 -1.887 . . . . 1.71 110.251 176.073 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -66.08 135.54 54.76 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 123.4 2.818 . . . . 1.69 117.842 177.276 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.5 p -69.83 160.91 30.89 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 117.547 -3.221 . . . . 1.33 112.873 176.795 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 mm -66.58 -42.28 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 128.025 2.53 . . . . 1.32 108.279 175.366 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -45.93 -49.62 15.52 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.084 2.624 . . . . 1.62 118.084 161.275 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -68.31 -45.53 72.72 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 127.547 3.029 . . . . 2.13 111.447 178.997 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.5 t -59.02 -30.1 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 115.209 1.559 . . . . 1.23 115.209 173.936 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -68.38 -35.56 77.88 Favored 'General case' 0 N--CA 1.43 -1.475 1 O-C-N 113.871 -5.518 . . . . 1.97 111.671 169.657 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.2 -46.76 82.6 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 124.106 1.908 . . . . 1.19 115.506 169.6 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -47.98 -49.84 29.41 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 127.0 2.12 . . . . 1.92 109.046 169.727 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.2 mt -62.63 -30.34 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 123.653 2.933 . . . . 1.94 116.856 175.462 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -68.48 -34.64 76.29 Favored 'General case' 0 N--CA 1.431 -1.414 1 CA-C-O 128.821 4.153 . . . . 1.9 114.52 -174.181 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -61.74 -41.41 97.62 Favored 'General case' 0 N--CA 1.432 -1.369 2 O-C-N 115.043 -4.786 . . . . 1.55 112.178 172.286 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -91.74 -65.65 0.99 Allowed 'General case' 0 N--CA 1.429 -1.495 1 O-C-N 115.556 -4.465 . . . . 2.95 107.467 -172.801 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -88.36 -17.77 29.85 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 126.111 2.862 . . . . 1.48 116.158 -165.241 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.75 34.31 28.12 Favored Glycine 0 N--CA 1.43 -1.747 0 O-C-N 117.648 -3.158 . . . . 1.12 116.248 176.629 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.8 mt -107.85 121.92 42.49 Favored Pre-proline 0 N--CA 1.429 -1.492 0 N-CA-C 107.011 -1.477 . . . . 2.07 107.011 -178.354 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.288 52.8 Cg_exo -51.36 146.8 23.54 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-O 113.875 -2.635 . . . . 1.39 116.357 175.78 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -68.67 -23.1 36.68 Favored 'Trans proline' 0 C--N 1.299 -2.058 1 C-N-CA 125.761 4.307 . . . . 1.68 110.249 -175.623 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -84.44 -18.48 35.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.555 2.428 . . . . 2.25 117.555 176.573 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -88.34 -24.15 23.21 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 115.465 1.654 . . . . 2.44 115.465 -177.59 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -100.57 139.25 36.52 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.568 1.547 . . . . 1.32 112.528 -177.201 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -118.4 133.14 56.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 107.89 -1.152 . . . . 3.19 107.89 175.172 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.6 mt -99.5 127.0 45.54 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.733 1.606 . . . . 1.75 114.762 -179.441 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.0 mm -107.86 138.41 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 1 O-C-N 130.357 4.786 . . . . 1.98 107.121 -177.09 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -145.72 140.05 26.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.441 -3.912 . . . . 1.94 102.274 171.552 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.301 . . 62.5 -96.13 0.05 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.604 1.561 . . . . 1.67 109.079 -174.66 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.61 24.59 1.2 Allowed Glycine 0 N--CA 1.429 -1.817 0 O-C-N 127.744 3.153 . . . . 1.3 110.217 -179.291 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -121.34 147.87 45.11 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.2 1.8 . . . . 2.89 107.793 -177.37 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -95.98 130.97 42.82 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.897 -1.956 . . . . 2.89 107.58 173.306 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mt -96.15 124.79 40.29 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.805 3.261 . . . . 1.34 119.805 -172.813 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -66.14 132.75 49.2 Favored 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 132.549 4.34 . . . . 1.94 114.024 177.429 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -63.64 -32.87 74.48 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.297 -3.377 . . . . 1.56 114.737 -169.239 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.84 25.71 7.28 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 116.374 -3.953 . . . . 0.97 115.362 173.662 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -121.47 168.28 11.88 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 120.766 2.283 . . . . 3.07 111.134 173.614 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 p -104.83 154.6 19.83 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.185 1.469 . . . . 1.34 111.262 -178.39 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.8 mt -51.48 -37.96 51.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.046 1.879 . . . . 1.63 113.268 173.444 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -59.16 -50.1 75.33 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.48 -3.263 . . . . 1.51 117.057 171.391 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -43.04 -47.72 5.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.986 -3.571 . . . . 1.9 113.882 168.046 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -77.97 -13.61 59.82 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 117.762 2.504 . . . . 0.97 117.762 177.415 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.5 m120 69.08 63.9 0.29 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.631 1.972 . . . . 2.35 112.723 178.523 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.4 mt -98.33 137.1 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 117.43 -3.293 . . . . 1.39 106.837 176.22 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -117.58 -179.47 3.74 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 106.32 -1.733 . . . . 2.58 106.32 -174.659 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -71.3 140.45 50.31 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 126.77 2.544 . . . . 2.58 115.363 176.712 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 22.9 mt-10 70.83 46.53 0.49 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 126.133 2.873 . . . . 1.71 114.099 177.308 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.3 m -109.42 135.46 50.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 112.076 -2.329 . . . . 1.34 113.298 -173.643 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.3 m -92.47 99.81 12.48 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.788 -3.07 . . . . 1.36 112.392 -173.985 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mp -81.95 146.35 29.82 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.168 -1.79 . . . . 2.03 106.168 176.344 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -107.91 138.44 44.16 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.934 -1.506 . . . . 2.31 106.934 -175.363 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 tt -106.56 122.07 45.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 119.983 1.265 . . . . 1.72 111.435 -177.606 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.6 m -107.84 122.45 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 104.922 -2.251 . . . . 1.8 104.922 175.5 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.8 tp -100.42 127.15 46.84 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.707 2.803 . . . . 3.26 116.863 -173.385 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -82.19 118.45 23.1 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.596 -2.565 . . . . 4.12 110.925 -179.564 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.1 mt -105.84 -51.3 3.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 126.328 2.267 . . . . 3.54 105.392 178.974 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.6 mtt85 -106.74 -72.8 0.71 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.275 -2.861 . . . . 7.32 103.275 173.782 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.85 151.9 5.58 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-O 125.577 2.765 . . . . 3.73 111.048 -169.324 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.815 0 O-C-N 117.356 -3.438 . . . . 3.87 109.423 -177.444 . . . . . . . . 0 0 . 1 . 124 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.3 ttp . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 117.391 2.367 . . . . 1.39 117.391 . . . . . . . . . 0 0 . 1 . 124 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -109.58 113.48 26.3 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.492 1.293 . . . . 2.2 114.492 -173.499 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.3 pt -111.41 171.15 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 119.597 -1.94 . . . . 1.32 110.062 174.246 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -124.65 122.67 38.17 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.869 2.068 . . . . 2.2 108.07 -176.617 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.6 t -104.41 114.17 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 118.549 -2.594 . . . . 1.23 110.091 171.169 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -93.37 158.22 15.84 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.06 -3.525 . . . . 2.51 108.909 178.063 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.9 p -119.27 172.91 7.27 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.533 -3.23 . . . . 1.41 114.369 -178.945 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.2 tp -72.55 -47.3 49.3 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.572 1.653 . . . . 2.95 110.97 178.647 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.9 p -73.65 -30.67 63.07 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.479 -1.388 . . . . 2.52 113.271 -176.398 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.07 2.07 0.65 Allowed Glycine 0 N--CA 1.43 -1.724 0 O-C-N 117.021 -3.55 . . . . 1.5 117.203 176.995 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -91.28 149.84 21.58 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 122.667 3.234 . . . . 1.79 108.57 -179.664 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.2 m -134.95 112.8 10.92 Favored 'General case' 0 N--CA 1.431 -1.398 1 N-CA-C 100.138 -4.023 . . . . 1.38 100.138 -179.806 . . . . . . . . 2 2 . 1 . 124 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 mt -106.31 113.35 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 129.741 3.217 . . . . 2.03 114.231 -171.682 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.6 m -74.75 114.98 13.81 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.662 -2.524 . . . . 1.61 115.542 173.445 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.1 mt -113.66 129.11 56.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.515 1.507 . . . . 2.15 109.088 -176.791 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -97.72 113.86 25.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.618 -1.301 . . . . 1.98 111.714 174.704 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -116.5 166.62 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 126.395 2.309 . . . . 1.52 110.569 -170.599 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -112.19 155.34 43.66 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 113.252 -3.261 . . . . 2.35 105.69 164.641 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.9 -21.73 63.81 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 CA-C-N 124.207 2.538 . . . . 1.31 117.433 -175.957 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.5 p -73.89 -17.31 61.06 Favored 'General case' 0 N--CA 1.431 -1.41 1 C-N-CA 134.307 5.043 . . . . 1.71 118.927 173.024 . . . . . . . . 2 2 . 1 . 124 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -69.14 143.47 54.11 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 125.475 2.56 . . . . 1.69 109.301 174.083 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 3.3 p -94.74 164.12 13.07 Favored 'General case' 0 N--CA 1.431 -1.408 1 O-C-N 116.197 -4.064 . . . . 1.33 105.154 -177.43 . . . . . . . . 3 3 . 1 . 124 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.1 mm -56.27 -42.91 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 126.666 2.479 . . . . 1.32 111.605 176.651 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -46.77 -50.55 18.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 116.213 1.931 . . . . 1.62 116.213 164.559 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -74.02 -24.97 59.63 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 121.919 2.145 . . . . 2.13 111.166 178.45 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.2 t -74.06 -33.27 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 116.867 -3.646 . . . . 1.23 111.322 176.44 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -71.16 -28.84 64.55 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.347 -3.971 . . . . 1.97 109.231 172.366 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.57 -28.13 69.66 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 115.914 -4.241 . . . . 1.19 117.377 168.192 . . . . . . . . 2 2 . 1 . 124 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -74.16 -30.87 62.47 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 122.593 2.452 . . . . 1.92 109.021 -178.134 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.0 mt -67.69 -35.71 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 O-C-N 127.216 2.822 . . . . 1.94 114.813 172.284 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -73.33 -15.8 61.38 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 118.993 2.96 . . . . 1.9 118.993 178.157 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -69.07 -43.0 75.48 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.436 1.273 . . . . 1.55 114.436 162.721 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -73.06 -61.07 1.94 Allowed 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 126.893 3.235 . . . . 2.95 112.348 -175.405 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -100.15 -30.34 11.99 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.133 -2.854 . . . . 1.48 110.16 -164.564 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.43 33.11 7.75 Favored Glycine 0 N--CA 1.431 -1.674 0 O-C-N 128.116 3.385 . . . . 1.12 115.729 173.239 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.3 mt -106.05 129.21 24.93 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 116.566 -1.683 . . . . 2.07 107.291 -177.975 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -62.82 142.65 89.57 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 124.405 3.404 . . . . 1.39 119.747 175.98 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.28 -17.65 35.07 Favored 'Trans proline' 0 C--N 1.299 -2.057 0 N-CA-C 118.445 2.441 . . . . 1.68 118.445 -178.111 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -68.15 -24.87 65.04 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.72 -1.237 . . . . 2.25 113.728 173.144 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -93.69 -18.11 22.48 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.746 1.736 . . . . 2.44 111.184 -179.493 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -95.02 154.15 17.3 Favored 'General case' 0 N--CA 1.431 -1.378 0 O-C-N 118.419 -2.676 . . . . 1.32 110.82 -176.264 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -141.32 151.35 43.53 Favored 'General case' 0 N--CA 1.43 -1.465 1 C-N-CA 133.284 4.633 . . . . 3.19 113.257 171.136 . . . . . . . . 2 2 . 1 . 124 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.5 mt -115.99 132.61 56.6 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.211 -2.806 . . . . 1.75 111.035 177.404 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.1 mt -109.73 123.1 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.354 -1.35 . . . . 1.98 107.354 -178.529 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -145.72 140.92 27.57 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.382 -2.699 . . . . 1.94 103.976 175.712 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.85 14.21 7.99 Favored 'General case' 0 N--CA 1.43 -1.434 1 C-N-CA 131.717 4.007 . . . . 1.67 114.53 -176.555 . . . . . . . . 2 2 . 1 . 124 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.95 -30.39 10.52 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 125.74 1.638 . . . . 1.3 115.441 -171.796 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -101.25 156.16 17.6 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 120.73 2.265 . . . . 2.89 115.422 -177.974 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -72.29 135.62 46.02 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 116.897 -1.525 . . . . 2.89 113.416 167.797 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.6 mt -89.05 145.57 25.39 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.102 2.228 . . . . 1.34 112.716 -176.119 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -72.55 139.24 47.4 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.203 -2.186 . . . . 1.94 111.549 173.418 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -66.99 -56.25 10.96 Favored 'General case' 0 N--CA 1.431 -1.409 1 C-N-CA 131.826 4.05 . . . . 1.56 119.49 -168.519 . . . . . . . . 2 2 . 1 . 124 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.6 37.14 2.78 Favored Glycine 0 N--CA 1.43 -1.757 0 O-C-N 117.936 -2.977 . . . . 0.97 116.775 175.564 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 22' ' ' THR . 83.3 mtt-85 -114.13 160.49 18.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.866 -2.549 . . . . 3.07 108.576 171.266 . . . . . . . . 2 2 . 1 . 124 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.452 54.7 p -87.49 146.27 25.89 Favored 'General case' 0 N--CA 1.43 -1.47 1 C-N-CA 132.103 4.161 . . . . 1.34 111.571 179.711 . . . . . . . . 4 3 . 1 . 124 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mt -55.46 -34.87 64.9 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 114.694 1.368 . . . . 1.63 114.694 172.026 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 p -64.11 -33.81 76.62 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.238 3.015 . . . . 1.51 112.975 178.567 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -66.62 -37.12 84.19 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 125.047 1.339 . . . . 1.9 113.74 178.226 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -85.92 -5.13 59.28 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.06 1.344 . . . . 0.97 110.038 175.152 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.4 t30 60.74 38.45 18.25 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 127.053 3.311 . . . . 2.35 116.257 179.139 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.0 mt -74.82 125.24 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 O-C-N 116.892 -3.63 . . . . 1.39 109.611 -177.405 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -99.19 -175.84 3.14 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.217 -2.802 . . . . 2.58 111.854 -176.982 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -70.68 160.67 32.18 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 124.116 1.912 . . . . 2.58 111.233 177.165 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.384 16.4 mt-10 44.83 48.54 9.1 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 118.133 2.642 . . . . 1.71 118.133 179.626 . . . . . . . . 2 2 . 1 . 124 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.6 m -107.28 144.05 34.66 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 127.34 2.9 . . . . 1.34 106.028 -175.941 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.6 m -108.75 103.81 12.96 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.586 -1.188 . . . . 1.36 108.118 -178.205 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mp -87.62 158.51 18.85 Favored 'General case' 0 N--CA 1.429 -1.475 1 C-N-CA 132.52 4.328 . . . . 2.03 106.377 173.339 . . . . . . . . 2 2 . 1 . 124 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -121.28 142.89 49.51 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 102.079 -3.304 . . . . 2.31 102.079 -174.085 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.5 tp -97.99 129.35 44.87 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 114.669 -2.586 . . . . 1.72 108.975 -179.784 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 m -129.72 168.05 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 121.642 2.019 . . . . 1.8 106.632 171.092 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.9 mt -112.49 143.9 42.85 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.384 -2.073 . . . . 3.26 106.772 -177.147 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -102.96 94.82 5.77 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.489 -0.778 . . . . 4.12 109.666 177.175 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.56 -176.83 3.19 Favored 'General case' 0 N--CA 1.43 -1.437 1 C-N-CA 134.083 4.953 . . . . 3.54 110.438 174.071 . . . . . . . . 3 3 . 1 . 124 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.8 mtm105 -81.02 132.63 35.38 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.596 2.617 . . . . 7.32 110.375 166.345 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.53 -133.72 11.46 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 119.287 -2.133 . . . . 3.73 115.036 -161.391 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.743 1 CA-C-O 112.132 -4.705 . . . . 3.87 113.841 -174.715 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptt? . . . . . 0 CA--C 1.489 -1.389 0 N-CA-C 108.363 -0.977 . . . . 1.39 108.363 . . . . . . . . . 0 0 . 1 . 125 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -102.39 131.58 48.94 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.009 2.124 . . . . 2.2 112.365 -172.147 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.412 HD13 HG22 ' A' ' 17' ' ' VAL . 23.1 pt -139.07 157.17 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-O 125.606 2.622 . . . . 1.32 106.625 176.651 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -109.01 121.7 45.69 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.834 -2.416 . . . . 2.2 112.764 -176.954 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.1 t -96.85 103.42 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 116.854 -3.654 . . . . 1.23 107.166 175.073 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -76.43 136.43 39.44 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 118.567 2.803 . . . . 2.51 118.567 168.272 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -83.33 169.96 15.08 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.065 -4.147 . . . . 1.41 109.847 177.622 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.2 mt -60.71 -42.64 97.64 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.419 -2.676 . . . . 2.95 115.455 170.324 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -75.44 -51.2 13.61 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 127.145 2.778 . . . . 2.52 116.148 -176.706 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.21 -44.84 0.19 Allowed Glycine 0 N--CA 1.431 -1.695 0 CA-C-O 113.956 -3.691 . . . . 1.5 114.161 -177.845 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -53.51 136.18 38.7 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 122.62 3.21 . . . . 1.79 118.625 -177.445 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.266 88.5 m -107.72 98.7 8.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.79 1.757 . . . . 1.38 107.818 178.4 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -80.72 98.64 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 125.695 2.664 . . . . 2.03 110.195 177.231 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.5 m -82.12 122.85 28.38 Favored 'General case' 0 N--CA 1.429 -1.498 1 O-C-N 115.153 -4.717 . . . . 1.61 110.722 178.269 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.5 mt -122.28 144.32 49.07 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.175 1.917 . . . . 2.15 116.175 -178.494 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -103.86 124.83 49.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 116.42 -2.112 . . . . 1.98 108.749 174.905 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.412 HG22 HD13 ' A' ' 3' ' ' ILE . 20.8 m -140.98 165.08 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.041 -1.662 . . . . 1.52 108.094 -171.122 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.293 4.6 mm-40 -102.75 150.19 37.49 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-O 114.538 -2.649 . . . . 2.35 110.518 163.578 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -75.96 -14.9 18.95 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 125.877 3.135 . . . . 1.31 109.12 -171.963 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.1 p -81.18 -1.31 44.16 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 123.836 1.779 . . . . 1.71 114.129 174.202 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -75.02 147.92 40.31 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 118.315 -2.74 . . . . 1.69 113.021 172.309 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.0 p -85.82 176.42 8.12 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 124.287 1.994 . . . . 1.33 112.894 -175.349 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.408 HG23 ' HB2' ' A' ' 50' ' ' LEU 0.252 20.8 mm -76.85 -37.23 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 116.345 -3.972 . . . . 1.32 106.278 177.832 . . . . . . . . 3 3 . 1 . 125 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -53.33 -36.36 61.2 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.282 -3.386 . . . . 1.62 112.027 169.027 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -74.83 -46.08 38.96 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 120.629 1.559 . . . . 2.13 112.281 177.365 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.1 t -57.3 -43.26 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 C-N-CA 128.829 2.852 . . . . 1.23 112.02 175.538 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -70.26 -34.26 72.6 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.661 2.467 . . . . 1.97 117.661 171.509 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.94 89.29 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.598 -1.939 . . . . 1.19 106.855 178.057 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -57.97 -41.52 83.1 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 119.292 3.071 . . . . 1.92 119.292 167.567 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.268 65.3 mt -63.22 -35.91 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.242 -2.786 . . . . 1.94 113.66 170.635 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -61.37 -41.26 96.81 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 130.747 3.619 . . . . 1.9 109.389 172.074 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -58.15 -57.53 12.45 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 114.45 1.278 . . . . 1.55 114.45 177.195 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -73.13 -63.59 1.15 Allowed 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 117.731 2.493 . . . . 2.95 117.731 -174.284 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -101.35 -19.06 15.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.071 -1.643 . . . . 1.48 111.566 -168.529 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.76 30.3 6.88 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 118.215 2.046 . . . . 1.12 118.215 173.696 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.9 mt -106.15 119.2 52.86 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-N 121.35 2.575 . . . . 2.07 109.104 -176.018 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -56.28 145.89 75.19 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 CA-C-N 127.263 3.629 . . . . 1.39 114.363 174.946 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -82.72 -5.31 11.56 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 124.499 3.466 . . . . 1.68 108.493 -166.214 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -80.93 -23.74 38.67 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.516 1.507 . . . . 2.25 111.384 176.389 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -90.07 -12.75 37.56 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.051 -2.281 . . . . 2.44 111.657 -178.192 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -87.21 123.49 32.28 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 130.167 3.387 . . . . 1.32 111.647 -174.682 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -123.47 114.13 19.69 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-O 125.107 2.384 . . . . 3.19 109.472 161.777 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.9 mt -87.18 138.6 31.35 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 124.346 2.022 . . . . 1.75 106.486 -178.553 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.6 mt -135.37 128.54 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 128.006 2.523 . . . . 1.98 110.209 -178.54 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -127.17 115.32 18.92 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 115.291 -4.631 . . . . 1.94 104.603 177.931 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 73.15 -58.52 0.6 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.729 2.812 . . . . 1.67 110.605 177.082 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -162.66 -13.73 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 O-C-N 120.502 -1.374 . . . . 1.3 111.849 -178.365 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -98.62 134.0 42.17 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.127 -1.536 . . . . 2.89 109.502 -177.163 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -73.27 140.61 46.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.838 2.055 . . . . 2.89 108.856 166.828 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.408 ' HB2' HG23 ' A' ' 23' ' ' ILE . 16.0 mt -97.56 123.28 41.39 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.204 -1.776 . . . . 1.34 106.204 -170.853 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -91.46 145.68 24.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.747 -2.471 . . . . 1.94 110.26 178.955 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -43.26 -57.59 2.92 Favored 'General case' 0 N--CA 1.43 -1.439 1 C-N-CA 131.993 4.117 . . . . 1.56 119.818 -175.757 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.15 7.29 8.13 Favored Glycine 0 N--CA 1.43 -1.728 1 N-CA-C 123.149 4.02 . . . . 0.97 123.149 168.524 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -98.23 167.07 11.09 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 120.656 2.228 . . . . 3.07 112.158 167.738 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.341 18.6 p -109.81 166.61 10.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.828 2.159 . . . . 1.34 116.828 -179.137 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.6 mt -61.98 -35.36 78.28 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.029 2.347 . . . . 1.63 111.62 172.21 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.8 t -75.84 -33.03 60.02 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.601 -2.562 . . . . 1.51 113.477 -179.997 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -56.42 -46.4 80.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.834 2.054 . . . . 1.9 114.116 166.248 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -84.77 -9.22 58.4 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 121.817 2.099 . . . . 0.97 112.756 -179.617 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.522 12.8 m120 81.68 46.52 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 125.867 1.667 . . . . 2.35 113.591 175.403 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.1 mt -96.8 118.81 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 113.495 -1.684 . . . . 1.39 114.012 179.931 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -115.1 -179.02 3.51 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 106.319 -1.734 . . . . 2.58 106.319 -174.964 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -62.05 151.87 34.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 127.801 2.441 . . . . 2.58 114.405 -178.675 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 66.2 29.55 9.66 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.797 2.237 . . . . 1.71 110.746 177.495 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.6 p -106.71 150.95 25.75 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 113.982 -5.449 . . . . 1.34 109.298 -176.158 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.4 m -103.14 122.18 44.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.329 2.49 . . . . 1.36 109.668 179.713 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -110.57 145.21 38.22 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 118.615 -2.553 . . . . 2.03 105.539 176.559 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -100.67 136.12 41.03 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 118.58 -2.575 . . . . 2.31 107.189 179.859 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.5 tp -113.96 123.96 50.99 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.961 -1.712 . . . . 1.72 108.21 174.691 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.8 t -105.85 134.51 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 103.083 -2.932 . . . . 1.8 103.083 176.04 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.8 tp -96.05 143.17 27.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.339 2.495 . . . . 3.26 111.985 174.825 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -117.05 148.7 41.27 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.348 -3.345 . . . . 4.12 105.781 174.839 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.463 4.6 mt -77.38 127.72 33.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 121.095 -0.242 . . . . 3.54 110.68 173.548 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.407 30.1 ttm180 -129.87 -73.93 0.56 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 123.169 0.587 . . . . 7.32 111.602 163.442 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.95 20.75 1.43 Allowed Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 120.208 2.843 . . . . 3.73 120.208 -166.305 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.728 1 O-C-N 116.176 -4.132 . . . . 3.87 108.317 177.04 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.4 ttp . . . . . 0 CA--C 1.49 -1.335 0 CA-C-O 117.396 -1.288 . . . . 1.39 110.935 . . . . . . . . . 0 0 . 1 . 126 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -81.34 133.1 35.37 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 120.405 1.457 . . . . 2.2 111.21 -179.136 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 pt -140.25 162.73 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 123.981 1.848 . . . . 1.32 108.072 173.565 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -120.66 133.31 55.37 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 102.226 -3.25 . . . . 2.2 102.226 -177.148 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.0 t -109.48 123.83 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 127.994 2.517 . . . . 1.23 104.831 167.829 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -101.06 124.16 46.34 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.787 -1.821 . . . . 2.51 111.43 176.74 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -85.84 151.81 23.5 Favored 'General case' 0 N--CA 1.431 -1.41 1 O-C-N 115.448 -4.533 . . . . 1.41 114.041 175.032 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.5 tp -34.56 -54.1 0.54 Allowed 'General case' 0 N--CA 1.43 -1.434 1 C-N-CA 133.018 4.527 . . . . 2.95 115.404 169.83 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.4 p -81.88 -31.78 31.32 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 125.872 1.982 . . . . 2.52 110.644 -170.93 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.78 17.28 0.11 Allowed Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 118.444 -1.836 . . . . 1.5 117.048 178.862 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.407 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 73.8 tttt -114.79 141.91 47.23 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 115.68 -4.423 . . . . 1.79 105.404 -177.685 . . . . . . . . 3 3 . 1 . 126 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.5 m -105.77 124.79 50.13 Favored 'General case' 0 N--CA 1.429 -1.522 0 O-C-N 123.358 0.411 . . . . 1.38 109.944 173.473 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mt -93.46 116.09 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 125.577 2.608 . . . . 2.03 105.933 179.889 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.2 m -92.26 102.45 14.95 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 115.507 -4.495 . . . . 1.61 107.323 174.72 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.5 mt -90.96 160.21 15.77 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.526 -1.359 . . . . 2.15 110.54 178.616 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -125.3 114.06 18.41 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 119.854 -1.779 . . . . 1.98 108.008 165.715 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.01 -176.2 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 119.205 -2.185 . . . . 1.52 110.382 -173.318 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -107.08 149.12 38.22 Favored Pre-proline 0 N--CA 1.43 -1.432 0 CA-C-O 114.096 -2.859 . . . . 2.35 109.622 167.145 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.39 -24.15 19.68 Favored 'Trans proline' 0 N--CA 1.433 -2.054 1 CA-C-N 128.661 4.129 . . . . 1.31 111.807 -171.561 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.8 m -102.03 16.29 26.47 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 126.318 2.261 . . . . 1.71 116.873 -179.352 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.83 157.56 25.68 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.306 1.527 . . . . 1.69 112.446 173.227 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.8 p -86.68 162.58 17.84 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.51 3.052 . . . . 1.33 116.204 -176.903 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mm -70.45 -38.96 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 1 O-C-N 115.124 -4.735 . . . . 1.32 107.512 -179.289 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -47.58 -54.11 12.7 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.346 3.058 . . . . 1.62 111.592 167.937 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -62.22 -36.98 83.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.945 2.898 . . . . 2.13 118.178 171.375 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.372 4.2 t -63.3 -39.31 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 116.57 -3.831 . . . . 1.23 112.52 174.847 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -65.91 -32.39 73.87 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.844 2.165 . . . . 1.97 116.844 172.089 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.82 -31.62 72.36 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.636 -1.915 . . . . 1.19 114.1 170.472 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -68.24 -26.88 65.91 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.276 1.988 . . . . 1.92 115.217 170.199 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.4 mt -75.2 -28.25 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 117.385 -3.322 . . . . 1.94 114.174 170.489 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -70.81 -38.39 73.29 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.352 2.501 . . . . 1.9 115.062 170.3 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.83 -36.84 85.23 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 116.748 -3.72 . . . . 1.55 111.917 172.513 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -85.35 -53.39 5.25 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.478 1.609 . . . . 2.95 110.919 -176.69 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.407 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 65.8 mm-40 -100.73 -43.98 5.96 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.882 -3.011 . . . . 1.48 117.141 -174.069 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.66 -0.73 18.03 Favored Glycine 0 N--CA 1.429 -1.806 0 CA-C-O 117.01 -1.994 . . . . 1.12 111.599 178.194 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.0 mt -70.22 130.72 89.23 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-N 121.099 2.45 . . . . 2.07 112.733 -178.805 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -76.32 154.3 36.29 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 O-C-N 115.556 -2.918 . . . . 1.39 116.023 174.788 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -71.8 -6.81 19.89 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 124.009 3.139 . . . . 1.68 113.039 -169.13 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -67.58 -35.03 78.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.345 3.058 . . . . 2.25 109.132 175.116 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -85.28 -22.32 28.64 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.384 -1.448 . . . . 2.44 113.396 178.708 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -83.19 119.16 24.19 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.028 -2.92 . . . . 1.32 117.622 -168.654 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.425 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 51.4 ttt180 -107.83 118.78 37.63 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 105.297 -2.112 . . . . 3.19 105.297 172.758 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.5 mt -113.73 122.51 47.33 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 116.375 -1.774 . . . . 1.75 108.671 -177.092 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.3 mt -120.19 136.2 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 124.574 2.13 . . . . 1.98 107.702 177.483 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -130.4 112.2 13.03 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.056 1.884 . . . . 1.94 109.496 171.45 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.65 -72.58 0.09 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.468 2.307 . . . . 1.67 114.021 177.968 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.7 -62.18 0.19 Allowed Glycine 0 N--CA 1.43 -1.751 0 O-C-N 120.835 -1.165 . . . . 1.3 112.675 -178.28 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -79.85 153.51 29.04 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 115.085 1.513 . . . . 2.89 115.085 -173.455 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -82.95 137.66 34.11 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.321 -2.737 . . . . 2.89 111.052 171.503 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.8 mt -84.87 121.57 27.92 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.488 -2.007 . . . . 1.34 114.835 -169.217 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.316 10.7 pt-20 -78.63 173.25 12.62 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 118.463 -2.648 . . . . 1.94 115.669 175.152 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -68.08 -58.68 4.09 Favored 'General case' 0 N--CA 1.429 -1.478 1 N-CA-C 125.054 5.205 . . . . 1.56 125.054 -177.023 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.65 56.59 1.37 Allowed Glycine 0 N--CA 1.43 -1.711 0 O-C-N 118.502 -2.624 . . . . 0.97 111.143 170.81 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -123.24 168.65 12.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.224 -2.139 . . . . 3.07 105.224 160.722 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.0 p -101.65 169.29 8.93 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.469 -1.394 . . . . 1.34 112.279 179.494 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mt -54.61 -44.9 73.51 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 114.717 1.377 . . . . 1.63 114.717 166.98 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.262 41.7 p -67.88 -24.38 65.22 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.258 2.623 . . . . 1.51 115.078 -176.651 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -70.59 -25.18 62.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.124 2.869 . . . . 1.9 115.793 176.195 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -95.81 -6.71 38.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.123 -2.308 . . . . 0.97 114.18 175.157 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.26 7.6 t30 76.53 43.16 0.15 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.864 -2.397 . . . . 2.35 110.166 179.56 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.7 mt -91.91 107.3 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.733 -1.229 . . . . 1.39 108.261 177.325 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -101.08 -170.82 1.89 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 126.184 2.897 . . . . 2.58 107.749 -174.304 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -63.69 141.91 58.59 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 111.318 -2.674 . . . . 2.58 110.693 171.822 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 69.05 20.84 7.59 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 110.734 -2.939 . . . . 1.71 116.877 177.008 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.6 m -88.88 159.37 17.72 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 116.165 1.913 . . . . 1.34 116.165 -170.899 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.2 m -101.32 115.79 31.3 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 117.007 -3.558 . . . . 1.36 110.49 -178.97 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -105.37 146.82 28.92 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.674 -1.232 . . . . 2.03 107.674 171.181 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -101.58 130.63 47.94 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 116.132 -1.89 . . . . 2.31 110.736 177.05 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.1 tp -115.12 108.29 16.44 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.205 1.366 . . . . 1.72 107.551 177.172 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 74.6 t -96.2 130.19 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 119.131 -2.23 . . . . 1.8 105.784 171.801 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.9 mt -92.76 130.69 38.3 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 120.275 1.398 . . . . 3.26 111.087 178.896 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -115.29 -166.27 1.11 Allowed 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 120.141 -1.6 . . . . 4.12 110.06 174.773 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mp -117.79 -59.01 1.96 Allowed 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.751 2.215 . . . . 3.54 107.592 -179.966 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -99.6 -74.55 0.59 Allowed 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.01 -4.806 . . . . 7.32 106.115 172.128 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.81 172.05 41.88 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 126.437 3.243 . . . . 3.73 111.849 -162.215 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.749 0 C-N-CA 128.444 2.926 . . . . 3.87 109.087 -170.418 . . . . . . . . 0 0 . 1 . 127 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 ptt? . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 104.575 -2.379 . . . . 1.39 104.575 . . . . . . . . . 0 0 . 1 . 127 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -119.08 154.54 33.02 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 124.53 3.332 . . . . 2.2 106.291 175.994 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -136.37 167.36 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 105.425 -2.065 . . . . 1.32 105.425 167.491 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -120.96 125.84 48.44 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.046 2.138 . . . . 2.2 108.129 -176.835 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.6 t -104.45 130.72 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.708 -3.12 . . . . 1.23 105.283 170.751 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.287 12.4 ttpt -127.03 122.08 33.39 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 129.715 4.384 . . . . 2.51 119.645 -177.12 . . . . . . . . 3 2 . 1 . 127 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 p -70.89 161.73 30.53 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 112.671 -2.059 . . . . 1.41 115.106 177.963 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.7 tp -54.31 -48.34 71.44 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.783 2.433 . . . . 2.95 115.465 174.058 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.31 -31.95 70.76 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.522 2.729 . . . . 2.52 115.582 -177.728 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.94 27.68 0.7 Allowed Glycine 0 N--CA 1.429 -1.775 0 CA-C-O 117.641 -1.644 . . . . 1.5 109.817 176.1 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.45 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 78.4 tttt -97.46 122.98 41.15 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.449 3.125 . . . . 1.79 108.318 -178.093 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.4 m -96.45 117.48 30.97 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 127.309 3.433 . . . . 1.38 107.156 172.661 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.8 mt -93.6 122.05 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 117.668 -3.145 . . . . 2.03 102.529 174.944 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -108.91 106.5 16.5 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 123.657 1.694 . . . . 1.61 109.943 174.256 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.4 mt -102.6 152.58 21.01 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 116.475 -3.89 . . . . 2.15 109.445 -178.033 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.68 130.44 42.58 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.382 -1.449 . . . . 1.98 110.869 169.299 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.66 163.01 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 114.196 -1.365 . . . . 1.52 110.232 -173.969 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -104.06 151.25 38.94 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 117.963 -2.961 . . . . 2.35 112.427 158.476 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -75.99 -7.29 18.16 Favored 'Trans proline' 0 N--CA 1.434 -1.998 1 CA-C-N 129.621 4.472 . . . . 1.31 117.359 -176.262 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.3 m -82.34 -9.95 59.27 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 128.36 2.664 . . . . 1.71 113.515 173.565 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -76.27 158.2 31.81 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 116.195 -2.202 . . . . 1.69 109.774 177.918 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.2 p -87.36 158.46 19.02 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 116.304 1.964 . . . . 1.33 116.304 177.307 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.0 mp -55.13 -46.02 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 118.402 -0.808 . . . . 1.32 111.428 172.187 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.264 42.9 tt0 -41.39 -44.41 2.81 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 120.11 3.374 . . . . 1.62 120.11 163.586 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -83.36 -34.26 25.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.346 -3.346 . . . . 2.13 110.524 -177.077 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.0 t -62.44 -37.82 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 O-C-N 117.016 -3.553 . . . . 1.23 108.076 170.727 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -67.17 -24.63 65.89 Favored 'General case' 0 N--CA 1.431 -1.412 1 CA-C-O 128.715 4.102 . . . . 1.97 119.518 175.64 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.6 -16.39 62.62 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 117.974 -2.954 . . . . 1.19 113.403 169.105 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -87.48 -30.94 20.27 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 116.008 -4.182 . . . . 1.92 112.429 179.01 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.287 51.3 mt -66.16 -19.01 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-O 124.519 2.104 . . . . 1.94 108.518 173.155 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -75.05 -43.97 50.35 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.681 -2.512 . . . . 1.9 112.295 178.458 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -65.81 -53.8 35.29 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.668 1.187 . . . . 1.55 110.143 168.948 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -59.89 -69.71 0.2 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.209 1.48 . . . . 2.95 112.64 -173.179 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.45 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 21.9 mm-40 -90.13 -40.82 12.0 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 128.672 2.789 . . . . 1.48 113.517 -166.848 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.22 31.6 3.75 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 116.244 -2.884 . . . . 1.12 111.849 172.53 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.1 mt -113.17 119.11 43.04 Favored Pre-proline 0 N--CA 1.429 -1.48 0 C-N-CA 126.939 2.096 . . . . 2.07 109.816 -177.001 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -63.1 156.24 56.26 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 125.276 3.984 . . . . 1.39 116.48 175.754 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.88 -21.05 16.55 Favored 'Trans proline' 0 N--CA 1.433 -2.072 0 CA-C-N 128.114 3.934 . . . . 1.68 115.945 -170.171 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.17 -34.08 69.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.777 2.431 . . . . 2.25 115.691 167.369 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -84.8 -1.9 56.99 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 125.743 2.687 . . . . 2.44 112.974 177.952 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -114.87 129.05 56.63 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 115.342 -4.599 . . . . 1.32 111.26 -171.895 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -129.04 134.81 48.27 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 104.638 -2.356 . . . . 3.19 104.638 171.562 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.3 mt -107.38 129.04 54.96 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 128.14 2.576 . . . . 1.75 108.39 -177.77 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.7 mm -105.99 125.44 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 131.282 3.833 . . . . 1.98 102.915 -174.433 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -116.56 110.79 19.02 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 120.651 1.569 . . . . 1.94 107.069 170.53 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.36 -101.61 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 104.826 -2.287 . . . . 1.67 104.826 177.467 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.63 2.98 15.4 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 125.881 1.988 . . . . 1.3 113.831 -179.578 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -115.45 157.07 24.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.214 1.483 . . . . 2.89 109.274 -179.096 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -94.02 144.42 25.48 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.766 -2.679 . . . . 2.89 103.766 179.512 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.8 mt -97.12 140.4 31.69 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.769 -3.082 . . . . 1.34 109.983 -175.441 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -79.39 149.02 31.77 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.294 -1.504 . . . . 1.94 113.184 172.923 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -76.81 -37.12 56.33 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 115.655 1.724 . . . . 1.56 115.655 -173.231 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.43 44.71 2.6 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-O 116.655 -2.192 . . . . 0.97 108.0 179.55 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -126.93 160.05 32.2 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 121.315 2.558 . . . . 3.07 106.07 168.343 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -84.19 175.62 9.33 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 126.553 3.073 . . . . 1.34 112.506 169.448 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.7 mt -71.54 -42.42 67.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.929 -3.607 . . . . 1.63 110.064 171.381 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 m -60.19 -38.85 84.52 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 128.823 2.849 . . . . 1.51 114.094 171.875 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -52.59 -36.6 56.45 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.973 2.953 . . . . 1.9 118.973 171.425 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -90.53 3.05 55.1 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 116.505 2.039 . . . . 0.97 116.505 176.442 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 64.31 27.33 13.77 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.751 2.42 . . . . 2.35 114.64 -173.944 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.257 75.7 mt -69.82 140.8 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 118.943 -2.348 . . . . 1.39 108.185 178.027 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -111.41 175.6 5.36 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.475 -2.016 . . . . 2.58 111.777 -174.441 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -64.0 148.28 50.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.411 -1.431 . . . . 2.58 111.713 166.15 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.338 35.9 mt-10 77.13 21.24 1.12 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.425 -2.047 . . . . 1.71 113.41 169.175 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.95 140.91 30.02 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.982 3.313 . . . . 1.34 112.949 -173.622 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.8 m -89.62 114.83 26.49 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.911 2.884 . . . . 1.36 111.746 -178.856 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -113.52 151.8 31.06 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.851 -3.031 . . . . 2.03 104.789 175.246 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -107.57 123.75 48.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 123.505 1.621 . . . . 2.31 109.854 -169.748 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.5 tp -90.96 110.63 21.88 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.148 -2.845 . . . . 1.72 113.275 -178.034 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.9 t -105.08 128.9 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 1 N-CA-C 99.468 -4.271 . . . . 1.8 99.468 176.67 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.0 tp -97.89 127.49 43.87 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 113.357 -1.747 . . . . 3.26 109.337 177.147 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -89.75 109.62 20.59 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.495 -1.684 . . . . 4.12 111.398 174.805 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.1 tp -127.45 -41.45 1.72 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 120.794 1.634 . . . . 3.54 109.708 173.103 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.9 ttp-105 -76.09 -52.66 9.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.466 -1.396 . . . . 7.32 111.783 171.127 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.48 -56.18 0.11 Allowed Glycine 0 N--CA 1.429 -1.77 1 CA-C-O 113.144 -4.142 . . . . 3.73 112.148 -172.964 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.769 0 N-CA-C 107.576 -2.21 . . . . 3.87 107.576 -179.844 . . . . . . . . 0 0 . 1 . 128 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 CA--C 1.489 -1.37 0 CA-C-O 122.74 1.257 . . . . 1.39 113.344 . . . . . . . . . 0 0 . 1 . 128 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -114.58 130.03 56.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 115.738 1.755 . . . . 2.2 115.738 -171.508 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.7 pt -120.46 151.67 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-O 115.244 -2.313 . . . . 1.32 111.686 177.693 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -110.66 118.83 37.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.674 -1.973 . . . . 2.2 105.674 -174.298 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.35 116.04 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 O-C-N 118.926 -2.359 . . . . 1.23 111.052 171.983 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.314 42.1 mtpt -104.32 136.3 44.17 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 127.997 3.76 . . . . 2.51 117.599 178.325 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 p -89.82 156.15 18.69 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.522 -2.611 . . . . 1.41 111.07 172.857 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.5 mt -63.6 -44.5 93.82 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.266 -3.396 . . . . 2.95 112.267 168.141 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.337 69.4 p -65.22 -38.47 90.5 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 116.453 -1.737 . . . . 2.52 114.009 -169.7 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.13 1.88 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 123.358 2.799 . . . . 1.5 116.009 167.802 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -98.68 144.82 27.53 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.304 3.052 . . . . 1.79 111.064 -179.587 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -131.07 139.69 49.93 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 118.028 -2.92 . . . . 1.38 106.51 168.084 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.412 HG22 HD12 ' A' ' 13' ' ' ILE . 28.4 pt -130.4 150.99 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 130.098 3.359 . . . . 2.03 106.558 179.165 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 m -107.05 127.15 53.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.946 -1.479 . . . . 1.61 108.022 175.247 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.3 mt -106.8 137.0 45.66 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 125.088 2.375 . . . . 2.15 109.81 169.754 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -89.99 126.47 35.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 128.414 3.959 . . . . 1.98 107.831 162.035 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -132.09 152.33 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 109.585 -3.461 . . . . 1.52 113.358 -173.186 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -99.99 146.18 31.47 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-O 114.776 -2.535 . . . . 2.35 106.459 168.083 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -80.42 -4.8 13.21 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 CA-C-N 128.087 3.924 . . . . 1.31 106.661 -171.302 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.4 p -85.56 -17.63 35.75 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 120.0 -1.687 . . . . 1.71 111.851 175.659 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -61.44 136.26 57.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.826 -2.421 . . . . 1.69 111.733 174.992 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.7 p -78.26 162.23 26.69 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.588 -3.195 . . . . 1.33 112.473 178.655 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.4 mm -64.35 -44.23 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-N 113.09 -1.868 . . . . 1.32 112.093 172.283 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.434 76.2 tt0 -35.26 -58.66 0.55 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.349 -3.344 . . . . 1.62 117.1 158.914 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -68.75 -34.27 75.32 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.018 -3.551 . . . . 2.13 116.253 -177.967 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.7 t -55.3 -44.6 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 118.143 -2.848 . . . . 1.23 116.907 164.518 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 43.3 mtmt -54.18 -49.82 68.44 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.045 3.338 . . . . 1.97 110.018 175.704 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.95 -26.67 67.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.875 -3.016 . . . . 1.19 112.898 178.706 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -67.83 -35.34 78.42 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.218 -2.801 . . . . 1.92 111.604 173.115 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.465 HD12 HG21 ' A' ' 30' ' ' ILE . 35.7 mt -71.36 -26.7 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 117.851 -1.54 . . . . 1.94 112.246 172.934 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -68.15 -37.96 81.6 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 118.854 -0.593 . . . . 1.9 110.889 -179.646 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -58.29 -44.62 88.58 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 123.45 1.595 . . . . 1.55 111.463 175.819 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -84.49 -80.55 0.2 Allowed 'General case' 0 N--CA 1.43 -1.446 1 C-N-CA 132.043 4.137 . . . . 2.95 114.302 -171.197 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -78.4 -27.13 46.69 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 123.742 1.734 . . . . 1.48 110.295 -171.965 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.23 28.63 16.89 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 118.73 -2.481 . . . . 1.12 108.262 170.395 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.9 mt -94.66 123.98 56.38 Favored Pre-proline 0 N--CA 1.431 -1.421 0 N-CA-C 103.98 -2.6 . . . . 2.07 103.98 179.961 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -62.13 145.64 96.33 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 C-N-CA 116.272 -2.018 . . . . 1.39 114.249 175.685 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 88.4 Cg_exo -66.32 -22.36 53.09 Favored 'Trans proline' 0 N--CA 1.433 -2.038 1 C-N-CA 126.201 4.6 . . . . 1.68 112.751 -175.653 . . . . . . . . 3 3 . 1 . 128 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -60.3 -31.98 70.77 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 131.544 3.938 . . . . 2.25 111.375 171.264 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -97.31 1.81 49.94 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 112.76 -2.018 . . . . 2.44 112.245 -178.617 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -100.56 100.14 10.83 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.659 -2.526 . . . . 1.32 111.793 -177.331 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.526 ' HG3' ' HB2' ' A' ' 72' ' ' ARG . 10.8 mtp180 -96.2 95.19 7.96 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.808 -1.807 . . . . 3.19 110.371 168.489 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.1 mt -72.73 127.34 32.26 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.448 1.499 . . . . 1.75 112.891 179.358 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.9 mm -118.36 135.51 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 123.483 2.856 . . . . 1.98 109.598 175.636 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -122.42 101.23 7.38 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.958 -2.339 . . . . 1.94 107.148 175.95 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.3 . . 78.04 -91.72 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.906 1.282 . . . . 1.67 109.935 179.027 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.18 21.09 2.63 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 104.595 -3.402 . . . . 1.3 104.595 -177.567 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -112.08 120.74 42.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.051 -1.852 . . . . 2.89 111.666 178.562 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -76.22 113.7 14.07 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.637 2.375 . . . . 2.89 108.563 166.416 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.6 mt -90.82 146.06 24.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.154 2.407 . . . . 1.34 109.329 -164.04 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -83.98 164.68 19.19 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.258 1.823 . . . . 1.94 112.284 175.281 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -89.32 -53.02 4.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 116.391 -3.943 . . . . 1.56 114.048 -167.691 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.84 18.58 4.81 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 120.118 2.807 . . . . 0.97 120.118 176.046 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.285 0.0 OUTLIER -79.43 152.3 30.39 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.731 1.752 . . . . 3.07 115.731 168.596 . . . . . . . . 3 3 . 1 . 128 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.9 p -89.37 170.48 10.52 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.558 -1.201 . . . . 1.34 111.513 168.523 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.8 mt -75.6 -32.09 60.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.457 -2.027 . . . . 1.63 109.138 177.374 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.294 1.1 t -62.89 -49.4 74.99 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.728 1.611 . . . . 1.51 109.619 -179.199 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -47.2 -50.59 20.54 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.511 2.324 . . . . 1.9 111.776 172.225 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -76.71 -6.53 52.55 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 119.637 3.199 . . . . 0.97 119.637 176.118 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 65.41 41.17 4.37 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.521 2.045 . . . . 2.35 116.521 -179.693 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.8 mt -95.05 114.89 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 101.71 -3.441 . . . . 1.39 101.71 179.146 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -102.26 -175.6 2.88 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.345 -1.298 . . . . 2.58 107.878 -178.072 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -61.03 142.91 56.26 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 117.448 2.388 . . . . 2.58 117.448 169.711 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.379 13.8 mt-10 75.17 19.71 2.22 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 129.965 4.541 . . . . 1.71 118.411 177.569 . . . . . . . . 3 2 . 1 . 128 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 m -92.74 153.52 18.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.538 2.399 . . . . 1.34 105.669 -173.445 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.8 m -106.09 103.52 13.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 131.207 3.803 . . . . 1.36 111.101 -176.358 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -94.47 168.52 10.82 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 105.045 -2.206 . . . . 2.03 105.045 174.405 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.97 162.84 32.17 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 105.499 -2.037 . . . . 2.31 105.499 -174.258 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.265 0.5 OUTLIER -144.77 121.91 11.47 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.983 -1.858 . . . . 1.72 105.983 -172.805 . . . . . . . . 3 3 . 1 . 128 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -115.69 125.65 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 129.416 3.086 . . . . 1.8 106.85 178.713 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.1 mt -80.43 125.09 29.5 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 119.594 -1.941 . . . . 3.26 114.783 -175.649 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.526 ' HB2' ' HG3' ' A' ' 42' ' ' ARG . 53.7 ttt180 -96.12 80.84 3.3 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.886 -1.052 . . . . 4.12 109.126 176.171 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.0 mt -98.3 -151.86 0.39 Allowed 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.265 -1.522 . . . . 3.54 109.487 169.97 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.4 mtm-85 -106.99 -62.73 1.37 Allowed 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 100.507 -3.886 . . . . 7.32 100.507 174.633 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.13 81.46 0.78 Allowed Glycine 0 N--CA 1.43 -1.755 0 CA-C-O 115.179 -3.012 . . . . 3.73 112.739 -171.788 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.769 0 CA-C-O 115.303 -2.943 . . . . 3.87 117.811 179.031 . . . . . . . . 0 0 . 1 . 129 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.7 ttp . . . . . 0 CA--C 1.491 -1.318 0 N-CA-C 118.974 2.953 . . . . 1.39 118.974 . . . . . . . . . 0 0 . 1 . 129 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.11 127.12 35.41 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 119.417 -2.052 . . . . 2.2 115.091 174.045 . . . . . . . . 2 2 . 1 . 129 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 pt -122.06 163.92 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.612 2.365 . . . . 1.32 114.598 166.534 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -112.0 123.62 50.65 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 116.108 -4.12 . . . . 2.2 113.835 176.169 . . . . . . . . 2 2 . 1 . 129 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.8 t -110.41 113.15 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 118.622 -2.549 . . . . 1.23 108.502 171.052 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -86.37 139.92 30.51 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.894 -1.503 . . . . 2.51 110.503 -178.719 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 p -100.25 175.37 5.74 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.453 2.073 . . . . 1.41 110.412 174.815 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.6 mt -80.56 -25.19 38.74 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 114.876 -4.89 . . . . 2.95 108.892 171.599 . . . . . . . . 2 2 . 1 . 129 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 p -65.88 -46.09 79.67 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.275 -3.39 . . . . 2.52 113.717 -176.092 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.2 6.56 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 112.134 -2.303 . . . . 1.5 117.345 173.765 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -98.85 150.62 21.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 128.157 3.837 . . . . 1.79 114.187 -173.199 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.2 m -114.98 90.93 3.46 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.722 -3.111 . . . . 1.38 105.578 169.822 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mt -80.9 111.15 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 O-C-N 120.805 -1.184 . . . . 2.03 109.36 -179.807 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.4 m -77.17 107.22 9.4 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.144 -2.223 . . . . 1.61 109.584 170.936 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.6 mt -103.64 148.6 25.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 126.764 3.173 . . . . 2.15 104.912 173.828 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -120.44 129.35 53.85 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.172 2.189 . . . . 1.98 113.1 166.703 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.0 m -143.02 174.07 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.486 -2.413 . . . . 1.52 104.486 -178.937 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -96.82 154.03 38.46 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 104.699 -2.334 . . . . 2.35 104.699 165.06 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -73.79 -15.56 23.92 Favored 'Trans proline' 0 C--N 1.3 -2.003 1 C-N-CA 125.871 4.381 . . . . 1.31 112.239 -176.252 . . . . . . . . 2 2 . 1 . 129 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.1 p -94.34 5.57 51.37 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.758 -3.089 . . . . 1.71 115.236 172.225 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -71.39 154.91 41.21 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.85 -1.157 . . . . 1.69 110.426 168.112 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.7 p -92.12 159.5 15.64 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.185 -1.043 . . . . 1.33 108.185 176.752 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -63.53 -16.49 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.463 1.905 . . . . 1.32 113.27 -179.543 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -62.93 -32.58 73.91 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.316 1.846 . . . . 1.62 115.781 166.68 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -72.78 -35.99 67.52 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.887 2.075 . . . . 2.13 111.788 168.765 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.9 t -57.53 -51.53 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 118.945 -2.347 . . . . 1.23 114.381 169.66 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -65.38 -35.99 82.64 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 129.152 2.981 . . . . 1.97 111.339 176.363 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.37 -45.54 69.26 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 116.045 1.868 . . . . 1.19 116.045 174.021 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -74.58 -28.56 60.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.599 1.559 . . . . 1.92 110.256 -179.837 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.6 mt -78.82 -29.17 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 1 O-C-N 115.457 -4.527 . . . . 1.94 114.083 172.669 . . . . . . . . 2 2 . 1 . 129 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -67.31 -32.29 73.17 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.523 -3.236 . . . . 1.9 113.061 170.022 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -61.0 -49.11 78.77 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.247 2.314 . . . . 1.55 117.247 169.666 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -89.23 -43.99 10.6 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.123 2.268 . . . . 2.95 117.123 -176.897 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -99.66 -36.87 9.35 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.434 -2.666 . . . . 1.48 113.182 -172.289 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.83 68.09 1.3 Allowed Glycine 0 N--CA 1.43 -1.704 0 CA-C-N 110.81 -2.905 . . . . 1.12 111.775 172.144 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 mt -126.85 119.2 22.49 Favored Pre-proline 0 N--CA 1.429 -1.508 0 O-C-N 126.637 2.022 . . . . 2.07 108.343 174.32 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -55.87 145.48 72.83 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-O 113.104 -2.956 . . . . 1.39 117.637 176.174 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -58.66 -22.52 61.12 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 123.418 2.746 . . . . 1.68 115.142 -175.025 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.02 -43.15 99.46 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 131.109 3.764 . . . . 2.25 109.357 173.887 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -83.79 -14.79 50.57 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 117.152 2.279 . . . . 2.44 117.152 -176.962 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -85.45 104.57 15.36 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 118.871 -2.393 . . . . 1.32 113.131 -175.726 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -96.23 101.04 12.63 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 106.327 -1.731 . . . . 3.19 106.327 175.16 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.4 mt -87.16 125.43 34.16 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.965 -2.334 . . . . 1.75 116.554 173.387 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.5 mm -108.57 106.36 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 118.853 -2.404 . . . . 1.98 109.114 178.226 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -92.99 91.97 7.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 118.977 -1.089 . . . . 1.94 110.578 171.149 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.49 -65.93 0.25 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.719 2.408 . . . . 1.67 112.811 -172.657 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.91 -14.82 0.4 Allowed Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 126.718 2.104 . . . . 1.3 112.923 -178.954 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -90.59 129.03 36.76 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 115.299 -2.56 . . . . 2.89 109.926 -176.83 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -83.17 117.24 22.77 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.302 -2.124 . . . . 2.89 112.309 165.934 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.7 mt -79.05 163.53 25.08 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 120.925 -1.109 . . . . 1.34 109.586 -166.181 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -125.64 128.53 47.99 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.329 1.852 . . . . 1.94 108.793 176.354 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.345 30.4 m-20 -45.62 -50.61 13.15 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.079 2.952 . . . . 1.56 115.489 -174.795 . . . . . . . . 2 2 . 1 . 129 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.15 20.59 15.7 Favored Glycine 0 N--CA 1.43 -1.765 1 O-C-N 115.535 -4.478 . . . . 0.97 114.343 175.675 . . . . . . . . 2 2 . 1 . 129 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -107.22 142.89 36.24 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 116.147 -4.149 . . . . 3.07 105.723 168.692 . . . . . . . . 2 2 . 1 . 129 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.5 p -70.09 168.51 15.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.949 -1.023 . . . . 1.34 113.136 175.803 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.415 ' HG ' HD12 ' A' ' 61' ' ' ILE . 6.3 mp -67.09 -42.32 84.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.683 1.993 . . . . 1.63 112.984 173.73 . . . . . . . . 2 2 . 1 . 129 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.2 p -52.79 -26.57 14.75 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 131.515 3.926 . . . . 1.51 112.216 179.455 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -75.77 -51.45 12.62 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-O 126.571 3.081 . . . . 1.9 116.922 175.697 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.272 35.3 m-85 -83.31 9.32 11.12 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.831 -3.043 . . . . 0.97 114.691 174.119 . . . . . . . . 2 2 . 1 . 129 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.7 t30 47.31 59.18 4.24 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 118.801 2.889 . . . . 2.35 118.801 -176.379 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.415 HD12 ' HG ' ' A' ' 56' ' ' LEU . 78.8 mt -93.95 122.3 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 104.489 -2.411 . . . . 1.39 104.489 179.523 . . . . . . . . 2 2 . 1 . 129 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -121.35 -160.99 0.88 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 122.217 2.28 . . . . 2.58 111.742 -173.12 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.462 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 77.5 tttt -59.44 136.06 57.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 119.173 3.027 . . . . 2.58 119.173 175.649 . . . . . . . . 2 2 . 1 . 129 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.462 ' HG3' ' HG2' ' A' ' 63' ' ' LYS 0.295 42.8 mt-10 64.04 25.65 13.86 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.206 -2.184 . . . . 1.71 114.738 172.914 . . . . . . . . 3 3 . 1 . 129 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.7 m -75.18 137.55 41.37 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 128.005 2.522 . . . . 1.34 114.817 179.862 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.2 m -91.66 104.79 17.22 Favored 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 127.105 2.753 . . . . 1.36 114.62 -176.632 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -92.62 128.6 38.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 116.785 -1.579 . . . . 2.03 111.588 171.551 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -96.47 114.73 26.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 104.407 -2.442 . . . . 2.31 104.407 -177.803 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.4 tp -92.38 120.55 33.01 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.584 -3.197 . . . . 1.72 106.91 -177.424 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.84 153.74 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 126.251 2.22 . . . . 1.8 106.159 174.956 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.9 tp -96.21 134.08 39.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 116.056 -2.258 . . . . 3.26 105.586 175.978 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -86.9 124.12 32.76 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.328 1.851 . . . . 4.12 110.925 179.946 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.8 mt -96.98 -173.83 2.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.307 1.443 . . . . 3.54 110.061 170.293 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.6 mtt85 -93.21 102.53 14.82 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 118.504 -2.623 . . . . 7.32 112.034 169.455 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.68 153.19 29.47 Favored Glycine 0 N--CA 1.43 -1.742 0 CA-C-O 126.183 3.102 . . . . 3.73 110.848 -165.886 . . . . . . . . 1 1 . 1 . 129 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.768 1 O-C-N 116.323 -4.045 . . . . 3.87 114.184 174.829 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ttt . . . . . 0 CA--C 1.49 -1.35 0 CA-C-O 117.206 -1.378 . . . . 1.39 109.387 . . . . . . . . . 0 0 . 1 . 130 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -86.33 135.17 33.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 115.895 -2.002 . . . . 2.2 113.301 -171.833 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 pt -129.91 153.06 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 122.105 2.23 . . . . 1.32 107.238 170.577 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.331 11.6 m-85 -115.82 122.62 45.94 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 116.876 -1.93 . . . . 2.2 110.974 177.298 . . . . . . . . 2 2 . 1 . 130 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.05 108.48 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 117.749 -3.094 . . . . 1.23 111.548 177.463 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -87.79 120.43 29.1 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.931 1.825 . . . . 2.51 108.537 -173.487 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.2 p -79.4 169.37 18.18 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 115.484 -4.51 . . . . 1.41 113.165 174.686 . . . . . . . . 2 2 . 1 . 130 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.3 mt -73.79 -26.35 60.58 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.004 -3.56 . . . . 2.95 112.222 164.851 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.5 p -75.25 -34.16 61.38 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 124.216 1.006 . . . . 2.52 111.824 -171.197 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.97 -8.0 2.44 Favored Glycine 0 N--CA 1.431 -1.678 0 CA-C-O 115.829 -2.651 . . . . 1.5 116.635 177.384 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -97.89 136.29 38.4 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 126.318 1.834 . . . . 1.79 109.983 -174.122 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -111.94 96.14 5.88 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.433 1.111 . . . . 1.38 109.363 169.759 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.7 pt -91.85 125.31 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 113.852 -1.522 . . . . 2.03 113.366 -175.149 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.8 m -91.22 109.6 20.87 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.424 -2.673 . . . . 1.61 105.443 -171.734 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.7 mt -93.34 153.16 18.7 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.371 -2.705 . . . . 2.15 108.306 176.826 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -92.78 121.56 34.28 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.524 1.929 . . . . 1.98 113.219 165.396 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.9 m -137.26 173.21 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 123.634 1.683 . . . . 1.52 108.082 176.741 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -121.8 154.97 60.77 Favored Pre-proline 0 N--CA 1.43 -1.439 0 O-C-N 117.999 -2.938 . . . . 2.35 108.529 162.869 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.287 40.1 Cg_endo -64.4 -18.6 63.63 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 C-N-CA 123.133 2.555 . . . . 1.31 117.493 -172.611 . . . . . . . . 2 2 . 1 . 130 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.2 m -89.31 7.78 33.85 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.397 2.046 . . . . 1.71 115.596 178.58 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -81.05 146.68 30.51 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 130.037 3.335 . . . . 1.69 108.238 173.984 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.308 30.3 p -75.39 164.83 26.0 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 118.324 -1.351 . . . . 1.33 113.073 172.986 . . . . . . . . 2 2 . 1 . 130 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.438 HD11 HG21 ' A' ' 23' ' ' ILE . 63.5 mt -78.97 -35.7 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 108.063 -1.088 . . . . 1.32 108.063 178.859 . . . . . . . . 2 2 . 1 . 130 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -47.07 -41.68 17.43 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.918 2.192 . . . . 1.62 116.918 162.796 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -64.95 -38.31 90.53 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.671 -4.393 . . . . 2.13 112.235 175.41 . . . . . . . . 2 2 . 1 . 130 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 68.3 t -69.49 -28.21 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 114.703 1.372 . . . . 1.23 114.703 174.489 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -69.8 -30.24 67.72 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.712 -2.492 . . . . 1.97 112.117 169.247 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.47 -27.23 65.05 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.56 -1.963 . . . . 1.19 110.909 174.418 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? -72.61 -35.86 67.95 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 120.748 1.613 . . . . 1.92 111.399 172.745 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.9 mt -60.54 -46.22 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 O-C-N 116.381 -3.949 . . . . 1.94 112.486 167.515 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -57.26 -45.73 83.73 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 117.968 -2.957 . . . . 1.9 116.449 175.016 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -45.31 -40.87 8.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 125.455 2.55 . . . . 1.55 114.804 166.907 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -87.5 -59.24 2.3 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.691 -3.13 . . . . 2.95 114.824 -173.966 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -97.4 -25.59 15.16 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.954 1.835 . . . . 1.48 109.009 -165.921 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.29 52.77 4.11 Favored Glycine 0 N--CA 1.429 -1.809 1 O-C-N 115.136 -4.727 . . . . 1.12 116.287 -178.175 . . . . . . . . 2 2 . 1 . 130 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.2 mt -130.57 109.81 16.07 Favored Pre-proline 0 N--CA 1.429 -1.505 0 CA-C-N 112.223 -1.988 . . . . 2.07 109.738 -176.81 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -60.59 139.09 84.12 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 N-CA-C 120.948 3.403 . . . . 1.39 120.948 -179.919 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.85 -27.92 29.16 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 C-N-CA 124.948 3.765 . . . . 1.68 117.088 -176.197 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.58 -34.63 72.95 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 123.211 2.732 . . . . 2.25 115.954 171.488 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -80.0 4.32 17.36 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 113.639 -3.077 . . . . 2.44 108.899 -175.057 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -141.98 150.6 41.59 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 125.118 3.599 . . . . 1.32 108.897 -176.832 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -130.46 149.91 51.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.195 -2.816 . . . . 3.19 105.317 168.601 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.3 mt -106.47 149.74 26.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.951 2.159 . . . . 1.75 112.657 174.859 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.489 HD11 HG21 ' A' ' 70' ' ' VAL . 9.5 mt -128.52 132.79 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 108.452 -0.944 . . . . 1.98 108.452 178.911 . . . . . . . . 2 2 . 1 . 130 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.264 50.4 t80 -117.07 121.05 40.21 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.537 1.637 . . . . 1.94 106.705 178.358 . . . . . . . . 2 2 . 1 . 130 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.52 -82.27 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.001 -3.562 . . . . 1.67 113.479 174.826 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.77 -26.02 1.47 Allowed Glycine 0 N--CA 1.43 -1.731 0 CA-C-N 122.356 2.344 . . . . 1.3 113.459 176.181 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -100.49 150.2 22.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.991 3.757 . . . . 2.89 117.466 178.875 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -74.48 133.51 42.34 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.982 -2.949 . . . . 2.89 112.718 172.601 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.0 mt -84.4 126.07 32.9 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.939 -2.975 . . . . 1.34 115.27 -171.856 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.18 125.57 24.94 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 125.953 2.787 . . . . 1.94 109.18 173.919 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -63.59 -45.7 89.2 Favored 'General case' 0 N--CA 1.429 -1.491 1 O-C-N 114.466 -5.146 . . . . 1.56 116.957 -172.81 . . . . . . . . 2 2 . 1 . 130 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.22 33.57 3.37 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-O 124.799 2.333 . . . . 0.97 118.504 177.226 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -110.83 167.14 10.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.878 -2.542 . . . . 3.07 112.134 167.071 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.9 p -87.4 176.83 7.32 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.802 2.841 . . . . 1.34 111.898 170.761 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.5 mt -82.25 -41.39 20.27 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 127.135 2.174 . . . . 1.63 108.645 -178.72 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.0 p -59.35 -41.56 89.51 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 129.205 3.002 . . . . 1.51 111.353 176.189 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -48.72 -52.01 25.81 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 128.704 2.802 . . . . 1.9 112.626 172.725 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -86.81 -3.69 59.09 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 115.606 1.706 . . . . 0.97 115.606 179.584 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.6 m120 73.47 37.87 0.68 Allowed 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.696 -1.138 . . . . 2.35 112.167 177.036 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.3 mt -84.97 129.08 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 119.713 -1.867 . . . . 1.39 113.17 173.614 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -116.53 -175.83 2.84 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.996 2.808 . . . . 2.58 113.2 -176.361 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -40.66 121.63 1.5 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 112.214 -2.266 . . . . 2.58 116.06 172.949 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 59.89 50.86 6.44 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 119.261 3.06 . . . . 1.71 119.261 179.06 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.1 m -89.79 133.92 34.46 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 116.479 -1.724 . . . . 1.34 112.207 -178.721 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.4 m -81.48 109.08 15.61 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 126.986 2.678 . . . . 1.36 110.538 179.087 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.58 169.71 8.36 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.465 1.939 . . . . 2.03 110.247 176.652 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -125.3 146.64 49.47 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.217 1.007 . . . . 2.31 108.887 -176.372 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.99 132.11 56.1 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 115.008 -2.425 . . . . 1.72 107.723 172.916 . . . . . . . . 2 2 . 1 . 130 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.489 HG21 HD11 ' A' ' 44' ' ' ILE . 27.6 m -121.26 164.24 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 121.889 2.131 . . . . 1.8 114.797 171.526 . . . . . . . . 2 2 . 1 . 130 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.2 tp -75.2 139.85 42.9 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.076 -2.89 . . . . 3.26 110.899 -179.484 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.1 ttt-85 -134.41 138.25 44.68 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 127.328 2.251 . . . . 4.12 113.036 177.618 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.3 mt -88.23 143.47 27.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.909 2.483 . . . . 3.54 110.473 170.658 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.409 ' H ' ' HG2' ' A' ' 74' ' ' ARG . 5.2 ptp85 -76.59 139.21 40.58 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 117.824 -3.047 . . . . 7.32 115.372 172.881 . . . . . . . . 2 2 . 1 . 130 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.41 86.86 1.95 Allowed Glycine 0 N--CA 1.431 -1.676 0 CA-C-N 111.73 -2.487 . . . . 3.73 113.371 -174.248 . . . . . . . . 1 1 . 1 . 130 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.756 0 O-C-N 120.137 -1.801 . . . . 3.87 111.46 -177.224 . . . . . . . . 0 0 . 1 . 131 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.6 ttp . . . . . 0 CA--C 1.49 -1.354 0 CA-C-O 125.828 2.728 . . . . 1.39 109.936 . . . . . . . . . 0 0 . 1 . 131 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -69.56 127.98 34.88 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 115.409 -2.234 . . . . 2.2 112.559 178.167 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.318 7.4 pt -133.27 150.03 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 107.151 -1.426 . . . . 1.32 107.151 172.511 . . . . . . . . 2 2 . 1 . 131 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -118.74 118.7 32.31 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.798 2.237 . . . . 2.2 112.942 -176.099 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -102.7 112.21 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.786 -3.071 . . . . 1.23 108.489 -179.993 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -96.1 138.31 33.9 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.021 -3.549 . . . . 2.51 111.334 177.699 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 p -89.25 -176.4 5.09 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 122.789 1.28 . . . . 1.41 112.602 178.551 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.4 tp -86.03 -34.59 20.72 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.2 -2.188 . . . . 2.95 110.311 170.4 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.7 p -56.6 -57.28 13.07 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.145 2.578 . . . . 2.52 113.327 -178.753 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.36 24.32 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.701 0 O-C-N 117.816 -3.052 . . . . 1.5 114.254 171.745 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -106.92 146.43 31.02 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.729 2.411 . . . . 1.79 105.705 -178.001 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.7 m -116.98 97.38 5.92 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.537 3.135 . . . . 1.38 103.054 171.154 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -80.41 116.77 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 106.44 -1.689 . . . . 2.03 106.44 -176.785 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 m -88.07 114.76 25.0 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.597 -4.439 . . . . 1.61 109.613 175.21 . . . . . . . . 2 2 . 1 . 131 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.8 mt -113.75 161.43 17.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 128.128 3.392 . . . . 2.15 108.829 178.127 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -118.01 112.66 20.56 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.386 2.993 . . . . 1.98 108.256 170.313 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.6 m -107.48 160.14 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.191 -2.818 . . . . 1.52 112.954 176.529 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -105.2 143.32 26.51 Favored Pre-proline 0 N--CA 1.43 -1.43 0 O-C-N 118.925 -2.359 . . . . 2.35 107.923 164.705 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -76.51 -13.53 18.33 Favored 'Trans proline' 0 C--N 1.299 -2.044 1 C-N-CA 127.476 5.45 . . . . 1.31 116.079 -166.118 . . . . . . . . 2 2 . 1 . 131 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -85.79 -2.16 57.95 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 121.413 1.915 . . . . 1.71 109.175 176.889 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -73.73 159.72 32.57 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 120.344 3.461 . . . . 1.69 120.344 169.68 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.3 p -79.75 163.53 24.4 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.869 -1.77 . . . . 1.33 114.988 177.521 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.7 mm -73.04 -25.23 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 118.344 -1.343 . . . . 1.32 111.421 177.307 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -50.93 -36.67 39.76 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.752 -2.467 . . . . 1.62 116.566 162.818 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -69.05 -24.67 64.2 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.671 2.789 . . . . 2.13 109.104 -177.825 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.34 -59.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 104.539 -2.393 . . . . 1.23 104.539 175.699 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -49.76 -38.57 34.52 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.123 2.569 . . . . 1.97 113.512 173.441 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.89 -30.93 71.22 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 123.097 2.68 . . . . 1.19 114.893 178.78 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -71.75 -29.12 64.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.865 -1.147 . . . . 1.92 112.477 175.202 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.5 mt -73.06 -33.28 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-O 125.912 2.768 . . . . 1.94 111.685 171.157 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -73.81 -41.93 61.65 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.113 -3.492 . . . . 1.9 105.927 177.04 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -61.64 -36.51 80.99 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.649 -2.532 . . . . 1.55 115.923 174.645 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -84.18 -51.22 7.21 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.04 -3.538 . . . . 2.95 113.085 -175.082 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -104.68 -36.83 7.31 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.271 -2.143 . . . . 1.48 114.574 -169.994 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.05 16.83 17.8 Favored Glycine 0 N--CA 1.429 -1.81 0 C-N-CA 115.381 -3.295 . . . . 1.12 110.249 175.263 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.9 mt -95.92 134.84 23.34 Favored Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 102.44 -3.17 . . . . 2.07 102.44 -175.073 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.459 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 17.2 Cg_exo -67.05 156.9 64.3 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 125.924 3.152 . . . . 1.39 114.904 174.558 . . . . . . . . 2 2 . 1 . 131 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -85.9 -14.96 4.99 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 CA-C-N 124.728 2.724 . . . . 1.68 115.586 -174.16 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -67.25 -29.96 69.72 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 114.808 -2.52 . . . . 2.25 108.954 169.044 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -83.05 -19.9 35.99 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 123.238 2.745 . . . . 2.44 113.183 -176.856 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 37' ' ' PRO . 77.7 mt-30 -87.8 107.59 18.73 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.7 2.0 . . . . 1.32 110.264 -170.709 . . . . . . . . 2 2 . 1 . 131 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -99.08 122.84 42.85 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.446 -1.687 . . . . 3.19 106.446 171.525 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.4 mt -104.0 127.31 51.55 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 124.846 1.341 . . . . 1.75 110.568 176.417 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.1 mt -115.16 115.4 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 119.388 -2.07 . . . . 1.98 108.314 179.847 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -104.07 102.76 12.5 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 113.456 -1.702 . . . . 1.94 107.477 175.002 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.02 -94.05 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.189 1.796 . . . . 1.67 110.353 -178.478 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.4 -19.08 6.35 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 128.25 2.833 . . . . 1.3 114.406 -177.443 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -98.55 137.08 37.72 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 125.946 2.784 . . . . 2.89 105.304 -175.876 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.4 113.97 26.26 Favored 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 119.224 -2.173 . . . . 2.89 107.168 172.972 . . . . . . . . 2 2 . 1 . 131 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.4 mt -77.36 144.43 37.98 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 121.524 1.966 . . . . 1.34 115.195 -163.134 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -90.24 150.39 21.98 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.878 2.471 . . . . 1.94 113.812 173.018 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -70.47 -59.77 2.66 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.755 2.422 . . . . 1.56 115.543 -168.086 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.92 22.55 0.9 Allowed Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 122.155 3.622 . . . . 0.97 122.155 169.987 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -97.91 162.72 13.1 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.137 -2.978 . . . . 3.07 109.06 168.633 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.6 p -100.12 176.79 5.28 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 124.007 3.094 . . . . 1.34 112.712 178.094 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 mt -65.75 -34.47 78.25 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.34 -2.1 . . . . 1.63 109.133 172.961 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -57.82 -42.78 84.99 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.814 1.783 . . . . 1.51 115.814 174.318 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -71.64 -30.32 65.62 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.609 -3.182 . . . . 1.9 115.129 -177.272 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -93.11 2.62 56.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 119.132 0.878 . . . . 0.97 113.063 176.017 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.9 m120 51.17 70.76 0.5 Allowed 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 130.705 3.602 . . . . 2.35 113.06 -176.009 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.6 mt -104.84 120.48 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 118.715 -2.491 . . . . 1.39 111.654 -179.344 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -110.85 176.53 4.99 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 111.053 -2.794 . . . . 2.58 115.743 -176.618 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -51.79 118.43 3.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 120.028 3.344 . . . . 2.58 120.028 173.74 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.386 26.2 mt-10 84.56 35.75 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.302 2.001 . . . . 1.71 111.657 171.109 . . . . . . . . 2 2 . 1 . 131 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.8 m -89.64 146.62 24.42 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.618 -2.552 . . . . 1.34 114.145 -174.633 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.3 m -108.1 107.96 18.84 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.672 -1.268 . . . . 1.36 112.341 -177.637 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -103.39 143.6 32.47 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 103.466 -2.79 . . . . 2.03 103.466 178.964 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.294 62.3 m80 -104.5 131.64 51.65 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 104.754 -2.313 . . . . 2.31 104.754 -177.095 . . . . . . . . 2 2 . 1 . 131 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.5 tp -95.83 110.56 22.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.943 2.306 . . . . 1.72 108.112 178.899 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 t -110.74 131.91 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 119.108 -2.245 . . . . 1.8 107.855 172.345 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.0 mt -97.74 138.0 35.78 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.153 -0.93 . . . . 3.26 112.329 176.035 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -149.9 126.25 10.79 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.137 -3.477 . . . . 4.12 105.751 -175.936 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.2 mt -72.55 159.21 34.29 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.366 1.866 . . . . 3.54 108.904 178.8 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -88.68 122.83 32.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.108 -2.87 . . . . 7.32 109.702 177.675 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.97 47.15 6.33 Favored Glycine 0 N--CA 1.428 -1.839 0 C-N-CA 120.217 -0.992 . . . . 3.73 113.779 -164.49 . . . . . . . . 1 1 . 1 . 131 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.792 0 CA-C-O 116.256 -2.413 . . . . 3.87 118.772 178.645 . . . . . . . . 0 0 . 1 . 132 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 ptt? . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 111.909 0.337 . . . . 1.39 111.909 . . . . . . . . . 0 0 . 1 . 132 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -98.59 144.16 28.19 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 126.569 3.08 . . . . 2.2 106.144 -178.518 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.7 pt -130.62 152.91 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 1 N-CA-C 99.206 -4.368 . . . . 1.32 99.206 178.136 . . . . . . . . 2 2 . 1 . 132 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -109.79 126.29 53.62 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.532 -2.605 . . . . 2.2 110.496 179.666 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.422 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 72.4 t -96.26 115.7 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 120.599 -1.313 . . . . 1.23 108.147 168.952 . . . . . . . . 2 2 . 1 . 132 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -91.77 137.95 31.95 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 106.044 -1.836 . . . . 2.51 106.044 177.162 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -87.82 -164.59 1.13 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.68 -1.263 . . . . 1.41 113.348 178.627 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.9 mt -82.09 -39.03 23.98 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 124.344 1.027 . . . . 2.95 110.359 176.216 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.289 44.9 p -75.41 -10.96 59.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.701 2.4 . . . . 2.52 108.946 -177.329 . . . . . . . . 2 2 . 1 . 132 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.28 39.42 5.69 Favored Glycine 0 N--CA 1.431 -1.664 1 C-N-CA 135.1 6.095 . . . . 1.5 114.094 172.473 . . . . . . . . 2 2 . 1 . 132 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -90.05 132.4 35.41 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.099 1.95 . . . . 1.79 106.788 -171.309 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.8 m -88.87 111.43 22.06 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.18 -2.2 . . . . 1.38 108.357 -174.627 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.422 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 31.8 mt -104.47 115.49 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 115.569 1.692 . . . . 2.03 115.569 176.429 . . . . . . . . 2 2 . 1 . 132 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 m -81.66 115.85 21.12 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 120.719 -1.238 . . . . 1.61 110.585 -179.129 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.0 mt -121.67 147.89 45.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 115.249 -2.31 . . . . 2.15 111.902 177.625 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -99.69 119.31 37.91 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 120.877 1.671 . . . . 1.98 115.48 171.63 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.82 167.75 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 130.403 3.481 . . . . 1.52 108.779 -177.598 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -118.62 167.44 11.63 Favored Pre-proline 0 N--CA 1.43 -1.47 0 O-C-N 118.477 -2.639 . . . . 2.35 106.953 162.41 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -67.54 -16.54 47.37 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 CA-C-N 125.248 2.91 . . . . 1.31 115.532 -170.654 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -74.86 -15.59 60.71 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 131.265 3.826 . . . . 1.71 117.905 174.41 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -69.66 138.34 52.93 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.061 -2.275 . . . . 1.69 115.09 171.024 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.1 p -79.16 179.52 7.32 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.187 -1.824 . . . . 1.33 114.76 -175.842 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -78.42 -33.75 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 118.934 -2.354 . . . . 1.32 110.799 176.513 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -49.9 -41.96 46.96 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.74 -3.1 . . . . 1.62 116.856 159.182 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.263 40.6 m-20 -76.48 -32.77 58.55 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 112.9 -3.429 . . . . 2.13 113.212 177.677 . . . . . . . . 2 2 . 1 . 132 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.9 t -66.44 -50.5 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 126.954 2.659 . . . . 1.23 113.363 167.855 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.6 mtmt -60.01 -31.17 69.69 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.078 -2.889 . . . . 1.97 116.601 169.109 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.78 -45.38 78.2 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.781 2.141 . . . . 1.19 116.781 170.307 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -65.71 -41.25 92.52 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.383 -3.948 . . . . 1.92 115.374 179.481 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.6 mm -56.83 -40.51 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.147 1.779 . . . . 1.94 113.685 166.773 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -59.81 -55.5 33.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.577 1.951 . . . . 1.9 115.168 171.693 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -46.82 -57.37 4.97 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 130.271 3.428 . . . . 1.55 112.528 175.26 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -85.89 -62.14 1.59 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.371 1.868 . . . . 2.95 112.525 -166.847 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -76.68 -23.01 53.2 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.406 2.002 . . . . 1.48 116.406 -175.459 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.59 20.11 38.72 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 118.556 2.182 . . . . 1.12 118.556 172.876 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.1 mt -101.51 134.79 20.04 Favored Pre-proline 0 N--CA 1.43 -1.465 0 CA-C-O 113.491 -3.147 . . . . 2.07 116.75 -174.564 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -64.52 132.56 33.7 Favored 'Trans proline' 0 C--N 1.3 -2.009 1 C-N-CA 126.319 4.679 . . . . 1.39 116.819 -179.046 . . . . . . . . 2 2 . 1 . 132 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -63.36 -14.71 43.83 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 CA-C-N 127.792 3.819 . . . . 1.68 116.467 -179.026 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -60.31 -27.91 67.69 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 117.758 2.503 . . . . 2.25 117.758 168.615 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -93.12 -29.52 15.72 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.599 -1.313 . . . . 2.44 108.669 -176.951 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -72.77 126.33 29.65 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 126.341 2.972 . . . . 1.32 112.972 -171.759 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -126.78 146.94 50.05 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 111.52 -2.582 . . . . 3.19 109.478 167.328 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 mt -117.28 127.64 54.28 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 114.158 1.17 . . . . 1.75 114.158 175.429 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mm -119.52 126.72 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 118.848 -2.407 . . . . 1.98 106.151 -175.999 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.471 ' CD2' HG12 ' A' ' 61' ' ' ILE . 49.0 t80 -137.79 121.17 17.06 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.865 -3.022 . . . . 1.94 103.328 176.038 . . . . . . . . 2 2 . 1 . 132 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.25 . . 43.51 62.54 1.85 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.216 3.006 . . . . 1.67 113.35 179.942 . . . . . . . . 2 2 . 1 . 132 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.72 -31.96 2.7 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 120.346 2.898 . . . . 1.3 120.346 177.863 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -89.79 127.02 35.9 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.568 1.947 . . . . 2.89 114.261 -178.31 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -73.68 116.38 14.2 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 115.708 -2.091 . . . . 2.89 108.521 173.156 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 mt -76.96 136.43 38.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 116.761 2.134 . . . . 1.34 116.761 -168.648 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -87.73 139.35 30.62 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 121.376 3.843 . . . . 1.94 121.376 179.826 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -47.01 -55.33 8.37 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 121.25 3.796 . . . . 1.56 121.25 -166.403 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.05 35.5 4.74 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 125.94 1.733 . . . . 0.97 116.902 179.433 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.3 mtt-85 -114.47 172.6 6.92 Favored 'General case' 0 N--CA 1.429 -1.482 1 O-C-N 116.0 -4.235 . . . . 3.07 100.864 168.496 . . . . . . . . 2 2 . 1 . 132 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -104.73 170.0 8.13 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.061 3.344 . . . . 1.34 114.282 179.07 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.8 mt -60.75 -41.62 95.77 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.813 1.412 . . . . 1.63 114.813 169.247 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.0 t -64.41 -28.26 69.56 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.575 2.131 . . . . 1.51 116.259 -178.46 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -59.17 -37.51 77.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.772 -3.705 . . . . 1.9 110.741 173.563 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -94.51 1.2 55.72 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.678 -1.264 . . . . 0.97 109.873 -179.301 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.303 32.8 m120 53.82 51.3 15.14 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 126.946 2.098 . . . . 2.35 111.032 -177.716 . . . . . . . . 2 2 . 1 . 132 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.471 HG12 ' CD2' ' A' ' 45' ' ' PHE . 76.8 mt -94.36 107.96 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 104.906 -2.257 . . . . 1.39 104.906 179.985 . . . . . . . . 2 2 . 1 . 132 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -81.79 -171.72 3.5 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 125.864 2.745 . . . . 2.58 111.773 -179.69 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -70.04 165.53 21.66 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 113.437 -5.789 . . . . 2.58 111.319 168.298 . . . . . . . . 2 2 . 1 . 132 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 63.57 22.96 13.41 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.239 1.971 . . . . 1.71 110.801 177.127 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -98.86 125.57 44.29 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 125.434 1.494 . . . . 1.34 107.285 -170.693 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.1 m -93.55 113.95 26.19 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 122.165 0.983 . . . . 1.36 111.029 -178.121 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -101.71 129.5 47.89 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 129.327 3.051 . . . . 2.03 113.06 -179.633 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -86.82 111.44 20.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 127.331 3.443 . . . . 2.31 111.652 -171.352 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 tp -87.68 111.39 21.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 116.874 -3.641 . . . . 1.72 108.564 -177.918 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 37.7 t -106.16 120.66 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 128.209 2.604 . . . . 1.8 109.098 -177.191 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.9 mt -108.94 105.33 14.82 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.823 1.649 . . . . 3.26 106.82 -179.523 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -99.33 123.07 43.31 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 124.683 2.182 . . . . 4.12 110.745 -177.601 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.8 mt -80.29 144.47 32.8 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.341 -3.975 . . . . 3.54 111.68 177.832 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -141.16 -82.64 0.22 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.041 -2.912 . . . . 7.32 109.083 179.048 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.29 -76.47 1.14 Allowed Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 110.78 -0.928 . . . . 3.73 110.78 -164.67 . . . . . . . . 1 1 . 1 . 132 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.775 1 CA-C-O 112.897 -4.279 . . . . 3.87 106.938 -179.55 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.516 ' HE3' HD11 ' A' ' 56' ' ' LEU . 11.6 ptt? . . . . . 0 CA--C 1.49 -1.352 0 CA-C-O 122.833 1.301 . . . . 1.39 114.384 . . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -108.86 130.31 55.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.54 -3.85 . . . . 2.2 107.148 -168.644 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -128.7 163.84 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 127.396 2.278 . . . . 1.32 110.711 173.728 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -123.33 129.26 51.07 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 112.714 -2.039 . . . . 2.2 113.717 179.91 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -111.96 118.61 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 118.917 -1.113 . . . . 1.23 108.607 172.191 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -89.28 134.25 34.13 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.073 -2.267 . . . . 2.51 113.74 171.089 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.4 p -85.82 167.73 14.92 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.833 2.16 . . . . 1.41 116.833 177.916 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.2 mt -69.07 -40.41 78.5 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 127.145 3.355 . . . . 2.95 109.793 175.348 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.274 17.2 p -57.1 -60.68 3.24 Favored 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 114.878 -4.889 . . . . 2.52 119.021 174.85 . . . . . . . . 3 2 . 1 . 133 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.67 6.33 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.768 0 CA-C-N 119.879 1.218 . . . . 1.5 112.642 177.811 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.2 ttpt -95.63 142.63 27.72 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 121.55 2.675 . . . . 1.79 109.769 -174.937 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.0 m -112.3 120.91 43.35 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.616 -1.624 . . . . 1.38 106.616 174.496 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 mt -102.09 123.91 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 116.494 -1.717 . . . . 2.03 106.933 -177.676 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.1 m -90.37 119.6 30.8 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 124.763 1.29 . . . . 1.61 111.002 175.726 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.0 mt -111.76 137.22 49.98 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 115.358 1.614 . . . . 2.15 115.358 178.713 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -91.49 119.63 31.61 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 117.95 2.574 . . . . 1.98 117.95 165.586 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.8 m -139.3 -178.25 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.414 1 N-CA-C 99.64 -4.207 . . . . 1.52 99.64 -175.303 . . . . . . . . 2 2 . 1 . 133 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -123.29 159.81 53.02 Favored Pre-proline 0 N--CA 1.43 -1.43 1 O-C-N 115.779 -4.326 . . . . 2.35 104.456 163.234 . . . . . . . . 2 2 . 1 . 133 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.47 -7.96 22.34 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 125.026 3.817 . . . . 1.31 112.802 -173.273 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.2 p -80.52 -7.1 59.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.541 2.736 . . . . 1.71 114.528 171.405 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -83.4 145.04 29.22 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.965 -2.334 . . . . 1.69 109.997 175.875 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.35 41.4 p -75.17 154.75 37.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 118.282 2.697 . . . . 1.33 118.282 176.143 . . . . . . . . 2 2 . 1 . 133 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.6 mm -58.36 -29.78 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 127.07 2.148 . . . . 1.32 113.765 171.486 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.62 -32.87 74.68 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.197 2.599 . . . . 1.62 110.815 167.465 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -72.53 -28.66 62.99 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 126.078 1.751 . . . . 2.13 111.541 179.758 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.42 -50.23 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 131.39 3.876 . . . . 1.23 110.605 168.496 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HZ1' ' CG ' ' A' ' 52' ' ' ASP . 87.2 mttt -69.18 -27.64 65.69 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 115.361 1.615 . . . . 1.97 115.361 173.045 . . . . . . . . 2 2 . 1 . 133 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.25 . . -72.79 -39.36 66.77 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.411 -1.431 . . . . 1.19 109.328 -178.945 . . . . . . . . 2 2 . 1 . 133 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -66.49 -39.61 88.82 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.326 3.05 . . . . 1.92 112.62 169.445 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.63 -30.85 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 117.674 -3.141 . . . . 1.94 114.796 169.478 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -65.09 -60.86 2.56 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.814 -1.804 . . . . 1.9 109.444 174.053 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -45.7 -39.57 8.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.929 2.937 . . . . 1.55 118.929 172.02 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -91.81 -63.2 1.28 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.582 2.753 . . . . 2.95 107.481 -172.282 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -93.11 -17.79 23.37 Favored 'General case' 0 N--CA 1.429 -1.521 0 O-C-N 117.272 -3.393 . . . . 1.48 115.541 -169.233 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.55 -4.84 62.06 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 108.712 -1.755 . . . . 1.12 108.712 170.793 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.2 mt -75.06 133.84 75.09 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 125.077 1.351 . . . . 2.07 112.785 -176.879 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -75.9 138.29 20.77 Favored 'Trans proline' 0 N--CA 1.433 -2.043 0 CA-C-O 114.122 -2.532 . . . . 1.39 115.766 -178.597 . . . . . . . . 2 2 . 1 . 133 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -64.67 -24.66 62.23 Favored 'Trans proline' 0 N--CA 1.433 -2.031 1 C-N-CA 125.996 4.464 . . . . 1.68 118.572 -172.176 . . . . . . . . 2 2 . 1 . 133 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -55.76 -36.05 66.88 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.212 3.445 . . . . 2.25 116.176 173.299 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -79.9 -11.89 59.78 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.025 1.73 . . . . 2.44 109.928 -178.842 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -86.58 121.21 28.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 118.737 2.865 . . . . 1.32 118.737 -169.172 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -110.44 110.55 21.34 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.211 1.368 . . . . 3.19 111.678 172.458 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.2 mt -97.93 119.43 36.53 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 123.675 2.943 . . . . 1.75 109.7 -176.001 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 29.6 mm -108.45 137.8 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 119.175 -2.203 . . . . 1.98 110.96 178.301 . . . . . . . . 2 2 . 1 . 133 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.422 ' HB2' HD13 ' A' ' 67' ' ' LEU . 87.4 t80 -130.06 121.67 26.87 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 104.604 -2.369 . . . . 1.94 104.604 173.121 . . . . . . . . 2 2 . 1 . 133 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.26 -100.47 0.06 Allowed 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 120.909 -1.12 . . . . 1.67 110.129 -178.793 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.69 10.39 6.75 Favored Glycine 0 N--CA 1.429 -1.817 0 C-N-CA 126.176 1.846 . . . . 1.3 115.348 174.186 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -110.38 137.66 47.8 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.729 -1.235 . . . . 2.89 112.72 -173.857 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -95.24 129.13 42.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 126.643 2.464 . . . . 2.89 109.421 176.826 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.2 mt -100.35 136.86 39.59 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 117.263 2.32 . . . . 1.34 117.263 -166.804 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -79.54 138.74 37.6 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.79 -2.444 . . . . 1.94 116.614 -178.164 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.469 ' CG ' ' HZ1' ' A' ' 27' ' ' LYS . 1.1 m-20 -60.97 -47.18 87.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.367 -2.708 . . . . 1.56 114.78 -168.869 . . . . . . . . 2 2 . 1 . 133 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.76 35.86 3.45 Favored Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 119.677 2.631 . . . . 0.97 119.677 173.058 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -114.97 160.51 19.48 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 123.102 1.429 . . . . 3.07 108.463 163.152 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.4 p -100.58 171.4 7.75 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.006 -3.559 . . . . 1.34 117.235 177.953 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.516 HD11 ' HE3' ' A' ' 1' ' ' MET . 3.2 mt -64.71 -23.61 67.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.712 1.72 . . . . 1.63 113.088 172.25 . . . . . . . . 2 2 . 1 . 133 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.271 19.2 t -60.4 -59.59 5.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.266 3.426 . . . . 1.51 116.111 174.993 . . . . . . . . 2 2 . 1 . 133 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -39.29 -41.27 0.87 Allowed 'General case' 0 N--CA 1.43 -1.458 1 C-N-CA 132.928 4.491 . . . . 1.9 118.74 165.632 . . . . . . . . 2 2 . 1 . 133 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -97.57 9.84 41.42 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 112.508 -3.615 . . . . 0.97 116.436 175.214 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.1 t30 52.84 51.22 16.36 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 131.213 5.321 . . . . 2.35 115.44 -175.486 . . . . . . . . 2 2 . 1 . 133 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.0 mt -101.79 116.94 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 125.574 2.607 . . . . 1.39 111.011 177.394 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -100.86 -153.59 0.45 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.15 -1.594 . . . . 2.58 109.824 -173.277 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -74.31 142.5 45.18 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 128.157 2.583 . . . . 2.58 116.422 175.74 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.252 49.0 mt-10 68.89 33.88 3.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.937 2.095 . . . . 1.71 108.072 176.782 . . . . . . . . 2 2 . 1 . 133 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.0 m -91.67 137.03 32.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 130.004 3.322 . . . . 1.34 113.969 -175.465 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.1 m -107.94 117.26 33.65 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 126.673 1.989 . . . . 1.36 114.962 -174.125 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.422 HD13 ' HB2' ' A' ' 45' ' ' PHE . 2.2 mm? -103.64 156.86 17.47 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 125.629 1.571 . . . . 2.03 108.332 177.08 . . . . . . . . 2 2 . 1 . 133 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.446 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 74.2 m80 -117.37 123.14 45.74 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 125.546 2.594 . . . . 2.31 108.13 -178.661 . . . . . . . . 2 2 . 1 . 133 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.2 tp -97.13 93.4 6.54 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.633 -2.542 . . . . 1.72 112.433 -179.916 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.5 t -91.46 136.27 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 127.831 2.452 . . . . 1.8 106.154 174.569 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.5 mt -109.47 164.04 12.87 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 124.506 2.098 . . . . 3.26 111.198 178.582 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -88.61 154.24 20.48 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 130.569 3.548 . . . . 4.12 108.309 168.528 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.2 mt -64.79 130.6 44.1 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 128.158 2.583 . . . . 3.54 113.198 171.965 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -79.66 115.76 19.46 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 116.668 2.099 . . . . 7.32 116.668 174.082 . . . . . . . . 1 1 . 1 . 133 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.65 -58.72 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.722 1 N-CA-C 101.887 -4.485 . . . . 3.73 101.887 -169.894 . . . . . . . . 2 2 . 1 . 133 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.782 0 N-CA-C 103.158 -3.977 . . . . 3.87 103.158 -178.022 . . . . . . . . 0 0 . 1 . 134 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.263 16.0 ptt? . . . . . 0 CA--C 1.49 -1.333 0 N-CA-C 114.366 1.247 . . . . 1.39 114.366 . . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -106.78 135.35 48.46 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 116.088 1.884 . . . . 2.2 116.088 -177.109 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.1 pt -120.42 165.11 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 101.514 -3.514 . . . . 1.32 101.514 176.657 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -116.83 147.53 42.04 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 121.989 0.9 . . . . 2.2 111.74 -179.732 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.347 65.0 t -123.34 113.79 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-O 123.703 1.716 . . . . 1.23 107.802 174.856 . . . . . . . . 2 2 . 1 . 134 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.458 ' HD2' HG23 ' A' ' 66' ' ' THR . 6.6 tttp -99.2 130.48 45.5 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.737 -2.477 . . . . 2.51 108.545 -178.618 . . . . . . . . 2 2 . 1 . 134 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.7 p -98.65 175.82 5.86 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.93 -1.731 . . . . 1.41 111.847 176.502 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.7 tp -77.32 -31.71 54.78 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 118.211 -1.396 . . . . 2.95 111.097 169.798 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.8 p -59.62 -27.31 66.21 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 131.62 3.968 . . . . 2.52 115.679 -177.425 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.01 56.6 0.62 Allowed Glycine 0 N--CA 1.43 -1.766 1 C-N-CA 135.417 6.246 . . . . 1.5 104.909 165.608 . . . . . . . . 2 2 . 1 . 134 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -125.73 141.96 51.75 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.306 -2.879 . . . . 1.79 107.807 177.642 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 100.0 m -120.53 112.69 19.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.556 -1.276 . . . . 1.38 107.556 175.921 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.3 mt -93.97 141.07 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 118.212 -2.805 . . . . 2.03 106.838 -178.634 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -104.42 117.74 34.9 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 124.551 2.12 . . . . 1.61 107.868 177.585 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.9 mt -116.06 128.7 55.9 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 111.75 -2.477 . . . . 2.15 107.735 -178.878 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -87.47 117.01 25.97 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 104.598 -2.371 . . . . 1.98 104.598 175.763 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.26 159.34 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 125.213 1.57 . . . . 1.52 107.591 -174.766 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 26.1 mt-10 -106.34 165.04 13.68 Favored Pre-proline 0 N--CA 1.429 -1.484 0 C-N-CA 125.502 1.521 . . . . 2.35 108.208 165.226 . . . . . . . . 2 2 . 1 . 134 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 95.7 Cg_exo -72.76 -22.38 20.44 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 125.073 3.849 . . . . 1.31 115.381 -173.18 . . . . . . . . 2 2 . 1 . 134 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.8 m -88.88 -1.33 58.04 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.796 -0.638 . . . . 1.71 112.32 -179.833 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -74.32 140.7 45.05 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.023 -2.923 . . . . 1.69 112.935 -179.318 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.0 p -76.5 162.39 27.85 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.772 -4.33 . . . . 1.33 113.499 177.873 . . . . . . . . 2 2 . 1 . 134 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mm -64.86 -29.05 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.29 -2.756 . . . . 1.32 114.325 175.48 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -61.28 -31.75 71.58 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 116.943 2.201 . . . . 1.62 116.943 164.921 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -75.43 -39.85 58.4 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.915 -1.116 . . . . 2.13 109.212 -179.344 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.0 t -63.67 -39.89 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 117.398 2.37 . . . . 1.23 117.398 171.535 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.257 66.4 mttt -61.22 -40.45 94.04 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 124.649 2.166 . . . . 1.97 114.934 172.529 . . . . . . . . 2 2 . 1 . 134 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.37 -39.77 67.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.974 -3.579 . . . . 1.19 113.6 172.506 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -68.76 -28.66 66.99 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 120.75 1.614 . . . . 1.92 109.855 172.519 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.1 mt -70.87 -24.8 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 116.95 -3.594 . . . . 1.94 115.402 174.381 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -62.11 -30.15 70.81 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.035 -2.916 . . . . 1.9 112.392 173.254 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -71.83 -20.04 61.89 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.896 -2.378 . . . . 1.55 113.205 175.801 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -103.11 -59.43 1.71 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.506 -1.664 . . . . 2.95 106.506 -173.907 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -105.57 -10.2 16.99 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.249 -1.341 . . . . 1.48 111.401 -164.45 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 56.3 54.0 38.97 Favored Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 125.757 1.646 . . . . 1.12 112.801 175.906 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.0 mt -118.49 127.55 26.5 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 127.236 2.214 . . . . 2.07 105.433 178.586 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -75.6 163.91 33.19 Favored 'Trans proline' 0 N--CA 1.432 -2.124 2 O-C-N 112.669 -4.438 . . . . 1.39 115.553 179.499 . . . . . . . . 2 2 . 1 . 134 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -70.63 -12.23 30.93 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 CA-C-N 123.622 2.329 . . . . 1.68 117.053 -177.238 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -75.2 -16.25 60.5 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 115.603 -4.436 . . . . 2.25 112.533 172.642 . . . . . . . . 2 2 . 1 . 134 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -90.26 -10.68 43.34 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 119.668 1.122 . . . . 2.44 109.773 -177.071 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -103.32 132.04 49.9 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 123.931 1.824 . . . . 1.32 106.1 -160.301 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -121.41 111.25 17.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 114.207 -1.361 . . . . 3.19 112.428 168.506 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.3 mt -90.13 132.37 35.48 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.552 -1.967 . . . . 1.75 115.751 179.362 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 mm -123.73 124.82 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-O 126.316 2.96 . . . . 1.98 112.331 -179.587 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.41 ' HB2' HD23 ' A' ' 67' ' ' LEU . 37.0 t80 -124.48 108.16 11.84 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 127.612 2.365 . . . . 1.94 108.529 177.15 . . . . . . . . 2 2 . 1 . 134 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.53 -74.3 0.09 Allowed 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 110.592 -3.003 . . . . 1.67 114.066 -178.056 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -147.67 -10.98 0.17 Allowed Glycine 0 N--CA 1.431 -1.679 1 C-N-CA 131.178 4.228 . . . . 1.3 114.631 -177.886 . . . . . . . . 2 2 . 1 . 134 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -94.93 122.43 37.56 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.515 -2.756 . . . . 2.89 113.909 -173.032 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -73.26 117.96 15.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.751 1.62 . . . . 2.89 111.273 168.76 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.8 mt -92.17 128.68 38.1 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 123.429 2.831 . . . . 1.34 113.186 -171.842 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -73.8 146.64 44.07 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.415 1.579 . . . . 1.94 112.963 178.956 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -66.1 -50.1 65.22 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.817 -2.427 . . . . 1.56 115.554 -170.288 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.92 52.85 1.93 Allowed Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 117.234 -2.412 . . . . 0.97 118.082 168.527 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -114.55 161.64 17.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.848 -1.908 . . . . 3.07 105.848 161.553 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.3 p -108.05 175.6 5.42 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 116.749 2.129 . . . . 1.34 116.749 178.11 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.3 mt -65.49 -31.62 72.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.158 2.885 . . . . 1.63 114.563 172.301 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 t -63.06 -44.41 95.89 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.879 -3.638 . . . . 1.51 118.011 171.511 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -64.74 -37.2 86.81 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 129.602 3.161 . . . . 1.9 110.269 -175.597 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -98.4 -10.16 24.13 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.788 2.835 . . . . 0.97 110.085 -174.305 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.1 m120 60.66 54.89 3.5 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 128.487 3.994 . . . . 2.35 113.003 178.715 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.9 mt -106.59 101.35 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-N 108.768 -3.833 . . . . 1.39 106.644 179.607 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -104.01 174.49 5.85 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 129.988 3.315 . . . . 2.58 111.583 -167.012 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -55.67 138.81 46.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.815 -3.053 . . . . 2.58 114.486 179.813 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 67.71 39.07 2.8 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 129.837 3.255 . . . . 1.71 112.783 -178.89 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.3 t -109.9 137.28 47.9 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.22 -1.77 . . . . 1.34 106.22 -169.494 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.458 HG23 ' HD2' ' A' ' 6' ' ' LYS . 44.6 m -96.81 110.0 22.57 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 129.148 2.979 . . . . 1.36 114.114 -176.031 . . . . . . . . 2 2 . 1 . 134 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.41 HD23 ' HB2' ' A' ' 45' ' ' PHE . 13.1 mt -95.06 147.28 23.59 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 127.647 2.379 . . . . 2.03 107.742 169.342 . . . . . . . . 2 2 . 1 . 134 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -109.31 123.43 49.28 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 103.735 -2.691 . . . . 2.31 103.735 -173.207 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.6 tp -81.9 107.23 14.45 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.246 -2.784 . . . . 1.72 109.011 173.706 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.4 t -98.37 144.69 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 127.923 3.264 . . . . 1.8 104.692 167.809 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.9 mt -109.19 137.08 47.63 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 117.841 -3.037 . . . . 3.26 110.593 178.755 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -85.11 -174.65 5.36 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 129.389 3.076 . . . . 4.12 112.151 177.486 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.0 mt -124.52 173.66 8.32 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 102.701 -3.074 . . . . 3.54 102.701 172.362 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.1 ttp180 -93.11 150.84 20.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.054 2.835 . . . . 7.32 118.267 175.045 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 134.6 -90.22 0.24 Allowed Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 112.548 -2.114 . . . . 3.73 112.472 -165.387 . . . . . . . . 1 1 . 1 . 134 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.727 0 N-CA-C 106.235 -2.746 . . . . 3.87 106.235 175.836 . . . . . . . . 0 0 . 1 . 135 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ptt? . . . . . 0 CA--C 1.489 -1.381 0 N-CA-C 112.017 0.377 . . . . 1.39 112.017 . . . . . . . . . 0 0 . 1 . 135 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -92.0 136.16 33.38 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.191 -2.193 . . . . 2.2 115.964 173.659 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.373 27.5 pt -116.61 161.66 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-O 114.541 -2.647 . . . . 1.32 112.378 165.839 . . . . . . . . 2 2 . 1 . 135 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -120.13 143.52 48.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 121.383 1.901 . . . . 2.2 110.91 177.226 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.83 127.55 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 112.33 -2.213 . . . . 1.23 108.198 175.654 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -97.4 138.83 34.26 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.343 -1.725 . . . . 2.51 106.343 177.256 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 p -97.57 -179.45 4.47 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 127.609 3.576 . . . . 1.41 110.867 173.027 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.8 mt -77.79 -51.33 10.68 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.208 -4.683 . . . . 2.95 112.624 175.315 . . . . . . . . 2 2 . 1 . 135 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.0 p -56.83 -43.87 81.48 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.464 2.024 . . . . 2.52 116.464 177.602 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.08 61.08 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 127.106 2.289 . . . . 1.5 111.118 177.978 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.38 156.48 48.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 103.1 -2.926 . . . . 1.79 103.1 178.38 . . . . . . . . 2 2 . 1 . 135 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.9 m -133.04 121.81 23.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.715 2.674 . . . . 1.38 110.805 -176.95 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mt -102.23 115.27 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 118.627 -2.546 . . . . 2.03 106.896 -175.998 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.2 m -93.19 115.73 28.34 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.163 -1.586 . . . . 1.61 106.784 174.867 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.3 mt -117.63 147.87 42.47 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 125.726 2.679 . . . . 2.15 112.022 -178.787 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -90.61 121.13 32.26 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.378 1.871 . . . . 1.98 110.525 177.346 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.6 m -140.99 167.38 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 116.534 -1.698 . . . . 1.52 111.829 -176.735 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -118.86 173.46 3.4 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-N 122.739 2.518 . . . . 2.35 114.182 156.96 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -75.7 -11.31 20.24 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 115.224 -2.717 . . . . 1.31 118.861 -179.479 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.6 m -79.57 -3.02 45.06 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.359 1.064 . . . . 1.71 112.062 170.493 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -81.33 151.57 27.95 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.517 -1.99 . . . . 1.69 107.884 178.781 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.269 17.3 p -92.52 164.03 13.6 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 115.088 1.514 . . . . 1.33 115.088 178.796 . . . . . . . . 2 2 . 1 . 135 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.9 mm -63.33 -22.38 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 116.267 1.951 . . . . 1.32 116.267 171.999 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -66.72 -45.34 79.01 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.149 3.379 . . . . 1.62 111.764 166.114 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -56.89 -38.16 72.39 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.343 -2.098 . . . . 2.13 114.504 178.133 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.1 t -66.26 -36.03 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 127.914 2.485 . . . . 1.23 114.245 174.979 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -67.4 -39.56 85.58 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.97 2.952 . . . . 1.97 118.97 173.582 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.28 -36.55 66.25 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 116.847 2.166 . . . . 1.19 116.847 170.547 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -60.42 -40.25 90.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.913 1.285 . . . . 1.92 114.224 170.048 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.3 mt -76.4 -31.42 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.438 1.495 . . . . 1.94 108.654 179.367 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -67.26 -43.55 81.59 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.171 -2.205 . . . . 1.9 113.904 174.851 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -58.13 -65.57 0.62 Allowed 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 130.386 3.474 . . . . 1.55 110.805 168.783 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -56.63 -53.55 56.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.926 3.306 . . . . 2.95 119.926 -175.252 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -120.87 -3.63 9.68 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.681 -1.6 . . . . 1.48 112.826 -164.845 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.83 -6.34 81.95 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 118.493 2.157 . . . . 1.12 118.493 169.527 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.7 mp -73.97 113.63 25.1 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 118.288 -2.889 . . . . 2.07 115.451 -170.665 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -60.23 146.44 96.39 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 124.974 3.783 . . . . 1.39 114.009 179.718 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -58.18 -24.91 69.26 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 C-N-CA 123.437 2.758 . . . . 1.68 117.224 -177.534 . . . . . . . . 2 2 . 1 . 135 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -70.8 -26.2 63.21 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 130.176 4.672 . . . . 2.25 112.702 179.296 . . . . . . . . 2 2 . 1 . 135 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -89.89 -16.26 30.4 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.21 -3.431 . . . . 2.44 112.492 -174.974 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -87.25 126.87 35.09 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 117.313 2.338 . . . . 1.32 117.313 -177.759 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -120.74 126.27 49.73 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.127 2.571 . . . . 3.19 108.099 164.883 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.435 HD23 HD11 ' A' ' 69' ' ' LEU . 90.9 mt -109.51 115.03 29.17 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.774 -3.079 . . . . 1.75 109.391 -174.993 . . . . . . . . 2 2 . 1 . 135 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.418 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 31.3 mm -101.18 134.72 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 125.943 1.697 . . . . 1.98 108.581 -177.028 . . . . . . . . 2 2 . 1 . 135 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.415 ' HB3' HD12 ' A' ' 50' ' ' LEU . 89.2 t80 -154.42 126.54 7.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.565 -2.383 . . . . 1.94 104.565 174.976 . . . . . . . . 2 2 . 1 . 135 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.52 45.12 16.85 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 125.958 2.789 . . . . 1.67 113.788 -177.264 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.49 2.27 20.08 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 111.97 -2.377 . . . . 1.3 118.737 -173.506 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -103.88 125.9 50.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.283 -3.481 . . . . 2.89 107.19 -175.523 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -74.0 122.01 21.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.083 -2.261 . . . . 2.89 107.258 163.707 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 45' ' ' PHE . 19.9 mt -78.24 127.02 31.64 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 130.459 3.504 . . . . 1.34 116.855 -177.396 . . . . . . . . 2 2 . 1 . 135 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -89.29 130.55 35.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 116.421 2.008 . . . . 1.94 116.421 173.871 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.53 -61.41 1.7 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 130.275 3.43 . . . . 1.56 115.898 -170.269 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.68 23.8 3.45 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 123.066 3.986 . . . . 0.97 123.066 173.199 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -99.73 165.44 11.59 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.363 1.465 . . . . 3.07 107.347 163.862 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.391 18.6 p -92.6 171.19 9.17 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 117.09 2.256 . . . . 1.34 117.09 177.097 . . . . . . . . 2 2 . 1 . 135 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.72 -33.79 64.52 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 114.897 -2.478 . . . . 1.63 107.374 170.987 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -73.46 -35.68 65.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.42 1.888 . . . . 1.51 107.94 -175.256 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.39 3.0 t0 -63.32 -53.98 44.25 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.941 1.353 . . . . 1.9 111.859 171.005 . . . . . . . . 2 2 . 1 . 135 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -73.19 -7.98 53.79 Favored 'General case' 0 N--CA 1.43 -1.454 2 O-C-N 115.318 -4.613 . . . . 0.97 122.295 177.112 . . . . . . . . 2 2 . 1 . 135 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.0 m120 70.2 56.42 0.29 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.568 1.692 . . . . 2.35 115.568 179.137 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.1 mt -104.71 108.29 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 128.097 3.373 . . . . 1.39 109.008 177.485 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -87.95 -175.39 5.09 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 125.265 2.46 . . . . 2.58 109.49 177.807 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -63.2 131.0 47.0 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 115.276 -4.64 . . . . 2.58 115.62 174.522 . . . . . . . . 2 2 . 1 . 135 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.662 17.9 mt-10 97.69 -5.31 0.05 Allowed 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 124.622 1.201 . . . . 1.71 112.284 174.315 . . . . . . . . 2 2 . 1 . 135 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -66.71 122.69 18.2 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.807 2.043 . . . . 1.34 115.455 -176.265 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.5 m -91.2 115.59 28.14 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 103.803 -2.666 . . . . 1.36 103.803 -178.682 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.4 mt -79.34 139.74 37.7 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.079 2.952 . . . . 2.03 112.245 165.343 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.418 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 42.6 m80 -108.7 117.08 33.25 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.95 -2.969 . . . . 2.31 114.702 -179.059 . . . . . . . . 2 2 . 1 . 135 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.435 HD11 HD23 ' A' ' 43' ' ' LEU . 23.9 tp -83.17 115.14 21.79 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 128.577 2.751 . . . . 1.72 111.746 -174.916 . . . . . . . . 2 2 . 1 . 135 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.2 t -104.25 133.27 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 105.354 -2.091 . . . . 1.8 105.354 174.498 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.8 mt -114.57 165.74 12.45 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 125.345 1.653 . . . . 3.26 110.036 -178.231 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -106.19 140.19 39.53 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 102.121 -3.289 . . . . 4.12 102.121 176.981 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.5 mt -86.26 170.71 11.85 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 116.288 -1.815 . . . . 3.54 112.298 178.89 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -79.06 85.0 5.01 Favored 'General case' 0 N--CA 1.431 -1.418 1 O-C-N 129.586 4.304 . . . . 7.32 115.443 171.567 . . . . . . . . 2 2 . 1 . 135 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.22 -94.58 0.1 OUTLIER Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 117.173 1.629 . . . . 3.73 117.173 -169.902 . . . . . . . . 1 1 . 1 . 135 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.725 0 CA-C-N 121.324 2.562 . . . . 3.87 112.447 179.053 . . . . . . . . 0 0 . 1 . 136 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 ptt? . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 122.104 0.954 . . . . 1.39 109.965 . . . . . . . . . 0 0 . 1 . 136 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -103.08 144.02 31.83 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.336 -1.302 . . . . 2.2 107.966 -177.381 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.2 pt -132.35 159.68 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 C-N-CA 127.341 2.256 . . . . 1.32 107.182 175.71 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -103.39 153.09 20.85 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 128.581 2.753 . . . . 2.2 111.574 178.752 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.5 t -137.7 104.68 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 106.636 -1.616 . . . . 1.23 106.636 177.546 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -90.59 117.62 29.4 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 127.062 3.315 . . . . 2.51 111.13 -179.791 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.1 p -80.22 174.5 11.53 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.137 -3.477 . . . . 1.41 115.567 179.303 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.2 mt -61.47 -52.74 63.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 124.875 1.359 . . . . 2.95 111.573 170.235 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.276 72.6 p -66.5 -38.17 86.65 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 119.465 -2.022 . . . . 2.52 115.625 -173.189 . . . . . . . . 2 2 . 1 . 136 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.75 52.12 0.17 Allowed Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 125.542 1.544 . . . . 1.5 116.49 173.578 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -119.3 149.27 42.06 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 103.475 -2.787 . . . . 1.79 103.475 174.773 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.3 m -119.28 115.05 23.36 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 125.497 1.748 . . . . 1.38 106.636 174.633 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mt -95.69 135.63 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.189 -2.195 . . . . 2.03 105.33 179.744 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.8 m -96.14 129.52 43.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.961 -2.977 . . . . 1.61 102.961 172.122 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.0 mt -124.29 133.89 53.36 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.104 -1.813 . . . . 2.15 106.104 -179.102 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -92.3 107.24 19.07 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.07 -2.268 . . . . 1.98 111.098 169.413 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 m -113.67 179.04 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 C-N-CA 127.734 2.414 . . . . 1.52 114.113 174.669 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -125.73 154.75 73.2 Favored Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 103.84 -2.652 . . . . 2.35 103.84 166.317 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.294 25.6 Cg_endo -66.74 -30.73 41.04 Favored 'Trans proline' 0 N--CA 1.434 -2.001 1 C-N-CA 125.577 4.185 . . . . 1.31 110.234 -172.031 . . . . . . . . 3 2 . 1 . 136 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.2 p -64.51 -16.94 63.39 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.552 3.141 . . . . 1.71 116.646 173.549 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -70.07 142.47 52.66 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.376 -2.077 . . . . 1.69 109.39 177.137 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.0 p -78.26 164.56 24.79 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 126.247 2.217 . . . . 1.33 112.941 174.237 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.4 mm -65.2 -32.6 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 117.142 2.275 . . . . 1.32 117.142 174.114 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -50.03 -49.88 49.44 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 126.386 2.993 . . . . 1.62 109.688 164.533 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -65.36 -37.21 86.35 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.407 -2.683 . . . . 2.13 116.295 -178.127 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.4 t -67.53 -27.89 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 121.254 1.843 . . . . 1.23 108.221 174.812 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -75.0 -27.32 60.09 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 121.005 1.729 . . . . 1.97 112.526 178.343 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.18 -31.74 69.35 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 117.3 -1.333 . . . . 1.19 111.457 173.844 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -69.05 -35.64 76.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.515 2.726 . . . . 1.92 109.914 175.033 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.8 mt -69.03 -43.66 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-N 113.789 -1.55 . . . . 1.94 111.359 171.134 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -62.68 -38.07 88.92 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.103 -2.248 . . . . 1.9 113.389 179.206 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -49.67 -49.5 47.2 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 130.272 3.429 . . . . 1.55 114.474 168.943 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -87.96 -58.45 2.56 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.106 -3.496 . . . . 2.95 117.002 -179.557 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -81.88 -43.97 17.47 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.695 1.712 . . . . 1.48 112.546 -166.086 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.1 63.35 1.14 Allowed Glycine 0 N--CA 1.431 -1.689 0 CA-C-N 111.946 -2.388 . . . . 1.12 112.586 176.001 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.2 mt -129.81 117.9 18.52 Favored Pre-proline 0 N--CA 1.429 -1.505 0 CA-C-O 115.789 -2.053 . . . . 2.07 106.074 -177.599 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -67.4 140.63 53.35 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 CA-C-N 127.493 3.712 . . . . 1.39 112.114 -179.904 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -51.9 -20.17 9.57 Favored 'Trans proline' 0 N--CA 1.433 -2.073 1 N-CA-C 122.719 4.084 . . . . 1.68 122.719 -175.958 . . . . . . . . 3 3 . 1 . 136 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.96 -39.55 72.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.805 2.842 . . . . 2.25 111.02 172.523 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -75.75 -36.0 60.01 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 116.706 -3.746 . . . . 2.44 111.496 179.878 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -93.52 142.45 27.33 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 119.951 -1.718 . . . . 1.32 107.036 -166.136 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -124.13 151.54 43.82 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.993 -1.692 . . . . 3.19 106.535 166.599 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.6 mt -121.64 123.9 43.02 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.084 1.421 . . . . 1.75 108.868 -179.559 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.4 mt -105.53 128.43 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 129.719 3.208 . . . . 1.98 110.664 -176.101 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.495 ' C ' ' H ' ' A' ' 47' ' ' GLY . 2.4 t80 -139.13 133.11 31.04 Favored 'General case' 0 N--CA 1.43 -1.473 1 N-CA-C 99.256 -4.35 . . . . 1.94 99.256 179.835 . . . . . . . . 3 3 . 1 . 136 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.57 -36.01 0.18 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 131.418 3.887 . . . . 1.67 113.557 179.504 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.495 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 164.91 -26.06 0.18 Allowed Glycine 0 N--CA 1.429 -1.781 0 O-C-N 116.964 -3.585 . . . . 1.3 111.245 178.297 . . . . . . . . 2 2 . 1 . 136 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -83.22 137.67 33.92 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.703 2.668 . . . . 2.89 111.611 -178.974 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 pm0 -92.4 126.99 37.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.26 -2.15 . . . . 2.89 109.514 177.019 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.293 34.8 mt -81.87 122.84 28.24 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.378 2.513 . . . . 1.34 109.899 -161.683 . . . . . . . . 2 2 . 1 . 136 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -77.99 130.64 36.75 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 116.801 -3.687 . . . . 1.94 108.119 178.601 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -46.57 -48.18 19.58 Favored 'General case' 0 N--CA 1.43 -1.472 1 C-N-CA 132.34 4.256 . . . . 1.56 115.028 -173.34 . . . . . . . . 2 2 . 1 . 136 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.65 49.61 3.89 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 128.425 2.917 . . . . 0.97 116.077 172.983 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -135.78 172.86 12.39 Favored 'General case' 0 N--CA 1.43 -1.464 1 N-CA-C 97.606 -4.961 . . . . 3.07 97.606 169.47 . . . . . . . . 2 2 . 1 . 136 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.5 p -99.14 169.21 9.56 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.232 -1.804 . . . . 1.34 114.56 170.3 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.5 mt -76.02 -21.68 56.59 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 112.324 -2.216 . . . . 1.63 109.161 176.907 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 t -73.86 -39.78 63.73 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.893 -0.594 . . . . 1.51 109.798 176.862 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -54.84 -40.8 69.98 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 120.442 3.497 . . . . 1.9 120.442 174.508 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -78.84 -15.03 58.89 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 128.121 2.568 . . . . 0.97 116.992 175.966 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 m120 68.74 51.54 0.59 Allowed 'General case' 0 N--CA 1.43 -1.445 1 C-N-CA 132.932 4.493 . . . . 2.35 113.88 -178.311 . . . . . . . . 2 2 . 1 . 136 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mp -82.15 116.86 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 117.39 -3.318 . . . . 1.39 108.976 175.516 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -95.95 165.07 12.44 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 111.884 -2.417 . . . . 2.58 115.531 177.309 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -53.49 135.23 40.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.359 -1.291 . . . . 2.58 113.576 176.269 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 63.84 34.29 11.96 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 118.674 2.842 . . . . 1.71 118.674 178.241 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.7 m -92.12 154.46 18.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.1 2.16 . . . . 1.34 114.277 -177.314 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.0 m -102.36 114.14 28.07 Favored 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 117.516 -3.24 . . . . 1.36 116.348 -179.957 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -87.15 147.7 25.51 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.651 -0.656 . . . . 2.03 109.855 165.806 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -114.92 120.77 41.06 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 123.797 0.839 . . . . 2.31 109.137 -178.692 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.4 tp -97.69 129.16 44.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.932 -2.355 . . . . 1.72 109.472 -175.565 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.83 164.52 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 129.887 3.275 . . . . 1.8 105.555 177.796 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.7 mt -119.08 175.73 5.64 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 116.794 -3.691 . . . . 3.26 109.364 179.553 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -106.75 177.65 4.79 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.845 -1.07 . . . . 4.12 111.994 172.505 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.297 92.9 mt -83.65 114.69 21.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.071 1.878 . . . . 3.54 116.071 169.57 . . . . . . . . 2 2 . 1 . 136 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -75.7 120.16 20.72 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.043 2.537 . . . . 7.32 117.147 179.308 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.93 -13.12 1.92 Allowed Glycine 0 N--CA 1.43 -1.759 0 CA-C-N 112.384 -2.189 . . . . 3.73 116.433 -175.031 . . . . . . . . 1 1 . 1 . 136 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.79 0 CA-C-N 119.724 1.762 . . . . 3.87 112.845 175.41 . . . . . . . . 0 0 . 1 . 137 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 ptt? . . . . . 0 CA--C 1.49 -1.339 0 CA-C-O 115.847 -2.025 . . . . 1.39 116.247 . . . . . . . . . 0 0 . 1 . 137 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.62 138.13 34.66 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 122.809 2.55 . . . . 2.2 109.978 -179.096 . . . . . . . . 2 2 . 1 . 137 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.8 pt -124.33 170.85 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 104.232 -2.507 . . . . 1.32 104.232 167.991 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -119.1 147.25 44.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.811 3.245 . . . . 2.2 107.051 -176.586 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.5 t -133.93 138.08 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 102.832 -3.025 . . . . 1.23 102.832 170.755 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -110.6 130.31 55.6 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.082 2.153 . . . . 2.51 107.328 177.768 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -81.8 -176.73 6.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 123.898 0.749 . . . . 1.41 111.966 174.977 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.7 mt -58.49 -47.51 83.84 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.171 2.988 . . . . 2.95 112.331 179.494 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.0 p -89.04 -35.73 16.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.161 -2.837 . . . . 2.52 106.529 -172.338 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.74 5.54 0.25 Allowed Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 119.938 2.735 . . . . 1.5 119.938 -178.497 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.1 ttpt -85.17 126.03 33.31 Favored 'General case' 0 N--CA 1.43 -1.443 2 O-C-N 113.803 -5.528 . . . . 1.79 108.895 -174.482 . . . . . . . . 2 2 . 1 . 137 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.293 66.0 m -83.77 114.9 21.94 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.058 2.361 . . . . 1.38 109.362 173.966 . . . . . . . . 2 2 . 1 . 137 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mt -98.25 116.7 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 124.553 2.121 . . . . 2.03 105.654 177.051 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.6 m -86.59 105.89 17.18 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.812 -3.055 . . . . 1.61 116.436 173.371 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.0 mt -113.41 115.99 28.93 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 117.199 -1.381 . . . . 2.15 113.319 -179.495 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.368 0.8 OUTLIER -67.94 111.71 4.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.811 1.291 . . . . 1.98 111.211 171.081 . . . . . . . . 3 3 . 1 . 137 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 m -117.0 169.81 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 117.039 -3.538 . . . . 1.52 112.678 179.334 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -112.82 165.57 12.83 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-N 121.512 1.96 . . . . 2.35 108.382 160.25 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -66.47 -28.31 46.01 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 CA-C-N 124.27 2.561 . . . . 1.31 114.313 -172.587 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.293 24.0 p -77.65 1.01 21.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 130.953 3.701 . . . . 1.71 119.475 177.143 . . . . . . . . 2 2 . 1 . 137 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -80.78 143.49 32.83 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.254 -1.529 . . . . 1.69 107.654 175.377 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.3 p -75.56 167.79 21.24 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.439 -0.578 . . . . 1.33 109.439 179.174 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -68.4 -37.18 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.672 -1.893 . . . . 1.32 115.158 175.849 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -49.74 -43.68 48.07 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 112.164 -2.289 . . . . 1.62 114.141 162.817 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -72.42 -28.42 62.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.852 -1.155 . . . . 2.13 113.868 176.104 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.7 t -71.56 -35.42 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 117.366 -3.334 . . . . 1.23 112.042 170.556 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -68.91 -35.66 77.1 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 124.45 1.094 . . . . 1.97 109.146 172.704 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.27 -40.65 96.94 Favored 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 118.78 -2.45 . . . . 1.19 112.97 172.485 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -61.09 -42.35 98.35 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 119.031 -2.293 . . . . 1.92 115.542 171.003 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.0 mt -58.89 -36.29 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 119.077 -2.264 . . . . 1.94 112.796 167.583 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -61.44 -40.21 93.65 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.49 -1.381 . . . . 1.9 113.501 176.44 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.45 -40.37 94.23 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 119.697 3.221 . . . . 1.55 119.697 162.931 . . . . . . . . 2 2 . 1 . 137 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt -78.68 -68.2 0.67 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.167 2.187 . . . . 2.95 107.935 -176.88 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -101.44 -19.19 15.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 116.857 -1.937 . . . . 1.48 111.238 -169.364 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.57 9.84 45.71 Favored Glycine 0 N--CA 1.431 -1.679 0 CA-C-O 114.748 -3.251 . . . . 1.12 115.877 176.156 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.1 mt -85.97 128.39 58.33 Favored Pre-proline 0 N--CA 1.429 -1.49 1 CA-C-O 110.901 -4.38 . . . . 2.07 106.797 -178.953 . . . . . . . . 2 2 . 1 . 137 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -80.65 153.12 20.11 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 CA-C-N 127.561 3.736 . . . . 1.39 110.671 -179.03 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.64 -19.95 41.24 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 124.829 3.686 . . . . 1.68 111.84 -165.768 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -68.16 -39.52 82.56 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 124.283 1.992 . . . . 2.25 116.276 173.009 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -73.04 -43.62 61.77 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 131.221 3.808 . . . . 2.44 115.119 174.091 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -60.75 137.22 58.22 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.584 -2.573 . . . . 1.32 111.094 -174.591 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -116.51 142.78 46.43 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 125.021 3.555 . . . . 3.19 107.402 167.294 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.43 HD11 HD13 ' A' ' 67' ' ' LEU . 74.9 mt -127.52 119.67 26.56 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.251 -2.129 . . . . 1.75 105.251 178.297 . . . . . . . . 2 2 . 1 . 137 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 mt -111.55 132.9 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 129.093 2.957 . . . . 1.98 110.672 -179.995 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -139.23 141.04 37.89 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.394 -2.076 . . . . 1.94 105.394 170.413 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.43 20.71 0.32 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.123 -2.861 . . . . 1.67 117.712 177.667 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.59 6.19 80.78 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 116.807 -3.683 . . . . 1.3 113.287 179.677 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -98.09 121.71 40.35 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 115.382 -2.247 . . . . 2.89 110.841 174.795 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -77.68 125.13 28.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.506 2.323 . . . . 2.89 105.897 171.945 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.288 22.2 mt -79.99 136.41 36.6 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.908 1.814 . . . . 1.34 112.402 -167.684 . . . . . . . . 2 2 . 1 . 137 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.32 46.1 mt-10 -81.19 129.65 34.68 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.113 -3.492 . . . . 1.94 113.574 173.039 . . . . . . . . 2 2 . 1 . 137 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -59.83 -46.05 90.46 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.807 2.521 . . . . 1.56 117.807 -172.211 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.9 49.02 2.25 Favored Glycine 0 N--CA 1.43 -1.704 1 O-C-N 113.098 -6.001 . . . . 0.97 110.149 173.14 . . . . . . . . 2 2 . 1 . 137 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -119.5 176.25 5.45 Favored 'General case' 0 N--CA 1.429 -1.477 1 O-C-N 116.232 -4.099 . . . . 3.07 105.388 161.561 . . . . . . . . 2 2 . 1 . 137 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.3 p -104.29 -175.54 2.82 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 117.904 -1.518 . . . . 1.34 114.245 175.385 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.0 mt -77.97 -29.27 49.65 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.783 -1.198 . . . . 1.63 110.818 173.888 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.9 t -73.58 -29.47 62.43 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.576 -1.328 . . . . 1.51 113.261 176.584 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -58.88 -28.91 66.6 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.833 2.901 . . . . 1.9 118.833 172.252 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.356 26.6 m-85 -100.18 8.96 43.47 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 115.671 1.73 . . . . 0.97 115.671 173.022 . . . . . . . . 2 2 . 1 . 137 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.7 m120 46.69 64.14 1.64 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.553 2.341 . . . . 2.35 113.019 -173.514 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.4 mt -104.5 121.87 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 103.213 -2.884 . . . . 1.39 103.213 177.218 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -96.84 -172.66 2.52 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.994 2.118 . . . . 2.58 106.494 -168.681 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.17 153.61 40.64 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 116.49 -2.084 . . . . 2.58 110.685 173.131 . . . . . . . . 2 2 . 1 . 137 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.301 41.5 mt-10 59.53 46.65 11.86 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 115.117 1.525 . . . . 1.71 115.117 177.729 . . . . . . . . 2 2 . 1 . 137 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -104.17 142.94 33.63 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 131.469 3.908 . . . . 1.34 106.305 178.75 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.4 m -108.77 118.02 35.71 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.176 1.941 . . . . 1.36 106.76 -179.832 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.43 HD13 HD11 ' A' ' 43' ' ' LEU . 74.4 mt -92.44 146.53 23.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 113.202 -1.817 . . . . 2.03 110.242 167.381 . . . . . . . . 2 2 . 1 . 137 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -105.33 115.45 30.27 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.691 2.186 . . . . 2.31 107.036 -179.771 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 tt -88.22 116.3 26.32 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 111.863 -2.426 . . . . 1.72 110.844 -179.625 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.9 t -119.75 -178.51 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.259 -2.126 . . . . 1.8 105.259 176.795 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.0 mt -126.97 146.38 50.35 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.173 -3.454 . . . . 3.26 113.354 177.889 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -75.03 144.37 43.08 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 130.139 4.649 . . . . 4.12 115.821 -175.638 . . . . . . . . 2 2 . 1 . 137 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.7 tp -103.59 148.47 25.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 101.78 -3.415 . . . . 3.54 101.78 174.605 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -130.85 147.02 52.45 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.849 -1.523 . . . . 7.32 112.676 174.102 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.82 -50.97 0.78 Allowed Glycine 0 N--CA 1.43 -1.743 0 O-C-N 119.404 -2.06 . . . . 3.73 112.899 -169.251 . . . . . . . . 1 1 . 1 . 137 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.81 0 C-N-CA 125.088 1.328 . . . . 3.87 110.892 179.344 . . . . . . . . 0 0 . 1 . 138 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ptt? . . . . . 0 CA--C 1.49 -1.344 0 N-CA-C 115.568 1.692 . . . . 1.39 115.568 . . . . . . . . . 0 0 . 1 . 138 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -99.16 142.45 30.63 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.173 -2.158 . . . . 2.2 105.173 179.508 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.458 HG13 ' HB2' ' A' ' 15' ' ' LEU . 3.1 pt -117.6 165.08 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 106.569 -1.641 . . . . 1.32 106.569 169.282 . . . . . . . . 2 2 . 1 . 138 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -118.35 121.14 39.66 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.559 -1.338 . . . . 2.2 108.49 179.053 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.3 t -103.37 138.76 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 104.685 -2.339 . . . . 1.23 104.685 171.369 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -111.94 143.58 42.68 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 113.427 -3.178 . . . . 2.51 112.248 173.228 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.5 p -88.61 -172.41 3.73 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.452 3.595 . . . . 1.41 112.915 179.243 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.1 mt -54.14 -38.83 65.91 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 127.028 3.299 . . . . 2.95 116.169 167.282 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -88.81 -35.58 16.53 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 114.297 -5.252 . . . . 2.52 113.002 179.842 . . . . . . . . 2 2 . 1 . 138 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.92 27.37 0.94 Allowed Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 117.745 -1.586 . . . . 1.5 114.541 -179.804 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.8 124.9 29.04 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 120.73 2.265 . . . . 1.79 109.784 -173.929 . . . . . . . . 2 2 . 1 . 138 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.528 1.7 m -78.64 118.63 20.93 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 113.835 -5.54 . . . . 1.38 118.25 176.98 . . . . . . . . 3 2 . 1 . 138 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mt -106.04 121.36 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 125.736 1.615 . . . . 2.03 110.099 172.873 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.251 6.4 m -92.51 108.93 20.34 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 116.854 2.168 . . . . 1.61 116.854 179.55 . . . . . . . . 2 2 . 1 . 138 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.458 ' HB2' HG13 ' A' ' 3' ' ' ILE . 21.5 mt -113.9 130.64 56.48 Favored 'General case' 0 N--CA 1.431 -1.409 1 O-C-N 115.141 -4.724 . . . . 2.15 110.651 -173.627 . . . . . . . . 3 3 . 1 . 138 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -84.81 101.06 11.97 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 116.688 -3.757 . . . . 1.98 111.184 169.61 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.411 HG21 HG12 ' A' ' 3' ' ' ILE . 15.0 m -114.18 164.26 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 121.154 -0.967 . . . . 1.52 110.089 -179.064 . . . . . . . . 2 2 . 1 . 138 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -102.14 161.4 23.51 Favored Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 127.395 2.278 . . . . 2.35 104.941 159.058 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -77.16 -7.65 17.25 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 CA-C-N 122.655 1.984 . . . . 1.31 107.523 -179.616 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 m -79.31 -14.92 58.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.692 1.597 . . . . 1.71 111.825 177.174 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -65.99 144.8 56.52 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.923 2.297 . . . . 1.69 105.948 -179.888 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.4 p -89.34 158.28 17.85 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.415 -1.72 . . . . 1.33 112.937 176.972 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.433 HD11 ' O ' ' A' ' 54' ' ' ARG 0.332 2.8 mp -53.53 -43.74 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 116.323 -3.985 . . . . 1.32 115.305 169.8 . . . . . . . . 3 3 . 1 . 138 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -41.18 -59.96 1.37 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.189 2.196 . . . . 1.62 114.941 165.888 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -72.24 -24.54 61.39 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 120.322 3.453 . . . . 2.13 120.322 -175.624 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -61.18 -32.22 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 120.361 -1.462 . . . . 1.23 113.198 168.777 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -60.06 -43.46 95.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 117.68 -1.152 . . . . 1.97 110.987 177.602 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.78 -27.06 63.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 125.008 1.443 . . . . 1.19 109.027 177.895 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -66.46 -30.8 71.22 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 118.273 -2.767 . . . . 1.92 110.64 173.535 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.6 mt -65.87 -31.42 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 129.686 3.194 . . . . 1.94 109.732 169.494 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.328 52.9 tt0 -69.33 -33.63 73.42 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.024 -2.922 . . . . 1.9 116.91 175.694 . . . . . . . . 2 2 . 1 . 138 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.261 11.9 m-20 -67.81 -36.87 81.17 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.422 2.289 . . . . 1.55 112.196 168.918 . . . . . . . . 2 2 . 1 . 138 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -76.49 -77.28 0.14 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.831 1.252 . . . . 2.95 110.995 -178.494 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -88.17 -66.92 0.87 Allowed 'General case' 0 N--CA 1.429 -1.487 1 C-N-CA 133.316 4.646 . . . . 1.48 114.743 -166.561 . . . . . . . . 2 2 . 1 . 138 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.76 29.66 0.74 Allowed Glycine 0 N--CA 1.43 -1.714 0 O-C-N 126.973 2.671 . . . . 1.12 110.599 166.932 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.6 mt -89.44 126.12 59.35 Favored Pre-proline 0 N--CA 1.43 -1.459 1 O-C-N 115.738 -4.39 . . . . 2.07 109.192 -179.448 . . . . . . . . 2 2 . 1 . 138 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -54.37 129.28 33.86 Favored 'Trans proline' 0 C--N 1.299 -2.035 1 C-N-CA 125.611 4.207 . . . . 1.39 116.274 175.674 . . . . . . . . 3 3 . 1 . 138 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -59.96 -14.24 26.87 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 CA-C-N 124.324 2.58 . . . . 1.68 116.511 -173.38 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -65.28 -21.92 66.79 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 128.826 2.851 . . . . 2.25 118.581 170.608 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -102.41 -9.4 20.32 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-O 116.406 -1.759 . . . . 2.44 108.715 -172.712 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -89.38 133.49 34.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.742 2.417 . . . . 1.32 114.993 -170.39 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -132.96 145.09 50.58 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.435 2.064 . . . . 3.19 106.906 169.621 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.5 mt -122.15 143.45 49.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.414 -2.054 . . . . 1.75 114.616 -177.992 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.5 mt -118.83 129.5 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 130.166 3.386 . . . . 1.98 108.887 -179.699 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -130.28 127.3 39.25 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.199 1.8 . . . . 1.94 109.816 167.641 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.85 12.8 0.93 Allowed 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.212 2.301 . . . . 1.67 117.212 -178.379 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.49 0.19 29.35 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 118.136 -2.852 . . . . 1.3 116.837 -174.388 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.307 64.5 mttt -114.62 137.18 52.2 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.748 1.737 . . . . 2.89 114.622 179.671 . . . . . . . . 2 2 . 1 . 138 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -86.01 138.5 31.92 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 117.188 -1.805 . . . . 2.89 107.845 174.192 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.7 mt -88.98 138.74 31.13 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.151 2.278 . . . . 1.34 117.151 -171.654 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -73.11 147.71 44.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 124.107 0.879 . . . . 1.94 113.356 169.932 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.72 -53.96 13.61 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.473 -2.017 . . . . 1.56 111.731 -168.532 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.87 44.1 2.93 Favored Glycine 0 N--CA 1.431 -1.666 0 O-C-N 126.702 2.501 . . . . 0.97 115.372 172.121 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.433 ' O ' HD11 ' A' ' 23' ' ' ILE . 18.0 mmt180 -116.91 165.37 13.41 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 125.43 2.538 . . . . 3.07 104.447 163.616 . . . . . . . . 2 2 . 1 . 138 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.9 p -96.66 163.76 12.88 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 112.89 -1.959 . . . . 1.34 110.605 172.873 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.2 mt -57.39 -40.43 78.2 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 127.345 2.258 . . . . 1.63 111.161 170.518 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.9 t -64.92 -40.94 95.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 126.646 2.466 . . . . 1.51 114.374 -179.174 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -56.0 -40.83 73.93 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.124 -3.485 . . . . 1.9 119.409 176.822 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -84.91 3.82 36.36 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 112.882 -1.963 . . . . 0.97 110.938 170.851 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.421 26.4 m120 62.49 38.64 12.5 Favored 'General case' 0 N--CA 1.43 -1.454 1 N-CA-C 121.957 4.058 . . . . 2.35 121.957 -174.382 . . . . . . . . 3 2 . 1 . 138 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.1 mt -93.65 123.65 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 117.281 -3.387 . . . . 1.39 109.107 -175.044 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -107.69 -172.48 2.08 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.178 1.353 . . . . 2.58 111.009 -172.577 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -56.16 144.35 29.91 Favored 'General case' 0 N--CA 1.428 -1.526 0 O-C-N 126.65 2.469 . . . . 2.58 113.658 168.315 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.294 35.5 mt-10 57.23 32.34 21.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.525 3.13 . . . . 1.71 117.052 173.226 . . . . . . . . 2 2 . 1 . 138 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 t -96.14 133.86 39.91 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.719 3.208 . . . . 1.34 109.996 -174.237 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.15 116.57 21.12 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 118.119 2.637 . . . . 1.36 118.119 177.344 . . . . . . . . 2 2 . 1 . 138 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.263 54.3 mt -101.46 140.24 36.03 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.847 -3.033 . . . . 2.03 106.291 173.542 . . . . . . . . 2 2 . 1 . 138 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -104.14 121.22 42.78 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 116.081 -1.914 . . . . 2.31 110.934 -174.556 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.3 tp -89.89 128.52 36.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.869 1.795 . . . . 1.72 115.365 178.48 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.4 m -127.09 151.71 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 1 CA-C-O 128.827 4.156 . . . . 1.8 104.86 176.778 . . . . . . . . 2 2 . 1 . 138 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.8 mt -115.51 141.88 47.46 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 116.188 -4.07 . . . . 3.26 111.481 -167.571 . . . . . . . . 2 2 . 1 . 138 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -77.27 168.0 20.77 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 115.359 -4.588 . . . . 4.12 118.022 174.012 . . . . . . . . 2 2 . 1 . 138 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.8 mt -97.6 -175.03 3.07 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 118.637 -2.539 . . . . 3.54 106.818 167.006 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -70.81 -55.45 8.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 114.971 -2.442 . . . . 7.32 114.058 -179.545 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.72 88.58 0.2 Allowed Glycine 0 N--CA 1.429 -1.779 0 O-C-N 126.702 2.501 . . . . 3.73 108.835 -172.493 . . . . . . . . 1 1 . 1 . 138 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.782 0 C-N-CA 130.456 3.884 . . . . 3.87 111.456 179.979 . . . . . . . . 0 0 . 1 . 139 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.294 45.1 ttp . . . . . 0 CA--C 1.491 -1.327 0 N-CA-C 113.749 1.018 . . . . 1.39 113.749 . . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -100.73 123.47 44.98 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 119.491 -0.883 . . . . 2.2 111.541 -177.499 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 pt -120.93 163.65 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.311 -0.996 . . . . 1.32 108.311 174.258 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -119.95 143.03 48.22 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 130.937 3.695 . . . . 2.2 109.738 -177.924 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.298 43.5 t -116.84 115.07 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 116.915 -3.616 . . . . 1.23 113.651 171.734 . . . . . . . . 2 2 . 1 . 139 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -95.53 143.8 26.54 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 115.949 -1.977 . . . . 2.51 108.374 -176.54 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.7 p -101.37 179.75 4.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 126.748 3.166 . . . . 1.41 112.213 173.058 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.3 mt -79.77 -10.42 59.78 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 111.607 -6.933 . . . . 2.95 115.062 173.218 . . . . . . . . 2 2 . 1 . 139 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.257 28.8 p -86.51 -51.64 6.06 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 126.321 2.962 . . . . 2.52 110.914 178.002 . . . . . . . . 2 2 . 1 . 139 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.7 -2.19 0.45 Allowed Glycine 0 N--CA 1.43 -1.705 0 O-C-N 118.198 -2.814 . . . . 1.5 112.343 177.891 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -78.19 142.58 37.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 123.078 3.439 . . . . 1.79 110.672 -179.627 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.6 m -107.95 132.88 53.03 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 123.863 1.792 . . . . 1.38 107.503 171.797 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -109.93 149.16 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 102.454 -3.165 . . . . 2.03 102.454 177.212 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.3 m -123.4 125.11 44.37 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.487 -3.883 . . . . 1.61 100.645 -177.256 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -126.51 159.11 34.35 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.357 2.263 . . . . 2.15 106.011 176.244 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -120.92 125.91 48.65 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.939 3.295 . . . . 1.98 108.576 169.839 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 m -132.28 158.41 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 129.843 3.257 . . . . 1.52 105.315 -173.059 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -114.38 141.13 26.03 Favored Pre-proline 0 N--CA 1.429 -1.476 0 N-CA-C 102.409 -3.182 . . . . 2.35 102.409 167.365 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -61.96 -7.52 9.83 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 C-N-CA 124.511 3.474 . . . . 1.31 116.169 -171.295 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 p -73.36 -14.71 61.33 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.161 2.984 . . . . 1.71 112.104 172.977 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -75.34 145.36 41.79 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 117.354 -3.341 . . . . 1.69 111.652 179.538 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 60.9 p -89.83 179.19 6.05 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.875 -1.141 . . . . 1.33 113.477 178.31 . . . . . . . . 2 2 . 1 . 139 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.3 mm -79.67 -22.59 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 121.289 1.859 . . . . 1.32 107.162 175.453 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -70.83 -31.4 68.12 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.052 2.141 . . . . 1.62 110.499 170.233 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -77.18 -35.42 55.84 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.65 2.38 . . . . 2.13 111.788 173.493 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.0 t -55.44 -55.11 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-N 123.819 3.009 . . . . 1.23 112.32 167.043 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -50.44 -39.2 47.03 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 126.298 2.249 . . . . 1.97 116.078 173.939 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.83 -35.82 80.94 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.075 1.75 . . . . 1.19 111.139 173.499 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -74.54 -22.8 58.83 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 115.825 -2.35 . . . . 1.92 111.429 174.062 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.287 55.5 mt -70.96 -30.48 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.389 -2.07 . . . . 1.94 111.931 171.572 . . . . . . . . 2 2 . 1 . 139 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -65.4 -38.09 88.91 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.768 -1.56 . . . . 1.9 110.306 175.481 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.57 -59.9 2.8 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 115.22 -4.675 . . . . 1.55 112.497 168.951 . . . . . . . . 2 2 . 1 . 139 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -60.75 -58.4 8.61 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.767 1.627 . . . . 2.95 112.367 -172.737 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -95.34 -56.21 2.79 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.917 -2.364 . . . . 1.48 109.611 -170.542 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.94 4.48 7.22 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 105.146 -3.182 . . . . 1.12 105.146 176.779 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mt -74.16 129.51 84.35 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 114.32 -2.753 . . . . 2.07 105.826 -173.878 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -70.58 154.23 64.62 Favored 'Trans proline' 0 N--CA 1.434 -2.009 0 C-N-CA 115.388 -2.608 . . . . 1.39 116.888 178.006 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.59 -4.88 13.83 Favored 'Trans proline' 0 C--N 1.3 -2.015 1 C-N-CA 125.544 4.162 . . . . 1.68 108.068 -172.647 . . . . . . . . 2 2 . 1 . 139 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -77.45 -40.09 44.46 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 125.669 3.849 . . . . 2.25 111.55 169.334 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -60.07 -28.62 67.95 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.668 2.47 . . . . 2.44 117.668 -178.981 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -89.47 151.77 21.82 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.182 1.944 . . . . 1.32 115.396 -178.223 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.28 83.9 mtt180 -135.8 139.8 43.77 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 101.258 -3.608 . . . . 3.19 101.258 170.104 . . . . . . . . 2 2 . 1 . 139 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 39.0 mt -122.14 128.6 51.46 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 124.67 3.396 . . . . 1.75 105.793 -178.682 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 mm -119.06 139.02 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 114.704 -2.57 . . . . 1.98 107.57 -178.888 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -131.53 126.51 35.09 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 115.921 -1.99 . . . . 1.94 106.358 171.964 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 82.23 -71.95 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 126.874 2.609 . . . . 1.67 106.188 -177.83 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.18 -26.57 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.659 0 C-N-CA 126.112 1.815 . . . . 1.3 114.206 -171.491 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -85.55 160.35 19.68 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.241 1.941 . . . . 2.89 116.241 172.809 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.277 49.2 tt0 -90.76 137.43 32.36 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.24 3.052 . . . . 2.89 119.24 170.324 . . . . . . . . 2 2 . 1 . 139 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.0 mt -94.45 127.73 40.55 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.082 -3.511 . . . . 1.34 109.274 -169.472 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -75.9 158.81 31.61 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 118.225 2.676 . . . . 1.94 118.225 179.885 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -63.44 -59.82 4.16 Favored 'General case' 0 N--CA 1.43 -1.473 1 N-CA-C 122.879 4.4 . . . . 1.56 122.879 -168.018 . . . . . . . . 2 2 . 1 . 139 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.44 23.51 8.44 Favored Glycine 0 N--CA 1.429 -1.795 0 CA-C-O 116.094 -2.503 . . . . 0.97 113.836 178.75 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -98.22 154.19 17.95 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 122.787 3.294 . . . . 3.07 109.106 168.35 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 31.1 p -85.7 177.3 7.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.873 -2.392 . . . . 1.34 115.591 171.356 . . . . . . . . 2 2 . 1 . 139 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.27 -40.89 90.41 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 111.667 -2.515 . . . . 1.63 111.297 173.225 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.4 m -70.9 -25.79 62.94 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.567 3.547 . . . . 1.51 112.307 178.435 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -66.69 -55.6 14.43 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 120.762 1.619 . . . . 1.9 113.182 170.773 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -75.42 3.69 8.72 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 120.544 3.535 . . . . 0.97 120.544 173.685 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 54.43 46.78 24.3 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.023 -2.298 . . . . 2.35 117.011 178.704 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.4 mt -97.06 103.92 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 104.867 -2.271 . . . . 1.39 104.867 -179.556 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -104.67 -172.79 2.16 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 125.4 2.524 . . . . 2.58 109.296 -172.862 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -53.5 139.82 30.0 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.127 -2.858 . . . . 2.58 112.958 -179.863 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.374 30.7 mt-10 59.77 21.9 10.74 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 130.945 3.698 . . . . 1.71 113.871 -179.057 . . . . . . . . 2 2 . 1 . 139 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.11 143.32 27.14 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.152 1.908 . . . . 1.34 116.152 -176.989 . . . . . . . . 2 2 . 1 . 139 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.7 m -106.67 121.08 43.64 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 123.769 0.668 . . . . 1.36 112.552 -171.441 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.2 mt -95.41 164.64 12.73 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 106.694 -1.595 . . . . 2.03 106.694 173.063 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -115.48 116.64 28.54 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.486 1.915 . . . . 2.31 110.733 -179.58 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.5 tp -92.76 125.6 37.45 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.682 1.706 . . . . 1.72 112.889 179.683 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.1 t -120.08 126.08 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 101.89 -3.374 . . . . 1.8 101.89 178.252 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.8 mt -101.85 153.85 19.46 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 126.229 2.918 . . . . 3.26 113.709 178.394 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -91.75 125.06 36.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.183 -2.198 . . . . 4.12 108.217 177.421 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.2 tp -120.01 -37.94 3.02 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 129.174 4.046 . . . . 3.54 111.246 170.205 . . . . . . . . 2 2 . 1 . 139 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.313 24.1 mtm-85 -107.43 -97.98 0.36 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.697 -1.223 . . . . 7.32 107.697 171.283 . . . . . . . . 2 2 . 1 . 139 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.2 123.69 0.78 Allowed Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 104.785 -3.326 . . . . 3.73 104.785 -161.392 . . . . . . . . 1 1 . 1 . 139 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.793 0 N-CA-C 105.098 -3.201 . . . . 3.87 105.098 -179.081 . . . . . . . . 0 0 . 1 . 140 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptt? . . . . . 0 CA--C 1.49 -1.355 0 N-CA-C 118.619 2.822 . . . . 1.39 118.619 . . . . . . . . . 0 0 . 1 . 140 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -85.78 146.83 26.6 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 117.823 -1.551 . . . . 2.2 110.191 179.722 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.2 pt -140.76 158.41 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 101.07 -3.678 . . . . 1.32 101.07 175.722 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -112.15 115.89 29.58 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 113.619 -1.628 . . . . 2.2 111.047 -176.816 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -85.84 113.69 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 118.942 -2.349 . . . . 1.23 107.749 171.594 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -104.06 122.23 44.85 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.13 -3.481 . . . . 2.51 111.868 177.688 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.448 HG23 HD23 ' A' ' 69' ' ' LEU . 27.2 p -83.47 158.05 22.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 123.481 1.61 . . . . 1.41 112.902 174.767 . . . . . . . . 2 2 . 1 . 140 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.6 mt -88.52 -23.92 23.06 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.606 -4.434 . . . . 2.95 109.173 176.36 . . . . . . . . 2 2 . 1 . 140 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -61.37 -37.89 85.0 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.199 -3.438 . . . . 2.52 110.699 174.415 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.23 -58.09 0.38 Allowed Glycine 0 N--CA 1.43 -1.76 0 O-C-N 121.75 -0.594 . . . . 1.5 112.896 176.272 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.261 19.3 ptmt -61.69 150.34 36.93 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.567 -3.314 . . . . 1.79 116.312 -170.675 . . . . . . . . 2 2 . 1 . 140 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.3 m -114.66 123.55 49.57 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.488 1.515 . . . . 1.38 108.237 169.811 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.2 mt -114.41 126.97 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.211 -3.43 . . . . 2.03 110.821 179.766 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.6 m -89.49 109.81 20.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.611 -2.556 . . . . 1.61 108.514 -177.256 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -107.12 157.51 17.8 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.92 -1.881 . . . . 2.15 105.92 179.629 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -106.68 133.6 51.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.069 1.748 . . . . 1.98 108.296 171.199 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.1 m -145.23 160.81 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 117.274 -1.346 . . . . 1.52 107.881 -178.484 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -95.98 155.59 38.12 Favored Pre-proline 0 N--CA 1.43 -1.462 0 N-CA-C 106.225 -1.768 . . . . 2.35 106.225 168.308 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.265 39.7 Cg_exo -66.28 -13.99 42.27 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 123.129 2.552 . . . . 1.31 115.456 -176.371 . . . . . . . . 2 2 . 1 . 140 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -111.2 25.59 11.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 122.658 1.218 . . . . 1.71 108.538 -179.751 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -84.17 137.14 33.67 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 116.841 -3.662 . . . . 1.69 104.613 174.388 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.335 80.4 p -67.05 165.21 16.2 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 117.773 2.509 . . . . 1.33 117.773 176.627 . . . . . . . . 3 3 . 1 . 140 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.2 mm -67.95 -38.05 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 116.966 -3.584 . . . . 1.32 109.517 175.269 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -46.87 -42.21 17.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 128.651 2.781 . . . . 1.62 113.688 168.596 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -80.08 -29.13 39.05 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.449 -2.657 . . . . 2.13 110.771 -178.268 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.274 12.0 t -67.81 -41.15 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 119.764 -1.835 . . . . 1.23 113.239 167.606 . . . . . . . . 2 2 . 1 . 140 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -65.04 -26.5 68.29 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.552 -2.593 . . . . 1.97 116.463 170.771 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.23 -31.2 68.51 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.429 -3.294 . . . . 1.19 112.51 172.184 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -73.45 -37.31 65.86 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 123.686 0.616 . . . . 1.92 111.651 174.584 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.5 mt -65.3 -35.09 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-O 124.442 2.068 . . . . 1.94 112.064 175.322 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -61.45 -41.82 97.8 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.045 3.738 . . . . 1.9 112.493 -178.783 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -68.47 -32.74 72.96 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 126.759 2.537 . . . . 1.55 115.347 167.943 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -79.13 -60.09 2.51 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 119.17 0.896 . . . . 2.95 112.497 -179.415 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -102.71 -20.84 14.22 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 118.246 -2.784 . . . . 1.48 112.545 -167.388 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.2 30.49 10.9 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 117.59 -2.243 . . . . 1.12 112.643 178.73 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.8 mt -109.56 111.49 59.34 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 116.544 -1.694 . . . . 2.07 108.435 -178.589 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -61.77 153.1 70.04 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 122.973 2.449 . . . . 1.39 113.362 179.816 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -70.96 -15.14 32.63 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-N 126.631 3.404 . . . . 1.68 118.961 -177.005 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -51.83 -46.0 64.17 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 126.301 2.251 . . . . 2.25 113.784 170.48 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -76.97 -5.43 48.58 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 116.988 -1.482 . . . . 2.44 111.424 -177.701 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -99.26 126.42 45.09 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 120.013 1.279 . . . . 1.32 109.842 -172.374 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -116.8 130.84 56.96 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 128.626 2.77 . . . . 3.19 104.443 164.508 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -107.54 132.43 53.26 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.309 -2.744 . . . . 1.75 111.669 173.74 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 49' ' ' GLN . 29.4 mm -109.63 141.96 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 119.881 -1.762 . . . . 1.98 108.74 179.556 . . . . . . . . 2 2 . 1 . 140 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -140.7 117.66 11.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.575 -1.268 . . . . 1.94 107.575 170.636 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.377 . . 72.98 -44.19 0.59 Allowed 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 129.594 3.157 . . . . 1.67 112.048 -175.827 . . . . . . . . 2 2 . 1 . 140 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 173.38 -42.45 0.15 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 128.039 2.733 . . . . 1.3 115.253 -171.947 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -74.13 157.5 35.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 118.584 -1.246 . . . . 2.89 110.262 178.663 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.41 ' HA ' HD12 ' A' ' 44' ' ' ILE . 53.5 mt-30 -87.58 143.59 27.12 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 126.319 1.848 . . . . 2.89 110.283 176.273 . . . . . . . . 2 2 . 1 . 140 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.3 mt -93.64 151.79 19.43 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 116.288 -4.008 . . . . 1.34 112.216 -176.655 . . . . . . . . 2 2 . 1 . 140 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -93.49 147.66 22.77 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 104.403 -2.443 . . . . 1.94 104.403 174.05 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -66.37 -52.68 44.39 Favored 'General case' 0 N--CA 1.43 -1.426 1 CA-C-O 128.599 4.047 . . . . 1.56 116.194 -170.938 . . . . . . . . 2 2 . 1 . 140 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.61 48.34 3.66 Favored Glycine 0 N--CA 1.43 -1.743 1 O-C-N 114.511 -5.118 . . . . 0.97 111.838 173.962 . . . . . . . . 2 2 . 1 . 140 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -130.67 161.84 30.74 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.547 -2.737 . . . . 3.07 105.742 162.071 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 14.0 p -95.7 179.72 5.02 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 117.036 -1.866 . . . . 1.34 110.076 -173.174 . . . . . . . . 2 2 . 1 . 140 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.9 mt -72.24 -41.68 66.54 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 116.783 -1.579 . . . . 1.63 113.082 172.378 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 t -68.34 -11.96 60.34 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 121.769 2.077 . . . . 1.51 114.869 172.617 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -79.92 -29.44 39.77 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 125.445 3.748 . . . . 1.9 110.405 177.826 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -90.68 -6.04 55.02 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.056 -3.528 . . . . 0.97 112.304 174.258 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 75.7 34.19 0.59 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.684 3.74 . . . . 2.35 113.174 175.889 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.7 mt -74.7 107.66 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 127.476 2.31 . . . . 1.39 111.917 175.685 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -84.74 178.51 7.62 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 126.728 2.517 . . . . 2.58 110.509 177.624 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -62.05 146.94 48.82 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 115.031 1.493 . . . . 2.58 115.031 172.451 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 64.29 39.41 7.32 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 122.827 1.299 . . . . 1.71 111.477 173.144 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 t -113.94 147.56 38.34 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.806 -1.543 . . . . 1.34 112.949 -173.806 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.2 m -93.96 130.14 40.18 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.726 -1.858 . . . . 1.36 113.777 178.446 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.7 mt -115.01 132.92 56.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.918 -1.882 . . . . 2.03 105.918 173.808 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -94.05 125.34 38.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.756 3.169 . . . . 2.31 111.278 -174.469 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.448 HD23 HG23 ' A' ' 7' ' ' THR . 11.8 tp -92.94 116.1 28.73 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 113.345 -5.847 . . . . 1.72 110.57 176.735 . . . . . . . . 3 3 . 1 . 140 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.0 t -111.77 126.03 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 128.474 2.709 . . . . 1.8 106.332 179.23 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mp -93.39 139.24 30.9 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.216 -2.802 . . . . 3.26 107.015 178.948 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -59.67 133.59 56.23 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 128.255 2.622 . . . . 4.12 116.549 -171.066 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.8 mt -102.88 160.08 14.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.032 -1.668 . . . . 3.54 106.836 168.125 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -124.36 140.7 52.71 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.173 -1.579 . . . . 7.32 111.798 168.07 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.86 40.81 1.05 Allowed Glycine 0 N--CA 1.429 -1.777 0 CA-C-O 114.372 -3.46 . . . . 3.73 107.386 -165.662 . . . . . . . . 1 1 . 1 . 140 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.812 0 C-N-CA 129.209 3.29 . . . . 3.87 115.133 -176.256 . . . . . . . . 0 0 . 1 . 141 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 ttp . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 123.405 1.574 . . . . 1.39 109.537 . . . . . . . . . 0 0 . 1 . 141 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -91.53 144.43 25.56 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.235 -4.666 . . . . 2.2 106.781 178.357 . . . . . . . . 2 2 . 1 . 141 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.3 pt -140.12 175.35 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 124.195 1.95 . . . . 1.32 106.974 169.008 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -116.29 143.54 45.4 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 104.736 -2.32 . . . . 2.2 104.736 176.557 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.92 117.74 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 1 O-C-N 129.425 4.203 . . . . 1.23 103.805 167.315 . . . . . . . . 2 2 . 1 . 141 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -105.75 141.3 37.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.411 -2.68 . . . . 2.51 114.13 173.582 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.1 p -84.25 171.34 12.83 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.35 -1.468 . . . . 1.41 112.658 177.058 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.258 13.1 tp -57.53 -44.09 84.84 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.754 2.822 . . . . 2.95 114.854 168.142 . . . . . . . . 2 2 . 1 . 141 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 p -75.83 -65.58 0.89 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.752 1.621 . . . . 2.52 112.844 -173.72 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.09 53.28 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.696 0 CA-C-O 117.574 -1.681 . . . . 1.5 116.585 175.599 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -128.6 124.52 36.07 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.29 -1.744 . . . . 1.79 106.29 -179.374 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.9 m -104.14 133.86 48.36 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 102.906 -2.998 . . . . 1.38 102.906 -178.778 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.8 mt -106.85 135.01 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 103.182 -2.896 . . . . 2.03 103.182 178.703 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.9 m -97.35 122.71 40.7 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.158 -2.214 . . . . 1.61 106.821 178.351 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.8 tp -129.02 124.18 34.28 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 117.217 2.303 . . . . 2.15 117.217 -175.379 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -79.86 124.63 28.82 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 117.166 -1.397 . . . . 1.98 107.443 174.47 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.0 m -134.77 177.57 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 128.668 2.787 . . . . 1.52 106.655 178.95 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -123.36 166.57 17.81 Favored Pre-proline 0 N--CA 1.43 -1.448 0 C-N-CA 127.187 2.195 . . . . 2.35 106.735 163.092 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -82.2 -17.31 7.95 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 122.915 2.41 . . . . 1.31 109.681 -174.37 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 m -90.35 5.19 48.4 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.255 -2.153 . . . . 1.71 110.318 178.156 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -84.2 158.55 21.26 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.112 -1.81 . . . . 1.69 106.112 177.324 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -92.78 163.94 13.54 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 123.579 1.657 . . . . 1.33 110.202 178.767 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mp -68.08 -34.82 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 127.272 3.415 . . . . 1.32 116.363 174.548 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -53.36 -44.07 68.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.724 -2.485 . . . . 1.62 117.59 161.699 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -66.37 -31.97 73.07 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.583 1.953 . . . . 2.13 109.801 175.847 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.51 -47.98 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 117.848 -3.032 . . . . 1.23 113.497 175.899 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.302 95.8 mttt -49.63 -40.82 40.64 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 130.275 3.43 . . . . 1.97 115.229 167.664 . . . . . . . . 2 2 . 1 . 141 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.89 -39.66 87.54 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.941 1.696 . . . . 1.19 113.494 177.923 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -66.03 -29.78 70.2 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 118.346 2.721 . . . . 1.92 118.346 167.929 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.1 mt -76.02 -33.65 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 118.496 -2.627 . . . . 1.94 114.827 171.841 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -69.6 -33.4 72.64 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.268 -1.333 . . . . 1.9 109.951 172.931 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.3 -59.54 4.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.078 1.751 . . . . 1.55 110.069 170.37 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -65.62 -60.52 2.83 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 130.463 3.505 . . . . 2.95 112.029 -168.478 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -102.85 -53.15 2.91 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.623 -3.173 . . . . 1.48 111.885 -175.521 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.05 38.02 0.4 Allowed Glycine 0 N--CA 1.43 -1.721 0 O-C-N 120.466 -1.396 . . . . 1.12 115.309 172.325 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.7 mt -110.24 126.43 28.95 Favored Pre-proline 0 N--CA 1.43 -1.435 0 C-N-CA 126.26 1.824 . . . . 2.07 108.695 -174.974 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.47 143.54 97.45 Favored 'Trans proline' 0 N--CA 1.434 -2.006 1 O-C-N 112.743 -4.398 . . . . 1.39 115.701 -178.411 . . . . . . . . 2 2 . 1 . 141 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -67.61 -14.15 41.17 Favored 'Trans proline' 0 N--CA 1.434 -2.029 0 N-CA-C 118.897 2.614 . . . . 1.68 118.897 -173.179 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -79.78 -36.71 36.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 125.37 1.669 . . . . 2.25 107.951 179.364 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -74.98 -30.2 61.12 Favored 'General case' 0 N--CA 1.431 -1.402 1 C-N-CA 133.634 4.773 . . . . 2.44 111.363 -169.035 . . . . . . . . 2 2 . 1 . 141 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -87.92 134.14 33.77 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.566 -2.584 . . . . 1.32 112.519 -173.41 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -112.71 142.84 44.86 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 116.74 -3.725 . . . . 3.19 107.012 168.408 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.3 mt -119.86 116.49 25.95 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 118.896 -2.378 . . . . 1.75 113.393 174.958 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.3 mt -88.87 137.01 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 127.875 2.47 . . . . 1.98 110.967 -178.901 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -154.9 131.18 10.36 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.685 2.184 . . . . 1.94 105.439 173.286 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.74 -64.75 0.1 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 119.395 3.109 . . . . 1.67 119.395 178.998 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -158.34 11.47 0.22 Allowed Glycine 0 N--CA 1.43 -1.703 0 CA-C-O 122.776 1.209 . . . . 1.3 112.914 177.835 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.5 pttt -144.94 177.23 8.9 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 111.964 -2.118 . . . . 2.89 111.486 -174.411 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -110.39 157.3 19.69 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.533 1.933 . . . . 2.89 108.707 171.982 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.6 mt -102.86 137.7 40.71 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 117.953 -1.022 . . . . 1.34 113.02 -173.837 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.506 ' HB2' ' HG2' ' A' ' 54' ' ' ARG . 49.8 mt-10 -75.44 141.82 43.09 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.89 2.876 . . . . 1.94 111.003 177.512 . . . . . . . . 2 2 . 1 . 141 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -69.21 -53.07 21.84 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 123.3 2.773 . . . . 1.56 116.005 -162.977 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.95 42.04 3.12 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 119.078 -2.264 . . . . 0.97 114.714 175.121 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.506 ' HG2' ' HB2' ' A' ' 51' ' ' GLU . 28.6 mmt180 -112.14 161.31 16.67 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 121.415 2.607 . . . . 3.07 104.142 166.766 . . . . . . . . 2 2 . 1 . 141 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.1 p -90.9 162.26 14.86 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 116.807 -3.683 . . . . 1.34 111.546 178.879 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.2 mt -63.86 -33.13 75.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.488 2.315 . . . . 1.63 110.573 169.566 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.5 p -63.57 -53.6 49.21 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.369 -2.707 . . . . 1.51 114.978 179.339 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -56.16 -34.19 65.92 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.424 -1.262 . . . . 1.9 114.385 173.875 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -82.01 -4.17 56.14 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.906 -1.121 . . . . 0.97 112.571 -176.896 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.261 19.4 m-80 58.42 41.89 22.13 Favored 'General case' 0 N--CA 1.431 -1.415 1 C-N-CA 133.043 4.537 . . . . 2.35 115.861 -174.418 . . . . . . . . 3 2 . 1 . 141 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.1 mt -85.32 122.51 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 117.607 -3.183 . . . . 1.39 112.576 178.188 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -97.54 -174.04 2.81 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 125.404 2.526 . . . . 2.58 113.251 -175.141 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -59.52 131.82 52.11 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 127.348 3.452 . . . . 2.58 116.702 170.82 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.308 13.6 mt-10 73.02 31.46 1.48 Allowed 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 127.04 3.305 . . . . 1.71 114.127 173.797 . . . . . . . . 2 2 . 1 . 141 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.5 m -88.84 160.98 16.97 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 118.523 -2.611 . . . . 1.34 108.68 -173.48 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.253 4.3 m -114.38 114.16 25.51 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 116.41 -3.931 . . . . 1.36 112.307 -178.424 . . . . . . . . 2 2 . 1 . 141 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.9 mt -93.87 128.24 40.05 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 129.909 3.284 . . . . 2.03 108.158 170.337 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -111.51 116.81 31.49 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 126.128 2.871 . . . . 2.31 115.184 -175.85 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.9 tp -84.53 116.98 23.42 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.852 -2.405 . . . . 1.72 113.852 -173.622 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.4 m -122.0 161.24 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 114.415 -1.266 . . . . 1.8 111.082 168.7 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.4 mt -92.14 170.09 10.1 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.055 -1.653 . . . . 3.26 107.598 178.981 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -119.51 144.87 46.79 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 101.061 -3.681 . . . . 4.12 101.061 -171.698 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.6 mt -104.34 171.51 7.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.414 -0.804 . . . . 3.54 109.186 176.993 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -83.21 117.72 23.12 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.101 -2.25 . . . . 7.32 116.228 177.236 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.55 80.99 0.17 Allowed Glycine 0 N--CA 1.429 -1.792 0 CA-C-O 116.454 -2.303 . . . . 3.73 113.278 -166.747 . . . . . . . . 1 1 . 1 . 141 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.789 0 CA-C-N 119.958 1.879 . . . . 3.87 112.402 174.861 . . . . . . . . 0 0 . 1 . 142 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 ptt? . . . . . 0 CA--C 1.489 -1.373 0 N-CA-C 113.809 1.04 . . . . 1.39 113.809 . . . . . . . . . 0 0 . 1 . 142 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -88.52 127.92 35.54 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.466 -1.396 . . . . 2.2 109.379 -176.449 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.8 pt -121.97 161.07 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 104.891 -2.262 . . . . 1.32 104.891 164.798 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -120.69 137.01 54.69 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.182 2.193 . . . . 2.2 106.865 176.449 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -119.07 125.31 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 128.281 2.632 . . . . 1.23 110.253 173.402 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -99.48 141.9 31.66 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.515 -1.991 . . . . 2.51 113.894 -178.215 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 p -102.19 175.63 5.46 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 121.165 1.802 . . . . 1.41 109.908 179.136 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.2 tp -44.6 -47.76 10.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.461 1.652 . . . . 2.95 115.461 167.996 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.8 p -80.55 -0.56 38.23 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 123.547 0.739 . . . . 2.52 112.401 -178.662 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.8 25.57 57.95 Favored Glycine 0 N--CA 1.43 -1.76 1 C-N-CA 134.18 5.657 . . . . 1.5 112.533 178.651 . . . . . . . . 2 2 . 1 . 142 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -71.01 127.1 31.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.862 -1.533 . . . . 1.79 106.862 -173.145 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.1 m -84.79 122.23 28.83 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 113.076 -3.45 . . . . 1.38 114.55 173.957 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.0 mt -98.99 119.64 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 105.323 -2.103 . . . . 2.03 105.323 173.086 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.5 m -90.63 111.47 22.81 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.312 2.258 . . . . 1.61 113.148 -178.986 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.0 mt -116.28 155.1 28.98 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 120.254 1.388 . . . . 2.15 111.45 -174.882 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -107.34 114.58 28.7 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 128.396 2.678 . . . . 1.98 105.134 172.377 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -124.68 164.12 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 118.185 -2.822 . . . . 1.52 106.831 179.117 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -102.84 147.84 34.68 Favored Pre-proline 0 N--CA 1.43 -1.453 1 C-N-CA 133.06 4.544 . . . . 2.35 114.308 159.792 . . . . . . . . 2 2 . 1 . 142 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -77.58 -12.67 16.72 Favored 'Trans proline' 0 C--N 1.3 -2.008 1 CA-C-N 129.347 4.374 . . . . 1.31 110.929 -166.521 . . . . . . . . 2 2 . 1 . 142 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 p -88.88 -0.51 57.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 115.311 -2.281 . . . . 1.71 113.295 178.342 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -74.31 149.67 40.54 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 125.276 1.61 . . . . 1.69 114.6 177.233 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.259 57.8 p -85.04 157.33 20.77 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 125.632 2.634 . . . . 1.33 110.153 -178.505 . . . . . . . . 2 2 . 1 . 142 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.3 mm -67.72 -32.03 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.492 -2.63 . . . . 1.32 109.783 175.665 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -61.89 -32.72 73.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.224 2.21 . . . . 1.62 116.096 165.086 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -81.17 -29.47 34.66 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 122.428 2.376 . . . . 2.13 113.162 176.023 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.8 -32.2 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.401 -1.333 . . . . 1.23 107.401 174.488 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HZ3' ' CG ' ' A' ' 52' ' ' ASP 0.319 48.8 mttt -51.69 -41.29 61.33 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 118.889 2.922 . . . . 1.97 118.889 172.95 . . . . . . . . 3 3 . 1 . 142 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.1 -40.73 59.11 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 117.512 2.412 . . . . 1.19 117.512 166.179 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -68.7 -48.99 62.47 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.405 2.526 . . . . 1.92 114.228 -178.933 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.415 ' H ' HG13 ' A' ' 30' ' ' ILE . 4.2 mt -54.74 -39.67 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 O-C-N 118.144 -2.848 . . . . 1.94 117.714 166.621 . . . . . . . . 2 2 . 1 . 142 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -68.52 -32.11 71.84 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.032 -2.917 . . . . 1.9 112.152 -179.801 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -59.93 -38.17 81.6 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.167 -2.833 . . . . 1.55 114.76 168.411 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -75.13 -66.24 0.78 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 127.586 2.354 . . . . 2.95 109.676 -178.761 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -106.41 -20.88 13.24 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 128.403 2.681 . . . . 1.48 111.824 -159.988 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.31 -2.27 70.89 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 121.773 3.469 . . . . 1.12 121.773 177.901 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.8 mt -68.93 129.37 92.34 Favored Pre-proline 0 N--CA 1.431 -1.41 0 C-N-CA 127.473 2.309 . . . . 2.07 113.561 -179.584 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.251 0.3 OUTLIER -72.52 143.74 38.97 Favored 'Trans proline' 0 C--N 1.299 -2.042 1 C-N-CA 125.496 4.131 . . . . 1.39 112.995 -173.285 . . . . . . . . 4 3 . 1 . 142 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.53 -11.95 33.79 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 121.813 1.683 . . . . 1.68 114.151 -178.53 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.48 -31.86 67.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.832 -1.168 . . . . 2.25 112.054 173.99 . . . . . . . . 2 2 . 1 . 142 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -96.88 -22.19 17.04 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 125.227 1.58 . . . . 2.44 113.903 -173.373 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -75.86 122.65 24.43 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 123.674 1.702 . . . . 1.32 111.921 178.705 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -121.99 143.76 49.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 117.721 -3.112 . . . . 3.19 106.134 168.653 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.45 150.53 29.73 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.181 -3.449 . . . . 1.75 110.999 178.972 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mt -129.69 140.04 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 N-CA-C 97.291 -5.077 . . . . 1.98 97.291 -179.583 . . . . . . . . 2 2 . 1 . 142 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -154.98 137.78 15.33 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.793 2.437 . . . . 1.94 105.448 169.492 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.406 . . 74.46 -49.52 0.67 Allowed 'General case' 0 N--CA 1.431 -1.385 1 C-N-CA 134.917 5.287 . . . . 1.67 115.425 178.999 . . . . . . . . 3 2 . 1 . 142 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -173.43 -23.92 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 106.095 -2.802 . . . . 1.3 106.095 -177.497 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -118.53 158.3 25.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.626 2.631 . . . . 2.89 113.281 -170.819 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -71.66 126.29 29.3 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.7 -1.963 . . . . 2.89 105.7 169.715 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.1 mt -82.97 141.66 31.96 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.861 2.464 . . . . 1.34 108.887 -175.962 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -81.42 152.69 27.3 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.491 -4.506 . . . . 1.94 106.589 171.889 . . . . . . . . 2 2 . 1 . 142 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.414 ' CG ' ' HZ3' ' A' ' 27' ' ' LYS . 11.9 m-20 -77.59 -57.22 3.93 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.287 -1.779 . . . . 1.56 111.654 -167.843 . . . . . . . . 2 2 . 1 . 142 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.34 17.59 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.752 0 CA-C-O 114.002 -3.666 . . . . 0.97 120.37 168.689 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -110.21 175.15 5.54 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 123.609 3.704 . . . . 3.07 105.122 176.307 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.0 p -102.41 171.9 7.19 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 128.242 3.877 . . . . 1.34 117.012 171.003 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.2 mt -65.32 -33.18 75.37 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 112.241 -2.254 . . . . 1.63 112.923 173.848 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 m -64.23 -36.25 83.47 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.142 2.645 . . . . 1.51 118.142 177.099 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -56.88 -42.89 80.62 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.493 2.717 . . . . 1.9 109.045 173.097 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -93.4 3.81 54.99 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.175 -3.453 . . . . 0.97 116.981 -177.905 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.321 69.9 m-80 71.48 29.96 2.58 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 125.936 2.779 . . . . 2.35 112.162 171.313 . . . . . . . . 2 2 . 1 . 142 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.3 mt -80.97 119.71 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 111.842 -2.436 . . . . 1.39 110.408 -178.071 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -115.59 -176.58 2.96 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.324 -3.36 . . . . 2.58 107.322 -173.386 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -64.2 153.49 37.79 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 117.728 -3.108 . . . . 2.58 117.433 177.322 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 64.0 20.27 12.12 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 130.506 3.522 . . . . 1.71 113.157 168.578 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.2 m -88.79 160.28 17.35 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 115.356 -2.259 . . . . 1.34 113.69 -172.286 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.0 m -101.92 95.93 6.71 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 115.573 -2.156 . . . . 1.36 111.163 -172.389 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -91.4 163.38 14.21 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 124.355 3.252 . . . . 2.03 106.819 179.373 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -123.04 152.31 41.1 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 124.584 2.135 . . . . 2.31 113.465 -178.173 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.6 tp -127.93 136.96 52.06 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.888 -1.758 . . . . 1.72 108.393 -176.694 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.4 m -135.14 156.76 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 104.003 -2.592 . . . . 1.8 104.003 178.94 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.3 mt -100.95 108.95 20.82 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.928 1.347 . . . . 3.26 113.71 179.357 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.97 88.17 6.85 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.226 2.21 . . . . 4.12 106.935 -179.247 . . . . . . . . 2 2 . 1 . 142 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.3 mt -105.04 -83.8 0.5 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.59 -1.633 . . . . 3.54 106.59 176.143 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 50.8 ttm-85 -145.28 -61.2 0.35 Allowed 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 125.928 1.691 . . . . 7.32 111.181 176.459 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.67 90.69 1.11 Allowed Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.268 -1.933 . . . . 3.73 108.268 -167.443 . . . . . . . . 1 1 . 1 . 142 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.757 0 CA-C-N 120.949 2.375 . . . . 3.87 107.809 -176.995 . . . . . . . . 0 0 . 1 . 143 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.368 0 N-CA-C 112.64 0.608 . . . . 1.39 112.64 . . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.04 146.72 23.51 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.8 -1.813 . . . . 2.2 110.467 179.078 . . . . . . . . 2 2 . 1 . 143 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 pt -127.99 170.03 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 103.997 -2.594 . . . . 1.32 103.997 168.147 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -124.28 142.22 51.43 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.505 -3.247 . . . . 2.2 106.327 -178.809 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.1 t -130.79 118.98 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-O 116.953 -1.499 . . . . 1.23 107.211 179.741 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -97.29 133.3 42.1 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 125.957 2.036 . . . . 2.51 112.782 176.859 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.9 p -74.29 -161.78 0.13 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.527 -2.608 . . . . 1.41 117.697 171.665 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.5 mt -71.0 -63.95 1.0 Allowed 'General case' 0 N--CA 1.429 -1.492 2 C-N-CA 134.428 5.091 . . . . 2.95 113.111 174.606 . . . . . . . . 2 2 . 1 . 143 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.5 p -69.09 -47.18 65.88 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 118.921 -2.362 . . . . 2.52 116.31 -176.405 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.06 1.22 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 121.594 3.398 . . . . 1.5 121.594 177.458 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.454 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 73.2 tttt -86.47 126.21 34.26 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 118.51 -2.759 . . . . 1.79 111.103 -173.494 . . . . . . . . 2 2 . 1 . 143 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.259 80.1 m -102.89 116.84 33.33 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 105.101 -2.185 . . . . 1.38 105.101 174.947 . . . . . . . . 2 2 . 1 . 143 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.5 pt -99.68 148.94 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 122.543 1.163 . . . . 2.03 111.101 173.102 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.251 37.5 m -106.66 101.97 11.38 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 127.05 2.14 . . . . 1.61 109.161 178.147 . . . . . . . . 2 2 . 1 . 143 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.6 mt -96.98 140.26 31.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 113.809 1.04 . . . . 2.15 113.809 179.376 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -104.13 130.92 51.87 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 126.247 2.927 . . . . 1.98 110.96 172.643 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.6 m -135.24 158.92 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 118.292 -2.755 . . . . 1.52 110.096 -169.49 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -103.93 147.0 33.61 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 106.337 -1.727 . . . . 2.35 106.337 160.397 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.364 43.9 Cg_endo -72.07 -0.89 9.21 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 124.937 2.799 . . . . 1.31 117.548 -176.554 . . . . . . . . 2 2 . 1 . 143 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.6 p -108.59 2.06 21.8 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.792 2.437 . . . . 1.71 106.146 -176.2 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.76 139.96 43.71 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 119.815 1.189 . . . . 1.69 113.514 171.393 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.8 p -79.11 167.36 21.15 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.227 2.441 . . . . 1.33 106.74 -179.046 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.2 mm -66.68 -33.6 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 115.358 -2.258 . . . . 1.32 111.104 176.624 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -54.46 -46.43 73.32 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 126.01 2.069 . . . . 1.62 111.79 171.593 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -70.24 -42.11 72.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 112.877 -3.44 . . . . 2.13 115.278 174.825 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.1 t -52.47 -32.76 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 122.266 2.303 . . . . 1.23 112.894 168.71 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -73.11 -31.49 64.36 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.407 -3.308 . . . . 1.97 113.447 178.454 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.27 -33.81 75.34 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.282 1.433 . . . . 1.19 110.683 167.432 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -73.23 -34.8 66.1 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.119 -4.113 . . . . 1.92 113.55 176.563 . . . . . . . . 2 2 . 1 . 143 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 99.6 mt -67.75 -31.02 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 127.777 2.431 . . . . 1.94 106.252 172.638 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -39.36 80.02 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 120.468 1.485 . . . . 1.9 114.014 174.214 . . . . . . . . 2 2 . 1 . 143 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -69.79 -47.12 64.06 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 116.77 -1.586 . . . . 1.55 108.846 175.633 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -75.82 -56.38 4.73 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 125.827 1.651 . . . . 2.95 114.237 -174.442 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.454 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 27.1 mm-40 -103.3 -25.09 13.45 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 117.428 -3.295 . . . . 1.48 110.603 -165.045 . . . . . . . . 2 2 . 1 . 143 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.41 32.95 8.98 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 115.769 -2.684 . . . . 1.12 111.796 -179.893 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mt -110.44 123.1 36.67 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 113.016 -3.373 . . . . 2.07 105.881 -176.403 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -62.16 144.82 96.23 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 124.072 3.181 . . . . 1.39 117.805 177.196 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -72.75 -2.04 11.29 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 123.821 3.014 . . . . 1.68 116.134 -170.193 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -73.06 -43.64 61.67 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.686 2.394 . . . . 2.25 109.276 169.076 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.292 31.1 mt-30 -66.35 -55.57 15.29 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.179 -1.576 . . . . 2.44 110.915 -172.667 . . . . . . . . 2 2 . 1 . 143 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.408 70.7 mt-30 -63.89 130.18 43.08 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 128.919 2.888 . . . . 1.32 112.595 -175.874 . . . . . . . . 2 2 . 1 . 143 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.43 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 13.2 tpp180 -120.31 115.63 23.95 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 103.25 -2.87 . . . . 3.19 103.25 174.026 . . . . . . . . 2 2 . 1 . 143 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.2 mt -97.91 142.52 29.54 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.317 -1.734 . . . . 1.75 106.317 179.557 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.7 mt -136.85 144.88 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 100.597 -3.853 . . . . 1.98 100.597 177.291 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -127.9 104.8 8.01 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 124.389 2.042 . . . . 1.94 106.944 173.736 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.3 . . 71.27 -75.28 0.08 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 112.454 -2.157 . . . . 1.67 113.747 -179.694 . . . . . . . . 2 2 . 1 . 143 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.75 -17.48 1.06 Allowed Glycine 0 N--CA 1.43 -1.71 0 CA-C-O 114.351 -3.472 . . . . 1.3 113.844 174.787 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -96.64 131.3 43.44 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 105.914 -1.884 . . . . 2.89 105.914 -174.378 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -83.28 132.51 35.03 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 131.369 3.867 . . . . 2.89 105.226 172.56 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.286 56.1 mt -85.93 146.37 26.73 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 115.585 -2.15 . . . . 1.34 105.782 -170.556 . . . . . . . . 2 2 . 1 . 143 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.467 ' HB2' ' HG2' ' A' ' 54' ' ' ARG . 45.0 mt-10 -109.15 165.29 11.72 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 125.631 3.832 . . . . 1.94 104.433 169.919 . . . . . . . . 2 2 . 1 . 143 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -76.77 -44.3 33.49 Favored 'General case' 0 N--CA 1.43 -1.434 2 C-N-CA 133.1 4.56 . . . . 1.56 122.423 -171.444 . . . . . . . . 2 2 . 1 . 143 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.68 43.13 2.76 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 126.428 1.966 . . . . 0.97 113.487 169.404 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.467 ' HG2' ' HB2' ' A' ' 51' ' ' GLU . 32.5 mmt180 -122.18 152.91 39.46 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.444 2.297 . . . . 3.07 111.231 170.491 . . . . . . . . 2 2 . 1 . 143 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.6 p -95.91 168.68 10.49 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 127.899 3.249 . . . . 1.34 112.221 177.934 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.3 mt -69.95 -33.12 71.69 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 116.735 -3.728 . . . . 1.63 109.837 176.952 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.2 t -68.86 -36.59 78.32 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.435 -3.29 . . . . 1.51 112.213 178.753 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -51.59 -49.5 62.0 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.233 -2.792 . . . . 1.9 112.504 176.391 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -87.53 -4.95 58.97 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 115.785 -4.322 . . . . 0.97 111.087 -179.163 . . . . . . . . 2 2 . 1 . 143 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.3 t30 54.26 53.45 10.93 Favored 'General case' 0 N--CA 1.43 -1.467 1 C-N-CA 132.597 4.359 . . . . 2.35 117.392 176.754 . . . . . . . . 2 2 . 1 . 143 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.0 mt -73.42 126.18 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 126.783 3.182 . . . . 1.39 112.559 -175.617 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -92.66 171.34 9.07 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 114.884 -4.885 . . . . 2.58 114.182 -176.603 . . . . . . . . 2 2 . 1 . 143 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -64.09 143.26 58.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 118.27 -2.769 . . . . 2.58 109.048 174.727 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 55.92 19.2 3.44 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 118.389 2.737 . . . . 1.71 118.389 -178.593 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -74.96 147.32 40.97 Favored 'General case' 0 N--CA 1.428 -1.54 0 O-C-N 120.028 -1.67 . . . . 1.34 106.941 -173.947 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.7 m -93.41 113.28 25.39 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.628 -1.92 . . . . 1.36 106.425 -176.981 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 mp -110.59 156.69 20.59 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 123.125 2.693 . . . . 2.03 104.041 175.558 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -106.35 144.14 33.46 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.136 -2.852 . . . . 2.31 110.155 -179.622 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.6 tp -128.01 115.9 19.21 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 102.947 -2.983 . . . . 1.72 102.947 179.369 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 3.9 t -93.89 138.22 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 119.18 -2.2 . . . . 1.8 106.218 177.334 . . . . . . . . 2 2 . 1 . 143 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.4 mt -128.47 127.38 42.36 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.814 1.768 . . . . 3.26 113.51 -175.474 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.4 ttt85 -96.66 137.01 36.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 131.133 3.773 . . . . 4.12 103.301 178.236 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.0 mt -98.32 157.13 16.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 112.039 -2.346 . . . . 3.54 112.28 173.651 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.5 mtm180 -96.2 -37.24 10.64 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.196 -2.815 . . . . 7.32 108.596 173.725 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.96 -96.31 0.14 Allowed Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 119.226 -1.464 . . . . 3.73 110.282 -164.994 . . . . . . . . 1 1 . 1 . 143 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.748 0 C-N-CA 129.904 3.621 . . . . 3.87 112.081 -179.064 . . . . . . . . 0 0 . 1 . 144 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 CA--C 1.489 -1.375 0 CA-C-O 123.218 1.485 . . . . 1.39 110.811 . . . . . . . . . 0 0 . 1 . 144 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -100.93 94.17 5.89 Favored 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 115.028 -4.795 . . . . 2.2 106.864 -173.984 . . . . . . . . 2 2 . 1 . 144 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.266 18.9 pt -85.35 149.84 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 1 O-C-N 129.244 4.09 . . . . 1.32 114.227 172.913 . . . . . . . . 3 2 . 1 . 144 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -107.75 108.13 19.21 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.09 2.556 . . . . 2.2 114.707 -179.358 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -94.55 116.27 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-N 119.91 1.232 . . . . 1.23 110.073 176.232 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -95.74 129.86 42.83 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 124.941 2.305 . . . . 2.51 110.232 176.357 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.0 p -74.03 -173.78 1.7 Allowed 'General case' 0 N--CA 1.431 -1.393 1 O-C-N 114.808 -4.932 . . . . 1.41 112.829 166.486 . . . . . . . . 2 2 . 1 . 144 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.1 mt -81.12 -49.53 10.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 125.959 2.037 . . . . 2.95 116.421 170.271 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 p -63.56 -56.02 19.21 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.858 -4.276 . . . . 2.52 111.87 -173.392 . . . . . . . . 2 2 . 1 . 144 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.22 53.7 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 116.778 -2.63 . . . . 1.5 111.745 173.098 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -136.7 125.16 23.48 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 121.491 2.646 . . . . 1.79 104.566 -174.193 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.8 m -107.04 113.35 26.77 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 118.668 -2.52 . . . . 1.38 114.431 175.876 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.6 mt -96.49 125.71 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 122.784 1.278 . . . . 2.03 111.96 -176.043 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 m -89.84 119.03 29.87 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.05 -2.906 . . . . 1.61 111.244 177.768 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.404 HD23 ' HG2' ' A' ' 29' ' ' LYS . 62.8 mt -116.53 153.07 32.85 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.309 -1.494 . . . . 2.15 109.013 -179.324 . . . . . . . . 2 2 . 1 . 144 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -109.29 130.7 55.49 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.262 -3.399 . . . . 1.98 107.561 172.198 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -144.42 173.61 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 123.31 1.529 . . . . 1.52 109.685 179.709 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -106.44 159.68 28.91 Favored Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 105.244 -2.132 . . . . 2.35 105.244 167.164 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -84.5 -11.33 8.27 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 O-C-N 113.87 -3.805 . . . . 1.31 106.486 -173.71 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.9 p -93.32 -3.37 53.59 Favored 'General case' 0 N--CA 1.43 -1.439 1 C-N-CA 131.769 4.028 . . . . 1.71 110.818 -174.154 . . . . . . . . 2 2 . 1 . 144 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -73.76 152.05 40.45 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.253 2.221 . . . . 1.69 107.22 177.269 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.6 p -86.35 156.5 20.19 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 116.906 -3.621 . . . . 1.33 106.73 175.09 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 mm -44.23 -48.55 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 1 C-N-CA 131.764 4.026 . . . . 1.32 112.12 174.842 . . . . . . . . 2 2 . 1 . 144 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -35.46 -57.72 0.61 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 119.019 2.97 . . . . 1.62 119.019 166.831 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -71.16 -27.77 63.78 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 113.367 -1.742 . . . . 2.13 113.848 179.461 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.37 -48.54 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 125.862 2.744 . . . . 1.23 114.085 170.868 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -60.22 -37.36 80.06 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.904 -3.623 . . . . 1.97 115.239 175.879 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.45 -14.35 61.23 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.304 -2.747 . . . . 1.19 112.694 179.509 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HG2' HD23 ' A' ' 15' ' ' LEU . 10.5 ttmt -74.18 -41.61 61.18 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.097 -1.627 . . . . 1.92 114.233 170.261 . . . . . . . . 2 2 . 1 . 144 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.3 mt -58.51 -46.29 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 123.234 1.492 . . . . 1.94 111.439 166.741 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -49.03 -42.83 39.6 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 125.194 2.426 . . . . 1.9 112.856 171.738 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.53 -58.91 6.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.869 -3.644 . . . . 1.55 113.787 168.827 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.9 tptt -68.82 -62.04 1.55 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.541 2.336 . . . . 2.95 113.429 -170.079 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -87.22 -45.2 10.85 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 128.061 2.545 . . . . 1.48 113.142 -168.57 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.11 39.89 3.91 Favored Glycine 0 N--CA 1.43 -1.751 0 CA-C-N 112.659 -2.064 . . . . 1.12 114.92 177.691 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.3 mt -106.7 134.16 19.95 Favored Pre-proline 0 N--CA 1.43 -1.466 0 C-N-CA 126.374 1.87 . . . . 2.07 107.01 -178.043 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.69 143.44 99.41 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-O 113.684 -2.715 . . . . 1.39 117.513 175.692 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -80.84 -2.31 11.75 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 126.497 3.356 . . . . 1.68 112.012 -168.331 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.74 -26.21 32.13 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 124.829 2.252 . . . . 2.25 111.66 170.393 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -84.86 -20.26 31.09 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.235 -2.791 . . . . 2.44 114.773 -176.065 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -85.85 117.93 25.02 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 114.944 -1.025 . . . . 1.32 111.266 -176.221 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.8 mtt-85 -113.22 116.01 29.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.669 -1.269 . . . . 3.19 108.706 169.772 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.5 mt -88.41 136.84 32.79 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.858 -1.151 . . . . 1.75 112.559 176.181 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -113.49 117.63 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 O-C-N 117.682 -3.136 . . . . 1.98 104.886 179.904 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -107.21 123.13 47.84 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 116.675 -3.766 . . . . 1.94 108.05 165.916 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.305 . . 64.29 -82.84 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 131.314 3.846 . . . . 1.67 114.215 -173.991 . . . . . . . . 2 2 . 1 . 144 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.66 3.06 2.03 Favored Glycine 0 N--CA 1.43 -1.719 0 O-C-N 116.65 -3.781 . . . . 1.3 105.466 -176.919 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -127.0 141.72 51.72 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 115.658 -4.436 . . . . 2.89 113.913 178.454 . . . . . . . . 2 2 . 1 . 144 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -65.38 142.98 58.03 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.246 2.219 . . . . 2.89 113.589 171.439 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.6 mt -96.36 123.46 40.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.765 -3.084 . . . . 1.34 113.493 -176.519 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -81.47 144.26 31.49 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 130.012 3.325 . . . . 1.94 112.959 -178.54 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.6 150.72 28.0 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.453 2.701 . . . . 1.56 107.385 -169.113 . . . . . . . . 2 2 . 1 . 144 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.97 -4.44 78.28 Favored Glycine 0 N--CA 1.429 -1.77 0 O-C-N 119.454 -2.029 . . . . 0.97 109.409 174.194 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -97.34 172.34 7.84 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.087 2.286 . . . . 3.07 110.392 171.433 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.6 p -110.83 174.32 5.91 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.504 -1.372 . . . . 1.34 112.57 173.282 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.1 mt -52.16 -34.67 46.0 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.844 2.458 . . . . 1.63 112.427 170.185 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.1 m -75.11 -34.56 61.72 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.701 2.501 . . . . 1.51 114.179 -172.579 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -51.31 -34.68 34.4 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 119.985 3.328 . . . . 1.9 119.985 170.442 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -92.56 -5.91 50.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 109.712 -3.404 . . . . 0.97 114.195 178.892 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.25 8.9 m120 64.92 50.3 1.96 Allowed 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.057 -2.902 . . . . 2.35 113.516 179.583 . . . . . . . . 2 2 . 1 . 144 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.8 mt -92.64 107.84 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 126.004 2.811 . . . . 1.39 110.903 178.409 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -89.49 172.61 8.86 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.207 -2.269 . . . . 2.58 106.231 -171.288 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -14.42 -89.35 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.007 3.323 . . . . 2.58 119.613 167.473 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -91.44 74.95 6.01 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.537 -4.477 . . . . 1.71 114.309 179.028 . . . . . . . . 2 2 . 1 . 144 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -94.41 144.85 25.21 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.89 -4.256 . . . . 1.34 119.657 177.024 . . . . . . . . 2 2 . 1 . 144 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.1 m -101.13 110.11 22.09 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.284 3.434 . . . . 1.36 106.472 -177.026 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -108.81 152.37 24.98 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.695 -1.965 . . . . 2.03 105.695 -177.672 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -116.53 133.24 56.25 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.618 -4.426 . . . . 2.31 110.0 -179.788 . . . . . . . . 2 2 . 1 . 144 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.0 tp -107.75 115.42 30.11 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 115.183 -2.341 . . . . 1.72 110.905 -174.173 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -111.75 146.93 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 126.059 2.837 . . . . 1.8 106.373 173.967 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.0 tp -93.72 120.54 34.11 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.935 -1.728 . . . . 3.26 111.877 -174.124 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.81 114.4 28.32 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.86 -1.163 . . . . 4.12 107.86 -177.365 . . . . . . . . 2 2 . 1 . 144 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 77.2 mt -103.51 -66.69 0.93 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 104.247 -2.501 . . . . 3.54 104.247 174.401 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -120.96 -147.09 0.38 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 116.73 -1.988 . . . . 7.32 107.367 164.649 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.39 -90.5 1.33 Allowed Glycine 0 N--CA 1.43 -1.725 0 CA-C-O 119.369 -0.684 . . . . 3.73 112.273 -163.254 . . . . . . . . 1 1 . 1 . 144 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.745 0 CA-C-N 119.839 1.82 . . . . 3.87 111.7 -172.036 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.5 ttp . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 113.994 1.109 . . . . 1.1 113.994 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -105.36 140.03 39.1 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.306 -3.371 . . . . 1.87 113.49 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 pt -125.88 153.02 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 114.933 -1.03 . . . . 0.72 109.672 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -99.88 135.54 41.15 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.802 2.041 . . . . 1.4 109.247 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.7 t -114.81 104.07 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 104.32 -2.474 . . . . 0.58 104.32 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -82.16 126.05 31.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.31 2.005 . . . . 2.09 111.962 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.3 p -83.94 -169.05 2.39 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 117.171 -3.455 . . . . 0.99 113.019 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.8 tp -73.46 -57.93 3.66 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.844 1.783 . . . . 2.53 113.103 170.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.4 p -67.86 -22.9 65.1 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.256 -3.402 . . . . 2.08 118.191 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.93 22.36 1.03 Allowed Glycine 0 N--CA 1.429 -1.774 0 C-N-CA 125.848 1.689 . . . . 1.31 115.111 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -88.31 131.02 34.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.031 2.133 . . . . 1.4 105.985 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -109.59 124.39 51.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 123.603 2.911 . . . . 0.78 104.382 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.1 mt -111.72 128.23 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 107.436 -1.32 . . . . 1.55 107.436 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.8 m -102.83 115.83 31.36 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.11 -0.994 . . . . 1.08 108.928 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -105.49 157.28 17.48 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.971 -1.081 . . . . 1.55 111.568 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.39 110.82 21.46 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.358 2.263 . . . . 1.95 106.524 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.0 m -118.84 159.02 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 126.791 2.557 . . . . 0.96 109.01 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -89.82 146.3 35.09 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-O 111.762 -3.97 . . . . 2.35 106.769 160.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -73.47 -5.61 17.4 Favored 'Trans proline' 0 N--CA 1.433 -2.05 0 CA-C-N 127.547 3.731 . . . . 0.95 115.142 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 m -90.08 7.58 37.03 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 125.228 1.58 . . . . 1.45 109.444 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -85.19 144.14 28.34 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.19 1.922 . . . . 1.69 116.19 172.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 37.6 p -82.9 160.5 22.11 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.323 -2.736 . . . . 0.75 115.657 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.454 15.5 mm -57.79 -38.99 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 123.419 1.581 . . . . 0.73 115.252 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -47.49 -45.05 25.88 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.357 1.984 . . . . 1.62 116.357 161.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -72.58 -20.8 61.25 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 126.533 1.933 . . . . 2.13 113.4 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.23 -39.37 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.99 -2.319 . . . . 0.62 108.394 172.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -66.05 -41.69 90.5 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.974 -2.329 . . . . 1.22 110.183 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.75 -43.79 66.02 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.956 -2.34 . . . . 0.51 116.033 173.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -61.7 -32.15 72.34 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 125.966 2.041 . . . . 1.44 113.593 170.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -81.81 -32.13 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 118.018 -2.927 . . . . 1.32 115.093 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -56.2 -38.71 71.36 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.868 1.794 . . . . 1.7 113.879 166.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -64.56 -50.39 67.47 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.903 2.881 . . . . 1.55 111.101 167.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -71.5 -62.84 1.26 Allowed 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 126.827 2.051 . . . . 2.62 111.569 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -101.25 -35.31 9.31 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 118.45 -2.656 . . . . 1.48 115.81 -170.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.93 11.06 29.07 Favored Glycine 0 N--CA 1.43 -1.751 0 CA-C-O 124.106 1.948 . . . . 1.12 113.188 175.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.5 mm -76.1 125.97 87.31 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-O 114.418 -2.706 . . . . 1.55 112.842 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.0 154.35 74.39 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 CA-C-N 128.252 3.983 . . . . 1.02 118.169 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -74.08 -9.6 22.17 Favored 'Trans proline' 0 C--N 1.299 -2.066 0 CA-C-N 123.844 2.409 . . . . 1.25 116.52 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -59.99 -44.38 94.56 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 118.378 -0.82 . . . . 2.25 111.254 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -79.6 -29.56 41.21 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.228 0.955 . . . . 2.02 110.604 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -66.66 107.68 2.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 121.044 3.72 . . . . 0.69 121.044 -172.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.427 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 29.5 mtt180 -101.38 139.31 37.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.075 -3.516 . . . . 2.78 110.478 171.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.6 mt -113.3 141.25 47.23 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.677 -2.514 . . . . 1.17 111.891 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mm -128.72 137.58 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 115.184 -2.341 . . . . 1.38 110.899 172.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.499 ' CE2' HG12 ' A' ' 61' ' ' ILE 0.293 10.9 t80 -115.67 -54.62 2.5 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.068 1.48 . . . . 1.5 107.766 176.098 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -121.46 -75.96 0.59 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 115.276 1.584 . . . . 1.21 115.276 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.96 -44.14 0.28 Allowed Glycine 0 N--CA 1.429 -1.767 0 O-C-N 119.412 -2.055 . . . . 1.3 114.166 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 mttm -91.93 151.37 20.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 120.784 2.292 . . . . 2.55 114.459 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -83.56 121.91 27.85 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 111.959 -2.382 . . . . 2.48 111.732 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mt -78.21 132.16 37.45 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.501 -1.681 . . . . 0.9 114.197 -162.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -87.62 155.87 19.75 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 115.986 -1.959 . . . . 1.94 115.002 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -66.77 -48.21 69.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.199 2.6 . . . . 1.56 116.099 -172.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.97 38.85 1.12 Allowed Glycine 0 N--CA 1.43 -1.737 1 N-CA-C 124.923 4.729 . . . . 0.97 124.923 174.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -139.59 150.65 45.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.099 -2.412 . . . . 2.49 109.337 171.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 24.5 p -91.28 158.81 16.36 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 111.901 -2.409 . . . . 0.76 113.437 -177.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.402 HD23 HD12 ' A' ' 61' ' ' ILE . 1.5 mt -48.93 -48.73 42.54 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.875 -4.265 . . . . 1.05 107.763 170.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.4 p -56.44 -39.57 73.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.874 2.546 . . . . 1.19 117.874 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -53.56 -57.36 11.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.884 -2.385 . . . . 1.9 112.807 171.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -63.49 -16.16 59.87 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 128.124 2.57 . . . . 0.89 115.149 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.2 t30 69.23 51.56 0.51 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.356 2.662 . . . . 1.84 112.593 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.499 HG12 ' CE2' ' A' ' 45' ' ' PHE . 34.6 mt -91.73 122.88 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 118.245 -2.784 . . . . 0.82 108.06 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -89.48 -167.6 1.91 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 125.192 1.557 . . . . 2.16 109.682 -174.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.296 40.2 tttm -75.7 138.16 41.13 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.478 -2.045 . . . . 2.12 105.478 172.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 55.3 51.88 12.36 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 130.925 3.69 . . . . 1.71 109.607 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.6 m -103.02 149.87 24.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.159 -2.163 . . . . 1.04 105.159 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.0 m -100.65 118.3 36.51 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 123.138 1.447 . . . . 0.79 112.613 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 61' ' ' ILE . 9.4 mp -102.2 148.19 25.73 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 105.782 -1.933 . . . . 1.4 105.782 170.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -99.38 130.12 45.63 Favored 'General case' 0 N--CA 1.43 -1.429 1 C-N-CA 131.932 4.093 . . . . 1.51 110.96 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.2 tp -108.86 116.06 31.27 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 115.075 -2.65 . . . . 1.14 105.964 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 98.6 t -99.92 130.92 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 108.516 -0.92 . . . . 1.23 108.516 173.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 71' ' ' LEU . 61.7 mt . . . . . 0 N--CA 1.43 -1.465 0 C-N-CA 129.232 3.013 . . . . 2.78 108.371 175.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.3 ttp . . . . . 0 CA--C 1.489 -1.376 0 CA-C-O 121.788 0.804 . . . . 1.1 111.326 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -96.06 140.75 30.34 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.327 -1.483 . . . . 1.87 113.769 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.6 pt -139.34 165.14 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 125.994 2.807 . . . . 0.72 105.823 171.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -124.64 140.86 52.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 112.715 -2.038 . . . . 1.4 111.08 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -109.67 120.83 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 O-C-N 120.307 -1.495 . . . . 0.58 113.05 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -94.75 137.92 33.23 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.195 -3.441 . . . . 2.09 112.126 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.258 74.8 p -81.32 -165.02 0.85 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.626 2.631 . . . . 0.99 110.815 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.8 tp -77.19 -44.69 29.22 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.083 -2.886 . . . . 2.53 113.835 169.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.49 -53.63 7.4 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.503 1.62 . . . . 2.08 107.863 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.82 21.71 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.706 1 O-C-N 115.673 -4.392 . . . . 1.31 113.018 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -85.9 139.75 30.97 Favored 'General case' 0 N--CA 1.431 -1.412 1 CA-C-N 125.283 4.541 . . . . 1.4 106.546 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 38.2 m -101.8 114.15 27.96 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.995 1.318 . . . . 0.78 110.345 171.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.0 mt -96.21 122.9 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 117.033 -3.542 . . . . 1.55 110.192 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.3 m -87.21 125.55 34.25 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.186 -1.571 . . . . 1.08 110.73 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.1 mt -126.69 152.46 46.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.615 -1.303 . . . . 1.55 112.084 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -123.36 105.57 9.94 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 111.781 -2.463 . . . . 1.95 110.07 173.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.1 m -121.64 -167.83 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 102.107 -3.294 . . . . 0.96 102.107 -176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -122.07 162.42 37.39 Favored Pre-proline 0 N--CA 1.431 -1.388 0 C-N-CA 126.982 2.113 . . . . 2.35 106.477 167.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -83.81 -14.65 7.49 Favored 'Trans proline' 0 N--CA 1.433 -2.064 0 CA-C-O 116.845 -1.398 . . . . 0.95 108.83 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.3 p -80.94 0.99 32.98 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 124.345 1.028 . . . . 1.45 112.648 171.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -83.54 157.03 22.5 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 125.466 2.555 . . . . 1.69 111.772 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.9 p -88.6 163.35 15.88 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 112.939 -1.937 . . . . 0.75 112.169 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.0 mm -63.29 -34.37 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-O 115.31 -2.281 . . . . 0.73 110.037 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -55.48 -46.94 76.83 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 122.215 2.279 . . . . 1.62 114.788 170.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -56.03 -37.73 69.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.267 1.58 . . . . 2.13 115.267 174.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -62.44 -40.46 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 119.7 -1.875 . . . . 0.62 113.864 172.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -61.85 -28.66 69.65 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.477 -1.39 . . . . 1.22 113.803 173.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.82 -28.11 61.46 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.3 2.24 . . . . 0.51 110.156 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -74.12 -36.13 64.17 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.907 -3.621 . . . . 1.44 111.162 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.6 mt -70.61 -39.9 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 123.157 1.456 . . . . 1.32 113.648 175.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -53.03 -38.7 62.62 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.079 -2.263 . . . . 1.7 115.779 169.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -68.88 -46.66 67.83 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.488 -2.008 . . . . 1.55 113.839 173.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -80.04 -55.78 4.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.58 1.552 . . . . 2.62 114.783 -174.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -94.06 -45.51 7.54 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 127.864 3.697 . . . . 1.48 110.928 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.27 56.34 0.7 Allowed Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 111.888 -2.415 . . . . 1.12 111.211 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.5 mt -124.86 127.78 25.04 Favored Pre-proline 0 N--CA 1.43 -1.434 0 N-CA-C 103.268 -2.864 . . . . 1.55 103.268 -167.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.28 32.2 Cg_exo -66.07 138.55 52.56 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 124.625 3.55 . . . . 1.02 109.314 -171.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -64.86 -14.19 43.66 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-O 114.219 -2.492 . . . . 1.25 114.321 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -74.04 -16.34 61.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 122.455 2.389 . . . . 2.25 114.427 164.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -92.06 4.2 53.6 Favored 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 118.756 -2.465 . . . . 2.02 112.168 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -113.48 101.01 8.96 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 127.832 3.682 . . . . 0.69 119.009 -172.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -94.06 122.67 36.8 Favored 'General case' 0 N--CA 1.431 -1.409 1 O-C-N 115.266 -4.646 . . . . 2.78 110.435 173.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.2 mt -112.11 124.81 53.22 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.706 -1.59 . . . . 1.17 106.706 -170.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 1.6 mm -111.0 144.48 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 129.345 3.058 . . . . 1.38 108.912 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -143.0 116.46 9.11 Favored 'General case' 0 N--CA 1.43 -1.442 1 N-CA-C 97.629 -4.952 . . . . 1.5 97.629 175.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 42.83 39.64 1.79 Allowed 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.1 -3.5 . . . . 1.21 120.349 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.21 -25.98 26.26 Favored Glycine 0 N--CA 1.431 -1.657 0 O-C-N 118.042 -2.911 . . . . 1.3 111.039 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -77.35 130.9 37.74 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.74 -3.8 . . . . 2.55 106.378 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -91.6 135.65 33.71 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.297 1.046 . . . . 2.48 112.764 165.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.1 mt -97.81 144.03 27.82 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.069 -2.269 . . . . 0.9 113.29 -166.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -86.45 147.33 26.04 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 119.533 -1.98 . . . . 1.94 115.563 174.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -55.88 -64.26 0.91 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 118.504 2.779 . . . . 1.56 118.504 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.51 22.1 9.5 Favored Glycine 0 N--CA 1.431 -1.693 1 N-CA-C 123.162 4.025 . . . . 0.97 123.162 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -86.14 156.27 20.42 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.92 2.888 . . . . 2.49 109.624 161.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.251 40.5 p -95.44 157.5 15.87 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 126.563 3.077 . . . . 0.76 112.426 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.8 mt -63.38 -31.85 73.11 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 117.422 -3.299 . . . . 1.05 111.769 168.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.4 t -67.61 -40.21 84.71 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.914 -4.241 . . . . 1.19 113.718 174.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -46.67 -53.61 11.3 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 116.743 2.127 . . . . 1.9 116.743 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.337 86.1 m-85 -60.21 -34.87 74.25 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 118.033 2.605 . . . . 0.89 118.033 175.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.294 67.1 m-80 91.84 66.19 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.66 2.384 . . . . 1.84 106.04 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.3 mt -108.68 118.01 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 125.441 2.543 . . . . 0.82 109.654 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -100.75 -179.66 4.14 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 109.94 -3.3 . . . . 2.16 107.27 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -56.93 149.68 18.25 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.89 2.182 . . . . 2.12 116.89 174.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 64.3 26.4 13.67 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 128.966 2.907 . . . . 1.71 110.478 170.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 m -81.7 136.96 35.46 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 116.404 -1.76 . . . . 1.04 107.839 -173.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.6 m -101.95 112.63 25.34 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 101.056 -3.683 . . . . 0.79 101.056 -172.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mp -103.05 156.91 17.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.71 3.204 . . . . 1.4 109.136 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.442 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 36.5 m80 -113.92 144.06 43.68 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 123.867 0.867 . . . . 1.51 109.326 -174.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.7 tp -115.42 111.68 21.17 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 130.593 3.557 . . . . 1.14 114.271 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.5 t -103.22 125.42 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 1 C-N-CA 132.41 4.284 . . . . 1.23 110.946 173.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 N--CA 1.43 -1.441 0 CA-C-O 124.731 2.205 . . . . 2.78 113.792 -179.721 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttp . . . . . 0 CA--C 1.49 -1.343 0 CA-C-O 124.335 2.017 . . . . 1.1 110.789 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -76.54 123.96 26.86 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.508 -3.245 . . . . 1.87 117.176 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -138.22 152.15 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 O-C-N 120.305 -1.497 . . . . 0.72 107.103 174.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -108.61 141.18 40.93 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 128.195 2.598 . . . . 1.4 111.616 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.555 HG21 HD11 ' A' ' 30' ' ' ILE . 17.5 t -121.9 128.76 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 114.242 -2.79 . . . . 0.58 107.883 171.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -120.49 133.28 55.43 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 124.535 3.334 . . . . 2.09 111.472 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.45 HG22 HD23 ' A' ' 69' ' ' LEU . 27.2 p -70.88 175.35 5.14 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.514 -1.366 . . . . 0.99 112.293 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.0 tp -65.57 -41.85 92.44 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 126.194 1.798 . . . . 2.53 115.193 169.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.5 m -66.49 -47.44 73.02 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.908 1.337 . . . . 2.08 108.197 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.38 42.79 0.11 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 117.957 -2.964 . . . . 1.31 114.029 169.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -97.18 117.66 31.89 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 115.565 -2.159 . . . . 1.4 108.024 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.5 m -92.14 125.74 36.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 122.396 2.362 . . . . 0.78 113.268 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mt -112.94 126.5 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 100.524 -3.88 . . . . 1.55 100.524 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.1 m -101.39 125.51 48.04 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 119.971 -1.705 . . . . 1.08 111.301 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.9 mt -126.2 159.42 33.03 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.453 2.073 . . . . 1.55 107.074 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -119.25 138.61 52.87 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 111.722 -2.49 . . . . 1.95 104.292 170.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.273 17.3 m -145.3 164.26 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 104.713 -2.329 . . . . 0.96 104.713 -176.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -98.8 145.02 29.23 Favored Pre-proline 0 N--CA 1.43 -1.468 0 O-C-N 125.828 1.955 . . . . 2.35 107.363 160.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.37 -14.27 31.0 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 CA-C-N 122.898 2.071 . . . . 0.95 112.017 -169.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.339 6.2 t -87.29 -7.66 57.59 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 125.181 3.628 . . . . 1.45 110.692 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -74.59 151.44 39.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.086 -2.259 . . . . 1.69 111.977 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.253 77.1 p -74.16 170.03 16.36 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 117.348 -3.345 . . . . 0.75 117.096 -172.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.415 HD12 HD13 ' A' ' 50' ' ' LEU . 21.5 mm -77.1 -38.14 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 103.755 -2.684 . . . . 0.73 103.755 173.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -42.12 -53.15 4.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.17 2.588 . . . . 1.62 113.427 161.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -59.87 -44.5 94.13 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.222 1.409 . . . . 2.13 112.779 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.6 t -64.49 -42.92 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 120.505 -1.372 . . . . 0.62 110.673 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -58.54 -40.91 84.32 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.575 1.95 . . . . 1.22 113.223 172.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.3 -37.06 84.1 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.188 -3.445 . . . . 0.51 110.246 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -67.43 -39.83 85.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.277 2.325 . . . . 1.44 117.277 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.555 HD11 HG21 ' A' ' 5' ' ' VAL . 9.9 mt -62.47 -48.02 90.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-O 127.066 3.317 . . . . 1.32 113.342 169.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -48.51 -39.66 24.04 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 113.923 -5.485 . . . . 1.7 115.678 167.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -59.56 -45.11 92.78 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.883 -3.011 . . . . 1.55 113.272 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -82.66 -83.18 0.13 Allowed 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.432 -1.321 . . . . 2.62 107.432 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.297 58.1 mm-40 -76.25 -28.19 57.01 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.6 -3.812 . . . . 1.48 114.654 -166.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.31 -8.19 22.74 Favored Glycine 0 N--CA 1.431 -1.652 0 O-C-N 120.718 -1.239 . . . . 1.12 112.693 167.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.1 mt -62.19 115.29 15.12 Favored Pre-proline 0 N--CA 1.43 -1.462 0 N-CA-C 116.993 2.22 . . . . 1.55 116.993 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -67.61 148.43 78.19 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 N-CA-C 119.573 2.874 . . . . 1.02 119.573 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -61.78 -32.91 86.21 Favored 'Trans proline' 0 N--CA 1.433 -2.038 1 C-N-CA 125.876 4.384 . . . . 1.25 113.068 -173.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -62.05 -30.89 71.29 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.769 1.766 . . . . 2.25 115.769 171.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -86.32 -24.68 25.79 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.797 1.639 . . . . 2.02 112.053 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -81.77 117.65 22.24 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 104.35 -2.463 . . . . 0.69 104.35 -176.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -109.19 124.97 51.71 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 103.845 -2.65 . . . . 2.78 103.845 169.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.8 mt -119.47 125.07 48.01 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 106.248 -1.76 . . . . 1.17 106.248 -172.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.8 mm -114.55 117.38 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 C-N-CA 127.905 2.482 . . . . 1.38 114.879 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -102.95 108.18 19.27 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.357 -1.349 . . . . 1.5 107.357 173.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.4 -98.78 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.517 -1.989 . . . . 1.21 110.397 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.91 30.62 3.34 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-O 125.38 2.655 . . . . 1.3 113.273 173.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -118.58 131.0 56.2 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.727 -2.043 . . . . 2.55 112.007 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -96.06 114.8 26.54 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.802 1.641 . . . . 2.48 108.994 171.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.415 HD13 HD12 ' A' ' 23' ' ' ILE . 1.6 mt -83.13 138.78 33.53 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.776 -3.078 . . . . 0.9 111.414 -166.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -92.08 138.77 31.26 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.32 -1.487 . . . . 1.94 108.691 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.39 -46.83 83.0 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.148 2.579 . . . . 1.56 115.547 -173.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.13 -5.23 58.29 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 120.51 2.964 . . . . 0.97 120.51 176.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 -88.99 169.8 11.22 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.137 -3.567 . . . . 2.49 111.283 162.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.7 p -92.81 171.2 9.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.582 2.067 . . . . 0.76 116.582 169.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 mt -59.18 -42.52 91.04 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 115.921 -1.99 . . . . 1.05 113.616 165.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.0 t -63.14 -36.46 83.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 125.497 1.748 . . . . 1.19 112.848 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -57.06 -35.28 69.15 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 117.855 2.539 . . . . 1.9 117.855 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -90.87 -0.58 57.76 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 125.767 1.627 . . . . 0.89 110.206 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 67.68 26.1 7.98 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 121.895 2.134 . . . . 1.84 112.679 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.7 mt -68.41 123.08 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 128.529 2.732 . . . . 0.82 106.253 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -124.5 -168.83 1.87 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.944 -2.973 . . . . 2.16 107.139 -171.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -53.31 134.8 39.58 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.363 3.465 . . . . 2.12 112.534 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.536 21.5 pt-20 64.65 15.96 10.04 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 129.214 3.005 . . . . 1.71 114.032 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.256 18.2 m -73.3 138.58 45.53 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.515 -3.241 . . . . 1.04 108.456 -173.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.7 m -109.62 98.2 7.61 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 127.924 3.265 . . . . 0.79 114.603 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.1 mp -74.48 148.78 40.7 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 112.334 -2.212 . . . . 1.4 109.716 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -112.27 115.46 28.82 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.615 -2.553 . . . . 1.51 109.423 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.45 HD23 HG22 ' A' ' 7' ' ' THR . 33.9 tp -101.7 113.97 27.61 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.477 1.608 . . . . 1.14 112.749 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -108.11 146.74 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 113.764 -1.562 . . . . 1.23 112.298 173.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.0 tp . . . . . 0 N--CA 1.43 -1.47 0 O-C-N 119.384 -2.072 . . . . 2.78 111.231 -176.401 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 ptt? . . . . . 0 CA--C 1.491 -1.316 0 CA-C-O 123.706 1.717 . . . . 1.1 111.274 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -100.76 133.41 45.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 126.859 3.219 . . . . 1.87 109.953 -174.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.2 pt -123.44 155.36 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 118.01 -2.931 . . . . 0.72 105.86 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -119.81 124.3 45.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.982 1.849 . . . . 1.4 110.26 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.406 HG21 HD11 ' A' ' 30' ' ' ILE . 2.5 t -100.56 95.74 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 126.846 3.212 . . . . 0.58 114.838 173.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -75.1 124.33 26.82 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.19 -2.194 . . . . 2.09 109.708 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.1 p -100.21 178.25 4.83 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 112.933 0.716 . . . . 0.99 112.933 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.5 tp -64.57 -64.29 0.91 Allowed 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 118.368 -2.708 . . . . 2.53 112.876 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.454 22.9 p -63.27 -36.83 84.98 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 119.502 3.149 . . . . 2.08 119.502 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.22 -52.82 0.12 Allowed Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 115.015 -3.469 . . . . 1.31 114.3 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -60.6 132.39 53.75 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 124.669 2.176 . . . . 1.4 116.412 -168.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.1 m -99.76 112.91 25.12 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.067 -3.521 . . . . 0.78 104.529 168.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mt -90.81 119.66 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 120.211 -0.595 . . . . 1.55 110.973 -173.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.6 m -85.69 112.17 20.78 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.048 -2.282 . . . . 1.08 108.222 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.4 mt -116.03 116.27 27.6 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 125.335 1.647 . . . . 1.55 112.724 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -84.93 124.09 31.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.502 -3.874 . . . . 1.95 115.778 167.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.03 163.15 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 125.779 2.704 . . . . 0.96 109.147 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -97.88 152.13 37.93 Favored Pre-proline 0 N--CA 1.431 -1.391 1 O-C-N 114.493 -5.13 . . . . 2.35 104.757 164.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -73.39 -3.07 13.06 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 125.273 3.982 . . . . 0.95 120.995 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.8 m -97.35 -4.82 37.79 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.539 -1.976 . . . . 1.45 109.227 172.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -71.44 146.22 48.78 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.756 -2.465 . . . . 1.69 111.16 173.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.4 p -79.59 154.67 28.57 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 118.757 2.873 . . . . 0.75 118.757 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.9 mm -57.7 -37.27 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 121.977 2.171 . . . . 0.73 113.125 175.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.436 30.6 tt0 -38.65 -52.43 1.66 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 119.497 3.147 . . . . 1.62 119.497 165.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -56.9 -45.06 82.85 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.166 1.913 . . . . 2.13 116.166 172.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.4 t -59.29 -43.4 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-O 124.771 2.224 . . . . 0.62 115.189 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -62.21 -45.97 90.96 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.947 2.499 . . . . 1.22 108.518 172.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.56 -30.5 69.82 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.618 2.822 . . . . 0.51 118.618 172.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -80.81 -29.38 36.0 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 116.235 -4.041 . . . . 1.44 106.627 172.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.406 HD11 HG21 ' A' ' 5' ' ' VAL . 95.1 mt -72.45 -34.4 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 116.503 -3.873 . . . . 1.32 112.621 174.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -52.1 -50.94 60.62 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 116.889 -3.632 . . . . 1.7 112.958 162.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -53.48 -45.31 69.54 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 128.238 2.615 . . . . 1.55 114.188 171.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -72.96 -70.12 0.38 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.053 -2.905 . . . . 2.62 111.214 -174.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -93.36 -43.61 8.69 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 128.455 2.702 . . . . 1.48 110.951 -165.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.18 50.37 2.25 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 125.862 1.696 . . . . 1.12 114.814 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.438 HD13 HD11 ' A' ' 71' ' ' LEU . 46.5 mt -118.05 137.99 25.04 Favored Pre-proline 0 N--CA 1.43 -1.463 1 N-CA-C 98.105 -4.776 . . . . 1.55 98.105 -176.051 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -65.35 154.79 71.99 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 C-N-CA 124.244 3.296 . . . . 1.02 115.783 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.55 -10.9 24.1 Favored 'Trans proline' 0 N--CA 1.434 -1.979 0 CA-C-O 114.047 -2.564 . . . . 1.25 117.107 -174.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.31 -50.54 38.28 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.729 2.518 . . . . 2.25 114.393 169.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -60.71 -33.78 73.39 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 128.197 2.599 . . . . 2.02 106.467 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -74.07 128.43 35.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 114.494 -2.669 . . . . 0.69 107.477 -170.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.555 ' HB2' HG23 ' A' ' 70' ' ' VAL . 61.5 mtp180 -111.53 115.26 28.89 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 127.093 2.745 . . . . 2.78 105.312 166.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.7 mt -97.14 129.49 44.52 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 120.543 -0.463 . . . . 1.17 112.226 173.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.59 138.83 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 128.118 2.567 . . . . 1.38 113.3 175.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -127.51 87.6 2.65 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.445 -2.035 . . . . 1.5 113.347 172.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.388 . . 84.97 -73.52 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.676 1.99 . . . . 1.21 108.444 -175.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.02 -21.48 0.28 Allowed Glycine 0 N--CA 1.431 -1.7 0 N-CA-C 109.439 -1.464 . . . . 1.3 109.439 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -80.02 128.22 33.23 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.309 1.444 . . . . 2.55 109.681 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -87.49 126.33 34.84 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 102.195 -3.261 . . . . 2.48 102.195 170.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.9 mt -89.19 127.37 35.74 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.847 1.308 . . . . 0.9 111.208 -164.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -77.17 142.25 39.73 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.153 -2.842 . . . . 1.94 115.664 174.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -56.68 -55.59 32.14 Favored 'General case' 0 N--CA 1.43 -1.456 1 C-N-CA 132.623 4.369 . . . . 1.56 115.402 -170.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.23 14.19 29.28 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 128.933 3.158 . . . . 0.97 112.773 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -109.51 164.45 12.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.326 3.563 . . . . 2.49 110.926 168.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.3 p -90.77 152.98 20.58 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 126.162 2.887 . . . . 0.76 115.109 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mt -56.4 -45.93 80.38 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.538 -3.226 . . . . 1.05 118.142 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.0 p -68.63 -13.4 62.33 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 118.095 2.628 . . . . 1.19 118.095 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -75.64 -34.28 60.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.291 -1.374 . . . . 1.9 107.291 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -85.35 1.83 46.85 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 117.581 -1.199 . . . . 0.89 111.787 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 65.83 36.77 5.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.563 2.745 . . . . 1.84 112.031 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.6 mt -87.64 121.45 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.149 -3.469 . . . . 0.82 111.532 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -122.11 -168.17 1.67 Allowed 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 105.829 -1.915 . . . . 2.16 105.829 -173.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -56.25 140.5 44.53 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 116.128 1.899 . . . . 2.12 116.128 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.307 98.5 mt-10 69.8 15.56 7.94 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 112.768 -2.015 . . . . 1.71 114.098 176.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.329 44.8 m -78.75 156.64 28.76 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 121.72 2.055 . . . . 1.04 111.107 -177.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.8 m -102.57 126.65 49.71 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 112.57 -2.105 . . . . 0.79 106.852 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -116.68 150.78 37.61 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 104.26 -2.496 . . . . 1.4 104.26 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -116.64 112.02 20.68 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 126.495 1.918 . . . . 1.51 106.403 -171.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.9 tp -98.22 122.18 41.06 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.103 -1.814 . . . . 1.14 106.103 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.555 HG23 ' HB2' ' A' ' 42' ' ' ARG . 4.5 m -126.74 150.93 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 113.368 -1.742 . . . . 1.23 107.466 173.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.438 HD11 HD13 ' A' ' 36' ' ' ILE . 42.3 mt . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 117.811 2.523 . . . . 2.78 117.811 -175.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.49 -1.336 0 N-CA-C 111.807 0.299 . . . . 1.1 111.807 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -97.48 136.67 37.57 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 124.012 0.82 . . . . 1.87 110.557 -172.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.433 HD12 HD13 ' A' ' 67' ' ' LEU . 19.2 pt -130.17 160.62 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 105.088 -2.19 . . . . 0.72 105.088 172.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -118.01 150.09 39.87 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 120.54 1.518 . . . . 1.4 109.826 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.4 t -132.47 122.87 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 105.913 -1.884 . . . . 0.58 105.913 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -97.31 147.83 23.75 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.863 1.792 . . . . 2.09 107.446 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.441 8.9 p -101.92 175.39 5.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.498 -3.876 . . . . 0.99 112.007 174.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.0 tp -58.34 -58.39 8.72 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.629 -1.919 . . . . 2.53 114.772 169.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.277 62.5 p -78.35 -14.53 59.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 119.26 3.059 . . . . 2.08 119.26 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.63 17.01 2.18 Favored Glycine 0 N--CA 1.429 -1.796 0 CA-C-O 115.003 -3.11 . . . . 1.31 117.905 173.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -94.8 122.07 37.05 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 101.699 -3.445 . . . . 1.4 101.699 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.265 10.7 m -92.59 116.19 28.78 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.462 -3.273 . . . . 0.78 111.06 169.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -102.22 135.47 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 118.335 -2.728 . . . . 1.55 117.206 172.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.2 m -103.62 137.74 41.25 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 101.367 -3.568 . . . . 1.08 101.367 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.4 mt -129.24 142.65 50.79 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 120.847 1.658 . . . . 1.55 111.704 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -101.57 117.4 34.84 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.852 2.861 . . . . 1.95 103.791 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -134.28 164.41 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 101.823 -3.399 . . . . 0.96 101.823 -172.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -109.16 159.56 30.76 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-N 110.169 -3.196 . . . . 2.35 107.402 166.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -81.24 -11.75 11.92 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 CA-C-N 124.734 2.727 . . . . 0.95 109.677 -172.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.1 m -86.83 -7.98 57.74 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 116.09 -4.132 . . . . 1.45 110.536 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -66.45 148.82 51.32 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 128.813 2.845 . . . . 1.69 107.848 170.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.1 p -93.12 -173.45 3.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.486 1.291 . . . . 0.75 114.486 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.6 mm -79.54 -37.88 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 125.431 1.492 . . . . 0.73 107.784 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -51.15 -48.24 61.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.599 1.96 . . . . 1.62 116.047 166.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -58.0 -48.99 78.38 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 122.821 1.296 . . . . 2.13 112.34 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.9 t -56.31 -52.5 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 114.785 1.402 . . . . 0.62 114.785 174.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -62.16 -22.56 65.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 128.22 3.867 . . . . 1.22 114.516 174.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.14 -35.9 61.62 Favored 'General case' 0 N--CA 1.429 -1.5 1 O-C-N 113.04 -6.037 . . . . 0.51 112.596 171.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -68.9 -30.88 69.45 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.972 -2.33 . . . . 1.44 108.945 171.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.0 mt -69.73 -31.69 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 1 O-C-N 112.779 -6.201 . . . . 1.32 112.474 176.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -64.37 -42.09 96.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.865 -1.772 . . . . 1.7 108.654 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -52.8 -49.66 65.18 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 114.611 1.337 . . . . 1.55 114.611 169.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -70.56 -73.7 0.16 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.822 -2.424 . . . . 2.62 115.797 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -90.95 -28.98 17.7 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.443 2.297 . . . . 1.48 113.898 -169.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.06 54.62 1.98 Allowed Glycine 0 N--CA 1.43 -1.732 1 O-C-N 115.244 -4.66 . . . . 1.12 114.614 173.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.4 mt -118.27 132.36 23.8 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 104.888 -2.264 . . . . 1.55 104.888 -173.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -63.17 150.84 87.47 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 O-C-N 114.09 -3.689 . . . . 1.02 117.132 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -67.75 -15.51 44.41 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 C-N-CA 124.376 3.384 . . . . 1.25 112.935 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.63 -30.97 61.83 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.831 2.53 . . . . 2.25 117.831 173.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -92.27 -26.65 18.05 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 123.419 1.58 . . . . 2.02 111.607 -172.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -75.44 112.1 11.41 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.763 1.625 . . . . 0.69 112.846 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -103.59 119.6 39.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.693 -3.754 . . . . 2.78 105.798 168.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.9 mt -96.16 129.73 43.39 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.852 -1.976 . . . . 1.17 107.051 173.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mm -104.68 135.68 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 128.679 2.792 . . . . 1.38 108.663 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -154.97 127.25 7.79 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 114.384 1.253 . . . . 1.5 114.384 170.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.43 27.8 3.87 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 115.935 1.828 . . . . 1.21 115.935 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.37 -12.32 61.68 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 115.992 1.157 . . . . 1.3 115.992 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -135.45 143.81 46.1 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.465 1.602 . . . . 2.55 114.578 -167.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -71.61 149.13 45.9 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 118.771 -2.456 . . . . 2.48 114.44 171.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.478 HD22 ' CD1' ' A' ' 59' ' ' TYR 0.308 55.1 mt -113.67 147.99 37.14 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 122.18 0.991 . . . . 0.9 113.106 -165.497 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -75.89 152.6 37.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 113.807 1.039 . . . . 1.94 113.807 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.351 0.9 OUTLIER -73.95 -51.07 17.23 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 116.099 1.888 . . . . 1.56 116.099 -169.843 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.34 32.77 3.03 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 119.678 2.631 . . . . 0.97 119.678 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -95.22 155.51 16.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.974 -3.074 . . . . 2.49 110.756 162.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.275 14.3 p -87.2 165.76 15.46 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 126.426 3.013 . . . . 0.76 111.163 175.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 37.6 mt -78.93 -20.51 49.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.823 -3.048 . . . . 1.05 109.698 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -70.96 -29.04 64.94 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 127.511 2.324 . . . . 1.19 112.375 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -68.28 -35.64 78.16 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.279 1.832 . . . . 1.9 114.628 170.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.478 ' CD1' HD22 ' A' ' 50' ' ' LEU . 60.2 m-85 -95.43 7.79 45.17 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.156 1.383 . . . . 0.89 109.709 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.2 m120 45.47 39.9 5.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.266 3.027 . . . . 1.84 114.687 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mt -78.02 105.44 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 105.667 -1.975 . . . . 0.82 105.667 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -78.08 -169.42 1.58 Allowed 'General case' 0 N--CA 1.43 -1.466 1 C-N-CA 131.964 4.106 . . . . 2.16 113.186 175.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -76.34 157.15 32.71 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.996 -2.94 . . . . 2.12 113.821 172.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.289 52.9 mt-10 68.35 22.8 7.85 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 111.852 -2.431 . . . . 1.71 111.949 171.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.0 m -86.14 125.8 33.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.059 2.944 . . . . 1.04 111.417 -174.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.6 m -92.14 120.27 32.57 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.96 -3.587 . . . . 0.79 106.218 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.433 HD13 HD12 ' A' ' 3' ' ' ILE . 9.3 mp -103.67 137.51 41.62 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 104.609 -2.367 . . . . 1.4 104.609 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -107.79 137.85 45.07 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 123.641 2.928 . . . . 1.51 115.008 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.4 tt -98.35 108.59 21.32 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.412 2.053 . . . . 1.14 111.422 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -110.9 130.2 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 C-N-CA 129.483 3.113 . . . . 1.23 111.612 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.6 mt . . . . . 0 N--CA 1.43 -1.473 0 O-C-N 116.333 -3.979 . . . . 2.78 115.46 -179.154 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptt? . . . . . 0 CA--C 1.489 -1.367 1 CA-C-O 109.231 -5.176 . . . . 1.1 110.82 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -117.56 145.05 44.53 Favored 'General case' 0 N--CA 1.43 -1.45 2 O-C-N 130.148 4.655 . . . . 1.87 122.534 174.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.336 15.5 pt -128.21 153.82 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 125.741 1.901 . . . . 0.72 109.176 175.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -112.15 121.07 43.93 Favored 'General case' 0 N--CA 1.429 -1.484 1 N-CA-C 99.583 -4.228 . . . . 1.4 99.583 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.2 t -113.51 112.12 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-O 124.973 2.32 . . . . 0.58 105.389 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -88.52 145.51 25.69 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.549 -3.219 . . . . 2.09 115.474 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.318 22.1 p -93.58 162.62 13.88 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.094 2.158 . . . . 0.99 108.762 177.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.37 -29.07 70.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.185 2.194 . . . . 2.53 111.552 176.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.315 28.4 p -83.25 -45.4 13.88 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 126.51 3.052 . . . . 2.08 113.145 -176.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.64 23.79 0.06 OUTLIER Glycine 0 N--CA 1.429 -1.773 1 O-C-N 114.769 -4.957 . . . . 1.31 116.653 172.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -103.67 135.86 44.45 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 103.603 -2.74 . . . . 1.4 103.603 -172.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.0 m -97.41 112.6 24.37 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 115.537 -2.173 . . . . 0.78 109.774 169.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -95.24 120.26 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 123.525 2.875 . . . . 1.55 105.188 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.4 m -92.37 124.7 36.62 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 105.271 -2.122 . . . . 1.08 105.271 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.1 mt -119.67 130.14 54.9 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.471 1.508 . . . . 1.55 111.573 -174.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -85.05 126.5 33.62 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 104.907 -2.257 . . . . 1.95 104.907 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.8 m -143.48 167.34 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 126.8 2.04 . . . . 0.96 112.479 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -120.9 160.67 43.84 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-O 115.231 -2.319 . . . . 2.35 112.329 163.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -60.12 -25.12 79.04 Favored 'Trans proline' 0 N--CA 1.433 -2.056 2 CA-C-N 128.948 4.231 . . . . 0.95 113.597 -176.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m -74.7 -20.9 59.67 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.277 2.231 . . . . 1.45 113.32 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -62.44 141.79 58.19 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.942 -2.973 . . . . 1.69 110.998 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 72.3 p -82.6 167.09 18.65 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.528 -1.669 . . . . 0.75 108.235 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.524 ' CG2' HD23 ' A' ' 43' ' ' LEU . 22.5 mm -66.28 -33.6 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 116.22 -1.848 . . . . 0.73 109.781 172.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -54.39 -33.31 59.03 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.658 2.096 . . . . 1.62 116.658 166.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -73.23 -35.19 66.22 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 120.881 1.673 . . . . 2.13 109.947 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.18 -51.66 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 125.016 1.326 . . . . 0.62 110.038 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -66.69 -25.87 66.76 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 117.58 -1.648 . . . . 1.22 115.141 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.91 -35.48 72.29 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.667 -2.52 . . . . 0.51 114.599 172.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -64.49 -29.87 70.9 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.447 -2.658 . . . . 1.44 113.001 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.03 -36.57 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 119.553 -1.967 . . . . 1.32 111.069 170.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -67.71 -41.32 83.77 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.947 -1.721 . . . . 1.7 109.488 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.56 -53.01 63.01 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.671 -1.893 . . . . 1.55 111.931 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -69.99 -59.63 2.8 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 123.646 1.688 . . . . 2.62 112.164 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -103.24 -28.85 11.64 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 118.815 -2.428 . . . . 1.48 110.312 -160.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.7 40.67 5.57 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 122.257 2.299 . . . . 1.12 115.579 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.7 mm -115.1 118.51 40.15 Favored Pre-proline 0 N--CA 1.43 -1.469 0 N-CA-C 104.445 -2.428 . . . . 1.55 104.445 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -74.5 144.81 32.68 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 124.196 2.534 . . . . 1.02 114.089 -175.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.96 -20.84 44.36 Favored 'Trans proline' 0 N--CA 1.433 -2.041 1 C-N-CA 125.923 4.416 . . . . 1.25 114.183 -175.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -48.48 -53.07 19.38 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.482 1.611 . . . . 2.25 111.331 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -78.18 -24.76 47.08 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 119.273 3.064 . . . . 2.02 119.273 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -66.5 141.49 57.86 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.83 -1.794 . . . . 0.69 112.928 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -135.38 124.47 24.37 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.684 -2.51 . . . . 2.78 110.245 171.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.524 HD23 ' CG2' ' A' ' 23' ' ' ILE 0.288 0.3 OUTLIER -92.51 123.94 36.18 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 120.726 1.603 . . . . 1.17 112.163 175.277 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.1 mm -107.33 128.87 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-O 122.273 1.035 . . . . 1.38 108.704 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.416 ' HB3' HD21 ' A' ' 50' ' ' LEU . 76.4 t80 -140.4 128.5 22.23 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.626 -1.296 . . . . 1.5 112.074 169.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.29 17.21 2.72 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 111.509 -2.587 . . . . 1.21 112.567 -174.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.31 -7.92 56.76 Favored Glycine 0 N--CA 1.43 -1.743 1 CA-C-O 111.724 -4.931 . . . . 1.3 115.41 -170.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -102.16 131.4 48.69 Favored 'General case' 0 N--CA 1.43 -1.443 1 CA-C-N 125.342 4.571 . . . . 2.55 112.057 177.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -79.09 125.31 29.25 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 125.714 2.673 . . . . 2.48 105.926 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 45' ' ' PHE 0.288 12.5 mt -84.77 129.9 34.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.004 -1.907 . . . . 0.9 109.091 -171.392 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -88.72 143.85 26.65 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 116.642 2.09 . . . . 1.94 116.642 -176.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.67 -36.92 85.82 Favored 'General case' 0 N--CA 1.431 -1.419 1 N-CA-C 122.967 4.432 . . . . 1.56 122.967 -169.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.92 10.25 63.41 Favored Glycine 0 N--CA 1.43 -1.726 1 O-C-N 115.626 -4.421 . . . . 0.97 117.952 169.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.25 24.1 mtt180 -107.47 152.07 24.71 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.126 1.917 . . . . 2.49 110.347 172.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 7.0 p -92.75 167.2 12.03 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 126.5 3.048 . . . . 0.76 118.895 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.1 mt -63.02 -22.96 67.22 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 116.114 -4.116 . . . . 1.05 118.382 170.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.3 t -79.75 -31.99 41.0 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.146 1.927 . . . . 1.19 114.128 171.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -60.13 -35.77 76.01 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.205 -2.184 . . . . 1.9 112.7 172.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -94.78 18.81 11.02 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 123.666 2.939 . . . . 0.89 111.194 170.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.56 3.1 p-10 43.61 48.04 6.4 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 129.547 3.139 . . . . 1.84 118.336 -177.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.7 mt -90.17 115.93 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 118.627 -2.546 . . . . 0.82 115.898 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -100.37 -176.5 3.23 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 131.583 3.953 . . . . 2.16 107.808 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -58.7 158.93 7.25 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.388 -2.695 . . . . 2.12 114.812 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 71.92 27.65 2.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.397 1.879 . . . . 1.71 110.671 168.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.2 m -96.1 135.86 37.33 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 125.683 2.659 . . . . 1.04 114.07 -173.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.3 m -94.67 108.93 20.91 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 113.541 -5.724 . . . . 0.79 105.248 -173.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 mp -97.73 159.0 15.2 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 127.278 3.418 . . . . 1.4 106.512 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -133.69 121.46 21.99 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.564 -2.585 . . . . 1.51 104.631 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.3 tp -89.52 132.14 35.21 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.299 -1.741 . . . . 1.14 106.299 -176.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -116.37 135.39 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 1 N-CA-C 99.32 -4.326 . . . . 1.23 99.32 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.6 mt . . . . . 0 N--CA 1.43 -1.466 0 O-C-N 119.811 -1.805 . . . . 2.78 109.182 -178.262 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 ttp . . . . . 0 CA--C 1.489 -1.376 0 CA-C-O 115.842 -2.028 . . . . 1.1 109.883 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -91.96 123.4 35.3 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 124.699 1.249 . . . . 1.87 110.939 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -124.9 159.51 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.455 -1.403 . . . . 0.72 110.855 172.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -108.12 128.21 54.48 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.729 0.811 . . . . 1.4 110.663 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.3 t -105.93 108.41 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 C-N-CA 128.722 2.809 . . . . 0.58 106.926 171.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -104.48 132.04 51.18 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 127.669 3.604 . . . . 2.09 110.332 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.8 p -100.28 164.36 11.98 Favored 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 115.603 -4.436 . . . . 0.99 107.818 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.1 mt -84.51 -3.8 58.6 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 109.339 -0.615 . . . . 2.53 109.339 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.3 p -90.11 -29.88 18.03 Favored 'General case' 0 N--CA 1.429 -1.505 1 O-C-N 116.191 -4.068 . . . . 2.08 111.333 -175.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.2 54.07 0.17 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 124.725 2.292 . . . . 1.31 115.317 175.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -153.68 138.43 17.03 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 115.028 -2.415 . . . . 1.4 107.461 -173.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.3 m -136.58 131.05 33.26 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 127.806 3.191 . . . . 0.78 103.616 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 pt -127.01 153.76 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 123.789 1.757 . . . . 1.55 108.506 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.6 m -109.62 109.19 19.87 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 112.871 -1.968 . . . . 1.08 111.743 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.251 41.3 mt -89.09 153.31 21.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.87 2.748 . . . . 1.55 106.278 175.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -126.59 113.46 16.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.888 -2.382 . . . . 1.95 107.342 174.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 m -130.09 -164.31 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 127.576 2.35 . . . . 0.96 108.14 -173.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -129.12 171.0 9.48 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 126.159 2.162 . . . . 2.35 107.588 163.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -70.61 -17.48 33.7 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 CA-C-O 123.254 1.272 . . . . 0.95 110.882 -173.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.15 2.57 53.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.145 1.165 . . . . 1.45 114.145 176.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.37 141.11 43.35 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.667 -2.52 . . . . 1.69 109.94 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 21.9 p -75.14 163.99 26.96 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.773 2.829 . . . . 0.75 109.605 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.1 mm -67.39 -33.73 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 124.092 1.901 . . . . 0.73 110.245 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -51.73 -45.94 63.82 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.981 -2.324 . . . . 1.62 116.822 163.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -67.07 -29.05 68.71 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 118.312 2.708 . . . . 2.13 118.312 173.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.0 t -74.31 -44.9 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 127.419 2.287 . . . . 0.62 108.892 176.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -62.86 -38.88 92.6 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 126.989 2.116 . . . . 1.22 112.864 174.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.83 -32.75 72.67 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.557 1.543 . . . . 0.51 113.313 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -61.37 -55.14 34.92 Favored 'General case' 0 N--CA 1.428 -1.532 0 O-C-N 118.201 -2.812 . . . . 1.44 111.989 165.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -53.7 -39.98 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 117.802 -3.061 . . . . 1.32 114.642 173.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -58.94 -38.99 80.29 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.868 1.318 . . . . 1.7 114.237 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -69.89 -55.03 10.79 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.151 -0.968 . . . . 1.55 110.67 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -65.89 -75.67 0.09 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.709 -3.12 . . . . 2.62 106.718 -175.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -78.5 -25.7 45.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.306 2.242 . . . . 1.48 113.356 -163.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.99 12.11 55.69 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 116.332 -2.371 . . . . 1.12 110.303 168.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.404 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 5.7 mt -88.84 126.33 59.8 Favored Pre-proline 0 N--CA 1.43 -1.454 0 CA-C-N 122.738 3.269 . . . . 1.55 108.453 -175.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 36' ' ' ILE . 19.5 Cg_endo -68.21 160.31 49.44 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 124.082 3.188 . . . . 1.02 109.894 -177.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.61 -7.64 13.61 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 115.105 -2.796 . . . . 1.25 116.277 -171.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -82.77 -22.25 34.37 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.767 -1.833 . . . . 2.25 108.267 175.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -80.6 -21.36 41.67 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.726 -2.484 . . . . 2.02 113.432 -175.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -113.65 137.44 51.6 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 118.131 0.423 . . . . 0.69 109.958 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -120.04 133.44 55.53 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.251 -1.531 . . . . 2.78 108.446 171.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.1 mt -105.31 121.35 43.69 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.393 2.997 . . . . 1.17 108.175 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.4 mm -111.3 131.0 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 116.555 -3.841 . . . . 1.38 107.194 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -124.26 118.57 27.09 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 105.114 -2.18 . . . . 1.5 105.114 170.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.304 . . 64.76 -89.23 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 130.154 3.382 . . . . 1.21 111.218 -171.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.76 -21.15 3.98 Favored Glycine 0 N--CA 1.429 -1.794 0 C-N-CA 127.025 2.25 . . . . 1.3 117.903 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.253 29.5 mttm -104.93 132.53 51.06 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 127.313 2.245 . . . . 2.55 114.777 -172.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -75.94 145.1 40.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.878 -1.056 . . . . 2.48 111.92 170.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 mt -98.06 143.5 28.55 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 125.478 1.736 . . . . 0.9 112.989 -172.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -95.95 135.84 37.17 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.883 -2.386 . . . . 1.94 116.068 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -47.24 -66.4 0.41 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 120.163 3.394 . . . . 1.56 120.163 -173.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.15 52.67 2.59 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 118.724 2.25 . . . . 0.97 118.724 169.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 22' ' ' THR . 40.0 mmt180 -134.95 157.86 45.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 116.408 -1.758 . . . . 2.49 107.964 172.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.287 6.5 p -88.65 172.92 8.92 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.486 1.612 . . . . 0.76 114.9 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.5 mt -72.46 -38.38 68.26 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 116.222 -4.049 . . . . 1.05 111.919 168.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.1 t -57.49 -38.96 75.42 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 129.486 3.114 . . . . 1.19 112.951 173.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -59.64 -32.85 70.83 Favored 'General case' 0 N--CA 1.43 -1.471 1 O-C-N 115.439 -4.538 . . . . 1.9 112.348 174.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -96.19 9.1 42.06 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 126.134 2.873 . . . . 0.89 112.412 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.6 m120 49.21 47.14 22.45 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 129.729 3.212 . . . . 1.84 109.327 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.1 mt -91.6 114.65 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 124.083 1.897 . . . . 0.82 109.722 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -97.05 -172.31 2.42 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.696 -1.594 . . . . 2.16 106.696 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -65.97 143.8 57.16 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.571 2.129 . . . . 2.12 113.77 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.279 70.5 mt-10 71.09 18.62 5.8 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 116.905 -3.622 . . . . 1.71 114.774 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.3 m -79.33 139.76 37.7 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.161 2.185 . . . . 1.04 115.513 -175.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.6 m -90.74 101.39 14.14 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 124.329 2.014 . . . . 0.79 115.416 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.6 143.96 34.27 Favored 'General case' 0 N--CA 1.429 -1.505 1 O-C-N 114.468 -5.145 . . . . 1.4 108.153 165.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -108.2 115.69 30.59 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.088 -3.508 . . . . 1.51 111.457 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tt -91.6 119.87 31.88 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 126.303 2.252 . . . . 1.14 111.429 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.88 147.39 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 126.403 3.001 . . . . 1.23 103.122 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.7 mt . . . . . 0 N--CA 1.429 -1.488 1 O-C-N 115.811 -4.306 . . . . 2.78 112.782 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 121.675 0.75 . . . . 1.1 112.74 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -107.79 135.69 48.78 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.331 -3.355 . . . . 1.87 111.42 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.1 pt -130.69 171.59 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 O-C-N 120.5 -1.375 . . . . 0.72 110.051 173.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -120.4 148.39 43.84 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 124.765 1.226 . . . . 1.4 113.749 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 67' ' ' LEU . 68.6 t -133.91 124.36 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 N-CA-C 104.775 -2.306 . . . . 0.58 104.775 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 tptt -92.27 135.83 33.69 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 109.659 -3.428 . . . . 2.09 114.954 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.289 38.0 p -83.24 -171.52 3.62 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.315 3.436 . . . . 0.99 110.58 -174.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.22 -49.65 73.35 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 125.325 2.488 . . . . 2.53 113.333 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.7 p -88.25 -43.4 11.61 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.591 -1.64 . . . . 2.08 113.522 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.04 -3.94 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.762 0 O-C-N 116.981 -3.574 . . . . 1.31 121.158 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -71.59 133.8 45.98 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 120.535 2.167 . . . . 1.4 114.016 -173.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.4 m -90.88 110.61 21.84 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 117.969 -1.493 . . . . 0.78 109.151 176.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 mt -93.41 135.54 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 125.234 1.414 . . . . 1.55 107.324 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.3 m -102.51 127.51 49.54 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.259 1.424 . . . . 1.08 111.295 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.5 mt -124.57 156.39 37.46 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 107.293 -1.373 . . . . 1.55 107.293 -177.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -104.57 123.11 46.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.149 2.18 . . . . 1.95 114.296 167.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.1 m -141.15 161.46 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 124.614 3.37 . . . . 0.96 103.227 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -111.86 157.28 39.99 Favored Pre-proline 0 N--CA 1.43 -1.466 0 N-CA-C 103.725 -2.694 . . . . 2.35 103.725 166.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.13 -9.83 19.29 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 C-N-CA 124.009 3.139 . . . . 0.95 111.686 -171.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.0 p -83.68 -9.93 58.52 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 114.807 -2.52 . . . . 1.45 112.426 171.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -67.44 145.62 54.82 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 124.353 3.251 . . . . 1.69 111.403 174.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.1 p -88.12 158.82 18.45 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 113.231 -5.918 . . . . 0.75 110.844 178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.4 mm -59.83 -32.33 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 119.786 3.254 . . . . 0.73 119.786 174.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -50.74 -47.56 59.36 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.264 1.95 . . . . 1.62 116.264 159.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -60.65 -38.22 84.13 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 125.51 1.524 . . . . 2.13 112.148 174.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.63 -43.61 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 124.798 1.239 . . . . 0.62 108.984 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -62.04 -33.03 73.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 118.434 2.753 . . . . 1.22 118.434 169.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.82 -33.65 76.35 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.349 1.46 . . . . 0.51 114.615 173.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -74.17 -18.13 60.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.287 3.035 . . . . 1.44 111.593 171.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.0 mt -82.46 -32.05 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 116.932 -3.605 . . . . 1.32 105.854 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -67.73 -33.97 75.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.458 -3.276 . . . . 1.7 113.245 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -56.77 -45.16 82.28 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.199 -1.563 . . . . 1.55 112.86 166.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -74.92 -67.82 0.61 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.945 -1.097 . . . . 2.62 112.721 -176.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -84.75 -45.76 12.07 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.679 2.791 . . . . 1.48 111.619 -167.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.97 -7.2 17.14 Favored Glycine 0 N--CA 1.429 -1.824 0 CA-C-O 123.228 1.46 . . . . 1.12 111.988 175.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.1 mt -71.99 122.81 88.31 Favored Pre-proline 0 N--CA 1.431 -1.418 0 C-N-CA 126.947 2.099 . . . . 1.55 110.597 -172.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.9 145.38 68.1 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 125.092 3.861 . . . . 1.02 112.06 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -63.32 -27.72 71.76 Favored 'Trans proline' 0 C--N 1.3 -2.006 1 C-N-CA 125.567 4.178 . . . . 1.25 111.425 -174.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -53.07 -50.81 63.62 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 122.612 2.46 . . . . 2.25 111.64 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -68.86 -26.92 65.38 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.541 2.336 . . . . 2.02 114.108 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -71.83 153.45 41.92 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.046 -2.909 . . . . 0.69 116.343 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -141.46 120.8 13.11 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.083 2.153 . . . . 2.78 106.421 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.1 mt -105.61 137.36 43.58 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 121.139 1.79 . . . . 1.17 111.542 174.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 mp -123.37 136.58 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 127.904 3.252 . . . . 1.38 110.784 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -156.31 131.28 9.13 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 115.743 -4.348 . . . . 1.5 112.747 174.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.447 . . 67.99 35.56 3.7 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.765 2.826 . . . . 1.21 116.563 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.04 -28.68 4.04 Favored Glycine 0 N--CA 1.431 -1.684 0 CA-C-O 124.745 2.303 . . . . 1.3 112.205 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -90.04 165.34 14.08 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.707 -3.819 . . . . 2.55 111.944 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -108.79 137.63 46.41 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 103.523 -2.769 . . . . 2.48 103.523 172.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.3 mt -78.9 153.27 30.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.15 -2.844 . . . . 0.9 112.605 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.318 10.0 tp10 -98.77 141.91 30.97 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.337 -1.477 . . . . 1.94 109.968 171.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.59 -57.35 10.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.256 2.455 . . . . 1.56 117.485 -166.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.81 39.68 2.85 Favored Glycine 0 N--CA 1.43 -1.762 1 O-C-N 114.254 -5.279 . . . . 0.97 118.949 165.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -113.63 160.83 18.16 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.001 1.72 . . . . 2.49 107.751 166.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.4 p -106.36 161.62 14.4 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.479 1.609 . . . . 0.76 113.694 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.45 -37.67 86.79 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.16 2.184 . . . . 1.05 113.881 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 t -63.82 -39.25 93.78 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 113.341 -3.219 . . . . 1.19 113.654 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.257 9.7 t70 -49.18 -71.03 0.07 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 127.89 3.244 . . . . 1.9 109.985 173.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -50.84 -27.33 7.14 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 130.051 3.34 . . . . 0.89 119.541 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m120 79.3 47.06 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 129.855 3.262 . . . . 1.84 114.487 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.2 mt -99.86 126.65 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 124.724 2.202 . . . . 0.82 108.372 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -102.09 -173.56 2.37 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 116.254 -4.028 . . . . 2.16 111.746 -173.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -68.43 149.62 49.1 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.964 2.316 . . . . 2.12 116.942 169.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 59.98 26.68 15.99 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.459 3.103 . . . . 1.71 113.262 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -88.74 131.87 34.85 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 128.814 2.845 . . . . 1.04 106.43 -174.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.7 m -99.8 111.86 24.15 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 105.446 -2.057 . . . . 0.79 105.446 -174.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.415 ' HB2' HG22 ' A' ' 5' ' ' VAL . 7.6 mp -83.09 159.93 22.01 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 106.307 -1.738 . . . . 1.4 106.307 168.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -110.86 132.4 54.23 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 117.498 -1.239 . . . . 1.51 110.049 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -98.6 132.52 43.94 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 103.225 -2.879 . . . . 1.14 103.225 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.2 t -126.12 156.81 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 129.952 3.301 . . . . 1.23 103.839 174.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.2 mt . . . . . 0 N--CA 1.43 -1.446 0 CA-C-O 125.525 2.583 . . . . 2.78 107.258 179.15 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ttt . . . . . 0 CA--C 1.491 -1.32 0 CA-C-O 121.045 0.45 . . . . 1.1 111.65 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -87.15 134.75 33.49 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.701 -2.499 . . . . 1.87 109.493 -172.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.404 HG12 HG22 ' A' ' 17' ' ' VAL . 6.0 pt -131.8 169.62 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 121.545 1.975 . . . . 0.72 108.017 174.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -121.56 157.58 30.42 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.88 -1.763 . . . . 1.4 107.558 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.7 t -123.17 132.74 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 125.657 1.848 . . . . 0.58 109.328 163.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.48 ' HB2' ' CG2' ' A' ' 66' ' ' THR . 26.3 tptt -98.98 134.79 41.31 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.359 -2.713 . . . . 2.09 107.856 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.6 p -85.95 -166.29 1.49 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.793 1.758 . . . . 0.99 114.962 176.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.9 mt -74.22 -47.5 34.91 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.704 -1.135 . . . . 2.53 112.171 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 p -77.61 -29.88 52.08 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 114.87 1.433 . . . . 2.08 114.87 -174.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.31 11.39 0.66 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 125.371 1.462 . . . . 1.31 115.3 172.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -81.42 140.82 34.44 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.806 -1.997 . . . . 1.4 107.626 -172.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.9 m -97.96 107.94 20.53 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.98 -1.464 . . . . 0.78 109.805 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -82.7 122.36 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 119.969 1.259 . . . . 1.55 108.563 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.2 m -95.0 114.22 26.0 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.925 -1.109 . . . . 1.08 113.786 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mp -116.33 160.45 20.49 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.358 1.614 . . . . 1.55 115.358 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.261 7.0 pt-20 -128.74 124.9 36.74 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 117.013 -1.875 . . . . 1.95 112.418 177.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.404 HG22 HG12 ' A' ' 3' ' ' ILE . 12.5 m -129.2 -167.42 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 113.765 -1.562 . . . . 0.96 110.454 -176.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -136.76 173.89 5.05 Favored Pre-proline 0 N--CA 1.431 -1.399 0 O-C-N 117.386 -3.321 . . . . 2.35 103.446 162.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -80.57 -8.36 13.64 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 CA-C-N 123.393 2.248 . . . . 0.95 117.751 -170.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.274 21.0 m -87.9 -19.85 26.77 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 126.812 2.57 . . . . 1.45 114.567 174.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -62.02 152.48 32.35 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.972 -2.955 . . . . 1.69 113.314 174.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 31.9 p -90.11 168.99 11.54 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.662 -2.523 . . . . 0.75 117.507 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.5 mm -64.92 -36.3 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 120.307 -1.496 . . . . 0.73 109.979 171.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -57.41 -30.5 65.01 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.498 2.719 . . . . 1.62 113.495 168.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -73.66 -32.71 64.14 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 114.338 -5.226 . . . . 2.13 111.235 176.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.6 t -63.11 -49.68 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.026 2.13 . . . . 0.62 111.688 174.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.495 ' HD3' ' HB3' ' A' ' 38' ' ' PRO . 55.9 mttt -58.56 -39.58 80.67 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 127.855 3.222 . . . . 1.22 114.083 176.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.71 -33.47 75.71 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 118.52 2.785 . . . . 0.51 118.52 173.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -75.0 -35.57 62.01 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 125.077 1.485 . . . . 1.44 111.464 170.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.68 -39.54 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 1 O-C-N 115.69 -4.381 . . . . 1.32 112.449 166.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -63.84 -41.47 97.81 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.614 -3.804 . . . . 1.7 113.833 172.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -55.37 -69.25 0.14 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 115.821 1.785 . . . . 1.55 115.821 170.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -68.44 -59.81 2.89 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.611 -3.806 . . . . 2.62 113.875 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -83.53 -43.24 15.95 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.208 -2.807 . . . . 1.48 111.196 -163.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.7 30.28 3.56 Favored Glycine 0 N--CA 1.43 -1.76 0 CA-C-O 124.386 2.103 . . . . 1.12 111.894 169.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 88.1 mt -105.95 134.77 19.59 Favored Pre-proline 0 N--CA 1.431 -1.41 0 O-C-N 117.661 -3.259 . . . . 1.55 104.876 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -72.98 158.66 49.38 Favored 'Trans proline' 0 C--N 1.3 -2.003 1 CA-C-N 129.411 4.397 . . . . 1.02 113.699 174.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.495 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 70.4 Cg_exo -73.44 -19.7 21.65 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 CA-C-O 114.455 -2.394 . . . . 1.25 117.939 -175.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -72.19 -12.08 61.02 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 127.334 2.896 . . . . 2.25 111.39 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -100.27 -15.83 17.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 116.239 -1.839 . . . . 2.02 112.226 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -88.37 139.49 30.43 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 130.031 3.333 . . . . 0.69 111.296 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -123.23 120.73 34.02 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 128.854 2.862 . . . . 2.78 107.583 165.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.5 mt -103.01 130.67 50.19 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 124.877 2.275 . . . . 1.17 108.92 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.7 mm -117.12 139.77 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 125.068 2.366 . . . . 1.38 107.287 -172.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -146.62 148.81 32.47 Favored 'General case' 0 N--CA 1.429 -1.497 1 O-C-N 113.693 -5.629 . . . . 1.5 108.157 168.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.66 30.3 8.54 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.217 1.932 . . . . 1.21 116.217 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.67 -29.8 5.64 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 124.887 1.232 . . . . 1.3 115.039 -173.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -82.1 142.96 31.82 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 128.706 2.802 . . . . 2.55 114.787 -174.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -90.56 132.46 35.7 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.006 1.73 . . . . 2.48 108.382 168.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mt -86.74 146.89 26.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.892 1.677 . . . . 0.9 111.845 -172.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -92.42 154.7 18.35 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 123.324 1.535 . . . . 1.94 111.043 171.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.64 -66.37 0.6 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 112.987 -1.915 . . . . 1.56 113.619 -163.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.31 64.48 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.723 0 O-C-N 118.763 -2.46 . . . . 0.97 113.916 162.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -140.94 151.04 43.89 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.228 -1.767 . . . . 2.49 106.228 168.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.25 18.5 p -85.14 169.83 13.49 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 121.747 2.067 . . . . 0.76 111.146 -178.835 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mt -69.83 -43.98 70.86 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 123.959 1.837 . . . . 1.05 113.859 173.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.1 t -57.89 -38.63 76.14 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.615 2.366 . . . . 1.19 114.271 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -57.36 -43.85 83.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.907 -1.746 . . . . 1.9 114.115 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -85.58 3.41 40.78 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.991 2.329 . . . . 0.89 114.033 172.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.4 m120 59.75 37.85 21.9 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.801 -3.062 . . . . 1.84 113.798 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.0 mt -74.15 116.4 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 125.527 1.531 . . . . 0.82 108.496 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -89.3 -174.62 4.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 117.364 2.357 . . . . 2.16 117.364 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -60.17 133.07 55.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.285 -2.134 . . . . 2.12 115.677 169.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.41 50.1 mt-10 64.33 41.96 5.56 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.684 -1.26 . . . . 1.71 112.678 174.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.257 62.6 m -106.55 163.81 12.58 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 103.25 -2.87 . . . . 1.04 103.25 -175.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.48 ' CG2' ' HB2' ' A' ' 6' ' ' LYS . 89.5 m -128.79 124.31 35.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.608 3.099 . . . . 0.79 109.39 -176.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.3 mt -91.49 162.46 14.54 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 110.385 -3.098 . . . . 1.4 108.926 172.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -127.57 119.88 26.97 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 117.351 -1.74 . . . . 1.51 109.596 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.1 tp -75.78 125.44 29.07 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.957 1.836 . . . . 1.14 115.957 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 t -123.59 148.36 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 103.277 -2.86 . . . . 1.23 103.277 171.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.7 mt . . . . . 0 N--CA 1.431 -1.422 0 CA-C-O 124.397 2.046 . . . . 2.78 110.603 -178.822 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 CA--C 1.491 -1.313 0 CA-C-O 124.834 2.254 . . . . 1.1 114.101 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -74.11 132.37 42.21 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 128.85 2.86 . . . . 1.87 107.971 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.0 pt -136.86 152.32 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 125.983 1.713 . . . . 0.72 109.452 171.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -117.26 148.23 41.85 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.269 -2.144 . . . . 1.4 115.809 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -125.11 107.46 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 104.673 -2.343 . . . . 0.58 104.673 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 tttp -91.3 132.52 36.1 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.59 -1.944 . . . . 2.09 110.681 176.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.3 p -87.49 176.21 7.59 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.609 2.448 . . . . 0.99 117.609 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.418 HD21 HG22 ' A' ' 70' ' ' VAL . 87.2 mt -60.99 -29.63 69.8 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.143 -3.473 . . . . 2.53 119.946 166.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 p -83.79 -87.4 0.11 Allowed 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 113.702 -1.59 . . . . 2.08 107.279 -175.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.74 48.74 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.732 0 O-C-N 118.911 -2.368 . . . . 1.31 107.956 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -128.24 135.32 49.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.512 2.325 . . . . 1.4 107.478 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.6 m -118.32 119.68 35.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.937 2.304 . . . . 0.78 105.857 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.1 mt -91.99 113.97 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 O-C-N 117.513 -3.242 . . . . 1.55 103.354 -172.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.3 m -86.5 113.33 22.34 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.022 -3.549 . . . . 1.08 109.157 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.6 mt -111.56 171.19 7.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 114.946 1.461 . . . . 1.55 114.946 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -125.48 121.87 34.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.101 -3.5 . . . . 1.95 115.609 168.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -130.23 175.67 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 118.987 -2.32 . . . . 0.96 106.942 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HG3' ' H ' ' A' ' 20' ' ' SER . 11.6 pt-20 -104.21 157.36 34.2 Favored Pre-proline 0 N--CA 1.431 -1.419 0 O-C-N 118.72 -2.487 . . . . 2.35 116.061 160.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -64.33 -9.1 18.7 Favored 'Trans proline' 0 N--CA 1.434 -2.012 2 CA-C-N 129.141 4.3 . . . . 0.95 114.443 -175.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.427 ' H ' ' HG3' ' A' ' 18' ' ' GLU 0.257 15.0 m -94.42 11.51 30.39 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 123.578 2.899 . . . . 1.45 117.481 171.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.98 138.54 36.07 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.97 -2.331 . . . . 1.69 115.221 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 p -76.07 159.4 30.81 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 114.325 1.231 . . . . 0.75 114.325 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.2 mm -68.13 -36.75 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 127.456 2.302 . . . . 0.73 107.762 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -59.36 -33.45 71.18 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.668 1.729 . . . . 1.62 115.668 165.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -69.6 -39.09 77.48 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.076 -3.515 . . . . 2.13 118.94 171.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.38 -39.8 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 126.346 2.974 . . . . 0.62 113.329 167.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -63.3 -37.59 87.86 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 116.251 -4.031 . . . . 1.22 112.459 -176.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.49 -19.04 63.74 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 128.284 2.634 . . . . 0.51 112.63 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -84.79 -30.91 24.22 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 117.66 -3.15 . . . . 1.44 110.365 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.4 mt -73.65 -35.84 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 123.831 1.777 . . . . 1.32 109.479 172.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -56.4 -50.76 70.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.547 -3.846 . . . . 1.7 111.397 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -53.89 -42.63 68.87 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 128.98 2.912 . . . . 1.55 112.144 174.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -83.2 -60.04 2.27 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.921 -2.987 . . . . 2.62 111.854 -174.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -97.66 -16.81 19.81 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 122.349 2.34 . . . . 1.48 112.243 -169.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.78 30.19 24.42 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 108.087 -2.005 . . . . 1.12 108.087 171.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.6 mt -102.23 133.7 20.46 Favored Pre-proline 0 N--CA 1.431 -1.401 0 N-CA-C 104.838 -2.282 . . . . 1.55 104.838 -174.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -76.07 161.87 35.09 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 O-C-N 115.105 -3.156 . . . . 1.02 114.21 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -70.76 -25.2 24.23 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 C-N-CA 122.867 2.378 . . . . 1.25 114.559 -170.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -74.03 -26.45 60.42 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.439 1.59 . . . . 2.25 112.247 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -84.31 -12.03 55.34 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.371 -1.456 . . . . 2.02 113.684 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -91.01 122.22 33.48 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 122.178 0.989 . . . . 0.69 110.849 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -101.06 102.64 13.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.603 1.192 . . . . 2.78 112.152 166.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.0 mt -84.73 125.43 32.54 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 115.925 1.824 . . . . 1.17 115.925 171.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.61 125.48 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 127.979 2.512 . . . . 1.38 108.461 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -132.52 126.9 33.97 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.96 -1.088 . . . . 1.5 110.572 173.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.21 -40.19 0.24 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.264 2.626 . . . . 1.21 116.56 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.44 -7.46 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.668 0 C-N-CA 128.812 3.101 . . . . 1.3 111.286 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -94.34 132.37 39.01 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 126.42 1.888 . . . . 2.55 110.82 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -87.75 148.24 24.82 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 107.347 -1.353 . . . . 2.48 107.347 172.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.35 6.9 mt -107.26 120.65 42.71 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.916 2.886 . . . . 0.9 110.41 -159.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.405 ' CD ' ' HE ' ' A' ' 54' ' ' ARG . 80.3 tt0 -88.32 136.95 32.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 129.027 3.954 . . . . 1.94 111.912 178.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -57.47 -59.94 4.4 Favored 'General case' 0 N--CA 1.431 -1.422 2 C-N-CA 134.983 5.313 . . . . 1.56 116.131 -168.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.11 29.11 2.81 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 119.687 -1.883 . . . . 0.97 115.998 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.405 ' HE ' ' CD ' ' A' ' 51' ' ' GLU . 28.8 mmt180 -105.47 156.12 18.51 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.283 -2.304 . . . . 2.49 108.489 165.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.3 p -93.05 170.35 9.72 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 119.918 -1.738 . . . . 0.76 109.267 172.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.0 mt -56.94 -41.49 78.34 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.711 2.805 . . . . 1.05 115.337 167.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.9 t -64.6 -32.15 73.68 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 128.504 2.722 . . . . 1.19 115.289 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -81.88 -21.02 37.69 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.378 2.671 . . . . 1.9 112.27 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -98.01 -11.96 22.44 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.595 -1.261 . . . . 0.89 107.595 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 67.63 42.92 1.95 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 128.122 3.82 . . . . 1.84 111.242 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.9 mt -89.75 114.05 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 126.836 3.208 . . . . 0.82 113.627 172.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -101.84 -165.93 1.24 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.524 -1.985 . . . . 2.16 105.777 -172.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -73.47 166.06 23.92 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 118.742 2.867 . . . . 2.12 118.742 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.554 13.5 pt-20 63.53 18.07 10.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.758 -2.464 . . . . 1.71 115.976 176.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.7 p -90.82 151.14 21.29 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.735 -1.575 . . . . 1.04 109.36 -175.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.0 m -118.74 92.84 3.91 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.465 1.602 . . . . 0.79 112.249 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.0 mt -75.0 136.79 41.25 Favored 'General case' 0 N--CA 1.43 -1.475 1 C-N-CA 132.851 4.46 . . . . 1.4 109.473 174.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -107.04 132.06 53.38 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.469 -2.019 . . . . 1.51 111.562 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.4 tp -113.15 112.54 23.97 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 128.273 3.892 . . . . 1.14 106.831 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.418 HG22 HD21 ' A' ' 8' ' ' LEU . 18.3 t -107.66 146.15 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 129.256 3.022 . . . . 1.23 105.357 174.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tm? . . . . . 0 N--CA 1.43 -1.435 0 N-CA-C 106.12 -1.807 . . . . 2.78 106.12 177.483 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 CA--C 1.49 -1.329 0 N-CA-C 114.211 1.189 . . . . 1.1 114.211 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.385 2.4 mp0 -94.27 130.89 40.37 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 116.518 -1.706 . . . . 1.87 113.96 -174.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.2 pt -123.35 159.61 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 119.266 0.939 . . . . 0.72 110.828 172.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -111.75 135.73 51.96 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.527 -2.608 . . . . 1.4 112.688 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.01 125.11 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 119.509 -1.994 . . . . 0.58 106.308 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -102.9 148.55 25.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.105 2.128 . . . . 2.09 112.916 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.261 6.4 p -98.55 159.05 15.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 125.377 1.673 . . . . 0.99 114.546 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.1 mt -49.82 -38.63 35.56 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.543 -2.598 . . . . 2.53 117.619 171.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.0 p -83.63 -12.33 56.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.481 2.562 . . . . 2.08 112.313 -171.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.42 7.09 26.7 Favored Glycine 0 N--CA 1.43 -1.754 0 CA-C-N 112.426 -2.17 . . . . 1.31 116.722 174.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -80.46 144.18 32.79 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 123.205 3.502 . . . . 1.4 109.053 -179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.9 m -125.94 94.44 4.11 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 106.982 -1.488 . . . . 0.78 106.982 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.4 4.4 pt -76.53 142.41 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 128.374 2.67 . . . . 1.55 112.427 174.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -108.32 129.7 55.22 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.545 -2.391 . . . . 1.08 104.545 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.8 mt -117.0 165.11 13.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 126.425 2.328 . . . . 1.55 107.307 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.296 66.1 tt0 -116.1 121.54 42.46 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.519 -2.613 . . . . 1.95 106.352 178.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.431 HG12 ' HE3' ' A' ' 29' ' ' LYS . 21.8 m -132.34 168.83 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 116.516 -1.707 . . . . 0.96 115.396 176.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -116.54 160.04 37.84 Favored Pre-proline 0 N--CA 1.43 -1.448 0 O-C-N 127.56 3.037 . . . . 2.35 107.21 167.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -65.42 -25.78 55.82 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 123.714 2.943 . . . . 0.95 112.62 -177.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 m -81.75 3.93 23.87 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 117.361 2.356 . . . . 1.45 117.361 172.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.58 137.56 40.87 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.543 -1.973 . . . . 1.69 109.673 173.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 p -73.92 157.3 36.52 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.96 -2.962 . . . . 0.75 112.523 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.7 mm -56.45 -32.66 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 123.984 1.849 . . . . 0.73 114.493 170.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -59.28 -44.1 92.48 Favored 'General case' 0 N--CA 1.43 -1.469 1 O-C-N 115.718 -4.364 . . . . 1.62 110.399 165.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -66.66 -32.09 73.18 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 116.978 -3.576 . . . . 2.13 110.344 175.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.559 HG21 HD21 ' A' ' 56' ' ' LEU . 34.4 t -66.09 -51.25 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 121.125 1.784 . . . . 0.62 107.811 175.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -59.4 -33.26 71.0 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.118 -3.489 . . . . 1.22 112.076 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.33 -19.31 65.9 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 116.648 2.092 . . . . 0.51 116.648 171.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.431 ' HE3' HG12 ' A' ' 17' ' ' VAL . 39.8 mttm -85.2 -18.81 32.95 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 123.488 2.858 . . . . 1.44 107.155 176.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.9 mt -87.46 -24.43 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 108.129 -1.063 . . . . 1.32 108.129 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -65.66 -44.05 87.47 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.464 2.764 . . . . 1.7 118.464 166.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -60.13 -62.2 2.04 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 113.701 -1.59 . . . . 1.55 110.37 168.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -69.58 -63.99 0.97 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.62 2.082 . . . . 2.62 116.62 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -87.41 -33.38 19.11 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.613 2.149 . . . . 1.48 114.944 -170.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.68 34.18 2.11 Favored Glycine 0 N--CA 1.43 -1.743 0 O-C-N 118.767 -2.458 . . . . 1.12 113.744 169.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.2 mt -108.8 123.11 38.05 Favored Pre-proline 0 N--CA 1.431 -1.424 0 O-C-N 119.884 -1.95 . . . . 1.55 105.786 -170.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -68.63 145.42 63.74 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 114.746 -3.344 . . . . 1.02 112.711 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.254 18.0 Cg_exo -66.18 -28.1 48.42 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 124.474 3.449 . . . . 1.25 117.295 -171.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.254 8.8 p-10 -56.94 -31.99 65.53 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.307 -3.995 . . . . 2.25 116.091 168.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -78.13 -25.38 47.36 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.725 2.01 . . . . 2.02 113.182 -176.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -90.91 147.9 22.82 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.767 1.627 . . . . 0.69 112.614 -173.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.272 91.8 mtt180 -122.71 146.75 47.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.982 -1.699 . . . . 2.78 108.131 162.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.0 mt -121.7 114.74 21.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.965 -1.71 . . . . 1.17 111.002 172.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.9 mt -104.22 116.2 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 117.771 -1.109 . . . . 1.38 111.312 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -112.9 131.79 55.58 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.009 -1.849 . . . . 1.5 106.009 170.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 82.48 -43.29 0.13 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.064 1.346 . . . . 1.21 111.189 172.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.28 -5.63 0.18 Allowed Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 114.423 -3.431 . . . . 1.3 107.05 -173.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -123.82 143.71 50.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 121.762 2.781 . . . . 2.55 113.258 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -69.17 138.85 54.46 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.026 -2.921 . . . . 2.48 115.407 173.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.7 mt -98.87 122.39 42.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.32 2.009 . . . . 0.9 105.848 -175.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -71.6 120.63 17.46 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 123.852 1.786 . . . . 1.94 115.111 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -44.78 -53.78 7.04 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.999 2.519 . . . . 1.56 114.536 -171.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.05 39.67 1.85 Allowed Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 118.471 2.149 . . . . 0.97 118.471 173.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -124.94 167.95 13.97 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 116.664 -3.844 . . . . 2.49 106.601 168.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.6 p -97.03 175.64 6.25 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.916 1.821 . . . . 0.76 115.916 169.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.559 HD21 HG21 ' A' ' 26' ' ' VAL . 5.5 mt -73.16 -22.65 60.46 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 127.037 3.303 . . . . 1.05 110.161 174.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -78.21 -41.33 34.8 Favored 'General case' 0 N--CA 1.43 -1.453 2 C-N-CA 133.464 4.706 . . . . 1.19 116.346 175.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -63.16 -32.68 74.12 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.801 1.762 . . . . 1.9 111.516 168.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -92.93 -0.45 57.22 Favored 'General case' 0 N--CA 1.431 -1.398 1 O-C-N 116.063 -4.148 . . . . 0.89 112.884 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 48.43 53.87 11.33 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.49 2.033 . . . . 1.84 116.49 -174.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.5 mt -97.06 129.42 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 129.155 2.982 . . . . 0.82 108.377 175.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -103.29 -167.97 1.45 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 115.536 1.68 . . . . 2.16 115.536 -172.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -55.63 139.53 44.21 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.022 1.119 . . . . 2.12 114.022 160.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.279 93.0 mt-10 60.0 52.22 5.35 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 120.097 3.369 . . . . 1.71 120.097 173.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.1 p -103.53 135.28 45.42 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.531 3.532 . . . . 1.04 109.399 -175.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 m -96.54 107.42 19.84 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 104.816 -2.29 . . . . 0.79 104.816 -176.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.0 mt -93.99 145.94 24.29 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 126.623 3.106 . . . . 1.4 104.122 170.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -111.15 118.93 37.33 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 112.996 -1.911 . . . . 1.51 107.766 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.0 tp -86.09 118.43 25.56 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.252 1.501 . . . . 1.14 109.003 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.13 129.74 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 124.862 2.267 . . . . 1.23 107.781 172.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.3 mt . . . . . 0 N--CA 1.43 -1.449 1 O-C-N 113.831 -5.543 . . . . 2.78 109.105 -178.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.342 0 N-CA-C 117.298 2.333 . . . . 1.1 117.298 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -93.19 115.39 28.01 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 119.991 3.33 . . . . 1.87 119.991 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.523 HG22 ' HB2' ' A' ' 65' ' ' SER . 8.9 pt -113.17 163.09 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-N 122.904 2.593 . . . . 0.72 109.842 173.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.298 79.6 m-85 -121.01 134.22 55.29 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.07 -1.456 . . . . 1.4 107.07 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.2 t -119.16 130.24 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 119.578 -1.951 . . . . 0.58 110.021 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -95.26 119.8 34.4 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.646 3.178 . . . . 2.09 106.511 -173.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -86.84 -173.71 4.6 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 115.914 -1.993 . . . . 0.99 108.204 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.7 mt -87.01 -29.27 22.1 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.423 2.689 . . . . 2.53 108.901 173.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -77.52 -7.71 56.69 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.618 2.451 . . . . 2.08 117.618 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.28 5.56 37.25 Favored Glycine 0 N--CA 1.43 -1.745 0 CA-C-O 124.183 1.991 . . . . 1.31 112.578 174.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -96.22 144.63 26.25 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.968 -2.489 . . . . 1.4 110.605 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -106.22 115.54 30.4 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 106.025 -1.843 . . . . 0.78 106.025 173.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -91.6 126.45 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 125.753 2.692 . . . . 1.55 107.606 173.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.5 m -96.94 113.59 25.14 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 116.536 -3.853 . . . . 1.08 111.051 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.0 mt -120.29 154.42 34.99 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 114.208 1.188 . . . . 1.55 114.208 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.444 ' O ' ' HE3' ' A' ' 29' ' ' LYS . 29.7 mt-10 -109.72 145.22 36.95 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.646 -0.872 . . . . 1.95 108.646 172.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -152.22 156.31 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 126.17 1.788 . . . . 0.96 108.874 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -95.51 154.13 39.35 Favored Pre-proline 0 N--CA 1.43 -1.465 0 CA-C-O 114.364 -2.732 . . . . 2.35 108.561 171.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 57.5 Cg_endo -74.31 -11.87 22.93 Favored 'Trans proline' 0 N--CA 1.433 -2.03 0 CA-C-N 126.902 3.501 . . . . 0.95 112.218 -172.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -78.96 4.78 13.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.946 2.499 . . . . 1.45 112.596 173.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -93.56 151.76 19.48 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 126.957 2.103 . . . . 1.69 115.584 173.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.5 p -82.55 161.07 22.43 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.24 -2.788 . . . . 0.75 115.933 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mm -60.8 -34.82 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.079 -2.888 . . . . 0.73 115.387 170.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -48.27 -36.29 13.78 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 120.402 3.482 . . . . 1.62 120.402 158.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -62.0 -33.37 74.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.715 -2.491 . . . . 2.13 113.955 175.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.91 -41.25 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 127.159 2.183 . . . . 0.62 112.752 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -67.54 -34.23 76.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 113.878 -1.51 . . . . 1.22 112.32 174.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.6 -41.32 98.34 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.773 -1.829 . . . . 0.51 115.814 170.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HE3' ' O ' ' A' ' 16' ' ' GLU . 58.9 mttm -62.59 -38.26 89.46 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.1 -2.25 . . . . 1.44 114.367 168.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.41 92.7 mt -62.23 -35.52 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-O 126.888 3.233 . . . . 1.32 113.836 174.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -66.56 -31.54 72.31 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.23 -2.169 . . . . 1.7 115.057 174.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -73.22 -53.78 10.07 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.236 -1.024 . . . . 1.55 108.236 171.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -65.41 -50.23 66.25 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.917 1.451 . . . . 2.62 114.917 -174.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -108.19 -48.95 3.27 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 126.269 1.828 . . . . 1.48 113.405 -172.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.27 16.66 3.83 Favored Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 119.445 -1.36 . . . . 1.12 114.863 175.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 mt -88.88 131.01 42.7 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 115.495 -2.193 . . . . 1.55 110.052 -174.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -69.21 161.68 44.85 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 CA-C-N 126.453 3.34 . . . . 1.02 117.924 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.96 -1.86 8.78 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 CA-C-N 122.574 1.955 . . . . 1.25 113.287 -167.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -84.47 -26.27 28.32 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 116.137 -4.102 . . . . 2.25 111.998 176.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -83.92 -34.49 24.48 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.676 -2.515 . . . . 2.02 111.006 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -76.42 121.0 22.43 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 117.8 2.519 . . . . 0.69 117.8 -175.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.6 mtt85 -103.0 164.51 11.57 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 125.574 1.796 . . . . 2.78 106.365 167.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.1 mp -129.85 134.02 47.28 Favored 'General case' 0 CA--C 1.489 -1.387 0 O-C-N 117.636 -3.165 . . . . 1.17 112.026 170.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.2 mt -125.21 124.92 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 CA-C-O 128.564 4.03 . . . . 1.38 109.524 177.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -127.99 139.74 52.39 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 115.379 -4.576 . . . . 1.5 107.072 171.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.302 . . 52.35 25.83 3.71 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.632 2.773 . . . . 1.21 115.764 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.99 13.1 72.62 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-O 114.17 -3.572 . . . . 1.3 110.906 -176.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -125.17 129.66 50.58 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.639 2.22 . . . . 2.55 105.211 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.288 16.7 tt0 -83.33 125.56 31.77 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.153 2.981 . . . . 2.48 111.022 173.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.438 HD22 ' CE1' ' A' ' 59' ' ' TYR . 53.4 mt -79.26 164.47 24.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.294 -1.775 . . . . 0.9 112.58 -167.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -95.3 153.36 17.71 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.622 -1.992 . . . . 1.94 105.622 175.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -79.76 -50.69 10.19 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.665 -1.272 . . . . 1.56 111.943 -167.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.62 60.23 3.62 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 120.562 2.985 . . . . 0.97 120.562 171.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -126.19 166.96 16.1 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 104.86 -2.274 . . . . 2.49 104.86 165.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.3 p -97.8 162.0 13.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.872 -2.64 . . . . 0.76 103.872 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 5.0 mt -63.99 -27.94 69.47 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 112.762 -2.017 . . . . 1.05 115.794 174.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.9 t -59.89 -45.78 91.44 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.817 2.447 . . . . 1.19 109.001 176.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -55.46 -31.93 62.36 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.867 -2.396 . . . . 1.9 116.257 175.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.438 ' CE1' HD22 ' A' ' 50' ' ' LEU . 88.2 m-85 -85.2 -0.42 54.56 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.195 1.798 . . . . 0.89 112.029 174.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.289 18.7 m120 49.26 50.91 17.25 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.935 -3.603 . . . . 1.84 115.512 -171.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.274 83.7 mt -93.38 125.02 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 127.545 2.338 . . . . 0.82 105.308 -173.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -105.77 -175.96 2.94 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.556 3.142 . . . . 2.16 107.411 -172.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -72.21 159.31 34.31 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.417 -1.427 . . . . 2.12 110.141 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 59.53 48.53 9.58 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.685 1.994 . . . . 1.71 112.828 174.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.523 ' HB2' HG22 ' A' ' 3' ' ' ILE . 34.6 m -111.85 137.57 49.63 Favored 'General case' 0 N--CA 1.429 -1.476 1 N-CA-C 99.314 -4.328 . . . . 1.04 99.314 -169.822 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.6 m -102.53 108.51 19.84 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.608 1.963 . . . . 0.79 109.861 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.8 mt -105.01 148.77 26.38 Favored 'General case' 0 CA--C 1.489 -1.39 0 CA-C-O 123.559 1.647 . . . . 1.4 113.897 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -102.39 132.35 48.45 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.204 -3.435 . . . . 1.51 109.764 -173.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.1 tp -91.66 119.36 31.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.224 -2.797 . . . . 1.14 109.507 175.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.21 137.26 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 O-C-N 118.11 -2.869 . . . . 1.23 107.041 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.431 -1.399 0 C-N-CA 116.804 -1.958 . . . . 2.78 110.769 172.956 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 115.436 1.643 . . . . 1.1 115.436 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -83.83 148.04 27.22 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 114.806 -2.521 . . . . 1.87 109.561 -176.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -142.43 168.43 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 1 O-C-N 130.8 5.062 . . . . 0.72 107.97 170.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -117.88 156.68 28.01 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 114.455 1.28 . . . . 1.4 114.455 171.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.9 t -134.36 128.04 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 101.381 -3.563 . . . . 0.58 101.381 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -98.92 106.88 19.19 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.905 2.187 . . . . 2.09 116.905 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.262 4.8 p -58.13 165.43 1.93 Allowed 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 125.508 1.523 . . . . 0.99 112.571 176.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.3 94.7 mt -60.18 -54.89 40.42 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 130.867 3.667 . . . . 2.53 110.995 176.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 p -76.8 -12.23 59.95 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 117.84 -3.038 . . . . 2.08 113.264 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.65 2.21 5.36 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 122.285 2.311 . . . . 1.31 113.448 166.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -77.02 143.23 39.49 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 116.241 -4.093 . . . . 1.4 114.027 -175.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.0 m -85.44 125.92 33.39 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.144 0.977 . . . . 0.78 112.446 166.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.3 mt -100.51 112.89 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 104.999 -2.223 . . . . 1.55 104.999 171.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 m -87.99 145.49 25.98 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 116.031 -2.267 . . . . 1.08 108.479 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.3 mt -141.17 174.89 10.1 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 120.427 1.467 . . . . 1.55 109.308 175.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -126.18 119.66 28.08 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.682 1.993 . . . . 1.95 110.288 167.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 m -121.19 153.49 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 126.447 1.899 . . . . 0.96 110.702 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.278 17.7 mm-40 -101.84 175.84 2.13 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-N 125.2 3.636 . . . . 2.35 110.957 155.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -74.76 -20.17 17.74 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 121.23 1.475 . . . . 0.95 110.106 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.8 m -76.21 -8.93 58.13 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 120.328 3.455 . . . . 1.45 120.328 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -80.45 142.5 34.23 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 116.772 -3.705 . . . . 1.69 110.198 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 38.4 p -82.99 179.98 7.61 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 123.275 1.512 . . . . 0.75 111.703 -176.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.9 mm -82.62 -31.12 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 116.657 -3.777 . . . . 0.73 109.201 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -63.41 -28.76 70.2 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.18 -2.2 . . . . 1.62 115.404 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -66.71 -46.08 76.67 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.005 1.722 . . . . 2.13 113.414 172.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.2 t -62.67 -42.11 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 119.148 -2.22 . . . . 0.62 109.554 176.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -71.46 -8.31 53.06 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 118.222 2.675 . . . . 1.22 118.222 169.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.03 -39.76 19.22 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.369 1.08 . . . . 0.51 112.828 169.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -59.24 -40.84 87.18 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.324 1.85 . . . . 1.44 111.186 174.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.7 mt -74.67 -26.35 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 115.588 1.699 . . . . 1.32 115.588 170.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -62.18 -39.23 92.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.481 -2.012 . . . . 1.7 113.49 167.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -55.8 -47.66 76.74 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 116.277 1.955 . . . . 1.55 116.277 165.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -90.06 -51.42 5.47 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 115.735 1.754 . . . . 2.62 115.735 -167.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -98.54 -39.44 8.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 106.038 -1.838 . . . . 1.48 106.038 -171.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.47 18.16 6.29 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 120.933 3.133 . . . . 1.12 120.933 174.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.2 mt -103.71 120.75 50.47 Favored Pre-proline 0 N--CA 1.43 -1.437 1 C-N-CA 134.775 5.23 . . . . 1.55 108.374 -163.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -57.28 137.17 80.43 Favored 'Trans proline' 0 C--N 1.299 -2.052 2 C-N-CA 125.726 4.284 . . . . 1.02 116.749 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -67.59 -12.58 36.12 Favored 'Trans proline' 0 N--CA 1.434 -2.027 0 CA-C-N 127.978 3.885 . . . . 1.25 120.197 -172.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -78.41 -16.1 57.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.633 1.973 . . . . 2.25 112.483 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -92.01 -37.41 12.84 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.407 -2.058 . . . . 2.02 110.979 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -69.47 126.99 31.43 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.68 2.392 . . . . 0.69 112.051 -171.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.44 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 29.9 mtt180 -103.99 126.73 51.33 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 120.303 -1.498 . . . . 2.78 110.952 158.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 43' ' ' LEU . 83.0 mt -104.84 118.12 35.75 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.356 -2.715 . . . . 1.17 106.427 175.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.5 mm -112.8 141.44 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.669 1.988 . . . . 1.38 105.831 -174.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -154.8 124.26 6.45 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.535 -1.654 . . . . 1.5 106.535 169.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.47 37.83 2.55 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 126.703 2.502 . . . . 1.21 110.383 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.13 -23.51 4.5 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 118.031 -2.033 . . . . 1.3 116.131 -175.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -87.23 142.07 28.17 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.554 -1.556 . . . . 2.55 114.831 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -87.0 135.03 33.42 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.354 -2.716 . . . . 2.48 108.864 172.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.6 mt -93.09 128.77 39.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.887 -1.133 . . . . 0.9 112.54 -175.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -84.32 132.01 34.65 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 117.604 2.446 . . . . 1.94 117.604 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -40.53 -67.93 0.21 Allowed 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 121.22 3.785 . . . . 1.56 121.22 -165.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.25 58.03 5.05 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 118.011 1.964 . . . . 0.97 118.011 171.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -129.09 157.85 40.6 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 103.562 -2.755 . . . . 2.49 103.562 168.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 68.2 p -98.92 167.51 10.7 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.955 -1.716 . . . . 0.76 113.603 175.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.87 -24.81 66.94 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.993 -1.692 . . . . 1.05 115.305 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.5 t -69.4 -39.7 77.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.586 1.954 . . . . 1.19 109.654 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -55.28 -40.01 70.53 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 115.446 1.647 . . . . 1.9 115.446 171.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -88.67 -2.03 58.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.046 1.738 . . . . 0.89 113.296 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 59.08 50.75 7.77 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 123.14 1.448 . . . . 1.84 110.853 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.7 mm -85.97 126.66 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-O 125.687 2.66 . . . . 0.82 105.699 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -91.92 174.21 7.45 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.572 -2.58 . . . . 2.16 113.476 -176.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.3 pttt -70.13 147.02 50.43 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.164 1.459 . . . . 2.12 113.65 173.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.322 41.1 mt-10 61.97 35.58 16.08 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 119.139 -2.225 . . . . 1.71 114.674 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 t -102.62 149.42 24.45 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 124.326 1.05 . . . . 1.04 110.505 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.5 m -96.95 110.68 23.16 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.058 2.543 . . . . 0.79 113.031 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.8 mt -90.03 153.13 20.8 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 118.065 -1.454 . . . . 1.4 109.966 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -104.19 123.82 48.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.125 1.44 . . . . 1.51 112.599 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.1 tp -94.46 128.79 41.25 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.126 -4.109 . . . . 1.14 108.282 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 89.0 t -120.87 154.21 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 102.239 -3.245 . . . . 1.23 102.239 172.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 N--CA 1.429 -1.515 0 O-C-N 120.594 -1.316 . . . . 2.78 108.587 -175.784 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 CA--C 1.491 -1.324 0 CA-C-O 118.376 -0.821 . . . . 1.1 112.089 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -99.27 126.98 45.21 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.727 0.775 . . . . 1.87 111.232 -176.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.6 pt -114.69 164.45 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 105.663 -1.977 . . . . 0.72 105.663 173.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -119.2 135.01 54.88 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 105.26 -2.126 . . . . 1.4 105.26 -175.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.5 t -117.79 118.22 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 102.98 -2.97 . . . . 0.58 102.98 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -108.98 135.92 49.36 Favored 'General case' 0 N--CA 1.429 -1.485 2 O-C-N 115.639 -4.413 . . . . 2.09 108.05 175.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.56 HG22 HD23 ' A' ' 69' ' ' LEU . 59.1 p -87.32 -177.05 5.86 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 125.119 2.39 . . . . 0.99 115.752 176.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.78 -30.31 64.0 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 124.733 2.206 . . . . 2.53 114.794 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p -77.94 -51.04 11.02 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 114.549 -5.094 . . . . 2.08 110.526 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.61 35.68 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.748 0 O-C-N 118.552 -2.593 . . . . 1.31 111.777 173.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -102.42 108.46 19.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.931 -2.248 . . . . 1.4 104.931 -170.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.9 m -83.7 114.9 21.9 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.535 2.734 . . . . 0.78 106.694 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.4 mt -101.54 146.43 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 100.522 -3.881 . . . . 1.55 100.522 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.7 m -118.21 130.82 56.3 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.851 2.739 . . . . 1.08 103.853 174.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.3 mt -125.75 139.98 53.07 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 113.275 -1.784 . . . . 1.55 108.283 -177.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.27 48.0 mt-10 -103.32 129.91 50.47 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 123.929 1.823 . . . . 1.95 111.341 170.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 m -137.31 166.22 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 113.929 -1.487 . . . . 0.96 110.669 -169.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -105.55 167.23 10.03 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 119.25 -2.156 . . . . 2.35 109.679 161.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -70.89 -13.1 31.6 Favored 'Trans proline' 0 N--CA 1.434 -1.99 0 N-CA-C 118.999 2.653 . . . . 0.95 118.999 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.8 p -93.11 4.22 54.38 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.499 1.92 . . . . 1.45 115.5 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -80.2 144.27 33.09 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 126.378 2.99 . . . . 1.69 111.929 170.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.3 p -80.27 158.62 26.12 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 128.335 2.654 . . . . 0.75 108.108 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.6 mm -64.99 -36.75 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 103.031 -2.951 . . . . 0.73 103.031 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -55.16 -46.26 75.73 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.353 -3.342 . . . . 1.62 117.259 170.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -64.28 -37.98 89.43 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 115.785 1.772 . . . . 2.13 115.785 171.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.5 t -53.2 -44.55 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 118.418 -2.676 . . . . 0.62 114.684 167.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt -62.56 -46.63 87.48 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.318 -1.489 . . . . 1.22 114.57 173.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.1 -37.4 69.32 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.782 1.633 . . . . 0.51 112.281 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -68.37 -31.2 70.4 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 117.052 -1.451 . . . . 1.44 112.865 173.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.1 mt -68.68 -41.69 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 120.153 1.342 . . . . 1.32 108.337 173.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -53.57 -45.47 69.93 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 117.575 -3.203 . . . . 1.7 114.148 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.27 20.9 t70 -55.49 -68.06 0.23 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.074 -1.642 . . . . 1.55 109.761 167.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -59.82 -55.4 34.68 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 119.436 3.124 . . . . 2.62 119.436 -173.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -95.03 -51.23 4.74 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.092 2.557 . . . . 1.48 113.449 -169.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.56 24.7 2.81 Favored Glycine 0 N--CA 1.43 -1.733 0 CA-C-O 116.942 -2.032 . . . . 1.12 115.771 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.9 mm -103.62 135.12 19.42 Favored Pre-proline 0 N--CA 1.429 -1.484 0 CA-C-N 121.63 2.715 . . . . 1.55 108.777 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -67.48 137.64 43.53 Favored 'Trans proline' 0 C--N 1.3 -1.998 3 C-N-CA 126.452 4.768 . . . . 1.02 115.355 178.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -59.14 -21.13 57.93 Favored 'Trans proline' 0 C--N 1.299 -2.047 1 C-N-CA 129.349 6.699 . . . . 1.25 111.461 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -62.59 -39.11 92.68 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 126.299 2.952 . . . . 2.25 114.292 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -77.75 -30.68 51.66 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 114.613 -5.054 . . . . 2.02 110.026 -173.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -79.44 151.02 31.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.703 -1.248 . . . . 0.69 112.495 -164.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -139.82 156.09 46.92 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 106.341 -1.725 . . . . 2.78 106.341 168.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 42.1 mt -136.59 126.43 25.74 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 118.86 0.754 . . . . 1.17 111.322 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.8 mm -104.62 145.93 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 O-C-N 126.471 2.357 . . . . 1.38 106.257 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -134.42 126.45 29.55 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 116.893 -3.629 . . . . 1.5 102.288 165.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.22 -55.9 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.45 1 C-N-CA 135.027 5.331 . . . . 1.21 118.945 -175.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.85 -16.8 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.723 0 O-C-N 120.132 -1.605 . . . . 1.3 113.757 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -95.29 162.36 13.71 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.542 1.537 . . . . 2.55 111.063 -178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -116.58 126.33 53.13 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.623 1.569 . . . . 2.48 107.139 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.3 mt -90.42 132.3 35.7 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 125.706 1.879 . . . . 0.9 108.748 -162.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -60.12 143.76 51.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.181 -2.825 . . . . 1.94 113.074 172.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -70.21 -43.21 71.14 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 112.899 -6.126 . . . . 1.56 113.92 -169.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.62 53.25 1.29 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 125.949 2.971 . . . . 0.97 109.718 174.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.5 mtt-85 -120.87 155.21 34.64 Favored 'General case' 0 N--CA 1.43 -1.468 1 N-CA-C 100.069 -4.049 . . . . 2.49 100.069 165.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.4 p -90.56 167.41 12.58 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 124.68 1.237 . . . . 0.76 113.346 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 mt -65.22 -42.93 92.97 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 127.299 2.874 . . . . 1.05 112.735 169.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.2 t -59.0 -40.11 83.91 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 120.041 1.291 . . . . 1.19 114.34 175.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.1 -40.96 95.71 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.726 2.121 . . . . 1.9 116.726 175.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -79.04 -10.1 59.73 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.77 1.294 . . . . 0.89 113.661 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.9 m120 68.33 40.19 2.11 Favored 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 135.507 5.523 . . . . 1.84 114.661 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.9 mt -72.33 139.6 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 127.328 2.251 . . . . 0.82 106.974 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -119.21 -178.48 3.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.942 2.306 . . . . 2.16 106.857 -175.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -65.43 147.66 53.04 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.117 2.389 . . . . 2.12 116.125 167.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.272 34.8 mt-10 70.31 21.57 5.73 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.673 1.989 . . . . 1.71 113.852 173.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -92.92 141.15 28.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.621 1.677 . . . . 1.04 108.778 -175.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.2 m -96.22 100.56 12.19 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 129.266 3.026 . . . . 0.79 112.721 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.326 18.6 mt -83.13 150.88 25.99 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 128.421 3.962 . . . . 1.4 103.699 170.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -106.92 98.93 8.53 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 110.365 -3.107 . . . . 1.51 116.919 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.56 HD23 HG22 ' A' ' 7' ' ' THR . 24.9 tp -63.65 116.69 5.91 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 116.914 2.19 . . . . 1.14 116.914 169.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.9 m -131.69 -178.78 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 102.779 -3.045 . . . . 1.23 102.779 175.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.9 mt . . . . . 0 N--CA 1.43 -1.46 0 N-CA-C 105.256 -2.127 . . . . 2.78 105.256 179.044 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.344 0 CA-C-O 118.34 -0.838 . . . . 1.1 111.149 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -95.66 131.4 41.94 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 116.302 1.964 . . . . 1.87 116.302 -171.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.9 pt -126.92 165.93 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 115.093 -2.385 . . . . 0.72 111.742 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -125.88 127.68 46.41 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 125.946 2.029 . . . . 1.4 106.321 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.9 t -112.83 111.9 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 CA-C-N 115.503 -0.771 . . . . 0.58 109.633 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -93.63 135.67 34.68 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 116.852 -3.655 . . . . 2.09 111.496 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.3 p -84.2 -167.64 1.84 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.844 -1.785 . . . . 0.99 109.559 173.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.0 mt -91.96 -23.48 19.56 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.107 -2.245 . . . . 2.53 112.226 171.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.1 p -80.96 -47.64 13.38 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.035 1.124 . . . . 2.08 114.035 -173.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.17 25.3 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 116.615 -2.707 . . . . 1.31 111.686 176.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -118.47 124.45 47.64 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.492 -0.929 . . . . 1.4 108.492 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -102.41 118.56 37.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 124.579 1.175 . . . . 0.78 110.231 167.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mt -105.22 129.45 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 127.832 2.453 . . . . 1.55 110.128 -170.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.4 m -99.34 110.06 22.61 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 127.427 2.954 . . . . 1.08 108.318 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.1 mt -121.49 147.07 46.26 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.059 2.838 . . . . 1.55 109.728 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -99.3 125.71 44.99 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.509 -3.869 . . . . 1.95 114.495 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.48 HG12 ' HE3' ' A' ' 29' ' ' LYS . 32.6 m -124.9 150.38 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 117.8 -3.063 . . . . 0.96 106.134 -176.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -86.21 140.23 34.49 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 112.907 -3.425 . . . . 2.35 113.018 166.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -77.44 5.14 5.35 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 CA-C-N 126.878 3.492 . . . . 0.95 112.69 -166.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 p -106.17 9.63 32.17 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.939 -2.976 . . . . 1.45 111.841 173.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -91.23 157.26 17.27 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 124.64 2.162 . . . . 1.69 110.253 171.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.422 ' O ' HG23 ' A' ' 26' ' ' VAL . 43.9 p -83.37 165.7 19.04 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.679 -2.513 . . . . 0.75 107.392 -175.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.412 11.3 mm -68.42 -37.49 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 C-N-CA 128.101 2.56 . . . . 0.73 110.51 176.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -56.96 -34.1 67.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 126.789 3.185 . . . . 1.62 115.966 169.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -83.05 -26.42 31.17 Favored 'General case' 0 N--CA 1.432 -1.374 1 O-C-N 111.808 -6.807 . . . . 2.13 113.405 177.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 22' ' ' THR . 44.3 t -52.66 -44.61 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.384 1.873 . . . . 0.62 113.436 165.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -67.38 -40.28 85.69 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.973 -2.329 . . . . 1.22 111.371 175.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.43 76.58 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.321 2.01 . . . . 0.51 113.808 175.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HE3' HG12 ' A' ' 17' ' ' VAL . 14.3 ttmm -64.66 -46.76 81.08 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 118.93 -2.356 . . . . 1.44 116.522 163.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.6 mt -61.51 -26.96 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 117.299 -3.376 . . . . 1.32 114.588 167.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -67.43 -45.47 75.98 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.851 -3.655 . . . . 1.7 109.905 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.26 -36.94 76.43 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 118.796 -2.44 . . . . 1.55 106.338 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -76.02 -55.94 5.13 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 123.585 2.902 . . . . 2.62 113.073 -171.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -112.32 -15.9 13.06 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 126.097 2.123 . . . . 1.48 115.146 -164.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.79 21.2 40.61 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-O 123.048 1.36 . . . . 1.12 115.375 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 mt -101.55 131.98 22.33 Favored Pre-proline 0 N--CA 1.43 -1.467 0 O-C-N 121.013 -1.287 . . . . 1.55 111.059 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.408 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 30.7 Cg_exo -70.47 145.0 51.84 Favored 'Trans proline' 0 C--N 1.3 -2.003 1 C-N-CA 126.302 4.668 . . . . 1.02 115.27 178.924 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -72.58 -6.52 19.2 Favored 'Trans proline' 0 N--CA 1.433 -2.03 1 C-N-CA 127.45 5.434 . . . . 1.25 117.21 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.98 -39.45 30.08 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.851 -1.781 . . . . 2.25 108.669 169.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -73.65 -36.46 65.39 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 125.163 1.539 . . . . 2.02 113.422 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 37' ' ' PRO . 74.3 mt-30 -74.04 135.06 43.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.322 1.23 . . . . 0.69 114.322 -175.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.1 ttt180 -122.13 117.68 26.84 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 114.859 -2.496 . . . . 2.78 107.901 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.1 mt -100.77 125.55 47.26 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 125.291 2.472 . . . . 1.17 105.935 -176.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.1 mt -106.05 142.71 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 1 O-C-N 115.903 -4.248 . . . . 1.38 101.904 176.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -153.8 133.56 13.03 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 127.486 3.517 . . . . 1.5 106.252 172.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.22 -57.99 0.28 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.064 2.546 . . . . 1.21 115.244 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -159.84 -18.59 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 108.616 -1.794 . . . . 1.3 108.616 -173.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -134.88 163.41 29.88 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.317 -3.461 . . . . 2.55 112.223 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.3 pm0 -71.16 152.7 43.14 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 117.81 -1.091 . . . . 2.48 111.885 170.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.2 mt -97.89 172.57 7.57 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.894 2.134 . . . . 0.9 114.538 -171.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -104.68 153.57 21.09 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.037 -2.914 . . . . 1.94 110.591 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -89.47 -52.05 5.23 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.284 -2.76 . . . . 1.56 109.085 -163.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.84 46.1 1.7 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 117.233 1.653 . . . . 0.97 117.233 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.353 17.7 mmt180 -128.22 165.92 19.56 Favored 'General case' 0 CA--C 1.489 -1.38 0 O-C-N 119.499 -2.177 . . . . 2.49 106.643 168.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.288 27.2 p -99.36 170.55 8.56 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.233 1.568 . . . . 0.76 115.233 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' A' ' 61' ' ' ILE . 11.3 mt -63.15 -40.32 97.22 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 127.2 2.2 . . . . 1.05 107.926 171.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 m -65.47 -48.85 71.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.634 3.174 . . . . 1.19 110.891 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -52.49 -41.82 63.72 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.427 1.584 . . . . 1.9 114.334 174.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -82.33 -7.23 59.63 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.424 -2.047 . . . . 0.89 114.062 175.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.1 t30 56.44 43.83 25.37 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.414 3.485 . . . . 1.84 112.535 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' A' ' 56' ' ' LEU . 62.9 mt -75.59 109.87 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-N 111.927 -2.397 . . . . 0.82 113.1 177.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -82.78 -178.19 7.01 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 120.435 -1.416 . . . . 2.16 107.855 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -66.5 149.3 50.64 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 125.083 1.353 . . . . 2.12 111.075 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 69.09 33.75 3.28 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 131.557 3.943 . . . . 1.71 107.668 168.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m -96.42 139.6 32.29 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 121.507 1.958 . . . . 1.04 111.713 -176.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 m -99.98 115.96 30.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.43 1.468 . . . . 0.79 110.939 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mp -104.47 155.33 18.89 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 112.194 -2.276 . . . . 1.4 106.29 173.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -107.34 122.92 47.55 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.885 3.274 . . . . 1.51 113.666 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.9 tp -101.42 102.09 12.82 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.243 -3.411 . . . . 1.14 106.06 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.4 m -111.96 -177.05 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 126.685 2.491 . . . . 1.23 105.686 172.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.373 18.0 mt . . . . . 0 N--CA 1.43 -1.473 0 C-N-CA 119.473 -0.891 . . . . 2.78 109.319 -176.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ptt? . . . . . 0 CA--C 1.49 -1.341 0 CA-C-O 124.85 2.262 . . . . 1.1 110.814 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -109.81 123.75 50.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 112.496 -2.138 . . . . 1.87 111.779 -173.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.404 HD11 HD12 ' A' ' 15' ' ' LEU . 2.2 pp -123.83 162.1 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 129.932 3.293 . . . . 0.72 111.344 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -123.52 136.76 54.74 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 122.782 1.277 . . . . 1.4 107.812 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.4 t -110.34 124.64 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-N 112.053 -2.34 . . . . 0.58 110.346 174.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 mmtt -95.9 117.53 30.77 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.35 1.06 . . . . 2.09 109.617 174.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.404 HG22 HD23 ' A' ' 69' ' ' LEU . 64.2 p -77.65 -177.55 4.87 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.359 2.028 . . . . 0.99 109.556 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.7 tp -58.49 -50.76 72.56 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 114.656 -5.028 . . . . 2.53 116.736 174.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.7 p -68.86 -6.31 26.32 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 111.624 -2.535 . . . . 2.08 114.763 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.17 9.68 44.25 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 117.518 -3.239 . . . . 1.31 110.434 173.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -84.03 126.87 33.47 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 107.503 -1.295 . . . . 1.4 107.503 -171.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 m -93.72 121.71 35.44 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.259 -0.882 . . . . 0.78 112.368 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.0 mt -115.13 126.53 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 107.055 -1.461 . . . . 1.55 107.055 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.8 m -102.36 121.72 42.86 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.604 -1.31 . . . . 1.08 113.529 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.404 HD12 HD11 ' A' ' 3' ' ' ILE . 83.0 mt -115.52 155.13 28.09 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.351 -2.718 . . . . 1.55 110.517 -174.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -110.18 109.32 19.78 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 125.051 1.469 . . . . 1.95 110.306 171.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -123.64 173.41 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 126.192 1.797 . . . . 0.96 109.876 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -115.68 157.27 44.86 Favored Pre-proline 0 N--CA 1.429 -1.494 0 CA-C-O 115.18 -2.343 . . . . 2.35 113.42 166.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.23 2.26 8.7 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 C-N-CA 124.441 3.427 . . . . 0.95 115.472 -176.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.6 p -95.61 -25.71 16.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.086 1.513 . . . . 1.45 115.086 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -69.72 154.8 41.47 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.163 2.985 . . . . 1.69 112.607 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.269 71.7 p -81.77 149.16 28.54 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 112.281 -2.236 . . . . 0.75 112.91 -175.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 35.2 mm -52.85 -44.01 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 117.592 -1.194 . . . . 0.73 112.676 171.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -43.39 -50.96 6.72 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.427 2.691 . . . . 1.62 111.501 162.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -66.35 -36.89 84.02 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 115.999 1.851 . . . . 2.13 115.999 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.24 -45.93 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-O 125.901 2.762 . . . . 0.62 113.779 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.2 mtmt -53.24 -31.25 42.5 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.395 -2.066 . . . . 1.22 115.445 166.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.88 -20.64 60.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 120.015 -0.674 . . . . 0.51 112.366 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -70.37 -38.29 74.71 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.98 -2.325 . . . . 1.44 114.428 173.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.6 mt -68.98 -31.95 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 127.085 2.154 . . . . 1.32 111.977 169.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -65.89 -52.85 46.54 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 115.654 -4.404 . . . . 1.7 110.102 174.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -56.77 -47.68 79.56 Favored 'General case' 0 N--CA 1.431 -1.391 1 O-C-N 114.511 -5.118 . . . . 1.55 108.767 170.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -65.99 -63.32 1.11 Allowed 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 123.315 2.779 . . . . 2.62 117.244 -176.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -93.46 -43.61 8.65 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.666 -1.896 . . . . 1.48 111.631 -174.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.05 81.06 1.5 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 125.899 2.944 . . . . 1.12 106.357 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.7 mt -155.78 126.44 3.47 Favored Pre-proline 0 N--CA 1.43 -1.472 1 N-CA-C 99.03 -4.433 . . . . 1.55 99.03 -170.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -70.0 148.7 64.09 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 CA-C-N 122.725 2.009 . . . . 1.02 112.247 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.335 36.2 Cg_endo -67.64 -20.87 46.37 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 CA-C-N 125.994 3.177 . . . . 1.25 115.697 -175.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -63.79 -31.35 72.5 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 129.832 3.253 . . . . 2.25 113.733 175.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -89.06 -16.99 30.23 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 119.532 -1.98 . . . . 2.02 106.934 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -88.37 124.64 34.13 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.117 -4.739 . . . . 0.69 111.621 -176.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -116.72 133.74 55.65 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.537 -0.912 . . . . 2.78 108.537 171.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.4 mt -112.06 125.34 53.99 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 126.23 2.919 . . . . 1.17 108.861 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.6 mt -111.1 145.61 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 127.485 2.314 . . . . 1.38 104.778 176.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -150.71 135.62 17.5 Favored 'General case' 0 N--CA 1.43 -1.448 1 N-CA-C 99.878 -4.119 . . . . 1.5 99.878 178.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.24 47.6 21.97 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.893 2.758 . . . . 1.21 114.02 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.74 -2.34 54.79 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 127.633 2.54 . . . . 1.3 116.017 175.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm -123.75 143.82 50.06 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.524 -2.163 . . . . 2.55 114.249 -174.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -66.37 127.18 31.24 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 111.411 -2.631 . . . . 2.48 114.906 171.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 mt -92.27 119.89 32.3 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 110.258 -3.156 . . . . 0.9 108.389 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -77.38 151.12 34.98 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 117.127 -1.415 . . . . 1.94 113.375 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.432 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 7.1 m-20 -72.35 -53.48 12.23 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.932 2.197 . . . . 1.56 116.932 -169.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.73 29.33 0.62 Allowed Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 120.266 2.866 . . . . 0.97 120.266 169.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -118.17 174.98 5.9 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 120.213 2.007 . . . . 2.49 108.327 170.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.4 p -104.08 179.19 4.34 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 126.099 2.856 . . . . 0.76 111.624 175.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.8 mt -71.4 -33.89 69.87 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 116.464 -3.898 . . . . 1.05 113.213 171.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -57.25 -44.83 84.21 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 125.269 2.461 . . . . 1.19 110.159 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -54.95 -33.52 62.4 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.332 -2.73 . . . . 1.9 117.218 176.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -101.05 -2.41 31.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.165 -1.584 . . . . 0.89 109.148 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.257 6.6 m120 64.39 55.17 1.43 Allowed 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 116.825 2.157 . . . . 1.84 116.825 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.5 mt -100.16 132.27 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 110.568 -3.014 . . . . 0.82 107.5 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -115.65 -164.16 0.94 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 123.469 0.707 . . . . 2.16 111.621 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -67.6 153.36 43.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.952 2.501 . . . . 2.12 108.531 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 54.47 26.96 7.67 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.478 2.711 . . . . 1.71 117.089 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.252 47.2 m -94.08 144.85 25.12 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.358 -1.464 . . . . 1.04 109.971 -173.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.4 m -102.41 103.53 13.93 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 126.549 1.94 . . . . 0.79 111.661 -171.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 mt -84.22 160.52 20.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.322 1.849 . . . . 1.4 111.758 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -123.43 123.96 41.83 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.529 -2.607 . . . . 1.51 104.114 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.404 HD23 HG22 ' A' ' 7' ' ' THR . 23.1 tp -95.63 120.93 36.74 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.295 2.638 . . . . 1.14 109.318 176.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.296 14.1 m -116.94 163.13 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 127.899 2.48 . . . . 1.23 111.425 168.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.3 mt . . . . . 0 N--CA 1.431 -1.421 0 C-N-CA 117.48 -1.688 . . . . 2.78 111.914 179.852 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 tmm? . . . . . 0 CA--C 1.491 -1.299 0 CA-C-O 116.791 -1.576 . . . . 1.1 114.134 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -91.64 115.38 28.0 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.827 2.558 . . . . 1.87 113.149 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.9 pt -104.88 152.57 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 124.376 2.036 . . . . 0.72 113.015 165.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -111.46 113.74 26.39 Favored 'General case' 0 N--CA 1.429 -1.49 1 O-C-N 114.825 -4.922 . . . . 1.4 108.697 -174.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.7 t -98.13 106.5 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-O 124.082 1.896 . . . . 0.58 106.067 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -94.62 121.3 36.04 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.791 -2.443 . . . . 2.09 112.779 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 p -89.24 163.82 15.22 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.543 -1.348 . . . . 0.99 108.203 174.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.9 tp -44.8 -56.88 4.11 Favored 'General case' 0 N--CA 1.43 -1.433 1 C-N-CA 133.229 4.611 . . . . 2.53 110.842 174.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.7 p -72.59 -19.73 61.42 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 113.061 -1.881 . . . . 2.08 115.275 -174.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.4 -14.86 4.22 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 117.293 -1.837 . . . . 1.31 116.689 166.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -75.04 133.21 41.67 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 120.343 2.072 . . . . 1.4 108.748 -168.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -105.15 118.89 37.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.028 -0.73 . . . . 0.78 109.028 172.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.12 112.31 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-O 126.112 2.863 . . . . 1.55 105.226 -178.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.7 m -88.72 131.52 34.99 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.186 -2.821 . . . . 1.08 106.862 -176.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.4 mt -135.32 131.21 36.18 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 124.642 1.213 . . . . 1.55 109.788 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -88.48 94.13 9.77 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.007 -2.308 . . . . 1.95 112.481 176.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.284 30.9 m -110.79 178.35 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 105.493 -2.04 . . . . 0.96 105.493 -177.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.41 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 22.7 mm-40 -122.34 155.5 61.88 Favored Pre-proline 0 N--CA 1.431 -1.412 0 O-C-N 119.532 -1.98 . . . . 2.35 109.786 161.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 94.3 Cg_endo -72.32 -23.09 21.09 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 C-N-CA 124.126 3.217 . . . . 0.95 112.975 -166.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.1 m -74.32 -11.21 60.2 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 116.17 1.915 . . . . 1.45 116.17 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -81.73 159.48 23.87 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 119.359 3.096 . . . . 1.69 119.359 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.257 7.3 p -78.07 147.71 34.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 119.067 2.988 . . . . 0.75 119.067 -177.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.1 mm -53.68 -38.36 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 123.86 3.027 . . . . 0.73 115.849 173.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -45.85 -38.12 6.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.86 2.911 . . . . 1.62 118.86 162.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -85.4 -23.7 27.84 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.86 -1.775 . . . . 2.13 113.719 175.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.94 -48.01 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 118.583 -2.573 . . . . 0.62 109.581 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -47.7 -37.4 13.01 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.761 3.245 . . . . 1.22 119.761 174.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.08 -33.12 71.5 Favored 'General case' 0 N--CA 1.43 -1.43 2 C-N-CA 133.53 4.732 . . . . 0.51 110.731 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -62.28 -26.42 68.4 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.133 3.012 . . . . 1.44 119.133 173.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.7 mt -82.67 -16.41 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 126.541 2.401 . . . . 1.32 114.292 175.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -82.17 -49.53 10.03 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.793 -1.929 . . . . 1.7 105.793 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -48.86 -61.28 2.13 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.874 2.47 . . . . 1.55 111.305 167.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -76.88 -62.57 1.6 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.968 -1.708 . . . . 2.62 112.959 -167.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -98.5 -42.77 7.15 Favored 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 115.247 -4.658 . . . . 1.48 110.806 -166.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.34 20.47 2.19 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 121.891 3.516 . . . . 1.12 121.891 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.1 mm -99.82 118.86 61.08 Favored Pre-proline 0 N--CA 1.43 -1.471 0 C-N-CA 126.337 1.855 . . . . 1.55 109.75 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -69.3 157.44 61.27 Favored 'Trans proline' 0 C--N 1.299 -2.064 0 CA-C-N 123.116 2.148 . . . . 1.02 115.795 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -73.15 -16.14 25.36 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 C-N-CA 124.343 3.362 . . . . 1.25 112.717 -173.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -85.87 -34.54 20.97 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.898 2.479 . . . . 2.25 112.409 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -79.44 3.66 17.86 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.332 2.653 . . . . 2.02 111.269 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -122.92 147.72 46.27 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 120.799 3.629 . . . . 0.69 120.799 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -125.19 129.21 49.65 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 124.011 3.096 . . . . 2.78 103.613 176.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.4 mt -105.92 132.91 51.45 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.128 -4.732 . . . . 1.17 109.274 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.4 mt -119.7 135.36 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 106.366 -1.716 . . . . 1.38 106.366 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -124.31 131.95 53.54 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.844 2.458 . . . . 1.5 104.434 169.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.16 -57.59 0.52 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.889 2.876 . . . . 1.21 113.799 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -169.09 -32.45 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.749 0 CA-C-O 125.67 2.816 . . . . 1.3 115.439 -173.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -95.79 162.78 13.45 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.645 -2.679 . . . . 2.55 114.078 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -90.3 145.45 24.97 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 121.514 3.894 . . . . 2.48 121.514 173.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.6 mt -92.33 128.28 38.12 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 124.505 2.098 . . . . 0.9 112.605 -170.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -75.96 134.93 40.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 130.257 3.423 . . . . 1.94 110.144 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.55 -49.93 74.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.417 2.687 . . . . 1.56 115.206 -172.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.31 34.59 3.93 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 119.681 2.633 . . . . 0.97 119.681 173.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -103.83 166.13 10.61 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 114.549 -2.861 . . . . 2.49 106.789 167.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.8 p -89.97 159.82 16.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.974 -2.953 . . . . 0.76 110.127 169.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.299 81.0 mt -60.16 -33.27 71.95 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.688 1.736 . . . . 1.05 115.688 168.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.6 t -76.76 -20.78 56.09 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.457 -3.277 . . . . 1.19 115.804 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.88 -36.14 82.94 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.486 1.115 . . . . 1.9 109.326 169.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -82.54 3.21 29.45 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.553 -1.967 . . . . 0.89 112.733 172.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.312 21.7 m120 51.92 34.75 14.2 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.594 -2.566 . . . . 1.84 115.822 -176.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.4 mt -68.81 105.52 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 120.581 -1.324 . . . . 0.82 109.009 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -97.23 167.25 11.15 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 128.437 2.695 . . . . 2.16 107.953 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -62.42 145.77 53.18 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 118.215 -2.803 . . . . 2.12 118.059 175.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.33 29.3 mt-10 71.37 28.7 2.89 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 113.156 -1.838 . . . . 1.71 112.149 -172.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 m -84.42 141.44 30.83 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 121.032 1.742 . . . . 1.04 115.242 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.3 m -94.87 109.03 21.06 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.967 -1.494 . . . . 0.79 106.967 -171.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.7 mt -95.04 130.59 41.66 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.979 2.172 . . . . 1.4 106.628 171.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.272 32.1 m80 -100.33 114.1 27.34 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.032 -1.47 . . . . 1.51 107.032 -175.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -87.71 110.12 20.2 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.017 1.727 . . . . 1.14 112.266 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.7 t -98.62 133.92 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 1 N-CA-C 99.212 -4.366 . . . . 1.23 99.212 169.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.265 13.5 tp . . . . . 0 N--CA 1.43 -1.449 0 O-C-N 119.25 -2.156 . . . . 2.78 107.983 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 CA--C 1.491 -1.299 0 CA-C-O 118.176 -0.916 . . . . 1.1 111.647 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -107.03 137.81 44.39 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.127 3.371 . . . . 1.87 106.103 -178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 pt -131.2 167.45 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.604 -3.185 . . . . 0.72 104.863 168.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.252 63.4 m-85 -121.88 125.18 45.84 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.469 1.108 . . . . 1.4 108.658 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.79 112.07 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 112.693 0.627 . . . . 0.58 112.693 172.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.4 ttmm -102.42 142.77 33.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.463 -1.31 . . . . 2.09 107.463 -172.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.1 p -93.06 167.21 11.94 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 127.392 3.472 . . . . 0.99 112.975 165.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.257 21.0 tp -71.89 -25.58 61.98 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.242 -3.411 . . . . 2.53 114.382 175.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.8 p -88.24 -36.7 16.6 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.344 -2.097 . . . . 2.08 112.631 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.66 8.95 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 116.768 -2.634 . . . . 1.31 118.933 166.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -104.48 133.28 49.61 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 122.721 3.26 . . . . 1.4 109.923 -171.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.1 m -117.22 112.74 21.23 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 118.514 -1.275 . . . . 0.78 112.635 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.31 19.7 pt -97.02 136.0 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 124.178 1.942 . . . . 1.55 111.882 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.1 m -97.65 126.75 43.15 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 116.931 -3.606 . . . . 1.08 108.415 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.3 mt -131.41 141.48 49.85 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 127.4 3.476 . . . . 1.55 109.632 -173.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -97.54 118.67 34.56 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 113.562 -5.711 . . . . 1.95 109.59 171.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.97 174.99 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 119.859 -1.775 . . . . 0.96 109.138 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -116.02 147.96 40.37 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-O 116.342 -1.789 . . . . 2.35 107.084 157.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.03 -18.06 35.98 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-O 113.741 -2.691 . . . . 0.95 109.557 -174.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.2 p -71.0 -9.47 58.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 122.892 2.587 . . . . 1.45 115.057 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -80.02 166.66 21.33 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 114.629 -5.044 . . . . 1.69 110.37 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.5 p -93.82 152.0 19.21 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 121.903 0.858 . . . . 0.75 110.699 -177.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.439 HD13 ' HB3' ' A' ' 50' ' ' LEU . 4.1 mt -59.65 -36.39 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 115.913 1.82 . . . . 0.73 115.913 173.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -44.18 -56.32 4.17 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 126.304 1.842 . . . . 1.62 115.357 162.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -61.54 -39.16 90.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 112.87 -3.443 . . . . 2.13 111.683 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.3 t -63.12 -38.63 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 122.247 2.294 . . . . 0.62 108.05 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -71.45 -26.77 62.87 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.81 2.893 . . . . 1.22 118.81 171.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.98 -24.5 65.15 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.897 -2.377 . . . . 0.51 111.107 168.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -70.23 -37.33 74.97 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.119 -2.238 . . . . 1.44 112.561 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.3 mt -58.55 -35.41 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 128.787 2.835 . . . . 1.32 109.903 167.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -65.24 -42.72 93.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.175 -2.345 . . . . 1.7 113.862 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -63.71 -32.07 73.44 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 126.515 2.384 . . . . 1.55 114.82 165.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -88.41 -65.84 0.98 Allowed 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.115 -2.24 . . . . 2.62 110.224 -167.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -99.42 -24.39 14.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.246 1.818 . . . . 1.48 110.863 -169.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.43 43.67 2.91 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-O 125.298 2.61 . . . . 1.12 111.066 170.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.3 mt -120.74 129.49 25.29 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 120.288 -1.713 . . . . 1.55 106.542 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.4 Cg_exo -71.61 150.69 57.44 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-N 124.82 2.757 . . . . 1.02 109.725 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -72.89 -12.29 26.13 Favored 'Trans proline' 0 C--N 1.298 -2.08 0 C-N-CA 122.511 2.141 . . . . 1.25 116.948 -173.263 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -81.12 -32.08 33.97 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 114.375 -5.203 . . . . 2.25 105.579 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -79.66 6.03 11.72 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 114.445 1.276 . . . . 2.02 114.445 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -149.51 147.42 28.18 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.804 -2.435 . . . . 0.69 114.253 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.277 60.2 mtt180 -129.78 162.12 29.16 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.051 -2.906 . . . . 2.78 108.563 171.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.9 mt -120.32 148.75 43.33 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 119.28 -2.138 . . . . 1.17 109.633 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.7 mt -127.61 129.04 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 124.87 2.271 . . . . 1.38 109.006 -172.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -118.08 125.72 50.86 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 104.785 -2.302 . . . . 1.5 104.785 170.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.268 . . 79.84 -54.26 0.39 Allowed 'General case' 0 N--CA 1.428 -1.535 0 O-C-N 118.446 -2.659 . . . . 1.21 111.876 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.72 -24.32 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.675 0 O-C-N 118.119 -2.863 . . . . 1.3 115.099 -170.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -97.35 141.35 30.55 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.337 -1.684 . . . . 2.55 107.524 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -76.77 120.3 21.73 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.464 3.106 . . . . 2.48 111.649 177.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.439 ' HB3' HD13 ' A' ' 23' ' ' ILE . 43.2 mt -80.85 144.99 31.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.095 -1.628 . . . . 0.9 109.656 -166.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -74.87 121.5 21.95 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.716 2.406 . . . . 1.94 112.117 175.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -65.05 -29.36 70.25 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 113.382 -1.735 . . . . 1.56 112.463 -171.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.16 33.15 4.6 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 120.79 3.076 . . . . 0.97 120.79 168.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.9 mtt-85 -132.67 176.07 8.77 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 101.037 -3.69 . . . . 2.49 101.037 166.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.6 p -108.63 175.33 5.51 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.299 1.439 . . . . 0.76 109.962 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.6 mt -68.3 -23.7 64.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.539 1.681 . . . . 1.05 115.539 173.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 t -65.25 -40.09 93.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.678 2.791 . . . . 1.19 111.486 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -70.62 -21.89 62.59 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.262 1.578 . . . . 1.9 115.262 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -96.39 -3.24 43.99 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.81 -3.056 . . . . 0.89 108.582 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 58.84 40.88 22.3 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 127.575 2.35 . . . . 1.84 112.987 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.9 mt -80.53 127.08 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 1 O-C-N 131.022 5.201 . . . . 0.82 104.949 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -93.71 -174.85 3.58 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 128.079 2.552 . . . . 2.16 111.243 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.7 pttp -72.35 151.27 42.8 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.432 -1.258 . . . . 2.12 111.536 174.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.375 11.7 mt-10 56.65 42.23 27.28 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.443 2.757 . . . . 1.71 118.443 176.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.5 m -100.65 143.53 30.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.593 -2.743 . . . . 1.04 103.593 -175.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -103.04 110.4 22.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 125.183 2.421 . . . . 0.79 108.202 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -96.04 115.33 27.27 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.074 3.35 . . . . 1.4 112.538 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -86.71 121.37 29.12 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.445 -2.035 . . . . 1.51 115.977 -171.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.2 tt -89.39 138.34 31.53 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.355 -2.716 . . . . 1.14 108.764 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -125.45 162.75 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 O-C-N 128.408 3.568 . . . . 1.23 111.702 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.6 mt . . . . . 0 N--CA 1.431 -1.408 0 CA-C-O 124.031 1.872 . . . . 2.78 109.45 -179.801 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ptt? . . . . . 0 CA--C 1.489 -1.373 0 CA-C-O 123.198 1.475 . . . . 1.1 109.361 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -118.03 139.42 51.22 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.618 -3.176 . . . . 1.87 108.621 -176.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.1 pt -125.13 144.6 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 CA-C-O 115.826 -2.035 . . . . 0.72 106.251 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -102.31 101.02 11.24 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 126.419 2.324 . . . . 1.4 108.705 -174.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 21.7 t -82.2 110.99 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 116.699 -3.751 . . . . 0.58 106.779 175.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -98.58 136.38 38.76 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 109.247 -0.649 . . . . 2.09 109.247 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 p -90.81 -155.42 0.39 Allowed 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.704 1.602 . . . . 0.99 108.15 175.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.4 mt -103.47 -60.78 1.51 Allowed 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 113.739 -3.029 . . . . 2.53 110.428 175.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 p -51.37 -41.68 60.82 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 133.894 6.996 . . . . 2.08 116.672 -174.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.46 -19.77 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 126.262 3.146 . . . . 1.31 120.398 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -71.67 151.48 43.64 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.169 -2.371 . . . . 1.4 110.805 -174.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.4 m -130.32 110.23 11.36 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.147 1.779 . . . . 0.78 110.635 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.47 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 4.8 mm -85.92 101.75 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 115.539 -2.172 . . . . 1.55 105.752 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.8 m -78.42 89.63 4.41 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 125.489 1.743 . . . . 1.08 111.119 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.8 mt -85.3 124.15 31.6 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.592 -3.193 . . . . 1.55 113.207 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -71.48 114.87 10.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 125.493 1.746 . . . . 1.95 112.431 161.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 m -134.18 165.43 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 120.253 -1.529 . . . . 0.96 108.851 -176.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -104.91 156.41 36.06 Favored Pre-proline 0 N--CA 1.429 -1.488 0 CA-C-O 116.401 -1.762 . . . . 2.35 106.879 167.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -79.5 -11.9 14.13 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 CA-C-N 126.047 3.195 . . . . 0.95 106.22 -170.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.9 p -73.35 -21.8 60.45 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.898 2.555 . . . . 1.45 117.898 173.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -63.54 147.18 52.1 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 125.441 1.713 . . . . 1.69 112.159 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.8 p -83.6 168.74 16.08 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.662 -1.274 . . . . 0.75 110.51 170.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.1 mm -68.77 -30.06 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 128.684 2.794 . . . . 0.73 108.91 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -48.8 -47.78 41.89 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.301 1.84 . . . . 1.62 113.73 166.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -63.87 -41.49 97.75 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.959 2.504 . . . . 2.13 111.516 173.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.9 t -67.75 -45.0 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 1 O-C-N 116.231 -4.043 . . . . 0.62 112.807 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -68.66 -22.32 64.39 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.274 1.511 . . . . 1.22 114.034 175.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.32 83.42 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.35 -3.969 . . . . 0.51 117.356 170.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -64.01 -29.49 70.64 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.285 -2.134 . . . . 1.44 113.991 165.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.456 HD13 HD13 ' A' ' 69' ' ' LEU 0.3 76.7 mt -72.89 -40.08 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 117.042 -3.536 . . . . 1.32 111.108 176.746 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -64.47 -46.86 81.26 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.819 2.048 . . . . 1.7 111.474 173.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.07 -54.38 25.38 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.434 -2.666 . . . . 1.55 116.974 167.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -73.61 -68.58 0.49 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.529 2.048 . . . . 2.62 116.529 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -84.19 -23.23 30.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.362 -1.29 . . . . 1.48 113.557 -167.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.25 24.56 14.21 Favored Glycine 0 N--CA 1.429 -1.769 1 CA-C-O 128.144 4.191 . . . . 1.12 114.301 170.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.7 mt -105.37 133.71 20.03 Favored Pre-proline 0 N--CA 1.429 -1.482 0 O-C-N 116.758 -3.789 . . . . 1.55 106.622 -170.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -65.55 146.6 85.14 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 CA-C-O 114.733 -2.278 . . . . 1.02 115.304 172.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -81.16 -9.49 12.76 Favored 'Trans proline' 0 N--CA 1.433 -2.058 0 CA-C-N 125.928 3.153 . . . . 1.25 108.462 -171.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -71.19 -23.79 62.1 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.482 -2.011 . . . . 2.25 111.344 168.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -92.15 -22.53 19.81 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 120.351 1.432 . . . . 2.02 107.848 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.307 74.5 mt-30 -79.31 152.66 30.37 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 125.324 2.488 . . . . 0.69 110.449 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -125.45 138.29 54.0 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.063 -4.148 . . . . 2.78 108.756 158.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.9 mt -116.47 111.56 20.17 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.424 -3.298 . . . . 1.17 104.405 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.6 mm -98.25 141.73 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 103.824 -2.658 . . . . 1.38 103.824 174.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -115.6 -109.44 0.36 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 114.877 -2.487 . . . . 1.5 109.372 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.99 -32.15 16.04 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 124.418 3.281 . . . . 1.21 112.912 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.81 -41.23 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 127.756 2.598 . . . . 1.3 114.086 -175.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -80.69 136.02 36.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.706 2.669 . . . . 2.55 110.56 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -89.95 95.53 10.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.704 2.802 . . . . 2.48 108.208 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 mt -57.01 140.93 47.49 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.988 -2.32 . . . . 0.9 115.32 -164.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.257 42.4 mt-10 -83.14 150.19 26.41 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.456 -1.402 . . . . 1.94 114.721 173.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -65.71 -52.3 52.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.235 2.309 . . . . 1.56 117.235 -169.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.15 56.97 1.76 Allowed Glycine 0 N--CA 1.43 -1.758 0 CA-C-N 108.533 -3.939 . . . . 0.97 113.6 173.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 54' ' ' ARG . 49.0 mmt-85 -132.45 168.54 18.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 129.162 3.507 . . . . 2.49 105.34 163.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -107.18 164.83 11.83 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.439 -1.71 . . . . 0.76 113.487 173.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.8 mt -66.53 -24.68 66.41 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.504 -1.373 . . . . 1.05 113.609 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.3 t -64.59 -39.79 94.36 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 128.749 2.82 . . . . 1.19 111.063 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -66.55 -31.39 72.08 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.082 -2.886 . . . . 1.9 116.211 173.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -90.5 2.65 55.52 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 115.439 1.644 . . . . 0.89 115.439 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 69.35 27.15 5.12 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 117.452 -1.261 . . . . 1.84 109.872 178.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.4 mt -79.65 128.02 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 126.149 2.88 . . . . 0.82 110.848 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -130.82 171.51 13.06 Favored 'General case' 0 N--CA 1.429 -1.494 1 O-C-N 115.043 -4.786 . . . . 2.16 108.469 -167.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -54.16 130.74 39.43 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.818 2.723 . . . . 2.12 115.641 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 65.94 34.9 6.81 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 130.032 3.333 . . . . 1.71 112.116 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.6 t -90.91 141.48 28.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.965 1.364 . . . . 1.04 112.217 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.0 m -83.99 111.85 19.64 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.989 1.716 . . . . 0.79 114.464 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -108.45 166.44 10.77 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.715 2.006 . . . . 1.4 112.058 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -123.21 132.16 53.94 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.328 -4.608 . . . . 1.51 110.879 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.456 HD13 HD13 ' A' ' 30' ' ' ILE . 22.0 tp -98.89 108.79 21.57 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.65 1.214 . . . . 1.14 108.484 174.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.5 t -105.88 143.12 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 128.926 2.891 . . . . 1.23 108.015 -178.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.8 mt . . . . . 0 N--CA 1.43 -1.473 0 CA-C-N 125.986 3.993 . . . . 2.78 108.848 -178.626 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ptt? . . . . . 0 CA--C 1.491 -1.314 0 CA-C-O 122.655 1.217 . . . . 1.1 112.804 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -96.0 139.97 31.42 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 107.45 -1.315 . . . . 1.87 107.45 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.256 16.3 pt -132.08 169.49 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 107.312 -1.366 . . . . 0.72 107.312 172.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -134.07 142.61 47.62 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.132 0.967 . . . . 1.4 113.02 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.57 134.13 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 O-C-N 118.837 -2.415 . . . . 0.58 110.416 168.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -96.79 149.11 22.21 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 117.419 -1.276 . . . . 2.09 109.63 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.321 4.8 p -103.85 -166.35 1.25 Allowed 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.501 2.375 . . . . 0.99 114.928 176.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.2 tp -76.18 -57.93 3.58 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 114.839 1.422 . . . . 2.53 114.839 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.2 p -70.5 -32.8 70.43 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 116.871 2.175 . . . . 2.08 116.871 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.07 58.32 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 118.757 -1.687 . . . . 1.31 115.597 172.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -118.18 138.2 52.47 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 121.109 2.455 . . . . 1.4 107.775 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.5 m -100.6 117.33 34.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 104.889 -2.263 . . . . 0.78 104.889 174.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.6 mt -96.47 116.54 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 106.219 -1.771 . . . . 1.55 106.219 174.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.406 3.6 m -83.08 121.53 27.16 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 126.039 1.736 . . . . 1.08 113.551 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.679 HD22 ' HB3' ' A' ' 29' ' ' LYS . 83.5 mt -123.03 143.16 50.13 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.635 -1.915 . . . . 1.55 112.201 -175.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -104.07 141.99 35.25 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 104.49 -2.411 . . . . 1.95 104.49 170.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.3 m -161.07 161.9 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 106.966 -1.494 . . . . 0.96 106.966 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 20' ' ' SER . 13.2 pt-20 -105.52 162.44 19.71 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-O 115.828 -2.034 . . . . 2.35 106.868 157.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.414 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 97.5 Cg_endo -74.33 -1.79 11.47 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 CA-C-N 124.592 2.676 . . . . 0.95 113.714 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.456 ' H ' ' HG3' ' A' ' 18' ' ' GLU . 67.1 m -90.72 -2.51 57.81 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 115.359 1.615 . . . . 1.45 115.359 171.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -66.73 131.07 45.18 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.146 2.403 . . . . 1.69 107.121 168.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 17.6 p -68.47 175.16 3.56 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 112.954 -1.93 . . . . 0.75 112.205 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.5 mm -74.66 -35.48 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 116.528 -3.858 . . . . 0.73 108.018 176.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -54.3 -46.66 72.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.213 -3.43 . . . . 1.62 115.351 165.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -56.86 -37.16 70.93 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 125.577 2.608 . . . . 2.13 112.79 171.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.56 -39.8 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 116.463 -3.898 . . . . 0.62 114.34 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -65.88 -33.3 75.52 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 117.621 2.452 . . . . 1.22 117.621 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.68 -23.75 61.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 111.598 -2.546 . . . . 0.51 110.691 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.679 ' HB3' HD22 ' A' ' 15' ' ' LEU . 42.2 mttm -75.72 -29.64 59.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 122.579 2.445 . . . . 1.44 113.564 168.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.6 mt -66.44 -42.29 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.908 -1.745 . . . . 1.32 110.195 171.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -58.54 -38.36 77.61 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.314 -3.366 . . . . 1.7 118.216 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -59.96 -32.83 71.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.989 2.218 . . . . 1.55 116.989 172.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.327 53.8 mmtt -89.15 -48.74 7.19 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.924 -3.61 . . . . 2.62 110.009 -174.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -112.39 -19.16 12.27 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 123.096 1.426 . . . . 1.48 114.164 -165.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.33 9.42 79.55 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 118.984 -2.323 . . . . 1.12 113.907 167.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.5 mt -81.58 133.26 53.04 Favored Pre-proline 0 N--CA 1.43 -1.457 0 O-C-N 120.951 -1.323 . . . . 1.55 112.237 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -69.17 148.78 69.63 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 CA-C-N 122.517 1.935 . . . . 1.02 113.681 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -71.14 -25.03 22.87 Favored 'Trans proline' 0 C--N 1.301 -1.953 1 C-N-CA 125.893 4.395 . . . . 1.25 115.211 -170.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -70.65 -27.13 63.81 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 128.348 2.659 . . . . 2.25 113.881 175.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -91.77 -1.94 57.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.432 2.293 . . . . 2.02 110.472 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -100.86 135.19 42.69 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.658 -1.901 . . . . 0.69 109.813 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 62.4 mtm180 -117.87 114.28 23.0 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.585 2.448 . . . . 2.78 110.191 173.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.516 ' HB3' HD12 ' A' ' 50' ' ' LEU . 76.6 mt -100.32 129.17 46.28 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 120.762 1.619 . . . . 1.17 110.515 -176.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.8 mm -110.77 128.17 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 125.638 1.575 . . . . 1.38 108.639 177.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -109.12 102.72 11.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.145 1.45 . . . . 1.5 107.155 170.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.312 . . 65.41 -63.62 0.2 Allowed 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.064 -2.897 . . . . 1.21 118.084 -173.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.429 ' H ' ' H ' ' A' ' 48' ' ' LYS . . . -162.6 -5.85 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.709 0 O-C-N 118.194 -2.816 . . . . 1.3 111.914 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.429 ' H ' ' H ' ' A' ' 47' ' ' GLY . 37.7 mtmt -95.38 143.08 27.03 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 125.843 1.555 . . . . 2.55 107.609 173.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -93.59 143.55 26.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.944 2.783 . . . . 2.48 111.37 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 43' ' ' LEU . 88.0 mt -94.76 132.05 39.94 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 113.857 -5.527 . . . . 0.9 108.217 -167.27 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -83.81 139.24 32.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.395 1.478 . . . . 1.94 109.292 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.287 8.5 m-20 -62.95 -50.11 72.09 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.499 -3.251 . . . . 1.56 119.701 -171.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.23 9.44 63.92 Favored Glycine 0 N--CA 1.43 -1.704 1 N-CA-C 123.183 4.033 . . . . 0.97 123.183 174.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -78.39 161.23 27.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 113.621 0.971 . . . . 2.49 113.621 168.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 81.1 p -89.39 164.9 14.67 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 118.955 2.946 . . . . 0.76 118.955 164.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 89.5 mt -64.32 -36.56 84.51 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.599 -3.188 . . . . 1.05 116.86 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.2 p -58.41 -29.0 65.74 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 128.1 2.56 . . . . 1.19 113.362 166.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -59.6 -47.5 85.35 Favored 'General case' 0 N--CA 1.43 -1.431 1 CA-C-N 127.312 4.596 . . . . 1.9 110.892 173.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -83.36 0.98 43.56 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.123 3.369 . . . . 0.89 114.056 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.3 m120 58.32 45.85 16.4 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.996 2.221 . . . . 1.84 116.996 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.4 mt -87.76 118.04 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 104.765 -2.309 . . . . 0.82 104.765 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -85.23 -163.21 0.81 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.737 -2.477 . . . . 2.16 109.029 -174.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 pttt -74.43 147.02 42.39 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.085 -2.259 . . . . 2.12 110.217 174.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 62.73 48.74 4.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.172 0.986 . . . . 1.71 109.622 170.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.1 m -108.59 141.29 40.73 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.853 -1.779 . . . . 1.04 110.203 -169.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.8 m -103.81 108.68 20.1 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 125.568 2.604 . . . . 0.79 108.656 -172.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mp -96.52 163.88 12.85 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 112.425 -2.17 . . . . 1.4 107.875 171.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -118.05 140.28 49.98 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.197 1.799 . . . . 1.51 111.937 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.7 tp -108.97 120.59 42.99 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.399 -3.313 . . . . 1.14 109.667 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.4 t -116.93 150.31 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 105.418 -2.067 . . . . 1.23 105.418 174.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 N--CA 1.43 -1.472 0 O-C-N 117.09 -3.506 . . . . 2.78 113.211 -177.049 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 ttp . . . . . 0 CA--C 1.49 -1.33 0 N-CA-C 116.563 2.061 . . . . 1.1 116.563 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -92.84 123.74 36.33 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.233 -2.792 . . . . 1.87 108.46 -170.74 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.335 50.4 pt -116.22 137.66 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.495 1.918 . . . . 0.72 112.73 176.771 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -104.83 100.05 9.69 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 116.58 2.067 . . . . 1.4 116.58 -176.371 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.3 t -84.53 96.9 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 124.537 2.113 . . . . 0.58 111.89 178.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -95.74 122.75 38.85 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.48 1.61 . . . . 2.09 109.423 -174.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 69' ' ' LEU 0.29 20.2 p -89.99 167.27 12.92 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.787 2.035 . . . . 0.99 114.19 -176.475 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.8 tp -66.24 -32.19 73.46 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 126.009 2.814 . . . . 2.53 115.455 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.6 p -77.44 -48.24 17.67 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.428 1.891 . . . . 2.08 111.854 -178.828 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.3 -1.21 0.53 Allowed Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 117.174 1.63 . . . . 1.31 117.174 173.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -78.11 139.66 39.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 119.372 1.586 . . . . 1.4 109.133 -177.196 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -104.17 112.09 24.95 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.644 -2.535 . . . . 0.78 105.435 169.179 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -93.06 105.51 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 103.413 -2.81 . . . . 1.55 103.413 178.141 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -84.74 107.08 16.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.006 2.224 . . . . 1.08 117.006 177.081 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.2 mt -105.27 136.72 44.27 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 121.122 1.783 . . . . 1.55 107.518 -175.076 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -87.99 90.9 8.57 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 124.154 1.931 . . . . 1.95 108.625 168.039 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.21 176.27 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 128.571 2.749 . . . . 0.96 109.11 -176.12 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -117.88 151.37 48.68 Favored Pre-proline 0 N--CA 1.431 -1.413 0 O-C-N 124.917 1.386 . . . . 2.35 108.638 161.331 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -74.26 -11.96 23.06 Favored 'Trans proline' 0 N--CA 1.434 -2.004 1 O-C-N 112.794 -4.371 . . . . 0.95 115.208 -170.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.4 p -81.98 -15.35 54.04 Favored 'General case' 0 N--CA 1.429 -1.476 1 C-N-CA 132.297 4.239 . . . . 1.45 110.315 174.682 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -68.62 153.38 43.88 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 120.756 1.616 . . . . 1.69 110.942 172.559 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 25.2 p -87.6 166.87 14.4 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.353 1.861 . . . . 0.75 108.93 -179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.2 mm -71.61 -36.0 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 124.455 2.074 . . . . 0.73 113.188 175.77 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -38.82 -42.97 0.88 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.853 -3.03 . . . . 1.62 117.047 159.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -76.94 -38.18 53.86 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.226 -2.796 . . . . 2.13 108.489 179.038 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.462 HG21 HD21 ' A' ' 56' ' ' LEU . 76.9 t -55.89 -39.09 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 127.354 2.261 . . . . 0.62 114.269 172.355 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 86.3 mttt -81.05 -19.34 44.0 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.612 -2.555 . . . . 1.22 115.88 173.752 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.07 -38.59 63.88 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 122.819 1.295 . . . . 0.51 109.486 174.31 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -63.24 -29.29 70.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.633 -2.542 . . . . 1.44 113.864 174.572 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.3 mt -77.88 -24.34 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 116.661 2.097 . . . . 1.32 116.661 169.156 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -76.42 -30.48 57.46 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.27 -3.394 . . . . 1.7 110.025 173.886 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -76.5 -43.33 40.02 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.805 1.288 . . . . 1.55 112.129 173.527 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -77.4 -69.36 0.54 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.347 -2.096 . . . . 2.62 114.506 -173.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -80.46 -51.17 9.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.677 -1.147 . . . . 1.48 113.153 -172.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.09 43.03 1.13 Allowed Glycine 0 N--CA 1.429 -1.796 0 O-C-N 125.508 1.755 . . . . 1.12 111.232 175.838 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.3 mt -104.3 132.99 20.45 Favored Pre-proline 0 N--CA 1.431 -1.386 0 C-N-CA 125.557 1.543 . . . . 1.55 107.377 -178.16 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -70.85 138.96 35.42 Favored 'Trans proline' 0 N--CA 1.433 -2.067 1 C-N-CA 126.054 4.502 . . . . 1.02 111.54 -178.553 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.431 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 36.3 Cg_exo -71.52 -19.47 28.33 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 O-C-N 117.924 -1.671 . . . . 1.25 112.434 -169.566 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -62.4 -35.02 77.9 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 114.83 1.418 . . . . 2.25 114.83 165.177 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -87.57 -13.93 41.55 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 124.037 0.935 . . . . 2.02 112.628 -179.173 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.329 71.3 mt-30 -84.78 113.01 21.02 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 120.957 1.708 . . . . 0.69 107.701 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -92.34 134.5 34.86 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 116.676 -1.63 . . . . 2.78 106.712 165.518 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.8 mt -127.79 125.42 39.81 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 102.629 -3.1 . . . . 1.17 102.629 177.138 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -115.13 137.3 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 115.947 -1.978 . . . . 1.38 105.788 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -124.06 107.4 11.25 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.227 2.285 . . . . 1.5 107.628 171.172 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.363 . . 74.55 -77.07 0.06 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.517 2.58 . . . . 1.21 114.922 -173.414 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.3 -0.67 0.24 Allowed Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 129.917 3.627 . . . . 1.3 115.42 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -111.56 114.01 26.8 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 124.663 1.185 . . . . 2.55 110.565 -179.556 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -81.13 127.94 33.19 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 124.56 1.144 . . . . 2.48 111.885 176.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.44 HD22 ' CD2' ' A' ' 59' ' ' TYR . 69.7 mt -79.82 120.36 23.97 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 120.338 3.458 . . . . 0.9 120.338 -162.569 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.288 37.1 mt-10 -78.22 138.63 38.74 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.216 -2.177 . . . . 1.94 113.758 -176.951 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.66 -45.33 92.36 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 112.616 -2.084 . . . . 1.56 113.072 -171.477 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.59 25.14 9.88 Favored Glycine 0 N--CA 1.43 -1.713 0 C-N-CA 125.763 1.649 . . . . 0.97 116.601 175.431 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -112.7 166.36 11.43 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.99 1.852 . . . . 2.49 110.309 165.362 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 12.2 p -101.28 169.17 9.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.134 -2.854 . . . . 0.76 106.424 176.369 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.462 HD21 HG21 ' A' ' 26' ' ' VAL . 62.6 mt -65.95 -38.19 87.96 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.576 2.608 . . . . 1.05 112.304 172.185 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.0 p -60.34 -41.1 92.89 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.923 -4.236 . . . . 1.19 116.067 -178.134 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -53.47 -49.7 66.88 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 117.715 2.487 . . . . 1.9 117.715 169.004 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.44 ' CD2' HD22 ' A' ' 50' ' ' LEU . 59.9 m-85 -67.26 -10.41 50.44 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.659 2.466 . . . . 0.89 117.659 173.396 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.309 64.8 t30 73.93 47.62 0.15 Allowed 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.573 -2.58 . . . . 1.84 105.167 -177.402 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.6 mt -100.59 119.82 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 102.829 -3.026 . . . . 0.82 102.829 177.261 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -115.09 -167.8 1.29 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 114.219 -1.355 . . . . 2.16 112.274 -176.175 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -60.27 138.86 57.87 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.611 2.448 . . . . 2.12 117.611 169.164 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.432 20.8 mt-10 69.19 22.97 6.54 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.007 2.225 . . . . 1.71 117.007 174.299 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.4 m -83.16 141.06 32.22 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.209 2.604 . . . . 1.04 113.913 -175.575 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.4 m -94.65 116.1 28.34 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.3 -3.375 . . . . 0.79 107.464 -174.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -109.68 128.38 55.22 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 104.87 -2.27 . . . . 1.4 104.87 174.42 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -88.8 121.53 31.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 114.531 -2.652 . . . . 1.51 115.085 -177.403 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.412 ' HB3' HG22 ' A' ' 7' ' ' THR . 9.8 tp -89.14 120.27 30.38 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 123.827 3.012 . . . . 1.14 114.376 175.685 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.45 169.23 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 120.651 -1.281 . . . . 1.23 107.852 172.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 N--CA 1.43 -1.462 0 O-C-N 117.89 -3.007 . . . . 2.78 107.528 177.783 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.316 0 N-CA-C 114.325 1.231 . . . . 1.1 114.325 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.267 0.7 OUTLIER -97.39 131.96 43.56 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.023 1.49 . . . . 1.87 115.023 -175.607 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -112.5 145.14 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 117.896 -3.002 . . . . 0.72 110.131 172.114 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -109.87 112.83 25.1 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 103.984 -2.599 . . . . 1.4 103.984 -173.832 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.52 103.1 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 104.071 -2.566 . . . . 0.58 104.071 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -102.76 131.11 49.83 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 112.58 0.585 . . . . 2.09 112.58 -179.681 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.4 p -93.16 176.81 6.27 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 128.155 3.409 . . . . 0.99 119.39 -177.157 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.3 tp -67.03 -37.57 84.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 124.92 3.509 . . . . 2.53 112.047 170.206 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.8 p -78.87 6.63 8.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 129.926 3.29 . . . . 2.08 111.313 -171.697 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.68 5.25 57.76 Favored Glycine 0 N--CA 1.43 -1.716 0 CA-C-N 125.001 3.546 . . . . 1.31 113.671 169.366 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -93.99 133.66 37.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.317 2.247 . . . . 1.4 115.719 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.5 m -108.39 117.18 33.48 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.277 -1.009 . . . . 0.78 108.277 171.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 mt -105.02 113.7 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 101.238 -3.615 . . . . 1.55 101.238 -179.569 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.4 m -101.19 117.33 34.79 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 120.819 1.645 . . . . 1.08 107.426 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.7 mt -102.06 151.38 22.23 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.985 3.314 . . . . 1.55 114.677 178.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -105.48 104.72 14.5 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 121.636 3.939 . . . . 1.95 121.636 168.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.432 HG12 ' HE2' ' A' ' 29' ' ' LYS . 14.3 m -119.91 168.36 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 112.452 -2.158 . . . . 0.96 109.528 -177.528 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -105.44 159.88 27.96 Favored Pre-proline 0 N--CA 1.431 -1.409 0 C-N-CA 125.713 1.605 . . . . 2.35 108.772 164.568 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.89 -18.44 16.88 Favored 'Trans proline' 0 N--CA 1.435 -1.967 0 O-C-N 115.767 -2.807 . . . . 0.95 113.537 -170.453 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.4 m -86.67 2.72 47.51 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.438 -2.039 . . . . 1.45 115.989 174.482 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -79.27 148.13 32.27 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 127.463 2.305 . . . . 1.69 109.766 172.124 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.5 p -76.99 161.04 28.67 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 127.147 2.179 . . . . 0.75 116.197 175.306 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.8 mm -71.56 -31.36 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 125.738 1.615 . . . . 0.73 111.944 173.546 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -50.87 -46.65 60.44 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.142 2.401 . . . . 1.62 114.562 162.852 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.282 6.3 t-20 -63.4 -45.13 92.45 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 116.226 -4.046 . . . . 2.13 114.949 176.755 . . . . . . . . 3 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -48.11 -38.81 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 127.893 2.477 . . . . 0.62 115.816 168.903 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -66.82 -34.58 78.13 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.392 -2.692 . . . . 1.22 113.603 173.252 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.0 -32.43 61.65 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.583 -2.573 . . . . 0.51 112.345 176.767 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HE2' HG12 ' A' ' 17' ' ' VAL . 38.4 mttp -58.5 -38.73 78.26 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 120.688 1.585 . . . . 1.44 115.199 165.671 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.7 mt -71.55 -37.34 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 130.766 3.626 . . . . 1.32 111.902 177.774 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -59.81 -47.43 85.73 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 129.027 2.931 . . . . 1.7 109.364 169.516 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.4 -54.9 41.41 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.613 2.625 . . . . 1.55 115.127 171.73 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -72.49 -67.51 0.55 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.712 -3.118 . . . . 2.62 112.696 -175.564 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -77.53 -55.37 5.43 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 120.035 -1.666 . . . . 1.48 114.639 -174.307 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.94 25.98 0.65 Allowed Glycine 0 N--CA 1.43 -1.716 0 O-C-N 118.136 -2.853 . . . . 1.12 110.326 174.608 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.0 mt -99.95 140.09 21.26 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-N 123.344 3.572 . . . . 1.55 105.365 -167.666 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 12.8 Cg_exo -66.85 159.04 53.47 Favored 'Trans proline' 0 N--CA 1.433 -2.066 0 CA-C-N 125.128 2.867 . . . . 1.02 111.053 176.131 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 73.7 Cg_exo -78.23 -3.52 13.49 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 CA-C-N 122.635 1.977 . . . . 1.25 111.907 -175.464 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.271 96.0 m-20 -88.22 -29.65 20.3 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 125.813 2.72 . . . . 2.25 112.727 174.827 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -84.51 16.04 3.38 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 116.351 1.982 . . . . 2.02 116.351 -179.079 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -126.08 129.72 49.69 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.93 1.292 . . . . 0.69 109.78 -176.752 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -118.7 134.78 54.88 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.443 2.697 . . . . 2.78 108.973 167.102 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.5 mt -120.01 123.98 44.78 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 113.715 -1.584 . . . . 1.17 114.303 178.363 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 23.7 mm -99.9 145.59 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 101.397 -3.557 . . . . 1.38 101.397 175.647 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.438 ' HB3' HD21 ' A' ' 50' ' ' LEU . 27.3 t80 -139.16 123.82 18.49 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 101.404 -3.554 . . . . 1.5 101.404 168.153 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.07 -68.59 0.21 Allowed 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 127.487 2.992 . . . . 1.21 112.402 -172.833 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.25 -32.03 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 114.412 -1.267 . . . . 1.3 115.117 -179.112 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.276 12.4 ptpt -74.93 151.15 38.9 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.174 1.175 . . . . 2.55 114.174 177.443 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -87.16 105.34 17.13 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 131.066 3.746 . . . . 2.48 113.326 174.582 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.452 HD22 ' CD2' ' A' ' 59' ' ' TYR . 61.9 mt -66.77 158.37 30.51 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.074 -2.266 . . . . 0.9 109.536 -161.285 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -91.27 156.18 18.0 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 124.855 2.264 . . . . 1.94 108.862 170.163 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -74.53 -66.37 0.75 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.504 -1.997 . . . . 1.56 114.186 -178.182 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.46 50.21 1.69 Allowed Glycine 0 N--CA 1.43 -1.761 0 O-C-N 118.057 -2.902 . . . . 0.97 115.177 168.245 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -122.7 160.38 25.99 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.346 -1.679 . . . . 2.49 106.962 159.464 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.2 p -85.68 169.17 13.72 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.675 -1.891 . . . . 0.76 113.325 176.132 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.1 mt -66.05 -33.12 75.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.844 2.458 . . . . 1.05 115.185 171.037 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.7 p -70.25 -32.91 70.96 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.408 -2.682 . . . . 1.19 114.784 176.092 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -67.59 -27.46 66.94 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.721 1.608 . . . . 1.9 115.252 177.021 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.452 ' CD2' HD22 ' A' ' 50' ' ' LEU . 59.8 m-85 -89.15 -14.8 35.33 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.074 2.25 . . . . 0.89 117.074 170.045 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.3 22.1 m120 75.77 45.68 0.12 Allowed 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.016 2.969 . . . . 1.84 119.016 -174.661 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.442 HG23 ' HB2' ' A' ' 65' ' ' SER . 16.1 mt -91.32 107.9 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 129.833 3.253 . . . . 0.82 107.576 172.653 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -99.73 -165.11 1.19 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.53 1.932 . . . . 2.16 108.359 179.279 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -56.7 144.41 32.58 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.35 -2.719 . . . . 2.12 114.887 170.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 68.46 17.98 9.04 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.269 2.462 . . . . 1.71 114.97 171.436 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.442 ' HB2' HG23 ' A' ' 61' ' ' ILE . 69.7 m -80.89 131.43 35.36 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 125.675 2.655 . . . . 1.04 110.938 -169.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.0 m -80.61 110.38 16.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.758 -1.565 . . . . 0.79 115.109 176.276 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.46 155.17 17.98 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.476 2.71 . . . . 1.4 106.148 172.489 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.505 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 60.8 m80 -119.14 109.63 16.11 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.44 -2.037 . . . . 1.51 112.722 -170.614 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.1 tp -93.48 112.3 24.17 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 125.125 1.516 . . . . 1.14 112.338 -172.7 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.68 125.5 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 127.921 2.488 . . . . 1.23 110.266 179.572 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.8 tp . . . . . 0 N--CA 1.43 -1.46 0 O-C-N 117.679 -3.138 . . . . 2.78 106.623 -175.133 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptt? . . . . . 0 CA--C 1.489 -1.398 0 CA-C-O 126.429 3.014 . . . . 1.1 113.551 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -89.03 125.4 34.99 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.444 -1.707 . . . . 1.87 110.888 -174.506 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 pt -121.05 146.61 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 104.773 -2.306 . . . . 0.72 104.773 166.33 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -97.17 134.69 40.16 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 131.618 3.967 . . . . 1.4 103.677 -179.472 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.5 t -130.4 106.18 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 124.488 2.09 . . . . 0.58 106.947 172.36 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -96.65 142.93 28.1 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.185 1.469 . . . . 2.09 112.914 -176.421 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.1 p -82.02 179.32 7.86 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 118.339 -2.725 . . . . 0.99 114.345 175.726 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.7 tp -81.08 -30.73 34.65 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.661 2.384 . . . . 2.53 107.12 175.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -75.01 -44.91 45.39 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.614 -3.804 . . . . 2.08 112.36 -170.354 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.98 -3.59 0.16 Allowed Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 117.577 -2.249 . . . . 1.31 114.732 173.038 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -110.99 138.89 46.84 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 114.574 1.324 . . . . 1.4 114.574 -172.245 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -102.21 128.86 48.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 115.138 -2.363 . . . . 0.78 112.936 177.884 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.294 30.6 pt -107.14 145.8 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 106.773 -1.566 . . . . 1.55 106.773 176.557 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.9 m -97.51 134.4 40.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 111.802 -2.454 . . . . 1.08 112.639 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.64 142.43 50.66 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.701 1.715 . . . . 1.55 109.728 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -108.75 122.79 47.89 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 116.479 -3.888 . . . . 1.95 109.012 169.015 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.6 m -136.29 154.54 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 125.38 1.472 . . . . 0.96 107.887 -171.135 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -95.26 152.63 39.52 Favored Pre-proline 0 N--CA 1.43 -1.437 0 C-N-CA 130.896 3.679 . . . . 2.35 108.397 160.117 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -76.27 -7.28 17.9 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 C-N-CA 123.769 2.979 . . . . 0.95 111.322 -174.673 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.5 m -94.91 0.51 54.8 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.125 1.77 . . . . 1.45 111.524 175.773 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.53 142.65 38.94 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.178 -2.826 . . . . 1.69 108.794 174.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 p -84.58 173.29 10.9 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 124.498 1.119 . . . . 0.75 113.393 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.2 mm -65.29 -36.41 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 118.766 -2.459 . . . . 0.73 112.682 170.753 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.307 3.1 mp0 -54.11 -48.49 70.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.874 -2.391 . . . . 1.62 116.084 165.969 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -63.24 -36.13 82.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 112.628 0.603 . . . . 2.13 112.628 175.19 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.9 t -62.11 -52.13 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 126.681 1.992 . . . . 0.62 111.932 175.404 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -57.71 -40.39 79.44 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.848 1.259 . . . . 1.22 111.82 176.693 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.312 . . -50.9 -38.93 52.87 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 120.458 3.503 . . . . 0.51 120.458 167.701 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -74.65 -24.1 58.77 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.424 -2.048 . . . . 1.44 115.277 177.034 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.9 mt -78.51 -35.65 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 129.313 3.045 . . . . 1.32 106.012 177.034 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -75.98 -36.56 59.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.823 -1.798 . . . . 1.7 111.972 -179.395 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -55.56 -48.04 75.41 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 128.55 2.74 . . . . 1.55 108.625 174.576 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -87.66 -59.49 2.23 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.125 -2.234 . . . . 2.62 114.478 -177.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -86.55 -25.4 25.06 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 115.11 1.522 . . . . 1.48 115.11 -172.043 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.14 26.55 33.63 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 119.441 -1.361 . . . . 1.12 113.156 175.888 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.7 mt -96.05 115.67 65.72 Favored Pre-proline 0 N--CA 1.43 -1.454 1 CA-C-O 111.631 -4.033 . . . . 1.55 110.103 -177.179 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.29 164.81 34.47 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 CA-C-N 126.975 3.527 . . . . 1.02 115.142 -177.8 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -65.37 -34.27 44.63 Favored 'Trans proline' 0 N--CA 1.434 -1.982 0 CA-C-O 115.833 -1.82 . . . . 1.25 116.717 -165.928 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -45.46 -38.74 6.44 Favored 'General case' 0 N--CA 1.43 -1.461 1 C-N-CA 132.382 4.273 . . . . 2.25 116.171 170.701 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -96.94 2.27 51.4 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.608 2.363 . . . . 2.02 113.856 -176.466 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -88.1 99.61 12.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 116.751 -3.718 . . . . 0.69 107.811 -173.065 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -90.66 112.02 23.59 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 118.384 -2.697 . . . . 2.78 109.88 163.247 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.8 mt -105.3 129.84 53.56 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.154 1.781 . . . . 1.17 109.805 175.087 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 3.4 mp -123.9 129.27 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 127.571 2.348 . . . . 1.38 109.136 177.201 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.46 ' HB3' HD21 ' A' ' 50' ' ' LEU . 73.1 t80 -123.14 114.29 20.12 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 104.438 -2.43 . . . . 1.5 104.438 171.478 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.37 -110.48 0.54 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 110.224 -3.171 . . . . 1.21 112.545 -170.918 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.13 4.27 35.59 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 126.492 1.996 . . . . 1.3 114.204 177.452 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -105.76 129.1 54.03 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.91 1.684 . . . . 2.55 114.739 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -82.5 126.6 32.43 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 126.558 1.943 . . . . 2.48 109.129 170.857 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.46 HD21 ' HB3' ' A' ' 45' ' ' PHE . 18.3 mt -79.5 128.89 33.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.501 1.92 . . . . 0.9 109.756 -173.811 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -112.68 179.13 4.06 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.207 2.432 . . . . 1.94 110.874 178.261 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -79.77 151.87 30.12 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 117.197 -1.801 . . . . 1.56 112.763 -171.774 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.71 -0.57 81.47 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 119.524 -1.985 . . . . 0.97 116.914 170.568 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -87.54 159.42 18.62 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 125.575 1.397 . . . . 2.49 110.505 169.501 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.266 70.4 p -100.08 167.52 10.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.937 2.303 . . . . 0.76 112.397 173.357 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.21 -29.75 70.85 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 117.086 -3.509 . . . . 1.05 112.221 164.484 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 t -68.8 -30.95 69.63 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.156 -1.59 . . . . 1.19 112.111 178.663 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -62.84 -50.34 71.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 114.904 1.446 . . . . 1.9 114.904 172.351 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -81.87 11.9 4.55 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 115.927 -1.987 . . . . 0.89 111.788 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 m120 56.96 46.08 20.1 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 125.559 2.6 . . . . 1.84 115.04 178.582 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.3 mt -91.82 122.61 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 112.354 -2.203 . . . . 0.82 110.154 178.808 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -108.58 173.53 6.28 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 127.176 2.797 . . . . 2.16 109.477 -173.929 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -59.53 142.7 52.06 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.482 1.66 . . . . 2.12 115.482 173.822 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 5.7 tt0 75.71 15.2 2.64 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 126.271 2.939 . . . . 1.71 116.32 174.07 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 m -77.35 139.97 39.86 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 113.605 -1.634 . . . . 1.04 108.048 -175.693 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -109.51 90.94 3.45 Favored 'General case' 0 N--CA 1.429 -1.497 1 O-C-N 116.016 -4.177 . . . . 0.79 114.772 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -65.45 153.13 42.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.904 2.288 . . . . 1.4 112.82 173.652 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.415 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 18.5 m80 -105.53 101.51 11.03 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 115.815 -4.303 . . . . 1.51 109.326 -178.864 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.0 tp -91.89 108.74 20.14 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 121.018 1.736 . . . . 1.14 110.116 173.563 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -98.69 129.98 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 1 C-N-CA 134.069 4.947 . . . . 1.23 106.804 173.479 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.4 tp . . . . . 0 N--CA 1.43 -1.45 0 CA-C-N 111.911 -2.404 . . . . 2.78 112.861 174.179 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptt? . . . . . 0 CA--C 1.49 -1.34 0 N-CA-C 113.533 0.938 . . . . 1.1 113.533 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -105.38 124.33 49.37 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.371 3.068 . . . . 1.87 112.688 -175.695 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.1 pt -123.8 155.36 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 C-N-CA 129.349 3.06 . . . . 0.72 110.645 175.166 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -114.42 132.8 56.12 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 112.305 -2.225 . . . . 1.4 112.007 -171.071 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.86 97.22 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 103.192 -2.892 . . . . 0.58 103.192 178.756 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -90.62 141.09 29.14 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.529 -1.982 . . . . 2.09 112.403 174.552 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.7 p -107.31 165.39 11.42 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 120.126 1.33 . . . . 0.99 110.406 176.876 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.3 tp -52.7 -36.18 56.84 Favored 'General case' 0 N--CA 1.43 -1.435 1 C-N-CA 134.79 5.236 . . . . 2.53 116.974 177.65 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.4 p -90.08 -19.81 23.91 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.789 -3.07 . . . . 2.08 111.195 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.56 12.38 2.5 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 118.878 -2.389 . . . . 1.31 114.592 169.945 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -94.21 135.4 35.64 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 119.809 1.805 . . . . 1.4 110.433 -176.894 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.1 m -115.41 108.7 16.85 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.625 -4.422 . . . . 0.78 108.506 178.45 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -81.48 124.01 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.455 2.302 . . . . 1.55 108.594 175.076 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.6 m -101.32 98.27 8.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.435 -2.666 . . . . 1.08 108.518 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 mt -100.07 139.91 35.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 127.821 3.676 . . . . 1.55 108.829 179.108 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -96.35 132.1 42.19 Favored 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 114.532 -5.105 . . . . 1.95 107.882 172.494 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.82 168.33 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 126.886 2.074 . . . . 0.96 109.763 179.007 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -105.43 160.61 25.44 Favored Pre-proline 0 N--CA 1.429 -1.477 0 O-C-N 119.457 -2.027 . . . . 2.35 105.927 165.694 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -79.59 -16.6 11.69 Favored 'Trans proline' 0 N--CA 1.434 -2.004 1 CA-C-N 129.395 4.391 . . . . 0.95 112.027 -168.437 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.8 p -85.32 2.9 42.14 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.681 -2.512 . . . . 1.45 116.272 173.855 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -71.12 140.04 50.48 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 125.44 1.713 . . . . 1.69 109.98 173.3 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.444 42.7 p -84.46 161.02 20.45 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.848 -1.782 . . . . 0.75 110.646 -178.624 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.9 mm -52.98 -27.86 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 C-N-CA 126.46 1.904 . . . . 0.73 115.124 170.471 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -57.65 -44.87 85.95 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.292 2.637 . . . . 1.62 115.687 167.278 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -65.13 -37.35 87.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.787 2.708 . . . . 2.13 115.598 178.573 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.417 HG21 HD21 ' A' ' 56' ' ' LEU . 21.3 t -72.75 -47.63 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 112.333 -2.212 . . . . 0.62 115.086 177.517 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -65.75 -17.05 64.35 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 114.581 1.326 . . . . 1.22 114.581 169.211 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.28 -41.28 17.02 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 119.958 1.253 . . . . 0.51 108.198 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -59.64 -31.83 69.89 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.143 1.905 . . . . 1.44 116.143 170.413 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.77 -49.73 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.453 1.597 . . . . 1.32 114.706 170.601 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -59.56 -37.51 78.65 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 113.662 0.986 . . . . 1.7 113.662 177.727 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.7 -37.95 77.21 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.62 -3.175 . . . . 1.55 113.684 176.357 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -92.56 -59.64 2.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.265 1.983 . . . . 2.62 114.364 -177.416 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -84.97 -27.45 26.49 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 118.622 -2.549 . . . . 1.48 113.074 -169.309 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.32 24.43 26.56 Favored Glycine 0 N--CA 1.431 -1.684 0 CA-C-O 124.497 2.165 . . . . 1.12 109.423 169.85 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.3 mt -91.82 112.79 56.41 Favored Pre-proline 0 N--CA 1.431 -1.411 0 CA-C-N 113.225 -1.487 . . . . 1.55 110.461 -171.365 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.255 18.4 Cg_exo -55.37 139.68 81.75 Favored 'Trans proline' 0 N--CA 1.433 -2.058 1 N-CA-C 123.69 4.458 . . . . 1.02 123.69 174.821 . . . . . . . . 3 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -62.01 -22.26 73.91 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 C-N-CA 123.659 2.906 . . . . 1.25 111.013 -175.748 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.63 -31.32 71.92 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.883 1.801 . . . . 2.25 110.864 173.043 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -88.09 -14.84 37.81 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 116.413 -3.929 . . . . 2.02 115.562 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -78.98 98.94 6.62 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 112.139 -2.301 . . . . 0.69 106.659 -173.102 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -102.8 107.48 18.36 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.097 -2.927 . . . . 2.78 103.097 169.754 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.4 mt -105.28 148.12 27.35 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 114.597 -2.841 . . . . 1.17 105.049 -175.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 mm -125.1 131.78 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 109.38 -0.6 . . . . 1.38 109.38 -179.258 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -122.23 108.79 13.69 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.888 -2.382 . . . . 1.5 104.799 168.432 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.87 -92.67 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.18 2.192 . . . . 1.21 110.01 179.051 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.4 -26.69 4.74 Favored Glycine 0 N--CA 1.429 -1.811 0 CA-C-N 113.68 -1.6 . . . . 1.3 109.974 -173.188 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.383 51.2 mttm -99.07 134.97 41.15 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.018 -3.048 . . . . 2.55 118.26 -176.304 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -90.08 116.04 27.8 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 105.836 -1.912 . . . . 2.48 105.836 176.206 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.3 118.97 10.09 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 123.607 1.67 . . . . 0.9 111.521 -169.923 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.12 154.13 20.41 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 116.531 -3.856 . . . . 1.94 110.682 -179.308 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -68.98 152.73 44.89 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.59 -1.943 . . . . 1.56 114.178 -173.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.47 10.55 85.65 Favored Glycine 0 N--CA 1.43 -1.709 0 O-C-N 119.454 -2.029 . . . . 0.97 112.57 173.224 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -104.24 171.3 7.41 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.992 2.33 . . . . 2.49 110.245 170.253 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.1 p -106.32 -174.09 2.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.524 -3.86 . . . . 0.76 104.876 174.324 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.417 HD21 HG21 ' A' ' 26' ' ' VAL . 80.8 mt -83.02 -35.56 25.69 Favored 'General case' 0 N--CA 1.431 -1.423 1 C-N-CA 133.367 4.667 . . . . 1.05 110.477 174.882 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -70.41 -25.88 63.42 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.221 -3.425 . . . . 1.19 114.938 175.726 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -59.9 -34.06 72.67 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.894 -3.004 . . . . 1.9 111.81 168.727 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -92.76 11.53 26.59 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 121.42 1.918 . . . . 0.89 111.177 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.33 10.9 m120 53.26 36.29 22.28 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 127.47 2.308 . . . . 1.84 116.34 -175.67 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.4 mt -85.9 129.2 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 127.625 2.37 . . . . 0.82 108.464 -176.713 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -123.66 -167.01 1.55 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.253 -2.779 . . . . 2.16 110.91 -173.676 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -58.44 141.42 51.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.651 0.982 . . . . 2.12 113.651 178.391 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 69.28 33.71 3.17 Favored 'General case' 0 N--CA 1.43 -1.465 1 C-N-CA 132.199 4.199 . . . . 1.71 109.316 175.6 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 m -101.24 142.93 31.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 123.075 2.671 . . . . 1.04 107.562 -172.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.3 m -102.4 102.74 13.1 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 116.083 -1.913 . . . . 0.79 110.65 -171.738 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.317 57.6 mt -78.69 147.37 33.52 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.767 -1.197 . . . . 1.4 107.767 169.26 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -101.73 128.12 48.2 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.998 -1.064 . . . . 1.51 109.006 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.2 tt -93.61 104.33 16.45 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 118.661 -2.525 . . . . 1.14 110.391 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.0 t -107.67 129.48 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 O-C-N 117.157 -3.464 . . . . 1.23 109.408 -179.09 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.4 mt . . . . . 0 N--CA 1.43 -1.444 0 O-C-N 118.201 -2.812 . . . . 2.78 111.651 -177.88 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.351 19.0 ptt? . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 118.131 -0.938 . . . . 1.1 111.139 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -100.69 132.9 45.85 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 125.965 1.706 . . . . 1.87 106.972 -171.171 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.04 157.5 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 115.181 -2.342 . . . . 0.72 109.525 166.249 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -107.59 143.95 35.31 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.161 1.458 . . . . 1.4 111.782 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 t -123.44 124.44 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 105.583 -2.006 . . . . 0.58 105.583 171.487 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -114.69 135.89 53.66 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 117.15 2.278 . . . . 2.09 117.15 178.973 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.515 21.3 p -69.59 -175.59 0.88 Allowed 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.82 2.247 . . . . 0.99 113.707 179.386 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.3 mt -89.99 -33.67 16.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.482 -3.261 . . . . 2.53 113.913 165.589 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 p -74.49 -56.08 5.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.865 -1.772 . . . . 2.08 114.606 -176.962 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.07 31.16 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 119.997 2.759 . . . . 1.31 119.997 174.412 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -121.8 128.48 51.74 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.507 2.099 . . . . 1.4 111.423 -175.467 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.278 32.3 m -103.5 130.55 50.9 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.271 -2.143 . . . . 0.78 111.541 172.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -100.67 149.83 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 129.682 3.193 . . . . 1.55 107.912 176.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.5 m -123.46 131.17 53.56 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 122.22 2.282 . . . . 1.08 105.468 172.082 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.8 mt -119.4 128.57 54.17 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 116.047 -1.93 . . . . 1.55 114.048 -179.6 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -80.0 112.43 17.29 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 115.138 1.533 . . . . 1.95 115.138 165.68 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.86 174.93 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.578 -2.576 . . . . 0.96 104.701 -171.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -124.02 171.67 6.76 Favored Pre-proline 0 N--CA 1.43 -1.475 0 CA-C-O 114.233 -2.794 . . . . 2.35 104.979 165.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -76.11 -7.75 18.34 Favored 'Trans proline' 0 N--CA 1.434 -1.996 1 CA-C-N 130.02 4.614 . . . . 0.95 114.093 -177.369 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.5 p -83.24 -15.92 48.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 129.922 3.289 . . . . 1.45 109.959 179.538 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.69 139.96 58.24 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 114.542 1.312 . . . . 1.69 114.542 174.99 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 p -85.3 164.45 18.0 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 118.109 -2.869 . . . . 0.75 115.929 172.594 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.4 mm -64.56 -24.92 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 119.152 -2.218 . . . . 0.73 115.611 173.269 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -74.98 -31.7 61.51 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 116.053 -1.927 . . . . 1.62 114.901 165.961 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -66.68 -41.23 88.45 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 120.4 1.455 . . . . 2.13 110.194 174.304 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.68 -48.43 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 114.29 -2.767 . . . . 0.62 111.135 174.772 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -54.86 -45.2 74.55 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 122.144 2.247 . . . . 1.22 114.002 176.219 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.05 -41.16 87.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.174 1.916 . . . . 0.51 116.174 168.588 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -61.06 -41.36 96.47 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.292 2.237 . . . . 1.44 110.435 173.36 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.4 mt -64.37 -32.91 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 121.096 1.771 . . . . 1.32 114.474 169.905 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -62.69 -43.07 99.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.431 1.092 . . . . 1.7 112.503 175.7 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -56.1 -42.5 76.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.391 -2.693 . . . . 1.55 113.567 174.082 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -74.99 -66.64 0.73 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.626 1.343 . . . . 2.62 114.626 -178.117 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -95.29 -21.23 18.55 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.241 2.617 . . . . 1.48 115.389 -166.681 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.37 1.78 68.74 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 127.954 3.284 . . . . 1.12 113.704 175.783 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 mt -72.1 126.63 91.14 Favored Pre-proline 0 N--CA 1.429 -1.481 0 C-N-CA 125.538 1.535 . . . . 1.55 113.44 -177.075 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.524 ' HG2' ' HG3' ' A' ' 40' ' ' GLN . 18.3 Cg_endo -72.67 150.62 50.92 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 O-C-N 113.651 -3.921 . . . . 1.02 116.341 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -63.59 -32.16 69.8 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 CA-C-N 124.045 2.48 . . . . 1.25 111.48 -171.263 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -57.61 -29.7 64.73 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 114.939 -4.851 . . . . 2.25 114.775 176.594 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.524 ' HG3' ' HG2' ' A' ' 37' ' ' PRO . 88.7 mt-30 -90.73 -21.0 21.79 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 119.108 -1.037 . . . . 2.02 111.138 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.279 57.9 mt-30 -78.68 140.0 38.42 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 120.328 -1.483 . . . . 0.69 114.134 -174.623 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -126.44 126.44 43.8 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.771 1.748 . . . . 2.78 106.741 170.397 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.305 29.3 mt -98.21 111.74 23.96 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 118.868 -2.395 . . . . 1.17 111.203 178.961 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mm -105.95 121.02 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 124.327 1.051 . . . . 1.38 111.846 -178.83 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -114.36 98.31 6.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 129.06 2.944 . . . . 1.5 112.638 168.135 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.1 -106.22 0.21 Allowed 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.335 -2.728 . . . . 1.21 113.837 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.94 -12.44 55.37 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 128.704 3.05 . . . . 1.3 112.867 -179.28 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -114.06 149.3 35.68 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 123.28 3.54 . . . . 2.55 106.403 -173.902 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -106.83 142.87 35.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 100.673 -3.825 . . . . 2.48 100.673 169.328 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 mt -103.24 130.19 50.41 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 116.434 -2.106 . . . . 0.9 111.655 -172.431 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -81.19 141.32 34.3 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 118.028 2.603 . . . . 1.94 118.028 -174.375 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -60.66 132.0 52.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.609 1.818 . . . . 1.56 108.94 -176.127 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.02 -19.13 44.52 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 126.159 1.838 . . . . 0.97 116.149 171.669 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.8 mtt180 -82.24 164.9 20.88 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 123.094 1.426 . . . . 2.49 113.5 170.25 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.2 p -87.99 162.99 16.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.487 3.041 . . . . 0.76 112.707 174.844 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.6 mt -61.11 -26.46 67.69 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 114.218 -5.301 . . . . 1.05 119.552 167.457 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.7 t -67.08 -35.03 78.94 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 112.925 -1.943 . . . . 1.19 112.729 176.242 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -56.7 -41.99 78.33 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.812 -3.055 . . . . 1.9 112.402 175.919 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -88.96 4.46 48.03 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 119.284 -2.135 . . . . 0.89 112.584 177.812 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.1 m120 58.33 47.34 14.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.801 2.889 . . . . 1.84 118.801 -178.227 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mt -96.17 130.05 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 124.789 1.306 . . . . 0.82 108.69 -178.892 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -114.23 -159.62 0.7 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 115.504 -2.479 . . . . 2.16 105.734 176.658 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -56.0 153.45 8.82 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 115.551 -4.468 . . . . 2.12 116.925 171.952 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 55.23 33.18 20.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.341 2.972 . . . . 1.71 110.987 173.213 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 m -89.52 143.08 27.1 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 113.962 -5.461 . . . . 1.04 110.584 -179.614 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.2 m -96.02 113.08 24.66 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.282 -2.118 . . . . 0.79 105.282 178.393 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mp -104.57 169.82 8.24 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 104.263 -2.495 . . . . 1.4 104.263 165.602 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -125.84 139.21 53.67 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 127.831 3.207 . . . . 1.51 112.827 -172.111 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.0 tp -98.67 123.38 42.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.789 -2.444 . . . . 1.14 112.038 177.312 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.16 162.25 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.849 -2.278 . . . . 1.23 104.849 174.504 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.5 mt . . . . . 0 N--CA 1.429 -1.486 0 CA-C-O 125.085 2.374 . . . . 2.78 109.947 -179.478 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ttp . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 123.506 1.622 . . . . 1.1 113.285 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -83.15 130.11 35.08 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 115.41 -4.556 . . . . 1.87 114.049 -178.28 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -126.17 161.83 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 115.704 -2.094 . . . . 0.72 108.516 168.934 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -112.76 137.61 50.81 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 104.865 -2.272 . . . . 1.4 104.865 -177.192 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 t -107.46 120.59 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 114.106 -1.406 . . . . 0.58 108.015 173.249 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -96.01 115.45 27.45 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.828 -2.42 . . . . 2.09 111.381 179.327 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.9 p -80.42 175.14 10.92 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 115.982 -4.199 . . . . 0.99 116.223 173.491 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.0 mt -80.5 -24.55 39.32 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.672 -1.232 . . . . 2.53 107.672 176.586 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.3 p -70.93 -39.93 72.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.332 -2.73 . . . . 2.08 108.96 175.508 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.86 50.63 0.55 Allowed Glycine 0 N--CA 1.429 -1.827 0 C-N-CA 126.36 1.933 . . . . 1.31 113.708 -177.568 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -124.21 136.93 54.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 101.556 -3.498 . . . . 1.4 101.556 -179.116 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.4 m -100.22 116.74 32.93 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.777 -3.077 . . . . 0.78 104.767 178.87 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mt -99.15 141.26 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 104.821 -2.288 . . . . 1.55 104.821 178.899 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.5 m -109.88 108.2 18.4 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 103.893 -2.632 . . . . 1.08 103.893 -175.649 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.8 mt -102.74 160.59 14.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.415 -2.678 . . . . 1.55 108.46 177.699 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -119.69 107.19 12.92 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 130.553 3.541 . . . . 1.95 107.919 172.227 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.267 23.2 m -121.58 -171.61 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.696 1.598 . . . . 0.96 109.391 -174.107 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -143.84 179.89 1.09 Allowed Pre-proline 0 N--CA 1.43 -1.428 0 C-N-CA 126.114 1.765 . . . . 2.35 112.672 167.769 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 57' ' ' SER . 11.4 Cg_exo -76.5 -28.0 7.18 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 125.317 2.935 . . . . 0.95 115.669 -176.504 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 p -77.8 -20.33 53.43 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.062 2.545 . . . . 1.45 113.43 -177.68 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.34 139.86 41.51 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 122.989 2.631 . . . . 1.69 112.813 172.531 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.1 p -84.17 175.37 9.51 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 124.295 1.038 . . . . 0.75 112.073 174.915 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.6 mm -74.8 -34.35 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-O 116.241 -1.838 . . . . 0.73 107.573 177.831 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -49.32 -41.7 39.28 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 129.008 2.923 . . . . 1.62 113.131 166.148 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -78.19 -28.61 48.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.394 -2.066 . . . . 2.13 113.075 177.593 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.39 -43.16 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 125.223 1.409 . . . . 0.62 107.459 171.95 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -55.06 -39.86 69.69 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 123.179 2.718 . . . . 1.22 113.178 169.11 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.61 -40.08 76.84 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 126.925 2.09 . . . . 0.51 110.774 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -68.51 -23.28 64.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.353 -2.092 . . . . 1.44 113.109 176.177 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.4 mt -82.81 -28.1 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 117.208 -1.797 . . . . 1.32 110.896 172.615 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -63.33 -44.52 94.7 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.976 -1.702 . . . . 1.7 110.98 177.373 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -56.28 -50.06 72.46 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.809 2.043 . . . . 1.55 111.225 173.193 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -66.08 -59.81 3.43 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 118.951 2.945 . . . . 2.62 118.951 -178.581 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -108.84 -25.58 10.71 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 128.828 2.851 . . . . 1.48 113.544 -165.973 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.02 47.91 7.31 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 123.908 0.755 . . . . 1.12 112.626 -177.869 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.9 mt -104.82 114.39 63.91 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 105.663 -1.977 . . . . 1.55 105.663 177.115 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -55.83 151.45 40.43 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 123.456 2.771 . . . . 1.02 116.154 175.396 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 16.3 Cg_exo -70.51 -22.81 28.15 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 126.099 3.214 . . . . 1.25 119.904 -173.882 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.59 -17.94 62.9 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.459 1.903 . . . . 2.25 110.977 171.921 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -79.51 -29.44 41.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 121.162 1.801 . . . . 2.02 109.472 175.704 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.417 ' HG2' HD11 ' A' ' 69' ' ' LEU . 76.2 mt-30 -84.51 140.08 31.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 118.744 2.868 . . . . 0.69 118.744 -167.803 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -129.99 116.61 18.83 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 104.65 -2.352 . . . . 2.78 104.65 167.412 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.8 mt -96.04 105.65 17.71 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.071 2.549 . . . . 1.17 114.58 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.5 mm -98.04 134.94 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 106.24 -1.763 . . . . 1.38 106.24 -172.692 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -130.08 95.14 3.86 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 116.089 -2.244 . . . . 1.5 107.277 171.305 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 74.33 -107.38 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.325 1.85 . . . . 1.21 111.098 -173.807 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.79 -12.5 24.2 Favored Glycine 0 N--CA 1.429 -1.768 0 O-C-N 118.482 -2.636 . . . . 1.3 109.029 -175.43 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -100.08 134.17 43.39 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.213 -1.757 . . . . 2.55 110.032 -174.51 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -84.37 132.87 34.55 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 103.146 -2.909 . . . . 2.48 103.146 167.383 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 mt -88.5 136.58 32.92 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.911 -2.368 . . . . 0.9 113.75 -179.101 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -73.52 138.65 45.15 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 126.134 2.146 . . . . 1.94 111.731 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -62.96 -39.72 95.52 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 117.599 2.444 . . . . 1.56 117.599 -166.761 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.21 16.43 55.83 Favored Glycine 0 N--CA 1.43 -1.708 0 O-C-N 117.575 -3.203 . . . . 0.97 111.779 175.837 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -95.34 174.4 7.05 Favored 'General case' 0 N--CA 1.429 -1.5 1 CA-C-N 125.407 4.604 . . . . 2.49 108.93 167.224 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.1 p -107.84 176.66 5.07 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 115.397 -2.521 . . . . 0.76 113.979 177.19 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.8 mt -57.91 -46.44 84.98 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 126.773 3.178 . . . . 1.05 113.162 169.627 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 2.1 t -62.27 -37.28 84.86 Favored 'General case' 0 N--CA 1.43 -1.435 1 CA-C-N 108.005 -4.18 . . . . 1.19 116.54 178.669 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -62.07 -36.4 81.55 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 120.389 1.45 . . . . 1.9 114.801 176.451 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -89.9 0.92 56.78 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 116.795 2.146 . . . . 0.89 116.795 177.914 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 m120 74.5 24.79 1.71 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.713 3.205 . . . . 1.84 114.849 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.3 mt -68.94 112.71 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 115.244 1.572 . . . . 0.82 115.244 174.577 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -107.04 -165.54 1.08 Allowed 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 125.007 1.323 . . . . 2.16 112.081 -177.42 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -67.72 153.23 44.17 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.483 1.66 . . . . 2.12 115.483 177.927 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 60.83 24.31 14.26 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 128.283 2.633 . . . . 1.71 116.056 179.519 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.3 m -89.3 148.34 23.61 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.056 -2.278 . . . . 1.04 110.404 -170.722 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.8 m -111.82 110.11 20.29 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.065 -2.897 . . . . 0.79 110.664 -173.904 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.3 mp -90.23 151.89 21.32 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 100.792 -3.781 . . . . 1.4 100.792 172.974 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -116.36 123.08 46.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.463 -2.023 . . . . 1.51 110.8 175.227 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.417 HD11 ' HG2' ' A' ' 41' ' ' GLN . 45.9 tp -95.04 101.97 13.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.653 -2.067 . . . . 1.14 108.651 -174.507 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.6 t -102.41 138.38 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 105.669 -1.975 . . . . 1.23 105.669 178.759 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.3 mt . . . . . 0 N--CA 1.43 -1.442 0 CA-C-O 123.432 1.587 . . . . 2.78 107.702 -179.73 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptt? . . . . . 0 CA--C 1.49 -1.364 0 CA-C-O 118.977 -0.535 . . . . 1.1 111.39 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -98.57 121.59 40.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.28 1.038 . . . . 1.87 109.442 -175.244 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.0 pt -119.44 155.04 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 123.317 1.532 . . . . 0.72 109.433 174.604 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -113.78 126.03 54.76 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.732 -1.855 . . . . 1.4 112.712 -179.127 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.506 HG21 HD11 ' A' ' 30' ' ' ILE . 40.5 t -104.88 114.25 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 105.259 -2.126 . . . . 0.58 105.259 178.601 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -103.74 121.5 43.13 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 129.232 3.013 . . . . 2.09 107.682 -175.676 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 p -86.49 -179.24 6.6 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 127.93 3.729 . . . . 0.99 117.797 179.248 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 8' ' ' LEU . 47.2 mt -83.06 -29.22 28.99 Favored 'General case' 0 N--CA 1.429 -1.505 1 O-C-N 110.91 -7.369 . . . . 2.53 111.913 168.774 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.9 p -64.7 -41.3 96.11 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 117.035 -3.54 . . . . 2.08 110.141 171.443 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.08 4.88 3.19 Favored Glycine 0 N--CA 1.431 -1.692 0 O-C-N 119.962 -1.711 . . . . 1.31 114.248 173.687 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -75.9 122.28 23.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 125.959 1.704 . . . . 1.4 111.23 -171.547 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.307 23.8 m -80.15 88.25 5.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.842 -3.661 . . . . 0.78 114.056 167.106 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.462 HD13 ' HG3' ' A' ' 34' ' ' GLU . 57.5 mt -82.71 130.34 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 103.067 -2.938 . . . . 1.55 103.067 -176.834 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.3 m -101.89 117.48 34.93 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.957 3.303 . . . . 1.08 107.196 -174.287 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.5 mt -131.21 152.43 50.5 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 124.925 3.511 . . . . 1.55 111.642 -178.396 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -106.64 105.13 15.01 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 126.586 1.955 . . . . 1.95 113.285 175.289 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 26' ' ' VAL . 12.4 m -118.09 174.45 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 126.476 1.91 . . . . 0.96 107.615 -175.446 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -126.43 165.62 26.91 Favored Pre-proline 0 N--CA 1.431 -1.39 0 O-C-N 118.638 -2.538 . . . . 2.35 106.203 166.619 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -75.77 -22.57 13.38 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 CA-C-N 124.639 2.693 . . . . 0.95 114.581 -171.305 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.0 m -85.44 15.49 4.43 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 116.354 -2.138 . . . . 1.45 112.591 174.58 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -91.39 167.35 12.34 Favored 'General case' 0 N--CA 1.431 -1.425 1 O-C-N 116.141 -4.1 . . . . 1.69 109.48 169.025 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 36.4 p -104.0 174.57 5.82 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.704 -1.135 . . . . 0.75 108.339 -175.382 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.417 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 27.9 mm -74.76 -31.71 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 127.854 2.462 . . . . 0.73 107.958 175.102 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -57.72 -40.5 79.7 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.633 1.716 . . . . 1.62 115.633 169.079 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -65.29 -48.77 71.99 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 124.23 1.967 . . . . 2.13 111.881 171.472 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.46 HG22 HG11 ' A' ' 17' ' ' VAL 0.28 47.5 t -54.17 -41.71 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 117.19 -3.444 . . . . 0.62 115.333 172.455 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 85.7 mttt -59.26 -46.72 87.75 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 118.046 2.61 . . . . 1.22 118.046 167.979 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.01 -38.93 80.36 Favored 'General case' 0 N--CA 1.432 -1.369 1 C-N-CA 131.714 4.006 . . . . 0.51 114.037 172.845 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.23 -42.93 99.29 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.908 1.683 . . . . 1.44 113.148 167.473 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.506 HD11 HG21 ' A' ' 5' ' ' VAL . 65.8 mt -69.16 -32.32 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 125.945 1.698 . . . . 1.32 110.109 179.14 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -69.92 -47.92 60.54 Favored 'General case' 0 N--CA 1.431 -1.404 1 O-C-N 115.853 -4.279 . . . . 1.7 114.248 175.013 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.27 16.4 t70 -44.53 -59.48 2.43 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 130.53 3.532 . . . . 1.55 110.132 166.297 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -67.81 -53.34 27.79 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.942 2.097 . . . . 2.62 112.557 -172.581 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HG3' HD13 ' A' ' 13' ' ' ILE . 19.4 mm-40 -102.06 -75.04 0.61 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.76 3.171 . . . . 1.48 112.184 -170.185 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.66 22.84 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.714 0 CA-C-O 124.309 2.061 . . . . 1.12 115.101 177.709 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mt -97.79 128.64 33.49 Favored Pre-proline 0 N--CA 1.43 -1.434 0 O-C-N 117.95 -3.088 . . . . 1.55 117.281 -172.319 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -63.03 137.88 64.55 Favored 'Trans proline' 0 N--CA 1.433 -2.032 0 O-C-N 114.65 -3.395 . . . . 1.02 113.309 178.473 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -59.92 -17.72 45.72 Favored 'Trans proline' 0 N--CA 1.434 -2.009 1 C-N-CA 125.474 4.116 . . . . 1.25 115.135 178.747 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -75.33 -28.42 59.64 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.028 -2.295 . . . . 2.25 112.289 169.87 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -82.01 -26.0 34.21 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.781 -2.449 . . . . 2.02 110.196 -173.866 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -87.58 124.22 33.27 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.451 -2.031 . . . . 0.69 114.475 -174.157 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -113.07 115.4 28.28 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 124.329 2.014 . . . . 2.78 109.291 170.098 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.252 4.2 mm? -95.97 116.34 28.79 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 125.544 2.592 . . . . 1.17 112.215 178.962 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 2.3 mm -98.23 122.85 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 1 O-C-N 114.918 -4.864 . . . . 1.38 108.655 178.956 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -138.22 142.32 39.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 116.755 -3.715 . . . . 1.5 103.143 168.245 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.317 . . 62.53 22.37 13.24 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.352 2.352 . . . . 1.21 117.352 177.609 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.04 -14.56 43.16 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 116.947 -3.595 . . . . 1.3 114.229 -175.104 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -100.2 161.36 13.66 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 128.479 2.712 . . . . 2.55 111.707 176.935 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -94.92 140.84 29.37 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 117.535 -3.228 . . . . 2.48 114.854 169.962 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.323 19.7 mt -80.04 135.61 36.4 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 126.426 3.012 . . . . 0.9 113.252 -176.48 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -89.02 144.15 26.35 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.976 -3.577 . . . . 1.94 115.47 175.348 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.269 16.5 m-20 -53.59 -65.78 0.51 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.715 -2.49 . . . . 1.56 116.281 -170.903 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.3 58.79 2.81 Favored Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 127.186 2.327 . . . . 0.97 116.816 167.196 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -139.37 144.98 38.43 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 102.734 -3.062 . . . . 2.49 102.734 166.918 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 60.8 p -79.72 160.98 26.03 Favored 'General case' 0 N--CA 1.429 -1.477 1 CA-C-O 128.785 4.136 . . . . 0.76 114.643 170.937 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.1 mt -71.28 -32.61 68.88 Favored 'General case' 0 N--CA 1.431 -1.391 1 O-C-N 114.351 -5.218 . . . . 1.05 107.066 -176.263 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.8 p -64.76 -35.97 82.8 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.489 2.403 . . . . 1.19 117.489 171.575 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.252 7.9 t70 -60.54 -44.5 96.02 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.048 2.832 . . . . 1.9 113.653 171.726 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -74.64 -22.62 58.82 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 117.788 -3.07 . . . . 0.89 113.936 176.412 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.322 63.6 m-80 68.24 54.32 0.57 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 126.083 2.849 . . . . 1.84 111.597 -178.629 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.9 mm -98.64 124.92 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 102.333 -3.21 . . . . 0.82 102.333 174.226 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -105.28 -174.99 2.67 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.529 -0.732 . . . . 2.16 110.183 -175.45 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -65.12 149.67 49.49 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 116.289 1.959 . . . . 2.12 116.289 169.954 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 77.11 11.42 2.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.87 1.268 . . . . 1.71 113.674 172.111 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.346 5.4 t -78.55 134.84 37.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.971 3.708 . . . . 1.04 120.909 -174.112 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.9 m -101.2 106.47 17.7 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.928 1.694 . . . . 0.79 108.918 -177.879 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.6 mt -88.8 138.56 31.3 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 118.561 -1.255 . . . . 1.4 108.496 170.073 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 40.8 m80 -94.56 125.36 39.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 123.958 1.837 . . . . 1.51 113.312 -176.677 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.7 tp -103.46 126.78 50.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.468 -3.27 . . . . 1.14 111.446 -173.975 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.3 t -118.16 147.07 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 102.258 -3.238 . . . . 1.23 102.258 173.143 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.5 mt . . . . . 0 N--CA 1.43 -1.439 0 CA-C-N 113.031 -1.895 . . . . 2.78 110.029 179.081 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 ptt? . . . . . 0 CA--C 1.49 -1.364 0 CA-C-O 124.246 1.974 . . . . 1.1 110.713 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -111.79 132.78 54.44 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 117.829 -3.044 . . . . 1.87 115.553 -171.722 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.2 pt -135.88 161.83 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 105.592 -2.003 . . . . 0.72 105.592 176.17 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -119.32 145.92 45.73 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 123.611 1.672 . . . . 1.4 109.847 -179.184 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.5 t -119.37 123.62 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 114.528 -1.214 . . . . 0.58 112.464 176.207 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -93.67 111.97 23.76 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 119.339 -0.945 . . . . 2.09 110.665 177.826 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.2 p -69.52 169.37 12.7 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.559 -1.963 . . . . 0.99 115.224 176.921 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.39 -25.87 61.66 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 118.552 -2.592 . . . . 2.53 112.723 178.482 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.9 p -74.6 -22.18 59.09 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 128.012 2.525 . . . . 2.08 115.175 177.317 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.76 52.53 2.43 Favored Glycine 0 N--CA 1.43 -1.712 0 C-N-CA 130.35 3.833 . . . . 1.31 111.71 175.998 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -116.68 140.88 48.91 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 102.432 -3.173 . . . . 1.4 102.432 -178.497 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.5 m -107.38 117.75 34.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 101.579 -3.489 . . . . 0.78 101.579 167.613 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.2 pt -96.04 166.83 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 118.131 -2.855 . . . . 1.55 105.258 173.852 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.0 m -122.28 141.41 51.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 116.712 -1.613 . . . . 1.08 107.925 175.228 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.0 mt -129.81 158.41 39.51 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 127.842 2.457 . . . . 1.55 110.29 173.603 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -111.99 136.53 51.21 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 106.45 -1.685 . . . . 1.95 106.45 167.546 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.7 m -136.17 166.11 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 125.553 1.541 . . . . 0.96 113.976 178.017 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -104.78 156.55 35.8 Favored Pre-proline 0 N--CA 1.43 -1.437 0 O-C-N 120.403 -1.436 . . . . 2.35 109.819 155.531 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -80.34 -5.53 13.51 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 O-C-N 114.624 -3.408 . . . . 0.95 109.908 -171.792 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.284 67.9 m -77.13 -17.77 58.38 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 116.951 -1.499 . . . . 1.45 110.028 171.135 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -60.98 134.47 57.13 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 120.681 1.582 . . . . 1.69 112.843 173.451 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 26' ' ' VAL . 61.7 p -71.58 159.68 34.02 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.286 1.517 . . . . 0.75 109.614 176.714 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.0 mm -69.87 -38.54 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 124.633 2.159 . . . . 0.73 111.285 -176.654 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -48.13 -42.63 29.78 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 128.794 2.837 . . . . 1.62 115.389 162.626 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -67.12 -32.79 74.16 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.201 -1.562 . . . . 2.13 109.194 178.456 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 22' ' ' THR . 4.4 t -71.3 -29.14 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 O-C-N 118.386 -2.696 . . . . 0.62 113.614 174.346 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -75.25 -35.76 61.36 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.23 -0.919 . . . . 1.22 108.787 176.812 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.05 -44.33 74.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.681 1.993 . . . . 0.51 111.788 170.787 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -58.45 -49.22 78.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 116.836 2.161 . . . . 1.44 116.836 173.424 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.418 3.3 mt -58.27 -37.38 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 118.383 2.734 . . . . 1.32 118.383 170.668 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.415 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 64.5 tt0 -63.71 -39.79 95.17 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 118.663 -1.215 . . . . 1.7 113.623 173.11 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -59.67 -58.92 6.49 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.935 1.694 . . . . 1.55 110.555 171.636 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -57.51 -65.66 0.59 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 125.919 1.687 . . . . 2.62 115.288 -179.304 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -106.72 -3.1 20.9 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 129.152 2.981 . . . . 1.48 111.971 -167.161 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.6 54.25 8.87 Favored Glycine 0 N--CA 1.431 -1.696 1 O-C-N 114.469 -5.144 . . . . 1.12 119.29 173.449 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.415 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 81.9 mt -132.27 135.29 26.15 Favored Pre-proline 0 N--CA 1.43 -1.439 0 N-CA-C 102.096 -3.298 . . . . 1.55 102.096 -174.527 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.69 152.27 58.8 Favored 'Trans proline' 0 N--CA 1.434 -2.005 2 C-N-CA 126.379 4.719 . . . . 1.02 108.664 177.941 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.44 -20.93 54.18 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 122.473 2.115 . . . . 1.25 111.449 -177.964 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -54.45 -50.02 68.69 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 131.497 3.919 . . . . 2.25 111.513 176.592 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -73.55 -35.06 65.44 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.307 -1.315 . . . . 2.02 112.293 177.731 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -71.67 123.75 23.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.939 2.199 . . . . 0.69 116.939 -172.663 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -113.38 126.05 54.93 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 122.771 2.532 . . . . 2.78 109.481 166.941 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.3 mt -97.76 132.69 43.16 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.721 -1.237 . . . . 1.17 112.803 178.706 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 mt -119.48 146.44 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 2 C-N-CA 135.113 5.365 . . . . 1.38 104.8 179.86 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.304 68.4 t80 -151.26 128.88 11.48 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 102.631 -3.099 . . . . 1.5 102.631 173.382 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.354 . . 52.1 42.56 30.62 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 121.471 3.878 . . . . 1.21 121.471 -178.368 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.38 -30.7 5.49 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-N 120.54 1.518 . . . . 1.3 116.329 179.472 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.331 16.3 pttm -94.55 148.38 22.31 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 129.934 3.294 . . . . 2.55 112.009 178.147 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -87.58 148.98 24.62 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 127.353 3.454 . . . . 2.48 112.8 169.363 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.424 HD22 ' CD2' ' A' ' 59' ' ' TYR . 55.8 mt -108.45 134.78 50.76 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.36 -2.2 . . . . 0.9 105.333 -175.478 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -88.57 153.72 20.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 126.281 1.832 . . . . 1.94 113.717 178.015 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -63.41 -55.27 25.74 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 117.228 2.307 . . . . 1.56 117.228 -169.527 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.03 62.11 4.59 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 125.825 2.903 . . . . 0.97 119.831 173.517 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.5 mmt-85 -140.5 171.5 14.04 Favored 'General case' 0 N--CA 1.429 -1.479 1 N-CA-C 99.238 -4.356 . . . . 2.49 99.238 171.641 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.8 p -111.36 168.62 9.38 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.747 -1.845 . . . . 0.76 115.476 166.359 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mt -64.11 -37.33 87.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 116.528 -3.858 . . . . 1.05 107.158 174.799 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -65.69 -34.91 79.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 125.973 3.988 . . . . 1.19 116.751 178.356 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -57.35 -45.63 84.16 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 117.322 2.342 . . . . 1.9 117.322 167.467 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.424 ' CD2' HD22 ' A' ' 50' ' ' LEU . 43.0 m-85 -87.14 -2.09 58.37 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.462 2.023 . . . . 0.89 116.462 174.586 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 54.63 74.98 0.32 Allowed 'General case' 0 N--CA 1.43 -1.43 1 C-N-CA 132.075 4.15 . . . . 1.84 110.83 -179.465 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.8 mt -116.99 113.41 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 103.005 -2.961 . . . . 0.82 103.005 -177.949 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -86.48 177.06 7.53 Favored 'General case' 0 N--CA 1.43 -1.452 1 CA-C-O 128.93 4.205 . . . . 2.16 107.908 -174.527 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -63.25 144.74 56.68 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 110.906 -2.861 . . . . 2.12 116.527 172.718 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.314 43.0 mt-10 73.83 26.05 1.87 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.811 3.196 . . . . 1.71 112.886 173.934 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.284 70.0 m -96.26 151.74 19.23 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.721 -3.112 . . . . 1.04 105.445 -177.196 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.0 m -109.44 120.08 41.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 120.959 1.709 . . . . 0.79 111.236 176.788 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mt -95.72 136.0 36.69 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 125.569 1.547 . . . . 1.4 109.973 176.444 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -98.64 118.53 35.56 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.435 -1.415 . . . . 1.51 112.806 -175.299 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.3 tp -99.55 118.01 35.19 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.21 2.204 . . . . 1.14 111.926 178.851 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.23 165.22 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 105.614 -1.995 . . . . 1.23 105.614 172.61 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.6 mt . . . . . 0 N--CA 1.43 -1.435 0 N-CA-C 114.436 1.273 . . . . 2.78 114.436 -176.122 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.315 0 N-CA-C 114.134 1.161 . . . . 1.1 114.134 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -86.62 146.23 26.41 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 123.301 1.524 . . . . 1.87 110.425 -176.88 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.5 pt -139.46 150.03 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 128.254 2.621 . . . . 0.72 109.483 174.355 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -103.53 118.28 36.37 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.452 -1.704 . . . . 1.4 111.753 177.18 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.3 t -94.31 110.7 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 117.735 -1.126 . . . . 0.58 109.047 170.341 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.3 tttp -110.17 139.25 45.52 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 122.574 2.443 . . . . 2.09 112.296 -176.529 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.358 58.0 p -85.05 165.67 17.32 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.859 -1.519 . . . . 0.99 108.793 -178.193 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.455 HD11 HG22 ' A' ' 70' ' ' VAL . 62.1 mt -78.23 -19.31 54.02 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 123.96 1.838 . . . . 2.53 112.157 170.584 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.06 -45.04 13.48 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 114.058 -1.428 . . . . 2.08 107.88 -173.702 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.47 1.31 0.21 Allowed Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 120.262 2.865 . . . . 1.31 120.262 167.249 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -86.55 146.78 26.23 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 119.256 1.528 . . . . 1.4 113.555 -176.751 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.4 m -114.04 110.49 20.12 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.957 2.789 . . . . 0.78 109.195 171.005 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.5 mt -91.83 109.65 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 124.513 2.102 . . . . 1.55 106.403 177.32 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 m -83.44 115.04 21.88 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.69 -3.756 . . . . 1.08 106.085 176.063 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mp -108.39 156.51 19.34 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 129.089 2.956 . . . . 1.55 109.856 175.138 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -118.61 131.73 56.19 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.149 -2.219 . . . . 1.95 111.184 166.605 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -138.67 171.36 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 125.807 1.643 . . . . 0.96 113.233 -175.462 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -102.54 156.1 35.69 Favored Pre-proline 0 N--CA 1.429 -1.48 0 N-CA-C 103.738 -2.69 . . . . 2.35 103.738 166.717 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.9 0.98 9.39 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 124.002 3.135 . . . . 0.95 109.891 179.835 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.4 p -84.03 -18.57 36.61 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.545 -1.972 . . . . 1.45 112.151 171.155 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -66.31 140.9 58.14 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 125.451 2.548 . . . . 1.69 110.917 173.962 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 3.0 p -80.34 163.97 23.49 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 114.95 -2.452 . . . . 0.75 116.055 179.003 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.492 HG13 ' HB3' ' A' ' 50' ' ' LEU . 19.4 mm -64.16 -36.49 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 123.412 2.824 . . . . 0.73 110.735 176.837 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -58.05 -32.84 68.4 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.86 1.664 . . . . 1.62 113.257 168.943 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.383 20.0 t-20 -64.18 -39.73 94.6 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.476 2.084 . . . . 2.13 114.322 174.184 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.5 t -64.55 -46.34 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 124.781 2.229 . . . . 0.62 113.761 174.968 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -66.63 -25.22 66.49 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 125.57 2.605 . . . . 1.22 117.139 -179.323 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.37 -43.25 81.87 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.569 3.556 . . . . 0.51 109.115 174.869 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -63.3 -39.17 93.82 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 116.02 -4.175 . . . . 1.44 113.789 173.997 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.8 mt -69.79 -30.29 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-O 122.837 1.304 . . . . 1.32 111.625 173.839 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.421 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 59.1 tt0 -75.15 -41.98 57.11 Favored 'General case' 0 N--CA 1.431 -1.401 1 O-C-N 113.66 -5.65 . . . . 1.7 106.757 175.87 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -54.62 -46.98 73.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.713 2.673 . . . . 1.55 118.191 168.207 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.282 26.4 tttp -89.49 -43.4 10.86 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 117.168 -3.457 . . . . 2.62 117.301 -174.008 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -101.57 -35.89 8.97 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 126.755 2.534 . . . . 1.48 108.919 -172.378 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.23 56.25 1.22 Allowed Glycine 0 N--CA 1.431 -1.663 0 C-N-CA 117.926 -2.083 . . . . 1.12 113.508 176.094 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.421 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 8.7 mt -134.31 130.62 20.22 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 103.436 -2.801 . . . . 1.55 103.436 -175.49 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -66.85 154.01 76.0 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 CA-C-N 124.387 2.603 . . . . 1.02 116.714 177.664 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -59.33 -31.96 95.89 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 124.051 3.167 . . . . 1.25 110.13 -176.528 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -55.22 -57.95 9.69 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 126.023 2.821 . . . . 2.25 114.741 177.043 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -61.64 -26.88 68.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.298 2.639 . . . . 2.02 110.395 -177.661 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.272 75.2 mt-30 -96.06 131.13 42.79 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.015 1.388 . . . . 0.69 107.41 -173.642 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -118.83 131.87 56.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.107 -1.406 . . . . 2.78 109.954 167.429 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 tp -110.06 119.88 40.68 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 104.679 -2.341 . . . . 1.17 104.679 179.123 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.308 1.7 mt -104.95 143.02 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 128.046 2.539 . . . . 1.38 115.106 179.23 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -155.85 123.08 5.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 125.37 3.713 . . . . 1.5 102.642 179.589 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.257 . . 62.97 30.1 16.43 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.445 2.387 . . . . 1.21 117.445 169.314 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.29 -22.82 32.82 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 125.294 1.621 . . . . 1.3 116.108 -174.161 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -99.36 130.97 45.68 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 118.174 -1.41 . . . . 2.55 114.033 -176.749 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -75.1 130.42 39.24 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 117.254 -1.778 . . . . 2.48 112.988 173.688 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.492 ' HB3' HG13 ' A' ' 23' ' ' ILE . 42.1 mt -76.53 140.95 41.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.699 2.481 . . . . 0.9 117.699 -170.83 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -82.78 135.6 34.93 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.631 -3.168 . . . . 1.94 110.59 177.609 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -54.99 -64.99 0.66 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.766 2.426 . . . . 1.56 112.435 -171.645 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.26 54.54 3.95 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 119.643 -1.91 . . . . 0.97 113.352 172.076 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.9 tpp85 -131.29 161.99 31.06 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 115.296 -2.288 . . . . 2.49 111.126 161.059 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 63.9 p -96.52 155.83 16.6 Favored 'General case' 0 N--CA 1.43 -1.456 1 CA-C-N 127.759 4.799 . . . . 0.76 112.445 178.554 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.1 mt -57.78 -24.24 56.19 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.146 1.778 . . . . 1.05 113.941 173.601 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.7 p -78.4 -27.93 46.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.099 -2.876 . . . . 1.19 115.499 177.404 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -67.73 -34.71 77.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.827 -3.046 . . . . 1.9 115.787 172.332 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.418 ' CE2' HD22 ' A' ' 50' ' ' LEU . 12.7 m-85 -85.94 -8.88 57.71 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.476 1.11 . . . . 0.89 109.381 175.249 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 59.0 54.13 5.19 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.528 -1.983 . . . . 1.84 112.438 178.84 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.1 mt -85.8 114.47 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 126.727 3.156 . . . . 0.82 108.227 174.299 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.283 83.6 mt-30 -91.18 177.6 6.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.369 -3.332 . . . . 2.16 111.409 178.339 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -72.65 160.8 31.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 115.724 -2.391 . . . . 2.12 113.563 178.881 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.433 30.5 mt-10 64.51 32.33 11.79 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 110.582 -3.008 . . . . 1.71 116.005 176.765 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.9 t -100.2 128.65 46.23 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 112.973 -1.921 . . . . 1.04 110.586 -166.26 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.37 2.4 m -75.87 93.74 3.24 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 121.88 2.127 . . . . 0.79 116.313 178.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 60.0 mt -81.39 156.8 25.25 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 130.663 3.585 . . . . 1.4 103.282 174.053 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -125.5 121.34 33.45 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 120.56 1.527 . . . . 1.51 113.035 -174.092 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.1 tp -96.64 110.69 23.07 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 105.812 -1.921 . . . . 1.14 105.812 -178.765 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.455 HG22 HD11 ' A' ' 8' ' ' LEU . 99.0 t -107.04 138.81 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 122.863 1.316 . . . . 1.23 111.457 172.474 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.4 mt . . . . . 0 N--CA 1.431 -1.414 0 O-C-N 120.46 -1.4 . . . . 2.78 113.117 -177.191 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 CA--C 1.491 -1.321 0 CA-C-O 118.985 -0.531 . . . . 1.1 110.664 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -84.95 134.24 34.25 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.49 1.116 . . . . 1.87 112.898 -178.551 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.5 pt -131.83 159.84 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 123.643 1.687 . . . . 0.72 109.666 166.453 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -120.84 149.53 42.44 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 102.492 -3.151 . . . . 1.4 102.492 -173.544 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.4 t -136.2 119.07 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.494 -1.379 . . . . 0.58 109.427 174.409 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -92.23 127.36 37.68 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.816 -1.084 . . . . 2.09 112.079 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.2 p -83.63 165.03 19.33 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.171 1.463 . . . . 0.99 112.111 -178.862 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.68 -31.42 72.63 Favored 'General case' 0 N--CA 1.429 -1.512 1 O-C-N 116.053 -4.154 . . . . 2.53 114.723 167.324 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.0 p -71.62 -48.64 46.68 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 124.285 0.991 . . . . 2.08 111.626 -175.217 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.52 41.64 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 119.273 -1.442 . . . . 1.31 110.674 -179.21 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.29 33.7 ttpt -133.57 149.89 51.65 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.07 -2.43 . . . . 1.4 106.775 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.9 m -95.41 113.94 25.66 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.161 2.584 . . . . 0.78 114.674 167.234 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 mt -82.39 119.25 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 117.645 -3.16 . . . . 1.55 110.305 172.215 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.8 m -104.32 111.27 23.84 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.874 -2.391 . . . . 1.08 107.896 178.093 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.8 mt -110.1 156.06 21.08 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 119.395 3.109 . . . . 1.55 119.395 -177.989 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 tp10 -103.39 107.23 17.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.206 -1.559 . . . . 1.95 113.307 168.779 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.7 m -121.17 164.77 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 115.879 -2.01 . . . . 0.96 112.944 174.375 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 9.3 mm-40 -111.69 169.51 6.25 Favored Pre-proline 0 N--CA 1.43 -1.439 0 O-C-N 125.055 1.472 . . . . 2.35 109.993 163.381 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 46.0 Cg_exo -77.38 -20.59 12.38 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 C-N-CA 122.808 2.339 . . . . 0.95 116.103 -174.122 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.7 m -82.99 3.26 30.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.8 1.64 . . . . 1.45 111.473 174.9 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -82.5 147.13 28.86 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.185 -2.822 . . . . 1.69 111.266 172.796 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.1 p -75.86 164.48 26.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.291 2.701 . . . . 0.75 118.291 174.215 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.4 mm -74.94 -29.12 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 118.279 -2.763 . . . . 0.73 110.687 178.402 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -53.37 -39.65 64.36 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 126.037 1.735 . . . . 1.62 112.529 163.708 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -60.1 -47.89 84.0 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.548 2.339 . . . . 2.13 114.793 173.206 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.7 t -60.61 -48.78 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 130.144 3.378 . . . . 0.62 112.237 177.661 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -60.09 -38.36 82.7 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 124.543 2.116 . . . . 1.22 115.083 173.991 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.85 -31.98 71.32 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 119.198 -2.189 . . . . 0.51 115.767 176.237 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -71.29 -37.44 71.86 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.498 2.094 . . . . 1.44 110.866 170.582 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.0 mt -67.14 -41.77 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 116.639 -3.788 . . . . 1.32 110.984 172.29 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -51.77 -33.06 33.47 Favored 'General case' 0 N--CA 1.43 -1.466 1 N-CA-C 122.31 4.189 . . . . 1.7 122.31 169.757 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -63.51 -42.18 98.49 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 117.04 -1.457 . . . . 1.55 110.057 174.132 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -85.13 -50.9 7.03 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 125.894 1.996 . . . . 2.62 110.414 -172.931 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -94.35 -27.18 16.22 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 113.567 0.951 . . . . 1.48 113.567 -168.517 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.31 -23.29 29.03 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-O 126.223 3.124 . . . . 1.12 113.759 168.025 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.2 mt -63.77 123.0 80.1 Favored Pre-proline 0 N--CA 1.431 -1.41 0 C-N-CA 128.461 2.704 . . . . 1.55 114.498 -172.691 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 59.0 Cg_endo -76.35 158.35 36.92 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 CA-C-N 126.387 3.317 . . . . 1.02 111.536 -172.025 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -54.91 -31.51 73.78 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 123.359 2.706 . . . . 1.25 116.597 -174.017 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -55.37 -42.87 74.54 Favored 'General case' 0 N--CA 1.43 -1.457 1 CA-C-O 129.263 4.363 . . . . 2.25 117.761 174.019 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -88.15 -25.54 22.91 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.94 -4.225 . . . . 2.02 112.503 -177.635 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -64.73 134.3 53.9 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.931 -1.731 . . . . 0.69 110.068 179.997 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -126.21 140.92 52.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.173 -2.829 . . . . 2.78 106.151 165.324 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 67' ' ' LEU . 85.9 mt -121.95 114.93 21.68 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.689 -2.05 . . . . 1.17 110.553 -178.837 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 mt -104.23 127.04 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 117.63 -3.168 . . . . 1.38 110.612 178.421 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -136.02 120.34 17.95 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.12 2.568 . . . . 1.5 107.196 176.317 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.313 . . 76.68 6.7 3.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.983 -1.698 . . . . 1.21 114.915 -177.438 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.78 -10.56 74.31 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 117.796 -3.065 . . . . 1.3 111.83 -175.267 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -92.17 146.42 23.73 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 105.978 -1.86 . . . . 2.55 105.978 170.976 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -94.43 141.89 28.06 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.162 1.385 . . . . 2.48 111.376 170.53 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -105.52 123.62 48.2 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 119.245 0.93 . . . . 0.9 109.196 -166.604 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -69.1 144.1 54.02 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.145 1.778 . . . . 1.94 111.85 174.509 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -60.6 -63.12 1.41 Allowed 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 130.975 3.71 . . . . 1.56 115.742 -169.179 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.75 23.12 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.714 1 C-N-CA 131.056 4.169 . . . . 0.97 121.317 170.85 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.296 65.1 mtt180 -123.61 162.91 22.06 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.053 -2.439 . . . . 2.49 111.598 165.467 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.0 p -84.12 154.44 23.15 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 125.543 2.592 . . . . 0.76 113.579 168.694 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mt -51.3 -34.12 31.84 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.759 -4.338 . . . . 1.05 113.883 175.529 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.7 p -79.44 -12.21 59.89 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 117.583 2.438 . . . . 1.19 117.583 179.812 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.85 -51.49 47.71 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 127.033 3.301 . . . . 1.9 108.481 171.247 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -66.75 -21.18 66.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.963 -2.961 . . . . 0.89 117.137 172.751 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.26 2.5 m-80 70.34 47.28 0.54 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.963 3.305 . . . . 1.84 111.997 -177.279 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.2 mm -78.72 113.63 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 117.907 -2.996 . . . . 0.82 106.695 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -97.89 175.15 6.25 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 126.049 1.739 . . . . 2.16 112.847 -177.644 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -59.62 132.75 54.93 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 114.59 1.33 . . . . 2.12 114.59 172.981 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.401 48.4 mt-10 85.57 17.01 0.13 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.554 1.645 . . . . 1.71 111.664 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.277 6.8 m -81.47 129.88 34.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.053 -2.28 . . . . 1.04 113.362 -173.928 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.8 m -103.45 106.4 16.91 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 127.923 3.265 . . . . 0.79 109.892 -175.617 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 43' ' ' LEU . 2.7 mt -87.07 155.62 20.07 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 126.045 2.831 . . . . 1.4 111.907 172.151 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -118.9 120.84 38.5 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 115.86 -2.019 . . . . 1.51 111.457 -179.103 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.8 tp -82.82 133.68 35.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.144 1.778 . . . . 1.14 107.652 179.007 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.08 157.66 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 102.527 -3.138 . . . . 1.23 102.527 175.483 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.5 mt . . . . . 0 N--CA 1.43 -1.456 0 CA-C-O 126.228 2.918 . . . . 2.78 111.061 -169.49 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 CA--C 1.49 -1.345 0 N-CA-C 106.879 -1.526 . . . . 1.1 106.879 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -104.04 124.96 49.99 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 118.695 -2.503 . . . . 1.87 108.695 -173.554 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.9 pt -116.2 160.9 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 118.163 -2.835 . . . . 0.72 109.177 170.176 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -103.61 134.57 46.72 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 125.967 1.707 . . . . 1.4 111.057 176.475 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.2 t -112.59 125.99 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 103.939 -2.615 . . . . 0.58 103.939 172.98 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -103.18 144.51 31.23 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.032 -3.543 . . . . 2.09 112.438 169.543 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.5 p -93.99 -177.51 4.35 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 124.7 1.25 . . . . 0.99 114.082 -178.839 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.482 HD11 ' H ' ' A' ' 71' ' ' LEU . 46.4 mt -72.29 -27.58 62.55 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 116.442 -1.742 . . . . 2.53 113.088 174.167 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 p -88.13 -62.41 1.5 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.914 1.34 . . . . 2.08 111.672 -172.169 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.86 36.61 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.7 0 CA-C-N 113.721 -1.581 . . . . 1.31 110.153 177.492 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -99.0 148.19 24.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 106.233 -1.766 . . . . 1.4 106.233 -179.468 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.6 m -114.04 127.28 55.87 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 122.373 2.351 . . . . 0.78 106.966 169.158 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mt -108.53 133.3 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.507 -1.996 . . . . 1.55 110.707 173.475 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.0 m -93.88 112.88 24.8 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.325 1.85 . . . . 1.08 109.705 174.101 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -110.29 143.64 40.18 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 121.607 2.003 . . . . 1.55 112.711 174.659 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -114.11 115.11 27.01 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.709 -2.495 . . . . 1.95 110.178 175.199 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.77 177.36 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 127.324 2.25 . . . . 0.96 108.871 -176.521 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -120.11 155.65 55.46 Favored Pre-proline 0 N--CA 1.43 -1.443 0 O-C-N 119.079 -2.263 . . . . 2.35 105.903 162.067 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -73.57 -10.41 23.62 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 124.351 2.59 . . . . 0.95 114.376 -170.232 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.273 48.9 m -87.19 -0.8 57.26 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 127.403 2.939 . . . . 1.45 112.556 175.098 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -68.58 150.28 48.2 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 117.044 -1.455 . . . . 1.69 109.583 179.128 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.3 p -87.59 170.94 10.86 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 125.522 2.582 . . . . 0.75 109.476 176.815 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.407 7.4 mm -61.36 -48.31 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 111.295 -2.684 . . . . 0.73 112.627 173.908 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -41.8 -51.43 4.23 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 119.97 3.322 . . . . 1.62 119.97 164.506 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -61.48 -24.6 66.69 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 119.055 2.983 . . . . 2.13 119.055 174.873 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.0 t -75.65 -39.42 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 125.465 2.555 . . . . 0.62 108.988 175.718 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.3 51.5 mtmt -65.24 -36.71 84.97 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.773 -1.83 . . . . 1.22 111.557 177.784 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.19 -24.1 66.56 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 128.32 2.648 . . . . 0.51 113.965 175.966 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -78.16 -38.63 43.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 126.838 2.586 . . . . 1.44 112.951 170.503 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.363 68.8 mt -65.84 -42.99 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-O 126.391 2.996 . . . . 1.32 111.915 172.304 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -57.79 -55.03 40.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 111.474 -2.603 . . . . 1.7 111.011 172.555 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.298 33.5 t70 -29.13 -56.64 0.14 Allowed 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 119.727 3.232 . . . . 1.55 119.727 170.898 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -81.45 -53.16 6.53 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 117.563 2.431 . . . . 2.62 117.563 -178.798 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -92.72 -22.62 19.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.178 -2.826 . . . . 1.48 106.525 -163.854 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.56 10.58 59.04 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 130.239 3.78 . . . . 1.12 114.701 177.042 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.5 mt -86.73 125.09 68.13 Favored Pre-proline 0 N--CA 1.43 -1.463 0 O-C-N 116.495 -3.944 . . . . 1.55 109.305 -174.231 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.465 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 29.9 Cg_exo -64.24 149.67 89.79 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 N-CA-C 120.86 3.369 . . . . 1.02 120.86 176.741 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 47.5 Cg_exo -69.32 -14.9 38.27 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 CA-C-N 124.966 2.809 . . . . 1.25 117.808 -175.714 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -83.09 -10.65 58.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.704 1.593 . . . . 2.25 110.784 176.714 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.16 -15.74 23.09 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.299 -1.501 . . . . 2.02 108.843 -179.664 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -93.44 124.32 37.35 Favored 'General case' 0 N--CA 1.43 -1.465 1 CA-C-O 129.352 4.406 . . . . 0.69 110.529 -179.324 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -106.65 110.07 22.15 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 114.009 -5.432 . . . . 2.78 104.205 169.963 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.6 mt -89.77 124.66 34.84 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 115.518 -2.182 . . . . 1.17 107.48 172.836 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.44 HD12 HG21 ' A' ' 70' ' ' VAL . 32.4 mt -121.62 136.76 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 128.005 3.316 . . . . 1.38 106.747 -178.255 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -147.44 123.7 10.89 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.718 -1.583 . . . . 1.5 108.245 -176.349 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.304 . . 82.35 -51.09 0.21 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 114.654 1.353 . . . . 1.21 114.654 173.365 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.61 -34.84 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 128.179 2.799 . . . . 1.3 113.739 -178.405 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -89.29 164.11 15.07 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 126.228 2.918 . . . . 2.55 112.24 -179.695 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -98.23 133.45 42.64 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.592 -1.943 . . . . 2.48 110.727 171.09 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.2 mt -88.71 129.56 35.51 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 118.774 -2.454 . . . . 0.9 114.827 -167.356 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.341 26.9 mt-10 -65.0 131.53 46.84 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.727 -1.858 . . . . 1.94 115.571 174.381 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -43.58 -63.75 0.78 Allowed 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 131.188 3.795 . . . . 1.56 114.716 -171.609 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.22 61.15 1.88 Allowed Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 112.364 -2.198 . . . . 0.97 117.323 174.202 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 -126.03 172.85 9.62 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.36 -2.089 . . . . 2.49 105.36 156.393 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.0 p -97.78 177.94 5.3 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 117.315 2.339 . . . . 0.76 117.315 169.557 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.8 mt -77.3 -32.28 55.29 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.247 -2.158 . . . . 1.05 109.77 173.702 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -66.6 -37.02 84.02 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 123.814 3.006 . . . . 1.19 114.136 171.484 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -54.24 -64.1 0.94 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 131.668 3.987 . . . . 1.9 115.022 169.921 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -62.99 -14.15 44.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.913 1.819 . . . . 0.89 115.913 173.901 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.345 29.0 m120 78.02 36.83 0.23 Allowed 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 116.794 -1.574 . . . . 1.84 114.79 179.329 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.9 mt -96.22 125.54 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 122.182 2.264 . . . . 0.82 110.96 -177.147 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -98.34 -179.91 4.51 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 118.095 2.628 . . . . 2.16 118.095 -171.498 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.304 21.7 pttp -65.87 145.83 55.46 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 118.749 -1.18 . . . . 2.12 109.328 170.373 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.269 19.4 mt-10 69.99 20.13 6.66 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 126.227 2.204 . . . . 1.71 113.142 171.815 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.2 m -87.13 148.13 25.34 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 118.027 -2.92 . . . . 1.04 111.239 179.668 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.6 m -92.89 98.4 11.35 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.829 2.159 . . . . 0.79 116.829 -177.31 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -84.82 145.53 27.81 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 113.987 -5.446 . . . . 1.4 113.744 172.072 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -117.03 119.5 35.47 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 118.918 -2.364 . . . . 1.51 109.702 -176.043 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.0 tp -84.88 102.44 13.11 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.967 3.307 . . . . 1.14 109.625 178.092 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 44' ' ' ILE 0.32 98.7 t -94.02 130.48 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 130.513 3.525 . . . . 1.23 107.28 170.814 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.482 ' H ' HD11 ' A' ' 8' ' ' LEU . 66.4 mt . . . . . 0 N--CA 1.429 -1.487 0 O-C-N 117.441 -3.287 . . . . 2.78 108.589 179.106 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttp . . . . . 0 CA--C 1.491 -1.324 0 CA-C-O 124.177 1.942 . . . . 1.1 114.399 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -106.25 141.41 37.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.808 -3.057 . . . . 1.87 111.692 -176.05 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 pt -127.35 173.16 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 131.566 3.947 . . . . 0.72 113.337 175.691 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -135.32 126.02 27.2 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.569 -2.582 . . . . 1.4 105.953 -178.544 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -115.24 118.74 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 106.25 -1.759 . . . . 0.58 106.25 173.443 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -100.28 145.24 28.35 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 118.202 -1.399 . . . . 2.09 111.525 175.383 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.2 p -101.2 160.53 14.32 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 128.931 2.892 . . . . 0.99 112.766 179.939 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 mt -71.14 -28.72 64.48 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.718 -1.864 . . . . 2.53 112.862 175.053 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 t -72.76 -38.6 67.28 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 121.744 2.066 . . . . 2.08 110.142 -177.782 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.27 -10.42 0.54 Allowed Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 125.347 1.451 . . . . 1.31 112.918 166.039 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -80.02 135.02 36.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.75 2.02 . . . . 1.4 113.735 -167.731 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.2 m -108.0 117.38 33.97 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.855 2.462 . . . . 0.78 109.484 176.204 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 mt -104.8 105.61 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 113.361 0.874 . . . . 1.55 113.361 178.332 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.8 m -79.31 118.19 21.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.347 -3.345 . . . . 1.08 108.819 -178.762 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.401 HD22 ' HB3' ' A' ' 29' ' ' LYS . 83.8 mt -120.78 153.58 36.86 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 116.803 -3.686 . . . . 1.55 111.605 -179.8 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -116.33 120.37 38.68 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.059 2.544 . . . . 1.95 110.256 168.382 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -131.92 167.82 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 105.894 -1.891 . . . . 0.96 105.894 -170.575 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -109.45 147.91 37.0 Favored Pre-proline 0 N--CA 1.43 -1.45 0 O-C-N 118.485 -2.635 . . . . 2.35 109.831 160.653 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.254 2.2 Cg_endo -57.11 -18.6 29.78 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 N-CA-C 120.619 3.277 . . . . 0.95 120.619 -173.18 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.9 m -91.05 3.64 54.2 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 125.92 1.688 . . . . 1.45 112.37 -178.709 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -71.78 161.73 30.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.481 2.312 . . . . 1.69 108.54 172.405 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.7 p -98.37 163.8 12.55 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 123.306 1.527 . . . . 0.75 107.657 178.471 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mm -54.38 -41.18 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 118.32 -2.738 . . . . 0.73 114.031 174.25 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.328 16.6 tt0 -54.86 -32.18 60.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.057 -2.277 . . . . 1.62 117.09 166.955 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -64.81 -38.49 91.17 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 129.483 3.113 . . . . 2.13 111.75 176.494 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.3 t -69.18 -40.68 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 119.523 -1.985 . . . . 0.62 107.629 179.254 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.517 ' HD3' ' HB2' ' A' ' 41' ' ' GLN . 74.1 mttt -61.19 -35.64 77.69 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.042 -2.911 . . . . 1.22 114.906 170.734 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.16 -25.21 65.15 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 114.539 -2.864 . . . . 0.51 118.701 177.963 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.401 ' HB3' HD22 ' A' ' 15' ' ' LEU . 54.2 mttp -67.92 -35.53 78.6 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 130.383 3.473 . . . . 1.44 107.201 168.654 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mt -74.07 -39.36 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 1 O-C-N 116.083 -4.136 . . . . 1.32 108.671 178.953 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -64.29 -37.12 86.35 Favored 'General case' 0 N--CA 1.428 -1.547 0 O-C-N 117.12 -3.488 . . . . 1.7 111.556 178.766 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -69.85 -43.6 71.58 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.417 1.103 . . . . 1.55 112.72 172.517 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -72.73 -48.19 40.73 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 120.399 3.481 . . . . 2.62 120.399 178.943 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -108.66 -30.85 7.99 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.467 -2.645 . . . . 1.48 112.489 -165.715 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.67 37.24 5.58 Favored Glycine 0 N--CA 1.43 -1.702 0 O-C-N 118.917 -2.364 . . . . 1.12 116.133 176.467 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.3 mt -113.89 126.18 28.42 Favored Pre-proline 0 N--CA 1.431 -1.412 0 CA-C-O 111.83 -3.938 . . . . 1.55 105.368 177.622 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.84 151.06 35.45 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-N 126.379 3.314 . . . . 1.02 110.77 -176.095 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -55.87 -31.85 82.83 Favored 'Trans proline' 0 N--CA 1.433 -2.047 1 C-N-CA 126.121 4.547 . . . . 1.25 112.806 -178.897 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -41.78 -49.11 4.38 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 113.229 -3.272 . . . . 2.25 117.372 165.935 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -80.55 -20.82 42.58 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 122.664 2.484 . . . . 2.02 117.279 177.514 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.517 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 72.1 mt-30 -76.82 130.86 38.21 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.999 1.32 . . . . 0.69 111.868 -172.086 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.523 ' HB2' HG23 ' A' ' 70' ' ' VAL . 70.0 mtt180 -120.33 131.01 54.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.432 -2.668 . . . . 2.78 108.561 169.653 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.7 mt -107.55 130.52 54.86 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 120.521 1.51 . . . . 1.17 110.795 179.663 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -105.03 127.92 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 125.742 1.617 . . . . 1.38 113.046 178.373 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -152.2 141.91 21.88 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.494 -2.78 . . . . 1.5 103.494 173.163 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.27 . . 64.71 14.38 9.06 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.124 2.392 . . . . 1.21 115.024 -179.013 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.49 18.51 75.71 Favored Glycine 0 N--CA 1.431 -1.674 0 O-C-N 117.511 -3.243 . . . . 1.3 118.23 179.295 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -126.18 150.18 48.5 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.277 3.031 . . . . 2.55 111.047 176.503 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -80.15 132.75 35.97 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 121.646 2.021 . . . . 2.48 112.129 169.705 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.404 HD22 ' CD1' ' A' ' 59' ' ' TYR . 21.3 mt -88.45 135.77 33.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.453 -3.904 . . . . 0.9 114.297 -173.248 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.93 125.84 27.58 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.034 2.934 . . . . 1.94 108.739 -179.76 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.32 1.0 OUTLIER -47.23 -47.4 24.57 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 120.829 3.64 . . . . 1.56 120.829 -174.12 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.84 32.11 7.18 Favored Glycine 0 N--CA 1.43 -1.712 0 CA-C-O 125.652 2.807 . . . . 0.97 118.795 -179.834 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -101.98 157.87 16.56 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.404 -3.409 . . . . 2.49 108.951 159.685 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -85.09 168.17 15.11 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.59 -1.186 . . . . 0.76 110.048 -179.337 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.6 mt -69.64 -41.01 76.16 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 124.86 1.35 . . . . 1.05 109.869 179.289 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.264 48.3 p -58.99 -18.75 37.05 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 117.32 2.341 . . . . 1.19 117.32 175.8 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -69.79 -45.04 68.86 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.657 2.383 . . . . 1.9 111.567 173.023 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.404 ' CD1' HD22 ' A' ' 50' ' ' LEU . 61.2 m-85 -83.5 2.96 34.35 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.399 -2.688 . . . . 0.89 113.309 174.19 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.4 m120 57.56 49.02 13.34 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 129.11 2.964 . . . . 1.84 117.203 177.394 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -85.14 114.29 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 128.564 2.746 . . . . 0.82 111.791 -175.96 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -93.14 -173.73 3.34 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.005 2.336 . . . . 2.16 112.633 -176.488 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -62.54 137.72 58.32 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 112.574 -2.103 . . . . 2.12 113.456 176.673 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 64.15 29.7 13.93 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 114.029 1.122 . . . . 1.71 114.029 170.143 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.6 m -81.43 143.24 32.26 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 123.288 1.518 . . . . 1.04 114.368 -178.753 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 m -99.16 117.06 32.79 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.58 -2.575 . . . . 0.79 111.382 -179.62 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -104.24 160.23 15.05 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.088 2.555 . . . . 1.4 106.261 174.439 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -124.94 135.56 52.95 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.211 -1.774 . . . . 1.51 106.211 -176.824 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.1 tp -99.57 128.75 45.68 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 105.449 -2.056 . . . . 1.14 105.449 -176.411 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.523 HG23 ' HB2' ' A' ' 42' ' ' ARG . 20.3 m -122.0 170.13 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 104.037 -2.579 . . . . 1.23 104.037 168.771 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 71' ' ' LEU . 89.5 mt . . . . . 0 N--CA 1.43 -1.429 0 CA-C-O 117.469 -1.253 . . . . 2.78 111.4 177.39 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tmm? . . . . . 0 CA--C 1.49 -1.352 0 CA-C-O 121.05 0.452 . . . . 1.1 110.579 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -108.72 129.31 55.36 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 117.228 2.307 . . . . 1.87 117.228 -177.537 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -129.28 170.62 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 106.28 -1.748 . . . . 0.72 106.28 175.544 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -121.94 140.15 52.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.921 -2.252 . . . . 1.4 104.921 -177.203 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.453 HG22 ' HB2' ' A' ' 67' ' ' LEU . 92.6 t -123.96 131.51 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 118.069 -2.894 . . . . 0.58 106.771 170.52 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -88.68 118.81 28.62 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.857 2.063 . . . . 2.09 115.352 171.454 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.5 p -83.49 176.06 9.34 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.238 -3.414 . . . . 0.99 111.619 173.775 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.3 mt -78.9 -17.17 56.0 Favored 'General case' 0 N--CA 1.43 -1.432 1 CA-C-O 129.617 4.532 . . . . 2.53 116.066 -179.762 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 p -95.27 -56.74 2.62 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.367 -3.333 . . . . 2.08 107.119 -170.601 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.4 23.65 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.728 0 CA-C-O 114.969 -3.128 . . . . 1.31 115.453 176.124 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -109.68 139.82 44.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 121.67 2.735 . . . . 1.4 108.467 -173.255 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.1 m -106.84 124.33 49.46 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 100.61 -3.848 . . . . 0.78 100.61 175.577 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.7 mt -94.62 123.14 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 N-CA-C 104.776 -2.305 . . . . 1.55 104.776 179.553 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.3 m -90.21 106.7 18.66 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.529 2.331 . . . . 1.08 109.369 176.617 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.3 mt -103.83 128.62 51.27 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.715 1.721 . . . . 1.55 108.396 -176.811 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -90.6 116.32 28.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.807 -3.058 . . . . 1.95 111.803 165.993 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.2 m -130.22 159.59 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.731 -2.481 . . . . 0.96 111.108 -171.358 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -99.68 146.07 31.21 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 118.591 -2.568 . . . . 2.35 108.209 170.875 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -73.44 -17.44 23.81 Favored 'Trans proline' 0 C--N 1.299 -2.059 0 CA-C-N 127.744 3.802 . . . . 0.95 113.52 -177.547 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -77.34 -2.55 35.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 123.206 2.73 . . . . 1.45 111.479 172.431 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -73.97 139.65 44.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 122.415 2.37 . . . . 1.69 109.03 178.588 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 p -74.51 158.65 33.41 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 111.015 -2.811 . . . . 0.75 110.847 170.257 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.403 HG12 ' H ' ' A' ' 23' ' ' ILE . 6.6 mm -61.78 -30.98 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 125.062 1.476 . . . . 0.73 113.388 174.484 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -52.0 -33.33 37.76 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.51 3.124 . . . . 1.62 116.162 165.766 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -85.45 -29.62 24.19 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.301 -2.749 . . . . 2.13 108.699 176.258 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.1 t -70.2 -42.1 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 117.126 -3.483 . . . . 0.62 110.898 178.886 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -63.3 -27.57 69.42 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.347 2.659 . . . . 1.22 113.14 170.194 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.43 -21.64 41.96 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 123.373 1.559 . . . . 0.51 110.933 175.504 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -75.56 -30.16 59.59 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.749 -3.094 . . . . 1.44 114.574 170.054 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.8 mt -66.88 -38.19 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 O-C-N 120.383 -1.448 . . . . 1.32 109.401 169.905 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.424 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 14.4 tt0 -57.43 -58.43 8.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.506 0.67 . . . . 1.7 112.624 170.819 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -47.61 -49.78 26.06 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.854 2.062 . . . . 1.55 110.438 178.638 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -65.13 -66.26 0.57 Allowed 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.969 2.908 . . . . 2.62 112.06 -176.375 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -95.62 -53.75 3.61 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 127.86 2.464 . . . . 1.48 113.351 -164.056 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.98 -43.6 0.6 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 106.693 -2.563 . . . . 1.12 106.693 -179.365 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.481 HG13 ' H ' ' A' ' 36' ' ' ILE . 7.8 mt -40.69 115.2 1.19 Allowed Pre-proline 0 N--CA 1.43 -1.452 1 N-CA-C 123.715 4.709 . . . . 1.55 123.715 -171.479 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -69.38 157.58 60.61 Favored 'Trans proline' 0 C--N 1.3 -1.993 2 CA-C-N 129.712 4.504 . . . . 1.02 108.448 -174.444 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.424 ' HD3' ' HB2' ' A' ' 31' ' ' GLN . 38.0 Cg_exo -65.65 -23.79 56.19 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 N-CA-C 117.522 2.085 . . . . 1.25 117.522 177.099 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.3 -12.98 47.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.624 -3.173 . . . . 2.25 118.46 174.873 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -97.39 -22.4 16.63 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 124.044 0.938 . . . . 2.02 108.977 -178.546 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -90.46 136.2 33.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 118.687 2.847 . . . . 0.69 118.687 -168.246 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -126.03 118.33 25.11 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.329 -2.1 . . . . 2.78 105.329 169.955 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.3 mt -96.94 122.34 39.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 123.962 0.905 . . . . 1.17 111.462 177.88 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 22.9 mm -105.58 141.6 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 128.326 2.651 . . . . 1.38 104.183 -176.961 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -140.71 132.74 27.82 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 116.82 -3.675 . . . . 1.5 103.622 168.054 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.42 . . 56.13 32.48 20.2 Favored 'General case' 0 N--CA 1.429 -1.48 1 CA-C-O 132.335 5.826 . . . . 1.21 121.617 174.25 . . . . . . . . 3 2 . 1 . 033 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.99 -15.21 39.34 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 108.461 -3.972 . . . . 1.3 109.793 179.206 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -87.16 129.49 34.92 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 128.549 2.74 . . . . 2.55 116.931 -178.106 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -74.4 114.91 13.33 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 128.692 2.797 . . . . 2.48 112.43 173.022 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.1 mt -85.58 147.65 26.31 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 115.922 1.823 . . . . 0.9 115.922 -174.273 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -93.16 138.38 31.63 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.592 -0.892 . . . . 1.94 108.592 179.937 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -66.79 -41.48 87.54 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 118.479 0.581 . . . . 1.56 112.028 -165.623 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.95 47.51 3.39 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 118.454 2.142 . . . . 0.97 118.454 176.498 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -134.49 171.65 14.01 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 102.312 -3.218 . . . . 2.49 102.312 171.409 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.2 p -113.81 177.83 4.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 125.275 2.464 . . . . 0.76 116.799 178.818 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.54 HD23 HD12 ' A' ' 61' ' ' ILE . 84.8 mt -66.91 -42.24 85.77 Favored 'General case' 0 N--CA 1.43 -1.427 1 C-N-CA 131.816 4.046 . . . . 1.05 109.084 173.9 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 t -59.56 -32.97 70.84 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 116.277 -4.014 . . . . 1.19 111.704 173.698 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.271 54.3 m-20 -81.39 -39.91 24.27 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.127 1.899 . . . . 1.9 116.127 179.629 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -84.05 -3.72 58.25 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.31 1.596 . . . . 0.89 115.31 176.72 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 74.12 36.72 0.66 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.079 2.552 . . . . 1.84 114.101 -177.744 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.54 HD12 HD23 ' A' ' 56' ' ' LEU . 11.7 mt -88.16 118.28 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 1 O-C-N 115.581 -4.449 . . . . 0.82 106.68 179.713 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -115.12 -164.9 0.97 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.272 -1.517 . . . . 2.16 115.023 -171.01 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -57.69 127.59 32.78 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 117.708 2.485 . . . . 2.12 117.708 174.927 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 69.69 34.57 2.65 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.449 3.023 . . . . 1.71 113.668 172.854 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m -88.1 129.57 35.26 Favored 'General case' 0 N--CA 1.429 -1.491 1 O-C-N 114.076 -5.39 . . . . 1.04 115.584 -177.955 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.0 m -85.09 88.68 7.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 118.533 2.79 . . . . 0.79 118.533 -175.671 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.518 HD11 HG21 ' A' ' 61' ' ' ILE . 10.3 mp -77.69 158.75 29.54 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 124.031 1.872 . . . . 1.4 107.147 179.332 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.466 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 72.3 m80 -119.62 140.88 49.9 Favored 'General case' 0 N--CA 1.43 -1.429 1 O-C-N 115.282 -4.636 . . . . 1.51 110.707 -179.746 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 tp -115.11 107.24 15.07 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 114.525 1.306 . . . . 1.14 114.525 -178.256 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.8 t -100.9 114.8 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 118.965 -2.335 . . . . 1.23 106.206 175.995 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.5 mt . . . . . 0 N--CA 1.43 -1.444 0 CA-C-O 124.362 2.029 . . . . 2.78 108.696 177.138 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.461 ' HG3' HG23 ' A' ' 17' ' ' VAL . 12.4 ptm . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 116.972 2.212 . . . . 1.1 116.972 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -108.66 163.74 12.98 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 127.464 2.306 . . . . 1.87 105.285 -179.593 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.7 pt -142.72 163.29 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 126.96 2.104 . . . . 0.72 106.085 168.865 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -126.03 110.14 13.22 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 124.517 1.135 . . . . 1.4 111.635 178.105 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.2 t -93.93 118.62 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 106.92 -1.511 . . . . 0.58 106.92 178.48 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -103.86 128.11 51.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.394 1.077 . . . . 2.09 109.619 177.236 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.5 p -85.21 165.7 17.16 Favored 'General case' 0 N--CA 1.429 -1.505 1 CA-C-O 128.979 4.228 . . . . 0.99 109.972 173.404 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.9 mt -59.35 -46.68 87.96 Favored 'General case' 0 N--CA 1.429 -1.502 1 O-C-N 115.269 -4.644 . . . . 2.53 113.113 166.153 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 p -55.99 -34.68 65.99 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 125.383 1.473 . . . . 2.08 111.952 -177.666 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.5 27.72 1.28 Allowed Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 117.718 -1.601 . . . . 1.31 112.533 174.55 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -106.83 151.46 25.17 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 117.242 -1.783 . . . . 1.4 110.028 -176.83 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.0 m -125.73 117.88 24.39 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.27 3.414 . . . . 0.78 108.343 174.055 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.365 11.5 pt -106.1 137.65 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.605 -2.56 . . . . 1.55 105.785 174.306 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.5 m -104.03 107.35 18.21 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.306 -1.316 . . . . 1.08 109.948 173.731 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.4 mt -102.52 149.6 24.23 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.262 2.225 . . . . 1.55 109.882 -175.8 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -103.25 132.12 49.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.176 -3.453 . . . . 1.95 110.979 177.479 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.461 HG23 ' HG3' ' A' ' 1' ' ' MET . 12.6 m -137.43 160.96 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 104.97 -2.233 . . . . 0.96 104.97 -169.078 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -107.5 155.97 38.66 Favored Pre-proline 0 N--CA 1.431 -1.392 0 O-C-N 120.484 -1.385 . . . . 2.35 108.872 166.352 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.67 -27.53 38.35 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 C-N-CA 124.274 3.316 . . . . 0.95 113.24 -166.715 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.6 m -92.17 3.74 54.69 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 116.014 -1.946 . . . . 1.45 113.626 -179.796 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -59.14 145.91 40.72 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 120.206 1.366 . . . . 1.69 113.284 171.824 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -79.73 159.45 26.61 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 104.873 -2.269 . . . . 0.75 104.873 175.462 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.3 mm -65.45 -37.81 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 119.399 -2.063 . . . . 0.73 110.159 177.095 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -49.49 -41.49 40.83 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 130.21 3.404 . . . . 1.62 117.69 164.571 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -77.64 -3.79 42.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 124.149 0.905 . . . . 2.13 113.184 174.79 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.04 -36.81 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 105.159 -2.163 . . . . 0.62 105.159 175.948 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -61.07 -38.17 85.28 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.496 2.093 . . . . 1.22 109.919 175.405 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.42 -36.3 68.8 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.402 -2.686 . . . . 0.51 117.856 167.029 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -69.0 -33.63 73.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.3 -4.0 . . . . 1.44 112.886 172.071 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.0 mt -66.16 -34.77 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 114.225 -2.798 . . . . 1.32 113.974 172.589 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -68.11 -39.24 82.82 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 122.359 2.345 . . . . 1.7 107.07 178.51 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -62.57 -47.06 85.5 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.468 -2.02 . . . . 1.55 110.246 178.718 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -75.52 -63.0 1.38 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.287 -2.133 . . . . 2.62 116.549 -177.389 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -94.41 -47.92 6.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.252 1.821 . . . . 1.48 115.432 -173.478 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.31 -2.4 6.19 Favored Glycine 0 N--CA 1.431 -1.698 0 CA-C-O 127.651 3.917 . . . . 1.12 112.862 174.523 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 21.2 mt -71.29 131.69 86.58 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 117.464 -3.374 . . . . 1.55 111.016 -175.085 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 17.2 Cg_exo -88.26 165.71 6.79 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 125.249 2.911 . . . . 1.02 110.371 -176.889 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.42 -14.76 28.02 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 C-N-CA 122.037 1.825 . . . . 1.25 115.265 -173.341 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -61.36 -36.64 80.75 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.882 3.273 . . . . 2.25 112.479 172.356 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -106.07 -9.83 16.81 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 126.5 1.92 . . . . 2.02 110.095 -172.474 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -82.27 103.34 11.79 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.258 -2.151 . . . . 0.69 112.213 -175.19 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -114.71 137.41 51.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.514 2.578 . . . . 2.78 105.392 164.851 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 mt -108.66 134.42 51.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.391 -3.943 . . . . 1.17 112.24 172.132 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 93.3 mt -116.44 128.92 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 125.923 2.773 . . . . 1.38 107.172 177.712 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -137.19 142.19 42.13 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.506 -2.622 . . . . 1.5 106.455 173.754 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.26 13.9 3.33 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.294 2.638 . . . . 1.21 117.121 -176.706 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.01 -16.85 57.95 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-O 122.78 1.211 . . . . 1.3 112.384 -178.324 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -101.47 154.22 19.02 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.759 -3.789 . . . . 2.55 108.631 -178.892 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -82.19 132.69 35.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 124.999 1.437 . . . . 2.48 111.674 170.265 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 mt -89.27 140.79 29.13 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 122.041 2.2 . . . . 0.9 114.301 -176.184 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -81.91 142.91 32.06 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 128.032 2.533 . . . . 1.94 110.943 178.265 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.02 -56.31 22.58 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.916 2.086 . . . . 1.56 113.352 -174.531 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.37 37.58 2.59 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 116.021 -2.544 . . . . 0.97 114.359 176.51 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -114.91 164.36 14.25 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.192 -1.781 . . . . 2.49 106.192 166.922 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -114.0 167.18 10.88 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.169 -2.207 . . . . 0.76 112.702 -176.932 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.9 mp -64.25 -42.12 96.65 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.514 2.726 . . . . 1.05 111.672 177.482 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.1 p -70.02 -37.46 75.64 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 117.81 -1.09 . . . . 1.19 113.081 -179.629 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.19 -40.76 98.44 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.004 1.722 . . . . 1.9 115.627 174.198 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -75.21 -16.47 60.48 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.987 -3.57 . . . . 0.89 107.557 177.398 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 70.97 48.64 0.38 Allowed 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.542 1.137 . . . . 1.84 112.421 -174.361 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.8 mt -86.5 107.88 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 113.56 -1.654 . . . . 0.82 110.216 175.831 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -95.38 -160.76 0.81 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.058 2.543 . . . . 2.16 112.071 -174.967 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -76.21 138.37 40.6 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 116.997 -3.564 . . . . 2.12 111.762 174.565 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.309 5.4 tt0 71.37 69.81 0.17 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 127.866 3.229 . . . . 1.71 110.991 174.529 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.397 55.2 m -116.01 144.61 43.86 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.423 -2.673 . . . . 1.04 109.287 -174.817 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.4 m -104.07 102.72 12.47 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.94 -1.504 . . . . 0.79 106.94 175.375 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.0 mt -91.31 123.93 35.12 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.518 -2.614 . . . . 1.4 108.023 170.757 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -92.65 109.14 20.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.645 0.778 . . . . 1.51 110.59 -178.093 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 tp -91.07 113.77 26.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.321 1.534 . . . . 1.14 112.378 -179.752 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.4 m -102.78 160.63 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 124.808 2.242 . . . . 1.23 106.43 178.548 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.6 tp . . . . . 0 N--CA 1.43 -1.435 0 CA-C-N 113.837 -1.529 . . . . 2.78 114.24 176.397 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptt? . . . . . 0 CA--C 1.49 -1.349 1 CA-C-O 129.473 4.463 . . . . 1.1 110.689 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -91.03 146.75 23.59 Favored 'General case' 0 N--CA 1.431 -1.41 1 O-C-N 113.862 -5.524 . . . . 1.87 110.089 -176.555 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.329 13.9 pt -135.97 153.0 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 129.346 3.058 . . . . 0.72 109.109 178.526 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -112.95 141.98 46.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 126.459 3.028 . . . . 1.4 107.755 176.096 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -134.56 122.02 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 118.263 -2.773 . . . . 0.58 107.842 170.238 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -96.23 137.26 35.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.771 -1.559 . . . . 2.09 111.027 175.41 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.415 HG22 HD23 ' A' ' 69' ' ' LEU 0.289 44.8 p -77.15 172.67 12.88 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 126.27 2.938 . . . . 0.99 110.363 175.035 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 tp -64.17 -51.34 64.28 Favored 'General case' 0 N--CA 1.429 -1.494 1 O-C-N 115.849 -4.282 . . . . 2.53 113.622 174.965 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.379 75.4 p -61.06 -41.7 97.09 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.563 1.69 . . . . 2.08 115.563 174.552 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.34 9.97 0.2 Allowed Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 116.945 1.538 . . . . 1.31 116.945 175.005 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -84.37 118.5 24.27 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.427 -2.219 . . . . 1.4 114.165 -174.353 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.6 m -93.47 126.77 38.79 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 121.785 2.084 . . . . 0.78 109.415 179.485 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mt -116.87 111.73 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 127.179 2.192 . . . . 1.55 113.153 -178.191 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.1 m -81.2 121.31 25.99 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 126.519 1.928 . . . . 1.08 107.596 177.087 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.5 mt -124.9 146.86 49.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 100.712 -3.81 . . . . 1.55 100.712 -179.475 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -106.18 122.68 46.69 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 118.393 -2.692 . . . . 1.95 108.371 169.909 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.9 m -129.74 152.04 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 126.584 3.087 . . . . 0.96 107.247 -172.99 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -94.1 151.05 39.35 Favored Pre-proline 0 N--CA 1.429 -1.507 1 O-C-N 114.869 -4.894 . . . . 2.35 106.254 156.273 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -76.53 -6.68 17.24 Favored 'Trans proline' 0 N--CA 1.433 -2.05 0 CA-C-N 125.72 3.078 . . . . 0.95 113.525 -174.756 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -87.01 -3.02 59.05 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 125.632 1.833 . . . . 1.45 111.913 -178.466 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -76.37 156.63 33.09 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 129.515 3.126 . . . . 1.69 109.334 171.383 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 4.5 p -84.98 166.61 16.61 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.402 -2.686 . . . . 0.75 111.794 177.529 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.22 -42.81 97.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 126.419 1.888 . . . . 0.73 109.395 174.939 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -46.35 -44.28 16.77 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.624 3.194 . . . . 1.62 119.624 164.812 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -67.17 -32.97 74.43 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.306 1.595 . . . . 2.13 115.306 173.522 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.3 t -64.15 -39.05 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 126.933 3.254 . . . . 0.62 111.966 169.771 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -59.15 -44.05 92.09 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.324 -2.735 . . . . 1.22 115.268 173.876 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.3 -33.0 65.13 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.056 -2.278 . . . . 0.51 111.401 173.788 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -76.54 -26.39 55.13 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 115.342 1.608 . . . . 1.44 115.342 173.96 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.7 mt -70.96 -28.25 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 119.739 -1.851 . . . . 1.32 114.558 169.146 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -70.92 -33.55 70.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.81 3.244 . . . . 1.7 108.111 179.559 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -74.95 -34.26 62.03 Favored 'General case' 0 N--CA 1.431 -1.408 1 C-N-CA 132.998 4.519 . . . . 1.55 112.356 175.47 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.9 mmtm -89.33 -64.72 1.1 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 127.959 3.742 . . . . 2.62 110.099 -171.078 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -93.93 -42.08 9.26 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.04 -2.287 . . . . 1.48 113.621 -170.533 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.73 5.74 21.93 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 121.254 3.261 . . . . 1.12 121.254 175.638 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.1 mt -74.92 129.69 82.68 Favored Pre-proline 0 N--CA 1.431 -1.414 0 C-N-CA 128.747 2.819 . . . . 1.55 110.436 -178.186 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.527 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 8.8 Cg_endo -77.3 141.93 20.84 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 126.077 3.206 . . . . 1.02 111.998 -177.244 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 32.8 Cg_exo -58.27 -17.53 33.28 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 N-CA-C 118.739 2.554 . . . . 1.25 118.739 -173.061 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -79.04 -23.2 44.43 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 114.863 1.431 . . . . 2.25 114.863 171.349 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -88.66 -13.75 39.06 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.351 -2.093 . . . . 2.02 108.111 176.765 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.329 69.2 mt-30 -98.12 143.76 28.31 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 121.163 1.802 . . . . 0.69 110.9 -174.316 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -135.87 135.79 40.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 121.398 0.618 . . . . 2.78 111.037 171.301 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.0 mt -102.84 134.75 45.72 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 117.254 -3.404 . . . . 1.17 115.702 172.139 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.3 mt -118.53 130.28 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 114.724 -1.125 . . . . 1.38 108.322 -179.484 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -136.29 123.15 21.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.139 -2.85 . . . . 1.5 118.009 176.167 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.54 40.44 23.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.046 1.738 . . . . 1.21 110.631 -171.445 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.92 -8.45 50.5 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-O 114.465 -3.408 . . . . 1.3 114.922 179.537 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -85.39 135.5 33.85 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 120.002 1.901 . . . . 2.55 110.706 175.348 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -84.69 120.69 26.69 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.748 2.689 . . . . 2.48 108.475 164.927 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.1 mt -80.25 107.99 13.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 118.204 2.668 . . . . 0.9 118.204 -173.726 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.269 33.2 mt-10 -52.9 121.98 8.36 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 121.525 3.898 . . . . 1.94 121.525 170.434 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.12 -57.82 1.25 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 131.158 3.783 . . . . 1.56 115.756 -174.075 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.89 39.19 2.84 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 127.73 2.586 . . . . 0.97 116.613 175.186 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -121.35 172.37 8.08 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.081 1.896 . . . . 2.49 106.142 167.385 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.301 62.2 p -87.83 176.67 7.27 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 118.944 -2.348 . . . . 0.76 113.959 168.663 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.4 mt -80.53 -25.78 38.47 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.446 1.899 . . . . 1.05 109.409 165.771 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.56 -39.55 62.21 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 107.657 -1.238 . . . . 1.19 107.657 -170.641 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -43.61 -57.79 2.98 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 126.783 2.033 . . . . 1.9 116.078 169.351 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -71.49 -1.31 12.87 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 119.279 3.066 . . . . 0.89 119.279 -178.588 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.396 23.1 m120 62.2 49.9 4.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 131.003 3.721 . . . . 1.84 113.083 -170.198 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.4 mt -87.64 137.31 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 123.508 2.867 . . . . 0.82 109.247 174.988 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -122.51 -176.56 3.41 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.833 2.254 . . . . 2.16 110.528 -175.762 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 ptmm? -62.59 139.55 58.63 Favored 'General case' 0 N--CA 1.429 -1.487 1 O-C-N 116.206 -4.059 . . . . 2.12 111.898 -177.513 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 62.61 31.52 16.79 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.856 2.862 . . . . 1.71 109.15 175.307 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 t -95.01 137.45 34.05 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.458 -2.651 . . . . 1.04 109.994 -179.897 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.2 m -88.07 121.58 30.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 126.929 2.643 . . . . 0.79 112.035 -177.767 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 72.2 mt -105.28 152.79 22.46 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 128.631 2.772 . . . . 1.4 105.871 176.9 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -101.82 125.32 48.47 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.439 -2.663 . . . . 1.51 107.261 -177.48 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.415 HD23 HG22 ' A' ' 7' ' ' THR . 27.2 tp -96.93 126.28 41.96 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 124.296 3.225 . . . . 1.14 110.949 178.131 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.9 m -131.1 176.98 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 118.366 -2.709 . . . . 1.23 111.162 172.012 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 N--CA 1.43 -1.46 0 O-C-N 119.724 -1.86 . . . . 2.78 114.064 178.431 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 112.157 0.429 . . . . 1.1 112.157 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -108.96 140.73 42.07 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.316 -2.74 . . . . 1.87 105.678 177.588 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.4 pt -128.86 153.17 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 106.486 -1.672 . . . . 0.72 106.486 173.477 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -109.75 105.82 15.21 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.501 -2.0 . . . . 1.4 115.226 179.188 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.0 t -94.58 115.95 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 117.801 -3.062 . . . . 0.58 105.762 176.565 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -95.39 156.91 16.12 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.689 2.185 . . . . 2.09 108.013 175.502 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.2 p -105.06 -171.61 1.95 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.994 1.318 . . . . 0.99 110.252 -178.404 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.9 mt -85.88 -36.84 19.71 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 115.701 -4.375 . . . . 2.53 114.242 172.477 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.251 38.6 p -80.06 -54.84 5.41 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.589 -2.004 . . . . 2.08 105.589 -175.339 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.02 23.77 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 120.241 2.856 . . . . 1.31 120.241 171.541 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -88.18 135.83 33.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 117.684 -1.15 . . . . 1.4 111.058 -179.917 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.8 m -109.79 111.65 23.23 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.359 -1.349 . . . . 0.78 107.359 169.851 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 mt -92.3 105.54 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 104.835 -2.283 . . . . 1.55 104.835 -177.315 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.8 m -85.36 107.6 17.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.673 -3.142 . . . . 1.08 106.174 178.159 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.8 mt -101.13 144.17 30.35 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 114.318 1.229 . . . . 1.55 114.318 -177.973 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -101.05 118.88 37.88 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.678 2.656 . . . . 1.95 110.875 174.952 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 m -130.26 158.57 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 123.863 1.792 . . . . 0.96 110.614 -172.412 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -113.26 170.73 4.99 Favored Pre-proline 0 N--CA 1.43 -1.45 0 O-C-N 117.772 -3.08 . . . . 2.35 105.408 159.358 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -87.21 -9.55 6.05 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 C-N-CA 122.342 2.028 . . . . 0.95 114.006 -167.836 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.261 81.5 p -85.04 0.85 50.14 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 131.284 3.833 . . . . 1.45 116.079 173.445 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -86.7 145.33 26.72 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.673 -3.142 . . . . 1.69 111.552 169.098 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.5 p -59.75 155.41 16.04 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.718 2.199 . . . . 0.75 112.559 168.979 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.253 3.3 mt -63.19 -37.13 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 119.654 -1.904 . . . . 0.73 112.551 170.332 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -53.09 -40.55 64.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.075 1.509 . . . . 1.62 115.075 165.655 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -61.02 -32.98 72.57 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 118.275 2.695 . . . . 2.13 118.275 174.186 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.318 45.6 t -71.2 -35.85 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 122.387 1.089 . . . . 0.62 110.196 -178.42 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -70.08 -24.37 63.22 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 132.042 4.137 . . . . 1.22 113.593 174.442 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.56 -33.99 62.82 Favored 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 116.298 -4.001 . . . . 0.51 111.644 174.941 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -69.1 -25.93 64.66 Favored 'General case' 0 N--CA 1.431 -1.395 1 O-C-N 114.972 -4.83 . . . . 1.44 115.522 178.429 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 mt -68.01 -39.64 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 1 C-N-CA 132.499 4.32 . . . . 1.32 112.397 170.594 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.11 -36.68 77.99 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.718 2.488 . . . . 1.7 117.718 178.332 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.03 -57.9 10.88 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 116.544 -1.693 . . . . 1.55 114.127 163.242 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -62.78 -61.84 2.13 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 118.284 2.698 . . . . 2.62 118.284 -177.722 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -93.79 -32.34 14.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.9 -3.0 . . . . 1.48 109.584 -171.81 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.88 16.78 22.86 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 116.92 -2.562 . . . . 1.12 115.629 172.699 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.4 mt -90.58 131.96 36.54 Favored Pre-proline 0 N--CA 1.43 -1.455 1 CA-C-O 110.889 -4.386 . . . . 1.55 110.66 179.237 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -57.68 146.67 83.96 Favored 'Trans proline' 0 C--N 1.299 -2.056 0 CA-C-N 127.664 3.773 . . . . 1.02 116.954 171.767 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.66 -13.38 13.28 Favored 'Trans proline' 0 N--CA 1.434 -2.027 1 C-N-CA 125.674 4.249 . . . . 1.25 113.985 -175.077 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.391 9.6 p-10 -62.83 -31.78 72.86 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 119.724 1.147 . . . . 2.25 113.708 166.325 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -80.75 -26.89 37.03 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 123.813 1.768 . . . . 2.02 113.284 -176.398 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -84.67 142.78 29.65 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 111.711 -2.495 . . . . 0.69 111.252 -173.651 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -143.35 142.6 31.35 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.921 -1.49 . . . . 2.78 111.845 171.644 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.6 mt -105.19 146.63 28.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.92 2.295 . . . . 1.17 106.387 -178.38 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 mt -118.76 138.93 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 128.582 2.753 . . . . 1.38 104.51 174.29 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -144.58 120.44 10.6 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 124.971 2.32 . . . . 1.5 104.789 177.109 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.38 13.58 5.52 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 127.865 2.466 . . . . 1.21 114.912 175.435 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.29 -22.57 38.58 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 127.487 2.47 . . . . 1.3 113.991 -171.571 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -80.57 134.96 36.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 126.548 3.07 . . . . 2.55 111.676 -177.267 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -77.8 128.79 34.57 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 117.195 -3.441 . . . . 2.48 111.942 176.778 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.6 mt -92.97 142.65 27.07 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.188 -2.195 . . . . 0.9 113.438 -172.356 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -79.86 148.01 31.5 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.077 2.951 . . . . 1.94 110.849 175.242 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -89.18 -34.27 16.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.167 1.914 . . . . 1.56 116.167 -168.468 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.36 21.03 6.42 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 128.488 2.947 . . . . 0.97 117.698 171.979 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -105.55 178.2 4.63 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 119.698 1.749 . . . . 2.49 108.187 169.311 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -108.84 -172.94 2.15 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 124.905 2.288 . . . . 0.76 107.274 167.164 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.6 mt -66.06 -43.87 86.2 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 128.436 3.97 . . . . 1.05 112.889 171.089 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.4 m -53.27 -25.97 16.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.179 -3.451 . . . . 1.19 118.291 -179.734 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -78.37 -44.83 23.99 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.115 2.966 . . . . 1.9 111.841 177.386 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -80.76 9.87 5.7 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 129.949 3.3 . . . . 0.89 114.648 174.949 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.27 10.2 p30 47.93 39.8 11.68 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 129.044 2.938 . . . . 1.84 114.176 -178.888 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.304 12.7 mt -77.92 127.56 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 116.856 -3.652 . . . . 0.82 109.555 179.966 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 -107.58 -178.37 3.61 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 125.655 2.645 . . . . 2.16 106.369 178.427 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -64.22 159.22 21.19 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 115.74 -4.35 . . . . 2.12 110.467 -177.484 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.421 19.9 mt-10 59.41 41.53 19.34 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 116.966 -3.583 . . . . 1.71 112.657 169.389 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.2 p -106.36 135.14 48.38 Favored 'General case' 0 N--CA 1.431 -1.397 1 O-C-N 114.857 -4.902 . . . . 1.04 109.9 -173.373 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.5 m -86.44 116.55 24.66 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.477 -2.64 . . . . 0.79 107.163 175.808 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.6 mp -109.45 160.57 16.09 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 112.862 -1.972 . . . . 1.4 110.29 172.594 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -127.39 139.53 52.78 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.949 -2.344 . . . . 1.51 112.046 -176.681 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.6 tp -103.46 127.13 50.91 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 130.695 3.598 . . . . 1.14 109.16 -177.495 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.0 m -135.15 163.95 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 O-C-N 116.351 -3.968 . . . . 1.23 110.557 166.476 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.6 mt . . . . . 0 N--CA 1.43 -1.466 0 CA-C-O 117.024 -1.465 . . . . 2.78 113.278 170.77 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 CA--C 1.49 -1.36 0 CA-C-O 125.998 2.809 . . . . 1.1 103.709 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -90.28 125.75 35.61 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.969 -3.582 . . . . 1.87 109.432 -179.328 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -127.65 150.49 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 118.926 -1.109 . . . . 0.72 109.092 170.148 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.262 33.3 m-85 -115.03 121.86 44.4 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 124.28 1.99 . . . . 1.4 112.314 -172.027 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -103.12 107.97 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 119.677 -1.889 . . . . 0.58 110.903 178.309 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -85.61 158.66 20.05 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 118.806 -2.434 . . . . 2.09 107.474 177.781 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.3 p -108.43 -167.52 1.24 Allowed 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 106.824 -1.547 . . . . 0.99 106.824 175.3 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.6 mt -88.69 -30.75 18.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 119.865 1.211 . . . . 2.53 109.171 178.592 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.9 p -70.57 -27.65 64.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.055 -2.278 . . . . 2.08 106.542 -179.478 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.34 18.66 6.13 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-O 122.432 1.018 . . . . 1.31 115.592 173.362 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -82.63 117.86 22.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 117.041 -1.457 . . . . 1.4 113.375 -177.463 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.288 89.2 m -85.35 115.41 23.08 Favored 'General case' 0 N--CA 1.431 -1.389 1 CA-C-N 126.202 4.092 . . . . 0.78 114.115 175.396 . . . . . . . . 3 2 . 1 . 037 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 13' ' ' ILE . 53.2 mt -100.56 107.31 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 1 O-C-N 114.963 -4.836 . . . . 1.55 110.6 178.629 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.7 m -80.68 116.3 20.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.954 -2.341 . . . . 1.08 114.057 175.562 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.9 mt -107.6 127.98 54.12 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.55 -1.969 . . . . 1.55 107.717 178.009 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -96.15 99.83 11.53 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.376 -2.702 . . . . 1.95 104.619 170.69 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.3 m -112.38 164.63 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 105.681 -1.97 . . . . 0.96 105.681 -176.406 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -104.78 163.73 16.61 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 105.618 -1.993 . . . . 2.35 105.618 165.663 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -86.82 -8.93 6.72 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 O-C-N 113.932 -3.773 . . . . 0.95 108.759 -166.402 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.25 4.9 p -90.72 1.14 57.12 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 119.763 -0.775 . . . . 1.45 111.674 177.149 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.27 36.2 m-20 -63.01 148.7 46.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 129.694 3.198 . . . . 1.69 108.737 172.173 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 23.5 p -97.99 163.87 12.59 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 118.846 -2.409 . . . . 0.75 112.632 173.893 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.417 HD12 HD13 ' A' ' 50' ' ' LEU 0.298 24.1 mm -63.41 -34.98 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 120.062 1.301 . . . . 0.73 111.099 -179.581 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -48.77 -39.95 27.04 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 117.948 -2.97 . . . . 1.62 115.243 160.279 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -75.84 -48.65 20.66 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.508 -2.62 . . . . 2.13 107.905 -176.741 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.401 ' CG2' HD11 ' A' ' 56' ' ' LEU . 52.6 t -49.1 -54.25 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.989 2.916 . . . . 0.62 116.334 172.56 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -50.97 -32.75 22.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.427 -1.421 . . . . 1.22 113.876 175.983 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.88 -40.02 91.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.181 3.372 . . . . 0.51 114.068 178.789 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -58.79 -40.94 85.49 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.78 -3.075 . . . . 1.44 112.378 176.245 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.4 mt -70.5 -31.6 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 116.487 -3.883 . . . . 1.32 112.061 176.139 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -69.13 -33.39 73.38 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 119.434 -2.041 . . . . 1.7 111.453 171.929 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.355 17.5 t70 -77.13 -44.3 30.87 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.43 2.011 . . . . 1.55 116.43 167.814 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -65.33 -60.56 2.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.194 -3.441 . . . . 2.62 111.092 -171.099 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -105.13 -37.16 7.02 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 124.283 1.992 . . . . 1.48 109.355 -166.251 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.92 38.39 2.35 Favored Glycine 0 N--CA 1.43 -1.752 0 O-C-N 117.56 -3.213 . . . . 1.12 111.575 168.752 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.5 mt -111.08 122.23 38.48 Favored Pre-proline 0 N--CA 1.43 -1.465 0 O-C-N 118.577 -2.719 . . . . 1.55 106.395 -174.441 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 18.5 Cg_endo -57.76 141.73 95.79 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 O-C-N 115.65 -2.868 . . . . 1.02 116.819 175.448 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 67.6 Cg_exo -64.83 -32.96 54.87 Favored 'Trans proline' 0 N--CA 1.433 -2.03 1 C-N-CA 127.54 5.493 . . . . 1.25 111.797 -174.136 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -51.14 -39.35 56.09 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 129.871 3.268 . . . . 2.25 113.996 168.158 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -82.19 -5.22 58.33 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.11 1.909 . . . . 2.02 112.688 178.248 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -99.6 113.76 26.38 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 116.333 -3.98 . . . . 0.69 108.27 -166.933 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -89.29 123.02 33.11 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 125.31 2.481 . . . . 2.78 104.823 163.017 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.2 mt -109.29 119.67 40.2 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.039 -5.413 . . . . 1.17 105.267 175.385 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.3 mm -108.51 133.16 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 128.306 2.643 . . . . 1.38 113.037 179.57 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -130.93 114.31 15.09 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 129.298 4.124 . . . . 1.5 111.05 174.074 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.01 -92.14 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.162 2.185 . . . . 1.21 113.306 -178.437 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.79 23.0 4.01 Favored Glycine 0 N--CA 1.431 -1.696 0 C-N-CA 127.676 2.56 . . . . 1.3 112.536 174.106 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.9 mmtt -123.33 129.95 52.04 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.09 -1.829 . . . . 2.55 110.212 -179.36 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -87.55 125.13 34.15 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 117.185 -3.447 . . . . 2.48 105.274 172.014 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.417 HD13 HD12 ' A' ' 23' ' ' ILE . 99.3 mt -82.11 126.69 32.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.082 -1.636 . . . . 0.9 111.906 -162.104 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -76.13 147.97 38.16 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.644 -2.535 . . . . 1.94 111.938 168.772 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.276 42.6 m-20 -61.11 -65.65 0.66 Allowed 'General case' 0 N--CA 1.431 -1.419 1 N-CA-C 123.201 4.519 . . . . 1.56 123.201 -171.271 . . . . . . . . 3 2 . 1 . 037 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.82 32.92 3.36 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 122.045 3.578 . . . . 0.97 122.045 178.886 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.7 mtt-85 -102.7 153.65 19.93 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 103.697 -2.705 . . . . 2.49 103.697 169.875 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.268 8.1 p -77.43 153.56 33.48 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 131.043 3.737 . . . . 0.76 110.328 171.733 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.401 HD11 ' CG2' ' A' ' 26' ' ' VAL . 1.5 mt -59.74 -42.15 92.52 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.017 -0.992 . . . . 1.05 111.847 172.118 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.6 p -56.81 -36.56 70.06 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.564 2.346 . . . . 1.19 111.725 179.067 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -66.41 -45.7 79.04 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.871 1.669 . . . . 1.9 111.7 -177.197 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -72.19 -9.16 58.08 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 116.966 2.21 . . . . 0.89 116.966 170.62 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 61.46 53.01 3.51 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.496 1.518 . . . . 1.84 112.504 -177.68 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.8 mt -89.05 113.78 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 130.791 3.637 . . . . 0.82 105.038 176.079 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -99.52 -169.9 1.82 Allowed 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.301 1.593 . . . . 2.16 115.301 178.504 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -66.32 141.25 58.06 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.765 1.745 . . . . 2.12 110.791 176.38 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 67.23 24.98 9.01 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 112.437 -2.165 . . . . 1.71 113.272 172.918 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.3 m -75.58 144.6 41.75 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.855 1.312 . . . . 1.04 112.732 -175.874 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 m -97.57 123.46 41.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 118.071 -1.451 . . . . 0.79 108.518 -176.081 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 mp -122.26 163.38 19.74 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 104.508 -2.404 . . . . 1.4 104.508 178.195 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.263 43.6 m80 -134.63 112.03 10.49 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.46 2.552 . . . . 1.51 110.822 -172.302 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.05 122.74 22.26 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.695 2.398 . . . . 1.14 111.605 175.397 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.5 t -123.01 136.27 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 102.506 -3.146 . . . . 1.23 102.506 175.202 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.7 tp . . . . . 0 N--CA 1.429 -1.487 1 O-C-N 114.822 -4.924 . . . . 2.78 111.027 -174.45 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 ptt? . . . . . 0 CA--C 1.491 -1.325 0 N-CA-C 118.225 2.676 . . . . 1.1 118.225 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.257 7.1 tt0 -117.83 123.27 45.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.677 2.791 . . . . 1.87 114.206 -178.498 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.4 pt -127.94 160.47 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 117.774 -3.079 . . . . 0.72 106.922 174.457 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -118.71 132.79 56.16 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.38 3.472 . . . . 1.4 106.231 -173.355 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 t -122.97 125.59 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 123.447 0.699 . . . . 0.58 110.772 170.851 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.344 19.4 mttm -103.05 145.41 29.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.967 2.794 . . . . 2.09 115.067 179.598 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.301 22.9 p -91.45 168.68 11.37 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.722 -4.362 . . . . 0.99 116.291 173.653 . . . . . . . . 3 2 . 1 . 038 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.342 31.6 tp -59.31 -56.65 19.4 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.673 2.101 . . . . 2.53 116.673 169.603 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 p -61.89 -60.85 3.03 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 114.35 -1.295 . . . . 2.08 112.002 -176.075 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.86 30.53 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 117.964 -2.065 . . . . 1.31 117.214 173.105 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -111.36 146.3 37.35 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.696 -2.061 . . . . 1.4 111.305 -178.509 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.8 m -112.69 104.61 12.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 104.065 -2.568 . . . . 0.78 104.065 167.602 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.2 mt -91.0 123.53 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 122.213 1.006 . . . . 1.55 108.379 -176.447 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 m -94.31 120.89 35.21 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 118.488 -2.632 . . . . 1.08 109.318 -179.957 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.6 mt -113.14 143.51 44.25 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 126.929 3.252 . . . . 1.55 112.215 179.551 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -86.2 112.35 21.26 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 111.805 -2.452 . . . . 1.95 107.004 171.237 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.13 149.86 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.989 1.716 . . . . 0.96 114.922 -177.613 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -108.79 149.54 39.65 Favored Pre-proline 0 N--CA 1.43 -1.438 0 N-CA-C 103.651 -2.722 . . . . 2.35 103.651 172.418 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -63.94 -19.7 67.0 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 123.428 2.752 . . . . 0.95 113.178 -173.84 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.4 p -80.73 -16.77 53.04 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 130.08 3.352 . . . . 1.45 110.683 -177.51 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -60.24 145.63 46.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 116.779 -1.968 . . . . 1.69 113.892 172.428 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.9 p -80.25 162.62 24.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.537 2.113 . . . . 0.75 108.905 176.461 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.491 HG23 HD12 ' A' ' 43' ' ' LEU . 24.3 mm -64.87 -30.5 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 126.833 3.206 . . . . 0.73 112.016 177.125 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.6 -39.17 91.27 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 114.693 -5.004 . . . . 1.62 112.217 167.059 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.253 15.8 m-80 -70.39 -32.73 70.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 119.892 1.224 . . . . 2.13 112.552 171.683 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.35 43.4 t -53.57 -48.67 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 1 O-C-N 114.287 -5.258 . . . . 0.62 112.72 167.825 . . . . . . . . 3 2 . 1 . 038 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -56.06 -41.25 74.78 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.187 1.921 . . . . 1.22 116.187 174.531 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.3 -31.74 72.96 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.431 1.493 . . . . 0.51 112.637 172.275 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -66.22 -38.59 88.3 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 127.494 3.521 . . . . 1.44 115.673 176.119 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.7 mt -73.07 -36.99 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 117.636 -3.165 . . . . 1.32 107.596 172.911 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.454 ' HG3' ' HD3' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -62.64 -35.2 78.85 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 123.851 3.023 . . . . 1.7 113.844 179.431 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.45 -54.72 24.39 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.461 1.904 . . . . 1.55 109.726 175.188 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.5 mmtt -57.83 -77.64 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.479 3.038 . . . . 2.62 115.638 -179.08 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -101.68 -20.78 14.85 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.166 -3.458 . . . . 1.48 110.142 -161.895 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.77 53.81 2.48 Favored Glycine 0 N--CA 1.431 -1.682 0 O-C-N 120.412 -1.43 . . . . 1.12 115.165 172.524 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.417 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 6.1 mt -108.05 117.04 55.99 Favored Pre-proline 0 N--CA 1.43 -1.436 0 CA-C-O 113.51 -3.138 . . . . 1.55 110.153 -175.773 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.499 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 50.3 Cg_exo -67.32 127.24 16.26 Favored 'Trans proline' 0 C--N 1.299 -2.054 0 CA-C-N 126.241 3.265 . . . . 1.02 117.292 -179.654 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 27.5 Cg_exo -59.49 -31.13 94.15 Favored 'Trans proline' 0 N--CA 1.434 -2.016 1 C-N-CA 127.527 5.485 . . . . 1.25 118.406 -172.402 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -64.9 -24.68 67.6 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.753 2.821 . . . . 2.25 108.445 178.721 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -94.02 12.71 25.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.912 -2.368 . . . . 2.02 116.53 173.733 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.275 9.6 mt-30 -115.29 147.21 40.69 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.217 2.437 . . . . 0.69 110.675 -178.893 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.6 ptt85 -135.02 134.65 40.66 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 112.907 -1.951 . . . . 2.78 106.048 163.853 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.491 HD12 HG23 ' A' ' 23' ' ' ILE . 44.3 mt -103.69 133.48 48.63 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 119.823 1.192 . . . . 1.17 113.203 179.64 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.4 mm -118.64 145.49 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 125.059 2.361 . . . . 1.38 108.553 177.9 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -134.54 108.79 8.29 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.013 -2.93 . . . . 1.5 103.92 172.295 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.519 . . 72.77 -97.33 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 116.666 2.099 . . . . 1.21 116.666 -176.961 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.9 17.52 1.97 Allowed Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 127.603 2.525 . . . . 1.3 108.532 -175.639 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.2 mttm -106.49 144.79 32.66 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.204 -2.35 . . . . 2.55 110.06 170.664 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -107.75 129.29 55.05 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.587 3.089 . . . . 2.48 115.345 169.649 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.7 mt -97.19 122.84 40.66 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.394 -3.941 . . . . 0.9 104.433 -160.342 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -77.09 138.66 39.67 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 117.633 -3.167 . . . . 1.94 111.72 172.397 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -54.91 -41.14 70.6 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 130.489 3.515 . . . . 1.56 115.978 -170.131 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.38 31.24 6.9 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 126.537 2.018 . . . . 0.97 115.051 174.935 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.87 165.28 11.83 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.224 -1.399 . . . . 2.49 107.224 166.426 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 5.4 p -95.62 171.52 8.62 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 119.034 2.976 . . . . 0.76 119.034 169.179 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -59.35 -39.1 82.16 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 121.59 1.995 . . . . 1.05 112.171 169.772 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 t -64.3 -37.86 88.98 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 116.944 2.202 . . . . 1.19 116.944 -179.151 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -61.19 -21.59 63.96 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.657 -1.902 . . . . 1.9 113.851 174.071 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -109.52 12.35 24.48 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.659 2.936 . . . . 0.89 115.685 -178.962 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.401 6.4 t-20 62.6 39.24 11.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.683 2.793 . . . . 1.84 116.71 -177.093 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.7 mt -90.84 105.5 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 112.661 -2.063 . . . . 0.82 112.556 178.046 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -98.9 -171.59 2.13 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 122.23 2.286 . . . . 2.16 107.111 -174.551 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.253 21.8 pttp -61.54 149.01 40.26 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 126.698 1.999 . . . . 2.12 115.604 176.354 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.317 36.1 mt-10 67.19 13.18 9.32 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.804 1.779 . . . . 1.71 115.804 175.123 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.6 m -66.44 148.74 51.45 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.477 -2.014 . . . . 1.04 112.271 -177.835 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.6 m -103.45 97.92 7.9 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.808 1.766 . . . . 0.79 115.494 173.751 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 mp -87.26 152.43 22.31 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.526 -1.984 . . . . 1.4 113.993 -178.924 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.6 m170 -120.79 129.07 53.44 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.158 -1.589 . . . . 1.51 109.87 -173.788 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.4 tp -95.34 128.82 42.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.576 -1.327 . . . . 1.14 114.374 -176.175 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.4 159.0 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 124.163 1.935 . . . . 1.23 113.669 177.371 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 tp . . . . . 0 N--CA 1.43 -1.433 0 O-C-N 120.786 -1.196 . . . . 2.78 110.852 -174.439 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.2 ttp . . . . . 0 CA--C 1.49 -1.355 0 CA-C-O 116.443 -1.741 . . . . 1.1 109.537 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -96.13 134.29 39.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.114 1.779 . . . . 1.87 109.064 176.69 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 pt -130.22 162.58 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 106.289 -1.745 . . . . 0.72 106.289 163.566 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -115.01 143.32 45.37 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.038 -1.664 . . . . 1.4 113.952 178.088 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.3 t -113.73 120.29 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 118.098 -2.876 . . . . 0.58 104.05 171.106 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -107.78 119.38 39.27 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 126.973 2.109 . . . . 2.09 106.641 177.547 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.3 p -84.13 163.55 19.73 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 121.165 -0.959 . . . . 0.99 111.724 -176.746 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.4 tp -39.56 -43.05 1.24 Allowed 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 118.713 2.857 . . . . 2.53 118.713 172.755 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.5 p -81.2 -24.86 37.16 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.892 1.995 . . . . 2.08 108.419 -176.7 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.44 31.24 3.3 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-O 125.402 2.668 . . . . 1.31 115.245 178.843 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -92.78 124.48 36.81 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.636 -2.685 . . . . 1.4 106.723 178.548 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -109.49 111.73 23.43 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.722 2.677 . . . . 0.78 112.026 175.315 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.262 36.1 pt -100.24 132.57 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 1 CA-C-O 128.847 4.165 . . . . 1.55 106.752 -178.691 . . . . . . . . 3 2 . 1 . 039 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 95.9 m -90.5 122.11 33.04 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.04 -2.913 . . . . 1.08 110.834 177.584 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.46 142.55 35.94 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.436 2.294 . . . . 1.55 112.675 176.547 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -110.57 118.61 36.68 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.548 2.339 . . . . 1.95 109.667 169.339 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.89 159.92 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 C-N-CA 124.016 0.926 . . . . 0.96 112.006 -178.676 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -92.05 156.26 42.36 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-O 116.424 -1.751 . . . . 2.35 112.693 159.57 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -73.11 -9.13 23.1 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 CA-C-N 126.139 3.228 . . . . 0.95 111.477 -177.285 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.4 m -79.04 -19.15 52.14 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 129.772 3.229 . . . . 1.45 108.545 177.934 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -61.04 137.45 58.23 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.488 2.774 . . . . 1.69 118.488 177.076 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.9 p -86.59 171.42 11.04 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 111.74 0.274 . . . . 0.75 111.74 177.193 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.402 HG13 ' HB3' ' A' ' 50' ' ' LEU . 10.0 mm -68.71 -33.79 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 114.588 1.329 . . . . 0.73 114.588 175.796 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -53.15 -43.44 67.0 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 117.551 2.426 . . . . 1.62 117.551 161.085 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -62.55 -42.53 99.59 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 120.553 1.524 . . . . 2.13 110.615 171.365 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 t -57.02 -48.84 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.449 1.5 . . . . 0.62 111.553 172.915 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -56.7 -34.53 67.52 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 116.953 -3.592 . . . . 1.22 117.627 172.977 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.85 -42.68 81.01 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 125.674 2.654 . . . . 0.51 112.922 176.819 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.27 13.6 mttm -60.02 -34.54 73.5 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 130.382 3.473 . . . . 1.44 115.174 173.584 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.0 mt -74.02 -35.44 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 129.395 3.078 . . . . 1.32 108.13 174.9 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -63.34 -32.03 73.35 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 119.705 3.224 . . . . 1.7 119.705 173.854 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -76.31 -20.41 57.31 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.631 1.973 . . . . 1.55 113.702 169.138 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -84.0 -47.44 10.97 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.657 -2.527 . . . . 2.62 109.942 177.42 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -131.86 -31.69 1.5 Allowed 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 118.453 2.76 . . . . 1.48 118.453 -167.421 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.57 60.99 1.07 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 104.248 -3.541 . . . . 1.12 104.248 169.997 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.1 mt -129.52 115.15 18.25 Favored Pre-proline 0 N--CA 1.43 -1.463 0 N-CA-C 104.699 -2.334 . . . . 1.55 104.699 178.077 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -70.57 160.2 50.27 Favored 'Trans proline' 0 N--CA 1.433 -2.053 1 CA-C-N 129.081 4.279 . . . . 1.02 116.19 -173.347 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.64 -35.13 99.08 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-N 123.682 2.351 . . . . 1.25 116.965 -176.551 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -55.7 -37.0 67.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.986 1.476 . . . . 2.25 114.986 171.635 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -84.32 -12.41 54.64 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 119.56 1.073 . . . . 2.02 111.657 -175.7 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -83.85 115.98 22.52 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.875 -1.528 . . . . 0.69 106.875 -178.561 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -109.2 95.41 5.62 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.525 1.766 . . . . 2.78 107.623 168.266 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.3 mt -87.57 132.53 34.02 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.184 -1.413 . . . . 1.17 107.184 -174.282 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.5 mm -117.19 133.83 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 126.77 2.028 . . . . 1.38 106.166 178.95 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.49 ' HB3' HD21 ' A' ' 50' ' ' LEU . 33.5 t80 -112.34 108.24 17.35 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.977 -1.86 . . . . 1.5 105.977 165.055 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.13 -83.31 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.924 2.89 . . . . 1.21 109.645 -177.474 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.15 -27.3 2.07 Favored Glycine 0 N--CA 1.43 -1.74 0 O-C-N 118.822 -2.424 . . . . 1.3 116.082 -176.019 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -95.59 155.23 16.83 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 126.353 2.978 . . . . 2.55 113.262 -178.572 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -93.91 129.09 40.48 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.77 -3.081 . . . . 2.48 107.764 178.766 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.49 HD21 ' HB3' ' A' ' 45' ' ' PHE . 29.2 mt -80.49 140.57 35.83 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.026 1.393 . . . . 0.9 112.469 -170.373 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -88.54 159.25 18.01 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.282 -4.011 . . . . 1.94 110.703 170.613 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.16 -50.79 15.16 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 127.207 2.203 . . . . 1.56 114.575 -171.264 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.83 62.82 0.78 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 119.058 -2.276 . . . . 0.97 117.14 171.499 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.25 31.4 mmt180 -122.66 153.62 39.12 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.956 -2.239 . . . . 2.49 104.956 164.728 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.1 p -89.62 171.94 9.31 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 119.488 1.04 . . . . 0.76 109.963 174.232 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 29.6 mt -81.18 -29.31 34.67 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.29 -0.881 . . . . 1.05 108.781 175.757 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 t -68.86 -35.76 77.3 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.101 -2.249 . . . . 1.19 112.272 179.053 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.84 -28.27 69.44 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.212 -2.805 . . . . 1.9 112.748 176.385 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -81.59 -13.12 58.4 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.162 -4.086 . . . . 0.89 115.432 179.578 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.7 m120 77.81 26.75 0.62 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 126.609 2.443 . . . . 1.84 111.152 178.688 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.8 mt -70.0 113.2 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 127.205 3.383 . . . . 0.82 114.79 -179.26 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -95.03 171.97 8.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 114.932 -2.707 . . . . 2.16 110.911 -178.329 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -62.64 145.9 53.43 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.297 -2.752 . . . . 2.12 110.062 176.769 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 58.37 38.53 25.82 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 125.663 2.649 . . . . 1.71 112.379 175.462 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.2 t -98.97 141.79 31.29 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 104.082 -2.562 . . . . 1.04 104.082 179.51 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -96.57 121.11 38.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 127.404 2.282 . . . . 0.79 110.34 178.185 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -101.85 158.89 15.8 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 102.307 -3.22 . . . . 1.4 102.307 174.912 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -114.42 127.79 56.01 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.033 1.733 . . . . 1.51 114.348 -176.19 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.465 ' C ' HD23 ' A' ' 69' ' ' LEU . 4.2 tt -108.48 123.77 49.4 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 106.635 -1.616 . . . . 1.14 106.635 -178.278 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 t -104.37 142.94 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 104.92 -2.252 . . . . 1.23 104.92 173.702 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.49 HD12 ' HA ' ' A' ' 71' ' ' LEU . 7.9 tp . . . . . 0 N--CA 1.43 -1.443 0 CA-C-O 116.375 -1.774 . . . . 2.78 110.939 174.334 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 124.2 1.952 . . . . 1.1 108.461 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -104.65 132.13 51.25 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.135 -1.603 . . . . 1.87 108.301 -174.981 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.434 HD12 HD22 ' A' ' 67' ' ' LEU . 8.4 pt -127.38 140.89 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 126.027 2.822 . . . . 0.72 107.526 175.333 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -101.75 131.69 47.89 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.397 -2.064 . . . . 1.4 111.3 -178.939 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.3 t -109.41 111.52 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 116.876 -3.64 . . . . 0.58 108.789 177.965 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.5 mtpt -93.36 139.29 30.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.612 -3.18 . . . . 2.09 106.93 175.912 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p -93.25 164.94 13.04 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 116.918 -1.515 . . . . 0.99 112.301 179.904 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.9 tp -65.87 -30.88 71.56 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.246 3.403 . . . . 2.53 113.379 166.339 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.315 70.2 p -61.61 -38.4 87.46 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.124 -4.11 . . . . 2.08 114.271 -178.815 . . . . . . . . 3 2 . 1 . 040 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.87 24.42 1.69 Allowed Glycine 0 N--CA 1.43 -1.726 1 C-N-CA 131.031 4.158 . . . . 1.31 114.416 174.191 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -101.6 153.15 20.01 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.054 -1.461 . . . . 1.4 107.054 -177.994 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -108.6 110.47 21.94 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 113.078 -1.874 . . . . 0.78 109.99 168.079 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 mt -92.35 119.91 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 121.129 1.786 . . . . 1.55 115.122 177.362 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.259 8.7 m -89.37 130.06 35.8 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 116.741 -3.725 . . . . 1.08 106.894 179.079 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.0 mt -133.08 156.41 47.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 118.605 -1.238 . . . . 1.55 107.967 177.898 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -112.74 129.37 56.44 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 117.52 -1.228 . . . . 1.95 109.594 165.833 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 m -127.31 177.55 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 126.645 1.978 . . . . 0.96 114.89 177.872 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -120.11 161.64 37.6 Favored Pre-proline 0 N--CA 1.43 -1.432 0 CA-C-O 115.119 -2.372 . . . . 2.35 110.878 164.261 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.256 33.8 Cg_endo -74.81 -12.63 21.95 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 C-N-CA 122.987 2.458 . . . . 0.95 112.649 -176.744 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.255 70.0 m -92.4 9.7 33.09 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.75 2.82 . . . . 1.45 111.724 173.253 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -84.96 139.0 32.14 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 121.67 2.032 . . . . 1.69 109.906 176.864 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.5 p -84.43 156.42 21.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.305 2.955 . . . . 0.75 112.342 176.113 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mm -64.48 -20.71 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 O-C-N 116.372 -3.955 . . . . 0.73 115.086 176.464 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -56.92 -51.87 67.43 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.367 2.508 . . . . 1.62 117.162 163.079 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -60.45 -31.99 70.96 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 111.048 -2.796 . . . . 2.13 116.571 170.535 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.2 t -65.78 -32.89 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 124.098 3.135 . . . . 0.62 112.202 175.804 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -71.71 -27.48 63.05 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.335 1.854 . . . . 1.22 112.082 175.882 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.04 -21.67 58.9 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.803 -2.436 . . . . 0.51 114.82 173.365 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -78.3 -30.5 48.4 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.608 -3.183 . . . . 1.44 108.206 178.584 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.4 mt -68.54 -33.3 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 129.309 3.044 . . . . 1.32 110.189 168.838 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -66.93 -29.47 69.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.712 -3.117 . . . . 1.7 113.885 167.324 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -74.58 -58.22 3.43 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 120.986 1.721 . . . . 1.55 110.464 172.162 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.2 tptt -57.79 -55.86 29.46 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.574 2.435 . . . . 2.62 117.574 -172.915 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -110.84 -36.43 5.69 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.473 2.082 . . . . 1.48 108.756 -164.905 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.85 66.34 1.0 Allowed Glycine 0 N--CA 1.429 -1.788 0 O-C-N 119.576 -1.953 . . . . 1.12 110.583 169.979 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.6 mt -126.93 130.12 23.86 Favored Pre-proline 0 N--CA 1.429 -1.488 0 CA-C-O 114.452 -2.689 . . . . 1.55 105.552 -178.341 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -62.11 150.42 86.68 Favored 'Trans proline' 0 N--CA 1.433 -2.056 0 C-N-CA 124.167 3.245 . . . . 1.02 111.582 178.82 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -87.13 -0.22 7.69 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 CA-C-N 120.853 1.341 . . . . 1.25 110.319 -162.535 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -71.47 -46.83 58.87 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.372 2.269 . . . . 2.25 112.719 170.719 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -69.41 -19.52 63.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.805 2.842 . . . . 2.02 115.599 -175.055 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -86.83 139.43 30.68 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 124.126 1.917 . . . . 0.69 111.053 -168.82 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.9 mtt180 -131.38 134.07 45.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.731 -3.731 . . . . 2.78 104.19 170.556 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.3 mt -114.21 117.03 30.04 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 114.038 -5.414 . . . . 1.17 112.826 175.296 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 mm -99.3 138.28 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 128.489 3.618 . . . . 1.38 114.439 178.684 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -129.5 96.27 4.23 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 120.836 1.653 . . . . 1.5 109.208 170.358 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.26 26.45 2.7 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 111.854 -3.927 . . . . 1.21 117.246 -179.608 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.39 -24.18 23.04 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 122.991 2.632 . . . . 1.3 112.731 -174.408 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -96.56 132.43 42.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.718 -2.636 . . . . 2.55 106.709 175.351 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.79 131.3 35.26 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.893 -2.379 . . . . 2.48 111.784 166.327 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.0 mt -79.01 128.85 33.78 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.033 1.333 . . . . 0.9 108.689 -173.088 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -80.26 138.93 36.86 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 121.564 1.984 . . . . 1.94 111.034 176.437 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.85 -55.38 14.46 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.525 3.157 . . . . 1.56 119.525 -173.254 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.23 39.96 2.12 Favored Glycine 0 N--CA 1.43 -1.733 0 O-C-N 124.662 1.226 . . . . 0.97 115.889 173.059 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.423 HH21 ' CG ' ' A' ' 58' ' ' ASP . 44.1 mmm-85 -117.73 161.07 20.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 124.814 0.949 . . . . 2.49 112.151 158.168 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -96.52 172.38 7.96 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 115.574 1.694 . . . . 0.76 115.574 173.301 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.1 mt -77.26 -25.4 51.44 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.014 1.116 . . . . 1.05 114.014 176.859 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.8 t -78.8 -33.43 46.26 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.106 -1.442 . . . . 1.19 107.106 -179.495 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.423 ' CG ' HH21 ' A' ' 54' ' ' ARG . 38.1 t0 -61.44 -52.82 62.97 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.365 2.666 . . . . 1.9 112.023 178.183 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -74.42 -7.49 53.11 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 126.813 3.197 . . . . 0.89 117.882 177.993 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.3 m120 62.8 46.15 5.29 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.2 -2.812 . . . . 1.84 115.509 179.702 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.4 mt -96.25 124.24 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 103.729 -2.693 . . . . 0.82 103.729 -177.699 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -112.44 -176.2 2.86 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 118.364 -1.334 . . . . 2.16 112.147 -175.055 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -55.06 137.52 46.23 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 126.768 3.175 . . . . 2.12 110.092 174.812 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 57.3 mt-10 76.3 12.98 2.6 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 126.116 2.865 . . . . 1.71 113.534 170.46 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -79.39 133.22 36.57 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 117.593 -3.192 . . . . 1.04 107.475 -170.813 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.1 m -86.07 113.79 22.42 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.85 -3.656 . . . . 0.79 113.848 178.58 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.434 HD22 HD12 ' A' ' 3' ' ' ILE . 9.7 mp -92.46 160.4 15.09 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.625 -1.922 . . . . 1.4 110.895 174.271 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -129.32 123.16 31.1 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.438 2.066 . . . . 1.51 108.351 -175.243 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.5 tp -93.65 125.23 38.15 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 130.892 3.677 . . . . 1.14 108.317 176.59 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.14 159.34 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 104.126 -2.546 . . . . 1.23 104.126 167.201 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.4 mt . . . . . 0 N--CA 1.429 -1.485 0 CA-C-O 122.653 1.216 . . . . 2.78 108.042 -179.668 . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptt? . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 123.259 1.504 . . . . 1.1 109.188 . . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -101.23 129.44 47.17 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.848 1.659 . . . . 1.87 111.038 -172.304 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.1 pt -125.44 174.48 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.775 -2.453 . . . . 0.72 110.007 176.196 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -119.77 140.91 50.01 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 116.055 1.872 . . . . 1.4 116.055 179.767 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.7 t -124.96 119.63 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 124.196 1.951 . . . . 0.58 105.898 171.606 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -95.44 127.32 41.38 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.627 -3.795 . . . . 2.09 111.68 179.441 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.0 p -73.39 -168.92 0.58 Allowed 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 125.031 2.348 . . . . 0.99 110.953 -176.069 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.536 HD11 ' H ' ' A' ' 71' ' ' LEU . 86.1 mt -86.9 -38.6 16.56 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 111.825 -2.443 . . . . 2.53 111.597 171.492 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.9 p -65.44 -27.35 68.46 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.427 1.891 . . . . 2.08 112.885 -175.9 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.57 22.97 5.25 Favored Glycine 0 N--CA 1.431 -1.669 0 O-C-N 118.151 -2.843 . . . . 1.31 119.108 177.845 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -108.04 138.53 44.14 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 105.602 -1.999 . . . . 1.4 105.602 -175.348 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.0 m -92.91 111.08 22.57 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.595 2.758 . . . . 0.78 108.044 177.149 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -89.85 137.16 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 116.48 -3.888 . . . . 1.55 105.075 -179.268 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.1 m -100.34 129.5 46.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.599 1.959 . . . . 1.08 110.36 -178.653 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.4 mt -129.36 155.38 45.75 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 119.651 1.114 . . . . 1.55 112.673 -175.923 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -116.22 112.25 21.35 Favored 'General case' 0 N--CA 1.429 -1.477 1 O-C-N 115.186 -4.696 . . . . 1.95 105.792 173.253 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.5 m -126.37 155.48 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 110.974 -2.83 . . . . 0.96 112.101 -179.0 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -103.28 159.5 29.1 Favored Pre-proline 0 N--CA 1.431 -1.392 1 O-C-N 114.639 -5.038 . . . . 2.35 109.644 165.485 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.66 -20.78 46.34 Favored 'Trans proline' 0 C--N 1.299 -2.039 1 O-C-N 113.297 -4.107 . . . . 0.95 115.455 -170.993 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 p -84.76 4.52 32.48 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.133 2.173 . . . . 1.45 112.121 175.543 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -75.58 138.2 41.3 Favored 'General case' 0 N--CA 1.431 -1.419 1 O-C-N 115.496 -4.502 . . . . 1.69 106.424 170.473 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.563 HG22 HG22 ' A' ' 55' ' ' THR . 64.6 p -87.02 159.76 18.85 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 125.935 2.022 . . . . 0.75 108.074 -179.225 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.7 mm -60.24 -37.02 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 124.168 0.987 . . . . 0.73 109.692 177.415 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.302 25.5 tt0 -47.12 -50.59 19.91 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.664 1.986 . . . . 1.62 113.385 164.465 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -68.86 -32.74 72.64 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 125.934 2.021 . . . . 2.13 109.745 -179.706 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.55 -38.94 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 120.642 1.565 . . . . 0.62 113.315 175.105 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -61.56 -38.67 88.34 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 122.605 1.193 . . . . 1.22 112.83 169.701 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.65 -25.86 57.22 Favored 'General case' 0 N--CA 1.43 -1.428 1 CA-C-O 129.274 4.368 . . . . 0.51 113.694 179.332 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -72.63 -34.05 67.06 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 114.856 -4.903 . . . . 1.44 111.647 171.703 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.253 97.1 mt -64.73 -48.57 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 O-C-N 120.015 -1.678 . . . . 1.32 109.401 171.126 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -56.63 -42.83 79.51 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 116.446 -3.909 . . . . 1.7 113.265 177.145 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -53.95 -47.26 71.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.815 3.197 . . . . 1.55 117.079 166.522 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.265 14.2 tppt? -73.24 -53.49 10.75 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.04 2.352 . . . . 2.62 114.144 -171.844 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -111.42 -30.1 7.53 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.738 -3.101 . . . . 1.48 109.993 -171.431 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.28 38.36 4.56 Favored Glycine 0 N--CA 1.429 -1.787 0 C-N-CA 125.465 1.507 . . . . 1.12 114.056 -179.586 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.4 mt -97.77 130.38 29.13 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-O 114.749 -2.548 . . . . 1.55 112.117 179.509 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -66.18 154.0 75.86 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 CA-C-N 125.356 2.948 . . . . 1.02 113.487 -173.475 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -65.62 -23.32 56.94 Favored 'Trans proline' 0 N--CA 1.432 -2.094 1 CA-C-N 129.094 4.283 . . . . 1.25 116.373 -177.668 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -69.0 -34.62 75.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.77 -2.456 . . . . 2.25 115.546 178.06 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -73.75 -12.79 60.82 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 124.38 1.05 . . . . 2.02 111.279 179.597 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -98.64 118.06 34.5 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 118.214 -2.804 . . . . 0.69 112.572 -167.951 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -106.51 114.64 28.87 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 126.259 2.224 . . . . 2.78 106.378 170.674 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.1 mt -98.03 109.42 22.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.99 1.853 . . . . 1.17 113.607 175.343 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.3 mt -100.48 112.2 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 128.356 2.662 . . . . 1.38 112.617 180.0 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -105.67 123.76 48.46 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.5 -2.625 . . . . 1.5 107.446 172.008 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.362 . . 69.46 -63.81 0.36 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.128 2.171 . . . . 1.21 110.694 -176.459 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.59 -16.81 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.791 0 N-CA-C 106.122 -2.791 . . . . 1.3 106.122 179.378 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -83.6 125.1 31.46 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.611 3.164 . . . . 2.55 106.848 -172.557 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.3 17.4 tt0 -83.96 115.48 22.33 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.176 1.547 . . . . 2.48 115.176 175.849 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.8 mt -75.58 133.85 40.84 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.173 1.789 . . . . 0.9 112.047 -171.018 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -87.15 151.43 23.21 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 127.859 2.464 . . . . 1.94 115.719 172.743 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -66.24 -44.65 83.12 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 128.364 2.665 . . . . 1.56 113.434 -160.147 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.15 51.25 1.29 Allowed Glycine 0 N--CA 1.43 -1.705 0 O-C-N 118.813 -2.43 . . . . 0.97 110.866 176.332 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -123.56 161.88 24.06 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.889 -1.948 . . . . 2.49 107.377 162.582 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.563 HG22 HG22 ' A' ' 22' ' ' THR . 18.7 p -107.89 172.61 6.73 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.084 -2.26 . . . . 0.76 110.741 179.693 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.407 HD23 HD12 ' A' ' 61' ' ' ILE . 20.8 mt -62.17 -38.41 88.95 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 126.758 2.536 . . . . 1.05 114.077 172.855 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -66.52 -30.8 71.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.916 2.486 . . . . 1.19 115.256 174.284 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -71.49 -43.9 65.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.752 -3.093 . . . . 1.9 111.393 171.222 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -91.55 8.26 37.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 124.964 1.415 . . . . 0.89 114.154 -177.877 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 47.23 49.24 15.54 Favored 'General case' 0 N--CA 1.43 -1.438 1 C-N-CA 132.459 4.304 . . . . 1.84 116.613 -179.462 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.567 HG21 HD21 ' A' ' 67' ' ' LEU . 76.8 mt -89.81 115.04 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 114.191 -2.814 . . . . 0.82 105.48 176.912 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -107.22 -166.66 1.18 Allowed 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 126.291 2.244 . . . . 2.16 112.88 -175.754 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -63.27 144.87 56.57 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 125.128 1.517 . . . . 2.12 113.586 -179.682 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.294 32.2 mt-10 67.28 15.13 9.91 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.629 1.971 . . . . 1.71 114.686 -179.766 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 t -90.17 135.94 33.35 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 123.537 1.636 . . . . 1.04 111.07 -173.903 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.2 m -96.09 113.84 25.49 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.821 3.648 . . . . 0.79 112.213 -172.397 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.567 HD21 HG21 ' A' ' 61' ' ' ILE . 10.5 mt -95.98 152.85 18.14 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 115.604 -4.435 . . . . 1.4 108.883 169.762 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -112.2 119.36 38.11 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 115.873 -2.331 . . . . 1.51 109.463 -174.488 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.6 tp -86.45 116.55 24.67 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.346 1.858 . . . . 1.14 111.454 -178.87 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.8 t -111.73 119.87 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 115.167 -2.349 . . . . 1.23 109.402 177.502 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.536 ' H ' HD11 ' A' ' 8' ' ' LEU 0.296 93.3 mt . . . . . 0 N--CA 1.431 -1.405 0 CA-C-N 121.211 1.823 . . . . 2.78 108.85 -173.482 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 CA--C 1.49 -1.327 0 N-CA-C 104.728 -2.323 . . . . 1.1 104.728 . . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -100.96 128.68 46.88 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.574 -1.954 . . . . 1.87 110.418 -173.675 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.8 pt -137.04 155.75 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 O-C-N 117.315 -3.365 . . . . 0.72 106.709 172.493 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -103.06 140.43 37.32 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.393 1.877 . . . . 1.4 106.716 -175.921 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.8 t -120.73 109.84 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 118.711 -2.493 . . . . 0.58 106.299 171.591 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.7 tttt -96.12 128.75 43.3 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 118.001 2.593 . . . . 2.09 118.001 -178.55 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.7 p -86.12 176.25 8.09 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 115.166 1.543 . . . . 0.99 115.166 174.07 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.8 mt -74.47 -22.85 58.89 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.699 -1.876 . . . . 2.53 115.558 172.76 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 p -67.34 -25.97 66.26 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.808 2.043 . . . . 2.08 113.103 176.602 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.27 28.61 5.74 Favored Glycine 0 N--CA 1.429 -1.803 0 C-N-CA 128.6 3.0 . . . . 1.31 114.29 179.743 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -111.55 141.13 45.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.895 3.712 . . . . 1.4 112.476 -173.014 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.2 m -96.34 116.68 29.43 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 127.891 3.71 . . . . 0.78 116.907 176.084 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mt -96.86 125.35 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 1 O-C-N 114.042 -5.411 . . . . 1.55 110.556 168.299 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.1 m -97.66 118.58 34.51 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 124.903 2.287 . . . . 1.08 106.039 -174.49 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.1 mt -105.48 145.6 30.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.506 -3.871 . . . . 1.55 111.279 -178.163 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -103.79 126.05 50.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.469 1.604 . . . . 1.95 107.219 167.987 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 m -144.43 161.67 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 117.249 -3.407 . . . . 0.96 112.481 -176.006 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -99.33 155.01 37.0 Favored Pre-proline 0 N--CA 1.431 -1.421 0 O-C-N 119.132 -2.23 . . . . 2.35 106.462 157.737 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -72.8 -9.65 24.02 Favored 'Trans proline' 0 N--CA 1.433 -2.064 0 C-N-CA 124.625 3.55 . . . . 0.95 111.755 173.907 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.5 m -87.93 0.71 55.53 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 131.109 3.763 . . . . 1.45 114.584 173.303 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -94.08 143.58 26.24 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 117.729 -3.107 . . . . 1.69 107.809 -179.315 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p -80.58 164.02 23.23 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 128.117 3.818 . . . . 0.75 110.165 176.973 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mm -59.22 -33.83 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 112.264 -2.244 . . . . 0.73 112.295 175.598 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -59.81 -30.99 69.3 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.585 -1.947 . . . . 1.62 111.627 175.733 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -74.9 -39.12 61.65 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.974 -3.579 . . . . 2.13 111.771 175.9 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.283 57.3 t -57.09 -60.48 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 O-C-N 118.07 -2.894 . . . . 0.62 110.233 172.368 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -53.51 -41.6 66.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 120.579 3.548 . . . . 1.22 120.579 177.318 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.14 -40.71 94.87 Favored 'General case' 0 CA--C 1.489 -1.394 0 O-C-N 119.412 -2.055 . . . . 0.51 111.794 169.932 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -63.95 -32.29 73.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.397 3.11 . . . . 1.44 119.397 170.488 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.2 mt -68.56 -39.04 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 O-C-N 124.871 1.357 . . . . 1.32 108.669 170.585 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -61.31 -43.92 98.07 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.12 2.39 . . . . 1.7 115.881 176.097 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.56 -46.2 91.06 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.122 -2.861 . . . . 1.55 113.933 174.105 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -68.41 -54.84 14.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.873 -3.642 . . . . 2.62 113.738 -179.828 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -104.78 -35.24 7.83 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.928 2.299 . . . . 1.48 116.82 -165.412 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.88 36.66 5.71 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-O 117.236 -1.869 . . . . 1.12 113.236 -179.645 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.8 mt -104.02 119.01 55.69 Favored Pre-proline 0 CA--C 1.489 -1.398 0 CA-C-O 113.78 -3.009 . . . . 1.55 103.585 -176.605 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.25 9.2 Cg_exo -62.81 161.68 28.08 Favored 'Trans proline' 0 N--CA 1.433 -2.031 1 C-N-CA 125.988 4.458 . . . . 1.02 116.611 176.147 . . . . . . . . 3 2 . 1 . 042 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.45 -25.13 11.47 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 CA-C-N 124.941 2.8 . . . . 1.25 117.904 -170.097 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -60.99 -49.13 78.69 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 125.968 2.794 . . . . 2.25 113.098 -179.416 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -62.26 -31.81 72.43 Favored 'General case' 0 N--CA 1.43 -1.45 1 C-N-CA 133.812 4.845 . . . . 2.02 112.727 176.225 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -75.73 130.81 39.26 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 117.736 -3.103 . . . . 0.69 114.413 -174.909 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.421 ' HB3' HG23 ' A' ' 70' ' ' VAL . 29.4 ttt180 -120.57 106.68 12.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.73 -1.211 . . . . 2.78 107.73 175.431 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.4 mt -91.41 129.65 37.37 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.17 2.588 . . . . 1.17 109.838 179.147 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.504 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 13.6 mt -121.79 146.26 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 127.013 2.125 . . . . 1.38 107.939 177.808 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.42 ' HB3' HD21 ' A' ' 50' ' ' LEU . 20.7 t80 -135.7 117.49 15.1 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 105.129 -2.174 . . . . 1.5 105.129 171.615 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.98 -68.88 0.12 Allowed 'General case' 0 N--CA 1.43 -1.464 1 C-N-CA 132.015 4.126 . . . . 1.21 107.612 179.943 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.4 14.11 0.45 Allowed Glycine 0 N--CA 1.43 -1.728 0 O-C-N 117.364 -3.335 . . . . 1.3 113.983 176.967 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -121.53 128.18 51.76 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 123.562 1.649 . . . . 2.55 108.208 -178.686 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -72.0 126.63 30.26 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.399 2.523 . . . . 2.48 109.234 169.47 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 45' ' ' PHE . 31.4 mt -83.27 145.43 29.11 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.261 -1.791 . . . . 0.9 107.464 -171.262 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -106.91 155.82 19.36 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-O 123.985 1.85 . . . . 1.94 113.327 -179.018 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -52.44 -60.28 3.42 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 121.12 3.748 . . . . 1.56 121.12 -168.071 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.9 37.69 2.68 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 129.82 3.581 . . . . 0.97 112.956 174.085 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -120.25 153.54 36.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 116.67 -1.634 . . . . 2.49 107.649 170.759 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.4 p -88.18 168.43 12.76 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 125.364 1.665 . . . . 0.76 113.72 164.918 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.7 mt -74.22 -27.78 60.95 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 116.183 -1.865 . . . . 1.05 109.659 178.031 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.1 p -64.66 -31.65 72.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 126.246 2.216 . . . . 1.19 115.115 174.582 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -55.05 -41.7 71.79 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 127.819 3.676 . . . . 1.9 114.772 171.306 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -84.16 -1.39 54.96 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 117.594 -3.191 . . . . 0.89 116.852 176.946 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.299 7.5 m120 65.85 40.96 4.0 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 125.854 2.74 . . . . 1.84 115.93 -176.927 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.6 mt -92.43 121.36 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 126.701 3.143 . . . . 0.82 111.032 177.969 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -110.64 179.34 4.1 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 111.374 -2.648 . . . . 2.16 108.71 -176.065 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -63.52 156.49 26.22 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 124.767 1.227 . . . . 2.12 113.961 179.22 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.451 65.6 mt-10 79.44 -4.03 2.05 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.323 -2.11 . . . . 1.71 113.485 172.793 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.298 49.7 m -73.14 154.08 40.49 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 117.699 2.481 . . . . 1.04 117.699 -174.578 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.7 m -112.73 124.02 51.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.58 -1.637 . . . . 0.79 106.58 178.247 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.2 mt -103.81 164.25 11.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.869 -1.16 . . . . 1.4 107.869 168.932 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.504 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 44.0 m170 -113.97 129.68 56.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 116.555 -1.688 . . . . 1.51 111.887 -176.902 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.7 tp -117.34 115.6 25.55 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 102.219 -3.252 . . . . 1.14 102.219 -176.125 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 42' ' ' ARG . 24.6 m -115.33 159.76 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 127.33 3.443 . . . . 1.23 102.747 173.909 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.43 -1.445 1 O-C-N 111.015 -7.303 . . . . 2.78 109.562 173.764 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.253 6.2 ptt? . . . . . 0 CA--C 1.49 -1.342 0 N-CA-C 113.775 1.028 . . . . 1.1 113.775 . . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.264 34.5 mt-30 -115.18 147.69 39.98 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 116.155 -4.091 . . . . 1.87 110.916 177.08 . . . . . . . . 3 2 . 1 . 043 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.8 pt -134.35 156.67 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 116.904 -3.623 . . . . 0.72 103.436 177.518 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -116.65 139.06 50.95 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.156 -1.59 . . . . 1.4 110.738 178.221 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.0 t -120.43 116.41 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-O 116.98 -1.486 . . . . 0.58 108.553 177.471 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -100.21 139.44 35.87 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 117.081 -1.848 . . . . 2.09 114.707 177.469 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 p -83.49 157.67 22.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.614 2.766 . . . . 0.99 113.234 174.205 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.1 tp -49.12 -41.1 34.79 Favored 'General case' 0 N--CA 1.43 -1.466 2 O-C-N 114.045 -5.41 . . . . 2.53 110.855 166.46 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.1 p -67.83 -28.26 67.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.948 1.832 . . . . 2.08 115.948 179.385 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.11 31.19 3.16 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 125.238 2.577 . . . . 1.31 113.849 173.454 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -109.6 133.39 53.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.743 -3.21 . . . . 1.4 104.181 -176.628 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.4 m -99.51 119.06 37.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.301 -3.374 . . . . 0.78 106.69 175.735 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mt -97.01 98.42 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.823 2.049 . . . . 1.55 106.836 175.997 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.6 m -87.35 125.86 34.51 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 125.401 2.524 . . . . 1.08 107.942 177.851 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.4 mt -116.94 162.59 17.52 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.542 -2.599 . . . . 1.55 107.272 -173.641 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -121.12 112.68 18.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.759 -2.463 . . . . 1.95 110.402 179.718 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -132.45 164.47 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 125.479 1.512 . . . . 0.96 114.356 -176.816 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -111.86 155.68 42.85 Favored Pre-proline 0 N--CA 1.43 -1.438 1 CA-C-O 110.828 -4.415 . . . . 2.35 104.471 164.806 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -69.92 -4.78 14.83 Favored 'Trans proline' 0 C--N 1.3 -2.023 1 CA-C-N 129.049 4.268 . . . . 0.95 114.808 -175.272 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 p -86.09 6.89 26.97 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.662 2.785 . . . . 1.45 111.633 170.714 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.5 133.33 47.56 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.973 -0.751 . . . . 1.69 108.973 169.008 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.7 p -79.96 167.63 20.24 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.731 -2.322 . . . . 0.75 104.731 177.412 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.3 mm -81.5 -21.64 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 117.536 -3.227 . . . . 0.73 109.302 176.849 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -55.1 -49.67 71.11 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 122.02 2.191 . . . . 1.62 109.59 161.348 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -59.14 -59.39 5.54 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 114.578 1.325 . . . . 2.13 114.578 -179.617 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.419 ' H ' HG23 ' A' ' 26' ' ' VAL . 15.2 t -45.1 -43.9 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 127.067 2.147 . . . . 0.62 114.483 172.167 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.454 ' HD2' ' HB2' ' A' ' 41' ' ' GLN 0.349 36.2 mtmt -60.17 -38.95 84.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 118.716 2.858 . . . . 1.22 118.716 171.491 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.57 -19.89 61.41 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.002 2.334 . . . . 0.51 117.024 179.584 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -78.71 -16.33 57.39 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 119.311 -2.118 . . . . 1.44 112.144 171.516 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.332 73.0 mt -78.32 -44.56 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 128.368 3.937 . . . . 1.32 108.751 172.179 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -57.4 -45.24 84.74 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 110.842 -2.89 . . . . 1.7 117.483 172.098 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -45.42 -45.25 12.68 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.872 1.669 . . . . 1.55 114.366 166.761 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -82.38 -68.8 0.67 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.364 -0.834 . . . . 2.62 111.741 -171.33 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -93.99 -20.75 19.69 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 125.789 1.931 . . . . 1.48 113.946 -169.667 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.23 -0.62 64.03 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 118.355 2.102 . . . . 1.12 118.355 175.753 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.9 mt -70.8 122.58 87.23 Favored Pre-proline 0 N--CA 1.429 -1.484 0 CA-C-O 113.955 -2.926 . . . . 1.55 105.303 -178.311 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.37 146.11 61.55 Favored 'Trans proline' 0 N--CA 1.433 -2.033 1 CA-C-O 106.609 -5.663 . . . . 1.02 116.565 177.873 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -55.63 -13.49 8.23 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 128.013 3.898 . . . . 1.25 122.196 -177.847 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -57.04 -41.54 78.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.991 2.517 . . . . 2.25 113.259 176.975 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.281 68.9 mt-30 -84.77 -27.0 27.18 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 126.331 1.852 . . . . 2.02 108.993 -170.437 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.454 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 61.1 mt-30 -71.23 139.92 50.24 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.509 2.781 . . . . 0.69 118.509 -171.496 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -133.83 129.24 36.21 Favored 'General case' 0 N--CA 1.43 -1.435 1 N-CA-C 99.126 -4.398 . . . . 2.78 99.126 172.493 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.46 ' HA ' HD23 ' A' ' 43' ' ' LEU . 23.9 mt -111.24 107.92 17.38 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 112.189 -2.278 . . . . 1.17 106.889 177.426 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 mm -97.26 133.98 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 115.003 -0.999 . . . . 1.38 108.699 176.227 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -122.32 100.6 7.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 101.772 -3.418 . . . . 1.5 101.772 176.794 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 81.65 -100.92 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 105.259 -2.126 . . . . 1.21 105.259 172.61 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.31 -10.16 7.49 Favored Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 107.033 -2.427 . . . . 1.3 107.033 179.284 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -100.94 148.32 25.14 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 119.96 1.88 . . . . 2.55 108.916 -173.478 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -105.4 129.04 53.8 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.795 -2.002 . . . . 2.48 113.661 178.284 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.4 mt -92.72 146.47 23.63 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 116.933 -1.508 . . . . 0.9 109.818 -167.058 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.1 148.94 21.69 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 128.786 3.804 . . . . 1.94 117.667 174.778 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.65 -59.73 4.76 Favored 'General case' 0 CA--C 1.488 -1.41 1 C-N-CA 133.241 4.617 . . . . 1.56 113.295 -169.527 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.66 46.7 3.49 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 119.508 -1.995 . . . . 0.97 116.515 175.458 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -127.75 -179.8 5.13 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 120.553 2.177 . . . . 2.49 112.043 166.805 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.2 p -104.53 172.47 6.77 Favored 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 116.011 -4.181 . . . . 0.76 117.835 178.715 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.5 mt -66.32 -29.63 69.87 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.704 -2.497 . . . . 1.05 111.006 173.105 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -71.69 -29.31 64.44 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 130.019 3.328 . . . . 1.19 117.453 178.367 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.327 23.6 m-20 -63.65 -36.58 84.29 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 119.231 -0.988 . . . . 1.9 112.709 170.118 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -93.42 12.85 23.49 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 117.166 2.284 . . . . 0.89 117.166 -174.996 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 50.08 32.62 6.02 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 118.137 2.643 . . . . 1.84 118.137 -175.304 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.8 mt -89.88 111.59 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 125.11 1.364 . . . . 0.82 110.498 -178.352 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -100.99 -165.68 1.23 Allowed 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 113.868 -1.514 . . . . 2.16 109.286 -173.768 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.5 pttp -68.78 149.81 48.58 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.534 2.111 . . . . 2.12 112.548 179.667 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.281 10.8 mt-10 66.66 30.13 8.39 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 125.619 2.628 . . . . 1.71 116.259 172.71 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.1 m -89.29 135.7 33.43 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.869 -2.394 . . . . 1.04 107.926 -170.697 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.6 m -105.06 106.36 16.81 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.913 -2.367 . . . . 0.79 108.818 -177.006 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -96.61 167.28 11.23 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.448 -2.032 . . . . 1.4 109.586 171.842 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -118.86 121.8 40.84 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 113.662 -1.608 . . . . 1.51 111.138 -170.338 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.9 tp -88.31 121.85 31.16 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.816 -1.549 . . . . 1.14 106.816 -177.449 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.6 t -114.26 124.51 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 106.487 -1.671 . . . . 1.23 106.487 179.308 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.0 mt . . . . . 0 N--CA 1.429 -1.479 0 O-C-N 116.366 -3.959 . . . . 2.78 111.763 179.673 . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptt? . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 121.808 0.813 . . . . 1.1 109.507 . . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -104.57 120.24 40.84 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 113.129 -3.32 . . . . 1.87 108.717 -175.829 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.265 9.2 pt -116.74 174.01 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 127.007 2.692 . . . . 0.72 114.281 171.365 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -125.68 140.22 52.89 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.897 2.879 . . . . 1.4 106.71 -178.278 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 67' ' ' LEU . 95.8 t -129.07 114.81 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.499 -2.001 . . . . 0.58 107.051 171.405 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -86.23 143.14 28.1 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.678 0.751 . . . . 2.09 111.339 -176.129 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.3 p -88.01 169.36 12.04 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.043 -2.286 . . . . 0.99 111.995 176.408 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.8 mt -56.42 -33.71 66.09 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 114.001 -5.437 . . . . 2.53 113.023 172.609 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.2 p -90.18 -34.9 15.66 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 114.835 1.42 . . . . 2.08 114.835 -172.69 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.71 -17.01 0.4 Allowed Glycine 0 N--CA 1.429 -1.771 0 C-N-CA 116.27 -2.872 . . . . 1.31 112.15 177.46 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -84.84 147.91 26.56 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 124.743 2.211 . . . . 1.4 111.326 -170.743 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.6 m -115.65 128.22 55.76 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.745 -3.722 . . . . 0.78 108.752 178.905 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 mt -95.32 137.92 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 119.662 -1.899 . . . . 1.55 107.02 177.055 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.7 m -95.31 111.43 23.29 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.526 -1.984 . . . . 1.08 112.945 175.623 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.7 mt -115.42 148.87 38.86 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.01 -1.681 . . . . 1.55 111.891 -177.831 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -115.29 109.78 18.45 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 103.449 -2.797 . . . . 1.95 103.449 179.49 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.6 m -120.78 170.2 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 124.993 2.33 . . . . 0.96 105.075 177.36 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -126.75 155.4 75.21 Favored Pre-proline 0 N--CA 1.43 -1.429 0 N-CA-C 104.814 -2.291 . . . . 2.35 104.814 168.818 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.45 -29.34 39.36 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 N-CA-C 120.924 3.394 . . . . 0.95 120.924 -176.679 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 m -76.13 4.37 8.7 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.424 2.379 . . . . 1.45 117.424 177.176 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -85.1 148.74 25.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 125.74 1.9 . . . . 1.69 114.878 177.637 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.3 p -90.1 169.96 10.73 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.35 -2.094 . . . . 0.75 114.225 175.595 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.8 mm -63.64 -41.31 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 1 O-C-N 115.867 -4.27 . . . . 0.73 114.462 176.255 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.382 76.8 tt0 -35.75 -55.73 0.71 Allowed 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 118.624 2.824 . . . . 1.62 118.624 155.583 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -56.83 -28.15 61.13 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.734 -1.854 . . . . 2.13 115.718 176.187 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.2 t -69.98 -42.63 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 117.988 -2.945 . . . . 0.62 108.998 175.208 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -56.29 -39.53 72.84 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.437 -2.039 . . . . 1.22 116.404 171.777 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.0 -49.48 72.3 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.073 -2.892 . . . . 0.51 115.659 174.469 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -52.83 -45.11 67.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.248 1.419 . . . . 1.44 113.131 170.715 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 30' ' ' ILE . 56.4 mt -69.29 -30.9 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 O-C-N 115.722 -4.361 . . . . 1.32 112.169 175.125 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.31 -40.04 71.06 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.119 -1.613 . . . . 1.7 111.041 173.369 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.02 -54.7 44.12 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 123.358 1.551 . . . . 1.55 112.304 170.117 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -72.94 -57.89 3.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 116.55 -3.844 . . . . 2.62 115.628 -174.617 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -94.28 -27.33 16.19 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.364 1.987 . . . . 1.48 116.364 -174.188 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.35 23.67 21.17 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 117.47 1.748 . . . . 1.12 117.47 178.614 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.1 mt -89.77 138.84 27.77 Favored Pre-proline 0 N--CA 1.431 -1.402 0 O-C-N 118.188 -2.948 . . . . 1.55 103.827 -173.194 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.57 151.37 64.38 Favored 'Trans proline' 0 C--N 1.299 -2.052 1 CA-C-N 130.675 4.848 . . . . 1.02 111.712 176.761 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -73.03 -19.0 23.55 Favored 'Trans proline' 0 C--N 1.3 -2.004 3 C-N-CA 126.53 4.82 . . . . 1.25 115.676 -176.729 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.27 -39.03 66.5 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 115.686 1.736 . . . . 2.25 115.686 177.421 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -89.71 -18.61 26.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.342 -1.355 . . . . 2.02 107.342 -173.071 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.454 ' HG2' HD11 ' A' ' 69' ' ' LEU . 67.9 mt-30 -78.35 100.2 6.67 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 117.728 2.492 . . . . 0.69 117.728 -167.639 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -97.85 122.99 41.61 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 119.292 0.951 . . . . 2.78 110.867 171.009 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.1 mt -92.76 105.72 17.81 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.214 2.911 . . . . 1.17 112.896 179.146 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mm -90.66 130.57 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 128.615 2.766 . . . . 1.38 109.783 -177.521 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -138.89 114.8 10.08 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 106.344 -1.724 . . . . 1.5 106.344 176.364 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.458 . . 68.16 24.98 7.45 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.098 -1.626 . . . . 1.21 113.405 173.605 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.24 -24.87 28.33 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 117.827 -1.54 . . . . 1.3 112.151 -173.189 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.5 tttt -106.44 128.99 54.49 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 122.239 3.02 . . . . 2.55 112.618 -179.685 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -78.48 138.22 38.33 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 112.124 -2.307 . . . . 2.48 112.865 168.964 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.1 mt -93.38 137.89 32.24 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 129.305 3.042 . . . . 0.9 108.959 -166.816 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -68.37 144.8 54.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.995 1.85 . . . . 1.94 115.995 173.11 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.15 -38.81 82.53 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 118.751 2.871 . . . . 1.56 118.751 -165.799 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.39 23.47 31.83 Favored Glycine 0 N--CA 1.43 -1.753 0 O-C-N 119.147 -2.221 . . . . 0.97 115.788 173.486 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -99.07 143.82 28.91 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 118.562 1.181 . . . . 2.49 109.104 166.416 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.251 72.1 p -80.9 162.57 23.87 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 126.277 2.235 . . . . 0.76 112.857 -179.76 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.9 -24.26 67.75 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.307 -2.746 . . . . 1.05 110.467 172.622 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.6 t -88.02 -11.08 48.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.936 -1.728 . . . . 1.19 110.431 -176.997 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -75.8 -42.75 49.1 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.659 -1.9 . . . . 1.9 109.526 173.08 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -79.63 -0.05 32.19 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.41 2.374 . . . . 0.89 117.41 176.13 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 64.01 39.76 7.68 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 115.733 1.753 . . . . 1.84 115.733 -179.48 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.1 mm -75.43 118.4 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 119.273 -2.142 . . . . 0.82 110.081 178.085 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -91.84 172.71 8.29 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.322 2.487 . . . . 2.16 114.394 177.373 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -66.98 140.28 57.72 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.451 -3.28 . . . . 2.12 107.607 179.635 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.386 6.3 tt0 85.71 12.7 0.2 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.812 1.645 . . . . 1.71 113.365 177.2 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.8 m -80.15 152.55 29.18 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 116.856 -3.652 . . . . 1.04 112.52 -172.687 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.83 115.48 30.17 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.76 2.219 . . . . 0.79 109.599 -178.006 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.451 ' HB2' HG22 ' A' ' 5' ' ' VAL . 10.5 mp -102.52 163.19 12.37 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 114.118 -5.364 . . . . 1.4 104.86 174.183 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -122.67 123.46 41.18 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.866 1.666 . . . . 1.51 109.942 176.496 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.454 HD11 ' HG2' ' A' ' 41' ' ' GLN . 24.1 tp -84.8 122.14 28.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.719 1.608 . . . . 1.14 114.144 179.067 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.1 t -117.82 138.47 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 102.156 -3.276 . . . . 1.23 102.156 177.737 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 71' ' ' LEU . 36.0 mt . . . . . 0 N--CA 1.43 -1.438 0 CA-C-O 123.057 1.408 . . . . 2.78 108.495 -177.156 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 3.3 ptt? . . . . . 0 CA--C 1.491 -1.32 0 N-CA-C 116.566 2.061 . . . . 1.1 116.566 . . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -103.05 112.52 25.41 Favored 'General case' 0 N--CA 1.429 -1.486 1 O-C-N 116.03 -4.169 . . . . 1.87 107.153 -168.571 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.3 pt -117.71 154.07 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 117.333 -1.318 . . . . 0.72 111.425 169.724 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -118.0 134.63 54.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 125.589 1.805 . . . . 1.4 113.815 -179.195 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -104.14 127.16 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 104.509 -2.404 . . . . 0.58 104.509 173.851 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -104.1 147.69 27.13 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.806 -1.553 . . . . 2.09 106.806 176.208 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.337 7.8 p -97.8 154.09 17.85 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 128.228 3.455 . . . . 0.99 113.378 174.119 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.5 mt -55.14 -36.85 66.23 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.87 2.468 . . . . 2.53 113.389 168.044 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.6 p -78.25 -47.31 18.2 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.592 -1.942 . . . . 2.08 112.489 -173.567 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.85 25.6 0.06 OUTLIER Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 117.3 1.68 . . . . 1.31 117.3 167.916 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -103.74 153.24 20.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 116.121 -1.895 . . . . 1.4 111.668 -179.115 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.3 m -116.24 124.59 50.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 106.716 -1.587 . . . . 0.78 106.716 173.67 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.8 mt -99.08 117.65 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 123.413 2.824 . . . . 1.55 104.042 179.768 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.0 m -98.18 112.58 24.5 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.971 -2.956 . . . . 1.08 107.958 -176.107 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.8 mt -96.6 143.98 27.07 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.766 -1.209 . . . . 1.55 109.491 -174.384 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -98.41 119.17 36.64 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 126.284 2.24 . . . . 1.95 106.727 166.211 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.15 172.27 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 CA-C-N 121.231 1.832 . . . . 0.96 110.433 -175.823 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -126.2 152.53 73.67 Favored Pre-proline 0 N--CA 1.429 -1.483 0 C-N-CA 127.873 2.469 . . . . 2.35 107.246 172.409 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -75.69 -26.63 9.67 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 N-CA-C 107.056 -1.94 . . . . 0.95 107.056 -170.626 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.8 p -78.9 -5.76 54.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.672 -2.517 . . . . 1.45 115.557 -179.241 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -70.0 157.87 36.7 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 124.197 0.935 . . . . 1.69 111.852 168.945 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.7 p -88.75 166.72 13.85 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.649 2.092 . . . . 0.75 116.649 175.373 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.5 mm -67.13 -38.88 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.39 -2.069 . . . . 0.73 107.588 175.017 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -49.07 -44.82 42.24 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 118.31 -2.744 . . . . 1.62 114.077 167.676 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -64.71 -22.33 66.96 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.898 2.079 . . . . 2.13 111.8 175.956 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.36 98.5 t -73.67 -39.53 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 124.055 1.883 . . . . 0.62 110.792 176.543 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -70.88 -38.95 73.08 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.91 2.484 . . . . 1.22 110.487 178.449 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.46 -38.16 63.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.692 2.797 . . . . 0.51 114.193 169.853 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -77.23 -38.36 51.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.815 -1.803 . . . . 1.44 112.109 177.164 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.1 mt -61.08 -36.55 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 124.451 1.101 . . . . 1.32 111.42 172.219 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -65.51 -38.2 88.99 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 123.743 1.735 . . . . 1.7 110.936 178.777 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.53 -41.1 98.64 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 117.822 -3.049 . . . . 1.55 113.023 176.6 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -81.59 -59.09 2.73 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 116.423 -1.751 . . . . 2.62 112.064 -176.766 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -98.72 -39.17 8.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.989 2.515 . . . . 1.48 114.119 -164.825 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.21 26.59 7.31 Favored Glycine 0 N--CA 1.431 -1.693 0 O-C-N 125.733 1.896 . . . . 1.12 111.753 173.503 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 36' ' ' ILE . 39.2 mt -102.31 128.39 28.44 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 118.712 -2.64 . . . . 1.55 105.923 -176.809 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.305 80.1 Cg_endo -68.54 158.48 57.52 Favored 'Trans proline' 0 C--N 1.299 -2.051 2 C-N-CA 128.958 6.438 . . . . 1.02 112.75 -175.937 . . . . . . . . 3 2 . 1 . 045 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -66.52 -31.68 41.12 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 CA-C-N 124.389 2.603 . . . . 1.25 112.364 -178.514 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -50.14 -47.55 54.13 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.755 2.872 . . . . 2.25 118.755 175.271 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -70.27 -19.77 63.09 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.32 2.341 . . . . 2.02 117.32 176.199 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -96.41 135.97 37.55 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 120.011 1.278 . . . . 0.69 110.398 -173.484 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -128.01 124.23 36.65 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 100.817 -3.771 . . . . 2.78 100.817 173.279 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.8 mt -104.88 129.51 53.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.451 -2.159 . . . . 1.17 110.735 178.21 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.5 mm -108.59 129.21 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 125.588 2.613 . . . . 1.38 110.198 178.473 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -130.15 130.82 45.25 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.939 -2.976 . . . . 1.5 109.502 172.068 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.255 . . 67.51 -75.23 0.06 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.21 1.481 . . . . 1.21 109.089 -173.08 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.428 ' H ' ' H ' ' A' ' 48' ' ' LYS . . . -161.38 -7.9 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 129.912 3.625 . . . . 1.3 112.3 -175.937 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.428 ' H ' ' H ' ' A' ' 47' ' ' GLY . 44.2 mttp -81.3 130.85 35.2 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.569 -1.548 . . . . 2.55 112.427 -177.467 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -91.2 106.87 18.82 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 114.905 -4.872 . . . . 2.48 104.003 169.671 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.4 mt -71.21 133.17 45.93 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 117.316 2.339 . . . . 0.9 117.316 -169.583 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -83.87 141.97 30.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 111.562 -2.563 . . . . 1.94 114.031 -178.795 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.6 -65.68 0.64 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.469 -2.644 . . . . 1.56 117.989 -161.573 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.3 54.26 4.92 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-O 126.339 3.189 . . . . 0.97 117.33 168.701 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -117.14 146.69 43.02 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 111.585 -2.307 . . . . 2.49 108.987 159.657 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.6 p -72.79 152.93 41.33 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.905 1.446 . . . . 0.76 114.905 169.351 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.6 mt -59.72 -36.8 77.31 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.708 2.803 . . . . 1.05 108.161 175.109 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.263 1.7 t -71.38 -26.11 62.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 127.333 2.896 . . . . 1.19 112.836 175.078 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -67.88 -47.57 68.48 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 123.805 3.002 . . . . 1.9 111.183 168.74 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -69.8 -23.15 63.29 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.732 -1.855 . . . . 0.89 114.692 176.963 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.7 t30 73.79 53.11 0.11 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 127.414 2.286 . . . . 1.84 109.668 -171.672 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.8 mt -95.91 119.79 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 103.524 -2.769 . . . . 0.82 103.524 174.163 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -105.18 -178.06 3.54 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.282 -2.136 . . . . 2.16 111.869 -179.038 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.362 14.1 ptmt -49.18 137.42 13.77 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 127.326 2.25 . . . . 2.12 115.668 172.852 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 77.91 11.31 2.0 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.714 1.605 . . . . 1.71 114.421 173.163 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.3 m -82.59 147.19 28.74 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 124.395 1.059 . . . . 1.04 113.188 -175.165 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.5 m -105.19 116.48 32.02 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.732 2.206 . . . . 0.79 110.625 179.635 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.8 mt -88.4 141.46 28.52 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.323 -2.736 . . . . 1.4 110.804 172.15 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -100.69 123.61 45.14 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.714 1.721 . . . . 1.51 107.448 173.75 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.8 tp -85.89 111.99 20.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.916 1.686 . . . . 1.14 113.745 176.86 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.7 t -111.51 134.3 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 2 CA-C-O 129.965 4.698 . . . . 1.23 99.757 178.947 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.6 mt . . . . . 0 N--CA 1.43 -1.473 0 O-C-N 118.023 -2.923 . . . . 2.78 115.687 -177.549 . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 CA--C 1.489 -1.371 0 CA-C-O 117.439 -1.267 . . . . 1.1 111.138 . . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -94.7 134.57 37.15 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.774 1.75 . . . . 1.87 111.374 -171.633 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -120.61 136.6 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.855 -3.028 . . . . 0.72 106.26 169.037 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -101.66 90.66 4.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 125.312 2.482 . . . . 1.4 111.701 -173.443 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.99 100.08 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.49 1 O-C-N 112.216 -6.553 . . . . 0.58 113.367 177.238 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -96.12 134.89 38.64 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.84 -1.163 . . . . 2.09 110.568 178.452 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.5 p -84.52 -178.78 6.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 131.049 3.74 . . . . 0.99 116.102 174.612 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.3 tp -79.01 -26.58 43.24 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.97 -4.206 . . . . 2.53 116.336 171.395 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.5 p -77.32 -34.01 55.41 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.253 2.93 . . . . 2.08 114.335 -179.167 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.32 4.16 2.6 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 119.27 -2.144 . . . . 1.31 111.455 174.464 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -82.4 122.74 28.39 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.82 -1.988 . . . . 1.4 111.531 -176.174 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 m -99.26 112.23 24.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.394 -2.691 . . . . 0.78 113.362 170.041 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.52 117.63 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 120.021 -1.674 . . . . 1.55 106.59 171.049 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.6 m -99.07 98.04 9.11 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.495 -1.669 . . . . 1.08 106.495 -178.362 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.1 mt -76.51 126.09 30.37 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.436 1.894 . . . . 1.55 111.294 -176.928 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -81.26 104.07 11.47 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.904 -2.997 . . . . 1.95 113.363 166.662 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 m -110.49 171.62 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 123.983 0.913 . . . . 0.96 111.596 -179.739 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -123.32 169.73 9.6 Favored Pre-proline 0 N--CA 1.43 -1.472 0 CA-C-O 116.278 -1.82 . . . . 2.35 107.387 158.22 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -78.66 -16.08 13.3 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 124.127 2.51 . . . . 0.95 112.719 -167.905 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.83 -19.21 65.8 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 114.886 -2.483 . . . . 1.45 113.886 174.537 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -72.18 143.63 48.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 125.189 1.555 . . . . 1.69 113.073 -174.863 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 26' ' ' VAL . 13.5 p -86.89 167.42 14.34 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.568 -1.958 . . . . 0.75 113.361 178.798 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 23' ' ' ILE . 42.4 mm -64.08 -37.16 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.536 -1.353 . . . . 0.73 111.84 172.962 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -53.03 -42.18 65.43 Favored 'General case' 0 N--CA 1.429 -1.492 1 O-C-N 115.458 -4.526 . . . . 1.62 114.866 163.639 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -72.72 -32.94 66.09 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.407 -2.683 . . . . 2.13 111.756 -178.621 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 55.1 t -62.56 -50.38 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 119.019 -2.3 . . . . 0.62 109.927 171.724 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -66.82 -18.59 65.45 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.142 1.377 . . . . 1.22 111.168 -179.227 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.0 -35.51 31.86 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 113.292 0.849 . . . . 0.51 113.292 169.816 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 55.1 mttp -63.46 -52.47 61.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.153 -2.217 . . . . 1.44 108.542 171.203 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.8 mt -53.92 -32.54 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 123.96 3.073 . . . . 1.32 117.397 174.83 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -71.1 -40.06 71.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.088 -2.883 . . . . 1.7 114.901 173.568 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.64 -56.85 16.16 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.09 -2.881 . . . . 1.55 107.428 168.836 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -71.22 -56.48 5.97 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.485 1.291 . . . . 2.62 114.485 -170.103 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -96.15 -24.79 16.12 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.151 2.58 . . . . 1.48 112.11 -168.972 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.55 37.53 13.99 Favored Glycine 0 N--CA 1.43 -1.751 0 CA-C-O 127.6 3.889 . . . . 1.12 113.71 173.853 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.7 mt -108.86 132.72 21.0 Favored Pre-proline 0 N--CA 1.429 -1.494 1 O-C-N 116.262 -4.081 . . . . 1.55 108.268 -178.539 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -68.51 142.88 55.29 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 C-N-CA 125.05 3.833 . . . . 1.02 120.817 -179.574 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.47 -9.11 21.32 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 123.731 2.954 . . . . 1.25 117.745 -171.376 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.74 -23.39 36.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.906 1.683 . . . . 2.25 112.697 166.85 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -86.15 -41.08 15.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 129.122 2.969 . . . . 2.02 111.123 -177.762 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.257 58.0 mt-30 -70.0 134.54 48.42 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 111.056 -2.793 . . . . 0.69 113.168 179.978 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -133.11 120.13 20.85 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.322 1.601 . . . . 2.78 115.322 175.074 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.6 mt -100.02 117.42 34.25 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 121.223 -0.923 . . . . 1.17 111.167 -177.214 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 44' ' ' ILE . 80.8 mt -110.33 129.19 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 126.964 2.106 . . . . 1.38 108.097 179.472 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -142.83 137.52 29.68 Favored 'General case' 0 N--CA 1.43 -1.463 1 N-CA-C 99.092 -4.41 . . . . 1.5 99.092 173.002 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.16 33.4 23.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 117.078 2.251 . . . . 1.21 117.078 175.695 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.57 9.18 73.53 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 116.198 -2.906 . . . . 1.3 115.459 -174.023 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -121.33 137.9 54.49 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.694 2.187 . . . . 2.55 109.732 -176.459 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -89.37 118.22 28.88 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 127.261 3.41 . . . . 2.48 102.155 179.281 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.1 mt -87.22 152.59 22.18 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.771 -3.706 . . . . 0.9 112.82 -170.715 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -97.4 163.9 12.68 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.104 -3.498 . . . . 1.94 109.535 179.633 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -72.88 -69.04 0.44 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.458 2.303 . . . . 1.56 114.168 -168.314 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.08 59.77 2.25 Favored Glycine 0 N--CA 1.43 -1.728 1 C-N-CA 131.455 4.359 . . . . 0.97 110.76 176.919 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.5 mmt-85 -142.74 148.46 37.28 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.073 -1.825 . . . . 2.49 106.073 169.7 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 72.6 p -86.43 170.24 12.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.217 -3.427 . . . . 0.76 108.617 178.72 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 31.3 mt -65.89 -39.1 90.32 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.794 2.838 . . . . 1.05 110.648 169.078 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 t -64.88 -37.03 86.26 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.825 -3.047 . . . . 1.19 114.966 177.726 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -60.48 -40.67 92.14 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 115.925 1.824 . . . . 1.9 115.925 177.486 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -77.25 -9.92 59.1 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.797 2.839 . . . . 0.89 114.246 171.809 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.258 9.6 t30 63.18 48.39 3.73 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 125.787 2.708 . . . . 1.84 113.368 -176.698 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.1 mt -96.47 100.24 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 1 C-N-CA 132.25 4.22 . . . . 0.82 104.843 179.352 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -90.75 -174.45 4.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 121.959 2.163 . . . . 2.16 106.591 -175.955 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -62.37 151.66 36.2 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.58 -1.646 . . . . 2.12 109.76 173.088 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.344 43.7 mt-10 67.4 21.88 9.57 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 128.983 2.913 . . . . 1.71 111.078 171.106 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.1 m -85.59 136.7 33.28 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 115.617 -2.135 . . . . 1.04 112.64 -178.396 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.0 m -90.72 111.13 22.36 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 120.234 1.379 . . . . 0.79 108.623 -178.764 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.3 mt -88.91 137.67 32.11 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.259 -3.4 . . . . 1.4 107.313 173.326 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -94.06 116.65 29.1 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.78 -2.45 . . . . 1.51 106.527 -174.046 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.1 tp -99.63 108.68 21.12 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.749 -1.844 . . . . 1.14 110.005 -176.909 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.3 t -98.52 132.73 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 131.262 3.825 . . . . 1.23 107.691 178.307 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.8 mt . . . . . 0 N--CA 1.43 -1.44 0 CA-C-O 127.458 3.504 . . . . 2.78 105.354 177.565 . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ptt? . . . . . 0 CA--C 1.489 -1.392 0 CA-C-O 121.792 0.806 . . . . 1.1 111.739 . . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -110.81 142.21 43.12 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.645 -1.909 . . . . 1.87 110.301 -169.694 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.2 pt -136.64 146.2 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 129.073 2.949 . . . . 0.72 109.809 178.42 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.422 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 25.3 m-85 -105.29 109.55 21.58 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 113.384 -1.735 . . . . 1.4 112.933 -178.497 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -100.49 103.06 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 117.601 -3.187 . . . . 0.58 108.703 176.227 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -91.76 131.57 37.03 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.73 -1.605 . . . . 2.09 113.049 176.486 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.351 0.0 OUTLIER -98.4 168.83 9.96 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.455 2.302 . . . . 0.99 109.32 -177.976 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.5 mt -67.67 -35.29 78.58 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 126.404 2.315 . . . . 2.53 112.686 -175.611 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.319 17.8 p -71.31 -35.66 71.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.893 1.679 . . . . 2.08 109.197 -176.388 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.29 -12.68 1.83 Allowed Glycine 0 N--CA 1.429 -1.805 0 O-C-N 118.949 -2.344 . . . . 1.31 115.758 178.031 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -80.29 134.45 36.08 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 124.946 2.308 . . . . 1.4 114.064 -175.654 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -99.82 127.3 45.99 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.197 -2.19 . . . . 0.78 109.518 173.813 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 mt -102.48 117.61 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 118.136 -2.853 . . . . 1.55 108.66 174.699 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.1 m -95.92 117.69 31.1 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 119.534 -0.866 . . . . 1.08 109.194 178.629 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.5 mt -119.21 150.27 40.35 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 121.212 -0.93 . . . . 1.55 112.627 177.371 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -101.07 139.91 36.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 127.762 3.164 . . . . 1.95 108.547 167.657 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.9 m -150.93 170.47 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 C-N-CA 129.969 3.307 . . . . 0.96 112.981 -178.383 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -108.47 156.9 37.84 Favored Pre-proline 0 CA--C 1.489 -1.383 0 CA-C-O 114.071 -2.871 . . . . 2.35 110.264 167.054 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -67.84 -21.27 44.51 Favored 'Trans proline' 0 N--CA 1.433 -2.065 0 C-N-CA 124.525 3.483 . . . . 0.95 111.827 -174.643 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.2 p -71.4 -6.64 41.74 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 130.511 3.525 . . . . 1.45 115.944 169.713 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.74 156.19 30.75 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.473 -2.017 . . . . 1.69 112.928 176.021 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.6 p -92.64 169.63 10.36 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.085 1.754 . . . . 0.75 113.128 176.512 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.5 mm -66.93 -30.97 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.806 -2.434 . . . . 0.73 114.975 173.579 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -57.25 -40.44 77.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.883 -3.01 . . . . 1.62 112.176 168.827 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -69.42 -23.65 63.73 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 113.217 0.821 . . . . 2.13 113.217 177.912 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.9 t -79.69 -46.54 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 119.647 -1.908 . . . . 0.62 113.48 176.38 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -68.85 -23.6 64.26 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 125.761 2.696 . . . . 1.22 115.017 176.614 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.84 -19.75 57.15 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.24 -3.412 . . . . 0.51 111.105 173.561 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -84.64 -34.85 22.99 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.173 2.416 . . . . 1.44 110.3 -179.838 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.7 mt -75.95 -22.13 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 117.965 -2.96 . . . . 1.32 107.767 175.822 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -70.23 -37.27 74.95 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 117.968 -2.958 . . . . 1.7 110.883 170.818 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.97 -59.33 3.58 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 120.467 -1.396 . . . . 1.55 110.873 172.438 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.256 32.6 tttp -59.18 -58.83 6.93 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.266 2.626 . . . . 2.62 111.25 -172.266 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -92.99 -74.7 0.51 Allowed 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.4 1.88 . . . . 1.48 109.612 -174.065 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 156.6 -14.23 0.35 Allowed Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 125.31 3.687 . . . . 1.12 110.274 177.186 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.6 mt -57.59 119.41 32.61 Favored Pre-proline 0 N--CA 1.43 -1.433 0 C-N-CA 128.929 2.892 . . . . 1.55 113.476 -172.891 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -60.22 147.09 94.85 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 CA-C-N 125.168 2.882 . . . . 1.02 117.534 171.789 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.304 73.6 Cg_endo -72.35 -18.25 26.57 Favored 'Trans proline' 0 N--CA 1.433 -2.031 1 C-N-CA 126.691 4.927 . . . . 1.25 114.615 -172.327 . . . . . . . . 3 2 . 1 . 047 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -73.36 -22.03 60.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 124.176 3.171 . . . . 2.25 109.373 174.799 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -87.4 -18.38 30.13 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.918 -2.364 . . . . 2.02 110.0 -178.724 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -96.12 116.27 28.72 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.726 -1.953 . . . . 0.69 105.726 -172.043 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -103.57 119.79 39.59 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 131.472 3.909 . . . . 2.78 107.851 168.695 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.5 mt -109.53 120.82 43.67 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.047 1.403 . . . . 1.17 110.916 179.631 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.414 HD11 HG21 ' A' ' 70' ' ' VAL . 1.4 mt -104.98 126.81 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 O-C-N 119.871 -1.768 . . . . 1.38 109.843 -179.614 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.498 ' CE2' HG12 ' A' ' 61' ' ' ILE . 49.3 t80 -134.12 127.79 32.82 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 116.881 -3.637 . . . . 1.5 112.936 173.762 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 35.39 38.75 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.843 1.657 . . . . 1.21 114.508 -171.51 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.27 -43.12 1.76 Allowed Glycine 0 N--CA 1.431 -1.699 0 O-C-N 118.012 -2.93 . . . . 1.3 113.096 175.752 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -72.46 144.03 48.22 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 119.374 1.587 . . . . 2.55 113.522 176.47 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.445 1.1 mp0 -99.14 112.8 24.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.325 -2.109 . . . . 2.48 112.101 169.742 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.8 mt -78.27 139.28 38.89 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 116.715 -3.741 . . . . 0.9 113.964 -158.393 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -82.05 141.8 32.87 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.747 2.419 . . . . 1.94 109.673 178.262 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.31 -48.46 71.32 Favored 'General case' 0 N--CA 1.43 -1.433 1 N-CA-C 121.91 4.041 . . . . 1.56 121.91 -173.378 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.92 63.25 1.52 Allowed Glycine 0 N--CA 1.431 -1.649 0 O-C-N 118.378 -2.701 . . . . 0.97 114.216 171.228 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -129.65 150.39 50.99 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.371 3.069 . . . . 2.49 105.932 167.62 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.7 p -87.41 170.15 11.63 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 119.071 -1.052 . . . . 0.76 110.048 177.662 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.6 mt -70.67 -30.11 66.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.591 1.956 . . . . 1.05 107.943 173.39 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.3 p -73.03 -43.0 62.56 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 116.241 -4.037 . . . . 1.19 118.036 175.382 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -44.05 -60.45 1.86 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.256 2.222 . . . . 1.9 116.584 167.058 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -73.25 3.78 5.34 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.424 -1.262 . . . . 0.89 112.054 179.61 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.2 t30 52.76 48.76 21.77 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.612 3.165 . . . . 1.84 114.654 -175.308 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.498 HG12 ' CE2' ' A' ' 45' ' ' PHE . 19.5 mt -94.92 124.74 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 116.528 -3.857 . . . . 0.82 108.281 175.785 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -114.33 -162.64 0.82 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 116.794 -3.691 . . . . 2.16 105.809 -165.299 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -67.87 139.59 56.51 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 124.935 2.302 . . . . 2.12 113.371 167.347 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.438 84.5 mt-10 70.81 38.3 1.22 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.912 -2.368 . . . . 1.71 111.191 171.043 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 m -95.53 115.24 27.16 Favored 'General case' 0 N--CA 1.43 -1.453 1 C-N-CA 133.734 4.813 . . . . 1.04 107.779 -170.31 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.422 ' HA ' ' HB2' ' A' ' 4' ' ' PHE 0.256 87.5 m -80.46 102.47 9.7 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.723 -1.236 . . . . 0.79 114.263 175.414 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.308 8.8 mt -89.21 135.61 33.48 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-O 123.904 1.812 . . . . 1.4 107.494 174.033 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -97.39 104.98 17.05 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.084 1.354 . . . . 1.51 107.586 -174.276 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.362 16.6 tp -76.43 115.42 16.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.371 -3.331 . . . . 1.14 114.335 174.906 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.414 HG21 HD11 ' A' ' 44' ' ' ILE . 66.0 t -108.48 128.77 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 115.554 -2.165 . . . . 1.23 106.508 172.212 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.8 mt . . . . . 0 N--CA 1.429 -1.486 0 CA-C-N 123.968 3.076 . . . . 2.78 109.019 176.285 . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.458 ' SD ' ' HA ' ' A' ' 63' ' ' LYS . 11.0 ptt? . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 117.878 -1.058 . . . . 1.1 112.834 . . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -86.4 129.43 34.86 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 120.878 1.672 . . . . 1.87 112.013 -179.881 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.261 32.5 pt -130.91 150.68 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.129 -3.482 . . . . 0.72 108.642 175.459 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -110.88 142.73 42.55 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 117.897 -3.002 . . . . 1.4 104.819 -178.653 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.4 t -124.1 108.49 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 107.082 -1.451 . . . . 0.58 107.082 172.748 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -98.28 132.1 44.05 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.89 -2.381 . . . . 2.09 110.633 -178.872 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.555 HG22 HD23 ' A' ' 69' ' ' LEU . 2.6 p -86.53 177.48 7.38 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.805 2.241 . . . . 0.99 113.682 178.797 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.317 43.0 mt -83.2 -38.99 21.56 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 119.153 -2.217 . . . . 2.53 109.828 170.073 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 p -63.71 -52.28 61.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.452 3.101 . . . . 2.08 113.963 179.69 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.84 11.31 0.04 OUTLIER Glycine 0 N--CA 1.429 -1.783 0 O-C-N 118.465 -2.647 . . . . 1.31 118.008 -175.136 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -115.59 150.95 35.83 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 105.824 -1.917 . . . . 1.4 105.824 -167.445 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.3 m -122.29 111.23 16.66 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 116.393 -1.765 . . . . 0.78 109.377 166.963 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -91.58 121.79 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 123.605 2.911 . . . . 1.55 109.952 177.622 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 m -87.55 114.18 23.92 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 127.189 3.376 . . . . 1.08 113.286 173.008 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.4 mt -110.8 154.74 23.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.918 -2.989 . . . . 1.55 112.88 -179.712 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -110.09 123.14 49.17 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 124.259 1.981 . . . . 1.95 108.028 166.283 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.96 170.59 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 118.672 -2.517 . . . . 0.96 107.116 -174.528 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -118.91 154.65 53.12 Favored Pre-proline 0 N--CA 1.43 -1.463 0 O-C-N 119.151 -2.218 . . . . 2.35 105.825 165.331 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -68.17 -16.54 44.53 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 O-C-N 114.683 -3.377 . . . . 0.95 114.276 -175.253 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.4 m -91.15 12.03 21.35 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 114.045 -5.409 . . . . 1.45 113.378 175.836 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -88.54 144.86 26.06 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 113.31 -3.356 . . . . 1.69 108.463 179.707 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.278 53.7 p -71.28 153.24 42.55 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.473 1.909 . . . . 0.75 109.758 -179.945 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.6 mm -54.09 -40.58 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 118.403 -2.685 . . . . 0.73 114.598 168.645 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -42.59 -46.29 4.88 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 117.675 2.472 . . . . 1.62 117.675 164.983 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.61 -46.03 84.38 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 111.625 -2.534 . . . . 2.13 112.478 178.151 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.6 t -59.01 -44.32 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 C-N-CA 126.743 2.017 . . . . 0.62 106.155 178.034 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.254 84.2 mttt -60.8 -42.61 97.97 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 116.203 -4.061 . . . . 1.22 114.124 177.473 . . . . . . . . 3 2 . 1 . 048 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.34 -20.68 62.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.448 -3.283 . . . . 0.51 116.379 175.091 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -72.68 -45.24 59.83 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.095 1.758 . . . . 1.44 112.359 170.442 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -48.69 -43.91 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.532 1.533 . . . . 1.32 112.756 163.264 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -66.05 -43.38 87.65 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.855 -3.653 . . . . 1.7 112.622 -179.537 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -53.77 -49.59 67.91 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.323 1.449 . . . . 1.55 110.339 168.26 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -80.97 -54.79 5.27 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.071 -2.893 . . . . 2.62 112.627 -174.815 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -99.62 -26.62 14.02 Favored 'General case' 0 N--CA 1.431 -1.401 1 O-C-N 112.694 -6.254 . . . . 1.48 109.03 -168.309 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.2 17.4 40.23 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 117.918 -2.989 . . . . 1.12 115.158 179.929 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.8 mt -84.83 123.28 74.17 Favored Pre-proline 0 N--CA 1.43 -1.471 0 CA-C-O 113.678 -3.058 . . . . 1.55 107.972 -177.404 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -69.81 144.4 53.61 Favored 'Trans proline' 0 N--CA 1.433 -2.037 1 CA-C-N 129.548 4.446 . . . . 1.02 114.205 -178.142 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_exo -62.08 -20.05 68.42 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 N-CA-C 121.185 3.494 . . . . 1.25 121.185 -165.425 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -66.79 -28.17 68.17 Favored 'General case' 0 N--CA 1.429 -1.49 1 O-C-N 129.998 4.561 . . . . 2.25 111.773 173.542 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -85.62 -24.59 27.05 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 116.296 -1.812 . . . . 2.02 110.457 -176.412 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.251 60.1 mt-30 -79.49 129.8 34.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 127.899 3.249 . . . . 0.69 110.959 -169.107 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -115.1 129.87 56.79 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.457 -2.053 . . . . 2.78 105.457 168.993 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.3 mt -114.1 126.96 55.68 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.139 -2.85 . . . . 1.17 111.093 179.647 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 59.8 mt -117.73 124.23 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-O 126.969 3.271 . . . . 1.38 111.245 -175.47 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -135.66 139.3 43.63 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 115.965 -4.21 . . . . 1.5 109.049 172.192 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.362 . . 58.68 25.21 13.05 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 123.779 2.991 . . . . 1.21 115.673 173.469 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.11 2.92 90.7 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 117.077 1.591 . . . . 1.3 117.077 -177.055 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -113.26 157.21 22.05 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.382 2.273 . . . . 2.55 115.61 176.773 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -97.54 139.66 33.12 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.431 -2.668 . . . . 2.48 109.674 173.079 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.3 mt -102.2 120.66 40.82 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.978 -2.951 . . . . 0.9 111.329 -170.362 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -67.28 148.01 52.25 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.191 1.552 . . . . 1.94 115.191 175.283 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.65 -47.11 76.67 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 120.75 3.611 . . . . 1.56 120.75 -174.37 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.39 18.01 21.03 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 115.372 -2.904 . . . . 0.97 118.766 173.684 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -102.79 156.74 17.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.77 2.785 . . . . 2.49 110.974 171.643 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 39.1 p -88.55 169.65 11.55 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 123.329 1.538 . . . . 0.76 115.008 172.817 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.333 77.3 mt -69.22 -23.96 63.95 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 116.011 -4.181 . . . . 1.05 110.809 170.713 . . . . . . . . 3 2 . 1 . 048 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -65.72 -36.4 83.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.8 2.44 . . . . 1.19 115.489 171.806 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -65.41 -38.59 90.38 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.698 1.599 . . . . 1.9 113.911 173.881 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -78.9 -25.28 43.79 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 115.328 -2.272 . . . . 0.89 113.901 175.323 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.279 1.9 m-80 70.8 58.46 0.21 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.107 1.763 . . . . 1.84 109.909 -171.299 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 mt -105.25 117.12 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 105.022 -2.214 . . . . 0.82 105.022 174.034 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -84.83 -175.16 5.65 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 124.837 2.256 . . . . 2.16 111.374 -169.216 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.458 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 59.7 tttt -20.98 -87.87 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.422 1 C-N-CA 134.351 5.06 . . . . 2.12 118.208 169.086 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -103.17 69.3 1.01 Allowed 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 122.408 2.367 . . . . 1.71 116.226 -179.97 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.3 m -91.85 152.38 20.12 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 114.797 -1.092 . . . . 1.04 112.762 -179.99 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.5 m -113.52 115.69 28.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.136 1.374 . . . . 0.79 109.851 174.024 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.3 mt -96.93 156.63 16.27 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.545 1.938 . . . . 1.4 110.83 -179.674 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.405 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 98.2 m-70 -110.9 129.65 55.81 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 100.991 -3.707 . . . . 1.51 100.991 -175.815 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.555 HD23 HG22 ' A' ' 7' ' ' THR . 29.0 tp -102.53 113.89 27.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 125.328 1.643 . . . . 1.14 108.441 178.509 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.96 148.79 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 125.497 2.57 . . . . 1.23 109.464 172.845 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.9 mt . . . . . 0 N--CA 1.43 -1.464 1 O-C-N 115.728 -4.358 . . . . 2.78 111.985 -177.708 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 ptt? . . . . . 0 CA--C 1.491 -1.316 0 N-CA-C 116.773 2.138 . . . . 1.1 116.773 . . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -87.62 121.17 29.72 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 122.566 2.439 . . . . 1.87 110.489 178.904 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 pt -108.42 153.09 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 127.699 2.4 . . . . 0.72 108.577 173.777 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -104.18 131.08 51.85 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.868 -1.16 . . . . 1.4 107.868 -179.744 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.5 t -121.01 121.47 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 104.481 -2.414 . . . . 0.58 104.481 168.054 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -100.25 128.18 46.37 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 126.632 1.973 . . . . 2.09 111.727 -176.971 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.353 30.5 p -77.41 -164.07 0.44 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.602 1.668 . . . . 0.99 114.42 179.201 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.308 10.3 mt -90.97 -40.6 11.59 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.704 -1.872 . . . . 2.53 112.911 169.159 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.0 p -64.75 -37.09 86.42 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.548 -2.595 . . . . 2.08 107.616 -176.409 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.35 51.97 0.31 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 128.067 2.746 . . . . 1.31 111.312 175.92 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -114.1 130.27 56.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 101.972 -3.344 . . . . 1.4 101.972 177.425 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.3 m -102.67 103.76 14.05 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 118.016 -2.927 . . . . 0.78 110.399 177.146 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.81 136.51 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 118.755 -2.465 . . . . 1.55 108.418 179.541 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.7 m -103.29 111.93 24.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 118.733 -0.651 . . . . 1.08 109.265 179.602 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.38 142.23 28.01 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 127.992 3.307 . . . . 1.55 109.253 -178.97 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -105.81 116.28 31.67 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 123.395 1.569 . . . . 1.95 113.044 164.407 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.78 179.46 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.039 -1.437 . . . . 0.96 109.635 -178.808 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 89.8 mt-10 -115.89 163.35 21.46 Favored Pre-proline 0 N--CA 1.432 -1.373 0 O-C-N 117.1 -3.5 . . . . 2.35 107.888 164.189 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 56.1 Cg_exo -70.51 -14.46 33.73 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 C-N-CA 122.603 2.202 . . . . 0.95 112.444 -177.688 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.0 p -90.6 -0.99 57.88 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.165 2.186 . . . . 1.45 112.675 179.335 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -75.89 137.51 40.46 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.602 -1.936 . . . . 1.69 112.321 174.284 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 17.2 p -78.87 170.84 16.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.902 1.81 . . . . 0.75 111.625 174.297 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.284 3.5 mp -64.43 -41.07 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.267 -3.396 . . . . 0.73 112.721 168.106 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -43.5 -50.97 6.96 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 117.133 2.271 . . . . 1.62 117.133 163.694 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -67.01 -34.58 78.04 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.234 -2.166 . . . . 2.13 110.743 179.11 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.25 -42.1 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 118.253 2.686 . . . . 0.62 118.253 170.548 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.413 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 40.1 mtmt -71.86 -34.96 69.65 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 117.621 -3.175 . . . . 1.22 117.091 174.337 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.39 -28.38 63.99 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.733 2.413 . . . . 0.51 113.116 179.254 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -71.53 -37.89 71.11 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.689 2.395 . . . . 1.44 110.345 168.616 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.1 mt -68.31 -38.81 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 125.282 1.433 . . . . 1.32 107.996 175.872 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.342 40.3 tt0 -56.44 -41.8 77.04 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 128.788 2.835 . . . . 1.7 114.057 171.035 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -60.51 -41.73 94.95 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 118.236 2.68 . . . . 1.55 118.236 162.013 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -76.28 -52.4 10.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.719 -3.113 . . . . 2.62 116.431 -173.748 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -100.31 -26.77 13.79 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.714 2.406 . . . . 1.48 111.152 -168.585 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.75 13.88 56.04 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 118.12 -2.862 . . . . 1.12 117.289 176.048 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.9 mt -98.7 117.86 63.89 Favored Pre-proline 0 N--CA 1.43 -1.431 0 C-N-CA 127.439 2.295 . . . . 1.55 110.094 -170.799 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.39 152.71 70.94 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 CA-C-N 125.273 2.919 . . . . 1.02 116.932 -178.593 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -81.8 8.73 4.28 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 CA-C-O 113.582 -2.757 . . . . 1.25 107.919 -165.808 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -73.37 -44.13 59.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 125.272 3.669 . . . . 2.25 113.167 168.939 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -72.61 -26.36 61.66 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.783 2.833 . . . . 2.02 107.926 -172.466 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.413 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 73.3 mt-30 -87.25 133.18 33.7 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 123.455 0.702 . . . . 0.69 111.518 -165.932 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -124.6 146.89 48.81 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.182 2.593 . . . . 2.78 105.167 166.01 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 69' ' ' LEU . 32.5 mt -129.33 128.06 42.36 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 129.168 2.987 . . . . 1.17 105.933 -177.709 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -121.01 115.66 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 105.339 -2.097 . . . . 1.38 105.339 -178.165 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.414 ' HB2' HD22 ' A' ' 67' ' ' LEU 0.262 23.8 t80 -101.45 117.37 34.8 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.736 -1.852 . . . . 1.5 106.397 171.127 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.54 -46.31 0.62 Allowed 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.45 2.7 . . . . 1.21 114.806 -177.086 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.04 -32.81 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 126.938 2.209 . . . . 1.3 110.186 -171.712 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.27 52.8 mttm -73.29 125.96 29.01 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 126.657 2.034 . . . . 2.55 114.685 175.272 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -82.79 136.36 34.69 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 128.382 3.944 . . . . 2.48 112.825 172.309 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.4 mt -99.89 132.53 45.19 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.125 -2.86 . . . . 0.9 111.628 -165.171 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -79.17 141.28 37.35 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 122.175 0.988 . . . . 1.94 112.426 174.728 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.82 -57.74 8.45 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 126.031 2.824 . . . . 1.56 116.273 -174.135 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.43 16.43 13.84 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 122.6 3.8 . . . . 0.97 122.6 174.502 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 -85.41 163.87 18.25 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.8 1.8 . . . . 2.49 111.14 161.17 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.7 p -89.66 169.66 11.13 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 115.365 1.617 . . . . 0.76 115.365 165.287 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.491 ' HA ' HD12 ' A' ' 61' ' ' ILE . 58.5 mt -64.6 -47.8 77.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 129.086 2.954 . . . . 1.05 108.666 172.147 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.7 m -57.65 -37.06 72.72 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.038 -2.289 . . . . 1.19 114.481 175.675 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -62.79 -54.37 39.99 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 129.764 3.226 . . . . 1.9 115.913 175.365 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -64.42 -12.38 42.65 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.564 -2.16 . . . . 0.89 116.294 169.404 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.2 m120 69.67 56.24 0.35 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 126.615 2.447 . . . . 1.84 113.175 -179.583 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 56' ' ' LEU . 65.9 mt -95.66 128.44 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 128.885 2.874 . . . . 0.82 106.433 -176.731 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -75.76 159.42 31.07 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 125.708 1.603 . . . . 2.16 109.875 -171.943 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -52.27 -35.26 49.57 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 120.448 3.499 . . . . 2.12 120.448 167.519 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -128.39 86.44 2.46 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 130.086 4.616 . . . . 1.71 105.011 174.437 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.44 172.76 11.2 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 117.895 -1.05 . . . . 1.04 110.997 -176.697 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.4 m -130.48 125.79 35.27 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 117.807 -1.092 . . . . 0.79 108.727 176.381 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.414 HD22 ' HB2' ' A' ' 45' ' ' PHE . 15.0 mt -104.12 145.64 29.89 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 128.773 2.829 . . . . 1.4 111.671 170.492 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -106.15 122.13 45.56 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.171 -1.58 . . . . 1.51 111.416 -172.277 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 43' ' ' LEU . 57.2 tp -90.22 118.69 29.93 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.208 -1.775 . . . . 1.14 106.208 -173.574 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.5 t -119.29 148.9 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 103.69 -2.707 . . . . 1.23 103.69 173.722 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 N--CA 1.431 -1.422 0 O-C-N 125.933 2.02 . . . . 2.78 108.401 -175.459 . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.368 0 CA-C-O 125.902 2.763 . . . . 1.1 115.991 . . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -82.21 99.19 9.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.174 -3.454 . . . . 1.87 107.851 172.029 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -92.92 134.42 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 120.7 -1.25 . . . . 0.72 113.827 168.944 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -94.77 109.45 21.41 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 129.554 3.142 . . . . 1.4 111.328 -176.497 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 t -90.18 102.54 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 123.747 0.819 . . . . 0.58 111.963 173.352 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -75.87 140.57 42.28 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.137 2.399 . . . . 2.09 108.838 172.869 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 p -108.94 162.39 14.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.809 -1.807 . . . . 0.99 108.424 176.786 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.486 HD11 HG13 ' A' ' 70' ' ' VAL . 5.2 mt -69.63 -32.76 71.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 128.278 3.894 . . . . 2.53 112.531 177.951 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.0 p -70.86 -35.73 72.52 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 130.405 3.482 . . . . 2.08 115.975 -174.707 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.58 15.66 0.95 Allowed Glycine 0 N--CA 1.431 -1.692 0 CA-C-O 116.954 -2.025 . . . . 1.31 117.263 170.468 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -116.87 172.28 7.36 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 120.333 2.066 . . . . 1.4 110.141 -178.26 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.4 m -123.87 106.6 10.58 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 128.134 2.574 . . . . 0.78 113.392 177.259 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -90.58 107.65 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 117.272 -1.347 . . . . 1.55 109.878 178.731 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.3 m -98.63 101.02 12.32 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.852 2.739 . . . . 1.08 106.907 -175.374 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.2 mt -102.15 141.62 34.7 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.284 -1.78 . . . . 1.55 111.658 -179.149 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -89.09 115.96 27.01 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.918 2.192 . . . . 1.95 116.918 163.599 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.407 HG12 ' HE3' ' A' ' 29' ' ' LYS . 15.1 m -127.32 170.26 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 128.79 2.836 . . . . 0.96 110.274 176.959 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -124.17 165.32 24.78 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 127.355 2.262 . . . . 2.35 109.527 167.417 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -69.1 -28.73 28.06 Favored 'Trans proline' 0 N--CA 1.434 -2.012 1 O-C-N 113.487 -4.007 . . . . 0.95 113.468 -168.062 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.7 m -83.93 6.07 23.1 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 114.565 -2.854 . . . . 1.45 111.2 -177.692 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -72.86 142.67 47.96 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.405 2.526 . . . . 1.69 108.168 173.432 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 38.2 p -84.41 164.83 18.65 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.668 -2.52 . . . . 0.75 109.249 -178.619 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.335 1.4 mp -70.25 -29.4 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.192 -2.193 . . . . 0.73 112.128 176.718 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -53.31 -46.68 69.52 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.797 -1.19 . . . . 1.62 113.536 165.649 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -62.05 -38.41 88.66 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 116.875 2.176 . . . . 2.13 116.875 177.496 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.1 -46.73 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 131.163 3.785 . . . . 0.62 111.294 173.028 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -65.63 -35.86 82.02 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.282 1.433 . . . . 1.22 111.127 179.043 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.24 74.7 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 115.739 -2.077 . . . . 0.51 113.775 174.446 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.407 ' HE3' HG12 ' A' ' 17' ' ' VAL . 25.7 mttm -72.79 -20.49 61.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.442 2.756 . . . . 1.44 118.442 175.327 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.0 mt -79.57 -34.13 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.98 2.112 . . . . 1.32 111.475 173.44 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -53.79 -41.88 67.71 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.494 -2.629 . . . . 1.7 112.687 175.09 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -67.49 -55.45 13.5 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.164 2.283 . . . . 1.55 117.164 170.028 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -66.46 -71.71 0.19 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.152 -2.218 . . . . 2.62 112.743 -174.461 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -74.19 -38.23 63.7 Favored 'General case' 0 N--CA 1.428 -1.527 0 O-C-N 118.095 -2.878 . . . . 1.48 113.535 -174.734 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.63 32.69 7.13 Favored Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 126.031 3.017 . . . . 1.12 113.267 -179.372 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.4 mt -101.11 125.14 39.1 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-N 111.144 -2.528 . . . . 1.55 107.812 -179.916 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -66.51 163.5 32.34 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 CA-C-O 112.374 -3.261 . . . . 1.02 114.773 -178.735 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -77.7 -16.52 14.7 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 CA-C-N 122.759 2.021 . . . . 1.25 113.444 -177.941 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -68.14 -35.83 78.71 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.77 -2.456 . . . . 2.25 109.935 168.54 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -76.82 -16.79 59.34 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.165 1.386 . . . . 2.02 114.62 -178.214 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -93.31 120.88 34.1 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.635 -3.79 . . . . 0.69 110.161 -173.31 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -103.58 116.27 32.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.503 -2.776 . . . . 2.78 103.503 167.842 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.5 mt -104.98 112.51 25.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 102.159 -3.274 . . . . 1.17 102.159 177.807 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.6 mm -103.23 137.39 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 105.45 -2.055 . . . . 1.38 105.45 177.379 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -129.33 109.34 11.02 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 103.749 -2.686 . . . . 1.5 103.749 176.855 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.402 . . 74.71 -86.58 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.144 -2.223 . . . . 1.21 112.37 177.855 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.28 1.09 1.85 Allowed Glycine 0 N--CA 1.43 -1.765 0 O-C-N 118.929 -2.357 . . . . 1.3 113.914 179.8 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -115.39 141.58 47.85 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 109.468 -0.567 . . . . 2.55 109.468 -178.707 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -86.06 134.25 33.84 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.742 2.417 . . . . 2.48 109.335 173.002 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.7 mt -85.14 121.81 28.43 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.63 2.826 . . . . 0.9 118.63 -179.601 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -81.5 142.19 33.13 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 116.336 1.976 . . . . 1.94 116.336 173.884 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.28 -54.53 19.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.224 1.409 . . . . 1.56 114.579 -167.81 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.0 15.89 2.96 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 120.043 2.777 . . . . 0.97 120.043 172.851 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.498 HH21 ' CG ' ' A' ' 58' ' ' ASP . 79.0 mtp180 -102.83 156.4 17.68 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 121.225 2.512 . . . . 2.49 107.772 165.722 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 16.7 p -82.59 161.73 22.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.321 2.249 . . . . 0.76 114.462 175.874 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -65.48 -28.72 69.41 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.403 2.001 . . . . 1.05 116.403 167.216 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.0 p -74.44 -21.92 59.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 117.08 2.252 . . . . 1.19 117.08 173.052 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.498 ' CG ' HH21 ' A' ' 54' ' ' ARG . 48.6 t0 -67.26 -40.97 86.28 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 118.296 -0.859 . . . . 1.9 110.999 172.346 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -77.53 -17.77 57.62 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 114.911 -2.471 . . . . 0.89 115.17 169.286 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 73.34 34.55 0.99 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.497 2.57 . . . . 1.84 116.367 -179.997 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.5 mt -65.38 124.58 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 116.384 -3.947 . . . . 0.82 115.528 179.618 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -61.43 164.55 5.57 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 119.987 3.328 . . . . 2.16 119.987 -178.082 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -60.08 -61.16 2.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.698 -3.126 . . . . 2.12 110.421 174.178 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -93.35 81.28 4.42 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 116.521 -2.071 . . . . 1.71 113.579 172.784 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.282 19.1 m -108.83 139.72 43.27 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 118.962 2.949 . . . . 1.04 118.962 -178.835 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.2 m -115.08 130.01 56.83 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.164 -1.421 . . . . 0.79 107.164 178.641 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -115.17 168.72 9.69 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 116.513 -1.708 . . . . 1.4 111.245 -179.345 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -122.88 122.84 39.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.29 1.436 . . . . 1.51 112.92 -179.22 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 tp -94.77 101.21 13.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.243 -1.536 . . . . 1.14 111.77 177.34 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.486 HG13 HD11 ' A' ' 8' ' ' LEU . 2.8 t -88.45 128.92 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 104.344 -2.465 . . . . 1.23 104.344 173.217 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.8 tp . . . . . 0 N--CA 1.43 -1.434 0 CA-C-O 115.585 -2.15 . . . . 2.78 113.074 175.185 . . . . . . . . 0 0 . 1 . 051 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 ptt? . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 123.773 1.749 . . . . 1.1 110.914 . . . . . . . . . 0 0 . 1 . 051 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -88.11 107.24 18.66 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 113.773 -5.579 . . . . 1.87 115.316 -178.687 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.3 pt -111.83 164.28 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 117.743 -3.098 . . . . 0.72 109.257 178.564 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -120.39 125.89 49.12 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 116.766 -3.709 . . . . 1.4 112.128 178.703 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 t -109.78 111.4 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 1 O-C-N 113.228 -5.92 . . . . 0.58 109.116 167.686 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -71.68 140.4 49.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.268 2.937 . . . . 2.09 111.124 175.097 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.1 p -87.93 177.75 6.88 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 113.25 -5.906 . . . . 0.99 110.769 169.744 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 tp -79.49 -51.28 9.54 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.334 -1.478 . . . . 2.53 108.422 179.631 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.1 p -65.7 -58.02 6.68 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.758 2.133 . . . . 2.08 116.758 -174.385 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.43 39.99 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.67 0 CA-C-O 115.054 -3.081 . . . . 1.31 110.546 -179.918 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -135.94 156.72 48.34 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 124.192 3.996 . . . . 1.4 110.571 -175.092 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.2 m -127.29 111.51 14.0 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 130.346 3.458 . . . . 0.78 107.514 177.814 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mt -88.28 118.92 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 123.924 3.056 . . . . 1.55 104.566 -177.94 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.9 m -98.73 122.09 41.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.224 -1.398 . . . . 1.08 107.224 178.229 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.8 mt -123.93 154.28 39.98 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 113.534 0.938 . . . . 1.55 113.534 -176.461 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -110.01 111.57 23.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 104.449 -2.426 . . . . 1.95 104.449 171.287 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.25 170.31 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 C-N-CA 127.443 2.297 . . . . 0.96 106.961 -179.91 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -117.97 156.59 49.99 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 105.209 -2.145 . . . . 2.35 105.209 167.035 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.421 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 18.4 Cg_endo -68.49 -16.28 42.77 Favored 'Trans proline' 0 C--N 1.299 -2.069 0 N-CA-C 116.386 1.648 . . . . 0.95 116.386 -177.786 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.2 m -85.02 -11.51 55.24 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-O 115.731 -2.08 . . . . 1.45 110.763 179.699 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.07 139.51 54.83 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 126.262 1.825 . . . . 1.69 109.691 173.379 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.36 35.8 p -71.25 150.89 44.8 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 128.552 2.741 . . . . 0.75 110.021 176.091 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 mt -62.1 -35.1 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 104.869 -2.271 . . . . 0.73 104.869 178.795 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.291 30.1 tt0 -52.95 -46.39 68.15 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 116.262 -4.024 . . . . 1.62 118.548 165.812 . . . . . . . . 3 2 . 1 . 051 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.338 83.9 m-20 -61.77 -35.62 78.67 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.439 1.496 . . . . 2.13 113.95 173.613 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.5 t -68.94 -36.21 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 123.482 1.611 . . . . 0.62 112.01 175.101 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -59.04 -30.44 68.04 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 119.125 -2.234 . . . . 1.22 115.252 163.84 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.21 -38.6 63.54 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 114.634 -5.042 . . . . 0.51 111.591 172.62 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.277 12.4 ttmm -57.32 -39.37 75.69 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.092 -2.88 . . . . 1.44 116.064 166.751 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.0 mt -57.34 -39.96 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 125.132 3.606 . . . . 1.32 114.57 166.945 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 37' ' ' PRO . 21.1 tt0 -66.85 -39.9 87.75 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.898 -1.751 . . . . 1.7 111.315 177.257 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -52.95 -43.51 66.38 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.579 2.066 . . . . 1.55 116.579 172.292 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -87.02 -47.57 8.83 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.664 -1.273 . . . . 2.62 113.289 -175.801 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -99.97 -55.68 2.57 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 116.941 -1.504 . . . . 1.48 107.214 -167.259 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.36 52.26 0.83 Allowed Glycine 0 N--CA 1.431 -1.695 0 CA-C-N 120.719 1.6 . . . . 1.12 112.607 -176.479 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.4 mt -130.74 126.29 21.79 Favored Pre-proline 0 N--CA 1.429 -1.48 0 N-CA-C 101.4 -3.556 . . . . 1.55 101.4 177.817 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 0.5 OUTLIER -60.8 140.75 92.27 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 CA-C-O 111.082 -3.799 . . . . 1.02 111.648 -177.698 . . . . . . . . 3 3 . 1 . 051 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -55.05 -23.8 37.17 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-N 124.925 2.795 . . . . 1.25 117.929 175.416 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -68.89 -23.13 64.16 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.309 1.226 . . . . 2.25 114.309 173.849 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -81.74 -20.96 38.23 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.877 1.323 . . . . 2.02 109.293 176.612 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -97.4 136.7 37.47 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.113 -2.867 . . . . 0.69 118.256 -173.849 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -123.77 108.09 12.14 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.185 -2.28 . . . . 2.78 111.533 173.595 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.406 ' HB3' HD12 ' A' ' 50' ' ' LEU . 16.5 mt -71.5 138.93 49.32 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 123.739 1.733 . . . . 1.17 112.053 176.903 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.316 47.0 mm -127.44 146.85 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 106.252 -1.759 . . . . 1.38 106.252 179.488 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -143.39 133.3 24.06 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.642 -1.911 . . . . 1.5 109.864 177.49 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.69 -83.91 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.412 2.285 . . . . 1.21 111.683 174.544 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -156.03 16.88 0.45 Allowed Glycine 0 N--CA 1.43 -1.759 0 O-C-N 125.647 1.842 . . . . 1.3 109.164 -178.215 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -126.7 167.0 16.33 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 126.077 2.846 . . . . 2.55 109.336 -177.984 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -93.0 162.68 13.95 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 114.607 -5.058 . . . . 2.48 105.874 170.521 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.406 HD12 ' HB3' ' A' ' 43' ' ' LEU . 98.0 mt -109.64 148.06 31.98 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.519 -3.238 . . . . 0.9 109.345 179.011 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -96.68 144.64 26.51 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.511 1.924 . . . . 1.94 110.909 171.681 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -85.88 -40.0 16.42 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 116.153 1.908 . . . . 1.56 116.153 -162.936 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.86 47.22 3.67 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-N 122.823 2.556 . . . . 0.97 113.657 171.505 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -131.84 164.28 26.4 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 104.175 -2.528 . . . . 2.49 104.175 170.353 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.363 20.4 p -90.93 174.74 7.27 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 118.717 -2.489 . . . . 0.76 115.147 -178.777 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 35.2 mt -73.04 -23.98 60.65 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.239 -1.538 . . . . 1.05 110.025 171.874 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -85.57 -41.12 15.55 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.69 1.367 . . . . 1.19 114.69 -177.27 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -53.05 -46.67 68.62 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.875 2.47 . . . . 1.9 111.815 168.881 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -75.06 -9.24 58.35 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 117.64 -3.162 . . . . 0.89 113.769 175.991 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.295 35.2 t-20 59.8 47.91 9.7 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 124.236 1.97 . . . . 1.84 114.896 -177.217 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.5 mm -74.75 130.91 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 128.102 2.561 . . . . 0.82 108.812 178.292 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -69.63 171.07 9.55 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.424 -3.298 . . . . 2.16 115.894 -176.691 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -57.36 -56.12 26.01 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 116.295 -4.003 . . . . 2.12 110.2 172.308 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -103.35 92.55 4.54 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.574 1.15 . . . . 1.71 109.389 171.733 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.3 t -115.14 144.69 43.28 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.644 2.09 . . . . 1.04 116.644 176.397 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.2 m -102.95 102.17 12.21 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.495 1.918 . . . . 0.79 110.875 179.695 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -106.69 172.88 6.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.893 -1.754 . . . . 1.4 109.304 178.292 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -123.7 137.35 54.72 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 118.151 2.648 . . . . 1.51 118.151 178.453 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.5 tp -95.64 118.69 32.8 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 112.744 -2.025 . . . . 1.14 111.282 177.064 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.2 t -122.53 121.67 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 125.862 1.665 . . . . 1.23 112.999 174.854 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 N--CA 1.431 -1.388 0 CA-C-O 126.974 3.273 . . . . 2.78 115.61 178.792 . . . . . . . . 0 0 . 1 . 052 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ttp . . . . . 0 CA--C 1.49 -1.335 0 N-CA-C 118.428 2.751 . . . . 1.1 118.428 . . . . . . . . . 0 0 . 1 . 052 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -75.05 124.49 27.08 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 115.078 1.51 . . . . 1.87 115.078 -177.991 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.1 pt -136.14 159.0 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 117.248 -3.408 . . . . 0.72 103.218 175.752 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -116.64 149.5 39.64 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 124.477 1.111 . . . . 1.4 108.607 176.65 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.71 113.31 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-N 111.298 -2.683 . . . . 0.58 107.854 170.458 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -101.68 132.03 47.6 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 103.516 -2.772 . . . . 2.09 103.516 -176.048 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.1 p -86.48 165.86 15.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.986 -3.571 . . . . 0.99 113.508 173.66 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.9 mt -81.95 -29.77 32.04 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.841 -2.412 . . . . 2.53 108.78 174.097 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.9 p -68.1 -48.24 66.03 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 125.185 1.553 . . . . 2.08 111.692 -174.85 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.34 44.63 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.772 0 CA-C-N 119.523 1.056 . . . . 1.31 114.815 168.014 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -143.43 147.17 34.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.684 2.183 . . . . 1.4 110.061 -162.53 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.3 m -112.84 135.04 54.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.48 -2.638 . . . . 0.78 105.038 171.427 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mt -111.57 107.54 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 126.585 1.954 . . . . 1.55 105.916 176.433 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.3 m -89.74 115.94 27.47 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.656 1.693 . . . . 1.08 108.789 -178.16 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.8 mt -115.31 154.99 28.13 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 125.421 2.534 . . . . 1.55 106.974 -170.348 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -112.06 117.68 33.33 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 115.382 -2.247 . . . . 1.95 108.044 166.191 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.413 HG12 ' HE3' ' A' ' 29' ' ' LYS . 23.0 m -129.73 177.47 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 101.859 -3.385 . . . . 0.96 101.859 -178.869 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -111.79 154.23 44.12 Favored Pre-proline 0 N--CA 1.43 -1.462 1 C-N-CA 133.196 4.598 . . . . 2.35 107.603 164.305 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -77.89 -5.46 15.3 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 125.078 3.852 . . . . 0.95 110.733 -172.404 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 m -101.57 3.25 39.83 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 123.529 1.633 . . . . 1.45 108.008 -175.53 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -81.91 149.84 28.04 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.394 1.257 . . . . 1.69 114.394 170.945 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 p -75.66 159.43 31.17 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 123.777 0.831 . . . . 0.75 111.075 -177.835 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.1 mm -67.65 -26.51 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.559 -1.338 . . . . 0.73 108.53 173.454 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -62.03 -34.61 76.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.143 1.792 . . . . 1.62 112.639 168.821 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -65.68 -40.8 92.72 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.748 1.619 . . . . 2.13 108.652 -179.08 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.7 t -64.8 -37.63 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-O 122.382 1.087 . . . . 0.62 113.278 175.947 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -59.97 -40.23 88.37 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 118.395 2.739 . . . . 1.22 118.395 166.292 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.56 -36.86 85.58 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.548 -1.97 . . . . 0.51 113.417 176.16 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.413 ' HE3' HG12 ' A' ' 17' ' ' VAL . 46.2 mttm -59.85 -48.01 83.41 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.577 -1.952 . . . . 1.44 114.805 170.628 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.8 mt -64.91 -32.81 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 119.22 -2.175 . . . . 1.32 112.976 172.029 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -62.98 -38.94 93.15 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.221 -1.55 . . . . 1.7 115.123 169.388 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -62.12 -44.06 97.47 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 123.423 1.582 . . . . 1.55 112.214 172.186 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -66.83 -55.79 13.26 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.572 -2.58 . . . . 2.62 116.002 178.555 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -100.03 -55.84 2.53 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.848 2.859 . . . . 1.48 108.952 -166.713 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.22 -9.56 9.51 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-O 123.443 1.579 . . . . 1.12 113.633 -176.154 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.9 mt -72.44 126.4 90.94 Favored Pre-proline 0 N--CA 1.43 -1.452 0 O-C-N 116.779 -3.777 . . . . 1.55 102.287 -175.635 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 72.6 Cg_endo -70.85 161.38 46.27 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.667 2.245 . . . . 1.02 112.511 175.105 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 20.4 Cg_exo -70.05 -12.17 31.84 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 C-N-CA 121.745 1.63 . . . . 1.25 113.477 -172.593 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -75.67 -27.08 58.17 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.422 2.058 . . . . 2.25 109.63 176.436 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -90.61 -20.07 22.98 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.091 -2.881 . . . . 2.02 108.022 -174.979 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -85.78 124.94 32.85 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.595 3.183 . . . . 0.69 119.595 178.911 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.4 ttm105 -109.31 118.71 37.4 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.467 -2.02 . . . . 2.78 110.538 171.654 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.267 66.9 mt -99.06 105.32 17.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 109.257 -0.645 . . . . 1.17 109.257 -178.944 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.554 HD12 HG21 ' A' ' 70' ' ' VAL . 40.7 mt -93.75 118.81 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-N 113.719 -1.582 . . . . 1.38 108.59 -179.343 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -138.54 138.26 37.83 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.158 -1.589 . . . . 1.5 110.772 173.865 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.16 41.61 26.86 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.053 2.941 . . . . 1.21 113.527 173.417 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.63 -18.01 22.21 Favored Glycine 0 N--CA 1.429 -1.789 1 CA-C-O 112.334 -4.592 . . . . 1.3 113.16 -179.832 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 172.3 7.3 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 123.534 3.667 . . . . 2.55 113.595 -178.544 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -104.57 134.84 47.06 Favored 'General case' 0 N--CA 1.431 -1.401 1 O-C-N 115.353 -4.592 . . . . 2.48 109.03 173.863 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.4 mt -76.3 155.05 34.59 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 123.842 1.782 . . . . 0.9 114.737 -173.661 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -98.85 141.99 30.94 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 124.78 2.229 . . . . 1.94 107.211 178.737 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -75.81 -41.93 51.34 Favored 'General case' 0 N--CA 1.43 -1.454 1 N-CA-C 124.093 4.849 . . . . 1.56 124.093 -167.018 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.04 0.5 89.02 Favored Glycine 0 N--CA 1.431 -1.665 0 O-C-N 116.563 -3.836 . . . . 0.97 110.856 170.232 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -71.55 151.22 44.03 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 122.465 3.132 . . . . 2.49 111.538 169.542 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.7 p -97.83 167.55 10.86 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.101 1.905 . . . . 0.76 111.684 -177.199 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.5 mt -69.37 -25.41 64.16 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.407 -3.308 . . . . 1.05 111.29 178.038 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.2 t -70.81 -39.56 73.01 Favored 'General case' 0 N--CA 1.431 -1.406 1 C-N-CA 132.845 4.458 . . . . 1.19 112.816 175.7 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -57.92 -34.61 70.05 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 124.858 2.266 . . . . 1.9 113.913 172.826 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -94.53 0.09 55.01 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 114.309 -5.244 . . . . 0.89 112.03 -178.208 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.0 m120 58.66 47.52 12.96 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 119.865 3.283 . . . . 1.84 119.865 -175.15 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.0 mt -83.21 105.91 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 126.336 1.854 . . . . 0.82 109.886 171.28 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -121.9 -48.23 2.14 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 124.213 1.958 . . . . 2.16 112.332 -179.246 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.2 mmtt -78.34 -173.95 3.52 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 112.739 -2.028 . . . . 2.12 115.728 176.907 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -71.44 69.79 0.6 Allowed 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 129.964 3.306 . . . . 1.71 112.796 177.267 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -90.59 158.4 16.99 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.511 3.124 . . . . 1.04 111.639 -175.364 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.8 m -118.66 118.36 31.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 104.496 -2.409 . . . . 0.79 104.496 -173.843 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.1 mt -94.57 148.61 22.08 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 103.33 -2.841 . . . . 1.4 103.33 172.105 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -108.63 112.87 25.44 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 126.032 2.825 . . . . 1.51 106.026 -176.489 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.0 tp -89.65 122.26 32.61 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.993 -3.567 . . . . 1.14 113.507 179.264 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.554 HG21 HD12 ' A' ' 44' ' ' ILE 0.33 3.2 t -125.52 145.85 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 114.23 -1.35 . . . . 1.23 108.148 -177.067 . . . . . . . . 3 3 . 1 . 052 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.8 tp . . . . . 0 N--CA 1.429 -1.491 0 C-N-CA 130.853 3.661 . . . . 2.78 106.567 -179.954 . . . . . . . . 0 0 . 1 . 053 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ptt? . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 123.816 1.77 . . . . 1.1 107.903 . . . . . . . . . 0 0 . 1 . 053 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -93.44 136.51 33.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 117.067 -3.521 . . . . 1.87 111.523 -179.252 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.2 pt -131.7 161.79 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 117.005 -3.559 . . . . 0.72 104.707 173.771 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -122.04 141.94 50.85 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.767 -1.561 . . . . 1.4 107.888 -170.615 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 t -117.21 120.66 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 103.311 -2.848 . . . . 0.58 103.311 175.748 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -95.81 130.38 42.76 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 119.067 -1.053 . . . . 2.09 108.28 175.409 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.9 p -84.2 -176.13 6.11 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.708 -2.495 . . . . 0.99 115.199 176.788 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mt -68.55 -41.16 80.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 119.805 1.184 . . . . 2.53 109.328 172.086 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -72.59 -13.92 61.5 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 127.972 2.509 . . . . 2.08 107.824 -178.764 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.28 30.53 9.17 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 120.734 1.606 . . . . 1.31 113.577 175.857 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -95.71 134.1 39.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 117.908 -3.113 . . . . 1.4 107.286 -171.412 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.1 m -86.66 90.45 8.27 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 118.537 2.791 . . . . 0.78 118.537 175.449 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.7 mm -79.77 112.01 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 126.977 2.673 . . . . 1.55 109.542 176.204 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.5 m -103.67 113.83 27.65 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 123.279 2.763 . . . . 1.08 109.854 179.788 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -106.63 143.39 34.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.137 -1.602 . . . . 1.55 109.325 -179.511 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -93.3 123.89 36.9 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 104.037 -2.579 . . . . 1.95 104.037 170.246 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 m -133.76 160.44 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-O 115.471 -2.204 . . . . 0.96 108.468 -175.716 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -109.25 160.59 27.03 Favored Pre-proline 0 N--CA 1.43 -1.466 0 N-CA-C 104.899 -2.26 . . . . 2.35 104.899 160.259 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.74 -14.3 24.37 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 C-N-CA 121.788 1.659 . . . . 0.95 113.887 -179.0 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.1 p -75.59 -25.76 57.29 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 114.0 1.111 . . . . 1.45 114.0 173.481 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -62.67 160.53 13.96 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.976 -1.703 . . . . 1.69 114.549 -179.524 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.334 20.4 p -93.67 166.62 12.13 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.939 2.94 . . . . 0.75 118.939 -179.828 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.436 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 32.6 mm -71.3 -34.1 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.311 1.445 . . . . 0.73 111.152 177.386 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -60.04 -34.75 73.82 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.156 2.28 . . . . 1.62 117.156 165.999 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -71.69 -40.42 69.57 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.745 -1.847 . . . . 2.13 113.783 173.67 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.8 t -60.3 -38.81 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 123.709 0.804 . . . . 0.62 111.728 174.228 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -60.74 -40.51 92.69 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.545 -3.222 . . . . 1.22 114.725 164.618 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.75 -33.62 76.29 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.412 1.577 . . . . 0.51 113.634 173.413 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -56.67 -46.89 80.84 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.997 -2.939 . . . . 1.44 117.461 173.22 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.8 mt -67.85 -39.09 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 125.422 2.534 . . . . 1.32 114.333 173.826 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -57.63 -37.93 74.15 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.16 -4.713 . . . . 1.7 111.991 172.256 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -67.05 -35.98 81.04 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.349 2.976 . . . . 1.55 114.045 177.535 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -82.82 -44.49 15.44 Favored 'General case' 0 N--CA 1.429 -1.499 1 O-C-N 115.389 -4.57 . . . . 2.62 108.614 -176.554 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -125.92 -17.13 5.44 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 122.045 2.202 . . . . 1.48 113.186 -166.866 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.05 27.97 7.54 Favored Glycine 0 N--CA 1.43 -1.713 0 CA-C-N 120.861 1.664 . . . . 1.12 113.703 173.171 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.6 mt -99.81 120.4 57.31 Favored Pre-proline 0 N--CA 1.43 -1.467 0 O-C-N 120.014 -1.874 . . . . 1.55 109.104 -172.0 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.74 136.25 61.13 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 C-N-CA 124.899 3.733 . . . . 1.02 112.252 179.624 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -55.94 -15.46 13.58 Favored 'Trans proline' 0 C--N 1.3 -2.008 1 C-N-CA 126.399 4.733 . . . . 1.25 118.219 -177.181 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -76.07 -26.41 56.5 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.735 0.779 . . . . 2.25 111.527 173.748 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -85.2 -30.03 24.23 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.391 2.043 . . . . 2.02 107.63 -177.79 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -74.71 118.18 17.39 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.783 -4.323 . . . . 0.69 112.092 -176.807 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.1 ttm-85 -121.7 116.33 24.33 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.685 -1.969 . . . . 2.78 105.685 170.56 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.5 mt -99.52 130.38 45.77 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.183 -1.043 . . . . 1.17 108.183 -179.772 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.3 mt -113.71 119.54 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 126.818 2.047 . . . . 1.38 112.085 174.715 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.528 ' HB3' HD21 ' A' ' 50' ' ' LEU . 51.6 t80 -114.72 132.11 56.54 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 102.865 -3.013 . . . . 1.5 102.865 174.653 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.39 -94.43 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.417 1 C-N-CA 132.138 4.175 . . . . 1.21 110.079 177.015 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.66 8.61 7.75 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 129.003 3.192 . . . . 1.3 113.059 176.217 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -106.04 137.9 43.16 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 129.5 3.12 . . . . 2.55 111.179 -178.527 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -103.47 113.92 27.79 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 125.543 2.592 . . . . 2.48 106.927 169.863 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.528 HD21 ' HB3' ' A' ' 45' ' ' PHE . 13.6 mt -67.75 126.15 28.48 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.358 -3.338 . . . . 0.9 113.67 -170.707 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -91.06 134.29 34.63 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 114.645 1.35 . . . . 1.94 114.645 174.446 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.436 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 4.6 m-20 -47.1 -52.39 15.42 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 119.893 3.294 . . . . 1.56 119.893 -171.785 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.23 68.78 0.96 Allowed Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 113.962 -3.688 . . . . 0.97 111.668 174.86 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.253 84.1 mmt-85 -139.55 164.74 29.11 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 102.53 -3.137 . . . . 2.49 102.53 167.851 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.9 p -93.54 166.34 12.3 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.188 2.423 . . . . 0.76 108.086 173.828 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 mt -59.91 -40.33 88.44 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.444 2.698 . . . . 1.05 108.961 171.079 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.2 t -54.88 -48.61 72.75 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.285 2.234 . . . . 1.19 113.465 176.158 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -50.77 -34.1 25.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 118.595 2.813 . . . . 1.9 118.595 170.791 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -90.48 1.19 56.91 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.151 1.38 . . . . 0.89 110.253 178.203 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.257 4.3 m120 52.08 43.56 30.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.093 2.557 . . . . 1.84 115.157 -174.231 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.4 mt -91.49 115.01 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 127.177 3.37 . . . . 0.82 113.487 177.574 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -95.47 -177.02 3.94 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.213 -2.804 . . . . 2.16 114.805 -176.214 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -62.62 152.45 35.1 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 115.049 -4.782 . . . . 2.12 116.722 169.723 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.331 31.4 mt-10 66.47 18.36 10.81 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.112 -2.243 . . . . 1.71 113.203 174.371 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.3 p -89.96 165.12 14.26 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 127.382 3.468 . . . . 1.04 111.517 -172.87 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.1 m -120.92 108.74 14.26 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 113.337 -5.852 . . . . 0.79 113.177 -177.807 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.0 mt -81.75 137.51 35.34 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 124.905 1.282 . . . . 1.4 113.238 166.794 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -98.33 115.25 28.03 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.904 -0.497 . . . . 1.51 110.323 -177.826 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.9 tp -93.72 112.37 24.23 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 126.197 2.186 . . . . 1.14 106.874 -177.12 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.27 143.42 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 128.468 2.707 . . . . 1.23 104.204 174.972 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.6 mt . . . . . 0 N--CA 1.43 -1.446 0 O-C-N 121.112 -0.992 . . . . 2.78 108.658 175.367 . . . . . . . . 0 0 . 1 . 054 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 108.268 -1.012 . . . . 1.1 108.268 . . . . . . . . . 0 0 . 1 . 054 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -100.62 130.13 46.64 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 115.698 -2.096 . . . . 1.87 112.199 179.766 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.3 pt -129.03 159.33 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 120.099 1.318 . . . . 0.72 107.948 171.798 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -106.81 143.35 35.03 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.341 -1.754 . . . . 1.4 110.456 -176.516 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.2 t -119.35 120.04 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 129.43 3.092 . . . . 0.58 108.328 177.715 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.0 mttp -105.28 141.54 36.63 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 116.06 1.874 . . . . 2.09 116.06 169.87 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 p -95.76 177.72 5.69 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.513 2.325 . . . . 0.99 113.195 177.929 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.6 tp -57.74 -45.74 85.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.052 0.941 . . . . 2.53 113.279 178.278 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.2 p -78.01 -14.13 59.62 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.022 2.344 . . . . 2.08 112.879 -175.148 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.15 30.3 4.82 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 117.148 -3.47 . . . . 1.31 114.997 172.882 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -91.91 111.3 22.78 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.049 -1.575 . . . . 1.4 108.782 -176.317 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 m -83.8 115.24 22.14 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.92 -2.988 . . . . 0.78 109.152 177.201 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.44 HG21 HD13 ' A' ' 13' ' ' ILE . 46.9 mt -101.33 126.73 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 106.85 -1.537 . . . . 1.55 106.85 175.297 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.6 m -104.55 125.39 50.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 102.587 -3.116 . . . . 1.08 102.587 -170.338 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.2 mt -128.35 150.73 49.96 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 126.706 2.002 . . . . 1.55 109.239 -173.83 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -115.93 131.5 56.92 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.844 -0.616 . . . . 1.95 112.074 170.245 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.451 HG21 HD13 ' A' ' 56' ' ' LEU . 10.3 m -144.29 165.78 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 125.363 1.665 . . . . 0.96 108.919 -174.433 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -101.07 153.02 37.99 Favored Pre-proline 0 N--CA 1.43 -1.475 0 O-C-N 117.63 -3.169 . . . . 2.35 111.442 165.294 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -67.74 -13.52 38.95 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 CA-C-N 126.932 3.511 . . . . 0.95 115.795 -173.437 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.1 p -84.22 0.86 47.18 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 131.553 3.941 . . . . 1.45 116.059 171.494 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -76.46 136.45 39.4 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 118.892 -2.38 . . . . 1.69 113.407 170.558 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 p -70.13 152.96 43.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.526 -3.233 . . . . 0.75 108.125 179.419 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.6 mm -57.53 -23.1 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 118.039 2.607 . . . . 0.73 118.039 167.858 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -53.74 -43.65 69.3 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.267 -3.396 . . . . 1.62 115.346 159.443 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.4 m-20 -66.54 -28.94 68.94 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.526 2.584 . . . . 2.13 117.746 177.686 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.3 -41.7 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 113.809 -1.541 . . . . 0.62 111.258 171.017 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.68 -33.8 69.14 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 126.512 1.925 . . . . 1.22 112.628 174.615 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.52 -44.25 84.94 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.051 2.14 . . . . 0.51 111.497 170.02 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -61.49 -38.49 87.5 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.692 2.397 . . . . 1.44 110.937 172.222 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.7 mt -70.48 -37.32 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 O-C-N 117.954 -2.966 . . . . 1.32 115.205 170.336 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -52.92 -46.51 68.11 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.632 2.634 . . . . 1.7 110.991 172.388 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -55.03 -59.76 4.3 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 116.181 -4.075 . . . . 1.55 114.713 172.913 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -69.65 -60.23 2.45 Favored 'General case' 0 N--CA 1.43 -1.461 1 CA-C-O 129.579 4.514 . . . . 2.62 110.592 -174.635 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -80.36 -59.93 2.51 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.672 -4.392 . . . . 1.48 114.046 -172.96 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.57 -16.23 6.26 Favored Glycine 0 N--CA 1.431 -1.695 0 CA-C-O 115.427 -2.874 . . . . 1.12 109.105 -179.483 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.9 mt -60.92 122.09 66.64 Favored Pre-proline 0 N--CA 1.431 -1.38 0 C-N-CA 126.877 2.071 . . . . 1.55 112.826 -170.363 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.67 142.98 99.3 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 N-CA-C 119.236 2.744 . . . . 1.02 119.236 -176.33 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -80.49 -9.92 13.46 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 115.82 -2.779 . . . . 1.25 115.072 -166.604 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.55 -14.99 57.75 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.116 2.566 . . . . 2.25 113.469 167.635 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -94.68 -32.31 13.43 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.509 -3.245 . . . . 2.02 110.364 178.522 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -62.93 145.29 55.57 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 113.407 -1.724 . . . . 0.69 113.432 179.521 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.428 ' HB2' HG23 ' A' ' 70' ' ' VAL . 92.5 mtt180 -134.91 130.31 35.69 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.534 -2.604 . . . . 2.78 106.127 164.154 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.4 mt -100.4 131.55 46.26 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.944 2.307 . . . . 1.17 108.21 172.902 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.4 mt -120.24 139.98 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 112.081 -2.327 . . . . 1.38 107.111 176.056 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -135.28 134.43 39.93 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 102.447 -3.168 . . . . 1.5 102.447 168.187 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.83 -68.5 0.22 Allowed 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.196 2.903 . . . . 1.21 113.511 177.171 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.69 -47.26 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.763 0 CA-C-O 127.433 3.796 . . . . 1.3 113.702 -174.692 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -73.85 138.86 44.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 127.59 3.567 . . . . 2.55 113.549 -178.021 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -73.58 124.33 25.7 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.905 -2.997 . . . . 2.48 115.032 166.771 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.6 mt -85.51 161.58 19.3 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.955 -1.716 . . . . 0.9 115.1 -178.016 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.282 27.8 mt-10 -104.77 143.45 33.1 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 120.554 3.538 . . . . 1.94 120.554 174.084 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -67.23 -43.57 81.63 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 116.338 -3.976 . . . . 1.56 116.304 -170.182 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.98 15.91 0.65 Allowed Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 130.437 3.875 . . . . 0.97 114.86 173.947 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -120.71 170.93 8.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.13 1.965 . . . . 2.49 111.738 166.557 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.3 p -107.21 177.51 4.83 Favored 'General case' 0 N--CA 1.429 -1.514 1 CA-C-O 128.554 4.026 . . . . 0.76 111.687 176.374 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.451 HD13 HG21 ' A' ' 17' ' ' VAL . 30.7 mt -70.32 -31.75 69.2 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.444 -2.66 . . . . 1.05 108.329 176.377 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -66.7 -41.05 88.63 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.964 -2.335 . . . . 1.19 115.126 -177.823 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -49.61 -45.98 48.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.077 2.151 . . . . 1.9 110.907 173.638 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -85.25 -0.67 55.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.027 2.346 . . . . 0.89 116.272 -178.174 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 56.78 37.42 28.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.04 2.936 . . . . 1.84 115.921 -178.527 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.2 mt -70.39 116.53 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 C-N-CA 128.681 2.792 . . . . 0.82 111.564 173.769 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -89.98 178.01 6.32 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.055 2.142 . . . . 2.16 108.411 174.21 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -67.51 152.89 44.88 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.12 1.914 . . . . 2.12 112.623 177.519 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.268 51.4 mt-10 67.31 27.43 8.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.989 -1.069 . . . . 1.71 113.68 169.434 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.9 m -98.91 144.49 28.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.684 3.194 . . . . 1.04 108.196 -175.253 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.6 m -108.93 120.79 43.56 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.143 -2.848 . . . . 0.79 109.393 -172.29 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -93.07 162.91 13.85 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.416 -1.327 . . . . 1.4 107.416 177.692 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -119.77 132.83 55.73 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.149 1.38 . . . . 1.51 112.968 -179.601 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.0 tp -118.5 116.57 26.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.529 -1.982 . . . . 1.14 109.854 -174.854 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' A' ' 42' ' ' ARG . 3.2 m -117.66 170.36 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 123.351 1.548 . . . . 1.23 110.902 172.516 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.1 mt . . . . . 0 N--CA 1.431 -1.423 0 CA-C-O 124.029 1.871 . . . . 2.78 115.072 174.11 . . . . . . . . 0 0 . 1 . 055 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.49 -1.361 0 CA-C-O 123.375 1.559 . . . . 1.1 109.497 . . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -104.96 142.32 34.99 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.555 -1.341 . . . . 1.87 109.446 -172.335 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.0 pt -131.81 155.05 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 124.723 1.209 . . . . 0.72 107.997 174.557 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.271 64.2 m-85 -108.33 125.27 51.51 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 112.957 0.725 . . . . 1.4 112.957 177.8 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -105.67 122.77 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 119.03 0.832 . . . . 0.58 109.625 173.257 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -94.61 124.57 38.73 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 128.712 2.805 . . . . 2.09 109.707 175.913 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.8 p -77.56 -173.52 2.99 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 127.627 2.371 . . . . 0.99 105.583 -178.55 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.7 mt -59.86 -48.11 83.0 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 129.802 3.241 . . . . 2.53 117.859 169.564 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.1 p -79.36 -15.43 57.91 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.626 3.571 . . . . 2.08 110.627 -179.202 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.14 44.53 5.62 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 126.914 2.197 . . . . 1.31 114.031 176.067 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -95.4 151.52 19.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 104.697 -2.334 . . . . 1.4 104.697 174.788 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.2 m -101.21 112.36 24.83 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 125.764 1.915 . . . . 0.78 112.08 179.795 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 mm -94.76 124.62 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 103.018 -2.956 . . . . 1.55 103.018 172.032 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.7 m -106.44 115.41 30.16 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.337 -3.352 . . . . 1.08 114.678 -178.999 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.259 34.6 mt -112.71 135.5 53.38 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.87 -2.394 . . . . 1.55 110.895 -175.957 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -75.8 116.39 16.45 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.142 -1.429 . . . . 1.95 107.142 161.085 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -127.85 175.74 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.241 1.417 . . . . 0.96 109.76 174.339 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -118.23 156.71 50.4 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-O 124.614 2.15 . . . . 2.35 109.629 167.064 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -71.79 -20.14 26.55 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 O-C-N 113.246 -4.134 . . . . 0.95 111.767 -175.72 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 p -87.36 3.58 46.39 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 130.788 3.635 . . . . 1.45 115.831 175.732 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -83.63 149.21 26.68 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.497 -2.627 . . . . 1.69 106.168 177.36 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 44.2 p -90.8 168.21 11.9 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 118.006 -0.997 . . . . 0.75 108.464 -177.789 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.324 40.9 mm -65.78 -24.61 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 N-CA-C 114.494 1.294 . . . . 0.73 114.494 173.937 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -69.07 -30.41 68.73 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 113.772 -3.013 . . . . 1.62 116.278 163.62 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -76.37 -25.66 54.85 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.207 1.821 . . . . 2.13 108.602 170.687 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.7 -50.25 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 121.879 2.127 . . . . 0.62 114.565 170.822 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -65.72 -34.67 78.73 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 118.454 2.761 . . . . 1.22 118.454 179.75 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.05 -38.87 73.85 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 114.177 -2.821 . . . . 0.51 111.736 168.555 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -66.59 -35.72 80.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 120.709 1.595 . . . . 1.44 114.013 174.28 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 53.8 mt -73.58 -24.28 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 119.777 -1.827 . . . . 1.32 114.803 173.159 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -75.73 -29.98 59.08 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.076 1.762 . . . . 1.7 111.773 172.066 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -72.1 -46.27 57.36 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.468 1.127 . . . . 1.55 112.996 175.831 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -65.17 -75.44 0.09 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 126.176 1.791 . . . . 2.62 111.935 -178.913 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -86.91 -42.31 13.29 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.588 2.355 . . . . 1.48 114.813 -169.532 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.96 31.67 2.22 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 118.277 -1.916 . . . . 1.12 111.948 174.574 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 36' ' ' ILE . 26.8 mt -102.09 124.4 40.11 Favored Pre-proline 0 N--CA 1.43 -1.426 0 CA-C-O 114.6 -2.619 . . . . 1.55 113.436 -175.509 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -60.79 138.7 81.03 Favored 'Trans proline' 0 N--CA 1.433 -2.064 0 CA-C-O 114.05 -2.562 . . . . 1.02 114.38 -176.715 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -62.83 -29.17 76.34 Favored 'Trans proline' 0 N--CA 1.434 -2.009 1 C-N-CA 127.49 5.46 . . . . 1.25 114.273 -171.947 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -62.76 -28.95 70.33 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.849 -2.407 . . . . 2.25 112.056 173.057 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -76.36 -13.18 60.15 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 116.785 2.143 . . . . 2.02 116.785 179.092 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -95.39 117.18 29.89 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.013 -3.555 . . . . 0.69 115.26 -172.361 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -107.27 127.09 53.24 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 127.2 2.2 . . . . 2.78 107.946 169.343 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.284 65.6 mt -109.49 138.69 45.48 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 105.263 -2.125 . . . . 1.17 105.263 -175.788 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.7 mm -122.37 126.23 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 109.74 -3.391 . . . . 1.38 107.325 179.801 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.42 ' HB2' HD11 ' A' ' 50' ' ' LEU . 67.4 t80 -120.46 108.93 14.7 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.652 -1.981 . . . . 1.5 105.652 172.317 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.92 -73.22 0.09 Allowed 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 126.526 1.93 . . . . 1.21 109.106 -179.443 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.41 ' H ' ' H ' ' A' ' 48' ' ' LYS . . . -160.73 7.84 0.11 Allowed Glycine 0 N--CA 1.43 -1.709 0 CA-C-O 124.898 2.388 . . . . 1.3 114.915 -174.039 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.41 ' H ' ' H ' ' A' ' 47' ' ' GLY . 12.4 tppt? -105.78 128.61 53.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 111.585 -2.307 . . . . 2.55 105.842 177.311 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -79.47 138.89 37.72 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.176 -0.952 . . . . 2.48 109.573 170.499 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' A' ' 45' ' ' PHE . 21.3 mt -101.73 126.44 48.59 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 121.649 2.022 . . . . 0.9 111.967 -165.966 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -88.56 156.3 19.14 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.285 -1.746 . . . . 1.94 106.285 178.73 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -76.04 -40.2 53.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 118.748 2.869 . . . . 1.56 118.748 -168.613 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.25 22.85 9.11 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 117.798 -3.064 . . . . 0.97 112.868 177.559 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -108.13 164.37 12.36 Favored 'General case' 0 N--CA 1.431 -1.397 1 O-C-N 116.294 -4.062 . . . . 2.49 106.918 164.786 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 37.0 p -101.1 168.78 9.37 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.989 2.116 . . . . 0.76 111.662 179.129 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -58.5 -42.86 88.59 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 112.119 -2.31 . . . . 1.05 110.275 169.926 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.388 5.6 t -64.03 -33.39 75.64 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.499 1.954 . . . . 1.19 112.973 -179.013 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -61.18 -34.42 75.04 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 119.834 3.272 . . . . 1.9 119.834 175.016 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -90.74 10.72 24.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 111.957 -2.383 . . . . 0.89 114.169 174.934 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.279 46.7 m-80 65.09 21.45 12.21 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 113.379 -5.825 . . . . 1.84 115.263 -178.878 . . . . . . . . 3 2 . 1 . 055 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.0 mt -75.9 106.74 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 124.777 1.231 . . . . 0.82 112.298 -178.326 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -98.45 -164.91 1.18 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.264 2.226 . . . . 2.16 106.465 -169.655 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.264 44.8 mttp -72.25 141.21 48.94 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.641 -2.537 . . . . 2.12 110.867 173.826 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.254 31.9 mt-10 74.32 15.48 3.53 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 125.956 2.035 . . . . 1.71 112.872 172.192 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.32 50.1 m -84.16 145.79 28.2 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.162 -3.461 . . . . 1.04 110.819 -172.165 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.0 m -97.35 118.9 34.86 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.161 2.184 . . . . 0.79 106.14 -175.552 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.3 mp -107.06 145.51 32.31 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.225 2.61 . . . . 1.4 111.854 171.902 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -119.36 139.28 52.23 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.455 -2.054 . . . . 1.51 105.455 -174.989 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tt -107.67 124.48 50.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 113.82 -1.536 . . . . 1.14 107.979 -173.948 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.2 t -116.68 132.53 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 CA-C-O 129.171 4.32 . . . . 1.23 105.035 174.345 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.431 -1.423 0 O-C-N 116.633 -3.792 . . . . 2.78 108.994 175.746 . . . . . . . . 0 0 . 1 . 056 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 CA--C 1.49 -1.327 0 CA-C-O 122.367 1.08 . . . . 1.1 110.552 . . . . . . . . . 0 0 . 1 . 056 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -111.65 136.91 50.23 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 117.477 -1.249 . . . . 1.87 109.831 -169.467 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.437 HD12 HD13 ' A' ' 67' ' ' LEU . 5.6 pt -135.56 159.39 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 122.489 2.404 . . . . 0.72 105.806 171.526 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -109.49 145.1 36.81 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.372 2.269 . . . . 1.4 107.781 -173.616 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.3 t -124.64 132.53 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.206 -1.776 . . . . 0.58 106.206 168.613 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 mmtm -97.09 143.59 27.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 104.975 -2.231 . . . . 2.09 104.975 169.472 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.7 p -90.36 -165.04 1.26 Allowed 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 130.272 3.429 . . . . 0.99 111.192 176.128 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.353 0.6 OUTLIER -64.63 -46.98 80.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 130.298 3.439 . . . . 2.53 113.042 175.992 . . . . . . . . 3 3 . 1 . 056 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.3 p -92.84 -37.34 12.35 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 126.381 2.991 . . . . 2.08 115.634 -178.6 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.05 -2.52 1.01 Allowed Glycine 0 N--CA 1.43 -1.721 0 O-C-N 116.301 -3.999 . . . . 1.31 117.701 178.215 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -74.92 120.97 21.19 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 122.7 3.25 . . . . 1.4 105.022 -166.905 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.7 m -71.17 117.23 12.42 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 126.56 2.413 . . . . 0.78 113.91 176.591 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.3 mm -98.84 138.68 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 117.08 -1.848 . . . . 1.55 107.78 173.522 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.4 m -106.3 112.81 25.99 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.702 2.001 . . . . 1.08 111.911 179.692 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.7 mt -108.57 144.26 36.5 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 116.177 -4.077 . . . . 1.55 115.268 175.141 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -90.85 123.71 34.6 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.172 1.789 . . . . 1.95 107.85 166.858 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 m -138.53 154.0 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 121.605 0.717 . . . . 0.96 109.639 -179.165 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -101.55 162.36 20.69 Favored Pre-proline 0 N--CA 1.429 -1.489 0 CA-C-O 115.597 -2.144 . . . . 2.35 109.603 167.365 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -81.7 -8.05 12.43 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 125.846 3.124 . . . . 0.95 112.089 178.694 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 p -81.13 -15.68 55.18 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.613 -0.721 . . . . 1.45 111.902 176.165 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -61.77 143.71 55.85 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 124.964 2.316 . . . . 1.69 115.376 178.933 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 25.0 p -90.58 165.25 13.86 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 115.759 -4.338 . . . . 0.75 108.664 178.5 . . . . . . . . 3 3 . 1 . 056 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.5 mm -71.98 -22.03 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-O 122.76 1.266 . . . . 0.73 109.961 -178.933 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -61.48 -35.36 77.44 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.075 -2.891 . . . . 1.62 118.07 160.681 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -76.53 -30.87 57.33 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 116.83 -3.669 . . . . 2.13 111.697 172.634 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.98 -41.92 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 O-C-N 120.156 -1.59 . . . . 0.62 111.809 179.982 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -61.35 -41.3 96.82 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.118 -2.239 . . . . 1.22 111.783 176.888 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.71 -39.6 81.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 126.538 2.399 . . . . 0.51 111.731 178.871 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.265 51.8 mttm -57.82 -53.94 52.48 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.102 -2.248 . . . . 1.44 110.333 173.465 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.253 64.8 mt -52.15 -41.4 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 130.122 3.369 . . . . 1.32 109.241 178.309 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -66.52 -50.82 61.93 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 130.261 3.424 . . . . 1.7 111.372 174.975 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -49.28 -45.54 45.17 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 124.13 3.15 . . . . 1.55 114.009 169.423 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -75.46 -66.56 0.76 Allowed 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 127.607 2.363 . . . . 2.62 114.137 -177.52 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -96.47 -18.46 19.84 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 117.508 2.41 . . . . 1.48 117.508 -173.042 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.51 46.84 5.36 Favored Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 118.696 2.238 . . . . 1.12 118.696 -177.731 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.8 mt -119.14 129.09 25.58 Favored Pre-proline 0 N--CA 1.43 -1.465 0 CA-C-O 111.704 -3.998 . . . . 1.55 106.376 -174.14 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -64.1 152.14 82.34 Favored 'Trans proline' 0 N--CA 1.433 -2.059 0 CA-C-O 112.132 -3.362 . . . . 1.02 119.896 172.122 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -81.4 -23.53 5.01 Favored 'Trans proline' 0 N--CA 1.433 -2.046 0 CA-C-N 127.253 3.626 . . . . 1.25 112.466 -166.484 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -56.43 -31.67 64.15 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.448 2.699 . . . . 2.25 110.663 175.126 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -93.52 6.97 46.44 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 111.184 -2.735 . . . . 2.02 108.44 -170.09 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -122.11 126.67 48.88 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 122.536 2.426 . . . . 0.69 109.4 -174.285 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -109.47 150.27 28.36 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 116.856 -1.545 . . . . 2.78 110.117 158.975 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.4 mt -125.8 136.06 52.7 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 107.468 -1.308 . . . . 1.17 107.468 176.295 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.9 mm -112.43 124.44 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 128.054 2.541 . . . . 1.38 111.397 -178.787 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -114.31 128.09 56.18 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 122.517 2.417 . . . . 1.5 108.901 168.673 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.66 -85.06 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.56 1.544 . . . . 1.21 110.125 -171.574 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -164.19 43.55 0.31 Allowed Glycine 0 N--CA 1.429 -1.78 0 O-C-N 121.091 -1.006 . . . . 1.3 111.929 178.079 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -135.26 135.83 41.2 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.16 2.184 . . . . 2.55 110.253 -179.768 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -89.32 116.08 27.27 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 114.505 1.298 . . . . 2.48 114.505 175.886 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.5 mt -67.88 160.51 28.3 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.981 2.324 . . . . 0.9 113.308 -168.447 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -103.98 135.11 46.11 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.863 -2.426 . . . . 1.94 109.868 172.519 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.261 2.9 m-20 -56.17 -49.38 74.16 Favored 'General case' 0 N--CA 1.43 -1.439 1 C-N-CA 132.311 4.244 . . . . 1.56 113.528 -172.913 . . . . . . . . 3 2 . 1 . 056 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.2 50.63 2.76 Favored Glycine 0 N--CA 1.43 -1.767 0 N-CA-C 119.689 2.636 . . . . 0.97 119.689 171.226 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -124.03 164.1 20.06 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.233 1.968 . . . . 2.49 106.136 163.062 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 66.6 p -106.12 164.01 12.33 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.211 -2.268 . . . . 0.76 113.859 175.117 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.4 mt -50.08 -37.52 34.13 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.712 -3.742 . . . . 1.05 114.518 168.566 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -64.25 -26.33 68.45 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.257 2.317 . . . . 1.19 117.257 176.703 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -70.15 -51.4 31.62 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.387 1.475 . . . . 1.9 108.036 177.805 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -76.89 2.7 13.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.057 2.143 . . . . 0.89 113.05 179.753 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.508 1.1 m-80 60.42 39.62 18.28 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.334 1.646 . . . . 1.84 114.096 179.778 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.4 mt -90.85 118.87 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 126.054 2.835 . . . . 0.82 113.241 -177.267 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -101.5 -167.37 1.41 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.159 -3.463 . . . . 2.16 113.8 -177.068 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.256 13.7 ptmt -58.5 153.97 14.95 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.851 -2.405 . . . . 2.12 116.329 174.759 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 49.0 42.49 20.87 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 129.745 3.218 . . . . 1.71 113.741 173.149 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.6 m -92.47 142.72 27.1 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 130.749 3.619 . . . . 1.04 105.535 -179.095 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.2 m -104.73 117.41 34.02 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.142 -2.17 . . . . 0.79 105.142 -175.012 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.437 HD13 HD12 ' A' ' 3' ' ' ILE . 5.1 mp -98.34 162.91 12.93 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 131.521 3.928 . . . . 1.4 110.045 171.05 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -123.08 126.36 46.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.083 -3.511 . . . . 1.51 111.472 -178.939 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.4 tp -95.9 113.92 25.59 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 107.07 -1.455 . . . . 1.14 107.07 -176.415 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.0 t -104.58 143.66 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 101.197 -3.631 . . . . 1.23 101.197 176.526 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.4 mt . . . . . 0 N--CA 1.43 -1.446 0 C-N-CA 113.181 -3.408 . . . . 2.78 110.927 -179.925 . . . . . . . . 0 0 . 1 . 057 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 116.883 -1.532 . . . . 1.1 111.724 . . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -97.17 140.67 31.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 127.273 3.416 . . . . 1.87 109.416 -174.66 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.0 pt -123.44 160.73 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 124.814 2.245 . . . . 0.72 110.996 171.323 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -108.91 143.08 38.62 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.234 -4.041 . . . . 1.4 111.419 -179.265 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.42 HG21 HD11 ' A' ' 30' ' ' ILE . 2.8 t -110.91 123.79 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.243 -3.411 . . . . 0.58 108.043 174.199 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 11' ' ' LYS . 73.9 tttt -119.45 138.89 52.83 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.033 1.397 . . . . 2.09 108.563 -178.618 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.0 p -103.69 168.98 8.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.438 -1.414 . . . . 0.99 108.176 -178.067 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.2 tp -66.34 -42.46 88.11 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.955 1.302 . . . . 2.53 112.285 172.464 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.6 p -76.89 -18.52 58.27 Favored 'General case' 0 N--CA 1.43 -1.463 1 CA-C-O 128.968 4.223 . . . . 2.08 110.064 -171.35 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.15 26.95 1.28 Allowed Glycine 0 N--CA 1.43 -1.727 1 O-C-N 116.004 -4.185 . . . . 1.31 118.002 166.285 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 63.4 tttt -91.98 133.87 35.32 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 117.258 -1.353 . . . . 1.4 110.241 -179.814 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m -122.43 105.94 10.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 125.627 1.83 . . . . 0.78 115.762 168.966 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 pt -114.79 164.92 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 125.92 2.771 . . . . 1.55 105.191 179.778 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.7 m -112.37 135.18 53.37 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.875 -3.015 . . . . 1.08 112.544 -178.37 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.8 mt -115.78 154.74 29.09 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.888 -1.758 . . . . 1.55 109.887 172.393 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -112.73 120.52 41.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.333 -1.48 . . . . 1.95 110.864 167.273 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.4 m -125.28 175.11 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 124.354 2.026 . . . . 0.96 108.427 178.508 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -114.29 171.96 3.98 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 104.7 -2.333 . . . . 2.35 104.7 164.075 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -83.38 -9.51 10.29 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 N-CA-C 107.174 -1.895 . . . . 0.95 107.174 -176.314 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.4 m -95.82 6.35 49.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.608 1.963 . . . . 1.45 115.415 173.48 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -77.09 153.8 33.96 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 104.727 -2.323 . . . . 1.69 104.727 170.296 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.5 p -86.95 162.1 17.87 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 116.158 -4.089 . . . . 0.75 110.218 168.904 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.306 23.1 mm -65.97 -38.89 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 118.159 -2.838 . . . . 0.73 111.31 179.17 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -50.79 -38.12 46.38 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 127.182 3.373 . . . . 1.62 117.597 166.941 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -75.07 -26.38 59.31 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.519 3.128 . . . . 2.13 110.915 172.792 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.38 -34.33 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 123.334 2.788 . . . . 0.62 109.547 170.831 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -70.49 -36.52 73.88 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.528 -1.983 . . . . 1.22 113.838 175.982 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.84 76.91 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 115.724 1.75 . . . . 0.51 115.724 173.278 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -58.26 -37.36 74.8 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.981 2.113 . . . . 1.44 111.964 175.018 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 5' ' ' VAL . 94.3 mt -75.94 -29.12 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 1 O-C-N 115.676 -4.39 . . . . 1.32 110.357 174.717 . . . . . . . . 3 3 . 1 . 057 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -69.05 -42.3 76.46 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 116.797 -3.689 . . . . 1.7 115.155 168.885 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.337 23.2 t70 -55.03 -49.18 72.2 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.238 -2.164 . . . . 1.55 112.396 168.811 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -70.49 -69.04 0.38 Allowed 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.011 -1.681 . . . . 2.62 113.753 -177.388 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -91.44 -48.71 6.73 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 112.287 -2.233 . . . . 1.48 110.187 -167.387 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.1 32.63 3.21 Favored Glycine 0 N--CA 1.429 -1.773 0 CA-C-O 125.183 2.546 . . . . 1.12 114.837 -179.037 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.8 mt -92.65 129.22 41.14 Favored Pre-proline 0 N--CA 1.43 -1.444 0 N-CA-C 102.49 -3.152 . . . . 1.55 102.49 -177.222 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -76.74 139.37 19.86 Favored 'Trans proline' 0 N--CA 1.433 -2.053 0 CA-C-O 114.156 -2.518 . . . . 1.02 112.737 -178.954 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -68.57 0.04 5.31 Favored 'Trans proline' 0 N--CA 1.433 -2.058 1 C-N-CA 125.624 4.216 . . . . 1.25 112.014 -169.501 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -64.92 -42.81 94.4 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.806 1.289 . . . . 2.25 113.097 166.36 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -75.49 -27.07 58.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.132 2.396 . . . . 2.02 111.034 -176.243 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -81.88 122.26 27.51 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 119.995 3.331 . . . . 0.69 119.995 -169.088 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -116.41 136.68 52.78 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 131.242 3.817 . . . . 2.78 108.976 170.453 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.9 mt -120.13 113.58 20.68 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.425 -4.547 . . . . 1.17 113.513 178.392 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.1 mm -102.19 143.01 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 126.889 3.233 . . . . 1.38 105.765 173.425 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.446 ' HB3' HD21 ' A' ' 50' ' ' LEU . 59.1 t80 -132.66 125.3 30.02 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 115.3 -4.625 . . . . 1.5 110.111 162.866 . . . . . . . . 3 3 . 1 . 057 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.63 -95.15 0.05 OUTLIER 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 124.171 1.938 . . . . 1.21 112.615 -172.428 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.74 20.16 3.1 Favored Glycine 0 N--CA 1.43 -1.757 0 O-C-N 119.208 -2.182 . . . . 1.3 111.3 176.352 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -111.85 135.35 52.59 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 128.675 2.79 . . . . 2.55 109.887 175.752 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -86.76 101.01 12.91 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 129.667 3.187 . . . . 2.48 109.591 168.921 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.446 HD21 ' HB3' ' A' ' 45' ' ' PHE . 21.1 mt -72.11 122.08 20.36 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.397 2.679 . . . . 0.9 112.781 -169.194 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -75.11 133.55 41.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 116.414 2.005 . . . . 1.94 116.414 174.786 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -45.52 -55.1 6.59 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 131.252 3.821 . . . . 1.56 116.298 -174.484 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.68 9.61 58.73 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 118.171 2.028 . . . . 0.97 118.171 173.491 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -91.58 165.51 13.3 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 121.836 2.818 . . . . 2.49 109.496 164.712 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.268 30.3 p -94.02 177.64 5.91 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.785 -1.197 . . . . 0.76 113.059 178.411 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mt -75.03 -27.95 60.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.65 2.643 . . . . 1.05 115.289 171.635 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.4 t -68.07 -39.94 82.83 Favored 'General case' 0 N--CA 1.429 -1.481 1 C-N-CA 132.575 4.35 . . . . 1.19 117.13 175.588 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.288 2.5 m-20 -55.52 -46.91 76.96 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.741 2.816 . . . . 1.9 109.567 175.955 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -83.34 -1.07 52.43 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 126.549 1.94 . . . . 0.89 116.105 176.155 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 63.26 47.34 4.09 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 128.877 2.871 . . . . 1.84 112.36 175.503 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.8 mt -85.52 130.25 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 127.676 2.39 . . . . 0.82 110.799 178.762 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -115.84 175.37 5.57 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 116.267 -4.021 . . . . 2.16 112.061 -173.632 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -50.38 146.65 5.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.899 -2.376 . . . . 2.12 114.423 169.116 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 63.43 23.02 13.52 Favored 'General case' 0 N--CA 1.43 -1.461 2 C-N-CA 132.773 4.429 . . . . 1.71 111.757 176.927 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -91.15 155.21 18.79 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 116.927 -3.608 . . . . 1.04 107.034 -178.588 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.4 m -103.41 116.12 31.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.123 -1.399 . . . . 0.79 112.062 -177.753 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -97.11 136.15 38.06 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 102.65 -3.093 . . . . 1.4 102.65 172.848 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -101.72 101.82 12.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.521 1.928 . . . . 1.51 110.377 -175.233 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.1 tp -80.18 124.85 29.15 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 125.93 2.019 . . . . 1.14 110.323 -179.242 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.9 t -126.58 124.14 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.183 -1.826 . . . . 1.23 107.249 -169.471 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.3 mt . . . . . 0 N--CA 1.43 -1.443 0 C-N-CA 117.943 -1.503 . . . . 2.78 114.709 -177.484 . . . . . . . . 0 0 . 1 . 058 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 123.649 1.69 . . . . 1.1 110.639 . . . . . . . . . 0 0 . 1 . 058 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -85.19 121.68 28.29 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.05 -2.906 . . . . 1.87 109.691 -176.817 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -118.83 171.59 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 125.392 2.52 . . . . 0.72 107.848 168.272 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -129.42 129.68 45.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 111.706 -2.497 . . . . 1.4 111.808 179.938 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.6 t -110.94 115.96 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 113.254 -1.794 . . . . 0.58 107.113 169.497 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -97.19 140.98 30.87 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 125.125 2.393 . . . . 2.09 107.786 175.464 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.0 p -82.17 178.64 8.16 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.973 -1.704 . . . . 0.99 114.494 179.796 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.2 tp -54.33 -47.0 73.01 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 116.169 -4.082 . . . . 2.53 112.423 167.556 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 p -71.65 -26.89 62.73 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.729 -3.732 . . . . 2.08 111.374 -178.424 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.1 26.93 6.09 Favored Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 126.491 1.996 . . . . 1.31 112.033 -178.02 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -83.19 128.38 34.44 Favored 'General case' 0 N--CA 1.43 -1.474 2 O-C-N 116.287 -4.067 . . . . 1.4 108.386 176.441 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -99.02 113.29 25.4 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 128.333 3.921 . . . . 0.78 109.979 -176.377 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mt -91.95 126.71 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 111.11 -2.768 . . . . 1.55 108.996 176.111 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.6 t -98.89 143.31 29.34 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 119.95 1.25 . . . . 1.08 111.174 172.958 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.9 mt -136.97 158.1 45.24 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.587 2.755 . . . . 1.55 108.592 -177.828 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -111.33 121.1 44.36 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.479 -1.388 . . . . 1.95 107.819 166.057 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.03 159.32 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 126.491 3.043 . . . . 0.96 106.488 -172.724 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -112.01 149.17 40.47 Favored Pre-proline 0 N--CA 1.43 -1.475 1 O-C-N 116.067 -4.145 . . . . 2.35 108.186 165.239 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -72.31 -9.42 24.28 Favored 'Trans proline' 0 C--N 1.299 -2.031 2 O-C-N 112.925 -4.303 . . . . 0.95 115.671 -173.526 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.7 p -89.03 2.98 53.2 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 111.656 -2.52 . . . . 1.45 111.364 177.795 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -78.3 157.95 29.03 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.65 2.092 . . . . 1.69 116.65 172.864 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 67.2 p -95.87 160.12 14.63 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.015 2.816 . . . . 0.75 110.184 169.844 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 mm -54.83 -32.03 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 117.447 -3.283 . . . . 0.73 115.561 166.385 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -51.29 -59.86 3.75 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 116.692 2.108 . . . . 1.62 116.692 160.901 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -54.26 -37.44 64.7 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 117.768 2.507 . . . . 2.13 117.768 174.476 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.4 t -56.54 -42.34 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 126.86 2.064 . . . . 0.62 115.1 167.46 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -68.82 -24.2 64.35 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 115.577 1.695 . . . . 1.22 115.577 174.915 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.34 83.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 116.795 -1.574 . . . . 0.51 112.901 166.349 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -68.23 -35.45 77.96 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 128.726 3.766 . . . . 1.44 115.999 -179.573 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.2 mt -79.98 -32.25 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 C-N-CA 128.634 2.773 . . . . 1.32 113.535 170.931 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -62.96 -51.53 66.53 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 115.781 -4.324 . . . . 1.7 114.058 167.155 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -52.18 -43.85 64.36 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.34 1.978 . . . . 1.55 116.34 169.145 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -84.83 -63.82 1.27 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.066 -1.646 . . . . 2.62 113.944 -177.898 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -96.62 -39.19 9.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.752 2.215 . . . . 1.48 115.86 -174.151 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.61 44.92 2.4 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 116.79 -3.694 . . . . 1.12 113.626 169.604 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.7 mt -103.95 130.84 22.67 Favored Pre-proline 0 N--CA 1.43 -1.451 1 N-CA-C 99.775 -4.157 . . . . 1.55 99.775 -174.489 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -54.16 135.15 63.54 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-O 112.205 -3.331 . . . . 1.02 116.058 -179.571 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.64 -26.12 63.33 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 CA-C-N 127.052 3.554 . . . . 1.25 119.863 -178.988 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -68.67 -37.29 79.5 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.378 -1.283 . . . . 2.25 113.727 177.634 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -73.1 -27.48 61.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.609 -3.182 . . . . 2.02 115.105 178.307 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -68.49 129.49 40.08 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.377 3.473 . . . . 0.69 120.377 177.526 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -127.92 114.99 17.87 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.66 1.984 . . . . 2.78 111.715 168.9 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.565 HD12 HD23 ' A' ' 67' ' ' LEU . 3.8 mm? -86.71 130.16 34.59 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 125.881 1.988 . . . . 1.17 108.248 176.949 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.1 mm -127.41 123.3 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 125.985 2.053 . . . . 1.38 108.131 177.101 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -123.3 124.06 42.14 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.648 1.69 . . . . 1.5 108.945 171.948 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.89 -92.85 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.503 2.721 . . . . 1.21 116.05 -172.886 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.31 -38.18 1.68 Allowed Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 126.462 1.982 . . . . 1.3 113.505 -177.854 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -82.39 146.83 29.13 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 129.897 3.279 . . . . 2.55 116.039 -172.304 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -92.49 141.09 28.89 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 118.966 -2.334 . . . . 2.48 108.953 171.801 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 43' ' ' LEU . 27.7 mt -98.4 128.43 44.78 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 104.418 -2.438 . . . . 0.9 104.418 -168.922 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.55 140.63 32.14 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.672 2.389 . . . . 1.94 112.936 173.396 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -56.57 -54.44 45.88 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.34 3.089 . . . . 1.56 119.34 -172.179 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.02 8.44 63.33 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 115.278 -2.957 . . . . 0.97 117.505 175.106 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 22' ' ' THR . 31.0 mmt180 -78.88 158.21 28.14 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 122.732 3.266 . . . . 2.49 115.124 163.041 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.7 p -89.4 156.59 18.58 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 122.758 2.526 . . . . 0.76 113.351 173.141 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.0 mt -53.8 -36.86 62.92 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.104 -0.953 . . . . 1.05 111.675 166.361 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -54.19 -48.05 71.39 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.232 -2.168 . . . . 1.19 113.863 -178.841 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -45.69 -43.93 13.07 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 119.984 3.327 . . . . 1.9 119.984 171.786 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -96.75 3.54 52.29 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.203 2.601 . . . . 0.89 111.176 178.944 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.4 m120 54.88 47.29 22.6 Favored 'General case' 0 N--CA 1.431 -1.384 0 O-C-N 119.32 -2.113 . . . . 1.84 112.862 -176.092 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.3 mt -80.5 117.5 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 122.184 2.265 . . . . 0.82 110.274 177.481 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -110.32 176.86 4.89 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 120.13 1.332 . . . . 2.16 108.423 -168.43 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.377 45.5 pttt -54.27 128.46 31.4 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 131.555 3.942 . . . . 2.12 115.172 174.191 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 64.17 48.18 3.02 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 128.021 2.528 . . . . 1.71 109.269 175.758 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.2 p -92.12 173.45 7.83 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.806 -3.059 . . . . 1.04 113.35 178.117 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.1 m -120.88 114.86 22.18 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.281 -2.137 . . . . 0.79 112.317 173.201 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.565 HD23 HD12 ' A' ' 43' ' ' LEU . 6.3 mp -105.11 155.1 19.32 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.062 1.745 . . . . 1.4 108.522 175.575 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -118.42 130.64 56.09 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 126.543 2.402 . . . . 1.51 105.179 -174.763 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.2 tp -99.38 117.77 34.53 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.411 1.084 . . . . 1.14 112.981 175.524 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.8 t -102.97 129.85 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-O 123.896 1.808 . . . . 1.23 109.134 172.6 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.4 mt . . . . . 0 N--CA 1.43 -1.471 0 O-C-N 117.939 -2.976 . . . . 2.78 108.522 178.087 . . . . . . . . 0 0 . 1 . 059 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 CA--C 1.491 -1.319 0 CA-C-O 122.992 1.377 . . . . 1.1 113.882 . . . . . . . . . 0 0 . 1 . 059 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -85.9 135.18 33.79 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.21 1.804 . . . . 1.87 110.175 -174.565 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 pt -135.97 161.01 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 120.003 -1.686 . . . . 0.72 111.815 174.199 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -118.04 141.43 48.47 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.161 -2.212 . . . . 1.4 107.819 -179.268 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 t -116.88 130.11 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 126.064 2.102 . . . . 0.58 107.185 173.566 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -115.06 123.44 49.02 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.133 -3.479 . . . . 2.09 113.722 179.02 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.3 p -68.0 171.22 7.08 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 124.522 2.106 . . . . 0.99 112.038 178.161 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 tp -71.77 -27.37 62.91 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 117.912 -2.993 . . . . 2.53 110.403 174.622 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 p -73.6 -30.32 62.92 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.758 -3.714 . . . . 2.08 106.46 178.546 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.26 -21.22 2.96 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 125.289 3.677 . . . . 1.31 113.041 -179.433 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -57.11 117.41 4.0 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 126.874 2.07 . . . . 1.4 114.185 -177.159 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.8 m -107.64 114.82 29.06 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.169 -1.789 . . . . 0.78 106.169 -179.798 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.516 HD12 ' CE ' ' A' ' 33' ' ' LYS . 26.9 pt -104.61 161.64 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 125.839 1.962 . . . . 1.55 105.883 -178.162 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -117.24 121.13 40.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.711 2.004 . . . . 1.08 108.861 -174.48 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.6 mt -122.99 164.42 18.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 126.289 2.947 . . . . 1.55 110.974 -177.657 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -129.0 132.4 47.52 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 116.406 -3.934 . . . . 1.95 110.884 174.828 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.7 m -137.59 -175.45 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-O 128.377 3.942 . . . . 0.96 112.047 -179.818 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -122.88 147.32 50.83 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-N 112.157 -2.292 . . . . 2.35 110.572 166.084 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -65.6 -20.09 60.07 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 O-C-N 114.036 -3.718 . . . . 0.95 115.276 -178.783 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.6 p -70.64 -21.92 62.57 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 117.45 -3.281 . . . . 1.45 112.154 177.862 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -62.86 146.7 52.16 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.994 2.961 . . . . 1.69 118.994 178.395 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.8 p -85.58 151.64 23.76 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 124.895 1.278 . . . . 0.75 108.191 177.358 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.2 mm -54.0 -41.34 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 129.225 3.01 . . . . 0.73 113.063 -179.884 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -44.56 -53.17 7.36 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 118.612 2.819 . . . . 1.62 118.612 161.777 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -50.8 -32.15 19.15 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 126.537 1.935 . . . . 2.13 113.693 174.096 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.9 t -77.44 -42.7 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 107.243 -1.391 . . . . 0.62 107.243 -177.305 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.496 ' HA ' HD12 ' A' ' 30' ' ' ILE . 40.8 mtmt -60.16 -42.3 94.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 120.393 1.451 . . . . 1.22 112.79 174.744 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.85 -20.53 65.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.594 1.558 . . . . 0.51 110.227 177.915 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -80.11 -40.79 26.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.969 2.319 . . . . 1.44 112.878 174.545 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 27' ' ' LYS . 33.2 mt -51.52 -42.57 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.551 -2.593 . . . . 1.32 113.65 165.68 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -54.17 -47.76 71.64 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.339 2.656 . . . . 1.7 113.613 177.559 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -56.71 -42.51 79.3 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.816 2.046 . . . . 1.55 115.058 170.884 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.516 ' CE ' HD12 ' A' ' 13' ' ' ILE . 52.3 tttp -74.26 -48.56 27.9 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.671 1.988 . . . . 2.62 114.654 -179.213 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -115.85 -15.09 11.3 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 123.911 1.815 . . . . 1.48 114.264 -171.061 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.17 21.67 32.1 Favored Glycine 0 N--CA 1.429 -1.789 1 O-C-N 113.848 -5.533 . . . . 1.12 113.012 171.394 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 mt -98.69 124.02 47.67 Favored Pre-proline 0 N--CA 1.431 -1.42 0 O-C-N 120.626 -1.514 . . . . 1.55 107.009 -175.328 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -67.97 152.54 76.77 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 C-N-CA 124.302 3.335 . . . . 1.02 113.779 178.043 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -82.47 -15.84 8.45 Favored 'Trans proline' 0 N--CA 1.433 -2.052 0 C-N-CA 123.704 2.936 . . . . 1.25 113.321 -163.304 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -72.7 -27.76 62.26 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 129.981 4.551 . . . . 2.25 113.889 175.333 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -82.03 -20.54 38.13 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.046 2.355 . . . . 2.02 112.522 179.132 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.276 76.8 mt-30 -97.11 145.39 26.04 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 127.805 3.669 . . . . 0.69 109.786 -171.867 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -139.18 122.58 17.18 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.101 -2.249 . . . . 2.78 113.903 172.539 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.2 mt -92.44 120.85 33.34 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.414 -1.428 . . . . 1.17 112.866 -176.299 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.5 mt -112.7 130.15 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 129.981 3.313 . . . . 1.38 107.92 -175.537 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -138.3 135.15 35.16 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.744 -1.222 . . . . 1.5 110.206 177.872 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.01 46.96 25.71 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.824 3.202 . . . . 1.21 116.675 179.592 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.17 -44.28 3.35 Favored Glycine 0 N--CA 1.43 -1.717 0 O-C-N 118.617 -2.552 . . . . 1.3 117.479 -177.147 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -86.67 159.5 19.17 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 118.89 1.345 . . . . 2.55 114.498 -176.228 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -83.54 135.01 34.8 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.411 -0.813 . . . . 2.48 109.501 174.497 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 mt -87.7 148.1 24.92 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.759 -1.2 . . . . 0.9 107.759 -179.011 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -99.69 134.54 42.44 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.26 -2.775 . . . . 1.94 110.027 -179.619 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -68.36 -25.86 65.29 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 117.692 2.478 . . . . 1.56 117.692 -167.626 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.05 14.76 64.13 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 115.617 -3.183 . . . . 0.97 117.662 169.091 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -96.84 176.51 5.95 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.991 1.377 . . . . 2.49 108.157 170.005 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.5 p -102.6 -174.72 2.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 116.328 -3.982 . . . . 0.76 117.182 177.648 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.259 60.2 mt -77.33 -38.54 50.17 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.632 -2.542 . . . . 1.05 111.255 174.301 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.1 p -72.28 -15.12 61.9 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 128.369 3.543 . . . . 1.19 118.387 179.012 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -66.09 -29.66 70.02 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.127 -1.608 . . . . 1.9 113.672 168.921 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -102.96 6.46 38.92 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 122.851 1.31 . . . . 0.89 109.83 -177.231 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.8 m120 55.45 35.41 25.01 Favored 'General case' 0 N--CA 1.431 -1.38 1 O-C-N 116.279 -4.013 . . . . 1.84 114.746 -173.507 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.9 mt -68.72 118.03 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.943 1.297 . . . . 0.82 113.475 175.073 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -115.55 -175.85 2.8 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 130.97 3.708 . . . . 2.16 112.859 -178.864 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -67.07 139.12 57.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.247 2.927 . . . . 2.12 110.894 -176.224 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.446 25.3 mt-10 85.38 9.07 0.35 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 111.439 -2.619 . . . . 1.71 116.015 176.652 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.0 m -74.23 133.43 42.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.859 -1.776 . . . . 1.04 114.371 -173.282 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.5 m -99.99 109.99 22.32 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 104.651 -2.351 . . . . 0.79 104.651 -169.595 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.19 151.47 19.44 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.274 2.23 . . . . 1.4 109.134 172.306 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -109.34 108.18 18.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 123.598 1.666 . . . . 1.51 112.228 -179.06 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.4 tp -85.08 120.38 26.52 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.516 2.103 . . . . 1.14 109.412 178.178 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.366 31.3 m -114.67 148.25 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 117.17 -3.456 . . . . 1.23 112.611 171.702 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.286 62.1 mt . . . . . 0 N--CA 1.43 -1.455 0 CA-C-O 125.986 2.803 . . . . 2.78 108.829 -179.076 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.295 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.359 0 CA-C-O 125.099 2.381 . . . . 1.1 115.096 . . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -87.78 128.5 35.32 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.46 -3.9 . . . . 1.87 111.475 179.317 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.7 pt -126.66 172.96 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 117.07 -3.519 . . . . 0.72 106.603 169.612 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -127.17 135.65 50.99 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 123.519 0.728 . . . . 1.4 110.861 -176.864 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.2 t -117.37 117.94 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 101.342 -3.577 . . . . 0.58 101.342 176.774 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.7 tttp -101.73 148.2 25.56 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.625 -3.797 . . . . 2.09 113.54 174.84 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.4 HG22 HD23 ' A' ' 69' ' ' LEU . 31.1 p -97.28 171.59 8.33 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.542 2.591 . . . . 0.99 108.751 176.946 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.6 mt -83.47 -4.79 58.84 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.811 -2.43 . . . . 2.53 114.205 172.544 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.2 p -88.83 -30.44 18.94 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 115.723 -2.084 . . . . 2.08 105.467 178.947 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.11 -2.17 10.69 Favored Glycine 0 N--CA 1.43 -1.754 1 O-C-N 129.471 4.232 . . . . 1.31 115.89 170.941 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -72.47 140.61 48.36 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.859 -1.163 . . . . 1.4 107.859 -176.421 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.6 m -108.3 124.58 50.55 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.848 -2.649 . . . . 0.78 103.848 177.419 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.3 mm -101.55 116.81 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 119.237 -2.165 . . . . 1.55 109.769 176.209 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.2 m -92.85 120.8 33.57 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 121.351 1.887 . . . . 1.08 107.891 -179.162 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 15' ' ' LEU . 39.4 mt -125.88 127.23 45.7 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.048 2.939 . . . . 1.55 110.261 -173.731 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -86.29 114.26 22.95 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 126.72 2.513 . . . . 1.95 113.075 166.409 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.1 m -129.28 167.11 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 118.044 -2.91 . . . . 0.96 109.103 -179.407 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.271 69.1 mm-40 -110.4 156.08 40.93 Favored Pre-proline 0 N--CA 1.431 -1.408 0 CA-C-O 117.839 -1.077 . . . . 2.35 108.573 164.851 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -71.08 -8.22 23.09 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 CA-C-N 123.217 2.185 . . . . 0.95 113.853 -175.175 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.1 p -81.49 -24.91 36.41 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.049 2.94 . . . . 1.45 113.284 178.535 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -66.74 154.55 40.44 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 117.687 -1.149 . . . . 1.69 111.985 178.97 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 19.0 p -87.13 175.94 7.83 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 106.303 -1.74 . . . . 0.75 106.303 -177.872 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.4 mm -73.31 -33.96 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 C-N-CA 123.889 0.876 . . . . 0.73 111.792 175.848 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -46.2 -41.14 12.35 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.678 3.191 . . . . 1.62 113.751 167.41 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -73.39 -22.13 60.33 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 115.513 -4.492 . . . . 2.13 114.205 179.275 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -74.51 -47.02 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 113.709 -1.587 . . . . 0.62 109.047 175.589 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -52.69 -27.77 18.89 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 128.419 3.574 . . . . 1.22 119.817 167.116 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.21 -37.38 57.84 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.461 -3.899 . . . . 0.51 110.781 172.54 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -70.22 -39.83 74.88 Favored 'General case' 0 N--CA 1.43 -1.444 2 O-C-N 111.372 -7.08 . . . . 1.44 110.68 177.269 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 53.5 mt -59.28 -42.29 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 1 O-C-N 115.989 -4.194 . . . . 1.32 111.05 173.038 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -65.55 -46.5 79.3 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.215 -3.428 . . . . 1.7 107.671 177.755 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -55.15 -64.99 0.66 Allowed 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.081 -4.762 . . . . 1.55 117.003 169.91 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -61.37 -57.18 13.32 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.226 -2.796 . . . . 2.62 113.215 -176.021 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -100.93 -46.1 5.22 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.957 2.903 . . . . 1.48 111.315 -165.639 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.01 22.75 5.18 Favored Glycine 0 N--CA 1.429 -1.79 0 O-C-N 116.649 -3.782 . . . . 1.12 113.781 170.61 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.9 mt -92.43 128.24 45.44 Favored Pre-proline 0 N--CA 1.432 -1.374 0 N-CA-C 101.666 -3.457 . . . . 1.55 101.666 -173.11 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -71.26 155.78 60.12 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 CA-C-O 112.67 -3.137 . . . . 1.02 114.961 175.681 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -65.61 -24.15 56.05 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 CA-C-N 124.861 2.772 . . . . 1.25 118.274 -179.163 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.83 -33.85 76.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.548 2.055 . . . . 2.25 116.548 172.866 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -83.41 -35.28 25.16 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 126.321 2.962 . . . . 2.02 112.603 -177.916 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -79.05 130.09 35.15 Favored 'General case' 0 N--CA 1.429 -1.482 1 O-C-N 115.575 -4.453 . . . . 0.69 111.816 -176.103 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -123.91 129.73 51.44 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.696 1.599 . . . . 2.78 106.686 166.776 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 mt -96.19 139.42 32.36 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 124.657 1.223 . . . . 1.17 113.595 173.692 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 60.1 mt -114.63 138.5 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.899 -3.0 . . . . 1.38 107.607 174.141 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -147.13 136.74 22.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.797 -3.064 . . . . 1.5 112.062 169.46 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.374 . . 63.53 -2.21 0.51 Allowed 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 116.677 2.103 . . . . 1.21 116.677 -178.426 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.21 -11.28 33.84 Favored Glycine 0 N--CA 1.429 -1.776 0 CA-C-O 126.648 3.36 . . . . 1.3 113.52 -173.862 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -90.23 128.98 36.53 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 117.592 -3.299 . . . . 2.55 108.795 -179.548 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -77.03 126.44 30.97 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.084 -3.51 . . . . 2.48 108.099 171.565 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.289 26.5 mt -79.17 127.96 32.7 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 118.136 2.643 . . . . 0.9 118.136 -170.519 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -83.43 149.49 26.64 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.584 2.068 . . . . 1.94 116.584 174.441 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.76 -36.11 72.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.142 2.577 . . . . 1.56 114.15 -171.782 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.46 10.59 68.81 Favored Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 114.572 -3.68 . . . . 0.97 119.141 171.233 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -80.06 154.3 28.21 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 126.594 1.996 . . . . 2.49 113.225 170.701 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 32.5 p -82.77 164.32 20.7 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 124.886 2.279 . . . . 0.76 111.098 167.902 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mt -75.43 -29.04 59.59 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 116.791 -3.693 . . . . 1.05 112.481 173.098 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 p -62.92 -40.6 98.1 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.39 -2.069 . . . . 1.19 112.491 173.9 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.278 2.0 t70 -53.62 -40.87 66.11 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 118.535 2.791 . . . . 1.9 118.535 172.833 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -79.66 -9.07 59.58 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 126.009 2.068 . . . . 0.89 116.077 172.184 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.4 m120 70.8 65.82 0.18 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 130.1 3.36 . . . . 1.84 108.557 -177.521 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.5 mt -108.78 124.18 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 O-C-N 117.068 -3.52 . . . . 0.82 111.009 -178.145 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -107.42 -173.83 2.38 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.53 1.532 . . . . 2.16 115.032 -178.045 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -70.87 145.83 49.99 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 119.086 -2.259 . . . . 2.12 113.006 176.709 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.35 31.7 mt-10 78.4 15.05 1.33 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.297 2.639 . . . . 1.71 112.333 165.847 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.5 m -86.61 146.0 26.51 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.314 -2.221 . . . . 1.04 110.265 -169.42 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.7 m -93.79 110.41 22.06 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.547 1.976 . . . . 0.79 116.007 179.406 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -87.29 151.52 23.06 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.497 -2.002 . . . . 1.4 110.184 172.511 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.426 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 39.7 m80 -109.57 100.8 9.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.785 -1.822 . . . . 1.51 114.62 -179.562 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.4 HD23 HG22 ' A' ' 7' ' ' THR 0.259 36.0 tp -84.96 115.73 22.97 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.386 -2.071 . . . . 1.14 108.489 -173.122 . . . . . . . . 3 3 . 1 . 060 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 m -107.74 153.16 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 126.238 1.815 . . . . 1.23 110.792 174.817 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.1 mt . . . . . 0 N--CA 1.43 -1.474 0 O-C-N 118.802 -2.436 . . . . 2.78 107.788 179.281 . . . . . . . . 0 0 . 1 . 061 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 ptt? . . . . . 0 CA--C 1.491 -1.294 0 N-CA-C 115.138 1.533 . . . . 1.1 115.138 . . . . . . . . . 0 0 . 1 . 061 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -87.45 135.12 33.46 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 124.835 1.334 . . . . 1.87 110.435 179.439 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -126.66 138.39 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 105.894 -1.891 . . . . 0.72 105.894 175.073 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -104.19 77.03 1.38 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.791 -1.095 . . . . 1.4 108.91 -176.105 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 t -63.42 105.29 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 116.213 1.931 . . . . 0.58 116.213 168.95 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.257 35.7 tptt -90.46 139.8 30.33 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 124.151 1.929 . . . . 2.09 112.652 179.095 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.3 p -91.17 -179.39 5.42 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.556 -1.965 . . . . 0.99 108.513 179.544 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.4 tp -66.23 -50.88 62.28 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 123.218 1.485 . . . . 2.53 113.903 179.997 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 p -74.69 -22.07 59.06 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.113 1.523 . . . . 2.08 115.113 -172.577 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.05 -2.53 2.96 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 117.679 -2.201 . . . . 1.31 114.817 172.49 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -78.86 131.09 36.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.165 -2.962 . . . . 1.4 112.146 -175.18 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.271 85.8 m -98.83 118.1 34.82 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.147 -2.221 . . . . 0.78 108.97 175.452 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.1 mm -102.39 118.68 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 125.175 1.547 . . . . 1.55 110.201 179.698 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.2 m -81.02 98.33 7.91 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.447 -1.251 . . . . 1.08 110.549 174.862 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.3 tp -100.69 158.08 16.21 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.016 -2.303 . . . . 1.55 110.118 -176.394 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -121.55 118.74 30.03 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.284 -1.006 . . . . 1.95 108.284 174.956 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 m -135.58 176.67 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 107.619 -1.252 . . . . 0.96 107.619 -177.581 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -124.25 166.7 18.2 Favored Pre-proline 0 N--CA 1.429 -1.482 0 O-C-N 118.547 -2.596 . . . . 2.35 109.644 170.275 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.359 14.5 Cg_endo -75.68 -16.27 18.83 Favored 'Trans proline' 0 C--N 1.299 -2.075 0 O-C-N 114.7 -3.368 . . . . 0.95 114.502 -175.99 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.9 p -90.87 2.57 56.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.206 -2.184 . . . . 1.45 107.334 -178.804 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -80.51 142.59 34.04 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.923 -1.736 . . . . 1.69 113.544 179.433 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.6 p -85.71 164.71 17.47 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 117.029 2.233 . . . . 0.75 117.029 177.783 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.5 HD11 HD23 ' A' ' 56' ' ' LEU . 42.9 mm -76.48 -31.06 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 101.738 -3.43 . . . . 0.73 101.738 -172.979 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -49.76 -47.01 51.21 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 115.641 1.719 . . . . 1.62 115.641 167.298 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -76.72 -30.82 56.81 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 115.87 -2.014 . . . . 2.13 112.533 177.328 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.31 -29.7 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 121.592 1.996 . . . . 0.62 114.463 177.551 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -74.55 -35.39 63.08 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 117.607 -1.187 . . . . 1.22 109.213 171.232 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -36.93 83.99 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 123.389 2.813 . . . . 0.51 112.619 171.007 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.6 mttm -63.94 -47.38 80.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 126.842 2.589 . . . . 1.44 114.804 170.364 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.43 HG21 HD13 ' A' ' 30' ' ' ILE . 60.9 mt -61.48 -36.38 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 1 O-C-N 114.462 -5.149 . . . . 1.32 109.756 171.066 . . . . . . . . 3 3 . 1 . 061 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -57.52 -54.27 48.71 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 117.14 -3.475 . . . . 1.7 113.152 172.734 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -52.75 -44.64 66.61 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.767 -1.208 . . . . 1.55 111.98 171.92 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -65.18 -57.41 8.6 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 127.612 2.365 . . . . 2.62 110.464 -173.369 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -105.75 -47.64 3.84 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 118.128 -2.857 . . . . 1.48 115.705 -169.611 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.42 4.63 8.96 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 119.547 -1.971 . . . . 1.12 114.17 -176.445 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.9 mt -83.5 127.37 68.48 Favored Pre-proline 0 N--CA 1.43 -1.462 0 O-C-N 119.026 -2.455 . . . . 1.55 110.478 -176.108 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -73.35 146.57 40.27 Favored 'Trans proline' 0 C--N 1.3 -2.014 2 O-C-N 110.895 -5.371 . . . . 1.02 113.389 179.135 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.06 -5.69 16.4 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 C-N-CA 126.107 4.538 . . . . 1.25 116.672 -176.931 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.53 -37.61 84.38 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.815 2.245 . . . . 2.25 110.782 169.343 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -85.17 -31.9 22.99 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 115.937 -1.982 . . . . 2.02 115.022 -177.411 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.359 46.7 mt-30 -67.58 113.47 5.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.388 2.675 . . . . 0.69 117.698 -172.089 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -122.01 115.47 22.58 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.327 -2.733 . . . . 2.78 109.551 172.765 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.9 mt -96.53 143.11 27.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.51 -1.369 . . . . 1.17 110.256 179.427 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.2 mm -124.6 148.64 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 102.679 -3.082 . . . . 1.38 102.679 175.423 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.407 ' HB3' HD21 ' A' ' 50' ' ' LEU . 69.4 t80 -139.53 112.86 8.27 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 101.156 -3.646 . . . . 1.5 101.156 173.982 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.96 28.76 14.49 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 126.286 2.241 . . . . 1.21 114.119 172.662 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.91 -17.1 56.68 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 124.938 1.256 . . . . 1.3 114.31 -175.168 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.316 34.7 ttmt -87.63 122.51 31.41 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.766 -2.608 . . . . 2.55 115.756 178.417 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -64.46 138.12 58.24 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 118.193 2.664 . . . . 2.48 118.193 171.718 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.407 HD21 ' HB3' ' A' ' 45' ' ' PHE . 39.7 mt -95.9 113.2 24.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.951 -1.022 . . . . 0.9 111.126 -172.326 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -77.5 142.56 39.03 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.873 -1.158 . . . . 1.94 107.873 -178.973 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.472 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 7.0 m-20 -56.96 -65.47 0.61 Allowed 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 119.29 3.071 . . . . 1.56 119.29 -168.723 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.1 25.5 0.15 Allowed Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 119.38 2.512 . . . . 0.97 119.38 171.943 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -105.97 158.0 17.1 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 119.773 1.786 . . . . 2.49 109.926 164.821 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.7 p -84.91 169.1 14.41 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 112.735 -2.03 . . . . 0.76 111.602 170.708 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.5 HD23 HD11 ' A' ' 23' ' ' ILE . 94.0 mt -66.02 -37.16 85.18 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 127.384 2.274 . . . . 1.05 111.739 171.543 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.9 p -69.39 -10.4 57.79 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 129.23 3.012 . . . . 1.19 115.016 173.806 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.99 -48.21 31.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.876 1.67 . . . . 1.9 110.362 169.84 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -85.63 -1.11 56.8 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 130.476 3.51 . . . . 0.89 113.775 -177.924 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.0 m120 57.21 54.32 6.9 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.604 2.361 . . . . 1.84 116.646 179.517 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 88.9 mt -100.27 109.8 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 126.846 2.058 . . . . 0.82 108.797 -179.194 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -93.74 -178.62 4.74 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.052 2.358 . . . . 2.16 110.422 -178.902 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -58.28 140.18 53.77 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.108 -3.495 . . . . 2.12 119.885 175.735 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.327 12.7 mt-10 67.98 40.56 2.26 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 123.778 0.674 . . . . 1.71 110.557 174.913 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 p -96.22 155.43 16.76 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 126.667 1.987 . . . . 1.04 108.547 176.106 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.4 m -104.68 85.75 2.37 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.689 -2.337 . . . . 0.79 104.689 -177.079 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -63.6 159.78 18.15 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 114.539 -5.1 . . . . 1.4 113.884 169.01 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -118.2 129.86 55.75 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.39 2.043 . . . . 1.51 108.584 -178.96 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.6 tp -116.67 131.27 56.99 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 116.065 -4.147 . . . . 1.14 113.242 175.351 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 m -135.1 167.9 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 103.437 -2.801 . . . . 1.23 103.437 175.727 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 66.4 mt . . . . . 0 N--CA 1.43 -1.428 0 CA-C-O 126.446 3.022 . . . . 2.78 113.958 179.596 . . . . . . . . 0 0 . 1 . 062 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 ttp . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 117.484 2.401 . . . . 1.1 117.484 . . . . . . . . . 0 0 . 1 . 062 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -100.03 124.01 44.91 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 124.53 1.144 . . . . 1.87 110.852 -176.337 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 17' ' ' VAL . 3.1 pt -129.11 157.89 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 105.571 -2.011 . . . . 0.72 105.571 172.003 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -108.79 134.67 51.17 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.023 1.729 . . . . 1.4 112.117 -174.854 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.491 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 42.1 t -111.85 115.01 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 122.15 0.976 . . . . 0.58 108.852 173.612 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -96.57 149.94 21.2 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.948 -2.345 . . . . 2.09 107.544 176.979 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.6 p -109.78 -149.21 0.44 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 116.275 -1.821 . . . . 0.99 107.462 176.464 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.2 tp -91.77 -58.12 2.52 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-N 122.809 2.55 . . . . 2.53 110.92 167.121 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.4 p -127.19 133.83 50.23 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 113.755 -3.022 . . . . 2.08 117.946 178.877 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.21 -116.97 2.71 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 103.307 -3.917 . . . . 1.31 103.307 173.983 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -119.67 164.62 15.62 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 121.831 -0.805 . . . . 1.4 108.87 -170.17 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.5 m -88.65 120.26 29.88 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 125.853 1.97 . . . . 0.78 109.652 168.958 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 15.6 mt -79.9 122.62 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-N 122.122 2.237 . . . . 1.55 114.983 -179.627 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.8 m -78.83 100.95 7.39 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.767 -1.833 . . . . 1.08 109.973 176.882 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tp -102.8 119.52 38.98 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 113.709 1.003 . . . . 1.55 113.709 -178.302 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -91.71 126.3 36.74 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.396 2.522 . . . . 1.95 112.983 168.574 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.401 HG21 HD13 ' A' ' 3' ' ' ILE . 19.7 m -142.89 171.46 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 1 C-N-CA 131.737 4.015 . . . . 0.96 110.868 -174.331 . . . . . . . . 3 3 . 1 . 062 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 41.5 mt-10 -114.24 169.14 6.9 Favored Pre-proline 0 N--CA 1.43 -1.462 0 C-N-CA 129.163 2.985 . . . . 2.35 106.737 166.428 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 82.1 Cg_exo -73.16 -18.11 24.01 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 N-CA-C 120.11 3.081 . . . . 0.95 120.11 -177.1 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.4 m -84.69 10.15 12.02 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 112.036 -2.347 . . . . 1.45 116.171 174.574 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.69 130.49 35.08 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 116.688 -3.757 . . . . 1.69 106.007 177.464 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 23.9 p -71.05 163.59 27.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.712 2.196 . . . . 0.75 108.493 171.18 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.5 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 49.1 mm -66.41 -34.07 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 113.625 -3.083 . . . . 0.73 105.381 175.951 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -61.65 -40.02 93.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 122.883 2.583 . . . . 1.62 116.207 171.731 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -69.59 -41.02 76.32 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 125.144 1.528 . . . . 2.13 112.476 177.653 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.5 t -49.85 -50.12 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 120.858 -1.151 . . . . 0.62 113.569 169.872 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -58.77 -37.32 76.02 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.152 -1.592 . . . . 1.22 113.735 170.319 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.59 -37.84 85.75 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.648 -2.533 . . . . 0.51 108.908 178.945 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -69.32 -38.29 78.14 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 129.087 2.955 . . . . 1.44 112.813 179.303 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.8 mt -69.1 -28.66 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 117.431 -3.293 . . . . 1.32 110.959 170.99 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -66.31 -47.19 74.36 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.519 1.528 . . . . 1.7 110.761 172.235 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -64.3 -28.81 69.97 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 114.519 1.303 . . . . 1.55 114.519 173.058 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -87.89 -46.89 9.01 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.087 -2.258 . . . . 2.62 115.12 -173.839 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -113.58 -29.35 7.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.056 1.742 . . . . 1.48 115.262 -175.486 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.19 4.03 38.42 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 119.305 -2.122 . . . . 1.12 118.165 175.074 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.9 mt -85.06 132.48 45.46 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 119.262 1.531 . . . . 1.55 110.771 -173.934 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -61.32 144.04 98.31 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 C-N-CA 123.464 2.776 . . . . 1.02 116.72 -179.721 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -59.43 -32.52 96.59 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 123.379 2.719 . . . . 1.25 114.141 -178.627 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -63.24 -18.11 63.19 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.928 2.936 . . . . 2.25 118.928 171.59 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -91.89 -23.19 19.71 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 116.295 -1.812 . . . . 2.02 107.1 -177.162 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -89.49 141.09 28.89 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 117.406 2.373 . . . . 0.69 117.406 -172.932 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -123.23 137.72 54.81 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.486 -2.008 . . . . 2.78 110.143 163.496 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.2 mt -112.25 140.0 47.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.882 -1.896 . . . . 1.17 105.882 179.742 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.7 mm -120.92 127.58 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 130.108 3.363 . . . . 1.38 108.668 177.985 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -139.27 126.02 20.77 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 104.721 -2.325 . . . . 1.5 104.721 172.16 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.97 41.27 10.65 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 121.037 3.717 . . . . 1.21 121.037 173.921 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.1 -17.59 58.43 Favored Glycine 0 N--CA 1.43 -1.71 0 O-C-N 117.659 -3.151 . . . . 1.3 113.267 -178.772 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -108.81 135.5 49.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.477 -2.778 . . . . 2.55 115.279 -178.866 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -87.6 127.06 35.27 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.114 0.959 . . . . 2.48 109.248 170.805 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.0 mt -89.41 144.99 25.63 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 126.576 3.084 . . . . 0.9 112.325 -163.638 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -95.09 125.16 39.56 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.428 -3.295 . . . . 1.94 114.806 -179.781 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.5 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 5.9 m-20 -48.05 -49.86 29.96 Favored 'General case' 0 N--CA 1.429 -1.491 1 C-N-CA 132.406 4.282 . . . . 1.56 119.766 -169.006 . . . . . . . . 3 3 . 1 . 062 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.42 46.2 3.18 Favored Glycine 0 N--CA 1.431 -1.673 0 CA-C-O 114.538 -3.368 . . . . 0.97 119.174 168.354 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -125.32 152.72 44.33 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.593 -2.743 . . . . 2.49 103.593 165.659 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 55.8 p -94.84 159.75 14.9 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.547 3.654 . . . . 0.76 116.039 176.857 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.6 mt -55.21 -40.49 70.84 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 115.682 1.734 . . . . 1.05 115.682 175.483 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 p -73.43 -9.28 58.53 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.181 -3.449 . . . . 1.19 118.41 179.506 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -93.21 -31.9 14.57 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 114.648 -2.596 . . . . 1.9 107.354 174.585 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -80.0 -5.51 55.87 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 125.892 1.995 . . . . 0.89 106.937 177.049 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 56.18 71.74 0.54 Allowed 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 115.053 -4.78 . . . . 1.84 111.813 -175.38 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.1 mt -115.87 111.9 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 105.001 -2.222 . . . . 0.82 105.001 178.619 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -95.34 -175.08 3.38 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.431 3.015 . . . . 2.16 109.621 -174.232 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -57.73 140.23 51.94 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 111.471 -2.604 . . . . 2.12 112.116 177.162 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.338 51.0 mt-10 69.38 20.85 7.17 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 125.214 1.406 . . . . 1.71 113.309 174.486 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.2 m -85.4 147.72 26.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 121.617 -0.677 . . . . 1.04 112.032 -172.459 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.2 m -104.5 111.07 23.6 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.052 -1.655 . . . . 0.79 112.921 -175.509 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -93.8 147.4 23.09 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.45 -1.406 . . . . 1.4 110.9 174.456 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -113.96 128.1 56.25 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.102 -2.874 . . . . 1.51 110.404 -177.367 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.0 tp -102.49 124.48 48.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 124.834 1.334 . . . . 1.14 112.995 -172.059 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.255 6.2 m -138.3 133.37 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.606 2.763 . . . . 1.23 107.662 -175.408 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 N--CA 1.43 -1.456 0 CA-C-O 125.144 2.402 . . . . 2.78 117.412 -175.995 . . . . . . . . 0 0 . 1 . 063 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ttp . . . . . 0 CA--C 1.49 -1.347 0 CA-C-O 116.447 -1.74 . . . . 1.1 107.145 . . . . . . . . . 0 0 . 1 . 063 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -116.55 128.91 55.85 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 124.665 1.228 . . . . 1.87 112.323 171.869 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.6 pt -121.06 173.55 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 119.116 -2.24 . . . . 0.72 107.648 169.521 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -128.3 150.93 49.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.98 -2.23 . . . . 1.4 104.98 -179.328 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.6 t -138.8 112.64 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 126.515 3.055 . . . . 0.58 112.627 174.469 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -89.51 153.25 20.95 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 111.072 -2.786 . . . . 2.09 115.509 -176.831 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 t -127.68 -160.55 1.02 Allowed 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 124.483 2.087 . . . . 0.99 107.853 170.864 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.8 mt -81.19 -85.53 0.1 Allowed 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 114.563 -5.086 . . . . 2.53 113.74 175.383 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.1 p -80.71 -41.34 23.8 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 128.764 2.826 . . . . 2.08 117.287 179.239 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.36 -168.31 11.16 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 118.696 -2.503 . . . . 1.31 118.622 176.181 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -60.34 151.31 28.1 Favored 'General case' 0 N--CA 1.43 -1.461 1 C-N-CA 131.735 4.014 . . . . 1.4 114.068 -172.808 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.8 m -98.18 117.23 32.09 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.453 -2.655 . . . . 0.78 104.216 163.659 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 pt -99.86 153.91 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 116.76 -3.713 . . . . 1.55 108.168 179.991 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.7 m -107.55 126.32 52.39 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 104.404 -2.443 . . . . 1.08 104.404 175.852 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.2 mt -117.38 129.04 55.61 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 123.388 1.566 . . . . 1.55 110.519 -179.263 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -96.73 125.99 41.57 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 116.641 -3.787 . . . . 1.95 104.343 174.305 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.25 27.4 m -136.8 170.42 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 129.264 3.025 . . . . 0.96 111.191 -170.871 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -109.7 156.0 40.47 Favored Pre-proline 0 N--CA 1.43 -1.442 0 CA-C-N 124.384 3.266 . . . . 2.35 107.324 166.728 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.86 -16.52 29.46 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 124.991 3.794 . . . . 0.95 114.787 -168.197 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.3 m -107.34 17.5 22.75 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 120.219 1.372 . . . . 1.45 110.21 177.574 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -73.75 151.09 40.74 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.306 -3.371 . . . . 1.69 113.164 171.053 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -91.53 160.07 15.6 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.913 1.816 . . . . 0.75 113.31 -178.525 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.315 26.0 mm -56.51 -37.9 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 116.381 1.993 . . . . 0.73 116.381 176.069 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -52.54 -43.39 65.13 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.844 2.165 . . . . 1.62 116.844 170.206 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -76.93 -42.4 39.51 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.229 -2.794 . . . . 2.13 108.346 -177.949 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.0 t -57.06 -45.62 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 118.177 2.658 . . . . 0.62 118.177 169.619 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -56.25 -40.71 74.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.021 1.328 . . . . 1.22 112.988 170.116 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.55 -33.55 75.27 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.779 2.432 . . . . 0.51 113.346 175.501 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -67.93 -40.19 83.37 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.474 2.709 . . . . 1.44 106.926 170.369 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.5 mt -62.31 -40.89 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 123.448 2.84 . . . . 1.32 113.117 173.092 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -55.64 -48.88 74.23 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.842 2.457 . . . . 1.7 114.503 170.503 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -58.03 -46.55 85.15 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.61 2.078 . . . . 1.55 116.61 170.853 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -76.71 -58.87 3.03 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 117.889 -3.007 . . . . 2.62 114.611 -177.353 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -88.51 -47.15 8.53 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.257 -1.527 . . . . 1.48 110.531 -170.294 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.85 34.84 1.95 Allowed Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 124.006 1.892 . . . . 1.12 113.72 177.367 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 mt -108.75 128.55 25.33 Favored Pre-proline 0 N--CA 1.431 -1.418 0 O-C-N 120.512 -1.581 . . . . 1.55 111.027 -176.935 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -63.36 141.13 80.2 Favored 'Trans proline' 0 N--CA 1.434 -1.98 0 CA-C-N 125.305 2.93 . . . . 1.02 114.111 173.694 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -75.07 -1.8 11.72 Favored 'Trans proline' 0 C--N 1.3 -1.994 1 C-N-CA 127.188 5.259 . . . . 1.25 113.904 -174.868 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -76.13 -34.2 59.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.905 2.482 . . . . 2.25 109.076 171.381 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -82.01 -25.97 34.25 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.056 2.36 . . . . 2.02 110.108 -175.591 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -82.22 125.02 30.44 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.766 2.698 . . . . 0.69 111.038 -171.746 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -114.99 98.07 6.6 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 109.335 -3.575 . . . . 2.78 109.694 167.837 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.3 mt -79.28 125.47 29.53 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 119.244 -2.16 . . . . 1.17 113.114 176.024 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.9 mm -112.92 123.33 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 O-C-N 119.469 -2.019 . . . . 1.38 106.04 176.18 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.439 ' HB2' HD23 ' A' ' 67' ' ' LEU . 10.9 t80 -91.03 -73.76 0.52 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 117.56 -1.656 . . . . 1.5 111.88 168.911 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.72 -69.32 0.65 Allowed 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 128.147 2.579 . . . . 1.21 114.035 179.895 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.47 17.48 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.72 1 O-C-N 112.9 -6.125 . . . . 1.3 115.914 -177.006 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -141.85 162.9 34.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 112.509 -1.845 . . . . 2.55 107.694 178.418 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -64.31 168.34 5.74 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 118.175 2.657 . . . . 2.48 118.175 168.146 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.458 HD22 ' CD2' ' A' ' 59' ' ' TYR . 91.4 mt -123.22 128.18 49.66 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.188 -2.195 . . . . 0.9 107.252 -172.622 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -90.06 152.86 20.96 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.796 1.776 . . . . 1.94 115.796 179.565 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.93 -37.82 79.13 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 129.731 3.212 . . . . 1.56 115.379 -165.375 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.88 43.84 1.8 Allowed Glycine 0 N--CA 1.43 -1.721 1 CA-C-O 113.096 -4.169 . . . . 0.97 109.616 169.913 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -122.12 162.0 22.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.524 3.162 . . . . 2.49 104.758 166.088 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.256 20.7 p -95.79 168.41 10.67 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 113.34 -1.755 . . . . 0.76 113.824 -177.551 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -56.96 -46.98 81.76 Favored 'General case' 0 N--CA 1.43 -1.468 1 C-N-CA 132.298 4.239 . . . . 1.05 115.768 168.666 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 t -60.94 -37.85 83.8 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 117.221 2.304 . . . . 1.19 117.221 173.73 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.276 11.7 t0 -46.19 -60.65 2.17 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 129.624 3.169 . . . . 1.9 111.869 178.171 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.458 ' CD2' HD22 ' A' ' 50' ' ' LEU . 60.6 m-85 -79.68 -1.66 39.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 112.57 -2.105 . . . . 0.89 116.397 -175.368 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.357 33.1 m120 73.89 52.22 0.11 Allowed 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 127.857 2.463 . . . . 1.84 114.176 -178.825 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.1 mt -96.31 117.44 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 103.901 -2.629 . . . . 0.82 103.901 -177.944 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -113.45 178.51 4.25 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 125.058 2.361 . . . . 2.16 111.578 -173.395 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -64.87 129.1 38.48 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 114.918 -4.864 . . . . 2.12 110.844 172.714 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.313 18.1 mt-10 80.03 36.18 0.13 Allowed 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 123.509 1.623 . . . . 1.71 114.558 178.108 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -107.18 125.18 50.78 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.203 2.201 . . . . 1.04 114.808 -176.205 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.9 m -97.32 117.69 32.11 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 121.323 -0.861 . . . . 0.79 111.029 -177.867 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.439 HD23 ' HB2' ' A' ' 45' ' ' PHE . 2.9 mp -101.88 164.7 11.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.479 1.133 . . . . 1.4 109.536 179.361 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -119.69 113.13 20.19 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 116.992 -1.48 . . . . 1.51 111.856 -176.496 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -80.55 131.97 35.6 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 124.654 1.221 . . . . 1.14 108.328 176.197 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.5 t -113.0 129.36 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 105.572 -2.01 . . . . 1.23 105.572 166.274 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 N--CA 1.431 -1.397 0 N-CA-C 108.555 -0.906 . . . . 2.78 108.555 179.644 . . . . . . . . 0 0 . 1 . 064 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ptt? . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 115.963 1.838 . . . . 1.1 115.963 . . . . . . . . . 0 0 . 1 . 064 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -102.91 127.71 50.01 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 114.923 -2.465 . . . . 1.87 112.592 -175.968 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.4 pt -124.54 176.53 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 123.104 2.683 . . . . 0.72 109.303 176.246 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -120.51 152.72 37.66 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.496 -2.627 . . . . 1.4 111.078 172.992 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.9 t -135.67 124.39 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 105.627 -1.99 . . . . 0.58 105.627 173.72 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -106.69 133.4 51.41 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 114.203 1.186 . . . . 2.09 114.203 175.67 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -95.99 165.39 12.29 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.669 1.588 . . . . 0.99 111.559 -179.588 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.258 43.2 mt -72.28 -28.58 63.19 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 118.037 2.606 . . . . 2.53 118.037 175.939 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 p -76.71 -26.98 55.27 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 126.805 2.042 . . . . 2.08 109.095 -179.362 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.6 46.46 0.48 Allowed Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 129.61 3.481 . . . . 1.31 114.951 167.07 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -109.82 133.83 52.72 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.707 3.203 . . . . 1.4 106.448 177.091 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 m -117.02 106.97 13.97 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 124.192 0.933 . . . . 0.78 109.34 167.521 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mt -85.49 136.95 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.358 1.863 . . . . 1.55 113.919 179.042 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.9 m -95.72 117.37 30.38 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 114.921 -2.466 . . . . 1.08 105.56 176.581 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.3 mt -129.08 137.83 51.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 124.651 3.387 . . . . 1.55 111.175 178.512 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -99.48 128.8 45.62 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 126.739 3.161 . . . . 1.95 110.082 172.379 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.69 172.76 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 101.922 -3.362 . . . . 0.96 101.922 -174.426 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -117.9 155.92 50.53 Favored Pre-proline 0 N--CA 1.43 -1.451 0 N-CA-C 104.276 -2.49 . . . . 2.35 104.276 163.392 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -73.73 -7.22 19.84 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 N-CA-C 115.702 1.385 . . . . 0.95 115.702 -170.414 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.1 p -97.57 -0.75 45.27 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 126.199 1.799 . . . . 1.45 109.188 178.179 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -76.89 148.88 36.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.482 -2.636 . . . . 1.69 108.287 173.785 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 72.5 p -85.91 165.13 17.02 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.938 2.495 . . . . 0.75 116.722 176.092 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.9 mm -70.27 -28.74 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 117.435 -3.291 . . . . 0.73 114.776 -178.146 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.25 75.3 tt0 -56.7 -46.56 81.15 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.015 1.388 . . . . 1.62 114.622 167.925 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -67.27 -37.32 83.27 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.362 -2.711 . . . . 2.13 110.798 179.688 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -66.72 -46.66 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 119.77 -1.831 . . . . 0.62 109.109 178.161 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -60.52 -39.22 87.03 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.903 -1.044 . . . . 1.22 112.446 174.724 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.46 -15.16 62.36 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 116.972 2.212 . . . . 0.51 116.972 175.532 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 29' ' ' LYS . 20.2 ttmm -85.3 -33.75 22.04 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.152 1.781 . . . . 1.44 114.316 177.735 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.3 mt -66.99 -47.43 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 1 C-N-CA 131.702 4.001 . . . . 1.32 106.718 166.634 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -47.8 -55.58 9.36 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 121.266 3.802 . . . . 1.7 121.266 173.534 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -34.21 -59.85 0.42 Allowed 'General case' 0 N--CA 1.431 -1.41 1 C-N-CA 131.777 4.031 . . . . 1.55 112.928 164.605 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -66.39 -57.61 7.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 118.488 2.773 . . . . 2.62 118.488 179.817 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -82.81 -45.64 14.07 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 130.411 3.484 . . . . 1.48 110.874 -171.093 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.18 47.27 1.74 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 107.6 -2.2 . . . . 1.12 107.6 174.178 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.7 mt -120.33 129.15 25.47 Favored Pre-proline 0 N--CA 1.431 -1.413 0 C-N-CA 127.504 2.322 . . . . 1.55 107.825 -169.143 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -72.65 145.69 42.1 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 114.007 -3.733 . . . . 1.02 112.375 175.691 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -65.18 -13.88 42.17 Favored 'Trans proline' 0 N--CA 1.433 -2.062 0 CA-C-N 126.668 3.417 . . . . 1.25 118.463 -177.392 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -56.24 -44.39 79.59 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 124.818 2.246 . . . . 2.25 114.227 175.088 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -90.27 -6.36 55.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 110.535 -3.03 . . . . 2.02 114.09 -177.678 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.415 ' HA ' HD23 ' A' ' 71' ' ' LEU . 66.5 mt-30 -103.77 139.63 38.73 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.353 -2.462 . . . . 0.69 104.353 -177.501 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -130.88 145.48 52.02 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.141 1.924 . . . . 2.78 108.711 167.962 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 mt -107.47 130.34 54.85 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.727 -1.583 . . . . 1.17 106.727 178.931 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 7.1 mm -112.28 140.14 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 105.293 -2.114 . . . . 1.38 105.293 177.925 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -155.07 126.99 7.58 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 125.07 2.367 . . . . 1.5 108.512 175.275 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.358 . . 61.86 34.05 17.27 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 127.747 3.641 . . . . 1.21 118.722 -175.885 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.31 -18.1 11.48 Favored Glycine 0 N--CA 1.429 -1.804 0 O-C-N 118.442 -2.661 . . . . 1.3 114.375 -178.495 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.263 30.0 mtmt -95.77 148.7 22.31 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.607 -3.29 . . . . 2.55 110.278 -177.393 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -88.09 122.1 31.27 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.26 2.225 . . . . 2.48 107.791 172.67 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.2 mt -74.04 162.07 29.4 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 110.06 -3.245 . . . . 0.9 112.433 -176.803 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -109.12 159.18 17.09 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.511 -3.243 . . . . 1.94 106.386 172.869 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.56 -58.56 3.22 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.829 2.852 . . . . 1.56 116.246 -169.93 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.94 43.13 2.59 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 127.356 2.407 . . . . 0.97 113.74 172.999 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -120.87 148.3 44.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.535 -3.332 . . . . 2.49 103.991 164.135 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.9 p -76.69 163.44 26.83 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 118.204 2.668 . . . . 0.76 118.204 170.609 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mt -55.55 -44.53 76.87 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.983 2.913 . . . . 1.05 109.9 170.461 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 p -59.44 -32.11 69.91 Favored 'General case' 0 N--CA 1.431 -1.412 1 O-C-N 129.813 4.446 . . . . 1.19 116.563 174.675 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -69.08 -34.8 75.71 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.609 1.671 . . . . 1.9 112.63 172.62 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -82.97 0.1 46.18 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.898 -3.626 . . . . 0.89 117.684 177.709 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.4 t30 48.96 43.7 22.0 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 131.661 3.984 . . . . 1.84 115.104 -176.535 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.2 mt -82.33 130.46 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 112.845 -1.98 . . . . 0.82 111.959 179.91 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -127.14 178.47 6.0 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 120.089 -1.632 . . . . 2.16 109.798 -173.446 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -57.56 154.72 10.8 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 115.412 1.634 . . . . 2.12 115.412 -178.281 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 61.33 11.02 3.39 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 126.277 1.831 . . . . 1.71 112.461 171.456 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.0 t -89.51 131.07 35.72 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 104.962 -2.236 . . . . 1.04 104.962 -174.069 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.0 m -96.32 114.14 25.79 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 102.761 -3.051 . . . . 0.79 102.761 -174.413 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mt -90.96 161.93 14.95 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.21 -2.806 . . . . 1.4 111.673 167.648 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.419 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 80.6 m80 -112.58 127.03 55.97 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 117.564 -1.208 . . . . 1.51 113.3 -177.54 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.4 tp -93.79 134.63 35.93 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 124.639 1.175 . . . . 1.14 110.635 176.805 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.0 m -129.92 156.47 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 103.823 -2.658 . . . . 1.23 103.823 174.503 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 41' ' ' GLN . 86.1 mt . . . . . 0 N--CA 1.431 -1.415 0 CA-C-O 125.059 2.361 . . . . 2.78 113.108 -179.755 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ptt? . . . . . 0 CA--C 1.49 -1.347 0 CA-C-O 123.032 1.396 . . . . 1.1 114.107 . . . . . . . . . 0 0 . 1 . 065 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -94.27 133.52 37.72 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 115.876 1.806 . . . . 1.87 115.876 -174.303 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.9 pt -127.44 153.78 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 120.727 -1.233 . . . . 0.72 109.627 173.993 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.304 58.2 m-85 -112.74 119.1 36.91 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 125.237 1.586 . . . . 1.4 113.099 -179.858 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.442 HG21 HD11 ' A' ' 30' ' ' ILE . 15.5 t -105.53 120.03 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 116.043 -2.263 . . . . 0.58 113.536 177.094 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -88.36 116.99 26.97 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.872 -2.392 . . . . 2.09 114.477 178.318 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.295 19.9 p -72.84 168.2 19.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.001 1.72 . . . . 0.99 112.988 178.774 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.417 HD21 HG12 ' A' ' 70' ' ' VAL 0.291 19.0 mt -66.15 -45.64 80.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.416 1.462 . . . . 2.53 113.862 173.981 . . . . . . . . 3 3 . 1 . 065 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -65.14 -67.24 0.45 Allowed 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 117.379 2.362 . . . . 2.08 117.379 176.555 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.75 22.57 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 117.967 -2.063 . . . . 1.31 115.502 177.893 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -106.37 130.48 54.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.44 -1.319 . . . . 1.4 107.44 -176.831 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.9 m -99.34 107.69 20.02 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 105.722 -1.955 . . . . 0.78 105.722 172.165 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.1 mt -78.57 119.27 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 118.948 -2.345 . . . . 1.55 110.661 -179.967 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.6 m -83.1 117.98 23.24 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.394 -1.442 . . . . 1.08 108.736 174.163 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.2 mt -111.79 164.15 13.38 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 118.841 0.746 . . . . 1.55 111.58 179.136 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.75 129.54 56.38 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.351 1.06 . . . . 1.95 109.05 167.539 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.09 161.53 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 104.307 -2.479 . . . . 0.96 104.307 178.046 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -106.71 137.43 19.47 Favored Pre-proline 0 N--CA 1.43 -1.437 0 C-N-CA 128.172 2.589 . . . . 2.35 108.647 163.162 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -68.0 -8.42 22.6 Favored 'Trans proline' 0 N--CA 1.433 -2.04 0 C-N-CA 122.672 2.248 . . . . 0.95 114.586 -174.023 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.6 p -101.35 10.59 40.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.458 2.39 . . . . 1.45 111.697 175.676 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -91.35 165.06 13.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.503 1.62 . . . . 1.69 108.692 -176.7 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -90.4 161.2 15.68 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.777 -4.327 . . . . 0.75 110.093 -178.56 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.3 mt -72.22 -34.29 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.438 -2.663 . . . . 0.73 115.703 -177.156 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -52.47 -45.14 65.97 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.418 2.377 . . . . 1.62 117.418 157.14 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -58.29 -38.73 77.62 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 116.364 -3.96 . . . . 2.13 110.919 175.093 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.74 -49.2 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 122.828 1.299 . . . . 0.62 112.217 170.75 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -55.81 -39.58 71.53 Favored 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 115.786 -4.321 . . . . 1.22 114.658 175.945 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.258 . . -55.86 -31.23 62.59 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.334 2.654 . . . . 0.51 113.2 168.562 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 30.1 mmmt -65.69 -36.25 83.08 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 116.51 -3.868 . . . . 1.44 114.797 173.839 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.442 HD11 HG21 ' A' ' 5' ' ' VAL . 19.0 mt -66.47 -34.41 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 114.932 1.456 . . . . 1.32 114.932 170.266 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -59.86 -38.94 83.58 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 130.106 3.362 . . . . 1.7 109.255 178.148 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -50.42 -46.64 56.56 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 119.452 3.13 . . . . 1.55 119.452 163.837 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -80.54 -45.65 17.08 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 124.884 1.274 . . . . 2.62 111.747 -177.728 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -100.89 -44.29 5.81 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.738 -1.208 . . . . 1.48 107.738 -166.923 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.37 16.99 47.91 Favored Glycine 0 N--CA 1.43 -1.707 0 O-C-N 118.296 -2.752 . . . . 1.12 114.725 177.742 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.1 mt -98.26 127.46 36.4 Favored Pre-proline 0 N--CA 1.43 -1.461 1 C-N-CA 132.235 4.214 . . . . 1.55 104.114 174.583 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.91 151.57 81.97 Favored 'Trans proline' 0 N--CA 1.432 -2.093 1 O-C-N 112.363 -4.599 . . . . 1.02 114.289 -177.928 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.2 -19.29 20.11 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 CA-C-N 124.288 2.567 . . . . 1.25 112.28 -169.633 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -57.84 -30.27 65.63 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 120.615 1.552 . . . . 2.25 114.103 168.033 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.272 32.3 tt0 -77.17 -33.36 56.48 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 118.044 -2.91 . . . . 2.02 112.809 178.799 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -80.57 148.18 30.46 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 117.391 2.367 . . . . 0.69 117.391 -172.97 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -146.64 139.41 25.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.662 -1.607 . . . . 2.78 106.662 173.736 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.1 mt -105.06 145.15 30.89 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.067 -3.521 . . . . 1.17 109.694 -178.634 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.5 mm -119.76 140.67 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 105.456 -2.053 . . . . 1.38 105.456 -178.322 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -147.57 135.04 20.79 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.985 -1.697 . . . . 1.5 110.401 170.919 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.87 8.46 0.16 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 130.213 3.405 . . . . 1.21 116.532 -177.158 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.36 -25.79 9.01 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 129.684 3.516 . . . . 1.3 113.738 -174.498 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -79.61 146.52 32.5 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 121.202 2.501 . . . . 2.55 111.147 179.01 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -89.47 123.46 33.61 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 101.259 -3.608 . . . . 2.48 101.259 172.648 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.7 mt -85.42 145.41 27.46 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 105.709 -1.96 . . . . 0.9 105.709 -172.208 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -79.56 154.88 28.46 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 115.886 1.81 . . . . 1.94 115.886 173.8 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -82.74 -47.36 12.05 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.43 -3.294 . . . . 1.56 117.595 -171.359 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.21 57.34 1.73 Allowed Glycine 0 N--CA 1.43 -1.737 1 O-C-N 116.286 -4.009 . . . . 0.97 111.447 178.432 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.0 ttt85 -138.08 164.37 29.27 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.815 -1.92 . . . . 2.49 105.815 171.822 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.7 p -101.76 153.84 19.44 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 116.495 2.035 . . . . 0.76 116.495 175.366 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.8 mt -53.0 -47.34 68.35 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 126.293 2.949 . . . . 1.05 113.996 177.948 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.4 p -60.86 -24.65 66.07 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.061 -4.15 . . . . 1.19 120.384 174.38 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.28 -30.18 70.55 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 123.147 2.703 . . . . 1.9 114.798 172.946 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -86.87 -12.79 46.76 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.733 2.813 . . . . 0.89 114.646 177.611 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 m120 66.47 45.03 2.21 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.472 -1.695 . . . . 1.84 114.582 -174.311 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.9 mt -98.32 106.71 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 128.327 3.917 . . . . 0.82 110.298 179.01 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -89.45 171.8 9.46 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 110.718 -2.947 . . . . 2.16 116.321 -170.933 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -52.53 137.7 29.55 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.536 1.935 . . . . 2.12 112.403 170.168 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.275 37.0 mt-10 56.4 41.56 28.76 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 119.926 3.306 . . . . 1.71 119.926 178.65 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.8 m -98.62 156.45 16.81 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.184 2.193 . . . . 1.04 110.166 -179.592 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.4 m -106.95 106.48 17.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.914 2.769 . . . . 0.79 111.746 -175.329 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -94.82 164.36 12.96 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.351 2.024 . . . . 1.4 109.298 176.343 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -137.5 122.08 18.5 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 126.235 2.921 . . . . 1.51 107.6 -179.386 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.5 tp -87.92 133.8 33.85 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 111.455 -2.611 . . . . 1.14 117.067 178.185 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.417 HG12 HD21 ' A' ' 8' ' ' LEU . 28.6 m -130.02 173.23 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.184 -2.822 . . . . 1.23 106.008 173.487 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.7 mt . . . . . 0 N--CA 1.429 -1.49 0 O-C-N 118.422 -2.673 . . . . 2.78 108.846 -173.954 . . . . . . . . 0 0 . 1 . 066 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 CA--C 1.49 -1.361 0 N-CA-C 120.207 3.41 . . . . 1.1 120.207 . . . . . . . . . 0 0 . 1 . 066 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -96.62 140.17 31.62 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 105.82 -1.919 . . . . 1.87 105.82 179.862 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.7 pt -136.43 165.16 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 129.928 3.291 . . . . 0.72 108.868 167.877 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -118.95 132.75 56.09 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.28 -2.138 . . . . 1.4 115.476 -175.812 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.7 t -118.29 121.64 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 1 O-C-N 116.056 -4.152 . . . . 0.58 112.825 176.634 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -91.15 128.11 36.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 118.456 2.762 . . . . 2.09 118.456 178.455 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.491 HG22 HD23 ' A' ' 69' ' ' LEU . 39.4 p -79.53 -177.83 6.01 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.069 2.366 . . . . 0.99 113.232 -177.293 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.3 mt -68.04 -43.6 78.34 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 113.939 -1.482 . . . . 2.53 113.203 166.506 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.6 p -73.89 -21.0 60.24 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 123.005 1.383 . . . . 2.08 108.919 -175.861 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.38 23.68 4.38 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 116.539 -3.851 . . . . 1.31 113.281 171.047 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -82.87 136.25 34.67 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 112.664 -3.541 . . . . 1.4 113.059 -176.932 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.4 m -95.69 118.86 33.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 123.916 3.053 . . . . 0.78 109.343 170.588 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.1 mt -90.74 123.58 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 130.509 3.524 . . . . 1.55 108.119 174.766 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 m -97.6 112.26 24.2 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 116.666 -3.771 . . . . 1.08 107.048 -179.67 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.4 mt -126.75 152.73 46.47 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.425 1.09 . . . . 1.55 113.469 -178.619 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -107.26 146.47 31.42 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.74 -1.207 . . . . 1.95 107.74 172.046 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 m -149.25 178.4 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 102.236 -3.246 . . . . 0.96 102.236 -177.479 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -138.55 157.57 71.95 Favored Pre-proline 0 N--CA 1.43 -1.47 0 CA-C-O 124.076 1.893 . . . . 2.35 106.196 158.996 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 47.6 Cg_exo -52.92 -23.7 22.03 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 124.943 3.762 . . . . 0.95 118.019 -175.221 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.1 m -79.26 -13.15 59.86 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 120.179 1.354 . . . . 1.45 114.107 178.775 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -72.57 153.87 41.07 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 112.73 0.641 . . . . 1.69 112.73 -179.943 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.2 p -87.41 167.42 14.03 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 126.403 3.001 . . . . 0.75 109.906 174.742 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 43' ' ' LEU . 26.7 mm -70.58 -34.19 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 1 O-C-N 116.236 -4.04 . . . . 0.73 109.107 174.202 . . . . . . . . 3 3 . 1 . 066 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.313 29.1 tt0 -51.89 -44.32 63.71 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 116.872 2.175 . . . . 1.62 116.872 168.088 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -71.15 -9.28 57.81 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 119.549 3.166 . . . . 2.13 119.549 179.642 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -87.12 -38.98 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 C-N-CA 126.208 1.803 . . . . 0.62 108.205 167.384 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -75.53 -24.28 56.74 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 117.462 2.393 . . . . 1.22 117.462 177.853 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.07 -45.24 89.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.822 2.449 . . . . 0.51 108.259 165.335 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -57.74 -31.95 66.97 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 118.01 2.596 . . . . 1.44 118.01 164.3 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.447 HD13 HD22 ' A' ' 69' ' ' LEU . 46.8 mt -78.14 -20.79 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 118.816 -2.428 . . . . 1.32 115.859 177.742 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -59.99 -30.13 68.92 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.891 -1.755 . . . . 1.7 112.725 165.606 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -74.06 -51.18 16.57 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.435 -2.041 . . . . 1.55 114.844 168.634 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -56.48 -55.34 34.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.675 -1.148 . . . . 2.62 111.573 -172.474 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -107.65 -57.71 2.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 126.134 2.147 . . . . 1.48 113.468 -173.188 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.16 9.5 2.12 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 127.05 2.719 . . . . 1.12 116.135 173.849 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.8 mt -88.96 139.19 29.0 Favored Pre-proline 0 N--CA 1.43 -1.467 1 CA-C-O 111.678 -4.01 . . . . 1.55 111.379 -174.665 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -77.81 151.53 28.11 Favored 'Trans proline' 0 C--N 1.3 -2.0 1 CA-C-N 133.151 5.732 . . . . 1.02 110.936 -171.945 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.45 -17.04 43.9 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 O-C-N 125.453 2.291 . . . . 1.25 112.641 -176.011 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -54.41 -59.95 3.99 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 114.807 -2.52 . . . . 2.25 110.998 167.628 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -70.39 -17.33 63.03 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.394 3.878 . . . . 2.02 117.55 -176.525 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -95.8 147.18 23.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.431 -0.793 . . . . 0.69 111.912 -178.984 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -136.59 139.56 42.21 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.604 -3.185 . . . . 2.78 113.186 170.674 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.402 HD12 HG23 ' A' ' 23' ' ' ILE . 18.8 mt -96.49 143.44 27.5 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.065 -3.522 . . . . 1.17 118.901 174.371 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.8 mt -119.53 139.84 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 102.409 -3.182 . . . . 1.38 102.409 179.317 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -145.58 120.57 10.03 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 101.47 -3.53 . . . . 1.5 101.47 168.673 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.8 52.08 1.71 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 120.05 3.352 . . . . 1.21 120.05 173.874 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.75 2.59 6.38 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 129.094 3.235 . . . . 1.3 116.939 177.818 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -120.93 152.9 37.94 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.609 -2.701 . . . . 2.55 109.56 174.873 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -84.96 138.33 32.55 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.337 2.494 . . . . 2.48 109.119 174.629 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.3 mt -94.69 145.21 25.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.239 2.216 . . . . 0.9 109.153 -175.913 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -85.97 142.67 28.63 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.932 -2.355 . . . . 1.94 113.869 170.432 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -59.05 -58.62 7.84 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.821 3.649 . . . . 1.56 112.64 -175.227 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.23 39.39 3.05 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 127.826 2.632 . . . . 0.97 115.301 172.474 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.483 ' HD2' ' HA ' ' A' ' 54' ' ' ARG . 18.7 mmm-85 -110.35 150.62 28.52 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.811 2.719 . . . . 2.49 107.333 155.232 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.1 p -76.28 155.98 33.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.322 -3.361 . . . . 0.76 109.841 172.632 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.519 HD22 HD12 ' A' ' 61' ' ' ILE . 46.8 mt -60.36 -39.4 87.05 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 114.309 1.225 . . . . 1.05 114.309 172.093 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.288 82.7 p -50.62 -42.4 56.03 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.306 -3.371 . . . . 1.19 112.504 175.347 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -56.49 -42.17 77.86 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.537 -3.227 . . . . 1.9 111.804 176.175 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -87.12 -13.57 43.8 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 114.5 -2.667 . . . . 0.89 112.769 177.125 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 70.23 24.71 4.77 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.704 2.669 . . . . 1.84 117.05 -178.971 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.519 HD12 HD22 ' A' ' 56' ' ' LEU . 7.0 mt -70.37 112.54 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 113.064 -1.88 . . . . 0.82 111.531 179.061 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -87.95 179.52 6.42 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.123 -1.611 . . . . 2.16 108.658 178.209 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -55.7 142.25 34.93 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 130.911 3.684 . . . . 2.12 117.796 173.251 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.46 37.6 mt-10 77.21 10.84 2.4 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.499 -2.001 . . . . 1.71 113.769 170.029 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.1 m -75.08 146.13 41.72 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.648 3.179 . . . . 1.04 111.717 177.773 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.2 m -111.02 113.22 25.6 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 125.323 2.487 . . . . 0.79 105.241 -179.294 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.4 mt -96.73 127.19 42.48 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 125.968 1.707 . . . . 1.4 111.39 175.883 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -84.89 136.84 33.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.987 -1.695 . . . . 1.51 109.842 -177.4 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.491 HD23 HG22 ' A' ' 7' ' ' THR . 1.7 tp -104.75 121.01 42.72 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.457 2.348 . . . . 1.14 105.26 178.792 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 m -123.65 163.95 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 119.59 -1.944 . . . . 1.23 106.299 172.847 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.6 mt . . . . . 0 N--CA 1.431 -1.397 0 O-C-N 119.389 -2.07 . . . . 2.78 112.019 176.281 . . . . . . . . 0 0 . 1 . 067 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 ptt? . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 114.284 1.216 . . . . 1.1 114.284 . . . . . . . . . 0 0 . 1 . 067 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -112.77 122.94 49.14 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 125.828 1.955 . . . . 1.87 112.229 -171.052 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.684 HG22 ' H ' ' A' ' 65' ' ' SER . 5.7 pt -113.07 157.61 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 126.324 2.265 . . . . 0.72 116.175 167.348 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -103.66 125.39 50.13 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.672 1.589 . . . . 1.4 110.165 -174.818 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 t -103.0 125.61 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.109 -2.245 . . . . 0.58 110.974 173.887 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -93.4 118.05 30.83 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.679 2.487 . . . . 2.09 113.009 176.097 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -94.84 171.53 8.72 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.566 -1.959 . . . . 0.99 109.749 -174.421 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.4 mt -83.19 -5.59 59.18 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 117.713 2.486 . . . . 2.53 117.713 171.613 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -88.64 -32.57 17.98 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 104.941 -2.244 . . . . 2.08 104.941 179.88 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.8 37.61 1.04 Allowed Glycine 0 N--CA 1.429 -1.777 0 C-N-CA 126.56 2.028 . . . . 1.31 110.853 -179.952 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -106.7 144.92 32.66 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.764 -1.433 . . . . 1.4 109.798 -179.94 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.5 m -104.84 114.41 28.61 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.564 2.746 . . . . 0.78 108.002 168.462 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.4 mt -109.96 116.66 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 118.55 -2.594 . . . . 1.55 105.062 -168.712 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 m -89.84 97.07 10.98 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.387 1.875 . . . . 1.08 109.944 179.005 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.2 mt -96.5 131.78 42.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 112.531 -2.122 . . . . 1.55 116.383 177.632 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -88.23 111.22 21.4 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.967 2.907 . . . . 1.95 109.787 172.461 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.54 158.26 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 116.565 -3.835 . . . . 0.96 104.447 -172.543 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -103.01 161.23 23.74 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 117.348 -1.311 . . . . 2.35 111.716 169.064 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -75.67 -11.95 20.27 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 CA-C-N 121.008 1.396 . . . . 0.95 113.731 -168.252 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.4 p -85.75 -6.3 59.13 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 125.611 1.819 . . . . 1.45 110.733 175.785 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -76.46 149.69 36.77 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 123.851 1.786 . . . . 1.69 109.138 172.574 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.299 63.3 p -90.17 166.54 13.32 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.881 2.277 . . . . 0.75 108.967 -179.578 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.461 HG23 HD12 ' A' ' 43' ' ' LEU . 19.8 mm -63.79 -36.69 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 111.933 -2.394 . . . . 0.73 110.1 179.956 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -53.14 -42.12 65.76 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 121.509 3.892 . . . . 1.62 121.509 163.142 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 -59.97 -27.51 66.89 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.406 2.373 . . . . 2.13 117.406 173.302 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.9 t -72.23 -47.14 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 C-N-CA 127.112 2.165 . . . . 0.62 114.331 169.302 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 79.5 mttt -60.37 -29.4 68.9 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 113.972 -1.467 . . . . 1.22 112.593 172.5 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.26 -25.58 65.25 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 116.002 -4.186 . . . . 0.51 117.295 -179.556 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -76.77 -35.1 57.93 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 127.156 2.182 . . . . 1.44 109.533 179.471 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.4 mt -71.64 -32.96 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 126.311 1.845 . . . . 1.32 108.88 174.344 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -62.84 -45.42 92.67 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.736 -4.353 . . . . 1.7 111.887 173.376 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -50.73 -60.91 2.56 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 116.206 1.928 . . . . 1.55 116.206 168.063 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -65.14 -62.28 1.64 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.067 2.547 . . . . 2.62 111.45 -174.472 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -105.41 -38.39 6.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.458 -1.401 . . . . 1.48 109.933 -160.596 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.7 -11.2 7.49 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 117.575 -3.203 . . . . 1.12 114.063 168.152 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.0 mt -67.1 124.18 88.21 Favored Pre-proline 0 N--CA 1.429 -1.497 0 O-C-N 119.814 -1.992 . . . . 1.55 108.549 -174.451 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.83 145.05 35.75 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 CA-C-N 120.847 1.338 . . . . 1.02 109.578 172.976 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.03 -0.39 3.99 Favored 'Trans proline' 0 C--N 1.3 -2.009 1 C-N-CA 127.634 5.556 . . . . 1.25 115.975 -169.732 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -91.36 -13.91 31.64 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.117 1.78 . . . . 2.25 113.028 169.99 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -87.94 -45.65 10.06 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 121.47 1.941 . . . . 2.02 111.793 178.815 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -79.33 126.69 31.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.375 2.512 . . . . 0.69 110.963 -176.384 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -113.35 151.15 31.61 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 117.538 -3.226 . . . . 2.78 107.683 171.537 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.461 HD12 HG23 ' A' ' 23' ' ' ILE . 85.1 mt -114.58 120.53 40.49 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 126.223 2.202 . . . . 1.17 111.676 176.817 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.269 82.7 mt -105.49 132.32 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 N-CA-C 115.195 1.554 . . . . 1.38 115.195 175.734 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -148.18 126.36 12.17 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 119.008 -2.308 . . . . 1.5 112.57 173.916 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.17 21.56 7.15 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.874 1.805 . . . . 1.21 115.874 -175.645 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.7 8.48 77.04 Favored Glycine 0 N--CA 1.429 -1.774 1 C-N-CA 131.967 4.603 . . . . 1.3 113.575 -173.451 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -101.38 128.99 47.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.858 -1.534 . . . . 2.55 106.858 179.14 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -74.21 112.03 9.95 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 127.893 2.477 . . . . 2.48 114.02 170.365 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 mt -83.11 124.27 30.32 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 117.741 -1.584 . . . . 0.9 114.725 -163.317 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -75.73 135.36 40.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.344 -3.347 . . . . 1.94 110.849 -178.976 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.413 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -63.05 -45.17 93.5 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 109.144 -3.662 . . . . 1.56 115.941 -168.317 . . . . . . . . 3 3 . 1 . 067 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.18 29.82 1.63 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 118.246 2.058 . . . . 0.97 118.246 166.703 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.5 mtp180 -120.53 158.16 27.89 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 124.21 1.957 . . . . 2.49 111.72 163.452 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.3 p -89.16 168.58 12.18 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 124.216 1.96 . . . . 0.76 114.312 171.585 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.331 8.4 mt -66.7 -38.52 86.9 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 110.845 -2.888 . . . . 1.05 105.25 174.603 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -68.09 -32.53 72.91 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.896 -3.002 . . . . 1.19 111.919 -179.021 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.32 38.0 t0 -63.08 -47.73 81.63 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.484 2.031 . . . . 1.9 116.484 174.219 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -73.86 -9.47 58.68 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.444 -3.91 . . . . 0.89 114.97 168.777 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.4 t30 66.63 58.37 0.64 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.662 2.385 . . . . 1.84 113.804 -178.883 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mt -100.67 120.78 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 126.253 1.821 . . . . 0.82 110.087 -178.15 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.23 174.78 5.98 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.539 1.638 . . . . 2.16 111.792 -174.521 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -53.66 148.51 9.62 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.876 -3.64 . . . . 2.12 114.959 169.199 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.251 86.3 mt-10 67.79 25.18 8.03 Favored 'General case' 0 N--CA 1.431 -1.378 1 C-N-CA 132.699 4.4 . . . . 1.71 110.372 178.495 . . . . . . . . 3 2 . 1 . 067 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.684 ' H ' HG22 ' A' ' 3' ' ' ILE . 69.0 m -75.86 143.9 41.52 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.58 2.61 . . . . 1.04 110.481 -177.496 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.6 m -100.64 97.16 7.86 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.949 -3.594 . . . . 0.79 110.209 -179.519 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.408 HD11 HD12 ' A' ' 3' ' ' ILE . 16.4 mt -91.64 128.76 37.59 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 126.033 2.083 . . . . 1.4 111.54 -178.676 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -89.09 116.12 27.13 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.93 -3.606 . . . . 1.51 113.09 177.34 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 tt -97.54 123.05 41.28 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 104.935 -2.246 . . . . 1.14 104.935 -177.737 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.52 176.41 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 O-C-N 118.686 -2.508 . . . . 1.23 106.135 174.677 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 N--CA 1.431 -1.39 0 CA-C-O 125.121 2.391 . . . . 2.78 105.58 173.385 . . . . . . . . 0 0 . 1 . 068 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 CA--C 1.49 -1.338 0 CA-C-O 118.662 -0.685 . . . . 1.1 112.825 . . . . . . . . . 0 0 . 1 . 068 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -97.96 148.74 23.16 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 120.316 1.416 . . . . 1.87 112.784 -176.492 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.0 pt -130.51 169.05 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.896 -2.377 . . . . 0.72 106.647 171.85 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -112.82 125.93 54.88 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.862 1.43 . . . . 1.4 114.862 179.585 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 t -114.76 116.64 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 126.782 3.182 . . . . 0.58 110.26 173.922 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -92.1 119.03 31.4 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 111.202 -2.726 . . . . 2.09 112.057 179.093 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.1 p -75.1 179.41 5.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.885 2.074 . . . . 0.99 111.488 -178.815 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.4 mt -60.59 -41.15 94.12 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.991 -1.068 . . . . 2.53 113.321 177.384 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.5 p -84.85 -38.21 19.76 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 115.491 -2.195 . . . . 2.08 116.9 178.434 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.92 29.57 0.22 Allowed Glycine 0 N--CA 1.429 -1.826 0 O-C-N 126.991 2.682 . . . . 1.31 111.91 175.571 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -86.76 131.49 34.12 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 119.99 1.895 . . . . 1.4 110.03 175.466 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.5 m -90.93 112.15 23.9 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 117.694 -1.603 . . . . 0.78 109.312 177.188 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.3 mm -95.43 117.21 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 102.666 -3.087 . . . . 1.55 102.666 178.72 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.7 m -100.32 105.13 16.63 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.176 -1.787 . . . . 1.08 106.176 -178.049 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.4 mt -103.12 146.24 28.69 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 118.592 -0.718 . . . . 1.55 109.881 -177.835 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -92.4 139.15 30.89 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 106.407 -1.701 . . . . 1.95 106.407 170.232 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.6 m -142.98 -177.58 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 100.204 -3.999 . . . . 0.96 100.204 -176.831 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -125.94 161.04 53.77 Favored Pre-proline 0 N--CA 1.43 -1.456 0 C-N-CA 128.28 2.632 . . . . 2.35 105.486 169.196 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -62.74 -21.99 73.51 Favored 'Trans proline' 0 C--N 1.3 -2.009 1 C-N-CA 127.832 5.688 . . . . 0.95 111.115 174.792 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 p -83.56 -5.59 59.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 125.898 1.999 . . . . 1.45 113.13 179.936 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -81.29 142.41 33.14 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 120.906 1.685 . . . . 1.69 112.533 179.18 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 61.2 p -87.88 165.28 15.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 128.143 3.402 . . . . 0.75 113.925 175.376 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.2 mm -62.67 -37.19 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 124.697 1.199 . . . . 0.73 111.643 177.957 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -54.94 -42.39 72.22 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 118.656 2.836 . . . . 1.62 118.656 168.515 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -62.88 -36.46 83.37 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 116.873 -3.642 . . . . 2.13 111.774 -178.998 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.3 t -59.83 -48.29 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 C-N-CA 128.84 2.856 . . . . 0.62 114.112 171.229 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -55.85 -43.68 77.31 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 115.242 1.571 . . . . 1.22 115.242 169.689 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.62 -36.69 85.06 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.585 -3.197 . . . . 0.51 115.939 172.467 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.281 41.2 mttm -54.42 -53.87 48.3 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.425 1.89 . . . . 1.44 112.566 167.867 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.9 mt -59.14 -34.79 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 O-C-N 118.198 -2.814 . . . . 1.32 117.751 176.373 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -69.14 -37.25 78.2 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 113.008 -1.906 . . . . 1.7 110.576 178.05 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -65.52 -41.85 92.65 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.988 2.327 . . . . 1.55 115.861 167.661 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -58.97 -82.12 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 125.779 2.704 . . . . 2.62 115.704 -177.73 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -95.56 -23.25 17.16 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.633 2.773 . . . . 1.48 112.939 -171.596 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.14 46.25 3.9 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 117.577 -2.249 . . . . 1.12 113.549 176.165 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.4 mt -105.38 132.09 21.18 Favored Pre-proline 0 N--CA 1.429 -1.475 0 CA-C-O 114.337 -2.744 . . . . 1.55 104.448 178.911 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -67.75 140.55 51.53 Favored 'Trans proline' 0 N--CA 1.434 -1.999 0 CA-C-N 125.439 2.978 . . . . 1.02 117.773 -178.402 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -75.27 -10.59 20.83 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 N-CA-C 120.835 3.359 . . . . 1.25 120.835 -174.173 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -88.7 17.77 5.25 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.35 1.46 . . . . 2.25 108.587 168.507 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -115.24 -31.68 5.91 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.927 -2.983 . . . . 2.02 107.167 -177.686 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -84.09 121.89 28.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 131.457 3.903 . . . . 0.69 117.315 -165.751 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -116.72 122.15 43.66 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.862 1.665 . . . . 2.78 107.545 -179.19 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -95.45 117.7 30.85 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 116.099 -1.905 . . . . 1.17 108.575 -178.427 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mm -101.62 125.11 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 129.308 3.043 . . . . 1.38 111.294 176.888 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -150.9 115.59 5.2 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 127.892 3.71 . . . . 1.5 106.886 174.694 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 46.34 0.77 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 109.098 -3.683 . . . . 1.21 113.939 178.872 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.02 -16.29 0.88 Allowed Glycine 0 N--CA 1.43 -1.712 0 CA-C-O 116.558 -2.246 . . . . 1.3 118.398 -171.189 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -101.5 157.13 17.04 Favored 'General case' 0 N--CA 1.43 -1.464 1 CA-C-N 125.797 4.799 . . . . 2.55 103.326 -175.047 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -95.44 141.86 28.49 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.517 2.103 . . . . 2.48 106.3 172.779 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.7 mt -89.84 136.58 32.96 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.65 -2.531 . . . . 0.9 116.658 -169.909 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -65.29 133.05 50.6 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 120.999 3.703 . . . . 1.94 120.999 175.501 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -60.07 -49.67 76.75 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.759 2.695 . . . . 1.56 114.436 -170.567 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.76 45.61 1.41 Allowed Glycine 0 N--CA 1.43 -1.733 0 CA-C-N 111.374 -2.648 . . . . 0.97 116.653 179.303 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.412 ' HD3' ' CE2' ' A' ' 59' ' ' TYR . 62.3 ttt180 -130.54 127.41 39.05 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 128.271 2.983 . . . . 2.49 112.769 169.576 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.375 2.6 p -63.04 167.04 5.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 121.038 3.718 . . . . 0.76 121.038 173.738 . . . . . . . . 3 3 . 1 . 068 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.4 mt -74.0 -43.28 58.59 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.662 -1.899 . . . . 1.05 110.935 176.464 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 t -60.59 -42.26 96.38 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 122.491 1.139 . . . . 1.19 114.035 176.053 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -56.03 -38.21 70.25 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 121.055 3.724 . . . . 1.9 121.055 173.575 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CE2' ' HD3' ' A' ' 54' ' ' ARG . 21.8 m-85 -80.99 -15.87 55.0 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.282 -2.137 . . . . 0.89 111.158 175.242 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.3 m120 77.94 34.63 0.31 Allowed 'General case' 0 N--CA 1.43 -1.462 1 C-N-CA 132.998 4.519 . . . . 1.84 114.067 -177.732 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -89.69 117.48 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 130.295 3.438 . . . . 0.82 114.901 176.61 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -110.34 -178.23 3.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.031 1.872 . . . . 2.16 108.536 -174.869 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -59.11 153.5 17.88 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.4 -3.313 . . . . 2.12 116.251 179.128 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.3 32.2 mt-10 65.11 31.45 10.99 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 125.223 1.409 . . . . 1.71 110.817 175.115 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.2 t -96.67 152.06 19.02 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 104.06 -2.57 . . . . 1.04 104.06 -175.458 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.3 m -109.95 109.53 20.17 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.781 -1.824 . . . . 0.79 113.84 178.515 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.1 mt -106.39 145.33 31.86 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 128.943 2.897 . . . . 1.4 109.384 176.407 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -109.41 127.52 54.44 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 114.239 -2.791 . . . . 1.51 112.72 -175.207 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.3 tp -93.81 120.89 34.67 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 123.444 2.838 . . . . 1.14 113.0 -175.517 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.9 t -110.62 149.42 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 108.101 -1.074 . . . . 1.23 108.101 175.923 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.2 mt . . . . . 0 N--CA 1.429 -1.478 0 CA-C-O 123.161 1.458 . . . . 2.78 114.531 -179.624 . . . . . . . . 0 0 . 1 . 069 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 CA--C 1.49 -1.331 0 CA-C-O 123.532 1.634 . . . . 1.1 113.204 . . . . . . . . . 0 0 . 1 . 069 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -106.29 125.48 51.05 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.886 -2.384 . . . . 1.87 111.088 -173.702 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.1 pt -120.82 165.58 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 106.266 -1.753 . . . . 0.72 106.266 169.584 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -120.11 139.54 52.43 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.27 -2.769 . . . . 1.4 114.814 -177.02 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.1 t -124.22 125.85 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 118.456 -2.652 . . . . 0.58 108.58 174.029 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -90.6 122.92 33.82 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.798 -4.314 . . . . 2.09 109.695 176.567 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.0 p -91.0 167.32 12.48 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 126.905 2.082 . . . . 0.99 114.828 -179.758 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.521 HD12 HD12 ' A' ' 71' ' ' LEU . 90.3 mt -69.64 -36.8 76.41 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 113.961 1.097 . . . . 2.53 113.961 179.607 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.2 p -74.39 -67.63 0.6 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 130.637 3.575 . . . . 2.08 111.808 -176.881 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.95 62.78 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.638 0 CA-C-O 115.37 -2.906 . . . . 1.31 117.596 171.644 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -150.71 139.16 20.47 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 125.725 2.679 . . . . 1.4 113.818 179.91 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.7 m -102.6 97.42 7.62 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 103.861 -2.644 . . . . 0.78 103.861 174.994 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 13' ' ' ILE . 2.6 mt -65.21 121.57 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 116.763 2.135 . . . . 1.55 116.763 176.184 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.4 m -84.94 105.94 16.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 122.572 2.442 . . . . 1.08 110.119 177.235 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.48 HD23 ' HE3' ' A' ' 33' ' ' LYS . 25.4 mt -101.11 133.77 45.13 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 123.44 1.591 . . . . 1.55 110.193 178.875 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -98.12 110.85 23.36 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 114.652 1.353 . . . . 1.95 114.652 166.909 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.9 m -127.08 176.36 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 128.169 2.588 . . . . 0.96 108.896 -174.8 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.417 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 79.1 mm-40 -116.18 163.76 20.42 Favored Pre-proline 0 N--CA 1.43 -1.455 0 C-N-CA 127.861 2.465 . . . . 2.35 106.56 161.777 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 17.7 Cg_endo -84.58 -6.91 9.82 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 O-C-N 116.569 -2.385 . . . . 0.95 109.751 -166.474 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.4 m -93.23 -6.28 48.0 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.501 2.037 . . . . 1.45 116.501 174.626 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -69.18 147.17 51.71 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 118.801 -1.16 . . . . 1.69 109.639 174.523 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 75.7 p -82.88 175.51 10.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.432 -2.043 . . . . 0.75 112.128 -178.72 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.8 mm -70.24 -42.89 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-O 123.918 1.818 . . . . 0.73 109.316 173.646 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -47.03 -47.77 22.29 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 119.022 2.971 . . . . 1.62 119.022 162.706 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -65.75 -38.18 88.38 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 116.174 -4.079 . . . . 2.13 114.132 174.958 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 56' ' ' LEU . 53.5 t -62.52 -39.31 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 126.758 3.171 . . . . 0.62 111.103 176.012 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -65.99 -33.43 75.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.586 -2.571 . . . . 1.22 114.094 174.131 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.59 -34.1 77.13 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.308 2.255 . . . . 0.51 115.004 173.739 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -74.67 -16.28 60.77 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.309 -2.744 . . . . 1.44 114.811 174.995 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.3 mt -87.0 -36.17 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 127.102 3.334 . . . . 1.32 107.487 171.657 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.97 -38.52 88.77 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.203 -2.811 . . . . 1.7 109.099 -178.274 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -55.93 -48.08 76.36 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.913 -2.992 . . . . 1.55 115.647 170.469 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HE3' HD23 ' A' ' 15' ' ' LEU . 61.9 mttm -79.37 -52.16 8.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.141 -1.6 . . . . 2.62 113.446 -176.243 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -112.44 -8.84 13.87 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.83 1.3 . . . . 1.48 110.386 -161.67 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.98 21.72 60.68 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 118.223 -2.798 . . . . 1.12 113.995 173.601 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mt -83.7 123.38 76.31 Favored Pre-proline 0 N--CA 1.431 -1.386 0 CA-C-O 112.655 -3.545 . . . . 1.55 115.342 -174.555 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -65.81 136.45 45.5 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 CA-C-N 127.199 3.607 . . . . 1.02 116.269 -179.69 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -60.71 -23.0 75.09 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 N-CA-C 117.383 2.032 . . . . 1.25 117.383 -177.286 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.17 -19.5 61.1 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.233 2.213 . . . . 2.25 109.9 177.716 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.418 ' HG2' HD22 ' A' ' 71' ' ' LEU . 17.4 tt0 -92.22 -39.84 11.32 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 130.271 3.428 . . . . 2.02 109.963 -170.654 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -74.45 123.77 25.32 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 113.458 -1.701 . . . . 0.69 113.863 -171.216 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -117.61 123.48 46.28 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 124.379 1.049 . . . . 2.78 109.216 167.792 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.5 mt -105.49 131.34 53.02 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.117 2.389 . . . . 1.17 106.264 -175.965 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.2 mm -116.9 145.57 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 120.349 -1.469 . . . . 1.38 113.49 -178.888 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -161.06 105.07 1.32 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.686 1.736 . . . . 1.5 115.686 174.821 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.468 . . 61.68 32.37 18.41 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 118.003 2.594 . . . . 1.21 118.003 -179.87 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.48 -15.55 45.86 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 119.163 0.892 . . . . 1.3 112.173 -177.497 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -102.46 124.71 48.51 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.732 -2.628 . . . . 2.55 115.277 174.694 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -81.3 145.97 30.63 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 102.714 -3.069 . . . . 2.48 102.714 165.129 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.3 mt -101.75 123.33 45.54 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 114.809 1.411 . . . . 0.9 114.809 -172.954 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.56 157.49 18.59 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 116.489 -2.085 . . . . 1.94 115.174 175.289 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.26 -63.55 1.19 Allowed 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 118.509 2.781 . . . . 1.56 118.509 -165.106 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.68 30.83 4.07 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 116.943 1.537 . . . . 0.97 116.943 176.418 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.7 mmt-85 -99.21 159.0 15.3 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 119.052 -1.059 . . . . 2.49 110.046 162.384 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.8 p -97.19 162.87 13.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.692 -3.755 . . . . 0.76 114.163 178.949 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.483 HD11 HG21 ' A' ' 26' ' ' VAL . 62.5 mt -58.24 -14.82 8.0 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 126.367 2.984 . . . . 1.05 113.864 170.436 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 t -85.12 -42.34 14.87 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.388 -2.695 . . . . 1.19 116.089 172.543 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -63.82 -39.48 94.34 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 127.833 2.453 . . . . 1.9 110.929 175.426 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -80.0 -8.7 59.49 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.784 2.034 . . . . 0.89 110.925 174.923 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.337 57.1 m-80 54.44 45.43 27.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.196 3.406 . . . . 1.84 120.196 -175.979 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.4 mm -78.68 123.99 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 126.132 1.773 . . . . 0.82 113.159 174.65 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -101.89 175.88 5.4 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 114.58 1.326 . . . . 2.16 114.58 -172.333 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -70.45 129.85 40.34 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 126.691 3.139 . . . . 2.12 112.537 -179.603 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.477 7.0 mt-10 67.7 35.99 3.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 125.499 2.571 . . . . 1.71 112.551 -179.858 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.301 4.4 t -94.63 126.94 40.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 109.559 -3.473 . . . . 1.04 110.29 -176.537 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.7 m -96.14 119.55 34.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.948 -1.72 . . . . 0.79 111.061 -169.845 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.5 mt -97.75 148.02 23.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 129.01 2.924 . . . . 1.4 108.745 175.249 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -106.71 137.42 44.76 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.744 -4.348 . . . . 1.51 106.264 178.566 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.5 tp -108.73 121.03 44.19 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.754 -3.091 . . . . 1.14 110.526 -178.106 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.0 t -109.85 153.6 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 130.969 3.707 . . . . 1.23 107.707 178.991 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.521 HD12 HD12 ' A' ' 8' ' ' LEU . 96.3 mt . . . . . 0 N--CA 1.429 -1.496 0 O-C-N 119.079 -2.263 . . . . 2.78 115.251 178.427 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 ptt? . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 115.09 1.515 . . . . 1.1 115.09 . . . . . . . . . 0 0 . 1 . 070 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -101.86 133.87 45.93 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.056 -1.652 . . . . 1.87 113.973 -172.652 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -130.77 159.93 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 104.321 -2.474 . . . . 0.72 104.321 174.275 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -119.55 120.87 38.0 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.065 2.946 . . . . 1.4 110.053 -174.111 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.421 HG21 HD11 ' A' ' 30' ' ' ILE . 94.9 t -105.69 115.19 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 119.889 -1.757 . . . . 0.58 110.439 172.979 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -96.37 134.21 39.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 103.639 -2.726 . . . . 2.09 103.639 179.626 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.269 28.0 p -80.86 169.85 17.04 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 118.044 -2.91 . . . . 0.99 112.665 171.813 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.4 mt -54.81 -49.64 70.52 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.961 3.305 . . . . 2.53 116.951 167.916 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.49 -62.26 1.47 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.408 3.004 . . . . 2.08 107.993 -172.029 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.78 12.27 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 116.929 -2.558 . . . . 1.31 116.78 179.618 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -101.01 154.43 18.71 Favored 'General case' 0 N--CA 1.429 -1.504 1 CA-C-N 126.147 4.974 . . . . 1.4 106.895 -169.148 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -113.04 108.91 17.97 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.426 -1.421 . . . . 0.78 108.928 167.063 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.405 ' CD1' HG23 ' A' ' 30' ' ' ILE . 46.9 mt -88.36 124.5 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 105.823 -1.918 . . . . 1.55 105.823 177.999 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.0 m -91.44 130.52 37.27 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 104.721 -2.325 . . . . 1.08 104.721 179.298 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mt -118.56 155.4 30.97 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 112.969 0.729 . . . . 1.55 112.969 179.685 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -113.03 130.14 56.25 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 100.596 -3.853 . . . . 1.95 100.596 167.765 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.1 m -143.95 156.35 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 126.39 1.876 . . . . 0.96 107.506 -176.805 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 36.1 mm-40 -114.21 154.46 46.26 Favored Pre-proline 0 N--CA 1.431 -1.416 0 C-N-CA 126.141 1.776 . . . . 2.35 110.036 168.042 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 53.4 Cg_exo -73.72 -25.7 14.4 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 CA-C-N 125.672 3.062 . . . . 0.95 117.195 -165.355 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -91.24 4.58 51.95 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 122.575 1.179 . . . . 1.45 113.657 177.984 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -64.77 149.43 49.3 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 115.018 -2.673 . . . . 1.69 112.649 165.995 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.319 21.6 p -87.03 169.45 12.41 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 116.049 -2.26 . . . . 0.75 112.743 177.656 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.91 -37.06 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 113.16 0.8 . . . . 0.73 113.16 171.185 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -57.42 -37.57 72.97 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.656 -3.152 . . . . 1.62 110.663 172.059 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -75.42 -28.12 59.27 Favored 'General case' 0 N--CA 1.43 -1.473 1 O-C-N 115.174 -4.704 . . . . 2.13 111.448 -179.217 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.9 t -71.07 -39.51 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.122 1.369 . . . . 0.62 112.474 172.239 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -63.83 -39.91 95.34 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 118.958 0.799 . . . . 1.22 111.97 170.966 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.14 68.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 119.977 3.325 . . . . 0.51 119.977 172.068 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -63.35 -35.44 80.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 115.32 -2.276 . . . . 1.44 112.91 165.856 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.421 HD11 HG21 ' A' ' 5' ' ' VAL . 15.3 mt -73.8 -40.17 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 123.138 2.699 . . . . 1.32 110.608 171.112 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -51.47 -45.89 62.92 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.671 2.788 . . . . 1.7 117.28 176.425 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -60.57 -28.83 68.77 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.433 -2.667 . . . . 1.55 116.279 174.957 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -94.93 -61.83 1.42 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 104.893 -2.262 . . . . 2.62 104.893 -173.139 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -98.87 -8.43 25.71 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 118.894 -2.378 . . . . 1.48 113.486 -169.744 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.76 5.64 89.68 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 118.389 -2.694 . . . . 1.12 113.365 174.695 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.1 mt -88.02 131.75 41.99 Favored Pre-proline 0 N--CA 1.429 -1.505 0 CA-C-N 121.523 2.662 . . . . 1.55 111.742 -175.086 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 74.0 Cg_exo -64.58 146.57 89.29 Favored 'Trans proline' 0 C--N 1.3 -1.993 1 CA-C-N 129.058 4.271 . . . . 1.02 118.274 -177.359 . . . . . . . . 3 3 . 1 . 070 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 34.5 Cg_exo -68.33 -11.86 33.23 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 C-N-CA 123.029 2.486 . . . . 1.25 113.696 -177.581 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -77.87 -24.98 48.32 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.787 -3.696 . . . . 2.25 110.757 170.787 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -83.16 -39.71 20.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 116.352 -2.139 . . . . 2.02 108.49 176.67 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -63.93 125.8 25.6 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 126.611 1.965 . . . . 0.69 113.604 -172.171 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -118.9 118.52 31.75 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.158 -2.839 . . . . 2.78 108.19 170.708 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' A' ' 43' ' ' LEU . 68.6 mt -98.4 128.81 44.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.139 -2.225 . . . . 1.17 112.243 -174.788 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mm -110.05 137.57 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 125.386 1.474 . . . . 1.38 107.543 -179.812 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -146.61 144.59 29.64 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 125.963 1.705 . . . . 1.5 108.392 165.806 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.24 -107.53 0.15 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 123.832 0.707 . . . . 1.21 112.014 172.496 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.2 18.11 4.75 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 108.134 -1.987 . . . . 1.3 108.134 177.333 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -133.45 149.28 51.78 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.606 1.669 . . . . 2.55 114.455 177.114 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -93.67 130.65 39.54 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.238 -4.039 . . . . 2.48 103.831 174.271 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.336 79.4 mt -87.24 138.06 31.81 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.589 -1.944 . . . . 0.9 113.743 -168.485 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -85.8 164.08 17.77 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 117.85 -3.031 . . . . 1.94 111.671 -179.4 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -67.44 -62.89 1.2 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.315 -3.99 . . . . 1.56 118.931 -170.45 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.93 40.17 0.82 Allowed Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 129.495 3.426 . . . . 0.97 114.03 172.04 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -119.51 158.9 25.34 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.484 3.142 . . . . 2.49 105.605 168.179 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.4 p -100.09 164.17 12.1 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 125.76 1.912 . . . . 0.76 115.356 176.714 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.18 -43.95 97.68 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 117.851 -3.031 . . . . 1.05 109.947 178.667 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.0 m -53.6 -49.51 67.65 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.424 -3.297 . . . . 1.19 116.405 170.759 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -51.82 -39.29 58.54 Favored 'General case' 0 N--CA 1.429 -1.475 1 O-C-N 116.225 -4.047 . . . . 1.9 114.764 172.317 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -85.87 -13.01 49.24 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.325 1.972 . . . . 0.89 116.325 177.006 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.416 27.9 m120 75.03 23.39 1.65 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 124.163 1.935 . . . . 1.84 115.712 -177.772 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.9 mt -77.07 102.06 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 118.34 -2.725 . . . . 0.82 111.77 179.112 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -90.53 -178.99 5.46 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 125.814 2.721 . . . . 2.16 110.398 -176.389 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.4 pttp -66.46 151.69 46.68 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.163 -3.461 . . . . 2.12 113.007 174.396 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.522 90.5 mt-10 90.71 -15.55 0.22 Allowed 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.995 2.918 . . . . 1.71 115.356 -179.102 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.6 m -68.54 137.38 54.3 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.643 2.831 . . . . 1.04 118.643 -171.244 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.5 m -96.6 109.18 21.84 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 119.795 -1.816 . . . . 0.79 113.533 -179.468 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -92.79 163.66 13.64 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.74 3.15 . . . . 1.4 109.92 174.43 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.279 39.1 m80 -124.56 119.82 30.17 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.35 -1.295 . . . . 1.51 107.678 -173.347 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.492 HD21 HD21 ' A' ' 71' ' ' LEU 0.263 3.4 tt -91.71 104.67 17.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.496 -3.253 . . . . 1.14 115.567 -177.05 . . . . . . . . 3 3 . 1 . 070 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.2 t -93.44 144.46 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 105.674 -1.973 . . . . 1.23 105.674 177.529 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.492 HD21 HD21 ' A' ' 69' ' ' LEU . 81.3 mt . . . . . 0 N--CA 1.431 -1.424 0 CA-C-O 125.601 2.62 . . . . 2.78 111.766 177.623 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptt? . . . . . 0 CA--C 1.49 -1.354 0 N-CA-C 107.393 -1.336 . . . . 1.1 107.393 . . . . . . . . . 0 0 . 1 . 071 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -94.23 126.92 39.77 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 114.134 1.161 . . . . 1.87 114.134 178.649 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.5 pt -115.91 163.08 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 107.628 -1.249 . . . . 0.72 107.628 165.886 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -125.05 132.65 53.16 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.984 -1.073 . . . . 1.4 108.111 -178.196 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.5 t -109.45 130.47 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 105.246 -2.131 . . . . 0.58 105.246 174.736 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -118.31 136.1 53.91 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.826 -2.421 . . . . 2.09 108.258 173.581 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.6 p -87.75 174.02 8.64 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 116.393 -3.942 . . . . 0.99 109.554 177.021 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.448 HD11 ' HA ' ' A' ' 70' ' ' VAL . 5.2 mt -73.43 -23.85 60.17 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 127.677 3.608 . . . . 2.53 117.802 172.193 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 p -88.98 -12.91 40.16 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.517 -3.239 . . . . 2.08 107.786 -175.08 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.4 32.53 3.93 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 115.519 0.968 . . . . 1.31 115.519 167.922 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -113.14 137.9 50.75 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 114.279 -2.968 . . . . 1.4 103.493 -178.228 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.271 32.9 m -109.01 125.2 51.82 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.484 2.088 . . . . 0.78 110.783 -179.129 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.7 mt -109.52 121.97 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.828 -3.045 . . . . 1.55 109.629 179.347 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.3 m -95.84 119.4 34.27 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 114.604 -5.06 . . . . 1.08 110.734 176.966 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.7 mt -126.99 138.97 53.35 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 116.953 -3.592 . . . . 1.55 117.49 -176.27 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -97.83 108.8 21.59 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.709 2.003 . . . . 1.95 109.683 178.781 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -120.11 157.23 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 128.283 2.633 . . . . 0.96 108.908 178.514 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -98.06 148.79 34.98 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-O 115.069 -2.396 . . . . 2.35 113.108 156.522 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.88 -13.77 34.83 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 125.29 3.993 . . . . 0.95 113.112 -172.459 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m -74.08 -25.76 60.0 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.705 1.878 . . . . 1.45 106.1 174.354 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -67.19 140.34 57.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.513 -2.617 . . . . 1.69 116.166 -179.828 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 50.7 p -83.28 161.16 21.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 111.397 -2.638 . . . . 0.75 113.094 -172.398 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.7 mm -59.09 -46.8 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 1 C-N-CA 134.742 5.217 . . . . 0.73 109.505 176.065 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -47.8 -40.08 19.99 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 127.084 2.154 . . . . 1.62 114.283 163.124 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -76.56 -24.64 53.57 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.765 -3.084 . . . . 2.13 116.71 176.304 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.3 t -74.63 -40.43 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 124.151 0.98 . . . . 0.62 111.733 173.996 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -61.38 -29.23 69.79 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.193 1.797 . . . . 1.22 113.249 173.357 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.22 -33.72 76.39 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.513 -1.992 . . . . 0.51 111.095 175.747 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.271 56.2 mttm -61.74 -43.05 99.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.475 -2.641 . . . . 1.44 114.985 176.287 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.0 mt -70.3 -33.87 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 C-N-CA 127.874 2.469 . . . . 1.32 109.364 175.402 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -64.14 -50.59 67.62 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 116.554 -3.841 . . . . 1.7 112.624 179.805 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -54.04 -49.7 68.38 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.293 2.637 . . . . 1.55 111.403 171.668 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -79.63 -61.23 2.06 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.55 2.426 . . . . 2.62 117.55 -178.478 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -87.3 -29.17 21.81 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.056 2.243 . . . . 1.48 117.056 -167.31 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.07 13.8 14.88 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 119.55 -1.309 . . . . 1.12 113.677 171.823 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.9 mt -96.14 119.67 64.08 Favored Pre-proline 0 N--CA 1.43 -1.434 1 CA-C-O 111.533 -4.079 . . . . 1.55 107.001 -171.053 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 67.8 Cg_endo -70.57 159.11 53.89 Favored 'Trans proline' 0 N--CA 1.433 -2.035 1 CA-C-N 129.31 4.361 . . . . 1.02 113.831 172.996 . . . . . . . . 3 3 . 1 . 071 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 52.9 Cg_exo -68.37 -26.37 35.08 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 C-N-CA 122.784 2.323 . . . . 1.25 113.759 -173.131 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -56.47 -33.34 65.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.985 2.514 . . . . 2.25 110.151 174.108 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -98.65 19.79 14.07 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.248 1.944 . . . . 2.02 116.248 175.972 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -127.44 113.15 15.81 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.985 -1.117 . . . . 0.69 107.985 -175.501 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.416 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 14.0 tpp180 -110.28 127.74 55.16 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.797 -0.816 . . . . 2.78 108.797 173.857 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.5 mt -110.3 143.01 41.14 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 112.791 -3.48 . . . . 1.17 114.566 179.419 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.2 mt -128.65 143.24 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 129.031 3.957 . . . . 1.38 105.165 -174.28 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -155.1 136.3 13.95 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.162 -2.211 . . . . 1.5 105.779 168.912 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.251 . . 61.81 26.17 15.84 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 118.556 2.798 . . . . 1.21 118.556 175.837 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.2 -14.13 63.12 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-O 117.557 -1.691 . . . . 1.3 110.604 -173.867 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -97.66 126.95 43.26 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 125.602 1.413 . . . . 2.55 112.794 -171.599 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -80.67 112.31 17.92 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 124.811 2.243 . . . . 2.48 106.448 170.54 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.5 mt -74.67 124.85 27.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.92 2.888 . . . . 0.9 115.664 -176.222 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -87.68 142.11 28.08 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 118.733 2.864 . . . . 1.94 118.733 178.772 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -46.83 -66.77 0.36 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.948 2.499 . . . . 1.56 117.692 -173.072 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.56 35.87 0.84 Allowed Glycine 0 N--CA 1.43 -1.723 0 CA-C-O 125.033 2.463 . . . . 0.97 116.871 171.023 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -115.81 175.64 5.44 Favored 'General case' 0 N--CA 1.429 -1.507 1 O-C-N 113.785 -5.538 . . . . 2.49 107.956 166.299 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 60.0 p -106.95 -174.68 2.59 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.515 -1.99 . . . . 0.76 110.759 175.665 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mt -80.91 -37.01 30.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.877 2.071 . . . . 1.05 108.995 176.449 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.8 t -57.14 -48.4 78.78 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 128.235 3.459 . . . . 1.19 110.884 174.538 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -49.62 -29.7 7.62 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.203 3.038 . . . . 1.9 119.203 175.665 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -111.33 1.55 17.15 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.621 -1.299 . . . . 0.89 109.315 -179.577 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 61.77 40.05 13.36 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.954 2.902 . . . . 1.84 109.324 -178.176 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.9 mt -78.59 114.82 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 124.257 1.98 . . . . 0.82 107.489 172.852 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.473 ' HB3' ' H ' ' A' ' 63' ' ' LYS . 35.5 mt-30 -108.59 -158.58 0.65 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.049 -2.907 . . . . 2.16 115.608 -179.325 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.473 ' H ' ' HB3' ' A' ' 62' ' ' GLN 0.273 25.3 pttt -74.67 138.74 43.04 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.72 -2.487 . . . . 2.12 113.822 -179.235 . . . . . . . . 3 3 . 1 . 071 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 71.87 31.2 2.13 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 124.723 2.201 . . . . 1.71 114.821 178.852 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.3 m -86.59 121.46 29.15 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 113.161 -1.836 . . . . 1.04 115.138 -178.786 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.1 m -92.88 120.48 33.27 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 118.0 -2.937 . . . . 0.79 107.382 176.028 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.1 mt -94.35 147.8 22.86 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.159 -1.837 . . . . 1.4 107.582 171.832 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -92.35 123.6 35.79 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.85 2.46 . . . . 1.51 108.34 176.941 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.47 117.54 31.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 122.257 2.299 . . . . 1.14 107.601 175.244 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.448 ' HA ' HD11 ' A' ' 8' ' ' LEU . 78.0 t -106.61 129.91 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 130.77 3.628 . . . . 1.23 102.672 -176.191 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.43 -1.443 0 O-C-N 118.446 -2.659 . . . . 2.78 114.129 171.266 . . . . . . . . 0 0 . 1 . 072 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ptt? . . . . . 0 CA--C 1.491 -1.323 0 N-CA-C 116.767 2.136 . . . . 1.1 116.767 . . . . . . . . . 0 0 . 1 . 072 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.293 19.6 mt-30 -107.47 129.52 54.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 103.941 -2.615 . . . . 1.87 103.941 -176.717 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.9 pt -113.79 153.89 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 117.524 -1.226 . . . . 0.72 110.795 165.623 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -107.02 147.64 29.68 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 122.389 1.09 . . . . 1.4 112.528 174.879 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.2 t -124.05 128.22 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.828 2.051 . . . . 0.58 108.105 176.488 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -107.31 144.93 33.45 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.319 -2.113 . . . . 2.09 106.432 178.822 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 p -89.19 -168.17 2.09 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.291 2.7 . . . . 0.99 118.291 179.796 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 mt -65.87 -52.89 46.35 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.956 1.703 . . . . 2.53 111.721 174.696 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.4 p -70.77 -52.59 19.69 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.081 -2.262 . . . . 2.08 115.428 -178.235 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.27 50.49 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 104.529 -3.428 . . . . 1.31 104.529 171.626 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -107.29 147.88 29.69 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.522 -2.752 . . . . 1.4 107.303 175.598 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.0 m -102.21 136.19 42.48 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 103.131 -2.915 . . . . 0.78 103.131 179.034 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.2 mt -122.75 120.75 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-O 125.371 2.51 . . . . 1.55 108.297 176.659 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.1 m -92.75 125.5 37.4 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.391 -2.693 . . . . 1.08 106.398 177.393 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 29' ' ' LYS . 68.5 mt -116.03 142.4 46.85 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 129.1 4.0 . . . . 1.55 112.657 170.452 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -98.73 123.73 43.13 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 120.656 1.571 . . . . 1.95 109.259 172.026 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.466 HG21 ' CD1' ' A' ' 56' ' ' LEU . 27.8 m -139.67 171.71 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 O-C-N 118.486 -2.634 . . . . 0.96 106.659 -177.788 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -121.47 162.15 37.66 Favored Pre-proline 0 N--CA 1.43 -1.468 0 N-CA-C 103.21 -2.885 . . . . 2.35 103.21 156.773 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -76.39 -3.4 13.77 Favored 'Trans proline' 0 N--CA 1.434 -1.971 0 C-N-CA 124.595 3.53 . . . . 0.95 111.192 -168.819 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.1 m -86.84 -5.25 59.16 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.614 3.102 . . . . 1.45 113.084 178.543 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -78.79 147.36 33.33 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.873 -3.642 . . . . 1.69 116.919 175.996 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 35.1 p -72.46 158.96 34.76 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 118.183 -0.913 . . . . 0.75 112.814 177.701 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.6 mm -67.87 -31.37 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 126.852 2.595 . . . . 0.73 112.813 173.713 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -60.47 -30.98 70.02 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.352 -2.718 . . . . 1.62 114.353 170.966 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -76.74 -35.82 57.52 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.846 -1.784 . . . . 2.13 109.41 176.037 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -69.82 -34.21 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 119.105 -2.247 . . . . 0.62 113.099 178.294 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -69.85 -18.18 63.42 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.114 -2.241 . . . . 1.22 115.869 170.783 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.07 -19.47 43.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.303 1.441 . . . . 0.51 112.474 -179.585 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.513 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.5 mttm -78.68 -33.4 47.02 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.171 1.788 . . . . 1.44 111.469 172.173 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.3 mt -76.53 -24.08 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 107.603 -1.258 . . . . 1.32 107.603 173.707 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -67.14 -32.08 72.95 Favored 'General case' 0 N--CA 1.429 -1.491 2 O-C-N 114.999 -4.813 . . . . 1.7 115.89 175.042 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -73.59 -31.12 63.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.836 -1.165 . . . . 1.55 112.09 166.795 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -83.66 -72.86 0.44 Allowed 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.45 -2.056 . . . . 2.62 105.45 -170.321 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -93.86 -7.62 42.7 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 115.574 1.694 . . . . 1.48 115.574 -167.309 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.76 16.22 77.98 Favored Glycine 0 N--CA 1.429 -1.782 0 O-C-N 117.679 -3.138 . . . . 1.12 115.74 176.729 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.1 mt -89.03 128.44 51.88 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 116.99 -3.653 . . . . 1.55 104.369 -178.977 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 17.0 Cg_exo -70.15 142.31 45.88 Favored 'Trans proline' 0 N--CA 1.433 -2.044 0 CA-C-N 126.671 3.418 . . . . 1.02 114.565 179.311 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 8.0 Cg_exo -58.1 -17.28 30.94 Favored 'Trans proline' 0 N--CA 1.434 -2.022 1 C-N-CA 126.345 4.696 . . . . 1.25 115.905 -176.942 . . . . . . . . 3 3 . 1 . 072 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -75.82 -18.98 59.28 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.346 2.339 . . . . 2.25 116.33 170.337 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -97.37 2.37 50.44 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 121.272 1.851 . . . . 2.02 115.94 179.885 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -105.79 139.75 39.88 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 111.058 -2.792 . . . . 0.69 111.408 -172.225 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -132.73 122.5 24.67 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.174 2.19 . . . . 2.78 112.536 167.59 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.2 mt -88.11 138.86 31.07 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 106.459 -1.682 . . . . 1.17 106.459 174.082 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mt -119.96 132.68 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 127.424 2.29 . . . . 1.38 105.209 178.344 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -155.16 123.1 5.78 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.165 2.257 . . . . 1.5 110.39 170.54 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.284 . . 75.41 37.01 0.46 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.623 3.569 . . . . 1.21 114.152 176.449 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.05 -24.05 6.43 Favored Glycine 0 N--CA 1.43 -1.749 0 CA-C-O 115.777 -2.679 . . . . 1.3 112.412 -173.929 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -102.94 148.1 26.08 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 120.66 2.23 . . . . 2.55 112.102 -175.834 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -88.15 150.46 23.32 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 122.068 0.937 . . . . 2.48 109.542 171.926 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.1 mt -97.02 133.42 41.72 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.251 1.82 . . . . 0.9 108.715 -169.561 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -80.73 146.09 31.21 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.393 -1.276 . . . . 1.94 109.754 177.166 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -65.39 -59.21 4.26 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.211 -3.43 . . . . 1.56 120.092 -169.542 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.98 32.06 1.51 Allowed Glycine 0 N--CA 1.431 -1.692 0 CA-C-N 111.479 -2.601 . . . . 0.97 119.171 173.079 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -105.12 176.69 5.08 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 104.2 -2.518 . . . . 2.49 104.2 164.676 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 67.3 p -107.26 167.22 10.07 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 112.612 -2.085 . . . . 0.76 112.022 171.462 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.466 ' CD1' HG21 ' A' ' 17' ' ' VAL . 66.9 mt -67.07 -38.31 85.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.058 2.837 . . . . 1.05 113.637 175.678 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.9 t -69.01 -19.2 64.12 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 119.666 3.21 . . . . 1.19 119.666 173.842 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -58.7 -51.99 67.6 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 114.875 -2.488 . . . . 1.9 104.658 172.844 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -81.69 -8.57 59.72 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 129.404 3.081 . . . . 0.89 113.488 -176.053 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 m120 59.98 56.68 3.32 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 116.589 -3.819 . . . . 1.84 117.677 -173.461 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.418 HG21 HD11 ' A' ' 67' ' ' LEU . 62.2 mt -96.54 117.71 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 104.968 -2.234 . . . . 0.82 104.968 -178.284 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -97.71 -176.57 3.51 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.037 -2.289 . . . . 2.16 105.755 -171.85 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.5 pttt -65.85 151.69 46.11 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.644 2.64 . . . . 2.12 116.471 174.521 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 60.98 15.26 5.95 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 131.654 3.981 . . . . 1.71 114.213 176.02 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 t -76.16 150.22 37.19 Favored 'General case' 0 N--CA 1.429 -1.486 1 C-N-CA 132.318 4.247 . . . . 1.04 109.134 -177.541 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.6 m -103.49 105.47 15.74 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.587 -3.196 . . . . 0.79 113.19 -179.417 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.418 HD11 HG21 ' A' ' 61' ' ' ILE . 6.2 mp -82.77 168.38 17.24 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 106.126 -1.805 . . . . 1.4 106.126 170.902 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -121.56 135.57 55.0 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.31 -2.744 . . . . 1.51 108.867 -179.271 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.4 tp -109.16 117.37 33.95 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.08 2.848 . . . . 1.14 111.386 -177.594 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 t -105.96 146.28 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 1 O-C-N 115.932 -4.23 . . . . 1.23 112.22 174.474 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.9 mt . . . . . 0 N--CA 1.43 -1.452 0 N-CA-C 117.847 2.536 . . . . 2.78 117.847 178.512 . . . . . . . . 0 0 . 1 . 073 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.269 0.7 OUTLIER . . . . . 0 CA--C 1.491 -1.312 0 N-CA-C 104.38 -2.452 . . . . 1.1 104.38 . . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -89.86 127.73 36.05 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 117.263 -1.351 . . . . 1.87 107.557 -179.114 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.522 HD12 HD22 ' A' ' 67' ' ' LEU . 40.3 pt -115.11 138.83 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 122.105 2.23 . . . . 0.72 106.658 165.764 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -97.88 118.23 33.98 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.13 0.972 . . . . 1.4 109.794 -178.008 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.5 t -99.56 124.38 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.613 1.965 . . . . 0.58 106.289 174.069 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -117.62 126.92 53.38 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 125.189 1.396 . . . . 2.09 110.155 -175.395 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.289 7.3 p -74.49 176.01 7.23 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 128.485 2.714 . . . . 0.99 117.344 -179.364 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.9 tp -67.99 -56.11 10.19 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.95 1.705 . . . . 2.53 113.219 166.224 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 p -62.52 -53.02 61.01 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 118.462 2.764 . . . . 2.08 118.462 -176.378 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.79 30.09 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 119.122 2.409 . . . . 1.31 119.122 176.87 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -103.58 138.48 40.2 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 119.061 1.43 . . . . 1.4 107.89 176.697 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.1 m -105.09 118.93 37.78 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.194 -2.15 . . . . 0.78 105.194 169.019 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.6 mt -101.49 115.22 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 106.741 -1.577 . . . . 1.55 106.741 176.592 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.9 m -96.52 124.35 40.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 120.804 1.638 . . . . 1.08 112.493 176.004 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.268 84.0 mt -116.03 127.71 55.12 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 127.959 3.743 . . . . 1.55 109.688 -173.217 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -80.02 108.21 13.43 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.1 -3.5 . . . . 1.95 114.68 168.723 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.87 160.87 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 125.373 1.469 . . . . 0.96 111.982 -179.082 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -97.46 161.44 25.96 Favored Pre-proline 0 N--CA 1.431 -1.388 0 C-N-CA 127.794 2.437 . . . . 2.35 107.065 159.852 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -71.14 -15.77 31.98 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 C-N-CA 124.164 3.243 . . . . 0.95 112.29 179.064 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 p -83.38 -2.6 56.16 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.347 1.459 . . . . 1.45 112.503 174.746 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -77.82 140.89 39.44 Favored 'General case' 0 N--CA 1.431 -1.4 1 O-C-N 116.216 -4.053 . . . . 1.69 110.579 169.805 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.361 22.9 p -81.05 176.23 9.99 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 110.759 -2.928 . . . . 0.75 114.892 179.717 . . . . . . . . 3 3 . 1 . 073 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -85.76 -20.77 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 CA-C-N 121.252 1.842 . . . . 0.73 108.526 175.581 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -56.01 -38.27 70.28 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.103 2.561 . . . . 1.62 113.058 165.37 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -71.88 -33.23 68.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.05 2.14 . . . . 2.13 114.961 176.348 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.327 79.1 t -65.33 -48.23 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 C-N-CA 128.065 2.546 . . . . 0.62 110.067 173.841 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -69.96 -26.81 64.28 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.945 -2.347 . . . . 1.22 115.552 174.703 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.75 -37.07 83.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.282 -2.761 . . . . 0.51 113.37 171.445 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.1 mttm -65.37 -51.61 59.26 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.91 -1.744 . . . . 1.44 114.356 176.2 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.7 mt -51.81 -37.43 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 128.064 3.792 . . . . 1.32 113.549 170.723 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -63.24 -44.56 94.86 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 114.748 -4.97 . . . . 1.7 118.308 170.001 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -55.57 -49.55 72.41 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 114.736 1.384 . . . . 1.55 114.736 167.831 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -74.71 -65.58 0.85 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.763 -2.017 . . . . 2.62 107.572 -170.075 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.261 13.8 mm-40 -85.21 -51.75 6.39 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.87 1.804 . . . . 1.48 115.87 -171.119 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.91 9.51 5.2 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 117.628 1.811 . . . . 1.12 117.628 -178.706 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.0 mt -87.82 135.35 33.86 Favored Pre-proline 0 N--CA 1.429 -1.5 0 CA-C-O 113.967 -2.92 . . . . 1.55 112.018 -173.224 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 51.4 Cg_endo -78.32 157.71 29.51 Favored 'Trans proline' 0 N--CA 1.434 -1.991 0 CA-C-N 124.632 2.69 . . . . 1.02 108.71 -178.944 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 29.0 Cg_exo -64.02 -17.09 58.45 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 125.08 3.854 . . . . 1.25 114.257 -178.235 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -67.21 -49.17 65.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 129.879 3.272 . . . . 2.25 111.868 175.768 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -70.95 -31.67 68.32 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.647 -2.533 . . . . 2.02 110.495 -175.951 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -80.01 120.12 23.76 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 130.025 3.33 . . . . 0.69 113.902 -175.095 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -113.63 123.67 50.48 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.221 -2.14 . . . . 2.78 105.221 167.507 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -108.34 126.3 52.69 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 102.984 -2.969 . . . . 1.17 102.984 178.822 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 68' ' ' HIS 0.253 37.8 mm -112.71 154.21 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 131.549 3.94 . . . . 1.38 106.255 177.592 . . . . . . . . 3 3 . 1 . 073 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -114.4 -94.01 0.48 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.535 -3.228 . . . . 1.5 102.744 175.307 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.38 -65.78 0.98 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 119.656 -0.818 . . . . 1.21 109.95 177.254 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.63 -13.43 0.73 Allowed Glycine 0 N--CA 1.429 -1.802 0 O-C-N 117.534 -3.229 . . . . 1.3 114.789 -173.705 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -105.95 150.44 25.67 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.828 2.051 . . . . 2.55 110.988 175.789 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -77.16 138.3 39.4 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 130.83 3.652 . . . . 2.48 110.033 178.774 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.4 mt -82.9 160.14 22.18 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.138 -1.601 . . . . 0.9 113.796 -176.478 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -102.99 151.51 22.39 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.981 1.712 . . . . 1.94 109.967 176.755 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.377 30.1 m-20 -75.02 -63.29 1.3 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 112.988 0.736 . . . . 1.56 112.988 -167.294 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.45 55.97 4.72 Favored Glycine 0 N--CA 1.431 -1.665 0 O-C-N 118.631 -2.543 . . . . 0.97 112.3 178.641 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -120.58 161.08 21.94 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 102.62 -3.104 . . . . 2.49 102.62 162.259 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 81.0 p -90.67 164.19 14.25 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.351 2.5 . . . . 0.76 109.23 168.251 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.9 mt -59.03 -34.43 71.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.658 2.783 . . . . 1.05 115.15 167.309 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.8 p -70.99 -21.51 62.3 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 114.606 1.335 . . . . 1.19 114.606 179.221 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -69.99 -34.54 73.47 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.8 2.84 . . . . 1.9 108.969 175.69 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -96.74 15.88 20.67 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.182 2.896 . . . . 0.89 112.964 176.458 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 m120 57.29 25.19 10.84 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 111.298 -2.683 . . . . 1.84 116.97 174.028 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.8 mt -81.63 98.97 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 106.043 -1.836 . . . . 0.82 106.043 178.629 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -112.92 -39.06 4.34 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.795 2.838 . . . . 2.16 104.569 -174.83 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -101.16 171.83 7.38 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.324 1.601 . . . . 2.12 115.324 167.294 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -45.11 103.05 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 129.953 3.301 . . . . 1.71 116.12 168.581 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.6 m -123.13 159.53 28.37 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.469 -4.519 . . . . 1.04 116.75 -175.952 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.2 m -101.88 126.79 48.85 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.843 -1.786 . . . . 0.79 111.822 -175.552 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.522 HD22 HD12 ' A' ' 3' ' ' ILE . 8.5 mp -107.56 142.6 37.22 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.847 3.659 . . . . 1.4 112.327 176.814 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.405 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 49.6 m80 -116.03 117.69 30.8 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.634 -1.917 . . . . 1.51 109.404 -175.469 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.1 tp -87.62 123.43 32.47 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.971 1.367 . . . . 1.14 111.057 -176.894 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.0 t -122.84 136.66 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.181 -2.2 . . . . 1.23 108.488 176.416 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.1 mt . . . . . 0 N--CA 1.43 -1.448 0 O-C-N 118.37 -2.706 . . . . 2.78 113.007 -174.165 . . . . . . . . 0 0 . 1 . 074 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.351 0 CA-C-O 116.147 -1.882 . . . . 1.1 113.619 . . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -119.22 125.92 50.3 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 120.403 1.456 . . . . 1.87 112.87 -178.028 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.9 pt -121.95 162.75 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 125.89 2.757 . . . . 0.72 107.241 170.582 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -103.89 149.04 25.45 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.5 2.32 . . . . 1.4 110.737 178.064 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.283 49.4 t -119.0 121.97 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 126.792 2.558 . . . . 0.58 106.071 171.067 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.7 tttt -101.9 140.13 36.6 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 126.53 2.394 . . . . 2.09 112.88 177.708 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.9 p -96.97 173.67 7.16 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.327 -2.733 . . . . 0.99 108.092 174.328 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.8 mt -56.61 -57.62 11.6 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.692 -1.88 . . . . 2.53 112.649 167.279 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.1 p -61.46 -30.69 70.75 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 117.66 2.467 . . . . 2.08 117.66 -179.244 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.87 15.91 1.31 Allowed Glycine 0 N--CA 1.429 -1.817 0 CA-C-O 114.784 -3.231 . . . . 1.31 114.715 170.004 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.0 tttt -90.13 115.23 27.22 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 122.768 3.284 . . . . 1.4 106.874 -173.573 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 m -87.16 115.35 24.49 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 113.926 -1.488 . . . . 0.78 113.543 175.454 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mt -103.07 127.46 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 116.533 2.049 . . . . 1.55 116.533 176.302 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.4 m -89.09 105.58 17.88 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 116.687 -3.758 . . . . 1.08 111.456 -174.974 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.9 mt -112.38 127.6 56.06 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 125.186 2.422 . . . . 1.55 110.378 178.537 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -92.74 117.14 29.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.543 3.068 . . . . 1.95 108.422 170.47 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 m -127.1 178.32 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 111.962 -2.381 . . . . 0.96 112.5 -179.444 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -105.38 154.14 39.21 Favored Pre-proline 0 N--CA 1.43 -1.441 0 C-N-CA 126.963 2.105 . . . . 2.35 109.846 165.241 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.11 -14.2 23.45 Favored 'Trans proline' 0 C--N 1.299 -2.028 1 CA-C-N 128.307 4.003 . . . . 0.95 107.157 -177.462 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 m -86.69 -4.88 59.23 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 115.08 1.511 . . . . 1.45 115.08 177.728 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -64.09 146.8 53.56 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.15 -2.219 . . . . 1.69 112.451 174.259 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 15.8 p -89.77 161.86 15.82 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 119.731 -1.855 . . . . 0.75 112.793 172.963 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.7 mm -58.51 -22.64 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.287 -3.383 . . . . 0.73 117.772 174.679 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.09 -59.13 5.54 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 117.857 -3.027 . . . . 1.62 110.985 161.745 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -51.98 -50.24 61.66 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.077 2.151 . . . . 2.13 111.687 176.616 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -61.51 -49.4 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 119.816 -1.802 . . . . 0.62 111.88 -177.9 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -68.53 -19.7 64.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 124.064 3.12 . . . . 1.22 112.238 175.585 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.12 -27.3 63.48 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.394 -2.066 . . . . 0.51 109.293 173.923 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -68.12 -48.18 66.13 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.835 2.054 . . . . 1.44 110.628 171.823 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mt -59.91 -36.06 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 113.794 1.035 . . . . 1.32 113.794 173.033 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -60.22 -43.65 95.84 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.633 -3.167 . . . . 1.7 114.496 175.121 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -47.06 -58.91 3.51 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.635 -3.791 . . . . 1.55 115.758 166.861 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -71.29 -53.56 13.84 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.707 -1.87 . . . . 2.62 113.257 -176.57 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -92.4 -58.89 2.23 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 125.002 1.439 . . . . 1.48 108.385 -167.091 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.53 -0.16 2.74 Favored Glycine 0 N--CA 1.429 -1.782 0 O-C-N 119.698 -1.877 . . . . 1.12 111.72 176.191 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.0 mt -74.46 128.78 85.24 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 114.094 -2.86 . . . . 1.55 113.29 -169.277 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -63.61 151.04 86.92 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 CA-C-N 122.618 1.971 . . . . 1.02 113.856 175.037 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.29 -4.46 15.1 Favored 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 124.188 3.259 . . . . 1.25 118.704 -178.883 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -80.55 -29.53 37.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 126.264 2.228 . . . . 2.25 114.799 170.751 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -79.37 -40.26 30.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.723 2.202 . . . . 2.02 111.784 177.593 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -70.04 95.94 1.01 Allowed 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 114.743 -4.973 . . . . 0.69 115.616 -171.186 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -90.66 132.22 35.9 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 118.526 -2.609 . . . . 2.78 107.589 172.219 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.5 mt -111.06 120.4 42.24 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.813 1.768 . . . . 1.17 110.589 178.449 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.9 mt -102.83 128.64 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 120.476 -1.39 . . . . 1.38 108.919 172.936 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -82.14 -76.85 0.24 Allowed 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.13 2.395 . . . . 1.5 108.673 174.245 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -96.04 -60.07 1.71 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.53 1.532 . . . . 1.21 110.565 -179.004 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.91 -48.01 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.806 0 CA-C-O 122.379 0.989 . . . . 1.3 112.377 -172.522 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -81.09 141.98 33.76 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.246 -1.149 . . . . 2.55 111.037 179.927 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 pm0 -77.38 152.19 34.51 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 117.285 -1.766 . . . . 2.48 111.915 176.761 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.0 mt -98.39 136.96 37.8 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 116.649 -2.02 . . . . 0.9 113.929 -167.047 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.03 144.71 48.71 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.538 2.335 . . . . 1.94 115.499 172.461 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -64.55 -56.19 15.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.805 3.642 . . . . 1.56 114.752 -175.578 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.47 64.37 3.99 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 121.072 3.189 . . . . 0.97 121.072 170.31 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -135.35 158.39 44.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.17 1.788 . . . . 2.49 106.651 161.651 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.259 17.0 p -80.72 164.94 22.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 117.659 2.466 . . . . 0.76 117.659 174.478 . . . . . . . . 3 3 . 1 . 074 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.2 mt -64.56 -33.8 76.76 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.388 -2.07 . . . . 1.05 113.118 175.791 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 t -68.79 -31.37 70.34 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.079 2.152 . . . . 1.19 116.337 177.096 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -57.24 -37.07 71.74 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 120.86 -1.15 . . . . 1.9 111.774 171.369 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -77.59 3.81 12.83 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 118.305 2.706 . . . . 0.89 118.305 174.63 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.66 17.3 m-80 81.76 12.01 0.69 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.034 2.605 . . . . 1.84 118.034 178.686 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.43 HG23 ' HB2' ' A' ' 65' ' ' SER . 9.2 mt -91.51 102.84 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 118.949 -2.344 . . . . 0.82 111.827 178.135 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -106.49 -26.21 11.52 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.739 1.615 . . . . 2.16 108.294 -171.555 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.5 tttp -137.66 -91.99 0.22 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 117.317 2.339 . . . . 2.12 117.317 175.918 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.14 126.09 49.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 121.284 -0.885 . . . . 1.71 111.518 -176.125 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.43 ' HB2' HG23 ' A' ' 61' ' ' ILE . 21.3 t -146.8 145.48 29.92 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.587 -1.188 . . . . 1.04 114.09 -173.714 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.9 m -118.43 109.09 15.83 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.714 -3.116 . . . . 0.79 103.673 179.752 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.6 mt -93.36 154.87 17.72 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.23 -2.137 . . . . 1.4 105.23 173.336 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -118.49 117.05 27.98 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.394 1.092 . . . . 1.51 113.472 -175.258 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.3 tp -79.59 94.62 5.69 Favored 'General case' 0 N--CA 1.43 -1.428 1 C-N-CA 132.904 4.481 . . . . 1.14 107.974 -171.728 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.27 121.44 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 C-N-CA 127.981 2.512 . . . . 1.23 108.613 175.716 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 N--CA 1.429 -1.48 0 CA-C-O 116.499 -1.715 . . . . 2.78 111.665 176.61 . . . . . . . . 0 0 . 1 . 075 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.491 -1.311 0 CA-C-O 118.621 -0.704 . . . . 1.1 110.359 . . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -100.56 122.37 43.14 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 119.57 1.077 . . . . 1.87 112.678 177.176 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.258 21.6 pt -106.97 147.57 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 118.188 -2.82 . . . . 0.72 109.551 -179.341 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -105.17 117.94 35.28 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 117.746 -3.096 . . . . 1.4 107.412 -177.683 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.3 t -99.55 96.41 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 120.09 -1.631 . . . . 0.58 108.825 173.219 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -78.99 112.23 15.98 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.762 2.425 . . . . 2.09 107.051 176.409 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.479 HG22 HD23 ' A' ' 69' ' ' LEU . 80.8 p -75.99 166.45 23.48 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 116.315 1.969 . . . . 0.99 116.315 -179.382 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.8 tp -54.54 -39.86 68.1 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 127.393 2.277 . . . . 2.53 110.336 161.753 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.0 p -75.82 -30.17 58.92 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.114 -1.616 . . . . 2.08 111.64 -178.985 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.32 38.78 1.59 Allowed Glycine 0 N--CA 1.43 -1.721 0 CA-C-O 124.385 2.103 . . . . 1.31 113.657 177.571 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -120.53 121.26 38.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 104.671 -2.344 . . . . 1.4 104.671 178.132 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.284 85.6 m -73.0 101.95 3.36 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 112.849 -1.978 . . . . 0.78 112.909 171.16 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 mt -96.62 128.34 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 105.33 -2.1 . . . . 1.55 105.33 -179.08 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.8 m -99.73 119.47 38.19 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.133 -1.062 . . . . 1.08 108.133 175.185 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.8 mt -120.29 128.93 53.75 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 127.837 2.455 . . . . 1.55 109.586 176.207 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -74.48 131.69 41.24 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.713 3.227 . . . . 1.95 119.713 162.939 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.2 m -139.26 176.69 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.718 -1.239 . . . . 0.96 113.62 174.193 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -101.84 163.33 18.0 Favored Pre-proline 0 N--CA 1.429 -1.494 0 O-C-N 116.98 -3.575 . . . . 2.35 104.781 160.123 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -77.83 -10.36 16.89 Favored 'Trans proline' 0 N--CA 1.433 -2.043 0 O-C-N 116.802 -2.262 . . . . 0.95 109.325 -179.582 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -79.9 -12.26 59.75 Favored 'General case' 0 N--CA 1.428 -1.531 1 O-C-N 116.002 -4.187 . . . . 1.45 116.882 174.55 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -76.16 151.59 36.91 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.559 1.647 . . . . 1.69 114.3 176.516 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.2 p -80.77 161.25 24.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.908 -1.745 . . . . 0.75 114.13 -177.79 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.0 mt -70.99 -35.99 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 120.428 -1.42 . . . . 0.73 109.374 174.35 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -49.31 -38.81 29.0 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.463 2.705 . . . . 1.62 112.374 162.255 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -70.79 -52.14 22.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.905 -2.997 . . . . 2.13 105.41 179.142 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.284 42.2 t -47.68 -57.56 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-N 121.797 2.09 . . . . 0.62 115.446 166.945 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -60.28 -31.19 70.0 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.103 -3.498 . . . . 1.22 112.307 179.094 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.7 -27.76 58.36 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 124.482 3.31 . . . . 0.51 111.343 -179.404 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.268 35.1 mttm -74.97 -26.84 59.88 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.592 2.757 . . . . 1.44 111.169 173.394 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.2 mt -69.41 -45.53 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 C-N-CA 128.9 2.88 . . . . 1.32 104.911 171.862 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -58.05 -39.35 78.23 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.484 2.313 . . . . 1.7 113.265 176.595 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.53 -56.07 21.44 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 127.203 3.382 . . . . 1.55 111.676 173.265 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -80.81 -58.84 2.91 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.604 -3.81 . . . . 2.62 113.332 -174.038 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -83.62 -50.61 8.04 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.595 -3.191 . . . . 1.48 111.786 -172.535 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.64 73.04 1.27 Allowed Glycine 0 N--CA 1.43 -1.701 0 CA-C-O 125.649 2.805 . . . . 1.12 110.203 179.963 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.9 mt -132.72 128.77 21.0 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-O 113.435 -3.174 . . . . 1.55 103.347 178.341 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -64.54 160.55 39.24 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 125.742 3.087 . . . . 1.02 117.115 179.944 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.01 -26.65 12.82 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 123.058 2.128 . . . . 1.25 111.018 -174.552 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.18 -39.15 81.63 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 117.882 -1.056 . . . . 2.25 112.766 171.203 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -83.78 -1.89 55.2 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 123.011 2.641 . . . . 2.02 112.593 -179.849 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -93.06 122.75 35.74 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 120.938 1.699 . . . . 0.69 108.712 -176.032 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -115.3 114.78 25.63 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 114.347 -1.297 . . . . 2.78 108.035 165.607 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.5 mt -98.63 122.59 42.03 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 123.774 1.749 . . . . 1.17 107.57 -179.264 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.3 mm -106.2 139.24 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 118.614 -2.554 . . . . 1.38 104.708 179.314 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -103.43 -92.67 0.34 Allowed 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 119.61 -1.931 . . . . 1.5 110.234 173.992 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.96 -84.29 0.51 Allowed 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.843 -1.91 . . . . 1.21 105.843 179.844 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.74 7.59 22.05 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 126.809 2.568 . . . . 1.3 112.361 -170.352 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -139.38 155.99 47.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.167 -1.784 . . . . 2.55 110.438 178.28 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -83.23 148.58 27.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.814 -1.178 . . . . 2.48 111.756 166.76 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.1 mt -86.75 131.14 34.21 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 119.26 -2.15 . . . . 0.9 110.806 -176.486 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -84.82 136.88 33.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.417 2.687 . . . . 1.94 110.405 175.016 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.39 -51.56 59.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.366 -3.334 . . . . 1.56 114.398 -167.088 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.61 26.38 2.71 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 123.293 2.769 . . . . 0.97 115.387 171.87 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -105.46 171.69 7.19 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.489 1.138 . . . . 2.49 110.813 165.539 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.6 p -98.82 172.43 7.45 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 127.852 3.691 . . . . 0.76 111.365 167.701 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.6 mt -64.0 -44.45 92.58 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 111.99 -2.368 . . . . 1.05 109.779 171.397 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 t -57.88 -37.45 73.98 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 116.851 2.167 . . . . 1.19 116.851 176.879 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -53.36 -21.66 6.14 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.741 -2.474 . . . . 1.9 113.497 175.687 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -112.27 22.14 15.04 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.5 -2.625 . . . . 0.89 113.206 177.334 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.504 1.0 OUTLIER 61.37 31.95 19.16 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 119.705 3.224 . . . . 1.84 119.705 177.968 . . . . . . . . 3 3 . 1 . 075 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.317 57.4 mt -86.2 125.8 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 118.322 -2.736 . . . . 0.82 105.009 177.968 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -148.77 -51.06 0.16 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.792 -2.442 . . . . 2.16 110.08 -170.831 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.4 tptp -79.47 -173.17 3.6 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 113.633 0.975 . . . . 2.12 113.633 169.352 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -73.05 95.88 2.09 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.123 2.392 . . . . 1.71 116.304 175.84 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.5 m -94.27 160.12 14.82 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 120.922 3.675 . . . . 1.04 120.922 -169.991 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.9 m -106.92 119.19 38.68 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 117.185 -1.388 . . . . 0.79 110.104 177.91 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -105.32 160.95 14.72 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 125.651 1.844 . . . . 1.4 106.61 168.471 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -127.08 124.47 39.31 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.273 -2.142 . . . . 1.51 108.864 -177.946 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 7' ' ' THR . 45.4 tp -99.55 112.17 24.42 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.059 1.344 . . . . 1.14 110.63 -174.42 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.1 t -97.6 120.56 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 C-N-CA 130.497 3.519 . . . . 1.23 112.737 174.018 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.4 mt . . . . . 0 N--CA 1.43 -1.437 0 C-N-CA 118.21 -1.396 . . . . 2.78 107.758 -177.787 . . . . . . . . 0 0 . 1 . 076 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ttp . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 118.662 2.838 . . . . 1.1 118.662 . . . . . . . . . 0 0 . 1 . 076 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -97.71 112.91 24.61 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.138 1.923 . . . . 1.87 109.623 -178.172 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.463 HG12 HG22 ' A' ' 17' ' ' VAL . 5.0 pt -109.14 146.77 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.038 -2.914 . . . . 0.72 109.368 175.083 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -106.32 124.06 49.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.091 2.956 . . . . 1.4 113.38 175.33 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.412 HG22 ' HB2' ' A' ' 67' ' ' LEU . 85.3 t -105.45 113.58 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 114.76 -1.109 . . . . 0.58 111.375 178.819 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -85.95 135.56 33.62 Favored 'General case' 0 N--CA 1.431 -1.423 2 O-C-N 113.041 -6.037 . . . . 2.09 115.826 179.038 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 p -99.1 173.11 6.97 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.653 -1.28 . . . . 0.99 109.708 178.797 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 tt -56.14 -49.14 74.77 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.22 1.008 . . . . 2.53 111.576 174.686 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -77.29 4.33 10.91 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.04 -2.287 . . . . 2.08 115.261 -177.425 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.16 17.63 46.17 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 119.497 2.559 . . . . 1.31 119.497 177.523 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -99.63 145.55 27.45 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 120.413 2.106 . . . . 1.4 109.939 -177.767 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.3 m -105.43 126.55 52.25 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.755 -1.216 . . . . 0.78 108.019 -173.036 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.9 mt -100.9 107.1 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.814 -3.054 . . . . 1.55 106.265 178.645 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 m -91.19 126.34 36.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.1 1.905 . . . . 1.08 108.021 -175.444 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.0 mt -126.63 160.75 29.81 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.867 2.867 . . . . 1.55 109.241 -178.473 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.342 43.6 mt-10 -122.85 115.62 22.29 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 125.658 2.647 . . . . 1.95 108.922 170.094 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.463 HG22 HG12 ' A' ' 3' ' ' ILE . 27.6 m -123.21 163.6 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 117.242 -3.411 . . . . 0.96 113.619 -178.591 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -98.2 145.45 29.85 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-O 116.634 -1.65 . . . . 2.35 112.816 162.735 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.49 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 21.1 Cg_exo -63.91 -9.87 20.67 Favored 'Trans proline' 0 N--CA 1.434 -1.999 2 CA-C-N 129.993 4.605 . . . . 0.95 114.149 -179.495 . . . . . . . . 3 3 . 1 . 076 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.6 p -84.57 -0.2 52.36 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 127.189 3.376 . . . . 1.45 116.099 173.526 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -80.67 156.01 26.53 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.816 -2.428 . . . . 1.69 106.356 176.0 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 p -104.37 165.77 10.84 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.52 -1.218 . . . . 0.75 113.245 176.292 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -58.43 -41.4 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.183 2.193 . . . . 0.73 112.496 176.695 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -44.17 -60.59 1.82 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.491 3.145 . . . . 1.62 119.491 162.024 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -58.96 -33.31 70.5 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 115.059 1.503 . . . . 2.13 115.059 177.85 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.23 -47.83 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 131.626 3.97 . . . . 0.62 115.406 172.478 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.33 27.1 mtmt -69.45 -32.43 71.37 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 111.561 -2.563 . . . . 1.22 110.944 177.946 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.66 -26.32 65.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.255 1.822 . . . . 0.51 113.537 171.79 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -75.97 -42.71 47.58 Favored 'General case' 0 N--CA 1.431 -1.411 1 C-N-CA 131.972 4.109 . . . . 1.44 108.427 -179.859 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt -61.08 -36.0 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 1 O-C-N 116.207 -4.058 . . . . 1.32 113.524 169.068 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -62.44 -37.54 86.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.052 2.541 . . . . 1.7 111.88 172.54 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.6 -52.18 41.48 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 119.548 3.166 . . . . 1.55 119.548 166.928 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -69.4 -51.5 35.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.662 1.185 . . . . 2.62 112.193 -176.546 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -110.34 -25.38 10.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.161 1.784 . . . . 1.48 112.159 -169.453 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.26 39.94 5.26 Favored Glycine 0 N--CA 1.429 -1.773 0 O-C-N 118.363 -2.711 . . . . 1.12 115.255 175.985 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.5 mt -117.97 126.65 27.14 Favored Pre-proline 0 N--CA 1.429 -1.483 0 CA-C-O 116.836 -1.554 . . . . 1.55 111.775 -174.111 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -63.78 145.39 90.78 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 CA-C-N 127.145 3.588 . . . . 1.02 116.932 178.283 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -66.72 -25.23 46.59 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 CA-C-N 120.686 1.281 . . . . 1.25 113.279 -175.137 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -70.78 -13.8 62.19 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 120.398 3.481 . . . . 2.25 120.398 177.476 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -84.76 -36.88 21.46 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 127.866 3.229 . . . . 2.02 108.165 174.043 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -76.91 108.88 10.27 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.067 2.365 . . . . 0.69 113.422 -173.378 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.425 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 56.2 mtt180 -102.19 114.76 29.18 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 114.611 -5.055 . . . . 2.78 110.756 162.725 . . . . . . . . 3 3 . 1 . 076 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 43' ' ' LEU . 64.9 mt -100.53 123.43 44.74 Favored 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 116.035 -4.166 . . . . 1.17 111.922 -177.687 . . . . . . . . 3 3 . 1 . 076 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.496 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 33.9 mm -109.4 136.33 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 112.255 -2.248 . . . . 1.38 110.635 -177.654 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -99.42 -88.05 0.35 Allowed 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.742 -1.849 . . . . 1.5 109.571 172.404 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -113.02 -8.63 13.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 126.595 3.093 . . . . 1.21 113.151 -176.186 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.14 -40.04 0.17 Allowed Glycine 0 N--CA 1.429 -1.816 1 N-CA-C 102.958 -4.057 . . . . 1.3 102.958 -178.37 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -75.96 150.57 37.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.47 1.605 . . . . 2.55 114.39 175.424 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -84.25 134.06 34.55 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.858 -3.026 . . . . 2.48 107.532 170.67 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.2 mt -82.38 124.94 30.47 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 129.208 4.068 . . . . 0.9 105.448 -173.715 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -80.25 140.86 36.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.364 3.468 . . . . 1.94 120.364 174.082 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.94 -62.82 1.39 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 116.479 2.029 . . . . 1.56 116.479 -170.723 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.1 56.68 4.97 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 118.512 2.165 . . . . 0.97 118.512 173.056 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.266 50.5 mmt-85 -133.35 151.57 51.86 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 107.623 -1.251 . . . . 2.49 107.623 169.108 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 4.5 p -74.2 169.04 18.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 127.027 3.299 . . . . 0.76 118.141 174.172 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.49 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 94.3 mt -74.4 -34.93 63.42 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.536 -4.477 . . . . 1.05 113.279 173.764 . . . . . . . . 3 3 . 1 . 076 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -66.52 -49.19 67.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.127 -2.76 . . . . 1.19 108.891 178.529 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -42.1 -45.16 3.89 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 120.258 3.429 . . . . 1.9 120.258 173.788 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -82.25 -20.81 36.86 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 115.988 1.847 . . . . 0.89 115.988 179.472 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 80.26 50.16 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 128.001 2.521 . . . . 1.84 111.057 -175.022 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.2 mt -93.2 115.94 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 124.809 1.244 . . . . 0.82 109.519 170.814 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -108.18 -174.86 2.62 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.991 2.116 . . . . 2.16 111.577 -167.197 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -65.58 -34.75 78.96 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.819 1.295 . . . . 2.12 112.821 172.066 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.258 13.5 pt-20 -77.04 -12.14 59.9 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.067 -2.896 . . . . 1.71 115.957 178.455 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.314 19.0 m -82.01 139.86 34.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 114.827 1.417 . . . . 1.04 114.827 -167.437 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.4 m -107.11 124.15 49.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.218 1.807 . . . . 0.79 111.609 -179.495 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.412 ' HB2' HG22 ' A' ' 5' ' ' VAL . 8.6 mp -96.85 149.5 21.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 123.198 2.726 . . . . 1.4 106.269 178.13 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.496 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 57.9 m80 -110.34 131.05 55.4 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.48 1.609 . . . . 1.51 113.413 176.735 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 43' ' ' LEU . 51.8 tp -110.14 135.57 50.72 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 125.527 2.584 . . . . 1.14 105.658 -174.93 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 53.1 t -125.54 123.85 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.082 -2.562 . . . . 1.23 104.082 175.826 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 N--CA 1.43 -1.465 0 O-C-N 120.77 -1.206 . . . . 2.78 111.821 177.623 . . . . . . . . 0 0 . 1 . 077 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ttp . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 116.743 -1.599 . . . . 1.1 112.034 . . . . . . . . . 0 0 . 1 . 077 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -93.5 111.62 23.33 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 115.316 -2.278 . . . . 1.87 111.185 -177.274 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.7 pt -106.47 167.98 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-O 125.992 2.806 . . . . 0.72 107.824 172.872 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -126.1 114.8 18.87 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.403 2.049 . . . . 1.4 113.129 -176.727 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.0 t -107.6 113.59 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 116.404 -3.935 . . . . 0.58 102.174 -179.002 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -82.74 143.93 30.55 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 116.103 -4.123 . . . . 2.09 116.49 177.166 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.569 HG21 ' HE2' ' A' ' 11' ' ' LYS . 20.2 p -93.85 158.46 15.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.558 1.943 . . . . 0.99 116.126 176.179 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.25 80.1 mt -64.44 -32.53 74.2 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.246 1.818 . . . . 2.53 114.648 175.906 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.7 p -71.61 -44.31 64.64 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.542 -1.349 . . . . 2.08 112.172 178.33 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.79 -33.75 0.44 Allowed Glycine 0 N--CA 1.43 -1.762 0 CA-C-O 125.516 2.731 . . . . 1.31 115.072 172.036 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.569 ' HE2' HG21 ' A' ' 7' ' ' THR 0.362 0.0 OUTLIER -70.9 153.41 42.72 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 110.879 -2.661 . . . . 1.4 115.434 -176.285 . . . . . . . . 4 4 . 1 . 077 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.9 m -103.21 136.38 43.11 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.051 -1.655 . . . . 0.78 110.432 177.642 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 69.7 mt -98.78 115.48 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 116.517 -1.706 . . . . 1.55 108.768 177.597 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 m -92.44 110.83 22.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.242 1.817 . . . . 1.08 111.767 179.95 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.9 mt -112.89 133.85 54.67 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 125.332 2.491 . . . . 1.55 110.803 -174.742 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -91.0 113.15 25.34 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 116.28 -4.012 . . . . 1.95 109.64 168.255 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.7 163.14 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 113.502 -1.681 . . . . 0.96 108.688 -177.378 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -104.55 131.0 22.26 Favored Pre-proline 0 N--CA 1.43 -1.434 0 O-C-N 125.792 1.933 . . . . 2.35 106.102 163.449 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.71 -14.04 24.77 Favored 'Trans proline' 0 C--N 1.3 -1.993 1 C-N-CA 127.827 5.684 . . . . 0.95 114.788 -178.542 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -85.96 -17.04 36.46 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.895 2.878 . . . . 1.45 114.858 -179.771 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -68.17 144.46 54.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 116.997 -1.478 . . . . 1.69 113.704 176.007 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.3 p -76.61 164.11 26.23 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 122.959 2.618 . . . . 0.75 110.332 -178.266 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.881 HD13 ' HB3' ' A' ' 50' ' ' LEU . 52.0 mt -67.86 -35.38 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 118.158 -2.838 . . . . 0.73 114.594 176.165 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -47.89 -37.65 14.59 Favored 'General case' 0 N--CA 1.431 -1.409 1 O-C-N 115.665 -4.397 . . . . 1.62 116.873 156.659 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -78.97 -30.22 44.35 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.43 -2.669 . . . . 2.13 111.087 177.094 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.7 t -61.83 -52.98 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 O-C-N 119.554 -1.966 . . . . 0.62 113.305 170.961 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -50.05 -40.73 45.97 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 127.892 3.245 . . . . 1.22 114.771 176.457 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.97 -37.37 68.96 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.839 -1.163 . . . . 0.51 112.432 173.388 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -70.16 -24.92 63.23 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 118.801 2.889 . . . . 1.44 118.801 174.548 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.8 mt -77.33 -42.37 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 129.051 2.94 . . . . 1.32 104.38 179.693 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -61.38 -47.9 83.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.418 -1.426 . . . . 1.7 110.585 179.947 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -41.71 -48.68 4.22 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 118.076 2.621 . . . . 1.55 118.076 170.329 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -79.0 -60.76 2.25 Favored 'General case' 0 N--CA 1.432 -1.372 0 O-C-N 119.192 -2.193 . . . . 2.62 108.607 -174.031 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -101.85 -17.37 16.22 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 119.862 1.21 . . . . 1.48 111.535 -163.922 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.98 46.89 5.77 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 123.844 1.802 . . . . 1.12 116.852 173.444 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.4 mt -129.3 129.1 23.27 Favored Pre-proline 0 N--CA 1.431 -1.395 0 O-C-N 120.211 -1.758 . . . . 1.55 112.162 -174.112 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -62.72 162.16 26.01 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 O-C-N 114.574 -3.435 . . . . 1.02 120.881 -177.278 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.7 -14.92 19.51 Favored 'Trans proline' 0 N--CA 1.433 -2.038 0 CA-C-N 127.825 3.83 . . . . 1.25 112.824 -178.398 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -60.47 -46.21 90.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.919 2.488 . . . . 2.25 109.398 173.41 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -83.77 -27.57 28.77 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 123.503 0.721 . . . . 2.02 112.473 -174.417 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -76.87 108.32 9.83 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.344 2.021 . . . . 0.69 110.731 -177.582 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -93.8 119.13 32.36 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.971 -3.581 . . . . 2.78 104.564 167.542 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.3 mt -98.41 138.38 35.73 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.278 -2.139 . . . . 1.17 108.688 174.277 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.41 134.1 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 101.735 -3.432 . . . . 1.38 101.735 -178.404 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -98.11 -107.23 0.18 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.187 -1.571 . . . . 1.5 109.736 170.171 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.66 -51.38 5.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.079 -2.263 . . . . 1.21 110.752 177.582 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.25 -40.17 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 128.955 3.169 . . . . 1.3 106.343 -171.074 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -74.5 146.77 42.44 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 112.878 0.696 . . . . 2.55 112.878 178.348 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.276 3.6 mp0 -97.92 145.65 26.25 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 100.308 -3.96 . . . . 2.48 100.308 171.879 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.881 ' HB3' HD13 ' A' ' 23' ' ' ILE . 78.8 mt -99.75 121.02 40.65 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 127.733 3.635 . . . . 0.9 108.437 -169.496 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -71.35 129.15 38.12 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.519 -2.613 . . . . 1.94 114.189 170.638 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.41 -48.04 47.46 Favored 'General case' 0 N--CA 1.431 -1.417 1 C-N-CA 131.966 4.106 . . . . 1.56 117.412 -175.071 . . . . . . . . 3 3 . 1 . 077 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.62 -9.58 62.19 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 119.157 2.423 . . . . 0.97 119.157 176.663 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -90.39 177.02 6.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 118.386 1.093 . . . . 2.49 109.247 179.412 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.5 p -108.23 164.36 12.38 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.184 1.393 . . . . 0.76 108.46 173.873 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.0 mt -58.4 -33.24 69.42 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.478 1.511 . . . . 1.05 111.421 171.629 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -64.27 -34.72 78.78 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 118.788 2.884 . . . . 1.19 118.788 176.728 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.284 64.6 m-20 -67.47 -29.79 69.33 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.42 -2.675 . . . . 1.9 111.785 178.429 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -92.53 -7.16 48.07 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 130.402 3.481 . . . . 0.89 112.088 178.664 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.268 71.6 m-80 61.96 60.82 1.47 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.213 1.482 . . . . 1.84 110.06 176.479 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.282 12.8 mt -83.69 130.43 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 128.054 2.542 . . . . 0.82 109.665 173.431 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -100.7 178.38 4.72 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 117.576 -1.202 . . . . 2.16 114.003 -171.453 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -44.19 -80.86 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.248 2.219 . . . . 2.12 116.684 173.627 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.341 0.8 OUTLIER -93.05 58.29 2.91 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 123.214 1.483 . . . . 1.71 113.622 -177.666 . . . . . . . . 3 3 . 1 . 077 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 p -92.3 139.87 30.17 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.952 2.501 . . . . 1.04 113.514 -175.039 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.4 m -109.79 124.12 50.74 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 104.122 -2.547 . . . . 0.79 104.122 -176.223 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -97.91 170.33 9.03 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 126.531 3.063 . . . . 1.4 104.815 172.361 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -120.76 125.51 47.77 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 118.037 -2.914 . . . . 1.51 105.09 -177.998 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.0 tp -95.17 107.16 19.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.471 2.081 . . . . 1.14 111.608 169.069 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -112.49 150.3 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 118.609 -2.557 . . . . 1.23 107.819 173.964 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.5 mt . . . . . 0 N--CA 1.43 -1.43 0 O-C-N 118.6 -2.563 . . . . 2.78 111.516 -178.788 . . . . . . . . 0 0 . 1 . 078 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tmm? . . . . . 0 CA--C 1.491 -1.32 0 N-CA-C 105.25 -2.13 . . . . 1.1 105.25 . . . . . . . . . 0 0 . 1 . 078 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.83 131.64 36.56 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.095 -3.503 . . . . 1.87 113.372 179.762 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.2 pt -116.48 148.15 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 129.245 3.018 . . . . 0.72 105.305 174.867 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -104.42 131.11 52.14 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.24 -1.538 . . . . 1.4 107.275 -179.546 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.0 t -109.79 118.66 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 105.185 -2.154 . . . . 0.58 105.185 177.083 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -105.08 130.39 53.28 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.475 -1.391 . . . . 2.09 110.066 176.277 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.8 p -69.93 167.02 18.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.549 2.118 . . . . 0.99 113.71 176.883 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.2 tp -56.01 -46.18 78.84 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 112.122 -2.308 . . . . 2.53 114.11 173.427 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 p -81.22 -21.15 39.75 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.299 2.333 . . . . 2.08 117.299 -176.248 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.76 1.69 4.1 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 122.686 3.834 . . . . 1.31 122.686 177.78 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -88.25 131.27 34.84 Favored 'General case' 0 N--CA 1.431 -1.397 1 O-C-N 115.855 -4.321 . . . . 1.4 109.978 -174.306 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.5 m -119.53 112.99 20.04 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 120.171 1.35 . . . . 0.78 113.384 179.626 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.9 pt -101.78 151.94 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 125.691 1.869 . . . . 1.55 107.61 -177.476 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.1 m -116.68 118.68 33.25 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 126.61 2.444 . . . . 1.08 110.012 -175.122 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.7 mt -102.96 149.22 24.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.518 -3.239 . . . . 1.55 107.247 177.977 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -102.48 123.36 46.1 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.225 -1.398 . . . . 1.95 107.225 165.762 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 m -131.77 147.66 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 106.67 -1.604 . . . . 0.96 106.67 -176.558 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -87.01 129.68 51.12 Favored Pre-proline 0 N--CA 1.429 -1.523 1 CA-C-O 111.438 -4.125 . . . . 2.35 110.132 163.875 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.31 -1.94 12.06 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 CA-C-N 127.809 3.825 . . . . 0.95 115.517 -166.246 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.2 m -84.19 2.66 38.72 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 116.301 -3.999 . . . . 1.45 116.513 172.917 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -81.36 163.32 22.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.514 -3.241 . . . . 1.69 113.174 174.952 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -90.98 157.95 16.99 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 125.729 2.68 . . . . 0.75 112.73 -178.538 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.44 -37.67 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.004 -2.935 . . . . 0.73 115.814 171.22 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -48.27 -41.21 27.22 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.647 -3.158 . . . . 1.62 117.879 167.811 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -73.8 -33.56 64.26 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.406 1.262 . . . . 2.13 114.406 172.568 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.5 -40.26 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 116.791 -3.693 . . . . 0.62 111.572 174.665 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -66.32 -35.74 81.14 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.288 -2.132 . . . . 1.22 110.115 177.58 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.439 . . -69.62 -27.02 64.72 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.883 2.473 . . . . 0.51 116.148 173.369 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -75.09 -34.84 61.8 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 120.702 -1.249 . . . . 1.44 111.698 172.391 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.1 mt -69.0 -33.73 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 117.425 -1.274 . . . . 1.32 112.666 168.38 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -65.2 -35.21 80.35 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.435 -1.32 . . . . 1.7 107.435 176.53 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.32 -26.9 68.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.041 2.237 . . . . 1.55 117.041 173.892 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -99.37 -69.71 0.76 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.522 1.629 . . . . 2.62 113.332 -172.734 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -84.8 -25.36 28.21 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.058 -2.901 . . . . 1.48 105.475 -169.314 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.88 58.88 2.56 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 107.928 -2.069 . . . . 1.12 107.928 178.948 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.3 mt -115.25 120.31 36.9 Favored Pre-proline 0 N--CA 1.43 -1.443 1 CA-C-O 110.705 -4.474 . . . . 1.55 107.411 -179.25 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -63.56 143.95 88.86 Favored 'Trans proline' 0 N--CA 1.434 -2.028 1 CA-C-N 128.555 4.091 . . . . 1.02 116.801 177.681 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -68.87 -18.37 41.33 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 CA-C-N 125.763 3.094 . . . . 1.25 115.015 -172.925 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.257 11.3 p-10 -77.51 -18.67 56.83 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 127.69 3.614 . . . . 2.25 113.729 178.413 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -90.32 -16.51 29.1 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 114.903 -4.873 . . . . 2.02 110.524 178.831 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -87.46 131.07 34.46 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 126.088 2.852 . . . . 0.69 116.638 -177.614 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -111.85 114.38 27.29 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.171 2.988 . . . . 2.78 111.304 172.361 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 39.5 mt -104.5 126.01 51.2 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 118.455 -2.653 . . . . 1.17 108.253 178.106 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.8 mt -119.72 153.76 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 N-CA-C 101.28 -3.6 . . . . 1.38 101.28 -179.185 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.567 ' HB3' HD21 ' A' ' 50' ' ' LEU 0.429 26.7 t80 -126.03 -73.15 0.63 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 119.052 -1.059 . . . . 1.5 112.738 167.964 . . . . . . . . 3 3 . 1 . 078 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.11 -40.12 8.57 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 114.115 -2.85 . . . . 1.21 115.29 178.768 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.89 -52.69 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 108.452 -1.859 . . . . 1.3 108.452 -175.873 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -89.12 163.46 15.45 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 122.084 2.942 . . . . 2.55 112.787 177.677 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -68.63 147.98 51.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 125.623 1.827 . . . . 2.48 112.053 170.669 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.567 HD21 ' HB3' ' A' ' 45' ' ' PHE . 24.1 mt -84.64 144.73 28.41 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 115.925 -1.988 . . . . 0.9 107.481 -175.436 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -90.97 155.38 18.76 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 125.799 3.908 . . . . 1.94 109.372 178.252 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -65.44 -57.85 7.27 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.87 3.268 . . . . 1.56 112.858 -172.81 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.67 62.62 1.64 Allowed Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 121.385 3.314 . . . . 0.97 121.385 168.506 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 ttm-85 -139.92 163.26 33.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 113.545 -1.328 . . . . 2.49 107.442 164.938 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.254 24.4 p -91.75 172.41 8.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.269 1.985 . . . . 0.76 112.149 -174.93 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.55 -46.0 64.38 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.322 -1.763 . . . . 1.05 111.065 168.594 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.273 1.2 t -63.51 -17.2 62.51 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.127 2.171 . . . . 1.19 114.747 175.733 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -77.73 -36.08 51.23 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 115.596 1.702 . . . . 1.9 115.596 170.268 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -87.22 7.08 29.98 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.289 1.995 . . . . 0.89 112.233 173.08 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 m120 44.06 59.83 3.02 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.887 3.675 . . . . 1.84 115.86 -174.649 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.449 HG12 ' CE2' ' A' ' 45' ' ' PHE . 46.8 mt -87.07 106.98 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 119.411 -2.055 . . . . 0.82 105.811 179.294 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -104.03 -170.31 1.76 Allowed 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 116.269 -0.423 . . . . 2.16 110.364 -179.97 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -27.99 137.46 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 130.16 3.384 . . . . 2.12 118.934 169.124 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 48.42 56.2 7.83 Favored 'General case' 0 N--CA 1.431 -1.385 1 C-N-CA 132.402 4.281 . . . . 1.71 114.948 176.679 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.4 m -116.91 135.45 53.71 Favored 'General case' 0 N--CA 1.432 -1.37 0 O-C-N 119.756 -1.84 . . . . 1.04 113.859 -173.938 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.2 m -102.35 99.87 9.98 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.195 2.998 . . . . 0.79 109.299 -176.471 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.61 135.35 48.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 116.339 -1.791 . . . . 1.4 111.968 169.465 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.6 m170 -91.11 100.37 13.22 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 127.864 2.466 . . . . 1.51 113.15 -176.898 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.2 tp -91.48 135.6 33.73 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 126.9 2.625 . . . . 1.14 114.083 177.681 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.6 t -135.16 120.46 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 129.841 3.256 . . . . 1.23 109.37 170.63 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.0 pp . . . . . 0 N--CA 1.429 -1.489 0 CA-C-N 124.366 3.257 . . . . 2.78 107.526 172.264 . . . . . . . . 0 0 . 1 . 079 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ptt? . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 114.363 1.246 . . . . 1.1 114.363 . . . . . . . . . 0 0 . 1 . 079 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -89.05 127.82 35.71 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.281 -2.762 . . . . 1.87 107.456 -175.778 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.8 pt -114.73 162.53 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 115.254 1.575 . . . . 0.72 115.254 171.67 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 64' ' ' GLU . 36.1 m-85 -116.15 121.34 41.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.538 -3.226 . . . . 1.4 110.962 -175.883 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.0 t -103.2 124.45 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 1 O-C-N 116.009 -4.182 . . . . 0.58 110.592 176.49 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -99.62 135.98 40.23 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.38 1.446 . . . . 2.09 109.407 179.744 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.1 p -88.17 -175.49 5.07 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 117.235 -1.364 . . . . 0.99 113.665 176.053 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.3 mt -62.47 -52.52 63.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 124.724 1.265 . . . . 2.53 112.308 170.232 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.5 p -74.53 -12.98 60.61 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 115.591 -2.147 . . . . 2.08 110.472 -178.327 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.54 9.23 25.53 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 122.14 3.616 . . . . 1.31 122.14 173.291 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.49 140.87 54.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.493 2.092 . . . . 1.4 107.659 -177.006 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.7 m -108.33 104.83 14.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.498 -3.251 . . . . 0.78 112.458 177.128 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.7 mt -98.12 120.57 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 125.046 1.466 . . . . 1.55 107.8 -176.13 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 m -90.99 115.92 28.38 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 127.332 2.895 . . . . 1.08 108.708 178.357 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 mt -123.35 137.45 54.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.26 1.824 . . . . 1.55 107.83 -178.261 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.89 130.93 35.33 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 101.997 -3.335 . . . . 1.95 101.997 170.146 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -138.27 158.78 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 126.022 2.82 . . . . 0.96 108.968 174.472 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -102.6 153.35 38.23 Favored Pre-proline 0 N--CA 1.43 -1.433 1 O-C-N 115.211 -4.681 . . . . 2.35 107.034 161.105 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -76.67 -7.66 17.74 Favored 'Trans proline' 0 N--CA 1.433 -2.037 1 CA-C-N 128.475 4.063 . . . . 0.95 112.567 -167.753 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -80.95 -8.92 59.87 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 126.037 1.735 . . . . 1.45 108.776 -179.01 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -66.7 141.17 57.86 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.661 1.984 . . . . 1.69 113.063 171.001 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 82.3 p -82.66 168.01 17.69 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.875 -2.391 . . . . 0.75 114.557 173.435 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.1 mm -64.41 -32.31 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 117.795 -3.065 . . . . 0.73 112.437 173.107 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -58.65 -39.35 80.35 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 115.957 -4.214 . . . . 1.62 115.02 169.539 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -63.48 -43.44 97.28 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 127.837 2.455 . . . . 2.13 111.728 174.874 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.6 t -61.81 -47.05 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 126.814 2.046 . . . . 0.62 110.554 175.255 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -62.68 -30.61 71.52 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 119.559 3.17 . . . . 1.22 119.559 170.838 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.76 -28.66 61.79 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 123.075 1.416 . . . . 0.51 112.836 175.819 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.289 18.5 ttmm -80.18 -36.45 34.99 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 129.551 3.14 . . . . 1.44 114.041 173.317 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.443 68.7 mt -62.68 -44.75 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 127.796 2.438 . . . . 1.32 112.368 168.093 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -55.92 -52.19 65.0 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.518 -3.239 . . . . 1.7 114.251 169.872 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -60.58 -42.95 97.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.625 2.083 . . . . 1.55 116.625 175.058 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -86.22 -50.16 7.18 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.776 1.274 . . . . 2.62 110.516 -173.435 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -94.82 -41.97 8.95 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 116.643 -3.786 . . . . 1.48 114.003 -171.691 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.94 22.65 6.81 Favored Glycine 0 N--CA 1.431 -1.699 0 CA-C-O 124.279 2.044 . . . . 1.12 111.836 174.02 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.4 mt -94.89 131.9 29.43 Favored Pre-proline 0 N--CA 1.43 -1.442 0 O-C-N 118.891 -2.535 . . . . 1.55 104.856 -173.168 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -64.72 144.62 84.5 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 C-N-CA 124.685 3.59 . . . . 1.02 119.293 -179.931 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -71.65 -15.46 30.38 Favored 'Trans proline' 0 N--CA 1.433 -2.085 0 C-N-CA 114.745 -3.036 . . . . 1.25 113.757 -172.124 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -65.43 -25.29 67.46 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 118.395 2.739 . . . . 2.25 118.395 175.261 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -96.68 -25.22 15.63 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 116.13 -4.106 . . . . 2.02 105.472 -172.044 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -75.38 103.42 5.51 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.396 -3.94 . . . . 0.69 114.533 -177.382 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -94.77 129.57 41.66 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.425 -2.047 . . . . 2.78 109.203 165.605 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' A' ' 43' ' ' LEU . 42.9 mt -115.08 127.32 55.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.5 -2.0 . . . . 1.17 108.694 -179.494 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 9.5 mm -116.31 155.37 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 127.994 2.518 . . . . 1.38 104.597 173.958 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -104.73 -83.32 0.5 Allowed 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.88 -2.637 . . . . 1.5 103.88 174.218 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.99 -43.69 6.6 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 113.95 -1.477 . . . . 1.21 110.787 179.199 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -173.81 -16.9 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 127.254 2.359 . . . . 1.3 114.23 -179.007 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -82.2 124.73 30.17 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 102.758 -3.053 . . . . 2.55 102.758 178.864 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.04 130.69 45.03 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.349 -2.719 . . . . 2.48 112.166 173.73 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.1 mt -87.41 132.32 34.02 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.108 -2.87 . . . . 0.9 107.432 -175.094 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -94.25 138.18 32.55 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 117.704 -1.141 . . . . 1.94 113.122 177.75 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -50.6 -56.07 13.44 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 130.866 3.666 . . . . 1.56 113.339 -166.813 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.85 52.98 4.48 Favored Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 118.024 1.969 . . . . 0.97 118.024 172.963 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.0 mmt-85 -126.94 159.23 34.65 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 105.942 -1.873 . . . . 2.49 105.942 165.438 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.299 35.6 p -89.7 170.78 10.16 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.566 -2.583 . . . . 0.76 113.277 175.808 . . . . . . . . 3 3 . 1 . 079 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mt -73.3 -32.55 64.69 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 106.416 -1.698 . . . . 1.05 106.416 173.381 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -64.38 -43.56 94.12 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 117.079 -1.439 . . . . 1.19 110.195 177.959 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -46.02 -45.79 16.13 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 122.383 2.356 . . . . 1.9 113.801 173.791 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -82.42 6.68 16.43 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.338 -1.476 . . . . 0.89 114.946 178.45 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.4 m120 61.79 37.96 15.18 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 131.25 3.82 . . . . 1.84 116.684 176.09 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -86.65 128.01 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 127.043 2.137 . . . . 0.82 105.761 -177.57 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -142.94 -47.31 0.31 Allowed 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.243 -1.536 . . . . 2.16 113.333 -172.318 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -88.6 -162.36 0.84 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.333 1.453 . . . . 2.12 114.465 179.917 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.44 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 24.8 mt-10 -84.51 75.45 10.27 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.002 -2.937 . . . . 1.71 111.74 179.598 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 m -82.42 144.09 30.73 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 119.985 3.328 . . . . 1.04 119.985 -175.834 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.3 m -91.7 106.47 18.5 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.2 -1.364 . . . . 0.79 111.44 179.63 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -85.26 154.96 21.59 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 128.317 3.913 . . . . 1.4 105.963 166.126 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.425 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 69.9 m80 -115.17 119.04 35.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 111.791 -2.458 . . . . 1.51 106.637 -176.525 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.5 tp -105.08 99.7 9.31 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 105.118 -2.178 . . . . 1.14 105.118 178.096 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.6 t -86.88 125.39 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 113.478 -1.692 . . . . 1.23 111.017 171.283 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.3 mt . . . . . 0 N--CA 1.43 -1.468 0 O-C-N 119.191 -2.193 . . . . 2.78 114.635 -179.111 . . . . . . . . 0 0 . 1 . 080 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.329 0 CA-C-O 119.556 -0.259 . . . . 1.1 111.252 . . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -114.0 113.26 24.54 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 101.531 -3.507 . . . . 1.87 101.531 -174.581 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.7 pt -92.52 166.66 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 122.601 2.455 . . . . 0.72 111.835 170.611 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -122.61 94.12 4.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.895 1.678 . . . . 1.4 110.831 176.142 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.4 t -77.05 115.11 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 O-C-N 118.035 -2.915 . . . . 0.58 113.557 174.742 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -94.84 128.89 41.91 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 117.083 -1.847 . . . . 2.09 113.74 -178.288 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 p -85.67 173.24 10.26 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 124.463 2.078 . . . . 0.99 109.914 177.126 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 mt -79.96 -33.97 39.13 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.242 -2.786 . . . . 2.53 108.406 172.845 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.9 p -71.77 -35.06 69.94 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 123.769 2.986 . . . . 2.08 113.568 179.898 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.81 8.41 0.92 Allowed Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 119.162 2.425 . . . . 1.31 119.162 176.957 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.0 tptt -96.94 144.55 26.75 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.898 -1.519 . . . . 1.4 106.898 -172.309 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.4 m -111.73 108.25 17.62 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.318 -2.845 . . . . 0.78 103.318 174.241 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.9 mt -82.27 111.1 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 113.526 -1.67 . . . . 1.55 108.276 179.472 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.5 m -85.23 106.84 16.95 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.194 1.398 . . . . 1.08 112.665 -178.756 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.4 mt -123.36 133.28 54.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 124.833 1.333 . . . . 1.55 107.871 -172.849 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -94.21 133.59 37.57 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.748 -1.845 . . . . 1.95 110.672 162.902 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.3 m -133.3 173.54 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 125.964 2.792 . . . . 0.96 108.997 176.744 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.267 39.5 mt-10 -123.42 167.08 15.79 Favored Pre-proline 0 N--CA 1.43 -1.451 0 N-CA-C 103.595 -2.743 . . . . 2.35 103.595 162.911 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -69.06 -11.54 32.0 Favored 'Trans proline' 0 N--CA 1.433 -2.065 0 N-CA-C 117.184 1.955 . . . . 0.95 117.184 179.395 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -79.27 -11.73 59.95 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 129.066 2.946 . . . . 1.45 112.07 179.001 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -74.76 141.22 44.42 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.16 -1.588 . . . . 1.69 113.098 175.425 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 57.2 p -84.46 164.35 18.89 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.865 -1.772 . . . . 0.75 107.957 174.875 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.275 1.9 mp -69.95 -27.77 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 119.232 -2.168 . . . . 0.73 113.429 178.86 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -53.34 -46.72 69.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.07 -2.269 . . . . 1.62 114.69 164.436 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -53.3 -40.8 65.04 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.532 -3.23 . . . . 2.13 113.714 172.633 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.06 -42.0 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 O-C-N 121.045 -1.034 . . . . 0.62 111.682 177.546 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -59.56 -36.89 77.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.057 -2.277 . . . . 1.22 115.03 173.634 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.17 73.64 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.052 2.095 . . . . 0.51 115.034 174.883 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -72.81 -37.19 67.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 131.418 3.887 . . . . 1.44 112.748 173.823 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.6 mt -73.6 -28.02 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 117.825 -3.047 . . . . 1.32 109.106 170.596 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -71.2 -35.22 71.47 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.859 -1.776 . . . . 1.7 110.228 176.613 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -69.64 -57.39 5.22 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.098 2.559 . . . . 1.55 109.066 176.41 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.254 22.6 mmtt -57.58 -73.44 0.07 Allowed 'General case' 0 CA--C 1.489 -1.384 0 C-N-CA 131.068 3.747 . . . . 2.62 115.104 178.449 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.276 47.0 mm-40 -88.73 -41.14 12.74 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.727 -2.483 . . . . 1.48 114.52 -168.105 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.62 34.43 2.86 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 126.421 1.962 . . . . 1.12 111.427 173.97 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.8 mm -92.93 135.31 26.15 Favored Pre-proline 0 N--CA 1.429 -1.488 0 CA-C-O 112.456 -3.64 . . . . 1.55 109.52 -177.586 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -75.48 136.02 18.93 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 CA-C-N 127.342 3.658 . . . . 1.02 112.638 176.75 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -60.9 -21.14 69.89 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 C-N-CA 123.574 2.85 . . . . 1.25 116.909 -173.629 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.55 -28.68 68.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 130.094 3.358 . . . . 2.25 113.135 172.814 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -80.98 -34.82 32.77 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 131.066 3.746 . . . . 2.02 113.663 -177.518 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -88.59 115.47 26.14 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 116.266 1.95 . . . . 0.69 116.266 -163.587 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -95.71 120.04 35.27 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.898 -2.376 . . . . 2.78 110.092 173.46 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 43' ' ' LEU 0.264 68.0 mt -97.43 99.17 10.6 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.132 1.787 . . . . 1.17 113.109 175.835 . . . . . . . . 3 3 . 1 . 080 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mm -95.05 130.65 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 128.857 2.863 . . . . 1.38 107.432 -174.788 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -111.7 -80.96 0.59 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 105.326 -2.102 . . . . 1.5 105.326 174.889 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.99 -95.67 0.35 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.777 -2.452 . . . . 1.21 111.016 -179.168 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.58 -4.12 54.91 Favored Glycine 0 N--CA 1.429 -1.772 0 O-C-N 119.551 -1.968 . . . . 1.3 113.634 -178.977 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -133.25 153.87 51.18 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.178 -2.366 . . . . 2.55 113.458 -177.581 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -82.31 141.41 32.91 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.045 -3.535 . . . . 2.48 109.483 162.948 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.8 mt -75.68 141.1 42.81 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.631 -2.543 . . . . 0.9 106.157 -178.909 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -86.42 137.34 32.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.204 -3.435 . . . . 1.94 115.077 176.773 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -53.03 -60.86 2.75 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 120.742 3.608 . . . . 1.56 120.742 -166.372 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.87 25.62 1.18 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 120.81 3.084 . . . . 0.97 120.81 170.128 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -113.87 159.82 19.43 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 127.325 2.427 . . . . 2.49 106.241 173.161 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 29.1 p -87.21 156.84 19.5 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.384 2.364 . . . . 0.76 117.384 -176.462 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.8 mt -53.62 -40.24 65.6 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 118.576 -2.577 . . . . 1.05 114.064 167.824 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.1 t -56.23 -36.69 68.76 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 115.573 1.694 . . . . 1.19 115.573 174.777 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -55.31 -30.49 60.32 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 120.795 3.628 . . . . 1.9 120.795 175.015 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -96.91 -1.24 46.22 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.843 -1.526 . . . . 0.89 109.906 -179.221 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.308 33.8 m-80 64.74 67.86 0.54 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.999 2.92 . . . . 1.84 109.44 -177.978 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.4 mt -124.34 114.02 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 1 C-N-CA 132.614 4.365 . . . . 0.82 101.794 179.851 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.25 57.0 mm-40 -139.77 -25.32 0.82 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 116.448 -1.739 . . . . 2.16 109.083 -176.104 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -107.45 -173.35 2.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 129.555 3.142 . . . . 2.12 110.977 -179.481 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -73.51 77.5 1.44 Allowed 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.938 1.295 . . . . 1.71 113.719 177.597 . . . . . . . . 3 3 . 1 . 080 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.379 54.3 p -80.06 158.56 26.43 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.046 1.339 . . . . 1.04 113.772 -170.386 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.48 HG22 ' CE1' ' A' ' 68' ' ' HIS . 2.9 m -107.96 115.46 30.17 Favored 'General case' 0 N--CA 1.431 -1.424 1 N-CA-C 99.636 -4.209 . . . . 0.79 99.636 179.097 . . . . . . . . 3 3 . 1 . 080 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mp -108.27 168.01 9.61 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 116.66 -3.775 . . . . 1.4 106.292 175.706 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.48 ' CE1' HG22 ' A' ' 66' ' ' THR . 86.3 m-70 -127.33 135.41 50.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.978 -1.701 . . . . 1.51 113.002 -178.554 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.259 42.0 tp -106.08 107.08 17.9 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.655 -2.528 . . . . 1.14 107.393 179.738 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 37.1 t -98.16 143.57 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 103.382 -2.821 . . . . 1.23 103.382 176.543 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.5 mt . . . . . 0 N--CA 1.43 -1.426 1 O-C-N 115.404 -4.56 . . . . 2.78 112.227 178.022 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ptt? . . . . . 0 CA--C 1.489 -1.387 0 CA-C-O 121.672 0.748 . . . . 1.1 112.948 . . . . . . . . . 0 0 . 1 . 081 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -95.54 137.88 33.99 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.939 -2.245 . . . . 1.87 104.939 -179.287 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.444 HD12 HD22 ' A' ' 67' ' ' LEU . 38.2 pt -123.14 155.95 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 124.398 2.047 . . . . 0.72 109.756 161.946 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -115.88 119.07 34.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.469 -3.269 . . . . 1.4 107.433 -172.363 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.495 HG22 ' HB2' ' A' ' 67' ' ' LEU . 40.0 t -110.83 117.89 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 119.032 -2.292 . . . . 0.58 106.028 -179.092 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -108.62 168.77 9.09 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 119.634 -0.827 . . . . 2.09 111.292 177.05 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -103.9 -165.93 1.2 Allowed 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 122.663 1.22 . . . . 0.99 109.743 173.979 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.0 tp -75.29 -49.99 17.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.136 2.174 . . . . 2.53 113.494 173.681 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.8 p -89.43 -37.68 14.64 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.122 -2.236 . . . . 2.08 114.445 -172.548 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.73 28.21 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.713 0 N-CA-C 121.981 3.552 . . . . 1.31 121.981 179.28 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -104.95 95.76 6.08 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 126.478 1.911 . . . . 1.4 114.366 -177.506 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.9 m -89.77 124.19 34.42 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 115.54 -2.464 . . . . 0.78 109.149 178.847 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 pt -119.32 128.57 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 117.688 -3.132 . . . . 1.55 107.5 172.675 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.3 m -95.76 122.94 39.07 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 116.133 -1.889 . . . . 1.08 110.016 -177.565 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.278 76.9 mt -119.89 128.17 53.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 121.925 2.148 . . . . 1.55 111.465 -177.502 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -80.03 122.23 26.49 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 125.487 1.742 . . . . 1.95 108.031 171.608 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 m -136.54 178.72 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 1 C-N-CA 131.797 4.039 . . . . 0.96 111.663 -173.963 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -125.84 162.55 44.65 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 113.046 -3.359 . . . . 2.35 107.303 166.411 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -74.16 -19.46 20.03 Favored 'Trans proline' 0 C--N 1.3 -2.013 1 CA-C-N 130.026 4.616 . . . . 0.95 111.886 -170.622 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.15 10.85 27.65 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 131.056 3.742 . . . . 1.45 110.925 -173.96 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -88.37 148.15 24.39 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.813 -3.679 . . . . 1.69 110.086 176.368 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 p -87.0 162.55 17.58 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.829 1.789 . . . . 0.75 115.829 -177.488 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.442 HD12 HD13 ' A' ' 50' ' ' LEU . 19.6 mm -66.47 -29.39 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 127.817 3.675 . . . . 0.73 114.859 173.389 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -58.51 -51.33 70.35 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 113.574 -5.704 . . . . 1.62 113.358 173.173 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -63.25 -40.02 96.24 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.69 1.596 . . . . 2.13 110.62 176.711 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.6 t -63.38 -33.91 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 117.729 -3.107 . . . . 0.62 116.077 176.455 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.487 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 37.4 mtmt -65.33 -32.18 73.7 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.17 -4.081 . . . . 1.22 111.8 174.386 . . . . . . . . 3 3 . 1 . 081 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.14 -23.35 62.99 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.191 1.796 . . . . 0.51 113.271 172.914 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -76.45 -41.18 48.28 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 126.307 2.955 . . . . 1.44 115.366 170.908 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.9 -35.13 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 118.608 -2.558 . . . . 1.32 109.672 171.139 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -62.81 -54.48 38.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.169 -3.457 . . . . 1.7 110.782 177.343 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -40.17 -52.44 2.59 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 125.619 1.567 . . . . 1.55 113.642 170.362 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -72.15 -67.05 0.57 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 115.958 1.836 . . . . 2.62 115.958 -176.818 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -101.38 -21.19 14.89 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.788 2.709 . . . . 1.48 113.829 -167.08 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.64 7.85 50.24 Favored Glycine 0 N--CA 1.43 -1.715 0 O-C-N 119.138 -2.226 . . . . 1.12 114.426 168.321 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.7 mt -81.46 117.8 69.65 Favored Pre-proline 0 N--CA 1.43 -1.433 0 N-CA-C 103.469 -2.789 . . . . 1.55 103.469 -166.614 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.91 137.28 61.73 Favored 'Trans proline' 0 N--CA 1.433 -2.066 0 C-N-CA 121.871 1.714 . . . . 1.02 114.231 -176.505 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -63.23 -8.82 15.35 Favored 'Trans proline' 0 N--CA 1.434 -1.999 0 N-CA-C 122.05 3.827 . . . . 1.25 122.05 -172.301 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -81.75 -14.35 56.58 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 119.929 -0.709 . . . . 2.25 112.0 168.668 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -90.77 -27.09 19.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.912 2.885 . . . . 2.02 110.38 -175.601 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.487 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 76.2 mt-30 -75.66 128.35 35.02 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 126.294 2.246 . . . . 0.69 114.76 -176.423 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -116.82 100.78 8.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.53 -3.856 . . . . 2.78 101.167 175.176 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 43' ' ' LEU . 94.4 mt -91.11 125.6 35.94 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 103.796 -2.668 . . . . 1.17 103.796 177.822 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 mm -120.76 130.97 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 103.888 -2.634 . . . . 1.38 103.888 178.907 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.667 ' HB2' HD21 ' A' ' 50' ' ' LEU . 1.8 t80 -84.32 -75.44 0.34 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 118.117 -0.945 . . . . 1.5 109.979 170.164 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.0 -77.63 0.59 Allowed 'General case' 0 N--CA 1.43 -1.429 2 O-C-N 115.822 -4.299 . . . . 1.21 104.909 173.589 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.8 -25.26 3.4 Favored Glycine 0 N--CA 1.429 -1.779 0 O-C-N 118.564 -2.585 . . . . 1.3 113.646 -177.971 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -84.43 138.08 33.03 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.835 -2.568 . . . . 2.55 117.503 176.66 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -71.0 142.37 50.96 Favored 'General case' 0 N--CA 1.431 -1.405 1 O-C-N 115.932 -4.23 . . . . 2.48 111.362 174.422 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' A' ' 45' ' ' PHE . 83.8 mt -90.98 141.85 28.4 Favored 'General case' 0 N--CA 1.429 -1.495 1 O-C-N 115.983 -4.198 . . . . 0.9 109.988 -175.835 . . . . . . . . 3 3 . 1 . 081 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -92.66 145.08 24.7 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 125.44 1.713 . . . . 1.94 111.935 -178.069 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.74 -63.36 1.33 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.383 2.04 . . . . 1.56 112.591 -167.619 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.4 39.37 2.49 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 116.745 -3.722 . . . . 0.97 116.106 177.184 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -115.56 159.38 21.33 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 121.511 2.656 . . . . 2.49 107.381 166.399 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.319 33.5 p -84.46 156.45 21.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 126.898 3.237 . . . . 0.76 110.754 176.777 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.1 mt -68.5 -25.94 65.21 Favored 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 111.544 -6.972 . . . . 1.05 115.287 171.776 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -66.65 -32.98 74.65 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.113 -3.492 . . . . 1.19 110.014 172.538 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -64.04 -34.08 77.2 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.075 -1.641 . . . . 1.9 114.47 171.382 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -89.42 -3.44 58.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.146 1.339 . . . . 0.89 111.892 177.025 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.6 m120 55.12 50.0 16.22 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 127.415 2.286 . . . . 1.84 115.948 -174.964 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.9 mt -77.88 126.99 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 113.161 -1.836 . . . . 0.82 108.6 178.474 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -102.46 175.35 5.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.111 1.764 . . . . 2.16 110.825 -176.28 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -72.97 -8.95 58.03 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 119.308 3.077 . . . . 2.12 119.308 177.604 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -106.85 7.48 30.19 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 125.707 1.879 . . . . 1.71 109.739 177.202 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 m -84.36 144.75 28.62 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.872 -1.768 . . . . 1.04 112.766 -171.635 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.3 m -110.32 120.04 41.14 Favored 'General case' 0 N--CA 1.431 -1.384 1 C-N-CA 133.065 4.546 . . . . 0.79 104.516 -177.007 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.495 ' HB2' HG22 ' A' ' 5' ' ' VAL . 7.9 mp -104.77 158.73 16.32 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.374 -2.825 . . . . 1.4 103.374 174.519 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -121.04 124.89 45.92 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.115 1.766 . . . . 1.51 109.413 -176.505 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.1 tp -105.7 99.73 9.32 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.897 1.681 . . . . 1.14 107.058 -177.812 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.7 152.04 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 105.682 -1.97 . . . . 1.23 105.682 171.247 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 N--CA 1.43 -1.474 0 O-C-N 119.164 -2.21 . . . . 2.78 107.001 176.377 . . . . . . . . 0 0 . 1 . 082 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 ptt? . . . . . 0 CA--C 1.489 -1.37 0 CA-C-O 124.694 2.188 . . . . 1.1 115.184 . . . . . . . . . 0 0 . 1 . 082 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -94.25 125.0 38.62 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.673 -2.517 . . . . 1.87 110.772 -179.715 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.6 pt -124.89 163.79 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 124.902 1.281 . . . . 0.72 112.339 171.696 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -114.42 159.18 20.59 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.137 2.875 . . . . 1.4 107.43 -178.248 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 60.0 t -143.05 134.34 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 102.539 -3.134 . . . . 0.58 102.539 177.283 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -113.73 131.78 56.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.856 1.312 . . . . 2.09 109.324 177.856 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.5 p -87.26 164.77 16.12 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 126.122 2.867 . . . . 0.99 107.801 179.845 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.1 mt -52.36 -56.71 13.09 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 116.173 -4.08 . . . . 2.53 114.696 170.647 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.4 p -69.51 -14.07 62.67 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.202 2.601 . . . . 2.08 114.142 -173.367 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.38 32.18 1.69 Allowed Glycine 0 N--CA 1.43 -1.745 1 N-CA-C 123.26 4.064 . . . . 1.31 123.26 169.246 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -111.6 148.43 33.33 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 115.217 -2.325 . . . . 1.4 114.955 -178.414 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.1 m -98.95 127.0 44.77 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 120.636 1.562 . . . . 0.78 108.067 175.712 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -103.73 123.6 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 125.991 2.805 . . . . 1.55 106.665 175.57 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.9 m -97.86 128.55 44.55 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.494 -3.879 . . . . 1.08 103.971 -178.096 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -125.61 133.08 52.36 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 121.688 2.04 . . . . 1.55 115.897 178.75 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -80.54 104.0 10.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 113.369 0.878 . . . . 1.95 113.369 162.318 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -114.9 154.1 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 119.211 -2.18 . . . . 0.96 109.583 177.967 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -113.86 151.39 44.7 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 102.923 -2.991 . . . . 2.35 102.923 164.261 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -68.29 -4.17 12.26 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-O 116.907 -1.372 . . . . 0.95 114.911 -173.39 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.2 p -93.11 -5.09 51.07 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.497 3.119 . . . . 1.45 113.065 -179.547 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -79.93 138.39 37.1 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.864 2.066 . . . . 1.69 108.132 174.599 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 39.3 p -76.22 173.78 10.95 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 128.392 3.949 . . . . 0.75 108.443 176.803 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.516 HG22 ' HE3' ' A' ' 27' ' ' LYS . 31.0 mm -74.67 -27.45 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 1 O-C-N 113.348 -5.845 . . . . 0.73 106.925 175.037 . . . . . . . . 3 3 . 1 . 082 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -65.6 -33.68 76.46 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 129.268 3.027 . . . . 1.62 111.433 172.079 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -83.96 -33.92 24.52 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.541 1.162 . . . . 2.13 111.825 172.867 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.26 29.0 t -64.62 -39.03 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 1 O-C-N 114.449 -5.157 . . . . 0.62 108.206 178.544 . . . . . . . . 3 2 . 1 . 082 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.516 ' HE3' HG22 ' A' ' 23' ' ' ILE 0.328 91.0 mttt -61.02 -47.87 84.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.23 -3.419 . . . . 1.22 113.528 173.486 . . . . . . . . 3 3 . 1 . 082 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.0 -39.65 63.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.849 -2.407 . . . . 0.51 109.648 170.961 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -61.22 -37.71 84.01 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.662 -4.398 . . . . 1.44 114.224 176.098 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.6 mt -77.7 -33.2 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 127.309 2.244 . . . . 1.32 112.101 171.851 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -60.77 -34.6 74.72 Favored 'General case' 0 N--CA 1.431 -1.384 1 O-C-N 115.647 -4.408 . . . . 1.7 118.452 171.902 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -67.83 -26.03 65.85 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 110.523 -3.035 . . . . 1.55 113.728 168.879 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -96.44 -58.52 2.04 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 104.633 -2.358 . . . . 2.62 104.633 -172.94 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -92.45 -44.38 8.69 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.776 -2.453 . . . . 1.48 115.145 -169.817 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.8 -11.0 10.24 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 119.299 -2.126 . . . . 1.12 111.402 176.718 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.0 mt -68.64 129.12 92.75 Favored Pre-proline 0 N--CA 1.429 -1.49 0 CA-C-O 112.896 -3.43 . . . . 1.55 109.165 -174.627 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -73.87 154.95 48.64 Favored 'Trans proline' 0 N--CA 1.433 -2.049 0 CA-C-N 126.783 3.458 . . . . 1.02 109.959 -174.667 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.39 -11.27 19.05 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 123.942 3.095 . . . . 1.25 111.654 -171.779 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -53.79 -59.14 5.0 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.906 2.482 . . . . 2.25 114.768 165.417 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -66.96 -23.79 65.99 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 118.911 2.93 . . . . 2.02 118.911 -177.871 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -83.97 134.69 34.64 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.415 1.886 . . . . 0.69 113.52 -170.311 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.255 47.8 mtt180 -119.34 114.44 22.36 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.382 -1.449 . . . . 2.78 109.847 172.11 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.0 mt -95.73 137.62 34.53 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.036 -1.839 . . . . 1.17 106.036 178.247 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.4 mt -135.37 136.78 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 128.261 2.625 . . . . 1.38 109.186 179.571 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -139.08 143.93 38.53 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 121.478 -0.764 . . . . 1.5 110.941 168.696 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.344 . . 54.4 27.57 8.35 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.712 -2.493 . . . . 1.21 115.499 176.658 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.88 -7.21 35.98 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-O 119.054 -0.859 . . . . 1.3 112.649 -170.583 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -87.2 139.93 30.06 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 123.032 3.416 . . . . 2.55 111.815 173.537 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -98.09 115.49 28.36 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.493 -2.004 . . . . 2.48 109.03 174.825 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 mt -83.24 159.42 21.97 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.425 -1.261 . . . . 0.9 112.961 -173.532 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -112.47 155.17 24.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 118.486 2.773 . . . . 1.94 118.486 172.471 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.51 -54.03 38.76 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 119.483 3.142 . . . . 1.56 119.483 -167.666 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.78 63.69 4.41 Favored Glycine 0 N--CA 1.431 -1.679 0 O-C-N 119.613 -1.929 . . . . 0.97 116.387 170.952 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -139.48 155.17 47.72 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.006 -2.22 . . . . 2.49 105.006 168.121 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 40.7 p -87.81 171.34 10.46 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.68 2.181 . . . . 0.76 109.481 176.274 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.0 mt -70.46 -37.69 74.34 Favored 'General case' 0 N--CA 1.43 -1.433 1 O-C-N 116.179 -4.076 . . . . 1.05 107.448 172.529 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.8 t -52.61 -45.83 66.74 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 118.5 2.778 . . . . 1.19 118.5 173.802 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -58.34 -53.74 54.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 130.7 3.6 . . . . 1.9 112.184 173.098 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -76.67 -2.1 31.11 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.863 -3.648 . . . . 0.89 115.876 -175.461 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.269 70.7 m-20 60.93 55.44 3.14 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.569 1.947 . . . . 1.84 116.036 -178.825 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.0 mt -106.76 128.01 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-O 115.586 -2.149 . . . . 0.82 108.925 174.872 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -107.39 -176.2 3.0 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 114.446 -2.692 . . . . 2.16 111.983 -170.024 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.1 ptmm? -59.14 146.48 38.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 126.706 2.504 . . . . 2.12 114.462 171.717 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.285 50.8 mt-10 69.87 20.5 6.68 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.281 1.515 . . . . 1.71 114.984 174.767 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.8 t -102.77 161.95 13.32 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 114.249 -1.341 . . . . 1.04 110.912 -171.917 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.2 m -121.18 120.12 34.31 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.629 -1.92 . . . . 0.79 114.144 -172.205 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 8.1 mt -92.15 164.06 13.71 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 122.749 1.262 . . . . 1.4 110.381 172.694 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -121.96 112.29 18.11 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.819 -3.051 . . . . 1.51 112.324 -179.234 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.5 tp -87.55 122.29 31.07 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 118.211 -2.806 . . . . 1.14 113.361 179.14 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.94 168.33 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 105.145 -2.169 . . . . 1.23 105.145 175.107 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.1 mt . . . . . 0 N--CA 1.43 -1.43 1 O-C-N 116.24 -4.037 . . . . 2.78 108.782 -176.533 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 CA--C 1.491 -1.312 0 CA-C-O 127.519 3.533 . . . . 1.1 115.955 . . . . . . . . . 0 0 . 1 . 083 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -81.77 140.2 34.38 Favored 'General case' 0 N--CA 1.431 -1.407 1 O-C-N 113.473 -5.767 . . . . 1.87 110.601 -175.387 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.5 pt -131.47 159.47 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 119.818 -1.801 . . . . 0.72 106.606 177.136 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -120.08 100.12 7.01 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.949 1.833 . . . . 1.4 112.048 -175.532 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -91.09 111.99 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 103.968 -2.605 . . . . 0.58 103.968 177.195 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.254 68.2 mmtt -90.68 141.09 29.15 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.232 -2.792 . . . . 2.09 110.85 177.666 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.5 p -93.96 176.29 6.39 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 120.586 3.55 . . . . 0.99 120.586 172.229 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.6 tp -66.11 -43.83 86.07 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 126.35 1.86 . . . . 2.53 110.497 -177.559 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.8 p -78.36 -49.55 13.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.063 3.357 . . . . 2.08 120.063 -171.641 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.9 32.59 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 128.321 2.867 . . . . 1.31 120.073 174.565 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.35 149.44 31.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.373 -0.973 . . . . 1.4 108.373 178.482 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -104.59 138.06 41.5 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.667 -2.521 . . . . 0.78 106.752 171.835 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.265 3.2 mt -106.12 92.91 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 122.793 1.282 . . . . 1.55 109.391 175.177 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.8 m -78.81 116.58 19.23 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 119.97 -1.706 . . . . 1.08 109.709 174.812 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.7 mt -125.51 149.26 48.45 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 106.849 -1.537 . . . . 1.55 106.849 -179.773 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -85.2 109.81 18.58 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 127.31 2.881 . . . . 1.95 117.386 165.227 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -121.88 164.07 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 121.879 2.127 . . . . 0.96 110.008 -178.799 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -112.06 157.75 38.85 Favored Pre-proline 0 N--CA 1.43 -1.435 0 C-N-CA 125.529 1.532 . . . . 2.35 109.482 164.858 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -86.48 -0.29 8.15 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 CA-C-N 125.658 3.057 . . . . 0.95 110.902 -170.281 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.1 p -89.82 -14.82 33.62 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 129.657 3.183 . . . . 1.45 111.251 175.205 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -68.03 142.37 55.91 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 127.086 3.327 . . . . 1.69 107.816 173.934 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.2 p -79.69 160.95 26.1 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.795 -2.441 . . . . 0.75 111.429 174.003 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mm -66.58 -27.17 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 1 O-C-N 115.628 -4.42 . . . . 0.73 111.743 171.513 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -56.98 -45.57 82.85 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 129.056 2.942 . . . . 1.62 109.836 167.913 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -65.45 -52.1 55.46 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.146 2.578 . . . . 2.13 111.752 176.626 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.82 -37.36 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 128.866 2.866 . . . . 0.62 109.404 177.046 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.84 -36.42 82.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 121.292 1.86 . . . . 1.22 115.467 174.81 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -24.81 67.78 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.257 1.206 . . . . 0.51 114.257 166.406 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -82.52 -25.57 33.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.756 -3.715 . . . . 1.44 111.618 173.747 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.8 mt -77.53 -29.09 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 117.915 -2.991 . . . . 1.32 111.103 175.093 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -66.61 -43.31 85.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 127.462 2.976 . . . . 1.7 111.567 173.536 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.263 31.6 t70 -49.6 -39.77 36.64 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 116.752 2.13 . . . . 1.55 116.752 168.03 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -86.07 -61.69 1.69 Allowed 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 118.289 2.7 . . . . 2.62 118.289 -178.153 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -95.19 -11.74 27.56 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.088 1.355 . . . . 1.48 113.052 -174.083 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.65 24.77 71.63 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 117.257 -3.402 . . . . 1.12 118.334 179.696 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.5 mt -99.62 132.37 23.21 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 116.852 -3.734 . . . . 1.55 110.218 -169.848 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 11.1 Cg_endo -72.91 152.51 52.11 Favored 'Trans proline' 0 C--N 1.299 -2.038 1 C-N-CA 125.518 4.145 . . . . 1.02 113.536 -175.255 . . . . . . . . 3 3 . 1 . 083 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 64.9 Cg_exo -66.92 -36.61 22.38 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 O-C-N 115.322 -3.041 . . . . 1.25 112.947 -175.046 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.26 -25.74 67.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 124.715 2.198 . . . . 2.25 115.774 178.405 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -91.24 -22.91 20.36 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.29 -1.506 . . . . 2.02 109.811 179.783 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -78.84 135.89 37.17 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.831 -3.043 . . . . 0.69 112.239 -177.517 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.346 38.2 ttt180 -124.25 123.51 40.39 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 116.973 -3.579 . . . . 2.78 109.288 167.948 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mt -105.63 127.17 52.9 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.672 2.177 . . . . 1.17 108.885 179.682 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.3 mm -114.37 143.17 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 131.273 3.829 . . . . 1.38 106.816 -177.683 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -131.07 100.05 5.09 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.723 -3.111 . . . . 1.5 107.973 175.998 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.351 . . 66.76 -61.53 0.32 Allowed 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 129.22 3.008 . . . . 1.21 114.856 -173.031 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.09 -24.31 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 106.538 -2.625 . . . . 1.3 106.538 -176.079 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -90.08 153.41 20.57 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.094 -2.416 . . . . 2.55 110.481 177.237 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -97.73 140.59 31.9 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 102.072 -3.307 . . . . 2.48 102.072 179.184 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.2 mt -116.47 127.08 54.25 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 115.961 -1.971 . . . . 0.9 110.767 -173.023 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -83.31 157.1 22.73 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 118.635 2.828 . . . . 1.94 118.635 -179.419 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -59.87 -63.85 1.16 Allowed 'General case' 0 N--CA 1.43 -1.444 1 N-CA-C 121.829 4.011 . . . . 1.56 121.829 -167.02 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.21 31.79 2.58 Favored Glycine 0 N--CA 1.43 -1.754 0 CA-C-N 113.572 -1.649 . . . . 0.97 117.114 172.05 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -98.25 164.77 12.17 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.486 -3.361 . . . . 2.49 109.04 159.616 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.455 11.9 p -95.69 172.83 7.8 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.65 2.38 . . . . 0.76 109.855 172.615 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.6 mp -76.01 -37.96 57.86 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.979 -1.009 . . . . 1.05 109.607 171.098 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -48.97 -50.03 37.62 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 116.588 2.07 . . . . 1.19 116.588 175.433 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -56.28 -35.44 67.49 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.352 2.661 . . . . 1.9 115.367 176.126 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -99.45 6.72 45.89 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.835 1.654 . . . . 0.89 112.849 178.342 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.9 m120 53.87 37.89 27.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.53 2.048 . . . . 1.84 116.53 -178.811 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.2 mm -82.27 114.69 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 126.691 1.996 . . . . 0.82 107.88 -173.896 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -103.61 -177.22 3.31 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.779 -2.451 . . . . 2.16 110.731 -173.61 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -58.45 146.29 35.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 127.143 2.177 . . . . 2.12 113.08 179.425 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.276 72.9 mt-10 64.03 19.42 11.75 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 128.325 3.516 . . . . 1.71 118.119 172.957 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.6 m -88.48 151.33 22.62 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.91 -1.885 . . . . 1.04 105.91 -168.778 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.0 m -90.12 110.38 21.39 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.269 2.228 . . . . 0.79 107.716 -179.364 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -102.34 155.76 18.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 102.214 -3.254 . . . . 1.4 102.214 174.055 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -129.16 128.24 43.01 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.974 -4.204 . . . . 1.51 115.34 -176.781 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.0 tp -108.34 124.21 50.0 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 124.749 1.281 . . . . 1.14 112.28 -174.686 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.431 15.6 m -118.17 -179.3 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 130.481 3.512 . . . . 1.23 108.812 170.202 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 N--CA 1.43 -1.442 0 O-C-N 116.398 -3.938 . . . . 2.78 113.099 179.038 . . . . . . . . 0 0 . 1 . 084 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 CA--C 1.489 -1.382 0 N-CA-C 115.709 1.744 . . . . 1.1 115.709 . . . . . . . . . 0 0 . 1 . 084 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -74.82 134.64 41.71 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 118.079 -0.962 . . . . 1.87 111.048 -177.683 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.445 HD12 HD12 ' A' ' 67' ' ' LEU . 45.5 pt -131.15 173.38 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-O 127.385 3.469 . . . . 0.72 108.341 174.769 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.439 ' HB2' ' HA ' ' A' ' 66' ' ' THR 0.251 22.9 m-85 -127.41 134.83 49.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.519 -3.238 . . . . 1.4 105.653 -171.465 . . . . . . . . 3 3 . 1 . 084 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -116.69 114.59 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.545 -2.021 . . . . 0.58 105.545 178.554 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -107.98 137.02 46.7 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 116.18 -4.075 . . . . 2.09 109.779 178.367 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.2 p -83.69 166.77 17.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.531 -1.981 . . . . 0.99 115.157 173.167 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.8 mt -39.14 -51.9 1.9 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 120.903 3.668 . . . . 2.53 120.903 167.021 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.8 p -82.99 -32.28 27.06 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 116.697 -3.752 . . . . 2.08 110.061 -175.544 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.44 24.66 0.16 Allowed Glycine 0 N--CA 1.43 -1.717 0 O-C-N 119.407 -2.058 . . . . 1.31 116.758 172.066 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -88.41 123.18 32.71 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.207 1.504 . . . . 1.4 112.707 -175.791 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -83.93 115.84 22.49 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 120.726 3.602 . . . . 0.78 120.726 172.939 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.4 mt -108.24 141.08 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 124.911 1.284 . . . . 1.55 111.136 176.352 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.8 m -116.97 137.21 52.37 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.523 -1.986 . . . . 1.08 107.152 178.419 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.8 mt -135.96 144.11 45.23 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.219 1.407 . . . . 1.55 112.007 -179.435 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -93.59 115.83 28.33 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.004 0.82 . . . . 1.95 111.168 169.283 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.53 HG11 HG22 ' A' ' 26' ' ' VAL . 11.5 m -118.57 173.4 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 101.914 -3.365 . . . . 0.96 101.914 178.377 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -118.25 160.24 40.19 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 103.488 -2.782 . . . . 2.35 103.488 167.435 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -64.71 -18.28 62.1 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 C-N-CA 124.558 3.505 . . . . 0.95 117.25 -173.183 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 m -104.08 19.72 19.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 126.622 2.451 . . . . 1.45 107.563 -178.346 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -82.03 140.96 33.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 113.449 0.907 . . . . 1.69 113.449 171.168 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.264 68.2 p -80.02 156.22 27.25 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.563 2.125 . . . . 0.75 113.491 174.99 . . . . . . . . 3 3 . 1 . 084 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.3 mm -58.62 -41.12 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.663 1.585 . . . . 0.73 111.621 175.074 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -46.54 -44.72 18.14 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.701 -1.875 . . . . 1.62 114.992 168.276 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -71.21 -35.58 71.57 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 125.658 1.583 . . . . 2.13 111.276 179.678 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.53 HG22 HG11 ' A' ' 17' ' ' VAL . 5.5 t -58.38 -45.69 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 117.587 -3.196 . . . . 0.62 114.199 167.989 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -65.77 -35.49 80.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 114.169 -2.824 . . . . 1.22 111.353 170.0 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.04 -29.21 68.13 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 123.365 2.802 . . . . 0.51 111.539 175.085 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.6 mttm -65.71 -21.98 66.57 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.571 -1.331 . . . . 1.44 114.049 171.752 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.2 mm -85.94 -23.92 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 127.252 2.221 . . . . 1.32 105.911 170.073 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.426 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 50.4 tt0 -77.04 -23.03 52.11 Favored 'General case' 0 N--CA 1.429 -1.482 2 O-C-N 114.538 -5.101 . . . . 1.7 111.265 173.717 . . . . . . . . 3 3 . 1 . 084 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -74.51 -40.45 61.77 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 114.716 1.376 . . . . 1.55 114.716 167.571 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -87.35 -66.31 0.92 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 116.592 2.071 . . . . 2.62 116.592 179.093 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -82.52 -32.11 28.85 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 118.057 -1.457 . . . . 1.48 109.625 -172.101 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.75 43.05 3.45 Favored Glycine 0 N--CA 1.429 -1.776 0 O-C-N 116.78 -3.7 . . . . 1.12 114.155 -176.193 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.4 mt -120.38 136.78 25.46 Favored Pre-proline 0 N--CA 1.429 -1.5 1 N-CA-C 99.808 -4.145 . . . . 1.55 99.808 -174.721 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -67.84 152.66 77.08 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 O-C-N 115.767 -2.807 . . . . 1.02 113.845 176.798 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.426 ' HD3' ' OE1' ' A' ' 31' ' ' GLN . 63.1 Cg_endo -78.41 -12.93 15.31 Favored 'Trans proline' 0 N--CA 1.433 -2.079 0 C-N-CA 117.529 -1.181 . . . . 1.25 110.713 -173.277 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -72.6 -38.5 67.82 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.347 -2.095 . . . . 2.25 113.89 170.885 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -69.97 -25.67 63.74 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.327 -2.733 . . . . 2.02 111.085 178.308 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -89.35 143.62 26.69 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.384 2.673 . . . . 0.69 115.873 -171.817 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -132.0 150.38 52.17 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 115.709 -2.091 . . . . 2.78 107.966 167.503 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.9 mt -106.14 138.85 41.6 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 124.553 3.342 . . . . 1.17 110.017 174.355 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 mt -112.67 146.12 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-O 125.03 2.347 . . . . 1.38 106.372 172.251 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.45 ' HB3' HD11 ' A' ' 50' ' ' LEU . 83.8 t80 -165.36 137.08 4.09 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 127.756 3.646 . . . . 1.5 105.166 174.653 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.53 19.51 11.53 Favored 'General case' 0 N--CA 1.431 -1.4 1 O-C-N 116.052 -4.155 . . . . 1.21 113.775 -176.622 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.13 -22.8 32.61 Favored Glycine 0 N--CA 1.431 -1.669 0 O-C-N 119.177 -2.202 . . . . 1.3 113.826 -175.5 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -93.0 157.54 16.26 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 121.539 3.903 . . . . 2.55 121.539 176.403 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -94.45 133.91 37.53 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 116.973 -1.891 . . . . 2.48 111.106 174.226 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 45' ' ' PHE . 19.9 mt -81.13 133.23 35.43 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.106 1.362 . . . . 0.9 113.069 -172.927 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -67.3 142.98 56.67 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.273 1.035 . . . . 1.94 109.725 170.136 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -77.0 -56.43 4.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.154 1.454 . . . . 1.56 110.381 -168.553 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.16 40.87 1.74 Allowed Glycine 0 N--CA 1.43 -1.765 1 O-C-N 116.225 -4.047 . . . . 0.97 118.198 171.33 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -117.73 161.2 20.08 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.626 -3.279 . . . . 2.49 106.555 167.745 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.5 p -86.23 177.19 7.58 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.094 -1.629 . . . . 0.76 114.233 176.11 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.0 mt -70.45 -44.69 67.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.672 -1.893 . . . . 1.05 110.4 176.106 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 t -63.01 -30.54 71.68 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.239 1.57 . . . . 1.19 115.239 -178.811 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -57.26 -46.7 82.81 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.806 2.442 . . . . 1.9 107.269 177.596 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.263 24.2 m-85 -87.15 -1.86 58.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.208 -3.432 . . . . 0.89 116.515 177.121 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 71.88 52.8 0.21 Allowed 'General case' 0 N--CA 1.43 -1.459 1 C-N-CA 133.87 4.868 . . . . 1.84 107.268 178.047 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 mt -96.7 126.27 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.123 -2.236 . . . . 0.82 107.747 -179.455 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.408 31.0 mt-30 -96.76 -167.49 1.56 Allowed 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 121.153 -0.967 . . . . 2.16 110.127 -171.582 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -75.05 151.32 38.7 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.699 1.6 . . . . 2.12 112.79 167.848 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.295 8.8 mt-10 66.6 27.31 9.59 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.579 2.351 . . . . 1.71 114.053 172.856 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.9 t -108.98 134.82 51.12 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 117.183 -3.448 . . . . 1.04 110.648 -172.961 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 97.9 m -82.11 104.21 12.28 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.449 2.547 . . . . 0.79 115.324 -178.346 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.445 HD12 HD12 ' A' ' 3' ' ' ILE . 93.6 mt -91.58 129.23 37.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.142 -2.849 . . . . 1.4 108.922 177.953 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -92.19 115.54 28.17 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.348 -2.72 . . . . 1.51 108.666 -173.22 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.4 tp -86.52 134.2 33.68 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 113.558 -3.115 . . . . 1.14 115.742 179.946 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 m -132.11 -172.63 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 127.892 3.245 . . . . 1.23 108.78 170.427 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.0 mt . . . . . 0 N--CA 1.43 -1.431 0 C-N-CA 126.317 1.847 . . . . 2.78 110.279 176.315 . . . . . . . . 0 0 . 1 . 085 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptt? . . . . . 0 CA--C 1.49 -1.328 0 N-CA-C 107.841 -1.17 . . . . 1.1 107.841 . . . . . . . . . 0 0 . 1 . 085 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -121.55 144.81 48.51 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 119.941 -0.704 . . . . 1.87 111.656 -176.02 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.2 pt -129.06 163.74 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 120.042 -1.661 . . . . 0.72 110.038 175.167 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -111.42 114.31 27.35 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.366 2.508 . . . . 1.4 108.539 -178.647 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 81.4 t -103.76 126.33 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 118.252 -2.78 . . . . 0.58 105.985 169.347 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -107.16 127.49 53.56 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 125.638 1.836 . . . . 2.09 110.385 174.109 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.3 p -81.15 170.31 16.3 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 129.805 3.242 . . . . 0.99 113.154 173.09 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.9 mt -67.2 -30.6 70.58 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.271 -2.143 . . . . 2.53 114.086 174.701 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 p -85.7 -5.42 59.26 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.556 -1.275 . . . . 2.08 107.556 -174.677 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.92 1.49 36.36 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 115.225 0.85 . . . . 1.31 115.225 170.592 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -78.64 114.57 17.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 118.54 1.17 . . . . 1.4 112.518 -178.123 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 m -79.64 130.44 35.37 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 120.708 1.595 . . . . 0.78 110.497 170.052 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mt -109.19 119.15 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 131.541 3.936 . . . . 1.55 106.554 174.528 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.2 m -92.41 95.66 9.79 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 107.143 -1.429 . . . . 1.08 107.143 178.765 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.3 mt -96.2 139.07 32.89 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 117.937 2.569 . . . . 1.55 117.937 -177.149 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -59.76 114.49 2.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 111.127 -2.761 . . . . 1.95 109.289 163.56 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.298 13.7 m -136.6 166.19 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 126.983 2.113 . . . . 0.96 109.708 173.795 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -125.28 162.42 44.18 Favored Pre-proline 0 N--CA 1.43 -1.473 0 N-CA-C 101.258 -3.608 . . . . 2.35 101.258 171.892 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -81.93 -6.55 12.29 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 O-C-N 117.739 -1.769 . . . . 0.95 107.909 -175.79 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.7 p -99.82 16.98 21.93 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.247 1.573 . . . . 1.45 115.247 176.445 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -78.14 144.29 36.54 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 129.56 3.144 . . . . 1.69 106.123 172.952 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.0 p -83.4 154.53 23.95 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.01 1.724 . . . . 0.75 111.586 175.548 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.0 mm -67.72 -36.3 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 124.897 1.373 . . . . 0.73 110.145 -179.523 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -59.95 -41.97 93.02 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.573 -1.955 . . . . 1.62 111.92 169.977 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.3 28.4 t-20 -61.55 -37.16 82.77 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.75 -3.094 . . . . 2.13 114.738 177.256 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.9 t -53.33 -51.39 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 124.522 1.138 . . . . 0.62 113.329 169.676 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -59.96 -31.86 70.27 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 114.071 1.137 . . . . 1.22 114.071 174.38 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.22 -33.45 73.32 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.168 -2.207 . . . . 0.51 113.376 170.893 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -71.2 -26.04 62.77 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 122.397 2.362 . . . . 1.44 110.247 173.544 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.3 mt -76.99 -26.54 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-N 121.28 1.855 . . . . 1.32 106.585 173.786 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -68.9 -48.51 63.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 121.194 1.816 . . . . 1.7 109.755 176.75 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -51.18 -39.08 55.63 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.071 -2.893 . . . . 1.55 113.616 174.184 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -82.92 -71.11 0.51 Allowed 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.877 2.471 . . . . 2.62 106.221 -174.978 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -100.42 -45.14 5.66 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.051 2.982 . . . . 1.48 119.051 -166.292 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.78 74.25 0.85 Allowed Glycine 0 N--CA 1.431 -1.694 0 CA-C-O 124.748 2.305 . . . . 1.12 115.946 166.37 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.89 127.24 23.94 Favored Pre-proline 0 N--CA 1.43 -1.466 0 CA-C-N 110.804 -2.698 . . . . 1.55 105.54 -178.724 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -58.42 134.92 64.48 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 CA-C-O 112.481 -3.216 . . . . 1.02 118.075 176.851 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -65.44 -14.97 47.68 Favored 'Trans proline' 0 C--N 1.299 -2.046 1 C-N-CA 126.51 4.807 . . . . 1.25 120.528 -174.407 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.85 -20.34 35.79 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.338 -2.101 . . . . 2.25 111.06 167.44 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -87.11 -29.02 22.15 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.517 1.962 . . . . 2.02 114.438 -175.476 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.329 1.5 pt20 -78.95 135.62 37.0 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 115.067 -2.397 . . . . 0.69 110.041 -176.468 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.31 65.9 mtt180 -104.15 136.44 43.77 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 128.482 3.614 . . . . 2.78 110.047 164.834 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.5 mt -108.89 132.83 53.67 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 126.67 3.128 . . . . 1.17 110.072 172.116 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 53.7 mt -119.58 142.06 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 118.822 -2.423 . . . . 1.38 106.51 -178.831 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -157.89 141.15 15.24 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 100.603 -3.851 . . . . 1.5 100.603 171.98 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.56 -44.96 0.61 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.385 3.074 . . . . 1.21 116.394 -173.948 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 166.78 -48.42 0.26 Allowed Glycine 0 N--CA 1.43 -1.731 0 CA-C-O 124.646 2.248 . . . . 1.3 109.598 -170.923 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -83.09 -179.97 7.58 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.443 2.016 . . . . 2.55 116.443 178.752 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -96.53 147.7 23.58 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.433 -2.042 . . . . 2.48 111.502 170.87 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.6 mt -94.54 134.11 37.45 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 104.583 -2.377 . . . . 0.9 104.583 -176.105 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -86.09 137.34 32.75 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.717 0.77 . . . . 1.94 111.436 176.478 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.13 -57.99 5.73 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.935 3.694 . . . . 1.56 117.746 -168.95 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.98 44.16 3.28 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 124.639 3.381 . . . . 0.97 120.041 176.318 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 -115.65 173.26 6.63 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.733 2.682 . . . . 2.49 104.479 165.685 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.7 p -108.88 173.8 6.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.534 -1.666 . . . . 0.76 112.258 176.406 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.15 -37.28 72.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 114.856 1.428 . . . . 1.05 114.856 170.062 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -57.51 -42.0 81.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.397 -2.689 . . . . 1.19 113.73 174.539 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -52.21 -41.22 62.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.185 2.661 . . . . 1.9 118.185 173.461 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -88.99 -16.06 32.64 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 128.366 2.667 . . . . 0.89 108.251 178.139 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.419 12.0 m-80 72.83 48.56 0.19 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.776 -1.203 . . . . 1.84 111.395 179.434 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.6 mt -87.92 122.22 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.97 -2.331 . . . . 0.82 107.954 -172.993 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -87.39 -177.12 5.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 117.38 -1.728 . . . . 2.16 114.373 -173.543 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.256 14.8 pttp -63.43 140.37 58.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.952 -3.593 . . . . 2.12 110.969 167.358 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 68.42 30.18 5.47 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 127.937 2.495 . . . . 1.71 111.642 177.908 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.1 m -88.02 145.24 26.08 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 119.097 -2.252 . . . . 1.04 113.278 -172.79 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.3 m -92.27 119.68 32.1 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 118.302 -2.749 . . . . 0.79 112.953 -179.923 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mt -104.95 131.36 52.55 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 119.7 -1.875 . . . . 1.4 107.718 165.3 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -94.92 135.51 36.35 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 103.701 -2.703 . . . . 1.51 103.701 -178.719 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.7 tp -106.96 123.17 47.79 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 127.226 2.211 . . . . 1.14 110.666 -172.18 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.329 0.1 OUTLIER -121.63 167.89 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.578 1.951 . . . . 1.23 112.596 176.499 . . . . . . . . 3 3 . 1 . 085 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 N--CA 1.431 -1.42 0 O-C-N 125.66 1.85 . . . . 2.78 108.697 177.979 . . . . . . . . 0 0 . 1 . 086 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 CA--C 1.491 -1.321 0 CA-C-O 116.583 -1.675 . . . . 1.1 114.993 . . . . . . . . . 0 0 . 1 . 086 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -93.35 122.81 36.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 128.69 2.796 . . . . 1.87 106.769 -177.367 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 pt -119.65 170.17 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 124.553 2.121 . . . . 0.72 108.124 169.539 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.263 72.7 m-85 -122.09 144.56 48.85 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.185 -3.447 . . . . 1.4 110.645 -179.652 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.83 128.9 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 120.482 -1.386 . . . . 0.58 108.045 173.327 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -93.28 132.36 37.54 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.753 -3.092 . . . . 2.09 108.573 171.206 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.9 p -74.16 -169.99 0.88 Allowed 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 117.338 2.347 . . . . 0.99 117.338 177.105 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.2 mt -72.69 -62.44 1.45 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.225 2.61 . . . . 2.53 106.377 173.743 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.8 p -56.76 -56.34 22.76 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 120.383 3.475 . . . . 2.08 120.383 -175.178 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.38 43.55 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.764 0 CA-C-O 119.219 -0.767 . . . . 1.31 111.35 177.968 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -126.49 155.56 42.12 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 130.279 3.432 . . . . 1.4 104.334 -179.002 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.9 m -125.32 119.05 27.3 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 104.839 -2.282 . . . . 0.78 104.839 -178.94 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -95.52 148.88 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 103.483 -2.784 . . . . 1.55 103.483 -176.421 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.3 m -117.41 117.85 30.6 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.452 2.548 . . . . 1.08 106.231 177.296 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.2 mt -116.37 138.19 51.54 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.7 -2.5 . . . . 1.55 111.179 -174.517 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.12 106.15 18.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.724 2.009 . . . . 1.95 115.143 170.713 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 m -127.87 167.79 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 125.538 2.589 . . . . 0.96 108.549 -172.937 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -110.1 161.78 23.03 Favored Pre-proline 0 N--CA 1.43 -1.453 0 O-C-N 116.584 -3.823 . . . . 2.35 108.257 162.682 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -73.06 -12.12 25.67 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-N 124.72 2.721 . . . . 0.95 113.275 -177.245 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 m -83.7 -9.14 59.05 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 115.124 -2.369 . . . . 1.45 109.339 175.523 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -74.0 155.86 38.15 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 124.391 3.269 . . . . 1.69 111.138 178.251 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.6 p -95.73 164.44 12.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.5 -1.375 . . . . 0.75 110.411 -177.19 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.6 mm -62.47 -31.11 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 124.581 1.153 . . . . 0.73 112.032 175.934 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -58.71 -47.52 84.29 Favored 'General case' 0 N--CA 1.429 -1.499 1 C-N-CA 134.097 4.959 . . . . 1.62 114.611 162.383 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.281 29.4 m120 -66.21 -37.95 86.8 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.483 -3.26 . . . . 2.13 106.93 178.947 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.4 t -71.2 -25.95 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 1 O-C-N 115.045 -4.784 . . . . 0.62 117.875 176.415 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -81.96 -32.92 30.49 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 104.635 -2.357 . . . . 1.22 104.635 178.994 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.4 68.0 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.872 -3.642 . . . . 0.51 111.407 172.715 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -67.15 -28.19 67.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 125.867 1.979 . . . . 1.44 109.921 171.595 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.1 mt -75.39 -18.04 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 116.514 -3.866 . . . . 1.32 113.93 170.138 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -68.35 -27.75 66.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 119.715 1.143 . . . . 1.7 111.694 167.667 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -68.57 -51.74 39.39 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.385 -3.322 . . . . 1.55 112.338 165.638 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -68.81 -74.81 0.12 Allowed 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.926 -2.359 . . . . 2.62 117.256 -175.603 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -90.73 -15.24 30.58 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 124.389 1.055 . . . . 1.48 113.122 -176.6 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.38 48.47 5.94 Favored Glycine 0 N--CA 1.43 -1.723 0 C-N-CA 119.276 -1.44 . . . . 1.12 115.967 168.046 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.4 mt -125.66 140.07 35.62 Favored Pre-proline 0 N--CA 1.429 -1.488 0 C-N-CA 126.781 2.033 . . . . 1.55 107.786 -175.51 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -67.83 149.9 78.4 Favored 'Trans proline' 0 N--CA 1.433 -2.055 2 C-N-CA 125.938 4.425 . . . . 1.02 112.285 -174.381 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.472 58.0 Cg_endo -61.22 -38.35 66.87 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 CA-C-N 127.293 3.64 . . . . 1.25 119.213 -179.972 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -57.44 -36.65 71.67 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 127.003 2.69 . . . . 2.25 114.178 -179.316 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -81.22 -13.11 58.88 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.576 2.065 . . . . 2.02 116.576 -177.021 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -92.19 141.94 28.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.94 -1.725 . . . . 0.69 110.822 -175.445 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -113.52 134.78 54.5 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 125.775 1.922 . . . . 2.78 110.702 167.515 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 69' ' ' LEU . 34.8 mt -116.73 111.96 20.52 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.022 -1.844 . . . . 1.17 106.022 -178.618 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.569 HD13 ' HA ' ' A' ' 49' ' ' GLN . 24.3 mm -102.46 135.58 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 118.626 -2.546 . . . . 1.38 108.063 -173.318 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -154.44 122.89 6.1 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 124.249 1.02 . . . . 1.5 111.166 171.687 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.92 46.64 4.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.801 2.239 . . . . 1.21 116.525 -177.448 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.24 -31.01 4.21 Favored Glycine 0 N--CA 1.43 -1.734 0 CA-C-N 113.875 -1.511 . . . . 1.3 114.505 175.528 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -96.68 156.74 16.22 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 124.867 2.27 . . . . 2.55 114.415 -177.299 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.569 ' HA ' HD13 ' A' ' 44' ' ' ILE . 39.3 tt0 -93.05 121.51 34.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 127.492 3.52 . . . . 2.48 109.867 175.349 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.3 mt -79.07 122.6 26.42 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 113.55 -5.719 . . . . 0.9 114.864 -172.901 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.259 53.4 mt-10 -70.59 139.67 51.49 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 121.171 3.767 . . . . 1.94 121.171 -178.222 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -52.54 -63.09 1.25 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.327 3.051 . . . . 1.56 116.74 -169.323 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.74 43.3 3.06 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 125.784 1.659 . . . . 0.97 113.12 172.296 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.5 mtt-85 -121.91 162.02 21.76 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.642 -2.681 . . . . 2.49 109.543 165.686 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.26 70.2 p -92.63 151.17 20.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.368 2.667 . . . . 0.76 110.372 178.519 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -50.96 -50.59 57.71 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 125.514 2.578 . . . . 1.05 110.9 167.438 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -48.36 -42.69 32.24 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 114.605 -5.059 . . . . 1.19 118.006 174.668 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -71.5 -16.85 62.36 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.938 2.199 . . . . 1.9 116.938 173.538 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -94.15 -2.91 51.92 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 126.167 1.787 . . . . 0.89 106.359 177.096 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.5 m120 66.03 32.3 8.44 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.922 1.689 . . . . 1.84 112.735 176.341 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.7 mt -91.03 121.55 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 126.842 3.211 . . . . 0.82 107.771 -177.537 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -113.1 -170.46 1.68 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.66 -3.15 . . . . 2.16 114.044 178.531 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -61.73 135.63 57.68 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 112.348 -2.206 . . . . 2.12 112.279 -179.689 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.272 12.9 mt-10 83.67 13.58 0.35 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.791 2.036 . . . . 1.71 116.086 173.119 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.8 t -88.11 145.34 25.99 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.843 2.057 . . . . 1.04 105.873 -170.364 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.2 m -108.31 110.16 21.67 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.7 -1.25 . . . . 0.79 110.497 -176.678 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.4 mt -90.34 150.83 21.73 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 127.424 3.488 . . . . 1.4 107.247 172.582 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -111.73 129.39 56.13 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.083 -4.761 . . . . 1.51 110.993 -179.48 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 43' ' ' LEU . 47.3 tp -98.28 133.13 43.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 128.106 3.812 . . . . 1.14 101.559 -171.234 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.55 163.06 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.986 -2.946 . . . . 1.23 106.668 172.516 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 71' ' ' LEU . 33.1 mt . . . . . 0 N--CA 1.431 -1.41 0 CA-C-O 125.643 2.64 . . . . 2.78 114.646 176.034 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 ptt? . . . . . 0 CA--C 1.491 -1.315 0 N-CA-C 115.303 1.594 . . . . 1.1 115.303 . . . . . . . . . 0 0 . 1 . 087 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.278 4.8 pt20 -127.02 138.93 53.33 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 129.042 3.963 . . . . 1.87 112.984 175.064 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.5 pt -127.2 151.05 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 130.794 3.638 . . . . 0.72 109.989 175.987 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -98.26 136.83 37.89 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 111.898 -2.41 . . . . 1.4 110.438 -179.056 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 89.2 t -112.66 125.84 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-O 114.692 -2.575 . . . . 0.58 111.397 171.982 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -105.29 128.43 53.45 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 123.122 2.692 . . . . 2.09 113.611 176.263 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.286 3.5 p -84.56 173.91 10.42 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 120.036 3.347 . . . . 0.99 120.036 177.576 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.77 -38.08 82.93 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 130.548 3.539 . . . . 2.53 111.302 -179.821 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.7 p -74.95 -45.42 42.42 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.485 1.514 . . . . 2.08 109.713 177.408 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.25 42.67 0.31 Allowed Glycine 0 N--CA 1.43 -1.728 0 O-C-N 125.944 2.027 . . . . 1.31 110.603 169.154 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -105.69 157.98 17.04 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.076 2.15 . . . . 1.4 106.279 -173.266 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -111.25 124.53 52.4 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 121.024 1.738 . . . . 0.78 106.33 175.414 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.472 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 20.0 mt -100.04 121.51 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 100.807 -3.775 . . . . 1.55 100.807 173.795 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.0 m -104.89 114.07 28.05 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.176 2.893 . . . . 1.08 105.675 175.087 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.6 mt -101.11 145.16 29.12 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 128.171 2.588 . . . . 1.55 112.772 -177.046 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -97.18 112.69 24.37 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 117.02 -1.467 . . . . 1.95 113.892 173.475 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.8 169.93 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 116.032 1.864 . . . . 0.96 116.032 -179.815 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -114.37 160.74 31.71 Favored Pre-proline 0 N--CA 1.43 -1.449 0 O-C-N 127.968 3.293 . . . . 2.35 109.424 165.954 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.34 -10.66 29.64 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 O-C-N 114.521 -3.463 . . . . 0.95 114.792 -173.687 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.8 p -85.87 -16.18 39.45 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.792 3.808 . . . . 1.45 111.468 177.881 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -70.19 147.8 49.41 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.408 -3.308 . . . . 1.69 114.064 -175.845 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.8 p -95.67 166.24 11.92 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 116.197 -4.064 . . . . 0.75 112.494 -177.299 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.331 29.7 mm -65.42 -31.79 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 116.81 2.152 . . . . 0.73 116.81 179.203 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -46.83 -52.08 15.08 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.19 2.196 . . . . 1.62 116.608 160.965 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -70.72 -35.81 72.9 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.704 2.002 . . . . 2.13 109.11 -177.974 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.9 t -70.04 -49.69 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 119.044 -2.285 . . . . 0.62 111.459 -179.489 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -62.56 -27.7 69.36 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.164 -2.21 . . . . 1.22 115.749 175.984 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.58 -40.53 97.18 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 128.661 2.785 . . . . 0.51 114.422 173.67 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -62.25 -26.93 68.66 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.303 2.241 . . . . 1.44 116.565 171.629 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.9 mt -74.09 -42.89 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 126.997 2.119 . . . . 1.32 111.701 171.913 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -62.68 -34.04 76.31 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.496 -1.229 . . . . 1.7 112.519 178.36 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.24 -47.04 81.2 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.437 -2.039 . . . . 1.55 115.643 171.831 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -78.9 -59.59 2.72 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.27 -1.786 . . . . 2.62 113.725 -177.343 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -101.28 -30.84 11.28 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 128.905 2.882 . . . . 1.48 109.989 -165.258 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.74 19.86 30.56 Favored Glycine 0 N--CA 1.429 -1.77 0 O-C-N 121.098 -1.001 . . . . 1.12 113.993 170.428 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.5 mt -91.3 123.42 64.2 Favored Pre-proline 0 N--CA 1.431 -1.409 0 CA-C-O 114.466 -2.683 . . . . 1.55 110.039 178.219 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -67.66 144.08 64.67 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 124.386 3.391 . . . . 1.02 110.187 -174.009 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.77 -24.41 47.15 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 C-N-CA 125.053 3.836 . . . . 1.25 113.03 -167.831 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -68.01 -26.05 65.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.892 2.477 . . . . 2.25 109.871 178.496 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -89.32 -18.69 26.45 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 125.427 2.537 . . . . 2.02 110.894 -176.275 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -82.18 125.87 31.41 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.621 -2.55 . . . . 0.69 112.059 -177.868 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.573 ' HB2' HG23 ' A' ' 70' ' ' VAL . 94.7 mtt180 -119.54 129.38 54.65 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 104.903 -2.258 . . . . 2.78 104.903 168.759 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.1 mt -103.01 139.48 38.52 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.63 -3.169 . . . . 1.17 111.022 176.69 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.456 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 17.8 mm -121.14 146.97 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 103.154 -2.906 . . . . 1.38 103.154 176.901 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -135.94 105.21 5.99 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 101.365 -3.569 . . . . 1.5 101.365 173.208 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.309 . . 70.65 -75.13 0.08 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.921 2.088 . . . . 1.21 115.054 179.283 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.34 -4.66 0.9 Allowed Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 113.481 -1.691 . . . . 1.3 115.101 -175.385 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.27 65.6 mttm -106.82 143.2 35.26 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.765 -0.828 . . . . 2.55 108.765 -178.85 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -86.44 128.51 34.96 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 117.375 -1.298 . . . . 2.48 108.371 164.775 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 mt -83.66 134.92 34.76 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 116.349 1.981 . . . . 0.9 116.349 -173.815 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -75.86 147.98 38.67 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.576 1.151 . . . . 1.94 111.56 175.182 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -68.53 -38.03 80.51 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 118.559 2.8 . . . . 1.56 118.559 -171.133 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.8 28.25 14.46 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 126.078 1.799 . . . . 0.97 113.49 176.703 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -100.34 163.97 12.15 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 121.234 -1.156 . . . . 2.49 111.671 167.222 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.8 p -96.5 -172.03 2.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.516 -1.99 . . . . 0.76 111.368 175.509 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.3 mt -87.83 -29.25 21.08 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 119.107 -2.245 . . . . 1.05 111.436 172.362 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.282 8.2 t -63.08 -37.49 87.43 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 120.916 3.673 . . . . 1.19 120.916 171.057 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -52.97 -40.38 63.69 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 113.458 -1.701 . . . . 1.9 113.923 170.249 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -93.76 -3.38 52.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.532 2.333 . . . . 0.89 112.485 -177.695 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.286 13.7 m120 66.35 33.05 7.27 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.714 1.721 . . . . 1.84 114.232 -174.046 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.279 33.7 mt -73.59 104.19 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 114.843 -2.503 . . . . 0.82 107.837 172.91 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -92.04 -164.04 1.12 Allowed 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 124.673 1.233 . . . . 2.16 110.101 179.772 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -72.0 156.5 39.16 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.04 1.4 . . . . 2.12 112.094 171.28 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.326 26.9 mt-10 61.26 28.7 18.2 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.033 -2.292 . . . . 1.71 115.628 175.956 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.0 t -101.18 154.89 18.36 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.951 -2.968 . . . . 1.04 109.597 -173.71 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.7 m -110.42 111.81 23.32 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.854 2.74 . . . . 0.79 112.5 -174.783 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.1 mt -93.02 147.52 22.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.308 -3.37 . . . . 1.4 108.008 170.526 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.456 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 5.5 m-70 -102.11 122.89 44.99 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 126.834 2.584 . . . . 1.51 104.721 -175.604 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.8 tp -93.96 137.92 32.65 Favored 'General case' 0 N--CA 1.428 -1.542 0 O-C-N 118.732 -2.48 . . . . 1.14 111.59 178.678 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' A' ' 42' ' ' ARG . 2.7 m -135.93 150.05 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 105.868 -1.901 . . . . 1.23 105.868 168.376 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.8 mt . . . . . 0 N--CA 1.43 -1.438 0 O-C-N 118.803 -2.436 . . . . 2.78 112.812 -175.054 . . . . . . . . 0 0 . 1 . 088 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ptt? . . . . . 0 CA--C 1.49 -1.357 0 CA-C-O 123.049 1.404 . . . . 1.1 114.281 . . . . . . . . . 0 0 . 1 . 088 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -77.89 124.3 27.83 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.224 3.01 . . . . 1.87 114.453 -179.402 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.277 9.8 pt -128.48 153.12 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.301 -2.749 . . . . 0.72 111.139 171.286 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -117.59 130.49 56.43 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.526 1.967 . . . . 1.4 110.666 -178.89 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.51 111.16 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 102.908 -2.997 . . . . 0.58 102.908 -179.749 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -93.13 133.4 36.34 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 124.153 1.93 . . . . 2.09 111.774 -178.231 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.307 3.9 p -102.3 161.48 13.66 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 117.376 2.362 . . . . 0.99 117.376 169.166 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.4 tp -78.78 -35.72 43.99 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 112.22 -2.264 . . . . 2.53 111.449 168.75 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.273 0.8 OUTLIER -63.91 -58.41 6.85 Favored 'General case' 0 N--CA 1.431 -1.412 1 C-N-CA 133.323 4.649 . . . . 2.08 111.716 -169.983 . . . . . . . . 4 3 . 1 . 088 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.85 -79.23 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 129.456 3.407 . . . . 1.31 120.515 176.422 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -77.92 165.4 24.14 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 129.831 3.252 . . . . 1.4 116.197 -170.281 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.8 m -115.66 120.58 39.85 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 103.452 -2.796 . . . . 0.78 103.452 168.315 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.4 mt -89.18 107.03 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.859 2.463 . . . . 1.55 105.93 -176.522 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.7 m -82.54 100.0 9.85 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 124.282 0.989 . . . . 1.08 113.434 178.944 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.1 mt -88.13 154.52 20.39 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.7 2.19 . . . . 1.55 115.911 -179.98 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -104.27 114.78 29.24 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 102.399 -3.186 . . . . 1.95 102.399 163.616 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.8 m -117.36 177.39 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.069 -2.269 . . . . 0.96 109.426 173.081 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -115.57 156.65 45.82 Favored Pre-proline 0 N--CA 1.429 -1.476 0 N-CA-C 104.623 -2.362 . . . . 2.35 104.623 154.913 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -78.53 -9.09 16.12 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 CA-C-N 127.334 3.655 . . . . 0.95 109.197 -171.589 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.1 p -81.45 -9.65 59.67 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.884 -2.385 . . . . 1.45 113.911 174.838 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -66.82 141.85 57.55 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 125.855 1.972 . . . . 1.69 111.83 172.704 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.647 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 52.6 p -81.35 170.34 16.13 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.795 -2.441 . . . . 0.75 112.699 176.852 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.462 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 25.2 mm -66.01 -26.18 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 129.179 2.991 . . . . 0.73 109.37 170.563 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -70.97 -33.85 70.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.164 1.935 . . . . 1.62 115.546 173.999 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.434 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 83.5 m-20 -66.02 -43.38 87.8 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.193 2.597 . . . . 2.13 111.878 169.723 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.25 -45.21 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 115.224 1.564 . . . . 0.62 115.224 174.059 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -67.11 -36.03 81.03 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 117.348 -3.345 . . . . 1.22 113.277 169.769 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.71 -25.02 62.48 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 118.501 -2.624 . . . . 0.51 117.454 172.122 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 25' ' ' ASN 0.356 44.5 mttm -69.63 -55.14 10.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.41 -2.681 . . . . 1.44 117.247 174.537 . . . . . . . . 3 3 . 1 . 088 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.2 mt -52.62 -47.07 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 1 C-N-CA 135.202 5.401 . . . . 1.32 106.419 173.615 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -50.02 -40.82 45.84 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 120.825 3.639 . . . . 1.7 120.825 177.129 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -66.56 -43.4 85.11 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.958 -3.589 . . . . 1.55 114.807 164.444 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -70.19 -49.98 44.83 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 127.656 3.598 . . . . 2.62 110.322 -169.95 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.264 28.7 mm-40 -120.3 4.72 10.76 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 111.286 -2.688 . . . . 1.48 112.726 -165.858 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.6 0.38 47.95 Favored Glycine 0 N--CA 1.431 -1.662 0 C-N-CA 115.678 -3.153 . . . . 1.12 119.222 173.605 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.5 mt -86.42 116.29 65.34 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 103.445 -2.798 . . . . 1.55 103.445 -169.202 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 36.9 Cg_endo -66.1 165.26 24.72 Favored 'Trans proline' 0 C--N 1.3 -2.016 1 C-N-CA 126.54 4.827 . . . . 1.02 115.695 176.389 . . . . . . . . 3 3 . 1 . 088 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.2 Cg_exo -79.38 -17.43 11.51 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 124.524 2.651 . . . . 1.25 112.994 -172.235 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -67.54 -27.49 67.0 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.373 2.035 . . . . 2.25 115.436 175.458 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -104.87 24.02 12.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.813 -2.429 . . . . 2.02 114.308 -178.032 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -123.53 119.0 28.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.987 2.515 . . . . 0.69 113.392 179.66 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.53 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 90.5 mtt-85 -113.94 120.8 41.9 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.806 1.642 . . . . 2.78 108.288 169.466 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.6 mt -104.51 126.62 51.77 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.143 -1.598 . . . . 1.17 111.219 -178.103 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mm -117.61 140.4 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 124.206 3.185 . . . . 1.38 112.755 177.131 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -152.56 132.57 13.4 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 104.752 -2.314 . . . . 1.5 104.752 175.959 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.91 21.92 11.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 115.968 -1.968 . . . . 1.21 115.178 179.64 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.66 -2.34 83.16 Favored Glycine 0 N--CA 1.431 -1.688 1 C-N-CA 132.379 4.8 . . . . 1.3 113.286 -179.38 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -101.01 137.57 39.2 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.842 0.829 . . . . 2.55 112.841 -178.983 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -70.68 127.13 31.62 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 117.194 -3.442 . . . . 2.48 115.808 166.627 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.405 ' HB3' HG13 ' A' ' 23' ' ' ILE . 36.9 mt -81.62 136.9 35.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.705 -1.872 . . . . 0.9 113.647 -176.075 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -85.74 144.14 27.94 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 119.031 2.974 . . . . 1.94 119.031 172.467 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.462 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 1.8 m-20 -67.12 -43.26 82.87 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 121.763 3.986 . . . . 1.56 121.763 -168.362 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.23 8.84 50.82 Favored Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 118.123 2.009 . . . . 0.97 118.123 170.446 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -101.59 149.55 24.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.679 1.704 . . . . 2.49 110.233 170.289 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.647 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.283 32.2 p -81.7 170.65 15.52 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.069 -2.894 . . . . 0.76 110.547 -178.211 . . . . . . . . 3 3 . 1 . 088 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.7 mt -67.8 -37.04 81.47 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 127.031 2.132 . . . . 1.05 110.062 167.672 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.382 4.9 t -59.4 -43.64 92.95 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.525 -3.234 . . . . 1.19 114.234 176.72 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -60.82 -44.63 96.64 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.113 2.863 . . . . 1.9 111.042 179.995 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -77.92 -6.76 55.37 Favored 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 114.939 -4.85 . . . . 0.89 115.883 178.416 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.304 13.1 m120 68.95 36.79 2.42 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.605 -2.559 . . . . 1.84 115.412 -178.206 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.2 mt -85.24 113.96 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 125.905 1.682 . . . . 0.82 111.968 177.635 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -103.64 -173.96 2.43 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 118.411 -1.316 . . . . 2.16 108.824 -174.933 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -53.42 147.48 10.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.419 3.009 . . . . 2.12 114.4 171.082 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 56.09 33.51 22.08 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 120.441 3.497 . . . . 1.71 120.441 -178.969 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.7 m -103.51 149.1 25.18 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.777 -1.556 . . . . 1.04 109.96 -177.151 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -103.58 112.06 24.8 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 126.132 1.773 . . . . 0.79 109.106 -170.452 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mt -90.24 140.72 29.41 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.458 -1.312 . . . . 1.4 107.458 174.15 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.375 66.9 m80 -107.28 118.1 35.82 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.665 -1.272 . . . . 1.51 108.116 178.308 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -88.02 121.44 30.43 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 121.378 -0.826 . . . . 1.14 109.761 179.875 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 59.6 t -105.69 135.46 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 104.473 -2.417 . . . . 1.23 104.473 174.242 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.428 0 N-CA-C 107.402 -1.332 . . . . 2.78 107.402 -179.5 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 CA--C 1.49 -1.34 0 N-CA-C 106.721 -1.585 . . . . 1.1 106.721 . . . . . . . . . 0 0 . 1 . 089 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -93.71 126.5 38.93 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.138 1.375 . . . . 1.87 112.692 179.698 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -127.25 166.98 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 105.002 -2.222 . . . . 0.72 105.002 167.759 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -123.27 145.05 49.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.076 2.95 . . . . 1.4 110.268 -177.716 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.2 t -124.91 124.18 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 106.691 -1.596 . . . . 0.58 106.691 173.677 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -106.41 128.59 54.16 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.601 2.36 . . . . 2.09 108.406 -178.73 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 p -87.4 179.44 6.58 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.02 2.343 . . . . 0.99 110.03 -179.399 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.331 14.2 tp -65.94 -41.95 90.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.918 2.487 . . . . 2.53 114.61 168.462 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.8 p -75.42 -38.54 59.75 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 120.817 -1.177 . . . . 2.08 108.307 -177.778 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.73 28.32 0.3 Allowed Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 123.652 0.644 . . . . 1.31 113.226 169.783 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -94.48 129.22 41.34 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.082 -2.422 . . . . 1.4 110.863 -177.134 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.8 m -116.36 90.21 3.28 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.937 2.78 . . . . 0.78 107.489 -174.345 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 pt -92.94 136.97 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 112.224 -2.262 . . . . 1.55 106.099 -178.876 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -94.86 128.37 41.57 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 130.22 3.408 . . . . 1.08 113.287 -178.801 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.9 mt -122.32 151.06 41.53 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.882 1.801 . . . . 1.55 112.88 178.184 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -114.54 112.7 23.36 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.657 1.218 . . . . 1.95 108.689 174.464 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m -118.27 175.11 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 118.715 -2.491 . . . . 0.96 111.548 -176.751 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -108.15 147.93 36.53 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-N 122.186 2.266 . . . . 2.35 106.784 160.498 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.13 -18.88 26.83 Favored 'Trans proline' 0 N--CA 1.433 -2.058 0 C-N-CA 123.718 2.945 . . . . 0.95 112.533 -174.548 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.3 p -90.57 9.92 27.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 121.725 2.057 . . . . 1.45 113.329 178.097 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -89.59 158.42 17.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.331 -3.355 . . . . 1.69 107.333 -179.865 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 69.6 p -80.6 171.11 15.46 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.297 1.221 . . . . 0.75 114.297 178.832 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.6 mm -69.77 -39.79 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 125.679 1.592 . . . . 0.73 108.91 175.993 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.26 86.7 tt0 -45.77 -45.75 14.84 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 117.613 2.449 . . . . 1.62 117.613 169.117 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -68.09 -35.66 78.54 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 118.058 2.614 . . . . 2.13 118.058 175.703 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 26' ' ' VAL . 10.8 t -62.96 -31.22 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 112.971 0.73 . . . . 0.62 112.971 170.783 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -71.5 -25.58 62.32 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 118.802 2.89 . . . . 1.22 118.802 167.327 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.87 -20.3 53.26 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 119.582 -1.949 . . . . 0.51 108.476 170.893 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -80.54 -23.51 39.94 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 120.419 1.463 . . . . 1.44 107.993 177.626 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.1 mt -81.85 -28.26 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.784 -2.447 . . . . 1.32 112.802 167.616 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 67.0 tt0 -65.74 -36.75 84.46 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 123.552 2.887 . . . . 1.7 113.362 173.655 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -60.05 -56.79 17.35 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 124.285 1.034 . . . . 1.55 111.781 170.118 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -77.34 -52.75 8.64 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 116.272 1.953 . . . . 2.62 116.272 -172.807 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -99.08 -25.1 14.66 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 119.348 -2.095 . . . . 1.48 108.407 -165.911 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.4 37.33 11.0 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 122.017 2.189 . . . . 1.12 113.161 175.668 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 mt -106.92 126.96 28.96 Favored Pre-proline 0 N--CA 1.43 -1.433 0 C-N-CA 127.671 2.388 . . . . 1.55 107.472 -178.752 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -68.82 150.2 73.49 Favored 'Trans proline' 0 N--CA 1.434 -1.977 0 O-C-N 115.28 -3.063 . . . . 1.02 116.585 -178.653 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -69.39 -14.5 37.37 Favored 'Trans proline' 0 N--CA 1.433 -2.061 0 CA-C-N 124.447 2.624 . . . . 1.25 117.886 -172.557 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -74.86 -34.09 62.22 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.993 1.854 . . . . 2.25 111.069 172.314 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -72.56 -28.41 62.81 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 115.165 -4.709 . . . . 2.02 114.523 -178.895 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -78.99 147.19 33.0 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.353 -1.467 . . . . 0.69 110.419 -173.382 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.277 12.1 tpt180 -133.35 120.12 20.58 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.07 -2.567 . . . . 2.78 104.07 170.773 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.2 mt -96.51 125.85 41.28 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.546 -1.346 . . . . 1.17 108.708 -177.899 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.278 6.2 mt -118.91 115.07 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 116.422 2.008 . . . . 1.38 116.422 -179.865 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -130.54 137.99 49.97 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 117.076 2.25 . . . . 1.5 117.076 164.97 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.291 . . 51.26 45.73 27.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.404 -3.31 . . . . 1.21 118.806 -175.487 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.6 -22.12 1.43 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 125.335 1.445 . . . . 1.3 113.646 -175.471 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -90.22 133.09 35.14 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 118.526 2.787 . . . . 2.55 118.526 -173.828 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -74.19 133.68 42.73 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 116.785 -3.697 . . . . 2.48 104.365 171.016 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.7 mt -91.17 123.69 34.81 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 127.07 3.319 . . . . 0.9 110.869 -175.741 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -85.19 135.5 33.92 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.165 -2.834 . . . . 1.94 116.105 175.966 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.488 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 3.4 m-20 -57.11 -53.04 62.6 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 129.973 3.309 . . . . 1.56 117.38 -160.958 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.09 21.51 1.35 Allowed Glycine 0 N--CA 1.43 -1.737 0 O-C-N 118.952 -2.342 . . . . 0.97 115.88 170.263 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -113.79 166.28 11.72 Favored 'General case' 0 N--CA 1.43 -1.451 1 CA-C-N 124.531 4.165 . . . . 2.49 108.251 168.979 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.8 p -97.78 173.47 7.09 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 123.551 1.644 . . . . 0.76 110.061 -179.173 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.9 mt -67.77 -31.91 72.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 114.317 1.229 . . . . 1.05 114.317 177.065 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.8 t -62.18 -44.73 95.94 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.043 3.337 . . . . 1.19 113.941 178.377 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -52.86 -38.54 61.68 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 125.141 1.526 . . . . 1.9 112.112 175.571 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -91.23 -1.0 57.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.335 1.854 . . . . 0.89 111.984 178.488 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.311 3.4 m120 61.72 31.26 18.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 119.446 3.128 . . . . 1.84 119.446 -179.526 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.4 mt -88.11 110.36 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 128.7 2.8 . . . . 0.82 104.469 -173.41 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -95.82 -169.91 2.03 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 112.373 -2.194 . . . . 2.16 106.288 -174.434 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -57.83 147.9 26.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 130.239 3.416 . . . . 2.12 117.797 172.894 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 55.89 49.33 16.19 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 115.817 1.784 . . . . 1.71 115.817 178.102 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 m -117.53 147.91 42.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.774 -1.195 . . . . 1.04 107.774 -174.62 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.4 m -99.2 105.41 17.45 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.355 3.462 . . . . 0.79 111.209 177.394 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.69 132.54 39.32 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.778 1.631 . . . . 1.4 108.505 178.072 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -89.13 124.88 34.74 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.95 -4.219 . . . . 1.51 106.395 -178.734 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.8 tp -95.13 122.09 37.44 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.716 -2.49 . . . . 1.14 105.842 171.214 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.1 t -115.14 151.4 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 127.872 2.469 . . . . 1.23 108.829 168.537 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.0 mt . . . . . 0 N--CA 1.429 -1.482 0 O-C-N 117.601 -3.187 . . . . 2.78 110.659 174.637 . . . . . . . . 0 0 . 1 . 090 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 CA--C 1.491 -1.304 0 CA-C-O 121.188 0.518 . . . . 1.1 110.677 . . . . . . . . . 0 0 . 1 . 090 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -110.6 121.31 45.02 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.489 -2.632 . . . . 1.87 111.44 -179.691 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.3 pt -108.73 172.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 114.588 -1.187 . . . . 0.72 111.792 169.621 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -120.4 160.08 23.81 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.76 -0.829 . . . . 1.4 108.76 178.879 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.7 t -139.56 133.46 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 117.381 -3.325 . . . . 0.58 106.815 168.851 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -110.76 137.57 48.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.551 -3.218 . . . . 2.09 109.415 177.323 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.275 11.1 p -81.67 -169.63 2.42 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 114.824 -4.923 . . . . 0.99 115.74 176.858 . . . . . . . . 3 2 . 1 . 090 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.322 13.1 mt -77.46 -37.34 51.69 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 113.656 0.984 . . . . 2.53 113.656 174.963 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.76 -37.72 22.26 Favored 'General case' 0 N--CA 1.429 -1.504 1 C-N-CA 133.61 4.764 . . . . 2.08 110.019 -169.501 . . . . . . . . 3 3 . 1 . 090 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.67 33.66 0.64 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 115.04 -3.089 . . . . 1.31 111.842 173.175 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -97.54 137.48 36.41 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.513 2.156 . . . . 1.4 106.572 -178.953 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 m -108.27 121.42 44.86 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 118.897 -0.573 . . . . 0.78 109.9 176.687 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mt -104.77 106.87 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 125.498 1.749 . . . . 1.55 111.444 179.081 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.9 m -80.78 94.72 6.46 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 130.485 3.514 . . . . 1.08 111.67 178.024 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.8 mt -98.02 130.99 44.82 Favored 'General case' 0 N--CA 1.429 -1.482 1 O-C-N 115.781 -4.324 . . . . 1.55 112.907 -174.898 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -92.08 125.92 36.96 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.182 1.81 . . . . 1.95 107.18 174.836 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.9 m -133.89 174.95 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 107.401 -1.333 . . . . 0.96 107.401 -173.569 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -126.26 159.99 59.83 Favored Pre-proline 0 N--CA 1.43 -1.443 0 O-C-N 120.378 -1.451 . . . . 2.35 108.09 163.694 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -78.02 -10.06 16.66 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 CA-C-N 126.29 3.282 . . . . 0.95 109.919 -172.561 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.9 p -78.34 -22.54 47.85 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 130.369 3.468 . . . . 1.45 113.951 174.598 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -68.08 142.39 55.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.104 2.162 . . . . 1.69 110.655 176.21 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 22.9 p -78.08 164.25 25.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.659 2.171 . . . . 0.75 113.424 175.346 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -59.91 -33.18 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.515 1.926 . . . . 0.73 111.189 173.127 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -63.32 -44.48 94.83 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.582 1.553 . . . . 1.62 113.196 172.141 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -60.83 -26.45 67.35 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 115.517 -2.183 . . . . 2.13 114.083 170.037 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.338 46.6 t -84.43 -25.97 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 CA-C-N 127.243 4.565 . . . . 0.62 109.658 179.146 . . . . . . . . 3 2 . 1 . 090 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -75.74 -30.71 59.32 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.575 -3.203 . . . . 1.22 110.766 173.676 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.61 93.06 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.248 -1.532 . . . . 0.51 112.123 174.872 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -58.95 -45.44 90.46 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.436 -3.29 . . . . 1.44 111.074 174.883 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.4 mt -58.48 -33.61 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.292 -3.38 . . . . 1.32 114.652 173.229 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -70.07 -34.85 73.71 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.507 2.41 . . . . 1.7 117.507 -179.673 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -72.82 -47.74 43.75 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 125.016 2.341 . . . . 1.55 116.387 164.506 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -63.86 -65.85 0.62 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.12 -3.488 . . . . 2.62 109.639 -173.673 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -94.23 -51.93 4.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.439 -2.663 . . . . 1.48 110.96 -168.406 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.56 73.19 0.97 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-N 115.489 -0.778 . . . . 1.12 112.276 179.374 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 mt -138.53 117.4 9.46 Favored Pre-proline 0 N--CA 1.429 -1.487 0 N-CA-C 102.427 -3.175 . . . . 1.55 102.427 -174.695 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -57.83 143.13 96.23 Favored 'Trans proline' 0 C--N 1.299 -2.059 0 CA-C-O 112.559 -3.184 . . . . 1.02 114.219 177.838 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -62.21 -15.92 47.52 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 CA-C-N 124.961 2.807 . . . . 1.25 115.926 178.404 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -63.73 -34.99 79.1 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 124.784 2.231 . . . . 2.25 115.907 173.976 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -81.81 -21.87 37.43 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.418 -2.676 . . . . 2.02 109.705 -177.86 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -82.06 104.53 12.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.642 1.686 . . . . 0.69 114.975 -173.767 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.5 tpp85 -100.59 123.37 44.7 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 112.455 -2.157 . . . . 2.78 107.282 162.54 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.0 mt -111.43 137.1 49.65 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.758 2.694 . . . . 1.17 106.531 178.713 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.0 mt -125.36 149.77 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 117.266 -3.396 . . . . 1.38 104.211 -179.654 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.31 84.1 t80 -146.84 135.58 22.17 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 116.564 2.061 . . . . 1.5 116.564 168.541 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.59 -67.3 0.21 Allowed 'General case' 0 N--CA 1.43 -1.45 1 C-N-CA 131.942 4.097 . . . . 1.21 112.317 179.464 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.59 15.42 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.648 0 C-N-CA 128.042 2.734 . . . . 1.3 107.861 174.441 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.1 mttp -123.11 134.14 54.24 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.6 -2.117 . . . . 2.55 107.269 -176.706 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -73.17 140.48 47.05 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 116.857 -1.937 . . . . 2.48 115.237 169.003 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 mt -94.89 133.34 38.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 116.703 -3.748 . . . . 0.9 108.33 -164.558 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -96.67 118.85 34.02 Favored 'General case' 0 N--CA 1.431 -1.393 1 O-C-N 115.46 -4.525 . . . . 1.94 109.46 -176.521 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -39.88 -51.31 2.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 117.797 2.517 . . . . 1.56 117.797 -175.817 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.53 39.54 0.22 Allowed Glycine 0 N--CA 1.429 -1.787 0 C-N-CA 128.04 2.733 . . . . 0.97 114.331 170.411 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -137.1 169.49 17.7 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 119.723 1.762 . . . . 2.49 111.619 164.847 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 44.8 p -98.51 166.36 11.39 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.45 1.9 . . . . 0.76 115.858 175.702 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mt -62.51 -36.47 82.66 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.379 -2.076 . . . . 1.05 112.227 172.167 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -60.64 -44.98 95.75 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.687 1.995 . . . . 1.19 116.336 175.359 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -60.62 -45.82 92.59 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 119.551 1.068 . . . . 1.9 111.8 179.951 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -77.65 -8.86 58.52 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 113.52 0.933 . . . . 0.89 113.52 179.242 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.29 71.4 m-80 62.26 51.29 3.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.048 2.139 . . . . 1.84 116.691 -174.749 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.0 mt -92.7 121.99 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 101.418 -3.549 . . . . 0.82 101.418 178.069 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -110.33 -168.49 1.32 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.197 -1.564 . . . . 2.16 112.676 178.923 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -68.74 155.93 39.22 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.586 -3.196 . . . . 2.12 107.83 -179.929 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 64.2 20.59 12.24 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 112.641 -2.072 . . . . 1.71 114.724 178.433 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.278 50.6 m -84.39 148.09 26.8 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-O 114.661 -2.59 . . . . 1.04 114.51 -174.068 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.0 m -109.59 113.62 26.56 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 115.963 -2.295 . . . . 0.79 109.993 176.657 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.6 mt -84.69 155.4 21.96 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.208 -1.558 . . . . 1.4 107.417 175.732 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -107.09 109.95 21.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 118.027 -0.987 . . . . 1.51 111.932 -174.699 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 tt -80.59 112.58 18.08 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.366 1.066 . . . . 1.14 113.065 174.348 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.4 t -109.77 122.06 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 127.267 2.227 . . . . 1.23 105.382 171.622 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 71' ' ' LEU . 53.9 mt . . . . . 0 N--CA 1.431 -1.391 0 N-CA-C 104.142 -2.54 . . . . 2.78 104.142 177.131 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptt? . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 117.885 2.55 . . . . 1.1 117.885 . . . . . . . . . 0 0 . 1 . 091 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -89.29 121.35 31.48 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.997 -1.064 . . . . 1.87 111.818 -173.585 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.8 pt -116.46 154.7 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 101.025 -3.695 . . . . 0.72 101.025 173.265 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -113.18 151.94 30.32 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 124.783 1.233 . . . . 1.4 111.623 179.943 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.1 t -134.58 127.64 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 122.745 2.521 . . . . 0.58 105.582 175.456 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -92.86 140.6 29.33 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.716 -1.865 . . . . 2.09 110.743 -179.793 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.0 p -87.13 -177.9 6.12 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.365 -0.976 . . . . 0.99 108.365 178.133 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 tp -64.7 -46.52 82.01 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.09 -4.131 . . . . 2.53 115.346 171.126 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -77.23 -21.45 53.76 Favored 'General case' 0 N--CA 1.43 -1.433 1 O-C-N 115.988 -4.195 . . . . 2.08 117.066 178.056 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.59 37.98 0.87 Allowed Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 121.037 3.175 . . . . 1.31 121.037 174.98 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -98.31 127.05 44.06 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 102.006 -3.331 . . . . 1.4 102.006 -177.358 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.0 m -91.68 118.18 30.42 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.134 -1.604 . . . . 0.78 113.871 175.841 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.293 10.4 mt -90.92 126.46 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 103.614 -2.736 . . . . 1.55 103.614 -179.855 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.2 m -98.84 120.16 38.81 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 123.527 2.876 . . . . 1.08 107.127 173.083 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.4 mt -118.38 117.11 28.16 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 125.095 2.379 . . . . 1.55 113.996 177.856 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -79.63 97.37 6.49 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.108 -1.62 . . . . 1.95 113.36 172.258 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -113.84 166.72 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 128.299 2.64 . . . . 0.96 110.915 -175.669 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -107.36 163.71 16.36 Favored Pre-proline 0 N--CA 1.429 -1.5 0 O-C-N 125.017 1.448 . . . . 2.35 111.79 162.02 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.43 -19.67 10.1 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 O-C-N 113.594 -3.951 . . . . 0.95 109.877 -175.172 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 m -81.56 -3.07 52.26 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 116.616 -1.659 . . . . 1.45 114.07 -179.573 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -72.72 142.78 48.19 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.498 1.519 . . . . 1.69 112.576 176.846 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 p -81.82 165.25 21.04 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 124.606 1.191 . . . . 0.75 110.52 176.319 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.422 ' CG2' HD12 ' A' ' 43' ' ' LEU . 4.4 mm -68.79 -24.64 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 1 O-C-N 115.285 -4.634 . . . . 0.73 113.122 178.882 . . . . . . . . 3 3 . 1 . 091 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -51.91 -45.84 64.38 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 129.661 3.185 . . . . 1.62 113.59 164.062 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -62.96 -36.98 85.27 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 115.624 1.713 . . . . 2.13 115.624 174.064 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.75 -48.4 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 127.177 2.191 . . . . 0.62 111.735 175.391 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.5 mttt -55.1 -34.06 63.35 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.339 1.977 . . . . 1.22 116.339 170.033 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.69 -23.79 61.71 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 116.011 1.856 . . . . 0.51 116.011 172.615 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -75.44 -33.49 60.9 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.955 2.902 . . . . 1.44 114.128 168.599 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.4 mt -76.41 -26.68 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 1 O-C-N 113.791 -5.568 . . . . 1.32 110.402 174.861 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -74.01 -25.3 59.82 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.964 -2.335 . . . . 1.7 106.475 178.808 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -86.13 -41.95 14.3 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.172 1.463 . . . . 1.55 114.483 171.122 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.3 mmtt -57.47 -65.7 0.58 Allowed 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 113.999 -5.438 . . . . 2.62 111.36 172.316 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -97.16 -35.53 10.75 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.023 2.529 . . . . 1.48 115.08 -168.067 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.18 44.98 3.65 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 119.896 -1.753 . . . . 1.12 114.093 179.162 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.3 mt -114.18 126.67 27.71 Favored Pre-proline 0 N--CA 1.43 -1.429 1 C-N-CA 134.79 5.236 . . . . 1.55 111.32 -178.76 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.78 156.16 43.97 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 CA-C-N 125.962 3.165 . . . . 1.02 113.442 179.372 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -65.31 -12.11 33.31 Favored 'Trans proline' 0 N--CA 1.433 -2.032 2 CA-C-N 131.235 5.048 . . . . 1.25 118.198 -173.021 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -63.95 -45.14 90.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 127.128 2.768 . . . . 2.25 113.132 175.231 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -84.37 -7.86 59.17 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.9 -3.0 . . . . 2.02 108.465 -175.831 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -92.01 129.74 37.9 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 115.71 -4.368 . . . . 0.69 109.457 -171.684 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -130.64 120.85 24.56 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 129.424 3.09 . . . . 2.78 105.925 172.511 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.422 HD12 ' CG2' ' A' ' 23' ' ' ILE . 82.5 mt -107.01 122.71 46.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.602 3.096 . . . . 1.17 113.474 -176.719 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 29.0 mm -109.9 123.32 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 111.786 -2.461 . . . . 1.38 109.087 177.549 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -101.83 111.41 23.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.53 -2.767 . . . . 1.5 103.53 167.919 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.05 -93.48 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 125.48 1.738 . . . . 1.21 108.905 172.901 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.37 14.04 3.48 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-O 116.208 -2.44 . . . . 1.3 114.15 176.583 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp -107.82 133.63 51.93 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 128.496 3.115 . . . . 2.55 112.858 179.904 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -86.94 115.98 24.7 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 126.018 2.818 . . . . 2.48 114.819 173.681 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.0 mt -73.79 143.88 45.81 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.898 -1.751 . . . . 0.9 112.214 -171.561 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -100.1 138.72 36.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 125.23 2.443 . . . . 1.94 115.568 174.236 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -48.46 -46.86 38.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.422 3.489 . . . . 1.56 119.847 -175.985 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.54 44.91 1.39 Allowed Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 127.105 2.288 . . . . 0.97 116.691 170.928 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.25 20.7 mmt85 -117.25 163.61 16.05 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 117.703 -3.234 . . . . 2.49 103.659 166.332 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.5 p -99.61 163.63 12.41 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.081 -3.512 . . . . 0.76 115.964 169.064 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.7 mt -57.54 -36.17 71.28 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 113.646 -1.615 . . . . 1.05 112.198 174.402 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 t -66.4 -37.75 85.94 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 116.132 1.901 . . . . 1.19 116.132 178.825 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -55.92 -32.15 63.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.37 1.868 . . . . 1.9 114.513 173.065 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -94.86 -8.01 38.54 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 122.951 1.358 . . . . 0.89 110.73 -178.936 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.8 m120 69.0 43.13 1.17 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.356 2.662 . . . . 1.84 114.668 -173.169 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.8 mt -84.9 128.82 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 126.014 2.816 . . . . 0.82 106.379 -179.127 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -109.06 179.99 4.01 Favored 'General case' 0 N--CA 1.431 -1.425 1 O-C-N 115.893 -4.255 . . . . 2.16 108.22 -176.86 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 35.2 ttpt -53.73 138.76 34.57 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 130.943 3.697 . . . . 2.12 115.41 167.005 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 63' ' ' LYS 0.343 9.7 pt-20 77.04 3.2 3.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.598 2.359 . . . . 1.71 117.145 171.828 . . . . . . . . 3 3 . 1 . 091 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.41 164.07 25.37 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 112.818 -1.992 . . . . 1.04 112.849 -176.661 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.3 m -120.0 121.1 38.18 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 124.34 2.019 . . . . 0.79 108.432 175.321 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.29 174.18 5.98 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 104.642 -2.355 . . . . 1.4 104.642 175.117 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 31.3 m170 -130.63 141.53 50.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.962 -1.496 . . . . 1.51 106.962 179.232 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.6 tp -112.23 110.78 21.23 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 129.993 3.317 . . . . 1.14 106.849 -174.259 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.1 t -112.83 123.05 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 C-N-CA 125.222 1.409 . . . . 1.23 109.676 176.93 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 N--CA 1.43 -1.466 0 CA-C-O 122.704 1.24 . . . . 2.78 111.63 178.036 . . . . . . . . 0 0 . 1 . 092 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ptt? . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 116.565 2.061 . . . . 1.1 116.565 . . . . . . . . . 0 0 . 1 . 092 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -106.88 123.09 47.66 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.133 -2.854 . . . . 1.87 111.887 -177.31 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.0 pt -127.19 155.61 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 112.028 -2.351 . . . . 0.72 108.535 170.05 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -124.55 137.22 54.42 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.384 1.073 . . . . 1.4 110.282 -176.014 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.1 t -116.6 101.49 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 129.422 3.089 . . . . 0.58 106.371 178.199 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -81.9 139.59 34.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.711 1.243 . . . . 2.09 112.653 178.769 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.2 p -100.43 -175.96 3.07 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 120.191 -1.568 . . . . 0.99 112.61 -179.147 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.2 mt -77.35 -43.19 33.82 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 112.82 -6.175 . . . . 2.53 111.185 178.205 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.8 p -70.05 -17.49 63.25 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.89 2.076 . . . . 2.08 111.526 -168.352 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.52 33.65 3.3 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 126.091 1.805 . . . . 1.31 116.15 170.317 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -108.56 148.44 30.29 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 103.226 -2.879 . . . . 1.4 103.226 -178.557 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 80.5 m -117.38 120.18 37.38 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 126.247 2.217 . . . . 0.78 109.007 -179.212 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.0 mm -98.72 108.7 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 126.48 3.038 . . . . 1.55 112.204 179.904 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.268 47.4 m -85.18 139.49 31.64 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.131 -3.48 . . . . 1.08 106.704 -175.377 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.1 mt -125.47 146.58 49.57 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.688 -2.507 . . . . 1.55 109.497 176.159 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -99.61 104.21 15.97 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 127.651 2.381 . . . . 1.95 110.726 163.95 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.478 HG21 ' CD1' ' A' ' 56' ' ' LEU . 33.7 m -124.8 176.3 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 119.069 -2.269 . . . . 0.96 111.037 177.728 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -115.47 155.65 46.92 Favored Pre-proline 0 N--CA 1.429 -1.508 0 N-CA-C 103.308 -2.849 . . . . 2.35 103.308 162.487 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -74.95 5.73 3.79 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 127.167 3.595 . . . . 0.95 112.026 -174.61 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.7 p -94.97 -8.73 36.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 130.405 3.482 . . . . 1.45 109.434 179.613 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -72.05 134.1 45.65 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.784 -2.448 . . . . 1.69 107.477 175.412 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.6 p -78.62 160.46 27.54 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 111.004 -2.816 . . . . 0.75 110.926 174.154 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -65.57 -31.39 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 117.176 -3.452 . . . . 0.73 116.246 177.692 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -40.16 -53.43 2.47 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.576 -3.828 . . . . 1.62 114.982 159.78 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -58.75 -39.29 80.51 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 125.117 2.389 . . . . 2.13 116.5 173.259 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.29 -42.57 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 129.909 3.284 . . . . 0.62 113.872 -179.346 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.28 39.0 mtmt -70.03 -33.5 72.05 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 126.469 2.355 . . . . 1.22 114.895 174.256 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.27 -34.03 76.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.221 1.563 . . . . 0.51 115.221 169.857 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -58.35 -31.41 67.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 127.986 3.755 . . . . 1.44 118.293 172.046 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.2 mt -84.41 -32.42 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 1 CA-C-N 108.299 -4.046 . . . . 1.32 110.151 179.256 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -63.63 -33.97 76.81 Favored 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 116.201 -4.062 . . . . 1.7 114.62 176.863 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -64.34 -47.09 80.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.616 1.566 . . . . 1.55 113.332 168.139 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -75.9 -62.29 1.64 Allowed 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 121.267 1.849 . . . . 2.62 114.101 -178.773 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -89.97 -18.25 26.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.952 1.251 . . . . 1.48 114.035 -171.477 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.62 13.85 46.0 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 120.469 -1.394 . . . . 1.12 111.264 167.534 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.7 mt -98.35 133.46 22.83 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 118.936 -2.508 . . . . 1.55 113.837 -173.93 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 72.3 Cg_exo -64.65 143.61 81.59 Favored 'Trans proline' 0 N--CA 1.433 -2.045 1 N-CA-C 124.499 4.769 . . . . 1.02 124.499 170.563 . . . . . . . . 3 3 . 1 . 092 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 13.4 Cg_exo -62.69 -21.01 72.54 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 124.435 3.423 . . . . 1.25 114.772 179.807 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -63.65 -21.61 66.46 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.517 2.043 . . . . 2.25 116.517 168.381 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -94.94 -38.62 10.61 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 103.994 -2.595 . . . . 2.02 103.994 179.127 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.331 76.5 mt-30 -80.23 132.2 35.82 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 114.255 1.206 . . . . 0.69 114.255 -171.696 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -123.33 151.59 42.31 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.295 2.638 . . . . 2.78 104.822 170.219 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.2 mt -127.84 127.47 43.52 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 124.444 2.069 . . . . 1.17 106.929 176.521 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.6 mt -104.72 137.66 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 101.48 -3.526 . . . . 1.38 101.48 171.107 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.281 2.8 t80 -130.14 103.94 7.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.802 -3.061 . . . . 1.5 103.669 170.401 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.391 . . 80.58 -98.44 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 123.812 1.767 . . . . 1.21 110.844 -178.18 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.6 -5.78 3.95 Favored Glycine 0 N--CA 1.429 -1.79 1 CA-C-O 113.243 -4.087 . . . . 1.3 109.043 -176.995 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -101.77 128.61 48.03 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 122.093 2.947 . . . . 2.55 111.136 177.067 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -88.19 117.84 27.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.638 3.575 . . . . 2.48 111.286 177.803 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 mt -75.9 148.14 38.48 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.289 1.995 . . . . 0.9 113.576 -166.947 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -99.0 153.0 19.19 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 111.586 -2.552 . . . . 1.94 111.436 175.604 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.22 -54.33 8.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.466 1.507 . . . . 1.56 114.832 -168.418 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.06 47.31 3.68 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-O 114.787 -3.229 . . . . 0.97 115.672 176.104 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -130.47 158.15 40.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.756 2.278 . . . . 2.49 110.224 165.82 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.328 27.1 p -84.85 169.11 14.47 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 113.67 -5.644 . . . . 0.76 114.557 179.704 . . . . . . . . 3 2 . 1 . 092 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.478 ' CD1' HG21 ' A' ' 17' ' ' VAL . 36.7 mt -65.73 -34.08 77.36 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 113.326 0.861 . . . . 1.05 113.326 172.251 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.6 t -70.95 -25.42 62.72 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 127.416 2.287 . . . . 1.19 111.231 179.57 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -68.03 -29.31 68.27 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 117.728 -1.13 . . . . 1.9 113.298 169.427 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -96.18 18.2 14.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.578 2.351 . . . . 0.89 105.67 176.158 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.6 m120 45.07 41.19 5.34 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 129.097 2.959 . . . . 1.84 118.727 -179.763 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.9 mt -92.65 131.01 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 118.915 -2.366 . . . . 0.82 105.113 -176.864 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -148.1 -34.91 0.22 Allowed 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.259 2.457 . . . . 2.16 110.022 -175.214 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -95.96 -179.6 4.75 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 118.934 -2.354 . . . . 2.12 109.526 174.544 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -68.31 97.56 0.75 Allowed 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 124.404 2.05 . . . . 1.71 116.202 175.745 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 98.2 p -91.85 138.97 31.12 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.362 -1.29 . . . . 1.04 109.739 -167.371 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.1 m -89.57 104.07 16.66 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 115.807 -2.357 . . . . 0.79 112.894 175.483 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mp -88.54 158.1 18.41 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.482 -1.386 . . . . 1.4 107.498 176.181 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -122.87 121.94 37.44 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 118.261 -2.774 . . . . 1.51 114.81 176.331 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 tt -82.57 117.99 22.96 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 116.962 -1.895 . . . . 1.14 115.301 -178.793 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.5 t -114.96 133.67 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 CA-C-O 126.368 2.985 . . . . 1.23 112.466 175.321 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.6 mt . . . . . 0 N--CA 1.429 -1.484 0 O-C-N 116.752 -3.718 . . . . 2.78 107.735 175.87 . . . . . . . . 0 0 . 1 . 093 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 ttp . . . . . 0 CA--C 1.491 -1.318 0 N-CA-C 113.991 1.108 . . . . 1.1 113.991 . . . . . . . . . 0 0 . 1 . 093 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -106.29 95.0 5.46 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.752 -2.467 . . . . 1.87 111.004 -166.316 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.9 pt -90.44 165.58 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 125.762 1.914 . . . . 0.72 111.842 177.855 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -121.41 130.86 53.84 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.393 -1.442 . . . . 1.4 107.338 178.388 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.62 108.45 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 O-C-N 119.816 -1.802 . . . . 0.58 108.44 174.41 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -99.63 133.59 43.74 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.214 1.405 . . . . 2.09 111.059 179.707 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.9 p -101.08 163.58 12.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 115.742 1.756 . . . . 0.99 115.742 -179.31 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 tp -51.58 -49.06 62.85 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.802 3.241 . . . . 2.53 114.303 170.058 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 p -74.86 -40.01 61.23 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.702 1.715 . . . . 2.08 114.201 -165.975 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.37 15.73 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.709 0 O-C-N 118.283 -2.761 . . . . 1.31 114.134 174.323 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -108.03 134.41 50.96 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 126.02 2.819 . . . . 1.4 114.864 -178.367 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.0 m -108.66 107.15 17.51 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 130.02 3.328 . . . . 0.78 105.089 174.059 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -88.4 131.79 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 1 O-C-N 116.066 -4.146 . . . . 1.55 107.318 174.828 . . . . . . . . 3 3 . 1 . 093 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 m -100.1 103.08 14.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 100.416 -3.92 . . . . 1.08 100.416 178.523 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.9 mt -102.97 130.72 50.15 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.055 1.883 . . . . 1.55 112.347 177.398 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -97.17 113.84 25.48 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.411 -2.681 . . . . 1.95 110.689 169.024 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.55 155.76 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 107.273 -1.38 . . . . 0.96 107.273 -177.443 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.325 19.5 mm-40 -86.61 152.8 55.02 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-N 121.644 2.02 . . . . 2.35 107.026 163.669 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -71.25 -16.71 31.45 Favored 'Trans proline' 0 C--N 1.3 -1.996 3 CA-C-N 129.823 4.544 . . . . 0.95 113.537 179.715 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 m -74.95 -6.07 47.26 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 126.042 2.089 . . . . 1.45 113.312 168.652 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -74.3 153.59 39.29 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.64 -2.537 . . . . 1.69 109.276 175.997 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 p -87.28 177.03 7.27 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.196 -2.815 . . . . 0.75 115.283 178.901 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.49 HD12 HD13 ' A' ' 50' ' ' LEU . 47.3 mm -76.79 -32.03 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 124.997 1.319 . . . . 0.73 108.758 174.179 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -53.39 -52.81 58.12 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.89 2.476 . . . . 1.62 113.256 170.488 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -62.58 -38.59 90.71 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 114.79 -2.528 . . . . 2.13 116.234 172.426 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.06 -44.71 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 123.265 2.757 . . . . 0.62 111.706 171.587 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -59.9 -32.79 71.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.77 -3.081 . . . . 1.22 112.181 175.482 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.57 -35.2 79.63 Favored 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.731 -4.355 . . . . 0.51 117.727 172.249 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -71.54 -27.03 62.9 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.576 -2.577 . . . . 1.44 114.281 176.053 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.3 mt -75.45 -36.82 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 117.372 -3.33 . . . . 1.32 109.103 173.67 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -63.09 -53.14 58.29 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.21 -1.556 . . . . 1.7 109.963 177.392 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -41.34 -63.5 0.69 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.688 2.847 . . . . 1.55 118.688 166.53 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -81.9 -36.47 28.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 117.08 2.252 . . . . 2.62 117.08 -166.112 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -103.09 -46.97 4.48 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.848 -1.782 . . . . 1.48 111.315 -175.223 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.96 25.36 2.31 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 123.913 0.768 . . . . 1.12 114.668 170.831 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.4 mt -107.09 127.36 28.12 Favored Pre-proline 0 N--CA 1.429 -1.493 0 O-C-N 118.575 -2.72 . . . . 1.55 109.445 -170.465 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -67.78 138.5 45.05 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 C-N-CA 123.286 2.658 . . . . 1.02 115.809 179.344 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.14 -13.63 31.28 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 CA-C-N 121.335 1.512 . . . . 1.25 115.11 -162.025 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -55.93 -27.8 53.97 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 129.509 3.124 . . . . 2.25 113.721 168.517 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -98.08 -0.14 45.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.8 -1.813 . . . . 2.02 111.149 -173.664 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -97.79 135.82 39.01 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.563 2.601 . . . . 0.69 112.646 -175.215 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -125.05 115.45 20.54 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.756 -1.84 . . . . 2.78 107.241 169.175 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mt -94.44 126.07 39.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.681 2.392 . . . . 1.17 113.807 177.888 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.3 mm -111.04 131.7 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 108.736 -0.838 . . . . 1.38 108.736 -175.913 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -123.67 87.46 2.74 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 127.124 2.17 . . . . 1.5 106.853 168.793 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.256 . . 69.18 -98.49 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.378 -2.076 . . . . 1.21 112.176 -178.441 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.06 6.65 13.13 Favored Glycine 0 N--CA 1.431 -1.653 0 O-C-N 118.352 -2.717 . . . . 1.3 111.571 177.762 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -99.36 130.25 45.63 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.91 -1.885 . . . . 2.55 105.91 178.74 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -103.4 107.25 18.01 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 111.156 -2.747 . . . . 2.48 109.597 170.268 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.49 HD13 HD12 ' A' ' 23' ' ' ILE . 53.3 mt -76.1 131.66 39.57 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 121.111 3.745 . . . . 0.9 121.111 -166.059 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -90.5 141.38 28.82 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 119.647 3.203 . . . . 1.94 119.647 176.536 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -42.96 -68.71 0.17 Allowed 'General case' 0 N--CA 1.431 -1.418 1 N-CA-C 122.337 4.199 . . . . 1.56 122.337 -171.752 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.6 25.15 1.15 Allowed Glycine 0 N--CA 1.429 -1.774 0 C-N-CA 129.194 3.283 . . . . 0.97 119.419 171.193 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -105.99 151.95 23.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.178 -3.542 . . . . 2.49 111.845 163.659 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.7 p -76.04 171.37 14.58 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 124.781 2.229 . . . . 0.76 116.412 172.811 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.629 HD23 HD12 ' A' ' 61' ' ' ILE . 47.9 mt -73.02 -27.69 61.91 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.305 -2.122 . . . . 1.05 113.312 167.838 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.9 p -78.49 -28.39 46.35 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-O 118.148 -0.929 . . . . 1.19 110.087 -177.978 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -56.34 -59.74 4.52 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.366 1.066 . . . . 1.9 111.14 171.909 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -62.85 -28.93 70.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 126.743 2.527 . . . . 0.89 114.507 -179.063 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 82.86 51.79 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.412 1 C-N-CA 132.95 4.5 . . . . 1.84 112.048 -178.466 . . . . . . . . 3 3 . 1 . 093 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.629 HD12 HD23 ' A' ' 56' ' ' LEU . 65.5 mt -84.09 114.7 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 108.373 -0.973 . . . . 0.82 108.373 -178.547 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -95.32 159.79 14.84 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 126.256 1.823 . . . . 2.16 114.118 -170.696 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.382 6.5 tmtm? -6.35 -81.31 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 120.233 3.419 . . . . 2.12 120.233 175.165 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -105.39 71.04 0.91 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.948 2.309 . . . . 1.71 110.962 -175.141 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.283 18.7 m -107.55 141.52 38.88 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 124.392 2.044 . . . . 1.04 107.216 -177.49 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.3 m -105.4 119.19 38.47 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.767 -1.833 . . . . 0.79 107.659 174.374 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -96.34 148.92 22.27 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.527 2.331 . . . . 1.4 107.563 174.314 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -126.15 122.33 35.38 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.148 -1.797 . . . . 1.51 106.148 -174.617 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.5 tp -82.29 135.61 35.18 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 125.062 2.363 . . . . 1.14 107.095 -176.143 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.0 t -135.17 150.21 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 1 N-CA-C 99.328 -4.323 . . . . 1.23 99.328 -179.208 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.43 -1.461 1 O-C-N 115.094 -4.754 . . . . 2.78 107.76 -176.919 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 ttp . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 109.275 -0.639 . . . . 1.1 109.275 . . . . . . . . . 0 0 . 1 . 094 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -102.68 117.6 35.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.811 -3.681 . . . . 1.87 107.85 -178.052 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.0 pt -117.12 149.54 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 125.69 2.662 . . . . 0.72 110.062 174.369 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -95.26 153.76 17.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.984 -2.322 . . . . 1.4 112.223 -177.062 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.9 t -137.37 114.24 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 117.957 -2.964 . . . . 0.58 108.286 172.464 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -86.69 122.51 30.69 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.344 2.257 . . . . 2.09 112.427 179.709 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.301 17.0 p -80.89 174.89 11.17 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.451 -0.795 . . . . 0.99 112.674 -177.378 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 tp -78.03 -25.69 48.0 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 119.176 3.028 . . . . 2.53 119.176 171.357 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.9 p -74.82 -46.55 35.89 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.736 -3.102 . . . . 2.08 112.054 -178.001 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.31 6.89 0.12 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 126.629 2.062 . . . . 1.31 110.014 174.137 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -84.0 144.68 28.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 121.415 2.608 . . . . 1.4 114.137 178.371 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.335 31.3 m -102.57 137.63 40.55 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.228 2.211 . . . . 0.78 111.452 167.306 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mt -125.04 129.54 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 1 C-N-CA 132.908 4.483 . . . . 1.55 110.361 177.082 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.6 m -101.06 117.8 35.74 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 125.615 1.822 . . . . 1.08 109.651 177.096 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -111.36 137.82 48.64 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.425 1.89 . . . . 1.55 111.166 173.763 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -90.38 134.28 34.43 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.154 -2.216 . . . . 1.95 106.305 163.711 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.7 m -142.82 161.95 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 C-N-CA 129.427 3.091 . . . . 0.96 111.789 179.503 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -98.06 149.02 35.3 Favored Pre-proline 0 N--CA 1.431 -1.417 0 O-C-N 117.328 -3.358 . . . . 2.35 108.026 165.474 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -69.82 -17.58 37.21 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 CA-C-N 128.182 3.958 . . . . 0.95 112.109 -179.183 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.0 p -77.95 -16.09 58.45 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.048 1.739 . . . . 1.45 112.984 175.784 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -66.86 134.26 51.72 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.535 -1.211 . . . . 1.69 113.213 178.757 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -69.03 168.38 13.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 115.346 1.61 . . . . 0.75 115.346 174.653 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.276 15.4 mm -76.06 -29.59 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 113.642 -1.617 . . . . 0.73 112.186 176.621 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -46.82 -48.87 20.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.641 3.176 . . . . 1.62 111.703 158.84 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -63.87 -37.22 86.59 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.296 1.438 . . . . 2.13 114.859 176.459 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.3 t -59.99 -43.06 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 118.983 -2.323 . . . . 0.62 116.535 173.593 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HD3' ' HB2' ' A' ' 41' ' ' GLN . 74.4 mttt -71.7 -33.75 69.04 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.241 1.816 . . . . 1.22 114.528 179.741 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.22 -17.76 60.27 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.026 -2.921 . . . . 0.51 109.978 173.412 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -89.93 -12.68 38.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.967 1.841 . . . . 1.44 113.646 173.824 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.8 mt -88.32 -23.52 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 119.918 -1.739 . . . . 1.32 110.671 169.432 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -69.73 -49.42 53.42 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.314 1.845 . . . . 1.7 108.673 172.04 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.306 33.1 t70 -53.7 -62.86 1.38 Allowed 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 123.189 2.722 . . . . 1.55 116.405 164.078 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -63.21 -62.39 1.72 Allowed 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.818 -3.052 . . . . 2.62 113.995 -170.938 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -96.02 -56.46 2.64 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.258 -2.776 . . . . 1.48 113.23 -170.935 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.91 5.49 1.03 Allowed Glycine 0 N--CA 1.431 -1.698 0 O-C-N 124.867 1.354 . . . . 1.12 114.497 170.739 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.5 mt -78.12 135.53 62.3 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-O 114.611 -2.614 . . . . 1.55 111.969 -174.578 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 3.0 Cg_endo -77.37 153.24 31.03 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 CA-C-N 125.413 2.969 . . . . 1.02 113.469 -178.024 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 85.9 Cg_exo -64.51 -24.66 63.34 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 CA-C-N 127.664 3.773 . . . . 1.25 115.603 -172.106 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -61.24 -33.25 73.21 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.613 -2.555 . . . . 2.25 117.254 173.792 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -76.97 -24.74 52.28 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.376 -3.327 . . . . 2.02 116.746 -178.29 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.484 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 68.0 mt-30 -80.9 107.86 14.08 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.28 2.232 . . . . 0.69 110.513 -172.468 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -103.5 119.67 39.35 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.094 -2.879 . . . . 2.78 106.577 168.713 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.7 mt -102.92 123.86 47.34 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 119.67 3.211 . . . . 1.17 119.67 -178.789 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -109.58 157.68 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 115.675 -2.107 . . . . 1.38 109.751 178.356 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -140.63 114.95 9.29 Favored 'General case' 0 N--CA 1.43 -1.453 1 N-CA-C 95.64 -5.689 . . . . 1.5 95.64 173.604 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.259 . . 55.9 -110.23 0.54 Allowed 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.299 -1.501 . . . . 1.21 114.348 -176.815 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.48 -8.71 24.55 Favored Glycine 0 N--CA 1.43 -1.738 0 CA-C-O 123.062 1.368 . . . . 1.3 112.967 -176.601 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -91.61 143.86 26.13 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.388 -3.419 . . . . 2.55 114.468 171.572 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -99.83 129.05 45.89 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.236 1.014 . . . . 2.48 108.634 170.365 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.1 mt -91.36 147.13 23.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.194 1.473 . . . . 0.9 113.234 -167.86 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -91.74 143.23 26.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.719 -1.863 . . . . 1.94 115.581 175.392 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.81 -47.68 77.16 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 118.646 2.832 . . . . 1.56 118.646 -173.504 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.55 26.04 2.75 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 122.934 3.934 . . . . 0.97 122.934 171.885 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.4 mtt-85 -111.46 146.67 36.82 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 118.813 -2.581 . . . . 2.49 110.589 169.84 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.343 43.7 p -70.98 170.9 11.8 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.638 2.637 . . . . 0.76 113.264 176.404 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mt -74.87 -27.96 60.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.318 -2.739 . . . . 1.05 109.779 168.571 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.6 t -65.75 -39.87 91.52 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 127.706 2.402 . . . . 1.19 114.752 178.977 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -51.0 -50.22 58.92 Favored 'General case' 0 N--CA 1.43 -1.452 1 CA-C-O 129.135 4.302 . . . . 1.9 112.505 174.544 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -88.15 -2.1 58.4 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.822 -3.049 . . . . 0.89 114.286 -178.904 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 63.73 55.73 1.63 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.61 1.964 . . . . 1.84 113.183 -176.381 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.1 mm -85.3 118.44 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-O 116.333 -1.794 . . . . 0.82 106.308 179.288 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -82.56 -170.52 3.0 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 128.035 3.334 . . . . 2.16 109.35 -176.69 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.28 92.4 mttt -72.61 -56.3 5.55 Favored 'General case' 0 N--CA 1.429 -1.495 1 N-CA-C 123.84 4.756 . . . . 2.12 123.84 -177.981 . . . . . . . . 3 2 . 1 . 094 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -74.3 27.14 0.08 Allowed 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.783 2.706 . . . . 1.71 115.01 -176.571 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.7 m -73.83 136.41 43.51 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.722 -4.361 . . . . 1.04 116.174 -174.859 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.8 m -112.98 108.97 18.08 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.478 2.085 . . . . 0.79 107.123 178.773 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -75.77 138.97 41.56 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 112.368 -2.197 . . . . 1.4 105.843 174.395 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -106.73 109.41 21.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.744 -3.098 . . . . 1.51 107.225 -170.339 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tp -106.48 126.0 51.7 Favored 'General case' 0 N--CA 1.43 -1.455 1 CA-C-O 128.81 4.148 . . . . 1.14 107.701 -171.69 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -112.85 138.74 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 109.353 -3.567 . . . . 1.23 105.906 -179.151 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.43 -1.467 0 C-N-CA 116.579 -2.049 . . . . 2.78 108.884 -173.899 . . . . . . . . 0 0 . 1 . 095 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ptt? . . . . . 0 CA--C 1.49 -1.356 0 CA-C-O 119.635 -0.221 . . . . 1.1 111.008 . . . . . . . . . 0 0 . 1 . 095 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -111.3 117.67 33.79 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.815 -1.178 . . . . 1.87 108.517 -176.594 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.425 HG12 HG22 ' A' ' 17' ' ' VAL . 16.8 pt -114.13 159.13 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 124.586 1.154 . . . . 0.72 113.054 -178.63 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -112.17 146.61 37.77 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 104.914 -2.254 . . . . 1.4 104.914 174.916 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.8 t -117.3 114.45 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 110.927 -2.851 . . . . 0.58 109.822 174.159 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -91.96 131.5 37.21 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 120.937 1.699 . . . . 2.09 110.329 175.838 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.295 39.4 p -83.12 174.13 11.09 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 126.535 3.064 . . . . 0.99 112.379 174.914 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.3 tp -57.96 -47.32 83.28 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.488 2.566 . . . . 2.53 117.818 172.746 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.3 p -86.4 -8.0 58.0 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.241 2.216 . . . . 2.08 110.103 -173.809 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.4 30.14 5.73 Favored Glycine 0 N--CA 1.431 -1.7 1 C-N-CA 132.932 5.063 . . . . 1.31 118.84 167.613 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -106.15 133.94 50.06 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.258 -2.319 . . . . 1.4 105.54 -176.038 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.7 m -105.05 118.7 37.2 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.239 -0.891 . . . . 0.78 110.155 -173.501 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.72 129.27 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 124.783 1.233 . . . . 1.55 109.982 -176.12 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 100.0 m -88.86 122.46 32.27 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 126.813 2.571 . . . . 1.08 106.409 177.931 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.2 tp -121.63 134.69 54.99 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.379 -2.076 . . . . 1.55 108.612 -178.616 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -94.02 99.92 12.14 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 129.643 3.177 . . . . 1.95 116.561 173.197 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.425 HG22 HG12 ' A' ' 3' ' ' ILE . 16.2 m -115.29 149.58 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 127.712 2.405 . . . . 0.96 112.681 -175.456 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -103.81 165.84 12.75 Favored Pre-proline 0 N--CA 1.43 -1.448 0 N-CA-C 106.625 -1.62 . . . . 2.35 106.625 168.274 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -79.56 -20.01 9.7 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 123.18 2.587 . . . . 0.95 107.625 -172.597 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.8 p -84.8 0.49 50.59 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.244 -2.16 . . . . 1.45 115.974 177.039 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -70.65 151.65 44.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.816 1.246 . . . . 1.69 110.611 173.913 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 p -84.78 166.64 16.79 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.421 1.488 . . . . 0.75 111.028 171.293 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.4 mm -75.12 -35.87 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 116.645 2.091 . . . . 0.73 116.645 173.335 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -48.31 -49.45 33.93 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.053 2.983 . . . . 1.62 119.053 163.536 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -58.49 -35.73 72.66 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.861 2.064 . . . . 2.13 112.899 173.892 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 t -72.76 -38.9 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 121.09 -1.006 . . . . 0.62 112.797 177.685 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -64.02 -31.26 72.38 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.495 -3.253 . . . . 1.22 111.409 170.514 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.43 -32.04 70.75 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 119.144 0.884 . . . . 0.51 111.695 175.246 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -68.86 -45.16 71.79 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.0 1.481 . . . . 1.44 115.0 171.888 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mt -59.03 -35.41 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 125.621 2.629 . . . . 1.32 113.553 177.428 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.298 26.3 tt0 -69.15 -40.89 77.95 Favored 'General case' 0 N--CA 1.428 -1.535 0 O-C-N 116.331 -3.981 . . . . 1.7 111.475 172.67 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -56.05 -61.79 2.14 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 122.969 2.622 . . . . 1.55 114.362 167.429 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.439 12.0 ptpt -76.77 -50.77 12.75 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 114.8 1.407 . . . . 2.62 114.8 -173.706 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -97.28 -48.44 5.33 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 125.577 2.608 . . . . 1.48 112.98 -170.248 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.93 67.02 0.75 Allowed Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 119.936 2.734 . . . . 1.12 119.936 -179.336 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.3 mt -127.26 135.24 27.12 Favored Pre-proline 0 N--CA 1.43 -1.446 0 N-CA-C 100.563 -3.865 . . . . 1.55 100.563 -177.303 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -85.55 135.17 4.99 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 C-N-CA 115.047 -2.835 . . . . 1.02 111.76 -175.202 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.29 -11.68 6.56 Favored 'Trans proline' 0 C--N 1.3 -2.0 1 C-N-CA 126.233 4.622 . . . . 1.25 117.41 -172.91 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -73.83 -23.7 59.69 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.82 1.415 . . . . 2.25 114.82 169.329 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -99.85 -3.06 33.37 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.023 -2.923 . . . . 2.02 113.871 -176.379 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -101.13 97.59 8.11 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.466 -2.021 . . . . 0.69 113.782 -172.706 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.8 ttt-85 -87.82 122.14 31.1 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 115.856 -2.021 . . . . 2.78 110.263 166.737 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.8 mt -111.08 131.5 55.02 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.886 2.18 . . . . 1.17 116.886 -177.717 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.91 136.23 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 105.691 -1.966 . . . . 1.38 105.691 -177.927 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -93.1 -105.42 0.12 Allowed 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.882 -1.508 . . . . 1.5 107.644 168.847 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.83 -69.81 0.79 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 113.934 1.087 . . . . 1.21 113.934 170.174 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.79 -28.57 5.29 Favored Glycine 0 N--CA 1.429 -1.779 0 O-C-N 119.701 -1.874 . . . . 1.3 109.5 -179.275 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -95.25 142.75 27.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 120.423 2.112 . . . . 2.55 108.599 -179.404 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -95.3 135.68 36.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 128.634 2.774 . . . . 2.48 104.394 166.851 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.1 mt -86.68 115.85 24.4 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 126.287 2.242 . . . . 0.9 116.777 -168.769 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -84.8 134.4 34.31 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 125.636 2.636 . . . . 1.94 111.776 179.014 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.283 20.0 m-20 -59.75 -40.38 87.92 Favored 'General case' 0 N--CA 1.43 -1.44 2 N-CA-C 127.458 6.095 . . . . 1.56 127.458 -168.547 . . . . . . . . 3 2 . 1 . 095 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.52 56.88 1.98 Allowed Glycine 0 N--CA 1.43 -1.703 0 O-C-N 119.256 -2.153 . . . . 0.97 113.518 167.736 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -131.93 162.25 31.12 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 127.811 2.444 . . . . 2.49 108.733 172.012 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.3 p -95.53 169.71 9.85 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 121.049 1.75 . . . . 0.76 110.134 173.948 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.451 ' HG ' HD12 ' A' ' 61' ' ' ILE 0.262 7.5 mp -59.02 -30.25 67.87 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 119.152 3.019 . . . . 1.05 119.152 161.906 . . . . . . . . 3 3 . 1 . 095 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 p -74.24 -23.62 59.18 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.909 -2.994 . . . . 1.19 109.118 177.614 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -74.63 -40.65 61.37 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 129.759 3.224 . . . . 1.9 112.696 178.784 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.254 46.8 m-85 -91.62 -0.67 57.6 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 113.469 -5.769 . . . . 0.89 109.505 177.553 . . . . . . . . 3 2 . 1 . 095 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.8 m120 63.74 56.78 1.48 Allowed 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 114.233 -2.794 . . . . 1.84 109.278 -179.029 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.451 HD12 ' HG ' ' A' ' 56' ' ' LEU 0.295 65.6 mt -84.66 126.18 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 127.886 2.474 . . . . 0.82 110.659 175.643 . . . . . . . . 3 3 . 1 . 095 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -107.58 170.92 7.68 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 117.925 -1.036 . . . . 2.16 108.277 -173.473 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -71.51 -29.3 64.63 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 115.478 -2.489 . . . . 2.12 113.981 -178.963 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -80.04 10.4 4.37 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 125.603 2.621 . . . . 1.71 113.972 -179.652 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.8 m -78.84 130.94 36.24 Favored 'General case' 0 N--CA 1.431 -1.406 1 O-C-N 116.096 -4.127 . . . . 1.04 116.899 -174.631 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.8 m -106.51 115.71 30.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.937 -1.938 . . . . 0.79 111.879 170.947 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.297 8.8 mp -87.61 157.61 19.08 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.744 -1.116 . . . . 1.4 109.439 177.103 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -128.54 123.93 34.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 103.36 -2.83 . . . . 1.51 103.36 -176.088 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.305 6.8 tt -103.56 115.42 30.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.253 1.021 . . . . 1.14 111.349 179.579 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.388 4.1 m -109.66 166.71 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 118.628 -2.545 . . . . 1.23 112.446 174.283 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.4 tp . . . . . 0 N--CA 1.431 -1.404 0 N-CA-C 117.365 2.358 . . . . 2.78 117.365 -178.45 . . . . . . . . 0 0 . 1 . 096 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 ptt? . . . . . 0 CA--C 1.49 -1.355 0 N-CA-C 113.268 0.84 . . . . 1.1 113.268 . . . . . . . . . 0 0 . 1 . 096 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -101.14 107.11 18.44 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 120.414 1.461 . . . . 1.87 112.021 -178.768 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.1 pt -89.62 155.9 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 C-N-CA 124.76 1.224 . . . . 0.72 111.431 176.763 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -104.88 140.99 37.32 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 123.303 1.525 . . . . 1.4 107.93 -179.894 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.6 t -124.43 114.97 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 103.584 -2.747 . . . . 0.58 103.584 174.298 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -96.59 138.14 34.62 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.828 -1.795 . . . . 2.09 111.481 -178.322 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.65 HG22 HD23 ' A' ' 69' ' ' LEU 0.346 18.3 p -91.73 166.86 12.56 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 116.429 -1.748 . . . . 0.99 110.977 175.204 . . . . . . . . 3 3 . 1 . 096 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.8 mt -68.95 -44.82 72.23 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 125.33 1.644 . . . . 2.53 111.182 171.784 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.1 p -62.17 -81.84 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 128.399 3.952 . . . . 2.08 113.299 -177.432 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.12 40.48 0.11 Allowed Glycine 0 N--CA 1.431 -1.692 1 O-C-N 116.299 -4.001 . . . . 1.31 119.243 174.819 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -122.87 142.39 50.84 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.069 1.435 . . . . 1.4 108.134 -177.206 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.6 m -120.63 118.66 30.72 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.759 2.423 . . . . 0.78 106.289 172.03 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.444 HD13 HG21 ' A' ' 13' ' ' ILE . 2.9 mt -97.59 133.2 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-O 124.978 2.323 . . . . 1.55 105.89 178.61 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 p -107.28 92.63 4.16 Favored 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 132.496 4.318 . . . . 1.08 107.091 -177.402 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.0 mt -101.31 130.36 47.46 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 125.313 1.633 . . . . 1.55 112.353 -179.198 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -74.7 107.49 6.84 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 115.269 -2.301 . . . . 1.95 109.758 171.314 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.1 m -127.57 173.32 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 105.847 -1.908 . . . . 0.96 105.847 -173.349 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -125.77 169.57 11.21 Favored Pre-proline 0 N--CA 1.431 -1.399 0 CA-C-O 112.903 -3.427 . . . . 2.35 106.285 163.849 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -74.87 -17.95 19.48 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 C-N-CA 124.028 3.152 . . . . 0.95 111.356 -175.192 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.6 p -78.17 -8.96 58.94 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.736 2.014 . . . . 1.45 115.656 176.339 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -74.29 137.88 43.19 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.69 -3.131 . . . . 1.69 112.567 176.565 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 29.6 p -76.42 154.84 34.47 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.697 1.999 . . . . 0.75 111.354 176.072 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.0 mm -54.42 -37.08 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 125.679 1.592 . . . . 0.73 112.072 173.96 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -53.32 -45.52 69.07 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.281 2.232 . . . . 1.62 116.783 162.599 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.413 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 5.5 t-20 -55.75 -42.22 75.11 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 119.09 -2.256 . . . . 2.13 115.642 171.692 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.0 t -66.33 -39.34 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 114.284 1.216 . . . . 0.62 114.284 179.204 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -63.27 -27.02 69.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.587 2.069 . . . . 1.22 116.587 168.931 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -64.71 -47.29 78.86 Favored 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 116.291 -4.005 . . . . 0.51 113.773 169.127 . . . . . . . . 3 3 . 1 . 096 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -55.47 -49.95 71.17 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 126.431 3.015 . . . . 1.44 116.672 169.634 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.1 mt -59.11 -40.14 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 O-C-N 116.394 -3.941 . . . . 1.32 114.291 169.921 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -61.09 -39.87 91.56 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.77 -1.831 . . . . 1.7 113.058 173.444 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -62.7 -50.68 70.2 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.511 2.041 . . . . 1.55 116.511 172.711 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -67.6 -61.18 2.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.863 2.465 . . . . 2.62 109.665 -173.583 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -94.93 -56.27 2.81 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.622 -2.549 . . . . 1.48 112.837 -169.719 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.73 -1.1 2.84 Favored Glycine 0 N--CA 1.431 -1.667 0 O-C-N 119.615 -1.928 . . . . 1.12 116.155 176.111 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.1 mt -90.84 134.51 30.27 Favored Pre-proline 0 N--CA 1.429 -1.481 0 O-C-N 119.959 -1.906 . . . . 1.55 107.486 -167.269 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 20.4 Cg_exo -61.08 153.05 67.14 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 O-C-N 115.121 -3.147 . . . . 1.02 114.943 173.5 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 99.0 Cg_exo -73.7 -19.02 21.75 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 122.815 2.041 . . . . 1.25 110.557 -177.644 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.265 3.3 m-20 -63.42 -28.57 70.06 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.12 -2.863 . . . . 2.25 116.897 170.276 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.251 18.6 mt-30 -85.95 -23.91 26.75 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 115.164 -0.925 . . . . 2.02 111.936 -179.552 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -78.43 134.46 37.37 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 120.346 3.461 . . . . 0.69 120.346 -178.456 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -122.57 130.64 53.23 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 105.092 -2.188 . . . . 2.78 105.092 175.465 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.2 mt -114.73 147.11 40.15 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 117.238 -3.414 . . . . 1.17 113.371 175.778 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.0 mt -144.25 136.97 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 C-N-CA 128.268 2.627 . . . . 1.38 104.084 -168.674 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -117.52 123.65 46.79 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 103.289 -2.856 . . . . 1.5 103.289 170.374 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.285 . . 63.3 -89.53 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.476 -2.64 . . . . 1.21 116.75 -176.816 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.9 4.82 3.6 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 105.38 -3.088 . . . . 1.3 105.38 -177.91 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -109.12 130.03 55.48 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.029 -2.454 . . . . 2.55 115.557 -174.538 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -70.32 130.9 43.21 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.836 1.655 . . . . 2.48 110.347 171.171 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.1 mt -99.32 159.15 15.21 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 124.43 3.286 . . . . 0.9 105.094 -168.202 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.491 ' HB3' ' HG3' ' A' ' 54' ' ' ARG . 37.6 tt0 -104.25 130.2 52.05 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 125.65 1.844 . . . . 1.94 114.036 174.5 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -50.25 -50.73 49.17 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.523 3.156 . . . . 1.56 119.523 -168.848 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.6 -9.43 65.15 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 119.832 2.693 . . . . 0.97 119.832 170.68 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.491 ' HG3' ' HB3' ' A' ' 51' ' ' GLU . 37.4 mtt180 -84.92 163.22 19.1 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 115.757 -4.378 . . . . 2.49 115.066 169.687 . . . . . . . . 3 3 . 1 . 096 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 43.0 p -84.02 174.66 10.12 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 118.582 2.808 . . . . 0.76 118.582 171.825 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.83 -31.29 72.41 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 117.922 2.564 . . . . 1.05 117.922 165.892 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.5 t -77.25 -25.2 51.28 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.937 2.095 . . . . 1.19 112.927 178.79 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -65.3 -33.49 76.1 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.316 -2.115 . . . . 1.9 111.898 169.45 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -91.81 4.51 52.69 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.316 -4.615 . . . . 0.89 113.439 170.059 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.663 2.9 m120 63.46 25.83 14.64 Favored 'General case' 0 N--CA 1.43 -1.439 1 N-CA-C 124.288 4.922 . . . . 1.84 124.288 -174.862 . . . . . . . . 3 2 . 1 . 096 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.4 mt -66.84 121.87 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 128.106 2.563 . . . . 0.82 110.541 -177.252 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -89.44 174.73 7.63 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.416 2.531 . . . . 2.16 112.349 -179.518 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -42.06 -56.65 2.75 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 128.023 3.773 . . . . 2.12 118.154 174.791 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -94.61 44.29 1.11 Allowed 'General case' 0 N--CA 1.429 -1.513 1 O-C-N 113.077 -6.015 . . . . 1.71 113.445 -175.269 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.31 38.8 m -92.65 133.73 35.7 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 118.73 -2.481 . . . . 1.04 115.478 -171.716 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.3 m -104.33 105.32 15.41 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 120.694 1.588 . . . . 0.79 107.448 175.004 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 67' ' ' LEU . 5.8 mp -81.74 161.85 23.17 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.299 2.0 . . . . 1.4 109.385 163.67 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.261 98.8 m-70 -118.45 130.7 56.11 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 112.493 -2.139 . . . . 1.51 108.966 -178.199 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.65 HD23 HG22 ' A' ' 7' ' ' THR . 49.8 tp -102.16 111.5 23.81 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 123.351 1.548 . . . . 1.14 110.228 179.295 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.289 40.0 t -109.48 129.79 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 118.218 2.673 . . . . 1.23 118.218 177.848 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.2 tp . . . . . 0 N--CA 1.43 -1.433 0 C-N-CA 115.889 -2.324 . . . . 2.78 113.741 -170.287 . . . . . . . . 0 0 . 1 . 097 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttp . . . . . 0 CA--C 1.491 -1.309 0 N-CA-C 116.139 1.904 . . . . 1.1 116.139 . . . . . . . . . 0 0 . 1 . 097 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -95.98 125.65 40.68 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 116.52 -3.863 . . . . 1.87 110.688 -174.312 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.6 pt -111.98 144.54 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 124.739 2.209 . . . . 0.72 110.12 169.121 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -108.34 112.67 25.24 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.131 -1.85 . . . . 1.4 110.63 -174.661 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.39 116.24 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-O 124.895 2.283 . . . . 0.58 107.262 178.564 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 tppt? -97.38 132.35 43.18 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.389 -3.945 . . . . 2.09 109.197 177.045 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.357 12.5 p -73.56 173.78 9.21 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.08 -2.262 . . . . 0.99 115.106 176.26 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.9 mt -70.92 -15.32 62.6 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.628 1.68 . . . . 2.53 114.985 172.962 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.7 p -109.24 -26.17 10.22 Favored 'General case' 0 N--CA 1.431 -1.399 1 O-C-N 116.025 -4.172 . . . . 2.08 107.264 -175.796 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.42 27.22 0.83 Allowed Glycine 0 N--CA 1.431 -1.651 0 O-C-N 118.968 -2.332 . . . . 1.31 117.12 169.383 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -100.66 118.41 36.74 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.808 2.304 . . . . 1.4 109.919 -168.712 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.4 m -81.44 122.48 27.56 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 119.557 -0.857 . . . . 0.78 110.012 178.518 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -111.14 133.77 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 102.729 -3.063 . . . . 1.55 102.729 173.518 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.8 m -111.63 125.73 54.26 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.277 -2.764 . . . . 1.08 108.815 -172.833 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.8 mt -119.01 135.45 54.62 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 120.739 1.609 . . . . 1.55 107.817 -177.369 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -91.43 112.57 24.54 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.143 -1.428 . . . . 1.95 107.143 169.966 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.7 m -127.53 165.85 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 C-N-CA 129.008 2.923 . . . . 0.96 116.02 -178.785 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -109.27 163.32 17.28 Favored Pre-proline 0 N--CA 1.43 -1.462 0 C-N-CA 119.717 -0.793 . . . . 2.35 111.601 163.876 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -82.18 -12.35 10.58 Favored 'Trans proline' 0 C--N 1.299 -2.049 0 O-C-N 114.531 -3.458 . . . . 0.95 113.729 -172.996 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.7 m -82.36 -5.92 58.93 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 124.792 1.307 . . . . 1.45 110.457 176.177 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -85.33 146.5 26.99 Favored 'General case' 0 N--CA 1.429 -1.498 1 O-C-N 114.652 -5.03 . . . . 1.69 109.776 178.783 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 68.9 p -77.55 161.78 27.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 118.289 -2.757 . . . . 0.75 112.159 178.629 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mp -68.81 -31.32 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 119.469 -2.019 . . . . 0.73 108.937 -179.818 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -46.48 -40.51 12.54 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.476 -2.015 . . . . 1.62 114.1 165.65 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -70.77 -29.55 65.8 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 117.514 2.413 . . . . 2.13 117.514 174.752 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.39 -39.61 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-N 113.428 -1.714 . . . . 0.62 109.289 176.809 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.3 84.2 mttt -60.73 -34.37 74.3 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 124.277 0.985 . . . . 1.22 111.974 169.275 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.62 -44.48 96.18 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.524 -2.61 . . . . 0.51 114.676 173.235 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -66.58 -43.55 84.64 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.425 -1.716 . . . . 1.44 115.014 172.397 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.5 mt -58.12 -31.07 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 116.652 -3.78 . . . . 1.32 113.327 170.656 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -60.34 -45.64 92.72 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 116.849 2.166 . . . . 1.7 116.849 170.69 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.87 -53.86 43.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.032 2.349 . . . . 1.55 114.151 174.92 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -56.81 -75.96 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 111.502 -2.59 . . . . 2.62 113.551 177.782 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -94.52 -21.38 18.91 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.433 3.123 . . . . 1.48 119.433 -169.068 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.75 43.38 3.63 Favored Glycine 0 N--CA 1.43 -1.755 1 O-C-N 114.802 -4.936 . . . . 1.12 113.471 175.886 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.7 mt -115.72 131.39 23.7 Favored Pre-proline 0 N--CA 1.43 -1.441 0 O-C-N 120.892 -1.357 . . . . 1.55 109.481 179.787 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -63.84 147.07 92.36 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 O-C-N 116.456 -2.444 . . . . 1.02 113.623 176.069 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.66 -22.89 64.04 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 C-N-CA 124.246 3.297 . . . . 1.25 115.991 -176.606 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.58 -24.47 65.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 128.395 2.678 . . . . 2.25 117.35 177.311 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -86.96 -33.22 19.72 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.014 -1.448 . . . . 2.02 107.257 -177.982 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -85.87 129.78 34.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.081 -1.637 . . . . 0.69 115.118 -168.642 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -115.97 142.24 47.06 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.599 1.959 . . . . 2.78 106.253 163.393 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.8 mt -117.7 125.56 50.9 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.306 -1.739 . . . . 1.17 106.306 178.89 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 39.3 mm -102.29 144.65 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 129.959 3.304 . . . . 1.38 107.259 174.222 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.315 17.4 t80 -143.0 114.83 8.18 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 105.235 -2.135 . . . . 1.5 105.235 171.57 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.5 17.73 9.03 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 127.524 3.535 . . . . 1.21 116.826 176.619 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.32 -7.55 54.31 Favored Glycine 0 N--CA 1.43 -1.712 1 O-C-N 114.323 -5.236 . . . . 1.3 111.527 -178.388 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -104.4 133.32 49.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.229 -1.748 . . . . 2.55 108.463 -175.801 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -74.42 125.64 28.97 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 112.901 -1.954 . . . . 2.48 111.372 169.033 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.1 mt -83.76 152.21 24.79 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 125.078 1.486 . . . . 0.9 108.719 -172.323 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -94.93 135.39 36.51 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 123.28 1.514 . . . . 1.94 111.073 176.074 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -54.59 -53.88 48.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 111.612 -2.54 . . . . 1.56 114.94 -171.801 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.38 63.17 2.72 Favored Glycine 0 N--CA 1.429 -1.803 0 O-C-N 119.297 -2.127 . . . . 0.97 114.554 169.347 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -133.99 158.56 43.2 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 100.794 -3.78 . . . . 2.49 100.794 161.169 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 45.8 p -88.41 171.01 10.44 Favored 'General case' 0 N--CA 1.43 -1.439 1 CA-C-O 129.288 4.375 . . . . 0.76 110.115 176.694 . . . . . . . . 3 3 . 1 . 097 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.32 -36.78 71.71 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 112.07 -6.643 . . . . 1.05 111.467 175.597 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.4 t -51.59 -35.07 39.95 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 129.158 2.983 . . . . 1.19 113.89 179.432 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -62.75 -30.36 71.38 Favored 'General case' 0 N--CA 1.43 -1.455 1 C-N-CA 132.855 4.462 . . . . 1.9 110.384 174.332 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -99.68 167.94 10.25 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.946 -2.346 . . . . 0.89 110.264 179.772 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -89.39 62.81 6.17 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 118.982 -2.324 . . . . 1.84 110.356 -179.829 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.8 mm -80.82 128.61 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 124.454 1.102 . . . . 0.82 108.283 177.858 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -100.17 -119.49 0.16 Allowed 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.49 2.404 . . . . 2.16 117.49 -169.941 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -100.39 -59.55 1.69 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.983 0.897 . . . . 2.12 111.192 177.703 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.32 75.23 1.64 Allowed 'General case' 0 N--CA 1.429 -1.523 0 O-C-N 118.321 -2.737 . . . . 1.71 107.684 177.278 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.0 m -91.47 142.6 27.49 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.907 -2.995 . . . . 1.04 109.573 -167.336 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.0 m -98.4 126.95 44.12 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.67 1.7 . . . . 0.79 107.118 178.871 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mp -110.15 166.18 11.16 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.659 -1.901 . . . . 1.4 107.088 176.157 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.549 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 98.4 m-70 -124.07 127.89 48.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.68 -3.762 . . . . 1.51 112.212 -170.109 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.0 tp -103.67 116.91 33.21 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 127.053 2.721 . . . . 1.14 113.022 -178.454 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.7 128.05 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 N-CA-C 105.329 -2.101 . . . . 1.23 105.329 178.351 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 N--CA 1.43 -1.466 0 O-C-N 124.2 0.937 . . . . 2.78 111.607 174.911 . . . . . . . . 0 0 . 1 . 098 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 ttp . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 120.56 0.219 . . . . 1.1 111.2 . . . . . . . . . 0 0 . 1 . 098 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -98.99 114.44 27.09 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.9 -2.259 . . . . 1.87 104.9 -170.069 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 pt -117.83 153.97 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 113.047 -1.888 . . . . 0.72 108.712 -179.722 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -118.88 113.53 21.2 Favored 'General case' 0 N--CA 1.43 -1.44 1 C-N-CA 132.556 4.342 . . . . 1.4 109.521 -175.93 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -104.23 121.49 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 100.812 -3.773 . . . . 0.58 100.812 177.364 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt -99.54 135.77 40.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.353 2.661 . . . . 2.09 110.878 177.511 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -92.64 -176.62 4.32 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.97 1.708 . . . . 0.99 112.125 173.229 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.5 mt -95.16 -11.72 27.64 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.953 2.101 . . . . 2.53 111.227 168.955 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.3 p -82.92 -46.41 12.99 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.368 2.032 . . . . 2.08 114.534 179.658 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.31 -13.5 0.29 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 117.546 -3.221 . . . . 1.31 111.141 170.976 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -86.82 128.26 35.03 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 119.902 1.851 . . . . 1.4 113.047 -165.654 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -92.52 115.64 28.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.834 -3.041 . . . . 0.78 108.353 175.037 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mt -99.08 117.25 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 1 O-C-N 115.967 -4.208 . . . . 1.55 109.455 -179.342 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.0 m -98.07 124.38 42.56 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.406 2.527 . . . . 1.08 108.459 -178.359 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.4 mt -118.99 138.33 52.89 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.348 1.61 . . . . 1.55 115.348 -179.968 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -103.46 102.37 12.28 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.69 -3.131 . . . . 1.95 109.927 175.219 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.9 m -114.75 170.78 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 128.421 2.688 . . . . 0.96 108.458 -175.296 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -118.18 157.48 48.82 Favored Pre-proline 0 N--CA 1.43 -1.459 0 O-C-N 118.393 -2.692 . . . . 2.35 107.521 163.775 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -62.7 -20.86 72.17 Favored 'Trans proline' 0 C--N 1.299 -2.055 0 C-N-CA 124.044 3.163 . . . . 0.95 115.508 -171.605 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 m -80.91 0.93 33.1 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 118.076 2.621 . . . . 1.45 118.076 173.862 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -87.43 163.91 16.48 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 102.457 -3.164 . . . . 1.69 102.457 175.624 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.2 p -90.8 -175.26 4.32 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.132 2.396 . . . . 0.75 114.006 176.142 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.4 mm -82.63 -36.41 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 O-C-N 116.893 -3.629 . . . . 0.73 106.61 178.917 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -50.97 -45.86 61.07 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.169 2.187 . . . . 1.62 112.478 167.168 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -64.27 -38.73 92.07 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.336 2.654 . . . . 2.13 107.202 175.787 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.8 t -59.27 -48.04 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 124.264 3.211 . . . . 0.62 114.364 176.805 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.262 37.8 mtmt -64.64 -41.73 95.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.46 1.504 . . . . 1.22 112.049 174.162 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.08 -32.38 72.91 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 117.067 2.247 . . . . 0.51 117.067 176.952 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -76.46 -36.54 57.85 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 125.092 1.495 . . . . 1.44 111.694 175.437 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.2 mt -71.9 -31.29 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 116.666 -3.772 . . . . 1.32 110.089 175.557 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -59.28 -59.1 6.0 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 113.579 -3.105 . . . . 1.7 107.74 169.985 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -50.16 -52.51 34.72 Favored 'General case' 0 N--CA 1.43 -1.432 1 CA-C-N 127.925 4.875 . . . . 1.55 111.79 166.418 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -61.66 -48.48 80.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.033 -2.917 . . . . 2.62 117.61 -167.952 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -112.59 -52.04 2.8 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 118.909 -1.116 . . . . 1.48 113.308 -168.317 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.21 36.25 0.43 Allowed Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 126.382 1.944 . . . . 1.12 114.305 178.934 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.8 mt -117.92 116.7 36.02 Favored Pre-proline 0 N--CA 1.429 -1.489 0 O-C-N 118.237 -2.919 . . . . 1.55 105.692 -171.239 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -59.93 154.0 53.51 Favored 'Trans proline' 0 C--N 1.299 -2.051 2 C-N-CA 126.67 4.913 . . . . 1.02 114.877 -179.954 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -73.36 -17.76 23.76 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 C-N-CA 124.566 3.511 . . . . 1.25 113.294 -176.55 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -84.25 -16.55 42.79 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.168 2.587 . . . . 2.25 108.986 -178.814 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.329 14.8 tt0 -97.86 -24.44 15.42 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 126.076 2.11 . . . . 2.02 109.925 -177.017 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -88.07 125.0 34.34 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 113.72 1.007 . . . . 0.69 113.72 -175.761 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -110.07 124.53 51.65 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.055 -0.72 . . . . 2.78 109.055 172.806 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.3 mt -107.84 114.83 29.04 Favored 'General case' 0 N--CA 1.429 -1.516 0 O-C-N 118.933 -2.354 . . . . 1.17 110.748 -173.102 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.7 mm -91.85 124.94 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 114.949 -1.023 . . . . 1.38 109.673 177.107 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -114.15 111.28 21.33 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.072 -1.085 . . . . 1.5 108.072 163.89 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.498 . . 68.01 -44.11 0.49 Allowed 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 127.039 3.305 . . . . 1.21 118.642 174.33 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.67 -47.66 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.738 0 O-C-N 116.798 -3.689 . . . . 1.3 108.246 -172.659 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -75.34 156.59 35.36 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 124.676 2.179 . . . . 2.55 112.319 179.612 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -104.82 135.48 46.11 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.173 -2.204 . . . . 2.48 105.718 169.131 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.418 HD22 ' CE2' ' A' ' 59' ' ' TYR . 12.8 mt -96.1 143.59 27.1 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.748 -1.845 . . . . 0.9 110.395 -169.675 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -83.67 147.44 27.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 113.312 -1.767 . . . . 1.94 115.303 172.449 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.61 -63.83 1.16 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 130.909 3.684 . . . . 1.56 113.216 -165.857 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.81 36.71 2.83 Favored Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 119.785 2.674 . . . . 0.97 119.785 171.637 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -102.73 152.43 21.24 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 120.999 0.428 . . . . 2.49 111.221 161.463 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.1 p -83.67 173.27 11.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 124.781 2.229 . . . . 0.76 109.219 171.677 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -72.7 -38.27 67.58 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.955 -2.966 . . . . 1.05 106.937 172.412 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.34 59.8 p -60.87 -24.76 66.18 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.528 1.931 . . . . 1.19 115.356 178.564 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.386 4.7 t0 -62.18 -38.4 88.91 Favored 'General case' 0 N--CA 1.429 -1.524 1 CA-C-O 129.017 4.246 . . . . 1.9 114.838 172.057 . . . . . . . . 3 2 . 1 . 098 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.418 ' CE2' HD22 ' A' ' 50' ' ' LEU . 76.8 m-85 -97.83 171.12 8.51 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 110.894 -2.867 . . . . 0.89 111.125 -179.367 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -89.68 43.16 1.13 Allowed 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.373 -2.704 . . . . 1.84 116.325 -175.136 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.3 mm -71.59 124.73 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 118.47 2.767 . . . . 0.82 118.47 -179.371 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -85.28 173.76 10.11 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 125.014 2.34 . . . . 2.16 109.125 -177.42 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.47 -48.83 77.91 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.497 -3.252 . . . . 2.12 115.568 173.858 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.06 64.09 0.93 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.445 -3.285 . . . . 1.71 111.964 175.365 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.5 m -87.39 141.65 28.47 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 117.896 2.554 . . . . 1.04 117.896 178.551 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.1 m -102.02 122.47 44.14 Favored 'General case' 0 N--CA 1.431 -1.409 1 CA-C-N 108.097 -4.138 . . . . 0.79 105.032 176.536 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -112.88 154.72 25.89 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 101.84 -3.392 . . . . 1.4 101.84 177.218 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -126.22 117.32 22.84 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.111 -2.243 . . . . 1.51 111.594 -175.534 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.251 3.9 tt -86.38 115.57 23.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 127.252 2.221 . . . . 1.14 108.946 -179.561 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.9 t -101.56 157.41 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 1 C-N-CA 133.523 4.729 . . . . 1.23 105.346 172.087 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.6 mt . . . . . 0 N--CA 1.431 -1.422 0 O-C-N 120.659 -1.275 . . . . 2.78 108.199 173.676 . . . . . . . . 0 0 . 1 . 099 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttp . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 114.076 1.139 . . . . 1.1 114.076 . . . . . . . . . 0 0 . 1 . 099 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -96.95 104.3 16.3 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 114.976 -2.44 . . . . 1.87 109.313 -172.636 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.43 HD12 HD13 ' A' ' 67' ' ' LEU . 13.4 pt -95.47 165.39 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 127.459 2.975 . . . . 0.72 111.977 174.94 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -117.5 136.3 53.33 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.359 1.464 . . . . 1.4 112.742 176.618 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.447 HG21 HD12 ' A' ' 15' ' ' LEU . 18.6 t -116.19 98.58 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 131.246 3.818 . . . . 0.58 111.123 177.21 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -84.53 134.46 34.42 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 119.168 0.895 . . . . 2.09 112.935 179.396 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -83.5 -174.86 5.53 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.809 -1.087 . . . . 0.99 110.95 176.864 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.7 tp -81.75 -41.54 21.08 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.609 1.195 . . . . 2.53 112.758 171.01 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.9 p -74.39 -21.78 59.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.769 2.137 . . . . 2.08 116.769 -177.452 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.45 -0.01 1.03 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 118.415 2.126 . . . . 1.31 118.415 166.62 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.8 tttp -91.24 126.4 36.31 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.132 -1.805 . . . . 1.4 114.303 -172.957 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.5 m -95.37 109.78 21.9 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 121.398 -0.814 . . . . 0.78 110.454 176.197 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.1 mt -89.85 137.29 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 113.162 -3.304 . . . . 1.55 102.324 -174.884 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 m -110.17 129.62 55.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 126.598 2.436 . . . . 1.08 105.397 -174.508 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.447 HD12 HG21 ' A' ' 5' ' ' VAL . 43.2 mt -133.33 125.76 29.91 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.02 -2.3 . . . . 1.55 105.081 -171.596 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -85.74 113.61 22.06 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.433 -3.292 . . . . 1.95 107.875 173.48 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.9 m -123.01 172.34 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 128.031 2.532 . . . . 0.96 111.741 176.447 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -126.01 156.71 71.35 Favored Pre-proline 0 N--CA 1.431 -1.42 0 C-N-CA 124.493 1.117 . . . . 2.35 109.315 164.153 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -64.17 -8.35 16.21 Favored 'Trans proline' 0 N--CA 1.433 -2.038 0 CA-C-N 126.678 3.421 . . . . 0.95 116.551 -174.761 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 p -93.77 -1.93 54.37 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.179 1.809 . . . . 1.45 111.966 178.635 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -73.38 156.0 38.78 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.519 -1.988 . . . . 1.69 110.672 172.569 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 58.3 p -95.63 173.47 7.47 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 114.842 1.423 . . . . 0.75 114.842 176.872 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.9 mm -67.05 -44.79 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 116.307 -1.806 . . . . 0.73 108.479 169.418 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -52.12 -33.54 40.3 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 117.287 2.328 . . . . 1.62 117.287 169.285 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -66.79 -42.72 85.55 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.868 -3.645 . . . . 2.13 113.186 174.463 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 t -53.32 -47.88 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 115.328 1.603 . . . . 0.62 115.328 171.303 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -65.73 -31.16 72.0 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 126.578 2.423 . . . . 1.22 114.734 176.217 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -43.47 98.75 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 120.96 1.709 . . . . 0.51 110.775 176.793 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -57.03 -38.12 72.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.978 1.844 . . . . 1.44 115.978 172.2 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.5 mt -69.75 -34.35 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 113.911 1.078 . . . . 1.32 113.911 168.555 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -69.07 -34.02 74.49 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 130.14 3.376 . . . . 1.7 115.388 174.905 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.351 36.8 t70 -71.19 -41.92 69.68 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 123.977 0.911 . . . . 1.55 113.043 166.509 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -81.12 -44.94 17.19 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 117.527 2.417 . . . . 2.62 117.527 -176.557 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -109.42 -46.84 3.48 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.502 -1.295 . . . . 1.48 107.502 -165.273 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.89 36.13 2.25 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 119.055 2.382 . . . . 1.12 119.055 173.271 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.451 HG21 HD22 ' A' ' 71' ' ' LEU . 9.9 mt -111.18 136.76 20.86 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-O 116.687 -1.625 . . . . 1.55 109.981 -177.575 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -70.85 160.58 48.92 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 CA-C-N 125.08 2.85 . . . . 1.02 112.48 -175.379 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.82 -19.84 52.53 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 N-CA-C 118.1 2.308 . . . . 1.25 118.1 178.535 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -62.55 -37.48 86.32 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 119.702 3.223 . . . . 2.25 119.702 171.545 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.34 18.4 mm100 -80.23 -29.76 38.5 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 108.666 -3.879 . . . . 2.02 111.763 -173.21 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -81.8 133.15 35.31 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.064 -1.425 . . . . 0.69 108.484 -175.181 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -123.86 110.92 15.47 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 106.325 -1.731 . . . . 2.78 106.325 175.046 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.8 mt -99.96 118.0 35.43 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.699 2.666 . . . . 1.17 105.556 -179.008 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.8 mm -109.75 116.05 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 104.152 -2.536 . . . . 1.38 104.152 -173.244 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -121.83 110.11 15.49 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.849 -2.278 . . . . 1.5 104.849 176.147 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.27 30.87 4.11 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.627 3.171 . . . . 1.21 110.658 175.951 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.71 -33.74 5.33 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 119.867 1.212 . . . . 1.3 112.396 -175.046 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -78.29 132.94 37.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.232 1.813 . . . . 2.55 108.83 -177.972 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -91.44 122.02 33.66 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.424 2.059 . . . . 2.48 109.409 170.992 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.2 mt -70.23 136.08 49.61 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 129.553 3.141 . . . . 0.9 113.691 -174.911 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -77.88 148.42 34.62 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.202 -1.561 . . . . 1.94 114.922 174.973 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -62.95 -63.13 1.3 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.14 -2.225 . . . . 1.56 116.94 -171.943 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.5 42.7 0.24 Allowed Glycine 0 N--CA 1.43 -1.729 1 N-CA-C 123.859 4.303 . . . . 0.97 123.859 167.554 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -117.12 164.43 14.77 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 114.238 -2.791 . . . . 2.49 111.14 168.453 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.0 p -96.39 169.64 9.78 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 122.64 2.473 . . . . 0.76 110.769 169.803 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.2 mt -75.88 -23.47 55.6 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.596 -2.565 . . . . 1.05 112.976 174.916 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.4 t -71.53 -29.59 64.95 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.859 2.17 . . . . 1.19 116.859 178.709 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -58.61 -49.29 78.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 131.434 3.893 . . . . 1.9 110.991 174.236 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -80.44 164.16 23.26 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 125.664 2.65 . . . . 0.89 105.833 -177.961 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -90.92 58.18 3.72 Favored 'General case' 0 N--CA 1.43 -1.473 1 O-C-N 114.139 -5.351 . . . . 1.84 113.484 -175.877 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.4 mm -93.24 143.64 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.521 -1.218 . . . . 0.82 109.702 179.878 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -96.63 -102.65 0.17 Allowed 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.41 1.084 . . . . 2.16 108.846 -174.343 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -131.04 -73.85 0.54 Allowed 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 113.67 0.989 . . . . 2.12 113.67 -179.995 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -98.9 52.09 0.97 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.139 1.447 . . . . 1.71 111.418 177.352 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -83.46 149.3 26.73 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 128.407 2.683 . . . . 1.04 111.388 -169.561 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.7 m -101.56 122.94 44.77 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.532 -1.667 . . . . 0.79 111.79 -174.818 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.43 HD13 HD12 ' A' ' 3' ' ' ILE . 7.0 mp -111.0 156.43 21.26 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 103.749 -2.686 . . . . 1.4 103.749 176.705 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -125.1 129.38 50.08 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 125.656 2.645 . . . . 1.51 108.213 -172.29 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.3 tp -98.62 114.16 26.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.769 -2.457 . . . . 1.14 111.52 179.909 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.2 t -105.71 135.67 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 C-N-CA 127.48 2.312 . . . . 1.23 105.241 174.732 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.451 HD22 HG21 ' A' ' 36' ' ' ILE . 81.5 mt . . . . . 0 N--CA 1.431 -1.413 0 O-C-N 117.465 -3.272 . . . . 2.78 112.193 175.645 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 CA--C 1.49 -1.355 0 N-CA-C 112.965 0.728 . . . . 1.1 112.965 . . . . . . . . . 0 0 . 1 . 100 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.86 134.69 36.92 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 122.793 1.283 . . . . 1.87 108.836 174.576 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.6 pt -125.76 157.51 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 105.965 -1.865 . . . . 0.72 105.965 164.023 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.424 ' HB3' ' CG2' ' A' ' 12' ' ' THR . 55.9 m-85 -113.72 114.66 26.68 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 125.661 2.648 . . . . 1.4 109.969 -178.612 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.4 t -97.45 106.06 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 113.548 -1.66 . . . . 0.58 111.568 177.303 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.278 85.9 mttt -91.77 122.72 34.58 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 116.92 -3.612 . . . . 2.09 112.044 -177.261 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.1 p -89.81 168.42 12.09 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.036 -2.915 . . . . 0.99 111.641 -179.031 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.8 mt -75.16 -36.55 61.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.957 -2.965 . . . . 2.53 114.3 176.44 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -74.83 -22.98 58.39 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 127.392 2.277 . . . . 2.08 112.416 -177.91 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.46 54.68 0.33 Allowed Glycine 0 N--CA 1.43 -1.757 0 O-C-N 119.528 -1.983 . . . . 1.31 116.191 171.709 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -141.46 140.34 33.55 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.413 -2.227 . . . . 1.4 112.642 169.689 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.424 ' CG2' ' HB3' ' A' ' 4' ' ' PHE . 32.4 m -95.8 105.37 17.37 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 111.767 -2.469 . . . . 0.78 105.294 174.438 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 80.2 mt -89.51 123.2 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.776 -2.453 . . . . 1.55 106.281 -178.025 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -95.44 122.98 38.74 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.191 1.472 . . . . 1.08 110.574 177.095 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.269 62.3 mt -111.86 142.53 44.13 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 128.943 2.897 . . . . 1.55 113.327 -175.074 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -98.75 103.72 15.7 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.163 1.459 . . . . 1.95 108.085 169.426 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.6 172.03 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 117.823 -1.551 . . . . 0.96 111.699 176.354 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -123.2 157.47 60.95 Favored Pre-proline 0 N--CA 1.43 -1.465 0 O-C-N 119.122 -2.236 . . . . 2.35 108.81 165.58 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.75 -7.74 17.7 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 CA-C-N 127.068 3.56 . . . . 0.95 112.998 -171.175 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.5 m -78.58 -25.07 45.2 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 127.303 2.877 . . . . 1.45 108.628 176.91 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -70.3 163.37 26.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.906 2.765 . . . . 1.69 111.528 -175.129 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 38.3 p -98.22 165.04 12.07 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.912 -1.742 . . . . 0.75 109.553 -177.034 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.8 mm -66.59 -32.24 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 126.965 2.106 . . . . 0.73 114.26 172.163 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -52.81 -35.19 56.55 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 130.986 3.714 . . . . 1.62 113.113 163.347 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -80.92 -28.3 35.86 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.555 -1.966 . . . . 2.13 113.522 176.874 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.2 t -67.92 -51.27 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 104.217 -2.512 . . . . 0.62 104.217 178.982 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -64.44 -28.76 69.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 116.66 -3.775 . . . . 1.22 113.215 179.739 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.11 -29.19 66.08 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 121.187 1.812 . . . . 0.51 114.704 175.01 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.06 -30.58 63.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.441 -1.412 . . . . 1.44 114.371 172.313 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.2 mt -65.95 -36.89 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 118.559 -2.588 . . . . 1.32 113.897 167.283 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -58.16 -47.39 83.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.014 2.926 . . . . 1.7 111.457 172.782 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -60.29 -57.14 14.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 118.906 2.928 . . . . 1.55 118.906 165.827 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -66.51 -56.82 9.07 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 128.398 3.952 . . . . 2.62 116.046 -175.912 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -96.17 -44.65 7.19 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.788 -3.695 . . . . 1.48 114.715 -170.378 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.03 32.05 2.31 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 117.44 -1.755 . . . . 1.12 113.824 176.575 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.5 mm -108.55 143.81 28.27 Favored Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 101.824 -3.399 . . . . 1.55 101.824 -174.088 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -73.11 154.47 52.27 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 N-CA-C 116.239 1.592 . . . . 1.02 116.239 174.552 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -78.29 -28.49 4.61 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 CA-C-N 120.644 1.266 . . . . 1.25 112.379 -173.766 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -59.83 -35.29 74.42 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.426 1.891 . . . . 2.25 113.404 173.535 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -81.34 -33.85 32.19 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 116.507 -3.871 . . . . 2.02 111.257 179.349 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.297 71.8 mt-30 -74.66 130.95 40.45 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 116.424 -1.75 . . . . 0.69 111.855 -175.832 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -115.62 125.1 52.49 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 121.703 2.047 . . . . 2.78 110.94 163.47 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.4 mt -99.8 127.36 45.95 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.317 -2.114 . . . . 1.17 110.766 179.169 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.9 mt -118.78 134.08 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 126.981 2.112 . . . . 1.38 108.551 -178.435 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 67' ' ' LEU . 34.4 t80 -128.54 137.79 51.92 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.503 -2.406 . . . . 1.5 104.503 169.091 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 37.32 39.72 0.17 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 118.483 2.771 . . . . 1.21 118.483 -176.078 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.66 -18.0 32.28 Favored Glycine 0 N--CA 1.43 -1.713 0 N-CA-C 119.976 2.75 . . . . 1.3 119.976 -177.921 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -81.32 134.11 35.53 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.756 -2.026 . . . . 2.55 109.45 175.824 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -93.23 106.94 18.84 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 125.957 2.036 . . . . 2.48 108.848 179.182 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.4 mt -66.12 137.03 56.76 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 110.567 -3.015 . . . . 0.9 106.545 -168.542 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -84.36 159.87 20.77 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.645 2.641 . . . . 1.94 109.619 174.18 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -70.38 -55.77 8.28 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 116.383 -3.948 . . . . 1.56 114.086 -167.854 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.65 49.67 4.1 Favored Glycine 0 N--CA 1.431 -1.643 0 C-N-CA 126.348 1.928 . . . . 0.97 110.495 178.182 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 -124.47 158.74 32.12 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.773 -1.936 . . . . 2.49 105.773 164.357 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 21.7 p -89.47 163.02 15.43 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.996 1.48 . . . . 0.76 114.996 175.035 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.8 mt -66.6 -35.49 80.32 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.747 -3.095 . . . . 1.05 105.719 178.571 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 t -58.41 -34.33 70.65 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 118.367 2.729 . . . . 1.19 118.367 173.172 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -74.86 -37.41 62.21 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 113.48 -1.691 . . . . 1.9 110.286 -179.615 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -80.44 5.41 15.14 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.205 -1.56 . . . . 0.89 114.017 172.655 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.275 14.0 m-80 62.48 31.42 17.08 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.632 1.573 . . . . 1.84 113.047 179.755 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.9 mt -78.93 122.22 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 125.351 1.461 . . . . 0.82 112.32 179.904 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -96.06 177.23 5.81 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 110.402 -3.09 . . . . 2.16 114.958 -177.752 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -54.47 130.84 41.07 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 115.746 1.758 . . . . 2.12 115.746 171.229 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.361 77.5 mt-10 62.72 55.46 2.13 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.502 -1.999 . . . . 1.71 116.307 -178.046 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.3 m -104.02 151.46 23.2 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.127 2.394 . . . . 1.04 109.667 -175.173 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.0 m -102.84 113.65 27.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.085 -2.884 . . . . 0.79 105.394 177.946 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.443 HD23 ' CD1' ' A' ' 45' ' ' PHE . 31.9 mt -110.24 165.74 11.52 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 105.858 -1.904 . . . . 1.4 105.858 174.791 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -124.01 126.29 46.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.853 -1.78 . . . . 1.51 111.765 -173.732 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.0 tp -105.27 134.86 47.68 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 126.001 1.72 . . . . 1.14 111.759 -176.484 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.1 m -137.29 158.76 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 125.142 2.401 . . . . 1.23 105.007 176.131 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.1 mt . . . . . 0 N--CA 1.43 -1.452 0 O-C-N 117.906 -2.996 . . . . 2.78 115.828 -177.207 . . . . . . . . 0 0 . 1 . 101 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.6 ptt? . . . . . 0 CA--C 1.49 -1.33 0 CA-C-O 119.657 -0.211 . . . . 1.1 110.758 . . . . . . . . . 0 0 . 1 . 101 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -88.44 149.78 23.5 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 117.153 -1.403 . . . . 1.87 110.42 177.222 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.494 HD11 HG11 ' A' ' 17' ' ' VAL . 9.5 pt -140.12 144.6 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.971 -2.233 . . . . 0.72 104.971 175.131 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -103.81 139.17 39.39 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 112.629 -3.628 . . . . 1.4 109.519 177.877 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.492 HG22 ' HB2' ' A' ' 67' ' ' LEU . 12.6 t -113.25 109.67 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 117.983 -2.948 . . . . 0.58 109.526 167.41 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -91.04 137.94 31.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.504 -2.623 . . . . 2.09 111.179 -178.208 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.263 67.8 p -82.34 -175.41 5.68 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 124.787 2.232 . . . . 0.99 115.323 177.707 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.1 mt -50.31 -55.93 13.4 Favored 'General case' 0 N--CA 1.43 -1.461 2 O-C-N 114.521 -5.112 . . . . 2.53 109.426 166.044 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.253 20.4 p -72.19 -31.09 65.57 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.533 -2.604 . . . . 2.08 110.383 -175.834 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.74 25.05 1.62 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 110.773 -0.931 . . . . 1.31 110.773 172.291 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -76.53 117.64 18.38 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.041 -3.035 . . . . 1.4 109.328 -179.976 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m -74.39 90.08 2.14 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.017 2.817 . . . . 0.78 113.42 175.694 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mt -83.07 125.73 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 117.249 -3.407 . . . . 1.55 108.456 -179.718 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.3 m -101.33 128.27 47.57 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 119.487 -2.008 . . . . 1.08 113.854 177.55 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.448 HD21 HG13 ' A' ' 30' ' ' ILE . 9.3 mp -128.89 154.67 46.28 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 126.0 2.063 . . . . 1.55 105.557 -175.956 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -100.7 129.29 46.58 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.245 -1.761 . . . . 1.95 106.245 171.883 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.494 HG11 HD11 ' A' ' 3' ' ' ILE . 27.2 m -135.46 155.88 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 O-C-N 127.904 3.252 . . . . 0.96 107.566 179.821 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -106.33 153.67 40.27 Favored Pre-proline 0 N--CA 1.43 -1.474 0 N-CA-C 102.915 -2.995 . . . . 2.35 102.915 161.897 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -70.68 -12.11 30.66 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 115.255 -3.076 . . . . 0.95 116.683 -177.356 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.8 p -90.42 7.08 40.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 117.365 -1.303 . . . . 1.45 109.685 175.039 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -81.31 146.23 30.48 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.927 2.775 . . . . 1.69 109.855 174.189 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.52 159.49 18.61 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.737 -3.102 . . . . 0.75 111.833 -174.289 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.1 mm -59.07 -43.03 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 124.472 1.109 . . . . 0.73 113.067 175.336 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -39.91 -41.66 1.21 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.725 3.602 . . . . 1.62 120.725 161.084 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -79.38 -25.1 42.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 114.721 -2.561 . . . . 2.13 111.716 173.268 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -68.37 -45.92 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 122.856 2.571 . . . . 0.62 110.668 173.417 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -58.73 -38.37 78.24 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.435 1.642 . . . . 1.22 115.435 174.18 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.27 -37.77 72.89 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.301 -2.124 . . . . 0.51 114.598 173.671 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.8 mttm -60.98 -44.77 96.88 Favored 'General case' 0 N--CA 1.431 -1.392 1 C-N-CA 131.884 4.073 . . . . 1.44 111.325 175.463 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.448 HG13 HD21 ' A' ' 15' ' ' LEU . 93.7 mt -66.54 -44.8 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 126.641 3.115 . . . . 1.32 114.602 172.022 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -50.27 -44.41 53.69 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.158 -2.839 . . . . 1.7 114.977 166.899 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -60.61 -59.2 5.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 115.74 -2.076 . . . . 1.55 108.6 175.544 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -68.01 -47.21 69.09 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 116.607 2.077 . . . . 2.62 116.607 -172.917 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -99.7 -46.36 5.45 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.972 2.509 . . . . 1.48 109.902 -165.58 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.92 22.59 5.9 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 126.484 2.365 . . . . 1.12 114.532 175.014 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mt -97.46 119.82 62.05 Favored Pre-proline 0 N--CA 1.43 -1.44 0 C-N-CA 125.628 1.571 . . . . 1.55 114.355 -174.432 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.74 161.01 30.9 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 116.854 -1.631 . . . . 1.02 113.728 -173.672 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -62.81 -19.68 69.2 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 123.809 3.006 . . . . 1.25 118.546 -171.186 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -67.82 -27.77 67.0 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.078 2.151 . . . . 2.25 114.194 177.338 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -94.34 -38.4 11.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.742 2.017 . . . . 2.02 113.568 -173.062 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -102.17 135.94 42.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.582 2.611 . . . . 0.69 115.156 -170.566 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -121.8 143.53 49.34 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.08 -2.263 . . . . 2.78 111.147 170.813 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -110.62 130.84 55.47 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.21 2.433 . . . . 1.17 112.313 178.72 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.0 mm -109.34 138.66 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 110.581 -3.009 . . . . 1.38 106.537 178.828 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.477 ' HB3' HD21 ' A' ' 50' ' ' LEU . 48.2 t80 -120.77 107.0 12.22 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.995 2.918 . . . . 1.5 109.144 163.558 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.371 . . 69.29 -93.64 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.881 3.229 . . . . 1.21 113.685 179.987 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.61 8.62 6.17 Favored Glycine 0 N--CA 1.43 -1.746 0 O-C-N 116.959 -3.588 . . . . 1.3 111.693 -177.773 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -117.65 138.54 51.9 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 119.61 -2.112 . . . . 2.55 107.462 -177.796 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -76.77 111.16 11.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 112.609 -2.087 . . . . 2.48 113.073 164.812 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.477 HD21 ' HB3' ' A' ' 45' ' ' PHE . 36.5 mt -66.25 113.89 4.92 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 118.423 0.556 . . . . 0.9 111.565 -174.418 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -76.21 129.26 36.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 127.52 3.534 . . . . 1.94 113.03 176.462 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -43.9 -53.43 6.11 Favored 'General case' 0 N--CA 1.43 -1.433 2 N-CA-C 124.061 4.837 . . . . 1.56 124.061 -173.163 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.35 43.97 3.15 Favored Glycine 0 N--CA 1.429 -1.797 0 O-C-N 119.861 -1.774 . . . . 0.97 115.338 175.996 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.311 33.6 mmt180 -118.29 171.79 7.89 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.953 2.311 . . . . 2.49 112.07 159.655 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.7 p -93.37 174.14 7.36 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.497 -2.627 . . . . 0.76 117.748 163.682 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.8 mt -67.16 -33.89 76.39 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 130.231 3.412 . . . . 1.05 114.845 165.057 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 t -65.43 -35.28 80.44 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.86 2.864 . . . . 1.19 114.288 173.315 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -68.41 -44.33 75.26 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 117.673 -1.156 . . . . 1.9 109.899 177.293 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -82.59 3.45 28.66 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 116.196 -1.859 . . . . 0.89 113.311 176.732 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.5 t30 58.27 50.61 9.45 Favored 'General case' 0 N--CA 1.43 -1.434 1 CA-C-O 129.264 4.364 . . . . 1.84 114.564 174.85 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.251 24.6 mt -105.1 115.48 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 C-N-CA 131.87 4.068 . . . . 0.82 108.59 177.641 . . . . . . . . 3 2 . 1 . 101 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -93.46 172.68 8.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 130.798 3.639 . . . . 2.16 112.167 -176.507 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -72.04 144.83 48.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 115.546 -2.462 . . . . 2.12 114.175 169.897 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.384 54.3 mt-10 72.06 23.42 3.45 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.759 1.266 . . . . 1.71 114.153 177.275 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.281 17.4 m -88.75 153.46 21.07 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.02 -2.585 . . . . 1.04 104.02 -172.424 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.5 m -103.12 115.05 29.85 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 125.818 2.723 . . . . 0.79 106.788 -178.819 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.492 ' HB2' HG22 ' A' ' 5' ' ' VAL . 8.1 mp -103.38 164.63 11.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 103.027 -2.953 . . . . 1.4 103.027 174.11 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -131.2 138.02 49.21 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.532 -1.355 . . . . 1.51 111.918 177.981 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.1 tp -106.93 117.78 34.96 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 129.221 3.008 . . . . 1.14 108.195 -177.849 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.7 m -115.5 175.06 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 107.119 -1.437 . . . . 1.23 107.119 165.803 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 N--CA 1.431 -1.406 0 O-C-N 120.914 -1.116 . . . . 2.78 109.412 -174.197 . . . . . . . . 0 0 . 1 . 102 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.1 ttp . . . . . 0 CA--C 1.491 -1.318 1 CA-C-O 129.664 4.554 . . . . 1.1 110.065 . . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.271 20.5 tt0 -93.81 113.44 25.48 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 114.487 -5.133 . . . . 1.87 110.305 -176.17 . . . . . . . . 3 2 . 1 . 102 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.481 HG12 HG22 ' A' ' 17' ' ' VAL . 15.0 pt -119.93 168.18 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.735 1.731 . . . . 0.72 107.119 170.348 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -131.4 157.61 42.99 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 103.268 -2.864 . . . . 1.4 103.268 -178.838 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.6 t -133.12 128.34 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 101.818 -3.401 . . . . 0.58 101.818 -178.34 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -119.39 119.38 33.77 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 122.591 1.186 . . . . 2.09 108.549 178.98 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.402 HG22 HD23 ' A' ' 69' ' ' LEU . 46.9 p -77.5 174.98 10.26 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 121.654 3.946 . . . . 0.99 121.654 -174.74 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.6 mt -52.02 -52.25 52.04 Favored 'General case' 0 N--CA 1.43 -1.443 1 CA-C-O 129.104 4.288 . . . . 2.53 115.218 169.082 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -72.2 -25.15 61.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.172 -2.83 . . . . 2.08 115.469 -178.066 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.33 19.25 4.29 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 124.778 3.444 . . . . 1.31 111.386 169.303 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -89.57 143.02 27.14 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 104.801 -2.296 . . . . 1.4 104.801 -176.638 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -110.28 119.74 40.22 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.361 1.553 . . . . 0.78 109.942 173.119 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.2 mt -98.8 122.25 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 125.631 2.634 . . . . 1.55 109.812 176.033 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.3 m -91.3 121.69 33.27 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.483 -3.26 . . . . 1.08 108.621 -179.74 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mt -116.92 163.5 16.11 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.028 -1.842 . . . . 1.55 106.028 -173.527 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -121.44 104.57 9.78 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.334 1.453 . . . . 1.95 107.305 169.983 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.481 HG22 HG12 ' A' ' 3' ' ' ILE . 27.2 m -106.11 -174.13 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 103.912 -2.625 . . . . 0.96 103.912 179.528 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -138.2 155.24 74.32 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 103.004 -2.962 . . . . 2.35 103.004 165.709 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -62.25 -11.88 24.43 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 126.529 3.368 . . . . 0.95 117.382 -173.384 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.9 m -85.22 -0.14 53.69 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.874 1.67 . . . . 1.45 113.025 -175.564 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -84.23 144.04 29.19 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 126.095 2.122 . . . . 1.69 110.735 -179.588 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 67.4 p -83.71 164.1 19.84 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.02 -1.9 . . . . 0.75 110.339 178.159 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.2 mm -68.32 -35.33 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 O-C-N 120.025 -1.672 . . . . 0.73 110.699 -179.912 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -45.8 -49.31 15.25 Favored 'General case' 0 N--CA 1.43 -1.446 1 C-N-CA 133.446 4.699 . . . . 1.62 110.773 163.424 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -73.78 -41.65 62.11 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.153 -2.217 . . . . 2.13 110.746 -176.486 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.1 t -61.56 -37.19 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 116.713 2.116 . . . . 0.62 116.713 170.856 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -56.88 -36.58 70.26 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 118.127 2.64 . . . . 1.22 118.127 170.762 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.56 80.78 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 118.68 -2.512 . . . . 0.51 111.196 166.437 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -68.32 -29.65 68.45 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 115.04 -4.788 . . . . 1.44 115.59 170.323 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.307 56.7 mt -70.09 -30.24 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-O 123.672 1.701 . . . . 1.32 106.816 175.281 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -69.34 -37.52 77.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.245 -1.534 . . . . 1.7 109.173 179.257 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -67.89 -54.63 17.32 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 126.876 2.61 . . . . 1.55 108.735 174.984 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -69.18 -54.63 13.82 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 118.579 -2.576 . . . . 2.62 111.833 -169.652 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -93.26 -59.54 2.0 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.157 -2.214 . . . . 1.48 112.31 -169.978 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.64 45.93 0.37 Allowed Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 107.03 -2.428 . . . . 1.12 107.03 176.444 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.4 mt -118.56 134.61 23.47 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 103.245 -2.872 . . . . 1.55 103.245 -176.662 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 76.4 Cg_exo -75.12 152.05 39.73 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-O 114.939 -2.192 . . . . 1.02 116.354 -177.618 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 81.0 Cg_exo -71.94 -14.3 29.33 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 CA-C-N 121.685 1.638 . . . . 1.25 115.769 -172.938 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.393 2.6 p30 -67.41 -48.64 66.72 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.959 1.704 . . . . 2.25 108.393 172.567 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -68.85 -16.74 63.86 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 116.35 -1.786 . . . . 2.02 113.574 -177.242 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -88.2 110.47 20.73 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 123.366 1.555 . . . . 0.69 108.347 -178.073 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -101.19 112.55 25.07 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.28 -2.118 . . . . 2.78 105.28 170.48 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.5 mt -107.79 128.56 54.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.091 -2.88 . . . . 1.17 111.647 -178.203 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 mt -107.74 136.7 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 1 C-N-CA 135.187 5.395 . . . . 1.38 105.752 -177.892 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.329 73.3 t80 -149.22 114.62 5.54 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 127.753 2.421 . . . . 1.5 105.42 173.624 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.59 30.45 15.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.863 2.465 . . . . 1.21 116.615 -178.839 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.67 -9.08 53.04 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-O 114.689 -3.284 . . . . 1.3 112.266 -176.385 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -92.11 134.3 34.97 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 115.692 -2.403 . . . . 2.55 114.305 167.868 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -86.93 123.58 32.21 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 118.956 -2.34 . . . . 2.48 109.174 173.473 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.8 mt -78.8 154.85 29.57 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.115 -2.241 . . . . 0.9 111.759 -159.29 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -91.47 150.66 21.13 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.43 -2.044 . . . . 1.94 110.468 173.898 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -71.99 -41.14 67.98 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 121.667 2.031 . . . . 1.56 115.481 -173.086 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.66 45.31 3.42 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 121.726 3.45 . . . . 0.97 121.726 170.291 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 mmt-85 -122.78 143.99 49.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 128.207 3.86 . . . . 2.49 101.473 168.748 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.312 80.8 p -82.63 167.08 18.62 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.257 -4.027 . . . . 0.76 114.591 168.543 . . . . . . . . 4 3 . 1 . 102 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -57.58 -46.68 83.69 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 126.955 2.102 . . . . 1.05 108.956 172.496 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.255 10.6 t -56.4 -38.61 71.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 130.131 3.372 . . . . 1.19 114.805 178.22 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -63.78 -61.72 2.11 Favored 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.411 -4.556 . . . . 1.9 115.172 172.766 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -64.55 -4.05 3.7 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.707 -1.87 . . . . 0.89 116.009 170.924 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.276 73.9 m-80 66.36 39.31 4.06 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.977 -2.952 . . . . 1.84 112.65 -175.701 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.0 mt -87.05 103.17 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.558 -2.589 . . . . 0.82 104.396 175.266 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -100.15 -172.42 2.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.306 1.842 . . . . 2.16 110.093 -172.454 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -58.99 140.31 55.84 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 127.613 3.578 . . . . 2.12 112.271 177.369 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 65.51 36.8 6.41 Favored 'General case' 0 N--CA 1.43 -1.438 1 C-N-CA 132.124 4.169 . . . . 1.71 112.089 175.75 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 m -88.22 159.64 18.06 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 114.473 -2.679 . . . . 1.04 111.435 -170.969 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.5 m -111.32 113.49 26.0 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 123.921 3.055 . . . . 0.79 108.645 172.887 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.3 mt -88.66 134.48 33.88 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 115.638 -2.425 . . . . 1.4 107.314 167.013 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -101.1 112.84 25.41 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.293 -3.38 . . . . 1.51 108.446 -171.952 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.402 HD23 HG22 ' A' ' 7' ' ' THR . 46.4 tp -92.69 117.87 30.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.894 3.277 . . . . 1.14 119.564 -173.75 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.89 124.65 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 102.384 -3.191 . . . . 1.23 102.384 172.941 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.7 tp . . . . . 0 N--CA 1.429 -1.48 0 O-C-N 116.882 -3.636 . . . . 2.78 109.012 171.51 . . . . . . . . 0 0 . 1 . 103 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 ptt? . . . . . 0 CA--C 1.491 -1.313 0 N-CA-C 119.601 3.185 . . . . 1.1 119.601 . . . . . . . . . 0 0 . 1 . 103 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -95.98 139.14 32.6 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.096 -2.253 . . . . 1.87 106.889 -174.616 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.0 pt -143.03 150.35 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 122.541 2.428 . . . . 0.72 109.983 169.654 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -108.77 134.02 52.04 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.4 -1.333 . . . . 1.4 107.4 -172.08 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -120.43 122.66 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 116.08 1.882 . . . . 0.58 116.08 166.553 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -94.33 130.1 40.76 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.978 2.511 . . . . 2.09 113.365 -176.013 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.6 p -97.14 153.28 18.07 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.958 -3.589 . . . . 0.99 107.853 -178.57 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.6 mt -61.91 -23.44 66.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 130.978 3.711 . . . . 2.53 112.841 174.095 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.8 p -77.78 -52.4 8.99 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 120.001 1.273 . . . . 2.08 113.754 178.872 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.05 11.51 0.03 OUTLIER Glycine 0 N--CA 1.429 -1.785 0 O-C-N 120.633 -1.292 . . . . 1.31 114.802 169.921 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -107.29 147.83 29.75 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 117.456 -3.379 . . . . 1.4 114.707 -173.276 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.7 m -112.69 116.96 30.96 Favored 'General case' 0 N--CA 1.43 -1.469 1 O-C-N 115.453 -4.529 . . . . 0.78 108.573 173.383 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mt -86.22 128.36 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 128.983 2.913 . . . . 1.55 105.93 -179.279 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.8 m -99.91 99.91 10.76 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.327 -3.358 . . . . 1.08 107.859 174.739 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.9 mt -97.09 145.39 26.03 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 115.973 -4.204 . . . . 1.55 109.721 177.219 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -97.2 132.14 43.26 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 125.32 2.486 . . . . 1.95 114.351 159.407 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -135.48 168.75 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 113.896 -1.502 . . . . 0.96 108.181 -176.148 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -116.08 152.27 47.55 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-O 116.147 -1.882 . . . . 2.35 106.539 166.914 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -76.33 -3.89 14.38 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-N 126.691 3.425 . . . . 0.95 112.999 -172.938 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -88.78 0.34 56.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 123.895 0.878 . . . . 1.45 111.988 173.525 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -82.07 147.33 29.17 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 125.042 1.337 . . . . 1.69 110.921 178.26 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 68.0 p -87.04 160.64 18.54 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.452 1.901 . . . . 0.75 112.349 -179.161 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.0 mm -75.99 -18.66 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 124.888 2.28 . . . . 0.73 114.441 -178.029 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.33 -44.58 94.5 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.37 -3.956 . . . . 1.62 111.298 158.407 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.307 18.3 m120 -50.82 -53.58 30.9 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 123.007 2.639 . . . . 2.13 114.18 169.054 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.501 HG21 HD21 ' A' ' 56' ' ' LEU 0.293 2.4 t -50.46 -43.89 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 119.272 3.064 . . . . 0.62 119.272 171.758 . . . . . . . . 3 3 . 1 . 103 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -74.54 -14.57 60.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.909 3.718 . . . . 1.22 114.515 174.245 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.262 . . -74.16 -34.35 63.8 Favored 'General case' 0 N--CA 1.431 -1.405 1 O-C-N 115.05 -4.781 . . . . 0.51 112.898 169.885 . . . . . . . . 3 2 . 1 . 103 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -64.09 -34.12 77.31 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.223 -1.353 . . . . 1.44 111.937 176.06 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.466 HD13 HD22 ' A' ' 69' ' ' LEU 0.46 36.5 mt -68.86 -38.47 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.877 1.799 . . . . 1.32 110.584 177.158 . . . . . . . . 3 3 . 1 . 103 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -64.81 -40.77 95.76 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.898 -2.376 . . . . 1.7 108.696 178.001 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -60.24 -40.85 91.68 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.684 1.735 . . . . 1.55 115.684 171.715 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -76.42 -67.68 0.67 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.886 -1.134 . . . . 2.62 112.748 -176.909 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -95.95 -45.1 7.07 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 116.645 -1.645 . . . . 1.48 111.027 -172.52 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.09 43.68 0.99 Allowed Glycine 0 N--CA 1.429 -1.78 0 CA-C-O 124.677 2.265 . . . . 1.12 117.237 174.852 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 mt -108.59 134.99 20.08 Favored Pre-proline 0 N--CA 1.43 -1.434 1 CA-C-O 111.536 -4.078 . . . . 1.55 102.736 -177.663 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -63.18 153.86 71.32 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 N-CA-C 120.024 3.048 . . . . 1.02 120.024 174.715 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -73.7 -24.75 15.44 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 CA-C-N 126.677 3.42 . . . . 1.25 113.014 -176.83 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.342 10.2 p-10 -65.86 -32.34 73.8 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 121.986 2.176 . . . . 2.25 111.951 170.528 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -73.84 -24.62 59.79 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.813 -2.429 . . . . 2.02 114.354 -179.174 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -92.11 145.59 24.39 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.929 -2.982 . . . . 0.69 110.225 -173.417 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.4 mtm180 -126.81 135.05 50.5 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 117.282 -1.342 . . . . 2.78 110.843 168.836 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.7 mt -103.42 124.99 49.75 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 123.715 2.962 . . . . 1.17 109.122 177.007 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.7 mm -114.88 120.48 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 104.749 -2.315 . . . . 1.38 104.749 177.908 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.457 ' HB3' HD21 ' A' ' 50' ' ' LEU . 35.7 t80 -130.02 136.28 49.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 129.277 3.031 . . . . 1.5 108.843 169.007 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.306 . . 54.6 31.58 15.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.278 1.584 . . . . 1.21 115.278 175.466 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.48 -20.82 6.83 Favored Glycine 0 N--CA 1.429 -1.805 0 O-C-N 119.176 -2.203 . . . . 1.3 115.438 -174.849 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.0 mttt -85.6 136.68 33.29 Favored 'General case' 0 N--CA 1.43 -1.468 2 C-N-CA 133.535 4.734 . . . . 2.55 110.802 -179.211 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -86.57 128.56 34.99 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.095 -1.866 . . . . 2.48 111.345 168.941 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' A' ' 45' ' ' PHE . 17.4 mt -83.76 127.24 33.66 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 104.927 -2.249 . . . . 0.9 104.927 -176.224 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -82.91 137.8 34.1 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.799 -3.063 . . . . 1.94 114.325 175.116 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -37.74 -72.8 0.05 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 131.087 3.755 . . . . 1.56 117.976 -177.676 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.86 51.79 4.6 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 120.696 3.038 . . . . 0.97 120.696 176.566 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.268 10.7 mmt180 -131.34 156.32 45.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.569 -3.313 . . . . 2.49 107.324 172.121 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.253 24.7 p -80.84 169.98 16.87 Favored 'General case' 0 N--CA 1.43 -1.442 2 O-C-N 114.123 -5.361 . . . . 0.76 116.647 176.733 . . . . . . . . 4 3 . 1 . 103 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.501 HD21 HG21 ' A' ' 26' ' ' VAL . 6.8 mt -63.87 -49.47 72.61 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.596 1.958 . . . . 1.05 109.186 171.663 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 t -57.29 -40.33 77.57 Favored 'General case' 0 N--CA 1.432 -1.363 0 O-C-N 118.774 -2.454 . . . . 1.19 111.632 177.137 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.4 -29.97 17.59 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 116.414 2.005 . . . . 1.9 116.414 167.876 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -99.95 7.86 44.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.069 -2.269 . . . . 0.89 115.373 171.846 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.294 7.7 m120 52.17 57.77 6.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 126.576 2.422 . . . . 1.84 117.433 -171.144 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mt -96.57 131.08 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 120.045 -1.659 . . . . 0.82 110.635 -177.876 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -97.68 -171.78 2.25 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 127.023 2.129 . . . . 2.16 114.339 -169.189 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -81.98 143.48 31.57 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.25 -1.531 . . . . 2.12 114.622 175.349 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.254 32.3 mt-10 65.43 21.32 11.86 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.426 2.01 . . . . 1.71 116.426 178.461 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.4 t -85.2 150.22 24.96 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 125.682 1.593 . . . . 1.04 112.741 -174.427 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.311 8.8 m -106.07 115.63 30.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 121.599 1.999 . . . . 0.79 113.648 -176.771 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 mt -101.36 164.15 11.92 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.105 -2.554 . . . . 1.4 104.105 173.759 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.293 74.1 m80 -123.73 135.54 53.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.833 -3.042 . . . . 1.51 107.392 178.431 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.466 HD22 HD13 ' A' ' 30' ' ' ILE . 36.4 tp -97.5 132.41 43.21 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 112.293 -2.231 . . . . 1.14 111.323 178.381 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.9 m -143.65 161.26 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 103.707 -2.701 . . . . 1.23 103.707 176.659 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.43 -1.463 0 CA-C-O 125.713 2.673 . . . . 2.78 112.846 -174.402 . . . . . . . . 0 0 . 1 . 104 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 CA--C 1.491 -1.324 0 CA-C-O 117.582 -1.199 . . . . 1.1 111.118 . . . . . . . . . 0 0 . 1 . 104 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -103.51 143.29 32.92 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 120.119 1.327 . . . . 1.87 110.979 179.837 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.9 pt -131.31 168.46 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 116.635 -1.65 . . . . 0.72 109.28 176.657 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -122.17 137.81 54.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 120.927 1.694 . . . . 1.4 113.163 177.283 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.407 HG22 ' HB2' ' A' ' 67' ' ' LEU . 4.3 t -122.22 131.3 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-O 125.842 2.734 . . . . 0.58 118.172 165.706 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -89.21 123.25 33.27 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 112.152 -2.294 . . . . 2.09 108.676 177.932 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.0 p -80.05 177.18 9.12 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.444 1.592 . . . . 0.99 112.758 169.455 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.0 mt -66.0 -46.31 78.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.299 -2.75 . . . . 2.53 113.909 176.165 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -65.04 -68.57 0.35 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.08 1.352 . . . . 2.08 108.488 179.379 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.67 -6.24 0.03 OUTLIER Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 117.454 1.742 . . . . 1.31 117.454 -176.203 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -71.62 141.73 49.96 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.304 -1.704 . . . . 1.4 114.664 -175.573 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.3 m -108.27 104.57 13.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 127.915 3.722 . . . . 0.78 111.183 172.435 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -88.59 115.57 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 1 O-C-N 115.874 -4.266 . . . . 1.55 109.743 179.248 . . . . . . . . 4 4 . 1 . 104 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.5 m -91.48 119.22 31.25 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.124 -2.176 . . . . 1.08 105.124 177.719 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 mt -115.42 139.51 49.96 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 125.102 2.382 . . . . 1.55 110.592 -171.378 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -87.97 120.75 29.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.201 -2.187 . . . . 1.95 108.038 174.852 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.9 177.02 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 125.741 1.901 . . . . 0.96 114.095 179.397 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -129.14 148.0 67.26 Favored Pre-proline 0 N--CA 1.43 -1.465 3 CA-C-O 108.292 -5.623 . . . . 2.35 110.668 166.82 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -61.35 -24.39 78.55 Favored 'Trans proline' 0 N--CA 1.434 -2.004 1 CA-C-N 128.843 4.194 . . . . 0.95 115.22 -174.216 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.4 p -69.75 -10.78 59.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.837 2.455 . . . . 1.45 116.072 177.045 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.305 36.4 m-20 -78.75 147.55 33.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 128.044 3.783 . . . . 1.69 108.576 -178.878 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 p -82.82 165.79 19.53 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 114.514 -2.66 . . . . 0.75 115.913 174.55 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.2 mm -66.08 -20.03 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-N 122.071 2.214 . . . . 0.73 111.18 178.289 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -64.68 -39.38 93.58 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 117.522 2.416 . . . . 1.62 117.522 169.51 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -72.74 -33.05 66.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.416 3.008 . . . . 2.13 108.665 179.591 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.6 t -69.09 -48.28 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 112.289 -2.232 . . . . 0.62 112.844 176.86 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.502 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 52.6 mtmt -55.84 -30.82 62.06 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 119.558 3.17 . . . . 1.22 119.558 160.052 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -31.96 72.76 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 124.312 3.233 . . . . 0.51 113.132 172.419 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -70.12 -29.13 66.0 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.544 -3.222 . . . . 1.44 113.342 172.562 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.9 mt -73.09 -39.17 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 120.017 -1.677 . . . . 1.32 112.544 176.255 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -58.21 -35.38 71.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 114.435 -2.698 . . . . 1.7 109.425 171.854 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -66.3 -50.66 62.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 123.355 2.798 . . . . 1.55 117.176 170.797 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -59.75 -61.01 2.94 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 116.949 -3.595 . . . . 2.62 111.616 -172.333 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -101.47 -44.9 5.47 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.449 -1.705 . . . . 1.48 108.893 -168.795 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.01 57.05 1.17 Allowed Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 118.502 -1.808 . . . . 1.12 111.383 178.821 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.0 mt -122.49 125.13 26.57 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 112.381 -3.675 . . . . 1.55 104.637 -177.58 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -57.64 138.42 86.04 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 CA-C-N 129.358 4.378 . . . . 1.02 116.708 177.276 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -54.39 -27.67 50.0 Favored 'Trans proline' 0 C--N 1.299 -2.076 1 C-N-CA 127.208 5.272 . . . . 1.25 117.414 -178.329 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -69.89 -39.41 76.26 Favored 'General case' 0 N--CA 1.431 -1.422 1 CA-C-O 111.334 -4.174 . . . . 2.25 110.086 171.663 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -61.65 -31.33 71.43 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 124.176 3.171 . . . . 2.02 114.326 177.701 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.502 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 63.0 mt-30 -78.13 135.27 37.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 120.354 3.464 . . . . 0.69 120.354 -177.447 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -135.05 146.98 49.48 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 102.512 -3.144 . . . . 2.78 102.512 173.23 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.5 mt -113.0 137.05 52.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.76 -2.462 . . . . 1.17 110.173 179.17 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.7 mm -117.47 133.9 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 124.994 2.33 . . . . 1.38 108.209 -178.551 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.444 ' HB3' HD21 ' A' ' 50' ' ' LEU . 7.7 t80 -147.47 138.02 23.32 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.29 -3.381 . . . . 1.5 112.338 169.787 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.76 43.27 30.33 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.412 3.085 . . . . 1.21 115.166 -178.525 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.55 -23.66 15.2 Favored Glycine 0 N--CA 1.429 -1.781 0 O-C-N 118.06 -2.9 . . . . 1.3 116.801 -176.373 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -119.03 166.81 12.42 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.056 -3.026 . . . . 2.55 112.841 -171.791 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.345 33.3 tt0 -98.78 153.41 18.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.126 -0.943 . . . . 2.48 112.435 178.192 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 45' ' ' PHE . 8.1 mt -110.56 126.58 54.57 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.675 1.59 . . . . 0.9 110.353 -173.302 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.493 ' HB2' ' HG3' ' A' ' 54' ' ' ARG . 28.2 mt-10 -73.73 141.63 46.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.19 2.596 . . . . 1.94 113.725 -178.1 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -46.98 -54.44 10.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 118.476 2.769 . . . . 1.56 118.476 -177.254 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.94 5.76 61.25 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 127.265 2.853 . . . . 0.97 120.088 172.893 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.493 ' HG3' ' HB2' ' A' ' 51' ' ' GLU . 6.3 mtt180 -87.92 154.33 20.6 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 120.092 1.946 . . . . 2.49 106.54 171.903 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.0 p -97.79 162.09 13.43 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.094 1.902 . . . . 0.76 115.79 172.038 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.38 -20.2 65.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.901 -2.999 . . . . 1.05 114.15 174.748 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.0 p -80.28 -31.86 38.26 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.541 3.137 . . . . 1.19 110.805 178.856 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.68 -46.22 39.26 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 112.834 -3.46 . . . . 1.9 111.799 175.483 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -76.52 -18.82 58.51 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 127.117 2.76 . . . . 0.89 110.654 178.095 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.7 t30 65.96 53.88 1.07 Allowed 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 127.073 2.149 . . . . 1.84 109.599 -176.264 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 mt -84.39 106.67 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 101.192 -3.633 . . . . 0.82 101.192 172.186 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -89.26 -174.43 4.4 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 122.248 2.295 . . . . 2.16 112.017 -178.713 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -60.53 137.55 58.15 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 123.638 1.685 . . . . 2.12 114.35 174.584 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 74.42 26.75 1.49 Allowed 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 131.492 3.917 . . . . 1.71 114.476 169.627 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.89 151.93 20.31 Favored 'General case' 0 N--CA 1.429 -1.491 1 C-N-CA 131.892 4.077 . . . . 1.04 105.613 -177.22 . . . . . . . . 3 3 . 1 . 104 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.4 m -107.3 126.25 52.21 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.57 -1.956 . . . . 0.79 112.411 178.364 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.407 ' HB2' HG22 ' A' ' 5' ' ' VAL . 66.4 mt -100.07 151.9 20.85 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 126.259 2.933 . . . . 1.4 106.532 169.561 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -113.35 116.58 29.92 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 116.035 -4.166 . . . . 1.51 112.584 179.083 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.7 tp -92.58 125.93 37.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.314 2.959 . . . . 1.14 107.826 -176.906 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.7 t -118.81 147.97 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 C-N-CA 127.216 2.206 . . . . 1.23 106.255 176.64 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.9 mt . . . . . 0 N--CA 1.429 -1.494 0 O-C-N 117.797 -3.064 . . . . 2.78 114.205 175.404 . . . . . . . . 0 0 . 1 . 105 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 ptt? . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 117.633 -1.175 . . . . 1.1 113.744 . . . . . . . . . 0 0 . 1 . 105 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -90.03 140.3 29.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 123.054 2.661 . . . . 1.87 112.907 175.357 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.2 pt -130.72 161.97 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 108.066 -1.087 . . . . 0.72 108.066 166.062 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -119.62 130.13 54.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.315 3.046 . . . . 1.4 111.245 172.656 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.0 t -109.56 121.4 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 111.677 -2.511 . . . . 0.58 108.554 172.954 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -97.24 123.36 41.0 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 117.784 -3.073 . . . . 2.09 112.595 174.637 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.6 p -78.78 174.53 11.36 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.148 3.356 . . . . 0.99 115.214 170.062 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.12 -43.18 74.93 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 116.416 -3.927 . . . . 2.53 115.935 178.412 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 p -73.36 -41.22 63.69 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.119 2.568 . . . . 2.08 110.957 -177.334 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.57 8.18 0.42 Allowed Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 115.514 -3.231 . . . . 1.31 116.178 170.766 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.23 133.96 35.91 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 104.583 -2.377 . . . . 1.4 104.583 -176.137 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.6 m -98.73 123.39 42.92 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.301 -1.5 . . . . 0.78 107.156 171.274 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -100.59 95.41 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 124.437 2.065 . . . . 1.55 109.871 175.676 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.4 m -76.53 115.42 16.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 105.256 -2.127 . . . . 1.08 105.256 177.923 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.5 mt -120.24 171.69 8.32 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.001 2.12 . . . . 1.55 112.215 -176.712 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -127.61 132.39 49.79 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 105.304 -2.11 . . . . 1.95 105.304 169.505 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.8 m -140.25 169.49 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 128.286 2.634 . . . . 0.96 108.549 -178.471 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -104.81 159.93 27.69 Favored Pre-proline 0 N--CA 1.43 -1.433 0 O-C-N 119.269 -2.144 . . . . 2.35 108.774 162.897 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -70.23 -19.06 34.37 Favored 'Trans proline' 0 N--CA 1.434 -2.01 1 O-C-N 112.146 -4.713 . . . . 0.95 106.999 -174.911 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -91.57 9.01 33.91 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.474 2.398 . . . . 1.45 117.474 -176.481 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -85.66 150.19 24.79 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 113.082 0.771 . . . . 1.69 113.082 173.098 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.8 p -78.35 160.14 27.99 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 123.395 1.569 . . . . 0.75 113.176 173.559 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -60.59 -33.86 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 126.615 1.966 . . . . 0.73 109.92 169.884 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.303 3.4 tt0 -47.03 -46.56 22.16 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.526 2.047 . . . . 1.62 116.526 158.766 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -75.53 -35.73 60.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 116.83 2.159 . . . . 2.13 116.83 -178.021 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.4 t -57.92 -47.18 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 111.683 -2.508 . . . . 0.62 111.374 173.417 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.286 37.6 mtmt -57.91 -29.83 65.42 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 121.692 3.96 . . . . 1.22 121.692 170.628 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.38 -33.06 62.95 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.892 -2.38 . . . . 0.51 112.872 169.645 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -61.5 -17.17 53.43 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.706 1.602 . . . . 1.44 113.735 167.677 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.9 mt -98.61 -36.15 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 125.636 2.636 . . . . 1.32 108.945 178.777 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.307 24.7 tt0 -45.18 -50.01 11.74 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 117.815 -3.053 . . . . 1.7 113.825 173.752 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.397 0.6 OUTLIER -62.01 -26.4 68.21 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.92 2.933 . . . . 1.55 118.92 174.879 . . . . . . . . 3 3 . 1 . 105 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -86.17 -78.7 0.27 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.182 2.593 . . . . 2.62 109.212 -178.61 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -89.21 -12.36 41.04 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 119.03 2.974 . . . . 1.48 119.03 -172.529 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.66 24.08 26.71 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 120.92 -1.112 . . . . 1.12 115.419 172.962 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.4 mt -104.28 133.88 19.98 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-O 112.594 -3.574 . . . . 1.55 107.765 -169.549 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 41.2 Cg_endo -77.51 158.95 32.49 Favored 'Trans proline' 0 N--CA 1.434 -1.974 0 CA-C-N 125.037 2.835 . . . . 1.02 115.397 -179.377 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 14.7 Cg_exo -61.92 -26.73 79.21 Favored 'Trans proline' 0 C--N 1.299 -2.03 1 C-N-CA 127.002 5.135 . . . . 1.25 117.358 -178.329 . . . . . . . . 3 3 . 1 . 105 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.342 0.2 OUTLIER -61.02 -51.2 70.2 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 130.275 3.43 . . . . 2.25 110.259 179.303 . . . . . . . . 3 3 . 1 . 105 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -74.71 -43.65 54.01 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.597 -1.26 . . . . 2.02 107.597 178.284 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -60.21 137.8 58.05 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 116.792 2.145 . . . . 0.69 116.792 -174.35 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -138.17 128.68 26.37 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 125.875 1.67 . . . . 2.78 109.955 175.351 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.261 85.2 mt -95.64 135.67 37.03 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.648 1.69 . . . . 1.17 110.488 174.608 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.251 37.2 mm -123.17 120.23 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 109.565 -3.47 . . . . 1.38 106.501 173.748 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -134.62 131.81 38.26 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.615 2.626 . . . . 1.5 108.886 171.127 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.58 45.52 24.17 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.405 2.743 . . . . 1.21 118.405 179.848 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.54 -45.98 1.99 Allowed Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 120.574 -0.822 . . . . 1.3 114.895 179.456 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -82.73 149.04 27.51 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.083 2.553 . . . . 2.55 116.252 179.372 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -81.27 125.71 30.66 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 129.041 2.936 . . . . 2.48 107.988 172.464 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 mt -88.09 146.53 25.39 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.74 1.257 . . . . 0.9 109.702 -173.437 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -98.07 146.54 25.44 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 126.087 2.851 . . . . 1.94 107.41 177.207 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.7 -61.49 2.57 Favored 'General case' 0 N--CA 1.43 -1.473 1 C-N-CA 133.675 4.79 . . . . 1.56 117.042 -168.753 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.41 12.63 1.8 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 120.088 2.795 . . . . 0.97 120.088 172.985 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -106.15 159.35 16.15 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.702 1.715 . . . . 2.49 113.274 178.06 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -95.48 162.98 13.42 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.878 -4.264 . . . . 0.76 110.945 -179.639 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.3 mt -64.28 -43.21 95.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.957 3.303 . . . . 1.05 108.242 178.538 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 p -60.8 -34.23 74.2 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 114.479 1.288 . . . . 1.19 114.479 -179.992 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -64.09 -37.24 86.72 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 129.774 3.23 . . . . 1.9 113.807 173.04 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -92.9 7.82 42.29 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.947 -2.971 . . . . 0.89 110.97 177.639 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.2 m120 55.5 39.15 31.02 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 130.917 3.687 . . . . 1.84 114.459 -175.897 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.427 HG21 HD21 ' A' ' 67' ' ' LEU . 33.2 mt -82.56 115.99 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 103.999 -2.593 . . . . 0.82 103.999 179.064 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -100.99 -179.94 4.19 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.917 2.294 . . . . 2.16 110.54 -176.655 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.284 32.7 pttt -54.41 137.07 43.14 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.674 -3.141 . . . . 2.12 119.085 169.232 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.292 59.3 mt-10 71.31 24.28 3.79 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.061 1.744 . . . . 1.71 113.748 171.919 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.7 p -91.23 159.32 16.11 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.256 2.622 . . . . 1.04 115.431 -174.827 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.1 m -105.97 100.32 9.87 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.201 3.0 . . . . 0.79 114.321 176.952 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.427 HD21 HG21 ' A' ' 61' ' ' ILE . 3.9 mp -97.9 146.84 25.05 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 103.31 -2.848 . . . . 1.4 103.31 170.893 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -109.31 145.65 35.64 Favored 'General case' 0 CA--C 1.489 -1.37 0 CA-C-O 114.498 -2.668 . . . . 1.51 110.299 -179.009 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.2 tp -111.7 119.88 40.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 127.347 2.904 . . . . 1.14 110.592 -173.582 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 m -113.31 151.58 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 118.968 -2.332 . . . . 1.23 111.326 172.959 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.2 mt . . . . . 0 N--CA 1.43 -1.463 0 C-N-CA 116.966 -1.894 . . . . 2.78 108.846 -179.624 . . . . . . . . 0 0 . 1 . 106 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.37 15.3 ptt? . . . . . 0 CA--C 1.489 -1.382 0 N-CA-C 115.006 1.484 . . . . 1.1 115.006 . . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -97.74 130.07 44.73 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 117.168 -1.813 . . . . 1.87 111.79 179.799 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.2 pt -121.15 169.06 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 103.247 -2.872 . . . . 0.72 103.247 175.953 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -128.4 126.39 40.53 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.691 -1.226 . . . . 1.4 107.691 -171.442 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.42 HG23 HD23 ' A' ' 15' ' ' LEU . 76.0 t -107.91 121.96 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 114.494 -1.23 . . . . 0.58 108.406 172.462 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -99.04 126.88 44.86 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.313 1.445 . . . . 2.09 108.902 175.903 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 p -69.69 -178.63 1.53 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.643 2.09 . . . . 0.99 116.643 175.024 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.7 tp -74.73 -38.55 62.25 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.943 -1.098 . . . . 2.53 112.126 173.529 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.2 p -79.33 -53.25 7.11 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.987 2.588 . . . . 2.08 117.987 176.697 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.99 7.89 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.778 0 CA-C-N 125.772 3.897 . . . . 1.31 115.096 179.988 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -99.77 139.6 35.19 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 115.198 -2.601 . . . . 1.4 113.695 -175.603 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.4 m -103.28 128.19 50.39 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 116.53 -2.068 . . . . 0.78 105.534 174.787 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.4 mt -116.32 123.98 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.661 2.784 . . . . 1.55 111.265 -177.72 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.8 m -96.64 126.41 41.79 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 105.847 -1.908 . . . . 1.08 105.847 -174.891 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.42 HD23 HG23 ' A' ' 5' ' ' VAL . 1.9 mm? -121.35 120.31 34.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.399 2.28 . . . . 1.55 111.222 -178.056 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -82.48 111.65 18.69 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.114 1.765 . . . . 1.95 108.16 172.667 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.263 23.8 m -134.97 -178.43 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 O-C-N 120.163 -1.586 . . . . 0.96 107.25 177.579 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -117.31 174.68 2.38 Favored Pre-proline 0 N--CA 1.43 -1.451 0 O-C-N 117.237 -3.414 . . . . 2.35 108.304 163.817 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -77.56 -19.04 13.28 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 117.377 -1.96 . . . . 0.95 113.215 -175.124 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.333 4.5 m -82.94 3.95 27.79 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 122.755 2.525 . . . . 1.45 115.387 176.816 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.269 2.8 m-20 -72.59 153.74 41.12 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 115.917 1.821 . . . . 1.69 115.917 172.114 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.5 p -89.85 153.86 20.32 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 117.481 -3.262 . . . . 0.75 111.424 -179.61 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.5 mm -47.63 -49.01 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 118.832 -2.417 . . . . 0.73 116.497 172.354 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -45.31 -35.71 3.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 117.101 2.26 . . . . 1.62 117.101 167.828 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -65.48 -32.42 74.01 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 122.02 2.191 . . . . 2.13 114.515 174.836 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.9 t -75.75 -40.19 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 120.112 -1.618 . . . . 0.62 109.772 -174.93 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -59.37 -32.07 69.8 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 113.251 -1.795 . . . . 1.22 114.957 167.556 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.17 84.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 114.98 -2.438 . . . . 0.51 112.905 171.748 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -70.2 -22.16 62.96 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 127.635 3.084 . . . . 1.44 115.023 -179.648 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.1 mm -79.38 -35.66 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 127.262 2.225 . . . . 1.32 109.513 175.446 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.35 8.7 tt0 -58.39 -48.78 79.54 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 126.539 2.399 . . . . 1.7 113.459 172.867 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -54.05 -53.04 58.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 111.647 -2.524 . . . . 1.55 113.145 168.949 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -87.53 -49.21 7.34 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.488 -3.258 . . . . 2.62 114.102 -167.522 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -96.36 -44.45 7.22 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 113.472 -1.695 . . . . 1.48 113.832 -172.202 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.74 -28.28 3.98 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 117.226 1.65 . . . . 1.12 117.226 169.56 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.494 HD12 ' H ' ' A' ' 36' ' ' ILE . 2.8 mp -57.45 138.17 81.43 Favored Pre-proline 0 N--CA 1.429 -1.496 0 N-CA-C 115.754 1.761 . . . . 1.55 115.754 -174.57 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -59.92 134.39 56.49 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 C-N-CA 123.872 3.048 . . . . 1.02 114.445 174.772 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -73.95 -16.75 22.93 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-O 112.004 -3.415 . . . . 1.25 112.74 -169.72 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.03 -38.33 90.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.596 2.617 . . . . 2.25 111.616 171.584 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -78.4 -18.29 55.23 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.765 -2.459 . . . . 2.02 114.739 178.521 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -88.66 138.64 31.24 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.781 2.229 . . . . 0.69 116.09 177.766 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -121.77 158.04 29.68 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.908 -3.62 . . . . 2.78 110.976 165.408 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.276 12.8 mt -119.26 125.16 48.47 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 126.285 1.834 . . . . 1.17 111.387 179.324 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.1 mt -113.08 136.88 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 106.932 -1.507 . . . . 1.38 106.932 -174.149 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -142.04 129.59 21.4 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.588 -1.32 . . . . 1.5 111.106 173.214 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.43 18.3 6.72 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 130.322 3.449 . . . . 1.21 116.334 -179.288 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.54 -3.76 57.89 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 126.561 2.029 . . . . 1.3 115.049 -175.624 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -108.0 133.3 52.51 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 126.421 3.01 . . . . 2.55 113.785 177.215 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -77.41 127.62 32.85 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.251 -4.031 . . . . 2.48 104.735 172.564 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.5 mt -89.61 147.33 23.98 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.283 -2.136 . . . . 0.9 116.73 -173.927 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -82.83 132.87 35.15 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.366 2.031 . . . . 1.94 112.572 171.435 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -60.9 -51.45 69.23 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 111.008 -2.814 . . . . 1.56 115.213 -172.671 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.19 46.95 3.62 Favored Glycine 0 N--CA 1.43 -1.747 0 CA-C-O 118.347 -1.252 . . . . 0.97 114.293 173.726 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -128.21 155.6 44.26 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.085 2.154 . . . . 2.49 113.152 168.8 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.342 70.1 p -82.04 164.01 21.7 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 121.692 2.042 . . . . 0.76 111.116 173.951 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mt -70.41 -26.98 63.93 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 111.302 -2.681 . . . . 1.05 111.698 170.314 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.254 23.2 t -65.74 -46.28 79.45 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 115.572 -2.156 . . . . 1.19 111.681 171.515 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -52.27 -28.36 18.56 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 117.999 2.592 . . . . 1.9 117.999 176.397 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -93.39 -11.46 32.19 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 117.593 -3.192 . . . . 0.89 111.31 -179.693 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.1 m120 67.23 50.5 0.98 Allowed 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 128.728 2.811 . . . . 1.84 113.308 -175.087 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.8 mt -95.46 110.54 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 1 CA-C-O 128.857 4.17 . . . . 0.82 107.674 177.366 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -89.84 -173.15 3.8 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 114.081 -5.387 . . . . 2.16 112.563 -179.589 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -61.73 166.48 4.3 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.118 -2.239 . . . . 2.12 111.329 175.1 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 49.79 28.82 2.9 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 118.471 2.767 . . . . 1.71 118.471 172.703 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.9 p -90.88 147.33 23.23 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.074 2.55 . . . . 1.04 113.054 -174.848 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.9 m -107.98 98.6 8.15 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 115.305 1.594 . . . . 0.79 115.305 -179.205 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.297 2.7 mp -84.01 156.22 22.38 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 129.176 2.99 . . . . 1.4 107.945 175.123 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -126.05 120.23 29.69 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 118.281 -1.368 . . . . 1.51 109.873 -176.614 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.9 tp -84.58 130.81 34.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.903 -2.373 . . . . 1.14 107.636 -179.879 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.5 m -125.04 140.47 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 126.388 2.994 . . . . 1.23 113.066 166.065 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.335 4.9 mt . . . . . 0 N--CA 1.43 -1.446 0 O-C-N 118.023 -2.923 . . . . 2.78 112.553 176.919 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptt? . . . . . 0 CA--C 1.491 -1.319 0 CA-C-O 117.99 -1.005 . . . . 1.1 111.215 . . . . . . . . . 0 0 . 1 . 107 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -115.42 135.05 54.51 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 127.476 2.985 . . . . 1.87 109.275 175.997 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt -117.25 163.54 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 106.832 -1.544 . . . . 0.72 106.832 171.25 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -109.53 136.08 49.49 Favored 'General case' 0 N--CA 1.431 -1.409 1 C-N-CA 132.429 4.292 . . . . 1.4 109.703 174.998 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.9 t -130.01 123.46 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 O-C-N 118.099 -2.876 . . . . 0.58 104.861 178.769 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -98.03 139.49 33.77 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.299 -3.376 . . . . 2.09 112.391 176.531 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.323 32.7 p -82.59 -171.67 3.62 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.831 -1.168 . . . . 0.99 111.676 176.319 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 71' ' ' LEU . 83.9 mt -61.71 -47.77 83.78 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.389 -1.444 . . . . 2.53 112.544 172.14 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.3 p -81.02 -22.84 39.06 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.969 -1.707 . . . . 2.08 109.1 -178.672 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.93 23.89 4.46 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 118.969 2.347 . . . . 1.31 118.969 172.375 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -77.73 134.4 38.1 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 120.054 1.927 . . . . 1.4 108.276 179.039 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.9 m -91.66 110.75 22.08 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.409 -2.057 . . . . 0.78 109.31 -173.272 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mt -100.86 125.91 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 125.742 1.617 . . . . 1.55 106.723 178.153 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.0 m -103.79 121.42 42.99 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.781 2.032 . . . . 1.08 108.207 179.613 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.5 mt -120.45 125.01 46.85 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.774 -2.454 . . . . 1.55 117.268 -178.621 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -70.69 117.56 12.36 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 124.774 1.296 . . . . 1.95 110.235 170.461 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.0 m -142.84 171.97 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 126.2 2.905 . . . . 0.96 109.064 178.231 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -118.58 158.62 46.7 Favored Pre-proline 0 N--CA 1.43 -1.428 1 O-C-N 114.087 -5.383 . . . . 2.35 106.484 163.509 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.08 -14.1 26.06 Favored 'Trans proline' 0 C--N 1.299 -2.048 1 C-N-CA 125.581 4.188 . . . . 0.95 110.235 -171.379 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 m -90.25 8.21 34.33 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 122.125 2.239 . . . . 1.45 110.24 177.773 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.35 147.03 28.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.593 -2.567 . . . . 1.69 110.285 171.388 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 47.0 p -86.71 161.35 18.47 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.663 -1.606 . . . . 0.75 106.663 -177.395 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 23' ' ' ILE 0.3 26.1 mm -64.98 -29.32 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 O-C-N 116.205 -4.06 . . . . 0.73 110.991 -178.374 . . . . . . . . 4 3 . 1 . 107 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -52.98 -47.49 68.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 129.009 2.924 . . . . 1.62 111.773 167.963 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.258 26.3 t30 -71.31 -32.85 69.1 Favored 'General case' 0 N--CA 1.431 -1.41 1 O-C-N 116.229 -4.044 . . . . 2.13 112.997 177.789 . . . . . . . . 3 2 . 1 . 107 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.0 t -63.15 -45.09 99.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 1 O-C-N 113.509 -5.744 . . . . 0.62 113.931 174.482 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.5 mttt -60.37 -38.71 84.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 128.006 3.316 . . . . 1.22 117.267 167.859 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.51 -41.6 85.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 123.901 1.81 . . . . 0.51 113.335 172.442 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -68.33 -29.46 68.21 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.545 -3.222 . . . . 1.44 117.156 171.107 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.8 mt -71.98 -43.92 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-N 120.898 1.681 . . . . 1.32 110.602 172.487 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -49.34 -45.84 46.13 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.575 2.35 . . . . 1.7 115.375 170.951 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -51.58 -46.53 63.53 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.751 2.215 . . . . 1.55 115.023 175.342 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 tttp -85.03 -57.73 2.98 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.681 -3.137 . . . . 2.62 113.008 -174.767 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -89.12 -46.81 8.54 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 129.824 3.25 . . . . 1.48 114.636 -168.274 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.88 27.08 3.35 Favored Glycine 0 N--CA 1.429 -1.798 1 O-C-N 114.637 -5.04 . . . . 1.12 110.455 169.981 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.0 mt -104.97 124.24 37.31 Favored Pre-proline 0 N--CA 1.429 -1.484 0 CA-C-O 113.883 -2.96 . . . . 1.55 107.087 -178.256 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -64.39 164.51 22.95 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 CA-C-N 127.969 3.882 . . . . 1.02 118.413 174.677 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -65.33 -26.65 55.91 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 123.815 3.01 . . . . 1.25 118.593 -176.847 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -55.96 -43.34 77.44 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 127.344 2.902 . . . . 2.25 113.062 173.774 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -85.38 -1.51 57.09 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 113.147 -1.842 . . . . 2.02 114.321 -170.317 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -107.6 103.62 12.97 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.146 1.378 . . . . 0.69 112.451 -171.946 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.257 72.6 mtt180 -96.39 116.74 29.53 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.286 -2.759 . . . . 2.78 107.849 167.74 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.1 mt -99.46 126.86 45.46 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.583 -3.198 . . . . 1.17 105.089 177.559 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -114.31 143.36 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 125.298 2.475 . . . . 1.38 107.966 176.481 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.515 ' C ' ' H ' ' A' ' 47' ' ' GLY . 34.9 t80 -141.2 127.37 19.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.346 -3.971 . . . . 1.5 108.888 171.964 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 75.93 -27.39 0.18 Allowed 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 127.953 2.501 . . . . 1.21 109.624 174.155 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 143.48 -13.02 2.25 Favored Glycine 0 N--CA 1.431 -1.694 0 CA-C-O 125.162 2.535 . . . . 1.3 113.55 -175.887 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -86.22 137.1 32.89 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 111.806 -2.197 . . . . 2.55 109.473 178.781 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -77.59 109.66 11.75 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.796 3.638 . . . . 2.48 110.508 169.092 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.8 mt -68.46 130.97 44.44 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 114.858 1.429 . . . . 0.9 114.858 -177.393 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -89.8 144.52 25.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.654 1.582 . . . . 1.94 113.285 177.891 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -60.87 -54.87 39.81 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.718 -3.114 . . . . 1.56 115.862 -171.933 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.42 28.86 0.85 Allowed Glycine 0 N--CA 1.43 -1.763 1 N-CA-C 123.754 4.262 . . . . 0.97 123.754 171.357 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -127.87 160.01 33.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.548 -1.56 . . . . 2.49 112.139 173.01 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.26 44.2 p -89.15 167.07 13.41 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.356 1.551 . . . . 0.76 109.974 -177.703 . . . . . . . . 3 3 . 1 . 107 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mt -64.81 -34.73 79.06 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 113.892 -1.503 . . . . 1.05 109.854 169.938 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.9 t -61.16 -41.81 97.43 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 122.598 1.189 . . . . 1.19 109.613 179.397 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -55.23 -41.87 72.63 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.569 -2.582 . . . . 1.9 117.56 176.309 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -84.9 -6.69 59.34 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 117.75 2.5 . . . . 0.89 117.75 -179.441 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.318 35.9 m120 68.62 50.57 0.67 Allowed 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 119.399 1.0 . . . . 1.84 111.999 -176.204 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.6 mt -103.44 108.73 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 121.704 0.764 . . . . 0.82 111.451 172.838 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -93.78 -175.8 3.85 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.297 2.639 . . . . 2.16 107.627 177.886 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -68.59 149.35 49.28 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 125.932 2.777 . . . . 2.12 113.747 171.275 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.429 75.3 mt-10 64.97 22.39 12.44 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 109.99 -3.277 . . . . 1.71 115.375 174.687 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.5 m -92.23 156.42 17.31 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.776 -3.077 . . . . 1.04 110.812 -176.883 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.2 m -106.89 110.19 22.28 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 126.521 2.388 . . . . 0.79 108.211 -173.005 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -93.22 141.33 28.54 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.59 1.556 . . . . 1.4 106.869 172.31 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -101.9 117.99 35.99 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.015 -2.928 . . . . 1.51 106.773 -177.902 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.8 tp -93.1 121.4 34.42 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.697 -2.502 . . . . 1.14 111.163 173.868 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.1 t -111.36 140.77 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 O-C-N 117.8 -3.062 . . . . 1.23 108.084 177.561 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.413 ' HB3' HD11 ' A' ' 8' ' ' LEU . 10.5 tp . . . . . 0 N--CA 1.43 -1.474 0 N-CA-C 116.39 1.996 . . . . 2.78 116.39 174.567 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ptt? . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 106.733 -1.58 . . . . 1.1 106.733 . . . . . . . . . 0 0 . 1 . 108 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.1 pm0 -107.15 131.6 53.96 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 114.28 1.215 . . . . 1.87 114.28 -178.863 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 pt -121.32 152.7 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 105.867 -1.901 . . . . 0.72 105.867 169.67 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.252 75.0 m-85 -113.89 135.34 54.08 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.035 -1.439 . . . . 1.4 108.88 -176.58 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.0 t -118.07 107.47 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 123.191 1.472 . . . . 0.58 111.405 178.709 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -89.02 138.23 31.59 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 118.239 -2.788 . . . . 2.09 118.278 174.686 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.329 27.8 p -94.81 154.35 17.3 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 110.725 -2.943 . . . . 0.99 110.013 178.309 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.282 43.1 mt -65.6 -41.64 92.57 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 131.012 3.725 . . . . 2.53 107.611 178.367 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 p -67.57 -46.17 73.45 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.138 1.375 . . . . 2.08 114.001 -176.7 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.05 50.57 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 125.406 1.479 . . . . 1.31 114.953 166.417 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -127.87 137.94 52.51 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.505 2.574 . . . . 1.4 107.652 -179.798 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.0 m -103.07 110.89 22.99 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 120.192 -1.567 . . . . 0.78 111.634 167.492 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.9 mm -97.54 112.72 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 104.545 -2.391 . . . . 1.55 104.545 -179.475 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.7 m -87.58 104.0 16.09 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.795 -1.191 . . . . 1.08 110.067 176.922 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.422 HD11 HG12 ' A' ' 30' ' ' ILE . 24.0 mt -101.54 134.76 44.16 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 105.598 -2.001 . . . . 1.55 105.598 -170.646 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -81.72 99.37 8.9 Favored 'General case' 0 N--CA 1.429 -1.492 1 O-C-N 116.116 -4.115 . . . . 1.95 116.395 165.233 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.5 m -109.22 -177.66 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.457 1 O-C-N 116.295 -4.003 . . . . 0.96 109.964 -179.693 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -124.11 158.5 60.42 Favored Pre-proline 0 N--CA 1.431 -1.417 0 CA-C-O 114.885 -2.483 . . . . 2.35 105.823 161.55 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -79.03 -6.82 15.18 Favored 'Trans proline' 0 N--CA 1.434 -2.019 1 CA-C-N 129.825 4.544 . . . . 0.95 111.894 -173.347 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.275 1.0 OUTLIER -82.79 2.2 35.22 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 116.448 2.018 . . . . 1.45 116.448 172.01 . . . . . . . . 3 3 . 1 . 108 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -78.02 134.63 37.76 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 116.566 2.062 . . . . 1.69 116.566 172.552 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.7 p -73.63 157.93 35.71 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.139 2.4 . . . . 0.75 110.134 174.569 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.266 35.4 mm -68.64 -37.31 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 112.392 -2.186 . . . . 0.73 110.075 -177.545 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -44.67 -46.53 10.3 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 128.329 2.652 . . . . 1.62 112.463 162.762 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -74.51 -38.63 62.79 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.748 2.69 . . . . 2.13 117.015 -179.679 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.7 t -65.11 -37.86 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 O-C-N 115.188 -4.695 . . . . 0.62 110.196 175.2 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -60.89 -29.72 69.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.838 -2.414 . . . . 1.22 115.334 172.34 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.48 -32.86 66.56 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.097 1.359 . . . . 0.51 112.162 174.325 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.28 0.4 OUTLIER -64.82 -32.95 74.89 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 130.371 3.469 . . . . 1.44 112.822 171.724 . . . . . . . . 3 3 . 1 . 108 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.422 HG12 HD11 ' A' ' 15' ' ' LEU . 15.3 mt -70.82 -41.15 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.579 2.351 . . . . 1.32 108.761 167.495 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.369 13.6 tt0 -57.83 -45.5 86.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 127.754 3.645 . . . . 1.7 117.259 170.065 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -52.45 -56.88 12.05 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.41 -3.306 . . . . 1.55 116.004 170.772 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -78.17 -51.12 10.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.92 -2.362 . . . . 2.62 113.074 -177.992 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -93.91 -62.19 1.4 Allowed 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.982 -2.949 . . . . 1.48 110.386 -170.973 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.15 53.68 0.35 Allowed Glycine 0 N--CA 1.431 -1.663 1 O-C-N 114.13 -5.356 . . . . 1.12 114.829 -179.489 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.9 mt -123.11 127.97 25.48 Favored Pre-proline 0 N--CA 1.43 -1.432 1 N-CA-C 99.661 -4.2 . . . . 1.55 99.661 -177.172 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.02 135.18 39.73 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 C-N-CA 123.022 2.482 . . . . 1.02 112.022 -179.319 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -46.47 -21.51 1.33 Allowed 'Trans proline' 0 N--CA 1.434 -1.999 1 C-N-CA 128.968 6.445 . . . . 1.25 121.96 179.612 . . . . . . . . 3 3 . 1 . 108 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -72.87 -50.41 24.06 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.881 2.472 . . . . 2.25 110.334 177.416 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -77.66 -7.22 56.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.551 3.072 . . . . 2.02 108.51 -172.977 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -91.72 124.02 35.55 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.387 -3.321 . . . . 0.69 113.424 -178.705 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -121.18 147.93 44.92 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.565 2.126 . . . . 2.78 105.467 169.008 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.262 29.5 mt -127.07 133.95 50.36 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 117.912 -1.515 . . . . 1.17 107.013 178.587 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.5 mt -106.39 147.98 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 127.948 3.28 . . . . 1.38 107.569 171.57 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -128.59 107.3 9.59 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.416 -2.068 . . . . 1.5 105.416 177.164 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.43 -42.13 0.49 Allowed 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 132.225 4.21 . . . . 1.21 113.216 177.38 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -172.23 -25.44 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 127.747 2.594 . . . . 1.3 109.435 -176.811 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -104.43 147.77 27.18 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.278 1.539 . . . . 2.55 113.48 -175.489 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -81.59 140.63 34.35 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.012 -1.449 . . . . 2.48 113.232 172.266 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.5 mt -98.44 144.76 27.45 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.378 1.561 . . . . 0.9 113.482 -177.883 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -99.04 144.82 27.75 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.601 -2.562 . . . . 1.94 108.277 170.501 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.92 -43.93 94.45 Favored 'General case' 0 CA--C 1.489 -1.391 1 C-N-CA 137.864 6.465 . . . . 1.56 114.513 -167.668 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.31 22.87 13.54 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 129.14 3.257 . . . . 0.97 111.847 168.605 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -98.57 168.34 10.23 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.812 2.244 . . . . 2.49 109.25 161.234 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.3 p -102.68 173.09 6.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.586 -2.571 . . . . 0.76 111.27 170.741 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.321 16.7 mt -76.68 -31.51 57.31 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.442 -2.036 . . . . 1.05 106.579 176.951 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 t -64.05 -41.77 97.27 Favored 'General case' 0 CA--C 1.489 -1.39 0 C-N-CA 124.796 1.238 . . . . 1.19 111.093 179.703 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -56.14 -41.01 74.7 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.843 2.164 . . . . 1.9 116.843 174.552 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -87.67 7.36 30.35 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.004 2.122 . . . . 0.89 112.781 179.456 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.277 35.0 m120 56.67 40.49 29.23 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.721 -2.487 . . . . 1.84 115.455 -179.855 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.2 mt -79.03 108.18 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 124.082 1.896 . . . . 0.82 112.116 171.916 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -95.01 -175.27 3.48 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.927 -1.733 . . . . 2.16 113.009 179.131 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -69.02 146.36 52.76 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 115.858 -2.02 . . . . 2.12 114.901 170.774 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 69.57 42.94 1.06 Allowed 'General case' 0 N--CA 1.431 -1.409 1 CA-C-O 130.943 5.163 . . . . 1.71 108.193 177.372 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.256 37.9 m -107.11 129.48 54.82 Favored 'General case' 0 N--CA 1.431 -1.411 1 O-C-N 113.693 -5.629 . . . . 1.04 115.809 176.943 . . . . . . . . 3 2 . 1 . 108 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.3 m -88.33 126.12 35.03 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 125.686 1.866 . . . . 0.79 111.815 177.53 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -112.57 151.7 29.75 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.67 2.788 . . . . 1.4 108.271 173.607 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -110.26 113.45 26.13 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.224 1.935 . . . . 1.51 116.224 -174.967 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.3 tp -82.21 112.97 19.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.203 -2.811 . . . . 1.14 113.39 -178.64 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.39 112.56 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 125.04 2.352 . . . . 1.23 112.593 179.408 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.7 tp . . . . . 0 N--CA 1.43 -1.426 0 O-C-N 118.935 -2.353 . . . . 2.78 107.644 -175.301 . . . . . . . . 0 0 . 1 . 109 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.324 0 N-CA-C 107.442 -1.318 . . . . 1.1 107.442 . . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -99.16 144.45 28.28 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.288 1.994 . . . . 1.87 108.857 -173.913 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 pt -118.7 145.52 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 120.201 -1.562 . . . . 0.72 110.818 169.946 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -100.86 104.13 15.34 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.714 -0.676 . . . . 1.4 110.965 -179.567 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.8 t -88.29 117.62 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.446 -2.034 . . . . 0.58 107.299 174.651 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -101.88 145.12 29.66 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 125.288 1.618 . . . . 2.09 107.264 -179.529 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -103.9 -166.54 1.26 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.582 2.134 . . . . 0.99 112.186 178.532 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.5 tp -61.14 -51.29 69.68 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.539 -4.476 . . . . 2.53 114.15 176.233 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 p -72.24 -24.69 61.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.443 -3.286 . . . . 2.08 110.458 178.523 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.25 38.1 2.73 Favored Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 115.043 -3.087 . . . . 1.31 112.167 179.261 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -95.67 130.06 42.67 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 121.492 2.646 . . . . 1.4 110.956 -178.74 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.1 m -80.0 120.74 24.6 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.091 2.956 . . . . 0.78 112.786 178.972 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mt -107.8 118.1 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 101.786 -3.413 . . . . 1.55 101.786 171.523 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.6 m -102.0 113.33 26.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 123.723 2.965 . . . . 1.08 107.462 -172.23 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.8 mt -108.58 137.05 47.17 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.231 -0.918 . . . . 1.55 110.924 177.543 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -80.94 112.86 18.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.872 1.269 . . . . 1.95 110.635 165.516 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -121.48 171.86 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 116.648 2.092 . . . . 0.96 116.648 174.866 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -106.14 158.05 33.44 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 104.115 -2.55 . . . . 2.35 104.115 164.712 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -82.51 4.61 6.95 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 O-C-N 114.656 -3.391 . . . . 0.95 109.095 179.926 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.6 p -92.66 -13.61 29.25 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.329 1.452 . . . . 1.45 114.561 175.661 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -66.67 135.88 54.72 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 126.109 2.861 . . . . 1.69 109.041 -179.416 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.263 23.8 p -68.96 158.33 34.91 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 116.451 -3.906 . . . . 0.75 113.534 177.881 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.401 7.9 mm -55.85 -41.77 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 124.623 2.154 . . . . 0.73 116.416 171.953 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -56.53 -39.65 73.72 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 119.546 3.165 . . . . 1.62 119.546 167.933 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -29.21 64.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.552 2.056 . . . . 2.13 116.552 172.321 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.44 -37.09 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 130.373 3.469 . . . . 0.62 109.635 168.732 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -81.44 -18.74 44.29 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 122.538 1.161 . . . . 1.22 109.793 -179.427 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.38 -17.34 58.28 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.651 -1.906 . . . . 0.51 111.532 168.242 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -83.64 -30.61 26.74 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 119.831 -1.793 . . . . 1.44 111.522 173.22 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.258 13.6 mt -73.01 -26.56 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 117.167 -3.458 . . . . 1.32 113.213 171.561 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -70.65 -51.36 28.46 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.492 3.517 . . . . 1.7 109.446 174.305 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -50.28 -45.16 54.22 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.608 2.763 . . . . 1.55 117.005 165.708 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -81.59 -60.15 2.36 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 113.869 1.063 . . . . 2.62 113.869 -179.646 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -95.13 -48.35 5.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.041 1.497 . . . . 1.48 115.041 -171.396 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.07 -2.0 6.25 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-O 124.222 2.012 . . . . 1.12 114.614 169.922 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.7 mt -74.03 117.61 62.76 Favored Pre-proline 0 N--CA 1.431 -1.409 0 C-N-CA 127.899 2.48 . . . . 1.55 105.039 -174.732 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -69.14 166.88 25.29 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 CA-C-O 111.815 -3.494 . . . . 1.02 117.074 178.03 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -66.19 -32.72 41.98 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 N-CA-C 120.133 3.09 . . . . 1.25 120.133 -174.64 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.379 38.0 m-20 -47.95 -36.63 12.83 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.974 2.109 . . . . 2.25 113.173 169.102 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -98.59 -4.74 33.35 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.964 -0.46 . . . . 2.02 111.802 -172.172 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -97.58 126.17 42.73 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.459 -2.025 . . . . 0.69 110.839 -179.685 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -106.83 116.82 32.59 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.08 2.152 . . . . 2.78 108.826 168.691 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.5 mt -104.84 115.73 30.79 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.8 -1.188 . . . . 1.17 112.037 -179.086 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.9 mm -110.65 126.17 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 127.129 2.172 . . . . 1.38 116.589 -179.779 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -127.92 104.0 7.56 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 104.792 -2.299 . . . . 1.5 104.792 174.97 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.284 . . 61.88 -117.03 0.62 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 110.641 -2.982 . . . . 1.21 110.976 -179.655 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.08 -27.12 29.28 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 119.876 -1.765 . . . . 1.3 110.634 -168.513 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -96.28 139.55 32.26 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 126.86 2.153 . . . . 2.55 115.36 -179.224 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -90.46 127.73 36.3 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 111.919 -2.4 . . . . 2.48 105.836 173.408 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.4 mt -83.85 117.17 23.13 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.363 -1.461 . . . . 0.9 112.445 -171.424 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -68.7 139.7 55.4 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 119.936 3.31 . . . . 1.94 119.936 172.381 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.52 -59.43 4.84 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 118.566 2.802 . . . . 1.56 118.566 -174.611 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.76 60.19 4.83 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-N 113.118 -1.855 . . . . 0.97 114.805 172.362 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -136.8 178.48 7.04 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.418 2.532 . . . . 2.49 106.038 164.521 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.6 p -110.38 176.6 4.98 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 116.604 -3.81 . . . . 0.76 106.961 170.241 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.6 mt -75.2 -33.92 61.46 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.32 -2.737 . . . . 1.05 109.024 177.302 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.6 t -56.01 -44.24 78.47 Favored 'General case' 0 N--CA 1.43 -1.436 1 C-N-CA 134.34 5.056 . . . . 1.19 109.685 176.84 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.251 33.6 m-20 -57.27 -39.79 76.36 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.542 -3.849 . . . . 1.9 118.25 175.653 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -96.67 -2.25 45.02 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 127.469 2.308 . . . . 0.89 112.76 179.476 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.9 m120 58.21 42.53 21.84 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.916 2.886 . . . . 1.84 118.713 -179.165 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.1 mt -94.36 114.38 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 119.439 -2.038 . . . . 0.82 108.596 -179.695 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -101.13 -172.77 2.23 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.742 2.417 . . . . 2.16 112.776 -179.85 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -45.56 151.55 0.39 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.492 -3.88 . . . . 2.12 120.577 174.056 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 50.96 34.93 11.45 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.694 1.368 . . . . 1.71 114.694 174.548 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.0 m -91.84 137.38 32.41 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.697 -1.592 . . . . 1.04 109.294 -176.257 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.2 m -86.7 111.45 20.69 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 124.981 1.425 . . . . 0.79 110.831 177.003 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -92.13 163.97 13.75 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 117.461 -3.274 . . . . 1.4 107.428 171.405 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -128.95 116.28 19.13 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 124.232 1.968 . . . . 1.51 110.031 179.93 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.7 tp -82.36 110.26 17.35 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.677 3.214 . . . . 1.14 119.677 174.548 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.6 t -113.19 142.8 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.686 -1.227 . . . . 1.23 107.686 -178.919 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.9 tp . . . . . 0 N--CA 1.429 -1.48 0 CA-C-N 122.919 2.6 . . . . 2.78 108.851 178.37 . . . . . . . . 0 0 . 1 . 110 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 114.307 1.225 . . . . 1.1 114.307 . . . . . . . . . 0 0 . 1 . 110 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -93.31 130.16 39.16 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.646 -2.534 . . . . 1.87 112.898 -175.967 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.5 pt -129.85 149.64 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 128.561 3.663 . . . . 0.72 110.614 176.149 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -109.0 130.69 55.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 113.052 -1.886 . . . . 1.4 107.854 -176.106 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.48 130.58 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 103.076 -2.935 . . . . 0.58 103.076 173.589 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -110.24 146.13 36.14 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 116.21 -4.056 . . . . 2.09 115.691 174.137 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.482 HG22 HD23 ' A' ' 69' ' ' LEU 0.251 2.9 p -104.34 171.63 7.23 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 119.727 1.149 . . . . 0.99 108.4 173.704 . . . . . . . . 3 3 . 1 . 110 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.9 mt -73.41 -40.26 64.42 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 117.242 -3.411 . . . . 2.53 114.962 174.592 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.0 p -80.72 -37.29 30.86 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.62 2.452 . . . . 2.08 117.62 -175.549 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.57 -55.14 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 116.252 -2.88 . . . . 1.31 119.801 174.973 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -54.18 129.62 35.52 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 121.102 3.742 . . . . 1.4 121.102 -178.311 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.7 m -112.6 115.23 28.27 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 104.498 -2.408 . . . . 0.78 104.498 168.261 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mt -95.03 129.06 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 107.474 -1.306 . . . . 1.55 107.474 -173.005 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.9 m -89.23 111.09 21.8 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.879 2.276 . . . . 1.08 106.634 172.832 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.8 mt -111.44 141.48 44.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 117.408 2.373 . . . . 1.55 117.408 174.527 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -103.37 115.94 31.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 130.64 3.576 . . . . 1.95 109.283 168.251 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.0 m -131.45 155.89 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.223 1.809 . . . . 0.96 112.994 -176.938 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -97.02 142.58 24.75 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-O 112.675 -3.536 . . . . 2.35 117.07 164.356 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' A' ' 56' ' ' LEU 0.267 18.8 Cg_endo -70.7 -24.68 25.11 Favored 'Trans proline' 0 C--N 1.299 -2.055 2 C-N-CA 127.502 5.468 . . . . 0.95 111.705 -170.373 . . . . . . . . 4 3 . 1 . 110 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.329 25.5 m -84.56 8.13 17.73 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 114.216 1.191 . . . . 1.45 114.216 173.916 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -78.13 149.0 33.89 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.992 2.517 . . . . 1.69 104.859 174.637 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.2 p -74.36 163.83 27.33 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.516 2.413 . . . . 0.75 117.516 169.907 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.2 mm -66.26 -36.22 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 121.673 2.033 . . . . 0.73 110.264 171.027 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -52.27 -43.55 64.47 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.391 -2.693 . . . . 1.62 116.709 171.839 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -57.44 -46.49 83.54 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.323 -2.11 . . . . 2.13 113.006 171.765 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.63 -39.23 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 120.408 1.458 . . . . 0.62 113.18 177.106 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.03 -33.0 74.75 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.113 1.153 . . . . 1.22 114.113 173.295 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.25 -27.8 66.66 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.476 1.11 . . . . 0.51 112.548 175.001 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -81.61 -26.34 34.95 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.699 -2.5 . . . . 1.44 109.221 176.913 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.4 mt -75.02 -30.44 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 122.213 2.278 . . . . 1.32 109.485 174.918 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -57.13 -48.81 77.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 130.17 3.388 . . . . 1.7 108.74 169.44 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.29 4.4 t70 -52.29 -58.63 6.05 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.015 1.726 . . . . 1.55 111.478 171.227 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -75.93 -62.47 1.58 Allowed 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 116.02 -4.175 . . . . 2.62 113.296 -172.553 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -96.37 -20.27 18.59 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 116.513 2.042 . . . . 1.48 116.513 -170.221 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.68 20.73 21.07 Favored Glycine 0 N--CA 1.429 -1.803 0 CA-C-O 125.24 2.578 . . . . 1.12 114.736 169.91 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.95 127.46 36.96 Favored Pre-proline 0 N--CA 1.43 -1.445 1 O-C-N 115.801 -4.353 . . . . 1.55 107.707 -174.385 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 52.7 Cg_exo -64.61 147.76 90.21 Favored 'Trans proline' 0 C--N 1.3 -2.016 1 CA-C-N 129.276 4.349 . . . . 1.02 115.017 -178.966 . . . . . . . . 3 3 . 1 . 110 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.1 Cg_exo -62.07 -12.43 26.38 Favored 'Trans proline' 0 N--CA 1.433 -2.049 0 C-N-CA 124.386 3.391 . . . . 1.25 111.672 -178.778 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -73.68 -30.4 62.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 124.629 3.377 . . . . 2.25 115.253 172.382 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -78.66 -32.49 47.2 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 119.181 -2.2 . . . . 2.02 115.498 -176.47 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -71.2 124.52 24.68 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 124.499 1.124 . . . . 0.69 111.326 -172.129 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -120.93 109.78 15.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 114.785 -1.098 . . . . 2.78 109.82 167.537 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.8 mt -90.3 124.43 34.89 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 106.224 -1.769 . . . . 1.17 106.224 -175.997 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.0 mm -102.6 121.1 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 129.685 3.194 . . . . 1.38 113.582 172.107 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -136.49 136.13 39.16 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.902 -1.749 . . . . 1.5 108.773 171.756 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.12 27.01 7.12 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 120.101 3.371 . . . . 1.21 120.101 -178.963 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.73 5.53 84.0 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 119.025 -1.56 . . . . 1.3 116.713 -175.05 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -114.48 143.03 45.6 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.246 1.819 . . . . 2.55 113.818 -178.609 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -97.45 116.18 29.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.674 -1.232 . . . . 2.48 107.674 176.898 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.49 120.91 25.1 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.679 -2.513 . . . . 0.9 108.498 -164.491 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -66.69 157.61 32.2 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 113.849 1.055 . . . . 1.94 113.849 173.659 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -69.72 -55.53 9.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 114.398 1.258 . . . . 1.56 114.398 -176.305 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.27 46.8 2.81 Favored Glycine 0 N--CA 1.43 -1.766 0 CA-C-N 120.202 1.365 . . . . 0.97 115.075 173.538 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -112.88 156.39 23.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 119.913 -1.934 . . . . 2.49 108.212 162.778 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.2 p -99.13 168.78 9.85 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 115.428 -4.545 . . . . 0.76 113.185 169.32 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.403 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 6.6 mt -63.81 -37.58 87.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 125.273 1.608 . . . . 1.05 112.367 173.291 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.6 t -71.89 -36.43 70.04 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 122.229 1.014 . . . . 1.19 113.355 -179.943 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -54.6 -36.73 64.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.5 3.519 . . . . 1.9 120.5 168.284 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -92.02 9.52 32.91 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.087 -1.449 . . . . 0.89 107.087 -179.964 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 46.42 44.03 12.49 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 117.068 2.247 . . . . 1.84 117.068 -169.65 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.4 mt -86.4 121.04 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 106.5 -1.667 . . . . 0.82 106.5 175.988 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -104.71 179.31 4.31 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 123.296 1.522 . . . . 2.16 107.67 179.632 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -48.84 155.01 0.63 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 117.584 2.439 . . . . 2.12 117.584 173.064 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.305 20.0 mt-10 62.46 25.47 15.18 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 119.068 2.988 . . . . 1.71 119.068 172.075 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -93.25 145.64 24.29 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.721 1.608 . . . . 1.04 113.213 -173.178 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.253 3.2 m -94.02 104.29 16.34 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.3 -4.0 . . . . 0.79 113.666 176.229 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -89.25 142.69 27.43 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 124.394 1.059 . . . . 1.4 109.638 172.645 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -105.05 119.66 39.58 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 116.448 -3.908 . . . . 1.51 108.607 -178.89 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.482 HD23 HG22 ' A' ' 7' ' ' THR . 44.7 tp -91.54 129.86 37.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.951 -3.593 . . . . 1.14 106.374 177.359 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.14 148.45 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 128.125 2.57 . . . . 1.23 106.376 174.297 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 71.2 mt . . . . . 0 N--CA 1.43 -1.449 1 O-C-N 115.913 -4.242 . . . . 2.78 110.442 175.651 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ptt? . . . . . 0 CA--C 1.49 -1.338 0 N-CA-C 109.758 -0.46 . . . . 1.1 109.758 . . . . . . . . . 0 0 . 1 . 111 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -99.43 126.55 45.36 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.49 2.716 . . . . 1.87 111.005 -177.007 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.4 pt -116.85 142.19 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 118.386 -2.696 . . . . 0.72 106.245 168.648 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -100.3 106.33 17.96 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.444 2.698 . . . . 1.4 109.205 -178.16 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.0 t -101.66 112.14 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 O-C-N 117.403 -3.311 . . . . 0.58 106.986 173.354 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.5 mttm -89.98 146.93 24.01 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.89 -3.006 . . . . 2.09 113.375 177.964 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.493 HG22 HD23 ' A' ' 69' ' ' LEU . 82.2 p -98.69 172.05 7.72 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.472 3.034 . . . . 0.99 108.097 172.651 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.6 mt -73.39 -26.47 61.0 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.666 -2.061 . . . . 2.53 113.67 166.181 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.9 p -71.94 -69.95 0.36 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.069 2.248 . . . . 2.08 117.069 -175.67 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.02 12.67 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.809 0 CA-C-O 115.619 -2.767 . . . . 1.31 111.859 176.738 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -108.09 126.91 53.3 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 120.461 2.131 . . . . 1.4 113.225 -177.423 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.2 m -103.78 103.44 13.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.927 -2.249 . . . . 0.78 104.927 173.219 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -82.85 113.93 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 O-C-N 117.129 -3.482 . . . . 1.55 110.912 177.446 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.5 m -79.76 116.25 19.82 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.902 -2.374 . . . . 1.08 105.545 172.647 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.5 mt -114.2 134.43 54.92 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.169 -1.419 . . . . 1.55 107.169 176.185 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -86.75 106.99 18.05 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.174 2.99 . . . . 1.95 114.07 167.719 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.74 165.42 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 112.981 -1.918 . . . . 0.96 109.571 -177.552 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -109.53 155.18 41.73 Favored Pre-proline 0 N--CA 1.429 -1.485 0 N-CA-C 109.38 -0.6 . . . . 2.35 109.38 162.421 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -73.56 -11.87 24.5 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 O-C-N 117.134 -2.087 . . . . 0.95 111.326 -173.01 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.6 p -89.13 0.21 56.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.943 2.897 . . . . 1.45 113.475 178.353 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -76.22 150.12 37.12 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 126.121 2.867 . . . . 1.69 114.456 170.361 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.3 p -85.11 153.12 22.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.232 -2.167 . . . . 0.75 112.567 176.081 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.2 mm -65.45 -36.15 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 120.512 1.506 . . . . 0.73 114.071 -178.954 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -58.28 -39.98 80.69 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.069 -2.269 . . . . 1.62 116.923 173.669 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.323 70.1 m-80 -66.03 -26.04 67.33 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 116.1 1.889 . . . . 2.13 116.1 170.524 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -72.04 -33.3 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-N 120.135 1.334 . . . . 0.62 111.854 170.838 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -83.14 -20.34 34.95 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.381 -2.699 . . . . 1.22 111.175 177.842 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.67 67.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 121.197 1.817 . . . . 0.51 114.012 171.476 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -72.32 -48.86 38.83 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 125.452 1.72 . . . . 1.44 111.261 175.277 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.5 mt -60.79 -33.25 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 125.695 1.598 . . . . 1.32 111.258 176.284 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -64.66 -60.04 3.58 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.644 1.212 . . . . 1.7 110.659 177.624 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -42.43 -56.67 2.93 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 115.368 1.618 . . . . 1.55 115.368 174.698 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -67.69 -59.91 2.95 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 113.977 1.103 . . . . 2.62 113.977 177.359 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -92.37 -58.52 2.35 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.354 -1.466 . . . . 1.48 111.66 -166.414 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.16 16.69 0.64 Allowed Glycine 0 N--CA 1.43 -1.746 0 O-C-N 119.814 -1.804 . . . . 1.12 115.579 175.049 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.415 HG21 HD22 ' A' ' 71' ' ' LEU . 2.4 mp -96.59 133.76 24.21 Favored Pre-proline 0 N--CA 1.43 -1.464 0 C-N-CA 119.291 -0.964 . . . . 1.55 110.903 -175.31 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.39 149.16 91.9 Favored 'Trans proline' 0 N--CA 1.435 -1.965 0 CA-C-N 125.036 2.834 . . . . 1.02 112.933 176.004 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -80.08 -11.25 13.62 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-O 115.702 -1.874 . . . . 1.25 108.9 -168.653 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -77.99 -24.49 48.0 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.871 2.123 . . . . 2.25 114.999 166.914 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -84.35 -34.28 23.68 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 124.244 1.973 . . . . 2.02 109.952 -177.773 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -72.38 100.06 2.58 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.437 -3.29 . . . . 0.69 112.069 179.797 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -86.65 135.37 33.43 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 121.558 1.981 . . . . 2.78 108.05 166.393 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 43' ' ' LEU 0.274 80.0 mt -104.17 125.82 50.78 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.631 3.586 . . . . 1.17 108.226 175.572 . . . . . . . . 3 3 . 1 . 111 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 29.8 mm -103.13 140.93 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 118.976 -2.327 . . . . 1.38 110.358 171.699 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -130.14 107.98 9.72 Favored 'General case' 0 N--CA 1.429 -1.479 1 N-CA-C 98.835 -4.505 . . . . 1.5 98.835 170.506 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.07 -84.89 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.246 1.818 . . . . 1.21 115.14 179.87 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.01 13.25 0.74 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 130.473 3.892 . . . . 1.3 111.338 -175.583 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -109.6 151.36 26.93 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 121.189 2.495 . . . . 2.55 104.439 168.268 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -94.42 132.81 38.67 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 130.031 3.332 . . . . 2.48 102.726 171.071 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.9 mt -91.38 133.2 35.65 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.481 -2.012 . . . . 0.9 107.011 -170.387 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -71.88 151.73 43.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.19 -3.443 . . . . 1.94 108.605 171.572 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.25 -40.81 36.06 Favored 'General case' 0 N--CA 1.429 -1.523 0 O-C-N 116.865 -3.647 . . . . 1.56 110.137 -168.81 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.04 45.45 3.42 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 118.193 -2.817 . . . . 0.97 117.149 172.265 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -116.25 167.5 10.96 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 118.417 -0.802 . . . . 2.49 109.778 163.007 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.6 p -96.9 175.84 6.19 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 127.398 3.475 . . . . 0.76 108.286 167.941 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.8 mt -72.45 -43.75 63.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.742 -3.099 . . . . 1.05 108.607 176.514 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.2 p -72.9 1.41 8.77 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 119.969 3.322 . . . . 1.19 119.969 179.301 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -82.45 -40.59 20.95 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.47 -2.644 . . . . 1.9 112.27 169.593 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -77.87 -7.3 56.51 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.072 2.549 . . . . 0.89 110.621 172.161 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.312 42.8 m-80 68.46 33.32 4.11 Favored 'General case' 0 N--CA 1.428 -1.539 0 O-C-N 116.669 -3.769 . . . . 1.84 115.829 -177.273 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.6 mt -81.31 125.29 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 CA-C-N 114.011 -1.45 . . . . 0.82 111.657 -179.573 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -108.1 -164.11 0.94 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 121.28 3.808 . . . . 2.16 121.28 -176.535 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -74.4 146.63 42.78 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 120.438 -1.414 . . . . 2.12 112.853 171.946 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.261 43.4 mt-10 68.59 18.17 8.89 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 126.901 2.08 . . . . 1.71 115.436 178.182 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -77.04 124.66 28.12 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.413 2.685 . . . . 1.04 113.482 -174.749 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.29 3.8 m -80.97 105.16 11.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 127.418 2.287 . . . . 0.79 115.143 175.845 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -103.52 166.76 10.23 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 125.58 2.61 . . . . 1.4 106.044 175.249 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.42 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 73.6 m80 -128.72 133.1 48.05 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.829 -4.295 . . . . 1.51 110.108 -172.12 . . . . . . . . 3 3 . 1 . 111 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.493 HD23 HG22 ' A' ' 7' ' ' THR . 36.6 tp -99.29 129.72 45.53 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.217 -0.927 . . . . 1.14 112.551 -176.368 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -131.05 123.4 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 122.074 2.216 . . . . 1.23 112.26 175.743 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.415 HD22 HG21 ' A' ' 36' ' ' ILE . 18.7 mt . . . . . 0 N--CA 1.43 -1.462 0 N-CA-C 117.65 2.463 . . . . 2.78 117.65 -178.397 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 113.311 0.856 . . . . 1.1 113.311 . . . . . . . . . 0 0 . 1 . 112 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -91.7 142.7 27.33 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.826 -1.916 . . . . 1.87 105.826 -178.046 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.0 pt -132.01 176.69 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 105.166 -2.161 . . . . 0.72 105.166 167.701 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -127.13 130.14 49.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.402 1.573 . . . . 1.4 109.079 176.299 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -109.49 110.09 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 126.231 2.919 . . . . 0.58 104.481 175.158 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 12' ' ' THR 0.27 23.7 ttmm -103.98 142.55 34.24 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 114.843 -4.911 . . . . 2.09 109.656 -178.422 . . . . . . . . 4 3 . 1 . 112 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.7 p -91.76 142.52 27.5 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 114.284 -2.77 . . . . 0.99 111.885 179.668 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.3 tp -59.97 -37.78 80.61 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.605 2.362 . . . . 2.53 109.532 165.711 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.9 -27.01 57.51 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 122.754 2.525 . . . . 2.08 110.192 -178.357 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.07 -77.38 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.739 1 N-CA-C 123.187 4.035 . . . . 1.31 123.187 176.297 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -72.59 157.51 37.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 129.266 3.568 . . . . 1.4 117.881 -174.694 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 3.3 m -105.11 133.88 49.15 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.944 2.497 . . . . 0.78 107.713 162.499 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 pt -113.18 143.88 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 101.584 -3.487 . . . . 1.55 101.584 176.319 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.3 m -99.85 128.65 45.93 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 114.753 -4.967 . . . . 1.08 104.159 174.397 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.7 mt -114.87 148.86 38.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.145 -3.472 . . . . 1.55 102.892 178.542 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -109.44 122.07 46.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.635 -1.987 . . . . 1.95 105.635 171.164 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.79 175.16 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-O 121.862 0.839 . . . . 0.96 111.136 -176.984 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.268 81.3 mt-10 -112.77 167.04 9.8 Favored Pre-proline 0 N--CA 1.431 -1.403 0 O-C-N 117.614 -3.178 . . . . 2.35 110.268 168.222 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -88.43 -8.75 5.27 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 CA-C-N 124.692 2.711 . . . . 0.95 110.513 -169.739 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 p -81.63 1.16 35.26 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 128.146 2.578 . . . . 1.45 115.897 172.958 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -77.52 137.74 38.79 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.058 -0.974 . . . . 1.69 108.507 175.25 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.3 p -79.29 156.36 28.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 128.198 2.599 . . . . 0.75 108.873 172.69 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.352 8.0 mm -61.64 -45.44 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 128.062 2.545 . . . . 0.73 114.764 -177.856 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.299 31.8 tt0 -48.83 -39.55 25.99 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 116.313 1.968 . . . . 1.62 116.313 167.292 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -73.55 -28.26 61.77 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 124.326 1.05 . . . . 2.13 111.575 179.793 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.2 t -69.06 -46.42 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 125.502 1.521 . . . . 0.62 109.262 171.297 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -62.21 -16.07 50.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 117.984 2.587 . . . . 1.22 117.984 176.878 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.82 -35.63 38.06 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 127.582 2.353 . . . . 0.51 109.574 171.465 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -70.02 -33.4 71.95 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.413 -1.429 . . . . 1.44 110.28 172.653 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.25 42.4 mt -63.63 -37.3 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 116.465 -3.897 . . . . 1.32 115.541 168.903 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.447 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 50.2 tt0 -69.62 -31.59 69.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 117.315 -1.326 . . . . 1.7 114.444 170.806 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.52 -45.48 65.47 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.393 1.451 . . . . 1.55 109.551 172.241 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -78.02 -64.78 1.08 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.049 -2.282 . . . . 2.62 114.41 -171.007 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.287 21.7 mm-40 -93.54 -45.78 7.59 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.716 1.246 . . . . 1.48 109.851 -172.745 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.88 64.15 0.34 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 106.067 -2.813 . . . . 1.12 106.067 167.069 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.447 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 8.8 mt -120.37 127.9 26.08 Favored Pre-proline 0 N--CA 1.43 -1.433 0 O-C-N 126.837 2.14 . . . . 1.55 111.448 -177.977 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -63.0 129.64 26.53 Favored 'Trans proline' 0 C--N 1.3 -2.023 1 CA-C-O 110.002 -4.249 . . . . 1.02 121.654 179.797 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -33.16 87.19 Favored 'Trans proline' 0 N--CA 1.434 -2.006 1 CA-C-N 129.243 4.337 . . . . 1.25 121.947 -175.142 . . . . . . . . 3 3 . 1 . 112 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -60.77 -37.81 83.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 125.243 3.656 . . . . 2.25 114.21 174.099 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -71.62 -28.05 63.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.107 -1.442 . . . . 2.02 107.107 -172.862 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -79.96 119.48 22.86 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.401 1.91 . . . . 0.69 115.382 -170.092 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.483 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 92.6 mtt180 -103.81 112.14 24.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 114.171 1.174 . . . . 2.78 114.171 166.821 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.6 mt -94.5 119.14 32.74 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.635 -3.166 . . . . 1.17 110.863 177.165 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.21 130.91 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 122.074 2.216 . . . . 1.38 108.152 174.484 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -118.3 114.94 23.72 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 102.953 -2.98 . . . . 1.5 102.953 171.445 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.383 . . 77.62 -63.9 0.32 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 125.961 2.791 . . . . 1.21 116.296 179.409 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.3 -60.66 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 127.213 2.339 . . . . 1.3 117.263 -172.55 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -68.26 125.41 26.31 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.971 2.908 . . . . 2.55 111.687 172.964 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -71.88 143.17 49.47 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 112.82 -1.991 . . . . 2.48 109.728 173.882 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.2 mt -80.05 128.57 33.65 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.875 1.67 . . . . 0.9 110.79 -178.04 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -86.07 148.31 25.77 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.445 -0.785 . . . . 1.94 109.107 176.002 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -59.41 -47.68 84.54 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 127.481 3.515 . . . . 1.56 117.16 -171.431 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.18 39.47 2.88 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 117.717 -3.114 . . . . 0.97 120.34 170.39 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.353 14.5 mmt180 -116.47 173.39 6.64 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 119.395 -0.922 . . . . 2.49 109.86 163.541 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.5 p -96.84 165.96 11.86 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 115.587 1.699 . . . . 0.76 115.587 168.754 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.0 mt -67.78 -32.55 73.2 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 123.04 1.4 . . . . 1.05 111.901 171.2 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.3 p -67.21 -16.19 64.15 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.256 -2.777 . . . . 1.19 112.895 174.909 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -69.81 -41.25 75.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 122.014 2.188 . . . . 1.9 115.236 177.467 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -90.35 -9.62 47.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.762 2.425 . . . . 0.89 109.724 -179.497 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.287 41.8 m-80 58.76 50.47 8.7 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 117.441 2.386 . . . . 1.84 117.441 -176.461 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.43 HG21 HD11 ' A' ' 67' ' ' LEU . 71.9 mt -86.42 118.2 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 126.409 3.004 . . . . 0.82 113.145 170.085 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -98.92 -178.16 3.86 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.638 -2.539 . . . . 2.16 111.277 -179.011 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -54.32 144.4 20.6 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.584 -2.573 . . . . 2.12 117.385 173.596 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.314 22.5 mt-10 66.66 27.39 9.44 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.737 -2.477 . . . . 1.71 117.068 174.825 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -101.09 153.46 19.55 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.232 -1.349 . . . . 1.04 108.877 -174.52 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.6 m -111.17 117.17 32.5 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.681 -3.137 . . . . 0.79 106.605 -175.125 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.43 HD11 HG21 ' A' ' 61' ' ' ILE . 7.7 mp -100.73 135.6 41.91 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.225 2.21 . . . . 1.4 106.047 176.798 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -99.57 117.44 33.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.403 -2.061 . . . . 1.51 110.178 -176.707 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.8 tp -86.96 119.44 27.17 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.465 3.506 . . . . 1.14 111.4 176.952 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 44.7 t -107.63 151.33 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 115.208 -2.33 . . . . 1.23 106.623 174.718 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 N--CA 1.43 -1.45 0 C-N-CA 115.26 -2.576 . . . . 2.78 107.465 179.667 . . . . . . . . 0 0 . 1 . 113 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 ttp . . . . . 0 CA--C 1.491 -1.318 0 CA-C-O 115.598 -2.144 . . . . 1.1 110.758 . . . . . . . . . 0 0 . 1 . 113 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -90.9 132.36 35.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.766 2.53 . . . . 1.87 112.547 -178.36 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.1 pt -111.68 149.18 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 122.077 2.217 . . . . 0.72 110.543 172.282 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -108.95 115.52 30.24 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.919 -1.882 . . . . 1.4 105.919 178.694 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.427 HG21 HD11 ' A' ' 30' ' ' ILE . 77.5 t -100.34 120.0 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 115.179 -2.343 . . . . 0.58 105.017 175.885 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.251 89.1 mttt -101.79 130.59 48.26 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 116.893 -1.527 . . . . 2.09 106.892 176.489 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.2 p -82.57 170.62 14.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 120.418 1.463 . . . . 0.99 111.621 176.039 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.2 tp -79.62 -28.02 40.97 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 125.712 2.673 . . . . 2.53 111.535 170.277 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.296 38.9 p -75.5 -50.1 16.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.339 -3.35 . . . . 2.08 113.38 -177.195 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.15 32.2 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 122.75 3.86 . . . . 1.31 122.75 167.182 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -135.71 147.45 48.49 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 121.405 2.603 . . . . 1.4 112.043 -175.059 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.8 m -97.09 122.8 40.5 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.882 -1.508 . . . . 0.78 107.956 173.265 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.9 mt -117.28 115.93 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 103.939 -2.615 . . . . 1.55 103.939 -175.155 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.4 m -94.72 104.6 16.52 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.961 1.362 . . . . 1.08 114.226 179.52 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.6 mt -97.27 140.43 31.75 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 119.113 -2.242 . . . . 1.55 111.116 -176.425 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -91.3 115.43 28.02 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 115.538 -4.476 . . . . 1.95 113.236 165.118 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -133.3 152.61 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 126.773 2.546 . . . . 0.96 107.762 -179.189 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -90.71 153.67 45.62 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 115.859 -2.02 . . . . 2.35 110.843 163.452 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -84.07 0.91 9.07 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 CA-C-N 126.07 3.204 . . . . 0.95 116.473 -171.749 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.8 p -85.94 -14.79 43.66 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.614 3.166 . . . . 1.45 111.051 174.612 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.284 18.7 m-20 -82.34 156.02 24.46 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.102 2.161 . . . . 1.69 112.359 177.823 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 60.0 p -78.07 171.15 15.45 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 127.284 3.421 . . . . 0.75 116.759 175.35 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.443 HD13 ' HG ' ' A' ' 56' ' ' LEU . 14.4 mm -74.76 -27.75 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 1 O-C-N 114.968 -4.833 . . . . 0.73 111.524 174.415 . . . . . . . . 3 3 . 1 . 113 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -54.43 -41.34 69.25 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 125.652 1.581 . . . . 1.62 108.964 165.536 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.263 18.1 t-20 -60.71 -44.3 96.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 124.483 2.087 . . . . 2.13 113.423 175.539 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.08 -50.13 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 113.143 -1.844 . . . . 0.62 111.53 174.194 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.404 ' HD2' ' OD2' ' A' ' 52' ' ' ASP . 94.0 mttt -64.64 -41.57 96.05 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.332 2.345 . . . . 1.22 117.332 174.588 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.99 -45.15 41.84 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.158 2.183 . . . . 0.51 115.431 168.375 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -62.72 -39.61 94.61 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 116.182 1.919 . . . . 1.44 116.182 170.652 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.427 HD11 HG21 ' A' ' 5' ' ' VAL 0.257 21.2 mt -63.51 -25.82 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 C-N-CA 125.296 1.438 . . . . 1.32 112.57 173.155 . . . . . . . . 3 3 . 1 . 113 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -77.61 -35.55 52.64 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.561 -0.745 . . . . 1.7 112.58 174.307 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.36 -44.14 95.85 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.139 1.447 . . . . 1.55 113.378 167.975 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -73.29 -66.65 0.66 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 119.783 3.253 . . . . 2.62 119.783 -176.821 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -95.14 -48.6 5.87 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 128.377 2.671 . . . . 1.48 110.348 -174.725 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.91 -10.82 6.64 Favored Glycine 0 N--CA 1.43 -1.757 0 O-C-N 127.049 2.718 . . . . 1.12 117.104 173.362 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mm -71.68 132.19 85.48 Favored Pre-proline 0 N--CA 1.43 -1.428 0 O-C-N 119.367 -2.255 . . . . 1.55 109.178 -173.271 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 43.2 Cg_endo -68.36 151.61 76.04 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 O-C-N 117.343 -1.978 . . . . 1.02 115.117 178.802 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -62.79 -25.49 74.74 Favored 'Trans proline' 0 N--CA 1.433 -2.035 1 C-N-CA 126.68 4.92 . . . . 1.25 112.703 -173.525 . . . . . . . . 4 4 . 1 . 113 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.85 -42.54 98.01 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 129.446 3.098 . . . . 2.25 108.38 -179.296 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -78.97 -22.72 45.21 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 117.469 2.396 . . . . 2.02 117.469 -177.998 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -85.89 129.0 34.96 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.205 1.479 . . . . 0.69 110.221 -169.567 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.43 ' HB2' HG23 ' A' ' 70' ' ' VAL . 92.2 mtt180 -116.29 117.33 29.71 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 125.156 2.407 . . . . 2.78 110.103 173.289 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.6 mt -96.27 128.16 42.93 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 114.336 -5.227 . . . . 1.17 105.936 179.098 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.447 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 15.3 mm -107.26 141.36 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 103.095 -2.928 . . . . 1.38 103.095 178.649 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.452 ' HB3' HD21 ' A' ' 50' ' ' LEU 0.296 26.1 t80 -140.58 109.46 6.04 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.53 1.932 . . . . 1.5 108.137 176.894 . . . . . . . . 3 3 . 1 . 113 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.371 . . 64.8 -75.46 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.51 2.324 . . . . 1.21 112.079 -172.101 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -137.44 -34.97 0.19 Allowed Glycine 0 N--CA 1.429 -1.824 0 O-C-N 123.999 0.812 . . . . 1.3 114.686 178.847 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -89.44 150.78 22.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.221 1.934 . . . . 2.55 116.221 -176.077 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -84.71 127.34 34.05 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 111.903 -2.408 . . . . 2.48 112.183 174.552 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 45' ' ' PHE . 39.1 mt -81.91 148.44 28.75 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 121.057 1.753 . . . . 0.9 112.492 -168.548 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -98.27 148.67 23.39 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 118.605 -1.238 . . . . 1.94 113.697 179.765 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.404 ' OD2' ' HD2' ' A' ' 27' ' ' LYS . 4.6 m-20 -60.69 -66.62 0.5 Allowed 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 116.197 -4.064 . . . . 1.56 117.288 -170.962 . . . . . . . . 3 3 . 1 . 113 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.27 32.25 0.32 Allowed Glycine 0 N--CA 1.432 -1.632 0 N-CA-C 122.607 3.803 . . . . 0.97 122.607 172.977 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -115.24 161.97 17.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.469 -2.049 . . . . 2.49 105.469 166.026 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 26.7 p -81.23 158.65 24.77 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.707 -1.871 . . . . 0.76 113.767 175.279 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.443 ' HG ' HD13 ' A' ' 23' ' ' ILE . 5.1 mt -65.78 -24.8 67.01 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.277 2.231 . . . . 1.05 114.591 175.757 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.4 p -83.46 -11.28 57.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.9 2.48 . . . . 1.19 111.467 178.667 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -61.85 -55.83 25.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.483 3.113 . . . . 1.9 108.089 167.26 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -76.81 -13.59 60.0 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 130.13 4.643 . . . . 0.89 113.713 -176.236 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 57.23 64.67 1.55 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 116.678 2.103 . . . . 1.84 116.678 -176.059 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.8 mm -78.54 104.53 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 105.549 -2.019 . . . . 0.82 105.549 174.892 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -73.32 169.94 16.07 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.056 1.342 . . . . 2.16 112.64 175.418 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -55.66 136.3 50.68 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.188 -3.445 . . . . 2.12 112.822 163.115 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 70.3 38.83 1.35 Allowed 'General case' 0 N--CA 1.429 -1.49 1 C-N-CA 135.946 5.698 . . . . 1.71 112.686 175.65 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.6 m -90.73 142.26 27.94 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 116.657 2.095 . . . . 1.04 116.657 -172.595 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.7 m -100.25 116.61 32.65 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 126.169 2.168 . . . . 0.79 107.224 -178.399 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -100.62 152.67 20.16 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.352 1.549 . . . . 1.4 111.362 168.875 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.447 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 33.8 m80 -120.93 130.53 53.9 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.086 -2.259 . . . . 1.51 107.511 -174.218 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 tp -112.14 118.2 34.7 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 116.574 2.064 . . . . 1.14 116.574 177.924 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.43 HG23 ' HB2' ' A' ' 42' ' ' ARG . 6.6 m -112.77 172.08 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 103.325 -2.843 . . . . 1.23 103.325 173.1 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.255 10.8 mt . . . . . 0 N--CA 1.43 -1.464 0 CA-C-N 113.857 -1.52 . . . . 2.78 112.428 178.111 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 ptt? . . . . . 0 CA--C 1.489 -1.372 0 CA-C-O 116.273 -1.822 . . . . 1.1 111.64 . . . . . . . . . 0 0 . 1 . 114 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -99.6 138.85 36.11 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 125.214 1.571 . . . . 1.87 109.824 -173.49 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.5 pt -123.28 160.81 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 128.37 3.938 . . . . 0.72 108.281 173.641 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -119.07 133.22 55.93 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 115.195 -4.69 . . . . 1.4 106.61 -176.556 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.97 119.48 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 106.204 -1.776 . . . . 0.58 106.204 175.973 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -106.34 133.94 50.25 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 115.79 -4.318 . . . . 2.09 111.354 178.568 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.1 p -89.19 178.99 6.22 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.452 -2.03 . . . . 0.99 115.599 -174.144 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.404 HD11 ' H ' ' A' ' 71' ' ' LEU . 5.8 mt -78.11 -22.42 48.94 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 121.727 2.058 . . . . 2.53 109.985 173.379 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.3 p -80.54 -36.27 33.3 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.357 -2.714 . . . . 2.08 109.666 -178.921 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.67 53.82 0.66 Allowed Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 130.088 3.709 . . . . 1.31 119.824 175.957 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -122.74 137.24 54.98 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.102 3.361 . . . . 1.4 105.005 -176.696 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.8 m -105.68 121.54 44.21 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-O 124.42 2.057 . . . . 0.78 108.46 179.823 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.5 mt -99.32 140.5 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.357 -2.714 . . . . 1.55 107.882 174.852 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.8 m -106.75 98.61 8.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.096 -2.252 . . . . 1.08 110.835 -178.606 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.7 mt -95.18 140.84 29.53 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 121.521 1.964 . . . . 1.55 112.933 179.942 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -97.29 134.41 40.62 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.989 -2.319 . . . . 1.95 109.16 169.772 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 m -138.87 156.66 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 127.042 2.137 . . . . 0.96 107.063 -174.141 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -106.37 160.75 25.11 Favored Pre-proline 0 N--CA 1.43 -1.446 0 O-C-N 118.197 -2.815 . . . . 2.35 107.317 162.671 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -71.25 -7.85 22.19 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 CA-C-N 124.394 2.605 . . . . 0.95 112.235 -172.136 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.3 p -93.89 -14.37 26.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.037 2.135 . . . . 1.45 111.894 -174.141 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -65.39 149.29 50.26 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 130.16 3.384 . . . . 1.69 105.635 174.246 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.509 HG22 HG22 ' A' ' 55' ' ' THR . 68.6 p -96.44 170.93 8.89 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 117.235 -1.364 . . . . 0.75 111.097 178.568 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.404 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 32.7 mm -62.16 -32.6 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.413 0 C-N-CA 126.658 1.983 . . . . 0.73 111.366 170.508 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.295 35.5 tt0 -54.15 -51.35 64.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.581 3.552 . . . . 1.62 108.86 169.453 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -57.22 -37.69 72.63 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.557 -2.59 . . . . 2.13 114.918 174.354 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 88.3 t -62.79 -44.82 99.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 114.803 1.408 . . . . 0.62 114.803 175.091 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -65.86 -30.2 70.78 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 129.539 3.136 . . . . 1.22 113.465 173.451 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.19 83.18 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.864 -3.648 . . . . 0.51 111.101 179.738 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -61.96 -42.37 99.04 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.529 -3.232 . . . . 1.44 115.203 174.0 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.1 mt -72.95 -23.75 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 123.439 1.59 . . . . 1.32 110.513 175.995 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -70.12 -35.01 73.8 Favored 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 114.517 -5.114 . . . . 1.7 112.623 169.559 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.69 -48.7 78.16 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.783 2.706 . . . . 1.55 112.558 175.412 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -82.55 -63.04 1.45 Allowed 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 114.406 -5.184 . . . . 2.62 114.88 -178.975 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -85.49 -15.4 42.95 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.948 -3.595 . . . . 1.48 116.918 -168.658 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.37 31.45 54.61 Favored Glycine 0 N--CA 1.429 -1.776 0 O-C-N 119.725 -1.859 . . . . 1.12 114.617 176.543 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mt -101.25 135.43 19.89 Favored Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 108.452 -0.944 . . . . 1.55 108.452 -173.702 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -68.1 151.26 77.44 Favored 'Trans proline' 0 N--CA 1.433 -2.03 0 CA-C-N 123.884 2.423 . . . . 1.02 111.608 179.901 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -73.17 -20.63 21.27 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-N 126.515 3.362 . . . . 1.25 111.242 -173.478 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -65.7 -29.99 70.61 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 126.191 2.9 . . . . 2.25 112.805 174.463 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -81.74 -25.7 35.15 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 114.667 -5.021 . . . . 2.02 107.944 -177.566 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -82.92 119.3 24.24 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.839 -2.413 . . . . 0.69 110.991 -169.775 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.358 80.2 mtp180 -108.18 124.98 51.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.519 -1.219 . . . . 2.78 110.229 163.942 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -107.2 116.73 32.44 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.431 2.539 . . . . 1.17 104.554 -177.771 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.3 mt -111.44 137.28 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 O-C-N 119.939 -1.726 . . . . 1.38 112.982 176.552 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -148.98 132.67 16.87 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 124.15 0.98 . . . . 1.5 111.089 174.249 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.354 . . 49.38 25.03 1.18 Allowed 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 120.256 3.428 . . . . 1.21 120.256 171.199 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.11 7.55 26.73 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 121.477 -0.765 . . . . 1.3 114.591 -177.881 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -149.0 153.53 38.06 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.442 -2.799 . . . . 2.55 110.632 -176.813 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -96.64 128.34 43.48 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 113.912 -1.495 . . . . 2.48 111.662 171.224 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.2 mt -81.49 121.21 25.99 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.648 2.468 . . . . 0.9 115.691 -174.593 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -73.72 137.32 43.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.094 2.627 . . . . 1.94 118.094 177.098 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -40.27 -64.49 0.5 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 131.431 3.892 . . . . 1.56 117.397 -171.319 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.31 16.64 12.5 Favored Glycine 0 N--CA 1.429 -1.798 1 CA-C-O 112.011 -4.772 . . . . 0.97 118.745 175.275 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.0 mtt180 -95.46 161.56 14.02 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 121.155 2.478 . . . . 2.49 110.163 171.632 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.509 HG22 HG22 ' A' ' 22' ' ' THR . 19.3 p -97.56 170.63 8.9 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 117.179 -1.809 . . . . 0.76 114.596 172.94 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.85 -39.79 82.36 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.274 -2.239 . . . . 1.05 111.828 176.506 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.3 t -61.75 -44.24 97.29 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 130.118 3.367 . . . . 1.19 113.56 175.067 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -59.57 -24.83 64.08 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 115.224 1.565 . . . . 1.9 115.224 174.201 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -106.36 9.45 31.85 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.069 -2.895 . . . . 0.89 112.601 175.08 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.6 m120 44.68 62.77 1.93 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 128.163 2.585 . . . . 1.84 114.155 -177.579 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.7 mt -108.35 127.55 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 129.398 3.079 . . . . 0.82 107.183 176.511 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -106.71 -174.11 2.46 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.541 2.336 . . . . 2.16 110.979 -172.978 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.2 ptmm? -61.2 148.16 41.81 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 114.73 1.382 . . . . 2.12 114.73 174.811 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 62.75 37.89 12.21 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 126.51 3.053 . . . . 1.71 112.921 169.957 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.7 m -84.03 133.06 34.68 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.924 2.297 . . . . 1.04 110.665 178.079 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.7 m -93.39 104.82 16.95 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.202 -2.186 . . . . 0.79 109.3 176.344 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.6 mt -88.1 147.38 24.97 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 123.184 0.593 . . . . 1.4 110.066 174.296 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -97.68 121.52 39.69 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 116.917 -1.516 . . . . 1.51 113.815 173.622 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.9 tp -91.01 111.97 23.66 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.591 2.756 . . . . 1.14 108.491 175.942 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.7 t -112.11 141.83 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 114.579 -1.192 . . . . 1.23 109.151 172.156 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.404 ' H ' HD11 ' A' ' 8' ' ' LEU . 64.4 mt . . . . . 0 N--CA 1.429 -1.504 0 N-CA-C 119.61 3.189 . . . . 2.78 119.61 179.639 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ptt? . . . . . 0 CA--C 1.489 -1.371 0 N-CA-C 112.624 0.601 . . . . 1.1 112.624 . . . . . . . . . 0 0 . 1 . 115 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.338 0.0 OUTLIER -97.83 133.72 41.95 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.129 -1.607 . . . . 1.87 111.446 179.286 . . . . . . . . 3 3 . 1 . 115 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.3 pt -115.74 158.88 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 103.637 -2.727 . . . . 0.72 103.637 169.74 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -112.34 137.89 49.85 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.452 2.701 . . . . 1.4 107.302 178.92 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.9 t -118.15 123.15 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 102.226 -3.25 . . . . 0.58 102.226 174.291 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.7 tppt? -100.36 126.96 46.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 126.144 2.878 . . . . 2.09 105.33 175.687 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 p -78.3 -162.91 0.39 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 120.253 3.427 . . . . 0.99 120.253 173.463 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 mt -88.31 -34.73 17.56 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 117.294 -1.336 . . . . 2.53 112.831 173.66 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 p -68.38 -32.74 73.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 127.536 2.334 . . . . 2.08 106.999 173.266 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.67 35.29 2.26 Favored Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 127.592 2.52 . . . . 1.31 107.744 168.367 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -80.57 134.36 35.91 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.258 -2.867 . . . . 1.4 103.258 178.876 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.9 m -95.02 91.49 6.39 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.855 -1.521 . . . . 0.78 114.341 175.042 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.4 mt -88.38 119.13 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 123.848 1.785 . . . . 1.55 106.714 -175.449 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.1 m -90.44 126.88 36.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.062 -2.273 . . . . 1.08 110.37 -177.268 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.5 mt -128.18 134.12 49.0 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.221 -3.424 . . . . 1.55 106.246 -175.238 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -98.15 132.24 43.84 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.615 -1.624 . . . . 1.95 106.615 171.87 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 m -140.61 164.79 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 126.962 2.105 . . . . 0.96 109.621 -173.938 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -109.58 151.92 42.5 Favored Pre-proline 0 N--CA 1.43 -1.454 0 CA-C-O 114.486 -2.673 . . . . 2.35 112.651 160.373 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 96.4 Cg_endo -70.52 -14.93 34.14 Favored 'Trans proline' 0 N--CA 1.433 -2.058 0 C-N-CA 125.09 3.86 . . . . 0.95 109.715 -165.29 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.1 m -82.93 -9.95 59.05 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 122.346 2.339 . . . . 1.45 108.974 176.919 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -66.74 142.5 57.37 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.443 3.497 . . . . 1.69 112.43 172.732 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 p -83.19 171.58 13.51 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 113.121 -5.987 . . . . 0.75 110.142 -174.632 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.1 mm -75.57 -30.55 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 122.949 1.357 . . . . 0.73 109.783 179.098 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.253 38.2 tt0 -45.34 -42.85 10.38 Favored 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 117.977 -2.952 . . . . 1.62 117.49 157.925 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -68.35 -38.52 81.55 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 125.336 1.648 . . . . 2.13 110.968 176.49 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.1 t -62.67 -35.28 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 125.156 2.408 . . . . 0.62 115.094 177.844 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HD3' ' HB2' ' A' ' 41' ' ' GLN . 90.1 mttt -68.31 -38.42 81.58 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.163 -1.586 . . . . 1.22 115.093 166.269 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.68 -22.42 66.63 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 118.465 2.765 . . . . 0.51 118.465 169.796 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -84.45 -29.48 26.06 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.675 -1.891 . . . . 1.44 111.901 173.947 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.8 mt -70.49 -38.06 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 124.164 1.935 . . . . 1.32 114.752 170.662 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.45 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 10.8 tt0 -65.51 -42.53 91.96 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 128.208 2.603 . . . . 1.7 109.66 171.926 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -58.09 -52.48 65.35 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.348 -3.345 . . . . 1.55 113.116 172.469 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -64.09 -66.32 0.56 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.618 3.58 . . . . 2.62 111.818 -176.179 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -89.84 -44.59 9.84 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 110.654 -2.976 . . . . 1.48 112.956 -172.119 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 113.42 0.69 24.89 Favored Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 117.649 1.82 . . . . 1.12 117.649 -177.899 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 mt -68.49 121.26 80.08 Favored Pre-proline 0 N--CA 1.429 -1.488 0 O-C-N 118.77 -2.606 . . . . 1.55 107.003 -176.549 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -67.88 164.68 30.7 Favored 'Trans proline' 0 N--CA 1.434 -1.989 1 C-N-CA 125.739 4.293 . . . . 1.02 112.126 -176.459 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -67.45 -34.16 27.2 Favored 'Trans proline' 0 N--CA 1.433 -2.05 1 C-N-CA 125.758 4.305 . . . . 1.25 113.173 -175.223 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -44.17 -48.94 9.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 126.604 3.097 . . . . 2.25 114.211 173.762 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -83.98 -17.0 41.99 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.146 -2.846 . . . . 2.02 115.951 -170.93 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.407 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 79.1 mt-30 -85.49 134.29 34.05 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.439 1.896 . . . . 0.69 111.218 -168.875 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -121.14 114.64 21.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 130.388 3.475 . . . . 2.78 108.606 167.467 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.4 mt -88.9 116.97 27.57 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.627 -1.921 . . . . 1.17 112.578 173.866 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.6 mm -106.4 141.1 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 102.652 -3.092 . . . . 1.38 102.652 -178.431 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -132.24 97.58 4.16 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 100.378 -3.934 . . . . 1.5 100.378 174.976 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.36 . . 79.5 -86.62 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.096 2.159 . . . . 1.21 106.858 -179.309 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.57 -6.55 1.8 Allowed Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 128.668 3.032 . . . . 1.3 111.179 -178.017 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -92.87 131.1 38.2 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.403 2.681 . . . . 2.55 109.135 -177.114 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -81.66 114.59 20.44 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 112.364 -2.198 . . . . 2.48 110.776 175.234 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.8 mt -83.23 148.62 27.3 Favored 'General case' 0 N--CA 1.431 -1.407 1 O-C-N 115.198 -4.689 . . . . 0.9 112.267 -174.521 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -100.3 149.36 23.68 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.499 1.919 . . . . 1.94 113.291 172.852 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -61.67 -61.15 2.72 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 130.49 3.516 . . . . 1.56 112.222 -169.525 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.82 20.52 0.2 Allowed Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 122.285 3.674 . . . . 0.97 122.285 171.705 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -107.67 154.13 21.92 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.135 -1.803 . . . . 2.49 113.042 167.02 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.3 p -94.21 168.45 10.91 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.805 2.891 . . . . 0.76 118.805 177.999 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 56.4 mt -62.77 -43.05 99.82 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.887 -1.758 . . . . 1.05 109.916 174.316 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 t -55.36 -43.66 75.27 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 120.342 3.46 . . . . 1.19 120.342 174.719 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -54.45 -42.2 70.34 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 128.287 2.635 . . . . 1.9 110.87 177.687 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -95.03 11.39 32.2 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 115.289 1.589 . . . . 0.89 115.289 -178.65 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 52.45 50.0 19.22 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 129.038 2.935 . . . . 1.84 110.98 -177.798 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.0 mt -91.94 114.19 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 N-CA-C 106.621 -1.622 . . . . 0.82 106.621 -179.068 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -94.16 -170.67 2.35 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 125.197 2.427 . . . . 2.16 109.494 -177.153 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.321 17.8 pttp -67.39 150.82 48.44 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 111.695 -2.502 . . . . 2.12 117.416 168.769 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.343 17.2 mt-10 68.38 9.52 7.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.942 2.201 . . . . 1.71 116.942 170.156 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.3 t -94.36 138.76 31.94 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 131.034 3.734 . . . . 1.04 107.855 -175.82 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.2 m -85.99 122.95 30.74 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 115.969 1.84 . . . . 0.79 115.969 179.225 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mp -99.78 157.45 16.49 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 101.472 -3.529 . . . . 1.4 101.472 169.674 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -121.04 117.27 26.81 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 113.995 1.109 . . . . 1.51 113.995 179.956 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.7 tp -88.85 110.37 21.0 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.413 2.054 . . . . 1.14 113.185 -178.713 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.7 t -107.04 147.82 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 117.981 -2.949 . . . . 1.23 106.124 171.605 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.0 mt . . . . . 0 N--CA 1.43 -1.435 0 O-C-N 119.159 -2.213 . . . . 2.78 109.437 -179.532 . . . . . . . . 0 0 . 1 . 116 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 119.322 -0.37 . . . . 1.1 110.208 . . . . . . . . . 0 0 . 1 . 116 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -102.7 132.42 48.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.66 -2.525 . . . . 1.87 106.83 -179.249 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.0 pt -132.42 167.02 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-O 116.376 -1.773 . . . . 0.72 108.001 173.923 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -124.1 149.08 46.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 122.349 2.34 . . . . 1.4 115.282 176.75 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 t -128.42 119.48 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 102.858 -3.016 . . . . 0.58 102.858 171.024 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -109.82 129.1 55.67 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 111.329 -2.669 . . . . 2.09 109.595 176.258 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 p -89.89 -173.87 4.05 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 126.546 3.069 . . . . 0.99 109.205 178.555 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.6 mt -91.48 3.66 54.43 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.678 -3.764 . . . . 2.53 117.739 169.51 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.2 p -76.6 -31.14 57.27 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.861 2.465 . . . . 2.08 108.578 177.899 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.22 -29.35 3.69 Favored Glycine 0 N--CA 1.43 -1.739 1 N-CA-C 102.78 -4.128 . . . . 1.31 102.78 179.904 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -63.58 131.21 47.33 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.406 2.002 . . . . 1.4 116.406 -170.898 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.9 m -102.1 117.48 34.89 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.345 -1.298 . . . . 0.78 108.895 169.112 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.283 7.7 mt -103.83 109.69 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 129.047 2.939 . . . . 1.55 106.243 -177.2 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.6 m -83.36 131.6 35.05 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.479 1.133 . . . . 1.08 110.21 177.559 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.3 mt -134.06 140.56 46.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.037 -2.289 . . . . 1.55 108.61 -175.759 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -84.3 124.14 30.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.487 2.715 . . . . 1.95 108.583 174.175 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.344 4.1 m -134.42 149.3 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 O-C-N 118.353 -2.717 . . . . 0.96 113.258 -176.423 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -95.73 141.72 23.57 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 115.233 -2.318 . . . . 2.35 105.331 165.291 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -81.98 -15.54 9.22 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 CA-C-N 126.484 3.351 . . . . 0.95 111.512 -167.899 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.8 m -71.56 -11.78 61.03 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 120.734 -1.229 . . . . 1.45 114.08 174.948 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -67.49 159.04 30.47 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.471 2.082 . . . . 1.69 112.235 177.455 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.6 p -87.12 177.37 7.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.323 -2.736 . . . . 0.75 109.1 -177.699 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.1 mt -84.12 -24.0 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 1 O-C-N 114.307 -5.246 . . . . 0.73 114.899 171.671 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.08 -28.39 69.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.153 1.908 . . . . 1.62 116.153 163.049 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -73.29 -36.27 66.26 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 121.221 1.828 . . . . 2.13 111.888 173.889 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.8 t -63.01 -48.8 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 128.504 2.722 . . . . 0.62 114.243 176.421 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -57.91 -33.96 69.32 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.633 2.086 . . . . 1.22 116.633 176.353 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.21 -24.16 67.75 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.227 1.936 . . . . 0.51 116.227 169.827 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -72.86 -31.66 64.89 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 126.397 2.999 . . . . 1.44 116.355 172.947 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.5 mm -68.37 -27.95 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 O-C-N 117.678 -3.139 . . . . 1.32 106.702 169.758 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.424 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 41.6 tt0 -71.49 -39.0 71.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.924 -2.36 . . . . 1.7 112.277 172.283 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -63.04 -41.43 99.51 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 118.227 2.677 . . . . 1.55 118.227 171.603 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -83.96 -58.16 2.9 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.824 2.05 . . . . 2.62 111.941 -174.878 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -97.99 -42.64 7.42 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.491 1.516 . . . . 1.48 109.698 -173.905 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 94.62 57.33 1.27 Allowed Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 128.142 2.782 . . . . 1.12 111.899 179.387 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.1 mt -115.23 122.31 33.47 Favored Pre-proline 0 N--CA 1.431 -1.423 0 N-CA-C 101.927 -3.36 . . . . 1.55 101.927 -177.957 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -66.94 149.29 82.99 Favored 'Trans proline' 0 C--N 1.3 -2.024 1 CA-C-O 108.871 -4.72 . . . . 1.02 108.283 -174.134 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -66.48 -8.54 21.13 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 CA-C-N 127.15 3.589 . . . . 1.25 116.496 -174.645 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.95 -35.16 62.14 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.234 1.969 . . . . 2.25 115.134 175.771 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -81.11 -15.68 55.24 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.214 -3.429 . . . . 2.02 111.753 -177.573 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -70.65 116.49 11.02 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.649 1.98 . . . . 0.69 112.875 -175.202 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.409 ' HB2' HG23 ' A' ' 70' ' ' VAL . 64.2 mtt180 -106.35 124.84 50.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.885 -3.009 . . . . 2.78 105.537 175.561 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.0 tp -112.46 125.58 54.38 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 123.987 1.851 . . . . 1.17 107.085 -175.674 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.1 mm -114.74 125.99 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 O-C-N 120.283 -1.511 . . . . 1.38 110.01 -175.733 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -138.22 118.73 13.86 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.987 -1.857 . . . . 1.5 105.987 171.512 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.6 35.99 1.75 Allowed 'General case' 0 N--CA 1.431 -1.421 1 CA-C-O 129.417 4.437 . . . . 1.21 115.946 175.195 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.29 -21.47 28.28 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 110.423 -3.081 . . . . 1.3 115.052 -175.925 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -100.43 148.38 24.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.138 2.273 . . . . 2.55 117.138 -178.524 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -76.49 119.33 20.19 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 129.901 3.281 . . . . 2.48 109.43 169.819 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.514 HD22 ' CG ' ' A' ' 59' ' ' TYR . 20.5 mt -85.92 147.04 26.43 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.675 2.179 . . . . 0.9 116.85 -177.073 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -92.21 136.65 33.02 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 117.382 -3.324 . . . . 1.94 115.087 176.297 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -66.1 -42.54 89.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.884 -3.01 . . . . 1.56 116.258 -173.19 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.88 -13.95 62.39 Favored Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 125.32 1.438 . . . . 0.97 116.673 169.317 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -77.99 160.55 28.1 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 121.027 2.414 . . . . 2.49 112.306 174.115 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.261 60.8 p -91.15 159.5 16.05 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 116.41 -3.931 . . . . 0.76 110.805 177.331 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mt -70.05 -26.25 63.94 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.285 -1.78 . . . . 1.05 110.095 179.852 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.5 p -77.07 -30.85 55.66 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.079 2.552 . . . . 1.19 111.799 176.527 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.284 3.5 t70 -60.89 -43.18 98.83 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.051 -3.53 . . . . 1.9 114.31 172.35 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.514 ' CG ' HD22 ' A' ' 50' ' ' LEU . 35.6 m-85 -85.27 -6.0 59.28 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 116.743 -1.599 . . . . 0.89 113.293 170.734 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.37 55.6 t30 68.9 50.54 0.61 Allowed 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 123.455 2.843 . . . . 1.84 113.11 175.79 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.46 HD13 HD21 ' A' ' 67' ' ' LEU . 68.2 mt -100.42 124.11 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 105.605 -1.998 . . . . 0.82 105.605 176.169 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -110.82 -173.1 2.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 129.337 3.055 . . . . 2.16 113.504 -177.832 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.314 26.2 tttm -46.4 124.05 5.43 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.961 2.505 . . . . 2.12 112.726 174.568 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.399 44.1 mt-10 61.9 43.16 9.53 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.235 3.014 . . . . 1.71 117.522 174.203 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 t -99.36 153.41 19.0 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.527 2.108 . . . . 1.04 109.876 -175.424 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.287 11.8 m -97.25 107.41 19.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.721 -1.862 . . . . 0.79 113.81 178.465 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.46 HD21 HD13 ' A' ' 61' ' ' ILE . 50.8 mt -88.34 139.8 30.12 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.414 -1.328 . . . . 1.4 107.414 170.196 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -107.38 133.55 51.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 124.628 1.205 . . . . 1.51 109.069 -177.972 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.329 36.9 tp -111.33 121.1 44.36 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 127.161 2.788 . . . . 1.14 109.473 -178.802 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.409 HG23 ' HB2' ' A' ' 42' ' ' ARG . 9.9 m -117.78 164.99 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 116.923 -1.513 . . . . 1.23 111.03 168.787 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.6 mt . . . . . 0 N--CA 1.431 -1.402 0 CA-C-N 122.223 2.283 . . . . 2.78 113.972 176.19 . . . . . . . . 0 0 . 1 . 117 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 114.926 1.454 . . . . 1.1 114.926 . . . . . . . . . 0 0 . 1 . 117 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -101.39 112.77 25.39 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.226 1.81 . . . . 1.87 107.537 -179.504 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -100.42 174.43 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 127.168 2.187 . . . . 0.72 114.183 166.908 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -123.83 141.37 52.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.969 -2.332 . . . . 1.4 110.869 -175.0 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.0 t -106.03 119.37 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 118.026 -2.921 . . . . 0.58 112.372 166.676 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -98.37 119.14 36.54 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 116.468 -3.895 . . . . 2.09 108.716 176.723 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p -73.57 173.26 9.96 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.601 -3.187 . . . . 0.99 119.599 174.036 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.2 mt -53.41 -54.06 42.28 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 118.157 2.651 . . . . 2.53 118.157 170.401 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.4 p -69.23 -24.59 64.03 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 126.393 2.308 . . . . 2.08 111.015 -177.748 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.21 38.07 0.97 Allowed Glycine 0 N--CA 1.43 -1.712 0 O-C-N 119.526 -1.984 . . . . 1.31 112.707 170.25 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -109.98 131.07 55.39 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.867 -3.137 . . . . 1.4 107.023 -173.149 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -89.68 106.62 18.58 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.857 2.063 . . . . 0.78 114.316 177.841 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.4 mt -104.99 120.37 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 103.502 -2.777 . . . . 1.55 103.502 -178.128 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -86.33 132.95 33.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.761 -1.109 . . . . 1.08 111.978 178.971 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.3 mt -136.53 132.9 35.87 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 115.208 -2.33 . . . . 1.55 114.893 -175.698 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -84.39 114.32 21.81 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 131.258 3.823 . . . . 1.95 111.48 173.974 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.5 m -140.77 167.1 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-O 125.097 2.38 . . . . 0.96 106.131 178.763 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -121.07 158.28 53.08 Favored Pre-proline 0 N--CA 1.431 -1.425 0 O-C-N 118.518 -2.613 . . . . 2.35 111.571 168.26 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -59.14 -16.53 33.95 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 O-C-N 111.538 -5.032 . . . . 0.95 116.41 -176.45 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.7 p -79.14 -5.29 53.82 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.086 1.513 . . . . 1.45 115.086 171.691 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.27 46.5 m-20 -76.93 142.62 40.0 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.779 -1.201 . . . . 1.69 109.743 -178.395 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.3 p -86.35 161.08 18.89 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.073 -1.084 . . . . 0.75 108.073 179.761 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.447 HG23 HD12 ' A' ' 43' ' ' LEU . 27.8 mm -58.03 -42.24 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 122.324 1.059 . . . . 0.73 110.727 176.291 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -37.66 -54.01 1.21 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 119.142 3.015 . . . . 1.62 119.142 160.864 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -55.77 -41.9 74.72 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.591 2.756 . . . . 2.13 113.315 176.905 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.6 t -61.66 -50.96 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 126.282 1.833 . . . . 0.62 111.742 173.55 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.4 mttt -61.47 -27.9 68.9 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.458 -3.276 . . . . 1.22 118.237 175.248 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.53 -27.57 64.27 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.56 2.124 . . . . 0.51 113.943 178.0 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -76.47 -36.51 57.82 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.803 -2.436 . . . . 1.44 112.479 176.044 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.56 -30.05 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.908 -1.496 . . . . 1.32 114.808 161.574 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -68.6 -33.36 73.91 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.448 1.476 . . . . 1.7 113.627 179.003 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -78.3 -53.85 6.85 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 117.235 -1.786 . . . . 1.55 115.092 166.354 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -59.19 -43.51 92.19 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 115.153 -2.356 . . . . 2.62 117.309 -174.925 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -108.14 -26.65 10.51 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 126.702 2.501 . . . . 1.48 110.524 -172.713 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.52 48.89 3.83 Favored Glycine 0 N--CA 1.43 -1.767 0 O-C-N 119.987 -1.695 . . . . 1.12 111.914 171.212 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.4 mt -128.57 125.37 23.11 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-O 115.622 -2.133 . . . . 1.55 109.822 -177.876 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 75.5 Cg_exo -66.85 148.76 82.92 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-N 125.484 2.994 . . . . 1.02 114.094 178.16 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 52.1 Cg_exo -69.33 -14.1 36.85 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 N-CA-C 116.63 1.742 . . . . 1.25 116.63 -170.933 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.56 -29.67 70.75 Favored 'General case' 0 N--CA 1.43 -1.449 1 C-N-CA 132.514 4.326 . . . . 2.25 109.029 169.788 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -90.87 -31.1 16.56 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.482 1.66 . . . . 2.02 115.482 -178.697 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.281 77.4 mt-30 -81.08 134.3 35.63 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.856 -1.164 . . . . 0.69 107.856 -175.012 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -121.15 133.4 55.2 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.914 -2.991 . . . . 2.78 105.98 168.898 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 43' ' ' LEU . 98.2 mt -98.01 126.49 43.46 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 105.781 -1.933 . . . . 1.17 105.781 -177.905 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 mm -110.84 138.86 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-N 122.466 2.393 . . . . 1.38 104.616 -178.407 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -144.48 130.15 19.11 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 106.376 -1.713 . . . . 1.5 106.376 163.49 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.05 24.78 14.86 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 120.381 3.474 . . . . 1.21 120.381 177.771 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.86 -18.51 57.39 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 115.72 -2.711 . . . . 1.3 108.439 -179.785 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -101.22 156.72 17.27 Favored 'General case' 0 N--CA 1.431 -1.422 1 CA-C-N 124.847 4.323 . . . . 2.55 111.028 177.382 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.291 39.9 tt0 -96.74 144.57 26.61 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.858 2.742 . . . . 2.48 107.95 175.185 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.6 mt -92.45 148.09 22.38 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.472 -3.268 . . . . 0.9 109.129 -178.727 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -92.93 144.45 25.25 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 130.611 3.564 . . . . 1.94 112.813 -179.522 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -63.64 -54.91 28.34 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.284 -3.385 . . . . 1.56 115.665 -167.479 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.86 42.36 3.05 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-O 123.299 1.5 . . . . 0.97 115.51 173.036 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -110.43 152.95 25.69 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.362 -2.257 . . . . 2.49 105.253 165.281 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.7 p -103.1 158.82 16.04 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.86 2.064 . . . . 0.76 108.256 -177.99 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.0 mt -65.44 -28.31 69.14 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 128.484 2.714 . . . . 1.05 108.378 176.042 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 p -64.59 -40.99 96.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.285 2.634 . . . . 1.19 115.461 171.874 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -65.24 -35.24 80.43 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 124.235 0.959 . . . . 1.9 113.411 176.623 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -85.43 3.1 41.67 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.336 1.606 . . . . 0.89 115.336 179.595 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.0 m120 56.02 32.27 19.62 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 110.698 -2.956 . . . . 1.84 117.895 -174.232 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.6 mm -72.17 130.02 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 1 O-C-N 115.325 -4.609 . . . . 0.82 116.582 176.594 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -117.61 174.81 5.95 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 128.115 2.566 . . . . 2.16 107.049 -168.106 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -54.32 152.8 5.96 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.058 1.503 . . . . 2.12 115.058 172.858 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.37 35.0 mt-10 73.55 14.03 4.37 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 125.554 2.597 . . . . 1.71 115.282 172.112 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.327 27.3 m -78.51 124.39 28.1 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 116.303 1.964 . . . . 1.04 116.303 -175.019 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.6 m -89.59 99.87 12.78 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 118.134 2.642 . . . . 0.79 118.134 177.913 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.5 mt -86.52 139.06 31.23 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.302 -2.481 . . . . 1.4 104.302 176.547 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -97.29 141.5 30.32 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.747 -3.096 . . . . 1.51 108.832 174.685 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.0 tp -106.62 125.62 51.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.11 1.909 . . . . 1.14 111.382 179.954 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.12 163.89 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 105.063 -2.199 . . . . 1.23 105.063 174.695 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.9 mt . . . . . 0 N--CA 1.43 -1.436 0 N-CA-C 101.799 -3.408 . . . . 2.78 101.799 -176.672 . . . . . . . . 0 0 . 1 . 118 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 ttp . . . . . 0 CA--C 1.491 -1.326 0 CA-C-O 118.61 -0.709 . . . . 1.1 112.597 . . . . . . . . . 0 0 . 1 . 118 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -94.31 133.54 37.75 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.562 -2.586 . . . . 1.87 111.716 178.576 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -123.37 159.34 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.269 2.628 . . . . 0.72 106.859 175.278 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.297 44.3 m-85 -128.96 121.71 28.6 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 123.887 1.803 . . . . 1.4 110.679 -177.604 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -100.52 105.01 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 125.851 2.739 . . . . 0.58 110.757 175.308 . . . . . . . . 3 3 . 1 . 118 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -88.13 138.59 31.31 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.547 -3.221 . . . . 2.09 110.066 176.241 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.9 p -90.52 -177.67 5.11 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 127.989 3.306 . . . . 0.99 116.18 -174.405 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.7 mt -82.74 -26.18 32.16 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.564 -1.96 . . . . 2.53 113.169 163.674 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.1 p -64.35 -62.58 1.52 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.507 1.923 . . . . 2.08 114.758 -174.262 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.49 31.61 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.757 0 N-CA-C 105.234 -3.147 . . . . 1.31 105.234 174.826 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -117.61 128.42 54.92 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 123.618 1.675 . . . . 1.4 109.025 -172.493 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.6 m -107.08 102.32 11.67 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 104.526 -2.398 . . . . 0.78 104.526 176.412 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.8 pt -91.27 133.06 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 120.778 1.626 . . . . 1.55 109.998 176.924 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.9 m -91.53 151.19 20.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 121.183 -0.948 . . . . 1.08 108.565 175.544 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.1 mt -144.31 139.39 28.52 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.106 -1.813 . . . . 1.55 106.106 176.48 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -78.0 116.19 18.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.101 1.519 . . . . 1.95 115.101 165.085 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.277 11.3 m -127.75 151.22 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 127.672 2.389 . . . . 0.96 106.839 178.49 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -94.87 161.96 26.8 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 118.107 -2.871 . . . . 2.35 112.622 157.828 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -73.45 -20.95 20.21 Favored 'Trans proline' 0 N--CA 1.433 -2.072 0 CA-C-N 126.69 3.425 . . . . 0.95 115.743 -174.895 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 p -72.59 5.32 3.14 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.488 3.915 . . . . 1.45 114.039 169.011 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -95.82 135.16 37.9 Favored 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 117.775 -3.078 . . . . 1.69 112.909 -179.604 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 26.6 p -67.79 173.98 3.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.21 -2.268 . . . . 0.75 114.225 177.414 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.6 mm -84.88 -29.7 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 118.143 -2.848 . . . . 0.73 105.156 176.861 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -48.95 -48.34 43.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.228 -2.795 . . . . 1.62 116.55 163.622 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -51.87 -50.27 61.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.861 -2.399 . . . . 2.13 115.148 167.369 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.2 t -55.97 -42.75 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 114.73 -2.557 . . . . 0.62 115.246 177.409 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -64.15 -41.11 97.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 125.101 2.382 . . . . 1.22 116.337 174.896 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.85 -43.73 81.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.51 3.124 . . . . 0.51 115.893 166.983 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.41 ' HB2' ' HE2' ' A' ' 29' ' ' LYS . 2.3 ttmm -58.86 -33.29 70.29 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 116.248 -4.033 . . . . 1.44 113.835 170.616 . . . . . . . . 3 3 . 1 . 118 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.9 mt -78.79 -31.09 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 112.907 -1.951 . . . . 1.32 108.969 176.521 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -71.15 -40.35 71.4 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 115.53 1.678 . . . . 1.7 115.53 177.868 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -58.01 -52.11 66.88 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.932 1.456 . . . . 1.55 114.932 168.001 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.2 tttp -70.23 -71.66 0.23 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.579 2.751 . . . . 2.62 113.361 -172.374 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -90.58 -34.24 15.57 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.048 -1.658 . . . . 1.48 111.616 -162.798 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.47 5.55 22.59 Favored Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 105.089 -3.204 . . . . 1.12 105.089 175.593 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 30.9 mt -80.17 122.37 82.86 Favored Pre-proline 0 N--CA 1.431 -1.41 0 CA-C-N 119.087 1.443 . . . . 1.55 108.475 -175.799 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 24.3 Cg_exo -68.31 150.75 76.52 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 C-N-CA 124.58 3.52 . . . . 1.02 110.653 -175.883 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.263 39.0 Cg_endo -62.91 -43.8 18.61 Favored 'Trans proline' 0 N--CA 1.433 -2.039 1 C-N-CA 126.963 5.109 . . . . 1.25 116.469 -168.904 . . . . . . . . 3 2 . 1 . 118 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -55.86 -26.56 47.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 121.792 3.997 . . . . 2.25 121.792 171.945 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -71.17 -34.89 71.36 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.585 1.954 . . . . 2.02 110.691 -179.322 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -70.62 97.71 1.38 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.165 2.283 . . . . 0.69 117.165 -175.299 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -87.44 126.14 34.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 118.341 -0.838 . . . . 2.78 108.96 161.957 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.0 mt -117.8 119.54 35.2 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 121.478 1.945 . . . . 1.17 108.431 -178.639 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 27.4 mt -108.3 128.94 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 128.53 2.732 . . . . 1.38 113.818 -172.426 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.429 ' CE2' HG12 ' A' ' 61' ' ' ILE 0.288 72.1 t80 -144.95 110.92 5.46 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 105.581 -2.007 . . . . 1.5 105.581 178.648 . . . . . . . . 3 3 . 1 . 118 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.82 45.25 7.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.867 1.802 . . . . 1.21 115.867 178.974 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.02 -4.85 36.25 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 120.681 3.032 . . . . 1.3 120.681 -171.534 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -96.3 119.72 35.31 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 130.155 4.091 . . . . 2.55 115.642 177.441 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -79.76 110.29 14.97 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 114.922 -4.861 . . . . 2.48 109.593 168.899 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.2 mt -82.12 146.35 29.66 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.041 -2.287 . . . . 0.9 110.827 -163.765 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -85.3 145.22 27.63 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.836 2.055 . . . . 1.94 114.004 173.536 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.39 -59.07 4.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.594 2.072 . . . . 1.56 116.594 -168.703 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.64 49.82 3.7 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-O 123.943 1.857 . . . . 0.97 116.905 173.744 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -118.25 156.48 28.75 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 101.489 -3.522 . . . . 2.49 101.489 165.443 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 16.9 p -100.07 162.48 12.95 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.686 -3.133 . . . . 0.76 112.784 174.005 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.4 mt -54.87 -48.27 73.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.777 2.831 . . . . 1.05 109.2 174.813 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 p -60.72 -37.92 83.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.07 2.148 . . . . 1.19 113.856 179.085 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -61.31 -33.93 74.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 122.637 2.471 . . . . 1.9 113.375 174.276 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -85.96 -14.34 44.94 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 127.002 2.121 . . . . 0.89 114.055 178.836 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.6 m120 66.84 50.34 1.11 Allowed 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 124.242 1.972 . . . . 1.84 111.739 -177.661 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.429 HG12 ' CE2' ' A' ' 45' ' ' PHE . 70.8 mt -95.78 128.71 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 119.951 -1.718 . . . . 0.82 108.457 174.629 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -100.1 175.98 5.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 112.159 -2.291 . . . . 2.16 111.07 -174.171 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -46.37 137.43 6.43 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.819 -3.05 . . . . 2.12 117.639 166.811 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.253 73.8 mt-10 69.57 14.04 8.27 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.287 -2.758 . . . . 1.71 117.682 175.455 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 m -76.1 148.95 37.53 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 120.438 -1.414 . . . . 1.04 112.826 -175.364 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.1 m -97.28 119.0 34.98 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 126.177 2.173 . . . . 0.79 111.258 -179.365 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.449 ' HB2' HG13 ' A' ' 5' ' ' VAL . 33.3 mt -103.8 136.68 43.03 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.053 -1.655 . . . . 1.4 107.851 170.235 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.431 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 63.5 m80 -91.64 107.5 19.25 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.298 2.332 . . . . 1.51 117.298 174.181 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.449 ' HB2' HG12 ' A' ' 5' ' ' VAL . 15.2 tp -88.09 117.04 26.7 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 124.835 1.254 . . . . 1.14 110.184 -179.334 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.2 t -120.84 143.25 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 126.493 3.044 . . . . 1.23 103.723 178.431 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 N--CA 1.43 -1.456 0 O-C-N 118.149 -2.845 . . . . 2.78 109.126 -175.422 . . . . . . . . 0 0 . 1 . 119 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.27 0.2 OUTLIER . . . . . 0 CA--C 1.491 -1.321 0 N-CA-C 107.138 -1.43 . . . . 1.1 107.138 . . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -115.38 119.96 38.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.765 2.026 . . . . 1.87 109.359 -178.41 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 pt -120.74 158.44 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 122.031 0.919 . . . . 0.72 112.716 -179.905 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -114.37 148.14 38.1 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.878 -2.389 . . . . 1.4 106.299 176.028 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.4 t -124.16 121.86 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 129.385 3.074 . . . . 0.58 105.51 173.118 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -107.16 137.69 44.75 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.305 2.642 . . . . 2.09 112.342 177.004 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.6 p -95.65 -176.83 3.86 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 123.376 1.56 . . . . 0.99 114.329 179.935 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.374 66.4 tp -57.54 -45.81 84.62 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 116.01 -4.181 . . . . 2.53 113.11 172.222 . . . . . . . . 3 2 . 1 . 119 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.5 p -80.11 -35.56 36.65 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 121.579 1.99 . . . . 2.08 111.844 -175.555 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.07 7.16 1.36 Allowed Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 119.524 1.057 . . . . 1.31 113.498 178.14 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.3 mtpt -76.6 130.65 38.15 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.676 -2.661 . . . . 1.4 111.65 -176.555 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.0 m -97.96 113.57 25.44 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 125.22 2.438 . . . . 0.78 113.203 -179.184 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.0 mt -92.4 95.15 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 119.101 -2.249 . . . . 1.55 110.369 178.327 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.6 m -81.48 118.82 23.03 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 120.473 1.488 . . . . 1.08 110.432 175.324 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.4 mt -119.85 153.64 35.51 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.567 -2.382 . . . . 1.55 104.567 178.275 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -110.44 120.17 41.57 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 111.558 -2.565 . . . . 1.95 107.493 174.25 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.87 -176.76 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.457 -2.652 . . . . 0.96 106.287 175.2 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -105.48 163.06 17.88 Favored Pre-proline 0 N--CA 1.431 -1.408 0 O-C-N 116.631 -3.793 . . . . 2.35 104.64 169.693 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -71.1 -14.74 32.03 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 124.012 2.468 . . . . 0.95 112.82 179.055 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.263 18.9 m -92.76 5.82 49.77 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 123.766 2.985 . . . . 1.45 111.572 -179.64 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -82.4 151.09 26.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 127.892 3.71 . . . . 1.69 108.706 176.445 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 68.7 p -79.49 170.57 16.38 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 113.586 -5.696 . . . . 0.75 113.596 179.322 . . . . . . . . 3 3 . 1 . 119 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.41 -30.57 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-N 113.561 -1.654 . . . . 0.73 110.873 178.572 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -54.82 -41.55 70.81 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.922 2.089 . . . . 1.62 113.724 169.36 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -61.9 -45.5 93.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.248 1.944 . . . . 2.13 116.248 171.252 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 56.4 t -51.51 -48.85 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 128.583 2.753 . . . . 0.62 107.896 175.445 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -67.42 -36.12 80.61 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 122.402 2.365 . . . . 1.22 117.384 175.197 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.02 -32.48 73.85 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 116.037 -4.164 . . . . 0.51 118.402 169.008 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -67.19 -31.05 71.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 112.483 -2.144 . . . . 1.44 114.839 170.142 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.293 57.3 mt -68.31 -25.43 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 CA-C-O 125.969 2.795 . . . . 1.32 113.683 172.339 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -85.47 -27.51 25.63 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.84 -4.287 . . . . 1.7 106.835 -174.32 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -78.09 -38.14 44.88 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 114.095 -3.042 . . . . 1.55 111.032 168.92 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -65.08 -61.46 2.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 112.986 0.736 . . . . 2.62 112.986 -172.243 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -106.09 -52.64 2.77 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.209 3.004 . . . . 1.48 108.969 -167.403 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.93 -15.8 5.86 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 119.096 2.398 . . . . 1.12 119.096 176.491 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mt -65.1 131.83 95.24 Favored Pre-proline 0 N--CA 1.43 -1.469 0 CA-C-O 116.499 -1.715 . . . . 1.55 110.337 -175.156 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 93.6 Cg_endo -74.93 155.36 43.25 Favored 'Trans proline' 0 N--CA 1.433 -2.038 0 C-N-CA 125.219 3.946 . . . . 1.02 112.814 -177.136 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.9 Cg_exo -63.84 -27.41 67.4 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 123.663 2.909 . . . . 1.25 119.056 -174.364 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.272 2.6 m-20 -62.08 -32.46 73.01 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.072 1.415 . . . . 2.25 113.39 177.268 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -87.81 -16.91 32.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.159 1.457 . . . . 2.02 114.085 -171.436 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -87.31 127.17 35.19 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 117.148 -1.406 . . . . 0.69 109.698 -174.909 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -118.44 128.18 54.37 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.441 -1.689 . . . . 2.78 106.441 170.421 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.2 mt -95.05 136.76 34.98 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.103 -2.873 . . . . 1.17 112.678 174.565 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 73.0 mt -125.38 117.92 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 124.415 2.055 . . . . 1.38 110.775 178.401 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -109.0 107.82 18.32 Favored 'General case' 0 N--CA 1.43 -1.439 1 N-CA-C 99.77 -4.159 . . . . 1.5 99.77 -178.534 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.88 -74.32 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.477 2.311 . . . . 1.21 113.716 -172.555 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.92 6.11 1.13 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 105.709 -2.956 . . . . 1.3 105.709 178.095 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -94.98 119.04 32.82 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.327 -3.455 . . . . 2.55 110.17 177.747 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -89.08 121.64 31.61 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.862 -2.399 . . . . 2.48 108.642 175.599 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.0 mt -80.08 164.67 23.19 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.158 -1.383 . . . . 0.9 111.599 -164.131 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -115.66 137.05 52.46 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 127.012 3.291 . . . . 1.94 111.396 174.552 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.28 -40.77 97.35 Favored 'General case' 0 N--CA 1.429 -1.483 1 N-CA-C 122.274 4.175 . . . . 1.56 122.274 -166.842 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.42 30.44 5.25 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 118.079 1.991 . . . . 0.97 118.079 171.385 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -105.86 162.61 13.41 Favored 'General case' 0 N--CA 1.43 -1.439 1 CA-C-O 130.099 4.762 . . . . 2.49 107.959 163.073 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 63.0 p -84.25 163.82 19.44 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 113.02 -6.05 . . . . 0.76 109.648 172.279 . . . . . . . . 3 3 . 1 . 119 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.2 mt -64.76 -42.7 94.92 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 121.0 -1.063 . . . . 1.05 109.086 172.432 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.3 p -66.32 -21.56 66.26 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.406 -3.309 . . . . 1.19 115.092 -179.22 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -59.34 -17.69 31.82 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 118.123 2.638 . . . . 1.9 118.123 167.017 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -115.79 11.22 15.56 Favored 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 114.561 -5.087 . . . . 0.89 109.189 178.835 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.334 1.3 t-20 67.01 33.97 5.42 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.568 1.947 . . . . 1.84 114.111 179.044 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.4 mt -92.03 126.37 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 104.759 -2.311 . . . . 0.82 104.759 -174.688 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -125.17 -171.46 2.37 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 119.488 1.04 . . . . 2.16 109.458 -169.25 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -52.68 141.7 20.26 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 118.452 -2.655 . . . . 2.12 112.842 165.722 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.316 4.2 mt-10 60.71 36.46 19.44 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.298 2.873 . . . . 1.71 115.926 175.066 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.4 t -109.49 140.82 42.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 111.562 -2.563 . . . . 1.04 106.74 -167.107 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.3 m -114.18 120.37 40.27 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.782 -1.192 . . . . 0.79 107.782 -167.759 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.7 mt -100.52 161.58 13.51 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.518 2.727 . . . . 1.4 111.186 173.795 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -123.79 109.65 13.92 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.122 2.169 . . . . 1.51 111.196 -177.616 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.9 tp -92.12 122.87 35.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 111.812 -2.449 . . . . 1.14 108.073 -175.008 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.327 4.7 m -118.4 141.03 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 118.802 -2.436 . . . . 1.23 110.953 175.63 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.9 mt . . . . . 0 N--CA 1.431 -1.414 0 O-C-N 117.926 -2.984 . . . . 2.78 110.145 177.226 . . . . . . . . 0 0 . 1 . 120 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 ptt? . . . . . 0 CA--C 1.491 -1.301 0 CA-C-O 120.957 0.408 . . . . 1.1 110.23 . . . . . . . . . 0 0 . 1 . 120 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -107.65 147.38 30.77 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.537 -0.727 . . . . 1.87 112.3 -176.681 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.3 pt -134.09 152.41 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 124.174 1.94 . . . . 0.72 106.385 172.935 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -109.7 134.37 52.05 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 127.019 2.128 . . . . 1.4 114.298 178.619 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -114.14 109.57 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 118.015 -2.928 . . . . 0.58 106.062 178.338 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 6' ' ' LYS . 17.9 tptm -93.61 131.38 38.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.219 -1.551 . . . . 2.09 111.83 178.673 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.1 p -89.07 -178.67 5.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.211 -2.806 . . . . 0.99 113.782 -178.428 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.263 35.4 tp -85.31 -33.47 22.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 119.292 -2.13 . . . . 2.53 108.198 171.85 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.259 59.9 p -68.33 -34.32 75.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.678 -1.889 . . . . 2.08 109.015 -174.095 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.0 44.54 0.44 Allowed Glycine 0 N--CA 1.431 -1.673 0 CA-C-O 115.376 -2.902 . . . . 1.31 113.513 178.378 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -127.55 148.69 50.34 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 114.076 -2.868 . . . . 1.4 110.853 -177.838 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.8 m -122.89 121.76 36.97 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 124.69 3.405 . . . . 0.78 103.626 177.126 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mt -98.13 124.54 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 1 O-C-N 115.971 -4.206 . . . . 1.55 104.355 179.1 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.0 m -101.29 118.2 36.51 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.261 -2.15 . . . . 1.08 107.876 179.912 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.7 mt -117.46 162.3 18.18 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.5 -2.625 . . . . 1.55 109.683 178.3 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -101.26 136.11 41.64 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 127.144 2.777 . . . . 1.95 112.656 166.545 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -142.36 171.26 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 128.085 2.554 . . . . 0.96 107.48 -176.236 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -118.53 148.22 43.65 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 101.904 -3.369 . . . . 2.35 101.904 163.139 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.97 -6.12 17.39 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 O-C-N 115.809 -2.785 . . . . 0.95 118.35 178.07 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.8 p -80.57 -5.77 57.28 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.475 2.71 . . . . 1.45 112.401 169.131 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -70.01 143.17 52.65 Favored 'General case' 0 N--CA 1.431 -1.413 1 CA-C-O 128.515 4.007 . . . . 1.69 111.706 171.129 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.395 53.6 p -75.09 157.05 35.38 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.02 -2.925 . . . . 0.75 112.848 176.493 . . . . . . . . 3 3 . 1 . 120 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.9 mm -71.53 -29.97 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 122.95 1.357 . . . . 0.73 109.634 179.131 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -46.57 -57.9 4.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.561 3.077 . . . . 1.62 115.538 164.661 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -54.48 -34.24 61.22 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 119.849 3.277 . . . . 2.13 119.849 178.017 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 68.9 t -71.05 -35.73 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 112.185 -2.28 . . . . 0.62 111.208 176.109 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -72.96 -34.11 66.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.011 -2.931 . . . . 1.22 113.456 171.76 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.98 -32.63 74.22 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 117.992 -2.943 . . . . 0.51 113.067 174.335 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt -72.42 -33.55 67.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 123.35 1.547 . . . . 1.44 114.853 174.279 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 30' ' ' ILE . 47.2 mt -72.39 -29.99 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 120.399 -1.438 . . . . 1.32 108.309 176.26 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.494 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 7.7 tt0 -64.0 -51.28 64.99 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.809 1.644 . . . . 1.7 112.549 171.803 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -60.75 -39.47 88.85 Favored 'General case' 0 N--CA 1.432 -1.368 0 O-C-N 120.121 -1.612 . . . . 1.55 113.509 175.549 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.6 tptt -67.83 -56.44 9.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.427 -1.421 . . . . 2.62 114.781 -173.818 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.307 71.4 mm-40 -113.71 -15.23 12.49 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 115.755 1.761 . . . . 1.48 115.755 -171.995 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.21 64.31 1.6 Allowed Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 125.169 1.366 . . . . 1.12 110.338 171.303 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.494 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 16.9 mt -141.53 117.07 7.13 Favored Pre-proline 0 N--CA 1.429 -1.485 0 N-CA-C 101.947 -3.353 . . . . 1.55 101.947 -176.436 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.472 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 57.3 Cg_exo -58.01 153.64 43.79 Favored 'Trans proline' 0 C--N 1.3 -2.002 1 C-N-CA 128.218 5.945 . . . . 1.02 111.93 178.149 . . . . . . . . 3 3 . 1 . 120 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 95.2 Cg_exo -71.73 -27.75 17.84 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 CA-C-N 125.454 2.984 . . . . 1.25 115.37 -171.825 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -61.36 -31.62 71.5 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.354 3.062 . . . . 2.25 113.912 178.007 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -92.57 -10.36 37.84 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 116.462 -3.899 . . . . 2.02 105.546 -172.332 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -92.87 132.47 36.98 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 124.062 3.119 . . . . 0.69 109.818 -172.041 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -103.52 125.56 50.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.762 -1.837 . . . . 2.78 109.369 163.811 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.6 mt -113.81 118.51 34.47 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.64 -2.537 . . . . 1.17 109.388 179.16 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mt -110.83 125.36 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 126.824 2.049 . . . . 1.38 109.794 -177.446 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -125.23 130.78 52.76 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.17 -1.789 . . . . 1.5 106.17 168.403 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.78 -76.44 0.07 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.804 1.242 . . . . 1.21 112.0 179.259 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -177.4 33.8 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.649 0 O-C-N 117.258 -3.401 . . . . 1.3 104.809 -175.482 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.32 122.29 16.69 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.644 1.978 . . . . 2.55 107.277 179.444 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -70.85 143.14 51.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.425 -2.672 . . . . 2.48 107.228 166.186 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.1 mt -99.97 139.99 34.83 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 125.268 1.605 . . . . 0.9 110.183 -173.107 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -83.05 161.64 21.63 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 117.767 -1.111 . . . . 1.94 108.886 176.44 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -73.49 -57.15 4.2 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 129.03 2.932 . . . . 1.56 117.131 -169.237 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.04 54.47 3.64 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 126.607 3.337 . . . . 0.97 120.048 172.631 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.253 79.2 mmt-85 -122.58 169.18 11.29 Favored 'General case' 0 N--CA 1.43 -1.444 1 C-N-CA 132.122 4.169 . . . . 2.49 103.306 169.257 . . . . . . . . 3 2 . 1 . 120 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 62.5 p -109.29 -179.72 3.92 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.409 -3.932 . . . . 0.76 108.464 170.561 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 79.8 mt -72.64 -33.67 66.77 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 130.825 3.65 . . . . 1.05 109.738 172.295 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.4 t -73.9 -37.74 64.57 Favored 'General case' 0 N--CA 1.43 -1.468 1 C-N-CA 131.976 4.111 . . . . 1.19 110.688 -176.214 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -64.08 -38.14 89.98 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 113.209 -1.814 . . . . 1.9 113.956 173.509 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -84.0 -2.83 57.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 113.945 -2.931 . . . . 0.89 112.47 170.463 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.417 8.1 t-20 56.9 46.34 19.8 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 121.24 1.836 . . . . 1.84 114.245 -177.043 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.2 mt -88.18 107.31 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 130.713 3.605 . . . . 0.82 108.212 176.621 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -79.33 -175.88 4.92 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.567 -2.583 . . . . 2.16 111.556 -177.131 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -72.88 149.1 43.78 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 118.382 -2.699 . . . . 2.12 108.305 172.98 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 71.51 18.32 5.46 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 126.615 3.102 . . . . 1.71 116.88 174.915 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -83.33 151.64 25.46 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.289 -3.382 . . . . 1.04 117.223 178.951 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.6 m -108.89 110.29 21.58 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.753 -1.203 . . . . 0.79 107.753 -173.604 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.7 mt -87.94 147.58 24.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 102.162 -3.273 . . . . 1.4 102.162 170.878 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -108.41 112.87 25.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.382 -1.34 . . . . 1.51 107.382 -175.761 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.7 tp -87.68 112.0 21.89 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.898 -2.376 . . . . 1.14 110.226 -178.81 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.7 t -111.13 120.23 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 103.055 -2.943 . . . . 1.23 103.055 178.368 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 123.732 1.73 . . . . 2.78 114.435 -178.312 . . . . . . . . 0 0 . 1 . 121 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 CA--C 1.49 -1.329 0 CA-C-O 125.53 2.586 . . . . 1.1 113.826 . . . . . . . . . 0 0 . 1 . 121 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -115.59 108.82 16.92 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.881 -2.387 . . . . 1.87 106.272 -173.861 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.3 pt -114.08 164.49 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 105.733 -1.951 . . . . 0.72 105.733 171.942 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -124.35 151.68 44.05 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.573 -2.01 . . . . 1.4 105.573 -172.09 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 t -134.1 118.52 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 102.86 -3.015 . . . . 0.58 102.86 174.545 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -90.83 141.4 28.85 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.434 -1.321 . . . . 2.09 107.434 171.055 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.2 p -91.49 -162.46 0.92 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.803 2.841 . . . . 0.99 111.45 -178.715 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.5 mt -83.2 -30.89 27.39 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 126.138 2.875 . . . . 2.53 110.132 178.493 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.8 p -82.09 -60.73 2.12 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 113.977 -5.452 . . . . 2.08 110.01 -171.615 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.93 31.41 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 125.03 1.3 . . . . 1.31 111.101 175.101 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -103.76 134.81 46.45 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.949 -4.265 . . . . 1.4 104.676 -174.609 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 m -80.98 119.63 23.75 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 112.779 -2.01 . . . . 0.78 109.908 167.675 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 mt -94.84 117.51 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 104.168 -2.531 . . . . 1.55 104.168 172.468 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.266 99.3 m -86.42 122.0 29.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 124.98 1.312 . . . . 1.08 109.683 179.227 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.492 HD11 HG13 ' A' ' 30' ' ' ILE . 89.3 mt -129.3 112.66 14.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 126.554 3.073 . . . . 1.55 109.146 -174.026 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -79.63 120.79 24.45 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 110.668 -2.969 . . . . 1.95 113.393 174.561 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.1 162.43 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 113.427 -1.715 . . . . 0.96 108.487 -175.235 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -118.54 170.53 6.32 Favored Pre-proline 0 N--CA 1.43 -1.435 0 O-C-N 116.836 -3.665 . . . . 2.35 108.85 168.13 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -62.9 -18.86 66.98 Favored 'Trans proline' 0 C--N 1.3 -1.982 1 C-N-CA 125.42 4.08 . . . . 0.95 120.813 -173.109 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.7 m -95.49 16.19 17.69 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 118.448 2.759 . . . . 1.45 118.448 171.049 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -77.25 148.45 35.77 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 124.746 2.212 . . . . 1.69 106.966 167.421 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.418 ' HB ' ' H ' ' A' ' 23' ' ' ILE . 71.4 p -97.73 -168.26 1.65 Allowed 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.028 -4.795 . . . . 0.75 114.109 175.791 . . . . . . . . 3 3 . 1 . 121 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.418 ' H ' ' HB ' ' A' ' 22' ' ' THR . 33.3 mm -89.1 -30.3 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 119.631 -1.918 . . . . 0.73 110.488 175.114 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -59.41 -32.19 69.95 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 128.0 2.52 . . . . 1.62 114.038 167.118 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.265 71.1 m-20 -64.23 -44.41 91.95 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 130.411 3.484 . . . . 2.13 115.348 161.709 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.9 t -65.91 -33.37 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 114.268 -2.973 . . . . 0.62 117.683 175.305 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.275 53.1 mtmt -73.11 -36.55 66.78 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.261 2.625 . . . . 1.22 109.227 -176.73 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.11 -32.84 71.06 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.631 -2.543 . . . . 0.51 111.197 174.569 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -74.95 -25.35 58.81 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 116.367 -3.958 . . . . 1.44 115.747 176.206 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.492 HG13 HD11 ' A' ' 15' ' ' LEU . 18.4 mt -80.83 -27.53 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 C-N-CA 117.181 -1.808 . . . . 1.32 113.88 172.933 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -64.09 -36.4 83.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.625 1.97 . . . . 1.7 114.351 169.997 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -60.54 -65.07 0.75 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 128.978 3.924 . . . . 1.55 109.786 167.859 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -67.6 -54.07 22.81 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 115.384 1.624 . . . . 2.62 115.384 -172.343 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -113.08 -25.1 9.1 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.951 -2.343 . . . . 1.48 115.001 -164.646 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.69 50.27 2.75 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 118.06 -2.019 . . . . 1.12 116.115 168.651 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.5 mt -120.72 128.4 25.8 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 130.389 3.476 . . . . 1.55 105.021 -178.623 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -63.98 146.73 91.6 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 124.403 3.402 . . . . 1.02 115.839 177.183 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -73.71 -9.05 22.25 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 124.356 3.37 . . . . 1.25 113.315 -171.268 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -87.86 -17.43 31.47 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 115.948 -2.301 . . . . 2.25 112.522 170.404 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -78.97 -25.21 43.48 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 120.179 1.354 . . . . 2.02 114.39 178.587 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -82.22 103.19 11.64 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.37 1.468 . . . . 0.69 113.131 -170.469 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 70' ' ' VAL . 93.9 mtt180 -90.89 118.33 30.2 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.934 -2.354 . . . . 2.78 112.677 170.553 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.409 HD12 HG23 ' A' ' 23' ' ' ILE . 76.9 mt -103.06 114.07 28.05 Favored 'General case' 0 N--CA 1.431 -1.392 1 CA-C-N 126.431 4.196 . . . . 1.17 113.698 -178.151 . . . . . . . . 3 3 . 1 . 121 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.8 mm -97.32 138.71 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 117.062 -1.447 . . . . 1.38 109.622 -177.13 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -157.35 129.46 7.2 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.596 -1.631 . . . . 1.5 106.596 176.251 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.06 9.12 2.91 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.181 1.792 . . . . 1.21 114.187 -174.483 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.57 -28.66 9.3 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 117.641 -1.644 . . . . 1.3 116.865 -176.092 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -96.47 153.8 17.63 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.417 2.377 . . . . 2.55 117.417 179.405 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -82.77 103.72 12.47 Favored 'General case' 0 N--CA 1.43 -1.433 1 C-N-CA 134.336 5.054 . . . . 2.48 112.911 178.017 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.9 mt -69.9 141.89 53.07 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.736 3.16 . . . . 0.9 115.219 -174.979 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.259 34.7 mt-10 -80.41 141.82 34.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.191 2.596 . . . . 1.94 114.381 176.831 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -53.03 -65.15 0.61 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 120.771 3.619 . . . . 1.56 120.771 -177.524 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.25 49.22 3.48 Favored Glycine 0 N--CA 1.43 -1.751 0 O-C-N 127.293 2.871 . . . . 0.97 111.807 178.799 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -118.86 147.63 43.75 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.544 -2.739 . . . . 2.49 104.825 168.873 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -79.66 173.4 12.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 117.125 -1.83 . . . . 0.76 115.16 175.74 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.29 -20.5 60.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.612 -2.555 . . . . 1.05 111.89 172.048 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 t -70.04 -49.03 55.38 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.207 -2.808 . . . . 1.19 110.952 177.6 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -57.04 -36.38 70.42 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.764 1.626 . . . . 1.9 114.02 175.824 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -92.83 5.73 50.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.097 2.159 . . . . 0.89 115.336 177.671 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.447 26.4 m120 44.82 43.25 6.79 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.247 2.619 . . . . 1.84 117.842 -176.796 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.8 mt -81.71 128.27 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 104.914 -2.254 . . . . 0.82 104.914 -176.339 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.268 10.2 mt-30 -105.85 179.94 4.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 127.774 3.171 . . . . 2.16 111.505 -174.155 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 pttp -69.02 129.02 38.73 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 124.807 1.243 . . . . 2.12 112.42 170.168 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 87.24 10.02 0.16 Allowed 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 126.837 2.055 . . . . 1.71 111.611 177.4 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.6 t -85.07 134.83 34.19 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 114.534 -5.104 . . . . 1.04 111.601 -173.542 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.8 m -99.97 120.93 40.57 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 123.697 1.713 . . . . 0.79 110.615 -177.811 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.0 mt -95.84 169.5 9.96 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.619 -1.628 . . . . 1.4 111.354 172.175 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -126.52 110.71 13.56 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.567 -1.958 . . . . 1.51 113.634 -173.281 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.7 tp -87.37 112.23 21.91 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.203 -1.56 . . . . 1.14 108.783 -175.824 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 42' ' ' ARG . 49.4 t -107.46 131.36 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 129.519 3.128 . . . . 1.23 112.068 170.881 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.6 mt . . . . . 0 N--CA 1.431 -1.381 0 O-C-N 120.056 -1.653 . . . . 2.78 111.289 -176.886 . . . . . . . . 0 0 . 1 . 122 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 CA--C 1.491 -1.315 0 CA-C-O 118.85 -0.595 . . . . 1.1 110.761 . . . . . . . . . 0 0 . 1 . 122 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -97.25 118.96 34.86 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 113.633 0.975 . . . . 1.87 113.633 -169.553 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.8 pt -125.59 169.62 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 120.504 1.502 . . . . 0.72 112.725 172.404 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -120.87 154.02 36.39 Favored 'General case' 0 N--CA 1.431 -1.407 1 O-C-N 114.913 -4.867 . . . . 1.4 110.628 -178.211 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.3 t -125.39 135.25 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 103.237 -2.875 . . . . 0.58 103.237 172.901 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -114.22 143.38 44.92 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.837 -3.039 . . . . 2.09 107.579 176.803 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -96.75 170.08 9.43 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.414 1.486 . . . . 0.99 114.566 176.552 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.3 mt -55.7 -45.53 77.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.554 -2.591 . . . . 2.53 110.246 174.355 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 p -73.64 -57.46 3.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 116.66 -1.638 . . . . 2.08 111.936 -177.001 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.11 19.25 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.7 0 CA-C-O 125.549 2.75 . . . . 1.31 117.485 179.156 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -102.99 122.33 44.39 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 111.659 -2.27 . . . . 1.4 109.004 -168.707 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.0 m -95.6 124.62 39.71 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.395 2.521 . . . . 0.78 110.96 177.305 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 mm -100.44 129.7 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 115.034 -2.412 . . . . 1.55 106.824 -179.097 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.4 m -89.72 104.84 17.36 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 124.133 3.152 . . . . 1.08 108.319 179.49 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.4 mt -108.73 146.52 33.39 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 125.455 3.752 . . . . 1.55 120.975 -178.845 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -98.33 131.83 44.31 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 114.245 -1.343 . . . . 1.95 109.44 169.682 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.7 m -144.5 162.47 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 1 C-N-CA 132.127 4.171 . . . . 0.96 108.214 177.831 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -114.13 150.8 44.22 Favored Pre-proline 0 N--CA 1.429 -1.477 0 C-N-CA 126.487 1.915 . . . . 2.35 108.452 166.428 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -62.47 -21.92 73.38 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-O 125.182 2.076 . . . . 0.95 114.59 -168.104 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.8 p -83.26 0.1 47.1 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.273 3.429 . . . . 1.45 111.193 178.923 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -79.99 151.97 29.71 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 115.974 -4.204 . . . . 1.69 105.473 172.525 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 35.0 p -93.57 173.48 7.67 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 112.721 -2.036 . . . . 0.75 113.372 177.865 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 42.2 mm -72.05 -33.13 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 O-C-N 120.542 -1.349 . . . . 0.73 108.276 -179.076 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -55.45 -44.96 76.85 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 125.516 2.579 . . . . 1.62 115.806 167.004 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 -60.09 -42.47 94.69 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 116.075 -4.141 . . . . 2.13 112.595 176.488 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.9 t -69.78 -42.04 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 C-N-CA 129.485 3.114 . . . . 0.62 109.737 172.152 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -64.85 -37.44 87.65 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 125.825 3.92 . . . . 1.22 112.267 -178.668 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.5 -31.59 56.29 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 119.926 3.306 . . . . 0.51 119.926 169.739 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.265 15.9 tppt? -80.15 -35.04 37.16 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 121.543 0.687 . . . . 1.44 111.977 174.087 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.8 mt -60.81 -42.49 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.371 -1.455 . . . . 1.32 114.289 171.215 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -56.11 -39.5 72.27 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.878 2.871 . . . . 1.7 111.622 173.845 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -70.57 -45.47 65.35 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 124.71 1.256 . . . . 1.55 113.718 176.698 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -70.67 -51.69 26.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 115.04 1.496 . . . . 2.62 115.04 -176.643 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -104.48 -14.14 15.8 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.682 1.993 . . . . 1.48 113.903 -168.66 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.21 49.23 34.22 Favored Glycine 0 N--CA 1.431 -1.648 0 O-C-N 118.238 -2.789 . . . . 1.12 112.987 175.438 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.407 ' CD1' HD21 ' A' ' 69' ' ' LEU . 56.9 mt -125.25 126.38 25.14 Favored Pre-proline 0 N--CA 1.429 -1.478 0 N-CA-C 105.047 -2.205 . . . . 1.55 105.047 178.735 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -66.84 150.29 83.24 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 125.237 3.958 . . . . 1.02 111.79 179.983 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -60.08 -31.51 93.47 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 C-N-CA 125.169 3.913 . . . . 1.25 114.721 -173.689 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -56.96 -41.4 78.27 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 130.33 3.452 . . . . 2.25 110.096 176.285 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -89.19 2.72 53.8 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.601 -1.312 . . . . 2.02 113.714 -178.307 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -90.01 116.51 28.1 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.429 2.692 . . . . 0.69 116.678 -173.697 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -111.96 109.03 18.58 Favored 'General case' 0 N--CA 1.429 -1.5 1 O-C-N 115.623 -4.423 . . . . 2.78 111.777 169.2 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 43' ' ' LEU . 51.8 mt -89.4 122.04 32.23 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.943 -1.723 . . . . 1.17 108.537 -178.879 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.3 mm -111.47 123.43 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 126.941 3.258 . . . . 1.38 111.474 177.316 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.276 69.6 t80 -132.31 134.7 45.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 116.531 -3.856 . . . . 1.5 104.533 173.104 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.99 28.22 0.59 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 119.77 3.248 . . . . 1.21 119.77 -177.62 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.8 -12.1 69.83 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 126.033 1.778 . . . . 1.3 111.598 -177.757 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -86.59 145.04 26.91 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.621 -1.517 . . . . 2.55 114.396 -179.347 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -87.09 109.76 19.64 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.033 -2.292 . . . . 2.48 109.615 171.893 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.7 mt -71.16 133.14 45.96 Favored 'General case' 0 N--CA 1.431 -1.423 1 CA-C-O 128.778 4.132 . . . . 0.9 109.303 -170.017 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -89.94 135.69 33.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.363 -3.961 . . . . 1.94 118.123 -179.791 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.407 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 9.0 m-20 -55.05 -54.22 45.83 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 116.864 -3.648 . . . . 1.56 119.332 -168.492 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.55 23.27 16.74 Favored Glycine 0 N--CA 1.429 -1.785 0 CA-C-O 118.424 -1.209 . . . . 0.97 112.026 177.298 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.4 mtt-85 -104.27 161.56 13.94 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 121.679 2.74 . . . . 2.49 108.624 165.981 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.1 p -97.89 156.63 16.51 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.557 2.743 . . . . 0.76 112.993 178.005 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.3 mt -58.86 -32.48 69.48 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.243 2.449 . . . . 1.05 114.878 179.712 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.5 p -69.03 -26.65 65.1 Favored 'General case' 0 N--CA 1.429 -1.52 0 O-C-N 116.627 -3.795 . . . . 1.19 117.558 176.376 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -68.61 -37.18 79.58 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.53 -1.981 . . . . 1.9 110.628 174.974 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -82.0 -13.57 57.21 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 115.262 -2.304 . . . . 0.89 106.779 -178.403 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.3 m120 65.82 56.44 0.89 Allowed 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 126.295 2.247 . . . . 1.84 108.437 -177.174 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.8 mt -99.32 136.17 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 103.922 -2.622 . . . . 0.82 103.922 179.545 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -109.69 178.16 4.51 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 126.318 2.961 . . . . 2.16 109.932 -178.799 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -60.8 152.32 27.38 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 112.4 -2.182 . . . . 2.12 116.212 167.778 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.277 53.4 mt-10 67.04 11.99 8.71 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 114.937 1.458 . . . . 1.71 114.937 -177.899 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -89.16 150.0 22.89 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.067 2.365 . . . . 1.04 109.485 -175.883 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.1 m -104.38 120.28 40.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.175 -1.578 . . . . 0.79 111.757 -176.918 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.3 mt -89.51 135.7 33.45 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.695 -1.878 . . . . 1.4 112.399 172.988 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -105.53 122.5 46.13 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.581 -2.574 . . . . 1.51 104.998 -174.792 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.407 HD21 ' CD1' ' A' ' 36' ' ' ILE . 60.0 tp -93.63 108.51 20.22 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.445 2.298 . . . . 1.14 110.803 -177.084 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.278 28.8 t -98.88 140.29 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 128.179 3.847 . . . . 1.23 105.07 173.216 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 N--CA 1.431 -1.388 0 O-C-N 118.621 -2.55 . . . . 2.78 106.756 170.643 . . . . . . . . 0 0 . 1 . 123 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.4 ttp . . . . . 0 CA--C 1.489 -1.388 0 CA-C-O 117.375 -1.298 . . . . 1.1 109.681 . . . . . . . . . 0 0 . 1 . 123 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -87.8 133.05 33.95 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 120.314 1.415 . . . . 1.87 114.681 -178.704 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pt -138.98 164.54 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 118.582 -2.574 . . . . 0.72 109.332 174.443 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -113.21 146.71 38.84 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 127.053 2.141 . . . . 1.4 110.852 -177.397 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.1 t -126.98 105.61 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 105.886 -1.894 . . . . 0.58 105.886 175.076 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -84.03 120.96 26.76 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 131.631 3.972 . . . . 2.09 115.293 173.761 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.2 p -104.41 -121.96 0.21 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.677 1.362 . . . . 0.99 114.677 -174.163 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.0 tp -159.98 -63.53 0.07 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 103.284 -2.858 . . . . 2.53 103.284 173.585 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.5 p -97.14 93.94 6.84 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 120.418 1.463 . . . . 2.08 111.901 -178.215 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.49 -146.93 17.63 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 127.842 2.639 . . . . 1.31 110.415 176.96 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -90.88 168.33 11.78 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 122.545 1.164 . . . . 1.4 112.154 -174.853 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -102.61 116.91 33.54 Favored 'General case' 0 N--CA 1.431 -1.383 1 N-CA-C 99.382 -4.303 . . . . 0.78 99.382 175.65 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.28 16.4 pt -84.33 152.17 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 128.097 2.559 . . . . 1.55 112.578 178.159 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 m -116.77 128.67 55.52 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 128.345 2.658 . . . . 1.08 106.263 176.617 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.6 mt -122.06 157.43 31.43 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.393 -2.692 . . . . 1.55 108.447 179.663 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -107.65 120.88 43.45 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.019 -2.301 . . . . 1.95 104.983 170.996 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.1 m -131.03 172.55 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 125.435 1.494 . . . . 0.96 109.806 -175.263 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -112.94 152.7 45.1 Favored Pre-proline 0 N--CA 1.43 -1.441 0 CA-C-O 116.304 -1.808 . . . . 2.35 111.136 164.911 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.76 -22.32 32.26 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 126.335 3.298 . . . . 0.95 114.118 -176.345 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.0 m -72.45 -12.88 61.28 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 116.137 -1.887 . . . . 1.45 110.251 176.073 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -66.08 135.54 54.76 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 123.4 2.818 . . . . 1.69 117.842 177.276 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.5 p -69.83 160.91 30.89 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 117.547 -3.221 . . . . 0.75 112.873 176.795 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 mm -66.58 -42.28 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 128.025 2.53 . . . . 0.73 108.279 175.366 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -45.93 -49.62 15.52 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.084 2.624 . . . . 1.62 118.084 161.275 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -68.31 -45.53 72.72 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 127.547 3.029 . . . . 2.13 111.447 178.997 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.453 HG21 HD11 ' A' ' 56' ' ' LEU . 58.5 t -59.02 -30.1 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 115.209 1.559 . . . . 0.62 115.209 173.936 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -68.38 -35.56 77.88 Favored 'General case' 0 N--CA 1.43 -1.475 1 O-C-N 113.871 -5.518 . . . . 1.22 111.671 169.657 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.2 -46.76 82.6 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 124.106 1.908 . . . . 0.51 115.506 169.6 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -47.98 -49.84 29.41 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 127.0 2.12 . . . . 1.44 109.046 169.727 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.2 mt -62.63 -30.34 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 123.653 2.933 . . . . 1.32 116.856 175.462 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -68.48 -34.64 76.29 Favored 'General case' 0 N--CA 1.431 -1.414 1 CA-C-O 128.821 4.153 . . . . 1.7 114.52 -174.181 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -61.74 -41.41 97.62 Favored 'General case' 0 N--CA 1.432 -1.369 2 O-C-N 115.043 -4.786 . . . . 1.55 112.178 172.286 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -91.74 -65.65 0.99 Allowed 'General case' 0 N--CA 1.429 -1.495 1 O-C-N 115.556 -4.465 . . . . 2.62 107.467 -172.801 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -88.36 -17.77 29.85 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 126.111 2.862 . . . . 1.48 116.158 -165.241 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.75 34.31 28.12 Favored Glycine 0 N--CA 1.43 -1.747 0 O-C-N 117.648 -3.158 . . . . 1.12 116.248 176.629 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.8 mt -107.85 121.92 42.49 Favored Pre-proline 0 N--CA 1.429 -1.492 0 N-CA-C 107.011 -1.477 . . . . 1.55 107.011 -178.354 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.288 52.8 Cg_exo -51.36 146.8 23.54 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-O 113.875 -2.635 . . . . 1.02 116.357 175.78 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -68.67 -23.1 36.68 Favored 'Trans proline' 0 C--N 1.299 -2.058 1 C-N-CA 125.761 4.307 . . . . 1.25 110.249 -175.623 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -84.44 -18.48 35.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.555 2.428 . . . . 2.25 117.555 176.573 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -88.34 -24.15 23.21 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 115.465 1.654 . . . . 2.02 115.465 -177.59 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -100.57 139.25 36.52 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.568 1.547 . . . . 0.69 112.528 -177.201 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -118.4 133.14 56.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 107.89 -1.152 . . . . 2.78 107.89 175.172 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.6 mt -99.5 127.0 45.54 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.733 1.606 . . . . 1.17 114.762 -179.441 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.0 mm -107.86 138.41 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 1 O-C-N 130.357 4.786 . . . . 1.38 107.121 -177.09 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -145.72 140.05 26.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.441 -3.912 . . . . 1.5 102.274 171.552 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.301 . . 62.5 -96.13 0.05 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.604 1.561 . . . . 1.21 109.079 -174.66 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.61 24.59 1.2 Allowed Glycine 0 N--CA 1.429 -1.817 0 O-C-N 127.744 3.153 . . . . 1.3 110.217 -179.291 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -121.34 147.87 45.11 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.2 1.8 . . . . 2.55 107.793 -177.37 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -95.98 130.97 42.82 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.897 -1.956 . . . . 2.48 107.58 173.306 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mt -96.15 124.79 40.29 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.805 3.261 . . . . 0.9 119.805 -172.813 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -66.14 132.75 49.2 Favored 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 132.549 4.34 . . . . 1.94 114.024 177.429 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -63.64 -32.87 74.48 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.297 -3.377 . . . . 1.56 114.737 -169.239 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.84 25.71 7.28 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 116.374 -3.953 . . . . 0.97 115.362 173.662 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -121.47 168.28 11.88 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 120.766 2.283 . . . . 2.49 111.134 173.614 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 p -104.83 154.6 19.83 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.185 1.469 . . . . 0.76 111.262 -178.39 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.453 HD11 HG21 ' A' ' 26' ' ' VAL . 24.8 mt -51.48 -37.96 51.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.046 1.879 . . . . 1.05 113.268 173.444 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -59.16 -50.1 75.33 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.48 -3.263 . . . . 1.19 117.057 171.391 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -43.04 -47.72 5.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.986 -3.571 . . . . 1.9 113.882 168.046 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -77.97 -13.61 59.82 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 117.762 2.504 . . . . 0.89 117.762 177.415 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.5 m120 69.08 63.9 0.29 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.631 1.972 . . . . 1.84 112.723 178.523 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.4 mt -98.33 137.1 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 117.43 -3.293 . . . . 0.82 106.837 176.22 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -117.58 -179.47 3.74 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 106.32 -1.733 . . . . 2.16 106.32 -174.659 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -71.3 140.45 50.31 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 126.77 2.544 . . . . 2.12 115.363 176.712 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 22.9 mt-10 70.83 46.53 0.49 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 126.133 2.873 . . . . 1.71 114.099 177.308 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.3 m -109.42 135.46 50.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 112.076 -2.329 . . . . 1.04 113.298 -173.643 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.3 m -92.47 99.81 12.48 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.788 -3.07 . . . . 0.79 112.392 -173.985 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mp -81.95 146.35 29.82 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.168 -1.79 . . . . 1.4 106.168 176.344 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -107.91 138.44 44.16 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.934 -1.506 . . . . 1.51 106.934 -175.363 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 tt -106.56 122.07 45.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 119.983 1.265 . . . . 1.14 111.435 -177.606 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.6 m -107.84 122.45 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 104.922 -2.251 . . . . 1.23 104.922 175.5 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 N--CA 1.429 -1.479 0 C-N-CA 128.707 2.803 . . . . 2.78 116.863 -173.385 . . . . . . . . 0 0 . 1 . 124 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.3 ttp . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 117.391 2.367 . . . . 1.1 117.391 . . . . . . . . . 0 0 . 1 . 124 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -109.58 113.48 26.3 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.492 1.293 . . . . 1.87 114.492 -173.499 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.51 HD12 HD13 ' A' ' 67' ' ' LEU . 20.3 pt -111.41 171.15 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 119.597 -1.94 . . . . 0.72 110.062 174.246 . . . . . . . . 2 2 . 1 . 124 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -124.65 122.67 38.17 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.869 2.068 . . . . 1.4 108.07 -176.617 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.507 HG22 ' HB2' ' A' ' 67' ' ' LEU . 45.6 t -104.41 114.17 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 118.549 -2.594 . . . . 0.58 110.091 171.169 . . . . . . . . 2 2 . 1 . 124 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -93.37 158.22 15.84 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.06 -3.525 . . . . 2.09 108.909 178.063 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.9 p -119.27 172.91 7.27 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.533 -3.23 . . . . 0.99 114.369 -178.945 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.2 tp -72.55 -47.3 49.3 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.572 1.653 . . . . 2.53 110.97 178.647 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.9 p -73.65 -30.67 63.07 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.479 -1.388 . . . . 2.08 113.271 -176.398 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.07 2.07 0.65 Allowed Glycine 0 N--CA 1.43 -1.724 0 O-C-N 117.021 -3.55 . . . . 1.31 117.203 176.995 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -91.28 149.84 21.58 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 122.667 3.234 . . . . 1.4 108.57 -179.664 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.2 m -134.95 112.8 10.92 Favored 'General case' 0 N--CA 1.431 -1.398 1 N-CA-C 100.138 -4.023 . . . . 0.78 100.138 -179.806 . . . . . . . . 2 2 . 1 . 124 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 mt -106.31 113.35 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 129.741 3.217 . . . . 1.55 114.231 -171.682 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.6 m -74.75 114.98 13.81 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.662 -2.524 . . . . 1.08 115.542 173.445 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.1 mt -113.66 129.11 56.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.515 1.507 . . . . 1.55 109.088 -176.791 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -97.72 113.86 25.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.618 -1.301 . . . . 1.95 111.714 174.704 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -116.5 166.62 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 126.395 2.309 . . . . 0.96 110.569 -170.599 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -112.19 155.34 43.66 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 113.252 -3.261 . . . . 2.35 105.69 164.641 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.9 -21.73 63.81 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 CA-C-N 124.207 2.538 . . . . 0.95 117.433 -175.957 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.5 p -73.89 -17.31 61.06 Favored 'General case' 0 N--CA 1.431 -1.41 1 C-N-CA 134.307 5.043 . . . . 1.45 118.927 173.024 . . . . . . . . 2 2 . 1 . 124 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -69.14 143.47 54.11 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 125.475 2.56 . . . . 1.69 109.301 174.083 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 3.3 p -94.74 164.12 13.07 Favored 'General case' 0 N--CA 1.431 -1.408 1 O-C-N 116.197 -4.064 . . . . 0.75 105.154 -177.43 . . . . . . . . 3 3 . 1 . 124 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.1 mm -56.27 -42.91 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 126.666 2.479 . . . . 0.73 111.605 176.651 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -46.77 -50.55 18.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 116.213 1.931 . . . . 1.62 116.213 164.559 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -74.02 -24.97 59.63 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 121.919 2.145 . . . . 2.13 111.166 178.45 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.2 t -74.06 -33.27 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 116.867 -3.646 . . . . 0.62 111.322 176.44 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -71.16 -28.84 64.55 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.347 -3.971 . . . . 1.22 109.231 172.366 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.57 -28.13 69.66 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 115.914 -4.241 . . . . 0.51 117.377 168.192 . . . . . . . . 2 2 . 1 . 124 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -74.16 -30.87 62.47 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 122.593 2.452 . . . . 1.44 109.021 -178.134 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.0 mt -67.69 -35.71 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 O-C-N 127.216 2.822 . . . . 1.32 114.813 172.284 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -73.33 -15.8 61.38 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 118.993 2.96 . . . . 1.7 118.993 178.157 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -69.07 -43.0 75.48 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.436 1.273 . . . . 1.55 114.436 162.721 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -73.06 -61.07 1.94 Allowed 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 126.893 3.235 . . . . 2.62 112.348 -175.405 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -100.15 -30.34 11.99 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.133 -2.854 . . . . 1.48 110.16 -164.564 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.43 33.11 7.75 Favored Glycine 0 N--CA 1.431 -1.674 0 O-C-N 128.116 3.385 . . . . 1.12 115.729 173.239 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.3 mt -106.05 129.21 24.93 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 116.566 -1.683 . . . . 1.55 107.291 -177.975 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -62.82 142.65 89.57 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 124.405 3.404 . . . . 1.02 119.747 175.98 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.28 -17.65 35.07 Favored 'Trans proline' 0 C--N 1.299 -2.057 0 N-CA-C 118.445 2.441 . . . . 1.25 118.445 -178.111 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -68.15 -24.87 65.04 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.72 -1.237 . . . . 2.25 113.728 173.144 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -93.69 -18.11 22.48 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.746 1.736 . . . . 2.02 111.184 -179.493 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -95.02 154.15 17.3 Favored 'General case' 0 N--CA 1.431 -1.378 0 O-C-N 118.419 -2.676 . . . . 0.69 110.82 -176.264 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -141.32 151.35 43.53 Favored 'General case' 0 N--CA 1.43 -1.465 1 C-N-CA 133.284 4.633 . . . . 2.78 113.257 171.136 . . . . . . . . 2 2 . 1 . 124 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.5 mt -115.99 132.61 56.6 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.211 -2.806 . . . . 1.17 111.035 177.404 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.1 mt -109.73 123.1 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.354 -1.35 . . . . 1.38 107.354 -178.529 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -145.72 140.92 27.57 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.382 -2.699 . . . . 1.5 103.976 175.712 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.85 14.21 7.99 Favored 'General case' 0 N--CA 1.43 -1.434 1 C-N-CA 131.717 4.007 . . . . 1.21 114.53 -176.555 . . . . . . . . 2 2 . 1 . 124 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.95 -30.39 10.52 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 125.74 1.638 . . . . 1.3 115.441 -171.796 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -101.25 156.16 17.6 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 120.73 2.265 . . . . 2.55 115.422 -177.974 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -72.29 135.62 46.02 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 116.897 -1.525 . . . . 2.48 113.416 167.797 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.6 mt -89.05 145.57 25.39 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.102 2.228 . . . . 0.9 112.716 -176.119 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -72.55 139.24 47.4 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.203 -2.186 . . . . 1.94 111.549 173.418 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -66.99 -56.25 10.96 Favored 'General case' 0 N--CA 1.431 -1.409 1 C-N-CA 131.826 4.05 . . . . 1.56 119.49 -168.519 . . . . . . . . 2 2 . 1 . 124 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.6 37.14 2.78 Favored Glycine 0 N--CA 1.43 -1.757 0 O-C-N 117.936 -2.977 . . . . 0.97 116.775 175.564 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -114.13 160.49 18.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.866 -2.549 . . . . 2.49 108.576 171.266 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.452 54.7 p -87.49 146.27 25.89 Favored 'General case' 0 N--CA 1.43 -1.47 1 C-N-CA 132.103 4.161 . . . . 0.76 111.571 179.711 . . . . . . . . 4 3 . 1 . 124 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mt -55.46 -34.87 64.9 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 114.694 1.368 . . . . 1.05 114.694 172.026 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 p -64.11 -33.81 76.62 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.238 3.015 . . . . 1.19 112.975 178.567 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -66.62 -37.12 84.19 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 125.047 1.339 . . . . 1.9 113.74 178.226 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -85.92 -5.13 59.28 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.06 1.344 . . . . 0.89 110.038 175.152 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.4 t30 60.74 38.45 18.25 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 127.053 3.311 . . . . 1.84 116.257 179.139 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.0 mt -74.82 125.24 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 O-C-N 116.892 -3.63 . . . . 0.82 109.611 -177.405 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -99.19 -175.84 3.14 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.217 -2.802 . . . . 2.16 111.854 -176.982 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -70.68 160.67 32.18 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 124.116 1.912 . . . . 2.12 111.233 177.165 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.384 16.4 mt-10 44.83 48.54 9.1 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 118.133 2.642 . . . . 1.71 118.133 179.626 . . . . . . . . 2 2 . 1 . 124 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.6 m -107.28 144.05 34.66 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 127.34 2.9 . . . . 1.04 106.028 -175.941 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.6 m -108.75 103.81 12.96 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.586 -1.188 . . . . 0.79 108.118 -178.205 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.51 HD13 HD12 ' A' ' 3' ' ' ILE . 4.1 mp -87.62 158.51 18.85 Favored 'General case' 0 N--CA 1.429 -1.475 1 C-N-CA 132.52 4.328 . . . . 1.4 106.377 173.339 . . . . . . . . 3 3 . 1 . 124 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -121.28 142.89 49.51 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 102.079 -3.304 . . . . 1.51 102.079 -174.085 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.5 tp -97.99 129.35 44.87 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 114.669 -2.586 . . . . 1.14 108.975 -179.784 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 m -129.72 168.05 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 121.642 2.019 . . . . 1.23 106.632 171.092 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.43 -1.456 0 O-C-N 119.384 -2.073 . . . . 2.78 106.772 -177.147 . . . . . . . . 0 0 . 1 . 125 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptt? . . . . . 0 CA--C 1.489 -1.389 0 N-CA-C 108.363 -0.977 . . . . 1.1 108.363 . . . . . . . . . 0 0 . 1 . 125 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -102.39 131.58 48.94 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.009 2.124 . . . . 1.87 112.365 -172.147 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.1 pt -139.07 157.17 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-O 125.606 2.622 . . . . 0.72 106.625 176.651 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -109.01 121.7 45.69 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.834 -2.416 . . . . 1.4 112.764 -176.954 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.1 t -96.85 103.42 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 116.854 -3.654 . . . . 0.58 107.166 175.073 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -76.43 136.43 39.44 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 118.567 2.803 . . . . 2.09 118.567 168.272 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -83.33 169.96 15.08 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.065 -4.147 . . . . 0.99 109.847 177.622 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.512 HD11 HG13 ' A' ' 70' ' ' VAL . 19.2 mt -60.71 -42.64 97.64 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.419 -2.676 . . . . 2.53 115.455 170.324 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -75.44 -51.2 13.61 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 127.145 2.778 . . . . 2.08 116.148 -176.706 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.21 -44.84 0.19 Allowed Glycine 0 N--CA 1.431 -1.695 0 CA-C-O 113.956 -3.691 . . . . 1.31 114.161 -177.845 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -53.51 136.18 38.7 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 122.62 3.21 . . . . 1.4 118.625 -177.445 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.266 88.5 m -107.72 98.7 8.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.79 1.757 . . . . 0.78 107.818 178.4 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -80.72 98.64 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 125.695 2.664 . . . . 1.55 110.195 177.231 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.5 m -82.12 122.85 28.38 Favored 'General case' 0 N--CA 1.429 -1.498 1 O-C-N 115.153 -4.717 . . . . 1.08 110.722 178.269 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.5 mt -122.28 144.32 49.07 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.175 1.917 . . . . 1.55 116.175 -178.494 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -103.86 124.83 49.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 116.42 -2.112 . . . . 1.95 108.749 174.905 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.8 m -140.98 165.08 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.041 -1.662 . . . . 0.96 108.094 -171.122 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.293 4.6 mm-40 -102.75 150.19 37.49 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-O 114.538 -2.649 . . . . 2.35 110.518 163.578 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.41 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 33.3 Cg_endo -75.96 -14.9 18.95 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 125.877 3.135 . . . . 0.95 109.12 -171.963 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.1 p -81.18 -1.31 44.16 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 123.836 1.779 . . . . 1.45 114.129 174.202 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -75.02 147.92 40.31 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 118.315 -2.74 . . . . 1.69 113.021 172.309 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.649 ' O ' HG23 ' A' ' 26' ' ' VAL . 41.0 p -85.82 176.42 8.12 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 124.287 1.994 . . . . 0.75 112.894 -175.349 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.252 20.8 mm -76.85 -37.23 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 116.345 -3.972 . . . . 0.73 106.278 177.832 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -53.33 -36.36 61.2 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.282 -3.386 . . . . 1.62 112.027 169.027 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -74.83 -46.08 38.96 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 120.629 1.559 . . . . 2.13 112.281 177.365 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 22' ' ' THR . 26.1 t -57.3 -43.26 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 C-N-CA 128.829 2.852 . . . . 0.62 112.02 175.538 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -70.26 -34.26 72.6 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.661 2.467 . . . . 1.22 117.661 171.509 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.94 89.29 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.598 -1.939 . . . . 0.51 106.855 178.057 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -57.97 -41.52 83.1 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 119.292 3.071 . . . . 1.44 119.292 167.567 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.268 65.3 mt -63.22 -35.91 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.242 -2.786 . . . . 1.32 113.66 170.635 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -61.37 -41.26 96.81 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 130.747 3.619 . . . . 1.7 109.389 172.074 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -58.15 -57.53 12.45 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 114.45 1.278 . . . . 1.55 114.45 177.195 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -73.13 -63.59 1.15 Allowed 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 117.731 2.493 . . . . 2.62 117.731 -174.284 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -101.35 -19.06 15.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.071 -1.643 . . . . 1.48 111.566 -168.529 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.76 30.3 6.88 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 118.215 2.046 . . . . 1.12 118.215 173.696 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.9 mt -106.15 119.2 52.86 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-N 121.35 2.575 . . . . 1.55 109.104 -176.018 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -56.28 145.89 75.19 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 CA-C-N 127.263 3.629 . . . . 1.02 114.363 174.946 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -82.72 -5.31 11.56 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 124.499 3.466 . . . . 1.25 108.493 -166.214 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -80.93 -23.74 38.67 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.516 1.507 . . . . 2.25 111.384 176.389 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -90.07 -12.75 37.56 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.051 -2.281 . . . . 2.02 111.657 -178.192 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -87.21 123.49 32.28 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 130.167 3.387 . . . . 0.69 111.647 -174.682 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -123.47 114.13 19.69 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-O 125.107 2.384 . . . . 2.78 109.472 161.777 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.9 mt -87.18 138.6 31.35 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 124.346 2.022 . . . . 1.17 106.486 -178.553 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.6 mt -135.37 128.54 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 128.006 2.523 . . . . 1.38 110.209 -178.54 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -127.17 115.32 18.92 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 115.291 -4.631 . . . . 1.5 104.603 177.931 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 73.15 -58.52 0.6 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.729 2.812 . . . . 1.21 110.605 177.082 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.412 ' H ' ' H ' ' A' ' 48' ' ' LYS . . . -162.66 -13.73 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 O-C-N 120.502 -1.374 . . . . 1.3 111.849 -178.365 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.412 ' H ' ' H ' ' A' ' 47' ' ' GLY . 48.4 mttt -98.62 134.0 42.17 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.127 -1.536 . . . . 2.55 109.502 -177.163 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -73.27 140.61 46.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.838 2.055 . . . . 2.48 108.856 166.828 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.0 mt -97.56 123.28 41.39 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.204 -1.776 . . . . 0.9 106.204 -170.853 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -91.46 145.68 24.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.747 -2.471 . . . . 1.94 110.26 178.955 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -43.26 -57.59 2.92 Favored 'General case' 0 N--CA 1.43 -1.439 1 C-N-CA 131.993 4.117 . . . . 1.56 119.818 -175.757 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.15 7.29 8.13 Favored Glycine 0 N--CA 1.43 -1.728 1 N-CA-C 123.149 4.02 . . . . 0.97 123.149 168.524 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -98.23 167.07 11.09 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 120.656 2.228 . . . . 2.49 112.158 167.738 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.341 18.6 p -109.81 166.61 10.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.828 2.159 . . . . 0.76 116.828 -179.137 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.6 mt -61.98 -35.36 78.28 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.029 2.347 . . . . 1.05 111.62 172.21 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 5.8 t -75.84 -33.03 60.02 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.601 -2.562 . . . . 1.19 113.477 -179.997 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -56.42 -46.4 80.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.834 2.054 . . . . 1.9 114.116 166.248 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -84.77 -9.22 58.4 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 121.817 2.099 . . . . 0.89 112.756 -179.617 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.522 12.8 m120 81.68 46.52 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 125.867 1.667 . . . . 1.84 113.591 175.403 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.1 mt -96.8 118.81 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 113.495 -1.684 . . . . 0.82 114.012 179.931 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -115.1 -179.02 3.51 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 106.319 -1.734 . . . . 2.16 106.319 -174.964 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -62.05 151.87 34.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 127.801 2.441 . . . . 2.12 114.405 -178.675 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 66.2 29.55 9.66 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.797 2.237 . . . . 1.71 110.746 177.495 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.6 p -106.71 150.95 25.75 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 113.982 -5.449 . . . . 1.04 109.298 -176.158 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.4 m -103.14 122.18 44.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.329 2.49 . . . . 0.79 109.668 179.713 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -110.57 145.21 38.22 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 118.615 -2.553 . . . . 1.4 105.539 176.559 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -100.67 136.12 41.03 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 118.58 -2.575 . . . . 1.51 107.189 179.859 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.5 tp -113.96 123.96 50.99 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.961 -1.712 . . . . 1.14 108.21 174.691 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.512 HG13 HD11 ' A' ' 8' ' ' LEU . 48.8 t -105.85 134.51 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 103.083 -2.932 . . . . 1.23 103.083 176.04 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.8 tp . . . . . 0 N--CA 1.43 -1.448 0 CA-C-O 125.339 2.495 . . . . 2.78 111.985 174.825 . . . . . . . . 0 0 . 1 . 126 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.4 ttp . . . . . 0 CA--C 1.49 -1.335 0 CA-C-O 117.396 -1.288 . . . . 1.1 110.935 . . . . . . . . . 0 0 . 1 . 126 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -81.34 133.1 35.37 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 120.405 1.457 . . . . 1.87 111.21 -179.136 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 pt -140.25 162.73 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 123.981 1.848 . . . . 0.72 108.072 173.565 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -120.66 133.31 55.37 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 102.226 -3.25 . . . . 1.4 102.226 -177.148 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.0 t -109.48 123.83 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 127.994 2.517 . . . . 0.58 104.831 167.829 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -101.06 124.16 46.34 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.787 -1.821 . . . . 2.09 111.43 176.74 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.423 HG22 HD23 ' A' ' 69' ' ' LEU . 1.3 p -85.84 151.81 23.5 Favored 'General case' 0 N--CA 1.431 -1.41 1 O-C-N 115.448 -4.533 . . . . 0.99 114.041 175.032 . . . . . . . . 3 3 . 1 . 126 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.5 tp -34.56 -54.1 0.54 Allowed 'General case' 0 N--CA 1.43 -1.434 1 C-N-CA 133.018 4.527 . . . . 2.53 115.404 169.83 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.4 p -81.88 -31.78 31.32 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 125.872 1.982 . . . . 2.08 110.644 -170.93 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.78 17.28 0.11 Allowed Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 118.444 -1.836 . . . . 1.31 117.048 178.862 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -114.79 141.91 47.23 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 115.68 -4.423 . . . . 1.4 105.404 -177.685 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.5 m -105.77 124.79 50.13 Favored 'General case' 0 N--CA 1.429 -1.522 0 O-C-N 123.358 0.411 . . . . 0.78 109.944 173.473 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.402 HD13 HG23 ' A' ' 30' ' ' ILE . 2.4 mt -93.46 116.09 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 125.577 2.608 . . . . 1.55 105.933 179.889 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.2 m -92.26 102.45 14.95 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 115.507 -4.495 . . . . 1.08 107.323 174.72 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.5 mt -90.96 160.21 15.77 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.526 -1.359 . . . . 1.55 110.54 178.616 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -125.3 114.06 18.41 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 119.854 -1.779 . . . . 1.95 108.008 165.715 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.01 -176.2 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 119.205 -2.185 . . . . 0.96 110.382 -173.318 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -107.08 149.12 38.22 Favored Pre-proline 0 N--CA 1.43 -1.432 0 CA-C-O 114.096 -2.859 . . . . 2.35 109.622 167.145 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.39 -24.15 19.68 Favored 'Trans proline' 0 N--CA 1.433 -2.054 1 CA-C-N 128.661 4.129 . . . . 0.95 111.807 -171.561 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.8 m -102.03 16.29 26.47 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 126.318 2.261 . . . . 1.45 116.873 -179.352 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.83 157.56 25.68 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.306 1.527 . . . . 1.69 112.446 173.227 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 1.8 p -86.68 162.58 17.84 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.51 3.052 . . . . 0.75 116.204 -176.903 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mm -70.45 -38.96 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 1 O-C-N 115.124 -4.735 . . . . 0.73 107.512 -179.289 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -47.58 -54.11 12.7 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.346 3.058 . . . . 1.62 111.592 167.937 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -62.22 -36.98 83.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.945 2.898 . . . . 2.13 118.178 171.375 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.372 4.2 t -63.3 -39.31 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 116.57 -3.831 . . . . 0.62 112.52 174.847 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -65.91 -32.39 73.87 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.844 2.165 . . . . 1.22 116.844 172.089 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.82 -31.62 72.36 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.636 -1.915 . . . . 0.51 114.1 170.472 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -68.24 -26.88 65.91 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.276 1.988 . . . . 1.44 115.217 170.199 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.402 HG23 HD13 ' A' ' 13' ' ' ILE . 84.4 mt -75.2 -28.25 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 117.385 -3.322 . . . . 1.32 114.174 170.489 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -70.81 -38.39 73.29 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.352 2.501 . . . . 1.7 115.062 170.3 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.83 -36.84 85.23 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 116.748 -3.72 . . . . 1.55 111.917 172.513 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -85.35 -53.39 5.25 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.478 1.609 . . . . 2.62 110.919 -176.69 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -100.73 -43.98 5.96 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.882 -3.011 . . . . 1.48 117.141 -174.069 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.66 -0.73 18.03 Favored Glycine 0 N--CA 1.429 -1.806 0 CA-C-O 117.01 -1.994 . . . . 1.12 111.599 178.194 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.0 mt -70.22 130.72 89.23 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-N 121.099 2.45 . . . . 1.55 112.733 -178.805 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -76.32 154.3 36.29 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 O-C-N 115.556 -2.918 . . . . 1.02 116.023 174.788 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -71.8 -6.81 19.89 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 124.009 3.139 . . . . 1.25 113.039 -169.13 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -67.58 -35.03 78.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.345 3.058 . . . . 2.25 109.132 175.116 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -85.28 -22.32 28.64 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.384 -1.448 . . . . 2.02 113.396 178.708 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -83.19 119.16 24.19 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.028 -2.92 . . . . 0.69 117.622 -168.654 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.425 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 51.4 ttt180 -107.83 118.78 37.63 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 105.297 -2.112 . . . . 2.78 105.297 172.758 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.5 mt -113.73 122.51 47.33 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 116.375 -1.774 . . . . 1.17 108.671 -177.092 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.3 mt -120.19 136.2 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 124.574 2.13 . . . . 1.38 107.702 177.483 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.447 ' HB3' HD21 ' A' ' 50' ' ' LEU . 84.9 t80 -130.4 112.2 13.03 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.056 1.884 . . . . 1.5 109.496 171.45 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.65 -72.58 0.09 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.468 2.307 . . . . 1.21 114.021 177.968 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.7 -62.18 0.19 Allowed Glycine 0 N--CA 1.43 -1.751 0 O-C-N 120.835 -1.165 . . . . 1.3 112.675 -178.28 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -79.85 153.51 29.04 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 115.085 1.513 . . . . 2.55 115.085 -173.455 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -82.95 137.66 34.11 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.321 -2.737 . . . . 2.48 111.052 171.503 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.447 HD21 ' HB3' ' A' ' 45' ' ' PHE . 11.8 mt -84.87 121.57 27.92 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.488 -2.007 . . . . 0.9 114.835 -169.217 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.316 10.7 pt-20 -78.63 173.25 12.62 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 118.463 -2.648 . . . . 1.94 115.669 175.152 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -68.08 -58.68 4.09 Favored 'General case' 0 N--CA 1.429 -1.478 1 N-CA-C 125.054 5.205 . . . . 1.56 125.054 -177.023 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.65 56.59 1.37 Allowed Glycine 0 N--CA 1.43 -1.711 0 O-C-N 118.502 -2.624 . . . . 0.97 111.143 170.81 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -123.24 168.65 12.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.224 -2.139 . . . . 2.49 105.224 160.722 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.0 p -101.65 169.29 8.93 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.469 -1.394 . . . . 0.76 112.279 179.494 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mt -54.61 -44.9 73.51 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 114.717 1.377 . . . . 1.05 114.717 166.98 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.262 41.7 p -67.88 -24.38 65.22 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.258 2.623 . . . . 1.19 115.078 -176.651 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -70.59 -25.18 62.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.124 2.869 . . . . 1.9 115.793 176.195 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -95.81 -6.71 38.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.123 -2.308 . . . . 0.89 114.18 175.157 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.26 7.6 t30 76.53 43.16 0.15 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.864 -2.397 . . . . 1.84 110.166 179.56 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 61' ' ' ILE . 77.7 mt -91.91 107.3 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.733 -1.229 . . . . 0.82 108.261 177.325 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -101.08 -170.82 1.89 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 126.184 2.897 . . . . 2.16 107.749 -174.304 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -63.69 141.91 58.59 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 111.318 -2.674 . . . . 2.12 110.693 171.822 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 69.05 20.84 7.59 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 110.734 -2.939 . . . . 1.71 116.877 177.008 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.6 m -88.88 159.37 17.72 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 116.165 1.913 . . . . 1.04 116.165 -170.899 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.2 m -101.32 115.79 31.3 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 117.007 -3.558 . . . . 0.79 110.49 -178.97 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -105.37 146.82 28.92 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.674 -1.232 . . . . 1.4 107.674 171.181 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -101.58 130.63 47.94 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 116.132 -1.89 . . . . 1.51 110.736 177.05 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.423 HD23 HG22 ' A' ' 7' ' ' THR . 25.1 tp -115.12 108.29 16.44 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.205 1.366 . . . . 1.14 107.551 177.172 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 74.6 t -96.2 130.19 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 119.131 -2.23 . . . . 1.23 105.784 171.801 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 N--CA 1.428 -1.543 0 CA-C-N 120.275 1.398 . . . . 2.78 111.087 178.896 . . . . . . . . 0 0 . 1 . 127 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 ptt? . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 104.575 -2.379 . . . . 1.1 104.575 . . . . . . . . . 0 0 . 1 . 127 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -119.08 154.54 33.02 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 124.53 3.332 . . . . 1.87 106.291 175.994 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -136.37 167.36 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 105.425 -2.065 . . . . 0.72 105.425 167.491 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -120.96 125.84 48.44 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.046 2.138 . . . . 1.4 108.129 -176.835 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.6 t -104.45 130.72 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.708 -3.12 . . . . 0.58 105.283 170.751 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.287 12.4 ttpt -127.03 122.08 33.39 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 129.715 4.384 . . . . 2.09 119.645 -177.12 . . . . . . . . 3 2 . 1 . 127 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 p -70.89 161.73 30.53 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 112.671 -2.059 . . . . 0.99 115.106 177.963 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.7 tp -54.31 -48.34 71.44 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.783 2.433 . . . . 2.53 115.465 174.058 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.31 -31.95 70.76 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.522 2.729 . . . . 2.08 115.582 -177.728 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.94 27.68 0.7 Allowed Glycine 0 N--CA 1.429 -1.775 0 CA-C-O 117.641 -1.644 . . . . 1.31 109.817 176.1 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -97.46 122.98 41.15 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.449 3.125 . . . . 1.4 108.318 -178.093 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.4 m -96.45 117.48 30.97 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 127.309 3.433 . . . . 0.78 107.156 172.661 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.8 mt -93.6 122.05 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 117.668 -3.145 . . . . 1.55 102.529 174.944 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -108.91 106.5 16.5 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 123.657 1.694 . . . . 1.08 109.943 174.256 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.4 mt -102.6 152.58 21.01 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 116.475 -3.89 . . . . 1.55 109.445 -178.033 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.68 130.44 42.58 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.382 -1.449 . . . . 1.95 110.869 169.299 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.66 163.01 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 114.196 -1.365 . . . . 0.96 110.232 -173.969 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -104.06 151.25 38.94 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 117.963 -2.961 . . . . 2.35 112.427 158.476 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -75.99 -7.29 18.16 Favored 'Trans proline' 0 N--CA 1.434 -1.998 1 CA-C-N 129.621 4.472 . . . . 0.95 117.359 -176.262 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.3 m -82.34 -9.95 59.27 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 128.36 2.664 . . . . 1.45 113.515 173.565 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -76.27 158.2 31.81 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 116.195 -2.202 . . . . 1.69 109.774 177.918 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.2 p -87.36 158.46 19.02 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 116.304 1.964 . . . . 0.75 116.304 177.307 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.0 mp -55.13 -46.02 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 118.402 -0.808 . . . . 0.73 111.428 172.187 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.264 42.9 tt0 -41.39 -44.41 2.81 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 120.11 3.374 . . . . 1.62 120.11 163.586 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -83.36 -34.26 25.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.346 -3.346 . . . . 2.13 110.524 -177.077 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.0 t -62.44 -37.82 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 O-C-N 117.016 -3.553 . . . . 0.62 108.076 170.727 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -67.17 -24.63 65.89 Favored 'General case' 0 N--CA 1.431 -1.412 1 CA-C-O 128.715 4.102 . . . . 1.22 119.518 175.64 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.6 -16.39 62.62 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 117.974 -2.954 . . . . 0.51 113.403 169.105 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -87.48 -30.94 20.27 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 116.008 -4.182 . . . . 1.44 112.429 179.01 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.287 51.3 mt -66.16 -19.01 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-O 124.519 2.104 . . . . 1.32 108.518 173.155 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -75.05 -43.97 50.35 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.681 -2.512 . . . . 1.7 112.295 178.458 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -65.81 -53.8 35.29 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.668 1.187 . . . . 1.55 110.143 168.948 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -59.89 -69.71 0.2 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.209 1.48 . . . . 2.62 112.64 -173.179 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -90.13 -40.82 12.0 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 128.672 2.789 . . . . 1.48 113.517 -166.848 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.22 31.6 3.75 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 116.244 -2.884 . . . . 1.12 111.849 172.53 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.1 mt -113.17 119.11 43.04 Favored Pre-proline 0 N--CA 1.429 -1.48 0 C-N-CA 126.939 2.096 . . . . 1.55 109.816 -177.001 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -63.1 156.24 56.26 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 125.276 3.984 . . . . 1.02 116.48 175.754 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.88 -21.05 16.55 Favored 'Trans proline' 0 N--CA 1.433 -2.072 0 CA-C-N 128.114 3.934 . . . . 1.25 115.945 -170.171 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.17 -34.08 69.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.777 2.431 . . . . 2.25 115.691 167.369 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -84.8 -1.9 56.99 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 125.743 2.687 . . . . 2.02 112.974 177.952 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -114.87 129.05 56.63 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 115.342 -4.599 . . . . 0.69 111.26 -171.895 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -129.04 134.81 48.27 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 104.638 -2.356 . . . . 2.78 104.638 171.562 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.3 mt -107.38 129.04 54.96 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 128.14 2.576 . . . . 1.17 108.39 -177.77 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.7 mm -105.99 125.44 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 131.282 3.833 . . . . 1.38 102.915 -174.433 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.405 ' HB3' HD21 ' A' ' 50' ' ' LEU . 41.8 t80 -116.56 110.79 19.02 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 120.651 1.569 . . . . 1.5 107.069 170.53 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.36 -101.61 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 104.826 -2.287 . . . . 1.21 104.826 177.467 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.63 2.98 15.4 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 125.881 1.988 . . . . 1.3 113.831 -179.578 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -115.45 157.07 24.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.214 1.483 . . . . 2.55 109.274 -179.096 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -94.02 144.42 25.48 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.766 -2.679 . . . . 2.48 103.766 179.512 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.405 HD21 ' HB3' ' A' ' 45' ' ' PHE . 27.8 mt -97.12 140.4 31.69 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.769 -3.082 . . . . 0.9 109.983 -175.441 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -79.39 149.02 31.77 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.294 -1.504 . . . . 1.94 113.184 172.923 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -76.81 -37.12 56.33 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 115.655 1.724 . . . . 1.56 115.655 -173.231 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.43 44.71 2.6 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-O 116.655 -2.192 . . . . 0.97 108.0 179.55 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -126.93 160.05 32.2 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 121.315 2.558 . . . . 2.49 106.07 168.343 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -84.19 175.62 9.33 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 126.553 3.073 . . . . 0.76 112.506 169.448 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.7 mt -71.54 -42.42 67.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.929 -3.607 . . . . 1.05 110.064 171.381 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 m -60.19 -38.85 84.52 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 128.823 2.849 . . . . 1.19 114.094 171.875 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -52.59 -36.6 56.45 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.973 2.953 . . . . 1.9 118.973 171.425 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -90.53 3.05 55.1 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 116.505 2.039 . . . . 0.89 116.505 176.442 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 64.31 27.33 13.77 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.751 2.42 . . . . 1.84 114.64 -173.944 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.257 75.7 mt -69.82 140.8 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 118.943 -2.348 . . . . 0.82 108.185 178.027 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -111.41 175.6 5.36 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.475 -2.016 . . . . 2.16 111.777 -174.441 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -64.0 148.28 50.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.411 -1.431 . . . . 2.12 111.713 166.15 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.338 35.9 mt-10 77.13 21.24 1.12 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.425 -2.047 . . . . 1.71 113.41 169.175 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.95 140.91 30.02 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.982 3.313 . . . . 1.04 112.949 -173.622 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.8 m -89.62 114.83 26.49 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.911 2.884 . . . . 0.79 111.746 -178.856 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -113.52 151.8 31.06 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.851 -3.031 . . . . 1.4 104.789 175.246 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -107.57 123.75 48.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 123.505 1.621 . . . . 1.51 109.854 -169.748 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.5 tp -90.96 110.63 21.88 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.148 -2.845 . . . . 1.14 113.275 -178.034 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.9 t -105.08 128.9 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 1 N-CA-C 99.468 -4.271 . . . . 1.23 99.468 176.67 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.0 tp . . . . . 0 N--CA 1.431 -1.409 0 CA-C-N 113.357 -1.747 . . . . 2.78 109.337 177.147 . . . . . . . . 0 0 . 1 . 128 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 CA--C 1.489 -1.37 0 CA-C-O 122.74 1.257 . . . . 1.1 113.344 . . . . . . . . . 0 0 . 1 . 128 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -114.58 130.03 56.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 115.738 1.755 . . . . 1.87 115.738 -171.508 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.7 pt -120.46 151.67 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-O 115.244 -2.313 . . . . 0.72 111.686 177.693 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -110.66 118.83 37.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.674 -1.973 . . . . 1.4 105.674 -174.298 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.35 116.04 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 O-C-N 118.926 -2.359 . . . . 0.58 111.052 171.983 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.314 42.1 mtpt -104.32 136.3 44.17 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 127.997 3.76 . . . . 2.09 117.599 178.325 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 p -89.82 156.15 18.69 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.522 -2.611 . . . . 0.99 111.07 172.857 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.5 mt -63.6 -44.5 93.82 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.266 -3.396 . . . . 2.53 112.267 168.141 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.337 69.4 p -65.22 -38.47 90.5 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 116.453 -1.737 . . . . 2.08 114.009 -169.7 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.13 1.88 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 123.358 2.799 . . . . 1.31 116.009 167.802 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -98.68 144.82 27.53 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.304 3.052 . . . . 1.4 111.064 -179.587 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -131.07 139.69 49.93 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 118.028 -2.92 . . . . 0.78 106.51 168.084 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.465 HG21 HD13 ' A' ' 13' ' ' ILE . 28.4 pt -130.4 150.99 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 130.098 3.359 . . . . 1.55 106.558 179.165 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 m -107.05 127.15 53.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.946 -1.479 . . . . 1.08 108.022 175.247 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.3 mt -106.8 137.0 45.66 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 125.088 2.375 . . . . 1.55 109.81 169.754 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -89.99 126.47 35.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 128.414 3.959 . . . . 1.95 107.831 162.035 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -132.09 152.33 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 109.585 -3.461 . . . . 0.96 113.358 -173.186 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -99.99 146.18 31.47 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-O 114.776 -2.535 . . . . 2.35 106.459 168.083 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -80.42 -4.8 13.21 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 CA-C-N 128.087 3.924 . . . . 0.95 106.661 -171.302 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.4 p -85.56 -17.63 35.75 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 120.0 -1.687 . . . . 1.45 111.851 175.659 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -61.44 136.26 57.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.826 -2.421 . . . . 1.69 111.733 174.992 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.7 p -78.26 162.23 26.69 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.588 -3.195 . . . . 0.75 112.473 178.655 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.4 mm -64.35 -44.23 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-N 113.09 -1.868 . . . . 0.73 112.093 172.283 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.434 76.2 tt0 -35.26 -58.66 0.55 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.349 -3.344 . . . . 1.62 117.1 158.914 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -68.75 -34.27 75.32 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.018 -3.551 . . . . 2.13 116.253 -177.967 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.7 t -55.3 -44.6 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 118.143 -2.848 . . . . 0.62 116.907 164.518 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 43.3 mtmt -54.18 -49.82 68.44 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.045 3.338 . . . . 1.22 110.018 175.704 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.95 -26.67 67.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.875 -3.016 . . . . 0.51 112.898 178.706 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -67.83 -35.34 78.42 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.218 -2.801 . . . . 1.44 111.604 173.115 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.7 mt -71.36 -26.7 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 117.851 -1.54 . . . . 1.32 112.246 172.934 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -68.15 -37.96 81.6 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 118.854 -0.593 . . . . 1.7 110.889 -179.646 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -58.29 -44.62 88.58 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 123.45 1.595 . . . . 1.55 111.463 175.819 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -84.49 -80.55 0.2 Allowed 'General case' 0 N--CA 1.43 -1.446 1 C-N-CA 132.043 4.137 . . . . 2.62 114.302 -171.197 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -78.4 -27.13 46.69 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 123.742 1.734 . . . . 1.48 110.295 -171.965 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.23 28.63 16.89 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 118.73 -2.481 . . . . 1.12 108.262 170.395 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.9 mt -94.66 123.98 56.38 Favored Pre-proline 0 N--CA 1.431 -1.421 0 N-CA-C 103.98 -2.6 . . . . 1.55 103.98 179.961 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 9.3 Cg_exo -62.13 145.64 96.33 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 C-N-CA 116.272 -2.018 . . . . 1.02 114.249 175.685 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 88.4 Cg_exo -66.32 -22.36 53.09 Favored 'Trans proline' 0 N--CA 1.433 -2.038 1 C-N-CA 126.201 4.6 . . . . 1.25 112.751 -175.653 . . . . . . . . 3 3 . 1 . 128 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -60.3 -31.98 70.77 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 131.544 3.938 . . . . 2.25 111.375 171.264 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -97.31 1.81 49.94 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 112.76 -2.018 . . . . 2.02 112.245 -178.617 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -100.56 100.14 10.83 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.659 -2.526 . . . . 0.69 111.793 -177.331 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -96.2 95.19 7.96 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.808 -1.807 . . . . 2.78 110.371 168.489 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.1 mt -72.73 127.34 32.26 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.448 1.499 . . . . 1.17 112.891 179.358 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.9 mm -118.36 135.51 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 123.483 2.856 . . . . 1.38 109.598 175.636 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -122.42 101.23 7.38 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.958 -2.339 . . . . 1.5 107.148 175.95 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.3 . . 78.04 -91.72 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.906 1.282 . . . . 1.21 109.935 179.027 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.18 21.09 2.63 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 104.595 -3.402 . . . . 1.3 104.595 -177.567 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -112.08 120.74 42.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.051 -1.852 . . . . 2.55 111.666 178.562 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -76.22 113.7 14.07 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.637 2.375 . . . . 2.48 108.563 166.416 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.6 mt -90.82 146.06 24.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.154 2.407 . . . . 0.9 109.329 -164.04 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -83.98 164.68 19.19 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.258 1.823 . . . . 1.94 112.284 175.281 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -89.32 -53.02 4.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 116.391 -3.943 . . . . 1.56 114.048 -167.691 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.84 18.58 4.81 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 120.118 2.807 . . . . 0.97 120.118 176.046 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.285 0.0 OUTLIER -79.43 152.3 30.39 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.731 1.752 . . . . 2.49 115.731 168.596 . . . . . . . . 3 3 . 1 . 128 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.9 p -89.37 170.48 10.52 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.558 -1.201 . . . . 0.76 111.513 168.523 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.8 mt -75.6 -32.09 60.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.457 -2.027 . . . . 1.05 109.138 177.374 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.294 1.1 t -62.89 -49.4 74.99 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.728 1.611 . . . . 1.19 109.619 -179.199 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -47.2 -50.59 20.54 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.511 2.324 . . . . 1.9 111.776 172.225 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -76.71 -6.53 52.55 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 119.637 3.199 . . . . 0.89 119.637 176.118 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 65.41 41.17 4.37 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.521 2.045 . . . . 1.84 116.521 -179.693 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.406 HG23 ' HB2' ' A' ' 65' ' ' SER . 55.8 mt -95.05 114.89 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 101.71 -3.441 . . . . 0.82 101.71 179.146 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -102.26 -175.6 2.88 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.345 -1.298 . . . . 2.16 107.878 -178.072 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -61.03 142.91 56.26 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 117.448 2.388 . . . . 2.12 117.448 169.711 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.379 13.8 mt-10 75.17 19.71 2.22 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 129.965 4.541 . . . . 1.71 118.411 177.569 . . . . . . . . 3 2 . 1 . 128 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.406 ' HB2' HG23 ' A' ' 61' ' ' ILE . 19.2 m -92.74 153.52 18.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.538 2.399 . . . . 1.04 105.669 -173.445 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.8 m -106.09 103.52 13.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 131.207 3.803 . . . . 0.79 111.101 -176.358 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -94.47 168.52 10.82 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 105.045 -2.206 . . . . 1.4 105.045 174.405 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.97 162.84 32.17 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 105.499 -2.037 . . . . 1.51 105.499 -174.258 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.265 0.5 OUTLIER -144.77 121.91 11.47 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.983 -1.858 . . . . 1.14 105.983 -172.805 . . . . . . . . 3 3 . 1 . 128 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -115.69 125.65 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 129.416 3.086 . . . . 1.23 106.85 178.713 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.1 mt . . . . . 0 N--CA 1.431 -1.411 0 O-C-N 119.594 -1.941 . . . . 2.78 114.783 -175.649 . . . . . . . . 0 0 . 1 . 129 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.7 ttp . . . . . 0 CA--C 1.491 -1.318 0 N-CA-C 118.974 2.953 . . . . 1.1 118.974 . . . . . . . . . 0 0 . 1 . 129 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.11 127.12 35.41 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 119.417 -2.052 . . . . 1.87 115.091 174.045 . . . . . . . . 2 2 . 1 . 129 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 pt -122.06 163.92 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.612 2.365 . . . . 0.72 114.598 166.534 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -112.0 123.62 50.65 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 116.108 -4.12 . . . . 1.4 113.835 176.169 . . . . . . . . 2 2 . 1 . 129 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.8 t -110.41 113.15 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 118.622 -2.549 . . . . 0.58 108.502 171.052 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -86.37 139.92 30.51 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.894 -1.503 . . . . 2.09 110.503 -178.719 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 p -100.25 175.37 5.74 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.453 2.073 . . . . 0.99 110.412 174.815 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.6 mt -80.56 -25.19 38.74 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 114.876 -4.89 . . . . 2.53 108.892 171.599 . . . . . . . . 2 2 . 1 . 129 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 p -65.88 -46.09 79.67 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.275 -3.39 . . . . 2.08 113.717 -176.092 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.2 6.56 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 112.134 -2.303 . . . . 1.31 117.345 173.765 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -98.85 150.62 21.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 128.157 3.837 . . . . 1.4 114.187 -173.199 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.2 m -114.98 90.93 3.46 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.722 -3.111 . . . . 0.78 105.578 169.822 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mt -80.9 111.15 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 O-C-N 120.805 -1.184 . . . . 1.55 109.36 -179.807 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.4 m -77.17 107.22 9.4 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.144 -2.223 . . . . 1.08 109.584 170.936 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.6 mt -103.64 148.6 25.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 126.764 3.173 . . . . 1.55 104.912 173.828 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -120.44 129.35 53.85 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.172 2.189 . . . . 1.95 113.1 166.703 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.0 m -143.02 174.07 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.486 -2.413 . . . . 0.96 104.486 -178.937 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -96.82 154.03 38.46 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 104.699 -2.334 . . . . 2.35 104.699 165.06 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -73.79 -15.56 23.92 Favored 'Trans proline' 0 C--N 1.3 -2.003 1 C-N-CA 125.871 4.381 . . . . 0.95 112.239 -176.252 . . . . . . . . 2 2 . 1 . 129 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.1 p -94.34 5.57 51.37 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.758 -3.089 . . . . 1.45 115.236 172.225 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -71.39 154.91 41.21 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.85 -1.157 . . . . 1.69 110.426 168.112 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 65.7 p -92.12 159.5 15.64 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.185 -1.043 . . . . 0.75 108.185 176.752 . . . . . . . . 2 2 . 1 . 129 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -63.53 -16.49 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.463 1.905 . . . . 0.73 113.27 -179.543 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -62.93 -32.58 73.91 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.316 1.846 . . . . 1.62 115.781 166.68 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -72.78 -35.99 67.52 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.887 2.075 . . . . 2.13 111.788 168.765 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.9 t -57.53 -51.53 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 118.945 -2.347 . . . . 0.62 114.381 169.66 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -65.38 -35.99 82.64 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 129.152 2.981 . . . . 1.22 111.339 176.363 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.37 -45.54 69.26 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 116.045 1.868 . . . . 0.51 116.045 174.021 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -74.58 -28.56 60.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.599 1.559 . . . . 1.44 110.256 -179.837 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.6 mt -78.82 -29.17 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 1 O-C-N 115.457 -4.527 . . . . 1.32 114.083 172.669 . . . . . . . . 2 2 . 1 . 129 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -67.31 -32.29 73.17 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.523 -3.236 . . . . 1.7 113.061 170.022 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -61.0 -49.11 78.77 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.247 2.314 . . . . 1.55 117.247 169.666 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -89.23 -43.99 10.6 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.123 2.268 . . . . 2.62 117.123 -176.897 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -99.66 -36.87 9.35 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.434 -2.666 . . . . 1.48 113.182 -172.289 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.83 68.09 1.3 Allowed Glycine 0 N--CA 1.43 -1.704 0 CA-C-N 110.81 -2.905 . . . . 1.12 111.775 172.144 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 mt -126.85 119.2 22.49 Favored Pre-proline 0 N--CA 1.429 -1.508 0 O-C-N 126.637 2.022 . . . . 1.55 108.343 174.32 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 9.1 Cg_exo -55.87 145.48 72.83 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-O 113.104 -2.956 . . . . 1.02 117.637 176.174 . . . . . . . . 2 2 . 1 . 129 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 27.6 Cg_exo -58.66 -22.52 61.12 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 123.418 2.746 . . . . 1.25 115.142 -175.025 . . . . . . . . 2 2 . 1 . 129 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.02 -43.15 99.46 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 131.109 3.764 . . . . 2.25 109.357 173.887 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -83.79 -14.79 50.57 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 117.152 2.279 . . . . 2.02 117.152 -176.962 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -85.45 104.57 15.36 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 118.871 -2.393 . . . . 0.69 113.131 -175.726 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -96.23 101.04 12.63 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 106.327 -1.731 . . . . 2.78 106.327 175.16 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.4 mt -87.16 125.43 34.16 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.965 -2.334 . . . . 1.17 116.554 173.387 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.5 mm -108.57 106.36 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 118.853 -2.404 . . . . 1.38 109.114 178.226 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -92.99 91.97 7.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 118.977 -1.089 . . . . 1.5 110.578 171.149 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.49 -65.93 0.25 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.719 2.408 . . . . 1.21 112.811 -172.657 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.91 -14.82 0.4 Allowed Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 126.718 2.104 . . . . 1.3 112.923 -178.954 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -90.59 129.03 36.76 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 115.299 -2.56 . . . . 2.55 109.926 -176.83 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -83.17 117.24 22.77 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.302 -2.124 . . . . 2.48 112.309 165.934 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.7 mt -79.05 163.53 25.08 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 120.925 -1.109 . . . . 0.9 109.586 -166.181 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -125.64 128.53 47.99 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.329 1.852 . . . . 1.94 108.793 176.354 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.345 30.4 m-20 -45.62 -50.61 13.15 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.079 2.952 . . . . 1.56 115.489 -174.795 . . . . . . . . 2 2 . 1 . 129 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.15 20.59 15.7 Favored Glycine 0 N--CA 1.43 -1.765 1 O-C-N 115.535 -4.478 . . . . 0.97 114.343 175.675 . . . . . . . . 2 2 . 1 . 129 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -107.22 142.89 36.24 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 116.147 -4.149 . . . . 2.49 105.723 168.692 . . . . . . . . 2 2 . 1 . 129 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 17.5 p -70.09 168.51 15.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.949 -1.023 . . . . 0.76 113.136 175.803 . . . . . . . . 2 2 . 1 . 129 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.455 ' HG ' HD12 ' A' ' 61' ' ' ILE . 6.3 mp -67.09 -42.32 84.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.683 1.993 . . . . 1.05 112.984 173.73 . . . . . . . . 2 2 . 1 . 129 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.2 p -52.79 -26.57 14.75 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 131.515 3.926 . . . . 1.19 112.216 179.455 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -75.77 -51.45 12.62 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-O 126.571 3.081 . . . . 1.9 116.922 175.697 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.272 35.3 m-85 -83.31 9.32 11.12 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.831 -3.043 . . . . 0.89 114.691 174.119 . . . . . . . . 2 2 . 1 . 129 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.7 t30 47.31 59.18 4.24 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 118.801 2.889 . . . . 1.84 118.801 -176.379 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.455 HD12 ' HG ' ' A' ' 56' ' ' LEU . 78.8 mt -93.95 122.3 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 104.489 -2.411 . . . . 0.82 104.489 179.523 . . . . . . . . 2 2 . 1 . 129 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -121.35 -160.99 0.88 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 122.217 2.28 . . . . 2.16 111.742 -173.12 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -59.44 136.06 57.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 119.173 3.027 . . . . 2.12 119.173 175.649 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.295 42.8 mt-10 64.04 25.65 13.86 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.206 -2.184 . . . . 1.71 114.738 172.914 . . . . . . . . 2 2 . 1 . 129 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.7 m -75.18 137.55 41.37 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 128.005 2.522 . . . . 1.04 114.817 179.862 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.2 m -91.66 104.79 17.22 Favored 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 127.105 2.753 . . . . 0.79 114.62 -176.632 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -92.62 128.6 38.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 116.785 -1.579 . . . . 1.4 111.588 171.551 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -96.47 114.73 26.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 104.407 -2.442 . . . . 1.51 104.407 -177.803 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.4 tp -92.38 120.55 33.01 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.584 -3.197 . . . . 1.14 106.91 -177.424 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.84 153.74 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 126.251 2.22 . . . . 1.23 106.159 174.956 . . . . . . . . 1 1 . 1 . 129 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.9 tp . . . . . 0 N--CA 1.43 -1.468 0 C-N-CA 116.056 -2.258 . . . . 2.78 105.586 175.978 . . . . . . . . 0 0 . 1 . 130 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.418 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 5.5 ttt . . . . . 0 CA--C 1.49 -1.35 0 CA-C-O 117.206 -1.378 . . . . 1.1 109.387 . . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -86.33 135.17 33.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 115.895 -2.002 . . . . 1.87 113.301 -171.833 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 pt -129.91 153.06 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 122.105 2.23 . . . . 0.72 107.238 170.577 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.331 11.6 m-85 -115.82 122.62 45.94 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 116.876 -1.93 . . . . 1.4 110.974 177.298 . . . . . . . . 2 2 . 1 . 130 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.05 108.48 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 117.749 -3.094 . . . . 0.58 111.548 177.463 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -87.79 120.43 29.1 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.931 1.825 . . . . 2.09 108.537 -173.487 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.2 p -79.4 169.37 18.18 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 115.484 -4.51 . . . . 0.99 113.165 174.686 . . . . . . . . 2 2 . 1 . 130 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.3 mt -73.79 -26.35 60.58 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.004 -3.56 . . . . 2.53 112.222 164.851 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.5 p -75.25 -34.16 61.38 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 124.216 1.006 . . . . 2.08 111.824 -171.197 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.97 -8.0 2.44 Favored Glycine 0 N--CA 1.431 -1.678 0 CA-C-O 115.829 -2.651 . . . . 1.31 116.635 177.384 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -97.89 136.29 38.4 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 126.318 1.834 . . . . 1.4 109.983 -174.122 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -111.94 96.14 5.88 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.433 1.111 . . . . 0.78 109.363 169.759 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.7 pt -91.85 125.31 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 113.852 -1.522 . . . . 1.55 113.366 -175.149 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.8 m -91.22 109.6 20.87 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.424 -2.673 . . . . 1.08 105.443 -171.734 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.7 mt -93.34 153.16 18.7 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.371 -2.705 . . . . 1.55 108.306 176.826 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -92.78 121.56 34.28 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.524 1.929 . . . . 1.95 113.219 165.396 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 1' ' ' MET . 28.9 m -137.26 173.21 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 123.634 1.683 . . . . 0.96 108.082 176.741 . . . . . . . . 2 2 . 1 . 130 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -121.8 154.97 60.77 Favored Pre-proline 0 N--CA 1.43 -1.439 0 O-C-N 117.999 -2.938 . . . . 2.35 108.529 162.869 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.287 40.1 Cg_endo -64.4 -18.6 63.63 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 C-N-CA 123.133 2.555 . . . . 0.95 117.493 -172.611 . . . . . . . . 2 2 . 1 . 130 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.2 m -89.31 7.78 33.85 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.397 2.046 . . . . 1.45 115.596 178.58 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -81.05 146.68 30.51 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 130.037 3.335 . . . . 1.69 108.238 173.984 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.308 30.3 p -75.39 164.83 26.0 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 118.324 -1.351 . . . . 0.75 113.073 172.986 . . . . . . . . 2 2 . 1 . 130 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.5 mt -78.97 -35.7 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 108.063 -1.088 . . . . 0.73 108.063 178.859 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -47.07 -41.68 17.43 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.918 2.192 . . . . 1.62 116.918 162.796 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -64.95 -38.31 90.53 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.671 -4.393 . . . . 2.13 112.235 175.41 . . . . . . . . 2 2 . 1 . 130 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.413 HG22 HG11 ' A' ' 17' ' ' VAL . 68.3 t -69.49 -28.21 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 114.703 1.372 . . . . 0.62 114.703 174.489 . . . . . . . . 2 2 . 1 . 130 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -69.8 -30.24 67.72 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.712 -2.492 . . . . 1.22 112.117 169.247 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.47 -27.23 65.05 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.56 -1.963 . . . . 0.51 110.909 174.418 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? -72.61 -35.86 67.95 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 120.748 1.613 . . . . 1.44 111.399 172.745 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.9 mt -60.54 -46.22 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 O-C-N 116.381 -3.949 . . . . 1.32 112.486 167.515 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -57.26 -45.73 83.73 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 117.968 -2.957 . . . . 1.7 116.449 175.016 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -45.31 -40.87 8.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 125.455 2.55 . . . . 1.55 114.804 166.907 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -87.5 -59.24 2.3 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.691 -3.13 . . . . 2.62 114.824 -173.966 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -97.4 -25.59 15.16 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.954 1.835 . . . . 1.48 109.009 -165.921 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.29 52.77 4.11 Favored Glycine 0 N--CA 1.429 -1.809 1 O-C-N 115.136 -4.727 . . . . 1.12 116.287 -178.175 . . . . . . . . 2 2 . 1 . 130 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.2 mt -130.57 109.81 16.07 Favored Pre-proline 0 N--CA 1.429 -1.505 0 CA-C-N 112.223 -1.988 . . . . 1.55 109.738 -176.81 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -60.59 139.09 84.12 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 N-CA-C 120.948 3.403 . . . . 1.02 120.948 -179.919 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.85 -27.92 29.16 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 C-N-CA 124.948 3.765 . . . . 1.25 117.088 -176.197 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.58 -34.63 72.95 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 123.211 2.732 . . . . 2.25 115.954 171.488 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -80.0 4.32 17.36 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 113.639 -3.077 . . . . 2.02 108.899 -175.057 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -141.98 150.6 41.59 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 125.118 3.599 . . . . 0.69 108.897 -176.832 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -130.46 149.91 51.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.195 -2.816 . . . . 2.78 105.317 168.601 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.3 mt -106.47 149.74 26.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.951 2.159 . . . . 1.17 112.657 174.859 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.5 mt -128.52 132.79 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 108.452 -0.944 . . . . 1.38 108.452 178.911 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.264 50.4 t80 -117.07 121.05 40.21 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.537 1.637 . . . . 1.5 106.705 178.358 . . . . . . . . 2 2 . 1 . 130 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.52 -82.27 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.001 -3.562 . . . . 1.21 113.479 174.826 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.77 -26.02 1.47 Allowed Glycine 0 N--CA 1.43 -1.731 0 CA-C-N 122.356 2.344 . . . . 1.3 113.459 176.181 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -100.49 150.2 22.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.991 3.757 . . . . 2.55 117.466 178.875 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -74.48 133.51 42.34 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.982 -2.949 . . . . 2.48 112.718 172.601 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.0 mt -84.4 126.07 32.9 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.939 -2.975 . . . . 0.9 115.27 -171.856 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.18 125.57 24.94 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 125.953 2.787 . . . . 1.94 109.18 173.919 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -63.59 -45.7 89.2 Favored 'General case' 0 N--CA 1.429 -1.491 1 O-C-N 114.466 -5.146 . . . . 1.56 116.957 -172.81 . . . . . . . . 2 2 . 1 . 130 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.22 33.57 3.37 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-O 124.799 2.333 . . . . 0.97 118.504 177.226 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -110.83 167.14 10.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.878 -2.542 . . . . 2.49 112.134 167.071 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.9 p -87.4 176.83 7.32 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.802 2.841 . . . . 0.76 111.898 170.761 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.5 mt -82.25 -41.39 20.27 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 127.135 2.174 . . . . 1.05 108.645 -178.72 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.0 p -59.35 -41.56 89.51 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 129.205 3.002 . . . . 1.19 111.353 176.189 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -48.72 -52.01 25.81 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 128.704 2.802 . . . . 1.9 112.626 172.725 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -86.81 -3.69 59.09 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 115.606 1.706 . . . . 0.89 115.606 179.584 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.6 m120 73.47 37.87 0.68 Allowed 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.696 -1.138 . . . . 1.84 112.167 177.036 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.3 mt -84.97 129.08 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 119.713 -1.867 . . . . 0.82 113.17 173.614 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -116.53 -175.83 2.84 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.996 2.808 . . . . 2.16 113.2 -176.361 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -40.66 121.63 1.5 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 112.214 -2.266 . . . . 2.12 116.06 172.949 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 59.89 50.86 6.44 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 119.261 3.06 . . . . 1.71 119.261 179.06 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.1 m -89.79 133.92 34.46 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 116.479 -1.724 . . . . 1.04 112.207 -178.721 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.4 m -81.48 109.08 15.61 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 126.986 2.678 . . . . 0.79 110.538 179.087 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.58 169.71 8.36 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.465 1.939 . . . . 1.4 110.247 176.652 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -125.3 146.64 49.47 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.217 1.007 . . . . 1.51 108.887 -176.372 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.99 132.11 56.1 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 115.008 -2.425 . . . . 1.14 107.723 172.916 . . . . . . . . 2 2 . 1 . 130 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.6 m -121.26 164.24 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 121.889 2.131 . . . . 1.23 114.797 171.526 . . . . . . . . 1 1 . 1 . 130 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.2 tp . . . . . 0 N--CA 1.431 -1.417 0 O-C-N 118.076 -2.89 . . . . 2.78 110.899 -179.484 . . . . . . . . 0 0 . 1 . 131 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.6 ttp . . . . . 0 CA--C 1.49 -1.354 0 CA-C-O 125.828 2.728 . . . . 1.1 109.936 . . . . . . . . . 0 0 . 1 . 131 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -69.56 127.98 34.88 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 115.409 -2.234 . . . . 1.87 112.559 178.167 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.318 7.4 pt -133.27 150.03 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 107.151 -1.426 . . . . 0.72 107.151 172.511 . . . . . . . . 2 2 . 1 . 131 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -118.74 118.7 32.31 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.798 2.237 . . . . 1.4 112.942 -176.099 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -102.7 112.21 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.786 -3.071 . . . . 0.58 108.489 -179.993 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.506 ' HE3' HG21 ' A' ' 66' ' ' THR . 75.9 mttt -96.1 138.31 33.9 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.021 -3.549 . . . . 2.09 111.334 177.699 . . . . . . . . 2 2 . 1 . 131 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 p -89.25 -176.4 5.09 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 122.789 1.28 . . . . 0.99 112.602 178.551 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.4 tp -86.03 -34.59 20.72 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.2 -2.188 . . . . 2.53 110.311 170.4 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.7 p -56.6 -57.28 13.07 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.145 2.578 . . . . 2.08 113.327 -178.753 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.36 24.32 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.701 0 O-C-N 117.816 -3.052 . . . . 1.31 114.254 171.745 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -106.92 146.43 31.02 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.729 2.411 . . . . 1.4 105.705 -178.001 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.7 m -116.98 97.38 5.92 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.537 3.135 . . . . 0.78 103.054 171.154 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -80.41 116.77 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 106.44 -1.689 . . . . 1.55 106.44 -176.785 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 m -88.07 114.76 25.0 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.597 -4.439 . . . . 1.08 109.613 175.21 . . . . . . . . 2 2 . 1 . 131 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.8 mt -113.75 161.43 17.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 128.128 3.392 . . . . 1.55 108.829 178.127 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -118.01 112.66 20.56 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.386 2.993 . . . . 1.95 108.256 170.313 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.6 m -107.48 160.14 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.191 -2.818 . . . . 0.96 112.954 176.529 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -105.2 143.32 26.51 Favored Pre-proline 0 N--CA 1.43 -1.43 0 O-C-N 118.925 -2.359 . . . . 2.35 107.923 164.705 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -76.51 -13.53 18.33 Favored 'Trans proline' 0 C--N 1.299 -2.044 1 C-N-CA 127.476 5.45 . . . . 0.95 116.079 -166.118 . . . . . . . . 2 2 . 1 . 131 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -85.79 -2.16 57.95 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 121.413 1.915 . . . . 1.45 109.175 176.889 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -73.73 159.72 32.57 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 120.344 3.461 . . . . 1.69 120.344 169.68 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 30.3 p -79.75 163.53 24.4 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.869 -1.77 . . . . 0.75 114.988 177.521 . . . . . . . . 2 2 . 1 . 131 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.7 mm -73.04 -25.23 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 118.344 -1.343 . . . . 0.73 111.421 177.307 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -50.93 -36.67 39.76 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.752 -2.467 . . . . 1.62 116.566 162.818 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -69.05 -24.67 64.2 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.671 2.789 . . . . 2.13 109.104 -177.825 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.34 -59.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 104.539 -2.393 . . . . 0.62 104.539 175.699 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -49.76 -38.57 34.52 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.123 2.569 . . . . 1.22 113.512 173.441 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.89 -30.93 71.22 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 123.097 2.68 . . . . 0.51 114.893 178.78 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -71.75 -29.12 64.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.865 -1.147 . . . . 1.44 112.477 175.202 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.5 mt -73.06 -33.28 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-O 125.912 2.768 . . . . 1.32 111.685 171.157 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -73.81 -41.93 61.65 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.113 -3.492 . . . . 1.7 105.927 177.04 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -61.64 -36.51 80.99 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.649 -2.532 . . . . 1.55 115.923 174.645 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -84.18 -51.22 7.21 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.04 -3.538 . . . . 2.62 113.085 -175.082 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -104.68 -36.83 7.31 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.271 -2.143 . . . . 1.48 114.574 -169.994 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.05 16.83 17.8 Favored Glycine 0 N--CA 1.429 -1.81 0 C-N-CA 115.381 -3.295 . . . . 1.12 110.249 175.263 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.9 mt -95.92 134.84 23.34 Favored Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 102.44 -3.17 . . . . 1.55 102.44 -175.073 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.428 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 17.2 Cg_exo -67.05 156.9 64.3 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 125.924 3.152 . . . . 1.02 114.904 174.558 . . . . . . . . 2 2 . 1 . 131 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -85.9 -14.96 4.99 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 CA-C-N 124.728 2.724 . . . . 1.25 115.586 -174.16 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -67.25 -29.96 69.72 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 114.808 -2.52 . . . . 2.25 108.954 169.044 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -83.05 -19.9 35.99 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 123.238 2.745 . . . . 2.02 113.183 -176.856 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 37' ' ' PRO . 77.7 mt-30 -87.8 107.59 18.73 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.7 2.0 . . . . 0.69 110.264 -170.709 . . . . . . . . 2 2 . 1 . 131 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -99.08 122.84 42.85 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.446 -1.687 . . . . 2.78 106.446 171.525 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.4 mt -104.0 127.31 51.55 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 124.846 1.341 . . . . 1.17 110.568 176.417 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.1 mt -115.16 115.4 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 119.388 -2.07 . . . . 1.38 108.314 179.847 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -104.07 102.76 12.5 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 113.456 -1.702 . . . . 1.5 107.477 175.002 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.02 -94.05 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.189 1.796 . . . . 1.21 110.353 -178.478 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.4 -19.08 6.35 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 128.25 2.833 . . . . 1.3 114.406 -177.443 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -98.55 137.08 37.72 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 125.946 2.784 . . . . 2.55 105.304 -175.876 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.4 113.97 26.26 Favored 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 119.224 -2.173 . . . . 2.48 107.168 172.972 . . . . . . . . 2 2 . 1 . 131 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.4 mt -77.36 144.43 37.98 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 121.524 1.966 . . . . 0.9 115.195 -163.134 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -90.24 150.39 21.98 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.878 2.471 . . . . 1.94 113.812 173.018 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -70.47 -59.77 2.66 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.755 2.422 . . . . 1.56 115.543 -168.086 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.92 22.55 0.9 Allowed Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 122.155 3.622 . . . . 0.97 122.155 169.987 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -97.91 162.72 13.1 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.137 -2.978 . . . . 2.49 109.06 168.633 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 44.6 p -100.12 176.79 5.28 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 124.007 3.094 . . . . 0.76 112.712 178.094 . . . . . . . . 2 2 . 1 . 131 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 mt -65.75 -34.47 78.25 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.34 -2.1 . . . . 1.05 109.133 172.961 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -57.82 -42.78 84.99 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.814 1.783 . . . . 1.19 115.814 174.318 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -71.64 -30.32 65.62 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.609 -3.182 . . . . 1.9 115.129 -177.272 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -93.11 2.62 56.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 119.132 0.878 . . . . 0.89 113.063 176.017 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.9 m120 51.17 70.76 0.5 Allowed 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 130.705 3.602 . . . . 1.84 113.06 -176.009 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.6 mt -104.84 120.48 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 118.715 -2.491 . . . . 0.82 111.654 -179.344 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -110.85 176.53 4.99 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 111.053 -2.794 . . . . 2.16 115.743 -176.618 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -51.79 118.43 3.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 120.028 3.344 . . . . 2.12 120.028 173.74 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.386 26.2 mt-10 84.56 35.75 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.302 2.001 . . . . 1.71 111.657 171.109 . . . . . . . . 2 2 . 1 . 131 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.8 m -89.64 146.62 24.42 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.618 -2.552 . . . . 1.04 114.145 -174.633 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.506 HG21 ' HE3' ' A' ' 6' ' ' LYS . 5.3 m -108.1 107.96 18.84 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.672 -1.268 . . . . 0.79 112.341 -177.637 . . . . . . . . 2 2 . 1 . 131 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -103.39 143.6 32.47 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 103.466 -2.79 . . . . 1.4 103.466 178.964 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.294 62.3 m80 -104.5 131.64 51.65 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 104.754 -2.313 . . . . 1.51 104.754 -177.095 . . . . . . . . 2 2 . 1 . 131 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.5 tp -95.83 110.56 22.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.943 2.306 . . . . 1.14 108.112 178.899 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 t -110.74 131.91 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 119.108 -2.245 . . . . 1.23 107.855 172.345 . . . . . . . . 1 1 . 1 . 131 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.0 mt . . . . . 0 N--CA 1.43 -1.439 0 CA-C-N 115.153 -0.93 . . . . 2.78 112.329 176.035 . . . . . . . . 0 0 . 1 . 132 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 ptt? . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 111.909 0.337 . . . . 1.1 111.909 . . . . . . . . . 0 0 . 1 . 132 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -98.59 144.16 28.19 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 126.569 3.08 . . . . 1.87 106.144 -178.518 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.7 pt -130.62 152.91 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 1 N-CA-C 99.206 -4.368 . . . . 0.72 99.206 178.136 . . . . . . . . 2 2 . 1 . 132 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -109.79 126.29 53.62 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.532 -2.605 . . . . 1.4 110.496 179.666 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.4 t -96.26 115.7 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 120.599 -1.313 . . . . 0.58 108.147 168.952 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -91.77 137.95 31.95 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 106.044 -1.836 . . . . 2.09 106.044 177.162 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -87.82 -164.59 1.13 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.68 -1.263 . . . . 0.99 113.348 178.627 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.9 mt -82.09 -39.03 23.98 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 124.344 1.027 . . . . 2.53 110.359 176.216 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.289 44.9 p -75.41 -10.96 59.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.701 2.4 . . . . 2.08 108.946 -177.329 . . . . . . . . 2 2 . 1 . 132 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.28 39.42 5.69 Favored Glycine 0 N--CA 1.431 -1.664 1 C-N-CA 135.1 6.095 . . . . 1.31 114.094 172.473 . . . . . . . . 2 2 . 1 . 132 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -90.05 132.4 35.41 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.099 1.95 . . . . 1.4 106.788 -171.309 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.8 m -88.87 111.43 22.06 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.18 -2.2 . . . . 0.78 108.357 -174.627 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.8 mt -104.47 115.49 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 115.569 1.692 . . . . 1.55 115.569 176.429 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 m -81.66 115.85 21.12 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 120.719 -1.238 . . . . 1.08 110.585 -179.129 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.0 mt -121.67 147.89 45.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 115.249 -2.31 . . . . 1.55 111.902 177.625 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -99.69 119.31 37.91 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 120.877 1.671 . . . . 1.95 115.48 171.63 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.82 167.75 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 130.403 3.481 . . . . 0.96 108.779 -177.598 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -118.62 167.44 11.63 Favored Pre-proline 0 N--CA 1.43 -1.47 0 O-C-N 118.477 -2.639 . . . . 2.35 106.953 162.41 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -67.54 -16.54 47.37 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 CA-C-N 125.248 2.91 . . . . 0.95 115.532 -170.654 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -74.86 -15.59 60.71 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 131.265 3.826 . . . . 1.45 117.905 174.41 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -69.66 138.34 52.93 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.061 -2.275 . . . . 1.69 115.09 171.024 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 26' ' ' VAL . 36.1 p -79.16 179.52 7.32 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.187 -1.824 . . . . 0.75 114.76 -175.842 . . . . . . . . 2 2 . 1 . 132 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -78.42 -33.75 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 118.934 -2.354 . . . . 0.73 110.799 176.513 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -49.9 -41.96 46.96 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.74 -3.1 . . . . 1.62 116.856 159.182 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.263 40.6 m-20 -76.48 -32.77 58.55 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 112.9 -3.429 . . . . 2.13 113.212 177.677 . . . . . . . . 2 2 . 1 . 132 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 22' ' ' THR . 1.9 t -66.44 -50.5 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 126.954 2.659 . . . . 0.62 113.363 167.855 . . . . . . . . 2 2 . 1 . 132 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.6 mtmt -60.01 -31.17 69.69 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.078 -2.889 . . . . 1.22 116.601 169.109 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.78 -45.38 78.2 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.781 2.141 . . . . 0.51 116.781 170.307 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -65.71 -41.25 92.52 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.383 -3.948 . . . . 1.44 115.374 179.481 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.6 mm -56.83 -40.51 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.147 1.779 . . . . 1.32 113.685 166.773 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -59.81 -55.5 33.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.577 1.951 . . . . 1.7 115.168 171.693 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -46.82 -57.37 4.97 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 130.271 3.428 . . . . 1.55 112.528 175.26 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -85.89 -62.14 1.59 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.371 1.868 . . . . 2.62 112.525 -166.847 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -76.68 -23.01 53.2 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.406 2.002 . . . . 1.48 116.406 -175.459 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.59 20.11 38.72 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 118.556 2.182 . . . . 1.12 118.556 172.876 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.1 mt -101.51 134.79 20.04 Favored Pre-proline 0 N--CA 1.43 -1.465 0 CA-C-O 113.491 -3.147 . . . . 1.55 116.75 -174.564 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -64.52 132.56 33.7 Favored 'Trans proline' 0 C--N 1.3 -2.009 1 C-N-CA 126.319 4.679 . . . . 1.02 116.819 -179.046 . . . . . . . . 2 2 . 1 . 132 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -63.36 -14.71 43.83 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 CA-C-N 127.792 3.819 . . . . 1.25 116.467 -179.026 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -60.31 -27.91 67.69 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 117.758 2.503 . . . . 2.25 117.758 168.615 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -93.12 -29.52 15.72 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.599 -1.313 . . . . 2.02 108.669 -176.951 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -72.77 126.33 29.65 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 126.341 2.972 . . . . 0.69 112.972 -171.759 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -126.78 146.94 50.05 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 111.52 -2.582 . . . . 2.78 109.478 167.328 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 mt -117.28 127.64 54.28 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 114.158 1.17 . . . . 1.17 114.158 175.429 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mm -119.52 126.72 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 118.848 -2.407 . . . . 1.38 106.151 -175.999 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.496 ' CD2' HG12 ' A' ' 61' ' ' ILE . 49.0 t80 -137.79 121.17 17.06 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.865 -3.022 . . . . 1.5 103.328 176.038 . . . . . . . . 2 2 . 1 . 132 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.25 . . 43.51 62.54 1.85 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.216 3.006 . . . . 1.21 113.35 179.942 . . . . . . . . 2 2 . 1 . 132 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.72 -31.96 2.7 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 120.346 2.898 . . . . 1.3 120.346 177.863 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -89.79 127.02 35.9 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.568 1.947 . . . . 2.55 114.261 -178.31 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -73.68 116.38 14.2 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 115.708 -2.091 . . . . 2.48 108.521 173.156 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 mt -76.96 136.43 38.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 116.761 2.134 . . . . 0.9 116.761 -168.648 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -87.73 139.35 30.62 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 121.376 3.843 . . . . 1.94 121.376 179.826 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -47.01 -55.33 8.37 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 121.25 3.796 . . . . 1.56 121.25 -166.403 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.05 35.5 4.74 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 125.94 1.733 . . . . 0.97 116.902 179.433 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.3 mtt-85 -114.47 172.6 6.92 Favored 'General case' 0 N--CA 1.429 -1.482 1 O-C-N 116.0 -4.235 . . . . 2.49 100.864 168.496 . . . . . . . . 2 2 . 1 . 132 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.6 p -104.73 170.0 8.13 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.061 3.344 . . . . 0.76 114.282 179.07 . . . . . . . . 2 2 . 1 . 132 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.8 mt -60.75 -41.62 95.77 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.813 1.412 . . . . 1.05 114.813 169.247 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.0 t -64.41 -28.26 69.56 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.575 2.131 . . . . 1.19 116.259 -178.46 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -59.17 -37.51 77.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.772 -3.705 . . . . 1.9 110.741 173.563 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -94.51 1.2 55.72 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.678 -1.264 . . . . 0.89 109.873 -179.301 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.303 32.8 m120 53.82 51.3 15.14 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 126.946 2.098 . . . . 1.84 111.032 -177.716 . . . . . . . . 2 2 . 1 . 132 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.496 HG12 ' CD2' ' A' ' 45' ' ' PHE . 76.8 mt -94.36 107.96 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 104.906 -2.257 . . . . 0.82 104.906 179.985 . . . . . . . . 2 2 . 1 . 132 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -81.79 -171.72 3.5 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 125.864 2.745 . . . . 2.16 111.773 -179.69 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -70.04 165.53 21.66 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 113.437 -5.789 . . . . 2.12 111.319 168.298 . . . . . . . . 2 2 . 1 . 132 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 63.57 22.96 13.41 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.239 1.971 . . . . 1.71 110.801 177.127 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -98.86 125.57 44.29 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 125.434 1.494 . . . . 1.04 107.285 -170.693 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.1 m -93.55 113.95 26.19 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 122.165 0.983 . . . . 0.79 111.029 -178.121 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -101.71 129.5 47.89 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 129.327 3.051 . . . . 1.4 113.06 -179.633 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -86.82 111.44 20.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 127.331 3.443 . . . . 1.51 111.652 -171.352 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 tp -87.68 111.39 21.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 116.874 -3.641 . . . . 1.14 108.564 -177.918 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 37.7 t -106.16 120.66 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 128.209 2.604 . . . . 1.23 109.098 -177.191 . . . . . . . . 1 1 . 1 . 132 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.9 mt . . . . . 0 N--CA 1.429 -1.477 0 C-N-CA 125.823 1.649 . . . . 2.78 106.82 -179.523 . . . . . . . . 0 0 . 1 . 133 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptt? . . . . . 0 CA--C 1.49 -1.352 0 CA-C-O 122.833 1.301 . . . . 1.1 114.384 . . . . . . . . . 0 0 . 1 . 133 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -108.86 130.31 55.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.54 -3.85 . . . . 1.87 107.148 -168.644 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -128.7 163.84 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 127.396 2.278 . . . . 0.72 110.711 173.728 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -123.33 129.26 51.07 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 112.714 -2.039 . . . . 1.4 113.717 179.91 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -111.96 118.61 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 118.917 -1.113 . . . . 0.58 108.607 172.191 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -89.28 134.25 34.13 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.073 -2.267 . . . . 2.09 113.74 171.089 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.403 HG22 HD23 ' A' ' 69' ' ' LEU . 81.4 p -85.82 167.73 14.92 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.833 2.16 . . . . 0.99 116.833 177.916 . . . . . . . . 2 2 . 1 . 133 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.2 mt -69.07 -40.41 78.5 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 127.145 3.355 . . . . 2.53 109.793 175.348 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.274 17.2 p -57.1 -60.68 3.24 Favored 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 114.878 -4.889 . . . . 2.08 119.021 174.85 . . . . . . . . 3 2 . 1 . 133 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.67 6.33 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.768 0 CA-C-N 119.879 1.218 . . . . 1.31 112.642 177.811 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.2 ttpt -95.63 142.63 27.72 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 121.55 2.675 . . . . 1.4 109.769 -174.937 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.0 m -112.3 120.91 43.35 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.616 -1.624 . . . . 0.78 106.616 174.496 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 mt -102.09 123.91 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 116.494 -1.717 . . . . 1.55 106.933 -177.676 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.1 m -90.37 119.6 30.8 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 124.763 1.29 . . . . 1.08 111.002 175.726 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.0 mt -111.76 137.22 49.98 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 115.358 1.614 . . . . 1.55 115.358 178.713 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -91.49 119.63 31.61 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 117.95 2.574 . . . . 1.95 117.95 165.586 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.8 m -139.3 -178.25 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.414 1 N-CA-C 99.64 -4.207 . . . . 0.96 99.64 -175.303 . . . . . . . . 2 2 . 1 . 133 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -123.29 159.81 53.02 Favored Pre-proline 0 N--CA 1.43 -1.43 1 O-C-N 115.779 -4.326 . . . . 2.35 104.456 163.234 . . . . . . . . 2 2 . 1 . 133 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 48.3 Cg_endo -69.47 -7.96 22.34 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 125.026 3.817 . . . . 0.95 112.802 -173.273 . . . . . . . . 2 2 . 1 . 133 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.2 p -80.52 -7.1 59.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.541 2.736 . . . . 1.45 114.528 171.405 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -83.4 145.04 29.22 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.965 -2.334 . . . . 1.69 109.997 175.875 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.35 41.4 p -75.17 154.75 37.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 118.282 2.697 . . . . 0.75 118.282 176.143 . . . . . . . . 2 2 . 1 . 133 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.6 mm -58.36 -29.78 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 127.07 2.148 . . . . 0.73 113.765 171.486 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.62 -32.87 74.68 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.197 2.599 . . . . 1.62 110.815 167.465 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -72.53 -28.66 62.99 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 126.078 1.751 . . . . 2.13 111.541 179.758 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.42 -50.23 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 131.39 3.876 . . . . 0.62 110.605 168.496 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -69.18 -27.64 65.69 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 115.361 1.615 . . . . 1.22 115.361 173.045 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.25 . . -72.79 -39.36 66.77 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.411 -1.431 . . . . 0.51 109.328 -178.945 . . . . . . . . 2 2 . 1 . 133 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -66.49 -39.61 88.82 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.326 3.05 . . . . 1.44 112.62 169.445 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.63 -30.85 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 117.674 -3.141 . . . . 1.32 114.796 169.478 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -65.09 -60.86 2.56 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.814 -1.804 . . . . 1.7 109.444 174.053 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -45.7 -39.57 8.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.929 2.937 . . . . 1.55 118.929 172.02 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -91.81 -63.2 1.28 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.582 2.753 . . . . 2.62 107.481 -172.282 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -93.11 -17.79 23.37 Favored 'General case' 0 N--CA 1.429 -1.521 0 O-C-N 117.272 -3.393 . . . . 1.48 115.541 -169.233 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.55 -4.84 62.06 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 108.712 -1.755 . . . . 1.12 108.712 170.793 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.2 mt -75.06 133.84 75.09 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 125.077 1.351 . . . . 1.55 112.785 -176.879 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -75.9 138.29 20.77 Favored 'Trans proline' 0 N--CA 1.433 -2.043 0 CA-C-O 114.122 -2.532 . . . . 1.02 115.766 -178.597 . . . . . . . . 2 2 . 1 . 133 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -64.67 -24.66 62.23 Favored 'Trans proline' 0 N--CA 1.433 -2.031 1 C-N-CA 125.996 4.464 . . . . 1.25 118.572 -172.176 . . . . . . . . 2 2 . 1 . 133 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -55.76 -36.05 66.88 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.212 3.445 . . . . 2.25 116.176 173.299 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -79.9 -11.89 59.78 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.025 1.73 . . . . 2.02 109.928 -178.842 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -86.58 121.21 28.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 118.737 2.865 . . . . 0.69 118.737 -169.172 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -110.44 110.55 21.34 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.211 1.368 . . . . 2.78 111.678 172.458 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.2 mt -97.93 119.43 36.53 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 123.675 2.943 . . . . 1.17 109.7 -176.001 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.6 mm -108.45 137.8 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 119.175 -2.203 . . . . 1.38 110.96 178.301 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -130.06 121.67 26.87 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 104.604 -2.369 . . . . 1.5 104.604 173.121 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.26 -100.47 0.06 Allowed 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 120.909 -1.12 . . . . 1.21 110.129 -178.793 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.69 10.39 6.75 Favored Glycine 0 N--CA 1.429 -1.817 0 C-N-CA 126.176 1.846 . . . . 1.3 115.348 174.186 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -110.38 137.66 47.8 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.729 -1.235 . . . . 2.55 112.72 -173.857 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -95.24 129.13 42.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 126.643 2.464 . . . . 2.48 109.421 176.826 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.2 mt -100.35 136.86 39.59 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 117.263 2.32 . . . . 0.9 117.263 -166.804 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -79.54 138.74 37.6 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.79 -2.444 . . . . 1.94 116.614 -178.164 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.97 -47.18 87.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.367 -2.708 . . . . 1.56 114.78 -168.869 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.76 35.86 3.45 Favored Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 119.677 2.631 . . . . 0.97 119.677 173.058 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -114.97 160.51 19.48 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 123.102 1.429 . . . . 2.49 108.463 163.152 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.4 p -100.58 171.4 7.75 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.006 -3.559 . . . . 0.76 117.235 177.953 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 3.2 mt -64.71 -23.61 67.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.712 1.72 . . . . 1.05 113.088 172.25 . . . . . . . . 2 2 . 1 . 133 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.271 19.2 t -60.4 -59.59 5.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.266 3.426 . . . . 1.19 116.111 174.993 . . . . . . . . 2 2 . 1 . 133 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -39.29 -41.27 0.87 Allowed 'General case' 0 N--CA 1.43 -1.458 1 C-N-CA 132.928 4.491 . . . . 1.9 118.74 165.632 . . . . . . . . 2 2 . 1 . 133 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -97.57 9.84 41.42 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 112.508 -3.615 . . . . 0.89 116.436 175.214 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.1 t30 52.84 51.22 16.36 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 131.213 5.321 . . . . 1.84 115.44 -175.486 . . . . . . . . 2 2 . 1 . 133 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.0 mt -101.79 116.94 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 125.574 2.607 . . . . 0.82 111.011 177.394 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -100.86 -153.59 0.45 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.15 -1.594 . . . . 2.16 109.824 -173.277 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -74.31 142.5 45.18 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 128.157 2.583 . . . . 2.12 116.422 175.74 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.252 49.0 mt-10 68.89 33.88 3.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.937 2.095 . . . . 1.71 108.072 176.782 . . . . . . . . 2 2 . 1 . 133 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.0 m -91.67 137.03 32.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 130.004 3.322 . . . . 1.04 113.969 -175.465 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.1 m -107.94 117.26 33.65 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 126.673 1.989 . . . . 0.79 114.962 -174.125 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.64 156.86 17.47 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 125.629 1.571 . . . . 1.4 108.332 177.08 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -117.37 123.14 45.74 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 125.546 2.594 . . . . 1.51 108.13 -178.661 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.403 HD23 HG22 ' A' ' 7' ' ' THR . 60.2 tp -97.13 93.4 6.54 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.633 -2.542 . . . . 1.14 112.433 -179.916 . . . . . . . . 2 2 . 1 . 133 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.5 t -91.46 136.27 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 127.831 2.452 . . . . 1.23 106.154 174.569 . . . . . . . . 1 1 . 1 . 133 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.5 mt . . . . . 0 N--CA 1.429 -1.501 0 CA-C-O 124.506 2.098 . . . . 2.78 111.198 178.582 . . . . . . . . 0 0 . 1 . 134 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.263 16.0 ptt? . . . . . 0 CA--C 1.49 -1.333 0 N-CA-C 114.366 1.247 . . . . 1.1 114.366 . . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -106.78 135.35 48.46 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 116.088 1.884 . . . . 1.87 116.088 -177.109 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.1 pt -120.42 165.11 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 101.514 -3.514 . . . . 0.72 101.514 176.657 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -116.83 147.53 42.04 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 121.989 0.9 . . . . 1.4 111.74 -179.732 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.347 65.0 t -123.34 113.79 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-O 123.703 1.716 . . . . 0.58 107.802 174.856 . . . . . . . . 2 2 . 1 . 134 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -99.2 130.48 45.5 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.737 -2.477 . . . . 2.09 108.545 -178.618 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.7 p -98.65 175.82 5.86 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.93 -1.731 . . . . 0.99 111.847 176.502 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.7 tp -77.32 -31.71 54.78 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 118.211 -1.396 . . . . 2.53 111.097 169.798 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.8 p -59.62 -27.31 66.21 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 131.62 3.968 . . . . 2.08 115.679 -177.425 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.01 56.6 0.62 Allowed Glycine 0 N--CA 1.43 -1.766 1 C-N-CA 135.417 6.246 . . . . 1.31 104.909 165.608 . . . . . . . . 2 2 . 1 . 134 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -125.73 141.96 51.75 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.306 -2.879 . . . . 1.4 107.807 177.642 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 100.0 m -120.53 112.69 19.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.556 -1.276 . . . . 0.78 107.556 175.921 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 13' ' ' ILE . 15.3 mt -93.97 141.07 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 118.212 -2.805 . . . . 1.55 106.838 -178.634 . . . . . . . . 2 2 . 1 . 134 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -104.42 117.74 34.9 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 124.551 2.12 . . . . 1.08 107.868 177.585 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.9 mt -116.06 128.7 55.9 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 111.75 -2.477 . . . . 1.55 107.735 -178.878 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -87.47 117.01 25.97 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 104.598 -2.371 . . . . 1.95 104.598 175.763 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.26 159.34 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 125.213 1.57 . . . . 0.96 107.591 -174.766 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 26.1 mt-10 -106.34 165.04 13.68 Favored Pre-proline 0 N--CA 1.429 -1.484 0 C-N-CA 125.502 1.521 . . . . 2.35 108.208 165.226 . . . . . . . . 2 2 . 1 . 134 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 95.7 Cg_exo -72.76 -22.38 20.44 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 125.073 3.849 . . . . 0.95 115.381 -173.18 . . . . . . . . 2 2 . 1 . 134 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.8 m -88.88 -1.33 58.04 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.796 -0.638 . . . . 1.45 112.32 -179.833 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -74.32 140.7 45.05 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.023 -2.923 . . . . 1.69 112.935 -179.318 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.0 p -76.5 162.39 27.85 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.772 -4.33 . . . . 0.75 113.499 177.873 . . . . . . . . 2 2 . 1 . 134 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mm -64.86 -29.05 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.29 -2.756 . . . . 0.73 114.325 175.48 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -61.28 -31.75 71.58 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 116.943 2.201 . . . . 1.62 116.943 164.921 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -75.43 -39.85 58.4 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.915 -1.116 . . . . 2.13 109.212 -179.344 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.0 t -63.67 -39.89 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 117.398 2.37 . . . . 0.62 117.398 171.535 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.257 66.4 mttt -61.22 -40.45 94.04 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 124.649 2.166 . . . . 1.22 114.934 172.529 . . . . . . . . 2 2 . 1 . 134 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.37 -39.77 67.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.974 -3.579 . . . . 0.51 113.6 172.506 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -68.76 -28.66 66.99 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 120.75 1.614 . . . . 1.44 109.855 172.519 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.1 mt -70.87 -24.8 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 116.95 -3.594 . . . . 1.32 115.402 174.381 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -62.11 -30.15 70.81 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.035 -2.916 . . . . 1.7 112.392 173.254 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -71.83 -20.04 61.89 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.896 -2.378 . . . . 1.55 113.205 175.801 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -103.11 -59.43 1.71 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.506 -1.664 . . . . 2.62 106.506 -173.907 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -105.57 -10.2 16.99 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.249 -1.341 . . . . 1.48 111.401 -164.45 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 56.3 54.0 38.97 Favored Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 125.757 1.646 . . . . 1.12 112.801 175.906 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.0 mt -118.49 127.55 26.5 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 127.236 2.214 . . . . 1.55 105.433 178.586 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 37.2 Cg_endo -75.6 163.91 33.19 Favored 'Trans proline' 0 N--CA 1.432 -2.124 2 O-C-N 112.669 -4.438 . . . . 1.02 115.553 179.499 . . . . . . . . 3 3 . 1 . 134 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 71.3 Cg_exo -70.63 -12.23 30.93 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 CA-C-N 123.622 2.329 . . . . 1.25 117.053 -177.238 . . . . . . . . 2 2 . 1 . 134 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -75.2 -16.25 60.5 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 115.603 -4.436 . . . . 2.25 112.533 172.642 . . . . . . . . 2 2 . 1 . 134 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -90.26 -10.68 43.34 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 119.668 1.122 . . . . 2.02 109.773 -177.071 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -103.32 132.04 49.9 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 123.931 1.824 . . . . 0.69 106.1 -160.301 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -121.41 111.25 17.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 114.207 -1.361 . . . . 2.78 112.428 168.506 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.3 mt -90.13 132.37 35.48 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.552 -1.967 . . . . 1.17 115.751 179.362 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 mm -123.73 124.82 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-O 126.316 2.96 . . . . 1.38 112.331 -179.587 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -124.48 108.16 11.84 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 127.612 2.365 . . . . 1.5 108.529 177.15 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.53 -74.3 0.09 Allowed 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 110.592 -3.003 . . . . 1.21 114.066 -178.056 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -147.67 -10.98 0.17 Allowed Glycine 0 N--CA 1.431 -1.679 1 C-N-CA 131.178 4.228 . . . . 1.3 114.631 -177.886 . . . . . . . . 2 2 . 1 . 134 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -94.93 122.43 37.56 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.515 -2.756 . . . . 2.55 113.909 -173.032 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -73.26 117.96 15.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.751 1.62 . . . . 2.48 111.273 168.76 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.8 mt -92.17 128.68 38.1 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 123.429 2.831 . . . . 0.9 113.186 -171.842 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -73.8 146.64 44.07 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.415 1.579 . . . . 1.94 112.963 178.956 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -66.1 -50.1 65.22 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.817 -2.427 . . . . 1.56 115.554 -170.288 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.92 52.85 1.93 Allowed Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 117.234 -2.412 . . . . 0.97 118.082 168.527 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -114.55 161.64 17.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.848 -1.908 . . . . 2.49 105.848 161.553 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.3 p -108.05 175.6 5.42 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 116.749 2.129 . . . . 0.76 116.749 178.11 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.3 mt -65.49 -31.62 72.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.158 2.885 . . . . 1.05 114.563 172.301 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 t -63.06 -44.41 95.89 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.879 -3.638 . . . . 1.19 118.011 171.511 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -64.74 -37.2 86.81 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 129.602 3.161 . . . . 1.9 110.269 -175.597 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -98.4 -10.16 24.13 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.788 2.835 . . . . 0.89 110.085 -174.305 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.1 m120 60.66 54.89 3.5 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 128.487 3.994 . . . . 1.84 113.003 178.715 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.9 mt -106.59 101.35 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-N 108.768 -3.833 . . . . 0.82 106.644 179.607 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -104.01 174.49 5.85 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 129.988 3.315 . . . . 2.16 111.583 -167.012 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -55.67 138.81 46.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.815 -3.053 . . . . 2.12 114.486 179.813 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 67.71 39.07 2.8 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 129.837 3.255 . . . . 1.71 112.783 -178.89 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.3 t -109.9 137.28 47.9 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.22 -1.77 . . . . 1.04 106.22 -169.494 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.6 m -96.81 110.0 22.57 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 129.148 2.979 . . . . 0.79 114.114 -176.031 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.1 mt -95.06 147.28 23.59 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 127.647 2.379 . . . . 1.4 107.742 169.342 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -109.31 123.43 49.28 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 103.735 -2.691 . . . . 1.51 103.735 -173.207 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.6 tp -81.9 107.23 14.45 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.246 -2.784 . . . . 1.14 109.011 173.706 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.4 t -98.37 144.69 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 127.923 3.264 . . . . 1.23 104.692 167.809 . . . . . . . . 1 1 . 1 . 134 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 N--CA 1.431 -1.407 0 O-C-N 117.841 -3.037 . . . . 2.78 110.593 178.755 . . . . . . . . 0 0 . 1 . 135 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ptt? . . . . . 0 CA--C 1.489 -1.381 0 N-CA-C 112.017 0.377 . . . . 1.1 112.017 . . . . . . . . . 0 0 . 1 . 135 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -92.0 136.16 33.38 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.191 -2.193 . . . . 1.87 115.964 173.659 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.373 27.5 pt -116.61 161.66 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-O 114.541 -2.647 . . . . 0.72 112.378 165.839 . . . . . . . . 2 2 . 1 . 135 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -120.13 143.52 48.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 121.383 1.901 . . . . 1.4 110.91 177.226 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.83 127.55 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 112.33 -2.213 . . . . 0.58 108.198 175.654 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -97.4 138.83 34.26 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.343 -1.725 . . . . 2.09 106.343 177.256 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 p -97.57 -179.45 4.47 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 127.609 3.576 . . . . 0.99 110.867 173.027 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.8 mt -77.79 -51.33 10.68 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.208 -4.683 . . . . 2.53 112.624 175.315 . . . . . . . . 2 2 . 1 . 135 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.0 p -56.83 -43.87 81.48 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.464 2.024 . . . . 2.08 116.464 177.602 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.08 61.08 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 127.106 2.289 . . . . 1.31 111.118 177.978 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.38 156.48 48.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 103.1 -2.926 . . . . 1.4 103.1 178.38 . . . . . . . . 2 2 . 1 . 135 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.9 m -133.04 121.81 23.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.715 2.674 . . . . 0.78 110.805 -176.95 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mt -102.23 115.27 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 118.627 -2.546 . . . . 1.55 106.896 -175.998 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.2 m -93.19 115.73 28.34 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.163 -1.586 . . . . 1.08 106.784 174.867 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.3 mt -117.63 147.87 42.47 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 125.726 2.679 . . . . 1.55 112.022 -178.787 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -90.61 121.13 32.26 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.378 1.871 . . . . 1.95 110.525 177.346 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.6 m -140.99 167.38 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 116.534 -1.698 . . . . 0.96 111.829 -176.735 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -118.86 173.46 3.4 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-N 122.739 2.518 . . . . 2.35 114.182 156.96 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -75.7 -11.31 20.24 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 115.224 -2.717 . . . . 0.95 118.861 -179.479 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.6 m -79.57 -3.02 45.06 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.359 1.064 . . . . 1.45 112.062 170.493 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -81.33 151.57 27.95 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.517 -1.99 . . . . 1.69 107.884 178.781 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.269 17.3 p -92.52 164.03 13.6 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 115.088 1.514 . . . . 0.75 115.088 178.796 . . . . . . . . 2 2 . 1 . 135 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.9 mm -63.33 -22.38 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 116.267 1.951 . . . . 0.73 116.267 171.999 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -66.72 -45.34 79.01 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.149 3.379 . . . . 1.62 111.764 166.114 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -56.89 -38.16 72.39 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.343 -2.098 . . . . 2.13 114.504 178.133 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.1 t -66.26 -36.03 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 127.914 2.485 . . . . 0.62 114.245 174.979 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -67.4 -39.56 85.58 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.97 2.952 . . . . 1.22 118.97 173.582 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.28 -36.55 66.25 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 116.847 2.166 . . . . 0.51 116.847 170.547 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -60.42 -40.25 90.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.913 1.285 . . . . 1.44 114.224 170.048 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.3 mt -76.4 -31.42 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.438 1.495 . . . . 1.32 108.654 179.367 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -67.26 -43.55 81.59 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.171 -2.205 . . . . 1.7 113.904 174.851 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -58.13 -65.57 0.62 Allowed 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 130.386 3.474 . . . . 1.55 110.805 168.783 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -56.63 -53.55 56.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.926 3.306 . . . . 2.62 119.926 -175.252 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -120.87 -3.63 9.68 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.681 -1.6 . . . . 1.48 112.826 -164.845 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.83 -6.34 81.95 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 118.493 2.157 . . . . 1.12 118.493 169.527 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.7 mp -73.97 113.63 25.1 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 118.288 -2.889 . . . . 1.55 115.451 -170.665 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 14.5 Cg_exo -60.23 146.44 96.39 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 124.974 3.783 . . . . 1.02 114.009 179.718 . . . . . . . . 2 2 . 1 . 135 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -58.18 -24.91 69.26 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 C-N-CA 123.437 2.758 . . . . 1.25 117.224 -177.534 . . . . . . . . 3 3 . 1 . 135 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -70.8 -26.2 63.21 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 130.176 4.672 . . . . 2.25 112.702 179.296 . . . . . . . . 2 2 . 1 . 135 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -89.89 -16.26 30.4 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.21 -3.431 . . . . 2.02 112.492 -174.974 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -87.25 126.87 35.09 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 117.313 2.338 . . . . 0.69 117.313 -177.759 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -120.74 126.27 49.73 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.127 2.571 . . . . 2.78 108.099 164.883 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.9 mt -109.51 115.03 29.17 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.774 -3.079 . . . . 1.17 109.391 -174.993 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.3 mm -101.18 134.72 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 125.943 1.697 . . . . 1.38 108.581 -177.028 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -154.42 126.54 7.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.565 -2.383 . . . . 1.5 104.565 174.976 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.52 45.12 16.85 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 125.958 2.789 . . . . 1.21 113.788 -177.264 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.49 2.27 20.08 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 111.97 -2.377 . . . . 1.3 118.737 -173.506 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -103.88 125.9 50.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.283 -3.481 . . . . 2.55 107.19 -175.523 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -74.0 122.01 21.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.083 -2.261 . . . . 2.48 107.258 163.707 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.9 mt -78.24 127.02 31.64 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 130.459 3.504 . . . . 0.9 116.855 -177.396 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -89.29 130.55 35.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 116.421 2.008 . . . . 1.94 116.421 173.871 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.53 -61.41 1.7 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 130.275 3.43 . . . . 1.56 115.898 -170.269 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.68 23.8 3.45 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 123.066 3.986 . . . . 0.97 123.066 173.199 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -99.73 165.44 11.59 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.363 1.465 . . . . 2.49 107.347 163.862 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.391 18.6 p -92.6 171.19 9.17 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 117.09 2.256 . . . . 0.76 117.09 177.097 . . . . . . . . 2 2 . 1 . 135 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.72 -33.79 64.52 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 114.897 -2.478 . . . . 1.05 107.374 170.987 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -73.46 -35.68 65.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.42 1.888 . . . . 1.19 107.94 -175.256 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.39 3.0 t0 -63.32 -53.98 44.25 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.941 1.353 . . . . 1.9 111.859 171.005 . . . . . . . . 2 2 . 1 . 135 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -73.19 -7.98 53.79 Favored 'General case' 0 N--CA 1.43 -1.454 2 O-C-N 115.318 -4.613 . . . . 0.89 122.295 177.112 . . . . . . . . 2 2 . 1 . 135 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.0 m120 70.2 56.42 0.29 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.568 1.692 . . . . 1.84 115.568 179.137 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.1 mt -104.71 108.29 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 128.097 3.373 . . . . 0.82 109.008 177.485 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -87.95 -175.39 5.09 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 125.265 2.46 . . . . 2.16 109.49 177.807 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -63.2 131.0 47.0 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 115.276 -4.64 . . . . 2.12 115.62 174.522 . . . . . . . . 2 2 . 1 . 135 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.662 17.9 mt-10 97.69 -5.31 0.05 Allowed 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 124.622 1.201 . . . . 1.71 112.284 174.315 . . . . . . . . 2 2 . 1 . 135 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -66.71 122.69 18.2 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.807 2.043 . . . . 1.04 115.455 -176.265 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.5 m -91.2 115.59 28.14 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 103.803 -2.666 . . . . 0.79 103.803 -178.682 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.4 mt -79.34 139.74 37.7 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.079 2.952 . . . . 1.4 112.245 165.343 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -108.7 117.08 33.25 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.95 -2.969 . . . . 1.51 114.702 -179.059 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.9 tp -83.17 115.14 21.79 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 128.577 2.751 . . . . 1.14 111.746 -174.916 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.2 t -104.25 133.27 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 105.354 -2.091 . . . . 1.23 105.354 174.498 . . . . . . . . 1 1 . 1 . 135 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 N--CA 1.431 -1.408 0 O-C-N 125.345 1.653 . . . . 2.78 110.036 -178.231 . . . . . . . . 0 0 . 1 . 136 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 ptt? . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 122.104 0.954 . . . . 1.1 109.965 . . . . . . . . . 0 0 . 1 . 136 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -103.08 144.02 31.83 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.336 -1.302 . . . . 1.87 107.966 -177.381 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.2 pt -132.35 159.68 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 C-N-CA 127.341 2.256 . . . . 0.72 107.182 175.71 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -103.39 153.09 20.85 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 128.581 2.753 . . . . 1.4 111.574 178.752 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.5 t -137.7 104.68 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 106.636 -1.616 . . . . 0.58 106.636 177.546 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -90.59 117.62 29.4 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 127.062 3.315 . . . . 2.09 111.13 -179.791 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.1 p -80.22 174.5 11.53 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.137 -3.477 . . . . 0.99 115.567 179.303 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.2 mt -61.47 -52.74 63.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 124.875 1.359 . . . . 2.53 111.573 170.235 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.276 72.6 p -66.5 -38.17 86.65 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 119.465 -2.022 . . . . 2.08 115.625 -173.189 . . . . . . . . 2 2 . 1 . 136 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.75 52.12 0.17 Allowed Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 125.542 1.544 . . . . 1.31 116.49 173.578 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -119.3 149.27 42.06 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 103.475 -2.787 . . . . 1.4 103.475 174.773 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.3 m -119.28 115.05 23.36 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 125.497 1.748 . . . . 0.78 106.636 174.633 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mt -95.69 135.63 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.189 -2.195 . . . . 1.55 105.33 179.744 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.8 m -96.14 129.52 43.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.961 -2.977 . . . . 1.08 102.961 172.122 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.0 mt -124.29 133.89 53.36 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.104 -1.813 . . . . 1.55 106.104 -179.102 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -92.3 107.24 19.07 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.07 -2.268 . . . . 1.95 111.098 169.413 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 m -113.67 179.04 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 C-N-CA 127.734 2.414 . . . . 0.96 114.113 174.669 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -125.73 154.75 73.2 Favored Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 103.84 -2.652 . . . . 2.35 103.84 166.317 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.294 25.6 Cg_endo -66.74 -30.73 41.04 Favored 'Trans proline' 0 N--CA 1.434 -2.001 1 C-N-CA 125.577 4.185 . . . . 0.95 110.234 -172.031 . . . . . . . . 3 2 . 1 . 136 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.2 p -64.51 -16.94 63.39 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.552 3.141 . . . . 1.45 116.646 173.549 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -70.07 142.47 52.66 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.376 -2.077 . . . . 1.69 109.39 177.137 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.0 p -78.26 164.56 24.79 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 126.247 2.217 . . . . 0.75 112.941 174.237 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.4 mm -65.2 -32.6 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 117.142 2.275 . . . . 0.73 117.142 174.114 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -50.03 -49.88 49.44 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 126.386 2.993 . . . . 1.62 109.688 164.533 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -65.36 -37.21 86.35 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.407 -2.683 . . . . 2.13 116.295 -178.127 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.4 t -67.53 -27.89 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 121.254 1.843 . . . . 0.62 108.221 174.812 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -75.0 -27.32 60.09 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 121.005 1.729 . . . . 1.22 112.526 178.343 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.18 -31.74 69.35 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 117.3 -1.333 . . . . 0.51 111.457 173.844 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -69.05 -35.64 76.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.515 2.726 . . . . 1.44 109.914 175.033 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.8 mt -69.03 -43.66 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-N 113.789 -1.55 . . . . 1.32 111.359 171.134 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -62.68 -38.07 88.92 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.103 -2.248 . . . . 1.7 113.389 179.206 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -49.67 -49.5 47.2 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 130.272 3.429 . . . . 1.55 114.474 168.943 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -87.96 -58.45 2.56 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.106 -3.496 . . . . 2.62 117.002 -179.557 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -81.88 -43.97 17.47 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.695 1.712 . . . . 1.48 112.546 -166.086 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.1 63.35 1.14 Allowed Glycine 0 N--CA 1.431 -1.689 0 CA-C-N 111.946 -2.388 . . . . 1.12 112.586 176.001 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.2 mt -129.81 117.9 18.52 Favored Pre-proline 0 N--CA 1.429 -1.505 0 CA-C-O 115.789 -2.053 . . . . 1.55 106.074 -177.599 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -67.4 140.63 53.35 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 CA-C-N 127.493 3.712 . . . . 1.02 112.114 -179.904 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -51.9 -20.17 9.57 Favored 'Trans proline' 0 N--CA 1.433 -2.073 1 N-CA-C 122.719 4.084 . . . . 1.25 122.719 -175.958 . . . . . . . . 3 3 . 1 . 136 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.96 -39.55 72.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.805 2.842 . . . . 2.25 111.02 172.523 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -75.75 -36.0 60.01 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 116.706 -3.746 . . . . 2.02 111.496 179.878 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -93.52 142.45 27.33 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 119.951 -1.718 . . . . 0.69 107.036 -166.136 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -124.13 151.54 43.82 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.993 -1.692 . . . . 2.78 106.535 166.599 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.6 mt -121.64 123.9 43.02 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.084 1.421 . . . . 1.17 108.868 -179.559 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.4 mt -105.53 128.43 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 129.719 3.208 . . . . 1.38 110.664 -176.101 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.416 ' C ' ' H ' ' A' ' 47' ' ' GLY . 2.4 t80 -139.13 133.11 31.04 Favored 'General case' 0 N--CA 1.43 -1.473 1 N-CA-C 99.256 -4.35 . . . . 1.5 99.256 179.835 . . . . . . . . 3 3 . 1 . 136 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.57 -36.01 0.18 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 131.418 3.887 . . . . 1.21 113.557 179.504 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 164.91 -26.06 0.18 Allowed Glycine 0 N--CA 1.429 -1.781 0 O-C-N 116.964 -3.585 . . . . 1.3 111.245 178.297 . . . . . . . . 2 2 . 1 . 136 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -83.22 137.67 33.92 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.703 2.668 . . . . 2.55 111.611 -178.974 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 pm0 -92.4 126.99 37.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.26 -2.15 . . . . 2.48 109.514 177.019 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.293 34.8 mt -81.87 122.84 28.24 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.378 2.513 . . . . 0.9 109.899 -161.683 . . . . . . . . 2 2 . 1 . 136 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -77.99 130.64 36.75 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 116.801 -3.687 . . . . 1.94 108.119 178.601 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -46.57 -48.18 19.58 Favored 'General case' 0 N--CA 1.43 -1.472 1 C-N-CA 132.34 4.256 . . . . 1.56 115.028 -173.34 . . . . . . . . 2 2 . 1 . 136 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.65 49.61 3.89 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 128.425 2.917 . . . . 0.97 116.077 172.983 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -135.78 172.86 12.39 Favored 'General case' 0 N--CA 1.43 -1.464 1 N-CA-C 97.606 -4.961 . . . . 2.49 97.606 169.47 . . . . . . . . 2 2 . 1 . 136 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.5 p -99.14 169.21 9.56 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.232 -1.804 . . . . 0.76 114.56 170.3 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.5 mt -76.02 -21.68 56.59 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 112.324 -2.216 . . . . 1.05 109.161 176.907 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 t -73.86 -39.78 63.73 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.893 -0.594 . . . . 1.19 109.798 176.862 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -54.84 -40.8 69.98 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 120.442 3.497 . . . . 1.9 120.442 174.508 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -78.84 -15.03 58.89 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 128.121 2.568 . . . . 0.89 116.992 175.966 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 m120 68.74 51.54 0.59 Allowed 'General case' 0 N--CA 1.43 -1.445 1 C-N-CA 132.932 4.493 . . . . 1.84 113.88 -178.311 . . . . . . . . 2 2 . 1 . 136 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mp -82.15 116.86 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 117.39 -3.318 . . . . 0.82 108.976 175.516 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -95.95 165.07 12.44 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 111.884 -2.417 . . . . 2.16 115.531 177.309 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -53.49 135.23 40.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.359 -1.291 . . . . 2.12 113.576 176.269 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 63.84 34.29 11.96 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 118.674 2.842 . . . . 1.71 118.674 178.241 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.7 m -92.12 154.46 18.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.1 2.16 . . . . 1.04 114.277 -177.314 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.0 m -102.36 114.14 28.07 Favored 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 117.516 -3.24 . . . . 0.79 116.348 -179.957 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -87.15 147.7 25.51 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.651 -0.656 . . . . 1.4 109.855 165.806 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -114.92 120.77 41.06 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 123.797 0.839 . . . . 1.51 109.137 -178.692 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.4 tp -97.69 129.16 44.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.932 -2.355 . . . . 1.14 109.472 -175.565 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.83 164.52 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 129.887 3.275 . . . . 1.23 105.555 177.796 . . . . . . . . 1 1 . 1 . 136 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.7 mt . . . . . 0 N--CA 1.429 -1.501 0 O-C-N 116.794 -3.691 . . . . 2.78 109.364 179.553 . . . . . . . . 0 0 . 1 . 137 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 ptt? . . . . . 0 CA--C 1.49 -1.339 0 CA-C-O 115.847 -2.025 . . . . 1.1 116.247 . . . . . . . . . 0 0 . 1 . 137 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.62 138.13 34.66 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 122.809 2.55 . . . . 1.87 109.978 -179.096 . . . . . . . . 2 2 . 1 . 137 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.8 pt -124.33 170.85 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 104.232 -2.507 . . . . 0.72 104.232 167.991 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.463 ' HB3' HG23 ' A' ' 12' ' ' THR . 22.2 m-85 -119.1 147.25 44.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.811 3.245 . . . . 1.4 107.051 -176.586 . . . . . . . . 2 2 . 1 . 137 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.5 t -133.93 138.08 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 102.832 -3.025 . . . . 0.58 102.832 170.755 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -110.6 130.31 55.6 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.082 2.153 . . . . 2.09 107.328 177.768 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -81.8 -176.73 6.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 123.898 0.749 . . . . 0.99 111.966 174.977 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.7 mt -58.49 -47.51 83.84 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.171 2.988 . . . . 2.53 112.331 179.494 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.0 p -89.04 -35.73 16.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.161 -2.837 . . . . 2.08 106.529 -172.338 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.74 5.54 0.25 Allowed Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 119.938 2.735 . . . . 1.31 119.938 -178.497 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.1 ttpt -85.17 126.03 33.31 Favored 'General case' 0 N--CA 1.43 -1.443 2 O-C-N 113.803 -5.528 . . . . 1.4 108.895 -174.482 . . . . . . . . 2 2 . 1 . 137 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.463 HG23 ' HB3' ' A' ' 4' ' ' PHE 0.293 66.0 m -83.77 114.9 21.94 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.058 2.361 . . . . 0.78 109.362 173.966 . . . . . . . . 3 3 . 1 . 137 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mt -98.25 116.7 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 124.553 2.121 . . . . 1.55 105.654 177.051 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.6 m -86.59 105.89 17.18 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.812 -3.055 . . . . 1.08 116.436 173.371 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.0 mt -113.41 115.99 28.93 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 117.199 -1.381 . . . . 1.55 113.319 -179.495 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.368 0.8 OUTLIER -67.94 111.71 4.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.811 1.291 . . . . 1.95 111.211 171.081 . . . . . . . . 3 3 . 1 . 137 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 m -117.0 169.81 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 117.039 -3.538 . . . . 0.96 112.678 179.334 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -112.82 165.57 12.83 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-N 121.512 1.96 . . . . 2.35 108.382 160.25 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -66.47 -28.31 46.01 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 CA-C-N 124.27 2.561 . . . . 0.95 114.313 -172.587 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.293 24.0 p -77.65 1.01 21.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 130.953 3.701 . . . . 1.45 119.475 177.143 . . . . . . . . 2 2 . 1 . 137 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -80.78 143.49 32.83 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.254 -1.529 . . . . 1.69 107.654 175.377 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.3 p -75.56 167.79 21.24 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.439 -0.578 . . . . 0.75 109.439 179.174 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -68.4 -37.18 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.672 -1.893 . . . . 0.73 115.158 175.849 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -49.74 -43.68 48.07 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 112.164 -2.289 . . . . 1.62 114.141 162.817 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -72.42 -28.42 62.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.852 -1.155 . . . . 2.13 113.868 176.104 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.7 t -71.56 -35.42 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 117.366 -3.334 . . . . 0.62 112.042 170.556 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -68.91 -35.66 77.1 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 124.45 1.094 . . . . 1.22 109.146 172.704 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.27 -40.65 96.94 Favored 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 118.78 -2.45 . . . . 0.51 112.97 172.485 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -61.09 -42.35 98.35 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 119.031 -2.293 . . . . 1.44 115.542 171.003 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.0 mt -58.89 -36.29 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 119.077 -2.264 . . . . 1.32 112.796 167.583 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -61.44 -40.21 93.65 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.49 -1.381 . . . . 1.7 113.501 176.44 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.45 -40.37 94.23 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 119.697 3.221 . . . . 1.55 119.697 162.931 . . . . . . . . 2 2 . 1 . 137 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt -78.68 -68.2 0.67 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.167 2.187 . . . . 2.62 107.935 -176.88 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -101.44 -19.19 15.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 116.857 -1.937 . . . . 1.48 111.238 -169.364 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.57 9.84 45.71 Favored Glycine 0 N--CA 1.431 -1.679 0 CA-C-O 114.748 -3.251 . . . . 1.12 115.877 176.156 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.581 HG22 ' HG3' ' A' ' 41' ' ' GLN . 19.1 mt -85.97 128.39 58.33 Favored Pre-proline 0 N--CA 1.429 -1.49 1 CA-C-O 110.901 -4.38 . . . . 1.55 106.797 -178.953 . . . . . . . . 3 3 . 1 . 137 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -80.65 153.12 20.11 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 CA-C-N 127.561 3.736 . . . . 1.02 110.671 -179.03 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.64 -19.95 41.24 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 124.829 3.686 . . . . 1.25 111.84 -165.768 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -68.16 -39.52 82.56 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 124.283 1.992 . . . . 2.25 116.276 173.009 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -73.04 -43.62 61.77 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 131.221 3.808 . . . . 2.02 115.119 174.091 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.581 ' HG3' HG22 ' A' ' 36' ' ' ILE . 55.7 mt-30 -60.75 137.22 58.22 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.584 -2.573 . . . . 0.69 111.094 -174.591 . . . . . . . . 2 2 . 1 . 137 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -116.51 142.78 46.43 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 125.021 3.555 . . . . 2.78 107.402 167.294 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.483 HD13 HD13 ' A' ' 67' ' ' LEU . 74.9 mt -127.52 119.67 26.56 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.251 -2.129 . . . . 1.17 105.251 178.297 . . . . . . . . 2 2 . 1 . 137 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.5 HD12 HG21 ' A' ' 70' ' ' VAL . 21.3 mt -111.55 132.9 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 129.093 2.957 . . . . 1.38 110.672 -179.995 . . . . . . . . 2 2 . 1 . 137 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -139.23 141.04 37.89 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.394 -2.076 . . . . 1.5 105.394 170.413 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.43 20.71 0.32 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.123 -2.861 . . . . 1.21 117.712 177.667 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.59 6.19 80.78 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 116.807 -3.683 . . . . 1.3 113.287 179.677 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -98.09 121.71 40.35 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 115.382 -2.247 . . . . 2.55 110.841 174.795 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -77.68 125.13 28.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.506 2.323 . . . . 2.48 105.897 171.945 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.288 22.2 mt -79.99 136.41 36.6 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.908 1.814 . . . . 0.9 112.402 -167.684 . . . . . . . . 2 2 . 1 . 137 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.32 46.1 mt-10 -81.19 129.65 34.68 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.113 -3.492 . . . . 1.94 113.574 173.039 . . . . . . . . 2 2 . 1 . 137 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -59.83 -46.05 90.46 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.807 2.521 . . . . 1.56 117.807 -172.211 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.9 49.02 2.25 Favored Glycine 0 N--CA 1.43 -1.704 1 O-C-N 113.098 -6.001 . . . . 0.97 110.149 173.14 . . . . . . . . 2 2 . 1 . 137 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -119.5 176.25 5.45 Favored 'General case' 0 N--CA 1.429 -1.477 1 O-C-N 116.232 -4.099 . . . . 2.49 105.388 161.561 . . . . . . . . 2 2 . 1 . 137 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.3 p -104.29 -175.54 2.82 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 117.904 -1.518 . . . . 0.76 114.245 175.385 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.0 mt -77.97 -29.27 49.65 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.783 -1.198 . . . . 1.05 110.818 173.888 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.9 t -73.58 -29.47 62.43 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.576 -1.328 . . . . 1.19 113.261 176.584 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -58.88 -28.91 66.6 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.833 2.901 . . . . 1.9 118.833 172.252 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.356 26.6 m-85 -100.18 8.96 43.47 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 115.671 1.73 . . . . 0.89 115.671 173.022 . . . . . . . . 2 2 . 1 . 137 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.7 m120 46.69 64.14 1.64 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.553 2.341 . . . . 1.84 113.019 -173.514 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.4 mt -104.5 121.87 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 103.213 -2.884 . . . . 0.82 103.213 177.218 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -96.84 -172.66 2.52 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.994 2.118 . . . . 2.16 106.494 -168.681 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.17 153.61 40.64 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 116.49 -2.084 . . . . 2.12 110.685 173.131 . . . . . . . . 2 2 . 1 . 137 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.301 41.5 mt-10 59.53 46.65 11.86 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 115.117 1.525 . . . . 1.71 115.117 177.729 . . . . . . . . 2 2 . 1 . 137 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -104.17 142.94 33.63 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 131.469 3.908 . . . . 1.04 106.305 178.75 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.4 m -108.77 118.02 35.71 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.176 1.941 . . . . 0.79 106.76 -179.832 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.483 HD13 HD13 ' A' ' 43' ' ' LEU . 74.4 mt -92.44 146.53 23.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 113.202 -1.817 . . . . 1.4 110.242 167.381 . . . . . . . . 2 2 . 1 . 137 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -105.33 115.45 30.27 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.691 2.186 . . . . 1.51 107.036 -179.771 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 tt -88.22 116.3 26.32 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 111.863 -2.426 . . . . 1.14 110.844 -179.625 . . . . . . . . 1 1 . 1 . 137 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.5 HG21 HD12 ' A' ' 44' ' ' ILE . 1.9 t -119.75 -178.51 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.259 -2.126 . . . . 1.23 105.259 176.795 . . . . . . . . 2 2 . 1 . 137 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.0 mt . . . . . 0 N--CA 1.43 -1.458 0 O-C-N 117.173 -3.454 . . . . 2.78 113.354 177.889 . . . . . . . . 0 0 . 1 . 138 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ptt? . . . . . 0 CA--C 1.49 -1.344 0 N-CA-C 115.568 1.692 . . . . 1.1 115.568 . . . . . . . . . 0 0 . 1 . 138 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -99.16 142.45 30.63 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.173 -2.158 . . . . 1.87 105.173 179.508 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.431 HG13 ' HB2' ' A' ' 15' ' ' LEU . 3.1 pt -117.6 165.08 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 106.569 -1.641 . . . . 0.72 106.569 169.282 . . . . . . . . 2 2 . 1 . 138 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -118.35 121.14 39.66 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.559 -1.338 . . . . 1.4 108.49 179.053 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.3 t -103.37 138.76 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 104.685 -2.339 . . . . 0.58 104.685 171.369 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -111.94 143.58 42.68 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 113.427 -3.178 . . . . 2.09 112.248 173.228 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.5 p -88.61 -172.41 3.73 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.452 3.595 . . . . 0.99 112.915 179.243 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.1 mt -54.14 -38.83 65.91 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 127.028 3.299 . . . . 2.53 116.169 167.282 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -88.81 -35.58 16.53 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 114.297 -5.252 . . . . 2.08 113.002 179.842 . . . . . . . . 2 2 . 1 . 138 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.92 27.37 0.94 Allowed Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 117.745 -1.586 . . . . 1.31 114.541 -179.804 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.8 124.9 29.04 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 120.73 2.265 . . . . 1.4 109.784 -173.929 . . . . . . . . 2 2 . 1 . 138 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.528 1.7 m -78.64 118.63 20.93 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 113.835 -5.54 . . . . 0.78 118.25 176.98 . . . . . . . . 3 2 . 1 . 138 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mt -106.04 121.36 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 125.736 1.615 . . . . 1.55 110.099 172.873 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.251 6.4 m -92.51 108.93 20.34 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 116.854 2.168 . . . . 1.08 116.854 179.55 . . . . . . . . 2 2 . 1 . 138 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.431 ' HB2' HG13 ' A' ' 3' ' ' ILE . 21.5 mt -113.9 130.64 56.48 Favored 'General case' 0 N--CA 1.431 -1.409 1 O-C-N 115.141 -4.724 . . . . 1.55 110.651 -173.627 . . . . . . . . 3 3 . 1 . 138 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -84.81 101.06 11.97 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 116.688 -3.757 . . . . 1.95 111.184 169.61 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.0 m -114.18 164.26 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 121.154 -0.967 . . . . 0.96 110.089 -179.064 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.403 ' O ' HD12 ' A' ' 56' ' ' LEU . 32.9 mt-10 -102.14 161.4 23.51 Favored Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 127.395 2.278 . . . . 2.35 104.941 159.058 . . . . . . . . 2 2 . 1 . 138 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -77.16 -7.65 17.25 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 CA-C-N 122.655 1.984 . . . . 0.95 107.523 -179.616 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 m -79.31 -14.92 58.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.692 1.597 . . . . 1.45 111.825 177.174 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -65.99 144.8 56.52 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.923 2.297 . . . . 1.69 105.948 -179.888 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.4 p -89.34 158.28 17.85 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.415 -1.72 . . . . 0.75 112.937 176.972 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.332 2.8 mp -53.53 -43.74 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 116.323 -3.985 . . . . 0.73 115.305 169.8 . . . . . . . . 2 2 . 1 . 138 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -41.18 -59.96 1.37 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.189 2.196 . . . . 1.62 114.941 165.888 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -72.24 -24.54 61.39 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 120.322 3.453 . . . . 2.13 120.322 -175.624 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -61.18 -32.22 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 120.361 -1.462 . . . . 0.62 113.198 168.777 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -60.06 -43.46 95.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 117.68 -1.152 . . . . 1.22 110.987 177.602 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.78 -27.06 63.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 125.008 1.443 . . . . 0.51 109.027 177.895 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -66.46 -30.8 71.22 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 118.273 -2.767 . . . . 1.44 110.64 173.535 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.6 mt -65.87 -31.42 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 129.686 3.194 . . . . 1.32 109.732 169.494 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.328 52.9 tt0 -69.33 -33.63 73.42 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.024 -2.922 . . . . 1.7 116.91 175.694 . . . . . . . . 2 2 . 1 . 138 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.261 11.9 m-20 -67.81 -36.87 81.17 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.422 2.289 . . . . 1.55 112.196 168.918 . . . . . . . . 2 2 . 1 . 138 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -76.49 -77.28 0.14 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.831 1.252 . . . . 2.62 110.995 -178.494 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -88.17 -66.92 0.87 Allowed 'General case' 0 N--CA 1.429 -1.487 1 C-N-CA 133.316 4.646 . . . . 1.48 114.743 -166.561 . . . . . . . . 2 2 . 1 . 138 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.76 29.66 0.74 Allowed Glycine 0 N--CA 1.43 -1.714 0 O-C-N 126.973 2.671 . . . . 1.12 110.599 166.932 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.6 mt -89.44 126.12 59.35 Favored Pre-proline 0 N--CA 1.43 -1.459 1 O-C-N 115.738 -4.39 . . . . 1.55 109.192 -179.448 . . . . . . . . 2 2 . 1 . 138 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -54.37 129.28 33.86 Favored 'Trans proline' 0 C--N 1.299 -2.035 1 C-N-CA 125.611 4.207 . . . . 1.02 116.274 175.674 . . . . . . . . 3 3 . 1 . 138 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -59.96 -14.24 26.87 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 CA-C-N 124.324 2.58 . . . . 1.25 116.511 -173.38 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -65.28 -21.92 66.79 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 128.826 2.851 . . . . 2.25 118.581 170.608 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -102.41 -9.4 20.32 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-O 116.406 -1.759 . . . . 2.02 108.715 -172.712 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -89.38 133.49 34.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.742 2.417 . . . . 0.69 114.993 -170.39 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.5 ' HB2' HG23 ' A' ' 70' ' ' VAL . 64.3 mtt180 -132.96 145.09 50.58 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.435 2.064 . . . . 2.78 106.906 169.621 . . . . . . . . 2 2 . 1 . 138 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.5 mt -122.15 143.45 49.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.414 -2.054 . . . . 1.17 114.616 -177.992 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.5 mt -118.83 129.5 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 130.166 3.386 . . . . 1.38 108.887 -179.699 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -130.28 127.3 39.25 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.199 1.8 . . . . 1.5 109.816 167.641 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.85 12.8 0.93 Allowed 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.212 2.301 . . . . 1.21 117.212 -178.379 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.49 0.19 29.35 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 118.136 -2.852 . . . . 1.3 116.837 -174.388 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.307 64.5 mttt -114.62 137.18 52.2 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.748 1.737 . . . . 2.55 114.622 179.671 . . . . . . . . 2 2 . 1 . 138 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -86.01 138.5 31.92 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 117.188 -1.805 . . . . 2.48 107.845 174.192 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.7 mt -88.98 138.74 31.13 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.151 2.278 . . . . 0.9 117.151 -171.654 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -73.11 147.71 44.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 124.107 0.879 . . . . 1.94 113.356 169.932 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.72 -53.96 13.61 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.473 -2.017 . . . . 1.56 111.731 -168.532 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.87 44.1 2.93 Favored Glycine 0 N--CA 1.431 -1.666 0 O-C-N 126.702 2.501 . . . . 0.97 115.372 172.121 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -116.91 165.37 13.41 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 125.43 2.538 . . . . 2.49 104.447 163.616 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.9 p -96.66 163.76 12.88 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 112.89 -1.959 . . . . 0.76 110.605 172.873 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 18' ' ' GLU . 96.2 mt -57.39 -40.43 78.2 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 127.345 2.258 . . . . 1.05 111.161 170.518 . . . . . . . . 2 2 . 1 . 138 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.9 t -64.92 -40.94 95.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 126.646 2.466 . . . . 1.19 114.374 -179.174 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -56.0 -40.83 73.93 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.124 -3.485 . . . . 1.9 119.409 176.822 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -84.91 3.82 36.36 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 112.882 -1.963 . . . . 0.89 110.938 170.851 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.421 26.4 m120 62.49 38.64 12.5 Favored 'General case' 0 N--CA 1.43 -1.454 1 N-CA-C 121.957 4.058 . . . . 1.84 121.957 -174.382 . . . . . . . . 3 2 . 1 . 138 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.1 mt -93.65 123.65 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 117.281 -3.387 . . . . 0.82 109.107 -175.044 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -107.69 -172.48 2.08 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.178 1.353 . . . . 2.16 111.009 -172.577 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -56.16 144.35 29.91 Favored 'General case' 0 N--CA 1.428 -1.526 0 O-C-N 126.65 2.469 . . . . 2.12 113.658 168.315 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.294 35.5 mt-10 57.23 32.34 21.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.525 3.13 . . . . 1.71 117.052 173.226 . . . . . . . . 2 2 . 1 . 138 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 t -96.14 133.86 39.91 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.719 3.208 . . . . 1.04 109.996 -174.237 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.15 116.57 21.12 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 118.119 2.637 . . . . 0.79 118.119 177.344 . . . . . . . . 2 2 . 1 . 138 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.263 54.3 mt -101.46 140.24 36.03 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.847 -3.033 . . . . 1.4 106.291 173.542 . . . . . . . . 2 2 . 1 . 138 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -104.14 121.22 42.78 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 116.081 -1.914 . . . . 1.51 110.934 -174.556 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.3 tp -89.89 128.52 36.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.869 1.795 . . . . 1.14 115.365 178.48 . . . . . . . . 1 1 . 1 . 138 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.5 HG23 ' HB2' ' A' ' 42' ' ' ARG . 35.4 m -127.09 151.71 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 1 CA-C-O 128.827 4.156 . . . . 1.23 104.86 176.778 . . . . . . . . 3 3 . 1 . 138 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.8 mt . . . . . 0 N--CA 1.43 -1.465 1 O-C-N 116.188 -4.07 . . . . 2.78 111.481 -167.571 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.294 45.1 ttp . . . . . 0 CA--C 1.491 -1.327 0 N-CA-C 113.749 1.018 . . . . 1.1 113.749 . . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -100.73 123.47 44.98 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 119.491 -0.883 . . . . 1.87 111.541 -177.499 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.451 HG12 HG22 ' A' ' 17' ' ' VAL . 6.6 pt -120.93 163.65 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.311 -0.996 . . . . 0.72 108.311 174.258 . . . . . . . . 2 2 . 1 . 139 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -119.95 143.03 48.22 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 130.937 3.695 . . . . 1.4 109.738 -177.924 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.298 43.5 t -116.84 115.07 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 116.915 -3.616 . . . . 0.58 113.651 171.734 . . . . . . . . 2 2 . 1 . 139 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -95.53 143.8 26.54 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 115.949 -1.977 . . . . 2.09 108.374 -176.54 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.7 p -101.37 179.75 4.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 126.748 3.166 . . . . 0.99 112.213 173.058 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.3 mt -79.77 -10.42 59.78 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 111.607 -6.933 . . . . 2.53 115.062 173.218 . . . . . . . . 2 2 . 1 . 139 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.257 28.8 p -86.51 -51.64 6.06 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 126.321 2.962 . . . . 2.08 110.914 178.002 . . . . . . . . 2 2 . 1 . 139 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.7 -2.19 0.45 Allowed Glycine 0 N--CA 1.43 -1.705 0 O-C-N 118.198 -2.814 . . . . 1.31 112.343 177.891 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -78.19 142.58 37.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 123.078 3.439 . . . . 1.4 110.672 -179.627 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.6 m -107.95 132.88 53.03 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 123.863 1.792 . . . . 0.78 107.503 171.797 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -109.93 149.16 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 102.454 -3.165 . . . . 1.55 102.454 177.212 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.3 m -123.4 125.11 44.37 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.487 -3.883 . . . . 1.08 100.645 -177.256 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -126.51 159.11 34.35 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.357 2.263 . . . . 1.55 106.011 176.244 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -120.92 125.91 48.65 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.939 3.295 . . . . 1.95 108.576 169.839 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.451 HG22 HG12 ' A' ' 3' ' ' ILE . 3.4 m -132.28 158.41 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 129.843 3.257 . . . . 0.96 105.315 -173.059 . . . . . . . . 2 2 . 1 . 139 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -114.38 141.13 26.03 Favored Pre-proline 0 N--CA 1.429 -1.476 0 N-CA-C 102.409 -3.182 . . . . 2.35 102.409 167.365 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -61.96 -7.52 9.83 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 C-N-CA 124.511 3.474 . . . . 0.95 116.169 -171.295 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 p -73.36 -14.71 61.33 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.161 2.984 . . . . 1.45 112.104 172.977 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -75.34 145.36 41.79 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 117.354 -3.341 . . . . 1.69 111.652 179.538 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 60.9 p -89.83 179.19 6.05 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.875 -1.141 . . . . 0.75 113.477 178.31 . . . . . . . . 2 2 . 1 . 139 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 23' ' ' ILE . 23.3 mm -79.67 -22.59 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 121.289 1.859 . . . . 0.73 107.162 175.453 . . . . . . . . 2 2 . 1 . 139 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -70.83 -31.4 68.12 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.052 2.141 . . . . 1.62 110.499 170.233 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -77.18 -35.42 55.84 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.65 2.38 . . . . 2.13 111.788 173.493 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.0 t -55.44 -55.11 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-N 123.819 3.009 . . . . 0.62 112.32 167.043 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -50.44 -39.2 47.03 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 126.298 2.249 . . . . 1.22 116.078 173.939 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.83 -35.82 80.94 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.075 1.75 . . . . 0.51 111.139 173.499 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -74.54 -22.8 58.83 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 115.825 -2.35 . . . . 1.44 111.429 174.062 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.287 55.5 mt -70.96 -30.48 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.389 -2.07 . . . . 1.32 111.931 171.572 . . . . . . . . 2 2 . 1 . 139 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -65.4 -38.09 88.91 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.768 -1.56 . . . . 1.7 110.306 175.481 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.57 -59.9 2.8 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 115.22 -4.675 . . . . 1.55 112.497 168.951 . . . . . . . . 2 2 . 1 . 139 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -60.75 -58.4 8.61 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.767 1.627 . . . . 2.62 112.367 -172.737 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -95.34 -56.21 2.79 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.917 -2.364 . . . . 1.48 109.611 -170.542 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.94 4.48 7.22 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 105.146 -3.182 . . . . 1.12 105.146 176.779 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mt -74.16 129.51 84.35 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 114.32 -2.753 . . . . 1.55 105.826 -173.878 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -70.58 154.23 64.62 Favored 'Trans proline' 0 N--CA 1.434 -2.009 0 C-N-CA 115.388 -2.608 . . . . 1.02 116.888 178.006 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.59 -4.88 13.83 Favored 'Trans proline' 0 C--N 1.3 -2.015 1 C-N-CA 125.544 4.162 . . . . 1.25 108.068 -172.647 . . . . . . . . 2 2 . 1 . 139 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -77.45 -40.09 44.46 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 125.669 3.849 . . . . 2.25 111.55 169.334 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -60.07 -28.62 67.95 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.668 2.47 . . . . 2.02 117.668 -178.981 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -89.47 151.77 21.82 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.182 1.944 . . . . 0.69 115.396 -178.223 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.28 83.9 mtt180 -135.8 139.8 43.77 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 101.258 -3.608 . . . . 2.78 101.258 170.104 . . . . . . . . 2 2 . 1 . 139 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 39.0 mt -122.14 128.6 51.46 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 124.67 3.396 . . . . 1.17 105.793 -178.682 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 mm -119.06 139.02 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 114.704 -2.57 . . . . 1.38 107.57 -178.888 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -131.53 126.51 35.09 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 115.921 -1.99 . . . . 1.5 106.358 171.964 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 82.23 -71.95 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 126.874 2.609 . . . . 1.21 106.188 -177.83 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.18 -26.57 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.659 0 C-N-CA 126.112 1.815 . . . . 1.3 114.206 -171.491 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -85.55 160.35 19.68 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.241 1.941 . . . . 2.55 116.241 172.809 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.277 49.2 tt0 -90.76 137.43 32.36 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.24 3.052 . . . . 2.48 119.24 170.324 . . . . . . . . 2 2 . 1 . 139 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.0 mt -94.45 127.73 40.55 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.082 -3.511 . . . . 0.9 109.274 -169.472 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -75.9 158.81 31.61 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 118.225 2.676 . . . . 1.94 118.225 179.885 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -63.44 -59.82 4.16 Favored 'General case' 0 N--CA 1.43 -1.473 1 N-CA-C 122.879 4.4 . . . . 1.56 122.879 -168.018 . . . . . . . . 2 2 . 1 . 139 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.44 23.51 8.44 Favored Glycine 0 N--CA 1.429 -1.795 0 CA-C-O 116.094 -2.503 . . . . 0.97 113.836 178.75 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -98.22 154.19 17.95 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 122.787 3.294 . . . . 2.49 109.106 168.35 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 31.1 p -85.7 177.3 7.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.873 -2.392 . . . . 0.76 115.591 171.356 . . . . . . . . 2 2 . 1 . 139 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.27 -40.89 90.41 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 111.667 -2.515 . . . . 1.05 111.297 173.225 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.4 m -70.9 -25.79 62.94 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.567 3.547 . . . . 1.19 112.307 178.435 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -66.69 -55.6 14.43 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 120.762 1.619 . . . . 1.9 113.182 170.773 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -75.42 3.69 8.72 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 120.544 3.535 . . . . 0.89 120.544 173.685 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 54.43 46.78 24.3 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.023 -2.298 . . . . 1.84 117.011 178.704 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.4 mt -97.06 103.92 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 104.867 -2.271 . . . . 0.82 104.867 -179.556 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -104.67 -172.79 2.16 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 125.4 2.524 . . . . 2.16 109.296 -172.862 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -53.5 139.82 30.0 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.127 -2.858 . . . . 2.12 112.958 -179.863 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.374 30.7 mt-10 59.77 21.9 10.74 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 130.945 3.698 . . . . 1.71 113.871 -179.057 . . . . . . . . 2 2 . 1 . 139 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.11 143.32 27.14 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.152 1.908 . . . . 1.04 116.152 -176.989 . . . . . . . . 2 2 . 1 . 139 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.7 m -106.67 121.08 43.64 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 123.769 0.668 . . . . 0.79 112.552 -171.441 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.2 mt -95.41 164.64 12.73 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 106.694 -1.595 . . . . 1.4 106.694 173.063 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -115.48 116.64 28.54 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.486 1.915 . . . . 1.51 110.733 -179.58 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.5 tp -92.76 125.6 37.45 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.682 1.706 . . . . 1.14 112.889 179.683 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.1 t -120.08 126.08 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 101.89 -3.374 . . . . 1.23 101.89 178.252 . . . . . . . . 1 1 . 1 . 139 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.8 mt . . . . . 0 N--CA 1.431 -1.417 0 CA-C-O 126.229 2.918 . . . . 2.78 113.709 178.394 . . . . . . . . 0 0 . 1 . 140 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptt? . . . . . 0 CA--C 1.49 -1.355 0 N-CA-C 118.619 2.822 . . . . 1.1 118.619 . . . . . . . . . 0 0 . 1 . 140 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -85.78 146.83 26.6 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 117.823 -1.551 . . . . 1.87 110.191 179.722 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.2 pt -140.76 158.41 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 101.07 -3.678 . . . . 0.72 101.07 175.722 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -112.15 115.89 29.58 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 113.619 -1.628 . . . . 1.4 111.047 -176.816 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -85.84 113.69 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 118.942 -2.349 . . . . 0.58 107.749 171.594 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -104.06 122.23 44.85 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.13 -3.481 . . . . 2.09 111.868 177.688 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.2 p -83.47 158.05 22.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 123.481 1.61 . . . . 0.99 112.902 174.767 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.6 mt -88.52 -23.92 23.06 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.606 -4.434 . . . . 2.53 109.173 176.36 . . . . . . . . 2 2 . 1 . 140 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -61.37 -37.89 85.0 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.199 -3.438 . . . . 2.08 110.699 174.415 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.23 -58.09 0.38 Allowed Glycine 0 N--CA 1.43 -1.76 0 O-C-N 121.75 -0.594 . . . . 1.31 112.896 176.272 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.261 19.3 ptmt -61.69 150.34 36.93 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.567 -3.314 . . . . 1.4 116.312 -170.675 . . . . . . . . 2 2 . 1 . 140 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.3 m -114.66 123.55 49.57 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.488 1.515 . . . . 0.78 108.237 169.811 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.2 mt -114.41 126.97 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.211 -3.43 . . . . 1.55 110.821 179.766 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.6 m -89.49 109.81 20.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.611 -2.556 . . . . 1.08 108.514 -177.256 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -107.12 157.51 17.8 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.92 -1.881 . . . . 1.55 105.92 179.629 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -106.68 133.6 51.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.069 1.748 . . . . 1.95 108.296 171.199 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.462 HG21 HD13 ' A' ' 56' ' ' LEU . 30.1 m -145.23 160.81 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 117.274 -1.346 . . . . 0.96 107.881 -178.484 . . . . . . . . 2 2 . 1 . 140 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -95.98 155.59 38.12 Favored Pre-proline 0 N--CA 1.43 -1.462 0 N-CA-C 106.225 -1.768 . . . . 2.35 106.225 168.308 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.265 39.7 Cg_exo -66.28 -13.99 42.27 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 123.129 2.552 . . . . 0.95 115.456 -176.371 . . . . . . . . 2 2 . 1 . 140 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -111.2 25.59 11.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 122.658 1.218 . . . . 1.45 108.538 -179.751 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -84.17 137.14 33.67 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 116.841 -3.662 . . . . 1.69 104.613 174.388 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.335 80.4 p -67.05 165.21 16.2 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 117.773 2.509 . . . . 0.75 117.773 176.627 . . . . . . . . 3 3 . 1 . 140 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.2 mm -67.95 -38.05 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 116.966 -3.584 . . . . 0.73 109.517 175.269 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -46.87 -42.21 17.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 128.651 2.781 . . . . 1.62 113.688 168.596 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -80.08 -29.13 39.05 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.449 -2.657 . . . . 2.13 110.771 -178.268 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.5 HG21 HD21 ' A' ' 56' ' ' LEU 0.274 12.0 t -67.81 -41.15 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 119.764 -1.835 . . . . 0.62 113.239 167.606 . . . . . . . . 3 3 . 1 . 140 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -65.04 -26.5 68.29 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.552 -2.593 . . . . 1.22 116.463 170.771 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.23 -31.2 68.51 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.429 -3.294 . . . . 0.51 112.51 172.184 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -73.45 -37.31 65.86 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 123.686 0.616 . . . . 1.44 111.651 174.584 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.5 mt -65.3 -35.09 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-O 124.442 2.068 . . . . 1.32 112.064 175.322 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -61.45 -41.82 97.8 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.045 3.738 . . . . 1.7 112.493 -178.783 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -68.47 -32.74 72.96 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 126.759 2.537 . . . . 1.55 115.347 167.943 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -79.13 -60.09 2.51 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 119.17 0.896 . . . . 2.62 112.497 -179.415 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -102.71 -20.84 14.22 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 118.246 -2.784 . . . . 1.48 112.545 -167.388 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.2 30.49 10.9 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 117.59 -2.243 . . . . 1.12 112.643 178.73 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.8 mt -109.56 111.49 59.34 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 116.544 -1.694 . . . . 1.55 108.435 -178.589 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -61.77 153.1 70.04 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 122.973 2.449 . . . . 1.02 113.362 179.816 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -70.96 -15.14 32.63 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-N 126.631 3.404 . . . . 1.25 118.961 -177.005 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -51.83 -46.0 64.17 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 126.301 2.251 . . . . 2.25 113.784 170.48 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -76.97 -5.43 48.58 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 116.988 -1.482 . . . . 2.02 111.424 -177.701 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -99.26 126.42 45.09 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 120.013 1.279 . . . . 0.69 109.842 -172.374 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -116.8 130.84 56.96 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 128.626 2.77 . . . . 2.78 104.443 164.508 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -107.54 132.43 53.26 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.309 -2.744 . . . . 1.17 111.669 173.74 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.4 mm -109.63 141.96 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 119.881 -1.762 . . . . 1.38 108.74 179.556 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -140.7 117.66 11.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.575 -1.268 . . . . 1.5 107.575 170.636 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.377 . . 72.98 -44.19 0.59 Allowed 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 129.594 3.157 . . . . 1.21 112.048 -175.827 . . . . . . . . 2 2 . 1 . 140 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 173.38 -42.45 0.15 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 128.039 2.733 . . . . 1.3 115.253 -171.947 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -74.13 157.5 35.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 118.584 -1.246 . . . . 2.55 110.262 178.663 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -87.58 143.59 27.12 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 126.319 1.848 . . . . 2.48 110.283 176.273 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.3 mt -93.64 151.79 19.43 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 116.288 -4.008 . . . . 0.9 112.216 -176.655 . . . . . . . . 2 2 . 1 . 140 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -93.49 147.66 22.77 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 104.403 -2.443 . . . . 1.94 104.403 174.05 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -66.37 -52.68 44.39 Favored 'General case' 0 N--CA 1.43 -1.426 1 CA-C-O 128.599 4.047 . . . . 1.56 116.194 -170.938 . . . . . . . . 2 2 . 1 . 140 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.61 48.34 3.66 Favored Glycine 0 N--CA 1.43 -1.743 1 O-C-N 114.511 -5.118 . . . . 0.97 111.838 173.962 . . . . . . . . 2 2 . 1 . 140 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -130.67 161.84 30.74 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.547 -2.737 . . . . 2.49 105.742 162.071 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 14.0 p -95.7 179.72 5.02 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 117.036 -1.866 . . . . 0.76 110.076 -173.174 . . . . . . . . 2 2 . 1 . 140 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.5 HD21 HG21 ' A' ' 26' ' ' VAL . 2.9 mt -72.24 -41.68 66.54 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 116.783 -1.579 . . . . 1.05 113.082 172.378 . . . . . . . . 2 2 . 1 . 140 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 t -68.34 -11.96 60.34 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 121.769 2.077 . . . . 1.19 114.869 172.617 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -79.92 -29.44 39.77 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 125.445 3.748 . . . . 1.9 110.405 177.826 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -90.68 -6.04 55.02 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.056 -3.528 . . . . 0.89 112.304 174.258 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 75.7 34.19 0.59 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.684 3.74 . . . . 1.84 113.174 175.889 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.705 HD13 HD21 ' A' ' 67' ' ' LEU . 37.7 mt -74.7 107.66 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 127.476 2.31 . . . . 0.82 111.917 175.685 . . . . . . . . 2 2 . 1 . 140 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -84.74 178.51 7.62 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 126.728 2.517 . . . . 2.16 110.509 177.624 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -62.05 146.94 48.82 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 115.031 1.493 . . . . 2.12 115.031 172.451 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 64.29 39.41 7.32 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 122.827 1.299 . . . . 1.71 111.477 173.144 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 t -113.94 147.56 38.34 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.806 -1.543 . . . . 1.04 112.949 -173.806 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.2 m -93.96 130.14 40.18 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.726 -1.858 . . . . 0.79 113.777 178.446 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.705 HD21 HD13 ' A' ' 61' ' ' ILE . 96.7 mt -115.01 132.92 56.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.918 -1.882 . . . . 1.4 105.918 173.808 . . . . . . . . 2 2 . 1 . 140 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -94.05 125.34 38.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.756 3.169 . . . . 1.51 111.278 -174.469 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 tp -92.94 116.1 28.73 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 113.345 -5.847 . . . . 1.14 110.57 176.735 . . . . . . . . 2 2 . 1 . 140 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.0 t -111.77 126.03 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 128.474 2.709 . . . . 1.23 106.332 179.23 . . . . . . . . 1 1 . 1 . 140 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 N--CA 1.43 -1.444 0 O-C-N 118.216 -2.802 . . . . 2.78 107.015 178.948 . . . . . . . . 0 0 . 1 . 141 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 ttp . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 123.405 1.574 . . . . 1.1 109.537 . . . . . . . . . 0 0 . 1 . 141 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -91.53 144.43 25.56 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.235 -4.666 . . . . 1.87 106.781 178.357 . . . . . . . . 2 2 . 1 . 141 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.3 pt -140.12 175.35 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 124.195 1.95 . . . . 0.72 106.974 169.008 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -116.29 143.54 45.4 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 104.736 -2.32 . . . . 1.4 104.736 176.557 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.92 117.74 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 1 O-C-N 129.425 4.203 . . . . 0.58 103.805 167.315 . . . . . . . . 2 2 . 1 . 141 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -105.75 141.3 37.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.411 -2.68 . . . . 2.09 114.13 173.582 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.1 p -84.25 171.34 12.83 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.35 -1.468 . . . . 0.99 112.658 177.058 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.258 13.1 tp -57.53 -44.09 84.84 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.754 2.822 . . . . 2.53 114.854 168.142 . . . . . . . . 2 2 . 1 . 141 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 p -75.83 -65.58 0.89 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.752 1.621 . . . . 2.08 112.844 -173.72 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.09 53.28 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.696 0 CA-C-O 117.574 -1.681 . . . . 1.31 116.585 175.599 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -128.6 124.52 36.07 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.29 -1.744 . . . . 1.4 106.29 -179.374 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.9 m -104.14 133.86 48.36 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 102.906 -2.998 . . . . 0.78 102.906 -178.778 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.8 mt -106.85 135.01 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 103.182 -2.896 . . . . 1.55 103.182 178.703 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.9 m -97.35 122.71 40.7 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.158 -2.214 . . . . 1.08 106.821 178.351 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.8 tp -129.02 124.18 34.28 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 117.217 2.303 . . . . 1.55 117.217 -175.379 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -79.86 124.63 28.82 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 117.166 -1.397 . . . . 1.95 107.443 174.47 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.0 m -134.77 177.57 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 128.668 2.787 . . . . 0.96 106.655 178.95 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.4 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 44.4 mt-10 -123.36 166.57 17.81 Favored Pre-proline 0 N--CA 1.43 -1.448 0 C-N-CA 127.187 2.195 . . . . 2.35 106.735 163.092 . . . . . . . . 2 2 . 1 . 141 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 58.2 Cg_endo -82.2 -17.31 7.95 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 122.915 2.41 . . . . 0.95 109.681 -174.37 . . . . . . . . 2 2 . 1 . 141 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 m -90.35 5.19 48.4 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.255 -2.153 . . . . 1.45 110.318 178.156 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -84.2 158.55 21.26 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.112 -1.81 . . . . 1.69 106.112 177.324 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -92.78 163.94 13.54 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 123.579 1.657 . . . . 0.75 110.202 178.767 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mp -68.08 -34.82 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 127.272 3.415 . . . . 0.73 116.363 174.548 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -53.36 -44.07 68.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.724 -2.485 . . . . 1.62 117.59 161.699 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -66.37 -31.97 73.07 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.583 1.953 . . . . 2.13 109.801 175.847 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.51 -47.98 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 117.848 -3.032 . . . . 0.62 113.497 175.899 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.302 95.8 mttt -49.63 -40.82 40.64 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 130.275 3.43 . . . . 1.22 115.229 167.664 . . . . . . . . 2 2 . 1 . 141 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.89 -39.66 87.54 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.941 1.696 . . . . 0.51 113.494 177.923 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -66.03 -29.78 70.2 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 118.346 2.721 . . . . 1.44 118.346 167.929 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.1 mt -76.02 -33.65 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 118.496 -2.627 . . . . 1.32 114.827 171.841 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -69.6 -33.4 72.64 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.268 -1.333 . . . . 1.7 109.951 172.931 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.3 -59.54 4.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.078 1.751 . . . . 1.55 110.069 170.37 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -65.62 -60.52 2.83 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 130.463 3.505 . . . . 2.62 112.029 -168.478 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -102.85 -53.15 2.91 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.623 -3.173 . . . . 1.48 111.885 -175.521 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.05 38.02 0.4 Allowed Glycine 0 N--CA 1.43 -1.721 0 O-C-N 120.466 -1.396 . . . . 1.12 115.309 172.325 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.7 mt -110.24 126.43 28.95 Favored Pre-proline 0 N--CA 1.43 -1.435 0 C-N-CA 126.26 1.824 . . . . 1.55 108.695 -174.974 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.47 143.54 97.45 Favored 'Trans proline' 0 N--CA 1.434 -2.006 1 O-C-N 112.743 -4.398 . . . . 1.02 115.701 -178.411 . . . . . . . . 2 2 . 1 . 141 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -67.61 -14.15 41.17 Favored 'Trans proline' 0 N--CA 1.434 -2.029 0 N-CA-C 118.897 2.614 . . . . 1.25 118.897 -173.179 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -79.78 -36.71 36.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 125.37 1.669 . . . . 2.25 107.951 179.364 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -74.98 -30.2 61.12 Favored 'General case' 0 N--CA 1.431 -1.402 1 C-N-CA 133.634 4.773 . . . . 2.02 111.363 -169.035 . . . . . . . . 2 2 . 1 . 141 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -87.92 134.14 33.77 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.566 -2.584 . . . . 0.69 112.519 -173.41 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.617 ' HB2' HG23 ' A' ' 70' ' ' VAL . 84.5 mtt180 -112.71 142.84 44.86 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 116.74 -3.725 . . . . 2.78 107.012 168.408 . . . . . . . . 2 2 . 1 . 141 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.3 mt -119.86 116.49 25.95 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 118.896 -2.378 . . . . 1.17 113.393 174.958 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.3 mt -88.87 137.01 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 127.875 2.47 . . . . 1.38 110.967 -178.901 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -154.9 131.18 10.36 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.685 2.184 . . . . 1.5 105.439 173.286 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.74 -64.75 0.1 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 119.395 3.109 . . . . 1.21 119.395 178.998 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -158.34 11.47 0.22 Allowed Glycine 0 N--CA 1.43 -1.703 0 CA-C-O 122.776 1.209 . . . . 1.3 112.914 177.835 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.5 pttt -144.94 177.23 8.9 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 111.964 -2.118 . . . . 2.55 111.486 -174.411 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -110.39 157.3 19.69 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.533 1.933 . . . . 2.48 108.707 171.982 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.6 mt -102.86 137.7 40.71 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 117.953 -1.022 . . . . 0.9 113.02 -173.837 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.472 ' HB2' ' HG2' ' A' ' 54' ' ' ARG . 49.8 mt-10 -75.44 141.82 43.09 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.89 2.876 . . . . 1.94 111.003 177.512 . . . . . . . . 2 2 . 1 . 141 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -69.21 -53.07 21.84 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 123.3 2.773 . . . . 1.56 116.005 -162.977 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.95 42.04 3.12 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 119.078 -2.264 . . . . 0.97 114.714 175.121 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.472 ' HG2' ' HB2' ' A' ' 51' ' ' GLU . 28.6 mmt180 -112.14 161.31 16.67 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 121.415 2.607 . . . . 2.49 104.142 166.766 . . . . . . . . 2 2 . 1 . 141 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.1 p -90.9 162.26 14.86 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 116.807 -3.683 . . . . 0.76 111.546 178.879 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.2 mt -63.86 -33.13 75.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.488 2.315 . . . . 1.05 110.573 169.566 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.5 p -63.57 -53.6 49.21 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.369 -2.707 . . . . 1.19 114.978 179.339 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -56.16 -34.19 65.92 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.424 -1.262 . . . . 1.9 114.385 173.875 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -82.01 -4.17 56.14 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.906 -1.121 . . . . 0.89 112.571 -176.896 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.261 19.4 m-80 58.42 41.89 22.13 Favored 'General case' 0 N--CA 1.431 -1.415 1 C-N-CA 133.043 4.537 . . . . 1.84 115.861 -174.418 . . . . . . . . 3 2 . 1 . 141 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.1 mt -85.32 122.51 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 117.607 -3.183 . . . . 0.82 112.576 178.188 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -97.54 -174.04 2.81 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 125.404 2.526 . . . . 2.16 113.251 -175.141 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -59.52 131.82 52.11 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 127.348 3.452 . . . . 2.12 116.702 170.82 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.308 13.6 mt-10 73.02 31.46 1.48 Allowed 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 127.04 3.305 . . . . 1.71 114.127 173.797 . . . . . . . . 2 2 . 1 . 141 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.5 m -88.84 160.98 16.97 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 118.523 -2.611 . . . . 1.04 108.68 -173.48 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.253 4.3 m -114.38 114.16 25.51 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 116.41 -3.931 . . . . 0.79 112.307 -178.424 . . . . . . . . 2 2 . 1 . 141 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.9 mt -93.87 128.24 40.05 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 129.909 3.284 . . . . 1.4 108.158 170.337 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -111.51 116.81 31.49 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 126.128 2.871 . . . . 1.51 115.184 -175.85 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.9 tp -84.53 116.98 23.42 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.852 -2.405 . . . . 1.14 113.852 -173.622 . . . . . . . . 1 1 . 1 . 141 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.617 HG23 ' HB2' ' A' ' 42' ' ' ARG . 31.4 m -122.0 161.24 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 114.415 -1.266 . . . . 1.23 111.082 168.7 . . . . . . . . 2 2 . 1 . 141 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.4 mt . . . . . 0 N--CA 1.429 -1.487 0 O-C-N 120.055 -1.653 . . . . 2.78 107.598 178.981 . . . . . . . . 0 0 . 1 . 142 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 ptt? . . . . . 0 CA--C 1.489 -1.373 0 N-CA-C 113.809 1.04 . . . . 1.1 113.809 . . . . . . . . . 0 0 . 1 . 142 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -88.52 127.92 35.54 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.466 -1.396 . . . . 1.87 109.379 -176.449 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.424 HD12 HD13 ' A' ' 67' ' ' LEU . 8.8 pt -121.97 161.07 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 104.891 -2.262 . . . . 0.72 104.891 164.798 . . . . . . . . 2 2 . 1 . 142 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -120.69 137.01 54.69 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.182 2.193 . . . . 1.4 106.865 176.449 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -119.07 125.31 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 128.281 2.632 . . . . 0.58 110.253 173.402 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -99.48 141.9 31.66 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.515 -1.991 . . . . 2.09 113.894 -178.215 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 p -102.19 175.63 5.46 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 121.165 1.802 . . . . 0.99 109.908 179.136 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.2 tp -44.6 -47.76 10.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.461 1.652 . . . . 2.53 115.461 167.996 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.8 p -80.55 -0.56 38.23 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 123.547 0.739 . . . . 2.08 112.401 -178.662 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.8 25.57 57.95 Favored Glycine 0 N--CA 1.43 -1.76 1 C-N-CA 134.18 5.657 . . . . 1.31 112.533 178.651 . . . . . . . . 2 2 . 1 . 142 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -71.01 127.1 31.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.862 -1.533 . . . . 1.4 106.862 -173.145 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.1 m -84.79 122.23 28.83 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 113.076 -3.45 . . . . 0.78 114.55 173.957 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.0 mt -98.99 119.64 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 105.323 -2.103 . . . . 1.55 105.323 173.086 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.5 m -90.63 111.47 22.81 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.312 2.258 . . . . 1.08 113.148 -178.986 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.0 mt -116.28 155.1 28.98 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 120.254 1.388 . . . . 1.55 111.45 -174.882 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -107.34 114.58 28.7 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 128.396 2.678 . . . . 1.95 105.134 172.377 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -124.68 164.12 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 118.185 -2.822 . . . . 0.96 106.831 179.117 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -102.84 147.84 34.68 Favored Pre-proline 0 N--CA 1.43 -1.453 1 C-N-CA 133.06 4.544 . . . . 2.35 114.308 159.792 . . . . . . . . 2 2 . 1 . 142 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -77.58 -12.67 16.72 Favored 'Trans proline' 0 C--N 1.3 -2.008 1 CA-C-N 129.347 4.374 . . . . 0.95 110.929 -166.521 . . . . . . . . 2 2 . 1 . 142 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 p -88.88 -0.51 57.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 115.311 -2.281 . . . . 1.45 113.295 178.342 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -74.31 149.67 40.54 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 125.276 1.61 . . . . 1.69 114.6 177.233 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.259 57.8 p -85.04 157.33 20.77 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 125.632 2.634 . . . . 0.75 110.153 -178.505 . . . . . . . . 2 2 . 1 . 142 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.3 mm -67.72 -32.03 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.492 -2.63 . . . . 0.73 109.783 175.665 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -61.89 -32.72 73.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.224 2.21 . . . . 1.62 116.096 165.086 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -81.17 -29.47 34.66 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 122.428 2.376 . . . . 2.13 113.162 176.023 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.8 -32.2 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.401 -1.333 . . . . 0.62 107.401 174.488 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.319 48.8 mttt -51.69 -41.29 61.33 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 118.889 2.922 . . . . 1.22 118.889 172.95 . . . . . . . . 2 2 . 1 . 142 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.1 -40.73 59.11 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 117.512 2.412 . . . . 0.51 117.512 166.179 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -68.7 -48.99 62.47 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.405 2.526 . . . . 1.44 114.228 -178.933 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 30' ' ' ILE . 4.2 mt -54.74 -39.67 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 O-C-N 118.144 -2.848 . . . . 1.32 117.714 166.621 . . . . . . . . 2 2 . 1 . 142 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -68.52 -32.11 71.84 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.032 -2.917 . . . . 1.7 112.152 -179.801 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -59.93 -38.17 81.6 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.167 -2.833 . . . . 1.55 114.76 168.411 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -75.13 -66.24 0.78 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 127.586 2.354 . . . . 2.62 109.676 -178.761 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -106.41 -20.88 13.24 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 128.403 2.681 . . . . 1.48 111.824 -159.988 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.31 -2.27 70.89 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 121.773 3.469 . . . . 1.12 121.773 177.901 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.8 mt -68.93 129.37 92.34 Favored Pre-proline 0 N--CA 1.431 -1.41 0 C-N-CA 127.473 2.309 . . . . 1.55 113.561 -179.584 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.251 0.3 OUTLIER -72.52 143.74 38.97 Favored 'Trans proline' 0 C--N 1.299 -2.042 1 C-N-CA 125.496 4.131 . . . . 1.02 112.995 -173.285 . . . . . . . . 4 3 . 1 . 142 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.53 -11.95 33.79 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 121.813 1.683 . . . . 1.25 114.151 -178.53 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.48 -31.86 67.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.832 -1.168 . . . . 2.25 112.054 173.99 . . . . . . . . 2 2 . 1 . 142 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -96.88 -22.19 17.04 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 125.227 1.58 . . . . 2.02 113.903 -173.373 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -75.86 122.65 24.43 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 123.674 1.702 . . . . 0.69 111.921 178.705 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -121.99 143.76 49.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 117.721 -3.112 . . . . 2.78 106.134 168.653 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.45 150.53 29.73 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.181 -3.449 . . . . 1.17 110.999 178.972 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mt -129.69 140.04 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 N-CA-C 97.291 -5.077 . . . . 1.38 97.291 -179.583 . . . . . . . . 2 2 . 1 . 142 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -154.98 137.78 15.33 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.793 2.437 . . . . 1.5 105.448 169.492 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.406 . . 74.46 -49.52 0.67 Allowed 'General case' 0 N--CA 1.431 -1.385 1 C-N-CA 134.917 5.287 . . . . 1.21 115.425 178.999 . . . . . . . . 3 2 . 1 . 142 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -173.43 -23.92 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 106.095 -2.802 . . . . 1.3 106.095 -177.497 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -118.53 158.3 25.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.626 2.631 . . . . 2.55 113.281 -170.819 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -71.66 126.29 29.3 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.7 -1.963 . . . . 2.48 105.7 169.715 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.1 mt -82.97 141.66 31.96 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.861 2.464 . . . . 0.9 108.887 -175.962 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -81.42 152.69 27.3 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.491 -4.506 . . . . 1.94 106.589 171.889 . . . . . . . . 2 2 . 1 . 142 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -77.59 -57.22 3.93 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.287 -1.779 . . . . 1.56 111.654 -167.843 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.34 17.59 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.752 0 CA-C-O 114.002 -3.666 . . . . 0.97 120.37 168.689 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -110.21 175.15 5.54 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 123.609 3.704 . . . . 2.49 105.122 176.307 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.0 p -102.41 171.9 7.19 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 128.242 3.877 . . . . 0.76 117.012 171.003 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.2 mt -65.32 -33.18 75.37 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 112.241 -2.254 . . . . 1.05 112.923 173.848 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 m -64.23 -36.25 83.47 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.142 2.645 . . . . 1.19 118.142 177.099 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -56.88 -42.89 80.62 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.493 2.717 . . . . 1.9 109.045 173.097 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -93.4 3.81 54.99 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.175 -3.453 . . . . 0.89 116.981 -177.905 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.321 69.9 m-80 71.48 29.96 2.58 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 125.936 2.779 . . . . 1.84 112.162 171.313 . . . . . . . . 2 2 . 1 . 142 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.3 mt -80.97 119.71 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 111.842 -2.436 . . . . 0.82 110.408 -178.071 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -115.59 -176.58 2.96 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.324 -3.36 . . . . 2.16 107.322 -173.386 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -64.2 153.49 37.79 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 117.728 -3.108 . . . . 2.12 117.433 177.322 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 64.0 20.27 12.12 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 130.506 3.522 . . . . 1.71 113.157 168.578 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.2 m -88.79 160.28 17.35 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 115.356 -2.259 . . . . 1.04 113.69 -172.286 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.0 m -101.92 95.93 6.71 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 115.573 -2.156 . . . . 0.79 111.163 -172.389 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.424 HD13 HD12 ' A' ' 3' ' ' ILE . 5.3 mp -91.4 163.38 14.21 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 124.355 3.252 . . . . 1.4 106.819 179.373 . . . . . . . . 2 2 . 1 . 142 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -123.04 152.31 41.1 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 124.584 2.135 . . . . 1.51 113.465 -178.173 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.6 tp -127.93 136.96 52.06 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.888 -1.758 . . . . 1.14 108.393 -176.694 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.4 m -135.14 156.76 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 104.003 -2.592 . . . . 1.23 104.003 178.94 . . . . . . . . 1 1 . 1 . 142 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.3 mt . . . . . 0 N--CA 1.43 -1.472 0 CA-C-O 122.928 1.347 . . . . 2.78 113.71 179.357 . . . . . . . . 0 0 . 1 . 143 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.368 0 N-CA-C 112.64 0.608 . . . . 1.1 112.64 . . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.04 146.72 23.51 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.8 -1.813 . . . . 1.87 110.467 179.078 . . . . . . . . 2 2 . 1 . 143 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 pt -127.99 170.03 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 103.997 -2.594 . . . . 0.72 103.997 168.147 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -124.28 142.22 51.43 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.505 -3.247 . . . . 1.4 106.327 -178.809 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.1 t -130.79 118.98 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-O 116.953 -1.499 . . . . 0.58 107.211 179.741 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -97.29 133.3 42.1 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 125.957 2.036 . . . . 2.09 112.782 176.859 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.4 ' HB ' ' H ' ' A' ' 8' ' ' LEU . 46.9 p -74.29 -161.78 0.13 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.527 -2.608 . . . . 0.99 117.697 171.665 . . . . . . . . 2 2 . 1 . 143 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.4 ' H ' ' HB ' ' A' ' 7' ' ' THR . 84.5 mt -71.0 -63.95 1.0 Allowed 'General case' 0 N--CA 1.429 -1.492 2 C-N-CA 134.428 5.091 . . . . 2.53 113.111 174.606 . . . . . . . . 3 3 . 1 . 143 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.5 p -69.09 -47.18 65.88 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 118.921 -2.362 . . . . 2.08 116.31 -176.405 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.06 1.22 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 121.594 3.398 . . . . 1.31 121.594 177.458 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -86.47 126.21 34.26 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 118.51 -2.759 . . . . 1.4 111.103 -173.494 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.259 80.1 m -102.89 116.84 33.33 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 105.101 -2.185 . . . . 0.78 105.101 174.947 . . . . . . . . 2 2 . 1 . 143 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.5 pt -99.68 148.94 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 122.543 1.163 . . . . 1.55 111.101 173.102 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.251 37.5 m -106.66 101.97 11.38 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 127.05 2.14 . . . . 1.08 109.161 178.147 . . . . . . . . 2 2 . 1 . 143 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.6 mt -96.98 140.26 31.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 113.809 1.04 . . . . 1.55 113.809 179.376 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -104.13 130.92 51.87 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 126.247 2.927 . . . . 1.95 110.96 172.643 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.6 m -135.24 158.92 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 118.292 -2.755 . . . . 0.96 110.096 -169.49 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -103.93 147.0 33.61 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 106.337 -1.727 . . . . 2.35 106.337 160.397 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.364 43.9 Cg_endo -72.07 -0.89 9.21 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 124.937 2.799 . . . . 0.95 117.548 -176.554 . . . . . . . . 2 2 . 1 . 143 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.6 p -108.59 2.06 21.8 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.792 2.437 . . . . 1.45 106.146 -176.2 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.76 139.96 43.71 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 119.815 1.189 . . . . 1.69 113.514 171.393 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 5.8 p -79.11 167.36 21.15 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.227 2.441 . . . . 0.75 106.74 -179.046 . . . . . . . . 2 2 . 1 . 143 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.2 mm -66.68 -33.6 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 115.358 -2.258 . . . . 0.73 111.104 176.624 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -54.46 -46.43 73.32 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 126.01 2.069 . . . . 1.62 111.79 171.593 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -70.24 -42.11 72.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 112.877 -3.44 . . . . 2.13 115.278 174.825 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.1 t -52.47 -32.76 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 122.266 2.303 . . . . 0.62 112.894 168.71 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 27.6 mttt -73.11 -31.49 64.36 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.407 -3.308 . . . . 1.22 113.447 178.454 . . . . . . . . 2 2 . 1 . 143 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.27 -33.81 75.34 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.282 1.433 . . . . 0.51 110.683 167.432 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -73.23 -34.8 66.1 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.119 -4.113 . . . . 1.44 113.55 176.563 . . . . . . . . 2 2 . 1 . 143 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 99.6 mt -67.75 -31.02 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 127.777 2.431 . . . . 1.32 106.252 172.638 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -39.36 80.02 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 120.468 1.485 . . . . 1.7 114.014 174.214 . . . . . . . . 2 2 . 1 . 143 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -69.79 -47.12 64.06 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 116.77 -1.586 . . . . 1.55 108.846 175.633 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -75.82 -56.38 4.73 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 125.827 1.651 . . . . 2.62 114.237 -174.442 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -103.3 -25.09 13.45 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 117.428 -3.295 . . . . 1.48 110.603 -165.045 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.41 32.95 8.98 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 115.769 -2.684 . . . . 1.12 111.796 -179.893 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mt -110.44 123.1 36.67 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 113.016 -3.373 . . . . 1.55 105.881 -176.403 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -62.16 144.82 96.23 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 124.072 3.181 . . . . 1.02 117.805 177.196 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 94.0 Cg_endo -72.75 -2.04 11.29 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 123.821 3.014 . . . . 1.25 116.134 -170.193 . . . . . . . . 2 2 . 1 . 143 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -73.06 -43.64 61.67 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.686 2.394 . . . . 2.25 109.276 169.076 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.292 31.1 mt-30 -66.35 -55.57 15.29 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.179 -1.576 . . . . 2.02 110.915 -172.667 . . . . . . . . 2 2 . 1 . 143 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.408 70.7 mt-30 -63.89 130.18 43.08 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 128.919 2.888 . . . . 0.69 112.595 -175.874 . . . . . . . . 2 2 . 1 . 143 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -120.31 115.63 23.95 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 103.25 -2.87 . . . . 2.78 103.25 174.026 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.2 mt -97.91 142.52 29.54 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.317 -1.734 . . . . 1.17 106.317 179.557 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.7 mt -136.85 144.88 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 100.597 -3.853 . . . . 1.38 100.597 177.291 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -127.9 104.8 8.01 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 124.389 2.042 . . . . 1.5 106.944 173.736 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.3 . . 71.27 -75.28 0.08 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 112.454 -2.157 . . . . 1.21 113.747 -179.694 . . . . . . . . 2 2 . 1 . 143 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.75 -17.48 1.06 Allowed Glycine 0 N--CA 1.43 -1.71 0 CA-C-O 114.351 -3.472 . . . . 1.3 113.844 174.787 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -96.64 131.3 43.44 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 105.914 -1.884 . . . . 2.55 105.914 -174.378 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -83.28 132.51 35.03 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 131.369 3.867 . . . . 2.48 105.226 172.56 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.286 56.1 mt -85.93 146.37 26.73 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 115.585 -2.15 . . . . 0.9 105.782 -170.556 . . . . . . . . 2 2 . 1 . 143 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -109.15 165.29 11.72 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 125.631 3.832 . . . . 1.94 104.433 169.919 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -76.77 -44.3 33.49 Favored 'General case' 0 N--CA 1.43 -1.434 2 C-N-CA 133.1 4.56 . . . . 1.56 122.423 -171.444 . . . . . . . . 2 2 . 1 . 143 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.68 43.13 2.76 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 126.428 1.966 . . . . 0.97 113.487 169.404 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -122.18 152.91 39.46 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.444 2.297 . . . . 2.49 111.231 170.491 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 77.6 p -95.91 168.68 10.49 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 127.899 3.249 . . . . 0.76 112.221 177.934 . . . . . . . . 2 2 . 1 . 143 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.3 mt -69.95 -33.12 71.69 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 116.735 -3.728 . . . . 1.05 109.837 176.952 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.2 t -68.86 -36.59 78.32 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.435 -3.29 . . . . 1.19 112.213 178.753 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -51.59 -49.5 62.0 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.233 -2.792 . . . . 1.9 112.504 176.391 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -87.53 -4.95 58.97 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 115.785 -4.322 . . . . 0.89 111.087 -179.163 . . . . . . . . 2 2 . 1 . 143 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.3 t30 54.26 53.45 10.93 Favored 'General case' 0 N--CA 1.43 -1.467 1 C-N-CA 132.597 4.359 . . . . 1.84 117.392 176.754 . . . . . . . . 2 2 . 1 . 143 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.0 mt -73.42 126.18 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 126.783 3.182 . . . . 0.82 112.559 -175.617 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -92.66 171.34 9.07 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 114.884 -4.885 . . . . 2.16 114.182 -176.603 . . . . . . . . 2 2 . 1 . 143 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -64.09 143.26 58.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 118.27 -2.769 . . . . 2.12 109.048 174.727 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 55.92 19.2 3.44 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 118.389 2.737 . . . . 1.71 118.389 -178.593 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -74.96 147.32 40.97 Favored 'General case' 0 N--CA 1.428 -1.54 0 O-C-N 120.028 -1.67 . . . . 1.04 106.941 -173.947 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.7 m -93.41 113.28 25.39 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.628 -1.92 . . . . 0.79 106.425 -176.981 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 mp -110.59 156.69 20.59 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 123.125 2.693 . . . . 1.4 104.041 175.558 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -106.35 144.14 33.46 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.136 -2.852 . . . . 1.51 110.155 -179.622 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.6 tp -128.01 115.9 19.21 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 102.947 -2.983 . . . . 1.14 102.947 179.369 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.89 138.22 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 119.18 -2.2 . . . . 1.23 106.218 177.334 . . . . . . . . 1 1 . 1 . 143 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.43 -1.442 0 CA-C-O 123.814 1.768 . . . . 2.78 113.51 -175.474 . . . . . . . . 0 0 . 1 . 144 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 CA--C 1.489 -1.375 0 CA-C-O 123.218 1.485 . . . . 1.1 110.811 . . . . . . . . . 0 0 . 1 . 144 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -100.93 94.17 5.89 Favored 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 115.028 -4.795 . . . . 1.87 106.864 -173.984 . . . . . . . . 2 2 . 1 . 144 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.266 18.9 pt -85.35 149.84 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 1 O-C-N 129.244 4.09 . . . . 0.72 114.227 172.913 . . . . . . . . 3 2 . 1 . 144 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -107.75 108.13 19.21 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.09 2.556 . . . . 1.4 114.707 -179.358 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -94.55 116.27 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-N 119.91 1.232 . . . . 0.58 110.073 176.232 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -95.74 129.86 42.83 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 124.941 2.305 . . . . 2.09 110.232 176.357 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.0 p -74.03 -173.78 1.7 Allowed 'General case' 0 N--CA 1.431 -1.393 1 O-C-N 114.808 -4.932 . . . . 0.99 112.829 166.486 . . . . . . . . 2 2 . 1 . 144 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.1 mt -81.12 -49.53 10.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 125.959 2.037 . . . . 2.53 116.421 170.271 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 p -63.56 -56.02 19.21 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.858 -4.276 . . . . 2.08 111.87 -173.392 . . . . . . . . 2 2 . 1 . 144 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.22 53.7 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 116.778 -2.63 . . . . 1.31 111.745 173.098 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -136.7 125.16 23.48 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 121.491 2.646 . . . . 1.4 104.566 -174.193 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.8 m -107.04 113.35 26.77 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 118.668 -2.52 . . . . 0.78 114.431 175.876 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.419 ' CG2' ' HG2' ' A' ' 33' ' ' LYS . 15.6 mt -96.49 125.71 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 122.784 1.278 . . . . 1.55 111.96 -176.043 . . . . . . . . 2 2 . 1 . 144 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 m -89.84 119.03 29.87 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.05 -2.906 . . . . 1.08 111.244 177.768 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.8 mt -116.53 153.07 32.85 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.309 -1.494 . . . . 1.55 109.013 -179.324 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -109.29 130.7 55.49 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.262 -3.399 . . . . 1.95 107.561 172.198 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -144.42 173.61 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 123.31 1.529 . . . . 0.96 109.685 179.709 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.434 ' O ' HD12 ' A' ' 56' ' ' LEU . 18.9 mm-40 -106.44 159.68 28.91 Favored Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 105.244 -2.132 . . . . 2.35 105.244 167.164 . . . . . . . . 2 2 . 1 . 144 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -84.5 -11.33 8.27 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 O-C-N 113.87 -3.805 . . . . 0.95 106.486 -173.71 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.9 p -93.32 -3.37 53.59 Favored 'General case' 0 N--CA 1.43 -1.439 1 C-N-CA 131.769 4.028 . . . . 1.45 110.818 -174.154 . . . . . . . . 2 2 . 1 . 144 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -73.76 152.05 40.45 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.253 2.221 . . . . 1.69 107.22 177.269 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.6 p -86.35 156.5 20.19 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 116.906 -3.621 . . . . 0.75 106.73 175.09 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 mm -44.23 -48.55 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 1 C-N-CA 131.764 4.026 . . . . 0.73 112.12 174.842 . . . . . . . . 2 2 . 1 . 144 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -35.46 -57.72 0.61 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 119.019 2.97 . . . . 1.62 119.019 166.831 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -71.16 -27.77 63.78 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 113.367 -1.742 . . . . 2.13 113.848 179.461 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.37 -48.54 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 125.862 2.744 . . . . 0.62 114.085 170.868 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -60.22 -37.36 80.06 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.904 -3.623 . . . . 1.22 115.239 175.879 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.45 -14.35 61.23 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.304 -2.747 . . . . 0.51 112.694 179.509 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 32' ' ' ASP . 10.5 ttmt -74.18 -41.61 61.18 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.097 -1.627 . . . . 1.44 114.233 170.261 . . . . . . . . 2 2 . 1 . 144 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.3 mt -58.51 -46.29 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 123.234 1.492 . . . . 1.32 111.439 166.741 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -49.03 -42.83 39.6 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 125.194 2.426 . . . . 1.7 112.856 171.738 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 29' ' ' LYS . 34.0 t70 -60.53 -58.91 6.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.869 -3.644 . . . . 1.55 113.787 168.827 . . . . . . . . 2 2 . 1 . 144 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.419 ' HG2' ' CG2' ' A' ' 13' ' ' ILE . 33.9 tptt -68.82 -62.04 1.55 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.541 2.336 . . . . 2.62 113.429 -170.079 . . . . . . . . 2 2 . 1 . 144 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -87.22 -45.2 10.85 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 128.061 2.545 . . . . 1.48 113.142 -168.57 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.11 39.89 3.91 Favored Glycine 0 N--CA 1.43 -1.751 0 CA-C-N 112.659 -2.064 . . . . 1.12 114.92 177.691 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.3 mt -106.7 134.16 19.95 Favored Pre-proline 0 N--CA 1.43 -1.466 0 C-N-CA 126.374 1.87 . . . . 1.55 107.01 -178.043 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.69 143.44 99.41 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-O 113.684 -2.715 . . . . 1.02 117.513 175.692 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -80.84 -2.31 11.75 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 126.497 3.356 . . . . 1.25 112.012 -168.331 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.74 -26.21 32.13 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 124.829 2.252 . . . . 2.25 111.66 170.393 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -84.86 -20.26 31.09 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.235 -2.791 . . . . 2.02 114.773 -176.065 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -85.85 117.93 25.02 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 114.944 -1.025 . . . . 0.69 111.266 -176.221 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.404 ' HB2' HG23 ' A' ' 70' ' ' VAL . 13.8 mtt-85 -113.22 116.01 29.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.669 -1.269 . . . . 2.78 108.706 169.772 . . . . . . . . 2 2 . 1 . 144 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.5 mt -88.41 136.84 32.79 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.858 -1.151 . . . . 1.17 112.559 176.181 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -113.49 117.63 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 O-C-N 117.682 -3.136 . . . . 1.38 104.886 179.904 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.417 ' HB3' HD21 ' A' ' 50' ' ' LEU . 50.0 t80 -107.21 123.13 47.84 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 116.675 -3.766 . . . . 1.5 108.05 165.916 . . . . . . . . 2 2 . 1 . 144 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.305 . . 64.29 -82.84 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 131.314 3.846 . . . . 1.21 114.215 -173.991 . . . . . . . . 2 2 . 1 . 144 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.66 3.06 2.03 Favored Glycine 0 N--CA 1.43 -1.719 0 O-C-N 116.65 -3.781 . . . . 1.3 105.466 -176.919 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -127.0 141.72 51.72 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 115.658 -4.436 . . . . 2.55 113.913 178.454 . . . . . . . . 2 2 . 1 . 144 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -65.38 142.98 58.03 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.246 2.219 . . . . 2.48 113.589 171.439 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.417 HD21 ' HB3' ' A' ' 45' ' ' PHE . 34.6 mt -96.36 123.46 40.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.765 -3.084 . . . . 0.9 113.493 -176.519 . . . . . . . . 2 2 . 1 . 144 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -81.47 144.26 31.49 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 130.012 3.325 . . . . 1.94 112.959 -178.54 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.6 150.72 28.0 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.453 2.701 . . . . 1.56 107.385 -169.113 . . . . . . . . 2 2 . 1 . 144 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.97 -4.44 78.28 Favored Glycine 0 N--CA 1.429 -1.77 0 O-C-N 119.454 -2.029 . . . . 0.97 109.409 174.194 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -97.34 172.34 7.84 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.087 2.286 . . . . 2.49 110.392 171.433 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.6 p -110.83 174.32 5.91 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.504 -1.372 . . . . 0.76 112.57 173.282 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 18' ' ' GLU . 67.1 mt -52.16 -34.67 46.0 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.844 2.458 . . . . 1.05 112.427 170.185 . . . . . . . . 2 2 . 1 . 144 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.1 m -75.11 -34.56 61.72 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.701 2.501 . . . . 1.19 114.179 -172.579 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -51.31 -34.68 34.4 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 119.985 3.328 . . . . 1.9 119.985 170.442 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -92.56 -5.91 50.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 109.712 -3.404 . . . . 0.89 114.195 178.892 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.25 8.9 m120 64.92 50.3 1.96 Allowed 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.057 -2.902 . . . . 1.84 113.516 179.583 . . . . . . . . 2 2 . 1 . 144 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.8 mt -92.64 107.84 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 126.004 2.811 . . . . 0.82 110.903 178.409 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -89.49 172.61 8.86 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.207 -2.269 . . . . 2.16 106.231 -171.288 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -14.42 -89.35 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.007 3.323 . . . . 2.12 119.613 167.473 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -91.44 74.95 6.01 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.537 -4.477 . . . . 1.71 114.309 179.028 . . . . . . . . 2 2 . 1 . 144 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -94.41 144.85 25.21 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.89 -4.256 . . . . 1.04 119.657 177.024 . . . . . . . . 2 2 . 1 . 144 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.1 m -101.13 110.11 22.09 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.284 3.434 . . . . 0.79 106.472 -177.026 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -108.81 152.37 24.98 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.695 -1.965 . . . . 1.4 105.695 -177.672 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -116.53 133.24 56.25 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.618 -4.426 . . . . 1.51 110.0 -179.788 . . . . . . . . 2 2 . 1 . 144 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.0 tp -107.75 115.42 30.11 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 115.183 -2.341 . . . . 1.14 110.905 -174.173 . . . . . . . . 1 1 . 1 . 144 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 42' ' ' ARG . 15.7 m -111.75 146.93 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 126.059 2.837 . . . . 1.23 106.373 173.967 . . . . . . . . 2 2 . 1 . 144 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.0 tp . . . . . 0 N--CA 1.431 -1.422 0 O-C-N 119.935 -1.728 . . . . 2.78 111.877 -174.124 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.5 ttp . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 113.994 1.109 . . . . 1.1 113.994 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -105.36 140.03 39.1 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.306 -3.371 . . . . 1.87 113.49 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 pt -125.88 153.02 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 114.933 -1.03 . . . . 0.72 109.672 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -99.88 135.54 41.15 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.802 2.041 . . . . 1.4 109.247 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.7 t -114.81 104.07 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 104.32 -2.474 . . . . 0.58 104.32 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -82.16 126.05 31.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.31 2.005 . . . . 2.09 111.962 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.3 p -83.94 -169.05 2.39 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 117.171 -3.455 . . . . 0.99 113.019 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.8 tp -73.46 -57.93 3.66 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.844 1.783 . . . . 2.53 113.103 170.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.4 p -67.86 -22.9 65.1 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.256 -3.402 . . . . 2.08 118.191 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.93 22.36 1.03 Allowed Glycine 0 N--CA 1.429 -1.774 0 C-N-CA 125.848 1.689 . . . . 1.31 115.111 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -88.31 131.02 34.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.031 2.133 . . . . 1.4 105.985 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -109.59 124.39 51.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 123.603 2.911 . . . . 0.78 104.382 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.1 mt -111.72 128.23 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 107.436 -1.32 . . . . 1.55 107.436 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.8 m -102.83 115.83 31.36 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.11 -0.994 . . . . 1.08 108.928 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -105.49 157.28 17.48 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.971 -1.081 . . . . 1.55 111.568 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.39 110.82 21.46 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.358 2.263 . . . . 1.95 106.524 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.0 m -118.84 159.02 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 126.791 2.557 . . . . 0.96 109.01 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -89.82 146.3 35.09 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-O 111.762 -3.97 . . . . 2.35 106.769 160.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -73.47 -5.61 17.4 Favored 'Trans proline' 0 N--CA 1.433 -2.05 0 CA-C-N 127.547 3.731 . . . . 0.95 115.142 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 m -90.08 7.58 37.03 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 125.228 1.58 . . . . 1.45 109.444 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -85.19 144.14 28.34 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.19 1.922 . . . . 1.69 116.19 172.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 37.6 p -82.9 160.5 22.11 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.323 -2.736 . . . . 0.75 115.657 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.454 15.5 mm -57.79 -38.99 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 123.419 1.581 . . . . 0.73 115.252 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -47.49 -45.05 25.88 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.357 1.984 . . . . 1.62 116.357 161.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -72.58 -20.8 61.25 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 126.533 1.933 . . . . 2.13 113.4 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.23 -39.37 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.99 -2.319 . . . . 0.62 108.394 172.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -66.05 -41.69 90.5 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.974 -2.329 . . . . 1.22 110.183 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.75 -43.79 66.02 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.956 -2.34 . . . . 0.51 116.033 173.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -61.7 -32.15 72.34 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 125.966 2.041 . . . . 1.44 113.593 170.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -81.81 -32.13 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 118.018 -2.927 . . . . 1.32 115.093 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -56.2 -38.71 71.36 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.868 1.794 . . . . 1.7 113.879 166.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -64.56 -50.39 67.47 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.903 2.881 . . . . 1.55 111.101 167.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -71.5 -62.84 1.26 Allowed 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 126.827 2.051 . . . . 2.62 111.569 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -101.25 -35.31 9.31 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 118.45 -2.656 . . . . 1.48 115.81 -170.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.93 11.06 29.07 Favored Glycine 0 N--CA 1.43 -1.751 0 CA-C-O 124.106 1.948 . . . . 1.12 113.188 175.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.5 mm -76.1 125.97 87.31 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-O 114.418 -2.706 . . . . 1.55 112.842 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.0 154.35 74.39 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 CA-C-N 128.252 3.983 . . . . 1.02 118.169 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -74.08 -9.6 22.17 Favored 'Trans proline' 0 C--N 1.299 -2.066 0 CA-C-N 123.844 2.409 . . . . 1.25 116.52 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -59.99 -44.38 94.56 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 118.378 -0.82 . . . . 2.25 111.254 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -79.6 -29.56 41.21 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.228 0.955 . . . . 2.02 110.604 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -66.66 107.68 2.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 121.044 3.72 . . . . 0.69 121.044 -172.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.427 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 29.5 mtt180 -101.38 139.31 37.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.075 -3.516 . . . . 2.78 110.478 171.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.6 mt -113.3 141.25 47.23 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.677 -2.514 . . . . 1.17 111.891 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mm -128.72 137.58 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 115.184 -2.341 . . . . 1.38 110.899 172.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.499 ' CE2' HG12 ' A' ' 61' ' ' ILE 0.293 10.9 t80 -115.67 -54.62 2.5 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.068 1.48 . . . . 1.5 107.766 176.098 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -121.46 -75.96 0.59 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 115.276 1.584 . . . . 1.21 115.276 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.96 -44.14 0.28 Allowed Glycine 0 N--CA 1.429 -1.767 0 O-C-N 119.412 -2.055 . . . . 1.3 114.166 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 mttm -91.93 151.37 20.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 120.784 2.292 . . . . 2.55 114.459 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -83.56 121.91 27.85 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 111.959 -2.382 . . . . 2.48 111.732 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mt -78.21 132.16 37.45 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.501 -1.681 . . . . 0.9 114.197 -162.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -87.62 155.87 19.75 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 115.986 -1.959 . . . . 1.94 115.002 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -66.77 -48.21 69.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.199 2.6 . . . . 1.56 116.099 -172.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.97 38.85 1.12 Allowed Glycine 0 N--CA 1.43 -1.737 1 N-CA-C 124.923 4.729 . . . . 0.97 124.923 174.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -139.59 150.65 45.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.099 -2.412 . . . . 2.49 109.337 171.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 24.5 p -91.28 158.81 16.36 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 111.901 -2.409 . . . . 0.76 113.437 -177.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.402 HD23 HD12 ' A' ' 61' ' ' ILE . 1.5 mt -48.93 -48.73 42.54 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.875 -4.265 . . . . 1.05 107.763 170.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.4 p -56.44 -39.57 73.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.874 2.546 . . . . 1.19 117.874 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -53.56 -57.36 11.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.884 -2.385 . . . . 1.9 112.807 171.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -63.49 -16.16 59.87 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 128.124 2.57 . . . . 0.89 115.149 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.2 t30 69.23 51.56 0.51 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.356 2.662 . . . . 1.84 112.593 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.499 HG12 ' CE2' ' A' ' 45' ' ' PHE . 34.6 mt -91.73 122.88 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 118.245 -2.784 . . . . 0.82 108.06 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -89.48 -167.6 1.91 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 125.192 1.557 . . . . 2.16 109.682 -174.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.296 40.2 tttm -75.7 138.16 41.13 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.478 -2.045 . . . . 2.12 105.478 172.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 55.3 51.88 12.36 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 130.925 3.69 . . . . 1.71 109.607 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.6 m -103.02 149.87 24.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.159 -2.163 . . . . 1.04 105.159 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.0 m -100.65 118.3 36.51 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 123.138 1.447 . . . . 0.79 112.613 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 61' ' ' ILE . 9.4 mp -102.2 148.19 25.73 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 105.782 -1.933 . . . . 1.4 105.782 170.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -99.38 130.12 45.63 Favored 'General case' 0 N--CA 1.43 -1.429 1 C-N-CA 131.932 4.093 . . . . 1.51 110.96 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.2 tp -108.86 116.06 31.27 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 115.075 -2.65 . . . . 1.14 105.964 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 98.6 t -99.92 130.92 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 108.516 -0.92 . . . . 1.23 108.516 173.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 71' ' ' LEU . 61.7 mt -90.06 111.85 23.09 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 129.232 3.013 . . . . 2.78 108.371 175.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -70.41 128.22 35.42 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 125.386 2.517 . . . . 3.75 111.085 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.4 mt -101.1 -70.09 0.75 Allowed 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.759 -3.088 . . . . 3.14 108.023 163.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -116.46 -58.97 2.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.137 -2.542 . . . . 6.8 104.137 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.55 119.4 0.56 Allowed Glycine 0 N--CA 1.43 -1.706 0 O-C-N 128.499 3.624 . . . . 3.57 116.723 -162.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.705 0 C-N-CA 126.564 2.031 . . . . 3.87 108.642 -178.453 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.3 ttp . . . . . 0 CA--C 1.489 -1.376 0 CA-C-O 121.788 0.804 . . . . 1.1 111.326 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -96.06 140.75 30.34 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.327 -1.483 . . . . 1.87 113.769 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.6 pt -139.34 165.14 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 125.994 2.807 . . . . 0.72 105.823 171.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -124.64 140.86 52.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 112.715 -2.038 . . . . 1.4 111.08 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -109.67 120.83 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 O-C-N 120.307 -1.495 . . . . 0.58 113.05 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -94.75 137.92 33.23 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.195 -3.441 . . . . 2.09 112.126 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.258 74.8 p -81.32 -165.02 0.85 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.626 2.631 . . . . 0.99 110.815 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.8 tp -77.19 -44.69 29.22 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.083 -2.886 . . . . 2.53 113.835 169.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.49 -53.63 7.4 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.503 1.62 . . . . 2.08 107.863 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.82 21.71 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.706 1 O-C-N 115.673 -4.392 . . . . 1.31 113.018 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -85.9 139.75 30.97 Favored 'General case' 0 N--CA 1.431 -1.412 1 CA-C-N 125.283 4.541 . . . . 1.4 106.546 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 38.2 m -101.8 114.15 27.96 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.995 1.318 . . . . 0.78 110.345 171.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.0 mt -96.21 122.9 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 117.033 -3.542 . . . . 1.55 110.192 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.3 m -87.21 125.55 34.25 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.186 -1.571 . . . . 1.08 110.73 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.1 mt -126.69 152.46 46.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.615 -1.303 . . . . 1.55 112.084 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -123.36 105.57 9.94 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 111.781 -2.463 . . . . 1.95 110.07 173.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.1 m -121.64 -167.83 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 102.107 -3.294 . . . . 0.96 102.107 -176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -122.07 162.42 37.39 Favored Pre-proline 0 N--CA 1.431 -1.388 0 C-N-CA 126.982 2.113 . . . . 2.35 106.477 167.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -83.81 -14.65 7.49 Favored 'Trans proline' 0 N--CA 1.433 -2.064 0 CA-C-O 116.845 -1.398 . . . . 0.95 108.83 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.3 p -80.94 0.99 32.98 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 124.345 1.028 . . . . 1.45 112.648 171.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -83.54 157.03 22.5 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 125.466 2.555 . . . . 1.69 111.772 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.9 p -88.6 163.35 15.88 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 112.939 -1.937 . . . . 0.75 112.169 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.0 mm -63.29 -34.37 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-O 115.31 -2.281 . . . . 0.73 110.037 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -55.48 -46.94 76.83 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 122.215 2.279 . . . . 1.62 114.788 170.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -56.03 -37.73 69.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.267 1.58 . . . . 2.13 115.267 174.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -62.44 -40.46 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 119.7 -1.875 . . . . 0.62 113.864 172.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -61.85 -28.66 69.65 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.477 -1.39 . . . . 1.22 113.803 173.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.82 -28.11 61.46 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.3 2.24 . . . . 0.51 110.156 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -74.12 -36.13 64.17 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.907 -3.621 . . . . 1.44 111.162 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.6 mt -70.61 -39.9 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 123.157 1.456 . . . . 1.32 113.648 175.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -53.03 -38.7 62.62 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.079 -2.263 . . . . 1.7 115.779 169.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -68.88 -46.66 67.83 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.488 -2.008 . . . . 1.55 113.839 173.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -80.04 -55.78 4.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.58 1.552 . . . . 2.62 114.783 -174.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -94.06 -45.51 7.54 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 127.864 3.697 . . . . 1.48 110.928 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.27 56.34 0.7 Allowed Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 111.888 -2.415 . . . . 1.12 111.211 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.5 mt -124.86 127.78 25.04 Favored Pre-proline 0 N--CA 1.43 -1.434 0 N-CA-C 103.268 -2.864 . . . . 1.55 103.268 -167.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.28 32.2 Cg_exo -66.07 138.55 52.56 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 124.625 3.55 . . . . 1.02 109.314 -171.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -64.86 -14.19 43.66 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-O 114.219 -2.492 . . . . 1.25 114.321 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -74.04 -16.34 61.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 122.455 2.389 . . . . 2.25 114.427 164.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -92.06 4.2 53.6 Favored 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 118.756 -2.465 . . . . 2.02 112.168 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -113.48 101.01 8.96 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 127.832 3.682 . . . . 0.69 119.009 -172.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -94.06 122.67 36.8 Favored 'General case' 0 N--CA 1.431 -1.409 1 O-C-N 115.266 -4.646 . . . . 2.78 110.435 173.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.2 mt -112.11 124.81 53.22 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.706 -1.59 . . . . 1.17 106.706 -170.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 1.6 mm -111.0 144.48 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 129.345 3.058 . . . . 1.38 108.912 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -143.0 116.46 9.11 Favored 'General case' 0 N--CA 1.43 -1.442 1 N-CA-C 97.629 -4.952 . . . . 1.5 97.629 175.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 42.83 39.64 1.79 Allowed 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.1 -3.5 . . . . 1.21 120.349 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.21 -25.98 26.26 Favored Glycine 0 N--CA 1.431 -1.657 0 O-C-N 118.042 -2.911 . . . . 1.3 111.039 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -77.35 130.9 37.74 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.74 -3.8 . . . . 2.55 106.378 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -91.6 135.65 33.71 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.297 1.046 . . . . 2.48 112.764 165.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.1 mt -97.81 144.03 27.82 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.069 -2.269 . . . . 0.9 113.29 -166.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -86.45 147.33 26.04 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 119.533 -1.98 . . . . 1.94 115.563 174.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -55.88 -64.26 0.91 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 118.504 2.779 . . . . 1.56 118.504 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.51 22.1 9.5 Favored Glycine 0 N--CA 1.431 -1.693 1 N-CA-C 123.162 4.025 . . . . 0.97 123.162 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -86.14 156.27 20.42 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.92 2.888 . . . . 2.49 109.624 161.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.251 40.5 p -95.44 157.5 15.87 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 126.563 3.077 . . . . 0.76 112.426 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.8 mt -63.38 -31.85 73.11 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 117.422 -3.299 . . . . 1.05 111.769 168.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.4 t -67.61 -40.21 84.71 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.914 -4.241 . . . . 1.19 113.718 174.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -46.67 -53.61 11.3 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 116.743 2.127 . . . . 1.9 116.743 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.337 86.1 m-85 -60.21 -34.87 74.25 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 118.033 2.605 . . . . 0.89 118.033 175.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.294 67.1 m-80 91.84 66.19 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.66 2.384 . . . . 1.84 106.04 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.3 mt -108.68 118.01 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 125.441 2.543 . . . . 0.82 109.654 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -100.75 -179.66 4.14 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 109.94 -3.3 . . . . 2.16 107.27 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -56.93 149.68 18.25 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.89 2.182 . . . . 2.12 116.89 174.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 64.3 26.4 13.67 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 128.966 2.907 . . . . 1.71 110.478 170.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 m -81.7 136.96 35.46 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 116.404 -1.76 . . . . 1.04 107.839 -173.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.6 m -101.95 112.63 25.34 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 101.056 -3.683 . . . . 0.79 101.056 -172.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mp -103.05 156.91 17.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.71 3.204 . . . . 1.4 109.136 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.442 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 36.5 m80 -113.92 144.06 43.68 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 123.867 0.867 . . . . 1.51 109.326 -174.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.7 tp -115.42 111.68 21.17 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 130.593 3.557 . . . . 1.14 114.271 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.5 t -103.22 125.42 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 1 C-N-CA 132.41 4.284 . . . . 1.23 110.946 173.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 tp -77.53 132.2 38.25 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.731 2.205 . . . . 2.78 113.792 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -117.01 92.9 3.99 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 116.909 -3.62 . . . . 3.75 113.954 175.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.1 mt -80.58 -179.13 7.05 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.365 2.031 . . . . 3.14 111.134 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -69.67 -44.57 70.22 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.251 -1.531 . . . . 6.8 112.004 172.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.93 49.36 0.88 Allowed Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 127.297 2.38 . . . . 3.57 109.121 -163.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.755 0 CA-C-O 123.892 1.829 . . . . 3.87 111.321 174.291 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttp . . . . . 0 CA--C 1.49 -1.343 0 CA-C-O 124.335 2.017 . . . . 1.1 110.789 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -76.54 123.96 26.86 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.508 -3.245 . . . . 1.87 117.176 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -138.22 152.15 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 O-C-N 120.305 -1.497 . . . . 0.72 107.103 174.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -108.61 141.18 40.93 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 128.195 2.598 . . . . 1.4 111.616 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.555 HG21 HD11 ' A' ' 30' ' ' ILE . 17.5 t -121.9 128.76 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 114.242 -2.79 . . . . 0.58 107.883 171.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -120.49 133.28 55.43 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 124.535 3.334 . . . . 2.09 111.472 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.45 HG22 HD23 ' A' ' 69' ' ' LEU . 27.2 p -70.88 175.35 5.14 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.514 -1.366 . . . . 0.99 112.293 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.0 tp -65.57 -41.85 92.44 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 126.194 1.798 . . . . 2.53 115.193 169.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.5 m -66.49 -47.44 73.02 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.908 1.337 . . . . 2.08 108.197 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.38 42.79 0.11 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 117.957 -2.964 . . . . 1.31 114.029 169.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -97.18 117.66 31.89 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 115.565 -2.159 . . . . 1.4 108.024 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.5 m -92.14 125.74 36.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 122.396 2.362 . . . . 0.78 113.268 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mt -112.94 126.5 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 100.524 -3.88 . . . . 1.55 100.524 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.1 m -101.39 125.51 48.04 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 119.971 -1.705 . . . . 1.08 111.301 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.9 mt -126.2 159.42 33.03 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.453 2.073 . . . . 1.55 107.074 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -119.25 138.61 52.87 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 111.722 -2.49 . . . . 1.95 104.292 170.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.273 17.3 m -145.3 164.26 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 104.713 -2.329 . . . . 0.96 104.713 -176.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -98.8 145.02 29.23 Favored Pre-proline 0 N--CA 1.43 -1.468 0 O-C-N 125.828 1.955 . . . . 2.35 107.363 160.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.37 -14.27 31.0 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 CA-C-N 122.898 2.071 . . . . 0.95 112.017 -169.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.339 6.2 t -87.29 -7.66 57.59 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 125.181 3.628 . . . . 1.45 110.692 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -74.59 151.44 39.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.086 -2.259 . . . . 1.69 111.977 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.253 77.1 p -74.16 170.03 16.36 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 117.348 -3.345 . . . . 0.75 117.096 -172.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.415 HD12 HD13 ' A' ' 50' ' ' LEU . 21.5 mm -77.1 -38.14 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 103.755 -2.684 . . . . 0.73 103.755 173.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -42.12 -53.15 4.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.17 2.588 . . . . 1.62 113.427 161.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -59.87 -44.5 94.13 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.222 1.409 . . . . 2.13 112.779 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.6 t -64.49 -42.92 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 120.505 -1.372 . . . . 0.62 110.673 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -58.54 -40.91 84.32 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.575 1.95 . . . . 1.22 113.223 172.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.3 -37.06 84.1 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.188 -3.445 . . . . 0.51 110.246 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -67.43 -39.83 85.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.277 2.325 . . . . 1.44 117.277 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.555 HD11 HG21 ' A' ' 5' ' ' VAL . 9.9 mt -62.47 -48.02 90.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-O 127.066 3.317 . . . . 1.32 113.342 169.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -48.51 -39.66 24.04 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 113.923 -5.485 . . . . 1.7 115.678 167.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -59.56 -45.11 92.78 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.883 -3.011 . . . . 1.55 113.272 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -82.66 -83.18 0.13 Allowed 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.432 -1.321 . . . . 2.62 107.432 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.297 58.1 mm-40 -76.25 -28.19 57.01 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.6 -3.812 . . . . 1.48 114.654 -166.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.31 -8.19 22.74 Favored Glycine 0 N--CA 1.431 -1.652 0 O-C-N 120.718 -1.239 . . . . 1.12 112.693 167.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.1 mt -62.19 115.29 15.12 Favored Pre-proline 0 N--CA 1.43 -1.462 0 N-CA-C 116.993 2.22 . . . . 1.55 116.993 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -67.61 148.43 78.19 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 N-CA-C 119.573 2.874 . . . . 1.02 119.573 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -61.78 -32.91 86.21 Favored 'Trans proline' 0 N--CA 1.433 -2.038 1 C-N-CA 125.876 4.384 . . . . 1.25 113.068 -173.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -62.05 -30.89 71.29 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.769 1.766 . . . . 2.25 115.769 171.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -86.32 -24.68 25.79 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.797 1.639 . . . . 2.02 112.053 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -81.77 117.65 22.24 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 104.35 -2.463 . . . . 0.69 104.35 -176.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -109.19 124.97 51.71 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 103.845 -2.65 . . . . 2.78 103.845 169.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.8 mt -119.47 125.07 48.01 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 106.248 -1.76 . . . . 1.17 106.248 -172.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.8 mm -114.55 117.38 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 C-N-CA 127.905 2.482 . . . . 1.38 114.879 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -102.95 108.18 19.27 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.357 -1.349 . . . . 1.5 107.357 173.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.4 -98.78 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.517 -1.989 . . . . 1.21 110.397 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.91 30.62 3.34 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-O 125.38 2.655 . . . . 1.3 113.273 173.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -118.58 131.0 56.2 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.727 -2.043 . . . . 2.55 112.007 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -96.06 114.8 26.54 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.802 1.641 . . . . 2.48 108.994 171.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.415 HD13 HD12 ' A' ' 23' ' ' ILE . 1.6 mt -83.13 138.78 33.53 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.776 -3.078 . . . . 0.9 111.414 -166.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -92.08 138.77 31.26 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.32 -1.487 . . . . 1.94 108.691 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.39 -46.83 83.0 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.148 2.579 . . . . 1.56 115.547 -173.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.13 -5.23 58.29 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 120.51 2.964 . . . . 0.97 120.51 176.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 -88.99 169.8 11.22 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.137 -3.567 . . . . 2.49 111.283 162.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.7 p -92.81 171.2 9.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.582 2.067 . . . . 0.76 116.582 169.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 mt -59.18 -42.52 91.04 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 115.921 -1.99 . . . . 1.05 113.616 165.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.0 t -63.14 -36.46 83.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 125.497 1.748 . . . . 1.19 112.848 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -57.06 -35.28 69.15 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 117.855 2.539 . . . . 1.9 117.855 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -90.87 -0.58 57.76 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 125.767 1.627 . . . . 0.89 110.206 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 67.68 26.1 7.98 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 121.895 2.134 . . . . 1.84 112.679 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.7 mt -68.41 123.08 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 128.529 2.732 . . . . 0.82 106.253 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -124.5 -168.83 1.87 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.944 -2.973 . . . . 2.16 107.139 -171.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -53.31 134.8 39.58 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.363 3.465 . . . . 2.12 112.534 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.536 21.5 pt-20 64.65 15.96 10.04 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 129.214 3.005 . . . . 1.71 114.032 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.256 18.2 m -73.3 138.58 45.53 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.515 -3.241 . . . . 1.04 108.456 -173.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.7 m -109.62 98.2 7.61 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 127.924 3.265 . . . . 0.79 114.603 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.1 mp -74.48 148.78 40.7 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 112.334 -2.212 . . . . 1.4 109.716 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -112.27 115.46 28.82 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.615 -2.553 . . . . 1.51 109.423 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.45 HD23 HG22 ' A' ' 7' ' ' THR . 33.9 tp -101.7 113.97 27.61 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.477 1.608 . . . . 1.14 112.749 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -108.11 146.74 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 113.764 -1.562 . . . . 1.23 112.298 173.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.0 tp -97.41 113.23 24.86 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.384 -2.072 . . . . 2.78 111.231 -176.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -79.54 116.98 20.07 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 130.509 3.524 . . . . 3.75 111.525 173.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.3 mt -95.72 164.92 12.56 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 125.772 1.92 . . . . 3.14 115.709 167.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 -69.44 -53.61 18.43 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.646 -3.159 . . . . 6.8 109.491 173.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.86 61.76 0.56 Allowed Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 125.561 2.756 . . . . 3.57 107.666 -169.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.805 0 O-C-N 116.925 -3.691 . . . . 3.87 107.834 174.694 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 ptt? . . . . . 0 CA--C 1.491 -1.316 0 CA-C-O 123.706 1.717 . . . . 1.1 111.274 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -100.76 133.41 45.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 126.859 3.219 . . . . 1.87 109.953 -174.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.2 pt -123.44 155.36 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 118.01 -2.931 . . . . 0.72 105.86 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -119.81 124.3 45.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.982 1.849 . . . . 1.4 110.26 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.406 HG21 HD11 ' A' ' 30' ' ' ILE . 2.5 t -100.56 95.74 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 126.846 3.212 . . . . 0.58 114.838 173.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -75.1 124.33 26.82 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.19 -2.194 . . . . 2.09 109.708 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.1 p -100.21 178.25 4.83 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 112.933 0.716 . . . . 0.99 112.933 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.5 tp -64.57 -64.29 0.91 Allowed 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 118.368 -2.708 . . . . 2.53 112.876 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.454 22.9 p -63.27 -36.83 84.98 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 119.502 3.149 . . . . 2.08 119.502 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.22 -52.82 0.12 Allowed Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 115.015 -3.469 . . . . 1.31 114.3 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -60.6 132.39 53.75 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 124.669 2.176 . . . . 1.4 116.412 -168.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.1 m -99.76 112.91 25.12 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.067 -3.521 . . . . 0.78 104.529 168.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mt -90.81 119.66 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 120.211 -0.595 . . . . 1.55 110.973 -173.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.6 m -85.69 112.17 20.78 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.048 -2.282 . . . . 1.08 108.222 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.4 mt -116.03 116.27 27.6 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 125.335 1.647 . . . . 1.55 112.724 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -84.93 124.09 31.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.502 -3.874 . . . . 1.95 115.778 167.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.03 163.15 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 125.779 2.704 . . . . 0.96 109.147 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -97.88 152.13 37.93 Favored Pre-proline 0 N--CA 1.431 -1.391 1 O-C-N 114.493 -5.13 . . . . 2.35 104.757 164.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -73.39 -3.07 13.06 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 125.273 3.982 . . . . 0.95 120.995 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.8 m -97.35 -4.82 37.79 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.539 -1.976 . . . . 1.45 109.227 172.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -71.44 146.22 48.78 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.756 -2.465 . . . . 1.69 111.16 173.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.4 p -79.59 154.67 28.57 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 118.757 2.873 . . . . 0.75 118.757 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.9 mm -57.7 -37.27 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 121.977 2.171 . . . . 0.73 113.125 175.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.436 30.6 tt0 -38.65 -52.43 1.66 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 119.497 3.147 . . . . 1.62 119.497 165.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -56.9 -45.06 82.85 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.166 1.913 . . . . 2.13 116.166 172.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.4 t -59.29 -43.4 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-O 124.771 2.224 . . . . 0.62 115.189 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -62.21 -45.97 90.96 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.947 2.499 . . . . 1.22 108.518 172.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.56 -30.5 69.82 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.618 2.822 . . . . 0.51 118.618 172.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -80.81 -29.38 36.0 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 116.235 -4.041 . . . . 1.44 106.627 172.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.406 HD11 HG21 ' A' ' 5' ' ' VAL . 95.1 mt -72.45 -34.4 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 116.503 -3.873 . . . . 1.32 112.621 174.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -52.1 -50.94 60.62 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 116.889 -3.632 . . . . 1.7 112.958 162.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -53.48 -45.31 69.54 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 128.238 2.615 . . . . 1.55 114.188 171.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -72.96 -70.12 0.38 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.053 -2.905 . . . . 2.62 111.214 -174.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -93.36 -43.61 8.69 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 128.455 2.702 . . . . 1.48 110.951 -165.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.18 50.37 2.25 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 125.862 1.696 . . . . 1.12 114.814 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.438 HD13 HD11 ' A' ' 71' ' ' LEU . 46.5 mt -118.05 137.99 25.04 Favored Pre-proline 0 N--CA 1.43 -1.463 1 N-CA-C 98.105 -4.776 . . . . 1.55 98.105 -176.051 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -65.35 154.79 71.99 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 C-N-CA 124.244 3.296 . . . . 1.02 115.783 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.55 -10.9 24.1 Favored 'Trans proline' 0 N--CA 1.434 -1.979 0 CA-C-O 114.047 -2.564 . . . . 1.25 117.107 -174.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.31 -50.54 38.28 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.729 2.518 . . . . 2.25 114.393 169.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -60.71 -33.78 73.39 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 128.197 2.599 . . . . 2.02 106.467 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -74.07 128.43 35.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 114.494 -2.669 . . . . 0.69 107.477 -170.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.555 ' HB2' HG23 ' A' ' 70' ' ' VAL . 61.5 mtp180 -111.53 115.26 28.89 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 127.093 2.745 . . . . 2.78 105.312 166.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.7 mt -97.14 129.49 44.52 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 120.543 -0.463 . . . . 1.17 112.226 173.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.59 138.83 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 128.118 2.567 . . . . 1.38 113.3 175.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -127.51 87.6 2.65 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.445 -2.035 . . . . 1.5 113.347 172.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.388 . . 84.97 -73.52 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.676 1.99 . . . . 1.21 108.444 -175.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.02 -21.48 0.28 Allowed Glycine 0 N--CA 1.431 -1.7 0 N-CA-C 109.439 -1.464 . . . . 1.3 109.439 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -80.02 128.22 33.23 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.309 1.444 . . . . 2.55 109.681 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -87.49 126.33 34.84 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 102.195 -3.261 . . . . 2.48 102.195 170.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.9 mt -89.19 127.37 35.74 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.847 1.308 . . . . 0.9 111.208 -164.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -77.17 142.25 39.73 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.153 -2.842 . . . . 1.94 115.664 174.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -56.68 -55.59 32.14 Favored 'General case' 0 N--CA 1.43 -1.456 1 C-N-CA 132.623 4.369 . . . . 1.56 115.402 -170.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.23 14.19 29.28 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 128.933 3.158 . . . . 0.97 112.773 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -109.51 164.45 12.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.326 3.563 . . . . 2.49 110.926 168.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.3 p -90.77 152.98 20.58 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 126.162 2.887 . . . . 0.76 115.109 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mt -56.4 -45.93 80.38 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.538 -3.226 . . . . 1.05 118.142 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.0 p -68.63 -13.4 62.33 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 118.095 2.628 . . . . 1.19 118.095 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -75.64 -34.28 60.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.291 -1.374 . . . . 1.9 107.291 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -85.35 1.83 46.85 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 117.581 -1.199 . . . . 0.89 111.787 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 65.83 36.77 5.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.563 2.745 . . . . 1.84 112.031 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.6 mt -87.64 121.45 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.149 -3.469 . . . . 0.82 111.532 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -122.11 -168.17 1.67 Allowed 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 105.829 -1.915 . . . . 2.16 105.829 -173.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -56.25 140.5 44.53 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 116.128 1.899 . . . . 2.12 116.128 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.307 98.5 mt-10 69.8 15.56 7.94 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 112.768 -2.015 . . . . 1.71 114.098 176.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.329 44.8 m -78.75 156.64 28.76 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 121.72 2.055 . . . . 1.04 111.107 -177.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.8 m -102.57 126.65 49.71 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 112.57 -2.105 . . . . 0.79 106.852 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -116.68 150.78 37.61 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 104.26 -2.496 . . . . 1.4 104.26 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -116.64 112.02 20.68 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 126.495 1.918 . . . . 1.51 106.403 -171.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.9 tp -98.22 122.18 41.06 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.103 -1.814 . . . . 1.14 106.103 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.555 HG23 ' HB2' ' A' ' 42' ' ' ARG . 4.5 m -126.74 150.93 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 113.368 -1.742 . . . . 1.23 107.466 173.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.438 HD11 HD13 ' A' ' 36' ' ' ILE . 42.3 mt -99.32 142.61 30.58 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 117.811 2.523 . . . . 2.78 117.811 -175.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.7 ttt-85 -110.9 77.5 1.04 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 103.587 -2.746 . . . . 3.75 103.587 172.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.0 mt -75.63 171.14 14.83 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 115.943 1.831 . . . . 3.14 115.943 168.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.7 ptt-85 -84.52 155.53 22.1 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 114.547 -2.861 . . . . 6.8 112.456 169.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.71 -43.5 1.2 Allowed Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 109.123 -1.591 . . . . 3.57 109.123 -168.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.756 0 CA-C-O 117.539 -1.701 . . . . 3.87 114.898 174.306 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.49 -1.336 0 N-CA-C 111.807 0.299 . . . . 1.1 111.807 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -97.48 136.67 37.57 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 124.012 0.82 . . . . 1.87 110.557 -172.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.433 HD12 HD13 ' A' ' 67' ' ' LEU . 19.2 pt -130.17 160.62 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 105.088 -2.19 . . . . 0.72 105.088 172.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -118.01 150.09 39.87 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 120.54 1.518 . . . . 1.4 109.826 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.4 t -132.47 122.87 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 105.913 -1.884 . . . . 0.58 105.913 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -97.31 147.83 23.75 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.863 1.792 . . . . 2.09 107.446 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.441 8.9 p -101.92 175.39 5.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.498 -3.876 . . . . 0.99 112.007 174.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.0 tp -58.34 -58.39 8.72 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.629 -1.919 . . . . 2.53 114.772 169.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.277 62.5 p -78.35 -14.53 59.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 119.26 3.059 . . . . 2.08 119.26 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.63 17.01 2.18 Favored Glycine 0 N--CA 1.429 -1.796 0 CA-C-O 115.003 -3.11 . . . . 1.31 117.905 173.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -94.8 122.07 37.05 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 101.699 -3.445 . . . . 1.4 101.699 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.265 10.7 m -92.59 116.19 28.78 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.462 -3.273 . . . . 0.78 111.06 169.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -102.22 135.47 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 118.335 -2.728 . . . . 1.55 117.206 172.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.2 m -103.62 137.74 41.25 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 101.367 -3.568 . . . . 1.08 101.367 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.4 mt -129.24 142.65 50.79 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 120.847 1.658 . . . . 1.55 111.704 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -101.57 117.4 34.84 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.852 2.861 . . . . 1.95 103.791 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -134.28 164.41 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 101.823 -3.399 . . . . 0.96 101.823 -172.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -109.16 159.56 30.76 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-N 110.169 -3.196 . . . . 2.35 107.402 166.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -81.24 -11.75 11.92 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 CA-C-N 124.734 2.727 . . . . 0.95 109.677 -172.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.1 m -86.83 -7.98 57.74 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 116.09 -4.132 . . . . 1.45 110.536 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -66.45 148.82 51.32 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 128.813 2.845 . . . . 1.69 107.848 170.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.1 p -93.12 -173.45 3.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.486 1.291 . . . . 0.75 114.486 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.6 mm -79.54 -37.88 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 125.431 1.492 . . . . 0.73 107.784 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -51.15 -48.24 61.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.599 1.96 . . . . 1.62 116.047 166.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -58.0 -48.99 78.38 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 122.821 1.296 . . . . 2.13 112.34 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.9 t -56.31 -52.5 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 114.785 1.402 . . . . 0.62 114.785 174.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -62.16 -22.56 65.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 128.22 3.867 . . . . 1.22 114.516 174.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.14 -35.9 61.62 Favored 'General case' 0 N--CA 1.429 -1.5 1 O-C-N 113.04 -6.037 . . . . 0.51 112.596 171.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -68.9 -30.88 69.45 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.972 -2.33 . . . . 1.44 108.945 171.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.0 mt -69.73 -31.69 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 1 O-C-N 112.779 -6.201 . . . . 1.32 112.474 176.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -64.37 -42.09 96.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.865 -1.772 . . . . 1.7 108.654 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -52.8 -49.66 65.18 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 114.611 1.337 . . . . 1.55 114.611 169.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -70.56 -73.7 0.16 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.822 -2.424 . . . . 2.62 115.797 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -90.95 -28.98 17.7 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.443 2.297 . . . . 1.48 113.898 -169.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.06 54.62 1.98 Allowed Glycine 0 N--CA 1.43 -1.732 1 O-C-N 115.244 -4.66 . . . . 1.12 114.614 173.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.4 mt -118.27 132.36 23.8 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 104.888 -2.264 . . . . 1.55 104.888 -173.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -63.17 150.84 87.47 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 O-C-N 114.09 -3.689 . . . . 1.02 117.132 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -67.75 -15.51 44.41 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 C-N-CA 124.376 3.384 . . . . 1.25 112.935 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.63 -30.97 61.83 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.831 2.53 . . . . 2.25 117.831 173.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -92.27 -26.65 18.05 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 123.419 1.58 . . . . 2.02 111.607 -172.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -75.44 112.1 11.41 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.763 1.625 . . . . 0.69 112.846 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -103.59 119.6 39.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.693 -3.754 . . . . 2.78 105.798 168.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.9 mt -96.16 129.73 43.39 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.852 -1.976 . . . . 1.17 107.051 173.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mm -104.68 135.68 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 128.679 2.792 . . . . 1.38 108.663 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -154.97 127.25 7.79 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 114.384 1.253 . . . . 1.5 114.384 170.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.43 27.8 3.87 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 115.935 1.828 . . . . 1.21 115.935 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.37 -12.32 61.68 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 115.992 1.157 . . . . 1.3 115.992 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -135.45 143.81 46.1 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.465 1.602 . . . . 2.55 114.578 -167.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -71.61 149.13 45.9 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 118.771 -2.456 . . . . 2.48 114.44 171.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.478 HD22 ' CD1' ' A' ' 59' ' ' TYR 0.308 55.1 mt -113.67 147.99 37.14 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 122.18 0.991 . . . . 0.9 113.106 -165.497 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -75.89 152.6 37.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 113.807 1.039 . . . . 1.94 113.807 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.351 0.9 OUTLIER -73.95 -51.07 17.23 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 116.099 1.888 . . . . 1.56 116.099 -169.843 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.34 32.77 3.03 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 119.678 2.631 . . . . 0.97 119.678 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -95.22 155.51 16.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.974 -3.074 . . . . 2.49 110.756 162.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.275 14.3 p -87.2 165.76 15.46 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 126.426 3.013 . . . . 0.76 111.163 175.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 37.6 mt -78.93 -20.51 49.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.823 -3.048 . . . . 1.05 109.698 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -70.96 -29.04 64.94 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 127.511 2.324 . . . . 1.19 112.375 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -68.28 -35.64 78.16 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.279 1.832 . . . . 1.9 114.628 170.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.478 ' CD1' HD22 ' A' ' 50' ' ' LEU . 60.2 m-85 -95.43 7.79 45.17 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.156 1.383 . . . . 0.89 109.709 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.2 m120 45.47 39.9 5.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.266 3.027 . . . . 1.84 114.687 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mt -78.02 105.44 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 105.667 -1.975 . . . . 0.82 105.667 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -78.08 -169.42 1.58 Allowed 'General case' 0 N--CA 1.43 -1.466 1 C-N-CA 131.964 4.106 . . . . 2.16 113.186 175.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -76.34 157.15 32.71 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.996 -2.94 . . . . 2.12 113.821 172.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.289 52.9 mt-10 68.35 22.8 7.85 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 111.852 -2.431 . . . . 1.71 111.949 171.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.0 m -86.14 125.8 33.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.059 2.944 . . . . 1.04 111.417 -174.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.6 m -92.14 120.27 32.57 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.96 -3.587 . . . . 0.79 106.218 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.433 HD13 HD12 ' A' ' 3' ' ' ILE . 9.3 mp -103.67 137.51 41.62 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 104.609 -2.367 . . . . 1.4 104.609 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -107.79 137.85 45.07 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 123.641 2.928 . . . . 1.51 115.008 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.4 tt -98.35 108.59 21.32 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.412 2.053 . . . . 1.14 111.422 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -110.9 130.2 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 C-N-CA 129.483 3.113 . . . . 1.23 111.612 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.6 mt -83.33 138.81 33.38 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 116.333 -3.979 . . . . 2.78 115.46 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -95.49 94.24 7.67 Favored 'General case' 0 N--CA 1.43 -1.475 1 N-CA-C 98.343 -4.688 . . . . 3.75 98.343 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.1 mt -81.53 154.76 26.09 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.215 -2.803 . . . . 3.14 117.833 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.255 68.9 mtt180 -74.68 147.02 41.85 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.741 2.497 . . . . 6.8 117.741 175.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 135.71 -75.78 0.4 Allowed Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 104.979 -3.249 . . . . 3.57 104.979 -167.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.795 0 N-CA-C 108.924 -1.67 . . . . 3.87 108.924 -174.661 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptt? . . . . . 0 CA--C 1.489 -1.367 1 CA-C-O 109.231 -5.176 . . . . 1.1 110.82 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -117.56 145.05 44.53 Favored 'General case' 0 N--CA 1.43 -1.45 2 O-C-N 130.148 4.655 . . . . 1.87 122.534 174.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.336 15.5 pt -128.21 153.82 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 125.741 1.901 . . . . 0.72 109.176 175.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -112.15 121.07 43.93 Favored 'General case' 0 N--CA 1.429 -1.484 1 N-CA-C 99.583 -4.228 . . . . 1.4 99.583 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.2 t -113.51 112.12 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-O 124.973 2.32 . . . . 0.58 105.389 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -88.52 145.51 25.69 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.549 -3.219 . . . . 2.09 115.474 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.318 22.1 p -93.58 162.62 13.88 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.094 2.158 . . . . 0.99 108.762 177.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.37 -29.07 70.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.185 2.194 . . . . 2.53 111.552 176.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.315 28.4 p -83.25 -45.4 13.88 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 126.51 3.052 . . . . 2.08 113.145 -176.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.64 23.79 0.06 OUTLIER Glycine 0 N--CA 1.429 -1.773 1 O-C-N 114.769 -4.957 . . . . 1.31 116.653 172.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -103.67 135.86 44.45 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 103.603 -2.74 . . . . 1.4 103.603 -172.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.0 m -97.41 112.6 24.37 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 115.537 -2.173 . . . . 0.78 109.774 169.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -95.24 120.26 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 123.525 2.875 . . . . 1.55 105.188 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.4 m -92.37 124.7 36.62 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 105.271 -2.122 . . . . 1.08 105.271 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.1 mt -119.67 130.14 54.9 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.471 1.508 . . . . 1.55 111.573 -174.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -85.05 126.5 33.62 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 104.907 -2.257 . . . . 1.95 104.907 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.8 m -143.48 167.34 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 126.8 2.04 . . . . 0.96 112.479 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -120.9 160.67 43.84 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-O 115.231 -2.319 . . . . 2.35 112.329 163.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -60.12 -25.12 79.04 Favored 'Trans proline' 0 N--CA 1.433 -2.056 2 CA-C-N 128.948 4.231 . . . . 0.95 113.597 -176.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m -74.7 -20.9 59.67 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.277 2.231 . . . . 1.45 113.32 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -62.44 141.79 58.19 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.942 -2.973 . . . . 1.69 110.998 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 72.3 p -82.6 167.09 18.65 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.528 -1.669 . . . . 0.75 108.235 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.524 ' CG2' HD23 ' A' ' 43' ' ' LEU . 22.5 mm -66.28 -33.6 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 116.22 -1.848 . . . . 0.73 109.781 172.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -54.39 -33.31 59.03 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.658 2.096 . . . . 1.62 116.658 166.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -73.23 -35.19 66.22 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 120.881 1.673 . . . . 2.13 109.947 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.18 -51.66 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 125.016 1.326 . . . . 0.62 110.038 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -66.69 -25.87 66.76 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 117.58 -1.648 . . . . 1.22 115.141 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.91 -35.48 72.29 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.667 -2.52 . . . . 0.51 114.599 172.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -64.49 -29.87 70.9 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.447 -2.658 . . . . 1.44 113.001 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.03 -36.57 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 119.553 -1.967 . . . . 1.32 111.069 170.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -67.71 -41.32 83.77 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.947 -1.721 . . . . 1.7 109.488 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.56 -53.01 63.01 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.671 -1.893 . . . . 1.55 111.931 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -69.99 -59.63 2.8 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 123.646 1.688 . . . . 2.62 112.164 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -103.24 -28.85 11.64 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 118.815 -2.428 . . . . 1.48 110.312 -160.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.7 40.67 5.57 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 122.257 2.299 . . . . 1.12 115.579 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.7 mm -115.1 118.51 40.15 Favored Pre-proline 0 N--CA 1.43 -1.469 0 N-CA-C 104.445 -2.428 . . . . 1.55 104.445 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -74.5 144.81 32.68 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 124.196 2.534 . . . . 1.02 114.089 -175.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.96 -20.84 44.36 Favored 'Trans proline' 0 N--CA 1.433 -2.041 1 C-N-CA 125.923 4.416 . . . . 1.25 114.183 -175.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -48.48 -53.07 19.38 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.482 1.611 . . . . 2.25 111.331 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -78.18 -24.76 47.08 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 119.273 3.064 . . . . 2.02 119.273 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -66.5 141.49 57.86 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.83 -1.794 . . . . 0.69 112.928 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -135.38 124.47 24.37 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.684 -2.51 . . . . 2.78 110.245 171.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.524 HD23 ' CG2' ' A' ' 23' ' ' ILE 0.288 0.3 OUTLIER -92.51 123.94 36.18 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 120.726 1.603 . . . . 1.17 112.163 175.277 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.1 mm -107.33 128.87 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-O 122.273 1.035 . . . . 1.38 108.704 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.416 ' HB3' HD21 ' A' ' 50' ' ' LEU . 76.4 t80 -140.4 128.5 22.23 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.626 -1.296 . . . . 1.5 112.074 169.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.29 17.21 2.72 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 111.509 -2.587 . . . . 1.21 112.567 -174.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.31 -7.92 56.76 Favored Glycine 0 N--CA 1.43 -1.743 1 CA-C-O 111.724 -4.931 . . . . 1.3 115.41 -170.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -102.16 131.4 48.69 Favored 'General case' 0 N--CA 1.43 -1.443 1 CA-C-N 125.342 4.571 . . . . 2.55 112.057 177.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -79.09 125.31 29.25 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 125.714 2.673 . . . . 2.48 105.926 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 45' ' ' PHE 0.288 12.5 mt -84.77 129.9 34.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.004 -1.907 . . . . 0.9 109.091 -171.392 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -88.72 143.85 26.65 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 116.642 2.09 . . . . 1.94 116.642 -176.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.67 -36.92 85.82 Favored 'General case' 0 N--CA 1.431 -1.419 1 N-CA-C 122.967 4.432 . . . . 1.56 122.967 -169.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.92 10.25 63.41 Favored Glycine 0 N--CA 1.43 -1.726 1 O-C-N 115.626 -4.421 . . . . 0.97 117.952 169.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.25 24.1 mtt180 -107.47 152.07 24.71 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.126 1.917 . . . . 2.49 110.347 172.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 7.0 p -92.75 167.2 12.03 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 126.5 3.048 . . . . 0.76 118.895 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.1 mt -63.02 -22.96 67.22 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 116.114 -4.116 . . . . 1.05 118.382 170.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.3 t -79.75 -31.99 41.0 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.146 1.927 . . . . 1.19 114.128 171.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -60.13 -35.77 76.01 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.205 -2.184 . . . . 1.9 112.7 172.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -94.78 18.81 11.02 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 123.666 2.939 . . . . 0.89 111.194 170.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.56 3.1 p-10 43.61 48.04 6.4 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 129.547 3.139 . . . . 1.84 118.336 -177.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.7 mt -90.17 115.93 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 118.627 -2.546 . . . . 0.82 115.898 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -100.37 -176.5 3.23 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 131.583 3.953 . . . . 2.16 107.808 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -58.7 158.93 7.25 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.388 -2.695 . . . . 2.12 114.812 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 71.92 27.65 2.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.397 1.879 . . . . 1.71 110.671 168.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.2 m -96.1 135.86 37.33 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 125.683 2.659 . . . . 1.04 114.07 -173.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.3 m -94.67 108.93 20.91 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 113.541 -5.724 . . . . 0.79 105.248 -173.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 mp -97.73 159.0 15.2 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 127.278 3.418 . . . . 1.4 106.512 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -133.69 121.46 21.99 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.564 -2.585 . . . . 1.51 104.631 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.3 tp -89.52 132.14 35.21 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.299 -1.741 . . . . 1.14 106.299 -176.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -116.37 135.39 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 1 N-CA-C 99.32 -4.326 . . . . 1.23 99.32 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.6 mt -114.11 98.99 7.3 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.811 -1.805 . . . . 2.78 109.182 -178.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -97.7 75.44 2.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.168 -1.79 . . . . 3.75 106.168 -174.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.7 tp -94.81 -70.94 0.69 Allowed 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 109.899 -3.319 . . . . 3.14 108.839 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -74.75 -44.37 50.06 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 113.034 -1.894 . . . . 6.8 111.34 172.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.28 20.16 57.53 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 120.199 2.84 . . . . 3.57 120.199 -163.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.796 1 N-CA-C 102.622 -4.191 . . . . 3.87 102.622 -171.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 ttp . . . . . 0 CA--C 1.489 -1.376 0 CA-C-O 115.842 -2.028 . . . . 1.1 109.883 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -91.96 123.4 35.3 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 124.699 1.249 . . . . 1.87 110.939 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -124.9 159.51 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.455 -1.403 . . . . 0.72 110.855 172.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -108.12 128.21 54.48 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.729 0.811 . . . . 1.4 110.663 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.3 t -105.93 108.41 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 C-N-CA 128.722 2.809 . . . . 0.58 106.926 171.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -104.48 132.04 51.18 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 127.669 3.604 . . . . 2.09 110.332 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.8 p -100.28 164.36 11.98 Favored 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 115.603 -4.436 . . . . 0.99 107.818 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.1 mt -84.51 -3.8 58.6 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 109.339 -0.615 . . . . 2.53 109.339 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.3 p -90.11 -29.88 18.03 Favored 'General case' 0 N--CA 1.429 -1.505 1 O-C-N 116.191 -4.068 . . . . 2.08 111.333 -175.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.2 54.07 0.17 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 124.725 2.292 . . . . 1.31 115.317 175.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -153.68 138.43 17.03 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 115.028 -2.415 . . . . 1.4 107.461 -173.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.3 m -136.58 131.05 33.26 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 127.806 3.191 . . . . 0.78 103.616 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 pt -127.01 153.76 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 123.789 1.757 . . . . 1.55 108.506 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.6 m -109.62 109.19 19.87 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 112.871 -1.968 . . . . 1.08 111.743 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.251 41.3 mt -89.09 153.31 21.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.87 2.748 . . . . 1.55 106.278 175.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -126.59 113.46 16.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.888 -2.382 . . . . 1.95 107.342 174.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 m -130.09 -164.31 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 127.576 2.35 . . . . 0.96 108.14 -173.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -129.12 171.0 9.48 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 126.159 2.162 . . . . 2.35 107.588 163.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -70.61 -17.48 33.7 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 CA-C-O 123.254 1.272 . . . . 0.95 110.882 -173.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.15 2.57 53.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.145 1.165 . . . . 1.45 114.145 176.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.37 141.11 43.35 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.667 -2.52 . . . . 1.69 109.94 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 21.9 p -75.14 163.99 26.96 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.773 2.829 . . . . 0.75 109.605 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.1 mm -67.39 -33.73 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 124.092 1.901 . . . . 0.73 110.245 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -51.73 -45.94 63.82 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.981 -2.324 . . . . 1.62 116.822 163.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -67.07 -29.05 68.71 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 118.312 2.708 . . . . 2.13 118.312 173.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.0 t -74.31 -44.9 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 127.419 2.287 . . . . 0.62 108.892 176.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -62.86 -38.88 92.6 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 126.989 2.116 . . . . 1.22 112.864 174.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.83 -32.75 72.67 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.557 1.543 . . . . 0.51 113.313 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -61.37 -55.14 34.92 Favored 'General case' 0 N--CA 1.428 -1.532 0 O-C-N 118.201 -2.812 . . . . 1.44 111.989 165.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -53.7 -39.98 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 117.802 -3.061 . . . . 1.32 114.642 173.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -58.94 -38.99 80.29 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.868 1.318 . . . . 1.7 114.237 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -69.89 -55.03 10.79 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.151 -0.968 . . . . 1.55 110.67 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -65.89 -75.67 0.09 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.709 -3.12 . . . . 2.62 106.718 -175.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -78.5 -25.7 45.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.306 2.242 . . . . 1.48 113.356 -163.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.99 12.11 55.69 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 116.332 -2.371 . . . . 1.12 110.303 168.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.404 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 5.7 mt -88.84 126.33 59.8 Favored Pre-proline 0 N--CA 1.43 -1.454 0 CA-C-N 122.738 3.269 . . . . 1.55 108.453 -175.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 36' ' ' ILE . 19.5 Cg_endo -68.21 160.31 49.44 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 124.082 3.188 . . . . 1.02 109.894 -177.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.61 -7.64 13.61 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 115.105 -2.796 . . . . 1.25 116.277 -171.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -82.77 -22.25 34.37 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.767 -1.833 . . . . 2.25 108.267 175.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -80.6 -21.36 41.67 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.726 -2.484 . . . . 2.02 113.432 -175.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -113.65 137.44 51.6 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 118.131 0.423 . . . . 0.69 109.958 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -120.04 133.44 55.53 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.251 -1.531 . . . . 2.78 108.446 171.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.1 mt -105.31 121.35 43.69 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.393 2.997 . . . . 1.17 108.175 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.4 mm -111.3 131.0 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 116.555 -3.841 . . . . 1.38 107.194 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -124.26 118.57 27.09 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 105.114 -2.18 . . . . 1.5 105.114 170.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.304 . . 64.76 -89.23 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 130.154 3.382 . . . . 1.21 111.218 -171.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.76 -21.15 3.98 Favored Glycine 0 N--CA 1.429 -1.794 0 C-N-CA 127.025 2.25 . . . . 1.3 117.903 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.253 29.5 mttm -104.93 132.53 51.06 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 127.313 2.245 . . . . 2.55 114.777 -172.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -75.94 145.1 40.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.878 -1.056 . . . . 2.48 111.92 170.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 mt -98.06 143.5 28.55 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 125.478 1.736 . . . . 0.9 112.989 -172.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -95.95 135.84 37.17 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.883 -2.386 . . . . 1.94 116.068 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -47.24 -66.4 0.41 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 120.163 3.394 . . . . 1.56 120.163 -173.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.15 52.67 2.59 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 118.724 2.25 . . . . 0.97 118.724 169.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 22' ' ' THR . 40.0 mmt180 -134.95 157.86 45.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 116.408 -1.758 . . . . 2.49 107.964 172.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.287 6.5 p -88.65 172.92 8.92 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.486 1.612 . . . . 0.76 114.9 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.5 mt -72.46 -38.38 68.26 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 116.222 -4.049 . . . . 1.05 111.919 168.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.1 t -57.49 -38.96 75.42 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 129.486 3.114 . . . . 1.19 112.951 173.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -59.64 -32.85 70.83 Favored 'General case' 0 N--CA 1.43 -1.471 1 O-C-N 115.439 -4.538 . . . . 1.9 112.348 174.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -96.19 9.1 42.06 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 126.134 2.873 . . . . 0.89 112.412 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.6 m120 49.21 47.14 22.45 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 129.729 3.212 . . . . 1.84 109.327 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.1 mt -91.6 114.65 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 124.083 1.897 . . . . 0.82 109.722 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -97.05 -172.31 2.42 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.696 -1.594 . . . . 2.16 106.696 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -65.97 143.8 57.16 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.571 2.129 . . . . 2.12 113.77 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.279 70.5 mt-10 71.09 18.62 5.8 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 116.905 -3.622 . . . . 1.71 114.774 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.3 m -79.33 139.76 37.7 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.161 2.185 . . . . 1.04 115.513 -175.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.6 m -90.74 101.39 14.14 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 124.329 2.014 . . . . 0.79 115.416 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.6 143.96 34.27 Favored 'General case' 0 N--CA 1.429 -1.505 1 O-C-N 114.468 -5.145 . . . . 1.4 108.153 165.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -108.2 115.69 30.59 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.088 -3.508 . . . . 1.51 111.457 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tt -91.6 119.87 31.88 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 126.303 2.252 . . . . 1.14 111.429 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.88 147.39 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 126.403 3.001 . . . . 1.23 103.122 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.7 mt -103.46 156.93 17.39 Favored 'General case' 0 N--CA 1.429 -1.488 1 O-C-N 115.811 -4.306 . . . . 2.78 112.782 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -76.37 87.86 3.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 124.856 2.265 . . . . 3.75 106.913 -170.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.6 mt -118.43 -59.0 1.93 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.068 -2.895 . . . . 3.14 106.774 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -73.72 150.58 41.1 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 130.796 3.639 . . . . 6.8 111.352 166.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -52.47 -59.26 9.29 Favored Glycine 0 N--CA 1.43 -1.761 1 C-N-CA 131.571 4.415 . . . . 3.57 111.814 -169.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.732 0 N-CA-C 116.254 1.262 . . . . 3.87 116.254 -175.83 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 121.675 0.75 . . . . 1.1 112.74 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -107.79 135.69 48.78 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.331 -3.355 . . . . 1.87 111.42 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.1 pt -130.69 171.59 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 O-C-N 120.5 -1.375 . . . . 0.72 110.051 173.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -120.4 148.39 43.84 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 124.765 1.226 . . . . 1.4 113.749 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 67' ' ' LEU . 68.6 t -133.91 124.36 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 N-CA-C 104.775 -2.306 . . . . 0.58 104.775 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 tptt -92.27 135.83 33.69 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 109.659 -3.428 . . . . 2.09 114.954 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.289 38.0 p -83.24 -171.52 3.62 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.315 3.436 . . . . 0.99 110.58 -174.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.22 -49.65 73.35 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 125.325 2.488 . . . . 2.53 113.333 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.7 p -88.25 -43.4 11.61 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.591 -1.64 . . . . 2.08 113.522 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.04 -3.94 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.762 0 O-C-N 116.981 -3.574 . . . . 1.31 121.158 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -71.59 133.8 45.98 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 120.535 2.167 . . . . 1.4 114.016 -173.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.4 m -90.88 110.61 21.84 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 117.969 -1.493 . . . . 0.78 109.151 176.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 mt -93.41 135.54 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 125.234 1.414 . . . . 1.55 107.324 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.3 m -102.51 127.51 49.54 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.259 1.424 . . . . 1.08 111.295 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.5 mt -124.57 156.39 37.46 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 107.293 -1.373 . . . . 1.55 107.293 -177.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -104.57 123.11 46.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.149 2.18 . . . . 1.95 114.296 167.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.1 m -141.15 161.46 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 124.614 3.37 . . . . 0.96 103.227 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -111.86 157.28 39.99 Favored Pre-proline 0 N--CA 1.43 -1.466 0 N-CA-C 103.725 -2.694 . . . . 2.35 103.725 166.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.13 -9.83 19.29 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 C-N-CA 124.009 3.139 . . . . 0.95 111.686 -171.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.0 p -83.68 -9.93 58.52 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 114.807 -2.52 . . . . 1.45 112.426 171.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -67.44 145.62 54.82 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 124.353 3.251 . . . . 1.69 111.403 174.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.1 p -88.12 158.82 18.45 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 113.231 -5.918 . . . . 0.75 110.844 178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.4 mm -59.83 -32.33 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 119.786 3.254 . . . . 0.73 119.786 174.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -50.74 -47.56 59.36 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.264 1.95 . . . . 1.62 116.264 159.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -60.65 -38.22 84.13 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 125.51 1.524 . . . . 2.13 112.148 174.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.63 -43.61 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 124.798 1.239 . . . . 0.62 108.984 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -62.04 -33.03 73.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 118.434 2.753 . . . . 1.22 118.434 169.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.82 -33.65 76.35 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.349 1.46 . . . . 0.51 114.615 173.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -74.17 -18.13 60.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.287 3.035 . . . . 1.44 111.593 171.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.0 mt -82.46 -32.05 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 116.932 -3.605 . . . . 1.32 105.854 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -67.73 -33.97 75.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.458 -3.276 . . . . 1.7 113.245 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -56.77 -45.16 82.28 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.199 -1.563 . . . . 1.55 112.86 166.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -74.92 -67.82 0.61 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.945 -1.097 . . . . 2.62 112.721 -176.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -84.75 -45.76 12.07 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.679 2.791 . . . . 1.48 111.619 -167.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.97 -7.2 17.14 Favored Glycine 0 N--CA 1.429 -1.824 0 CA-C-O 123.228 1.46 . . . . 1.12 111.988 175.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.1 mt -71.99 122.81 88.31 Favored Pre-proline 0 N--CA 1.431 -1.418 0 C-N-CA 126.947 2.099 . . . . 1.55 110.597 -172.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.9 145.38 68.1 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 125.092 3.861 . . . . 1.02 112.06 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -63.32 -27.72 71.76 Favored 'Trans proline' 0 C--N 1.3 -2.006 1 C-N-CA 125.567 4.178 . . . . 1.25 111.425 -174.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -53.07 -50.81 63.62 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 122.612 2.46 . . . . 2.25 111.64 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -68.86 -26.92 65.38 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.541 2.336 . . . . 2.02 114.108 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -71.83 153.45 41.92 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.046 -2.909 . . . . 0.69 116.343 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -141.46 120.8 13.11 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.083 2.153 . . . . 2.78 106.421 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.1 mt -105.61 137.36 43.58 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 121.139 1.79 . . . . 1.17 111.542 174.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 mp -123.37 136.58 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 127.904 3.252 . . . . 1.38 110.784 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -156.31 131.28 9.13 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 115.743 -4.348 . . . . 1.5 112.747 174.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.447 . . 67.99 35.56 3.7 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.765 2.826 . . . . 1.21 116.563 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.04 -28.68 4.04 Favored Glycine 0 N--CA 1.431 -1.684 0 CA-C-O 124.745 2.303 . . . . 1.3 112.205 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -90.04 165.34 14.08 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.707 -3.819 . . . . 2.55 111.944 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -108.79 137.63 46.41 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 103.523 -2.769 . . . . 2.48 103.523 172.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.3 mt -78.9 153.27 30.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.15 -2.844 . . . . 0.9 112.605 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.318 10.0 tp10 -98.77 141.91 30.97 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.337 -1.477 . . . . 1.94 109.968 171.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.59 -57.35 10.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.256 2.455 . . . . 1.56 117.485 -166.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.81 39.68 2.85 Favored Glycine 0 N--CA 1.43 -1.762 1 O-C-N 114.254 -5.279 . . . . 0.97 118.949 165.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -113.63 160.83 18.16 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.001 1.72 . . . . 2.49 107.751 166.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.4 p -106.36 161.62 14.4 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.479 1.609 . . . . 0.76 113.694 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.45 -37.67 86.79 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.16 2.184 . . . . 1.05 113.881 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 t -63.82 -39.25 93.78 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 113.341 -3.219 . . . . 1.19 113.654 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.257 9.7 t70 -49.18 -71.03 0.07 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 127.89 3.244 . . . . 1.9 109.985 173.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -50.84 -27.33 7.14 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 130.051 3.34 . . . . 0.89 119.541 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m120 79.3 47.06 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 129.855 3.262 . . . . 1.84 114.487 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.2 mt -99.86 126.65 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 124.724 2.202 . . . . 0.82 108.372 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -102.09 -173.56 2.37 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 116.254 -4.028 . . . . 2.16 111.746 -173.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -68.43 149.62 49.1 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.964 2.316 . . . . 2.12 116.942 169.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 59.98 26.68 15.99 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.459 3.103 . . . . 1.71 113.262 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -88.74 131.87 34.85 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 128.814 2.845 . . . . 1.04 106.43 -174.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.7 m -99.8 111.86 24.15 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 105.446 -2.057 . . . . 0.79 105.446 -174.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.415 ' HB2' HG22 ' A' ' 5' ' ' VAL . 7.6 mp -83.09 159.93 22.01 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 106.307 -1.738 . . . . 1.4 106.307 168.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -110.86 132.4 54.23 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 117.498 -1.239 . . . . 1.51 110.049 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -98.6 132.52 43.94 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 103.225 -2.879 . . . . 1.14 103.225 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.2 t -126.12 156.81 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 129.952 3.301 . . . . 1.23 103.839 174.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.2 mt -126.39 176.09 7.38 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.525 2.583 . . . . 2.78 107.258 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -53.9 -58.57 6.8 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 128.593 2.757 . . . . 3.75 110.756 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.7 mt -86.74 131.6 34.09 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 131.288 3.835 . . . . 3.14 109.879 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -86.13 -82.47 0.2 Allowed 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 113.786 -1.552 . . . . 6.8 111.661 170.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.26 -61.03 1.87 Allowed Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 108.218 -1.953 . . . . 3.57 108.218 -164.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.757 0 N-CA-C 107.218 -2.353 . . . . 3.87 107.218 179.477 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ttt . . . . . 0 CA--C 1.491 -1.32 0 CA-C-O 121.045 0.45 . . . . 1.1 111.65 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -87.15 134.75 33.49 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.701 -2.499 . . . . 1.87 109.493 -172.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.404 HG12 HG22 ' A' ' 17' ' ' VAL . 6.0 pt -131.8 169.62 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 121.545 1.975 . . . . 0.72 108.017 174.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -121.56 157.58 30.42 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.88 -1.763 . . . . 1.4 107.558 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.7 t -123.17 132.74 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 125.657 1.848 . . . . 0.58 109.328 163.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.48 ' HB2' ' CG2' ' A' ' 66' ' ' THR . 26.3 tptt -98.98 134.79 41.31 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.359 -2.713 . . . . 2.09 107.856 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.6 p -85.95 -166.29 1.49 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.793 1.758 . . . . 0.99 114.962 176.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.9 mt -74.22 -47.5 34.91 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.704 -1.135 . . . . 2.53 112.171 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 p -77.61 -29.88 52.08 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 114.87 1.433 . . . . 2.08 114.87 -174.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.31 11.39 0.66 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 125.371 1.462 . . . . 1.31 115.3 172.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -81.42 140.82 34.44 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.806 -1.997 . . . . 1.4 107.626 -172.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.9 m -97.96 107.94 20.53 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.98 -1.464 . . . . 0.78 109.805 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -82.7 122.36 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 119.969 1.259 . . . . 1.55 108.563 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.2 m -95.0 114.22 26.0 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.925 -1.109 . . . . 1.08 113.786 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mp -116.33 160.45 20.49 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.358 1.614 . . . . 1.55 115.358 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.261 7.0 pt-20 -128.74 124.9 36.74 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 117.013 -1.875 . . . . 1.95 112.418 177.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.404 HG22 HG12 ' A' ' 3' ' ' ILE . 12.5 m -129.2 -167.42 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 113.765 -1.562 . . . . 0.96 110.454 -176.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -136.76 173.89 5.05 Favored Pre-proline 0 N--CA 1.431 -1.399 0 O-C-N 117.386 -3.321 . . . . 2.35 103.446 162.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -80.57 -8.36 13.64 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 CA-C-N 123.393 2.248 . . . . 0.95 117.751 -170.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.274 21.0 m -87.9 -19.85 26.77 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 126.812 2.57 . . . . 1.45 114.567 174.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -62.02 152.48 32.35 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.972 -2.955 . . . . 1.69 113.314 174.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 31.9 p -90.11 168.99 11.54 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.662 -2.523 . . . . 0.75 117.507 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.5 mm -64.92 -36.3 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 120.307 -1.496 . . . . 0.73 109.979 171.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -57.41 -30.5 65.01 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.498 2.719 . . . . 1.62 113.495 168.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -73.66 -32.71 64.14 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 114.338 -5.226 . . . . 2.13 111.235 176.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.6 t -63.11 -49.68 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.026 2.13 . . . . 0.62 111.688 174.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.495 ' HD3' ' HB3' ' A' ' 38' ' ' PRO . 55.9 mttt -58.56 -39.58 80.67 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 127.855 3.222 . . . . 1.22 114.083 176.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.71 -33.47 75.71 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 118.52 2.785 . . . . 0.51 118.52 173.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -75.0 -35.57 62.01 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 125.077 1.485 . . . . 1.44 111.464 170.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.68 -39.54 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 1 O-C-N 115.69 -4.381 . . . . 1.32 112.449 166.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -63.84 -41.47 97.81 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.614 -3.804 . . . . 1.7 113.833 172.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -55.37 -69.25 0.14 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 115.821 1.785 . . . . 1.55 115.821 170.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -68.44 -59.81 2.89 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.611 -3.806 . . . . 2.62 113.875 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -83.53 -43.24 15.95 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.208 -2.807 . . . . 1.48 111.196 -163.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.7 30.28 3.56 Favored Glycine 0 N--CA 1.43 -1.76 0 CA-C-O 124.386 2.103 . . . . 1.12 111.894 169.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 88.1 mt -105.95 134.77 19.59 Favored Pre-proline 0 N--CA 1.431 -1.41 0 O-C-N 117.661 -3.259 . . . . 1.55 104.876 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -72.98 158.66 49.38 Favored 'Trans proline' 0 C--N 1.3 -2.003 1 CA-C-N 129.411 4.397 . . . . 1.02 113.699 174.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.495 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 70.4 Cg_exo -73.44 -19.7 21.65 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 CA-C-O 114.455 -2.394 . . . . 1.25 117.939 -175.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -72.19 -12.08 61.02 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 127.334 2.896 . . . . 2.25 111.39 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -100.27 -15.83 17.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 116.239 -1.839 . . . . 2.02 112.226 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -88.37 139.49 30.43 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 130.031 3.333 . . . . 0.69 111.296 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -123.23 120.73 34.02 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 128.854 2.862 . . . . 2.78 107.583 165.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.5 mt -103.01 130.67 50.19 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 124.877 2.275 . . . . 1.17 108.92 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.7 mm -117.12 139.77 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 125.068 2.366 . . . . 1.38 107.287 -172.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -146.62 148.81 32.47 Favored 'General case' 0 N--CA 1.429 -1.497 1 O-C-N 113.693 -5.629 . . . . 1.5 108.157 168.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.66 30.3 8.54 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.217 1.932 . . . . 1.21 116.217 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.67 -29.8 5.64 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 124.887 1.232 . . . . 1.3 115.039 -173.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -82.1 142.96 31.82 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 128.706 2.802 . . . . 2.55 114.787 -174.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -90.56 132.46 35.7 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.006 1.73 . . . . 2.48 108.382 168.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mt -86.74 146.89 26.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.892 1.677 . . . . 0.9 111.845 -172.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -92.42 154.7 18.35 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 123.324 1.535 . . . . 1.94 111.043 171.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.64 -66.37 0.6 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 112.987 -1.915 . . . . 1.56 113.619 -163.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.31 64.48 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.723 0 O-C-N 118.763 -2.46 . . . . 0.97 113.916 162.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -140.94 151.04 43.89 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.228 -1.767 . . . . 2.49 106.228 168.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.25 18.5 p -85.14 169.83 13.49 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 121.747 2.067 . . . . 0.76 111.146 -178.835 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mt -69.83 -43.98 70.86 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 123.959 1.837 . . . . 1.05 113.859 173.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.1 t -57.89 -38.63 76.14 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.615 2.366 . . . . 1.19 114.271 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -57.36 -43.85 83.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.907 -1.746 . . . . 1.9 114.115 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -85.58 3.41 40.78 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.991 2.329 . . . . 0.89 114.033 172.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.4 m120 59.75 37.85 21.9 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.801 -3.062 . . . . 1.84 113.798 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.0 mt -74.15 116.4 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 125.527 1.531 . . . . 0.82 108.496 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -89.3 -174.62 4.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 117.364 2.357 . . . . 2.16 117.364 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -60.17 133.07 55.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.285 -2.134 . . . . 2.12 115.677 169.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.41 50.1 mt-10 64.33 41.96 5.56 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.684 -1.26 . . . . 1.71 112.678 174.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.257 62.6 m -106.55 163.81 12.58 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 103.25 -2.87 . . . . 1.04 103.25 -175.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.48 ' CG2' ' HB2' ' A' ' 6' ' ' LYS . 89.5 m -128.79 124.31 35.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.608 3.099 . . . . 0.79 109.39 -176.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.3 mt -91.49 162.46 14.54 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 110.385 -3.098 . . . . 1.4 108.926 172.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -127.57 119.88 26.97 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 117.351 -1.74 . . . . 1.51 109.596 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.1 tp -75.78 125.44 29.07 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.957 1.836 . . . . 1.14 115.957 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 t -123.59 148.36 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 103.277 -2.86 . . . . 1.23 103.277 171.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.7 mt -121.53 147.01 46.36 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 124.397 2.046 . . . . 2.78 110.603 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -68.81 -51.12 44.16 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 112.485 -2.143 . . . . 3.75 116.415 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.3 mt -106.12 -158.66 0.67 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.071 -1.825 . . . . 3.14 106.071 175.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -89.14 147.57 24.13 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 117.473 -1.691 . . . . 6.8 108.208 167.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.81 87.62 0.37 Allowed Glycine 0 N--CA 1.429 -1.768 0 O-C-N 119.301 -2.124 . . . . 3.57 112.09 -172.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.732 0 CA-C-O 126.312 3.173 . . . . 3.87 115.152 177.508 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 CA--C 1.491 -1.313 0 CA-C-O 124.834 2.254 . . . . 1.1 114.101 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -74.11 132.37 42.21 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 128.85 2.86 . . . . 1.87 107.971 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.0 pt -136.86 152.32 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 125.983 1.713 . . . . 0.72 109.452 171.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -117.26 148.23 41.85 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.269 -2.144 . . . . 1.4 115.809 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -125.11 107.46 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 104.673 -2.343 . . . . 0.58 104.673 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 tttp -91.3 132.52 36.1 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.59 -1.944 . . . . 2.09 110.681 176.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.3 p -87.49 176.21 7.59 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.609 2.448 . . . . 0.99 117.609 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.418 HD21 HG22 ' A' ' 70' ' ' VAL . 87.2 mt -60.99 -29.63 69.8 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.143 -3.473 . . . . 2.53 119.946 166.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 p -83.79 -87.4 0.11 Allowed 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 113.702 -1.59 . . . . 2.08 107.279 -175.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.74 48.74 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.732 0 O-C-N 118.911 -2.368 . . . . 1.31 107.956 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -128.24 135.32 49.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.512 2.325 . . . . 1.4 107.478 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.6 m -118.32 119.68 35.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.937 2.304 . . . . 0.78 105.857 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.1 mt -91.99 113.97 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 O-C-N 117.513 -3.242 . . . . 1.55 103.354 -172.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.3 m -86.5 113.33 22.34 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.022 -3.549 . . . . 1.08 109.157 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.6 mt -111.56 171.19 7.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 114.946 1.461 . . . . 1.55 114.946 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -125.48 121.87 34.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.101 -3.5 . . . . 1.95 115.609 168.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -130.23 175.67 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 118.987 -2.32 . . . . 0.96 106.942 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HG3' ' H ' ' A' ' 20' ' ' SER . 11.6 pt-20 -104.21 157.36 34.2 Favored Pre-proline 0 N--CA 1.431 -1.419 0 O-C-N 118.72 -2.487 . . . . 2.35 116.061 160.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -64.33 -9.1 18.7 Favored 'Trans proline' 0 N--CA 1.434 -2.012 2 CA-C-N 129.141 4.3 . . . . 0.95 114.443 -175.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.427 ' H ' ' HG3' ' A' ' 18' ' ' GLU 0.257 15.0 m -94.42 11.51 30.39 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 123.578 2.899 . . . . 1.45 117.481 171.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.98 138.54 36.07 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.97 -2.331 . . . . 1.69 115.221 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 p -76.07 159.4 30.81 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 114.325 1.231 . . . . 0.75 114.325 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.2 mm -68.13 -36.75 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 127.456 2.302 . . . . 0.73 107.762 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -59.36 -33.45 71.18 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.668 1.729 . . . . 1.62 115.668 165.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -69.6 -39.09 77.48 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.076 -3.515 . . . . 2.13 118.94 171.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.38 -39.8 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 126.346 2.974 . . . . 0.62 113.329 167.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -63.3 -37.59 87.86 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 116.251 -4.031 . . . . 1.22 112.459 -176.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.49 -19.04 63.74 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 128.284 2.634 . . . . 0.51 112.63 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -84.79 -30.91 24.22 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 117.66 -3.15 . . . . 1.44 110.365 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.4 mt -73.65 -35.84 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 123.831 1.777 . . . . 1.32 109.479 172.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -56.4 -50.76 70.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.547 -3.846 . . . . 1.7 111.397 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -53.89 -42.63 68.87 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 128.98 2.912 . . . . 1.55 112.144 174.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -83.2 -60.04 2.27 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.921 -2.987 . . . . 2.62 111.854 -174.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -97.66 -16.81 19.81 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 122.349 2.34 . . . . 1.48 112.243 -169.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.78 30.19 24.42 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 108.087 -2.005 . . . . 1.12 108.087 171.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.6 mt -102.23 133.7 20.46 Favored Pre-proline 0 N--CA 1.431 -1.401 0 N-CA-C 104.838 -2.282 . . . . 1.55 104.838 -174.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -76.07 161.87 35.09 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 O-C-N 115.105 -3.156 . . . . 1.02 114.21 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -70.76 -25.2 24.23 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 C-N-CA 122.867 2.378 . . . . 1.25 114.559 -170.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -74.03 -26.45 60.42 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.439 1.59 . . . . 2.25 112.247 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -84.31 -12.03 55.34 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.371 -1.456 . . . . 2.02 113.684 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -91.01 122.22 33.48 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 122.178 0.989 . . . . 0.69 110.849 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -101.06 102.64 13.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.603 1.192 . . . . 2.78 112.152 166.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.0 mt -84.73 125.43 32.54 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 115.925 1.824 . . . . 1.17 115.925 171.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.61 125.48 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 127.979 2.512 . . . . 1.38 108.461 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -132.52 126.9 33.97 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.96 -1.088 . . . . 1.5 110.572 173.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.21 -40.19 0.24 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.264 2.626 . . . . 1.21 116.56 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.44 -7.46 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.668 0 C-N-CA 128.812 3.101 . . . . 1.3 111.286 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -94.34 132.37 39.01 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 126.42 1.888 . . . . 2.55 110.82 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -87.75 148.24 24.82 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 107.347 -1.353 . . . . 2.48 107.347 172.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.35 6.9 mt -107.26 120.65 42.71 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.916 2.886 . . . . 0.9 110.41 -159.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.405 ' CD ' ' HE ' ' A' ' 54' ' ' ARG . 80.3 tt0 -88.32 136.95 32.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 129.027 3.954 . . . . 1.94 111.912 178.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -57.47 -59.94 4.4 Favored 'General case' 0 N--CA 1.431 -1.422 2 C-N-CA 134.983 5.313 . . . . 1.56 116.131 -168.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.11 29.11 2.81 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 119.687 -1.883 . . . . 0.97 115.998 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.405 ' HE ' ' CD ' ' A' ' 51' ' ' GLU . 28.8 mmt180 -105.47 156.12 18.51 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.283 -2.304 . . . . 2.49 108.489 165.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.3 p -93.05 170.35 9.72 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 119.918 -1.738 . . . . 0.76 109.267 172.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.0 mt -56.94 -41.49 78.34 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.711 2.805 . . . . 1.05 115.337 167.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.9 t -64.6 -32.15 73.68 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 128.504 2.722 . . . . 1.19 115.289 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -81.88 -21.02 37.69 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.378 2.671 . . . . 1.9 112.27 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -98.01 -11.96 22.44 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.595 -1.261 . . . . 0.89 107.595 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 67.63 42.92 1.95 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 128.122 3.82 . . . . 1.84 111.242 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.9 mt -89.75 114.05 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 126.836 3.208 . . . . 0.82 113.627 172.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -101.84 -165.93 1.24 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.524 -1.985 . . . . 2.16 105.777 -172.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -73.47 166.06 23.92 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 118.742 2.867 . . . . 2.12 118.742 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.554 13.5 pt-20 63.53 18.07 10.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.758 -2.464 . . . . 1.71 115.976 176.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.7 p -90.82 151.14 21.29 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.735 -1.575 . . . . 1.04 109.36 -175.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.0 m -118.74 92.84 3.91 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.465 1.602 . . . . 0.79 112.249 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.0 mt -75.0 136.79 41.25 Favored 'General case' 0 N--CA 1.43 -1.475 1 C-N-CA 132.851 4.46 . . . . 1.4 109.473 174.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -107.04 132.06 53.38 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.469 -2.019 . . . . 1.51 111.562 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.4 tp -113.15 112.54 23.97 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 128.273 3.892 . . . . 1.14 106.831 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.418 HG22 HD21 ' A' ' 8' ' ' LEU . 18.3 t -107.66 146.15 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 129.256 3.022 . . . . 1.23 105.357 174.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -88.29 127.84 35.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.12 -1.807 . . . . 2.78 106.12 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -73.69 110.2 7.79 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 126.958 2.103 . . . . 3.75 112.95 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.4 mt -87.52 164.0 16.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.116 1.913 . . . . 3.14 114.99 173.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -70.0 103.09 2.16 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 111.907 -2.406 . . . . 6.8 116.771 172.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 150.51 -115.79 0.73 Allowed Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 116.271 1.269 . . . . 3.57 116.271 -166.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.793 0 CA-C-O 126.416 3.231 . . . . 3.87 109.949 -179.498 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 CA--C 1.49 -1.329 0 N-CA-C 114.211 1.189 . . . . 1.1 114.211 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.385 2.4 mp0 -94.27 130.89 40.37 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 116.518 -1.706 . . . . 1.87 113.96 -174.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.2 pt -123.35 159.61 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 119.266 0.939 . . . . 0.72 110.828 172.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -111.75 135.73 51.96 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.527 -2.608 . . . . 1.4 112.688 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.01 125.11 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 119.509 -1.994 . . . . 0.58 106.308 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -102.9 148.55 25.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.105 2.128 . . . . 2.09 112.916 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.261 6.4 p -98.55 159.05 15.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 125.377 1.673 . . . . 0.99 114.546 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.1 mt -49.82 -38.63 35.56 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.543 -2.598 . . . . 2.53 117.619 171.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.0 p -83.63 -12.33 56.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.481 2.562 . . . . 2.08 112.313 -171.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.42 7.09 26.7 Favored Glycine 0 N--CA 1.43 -1.754 0 CA-C-N 112.426 -2.17 . . . . 1.31 116.722 174.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -80.46 144.18 32.79 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 123.205 3.502 . . . . 1.4 109.053 -179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.9 m -125.94 94.44 4.11 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 106.982 -1.488 . . . . 0.78 106.982 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.4 4.4 pt -76.53 142.41 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 128.374 2.67 . . . . 1.55 112.427 174.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -108.32 129.7 55.22 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.545 -2.391 . . . . 1.08 104.545 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.8 mt -117.0 165.11 13.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 126.425 2.328 . . . . 1.55 107.307 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.296 66.1 tt0 -116.1 121.54 42.46 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.519 -2.613 . . . . 1.95 106.352 178.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.431 HG12 ' HE3' ' A' ' 29' ' ' LYS . 21.8 m -132.34 168.83 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 116.516 -1.707 . . . . 0.96 115.396 176.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -116.54 160.04 37.84 Favored Pre-proline 0 N--CA 1.43 -1.448 0 O-C-N 127.56 3.037 . . . . 2.35 107.21 167.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -65.42 -25.78 55.82 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 123.714 2.943 . . . . 0.95 112.62 -177.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 m -81.75 3.93 23.87 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 117.361 2.356 . . . . 1.45 117.361 172.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.58 137.56 40.87 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.543 -1.973 . . . . 1.69 109.673 173.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 p -73.92 157.3 36.52 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.96 -2.962 . . . . 0.75 112.523 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.7 mm -56.45 -32.66 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 123.984 1.849 . . . . 0.73 114.493 170.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -59.28 -44.1 92.48 Favored 'General case' 0 N--CA 1.43 -1.469 1 O-C-N 115.718 -4.364 . . . . 1.62 110.399 165.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -66.66 -32.09 73.18 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 116.978 -3.576 . . . . 2.13 110.344 175.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.559 HG21 HD21 ' A' ' 56' ' ' LEU . 34.4 t -66.09 -51.25 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 121.125 1.784 . . . . 0.62 107.811 175.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -59.4 -33.26 71.0 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.118 -3.489 . . . . 1.22 112.076 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.33 -19.31 65.9 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 116.648 2.092 . . . . 0.51 116.648 171.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.431 ' HE3' HG12 ' A' ' 17' ' ' VAL . 39.8 mttm -85.2 -18.81 32.95 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 123.488 2.858 . . . . 1.44 107.155 176.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.9 mt -87.46 -24.43 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 108.129 -1.063 . . . . 1.32 108.129 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -65.66 -44.05 87.47 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.464 2.764 . . . . 1.7 118.464 166.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -60.13 -62.2 2.04 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 113.701 -1.59 . . . . 1.55 110.37 168.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -69.58 -63.99 0.97 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.62 2.082 . . . . 2.62 116.62 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -87.41 -33.38 19.11 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.613 2.149 . . . . 1.48 114.944 -170.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.68 34.18 2.11 Favored Glycine 0 N--CA 1.43 -1.743 0 O-C-N 118.767 -2.458 . . . . 1.12 113.744 169.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.2 mt -108.8 123.11 38.05 Favored Pre-proline 0 N--CA 1.431 -1.424 0 O-C-N 119.884 -1.95 . . . . 1.55 105.786 -170.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -68.63 145.42 63.74 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 114.746 -3.344 . . . . 1.02 112.711 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.254 18.0 Cg_exo -66.18 -28.1 48.42 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 124.474 3.449 . . . . 1.25 117.295 -171.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.254 8.8 p-10 -56.94 -31.99 65.53 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.307 -3.995 . . . . 2.25 116.091 168.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -78.13 -25.38 47.36 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.725 2.01 . . . . 2.02 113.182 -176.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -90.91 147.9 22.82 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.767 1.627 . . . . 0.69 112.614 -173.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.272 91.8 mtt180 -122.71 146.75 47.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.982 -1.699 . . . . 2.78 108.131 162.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.0 mt -121.7 114.74 21.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.965 -1.71 . . . . 1.17 111.002 172.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.9 mt -104.22 116.2 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 117.771 -1.109 . . . . 1.38 111.312 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -112.9 131.79 55.58 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.009 -1.849 . . . . 1.5 106.009 170.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 82.48 -43.29 0.13 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.064 1.346 . . . . 1.21 111.189 172.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.28 -5.63 0.18 Allowed Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 114.423 -3.431 . . . . 1.3 107.05 -173.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -123.82 143.71 50.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 121.762 2.781 . . . . 2.55 113.258 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -69.17 138.85 54.46 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.026 -2.921 . . . . 2.48 115.407 173.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.7 mt -98.87 122.39 42.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.32 2.009 . . . . 0.9 105.848 -175.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -71.6 120.63 17.46 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 123.852 1.786 . . . . 1.94 115.111 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -44.78 -53.78 7.04 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.999 2.519 . . . . 1.56 114.536 -171.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.05 39.67 1.85 Allowed Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 118.471 2.149 . . . . 0.97 118.471 173.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -124.94 167.95 13.97 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 116.664 -3.844 . . . . 2.49 106.601 168.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.6 p -97.03 175.64 6.25 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.916 1.821 . . . . 0.76 115.916 169.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.559 HD21 HG21 ' A' ' 26' ' ' VAL . 5.5 mt -73.16 -22.65 60.46 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 127.037 3.303 . . . . 1.05 110.161 174.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -78.21 -41.33 34.8 Favored 'General case' 0 N--CA 1.43 -1.453 2 C-N-CA 133.464 4.706 . . . . 1.19 116.346 175.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -63.16 -32.68 74.12 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.801 1.762 . . . . 1.9 111.516 168.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -92.93 -0.45 57.22 Favored 'General case' 0 N--CA 1.431 -1.398 1 O-C-N 116.063 -4.148 . . . . 0.89 112.884 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 48.43 53.87 11.33 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.49 2.033 . . . . 1.84 116.49 -174.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.5 mt -97.06 129.42 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 129.155 2.982 . . . . 0.82 108.377 175.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -103.29 -167.97 1.45 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 115.536 1.68 . . . . 2.16 115.536 -172.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -55.63 139.53 44.21 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.022 1.119 . . . . 2.12 114.022 160.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.279 93.0 mt-10 60.0 52.22 5.35 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 120.097 3.369 . . . . 1.71 120.097 173.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.1 p -103.53 135.28 45.42 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.531 3.532 . . . . 1.04 109.399 -175.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 m -96.54 107.42 19.84 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 104.816 -2.29 . . . . 0.79 104.816 -176.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.0 mt -93.99 145.94 24.29 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 126.623 3.106 . . . . 1.4 104.122 170.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -111.15 118.93 37.33 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 112.996 -1.911 . . . . 1.51 107.766 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.0 tp -86.09 118.43 25.56 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.252 1.501 . . . . 1.14 109.003 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.13 129.74 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 124.862 2.267 . . . . 1.23 107.781 172.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.3 mt -104.94 149.76 25.46 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 113.831 -5.543 . . . . 2.78 109.105 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -75.54 165.37 25.2 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 117.298 -1.761 . . . . 3.75 109.835 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.9 mt -73.89 145.51 44.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.223 2.916 . . . . 3.14 112.682 168.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -83.32 -158.44 0.29 Allowed 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.715 -2.491 . . . . 6.8 117.362 170.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.57 77.79 0.49 Allowed Glycine 0 N--CA 1.431 -1.696 0 O-C-N 120.774 -1.204 . . . . 3.57 112.077 -168.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.818 0 O-C-N 119.522 -2.163 . . . . 3.87 115.343 178.226 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.342 0 N-CA-C 117.298 2.333 . . . . 1.1 117.298 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -93.19 115.39 28.01 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 119.991 3.33 . . . . 1.87 119.991 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.523 HG22 ' HB2' ' A' ' 65' ' ' SER . 8.9 pt -113.17 163.09 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-N 122.904 2.593 . . . . 0.72 109.842 173.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.298 79.6 m-85 -121.01 134.22 55.29 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.07 -1.456 . . . . 1.4 107.07 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.2 t -119.16 130.24 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 119.578 -1.951 . . . . 0.58 110.021 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -95.26 119.8 34.4 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.646 3.178 . . . . 2.09 106.511 -173.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -86.84 -173.71 4.6 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 115.914 -1.993 . . . . 0.99 108.204 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.7 mt -87.01 -29.27 22.1 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.423 2.689 . . . . 2.53 108.901 173.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -77.52 -7.71 56.69 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.618 2.451 . . . . 2.08 117.618 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.28 5.56 37.25 Favored Glycine 0 N--CA 1.43 -1.745 0 CA-C-O 124.183 1.991 . . . . 1.31 112.578 174.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -96.22 144.63 26.25 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.968 -2.489 . . . . 1.4 110.605 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -106.22 115.54 30.4 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 106.025 -1.843 . . . . 0.78 106.025 173.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -91.6 126.45 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 125.753 2.692 . . . . 1.55 107.606 173.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.5 m -96.94 113.59 25.14 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 116.536 -3.853 . . . . 1.08 111.051 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.0 mt -120.29 154.42 34.99 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 114.208 1.188 . . . . 1.55 114.208 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.444 ' O ' ' HE3' ' A' ' 29' ' ' LYS . 29.7 mt-10 -109.72 145.22 36.95 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.646 -0.872 . . . . 1.95 108.646 172.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -152.22 156.31 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 126.17 1.788 . . . . 0.96 108.874 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -95.51 154.13 39.35 Favored Pre-proline 0 N--CA 1.43 -1.465 0 CA-C-O 114.364 -2.732 . . . . 2.35 108.561 171.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 57.5 Cg_endo -74.31 -11.87 22.93 Favored 'Trans proline' 0 N--CA 1.433 -2.03 0 CA-C-N 126.902 3.501 . . . . 0.95 112.218 -172.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -78.96 4.78 13.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.946 2.499 . . . . 1.45 112.596 173.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -93.56 151.76 19.48 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 126.957 2.103 . . . . 1.69 115.584 173.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.5 p -82.55 161.07 22.43 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.24 -2.788 . . . . 0.75 115.933 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mm -60.8 -34.82 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.079 -2.888 . . . . 0.73 115.387 170.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -48.27 -36.29 13.78 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 120.402 3.482 . . . . 1.62 120.402 158.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -62.0 -33.37 74.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.715 -2.491 . . . . 2.13 113.955 175.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.91 -41.25 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 127.159 2.183 . . . . 0.62 112.752 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -67.54 -34.23 76.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 113.878 -1.51 . . . . 1.22 112.32 174.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.6 -41.32 98.34 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.773 -1.829 . . . . 0.51 115.814 170.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HE3' ' O ' ' A' ' 16' ' ' GLU . 58.9 mttm -62.59 -38.26 89.46 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.1 -2.25 . . . . 1.44 114.367 168.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.41 92.7 mt -62.23 -35.52 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-O 126.888 3.233 . . . . 1.32 113.836 174.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -66.56 -31.54 72.31 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.23 -2.169 . . . . 1.7 115.057 174.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -73.22 -53.78 10.07 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.236 -1.024 . . . . 1.55 108.236 171.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -65.41 -50.23 66.25 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.917 1.451 . . . . 2.62 114.917 -174.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -108.19 -48.95 3.27 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 126.269 1.828 . . . . 1.48 113.405 -172.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.27 16.66 3.83 Favored Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 119.445 -1.36 . . . . 1.12 114.863 175.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 mt -88.88 131.01 42.7 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 115.495 -2.193 . . . . 1.55 110.052 -174.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -69.21 161.68 44.85 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 CA-C-N 126.453 3.34 . . . . 1.02 117.924 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.96 -1.86 8.78 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 CA-C-N 122.574 1.955 . . . . 1.25 113.287 -167.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -84.47 -26.27 28.32 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 116.137 -4.102 . . . . 2.25 111.998 176.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -83.92 -34.49 24.48 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.676 -2.515 . . . . 2.02 111.006 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -76.42 121.0 22.43 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 117.8 2.519 . . . . 0.69 117.8 -175.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.6 mtt85 -103.0 164.51 11.57 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 125.574 1.796 . . . . 2.78 106.365 167.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.1 mp -129.85 134.02 47.28 Favored 'General case' 0 CA--C 1.489 -1.387 0 O-C-N 117.636 -3.165 . . . . 1.17 112.026 170.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.2 mt -125.21 124.92 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 CA-C-O 128.564 4.03 . . . . 1.38 109.524 177.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -127.99 139.74 52.39 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 115.379 -4.576 . . . . 1.5 107.072 171.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.302 . . 52.35 25.83 3.71 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.632 2.773 . . . . 1.21 115.764 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.99 13.1 72.62 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-O 114.17 -3.572 . . . . 1.3 110.906 -176.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -125.17 129.66 50.58 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.639 2.22 . . . . 2.55 105.211 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.288 16.7 tt0 -83.33 125.56 31.77 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.153 2.981 . . . . 2.48 111.022 173.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.438 HD22 ' CE1' ' A' ' 59' ' ' TYR . 53.4 mt -79.26 164.47 24.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.294 -1.775 . . . . 0.9 112.58 -167.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -95.3 153.36 17.71 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.622 -1.992 . . . . 1.94 105.622 175.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -79.76 -50.69 10.19 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.665 -1.272 . . . . 1.56 111.943 -167.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.62 60.23 3.62 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 120.562 2.985 . . . . 0.97 120.562 171.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -126.19 166.96 16.1 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 104.86 -2.274 . . . . 2.49 104.86 165.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.3 p -97.8 162.0 13.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.872 -2.64 . . . . 0.76 103.872 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 5.0 mt -63.99 -27.94 69.47 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 112.762 -2.017 . . . . 1.05 115.794 174.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.9 t -59.89 -45.78 91.44 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.817 2.447 . . . . 1.19 109.001 176.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -55.46 -31.93 62.36 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.867 -2.396 . . . . 1.9 116.257 175.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.438 ' CE1' HD22 ' A' ' 50' ' ' LEU . 88.2 m-85 -85.2 -0.42 54.56 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.195 1.798 . . . . 0.89 112.029 174.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.289 18.7 m120 49.26 50.91 17.25 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.935 -3.603 . . . . 1.84 115.512 -171.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.274 83.7 mt -93.38 125.02 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 127.545 2.338 . . . . 0.82 105.308 -173.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -105.77 -175.96 2.94 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.556 3.142 . . . . 2.16 107.411 -172.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -72.21 159.31 34.31 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.417 -1.427 . . . . 2.12 110.141 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 59.53 48.53 9.58 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.685 1.994 . . . . 1.71 112.828 174.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.523 ' HB2' HG22 ' A' ' 3' ' ' ILE . 34.6 m -111.85 137.57 49.63 Favored 'General case' 0 N--CA 1.429 -1.476 1 N-CA-C 99.314 -4.328 . . . . 1.04 99.314 -169.822 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.6 m -102.53 108.51 19.84 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.608 1.963 . . . . 0.79 109.861 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.8 mt -105.01 148.77 26.38 Favored 'General case' 0 CA--C 1.489 -1.39 0 CA-C-O 123.559 1.647 . . . . 1.4 113.897 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -102.39 132.35 48.45 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.204 -3.435 . . . . 1.51 109.764 -173.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.1 tp -91.66 119.36 31.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.224 -2.797 . . . . 1.14 109.507 175.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.21 137.26 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 O-C-N 118.11 -2.869 . . . . 1.23 107.041 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.8 mt -119.97 -165.51 1.18 Allowed 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 116.804 -1.958 . . . . 2.78 110.769 172.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.4 mmt-85 -90.98 -67.05 0.88 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.744 2.688 . . . . 3.75 105.294 170.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.6 mt -125.08 156.32 38.43 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.571 -1.956 . . . . 3.14 111.22 172.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -78.04 157.93 29.4 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.306 2.642 . . . . 6.8 108.286 171.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.15 -121.49 1.69 Allowed Glycine 0 N--CA 1.429 -1.795 0 O-C-N 118.028 -2.92 . . . . 3.57 109.296 -171.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.745 0 O-C-N 120.075 -1.838 . . . . 3.87 117.628 -179.558 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 115.436 1.643 . . . . 1.1 115.436 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -83.83 148.04 27.22 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 114.806 -2.521 . . . . 1.87 109.561 -176.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -142.43 168.43 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 1 O-C-N 130.8 5.062 . . . . 0.72 107.97 170.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -117.88 156.68 28.01 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 114.455 1.28 . . . . 1.4 114.455 171.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.9 t -134.36 128.04 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 101.381 -3.563 . . . . 0.58 101.381 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -98.92 106.88 19.19 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.905 2.187 . . . . 2.09 116.905 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.262 4.8 p -58.13 165.43 1.93 Allowed 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 125.508 1.523 . . . . 0.99 112.571 176.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.3 94.7 mt -60.18 -54.89 40.42 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 130.867 3.667 . . . . 2.53 110.995 176.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 p -76.8 -12.23 59.95 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 117.84 -3.038 . . . . 2.08 113.264 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.65 2.21 5.36 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 122.285 2.311 . . . . 1.31 113.448 166.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -77.02 143.23 39.49 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 116.241 -4.093 . . . . 1.4 114.027 -175.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.0 m -85.44 125.92 33.39 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.144 0.977 . . . . 0.78 112.446 166.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.3 mt -100.51 112.89 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 104.999 -2.223 . . . . 1.55 104.999 171.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 m -87.99 145.49 25.98 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 116.031 -2.267 . . . . 1.08 108.479 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.3 mt -141.17 174.89 10.1 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 120.427 1.467 . . . . 1.55 109.308 175.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -126.18 119.66 28.08 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.682 1.993 . . . . 1.95 110.288 167.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 m -121.19 153.49 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 126.447 1.899 . . . . 0.96 110.702 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.278 17.7 mm-40 -101.84 175.84 2.13 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-N 125.2 3.636 . . . . 2.35 110.957 155.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -74.76 -20.17 17.74 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 121.23 1.475 . . . . 0.95 110.106 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.8 m -76.21 -8.93 58.13 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 120.328 3.455 . . . . 1.45 120.328 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -80.45 142.5 34.23 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 116.772 -3.705 . . . . 1.69 110.198 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 38.4 p -82.99 179.98 7.61 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 123.275 1.512 . . . . 0.75 111.703 -176.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.9 mm -82.62 -31.12 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 116.657 -3.777 . . . . 0.73 109.201 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -63.41 -28.76 70.2 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.18 -2.2 . . . . 1.62 115.404 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -66.71 -46.08 76.67 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.005 1.722 . . . . 2.13 113.414 172.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.2 t -62.67 -42.11 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 119.148 -2.22 . . . . 0.62 109.554 176.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -71.46 -8.31 53.06 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 118.222 2.675 . . . . 1.22 118.222 169.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.03 -39.76 19.22 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.369 1.08 . . . . 0.51 112.828 169.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -59.24 -40.84 87.18 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.324 1.85 . . . . 1.44 111.186 174.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.7 mt -74.67 -26.35 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 115.588 1.699 . . . . 1.32 115.588 170.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -62.18 -39.23 92.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.481 -2.012 . . . . 1.7 113.49 167.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -55.8 -47.66 76.74 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 116.277 1.955 . . . . 1.55 116.277 165.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -90.06 -51.42 5.47 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 115.735 1.754 . . . . 2.62 115.735 -167.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -98.54 -39.44 8.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 106.038 -1.838 . . . . 1.48 106.038 -171.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.47 18.16 6.29 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 120.933 3.133 . . . . 1.12 120.933 174.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.2 mt -103.71 120.75 50.47 Favored Pre-proline 0 N--CA 1.43 -1.437 1 C-N-CA 134.775 5.23 . . . . 1.55 108.374 -163.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -57.28 137.17 80.43 Favored 'Trans proline' 0 C--N 1.299 -2.052 2 C-N-CA 125.726 4.284 . . . . 1.02 116.749 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -67.59 -12.58 36.12 Favored 'Trans proline' 0 N--CA 1.434 -2.027 0 CA-C-N 127.978 3.885 . . . . 1.25 120.197 -172.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -78.41 -16.1 57.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.633 1.973 . . . . 2.25 112.483 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -92.01 -37.41 12.84 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.407 -2.058 . . . . 2.02 110.979 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -69.47 126.99 31.43 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.68 2.392 . . . . 0.69 112.051 -171.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.44 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 29.9 mtt180 -103.99 126.73 51.33 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 120.303 -1.498 . . . . 2.78 110.952 158.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 43' ' ' LEU . 83.0 mt -104.84 118.12 35.75 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.356 -2.715 . . . . 1.17 106.427 175.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.5 mm -112.8 141.44 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.669 1.988 . . . . 1.38 105.831 -174.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -154.8 124.26 6.45 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.535 -1.654 . . . . 1.5 106.535 169.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.47 37.83 2.55 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 126.703 2.502 . . . . 1.21 110.383 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.13 -23.51 4.5 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 118.031 -2.033 . . . . 1.3 116.131 -175.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -87.23 142.07 28.17 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.554 -1.556 . . . . 2.55 114.831 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -87.0 135.03 33.42 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.354 -2.716 . . . . 2.48 108.864 172.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.6 mt -93.09 128.77 39.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.887 -1.133 . . . . 0.9 112.54 -175.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -84.32 132.01 34.65 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 117.604 2.446 . . . . 1.94 117.604 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -40.53 -67.93 0.21 Allowed 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 121.22 3.785 . . . . 1.56 121.22 -165.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.25 58.03 5.05 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 118.011 1.964 . . . . 0.97 118.011 171.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -129.09 157.85 40.6 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 103.562 -2.755 . . . . 2.49 103.562 168.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 68.2 p -98.92 167.51 10.7 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.955 -1.716 . . . . 0.76 113.603 175.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.87 -24.81 66.94 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.993 -1.692 . . . . 1.05 115.305 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.5 t -69.4 -39.7 77.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.586 1.954 . . . . 1.19 109.654 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -55.28 -40.01 70.53 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 115.446 1.647 . . . . 1.9 115.446 171.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -88.67 -2.03 58.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.046 1.738 . . . . 0.89 113.296 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 59.08 50.75 7.77 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 123.14 1.448 . . . . 1.84 110.853 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.7 mm -85.97 126.66 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-O 125.687 2.66 . . . . 0.82 105.699 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -91.92 174.21 7.45 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.572 -2.58 . . . . 2.16 113.476 -176.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.3 pttt -70.13 147.02 50.43 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.164 1.459 . . . . 2.12 113.65 173.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.322 41.1 mt-10 61.97 35.58 16.08 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 119.139 -2.225 . . . . 1.71 114.674 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 t -102.62 149.42 24.45 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 124.326 1.05 . . . . 1.04 110.505 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.5 m -96.95 110.68 23.16 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.058 2.543 . . . . 0.79 113.031 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.8 mt -90.03 153.13 20.8 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 118.065 -1.454 . . . . 1.4 109.966 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -104.19 123.82 48.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.125 1.44 . . . . 1.51 112.599 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.1 tp -94.46 128.79 41.25 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.126 -4.109 . . . . 1.14 108.282 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 89.0 t -120.87 154.21 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 102.239 -3.245 . . . . 1.23 102.239 172.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.0 mt -130.53 155.7 46.05 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 120.594 -1.316 . . . . 2.78 108.587 -175.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.4 ttp180 -70.8 -48.84 52.08 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 130.386 3.474 . . . . 3.75 110.34 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 55.7 mt -90.56 160.39 15.97 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.535 1.636 . . . . 3.14 110.967 170.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.329 1.0 OUTLIER -90.61 -40.97 11.61 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 116.545 -3.847 . . . . 6.8 113.08 169.552 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.17 -59.28 1.39 Allowed Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 125.891 1.71 . . . . 3.57 111.219 -163.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.744 1 CA-C-O 112.0 -4.778 . . . . 3.87 112.951 175.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 CA--C 1.491 -1.324 0 CA-C-O 118.376 -0.821 . . . . 1.1 112.089 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -99.27 126.98 45.21 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.727 0.775 . . . . 1.87 111.232 -176.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.6 pt -114.69 164.45 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 105.663 -1.977 . . . . 0.72 105.663 173.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -119.2 135.01 54.88 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 105.26 -2.126 . . . . 1.4 105.26 -175.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.5 t -117.79 118.22 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 102.98 -2.97 . . . . 0.58 102.98 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -108.98 135.92 49.36 Favored 'General case' 0 N--CA 1.429 -1.485 2 O-C-N 115.639 -4.413 . . . . 2.09 108.05 175.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.56 HG22 HD23 ' A' ' 69' ' ' LEU . 59.1 p -87.32 -177.05 5.86 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 125.119 2.39 . . . . 0.99 115.752 176.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.78 -30.31 64.0 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 124.733 2.206 . . . . 2.53 114.794 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p -77.94 -51.04 11.02 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 114.549 -5.094 . . . . 2.08 110.526 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.61 35.68 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.748 0 O-C-N 118.552 -2.593 . . . . 1.31 111.777 173.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -102.42 108.46 19.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.931 -2.248 . . . . 1.4 104.931 -170.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.9 m -83.7 114.9 21.9 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.535 2.734 . . . . 0.78 106.694 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.4 mt -101.54 146.43 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 100.522 -3.881 . . . . 1.55 100.522 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.7 m -118.21 130.82 56.3 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.851 2.739 . . . . 1.08 103.853 174.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.3 mt -125.75 139.98 53.07 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 113.275 -1.784 . . . . 1.55 108.283 -177.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.27 48.0 mt-10 -103.32 129.91 50.47 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 123.929 1.823 . . . . 1.95 111.341 170.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 m -137.31 166.22 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 113.929 -1.487 . . . . 0.96 110.669 -169.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -105.55 167.23 10.03 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 119.25 -2.156 . . . . 2.35 109.679 161.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -70.89 -13.1 31.6 Favored 'Trans proline' 0 N--CA 1.434 -1.99 0 N-CA-C 118.999 2.653 . . . . 0.95 118.999 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.8 p -93.11 4.22 54.38 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.499 1.92 . . . . 1.45 115.5 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -80.2 144.27 33.09 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 126.378 2.99 . . . . 1.69 111.929 170.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.3 p -80.27 158.62 26.12 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 128.335 2.654 . . . . 0.75 108.108 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.6 mm -64.99 -36.75 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 103.031 -2.951 . . . . 0.73 103.031 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -55.16 -46.26 75.73 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.353 -3.342 . . . . 1.62 117.259 170.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -64.28 -37.98 89.43 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 115.785 1.772 . . . . 2.13 115.785 171.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.5 t -53.2 -44.55 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 118.418 -2.676 . . . . 0.62 114.684 167.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt -62.56 -46.63 87.48 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.318 -1.489 . . . . 1.22 114.57 173.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.1 -37.4 69.32 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.782 1.633 . . . . 0.51 112.281 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -68.37 -31.2 70.4 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 117.052 -1.451 . . . . 1.44 112.865 173.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.1 mt -68.68 -41.69 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 120.153 1.342 . . . . 1.32 108.337 173.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -53.57 -45.47 69.93 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 117.575 -3.203 . . . . 1.7 114.148 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.27 20.9 t70 -55.49 -68.06 0.23 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.074 -1.642 . . . . 1.55 109.761 167.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -59.82 -55.4 34.68 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 119.436 3.124 . . . . 2.62 119.436 -173.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -95.03 -51.23 4.74 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.092 2.557 . . . . 1.48 113.449 -169.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.56 24.7 2.81 Favored Glycine 0 N--CA 1.43 -1.733 0 CA-C-O 116.942 -2.032 . . . . 1.12 115.771 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.9 mm -103.62 135.12 19.42 Favored Pre-proline 0 N--CA 1.429 -1.484 0 CA-C-N 121.63 2.715 . . . . 1.55 108.777 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -67.48 137.64 43.53 Favored 'Trans proline' 0 C--N 1.3 -1.998 3 C-N-CA 126.452 4.768 . . . . 1.02 115.355 178.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -59.14 -21.13 57.93 Favored 'Trans proline' 0 C--N 1.299 -2.047 1 C-N-CA 129.349 6.699 . . . . 1.25 111.461 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -62.59 -39.11 92.68 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 126.299 2.952 . . . . 2.25 114.292 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -77.75 -30.68 51.66 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 114.613 -5.054 . . . . 2.02 110.026 -173.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -79.44 151.02 31.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.703 -1.248 . . . . 0.69 112.495 -164.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -139.82 156.09 46.92 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 106.341 -1.725 . . . . 2.78 106.341 168.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 42.1 mt -136.59 126.43 25.74 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 118.86 0.754 . . . . 1.17 111.322 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.8 mm -104.62 145.93 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 O-C-N 126.471 2.357 . . . . 1.38 106.257 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -134.42 126.45 29.55 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 116.893 -3.629 . . . . 1.5 102.288 165.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.22 -55.9 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.45 1 C-N-CA 135.027 5.331 . . . . 1.21 118.945 -175.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.85 -16.8 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.723 0 O-C-N 120.132 -1.605 . . . . 1.3 113.757 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -95.29 162.36 13.71 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.542 1.537 . . . . 2.55 111.063 -178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -116.58 126.33 53.13 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.623 1.569 . . . . 2.48 107.139 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.3 mt -90.42 132.3 35.7 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 125.706 1.879 . . . . 0.9 108.748 -162.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -60.12 143.76 51.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.181 -2.825 . . . . 1.94 113.074 172.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -70.21 -43.21 71.14 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 112.899 -6.126 . . . . 1.56 113.92 -169.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.62 53.25 1.29 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 125.949 2.971 . . . . 0.97 109.718 174.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.5 mtt-85 -120.87 155.21 34.64 Favored 'General case' 0 N--CA 1.43 -1.468 1 N-CA-C 100.069 -4.049 . . . . 2.49 100.069 165.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.4 p -90.56 167.41 12.58 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 124.68 1.237 . . . . 0.76 113.346 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 mt -65.22 -42.93 92.97 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 127.299 2.874 . . . . 1.05 112.735 169.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.2 t -59.0 -40.11 83.91 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 120.041 1.291 . . . . 1.19 114.34 175.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.1 -40.96 95.71 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.726 2.121 . . . . 1.9 116.726 175.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -79.04 -10.1 59.73 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.77 1.294 . . . . 0.89 113.661 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.9 m120 68.33 40.19 2.11 Favored 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 135.507 5.523 . . . . 1.84 114.661 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.9 mt -72.33 139.6 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 127.328 2.251 . . . . 0.82 106.974 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -119.21 -178.48 3.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.942 2.306 . . . . 2.16 106.857 -175.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -65.43 147.66 53.04 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.117 2.389 . . . . 2.12 116.125 167.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.272 34.8 mt-10 70.31 21.57 5.73 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.673 1.989 . . . . 1.71 113.852 173.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -92.92 141.15 28.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.621 1.677 . . . . 1.04 108.778 -175.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.2 m -96.22 100.56 12.19 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 129.266 3.026 . . . . 0.79 112.721 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.326 18.6 mt -83.13 150.88 25.99 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 128.421 3.962 . . . . 1.4 103.699 170.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -106.92 98.93 8.53 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 110.365 -3.107 . . . . 1.51 116.919 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.56 HD23 HG22 ' A' ' 7' ' ' THR . 24.9 tp -63.65 116.69 5.91 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 116.914 2.19 . . . . 1.14 116.914 169.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.9 m -131.69 -178.78 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 102.779 -3.045 . . . . 1.23 102.779 175.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.9 mt -118.37 174.41 6.26 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 105.256 -2.127 . . . . 2.78 105.256 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.293 12.4 ptt180 -51.58 -48.7 63.06 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.756 1.762 . . . . 3.75 115.756 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.1 mt -79.57 120.47 23.97 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 129.285 3.034 . . . . 3.14 110.677 173.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -71.09 122.5 20.2 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.86 2.118 . . . . 6.8 106.161 170.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.53 108.85 0.3 Allowed Glycine 0 N--CA 1.429 -1.805 0 O-C-N 120.32 -1.488 . . . . 3.57 110.784 -166.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.755 0 N-CA-C 110.439 -1.064 . . . . 3.87 110.439 176.734 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.344 0 CA-C-O 118.34 -0.838 . . . . 1.1 111.149 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -95.66 131.4 41.94 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 116.302 1.964 . . . . 1.87 116.302 -171.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.9 pt -126.92 165.93 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 115.093 -2.385 . . . . 0.72 111.742 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -125.88 127.68 46.41 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 125.946 2.029 . . . . 1.4 106.321 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.9 t -112.83 111.9 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 CA-C-N 115.503 -0.771 . . . . 0.58 109.633 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -93.63 135.67 34.68 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 116.852 -3.655 . . . . 2.09 111.496 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.3 p -84.2 -167.64 1.84 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.844 -1.785 . . . . 0.99 109.559 173.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.0 mt -91.96 -23.48 19.56 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.107 -2.245 . . . . 2.53 112.226 171.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.1 p -80.96 -47.64 13.38 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.035 1.124 . . . . 2.08 114.035 -173.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.17 25.3 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 116.615 -2.707 . . . . 1.31 111.686 176.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -118.47 124.45 47.64 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.492 -0.929 . . . . 1.4 108.492 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -102.41 118.56 37.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 124.579 1.175 . . . . 0.78 110.231 167.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mt -105.22 129.45 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 127.832 2.453 . . . . 1.55 110.128 -170.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.4 m -99.34 110.06 22.61 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 127.427 2.954 . . . . 1.08 108.318 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.1 mt -121.49 147.07 46.26 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.059 2.838 . . . . 1.55 109.728 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -99.3 125.71 44.99 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.509 -3.869 . . . . 1.95 114.495 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.48 HG12 ' HE3' ' A' ' 29' ' ' LYS . 32.6 m -124.9 150.38 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 117.8 -3.063 . . . . 0.96 106.134 -176.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -86.21 140.23 34.49 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 112.907 -3.425 . . . . 2.35 113.018 166.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -77.44 5.14 5.35 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 CA-C-N 126.878 3.492 . . . . 0.95 112.69 -166.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 p -106.17 9.63 32.17 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.939 -2.976 . . . . 1.45 111.841 173.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -91.23 157.26 17.27 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 124.64 2.162 . . . . 1.69 110.253 171.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.422 ' O ' HG23 ' A' ' 26' ' ' VAL . 43.9 p -83.37 165.7 19.04 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.679 -2.513 . . . . 0.75 107.392 -175.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.412 11.3 mm -68.42 -37.49 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 C-N-CA 128.101 2.56 . . . . 0.73 110.51 176.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -56.96 -34.1 67.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 126.789 3.185 . . . . 1.62 115.966 169.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -83.05 -26.42 31.17 Favored 'General case' 0 N--CA 1.432 -1.374 1 O-C-N 111.808 -6.807 . . . . 2.13 113.405 177.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 22' ' ' THR . 44.3 t -52.66 -44.61 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.384 1.873 . . . . 0.62 113.436 165.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -67.38 -40.28 85.69 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.973 -2.329 . . . . 1.22 111.371 175.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.43 76.58 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.321 2.01 . . . . 0.51 113.808 175.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HE3' HG12 ' A' ' 17' ' ' VAL . 14.3 ttmm -64.66 -46.76 81.08 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 118.93 -2.356 . . . . 1.44 116.522 163.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.6 mt -61.51 -26.96 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 117.299 -3.376 . . . . 1.32 114.588 167.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -67.43 -45.47 75.98 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.851 -3.655 . . . . 1.7 109.905 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.26 -36.94 76.43 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 118.796 -2.44 . . . . 1.55 106.338 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -76.02 -55.94 5.13 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 123.585 2.902 . . . . 2.62 113.073 -171.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -112.32 -15.9 13.06 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 126.097 2.123 . . . . 1.48 115.146 -164.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.79 21.2 40.61 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-O 123.048 1.36 . . . . 1.12 115.375 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 mt -101.55 131.98 22.33 Favored Pre-proline 0 N--CA 1.43 -1.467 0 O-C-N 121.013 -1.287 . . . . 1.55 111.059 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.408 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 30.7 Cg_exo -70.47 145.0 51.84 Favored 'Trans proline' 0 C--N 1.3 -2.003 1 C-N-CA 126.302 4.668 . . . . 1.02 115.27 178.924 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -72.58 -6.52 19.2 Favored 'Trans proline' 0 N--CA 1.433 -2.03 1 C-N-CA 127.45 5.434 . . . . 1.25 117.21 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.98 -39.45 30.08 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.851 -1.781 . . . . 2.25 108.669 169.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -73.65 -36.46 65.39 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 125.163 1.539 . . . . 2.02 113.422 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 37' ' ' PRO . 74.3 mt-30 -74.04 135.06 43.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.322 1.23 . . . . 0.69 114.322 -175.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.1 ttt180 -122.13 117.68 26.84 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 114.859 -2.496 . . . . 2.78 107.901 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.1 mt -100.77 125.55 47.26 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 125.291 2.472 . . . . 1.17 105.935 -176.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.1 mt -106.05 142.71 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 1 O-C-N 115.903 -4.248 . . . . 1.38 101.904 176.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -153.8 133.56 13.03 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 127.486 3.517 . . . . 1.5 106.252 172.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.22 -57.99 0.28 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.064 2.546 . . . . 1.21 115.244 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -159.84 -18.59 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 108.616 -1.794 . . . . 1.3 108.616 -173.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -134.88 163.41 29.88 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.317 -3.461 . . . . 2.55 112.223 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.3 pm0 -71.16 152.7 43.14 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 117.81 -1.091 . . . . 2.48 111.885 170.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.2 mt -97.89 172.57 7.57 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.894 2.134 . . . . 0.9 114.538 -171.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -104.68 153.57 21.09 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.037 -2.914 . . . . 1.94 110.591 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -89.47 -52.05 5.23 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.284 -2.76 . . . . 1.56 109.085 -163.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.84 46.1 1.7 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 117.233 1.653 . . . . 0.97 117.233 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.353 17.7 mmt180 -128.22 165.92 19.56 Favored 'General case' 0 CA--C 1.489 -1.38 0 O-C-N 119.499 -2.177 . . . . 2.49 106.643 168.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.288 27.2 p -99.36 170.55 8.56 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.233 1.568 . . . . 0.76 115.233 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' A' ' 61' ' ' ILE . 11.3 mt -63.15 -40.32 97.22 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 127.2 2.2 . . . . 1.05 107.926 171.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 m -65.47 -48.85 71.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.634 3.174 . . . . 1.19 110.891 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -52.49 -41.82 63.72 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.427 1.584 . . . . 1.9 114.334 174.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -82.33 -7.23 59.63 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.424 -2.047 . . . . 0.89 114.062 175.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.1 t30 56.44 43.83 25.37 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.414 3.485 . . . . 1.84 112.535 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' A' ' 56' ' ' LEU . 62.9 mt -75.59 109.87 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-N 111.927 -2.397 . . . . 0.82 113.1 177.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -82.78 -178.19 7.01 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 120.435 -1.416 . . . . 2.16 107.855 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -66.5 149.3 50.64 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 125.083 1.353 . . . . 2.12 111.075 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 69.09 33.75 3.28 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 131.557 3.943 . . . . 1.71 107.668 168.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m -96.42 139.6 32.29 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 121.507 1.958 . . . . 1.04 111.713 -176.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 m -99.98 115.96 30.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.43 1.468 . . . . 0.79 110.939 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mp -104.47 155.33 18.89 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 112.194 -2.276 . . . . 1.4 106.29 173.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -107.34 122.92 47.55 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.885 3.274 . . . . 1.51 113.666 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.9 tp -101.42 102.09 12.82 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.243 -3.411 . . . . 1.14 106.06 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.4 m -111.96 -177.05 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 126.685 2.491 . . . . 1.23 105.686 172.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.373 18.0 mt -128.47 178.38 6.33 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 119.473 -0.891 . . . . 2.78 109.319 -176.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.421 HH21 ' C ' ' A' ' 76' ' ' GLY . 9.1 ptm85 -116.04 160.85 19.73 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 102.549 -3.13 . . . . 3.75 102.549 177.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.5 mt -76.12 168.55 19.84 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.716 -3.115 . . . . 3.14 105.906 172.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -86.1 126.37 34.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.641 1.576 . . . . 6.8 112.637 166.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 135.61 2.69 2.82 Favored Glycine 0 N--CA 1.429 -1.804 0 O-C-N 126.321 2.263 . . . . 3.57 113.601 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.421 ' C ' HH21 ' A' ' 72' ' ' ARG . . . . . . . . 0 C--O 1.26 1.751 0 N-CA-C 107.683 -2.167 . . . . 3.87 107.683 -173.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ptt? . . . . . 0 CA--C 1.49 -1.341 0 CA-C-O 124.85 2.262 . . . . 1.1 110.814 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -109.81 123.75 50.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 112.496 -2.138 . . . . 1.87 111.779 -173.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.404 HD11 HD12 ' A' ' 15' ' ' LEU . 2.2 pp -123.83 162.1 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 129.932 3.293 . . . . 0.72 111.344 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -123.52 136.76 54.74 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 122.782 1.277 . . . . 1.4 107.812 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.4 t -110.34 124.64 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-N 112.053 -2.34 . . . . 0.58 110.346 174.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 mmtt -95.9 117.53 30.77 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.35 1.06 . . . . 2.09 109.617 174.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.404 HG22 HD23 ' A' ' 69' ' ' LEU . 64.2 p -77.65 -177.55 4.87 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.359 2.028 . . . . 0.99 109.556 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.7 tp -58.49 -50.76 72.56 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 114.656 -5.028 . . . . 2.53 116.736 174.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.7 p -68.86 -6.31 26.32 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 111.624 -2.535 . . . . 2.08 114.763 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.17 9.68 44.25 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 117.518 -3.239 . . . . 1.31 110.434 173.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -84.03 126.87 33.47 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 107.503 -1.295 . . . . 1.4 107.503 -171.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 m -93.72 121.71 35.44 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.259 -0.882 . . . . 0.78 112.368 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.0 mt -115.13 126.53 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 107.055 -1.461 . . . . 1.55 107.055 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.8 m -102.36 121.72 42.86 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.604 -1.31 . . . . 1.08 113.529 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.404 HD12 HD11 ' A' ' 3' ' ' ILE . 83.0 mt -115.52 155.13 28.09 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.351 -2.718 . . . . 1.55 110.517 -174.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -110.18 109.32 19.78 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 125.051 1.469 . . . . 1.95 110.306 171.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -123.64 173.41 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 126.192 1.797 . . . . 0.96 109.876 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -115.68 157.27 44.86 Favored Pre-proline 0 N--CA 1.429 -1.494 0 CA-C-O 115.18 -2.343 . . . . 2.35 113.42 166.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.23 2.26 8.7 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 C-N-CA 124.441 3.427 . . . . 0.95 115.472 -176.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.6 p -95.61 -25.71 16.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.086 1.513 . . . . 1.45 115.086 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -69.72 154.8 41.47 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.163 2.985 . . . . 1.69 112.607 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.269 71.7 p -81.77 149.16 28.54 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 112.281 -2.236 . . . . 0.75 112.91 -175.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 35.2 mm -52.85 -44.01 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 117.592 -1.194 . . . . 0.73 112.676 171.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -43.39 -50.96 6.72 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.427 2.691 . . . . 1.62 111.501 162.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -66.35 -36.89 84.02 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 115.999 1.851 . . . . 2.13 115.999 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.24 -45.93 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-O 125.901 2.762 . . . . 0.62 113.779 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.2 mtmt -53.24 -31.25 42.5 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.395 -2.066 . . . . 1.22 115.445 166.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.88 -20.64 60.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 120.015 -0.674 . . . . 0.51 112.366 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -70.37 -38.29 74.71 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.98 -2.325 . . . . 1.44 114.428 173.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.6 mt -68.98 -31.95 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 127.085 2.154 . . . . 1.32 111.977 169.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -65.89 -52.85 46.54 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 115.654 -4.404 . . . . 1.7 110.102 174.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -56.77 -47.68 79.56 Favored 'General case' 0 N--CA 1.431 -1.391 1 O-C-N 114.511 -5.118 . . . . 1.55 108.767 170.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -65.99 -63.32 1.11 Allowed 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 123.315 2.779 . . . . 2.62 117.244 -176.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -93.46 -43.61 8.65 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.666 -1.896 . . . . 1.48 111.631 -174.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.05 81.06 1.5 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 125.899 2.944 . . . . 1.12 106.357 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.7 mt -155.78 126.44 3.47 Favored Pre-proline 0 N--CA 1.43 -1.472 1 N-CA-C 99.03 -4.433 . . . . 1.55 99.03 -170.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -70.0 148.7 64.09 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 CA-C-N 122.725 2.009 . . . . 1.02 112.247 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.335 36.2 Cg_endo -67.64 -20.87 46.37 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 CA-C-N 125.994 3.177 . . . . 1.25 115.697 -175.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -63.79 -31.35 72.5 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 129.832 3.253 . . . . 2.25 113.733 175.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -89.06 -16.99 30.23 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 119.532 -1.98 . . . . 2.02 106.934 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -88.37 124.64 34.13 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.117 -4.739 . . . . 0.69 111.621 -176.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -116.72 133.74 55.65 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.537 -0.912 . . . . 2.78 108.537 171.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.4 mt -112.06 125.34 53.99 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 126.23 2.919 . . . . 1.17 108.861 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.6 mt -111.1 145.61 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 127.485 2.314 . . . . 1.38 104.778 176.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -150.71 135.62 17.5 Favored 'General case' 0 N--CA 1.43 -1.448 1 N-CA-C 99.878 -4.119 . . . . 1.5 99.878 178.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.24 47.6 21.97 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.893 2.758 . . . . 1.21 114.02 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.74 -2.34 54.79 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 127.633 2.54 . . . . 1.3 116.017 175.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm -123.75 143.82 50.06 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.524 -2.163 . . . . 2.55 114.249 -174.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -66.37 127.18 31.24 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 111.411 -2.631 . . . . 2.48 114.906 171.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 mt -92.27 119.89 32.3 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 110.258 -3.156 . . . . 0.9 108.389 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -77.38 151.12 34.98 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 117.127 -1.415 . . . . 1.94 113.375 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.432 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 7.1 m-20 -72.35 -53.48 12.23 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.932 2.197 . . . . 1.56 116.932 -169.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.73 29.33 0.62 Allowed Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 120.266 2.866 . . . . 0.97 120.266 169.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -118.17 174.98 5.9 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 120.213 2.007 . . . . 2.49 108.327 170.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.4 p -104.08 179.19 4.34 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 126.099 2.856 . . . . 0.76 111.624 175.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.8 mt -71.4 -33.89 69.87 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 116.464 -3.898 . . . . 1.05 113.213 171.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -57.25 -44.83 84.21 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 125.269 2.461 . . . . 1.19 110.159 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -54.95 -33.52 62.4 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.332 -2.73 . . . . 1.9 117.218 176.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -101.05 -2.41 31.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.165 -1.584 . . . . 0.89 109.148 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.257 6.6 m120 64.39 55.17 1.43 Allowed 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 116.825 2.157 . . . . 1.84 116.825 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.5 mt -100.16 132.27 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 110.568 -3.014 . . . . 0.82 107.5 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -115.65 -164.16 0.94 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 123.469 0.707 . . . . 2.16 111.621 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -67.6 153.36 43.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.952 2.501 . . . . 2.12 108.531 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 54.47 26.96 7.67 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.478 2.711 . . . . 1.71 117.089 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.252 47.2 m -94.08 144.85 25.12 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.358 -1.464 . . . . 1.04 109.971 -173.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.4 m -102.41 103.53 13.93 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 126.549 1.94 . . . . 0.79 111.661 -171.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 mt -84.22 160.52 20.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.322 1.849 . . . . 1.4 111.758 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -123.43 123.96 41.83 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.529 -2.607 . . . . 1.51 104.114 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.404 HD23 HG22 ' A' ' 7' ' ' THR . 23.1 tp -95.63 120.93 36.74 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.295 2.638 . . . . 1.14 109.318 176.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.296 14.1 m -116.94 163.13 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 127.899 2.48 . . . . 1.23 111.425 168.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.3 mt -115.81 134.29 55.15 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 117.48 -1.688 . . . . 2.78 111.914 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -90.34 100.48 13.31 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-O 126.005 2.812 . . . . 3.75 116.593 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.7 mt -117.29 170.97 8.28 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 123.957 1.837 . . . . 3.14 110.343 166.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -85.47 158.67 20.13 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 113.653 -1.612 . . . . 6.8 111.126 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.58 47.96 6.52 Favored Glycine 0 N--CA 1.43 -1.745 0 CA-C-O 116.815 -2.103 . . . . 3.57 116.892 -166.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.767 0 CA-C-N 121.617 2.708 . . . . 3.87 106.502 -177.404 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 tmm? . . . . . 0 CA--C 1.491 -1.299 0 CA-C-O 116.791 -1.576 . . . . 1.1 114.134 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -91.64 115.38 28.0 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.827 2.558 . . . . 1.87 113.149 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.9 pt -104.88 152.57 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 124.376 2.036 . . . . 0.72 113.015 165.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -111.46 113.74 26.39 Favored 'General case' 0 N--CA 1.429 -1.49 1 O-C-N 114.825 -4.922 . . . . 1.4 108.697 -174.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.7 t -98.13 106.5 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-O 124.082 1.896 . . . . 0.58 106.067 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -94.62 121.3 36.04 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.791 -2.443 . . . . 2.09 112.779 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 p -89.24 163.82 15.22 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.543 -1.348 . . . . 0.99 108.203 174.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.9 tp -44.8 -56.88 4.11 Favored 'General case' 0 N--CA 1.43 -1.433 1 C-N-CA 133.229 4.611 . . . . 2.53 110.842 174.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.7 p -72.59 -19.73 61.42 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 113.061 -1.881 . . . . 2.08 115.275 -174.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.4 -14.86 4.22 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 117.293 -1.837 . . . . 1.31 116.689 166.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -75.04 133.21 41.67 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 120.343 2.072 . . . . 1.4 108.748 -168.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -105.15 118.89 37.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.028 -0.73 . . . . 0.78 109.028 172.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.12 112.31 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-O 126.112 2.863 . . . . 1.55 105.226 -178.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.7 m -88.72 131.52 34.99 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.186 -2.821 . . . . 1.08 106.862 -176.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.4 mt -135.32 131.21 36.18 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 124.642 1.213 . . . . 1.55 109.788 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -88.48 94.13 9.77 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.007 -2.308 . . . . 1.95 112.481 176.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.284 30.9 m -110.79 178.35 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 105.493 -2.04 . . . . 0.96 105.493 -177.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.41 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 22.7 mm-40 -122.34 155.5 61.88 Favored Pre-proline 0 N--CA 1.431 -1.412 0 O-C-N 119.532 -1.98 . . . . 2.35 109.786 161.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 94.3 Cg_endo -72.32 -23.09 21.09 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 C-N-CA 124.126 3.217 . . . . 0.95 112.975 -166.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.1 m -74.32 -11.21 60.2 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 116.17 1.915 . . . . 1.45 116.17 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -81.73 159.48 23.87 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 119.359 3.096 . . . . 1.69 119.359 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.257 7.3 p -78.07 147.71 34.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 119.067 2.988 . . . . 0.75 119.067 -177.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.1 mm -53.68 -38.36 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 123.86 3.027 . . . . 0.73 115.849 173.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -45.85 -38.12 6.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.86 2.911 . . . . 1.62 118.86 162.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -85.4 -23.7 27.84 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.86 -1.775 . . . . 2.13 113.719 175.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.94 -48.01 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 118.583 -2.573 . . . . 0.62 109.581 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -47.7 -37.4 13.01 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.761 3.245 . . . . 1.22 119.761 174.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.08 -33.12 71.5 Favored 'General case' 0 N--CA 1.43 -1.43 2 C-N-CA 133.53 4.732 . . . . 0.51 110.731 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -62.28 -26.42 68.4 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.133 3.012 . . . . 1.44 119.133 173.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.7 mt -82.67 -16.41 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 126.541 2.401 . . . . 1.32 114.292 175.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -82.17 -49.53 10.03 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.793 -1.929 . . . . 1.7 105.793 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -48.86 -61.28 2.13 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.874 2.47 . . . . 1.55 111.305 167.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -76.88 -62.57 1.6 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.968 -1.708 . . . . 2.62 112.959 -167.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -98.5 -42.77 7.15 Favored 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 115.247 -4.658 . . . . 1.48 110.806 -166.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.34 20.47 2.19 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 121.891 3.516 . . . . 1.12 121.891 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.1 mm -99.82 118.86 61.08 Favored Pre-proline 0 N--CA 1.43 -1.471 0 C-N-CA 126.337 1.855 . . . . 1.55 109.75 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -69.3 157.44 61.27 Favored 'Trans proline' 0 C--N 1.299 -2.064 0 CA-C-N 123.116 2.148 . . . . 1.02 115.795 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -73.15 -16.14 25.36 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 C-N-CA 124.343 3.362 . . . . 1.25 112.717 -173.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -85.87 -34.54 20.97 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.898 2.479 . . . . 2.25 112.409 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -79.44 3.66 17.86 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.332 2.653 . . . . 2.02 111.269 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -122.92 147.72 46.27 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 120.799 3.629 . . . . 0.69 120.799 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -125.19 129.21 49.65 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 124.011 3.096 . . . . 2.78 103.613 176.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.4 mt -105.92 132.91 51.45 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.128 -4.732 . . . . 1.17 109.274 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.4 mt -119.7 135.36 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 106.366 -1.716 . . . . 1.38 106.366 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -124.31 131.95 53.54 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.844 2.458 . . . . 1.5 104.434 169.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.16 -57.59 0.52 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.889 2.876 . . . . 1.21 113.799 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -169.09 -32.45 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.749 0 CA-C-O 125.67 2.816 . . . . 1.3 115.439 -173.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -95.79 162.78 13.45 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.645 -2.679 . . . . 2.55 114.078 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -90.3 145.45 24.97 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 121.514 3.894 . . . . 2.48 121.514 173.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.6 mt -92.33 128.28 38.12 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 124.505 2.098 . . . . 0.9 112.605 -170.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -75.96 134.93 40.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 130.257 3.423 . . . . 1.94 110.144 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.55 -49.93 74.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.417 2.687 . . . . 1.56 115.206 -172.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.31 34.59 3.93 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 119.681 2.633 . . . . 0.97 119.681 173.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -103.83 166.13 10.61 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 114.549 -2.861 . . . . 2.49 106.789 167.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.8 p -89.97 159.82 16.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.974 -2.953 . . . . 0.76 110.127 169.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.299 81.0 mt -60.16 -33.27 71.95 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.688 1.736 . . . . 1.05 115.688 168.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.6 t -76.76 -20.78 56.09 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.457 -3.277 . . . . 1.19 115.804 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.88 -36.14 82.94 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.486 1.115 . . . . 1.9 109.326 169.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -82.54 3.21 29.45 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.553 -1.967 . . . . 0.89 112.733 172.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.312 21.7 m120 51.92 34.75 14.2 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.594 -2.566 . . . . 1.84 115.822 -176.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.4 mt -68.81 105.52 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 120.581 -1.324 . . . . 0.82 109.009 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -97.23 167.25 11.15 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 128.437 2.695 . . . . 2.16 107.953 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -62.42 145.77 53.18 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 118.215 -2.803 . . . . 2.12 118.059 175.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.33 29.3 mt-10 71.37 28.7 2.89 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 113.156 -1.838 . . . . 1.71 112.149 -172.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 m -84.42 141.44 30.83 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 121.032 1.742 . . . . 1.04 115.242 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.3 m -94.87 109.03 21.06 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.967 -1.494 . . . . 0.79 106.967 -171.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.7 mt -95.04 130.59 41.66 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.979 2.172 . . . . 1.4 106.628 171.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.272 32.1 m80 -100.33 114.1 27.34 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.032 -1.47 . . . . 1.51 107.032 -175.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -87.71 110.12 20.2 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.017 1.727 . . . . 1.14 112.266 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.7 t -98.62 133.92 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 1 N-CA-C 99.212 -4.366 . . . . 1.23 99.212 169.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.265 13.5 tp -94.04 127.35 39.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.25 -2.156 . . . . 2.78 107.983 177.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -95.77 124.25 39.7 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.292 -2.13 . . . . 3.75 111.023 -173.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.2 tp -99.36 -68.55 0.8 Allowed 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 122.843 1.306 . . . . 3.14 109.68 170.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 74' ' ' ARG . 29.0 ttm105 -103.69 -82.13 0.5 Allowed 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.838 -2.414 . . . . 6.8 109.829 175.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.29 38.33 0.23 Allowed Glycine 0 N--CA 1.43 -1.735 1 O-C-N 114.675 -5.016 . . . . 3.57 110.696 -166.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.764 0 N-CA-C 107.424 -2.27 . . . . 3.87 107.424 -175.414 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 CA--C 1.491 -1.299 0 CA-C-O 118.176 -0.916 . . . . 1.1 111.647 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -107.03 137.81 44.39 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.127 3.371 . . . . 1.87 106.103 -178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 pt -131.2 167.45 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.604 -3.185 . . . . 0.72 104.863 168.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.252 63.4 m-85 -121.88 125.18 45.84 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.469 1.108 . . . . 1.4 108.658 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.79 112.07 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 112.693 0.627 . . . . 0.58 112.693 172.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.4 ttmm -102.42 142.77 33.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.463 -1.31 . . . . 2.09 107.463 -172.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.1 p -93.06 167.21 11.94 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 127.392 3.472 . . . . 0.99 112.975 165.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.257 21.0 tp -71.89 -25.58 61.98 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.242 -3.411 . . . . 2.53 114.382 175.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.8 p -88.24 -36.7 16.6 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.344 -2.097 . . . . 2.08 112.631 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.66 8.95 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 116.768 -2.634 . . . . 1.31 118.933 166.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -104.48 133.28 49.61 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 122.721 3.26 . . . . 1.4 109.923 -171.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.1 m -117.22 112.74 21.23 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 118.514 -1.275 . . . . 0.78 112.635 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.31 19.7 pt -97.02 136.0 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 124.178 1.942 . . . . 1.55 111.882 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.1 m -97.65 126.75 43.15 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 116.931 -3.606 . . . . 1.08 108.415 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.3 mt -131.41 141.48 49.85 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 127.4 3.476 . . . . 1.55 109.632 -173.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -97.54 118.67 34.56 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 113.562 -5.711 . . . . 1.95 109.59 171.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.97 174.99 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 119.859 -1.775 . . . . 0.96 109.138 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -116.02 147.96 40.37 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-O 116.342 -1.789 . . . . 2.35 107.084 157.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.03 -18.06 35.98 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-O 113.741 -2.691 . . . . 0.95 109.557 -174.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.2 p -71.0 -9.47 58.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 122.892 2.587 . . . . 1.45 115.057 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -80.02 166.66 21.33 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 114.629 -5.044 . . . . 1.69 110.37 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.5 p -93.82 152.0 19.21 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 121.903 0.858 . . . . 0.75 110.699 -177.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.439 HD13 ' HB3' ' A' ' 50' ' ' LEU . 4.1 mt -59.65 -36.39 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 115.913 1.82 . . . . 0.73 115.913 173.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -44.18 -56.32 4.17 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 126.304 1.842 . . . . 1.62 115.357 162.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -61.54 -39.16 90.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 112.87 -3.443 . . . . 2.13 111.683 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.3 t -63.12 -38.63 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 122.247 2.294 . . . . 0.62 108.05 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -71.45 -26.77 62.87 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.81 2.893 . . . . 1.22 118.81 171.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.98 -24.5 65.15 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.897 -2.377 . . . . 0.51 111.107 168.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -70.23 -37.33 74.97 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.119 -2.238 . . . . 1.44 112.561 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.3 mt -58.55 -35.41 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 128.787 2.835 . . . . 1.32 109.903 167.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -65.24 -42.72 93.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.175 -2.345 . . . . 1.7 113.862 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -63.71 -32.07 73.44 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 126.515 2.384 . . . . 1.55 114.82 165.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -88.41 -65.84 0.98 Allowed 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.115 -2.24 . . . . 2.62 110.224 -167.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -99.42 -24.39 14.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.246 1.818 . . . . 1.48 110.863 -169.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.43 43.67 2.91 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-O 125.298 2.61 . . . . 1.12 111.066 170.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.3 mt -120.74 129.49 25.29 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 120.288 -1.713 . . . . 1.55 106.542 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.4 Cg_exo -71.61 150.69 57.44 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-N 124.82 2.757 . . . . 1.02 109.725 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -72.89 -12.29 26.13 Favored 'Trans proline' 0 C--N 1.298 -2.08 0 C-N-CA 122.511 2.141 . . . . 1.25 116.948 -173.263 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -81.12 -32.08 33.97 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 114.375 -5.203 . . . . 2.25 105.579 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -79.66 6.03 11.72 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 114.445 1.276 . . . . 2.02 114.445 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -149.51 147.42 28.18 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.804 -2.435 . . . . 0.69 114.253 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.277 60.2 mtt180 -129.78 162.12 29.16 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.051 -2.906 . . . . 2.78 108.563 171.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.9 mt -120.32 148.75 43.33 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 119.28 -2.138 . . . . 1.17 109.633 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.7 mt -127.61 129.04 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 124.87 2.271 . . . . 1.38 109.006 -172.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -118.08 125.72 50.86 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 104.785 -2.302 . . . . 1.5 104.785 170.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.268 . . 79.84 -54.26 0.39 Allowed 'General case' 0 N--CA 1.428 -1.535 0 O-C-N 118.446 -2.659 . . . . 1.21 111.876 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.72 -24.32 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.675 0 O-C-N 118.119 -2.863 . . . . 1.3 115.099 -170.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -97.35 141.35 30.55 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.337 -1.684 . . . . 2.55 107.524 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -76.77 120.3 21.73 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.464 3.106 . . . . 2.48 111.649 177.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.439 ' HB3' HD13 ' A' ' 23' ' ' ILE . 43.2 mt -80.85 144.99 31.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.095 -1.628 . . . . 0.9 109.656 -166.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -74.87 121.5 21.95 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.716 2.406 . . . . 1.94 112.117 175.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -65.05 -29.36 70.25 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 113.382 -1.735 . . . . 1.56 112.463 -171.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.16 33.15 4.6 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 120.79 3.076 . . . . 0.97 120.79 168.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.9 mtt-85 -132.67 176.07 8.77 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 101.037 -3.69 . . . . 2.49 101.037 166.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.6 p -108.63 175.33 5.51 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.299 1.439 . . . . 0.76 109.962 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.6 mt -68.3 -23.7 64.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.539 1.681 . . . . 1.05 115.539 173.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 t -65.25 -40.09 93.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.678 2.791 . . . . 1.19 111.486 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -70.62 -21.89 62.59 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.262 1.578 . . . . 1.9 115.262 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -96.39 -3.24 43.99 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.81 -3.056 . . . . 0.89 108.582 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 58.84 40.88 22.3 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 127.575 2.35 . . . . 1.84 112.987 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.9 mt -80.53 127.08 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 1 O-C-N 131.022 5.201 . . . . 0.82 104.949 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -93.71 -174.85 3.58 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 128.079 2.552 . . . . 2.16 111.243 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.7 pttp -72.35 151.27 42.8 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.432 -1.258 . . . . 2.12 111.536 174.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.375 11.7 mt-10 56.65 42.23 27.28 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.443 2.757 . . . . 1.71 118.443 176.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.5 m -100.65 143.53 30.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.593 -2.743 . . . . 1.04 103.593 -175.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -103.04 110.4 22.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 125.183 2.421 . . . . 0.79 108.202 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -96.04 115.33 27.27 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.074 3.35 . . . . 1.4 112.538 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -86.71 121.37 29.12 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.445 -2.035 . . . . 1.51 115.977 -171.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.2 tt -89.39 138.34 31.53 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.355 -2.716 . . . . 1.14 108.764 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -125.45 162.75 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 O-C-N 128.408 3.568 . . . . 1.23 111.702 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.6 mt -100.09 152.51 20.15 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 124.031 1.872 . . . . 2.78 109.45 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.9 ttt-85 -137.1 140.91 42.26 Favored 'General case' 0 N--CA 1.43 -1.473 1 CA-C-O 128.864 4.173 . . . . 3.75 117.382 -177.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 73' ' ' LEU . 31.7 mt -99.35 157.01 16.7 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.654 -3.779 . . . . 3.14 107.215 175.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -77.26 94.77 4.2 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.715 2.806 . . . . 6.8 111.652 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.68 -149.95 19.02 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 107.519 -2.232 . . . . 3.57 107.519 -170.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.782 0 O-C-N 118.43 -2.806 . . . . 3.87 110.654 -177.275 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ptt? . . . . . 0 CA--C 1.489 -1.373 0 CA-C-O 123.198 1.475 . . . . 1.1 109.361 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -118.03 139.42 51.22 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.618 -3.176 . . . . 1.87 108.621 -176.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.1 pt -125.13 144.6 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 CA-C-O 115.826 -2.035 . . . . 0.72 106.251 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -102.31 101.02 11.24 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 126.419 2.324 . . . . 1.4 108.705 -174.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 21.7 t -82.2 110.99 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 116.699 -3.751 . . . . 0.58 106.779 175.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -98.58 136.38 38.76 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 109.247 -0.649 . . . . 2.09 109.247 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 p -90.81 -155.42 0.39 Allowed 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.704 1.602 . . . . 0.99 108.15 175.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.4 mt -103.47 -60.78 1.51 Allowed 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 113.739 -3.029 . . . . 2.53 110.428 175.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 p -51.37 -41.68 60.82 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 133.894 6.996 . . . . 2.08 116.672 -174.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.46 -19.77 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 126.262 3.146 . . . . 1.31 120.398 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -71.67 151.48 43.64 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.169 -2.371 . . . . 1.4 110.805 -174.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.4 m -130.32 110.23 11.36 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.147 1.779 . . . . 0.78 110.635 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.47 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 4.8 mm -85.92 101.75 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 115.539 -2.172 . . . . 1.55 105.752 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.8 m -78.42 89.63 4.41 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 125.489 1.743 . . . . 1.08 111.119 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.8 mt -85.3 124.15 31.6 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.592 -3.193 . . . . 1.55 113.207 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -71.48 114.87 10.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 125.493 1.746 . . . . 1.95 112.431 161.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 m -134.18 165.43 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 120.253 -1.529 . . . . 0.96 108.851 -176.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -104.91 156.41 36.06 Favored Pre-proline 0 N--CA 1.429 -1.488 0 CA-C-O 116.401 -1.762 . . . . 2.35 106.879 167.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -79.5 -11.9 14.13 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 CA-C-N 126.047 3.195 . . . . 0.95 106.22 -170.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.9 p -73.35 -21.8 60.45 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.898 2.555 . . . . 1.45 117.898 173.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -63.54 147.18 52.1 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 125.441 1.713 . . . . 1.69 112.159 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.8 p -83.6 168.74 16.08 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.662 -1.274 . . . . 0.75 110.51 170.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.1 mm -68.77 -30.06 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 128.684 2.794 . . . . 0.73 108.91 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -48.8 -47.78 41.89 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.301 1.84 . . . . 1.62 113.73 166.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -63.87 -41.49 97.75 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.959 2.504 . . . . 2.13 111.516 173.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.9 t -67.75 -45.0 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 1 O-C-N 116.231 -4.043 . . . . 0.62 112.807 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -68.66 -22.32 64.39 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.274 1.511 . . . . 1.22 114.034 175.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.32 83.42 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.35 -3.969 . . . . 0.51 117.356 170.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -64.01 -29.49 70.64 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.285 -2.134 . . . . 1.44 113.991 165.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.456 HD13 HD13 ' A' ' 69' ' ' LEU 0.3 76.7 mt -72.89 -40.08 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 117.042 -3.536 . . . . 1.32 111.108 176.746 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -64.47 -46.86 81.26 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.819 2.048 . . . . 1.7 111.474 173.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.07 -54.38 25.38 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.434 -2.666 . . . . 1.55 116.974 167.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -73.61 -68.58 0.49 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.529 2.048 . . . . 2.62 116.529 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -84.19 -23.23 30.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.362 -1.29 . . . . 1.48 113.557 -167.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.25 24.56 14.21 Favored Glycine 0 N--CA 1.429 -1.769 1 CA-C-O 128.144 4.191 . . . . 1.12 114.301 170.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.7 mt -105.37 133.71 20.03 Favored Pre-proline 0 N--CA 1.429 -1.482 0 O-C-N 116.758 -3.789 . . . . 1.55 106.622 -170.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -65.55 146.6 85.14 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 CA-C-O 114.733 -2.278 . . . . 1.02 115.304 172.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -81.16 -9.49 12.76 Favored 'Trans proline' 0 N--CA 1.433 -2.058 0 CA-C-N 125.928 3.153 . . . . 1.25 108.462 -171.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -71.19 -23.79 62.1 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.482 -2.011 . . . . 2.25 111.344 168.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -92.15 -22.53 19.81 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 120.351 1.432 . . . . 2.02 107.848 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.307 74.5 mt-30 -79.31 152.66 30.37 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 125.324 2.488 . . . . 0.69 110.449 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -125.45 138.29 54.0 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.063 -4.148 . . . . 2.78 108.756 158.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.9 mt -116.47 111.56 20.17 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.424 -3.298 . . . . 1.17 104.405 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.6 mm -98.25 141.73 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 103.824 -2.658 . . . . 1.38 103.824 174.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -115.6 -109.44 0.36 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 114.877 -2.487 . . . . 1.5 109.372 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.99 -32.15 16.04 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 124.418 3.281 . . . . 1.21 112.912 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.81 -41.23 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 127.756 2.598 . . . . 1.3 114.086 -175.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -80.69 136.02 36.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.706 2.669 . . . . 2.55 110.56 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -89.95 95.53 10.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.704 2.802 . . . . 2.48 108.208 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 mt -57.01 140.93 47.49 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.988 -2.32 . . . . 0.9 115.32 -164.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.257 42.4 mt-10 -83.14 150.19 26.41 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.456 -1.402 . . . . 1.94 114.721 173.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -65.71 -52.3 52.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.235 2.309 . . . . 1.56 117.235 -169.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.15 56.97 1.76 Allowed Glycine 0 N--CA 1.43 -1.758 0 CA-C-N 108.533 -3.939 . . . . 0.97 113.6 173.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 54' ' ' ARG . 49.0 mmt-85 -132.45 168.54 18.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 129.162 3.507 . . . . 2.49 105.34 163.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -107.18 164.83 11.83 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.439 -1.71 . . . . 0.76 113.487 173.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.8 mt -66.53 -24.68 66.41 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.504 -1.373 . . . . 1.05 113.609 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.3 t -64.59 -39.79 94.36 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 128.749 2.82 . . . . 1.19 111.063 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -66.55 -31.39 72.08 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.082 -2.886 . . . . 1.9 116.211 173.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -90.5 2.65 55.52 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 115.439 1.644 . . . . 0.89 115.439 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 69.35 27.15 5.12 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 117.452 -1.261 . . . . 1.84 109.872 178.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.4 mt -79.65 128.02 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 126.149 2.88 . . . . 0.82 110.848 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -130.82 171.51 13.06 Favored 'General case' 0 N--CA 1.429 -1.494 1 O-C-N 115.043 -4.786 . . . . 2.16 108.469 -167.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -54.16 130.74 39.43 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.818 2.723 . . . . 2.12 115.641 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 65.94 34.9 6.81 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 130.032 3.333 . . . . 1.71 112.116 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.6 t -90.91 141.48 28.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.965 1.364 . . . . 1.04 112.217 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.0 m -83.99 111.85 19.64 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.989 1.716 . . . . 0.79 114.464 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -108.45 166.44 10.77 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.715 2.006 . . . . 1.4 112.058 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -123.21 132.16 53.94 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.328 -4.608 . . . . 1.51 110.879 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.456 HD13 HD13 ' A' ' 30' ' ' ILE . 22.0 tp -98.89 108.79 21.57 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.65 1.214 . . . . 1.14 108.484 174.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.5 t -105.88 143.12 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 128.926 2.891 . . . . 1.23 108.015 -178.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.8 mt -123.14 147.37 46.87 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 125.986 3.993 . . . . 2.78 108.848 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.7 mtp180 -95.74 -169.15 1.89 Allowed 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 126.689 3.138 . . . . 3.75 103.8 173.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.2 mt -106.13 -56.09 2.23 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 111.315 -2.675 . . . . 3.14 110.57 168.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.61 172.38 13.1 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 114.153 -2.832 . . . . 6.8 108.02 171.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.86 -169.3 42.54 Favored Glycine 0 N--CA 1.43 -1.747 0 CA-C-N 121.376 1.898 . . . . 3.57 113.318 -171.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.808 0 CA-C-O 115.495 -2.836 . . . . 3.87 107.219 -177.681 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ptt? . . . . . 0 CA--C 1.491 -1.314 0 CA-C-O 122.655 1.217 . . . . 1.1 112.804 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -96.0 139.97 31.42 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 107.45 -1.315 . . . . 1.87 107.45 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.256 16.3 pt -132.08 169.49 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 107.312 -1.366 . . . . 0.72 107.312 172.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -134.07 142.61 47.62 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.132 0.967 . . . . 1.4 113.02 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.57 134.13 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 O-C-N 118.837 -2.415 . . . . 0.58 110.416 168.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -96.79 149.11 22.21 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 117.419 -1.276 . . . . 2.09 109.63 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.321 4.8 p -103.85 -166.35 1.25 Allowed 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.501 2.375 . . . . 0.99 114.928 176.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.2 tp -76.18 -57.93 3.58 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 114.839 1.422 . . . . 2.53 114.839 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.2 p -70.5 -32.8 70.43 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 116.871 2.175 . . . . 2.08 116.871 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.07 58.32 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 118.757 -1.687 . . . . 1.31 115.597 172.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -118.18 138.2 52.47 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 121.109 2.455 . . . . 1.4 107.775 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.5 m -100.6 117.33 34.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 104.889 -2.263 . . . . 0.78 104.889 174.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.6 mt -96.47 116.54 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 106.219 -1.771 . . . . 1.55 106.219 174.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.406 3.6 m -83.08 121.53 27.16 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 126.039 1.736 . . . . 1.08 113.551 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.679 HD22 ' HB3' ' A' ' 29' ' ' LYS . 83.5 mt -123.03 143.16 50.13 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.635 -1.915 . . . . 1.55 112.201 -175.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -104.07 141.99 35.25 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 104.49 -2.411 . . . . 1.95 104.49 170.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.3 m -161.07 161.9 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 106.966 -1.494 . . . . 0.96 106.966 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 20' ' ' SER . 13.2 pt-20 -105.52 162.44 19.71 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-O 115.828 -2.034 . . . . 2.35 106.868 157.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.414 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 97.5 Cg_endo -74.33 -1.79 11.47 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 CA-C-N 124.592 2.676 . . . . 0.95 113.714 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.456 ' H ' ' HG3' ' A' ' 18' ' ' GLU . 67.1 m -90.72 -2.51 57.81 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 115.359 1.615 . . . . 1.45 115.359 171.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -66.73 131.07 45.18 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.146 2.403 . . . . 1.69 107.121 168.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 17.6 p -68.47 175.16 3.56 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 112.954 -1.93 . . . . 0.75 112.205 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.5 mm -74.66 -35.48 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 116.528 -3.858 . . . . 0.73 108.018 176.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -54.3 -46.66 72.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.213 -3.43 . . . . 1.62 115.351 165.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -56.86 -37.16 70.93 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 125.577 2.608 . . . . 2.13 112.79 171.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.56 -39.8 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 116.463 -3.898 . . . . 0.62 114.34 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -65.88 -33.3 75.52 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 117.621 2.452 . . . . 1.22 117.621 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.68 -23.75 61.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 111.598 -2.546 . . . . 0.51 110.691 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.679 ' HB3' HD22 ' A' ' 15' ' ' LEU . 42.2 mttm -75.72 -29.64 59.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 122.579 2.445 . . . . 1.44 113.564 168.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.6 mt -66.44 -42.29 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.908 -1.745 . . . . 1.32 110.195 171.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -58.54 -38.36 77.61 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.314 -3.366 . . . . 1.7 118.216 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -59.96 -32.83 71.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.989 2.218 . . . . 1.55 116.989 172.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.327 53.8 mmtt -89.15 -48.74 7.19 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.924 -3.61 . . . . 2.62 110.009 -174.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -112.39 -19.16 12.27 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 123.096 1.426 . . . . 1.48 114.164 -165.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.33 9.42 79.55 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 118.984 -2.323 . . . . 1.12 113.907 167.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.5 mt -81.58 133.26 53.04 Favored Pre-proline 0 N--CA 1.43 -1.457 0 O-C-N 120.951 -1.323 . . . . 1.55 112.237 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -69.17 148.78 69.63 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 CA-C-N 122.517 1.935 . . . . 1.02 113.681 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -71.14 -25.03 22.87 Favored 'Trans proline' 0 C--N 1.301 -1.953 1 C-N-CA 125.893 4.395 . . . . 1.25 115.211 -170.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -70.65 -27.13 63.81 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 128.348 2.659 . . . . 2.25 113.881 175.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -91.77 -1.94 57.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.432 2.293 . . . . 2.02 110.472 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -100.86 135.19 42.69 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.658 -1.901 . . . . 0.69 109.813 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 62.4 mtm180 -117.87 114.28 23.0 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.585 2.448 . . . . 2.78 110.191 173.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.516 ' HB3' HD12 ' A' ' 50' ' ' LEU . 76.6 mt -100.32 129.17 46.28 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 120.762 1.619 . . . . 1.17 110.515 -176.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.8 mm -110.77 128.17 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 125.638 1.575 . . . . 1.38 108.639 177.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -109.12 102.72 11.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.145 1.45 . . . . 1.5 107.155 170.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.312 . . 65.41 -63.62 0.2 Allowed 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.064 -2.897 . . . . 1.21 118.084 -173.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.429 ' H ' ' H ' ' A' ' 48' ' ' LYS . . . -162.6 -5.85 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.709 0 O-C-N 118.194 -2.816 . . . . 1.3 111.914 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.429 ' H ' ' H ' ' A' ' 47' ' ' GLY . 37.7 mtmt -95.38 143.08 27.03 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 125.843 1.555 . . . . 2.55 107.609 173.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -93.59 143.55 26.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.944 2.783 . . . . 2.48 111.37 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 43' ' ' LEU . 88.0 mt -94.76 132.05 39.94 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 113.857 -5.527 . . . . 0.9 108.217 -167.27 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -83.81 139.24 32.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.395 1.478 . . . . 1.94 109.292 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.287 8.5 m-20 -62.95 -50.11 72.09 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.499 -3.251 . . . . 1.56 119.701 -171.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.23 9.44 63.92 Favored Glycine 0 N--CA 1.43 -1.704 1 N-CA-C 123.183 4.033 . . . . 0.97 123.183 174.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -78.39 161.23 27.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 113.621 0.971 . . . . 2.49 113.621 168.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 81.1 p -89.39 164.9 14.67 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 118.955 2.946 . . . . 0.76 118.955 164.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 89.5 mt -64.32 -36.56 84.51 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.599 -3.188 . . . . 1.05 116.86 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.2 p -58.41 -29.0 65.74 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 128.1 2.56 . . . . 1.19 113.362 166.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -59.6 -47.5 85.35 Favored 'General case' 0 N--CA 1.43 -1.431 1 CA-C-N 127.312 4.596 . . . . 1.9 110.892 173.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -83.36 0.98 43.56 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.123 3.369 . . . . 0.89 114.056 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.3 m120 58.32 45.85 16.4 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.996 2.221 . . . . 1.84 116.996 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.4 mt -87.76 118.04 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 104.765 -2.309 . . . . 0.82 104.765 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -85.23 -163.21 0.81 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.737 -2.477 . . . . 2.16 109.029 -174.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 pttt -74.43 147.02 42.39 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.085 -2.259 . . . . 2.12 110.217 174.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 62.73 48.74 4.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.172 0.986 . . . . 1.71 109.622 170.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.1 m -108.59 141.29 40.73 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.853 -1.779 . . . . 1.04 110.203 -169.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.8 m -103.81 108.68 20.1 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 125.568 2.604 . . . . 0.79 108.656 -172.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mp -96.52 163.88 12.85 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 112.425 -2.17 . . . . 1.4 107.875 171.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -118.05 140.28 49.98 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.197 1.799 . . . . 1.51 111.937 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.7 tp -108.97 120.59 42.99 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.399 -3.313 . . . . 1.14 109.667 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.4 t -116.93 150.31 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 105.418 -2.067 . . . . 1.23 105.418 174.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.6 155.88 17.82 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.09 -3.506 . . . . 2.78 113.211 -177.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -136.81 127.97 27.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 116.903 -1.523 . . . . 3.75 112.031 -177.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 tp -98.64 -65.2 0.98 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.75 2.02 . . . . 3.14 111.314 169.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -146.63 -104.22 0.1 Allowed 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.521 1.153 . . . . 6.8 111.811 170.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.58 64.41 1.55 Allowed Glycine 0 N--CA 1.429 -1.797 0 O-C-N 118.394 -2.691 . . . . 3.57 116.942 -167.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.727 0 N-CA-C 106.825 -2.51 . . . . 3.87 106.825 176.678 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 ttp . . . . . 0 CA--C 1.49 -1.33 0 N-CA-C 116.563 2.061 . . . . 1.1 116.563 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -92.84 123.74 36.33 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.233 -2.792 . . . . 1.87 108.46 -170.74 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.335 50.4 pt -116.22 137.66 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.495 1.918 . . . . 0.72 112.73 176.771 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -104.83 100.05 9.69 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 116.58 2.067 . . . . 1.4 116.58 -176.371 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.3 t -84.53 96.9 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 124.537 2.113 . . . . 0.58 111.89 178.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -95.74 122.75 38.85 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.48 1.61 . . . . 2.09 109.423 -174.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 69' ' ' LEU 0.29 20.2 p -89.99 167.27 12.92 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.787 2.035 . . . . 0.99 114.19 -176.475 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.8 tp -66.24 -32.19 73.46 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 126.009 2.814 . . . . 2.53 115.455 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.6 p -77.44 -48.24 17.67 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.428 1.891 . . . . 2.08 111.854 -178.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.3 -1.21 0.53 Allowed Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 117.174 1.63 . . . . 1.31 117.174 173.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -78.11 139.66 39.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 119.372 1.586 . . . . 1.4 109.133 -177.196 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -104.17 112.09 24.95 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.644 -2.535 . . . . 0.78 105.435 169.179 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -93.06 105.51 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 103.413 -2.81 . . . . 1.55 103.413 178.141 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -84.74 107.08 16.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.006 2.224 . . . . 1.08 117.006 177.081 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.2 mt -105.27 136.72 44.27 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 121.122 1.783 . . . . 1.55 107.518 -175.076 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -87.99 90.9 8.57 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 124.154 1.931 . . . . 1.95 108.625 168.039 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.21 176.27 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 128.571 2.749 . . . . 0.96 109.11 -176.12 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -117.88 151.37 48.68 Favored Pre-proline 0 N--CA 1.431 -1.413 0 O-C-N 124.917 1.386 . . . . 2.35 108.638 161.331 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -74.26 -11.96 23.06 Favored 'Trans proline' 0 N--CA 1.434 -2.004 1 O-C-N 112.794 -4.371 . . . . 0.95 115.208 -170.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.4 p -81.98 -15.35 54.04 Favored 'General case' 0 N--CA 1.429 -1.476 1 C-N-CA 132.297 4.239 . . . . 1.45 110.315 174.682 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -68.62 153.38 43.88 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 120.756 1.616 . . . . 1.69 110.942 172.559 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 25.2 p -87.6 166.87 14.4 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.353 1.861 . . . . 0.75 108.93 -179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.2 mm -71.61 -36.0 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 124.455 2.074 . . . . 0.73 113.188 175.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -38.82 -42.97 0.88 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.853 -3.03 . . . . 1.62 117.047 159.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -76.94 -38.18 53.86 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.226 -2.796 . . . . 2.13 108.489 179.038 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.462 HG21 HD21 ' A' ' 56' ' ' LEU . 76.9 t -55.89 -39.09 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 127.354 2.261 . . . . 0.62 114.269 172.355 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 86.3 mttt -81.05 -19.34 44.0 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.612 -2.555 . . . . 1.22 115.88 173.752 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.07 -38.59 63.88 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 122.819 1.295 . . . . 0.51 109.486 174.31 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -63.24 -29.29 70.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.633 -2.542 . . . . 1.44 113.864 174.572 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.3 mt -77.88 -24.34 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 116.661 2.097 . . . . 1.32 116.661 169.156 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -76.42 -30.48 57.46 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.27 -3.394 . . . . 1.7 110.025 173.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -76.5 -43.33 40.02 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.805 1.288 . . . . 1.55 112.129 173.527 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -77.4 -69.36 0.54 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.347 -2.096 . . . . 2.62 114.506 -173.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -80.46 -51.17 9.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.677 -1.147 . . . . 1.48 113.153 -172.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.09 43.03 1.13 Allowed Glycine 0 N--CA 1.429 -1.796 0 O-C-N 125.508 1.755 . . . . 1.12 111.232 175.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.3 mt -104.3 132.99 20.45 Favored Pre-proline 0 N--CA 1.431 -1.386 0 C-N-CA 125.557 1.543 . . . . 1.55 107.377 -178.16 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -70.85 138.96 35.42 Favored 'Trans proline' 0 N--CA 1.433 -2.067 1 C-N-CA 126.054 4.502 . . . . 1.02 111.54 -178.553 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.431 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 36.3 Cg_exo -71.52 -19.47 28.33 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 O-C-N 117.924 -1.671 . . . . 1.25 112.434 -169.566 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -62.4 -35.02 77.9 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 114.83 1.418 . . . . 2.25 114.83 165.177 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -87.57 -13.93 41.55 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 124.037 0.935 . . . . 2.02 112.628 -179.173 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.329 71.3 mt-30 -84.78 113.01 21.02 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 120.957 1.708 . . . . 0.69 107.701 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -92.34 134.5 34.86 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 116.676 -1.63 . . . . 2.78 106.712 165.518 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.8 mt -127.79 125.42 39.81 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 102.629 -3.1 . . . . 1.17 102.629 177.138 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -115.13 137.3 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 115.947 -1.978 . . . . 1.38 105.788 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -124.06 107.4 11.25 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.227 2.285 . . . . 1.5 107.628 171.172 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.363 . . 74.55 -77.07 0.06 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.517 2.58 . . . . 1.21 114.922 -173.414 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.3 -0.67 0.24 Allowed Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 129.917 3.627 . . . . 1.3 115.42 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -111.56 114.01 26.8 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 124.663 1.185 . . . . 2.55 110.565 -179.556 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -81.13 127.94 33.19 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 124.56 1.144 . . . . 2.48 111.885 176.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.44 HD22 ' CD2' ' A' ' 59' ' ' TYR . 69.7 mt -79.82 120.36 23.97 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 120.338 3.458 . . . . 0.9 120.338 -162.569 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.288 37.1 mt-10 -78.22 138.63 38.74 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.216 -2.177 . . . . 1.94 113.758 -176.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.66 -45.33 92.36 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 112.616 -2.084 . . . . 1.56 113.072 -171.477 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.59 25.14 9.88 Favored Glycine 0 N--CA 1.43 -1.713 0 C-N-CA 125.763 1.649 . . . . 0.97 116.601 175.431 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -112.7 166.36 11.43 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.99 1.852 . . . . 2.49 110.309 165.362 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 12.2 p -101.28 169.17 9.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.134 -2.854 . . . . 0.76 106.424 176.369 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.462 HD21 HG21 ' A' ' 26' ' ' VAL . 62.6 mt -65.95 -38.19 87.96 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.576 2.608 . . . . 1.05 112.304 172.185 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.0 p -60.34 -41.1 92.89 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.923 -4.236 . . . . 1.19 116.067 -178.134 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -53.47 -49.7 66.88 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 117.715 2.487 . . . . 1.9 117.715 169.004 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.44 ' CD2' HD22 ' A' ' 50' ' ' LEU . 59.9 m-85 -67.26 -10.41 50.44 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.659 2.466 . . . . 0.89 117.659 173.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.309 64.8 t30 73.93 47.62 0.15 Allowed 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.573 -2.58 . . . . 1.84 105.167 -177.402 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.6 mt -100.59 119.82 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 102.829 -3.026 . . . . 0.82 102.829 177.261 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -115.09 -167.8 1.29 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 114.219 -1.355 . . . . 2.16 112.274 -176.175 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -60.27 138.86 57.87 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.611 2.448 . . . . 2.12 117.611 169.164 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.432 20.8 mt-10 69.19 22.97 6.54 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.007 2.225 . . . . 1.71 117.007 174.299 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.4 m -83.16 141.06 32.22 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.209 2.604 . . . . 1.04 113.913 -175.575 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.4 m -94.65 116.1 28.34 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.3 -3.375 . . . . 0.79 107.464 -174.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -109.68 128.38 55.22 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 104.87 -2.27 . . . . 1.4 104.87 174.42 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -88.8 121.53 31.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 114.531 -2.652 . . . . 1.51 115.085 -177.403 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.412 ' HB3' HG22 ' A' ' 7' ' ' THR . 9.8 tp -89.14 120.27 30.38 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 123.827 3.012 . . . . 1.14 114.376 175.685 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.45 169.23 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 120.651 -1.281 . . . . 1.23 107.852 172.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.3 mt -112.05 159.36 18.54 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.89 -3.007 . . . . 2.78 107.528 177.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -128.9 156.22 44.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.344 -0.844 . . . . 3.75 109.212 175.527 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.9 mt -86.17 -107.65 0.06 Allowed 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.395 -1.44 . . . . 3.14 108.337 170.305 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -78.97 -55.63 4.99 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 128.046 3.784 . . . . 6.8 110.189 172.675 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.8 142.67 9.94 Favored Glycine 0 N--CA 1.429 -1.802 1 O-C-N 116.285 -4.009 . . . . 3.57 106.71 -168.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.805 0 N-CA-C 106.585 -2.606 . . . . 3.87 106.585 176.075 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.316 0 N-CA-C 114.325 1.231 . . . . 1.1 114.325 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.267 0.7 OUTLIER -97.39 131.96 43.56 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.023 1.49 . . . . 1.87 115.023 -175.607 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -112.5 145.14 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 117.896 -3.002 . . . . 0.72 110.131 172.114 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -109.87 112.83 25.1 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 103.984 -2.599 . . . . 1.4 103.984 -173.832 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.52 103.1 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 104.071 -2.566 . . . . 0.58 104.071 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -102.76 131.11 49.83 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 112.58 0.585 . . . . 2.09 112.58 -179.681 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.4 p -93.16 176.81 6.27 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 128.155 3.409 . . . . 0.99 119.39 -177.157 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.3 tp -67.03 -37.57 84.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 124.92 3.509 . . . . 2.53 112.047 170.206 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.8 p -78.87 6.63 8.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 129.926 3.29 . . . . 2.08 111.313 -171.697 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.68 5.25 57.76 Favored Glycine 0 N--CA 1.43 -1.716 0 CA-C-N 125.001 3.546 . . . . 1.31 113.671 169.366 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -93.99 133.66 37.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.317 2.247 . . . . 1.4 115.719 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.5 m -108.39 117.18 33.48 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.277 -1.009 . . . . 0.78 108.277 171.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 mt -105.02 113.7 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 101.238 -3.615 . . . . 1.55 101.238 -179.569 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.4 m -101.19 117.33 34.79 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 120.819 1.645 . . . . 1.08 107.426 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.7 mt -102.06 151.38 22.23 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.985 3.314 . . . . 1.55 114.677 178.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -105.48 104.72 14.5 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 121.636 3.939 . . . . 1.95 121.636 168.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.432 HG12 ' HE2' ' A' ' 29' ' ' LYS . 14.3 m -119.91 168.36 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 112.452 -2.158 . . . . 0.96 109.528 -177.528 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -105.44 159.88 27.96 Favored Pre-proline 0 N--CA 1.431 -1.409 0 C-N-CA 125.713 1.605 . . . . 2.35 108.772 164.568 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.89 -18.44 16.88 Favored 'Trans proline' 0 N--CA 1.435 -1.967 0 O-C-N 115.767 -2.807 . . . . 0.95 113.537 -170.453 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.4 m -86.67 2.72 47.51 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.438 -2.039 . . . . 1.45 115.989 174.482 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -79.27 148.13 32.27 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 127.463 2.305 . . . . 1.69 109.766 172.124 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.5 p -76.99 161.04 28.67 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 127.147 2.179 . . . . 0.75 116.197 175.306 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.8 mm -71.56 -31.36 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 125.738 1.615 . . . . 0.73 111.944 173.546 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -50.87 -46.65 60.44 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.142 2.401 . . . . 1.62 114.562 162.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.282 6.3 t-20 -63.4 -45.13 92.45 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 116.226 -4.046 . . . . 2.13 114.949 176.755 . . . . . . . . 3 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -48.11 -38.81 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 127.893 2.477 . . . . 0.62 115.816 168.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -66.82 -34.58 78.13 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.392 -2.692 . . . . 1.22 113.603 173.252 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.0 -32.43 61.65 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.583 -2.573 . . . . 0.51 112.345 176.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HE2' HG12 ' A' ' 17' ' ' VAL . 38.4 mttp -58.5 -38.73 78.26 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 120.688 1.585 . . . . 1.44 115.199 165.671 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.7 mt -71.55 -37.34 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 130.766 3.626 . . . . 1.32 111.902 177.774 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -59.81 -47.43 85.73 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 129.027 2.931 . . . . 1.7 109.364 169.516 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.4 -54.9 41.41 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.613 2.625 . . . . 1.55 115.127 171.73 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -72.49 -67.51 0.55 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.712 -3.118 . . . . 2.62 112.696 -175.564 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -77.53 -55.37 5.43 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 120.035 -1.666 . . . . 1.48 114.639 -174.307 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.94 25.98 0.65 Allowed Glycine 0 N--CA 1.43 -1.716 0 O-C-N 118.136 -2.853 . . . . 1.12 110.326 174.608 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.0 mt -99.95 140.09 21.26 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-N 123.344 3.572 . . . . 1.55 105.365 -167.666 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 12.8 Cg_exo -66.85 159.04 53.47 Favored 'Trans proline' 0 N--CA 1.433 -2.066 0 CA-C-N 125.128 2.867 . . . . 1.02 111.053 176.131 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 73.7 Cg_exo -78.23 -3.52 13.49 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 CA-C-N 122.635 1.977 . . . . 1.25 111.907 -175.464 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.271 96.0 m-20 -88.22 -29.65 20.3 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 125.813 2.72 . . . . 2.25 112.727 174.827 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -84.51 16.04 3.38 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 116.351 1.982 . . . . 2.02 116.351 -179.079 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -126.08 129.72 49.69 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.93 1.292 . . . . 0.69 109.78 -176.752 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -118.7 134.78 54.88 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.443 2.697 . . . . 2.78 108.973 167.102 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.5 mt -120.01 123.98 44.78 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 113.715 -1.584 . . . . 1.17 114.303 178.363 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 23.7 mm -99.9 145.59 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 101.397 -3.557 . . . . 1.38 101.397 175.647 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.438 ' HB3' HD21 ' A' ' 50' ' ' LEU . 27.3 t80 -139.16 123.82 18.49 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 101.404 -3.554 . . . . 1.5 101.404 168.153 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.07 -68.59 0.21 Allowed 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 127.487 2.992 . . . . 1.21 112.402 -172.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.25 -32.03 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 114.412 -1.267 . . . . 1.3 115.117 -179.112 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.276 12.4 ptpt -74.93 151.15 38.9 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.174 1.175 . . . . 2.55 114.174 177.443 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -87.16 105.34 17.13 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 131.066 3.746 . . . . 2.48 113.326 174.582 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.452 HD22 ' CD2' ' A' ' 59' ' ' TYR . 61.9 mt -66.77 158.37 30.51 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.074 -2.266 . . . . 0.9 109.536 -161.285 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -91.27 156.18 18.0 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 124.855 2.264 . . . . 1.94 108.862 170.163 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -74.53 -66.37 0.75 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.504 -1.997 . . . . 1.56 114.186 -178.182 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.46 50.21 1.69 Allowed Glycine 0 N--CA 1.43 -1.761 0 O-C-N 118.057 -2.902 . . . . 0.97 115.177 168.245 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -122.7 160.38 25.99 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.346 -1.679 . . . . 2.49 106.962 159.464 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.2 p -85.68 169.17 13.72 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.675 -1.891 . . . . 0.76 113.325 176.132 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.1 mt -66.05 -33.12 75.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.844 2.458 . . . . 1.05 115.185 171.037 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.7 p -70.25 -32.91 70.96 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.408 -2.682 . . . . 1.19 114.784 176.092 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -67.59 -27.46 66.94 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.721 1.608 . . . . 1.9 115.252 177.021 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' CD2' HD22 ' A' ' 50' ' ' LEU . 59.8 m-85 -89.15 -14.8 35.33 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.074 2.25 . . . . 0.89 117.074 170.045 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.3 22.1 m120 75.77 45.68 0.12 Allowed 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.016 2.969 . . . . 1.84 119.016 -174.661 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.442 HG23 ' HB2' ' A' ' 65' ' ' SER . 16.1 mt -91.32 107.9 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 129.833 3.253 . . . . 0.82 107.576 172.653 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -99.73 -165.11 1.19 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.53 1.932 . . . . 2.16 108.359 179.279 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -56.7 144.41 32.58 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.35 -2.719 . . . . 2.12 114.887 170.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 68.46 17.98 9.04 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.269 2.462 . . . . 1.71 114.97 171.436 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.442 ' HB2' HG23 ' A' ' 61' ' ' ILE . 69.7 m -80.89 131.43 35.36 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 125.675 2.655 . . . . 1.04 110.938 -169.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.0 m -80.61 110.38 16.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.758 -1.565 . . . . 0.79 115.109 176.276 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.46 155.17 17.98 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.476 2.71 . . . . 1.4 106.148 172.489 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.505 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 60.8 m80 -119.14 109.63 16.11 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.44 -2.037 . . . . 1.51 112.722 -170.614 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.1 tp -93.48 112.3 24.17 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 125.125 1.516 . . . . 1.14 112.338 -172.7 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.68 125.5 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 127.921 2.488 . . . . 1.23 110.266 179.572 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.8 tp -88.54 138.58 31.3 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.679 -3.138 . . . . 2.78 106.623 -175.133 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -106.24 102.4 11.81 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.28 -3.388 . . . . 3.75 105.974 -179.66 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.9 mt -80.52 153.46 28.12 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.614 -2.554 . . . . 3.14 114.21 171.409 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.78 108.57 18.77 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.478 -2.639 . . . . 6.8 107.296 168.676 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.93 41.82 0.03 OUTLIER Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 116.734 -2.651 . . . . 3.57 108.957 -171.209 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.734 0 N-CA-C 108.258 -1.937 . . . . 3.87 108.258 -178.017 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptt? . . . . . 0 CA--C 1.489 -1.398 0 CA-C-O 126.429 3.014 . . . . 1.1 113.551 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -89.03 125.4 34.99 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.444 -1.707 . . . . 1.87 110.888 -174.506 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 pt -121.05 146.61 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 104.773 -2.306 . . . . 0.72 104.773 166.33 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -97.17 134.69 40.16 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 131.618 3.967 . . . . 1.4 103.677 -179.472 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.5 t -130.4 106.18 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 124.488 2.09 . . . . 0.58 106.947 172.36 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -96.65 142.93 28.1 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.185 1.469 . . . . 2.09 112.914 -176.421 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.1 p -82.02 179.32 7.86 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 118.339 -2.725 . . . . 0.99 114.345 175.726 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.7 tp -81.08 -30.73 34.65 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.661 2.384 . . . . 2.53 107.12 175.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -75.01 -44.91 45.39 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.614 -3.804 . . . . 2.08 112.36 -170.354 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.98 -3.59 0.16 Allowed Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 117.577 -2.249 . . . . 1.31 114.732 173.038 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -110.99 138.89 46.84 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 114.574 1.324 . . . . 1.4 114.574 -172.245 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -102.21 128.86 48.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 115.138 -2.363 . . . . 0.78 112.936 177.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.294 30.6 pt -107.14 145.8 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 106.773 -1.566 . . . . 1.55 106.773 176.557 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.9 m -97.51 134.4 40.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 111.802 -2.454 . . . . 1.08 112.639 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.64 142.43 50.66 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.701 1.715 . . . . 1.55 109.728 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -108.75 122.79 47.89 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 116.479 -3.888 . . . . 1.95 109.012 169.015 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.6 m -136.29 154.54 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 125.38 1.472 . . . . 0.96 107.887 -171.135 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -95.26 152.63 39.52 Favored Pre-proline 0 N--CA 1.43 -1.437 0 C-N-CA 130.896 3.679 . . . . 2.35 108.397 160.117 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -76.27 -7.28 17.9 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 C-N-CA 123.769 2.979 . . . . 0.95 111.322 -174.673 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.5 m -94.91 0.51 54.8 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.125 1.77 . . . . 1.45 111.524 175.773 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.53 142.65 38.94 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.178 -2.826 . . . . 1.69 108.794 174.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 p -84.58 173.29 10.9 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 124.498 1.119 . . . . 0.75 113.393 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.2 mm -65.29 -36.41 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 118.766 -2.459 . . . . 0.73 112.682 170.753 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.307 3.1 mp0 -54.11 -48.49 70.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.874 -2.391 . . . . 1.62 116.084 165.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -63.24 -36.13 82.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 112.628 0.603 . . . . 2.13 112.628 175.19 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.9 t -62.11 -52.13 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 126.681 1.992 . . . . 0.62 111.932 175.404 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -57.71 -40.39 79.44 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.848 1.259 . . . . 1.22 111.82 176.693 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.312 . . -50.9 -38.93 52.87 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 120.458 3.503 . . . . 0.51 120.458 167.701 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -74.65 -24.1 58.77 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.424 -2.048 . . . . 1.44 115.277 177.034 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.9 mt -78.51 -35.65 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 129.313 3.045 . . . . 1.32 106.012 177.034 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -75.98 -36.56 59.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.823 -1.798 . . . . 1.7 111.972 -179.395 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -55.56 -48.04 75.41 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 128.55 2.74 . . . . 1.55 108.625 174.576 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -87.66 -59.49 2.23 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.125 -2.234 . . . . 2.62 114.478 -177.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -86.55 -25.4 25.06 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 115.11 1.522 . . . . 1.48 115.11 -172.043 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.14 26.55 33.63 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 119.441 -1.361 . . . . 1.12 113.156 175.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.7 mt -96.05 115.67 65.72 Favored Pre-proline 0 N--CA 1.43 -1.454 1 CA-C-O 111.631 -4.033 . . . . 1.55 110.103 -177.179 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.29 164.81 34.47 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 CA-C-N 126.975 3.527 . . . . 1.02 115.142 -177.8 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -65.37 -34.27 44.63 Favored 'Trans proline' 0 N--CA 1.434 -1.982 0 CA-C-O 115.833 -1.82 . . . . 1.25 116.717 -165.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -45.46 -38.74 6.44 Favored 'General case' 0 N--CA 1.43 -1.461 1 C-N-CA 132.382 4.273 . . . . 2.25 116.171 170.701 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -96.94 2.27 51.4 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.608 2.363 . . . . 2.02 113.856 -176.466 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -88.1 99.61 12.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 116.751 -3.718 . . . . 0.69 107.811 -173.065 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -90.66 112.02 23.59 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 118.384 -2.697 . . . . 2.78 109.88 163.247 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.8 mt -105.3 129.84 53.56 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.154 1.781 . . . . 1.17 109.805 175.087 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 3.4 mp -123.9 129.27 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 127.571 2.348 . . . . 1.38 109.136 177.201 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.46 ' HB3' HD21 ' A' ' 50' ' ' LEU . 73.1 t80 -123.14 114.29 20.12 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 104.438 -2.43 . . . . 1.5 104.438 171.478 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.37 -110.48 0.54 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 110.224 -3.171 . . . . 1.21 112.545 -170.918 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.13 4.27 35.59 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 126.492 1.996 . . . . 1.3 114.204 177.452 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -105.76 129.1 54.03 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.91 1.684 . . . . 2.55 114.739 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -82.5 126.6 32.43 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 126.558 1.943 . . . . 2.48 109.129 170.857 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.46 HD21 ' HB3' ' A' ' 45' ' ' PHE . 18.3 mt -79.5 128.89 33.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.501 1.92 . . . . 0.9 109.756 -173.811 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -112.68 179.13 4.06 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.207 2.432 . . . . 1.94 110.874 178.261 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -79.77 151.87 30.12 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 117.197 -1.801 . . . . 1.56 112.763 -171.774 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.71 -0.57 81.47 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 119.524 -1.985 . . . . 0.97 116.914 170.568 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -87.54 159.42 18.62 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 125.575 1.397 . . . . 2.49 110.505 169.501 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.266 70.4 p -100.08 167.52 10.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.937 2.303 . . . . 0.76 112.397 173.357 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.21 -29.75 70.85 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 117.086 -3.509 . . . . 1.05 112.221 164.484 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 t -68.8 -30.95 69.63 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.156 -1.59 . . . . 1.19 112.111 178.663 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -62.84 -50.34 71.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 114.904 1.446 . . . . 1.9 114.904 172.351 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -81.87 11.9 4.55 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 115.927 -1.987 . . . . 0.89 111.788 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 m120 56.96 46.08 20.1 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 125.559 2.6 . . . . 1.84 115.04 178.582 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.3 mt -91.82 122.61 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 112.354 -2.203 . . . . 0.82 110.154 178.808 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -108.58 173.53 6.28 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 127.176 2.797 . . . . 2.16 109.477 -173.929 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -59.53 142.7 52.06 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.482 1.66 . . . . 2.12 115.482 173.822 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 5.7 tt0 75.71 15.2 2.64 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 126.271 2.939 . . . . 1.71 116.32 174.07 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 m -77.35 139.97 39.86 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 113.605 -1.634 . . . . 1.04 108.048 -175.693 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -109.51 90.94 3.45 Favored 'General case' 0 N--CA 1.429 -1.497 1 O-C-N 116.016 -4.177 . . . . 0.79 114.772 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -65.45 153.13 42.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.904 2.288 . . . . 1.4 112.82 173.652 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.415 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 18.5 m80 -105.53 101.51 11.03 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 115.815 -4.303 . . . . 1.51 109.326 -178.864 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.0 tp -91.89 108.74 20.14 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 121.018 1.736 . . . . 1.14 110.116 173.563 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -98.69 129.98 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 1 C-N-CA 134.069 4.947 . . . . 1.23 106.804 173.479 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.4 tp -102.42 116.71 33.19 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 111.911 -2.404 . . . . 2.78 112.861 174.179 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.86 159.33 15.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.772 2.138 . . . . 3.75 116.772 176.56 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.9 mt -81.17 -100.22 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.443 2.544 . . . . 3.14 110.776 171.807 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -87.17 168.19 13.46 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 115.858 -4.276 . . . . 6.8 111.061 172.77 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.07 166.76 38.08 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 106.43 -2.668 . . . . 3.57 106.43 -168.658 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.744 1 CA-C-O 113.232 -4.094 . . . . 3.87 106.312 178.721 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptt? . . . . . 0 CA--C 1.49 -1.34 0 N-CA-C 113.533 0.938 . . . . 1.1 113.533 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -105.38 124.33 49.37 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.371 3.068 . . . . 1.87 112.688 -175.695 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.1 pt -123.8 155.36 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 C-N-CA 129.349 3.06 . . . . 0.72 110.645 175.166 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -114.42 132.8 56.12 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 112.305 -2.225 . . . . 1.4 112.007 -171.071 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.86 97.22 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 103.192 -2.892 . . . . 0.58 103.192 178.756 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -90.62 141.09 29.14 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.529 -1.982 . . . . 2.09 112.403 174.552 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.7 p -107.31 165.39 11.42 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 120.126 1.33 . . . . 0.99 110.406 176.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.3 tp -52.7 -36.18 56.84 Favored 'General case' 0 N--CA 1.43 -1.435 1 C-N-CA 134.79 5.236 . . . . 2.53 116.974 177.65 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.4 p -90.08 -19.81 23.91 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.789 -3.07 . . . . 2.08 111.195 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.56 12.38 2.5 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 118.878 -2.389 . . . . 1.31 114.592 169.945 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -94.21 135.4 35.64 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 119.809 1.805 . . . . 1.4 110.433 -176.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.1 m -115.41 108.7 16.85 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.625 -4.422 . . . . 0.78 108.506 178.45 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -81.48 124.01 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.455 2.302 . . . . 1.55 108.594 175.076 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.6 m -101.32 98.27 8.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.435 -2.666 . . . . 1.08 108.518 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 mt -100.07 139.91 35.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 127.821 3.676 . . . . 1.55 108.829 179.108 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -96.35 132.1 42.19 Favored 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 114.532 -5.105 . . . . 1.95 107.882 172.494 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.82 168.33 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 126.886 2.074 . . . . 0.96 109.763 179.007 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -105.43 160.61 25.44 Favored Pre-proline 0 N--CA 1.429 -1.477 0 O-C-N 119.457 -2.027 . . . . 2.35 105.927 165.694 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -79.59 -16.6 11.69 Favored 'Trans proline' 0 N--CA 1.434 -2.004 1 CA-C-N 129.395 4.391 . . . . 0.95 112.027 -168.437 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.8 p -85.32 2.9 42.14 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.681 -2.512 . . . . 1.45 116.272 173.855 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -71.12 140.04 50.48 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 125.44 1.713 . . . . 1.69 109.98 173.3 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.444 42.7 p -84.46 161.02 20.45 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.848 -1.782 . . . . 0.75 110.646 -178.624 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.9 mm -52.98 -27.86 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 C-N-CA 126.46 1.904 . . . . 0.73 115.124 170.471 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -57.65 -44.87 85.95 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.292 2.637 . . . . 1.62 115.687 167.278 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -65.13 -37.35 87.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.787 2.708 . . . . 2.13 115.598 178.573 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.417 HG21 HD21 ' A' ' 56' ' ' LEU . 21.3 t -72.75 -47.63 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 112.333 -2.212 . . . . 0.62 115.086 177.517 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -65.75 -17.05 64.35 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 114.581 1.326 . . . . 1.22 114.581 169.211 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.28 -41.28 17.02 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 119.958 1.253 . . . . 0.51 108.198 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -59.64 -31.83 69.89 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.143 1.905 . . . . 1.44 116.143 170.413 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.77 -49.73 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.453 1.597 . . . . 1.32 114.706 170.601 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -59.56 -37.51 78.65 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 113.662 0.986 . . . . 1.7 113.662 177.727 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.7 -37.95 77.21 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.62 -3.175 . . . . 1.55 113.684 176.357 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -92.56 -59.64 2.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.265 1.983 . . . . 2.62 114.364 -177.416 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -84.97 -27.45 26.49 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 118.622 -2.549 . . . . 1.48 113.074 -169.309 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.32 24.43 26.56 Favored Glycine 0 N--CA 1.431 -1.684 0 CA-C-O 124.497 2.165 . . . . 1.12 109.423 169.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.3 mt -91.82 112.79 56.41 Favored Pre-proline 0 N--CA 1.431 -1.411 0 CA-C-N 113.225 -1.487 . . . . 1.55 110.461 -171.365 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.255 18.4 Cg_exo -55.37 139.68 81.75 Favored 'Trans proline' 0 N--CA 1.433 -2.058 1 N-CA-C 123.69 4.458 . . . . 1.02 123.69 174.821 . . . . . . . . 3 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -62.01 -22.26 73.91 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 C-N-CA 123.659 2.906 . . . . 1.25 111.013 -175.748 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.63 -31.32 71.92 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.883 1.801 . . . . 2.25 110.864 173.043 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -88.09 -14.84 37.81 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 116.413 -3.929 . . . . 2.02 115.562 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -78.98 98.94 6.62 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 112.139 -2.301 . . . . 0.69 106.659 -173.102 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -102.8 107.48 18.36 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.097 -2.927 . . . . 2.78 103.097 169.754 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.4 mt -105.28 148.12 27.35 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 114.597 -2.841 . . . . 1.17 105.049 -175.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 mm -125.1 131.78 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 109.38 -0.6 . . . . 1.38 109.38 -179.258 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -122.23 108.79 13.69 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.888 -2.382 . . . . 1.5 104.799 168.432 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.87 -92.67 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.18 2.192 . . . . 1.21 110.01 179.051 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.4 -26.69 4.74 Favored Glycine 0 N--CA 1.429 -1.811 0 CA-C-N 113.68 -1.6 . . . . 1.3 109.974 -173.188 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.383 51.2 mttm -99.07 134.97 41.15 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.018 -3.048 . . . . 2.55 118.26 -176.304 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -90.08 116.04 27.8 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 105.836 -1.912 . . . . 2.48 105.836 176.206 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.3 118.97 10.09 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 123.607 1.67 . . . . 0.9 111.521 -169.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.12 154.13 20.41 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 116.531 -3.856 . . . . 1.94 110.682 -179.308 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -68.98 152.73 44.89 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.59 -1.943 . . . . 1.56 114.178 -173.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.47 10.55 85.65 Favored Glycine 0 N--CA 1.43 -1.709 0 O-C-N 119.454 -2.029 . . . . 0.97 112.57 173.224 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -104.24 171.3 7.41 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.992 2.33 . . . . 2.49 110.245 170.253 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.1 p -106.32 -174.09 2.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.524 -3.86 . . . . 0.76 104.876 174.324 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.417 HD21 HG21 ' A' ' 26' ' ' VAL . 80.8 mt -83.02 -35.56 25.69 Favored 'General case' 0 N--CA 1.431 -1.423 1 C-N-CA 133.367 4.667 . . . . 1.05 110.477 174.882 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -70.41 -25.88 63.42 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.221 -3.425 . . . . 1.19 114.938 175.726 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -59.9 -34.06 72.67 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.894 -3.004 . . . . 1.9 111.81 168.727 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -92.76 11.53 26.59 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 121.42 1.918 . . . . 0.89 111.177 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.33 10.9 m120 53.26 36.29 22.28 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 127.47 2.308 . . . . 1.84 116.34 -175.67 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.4 mt -85.9 129.2 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 127.625 2.37 . . . . 0.82 108.464 -176.713 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -123.66 -167.01 1.55 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.253 -2.779 . . . . 2.16 110.91 -173.676 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -58.44 141.42 51.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.651 0.982 . . . . 2.12 113.651 178.391 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 69.28 33.71 3.17 Favored 'General case' 0 N--CA 1.43 -1.465 1 C-N-CA 132.199 4.199 . . . . 1.71 109.316 175.6 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 m -101.24 142.93 31.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 123.075 2.671 . . . . 1.04 107.562 -172.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.3 m -102.4 102.74 13.1 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 116.083 -1.913 . . . . 0.79 110.65 -171.738 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.317 57.6 mt -78.69 147.37 33.52 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.767 -1.197 . . . . 1.4 107.767 169.26 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -101.73 128.12 48.2 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.998 -1.064 . . . . 1.51 109.006 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.2 tt -93.61 104.33 16.45 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 118.661 -2.525 . . . . 1.14 110.391 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.0 t -107.67 129.48 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 O-C-N 117.157 -3.464 . . . . 1.23 109.408 -179.09 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.4 mt -97.82 125.37 42.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.201 -2.812 . . . . 2.78 111.651 -177.88 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -87.17 130.02 34.71 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.665 3.586 . . . . 3.75 108.074 178.899 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.4 tp -97.43 -62.92 1.18 Allowed 'General case' 0 N--CA 1.432 -1.361 0 CA-C-O 123.917 1.818 . . . . 3.14 111.439 174.13 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -137.99 146.66 43.39 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 111.901 -2.409 . . . . 6.8 111.593 175.504 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.56 179.6 29.12 Favored Glycine 0 N--CA 1.43 -1.723 0 O-C-N 119.106 -2.246 . . . . 3.57 110.815 -168.032 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.747 1 O-C-N 115.97 -4.253 . . . . 3.87 120.793 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.351 19.0 ptt? . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 118.131 -0.938 . . . . 1.1 111.139 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -100.69 132.9 45.85 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 125.965 1.706 . . . . 1.87 106.972 -171.171 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.04 157.5 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 115.181 -2.342 . . . . 0.72 109.525 166.249 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -107.59 143.95 35.31 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.161 1.458 . . . . 1.4 111.782 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 t -123.44 124.44 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 105.583 -2.006 . . . . 0.58 105.583 171.487 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -114.69 135.89 53.66 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 117.15 2.278 . . . . 2.09 117.15 178.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.515 21.3 p -69.59 -175.59 0.88 Allowed 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.82 2.247 . . . . 0.99 113.707 179.386 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.3 mt -89.99 -33.67 16.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.482 -3.261 . . . . 2.53 113.913 165.589 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 p -74.49 -56.08 5.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.865 -1.772 . . . . 2.08 114.606 -176.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.07 31.16 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 119.997 2.759 . . . . 1.31 119.997 174.412 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -121.8 128.48 51.74 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.507 2.099 . . . . 1.4 111.423 -175.467 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.278 32.3 m -103.5 130.55 50.9 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.271 -2.143 . . . . 0.78 111.541 172.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -100.67 149.83 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 129.682 3.193 . . . . 1.55 107.912 176.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.5 m -123.46 131.17 53.56 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 122.22 2.282 . . . . 1.08 105.468 172.082 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.8 mt -119.4 128.57 54.17 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 116.047 -1.93 . . . . 1.55 114.048 -179.6 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -80.0 112.43 17.29 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 115.138 1.533 . . . . 1.95 115.138 165.68 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.86 174.93 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.578 -2.576 . . . . 0.96 104.701 -171.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -124.02 171.67 6.76 Favored Pre-proline 0 N--CA 1.43 -1.475 0 CA-C-O 114.233 -2.794 . . . . 2.35 104.979 165.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -76.11 -7.75 18.34 Favored 'Trans proline' 0 N--CA 1.434 -1.996 1 CA-C-N 130.02 4.614 . . . . 0.95 114.093 -177.369 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.5 p -83.24 -15.92 48.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 129.922 3.289 . . . . 1.45 109.959 179.538 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.69 139.96 58.24 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 114.542 1.312 . . . . 1.69 114.542 174.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 p -85.3 164.45 18.0 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 118.109 -2.869 . . . . 0.75 115.929 172.594 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.4 mm -64.56 -24.92 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 119.152 -2.218 . . . . 0.73 115.611 173.269 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -74.98 -31.7 61.51 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 116.053 -1.927 . . . . 1.62 114.901 165.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -66.68 -41.23 88.45 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 120.4 1.455 . . . . 2.13 110.194 174.304 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.68 -48.43 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 114.29 -2.767 . . . . 0.62 111.135 174.772 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -54.86 -45.2 74.55 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 122.144 2.247 . . . . 1.22 114.002 176.219 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.05 -41.16 87.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.174 1.916 . . . . 0.51 116.174 168.588 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -61.06 -41.36 96.47 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.292 2.237 . . . . 1.44 110.435 173.36 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.4 mt -64.37 -32.91 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 121.096 1.771 . . . . 1.32 114.474 169.905 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -62.69 -43.07 99.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.431 1.092 . . . . 1.7 112.503 175.7 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -56.1 -42.5 76.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.391 -2.693 . . . . 1.55 113.567 174.082 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -74.99 -66.64 0.73 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.626 1.343 . . . . 2.62 114.626 -178.117 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -95.29 -21.23 18.55 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.241 2.617 . . . . 1.48 115.389 -166.681 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.37 1.78 68.74 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 127.954 3.284 . . . . 1.12 113.704 175.783 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 mt -72.1 126.63 91.14 Favored Pre-proline 0 N--CA 1.429 -1.481 0 C-N-CA 125.538 1.535 . . . . 1.55 113.44 -177.075 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.524 ' HG2' ' HG3' ' A' ' 40' ' ' GLN . 18.3 Cg_endo -72.67 150.62 50.92 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 O-C-N 113.651 -3.921 . . . . 1.02 116.341 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -63.59 -32.16 69.8 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 CA-C-N 124.045 2.48 . . . . 1.25 111.48 -171.263 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -57.61 -29.7 64.73 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 114.939 -4.851 . . . . 2.25 114.775 176.594 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.524 ' HG3' ' HG2' ' A' ' 37' ' ' PRO . 88.7 mt-30 -90.73 -21.0 21.79 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 119.108 -1.037 . . . . 2.02 111.138 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.279 57.9 mt-30 -78.68 140.0 38.42 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 120.328 -1.483 . . . . 0.69 114.134 -174.623 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -126.44 126.44 43.8 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.771 1.748 . . . . 2.78 106.741 170.397 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.305 29.3 mt -98.21 111.74 23.96 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 118.868 -2.395 . . . . 1.17 111.203 178.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mm -105.95 121.02 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 124.327 1.051 . . . . 1.38 111.846 -178.83 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -114.36 98.31 6.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 129.06 2.944 . . . . 1.5 112.638 168.135 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.1 -106.22 0.21 Allowed 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.335 -2.728 . . . . 1.21 113.837 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.94 -12.44 55.37 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 128.704 3.05 . . . . 1.3 112.867 -179.28 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -114.06 149.3 35.68 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 123.28 3.54 . . . . 2.55 106.403 -173.902 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -106.83 142.87 35.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 100.673 -3.825 . . . . 2.48 100.673 169.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 mt -103.24 130.19 50.41 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 116.434 -2.106 . . . . 0.9 111.655 -172.431 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -81.19 141.32 34.3 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 118.028 2.603 . . . . 1.94 118.028 -174.375 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -60.66 132.0 52.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.609 1.818 . . . . 1.56 108.94 -176.127 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.02 -19.13 44.52 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 126.159 1.838 . . . . 0.97 116.149 171.669 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.8 mtt180 -82.24 164.9 20.88 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 123.094 1.426 . . . . 2.49 113.5 170.25 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.2 p -87.99 162.99 16.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.487 3.041 . . . . 0.76 112.707 174.844 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.6 mt -61.11 -26.46 67.69 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 114.218 -5.301 . . . . 1.05 119.552 167.457 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.7 t -67.08 -35.03 78.94 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 112.925 -1.943 . . . . 1.19 112.729 176.242 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -56.7 -41.99 78.33 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.812 -3.055 . . . . 1.9 112.402 175.919 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -88.96 4.46 48.03 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 119.284 -2.135 . . . . 0.89 112.584 177.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.1 m120 58.33 47.34 14.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.801 2.889 . . . . 1.84 118.801 -178.227 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mt -96.17 130.05 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 124.789 1.306 . . . . 0.82 108.69 -178.892 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -114.23 -159.62 0.7 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 115.504 -2.479 . . . . 2.16 105.734 176.658 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -56.0 153.45 8.82 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 115.551 -4.468 . . . . 2.12 116.925 171.952 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 55.23 33.18 20.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.341 2.972 . . . . 1.71 110.987 173.213 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 m -89.52 143.08 27.1 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 113.962 -5.461 . . . . 1.04 110.584 -179.614 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.2 m -96.02 113.08 24.66 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.282 -2.118 . . . . 0.79 105.282 178.393 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mp -104.57 169.82 8.24 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 104.263 -2.495 . . . . 1.4 104.263 165.602 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -125.84 139.21 53.67 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 127.831 3.207 . . . . 1.51 112.827 -172.111 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.0 tp -98.67 123.38 42.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.789 -2.444 . . . . 1.14 112.038 177.312 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.16 162.25 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.849 -2.278 . . . . 1.23 104.849 174.504 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.5 mt -129.03 147.03 50.86 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.085 2.374 . . . . 2.78 109.947 -179.478 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.286 68.3 ttt180 -82.92 140.22 32.95 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 110.313 -3.13 . . . . 3.75 109.87 179.213 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.9 mt -106.78 74.26 0.99 Allowed 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.781 -3.075 . . . . 3.14 114.963 178.617 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -64.28 -31.92 73.31 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.49 -2.006 . . . . 6.8 112.437 169.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.81 -44.63 1.62 Allowed Glycine 0 N--CA 1.43 -1.706 0 O-C-N 117.74 -3.1 . . . . 3.57 114.556 -175.223 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.782 0 N-CA-C 107.641 -2.184 . . . . 3.87 107.641 -176.48 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ttp . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 123.506 1.622 . . . . 1.1 113.285 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -83.15 130.11 35.08 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 115.41 -4.556 . . . . 1.87 114.049 -178.28 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -126.17 161.83 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 115.704 -2.094 . . . . 0.72 108.516 168.934 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -112.76 137.61 50.81 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 104.865 -2.272 . . . . 1.4 104.865 -177.192 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 t -107.46 120.59 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 114.106 -1.406 . . . . 0.58 108.015 173.249 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -96.01 115.45 27.45 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.828 -2.42 . . . . 2.09 111.381 179.327 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.9 p -80.42 175.14 10.92 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 115.982 -4.199 . . . . 0.99 116.223 173.491 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.0 mt -80.5 -24.55 39.32 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.672 -1.232 . . . . 2.53 107.672 176.586 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.3 p -70.93 -39.93 72.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.332 -2.73 . . . . 2.08 108.96 175.508 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.86 50.63 0.55 Allowed Glycine 0 N--CA 1.429 -1.827 0 C-N-CA 126.36 1.933 . . . . 1.31 113.708 -177.568 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -124.21 136.93 54.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 101.556 -3.498 . . . . 1.4 101.556 -179.116 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.4 m -100.22 116.74 32.93 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.777 -3.077 . . . . 0.78 104.767 178.87 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mt -99.15 141.26 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 104.821 -2.288 . . . . 1.55 104.821 178.899 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.5 m -109.88 108.2 18.4 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 103.893 -2.632 . . . . 1.08 103.893 -175.649 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.8 mt -102.74 160.59 14.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.415 -2.678 . . . . 1.55 108.46 177.699 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -119.69 107.19 12.92 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 130.553 3.541 . . . . 1.95 107.919 172.227 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.267 23.2 m -121.58 -171.61 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.696 1.598 . . . . 0.96 109.391 -174.107 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -143.84 179.89 1.09 Allowed Pre-proline 0 N--CA 1.43 -1.428 0 C-N-CA 126.114 1.765 . . . . 2.35 112.672 167.769 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 57' ' ' SER . 11.4 Cg_exo -76.5 -28.0 7.18 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 125.317 2.935 . . . . 0.95 115.669 -176.504 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 p -77.8 -20.33 53.43 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.062 2.545 . . . . 1.45 113.43 -177.68 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.34 139.86 41.51 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 122.989 2.631 . . . . 1.69 112.813 172.531 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.1 p -84.17 175.37 9.51 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 124.295 1.038 . . . . 0.75 112.073 174.915 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.6 mm -74.8 -34.35 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-O 116.241 -1.838 . . . . 0.73 107.573 177.831 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -49.32 -41.7 39.28 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 129.008 2.923 . . . . 1.62 113.131 166.148 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -78.19 -28.61 48.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.394 -2.066 . . . . 2.13 113.075 177.593 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.39 -43.16 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 125.223 1.409 . . . . 0.62 107.459 171.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -55.06 -39.86 69.69 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 123.179 2.718 . . . . 1.22 113.178 169.11 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.61 -40.08 76.84 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 126.925 2.09 . . . . 0.51 110.774 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -68.51 -23.28 64.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.353 -2.092 . . . . 1.44 113.109 176.177 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.4 mt -82.81 -28.1 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 117.208 -1.797 . . . . 1.32 110.896 172.615 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -63.33 -44.52 94.7 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.976 -1.702 . . . . 1.7 110.98 177.373 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -56.28 -50.06 72.46 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.809 2.043 . . . . 1.55 111.225 173.193 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -66.08 -59.81 3.43 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 118.951 2.945 . . . . 2.62 118.951 -178.581 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -108.84 -25.58 10.71 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 128.828 2.851 . . . . 1.48 113.544 -165.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.02 47.91 7.31 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 123.908 0.755 . . . . 1.12 112.626 -177.869 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.9 mt -104.82 114.39 63.91 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 105.663 -1.977 . . . . 1.55 105.663 177.115 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -55.83 151.45 40.43 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 123.456 2.771 . . . . 1.02 116.154 175.396 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 16.3 Cg_exo -70.51 -22.81 28.15 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 126.099 3.214 . . . . 1.25 119.904 -173.882 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.59 -17.94 62.9 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.459 1.903 . . . . 2.25 110.977 171.921 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -79.51 -29.44 41.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 121.162 1.801 . . . . 2.02 109.472 175.704 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.417 ' HG2' HD11 ' A' ' 69' ' ' LEU . 76.2 mt-30 -84.51 140.08 31.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 118.744 2.868 . . . . 0.69 118.744 -167.803 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -129.99 116.61 18.83 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 104.65 -2.352 . . . . 2.78 104.65 167.412 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.8 mt -96.04 105.65 17.71 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.071 2.549 . . . . 1.17 114.58 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.5 mm -98.04 134.94 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 106.24 -1.763 . . . . 1.38 106.24 -172.692 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -130.08 95.14 3.86 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 116.089 -2.244 . . . . 1.5 107.277 171.305 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 74.33 -107.38 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.325 1.85 . . . . 1.21 111.098 -173.807 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.79 -12.5 24.2 Favored Glycine 0 N--CA 1.429 -1.768 0 O-C-N 118.482 -2.636 . . . . 1.3 109.029 -175.43 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -100.08 134.17 43.39 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.213 -1.757 . . . . 2.55 110.032 -174.51 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -84.37 132.87 34.55 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 103.146 -2.909 . . . . 2.48 103.146 167.383 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 mt -88.5 136.58 32.92 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.911 -2.368 . . . . 0.9 113.75 -179.101 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -73.52 138.65 45.15 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 126.134 2.146 . . . . 1.94 111.731 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -62.96 -39.72 95.52 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 117.599 2.444 . . . . 1.56 117.599 -166.761 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.21 16.43 55.83 Favored Glycine 0 N--CA 1.43 -1.708 0 O-C-N 117.575 -3.203 . . . . 0.97 111.779 175.837 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -95.34 174.4 7.05 Favored 'General case' 0 N--CA 1.429 -1.5 1 CA-C-N 125.407 4.604 . . . . 2.49 108.93 167.224 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.1 p -107.84 176.66 5.07 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 115.397 -2.521 . . . . 0.76 113.979 177.19 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.8 mt -57.91 -46.44 84.98 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 126.773 3.178 . . . . 1.05 113.162 169.627 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 2.1 t -62.27 -37.28 84.86 Favored 'General case' 0 N--CA 1.43 -1.435 1 CA-C-N 108.005 -4.18 . . . . 1.19 116.54 178.669 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -62.07 -36.4 81.55 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 120.389 1.45 . . . . 1.9 114.801 176.451 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -89.9 0.92 56.78 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 116.795 2.146 . . . . 0.89 116.795 177.914 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 m120 74.5 24.79 1.71 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.713 3.205 . . . . 1.84 114.849 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.3 mt -68.94 112.71 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 115.244 1.572 . . . . 0.82 115.244 174.577 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -107.04 -165.54 1.08 Allowed 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 125.007 1.323 . . . . 2.16 112.081 -177.42 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -67.72 153.23 44.17 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.483 1.66 . . . . 2.12 115.483 177.927 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 60.83 24.31 14.26 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 128.283 2.633 . . . . 1.71 116.056 179.519 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.3 m -89.3 148.34 23.61 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.056 -2.278 . . . . 1.04 110.404 -170.722 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.8 m -111.82 110.11 20.29 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.065 -2.897 . . . . 0.79 110.664 -173.904 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.3 mp -90.23 151.89 21.32 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 100.792 -3.781 . . . . 1.4 100.792 172.974 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -116.36 123.08 46.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.463 -2.023 . . . . 1.51 110.8 175.227 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.417 HD11 ' HG2' ' A' ' 41' ' ' GLN . 45.9 tp -95.04 101.97 13.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.653 -2.067 . . . . 1.14 108.651 -174.507 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.6 t -102.41 138.38 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 105.669 -1.975 . . . . 1.23 105.669 178.759 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.3 mt -116.48 164.16 14.99 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.432 1.587 . . . . 2.78 107.702 -179.73 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -87.5 150.46 23.72 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 111.094 -2.776 . . . . 3.75 110.243 174.453 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.0 mt -48.04 120.65 3.64 Favored 'General case' 0 N--CA 1.43 -1.442 1 N-CA-C 123.149 4.5 . . . . 3.14 123.149 177.816 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.418 ' HB3' ' H ' ' A' ' 75' ' ' GLY . 26.3 ttt180 -106.2 -79.31 0.57 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.317 2.008 . . . . 6.8 115.28 170.734 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.418 ' H ' ' HB3' ' A' ' 74' ' ' ARG . . . 142.99 82.25 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 103.951 -3.66 . . . . 3.57 103.951 -167.321 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.753 0 CA-C-N 120.283 2.041 . . . . 3.87 110.319 -171.078 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptt? . . . . . 0 CA--C 1.49 -1.364 0 CA-C-O 118.977 -0.535 . . . . 1.1 111.39 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -98.57 121.59 40.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.28 1.038 . . . . 1.87 109.442 -175.244 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.0 pt -119.44 155.04 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 123.317 1.532 . . . . 0.72 109.433 174.604 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -113.78 126.03 54.76 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.732 -1.855 . . . . 1.4 112.712 -179.127 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.506 HG21 HD11 ' A' ' 30' ' ' ILE . 40.5 t -104.88 114.25 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 105.259 -2.126 . . . . 0.58 105.259 178.601 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -103.74 121.5 43.13 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 129.232 3.013 . . . . 2.09 107.682 -175.676 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 p -86.49 -179.24 6.6 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 127.93 3.729 . . . . 0.99 117.797 179.248 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 8' ' ' LEU . 47.2 mt -83.06 -29.22 28.99 Favored 'General case' 0 N--CA 1.429 -1.505 1 O-C-N 110.91 -7.369 . . . . 2.53 111.913 168.774 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.9 p -64.7 -41.3 96.11 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 117.035 -3.54 . . . . 2.08 110.141 171.443 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.08 4.88 3.19 Favored Glycine 0 N--CA 1.431 -1.692 0 O-C-N 119.962 -1.711 . . . . 1.31 114.248 173.687 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -75.9 122.28 23.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 125.959 1.704 . . . . 1.4 111.23 -171.547 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.307 23.8 m -80.15 88.25 5.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.842 -3.661 . . . . 0.78 114.056 167.106 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.462 HD13 ' HG3' ' A' ' 34' ' ' GLU . 57.5 mt -82.71 130.34 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 103.067 -2.938 . . . . 1.55 103.067 -176.834 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.3 m -101.89 117.48 34.93 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.957 3.303 . . . . 1.08 107.196 -174.287 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.5 mt -131.21 152.43 50.5 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 124.925 3.511 . . . . 1.55 111.642 -178.396 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -106.64 105.13 15.01 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 126.586 1.955 . . . . 1.95 113.285 175.289 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 26' ' ' VAL . 12.4 m -118.09 174.45 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 126.476 1.91 . . . . 0.96 107.615 -175.446 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -126.43 165.62 26.91 Favored Pre-proline 0 N--CA 1.431 -1.39 0 O-C-N 118.638 -2.538 . . . . 2.35 106.203 166.619 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -75.77 -22.57 13.38 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 CA-C-N 124.639 2.693 . . . . 0.95 114.581 -171.305 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.0 m -85.44 15.49 4.43 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 116.354 -2.138 . . . . 1.45 112.591 174.58 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -91.39 167.35 12.34 Favored 'General case' 0 N--CA 1.431 -1.425 1 O-C-N 116.141 -4.1 . . . . 1.69 109.48 169.025 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 36.4 p -104.0 174.57 5.82 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.704 -1.135 . . . . 0.75 108.339 -175.382 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.417 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 27.9 mm -74.76 -31.71 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 127.854 2.462 . . . . 0.73 107.958 175.102 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -57.72 -40.5 79.7 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.633 1.716 . . . . 1.62 115.633 169.079 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -65.29 -48.77 71.99 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 124.23 1.967 . . . . 2.13 111.881 171.472 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.46 HG22 HG11 ' A' ' 17' ' ' VAL 0.28 47.5 t -54.17 -41.71 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 117.19 -3.444 . . . . 0.62 115.333 172.455 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 85.7 mttt -59.26 -46.72 87.75 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 118.046 2.61 . . . . 1.22 118.046 167.979 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.01 -38.93 80.36 Favored 'General case' 0 N--CA 1.432 -1.369 1 C-N-CA 131.714 4.006 . . . . 0.51 114.037 172.845 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.23 -42.93 99.29 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.908 1.683 . . . . 1.44 113.148 167.473 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.506 HD11 HG21 ' A' ' 5' ' ' VAL . 65.8 mt -69.16 -32.32 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 125.945 1.698 . . . . 1.32 110.109 179.14 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -69.92 -47.92 60.54 Favored 'General case' 0 N--CA 1.431 -1.404 1 O-C-N 115.853 -4.279 . . . . 1.7 114.248 175.013 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.27 16.4 t70 -44.53 -59.48 2.43 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 130.53 3.532 . . . . 1.55 110.132 166.297 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -67.81 -53.34 27.79 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.942 2.097 . . . . 2.62 112.557 -172.581 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HG3' HD13 ' A' ' 13' ' ' ILE . 19.4 mm-40 -102.06 -75.04 0.61 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.76 3.171 . . . . 1.48 112.184 -170.185 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.66 22.84 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.714 0 CA-C-O 124.309 2.061 . . . . 1.12 115.101 177.709 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mt -97.79 128.64 33.49 Favored Pre-proline 0 N--CA 1.43 -1.434 0 O-C-N 117.95 -3.088 . . . . 1.55 117.281 -172.319 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -63.03 137.88 64.55 Favored 'Trans proline' 0 N--CA 1.433 -2.032 0 O-C-N 114.65 -3.395 . . . . 1.02 113.309 178.473 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -59.92 -17.72 45.72 Favored 'Trans proline' 0 N--CA 1.434 -2.009 1 C-N-CA 125.474 4.116 . . . . 1.25 115.135 178.747 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -75.33 -28.42 59.64 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.028 -2.295 . . . . 2.25 112.289 169.87 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -82.01 -26.0 34.21 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.781 -2.449 . . . . 2.02 110.196 -173.866 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -87.58 124.22 33.27 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.451 -2.031 . . . . 0.69 114.475 -174.157 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -113.07 115.4 28.28 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 124.329 2.014 . . . . 2.78 109.291 170.098 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.252 4.2 mm? -95.97 116.34 28.79 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 125.544 2.592 . . . . 1.17 112.215 178.962 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 2.3 mm -98.23 122.85 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 1 O-C-N 114.918 -4.864 . . . . 1.38 108.655 178.956 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -138.22 142.32 39.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 116.755 -3.715 . . . . 1.5 103.143 168.245 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.317 . . 62.53 22.37 13.24 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.352 2.352 . . . . 1.21 117.352 177.609 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.04 -14.56 43.16 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 116.947 -3.595 . . . . 1.3 114.229 -175.104 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -100.2 161.36 13.66 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 128.479 2.712 . . . . 2.55 111.707 176.935 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -94.92 140.84 29.37 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 117.535 -3.228 . . . . 2.48 114.854 169.962 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.323 19.7 mt -80.04 135.61 36.4 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 126.426 3.012 . . . . 0.9 113.252 -176.48 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -89.02 144.15 26.35 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.976 -3.577 . . . . 1.94 115.47 175.348 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.269 16.5 m-20 -53.59 -65.78 0.51 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.715 -2.49 . . . . 1.56 116.281 -170.903 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.3 58.79 2.81 Favored Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 127.186 2.327 . . . . 0.97 116.816 167.196 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -139.37 144.98 38.43 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 102.734 -3.062 . . . . 2.49 102.734 166.918 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 60.8 p -79.72 160.98 26.03 Favored 'General case' 0 N--CA 1.429 -1.477 1 CA-C-O 128.785 4.136 . . . . 0.76 114.643 170.937 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.1 mt -71.28 -32.61 68.88 Favored 'General case' 0 N--CA 1.431 -1.391 1 O-C-N 114.351 -5.218 . . . . 1.05 107.066 -176.263 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.8 p -64.76 -35.97 82.8 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.489 2.403 . . . . 1.19 117.489 171.575 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.252 7.9 t70 -60.54 -44.5 96.02 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.048 2.832 . . . . 1.9 113.653 171.726 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -74.64 -22.62 58.82 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 117.788 -3.07 . . . . 0.89 113.936 176.412 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.322 63.6 m-80 68.24 54.32 0.57 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 126.083 2.849 . . . . 1.84 111.597 -178.629 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.9 mm -98.64 124.92 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 102.333 -3.21 . . . . 0.82 102.333 174.226 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -105.28 -174.99 2.67 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.529 -0.732 . . . . 2.16 110.183 -175.45 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -65.12 149.67 49.49 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 116.289 1.959 . . . . 2.12 116.289 169.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 77.11 11.42 2.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.87 1.268 . . . . 1.71 113.674 172.111 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.346 5.4 t -78.55 134.84 37.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.971 3.708 . . . . 1.04 120.909 -174.112 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.9 m -101.2 106.47 17.7 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.928 1.694 . . . . 0.79 108.918 -177.879 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.6 mt -88.8 138.56 31.3 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 118.561 -1.255 . . . . 1.4 108.496 170.073 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 40.8 m80 -94.56 125.36 39.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 123.958 1.837 . . . . 1.51 113.312 -176.677 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.7 tp -103.46 126.78 50.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.468 -3.27 . . . . 1.14 111.446 -173.975 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.3 t -118.16 147.07 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 102.258 -3.238 . . . . 1.23 102.258 173.143 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.5 mt -111.07 137.59 48.54 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 113.031 -1.895 . . . . 2.78 110.029 179.081 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -94.2 86.94 5.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.267 2.227 . . . . 3.75 106.805 179.495 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.2 mt -89.83 158.9 17.27 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 125.807 2.718 . . . . 3.14 110.473 176.549 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -97.02 148.49 22.94 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.867 -3.645 . . . . 6.8 108.1 171.502 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.92 -86.65 0.45 Allowed Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 108.293 -1.923 . . . . 3.57 108.293 -166.842 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.733 0 CA-C-N 110.562 -2.819 . . . . 3.87 108.082 -173.418 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 ptt? . . . . . 0 CA--C 1.49 -1.364 0 CA-C-O 124.246 1.974 . . . . 1.1 110.713 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -111.79 132.78 54.44 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 117.829 -3.044 . . . . 1.87 115.553 -171.722 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.2 pt -135.88 161.83 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 105.592 -2.003 . . . . 0.72 105.592 176.17 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -119.32 145.92 45.73 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 123.611 1.672 . . . . 1.4 109.847 -179.184 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.5 t -119.37 123.62 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 114.528 -1.214 . . . . 0.58 112.464 176.207 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -93.67 111.97 23.76 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 119.339 -0.945 . . . . 2.09 110.665 177.826 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.2 p -69.52 169.37 12.7 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.559 -1.963 . . . . 0.99 115.224 176.921 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.39 -25.87 61.66 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 118.552 -2.592 . . . . 2.53 112.723 178.482 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.9 p -74.6 -22.18 59.09 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 128.012 2.525 . . . . 2.08 115.175 177.317 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.76 52.53 2.43 Favored Glycine 0 N--CA 1.43 -1.712 0 C-N-CA 130.35 3.833 . . . . 1.31 111.71 175.998 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -116.68 140.88 48.91 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 102.432 -3.173 . . . . 1.4 102.432 -178.497 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.5 m -107.38 117.75 34.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 101.579 -3.489 . . . . 0.78 101.579 167.613 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.2 pt -96.04 166.83 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 118.131 -2.855 . . . . 1.55 105.258 173.852 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.0 m -122.28 141.41 51.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 116.712 -1.613 . . . . 1.08 107.925 175.228 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.0 mt -129.81 158.41 39.51 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 127.842 2.457 . . . . 1.55 110.29 173.603 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -111.99 136.53 51.21 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 106.45 -1.685 . . . . 1.95 106.45 167.546 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.7 m -136.17 166.11 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 125.553 1.541 . . . . 0.96 113.976 178.017 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -104.78 156.55 35.8 Favored Pre-proline 0 N--CA 1.43 -1.437 0 O-C-N 120.403 -1.436 . . . . 2.35 109.819 155.531 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -80.34 -5.53 13.51 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 O-C-N 114.624 -3.408 . . . . 0.95 109.908 -171.792 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.284 67.9 m -77.13 -17.77 58.38 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 116.951 -1.499 . . . . 1.45 110.028 171.135 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -60.98 134.47 57.13 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 120.681 1.582 . . . . 1.69 112.843 173.451 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 26' ' ' VAL . 61.7 p -71.58 159.68 34.02 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.286 1.517 . . . . 0.75 109.614 176.714 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.0 mm -69.87 -38.54 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 124.633 2.159 . . . . 0.73 111.285 -176.654 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -48.13 -42.63 29.78 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 128.794 2.837 . . . . 1.62 115.389 162.626 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -67.12 -32.79 74.16 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.201 -1.562 . . . . 2.13 109.194 178.456 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 22' ' ' THR . 4.4 t -71.3 -29.14 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 O-C-N 118.386 -2.696 . . . . 0.62 113.614 174.346 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -75.25 -35.76 61.36 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.23 -0.919 . . . . 1.22 108.787 176.812 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.05 -44.33 74.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.681 1.993 . . . . 0.51 111.788 170.787 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -58.45 -49.22 78.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 116.836 2.161 . . . . 1.44 116.836 173.424 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.418 3.3 mt -58.27 -37.38 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 118.383 2.734 . . . . 1.32 118.383 170.668 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.415 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 64.5 tt0 -63.71 -39.79 95.17 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 118.663 -1.215 . . . . 1.7 113.623 173.11 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -59.67 -58.92 6.49 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.935 1.694 . . . . 1.55 110.555 171.636 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -57.51 -65.66 0.59 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 125.919 1.687 . . . . 2.62 115.288 -179.304 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -106.72 -3.1 20.9 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 129.152 2.981 . . . . 1.48 111.971 -167.161 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.6 54.25 8.87 Favored Glycine 0 N--CA 1.431 -1.696 1 O-C-N 114.469 -5.144 . . . . 1.12 119.29 173.449 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.415 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 81.9 mt -132.27 135.29 26.15 Favored Pre-proline 0 N--CA 1.43 -1.439 0 N-CA-C 102.096 -3.298 . . . . 1.55 102.096 -174.527 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.69 152.27 58.8 Favored 'Trans proline' 0 N--CA 1.434 -2.005 2 C-N-CA 126.379 4.719 . . . . 1.02 108.664 177.941 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.44 -20.93 54.18 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 122.473 2.115 . . . . 1.25 111.449 -177.964 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -54.45 -50.02 68.69 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 131.497 3.919 . . . . 2.25 111.513 176.592 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -73.55 -35.06 65.44 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.307 -1.315 . . . . 2.02 112.293 177.731 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -71.67 123.75 23.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.939 2.199 . . . . 0.69 116.939 -172.663 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -113.38 126.05 54.93 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 122.771 2.532 . . . . 2.78 109.481 166.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.3 mt -97.76 132.69 43.16 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.721 -1.237 . . . . 1.17 112.803 178.706 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 mt -119.48 146.44 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 2 C-N-CA 135.113 5.365 . . . . 1.38 104.8 179.86 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.304 68.4 t80 -151.26 128.88 11.48 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 102.631 -3.099 . . . . 1.5 102.631 173.382 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.354 . . 52.1 42.56 30.62 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 121.471 3.878 . . . . 1.21 121.471 -178.368 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.38 -30.7 5.49 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-N 120.54 1.518 . . . . 1.3 116.329 179.472 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.331 16.3 pttm -94.55 148.38 22.31 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 129.934 3.294 . . . . 2.55 112.009 178.147 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -87.58 148.98 24.62 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 127.353 3.454 . . . . 2.48 112.8 169.363 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.424 HD22 ' CD2' ' A' ' 59' ' ' TYR . 55.8 mt -108.45 134.78 50.76 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.36 -2.2 . . . . 0.9 105.333 -175.478 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -88.57 153.72 20.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 126.281 1.832 . . . . 1.94 113.717 178.015 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -63.41 -55.27 25.74 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 117.228 2.307 . . . . 1.56 117.228 -169.527 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.03 62.11 4.59 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 125.825 2.903 . . . . 0.97 119.831 173.517 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.5 mmt-85 -140.5 171.5 14.04 Favored 'General case' 0 N--CA 1.429 -1.479 1 N-CA-C 99.238 -4.356 . . . . 2.49 99.238 171.641 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.8 p -111.36 168.62 9.38 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.747 -1.845 . . . . 0.76 115.476 166.359 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mt -64.11 -37.33 87.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 116.528 -3.858 . . . . 1.05 107.158 174.799 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -65.69 -34.91 79.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 125.973 3.988 . . . . 1.19 116.751 178.356 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -57.35 -45.63 84.16 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 117.322 2.342 . . . . 1.9 117.322 167.467 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.424 ' CD2' HD22 ' A' ' 50' ' ' LEU . 43.0 m-85 -87.14 -2.09 58.37 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.462 2.023 . . . . 0.89 116.462 174.586 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 54.63 74.98 0.32 Allowed 'General case' 0 N--CA 1.43 -1.43 1 C-N-CA 132.075 4.15 . . . . 1.84 110.83 -179.465 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.8 mt -116.99 113.41 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 103.005 -2.961 . . . . 0.82 103.005 -177.949 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -86.48 177.06 7.53 Favored 'General case' 0 N--CA 1.43 -1.452 1 CA-C-O 128.93 4.205 . . . . 2.16 107.908 -174.527 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -63.25 144.74 56.68 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 110.906 -2.861 . . . . 2.12 116.527 172.718 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.314 43.0 mt-10 73.83 26.05 1.87 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.811 3.196 . . . . 1.71 112.886 173.934 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.284 70.0 m -96.26 151.74 19.23 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.721 -3.112 . . . . 1.04 105.445 -177.196 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.0 m -109.44 120.08 41.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 120.959 1.709 . . . . 0.79 111.236 176.788 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mt -95.72 136.0 36.69 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 125.569 1.547 . . . . 1.4 109.973 176.444 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -98.64 118.53 35.56 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.435 -1.415 . . . . 1.51 112.806 -175.299 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.3 tp -99.55 118.01 35.19 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.21 2.204 . . . . 1.14 111.926 178.851 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.23 165.22 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 105.614 -1.995 . . . . 1.23 105.614 172.61 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.6 mt -97.34 153.01 18.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 114.436 1.273 . . . . 2.78 114.436 -176.122 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -103.73 115.24 30.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 116.632 -1.652 . . . . 3.75 113.326 176.383 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.5 mt -87.54 62.32 7.03 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 121.904 2.138 . . . . 3.14 116.125 173.208 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -73.12 138.35 45.73 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.059 2.544 . . . . 6.8 111.14 171.977 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.13 60.52 0.48 Allowed Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 104.235 -3.546 . . . . 3.57 104.235 -173.906 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.794 0 N-CA-C 107.481 -2.248 . . . . 3.87 107.481 178.122 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.315 0 N-CA-C 114.134 1.161 . . . . 1.1 114.134 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -86.62 146.23 26.41 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 123.301 1.524 . . . . 1.87 110.425 -176.88 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.5 pt -139.46 150.03 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 128.254 2.621 . . . . 0.72 109.483 174.355 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -103.53 118.28 36.37 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.452 -1.704 . . . . 1.4 111.753 177.18 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.3 t -94.31 110.7 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 117.735 -1.126 . . . . 0.58 109.047 170.341 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.3 tttp -110.17 139.25 45.52 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 122.574 2.443 . . . . 2.09 112.296 -176.529 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.358 58.0 p -85.05 165.67 17.32 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.859 -1.519 . . . . 0.99 108.793 -178.193 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.455 HD11 HG22 ' A' ' 70' ' ' VAL . 62.1 mt -78.23 -19.31 54.02 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 123.96 1.838 . . . . 2.53 112.157 170.584 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.06 -45.04 13.48 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 114.058 -1.428 . . . . 2.08 107.88 -173.702 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.47 1.31 0.21 Allowed Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 120.262 2.865 . . . . 1.31 120.262 167.249 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -86.55 146.78 26.23 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 119.256 1.528 . . . . 1.4 113.555 -176.751 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.4 m -114.04 110.49 20.12 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.957 2.789 . . . . 0.78 109.195 171.005 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.5 mt -91.83 109.65 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 124.513 2.102 . . . . 1.55 106.403 177.32 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 m -83.44 115.04 21.88 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.69 -3.756 . . . . 1.08 106.085 176.063 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mp -108.39 156.51 19.34 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 129.089 2.956 . . . . 1.55 109.856 175.138 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -118.61 131.73 56.19 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.149 -2.219 . . . . 1.95 111.184 166.605 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -138.67 171.36 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 125.807 1.643 . . . . 0.96 113.233 -175.462 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -102.54 156.1 35.69 Favored Pre-proline 0 N--CA 1.429 -1.48 0 N-CA-C 103.738 -2.69 . . . . 2.35 103.738 166.717 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.9 0.98 9.39 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 124.002 3.135 . . . . 0.95 109.891 179.835 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.4 p -84.03 -18.57 36.61 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.545 -1.972 . . . . 1.45 112.151 171.155 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -66.31 140.9 58.14 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 125.451 2.548 . . . . 1.69 110.917 173.962 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 3.0 p -80.34 163.97 23.49 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 114.95 -2.452 . . . . 0.75 116.055 179.003 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.492 HG13 ' HB3' ' A' ' 50' ' ' LEU . 19.4 mm -64.16 -36.49 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 123.412 2.824 . . . . 0.73 110.735 176.837 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -58.05 -32.84 68.4 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.86 1.664 . . . . 1.62 113.257 168.943 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.383 20.0 t-20 -64.18 -39.73 94.6 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.476 2.084 . . . . 2.13 114.322 174.184 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.5 t -64.55 -46.34 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 124.781 2.229 . . . . 0.62 113.761 174.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -66.63 -25.22 66.49 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 125.57 2.605 . . . . 1.22 117.139 -179.323 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.37 -43.25 81.87 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.569 3.556 . . . . 0.51 109.115 174.869 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -63.3 -39.17 93.82 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 116.02 -4.175 . . . . 1.44 113.789 173.997 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.8 mt -69.79 -30.29 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-O 122.837 1.304 . . . . 1.32 111.625 173.839 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.421 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 59.1 tt0 -75.15 -41.98 57.11 Favored 'General case' 0 N--CA 1.431 -1.401 1 O-C-N 113.66 -5.65 . . . . 1.7 106.757 175.87 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -54.62 -46.98 73.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.713 2.673 . . . . 1.55 118.191 168.207 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.282 26.4 tttp -89.49 -43.4 10.86 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 117.168 -3.457 . . . . 2.62 117.301 -174.008 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -101.57 -35.89 8.97 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 126.755 2.534 . . . . 1.48 108.919 -172.378 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.23 56.25 1.22 Allowed Glycine 0 N--CA 1.431 -1.663 0 C-N-CA 117.926 -2.083 . . . . 1.12 113.508 176.094 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.421 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 8.7 mt -134.31 130.62 20.22 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 103.436 -2.801 . . . . 1.55 103.436 -175.49 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -66.85 154.01 76.0 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 CA-C-N 124.387 2.603 . . . . 1.02 116.714 177.664 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -59.33 -31.96 95.89 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 124.051 3.167 . . . . 1.25 110.13 -176.528 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -55.22 -57.95 9.69 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 126.023 2.821 . . . . 2.25 114.741 177.043 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -61.64 -26.88 68.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.298 2.639 . . . . 2.02 110.395 -177.661 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.272 75.2 mt-30 -96.06 131.13 42.79 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.015 1.388 . . . . 0.69 107.41 -173.642 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -118.83 131.87 56.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.107 -1.406 . . . . 2.78 109.954 167.429 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 tp -110.06 119.88 40.68 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 104.679 -2.341 . . . . 1.17 104.679 179.123 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.308 1.7 mt -104.95 143.02 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 128.046 2.539 . . . . 1.38 115.106 179.23 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -155.85 123.08 5.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 125.37 3.713 . . . . 1.5 102.642 179.589 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.257 . . 62.97 30.1 16.43 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.445 2.387 . . . . 1.21 117.445 169.314 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.29 -22.82 32.82 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 125.294 1.621 . . . . 1.3 116.108 -174.161 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -99.36 130.97 45.68 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 118.174 -1.41 . . . . 2.55 114.033 -176.749 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -75.1 130.42 39.24 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 117.254 -1.778 . . . . 2.48 112.988 173.688 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.492 ' HB3' HG13 ' A' ' 23' ' ' ILE . 42.1 mt -76.53 140.95 41.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.699 2.481 . . . . 0.9 117.699 -170.83 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -82.78 135.6 34.93 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.631 -3.168 . . . . 1.94 110.59 177.609 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -54.99 -64.99 0.66 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.766 2.426 . . . . 1.56 112.435 -171.645 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.26 54.54 3.95 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 119.643 -1.91 . . . . 0.97 113.352 172.076 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.9 tpp85 -131.29 161.99 31.06 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 115.296 -2.288 . . . . 2.49 111.126 161.059 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 63.9 p -96.52 155.83 16.6 Favored 'General case' 0 N--CA 1.43 -1.456 1 CA-C-N 127.759 4.799 . . . . 0.76 112.445 178.554 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.1 mt -57.78 -24.24 56.19 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.146 1.778 . . . . 1.05 113.941 173.601 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.7 p -78.4 -27.93 46.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.099 -2.876 . . . . 1.19 115.499 177.404 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -67.73 -34.71 77.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.827 -3.046 . . . . 1.9 115.787 172.332 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.418 ' CE2' HD22 ' A' ' 50' ' ' LEU . 12.7 m-85 -85.94 -8.88 57.71 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.476 1.11 . . . . 0.89 109.381 175.249 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 59.0 54.13 5.19 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.528 -1.983 . . . . 1.84 112.438 178.84 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.1 mt -85.8 114.47 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 126.727 3.156 . . . . 0.82 108.227 174.299 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.283 83.6 mt-30 -91.18 177.6 6.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.369 -3.332 . . . . 2.16 111.409 178.339 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -72.65 160.8 31.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 115.724 -2.391 . . . . 2.12 113.563 178.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.433 30.5 mt-10 64.51 32.33 11.79 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 110.582 -3.008 . . . . 1.71 116.005 176.765 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.9 t -100.2 128.65 46.23 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 112.973 -1.921 . . . . 1.04 110.586 -166.26 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.37 2.4 m -75.87 93.74 3.24 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 121.88 2.127 . . . . 0.79 116.313 178.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 60.0 mt -81.39 156.8 25.25 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 130.663 3.585 . . . . 1.4 103.282 174.053 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -125.5 121.34 33.45 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 120.56 1.527 . . . . 1.51 113.035 -174.092 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.1 tp -96.64 110.69 23.07 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 105.812 -1.921 . . . . 1.14 105.812 -178.765 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.455 HG22 HD11 ' A' ' 8' ' ' LEU . 99.0 t -107.04 138.81 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 122.863 1.316 . . . . 1.23 111.457 172.474 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.4 mt -107.64 144.38 34.78 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.46 -1.4 . . . . 2.78 113.117 -177.191 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -88.08 72.01 9.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 104.798 -2.297 . . . . 3.75 104.798 173.802 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.9 mt -61.21 142.47 56.75 Favored 'General case' 0 N--CA 1.43 -1.445 1 C-N-CA 132.41 4.284 . . . . 3.14 108.625 177.413 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.262 32.8 ttm180 -73.09 118.94 16.66 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 116.147 -1.883 . . . . 6.8 112.891 172.445 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.46 -83.18 0.16 Allowed Glycine 0 N--CA 1.43 -1.701 0 CA-C-O 123.115 1.397 . . . . 3.57 110.145 179.25 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.72 0 C-N-CA 129.246 3.308 . . . . 3.87 110.678 -176.604 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 CA--C 1.491 -1.321 0 CA-C-O 118.985 -0.531 . . . . 1.1 110.664 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -84.95 134.24 34.25 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.49 1.116 . . . . 1.87 112.898 -178.551 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.5 pt -131.83 159.84 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 123.643 1.687 . . . . 0.72 109.666 166.453 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -120.84 149.53 42.44 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 102.492 -3.151 . . . . 1.4 102.492 -173.544 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.4 t -136.2 119.07 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.494 -1.379 . . . . 0.58 109.427 174.409 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -92.23 127.36 37.68 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.816 -1.084 . . . . 2.09 112.079 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.2 p -83.63 165.03 19.33 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.171 1.463 . . . . 0.99 112.111 -178.862 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.68 -31.42 72.63 Favored 'General case' 0 N--CA 1.429 -1.512 1 O-C-N 116.053 -4.154 . . . . 2.53 114.723 167.324 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.0 p -71.62 -48.64 46.68 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 124.285 0.991 . . . . 2.08 111.626 -175.217 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.52 41.64 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 119.273 -1.442 . . . . 1.31 110.674 -179.21 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.29 33.7 ttpt -133.57 149.89 51.65 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.07 -2.43 . . . . 1.4 106.775 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.9 m -95.41 113.94 25.66 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.161 2.584 . . . . 0.78 114.674 167.234 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 mt -82.39 119.25 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 117.645 -3.16 . . . . 1.55 110.305 172.215 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.8 m -104.32 111.27 23.84 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.874 -2.391 . . . . 1.08 107.896 178.093 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.8 mt -110.1 156.06 21.08 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 119.395 3.109 . . . . 1.55 119.395 -177.989 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 tp10 -103.39 107.23 17.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.206 -1.559 . . . . 1.95 113.307 168.779 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.7 m -121.17 164.77 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 115.879 -2.01 . . . . 0.96 112.944 174.375 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 9.3 mm-40 -111.69 169.51 6.25 Favored Pre-proline 0 N--CA 1.43 -1.439 0 O-C-N 125.055 1.472 . . . . 2.35 109.993 163.381 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 46.0 Cg_exo -77.38 -20.59 12.38 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 C-N-CA 122.808 2.339 . . . . 0.95 116.103 -174.122 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.7 m -82.99 3.26 30.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.8 1.64 . . . . 1.45 111.473 174.9 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -82.5 147.13 28.86 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.185 -2.822 . . . . 1.69 111.266 172.796 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.1 p -75.86 164.48 26.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.291 2.701 . . . . 0.75 118.291 174.215 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.4 mm -74.94 -29.12 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 118.279 -2.763 . . . . 0.73 110.687 178.402 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -53.37 -39.65 64.36 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 126.037 1.735 . . . . 1.62 112.529 163.708 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -60.1 -47.89 84.0 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.548 2.339 . . . . 2.13 114.793 173.206 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.7 t -60.61 -48.78 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 130.144 3.378 . . . . 0.62 112.237 177.661 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -60.09 -38.36 82.7 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 124.543 2.116 . . . . 1.22 115.083 173.991 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.85 -31.98 71.32 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 119.198 -2.189 . . . . 0.51 115.767 176.237 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -71.29 -37.44 71.86 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.498 2.094 . . . . 1.44 110.866 170.582 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.0 mt -67.14 -41.77 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 116.639 -3.788 . . . . 1.32 110.984 172.29 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -51.77 -33.06 33.47 Favored 'General case' 0 N--CA 1.43 -1.466 1 N-CA-C 122.31 4.189 . . . . 1.7 122.31 169.757 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -63.51 -42.18 98.49 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 117.04 -1.457 . . . . 1.55 110.057 174.132 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -85.13 -50.9 7.03 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 125.894 1.996 . . . . 2.62 110.414 -172.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -94.35 -27.18 16.22 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 113.567 0.951 . . . . 1.48 113.567 -168.517 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.31 -23.29 29.03 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-O 126.223 3.124 . . . . 1.12 113.759 168.025 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.2 mt -63.77 123.0 80.1 Favored Pre-proline 0 N--CA 1.431 -1.41 0 C-N-CA 128.461 2.704 . . . . 1.55 114.498 -172.691 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 59.0 Cg_endo -76.35 158.35 36.92 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 CA-C-N 126.387 3.317 . . . . 1.02 111.536 -172.025 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -54.91 -31.51 73.78 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 123.359 2.706 . . . . 1.25 116.597 -174.017 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -55.37 -42.87 74.54 Favored 'General case' 0 N--CA 1.43 -1.457 1 CA-C-O 129.263 4.363 . . . . 2.25 117.761 174.019 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -88.15 -25.54 22.91 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.94 -4.225 . . . . 2.02 112.503 -177.635 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -64.73 134.3 53.9 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.931 -1.731 . . . . 0.69 110.068 179.997 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -126.21 140.92 52.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.173 -2.829 . . . . 2.78 106.151 165.324 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 67' ' ' LEU . 85.9 mt -121.95 114.93 21.68 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.689 -2.05 . . . . 1.17 110.553 -178.837 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 mt -104.23 127.04 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 117.63 -3.168 . . . . 1.38 110.612 178.421 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -136.02 120.34 17.95 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.12 2.568 . . . . 1.5 107.196 176.317 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.313 . . 76.68 6.7 3.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.983 -1.698 . . . . 1.21 114.915 -177.438 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.78 -10.56 74.31 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 117.796 -3.065 . . . . 1.3 111.83 -175.267 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -92.17 146.42 23.73 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 105.978 -1.86 . . . . 2.55 105.978 170.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -94.43 141.89 28.06 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.162 1.385 . . . . 2.48 111.376 170.53 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -105.52 123.62 48.2 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 119.245 0.93 . . . . 0.9 109.196 -166.604 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -69.1 144.1 54.02 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.145 1.778 . . . . 1.94 111.85 174.509 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -60.6 -63.12 1.41 Allowed 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 130.975 3.71 . . . . 1.56 115.742 -169.179 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.75 23.12 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.714 1 C-N-CA 131.056 4.169 . . . . 0.97 121.317 170.85 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.296 65.1 mtt180 -123.61 162.91 22.06 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.053 -2.439 . . . . 2.49 111.598 165.467 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.0 p -84.12 154.44 23.15 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 125.543 2.592 . . . . 0.76 113.579 168.694 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mt -51.3 -34.12 31.84 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.759 -4.338 . . . . 1.05 113.883 175.529 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.7 p -79.44 -12.21 59.89 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 117.583 2.438 . . . . 1.19 117.583 179.812 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.85 -51.49 47.71 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 127.033 3.301 . . . . 1.9 108.481 171.247 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -66.75 -21.18 66.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.963 -2.961 . . . . 0.89 117.137 172.751 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.26 2.5 m-80 70.34 47.28 0.54 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.963 3.305 . . . . 1.84 111.997 -177.279 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.2 mm -78.72 113.63 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 117.907 -2.996 . . . . 0.82 106.695 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -97.89 175.15 6.25 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 126.049 1.739 . . . . 2.16 112.847 -177.644 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -59.62 132.75 54.93 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 114.59 1.33 . . . . 2.12 114.59 172.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.401 48.4 mt-10 85.57 17.01 0.13 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.554 1.645 . . . . 1.71 111.664 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.277 6.8 m -81.47 129.88 34.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.053 -2.28 . . . . 1.04 113.362 -173.928 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.8 m -103.45 106.4 16.91 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 127.923 3.265 . . . . 0.79 109.892 -175.617 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 43' ' ' LEU . 2.7 mt -87.07 155.62 20.07 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 126.045 2.831 . . . . 1.4 111.907 172.151 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -118.9 120.84 38.5 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 115.86 -2.019 . . . . 1.51 111.457 -179.103 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.8 tp -82.82 133.68 35.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.144 1.778 . . . . 1.14 107.652 179.007 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.08 157.66 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 102.527 -3.138 . . . . 1.23 102.527 175.483 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.5 mt -122.65 141.2 52.0 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.228 2.918 . . . . 2.78 111.061 -169.49 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -95.39 89.09 5.32 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 128.063 3.792 . . . . 3.75 109.472 -171.886 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.9 mt -59.89 172.71 0.7 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 111.911 -2.404 . . . . 3.14 112.032 169.562 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -81.13 143.09 32.66 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 117.67 2.47 . . . . 6.8 117.67 168.764 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.47 -32.61 0.22 Allowed Glycine 0 N--CA 1.43 -1.75 0 O-C-N 116.785 -3.697 . . . . 3.57 110.758 -170.225 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.698 0 N-CA-C 104.647 -3.381 . . . . 3.87 104.647 -174.986 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 CA--C 1.49 -1.345 0 N-CA-C 106.879 -1.526 . . . . 1.1 106.879 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -104.04 124.96 49.99 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 118.695 -2.503 . . . . 1.87 108.695 -173.554 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.9 pt -116.2 160.9 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 118.163 -2.835 . . . . 0.72 109.177 170.176 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -103.61 134.57 46.72 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 125.967 1.707 . . . . 1.4 111.057 176.475 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.2 t -112.59 125.99 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 103.939 -2.615 . . . . 0.58 103.939 172.98 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -103.18 144.51 31.23 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.032 -3.543 . . . . 2.09 112.438 169.543 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.5 p -93.99 -177.51 4.35 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 124.7 1.25 . . . . 0.99 114.082 -178.839 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.482 HD11 ' H ' ' A' ' 71' ' ' LEU . 46.4 mt -72.29 -27.58 62.55 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 116.442 -1.742 . . . . 2.53 113.088 174.167 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 p -88.13 -62.41 1.5 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.914 1.34 . . . . 2.08 111.672 -172.169 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.86 36.61 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.7 0 CA-C-N 113.721 -1.581 . . . . 1.31 110.153 177.492 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -99.0 148.19 24.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 106.233 -1.766 . . . . 1.4 106.233 -179.468 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.6 m -114.04 127.28 55.87 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 122.373 2.351 . . . . 0.78 106.966 169.158 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mt -108.53 133.3 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.507 -1.996 . . . . 1.55 110.707 173.475 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.0 m -93.88 112.88 24.8 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.325 1.85 . . . . 1.08 109.705 174.101 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -110.29 143.64 40.18 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 121.607 2.003 . . . . 1.55 112.711 174.659 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -114.11 115.11 27.01 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.709 -2.495 . . . . 1.95 110.178 175.199 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.77 177.36 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 127.324 2.25 . . . . 0.96 108.871 -176.521 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -120.11 155.65 55.46 Favored Pre-proline 0 N--CA 1.43 -1.443 0 O-C-N 119.079 -2.263 . . . . 2.35 105.903 162.067 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -73.57 -10.41 23.62 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 124.351 2.59 . . . . 0.95 114.376 -170.232 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.273 48.9 m -87.19 -0.8 57.26 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 127.403 2.939 . . . . 1.45 112.556 175.098 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -68.58 150.28 48.2 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 117.044 -1.455 . . . . 1.69 109.583 179.128 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.3 p -87.59 170.94 10.86 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 125.522 2.582 . . . . 0.75 109.476 176.815 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.407 7.4 mm -61.36 -48.31 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 111.295 -2.684 . . . . 0.73 112.627 173.908 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -41.8 -51.43 4.23 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 119.97 3.322 . . . . 1.62 119.97 164.506 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -61.48 -24.6 66.69 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 119.055 2.983 . . . . 2.13 119.055 174.873 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.0 t -75.65 -39.42 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 125.465 2.555 . . . . 0.62 108.988 175.718 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.3 51.5 mtmt -65.24 -36.71 84.97 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.773 -1.83 . . . . 1.22 111.557 177.784 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.19 -24.1 66.56 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 128.32 2.648 . . . . 0.51 113.965 175.966 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -78.16 -38.63 43.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 126.838 2.586 . . . . 1.44 112.951 170.503 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.363 68.8 mt -65.84 -42.99 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-O 126.391 2.996 . . . . 1.32 111.915 172.304 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -57.79 -55.03 40.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 111.474 -2.603 . . . . 1.7 111.011 172.555 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.298 33.5 t70 -29.13 -56.64 0.14 Allowed 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 119.727 3.232 . . . . 1.55 119.727 170.898 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -81.45 -53.16 6.53 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 117.563 2.431 . . . . 2.62 117.563 -178.798 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -92.72 -22.62 19.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.178 -2.826 . . . . 1.48 106.525 -163.854 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.56 10.58 59.04 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 130.239 3.78 . . . . 1.12 114.701 177.042 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.5 mt -86.73 125.09 68.13 Favored Pre-proline 0 N--CA 1.43 -1.463 0 O-C-N 116.495 -3.944 . . . . 1.55 109.305 -174.231 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.465 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 29.9 Cg_exo -64.24 149.67 89.79 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 N-CA-C 120.86 3.369 . . . . 1.02 120.86 176.741 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 47.5 Cg_exo -69.32 -14.9 38.27 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 CA-C-N 124.966 2.809 . . . . 1.25 117.808 -175.714 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -83.09 -10.65 58.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.704 1.593 . . . . 2.25 110.784 176.714 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.16 -15.74 23.09 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.299 -1.501 . . . . 2.02 108.843 -179.664 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -93.44 124.32 37.35 Favored 'General case' 0 N--CA 1.43 -1.465 1 CA-C-O 129.352 4.406 . . . . 0.69 110.529 -179.324 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -106.65 110.07 22.15 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 114.009 -5.432 . . . . 2.78 104.205 169.963 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.6 mt -89.77 124.66 34.84 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 115.518 -2.182 . . . . 1.17 107.48 172.836 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.44 HD12 HG21 ' A' ' 70' ' ' VAL . 32.4 mt -121.62 136.76 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 128.005 3.316 . . . . 1.38 106.747 -178.255 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -147.44 123.7 10.89 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.718 -1.583 . . . . 1.5 108.245 -176.349 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.304 . . 82.35 -51.09 0.21 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 114.654 1.353 . . . . 1.21 114.654 173.365 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.61 -34.84 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 128.179 2.799 . . . . 1.3 113.739 -178.405 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -89.29 164.11 15.07 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 126.228 2.918 . . . . 2.55 112.24 -179.695 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -98.23 133.45 42.64 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.592 -1.943 . . . . 2.48 110.727 171.09 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.2 mt -88.71 129.56 35.51 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 118.774 -2.454 . . . . 0.9 114.827 -167.356 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.341 26.9 mt-10 -65.0 131.53 46.84 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.727 -1.858 . . . . 1.94 115.571 174.381 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -43.58 -63.75 0.78 Allowed 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 131.188 3.795 . . . . 1.56 114.716 -171.609 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.22 61.15 1.88 Allowed Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 112.364 -2.198 . . . . 0.97 117.323 174.202 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 -126.03 172.85 9.62 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.36 -2.089 . . . . 2.49 105.36 156.393 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.0 p -97.78 177.94 5.3 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 117.315 2.339 . . . . 0.76 117.315 169.557 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.8 mt -77.3 -32.28 55.29 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.247 -2.158 . . . . 1.05 109.77 173.702 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -66.6 -37.02 84.02 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 123.814 3.006 . . . . 1.19 114.136 171.484 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -54.24 -64.1 0.94 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 131.668 3.987 . . . . 1.9 115.022 169.921 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -62.99 -14.15 44.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.913 1.819 . . . . 0.89 115.913 173.901 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.345 29.0 m120 78.02 36.83 0.23 Allowed 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 116.794 -1.574 . . . . 1.84 114.79 179.329 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.9 mt -96.22 125.54 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 122.182 2.264 . . . . 0.82 110.96 -177.147 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -98.34 -179.91 4.51 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 118.095 2.628 . . . . 2.16 118.095 -171.498 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.304 21.7 pttp -65.87 145.83 55.46 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 118.749 -1.18 . . . . 2.12 109.328 170.373 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.269 19.4 mt-10 69.99 20.13 6.66 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 126.227 2.204 . . . . 1.71 113.142 171.815 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.2 m -87.13 148.13 25.34 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 118.027 -2.92 . . . . 1.04 111.239 179.668 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.6 m -92.89 98.4 11.35 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.829 2.159 . . . . 0.79 116.829 -177.31 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -84.82 145.53 27.81 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 113.987 -5.446 . . . . 1.4 113.744 172.072 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -117.03 119.5 35.47 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 118.918 -2.364 . . . . 1.51 109.702 -176.043 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.0 tp -84.88 102.44 13.11 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.967 3.307 . . . . 1.14 109.625 178.092 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 44' ' ' ILE 0.32 98.7 t -94.02 130.48 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 130.513 3.525 . . . . 1.23 107.28 170.814 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.482 ' H ' HD11 ' A' ' 8' ' ' LEU . 66.4 mt -100.13 141.38 33.05 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.441 -3.287 . . . . 2.78 108.589 179.106 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -74.8 -39.81 61.5 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.628 -3.17 . . . . 3.75 114.333 176.578 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.273 17.1 mt -109.82 -163.24 0.85 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.247 3.019 . . . . 3.14 111.637 164.057 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -64.94 137.89 58.02 Favored 'General case' 0 N--CA 1.43 -1.44 2 CA-C-O 129.388 4.423 . . . . 6.8 107.897 165.364 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.78 36.46 0.19 Allowed Glycine 0 N--CA 1.43 -1.707 1 O-C-N 115.27 -4.644 . . . . 3.57 113.626 -175.834 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.788 0 CA-C-O 125.85 2.916 . . . . 3.87 113.922 179.693 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttp . . . . . 0 CA--C 1.491 -1.324 0 CA-C-O 124.177 1.942 . . . . 1.1 114.399 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -106.25 141.41 37.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.808 -3.057 . . . . 1.87 111.692 -176.05 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 pt -127.35 173.16 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 131.566 3.947 . . . . 0.72 113.337 175.691 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -135.32 126.02 27.2 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.569 -2.582 . . . . 1.4 105.953 -178.544 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -115.24 118.74 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 106.25 -1.759 . . . . 0.58 106.25 173.443 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -100.28 145.24 28.35 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 118.202 -1.399 . . . . 2.09 111.525 175.383 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.2 p -101.2 160.53 14.32 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 128.931 2.892 . . . . 0.99 112.766 179.939 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 mt -71.14 -28.72 64.48 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.718 -1.864 . . . . 2.53 112.862 175.053 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 t -72.76 -38.6 67.28 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 121.744 2.066 . . . . 2.08 110.142 -177.782 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.27 -10.42 0.54 Allowed Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 125.347 1.451 . . . . 1.31 112.918 166.039 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -80.02 135.02 36.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.75 2.02 . . . . 1.4 113.735 -167.731 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.2 m -108.0 117.38 33.97 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.855 2.462 . . . . 0.78 109.484 176.204 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 mt -104.8 105.61 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 113.361 0.874 . . . . 1.55 113.361 178.332 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.8 m -79.31 118.19 21.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.347 -3.345 . . . . 1.08 108.819 -178.762 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.401 HD22 ' HB3' ' A' ' 29' ' ' LYS . 83.8 mt -120.78 153.58 36.86 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 116.803 -3.686 . . . . 1.55 111.605 -179.8 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -116.33 120.37 38.68 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.059 2.544 . . . . 1.95 110.256 168.382 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -131.92 167.82 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 105.894 -1.891 . . . . 0.96 105.894 -170.575 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -109.45 147.91 37.0 Favored Pre-proline 0 N--CA 1.43 -1.45 0 O-C-N 118.485 -2.635 . . . . 2.35 109.831 160.653 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.254 2.2 Cg_endo -57.11 -18.6 29.78 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 N-CA-C 120.619 3.277 . . . . 0.95 120.619 -173.18 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.9 m -91.05 3.64 54.2 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 125.92 1.688 . . . . 1.45 112.37 -178.709 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -71.78 161.73 30.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.481 2.312 . . . . 1.69 108.54 172.405 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.7 p -98.37 163.8 12.55 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 123.306 1.527 . . . . 0.75 107.657 178.471 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mm -54.38 -41.18 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 118.32 -2.738 . . . . 0.73 114.031 174.25 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.328 16.6 tt0 -54.86 -32.18 60.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.057 -2.277 . . . . 1.62 117.09 166.955 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -64.81 -38.49 91.17 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 129.483 3.113 . . . . 2.13 111.75 176.494 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.3 t -69.18 -40.68 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 119.523 -1.985 . . . . 0.62 107.629 179.254 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.517 ' HD3' ' HB2' ' A' ' 41' ' ' GLN . 74.1 mttt -61.19 -35.64 77.69 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.042 -2.911 . . . . 1.22 114.906 170.734 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.16 -25.21 65.15 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 114.539 -2.864 . . . . 0.51 118.701 177.963 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.401 ' HB3' HD22 ' A' ' 15' ' ' LEU . 54.2 mttp -67.92 -35.53 78.6 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 130.383 3.473 . . . . 1.44 107.201 168.654 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mt -74.07 -39.36 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 1 O-C-N 116.083 -4.136 . . . . 1.32 108.671 178.953 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -64.29 -37.12 86.35 Favored 'General case' 0 N--CA 1.428 -1.547 0 O-C-N 117.12 -3.488 . . . . 1.7 111.556 178.766 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -69.85 -43.6 71.58 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.417 1.103 . . . . 1.55 112.72 172.517 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -72.73 -48.19 40.73 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 120.399 3.481 . . . . 2.62 120.399 178.943 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -108.66 -30.85 7.99 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.467 -2.645 . . . . 1.48 112.489 -165.715 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.67 37.24 5.58 Favored Glycine 0 N--CA 1.43 -1.702 0 O-C-N 118.917 -2.364 . . . . 1.12 116.133 176.467 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.3 mt -113.89 126.18 28.42 Favored Pre-proline 0 N--CA 1.431 -1.412 0 CA-C-O 111.83 -3.938 . . . . 1.55 105.368 177.622 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.84 151.06 35.45 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-N 126.379 3.314 . . . . 1.02 110.77 -176.095 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -55.87 -31.85 82.83 Favored 'Trans proline' 0 N--CA 1.433 -2.047 1 C-N-CA 126.121 4.547 . . . . 1.25 112.806 -178.897 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -41.78 -49.11 4.38 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 113.229 -3.272 . . . . 2.25 117.372 165.935 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -80.55 -20.82 42.58 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 122.664 2.484 . . . . 2.02 117.279 177.514 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.517 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 72.1 mt-30 -76.82 130.86 38.21 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.999 1.32 . . . . 0.69 111.868 -172.086 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.523 ' HB2' HG23 ' A' ' 70' ' ' VAL . 70.0 mtt180 -120.33 131.01 54.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.432 -2.668 . . . . 2.78 108.561 169.653 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.7 mt -107.55 130.52 54.86 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 120.521 1.51 . . . . 1.17 110.795 179.663 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -105.03 127.92 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 125.742 1.617 . . . . 1.38 113.046 178.373 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -152.2 141.91 21.88 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.494 -2.78 . . . . 1.5 103.494 173.163 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.27 . . 64.71 14.38 9.06 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.124 2.392 . . . . 1.21 115.024 -179.013 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.49 18.51 75.71 Favored Glycine 0 N--CA 1.431 -1.674 0 O-C-N 117.511 -3.243 . . . . 1.3 118.23 179.295 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -126.18 150.18 48.5 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.277 3.031 . . . . 2.55 111.047 176.503 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -80.15 132.75 35.97 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 121.646 2.021 . . . . 2.48 112.129 169.705 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.404 HD22 ' CD1' ' A' ' 59' ' ' TYR . 21.3 mt -88.45 135.77 33.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.453 -3.904 . . . . 0.9 114.297 -173.248 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.93 125.84 27.58 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.034 2.934 . . . . 1.94 108.739 -179.76 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.32 1.0 OUTLIER -47.23 -47.4 24.57 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 120.829 3.64 . . . . 1.56 120.829 -174.12 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.84 32.11 7.18 Favored Glycine 0 N--CA 1.43 -1.712 0 CA-C-O 125.652 2.807 . . . . 0.97 118.795 -179.834 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -101.98 157.87 16.56 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.404 -3.409 . . . . 2.49 108.951 159.685 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -85.09 168.17 15.11 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.59 -1.186 . . . . 0.76 110.048 -179.337 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.6 mt -69.64 -41.01 76.16 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 124.86 1.35 . . . . 1.05 109.869 179.289 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.264 48.3 p -58.99 -18.75 37.05 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 117.32 2.341 . . . . 1.19 117.32 175.8 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -69.79 -45.04 68.86 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.657 2.383 . . . . 1.9 111.567 173.023 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.404 ' CD1' HD22 ' A' ' 50' ' ' LEU . 61.2 m-85 -83.5 2.96 34.35 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.399 -2.688 . . . . 0.89 113.309 174.19 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.4 m120 57.56 49.02 13.34 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 129.11 2.964 . . . . 1.84 117.203 177.394 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -85.14 114.29 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 128.564 2.746 . . . . 0.82 111.791 -175.96 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -93.14 -173.73 3.34 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.005 2.336 . . . . 2.16 112.633 -176.488 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -62.54 137.72 58.32 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 112.574 -2.103 . . . . 2.12 113.456 176.673 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 64.15 29.7 13.93 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 114.029 1.122 . . . . 1.71 114.029 170.143 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.6 m -81.43 143.24 32.26 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 123.288 1.518 . . . . 1.04 114.368 -178.753 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 m -99.16 117.06 32.79 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.58 -2.575 . . . . 0.79 111.382 -179.62 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -104.24 160.23 15.05 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.088 2.555 . . . . 1.4 106.261 174.439 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -124.94 135.56 52.95 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.211 -1.774 . . . . 1.51 106.211 -176.824 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.1 tp -99.57 128.75 45.68 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 105.449 -2.056 . . . . 1.14 105.449 -176.411 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.523 HG23 ' HB2' ' A' ' 42' ' ' ARG . 20.3 m -122.0 170.13 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 104.037 -2.579 . . . . 1.23 104.037 168.771 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 71' ' ' LEU . 89.5 mt -122.44 153.51 39.0 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 117.469 -1.253 . . . . 2.78 111.4 177.39 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.274 49.1 ttp180 -60.95 123.63 18.15 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 127.412 2.945 . . . . 3.75 115.454 175.019 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.4 mt -99.87 -172.83 2.31 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 123.94 0.896 . . . . 3.14 112.822 177.495 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -88.14 86.48 7.1 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.392 2.677 . . . . 6.8 113.608 169.012 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.09 -110.56 0.41 Allowed Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 110.731 -0.948 . . . . 3.57 110.731 -169.818 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.774 0 CA-C-O 115.443 -2.865 . . . . 3.87 111.836 -174.454 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tmm? . . . . . 0 CA--C 1.49 -1.352 0 CA-C-O 121.05 0.452 . . . . 1.1 110.579 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -108.72 129.31 55.36 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 117.228 2.307 . . . . 1.87 117.228 -177.537 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -129.28 170.62 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 106.28 -1.748 . . . . 0.72 106.28 175.544 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -121.94 140.15 52.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.921 -2.252 . . . . 1.4 104.921 -177.203 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.453 HG22 ' HB2' ' A' ' 67' ' ' LEU . 92.6 t -123.96 131.51 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 118.069 -2.894 . . . . 0.58 106.771 170.52 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -88.68 118.81 28.62 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.857 2.063 . . . . 2.09 115.352 171.454 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.5 p -83.49 176.06 9.34 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.238 -3.414 . . . . 0.99 111.619 173.775 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.3 mt -78.9 -17.17 56.0 Favored 'General case' 0 N--CA 1.43 -1.432 1 CA-C-O 129.617 4.532 . . . . 2.53 116.066 -179.762 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 p -95.27 -56.74 2.62 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.367 -3.333 . . . . 2.08 107.119 -170.601 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.4 23.65 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.728 0 CA-C-O 114.969 -3.128 . . . . 1.31 115.453 176.124 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -109.68 139.82 44.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 121.67 2.735 . . . . 1.4 108.467 -173.255 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.1 m -106.84 124.33 49.46 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 100.61 -3.848 . . . . 0.78 100.61 175.577 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.7 mt -94.62 123.14 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 N-CA-C 104.776 -2.305 . . . . 1.55 104.776 179.553 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.3 m -90.21 106.7 18.66 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.529 2.331 . . . . 1.08 109.369 176.617 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.3 mt -103.83 128.62 51.27 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.715 1.721 . . . . 1.55 108.396 -176.811 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -90.6 116.32 28.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.807 -3.058 . . . . 1.95 111.803 165.993 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.2 m -130.22 159.59 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.731 -2.481 . . . . 0.96 111.108 -171.358 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -99.68 146.07 31.21 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 118.591 -2.568 . . . . 2.35 108.209 170.875 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -73.44 -17.44 23.81 Favored 'Trans proline' 0 C--N 1.299 -2.059 0 CA-C-N 127.744 3.802 . . . . 0.95 113.52 -177.547 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -77.34 -2.55 35.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 123.206 2.73 . . . . 1.45 111.479 172.431 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -73.97 139.65 44.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 122.415 2.37 . . . . 1.69 109.03 178.588 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 p -74.51 158.65 33.41 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 111.015 -2.811 . . . . 0.75 110.847 170.257 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.403 HG12 ' H ' ' A' ' 23' ' ' ILE . 6.6 mm -61.78 -30.98 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 125.062 1.476 . . . . 0.73 113.388 174.484 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -52.0 -33.33 37.76 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.51 3.124 . . . . 1.62 116.162 165.766 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -85.45 -29.62 24.19 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.301 -2.749 . . . . 2.13 108.699 176.258 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.1 t -70.2 -42.1 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 117.126 -3.483 . . . . 0.62 110.898 178.886 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -63.3 -27.57 69.42 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.347 2.659 . . . . 1.22 113.14 170.194 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.43 -21.64 41.96 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 123.373 1.559 . . . . 0.51 110.933 175.504 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -75.56 -30.16 59.59 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.749 -3.094 . . . . 1.44 114.574 170.054 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.8 mt -66.88 -38.19 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 O-C-N 120.383 -1.448 . . . . 1.32 109.401 169.905 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.424 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 14.4 tt0 -57.43 -58.43 8.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.506 0.67 . . . . 1.7 112.624 170.819 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -47.61 -49.78 26.06 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.854 2.062 . . . . 1.55 110.438 178.638 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -65.13 -66.26 0.57 Allowed 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.969 2.908 . . . . 2.62 112.06 -176.375 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -95.62 -53.75 3.61 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 127.86 2.464 . . . . 1.48 113.351 -164.056 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.98 -43.6 0.6 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 106.693 -2.563 . . . . 1.12 106.693 -179.365 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.481 HG13 ' H ' ' A' ' 36' ' ' ILE . 7.8 mt -40.69 115.2 1.19 Allowed Pre-proline 0 N--CA 1.43 -1.452 1 N-CA-C 123.715 4.709 . . . . 1.55 123.715 -171.479 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -69.38 157.58 60.61 Favored 'Trans proline' 0 C--N 1.3 -1.993 2 CA-C-N 129.712 4.504 . . . . 1.02 108.448 -174.444 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.424 ' HD3' ' HB2' ' A' ' 31' ' ' GLN . 38.0 Cg_exo -65.65 -23.79 56.19 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 N-CA-C 117.522 2.085 . . . . 1.25 117.522 177.099 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.3 -12.98 47.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.624 -3.173 . . . . 2.25 118.46 174.873 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -97.39 -22.4 16.63 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 124.044 0.938 . . . . 2.02 108.977 -178.546 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -90.46 136.2 33.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 118.687 2.847 . . . . 0.69 118.687 -168.246 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -126.03 118.33 25.11 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.329 -2.1 . . . . 2.78 105.329 169.955 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.3 mt -96.94 122.34 39.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 123.962 0.905 . . . . 1.17 111.462 177.88 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 22.9 mm -105.58 141.6 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 128.326 2.651 . . . . 1.38 104.183 -176.961 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -140.71 132.74 27.82 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 116.82 -3.675 . . . . 1.5 103.622 168.054 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.42 . . 56.13 32.48 20.2 Favored 'General case' 0 N--CA 1.429 -1.48 1 CA-C-O 132.335 5.826 . . . . 1.21 121.617 174.25 . . . . . . . . 3 2 . 1 . 033 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.99 -15.21 39.34 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 108.461 -3.972 . . . . 1.3 109.793 179.206 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -87.16 129.49 34.92 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 128.549 2.74 . . . . 2.55 116.931 -178.106 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -74.4 114.91 13.33 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 128.692 2.797 . . . . 2.48 112.43 173.022 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.1 mt -85.58 147.65 26.31 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 115.922 1.823 . . . . 0.9 115.922 -174.273 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -93.16 138.38 31.63 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.592 -0.892 . . . . 1.94 108.592 179.937 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -66.79 -41.48 87.54 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 118.479 0.581 . . . . 1.56 112.028 -165.623 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.95 47.51 3.39 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 118.454 2.142 . . . . 0.97 118.454 176.498 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -134.49 171.65 14.01 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 102.312 -3.218 . . . . 2.49 102.312 171.409 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.2 p -113.81 177.83 4.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 125.275 2.464 . . . . 0.76 116.799 178.818 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.54 HD23 HD12 ' A' ' 61' ' ' ILE . 84.8 mt -66.91 -42.24 85.77 Favored 'General case' 0 N--CA 1.43 -1.427 1 C-N-CA 131.816 4.046 . . . . 1.05 109.084 173.9 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 t -59.56 -32.97 70.84 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 116.277 -4.014 . . . . 1.19 111.704 173.698 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.271 54.3 m-20 -81.39 -39.91 24.27 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.127 1.899 . . . . 1.9 116.127 179.629 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -84.05 -3.72 58.25 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.31 1.596 . . . . 0.89 115.31 176.72 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 74.12 36.72 0.66 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.079 2.552 . . . . 1.84 114.101 -177.744 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.54 HD12 HD23 ' A' ' 56' ' ' LEU . 11.7 mt -88.16 118.28 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 1 O-C-N 115.581 -4.449 . . . . 0.82 106.68 179.713 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -115.12 -164.9 0.97 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.272 -1.517 . . . . 2.16 115.023 -171.01 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -57.69 127.59 32.78 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 117.708 2.485 . . . . 2.12 117.708 174.927 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 69.69 34.57 2.65 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.449 3.023 . . . . 1.71 113.668 172.854 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m -88.1 129.57 35.26 Favored 'General case' 0 N--CA 1.429 -1.491 1 O-C-N 114.076 -5.39 . . . . 1.04 115.584 -177.955 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.0 m -85.09 88.68 7.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 118.533 2.79 . . . . 0.79 118.533 -175.671 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.518 HD11 HG21 ' A' ' 61' ' ' ILE . 10.3 mp -77.69 158.75 29.54 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 124.031 1.872 . . . . 1.4 107.147 179.332 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.466 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 72.3 m80 -119.62 140.88 49.9 Favored 'General case' 0 N--CA 1.43 -1.429 1 O-C-N 115.282 -4.636 . . . . 1.51 110.707 -179.746 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 tp -115.11 107.24 15.07 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 114.525 1.306 . . . . 1.14 114.525 -178.256 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.8 t -100.9 114.8 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 118.965 -2.335 . . . . 1.23 106.206 175.995 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.5 mt -97.57 158.2 15.61 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.362 2.029 . . . . 2.78 108.696 177.138 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -100.37 159.5 15.08 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.872 2.469 . . . . 3.75 106.582 -174.906 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.4 mt -81.67 85.13 6.62 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 121.839 -0.538 . . . . 3.14 111.135 168.749 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.4 ttt85 -82.8 -63.58 1.34 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.693 1.738 . . . . 6.8 115.693 169.562 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.94 -97.41 0.2 Allowed Glycine 0 N--CA 1.431 -1.692 0 O-C-N 118.675 -2.516 . . . . 3.57 113.316 -169.105 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.767 0 N-CA-C 107.914 -2.074 . . . . 3.87 107.914 -177.654 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.461 ' HG3' HG23 ' A' ' 17' ' ' VAL . 12.4 ptm . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 116.972 2.212 . . . . 1.1 116.972 . . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -108.66 163.74 12.98 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 127.464 2.306 . . . . 1.87 105.285 -179.593 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.7 pt -142.72 163.29 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 126.96 2.104 . . . . 0.72 106.085 168.865 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -126.03 110.14 13.22 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 124.517 1.135 . . . . 1.4 111.635 178.105 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.2 t -93.93 118.62 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 106.92 -1.511 . . . . 0.58 106.92 178.48 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -103.86 128.11 51.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.394 1.077 . . . . 2.09 109.619 177.236 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.5 p -85.21 165.7 17.16 Favored 'General case' 0 N--CA 1.429 -1.505 1 CA-C-O 128.979 4.228 . . . . 0.99 109.972 173.404 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.9 mt -59.35 -46.68 87.96 Favored 'General case' 0 N--CA 1.429 -1.502 1 O-C-N 115.269 -4.644 . . . . 2.53 113.113 166.153 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 p -55.99 -34.68 65.99 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 125.383 1.473 . . . . 2.08 111.952 -177.666 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.5 27.72 1.28 Allowed Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 117.718 -1.601 . . . . 1.31 112.533 174.55 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -106.83 151.46 25.17 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 117.242 -1.783 . . . . 1.4 110.028 -176.83 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.0 m -125.73 117.88 24.39 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.27 3.414 . . . . 0.78 108.343 174.055 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.365 11.5 pt -106.1 137.65 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.605 -2.56 . . . . 1.55 105.785 174.306 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.5 m -104.03 107.35 18.21 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.306 -1.316 . . . . 1.08 109.948 173.731 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.4 mt -102.52 149.6 24.23 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.262 2.225 . . . . 1.55 109.882 -175.8 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -103.25 132.12 49.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.176 -3.453 . . . . 1.95 110.979 177.479 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.461 HG23 ' HG3' ' A' ' 1' ' ' MET . 12.6 m -137.43 160.96 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 104.97 -2.233 . . . . 0.96 104.97 -169.078 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -107.5 155.97 38.66 Favored Pre-proline 0 N--CA 1.431 -1.392 0 O-C-N 120.484 -1.385 . . . . 2.35 108.872 166.352 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.67 -27.53 38.35 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 C-N-CA 124.274 3.316 . . . . 0.95 113.24 -166.715 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.6 m -92.17 3.74 54.69 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 116.014 -1.946 . . . . 1.45 113.626 -179.796 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -59.14 145.91 40.72 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 120.206 1.366 . . . . 1.69 113.284 171.824 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -79.73 159.45 26.61 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 104.873 -2.269 . . . . 0.75 104.873 175.462 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.3 mm -65.45 -37.81 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 119.399 -2.063 . . . . 0.73 110.159 177.095 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -49.49 -41.49 40.83 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 130.21 3.404 . . . . 1.62 117.69 164.571 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -77.64 -3.79 42.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 124.149 0.905 . . . . 2.13 113.184 174.79 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.04 -36.81 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 105.159 -2.163 . . . . 0.62 105.159 175.948 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -61.07 -38.17 85.28 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.496 2.093 . . . . 1.22 109.919 175.405 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.42 -36.3 68.8 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.402 -2.686 . . . . 0.51 117.856 167.029 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -69.0 -33.63 73.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.3 -4.0 . . . . 1.44 112.886 172.071 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.0 mt -66.16 -34.77 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 114.225 -2.798 . . . . 1.32 113.974 172.589 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -68.11 -39.24 82.82 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 122.359 2.345 . . . . 1.7 107.07 178.51 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -62.57 -47.06 85.5 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.468 -2.02 . . . . 1.55 110.246 178.718 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -75.52 -63.0 1.38 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.287 -2.133 . . . . 2.62 116.549 -177.389 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -94.41 -47.92 6.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.252 1.821 . . . . 1.48 115.432 -173.478 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.31 -2.4 6.19 Favored Glycine 0 N--CA 1.431 -1.698 0 CA-C-O 127.651 3.917 . . . . 1.12 112.862 174.523 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 21.2 mt -71.29 131.69 86.58 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 117.464 -3.374 . . . . 1.55 111.016 -175.085 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 17.2 Cg_exo -88.26 165.71 6.79 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 125.249 2.911 . . . . 1.02 110.371 -176.889 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.42 -14.76 28.02 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 C-N-CA 122.037 1.825 . . . . 1.25 115.265 -173.341 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -61.36 -36.64 80.75 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.882 3.273 . . . . 2.25 112.479 172.356 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -106.07 -9.83 16.81 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 126.5 1.92 . . . . 2.02 110.095 -172.474 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -82.27 103.34 11.79 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.258 -2.151 . . . . 0.69 112.213 -175.19 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -114.71 137.41 51.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.514 2.578 . . . . 2.78 105.392 164.851 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 mt -108.66 134.42 51.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.391 -3.943 . . . . 1.17 112.24 172.132 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 93.3 mt -116.44 128.92 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 125.923 2.773 . . . . 1.38 107.172 177.712 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -137.19 142.19 42.13 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.506 -2.622 . . . . 1.5 106.455 173.754 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.26 13.9 3.33 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.294 2.638 . . . . 1.21 117.121 -176.706 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.01 -16.85 57.95 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-O 122.78 1.211 . . . . 1.3 112.384 -178.324 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -101.47 154.22 19.02 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.759 -3.789 . . . . 2.55 108.631 -178.892 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -82.19 132.69 35.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 124.999 1.437 . . . . 2.48 111.674 170.265 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 mt -89.27 140.79 29.13 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 122.041 2.2 . . . . 0.9 114.301 -176.184 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -81.91 142.91 32.06 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 128.032 2.533 . . . . 1.94 110.943 178.265 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.02 -56.31 22.58 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.916 2.086 . . . . 1.56 113.352 -174.531 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.37 37.58 2.59 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 116.021 -2.544 . . . . 0.97 114.359 176.51 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -114.91 164.36 14.25 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.192 -1.781 . . . . 2.49 106.192 166.922 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -114.0 167.18 10.88 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.169 -2.207 . . . . 0.76 112.702 -176.932 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.9 mp -64.25 -42.12 96.65 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.514 2.726 . . . . 1.05 111.672 177.482 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.1 p -70.02 -37.46 75.64 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 117.81 -1.09 . . . . 1.19 113.081 -179.629 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.19 -40.76 98.44 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.004 1.722 . . . . 1.9 115.627 174.198 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -75.21 -16.47 60.48 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.987 -3.57 . . . . 0.89 107.557 177.398 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 70.97 48.64 0.38 Allowed 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.542 1.137 . . . . 1.84 112.421 -174.361 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.8 mt -86.5 107.88 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 113.56 -1.654 . . . . 0.82 110.216 175.831 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -95.38 -160.76 0.81 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.058 2.543 . . . . 2.16 112.071 -174.967 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -76.21 138.37 40.6 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 116.997 -3.564 . . . . 2.12 111.762 174.565 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.309 5.4 tt0 71.37 69.81 0.17 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 127.866 3.229 . . . . 1.71 110.991 174.529 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.397 55.2 m -116.01 144.61 43.86 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.423 -2.673 . . . . 1.04 109.287 -174.817 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.4 m -104.07 102.72 12.47 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.94 -1.504 . . . . 0.79 106.94 175.375 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.0 mt -91.31 123.93 35.12 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.518 -2.614 . . . . 1.4 108.023 170.757 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -92.65 109.14 20.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.645 0.778 . . . . 1.51 110.59 -178.093 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 tp -91.07 113.77 26.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.321 1.534 . . . . 1.14 112.378 -179.752 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.4 m -102.78 160.63 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 124.808 2.242 . . . . 1.23 106.43 178.548 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.6 tp -96.05 115.81 28.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.837 -1.529 . . . . 2.78 114.24 176.397 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -95.94 121.9 38.17 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 105.018 -2.216 . . . . 3.75 105.018 -179.732 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.4 mt -96.28 175.91 6.26 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.26 -0.882 . . . . 3.14 112.416 172.289 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -84.7 106.05 15.95 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.413 2.054 . . . . 6.8 114.175 174.586 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.31 -165.27 37.84 Favored Glycine 0 N--CA 1.43 -1.738 0 O-C-N 119.445 -2.035 . . . . 3.57 113.706 -166.228 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.772 0 CA-C-O 115.597 -2.78 . . . . 3.87 109.993 -176.036 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptt? . . . . . 0 CA--C 1.49 -1.349 1 CA-C-O 129.473 4.463 . . . . 1.1 110.689 . . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -91.03 146.75 23.59 Favored 'General case' 0 N--CA 1.431 -1.41 1 O-C-N 113.862 -5.524 . . . . 1.87 110.089 -176.555 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.329 13.9 pt -135.97 153.0 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 129.346 3.058 . . . . 0.72 109.109 178.526 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -112.95 141.98 46.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 126.459 3.028 . . . . 1.4 107.755 176.096 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -134.56 122.02 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 118.263 -2.773 . . . . 0.58 107.842 170.238 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -96.23 137.26 35.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.771 -1.559 . . . . 2.09 111.027 175.41 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.415 HG22 HD23 ' A' ' 69' ' ' LEU 0.289 44.8 p -77.15 172.67 12.88 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 126.27 2.938 . . . . 0.99 110.363 175.035 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 tp -64.17 -51.34 64.28 Favored 'General case' 0 N--CA 1.429 -1.494 1 O-C-N 115.849 -4.282 . . . . 2.53 113.622 174.965 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.379 75.4 p -61.06 -41.7 97.09 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.563 1.69 . . . . 2.08 115.563 174.552 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.34 9.97 0.2 Allowed Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 116.945 1.538 . . . . 1.31 116.945 175.005 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -84.37 118.5 24.27 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.427 -2.219 . . . . 1.4 114.165 -174.353 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.6 m -93.47 126.77 38.79 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 121.785 2.084 . . . . 0.78 109.415 179.485 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mt -116.87 111.73 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 127.179 2.192 . . . . 1.55 113.153 -178.191 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.1 m -81.2 121.31 25.99 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 126.519 1.928 . . . . 1.08 107.596 177.087 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.5 mt -124.9 146.86 49.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 100.712 -3.81 . . . . 1.55 100.712 -179.475 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -106.18 122.68 46.69 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 118.393 -2.692 . . . . 1.95 108.371 169.909 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.9 m -129.74 152.04 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 126.584 3.087 . . . . 0.96 107.247 -172.99 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -94.1 151.05 39.35 Favored Pre-proline 0 N--CA 1.429 -1.507 1 O-C-N 114.869 -4.894 . . . . 2.35 106.254 156.273 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -76.53 -6.68 17.24 Favored 'Trans proline' 0 N--CA 1.433 -2.05 0 CA-C-N 125.72 3.078 . . . . 0.95 113.525 -174.756 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -87.01 -3.02 59.05 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 125.632 1.833 . . . . 1.45 111.913 -178.466 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -76.37 156.63 33.09 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 129.515 3.126 . . . . 1.69 109.334 171.383 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 4.5 p -84.98 166.61 16.61 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.402 -2.686 . . . . 0.75 111.794 177.529 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.22 -42.81 97.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 126.419 1.888 . . . . 0.73 109.395 174.939 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -46.35 -44.28 16.77 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.624 3.194 . . . . 1.62 119.624 164.812 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -67.17 -32.97 74.43 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.306 1.595 . . . . 2.13 115.306 173.522 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.3 t -64.15 -39.05 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 126.933 3.254 . . . . 0.62 111.966 169.771 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -59.15 -44.05 92.09 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.324 -2.735 . . . . 1.22 115.268 173.876 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.3 -33.0 65.13 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.056 -2.278 . . . . 0.51 111.401 173.788 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -76.54 -26.39 55.13 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 115.342 1.608 . . . . 1.44 115.342 173.96 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.7 mt -70.96 -28.25 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 119.739 -1.851 . . . . 1.32 114.558 169.146 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -70.92 -33.55 70.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.81 3.244 . . . . 1.7 108.111 179.559 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -74.95 -34.26 62.03 Favored 'General case' 0 N--CA 1.431 -1.408 1 C-N-CA 132.998 4.519 . . . . 1.55 112.356 175.47 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.9 mmtm -89.33 -64.72 1.1 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 127.959 3.742 . . . . 2.62 110.099 -171.078 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -93.93 -42.08 9.26 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.04 -2.287 . . . . 1.48 113.621 -170.533 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.73 5.74 21.93 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 121.254 3.261 . . . . 1.12 121.254 175.638 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.1 mt -74.92 129.69 82.68 Favored Pre-proline 0 N--CA 1.431 -1.414 0 C-N-CA 128.747 2.819 . . . . 1.55 110.436 -178.186 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.527 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 8.8 Cg_endo -77.3 141.93 20.84 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 126.077 3.206 . . . . 1.02 111.998 -177.244 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 32.8 Cg_exo -58.27 -17.53 33.28 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 N-CA-C 118.739 2.554 . . . . 1.25 118.739 -173.061 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -79.04 -23.2 44.43 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 114.863 1.431 . . . . 2.25 114.863 171.349 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -88.66 -13.75 39.06 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.351 -2.093 . . . . 2.02 108.111 176.765 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.329 69.2 mt-30 -98.12 143.76 28.31 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 121.163 1.802 . . . . 0.69 110.9 -174.316 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -135.87 135.79 40.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 121.398 0.618 . . . . 2.78 111.037 171.301 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.0 mt -102.84 134.75 45.72 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 117.254 -3.404 . . . . 1.17 115.702 172.139 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.3 mt -118.53 130.28 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 114.724 -1.125 . . . . 1.38 108.322 -179.484 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -136.29 123.15 21.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.139 -2.85 . . . . 1.5 118.009 176.167 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.54 40.44 23.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.046 1.738 . . . . 1.21 110.631 -171.445 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.92 -8.45 50.5 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-O 114.465 -3.408 . . . . 1.3 114.922 179.537 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -85.39 135.5 33.85 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 120.002 1.901 . . . . 2.55 110.706 175.348 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -84.69 120.69 26.69 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.748 2.689 . . . . 2.48 108.475 164.927 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.1 mt -80.25 107.99 13.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 118.204 2.668 . . . . 0.9 118.204 -173.726 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.269 33.2 mt-10 -52.9 121.98 8.36 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 121.525 3.898 . . . . 1.94 121.525 170.434 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.12 -57.82 1.25 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 131.158 3.783 . . . . 1.56 115.756 -174.075 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.89 39.19 2.84 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 127.73 2.586 . . . . 0.97 116.613 175.186 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -121.35 172.37 8.08 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.081 1.896 . . . . 2.49 106.142 167.385 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.301 62.2 p -87.83 176.67 7.27 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 118.944 -2.348 . . . . 0.76 113.959 168.663 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.4 mt -80.53 -25.78 38.47 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.446 1.899 . . . . 1.05 109.409 165.771 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.56 -39.55 62.21 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 107.657 -1.238 . . . . 1.19 107.657 -170.641 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -43.61 -57.79 2.98 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 126.783 2.033 . . . . 1.9 116.078 169.351 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -71.49 -1.31 12.87 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 119.279 3.066 . . . . 0.89 119.279 -178.588 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.396 23.1 m120 62.2 49.9 4.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 131.003 3.721 . . . . 1.84 113.083 -170.198 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.4 mt -87.64 137.31 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 123.508 2.867 . . . . 0.82 109.247 174.988 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -122.51 -176.56 3.41 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.833 2.254 . . . . 2.16 110.528 -175.762 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 ptmm? -62.59 139.55 58.63 Favored 'General case' 0 N--CA 1.429 -1.487 1 O-C-N 116.206 -4.059 . . . . 2.12 111.898 -177.513 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 62.61 31.52 16.79 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.856 2.862 . . . . 1.71 109.15 175.307 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 t -95.01 137.45 34.05 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.458 -2.651 . . . . 1.04 109.994 -179.897 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.2 m -88.07 121.58 30.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 126.929 2.643 . . . . 0.79 112.035 -177.767 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 72.2 mt -105.28 152.79 22.46 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 128.631 2.772 . . . . 1.4 105.871 176.9 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -101.82 125.32 48.47 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.439 -2.663 . . . . 1.51 107.261 -177.48 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.415 HD23 HG22 ' A' ' 7' ' ' THR . 27.2 tp -96.93 126.28 41.96 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 124.296 3.225 . . . . 1.14 110.949 178.131 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.9 m -131.1 176.98 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 118.366 -2.709 . . . . 1.23 111.162 172.012 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 67.7 mt -101.39 133.49 45.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.724 -1.86 . . . . 2.78 114.064 178.431 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.3 ttt-85 -86.56 75.93 9.65 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 126.501 1.92 . . . . 3.75 110.805 170.613 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.9 mt -81.95 163.19 22.36 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 113.627 -1.624 . . . . 3.14 110.781 -178.27 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -73.04 -178.5 2.85 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 127.359 2.264 . . . . 6.8 116.683 174.464 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.24 40.65 9.02 Favored Glycine 0 N--CA 1.432 -1.619 0 N-CA-C 120.03 2.772 . . . . 3.57 120.03 -170.286 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.773 0 C-N-CA 116.604 -2.713 . . . . 3.87 111.608 -175.488 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 112.157 0.429 . . . . 1.1 112.157 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -108.96 140.73 42.07 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.316 -2.74 . . . . 1.87 105.678 177.588 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.4 pt -128.86 153.17 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 106.486 -1.672 . . . . 0.72 106.486 173.477 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -109.75 105.82 15.21 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.501 -2.0 . . . . 1.4 115.226 179.188 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.0 t -94.58 115.95 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 117.801 -3.062 . . . . 0.58 105.762 176.565 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -95.39 156.91 16.12 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.689 2.185 . . . . 2.09 108.013 175.502 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.2 p -105.06 -171.61 1.95 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.994 1.318 . . . . 0.99 110.252 -178.404 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.9 mt -85.88 -36.84 19.71 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 115.701 -4.375 . . . . 2.53 114.242 172.477 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.251 38.6 p -80.06 -54.84 5.41 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.589 -2.004 . . . . 2.08 105.589 -175.339 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.02 23.77 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 120.241 2.856 . . . . 1.31 120.241 171.541 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -88.18 135.83 33.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 117.684 -1.15 . . . . 1.4 111.058 -179.917 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.8 m -109.79 111.65 23.23 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.359 -1.349 . . . . 0.78 107.359 169.851 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 mt -92.3 105.54 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 104.835 -2.283 . . . . 1.55 104.835 -177.315 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.8 m -85.36 107.6 17.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.673 -3.142 . . . . 1.08 106.174 178.159 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.8 mt -101.13 144.17 30.35 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 114.318 1.229 . . . . 1.55 114.318 -177.973 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -101.05 118.88 37.88 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.678 2.656 . . . . 1.95 110.875 174.952 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 m -130.26 158.57 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 123.863 1.792 . . . . 0.96 110.614 -172.412 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -113.26 170.73 4.99 Favored Pre-proline 0 N--CA 1.43 -1.45 0 O-C-N 117.772 -3.08 . . . . 2.35 105.408 159.358 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -87.21 -9.55 6.05 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 C-N-CA 122.342 2.028 . . . . 0.95 114.006 -167.836 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.261 81.5 p -85.04 0.85 50.14 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 131.284 3.833 . . . . 1.45 116.079 173.445 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -86.7 145.33 26.72 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.673 -3.142 . . . . 1.69 111.552 169.098 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.5 p -59.75 155.41 16.04 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.718 2.199 . . . . 0.75 112.559 168.979 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.253 3.3 mt -63.19 -37.13 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 119.654 -1.904 . . . . 0.73 112.551 170.332 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -53.09 -40.55 64.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.075 1.509 . . . . 1.62 115.075 165.655 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -61.02 -32.98 72.57 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 118.275 2.695 . . . . 2.13 118.275 174.186 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.318 45.6 t -71.2 -35.85 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 122.387 1.089 . . . . 0.62 110.196 -178.42 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -70.08 -24.37 63.22 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 132.042 4.137 . . . . 1.22 113.593 174.442 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.56 -33.99 62.82 Favored 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 116.298 -4.001 . . . . 0.51 111.644 174.941 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -69.1 -25.93 64.66 Favored 'General case' 0 N--CA 1.431 -1.395 1 O-C-N 114.972 -4.83 . . . . 1.44 115.522 178.429 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 mt -68.01 -39.64 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 1 C-N-CA 132.499 4.32 . . . . 1.32 112.397 170.594 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.11 -36.68 77.99 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.718 2.488 . . . . 1.7 117.718 178.332 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.03 -57.9 10.88 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 116.544 -1.693 . . . . 1.55 114.127 163.242 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -62.78 -61.84 2.13 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 118.284 2.698 . . . . 2.62 118.284 -177.722 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -93.79 -32.34 14.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.9 -3.0 . . . . 1.48 109.584 -171.81 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.88 16.78 22.86 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 116.92 -2.562 . . . . 1.12 115.629 172.699 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.4 mt -90.58 131.96 36.54 Favored Pre-proline 0 N--CA 1.43 -1.455 1 CA-C-O 110.889 -4.386 . . . . 1.55 110.66 179.237 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -57.68 146.67 83.96 Favored 'Trans proline' 0 C--N 1.299 -2.056 0 CA-C-N 127.664 3.773 . . . . 1.02 116.954 171.767 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.66 -13.38 13.28 Favored 'Trans proline' 0 N--CA 1.434 -2.027 1 C-N-CA 125.674 4.249 . . . . 1.25 113.985 -175.077 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.391 9.6 p-10 -62.83 -31.78 72.86 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 119.724 1.147 . . . . 2.25 113.708 166.325 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -80.75 -26.89 37.03 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 123.813 1.768 . . . . 2.02 113.284 -176.398 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -84.67 142.78 29.65 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 111.711 -2.495 . . . . 0.69 111.252 -173.651 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -143.35 142.6 31.35 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.921 -1.49 . . . . 2.78 111.845 171.644 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.6 mt -105.19 146.63 28.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.92 2.295 . . . . 1.17 106.387 -178.38 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 mt -118.76 138.93 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 128.582 2.753 . . . . 1.38 104.51 174.29 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -144.58 120.44 10.6 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 124.971 2.32 . . . . 1.5 104.789 177.109 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.38 13.58 5.52 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 127.865 2.466 . . . . 1.21 114.912 175.435 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.29 -22.57 38.58 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 127.487 2.47 . . . . 1.3 113.991 -171.571 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -80.57 134.96 36.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 126.548 3.07 . . . . 2.55 111.676 -177.267 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -77.8 128.79 34.57 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 117.195 -3.441 . . . . 2.48 111.942 176.778 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.6 mt -92.97 142.65 27.07 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.188 -2.195 . . . . 0.9 113.438 -172.356 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -79.86 148.01 31.5 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.077 2.951 . . . . 1.94 110.849 175.242 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -89.18 -34.27 16.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.167 1.914 . . . . 1.56 116.167 -168.468 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.36 21.03 6.42 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 128.488 2.947 . . . . 0.97 117.698 171.979 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -105.55 178.2 4.63 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 119.698 1.749 . . . . 2.49 108.187 169.311 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -108.84 -172.94 2.15 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 124.905 2.288 . . . . 0.76 107.274 167.164 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.6 mt -66.06 -43.87 86.2 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 128.436 3.97 . . . . 1.05 112.889 171.089 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.4 m -53.27 -25.97 16.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.179 -3.451 . . . . 1.19 118.291 -179.734 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -78.37 -44.83 23.99 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.115 2.966 . . . . 1.9 111.841 177.386 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -80.76 9.87 5.7 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 129.949 3.3 . . . . 0.89 114.648 174.949 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.27 10.2 p30 47.93 39.8 11.68 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 129.044 2.938 . . . . 1.84 114.176 -178.888 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.304 12.7 mt -77.92 127.56 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 116.856 -3.652 . . . . 0.82 109.555 179.966 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 -107.58 -178.37 3.61 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 125.655 2.645 . . . . 2.16 106.369 178.427 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -64.22 159.22 21.19 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 115.74 -4.35 . . . . 2.12 110.467 -177.484 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.421 19.9 mt-10 59.41 41.53 19.34 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 116.966 -3.583 . . . . 1.71 112.657 169.389 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.2 p -106.36 135.14 48.38 Favored 'General case' 0 N--CA 1.431 -1.397 1 O-C-N 114.857 -4.902 . . . . 1.04 109.9 -173.373 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.5 m -86.44 116.55 24.66 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.477 -2.64 . . . . 0.79 107.163 175.808 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.6 mp -109.45 160.57 16.09 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 112.862 -1.972 . . . . 1.4 110.29 172.594 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -127.39 139.53 52.78 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.949 -2.344 . . . . 1.51 112.046 -176.681 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.6 tp -103.46 127.13 50.91 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 130.695 3.598 . . . . 1.14 109.16 -177.495 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.0 m -135.15 163.95 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 O-C-N 116.351 -3.968 . . . . 1.23 110.557 166.476 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.6 mt -98.07 158.69 15.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 117.024 -1.465 . . . . 2.78 113.278 170.77 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -80.45 142.48 34.25 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 117.125 2.269 . . . . 3.75 117.125 -178.5 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.5 mt -88.4 112.81 23.33 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 104.692 -2.336 . . . . 3.14 104.692 172.95 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -81.46 120.45 25.02 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 114.146 -5.346 . . . . 6.8 110.65 173.827 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.1 -128.72 1.1 Allowed Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 107.131 -2.388 . . . . 3.57 107.131 -173.543 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.778 0 C-N-CA 128.153 2.787 . . . . 3.87 111.496 -178.262 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 CA--C 1.49 -1.36 0 CA-C-O 125.998 2.809 . . . . 1.1 103.709 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -90.28 125.75 35.61 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.969 -3.582 . . . . 1.87 109.432 -179.328 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -127.65 150.49 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 118.926 -1.109 . . . . 0.72 109.092 170.148 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.262 33.3 m-85 -115.03 121.86 44.4 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 124.28 1.99 . . . . 1.4 112.314 -172.027 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -103.12 107.97 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 119.677 -1.889 . . . . 0.58 110.903 178.309 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -85.61 158.66 20.05 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 118.806 -2.434 . . . . 2.09 107.474 177.781 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.3 p -108.43 -167.52 1.24 Allowed 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 106.824 -1.547 . . . . 0.99 106.824 175.3 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.6 mt -88.69 -30.75 18.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 119.865 1.211 . . . . 2.53 109.171 178.592 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.9 p -70.57 -27.65 64.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.055 -2.278 . . . . 2.08 106.542 -179.478 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.34 18.66 6.13 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-O 122.432 1.018 . . . . 1.31 115.592 173.362 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -82.63 117.86 22.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 117.041 -1.457 . . . . 1.4 113.375 -177.463 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.288 89.2 m -85.35 115.41 23.08 Favored 'General case' 0 N--CA 1.431 -1.389 1 CA-C-N 126.202 4.092 . . . . 0.78 114.115 175.396 . . . . . . . . 3 2 . 1 . 037 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 13' ' ' ILE . 53.2 mt -100.56 107.31 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 1 O-C-N 114.963 -4.836 . . . . 1.55 110.6 178.629 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.7 m -80.68 116.3 20.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.954 -2.341 . . . . 1.08 114.057 175.562 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.9 mt -107.6 127.98 54.12 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.55 -1.969 . . . . 1.55 107.717 178.009 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -96.15 99.83 11.53 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.376 -2.702 . . . . 1.95 104.619 170.69 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.3 m -112.38 164.63 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 105.681 -1.97 . . . . 0.96 105.681 -176.406 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -104.78 163.73 16.61 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 105.618 -1.993 . . . . 2.35 105.618 165.663 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -86.82 -8.93 6.72 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 O-C-N 113.932 -3.773 . . . . 0.95 108.759 -166.402 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.25 4.9 p -90.72 1.14 57.12 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 119.763 -0.775 . . . . 1.45 111.674 177.149 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.27 36.2 m-20 -63.01 148.7 46.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 129.694 3.198 . . . . 1.69 108.737 172.173 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 23.5 p -97.99 163.87 12.59 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 118.846 -2.409 . . . . 0.75 112.632 173.893 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.417 HD12 HD13 ' A' ' 50' ' ' LEU 0.298 24.1 mm -63.41 -34.98 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 120.062 1.301 . . . . 0.73 111.099 -179.581 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -48.77 -39.95 27.04 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 117.948 -2.97 . . . . 1.62 115.243 160.279 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -75.84 -48.65 20.66 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.508 -2.62 . . . . 2.13 107.905 -176.741 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.401 ' CG2' HD11 ' A' ' 56' ' ' LEU . 52.6 t -49.1 -54.25 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.989 2.916 . . . . 0.62 116.334 172.56 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -50.97 -32.75 22.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.427 -1.421 . . . . 1.22 113.876 175.983 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.88 -40.02 91.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.181 3.372 . . . . 0.51 114.068 178.789 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -58.79 -40.94 85.49 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.78 -3.075 . . . . 1.44 112.378 176.245 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.4 mt -70.5 -31.6 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 116.487 -3.883 . . . . 1.32 112.061 176.139 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -69.13 -33.39 73.38 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 119.434 -2.041 . . . . 1.7 111.453 171.929 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.355 17.5 t70 -77.13 -44.3 30.87 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.43 2.011 . . . . 1.55 116.43 167.814 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -65.33 -60.56 2.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.194 -3.441 . . . . 2.62 111.092 -171.099 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -105.13 -37.16 7.02 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 124.283 1.992 . . . . 1.48 109.355 -166.251 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.92 38.39 2.35 Favored Glycine 0 N--CA 1.43 -1.752 0 O-C-N 117.56 -3.213 . . . . 1.12 111.575 168.752 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.5 mt -111.08 122.23 38.48 Favored Pre-proline 0 N--CA 1.43 -1.465 0 O-C-N 118.577 -2.719 . . . . 1.55 106.395 -174.441 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 18.5 Cg_endo -57.76 141.73 95.79 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 O-C-N 115.65 -2.868 . . . . 1.02 116.819 175.448 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 67.6 Cg_exo -64.83 -32.96 54.87 Favored 'Trans proline' 0 N--CA 1.433 -2.03 1 C-N-CA 127.54 5.493 . . . . 1.25 111.797 -174.136 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -51.14 -39.35 56.09 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 129.871 3.268 . . . . 2.25 113.996 168.158 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -82.19 -5.22 58.33 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.11 1.909 . . . . 2.02 112.688 178.248 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -99.6 113.76 26.38 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 116.333 -3.98 . . . . 0.69 108.27 -166.933 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -89.29 123.02 33.11 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 125.31 2.481 . . . . 2.78 104.823 163.017 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.2 mt -109.29 119.67 40.2 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.039 -5.413 . . . . 1.17 105.267 175.385 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.3 mm -108.51 133.16 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 128.306 2.643 . . . . 1.38 113.037 179.57 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -130.93 114.31 15.09 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 129.298 4.124 . . . . 1.5 111.05 174.074 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.01 -92.14 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.162 2.185 . . . . 1.21 113.306 -178.437 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.79 23.0 4.01 Favored Glycine 0 N--CA 1.431 -1.696 0 C-N-CA 127.676 2.56 . . . . 1.3 112.536 174.106 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.9 mmtt -123.33 129.95 52.04 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.09 -1.829 . . . . 2.55 110.212 -179.36 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -87.55 125.13 34.15 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 117.185 -3.447 . . . . 2.48 105.274 172.014 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.417 HD13 HD12 ' A' ' 23' ' ' ILE . 99.3 mt -82.11 126.69 32.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.082 -1.636 . . . . 0.9 111.906 -162.104 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -76.13 147.97 38.16 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.644 -2.535 . . . . 1.94 111.938 168.772 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.276 42.6 m-20 -61.11 -65.65 0.66 Allowed 'General case' 0 N--CA 1.431 -1.419 1 N-CA-C 123.201 4.519 . . . . 1.56 123.201 -171.271 . . . . . . . . 3 2 . 1 . 037 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.82 32.92 3.36 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 122.045 3.578 . . . . 0.97 122.045 178.886 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.7 mtt-85 -102.7 153.65 19.93 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 103.697 -2.705 . . . . 2.49 103.697 169.875 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.268 8.1 p -77.43 153.56 33.48 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 131.043 3.737 . . . . 0.76 110.328 171.733 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.401 HD11 ' CG2' ' A' ' 26' ' ' VAL . 1.5 mt -59.74 -42.15 92.52 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.017 -0.992 . . . . 1.05 111.847 172.118 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.6 p -56.81 -36.56 70.06 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.564 2.346 . . . . 1.19 111.725 179.067 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -66.41 -45.7 79.04 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.871 1.669 . . . . 1.9 111.7 -177.197 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -72.19 -9.16 58.08 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 116.966 2.21 . . . . 0.89 116.966 170.62 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 61.46 53.01 3.51 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.496 1.518 . . . . 1.84 112.504 -177.68 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.8 mt -89.05 113.78 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 130.791 3.637 . . . . 0.82 105.038 176.079 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -99.52 -169.9 1.82 Allowed 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.301 1.593 . . . . 2.16 115.301 178.504 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -66.32 141.25 58.06 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.765 1.745 . . . . 2.12 110.791 176.38 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 67.23 24.98 9.01 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 112.437 -2.165 . . . . 1.71 113.272 172.918 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.3 m -75.58 144.6 41.75 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.855 1.312 . . . . 1.04 112.732 -175.874 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 m -97.57 123.46 41.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 118.071 -1.451 . . . . 0.79 108.518 -176.081 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 mp -122.26 163.38 19.74 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 104.508 -2.404 . . . . 1.4 104.508 178.195 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.263 43.6 m80 -134.63 112.03 10.49 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.46 2.552 . . . . 1.51 110.822 -172.302 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.05 122.74 22.26 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.695 2.398 . . . . 1.14 111.605 175.397 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.5 t -123.01 136.27 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 102.506 -3.146 . . . . 1.23 102.506 175.202 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.7 tp -98.35 125.68 43.58 Favored 'General case' 0 N--CA 1.429 -1.487 1 O-C-N 114.822 -4.924 . . . . 2.78 111.027 -174.45 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -84.5 117.11 23.48 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.18 1.792 . . . . 3.75 109.225 176.075 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.6 mt -83.07 -166.45 1.35 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.988 1.715 . . . . 3.14 112.223 168.712 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -83.81 176.19 9.11 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.825 1.774 . . . . 6.8 112.506 172.127 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.93 42.77 96.72 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 118.125 2.01 . . . . 3.57 118.125 -167.291 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.83 0 O-C-N 119.908 -1.936 . . . . 3.87 109.24 172.188 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 ptt? . . . . . 0 CA--C 1.491 -1.325 0 N-CA-C 118.225 2.676 . . . . 1.1 118.225 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.257 7.1 tt0 -117.83 123.27 45.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.677 2.791 . . . . 1.87 114.206 -178.498 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.4 pt -127.94 160.47 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 117.774 -3.079 . . . . 0.72 106.922 174.457 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -118.71 132.79 56.16 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.38 3.472 . . . . 1.4 106.231 -173.355 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 t -122.97 125.59 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 123.447 0.699 . . . . 0.58 110.772 170.851 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.344 19.4 mttm -103.05 145.41 29.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.967 2.794 . . . . 2.09 115.067 179.598 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.301 22.9 p -91.45 168.68 11.37 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.722 -4.362 . . . . 0.99 116.291 173.653 . . . . . . . . 3 2 . 1 . 038 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.342 31.6 tp -59.31 -56.65 19.4 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.673 2.101 . . . . 2.53 116.673 169.603 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 p -61.89 -60.85 3.03 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 114.35 -1.295 . . . . 2.08 112.002 -176.075 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.86 30.53 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 117.964 -2.065 . . . . 1.31 117.214 173.105 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -111.36 146.3 37.35 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.696 -2.061 . . . . 1.4 111.305 -178.509 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.8 m -112.69 104.61 12.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 104.065 -2.568 . . . . 0.78 104.065 167.602 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.2 mt -91.0 123.53 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 122.213 1.006 . . . . 1.55 108.379 -176.447 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 m -94.31 120.89 35.21 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 118.488 -2.632 . . . . 1.08 109.318 -179.957 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.6 mt -113.14 143.51 44.25 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 126.929 3.252 . . . . 1.55 112.215 179.551 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -86.2 112.35 21.26 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 111.805 -2.452 . . . . 1.95 107.004 171.237 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.13 149.86 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.989 1.716 . . . . 0.96 114.922 -177.613 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -108.79 149.54 39.65 Favored Pre-proline 0 N--CA 1.43 -1.438 0 N-CA-C 103.651 -2.722 . . . . 2.35 103.651 172.418 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -63.94 -19.7 67.0 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 123.428 2.752 . . . . 0.95 113.178 -173.84 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.4 p -80.73 -16.77 53.04 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 130.08 3.352 . . . . 1.45 110.683 -177.51 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -60.24 145.63 46.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 116.779 -1.968 . . . . 1.69 113.892 172.428 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.9 p -80.25 162.62 24.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.537 2.113 . . . . 0.75 108.905 176.461 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.491 HG23 HD12 ' A' ' 43' ' ' LEU . 24.3 mm -64.87 -30.5 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 126.833 3.206 . . . . 0.73 112.016 177.125 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.6 -39.17 91.27 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 114.693 -5.004 . . . . 1.62 112.217 167.059 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.253 15.8 m-80 -70.39 -32.73 70.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 119.892 1.224 . . . . 2.13 112.552 171.683 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.35 43.4 t -53.57 -48.67 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 1 O-C-N 114.287 -5.258 . . . . 0.62 112.72 167.825 . . . . . . . . 3 2 . 1 . 038 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -56.06 -41.25 74.78 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.187 1.921 . . . . 1.22 116.187 174.531 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.3 -31.74 72.96 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.431 1.493 . . . . 0.51 112.637 172.275 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -66.22 -38.59 88.3 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 127.494 3.521 . . . . 1.44 115.673 176.119 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.7 mt -73.07 -36.99 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 117.636 -3.165 . . . . 1.32 107.596 172.911 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.454 ' HG3' ' HD3' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -62.64 -35.2 78.85 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 123.851 3.023 . . . . 1.7 113.844 179.431 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.45 -54.72 24.39 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.461 1.904 . . . . 1.55 109.726 175.188 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.5 mmtt -57.83 -77.64 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.479 3.038 . . . . 2.62 115.638 -179.08 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -101.68 -20.78 14.85 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.166 -3.458 . . . . 1.48 110.142 -161.895 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.77 53.81 2.48 Favored Glycine 0 N--CA 1.431 -1.682 0 O-C-N 120.412 -1.43 . . . . 1.12 115.165 172.524 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.417 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 6.1 mt -108.05 117.04 55.99 Favored Pre-proline 0 N--CA 1.43 -1.436 0 CA-C-O 113.51 -3.138 . . . . 1.55 110.153 -175.773 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.499 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 50.3 Cg_exo -67.32 127.24 16.26 Favored 'Trans proline' 0 C--N 1.299 -2.054 0 CA-C-N 126.241 3.265 . . . . 1.02 117.292 -179.654 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 27.5 Cg_exo -59.49 -31.13 94.15 Favored 'Trans proline' 0 N--CA 1.434 -2.016 1 C-N-CA 127.527 5.485 . . . . 1.25 118.406 -172.402 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -64.9 -24.68 67.6 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.753 2.821 . . . . 2.25 108.445 178.721 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -94.02 12.71 25.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.912 -2.368 . . . . 2.02 116.53 173.733 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.275 9.6 mt-30 -115.29 147.21 40.69 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.217 2.437 . . . . 0.69 110.675 -178.893 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.6 ptt85 -135.02 134.65 40.66 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 112.907 -1.951 . . . . 2.78 106.048 163.853 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.491 HD12 HG23 ' A' ' 23' ' ' ILE . 44.3 mt -103.69 133.48 48.63 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 119.823 1.192 . . . . 1.17 113.203 179.64 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.4 mm -118.64 145.49 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 125.059 2.361 . . . . 1.38 108.553 177.9 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -134.54 108.79 8.29 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.013 -2.93 . . . . 1.5 103.92 172.295 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.519 . . 72.77 -97.33 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 116.666 2.099 . . . . 1.21 116.666 -176.961 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.9 17.52 1.97 Allowed Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 127.603 2.525 . . . . 1.3 108.532 -175.639 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.2 mttm -106.49 144.79 32.66 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.204 -2.35 . . . . 2.55 110.06 170.664 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -107.75 129.29 55.05 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.587 3.089 . . . . 2.48 115.345 169.649 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.7 mt -97.19 122.84 40.66 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.394 -3.941 . . . . 0.9 104.433 -160.342 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -77.09 138.66 39.67 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 117.633 -3.167 . . . . 1.94 111.72 172.397 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -54.91 -41.14 70.6 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 130.489 3.515 . . . . 1.56 115.978 -170.131 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.38 31.24 6.9 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 126.537 2.018 . . . . 0.97 115.051 174.935 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.87 165.28 11.83 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.224 -1.399 . . . . 2.49 107.224 166.426 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 5.4 p -95.62 171.52 8.62 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 119.034 2.976 . . . . 0.76 119.034 169.179 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -59.35 -39.1 82.16 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 121.59 1.995 . . . . 1.05 112.171 169.772 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 t -64.3 -37.86 88.98 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 116.944 2.202 . . . . 1.19 116.944 -179.151 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -61.19 -21.59 63.96 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.657 -1.902 . . . . 1.9 113.851 174.071 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -109.52 12.35 24.48 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.659 2.936 . . . . 0.89 115.685 -178.962 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.401 6.4 t-20 62.6 39.24 11.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.683 2.793 . . . . 1.84 116.71 -177.093 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.7 mt -90.84 105.5 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 112.661 -2.063 . . . . 0.82 112.556 178.046 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -98.9 -171.59 2.13 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 122.23 2.286 . . . . 2.16 107.111 -174.551 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.253 21.8 pttp -61.54 149.01 40.26 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 126.698 1.999 . . . . 2.12 115.604 176.354 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.317 36.1 mt-10 67.19 13.18 9.32 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.804 1.779 . . . . 1.71 115.804 175.123 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.6 m -66.44 148.74 51.45 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.477 -2.014 . . . . 1.04 112.271 -177.835 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.6 m -103.45 97.92 7.9 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.808 1.766 . . . . 0.79 115.494 173.751 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 mp -87.26 152.43 22.31 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.526 -1.984 . . . . 1.4 113.993 -178.924 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.6 m170 -120.79 129.07 53.44 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.158 -1.589 . . . . 1.51 109.87 -173.788 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.4 tp -95.34 128.82 42.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.576 -1.327 . . . . 1.14 114.374 -176.175 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.4 159.0 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 124.163 1.935 . . . . 1.23 113.669 177.371 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 tp -88.55 138.71 31.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.786 -1.196 . . . . 2.78 110.852 -174.439 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -99.21 139.68 34.5 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.854 3.216 . . . . 3.75 106.186 178.407 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.7 mt -131.15 112.75 13.12 Favored 'General case' 0 N--CA 1.43 -1.428 1 N-CA-C 98.629 -4.582 . . . . 3.14 98.629 173.026 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -82.46 147.03 28.95 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.786 2.143 . . . . 6.8 116.786 168.771 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.86 -76.79 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 108.384 -1.886 . . . . 3.57 108.384 -168.528 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.761 0 C-N-CA 118.767 -1.682 . . . . 3.87 115.006 177.104 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.2 ttp . . . . . 0 CA--C 1.49 -1.355 0 CA-C-O 116.443 -1.741 . . . . 1.1 109.537 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -96.13 134.29 39.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.114 1.779 . . . . 1.87 109.064 176.69 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 pt -130.22 162.58 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 106.289 -1.745 . . . . 0.72 106.289 163.566 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -115.01 143.32 45.37 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.038 -1.664 . . . . 1.4 113.952 178.088 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.3 t -113.73 120.29 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 118.098 -2.876 . . . . 0.58 104.05 171.106 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -107.78 119.38 39.27 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 126.973 2.109 . . . . 2.09 106.641 177.547 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.3 p -84.13 163.55 19.73 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 121.165 -0.959 . . . . 0.99 111.724 -176.746 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.4 tp -39.56 -43.05 1.24 Allowed 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 118.713 2.857 . . . . 2.53 118.713 172.755 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.5 p -81.2 -24.86 37.16 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.892 1.995 . . . . 2.08 108.419 -176.7 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.44 31.24 3.3 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-O 125.402 2.668 . . . . 1.31 115.245 178.843 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -92.78 124.48 36.81 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.636 -2.685 . . . . 1.4 106.723 178.548 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -109.49 111.73 23.43 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.722 2.677 . . . . 0.78 112.026 175.315 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.262 36.1 pt -100.24 132.57 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 1 CA-C-O 128.847 4.165 . . . . 1.55 106.752 -178.691 . . . . . . . . 3 2 . 1 . 039 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 95.9 m -90.5 122.11 33.04 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.04 -2.913 . . . . 1.08 110.834 177.584 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.46 142.55 35.94 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.436 2.294 . . . . 1.55 112.675 176.547 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -110.57 118.61 36.68 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.548 2.339 . . . . 1.95 109.667 169.339 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.89 159.92 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 C-N-CA 124.016 0.926 . . . . 0.96 112.006 -178.676 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -92.05 156.26 42.36 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-O 116.424 -1.751 . . . . 2.35 112.693 159.57 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -73.11 -9.13 23.1 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 CA-C-N 126.139 3.228 . . . . 0.95 111.477 -177.285 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.4 m -79.04 -19.15 52.14 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 129.772 3.229 . . . . 1.45 108.545 177.934 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -61.04 137.45 58.23 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.488 2.774 . . . . 1.69 118.488 177.076 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.9 p -86.59 171.42 11.04 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 111.74 0.274 . . . . 0.75 111.74 177.193 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.402 HG13 ' HB3' ' A' ' 50' ' ' LEU . 10.0 mm -68.71 -33.79 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 114.588 1.329 . . . . 0.73 114.588 175.796 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -53.15 -43.44 67.0 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 117.551 2.426 . . . . 1.62 117.551 161.085 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -62.55 -42.53 99.59 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 120.553 1.524 . . . . 2.13 110.615 171.365 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 t -57.02 -48.84 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.449 1.5 . . . . 0.62 111.553 172.915 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -56.7 -34.53 67.52 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 116.953 -3.592 . . . . 1.22 117.627 172.977 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.85 -42.68 81.01 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 125.674 2.654 . . . . 0.51 112.922 176.819 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.27 13.6 mttm -60.02 -34.54 73.5 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 130.382 3.473 . . . . 1.44 115.174 173.584 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.0 mt -74.02 -35.44 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 129.395 3.078 . . . . 1.32 108.13 174.9 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -63.34 -32.03 73.35 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 119.705 3.224 . . . . 1.7 119.705 173.854 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -76.31 -20.41 57.31 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.631 1.973 . . . . 1.55 113.702 169.138 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -84.0 -47.44 10.97 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.657 -2.527 . . . . 2.62 109.942 177.42 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -131.86 -31.69 1.5 Allowed 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 118.453 2.76 . . . . 1.48 118.453 -167.421 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.57 60.99 1.07 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 104.248 -3.541 . . . . 1.12 104.248 169.997 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.1 mt -129.52 115.15 18.25 Favored Pre-proline 0 N--CA 1.43 -1.463 0 N-CA-C 104.699 -2.334 . . . . 1.55 104.699 178.077 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -70.57 160.2 50.27 Favored 'Trans proline' 0 N--CA 1.433 -2.053 1 CA-C-N 129.081 4.279 . . . . 1.02 116.19 -173.347 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.64 -35.13 99.08 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-N 123.682 2.351 . . . . 1.25 116.965 -176.551 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -55.7 -37.0 67.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.986 1.476 . . . . 2.25 114.986 171.635 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -84.32 -12.41 54.64 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 119.56 1.073 . . . . 2.02 111.657 -175.7 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -83.85 115.98 22.52 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.875 -1.528 . . . . 0.69 106.875 -178.561 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -109.2 95.41 5.62 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.525 1.766 . . . . 2.78 107.623 168.266 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.3 mt -87.57 132.53 34.02 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.184 -1.413 . . . . 1.17 107.184 -174.282 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.5 mm -117.19 133.83 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 126.77 2.028 . . . . 1.38 106.166 178.95 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.49 ' HB3' HD21 ' A' ' 50' ' ' LEU . 33.5 t80 -112.34 108.24 17.35 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.977 -1.86 . . . . 1.5 105.977 165.055 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.13 -83.31 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.924 2.89 . . . . 1.21 109.645 -177.474 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.15 -27.3 2.07 Favored Glycine 0 N--CA 1.43 -1.74 0 O-C-N 118.822 -2.424 . . . . 1.3 116.082 -176.019 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -95.59 155.23 16.83 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 126.353 2.978 . . . . 2.55 113.262 -178.572 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -93.91 129.09 40.48 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.77 -3.081 . . . . 2.48 107.764 178.766 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.49 HD21 ' HB3' ' A' ' 45' ' ' PHE . 29.2 mt -80.49 140.57 35.83 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.026 1.393 . . . . 0.9 112.469 -170.373 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -88.54 159.25 18.01 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.282 -4.011 . . . . 1.94 110.703 170.613 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.16 -50.79 15.16 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 127.207 2.203 . . . . 1.56 114.575 -171.264 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.83 62.82 0.78 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 119.058 -2.276 . . . . 0.97 117.14 171.499 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.25 31.4 mmt180 -122.66 153.62 39.12 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.956 -2.239 . . . . 2.49 104.956 164.728 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.1 p -89.62 171.94 9.31 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 119.488 1.04 . . . . 0.76 109.963 174.232 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 29.6 mt -81.18 -29.31 34.67 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.29 -0.881 . . . . 1.05 108.781 175.757 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 t -68.86 -35.76 77.3 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.101 -2.249 . . . . 1.19 112.272 179.053 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.84 -28.27 69.44 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.212 -2.805 . . . . 1.9 112.748 176.385 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -81.59 -13.12 58.4 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.162 -4.086 . . . . 0.89 115.432 179.578 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.7 m120 77.81 26.75 0.62 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 126.609 2.443 . . . . 1.84 111.152 178.688 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.8 mt -70.0 113.2 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 127.205 3.383 . . . . 0.82 114.79 -179.26 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -95.03 171.97 8.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 114.932 -2.707 . . . . 2.16 110.911 -178.329 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -62.64 145.9 53.43 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.297 -2.752 . . . . 2.12 110.062 176.769 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 58.37 38.53 25.82 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 125.663 2.649 . . . . 1.71 112.379 175.462 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.2 t -98.97 141.79 31.29 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 104.082 -2.562 . . . . 1.04 104.082 179.51 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -96.57 121.11 38.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 127.404 2.282 . . . . 0.79 110.34 178.185 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -101.85 158.89 15.8 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 102.307 -3.22 . . . . 1.4 102.307 174.912 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -114.42 127.79 56.01 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.033 1.733 . . . . 1.51 114.348 -176.19 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.465 ' C ' HD23 ' A' ' 69' ' ' LEU . 4.2 tt -108.48 123.77 49.4 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 106.635 -1.616 . . . . 1.14 106.635 -178.278 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 t -104.37 142.94 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 104.92 -2.252 . . . . 1.23 104.92 173.702 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.49 HD12 ' HA ' ' A' ' 71' ' ' LEU . 7.9 tp -83.46 111.11 18.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.375 -1.774 . . . . 2.78 110.939 174.334 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -76.58 98.86 4.8 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 130.644 3.578 . . . . 3.75 108.26 168.726 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.7 tp -93.18 82.26 4.54 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 127.739 3.637 . . . . 3.14 111.478 170.738 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -75.66 -64.76 1.01 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.312 -2.742 . . . . 6.8 111.328 172.828 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.56 144.27 4.37 Favored Glycine 0 N--CA 1.431 -1.691 0 O-C-N 119.25 -2.156 . . . . 3.57 107.77 -168.123 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.776 0 CA-C-O 117.102 -1.944 . . . . 3.87 113.959 174.52 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 124.2 1.952 . . . . 1.1 108.461 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -104.65 132.13 51.25 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.135 -1.603 . . . . 1.87 108.301 -174.981 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.434 HD12 HD22 ' A' ' 67' ' ' LEU . 8.4 pt -127.38 140.89 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 126.027 2.822 . . . . 0.72 107.526 175.333 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -101.75 131.69 47.89 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.397 -2.064 . . . . 1.4 111.3 -178.939 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.3 t -109.41 111.52 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 116.876 -3.64 . . . . 0.58 108.789 177.965 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.5 mtpt -93.36 139.29 30.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.612 -3.18 . . . . 2.09 106.93 175.912 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p -93.25 164.94 13.04 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 116.918 -1.515 . . . . 0.99 112.301 179.904 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.9 tp -65.87 -30.88 71.56 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.246 3.403 . . . . 2.53 113.379 166.339 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.315 70.2 p -61.61 -38.4 87.46 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.124 -4.11 . . . . 2.08 114.271 -178.815 . . . . . . . . 3 2 . 1 . 040 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.87 24.42 1.69 Allowed Glycine 0 N--CA 1.43 -1.726 1 C-N-CA 131.031 4.158 . . . . 1.31 114.416 174.191 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -101.6 153.15 20.01 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.054 -1.461 . . . . 1.4 107.054 -177.994 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -108.6 110.47 21.94 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 113.078 -1.874 . . . . 0.78 109.99 168.079 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 mt -92.35 119.91 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 121.129 1.786 . . . . 1.55 115.122 177.362 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.259 8.7 m -89.37 130.06 35.8 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 116.741 -3.725 . . . . 1.08 106.894 179.079 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.0 mt -133.08 156.41 47.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 118.605 -1.238 . . . . 1.55 107.967 177.898 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -112.74 129.37 56.44 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 117.52 -1.228 . . . . 1.95 109.594 165.833 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 m -127.31 177.55 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 126.645 1.978 . . . . 0.96 114.89 177.872 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -120.11 161.64 37.6 Favored Pre-proline 0 N--CA 1.43 -1.432 0 CA-C-O 115.119 -2.372 . . . . 2.35 110.878 164.261 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.256 33.8 Cg_endo -74.81 -12.63 21.95 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 C-N-CA 122.987 2.458 . . . . 0.95 112.649 -176.744 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.255 70.0 m -92.4 9.7 33.09 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.75 2.82 . . . . 1.45 111.724 173.253 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -84.96 139.0 32.14 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 121.67 2.032 . . . . 1.69 109.906 176.864 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.5 p -84.43 156.42 21.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.305 2.955 . . . . 0.75 112.342 176.113 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mm -64.48 -20.71 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 O-C-N 116.372 -3.955 . . . . 0.73 115.086 176.464 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -56.92 -51.87 67.43 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.367 2.508 . . . . 1.62 117.162 163.079 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -60.45 -31.99 70.96 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 111.048 -2.796 . . . . 2.13 116.571 170.535 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.2 t -65.78 -32.89 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 124.098 3.135 . . . . 0.62 112.202 175.804 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -71.71 -27.48 63.05 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.335 1.854 . . . . 1.22 112.082 175.882 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.04 -21.67 58.9 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.803 -2.436 . . . . 0.51 114.82 173.365 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -78.3 -30.5 48.4 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.608 -3.183 . . . . 1.44 108.206 178.584 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.4 mt -68.54 -33.3 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 129.309 3.044 . . . . 1.32 110.189 168.838 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -66.93 -29.47 69.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.712 -3.117 . . . . 1.7 113.885 167.324 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -74.58 -58.22 3.43 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 120.986 1.721 . . . . 1.55 110.464 172.162 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.2 tptt -57.79 -55.86 29.46 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.574 2.435 . . . . 2.62 117.574 -172.915 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -110.84 -36.43 5.69 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.473 2.082 . . . . 1.48 108.756 -164.905 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.85 66.34 1.0 Allowed Glycine 0 N--CA 1.429 -1.788 0 O-C-N 119.576 -1.953 . . . . 1.12 110.583 169.979 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.6 mt -126.93 130.12 23.86 Favored Pre-proline 0 N--CA 1.429 -1.488 0 CA-C-O 114.452 -2.689 . . . . 1.55 105.552 -178.341 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -62.11 150.42 86.68 Favored 'Trans proline' 0 N--CA 1.433 -2.056 0 C-N-CA 124.167 3.245 . . . . 1.02 111.582 178.82 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -87.13 -0.22 7.69 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 CA-C-N 120.853 1.341 . . . . 1.25 110.319 -162.535 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -71.47 -46.83 58.87 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.372 2.269 . . . . 2.25 112.719 170.719 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -69.41 -19.52 63.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.805 2.842 . . . . 2.02 115.599 -175.055 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -86.83 139.43 30.68 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 124.126 1.917 . . . . 0.69 111.053 -168.82 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.9 mtt180 -131.38 134.07 45.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.731 -3.731 . . . . 2.78 104.19 170.556 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.3 mt -114.21 117.03 30.04 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 114.038 -5.414 . . . . 1.17 112.826 175.296 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 mm -99.3 138.28 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 128.489 3.618 . . . . 1.38 114.439 178.684 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -129.5 96.27 4.23 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 120.836 1.653 . . . . 1.5 109.208 170.358 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.26 26.45 2.7 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 111.854 -3.927 . . . . 1.21 117.246 -179.608 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.39 -24.18 23.04 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 122.991 2.632 . . . . 1.3 112.731 -174.408 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -96.56 132.43 42.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.718 -2.636 . . . . 2.55 106.709 175.351 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.79 131.3 35.26 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.893 -2.379 . . . . 2.48 111.784 166.327 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.0 mt -79.01 128.85 33.78 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.033 1.333 . . . . 0.9 108.689 -173.088 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -80.26 138.93 36.86 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 121.564 1.984 . . . . 1.94 111.034 176.437 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.85 -55.38 14.46 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.525 3.157 . . . . 1.56 119.525 -173.254 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.23 39.96 2.12 Favored Glycine 0 N--CA 1.43 -1.733 0 O-C-N 124.662 1.226 . . . . 0.97 115.889 173.059 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.423 HH21 ' CG ' ' A' ' 58' ' ' ASP . 44.1 mmm-85 -117.73 161.07 20.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 124.814 0.949 . . . . 2.49 112.151 158.168 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -96.52 172.38 7.96 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 115.574 1.694 . . . . 0.76 115.574 173.301 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.1 mt -77.26 -25.4 51.44 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.014 1.116 . . . . 1.05 114.014 176.859 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.8 t -78.8 -33.43 46.26 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.106 -1.442 . . . . 1.19 107.106 -179.495 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.423 ' CG ' HH21 ' A' ' 54' ' ' ARG . 38.1 t0 -61.44 -52.82 62.97 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.365 2.666 . . . . 1.9 112.023 178.183 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -74.42 -7.49 53.11 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 126.813 3.197 . . . . 0.89 117.882 177.993 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.3 m120 62.8 46.15 5.29 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.2 -2.812 . . . . 1.84 115.509 179.702 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.4 mt -96.25 124.24 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 103.729 -2.693 . . . . 0.82 103.729 -177.699 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -112.44 -176.2 2.86 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 118.364 -1.334 . . . . 2.16 112.147 -175.055 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -55.06 137.52 46.23 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 126.768 3.175 . . . . 2.12 110.092 174.812 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 57.3 mt-10 76.3 12.98 2.6 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 126.116 2.865 . . . . 1.71 113.534 170.46 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -79.39 133.22 36.57 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 117.593 -3.192 . . . . 1.04 107.475 -170.813 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.1 m -86.07 113.79 22.42 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.85 -3.656 . . . . 0.79 113.848 178.58 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.434 HD22 HD12 ' A' ' 3' ' ' ILE . 9.7 mp -92.46 160.4 15.09 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.625 -1.922 . . . . 1.4 110.895 174.271 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -129.32 123.16 31.1 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.438 2.066 . . . . 1.51 108.351 -175.243 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.5 tp -93.65 125.23 38.15 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 130.892 3.677 . . . . 1.14 108.317 176.59 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.14 159.34 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 104.126 -2.546 . . . . 1.23 104.126 167.201 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.4 mt -115.97 138.89 50.78 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 122.653 1.216 . . . . 2.78 108.042 -179.668 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 ttt-85 -100.2 130.32 46.32 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 104.538 -2.394 . . . . 3.75 104.538 -179.554 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.6 tp -115.13 -54.78 2.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.931 -1.137 . . . . 3.14 107.931 171.723 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -103.66 -42.01 5.77 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 118.495 -2.628 . . . . 6.8 108.353 176.928 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.77 -138.02 3.63 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-O 124.735 2.297 . . . . 3.57 113.266 -173.771 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.763 0 O-C-N 119.192 -2.358 . . . . 3.87 109.041 176.959 . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptt? . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 123.259 1.504 . . . . 1.1 109.188 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -101.23 129.44 47.17 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.848 1.659 . . . . 1.87 111.038 -172.304 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.1 pt -125.44 174.48 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.775 -2.453 . . . . 0.72 110.007 176.196 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -119.77 140.91 50.01 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 116.055 1.872 . . . . 1.4 116.055 179.767 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.7 t -124.96 119.63 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 124.196 1.951 . . . . 0.58 105.898 171.606 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -95.44 127.32 41.38 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.627 -3.795 . . . . 2.09 111.68 179.441 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.0 p -73.39 -168.92 0.58 Allowed 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 125.031 2.348 . . . . 0.99 110.953 -176.069 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.536 HD11 ' H ' ' A' ' 71' ' ' LEU . 86.1 mt -86.9 -38.6 16.56 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 111.825 -2.443 . . . . 2.53 111.597 171.492 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.9 p -65.44 -27.35 68.46 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.427 1.891 . . . . 2.08 112.885 -175.9 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.57 22.97 5.25 Favored Glycine 0 N--CA 1.431 -1.669 0 O-C-N 118.151 -2.843 . . . . 1.31 119.108 177.845 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -108.04 138.53 44.14 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 105.602 -1.999 . . . . 1.4 105.602 -175.348 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.0 m -92.91 111.08 22.57 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.595 2.758 . . . . 0.78 108.044 177.149 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -89.85 137.16 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 116.48 -3.888 . . . . 1.55 105.075 -179.268 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.1 m -100.34 129.5 46.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.599 1.959 . . . . 1.08 110.36 -178.653 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.4 mt -129.36 155.38 45.75 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 119.651 1.114 . . . . 1.55 112.673 -175.923 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -116.22 112.25 21.35 Favored 'General case' 0 N--CA 1.429 -1.477 1 O-C-N 115.186 -4.696 . . . . 1.95 105.792 173.253 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.5 m -126.37 155.48 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 110.974 -2.83 . . . . 0.96 112.101 -179.0 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -103.28 159.5 29.1 Favored Pre-proline 0 N--CA 1.431 -1.392 1 O-C-N 114.639 -5.038 . . . . 2.35 109.644 165.485 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.66 -20.78 46.34 Favored 'Trans proline' 0 C--N 1.299 -2.039 1 O-C-N 113.297 -4.107 . . . . 0.95 115.455 -170.993 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 p -84.76 4.52 32.48 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.133 2.173 . . . . 1.45 112.121 175.543 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -75.58 138.2 41.3 Favored 'General case' 0 N--CA 1.431 -1.419 1 O-C-N 115.496 -4.502 . . . . 1.69 106.424 170.473 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.563 HG22 HG22 ' A' ' 55' ' ' THR . 64.6 p -87.02 159.76 18.85 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 125.935 2.022 . . . . 0.75 108.074 -179.225 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.7 mm -60.24 -37.02 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 124.168 0.987 . . . . 0.73 109.692 177.415 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.302 25.5 tt0 -47.12 -50.59 19.91 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.664 1.986 . . . . 1.62 113.385 164.465 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -68.86 -32.74 72.64 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 125.934 2.021 . . . . 2.13 109.745 -179.706 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.55 -38.94 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 120.642 1.565 . . . . 0.62 113.315 175.105 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -61.56 -38.67 88.34 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 122.605 1.193 . . . . 1.22 112.83 169.701 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.65 -25.86 57.22 Favored 'General case' 0 N--CA 1.43 -1.428 1 CA-C-O 129.274 4.368 . . . . 0.51 113.694 179.332 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -72.63 -34.05 67.06 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 114.856 -4.903 . . . . 1.44 111.647 171.703 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.253 97.1 mt -64.73 -48.57 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 O-C-N 120.015 -1.678 . . . . 1.32 109.401 171.126 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -56.63 -42.83 79.51 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 116.446 -3.909 . . . . 1.7 113.265 177.145 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -53.95 -47.26 71.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.815 3.197 . . . . 1.55 117.079 166.522 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.265 14.2 tppt? -73.24 -53.49 10.75 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.04 2.352 . . . . 2.62 114.144 -171.844 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -111.42 -30.1 7.53 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.738 -3.101 . . . . 1.48 109.993 -171.431 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.28 38.36 4.56 Favored Glycine 0 N--CA 1.429 -1.787 0 C-N-CA 125.465 1.507 . . . . 1.12 114.056 -179.586 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.4 mt -97.77 130.38 29.13 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-O 114.749 -2.548 . . . . 1.55 112.117 179.509 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -66.18 154.0 75.86 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 CA-C-N 125.356 2.948 . . . . 1.02 113.487 -173.475 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -65.62 -23.32 56.94 Favored 'Trans proline' 0 N--CA 1.432 -2.094 1 CA-C-N 129.094 4.283 . . . . 1.25 116.373 -177.668 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -69.0 -34.62 75.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.77 -2.456 . . . . 2.25 115.546 178.06 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -73.75 -12.79 60.82 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 124.38 1.05 . . . . 2.02 111.279 179.597 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -98.64 118.06 34.5 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 118.214 -2.804 . . . . 0.69 112.572 -167.951 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -106.51 114.64 28.87 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 126.259 2.224 . . . . 2.78 106.378 170.674 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.1 mt -98.03 109.42 22.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.99 1.853 . . . . 1.17 113.607 175.343 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.3 mt -100.48 112.2 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 128.356 2.662 . . . . 1.38 112.617 180.0 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -105.67 123.76 48.46 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.5 -2.625 . . . . 1.5 107.446 172.008 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.362 . . 69.46 -63.81 0.36 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.128 2.171 . . . . 1.21 110.694 -176.459 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.59 -16.81 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.791 0 N-CA-C 106.122 -2.791 . . . . 1.3 106.122 179.378 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -83.6 125.1 31.46 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.611 3.164 . . . . 2.55 106.848 -172.557 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.3 17.4 tt0 -83.96 115.48 22.33 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.176 1.547 . . . . 2.48 115.176 175.849 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.8 mt -75.58 133.85 40.84 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.173 1.789 . . . . 0.9 112.047 -171.018 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -87.15 151.43 23.21 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 127.859 2.464 . . . . 1.94 115.719 172.743 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -66.24 -44.65 83.12 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 128.364 2.665 . . . . 1.56 113.434 -160.147 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.15 51.25 1.29 Allowed Glycine 0 N--CA 1.43 -1.705 0 O-C-N 118.813 -2.43 . . . . 0.97 110.866 176.332 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -123.56 161.88 24.06 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.889 -1.948 . . . . 2.49 107.377 162.582 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.563 HG22 HG22 ' A' ' 22' ' ' THR . 18.7 p -107.89 172.61 6.73 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.084 -2.26 . . . . 0.76 110.741 179.693 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.407 HD23 HD12 ' A' ' 61' ' ' ILE . 20.8 mt -62.17 -38.41 88.95 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 126.758 2.536 . . . . 1.05 114.077 172.855 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -66.52 -30.8 71.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.916 2.486 . . . . 1.19 115.256 174.284 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -71.49 -43.9 65.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.752 -3.093 . . . . 1.9 111.393 171.222 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -91.55 8.26 37.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 124.964 1.415 . . . . 0.89 114.154 -177.877 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 47.23 49.24 15.54 Favored 'General case' 0 N--CA 1.43 -1.438 1 C-N-CA 132.459 4.304 . . . . 1.84 116.613 -179.462 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.567 HG21 HD21 ' A' ' 67' ' ' LEU . 76.8 mt -89.81 115.04 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 114.191 -2.814 . . . . 0.82 105.48 176.912 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -107.22 -166.66 1.18 Allowed 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 126.291 2.244 . . . . 2.16 112.88 -175.754 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -63.27 144.87 56.57 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 125.128 1.517 . . . . 2.12 113.586 -179.682 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.294 32.2 mt-10 67.28 15.13 9.91 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.629 1.971 . . . . 1.71 114.686 -179.766 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 t -90.17 135.94 33.35 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 123.537 1.636 . . . . 1.04 111.07 -173.903 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.2 m -96.09 113.84 25.49 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.821 3.648 . . . . 0.79 112.213 -172.397 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.567 HD21 HG21 ' A' ' 61' ' ' ILE . 10.5 mt -95.98 152.85 18.14 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 115.604 -4.435 . . . . 1.4 108.883 169.762 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -112.2 119.36 38.11 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 115.873 -2.331 . . . . 1.51 109.463 -174.488 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.6 tp -86.45 116.55 24.67 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.346 1.858 . . . . 1.14 111.454 -178.87 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.8 t -111.73 119.87 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 115.167 -2.349 . . . . 1.23 109.402 177.502 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.536 ' H ' HD11 ' A' ' 8' ' ' LEU 0.296 93.3 mt -79.96 137.13 36.79 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 121.211 1.823 . . . . 2.78 108.85 -173.482 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -99.46 79.36 2.28 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.335 1.54 . . . . 3.75 109.364 174.715 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.5 mt -88.99 -103.59 0.09 Allowed 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.305 -1.771 . . . . 3.14 113.006 175.994 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.273 46.5 mtt85 -127.28 145.06 50.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 105.931 -1.877 . . . . 6.8 105.931 170.15 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.41 -91.88 0.15 Allowed Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 108.0 -2.04 . . . . 3.57 108.0 -167.982 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.774 0 N-CA-C 105.146 -3.182 . . . . 3.87 105.146 -178.837 . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 CA--C 1.49 -1.327 0 N-CA-C 104.728 -2.323 . . . . 1.1 104.728 . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -100.96 128.68 46.88 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.574 -1.954 . . . . 1.87 110.418 -173.675 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.8 pt -137.04 155.75 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 O-C-N 117.315 -3.365 . . . . 0.72 106.709 172.493 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -103.06 140.43 37.32 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.393 1.877 . . . . 1.4 106.716 -175.921 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.8 t -120.73 109.84 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 118.711 -2.493 . . . . 0.58 106.299 171.591 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.7 tttt -96.12 128.75 43.3 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 118.001 2.593 . . . . 2.09 118.001 -178.55 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.7 p -86.12 176.25 8.09 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 115.166 1.543 . . . . 0.99 115.166 174.07 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.8 mt -74.47 -22.85 58.89 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.699 -1.876 . . . . 2.53 115.558 172.76 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 p -67.34 -25.97 66.26 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.808 2.043 . . . . 2.08 113.103 176.602 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.27 28.61 5.74 Favored Glycine 0 N--CA 1.429 -1.803 0 C-N-CA 128.6 3.0 . . . . 1.31 114.29 179.743 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -111.55 141.13 45.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.895 3.712 . . . . 1.4 112.476 -173.014 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.2 m -96.34 116.68 29.43 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 127.891 3.71 . . . . 0.78 116.907 176.084 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mt -96.86 125.35 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 1 O-C-N 114.042 -5.411 . . . . 1.55 110.556 168.299 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.1 m -97.66 118.58 34.51 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 124.903 2.287 . . . . 1.08 106.039 -174.49 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.1 mt -105.48 145.6 30.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.506 -3.871 . . . . 1.55 111.279 -178.163 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -103.79 126.05 50.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.469 1.604 . . . . 1.95 107.219 167.987 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 m -144.43 161.67 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 117.249 -3.407 . . . . 0.96 112.481 -176.006 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -99.33 155.01 37.0 Favored Pre-proline 0 N--CA 1.431 -1.421 0 O-C-N 119.132 -2.23 . . . . 2.35 106.462 157.737 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -72.8 -9.65 24.02 Favored 'Trans proline' 0 N--CA 1.433 -2.064 0 C-N-CA 124.625 3.55 . . . . 0.95 111.755 173.907 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.5 m -87.93 0.71 55.53 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 131.109 3.763 . . . . 1.45 114.584 173.303 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -94.08 143.58 26.24 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 117.729 -3.107 . . . . 1.69 107.809 -179.315 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p -80.58 164.02 23.23 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 128.117 3.818 . . . . 0.75 110.165 176.973 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mm -59.22 -33.83 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 112.264 -2.244 . . . . 0.73 112.295 175.598 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -59.81 -30.99 69.3 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.585 -1.947 . . . . 1.62 111.627 175.733 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -74.9 -39.12 61.65 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.974 -3.579 . . . . 2.13 111.771 175.9 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.283 57.3 t -57.09 -60.48 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 O-C-N 118.07 -2.894 . . . . 0.62 110.233 172.368 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -53.51 -41.6 66.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 120.579 3.548 . . . . 1.22 120.579 177.318 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.14 -40.71 94.87 Favored 'General case' 0 CA--C 1.489 -1.394 0 O-C-N 119.412 -2.055 . . . . 0.51 111.794 169.932 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -63.95 -32.29 73.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.397 3.11 . . . . 1.44 119.397 170.488 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.2 mt -68.56 -39.04 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 O-C-N 124.871 1.357 . . . . 1.32 108.669 170.585 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -61.31 -43.92 98.07 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.12 2.39 . . . . 1.7 115.881 176.097 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.56 -46.2 91.06 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.122 -2.861 . . . . 1.55 113.933 174.105 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -68.41 -54.84 14.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.873 -3.642 . . . . 2.62 113.738 -179.828 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -104.78 -35.24 7.83 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.928 2.299 . . . . 1.48 116.82 -165.412 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.88 36.66 5.71 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-O 117.236 -1.869 . . . . 1.12 113.236 -179.645 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.8 mt -104.02 119.01 55.69 Favored Pre-proline 0 CA--C 1.489 -1.398 0 CA-C-O 113.78 -3.009 . . . . 1.55 103.585 -176.605 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.25 9.2 Cg_exo -62.81 161.68 28.08 Favored 'Trans proline' 0 N--CA 1.433 -2.031 1 C-N-CA 125.988 4.458 . . . . 1.02 116.611 176.147 . . . . . . . . 3 2 . 1 . 042 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.45 -25.13 11.47 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 CA-C-N 124.941 2.8 . . . . 1.25 117.904 -170.097 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -60.99 -49.13 78.69 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 125.968 2.794 . . . . 2.25 113.098 -179.416 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -62.26 -31.81 72.43 Favored 'General case' 0 N--CA 1.43 -1.45 1 C-N-CA 133.812 4.845 . . . . 2.02 112.727 176.225 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -75.73 130.81 39.26 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 117.736 -3.103 . . . . 0.69 114.413 -174.909 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.421 ' HB3' HG23 ' A' ' 70' ' ' VAL . 29.4 ttt180 -120.57 106.68 12.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.73 -1.211 . . . . 2.78 107.73 175.431 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.4 mt -91.41 129.65 37.37 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.17 2.588 . . . . 1.17 109.838 179.147 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.504 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 13.6 mt -121.79 146.26 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 127.013 2.125 . . . . 1.38 107.939 177.808 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.42 ' HB3' HD21 ' A' ' 50' ' ' LEU . 20.7 t80 -135.7 117.49 15.1 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 105.129 -2.174 . . . . 1.5 105.129 171.615 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.98 -68.88 0.12 Allowed 'General case' 0 N--CA 1.43 -1.464 1 C-N-CA 132.015 4.126 . . . . 1.21 107.612 179.943 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.4 14.11 0.45 Allowed Glycine 0 N--CA 1.43 -1.728 0 O-C-N 117.364 -3.335 . . . . 1.3 113.983 176.967 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -121.53 128.18 51.76 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 123.562 1.649 . . . . 2.55 108.208 -178.686 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -72.0 126.63 30.26 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.399 2.523 . . . . 2.48 109.234 169.47 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 45' ' ' PHE . 31.4 mt -83.27 145.43 29.11 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.261 -1.791 . . . . 0.9 107.464 -171.262 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -106.91 155.82 19.36 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-O 123.985 1.85 . . . . 1.94 113.327 -179.018 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -52.44 -60.28 3.42 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 121.12 3.748 . . . . 1.56 121.12 -168.071 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.9 37.69 2.68 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 129.82 3.581 . . . . 0.97 112.956 174.085 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -120.25 153.54 36.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 116.67 -1.634 . . . . 2.49 107.649 170.759 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.4 p -88.18 168.43 12.76 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 125.364 1.665 . . . . 0.76 113.72 164.918 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.7 mt -74.22 -27.78 60.95 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 116.183 -1.865 . . . . 1.05 109.659 178.031 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.1 p -64.66 -31.65 72.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 126.246 2.216 . . . . 1.19 115.115 174.582 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -55.05 -41.7 71.79 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 127.819 3.676 . . . . 1.9 114.772 171.306 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -84.16 -1.39 54.96 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 117.594 -3.191 . . . . 0.89 116.852 176.946 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.299 7.5 m120 65.85 40.96 4.0 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 125.854 2.74 . . . . 1.84 115.93 -176.927 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.6 mt -92.43 121.36 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 126.701 3.143 . . . . 0.82 111.032 177.969 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -110.64 179.34 4.1 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 111.374 -2.648 . . . . 2.16 108.71 -176.065 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -63.52 156.49 26.22 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 124.767 1.227 . . . . 2.12 113.961 179.22 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.451 65.6 mt-10 79.44 -4.03 2.05 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.323 -2.11 . . . . 1.71 113.485 172.793 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.298 49.7 m -73.14 154.08 40.49 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 117.699 2.481 . . . . 1.04 117.699 -174.578 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.7 m -112.73 124.02 51.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.58 -1.637 . . . . 0.79 106.58 178.247 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.2 mt -103.81 164.25 11.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.869 -1.16 . . . . 1.4 107.869 168.932 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.504 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 44.0 m170 -113.97 129.68 56.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 116.555 -1.688 . . . . 1.51 111.887 -176.902 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.7 tp -117.34 115.6 25.55 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 102.219 -3.252 . . . . 1.14 102.219 -176.125 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 42' ' ' ARG . 24.6 m -115.33 159.76 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 127.33 3.443 . . . . 1.23 102.747 173.909 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.58 144.24 26.2 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 111.015 -7.303 . . . . 2.78 109.562 173.764 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -110.29 137.3 48.21 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 130.301 3.44 . . . . 3.75 113.83 176.445 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.3 mt -104.6 149.67 25.32 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 126.089 2.852 . . . . 3.14 109.464 171.879 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -83.46 161.19 21.37 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.429 -3.919 . . . . 6.8 116.622 169.18 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.0 -64.68 0.84 Allowed Glycine 0 N--CA 1.429 -1.79 0 C-N-CA 124.609 1.099 . . . . 3.57 111.249 -166.582 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.789 0 CA-C-O 123.193 1.44 . . . . 3.87 115.258 177.134 . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.253 6.2 ptt? . . . . . 0 CA--C 1.49 -1.342 0 N-CA-C 113.775 1.028 . . . . 1.1 113.775 . . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.264 34.5 mt-30 -115.18 147.69 39.98 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 116.155 -4.091 . . . . 1.87 110.916 177.08 . . . . . . . . 3 2 . 1 . 043 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.8 pt -134.35 156.67 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 116.904 -3.623 . . . . 0.72 103.436 177.518 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -116.65 139.06 50.95 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.156 -1.59 . . . . 1.4 110.738 178.221 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.0 t -120.43 116.41 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-O 116.98 -1.486 . . . . 0.58 108.553 177.471 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -100.21 139.44 35.87 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 117.081 -1.848 . . . . 2.09 114.707 177.469 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 p -83.49 157.67 22.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.614 2.766 . . . . 0.99 113.234 174.205 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.1 tp -49.12 -41.1 34.79 Favored 'General case' 0 N--CA 1.43 -1.466 2 O-C-N 114.045 -5.41 . . . . 2.53 110.855 166.46 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.1 p -67.83 -28.26 67.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.948 1.832 . . . . 2.08 115.948 179.385 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.11 31.19 3.16 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 125.238 2.577 . . . . 1.31 113.849 173.454 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -109.6 133.39 53.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.743 -3.21 . . . . 1.4 104.181 -176.628 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.4 m -99.51 119.06 37.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.301 -3.374 . . . . 0.78 106.69 175.735 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mt -97.01 98.42 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.823 2.049 . . . . 1.55 106.836 175.997 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.6 m -87.35 125.86 34.51 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 125.401 2.524 . . . . 1.08 107.942 177.851 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.4 mt -116.94 162.59 17.52 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.542 -2.599 . . . . 1.55 107.272 -173.641 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -121.12 112.68 18.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.759 -2.463 . . . . 1.95 110.402 179.718 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -132.45 164.47 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 125.479 1.512 . . . . 0.96 114.356 -176.816 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -111.86 155.68 42.85 Favored Pre-proline 0 N--CA 1.43 -1.438 1 CA-C-O 110.828 -4.415 . . . . 2.35 104.471 164.806 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -69.92 -4.78 14.83 Favored 'Trans proline' 0 C--N 1.3 -2.023 1 CA-C-N 129.049 4.268 . . . . 0.95 114.808 -175.272 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 p -86.09 6.89 26.97 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.662 2.785 . . . . 1.45 111.633 170.714 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.5 133.33 47.56 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.973 -0.751 . . . . 1.69 108.973 169.008 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.7 p -79.96 167.63 20.24 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.731 -2.322 . . . . 0.75 104.731 177.412 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.3 mm -81.5 -21.64 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 117.536 -3.227 . . . . 0.73 109.302 176.849 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -55.1 -49.67 71.11 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 122.02 2.191 . . . . 1.62 109.59 161.348 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -59.14 -59.39 5.54 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 114.578 1.325 . . . . 2.13 114.578 -179.617 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.419 ' H ' HG23 ' A' ' 26' ' ' VAL . 15.2 t -45.1 -43.9 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 127.067 2.147 . . . . 0.62 114.483 172.167 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.454 ' HD2' ' HB2' ' A' ' 41' ' ' GLN 0.349 36.2 mtmt -60.17 -38.95 84.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 118.716 2.858 . . . . 1.22 118.716 171.491 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.57 -19.89 61.41 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.002 2.334 . . . . 0.51 117.024 179.584 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -78.71 -16.33 57.39 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 119.311 -2.118 . . . . 1.44 112.144 171.516 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.332 73.0 mt -78.32 -44.56 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 128.368 3.937 . . . . 1.32 108.751 172.179 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -57.4 -45.24 84.74 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 110.842 -2.89 . . . . 1.7 117.483 172.098 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -45.42 -45.25 12.68 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.872 1.669 . . . . 1.55 114.366 166.761 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -82.38 -68.8 0.67 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.364 -0.834 . . . . 2.62 111.741 -171.33 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -93.99 -20.75 19.69 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 125.789 1.931 . . . . 1.48 113.946 -169.667 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.23 -0.62 64.03 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 118.355 2.102 . . . . 1.12 118.355 175.753 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.9 mt -70.8 122.58 87.23 Favored Pre-proline 0 N--CA 1.429 -1.484 0 CA-C-O 113.955 -2.926 . . . . 1.55 105.303 -178.311 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.37 146.11 61.55 Favored 'Trans proline' 0 N--CA 1.433 -2.033 1 CA-C-O 106.609 -5.663 . . . . 1.02 116.565 177.873 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -55.63 -13.49 8.23 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 128.013 3.898 . . . . 1.25 122.196 -177.847 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -57.04 -41.54 78.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.991 2.517 . . . . 2.25 113.259 176.975 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.281 68.9 mt-30 -84.77 -27.0 27.18 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 126.331 1.852 . . . . 2.02 108.993 -170.437 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.454 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 61.1 mt-30 -71.23 139.92 50.24 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.509 2.781 . . . . 0.69 118.509 -171.496 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -133.83 129.24 36.21 Favored 'General case' 0 N--CA 1.43 -1.435 1 N-CA-C 99.126 -4.398 . . . . 2.78 99.126 172.493 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.46 ' HA ' HD23 ' A' ' 43' ' ' LEU . 23.9 mt -111.24 107.92 17.38 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 112.189 -2.278 . . . . 1.17 106.889 177.426 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 mm -97.26 133.98 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 115.003 -0.999 . . . . 1.38 108.699 176.227 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -122.32 100.6 7.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 101.772 -3.418 . . . . 1.5 101.772 176.794 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 81.65 -100.92 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 105.259 -2.126 . . . . 1.21 105.259 172.61 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.31 -10.16 7.49 Favored Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 107.033 -2.427 . . . . 1.3 107.033 179.284 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -100.94 148.32 25.14 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 119.96 1.88 . . . . 2.55 108.916 -173.478 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -105.4 129.04 53.8 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.795 -2.002 . . . . 2.48 113.661 178.284 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.4 mt -92.72 146.47 23.63 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 116.933 -1.508 . . . . 0.9 109.818 -167.058 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.1 148.94 21.69 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 128.786 3.804 . . . . 1.94 117.667 174.778 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.65 -59.73 4.76 Favored 'General case' 0 CA--C 1.488 -1.41 1 C-N-CA 133.241 4.617 . . . . 1.56 113.295 -169.527 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.66 46.7 3.49 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 119.508 -1.995 . . . . 0.97 116.515 175.458 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -127.75 -179.8 5.13 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 120.553 2.177 . . . . 2.49 112.043 166.805 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.2 p -104.53 172.47 6.77 Favored 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 116.011 -4.181 . . . . 0.76 117.835 178.715 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.5 mt -66.32 -29.63 69.87 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.704 -2.497 . . . . 1.05 111.006 173.105 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -71.69 -29.31 64.44 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 130.019 3.328 . . . . 1.19 117.453 178.367 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.327 23.6 m-20 -63.65 -36.58 84.29 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 119.231 -0.988 . . . . 1.9 112.709 170.118 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -93.42 12.85 23.49 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 117.166 2.284 . . . . 0.89 117.166 -174.996 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 50.08 32.62 6.02 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 118.137 2.643 . . . . 1.84 118.137 -175.304 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.8 mt -89.88 111.59 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 125.11 1.364 . . . . 0.82 110.498 -178.352 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -100.99 -165.68 1.23 Allowed 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 113.868 -1.514 . . . . 2.16 109.286 -173.768 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.5 pttp -68.78 149.81 48.58 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.534 2.111 . . . . 2.12 112.548 179.667 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.281 10.8 mt-10 66.66 30.13 8.39 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 125.619 2.628 . . . . 1.71 116.259 172.71 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.1 m -89.29 135.7 33.43 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.869 -2.394 . . . . 1.04 107.926 -170.697 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.6 m -105.06 106.36 16.81 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.913 -2.367 . . . . 0.79 108.818 -177.006 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -96.61 167.28 11.23 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.448 -2.032 . . . . 1.4 109.586 171.842 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -118.86 121.8 40.84 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 113.662 -1.608 . . . . 1.51 111.138 -170.338 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.9 tp -88.31 121.85 31.16 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.816 -1.549 . . . . 1.14 106.816 -177.449 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.6 t -114.26 124.51 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 106.487 -1.671 . . . . 1.23 106.487 179.308 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.0 mt -115.04 -173.86 2.39 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 116.366 -3.959 . . . . 2.78 111.763 179.673 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -95.86 -167.48 1.6 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.952 2.575 . . . . 3.75 117.952 171.263 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.9 mt -81.05 118.29 22.37 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 116.141 -1.885 . . . . 3.14 110.818 174.944 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -75.39 98.15 3.8 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 121.946 2.157 . . . . 6.8 115.845 168.504 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.95 -30.89 0.39 Allowed Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 104.985 -3.246 . . . . 3.57 104.985 -167.19 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.764 0 O-C-N 118.838 -2.566 . . . . 3.87 107.972 -173.927 . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptt? . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 121.808 0.813 . . . . 1.1 109.507 . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -104.57 120.24 40.84 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 113.129 -3.32 . . . . 1.87 108.717 -175.829 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.265 9.2 pt -116.74 174.01 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 127.007 2.692 . . . . 0.72 114.281 171.365 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -125.68 140.22 52.89 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.897 2.879 . . . . 1.4 106.71 -178.278 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 67' ' ' LEU . 95.8 t -129.07 114.81 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.499 -2.001 . . . . 0.58 107.051 171.405 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -86.23 143.14 28.1 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.678 0.751 . . . . 2.09 111.339 -176.129 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.3 p -88.01 169.36 12.04 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.043 -2.286 . . . . 0.99 111.995 176.408 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.8 mt -56.42 -33.71 66.09 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 114.001 -5.437 . . . . 2.53 113.023 172.609 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.2 p -90.18 -34.9 15.66 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 114.835 1.42 . . . . 2.08 114.835 -172.69 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.71 -17.01 0.4 Allowed Glycine 0 N--CA 1.429 -1.771 0 C-N-CA 116.27 -2.872 . . . . 1.31 112.15 177.46 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -84.84 147.91 26.56 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 124.743 2.211 . . . . 1.4 111.326 -170.743 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.6 m -115.65 128.22 55.76 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.745 -3.722 . . . . 0.78 108.752 178.905 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 mt -95.32 137.92 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 119.662 -1.899 . . . . 1.55 107.02 177.055 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.7 m -95.31 111.43 23.29 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.526 -1.984 . . . . 1.08 112.945 175.623 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.7 mt -115.42 148.87 38.86 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.01 -1.681 . . . . 1.55 111.891 -177.831 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -115.29 109.78 18.45 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 103.449 -2.797 . . . . 1.95 103.449 179.49 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.6 m -120.78 170.2 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 124.993 2.33 . . . . 0.96 105.075 177.36 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -126.75 155.4 75.21 Favored Pre-proline 0 N--CA 1.43 -1.429 0 N-CA-C 104.814 -2.291 . . . . 2.35 104.814 168.818 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.45 -29.34 39.36 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 N-CA-C 120.924 3.394 . . . . 0.95 120.924 -176.679 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 m -76.13 4.37 8.7 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.424 2.379 . . . . 1.45 117.424 177.176 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -85.1 148.74 25.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 125.74 1.9 . . . . 1.69 114.878 177.637 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.3 p -90.1 169.96 10.73 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.35 -2.094 . . . . 0.75 114.225 175.595 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.8 mm -63.64 -41.31 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 1 O-C-N 115.867 -4.27 . . . . 0.73 114.462 176.255 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.382 76.8 tt0 -35.75 -55.73 0.71 Allowed 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 118.624 2.824 . . . . 1.62 118.624 155.583 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -56.83 -28.15 61.13 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.734 -1.854 . . . . 2.13 115.718 176.187 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.2 t -69.98 -42.63 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 117.988 -2.945 . . . . 0.62 108.998 175.208 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -56.29 -39.53 72.84 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.437 -2.039 . . . . 1.22 116.404 171.777 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.0 -49.48 72.3 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.073 -2.892 . . . . 0.51 115.659 174.469 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -52.83 -45.11 67.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.248 1.419 . . . . 1.44 113.131 170.715 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 30' ' ' ILE . 56.4 mt -69.29 -30.9 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 O-C-N 115.722 -4.361 . . . . 1.32 112.169 175.125 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.31 -40.04 71.06 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.119 -1.613 . . . . 1.7 111.041 173.369 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.02 -54.7 44.12 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 123.358 1.551 . . . . 1.55 112.304 170.117 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -72.94 -57.89 3.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 116.55 -3.844 . . . . 2.62 115.628 -174.617 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -94.28 -27.33 16.19 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.364 1.987 . . . . 1.48 116.364 -174.188 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.35 23.67 21.17 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 117.47 1.748 . . . . 1.12 117.47 178.614 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.1 mt -89.77 138.84 27.77 Favored Pre-proline 0 N--CA 1.431 -1.402 0 O-C-N 118.188 -2.948 . . . . 1.55 103.827 -173.194 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.57 151.37 64.38 Favored 'Trans proline' 0 C--N 1.299 -2.052 1 CA-C-N 130.675 4.848 . . . . 1.02 111.712 176.761 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -73.03 -19.0 23.55 Favored 'Trans proline' 0 C--N 1.3 -2.004 3 C-N-CA 126.53 4.82 . . . . 1.25 115.676 -176.729 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.27 -39.03 66.5 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 115.686 1.736 . . . . 2.25 115.686 177.421 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -89.71 -18.61 26.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.342 -1.355 . . . . 2.02 107.342 -173.071 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.454 ' HG2' HD11 ' A' ' 69' ' ' LEU . 67.9 mt-30 -78.35 100.2 6.67 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 117.728 2.492 . . . . 0.69 117.728 -167.639 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -97.85 122.99 41.61 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 119.292 0.951 . . . . 2.78 110.867 171.009 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.1 mt -92.76 105.72 17.81 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.214 2.911 . . . . 1.17 112.896 179.146 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mm -90.66 130.57 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 128.615 2.766 . . . . 1.38 109.783 -177.521 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -138.89 114.8 10.08 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 106.344 -1.724 . . . . 1.5 106.344 176.364 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.458 . . 68.16 24.98 7.45 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.098 -1.626 . . . . 1.21 113.405 173.605 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.24 -24.87 28.33 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 117.827 -1.54 . . . . 1.3 112.151 -173.189 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.5 tttt -106.44 128.99 54.49 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 122.239 3.02 . . . . 2.55 112.618 -179.685 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -78.48 138.22 38.33 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 112.124 -2.307 . . . . 2.48 112.865 168.964 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.1 mt -93.38 137.89 32.24 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 129.305 3.042 . . . . 0.9 108.959 -166.816 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -68.37 144.8 54.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.995 1.85 . . . . 1.94 115.995 173.11 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.15 -38.81 82.53 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 118.751 2.871 . . . . 1.56 118.751 -165.799 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.39 23.47 31.83 Favored Glycine 0 N--CA 1.43 -1.753 0 O-C-N 119.147 -2.221 . . . . 0.97 115.788 173.486 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -99.07 143.82 28.91 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 118.562 1.181 . . . . 2.49 109.104 166.416 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.251 72.1 p -80.9 162.57 23.87 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 126.277 2.235 . . . . 0.76 112.857 -179.76 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.9 -24.26 67.75 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.307 -2.746 . . . . 1.05 110.467 172.622 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.6 t -88.02 -11.08 48.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.936 -1.728 . . . . 1.19 110.431 -176.997 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -75.8 -42.75 49.1 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.659 -1.9 . . . . 1.9 109.526 173.08 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -79.63 -0.05 32.19 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.41 2.374 . . . . 0.89 117.41 176.13 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 64.01 39.76 7.68 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 115.733 1.753 . . . . 1.84 115.733 -179.48 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.1 mm -75.43 118.4 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 119.273 -2.142 . . . . 0.82 110.081 178.085 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -91.84 172.71 8.29 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.322 2.487 . . . . 2.16 114.394 177.373 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -66.98 140.28 57.72 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.451 -3.28 . . . . 2.12 107.607 179.635 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.386 6.3 tt0 85.71 12.7 0.2 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.812 1.645 . . . . 1.71 113.365 177.2 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.8 m -80.15 152.55 29.18 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 116.856 -3.652 . . . . 1.04 112.52 -172.687 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.83 115.48 30.17 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.76 2.219 . . . . 0.79 109.599 -178.006 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.451 ' HB2' HG22 ' A' ' 5' ' ' VAL . 10.5 mp -102.52 163.19 12.37 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 114.118 -5.364 . . . . 1.4 104.86 174.183 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -122.67 123.46 41.18 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.866 1.666 . . . . 1.51 109.942 176.496 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.454 HD11 ' HG2' ' A' ' 41' ' ' GLN . 24.1 tp -84.8 122.14 28.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.719 1.608 . . . . 1.14 114.144 179.067 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.1 t -117.82 138.47 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 102.156 -3.276 . . . . 1.23 102.156 177.737 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 71' ' ' LEU . 36.0 mt -104.3 115.17 29.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.057 1.408 . . . . 2.78 108.495 -177.156 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -65.59 148.94 50.9 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 113.083 -1.871 . . . . 3.75 107.828 -177.99 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.379 29.0 tp -91.0 119.44 31.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.647 -1.983 . . . . 3.14 105.647 173.692 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 -69.48 128.83 37.89 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 119.387 -2.07 . . . . 6.8 112.7 166.263 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.95 108.98 1.86 Allowed Glycine 0 N--CA 1.43 -1.731 0 O-C-N 123.498 0.499 . . . . 3.57 112.427 -158.378 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.733 0 C-N-CA 126.076 1.798 . . . . 3.87 113.234 -175.299 . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 3.3 ptt? . . . . . 0 CA--C 1.491 -1.32 0 N-CA-C 116.566 2.061 . . . . 1.1 116.566 . . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -103.05 112.52 25.41 Favored 'General case' 0 N--CA 1.429 -1.486 1 O-C-N 116.03 -4.169 . . . . 1.87 107.153 -168.571 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.3 pt -117.71 154.07 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 117.333 -1.318 . . . . 0.72 111.425 169.724 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -118.0 134.63 54.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 125.589 1.805 . . . . 1.4 113.815 -179.195 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -104.14 127.16 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 104.509 -2.404 . . . . 0.58 104.509 173.851 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -104.1 147.69 27.13 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.806 -1.553 . . . . 2.09 106.806 176.208 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.337 7.8 p -97.8 154.09 17.85 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 128.228 3.455 . . . . 0.99 113.378 174.119 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.5 mt -55.14 -36.85 66.23 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.87 2.468 . . . . 2.53 113.389 168.044 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.6 p -78.25 -47.31 18.2 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.592 -1.942 . . . . 2.08 112.489 -173.567 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.85 25.6 0.06 OUTLIER Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 117.3 1.68 . . . . 1.31 117.3 167.916 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -103.74 153.24 20.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 116.121 -1.895 . . . . 1.4 111.668 -179.115 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.3 m -116.24 124.59 50.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 106.716 -1.587 . . . . 0.78 106.716 173.67 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.8 mt -99.08 117.65 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 123.413 2.824 . . . . 1.55 104.042 179.768 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.0 m -98.18 112.58 24.5 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.971 -2.956 . . . . 1.08 107.958 -176.107 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.8 mt -96.6 143.98 27.07 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.766 -1.209 . . . . 1.55 109.491 -174.384 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -98.41 119.17 36.64 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 126.284 2.24 . . . . 1.95 106.727 166.211 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.15 172.27 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 CA-C-N 121.231 1.832 . . . . 0.96 110.433 -175.823 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -126.2 152.53 73.67 Favored Pre-proline 0 N--CA 1.429 -1.483 0 C-N-CA 127.873 2.469 . . . . 2.35 107.246 172.409 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -75.69 -26.63 9.67 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 N-CA-C 107.056 -1.94 . . . . 0.95 107.056 -170.626 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.8 p -78.9 -5.76 54.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.672 -2.517 . . . . 1.45 115.557 -179.241 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -70.0 157.87 36.7 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 124.197 0.935 . . . . 1.69 111.852 168.945 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.7 p -88.75 166.72 13.85 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.649 2.092 . . . . 0.75 116.649 175.373 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.5 mm -67.13 -38.88 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.39 -2.069 . . . . 0.73 107.588 175.017 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -49.07 -44.82 42.24 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 118.31 -2.744 . . . . 1.62 114.077 167.676 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -64.71 -22.33 66.96 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.898 2.079 . . . . 2.13 111.8 175.956 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.36 98.5 t -73.67 -39.53 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 124.055 1.883 . . . . 0.62 110.792 176.543 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -70.88 -38.95 73.08 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.91 2.484 . . . . 1.22 110.487 178.449 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.46 -38.16 63.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.692 2.797 . . . . 0.51 114.193 169.853 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -77.23 -38.36 51.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.815 -1.803 . . . . 1.44 112.109 177.164 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.1 mt -61.08 -36.55 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 124.451 1.101 . . . . 1.32 111.42 172.219 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -65.51 -38.2 88.99 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 123.743 1.735 . . . . 1.7 110.936 178.777 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.53 -41.1 98.64 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 117.822 -3.049 . . . . 1.55 113.023 176.6 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -81.59 -59.09 2.73 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 116.423 -1.751 . . . . 2.62 112.064 -176.766 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -98.72 -39.17 8.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.989 2.515 . . . . 1.48 114.119 -164.825 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.21 26.59 7.31 Favored Glycine 0 N--CA 1.431 -1.693 0 O-C-N 125.733 1.896 . . . . 1.12 111.753 173.503 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 36' ' ' ILE . 39.2 mt -102.31 128.39 28.44 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 118.712 -2.64 . . . . 1.55 105.923 -176.809 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.305 80.1 Cg_endo -68.54 158.48 57.52 Favored 'Trans proline' 0 C--N 1.299 -2.051 2 C-N-CA 128.958 6.438 . . . . 1.02 112.75 -175.937 . . . . . . . . 3 2 . 1 . 045 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -66.52 -31.68 41.12 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 CA-C-N 124.389 2.603 . . . . 1.25 112.364 -178.514 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -50.14 -47.55 54.13 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.755 2.872 . . . . 2.25 118.755 175.271 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -70.27 -19.77 63.09 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.32 2.341 . . . . 2.02 117.32 176.199 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -96.41 135.97 37.55 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 120.011 1.278 . . . . 0.69 110.398 -173.484 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -128.01 124.23 36.65 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 100.817 -3.771 . . . . 2.78 100.817 173.279 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.8 mt -104.88 129.51 53.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.451 -2.159 . . . . 1.17 110.735 178.21 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.5 mm -108.59 129.21 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 125.588 2.613 . . . . 1.38 110.198 178.473 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -130.15 130.82 45.25 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.939 -2.976 . . . . 1.5 109.502 172.068 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.255 . . 67.51 -75.23 0.06 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.21 1.481 . . . . 1.21 109.089 -173.08 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.428 ' H ' ' H ' ' A' ' 48' ' ' LYS . . . -161.38 -7.9 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 129.912 3.625 . . . . 1.3 112.3 -175.937 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.428 ' H ' ' H ' ' A' ' 47' ' ' GLY . 44.2 mttp -81.3 130.85 35.2 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.569 -1.548 . . . . 2.55 112.427 -177.467 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -91.2 106.87 18.82 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 114.905 -4.872 . . . . 2.48 104.003 169.671 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.4 mt -71.21 133.17 45.93 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 117.316 2.339 . . . . 0.9 117.316 -169.583 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -83.87 141.97 30.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 111.562 -2.563 . . . . 1.94 114.031 -178.795 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.6 -65.68 0.64 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.469 -2.644 . . . . 1.56 117.989 -161.573 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.3 54.26 4.92 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-O 126.339 3.189 . . . . 0.97 117.33 168.701 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -117.14 146.69 43.02 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 111.585 -2.307 . . . . 2.49 108.987 159.657 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.6 p -72.79 152.93 41.33 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.905 1.446 . . . . 0.76 114.905 169.351 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.6 mt -59.72 -36.8 77.31 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.708 2.803 . . . . 1.05 108.161 175.109 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.263 1.7 t -71.38 -26.11 62.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 127.333 2.896 . . . . 1.19 112.836 175.078 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -67.88 -47.57 68.48 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 123.805 3.002 . . . . 1.9 111.183 168.74 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -69.8 -23.15 63.29 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.732 -1.855 . . . . 0.89 114.692 176.963 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.7 t30 73.79 53.11 0.11 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 127.414 2.286 . . . . 1.84 109.668 -171.672 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.8 mt -95.91 119.79 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 103.524 -2.769 . . . . 0.82 103.524 174.163 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -105.18 -178.06 3.54 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.282 -2.136 . . . . 2.16 111.869 -179.038 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.362 14.1 ptmt -49.18 137.42 13.77 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 127.326 2.25 . . . . 2.12 115.668 172.852 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 77.91 11.31 2.0 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.714 1.605 . . . . 1.71 114.421 173.163 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.3 m -82.59 147.19 28.74 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 124.395 1.059 . . . . 1.04 113.188 -175.165 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.5 m -105.19 116.48 32.02 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.732 2.206 . . . . 0.79 110.625 179.635 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.8 mt -88.4 141.46 28.52 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.323 -2.736 . . . . 1.4 110.804 172.15 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -100.69 123.61 45.14 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.714 1.721 . . . . 1.51 107.448 173.75 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.8 tp -85.89 111.99 20.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.916 1.686 . . . . 1.14 113.745 176.86 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.7 t -111.51 134.3 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 2 CA-C-O 129.965 4.698 . . . . 1.23 99.757 178.947 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.6 mt -116.85 133.02 56.53 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.023 -2.923 . . . . 2.78 115.687 -177.549 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -125.51 178.75 5.47 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 117.389 2.366 . . . . 3.75 117.389 178.218 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.3 mt -90.96 -58.38 2.49 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 123.596 2.907 . . . . 3.14 110.578 169.789 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -109.73 -55.36 2.45 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 126.34 2.275 . . . . 6.8 108.394 172.973 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.7 -131.11 1.97 Allowed Glycine 0 N--CA 1.432 -1.633 0 CA-C-O 117.736 -1.591 . . . . 3.57 111.612 -159.354 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.8 0 CA-C-N 118.68 1.24 . . . . 3.87 112.259 -176.346 . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 CA--C 1.489 -1.371 0 CA-C-O 117.439 -1.267 . . . . 1.1 111.138 . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -94.7 134.57 37.15 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.774 1.75 . . . . 1.87 111.374 -171.633 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -120.61 136.6 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.855 -3.028 . . . . 0.72 106.26 169.037 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -101.66 90.66 4.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 125.312 2.482 . . . . 1.4 111.701 -173.443 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.99 100.08 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.49 1 O-C-N 112.216 -6.553 . . . . 0.58 113.367 177.238 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -96.12 134.89 38.64 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.84 -1.163 . . . . 2.09 110.568 178.452 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.5 p -84.52 -178.78 6.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 131.049 3.74 . . . . 0.99 116.102 174.612 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.3 tp -79.01 -26.58 43.24 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.97 -4.206 . . . . 2.53 116.336 171.395 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.5 p -77.32 -34.01 55.41 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.253 2.93 . . . . 2.08 114.335 -179.167 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.32 4.16 2.6 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 119.27 -2.144 . . . . 1.31 111.455 174.464 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -82.4 122.74 28.39 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.82 -1.988 . . . . 1.4 111.531 -176.174 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 m -99.26 112.23 24.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.394 -2.691 . . . . 0.78 113.362 170.041 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.52 117.63 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 120.021 -1.674 . . . . 1.55 106.59 171.049 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.6 m -99.07 98.04 9.11 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.495 -1.669 . . . . 1.08 106.495 -178.362 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.1 mt -76.51 126.09 30.37 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.436 1.894 . . . . 1.55 111.294 -176.928 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -81.26 104.07 11.47 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.904 -2.997 . . . . 1.95 113.363 166.662 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 m -110.49 171.62 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 123.983 0.913 . . . . 0.96 111.596 -179.739 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -123.32 169.73 9.6 Favored Pre-proline 0 N--CA 1.43 -1.472 0 CA-C-O 116.278 -1.82 . . . . 2.35 107.387 158.22 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -78.66 -16.08 13.3 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 124.127 2.51 . . . . 0.95 112.719 -167.905 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.83 -19.21 65.8 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 114.886 -2.483 . . . . 1.45 113.886 174.537 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -72.18 143.63 48.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 125.189 1.555 . . . . 1.69 113.073 -174.863 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 26' ' ' VAL . 13.5 p -86.89 167.42 14.34 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.568 -1.958 . . . . 0.75 113.361 178.798 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 23' ' ' ILE . 42.4 mm -64.08 -37.16 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.536 -1.353 . . . . 0.73 111.84 172.962 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -53.03 -42.18 65.43 Favored 'General case' 0 N--CA 1.429 -1.492 1 O-C-N 115.458 -4.526 . . . . 1.62 114.866 163.639 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -72.72 -32.94 66.09 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.407 -2.683 . . . . 2.13 111.756 -178.621 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 55.1 t -62.56 -50.38 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 119.019 -2.3 . . . . 0.62 109.927 171.724 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -66.82 -18.59 65.45 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.142 1.377 . . . . 1.22 111.168 -179.227 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.0 -35.51 31.86 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 113.292 0.849 . . . . 0.51 113.292 169.816 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 55.1 mttp -63.46 -52.47 61.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.153 -2.217 . . . . 1.44 108.542 171.203 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.8 mt -53.92 -32.54 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 123.96 3.073 . . . . 1.32 117.397 174.83 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -71.1 -40.06 71.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.088 -2.883 . . . . 1.7 114.901 173.568 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.64 -56.85 16.16 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.09 -2.881 . . . . 1.55 107.428 168.836 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -71.22 -56.48 5.97 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.485 1.291 . . . . 2.62 114.485 -170.103 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -96.15 -24.79 16.12 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.151 2.58 . . . . 1.48 112.11 -168.972 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.55 37.53 13.99 Favored Glycine 0 N--CA 1.43 -1.751 0 CA-C-O 127.6 3.889 . . . . 1.12 113.71 173.853 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.7 mt -108.86 132.72 21.0 Favored Pre-proline 0 N--CA 1.429 -1.494 1 O-C-N 116.262 -4.081 . . . . 1.55 108.268 -178.539 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -68.51 142.88 55.29 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 C-N-CA 125.05 3.833 . . . . 1.02 120.817 -179.574 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.47 -9.11 21.32 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 123.731 2.954 . . . . 1.25 117.745 -171.376 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.74 -23.39 36.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.906 1.683 . . . . 2.25 112.697 166.85 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -86.15 -41.08 15.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 129.122 2.969 . . . . 2.02 111.123 -177.762 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.257 58.0 mt-30 -70.0 134.54 48.42 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 111.056 -2.793 . . . . 0.69 113.168 179.978 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -133.11 120.13 20.85 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.322 1.601 . . . . 2.78 115.322 175.074 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.6 mt -100.02 117.42 34.25 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 121.223 -0.923 . . . . 1.17 111.167 -177.214 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 44' ' ' ILE . 80.8 mt -110.33 129.19 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 126.964 2.106 . . . . 1.38 108.097 179.472 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -142.83 137.52 29.68 Favored 'General case' 0 N--CA 1.43 -1.463 1 N-CA-C 99.092 -4.41 . . . . 1.5 99.092 173.002 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.16 33.4 23.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 117.078 2.251 . . . . 1.21 117.078 175.695 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.57 9.18 73.53 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 116.198 -2.906 . . . . 1.3 115.459 -174.023 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -121.33 137.9 54.49 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.694 2.187 . . . . 2.55 109.732 -176.459 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -89.37 118.22 28.88 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 127.261 3.41 . . . . 2.48 102.155 179.281 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.1 mt -87.22 152.59 22.18 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.771 -3.706 . . . . 0.9 112.82 -170.715 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -97.4 163.9 12.68 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.104 -3.498 . . . . 1.94 109.535 179.633 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -72.88 -69.04 0.44 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.458 2.303 . . . . 1.56 114.168 -168.314 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.08 59.77 2.25 Favored Glycine 0 N--CA 1.43 -1.728 1 C-N-CA 131.455 4.359 . . . . 0.97 110.76 176.919 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.5 mmt-85 -142.74 148.46 37.28 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.073 -1.825 . . . . 2.49 106.073 169.7 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 72.6 p -86.43 170.24 12.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.217 -3.427 . . . . 0.76 108.617 178.72 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 31.3 mt -65.89 -39.1 90.32 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.794 2.838 . . . . 1.05 110.648 169.078 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 t -64.88 -37.03 86.26 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.825 -3.047 . . . . 1.19 114.966 177.726 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -60.48 -40.67 92.14 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 115.925 1.824 . . . . 1.9 115.925 177.486 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -77.25 -9.92 59.1 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.797 2.839 . . . . 0.89 114.246 171.809 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.258 9.6 t30 63.18 48.39 3.73 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 125.787 2.708 . . . . 1.84 113.368 -176.698 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.1 mt -96.47 100.24 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 1 C-N-CA 132.25 4.22 . . . . 0.82 104.843 179.352 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -90.75 -174.45 4.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 121.959 2.163 . . . . 2.16 106.591 -175.955 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -62.37 151.66 36.2 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.58 -1.646 . . . . 2.12 109.76 173.088 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.344 43.7 mt-10 67.4 21.88 9.57 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 128.983 2.913 . . . . 1.71 111.078 171.106 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.1 m -85.59 136.7 33.28 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 115.617 -2.135 . . . . 1.04 112.64 -178.396 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.0 m -90.72 111.13 22.36 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 120.234 1.379 . . . . 0.79 108.623 -178.764 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.3 mt -88.91 137.67 32.11 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.259 -3.4 . . . . 1.4 107.313 173.326 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -94.06 116.65 29.1 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.78 -2.45 . . . . 1.51 106.527 -174.046 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.1 tp -99.63 108.68 21.12 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.749 -1.844 . . . . 1.14 110.005 -176.909 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.3 t -98.52 132.73 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 131.262 3.825 . . . . 1.23 107.691 178.307 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.8 mt -112.86 106.84 15.24 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 127.458 3.504 . . . . 2.78 105.354 177.565 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -63.84 160.69 16.9 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 115.113 -4.742 . . . . 3.75 115.23 -179.38 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.6 mt -113.09 174.36 5.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.732 2.413 . . . . 3.14 106.539 171.419 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -99.98 155.38 17.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.11 -3.494 . . . . 6.8 112.994 171.726 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.38 -91.1 0.56 Allowed Glycine 0 N--CA 1.43 -1.739 0 CA-C-O 117.315 -1.825 . . . . 3.57 112.345 -170.617 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.75 0 CA-C-N 123.804 3.802 . . . . 3.87 107.784 174.578 . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ptt? . . . . . 0 CA--C 1.489 -1.392 0 CA-C-O 121.792 0.806 . . . . 1.1 111.739 . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -110.81 142.21 43.12 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.645 -1.909 . . . . 1.87 110.301 -169.694 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.2 pt -136.64 146.2 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 129.073 2.949 . . . . 0.72 109.809 178.42 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.422 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 25.3 m-85 -105.29 109.55 21.58 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 113.384 -1.735 . . . . 1.4 112.933 -178.497 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -100.49 103.06 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 117.601 -3.187 . . . . 0.58 108.703 176.227 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -91.76 131.57 37.03 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.73 -1.605 . . . . 2.09 113.049 176.486 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.351 0.0 OUTLIER -98.4 168.83 9.96 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.455 2.302 . . . . 0.99 109.32 -177.976 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.5 mt -67.67 -35.29 78.58 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 126.404 2.315 . . . . 2.53 112.686 -175.611 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.319 17.8 p -71.31 -35.66 71.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.893 1.679 . . . . 2.08 109.197 -176.388 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.29 -12.68 1.83 Allowed Glycine 0 N--CA 1.429 -1.805 0 O-C-N 118.949 -2.344 . . . . 1.31 115.758 178.031 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -80.29 134.45 36.08 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 124.946 2.308 . . . . 1.4 114.064 -175.654 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -99.82 127.3 45.99 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.197 -2.19 . . . . 0.78 109.518 173.813 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 mt -102.48 117.61 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 118.136 -2.853 . . . . 1.55 108.66 174.699 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.1 m -95.92 117.69 31.1 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 119.534 -0.866 . . . . 1.08 109.194 178.629 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.5 mt -119.21 150.27 40.35 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 121.212 -0.93 . . . . 1.55 112.627 177.371 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -101.07 139.91 36.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 127.762 3.164 . . . . 1.95 108.547 167.657 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.9 m -150.93 170.47 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 C-N-CA 129.969 3.307 . . . . 0.96 112.981 -178.383 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -108.47 156.9 37.84 Favored Pre-proline 0 CA--C 1.489 -1.383 0 CA-C-O 114.071 -2.871 . . . . 2.35 110.264 167.054 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -67.84 -21.27 44.51 Favored 'Trans proline' 0 N--CA 1.433 -2.065 0 C-N-CA 124.525 3.483 . . . . 0.95 111.827 -174.643 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.2 p -71.4 -6.64 41.74 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 130.511 3.525 . . . . 1.45 115.944 169.713 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.74 156.19 30.75 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.473 -2.017 . . . . 1.69 112.928 176.021 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.6 p -92.64 169.63 10.36 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.085 1.754 . . . . 0.75 113.128 176.512 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.5 mm -66.93 -30.97 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.806 -2.434 . . . . 0.73 114.975 173.579 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -57.25 -40.44 77.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.883 -3.01 . . . . 1.62 112.176 168.827 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -69.42 -23.65 63.73 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 113.217 0.821 . . . . 2.13 113.217 177.912 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.9 t -79.69 -46.54 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 119.647 -1.908 . . . . 0.62 113.48 176.38 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -68.85 -23.6 64.26 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 125.761 2.696 . . . . 1.22 115.017 176.614 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.84 -19.75 57.15 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.24 -3.412 . . . . 0.51 111.105 173.561 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -84.64 -34.85 22.99 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.173 2.416 . . . . 1.44 110.3 -179.838 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.7 mt -75.95 -22.13 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 117.965 -2.96 . . . . 1.32 107.767 175.822 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -70.23 -37.27 74.95 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 117.968 -2.958 . . . . 1.7 110.883 170.818 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.97 -59.33 3.58 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 120.467 -1.396 . . . . 1.55 110.873 172.438 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.256 32.6 tttp -59.18 -58.83 6.93 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.266 2.626 . . . . 2.62 111.25 -172.266 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -92.99 -74.7 0.51 Allowed 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.4 1.88 . . . . 1.48 109.612 -174.065 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 156.6 -14.23 0.35 Allowed Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 125.31 3.687 . . . . 1.12 110.274 177.186 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.6 mt -57.59 119.41 32.61 Favored Pre-proline 0 N--CA 1.43 -1.433 0 C-N-CA 128.929 2.892 . . . . 1.55 113.476 -172.891 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -60.22 147.09 94.85 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 CA-C-N 125.168 2.882 . . . . 1.02 117.534 171.789 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.304 73.6 Cg_endo -72.35 -18.25 26.57 Favored 'Trans proline' 0 N--CA 1.433 -2.031 1 C-N-CA 126.691 4.927 . . . . 1.25 114.615 -172.327 . . . . . . . . 3 2 . 1 . 047 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -73.36 -22.03 60.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 124.176 3.171 . . . . 2.25 109.373 174.799 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -87.4 -18.38 30.13 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.918 -2.364 . . . . 2.02 110.0 -178.724 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -96.12 116.27 28.72 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.726 -1.953 . . . . 0.69 105.726 -172.043 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -103.57 119.79 39.59 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 131.472 3.909 . . . . 2.78 107.851 168.695 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.5 mt -109.53 120.82 43.67 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.047 1.403 . . . . 1.17 110.916 179.631 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.414 HD11 HG21 ' A' ' 70' ' ' VAL . 1.4 mt -104.98 126.81 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 O-C-N 119.871 -1.768 . . . . 1.38 109.843 -179.614 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.498 ' CE2' HG12 ' A' ' 61' ' ' ILE . 49.3 t80 -134.12 127.79 32.82 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 116.881 -3.637 . . . . 1.5 112.936 173.762 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 35.39 38.75 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.843 1.657 . . . . 1.21 114.508 -171.51 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.27 -43.12 1.76 Allowed Glycine 0 N--CA 1.431 -1.699 0 O-C-N 118.012 -2.93 . . . . 1.3 113.096 175.752 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -72.46 144.03 48.22 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 119.374 1.587 . . . . 2.55 113.522 176.47 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.445 1.1 mp0 -99.14 112.8 24.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.325 -2.109 . . . . 2.48 112.101 169.742 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.8 mt -78.27 139.28 38.89 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 116.715 -3.741 . . . . 0.9 113.964 -158.393 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -82.05 141.8 32.87 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.747 2.419 . . . . 1.94 109.673 178.262 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.31 -48.46 71.32 Favored 'General case' 0 N--CA 1.43 -1.433 1 N-CA-C 121.91 4.041 . . . . 1.56 121.91 -173.378 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.92 63.25 1.52 Allowed Glycine 0 N--CA 1.431 -1.649 0 O-C-N 118.378 -2.701 . . . . 0.97 114.216 171.228 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -129.65 150.39 50.99 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.371 3.069 . . . . 2.49 105.932 167.62 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.7 p -87.41 170.15 11.63 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 119.071 -1.052 . . . . 0.76 110.048 177.662 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.6 mt -70.67 -30.11 66.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.591 1.956 . . . . 1.05 107.943 173.39 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.3 p -73.03 -43.0 62.56 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 116.241 -4.037 . . . . 1.19 118.036 175.382 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -44.05 -60.45 1.86 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.256 2.222 . . . . 1.9 116.584 167.058 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -73.25 3.78 5.34 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.424 -1.262 . . . . 0.89 112.054 179.61 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.2 t30 52.76 48.76 21.77 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.612 3.165 . . . . 1.84 114.654 -175.308 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.498 HG12 ' CE2' ' A' ' 45' ' ' PHE . 19.5 mt -94.92 124.74 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 116.528 -3.857 . . . . 0.82 108.281 175.785 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -114.33 -162.64 0.82 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 116.794 -3.691 . . . . 2.16 105.809 -165.299 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -67.87 139.59 56.51 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 124.935 2.302 . . . . 2.12 113.371 167.347 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.438 84.5 mt-10 70.81 38.3 1.22 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.912 -2.368 . . . . 1.71 111.191 171.043 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 m -95.53 115.24 27.16 Favored 'General case' 0 N--CA 1.43 -1.453 1 C-N-CA 133.734 4.813 . . . . 1.04 107.779 -170.31 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.422 ' HA ' ' HB2' ' A' ' 4' ' ' PHE 0.256 87.5 m -80.46 102.47 9.7 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.723 -1.236 . . . . 0.79 114.263 175.414 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.308 8.8 mt -89.21 135.61 33.48 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-O 123.904 1.812 . . . . 1.4 107.494 174.033 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -97.39 104.98 17.05 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.084 1.354 . . . . 1.51 107.586 -174.276 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.362 16.6 tp -76.43 115.42 16.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.371 -3.331 . . . . 1.14 114.335 174.906 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.414 HG21 HD11 ' A' ' 44' ' ' ILE . 66.0 t -108.48 128.77 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 115.554 -2.165 . . . . 1.23 106.508 172.212 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.8 mt -96.86 161.05 14.03 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 123.968 3.076 . . . . 2.78 109.019 176.285 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -95.6 98.1 10.24 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 103.089 -2.93 . . . . 3.75 103.089 174.976 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.3 mt -97.83 147.72 24.13 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 124.478 2.085 . . . . 3.14 107.881 171.632 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -86.32 123.6 31.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.052 -1.431 . . . . 6.8 109.7 171.557 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.19 -87.97 0.27 Allowed Glycine 0 N--CA 1.43 -1.747 0 CA-C-O 116.238 -2.423 . . . . 3.57 109.11 -173.969 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.74 0 CA-C-O 116.82 -2.1 . . . . 3.87 110.748 178.333 . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.458 ' SD ' ' HA ' ' A' ' 63' ' ' LYS . 11.0 ptt? . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 117.878 -1.058 . . . . 1.1 112.834 . . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -86.4 129.43 34.86 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 120.878 1.672 . . . . 1.87 112.013 -179.881 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.261 32.5 pt -130.91 150.68 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.129 -3.482 . . . . 0.72 108.642 175.459 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -110.88 142.73 42.55 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 117.897 -3.002 . . . . 1.4 104.819 -178.653 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.4 t -124.1 108.49 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 107.082 -1.451 . . . . 0.58 107.082 172.748 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -98.28 132.1 44.05 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.89 -2.381 . . . . 2.09 110.633 -178.872 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.555 HG22 HD23 ' A' ' 69' ' ' LEU . 2.6 p -86.53 177.48 7.38 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.805 2.241 . . . . 0.99 113.682 178.797 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.317 43.0 mt -83.2 -38.99 21.56 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 119.153 -2.217 . . . . 2.53 109.828 170.073 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 p -63.71 -52.28 61.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.452 3.101 . . . . 2.08 113.963 179.69 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.84 11.31 0.04 OUTLIER Glycine 0 N--CA 1.429 -1.783 0 O-C-N 118.465 -2.647 . . . . 1.31 118.008 -175.136 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -115.59 150.95 35.83 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 105.824 -1.917 . . . . 1.4 105.824 -167.445 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.3 m -122.29 111.23 16.66 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 116.393 -1.765 . . . . 0.78 109.377 166.963 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -91.58 121.79 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 123.605 2.911 . . . . 1.55 109.952 177.622 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 m -87.55 114.18 23.92 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 127.189 3.376 . . . . 1.08 113.286 173.008 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.4 mt -110.8 154.74 23.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.918 -2.989 . . . . 1.55 112.88 -179.712 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -110.09 123.14 49.17 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 124.259 1.981 . . . . 1.95 108.028 166.283 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.96 170.59 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 118.672 -2.517 . . . . 0.96 107.116 -174.528 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -118.91 154.65 53.12 Favored Pre-proline 0 N--CA 1.43 -1.463 0 O-C-N 119.151 -2.218 . . . . 2.35 105.825 165.331 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -68.17 -16.54 44.53 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 O-C-N 114.683 -3.377 . . . . 0.95 114.276 -175.253 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.4 m -91.15 12.03 21.35 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 114.045 -5.409 . . . . 1.45 113.378 175.836 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -88.54 144.86 26.06 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 113.31 -3.356 . . . . 1.69 108.463 179.707 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.278 53.7 p -71.28 153.24 42.55 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.473 1.909 . . . . 0.75 109.758 -179.945 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.6 mm -54.09 -40.58 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 118.403 -2.685 . . . . 0.73 114.598 168.645 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -42.59 -46.29 4.88 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 117.675 2.472 . . . . 1.62 117.675 164.983 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.61 -46.03 84.38 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 111.625 -2.534 . . . . 2.13 112.478 178.151 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.6 t -59.01 -44.32 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 C-N-CA 126.743 2.017 . . . . 0.62 106.155 178.034 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.254 84.2 mttt -60.8 -42.61 97.97 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 116.203 -4.061 . . . . 1.22 114.124 177.473 . . . . . . . . 3 2 . 1 . 048 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.34 -20.68 62.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.448 -3.283 . . . . 0.51 116.379 175.091 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -72.68 -45.24 59.83 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.095 1.758 . . . . 1.44 112.359 170.442 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -48.69 -43.91 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.532 1.533 . . . . 1.32 112.756 163.264 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -66.05 -43.38 87.65 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.855 -3.653 . . . . 1.7 112.622 -179.537 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -53.77 -49.59 67.91 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.323 1.449 . . . . 1.55 110.339 168.26 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -80.97 -54.79 5.27 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.071 -2.893 . . . . 2.62 112.627 -174.815 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -99.62 -26.62 14.02 Favored 'General case' 0 N--CA 1.431 -1.401 1 O-C-N 112.694 -6.254 . . . . 1.48 109.03 -168.309 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.2 17.4 40.23 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 117.918 -2.989 . . . . 1.12 115.158 179.929 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.8 mt -84.83 123.28 74.17 Favored Pre-proline 0 N--CA 1.43 -1.471 0 CA-C-O 113.678 -3.058 . . . . 1.55 107.972 -177.404 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -69.81 144.4 53.61 Favored 'Trans proline' 0 N--CA 1.433 -2.037 1 CA-C-N 129.548 4.446 . . . . 1.02 114.205 -178.142 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_exo -62.08 -20.05 68.42 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 N-CA-C 121.185 3.494 . . . . 1.25 121.185 -165.425 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -66.79 -28.17 68.17 Favored 'General case' 0 N--CA 1.429 -1.49 1 O-C-N 129.998 4.561 . . . . 2.25 111.773 173.542 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -85.62 -24.59 27.05 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 116.296 -1.812 . . . . 2.02 110.457 -176.412 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.251 60.1 mt-30 -79.49 129.8 34.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 127.899 3.249 . . . . 0.69 110.959 -169.107 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -115.1 129.87 56.79 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.457 -2.053 . . . . 2.78 105.457 168.993 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.3 mt -114.1 126.96 55.68 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.139 -2.85 . . . . 1.17 111.093 179.647 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 59.8 mt -117.73 124.23 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-O 126.969 3.271 . . . . 1.38 111.245 -175.47 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -135.66 139.3 43.63 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 115.965 -4.21 . . . . 1.5 109.049 172.192 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.362 . . 58.68 25.21 13.05 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 123.779 2.991 . . . . 1.21 115.673 173.469 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.11 2.92 90.7 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 117.077 1.591 . . . . 1.3 117.077 -177.055 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -113.26 157.21 22.05 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.382 2.273 . . . . 2.55 115.61 176.773 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -97.54 139.66 33.12 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.431 -2.668 . . . . 2.48 109.674 173.079 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.3 mt -102.2 120.66 40.82 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.978 -2.951 . . . . 0.9 111.329 -170.362 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -67.28 148.01 52.25 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.191 1.552 . . . . 1.94 115.191 175.283 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.65 -47.11 76.67 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 120.75 3.611 . . . . 1.56 120.75 -174.37 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.39 18.01 21.03 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 115.372 -2.904 . . . . 0.97 118.766 173.684 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -102.79 156.74 17.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.77 2.785 . . . . 2.49 110.974 171.643 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 39.1 p -88.55 169.65 11.55 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 123.329 1.538 . . . . 0.76 115.008 172.817 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.333 77.3 mt -69.22 -23.96 63.95 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 116.011 -4.181 . . . . 1.05 110.809 170.713 . . . . . . . . 3 2 . 1 . 048 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -65.72 -36.4 83.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.8 2.44 . . . . 1.19 115.489 171.806 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -65.41 -38.59 90.38 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.698 1.599 . . . . 1.9 113.911 173.881 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -78.9 -25.28 43.79 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 115.328 -2.272 . . . . 0.89 113.901 175.323 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.279 1.9 m-80 70.8 58.46 0.21 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.107 1.763 . . . . 1.84 109.909 -171.299 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 mt -105.25 117.12 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 105.022 -2.214 . . . . 0.82 105.022 174.034 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -84.83 -175.16 5.65 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 124.837 2.256 . . . . 2.16 111.374 -169.216 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.458 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 59.7 tttt -20.98 -87.87 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.422 1 C-N-CA 134.351 5.06 . . . . 2.12 118.208 169.086 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -103.17 69.3 1.01 Allowed 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 122.408 2.367 . . . . 1.71 116.226 -179.97 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.3 m -91.85 152.38 20.12 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 114.797 -1.092 . . . . 1.04 112.762 -179.99 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.5 m -113.52 115.69 28.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.136 1.374 . . . . 0.79 109.851 174.024 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.3 mt -96.93 156.63 16.27 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.545 1.938 . . . . 1.4 110.83 -179.674 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.405 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 98.2 m-70 -110.9 129.65 55.81 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 100.991 -3.707 . . . . 1.51 100.991 -175.815 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.555 HD23 HG22 ' A' ' 7' ' ' THR . 29.0 tp -102.53 113.89 27.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 125.328 1.643 . . . . 1.14 108.441 178.509 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.96 148.79 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 125.497 2.57 . . . . 1.23 109.464 172.845 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.9 mt -112.62 150.54 31.27 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.728 -4.358 . . . . 2.78 111.985 -177.708 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -78.74 162.55 26.08 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.135 -2.172 . . . . 3.75 105.135 179.533 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.3 mt -78.34 104.53 8.99 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 115.275 -2.57 . . . . 3.14 116.746 172.668 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -85.92 -55.35 3.99 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.997 -1.689 . . . . 6.8 112.333 173.738 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 143.03 -68.98 0.43 Allowed Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 117.79 -1.561 . . . . 3.57 112.593 -175.716 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.733 0 CA-C-N 123.658 3.729 . . . . 3.87 108.563 -178.205 . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 ptt? . . . . . 0 CA--C 1.491 -1.316 0 N-CA-C 116.773 2.138 . . . . 1.1 116.773 . . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -87.62 121.17 29.72 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 122.566 2.439 . . . . 1.87 110.489 178.904 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 pt -108.42 153.09 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 127.699 2.4 . . . . 0.72 108.577 173.777 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -104.18 131.08 51.85 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.868 -1.16 . . . . 1.4 107.868 -179.744 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.5 t -121.01 121.47 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 104.481 -2.414 . . . . 0.58 104.481 168.054 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -100.25 128.18 46.37 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 126.632 1.973 . . . . 2.09 111.727 -176.971 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.353 30.5 p -77.41 -164.07 0.44 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.602 1.668 . . . . 0.99 114.42 179.201 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.308 10.3 mt -90.97 -40.6 11.59 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.704 -1.872 . . . . 2.53 112.911 169.159 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.0 p -64.75 -37.09 86.42 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.548 -2.595 . . . . 2.08 107.616 -176.409 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.35 51.97 0.31 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 128.067 2.746 . . . . 1.31 111.312 175.92 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -114.1 130.27 56.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 101.972 -3.344 . . . . 1.4 101.972 177.425 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.3 m -102.67 103.76 14.05 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 118.016 -2.927 . . . . 0.78 110.399 177.146 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.81 136.51 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 118.755 -2.465 . . . . 1.55 108.418 179.541 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.7 m -103.29 111.93 24.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 118.733 -0.651 . . . . 1.08 109.265 179.602 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.38 142.23 28.01 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 127.992 3.307 . . . . 1.55 109.253 -178.97 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -105.81 116.28 31.67 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 123.395 1.569 . . . . 1.95 113.044 164.407 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.78 179.46 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.039 -1.437 . . . . 0.96 109.635 -178.808 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 89.8 mt-10 -115.89 163.35 21.46 Favored Pre-proline 0 N--CA 1.432 -1.373 0 O-C-N 117.1 -3.5 . . . . 2.35 107.888 164.189 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 56.1 Cg_exo -70.51 -14.46 33.73 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 C-N-CA 122.603 2.202 . . . . 0.95 112.444 -177.688 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.0 p -90.6 -0.99 57.88 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.165 2.186 . . . . 1.45 112.675 179.335 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -75.89 137.51 40.46 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.602 -1.936 . . . . 1.69 112.321 174.284 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 17.2 p -78.87 170.84 16.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.902 1.81 . . . . 0.75 111.625 174.297 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.284 3.5 mp -64.43 -41.07 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.267 -3.396 . . . . 0.73 112.721 168.106 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -43.5 -50.97 6.96 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 117.133 2.271 . . . . 1.62 117.133 163.694 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -67.01 -34.58 78.04 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.234 -2.166 . . . . 2.13 110.743 179.11 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.25 -42.1 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 118.253 2.686 . . . . 0.62 118.253 170.548 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.413 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 40.1 mtmt -71.86 -34.96 69.65 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 117.621 -3.175 . . . . 1.22 117.091 174.337 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.39 -28.38 63.99 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.733 2.413 . . . . 0.51 113.116 179.254 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -71.53 -37.89 71.11 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.689 2.395 . . . . 1.44 110.345 168.616 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.1 mt -68.31 -38.81 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 125.282 1.433 . . . . 1.32 107.996 175.872 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.342 40.3 tt0 -56.44 -41.8 77.04 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 128.788 2.835 . . . . 1.7 114.057 171.035 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -60.51 -41.73 94.95 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 118.236 2.68 . . . . 1.55 118.236 162.013 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -76.28 -52.4 10.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.719 -3.113 . . . . 2.62 116.431 -173.748 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -100.31 -26.77 13.79 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.714 2.406 . . . . 1.48 111.152 -168.585 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.75 13.88 56.04 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 118.12 -2.862 . . . . 1.12 117.289 176.048 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.9 mt -98.7 117.86 63.89 Favored Pre-proline 0 N--CA 1.43 -1.431 0 C-N-CA 127.439 2.295 . . . . 1.55 110.094 -170.799 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.39 152.71 70.94 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 CA-C-N 125.273 2.919 . . . . 1.02 116.932 -178.593 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -81.8 8.73 4.28 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 CA-C-O 113.582 -2.757 . . . . 1.25 107.919 -165.808 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -73.37 -44.13 59.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 125.272 3.669 . . . . 2.25 113.167 168.939 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -72.61 -26.36 61.66 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.783 2.833 . . . . 2.02 107.926 -172.466 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.413 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 73.3 mt-30 -87.25 133.18 33.7 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 123.455 0.702 . . . . 0.69 111.518 -165.932 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -124.6 146.89 48.81 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.182 2.593 . . . . 2.78 105.167 166.01 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 69' ' ' LEU . 32.5 mt -129.33 128.06 42.36 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 129.168 2.987 . . . . 1.17 105.933 -177.709 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -121.01 115.66 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 105.339 -2.097 . . . . 1.38 105.339 -178.165 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.414 ' HB2' HD22 ' A' ' 67' ' ' LEU 0.262 23.8 t80 -101.45 117.37 34.8 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.736 -1.852 . . . . 1.5 106.397 171.127 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.54 -46.31 0.62 Allowed 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.45 2.7 . . . . 1.21 114.806 -177.086 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.04 -32.81 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 126.938 2.209 . . . . 1.3 110.186 -171.712 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.27 52.8 mttm -73.29 125.96 29.01 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 126.657 2.034 . . . . 2.55 114.685 175.272 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -82.79 136.36 34.69 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 128.382 3.944 . . . . 2.48 112.825 172.309 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.4 mt -99.89 132.53 45.19 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.125 -2.86 . . . . 0.9 111.628 -165.171 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -79.17 141.28 37.35 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 122.175 0.988 . . . . 1.94 112.426 174.728 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.82 -57.74 8.45 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 126.031 2.824 . . . . 1.56 116.273 -174.135 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.43 16.43 13.84 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 122.6 3.8 . . . . 0.97 122.6 174.502 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 -85.41 163.87 18.25 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.8 1.8 . . . . 2.49 111.14 161.17 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.7 p -89.66 169.66 11.13 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 115.365 1.617 . . . . 0.76 115.365 165.287 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.491 ' HA ' HD12 ' A' ' 61' ' ' ILE . 58.5 mt -64.6 -47.8 77.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 129.086 2.954 . . . . 1.05 108.666 172.147 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.7 m -57.65 -37.06 72.72 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.038 -2.289 . . . . 1.19 114.481 175.675 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -62.79 -54.37 39.99 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 129.764 3.226 . . . . 1.9 115.913 175.365 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -64.42 -12.38 42.65 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.564 -2.16 . . . . 0.89 116.294 169.404 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.2 m120 69.67 56.24 0.35 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 126.615 2.447 . . . . 1.84 113.175 -179.583 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 56' ' ' LEU . 65.9 mt -95.66 128.44 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 128.885 2.874 . . . . 0.82 106.433 -176.731 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -75.76 159.42 31.07 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 125.708 1.603 . . . . 2.16 109.875 -171.943 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -52.27 -35.26 49.57 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 120.448 3.499 . . . . 2.12 120.448 167.519 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -128.39 86.44 2.46 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 130.086 4.616 . . . . 1.71 105.011 174.437 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.44 172.76 11.2 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 117.895 -1.05 . . . . 1.04 110.997 -176.697 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.4 m -130.48 125.79 35.27 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 117.807 -1.092 . . . . 0.79 108.727 176.381 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.414 HD22 ' HB2' ' A' ' 45' ' ' PHE . 15.0 mt -104.12 145.64 29.89 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 128.773 2.829 . . . . 1.4 111.671 170.492 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -106.15 122.13 45.56 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.171 -1.58 . . . . 1.51 111.416 -172.277 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 43' ' ' LEU . 57.2 tp -90.22 118.69 29.93 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.208 -1.775 . . . . 1.14 106.208 -173.574 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.5 t -119.29 148.9 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 103.69 -2.707 . . . . 1.23 103.69 173.722 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.9 mt -122.46 151.52 41.2 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 125.933 2.02 . . . . 2.78 108.401 -175.459 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -80.82 179.87 7.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.935 -1.876 . . . . 3.75 105.935 171.028 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.6 mt -69.73 154.88 41.36 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.214 -2.179 . . . . 3.14 110.264 164.534 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 -78.46 123.19 26.77 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.435 2.064 . . . . 6.8 113.303 -179.543 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.42 51.67 50.27 Favored Glycine 0 N--CA 1.431 -1.672 0 O-C-N 118.761 -2.462 . . . . 3.57 111.863 -166.189 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.741 0 CA-C-O 113.716 -3.824 . . . . 3.87 113.288 -178.673 . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.368 0 CA-C-O 125.902 2.763 . . . . 1.1 115.991 . . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -82.21 99.19 9.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.174 -3.454 . . . . 1.87 107.851 172.029 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -92.92 134.42 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 120.7 -1.25 . . . . 0.72 113.827 168.944 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -94.77 109.45 21.41 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 129.554 3.142 . . . . 1.4 111.328 -176.497 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 t -90.18 102.54 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 123.747 0.819 . . . . 0.58 111.963 173.352 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -75.87 140.57 42.28 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.137 2.399 . . . . 2.09 108.838 172.869 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 p -108.94 162.39 14.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.809 -1.807 . . . . 0.99 108.424 176.786 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.486 HD11 HG13 ' A' ' 70' ' ' VAL . 5.2 mt -69.63 -32.76 71.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 128.278 3.894 . . . . 2.53 112.531 177.951 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.0 p -70.86 -35.73 72.52 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 130.405 3.482 . . . . 2.08 115.975 -174.707 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.58 15.66 0.95 Allowed Glycine 0 N--CA 1.431 -1.692 0 CA-C-O 116.954 -2.025 . . . . 1.31 117.263 170.468 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -116.87 172.28 7.36 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 120.333 2.066 . . . . 1.4 110.141 -178.26 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.4 m -123.87 106.6 10.58 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 128.134 2.574 . . . . 0.78 113.392 177.259 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -90.58 107.65 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 117.272 -1.347 . . . . 1.55 109.878 178.731 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.3 m -98.63 101.02 12.32 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.852 2.739 . . . . 1.08 106.907 -175.374 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.2 mt -102.15 141.62 34.7 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.284 -1.78 . . . . 1.55 111.658 -179.149 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -89.09 115.96 27.01 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.918 2.192 . . . . 1.95 116.918 163.599 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.407 HG12 ' HE3' ' A' ' 29' ' ' LYS . 15.1 m -127.32 170.26 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 128.79 2.836 . . . . 0.96 110.274 176.959 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -124.17 165.32 24.78 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 127.355 2.262 . . . . 2.35 109.527 167.417 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -69.1 -28.73 28.06 Favored 'Trans proline' 0 N--CA 1.434 -2.012 1 O-C-N 113.487 -4.007 . . . . 0.95 113.468 -168.062 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.7 m -83.93 6.07 23.1 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 114.565 -2.854 . . . . 1.45 111.2 -177.692 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -72.86 142.67 47.96 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.405 2.526 . . . . 1.69 108.168 173.432 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 38.2 p -84.41 164.83 18.65 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.668 -2.52 . . . . 0.75 109.249 -178.619 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.335 1.4 mp -70.25 -29.4 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.192 -2.193 . . . . 0.73 112.128 176.718 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -53.31 -46.68 69.52 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.797 -1.19 . . . . 1.62 113.536 165.649 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -62.05 -38.41 88.66 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 116.875 2.176 . . . . 2.13 116.875 177.496 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.1 -46.73 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 131.163 3.785 . . . . 0.62 111.294 173.028 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -65.63 -35.86 82.02 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.282 1.433 . . . . 1.22 111.127 179.043 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.24 74.7 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 115.739 -2.077 . . . . 0.51 113.775 174.446 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.407 ' HE3' HG12 ' A' ' 17' ' ' VAL . 25.7 mttm -72.79 -20.49 61.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.442 2.756 . . . . 1.44 118.442 175.327 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.0 mt -79.57 -34.13 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.98 2.112 . . . . 1.32 111.475 173.44 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -53.79 -41.88 67.71 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.494 -2.629 . . . . 1.7 112.687 175.09 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -67.49 -55.45 13.5 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.164 2.283 . . . . 1.55 117.164 170.028 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -66.46 -71.71 0.19 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.152 -2.218 . . . . 2.62 112.743 -174.461 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -74.19 -38.23 63.7 Favored 'General case' 0 N--CA 1.428 -1.527 0 O-C-N 118.095 -2.878 . . . . 1.48 113.535 -174.734 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.63 32.69 7.13 Favored Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 126.031 3.017 . . . . 1.12 113.267 -179.372 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.4 mt -101.11 125.14 39.1 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-N 111.144 -2.528 . . . . 1.55 107.812 -179.916 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -66.51 163.5 32.34 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 CA-C-O 112.374 -3.261 . . . . 1.02 114.773 -178.735 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -77.7 -16.52 14.7 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 CA-C-N 122.759 2.021 . . . . 1.25 113.444 -177.941 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -68.14 -35.83 78.71 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.77 -2.456 . . . . 2.25 109.935 168.54 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -76.82 -16.79 59.34 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.165 1.386 . . . . 2.02 114.62 -178.214 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -93.31 120.88 34.1 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.635 -3.79 . . . . 0.69 110.161 -173.31 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -103.58 116.27 32.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.503 -2.776 . . . . 2.78 103.503 167.842 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.5 mt -104.98 112.51 25.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 102.159 -3.274 . . . . 1.17 102.159 177.807 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.6 mm -103.23 137.39 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 105.45 -2.055 . . . . 1.38 105.45 177.379 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -129.33 109.34 11.02 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 103.749 -2.686 . . . . 1.5 103.749 176.855 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.402 . . 74.71 -86.58 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.144 -2.223 . . . . 1.21 112.37 177.855 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.28 1.09 1.85 Allowed Glycine 0 N--CA 1.43 -1.765 0 O-C-N 118.929 -2.357 . . . . 1.3 113.914 179.8 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -115.39 141.58 47.85 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 109.468 -0.567 . . . . 2.55 109.468 -178.707 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -86.06 134.25 33.84 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.742 2.417 . . . . 2.48 109.335 173.002 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.7 mt -85.14 121.81 28.43 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.63 2.826 . . . . 0.9 118.63 -179.601 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -81.5 142.19 33.13 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 116.336 1.976 . . . . 1.94 116.336 173.884 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.28 -54.53 19.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.224 1.409 . . . . 1.56 114.579 -167.81 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.0 15.89 2.96 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 120.043 2.777 . . . . 0.97 120.043 172.851 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.498 HH21 ' CG ' ' A' ' 58' ' ' ASP . 79.0 mtp180 -102.83 156.4 17.68 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 121.225 2.512 . . . . 2.49 107.772 165.722 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 16.7 p -82.59 161.73 22.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.321 2.249 . . . . 0.76 114.462 175.874 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -65.48 -28.72 69.41 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.403 2.001 . . . . 1.05 116.403 167.216 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.0 p -74.44 -21.92 59.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 117.08 2.252 . . . . 1.19 117.08 173.052 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.498 ' CG ' HH21 ' A' ' 54' ' ' ARG . 48.6 t0 -67.26 -40.97 86.28 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 118.296 -0.859 . . . . 1.9 110.999 172.346 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -77.53 -17.77 57.62 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 114.911 -2.471 . . . . 0.89 115.17 169.286 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 73.34 34.55 0.99 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.497 2.57 . . . . 1.84 116.367 -179.997 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.5 mt -65.38 124.58 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 116.384 -3.947 . . . . 0.82 115.528 179.618 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -61.43 164.55 5.57 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 119.987 3.328 . . . . 2.16 119.987 -178.082 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -60.08 -61.16 2.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.698 -3.126 . . . . 2.12 110.421 174.178 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -93.35 81.28 4.42 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 116.521 -2.071 . . . . 1.71 113.579 172.784 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.282 19.1 m -108.83 139.72 43.27 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 118.962 2.949 . . . . 1.04 118.962 -178.835 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.2 m -115.08 130.01 56.83 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.164 -1.421 . . . . 0.79 107.164 178.641 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -115.17 168.72 9.69 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 116.513 -1.708 . . . . 1.4 111.245 -179.345 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -122.88 122.84 39.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.29 1.436 . . . . 1.51 112.92 -179.22 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 tp -94.77 101.21 13.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.243 -1.536 . . . . 1.14 111.77 177.34 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.486 HG13 HD11 ' A' ' 8' ' ' LEU . 2.8 t -88.45 128.92 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 104.344 -2.465 . . . . 1.23 104.344 173.217 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.8 tp -85.13 129.19 34.85 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 115.585 -2.15 . . . . 2.78 113.074 175.185 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -92.82 143.56 26.15 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.672 -1.603 . . . . 3.75 106.672 174.52 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.7 mt -71.98 175.06 6.21 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.374 -2.704 . . . . 3.14 113.55 -175.84 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -74.36 -39.07 63.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.909 2.766 . . . . 6.8 109.622 168.95 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.47 73.87 0.45 Allowed Glycine 0 N--CA 1.43 -1.756 1 CA-C-O 129.818 5.121 . . . . 3.57 112.017 -168.538 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.825 0 CA-C-O 113.602 -3.888 . . . . 3.87 106.214 -175.915 . . . . . . . . 0 0 . 1 . 051 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 ptt? . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 123.773 1.749 . . . . 1.1 110.914 . . . . . . . . . 0 0 . 1 . 051 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -88.11 107.24 18.66 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 113.773 -5.579 . . . . 1.87 115.316 -178.687 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.3 pt -111.83 164.28 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 117.743 -3.098 . . . . 0.72 109.257 178.564 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -120.39 125.89 49.12 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 116.766 -3.709 . . . . 1.4 112.128 178.703 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 t -109.78 111.4 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 1 O-C-N 113.228 -5.92 . . . . 0.58 109.116 167.686 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -71.68 140.4 49.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.268 2.937 . . . . 2.09 111.124 175.097 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.1 p -87.93 177.75 6.88 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 113.25 -5.906 . . . . 0.99 110.769 169.744 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 tp -79.49 -51.28 9.54 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.334 -1.478 . . . . 2.53 108.422 179.631 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.1 p -65.7 -58.02 6.68 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.758 2.133 . . . . 2.08 116.758 -174.385 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.43 39.99 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.67 0 CA-C-O 115.054 -3.081 . . . . 1.31 110.546 -179.918 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -135.94 156.72 48.34 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 124.192 3.996 . . . . 1.4 110.571 -175.092 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.2 m -127.29 111.51 14.0 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 130.346 3.458 . . . . 0.78 107.514 177.814 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mt -88.28 118.92 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 123.924 3.056 . . . . 1.55 104.566 -177.94 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.9 m -98.73 122.09 41.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.224 -1.398 . . . . 1.08 107.224 178.229 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.8 mt -123.93 154.28 39.98 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 113.534 0.938 . . . . 1.55 113.534 -176.461 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -110.01 111.57 23.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 104.449 -2.426 . . . . 1.95 104.449 171.287 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.25 170.31 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 C-N-CA 127.443 2.297 . . . . 0.96 106.961 -179.91 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -117.97 156.59 49.99 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 105.209 -2.145 . . . . 2.35 105.209 167.035 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.421 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 18.4 Cg_endo -68.49 -16.28 42.77 Favored 'Trans proline' 0 C--N 1.299 -2.069 0 N-CA-C 116.386 1.648 . . . . 0.95 116.386 -177.786 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.2 m -85.02 -11.51 55.24 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-O 115.731 -2.08 . . . . 1.45 110.763 179.699 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.07 139.51 54.83 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 126.262 1.825 . . . . 1.69 109.691 173.379 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.36 35.8 p -71.25 150.89 44.8 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 128.552 2.741 . . . . 0.75 110.021 176.091 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 mt -62.1 -35.1 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 104.869 -2.271 . . . . 0.73 104.869 178.795 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.291 30.1 tt0 -52.95 -46.39 68.15 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 116.262 -4.024 . . . . 1.62 118.548 165.812 . . . . . . . . 3 2 . 1 . 051 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.338 83.9 m-20 -61.77 -35.62 78.67 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.439 1.496 . . . . 2.13 113.95 173.613 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.5 t -68.94 -36.21 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 123.482 1.611 . . . . 0.62 112.01 175.101 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -59.04 -30.44 68.04 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 119.125 -2.234 . . . . 1.22 115.252 163.84 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.21 -38.6 63.54 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 114.634 -5.042 . . . . 0.51 111.591 172.62 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.277 12.4 ttmm -57.32 -39.37 75.69 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.092 -2.88 . . . . 1.44 116.064 166.751 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.0 mt -57.34 -39.96 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 125.132 3.606 . . . . 1.32 114.57 166.945 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 37' ' ' PRO . 21.1 tt0 -66.85 -39.9 87.75 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.898 -1.751 . . . . 1.7 111.315 177.257 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -52.95 -43.51 66.38 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.579 2.066 . . . . 1.55 116.579 172.292 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -87.02 -47.57 8.83 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.664 -1.273 . . . . 2.62 113.289 -175.801 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -99.97 -55.68 2.57 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 116.941 -1.504 . . . . 1.48 107.214 -167.259 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.36 52.26 0.83 Allowed Glycine 0 N--CA 1.431 -1.695 0 CA-C-N 120.719 1.6 . . . . 1.12 112.607 -176.479 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.4 mt -130.74 126.29 21.79 Favored Pre-proline 0 N--CA 1.429 -1.48 0 N-CA-C 101.4 -3.556 . . . . 1.55 101.4 177.817 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 0.5 OUTLIER -60.8 140.75 92.27 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 CA-C-O 111.082 -3.799 . . . . 1.02 111.648 -177.698 . . . . . . . . 3 3 . 1 . 051 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -55.05 -23.8 37.17 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-N 124.925 2.795 . . . . 1.25 117.929 175.416 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -68.89 -23.13 64.16 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.309 1.226 . . . . 2.25 114.309 173.849 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -81.74 -20.96 38.23 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.877 1.323 . . . . 2.02 109.293 176.612 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -97.4 136.7 37.47 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.113 -2.867 . . . . 0.69 118.256 -173.849 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -123.77 108.09 12.14 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.185 -2.28 . . . . 2.78 111.533 173.595 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.406 ' HB3' HD12 ' A' ' 50' ' ' LEU . 16.5 mt -71.5 138.93 49.32 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 123.739 1.733 . . . . 1.17 112.053 176.903 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.316 47.0 mm -127.44 146.85 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 106.252 -1.759 . . . . 1.38 106.252 179.488 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -143.39 133.3 24.06 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.642 -1.911 . . . . 1.5 109.864 177.49 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.69 -83.91 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.412 2.285 . . . . 1.21 111.683 174.544 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -156.03 16.88 0.45 Allowed Glycine 0 N--CA 1.43 -1.759 0 O-C-N 125.647 1.842 . . . . 1.3 109.164 -178.215 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -126.7 167.0 16.33 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 126.077 2.846 . . . . 2.55 109.336 -177.984 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -93.0 162.68 13.95 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 114.607 -5.058 . . . . 2.48 105.874 170.521 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.406 HD12 ' HB3' ' A' ' 43' ' ' LEU . 98.0 mt -109.64 148.06 31.98 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.519 -3.238 . . . . 0.9 109.345 179.011 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -96.68 144.64 26.51 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.511 1.924 . . . . 1.94 110.909 171.681 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -85.88 -40.0 16.42 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 116.153 1.908 . . . . 1.56 116.153 -162.936 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.86 47.22 3.67 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-N 122.823 2.556 . . . . 0.97 113.657 171.505 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -131.84 164.28 26.4 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 104.175 -2.528 . . . . 2.49 104.175 170.353 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.363 20.4 p -90.93 174.74 7.27 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 118.717 -2.489 . . . . 0.76 115.147 -178.777 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 35.2 mt -73.04 -23.98 60.65 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.239 -1.538 . . . . 1.05 110.025 171.874 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -85.57 -41.12 15.55 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.69 1.367 . . . . 1.19 114.69 -177.27 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -53.05 -46.67 68.62 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.875 2.47 . . . . 1.9 111.815 168.881 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -75.06 -9.24 58.35 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 117.64 -3.162 . . . . 0.89 113.769 175.991 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.295 35.2 t-20 59.8 47.91 9.7 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 124.236 1.97 . . . . 1.84 114.896 -177.217 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.5 mm -74.75 130.91 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 128.102 2.561 . . . . 0.82 108.812 178.292 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -69.63 171.07 9.55 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.424 -3.298 . . . . 2.16 115.894 -176.691 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -57.36 -56.12 26.01 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 116.295 -4.003 . . . . 2.12 110.2 172.308 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -103.35 92.55 4.54 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.574 1.15 . . . . 1.71 109.389 171.733 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.3 t -115.14 144.69 43.28 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.644 2.09 . . . . 1.04 116.644 176.397 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.2 m -102.95 102.17 12.21 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.495 1.918 . . . . 0.79 110.875 179.695 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -106.69 172.88 6.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.893 -1.754 . . . . 1.4 109.304 178.292 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -123.7 137.35 54.72 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 118.151 2.648 . . . . 1.51 118.151 178.453 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.5 tp -95.64 118.69 32.8 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 112.744 -2.025 . . . . 1.14 111.282 177.064 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.2 t -122.53 121.67 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 125.862 1.665 . . . . 1.23 112.999 174.854 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.1 mt -83.05 140.95 32.4 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-O 126.974 3.273 . . . . 2.78 115.61 178.792 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -91.66 110.98 22.32 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.9 -3.625 . . . . 3.75 111.071 169.701 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.8 mt -83.28 141.09 32.09 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 105.994 -1.854 . . . . 3.14 105.994 173.252 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -74.08 146.0 43.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.743 2.127 . . . . 6.8 116.743 177.518 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.31 -78.02 0.32 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 128.958 3.17 . . . . 3.57 117.012 -168.564 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.748 0 CA-C-O 116.837 -2.091 . . . . 3.87 108.022 -178.032 . . . . . . . . 0 0 . 1 . 052 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ttp . . . . . 0 CA--C 1.49 -1.335 0 N-CA-C 118.428 2.751 . . . . 1.1 118.428 . . . . . . . . . 0 0 . 1 . 052 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -75.05 124.49 27.08 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 115.078 1.51 . . . . 1.87 115.078 -177.991 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.1 pt -136.14 159.0 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 117.248 -3.408 . . . . 0.72 103.218 175.752 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -116.64 149.5 39.64 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 124.477 1.111 . . . . 1.4 108.607 176.65 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.71 113.31 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-N 111.298 -2.683 . . . . 0.58 107.854 170.458 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -101.68 132.03 47.6 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 103.516 -2.772 . . . . 2.09 103.516 -176.048 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.1 p -86.48 165.86 15.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.986 -3.571 . . . . 0.99 113.508 173.66 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.9 mt -81.95 -29.77 32.04 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.841 -2.412 . . . . 2.53 108.78 174.097 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.9 p -68.1 -48.24 66.03 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 125.185 1.553 . . . . 2.08 111.692 -174.85 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.34 44.63 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.772 0 CA-C-N 119.523 1.056 . . . . 1.31 114.815 168.014 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -143.43 147.17 34.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.684 2.183 . . . . 1.4 110.061 -162.53 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.3 m -112.84 135.04 54.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.48 -2.638 . . . . 0.78 105.038 171.427 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mt -111.57 107.54 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 126.585 1.954 . . . . 1.55 105.916 176.433 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.3 m -89.74 115.94 27.47 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.656 1.693 . . . . 1.08 108.789 -178.16 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.8 mt -115.31 154.99 28.13 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 125.421 2.534 . . . . 1.55 106.974 -170.348 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -112.06 117.68 33.33 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 115.382 -2.247 . . . . 1.95 108.044 166.191 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.413 HG12 ' HE3' ' A' ' 29' ' ' LYS . 23.0 m -129.73 177.47 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 101.859 -3.385 . . . . 0.96 101.859 -178.869 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -111.79 154.23 44.12 Favored Pre-proline 0 N--CA 1.43 -1.462 1 C-N-CA 133.196 4.598 . . . . 2.35 107.603 164.305 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -77.89 -5.46 15.3 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 125.078 3.852 . . . . 0.95 110.733 -172.404 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 m -101.57 3.25 39.83 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 123.529 1.633 . . . . 1.45 108.008 -175.53 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -81.91 149.84 28.04 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.394 1.257 . . . . 1.69 114.394 170.945 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 p -75.66 159.43 31.17 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 123.777 0.831 . . . . 0.75 111.075 -177.835 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.1 mm -67.65 -26.51 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.559 -1.338 . . . . 0.73 108.53 173.454 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -62.03 -34.61 76.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.143 1.792 . . . . 1.62 112.639 168.821 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -65.68 -40.8 92.72 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.748 1.619 . . . . 2.13 108.652 -179.08 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.7 t -64.8 -37.63 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-O 122.382 1.087 . . . . 0.62 113.278 175.947 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -59.97 -40.23 88.37 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 118.395 2.739 . . . . 1.22 118.395 166.292 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.56 -36.86 85.58 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.548 -1.97 . . . . 0.51 113.417 176.16 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.413 ' HE3' HG12 ' A' ' 17' ' ' VAL . 46.2 mttm -59.85 -48.01 83.41 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.577 -1.952 . . . . 1.44 114.805 170.628 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.8 mt -64.91 -32.81 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 119.22 -2.175 . . . . 1.32 112.976 172.029 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -62.98 -38.94 93.15 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.221 -1.55 . . . . 1.7 115.123 169.388 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -62.12 -44.06 97.47 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 123.423 1.582 . . . . 1.55 112.214 172.186 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -66.83 -55.79 13.26 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.572 -2.58 . . . . 2.62 116.002 178.555 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -100.03 -55.84 2.53 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.848 2.859 . . . . 1.48 108.952 -166.713 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.22 -9.56 9.51 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-O 123.443 1.579 . . . . 1.12 113.633 -176.154 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.9 mt -72.44 126.4 90.94 Favored Pre-proline 0 N--CA 1.43 -1.452 0 O-C-N 116.779 -3.777 . . . . 1.55 102.287 -175.635 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 72.6 Cg_endo -70.85 161.38 46.27 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.667 2.245 . . . . 1.02 112.511 175.105 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 20.4 Cg_exo -70.05 -12.17 31.84 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 C-N-CA 121.745 1.63 . . . . 1.25 113.477 -172.593 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -75.67 -27.08 58.17 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.422 2.058 . . . . 2.25 109.63 176.436 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -90.61 -20.07 22.98 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.091 -2.881 . . . . 2.02 108.022 -174.979 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -85.78 124.94 32.85 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.595 3.183 . . . . 0.69 119.595 178.911 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.4 ttm105 -109.31 118.71 37.4 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.467 -2.02 . . . . 2.78 110.538 171.654 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.267 66.9 mt -99.06 105.32 17.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 109.257 -0.645 . . . . 1.17 109.257 -178.944 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.554 HD12 HG21 ' A' ' 70' ' ' VAL . 40.7 mt -93.75 118.81 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-N 113.719 -1.582 . . . . 1.38 108.59 -179.343 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -138.54 138.26 37.83 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.158 -1.589 . . . . 1.5 110.772 173.865 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.16 41.61 26.86 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.053 2.941 . . . . 1.21 113.527 173.417 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.63 -18.01 22.21 Favored Glycine 0 N--CA 1.429 -1.789 1 CA-C-O 112.334 -4.592 . . . . 1.3 113.16 -179.832 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 172.3 7.3 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 123.534 3.667 . . . . 2.55 113.595 -178.544 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -104.57 134.84 47.06 Favored 'General case' 0 N--CA 1.431 -1.401 1 O-C-N 115.353 -4.592 . . . . 2.48 109.03 173.863 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.4 mt -76.3 155.05 34.59 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 123.842 1.782 . . . . 0.9 114.737 -173.661 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -98.85 141.99 30.94 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 124.78 2.229 . . . . 1.94 107.211 178.737 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -75.81 -41.93 51.34 Favored 'General case' 0 N--CA 1.43 -1.454 1 N-CA-C 124.093 4.849 . . . . 1.56 124.093 -167.018 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.04 0.5 89.02 Favored Glycine 0 N--CA 1.431 -1.665 0 O-C-N 116.563 -3.836 . . . . 0.97 110.856 170.232 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -71.55 151.22 44.03 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 122.465 3.132 . . . . 2.49 111.538 169.542 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.7 p -97.83 167.55 10.86 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.101 1.905 . . . . 0.76 111.684 -177.199 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.5 mt -69.37 -25.41 64.16 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.407 -3.308 . . . . 1.05 111.29 178.038 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.2 t -70.81 -39.56 73.01 Favored 'General case' 0 N--CA 1.431 -1.406 1 C-N-CA 132.845 4.458 . . . . 1.19 112.816 175.7 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -57.92 -34.61 70.05 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 124.858 2.266 . . . . 1.9 113.913 172.826 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -94.53 0.09 55.01 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 114.309 -5.244 . . . . 0.89 112.03 -178.208 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.0 m120 58.66 47.52 12.96 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 119.865 3.283 . . . . 1.84 119.865 -175.15 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.0 mt -83.21 105.91 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 126.336 1.854 . . . . 0.82 109.886 171.28 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -121.9 -48.23 2.14 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 124.213 1.958 . . . . 2.16 112.332 -179.246 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.2 mmtt -78.34 -173.95 3.52 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 112.739 -2.028 . . . . 2.12 115.728 176.907 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -71.44 69.79 0.6 Allowed 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 129.964 3.306 . . . . 1.71 112.796 177.267 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -90.59 158.4 16.99 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.511 3.124 . . . . 1.04 111.639 -175.364 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.8 m -118.66 118.36 31.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 104.496 -2.409 . . . . 0.79 104.496 -173.843 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.1 mt -94.57 148.61 22.08 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 103.33 -2.841 . . . . 1.4 103.33 172.105 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -108.63 112.87 25.44 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 126.032 2.825 . . . . 1.51 106.026 -176.489 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.0 tp -89.65 122.26 32.61 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.993 -3.567 . . . . 1.14 113.507 179.264 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.554 HG21 HD12 ' A' ' 44' ' ' ILE 0.33 3.2 t -125.52 145.85 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 114.23 -1.35 . . . . 1.23 108.148 -177.067 . . . . . . . . 3 3 . 1 . 052 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.8 tp -81.24 127.08 32.31 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 130.853 3.661 . . . . 2.78 106.567 -179.954 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -102.5 97.77 7.94 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.274 3.03 . . . . 3.75 112.183 176.107 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.8 mt -113.88 -92.96 0.48 Allowed 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.614 -1.929 . . . . 3.14 108.162 174.749 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.8 mtm-85 -99.22 -121.61 0.15 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.896 1.679 . . . . 6.8 113.588 168.87 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.95 112.69 3.27 Favored Glycine 0 N--CA 1.429 -1.769 1 CA-C-O 128.946 4.636 . . . . 3.57 108.953 -169.164 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.751 0 O-C-N 118.874 -2.545 . . . . 3.87 109.791 -174.128 . . . . . . . . 0 0 . 1 . 053 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ptt? . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 123.816 1.77 . . . . 1.1 107.903 . . . . . . . . . 0 0 . 1 . 053 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -93.44 136.51 33.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 117.067 -3.521 . . . . 1.87 111.523 -179.252 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.2 pt -131.7 161.79 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 117.005 -3.559 . . . . 0.72 104.707 173.771 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -122.04 141.94 50.85 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.767 -1.561 . . . . 1.4 107.888 -170.615 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 t -117.21 120.66 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 103.311 -2.848 . . . . 0.58 103.311 175.748 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -95.81 130.38 42.76 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 119.067 -1.053 . . . . 2.09 108.28 175.409 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.9 p -84.2 -176.13 6.11 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.708 -2.495 . . . . 0.99 115.199 176.788 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mt -68.55 -41.16 80.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 119.805 1.184 . . . . 2.53 109.328 172.086 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -72.59 -13.92 61.5 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 127.972 2.509 . . . . 2.08 107.824 -178.764 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.28 30.53 9.17 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 120.734 1.606 . . . . 1.31 113.577 175.857 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -95.71 134.1 39.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 117.908 -3.113 . . . . 1.4 107.286 -171.412 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.1 m -86.66 90.45 8.27 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 118.537 2.791 . . . . 0.78 118.537 175.449 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.7 mm -79.77 112.01 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 126.977 2.673 . . . . 1.55 109.542 176.204 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.5 m -103.67 113.83 27.65 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 123.279 2.763 . . . . 1.08 109.854 179.788 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -106.63 143.39 34.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.137 -1.602 . . . . 1.55 109.325 -179.511 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -93.3 123.89 36.9 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 104.037 -2.579 . . . . 1.95 104.037 170.246 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 m -133.76 160.44 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-O 115.471 -2.204 . . . . 0.96 108.468 -175.716 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -109.25 160.59 27.03 Favored Pre-proline 0 N--CA 1.43 -1.466 0 N-CA-C 104.899 -2.26 . . . . 2.35 104.899 160.259 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.74 -14.3 24.37 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 C-N-CA 121.788 1.659 . . . . 0.95 113.887 -179.0 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.1 p -75.59 -25.76 57.29 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 114.0 1.111 . . . . 1.45 114.0 173.481 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -62.67 160.53 13.96 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.976 -1.703 . . . . 1.69 114.549 -179.524 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.334 20.4 p -93.67 166.62 12.13 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.939 2.94 . . . . 0.75 118.939 -179.828 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.436 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 32.6 mm -71.3 -34.1 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.311 1.445 . . . . 0.73 111.152 177.386 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -60.04 -34.75 73.82 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.156 2.28 . . . . 1.62 117.156 165.999 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -71.69 -40.42 69.57 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.745 -1.847 . . . . 2.13 113.783 173.67 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.8 t -60.3 -38.81 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 123.709 0.804 . . . . 0.62 111.728 174.228 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -60.74 -40.51 92.69 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.545 -3.222 . . . . 1.22 114.725 164.618 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.75 -33.62 76.29 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.412 1.577 . . . . 0.51 113.634 173.413 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -56.67 -46.89 80.84 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.997 -2.939 . . . . 1.44 117.461 173.22 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.8 mt -67.85 -39.09 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 125.422 2.534 . . . . 1.32 114.333 173.826 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -57.63 -37.93 74.15 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.16 -4.713 . . . . 1.7 111.991 172.256 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -67.05 -35.98 81.04 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.349 2.976 . . . . 1.55 114.045 177.535 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -82.82 -44.49 15.44 Favored 'General case' 0 N--CA 1.429 -1.499 1 O-C-N 115.389 -4.57 . . . . 2.62 108.614 -176.554 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -125.92 -17.13 5.44 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 122.045 2.202 . . . . 1.48 113.186 -166.866 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.05 27.97 7.54 Favored Glycine 0 N--CA 1.43 -1.713 0 CA-C-N 120.861 1.664 . . . . 1.12 113.703 173.171 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.6 mt -99.81 120.4 57.31 Favored Pre-proline 0 N--CA 1.43 -1.467 0 O-C-N 120.014 -1.874 . . . . 1.55 109.104 -172.0 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.74 136.25 61.13 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 C-N-CA 124.899 3.733 . . . . 1.02 112.252 179.624 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -55.94 -15.46 13.58 Favored 'Trans proline' 0 C--N 1.3 -2.008 1 C-N-CA 126.399 4.733 . . . . 1.25 118.219 -177.181 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -76.07 -26.41 56.5 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.735 0.779 . . . . 2.25 111.527 173.748 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -85.2 -30.03 24.23 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.391 2.043 . . . . 2.02 107.63 -177.79 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -74.71 118.18 17.39 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.783 -4.323 . . . . 0.69 112.092 -176.807 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.1 ttm-85 -121.7 116.33 24.33 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.685 -1.969 . . . . 2.78 105.685 170.56 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.5 mt -99.52 130.38 45.77 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.183 -1.043 . . . . 1.17 108.183 -179.772 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.3 mt -113.71 119.54 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 126.818 2.047 . . . . 1.38 112.085 174.715 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.528 ' HB3' HD21 ' A' ' 50' ' ' LEU . 51.6 t80 -114.72 132.11 56.54 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 102.865 -3.013 . . . . 1.5 102.865 174.653 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.39 -94.43 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.417 1 C-N-CA 132.138 4.175 . . . . 1.21 110.079 177.015 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.66 8.61 7.75 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 129.003 3.192 . . . . 1.3 113.059 176.217 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -106.04 137.9 43.16 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 129.5 3.12 . . . . 2.55 111.179 -178.527 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -103.47 113.92 27.79 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 125.543 2.592 . . . . 2.48 106.927 169.863 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.528 HD21 ' HB3' ' A' ' 45' ' ' PHE . 13.6 mt -67.75 126.15 28.48 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.358 -3.338 . . . . 0.9 113.67 -170.707 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -91.06 134.29 34.63 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 114.645 1.35 . . . . 1.94 114.645 174.446 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.436 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 4.6 m-20 -47.1 -52.39 15.42 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 119.893 3.294 . . . . 1.56 119.893 -171.785 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.23 68.78 0.96 Allowed Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 113.962 -3.688 . . . . 0.97 111.668 174.86 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.253 84.1 mmt-85 -139.55 164.74 29.11 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 102.53 -3.137 . . . . 2.49 102.53 167.851 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.9 p -93.54 166.34 12.3 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.188 2.423 . . . . 0.76 108.086 173.828 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 mt -59.91 -40.33 88.44 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.444 2.698 . . . . 1.05 108.961 171.079 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.2 t -54.88 -48.61 72.75 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.285 2.234 . . . . 1.19 113.465 176.158 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -50.77 -34.1 25.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 118.595 2.813 . . . . 1.9 118.595 170.791 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -90.48 1.19 56.91 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.151 1.38 . . . . 0.89 110.253 178.203 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.257 4.3 m120 52.08 43.56 30.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.093 2.557 . . . . 1.84 115.157 -174.231 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.4 mt -91.49 115.01 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 127.177 3.37 . . . . 0.82 113.487 177.574 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -95.47 -177.02 3.94 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.213 -2.804 . . . . 2.16 114.805 -176.214 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -62.62 152.45 35.1 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 115.049 -4.782 . . . . 2.12 116.722 169.723 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.331 31.4 mt-10 66.47 18.36 10.81 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.112 -2.243 . . . . 1.71 113.203 174.371 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.3 p -89.96 165.12 14.26 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 127.382 3.468 . . . . 1.04 111.517 -172.87 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.1 m -120.92 108.74 14.26 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 113.337 -5.852 . . . . 0.79 113.177 -177.807 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.0 mt -81.75 137.51 35.34 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 124.905 1.282 . . . . 1.4 113.238 166.794 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -98.33 115.25 28.03 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.904 -0.497 . . . . 1.51 110.323 -177.826 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.9 tp -93.72 112.37 24.23 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 126.197 2.186 . . . . 1.14 106.874 -177.12 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.27 143.42 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 128.468 2.707 . . . . 1.23 104.204 174.972 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.6 mt -103.26 113.57 27.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 121.112 -0.992 . . . . 2.78 108.658 175.367 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -78.49 146.83 34.17 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 117.715 -1.136 . . . . 3.75 109.209 -179.131 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.9 mt -102.64 166.64 10.39 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 119.638 1.108 . . . . 3.14 111.42 173.055 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -92.78 93.36 8.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.02 2.343 . . . . 6.8 113.502 176.142 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.37 -95.28 0.1 Allowed Glycine 0 N--CA 1.43 -1.707 0 O-C-N 117.747 -3.096 . . . . 3.57 109.171 -174.281 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.711 0 C-N-CA 117.66 -2.209 . . . . 3.87 111.634 175.994 . . . . . . . . 0 0 . 1 . 054 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 108.268 -1.012 . . . . 1.1 108.268 . . . . . . . . . 0 0 . 1 . 054 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -100.62 130.13 46.64 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 115.698 -2.096 . . . . 1.87 112.199 179.766 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.3 pt -129.03 159.33 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 120.099 1.318 . . . . 0.72 107.948 171.798 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -106.81 143.35 35.03 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.341 -1.754 . . . . 1.4 110.456 -176.516 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.2 t -119.35 120.04 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 129.43 3.092 . . . . 0.58 108.328 177.715 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.0 mttp -105.28 141.54 36.63 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 116.06 1.874 . . . . 2.09 116.06 169.87 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 p -95.76 177.72 5.69 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.513 2.325 . . . . 0.99 113.195 177.929 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.6 tp -57.74 -45.74 85.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.052 0.941 . . . . 2.53 113.279 178.278 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.2 p -78.01 -14.13 59.62 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.022 2.344 . . . . 2.08 112.879 -175.148 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.15 30.3 4.82 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 117.148 -3.47 . . . . 1.31 114.997 172.882 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -91.91 111.3 22.78 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.049 -1.575 . . . . 1.4 108.782 -176.317 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 m -83.8 115.24 22.14 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.92 -2.988 . . . . 0.78 109.152 177.201 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.44 HG21 HD13 ' A' ' 13' ' ' ILE . 46.9 mt -101.33 126.73 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 106.85 -1.537 . . . . 1.55 106.85 175.297 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.6 m -104.55 125.39 50.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 102.587 -3.116 . . . . 1.08 102.587 -170.338 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.2 mt -128.35 150.73 49.96 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 126.706 2.002 . . . . 1.55 109.239 -173.83 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -115.93 131.5 56.92 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.844 -0.616 . . . . 1.95 112.074 170.245 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.451 HG21 HD13 ' A' ' 56' ' ' LEU . 10.3 m -144.29 165.78 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 125.363 1.665 . . . . 0.96 108.919 -174.433 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -101.07 153.02 37.99 Favored Pre-proline 0 N--CA 1.43 -1.475 0 O-C-N 117.63 -3.169 . . . . 2.35 111.442 165.294 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -67.74 -13.52 38.95 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 CA-C-N 126.932 3.511 . . . . 0.95 115.795 -173.437 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.1 p -84.22 0.86 47.18 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 131.553 3.941 . . . . 1.45 116.059 171.494 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -76.46 136.45 39.4 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 118.892 -2.38 . . . . 1.69 113.407 170.558 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 p -70.13 152.96 43.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.526 -3.233 . . . . 0.75 108.125 179.419 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.6 mm -57.53 -23.1 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 118.039 2.607 . . . . 0.73 118.039 167.858 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -53.74 -43.65 69.3 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.267 -3.396 . . . . 1.62 115.346 159.443 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.4 m-20 -66.54 -28.94 68.94 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.526 2.584 . . . . 2.13 117.746 177.686 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.3 -41.7 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 113.809 -1.541 . . . . 0.62 111.258 171.017 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.68 -33.8 69.14 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 126.512 1.925 . . . . 1.22 112.628 174.615 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.52 -44.25 84.94 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.051 2.14 . . . . 0.51 111.497 170.02 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -61.49 -38.49 87.5 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.692 2.397 . . . . 1.44 110.937 172.222 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.7 mt -70.48 -37.32 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 O-C-N 117.954 -2.966 . . . . 1.32 115.205 170.336 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -52.92 -46.51 68.11 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.632 2.634 . . . . 1.7 110.991 172.388 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -55.03 -59.76 4.3 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 116.181 -4.075 . . . . 1.55 114.713 172.913 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -69.65 -60.23 2.45 Favored 'General case' 0 N--CA 1.43 -1.461 1 CA-C-O 129.579 4.514 . . . . 2.62 110.592 -174.635 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -80.36 -59.93 2.51 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.672 -4.392 . . . . 1.48 114.046 -172.96 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.57 -16.23 6.26 Favored Glycine 0 N--CA 1.431 -1.695 0 CA-C-O 115.427 -2.874 . . . . 1.12 109.105 -179.483 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.9 mt -60.92 122.09 66.64 Favored Pre-proline 0 N--CA 1.431 -1.38 0 C-N-CA 126.877 2.071 . . . . 1.55 112.826 -170.363 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.67 142.98 99.3 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 N-CA-C 119.236 2.744 . . . . 1.02 119.236 -176.33 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -80.49 -9.92 13.46 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 115.82 -2.779 . . . . 1.25 115.072 -166.604 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.55 -14.99 57.75 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.116 2.566 . . . . 2.25 113.469 167.635 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -94.68 -32.31 13.43 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.509 -3.245 . . . . 2.02 110.364 178.522 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -62.93 145.29 55.57 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 113.407 -1.724 . . . . 0.69 113.432 179.521 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.428 ' HB2' HG23 ' A' ' 70' ' ' VAL . 92.5 mtt180 -134.91 130.31 35.69 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.534 -2.604 . . . . 2.78 106.127 164.154 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.4 mt -100.4 131.55 46.26 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.944 2.307 . . . . 1.17 108.21 172.902 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.4 mt -120.24 139.98 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 112.081 -2.327 . . . . 1.38 107.111 176.056 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -135.28 134.43 39.93 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 102.447 -3.168 . . . . 1.5 102.447 168.187 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.83 -68.5 0.22 Allowed 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.196 2.903 . . . . 1.21 113.511 177.171 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.69 -47.26 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.763 0 CA-C-O 127.433 3.796 . . . . 1.3 113.702 -174.692 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -73.85 138.86 44.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 127.59 3.567 . . . . 2.55 113.549 -178.021 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -73.58 124.33 25.7 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.905 -2.997 . . . . 2.48 115.032 166.771 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.6 mt -85.51 161.58 19.3 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.955 -1.716 . . . . 0.9 115.1 -178.016 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.282 27.8 mt-10 -104.77 143.45 33.1 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 120.554 3.538 . . . . 1.94 120.554 174.084 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -67.23 -43.57 81.63 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 116.338 -3.976 . . . . 1.56 116.304 -170.182 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.98 15.91 0.65 Allowed Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 130.437 3.875 . . . . 0.97 114.86 173.947 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -120.71 170.93 8.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.13 1.965 . . . . 2.49 111.738 166.557 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.3 p -107.21 177.51 4.83 Favored 'General case' 0 N--CA 1.429 -1.514 1 CA-C-O 128.554 4.026 . . . . 0.76 111.687 176.374 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.451 HD13 HG21 ' A' ' 17' ' ' VAL . 30.7 mt -70.32 -31.75 69.2 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.444 -2.66 . . . . 1.05 108.329 176.377 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -66.7 -41.05 88.63 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.964 -2.335 . . . . 1.19 115.126 -177.823 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -49.61 -45.98 48.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.077 2.151 . . . . 1.9 110.907 173.638 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -85.25 -0.67 55.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.027 2.346 . . . . 0.89 116.272 -178.174 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 56.78 37.42 28.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.04 2.936 . . . . 1.84 115.921 -178.527 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.2 mt -70.39 116.53 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 C-N-CA 128.681 2.792 . . . . 0.82 111.564 173.769 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -89.98 178.01 6.32 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.055 2.142 . . . . 2.16 108.411 174.21 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -67.51 152.89 44.88 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.12 1.914 . . . . 2.12 112.623 177.519 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.268 51.4 mt-10 67.31 27.43 8.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.989 -1.069 . . . . 1.71 113.68 169.434 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.9 m -98.91 144.49 28.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.684 3.194 . . . . 1.04 108.196 -175.253 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.6 m -108.93 120.79 43.56 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.143 -2.848 . . . . 0.79 109.393 -172.29 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -93.07 162.91 13.85 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.416 -1.327 . . . . 1.4 107.416 177.692 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -119.77 132.83 55.73 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.149 1.38 . . . . 1.51 112.968 -179.601 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.0 tp -118.5 116.57 26.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.529 -1.982 . . . . 1.14 109.854 -174.854 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' A' ' 42' ' ' ARG . 3.2 m -117.66 170.36 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 123.351 1.548 . . . . 1.23 110.902 172.516 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.1 mt -108.57 151.8 25.62 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.029 1.871 . . . . 2.78 115.072 174.11 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -78.84 140.13 38.22 Favored 'General case' 0 N--CA 1.429 -1.492 1 C-N-CA 131.852 4.061 . . . . 3.75 113.992 176.721 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.0 mt -88.76 141.32 28.61 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 124.675 2.179 . . . . 3.14 111.379 168.571 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -64.78 133.87 52.92 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 114.44 -5.162 . . . . 6.8 113.072 170.656 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 135.07 -43.56 1.25 Allowed Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 125.439 1.495 . . . . 3.57 112.982 -166.169 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.765 0 CA-C-N 119.745 1.772 . . . . 3.87 116.491 -178.307 . . . . . . . . 0 0 . 1 . 055 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.49 -1.361 0 CA-C-O 123.375 1.559 . . . . 1.1 109.497 . . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -104.96 142.32 34.99 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.555 -1.341 . . . . 1.87 109.446 -172.335 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.0 pt -131.81 155.05 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 124.723 1.209 . . . . 0.72 107.997 174.557 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.271 64.2 m-85 -108.33 125.27 51.51 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 112.957 0.725 . . . . 1.4 112.957 177.8 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -105.67 122.77 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 119.03 0.832 . . . . 0.58 109.625 173.257 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -94.61 124.57 38.73 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 128.712 2.805 . . . . 2.09 109.707 175.913 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.8 p -77.56 -173.52 2.99 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 127.627 2.371 . . . . 0.99 105.583 -178.55 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.7 mt -59.86 -48.11 83.0 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 129.802 3.241 . . . . 2.53 117.859 169.564 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.1 p -79.36 -15.43 57.91 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.626 3.571 . . . . 2.08 110.627 -179.202 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.14 44.53 5.62 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 126.914 2.197 . . . . 1.31 114.031 176.067 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -95.4 151.52 19.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 104.697 -2.334 . . . . 1.4 104.697 174.788 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.2 m -101.21 112.36 24.83 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 125.764 1.915 . . . . 0.78 112.08 179.795 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 mm -94.76 124.62 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 103.018 -2.956 . . . . 1.55 103.018 172.032 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.7 m -106.44 115.41 30.16 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.337 -3.352 . . . . 1.08 114.678 -178.999 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.259 34.6 mt -112.71 135.5 53.38 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.87 -2.394 . . . . 1.55 110.895 -175.957 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -75.8 116.39 16.45 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.142 -1.429 . . . . 1.95 107.142 161.085 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -127.85 175.74 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.241 1.417 . . . . 0.96 109.76 174.339 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -118.23 156.71 50.4 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-O 124.614 2.15 . . . . 2.35 109.629 167.064 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -71.79 -20.14 26.55 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 O-C-N 113.246 -4.134 . . . . 0.95 111.767 -175.72 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 p -87.36 3.58 46.39 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 130.788 3.635 . . . . 1.45 115.831 175.732 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -83.63 149.21 26.68 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.497 -2.627 . . . . 1.69 106.168 177.36 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 44.2 p -90.8 168.21 11.9 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 118.006 -0.997 . . . . 0.75 108.464 -177.789 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.324 40.9 mm -65.78 -24.61 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 N-CA-C 114.494 1.294 . . . . 0.73 114.494 173.937 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -69.07 -30.41 68.73 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 113.772 -3.013 . . . . 1.62 116.278 163.62 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -76.37 -25.66 54.85 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.207 1.821 . . . . 2.13 108.602 170.687 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.7 -50.25 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 121.879 2.127 . . . . 0.62 114.565 170.822 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -65.72 -34.67 78.73 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 118.454 2.761 . . . . 1.22 118.454 179.75 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.05 -38.87 73.85 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 114.177 -2.821 . . . . 0.51 111.736 168.555 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -66.59 -35.72 80.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 120.709 1.595 . . . . 1.44 114.013 174.28 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 53.8 mt -73.58 -24.28 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 119.777 -1.827 . . . . 1.32 114.803 173.159 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -75.73 -29.98 59.08 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.076 1.762 . . . . 1.7 111.773 172.066 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -72.1 -46.27 57.36 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.468 1.127 . . . . 1.55 112.996 175.831 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -65.17 -75.44 0.09 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 126.176 1.791 . . . . 2.62 111.935 -178.913 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -86.91 -42.31 13.29 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.588 2.355 . . . . 1.48 114.813 -169.532 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.96 31.67 2.22 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 118.277 -1.916 . . . . 1.12 111.948 174.574 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 36' ' ' ILE . 26.8 mt -102.09 124.4 40.11 Favored Pre-proline 0 N--CA 1.43 -1.426 0 CA-C-O 114.6 -2.619 . . . . 1.55 113.436 -175.509 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -60.79 138.7 81.03 Favored 'Trans proline' 0 N--CA 1.433 -2.064 0 CA-C-O 114.05 -2.562 . . . . 1.02 114.38 -176.715 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -62.83 -29.17 76.34 Favored 'Trans proline' 0 N--CA 1.434 -2.009 1 C-N-CA 127.49 5.46 . . . . 1.25 114.273 -171.947 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -62.76 -28.95 70.33 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.849 -2.407 . . . . 2.25 112.056 173.057 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -76.36 -13.18 60.15 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 116.785 2.143 . . . . 2.02 116.785 179.092 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -95.39 117.18 29.89 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.013 -3.555 . . . . 0.69 115.26 -172.361 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -107.27 127.09 53.24 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 127.2 2.2 . . . . 2.78 107.946 169.343 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.284 65.6 mt -109.49 138.69 45.48 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 105.263 -2.125 . . . . 1.17 105.263 -175.788 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.7 mm -122.37 126.23 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 109.74 -3.391 . . . . 1.38 107.325 179.801 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.42 ' HB2' HD11 ' A' ' 50' ' ' LEU . 67.4 t80 -120.46 108.93 14.7 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.652 -1.981 . . . . 1.5 105.652 172.317 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.92 -73.22 0.09 Allowed 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 126.526 1.93 . . . . 1.21 109.106 -179.443 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.41 ' H ' ' H ' ' A' ' 48' ' ' LYS . . . -160.73 7.84 0.11 Allowed Glycine 0 N--CA 1.43 -1.709 0 CA-C-O 124.898 2.388 . . . . 1.3 114.915 -174.039 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.41 ' H ' ' H ' ' A' ' 47' ' ' GLY . 12.4 tppt? -105.78 128.61 53.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 111.585 -2.307 . . . . 2.55 105.842 177.311 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -79.47 138.89 37.72 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.176 -0.952 . . . . 2.48 109.573 170.499 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' A' ' 45' ' ' PHE . 21.3 mt -101.73 126.44 48.59 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 121.649 2.022 . . . . 0.9 111.967 -165.966 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -88.56 156.3 19.14 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.285 -1.746 . . . . 1.94 106.285 178.73 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -76.04 -40.2 53.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 118.748 2.869 . . . . 1.56 118.748 -168.613 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.25 22.85 9.11 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 117.798 -3.064 . . . . 0.97 112.868 177.559 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -108.13 164.37 12.36 Favored 'General case' 0 N--CA 1.431 -1.397 1 O-C-N 116.294 -4.062 . . . . 2.49 106.918 164.786 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 37.0 p -101.1 168.78 9.37 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.989 2.116 . . . . 0.76 111.662 179.129 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -58.5 -42.86 88.59 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 112.119 -2.31 . . . . 1.05 110.275 169.926 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.388 5.6 t -64.03 -33.39 75.64 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.499 1.954 . . . . 1.19 112.973 -179.013 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -61.18 -34.42 75.04 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 119.834 3.272 . . . . 1.9 119.834 175.016 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -90.74 10.72 24.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 111.957 -2.383 . . . . 0.89 114.169 174.934 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.279 46.7 m-80 65.09 21.45 12.21 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 113.379 -5.825 . . . . 1.84 115.263 -178.878 . . . . . . . . 3 2 . 1 . 055 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.0 mt -75.9 106.74 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 124.777 1.231 . . . . 0.82 112.298 -178.326 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -98.45 -164.91 1.18 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.264 2.226 . . . . 2.16 106.465 -169.655 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.264 44.8 mttp -72.25 141.21 48.94 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.641 -2.537 . . . . 2.12 110.867 173.826 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.254 31.9 mt-10 74.32 15.48 3.53 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 125.956 2.035 . . . . 1.71 112.872 172.192 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.32 50.1 m -84.16 145.79 28.2 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.162 -3.461 . . . . 1.04 110.819 -172.165 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.0 m -97.35 118.9 34.86 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.161 2.184 . . . . 0.79 106.14 -175.552 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.3 mp -107.06 145.51 32.31 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.225 2.61 . . . . 1.4 111.854 171.902 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -119.36 139.28 52.23 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.455 -2.054 . . . . 1.51 105.455 -174.989 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tt -107.67 124.48 50.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 113.82 -1.536 . . . . 1.14 107.979 -173.948 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.2 t -116.68 132.53 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 CA-C-O 129.171 4.32 . . . . 1.23 105.035 174.345 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.4 mt -94.08 134.62 36.31 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 116.633 -3.792 . . . . 2.78 108.994 175.746 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -110.52 116.28 31.11 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 128.305 3.907 . . . . 3.75 113.097 174.539 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 73' ' ' LEU . 91.5 mt -81.9 100.08 9.43 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.892 -2.38 . . . . 3.14 111.466 163.942 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -71.68 -48.8 45.06 Favored 'General case' 0 N--CA 1.431 -1.41 1 CA-C-O 128.515 4.007 . . . . 6.8 110.764 167.267 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -131.53 -78.62 0.17 Allowed Glycine 0 N--CA 1.431 -1.677 1 O-C-N 116.166 -4.084 . . . . 3.57 106.226 -174.694 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.753 0 CA-C-O 114.552 -3.36 . . . . 3.87 105.87 178.44 . . . . . . . . 0 0 . 1 . 056 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 CA--C 1.49 -1.327 0 CA-C-O 122.367 1.08 . . . . 1.1 110.552 . . . . . . . . . 0 0 . 1 . 056 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -111.65 136.91 50.23 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 117.477 -1.249 . . . . 1.87 109.831 -169.467 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.437 HD12 HD13 ' A' ' 67' ' ' LEU . 5.6 pt -135.56 159.39 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 122.489 2.404 . . . . 0.72 105.806 171.526 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -109.49 145.1 36.81 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.372 2.269 . . . . 1.4 107.781 -173.616 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.3 t -124.64 132.53 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.206 -1.776 . . . . 0.58 106.206 168.613 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 mmtm -97.09 143.59 27.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 104.975 -2.231 . . . . 2.09 104.975 169.472 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.7 p -90.36 -165.04 1.26 Allowed 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 130.272 3.429 . . . . 0.99 111.192 176.128 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.353 0.6 OUTLIER -64.63 -46.98 80.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 130.298 3.439 . . . . 2.53 113.042 175.992 . . . . . . . . 3 3 . 1 . 056 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.3 p -92.84 -37.34 12.35 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 126.381 2.991 . . . . 2.08 115.634 -178.6 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.05 -2.52 1.01 Allowed Glycine 0 N--CA 1.43 -1.721 0 O-C-N 116.301 -3.999 . . . . 1.31 117.701 178.215 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -74.92 120.97 21.19 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 122.7 3.25 . . . . 1.4 105.022 -166.905 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.7 m -71.17 117.23 12.42 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 126.56 2.413 . . . . 0.78 113.91 176.591 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.3 mm -98.84 138.68 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 117.08 -1.848 . . . . 1.55 107.78 173.522 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.4 m -106.3 112.81 25.99 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.702 2.001 . . . . 1.08 111.911 179.692 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.7 mt -108.57 144.26 36.5 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 116.177 -4.077 . . . . 1.55 115.268 175.141 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -90.85 123.71 34.6 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.172 1.789 . . . . 1.95 107.85 166.858 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 m -138.53 154.0 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 121.605 0.717 . . . . 0.96 109.639 -179.165 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -101.55 162.36 20.69 Favored Pre-proline 0 N--CA 1.429 -1.489 0 CA-C-O 115.597 -2.144 . . . . 2.35 109.603 167.365 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -81.7 -8.05 12.43 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 125.846 3.124 . . . . 0.95 112.089 178.694 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 p -81.13 -15.68 55.18 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.613 -0.721 . . . . 1.45 111.902 176.165 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -61.77 143.71 55.85 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 124.964 2.316 . . . . 1.69 115.376 178.933 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 25.0 p -90.58 165.25 13.86 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 115.759 -4.338 . . . . 0.75 108.664 178.5 . . . . . . . . 3 3 . 1 . 056 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.5 mm -71.98 -22.03 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-O 122.76 1.266 . . . . 0.73 109.961 -178.933 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -61.48 -35.36 77.44 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.075 -2.891 . . . . 1.62 118.07 160.681 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -76.53 -30.87 57.33 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 116.83 -3.669 . . . . 2.13 111.697 172.634 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.98 -41.92 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 O-C-N 120.156 -1.59 . . . . 0.62 111.809 179.982 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -61.35 -41.3 96.82 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.118 -2.239 . . . . 1.22 111.783 176.888 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.71 -39.6 81.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 126.538 2.399 . . . . 0.51 111.731 178.871 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.265 51.8 mttm -57.82 -53.94 52.48 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.102 -2.248 . . . . 1.44 110.333 173.465 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.253 64.8 mt -52.15 -41.4 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 130.122 3.369 . . . . 1.32 109.241 178.309 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -66.52 -50.82 61.93 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 130.261 3.424 . . . . 1.7 111.372 174.975 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -49.28 -45.54 45.17 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 124.13 3.15 . . . . 1.55 114.009 169.423 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -75.46 -66.56 0.76 Allowed 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 127.607 2.363 . . . . 2.62 114.137 -177.52 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -96.47 -18.46 19.84 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 117.508 2.41 . . . . 1.48 117.508 -173.042 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.51 46.84 5.36 Favored Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 118.696 2.238 . . . . 1.12 118.696 -177.731 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.8 mt -119.14 129.09 25.58 Favored Pre-proline 0 N--CA 1.43 -1.465 0 CA-C-O 111.704 -3.998 . . . . 1.55 106.376 -174.14 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -64.1 152.14 82.34 Favored 'Trans proline' 0 N--CA 1.433 -2.059 0 CA-C-O 112.132 -3.362 . . . . 1.02 119.896 172.122 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -81.4 -23.53 5.01 Favored 'Trans proline' 0 N--CA 1.433 -2.046 0 CA-C-N 127.253 3.626 . . . . 1.25 112.466 -166.484 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -56.43 -31.67 64.15 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.448 2.699 . . . . 2.25 110.663 175.126 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -93.52 6.97 46.44 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 111.184 -2.735 . . . . 2.02 108.44 -170.09 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -122.11 126.67 48.88 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 122.536 2.426 . . . . 0.69 109.4 -174.285 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -109.47 150.27 28.36 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 116.856 -1.545 . . . . 2.78 110.117 158.975 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.4 mt -125.8 136.06 52.7 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 107.468 -1.308 . . . . 1.17 107.468 176.295 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.9 mm -112.43 124.44 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 128.054 2.541 . . . . 1.38 111.397 -178.787 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -114.31 128.09 56.18 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 122.517 2.417 . . . . 1.5 108.901 168.673 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.66 -85.06 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.56 1.544 . . . . 1.21 110.125 -171.574 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -164.19 43.55 0.31 Allowed Glycine 0 N--CA 1.429 -1.78 0 O-C-N 121.091 -1.006 . . . . 1.3 111.929 178.079 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -135.26 135.83 41.2 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.16 2.184 . . . . 2.55 110.253 -179.768 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -89.32 116.08 27.27 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 114.505 1.298 . . . . 2.48 114.505 175.886 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.5 mt -67.88 160.51 28.3 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.981 2.324 . . . . 0.9 113.308 -168.447 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -103.98 135.11 46.11 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.863 -2.426 . . . . 1.94 109.868 172.519 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.261 2.9 m-20 -56.17 -49.38 74.16 Favored 'General case' 0 N--CA 1.43 -1.439 1 C-N-CA 132.311 4.244 . . . . 1.56 113.528 -172.913 . . . . . . . . 3 2 . 1 . 056 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.2 50.63 2.76 Favored Glycine 0 N--CA 1.43 -1.767 0 N-CA-C 119.689 2.636 . . . . 0.97 119.689 171.226 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -124.03 164.1 20.06 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.233 1.968 . . . . 2.49 106.136 163.062 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 66.6 p -106.12 164.01 12.33 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.211 -2.268 . . . . 0.76 113.859 175.117 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.4 mt -50.08 -37.52 34.13 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.712 -3.742 . . . . 1.05 114.518 168.566 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -64.25 -26.33 68.45 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.257 2.317 . . . . 1.19 117.257 176.703 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -70.15 -51.4 31.62 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.387 1.475 . . . . 1.9 108.036 177.805 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -76.89 2.7 13.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.057 2.143 . . . . 0.89 113.05 179.753 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.508 1.1 m-80 60.42 39.62 18.28 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.334 1.646 . . . . 1.84 114.096 179.778 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.4 mt -90.85 118.87 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 126.054 2.835 . . . . 0.82 113.241 -177.267 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -101.5 -167.37 1.41 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.159 -3.463 . . . . 2.16 113.8 -177.068 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.256 13.7 ptmt -58.5 153.97 14.95 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.851 -2.405 . . . . 2.12 116.329 174.759 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 49.0 42.49 20.87 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 129.745 3.218 . . . . 1.71 113.741 173.149 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.6 m -92.47 142.72 27.1 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 130.749 3.619 . . . . 1.04 105.535 -179.095 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.2 m -104.73 117.41 34.02 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.142 -2.17 . . . . 0.79 105.142 -175.012 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.437 HD13 HD12 ' A' ' 3' ' ' ILE . 5.1 mp -98.34 162.91 12.93 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 131.521 3.928 . . . . 1.4 110.045 171.05 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -123.08 126.36 46.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.083 -3.511 . . . . 1.51 111.472 -178.939 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.4 tp -95.9 113.92 25.59 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 107.07 -1.455 . . . . 1.14 107.07 -176.415 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.0 t -104.58 143.66 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 101.197 -3.631 . . . . 1.23 101.197 176.526 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.4 mt -106.88 135.42 48.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 113.181 -3.408 . . . . 2.78 110.927 -179.925 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -102.65 130.47 49.56 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.644 -1.285 . . . . 3.75 108.309 -179.176 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.264 0.7 OUTLIER -70.46 176.5 4.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.098 2.559 . . . . 3.14 117.737 166.24 . . . . . . . . 3 3 . 1 . 056 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -96.49 102.61 14.42 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.02 -2.925 . . . . 6.8 112.499 175.414 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.85 45.17 0.31 Allowed Glycine 0 N--CA 1.429 -1.778 0 O-C-N 118.659 -2.526 . . . . 3.57 111.045 -175.867 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.718 0 N-CA-C 107.673 -2.171 . . . . 3.87 107.673 169.961 . . . . . . . . 0 0 . 1 . 057 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 116.883 -1.532 . . . . 1.1 111.724 . . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -97.17 140.67 31.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 127.273 3.416 . . . . 1.87 109.416 -174.66 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.0 pt -123.44 160.73 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 124.814 2.245 . . . . 0.72 110.996 171.323 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -108.91 143.08 38.62 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.234 -4.041 . . . . 1.4 111.419 -179.265 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.42 HG21 HD11 ' A' ' 30' ' ' ILE . 2.8 t -110.91 123.79 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.243 -3.411 . . . . 0.58 108.043 174.199 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 11' ' ' LYS . 73.9 tttt -119.45 138.89 52.83 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.033 1.397 . . . . 2.09 108.563 -178.618 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.0 p -103.69 168.98 8.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.438 -1.414 . . . . 0.99 108.176 -178.067 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.2 tp -66.34 -42.46 88.11 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.955 1.302 . . . . 2.53 112.285 172.464 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.6 p -76.89 -18.52 58.27 Favored 'General case' 0 N--CA 1.43 -1.463 1 CA-C-O 128.968 4.223 . . . . 2.08 110.064 -171.35 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.15 26.95 1.28 Allowed Glycine 0 N--CA 1.43 -1.727 1 O-C-N 116.004 -4.185 . . . . 1.31 118.002 166.285 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 63.4 tttt -91.98 133.87 35.32 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 117.258 -1.353 . . . . 1.4 110.241 -179.814 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m -122.43 105.94 10.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 125.627 1.83 . . . . 0.78 115.762 168.966 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 pt -114.79 164.92 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 125.92 2.771 . . . . 1.55 105.191 179.778 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.7 m -112.37 135.18 53.37 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.875 -3.015 . . . . 1.08 112.544 -178.37 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.8 mt -115.78 154.74 29.09 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.888 -1.758 . . . . 1.55 109.887 172.393 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -112.73 120.52 41.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.333 -1.48 . . . . 1.95 110.864 167.273 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.4 m -125.28 175.11 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 124.354 2.026 . . . . 0.96 108.427 178.508 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -114.29 171.96 3.98 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 104.7 -2.333 . . . . 2.35 104.7 164.075 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -83.38 -9.51 10.29 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 N-CA-C 107.174 -1.895 . . . . 0.95 107.174 -176.314 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.4 m -95.82 6.35 49.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.608 1.963 . . . . 1.45 115.415 173.48 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -77.09 153.8 33.96 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 104.727 -2.323 . . . . 1.69 104.727 170.296 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.5 p -86.95 162.1 17.87 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 116.158 -4.089 . . . . 0.75 110.218 168.904 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.306 23.1 mm -65.97 -38.89 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 118.159 -2.838 . . . . 0.73 111.31 179.17 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -50.79 -38.12 46.38 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 127.182 3.373 . . . . 1.62 117.597 166.941 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -75.07 -26.38 59.31 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.519 3.128 . . . . 2.13 110.915 172.792 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.38 -34.33 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 123.334 2.788 . . . . 0.62 109.547 170.831 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -70.49 -36.52 73.88 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.528 -1.983 . . . . 1.22 113.838 175.982 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.84 76.91 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 115.724 1.75 . . . . 0.51 115.724 173.278 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -58.26 -37.36 74.8 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.981 2.113 . . . . 1.44 111.964 175.018 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 5' ' ' VAL . 94.3 mt -75.94 -29.12 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 1 O-C-N 115.676 -4.39 . . . . 1.32 110.357 174.717 . . . . . . . . 3 3 . 1 . 057 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -69.05 -42.3 76.46 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 116.797 -3.689 . . . . 1.7 115.155 168.885 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.337 23.2 t70 -55.03 -49.18 72.2 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.238 -2.164 . . . . 1.55 112.396 168.811 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -70.49 -69.04 0.38 Allowed 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.011 -1.681 . . . . 2.62 113.753 -177.388 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -91.44 -48.71 6.73 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 112.287 -2.233 . . . . 1.48 110.187 -167.387 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.1 32.63 3.21 Favored Glycine 0 N--CA 1.429 -1.773 0 CA-C-O 125.183 2.546 . . . . 1.12 114.837 -179.037 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.8 mt -92.65 129.22 41.14 Favored Pre-proline 0 N--CA 1.43 -1.444 0 N-CA-C 102.49 -3.152 . . . . 1.55 102.49 -177.222 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -76.74 139.37 19.86 Favored 'Trans proline' 0 N--CA 1.433 -2.053 0 CA-C-O 114.156 -2.518 . . . . 1.02 112.737 -178.954 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -68.57 0.04 5.31 Favored 'Trans proline' 0 N--CA 1.433 -2.058 1 C-N-CA 125.624 4.216 . . . . 1.25 112.014 -169.501 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -64.92 -42.81 94.4 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.806 1.289 . . . . 2.25 113.097 166.36 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -75.49 -27.07 58.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.132 2.396 . . . . 2.02 111.034 -176.243 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -81.88 122.26 27.51 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 119.995 3.331 . . . . 0.69 119.995 -169.088 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -116.41 136.68 52.78 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 131.242 3.817 . . . . 2.78 108.976 170.453 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.9 mt -120.13 113.58 20.68 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.425 -4.547 . . . . 1.17 113.513 178.392 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.1 mm -102.19 143.01 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 126.889 3.233 . . . . 1.38 105.765 173.425 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.446 ' HB3' HD21 ' A' ' 50' ' ' LEU . 59.1 t80 -132.66 125.3 30.02 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 115.3 -4.625 . . . . 1.5 110.111 162.866 . . . . . . . . 3 3 . 1 . 057 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.63 -95.15 0.05 OUTLIER 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 124.171 1.938 . . . . 1.21 112.615 -172.428 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.74 20.16 3.1 Favored Glycine 0 N--CA 1.43 -1.757 0 O-C-N 119.208 -2.182 . . . . 1.3 111.3 176.352 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -111.85 135.35 52.59 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 128.675 2.79 . . . . 2.55 109.887 175.752 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -86.76 101.01 12.91 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 129.667 3.187 . . . . 2.48 109.591 168.921 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.446 HD21 ' HB3' ' A' ' 45' ' ' PHE . 21.1 mt -72.11 122.08 20.36 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.397 2.679 . . . . 0.9 112.781 -169.194 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -75.11 133.55 41.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 116.414 2.005 . . . . 1.94 116.414 174.786 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -45.52 -55.1 6.59 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 131.252 3.821 . . . . 1.56 116.298 -174.484 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.68 9.61 58.73 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 118.171 2.028 . . . . 0.97 118.171 173.491 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -91.58 165.51 13.3 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 121.836 2.818 . . . . 2.49 109.496 164.712 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.268 30.3 p -94.02 177.64 5.91 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.785 -1.197 . . . . 0.76 113.059 178.411 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mt -75.03 -27.95 60.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.65 2.643 . . . . 1.05 115.289 171.635 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.4 t -68.07 -39.94 82.83 Favored 'General case' 0 N--CA 1.429 -1.481 1 C-N-CA 132.575 4.35 . . . . 1.19 117.13 175.588 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.288 2.5 m-20 -55.52 -46.91 76.96 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.741 2.816 . . . . 1.9 109.567 175.955 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -83.34 -1.07 52.43 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 126.549 1.94 . . . . 0.89 116.105 176.155 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 63.26 47.34 4.09 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 128.877 2.871 . . . . 1.84 112.36 175.503 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.8 mt -85.52 130.25 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 127.676 2.39 . . . . 0.82 110.799 178.762 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -115.84 175.37 5.57 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 116.267 -4.021 . . . . 2.16 112.061 -173.632 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -50.38 146.65 5.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.899 -2.376 . . . . 2.12 114.423 169.116 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 63.43 23.02 13.52 Favored 'General case' 0 N--CA 1.43 -1.461 2 C-N-CA 132.773 4.429 . . . . 1.71 111.757 176.927 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -91.15 155.21 18.79 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 116.927 -3.608 . . . . 1.04 107.034 -178.588 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.4 m -103.41 116.12 31.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.123 -1.399 . . . . 0.79 112.062 -177.753 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -97.11 136.15 38.06 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 102.65 -3.093 . . . . 1.4 102.65 172.848 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -101.72 101.82 12.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.521 1.928 . . . . 1.51 110.377 -175.233 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.1 tp -80.18 124.85 29.15 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 125.93 2.019 . . . . 1.14 110.323 -179.242 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.9 t -126.58 124.14 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.183 -1.826 . . . . 1.23 107.249 -169.471 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.3 mt -100.85 133.8 44.79 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 117.943 -1.503 . . . . 2.78 114.709 -177.484 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -82.1 79.38 8.61 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.786 2.434 . . . . 3.75 111.959 175.208 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.7 mt -94.71 -50.34 5.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 114.88 -2.486 . . . . 3.14 111.004 167.733 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.266 21.3 ttt180 -92.42 -86.44 0.24 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 125.796 1.935 . . . . 6.8 108.458 171.543 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.77 80.51 0.85 Allowed Glycine 0 N--CA 1.43 -1.755 0 O-C-N 118.861 -2.399 . . . . 3.57 114.699 -173.101 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.802 0 CA-C-O 114.001 -3.666 . . . . 3.87 107.999 174.108 . . . . . . . . 0 0 . 1 . 058 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 123.649 1.69 . . . . 1.1 110.639 . . . . . . . . . 0 0 . 1 . 058 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -85.19 121.68 28.29 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.05 -2.906 . . . . 1.87 109.691 -176.817 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -118.83 171.59 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 125.392 2.52 . . . . 0.72 107.848 168.272 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -129.42 129.68 45.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 111.706 -2.497 . . . . 1.4 111.808 179.938 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.6 t -110.94 115.96 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 113.254 -1.794 . . . . 0.58 107.113 169.497 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -97.19 140.98 30.87 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 125.125 2.393 . . . . 2.09 107.786 175.464 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.0 p -82.17 178.64 8.16 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.973 -1.704 . . . . 0.99 114.494 179.796 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.2 tp -54.33 -47.0 73.01 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 116.169 -4.082 . . . . 2.53 112.423 167.556 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 p -71.65 -26.89 62.73 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.729 -3.732 . . . . 2.08 111.374 -178.424 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.1 26.93 6.09 Favored Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 126.491 1.996 . . . . 1.31 112.033 -178.02 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -83.19 128.38 34.44 Favored 'General case' 0 N--CA 1.43 -1.474 2 O-C-N 116.287 -4.067 . . . . 1.4 108.386 176.441 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -99.02 113.29 25.4 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 128.333 3.921 . . . . 0.78 109.979 -176.377 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mt -91.95 126.71 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 111.11 -2.768 . . . . 1.55 108.996 176.111 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.6 t -98.89 143.31 29.34 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 119.95 1.25 . . . . 1.08 111.174 172.958 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.9 mt -136.97 158.1 45.24 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.587 2.755 . . . . 1.55 108.592 -177.828 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -111.33 121.1 44.36 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.479 -1.388 . . . . 1.95 107.819 166.057 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.03 159.32 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 126.491 3.043 . . . . 0.96 106.488 -172.724 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -112.01 149.17 40.47 Favored Pre-proline 0 N--CA 1.43 -1.475 1 O-C-N 116.067 -4.145 . . . . 2.35 108.186 165.239 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -72.31 -9.42 24.28 Favored 'Trans proline' 0 C--N 1.299 -2.031 2 O-C-N 112.925 -4.303 . . . . 0.95 115.671 -173.526 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.7 p -89.03 2.98 53.2 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 111.656 -2.52 . . . . 1.45 111.364 177.795 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -78.3 157.95 29.03 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.65 2.092 . . . . 1.69 116.65 172.864 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 67.2 p -95.87 160.12 14.63 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.015 2.816 . . . . 0.75 110.184 169.844 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 mm -54.83 -32.03 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 117.447 -3.283 . . . . 0.73 115.561 166.385 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -51.29 -59.86 3.75 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 116.692 2.108 . . . . 1.62 116.692 160.901 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -54.26 -37.44 64.7 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 117.768 2.507 . . . . 2.13 117.768 174.476 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.4 t -56.54 -42.34 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 126.86 2.064 . . . . 0.62 115.1 167.46 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -68.82 -24.2 64.35 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 115.577 1.695 . . . . 1.22 115.577 174.915 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.34 83.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 116.795 -1.574 . . . . 0.51 112.901 166.349 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -68.23 -35.45 77.96 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 128.726 3.766 . . . . 1.44 115.999 -179.573 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.2 mt -79.98 -32.25 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 C-N-CA 128.634 2.773 . . . . 1.32 113.535 170.931 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -62.96 -51.53 66.53 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 115.781 -4.324 . . . . 1.7 114.058 167.155 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -52.18 -43.85 64.36 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.34 1.978 . . . . 1.55 116.34 169.145 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -84.83 -63.82 1.27 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.066 -1.646 . . . . 2.62 113.944 -177.898 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -96.62 -39.19 9.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.752 2.215 . . . . 1.48 115.86 -174.151 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.61 44.92 2.4 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 116.79 -3.694 . . . . 1.12 113.626 169.604 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.7 mt -103.95 130.84 22.67 Favored Pre-proline 0 N--CA 1.43 -1.451 1 N-CA-C 99.775 -4.157 . . . . 1.55 99.775 -174.489 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -54.16 135.15 63.54 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-O 112.205 -3.331 . . . . 1.02 116.058 -179.571 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.64 -26.12 63.33 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 CA-C-N 127.052 3.554 . . . . 1.25 119.863 -178.988 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -68.67 -37.29 79.5 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.378 -1.283 . . . . 2.25 113.727 177.634 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -73.1 -27.48 61.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.609 -3.182 . . . . 2.02 115.105 178.307 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -68.49 129.49 40.08 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.377 3.473 . . . . 0.69 120.377 177.526 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -127.92 114.99 17.87 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.66 1.984 . . . . 2.78 111.715 168.9 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.565 HD12 HD23 ' A' ' 67' ' ' LEU . 3.8 mm? -86.71 130.16 34.59 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 125.881 1.988 . . . . 1.17 108.248 176.949 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.1 mm -127.41 123.3 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 125.985 2.053 . . . . 1.38 108.131 177.101 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -123.3 124.06 42.14 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.648 1.69 . . . . 1.5 108.945 171.948 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.89 -92.85 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.503 2.721 . . . . 1.21 116.05 -172.886 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.31 -38.18 1.68 Allowed Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 126.462 1.982 . . . . 1.3 113.505 -177.854 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -82.39 146.83 29.13 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 129.897 3.279 . . . . 2.55 116.039 -172.304 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -92.49 141.09 28.89 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 118.966 -2.334 . . . . 2.48 108.953 171.801 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 43' ' ' LEU . 27.7 mt -98.4 128.43 44.78 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 104.418 -2.438 . . . . 0.9 104.418 -168.922 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.55 140.63 32.14 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.672 2.389 . . . . 1.94 112.936 173.396 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -56.57 -54.44 45.88 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.34 3.089 . . . . 1.56 119.34 -172.179 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.02 8.44 63.33 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 115.278 -2.957 . . . . 0.97 117.505 175.106 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 22' ' ' THR . 31.0 mmt180 -78.88 158.21 28.14 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 122.732 3.266 . . . . 2.49 115.124 163.041 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.7 p -89.4 156.59 18.58 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 122.758 2.526 . . . . 0.76 113.351 173.141 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.0 mt -53.8 -36.86 62.92 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.104 -0.953 . . . . 1.05 111.675 166.361 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -54.19 -48.05 71.39 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.232 -2.168 . . . . 1.19 113.863 -178.841 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -45.69 -43.93 13.07 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 119.984 3.327 . . . . 1.9 119.984 171.786 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -96.75 3.54 52.29 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.203 2.601 . . . . 0.89 111.176 178.944 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.4 m120 54.88 47.29 22.6 Favored 'General case' 0 N--CA 1.431 -1.384 0 O-C-N 119.32 -2.113 . . . . 1.84 112.862 -176.092 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.3 mt -80.5 117.5 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 122.184 2.265 . . . . 0.82 110.274 177.481 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -110.32 176.86 4.89 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 120.13 1.332 . . . . 2.16 108.423 -168.43 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.377 45.5 pttt -54.27 128.46 31.4 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 131.555 3.942 . . . . 2.12 115.172 174.191 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 64.17 48.18 3.02 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 128.021 2.528 . . . . 1.71 109.269 175.758 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.2 p -92.12 173.45 7.83 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.806 -3.059 . . . . 1.04 113.35 178.117 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.1 m -120.88 114.86 22.18 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.281 -2.137 . . . . 0.79 112.317 173.201 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.565 HD23 HD12 ' A' ' 43' ' ' LEU . 6.3 mp -105.11 155.1 19.32 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.062 1.745 . . . . 1.4 108.522 175.575 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -118.42 130.64 56.09 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 126.543 2.402 . . . . 1.51 105.179 -174.763 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.2 tp -99.38 117.77 34.53 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.411 1.084 . . . . 1.14 112.981 175.524 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.8 t -102.97 129.85 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-O 123.896 1.808 . . . . 1.23 109.134 172.6 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.4 mt -105.6 105.4 15.43 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.939 -2.976 . . . . 2.78 108.522 178.087 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -77.98 127.48 32.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.179 1.392 . . . . 3.75 108.242 172.788 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.1 mt -81.69 145.25 30.63 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.616 -0.678 . . . . 3.14 110.375 170.89 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -117.8 -60.84 1.76 Allowed 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 104.57 -2.381 . . . . 6.8 104.57 175.702 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.09 -58.47 0.56 Allowed Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 127.689 2.566 . . . . 3.57 111.791 -162.36 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.742 1 N-CA-C 102.133 -4.387 . . . . 3.87 102.133 179.941 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 CA--C 1.491 -1.319 0 CA-C-O 122.992 1.377 . . . . 1.1 113.882 . . . . . . . . . 0 0 . 1 . 059 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -85.9 135.18 33.79 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.21 1.804 . . . . 1.87 110.175 -174.565 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 pt -135.97 161.01 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 120.003 -1.686 . . . . 0.72 111.815 174.199 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -118.04 141.43 48.47 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.161 -2.212 . . . . 1.4 107.819 -179.268 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 t -116.88 130.11 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 126.064 2.102 . . . . 0.58 107.185 173.566 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -115.06 123.44 49.02 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.133 -3.479 . . . . 2.09 113.722 179.02 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.3 p -68.0 171.22 7.08 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 124.522 2.106 . . . . 0.99 112.038 178.161 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 tp -71.77 -27.37 62.91 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 117.912 -2.993 . . . . 2.53 110.403 174.622 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 p -73.6 -30.32 62.92 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.758 -3.714 . . . . 2.08 106.46 178.546 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.26 -21.22 2.96 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 125.289 3.677 . . . . 1.31 113.041 -179.433 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -57.11 117.41 4.0 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 126.874 2.07 . . . . 1.4 114.185 -177.159 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.8 m -107.64 114.82 29.06 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.169 -1.789 . . . . 0.78 106.169 -179.798 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.516 HD12 ' CE ' ' A' ' 33' ' ' LYS . 26.9 pt -104.61 161.64 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 125.839 1.962 . . . . 1.55 105.883 -178.162 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -117.24 121.13 40.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.711 2.004 . . . . 1.08 108.861 -174.48 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.6 mt -122.99 164.42 18.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 126.289 2.947 . . . . 1.55 110.974 -177.657 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -129.0 132.4 47.52 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 116.406 -3.934 . . . . 1.95 110.884 174.828 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.7 m -137.59 -175.45 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-O 128.377 3.942 . . . . 0.96 112.047 -179.818 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -122.88 147.32 50.83 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-N 112.157 -2.292 . . . . 2.35 110.572 166.084 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -65.6 -20.09 60.07 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 O-C-N 114.036 -3.718 . . . . 0.95 115.276 -178.783 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.6 p -70.64 -21.92 62.57 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 117.45 -3.281 . . . . 1.45 112.154 177.862 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -62.86 146.7 52.16 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.994 2.961 . . . . 1.69 118.994 178.395 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.8 p -85.58 151.64 23.76 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 124.895 1.278 . . . . 0.75 108.191 177.358 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.2 mm -54.0 -41.34 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 129.225 3.01 . . . . 0.73 113.063 -179.884 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -44.56 -53.17 7.36 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 118.612 2.819 . . . . 1.62 118.612 161.777 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -50.8 -32.15 19.15 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 126.537 1.935 . . . . 2.13 113.693 174.096 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.9 t -77.44 -42.7 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 107.243 -1.391 . . . . 0.62 107.243 -177.305 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.496 ' HA ' HD12 ' A' ' 30' ' ' ILE . 40.8 mtmt -60.16 -42.3 94.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 120.393 1.451 . . . . 1.22 112.79 174.744 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.85 -20.53 65.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.594 1.558 . . . . 0.51 110.227 177.915 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -80.11 -40.79 26.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.969 2.319 . . . . 1.44 112.878 174.545 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 27' ' ' LYS . 33.2 mt -51.52 -42.57 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.551 -2.593 . . . . 1.32 113.65 165.68 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -54.17 -47.76 71.64 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.339 2.656 . . . . 1.7 113.613 177.559 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -56.71 -42.51 79.3 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.816 2.046 . . . . 1.55 115.058 170.884 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.516 ' CE ' HD12 ' A' ' 13' ' ' ILE . 52.3 tttp -74.26 -48.56 27.9 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.671 1.988 . . . . 2.62 114.654 -179.213 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -115.85 -15.09 11.3 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 123.911 1.815 . . . . 1.48 114.264 -171.061 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.17 21.67 32.1 Favored Glycine 0 N--CA 1.429 -1.789 1 O-C-N 113.848 -5.533 . . . . 1.12 113.012 171.394 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 mt -98.69 124.02 47.67 Favored Pre-proline 0 N--CA 1.431 -1.42 0 O-C-N 120.626 -1.514 . . . . 1.55 107.009 -175.328 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -67.97 152.54 76.77 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 C-N-CA 124.302 3.335 . . . . 1.02 113.779 178.043 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -82.47 -15.84 8.45 Favored 'Trans proline' 0 N--CA 1.433 -2.052 0 C-N-CA 123.704 2.936 . . . . 1.25 113.321 -163.304 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -72.7 -27.76 62.26 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 129.981 4.551 . . . . 2.25 113.889 175.333 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -82.03 -20.54 38.13 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.046 2.355 . . . . 2.02 112.522 179.132 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.276 76.8 mt-30 -97.11 145.39 26.04 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 127.805 3.669 . . . . 0.69 109.786 -171.867 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -139.18 122.58 17.18 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.101 -2.249 . . . . 2.78 113.903 172.539 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.2 mt -92.44 120.85 33.34 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.414 -1.428 . . . . 1.17 112.866 -176.299 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.5 mt -112.7 130.15 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 129.981 3.313 . . . . 1.38 107.92 -175.537 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -138.3 135.15 35.16 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.744 -1.222 . . . . 1.5 110.206 177.872 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.01 46.96 25.71 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.824 3.202 . . . . 1.21 116.675 179.592 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.17 -44.28 3.35 Favored Glycine 0 N--CA 1.43 -1.717 0 O-C-N 118.617 -2.552 . . . . 1.3 117.479 -177.147 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -86.67 159.5 19.17 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 118.89 1.345 . . . . 2.55 114.498 -176.228 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -83.54 135.01 34.8 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.411 -0.813 . . . . 2.48 109.501 174.497 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 mt -87.7 148.1 24.92 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.759 -1.2 . . . . 0.9 107.759 -179.011 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -99.69 134.54 42.44 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.26 -2.775 . . . . 1.94 110.027 -179.619 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -68.36 -25.86 65.29 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 117.692 2.478 . . . . 1.56 117.692 -167.626 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.05 14.76 64.13 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 115.617 -3.183 . . . . 0.97 117.662 169.091 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -96.84 176.51 5.95 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.991 1.377 . . . . 2.49 108.157 170.005 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.5 p -102.6 -174.72 2.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 116.328 -3.982 . . . . 0.76 117.182 177.648 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.259 60.2 mt -77.33 -38.54 50.17 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.632 -2.542 . . . . 1.05 111.255 174.301 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.1 p -72.28 -15.12 61.9 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 128.369 3.543 . . . . 1.19 118.387 179.012 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -66.09 -29.66 70.02 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.127 -1.608 . . . . 1.9 113.672 168.921 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -102.96 6.46 38.92 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 122.851 1.31 . . . . 0.89 109.83 -177.231 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.8 m120 55.45 35.41 25.01 Favored 'General case' 0 N--CA 1.431 -1.38 1 O-C-N 116.279 -4.013 . . . . 1.84 114.746 -173.507 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.9 mt -68.72 118.03 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.943 1.297 . . . . 0.82 113.475 175.073 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -115.55 -175.85 2.8 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 130.97 3.708 . . . . 2.16 112.859 -178.864 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -67.07 139.12 57.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.247 2.927 . . . . 2.12 110.894 -176.224 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.446 25.3 mt-10 85.38 9.07 0.35 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 111.439 -2.619 . . . . 1.71 116.015 176.652 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.0 m -74.23 133.43 42.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.859 -1.776 . . . . 1.04 114.371 -173.282 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.5 m -99.99 109.99 22.32 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 104.651 -2.351 . . . . 0.79 104.651 -169.595 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.19 151.47 19.44 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.274 2.23 . . . . 1.4 109.134 172.306 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -109.34 108.18 18.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 123.598 1.666 . . . . 1.51 112.228 -179.06 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.4 tp -85.08 120.38 26.52 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.516 2.103 . . . . 1.14 109.412 178.178 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.366 31.3 m -114.67 148.25 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 117.17 -3.456 . . . . 1.23 112.611 171.702 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.286 62.1 mt -109.1 132.8 53.77 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.986 2.803 . . . . 2.78 108.829 -179.076 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -137.29 73.79 1.46 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.242 -2.132 . . . . 3.75 105.242 -179.546 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 pp -84.28 162.03 20.26 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 116.635 2.087 . . . . 3.14 116.635 -178.686 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -105.75 -45.52 4.37 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 115.75 -2.072 . . . . 6.8 108.999 172.755 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.75 -98.69 0.12 Allowed Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 104.761 -3.335 . . . . 3.57 104.761 -168.248 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.751 0 O-C-N 119.459 -2.2 . . . . 3.87 113.235 177.634 . . . . . . . . 0 0 . 1 . 060 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.295 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.359 0 CA-C-O 125.099 2.381 . . . . 1.1 115.096 . . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -87.78 128.5 35.32 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.46 -3.9 . . . . 1.87 111.475 179.317 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.7 pt -126.66 172.96 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 117.07 -3.519 . . . . 0.72 106.603 169.612 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -127.17 135.65 50.99 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 123.519 0.728 . . . . 1.4 110.861 -176.864 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.2 t -117.37 117.94 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 101.342 -3.577 . . . . 0.58 101.342 176.774 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.7 tttp -101.73 148.2 25.56 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.625 -3.797 . . . . 2.09 113.54 174.84 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.4 HG22 HD23 ' A' ' 69' ' ' LEU . 31.1 p -97.28 171.59 8.33 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.542 2.591 . . . . 0.99 108.751 176.946 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.6 mt -83.47 -4.79 58.84 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.811 -2.43 . . . . 2.53 114.205 172.544 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.2 p -88.83 -30.44 18.94 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 115.723 -2.084 . . . . 2.08 105.467 178.947 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.11 -2.17 10.69 Favored Glycine 0 N--CA 1.43 -1.754 1 O-C-N 129.471 4.232 . . . . 1.31 115.89 170.941 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -72.47 140.61 48.36 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.859 -1.163 . . . . 1.4 107.859 -176.421 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.6 m -108.3 124.58 50.55 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.848 -2.649 . . . . 0.78 103.848 177.419 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.3 mm -101.55 116.81 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 119.237 -2.165 . . . . 1.55 109.769 176.209 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.2 m -92.85 120.8 33.57 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 121.351 1.887 . . . . 1.08 107.891 -179.162 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 15' ' ' LEU . 39.4 mt -125.88 127.23 45.7 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.048 2.939 . . . . 1.55 110.261 -173.731 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -86.29 114.26 22.95 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 126.72 2.513 . . . . 1.95 113.075 166.409 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.1 m -129.28 167.11 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 118.044 -2.91 . . . . 0.96 109.103 -179.407 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.271 69.1 mm-40 -110.4 156.08 40.93 Favored Pre-proline 0 N--CA 1.431 -1.408 0 CA-C-O 117.839 -1.077 . . . . 2.35 108.573 164.851 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -71.08 -8.22 23.09 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 CA-C-N 123.217 2.185 . . . . 0.95 113.853 -175.175 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.1 p -81.49 -24.91 36.41 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.049 2.94 . . . . 1.45 113.284 178.535 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -66.74 154.55 40.44 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 117.687 -1.149 . . . . 1.69 111.985 178.97 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 19.0 p -87.13 175.94 7.83 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 106.303 -1.74 . . . . 0.75 106.303 -177.872 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.4 mm -73.31 -33.96 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 C-N-CA 123.889 0.876 . . . . 0.73 111.792 175.848 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -46.2 -41.14 12.35 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.678 3.191 . . . . 1.62 113.751 167.41 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -73.39 -22.13 60.33 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 115.513 -4.492 . . . . 2.13 114.205 179.275 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -74.51 -47.02 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 113.709 -1.587 . . . . 0.62 109.047 175.589 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -52.69 -27.77 18.89 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 128.419 3.574 . . . . 1.22 119.817 167.116 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.21 -37.38 57.84 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.461 -3.899 . . . . 0.51 110.781 172.54 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -70.22 -39.83 74.88 Favored 'General case' 0 N--CA 1.43 -1.444 2 O-C-N 111.372 -7.08 . . . . 1.44 110.68 177.269 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 53.5 mt -59.28 -42.29 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 1 O-C-N 115.989 -4.194 . . . . 1.32 111.05 173.038 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -65.55 -46.5 79.3 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.215 -3.428 . . . . 1.7 107.671 177.755 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -55.15 -64.99 0.66 Allowed 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.081 -4.762 . . . . 1.55 117.003 169.91 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -61.37 -57.18 13.32 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.226 -2.796 . . . . 2.62 113.215 -176.021 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -100.93 -46.1 5.22 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.957 2.903 . . . . 1.48 111.315 -165.639 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.01 22.75 5.18 Favored Glycine 0 N--CA 1.429 -1.79 0 O-C-N 116.649 -3.782 . . . . 1.12 113.781 170.61 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.9 mt -92.43 128.24 45.44 Favored Pre-proline 0 N--CA 1.432 -1.374 0 N-CA-C 101.666 -3.457 . . . . 1.55 101.666 -173.11 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -71.26 155.78 60.12 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 CA-C-O 112.67 -3.137 . . . . 1.02 114.961 175.681 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -65.61 -24.15 56.05 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 CA-C-N 124.861 2.772 . . . . 1.25 118.274 -179.163 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.83 -33.85 76.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.548 2.055 . . . . 2.25 116.548 172.866 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -83.41 -35.28 25.16 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 126.321 2.962 . . . . 2.02 112.603 -177.916 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -79.05 130.09 35.15 Favored 'General case' 0 N--CA 1.429 -1.482 1 O-C-N 115.575 -4.453 . . . . 0.69 111.816 -176.103 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -123.91 129.73 51.44 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.696 1.599 . . . . 2.78 106.686 166.776 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 mt -96.19 139.42 32.36 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 124.657 1.223 . . . . 1.17 113.595 173.692 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 60.1 mt -114.63 138.5 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.899 -3.0 . . . . 1.38 107.607 174.141 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -147.13 136.74 22.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.797 -3.064 . . . . 1.5 112.062 169.46 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.374 . . 63.53 -2.21 0.51 Allowed 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 116.677 2.103 . . . . 1.21 116.677 -178.426 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.21 -11.28 33.84 Favored Glycine 0 N--CA 1.429 -1.776 0 CA-C-O 126.648 3.36 . . . . 1.3 113.52 -173.862 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -90.23 128.98 36.53 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 117.592 -3.299 . . . . 2.55 108.795 -179.548 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -77.03 126.44 30.97 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.084 -3.51 . . . . 2.48 108.099 171.565 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.289 26.5 mt -79.17 127.96 32.7 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 118.136 2.643 . . . . 0.9 118.136 -170.519 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -83.43 149.49 26.64 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.584 2.068 . . . . 1.94 116.584 174.441 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.76 -36.11 72.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.142 2.577 . . . . 1.56 114.15 -171.782 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.46 10.59 68.81 Favored Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 114.572 -3.68 . . . . 0.97 119.141 171.233 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -80.06 154.3 28.21 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 126.594 1.996 . . . . 2.49 113.225 170.701 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 32.5 p -82.77 164.32 20.7 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 124.886 2.279 . . . . 0.76 111.098 167.902 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mt -75.43 -29.04 59.59 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 116.791 -3.693 . . . . 1.05 112.481 173.098 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 p -62.92 -40.6 98.1 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.39 -2.069 . . . . 1.19 112.491 173.9 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.278 2.0 t70 -53.62 -40.87 66.11 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 118.535 2.791 . . . . 1.9 118.535 172.833 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -79.66 -9.07 59.58 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 126.009 2.068 . . . . 0.89 116.077 172.184 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.4 m120 70.8 65.82 0.18 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 130.1 3.36 . . . . 1.84 108.557 -177.521 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.5 mt -108.78 124.18 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 O-C-N 117.068 -3.52 . . . . 0.82 111.009 -178.145 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -107.42 -173.83 2.38 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.53 1.532 . . . . 2.16 115.032 -178.045 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -70.87 145.83 49.99 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 119.086 -2.259 . . . . 2.12 113.006 176.709 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.35 31.7 mt-10 78.4 15.05 1.33 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.297 2.639 . . . . 1.71 112.333 165.847 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.5 m -86.61 146.0 26.51 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.314 -2.221 . . . . 1.04 110.265 -169.42 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.7 m -93.79 110.41 22.06 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.547 1.976 . . . . 0.79 116.007 179.406 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -87.29 151.52 23.06 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.497 -2.002 . . . . 1.4 110.184 172.511 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.426 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 39.7 m80 -109.57 100.8 9.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.785 -1.822 . . . . 1.51 114.62 -179.562 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.4 HD23 HG22 ' A' ' 7' ' ' THR 0.259 36.0 tp -84.96 115.73 22.97 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.386 -2.071 . . . . 1.14 108.489 -173.122 . . . . . . . . 3 3 . 1 . 060 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 m -107.74 153.16 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 126.238 1.815 . . . . 1.23 110.792 174.817 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.1 mt -122.21 144.56 48.89 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.802 -2.436 . . . . 2.78 107.788 179.281 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.64 88.56 3.86 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 127.935 3.272 . . . . 3.75 109.068 179.747 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.6 mt -119.17 -91.27 0.56 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.999 1.32 . . . . 3.14 112.127 -177.915 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 -141.24 144.84 34.93 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.39 -1.444 . . . . 6.8 108.224 -178.674 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.17 -114.9 5.1 Favored Glycine 0 N--CA 1.429 -1.771 0 O-C-N 118.352 -2.718 . . . . 3.57 108.654 -169.828 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.754 0 CA-C-O 115.225 -2.986 . . . . 3.87 114.614 -168.994 . . . . . . . . 0 0 . 1 . 061 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 ptt? . . . . . 0 CA--C 1.491 -1.294 0 N-CA-C 115.138 1.533 . . . . 1.1 115.138 . . . . . . . . . 0 0 . 1 . 061 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -87.45 135.12 33.46 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 124.835 1.334 . . . . 1.87 110.435 179.439 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -126.66 138.39 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 105.894 -1.891 . . . . 0.72 105.894 175.073 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -104.19 77.03 1.38 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.791 -1.095 . . . . 1.4 108.91 -176.105 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 t -63.42 105.29 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 116.213 1.931 . . . . 0.58 116.213 168.95 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.257 35.7 tptt -90.46 139.8 30.33 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 124.151 1.929 . . . . 2.09 112.652 179.095 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.3 p -91.17 -179.39 5.42 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.556 -1.965 . . . . 0.99 108.513 179.544 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.4 tp -66.23 -50.88 62.28 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 123.218 1.485 . . . . 2.53 113.903 179.997 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 p -74.69 -22.07 59.06 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.113 1.523 . . . . 2.08 115.113 -172.577 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.05 -2.53 2.96 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 117.679 -2.201 . . . . 1.31 114.817 172.49 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -78.86 131.09 36.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.165 -2.962 . . . . 1.4 112.146 -175.18 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.271 85.8 m -98.83 118.1 34.82 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.147 -2.221 . . . . 0.78 108.97 175.452 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.1 mm -102.39 118.68 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 125.175 1.547 . . . . 1.55 110.201 179.698 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.2 m -81.02 98.33 7.91 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.447 -1.251 . . . . 1.08 110.549 174.862 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.3 tp -100.69 158.08 16.21 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.016 -2.303 . . . . 1.55 110.118 -176.394 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -121.55 118.74 30.03 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.284 -1.006 . . . . 1.95 108.284 174.956 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 m -135.58 176.67 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 107.619 -1.252 . . . . 0.96 107.619 -177.581 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -124.25 166.7 18.2 Favored Pre-proline 0 N--CA 1.429 -1.482 0 O-C-N 118.547 -2.596 . . . . 2.35 109.644 170.275 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.359 14.5 Cg_endo -75.68 -16.27 18.83 Favored 'Trans proline' 0 C--N 1.299 -2.075 0 O-C-N 114.7 -3.368 . . . . 0.95 114.502 -175.99 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.9 p -90.87 2.57 56.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.206 -2.184 . . . . 1.45 107.334 -178.804 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -80.51 142.59 34.04 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.923 -1.736 . . . . 1.69 113.544 179.433 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.6 p -85.71 164.71 17.47 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 117.029 2.233 . . . . 0.75 117.029 177.783 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.5 HD11 HD23 ' A' ' 56' ' ' LEU . 42.9 mm -76.48 -31.06 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 101.738 -3.43 . . . . 0.73 101.738 -172.979 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -49.76 -47.01 51.21 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 115.641 1.719 . . . . 1.62 115.641 167.298 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -76.72 -30.82 56.81 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 115.87 -2.014 . . . . 2.13 112.533 177.328 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.31 -29.7 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 121.592 1.996 . . . . 0.62 114.463 177.551 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -74.55 -35.39 63.08 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 117.607 -1.187 . . . . 1.22 109.213 171.232 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -36.93 83.99 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 123.389 2.813 . . . . 0.51 112.619 171.007 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.6 mttm -63.94 -47.38 80.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 126.842 2.589 . . . . 1.44 114.804 170.364 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.43 HG21 HD13 ' A' ' 30' ' ' ILE . 60.9 mt -61.48 -36.38 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 1 O-C-N 114.462 -5.149 . . . . 1.32 109.756 171.066 . . . . . . . . 3 3 . 1 . 061 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -57.52 -54.27 48.71 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 117.14 -3.475 . . . . 1.7 113.152 172.734 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -52.75 -44.64 66.61 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.767 -1.208 . . . . 1.55 111.98 171.92 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -65.18 -57.41 8.6 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 127.612 2.365 . . . . 2.62 110.464 -173.369 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -105.75 -47.64 3.84 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 118.128 -2.857 . . . . 1.48 115.705 -169.611 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.42 4.63 8.96 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 119.547 -1.971 . . . . 1.12 114.17 -176.445 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.9 mt -83.5 127.37 68.48 Favored Pre-proline 0 N--CA 1.43 -1.462 0 O-C-N 119.026 -2.455 . . . . 1.55 110.478 -176.108 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -73.35 146.57 40.27 Favored 'Trans proline' 0 C--N 1.3 -2.014 2 O-C-N 110.895 -5.371 . . . . 1.02 113.389 179.135 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.06 -5.69 16.4 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 C-N-CA 126.107 4.538 . . . . 1.25 116.672 -176.931 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.53 -37.61 84.38 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.815 2.245 . . . . 2.25 110.782 169.343 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -85.17 -31.9 22.99 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 115.937 -1.982 . . . . 2.02 115.022 -177.411 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.359 46.7 mt-30 -67.58 113.47 5.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.388 2.675 . . . . 0.69 117.698 -172.089 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -122.01 115.47 22.58 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.327 -2.733 . . . . 2.78 109.551 172.765 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.9 mt -96.53 143.11 27.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.51 -1.369 . . . . 1.17 110.256 179.427 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.2 mm -124.6 148.64 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 102.679 -3.082 . . . . 1.38 102.679 175.423 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.407 ' HB3' HD21 ' A' ' 50' ' ' LEU . 69.4 t80 -139.53 112.86 8.27 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 101.156 -3.646 . . . . 1.5 101.156 173.982 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.96 28.76 14.49 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 126.286 2.241 . . . . 1.21 114.119 172.662 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.91 -17.1 56.68 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 124.938 1.256 . . . . 1.3 114.31 -175.168 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.316 34.7 ttmt -87.63 122.51 31.41 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.766 -2.608 . . . . 2.55 115.756 178.417 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -64.46 138.12 58.24 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 118.193 2.664 . . . . 2.48 118.193 171.718 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.407 HD21 ' HB3' ' A' ' 45' ' ' PHE . 39.7 mt -95.9 113.2 24.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.951 -1.022 . . . . 0.9 111.126 -172.326 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -77.5 142.56 39.03 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.873 -1.158 . . . . 1.94 107.873 -178.973 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.472 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 7.0 m-20 -56.96 -65.47 0.61 Allowed 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 119.29 3.071 . . . . 1.56 119.29 -168.723 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.1 25.5 0.15 Allowed Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 119.38 2.512 . . . . 0.97 119.38 171.943 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -105.97 158.0 17.1 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 119.773 1.786 . . . . 2.49 109.926 164.821 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.7 p -84.91 169.1 14.41 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 112.735 -2.03 . . . . 0.76 111.602 170.708 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.5 HD23 HD11 ' A' ' 23' ' ' ILE . 94.0 mt -66.02 -37.16 85.18 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 127.384 2.274 . . . . 1.05 111.739 171.543 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.9 p -69.39 -10.4 57.79 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 129.23 3.012 . . . . 1.19 115.016 173.806 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.99 -48.21 31.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.876 1.67 . . . . 1.9 110.362 169.84 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -85.63 -1.11 56.8 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 130.476 3.51 . . . . 0.89 113.775 -177.924 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.0 m120 57.21 54.32 6.9 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.604 2.361 . . . . 1.84 116.646 179.517 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 88.9 mt -100.27 109.8 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 126.846 2.058 . . . . 0.82 108.797 -179.194 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -93.74 -178.62 4.74 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.052 2.358 . . . . 2.16 110.422 -178.902 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -58.28 140.18 53.77 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.108 -3.495 . . . . 2.12 119.885 175.735 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.327 12.7 mt-10 67.98 40.56 2.26 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 123.778 0.674 . . . . 1.71 110.557 174.913 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 p -96.22 155.43 16.76 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 126.667 1.987 . . . . 1.04 108.547 176.106 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.4 m -104.68 85.75 2.37 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.689 -2.337 . . . . 0.79 104.689 -177.079 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -63.6 159.78 18.15 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 114.539 -5.1 . . . . 1.4 113.884 169.01 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -118.2 129.86 55.75 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.39 2.043 . . . . 1.51 108.584 -178.96 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.6 tp -116.67 131.27 56.99 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 116.065 -4.147 . . . . 1.14 113.242 175.351 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 m -135.1 167.9 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 103.437 -2.801 . . . . 1.23 103.437 175.727 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 66.4 mt -121.83 155.27 35.72 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 126.446 3.022 . . . . 2.78 113.958 179.596 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -110.56 121.19 44.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 130.264 3.426 . . . . 3.75 112.862 -174.193 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.1 mt -128.24 -71.67 0.64 Allowed 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 124.984 1.428 . . . . 3.14 113.26 171.614 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 64.9 ttp85 -72.9 140.87 47.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 117.39 2.367 . . . . 6.8 117.39 173.927 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.56 81.85 1.54 Allowed Glycine 0 N--CA 1.43 -1.702 1 O-C-N 115.975 -4.203 . . . . 3.57 114.573 -171.001 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.755 0 CA-C-O 114.911 -3.16 . . . . 3.87 113.794 -172.658 . . . . . . . . 0 0 . 1 . 062 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 ttp . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 117.484 2.401 . . . . 1.1 117.484 . . . . . . . . . 0 0 . 1 . 062 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -100.03 124.01 44.91 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 124.53 1.144 . . . . 1.87 110.852 -176.337 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 17' ' ' VAL . 3.1 pt -129.11 157.89 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 105.571 -2.011 . . . . 0.72 105.571 172.003 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -108.79 134.67 51.17 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.023 1.729 . . . . 1.4 112.117 -174.854 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.491 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 42.1 t -111.85 115.01 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 122.15 0.976 . . . . 0.58 108.852 173.612 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -96.57 149.94 21.2 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.948 -2.345 . . . . 2.09 107.544 176.979 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.6 p -109.78 -149.21 0.44 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 116.275 -1.821 . . . . 0.99 107.462 176.464 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.2 tp -91.77 -58.12 2.52 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-N 122.809 2.55 . . . . 2.53 110.92 167.121 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.4 p -127.19 133.83 50.23 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 113.755 -3.022 . . . . 2.08 117.946 178.877 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.21 -116.97 2.71 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 103.307 -3.917 . . . . 1.31 103.307 173.983 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -119.67 164.62 15.62 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 121.831 -0.805 . . . . 1.4 108.87 -170.17 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.5 m -88.65 120.26 29.88 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 125.853 1.97 . . . . 0.78 109.652 168.958 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 15.6 mt -79.9 122.62 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-N 122.122 2.237 . . . . 1.55 114.983 -179.627 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.8 m -78.83 100.95 7.39 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.767 -1.833 . . . . 1.08 109.973 176.882 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tp -102.8 119.52 38.98 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 113.709 1.003 . . . . 1.55 113.709 -178.302 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -91.71 126.3 36.74 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.396 2.522 . . . . 1.95 112.983 168.574 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.401 HG21 HD13 ' A' ' 3' ' ' ILE . 19.7 m -142.89 171.46 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 1 C-N-CA 131.737 4.015 . . . . 0.96 110.868 -174.331 . . . . . . . . 3 3 . 1 . 062 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 41.5 mt-10 -114.24 169.14 6.9 Favored Pre-proline 0 N--CA 1.43 -1.462 0 C-N-CA 129.163 2.985 . . . . 2.35 106.737 166.428 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 82.1 Cg_exo -73.16 -18.11 24.01 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 N-CA-C 120.11 3.081 . . . . 0.95 120.11 -177.1 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.4 m -84.69 10.15 12.02 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 112.036 -2.347 . . . . 1.45 116.171 174.574 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.69 130.49 35.08 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 116.688 -3.757 . . . . 1.69 106.007 177.464 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 23.9 p -71.05 163.59 27.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.712 2.196 . . . . 0.75 108.493 171.18 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.5 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 49.1 mm -66.41 -34.07 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 113.625 -3.083 . . . . 0.73 105.381 175.951 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -61.65 -40.02 93.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 122.883 2.583 . . . . 1.62 116.207 171.731 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -69.59 -41.02 76.32 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 125.144 1.528 . . . . 2.13 112.476 177.653 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.5 t -49.85 -50.12 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 120.858 -1.151 . . . . 0.62 113.569 169.872 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -58.77 -37.32 76.02 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.152 -1.592 . . . . 1.22 113.735 170.319 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.59 -37.84 85.75 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.648 -2.533 . . . . 0.51 108.908 178.945 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -69.32 -38.29 78.14 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 129.087 2.955 . . . . 1.44 112.813 179.303 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.8 mt -69.1 -28.66 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 117.431 -3.293 . . . . 1.32 110.959 170.99 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -66.31 -47.19 74.36 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.519 1.528 . . . . 1.7 110.761 172.235 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -64.3 -28.81 69.97 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 114.519 1.303 . . . . 1.55 114.519 173.058 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -87.89 -46.89 9.01 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.087 -2.258 . . . . 2.62 115.12 -173.839 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -113.58 -29.35 7.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.056 1.742 . . . . 1.48 115.262 -175.486 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.19 4.03 38.42 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 119.305 -2.122 . . . . 1.12 118.165 175.074 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.9 mt -85.06 132.48 45.46 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 119.262 1.531 . . . . 1.55 110.771 -173.934 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -61.32 144.04 98.31 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 C-N-CA 123.464 2.776 . . . . 1.02 116.72 -179.721 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -59.43 -32.52 96.59 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 123.379 2.719 . . . . 1.25 114.141 -178.627 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -63.24 -18.11 63.19 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.928 2.936 . . . . 2.25 118.928 171.59 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -91.89 -23.19 19.71 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 116.295 -1.812 . . . . 2.02 107.1 -177.162 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -89.49 141.09 28.89 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 117.406 2.373 . . . . 0.69 117.406 -172.932 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -123.23 137.72 54.81 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.486 -2.008 . . . . 2.78 110.143 163.496 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.2 mt -112.25 140.0 47.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.882 -1.896 . . . . 1.17 105.882 179.742 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.7 mm -120.92 127.58 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 130.108 3.363 . . . . 1.38 108.668 177.985 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -139.27 126.02 20.77 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 104.721 -2.325 . . . . 1.5 104.721 172.16 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.97 41.27 10.65 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 121.037 3.717 . . . . 1.21 121.037 173.921 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.1 -17.59 58.43 Favored Glycine 0 N--CA 1.43 -1.71 0 O-C-N 117.659 -3.151 . . . . 1.3 113.267 -178.772 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -108.81 135.5 49.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.477 -2.778 . . . . 2.55 115.279 -178.866 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -87.6 127.06 35.27 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.114 0.959 . . . . 2.48 109.248 170.805 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.0 mt -89.41 144.99 25.63 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 126.576 3.084 . . . . 0.9 112.325 -163.638 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -95.09 125.16 39.56 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.428 -3.295 . . . . 1.94 114.806 -179.781 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.5 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 5.9 m-20 -48.05 -49.86 29.96 Favored 'General case' 0 N--CA 1.429 -1.491 1 C-N-CA 132.406 4.282 . . . . 1.56 119.766 -169.006 . . . . . . . . 3 3 . 1 . 062 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.42 46.2 3.18 Favored Glycine 0 N--CA 1.431 -1.673 0 CA-C-O 114.538 -3.368 . . . . 0.97 119.174 168.354 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -125.32 152.72 44.33 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.593 -2.743 . . . . 2.49 103.593 165.659 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 55.8 p -94.84 159.75 14.9 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.547 3.654 . . . . 0.76 116.039 176.857 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.6 mt -55.21 -40.49 70.84 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 115.682 1.734 . . . . 1.05 115.682 175.483 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 p -73.43 -9.28 58.53 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.181 -3.449 . . . . 1.19 118.41 179.506 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -93.21 -31.9 14.57 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 114.648 -2.596 . . . . 1.9 107.354 174.585 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -80.0 -5.51 55.87 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 125.892 1.995 . . . . 0.89 106.937 177.049 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 56.18 71.74 0.54 Allowed 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 115.053 -4.78 . . . . 1.84 111.813 -175.38 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.1 mt -115.87 111.9 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 105.001 -2.222 . . . . 0.82 105.001 178.619 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -95.34 -175.08 3.38 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.431 3.015 . . . . 2.16 109.621 -174.232 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -57.73 140.23 51.94 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 111.471 -2.604 . . . . 2.12 112.116 177.162 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.338 51.0 mt-10 69.38 20.85 7.17 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 125.214 1.406 . . . . 1.71 113.309 174.486 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.2 m -85.4 147.72 26.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 121.617 -0.677 . . . . 1.04 112.032 -172.459 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.2 m -104.5 111.07 23.6 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.052 -1.655 . . . . 0.79 112.921 -175.509 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -93.8 147.4 23.09 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.45 -1.406 . . . . 1.4 110.9 174.456 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -113.96 128.1 56.25 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.102 -2.874 . . . . 1.51 110.404 -177.367 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.0 tp -102.49 124.48 48.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 124.834 1.334 . . . . 1.14 112.995 -172.059 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.255 6.2 m -138.3 133.37 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.606 2.763 . . . . 1.23 107.662 -175.408 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.4 mt -98.03 159.07 15.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.144 2.402 . . . . 2.78 117.412 -175.995 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -67.76 122.37 17.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 111.962 -2.381 . . . . 3.75 114.976 -175.381 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 tp -141.95 -46.7 0.35 Allowed 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.615 -3.178 . . . . 3.14 113.299 -179.916 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.7 mtt85 -63.53 -69.34 0.28 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 116.172 -2.211 . . . . 6.8 115.503 173.711 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.66 -79.19 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 106.609 -2.596 . . . . 3.57 106.609 -164.906 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.728 0 N-CA-C 105.5 -3.04 . . . . 3.87 105.5 -172.059 . . . . . . . . 0 0 . 1 . 063 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ttp . . . . . 0 CA--C 1.49 -1.347 0 CA-C-O 116.447 -1.74 . . . . 1.1 107.145 . . . . . . . . . 0 0 . 1 . 063 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -116.55 128.91 55.85 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 124.665 1.228 . . . . 1.87 112.323 171.869 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.6 pt -121.06 173.55 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 119.116 -2.24 . . . . 0.72 107.648 169.521 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -128.3 150.93 49.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.98 -2.23 . . . . 1.4 104.98 -179.328 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.6 t -138.8 112.64 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 126.515 3.055 . . . . 0.58 112.627 174.469 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -89.51 153.25 20.95 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 111.072 -2.786 . . . . 2.09 115.509 -176.831 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 t -127.68 -160.55 1.02 Allowed 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 124.483 2.087 . . . . 0.99 107.853 170.864 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.8 mt -81.19 -85.53 0.1 Allowed 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 114.563 -5.086 . . . . 2.53 113.74 175.383 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.1 p -80.71 -41.34 23.8 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 128.764 2.826 . . . . 2.08 117.287 179.239 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.36 -168.31 11.16 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 118.696 -2.503 . . . . 1.31 118.622 176.181 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -60.34 151.31 28.1 Favored 'General case' 0 N--CA 1.43 -1.461 1 C-N-CA 131.735 4.014 . . . . 1.4 114.068 -172.808 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.8 m -98.18 117.23 32.09 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.453 -2.655 . . . . 0.78 104.216 163.659 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 pt -99.86 153.91 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 116.76 -3.713 . . . . 1.55 108.168 179.991 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.7 m -107.55 126.32 52.39 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 104.404 -2.443 . . . . 1.08 104.404 175.852 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.2 mt -117.38 129.04 55.61 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 123.388 1.566 . . . . 1.55 110.519 -179.263 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -96.73 125.99 41.57 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 116.641 -3.787 . . . . 1.95 104.343 174.305 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.25 27.4 m -136.8 170.42 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 129.264 3.025 . . . . 0.96 111.191 -170.871 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -109.7 156.0 40.47 Favored Pre-proline 0 N--CA 1.43 -1.442 0 CA-C-N 124.384 3.266 . . . . 2.35 107.324 166.728 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.86 -16.52 29.46 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 124.991 3.794 . . . . 0.95 114.787 -168.197 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.3 m -107.34 17.5 22.75 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 120.219 1.372 . . . . 1.45 110.21 177.574 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -73.75 151.09 40.74 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.306 -3.371 . . . . 1.69 113.164 171.053 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -91.53 160.07 15.6 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.913 1.816 . . . . 0.75 113.31 -178.525 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.315 26.0 mm -56.51 -37.9 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 116.381 1.993 . . . . 0.73 116.381 176.069 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -52.54 -43.39 65.13 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.844 2.165 . . . . 1.62 116.844 170.206 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -76.93 -42.4 39.51 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.229 -2.794 . . . . 2.13 108.346 -177.949 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.0 t -57.06 -45.62 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 118.177 2.658 . . . . 0.62 118.177 169.619 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -56.25 -40.71 74.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.021 1.328 . . . . 1.22 112.988 170.116 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.55 -33.55 75.27 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.779 2.432 . . . . 0.51 113.346 175.501 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -67.93 -40.19 83.37 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.474 2.709 . . . . 1.44 106.926 170.369 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.5 mt -62.31 -40.89 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 123.448 2.84 . . . . 1.32 113.117 173.092 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -55.64 -48.88 74.23 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.842 2.457 . . . . 1.7 114.503 170.503 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -58.03 -46.55 85.15 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.61 2.078 . . . . 1.55 116.61 170.853 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -76.71 -58.87 3.03 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 117.889 -3.007 . . . . 2.62 114.611 -177.353 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -88.51 -47.15 8.53 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.257 -1.527 . . . . 1.48 110.531 -170.294 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.85 34.84 1.95 Allowed Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 124.006 1.892 . . . . 1.12 113.72 177.367 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 mt -108.75 128.55 25.33 Favored Pre-proline 0 N--CA 1.431 -1.418 0 O-C-N 120.512 -1.581 . . . . 1.55 111.027 -176.935 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -63.36 141.13 80.2 Favored 'Trans proline' 0 N--CA 1.434 -1.98 0 CA-C-N 125.305 2.93 . . . . 1.02 114.111 173.694 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -75.07 -1.8 11.72 Favored 'Trans proline' 0 C--N 1.3 -1.994 1 C-N-CA 127.188 5.259 . . . . 1.25 113.904 -174.868 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -76.13 -34.2 59.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.905 2.482 . . . . 2.25 109.076 171.381 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -82.01 -25.97 34.25 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.056 2.36 . . . . 2.02 110.108 -175.591 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -82.22 125.02 30.44 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.766 2.698 . . . . 0.69 111.038 -171.746 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -114.99 98.07 6.6 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 109.335 -3.575 . . . . 2.78 109.694 167.837 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.3 mt -79.28 125.47 29.53 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 119.244 -2.16 . . . . 1.17 113.114 176.024 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.9 mm -112.92 123.33 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 O-C-N 119.469 -2.019 . . . . 1.38 106.04 176.18 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.439 ' HB2' HD23 ' A' ' 67' ' ' LEU . 10.9 t80 -91.03 -73.76 0.52 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 117.56 -1.656 . . . . 1.5 111.88 168.911 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.72 -69.32 0.65 Allowed 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 128.147 2.579 . . . . 1.21 114.035 179.895 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.47 17.48 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.72 1 O-C-N 112.9 -6.125 . . . . 1.3 115.914 -177.006 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -141.85 162.9 34.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 112.509 -1.845 . . . . 2.55 107.694 178.418 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -64.31 168.34 5.74 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 118.175 2.657 . . . . 2.48 118.175 168.146 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.458 HD22 ' CD2' ' A' ' 59' ' ' TYR . 91.4 mt -123.22 128.18 49.66 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.188 -2.195 . . . . 0.9 107.252 -172.622 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -90.06 152.86 20.96 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.796 1.776 . . . . 1.94 115.796 179.565 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.93 -37.82 79.13 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 129.731 3.212 . . . . 1.56 115.379 -165.375 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.88 43.84 1.8 Allowed Glycine 0 N--CA 1.43 -1.721 1 CA-C-O 113.096 -4.169 . . . . 0.97 109.616 169.913 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -122.12 162.0 22.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.524 3.162 . . . . 2.49 104.758 166.088 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.256 20.7 p -95.79 168.41 10.67 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 113.34 -1.755 . . . . 0.76 113.824 -177.551 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -56.96 -46.98 81.76 Favored 'General case' 0 N--CA 1.43 -1.468 1 C-N-CA 132.298 4.239 . . . . 1.05 115.768 168.666 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 t -60.94 -37.85 83.8 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 117.221 2.304 . . . . 1.19 117.221 173.73 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.276 11.7 t0 -46.19 -60.65 2.17 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 129.624 3.169 . . . . 1.9 111.869 178.171 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.458 ' CD2' HD22 ' A' ' 50' ' ' LEU . 60.6 m-85 -79.68 -1.66 39.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 112.57 -2.105 . . . . 0.89 116.397 -175.368 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.357 33.1 m120 73.89 52.22 0.11 Allowed 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 127.857 2.463 . . . . 1.84 114.176 -178.825 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.1 mt -96.31 117.44 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 103.901 -2.629 . . . . 0.82 103.901 -177.944 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -113.45 178.51 4.25 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 125.058 2.361 . . . . 2.16 111.578 -173.395 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -64.87 129.1 38.48 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 114.918 -4.864 . . . . 2.12 110.844 172.714 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.313 18.1 mt-10 80.03 36.18 0.13 Allowed 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 123.509 1.623 . . . . 1.71 114.558 178.108 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -107.18 125.18 50.78 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.203 2.201 . . . . 1.04 114.808 -176.205 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.9 m -97.32 117.69 32.11 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 121.323 -0.861 . . . . 0.79 111.029 -177.867 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.439 HD23 ' HB2' ' A' ' 45' ' ' PHE . 2.9 mp -101.88 164.7 11.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.479 1.133 . . . . 1.4 109.536 179.361 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -119.69 113.13 20.19 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 116.992 -1.48 . . . . 1.51 111.856 -176.496 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -80.55 131.97 35.6 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 124.654 1.221 . . . . 1.14 108.328 176.197 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.5 t -113.0 129.36 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 105.572 -2.01 . . . . 1.23 105.572 166.274 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.7 tp -97.68 107.19 19.64 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.555 -0.906 . . . . 2.78 108.555 179.644 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.53 -166.22 1.26 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.966 1.841 . . . . 3.75 108.953 179.104 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.9 mt -122.74 166.34 15.1 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 103.545 -2.761 . . . . 3.14 103.545 169.808 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -76.48 109.42 10.19 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.293 -1.504 . . . . 6.8 111.577 178.774 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.14 89.98 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.759 0 CA-C-O 125.031 2.462 . . . . 3.57 117.525 -170.496 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.717 0 CA-C-O 114.32 -3.489 . . . . 3.87 109.929 179.885 . . . . . . . . 0 0 . 1 . 064 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ptt? . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 115.963 1.838 . . . . 1.1 115.963 . . . . . . . . . 0 0 . 1 . 064 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -102.91 127.71 50.01 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 114.923 -2.465 . . . . 1.87 112.592 -175.968 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.4 pt -124.54 176.53 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 123.104 2.683 . . . . 0.72 109.303 176.246 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -120.51 152.72 37.66 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.496 -2.627 . . . . 1.4 111.078 172.992 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.9 t -135.67 124.39 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 105.627 -1.99 . . . . 0.58 105.627 173.72 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -106.69 133.4 51.41 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 114.203 1.186 . . . . 2.09 114.203 175.67 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -95.99 165.39 12.29 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.669 1.588 . . . . 0.99 111.559 -179.588 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.258 43.2 mt -72.28 -28.58 63.19 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 118.037 2.606 . . . . 2.53 118.037 175.939 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 p -76.71 -26.98 55.27 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 126.805 2.042 . . . . 2.08 109.095 -179.362 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.6 46.46 0.48 Allowed Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 129.61 3.481 . . . . 1.31 114.951 167.07 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -109.82 133.83 52.72 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.707 3.203 . . . . 1.4 106.448 177.091 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 m -117.02 106.97 13.97 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 124.192 0.933 . . . . 0.78 109.34 167.521 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mt -85.49 136.95 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.358 1.863 . . . . 1.55 113.919 179.042 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.9 m -95.72 117.37 30.38 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 114.921 -2.466 . . . . 1.08 105.56 176.581 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.3 mt -129.08 137.83 51.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 124.651 3.387 . . . . 1.55 111.175 178.512 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -99.48 128.8 45.62 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 126.739 3.161 . . . . 1.95 110.082 172.379 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.69 172.76 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 101.922 -3.362 . . . . 0.96 101.922 -174.426 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -117.9 155.92 50.53 Favored Pre-proline 0 N--CA 1.43 -1.451 0 N-CA-C 104.276 -2.49 . . . . 2.35 104.276 163.392 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -73.73 -7.22 19.84 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 N-CA-C 115.702 1.385 . . . . 0.95 115.702 -170.414 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.1 p -97.57 -0.75 45.27 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 126.199 1.799 . . . . 1.45 109.188 178.179 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -76.89 148.88 36.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.482 -2.636 . . . . 1.69 108.287 173.785 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 72.5 p -85.91 165.13 17.02 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.938 2.495 . . . . 0.75 116.722 176.092 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.9 mm -70.27 -28.74 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 117.435 -3.291 . . . . 0.73 114.776 -178.146 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.25 75.3 tt0 -56.7 -46.56 81.15 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.015 1.388 . . . . 1.62 114.622 167.925 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -67.27 -37.32 83.27 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.362 -2.711 . . . . 2.13 110.798 179.688 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -66.72 -46.66 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 119.77 -1.831 . . . . 0.62 109.109 178.161 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -60.52 -39.22 87.03 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.903 -1.044 . . . . 1.22 112.446 174.724 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.46 -15.16 62.36 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 116.972 2.212 . . . . 0.51 116.972 175.532 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 29' ' ' LYS . 20.2 ttmm -85.3 -33.75 22.04 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.152 1.781 . . . . 1.44 114.316 177.735 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.3 mt -66.99 -47.43 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 1 C-N-CA 131.702 4.001 . . . . 1.32 106.718 166.634 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -47.8 -55.58 9.36 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 121.266 3.802 . . . . 1.7 121.266 173.534 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -34.21 -59.85 0.42 Allowed 'General case' 0 N--CA 1.431 -1.41 1 C-N-CA 131.777 4.031 . . . . 1.55 112.928 164.605 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -66.39 -57.61 7.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 118.488 2.773 . . . . 2.62 118.488 179.817 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -82.81 -45.64 14.07 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 130.411 3.484 . . . . 1.48 110.874 -171.093 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.18 47.27 1.74 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 107.6 -2.2 . . . . 1.12 107.6 174.178 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.7 mt -120.33 129.15 25.47 Favored Pre-proline 0 N--CA 1.431 -1.413 0 C-N-CA 127.504 2.322 . . . . 1.55 107.825 -169.143 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -72.65 145.69 42.1 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 114.007 -3.733 . . . . 1.02 112.375 175.691 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -65.18 -13.88 42.17 Favored 'Trans proline' 0 N--CA 1.433 -2.062 0 CA-C-N 126.668 3.417 . . . . 1.25 118.463 -177.392 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -56.24 -44.39 79.59 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 124.818 2.246 . . . . 2.25 114.227 175.088 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -90.27 -6.36 55.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 110.535 -3.03 . . . . 2.02 114.09 -177.678 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.415 ' HA ' HD23 ' A' ' 71' ' ' LEU . 66.5 mt-30 -103.77 139.63 38.73 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.353 -2.462 . . . . 0.69 104.353 -177.501 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -130.88 145.48 52.02 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.141 1.924 . . . . 2.78 108.711 167.962 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 mt -107.47 130.34 54.85 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.727 -1.583 . . . . 1.17 106.727 178.931 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 7.1 mm -112.28 140.14 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 105.293 -2.114 . . . . 1.38 105.293 177.925 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -155.07 126.99 7.58 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 125.07 2.367 . . . . 1.5 108.512 175.275 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.358 . . 61.86 34.05 17.27 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 127.747 3.641 . . . . 1.21 118.722 -175.885 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.31 -18.1 11.48 Favored Glycine 0 N--CA 1.429 -1.804 0 O-C-N 118.442 -2.661 . . . . 1.3 114.375 -178.495 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.263 30.0 mtmt -95.77 148.7 22.31 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.607 -3.29 . . . . 2.55 110.278 -177.393 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -88.09 122.1 31.27 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.26 2.225 . . . . 2.48 107.791 172.67 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.2 mt -74.04 162.07 29.4 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 110.06 -3.245 . . . . 0.9 112.433 -176.803 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -109.12 159.18 17.09 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.511 -3.243 . . . . 1.94 106.386 172.869 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.56 -58.56 3.22 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.829 2.852 . . . . 1.56 116.246 -169.93 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.94 43.13 2.59 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 127.356 2.407 . . . . 0.97 113.74 172.999 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -120.87 148.3 44.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.535 -3.332 . . . . 2.49 103.991 164.135 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.9 p -76.69 163.44 26.83 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 118.204 2.668 . . . . 0.76 118.204 170.609 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mt -55.55 -44.53 76.87 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.983 2.913 . . . . 1.05 109.9 170.461 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 p -59.44 -32.11 69.91 Favored 'General case' 0 N--CA 1.431 -1.412 1 O-C-N 129.813 4.446 . . . . 1.19 116.563 174.675 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -69.08 -34.8 75.71 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.609 1.671 . . . . 1.9 112.63 172.62 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -82.97 0.1 46.18 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.898 -3.626 . . . . 0.89 117.684 177.709 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.4 t30 48.96 43.7 22.0 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 131.661 3.984 . . . . 1.84 115.104 -176.535 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.2 mt -82.33 130.46 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 112.845 -1.98 . . . . 0.82 111.959 179.91 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -127.14 178.47 6.0 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 120.089 -1.632 . . . . 2.16 109.798 -173.446 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -57.56 154.72 10.8 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 115.412 1.634 . . . . 2.12 115.412 -178.281 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 61.33 11.02 3.39 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 126.277 1.831 . . . . 1.71 112.461 171.456 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.0 t -89.51 131.07 35.72 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 104.962 -2.236 . . . . 1.04 104.962 -174.069 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.0 m -96.32 114.14 25.79 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 102.761 -3.051 . . . . 0.79 102.761 -174.413 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mt -90.96 161.93 14.95 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.21 -2.806 . . . . 1.4 111.673 167.648 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.419 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 80.6 m80 -112.58 127.03 55.97 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 117.564 -1.208 . . . . 1.51 113.3 -177.54 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.4 tp -93.79 134.63 35.93 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 124.639 1.175 . . . . 1.14 110.635 176.805 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.0 m -129.92 156.47 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 103.823 -2.658 . . . . 1.23 103.823 174.503 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 41' ' ' GLN . 86.1 mt -125.56 125.97 44.06 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 125.059 2.361 . . . . 2.78 113.108 -179.755 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -80.09 -176.73 5.69 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.742 -4.349 . . . . 3.75 112.954 -175.578 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.1 mt -103.26 169.56 8.47 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.116 -3.49 . . . . 3.14 111.942 162.49 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.2 mtt180 -70.3 107.0 3.55 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 124.481 1.113 . . . . 6.8 113.065 168.167 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.91 6.4 54.21 Favored Glycine 0 N--CA 1.43 -1.71 0 CA-C-O 122.58 1.1 . . . . 3.57 112.564 -168.473 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.791 0 CA-C-O 117.267 -1.852 . . . . 3.87 113.171 177.243 . . . . . . . . 0 0 . 1 . 065 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ptt? . . . . . 0 CA--C 1.49 -1.347 0 CA-C-O 123.032 1.396 . . . . 1.1 114.107 . . . . . . . . . 0 0 . 1 . 065 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -94.27 133.52 37.72 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 115.876 1.806 . . . . 1.87 115.876 -174.303 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.9 pt -127.44 153.78 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 120.727 -1.233 . . . . 0.72 109.627 173.993 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.304 58.2 m-85 -112.74 119.1 36.91 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 125.237 1.586 . . . . 1.4 113.099 -179.858 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.442 HG21 HD11 ' A' ' 30' ' ' ILE . 15.5 t -105.53 120.03 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 116.043 -2.263 . . . . 0.58 113.536 177.094 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -88.36 116.99 26.97 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.872 -2.392 . . . . 2.09 114.477 178.318 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.295 19.9 p -72.84 168.2 19.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.001 1.72 . . . . 0.99 112.988 178.774 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.417 HD21 HG12 ' A' ' 70' ' ' VAL 0.291 19.0 mt -66.15 -45.64 80.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.416 1.462 . . . . 2.53 113.862 173.981 . . . . . . . . 3 3 . 1 . 065 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -65.14 -67.24 0.45 Allowed 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 117.379 2.362 . . . . 2.08 117.379 176.555 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.75 22.57 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 117.967 -2.063 . . . . 1.31 115.502 177.893 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -106.37 130.48 54.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.44 -1.319 . . . . 1.4 107.44 -176.831 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.9 m -99.34 107.69 20.02 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 105.722 -1.955 . . . . 0.78 105.722 172.165 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.1 mt -78.57 119.27 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 118.948 -2.345 . . . . 1.55 110.661 -179.967 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.6 m -83.1 117.98 23.24 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.394 -1.442 . . . . 1.08 108.736 174.163 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.2 mt -111.79 164.15 13.38 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 118.841 0.746 . . . . 1.55 111.58 179.136 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.75 129.54 56.38 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.351 1.06 . . . . 1.95 109.05 167.539 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.09 161.53 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 104.307 -2.479 . . . . 0.96 104.307 178.046 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -106.71 137.43 19.47 Favored Pre-proline 0 N--CA 1.43 -1.437 0 C-N-CA 128.172 2.589 . . . . 2.35 108.647 163.162 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -68.0 -8.42 22.6 Favored 'Trans proline' 0 N--CA 1.433 -2.04 0 C-N-CA 122.672 2.248 . . . . 0.95 114.586 -174.023 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.6 p -101.35 10.59 40.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.458 2.39 . . . . 1.45 111.697 175.676 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -91.35 165.06 13.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.503 1.62 . . . . 1.69 108.692 -176.7 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -90.4 161.2 15.68 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.777 -4.327 . . . . 0.75 110.093 -178.56 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.3 mt -72.22 -34.29 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.438 -2.663 . . . . 0.73 115.703 -177.156 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -52.47 -45.14 65.97 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.418 2.377 . . . . 1.62 117.418 157.14 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -58.29 -38.73 77.62 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 116.364 -3.96 . . . . 2.13 110.919 175.093 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.74 -49.2 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 122.828 1.299 . . . . 0.62 112.217 170.75 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -55.81 -39.58 71.53 Favored 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 115.786 -4.321 . . . . 1.22 114.658 175.945 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.258 . . -55.86 -31.23 62.59 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.334 2.654 . . . . 0.51 113.2 168.562 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 30.1 mmmt -65.69 -36.25 83.08 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 116.51 -3.868 . . . . 1.44 114.797 173.839 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.442 HD11 HG21 ' A' ' 5' ' ' VAL . 19.0 mt -66.47 -34.41 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 114.932 1.456 . . . . 1.32 114.932 170.266 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -59.86 -38.94 83.58 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 130.106 3.362 . . . . 1.7 109.255 178.148 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -50.42 -46.64 56.56 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 119.452 3.13 . . . . 1.55 119.452 163.837 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -80.54 -45.65 17.08 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 124.884 1.274 . . . . 2.62 111.747 -177.728 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -100.89 -44.29 5.81 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.738 -1.208 . . . . 1.48 107.738 -166.923 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.37 16.99 47.91 Favored Glycine 0 N--CA 1.43 -1.707 0 O-C-N 118.296 -2.752 . . . . 1.12 114.725 177.742 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.1 mt -98.26 127.46 36.4 Favored Pre-proline 0 N--CA 1.43 -1.461 1 C-N-CA 132.235 4.214 . . . . 1.55 104.114 174.583 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.91 151.57 81.97 Favored 'Trans proline' 0 N--CA 1.432 -2.093 1 O-C-N 112.363 -4.599 . . . . 1.02 114.289 -177.928 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.2 -19.29 20.11 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 CA-C-N 124.288 2.567 . . . . 1.25 112.28 -169.633 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -57.84 -30.27 65.63 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 120.615 1.552 . . . . 2.25 114.103 168.033 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.272 32.3 tt0 -77.17 -33.36 56.48 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 118.044 -2.91 . . . . 2.02 112.809 178.799 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -80.57 148.18 30.46 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 117.391 2.367 . . . . 0.69 117.391 -172.97 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -146.64 139.41 25.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.662 -1.607 . . . . 2.78 106.662 173.736 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.1 mt -105.06 145.15 30.89 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.067 -3.521 . . . . 1.17 109.694 -178.634 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.5 mm -119.76 140.67 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 105.456 -2.053 . . . . 1.38 105.456 -178.322 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -147.57 135.04 20.79 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.985 -1.697 . . . . 1.5 110.401 170.919 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.87 8.46 0.16 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 130.213 3.405 . . . . 1.21 116.532 -177.158 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.36 -25.79 9.01 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 129.684 3.516 . . . . 1.3 113.738 -174.498 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -79.61 146.52 32.5 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 121.202 2.501 . . . . 2.55 111.147 179.01 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -89.47 123.46 33.61 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 101.259 -3.608 . . . . 2.48 101.259 172.648 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.7 mt -85.42 145.41 27.46 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 105.709 -1.96 . . . . 0.9 105.709 -172.208 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -79.56 154.88 28.46 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 115.886 1.81 . . . . 1.94 115.886 173.8 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -82.74 -47.36 12.05 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.43 -3.294 . . . . 1.56 117.595 -171.359 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.21 57.34 1.73 Allowed Glycine 0 N--CA 1.43 -1.737 1 O-C-N 116.286 -4.009 . . . . 0.97 111.447 178.432 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.0 ttt85 -138.08 164.37 29.27 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.815 -1.92 . . . . 2.49 105.815 171.822 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.7 p -101.76 153.84 19.44 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 116.495 2.035 . . . . 0.76 116.495 175.366 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.8 mt -53.0 -47.34 68.35 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 126.293 2.949 . . . . 1.05 113.996 177.948 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.4 p -60.86 -24.65 66.07 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.061 -4.15 . . . . 1.19 120.384 174.38 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.28 -30.18 70.55 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 123.147 2.703 . . . . 1.9 114.798 172.946 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -86.87 -12.79 46.76 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.733 2.813 . . . . 0.89 114.646 177.611 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 m120 66.47 45.03 2.21 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.472 -1.695 . . . . 1.84 114.582 -174.311 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.9 mt -98.32 106.71 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 128.327 3.917 . . . . 0.82 110.298 179.01 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -89.45 171.8 9.46 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 110.718 -2.947 . . . . 2.16 116.321 -170.933 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -52.53 137.7 29.55 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.536 1.935 . . . . 2.12 112.403 170.168 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.275 37.0 mt-10 56.4 41.56 28.76 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 119.926 3.306 . . . . 1.71 119.926 178.65 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.8 m -98.62 156.45 16.81 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.184 2.193 . . . . 1.04 110.166 -179.592 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.4 m -106.95 106.48 17.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.914 2.769 . . . . 0.79 111.746 -175.329 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -94.82 164.36 12.96 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.351 2.024 . . . . 1.4 109.298 176.343 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -137.5 122.08 18.5 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 126.235 2.921 . . . . 1.51 107.6 -179.386 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.5 tp -87.92 133.8 33.85 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 111.455 -2.611 . . . . 1.14 117.067 178.185 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.417 HG12 HD21 ' A' ' 8' ' ' LEU . 28.6 m -130.02 173.23 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.184 -2.822 . . . . 1.23 106.008 173.487 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.7 mt -134.05 153.79 51.57 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.422 -2.673 . . . . 2.78 108.846 -173.954 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -61.91 113.52 2.84 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 121.693 0.758 . . . . 3.75 112.611 179.027 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.7 mt -91.18 164.68 13.82 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 127.366 3.46 . . . . 3.14 107.688 167.314 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 52.3 mtt85 -91.44 167.5 12.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.91 -2.404 . . . . 6.8 108.881 172.803 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.35 28.63 7.95 Favored Glycine 0 N--CA 1.43 -1.723 0 O-C-N 118.193 -2.817 . . . . 3.57 114.606 -166.633 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.804 1 C-N-CA 133.546 5.355 . . . . 3.87 109.619 175.962 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 CA--C 1.49 -1.361 0 N-CA-C 120.207 3.41 . . . . 1.1 120.207 . . . . . . . . . 0 0 . 1 . 066 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -96.62 140.17 31.62 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 105.82 -1.919 . . . . 1.87 105.82 179.862 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.7 pt -136.43 165.16 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 129.928 3.291 . . . . 0.72 108.868 167.877 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -118.95 132.75 56.09 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.28 -2.138 . . . . 1.4 115.476 -175.812 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.7 t -118.29 121.64 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 1 O-C-N 116.056 -4.152 . . . . 0.58 112.825 176.634 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -91.15 128.11 36.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 118.456 2.762 . . . . 2.09 118.456 178.455 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.491 HG22 HD23 ' A' ' 69' ' ' LEU . 39.4 p -79.53 -177.83 6.01 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.069 2.366 . . . . 0.99 113.232 -177.293 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.3 mt -68.04 -43.6 78.34 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 113.939 -1.482 . . . . 2.53 113.203 166.506 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.6 p -73.89 -21.0 60.24 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 123.005 1.383 . . . . 2.08 108.919 -175.861 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.38 23.68 4.38 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 116.539 -3.851 . . . . 1.31 113.281 171.047 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -82.87 136.25 34.67 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 112.664 -3.541 . . . . 1.4 113.059 -176.932 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.4 m -95.69 118.86 33.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 123.916 3.053 . . . . 0.78 109.343 170.588 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.1 mt -90.74 123.58 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 130.509 3.524 . . . . 1.55 108.119 174.766 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 m -97.6 112.26 24.2 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 116.666 -3.771 . . . . 1.08 107.048 -179.67 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.4 mt -126.75 152.73 46.47 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.425 1.09 . . . . 1.55 113.469 -178.619 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -107.26 146.47 31.42 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.74 -1.207 . . . . 1.95 107.74 172.046 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 m -149.25 178.4 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 102.236 -3.246 . . . . 0.96 102.236 -177.479 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -138.55 157.57 71.95 Favored Pre-proline 0 N--CA 1.43 -1.47 0 CA-C-O 124.076 1.893 . . . . 2.35 106.196 158.996 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 47.6 Cg_exo -52.92 -23.7 22.03 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 124.943 3.762 . . . . 0.95 118.019 -175.221 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.1 m -79.26 -13.15 59.86 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 120.179 1.354 . . . . 1.45 114.107 178.775 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -72.57 153.87 41.07 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 112.73 0.641 . . . . 1.69 112.73 -179.943 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.2 p -87.41 167.42 14.03 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 126.403 3.001 . . . . 0.75 109.906 174.742 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 43' ' ' LEU . 26.7 mm -70.58 -34.19 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 1 O-C-N 116.236 -4.04 . . . . 0.73 109.107 174.202 . . . . . . . . 3 3 . 1 . 066 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.313 29.1 tt0 -51.89 -44.32 63.71 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 116.872 2.175 . . . . 1.62 116.872 168.088 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -71.15 -9.28 57.81 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 119.549 3.166 . . . . 2.13 119.549 179.642 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -87.12 -38.98 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 C-N-CA 126.208 1.803 . . . . 0.62 108.205 167.384 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -75.53 -24.28 56.74 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 117.462 2.393 . . . . 1.22 117.462 177.853 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.07 -45.24 89.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.822 2.449 . . . . 0.51 108.259 165.335 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -57.74 -31.95 66.97 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 118.01 2.596 . . . . 1.44 118.01 164.3 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.447 HD13 HD22 ' A' ' 69' ' ' LEU . 46.8 mt -78.14 -20.79 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 118.816 -2.428 . . . . 1.32 115.859 177.742 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -59.99 -30.13 68.92 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.891 -1.755 . . . . 1.7 112.725 165.606 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -74.06 -51.18 16.57 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.435 -2.041 . . . . 1.55 114.844 168.634 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -56.48 -55.34 34.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.675 -1.148 . . . . 2.62 111.573 -172.474 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -107.65 -57.71 2.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 126.134 2.147 . . . . 1.48 113.468 -173.188 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.16 9.5 2.12 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 127.05 2.719 . . . . 1.12 116.135 173.849 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.8 mt -88.96 139.19 29.0 Favored Pre-proline 0 N--CA 1.43 -1.467 1 CA-C-O 111.678 -4.01 . . . . 1.55 111.379 -174.665 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -77.81 151.53 28.11 Favored 'Trans proline' 0 C--N 1.3 -2.0 1 CA-C-N 133.151 5.732 . . . . 1.02 110.936 -171.945 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.45 -17.04 43.9 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 O-C-N 125.453 2.291 . . . . 1.25 112.641 -176.011 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -54.41 -59.95 3.99 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 114.807 -2.52 . . . . 2.25 110.998 167.628 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -70.39 -17.33 63.03 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.394 3.878 . . . . 2.02 117.55 -176.525 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -95.8 147.18 23.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.431 -0.793 . . . . 0.69 111.912 -178.984 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -136.59 139.56 42.21 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.604 -3.185 . . . . 2.78 113.186 170.674 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.402 HD12 HG23 ' A' ' 23' ' ' ILE . 18.8 mt -96.49 143.44 27.5 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.065 -3.522 . . . . 1.17 118.901 174.371 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.8 mt -119.53 139.84 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 102.409 -3.182 . . . . 1.38 102.409 179.317 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -145.58 120.57 10.03 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 101.47 -3.53 . . . . 1.5 101.47 168.673 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.8 52.08 1.71 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 120.05 3.352 . . . . 1.21 120.05 173.874 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.75 2.59 6.38 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 129.094 3.235 . . . . 1.3 116.939 177.818 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -120.93 152.9 37.94 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.609 -2.701 . . . . 2.55 109.56 174.873 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -84.96 138.33 32.55 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.337 2.494 . . . . 2.48 109.119 174.629 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.3 mt -94.69 145.21 25.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.239 2.216 . . . . 0.9 109.153 -175.913 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -85.97 142.67 28.63 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.932 -2.355 . . . . 1.94 113.869 170.432 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -59.05 -58.62 7.84 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.821 3.649 . . . . 1.56 112.64 -175.227 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.23 39.39 3.05 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 127.826 2.632 . . . . 0.97 115.301 172.474 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.483 ' HD2' ' HA ' ' A' ' 54' ' ' ARG . 18.7 mmm-85 -110.35 150.62 28.52 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.811 2.719 . . . . 2.49 107.333 155.232 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.1 p -76.28 155.98 33.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.322 -3.361 . . . . 0.76 109.841 172.632 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.519 HD22 HD12 ' A' ' 61' ' ' ILE . 46.8 mt -60.36 -39.4 87.05 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 114.309 1.225 . . . . 1.05 114.309 172.093 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.288 82.7 p -50.62 -42.4 56.03 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.306 -3.371 . . . . 1.19 112.504 175.347 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -56.49 -42.17 77.86 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.537 -3.227 . . . . 1.9 111.804 176.175 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -87.12 -13.57 43.8 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 114.5 -2.667 . . . . 0.89 112.769 177.125 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 70.23 24.71 4.77 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.704 2.669 . . . . 1.84 117.05 -178.971 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.519 HD12 HD22 ' A' ' 56' ' ' LEU . 7.0 mt -70.37 112.54 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 113.064 -1.88 . . . . 0.82 111.531 179.061 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -87.95 179.52 6.42 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.123 -1.611 . . . . 2.16 108.658 178.209 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -55.7 142.25 34.93 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 130.911 3.684 . . . . 2.12 117.796 173.251 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.46 37.6 mt-10 77.21 10.84 2.4 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.499 -2.001 . . . . 1.71 113.769 170.029 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.1 m -75.08 146.13 41.72 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.648 3.179 . . . . 1.04 111.717 177.773 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.2 m -111.02 113.22 25.6 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 125.323 2.487 . . . . 0.79 105.241 -179.294 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.4 mt -96.73 127.19 42.48 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 125.968 1.707 . . . . 1.4 111.39 175.883 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -84.89 136.84 33.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.987 -1.695 . . . . 1.51 109.842 -177.4 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.491 HD23 HG22 ' A' ' 7' ' ' THR . 1.7 tp -104.75 121.01 42.72 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.457 2.348 . . . . 1.14 105.26 178.792 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 m -123.65 163.95 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 119.59 -1.944 . . . . 1.23 106.299 172.847 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.6 mt -85.67 165.88 16.62 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 119.389 -2.07 . . . . 2.78 112.019 176.281 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -76.58 83.81 3.25 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 124.952 1.301 . . . . 3.75 109.559 174.955 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.3 mt -101.6 158.1 16.34 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 111.727 -2.488 . . . . 3.14 107.835 167.333 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -103.22 162.49 12.94 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.111 1.764 . . . . 6.8 110.175 171.161 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.38 -93.57 1.9 Allowed Glycine 0 N--CA 1.43 -1.754 0 C-N-CA 128.549 2.976 . . . . 3.57 114.874 -166.66 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.762 0 O-C-N 118.624 -2.692 . . . . 3.87 115.967 174.791 . . . . . . . . 0 0 . 1 . 067 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 ptt? . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 114.284 1.216 . . . . 1.1 114.284 . . . . . . . . . 0 0 . 1 . 067 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -112.77 122.94 49.14 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 125.828 1.955 . . . . 1.87 112.229 -171.052 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.684 HG22 ' H ' ' A' ' 65' ' ' SER . 5.7 pt -113.07 157.61 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 126.324 2.265 . . . . 0.72 116.175 167.348 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -103.66 125.39 50.13 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.672 1.589 . . . . 1.4 110.165 -174.818 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 t -103.0 125.61 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.109 -2.245 . . . . 0.58 110.974 173.887 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -93.4 118.05 30.83 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.679 2.487 . . . . 2.09 113.009 176.097 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -94.84 171.53 8.72 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.566 -1.959 . . . . 0.99 109.749 -174.421 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.4 mt -83.19 -5.59 59.18 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 117.713 2.486 . . . . 2.53 117.713 171.613 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -88.64 -32.57 17.98 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 104.941 -2.244 . . . . 2.08 104.941 179.88 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.8 37.61 1.04 Allowed Glycine 0 N--CA 1.429 -1.777 0 C-N-CA 126.56 2.028 . . . . 1.31 110.853 -179.952 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -106.7 144.92 32.66 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.764 -1.433 . . . . 1.4 109.798 -179.94 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.5 m -104.84 114.41 28.61 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.564 2.746 . . . . 0.78 108.002 168.462 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.4 mt -109.96 116.66 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 118.55 -2.594 . . . . 1.55 105.062 -168.712 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 m -89.84 97.07 10.98 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.387 1.875 . . . . 1.08 109.944 179.005 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.2 mt -96.5 131.78 42.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 112.531 -2.122 . . . . 1.55 116.383 177.632 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -88.23 111.22 21.4 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.967 2.907 . . . . 1.95 109.787 172.461 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.54 158.26 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 116.565 -3.835 . . . . 0.96 104.447 -172.543 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -103.01 161.23 23.74 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 117.348 -1.311 . . . . 2.35 111.716 169.064 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -75.67 -11.95 20.27 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 CA-C-N 121.008 1.396 . . . . 0.95 113.731 -168.252 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.4 p -85.75 -6.3 59.13 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 125.611 1.819 . . . . 1.45 110.733 175.785 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -76.46 149.69 36.77 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 123.851 1.786 . . . . 1.69 109.138 172.574 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.299 63.3 p -90.17 166.54 13.32 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.881 2.277 . . . . 0.75 108.967 -179.578 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.461 HG23 HD12 ' A' ' 43' ' ' LEU . 19.8 mm -63.79 -36.69 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 111.933 -2.394 . . . . 0.73 110.1 179.956 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -53.14 -42.12 65.76 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 121.509 3.892 . . . . 1.62 121.509 163.142 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 -59.97 -27.51 66.89 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.406 2.373 . . . . 2.13 117.406 173.302 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.9 t -72.23 -47.14 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 C-N-CA 127.112 2.165 . . . . 0.62 114.331 169.302 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 79.5 mttt -60.37 -29.4 68.9 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 113.972 -1.467 . . . . 1.22 112.593 172.5 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.26 -25.58 65.25 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 116.002 -4.186 . . . . 0.51 117.295 -179.556 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -76.77 -35.1 57.93 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 127.156 2.182 . . . . 1.44 109.533 179.471 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.4 mt -71.64 -32.96 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 126.311 1.845 . . . . 1.32 108.88 174.344 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -62.84 -45.42 92.67 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.736 -4.353 . . . . 1.7 111.887 173.376 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -50.73 -60.91 2.56 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 116.206 1.928 . . . . 1.55 116.206 168.063 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -65.14 -62.28 1.64 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.067 2.547 . . . . 2.62 111.45 -174.472 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -105.41 -38.39 6.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.458 -1.401 . . . . 1.48 109.933 -160.596 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.7 -11.2 7.49 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 117.575 -3.203 . . . . 1.12 114.063 168.152 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.0 mt -67.1 124.18 88.21 Favored Pre-proline 0 N--CA 1.429 -1.497 0 O-C-N 119.814 -1.992 . . . . 1.55 108.549 -174.451 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.83 145.05 35.75 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 CA-C-N 120.847 1.338 . . . . 1.02 109.578 172.976 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.03 -0.39 3.99 Favored 'Trans proline' 0 C--N 1.3 -2.009 1 C-N-CA 127.634 5.556 . . . . 1.25 115.975 -169.732 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -91.36 -13.91 31.64 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.117 1.78 . . . . 2.25 113.028 169.99 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -87.94 -45.65 10.06 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 121.47 1.941 . . . . 2.02 111.793 178.815 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -79.33 126.69 31.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.375 2.512 . . . . 0.69 110.963 -176.384 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -113.35 151.15 31.61 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 117.538 -3.226 . . . . 2.78 107.683 171.537 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.461 HD12 HG23 ' A' ' 23' ' ' ILE . 85.1 mt -114.58 120.53 40.49 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 126.223 2.202 . . . . 1.17 111.676 176.817 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.269 82.7 mt -105.49 132.32 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 N-CA-C 115.195 1.554 . . . . 1.38 115.195 175.734 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -148.18 126.36 12.17 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 119.008 -2.308 . . . . 1.5 112.57 173.916 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.17 21.56 7.15 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.874 1.805 . . . . 1.21 115.874 -175.645 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.7 8.48 77.04 Favored Glycine 0 N--CA 1.429 -1.774 1 C-N-CA 131.967 4.603 . . . . 1.3 113.575 -173.451 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -101.38 128.99 47.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.858 -1.534 . . . . 2.55 106.858 179.14 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -74.21 112.03 9.95 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 127.893 2.477 . . . . 2.48 114.02 170.365 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 mt -83.11 124.27 30.32 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 117.741 -1.584 . . . . 0.9 114.725 -163.317 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -75.73 135.36 40.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.344 -3.347 . . . . 1.94 110.849 -178.976 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.413 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -63.05 -45.17 93.5 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 109.144 -3.662 . . . . 1.56 115.941 -168.317 . . . . . . . . 3 3 . 1 . 067 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.18 29.82 1.63 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 118.246 2.058 . . . . 0.97 118.246 166.703 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.5 mtp180 -120.53 158.16 27.89 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 124.21 1.957 . . . . 2.49 111.72 163.452 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.3 p -89.16 168.58 12.18 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 124.216 1.96 . . . . 0.76 114.312 171.585 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.331 8.4 mt -66.7 -38.52 86.9 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 110.845 -2.888 . . . . 1.05 105.25 174.603 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -68.09 -32.53 72.91 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.896 -3.002 . . . . 1.19 111.919 -179.021 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.32 38.0 t0 -63.08 -47.73 81.63 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.484 2.031 . . . . 1.9 116.484 174.219 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -73.86 -9.47 58.68 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.444 -3.91 . . . . 0.89 114.97 168.777 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.4 t30 66.63 58.37 0.64 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.662 2.385 . . . . 1.84 113.804 -178.883 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mt -100.67 120.78 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 126.253 1.821 . . . . 0.82 110.087 -178.15 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.23 174.78 5.98 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.539 1.638 . . . . 2.16 111.792 -174.521 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -53.66 148.51 9.62 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.876 -3.64 . . . . 2.12 114.959 169.199 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.251 86.3 mt-10 67.79 25.18 8.03 Favored 'General case' 0 N--CA 1.431 -1.378 1 C-N-CA 132.699 4.4 . . . . 1.71 110.372 178.495 . . . . . . . . 3 2 . 1 . 067 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.684 ' H ' HG22 ' A' ' 3' ' ' ILE . 69.0 m -75.86 143.9 41.52 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.58 2.61 . . . . 1.04 110.481 -177.496 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.6 m -100.64 97.16 7.86 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.949 -3.594 . . . . 0.79 110.209 -179.519 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.408 HD11 HD12 ' A' ' 3' ' ' ILE . 16.4 mt -91.64 128.76 37.59 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 126.033 2.083 . . . . 1.4 111.54 -178.676 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -89.09 116.12 27.13 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.93 -3.606 . . . . 1.51 113.09 177.34 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 tt -97.54 123.05 41.28 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 104.935 -2.246 . . . . 1.14 104.935 -177.737 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.52 176.41 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 O-C-N 118.686 -2.508 . . . . 1.23 106.135 174.677 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.7 mt -118.08 162.57 17.98 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 125.121 2.391 . . . . 2.78 105.58 173.385 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -57.13 159.04 4.63 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 115.971 -4.206 . . . . 3.75 114.7 173.598 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.7 mt -111.89 -146.64 0.41 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 103.091 -2.929 . . . . 3.14 103.091 169.862 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -98.38 157.95 15.88 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 129.986 3.314 . . . . 6.8 107.488 175.018 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.83 -123.04 6.01 Favored Glycine 0 N--CA 1.43 -1.738 0 CA-C-N 123.073 2.67 . . . . 3.57 117.726 -164.011 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.786 0 N-CA-C 106.98 -2.448 . . . . 3.87 106.98 -179.429 . . . . . . . . 0 0 . 1 . 068 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 CA--C 1.49 -1.338 0 CA-C-O 118.662 -0.685 . . . . 1.1 112.825 . . . . . . . . . 0 0 . 1 . 068 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -97.96 148.74 23.16 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 120.316 1.416 . . . . 1.87 112.784 -176.492 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.0 pt -130.51 169.05 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.896 -2.377 . . . . 0.72 106.647 171.85 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -112.82 125.93 54.88 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.862 1.43 . . . . 1.4 114.862 179.585 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 t -114.76 116.64 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 126.782 3.182 . . . . 0.58 110.26 173.922 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -92.1 119.03 31.4 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 111.202 -2.726 . . . . 2.09 112.057 179.093 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.1 p -75.1 179.41 5.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.885 2.074 . . . . 0.99 111.488 -178.815 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.4 mt -60.59 -41.15 94.12 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.991 -1.068 . . . . 2.53 113.321 177.384 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.5 p -84.85 -38.21 19.76 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 115.491 -2.195 . . . . 2.08 116.9 178.434 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.92 29.57 0.22 Allowed Glycine 0 N--CA 1.429 -1.826 0 O-C-N 126.991 2.682 . . . . 1.31 111.91 175.571 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -86.76 131.49 34.12 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 119.99 1.895 . . . . 1.4 110.03 175.466 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.5 m -90.93 112.15 23.9 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 117.694 -1.603 . . . . 0.78 109.312 177.188 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.3 mm -95.43 117.21 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 102.666 -3.087 . . . . 1.55 102.666 178.72 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.7 m -100.32 105.13 16.63 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.176 -1.787 . . . . 1.08 106.176 -178.049 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.4 mt -103.12 146.24 28.69 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 118.592 -0.718 . . . . 1.55 109.881 -177.835 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -92.4 139.15 30.89 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 106.407 -1.701 . . . . 1.95 106.407 170.232 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.6 m -142.98 -177.58 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 100.204 -3.999 . . . . 0.96 100.204 -176.831 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -125.94 161.04 53.77 Favored Pre-proline 0 N--CA 1.43 -1.456 0 C-N-CA 128.28 2.632 . . . . 2.35 105.486 169.196 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -62.74 -21.99 73.51 Favored 'Trans proline' 0 C--N 1.3 -2.009 1 C-N-CA 127.832 5.688 . . . . 0.95 111.115 174.792 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 p -83.56 -5.59 59.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 125.898 1.999 . . . . 1.45 113.13 179.936 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -81.29 142.41 33.14 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 120.906 1.685 . . . . 1.69 112.533 179.18 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 61.2 p -87.88 165.28 15.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 128.143 3.402 . . . . 0.75 113.925 175.376 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.2 mm -62.67 -37.19 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 124.697 1.199 . . . . 0.73 111.643 177.957 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -54.94 -42.39 72.22 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 118.656 2.836 . . . . 1.62 118.656 168.515 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -62.88 -36.46 83.37 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 116.873 -3.642 . . . . 2.13 111.774 -178.998 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.3 t -59.83 -48.29 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 C-N-CA 128.84 2.856 . . . . 0.62 114.112 171.229 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -55.85 -43.68 77.31 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 115.242 1.571 . . . . 1.22 115.242 169.689 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.62 -36.69 85.06 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.585 -3.197 . . . . 0.51 115.939 172.467 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.281 41.2 mttm -54.42 -53.87 48.3 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.425 1.89 . . . . 1.44 112.566 167.867 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.9 mt -59.14 -34.79 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 O-C-N 118.198 -2.814 . . . . 1.32 117.751 176.373 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -69.14 -37.25 78.2 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 113.008 -1.906 . . . . 1.7 110.576 178.05 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -65.52 -41.85 92.65 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.988 2.327 . . . . 1.55 115.861 167.661 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -58.97 -82.12 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 125.779 2.704 . . . . 2.62 115.704 -177.73 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -95.56 -23.25 17.16 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.633 2.773 . . . . 1.48 112.939 -171.596 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.14 46.25 3.9 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 117.577 -2.249 . . . . 1.12 113.549 176.165 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.4 mt -105.38 132.09 21.18 Favored Pre-proline 0 N--CA 1.429 -1.475 0 CA-C-O 114.337 -2.744 . . . . 1.55 104.448 178.911 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -67.75 140.55 51.53 Favored 'Trans proline' 0 N--CA 1.434 -1.999 0 CA-C-N 125.439 2.978 . . . . 1.02 117.773 -178.402 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -75.27 -10.59 20.83 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 N-CA-C 120.835 3.359 . . . . 1.25 120.835 -174.173 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -88.7 17.77 5.25 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.35 1.46 . . . . 2.25 108.587 168.507 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -115.24 -31.68 5.91 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.927 -2.983 . . . . 2.02 107.167 -177.686 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -84.09 121.89 28.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 131.457 3.903 . . . . 0.69 117.315 -165.751 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -116.72 122.15 43.66 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.862 1.665 . . . . 2.78 107.545 -179.19 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -95.45 117.7 30.85 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 116.099 -1.905 . . . . 1.17 108.575 -178.427 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mm -101.62 125.11 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 129.308 3.043 . . . . 1.38 111.294 176.888 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -150.9 115.59 5.2 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 127.892 3.71 . . . . 1.5 106.886 174.694 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 46.34 0.77 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 109.098 -3.683 . . . . 1.21 113.939 178.872 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.02 -16.29 0.88 Allowed Glycine 0 N--CA 1.43 -1.712 0 CA-C-O 116.558 -2.246 . . . . 1.3 118.398 -171.189 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -101.5 157.13 17.04 Favored 'General case' 0 N--CA 1.43 -1.464 1 CA-C-N 125.797 4.799 . . . . 2.55 103.326 -175.047 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -95.44 141.86 28.49 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.517 2.103 . . . . 2.48 106.3 172.779 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.7 mt -89.84 136.58 32.96 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.65 -2.531 . . . . 0.9 116.658 -169.909 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -65.29 133.05 50.6 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 120.999 3.703 . . . . 1.94 120.999 175.501 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -60.07 -49.67 76.75 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.759 2.695 . . . . 1.56 114.436 -170.567 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.76 45.61 1.41 Allowed Glycine 0 N--CA 1.43 -1.733 0 CA-C-N 111.374 -2.648 . . . . 0.97 116.653 179.303 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.412 ' HD3' ' CE2' ' A' ' 59' ' ' TYR . 62.3 ttt180 -130.54 127.41 39.05 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 128.271 2.983 . . . . 2.49 112.769 169.576 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.375 2.6 p -63.04 167.04 5.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 121.038 3.718 . . . . 0.76 121.038 173.738 . . . . . . . . 3 3 . 1 . 068 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.4 mt -74.0 -43.28 58.59 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.662 -1.899 . . . . 1.05 110.935 176.464 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 t -60.59 -42.26 96.38 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 122.491 1.139 . . . . 1.19 114.035 176.053 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -56.03 -38.21 70.25 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 121.055 3.724 . . . . 1.9 121.055 173.575 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CE2' ' HD3' ' A' ' 54' ' ' ARG . 21.8 m-85 -80.99 -15.87 55.0 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.282 -2.137 . . . . 0.89 111.158 175.242 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.3 m120 77.94 34.63 0.31 Allowed 'General case' 0 N--CA 1.43 -1.462 1 C-N-CA 132.998 4.519 . . . . 1.84 114.067 -177.732 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -89.69 117.48 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 130.295 3.438 . . . . 0.82 114.901 176.61 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -110.34 -178.23 3.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.031 1.872 . . . . 2.16 108.536 -174.869 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -59.11 153.5 17.88 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.4 -3.313 . . . . 2.12 116.251 179.128 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.3 32.2 mt-10 65.11 31.45 10.99 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 125.223 1.409 . . . . 1.71 110.817 175.115 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.2 t -96.67 152.06 19.02 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 104.06 -2.57 . . . . 1.04 104.06 -175.458 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.3 m -109.95 109.53 20.17 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.781 -1.824 . . . . 0.79 113.84 178.515 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.1 mt -106.39 145.33 31.86 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 128.943 2.897 . . . . 1.4 109.384 176.407 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -109.41 127.52 54.44 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 114.239 -2.791 . . . . 1.51 112.72 -175.207 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.3 tp -93.81 120.89 34.67 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 123.444 2.838 . . . . 1.14 113.0 -175.517 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.9 t -110.62 149.42 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 108.101 -1.074 . . . . 1.23 108.101 175.923 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.2 mt -123.95 131.58 53.59 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.161 1.458 . . . . 2.78 114.531 -179.624 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.317 50.5 ptt85 -72.84 161.95 30.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.937 -3.602 . . . . 3.75 113.098 -178.344 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.16 112.73 3.15 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 117.864 2.542 . . . . 3.14 117.864 170.383 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.256 31.2 ptt180 -75.24 144.82 42.39 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 125.773 1.921 . . . . 6.8 114.968 -178.479 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.55 90.17 2.09 Favored Glycine 0 N--CA 1.429 -1.793 0 O-C-N 126.579 2.425 . . . . 3.57 115.604 -161.401 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.731 0 C-N-CA 126.777 2.132 . . . . 3.87 113.419 -174.613 . . . . . . . . 0 0 . 1 . 069 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 CA--C 1.49 -1.331 0 CA-C-O 123.532 1.634 . . . . 1.1 113.204 . . . . . . . . . 0 0 . 1 . 069 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -106.29 125.48 51.05 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.886 -2.384 . . . . 1.87 111.088 -173.702 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.1 pt -120.82 165.58 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 106.266 -1.753 . . . . 0.72 106.266 169.584 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -120.11 139.54 52.43 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.27 -2.769 . . . . 1.4 114.814 -177.02 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.1 t -124.22 125.85 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 118.456 -2.652 . . . . 0.58 108.58 174.029 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -90.6 122.92 33.82 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.798 -4.314 . . . . 2.09 109.695 176.567 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.0 p -91.0 167.32 12.48 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 126.905 2.082 . . . . 0.99 114.828 -179.758 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.521 HD12 HD12 ' A' ' 71' ' ' LEU . 90.3 mt -69.64 -36.8 76.41 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 113.961 1.097 . . . . 2.53 113.961 179.607 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.2 p -74.39 -67.63 0.6 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 130.637 3.575 . . . . 2.08 111.808 -176.881 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.95 62.78 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.638 0 CA-C-O 115.37 -2.906 . . . . 1.31 117.596 171.644 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -150.71 139.16 20.47 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 125.725 2.679 . . . . 1.4 113.818 179.91 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.7 m -102.6 97.42 7.62 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 103.861 -2.644 . . . . 0.78 103.861 174.994 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 13' ' ' ILE . 2.6 mt -65.21 121.57 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 116.763 2.135 . . . . 1.55 116.763 176.184 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.4 m -84.94 105.94 16.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 122.572 2.442 . . . . 1.08 110.119 177.235 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.48 HD23 ' HE3' ' A' ' 33' ' ' LYS . 25.4 mt -101.11 133.77 45.13 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 123.44 1.591 . . . . 1.55 110.193 178.875 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -98.12 110.85 23.36 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 114.652 1.353 . . . . 1.95 114.652 166.909 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.9 m -127.08 176.36 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 128.169 2.588 . . . . 0.96 108.896 -174.8 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.417 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 79.1 mm-40 -116.18 163.76 20.42 Favored Pre-proline 0 N--CA 1.43 -1.455 0 C-N-CA 127.861 2.465 . . . . 2.35 106.56 161.777 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 17.7 Cg_endo -84.58 -6.91 9.82 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 O-C-N 116.569 -2.385 . . . . 0.95 109.751 -166.474 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.4 m -93.23 -6.28 48.0 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.501 2.037 . . . . 1.45 116.501 174.626 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -69.18 147.17 51.71 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 118.801 -1.16 . . . . 1.69 109.639 174.523 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 75.7 p -82.88 175.51 10.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.432 -2.043 . . . . 0.75 112.128 -178.72 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.8 mm -70.24 -42.89 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-O 123.918 1.818 . . . . 0.73 109.316 173.646 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -47.03 -47.77 22.29 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 119.022 2.971 . . . . 1.62 119.022 162.706 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -65.75 -38.18 88.38 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 116.174 -4.079 . . . . 2.13 114.132 174.958 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 56' ' ' LEU . 53.5 t -62.52 -39.31 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 126.758 3.171 . . . . 0.62 111.103 176.012 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -65.99 -33.43 75.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.586 -2.571 . . . . 1.22 114.094 174.131 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.59 -34.1 77.13 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.308 2.255 . . . . 0.51 115.004 173.739 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -74.67 -16.28 60.77 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.309 -2.744 . . . . 1.44 114.811 174.995 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.3 mt -87.0 -36.17 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 127.102 3.334 . . . . 1.32 107.487 171.657 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.97 -38.52 88.77 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.203 -2.811 . . . . 1.7 109.099 -178.274 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -55.93 -48.08 76.36 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.913 -2.992 . . . . 1.55 115.647 170.469 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HE3' HD23 ' A' ' 15' ' ' LEU . 61.9 mttm -79.37 -52.16 8.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.141 -1.6 . . . . 2.62 113.446 -176.243 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -112.44 -8.84 13.87 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.83 1.3 . . . . 1.48 110.386 -161.67 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.98 21.72 60.68 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 118.223 -2.798 . . . . 1.12 113.995 173.601 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mt -83.7 123.38 76.31 Favored Pre-proline 0 N--CA 1.431 -1.386 0 CA-C-O 112.655 -3.545 . . . . 1.55 115.342 -174.555 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -65.81 136.45 45.5 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 CA-C-N 127.199 3.607 . . . . 1.02 116.269 -179.69 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -60.71 -23.0 75.09 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 N-CA-C 117.383 2.032 . . . . 1.25 117.383 -177.286 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.17 -19.5 61.1 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.233 2.213 . . . . 2.25 109.9 177.716 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.418 ' HG2' HD22 ' A' ' 71' ' ' LEU . 17.4 tt0 -92.22 -39.84 11.32 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 130.271 3.428 . . . . 2.02 109.963 -170.654 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -74.45 123.77 25.32 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 113.458 -1.701 . . . . 0.69 113.863 -171.216 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.5 HH12 ' C ' ' A' ' 76' ' ' GLY . 81.4 mtt180 -117.61 123.48 46.28 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 124.379 1.049 . . . . 2.78 109.216 167.792 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.5 mt -105.49 131.34 53.02 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.117 2.389 . . . . 1.17 106.264 -175.965 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.2 mm -116.9 145.57 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 120.349 -1.469 . . . . 1.38 113.49 -178.888 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -161.06 105.07 1.32 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.686 1.736 . . . . 1.5 115.686 174.821 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.468 . . 61.68 32.37 18.41 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 118.003 2.594 . . . . 1.21 118.003 -179.87 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.48 -15.55 45.86 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 119.163 0.892 . . . . 1.3 112.173 -177.497 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -102.46 124.71 48.51 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.732 -2.628 . . . . 2.55 115.277 174.694 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -81.3 145.97 30.63 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 102.714 -3.069 . . . . 2.48 102.714 165.129 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.3 mt -101.75 123.33 45.54 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 114.809 1.411 . . . . 0.9 114.809 -172.954 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.56 157.49 18.59 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 116.489 -2.085 . . . . 1.94 115.174 175.289 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.26 -63.55 1.19 Allowed 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 118.509 2.781 . . . . 1.56 118.509 -165.106 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.68 30.83 4.07 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 116.943 1.537 . . . . 0.97 116.943 176.418 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.7 mmt-85 -99.21 159.0 15.3 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 119.052 -1.059 . . . . 2.49 110.046 162.384 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.8 p -97.19 162.87 13.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.692 -3.755 . . . . 0.76 114.163 178.949 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.483 HD11 HG21 ' A' ' 26' ' ' VAL . 62.5 mt -58.24 -14.82 8.0 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 126.367 2.984 . . . . 1.05 113.864 170.436 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 t -85.12 -42.34 14.87 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.388 -2.695 . . . . 1.19 116.089 172.543 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -63.82 -39.48 94.34 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 127.833 2.453 . . . . 1.9 110.929 175.426 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -80.0 -8.7 59.49 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.784 2.034 . . . . 0.89 110.925 174.923 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.337 57.1 m-80 54.44 45.43 27.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.196 3.406 . . . . 1.84 120.196 -175.979 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.4 mm -78.68 123.99 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 126.132 1.773 . . . . 0.82 113.159 174.65 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -101.89 175.88 5.4 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 114.58 1.326 . . . . 2.16 114.58 -172.333 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -70.45 129.85 40.34 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 126.691 3.139 . . . . 2.12 112.537 -179.603 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.477 7.0 mt-10 67.7 35.99 3.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 125.499 2.571 . . . . 1.71 112.551 -179.858 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.301 4.4 t -94.63 126.94 40.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 109.559 -3.473 . . . . 1.04 110.29 -176.537 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.7 m -96.14 119.55 34.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.948 -1.72 . . . . 0.79 111.061 -169.845 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.5 mt -97.75 148.02 23.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 129.01 2.924 . . . . 1.4 108.745 175.249 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -106.71 137.42 44.76 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.744 -4.348 . . . . 1.51 106.264 178.566 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.5 tp -108.73 121.03 44.19 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.754 -3.091 . . . . 1.14 110.526 -178.106 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.0 t -109.85 153.6 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 130.969 3.707 . . . . 1.23 107.707 178.991 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.521 HD12 HD12 ' A' ' 8' ' ' LEU . 96.3 mt -125.23 157.73 35.82 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 119.079 -2.263 . . . . 2.78 115.251 178.427 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -94.16 151.92 19.12 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 115.6 -2.143 . . . . 3.75 110.113 -174.455 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.3 mt -128.28 -87.76 0.55 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.741 1.386 . . . . 3.14 114.741 177.373 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -109.86 -111.41 0.32 Allowed 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.497 2.094 . . . . 6.8 106.487 165.965 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.72 53.76 0.59 Allowed Glycine 0 N--CA 1.432 -1.626 0 O-C-N 117.741 -3.099 . . . . 3.57 108.69 -158.605 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.5 ' C ' HH12 ' A' ' 42' ' ' ARG . . . . . . . . 0 C--O 1.26 1.773 0 C-N-CA 126.948 2.213 . . . . 3.87 114.935 172.441 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 ptt? . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 115.09 1.515 . . . . 1.1 115.09 . . . . . . . . . 0 0 . 1 . 070 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -101.86 133.87 45.93 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.056 -1.652 . . . . 1.87 113.973 -172.652 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -130.77 159.93 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 104.321 -2.474 . . . . 0.72 104.321 174.275 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -119.55 120.87 38.0 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.065 2.946 . . . . 1.4 110.053 -174.111 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.421 HG21 HD11 ' A' ' 30' ' ' ILE . 94.9 t -105.69 115.19 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 119.889 -1.757 . . . . 0.58 110.439 172.979 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -96.37 134.21 39.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 103.639 -2.726 . . . . 2.09 103.639 179.626 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.269 28.0 p -80.86 169.85 17.04 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 118.044 -2.91 . . . . 0.99 112.665 171.813 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.4 mt -54.81 -49.64 70.52 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.961 3.305 . . . . 2.53 116.951 167.916 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.49 -62.26 1.47 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.408 3.004 . . . . 2.08 107.993 -172.029 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.78 12.27 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 116.929 -2.558 . . . . 1.31 116.78 179.618 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -101.01 154.43 18.71 Favored 'General case' 0 N--CA 1.429 -1.504 1 CA-C-N 126.147 4.974 . . . . 1.4 106.895 -169.148 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -113.04 108.91 17.97 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.426 -1.421 . . . . 0.78 108.928 167.063 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.405 ' CD1' HG23 ' A' ' 30' ' ' ILE . 46.9 mt -88.36 124.5 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 105.823 -1.918 . . . . 1.55 105.823 177.999 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.0 m -91.44 130.52 37.27 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 104.721 -2.325 . . . . 1.08 104.721 179.298 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mt -118.56 155.4 30.97 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 112.969 0.729 . . . . 1.55 112.969 179.685 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -113.03 130.14 56.25 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 100.596 -3.853 . . . . 1.95 100.596 167.765 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.1 m -143.95 156.35 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 126.39 1.876 . . . . 0.96 107.506 -176.805 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 36.1 mm-40 -114.21 154.46 46.26 Favored Pre-proline 0 N--CA 1.431 -1.416 0 C-N-CA 126.141 1.776 . . . . 2.35 110.036 168.042 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 53.4 Cg_exo -73.72 -25.7 14.4 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 CA-C-N 125.672 3.062 . . . . 0.95 117.195 -165.355 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -91.24 4.58 51.95 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 122.575 1.179 . . . . 1.45 113.657 177.984 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -64.77 149.43 49.3 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 115.018 -2.673 . . . . 1.69 112.649 165.995 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.319 21.6 p -87.03 169.45 12.41 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 116.049 -2.26 . . . . 0.75 112.743 177.656 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.91 -37.06 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 113.16 0.8 . . . . 0.73 113.16 171.185 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -57.42 -37.57 72.97 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.656 -3.152 . . . . 1.62 110.663 172.059 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -75.42 -28.12 59.27 Favored 'General case' 0 N--CA 1.43 -1.473 1 O-C-N 115.174 -4.704 . . . . 2.13 111.448 -179.217 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.9 t -71.07 -39.51 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.122 1.369 . . . . 0.62 112.474 172.239 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -63.83 -39.91 95.34 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 118.958 0.799 . . . . 1.22 111.97 170.966 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.14 68.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 119.977 3.325 . . . . 0.51 119.977 172.068 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -63.35 -35.44 80.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 115.32 -2.276 . . . . 1.44 112.91 165.856 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.421 HD11 HG21 ' A' ' 5' ' ' VAL . 15.3 mt -73.8 -40.17 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 123.138 2.699 . . . . 1.32 110.608 171.112 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -51.47 -45.89 62.92 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.671 2.788 . . . . 1.7 117.28 176.425 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -60.57 -28.83 68.77 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.433 -2.667 . . . . 1.55 116.279 174.957 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -94.93 -61.83 1.42 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 104.893 -2.262 . . . . 2.62 104.893 -173.139 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -98.87 -8.43 25.71 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 118.894 -2.378 . . . . 1.48 113.486 -169.744 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.76 5.64 89.68 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 118.389 -2.694 . . . . 1.12 113.365 174.695 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.1 mt -88.02 131.75 41.99 Favored Pre-proline 0 N--CA 1.429 -1.505 0 CA-C-N 121.523 2.662 . . . . 1.55 111.742 -175.086 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 74.0 Cg_exo -64.58 146.57 89.29 Favored 'Trans proline' 0 C--N 1.3 -1.993 1 CA-C-N 129.058 4.271 . . . . 1.02 118.274 -177.359 . . . . . . . . 3 3 . 1 . 070 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 34.5 Cg_exo -68.33 -11.86 33.23 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 C-N-CA 123.029 2.486 . . . . 1.25 113.696 -177.581 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -77.87 -24.98 48.32 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.787 -3.696 . . . . 2.25 110.757 170.787 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -83.16 -39.71 20.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 116.352 -2.139 . . . . 2.02 108.49 176.67 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -63.93 125.8 25.6 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 126.611 1.965 . . . . 0.69 113.604 -172.171 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -118.9 118.52 31.75 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.158 -2.839 . . . . 2.78 108.19 170.708 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' A' ' 43' ' ' LEU . 68.6 mt -98.4 128.81 44.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.139 -2.225 . . . . 1.17 112.243 -174.788 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mm -110.05 137.57 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 125.386 1.474 . . . . 1.38 107.543 -179.812 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -146.61 144.59 29.64 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 125.963 1.705 . . . . 1.5 108.392 165.806 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.24 -107.53 0.15 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 123.832 0.707 . . . . 1.21 112.014 172.496 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.2 18.11 4.75 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 108.134 -1.987 . . . . 1.3 108.134 177.333 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -133.45 149.28 51.78 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.606 1.669 . . . . 2.55 114.455 177.114 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -93.67 130.65 39.54 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.238 -4.039 . . . . 2.48 103.831 174.271 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.336 79.4 mt -87.24 138.06 31.81 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.589 -1.944 . . . . 0.9 113.743 -168.485 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -85.8 164.08 17.77 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 117.85 -3.031 . . . . 1.94 111.671 -179.4 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -67.44 -62.89 1.2 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.315 -3.99 . . . . 1.56 118.931 -170.45 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.93 40.17 0.82 Allowed Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 129.495 3.426 . . . . 0.97 114.03 172.04 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -119.51 158.9 25.34 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.484 3.142 . . . . 2.49 105.605 168.179 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.4 p -100.09 164.17 12.1 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 125.76 1.912 . . . . 0.76 115.356 176.714 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.18 -43.95 97.68 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 117.851 -3.031 . . . . 1.05 109.947 178.667 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.0 m -53.6 -49.51 67.65 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.424 -3.297 . . . . 1.19 116.405 170.759 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -51.82 -39.29 58.54 Favored 'General case' 0 N--CA 1.429 -1.475 1 O-C-N 116.225 -4.047 . . . . 1.9 114.764 172.317 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -85.87 -13.01 49.24 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.325 1.972 . . . . 0.89 116.325 177.006 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.416 27.9 m120 75.03 23.39 1.65 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 124.163 1.935 . . . . 1.84 115.712 -177.772 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.9 mt -77.07 102.06 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 118.34 -2.725 . . . . 0.82 111.77 179.112 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -90.53 -178.99 5.46 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 125.814 2.721 . . . . 2.16 110.398 -176.389 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.4 pttp -66.46 151.69 46.68 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.163 -3.461 . . . . 2.12 113.007 174.396 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.522 90.5 mt-10 90.71 -15.55 0.22 Allowed 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.995 2.918 . . . . 1.71 115.356 -179.102 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.6 m -68.54 137.38 54.3 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.643 2.831 . . . . 1.04 118.643 -171.244 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.5 m -96.6 109.18 21.84 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 119.795 -1.816 . . . . 0.79 113.533 -179.468 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -92.79 163.66 13.64 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.74 3.15 . . . . 1.4 109.92 174.43 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.279 39.1 m80 -124.56 119.82 30.17 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.35 -1.295 . . . . 1.51 107.678 -173.347 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.492 HD21 HD21 ' A' ' 71' ' ' LEU 0.263 3.4 tt -91.71 104.67 17.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.496 -3.253 . . . . 1.14 115.567 -177.05 . . . . . . . . 3 3 . 1 . 070 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.2 t -93.44 144.46 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 105.674 -1.973 . . . . 1.23 105.674 177.529 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.492 HD21 HD21 ' A' ' 69' ' ' LEU . 81.3 mt -117.24 145.55 43.85 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.601 2.62 . . . . 2.78 111.766 177.623 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -94.82 149.61 21.06 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 116.04 -4.163 . . . . 3.75 103.956 176.382 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.1 tp -76.56 127.65 33.22 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 130.581 3.553 . . . . 3.14 107.31 179.144 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -68.1 -84.52 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.049 -2.907 . . . . 6.8 116.324 174.466 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.82 -88.31 0.58 Allowed Glycine 0 N--CA 1.43 -1.735 1 N-CA-C 97.972 -6.051 . . . . 3.57 97.972 -173.244 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.748 0 CA-C-O 114.535 -3.369 . . . . 3.87 109.327 177.688 . . . . . . . . 0 0 . 1 . 071 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptt? . . . . . 0 CA--C 1.49 -1.354 0 N-CA-C 107.393 -1.336 . . . . 1.1 107.393 . . . . . . . . . 0 0 . 1 . 071 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -94.23 126.92 39.77 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 114.134 1.161 . . . . 1.87 114.134 178.649 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.5 pt -115.91 163.08 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 107.628 -1.249 . . . . 0.72 107.628 165.886 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -125.05 132.65 53.16 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.984 -1.073 . . . . 1.4 108.111 -178.196 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.5 t -109.45 130.47 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 105.246 -2.131 . . . . 0.58 105.246 174.736 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -118.31 136.1 53.91 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.826 -2.421 . . . . 2.09 108.258 173.581 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.6 p -87.75 174.02 8.64 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 116.393 -3.942 . . . . 0.99 109.554 177.021 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.448 HD11 ' HA ' ' A' ' 70' ' ' VAL . 5.2 mt -73.43 -23.85 60.17 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 127.677 3.608 . . . . 2.53 117.802 172.193 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 p -88.98 -12.91 40.16 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.517 -3.239 . . . . 2.08 107.786 -175.08 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.4 32.53 3.93 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 115.519 0.968 . . . . 1.31 115.519 167.922 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -113.14 137.9 50.75 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 114.279 -2.968 . . . . 1.4 103.493 -178.228 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.271 32.9 m -109.01 125.2 51.82 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.484 2.088 . . . . 0.78 110.783 -179.129 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.7 mt -109.52 121.97 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.828 -3.045 . . . . 1.55 109.629 179.347 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.3 m -95.84 119.4 34.27 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 114.604 -5.06 . . . . 1.08 110.734 176.966 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.7 mt -126.99 138.97 53.35 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 116.953 -3.592 . . . . 1.55 117.49 -176.27 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -97.83 108.8 21.59 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.709 2.003 . . . . 1.95 109.683 178.781 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -120.11 157.23 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 128.283 2.633 . . . . 0.96 108.908 178.514 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -98.06 148.79 34.98 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-O 115.069 -2.396 . . . . 2.35 113.108 156.522 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.88 -13.77 34.83 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 125.29 3.993 . . . . 0.95 113.112 -172.459 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m -74.08 -25.76 60.0 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.705 1.878 . . . . 1.45 106.1 174.354 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -67.19 140.34 57.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.513 -2.617 . . . . 1.69 116.166 -179.828 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 50.7 p -83.28 161.16 21.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 111.397 -2.638 . . . . 0.75 113.094 -172.398 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.7 mm -59.09 -46.8 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 1 C-N-CA 134.742 5.217 . . . . 0.73 109.505 176.065 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -47.8 -40.08 19.99 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 127.084 2.154 . . . . 1.62 114.283 163.124 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -76.56 -24.64 53.57 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.765 -3.084 . . . . 2.13 116.71 176.304 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.3 t -74.63 -40.43 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 124.151 0.98 . . . . 0.62 111.733 173.996 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -61.38 -29.23 69.79 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.193 1.797 . . . . 1.22 113.249 173.357 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.22 -33.72 76.39 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.513 -1.992 . . . . 0.51 111.095 175.747 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.271 56.2 mttm -61.74 -43.05 99.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.475 -2.641 . . . . 1.44 114.985 176.287 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.0 mt -70.3 -33.87 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 C-N-CA 127.874 2.469 . . . . 1.32 109.364 175.402 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -64.14 -50.59 67.62 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 116.554 -3.841 . . . . 1.7 112.624 179.805 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -54.04 -49.7 68.38 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.293 2.637 . . . . 1.55 111.403 171.668 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -79.63 -61.23 2.06 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.55 2.426 . . . . 2.62 117.55 -178.478 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -87.3 -29.17 21.81 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.056 2.243 . . . . 1.48 117.056 -167.31 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.07 13.8 14.88 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 119.55 -1.309 . . . . 1.12 113.677 171.823 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.9 mt -96.14 119.67 64.08 Favored Pre-proline 0 N--CA 1.43 -1.434 1 CA-C-O 111.533 -4.079 . . . . 1.55 107.001 -171.053 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 67.8 Cg_endo -70.57 159.11 53.89 Favored 'Trans proline' 0 N--CA 1.433 -2.035 1 CA-C-N 129.31 4.361 . . . . 1.02 113.831 172.996 . . . . . . . . 3 3 . 1 . 071 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 52.9 Cg_exo -68.37 -26.37 35.08 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 C-N-CA 122.784 2.323 . . . . 1.25 113.759 -173.131 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -56.47 -33.34 65.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.985 2.514 . . . . 2.25 110.151 174.108 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -98.65 19.79 14.07 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.248 1.944 . . . . 2.02 116.248 175.972 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -127.44 113.15 15.81 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.985 -1.117 . . . . 0.69 107.985 -175.501 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.416 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 14.0 tpp180 -110.28 127.74 55.16 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.797 -0.816 . . . . 2.78 108.797 173.857 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.5 mt -110.3 143.01 41.14 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 112.791 -3.48 . . . . 1.17 114.566 179.419 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.2 mt -128.65 143.24 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 129.031 3.957 . . . . 1.38 105.165 -174.28 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -155.1 136.3 13.95 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.162 -2.211 . . . . 1.5 105.779 168.912 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.251 . . 61.81 26.17 15.84 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 118.556 2.798 . . . . 1.21 118.556 175.837 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.2 -14.13 63.12 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-O 117.557 -1.691 . . . . 1.3 110.604 -173.867 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -97.66 126.95 43.26 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 125.602 1.413 . . . . 2.55 112.794 -171.599 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -80.67 112.31 17.92 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 124.811 2.243 . . . . 2.48 106.448 170.54 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.5 mt -74.67 124.85 27.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.92 2.888 . . . . 0.9 115.664 -176.222 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -87.68 142.11 28.08 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 118.733 2.864 . . . . 1.94 118.733 178.772 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -46.83 -66.77 0.36 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.948 2.499 . . . . 1.56 117.692 -173.072 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.56 35.87 0.84 Allowed Glycine 0 N--CA 1.43 -1.723 0 CA-C-O 125.033 2.463 . . . . 0.97 116.871 171.023 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -115.81 175.64 5.44 Favored 'General case' 0 N--CA 1.429 -1.507 1 O-C-N 113.785 -5.538 . . . . 2.49 107.956 166.299 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 60.0 p -106.95 -174.68 2.59 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.515 -1.99 . . . . 0.76 110.759 175.665 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mt -80.91 -37.01 30.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.877 2.071 . . . . 1.05 108.995 176.449 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.8 t -57.14 -48.4 78.78 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 128.235 3.459 . . . . 1.19 110.884 174.538 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -49.62 -29.7 7.62 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.203 3.038 . . . . 1.9 119.203 175.665 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -111.33 1.55 17.15 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.621 -1.299 . . . . 0.89 109.315 -179.577 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 61.77 40.05 13.36 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.954 2.902 . . . . 1.84 109.324 -178.176 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.9 mt -78.59 114.82 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 124.257 1.98 . . . . 0.82 107.489 172.852 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.473 ' HB3' ' H ' ' A' ' 63' ' ' LYS . 35.5 mt-30 -108.59 -158.58 0.65 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.049 -2.907 . . . . 2.16 115.608 -179.325 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.473 ' H ' ' HB3' ' A' ' 62' ' ' GLN 0.273 25.3 pttt -74.67 138.74 43.04 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.72 -2.487 . . . . 2.12 113.822 -179.235 . . . . . . . . 3 3 . 1 . 071 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 71.87 31.2 2.13 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 124.723 2.201 . . . . 1.71 114.821 178.852 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.3 m -86.59 121.46 29.15 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 113.161 -1.836 . . . . 1.04 115.138 -178.786 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.1 m -92.88 120.48 33.27 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 118.0 -2.937 . . . . 0.79 107.382 176.028 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.1 mt -94.35 147.8 22.86 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.159 -1.837 . . . . 1.4 107.582 171.832 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -92.35 123.6 35.79 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.85 2.46 . . . . 1.51 108.34 176.941 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.47 117.54 31.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 122.257 2.299 . . . . 1.14 107.601 175.244 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.448 ' HA ' HD11 ' A' ' 8' ' ' LEU . 78.0 t -106.61 129.91 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 130.77 3.628 . . . . 1.23 102.672 -176.191 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -86.88 131.99 33.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.446 -2.659 . . . . 2.78 114.129 171.266 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -114.33 167.73 10.46 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.002 -2.311 . . . . 3.75 110.554 -175.949 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.4 mt -115.04 143.97 44.35 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 118.752 -2.467 . . . . 3.14 108.785 172.653 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -60.75 108.94 0.92 Allowed 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.662 -1.899 . . . . 6.8 115.838 173.183 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 131.53 -35.55 2.39 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.281 -1.512 . . . . 3.57 114.367 -166.225 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.796 1 O-C-N 116.348 -4.031 . . . . 3.87 111.807 -173.996 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ptt? . . . . . 0 CA--C 1.491 -1.323 0 N-CA-C 116.767 2.136 . . . . 1.1 116.767 . . . . . . . . . 0 0 . 1 . 072 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.293 19.6 mt-30 -107.47 129.52 54.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 103.941 -2.615 . . . . 1.87 103.941 -176.717 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.9 pt -113.79 153.89 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 117.524 -1.226 . . . . 0.72 110.795 165.623 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -107.02 147.64 29.68 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 122.389 1.09 . . . . 1.4 112.528 174.879 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.2 t -124.05 128.22 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.828 2.051 . . . . 0.58 108.105 176.488 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -107.31 144.93 33.45 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.319 -2.113 . . . . 2.09 106.432 178.822 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 p -89.19 -168.17 2.09 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.291 2.7 . . . . 0.99 118.291 179.796 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 mt -65.87 -52.89 46.35 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.956 1.703 . . . . 2.53 111.721 174.696 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.4 p -70.77 -52.59 19.69 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.081 -2.262 . . . . 2.08 115.428 -178.235 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.27 50.49 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 104.529 -3.428 . . . . 1.31 104.529 171.626 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -107.29 147.88 29.69 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.522 -2.752 . . . . 1.4 107.303 175.598 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.0 m -102.21 136.19 42.48 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 103.131 -2.915 . . . . 0.78 103.131 179.034 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.2 mt -122.75 120.75 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-O 125.371 2.51 . . . . 1.55 108.297 176.659 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.1 m -92.75 125.5 37.4 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.391 -2.693 . . . . 1.08 106.398 177.393 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 29' ' ' LYS . 68.5 mt -116.03 142.4 46.85 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 129.1 4.0 . . . . 1.55 112.657 170.452 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -98.73 123.73 43.13 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 120.656 1.571 . . . . 1.95 109.259 172.026 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.466 HG21 ' CD1' ' A' ' 56' ' ' LEU . 27.8 m -139.67 171.71 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 O-C-N 118.486 -2.634 . . . . 0.96 106.659 -177.788 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -121.47 162.15 37.66 Favored Pre-proline 0 N--CA 1.43 -1.468 0 N-CA-C 103.21 -2.885 . . . . 2.35 103.21 156.773 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -76.39 -3.4 13.77 Favored 'Trans proline' 0 N--CA 1.434 -1.971 0 C-N-CA 124.595 3.53 . . . . 0.95 111.192 -168.819 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.1 m -86.84 -5.25 59.16 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.614 3.102 . . . . 1.45 113.084 178.543 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -78.79 147.36 33.33 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.873 -3.642 . . . . 1.69 116.919 175.996 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 35.1 p -72.46 158.96 34.76 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 118.183 -0.913 . . . . 0.75 112.814 177.701 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.6 mm -67.87 -31.37 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 126.852 2.595 . . . . 0.73 112.813 173.713 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -60.47 -30.98 70.02 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.352 -2.718 . . . . 1.62 114.353 170.966 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -76.74 -35.82 57.52 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.846 -1.784 . . . . 2.13 109.41 176.037 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -69.82 -34.21 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 119.105 -2.247 . . . . 0.62 113.099 178.294 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -69.85 -18.18 63.42 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.114 -2.241 . . . . 1.22 115.869 170.783 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.07 -19.47 43.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.303 1.441 . . . . 0.51 112.474 -179.585 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.513 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.5 mttm -78.68 -33.4 47.02 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.171 1.788 . . . . 1.44 111.469 172.173 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.3 mt -76.53 -24.08 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 107.603 -1.258 . . . . 1.32 107.603 173.707 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -67.14 -32.08 72.95 Favored 'General case' 0 N--CA 1.429 -1.491 2 O-C-N 114.999 -4.813 . . . . 1.7 115.89 175.042 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -73.59 -31.12 63.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.836 -1.165 . . . . 1.55 112.09 166.795 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -83.66 -72.86 0.44 Allowed 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.45 -2.056 . . . . 2.62 105.45 -170.321 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -93.86 -7.62 42.7 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 115.574 1.694 . . . . 1.48 115.574 -167.309 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.76 16.22 77.98 Favored Glycine 0 N--CA 1.429 -1.782 0 O-C-N 117.679 -3.138 . . . . 1.12 115.74 176.729 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.1 mt -89.03 128.44 51.88 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 116.99 -3.653 . . . . 1.55 104.369 -178.977 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 17.0 Cg_exo -70.15 142.31 45.88 Favored 'Trans proline' 0 N--CA 1.433 -2.044 0 CA-C-N 126.671 3.418 . . . . 1.02 114.565 179.311 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 8.0 Cg_exo -58.1 -17.28 30.94 Favored 'Trans proline' 0 N--CA 1.434 -2.022 1 C-N-CA 126.345 4.696 . . . . 1.25 115.905 -176.942 . . . . . . . . 3 3 . 1 . 072 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -75.82 -18.98 59.28 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.346 2.339 . . . . 2.25 116.33 170.337 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -97.37 2.37 50.44 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 121.272 1.851 . . . . 2.02 115.94 179.885 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -105.79 139.75 39.88 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 111.058 -2.792 . . . . 0.69 111.408 -172.225 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -132.73 122.5 24.67 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.174 2.19 . . . . 2.78 112.536 167.59 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.2 mt -88.11 138.86 31.07 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 106.459 -1.682 . . . . 1.17 106.459 174.082 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mt -119.96 132.68 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 127.424 2.29 . . . . 1.38 105.209 178.344 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -155.16 123.1 5.78 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.165 2.257 . . . . 1.5 110.39 170.54 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.284 . . 75.41 37.01 0.46 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.623 3.569 . . . . 1.21 114.152 176.449 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.05 -24.05 6.43 Favored Glycine 0 N--CA 1.43 -1.749 0 CA-C-O 115.777 -2.679 . . . . 1.3 112.412 -173.929 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -102.94 148.1 26.08 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 120.66 2.23 . . . . 2.55 112.102 -175.834 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -88.15 150.46 23.32 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 122.068 0.937 . . . . 2.48 109.542 171.926 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.1 mt -97.02 133.42 41.72 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.251 1.82 . . . . 0.9 108.715 -169.561 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -80.73 146.09 31.21 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.393 -1.276 . . . . 1.94 109.754 177.166 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -65.39 -59.21 4.26 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.211 -3.43 . . . . 1.56 120.092 -169.542 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.98 32.06 1.51 Allowed Glycine 0 N--CA 1.431 -1.692 0 CA-C-N 111.479 -2.601 . . . . 0.97 119.171 173.079 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -105.12 176.69 5.08 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 104.2 -2.518 . . . . 2.49 104.2 164.676 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 67.3 p -107.26 167.22 10.07 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 112.612 -2.085 . . . . 0.76 112.022 171.462 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.466 ' CD1' HG21 ' A' ' 17' ' ' VAL . 66.9 mt -67.07 -38.31 85.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.058 2.837 . . . . 1.05 113.637 175.678 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.9 t -69.01 -19.2 64.12 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 119.666 3.21 . . . . 1.19 119.666 173.842 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -58.7 -51.99 67.6 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 114.875 -2.488 . . . . 1.9 104.658 172.844 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -81.69 -8.57 59.72 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 129.404 3.081 . . . . 0.89 113.488 -176.053 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 m120 59.98 56.68 3.32 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 116.589 -3.819 . . . . 1.84 117.677 -173.461 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.418 HG21 HD11 ' A' ' 67' ' ' LEU . 62.2 mt -96.54 117.71 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 104.968 -2.234 . . . . 0.82 104.968 -178.284 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -97.71 -176.57 3.51 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.037 -2.289 . . . . 2.16 105.755 -171.85 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.5 pttt -65.85 151.69 46.11 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.644 2.64 . . . . 2.12 116.471 174.521 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 60.98 15.26 5.95 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 131.654 3.981 . . . . 1.71 114.213 176.02 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 t -76.16 150.22 37.19 Favored 'General case' 0 N--CA 1.429 -1.486 1 C-N-CA 132.318 4.247 . . . . 1.04 109.134 -177.541 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.6 m -103.49 105.47 15.74 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.587 -3.196 . . . . 0.79 113.19 -179.417 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.418 HD11 HG21 ' A' ' 61' ' ' ILE . 6.2 mp -82.77 168.38 17.24 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 106.126 -1.805 . . . . 1.4 106.126 170.902 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -121.56 135.57 55.0 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.31 -2.744 . . . . 1.51 108.867 -179.271 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.4 tp -109.16 117.37 33.95 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.08 2.848 . . . . 1.14 111.386 -177.594 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 t -105.96 146.28 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 1 O-C-N 115.932 -4.23 . . . . 1.23 112.22 174.474 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.9 mt -108.12 126.28 52.58 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 117.847 2.536 . . . . 2.78 117.847 178.512 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -88.03 156.41 19.31 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.341 -2.099 . . . . 3.75 107.334 176.494 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.9 tp -124.2 -84.09 0.65 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 118.33 -0.843 . . . . 3.14 111.905 178.37 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -95.84 -81.04 0.41 Allowed 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 131.59 3.956 . . . . 6.8 111.878 175.019 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.48 135.35 3.67 Favored Glycine 0 N--CA 1.431 -1.666 1 CA-C-O 111.563 -5.02 . . . . 3.57 108.525 -164.567 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.767 0 O-C-N 127.754 2.679 . . . . 3.87 111.034 179.711 . . . . . . . . 0 0 . 1 . 073 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.269 0.7 OUTLIER . . . . . 0 CA--C 1.491 -1.312 0 N-CA-C 104.38 -2.452 . . . . 1.1 104.38 . . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -89.86 127.73 36.05 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 117.263 -1.351 . . . . 1.87 107.557 -179.114 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.522 HD12 HD22 ' A' ' 67' ' ' LEU . 40.3 pt -115.11 138.83 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 122.105 2.23 . . . . 0.72 106.658 165.764 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -97.88 118.23 33.98 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.13 0.972 . . . . 1.4 109.794 -178.008 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.5 t -99.56 124.38 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.613 1.965 . . . . 0.58 106.289 174.069 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -117.62 126.92 53.38 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 125.189 1.396 . . . . 2.09 110.155 -175.395 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.289 7.3 p -74.49 176.01 7.23 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 128.485 2.714 . . . . 0.99 117.344 -179.364 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.9 tp -67.99 -56.11 10.19 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.95 1.705 . . . . 2.53 113.219 166.224 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 p -62.52 -53.02 61.01 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 118.462 2.764 . . . . 2.08 118.462 -176.378 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.79 30.09 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 119.122 2.409 . . . . 1.31 119.122 176.87 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -103.58 138.48 40.2 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 119.061 1.43 . . . . 1.4 107.89 176.697 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.1 m -105.09 118.93 37.78 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.194 -2.15 . . . . 0.78 105.194 169.019 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.6 mt -101.49 115.22 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 106.741 -1.577 . . . . 1.55 106.741 176.592 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.9 m -96.52 124.35 40.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 120.804 1.638 . . . . 1.08 112.493 176.004 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.268 84.0 mt -116.03 127.71 55.12 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 127.959 3.743 . . . . 1.55 109.688 -173.217 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -80.02 108.21 13.43 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.1 -3.5 . . . . 1.95 114.68 168.723 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.87 160.87 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 125.373 1.469 . . . . 0.96 111.982 -179.082 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -97.46 161.44 25.96 Favored Pre-proline 0 N--CA 1.431 -1.388 0 C-N-CA 127.794 2.437 . . . . 2.35 107.065 159.852 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -71.14 -15.77 31.98 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 C-N-CA 124.164 3.243 . . . . 0.95 112.29 179.064 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 p -83.38 -2.6 56.16 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.347 1.459 . . . . 1.45 112.503 174.746 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -77.82 140.89 39.44 Favored 'General case' 0 N--CA 1.431 -1.4 1 O-C-N 116.216 -4.053 . . . . 1.69 110.579 169.805 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.361 22.9 p -81.05 176.23 9.99 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 110.759 -2.928 . . . . 0.75 114.892 179.717 . . . . . . . . 3 3 . 1 . 073 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -85.76 -20.77 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 CA-C-N 121.252 1.842 . . . . 0.73 108.526 175.581 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -56.01 -38.27 70.28 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.103 2.561 . . . . 1.62 113.058 165.37 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -71.88 -33.23 68.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.05 2.14 . . . . 2.13 114.961 176.348 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.327 79.1 t -65.33 -48.23 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 C-N-CA 128.065 2.546 . . . . 0.62 110.067 173.841 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -69.96 -26.81 64.28 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.945 -2.347 . . . . 1.22 115.552 174.703 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.75 -37.07 83.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.282 -2.761 . . . . 0.51 113.37 171.445 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.1 mttm -65.37 -51.61 59.26 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.91 -1.744 . . . . 1.44 114.356 176.2 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.7 mt -51.81 -37.43 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 128.064 3.792 . . . . 1.32 113.549 170.723 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -63.24 -44.56 94.86 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 114.748 -4.97 . . . . 1.7 118.308 170.001 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -55.57 -49.55 72.41 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 114.736 1.384 . . . . 1.55 114.736 167.831 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -74.71 -65.58 0.85 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.763 -2.017 . . . . 2.62 107.572 -170.075 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.261 13.8 mm-40 -85.21 -51.75 6.39 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.87 1.804 . . . . 1.48 115.87 -171.119 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.91 9.51 5.2 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 117.628 1.811 . . . . 1.12 117.628 -178.706 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.0 mt -87.82 135.35 33.86 Favored Pre-proline 0 N--CA 1.429 -1.5 0 CA-C-O 113.967 -2.92 . . . . 1.55 112.018 -173.224 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 51.4 Cg_endo -78.32 157.71 29.51 Favored 'Trans proline' 0 N--CA 1.434 -1.991 0 CA-C-N 124.632 2.69 . . . . 1.02 108.71 -178.944 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 29.0 Cg_exo -64.02 -17.09 58.45 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 125.08 3.854 . . . . 1.25 114.257 -178.235 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -67.21 -49.17 65.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 129.879 3.272 . . . . 2.25 111.868 175.768 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -70.95 -31.67 68.32 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.647 -2.533 . . . . 2.02 110.495 -175.951 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -80.01 120.12 23.76 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 130.025 3.33 . . . . 0.69 113.902 -175.095 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -113.63 123.67 50.48 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.221 -2.14 . . . . 2.78 105.221 167.507 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -108.34 126.3 52.69 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 102.984 -2.969 . . . . 1.17 102.984 178.822 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 68' ' ' HIS 0.253 37.8 mm -112.71 154.21 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 131.549 3.94 . . . . 1.38 106.255 177.592 . . . . . . . . 3 3 . 1 . 073 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -114.4 -94.01 0.48 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.535 -3.228 . . . . 1.5 102.744 175.307 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.38 -65.78 0.98 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 119.656 -0.818 . . . . 1.21 109.95 177.254 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.63 -13.43 0.73 Allowed Glycine 0 N--CA 1.429 -1.802 0 O-C-N 117.534 -3.229 . . . . 1.3 114.789 -173.705 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -105.95 150.44 25.67 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.828 2.051 . . . . 2.55 110.988 175.789 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -77.16 138.3 39.4 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 130.83 3.652 . . . . 2.48 110.033 178.774 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.4 mt -82.9 160.14 22.18 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.138 -1.601 . . . . 0.9 113.796 -176.478 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -102.99 151.51 22.39 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.981 1.712 . . . . 1.94 109.967 176.755 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.377 30.1 m-20 -75.02 -63.29 1.3 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 112.988 0.736 . . . . 1.56 112.988 -167.294 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.45 55.97 4.72 Favored Glycine 0 N--CA 1.431 -1.665 0 O-C-N 118.631 -2.543 . . . . 0.97 112.3 178.641 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -120.58 161.08 21.94 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 102.62 -3.104 . . . . 2.49 102.62 162.259 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 81.0 p -90.67 164.19 14.25 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.351 2.5 . . . . 0.76 109.23 168.251 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.9 mt -59.03 -34.43 71.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.658 2.783 . . . . 1.05 115.15 167.309 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.8 p -70.99 -21.51 62.3 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 114.606 1.335 . . . . 1.19 114.606 179.221 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -69.99 -34.54 73.47 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.8 2.84 . . . . 1.9 108.969 175.69 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -96.74 15.88 20.67 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.182 2.896 . . . . 0.89 112.964 176.458 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 m120 57.29 25.19 10.84 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 111.298 -2.683 . . . . 1.84 116.97 174.028 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.8 mt -81.63 98.97 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 106.043 -1.836 . . . . 0.82 106.043 178.629 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -112.92 -39.06 4.34 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.795 2.838 . . . . 2.16 104.569 -174.83 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -101.16 171.83 7.38 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.324 1.601 . . . . 2.12 115.324 167.294 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -45.11 103.05 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 129.953 3.301 . . . . 1.71 116.12 168.581 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.6 m -123.13 159.53 28.37 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.469 -4.519 . . . . 1.04 116.75 -175.952 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.2 m -101.88 126.79 48.85 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.843 -1.786 . . . . 0.79 111.822 -175.552 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.522 HD22 HD12 ' A' ' 3' ' ' ILE . 8.5 mp -107.56 142.6 37.22 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.847 3.659 . . . . 1.4 112.327 176.814 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.405 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 49.6 m80 -116.03 117.69 30.8 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.634 -1.917 . . . . 1.51 109.404 -175.469 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.1 tp -87.62 123.43 32.47 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.971 1.367 . . . . 1.14 111.057 -176.894 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.0 t -122.84 136.66 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.181 -2.2 . . . . 1.23 108.488 176.416 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.1 mt -112.31 126.85 55.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.37 -2.706 . . . . 2.78 113.007 -174.165 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.487 ' HE ' ' HA2' ' A' ' 76' ' ' GLY . 49.2 mmt-85 -112.67 -177.38 3.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 119.558 -0.857 . . . . 3.75 109.292 172.248 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.7 mt -85.06 -39.5 17.91 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 125.722 1.609 . . . . 3.14 108.514 172.024 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.9 ttt-85 -148.03 -68.31 0.24 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.685 1.365 . . . . 6.8 114.685 168.208 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.85 -3.86 3.53 Favored Glycine 0 N--CA 1.431 -1.697 0 O-C-N 119.411 -2.055 . . . . 3.57 113.339 -171.19 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.487 ' HA2' ' HE ' ' A' ' 72' ' ' ARG . . . . . . . . 0 C--O 1.26 1.74 0 O-C-N 117.881 -3.129 . . . . 3.87 107.025 174.927 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.351 0 CA-C-O 116.147 -1.882 . . . . 1.1 113.619 . . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -119.22 125.92 50.3 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 120.403 1.456 . . . . 1.87 112.87 -178.028 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.9 pt -121.95 162.75 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 125.89 2.757 . . . . 0.72 107.241 170.582 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -103.89 149.04 25.45 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.5 2.32 . . . . 1.4 110.737 178.064 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.283 49.4 t -119.0 121.97 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 126.792 2.558 . . . . 0.58 106.071 171.067 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.7 tttt -101.9 140.13 36.6 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 126.53 2.394 . . . . 2.09 112.88 177.708 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.9 p -96.97 173.67 7.16 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.327 -2.733 . . . . 0.99 108.092 174.328 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.8 mt -56.61 -57.62 11.6 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.692 -1.88 . . . . 2.53 112.649 167.279 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.1 p -61.46 -30.69 70.75 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 117.66 2.467 . . . . 2.08 117.66 -179.244 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.87 15.91 1.31 Allowed Glycine 0 N--CA 1.429 -1.817 0 CA-C-O 114.784 -3.231 . . . . 1.31 114.715 170.004 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.0 tttt -90.13 115.23 27.22 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 122.768 3.284 . . . . 1.4 106.874 -173.573 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 m -87.16 115.35 24.49 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 113.926 -1.488 . . . . 0.78 113.543 175.454 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mt -103.07 127.46 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 116.533 2.049 . . . . 1.55 116.533 176.302 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.4 m -89.09 105.58 17.88 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 116.687 -3.758 . . . . 1.08 111.456 -174.974 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.9 mt -112.38 127.6 56.06 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 125.186 2.422 . . . . 1.55 110.378 178.537 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -92.74 117.14 29.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.543 3.068 . . . . 1.95 108.422 170.47 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 m -127.1 178.32 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 111.962 -2.381 . . . . 0.96 112.5 -179.444 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -105.38 154.14 39.21 Favored Pre-proline 0 N--CA 1.43 -1.441 0 C-N-CA 126.963 2.105 . . . . 2.35 109.846 165.241 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.11 -14.2 23.45 Favored 'Trans proline' 0 C--N 1.299 -2.028 1 CA-C-N 128.307 4.003 . . . . 0.95 107.157 -177.462 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 m -86.69 -4.88 59.23 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 115.08 1.511 . . . . 1.45 115.08 177.728 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -64.09 146.8 53.56 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.15 -2.219 . . . . 1.69 112.451 174.259 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 15.8 p -89.77 161.86 15.82 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 119.731 -1.855 . . . . 0.75 112.793 172.963 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.7 mm -58.51 -22.64 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.287 -3.383 . . . . 0.73 117.772 174.679 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.09 -59.13 5.54 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 117.857 -3.027 . . . . 1.62 110.985 161.745 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -51.98 -50.24 61.66 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.077 2.151 . . . . 2.13 111.687 176.616 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -61.51 -49.4 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 119.816 -1.802 . . . . 0.62 111.88 -177.9 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -68.53 -19.7 64.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 124.064 3.12 . . . . 1.22 112.238 175.585 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.12 -27.3 63.48 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.394 -2.066 . . . . 0.51 109.293 173.923 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -68.12 -48.18 66.13 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.835 2.054 . . . . 1.44 110.628 171.823 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mt -59.91 -36.06 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 113.794 1.035 . . . . 1.32 113.794 173.033 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -60.22 -43.65 95.84 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.633 -3.167 . . . . 1.7 114.496 175.121 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -47.06 -58.91 3.51 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.635 -3.791 . . . . 1.55 115.758 166.861 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -71.29 -53.56 13.84 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.707 -1.87 . . . . 2.62 113.257 -176.57 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -92.4 -58.89 2.23 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 125.002 1.439 . . . . 1.48 108.385 -167.091 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.53 -0.16 2.74 Favored Glycine 0 N--CA 1.429 -1.782 0 O-C-N 119.698 -1.877 . . . . 1.12 111.72 176.191 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.0 mt -74.46 128.78 85.24 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 114.094 -2.86 . . . . 1.55 113.29 -169.277 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -63.61 151.04 86.92 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 CA-C-N 122.618 1.971 . . . . 1.02 113.856 175.037 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.29 -4.46 15.1 Favored 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 124.188 3.259 . . . . 1.25 118.704 -178.883 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -80.55 -29.53 37.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 126.264 2.228 . . . . 2.25 114.799 170.751 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -79.37 -40.26 30.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.723 2.202 . . . . 2.02 111.784 177.593 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -70.04 95.94 1.01 Allowed 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 114.743 -4.973 . . . . 0.69 115.616 -171.186 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -90.66 132.22 35.9 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 118.526 -2.609 . . . . 2.78 107.589 172.219 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.5 mt -111.06 120.4 42.24 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.813 1.768 . . . . 1.17 110.589 178.449 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.9 mt -102.83 128.64 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 120.476 -1.39 . . . . 1.38 108.919 172.936 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -82.14 -76.85 0.24 Allowed 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.13 2.395 . . . . 1.5 108.673 174.245 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -96.04 -60.07 1.71 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.53 1.532 . . . . 1.21 110.565 -179.004 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.91 -48.01 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.806 0 CA-C-O 122.379 0.989 . . . . 1.3 112.377 -172.522 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -81.09 141.98 33.76 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.246 -1.149 . . . . 2.55 111.037 179.927 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 pm0 -77.38 152.19 34.51 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 117.285 -1.766 . . . . 2.48 111.915 176.761 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.0 mt -98.39 136.96 37.8 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 116.649 -2.02 . . . . 0.9 113.929 -167.047 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.03 144.71 48.71 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.538 2.335 . . . . 1.94 115.499 172.461 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -64.55 -56.19 15.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.805 3.642 . . . . 1.56 114.752 -175.578 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.47 64.37 3.99 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 121.072 3.189 . . . . 0.97 121.072 170.31 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -135.35 158.39 44.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.17 1.788 . . . . 2.49 106.651 161.651 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.259 17.0 p -80.72 164.94 22.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 117.659 2.466 . . . . 0.76 117.659 174.478 . . . . . . . . 3 3 . 1 . 074 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.2 mt -64.56 -33.8 76.76 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.388 -2.07 . . . . 1.05 113.118 175.791 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 t -68.79 -31.37 70.34 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.079 2.152 . . . . 1.19 116.337 177.096 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -57.24 -37.07 71.74 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 120.86 -1.15 . . . . 1.9 111.774 171.369 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -77.59 3.81 12.83 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 118.305 2.706 . . . . 0.89 118.305 174.63 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.66 17.3 m-80 81.76 12.01 0.69 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.034 2.605 . . . . 1.84 118.034 178.686 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.43 HG23 ' HB2' ' A' ' 65' ' ' SER . 9.2 mt -91.51 102.84 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 118.949 -2.344 . . . . 0.82 111.827 178.135 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -106.49 -26.21 11.52 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.739 1.615 . . . . 2.16 108.294 -171.555 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.5 tttp -137.66 -91.99 0.22 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 117.317 2.339 . . . . 2.12 117.317 175.918 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.14 126.09 49.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 121.284 -0.885 . . . . 1.71 111.518 -176.125 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.43 ' HB2' HG23 ' A' ' 61' ' ' ILE . 21.3 t -146.8 145.48 29.92 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.587 -1.188 . . . . 1.04 114.09 -173.714 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.9 m -118.43 109.09 15.83 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.714 -3.116 . . . . 0.79 103.673 179.752 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.6 mt -93.36 154.87 17.72 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.23 -2.137 . . . . 1.4 105.23 173.336 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -118.49 117.05 27.98 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.394 1.092 . . . . 1.51 113.472 -175.258 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.3 tp -79.59 94.62 5.69 Favored 'General case' 0 N--CA 1.43 -1.428 1 C-N-CA 132.904 4.481 . . . . 1.14 107.974 -171.728 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.27 121.44 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 C-N-CA 127.981 2.512 . . . . 1.23 108.613 175.716 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.1 mp -90.09 90.33 8.07 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 116.499 -1.715 . . . . 2.78 111.665 176.61 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -104.92 133.67 49.33 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 126.841 2.588 . . . . 3.75 106.101 177.718 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.3 mt -79.81 150.01 30.85 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 124.761 3.437 . . . . 3.14 112.954 174.685 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -59.45 168.31 1.6 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 130.188 3.395 . . . . 6.8 117.528 171.504 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 150.42 -77.22 0.23 Allowed Glycine 0 N--CA 1.43 -1.718 0 O-C-N 118.031 -2.918 . . . . 3.57 108.696 -170.704 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.774 0 N-CA-C 104.177 -3.569 . . . . 3.87 104.177 -177.214 . . . . . . . . 0 0 . 1 . 075 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.491 -1.311 0 CA-C-O 118.621 -0.704 . . . . 1.1 110.359 . . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -100.56 122.37 43.14 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 119.57 1.077 . . . . 1.87 112.678 177.176 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.258 21.6 pt -106.97 147.57 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 118.188 -2.82 . . . . 0.72 109.551 -179.341 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -105.17 117.94 35.28 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 117.746 -3.096 . . . . 1.4 107.412 -177.683 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.3 t -99.55 96.41 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 120.09 -1.631 . . . . 0.58 108.825 173.219 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -78.99 112.23 15.98 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.762 2.425 . . . . 2.09 107.051 176.409 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.479 HG22 HD23 ' A' ' 69' ' ' LEU . 80.8 p -75.99 166.45 23.48 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 116.315 1.969 . . . . 0.99 116.315 -179.382 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.8 tp -54.54 -39.86 68.1 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 127.393 2.277 . . . . 2.53 110.336 161.753 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.0 p -75.82 -30.17 58.92 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.114 -1.616 . . . . 2.08 111.64 -178.985 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.32 38.78 1.59 Allowed Glycine 0 N--CA 1.43 -1.721 0 CA-C-O 124.385 2.103 . . . . 1.31 113.657 177.571 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -120.53 121.26 38.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 104.671 -2.344 . . . . 1.4 104.671 178.132 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.284 85.6 m -73.0 101.95 3.36 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 112.849 -1.978 . . . . 0.78 112.909 171.16 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 mt -96.62 128.34 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 105.33 -2.1 . . . . 1.55 105.33 -179.08 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.8 m -99.73 119.47 38.19 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.133 -1.062 . . . . 1.08 108.133 175.185 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.8 mt -120.29 128.93 53.75 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 127.837 2.455 . . . . 1.55 109.586 176.207 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -74.48 131.69 41.24 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.713 3.227 . . . . 1.95 119.713 162.939 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.2 m -139.26 176.69 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.718 -1.239 . . . . 0.96 113.62 174.193 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -101.84 163.33 18.0 Favored Pre-proline 0 N--CA 1.429 -1.494 0 O-C-N 116.98 -3.575 . . . . 2.35 104.781 160.123 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -77.83 -10.36 16.89 Favored 'Trans proline' 0 N--CA 1.433 -2.043 0 O-C-N 116.802 -2.262 . . . . 0.95 109.325 -179.582 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -79.9 -12.26 59.75 Favored 'General case' 0 N--CA 1.428 -1.531 1 O-C-N 116.002 -4.187 . . . . 1.45 116.882 174.55 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -76.16 151.59 36.91 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.559 1.647 . . . . 1.69 114.3 176.516 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.2 p -80.77 161.25 24.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.908 -1.745 . . . . 0.75 114.13 -177.79 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.0 mt -70.99 -35.99 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 120.428 -1.42 . . . . 0.73 109.374 174.35 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -49.31 -38.81 29.0 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.463 2.705 . . . . 1.62 112.374 162.255 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -70.79 -52.14 22.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.905 -2.997 . . . . 2.13 105.41 179.142 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.284 42.2 t -47.68 -57.56 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-N 121.797 2.09 . . . . 0.62 115.446 166.945 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -60.28 -31.19 70.0 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.103 -3.498 . . . . 1.22 112.307 179.094 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.7 -27.76 58.36 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 124.482 3.31 . . . . 0.51 111.343 -179.404 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.268 35.1 mttm -74.97 -26.84 59.88 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.592 2.757 . . . . 1.44 111.169 173.394 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.2 mt -69.41 -45.53 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 C-N-CA 128.9 2.88 . . . . 1.32 104.911 171.862 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -58.05 -39.35 78.23 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.484 2.313 . . . . 1.7 113.265 176.595 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.53 -56.07 21.44 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 127.203 3.382 . . . . 1.55 111.676 173.265 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -80.81 -58.84 2.91 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.604 -3.81 . . . . 2.62 113.332 -174.038 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -83.62 -50.61 8.04 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.595 -3.191 . . . . 1.48 111.786 -172.535 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.64 73.04 1.27 Allowed Glycine 0 N--CA 1.43 -1.701 0 CA-C-O 125.649 2.805 . . . . 1.12 110.203 179.963 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.9 mt -132.72 128.77 21.0 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-O 113.435 -3.174 . . . . 1.55 103.347 178.341 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -64.54 160.55 39.24 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 125.742 3.087 . . . . 1.02 117.115 179.944 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.01 -26.65 12.82 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 123.058 2.128 . . . . 1.25 111.018 -174.552 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.18 -39.15 81.63 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 117.882 -1.056 . . . . 2.25 112.766 171.203 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -83.78 -1.89 55.2 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 123.011 2.641 . . . . 2.02 112.593 -179.849 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -93.06 122.75 35.74 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 120.938 1.699 . . . . 0.69 108.712 -176.032 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.495 HH22 ' C ' ' A' ' 76' ' ' GLY . 97.0 mtt180 -115.3 114.78 25.63 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 114.347 -1.297 . . . . 2.78 108.035 165.607 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.5 mt -98.63 122.59 42.03 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 123.774 1.749 . . . . 1.17 107.57 -179.264 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.3 mm -106.2 139.24 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 118.614 -2.554 . . . . 1.38 104.708 179.314 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -103.43 -92.67 0.34 Allowed 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 119.61 -1.931 . . . . 1.5 110.234 173.992 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.96 -84.29 0.51 Allowed 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.843 -1.91 . . . . 1.21 105.843 179.844 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.74 7.59 22.05 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 126.809 2.568 . . . . 1.3 112.361 -170.352 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -139.38 155.99 47.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.167 -1.784 . . . . 2.55 110.438 178.28 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -83.23 148.58 27.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.814 -1.178 . . . . 2.48 111.756 166.76 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.1 mt -86.75 131.14 34.21 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 119.26 -2.15 . . . . 0.9 110.806 -176.486 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -84.82 136.88 33.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.417 2.687 . . . . 1.94 110.405 175.016 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.39 -51.56 59.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.366 -3.334 . . . . 1.56 114.398 -167.088 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.61 26.38 2.71 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 123.293 2.769 . . . . 0.97 115.387 171.87 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -105.46 171.69 7.19 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.489 1.138 . . . . 2.49 110.813 165.539 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.6 p -98.82 172.43 7.45 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 127.852 3.691 . . . . 0.76 111.365 167.701 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.6 mt -64.0 -44.45 92.58 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 111.99 -2.368 . . . . 1.05 109.779 171.397 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 t -57.88 -37.45 73.98 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 116.851 2.167 . . . . 1.19 116.851 176.879 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -53.36 -21.66 6.14 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.741 -2.474 . . . . 1.9 113.497 175.687 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -112.27 22.14 15.04 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.5 -2.625 . . . . 0.89 113.206 177.334 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.504 1.0 OUTLIER 61.37 31.95 19.16 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 119.705 3.224 . . . . 1.84 119.705 177.968 . . . . . . . . 3 3 . 1 . 075 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.317 57.4 mt -86.2 125.8 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 118.322 -2.736 . . . . 0.82 105.009 177.968 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -148.77 -51.06 0.16 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.792 -2.442 . . . . 2.16 110.08 -170.831 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.4 tptp -79.47 -173.17 3.6 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 113.633 0.975 . . . . 2.12 113.633 169.352 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -73.05 95.88 2.09 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.123 2.392 . . . . 1.71 116.304 175.84 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.5 m -94.27 160.12 14.82 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 120.922 3.675 . . . . 1.04 120.922 -169.991 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.9 m -106.92 119.19 38.68 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 117.185 -1.388 . . . . 0.79 110.104 177.91 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -105.32 160.95 14.72 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 125.651 1.844 . . . . 1.4 106.61 168.471 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -127.08 124.47 39.31 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.273 -2.142 . . . . 1.51 108.864 -177.946 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 7' ' ' THR . 45.4 tp -99.55 112.17 24.42 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.059 1.344 . . . . 1.14 110.63 -174.42 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.1 t -97.6 120.56 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 C-N-CA 130.497 3.519 . . . . 1.23 112.737 174.018 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.4 mt -101.09 123.43 45.24 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 118.21 -1.396 . . . . 2.78 107.758 -177.787 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -140.76 -166.25 2.11 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.725 2.202 . . . . 3.75 110.332 174.533 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 mt -90.68 151.87 21.08 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.372 -3.33 . . . . 3.14 110.4 170.422 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.254 69.5 ttt180 -101.0 138.88 37.46 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 125.506 1.754 . . . . 6.8 112.119 172.134 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.73 37.13 4.56 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 105.179 -3.168 . . . . 3.57 105.179 -166.568 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.495 ' C ' HH22 ' A' ' 42' ' ' ARG . . . . . . . . 0 C--O 1.26 1.776 0 O-C-N 116.632 -3.864 . . . . 3.87 110.057 -178.668 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ttp . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 118.662 2.838 . . . . 1.1 118.662 . . . . . . . . . 0 0 . 1 . 076 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -97.71 112.91 24.61 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.138 1.923 . . . . 1.87 109.623 -178.172 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.463 HG12 HG22 ' A' ' 17' ' ' VAL . 5.0 pt -109.14 146.77 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.038 -2.914 . . . . 0.72 109.368 175.083 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -106.32 124.06 49.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.091 2.956 . . . . 1.4 113.38 175.33 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.412 HG22 ' HB2' ' A' ' 67' ' ' LEU . 85.3 t -105.45 113.58 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 114.76 -1.109 . . . . 0.58 111.375 178.819 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -85.95 135.56 33.62 Favored 'General case' 0 N--CA 1.431 -1.423 2 O-C-N 113.041 -6.037 . . . . 2.09 115.826 179.038 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 p -99.1 173.11 6.97 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.653 -1.28 . . . . 0.99 109.708 178.797 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 tt -56.14 -49.14 74.77 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.22 1.008 . . . . 2.53 111.576 174.686 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -77.29 4.33 10.91 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.04 -2.287 . . . . 2.08 115.261 -177.425 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.16 17.63 46.17 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 119.497 2.559 . . . . 1.31 119.497 177.523 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -99.63 145.55 27.45 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 120.413 2.106 . . . . 1.4 109.939 -177.767 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.3 m -105.43 126.55 52.25 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.755 -1.216 . . . . 0.78 108.019 -173.036 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.9 mt -100.9 107.1 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.814 -3.054 . . . . 1.55 106.265 178.645 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 m -91.19 126.34 36.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.1 1.905 . . . . 1.08 108.021 -175.444 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.0 mt -126.63 160.75 29.81 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.867 2.867 . . . . 1.55 109.241 -178.473 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.342 43.6 mt-10 -122.85 115.62 22.29 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 125.658 2.647 . . . . 1.95 108.922 170.094 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.463 HG22 HG12 ' A' ' 3' ' ' ILE . 27.6 m -123.21 163.6 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 117.242 -3.411 . . . . 0.96 113.619 -178.591 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -98.2 145.45 29.85 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-O 116.634 -1.65 . . . . 2.35 112.816 162.735 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.49 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 21.1 Cg_exo -63.91 -9.87 20.67 Favored 'Trans proline' 0 N--CA 1.434 -1.999 2 CA-C-N 129.993 4.605 . . . . 0.95 114.149 -179.495 . . . . . . . . 3 3 . 1 . 076 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.6 p -84.57 -0.2 52.36 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 127.189 3.376 . . . . 1.45 116.099 173.526 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -80.67 156.01 26.53 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.816 -2.428 . . . . 1.69 106.356 176.0 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 p -104.37 165.77 10.84 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.52 -1.218 . . . . 0.75 113.245 176.292 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -58.43 -41.4 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.183 2.193 . . . . 0.73 112.496 176.695 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -44.17 -60.59 1.82 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.491 3.145 . . . . 1.62 119.491 162.024 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -58.96 -33.31 70.5 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 115.059 1.503 . . . . 2.13 115.059 177.85 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.23 -47.83 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 131.626 3.97 . . . . 0.62 115.406 172.478 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.33 27.1 mtmt -69.45 -32.43 71.37 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 111.561 -2.563 . . . . 1.22 110.944 177.946 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.66 -26.32 65.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.255 1.822 . . . . 0.51 113.537 171.79 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -75.97 -42.71 47.58 Favored 'General case' 0 N--CA 1.431 -1.411 1 C-N-CA 131.972 4.109 . . . . 1.44 108.427 -179.859 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt -61.08 -36.0 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 1 O-C-N 116.207 -4.058 . . . . 1.32 113.524 169.068 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -62.44 -37.54 86.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.052 2.541 . . . . 1.7 111.88 172.54 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.6 -52.18 41.48 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 119.548 3.166 . . . . 1.55 119.548 166.928 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -69.4 -51.5 35.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.662 1.185 . . . . 2.62 112.193 -176.546 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -110.34 -25.38 10.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.161 1.784 . . . . 1.48 112.159 -169.453 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.26 39.94 5.26 Favored Glycine 0 N--CA 1.429 -1.773 0 O-C-N 118.363 -2.711 . . . . 1.12 115.255 175.985 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.5 mt -117.97 126.65 27.14 Favored Pre-proline 0 N--CA 1.429 -1.483 0 CA-C-O 116.836 -1.554 . . . . 1.55 111.775 -174.111 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -63.78 145.39 90.78 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 CA-C-N 127.145 3.588 . . . . 1.02 116.932 178.283 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -66.72 -25.23 46.59 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 CA-C-N 120.686 1.281 . . . . 1.25 113.279 -175.137 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -70.78 -13.8 62.19 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 120.398 3.481 . . . . 2.25 120.398 177.476 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -84.76 -36.88 21.46 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 127.866 3.229 . . . . 2.02 108.165 174.043 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -76.91 108.88 10.27 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.067 2.365 . . . . 0.69 113.422 -173.378 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.425 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 56.2 mtt180 -102.19 114.76 29.18 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 114.611 -5.055 . . . . 2.78 110.756 162.725 . . . . . . . . 3 3 . 1 . 076 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 43' ' ' LEU . 64.9 mt -100.53 123.43 44.74 Favored 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 116.035 -4.166 . . . . 1.17 111.922 -177.687 . . . . . . . . 3 3 . 1 . 076 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.496 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 33.9 mm -109.4 136.33 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 112.255 -2.248 . . . . 1.38 110.635 -177.654 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -99.42 -88.05 0.35 Allowed 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.742 -1.849 . . . . 1.5 109.571 172.404 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -113.02 -8.63 13.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 126.595 3.093 . . . . 1.21 113.151 -176.186 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.14 -40.04 0.17 Allowed Glycine 0 N--CA 1.429 -1.816 1 N-CA-C 102.958 -4.057 . . . . 1.3 102.958 -178.37 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -75.96 150.57 37.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.47 1.605 . . . . 2.55 114.39 175.424 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -84.25 134.06 34.55 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.858 -3.026 . . . . 2.48 107.532 170.67 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.2 mt -82.38 124.94 30.47 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 129.208 4.068 . . . . 0.9 105.448 -173.715 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -80.25 140.86 36.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.364 3.468 . . . . 1.94 120.364 174.082 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.94 -62.82 1.39 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 116.479 2.029 . . . . 1.56 116.479 -170.723 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.1 56.68 4.97 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 118.512 2.165 . . . . 0.97 118.512 173.056 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.266 50.5 mmt-85 -133.35 151.57 51.86 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 107.623 -1.251 . . . . 2.49 107.623 169.108 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 4.5 p -74.2 169.04 18.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 127.027 3.299 . . . . 0.76 118.141 174.172 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.49 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 94.3 mt -74.4 -34.93 63.42 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.536 -4.477 . . . . 1.05 113.279 173.764 . . . . . . . . 3 3 . 1 . 076 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -66.52 -49.19 67.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.127 -2.76 . . . . 1.19 108.891 178.529 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -42.1 -45.16 3.89 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 120.258 3.429 . . . . 1.9 120.258 173.788 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -82.25 -20.81 36.86 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 115.988 1.847 . . . . 0.89 115.988 179.472 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 80.26 50.16 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 128.001 2.521 . . . . 1.84 111.057 -175.022 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.2 mt -93.2 115.94 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 124.809 1.244 . . . . 0.82 109.519 170.814 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -108.18 -174.86 2.62 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.991 2.116 . . . . 2.16 111.577 -167.197 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -65.58 -34.75 78.96 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.819 1.295 . . . . 2.12 112.821 172.066 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.258 13.5 pt-20 -77.04 -12.14 59.9 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.067 -2.896 . . . . 1.71 115.957 178.455 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.314 19.0 m -82.01 139.86 34.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 114.827 1.417 . . . . 1.04 114.827 -167.437 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.4 m -107.11 124.15 49.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.218 1.807 . . . . 0.79 111.609 -179.495 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.412 ' HB2' HG22 ' A' ' 5' ' ' VAL . 8.6 mp -96.85 149.5 21.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 123.198 2.726 . . . . 1.4 106.269 178.13 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.496 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 57.9 m80 -110.34 131.05 55.4 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.48 1.609 . . . . 1.51 113.413 176.735 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 43' ' ' LEU . 51.8 tp -110.14 135.57 50.72 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 125.527 2.584 . . . . 1.14 105.658 -174.93 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 53.1 t -125.54 123.85 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.082 -2.562 . . . . 1.23 104.082 175.826 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.5 mt -103.87 124.94 49.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.77 -1.206 . . . . 2.78 111.821 177.623 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.9 mmt85 -116.82 145.82 43.29 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.348 1.059 . . . . 3.75 111.514 176.416 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.8 tp -141.97 -78.42 0.25 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 104.945 -2.243 . . . . 3.14 104.945 167.013 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.1 mtm-85 -80.25 106.87 12.59 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 118.888 -2.382 . . . . 6.8 108.932 174.929 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.57 -160.01 31.04 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-O 121.825 0.68 . . . . 3.57 113.485 -167.674 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.777 0 C-N-CA 127.875 2.655 . . . . 3.87 109.619 176.759 . . . . . . . . 0 0 . 1 . 077 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ttp . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 116.743 -1.599 . . . . 1.1 112.034 . . . . . . . . . 0 0 . 1 . 077 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -93.5 111.62 23.33 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 115.316 -2.278 . . . . 1.87 111.185 -177.274 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.7 pt -106.47 167.98 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-O 125.992 2.806 . . . . 0.72 107.824 172.872 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -126.1 114.8 18.87 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.403 2.049 . . . . 1.4 113.129 -176.727 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.0 t -107.6 113.59 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 116.404 -3.935 . . . . 0.58 102.174 -179.002 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -82.74 143.93 30.55 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 116.103 -4.123 . . . . 2.09 116.49 177.166 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.569 HG21 ' HE2' ' A' ' 11' ' ' LYS . 20.2 p -93.85 158.46 15.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.558 1.943 . . . . 0.99 116.126 176.179 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.25 80.1 mt -64.44 -32.53 74.2 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.246 1.818 . . . . 2.53 114.648 175.906 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.7 p -71.61 -44.31 64.64 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.542 -1.349 . . . . 2.08 112.172 178.33 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.79 -33.75 0.44 Allowed Glycine 0 N--CA 1.43 -1.762 0 CA-C-O 125.516 2.731 . . . . 1.31 115.072 172.036 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.569 ' HE2' HG21 ' A' ' 7' ' ' THR 0.362 0.0 OUTLIER -70.9 153.41 42.72 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 110.879 -2.661 . . . . 1.4 115.434 -176.285 . . . . . . . . 4 4 . 1 . 077 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.9 m -103.21 136.38 43.11 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.051 -1.655 . . . . 0.78 110.432 177.642 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 69.7 mt -98.78 115.48 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 116.517 -1.706 . . . . 1.55 108.768 177.597 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 m -92.44 110.83 22.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.242 1.817 . . . . 1.08 111.767 179.95 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.9 mt -112.89 133.85 54.67 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 125.332 2.491 . . . . 1.55 110.803 -174.742 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -91.0 113.15 25.34 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 116.28 -4.012 . . . . 1.95 109.64 168.255 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.7 163.14 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 113.502 -1.681 . . . . 0.96 108.688 -177.378 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -104.55 131.0 22.26 Favored Pre-proline 0 N--CA 1.43 -1.434 0 O-C-N 125.792 1.933 . . . . 2.35 106.102 163.449 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.71 -14.04 24.77 Favored 'Trans proline' 0 C--N 1.3 -1.993 1 C-N-CA 127.827 5.684 . . . . 0.95 114.788 -178.542 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -85.96 -17.04 36.46 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.895 2.878 . . . . 1.45 114.858 -179.771 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -68.17 144.46 54.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 116.997 -1.478 . . . . 1.69 113.704 176.007 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.3 p -76.61 164.11 26.23 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 122.959 2.618 . . . . 0.75 110.332 -178.266 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.881 HD13 ' HB3' ' A' ' 50' ' ' LEU . 52.0 mt -67.86 -35.38 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 118.158 -2.838 . . . . 0.73 114.594 176.165 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -47.89 -37.65 14.59 Favored 'General case' 0 N--CA 1.431 -1.409 1 O-C-N 115.665 -4.397 . . . . 1.62 116.873 156.659 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -78.97 -30.22 44.35 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.43 -2.669 . . . . 2.13 111.087 177.094 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.7 t -61.83 -52.98 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 O-C-N 119.554 -1.966 . . . . 0.62 113.305 170.961 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -50.05 -40.73 45.97 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 127.892 3.245 . . . . 1.22 114.771 176.457 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.97 -37.37 68.96 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.839 -1.163 . . . . 0.51 112.432 173.388 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -70.16 -24.92 63.23 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 118.801 2.889 . . . . 1.44 118.801 174.548 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.8 mt -77.33 -42.37 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 129.051 2.94 . . . . 1.32 104.38 179.693 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -61.38 -47.9 83.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.418 -1.426 . . . . 1.7 110.585 179.947 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -41.71 -48.68 4.22 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 118.076 2.621 . . . . 1.55 118.076 170.329 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -79.0 -60.76 2.25 Favored 'General case' 0 N--CA 1.432 -1.372 0 O-C-N 119.192 -2.193 . . . . 2.62 108.607 -174.031 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -101.85 -17.37 16.22 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 119.862 1.21 . . . . 1.48 111.535 -163.922 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.98 46.89 5.77 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 123.844 1.802 . . . . 1.12 116.852 173.444 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.4 mt -129.3 129.1 23.27 Favored Pre-proline 0 N--CA 1.431 -1.395 0 O-C-N 120.211 -1.758 . . . . 1.55 112.162 -174.112 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -62.72 162.16 26.01 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 O-C-N 114.574 -3.435 . . . . 1.02 120.881 -177.278 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.7 -14.92 19.51 Favored 'Trans proline' 0 N--CA 1.433 -2.038 0 CA-C-N 127.825 3.83 . . . . 1.25 112.824 -178.398 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -60.47 -46.21 90.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.919 2.488 . . . . 2.25 109.398 173.41 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -83.77 -27.57 28.77 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 123.503 0.721 . . . . 2.02 112.473 -174.417 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -76.87 108.32 9.83 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.344 2.021 . . . . 0.69 110.731 -177.582 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -93.8 119.13 32.36 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.971 -3.581 . . . . 2.78 104.564 167.542 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.3 mt -98.41 138.38 35.73 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.278 -2.139 . . . . 1.17 108.688 174.277 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.41 134.1 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 101.735 -3.432 . . . . 1.38 101.735 -178.404 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -98.11 -107.23 0.18 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.187 -1.571 . . . . 1.5 109.736 170.171 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.66 -51.38 5.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.079 -2.263 . . . . 1.21 110.752 177.582 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.25 -40.17 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 128.955 3.169 . . . . 1.3 106.343 -171.074 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -74.5 146.77 42.44 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 112.878 0.696 . . . . 2.55 112.878 178.348 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.276 3.6 mp0 -97.92 145.65 26.25 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 100.308 -3.96 . . . . 2.48 100.308 171.879 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.881 ' HB3' HD13 ' A' ' 23' ' ' ILE . 78.8 mt -99.75 121.02 40.65 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 127.733 3.635 . . . . 0.9 108.437 -169.496 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -71.35 129.15 38.12 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.519 -2.613 . . . . 1.94 114.189 170.638 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.41 -48.04 47.46 Favored 'General case' 0 N--CA 1.431 -1.417 1 C-N-CA 131.966 4.106 . . . . 1.56 117.412 -175.071 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.62 -9.58 62.19 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 119.157 2.423 . . . . 0.97 119.157 176.663 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -90.39 177.02 6.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 118.386 1.093 . . . . 2.49 109.247 179.412 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.5 p -108.23 164.36 12.38 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.184 1.393 . . . . 0.76 108.46 173.873 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.0 mt -58.4 -33.24 69.42 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.478 1.511 . . . . 1.05 111.421 171.629 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -64.27 -34.72 78.78 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 118.788 2.884 . . . . 1.19 118.788 176.728 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.284 64.6 m-20 -67.47 -29.79 69.33 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.42 -2.675 . . . . 1.9 111.785 178.429 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -92.53 -7.16 48.07 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 130.402 3.481 . . . . 0.89 112.088 178.664 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.268 71.6 m-80 61.96 60.82 1.47 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.213 1.482 . . . . 1.84 110.06 176.479 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.282 12.8 mt -83.69 130.43 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 128.054 2.542 . . . . 0.82 109.665 173.431 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -100.7 178.38 4.72 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 117.576 -1.202 . . . . 2.16 114.003 -171.453 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -44.19 -80.86 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.248 2.219 . . . . 2.12 116.684 173.627 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.341 0.8 OUTLIER -93.05 58.29 2.91 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 123.214 1.483 . . . . 1.71 113.622 -177.666 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 p -92.3 139.87 30.17 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.952 2.501 . . . . 1.04 113.514 -175.039 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.4 m -109.79 124.12 50.74 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 104.122 -2.547 . . . . 0.79 104.122 -176.223 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -97.91 170.33 9.03 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 126.531 3.063 . . . . 1.4 104.815 172.361 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -120.76 125.51 47.77 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 118.037 -2.914 . . . . 1.51 105.09 -177.998 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.0 tp -95.17 107.16 19.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.471 2.081 . . . . 1.14 111.608 169.069 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -112.49 150.3 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 118.609 -2.557 . . . . 1.23 107.819 173.964 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.5 mt -112.03 109.88 19.87 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.6 -2.563 . . . . 2.78 111.516 -178.788 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 mmt85 -115.31 171.33 7.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 102.354 -3.202 . . . . 3.75 102.354 178.571 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.9 mt -87.82 -174.74 4.87 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.609 1.707 . . . . 3.14 115.609 174.176 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.3 ttt180 -71.01 123.92 23.18 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 125.582 2.61 . . . . 6.8 113.288 165.968 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.87 37.36 0.29 Allowed Glycine 0 N--CA 1.43 -1.711 1 O-C-N 114.372 -5.205 . . . . 3.57 111.511 -166.862 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.789 0 O-C-N 118.958 -2.495 . . . . 3.87 114.085 -177.637 . . . . . . . . 0 0 . 1 . 078 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tmm? . . . . . 0 CA--C 1.491 -1.32 0 N-CA-C 105.25 -2.13 . . . . 1.1 105.25 . . . . . . . . . 0 0 . 1 . 078 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.83 131.64 36.56 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.095 -3.503 . . . . 1.87 113.372 179.762 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.2 pt -116.48 148.15 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 129.245 3.018 . . . . 0.72 105.305 174.867 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -104.42 131.11 52.14 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.24 -1.538 . . . . 1.4 107.275 -179.546 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.0 t -109.79 118.66 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 105.185 -2.154 . . . . 0.58 105.185 177.083 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -105.08 130.39 53.28 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.475 -1.391 . . . . 2.09 110.066 176.277 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.8 p -69.93 167.02 18.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.549 2.118 . . . . 0.99 113.71 176.883 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.2 tp -56.01 -46.18 78.84 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 112.122 -2.308 . . . . 2.53 114.11 173.427 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 p -81.22 -21.15 39.75 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.299 2.333 . . . . 2.08 117.299 -176.248 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.76 1.69 4.1 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 122.686 3.834 . . . . 1.31 122.686 177.78 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -88.25 131.27 34.84 Favored 'General case' 0 N--CA 1.431 -1.397 1 O-C-N 115.855 -4.321 . . . . 1.4 109.978 -174.306 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.5 m -119.53 112.99 20.04 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 120.171 1.35 . . . . 0.78 113.384 179.626 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.9 pt -101.78 151.94 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 125.691 1.869 . . . . 1.55 107.61 -177.476 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.1 m -116.68 118.68 33.25 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 126.61 2.444 . . . . 1.08 110.012 -175.122 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.7 mt -102.96 149.22 24.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.518 -3.239 . . . . 1.55 107.247 177.977 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -102.48 123.36 46.1 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.225 -1.398 . . . . 1.95 107.225 165.762 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 m -131.77 147.66 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 106.67 -1.604 . . . . 0.96 106.67 -176.558 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -87.01 129.68 51.12 Favored Pre-proline 0 N--CA 1.429 -1.523 1 CA-C-O 111.438 -4.125 . . . . 2.35 110.132 163.875 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.31 -1.94 12.06 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 CA-C-N 127.809 3.825 . . . . 0.95 115.517 -166.246 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.2 m -84.19 2.66 38.72 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 116.301 -3.999 . . . . 1.45 116.513 172.917 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -81.36 163.32 22.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.514 -3.241 . . . . 1.69 113.174 174.952 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -90.98 157.95 16.99 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 125.729 2.68 . . . . 0.75 112.73 -178.538 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.44 -37.67 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.004 -2.935 . . . . 0.73 115.814 171.22 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -48.27 -41.21 27.22 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.647 -3.158 . . . . 1.62 117.879 167.811 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -73.8 -33.56 64.26 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.406 1.262 . . . . 2.13 114.406 172.568 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.5 -40.26 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 116.791 -3.693 . . . . 0.62 111.572 174.665 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -66.32 -35.74 81.14 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.288 -2.132 . . . . 1.22 110.115 177.58 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.439 . . -69.62 -27.02 64.72 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.883 2.473 . . . . 0.51 116.148 173.369 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -75.09 -34.84 61.8 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 120.702 -1.249 . . . . 1.44 111.698 172.391 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.1 mt -69.0 -33.73 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 117.425 -1.274 . . . . 1.32 112.666 168.38 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -65.2 -35.21 80.35 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.435 -1.32 . . . . 1.7 107.435 176.53 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.32 -26.9 68.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.041 2.237 . . . . 1.55 117.041 173.892 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -99.37 -69.71 0.76 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.522 1.629 . . . . 2.62 113.332 -172.734 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -84.8 -25.36 28.21 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.058 -2.901 . . . . 1.48 105.475 -169.314 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.88 58.88 2.56 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 107.928 -2.069 . . . . 1.12 107.928 178.948 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.3 mt -115.25 120.31 36.9 Favored Pre-proline 0 N--CA 1.43 -1.443 1 CA-C-O 110.705 -4.474 . . . . 1.55 107.411 -179.25 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -63.56 143.95 88.86 Favored 'Trans proline' 0 N--CA 1.434 -2.028 1 CA-C-N 128.555 4.091 . . . . 1.02 116.801 177.681 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -68.87 -18.37 41.33 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 CA-C-N 125.763 3.094 . . . . 1.25 115.015 -172.925 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.257 11.3 p-10 -77.51 -18.67 56.83 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 127.69 3.614 . . . . 2.25 113.729 178.413 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -90.32 -16.51 29.1 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 114.903 -4.873 . . . . 2.02 110.524 178.831 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -87.46 131.07 34.46 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 126.088 2.852 . . . . 0.69 116.638 -177.614 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -111.85 114.38 27.29 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.171 2.988 . . . . 2.78 111.304 172.361 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 39.5 mt -104.5 126.01 51.2 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 118.455 -2.653 . . . . 1.17 108.253 178.106 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.8 mt -119.72 153.76 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 N-CA-C 101.28 -3.6 . . . . 1.38 101.28 -179.185 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.567 ' HB3' HD21 ' A' ' 50' ' ' LEU 0.429 26.7 t80 -126.03 -73.15 0.63 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 119.052 -1.059 . . . . 1.5 112.738 167.964 . . . . . . . . 3 3 . 1 . 078 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.11 -40.12 8.57 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 114.115 -2.85 . . . . 1.21 115.29 178.768 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.89 -52.69 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 108.452 -1.859 . . . . 1.3 108.452 -175.873 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -89.12 163.46 15.45 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 122.084 2.942 . . . . 2.55 112.787 177.677 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -68.63 147.98 51.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 125.623 1.827 . . . . 2.48 112.053 170.669 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.567 HD21 ' HB3' ' A' ' 45' ' ' PHE . 24.1 mt -84.64 144.73 28.41 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 115.925 -1.988 . . . . 0.9 107.481 -175.436 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -90.97 155.38 18.76 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 125.799 3.908 . . . . 1.94 109.372 178.252 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -65.44 -57.85 7.27 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.87 3.268 . . . . 1.56 112.858 -172.81 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.67 62.62 1.64 Allowed Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 121.385 3.314 . . . . 0.97 121.385 168.506 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 ttm-85 -139.92 163.26 33.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 113.545 -1.328 . . . . 2.49 107.442 164.938 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.254 24.4 p -91.75 172.41 8.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.269 1.985 . . . . 0.76 112.149 -174.93 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.55 -46.0 64.38 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.322 -1.763 . . . . 1.05 111.065 168.594 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.273 1.2 t -63.51 -17.2 62.51 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.127 2.171 . . . . 1.19 114.747 175.733 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -77.73 -36.08 51.23 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 115.596 1.702 . . . . 1.9 115.596 170.268 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -87.22 7.08 29.98 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.289 1.995 . . . . 0.89 112.233 173.08 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 m120 44.06 59.83 3.02 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.887 3.675 . . . . 1.84 115.86 -174.649 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.449 HG12 ' CE2' ' A' ' 45' ' ' PHE . 46.8 mt -87.07 106.98 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 119.411 -2.055 . . . . 0.82 105.811 179.294 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -104.03 -170.31 1.76 Allowed 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 116.269 -0.423 . . . . 2.16 110.364 -179.97 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -27.99 137.46 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 130.16 3.384 . . . . 2.12 118.934 169.124 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 48.42 56.2 7.83 Favored 'General case' 0 N--CA 1.431 -1.385 1 C-N-CA 132.402 4.281 . . . . 1.71 114.948 176.679 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.4 m -116.91 135.45 53.71 Favored 'General case' 0 N--CA 1.432 -1.37 0 O-C-N 119.756 -1.84 . . . . 1.04 113.859 -173.938 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.2 m -102.35 99.87 9.98 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.195 2.998 . . . . 0.79 109.299 -176.471 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.61 135.35 48.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 116.339 -1.791 . . . . 1.4 111.968 169.465 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.6 m170 -91.11 100.37 13.22 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 127.864 2.466 . . . . 1.51 113.15 -176.898 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.2 tp -91.48 135.6 33.73 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 126.9 2.625 . . . . 1.14 114.083 177.681 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.6 t -135.16 120.46 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 129.841 3.256 . . . . 1.23 109.37 170.63 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.0 pp -91.56 149.22 21.77 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 124.366 3.257 . . . . 2.78 107.526 172.264 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -96.88 112.33 24.13 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 122.706 1.241 . . . . 3.75 113.235 -177.563 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 53.6 mt -71.34 172.11 9.99 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.317 1.969 . . . . 3.14 116.317 173.441 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.4 mtt85 -63.34 -80.98 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 115.274 1.583 . . . . 6.8 115.274 177.481 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.06 90.76 0.89 Allowed Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 106.858 -2.497 . . . . 3.57 106.858 -168.704 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.773 0 C-N-CA 127.419 2.437 . . . . 3.87 114.616 -175.293 . . . . . . . . 0 0 . 1 . 079 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ptt? . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 114.363 1.246 . . . . 1.1 114.363 . . . . . . . . . 0 0 . 1 . 079 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -89.05 127.82 35.71 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.281 -2.762 . . . . 1.87 107.456 -175.778 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.8 pt -114.73 162.53 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 115.254 1.575 . . . . 0.72 115.254 171.67 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 64' ' ' GLU . 36.1 m-85 -116.15 121.34 41.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.538 -3.226 . . . . 1.4 110.962 -175.883 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.0 t -103.2 124.45 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 1 O-C-N 116.009 -4.182 . . . . 0.58 110.592 176.49 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -99.62 135.98 40.23 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.38 1.446 . . . . 2.09 109.407 179.744 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.1 p -88.17 -175.49 5.07 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 117.235 -1.364 . . . . 0.99 113.665 176.053 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.3 mt -62.47 -52.52 63.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 124.724 1.265 . . . . 2.53 112.308 170.232 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.5 p -74.53 -12.98 60.61 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 115.591 -2.147 . . . . 2.08 110.472 -178.327 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.54 9.23 25.53 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 122.14 3.616 . . . . 1.31 122.14 173.291 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.49 140.87 54.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.493 2.092 . . . . 1.4 107.659 -177.006 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.7 m -108.33 104.83 14.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.498 -3.251 . . . . 0.78 112.458 177.128 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.7 mt -98.12 120.57 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 125.046 1.466 . . . . 1.55 107.8 -176.13 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 m -90.99 115.92 28.38 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 127.332 2.895 . . . . 1.08 108.708 178.357 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 mt -123.35 137.45 54.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.26 1.824 . . . . 1.55 107.83 -178.261 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.89 130.93 35.33 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 101.997 -3.335 . . . . 1.95 101.997 170.146 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -138.27 158.78 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 126.022 2.82 . . . . 0.96 108.968 174.472 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -102.6 153.35 38.23 Favored Pre-proline 0 N--CA 1.43 -1.433 1 O-C-N 115.211 -4.681 . . . . 2.35 107.034 161.105 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -76.67 -7.66 17.74 Favored 'Trans proline' 0 N--CA 1.433 -2.037 1 CA-C-N 128.475 4.063 . . . . 0.95 112.567 -167.753 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -80.95 -8.92 59.87 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 126.037 1.735 . . . . 1.45 108.776 -179.01 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -66.7 141.17 57.86 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.661 1.984 . . . . 1.69 113.063 171.001 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 82.3 p -82.66 168.01 17.69 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.875 -2.391 . . . . 0.75 114.557 173.435 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.1 mm -64.41 -32.31 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 117.795 -3.065 . . . . 0.73 112.437 173.107 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -58.65 -39.35 80.35 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 115.957 -4.214 . . . . 1.62 115.02 169.539 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -63.48 -43.44 97.28 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 127.837 2.455 . . . . 2.13 111.728 174.874 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.6 t -61.81 -47.05 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 126.814 2.046 . . . . 0.62 110.554 175.255 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -62.68 -30.61 71.52 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 119.559 3.17 . . . . 1.22 119.559 170.838 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.76 -28.66 61.79 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 123.075 1.416 . . . . 0.51 112.836 175.819 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.289 18.5 ttmm -80.18 -36.45 34.99 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 129.551 3.14 . . . . 1.44 114.041 173.317 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.443 68.7 mt -62.68 -44.75 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 127.796 2.438 . . . . 1.32 112.368 168.093 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -55.92 -52.19 65.0 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.518 -3.239 . . . . 1.7 114.251 169.872 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -60.58 -42.95 97.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.625 2.083 . . . . 1.55 116.625 175.058 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -86.22 -50.16 7.18 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.776 1.274 . . . . 2.62 110.516 -173.435 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -94.82 -41.97 8.95 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 116.643 -3.786 . . . . 1.48 114.003 -171.691 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.94 22.65 6.81 Favored Glycine 0 N--CA 1.431 -1.699 0 CA-C-O 124.279 2.044 . . . . 1.12 111.836 174.02 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.4 mt -94.89 131.9 29.43 Favored Pre-proline 0 N--CA 1.43 -1.442 0 O-C-N 118.891 -2.535 . . . . 1.55 104.856 -173.168 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -64.72 144.62 84.5 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 C-N-CA 124.685 3.59 . . . . 1.02 119.293 -179.931 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -71.65 -15.46 30.38 Favored 'Trans proline' 0 N--CA 1.433 -2.085 0 C-N-CA 114.745 -3.036 . . . . 1.25 113.757 -172.124 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -65.43 -25.29 67.46 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 118.395 2.739 . . . . 2.25 118.395 175.261 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -96.68 -25.22 15.63 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 116.13 -4.106 . . . . 2.02 105.472 -172.044 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -75.38 103.42 5.51 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.396 -3.94 . . . . 0.69 114.533 -177.382 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -94.77 129.57 41.66 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.425 -2.047 . . . . 2.78 109.203 165.605 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' A' ' 43' ' ' LEU . 42.9 mt -115.08 127.32 55.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.5 -2.0 . . . . 1.17 108.694 -179.494 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 9.5 mm -116.31 155.37 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 127.994 2.518 . . . . 1.38 104.597 173.958 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -104.73 -83.32 0.5 Allowed 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.88 -2.637 . . . . 1.5 103.88 174.218 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.99 -43.69 6.6 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 113.95 -1.477 . . . . 1.21 110.787 179.199 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -173.81 -16.9 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 127.254 2.359 . . . . 1.3 114.23 -179.007 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -82.2 124.73 30.17 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 102.758 -3.053 . . . . 2.55 102.758 178.864 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.04 130.69 45.03 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.349 -2.719 . . . . 2.48 112.166 173.73 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.1 mt -87.41 132.32 34.02 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.108 -2.87 . . . . 0.9 107.432 -175.094 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -94.25 138.18 32.55 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 117.704 -1.141 . . . . 1.94 113.122 177.75 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -50.6 -56.07 13.44 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 130.866 3.666 . . . . 1.56 113.339 -166.813 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.85 52.98 4.48 Favored Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 118.024 1.969 . . . . 0.97 118.024 172.963 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.0 mmt-85 -126.94 159.23 34.65 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 105.942 -1.873 . . . . 2.49 105.942 165.438 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.299 35.6 p -89.7 170.78 10.16 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.566 -2.583 . . . . 0.76 113.277 175.808 . . . . . . . . 3 3 . 1 . 079 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mt -73.3 -32.55 64.69 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 106.416 -1.698 . . . . 1.05 106.416 173.381 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -64.38 -43.56 94.12 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 117.079 -1.439 . . . . 1.19 110.195 177.959 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -46.02 -45.79 16.13 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 122.383 2.356 . . . . 1.9 113.801 173.791 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -82.42 6.68 16.43 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.338 -1.476 . . . . 0.89 114.946 178.45 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.4 m120 61.79 37.96 15.18 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 131.25 3.82 . . . . 1.84 116.684 176.09 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -86.65 128.01 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 127.043 2.137 . . . . 0.82 105.761 -177.57 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -142.94 -47.31 0.31 Allowed 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.243 -1.536 . . . . 2.16 113.333 -172.318 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -88.6 -162.36 0.84 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.333 1.453 . . . . 2.12 114.465 179.917 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.44 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 24.8 mt-10 -84.51 75.45 10.27 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.002 -2.937 . . . . 1.71 111.74 179.598 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 m -82.42 144.09 30.73 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 119.985 3.328 . . . . 1.04 119.985 -175.834 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.3 m -91.7 106.47 18.5 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.2 -1.364 . . . . 0.79 111.44 179.63 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -85.26 154.96 21.59 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 128.317 3.913 . . . . 1.4 105.963 166.126 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.425 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 69.9 m80 -115.17 119.04 35.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 111.791 -2.458 . . . . 1.51 106.637 -176.525 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.5 tp -105.08 99.7 9.31 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 105.118 -2.178 . . . . 1.14 105.118 178.096 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.6 t -86.88 125.39 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 113.478 -1.692 . . . . 1.23 111.017 171.283 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.3 mt -92.5 119.57 32.12 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.191 -2.193 . . . . 2.78 114.635 -179.111 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -76.17 95.54 3.71 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.407 1.099 . . . . 3.75 112.432 178.602 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.0 mt -104.37 -41.38 5.78 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 116.291 -4.005 . . . . 3.14 106.57 176.257 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -77.2 -59.43 2.78 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 120.886 1.676 . . . . 6.8 114.052 173.422 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.47 -82.15 0.12 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 118.487 -2.633 . . . . 3.57 110.059 -169.579 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.699 1 C-N-CA 131.285 4.278 . . . . 3.87 113.374 173.877 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.329 0 CA-C-O 119.556 -0.259 . . . . 1.1 111.252 . . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -114.0 113.26 24.54 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 101.531 -3.507 . . . . 1.87 101.531 -174.581 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.7 pt -92.52 166.66 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 122.601 2.455 . . . . 0.72 111.835 170.611 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -122.61 94.12 4.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.895 1.678 . . . . 1.4 110.831 176.142 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.4 t -77.05 115.11 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 O-C-N 118.035 -2.915 . . . . 0.58 113.557 174.742 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -94.84 128.89 41.91 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 117.083 -1.847 . . . . 2.09 113.74 -178.288 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 p -85.67 173.24 10.26 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 124.463 2.078 . . . . 0.99 109.914 177.126 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 mt -79.96 -33.97 39.13 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.242 -2.786 . . . . 2.53 108.406 172.845 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.9 p -71.77 -35.06 69.94 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 123.769 2.986 . . . . 2.08 113.568 179.898 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.81 8.41 0.92 Allowed Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 119.162 2.425 . . . . 1.31 119.162 176.957 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.0 tptt -96.94 144.55 26.75 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.898 -1.519 . . . . 1.4 106.898 -172.309 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.4 m -111.73 108.25 17.62 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.318 -2.845 . . . . 0.78 103.318 174.241 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.9 mt -82.27 111.1 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 113.526 -1.67 . . . . 1.55 108.276 179.472 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.5 m -85.23 106.84 16.95 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.194 1.398 . . . . 1.08 112.665 -178.756 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.4 mt -123.36 133.28 54.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 124.833 1.333 . . . . 1.55 107.871 -172.849 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -94.21 133.59 37.57 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.748 -1.845 . . . . 1.95 110.672 162.902 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.3 m -133.3 173.54 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 125.964 2.792 . . . . 0.96 108.997 176.744 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.267 39.5 mt-10 -123.42 167.08 15.79 Favored Pre-proline 0 N--CA 1.43 -1.451 0 N-CA-C 103.595 -2.743 . . . . 2.35 103.595 162.911 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -69.06 -11.54 32.0 Favored 'Trans proline' 0 N--CA 1.433 -2.065 0 N-CA-C 117.184 1.955 . . . . 0.95 117.184 179.395 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -79.27 -11.73 59.95 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 129.066 2.946 . . . . 1.45 112.07 179.001 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -74.76 141.22 44.42 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.16 -1.588 . . . . 1.69 113.098 175.425 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 57.2 p -84.46 164.35 18.89 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.865 -1.772 . . . . 0.75 107.957 174.875 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.275 1.9 mp -69.95 -27.77 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 119.232 -2.168 . . . . 0.73 113.429 178.86 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -53.34 -46.72 69.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.07 -2.269 . . . . 1.62 114.69 164.436 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -53.3 -40.8 65.04 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.532 -3.23 . . . . 2.13 113.714 172.633 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.06 -42.0 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 O-C-N 121.045 -1.034 . . . . 0.62 111.682 177.546 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -59.56 -36.89 77.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.057 -2.277 . . . . 1.22 115.03 173.634 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.17 73.64 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.052 2.095 . . . . 0.51 115.034 174.883 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -72.81 -37.19 67.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 131.418 3.887 . . . . 1.44 112.748 173.823 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.6 mt -73.6 -28.02 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 117.825 -3.047 . . . . 1.32 109.106 170.596 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -71.2 -35.22 71.47 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.859 -1.776 . . . . 1.7 110.228 176.613 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -69.64 -57.39 5.22 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.098 2.559 . . . . 1.55 109.066 176.41 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.254 22.6 mmtt -57.58 -73.44 0.07 Allowed 'General case' 0 CA--C 1.489 -1.384 0 C-N-CA 131.068 3.747 . . . . 2.62 115.104 178.449 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.276 47.0 mm-40 -88.73 -41.14 12.74 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.727 -2.483 . . . . 1.48 114.52 -168.105 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.62 34.43 2.86 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 126.421 1.962 . . . . 1.12 111.427 173.97 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.8 mm -92.93 135.31 26.15 Favored Pre-proline 0 N--CA 1.429 -1.488 0 CA-C-O 112.456 -3.64 . . . . 1.55 109.52 -177.586 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -75.48 136.02 18.93 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 CA-C-N 127.342 3.658 . . . . 1.02 112.638 176.75 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -60.9 -21.14 69.89 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 C-N-CA 123.574 2.85 . . . . 1.25 116.909 -173.629 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.55 -28.68 68.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 130.094 3.358 . . . . 2.25 113.135 172.814 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -80.98 -34.82 32.77 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 131.066 3.746 . . . . 2.02 113.663 -177.518 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -88.59 115.47 26.14 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 116.266 1.95 . . . . 0.69 116.266 -163.587 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -95.71 120.04 35.27 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.898 -2.376 . . . . 2.78 110.092 173.46 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 43' ' ' LEU 0.264 68.0 mt -97.43 99.17 10.6 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.132 1.787 . . . . 1.17 113.109 175.835 . . . . . . . . 3 3 . 1 . 080 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mm -95.05 130.65 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 128.857 2.863 . . . . 1.38 107.432 -174.788 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -111.7 -80.96 0.59 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 105.326 -2.102 . . . . 1.5 105.326 174.889 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.99 -95.67 0.35 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.777 -2.452 . . . . 1.21 111.016 -179.168 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.58 -4.12 54.91 Favored Glycine 0 N--CA 1.429 -1.772 0 O-C-N 119.551 -1.968 . . . . 1.3 113.634 -178.977 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -133.25 153.87 51.18 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.178 -2.366 . . . . 2.55 113.458 -177.581 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -82.31 141.41 32.91 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.045 -3.535 . . . . 2.48 109.483 162.948 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.8 mt -75.68 141.1 42.81 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.631 -2.543 . . . . 0.9 106.157 -178.909 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -86.42 137.34 32.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.204 -3.435 . . . . 1.94 115.077 176.773 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -53.03 -60.86 2.75 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 120.742 3.608 . . . . 1.56 120.742 -166.372 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.87 25.62 1.18 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 120.81 3.084 . . . . 0.97 120.81 170.128 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -113.87 159.82 19.43 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 127.325 2.427 . . . . 2.49 106.241 173.161 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 29.1 p -87.21 156.84 19.5 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.384 2.364 . . . . 0.76 117.384 -176.462 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.8 mt -53.62 -40.24 65.6 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 118.576 -2.577 . . . . 1.05 114.064 167.824 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.1 t -56.23 -36.69 68.76 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 115.573 1.694 . . . . 1.19 115.573 174.777 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -55.31 -30.49 60.32 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 120.795 3.628 . . . . 1.9 120.795 175.015 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -96.91 -1.24 46.22 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.843 -1.526 . . . . 0.89 109.906 -179.221 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.308 33.8 m-80 64.74 67.86 0.54 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.999 2.92 . . . . 1.84 109.44 -177.978 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.4 mt -124.34 114.02 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 1 C-N-CA 132.614 4.365 . . . . 0.82 101.794 179.851 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.25 57.0 mm-40 -139.77 -25.32 0.82 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 116.448 -1.739 . . . . 2.16 109.083 -176.104 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -107.45 -173.35 2.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 129.555 3.142 . . . . 2.12 110.977 -179.481 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -73.51 77.5 1.44 Allowed 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.938 1.295 . . . . 1.71 113.719 177.597 . . . . . . . . 3 3 . 1 . 080 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.379 54.3 p -80.06 158.56 26.43 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.046 1.339 . . . . 1.04 113.772 -170.386 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.48 HG22 ' CE1' ' A' ' 68' ' ' HIS . 2.9 m -107.96 115.46 30.17 Favored 'General case' 0 N--CA 1.431 -1.424 1 N-CA-C 99.636 -4.209 . . . . 0.79 99.636 179.097 . . . . . . . . 3 3 . 1 . 080 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mp -108.27 168.01 9.61 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 116.66 -3.775 . . . . 1.4 106.292 175.706 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.48 ' CE1' HG22 ' A' ' 66' ' ' THR . 86.3 m-70 -127.33 135.41 50.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.978 -1.701 . . . . 1.51 113.002 -178.554 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.259 42.0 tp -106.08 107.08 17.9 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.655 -2.528 . . . . 1.14 107.393 179.738 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 37.1 t -98.16 143.57 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 103.382 -2.821 . . . . 1.23 103.382 176.543 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.5 mt -110.97 141.74 44.02 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.404 -4.56 . . . . 2.78 112.227 178.022 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.436 HH21 ' C ' ' A' ' 76' ' ' GLY . 76.7 mtp180 -90.06 154.66 19.63 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 124.413 1.085 . . . . 3.75 112.726 174.945 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.9 mt -98.89 161.69 13.5 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 127.137 2.175 . . . . 3.14 107.822 -178.966 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 ptt-85 -69.81 129.85 40.67 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 126.612 2.445 . . . . 6.8 115.709 166.519 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.26 60.47 3.06 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-O 117.157 -1.913 . . . . 3.57 110.819 -159.605 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.436 ' C ' HH21 ' A' ' 72' ' ' ARG . . . . . . . . 0 C--O 1.26 1.724 0 CA-C-N 118.57 1.185 . . . . 3.87 111.147 -177.428 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ptt? . . . . . 0 CA--C 1.489 -1.387 0 CA-C-O 121.672 0.748 . . . . 1.1 112.948 . . . . . . . . . 0 0 . 1 . 081 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -95.54 137.88 33.99 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.939 -2.245 . . . . 1.87 104.939 -179.287 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.444 HD12 HD22 ' A' ' 67' ' ' LEU . 38.2 pt -123.14 155.95 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 124.398 2.047 . . . . 0.72 109.756 161.946 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -115.88 119.07 34.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.469 -3.269 . . . . 1.4 107.433 -172.363 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.495 HG22 ' HB2' ' A' ' 67' ' ' LEU . 40.0 t -110.83 117.89 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 119.032 -2.292 . . . . 0.58 106.028 -179.092 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -108.62 168.77 9.09 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 119.634 -0.827 . . . . 2.09 111.292 177.05 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -103.9 -165.93 1.2 Allowed 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 122.663 1.22 . . . . 0.99 109.743 173.979 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.0 tp -75.29 -49.99 17.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.136 2.174 . . . . 2.53 113.494 173.681 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.8 p -89.43 -37.68 14.64 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.122 -2.236 . . . . 2.08 114.445 -172.548 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.73 28.21 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.713 0 N-CA-C 121.981 3.552 . . . . 1.31 121.981 179.28 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -104.95 95.76 6.08 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 126.478 1.911 . . . . 1.4 114.366 -177.506 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.9 m -89.77 124.19 34.42 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 115.54 -2.464 . . . . 0.78 109.149 178.847 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 pt -119.32 128.57 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 117.688 -3.132 . . . . 1.55 107.5 172.675 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.3 m -95.76 122.94 39.07 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 116.133 -1.889 . . . . 1.08 110.016 -177.565 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.278 76.9 mt -119.89 128.17 53.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 121.925 2.148 . . . . 1.55 111.465 -177.502 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -80.03 122.23 26.49 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 125.487 1.742 . . . . 1.95 108.031 171.608 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 m -136.54 178.72 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 1 C-N-CA 131.797 4.039 . . . . 0.96 111.663 -173.963 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -125.84 162.55 44.65 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 113.046 -3.359 . . . . 2.35 107.303 166.411 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -74.16 -19.46 20.03 Favored 'Trans proline' 0 C--N 1.3 -2.013 1 CA-C-N 130.026 4.616 . . . . 0.95 111.886 -170.622 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.15 10.85 27.65 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 131.056 3.742 . . . . 1.45 110.925 -173.96 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -88.37 148.15 24.39 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.813 -3.679 . . . . 1.69 110.086 176.368 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 p -87.0 162.55 17.58 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.829 1.789 . . . . 0.75 115.829 -177.488 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.442 HD12 HD13 ' A' ' 50' ' ' LEU . 19.6 mm -66.47 -29.39 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 127.817 3.675 . . . . 0.73 114.859 173.389 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -58.51 -51.33 70.35 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 113.574 -5.704 . . . . 1.62 113.358 173.173 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -63.25 -40.02 96.24 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.69 1.596 . . . . 2.13 110.62 176.711 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.6 t -63.38 -33.91 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 117.729 -3.107 . . . . 0.62 116.077 176.455 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.487 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 37.4 mtmt -65.33 -32.18 73.7 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.17 -4.081 . . . . 1.22 111.8 174.386 . . . . . . . . 3 3 . 1 . 081 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.14 -23.35 62.99 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.191 1.796 . . . . 0.51 113.271 172.914 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -76.45 -41.18 48.28 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 126.307 2.955 . . . . 1.44 115.366 170.908 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.9 -35.13 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 118.608 -2.558 . . . . 1.32 109.672 171.139 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -62.81 -54.48 38.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.169 -3.457 . . . . 1.7 110.782 177.343 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -40.17 -52.44 2.59 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 125.619 1.567 . . . . 1.55 113.642 170.362 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -72.15 -67.05 0.57 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 115.958 1.836 . . . . 2.62 115.958 -176.818 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -101.38 -21.19 14.89 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.788 2.709 . . . . 1.48 113.829 -167.08 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.64 7.85 50.24 Favored Glycine 0 N--CA 1.43 -1.715 0 O-C-N 119.138 -2.226 . . . . 1.12 114.426 168.321 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.7 mt -81.46 117.8 69.65 Favored Pre-proline 0 N--CA 1.43 -1.433 0 N-CA-C 103.469 -2.789 . . . . 1.55 103.469 -166.614 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.91 137.28 61.73 Favored 'Trans proline' 0 N--CA 1.433 -2.066 0 C-N-CA 121.871 1.714 . . . . 1.02 114.231 -176.505 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -63.23 -8.82 15.35 Favored 'Trans proline' 0 N--CA 1.434 -1.999 0 N-CA-C 122.05 3.827 . . . . 1.25 122.05 -172.301 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -81.75 -14.35 56.58 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 119.929 -0.709 . . . . 2.25 112.0 168.668 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -90.77 -27.09 19.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.912 2.885 . . . . 2.02 110.38 -175.601 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.487 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 76.2 mt-30 -75.66 128.35 35.02 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 126.294 2.246 . . . . 0.69 114.76 -176.423 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -116.82 100.78 8.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.53 -3.856 . . . . 2.78 101.167 175.176 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 43' ' ' LEU . 94.4 mt -91.11 125.6 35.94 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 103.796 -2.668 . . . . 1.17 103.796 177.822 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 mm -120.76 130.97 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 103.888 -2.634 . . . . 1.38 103.888 178.907 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.667 ' HB2' HD21 ' A' ' 50' ' ' LEU . 1.8 t80 -84.32 -75.44 0.34 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 118.117 -0.945 . . . . 1.5 109.979 170.164 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.0 -77.63 0.59 Allowed 'General case' 0 N--CA 1.43 -1.429 2 O-C-N 115.822 -4.299 . . . . 1.21 104.909 173.589 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.8 -25.26 3.4 Favored Glycine 0 N--CA 1.429 -1.779 0 O-C-N 118.564 -2.585 . . . . 1.3 113.646 -177.971 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -84.43 138.08 33.03 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.835 -2.568 . . . . 2.55 117.503 176.66 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -71.0 142.37 50.96 Favored 'General case' 0 N--CA 1.431 -1.405 1 O-C-N 115.932 -4.23 . . . . 2.48 111.362 174.422 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' A' ' 45' ' ' PHE . 83.8 mt -90.98 141.85 28.4 Favored 'General case' 0 N--CA 1.429 -1.495 1 O-C-N 115.983 -4.198 . . . . 0.9 109.988 -175.835 . . . . . . . . 3 3 . 1 . 081 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -92.66 145.08 24.7 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 125.44 1.713 . . . . 1.94 111.935 -178.069 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.74 -63.36 1.33 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.383 2.04 . . . . 1.56 112.591 -167.619 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.4 39.37 2.49 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 116.745 -3.722 . . . . 0.97 116.106 177.184 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -115.56 159.38 21.33 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 121.511 2.656 . . . . 2.49 107.381 166.399 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.319 33.5 p -84.46 156.45 21.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 126.898 3.237 . . . . 0.76 110.754 176.777 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.1 mt -68.5 -25.94 65.21 Favored 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 111.544 -6.972 . . . . 1.05 115.287 171.776 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -66.65 -32.98 74.65 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.113 -3.492 . . . . 1.19 110.014 172.538 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -64.04 -34.08 77.2 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.075 -1.641 . . . . 1.9 114.47 171.382 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -89.42 -3.44 58.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.146 1.339 . . . . 0.89 111.892 177.025 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.6 m120 55.12 50.0 16.22 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 127.415 2.286 . . . . 1.84 115.948 -174.964 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.9 mt -77.88 126.99 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 113.161 -1.836 . . . . 0.82 108.6 178.474 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -102.46 175.35 5.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.111 1.764 . . . . 2.16 110.825 -176.28 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -72.97 -8.95 58.03 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 119.308 3.077 . . . . 2.12 119.308 177.604 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -106.85 7.48 30.19 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 125.707 1.879 . . . . 1.71 109.739 177.202 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 m -84.36 144.75 28.62 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.872 -1.768 . . . . 1.04 112.766 -171.635 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.3 m -110.32 120.04 41.14 Favored 'General case' 0 N--CA 1.431 -1.384 1 C-N-CA 133.065 4.546 . . . . 0.79 104.516 -177.007 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.495 ' HB2' HG22 ' A' ' 5' ' ' VAL . 7.9 mp -104.77 158.73 16.32 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.374 -2.825 . . . . 1.4 103.374 174.519 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -121.04 124.89 45.92 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.115 1.766 . . . . 1.51 109.413 -176.505 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.1 tp -105.7 99.73 9.32 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.897 1.681 . . . . 1.14 107.058 -177.812 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.7 152.04 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 105.682 -1.97 . . . . 1.23 105.682 171.247 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.2 mt -109.36 127.99 54.77 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.164 -2.21 . . . . 2.78 107.001 176.377 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -84.89 121.14 27.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.029 2.532 . . . . 3.75 109.406 178.113 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.5 mt -66.48 144.26 56.59 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.174 -3.454 . . . . 3.14 113.244 166.309 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -76.23 110.12 10.48 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 126.44 3.019 . . . . 6.8 109.317 169.664 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.94 -51.28 0.18 Allowed Glycine 0 N--CA 1.43 -1.733 0 O-C-N 116.707 -3.746 . . . . 3.57 105.743 -173.96 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.745 0 N-CA-C 106.494 -2.642 . . . . 3.87 106.494 175.534 . . . . . . . . 0 0 . 1 . 082 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 ptt? . . . . . 0 CA--C 1.489 -1.37 0 CA-C-O 124.694 2.188 . . . . 1.1 115.184 . . . . . . . . . 0 0 . 1 . 082 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -94.25 125.0 38.62 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.673 -2.517 . . . . 1.87 110.772 -179.715 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.6 pt -124.89 163.79 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 124.902 1.281 . . . . 0.72 112.339 171.696 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -114.42 159.18 20.59 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.137 2.875 . . . . 1.4 107.43 -178.248 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 60.0 t -143.05 134.34 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 102.539 -3.134 . . . . 0.58 102.539 177.283 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -113.73 131.78 56.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.856 1.312 . . . . 2.09 109.324 177.856 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.5 p -87.26 164.77 16.12 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 126.122 2.867 . . . . 0.99 107.801 179.845 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.1 mt -52.36 -56.71 13.09 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 116.173 -4.08 . . . . 2.53 114.696 170.647 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.4 p -69.51 -14.07 62.67 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.202 2.601 . . . . 2.08 114.142 -173.367 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.38 32.18 1.69 Allowed Glycine 0 N--CA 1.43 -1.745 1 N-CA-C 123.26 4.064 . . . . 1.31 123.26 169.246 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -111.6 148.43 33.33 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 115.217 -2.325 . . . . 1.4 114.955 -178.414 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.1 m -98.95 127.0 44.77 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 120.636 1.562 . . . . 0.78 108.067 175.712 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -103.73 123.6 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 125.991 2.805 . . . . 1.55 106.665 175.57 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.9 m -97.86 128.55 44.55 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.494 -3.879 . . . . 1.08 103.971 -178.096 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -125.61 133.08 52.36 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 121.688 2.04 . . . . 1.55 115.897 178.75 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -80.54 104.0 10.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 113.369 0.878 . . . . 1.95 113.369 162.318 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -114.9 154.1 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 119.211 -2.18 . . . . 0.96 109.583 177.967 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -113.86 151.39 44.7 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 102.923 -2.991 . . . . 2.35 102.923 164.261 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -68.29 -4.17 12.26 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-O 116.907 -1.372 . . . . 0.95 114.911 -173.39 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.2 p -93.11 -5.09 51.07 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.497 3.119 . . . . 1.45 113.065 -179.547 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -79.93 138.39 37.1 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.864 2.066 . . . . 1.69 108.132 174.599 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 39.3 p -76.22 173.78 10.95 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 128.392 3.949 . . . . 0.75 108.443 176.803 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.516 HG22 ' HE3' ' A' ' 27' ' ' LYS . 31.0 mm -74.67 -27.45 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 1 O-C-N 113.348 -5.845 . . . . 0.73 106.925 175.037 . . . . . . . . 3 3 . 1 . 082 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -65.6 -33.68 76.46 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 129.268 3.027 . . . . 1.62 111.433 172.079 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -83.96 -33.92 24.52 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.541 1.162 . . . . 2.13 111.825 172.867 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.26 29.0 t -64.62 -39.03 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 1 O-C-N 114.449 -5.157 . . . . 0.62 108.206 178.544 . . . . . . . . 3 2 . 1 . 082 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.516 ' HE3' HG22 ' A' ' 23' ' ' ILE 0.328 91.0 mttt -61.02 -47.87 84.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.23 -3.419 . . . . 1.22 113.528 173.486 . . . . . . . . 3 3 . 1 . 082 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.0 -39.65 63.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.849 -2.407 . . . . 0.51 109.648 170.961 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -61.22 -37.71 84.01 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.662 -4.398 . . . . 1.44 114.224 176.098 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.6 mt -77.7 -33.2 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 127.309 2.244 . . . . 1.32 112.101 171.851 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -60.77 -34.6 74.72 Favored 'General case' 0 N--CA 1.431 -1.384 1 O-C-N 115.647 -4.408 . . . . 1.7 118.452 171.902 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -67.83 -26.03 65.85 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 110.523 -3.035 . . . . 1.55 113.728 168.879 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -96.44 -58.52 2.04 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 104.633 -2.358 . . . . 2.62 104.633 -172.94 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -92.45 -44.38 8.69 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.776 -2.453 . . . . 1.48 115.145 -169.817 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.8 -11.0 10.24 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 119.299 -2.126 . . . . 1.12 111.402 176.718 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.0 mt -68.64 129.12 92.75 Favored Pre-proline 0 N--CA 1.429 -1.49 0 CA-C-O 112.896 -3.43 . . . . 1.55 109.165 -174.627 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -73.87 154.95 48.64 Favored 'Trans proline' 0 N--CA 1.433 -2.049 0 CA-C-N 126.783 3.458 . . . . 1.02 109.959 -174.667 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.39 -11.27 19.05 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 123.942 3.095 . . . . 1.25 111.654 -171.779 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -53.79 -59.14 5.0 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.906 2.482 . . . . 2.25 114.768 165.417 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -66.96 -23.79 65.99 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 118.911 2.93 . . . . 2.02 118.911 -177.871 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -83.97 134.69 34.64 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.415 1.886 . . . . 0.69 113.52 -170.311 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.255 47.8 mtt180 -119.34 114.44 22.36 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.382 -1.449 . . . . 2.78 109.847 172.11 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.0 mt -95.73 137.62 34.53 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.036 -1.839 . . . . 1.17 106.036 178.247 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.4 mt -135.37 136.78 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 128.261 2.625 . . . . 1.38 109.186 179.571 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -139.08 143.93 38.53 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 121.478 -0.764 . . . . 1.5 110.941 168.696 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.344 . . 54.4 27.57 8.35 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.712 -2.493 . . . . 1.21 115.499 176.658 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.88 -7.21 35.98 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-O 119.054 -0.859 . . . . 1.3 112.649 -170.583 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -87.2 139.93 30.06 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 123.032 3.416 . . . . 2.55 111.815 173.537 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -98.09 115.49 28.36 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.493 -2.004 . . . . 2.48 109.03 174.825 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 mt -83.24 159.42 21.97 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.425 -1.261 . . . . 0.9 112.961 -173.532 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -112.47 155.17 24.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 118.486 2.773 . . . . 1.94 118.486 172.471 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.51 -54.03 38.76 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 119.483 3.142 . . . . 1.56 119.483 -167.666 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.78 63.69 4.41 Favored Glycine 0 N--CA 1.431 -1.679 0 O-C-N 119.613 -1.929 . . . . 0.97 116.387 170.952 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -139.48 155.17 47.72 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.006 -2.22 . . . . 2.49 105.006 168.121 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 40.7 p -87.81 171.34 10.46 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.68 2.181 . . . . 0.76 109.481 176.274 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.0 mt -70.46 -37.69 74.34 Favored 'General case' 0 N--CA 1.43 -1.433 1 O-C-N 116.179 -4.076 . . . . 1.05 107.448 172.529 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.8 t -52.61 -45.83 66.74 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 118.5 2.778 . . . . 1.19 118.5 173.802 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -58.34 -53.74 54.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 130.7 3.6 . . . . 1.9 112.184 173.098 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -76.67 -2.1 31.11 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.863 -3.648 . . . . 0.89 115.876 -175.461 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.269 70.7 m-20 60.93 55.44 3.14 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.569 1.947 . . . . 1.84 116.036 -178.825 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.0 mt -106.76 128.01 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-O 115.586 -2.149 . . . . 0.82 108.925 174.872 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -107.39 -176.2 3.0 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 114.446 -2.692 . . . . 2.16 111.983 -170.024 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.1 ptmm? -59.14 146.48 38.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 126.706 2.504 . . . . 2.12 114.462 171.717 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.285 50.8 mt-10 69.87 20.5 6.68 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.281 1.515 . . . . 1.71 114.984 174.767 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.8 t -102.77 161.95 13.32 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 114.249 -1.341 . . . . 1.04 110.912 -171.917 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.2 m -121.18 120.12 34.31 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.629 -1.92 . . . . 0.79 114.144 -172.205 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 8.1 mt -92.15 164.06 13.71 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 122.749 1.262 . . . . 1.4 110.381 172.694 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -121.96 112.29 18.11 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.819 -3.051 . . . . 1.51 112.324 -179.234 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.5 tp -87.55 122.29 31.07 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 118.211 -2.806 . . . . 1.14 113.361 179.14 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.94 168.33 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 105.145 -2.169 . . . . 1.23 105.145 175.107 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.1 mt -122.32 169.51 10.86 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 116.24 -4.037 . . . . 2.78 108.782 -176.533 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -87.69 154.51 20.52 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.07 -1.085 . . . . 3.75 108.07 173.394 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 tt -151.88 -48.59 0.11 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 103.86 -2.645 . . . . 3.14 103.86 166.755 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -82.53 -49.44 9.89 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 120.849 1.659 . . . . 6.8 110.114 172.436 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.89 161.01 37.08 Favored Glycine 0 N--CA 1.429 -1.767 0 O-C-N 118.239 -2.788 . . . . 3.57 109.264 -168.809 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.778 0 C-N-CA 127.874 2.654 . . . . 3.87 112.236 170.812 . . . . . . . . 0 0 . 1 . 083 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 CA--C 1.491 -1.312 0 CA-C-O 127.519 3.533 . . . . 1.1 115.955 . . . . . . . . . 0 0 . 1 . 083 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -81.77 140.2 34.38 Favored 'General case' 0 N--CA 1.431 -1.407 1 O-C-N 113.473 -5.767 . . . . 1.87 110.601 -175.387 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.5 pt -131.47 159.47 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 119.818 -1.801 . . . . 0.72 106.606 177.136 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -120.08 100.12 7.01 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.949 1.833 . . . . 1.4 112.048 -175.532 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -91.09 111.99 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 103.968 -2.605 . . . . 0.58 103.968 177.195 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.254 68.2 mmtt -90.68 141.09 29.15 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.232 -2.792 . . . . 2.09 110.85 177.666 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.5 p -93.96 176.29 6.39 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 120.586 3.55 . . . . 0.99 120.586 172.229 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.6 tp -66.11 -43.83 86.07 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 126.35 1.86 . . . . 2.53 110.497 -177.559 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.8 p -78.36 -49.55 13.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.063 3.357 . . . . 2.08 120.063 -171.641 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.9 32.59 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 128.321 2.867 . . . . 1.31 120.073 174.565 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.35 149.44 31.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.373 -0.973 . . . . 1.4 108.373 178.482 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -104.59 138.06 41.5 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.667 -2.521 . . . . 0.78 106.752 171.835 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.265 3.2 mt -106.12 92.91 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 122.793 1.282 . . . . 1.55 109.391 175.177 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.8 m -78.81 116.58 19.23 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 119.97 -1.706 . . . . 1.08 109.709 174.812 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.7 mt -125.51 149.26 48.45 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 106.849 -1.537 . . . . 1.55 106.849 -179.773 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -85.2 109.81 18.58 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 127.31 2.881 . . . . 1.95 117.386 165.227 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -121.88 164.07 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 121.879 2.127 . . . . 0.96 110.008 -178.799 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -112.06 157.75 38.85 Favored Pre-proline 0 N--CA 1.43 -1.435 0 C-N-CA 125.529 1.532 . . . . 2.35 109.482 164.858 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -86.48 -0.29 8.15 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 CA-C-N 125.658 3.057 . . . . 0.95 110.902 -170.281 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.1 p -89.82 -14.82 33.62 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 129.657 3.183 . . . . 1.45 111.251 175.205 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -68.03 142.37 55.91 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 127.086 3.327 . . . . 1.69 107.816 173.934 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.2 p -79.69 160.95 26.1 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.795 -2.441 . . . . 0.75 111.429 174.003 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mm -66.58 -27.17 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 1 O-C-N 115.628 -4.42 . . . . 0.73 111.743 171.513 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -56.98 -45.57 82.85 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 129.056 2.942 . . . . 1.62 109.836 167.913 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -65.45 -52.1 55.46 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.146 2.578 . . . . 2.13 111.752 176.626 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.82 -37.36 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 128.866 2.866 . . . . 0.62 109.404 177.046 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.84 -36.42 82.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 121.292 1.86 . . . . 1.22 115.467 174.81 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -24.81 67.78 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.257 1.206 . . . . 0.51 114.257 166.406 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -82.52 -25.57 33.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.756 -3.715 . . . . 1.44 111.618 173.747 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.8 mt -77.53 -29.09 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 117.915 -2.991 . . . . 1.32 111.103 175.093 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -66.61 -43.31 85.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 127.462 2.976 . . . . 1.7 111.567 173.536 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.263 31.6 t70 -49.6 -39.77 36.64 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 116.752 2.13 . . . . 1.55 116.752 168.03 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -86.07 -61.69 1.69 Allowed 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 118.289 2.7 . . . . 2.62 118.289 -178.153 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -95.19 -11.74 27.56 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.088 1.355 . . . . 1.48 113.052 -174.083 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.65 24.77 71.63 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 117.257 -3.402 . . . . 1.12 118.334 179.696 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.5 mt -99.62 132.37 23.21 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 116.852 -3.734 . . . . 1.55 110.218 -169.848 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 11.1 Cg_endo -72.91 152.51 52.11 Favored 'Trans proline' 0 C--N 1.299 -2.038 1 C-N-CA 125.518 4.145 . . . . 1.02 113.536 -175.255 . . . . . . . . 3 3 . 1 . 083 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 64.9 Cg_exo -66.92 -36.61 22.38 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 O-C-N 115.322 -3.041 . . . . 1.25 112.947 -175.046 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.26 -25.74 67.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 124.715 2.198 . . . . 2.25 115.774 178.405 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -91.24 -22.91 20.36 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.29 -1.506 . . . . 2.02 109.811 179.783 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -78.84 135.89 37.17 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.831 -3.043 . . . . 0.69 112.239 -177.517 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.346 38.2 ttt180 -124.25 123.51 40.39 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 116.973 -3.579 . . . . 2.78 109.288 167.948 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mt -105.63 127.17 52.9 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.672 2.177 . . . . 1.17 108.885 179.682 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.3 mm -114.37 143.17 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 131.273 3.829 . . . . 1.38 106.816 -177.683 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -131.07 100.05 5.09 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.723 -3.111 . . . . 1.5 107.973 175.998 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.351 . . 66.76 -61.53 0.32 Allowed 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 129.22 3.008 . . . . 1.21 114.856 -173.031 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.09 -24.31 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 106.538 -2.625 . . . . 1.3 106.538 -176.079 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -90.08 153.41 20.57 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.094 -2.416 . . . . 2.55 110.481 177.237 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -97.73 140.59 31.9 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 102.072 -3.307 . . . . 2.48 102.072 179.184 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.2 mt -116.47 127.08 54.25 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 115.961 -1.971 . . . . 0.9 110.767 -173.023 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -83.31 157.1 22.73 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 118.635 2.828 . . . . 1.94 118.635 -179.419 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -59.87 -63.85 1.16 Allowed 'General case' 0 N--CA 1.43 -1.444 1 N-CA-C 121.829 4.011 . . . . 1.56 121.829 -167.02 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.21 31.79 2.58 Favored Glycine 0 N--CA 1.43 -1.754 0 CA-C-N 113.572 -1.649 . . . . 0.97 117.114 172.05 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -98.25 164.77 12.17 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.486 -3.361 . . . . 2.49 109.04 159.616 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.455 11.9 p -95.69 172.83 7.8 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.65 2.38 . . . . 0.76 109.855 172.615 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.6 mp -76.01 -37.96 57.86 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.979 -1.009 . . . . 1.05 109.607 171.098 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -48.97 -50.03 37.62 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 116.588 2.07 . . . . 1.19 116.588 175.433 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -56.28 -35.44 67.49 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.352 2.661 . . . . 1.9 115.367 176.126 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -99.45 6.72 45.89 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.835 1.654 . . . . 0.89 112.849 178.342 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.9 m120 53.87 37.89 27.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.53 2.048 . . . . 1.84 116.53 -178.811 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.2 mm -82.27 114.69 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 126.691 1.996 . . . . 0.82 107.88 -173.896 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -103.61 -177.22 3.31 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.779 -2.451 . . . . 2.16 110.731 -173.61 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -58.45 146.29 35.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 127.143 2.177 . . . . 2.12 113.08 179.425 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.276 72.9 mt-10 64.03 19.42 11.75 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 128.325 3.516 . . . . 1.71 118.119 172.957 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.6 m -88.48 151.33 22.62 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.91 -1.885 . . . . 1.04 105.91 -168.778 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.0 m -90.12 110.38 21.39 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.269 2.228 . . . . 0.79 107.716 -179.364 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -102.34 155.76 18.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 102.214 -3.254 . . . . 1.4 102.214 174.055 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -129.16 128.24 43.01 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.974 -4.204 . . . . 1.51 115.34 -176.781 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.0 tp -108.34 124.21 50.0 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 124.749 1.281 . . . . 1.14 112.28 -174.686 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.431 15.6 m -118.17 -179.3 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 130.481 3.512 . . . . 1.23 108.812 170.202 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.1 mt -131.41 150.92 51.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.398 -3.938 . . . . 2.78 113.099 179.038 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -84.48 160.11 20.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 127.628 3.08 . . . . 3.75 114.076 176.645 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.8 mt -104.19 -179.38 3.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.704 -2.702 . . . . 3.14 103.704 168.499 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.8 mtt85 -79.39 155.12 28.53 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.97 -2.956 . . . . 6.8 112.774 168.825 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.93 -137.05 12.82 Favored Glycine 0 N--CA 1.43 -1.762 0 O-C-N 118.336 -2.727 . . . . 3.57 108.718 -161.746 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.825 0 C-N-CA 117.798 -2.144 . . . . 3.87 108.783 174.075 . . . . . . . . 0 0 . 1 . 084 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 CA--C 1.489 -1.382 0 N-CA-C 115.709 1.744 . . . . 1.1 115.709 . . . . . . . . . 0 0 . 1 . 084 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -74.82 134.64 41.71 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 118.079 -0.962 . . . . 1.87 111.048 -177.683 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.445 HD12 HD12 ' A' ' 67' ' ' LEU . 45.5 pt -131.15 173.38 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-O 127.385 3.469 . . . . 0.72 108.341 174.769 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.439 ' HB2' ' HA ' ' A' ' 66' ' ' THR 0.251 22.9 m-85 -127.41 134.83 49.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.519 -3.238 . . . . 1.4 105.653 -171.465 . . . . . . . . 3 3 . 1 . 084 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -116.69 114.59 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.545 -2.021 . . . . 0.58 105.545 178.554 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -107.98 137.02 46.7 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 116.18 -4.075 . . . . 2.09 109.779 178.367 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.2 p -83.69 166.77 17.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.531 -1.981 . . . . 0.99 115.157 173.167 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.8 mt -39.14 -51.9 1.9 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 120.903 3.668 . . . . 2.53 120.903 167.021 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.8 p -82.99 -32.28 27.06 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 116.697 -3.752 . . . . 2.08 110.061 -175.544 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.44 24.66 0.16 Allowed Glycine 0 N--CA 1.43 -1.717 0 O-C-N 119.407 -2.058 . . . . 1.31 116.758 172.066 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -88.41 123.18 32.71 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.207 1.504 . . . . 1.4 112.707 -175.791 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -83.93 115.84 22.49 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 120.726 3.602 . . . . 0.78 120.726 172.939 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.4 mt -108.24 141.08 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 124.911 1.284 . . . . 1.55 111.136 176.352 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.8 m -116.97 137.21 52.37 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.523 -1.986 . . . . 1.08 107.152 178.419 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.8 mt -135.96 144.11 45.23 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.219 1.407 . . . . 1.55 112.007 -179.435 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -93.59 115.83 28.33 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.004 0.82 . . . . 1.95 111.168 169.283 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.53 HG11 HG22 ' A' ' 26' ' ' VAL . 11.5 m -118.57 173.4 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 101.914 -3.365 . . . . 0.96 101.914 178.377 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -118.25 160.24 40.19 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 103.488 -2.782 . . . . 2.35 103.488 167.435 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -64.71 -18.28 62.1 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 C-N-CA 124.558 3.505 . . . . 0.95 117.25 -173.183 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 m -104.08 19.72 19.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 126.622 2.451 . . . . 1.45 107.563 -178.346 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -82.03 140.96 33.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 113.449 0.907 . . . . 1.69 113.449 171.168 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.264 68.2 p -80.02 156.22 27.25 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.563 2.125 . . . . 0.75 113.491 174.99 . . . . . . . . 3 3 . 1 . 084 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.3 mm -58.62 -41.12 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.663 1.585 . . . . 0.73 111.621 175.074 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -46.54 -44.72 18.14 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.701 -1.875 . . . . 1.62 114.992 168.276 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -71.21 -35.58 71.57 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 125.658 1.583 . . . . 2.13 111.276 179.678 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.53 HG22 HG11 ' A' ' 17' ' ' VAL . 5.5 t -58.38 -45.69 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 117.587 -3.196 . . . . 0.62 114.199 167.989 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -65.77 -35.49 80.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 114.169 -2.824 . . . . 1.22 111.353 170.0 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.04 -29.21 68.13 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 123.365 2.802 . . . . 0.51 111.539 175.085 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.6 mttm -65.71 -21.98 66.57 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.571 -1.331 . . . . 1.44 114.049 171.752 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.2 mm -85.94 -23.92 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 127.252 2.221 . . . . 1.32 105.911 170.073 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.426 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 50.4 tt0 -77.04 -23.03 52.11 Favored 'General case' 0 N--CA 1.429 -1.482 2 O-C-N 114.538 -5.101 . . . . 1.7 111.265 173.717 . . . . . . . . 3 3 . 1 . 084 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -74.51 -40.45 61.77 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 114.716 1.376 . . . . 1.55 114.716 167.571 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -87.35 -66.31 0.92 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 116.592 2.071 . . . . 2.62 116.592 179.093 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -82.52 -32.11 28.85 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 118.057 -1.457 . . . . 1.48 109.625 -172.101 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.75 43.05 3.45 Favored Glycine 0 N--CA 1.429 -1.776 0 O-C-N 116.78 -3.7 . . . . 1.12 114.155 -176.193 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.4 mt -120.38 136.78 25.46 Favored Pre-proline 0 N--CA 1.429 -1.5 1 N-CA-C 99.808 -4.145 . . . . 1.55 99.808 -174.721 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -67.84 152.66 77.08 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 O-C-N 115.767 -2.807 . . . . 1.02 113.845 176.798 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.426 ' HD3' ' OE1' ' A' ' 31' ' ' GLN . 63.1 Cg_endo -78.41 -12.93 15.31 Favored 'Trans proline' 0 N--CA 1.433 -2.079 0 C-N-CA 117.529 -1.181 . . . . 1.25 110.713 -173.277 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -72.6 -38.5 67.82 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.347 -2.095 . . . . 2.25 113.89 170.885 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -69.97 -25.67 63.74 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.327 -2.733 . . . . 2.02 111.085 178.308 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -89.35 143.62 26.69 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.384 2.673 . . . . 0.69 115.873 -171.817 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -132.0 150.38 52.17 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 115.709 -2.091 . . . . 2.78 107.966 167.503 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.9 mt -106.14 138.85 41.6 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 124.553 3.342 . . . . 1.17 110.017 174.355 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 mt -112.67 146.12 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-O 125.03 2.347 . . . . 1.38 106.372 172.251 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.45 ' HB3' HD11 ' A' ' 50' ' ' LEU . 83.8 t80 -165.36 137.08 4.09 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 127.756 3.646 . . . . 1.5 105.166 174.653 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.53 19.51 11.53 Favored 'General case' 0 N--CA 1.431 -1.4 1 O-C-N 116.052 -4.155 . . . . 1.21 113.775 -176.622 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.13 -22.8 32.61 Favored Glycine 0 N--CA 1.431 -1.669 0 O-C-N 119.177 -2.202 . . . . 1.3 113.826 -175.5 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -93.0 157.54 16.26 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 121.539 3.903 . . . . 2.55 121.539 176.403 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -94.45 133.91 37.53 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 116.973 -1.891 . . . . 2.48 111.106 174.226 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 45' ' ' PHE . 19.9 mt -81.13 133.23 35.43 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.106 1.362 . . . . 0.9 113.069 -172.927 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -67.3 142.98 56.67 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.273 1.035 . . . . 1.94 109.725 170.136 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -77.0 -56.43 4.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.154 1.454 . . . . 1.56 110.381 -168.553 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.16 40.87 1.74 Allowed Glycine 0 N--CA 1.43 -1.765 1 O-C-N 116.225 -4.047 . . . . 0.97 118.198 171.33 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -117.73 161.2 20.08 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.626 -3.279 . . . . 2.49 106.555 167.745 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.5 p -86.23 177.19 7.58 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.094 -1.629 . . . . 0.76 114.233 176.11 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.0 mt -70.45 -44.69 67.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.672 -1.893 . . . . 1.05 110.4 176.106 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 t -63.01 -30.54 71.68 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.239 1.57 . . . . 1.19 115.239 -178.811 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -57.26 -46.7 82.81 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.806 2.442 . . . . 1.9 107.269 177.596 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.263 24.2 m-85 -87.15 -1.86 58.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.208 -3.432 . . . . 0.89 116.515 177.121 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 71.88 52.8 0.21 Allowed 'General case' 0 N--CA 1.43 -1.459 1 C-N-CA 133.87 4.868 . . . . 1.84 107.268 178.047 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 mt -96.7 126.27 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.123 -2.236 . . . . 0.82 107.747 -179.455 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.408 31.0 mt-30 -96.76 -167.49 1.56 Allowed 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 121.153 -0.967 . . . . 2.16 110.127 -171.582 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -75.05 151.32 38.7 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.699 1.6 . . . . 2.12 112.79 167.848 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.295 8.8 mt-10 66.6 27.31 9.59 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.579 2.351 . . . . 1.71 114.053 172.856 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.9 t -108.98 134.82 51.12 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 117.183 -3.448 . . . . 1.04 110.648 -172.961 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 97.9 m -82.11 104.21 12.28 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.449 2.547 . . . . 0.79 115.324 -178.346 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.445 HD12 HD12 ' A' ' 3' ' ' ILE . 93.6 mt -91.58 129.23 37.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.142 -2.849 . . . . 1.4 108.922 177.953 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -92.19 115.54 28.17 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.348 -2.72 . . . . 1.51 108.666 -173.22 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.4 tp -86.52 134.2 33.68 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 113.558 -3.115 . . . . 1.14 115.742 179.946 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 m -132.11 -172.63 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 127.892 3.245 . . . . 1.23 108.78 170.427 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.0 mt -114.82 -179.12 3.54 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.317 1.847 . . . . 2.78 110.279 176.315 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.258 12.5 ptt180 -76.47 161.42 28.66 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 125.567 1.792 . . . . 3.75 113.853 179.874 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.1 mt -93.93 166.75 12.02 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 124.744 1.217 . . . . 3.14 110.816 166.733 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.256 26.2 mmt180 -98.69 150.9 21.31 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.071 -1.455 . . . . 6.8 107.071 170.004 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.24 -139.09 6.32 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 127.381 2.419 . . . . 3.57 111.182 -170.374 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.806 0 CA-C-O 125.46 2.7 . . . . 3.87 110.925 177.157 . . . . . . . . 0 0 . 1 . 085 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptt? . . . . . 0 CA--C 1.49 -1.328 0 N-CA-C 107.841 -1.17 . . . . 1.1 107.841 . . . . . . . . . 0 0 . 1 . 085 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -121.55 144.81 48.51 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 119.941 -0.704 . . . . 1.87 111.656 -176.02 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.2 pt -129.06 163.74 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 120.042 -1.661 . . . . 0.72 110.038 175.167 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -111.42 114.31 27.35 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.366 2.508 . . . . 1.4 108.539 -178.647 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 81.4 t -103.76 126.33 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 118.252 -2.78 . . . . 0.58 105.985 169.347 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -107.16 127.49 53.56 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 125.638 1.836 . . . . 2.09 110.385 174.109 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.3 p -81.15 170.31 16.3 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 129.805 3.242 . . . . 0.99 113.154 173.09 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.9 mt -67.2 -30.6 70.58 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.271 -2.143 . . . . 2.53 114.086 174.701 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 p -85.7 -5.42 59.26 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.556 -1.275 . . . . 2.08 107.556 -174.677 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.92 1.49 36.36 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 115.225 0.85 . . . . 1.31 115.225 170.592 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -78.64 114.57 17.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 118.54 1.17 . . . . 1.4 112.518 -178.123 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 m -79.64 130.44 35.37 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 120.708 1.595 . . . . 0.78 110.497 170.052 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mt -109.19 119.15 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 131.541 3.936 . . . . 1.55 106.554 174.528 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.2 m -92.41 95.66 9.79 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 107.143 -1.429 . . . . 1.08 107.143 178.765 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.3 mt -96.2 139.07 32.89 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 117.937 2.569 . . . . 1.55 117.937 -177.149 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -59.76 114.49 2.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 111.127 -2.761 . . . . 1.95 109.289 163.56 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.298 13.7 m -136.6 166.19 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 126.983 2.113 . . . . 0.96 109.708 173.795 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -125.28 162.42 44.18 Favored Pre-proline 0 N--CA 1.43 -1.473 0 N-CA-C 101.258 -3.608 . . . . 2.35 101.258 171.892 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -81.93 -6.55 12.29 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 O-C-N 117.739 -1.769 . . . . 0.95 107.909 -175.79 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.7 p -99.82 16.98 21.93 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.247 1.573 . . . . 1.45 115.247 176.445 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -78.14 144.29 36.54 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 129.56 3.144 . . . . 1.69 106.123 172.952 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.0 p -83.4 154.53 23.95 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.01 1.724 . . . . 0.75 111.586 175.548 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.0 mm -67.72 -36.3 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 124.897 1.373 . . . . 0.73 110.145 -179.523 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -59.95 -41.97 93.02 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.573 -1.955 . . . . 1.62 111.92 169.977 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.3 28.4 t-20 -61.55 -37.16 82.77 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.75 -3.094 . . . . 2.13 114.738 177.256 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.9 t -53.33 -51.39 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 124.522 1.138 . . . . 0.62 113.329 169.676 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -59.96 -31.86 70.27 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 114.071 1.137 . . . . 1.22 114.071 174.38 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.22 -33.45 73.32 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.168 -2.207 . . . . 0.51 113.376 170.893 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -71.2 -26.04 62.77 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 122.397 2.362 . . . . 1.44 110.247 173.544 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.3 mt -76.99 -26.54 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-N 121.28 1.855 . . . . 1.32 106.585 173.786 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -68.9 -48.51 63.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 121.194 1.816 . . . . 1.7 109.755 176.75 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -51.18 -39.08 55.63 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.071 -2.893 . . . . 1.55 113.616 174.184 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -82.92 -71.11 0.51 Allowed 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.877 2.471 . . . . 2.62 106.221 -174.978 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -100.42 -45.14 5.66 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.051 2.982 . . . . 1.48 119.051 -166.292 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.78 74.25 0.85 Allowed Glycine 0 N--CA 1.431 -1.694 0 CA-C-O 124.748 2.305 . . . . 1.12 115.946 166.37 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.89 127.24 23.94 Favored Pre-proline 0 N--CA 1.43 -1.466 0 CA-C-N 110.804 -2.698 . . . . 1.55 105.54 -178.724 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -58.42 134.92 64.48 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 CA-C-O 112.481 -3.216 . . . . 1.02 118.075 176.851 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -65.44 -14.97 47.68 Favored 'Trans proline' 0 C--N 1.299 -2.046 1 C-N-CA 126.51 4.807 . . . . 1.25 120.528 -174.407 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.85 -20.34 35.79 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.338 -2.101 . . . . 2.25 111.06 167.44 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -87.11 -29.02 22.15 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.517 1.962 . . . . 2.02 114.438 -175.476 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.329 1.5 pt20 -78.95 135.62 37.0 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 115.067 -2.397 . . . . 0.69 110.041 -176.468 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.31 65.9 mtt180 -104.15 136.44 43.77 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 128.482 3.614 . . . . 2.78 110.047 164.834 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.5 mt -108.89 132.83 53.67 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 126.67 3.128 . . . . 1.17 110.072 172.116 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 53.7 mt -119.58 142.06 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 118.822 -2.423 . . . . 1.38 106.51 -178.831 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -157.89 141.15 15.24 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 100.603 -3.851 . . . . 1.5 100.603 171.98 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.56 -44.96 0.61 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.385 3.074 . . . . 1.21 116.394 -173.948 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 166.78 -48.42 0.26 Allowed Glycine 0 N--CA 1.43 -1.731 0 CA-C-O 124.646 2.248 . . . . 1.3 109.598 -170.923 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -83.09 -179.97 7.58 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.443 2.016 . . . . 2.55 116.443 178.752 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -96.53 147.7 23.58 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.433 -2.042 . . . . 2.48 111.502 170.87 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.6 mt -94.54 134.11 37.45 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 104.583 -2.377 . . . . 0.9 104.583 -176.105 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -86.09 137.34 32.75 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.717 0.77 . . . . 1.94 111.436 176.478 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.13 -57.99 5.73 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.935 3.694 . . . . 1.56 117.746 -168.95 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.98 44.16 3.28 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 124.639 3.381 . . . . 0.97 120.041 176.318 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 -115.65 173.26 6.63 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.733 2.682 . . . . 2.49 104.479 165.685 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.7 p -108.88 173.8 6.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.534 -1.666 . . . . 0.76 112.258 176.406 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.15 -37.28 72.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 114.856 1.428 . . . . 1.05 114.856 170.062 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -57.51 -42.0 81.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.397 -2.689 . . . . 1.19 113.73 174.539 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -52.21 -41.22 62.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.185 2.661 . . . . 1.9 118.185 173.461 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -88.99 -16.06 32.64 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 128.366 2.667 . . . . 0.89 108.251 178.139 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.419 12.0 m-80 72.83 48.56 0.19 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.776 -1.203 . . . . 1.84 111.395 179.434 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.6 mt -87.92 122.22 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.97 -2.331 . . . . 0.82 107.954 -172.993 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -87.39 -177.12 5.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 117.38 -1.728 . . . . 2.16 114.373 -173.543 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.256 14.8 pttp -63.43 140.37 58.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.952 -3.593 . . . . 2.12 110.969 167.358 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 68.42 30.18 5.47 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 127.937 2.495 . . . . 1.71 111.642 177.908 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.1 m -88.02 145.24 26.08 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 119.097 -2.252 . . . . 1.04 113.278 -172.79 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.3 m -92.27 119.68 32.1 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 118.302 -2.749 . . . . 0.79 112.953 -179.923 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mt -104.95 131.36 52.55 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 119.7 -1.875 . . . . 1.4 107.718 165.3 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -94.92 135.51 36.35 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 103.701 -2.703 . . . . 1.51 103.701 -178.719 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.7 tp -106.96 123.17 47.79 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 127.226 2.211 . . . . 1.14 110.666 -172.18 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.329 0.1 OUTLIER -121.63 167.89 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.578 1.951 . . . . 1.23 112.596 176.499 . . . . . . . . 3 3 . 1 . 085 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.0 mt -127.18 140.15 52.44 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 125.66 1.85 . . . . 2.78 108.697 177.979 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -84.92 168.98 14.52 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.436 2.065 . . . . 3.75 112.505 172.353 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.8 mt -84.35 108.7 17.33 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.412 -3.305 . . . . 3.14 110.516 174.721 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -72.71 -57.62 3.97 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.842 -1.54 . . . . 6.8 106.842 168.137 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.34 88.53 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.752 1 O-C-N 116.287 -4.008 . . . . 3.57 106.265 -172.072 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.802 0 C-N-CA 116.313 -2.851 . . . . 3.87 116.327 -171.412 . . . . . . . . 0 0 . 1 . 086 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 CA--C 1.491 -1.321 0 CA-C-O 116.583 -1.675 . . . . 1.1 114.993 . . . . . . . . . 0 0 . 1 . 086 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -93.35 122.81 36.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 128.69 2.796 . . . . 1.87 106.769 -177.367 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 pt -119.65 170.17 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 124.553 2.121 . . . . 0.72 108.124 169.539 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.263 72.7 m-85 -122.09 144.56 48.85 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.185 -3.447 . . . . 1.4 110.645 -179.652 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.83 128.9 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 120.482 -1.386 . . . . 0.58 108.045 173.327 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -93.28 132.36 37.54 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.753 -3.092 . . . . 2.09 108.573 171.206 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.9 p -74.16 -169.99 0.88 Allowed 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 117.338 2.347 . . . . 0.99 117.338 177.105 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.2 mt -72.69 -62.44 1.45 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.225 2.61 . . . . 2.53 106.377 173.743 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.8 p -56.76 -56.34 22.76 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 120.383 3.475 . . . . 2.08 120.383 -175.178 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.38 43.55 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.764 0 CA-C-O 119.219 -0.767 . . . . 1.31 111.35 177.968 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -126.49 155.56 42.12 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 130.279 3.432 . . . . 1.4 104.334 -179.002 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.9 m -125.32 119.05 27.3 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 104.839 -2.282 . . . . 0.78 104.839 -178.94 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -95.52 148.88 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 103.483 -2.784 . . . . 1.55 103.483 -176.421 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.3 m -117.41 117.85 30.6 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.452 2.548 . . . . 1.08 106.231 177.296 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.2 mt -116.37 138.19 51.54 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.7 -2.5 . . . . 1.55 111.179 -174.517 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.12 106.15 18.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.724 2.009 . . . . 1.95 115.143 170.713 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 m -127.87 167.79 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 125.538 2.589 . . . . 0.96 108.549 -172.937 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -110.1 161.78 23.03 Favored Pre-proline 0 N--CA 1.43 -1.453 0 O-C-N 116.584 -3.823 . . . . 2.35 108.257 162.682 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -73.06 -12.12 25.67 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-N 124.72 2.721 . . . . 0.95 113.275 -177.245 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 m -83.7 -9.14 59.05 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 115.124 -2.369 . . . . 1.45 109.339 175.523 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -74.0 155.86 38.15 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 124.391 3.269 . . . . 1.69 111.138 178.251 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.6 p -95.73 164.44 12.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.5 -1.375 . . . . 0.75 110.411 -177.19 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.6 mm -62.47 -31.11 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 124.581 1.153 . . . . 0.73 112.032 175.934 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -58.71 -47.52 84.29 Favored 'General case' 0 N--CA 1.429 -1.499 1 C-N-CA 134.097 4.959 . . . . 1.62 114.611 162.383 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.281 29.4 m120 -66.21 -37.95 86.8 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.483 -3.26 . . . . 2.13 106.93 178.947 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.4 t -71.2 -25.95 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 1 O-C-N 115.045 -4.784 . . . . 0.62 117.875 176.415 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -81.96 -32.92 30.49 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 104.635 -2.357 . . . . 1.22 104.635 178.994 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.4 68.0 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.872 -3.642 . . . . 0.51 111.407 172.715 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -67.15 -28.19 67.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 125.867 1.979 . . . . 1.44 109.921 171.595 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.1 mt -75.39 -18.04 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 116.514 -3.866 . . . . 1.32 113.93 170.138 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -68.35 -27.75 66.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 119.715 1.143 . . . . 1.7 111.694 167.667 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -68.57 -51.74 39.39 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.385 -3.322 . . . . 1.55 112.338 165.638 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -68.81 -74.81 0.12 Allowed 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.926 -2.359 . . . . 2.62 117.256 -175.603 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -90.73 -15.24 30.58 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 124.389 1.055 . . . . 1.48 113.122 -176.6 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.38 48.47 5.94 Favored Glycine 0 N--CA 1.43 -1.723 0 C-N-CA 119.276 -1.44 . . . . 1.12 115.967 168.046 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.4 mt -125.66 140.07 35.62 Favored Pre-proline 0 N--CA 1.429 -1.488 0 C-N-CA 126.781 2.033 . . . . 1.55 107.786 -175.51 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -67.83 149.9 78.4 Favored 'Trans proline' 0 N--CA 1.433 -2.055 2 C-N-CA 125.938 4.425 . . . . 1.02 112.285 -174.381 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.472 58.0 Cg_endo -61.22 -38.35 66.87 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 CA-C-N 127.293 3.64 . . . . 1.25 119.213 -179.972 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -57.44 -36.65 71.67 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 127.003 2.69 . . . . 2.25 114.178 -179.316 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -81.22 -13.11 58.88 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.576 2.065 . . . . 2.02 116.576 -177.021 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -92.19 141.94 28.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.94 -1.725 . . . . 0.69 110.822 -175.445 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -113.52 134.78 54.5 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 125.775 1.922 . . . . 2.78 110.702 167.515 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 69' ' ' LEU . 34.8 mt -116.73 111.96 20.52 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.022 -1.844 . . . . 1.17 106.022 -178.618 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.569 HD13 ' HA ' ' A' ' 49' ' ' GLN . 24.3 mm -102.46 135.58 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 118.626 -2.546 . . . . 1.38 108.063 -173.318 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -154.44 122.89 6.1 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 124.249 1.02 . . . . 1.5 111.166 171.687 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.92 46.64 4.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.801 2.239 . . . . 1.21 116.525 -177.448 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.24 -31.01 4.21 Favored Glycine 0 N--CA 1.43 -1.734 0 CA-C-N 113.875 -1.511 . . . . 1.3 114.505 175.528 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -96.68 156.74 16.22 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 124.867 2.27 . . . . 2.55 114.415 -177.299 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.569 ' HA ' HD13 ' A' ' 44' ' ' ILE . 39.3 tt0 -93.05 121.51 34.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 127.492 3.52 . . . . 2.48 109.867 175.349 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.3 mt -79.07 122.6 26.42 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 113.55 -5.719 . . . . 0.9 114.864 -172.901 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.259 53.4 mt-10 -70.59 139.67 51.49 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 121.171 3.767 . . . . 1.94 121.171 -178.222 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -52.54 -63.09 1.25 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.327 3.051 . . . . 1.56 116.74 -169.323 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.74 43.3 3.06 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 125.784 1.659 . . . . 0.97 113.12 172.296 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.5 mtt-85 -121.91 162.02 21.76 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.642 -2.681 . . . . 2.49 109.543 165.686 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.26 70.2 p -92.63 151.17 20.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.368 2.667 . . . . 0.76 110.372 178.519 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -50.96 -50.59 57.71 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 125.514 2.578 . . . . 1.05 110.9 167.438 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -48.36 -42.69 32.24 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 114.605 -5.059 . . . . 1.19 118.006 174.668 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -71.5 -16.85 62.36 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.938 2.199 . . . . 1.9 116.938 173.538 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -94.15 -2.91 51.92 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 126.167 1.787 . . . . 0.89 106.359 177.096 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.5 m120 66.03 32.3 8.44 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.922 1.689 . . . . 1.84 112.735 176.341 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.7 mt -91.03 121.55 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 126.842 3.211 . . . . 0.82 107.771 -177.537 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -113.1 -170.46 1.68 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.66 -3.15 . . . . 2.16 114.044 178.531 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -61.73 135.63 57.68 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 112.348 -2.206 . . . . 2.12 112.279 -179.689 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.272 12.9 mt-10 83.67 13.58 0.35 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.791 2.036 . . . . 1.71 116.086 173.119 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.8 t -88.11 145.34 25.99 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.843 2.057 . . . . 1.04 105.873 -170.364 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.2 m -108.31 110.16 21.67 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.7 -1.25 . . . . 0.79 110.497 -176.678 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.4 mt -90.34 150.83 21.73 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 127.424 3.488 . . . . 1.4 107.247 172.582 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -111.73 129.39 56.13 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.083 -4.761 . . . . 1.51 110.993 -179.48 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 43' ' ' LEU . 47.3 tp -98.28 133.13 43.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 128.106 3.812 . . . . 1.14 101.559 -171.234 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.55 163.06 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.986 -2.946 . . . . 1.23 106.668 172.516 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 71' ' ' LEU . 33.1 mt -100.96 154.92 18.28 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 125.643 2.64 . . . . 2.78 114.646 176.034 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -65.82 -64.34 0.88 Allowed 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 116.244 -4.035 . . . . 3.75 112.71 -177.428 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.5 tp -121.14 109.9 15.55 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 126.613 1.965 . . . . 3.14 109.145 173.466 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -151.77 -59.95 0.16 Allowed 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 104.704 -2.332 . . . . 6.8 104.704 171.863 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.24 -99.65 0.15 Allowed Glycine 0 N--CA 1.43 -1.701 0 O-C-N 117.898 -3.002 . . . . 3.57 107.539 -172.515 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.773 0 C-N-CA 127.491 2.472 . . . . 3.87 109.774 -174.936 . . . . . . . . 0 0 . 1 . 087 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 ptt? . . . . . 0 CA--C 1.491 -1.315 0 N-CA-C 115.303 1.594 . . . . 1.1 115.303 . . . . . . . . . 0 0 . 1 . 087 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.278 4.8 pt20 -127.02 138.93 53.33 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 129.042 3.963 . . . . 1.87 112.984 175.064 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.5 pt -127.2 151.05 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 130.794 3.638 . . . . 0.72 109.989 175.987 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -98.26 136.83 37.89 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 111.898 -2.41 . . . . 1.4 110.438 -179.056 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 89.2 t -112.66 125.84 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-O 114.692 -2.575 . . . . 0.58 111.397 171.982 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -105.29 128.43 53.45 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 123.122 2.692 . . . . 2.09 113.611 176.263 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.286 3.5 p -84.56 173.91 10.42 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 120.036 3.347 . . . . 0.99 120.036 177.576 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.77 -38.08 82.93 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 130.548 3.539 . . . . 2.53 111.302 -179.821 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.7 p -74.95 -45.42 42.42 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.485 1.514 . . . . 2.08 109.713 177.408 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.25 42.67 0.31 Allowed Glycine 0 N--CA 1.43 -1.728 0 O-C-N 125.944 2.027 . . . . 1.31 110.603 169.154 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -105.69 157.98 17.04 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.076 2.15 . . . . 1.4 106.279 -173.266 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -111.25 124.53 52.4 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 121.024 1.738 . . . . 0.78 106.33 175.414 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.472 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 20.0 mt -100.04 121.51 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 100.807 -3.775 . . . . 1.55 100.807 173.795 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.0 m -104.89 114.07 28.05 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.176 2.893 . . . . 1.08 105.675 175.087 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.6 mt -101.11 145.16 29.12 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 128.171 2.588 . . . . 1.55 112.772 -177.046 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -97.18 112.69 24.37 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 117.02 -1.467 . . . . 1.95 113.892 173.475 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.8 169.93 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 116.032 1.864 . . . . 0.96 116.032 -179.815 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -114.37 160.74 31.71 Favored Pre-proline 0 N--CA 1.43 -1.449 0 O-C-N 127.968 3.293 . . . . 2.35 109.424 165.954 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.34 -10.66 29.64 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 O-C-N 114.521 -3.463 . . . . 0.95 114.792 -173.687 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.8 p -85.87 -16.18 39.45 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.792 3.808 . . . . 1.45 111.468 177.881 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -70.19 147.8 49.41 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.408 -3.308 . . . . 1.69 114.064 -175.845 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.8 p -95.67 166.24 11.92 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 116.197 -4.064 . . . . 0.75 112.494 -177.299 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.331 29.7 mm -65.42 -31.79 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 116.81 2.152 . . . . 0.73 116.81 179.203 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -46.83 -52.08 15.08 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.19 2.196 . . . . 1.62 116.608 160.965 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -70.72 -35.81 72.9 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.704 2.002 . . . . 2.13 109.11 -177.974 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.9 t -70.04 -49.69 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 119.044 -2.285 . . . . 0.62 111.459 -179.489 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -62.56 -27.7 69.36 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.164 -2.21 . . . . 1.22 115.749 175.984 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.58 -40.53 97.18 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 128.661 2.785 . . . . 0.51 114.422 173.67 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -62.25 -26.93 68.66 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.303 2.241 . . . . 1.44 116.565 171.629 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.9 mt -74.09 -42.89 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 126.997 2.119 . . . . 1.32 111.701 171.913 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -62.68 -34.04 76.31 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.496 -1.229 . . . . 1.7 112.519 178.36 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.24 -47.04 81.2 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.437 -2.039 . . . . 1.55 115.643 171.831 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -78.9 -59.59 2.72 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.27 -1.786 . . . . 2.62 113.725 -177.343 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -101.28 -30.84 11.28 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 128.905 2.882 . . . . 1.48 109.989 -165.258 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.74 19.86 30.56 Favored Glycine 0 N--CA 1.429 -1.77 0 O-C-N 121.098 -1.001 . . . . 1.12 113.993 170.428 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.5 mt -91.3 123.42 64.2 Favored Pre-proline 0 N--CA 1.431 -1.409 0 CA-C-O 114.466 -2.683 . . . . 1.55 110.039 178.219 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -67.66 144.08 64.67 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 124.386 3.391 . . . . 1.02 110.187 -174.009 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.77 -24.41 47.15 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 C-N-CA 125.053 3.836 . . . . 1.25 113.03 -167.831 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -68.01 -26.05 65.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.892 2.477 . . . . 2.25 109.871 178.496 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -89.32 -18.69 26.45 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 125.427 2.537 . . . . 2.02 110.894 -176.275 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -82.18 125.87 31.41 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.621 -2.55 . . . . 0.69 112.059 -177.868 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.573 ' HB2' HG23 ' A' ' 70' ' ' VAL . 94.7 mtt180 -119.54 129.38 54.65 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 104.903 -2.258 . . . . 2.78 104.903 168.759 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.1 mt -103.01 139.48 38.52 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.63 -3.169 . . . . 1.17 111.022 176.69 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.456 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 17.8 mm -121.14 146.97 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 103.154 -2.906 . . . . 1.38 103.154 176.901 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -135.94 105.21 5.99 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 101.365 -3.569 . . . . 1.5 101.365 173.208 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.309 . . 70.65 -75.13 0.08 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.921 2.088 . . . . 1.21 115.054 179.283 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.34 -4.66 0.9 Allowed Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 113.481 -1.691 . . . . 1.3 115.101 -175.385 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.27 65.6 mttm -106.82 143.2 35.26 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.765 -0.828 . . . . 2.55 108.765 -178.85 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -86.44 128.51 34.96 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 117.375 -1.298 . . . . 2.48 108.371 164.775 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 mt -83.66 134.92 34.76 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 116.349 1.981 . . . . 0.9 116.349 -173.815 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -75.86 147.98 38.67 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.576 1.151 . . . . 1.94 111.56 175.182 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -68.53 -38.03 80.51 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 118.559 2.8 . . . . 1.56 118.559 -171.133 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.8 28.25 14.46 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 126.078 1.799 . . . . 0.97 113.49 176.703 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -100.34 163.97 12.15 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 121.234 -1.156 . . . . 2.49 111.671 167.222 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.8 p -96.5 -172.03 2.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.516 -1.99 . . . . 0.76 111.368 175.509 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.3 mt -87.83 -29.25 21.08 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 119.107 -2.245 . . . . 1.05 111.436 172.362 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.282 8.2 t -63.08 -37.49 87.43 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 120.916 3.673 . . . . 1.19 120.916 171.057 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -52.97 -40.38 63.69 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 113.458 -1.701 . . . . 1.9 113.923 170.249 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -93.76 -3.38 52.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.532 2.333 . . . . 0.89 112.485 -177.695 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.286 13.7 m120 66.35 33.05 7.27 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.714 1.721 . . . . 1.84 114.232 -174.046 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.279 33.7 mt -73.59 104.19 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 114.843 -2.503 . . . . 0.82 107.837 172.91 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -92.04 -164.04 1.12 Allowed 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 124.673 1.233 . . . . 2.16 110.101 179.772 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -72.0 156.5 39.16 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.04 1.4 . . . . 2.12 112.094 171.28 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.326 26.9 mt-10 61.26 28.7 18.2 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.033 -2.292 . . . . 1.71 115.628 175.956 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.0 t -101.18 154.89 18.36 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.951 -2.968 . . . . 1.04 109.597 -173.71 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.7 m -110.42 111.81 23.32 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.854 2.74 . . . . 0.79 112.5 -174.783 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.1 mt -93.02 147.52 22.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.308 -3.37 . . . . 1.4 108.008 170.526 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.456 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 5.5 m-70 -102.11 122.89 44.99 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 126.834 2.584 . . . . 1.51 104.721 -175.604 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.8 tp -93.96 137.92 32.65 Favored 'General case' 0 N--CA 1.428 -1.542 0 O-C-N 118.732 -2.48 . . . . 1.14 111.59 178.678 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' A' ' 42' ' ' ARG . 2.7 m -135.93 150.05 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 105.868 -1.901 . . . . 1.23 105.868 168.376 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.8 mt -112.64 158.68 19.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.803 -2.436 . . . . 2.78 112.812 -175.054 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -97.12 177.79 5.47 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.649 2.78 . . . . 3.75 104.381 176.702 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.2 mt -88.16 155.93 19.51 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.242 2.448 . . . . 3.14 107.791 174.171 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -83.39 159.21 21.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 112.96 -1.927 . . . . 6.8 113.953 172.311 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.6 -58.09 0.16 Allowed Glycine 0 N--CA 1.43 -1.731 0 CA-C-O 127.079 3.599 . . . . 3.57 116.137 -172.29 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.772 0 N-CA-C 104.144 -3.583 . . . . 3.87 104.144 172.412 . . . . . . . . 0 0 . 1 . 088 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ptt? . . . . . 0 CA--C 1.49 -1.357 0 CA-C-O 123.049 1.404 . . . . 1.1 114.281 . . . . . . . . . 0 0 . 1 . 088 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -77.89 124.3 27.83 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.224 3.01 . . . . 1.87 114.453 -179.402 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.277 9.8 pt -128.48 153.12 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.301 -2.749 . . . . 0.72 111.139 171.286 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -117.59 130.49 56.43 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.526 1.967 . . . . 1.4 110.666 -178.89 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.51 111.16 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 102.908 -2.997 . . . . 0.58 102.908 -179.749 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -93.13 133.4 36.34 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 124.153 1.93 . . . . 2.09 111.774 -178.231 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.307 3.9 p -102.3 161.48 13.66 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 117.376 2.362 . . . . 0.99 117.376 169.166 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.4 tp -78.78 -35.72 43.99 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 112.22 -2.264 . . . . 2.53 111.449 168.75 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.273 0.8 OUTLIER -63.91 -58.41 6.85 Favored 'General case' 0 N--CA 1.431 -1.412 1 C-N-CA 133.323 4.649 . . . . 2.08 111.716 -169.983 . . . . . . . . 4 3 . 1 . 088 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.85 -79.23 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 129.456 3.407 . . . . 1.31 120.515 176.422 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -77.92 165.4 24.14 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 129.831 3.252 . . . . 1.4 116.197 -170.281 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.8 m -115.66 120.58 39.85 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 103.452 -2.796 . . . . 0.78 103.452 168.315 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.4 mt -89.18 107.03 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.859 2.463 . . . . 1.55 105.93 -176.522 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.7 m -82.54 100.0 9.85 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 124.282 0.989 . . . . 1.08 113.434 178.944 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.1 mt -88.13 154.52 20.39 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.7 2.19 . . . . 1.55 115.911 -179.98 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -104.27 114.78 29.24 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 102.399 -3.186 . . . . 1.95 102.399 163.616 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.8 m -117.36 177.39 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.069 -2.269 . . . . 0.96 109.426 173.081 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -115.57 156.65 45.82 Favored Pre-proline 0 N--CA 1.429 -1.476 0 N-CA-C 104.623 -2.362 . . . . 2.35 104.623 154.913 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -78.53 -9.09 16.12 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 CA-C-N 127.334 3.655 . . . . 0.95 109.197 -171.589 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.1 p -81.45 -9.65 59.67 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.884 -2.385 . . . . 1.45 113.911 174.838 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -66.82 141.85 57.55 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 125.855 1.972 . . . . 1.69 111.83 172.704 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.647 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 52.6 p -81.35 170.34 16.13 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.795 -2.441 . . . . 0.75 112.699 176.852 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.462 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 25.2 mm -66.01 -26.18 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 129.179 2.991 . . . . 0.73 109.37 170.563 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -70.97 -33.85 70.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.164 1.935 . . . . 1.62 115.546 173.999 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.434 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 83.5 m-20 -66.02 -43.38 87.8 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.193 2.597 . . . . 2.13 111.878 169.723 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.25 -45.21 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 115.224 1.564 . . . . 0.62 115.224 174.059 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -67.11 -36.03 81.03 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 117.348 -3.345 . . . . 1.22 113.277 169.769 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.71 -25.02 62.48 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 118.501 -2.624 . . . . 0.51 117.454 172.122 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 25' ' ' ASN 0.356 44.5 mttm -69.63 -55.14 10.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.41 -2.681 . . . . 1.44 117.247 174.537 . . . . . . . . 3 3 . 1 . 088 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.2 mt -52.62 -47.07 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 1 C-N-CA 135.202 5.401 . . . . 1.32 106.419 173.615 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -50.02 -40.82 45.84 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 120.825 3.639 . . . . 1.7 120.825 177.129 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -66.56 -43.4 85.11 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.958 -3.589 . . . . 1.55 114.807 164.444 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -70.19 -49.98 44.83 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 127.656 3.598 . . . . 2.62 110.322 -169.95 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.264 28.7 mm-40 -120.3 4.72 10.76 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 111.286 -2.688 . . . . 1.48 112.726 -165.858 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.6 0.38 47.95 Favored Glycine 0 N--CA 1.431 -1.662 0 C-N-CA 115.678 -3.153 . . . . 1.12 119.222 173.605 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.5 mt -86.42 116.29 65.34 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 103.445 -2.798 . . . . 1.55 103.445 -169.202 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 36.9 Cg_endo -66.1 165.26 24.72 Favored 'Trans proline' 0 C--N 1.3 -2.016 1 C-N-CA 126.54 4.827 . . . . 1.02 115.695 176.389 . . . . . . . . 3 3 . 1 . 088 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.2 Cg_exo -79.38 -17.43 11.51 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 124.524 2.651 . . . . 1.25 112.994 -172.235 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -67.54 -27.49 67.0 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.373 2.035 . . . . 2.25 115.436 175.458 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -104.87 24.02 12.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.813 -2.429 . . . . 2.02 114.308 -178.032 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -123.53 119.0 28.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.987 2.515 . . . . 0.69 113.392 179.66 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.53 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 90.5 mtt-85 -113.94 120.8 41.9 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.806 1.642 . . . . 2.78 108.288 169.466 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.6 mt -104.51 126.62 51.77 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.143 -1.598 . . . . 1.17 111.219 -178.103 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mm -117.61 140.4 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 124.206 3.185 . . . . 1.38 112.755 177.131 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -152.56 132.57 13.4 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 104.752 -2.314 . . . . 1.5 104.752 175.959 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.91 21.92 11.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 115.968 -1.968 . . . . 1.21 115.178 179.64 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.66 -2.34 83.16 Favored Glycine 0 N--CA 1.431 -1.688 1 C-N-CA 132.379 4.8 . . . . 1.3 113.286 -179.38 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -101.01 137.57 39.2 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.842 0.829 . . . . 2.55 112.841 -178.983 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -70.68 127.13 31.62 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 117.194 -3.442 . . . . 2.48 115.808 166.627 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.405 ' HB3' HG13 ' A' ' 23' ' ' ILE . 36.9 mt -81.62 136.9 35.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.705 -1.872 . . . . 0.9 113.647 -176.075 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -85.74 144.14 27.94 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 119.031 2.974 . . . . 1.94 119.031 172.467 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.462 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 1.8 m-20 -67.12 -43.26 82.87 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 121.763 3.986 . . . . 1.56 121.763 -168.362 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.23 8.84 50.82 Favored Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 118.123 2.009 . . . . 0.97 118.123 170.446 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -101.59 149.55 24.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.679 1.704 . . . . 2.49 110.233 170.289 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.647 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.283 32.2 p -81.7 170.65 15.52 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.069 -2.894 . . . . 0.76 110.547 -178.211 . . . . . . . . 3 3 . 1 . 088 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.7 mt -67.8 -37.04 81.47 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 127.031 2.132 . . . . 1.05 110.062 167.672 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.382 4.9 t -59.4 -43.64 92.95 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.525 -3.234 . . . . 1.19 114.234 176.72 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -60.82 -44.63 96.64 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.113 2.863 . . . . 1.9 111.042 179.995 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -77.92 -6.76 55.37 Favored 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 114.939 -4.85 . . . . 0.89 115.883 178.416 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.304 13.1 m120 68.95 36.79 2.42 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.605 -2.559 . . . . 1.84 115.412 -178.206 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.2 mt -85.24 113.96 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 125.905 1.682 . . . . 0.82 111.968 177.635 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -103.64 -173.96 2.43 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 118.411 -1.316 . . . . 2.16 108.824 -174.933 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -53.42 147.48 10.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.419 3.009 . . . . 2.12 114.4 171.082 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 56.09 33.51 22.08 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 120.441 3.497 . . . . 1.71 120.441 -178.969 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.7 m -103.51 149.1 25.18 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.777 -1.556 . . . . 1.04 109.96 -177.151 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -103.58 112.06 24.8 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 126.132 1.773 . . . . 0.79 109.106 -170.452 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mt -90.24 140.72 29.41 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.458 -1.312 . . . . 1.4 107.458 174.15 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.375 66.9 m80 -107.28 118.1 35.82 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.665 -1.272 . . . . 1.51 108.116 178.308 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -88.02 121.44 30.43 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 121.378 -0.826 . . . . 1.14 109.761 179.875 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 59.6 t -105.69 135.46 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 104.473 -2.417 . . . . 1.23 104.473 174.242 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.69 157.75 16.01 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.402 -1.332 . . . . 2.78 107.402 -179.5 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -129.95 174.34 9.85 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.34 -1.726 . . . . 3.75 106.34 175.455 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.0 mt -105.82 157.83 17.18 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.796 2.038 . . . . 3.14 106.92 177.054 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -66.39 93.59 0.23 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.161 2.184 . . . . 6.8 110.4 165.96 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.98 100.22 1.61 Allowed Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 127.809 2.623 . . . . 3.57 113.206 -166.652 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.745 0 CA-C-O 113.701 -3.833 . . . . 3.87 116.692 -175.974 . . . . . . . . 0 0 . 1 . 089 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 CA--C 1.49 -1.34 0 N-CA-C 106.721 -1.585 . . . . 1.1 106.721 . . . . . . . . . 0 0 . 1 . 089 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -93.71 126.5 38.93 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.138 1.375 . . . . 1.87 112.692 179.698 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -127.25 166.98 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 105.002 -2.222 . . . . 0.72 105.002 167.759 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -123.27 145.05 49.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.076 2.95 . . . . 1.4 110.268 -177.716 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.2 t -124.91 124.18 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 106.691 -1.596 . . . . 0.58 106.691 173.677 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -106.41 128.59 54.16 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.601 2.36 . . . . 2.09 108.406 -178.73 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 p -87.4 179.44 6.58 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.02 2.343 . . . . 0.99 110.03 -179.399 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.331 14.2 tp -65.94 -41.95 90.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.918 2.487 . . . . 2.53 114.61 168.462 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.8 p -75.42 -38.54 59.75 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 120.817 -1.177 . . . . 2.08 108.307 -177.778 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.73 28.32 0.3 Allowed Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 123.652 0.644 . . . . 1.31 113.226 169.783 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -94.48 129.22 41.34 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.082 -2.422 . . . . 1.4 110.863 -177.134 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.8 m -116.36 90.21 3.28 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.937 2.78 . . . . 0.78 107.489 -174.345 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 pt -92.94 136.97 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 112.224 -2.262 . . . . 1.55 106.099 -178.876 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -94.86 128.37 41.57 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 130.22 3.408 . . . . 1.08 113.287 -178.801 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.9 mt -122.32 151.06 41.53 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.882 1.801 . . . . 1.55 112.88 178.184 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -114.54 112.7 23.36 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.657 1.218 . . . . 1.95 108.689 174.464 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m -118.27 175.11 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 118.715 -2.491 . . . . 0.96 111.548 -176.751 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -108.15 147.93 36.53 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-N 122.186 2.266 . . . . 2.35 106.784 160.498 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.13 -18.88 26.83 Favored 'Trans proline' 0 N--CA 1.433 -2.058 0 C-N-CA 123.718 2.945 . . . . 0.95 112.533 -174.548 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.3 p -90.57 9.92 27.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 121.725 2.057 . . . . 1.45 113.329 178.097 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -89.59 158.42 17.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.331 -3.355 . . . . 1.69 107.333 -179.865 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 69.6 p -80.6 171.11 15.46 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.297 1.221 . . . . 0.75 114.297 178.832 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.6 mm -69.77 -39.79 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 125.679 1.592 . . . . 0.73 108.91 175.993 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.26 86.7 tt0 -45.77 -45.75 14.84 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 117.613 2.449 . . . . 1.62 117.613 169.117 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -68.09 -35.66 78.54 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 118.058 2.614 . . . . 2.13 118.058 175.703 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 26' ' ' VAL . 10.8 t -62.96 -31.22 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 112.971 0.73 . . . . 0.62 112.971 170.783 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -71.5 -25.58 62.32 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 118.802 2.89 . . . . 1.22 118.802 167.327 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.87 -20.3 53.26 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 119.582 -1.949 . . . . 0.51 108.476 170.893 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -80.54 -23.51 39.94 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 120.419 1.463 . . . . 1.44 107.993 177.626 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.1 mt -81.85 -28.26 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.784 -2.447 . . . . 1.32 112.802 167.616 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 67.0 tt0 -65.74 -36.75 84.46 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 123.552 2.887 . . . . 1.7 113.362 173.655 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -60.05 -56.79 17.35 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 124.285 1.034 . . . . 1.55 111.781 170.118 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -77.34 -52.75 8.64 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 116.272 1.953 . . . . 2.62 116.272 -172.807 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -99.08 -25.1 14.66 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 119.348 -2.095 . . . . 1.48 108.407 -165.911 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.4 37.33 11.0 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 122.017 2.189 . . . . 1.12 113.161 175.668 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 mt -106.92 126.96 28.96 Favored Pre-proline 0 N--CA 1.43 -1.433 0 C-N-CA 127.671 2.388 . . . . 1.55 107.472 -178.752 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -68.82 150.2 73.49 Favored 'Trans proline' 0 N--CA 1.434 -1.977 0 O-C-N 115.28 -3.063 . . . . 1.02 116.585 -178.653 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -69.39 -14.5 37.37 Favored 'Trans proline' 0 N--CA 1.433 -2.061 0 CA-C-N 124.447 2.624 . . . . 1.25 117.886 -172.557 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -74.86 -34.09 62.22 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.993 1.854 . . . . 2.25 111.069 172.314 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -72.56 -28.41 62.81 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 115.165 -4.709 . . . . 2.02 114.523 -178.895 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -78.99 147.19 33.0 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.353 -1.467 . . . . 0.69 110.419 -173.382 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.277 12.1 tpt180 -133.35 120.12 20.58 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.07 -2.567 . . . . 2.78 104.07 170.773 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.2 mt -96.51 125.85 41.28 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.546 -1.346 . . . . 1.17 108.708 -177.899 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.278 6.2 mt -118.91 115.07 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 116.422 2.008 . . . . 1.38 116.422 -179.865 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -130.54 137.99 49.97 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 117.076 2.25 . . . . 1.5 117.076 164.97 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.291 . . 51.26 45.73 27.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.404 -3.31 . . . . 1.21 118.806 -175.487 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.6 -22.12 1.43 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 125.335 1.445 . . . . 1.3 113.646 -175.471 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -90.22 133.09 35.14 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 118.526 2.787 . . . . 2.55 118.526 -173.828 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -74.19 133.68 42.73 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 116.785 -3.697 . . . . 2.48 104.365 171.016 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.7 mt -91.17 123.69 34.81 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 127.07 3.319 . . . . 0.9 110.869 -175.741 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -85.19 135.5 33.92 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.165 -2.834 . . . . 1.94 116.105 175.966 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.488 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 3.4 m-20 -57.11 -53.04 62.6 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 129.973 3.309 . . . . 1.56 117.38 -160.958 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.09 21.51 1.35 Allowed Glycine 0 N--CA 1.43 -1.737 0 O-C-N 118.952 -2.342 . . . . 0.97 115.88 170.263 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -113.79 166.28 11.72 Favored 'General case' 0 N--CA 1.43 -1.451 1 CA-C-N 124.531 4.165 . . . . 2.49 108.251 168.979 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.8 p -97.78 173.47 7.09 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 123.551 1.644 . . . . 0.76 110.061 -179.173 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.9 mt -67.77 -31.91 72.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 114.317 1.229 . . . . 1.05 114.317 177.065 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.8 t -62.18 -44.73 95.94 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.043 3.337 . . . . 1.19 113.941 178.377 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -52.86 -38.54 61.68 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 125.141 1.526 . . . . 1.9 112.112 175.571 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -91.23 -1.0 57.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.335 1.854 . . . . 0.89 111.984 178.488 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.311 3.4 m120 61.72 31.26 18.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 119.446 3.128 . . . . 1.84 119.446 -179.526 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.4 mt -88.11 110.36 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 128.7 2.8 . . . . 0.82 104.469 -173.41 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -95.82 -169.91 2.03 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 112.373 -2.194 . . . . 2.16 106.288 -174.434 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -57.83 147.9 26.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 130.239 3.416 . . . . 2.12 117.797 172.894 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 55.89 49.33 16.19 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 115.817 1.784 . . . . 1.71 115.817 178.102 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 m -117.53 147.91 42.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.774 -1.195 . . . . 1.04 107.774 -174.62 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.4 m -99.2 105.41 17.45 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.355 3.462 . . . . 0.79 111.209 177.394 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.69 132.54 39.32 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.778 1.631 . . . . 1.4 108.505 178.072 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -89.13 124.88 34.74 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.95 -4.219 . . . . 1.51 106.395 -178.734 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.8 tp -95.13 122.09 37.44 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.716 -2.49 . . . . 1.14 105.842 171.214 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.1 t -115.14 151.4 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 127.872 2.469 . . . . 1.23 108.829 168.537 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.0 mt -98.7 126.39 44.29 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.601 -3.187 . . . . 2.78 110.659 174.637 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.9 ttt85 -107.05 84.36 1.97 Allowed 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.362 2.506 . . . . 3.75 110.9 178.818 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.0 mt -87.41 -53.46 4.81 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 116.561 -3.837 . . . . 3.14 109.781 175.024 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.3 ttt-85 -107.51 -58.06 2.01 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.03 2.132 . . . . 6.8 105.555 169.987 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.25 -179.58 24.06 Favored Glycine 0 N--CA 1.429 -1.775 0 O-C-N 119.102 -2.249 . . . . 3.57 108.377 -163.025 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.721 0 C-N-CA 126.713 2.102 . . . . 3.87 109.565 177.579 . . . . . . . . 0 0 . 1 . 090 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 CA--C 1.491 -1.304 0 CA-C-O 121.188 0.518 . . . . 1.1 110.677 . . . . . . . . . 0 0 . 1 . 090 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -110.6 121.31 45.02 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.489 -2.632 . . . . 1.87 111.44 -179.691 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.3 pt -108.73 172.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 114.588 -1.187 . . . . 0.72 111.792 169.621 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -120.4 160.08 23.81 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.76 -0.829 . . . . 1.4 108.76 178.879 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.7 t -139.56 133.46 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 117.381 -3.325 . . . . 0.58 106.815 168.851 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -110.76 137.57 48.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.551 -3.218 . . . . 2.09 109.415 177.323 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.275 11.1 p -81.67 -169.63 2.42 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 114.824 -4.923 . . . . 0.99 115.74 176.858 . . . . . . . . 3 2 . 1 . 090 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.322 13.1 mt -77.46 -37.34 51.69 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 113.656 0.984 . . . . 2.53 113.656 174.963 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.76 -37.72 22.26 Favored 'General case' 0 N--CA 1.429 -1.504 1 C-N-CA 133.61 4.764 . . . . 2.08 110.019 -169.501 . . . . . . . . 3 3 . 1 . 090 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.67 33.66 0.64 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 115.04 -3.089 . . . . 1.31 111.842 173.175 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -97.54 137.48 36.41 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.513 2.156 . . . . 1.4 106.572 -178.953 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 m -108.27 121.42 44.86 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 118.897 -0.573 . . . . 0.78 109.9 176.687 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mt -104.77 106.87 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 125.498 1.749 . . . . 1.55 111.444 179.081 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.9 m -80.78 94.72 6.46 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 130.485 3.514 . . . . 1.08 111.67 178.024 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.8 mt -98.02 130.99 44.82 Favored 'General case' 0 N--CA 1.429 -1.482 1 O-C-N 115.781 -4.324 . . . . 1.55 112.907 -174.898 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -92.08 125.92 36.96 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.182 1.81 . . . . 1.95 107.18 174.836 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.9 m -133.89 174.95 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 107.401 -1.333 . . . . 0.96 107.401 -173.569 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -126.26 159.99 59.83 Favored Pre-proline 0 N--CA 1.43 -1.443 0 O-C-N 120.378 -1.451 . . . . 2.35 108.09 163.694 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -78.02 -10.06 16.66 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 CA-C-N 126.29 3.282 . . . . 0.95 109.919 -172.561 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.9 p -78.34 -22.54 47.85 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 130.369 3.468 . . . . 1.45 113.951 174.598 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -68.08 142.39 55.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.104 2.162 . . . . 1.69 110.655 176.21 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 22.9 p -78.08 164.25 25.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.659 2.171 . . . . 0.75 113.424 175.346 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -59.91 -33.18 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.515 1.926 . . . . 0.73 111.189 173.127 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -63.32 -44.48 94.83 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.582 1.553 . . . . 1.62 113.196 172.141 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -60.83 -26.45 67.35 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 115.517 -2.183 . . . . 2.13 114.083 170.037 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.338 46.6 t -84.43 -25.97 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 CA-C-N 127.243 4.565 . . . . 0.62 109.658 179.146 . . . . . . . . 3 2 . 1 . 090 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -75.74 -30.71 59.32 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.575 -3.203 . . . . 1.22 110.766 173.676 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.61 93.06 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.248 -1.532 . . . . 0.51 112.123 174.872 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -58.95 -45.44 90.46 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.436 -3.29 . . . . 1.44 111.074 174.883 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.4 mt -58.48 -33.61 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.292 -3.38 . . . . 1.32 114.652 173.229 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -70.07 -34.85 73.71 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.507 2.41 . . . . 1.7 117.507 -179.673 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -72.82 -47.74 43.75 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 125.016 2.341 . . . . 1.55 116.387 164.506 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -63.86 -65.85 0.62 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.12 -3.488 . . . . 2.62 109.639 -173.673 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -94.23 -51.93 4.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.439 -2.663 . . . . 1.48 110.96 -168.406 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.56 73.19 0.97 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-N 115.489 -0.778 . . . . 1.12 112.276 179.374 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 mt -138.53 117.4 9.46 Favored Pre-proline 0 N--CA 1.429 -1.487 0 N-CA-C 102.427 -3.175 . . . . 1.55 102.427 -174.695 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -57.83 143.13 96.23 Favored 'Trans proline' 0 C--N 1.299 -2.059 0 CA-C-O 112.559 -3.184 . . . . 1.02 114.219 177.838 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -62.21 -15.92 47.52 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 CA-C-N 124.961 2.807 . . . . 1.25 115.926 178.404 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -63.73 -34.99 79.1 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 124.784 2.231 . . . . 2.25 115.907 173.976 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -81.81 -21.87 37.43 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.418 -2.676 . . . . 2.02 109.705 -177.86 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -82.06 104.53 12.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.642 1.686 . . . . 0.69 114.975 -173.767 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.5 tpp85 -100.59 123.37 44.7 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 112.455 -2.157 . . . . 2.78 107.282 162.54 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.0 mt -111.43 137.1 49.65 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.758 2.694 . . . . 1.17 106.531 178.713 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.0 mt -125.36 149.77 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 117.266 -3.396 . . . . 1.38 104.211 -179.654 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.31 84.1 t80 -146.84 135.58 22.17 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 116.564 2.061 . . . . 1.5 116.564 168.541 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.59 -67.3 0.21 Allowed 'General case' 0 N--CA 1.43 -1.45 1 C-N-CA 131.942 4.097 . . . . 1.21 112.317 179.464 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.59 15.42 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.648 0 C-N-CA 128.042 2.734 . . . . 1.3 107.861 174.441 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.1 mttp -123.11 134.14 54.24 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.6 -2.117 . . . . 2.55 107.269 -176.706 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -73.17 140.48 47.05 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 116.857 -1.937 . . . . 2.48 115.237 169.003 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 mt -94.89 133.34 38.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 116.703 -3.748 . . . . 0.9 108.33 -164.558 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -96.67 118.85 34.02 Favored 'General case' 0 N--CA 1.431 -1.393 1 O-C-N 115.46 -4.525 . . . . 1.94 109.46 -176.521 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -39.88 -51.31 2.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 117.797 2.517 . . . . 1.56 117.797 -175.817 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.53 39.54 0.22 Allowed Glycine 0 N--CA 1.429 -1.787 0 C-N-CA 128.04 2.733 . . . . 0.97 114.331 170.411 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -137.1 169.49 17.7 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 119.723 1.762 . . . . 2.49 111.619 164.847 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 44.8 p -98.51 166.36 11.39 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.45 1.9 . . . . 0.76 115.858 175.702 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mt -62.51 -36.47 82.66 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.379 -2.076 . . . . 1.05 112.227 172.167 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -60.64 -44.98 95.75 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.687 1.995 . . . . 1.19 116.336 175.359 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -60.62 -45.82 92.59 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 119.551 1.068 . . . . 1.9 111.8 179.951 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -77.65 -8.86 58.52 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 113.52 0.933 . . . . 0.89 113.52 179.242 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.29 71.4 m-80 62.26 51.29 3.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.048 2.139 . . . . 1.84 116.691 -174.749 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.0 mt -92.7 121.99 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 101.418 -3.549 . . . . 0.82 101.418 178.069 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -110.33 -168.49 1.32 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.197 -1.564 . . . . 2.16 112.676 178.923 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -68.74 155.93 39.22 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.586 -3.196 . . . . 2.12 107.83 -179.929 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 64.2 20.59 12.24 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 112.641 -2.072 . . . . 1.71 114.724 178.433 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.278 50.6 m -84.39 148.09 26.8 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-O 114.661 -2.59 . . . . 1.04 114.51 -174.068 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.0 m -109.59 113.62 26.56 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 115.963 -2.295 . . . . 0.79 109.993 176.657 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.6 mt -84.69 155.4 21.96 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.208 -1.558 . . . . 1.4 107.417 175.732 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -107.09 109.95 21.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 118.027 -0.987 . . . . 1.51 111.932 -174.699 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 tt -80.59 112.58 18.08 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.366 1.066 . . . . 1.14 113.065 174.348 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.4 t -109.77 122.06 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 127.267 2.227 . . . . 1.23 105.382 171.622 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 71' ' ' LEU . 53.9 mt -81.94 122.53 27.88 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 104.142 -2.54 . . . . 2.78 104.142 177.131 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -116.36 145.96 42.82 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 129.735 3.214 . . . . 3.75 107.374 -176.385 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.49 117.45 6.21 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.44 2.696 . . . . 3.14 109.526 173.797 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -59.75 158.65 9.97 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 121.264 3.801 . . . . 6.8 121.264 174.645 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.28 65.3 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.749 0 O-C-N 120.963 -1.086 . . . . 3.57 113.768 -166.953 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.789 0 C-N-CA 126.988 2.232 . . . . 3.87 111.73 -172.424 . . . . . . . . 0 0 . 1 . 091 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptt? . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 117.885 2.55 . . . . 1.1 117.885 . . . . . . . . . 0 0 . 1 . 091 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -89.29 121.35 31.48 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.997 -1.064 . . . . 1.87 111.818 -173.585 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.8 pt -116.46 154.7 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 101.025 -3.695 . . . . 0.72 101.025 173.265 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -113.18 151.94 30.32 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 124.783 1.233 . . . . 1.4 111.623 179.943 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.1 t -134.58 127.64 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 122.745 2.521 . . . . 0.58 105.582 175.456 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -92.86 140.6 29.33 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.716 -1.865 . . . . 2.09 110.743 -179.793 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.0 p -87.13 -177.9 6.12 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.365 -0.976 . . . . 0.99 108.365 178.133 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 tp -64.7 -46.52 82.01 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.09 -4.131 . . . . 2.53 115.346 171.126 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -77.23 -21.45 53.76 Favored 'General case' 0 N--CA 1.43 -1.433 1 O-C-N 115.988 -4.195 . . . . 2.08 117.066 178.056 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.59 37.98 0.87 Allowed Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 121.037 3.175 . . . . 1.31 121.037 174.98 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -98.31 127.05 44.06 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 102.006 -3.331 . . . . 1.4 102.006 -177.358 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.0 m -91.68 118.18 30.42 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.134 -1.604 . . . . 0.78 113.871 175.841 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.293 10.4 mt -90.92 126.46 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 103.614 -2.736 . . . . 1.55 103.614 -179.855 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.2 m -98.84 120.16 38.81 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 123.527 2.876 . . . . 1.08 107.127 173.083 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.4 mt -118.38 117.11 28.16 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 125.095 2.379 . . . . 1.55 113.996 177.856 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -79.63 97.37 6.49 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.108 -1.62 . . . . 1.95 113.36 172.258 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -113.84 166.72 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 128.299 2.64 . . . . 0.96 110.915 -175.669 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -107.36 163.71 16.36 Favored Pre-proline 0 N--CA 1.429 -1.5 0 O-C-N 125.017 1.448 . . . . 2.35 111.79 162.02 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.43 -19.67 10.1 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 O-C-N 113.594 -3.951 . . . . 0.95 109.877 -175.172 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 m -81.56 -3.07 52.26 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 116.616 -1.659 . . . . 1.45 114.07 -179.573 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -72.72 142.78 48.19 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.498 1.519 . . . . 1.69 112.576 176.846 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 p -81.82 165.25 21.04 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 124.606 1.191 . . . . 0.75 110.52 176.319 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.422 ' CG2' HD12 ' A' ' 43' ' ' LEU . 4.4 mm -68.79 -24.64 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 1 O-C-N 115.285 -4.634 . . . . 0.73 113.122 178.882 . . . . . . . . 3 3 . 1 . 091 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -51.91 -45.84 64.38 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 129.661 3.185 . . . . 1.62 113.59 164.062 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -62.96 -36.98 85.27 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 115.624 1.713 . . . . 2.13 115.624 174.064 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.75 -48.4 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 127.177 2.191 . . . . 0.62 111.735 175.391 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.5 mttt -55.1 -34.06 63.35 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.339 1.977 . . . . 1.22 116.339 170.033 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.69 -23.79 61.71 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 116.011 1.856 . . . . 0.51 116.011 172.615 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -75.44 -33.49 60.9 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.955 2.902 . . . . 1.44 114.128 168.599 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.4 mt -76.41 -26.68 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 1 O-C-N 113.791 -5.568 . . . . 1.32 110.402 174.861 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -74.01 -25.3 59.82 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.964 -2.335 . . . . 1.7 106.475 178.808 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -86.13 -41.95 14.3 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.172 1.463 . . . . 1.55 114.483 171.122 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.3 mmtt -57.47 -65.7 0.58 Allowed 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 113.999 -5.438 . . . . 2.62 111.36 172.316 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -97.16 -35.53 10.75 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.023 2.529 . . . . 1.48 115.08 -168.067 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.18 44.98 3.65 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 119.896 -1.753 . . . . 1.12 114.093 179.162 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.3 mt -114.18 126.67 27.71 Favored Pre-proline 0 N--CA 1.43 -1.429 1 C-N-CA 134.79 5.236 . . . . 1.55 111.32 -178.76 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.78 156.16 43.97 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 CA-C-N 125.962 3.165 . . . . 1.02 113.442 179.372 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -65.31 -12.11 33.31 Favored 'Trans proline' 0 N--CA 1.433 -2.032 2 CA-C-N 131.235 5.048 . . . . 1.25 118.198 -173.021 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -63.95 -45.14 90.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 127.128 2.768 . . . . 2.25 113.132 175.231 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -84.37 -7.86 59.17 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.9 -3.0 . . . . 2.02 108.465 -175.831 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -92.01 129.74 37.9 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 115.71 -4.368 . . . . 0.69 109.457 -171.684 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -130.64 120.85 24.56 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 129.424 3.09 . . . . 2.78 105.925 172.511 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.422 HD12 ' CG2' ' A' ' 23' ' ' ILE . 82.5 mt -107.01 122.71 46.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.602 3.096 . . . . 1.17 113.474 -176.719 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 29.0 mm -109.9 123.32 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 111.786 -2.461 . . . . 1.38 109.087 177.549 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -101.83 111.41 23.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.53 -2.767 . . . . 1.5 103.53 167.919 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.05 -93.48 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 125.48 1.738 . . . . 1.21 108.905 172.901 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.37 14.04 3.48 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-O 116.208 -2.44 . . . . 1.3 114.15 176.583 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp -107.82 133.63 51.93 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 128.496 3.115 . . . . 2.55 112.858 179.904 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -86.94 115.98 24.7 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 126.018 2.818 . . . . 2.48 114.819 173.681 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.0 mt -73.79 143.88 45.81 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.898 -1.751 . . . . 0.9 112.214 -171.561 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -100.1 138.72 36.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 125.23 2.443 . . . . 1.94 115.568 174.236 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -48.46 -46.86 38.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.422 3.489 . . . . 1.56 119.847 -175.985 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.54 44.91 1.39 Allowed Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 127.105 2.288 . . . . 0.97 116.691 170.928 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.25 20.7 mmt85 -117.25 163.61 16.05 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 117.703 -3.234 . . . . 2.49 103.659 166.332 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.5 p -99.61 163.63 12.41 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.081 -3.512 . . . . 0.76 115.964 169.064 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.7 mt -57.54 -36.17 71.28 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 113.646 -1.615 . . . . 1.05 112.198 174.402 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 t -66.4 -37.75 85.94 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 116.132 1.901 . . . . 1.19 116.132 178.825 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -55.92 -32.15 63.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.37 1.868 . . . . 1.9 114.513 173.065 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -94.86 -8.01 38.54 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 122.951 1.358 . . . . 0.89 110.73 -178.936 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.8 m120 69.0 43.13 1.17 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.356 2.662 . . . . 1.84 114.668 -173.169 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.8 mt -84.9 128.82 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 126.014 2.816 . . . . 0.82 106.379 -179.127 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -109.06 179.99 4.01 Favored 'General case' 0 N--CA 1.431 -1.425 1 O-C-N 115.893 -4.255 . . . . 2.16 108.22 -176.86 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 35.2 ttpt -53.73 138.76 34.57 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 130.943 3.697 . . . . 2.12 115.41 167.005 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 63' ' ' LYS 0.343 9.7 pt-20 77.04 3.2 3.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.598 2.359 . . . . 1.71 117.145 171.828 . . . . . . . . 3 3 . 1 . 091 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.41 164.07 25.37 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 112.818 -1.992 . . . . 1.04 112.849 -176.661 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.3 m -120.0 121.1 38.18 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 124.34 2.019 . . . . 0.79 108.432 175.321 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.29 174.18 5.98 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 104.642 -2.355 . . . . 1.4 104.642 175.117 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 31.3 m170 -130.63 141.53 50.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.962 -1.496 . . . . 1.51 106.962 179.232 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.6 tp -112.23 110.78 21.23 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 129.993 3.317 . . . . 1.14 106.849 -174.259 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.1 t -112.83 123.05 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 C-N-CA 125.222 1.409 . . . . 1.23 109.676 176.93 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.7 mt -87.32 152.98 21.82 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.704 1.24 . . . . 2.78 111.63 178.036 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -117.92 142.17 47.63 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 129.275 3.03 . . . . 3.75 109.794 169.88 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.4 mt -96.66 -179.65 4.67 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.492 1.615 . . . . 3.14 111.515 171.894 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.1 ttm-85 -81.24 140.67 34.75 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 117.961 -1.496 . . . . 6.8 110.311 169.006 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.98 -73.26 0.25 Allowed Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 106.303 -2.719 . . . . 3.57 106.303 -174.069 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.842 0 CA-C-N 122.311 3.056 . . . . 3.87 113.829 174.845 . . . . . . . . 0 0 . 1 . 092 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ptt? . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 116.565 2.061 . . . . 1.1 116.565 . . . . . . . . . 0 0 . 1 . 092 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -106.88 123.09 47.66 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.133 -2.854 . . . . 1.87 111.887 -177.31 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.0 pt -127.19 155.61 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 112.028 -2.351 . . . . 0.72 108.535 170.05 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -124.55 137.22 54.42 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.384 1.073 . . . . 1.4 110.282 -176.014 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.1 t -116.6 101.49 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 129.422 3.089 . . . . 0.58 106.371 178.199 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -81.9 139.59 34.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.711 1.243 . . . . 2.09 112.653 178.769 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.2 p -100.43 -175.96 3.07 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 120.191 -1.568 . . . . 0.99 112.61 -179.147 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.2 mt -77.35 -43.19 33.82 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 112.82 -6.175 . . . . 2.53 111.185 178.205 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.8 p -70.05 -17.49 63.25 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.89 2.076 . . . . 2.08 111.526 -168.352 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.52 33.65 3.3 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 126.091 1.805 . . . . 1.31 116.15 170.317 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -108.56 148.44 30.29 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 103.226 -2.879 . . . . 1.4 103.226 -178.557 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 80.5 m -117.38 120.18 37.38 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 126.247 2.217 . . . . 0.78 109.007 -179.212 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.0 mm -98.72 108.7 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 126.48 3.038 . . . . 1.55 112.204 179.904 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.268 47.4 m -85.18 139.49 31.64 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.131 -3.48 . . . . 1.08 106.704 -175.377 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.1 mt -125.47 146.58 49.57 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.688 -2.507 . . . . 1.55 109.497 176.159 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -99.61 104.21 15.97 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 127.651 2.381 . . . . 1.95 110.726 163.95 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.478 HG21 ' CD1' ' A' ' 56' ' ' LEU . 33.7 m -124.8 176.3 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 119.069 -2.269 . . . . 0.96 111.037 177.728 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -115.47 155.65 46.92 Favored Pre-proline 0 N--CA 1.429 -1.508 0 N-CA-C 103.308 -2.849 . . . . 2.35 103.308 162.487 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -74.95 5.73 3.79 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 127.167 3.595 . . . . 0.95 112.026 -174.61 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.7 p -94.97 -8.73 36.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 130.405 3.482 . . . . 1.45 109.434 179.613 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -72.05 134.1 45.65 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.784 -2.448 . . . . 1.69 107.477 175.412 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.6 p -78.62 160.46 27.54 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 111.004 -2.816 . . . . 0.75 110.926 174.154 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -65.57 -31.39 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 117.176 -3.452 . . . . 0.73 116.246 177.692 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -40.16 -53.43 2.47 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.576 -3.828 . . . . 1.62 114.982 159.78 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -58.75 -39.29 80.51 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 125.117 2.389 . . . . 2.13 116.5 173.259 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.29 -42.57 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 129.909 3.284 . . . . 0.62 113.872 -179.346 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.28 39.0 mtmt -70.03 -33.5 72.05 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 126.469 2.355 . . . . 1.22 114.895 174.256 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.27 -34.03 76.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.221 1.563 . . . . 0.51 115.221 169.857 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -58.35 -31.41 67.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 127.986 3.755 . . . . 1.44 118.293 172.046 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.2 mt -84.41 -32.42 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 1 CA-C-N 108.299 -4.046 . . . . 1.32 110.151 179.256 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -63.63 -33.97 76.81 Favored 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 116.201 -4.062 . . . . 1.7 114.62 176.863 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -64.34 -47.09 80.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.616 1.566 . . . . 1.55 113.332 168.139 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -75.9 -62.29 1.64 Allowed 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 121.267 1.849 . . . . 2.62 114.101 -178.773 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -89.97 -18.25 26.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.952 1.251 . . . . 1.48 114.035 -171.477 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.62 13.85 46.0 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 120.469 -1.394 . . . . 1.12 111.264 167.534 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.7 mt -98.35 133.46 22.83 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 118.936 -2.508 . . . . 1.55 113.837 -173.93 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 72.3 Cg_exo -64.65 143.61 81.59 Favored 'Trans proline' 0 N--CA 1.433 -2.045 1 N-CA-C 124.499 4.769 . . . . 1.02 124.499 170.563 . . . . . . . . 3 3 . 1 . 092 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 13.4 Cg_exo -62.69 -21.01 72.54 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 124.435 3.423 . . . . 1.25 114.772 179.807 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -63.65 -21.61 66.46 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.517 2.043 . . . . 2.25 116.517 168.381 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -94.94 -38.62 10.61 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 103.994 -2.595 . . . . 2.02 103.994 179.127 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.331 76.5 mt-30 -80.23 132.2 35.82 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 114.255 1.206 . . . . 0.69 114.255 -171.696 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -123.33 151.59 42.31 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.295 2.638 . . . . 2.78 104.822 170.219 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.2 mt -127.84 127.47 43.52 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 124.444 2.069 . . . . 1.17 106.929 176.521 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.6 mt -104.72 137.66 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 101.48 -3.526 . . . . 1.38 101.48 171.107 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.281 2.8 t80 -130.14 103.94 7.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.802 -3.061 . . . . 1.5 103.669 170.401 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.391 . . 80.58 -98.44 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 123.812 1.767 . . . . 1.21 110.844 -178.18 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.6 -5.78 3.95 Favored Glycine 0 N--CA 1.429 -1.79 1 CA-C-O 113.243 -4.087 . . . . 1.3 109.043 -176.995 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -101.77 128.61 48.03 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 122.093 2.947 . . . . 2.55 111.136 177.067 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -88.19 117.84 27.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.638 3.575 . . . . 2.48 111.286 177.803 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 mt -75.9 148.14 38.48 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.289 1.995 . . . . 0.9 113.576 -166.947 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -99.0 153.0 19.19 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 111.586 -2.552 . . . . 1.94 111.436 175.604 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.22 -54.33 8.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.466 1.507 . . . . 1.56 114.832 -168.418 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.06 47.31 3.68 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-O 114.787 -3.229 . . . . 0.97 115.672 176.104 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -130.47 158.15 40.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.756 2.278 . . . . 2.49 110.224 165.82 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.328 27.1 p -84.85 169.11 14.47 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 113.67 -5.644 . . . . 0.76 114.557 179.704 . . . . . . . . 3 2 . 1 . 092 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.478 ' CD1' HG21 ' A' ' 17' ' ' VAL . 36.7 mt -65.73 -34.08 77.36 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 113.326 0.861 . . . . 1.05 113.326 172.251 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.6 t -70.95 -25.42 62.72 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 127.416 2.287 . . . . 1.19 111.231 179.57 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -68.03 -29.31 68.27 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 117.728 -1.13 . . . . 1.9 113.298 169.427 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -96.18 18.2 14.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.578 2.351 . . . . 0.89 105.67 176.158 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.6 m120 45.07 41.19 5.34 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 129.097 2.959 . . . . 1.84 118.727 -179.763 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.9 mt -92.65 131.01 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 118.915 -2.366 . . . . 0.82 105.113 -176.864 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -148.1 -34.91 0.22 Allowed 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.259 2.457 . . . . 2.16 110.022 -175.214 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -95.96 -179.6 4.75 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 118.934 -2.354 . . . . 2.12 109.526 174.544 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -68.31 97.56 0.75 Allowed 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 124.404 2.05 . . . . 1.71 116.202 175.745 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 98.2 p -91.85 138.97 31.12 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.362 -1.29 . . . . 1.04 109.739 -167.371 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.1 m -89.57 104.07 16.66 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 115.807 -2.357 . . . . 0.79 112.894 175.483 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mp -88.54 158.1 18.41 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.482 -1.386 . . . . 1.4 107.498 176.181 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -122.87 121.94 37.44 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 118.261 -2.774 . . . . 1.51 114.81 176.331 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 tt -82.57 117.99 22.96 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 116.962 -1.895 . . . . 1.14 115.301 -178.793 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.5 t -114.96 133.67 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 CA-C-O 126.368 2.985 . . . . 1.23 112.466 175.321 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.6 mt -92.62 141.31 28.63 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.752 -3.718 . . . . 2.78 107.735 175.87 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -124.35 98.66 5.85 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 112.512 -2.131 . . . . 3.75 105.637 177.139 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.8 mt -91.78 -75.79 0.47 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 129.703 3.201 . . . . 3.14 119.466 176.773 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 53.1 ttm-85 -99.42 -64.16 1.06 Allowed 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 129.313 4.133 . . . . 6.8 106.164 175.317 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.05 111.36 0.3 Allowed Glycine 0 N--CA 1.43 -1.713 0 O-C-N 126.871 2.607 . . . . 3.57 108.602 -175.525 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.791 1 CA-C-O 112.434 -4.536 . . . . 3.87 110.503 -178.435 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 ttp . . . . . 0 CA--C 1.491 -1.318 0 N-CA-C 113.991 1.108 . . . . 1.1 113.991 . . . . . . . . . 0 0 . 1 . 093 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -106.29 95.0 5.46 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.752 -2.467 . . . . 1.87 111.004 -166.316 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.9 pt -90.44 165.58 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 125.762 1.914 . . . . 0.72 111.842 177.855 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -121.41 130.86 53.84 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.393 -1.442 . . . . 1.4 107.338 178.388 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.62 108.45 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 O-C-N 119.816 -1.802 . . . . 0.58 108.44 174.41 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -99.63 133.59 43.74 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.214 1.405 . . . . 2.09 111.059 179.707 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.9 p -101.08 163.58 12.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 115.742 1.756 . . . . 0.99 115.742 -179.31 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 tp -51.58 -49.06 62.85 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.802 3.241 . . . . 2.53 114.303 170.058 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 p -74.86 -40.01 61.23 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.702 1.715 . . . . 2.08 114.201 -165.975 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.37 15.73 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.709 0 O-C-N 118.283 -2.761 . . . . 1.31 114.134 174.323 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -108.03 134.41 50.96 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 126.02 2.819 . . . . 1.4 114.864 -178.367 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.0 m -108.66 107.15 17.51 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 130.02 3.328 . . . . 0.78 105.089 174.059 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -88.4 131.79 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 1 O-C-N 116.066 -4.146 . . . . 1.55 107.318 174.828 . . . . . . . . 3 3 . 1 . 093 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 m -100.1 103.08 14.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 100.416 -3.92 . . . . 1.08 100.416 178.523 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.9 mt -102.97 130.72 50.15 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.055 1.883 . . . . 1.55 112.347 177.398 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -97.17 113.84 25.48 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.411 -2.681 . . . . 1.95 110.689 169.024 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.55 155.76 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 107.273 -1.38 . . . . 0.96 107.273 -177.443 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.325 19.5 mm-40 -86.61 152.8 55.02 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-N 121.644 2.02 . . . . 2.35 107.026 163.669 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -71.25 -16.71 31.45 Favored 'Trans proline' 0 C--N 1.3 -1.996 3 CA-C-N 129.823 4.544 . . . . 0.95 113.537 179.715 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 m -74.95 -6.07 47.26 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 126.042 2.089 . . . . 1.45 113.312 168.652 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -74.3 153.59 39.29 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.64 -2.537 . . . . 1.69 109.276 175.997 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 p -87.28 177.03 7.27 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.196 -2.815 . . . . 0.75 115.283 178.901 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.49 HD12 HD13 ' A' ' 50' ' ' LEU . 47.3 mm -76.79 -32.03 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 124.997 1.319 . . . . 0.73 108.758 174.179 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -53.39 -52.81 58.12 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.89 2.476 . . . . 1.62 113.256 170.488 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -62.58 -38.59 90.71 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 114.79 -2.528 . . . . 2.13 116.234 172.426 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.06 -44.71 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 123.265 2.757 . . . . 0.62 111.706 171.587 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -59.9 -32.79 71.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.77 -3.081 . . . . 1.22 112.181 175.482 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.57 -35.2 79.63 Favored 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.731 -4.355 . . . . 0.51 117.727 172.249 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -71.54 -27.03 62.9 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.576 -2.577 . . . . 1.44 114.281 176.053 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.3 mt -75.45 -36.82 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 117.372 -3.33 . . . . 1.32 109.103 173.67 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -63.09 -53.14 58.29 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.21 -1.556 . . . . 1.7 109.963 177.392 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -41.34 -63.5 0.69 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.688 2.847 . . . . 1.55 118.688 166.53 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -81.9 -36.47 28.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 117.08 2.252 . . . . 2.62 117.08 -166.112 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -103.09 -46.97 4.48 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.848 -1.782 . . . . 1.48 111.315 -175.223 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.96 25.36 2.31 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 123.913 0.768 . . . . 1.12 114.668 170.831 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.4 mt -107.09 127.36 28.12 Favored Pre-proline 0 N--CA 1.429 -1.493 0 O-C-N 118.575 -2.72 . . . . 1.55 109.445 -170.465 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -67.78 138.5 45.05 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 C-N-CA 123.286 2.658 . . . . 1.02 115.809 179.344 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.14 -13.63 31.28 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 CA-C-N 121.335 1.512 . . . . 1.25 115.11 -162.025 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -55.93 -27.8 53.97 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 129.509 3.124 . . . . 2.25 113.721 168.517 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -98.08 -0.14 45.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.8 -1.813 . . . . 2.02 111.149 -173.664 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -97.79 135.82 39.01 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.563 2.601 . . . . 0.69 112.646 -175.215 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -125.05 115.45 20.54 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.756 -1.84 . . . . 2.78 107.241 169.175 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mt -94.44 126.07 39.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.681 2.392 . . . . 1.17 113.807 177.888 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.3 mm -111.04 131.7 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 108.736 -0.838 . . . . 1.38 108.736 -175.913 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -123.67 87.46 2.74 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 127.124 2.17 . . . . 1.5 106.853 168.793 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.256 . . 69.18 -98.49 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.378 -2.076 . . . . 1.21 112.176 -178.441 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.06 6.65 13.13 Favored Glycine 0 N--CA 1.431 -1.653 0 O-C-N 118.352 -2.717 . . . . 1.3 111.571 177.762 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -99.36 130.25 45.63 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.91 -1.885 . . . . 2.55 105.91 178.74 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -103.4 107.25 18.01 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 111.156 -2.747 . . . . 2.48 109.597 170.268 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.49 HD13 HD12 ' A' ' 23' ' ' ILE . 53.3 mt -76.1 131.66 39.57 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 121.111 3.745 . . . . 0.9 121.111 -166.059 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -90.5 141.38 28.82 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 119.647 3.203 . . . . 1.94 119.647 176.536 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -42.96 -68.71 0.17 Allowed 'General case' 0 N--CA 1.431 -1.418 1 N-CA-C 122.337 4.199 . . . . 1.56 122.337 -171.752 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.6 25.15 1.15 Allowed Glycine 0 N--CA 1.429 -1.774 0 C-N-CA 129.194 3.283 . . . . 0.97 119.419 171.193 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -105.99 151.95 23.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.178 -3.542 . . . . 2.49 111.845 163.659 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.7 p -76.04 171.37 14.58 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 124.781 2.229 . . . . 0.76 116.412 172.811 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.629 HD23 HD12 ' A' ' 61' ' ' ILE . 47.9 mt -73.02 -27.69 61.91 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.305 -2.122 . . . . 1.05 113.312 167.838 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.9 p -78.49 -28.39 46.35 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-O 118.148 -0.929 . . . . 1.19 110.087 -177.978 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -56.34 -59.74 4.52 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.366 1.066 . . . . 1.9 111.14 171.909 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -62.85 -28.93 70.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 126.743 2.527 . . . . 0.89 114.507 -179.063 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 82.86 51.79 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.412 1 C-N-CA 132.95 4.5 . . . . 1.84 112.048 -178.466 . . . . . . . . 3 3 . 1 . 093 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.629 HD12 HD23 ' A' ' 56' ' ' LEU . 65.5 mt -84.09 114.7 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 108.373 -0.973 . . . . 0.82 108.373 -178.547 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -95.32 159.79 14.84 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 126.256 1.823 . . . . 2.16 114.118 -170.696 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.382 6.5 tmtm? -6.35 -81.31 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 120.233 3.419 . . . . 2.12 120.233 175.165 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -105.39 71.04 0.91 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.948 2.309 . . . . 1.71 110.962 -175.141 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.283 18.7 m -107.55 141.52 38.88 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 124.392 2.044 . . . . 1.04 107.216 -177.49 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.3 m -105.4 119.19 38.47 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.767 -1.833 . . . . 0.79 107.659 174.374 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -96.34 148.92 22.27 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.527 2.331 . . . . 1.4 107.563 174.314 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -126.15 122.33 35.38 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.148 -1.797 . . . . 1.51 106.148 -174.617 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.5 tp -82.29 135.61 35.18 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 125.062 2.363 . . . . 1.14 107.095 -176.143 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.0 t -135.17 150.21 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 1 N-CA-C 99.328 -4.323 . . . . 1.23 99.328 -179.208 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.3 mt -111.56 146.95 36.44 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 115.094 -4.754 . . . . 2.78 107.76 -176.919 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -95.28 130.8 41.9 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 110.403 -3.09 . . . . 3.75 108.709 -179.479 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.345 47.4 mt -111.54 167.52 10.26 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.366 -3.334 . . . . 3.14 109.364 168.374 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -60.99 -57.84 10.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 118.154 -0.926 . . . . 6.8 110.16 169.107 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.73 59.95 4.71 Favored Glycine 0 N--CA 1.43 -1.726 0 CA-C-N 123.62 2.918 . . . . 3.57 110.501 -168.752 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.734 0 O-C-N 120.381 -1.658 . . . . 3.87 113.767 -179.961 . . . . . . . . 0 0 . 1 . 094 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 ttp . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 109.275 -0.639 . . . . 1.1 109.275 . . . . . . . . . 0 0 . 1 . 094 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -102.68 117.6 35.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.811 -3.681 . . . . 1.87 107.85 -178.052 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.0 pt -117.12 149.54 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 125.69 2.662 . . . . 0.72 110.062 174.369 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -95.26 153.76 17.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.984 -2.322 . . . . 1.4 112.223 -177.062 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.9 t -137.37 114.24 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 117.957 -2.964 . . . . 0.58 108.286 172.464 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -86.69 122.51 30.69 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.344 2.257 . . . . 2.09 112.427 179.709 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.301 17.0 p -80.89 174.89 11.17 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.451 -0.795 . . . . 0.99 112.674 -177.378 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 tp -78.03 -25.69 48.0 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 119.176 3.028 . . . . 2.53 119.176 171.357 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.9 p -74.82 -46.55 35.89 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.736 -3.102 . . . . 2.08 112.054 -178.001 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.31 6.89 0.12 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 126.629 2.062 . . . . 1.31 110.014 174.137 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -84.0 144.68 28.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 121.415 2.608 . . . . 1.4 114.137 178.371 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.335 31.3 m -102.57 137.63 40.55 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.228 2.211 . . . . 0.78 111.452 167.306 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mt -125.04 129.54 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 1 C-N-CA 132.908 4.483 . . . . 1.55 110.361 177.082 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.6 m -101.06 117.8 35.74 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 125.615 1.822 . . . . 1.08 109.651 177.096 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -111.36 137.82 48.64 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.425 1.89 . . . . 1.55 111.166 173.763 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -90.38 134.28 34.43 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.154 -2.216 . . . . 1.95 106.305 163.711 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.7 m -142.82 161.95 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 C-N-CA 129.427 3.091 . . . . 0.96 111.789 179.503 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -98.06 149.02 35.3 Favored Pre-proline 0 N--CA 1.431 -1.417 0 O-C-N 117.328 -3.358 . . . . 2.35 108.026 165.474 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -69.82 -17.58 37.21 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 CA-C-N 128.182 3.958 . . . . 0.95 112.109 -179.183 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.0 p -77.95 -16.09 58.45 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.048 1.739 . . . . 1.45 112.984 175.784 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -66.86 134.26 51.72 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.535 -1.211 . . . . 1.69 113.213 178.757 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -69.03 168.38 13.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 115.346 1.61 . . . . 0.75 115.346 174.653 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.276 15.4 mm -76.06 -29.59 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 113.642 -1.617 . . . . 0.73 112.186 176.621 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -46.82 -48.87 20.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.641 3.176 . . . . 1.62 111.703 158.84 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -63.87 -37.22 86.59 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.296 1.438 . . . . 2.13 114.859 176.459 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.3 t -59.99 -43.06 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 118.983 -2.323 . . . . 0.62 116.535 173.593 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HD3' ' HB2' ' A' ' 41' ' ' GLN . 74.4 mttt -71.7 -33.75 69.04 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.241 1.816 . . . . 1.22 114.528 179.741 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.22 -17.76 60.27 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.026 -2.921 . . . . 0.51 109.978 173.412 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -89.93 -12.68 38.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.967 1.841 . . . . 1.44 113.646 173.824 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.8 mt -88.32 -23.52 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 119.918 -1.739 . . . . 1.32 110.671 169.432 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -69.73 -49.42 53.42 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.314 1.845 . . . . 1.7 108.673 172.04 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.306 33.1 t70 -53.7 -62.86 1.38 Allowed 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 123.189 2.722 . . . . 1.55 116.405 164.078 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -63.21 -62.39 1.72 Allowed 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.818 -3.052 . . . . 2.62 113.995 -170.938 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -96.02 -56.46 2.64 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.258 -2.776 . . . . 1.48 113.23 -170.935 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.91 5.49 1.03 Allowed Glycine 0 N--CA 1.431 -1.698 0 O-C-N 124.867 1.354 . . . . 1.12 114.497 170.739 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.5 mt -78.12 135.53 62.3 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-O 114.611 -2.614 . . . . 1.55 111.969 -174.578 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 3.0 Cg_endo -77.37 153.24 31.03 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 CA-C-N 125.413 2.969 . . . . 1.02 113.469 -178.024 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 85.9 Cg_exo -64.51 -24.66 63.34 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 CA-C-N 127.664 3.773 . . . . 1.25 115.603 -172.106 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -61.24 -33.25 73.21 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.613 -2.555 . . . . 2.25 117.254 173.792 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -76.97 -24.74 52.28 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.376 -3.327 . . . . 2.02 116.746 -178.29 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.484 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 68.0 mt-30 -80.9 107.86 14.08 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.28 2.232 . . . . 0.69 110.513 -172.468 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -103.5 119.67 39.35 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.094 -2.879 . . . . 2.78 106.577 168.713 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.7 mt -102.92 123.86 47.34 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 119.67 3.211 . . . . 1.17 119.67 -178.789 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -109.58 157.68 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 115.675 -2.107 . . . . 1.38 109.751 178.356 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -140.63 114.95 9.29 Favored 'General case' 0 N--CA 1.43 -1.453 1 N-CA-C 95.64 -5.689 . . . . 1.5 95.64 173.604 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.259 . . 55.9 -110.23 0.54 Allowed 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.299 -1.501 . . . . 1.21 114.348 -176.815 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.48 -8.71 24.55 Favored Glycine 0 N--CA 1.43 -1.738 0 CA-C-O 123.062 1.368 . . . . 1.3 112.967 -176.601 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -91.61 143.86 26.13 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.388 -3.419 . . . . 2.55 114.468 171.572 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -99.83 129.05 45.89 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.236 1.014 . . . . 2.48 108.634 170.365 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.1 mt -91.36 147.13 23.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.194 1.473 . . . . 0.9 113.234 -167.86 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -91.74 143.23 26.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.719 -1.863 . . . . 1.94 115.581 175.392 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.81 -47.68 77.16 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 118.646 2.832 . . . . 1.56 118.646 -173.504 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.55 26.04 2.75 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 122.934 3.934 . . . . 0.97 122.934 171.885 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.4 mtt-85 -111.46 146.67 36.82 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 118.813 -2.581 . . . . 2.49 110.589 169.84 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.343 43.7 p -70.98 170.9 11.8 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.638 2.637 . . . . 0.76 113.264 176.404 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mt -74.87 -27.96 60.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.318 -2.739 . . . . 1.05 109.779 168.571 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.6 t -65.75 -39.87 91.52 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 127.706 2.402 . . . . 1.19 114.752 178.977 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -51.0 -50.22 58.92 Favored 'General case' 0 N--CA 1.43 -1.452 1 CA-C-O 129.135 4.302 . . . . 1.9 112.505 174.544 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -88.15 -2.1 58.4 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.822 -3.049 . . . . 0.89 114.286 -178.904 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 63.73 55.73 1.63 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.61 1.964 . . . . 1.84 113.183 -176.381 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.1 mm -85.3 118.44 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-O 116.333 -1.794 . . . . 0.82 106.308 179.288 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -82.56 -170.52 3.0 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 128.035 3.334 . . . . 2.16 109.35 -176.69 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.28 92.4 mttt -72.61 -56.3 5.55 Favored 'General case' 0 N--CA 1.429 -1.495 1 N-CA-C 123.84 4.756 . . . . 2.12 123.84 -177.981 . . . . . . . . 3 2 . 1 . 094 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -74.3 27.14 0.08 Allowed 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.783 2.706 . . . . 1.71 115.01 -176.571 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.7 m -73.83 136.41 43.51 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.722 -4.361 . . . . 1.04 116.174 -174.859 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.8 m -112.98 108.97 18.08 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.478 2.085 . . . . 0.79 107.123 178.773 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -75.77 138.97 41.56 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 112.368 -2.197 . . . . 1.4 105.843 174.395 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -106.73 109.41 21.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.744 -3.098 . . . . 1.51 107.225 -170.339 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tp -106.48 126.0 51.7 Favored 'General case' 0 N--CA 1.43 -1.455 1 CA-C-O 128.81 4.148 . . . . 1.14 107.701 -171.69 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -112.85 138.74 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 109.353 -3.567 . . . . 1.23 105.906 -179.151 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -104.41 132.85 50.2 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 116.579 -2.049 . . . . 2.78 108.884 -173.899 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 ptt-85 -121.93 166.39 14.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 113.124 -1.853 . . . . 3.75 112.536 177.128 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.7 mt -89.42 166.56 13.63 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.053 0.93 . . . . 3.14 110.852 171.025 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -85.91 135.56 33.63 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 114.554 1.316 . . . . 6.8 114.554 174.759 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.51 -54.1 0.12 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 118.183 -2.823 . . . . 3.57 113.066 -161.596 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.784 0 CA-C-N 120.267 2.034 . . . . 3.87 114.149 175.628 . . . . . . . . 0 0 . 1 . 095 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ptt? . . . . . 0 CA--C 1.49 -1.356 0 CA-C-O 119.635 -0.221 . . . . 1.1 111.008 . . . . . . . . . 0 0 . 1 . 095 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -111.3 117.67 33.79 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.815 -1.178 . . . . 1.87 108.517 -176.594 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.425 HG12 HG22 ' A' ' 17' ' ' VAL . 16.8 pt -114.13 159.13 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 124.586 1.154 . . . . 0.72 113.054 -178.63 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -112.17 146.61 37.77 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 104.914 -2.254 . . . . 1.4 104.914 174.916 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.8 t -117.3 114.45 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 110.927 -2.851 . . . . 0.58 109.822 174.159 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -91.96 131.5 37.21 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 120.937 1.699 . . . . 2.09 110.329 175.838 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.295 39.4 p -83.12 174.13 11.09 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 126.535 3.064 . . . . 0.99 112.379 174.914 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.3 tp -57.96 -47.32 83.28 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.488 2.566 . . . . 2.53 117.818 172.746 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.3 p -86.4 -8.0 58.0 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.241 2.216 . . . . 2.08 110.103 -173.809 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.4 30.14 5.73 Favored Glycine 0 N--CA 1.431 -1.7 1 C-N-CA 132.932 5.063 . . . . 1.31 118.84 167.613 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -106.15 133.94 50.06 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.258 -2.319 . . . . 1.4 105.54 -176.038 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.7 m -105.05 118.7 37.2 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.239 -0.891 . . . . 0.78 110.155 -173.501 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.72 129.27 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 124.783 1.233 . . . . 1.55 109.982 -176.12 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 100.0 m -88.86 122.46 32.27 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 126.813 2.571 . . . . 1.08 106.409 177.931 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.2 tp -121.63 134.69 54.99 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.379 -2.076 . . . . 1.55 108.612 -178.616 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -94.02 99.92 12.14 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 129.643 3.177 . . . . 1.95 116.561 173.197 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.425 HG22 HG12 ' A' ' 3' ' ' ILE . 16.2 m -115.29 149.58 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 127.712 2.405 . . . . 0.96 112.681 -175.456 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -103.81 165.84 12.75 Favored Pre-proline 0 N--CA 1.43 -1.448 0 N-CA-C 106.625 -1.62 . . . . 2.35 106.625 168.274 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -79.56 -20.01 9.7 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 123.18 2.587 . . . . 0.95 107.625 -172.597 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.8 p -84.8 0.49 50.59 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.244 -2.16 . . . . 1.45 115.974 177.039 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -70.65 151.65 44.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.816 1.246 . . . . 1.69 110.611 173.913 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 p -84.78 166.64 16.79 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.421 1.488 . . . . 0.75 111.028 171.293 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.4 mm -75.12 -35.87 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 116.645 2.091 . . . . 0.73 116.645 173.335 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -48.31 -49.45 33.93 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.053 2.983 . . . . 1.62 119.053 163.536 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -58.49 -35.73 72.66 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.861 2.064 . . . . 2.13 112.899 173.892 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 t -72.76 -38.9 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 121.09 -1.006 . . . . 0.62 112.797 177.685 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -64.02 -31.26 72.38 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.495 -3.253 . . . . 1.22 111.409 170.514 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.43 -32.04 70.75 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 119.144 0.884 . . . . 0.51 111.695 175.246 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -68.86 -45.16 71.79 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.0 1.481 . . . . 1.44 115.0 171.888 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mt -59.03 -35.41 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 125.621 2.629 . . . . 1.32 113.553 177.428 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.298 26.3 tt0 -69.15 -40.89 77.95 Favored 'General case' 0 N--CA 1.428 -1.535 0 O-C-N 116.331 -3.981 . . . . 1.7 111.475 172.67 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -56.05 -61.79 2.14 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 122.969 2.622 . . . . 1.55 114.362 167.429 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.439 12.0 ptpt -76.77 -50.77 12.75 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 114.8 1.407 . . . . 2.62 114.8 -173.706 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -97.28 -48.44 5.33 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 125.577 2.608 . . . . 1.48 112.98 -170.248 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.93 67.02 0.75 Allowed Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 119.936 2.734 . . . . 1.12 119.936 -179.336 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.3 mt -127.26 135.24 27.12 Favored Pre-proline 0 N--CA 1.43 -1.446 0 N-CA-C 100.563 -3.865 . . . . 1.55 100.563 -177.303 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -85.55 135.17 4.99 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 C-N-CA 115.047 -2.835 . . . . 1.02 111.76 -175.202 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.29 -11.68 6.56 Favored 'Trans proline' 0 C--N 1.3 -2.0 1 C-N-CA 126.233 4.622 . . . . 1.25 117.41 -172.91 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -73.83 -23.7 59.69 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.82 1.415 . . . . 2.25 114.82 169.329 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -99.85 -3.06 33.37 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.023 -2.923 . . . . 2.02 113.871 -176.379 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -101.13 97.59 8.11 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.466 -2.021 . . . . 0.69 113.782 -172.706 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.8 ttt-85 -87.82 122.14 31.1 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 115.856 -2.021 . . . . 2.78 110.263 166.737 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.8 mt -111.08 131.5 55.02 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.886 2.18 . . . . 1.17 116.886 -177.717 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.91 136.23 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 105.691 -1.966 . . . . 1.38 105.691 -177.927 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -93.1 -105.42 0.12 Allowed 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.882 -1.508 . . . . 1.5 107.644 168.847 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.83 -69.81 0.79 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 113.934 1.087 . . . . 1.21 113.934 170.174 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.79 -28.57 5.29 Favored Glycine 0 N--CA 1.429 -1.779 0 O-C-N 119.701 -1.874 . . . . 1.3 109.5 -179.275 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -95.25 142.75 27.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 120.423 2.112 . . . . 2.55 108.599 -179.404 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -95.3 135.68 36.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 128.634 2.774 . . . . 2.48 104.394 166.851 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.1 mt -86.68 115.85 24.4 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 126.287 2.242 . . . . 0.9 116.777 -168.769 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -84.8 134.4 34.31 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 125.636 2.636 . . . . 1.94 111.776 179.014 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.283 20.0 m-20 -59.75 -40.38 87.92 Favored 'General case' 0 N--CA 1.43 -1.44 2 N-CA-C 127.458 6.095 . . . . 1.56 127.458 -168.547 . . . . . . . . 3 2 . 1 . 095 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.52 56.88 1.98 Allowed Glycine 0 N--CA 1.43 -1.703 0 O-C-N 119.256 -2.153 . . . . 0.97 113.518 167.736 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -131.93 162.25 31.12 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 127.811 2.444 . . . . 2.49 108.733 172.012 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.3 p -95.53 169.71 9.85 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 121.049 1.75 . . . . 0.76 110.134 173.948 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.451 ' HG ' HD12 ' A' ' 61' ' ' ILE 0.262 7.5 mp -59.02 -30.25 67.87 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 119.152 3.019 . . . . 1.05 119.152 161.906 . . . . . . . . 3 3 . 1 . 095 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 p -74.24 -23.62 59.18 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.909 -2.994 . . . . 1.19 109.118 177.614 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -74.63 -40.65 61.37 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 129.759 3.224 . . . . 1.9 112.696 178.784 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.254 46.8 m-85 -91.62 -0.67 57.6 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 113.469 -5.769 . . . . 0.89 109.505 177.553 . . . . . . . . 3 2 . 1 . 095 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.8 m120 63.74 56.78 1.48 Allowed 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 114.233 -2.794 . . . . 1.84 109.278 -179.029 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.451 HD12 ' HG ' ' A' ' 56' ' ' LEU 0.295 65.6 mt -84.66 126.18 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 127.886 2.474 . . . . 0.82 110.659 175.643 . . . . . . . . 3 3 . 1 . 095 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -107.58 170.92 7.68 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 117.925 -1.036 . . . . 2.16 108.277 -173.473 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -71.51 -29.3 64.63 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 115.478 -2.489 . . . . 2.12 113.981 -178.963 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -80.04 10.4 4.37 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 125.603 2.621 . . . . 1.71 113.972 -179.652 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.8 m -78.84 130.94 36.24 Favored 'General case' 0 N--CA 1.431 -1.406 1 O-C-N 116.096 -4.127 . . . . 1.04 116.899 -174.631 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.8 m -106.51 115.71 30.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.937 -1.938 . . . . 0.79 111.879 170.947 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.297 8.8 mp -87.61 157.61 19.08 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.744 -1.116 . . . . 1.4 109.439 177.103 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -128.54 123.93 34.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 103.36 -2.83 . . . . 1.51 103.36 -176.088 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.305 6.8 tt -103.56 115.42 30.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.253 1.021 . . . . 1.14 111.349 179.579 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.388 4.1 m -109.66 166.71 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 118.628 -2.545 . . . . 1.23 112.446 174.283 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.4 tp -75.04 109.84 8.84 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 117.365 2.358 . . . . 2.78 117.365 -178.45 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.36 138.71 38.93 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 120.096 -0.642 . . . . 3.75 110.796 179.731 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 55.4 mt -112.92 166.67 11.18 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 119.767 -1.833 . . . . 3.14 110.704 -176.929 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.0 ttm-85 -79.17 139.26 38.04 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 127.372 3.463 . . . . 6.8 112.173 178.362 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.54 -112.2 0.51 Allowed Glycine 0 N--CA 1.43 -1.736 1 O-C-N 113.652 -5.655 . . . . 3.57 113.661 -165.914 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.772 0 N-CA-C 108.614 -1.795 . . . . 3.87 108.614 -172.657 . . . . . . . . 0 0 . 1 . 096 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 ptt? . . . . . 0 CA--C 1.49 -1.355 0 N-CA-C 113.268 0.84 . . . . 1.1 113.268 . . . . . . . . . 0 0 . 1 . 096 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -101.14 107.11 18.44 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 120.414 1.461 . . . . 1.87 112.021 -178.768 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.1 pt -89.62 155.9 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 C-N-CA 124.76 1.224 . . . . 0.72 111.431 176.763 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -104.88 140.99 37.32 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 123.303 1.525 . . . . 1.4 107.93 -179.894 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.6 t -124.43 114.97 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 103.584 -2.747 . . . . 0.58 103.584 174.298 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -96.59 138.14 34.62 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.828 -1.795 . . . . 2.09 111.481 -178.322 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.65 HG22 HD23 ' A' ' 69' ' ' LEU 0.346 18.3 p -91.73 166.86 12.56 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 116.429 -1.748 . . . . 0.99 110.977 175.204 . . . . . . . . 3 3 . 1 . 096 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.8 mt -68.95 -44.82 72.23 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 125.33 1.644 . . . . 2.53 111.182 171.784 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.1 p -62.17 -81.84 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 128.399 3.952 . . . . 2.08 113.299 -177.432 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.12 40.48 0.11 Allowed Glycine 0 N--CA 1.431 -1.692 1 O-C-N 116.299 -4.001 . . . . 1.31 119.243 174.819 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -122.87 142.39 50.84 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.069 1.435 . . . . 1.4 108.134 -177.206 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.6 m -120.63 118.66 30.72 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.759 2.423 . . . . 0.78 106.289 172.03 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.444 HD13 HG21 ' A' ' 13' ' ' ILE . 2.9 mt -97.59 133.2 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-O 124.978 2.323 . . . . 1.55 105.89 178.61 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 p -107.28 92.63 4.16 Favored 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 132.496 4.318 . . . . 1.08 107.091 -177.402 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.0 mt -101.31 130.36 47.46 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 125.313 1.633 . . . . 1.55 112.353 -179.198 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -74.7 107.49 6.84 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 115.269 -2.301 . . . . 1.95 109.758 171.314 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.1 m -127.57 173.32 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 105.847 -1.908 . . . . 0.96 105.847 -173.349 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -125.77 169.57 11.21 Favored Pre-proline 0 N--CA 1.431 -1.399 0 CA-C-O 112.903 -3.427 . . . . 2.35 106.285 163.849 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -74.87 -17.95 19.48 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 C-N-CA 124.028 3.152 . . . . 0.95 111.356 -175.192 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.6 p -78.17 -8.96 58.94 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.736 2.014 . . . . 1.45 115.656 176.339 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -74.29 137.88 43.19 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.69 -3.131 . . . . 1.69 112.567 176.565 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 29.6 p -76.42 154.84 34.47 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.697 1.999 . . . . 0.75 111.354 176.072 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.0 mm -54.42 -37.08 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 125.679 1.592 . . . . 0.73 112.072 173.96 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -53.32 -45.52 69.07 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.281 2.232 . . . . 1.62 116.783 162.599 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.413 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 5.5 t-20 -55.75 -42.22 75.11 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 119.09 -2.256 . . . . 2.13 115.642 171.692 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.0 t -66.33 -39.34 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 114.284 1.216 . . . . 0.62 114.284 179.204 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -63.27 -27.02 69.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.587 2.069 . . . . 1.22 116.587 168.931 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -64.71 -47.29 78.86 Favored 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 116.291 -4.005 . . . . 0.51 113.773 169.127 . . . . . . . . 3 3 . 1 . 096 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -55.47 -49.95 71.17 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 126.431 3.015 . . . . 1.44 116.672 169.634 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.1 mt -59.11 -40.14 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 O-C-N 116.394 -3.941 . . . . 1.32 114.291 169.921 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -61.09 -39.87 91.56 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.77 -1.831 . . . . 1.7 113.058 173.444 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -62.7 -50.68 70.2 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.511 2.041 . . . . 1.55 116.511 172.711 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -67.6 -61.18 2.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.863 2.465 . . . . 2.62 109.665 -173.583 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -94.93 -56.27 2.81 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.622 -2.549 . . . . 1.48 112.837 -169.719 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.73 -1.1 2.84 Favored Glycine 0 N--CA 1.431 -1.667 0 O-C-N 119.615 -1.928 . . . . 1.12 116.155 176.111 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.1 mt -90.84 134.51 30.27 Favored Pre-proline 0 N--CA 1.429 -1.481 0 O-C-N 119.959 -1.906 . . . . 1.55 107.486 -167.269 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 20.4 Cg_exo -61.08 153.05 67.14 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 O-C-N 115.121 -3.147 . . . . 1.02 114.943 173.5 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 99.0 Cg_exo -73.7 -19.02 21.75 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 122.815 2.041 . . . . 1.25 110.557 -177.644 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.265 3.3 m-20 -63.42 -28.57 70.06 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.12 -2.863 . . . . 2.25 116.897 170.276 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.251 18.6 mt-30 -85.95 -23.91 26.75 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 115.164 -0.925 . . . . 2.02 111.936 -179.552 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -78.43 134.46 37.37 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 120.346 3.461 . . . . 0.69 120.346 -178.456 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -122.57 130.64 53.23 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 105.092 -2.188 . . . . 2.78 105.092 175.465 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.2 mt -114.73 147.11 40.15 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 117.238 -3.414 . . . . 1.17 113.371 175.778 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.0 mt -144.25 136.97 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 C-N-CA 128.268 2.627 . . . . 1.38 104.084 -168.674 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -117.52 123.65 46.79 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 103.289 -2.856 . . . . 1.5 103.289 170.374 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.285 . . 63.3 -89.53 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.476 -2.64 . . . . 1.21 116.75 -176.816 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.9 4.82 3.6 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 105.38 -3.088 . . . . 1.3 105.38 -177.91 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -109.12 130.03 55.48 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.029 -2.454 . . . . 2.55 115.557 -174.538 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -70.32 130.9 43.21 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.836 1.655 . . . . 2.48 110.347 171.171 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.1 mt -99.32 159.15 15.21 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 124.43 3.286 . . . . 0.9 105.094 -168.202 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.491 ' HB3' ' HG3' ' A' ' 54' ' ' ARG . 37.6 tt0 -104.25 130.2 52.05 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 125.65 1.844 . . . . 1.94 114.036 174.5 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -50.25 -50.73 49.17 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.523 3.156 . . . . 1.56 119.523 -168.848 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.6 -9.43 65.15 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 119.832 2.693 . . . . 0.97 119.832 170.68 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.491 ' HG3' ' HB3' ' A' ' 51' ' ' GLU . 37.4 mtt180 -84.92 163.22 19.1 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 115.757 -4.378 . . . . 2.49 115.066 169.687 . . . . . . . . 3 3 . 1 . 096 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 43.0 p -84.02 174.66 10.12 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 118.582 2.808 . . . . 0.76 118.582 171.825 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.83 -31.29 72.41 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 117.922 2.564 . . . . 1.05 117.922 165.892 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.5 t -77.25 -25.2 51.28 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.937 2.095 . . . . 1.19 112.927 178.79 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -65.3 -33.49 76.1 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.316 -2.115 . . . . 1.9 111.898 169.45 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -91.81 4.51 52.69 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.316 -4.615 . . . . 0.89 113.439 170.059 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.663 2.9 m120 63.46 25.83 14.64 Favored 'General case' 0 N--CA 1.43 -1.439 1 N-CA-C 124.288 4.922 . . . . 1.84 124.288 -174.862 . . . . . . . . 3 2 . 1 . 096 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.4 mt -66.84 121.87 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 128.106 2.563 . . . . 0.82 110.541 -177.252 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -89.44 174.73 7.63 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.416 2.531 . . . . 2.16 112.349 -179.518 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -42.06 -56.65 2.75 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 128.023 3.773 . . . . 2.12 118.154 174.791 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -94.61 44.29 1.11 Allowed 'General case' 0 N--CA 1.429 -1.513 1 O-C-N 113.077 -6.015 . . . . 1.71 113.445 -175.269 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.31 38.8 m -92.65 133.73 35.7 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 118.73 -2.481 . . . . 1.04 115.478 -171.716 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.3 m -104.33 105.32 15.41 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 120.694 1.588 . . . . 0.79 107.448 175.004 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 67' ' ' LEU . 5.8 mp -81.74 161.85 23.17 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.299 2.0 . . . . 1.4 109.385 163.67 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.261 98.8 m-70 -118.45 130.7 56.11 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 112.493 -2.139 . . . . 1.51 108.966 -178.199 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.65 HD23 HG22 ' A' ' 7' ' ' THR . 49.8 tp -102.16 111.5 23.81 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 123.351 1.548 . . . . 1.14 110.228 179.295 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.289 40.0 t -109.48 129.79 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 118.218 2.673 . . . . 1.23 118.218 177.848 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.2 tp -115.01 116.44 28.46 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 115.889 -2.324 . . . . 2.78 113.741 -170.287 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.89 179.55 4.09 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 119.023 0.828 . . . . 3.75 109.803 -179.982 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.7 tp -72.4 -83.26 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.274 2.63 . . . . 3.14 114.612 173.035 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -162.37 150.42 14.4 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 101.108 -3.664 . . . . 6.8 101.108 164.313 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.95 143.58 7.78 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 104.967 -3.253 . . . . 3.57 104.967 -167.716 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.757 0 CA-C-N 123.264 3.532 . . . . 3.87 114.712 174.064 . . . . . . . . 0 0 . 1 . 097 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttp . . . . . 0 CA--C 1.491 -1.309 0 N-CA-C 116.139 1.904 . . . . 1.1 116.139 . . . . . . . . . 0 0 . 1 . 097 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -95.98 125.65 40.68 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 116.52 -3.863 . . . . 1.87 110.688 -174.312 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.6 pt -111.98 144.54 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 124.739 2.209 . . . . 0.72 110.12 169.121 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -108.34 112.67 25.24 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.131 -1.85 . . . . 1.4 110.63 -174.661 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.39 116.24 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-O 124.895 2.283 . . . . 0.58 107.262 178.564 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 tppt? -97.38 132.35 43.18 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.389 -3.945 . . . . 2.09 109.197 177.045 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.357 12.5 p -73.56 173.78 9.21 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.08 -2.262 . . . . 0.99 115.106 176.26 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.9 mt -70.92 -15.32 62.6 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.628 1.68 . . . . 2.53 114.985 172.962 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.7 p -109.24 -26.17 10.22 Favored 'General case' 0 N--CA 1.431 -1.399 1 O-C-N 116.025 -4.172 . . . . 2.08 107.264 -175.796 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.42 27.22 0.83 Allowed Glycine 0 N--CA 1.431 -1.651 0 O-C-N 118.968 -2.332 . . . . 1.31 117.12 169.383 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -100.66 118.41 36.74 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.808 2.304 . . . . 1.4 109.919 -168.712 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.4 m -81.44 122.48 27.56 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 119.557 -0.857 . . . . 0.78 110.012 178.518 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -111.14 133.77 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 102.729 -3.063 . . . . 1.55 102.729 173.518 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.8 m -111.63 125.73 54.26 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.277 -2.764 . . . . 1.08 108.815 -172.833 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.8 mt -119.01 135.45 54.62 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 120.739 1.609 . . . . 1.55 107.817 -177.369 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -91.43 112.57 24.54 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.143 -1.428 . . . . 1.95 107.143 169.966 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.7 m -127.53 165.85 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 C-N-CA 129.008 2.923 . . . . 0.96 116.02 -178.785 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -109.27 163.32 17.28 Favored Pre-proline 0 N--CA 1.43 -1.462 0 C-N-CA 119.717 -0.793 . . . . 2.35 111.601 163.876 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -82.18 -12.35 10.58 Favored 'Trans proline' 0 C--N 1.299 -2.049 0 O-C-N 114.531 -3.458 . . . . 0.95 113.729 -172.996 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.7 m -82.36 -5.92 58.93 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 124.792 1.307 . . . . 1.45 110.457 176.177 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -85.33 146.5 26.99 Favored 'General case' 0 N--CA 1.429 -1.498 1 O-C-N 114.652 -5.03 . . . . 1.69 109.776 178.783 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 68.9 p -77.55 161.78 27.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 118.289 -2.757 . . . . 0.75 112.159 178.629 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mp -68.81 -31.32 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 119.469 -2.019 . . . . 0.73 108.937 -179.818 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -46.48 -40.51 12.54 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.476 -2.015 . . . . 1.62 114.1 165.65 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -70.77 -29.55 65.8 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 117.514 2.413 . . . . 2.13 117.514 174.752 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.39 -39.61 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-N 113.428 -1.714 . . . . 0.62 109.289 176.809 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.3 84.2 mttt -60.73 -34.37 74.3 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 124.277 0.985 . . . . 1.22 111.974 169.275 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.62 -44.48 96.18 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.524 -2.61 . . . . 0.51 114.676 173.235 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -66.58 -43.55 84.64 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.425 -1.716 . . . . 1.44 115.014 172.397 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.5 mt -58.12 -31.07 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 116.652 -3.78 . . . . 1.32 113.327 170.656 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -60.34 -45.64 92.72 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 116.849 2.166 . . . . 1.7 116.849 170.69 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.87 -53.86 43.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.032 2.349 . . . . 1.55 114.151 174.92 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -56.81 -75.96 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 111.502 -2.59 . . . . 2.62 113.551 177.782 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -94.52 -21.38 18.91 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.433 3.123 . . . . 1.48 119.433 -169.068 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.75 43.38 3.63 Favored Glycine 0 N--CA 1.43 -1.755 1 O-C-N 114.802 -4.936 . . . . 1.12 113.471 175.886 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.7 mt -115.72 131.39 23.7 Favored Pre-proline 0 N--CA 1.43 -1.441 0 O-C-N 120.892 -1.357 . . . . 1.55 109.481 179.787 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -63.84 147.07 92.36 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 O-C-N 116.456 -2.444 . . . . 1.02 113.623 176.069 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.66 -22.89 64.04 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 C-N-CA 124.246 3.297 . . . . 1.25 115.991 -176.606 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.58 -24.47 65.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 128.395 2.678 . . . . 2.25 117.35 177.311 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -86.96 -33.22 19.72 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.014 -1.448 . . . . 2.02 107.257 -177.982 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -85.87 129.78 34.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.081 -1.637 . . . . 0.69 115.118 -168.642 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -115.97 142.24 47.06 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.599 1.959 . . . . 2.78 106.253 163.393 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.8 mt -117.7 125.56 50.9 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.306 -1.739 . . . . 1.17 106.306 178.89 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 39.3 mm -102.29 144.65 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 129.959 3.304 . . . . 1.38 107.259 174.222 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.315 17.4 t80 -143.0 114.83 8.18 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 105.235 -2.135 . . . . 1.5 105.235 171.57 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.5 17.73 9.03 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 127.524 3.535 . . . . 1.21 116.826 176.619 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.32 -7.55 54.31 Favored Glycine 0 N--CA 1.43 -1.712 1 O-C-N 114.323 -5.236 . . . . 1.3 111.527 -178.388 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -104.4 133.32 49.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.229 -1.748 . . . . 2.55 108.463 -175.801 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -74.42 125.64 28.97 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 112.901 -1.954 . . . . 2.48 111.372 169.033 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.1 mt -83.76 152.21 24.79 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 125.078 1.486 . . . . 0.9 108.719 -172.323 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -94.93 135.39 36.51 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 123.28 1.514 . . . . 1.94 111.073 176.074 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -54.59 -53.88 48.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 111.612 -2.54 . . . . 1.56 114.94 -171.801 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.38 63.17 2.72 Favored Glycine 0 N--CA 1.429 -1.803 0 O-C-N 119.297 -2.127 . . . . 0.97 114.554 169.347 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -133.99 158.56 43.2 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 100.794 -3.78 . . . . 2.49 100.794 161.169 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 45.8 p -88.41 171.01 10.44 Favored 'General case' 0 N--CA 1.43 -1.439 1 CA-C-O 129.288 4.375 . . . . 0.76 110.115 176.694 . . . . . . . . 3 3 . 1 . 097 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.32 -36.78 71.71 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 112.07 -6.643 . . . . 1.05 111.467 175.597 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.4 t -51.59 -35.07 39.95 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 129.158 2.983 . . . . 1.19 113.89 179.432 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -62.75 -30.36 71.38 Favored 'General case' 0 N--CA 1.43 -1.455 1 C-N-CA 132.855 4.462 . . . . 1.9 110.384 174.332 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -99.68 167.94 10.25 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.946 -2.346 . . . . 0.89 110.264 179.772 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -89.39 62.81 6.17 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 118.982 -2.324 . . . . 1.84 110.356 -179.829 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.8 mm -80.82 128.61 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 124.454 1.102 . . . . 0.82 108.283 177.858 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -100.17 -119.49 0.16 Allowed 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.49 2.404 . . . . 2.16 117.49 -169.941 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -100.39 -59.55 1.69 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.983 0.897 . . . . 2.12 111.192 177.703 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.32 75.23 1.64 Allowed 'General case' 0 N--CA 1.429 -1.523 0 O-C-N 118.321 -2.737 . . . . 1.71 107.684 177.278 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.0 m -91.47 142.6 27.49 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.907 -2.995 . . . . 1.04 109.573 -167.336 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.0 m -98.4 126.95 44.12 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.67 1.7 . . . . 0.79 107.118 178.871 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mp -110.15 166.18 11.16 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.659 -1.901 . . . . 1.4 107.088 176.157 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.549 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 98.4 m-70 -124.07 127.89 48.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.68 -3.762 . . . . 1.51 112.212 -170.109 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.0 tp -103.67 116.91 33.21 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 127.053 2.721 . . . . 1.14 113.022 -178.454 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.7 128.05 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 N-CA-C 105.329 -2.101 . . . . 1.23 105.329 178.351 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.7 mt -97.86 123.0 41.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 124.2 0.937 . . . . 2.78 111.607 174.911 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -89.25 114.01 25.32 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.636 2.375 . . . . 3.75 107.029 175.445 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.6 mt -93.09 137.9 32.03 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.945 -4.222 . . . . 3.14 108.62 171.735 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.269 48.9 mtp85 -73.25 140.83 47.14 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.853 -1.521 . . . . 6.8 110.565 168.051 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.73 -74.14 0.23 Allowed Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 105.711 -2.956 . . . . 3.57 105.711 -168.756 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.794 0 C-N-CA 127.594 2.521 . . . . 3.87 114.799 179.201 . . . . . . . . 0 0 . 1 . 098 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 ttp . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 120.56 0.219 . . . . 1.1 111.2 . . . . . . . . . 0 0 . 1 . 098 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -98.99 114.44 27.09 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.9 -2.259 . . . . 1.87 104.9 -170.069 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 pt -117.83 153.97 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 113.047 -1.888 . . . . 0.72 108.712 -179.722 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -118.88 113.53 21.2 Favored 'General case' 0 N--CA 1.43 -1.44 1 C-N-CA 132.556 4.342 . . . . 1.4 109.521 -175.93 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -104.23 121.49 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 100.812 -3.773 . . . . 0.58 100.812 177.364 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt -99.54 135.77 40.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.353 2.661 . . . . 2.09 110.878 177.511 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -92.64 -176.62 4.32 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.97 1.708 . . . . 0.99 112.125 173.229 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.5 mt -95.16 -11.72 27.64 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.953 2.101 . . . . 2.53 111.227 168.955 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.3 p -82.92 -46.41 12.99 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.368 2.032 . . . . 2.08 114.534 179.658 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.31 -13.5 0.29 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 117.546 -3.221 . . . . 1.31 111.141 170.976 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -86.82 128.26 35.03 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 119.902 1.851 . . . . 1.4 113.047 -165.654 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -92.52 115.64 28.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.834 -3.041 . . . . 0.78 108.353 175.037 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mt -99.08 117.25 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 1 O-C-N 115.967 -4.208 . . . . 1.55 109.455 -179.342 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.0 m -98.07 124.38 42.56 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.406 2.527 . . . . 1.08 108.459 -178.359 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.4 mt -118.99 138.33 52.89 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.348 1.61 . . . . 1.55 115.348 -179.968 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -103.46 102.37 12.28 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.69 -3.131 . . . . 1.95 109.927 175.219 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.9 m -114.75 170.78 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 128.421 2.688 . . . . 0.96 108.458 -175.296 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -118.18 157.48 48.82 Favored Pre-proline 0 N--CA 1.43 -1.459 0 O-C-N 118.393 -2.692 . . . . 2.35 107.521 163.775 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -62.7 -20.86 72.17 Favored 'Trans proline' 0 C--N 1.299 -2.055 0 C-N-CA 124.044 3.163 . . . . 0.95 115.508 -171.605 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 m -80.91 0.93 33.1 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 118.076 2.621 . . . . 1.45 118.076 173.862 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -87.43 163.91 16.48 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 102.457 -3.164 . . . . 1.69 102.457 175.624 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.2 p -90.8 -175.26 4.32 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.132 2.396 . . . . 0.75 114.006 176.142 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.4 mm -82.63 -36.41 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 O-C-N 116.893 -3.629 . . . . 0.73 106.61 178.917 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -50.97 -45.86 61.07 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.169 2.187 . . . . 1.62 112.478 167.168 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -64.27 -38.73 92.07 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.336 2.654 . . . . 2.13 107.202 175.787 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.8 t -59.27 -48.04 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 124.264 3.211 . . . . 0.62 114.364 176.805 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.262 37.8 mtmt -64.64 -41.73 95.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.46 1.504 . . . . 1.22 112.049 174.162 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.08 -32.38 72.91 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 117.067 2.247 . . . . 0.51 117.067 176.952 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -76.46 -36.54 57.85 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 125.092 1.495 . . . . 1.44 111.694 175.437 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.2 mt -71.9 -31.29 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 116.666 -3.772 . . . . 1.32 110.089 175.557 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -59.28 -59.1 6.0 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 113.579 -3.105 . . . . 1.7 107.74 169.985 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -50.16 -52.51 34.72 Favored 'General case' 0 N--CA 1.43 -1.432 1 CA-C-N 127.925 4.875 . . . . 1.55 111.79 166.418 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -61.66 -48.48 80.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.033 -2.917 . . . . 2.62 117.61 -167.952 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -112.59 -52.04 2.8 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 118.909 -1.116 . . . . 1.48 113.308 -168.317 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.21 36.25 0.43 Allowed Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 126.382 1.944 . . . . 1.12 114.305 178.934 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.8 mt -117.92 116.7 36.02 Favored Pre-proline 0 N--CA 1.429 -1.489 0 O-C-N 118.237 -2.919 . . . . 1.55 105.692 -171.239 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -59.93 154.0 53.51 Favored 'Trans proline' 0 C--N 1.299 -2.051 2 C-N-CA 126.67 4.913 . . . . 1.02 114.877 -179.954 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -73.36 -17.76 23.76 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 C-N-CA 124.566 3.511 . . . . 1.25 113.294 -176.55 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -84.25 -16.55 42.79 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.168 2.587 . . . . 2.25 108.986 -178.814 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.329 14.8 tt0 -97.86 -24.44 15.42 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 126.076 2.11 . . . . 2.02 109.925 -177.017 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -88.07 125.0 34.34 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 113.72 1.007 . . . . 0.69 113.72 -175.761 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -110.07 124.53 51.65 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.055 -0.72 . . . . 2.78 109.055 172.806 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.3 mt -107.84 114.83 29.04 Favored 'General case' 0 N--CA 1.429 -1.516 0 O-C-N 118.933 -2.354 . . . . 1.17 110.748 -173.102 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.7 mm -91.85 124.94 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 114.949 -1.023 . . . . 1.38 109.673 177.107 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -114.15 111.28 21.33 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.072 -1.085 . . . . 1.5 108.072 163.89 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.498 . . 68.01 -44.11 0.49 Allowed 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 127.039 3.305 . . . . 1.21 118.642 174.33 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.67 -47.66 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.738 0 O-C-N 116.798 -3.689 . . . . 1.3 108.246 -172.659 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -75.34 156.59 35.36 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 124.676 2.179 . . . . 2.55 112.319 179.612 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -104.82 135.48 46.11 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.173 -2.204 . . . . 2.48 105.718 169.131 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.418 HD22 ' CE2' ' A' ' 59' ' ' TYR . 12.8 mt -96.1 143.59 27.1 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.748 -1.845 . . . . 0.9 110.395 -169.675 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -83.67 147.44 27.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 113.312 -1.767 . . . . 1.94 115.303 172.449 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.61 -63.83 1.16 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 130.909 3.684 . . . . 1.56 113.216 -165.857 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.81 36.71 2.83 Favored Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 119.785 2.674 . . . . 0.97 119.785 171.637 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -102.73 152.43 21.24 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 120.999 0.428 . . . . 2.49 111.221 161.463 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.1 p -83.67 173.27 11.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 124.781 2.229 . . . . 0.76 109.219 171.677 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -72.7 -38.27 67.58 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.955 -2.966 . . . . 1.05 106.937 172.412 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.34 59.8 p -60.87 -24.76 66.18 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.528 1.931 . . . . 1.19 115.356 178.564 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.386 4.7 t0 -62.18 -38.4 88.91 Favored 'General case' 0 N--CA 1.429 -1.524 1 CA-C-O 129.017 4.246 . . . . 1.9 114.838 172.057 . . . . . . . . 3 2 . 1 . 098 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.418 ' CE2' HD22 ' A' ' 50' ' ' LEU . 76.8 m-85 -97.83 171.12 8.51 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 110.894 -2.867 . . . . 0.89 111.125 -179.367 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -89.68 43.16 1.13 Allowed 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.373 -2.704 . . . . 1.84 116.325 -175.136 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.3 mm -71.59 124.73 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 118.47 2.767 . . . . 0.82 118.47 -179.371 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -85.28 173.76 10.11 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 125.014 2.34 . . . . 2.16 109.125 -177.42 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.47 -48.83 77.91 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.497 -3.252 . . . . 2.12 115.568 173.858 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.06 64.09 0.93 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.445 -3.285 . . . . 1.71 111.964 175.365 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.5 m -87.39 141.65 28.47 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 117.896 2.554 . . . . 1.04 117.896 178.551 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.1 m -102.02 122.47 44.14 Favored 'General case' 0 N--CA 1.431 -1.409 1 CA-C-N 108.097 -4.138 . . . . 0.79 105.032 176.536 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -112.88 154.72 25.89 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 101.84 -3.392 . . . . 1.4 101.84 177.218 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -126.22 117.32 22.84 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.111 -2.243 . . . . 1.51 111.594 -175.534 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.251 3.9 tt -86.38 115.57 23.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 127.252 2.221 . . . . 1.14 108.946 -179.561 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.9 t -101.56 157.41 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 1 C-N-CA 133.523 4.729 . . . . 1.23 105.346 172.087 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.6 mt -121.98 161.82 22.22 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.659 -1.275 . . . . 2.78 108.199 173.676 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -135.63 167.93 20.2 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 115.967 -1.968 . . . . 3.75 107.346 -175.199 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.2 mt -107.78 145.47 33.51 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 121.277 1.853 . . . . 3.14 112.052 175.857 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -84.81 147.14 26.99 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.97 1.841 . . . . 6.8 115.97 174.786 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.82 57.21 0.87 Allowed Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 105.354 -3.098 . . . . 3.57 105.354 -163.815 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.729 0 C-N-CA 128.728 3.061 . . . . 3.87 114.282 177.328 . . . . . . . . 0 0 . 1 . 099 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttp . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 114.076 1.139 . . . . 1.1 114.076 . . . . . . . . . 0 0 . 1 . 099 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -96.95 104.3 16.3 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 114.976 -2.44 . . . . 1.87 109.313 -172.636 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.43 HD12 HD13 ' A' ' 67' ' ' LEU . 13.4 pt -95.47 165.39 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 127.459 2.975 . . . . 0.72 111.977 174.94 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -117.5 136.3 53.33 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.359 1.464 . . . . 1.4 112.742 176.618 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.447 HG21 HD12 ' A' ' 15' ' ' LEU . 18.6 t -116.19 98.58 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 131.246 3.818 . . . . 0.58 111.123 177.21 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -84.53 134.46 34.42 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 119.168 0.895 . . . . 2.09 112.935 179.396 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -83.5 -174.86 5.53 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.809 -1.087 . . . . 0.99 110.95 176.864 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.7 tp -81.75 -41.54 21.08 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.609 1.195 . . . . 2.53 112.758 171.01 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.9 p -74.39 -21.78 59.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.769 2.137 . . . . 2.08 116.769 -177.452 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.45 -0.01 1.03 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 118.415 2.126 . . . . 1.31 118.415 166.62 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.8 tttp -91.24 126.4 36.31 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.132 -1.805 . . . . 1.4 114.303 -172.957 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.5 m -95.37 109.78 21.9 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 121.398 -0.814 . . . . 0.78 110.454 176.197 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.1 mt -89.85 137.29 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 113.162 -3.304 . . . . 1.55 102.324 -174.884 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 m -110.17 129.62 55.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 126.598 2.436 . . . . 1.08 105.397 -174.508 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.447 HD12 HG21 ' A' ' 5' ' ' VAL . 43.2 mt -133.33 125.76 29.91 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.02 -2.3 . . . . 1.55 105.081 -171.596 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -85.74 113.61 22.06 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.433 -3.292 . . . . 1.95 107.875 173.48 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.9 m -123.01 172.34 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 128.031 2.532 . . . . 0.96 111.741 176.447 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -126.01 156.71 71.35 Favored Pre-proline 0 N--CA 1.431 -1.42 0 C-N-CA 124.493 1.117 . . . . 2.35 109.315 164.153 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -64.17 -8.35 16.21 Favored 'Trans proline' 0 N--CA 1.433 -2.038 0 CA-C-N 126.678 3.421 . . . . 0.95 116.551 -174.761 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 p -93.77 -1.93 54.37 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.179 1.809 . . . . 1.45 111.966 178.635 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -73.38 156.0 38.78 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.519 -1.988 . . . . 1.69 110.672 172.569 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 58.3 p -95.63 173.47 7.47 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 114.842 1.423 . . . . 0.75 114.842 176.872 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.9 mm -67.05 -44.79 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 116.307 -1.806 . . . . 0.73 108.479 169.418 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -52.12 -33.54 40.3 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 117.287 2.328 . . . . 1.62 117.287 169.285 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -66.79 -42.72 85.55 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.868 -3.645 . . . . 2.13 113.186 174.463 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 t -53.32 -47.88 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 115.328 1.603 . . . . 0.62 115.328 171.303 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -65.73 -31.16 72.0 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 126.578 2.423 . . . . 1.22 114.734 176.217 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -43.47 98.75 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 120.96 1.709 . . . . 0.51 110.775 176.793 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -57.03 -38.12 72.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.978 1.844 . . . . 1.44 115.978 172.2 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.5 mt -69.75 -34.35 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 113.911 1.078 . . . . 1.32 113.911 168.555 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -69.07 -34.02 74.49 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 130.14 3.376 . . . . 1.7 115.388 174.905 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.351 36.8 t70 -71.19 -41.92 69.68 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 123.977 0.911 . . . . 1.55 113.043 166.509 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -81.12 -44.94 17.19 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 117.527 2.417 . . . . 2.62 117.527 -176.557 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -109.42 -46.84 3.48 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.502 -1.295 . . . . 1.48 107.502 -165.273 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.89 36.13 2.25 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 119.055 2.382 . . . . 1.12 119.055 173.271 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.451 HG21 HD22 ' A' ' 71' ' ' LEU . 9.9 mt -111.18 136.76 20.86 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-O 116.687 -1.625 . . . . 1.55 109.981 -177.575 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -70.85 160.58 48.92 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 CA-C-N 125.08 2.85 . . . . 1.02 112.48 -175.379 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.82 -19.84 52.53 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 N-CA-C 118.1 2.308 . . . . 1.25 118.1 178.535 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -62.55 -37.48 86.32 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 119.702 3.223 . . . . 2.25 119.702 171.545 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.34 18.4 mm100 -80.23 -29.76 38.5 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 108.666 -3.879 . . . . 2.02 111.763 -173.21 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -81.8 133.15 35.31 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.064 -1.425 . . . . 0.69 108.484 -175.181 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -123.86 110.92 15.47 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 106.325 -1.731 . . . . 2.78 106.325 175.046 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.8 mt -99.96 118.0 35.43 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.699 2.666 . . . . 1.17 105.556 -179.008 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.8 mm -109.75 116.05 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 104.152 -2.536 . . . . 1.38 104.152 -173.244 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -121.83 110.11 15.49 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.849 -2.278 . . . . 1.5 104.849 176.147 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.27 30.87 4.11 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.627 3.171 . . . . 1.21 110.658 175.951 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.71 -33.74 5.33 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 119.867 1.212 . . . . 1.3 112.396 -175.046 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -78.29 132.94 37.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.232 1.813 . . . . 2.55 108.83 -177.972 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -91.44 122.02 33.66 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.424 2.059 . . . . 2.48 109.409 170.992 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.2 mt -70.23 136.08 49.61 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 129.553 3.141 . . . . 0.9 113.691 -174.911 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -77.88 148.42 34.62 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.202 -1.561 . . . . 1.94 114.922 174.973 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -62.95 -63.13 1.3 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.14 -2.225 . . . . 1.56 116.94 -171.943 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.5 42.7 0.24 Allowed Glycine 0 N--CA 1.43 -1.729 1 N-CA-C 123.859 4.303 . . . . 0.97 123.859 167.554 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -117.12 164.43 14.77 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 114.238 -2.791 . . . . 2.49 111.14 168.453 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.0 p -96.39 169.64 9.78 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 122.64 2.473 . . . . 0.76 110.769 169.803 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.2 mt -75.88 -23.47 55.6 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.596 -2.565 . . . . 1.05 112.976 174.916 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.4 t -71.53 -29.59 64.95 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.859 2.17 . . . . 1.19 116.859 178.709 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -58.61 -49.29 78.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 131.434 3.893 . . . . 1.9 110.991 174.236 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -80.44 164.16 23.26 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 125.664 2.65 . . . . 0.89 105.833 -177.961 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -90.92 58.18 3.72 Favored 'General case' 0 N--CA 1.43 -1.473 1 O-C-N 114.139 -5.351 . . . . 1.84 113.484 -175.877 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.4 mm -93.24 143.64 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.521 -1.218 . . . . 0.82 109.702 179.878 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -96.63 -102.65 0.17 Allowed 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.41 1.084 . . . . 2.16 108.846 -174.343 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -131.04 -73.85 0.54 Allowed 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 113.67 0.989 . . . . 2.12 113.67 -179.995 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -98.9 52.09 0.97 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.139 1.447 . . . . 1.71 111.418 177.352 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -83.46 149.3 26.73 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 128.407 2.683 . . . . 1.04 111.388 -169.561 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.7 m -101.56 122.94 44.77 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.532 -1.667 . . . . 0.79 111.79 -174.818 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.43 HD13 HD12 ' A' ' 3' ' ' ILE . 7.0 mp -111.0 156.43 21.26 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 103.749 -2.686 . . . . 1.4 103.749 176.705 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -125.1 129.38 50.08 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 125.656 2.645 . . . . 1.51 108.213 -172.29 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.3 tp -98.62 114.16 26.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.769 -2.457 . . . . 1.14 111.52 179.909 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.2 t -105.71 135.67 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 C-N-CA 127.48 2.312 . . . . 1.23 105.241 174.732 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.451 HD22 HG21 ' A' ' 36' ' ' ILE . 81.5 mt -97.59 140.95 31.24 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.465 -3.272 . . . . 2.78 112.193 175.645 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -77.44 163.73 26.1 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.55 1.94 . . . . 3.75 111.297 176.325 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 46.1 tp -70.06 119.5 14.36 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 117.876 -3.015 . . . . 3.14 110.182 179.711 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -64.6 153.75 38.35 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.748 3.619 . . . . 6.8 114.814 168.172 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.41 -65.43 0.34 Allowed Glycine 0 N--CA 1.43 -1.72 0 O-C-N 120.035 -1.666 . . . . 3.57 111.8 -165.793 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.742 0 C-N-CA 126.273 1.892 . . . . 3.87 112.693 -176.698 . . . . . . . . 0 0 . 1 . 100 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 CA--C 1.49 -1.355 0 N-CA-C 112.965 0.728 . . . . 1.1 112.965 . . . . . . . . . 0 0 . 1 . 100 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.86 134.69 36.92 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 122.793 1.283 . . . . 1.87 108.836 174.576 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.6 pt -125.76 157.51 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 105.965 -1.865 . . . . 0.72 105.965 164.023 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.424 ' HB3' ' CG2' ' A' ' 12' ' ' THR . 55.9 m-85 -113.72 114.66 26.68 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 125.661 2.648 . . . . 1.4 109.969 -178.612 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.4 t -97.45 106.06 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 113.548 -1.66 . . . . 0.58 111.568 177.303 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.278 85.9 mttt -91.77 122.72 34.58 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 116.92 -3.612 . . . . 2.09 112.044 -177.261 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.1 p -89.81 168.42 12.09 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.036 -2.915 . . . . 0.99 111.641 -179.031 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.8 mt -75.16 -36.55 61.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.957 -2.965 . . . . 2.53 114.3 176.44 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -74.83 -22.98 58.39 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 127.392 2.277 . . . . 2.08 112.416 -177.91 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.46 54.68 0.33 Allowed Glycine 0 N--CA 1.43 -1.757 0 O-C-N 119.528 -1.983 . . . . 1.31 116.191 171.709 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -141.46 140.34 33.55 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.413 -2.227 . . . . 1.4 112.642 169.689 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.424 ' CG2' ' HB3' ' A' ' 4' ' ' PHE . 32.4 m -95.8 105.37 17.37 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 111.767 -2.469 . . . . 0.78 105.294 174.438 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 80.2 mt -89.51 123.2 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.776 -2.453 . . . . 1.55 106.281 -178.025 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -95.44 122.98 38.74 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.191 1.472 . . . . 1.08 110.574 177.095 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.269 62.3 mt -111.86 142.53 44.13 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 128.943 2.897 . . . . 1.55 113.327 -175.074 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -98.75 103.72 15.7 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.163 1.459 . . . . 1.95 108.085 169.426 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.6 172.03 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 117.823 -1.551 . . . . 0.96 111.699 176.354 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -123.2 157.47 60.95 Favored Pre-proline 0 N--CA 1.43 -1.465 0 O-C-N 119.122 -2.236 . . . . 2.35 108.81 165.58 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.75 -7.74 17.7 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 CA-C-N 127.068 3.56 . . . . 0.95 112.998 -171.175 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.5 m -78.58 -25.07 45.2 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 127.303 2.877 . . . . 1.45 108.628 176.91 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -70.3 163.37 26.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.906 2.765 . . . . 1.69 111.528 -175.129 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 38.3 p -98.22 165.04 12.07 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.912 -1.742 . . . . 0.75 109.553 -177.034 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.8 mm -66.59 -32.24 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 126.965 2.106 . . . . 0.73 114.26 172.163 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -52.81 -35.19 56.55 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 130.986 3.714 . . . . 1.62 113.113 163.347 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -80.92 -28.3 35.86 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.555 -1.966 . . . . 2.13 113.522 176.874 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.2 t -67.92 -51.27 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 104.217 -2.512 . . . . 0.62 104.217 178.982 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -64.44 -28.76 69.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 116.66 -3.775 . . . . 1.22 113.215 179.739 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.11 -29.19 66.08 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 121.187 1.812 . . . . 0.51 114.704 175.01 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.06 -30.58 63.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.441 -1.412 . . . . 1.44 114.371 172.313 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.2 mt -65.95 -36.89 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 118.559 -2.588 . . . . 1.32 113.897 167.283 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -58.16 -47.39 83.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.014 2.926 . . . . 1.7 111.457 172.782 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -60.29 -57.14 14.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 118.906 2.928 . . . . 1.55 118.906 165.827 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -66.51 -56.82 9.07 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 128.398 3.952 . . . . 2.62 116.046 -175.912 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -96.17 -44.65 7.19 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.788 -3.695 . . . . 1.48 114.715 -170.378 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.03 32.05 2.31 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 117.44 -1.755 . . . . 1.12 113.824 176.575 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.5 mm -108.55 143.81 28.27 Favored Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 101.824 -3.399 . . . . 1.55 101.824 -174.088 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -73.11 154.47 52.27 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 N-CA-C 116.239 1.592 . . . . 1.02 116.239 174.552 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -78.29 -28.49 4.61 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 CA-C-N 120.644 1.266 . . . . 1.25 112.379 -173.766 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -59.83 -35.29 74.42 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.426 1.891 . . . . 2.25 113.404 173.535 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -81.34 -33.85 32.19 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 116.507 -3.871 . . . . 2.02 111.257 179.349 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.297 71.8 mt-30 -74.66 130.95 40.45 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 116.424 -1.75 . . . . 0.69 111.855 -175.832 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -115.62 125.1 52.49 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 121.703 2.047 . . . . 2.78 110.94 163.47 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.4 mt -99.8 127.36 45.95 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.317 -2.114 . . . . 1.17 110.766 179.169 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.9 mt -118.78 134.08 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 126.981 2.112 . . . . 1.38 108.551 -178.435 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 67' ' ' LEU . 34.4 t80 -128.54 137.79 51.92 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.503 -2.406 . . . . 1.5 104.503 169.091 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 37.32 39.72 0.17 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 118.483 2.771 . . . . 1.21 118.483 -176.078 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.66 -18.0 32.28 Favored Glycine 0 N--CA 1.43 -1.713 0 N-CA-C 119.976 2.75 . . . . 1.3 119.976 -177.921 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -81.32 134.11 35.53 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.756 -2.026 . . . . 2.55 109.45 175.824 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -93.23 106.94 18.84 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 125.957 2.036 . . . . 2.48 108.848 179.182 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.4 mt -66.12 137.03 56.76 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 110.567 -3.015 . . . . 0.9 106.545 -168.542 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -84.36 159.87 20.77 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.645 2.641 . . . . 1.94 109.619 174.18 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -70.38 -55.77 8.28 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 116.383 -3.948 . . . . 1.56 114.086 -167.854 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.65 49.67 4.1 Favored Glycine 0 N--CA 1.431 -1.643 0 C-N-CA 126.348 1.928 . . . . 0.97 110.495 178.182 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 -124.47 158.74 32.12 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.773 -1.936 . . . . 2.49 105.773 164.357 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 21.7 p -89.47 163.02 15.43 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.996 1.48 . . . . 0.76 114.996 175.035 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.8 mt -66.6 -35.49 80.32 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.747 -3.095 . . . . 1.05 105.719 178.571 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 t -58.41 -34.33 70.65 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 118.367 2.729 . . . . 1.19 118.367 173.172 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -74.86 -37.41 62.21 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 113.48 -1.691 . . . . 1.9 110.286 -179.615 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -80.44 5.41 15.14 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.205 -1.56 . . . . 0.89 114.017 172.655 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.275 14.0 m-80 62.48 31.42 17.08 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.632 1.573 . . . . 1.84 113.047 179.755 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.9 mt -78.93 122.22 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 125.351 1.461 . . . . 0.82 112.32 179.904 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -96.06 177.23 5.81 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 110.402 -3.09 . . . . 2.16 114.958 -177.752 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -54.47 130.84 41.07 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 115.746 1.758 . . . . 2.12 115.746 171.229 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.361 77.5 mt-10 62.72 55.46 2.13 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.502 -1.999 . . . . 1.71 116.307 -178.046 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.3 m -104.02 151.46 23.2 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.127 2.394 . . . . 1.04 109.667 -175.173 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.0 m -102.84 113.65 27.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.085 -2.884 . . . . 0.79 105.394 177.946 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.443 HD23 ' CD1' ' A' ' 45' ' ' PHE . 31.9 mt -110.24 165.74 11.52 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 105.858 -1.904 . . . . 1.4 105.858 174.791 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -124.01 126.29 46.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.853 -1.78 . . . . 1.51 111.765 -173.732 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.0 tp -105.27 134.86 47.68 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 126.001 1.72 . . . . 1.14 111.759 -176.484 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.1 m -137.29 158.76 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 125.142 2.401 . . . . 1.23 105.007 176.131 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.1 mt -120.56 158.47 27.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.906 -2.996 . . . . 2.78 115.828 -177.207 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -89.27 138.14 31.7 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 123.644 1.688 . . . . 3.75 106.535 177.963 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.9 mt -97.08 -150.43 0.34 Allowed 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 127.687 2.395 . . . . 3.14 113.376 175.566 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -121.28 133.59 55.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 107.458 -1.312 . . . . 6.8 107.458 174.249 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.79 63.28 0.68 Allowed Glycine 0 N--CA 1.431 -1.7 0 O-C-N 120.509 -1.369 . . . . 3.57 110.054 -170.513 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.729 0 O-C-N 119.274 -2.309 . . . . 3.87 112.424 -178.412 . . . . . . . . 0 0 . 1 . 101 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.6 ptt? . . . . . 0 CA--C 1.49 -1.33 0 CA-C-O 119.657 -0.211 . . . . 1.1 110.758 . . . . . . . . . 0 0 . 1 . 101 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -88.44 149.78 23.5 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 117.153 -1.403 . . . . 1.87 110.42 177.222 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.494 HD11 HG11 ' A' ' 17' ' ' VAL . 9.5 pt -140.12 144.6 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.971 -2.233 . . . . 0.72 104.971 175.131 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -103.81 139.17 39.39 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 112.629 -3.628 . . . . 1.4 109.519 177.877 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.492 HG22 ' HB2' ' A' ' 67' ' ' LEU . 12.6 t -113.25 109.67 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 117.983 -2.948 . . . . 0.58 109.526 167.41 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -91.04 137.94 31.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.504 -2.623 . . . . 2.09 111.179 -178.208 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.263 67.8 p -82.34 -175.41 5.68 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 124.787 2.232 . . . . 0.99 115.323 177.707 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.1 mt -50.31 -55.93 13.4 Favored 'General case' 0 N--CA 1.43 -1.461 2 O-C-N 114.521 -5.112 . . . . 2.53 109.426 166.044 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.253 20.4 p -72.19 -31.09 65.57 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.533 -2.604 . . . . 2.08 110.383 -175.834 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.74 25.05 1.62 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 110.773 -0.931 . . . . 1.31 110.773 172.291 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -76.53 117.64 18.38 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.041 -3.035 . . . . 1.4 109.328 -179.976 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m -74.39 90.08 2.14 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.017 2.817 . . . . 0.78 113.42 175.694 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mt -83.07 125.73 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 117.249 -3.407 . . . . 1.55 108.456 -179.718 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.3 m -101.33 128.27 47.57 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 119.487 -2.008 . . . . 1.08 113.854 177.55 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.448 HD21 HG13 ' A' ' 30' ' ' ILE . 9.3 mp -128.89 154.67 46.28 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 126.0 2.063 . . . . 1.55 105.557 -175.956 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -100.7 129.29 46.58 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.245 -1.761 . . . . 1.95 106.245 171.883 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.494 HG11 HD11 ' A' ' 3' ' ' ILE . 27.2 m -135.46 155.88 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 O-C-N 127.904 3.252 . . . . 0.96 107.566 179.821 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -106.33 153.67 40.27 Favored Pre-proline 0 N--CA 1.43 -1.474 0 N-CA-C 102.915 -2.995 . . . . 2.35 102.915 161.897 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -70.68 -12.11 30.66 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 115.255 -3.076 . . . . 0.95 116.683 -177.356 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.8 p -90.42 7.08 40.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 117.365 -1.303 . . . . 1.45 109.685 175.039 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -81.31 146.23 30.48 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.927 2.775 . . . . 1.69 109.855 174.189 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.52 159.49 18.61 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.737 -3.102 . . . . 0.75 111.833 -174.289 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.1 mm -59.07 -43.03 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 124.472 1.109 . . . . 0.73 113.067 175.336 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -39.91 -41.66 1.21 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.725 3.602 . . . . 1.62 120.725 161.084 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -79.38 -25.1 42.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 114.721 -2.561 . . . . 2.13 111.716 173.268 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -68.37 -45.92 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 122.856 2.571 . . . . 0.62 110.668 173.417 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -58.73 -38.37 78.24 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.435 1.642 . . . . 1.22 115.435 174.18 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.27 -37.77 72.89 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.301 -2.124 . . . . 0.51 114.598 173.671 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.8 mttm -60.98 -44.77 96.88 Favored 'General case' 0 N--CA 1.431 -1.392 1 C-N-CA 131.884 4.073 . . . . 1.44 111.325 175.463 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.448 HG13 HD21 ' A' ' 15' ' ' LEU . 93.7 mt -66.54 -44.8 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 126.641 3.115 . . . . 1.32 114.602 172.022 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -50.27 -44.41 53.69 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.158 -2.839 . . . . 1.7 114.977 166.899 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -60.61 -59.2 5.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 115.74 -2.076 . . . . 1.55 108.6 175.544 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -68.01 -47.21 69.09 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 116.607 2.077 . . . . 2.62 116.607 -172.917 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -99.7 -46.36 5.45 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.972 2.509 . . . . 1.48 109.902 -165.58 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.92 22.59 5.9 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 126.484 2.365 . . . . 1.12 114.532 175.014 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mt -97.46 119.82 62.05 Favored Pre-proline 0 N--CA 1.43 -1.44 0 C-N-CA 125.628 1.571 . . . . 1.55 114.355 -174.432 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.74 161.01 30.9 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 116.854 -1.631 . . . . 1.02 113.728 -173.672 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -62.81 -19.68 69.2 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 123.809 3.006 . . . . 1.25 118.546 -171.186 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -67.82 -27.77 67.0 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.078 2.151 . . . . 2.25 114.194 177.338 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -94.34 -38.4 11.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.742 2.017 . . . . 2.02 113.568 -173.062 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -102.17 135.94 42.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.582 2.611 . . . . 0.69 115.156 -170.566 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -121.8 143.53 49.34 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.08 -2.263 . . . . 2.78 111.147 170.813 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -110.62 130.84 55.47 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.21 2.433 . . . . 1.17 112.313 178.72 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.0 mm -109.34 138.66 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 110.581 -3.009 . . . . 1.38 106.537 178.828 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.477 ' HB3' HD21 ' A' ' 50' ' ' LEU . 48.2 t80 -120.77 107.0 12.22 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.995 2.918 . . . . 1.5 109.144 163.558 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.371 . . 69.29 -93.64 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.881 3.229 . . . . 1.21 113.685 179.987 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.61 8.62 6.17 Favored Glycine 0 N--CA 1.43 -1.746 0 O-C-N 116.959 -3.588 . . . . 1.3 111.693 -177.773 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -117.65 138.54 51.9 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 119.61 -2.112 . . . . 2.55 107.462 -177.796 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -76.77 111.16 11.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 112.609 -2.087 . . . . 2.48 113.073 164.812 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.477 HD21 ' HB3' ' A' ' 45' ' ' PHE . 36.5 mt -66.25 113.89 4.92 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 118.423 0.556 . . . . 0.9 111.565 -174.418 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -76.21 129.26 36.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 127.52 3.534 . . . . 1.94 113.03 176.462 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -43.9 -53.43 6.11 Favored 'General case' 0 N--CA 1.43 -1.433 2 N-CA-C 124.061 4.837 . . . . 1.56 124.061 -173.163 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.35 43.97 3.15 Favored Glycine 0 N--CA 1.429 -1.797 0 O-C-N 119.861 -1.774 . . . . 0.97 115.338 175.996 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.311 33.6 mmt180 -118.29 171.79 7.89 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.953 2.311 . . . . 2.49 112.07 159.655 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.7 p -93.37 174.14 7.36 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.497 -2.627 . . . . 0.76 117.748 163.682 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.8 mt -67.16 -33.89 76.39 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 130.231 3.412 . . . . 1.05 114.845 165.057 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 t -65.43 -35.28 80.44 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.86 2.864 . . . . 1.19 114.288 173.315 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -68.41 -44.33 75.26 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 117.673 -1.156 . . . . 1.9 109.899 177.293 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -82.59 3.45 28.66 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 116.196 -1.859 . . . . 0.89 113.311 176.732 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.5 t30 58.27 50.61 9.45 Favored 'General case' 0 N--CA 1.43 -1.434 1 CA-C-O 129.264 4.364 . . . . 1.84 114.564 174.85 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.251 24.6 mt -105.1 115.48 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 C-N-CA 131.87 4.068 . . . . 0.82 108.59 177.641 . . . . . . . . 3 2 . 1 . 101 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -93.46 172.68 8.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 130.798 3.639 . . . . 2.16 112.167 -176.507 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -72.04 144.83 48.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 115.546 -2.462 . . . . 2.12 114.175 169.897 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.384 54.3 mt-10 72.06 23.42 3.45 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.759 1.266 . . . . 1.71 114.153 177.275 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.281 17.4 m -88.75 153.46 21.07 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.02 -2.585 . . . . 1.04 104.02 -172.424 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.5 m -103.12 115.05 29.85 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 125.818 2.723 . . . . 0.79 106.788 -178.819 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.492 ' HB2' HG22 ' A' ' 5' ' ' VAL . 8.1 mp -103.38 164.63 11.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 103.027 -2.953 . . . . 1.4 103.027 174.11 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -131.2 138.02 49.21 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.532 -1.355 . . . . 1.51 111.918 177.981 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.1 tp -106.93 117.78 34.96 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 129.221 3.008 . . . . 1.14 108.195 -177.849 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.7 m -115.5 175.06 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 107.119 -1.437 . . . . 1.23 107.119 165.803 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pp -159.18 -179.04 7.64 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.914 -1.116 . . . . 2.78 109.412 -174.197 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -128.37 139.09 52.57 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 129.282 3.033 . . . . 3.75 103.901 173.37 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.5 mt -83.76 148.11 27.23 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 105.777 -1.934 . . . . 3.14 105.777 168.537 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -80.87 133.98 35.68 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.674 -1.891 . . . . 6.8 114.263 178.604 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.46 42.01 1.94 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 127.138 2.304 . . . . 3.57 113.032 -174.327 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.702 0 CA-C-N 120.553 2.176 . . . . 3.87 115.226 -177.782 . . . . . . . . 0 0 . 1 . 102 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.1 ttp . . . . . 0 CA--C 1.491 -1.318 1 CA-C-O 129.664 4.554 . . . . 1.1 110.065 . . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.271 20.5 tt0 -93.81 113.44 25.48 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 114.487 -5.133 . . . . 1.87 110.305 -176.17 . . . . . . . . 3 2 . 1 . 102 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.481 HG12 HG22 ' A' ' 17' ' ' VAL . 15.0 pt -119.93 168.18 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.735 1.731 . . . . 0.72 107.119 170.348 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -131.4 157.61 42.99 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 103.268 -2.864 . . . . 1.4 103.268 -178.838 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.6 t -133.12 128.34 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 101.818 -3.401 . . . . 0.58 101.818 -178.34 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -119.39 119.38 33.77 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 122.591 1.186 . . . . 2.09 108.549 178.98 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.402 HG22 HD23 ' A' ' 69' ' ' LEU . 46.9 p -77.5 174.98 10.26 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 121.654 3.946 . . . . 0.99 121.654 -174.74 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.6 mt -52.02 -52.25 52.04 Favored 'General case' 0 N--CA 1.43 -1.443 1 CA-C-O 129.104 4.288 . . . . 2.53 115.218 169.082 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -72.2 -25.15 61.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.172 -2.83 . . . . 2.08 115.469 -178.066 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.33 19.25 4.29 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 124.778 3.444 . . . . 1.31 111.386 169.303 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -89.57 143.02 27.14 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 104.801 -2.296 . . . . 1.4 104.801 -176.638 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -110.28 119.74 40.22 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.361 1.553 . . . . 0.78 109.942 173.119 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.2 mt -98.8 122.25 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 125.631 2.634 . . . . 1.55 109.812 176.033 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.3 m -91.3 121.69 33.27 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.483 -3.26 . . . . 1.08 108.621 -179.74 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mt -116.92 163.5 16.11 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.028 -1.842 . . . . 1.55 106.028 -173.527 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -121.44 104.57 9.78 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.334 1.453 . . . . 1.95 107.305 169.983 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.481 HG22 HG12 ' A' ' 3' ' ' ILE . 27.2 m -106.11 -174.13 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 103.912 -2.625 . . . . 0.96 103.912 179.528 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -138.2 155.24 74.32 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 103.004 -2.962 . . . . 2.35 103.004 165.709 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -62.25 -11.88 24.43 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 126.529 3.368 . . . . 0.95 117.382 -173.384 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.9 m -85.22 -0.14 53.69 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.874 1.67 . . . . 1.45 113.025 -175.564 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -84.23 144.04 29.19 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 126.095 2.122 . . . . 1.69 110.735 -179.588 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 67.4 p -83.71 164.1 19.84 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.02 -1.9 . . . . 0.75 110.339 178.159 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.2 mm -68.32 -35.33 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 O-C-N 120.025 -1.672 . . . . 0.73 110.699 -179.912 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -45.8 -49.31 15.25 Favored 'General case' 0 N--CA 1.43 -1.446 1 C-N-CA 133.446 4.699 . . . . 1.62 110.773 163.424 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -73.78 -41.65 62.11 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.153 -2.217 . . . . 2.13 110.746 -176.486 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.1 t -61.56 -37.19 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 116.713 2.116 . . . . 0.62 116.713 170.856 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -56.88 -36.58 70.26 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 118.127 2.64 . . . . 1.22 118.127 170.762 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.56 80.78 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 118.68 -2.512 . . . . 0.51 111.196 166.437 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -68.32 -29.65 68.45 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 115.04 -4.788 . . . . 1.44 115.59 170.323 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.307 56.7 mt -70.09 -30.24 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-O 123.672 1.701 . . . . 1.32 106.816 175.281 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -69.34 -37.52 77.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.245 -1.534 . . . . 1.7 109.173 179.257 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -67.89 -54.63 17.32 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 126.876 2.61 . . . . 1.55 108.735 174.984 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -69.18 -54.63 13.82 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 118.579 -2.576 . . . . 2.62 111.833 -169.652 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -93.26 -59.54 2.0 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.157 -2.214 . . . . 1.48 112.31 -169.978 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.64 45.93 0.37 Allowed Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 107.03 -2.428 . . . . 1.12 107.03 176.444 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.4 mt -118.56 134.61 23.47 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 103.245 -2.872 . . . . 1.55 103.245 -176.662 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 76.4 Cg_exo -75.12 152.05 39.73 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-O 114.939 -2.192 . . . . 1.02 116.354 -177.618 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 81.0 Cg_exo -71.94 -14.3 29.33 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 CA-C-N 121.685 1.638 . . . . 1.25 115.769 -172.938 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.393 2.6 p30 -67.41 -48.64 66.72 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.959 1.704 . . . . 2.25 108.393 172.567 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -68.85 -16.74 63.86 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 116.35 -1.786 . . . . 2.02 113.574 -177.242 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -88.2 110.47 20.73 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 123.366 1.555 . . . . 0.69 108.347 -178.073 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -101.19 112.55 25.07 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.28 -2.118 . . . . 2.78 105.28 170.48 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.5 mt -107.79 128.56 54.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.091 -2.88 . . . . 1.17 111.647 -178.203 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 mt -107.74 136.7 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 1 C-N-CA 135.187 5.395 . . . . 1.38 105.752 -177.892 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.329 73.3 t80 -149.22 114.62 5.54 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 127.753 2.421 . . . . 1.5 105.42 173.624 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.59 30.45 15.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.863 2.465 . . . . 1.21 116.615 -178.839 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.67 -9.08 53.04 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-O 114.689 -3.284 . . . . 1.3 112.266 -176.385 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -92.11 134.3 34.97 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 115.692 -2.403 . . . . 2.55 114.305 167.868 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -86.93 123.58 32.21 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 118.956 -2.34 . . . . 2.48 109.174 173.473 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.8 mt -78.8 154.85 29.57 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.115 -2.241 . . . . 0.9 111.759 -159.29 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -91.47 150.66 21.13 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.43 -2.044 . . . . 1.94 110.468 173.898 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -71.99 -41.14 67.98 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 121.667 2.031 . . . . 1.56 115.481 -173.086 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.66 45.31 3.42 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 121.726 3.45 . . . . 0.97 121.726 170.291 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 mmt-85 -122.78 143.99 49.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 128.207 3.86 . . . . 2.49 101.473 168.748 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.312 80.8 p -82.63 167.08 18.62 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.257 -4.027 . . . . 0.76 114.591 168.543 . . . . . . . . 4 3 . 1 . 102 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -57.58 -46.68 83.69 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 126.955 2.102 . . . . 1.05 108.956 172.496 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.255 10.6 t -56.4 -38.61 71.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 130.131 3.372 . . . . 1.19 114.805 178.22 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -63.78 -61.72 2.11 Favored 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.411 -4.556 . . . . 1.9 115.172 172.766 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -64.55 -4.05 3.7 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.707 -1.87 . . . . 0.89 116.009 170.924 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.276 73.9 m-80 66.36 39.31 4.06 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.977 -2.952 . . . . 1.84 112.65 -175.701 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.0 mt -87.05 103.17 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.558 -2.589 . . . . 0.82 104.396 175.266 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -100.15 -172.42 2.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.306 1.842 . . . . 2.16 110.093 -172.454 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -58.99 140.31 55.84 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 127.613 3.578 . . . . 2.12 112.271 177.369 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 65.51 36.8 6.41 Favored 'General case' 0 N--CA 1.43 -1.438 1 C-N-CA 132.124 4.169 . . . . 1.71 112.089 175.75 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 m -88.22 159.64 18.06 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 114.473 -2.679 . . . . 1.04 111.435 -170.969 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.5 m -111.32 113.49 26.0 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 123.921 3.055 . . . . 0.79 108.645 172.887 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.3 mt -88.66 134.48 33.88 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 115.638 -2.425 . . . . 1.4 107.314 167.013 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -101.1 112.84 25.41 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.293 -3.38 . . . . 1.51 108.446 -171.952 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.402 HD23 HG22 ' A' ' 7' ' ' THR . 46.4 tp -92.69 117.87 30.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.894 3.277 . . . . 1.14 119.564 -173.75 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.89 124.65 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 102.384 -3.191 . . . . 1.23 102.384 172.941 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.7 tp -87.71 128.06 35.3 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 116.882 -3.636 . . . . 2.78 109.012 171.51 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -78.81 94.26 5.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.887 -2.383 . . . . 3.75 108.632 174.543 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.55 ' H ' HD23 ' A' ' 73' ' ' LEU . 2.6 pt? -80.04 -176.64 5.62 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 127.219 2.824 . . . . 3.14 107.937 173.397 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -117.1 142.84 46.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.433 2.293 . . . . 6.8 114.998 166.235 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.35 41.86 44.03 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 120.428 -1.42 . . . . 3.57 113.424 -173.633 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.797 0 CA-C-O 113.868 -3.74 . . . . 3.87 108.55 -177.82 . . . . . . . . 0 0 . 1 . 103 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 ptt? . . . . . 0 CA--C 1.491 -1.313 0 N-CA-C 119.601 3.185 . . . . 1.1 119.601 . . . . . . . . . 0 0 . 1 . 103 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -95.98 139.14 32.6 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.096 -2.253 . . . . 1.87 106.889 -174.616 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.0 pt -143.03 150.35 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 122.541 2.428 . . . . 0.72 109.983 169.654 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -108.77 134.02 52.04 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.4 -1.333 . . . . 1.4 107.4 -172.08 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -120.43 122.66 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 116.08 1.882 . . . . 0.58 116.08 166.553 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -94.33 130.1 40.76 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.978 2.511 . . . . 2.09 113.365 -176.013 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.6 p -97.14 153.28 18.07 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.958 -3.589 . . . . 0.99 107.853 -178.57 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.6 mt -61.91 -23.44 66.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 130.978 3.711 . . . . 2.53 112.841 174.095 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.8 p -77.78 -52.4 8.99 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 120.001 1.273 . . . . 2.08 113.754 178.872 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.05 11.51 0.03 OUTLIER Glycine 0 N--CA 1.429 -1.785 0 O-C-N 120.633 -1.292 . . . . 1.31 114.802 169.921 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -107.29 147.83 29.75 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 117.456 -3.379 . . . . 1.4 114.707 -173.276 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.7 m -112.69 116.96 30.96 Favored 'General case' 0 N--CA 1.43 -1.469 1 O-C-N 115.453 -4.529 . . . . 0.78 108.573 173.383 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mt -86.22 128.36 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 128.983 2.913 . . . . 1.55 105.93 -179.279 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.8 m -99.91 99.91 10.76 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.327 -3.358 . . . . 1.08 107.859 174.739 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.9 mt -97.09 145.39 26.03 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 115.973 -4.204 . . . . 1.55 109.721 177.219 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -97.2 132.14 43.26 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 125.32 2.486 . . . . 1.95 114.351 159.407 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -135.48 168.75 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 113.896 -1.502 . . . . 0.96 108.181 -176.148 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -116.08 152.27 47.55 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-O 116.147 -1.882 . . . . 2.35 106.539 166.914 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -76.33 -3.89 14.38 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-N 126.691 3.425 . . . . 0.95 112.999 -172.938 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -88.78 0.34 56.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 123.895 0.878 . . . . 1.45 111.988 173.525 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -82.07 147.33 29.17 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 125.042 1.337 . . . . 1.69 110.921 178.26 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 68.0 p -87.04 160.64 18.54 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.452 1.901 . . . . 0.75 112.349 -179.161 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.0 mm -75.99 -18.66 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 124.888 2.28 . . . . 0.73 114.441 -178.029 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.33 -44.58 94.5 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.37 -3.956 . . . . 1.62 111.298 158.407 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.307 18.3 m120 -50.82 -53.58 30.9 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 123.007 2.639 . . . . 2.13 114.18 169.054 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.501 HG21 HD21 ' A' ' 56' ' ' LEU 0.293 2.4 t -50.46 -43.89 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 119.272 3.064 . . . . 0.62 119.272 171.758 . . . . . . . . 3 3 . 1 . 103 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -74.54 -14.57 60.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.909 3.718 . . . . 1.22 114.515 174.245 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.262 . . -74.16 -34.35 63.8 Favored 'General case' 0 N--CA 1.431 -1.405 1 O-C-N 115.05 -4.781 . . . . 0.51 112.898 169.885 . . . . . . . . 3 2 . 1 . 103 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -64.09 -34.12 77.31 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.223 -1.353 . . . . 1.44 111.937 176.06 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.466 HD13 HD22 ' A' ' 69' ' ' LEU 0.46 36.5 mt -68.86 -38.47 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.877 1.799 . . . . 1.32 110.584 177.158 . . . . . . . . 3 3 . 1 . 103 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -64.81 -40.77 95.76 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.898 -2.376 . . . . 1.7 108.696 178.001 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -60.24 -40.85 91.68 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.684 1.735 . . . . 1.55 115.684 171.715 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -76.42 -67.68 0.67 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.886 -1.134 . . . . 2.62 112.748 -176.909 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -95.95 -45.1 7.07 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 116.645 -1.645 . . . . 1.48 111.027 -172.52 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.09 43.68 0.99 Allowed Glycine 0 N--CA 1.429 -1.78 0 CA-C-O 124.677 2.265 . . . . 1.12 117.237 174.852 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 mt -108.59 134.99 20.08 Favored Pre-proline 0 N--CA 1.43 -1.434 1 CA-C-O 111.536 -4.078 . . . . 1.55 102.736 -177.663 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -63.18 153.86 71.32 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 N-CA-C 120.024 3.048 . . . . 1.02 120.024 174.715 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -73.7 -24.75 15.44 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 CA-C-N 126.677 3.42 . . . . 1.25 113.014 -176.83 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.342 10.2 p-10 -65.86 -32.34 73.8 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 121.986 2.176 . . . . 2.25 111.951 170.528 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -73.84 -24.62 59.79 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.813 -2.429 . . . . 2.02 114.354 -179.174 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -92.11 145.59 24.39 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.929 -2.982 . . . . 0.69 110.225 -173.417 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.4 mtm180 -126.81 135.05 50.5 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 117.282 -1.342 . . . . 2.78 110.843 168.836 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.7 mt -103.42 124.99 49.75 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 123.715 2.962 . . . . 1.17 109.122 177.007 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.7 mm -114.88 120.48 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 104.749 -2.315 . . . . 1.38 104.749 177.908 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.457 ' HB3' HD21 ' A' ' 50' ' ' LEU . 35.7 t80 -130.02 136.28 49.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 129.277 3.031 . . . . 1.5 108.843 169.007 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.306 . . 54.6 31.58 15.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.278 1.584 . . . . 1.21 115.278 175.466 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.48 -20.82 6.83 Favored Glycine 0 N--CA 1.429 -1.805 0 O-C-N 119.176 -2.203 . . . . 1.3 115.438 -174.849 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.0 mttt -85.6 136.68 33.29 Favored 'General case' 0 N--CA 1.43 -1.468 2 C-N-CA 133.535 4.734 . . . . 2.55 110.802 -179.211 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -86.57 128.56 34.99 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.095 -1.866 . . . . 2.48 111.345 168.941 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' A' ' 45' ' ' PHE . 17.4 mt -83.76 127.24 33.66 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 104.927 -2.249 . . . . 0.9 104.927 -176.224 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -82.91 137.8 34.1 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.799 -3.063 . . . . 1.94 114.325 175.116 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -37.74 -72.8 0.05 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 131.087 3.755 . . . . 1.56 117.976 -177.676 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.86 51.79 4.6 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 120.696 3.038 . . . . 0.97 120.696 176.566 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.268 10.7 mmt180 -131.34 156.32 45.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.569 -3.313 . . . . 2.49 107.324 172.121 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.253 24.7 p -80.84 169.98 16.87 Favored 'General case' 0 N--CA 1.43 -1.442 2 O-C-N 114.123 -5.361 . . . . 0.76 116.647 176.733 . . . . . . . . 4 3 . 1 . 103 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.501 HD21 HG21 ' A' ' 26' ' ' VAL . 6.8 mt -63.87 -49.47 72.61 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.596 1.958 . . . . 1.05 109.186 171.663 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 t -57.29 -40.33 77.57 Favored 'General case' 0 N--CA 1.432 -1.363 0 O-C-N 118.774 -2.454 . . . . 1.19 111.632 177.137 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.4 -29.97 17.59 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 116.414 2.005 . . . . 1.9 116.414 167.876 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -99.95 7.86 44.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.069 -2.269 . . . . 0.89 115.373 171.846 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.294 7.7 m120 52.17 57.77 6.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 126.576 2.422 . . . . 1.84 117.433 -171.144 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mt -96.57 131.08 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 120.045 -1.659 . . . . 0.82 110.635 -177.876 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -97.68 -171.78 2.25 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 127.023 2.129 . . . . 2.16 114.339 -169.189 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -81.98 143.48 31.57 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.25 -1.531 . . . . 2.12 114.622 175.349 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.254 32.3 mt-10 65.43 21.32 11.86 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.426 2.01 . . . . 1.71 116.426 178.461 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.4 t -85.2 150.22 24.96 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 125.682 1.593 . . . . 1.04 112.741 -174.427 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.311 8.8 m -106.07 115.63 30.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 121.599 1.999 . . . . 0.79 113.648 -176.771 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 mt -101.36 164.15 11.92 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.105 -2.554 . . . . 1.4 104.105 173.759 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.293 74.1 m80 -123.73 135.54 53.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.833 -3.042 . . . . 1.51 107.392 178.431 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.466 HD22 HD13 ' A' ' 30' ' ' ILE . 36.4 tp -97.5 132.41 43.21 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 112.293 -2.231 . . . . 1.14 111.323 178.381 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.9 m -143.65 161.26 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 103.707 -2.701 . . . . 1.23 103.707 176.659 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.6 mt -95.68 166.72 11.69 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.713 2.673 . . . . 2.78 112.846 -174.402 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -71.52 132.07 44.18 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 129.006 2.922 . . . . 3.75 110.853 177.099 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.3 mt -93.52 77.73 4.38 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 127.172 2.189 . . . . 3.14 109.451 171.54 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -91.95 -58.42 2.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.284 -1.376 . . . . 6.8 107.284 174.701 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.74 -91.51 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 127.623 2.535 . . . . 3.57 112.971 -175.193 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.262 1.861 0 C-N-CA 129.774 3.559 . . . . 3.87 112.044 178.529 . . . . . . . . 0 0 . 1 . 104 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 CA--C 1.491 -1.324 0 CA-C-O 117.582 -1.199 . . . . 1.1 111.118 . . . . . . . . . 0 0 . 1 . 104 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -103.51 143.29 32.92 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 120.119 1.327 . . . . 1.87 110.979 179.837 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.9 pt -131.31 168.46 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 116.635 -1.65 . . . . 0.72 109.28 176.657 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -122.17 137.81 54.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 120.927 1.694 . . . . 1.4 113.163 177.283 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.407 HG22 ' HB2' ' A' ' 67' ' ' LEU . 4.3 t -122.22 131.3 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-O 125.842 2.734 . . . . 0.58 118.172 165.706 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -89.21 123.25 33.27 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 112.152 -2.294 . . . . 2.09 108.676 177.932 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.0 p -80.05 177.18 9.12 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.444 1.592 . . . . 0.99 112.758 169.455 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.0 mt -66.0 -46.31 78.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.299 -2.75 . . . . 2.53 113.909 176.165 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -65.04 -68.57 0.35 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.08 1.352 . . . . 2.08 108.488 179.379 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.67 -6.24 0.03 OUTLIER Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 117.454 1.742 . . . . 1.31 117.454 -176.203 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -71.62 141.73 49.96 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.304 -1.704 . . . . 1.4 114.664 -175.573 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.3 m -108.27 104.57 13.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 127.915 3.722 . . . . 0.78 111.183 172.435 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -88.59 115.57 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 1 O-C-N 115.874 -4.266 . . . . 1.55 109.743 179.248 . . . . . . . . 4 4 . 1 . 104 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.5 m -91.48 119.22 31.25 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.124 -2.176 . . . . 1.08 105.124 177.719 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 mt -115.42 139.51 49.96 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 125.102 2.382 . . . . 1.55 110.592 -171.378 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -87.97 120.75 29.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.201 -2.187 . . . . 1.95 108.038 174.852 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.9 177.02 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 125.741 1.901 . . . . 0.96 114.095 179.397 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -129.14 148.0 67.26 Favored Pre-proline 0 N--CA 1.43 -1.465 3 CA-C-O 108.292 -5.623 . . . . 2.35 110.668 166.82 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -61.35 -24.39 78.55 Favored 'Trans proline' 0 N--CA 1.434 -2.004 1 CA-C-N 128.843 4.194 . . . . 0.95 115.22 -174.216 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.4 p -69.75 -10.78 59.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.837 2.455 . . . . 1.45 116.072 177.045 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.305 36.4 m-20 -78.75 147.55 33.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 128.044 3.783 . . . . 1.69 108.576 -178.878 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 p -82.82 165.79 19.53 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 114.514 -2.66 . . . . 0.75 115.913 174.55 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.2 mm -66.08 -20.03 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-N 122.071 2.214 . . . . 0.73 111.18 178.289 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -64.68 -39.38 93.58 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 117.522 2.416 . . . . 1.62 117.522 169.51 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -72.74 -33.05 66.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.416 3.008 . . . . 2.13 108.665 179.591 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.6 t -69.09 -48.28 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 112.289 -2.232 . . . . 0.62 112.844 176.86 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.502 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 52.6 mtmt -55.84 -30.82 62.06 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 119.558 3.17 . . . . 1.22 119.558 160.052 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -31.96 72.76 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 124.312 3.233 . . . . 0.51 113.132 172.419 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -70.12 -29.13 66.0 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.544 -3.222 . . . . 1.44 113.342 172.562 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.9 mt -73.09 -39.17 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 120.017 -1.677 . . . . 1.32 112.544 176.255 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -58.21 -35.38 71.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 114.435 -2.698 . . . . 1.7 109.425 171.854 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -66.3 -50.66 62.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 123.355 2.798 . . . . 1.55 117.176 170.797 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -59.75 -61.01 2.94 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 116.949 -3.595 . . . . 2.62 111.616 -172.333 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -101.47 -44.9 5.47 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.449 -1.705 . . . . 1.48 108.893 -168.795 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.01 57.05 1.17 Allowed Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 118.502 -1.808 . . . . 1.12 111.383 178.821 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.0 mt -122.49 125.13 26.57 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 112.381 -3.675 . . . . 1.55 104.637 -177.58 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -57.64 138.42 86.04 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 CA-C-N 129.358 4.378 . . . . 1.02 116.708 177.276 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -54.39 -27.67 50.0 Favored 'Trans proline' 0 C--N 1.299 -2.076 1 C-N-CA 127.208 5.272 . . . . 1.25 117.414 -178.329 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -69.89 -39.41 76.26 Favored 'General case' 0 N--CA 1.431 -1.422 1 CA-C-O 111.334 -4.174 . . . . 2.25 110.086 171.663 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -61.65 -31.33 71.43 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 124.176 3.171 . . . . 2.02 114.326 177.701 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.502 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 63.0 mt-30 -78.13 135.27 37.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 120.354 3.464 . . . . 0.69 120.354 -177.447 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -135.05 146.98 49.48 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 102.512 -3.144 . . . . 2.78 102.512 173.23 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.5 mt -113.0 137.05 52.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.76 -2.462 . . . . 1.17 110.173 179.17 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.7 mm -117.47 133.9 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 124.994 2.33 . . . . 1.38 108.209 -178.551 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.444 ' HB3' HD21 ' A' ' 50' ' ' LEU . 7.7 t80 -147.47 138.02 23.32 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.29 -3.381 . . . . 1.5 112.338 169.787 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.76 43.27 30.33 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.412 3.085 . . . . 1.21 115.166 -178.525 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.55 -23.66 15.2 Favored Glycine 0 N--CA 1.429 -1.781 0 O-C-N 118.06 -2.9 . . . . 1.3 116.801 -176.373 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -119.03 166.81 12.42 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.056 -3.026 . . . . 2.55 112.841 -171.791 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.345 33.3 tt0 -98.78 153.41 18.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.126 -0.943 . . . . 2.48 112.435 178.192 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 45' ' ' PHE . 8.1 mt -110.56 126.58 54.57 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.675 1.59 . . . . 0.9 110.353 -173.302 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.493 ' HB2' ' HG3' ' A' ' 54' ' ' ARG . 28.2 mt-10 -73.73 141.63 46.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.19 2.596 . . . . 1.94 113.725 -178.1 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -46.98 -54.44 10.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 118.476 2.769 . . . . 1.56 118.476 -177.254 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.94 5.76 61.25 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 127.265 2.853 . . . . 0.97 120.088 172.893 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.493 ' HG3' ' HB2' ' A' ' 51' ' ' GLU . 6.3 mtt180 -87.92 154.33 20.6 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 120.092 1.946 . . . . 2.49 106.54 171.903 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.0 p -97.79 162.09 13.43 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.094 1.902 . . . . 0.76 115.79 172.038 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.38 -20.2 65.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.901 -2.999 . . . . 1.05 114.15 174.748 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.0 p -80.28 -31.86 38.26 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.541 3.137 . . . . 1.19 110.805 178.856 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.68 -46.22 39.26 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 112.834 -3.46 . . . . 1.9 111.799 175.483 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -76.52 -18.82 58.51 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 127.117 2.76 . . . . 0.89 110.654 178.095 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.7 t30 65.96 53.88 1.07 Allowed 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 127.073 2.149 . . . . 1.84 109.599 -176.264 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 mt -84.39 106.67 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 101.192 -3.633 . . . . 0.82 101.192 172.186 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -89.26 -174.43 4.4 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 122.248 2.295 . . . . 2.16 112.017 -178.713 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -60.53 137.55 58.15 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 123.638 1.685 . . . . 2.12 114.35 174.584 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 74.42 26.75 1.49 Allowed 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 131.492 3.917 . . . . 1.71 114.476 169.627 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.89 151.93 20.31 Favored 'General case' 0 N--CA 1.429 -1.491 1 C-N-CA 131.892 4.077 . . . . 1.04 105.613 -177.22 . . . . . . . . 3 3 . 1 . 104 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.4 m -107.3 126.25 52.21 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.57 -1.956 . . . . 0.79 112.411 178.364 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.407 ' HB2' HG22 ' A' ' 5' ' ' VAL . 66.4 mt -100.07 151.9 20.85 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 126.259 2.933 . . . . 1.4 106.532 169.561 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -113.35 116.58 29.92 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 116.035 -4.166 . . . . 1.51 112.584 179.083 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.7 tp -92.58 125.93 37.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.314 2.959 . . . . 1.14 107.826 -176.906 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.7 t -118.81 147.97 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 C-N-CA 127.216 2.206 . . . . 1.23 106.255 176.64 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.9 mt -114.2 156.11 24.87 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.797 -3.064 . . . . 2.78 114.205 175.404 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -80.25 141.11 35.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.681 -3.137 . . . . 3.75 112.09 177.857 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.579 ' H ' HD23 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -75.02 155.06 37.7 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.319 -2.113 . . . . 3.14 113.673 177.043 . . . . . . . . 3 3 . 1 . 104 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.7 mtm-85 -76.14 134.43 39.96 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.373 1.99 . . . . 6.8 116.373 174.871 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.58 -144.9 4.53 Favored Glycine 0 N--CA 1.431 -1.667 0 CA-C-N 123.311 2.778 . . . . 3.57 108.438 -170.013 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.827 0 N-CA-C 108.174 -1.97 . . . . 3.87 108.174 -176.329 . . . . . . . . 0 0 . 1 . 105 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 ptt? . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 117.633 -1.175 . . . . 1.1 113.744 . . . . . . . . . 0 0 . 1 . 105 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -90.03 140.3 29.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 123.054 2.661 . . . . 1.87 112.907 175.357 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.2 pt -130.72 161.97 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 108.066 -1.087 . . . . 0.72 108.066 166.062 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -119.62 130.13 54.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.315 3.046 . . . . 1.4 111.245 172.656 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.0 t -109.56 121.4 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 111.677 -2.511 . . . . 0.58 108.554 172.954 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -97.24 123.36 41.0 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 117.784 -3.073 . . . . 2.09 112.595 174.637 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.6 p -78.78 174.53 11.36 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.148 3.356 . . . . 0.99 115.214 170.062 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.12 -43.18 74.93 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 116.416 -3.927 . . . . 2.53 115.935 178.412 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 p -73.36 -41.22 63.69 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.119 2.568 . . . . 2.08 110.957 -177.334 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.57 8.18 0.42 Allowed Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 115.514 -3.231 . . . . 1.31 116.178 170.766 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.23 133.96 35.91 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 104.583 -2.377 . . . . 1.4 104.583 -176.137 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.6 m -98.73 123.39 42.92 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.301 -1.5 . . . . 0.78 107.156 171.274 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -100.59 95.41 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 124.437 2.065 . . . . 1.55 109.871 175.676 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.4 m -76.53 115.42 16.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 105.256 -2.127 . . . . 1.08 105.256 177.923 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.5 mt -120.24 171.69 8.32 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.001 2.12 . . . . 1.55 112.215 -176.712 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -127.61 132.39 49.79 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 105.304 -2.11 . . . . 1.95 105.304 169.505 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.8 m -140.25 169.49 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 128.286 2.634 . . . . 0.96 108.549 -178.471 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -104.81 159.93 27.69 Favored Pre-proline 0 N--CA 1.43 -1.433 0 O-C-N 119.269 -2.144 . . . . 2.35 108.774 162.897 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -70.23 -19.06 34.37 Favored 'Trans proline' 0 N--CA 1.434 -2.01 1 O-C-N 112.146 -4.713 . . . . 0.95 106.999 -174.911 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -91.57 9.01 33.91 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.474 2.398 . . . . 1.45 117.474 -176.481 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -85.66 150.19 24.79 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 113.082 0.771 . . . . 1.69 113.082 173.098 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.8 p -78.35 160.14 27.99 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 123.395 1.569 . . . . 0.75 113.176 173.559 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -60.59 -33.86 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 126.615 1.966 . . . . 0.73 109.92 169.884 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.303 3.4 tt0 -47.03 -46.56 22.16 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.526 2.047 . . . . 1.62 116.526 158.766 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -75.53 -35.73 60.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 116.83 2.159 . . . . 2.13 116.83 -178.021 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.4 t -57.92 -47.18 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 111.683 -2.508 . . . . 0.62 111.374 173.417 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.286 37.6 mtmt -57.91 -29.83 65.42 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 121.692 3.96 . . . . 1.22 121.692 170.628 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.38 -33.06 62.95 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.892 -2.38 . . . . 0.51 112.872 169.645 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -61.5 -17.17 53.43 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.706 1.602 . . . . 1.44 113.735 167.677 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.9 mt -98.61 -36.15 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 125.636 2.636 . . . . 1.32 108.945 178.777 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.307 24.7 tt0 -45.18 -50.01 11.74 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 117.815 -3.053 . . . . 1.7 113.825 173.752 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.397 0.6 OUTLIER -62.01 -26.4 68.21 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.92 2.933 . . . . 1.55 118.92 174.879 . . . . . . . . 3 3 . 1 . 105 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -86.17 -78.7 0.27 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.182 2.593 . . . . 2.62 109.212 -178.61 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -89.21 -12.36 41.04 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 119.03 2.974 . . . . 1.48 119.03 -172.529 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.66 24.08 26.71 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 120.92 -1.112 . . . . 1.12 115.419 172.962 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.4 mt -104.28 133.88 19.98 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-O 112.594 -3.574 . . . . 1.55 107.765 -169.549 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 41.2 Cg_endo -77.51 158.95 32.49 Favored 'Trans proline' 0 N--CA 1.434 -1.974 0 CA-C-N 125.037 2.835 . . . . 1.02 115.397 -179.377 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 14.7 Cg_exo -61.92 -26.73 79.21 Favored 'Trans proline' 0 C--N 1.299 -2.03 1 C-N-CA 127.002 5.135 . . . . 1.25 117.358 -178.329 . . . . . . . . 3 3 . 1 . 105 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.342 0.2 OUTLIER -61.02 -51.2 70.2 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 130.275 3.43 . . . . 2.25 110.259 179.303 . . . . . . . . 3 3 . 1 . 105 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -74.71 -43.65 54.01 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.597 -1.26 . . . . 2.02 107.597 178.284 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -60.21 137.8 58.05 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 116.792 2.145 . . . . 0.69 116.792 -174.35 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -138.17 128.68 26.37 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 125.875 1.67 . . . . 2.78 109.955 175.351 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.261 85.2 mt -95.64 135.67 37.03 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.648 1.69 . . . . 1.17 110.488 174.608 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.251 37.2 mm -123.17 120.23 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 109.565 -3.47 . . . . 1.38 106.501 173.748 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -134.62 131.81 38.26 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.615 2.626 . . . . 1.5 108.886 171.127 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.58 45.52 24.17 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.405 2.743 . . . . 1.21 118.405 179.848 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.54 -45.98 1.99 Allowed Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 120.574 -0.822 . . . . 1.3 114.895 179.456 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -82.73 149.04 27.51 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.083 2.553 . . . . 2.55 116.252 179.372 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -81.27 125.71 30.66 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 129.041 2.936 . . . . 2.48 107.988 172.464 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 mt -88.09 146.53 25.39 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.74 1.257 . . . . 0.9 109.702 -173.437 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -98.07 146.54 25.44 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 126.087 2.851 . . . . 1.94 107.41 177.207 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.7 -61.49 2.57 Favored 'General case' 0 N--CA 1.43 -1.473 1 C-N-CA 133.675 4.79 . . . . 1.56 117.042 -168.753 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.41 12.63 1.8 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 120.088 2.795 . . . . 0.97 120.088 172.985 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -106.15 159.35 16.15 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.702 1.715 . . . . 2.49 113.274 178.06 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -95.48 162.98 13.42 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.878 -4.264 . . . . 0.76 110.945 -179.639 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.3 mt -64.28 -43.21 95.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.957 3.303 . . . . 1.05 108.242 178.538 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 p -60.8 -34.23 74.2 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 114.479 1.288 . . . . 1.19 114.479 -179.992 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -64.09 -37.24 86.72 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 129.774 3.23 . . . . 1.9 113.807 173.04 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -92.9 7.82 42.29 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.947 -2.971 . . . . 0.89 110.97 177.639 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.2 m120 55.5 39.15 31.02 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 130.917 3.687 . . . . 1.84 114.459 -175.897 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.427 HG21 HD21 ' A' ' 67' ' ' LEU . 33.2 mt -82.56 115.99 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 103.999 -2.593 . . . . 0.82 103.999 179.064 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -100.99 -179.94 4.19 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.917 2.294 . . . . 2.16 110.54 -176.655 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.284 32.7 pttt -54.41 137.07 43.14 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.674 -3.141 . . . . 2.12 119.085 169.232 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.292 59.3 mt-10 71.31 24.28 3.79 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.061 1.744 . . . . 1.71 113.748 171.919 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.7 p -91.23 159.32 16.11 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.256 2.622 . . . . 1.04 115.431 -174.827 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.1 m -105.97 100.32 9.87 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.201 3.0 . . . . 0.79 114.321 176.952 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.427 HD21 HG21 ' A' ' 61' ' ' ILE . 3.9 mp -97.9 146.84 25.05 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 103.31 -2.848 . . . . 1.4 103.31 170.893 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -109.31 145.65 35.64 Favored 'General case' 0 CA--C 1.489 -1.37 0 CA-C-O 114.498 -2.668 . . . . 1.51 110.299 -179.009 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.2 tp -111.7 119.88 40.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 127.347 2.904 . . . . 1.14 110.592 -173.582 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 m -113.31 151.58 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 118.968 -2.332 . . . . 1.23 111.326 172.959 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.2 mt -110.86 124.75 52.67 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 116.966 -1.894 . . . . 2.78 108.846 -179.624 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -60.81 142.06 56.44 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 126.817 2.573 . . . . 3.75 113.892 -176.606 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.5 mt -114.17 139.28 49.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 103.898 -2.63 . . . . 3.14 103.898 174.576 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -80.46 143.41 33.4 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.161 2.184 . . . . 6.8 108.184 175.485 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.34 -71.29 0.43 Allowed Glycine 0 N--CA 1.429 -1.784 0 CA-C-O 124.698 2.277 . . . . 3.57 108.604 -162.706 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.756 0 O-C-N 119.156 -2.379 . . . . 3.87 113.689 176.078 . . . . . . . . 0 0 . 1 . 106 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.37 15.3 ptt? . . . . . 0 CA--C 1.489 -1.382 0 N-CA-C 115.006 1.484 . . . . 1.1 115.006 . . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -97.74 130.07 44.73 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 117.168 -1.813 . . . . 1.87 111.79 179.799 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.2 pt -121.15 169.06 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 103.247 -2.872 . . . . 0.72 103.247 175.953 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -128.4 126.39 40.53 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.691 -1.226 . . . . 1.4 107.691 -171.442 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.42 HG23 HD23 ' A' ' 15' ' ' LEU . 76.0 t -107.91 121.96 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 114.494 -1.23 . . . . 0.58 108.406 172.462 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -99.04 126.88 44.86 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.313 1.445 . . . . 2.09 108.902 175.903 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 p -69.69 -178.63 1.53 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.643 2.09 . . . . 0.99 116.643 175.024 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.7 tp -74.73 -38.55 62.25 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.943 -1.098 . . . . 2.53 112.126 173.529 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.2 p -79.33 -53.25 7.11 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.987 2.588 . . . . 2.08 117.987 176.697 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.99 7.89 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.778 0 CA-C-N 125.772 3.897 . . . . 1.31 115.096 179.988 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -99.77 139.6 35.19 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 115.198 -2.601 . . . . 1.4 113.695 -175.603 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.4 m -103.28 128.19 50.39 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 116.53 -2.068 . . . . 0.78 105.534 174.787 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.4 mt -116.32 123.98 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.661 2.784 . . . . 1.55 111.265 -177.72 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.8 m -96.64 126.41 41.79 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 105.847 -1.908 . . . . 1.08 105.847 -174.891 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.42 HD23 HG23 ' A' ' 5' ' ' VAL . 1.9 mm? -121.35 120.31 34.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.399 2.28 . . . . 1.55 111.222 -178.056 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -82.48 111.65 18.69 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.114 1.765 . . . . 1.95 108.16 172.667 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.263 23.8 m -134.97 -178.43 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 O-C-N 120.163 -1.586 . . . . 0.96 107.25 177.579 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -117.31 174.68 2.38 Favored Pre-proline 0 N--CA 1.43 -1.451 0 O-C-N 117.237 -3.414 . . . . 2.35 108.304 163.817 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -77.56 -19.04 13.28 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 117.377 -1.96 . . . . 0.95 113.215 -175.124 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.333 4.5 m -82.94 3.95 27.79 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 122.755 2.525 . . . . 1.45 115.387 176.816 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.269 2.8 m-20 -72.59 153.74 41.12 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 115.917 1.821 . . . . 1.69 115.917 172.114 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.5 p -89.85 153.86 20.32 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 117.481 -3.262 . . . . 0.75 111.424 -179.61 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.5 mm -47.63 -49.01 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 118.832 -2.417 . . . . 0.73 116.497 172.354 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -45.31 -35.71 3.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 117.101 2.26 . . . . 1.62 117.101 167.828 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -65.48 -32.42 74.01 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 122.02 2.191 . . . . 2.13 114.515 174.836 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.9 t -75.75 -40.19 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 120.112 -1.618 . . . . 0.62 109.772 -174.93 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -59.37 -32.07 69.8 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 113.251 -1.795 . . . . 1.22 114.957 167.556 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.17 84.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 114.98 -2.438 . . . . 0.51 112.905 171.748 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -70.2 -22.16 62.96 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 127.635 3.084 . . . . 1.44 115.023 -179.648 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.1 mm -79.38 -35.66 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 127.262 2.225 . . . . 1.32 109.513 175.446 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.35 8.7 tt0 -58.39 -48.78 79.54 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 126.539 2.399 . . . . 1.7 113.459 172.867 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -54.05 -53.04 58.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 111.647 -2.524 . . . . 1.55 113.145 168.949 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -87.53 -49.21 7.34 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.488 -3.258 . . . . 2.62 114.102 -167.522 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -96.36 -44.45 7.22 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 113.472 -1.695 . . . . 1.48 113.832 -172.202 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.74 -28.28 3.98 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 117.226 1.65 . . . . 1.12 117.226 169.56 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.494 HD12 ' H ' ' A' ' 36' ' ' ILE . 2.8 mp -57.45 138.17 81.43 Favored Pre-proline 0 N--CA 1.429 -1.496 0 N-CA-C 115.754 1.761 . . . . 1.55 115.754 -174.57 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -59.92 134.39 56.49 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 C-N-CA 123.872 3.048 . . . . 1.02 114.445 174.772 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -73.95 -16.75 22.93 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-O 112.004 -3.415 . . . . 1.25 112.74 -169.72 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.03 -38.33 90.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.596 2.617 . . . . 2.25 111.616 171.584 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -78.4 -18.29 55.23 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.765 -2.459 . . . . 2.02 114.739 178.521 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -88.66 138.64 31.24 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.781 2.229 . . . . 0.69 116.09 177.766 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -121.77 158.04 29.68 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.908 -3.62 . . . . 2.78 110.976 165.408 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.276 12.8 mt -119.26 125.16 48.47 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 126.285 1.834 . . . . 1.17 111.387 179.324 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.1 mt -113.08 136.88 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 106.932 -1.507 . . . . 1.38 106.932 -174.149 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -142.04 129.59 21.4 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.588 -1.32 . . . . 1.5 111.106 173.214 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.43 18.3 6.72 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 130.322 3.449 . . . . 1.21 116.334 -179.288 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.54 -3.76 57.89 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 126.561 2.029 . . . . 1.3 115.049 -175.624 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -108.0 133.3 52.51 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 126.421 3.01 . . . . 2.55 113.785 177.215 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -77.41 127.62 32.85 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.251 -4.031 . . . . 2.48 104.735 172.564 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.5 mt -89.61 147.33 23.98 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.283 -2.136 . . . . 0.9 116.73 -173.927 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -82.83 132.87 35.15 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.366 2.031 . . . . 1.94 112.572 171.435 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -60.9 -51.45 69.23 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 111.008 -2.814 . . . . 1.56 115.213 -172.671 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.19 46.95 3.62 Favored Glycine 0 N--CA 1.43 -1.747 0 CA-C-O 118.347 -1.252 . . . . 0.97 114.293 173.726 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -128.21 155.6 44.26 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.085 2.154 . . . . 2.49 113.152 168.8 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.342 70.1 p -82.04 164.01 21.7 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 121.692 2.042 . . . . 0.76 111.116 173.951 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mt -70.41 -26.98 63.93 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 111.302 -2.681 . . . . 1.05 111.698 170.314 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.254 23.2 t -65.74 -46.28 79.45 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 115.572 -2.156 . . . . 1.19 111.681 171.515 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -52.27 -28.36 18.56 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 117.999 2.592 . . . . 1.9 117.999 176.397 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -93.39 -11.46 32.19 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 117.593 -3.192 . . . . 0.89 111.31 -179.693 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.1 m120 67.23 50.5 0.98 Allowed 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 128.728 2.811 . . . . 1.84 113.308 -175.087 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.8 mt -95.46 110.54 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 1 CA-C-O 128.857 4.17 . . . . 0.82 107.674 177.366 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -89.84 -173.15 3.8 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 114.081 -5.387 . . . . 2.16 112.563 -179.589 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -61.73 166.48 4.3 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.118 -2.239 . . . . 2.12 111.329 175.1 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 49.79 28.82 2.9 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 118.471 2.767 . . . . 1.71 118.471 172.703 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.9 p -90.88 147.33 23.23 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.074 2.55 . . . . 1.04 113.054 -174.848 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.9 m -107.98 98.6 8.15 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 115.305 1.594 . . . . 0.79 115.305 -179.205 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.297 2.7 mp -84.01 156.22 22.38 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 129.176 2.99 . . . . 1.4 107.945 175.123 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -126.05 120.23 29.69 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 118.281 -1.368 . . . . 1.51 109.873 -176.614 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.9 tp -84.58 130.81 34.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.903 -2.373 . . . . 1.14 107.636 -179.879 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.5 m -125.04 140.47 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 126.388 2.994 . . . . 1.23 113.066 166.065 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.335 4.9 mt -80.32 125.98 30.58 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.023 -2.923 . . . . 2.78 112.553 176.919 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -96.88 97.68 9.48 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.616 -1.302 . . . . 3.75 111.591 176.017 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -92.46 -68.43 0.8 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 124.884 1.274 . . . . 3.14 111.075 178.032 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.9 ptt-85 -65.6 147.36 53.53 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 126.22 2.914 . . . . 6.8 106.916 -179.652 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.69 80.42 0.64 Allowed Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 116.782 -2.628 . . . . 3.57 113.001 -171.31 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.761 0 N-CA-C 107.952 -2.059 . . . . 3.87 107.952 -169.16 . . . . . . . . 0 0 . 1 . 107 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptt? . . . . . 0 CA--C 1.491 -1.319 0 CA-C-O 117.99 -1.005 . . . . 1.1 111.215 . . . . . . . . . 0 0 . 1 . 107 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -115.42 135.05 54.51 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 127.476 2.985 . . . . 1.87 109.275 175.997 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt -117.25 163.54 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 106.832 -1.544 . . . . 0.72 106.832 171.25 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -109.53 136.08 49.49 Favored 'General case' 0 N--CA 1.431 -1.409 1 C-N-CA 132.429 4.292 . . . . 1.4 109.703 174.998 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.9 t -130.01 123.46 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 O-C-N 118.099 -2.876 . . . . 0.58 104.861 178.769 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -98.03 139.49 33.77 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.299 -3.376 . . . . 2.09 112.391 176.531 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.323 32.7 p -82.59 -171.67 3.62 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.831 -1.168 . . . . 0.99 111.676 176.319 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 71' ' ' LEU . 83.9 mt -61.71 -47.77 83.78 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.389 -1.444 . . . . 2.53 112.544 172.14 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.3 p -81.02 -22.84 39.06 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.969 -1.707 . . . . 2.08 109.1 -178.672 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.93 23.89 4.46 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 118.969 2.347 . . . . 1.31 118.969 172.375 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -77.73 134.4 38.1 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 120.054 1.927 . . . . 1.4 108.276 179.039 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.9 m -91.66 110.75 22.08 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.409 -2.057 . . . . 0.78 109.31 -173.272 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mt -100.86 125.91 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 125.742 1.617 . . . . 1.55 106.723 178.153 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.0 m -103.79 121.42 42.99 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.781 2.032 . . . . 1.08 108.207 179.613 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.5 mt -120.45 125.01 46.85 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.774 -2.454 . . . . 1.55 117.268 -178.621 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -70.69 117.56 12.36 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 124.774 1.296 . . . . 1.95 110.235 170.461 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.0 m -142.84 171.97 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 126.2 2.905 . . . . 0.96 109.064 178.231 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -118.58 158.62 46.7 Favored Pre-proline 0 N--CA 1.43 -1.428 1 O-C-N 114.087 -5.383 . . . . 2.35 106.484 163.509 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.08 -14.1 26.06 Favored 'Trans proline' 0 C--N 1.299 -2.048 1 C-N-CA 125.581 4.188 . . . . 0.95 110.235 -171.379 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 m -90.25 8.21 34.33 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 122.125 2.239 . . . . 1.45 110.24 177.773 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.35 147.03 28.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.593 -2.567 . . . . 1.69 110.285 171.388 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 47.0 p -86.71 161.35 18.47 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.663 -1.606 . . . . 0.75 106.663 -177.395 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 23' ' ' ILE 0.3 26.1 mm -64.98 -29.32 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 O-C-N 116.205 -4.06 . . . . 0.73 110.991 -178.374 . . . . . . . . 4 3 . 1 . 107 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -52.98 -47.49 68.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 129.009 2.924 . . . . 1.62 111.773 167.963 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.258 26.3 t30 -71.31 -32.85 69.1 Favored 'General case' 0 N--CA 1.431 -1.41 1 O-C-N 116.229 -4.044 . . . . 2.13 112.997 177.789 . . . . . . . . 3 2 . 1 . 107 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.0 t -63.15 -45.09 99.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 1 O-C-N 113.509 -5.744 . . . . 0.62 113.931 174.482 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.5 mttt -60.37 -38.71 84.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 128.006 3.316 . . . . 1.22 117.267 167.859 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.51 -41.6 85.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 123.901 1.81 . . . . 0.51 113.335 172.442 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -68.33 -29.46 68.21 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.545 -3.222 . . . . 1.44 117.156 171.107 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.8 mt -71.98 -43.92 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-N 120.898 1.681 . . . . 1.32 110.602 172.487 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -49.34 -45.84 46.13 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.575 2.35 . . . . 1.7 115.375 170.951 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -51.58 -46.53 63.53 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.751 2.215 . . . . 1.55 115.023 175.342 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 tttp -85.03 -57.73 2.98 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.681 -3.137 . . . . 2.62 113.008 -174.767 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -89.12 -46.81 8.54 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 129.824 3.25 . . . . 1.48 114.636 -168.274 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.88 27.08 3.35 Favored Glycine 0 N--CA 1.429 -1.798 1 O-C-N 114.637 -5.04 . . . . 1.12 110.455 169.981 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.0 mt -104.97 124.24 37.31 Favored Pre-proline 0 N--CA 1.429 -1.484 0 CA-C-O 113.883 -2.96 . . . . 1.55 107.087 -178.256 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -64.39 164.51 22.95 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 CA-C-N 127.969 3.882 . . . . 1.02 118.413 174.677 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -65.33 -26.65 55.91 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 123.815 3.01 . . . . 1.25 118.593 -176.847 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -55.96 -43.34 77.44 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 127.344 2.902 . . . . 2.25 113.062 173.774 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -85.38 -1.51 57.09 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 113.147 -1.842 . . . . 2.02 114.321 -170.317 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -107.6 103.62 12.97 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.146 1.378 . . . . 0.69 112.451 -171.946 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.257 72.6 mtt180 -96.39 116.74 29.53 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.286 -2.759 . . . . 2.78 107.849 167.74 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.1 mt -99.46 126.86 45.46 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.583 -3.198 . . . . 1.17 105.089 177.559 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -114.31 143.36 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 125.298 2.475 . . . . 1.38 107.966 176.481 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.515 ' C ' ' H ' ' A' ' 47' ' ' GLY . 34.9 t80 -141.2 127.37 19.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.346 -3.971 . . . . 1.5 108.888 171.964 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 75.93 -27.39 0.18 Allowed 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 127.953 2.501 . . . . 1.21 109.624 174.155 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 143.48 -13.02 2.25 Favored Glycine 0 N--CA 1.431 -1.694 0 CA-C-O 125.162 2.535 . . . . 1.3 113.55 -175.887 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -86.22 137.1 32.89 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 111.806 -2.197 . . . . 2.55 109.473 178.781 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -77.59 109.66 11.75 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.796 3.638 . . . . 2.48 110.508 169.092 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.8 mt -68.46 130.97 44.44 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 114.858 1.429 . . . . 0.9 114.858 -177.393 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -89.8 144.52 25.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.654 1.582 . . . . 1.94 113.285 177.891 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -60.87 -54.87 39.81 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.718 -3.114 . . . . 1.56 115.862 -171.933 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.42 28.86 0.85 Allowed Glycine 0 N--CA 1.43 -1.763 1 N-CA-C 123.754 4.262 . . . . 0.97 123.754 171.357 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -127.87 160.01 33.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.548 -1.56 . . . . 2.49 112.139 173.01 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.26 44.2 p -89.15 167.07 13.41 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.356 1.551 . . . . 0.76 109.974 -177.703 . . . . . . . . 3 3 . 1 . 107 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mt -64.81 -34.73 79.06 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 113.892 -1.503 . . . . 1.05 109.854 169.938 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.9 t -61.16 -41.81 97.43 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 122.598 1.189 . . . . 1.19 109.613 179.397 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -55.23 -41.87 72.63 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.569 -2.582 . . . . 1.9 117.56 176.309 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -84.9 -6.69 59.34 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 117.75 2.5 . . . . 0.89 117.75 -179.441 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.318 35.9 m120 68.62 50.57 0.67 Allowed 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 119.399 1.0 . . . . 1.84 111.999 -176.204 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.6 mt -103.44 108.73 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 121.704 0.764 . . . . 0.82 111.451 172.838 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -93.78 -175.8 3.85 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.297 2.639 . . . . 2.16 107.627 177.886 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -68.59 149.35 49.28 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 125.932 2.777 . . . . 2.12 113.747 171.275 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.429 75.3 mt-10 64.97 22.39 12.44 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 109.99 -3.277 . . . . 1.71 115.375 174.687 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.5 m -92.23 156.42 17.31 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.776 -3.077 . . . . 1.04 110.812 -176.883 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.2 m -106.89 110.19 22.28 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 126.521 2.388 . . . . 0.79 108.211 -173.005 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -93.22 141.33 28.54 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.59 1.556 . . . . 1.4 106.869 172.31 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -101.9 117.99 35.99 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.015 -2.928 . . . . 1.51 106.773 -177.902 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.8 tp -93.1 121.4 34.42 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.697 -2.502 . . . . 1.14 111.163 173.868 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.1 t -111.36 140.77 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 O-C-N 117.8 -3.062 . . . . 1.23 108.084 177.561 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.413 ' HB3' HD11 ' A' ' 8' ' ' LEU . 10.5 tp -85.87 126.17 33.86 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 116.39 1.996 . . . . 2.78 116.39 174.567 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -91.72 115.98 28.5 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 124.631 1.172 . . . . 3.75 108.106 -174.105 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.7 mt -111.43 -146.46 0.41 Allowed 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.539 1.136 . . . . 3.14 109.884 175.017 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -109.75 123.76 50.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 115.6 1.704 . . . . 6.8 115.6 177.581 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.31 100.09 0.86 Allowed Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 122.691 3.836 . . . . 3.57 122.691 -163.297 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.765 0 CA-C-O 117.563 -1.687 . . . . 3.87 110.366 175.625 . . . . . . . . 0 0 . 1 . 108 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ptt? . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 106.733 -1.58 . . . . 1.1 106.733 . . . . . . . . . 0 0 . 1 . 108 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.1 pm0 -107.15 131.6 53.96 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 114.28 1.215 . . . . 1.87 114.28 -178.863 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 pt -121.32 152.7 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 105.867 -1.901 . . . . 0.72 105.867 169.67 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.252 75.0 m-85 -113.89 135.34 54.08 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.035 -1.439 . . . . 1.4 108.88 -176.58 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.0 t -118.07 107.47 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 123.191 1.472 . . . . 0.58 111.405 178.709 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -89.02 138.23 31.59 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 118.239 -2.788 . . . . 2.09 118.278 174.686 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.329 27.8 p -94.81 154.35 17.3 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 110.725 -2.943 . . . . 0.99 110.013 178.309 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.282 43.1 mt -65.6 -41.64 92.57 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 131.012 3.725 . . . . 2.53 107.611 178.367 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 p -67.57 -46.17 73.45 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.138 1.375 . . . . 2.08 114.001 -176.7 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.05 50.57 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 125.406 1.479 . . . . 1.31 114.953 166.417 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -127.87 137.94 52.51 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.505 2.574 . . . . 1.4 107.652 -179.798 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.0 m -103.07 110.89 22.99 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 120.192 -1.567 . . . . 0.78 111.634 167.492 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.9 mm -97.54 112.72 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 104.545 -2.391 . . . . 1.55 104.545 -179.475 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.7 m -87.58 104.0 16.09 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.795 -1.191 . . . . 1.08 110.067 176.922 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.422 HD11 HG12 ' A' ' 30' ' ' ILE . 24.0 mt -101.54 134.76 44.16 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 105.598 -2.001 . . . . 1.55 105.598 -170.646 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -81.72 99.37 8.9 Favored 'General case' 0 N--CA 1.429 -1.492 1 O-C-N 116.116 -4.115 . . . . 1.95 116.395 165.233 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.5 m -109.22 -177.66 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.457 1 O-C-N 116.295 -4.003 . . . . 0.96 109.964 -179.693 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -124.11 158.5 60.42 Favored Pre-proline 0 N--CA 1.431 -1.417 0 CA-C-O 114.885 -2.483 . . . . 2.35 105.823 161.55 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -79.03 -6.82 15.18 Favored 'Trans proline' 0 N--CA 1.434 -2.019 1 CA-C-N 129.825 4.544 . . . . 0.95 111.894 -173.347 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.275 1.0 OUTLIER -82.79 2.2 35.22 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 116.448 2.018 . . . . 1.45 116.448 172.01 . . . . . . . . 3 3 . 1 . 108 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -78.02 134.63 37.76 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 116.566 2.062 . . . . 1.69 116.566 172.552 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.7 p -73.63 157.93 35.71 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.139 2.4 . . . . 0.75 110.134 174.569 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.266 35.4 mm -68.64 -37.31 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 112.392 -2.186 . . . . 0.73 110.075 -177.545 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -44.67 -46.53 10.3 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 128.329 2.652 . . . . 1.62 112.463 162.762 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -74.51 -38.63 62.79 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.748 2.69 . . . . 2.13 117.015 -179.679 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.7 t -65.11 -37.86 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 O-C-N 115.188 -4.695 . . . . 0.62 110.196 175.2 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -60.89 -29.72 69.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.838 -2.414 . . . . 1.22 115.334 172.34 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.48 -32.86 66.56 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.097 1.359 . . . . 0.51 112.162 174.325 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.28 0.4 OUTLIER -64.82 -32.95 74.89 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 130.371 3.469 . . . . 1.44 112.822 171.724 . . . . . . . . 3 3 . 1 . 108 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.422 HG12 HD11 ' A' ' 15' ' ' LEU . 15.3 mt -70.82 -41.15 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.579 2.351 . . . . 1.32 108.761 167.495 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.369 13.6 tt0 -57.83 -45.5 86.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 127.754 3.645 . . . . 1.7 117.259 170.065 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -52.45 -56.88 12.05 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.41 -3.306 . . . . 1.55 116.004 170.772 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -78.17 -51.12 10.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.92 -2.362 . . . . 2.62 113.074 -177.992 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -93.91 -62.19 1.4 Allowed 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.982 -2.949 . . . . 1.48 110.386 -170.973 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.15 53.68 0.35 Allowed Glycine 0 N--CA 1.431 -1.663 1 O-C-N 114.13 -5.356 . . . . 1.12 114.829 -179.489 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.9 mt -123.11 127.97 25.48 Favored Pre-proline 0 N--CA 1.43 -1.432 1 N-CA-C 99.661 -4.2 . . . . 1.55 99.661 -177.172 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.02 135.18 39.73 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 C-N-CA 123.022 2.482 . . . . 1.02 112.022 -179.319 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -46.47 -21.51 1.33 Allowed 'Trans proline' 0 N--CA 1.434 -1.999 1 C-N-CA 128.968 6.445 . . . . 1.25 121.96 179.612 . . . . . . . . 3 3 . 1 . 108 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -72.87 -50.41 24.06 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.881 2.472 . . . . 2.25 110.334 177.416 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -77.66 -7.22 56.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.551 3.072 . . . . 2.02 108.51 -172.977 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -91.72 124.02 35.55 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.387 -3.321 . . . . 0.69 113.424 -178.705 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -121.18 147.93 44.92 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.565 2.126 . . . . 2.78 105.467 169.008 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.262 29.5 mt -127.07 133.95 50.36 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 117.912 -1.515 . . . . 1.17 107.013 178.587 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.5 mt -106.39 147.98 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 127.948 3.28 . . . . 1.38 107.569 171.57 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -128.59 107.3 9.59 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.416 -2.068 . . . . 1.5 105.416 177.164 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.43 -42.13 0.49 Allowed 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 132.225 4.21 . . . . 1.21 113.216 177.38 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -172.23 -25.44 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 127.747 2.594 . . . . 1.3 109.435 -176.811 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -104.43 147.77 27.18 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.278 1.539 . . . . 2.55 113.48 -175.489 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -81.59 140.63 34.35 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.012 -1.449 . . . . 2.48 113.232 172.266 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.5 mt -98.44 144.76 27.45 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.378 1.561 . . . . 0.9 113.482 -177.883 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -99.04 144.82 27.75 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.601 -2.562 . . . . 1.94 108.277 170.501 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.92 -43.93 94.45 Favored 'General case' 0 CA--C 1.489 -1.391 1 C-N-CA 137.864 6.465 . . . . 1.56 114.513 -167.668 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.31 22.87 13.54 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 129.14 3.257 . . . . 0.97 111.847 168.605 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -98.57 168.34 10.23 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.812 2.244 . . . . 2.49 109.25 161.234 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.3 p -102.68 173.09 6.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.586 -2.571 . . . . 0.76 111.27 170.741 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.321 16.7 mt -76.68 -31.51 57.31 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.442 -2.036 . . . . 1.05 106.579 176.951 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 t -64.05 -41.77 97.27 Favored 'General case' 0 CA--C 1.489 -1.39 0 C-N-CA 124.796 1.238 . . . . 1.19 111.093 179.703 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -56.14 -41.01 74.7 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.843 2.164 . . . . 1.9 116.843 174.552 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -87.67 7.36 30.35 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.004 2.122 . . . . 0.89 112.781 179.456 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.277 35.0 m120 56.67 40.49 29.23 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.721 -2.487 . . . . 1.84 115.455 -179.855 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.2 mt -79.03 108.18 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 124.082 1.896 . . . . 0.82 112.116 171.916 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -95.01 -175.27 3.48 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.927 -1.733 . . . . 2.16 113.009 179.131 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -69.02 146.36 52.76 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 115.858 -2.02 . . . . 2.12 114.901 170.774 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 69.57 42.94 1.06 Allowed 'General case' 0 N--CA 1.431 -1.409 1 CA-C-O 130.943 5.163 . . . . 1.71 108.193 177.372 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.256 37.9 m -107.11 129.48 54.82 Favored 'General case' 0 N--CA 1.431 -1.411 1 O-C-N 113.693 -5.629 . . . . 1.04 115.809 176.943 . . . . . . . . 3 2 . 1 . 108 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.3 m -88.33 126.12 35.03 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 125.686 1.866 . . . . 0.79 111.815 177.53 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -112.57 151.7 29.75 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.67 2.788 . . . . 1.4 108.271 173.607 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -110.26 113.45 26.13 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.224 1.935 . . . . 1.51 116.224 -174.967 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.3 tp -82.21 112.97 19.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.203 -2.811 . . . . 1.14 113.39 -178.64 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.39 112.56 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 125.04 2.352 . . . . 1.23 112.593 179.408 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.7 tp -86.52 122.6 30.69 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.935 -2.353 . . . . 2.78 107.644 -175.301 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.63 161.87 28.64 Favored 'General case' 0 N--CA 1.428 -1.532 0 O-C-N 127.951 3.282 . . . . 3.75 113.902 -178.679 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.2 mt -120.72 167.16 12.76 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 104.62 -2.363 . . . . 3.14 104.62 170.45 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.1 mtt-85 -71.25 141.8 50.57 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.58 3.152 . . . . 6.8 115.402 168.155 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.54 -71.13 0.43 Allowed Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 128.254 2.835 . . . . 3.57 109.366 -168.876 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.748 0 C-N-CA 114.686 -3.626 . . . . 3.87 104.368 -178.986 . . . . . . . . 0 0 . 1 . 109 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.324 0 N-CA-C 107.442 -1.318 . . . . 1.1 107.442 . . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -99.16 144.45 28.28 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.288 1.994 . . . . 1.87 108.857 -173.913 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 pt -118.7 145.52 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 120.201 -1.562 . . . . 0.72 110.818 169.946 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -100.86 104.13 15.34 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.714 -0.676 . . . . 1.4 110.965 -179.567 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.8 t -88.29 117.62 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.446 -2.034 . . . . 0.58 107.299 174.651 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -101.88 145.12 29.66 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 125.288 1.618 . . . . 2.09 107.264 -179.529 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -103.9 -166.54 1.26 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.582 2.134 . . . . 0.99 112.186 178.532 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.5 tp -61.14 -51.29 69.68 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.539 -4.476 . . . . 2.53 114.15 176.233 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 p -72.24 -24.69 61.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.443 -3.286 . . . . 2.08 110.458 178.523 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.25 38.1 2.73 Favored Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 115.043 -3.087 . . . . 1.31 112.167 179.261 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -95.67 130.06 42.67 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 121.492 2.646 . . . . 1.4 110.956 -178.74 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.1 m -80.0 120.74 24.6 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.091 2.956 . . . . 0.78 112.786 178.972 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mt -107.8 118.1 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 101.786 -3.413 . . . . 1.55 101.786 171.523 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.6 m -102.0 113.33 26.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 123.723 2.965 . . . . 1.08 107.462 -172.23 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.8 mt -108.58 137.05 47.17 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.231 -0.918 . . . . 1.55 110.924 177.543 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -80.94 112.86 18.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.872 1.269 . . . . 1.95 110.635 165.516 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -121.48 171.86 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 116.648 2.092 . . . . 0.96 116.648 174.866 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -106.14 158.05 33.44 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 104.115 -2.55 . . . . 2.35 104.115 164.712 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -82.51 4.61 6.95 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 O-C-N 114.656 -3.391 . . . . 0.95 109.095 179.926 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.6 p -92.66 -13.61 29.25 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.329 1.452 . . . . 1.45 114.561 175.661 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -66.67 135.88 54.72 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 126.109 2.861 . . . . 1.69 109.041 -179.416 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.263 23.8 p -68.96 158.33 34.91 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 116.451 -3.906 . . . . 0.75 113.534 177.881 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.401 7.9 mm -55.85 -41.77 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 124.623 2.154 . . . . 0.73 116.416 171.953 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -56.53 -39.65 73.72 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 119.546 3.165 . . . . 1.62 119.546 167.933 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -29.21 64.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.552 2.056 . . . . 2.13 116.552 172.321 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.44 -37.09 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 130.373 3.469 . . . . 0.62 109.635 168.732 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -81.44 -18.74 44.29 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 122.538 1.161 . . . . 1.22 109.793 -179.427 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.38 -17.34 58.28 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.651 -1.906 . . . . 0.51 111.532 168.242 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -83.64 -30.61 26.74 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 119.831 -1.793 . . . . 1.44 111.522 173.22 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.258 13.6 mt -73.01 -26.56 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 117.167 -3.458 . . . . 1.32 113.213 171.561 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -70.65 -51.36 28.46 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.492 3.517 . . . . 1.7 109.446 174.305 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -50.28 -45.16 54.22 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.608 2.763 . . . . 1.55 117.005 165.708 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -81.59 -60.15 2.36 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 113.869 1.063 . . . . 2.62 113.869 -179.646 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -95.13 -48.35 5.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.041 1.497 . . . . 1.48 115.041 -171.396 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.07 -2.0 6.25 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-O 124.222 2.012 . . . . 1.12 114.614 169.922 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.7 mt -74.03 117.61 62.76 Favored Pre-proline 0 N--CA 1.431 -1.409 0 C-N-CA 127.899 2.48 . . . . 1.55 105.039 -174.732 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -69.14 166.88 25.29 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 CA-C-O 111.815 -3.494 . . . . 1.02 117.074 178.03 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -66.19 -32.72 41.98 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 N-CA-C 120.133 3.09 . . . . 1.25 120.133 -174.64 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.379 38.0 m-20 -47.95 -36.63 12.83 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.974 2.109 . . . . 2.25 113.173 169.102 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -98.59 -4.74 33.35 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.964 -0.46 . . . . 2.02 111.802 -172.172 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -97.58 126.17 42.73 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.459 -2.025 . . . . 0.69 110.839 -179.685 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -106.83 116.82 32.59 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.08 2.152 . . . . 2.78 108.826 168.691 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.5 mt -104.84 115.73 30.79 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.8 -1.188 . . . . 1.17 112.037 -179.086 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.9 mm -110.65 126.17 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 127.129 2.172 . . . . 1.38 116.589 -179.779 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -127.92 104.0 7.56 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 104.792 -2.299 . . . . 1.5 104.792 174.97 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.284 . . 61.88 -117.03 0.62 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 110.641 -2.982 . . . . 1.21 110.976 -179.655 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.08 -27.12 29.28 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 119.876 -1.765 . . . . 1.3 110.634 -168.513 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -96.28 139.55 32.26 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 126.86 2.153 . . . . 2.55 115.36 -179.224 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -90.46 127.73 36.3 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 111.919 -2.4 . . . . 2.48 105.836 173.408 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.4 mt -83.85 117.17 23.13 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.363 -1.461 . . . . 0.9 112.445 -171.424 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -68.7 139.7 55.4 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 119.936 3.31 . . . . 1.94 119.936 172.381 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.52 -59.43 4.84 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 118.566 2.802 . . . . 1.56 118.566 -174.611 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.76 60.19 4.83 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-N 113.118 -1.855 . . . . 0.97 114.805 172.362 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -136.8 178.48 7.04 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.418 2.532 . . . . 2.49 106.038 164.521 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.6 p -110.38 176.6 4.98 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 116.604 -3.81 . . . . 0.76 106.961 170.241 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.6 mt -75.2 -33.92 61.46 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.32 -2.737 . . . . 1.05 109.024 177.302 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.6 t -56.01 -44.24 78.47 Favored 'General case' 0 N--CA 1.43 -1.436 1 C-N-CA 134.34 5.056 . . . . 1.19 109.685 176.84 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.251 33.6 m-20 -57.27 -39.79 76.36 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.542 -3.849 . . . . 1.9 118.25 175.653 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -96.67 -2.25 45.02 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 127.469 2.308 . . . . 0.89 112.76 179.476 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.9 m120 58.21 42.53 21.84 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.916 2.886 . . . . 1.84 118.713 -179.165 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.1 mt -94.36 114.38 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 119.439 -2.038 . . . . 0.82 108.596 -179.695 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -101.13 -172.77 2.23 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.742 2.417 . . . . 2.16 112.776 -179.85 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -45.56 151.55 0.39 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.492 -3.88 . . . . 2.12 120.577 174.056 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 50.96 34.93 11.45 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.694 1.368 . . . . 1.71 114.694 174.548 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.0 m -91.84 137.38 32.41 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.697 -1.592 . . . . 1.04 109.294 -176.257 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.2 m -86.7 111.45 20.69 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 124.981 1.425 . . . . 0.79 110.831 177.003 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -92.13 163.97 13.75 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 117.461 -3.274 . . . . 1.4 107.428 171.405 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -128.95 116.28 19.13 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 124.232 1.968 . . . . 1.51 110.031 179.93 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.7 tp -82.36 110.26 17.35 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.677 3.214 . . . . 1.14 119.677 174.548 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.6 t -113.19 142.8 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.686 -1.227 . . . . 1.23 107.686 -178.919 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.9 tp -91.31 128.07 37.0 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 122.919 2.6 . . . . 2.78 108.851 178.37 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -96.29 135.33 38.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.426 2.69 . . . . 3.75 108.242 -178.391 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.26 0.0 OUTLIER -115.44 164.01 14.9 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 108.996 -3.729 . . . . 3.14 113.779 173.272 . . . . . . . . 3 3 . 1 . 109 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -66.11 64.59 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.043 -1.661 . . . . 6.8 114.716 163.703 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.75 90.84 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 129.751 3.548 . . . . 3.57 115.582 -161.553 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.723 1 C-N-CA 132.544 4.878 . . . . 3.87 118.103 170.884 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 114.307 1.225 . . . . 1.1 114.307 . . . . . . . . . 0 0 . 1 . 110 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -93.31 130.16 39.16 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.646 -2.534 . . . . 1.87 112.898 -175.967 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.5 pt -129.85 149.64 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 128.561 3.663 . . . . 0.72 110.614 176.149 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -109.0 130.69 55.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 113.052 -1.886 . . . . 1.4 107.854 -176.106 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.48 130.58 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 103.076 -2.935 . . . . 0.58 103.076 173.589 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -110.24 146.13 36.14 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 116.21 -4.056 . . . . 2.09 115.691 174.137 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.482 HG22 HD23 ' A' ' 69' ' ' LEU 0.251 2.9 p -104.34 171.63 7.23 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 119.727 1.149 . . . . 0.99 108.4 173.704 . . . . . . . . 3 3 . 1 . 110 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.9 mt -73.41 -40.26 64.42 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 117.242 -3.411 . . . . 2.53 114.962 174.592 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.0 p -80.72 -37.29 30.86 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.62 2.452 . . . . 2.08 117.62 -175.549 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.57 -55.14 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 116.252 -2.88 . . . . 1.31 119.801 174.973 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -54.18 129.62 35.52 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 121.102 3.742 . . . . 1.4 121.102 -178.311 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.7 m -112.6 115.23 28.27 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 104.498 -2.408 . . . . 0.78 104.498 168.261 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mt -95.03 129.06 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 107.474 -1.306 . . . . 1.55 107.474 -173.005 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.9 m -89.23 111.09 21.8 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.879 2.276 . . . . 1.08 106.634 172.832 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.8 mt -111.44 141.48 44.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 117.408 2.373 . . . . 1.55 117.408 174.527 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -103.37 115.94 31.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 130.64 3.576 . . . . 1.95 109.283 168.251 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.0 m -131.45 155.89 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.223 1.809 . . . . 0.96 112.994 -176.938 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -97.02 142.58 24.75 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-O 112.675 -3.536 . . . . 2.35 117.07 164.356 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' A' ' 56' ' ' LEU 0.267 18.8 Cg_endo -70.7 -24.68 25.11 Favored 'Trans proline' 0 C--N 1.299 -2.055 2 C-N-CA 127.502 5.468 . . . . 0.95 111.705 -170.373 . . . . . . . . 4 3 . 1 . 110 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.329 25.5 m -84.56 8.13 17.73 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 114.216 1.191 . . . . 1.45 114.216 173.916 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -78.13 149.0 33.89 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.992 2.517 . . . . 1.69 104.859 174.637 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.2 p -74.36 163.83 27.33 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.516 2.413 . . . . 0.75 117.516 169.907 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.2 mm -66.26 -36.22 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 121.673 2.033 . . . . 0.73 110.264 171.027 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -52.27 -43.55 64.47 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.391 -2.693 . . . . 1.62 116.709 171.839 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -57.44 -46.49 83.54 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.323 -2.11 . . . . 2.13 113.006 171.765 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.63 -39.23 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 120.408 1.458 . . . . 0.62 113.18 177.106 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.03 -33.0 74.75 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.113 1.153 . . . . 1.22 114.113 173.295 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.25 -27.8 66.66 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.476 1.11 . . . . 0.51 112.548 175.001 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -81.61 -26.34 34.95 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.699 -2.5 . . . . 1.44 109.221 176.913 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.4 mt -75.02 -30.44 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 122.213 2.278 . . . . 1.32 109.485 174.918 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -57.13 -48.81 77.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 130.17 3.388 . . . . 1.7 108.74 169.44 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.29 4.4 t70 -52.29 -58.63 6.05 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.015 1.726 . . . . 1.55 111.478 171.227 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -75.93 -62.47 1.58 Allowed 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 116.02 -4.175 . . . . 2.62 113.296 -172.553 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -96.37 -20.27 18.59 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 116.513 2.042 . . . . 1.48 116.513 -170.221 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.68 20.73 21.07 Favored Glycine 0 N--CA 1.429 -1.803 0 CA-C-O 125.24 2.578 . . . . 1.12 114.736 169.91 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.95 127.46 36.96 Favored Pre-proline 0 N--CA 1.43 -1.445 1 O-C-N 115.801 -4.353 . . . . 1.55 107.707 -174.385 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 52.7 Cg_exo -64.61 147.76 90.21 Favored 'Trans proline' 0 C--N 1.3 -2.016 1 CA-C-N 129.276 4.349 . . . . 1.02 115.017 -178.966 . . . . . . . . 3 3 . 1 . 110 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.1 Cg_exo -62.07 -12.43 26.38 Favored 'Trans proline' 0 N--CA 1.433 -2.049 0 C-N-CA 124.386 3.391 . . . . 1.25 111.672 -178.778 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -73.68 -30.4 62.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 124.629 3.377 . . . . 2.25 115.253 172.382 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -78.66 -32.49 47.2 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 119.181 -2.2 . . . . 2.02 115.498 -176.47 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -71.2 124.52 24.68 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 124.499 1.124 . . . . 0.69 111.326 -172.129 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -120.93 109.78 15.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 114.785 -1.098 . . . . 2.78 109.82 167.537 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.8 mt -90.3 124.43 34.89 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 106.224 -1.769 . . . . 1.17 106.224 -175.997 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.0 mm -102.6 121.1 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 129.685 3.194 . . . . 1.38 113.582 172.107 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -136.49 136.13 39.16 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.902 -1.749 . . . . 1.5 108.773 171.756 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.12 27.01 7.12 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 120.101 3.371 . . . . 1.21 120.101 -178.963 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.73 5.53 84.0 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 119.025 -1.56 . . . . 1.3 116.713 -175.05 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -114.48 143.03 45.6 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.246 1.819 . . . . 2.55 113.818 -178.609 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -97.45 116.18 29.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.674 -1.232 . . . . 2.48 107.674 176.898 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.49 120.91 25.1 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.679 -2.513 . . . . 0.9 108.498 -164.491 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -66.69 157.61 32.2 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 113.849 1.055 . . . . 1.94 113.849 173.659 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -69.72 -55.53 9.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 114.398 1.258 . . . . 1.56 114.398 -176.305 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.27 46.8 2.81 Favored Glycine 0 N--CA 1.43 -1.766 0 CA-C-N 120.202 1.365 . . . . 0.97 115.075 173.538 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -112.88 156.39 23.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 119.913 -1.934 . . . . 2.49 108.212 162.778 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.2 p -99.13 168.78 9.85 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 115.428 -4.545 . . . . 0.76 113.185 169.32 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.403 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 6.6 mt -63.81 -37.58 87.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 125.273 1.608 . . . . 1.05 112.367 173.291 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.6 t -71.89 -36.43 70.04 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 122.229 1.014 . . . . 1.19 113.355 -179.943 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -54.6 -36.73 64.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.5 3.519 . . . . 1.9 120.5 168.284 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -92.02 9.52 32.91 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.087 -1.449 . . . . 0.89 107.087 -179.964 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 46.42 44.03 12.49 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 117.068 2.247 . . . . 1.84 117.068 -169.65 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.4 mt -86.4 121.04 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 106.5 -1.667 . . . . 0.82 106.5 175.988 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -104.71 179.31 4.31 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 123.296 1.522 . . . . 2.16 107.67 179.632 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -48.84 155.01 0.63 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 117.584 2.439 . . . . 2.12 117.584 173.064 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.305 20.0 mt-10 62.46 25.47 15.18 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 119.068 2.988 . . . . 1.71 119.068 172.075 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -93.25 145.64 24.29 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.721 1.608 . . . . 1.04 113.213 -173.178 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.253 3.2 m -94.02 104.29 16.34 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.3 -4.0 . . . . 0.79 113.666 176.229 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -89.25 142.69 27.43 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 124.394 1.059 . . . . 1.4 109.638 172.645 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -105.05 119.66 39.58 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 116.448 -3.908 . . . . 1.51 108.607 -178.89 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.482 HD23 HG22 ' A' ' 7' ' ' THR . 44.7 tp -91.54 129.86 37.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.951 -3.593 . . . . 1.14 106.374 177.359 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.14 148.45 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 128.125 2.57 . . . . 1.23 106.376 174.297 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 71.2 mt -119.72 170.35 9.29 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.913 -4.242 . . . . 2.78 110.442 175.651 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 ptt85 -90.83 111.64 23.12 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.943 -1.132 . . . . 3.75 107.943 169.57 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.5 tp -105.49 -81.08 0.54 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.913 -1.884 . . . . 3.14 105.913 166.184 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -77.21 168.58 19.81 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 127.171 2.188 . . . . 6.8 110.993 170.906 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.15 71.49 0.63 Allowed Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 107.584 -2.206 . . . . 3.57 107.584 -178.43 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.729 0 N-CA-C 107.802 -2.119 . . . . 3.87 107.802 -178.925 . . . . . . . . 0 0 . 1 . 111 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ptt? . . . . . 0 CA--C 1.49 -1.338 0 N-CA-C 109.758 -0.46 . . . . 1.1 109.758 . . . . . . . . . 0 0 . 1 . 111 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -99.43 126.55 45.36 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.49 2.716 . . . . 1.87 111.005 -177.007 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.4 pt -116.85 142.19 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 118.386 -2.696 . . . . 0.72 106.245 168.648 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -100.3 106.33 17.96 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.444 2.698 . . . . 1.4 109.205 -178.16 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.0 t -101.66 112.14 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 O-C-N 117.403 -3.311 . . . . 0.58 106.986 173.354 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.5 mttm -89.98 146.93 24.01 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.89 -3.006 . . . . 2.09 113.375 177.964 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.493 HG22 HD23 ' A' ' 69' ' ' LEU . 82.2 p -98.69 172.05 7.72 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.472 3.034 . . . . 0.99 108.097 172.651 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.6 mt -73.39 -26.47 61.0 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.666 -2.061 . . . . 2.53 113.67 166.181 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.9 p -71.94 -69.95 0.36 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.069 2.248 . . . . 2.08 117.069 -175.67 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.02 12.67 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.809 0 CA-C-O 115.619 -2.767 . . . . 1.31 111.859 176.738 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -108.09 126.91 53.3 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 120.461 2.131 . . . . 1.4 113.225 -177.423 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.2 m -103.78 103.44 13.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.927 -2.249 . . . . 0.78 104.927 173.219 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -82.85 113.93 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 O-C-N 117.129 -3.482 . . . . 1.55 110.912 177.446 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.5 m -79.76 116.25 19.82 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.902 -2.374 . . . . 1.08 105.545 172.647 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.5 mt -114.2 134.43 54.92 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.169 -1.419 . . . . 1.55 107.169 176.185 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -86.75 106.99 18.05 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.174 2.99 . . . . 1.95 114.07 167.719 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.74 165.42 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 112.981 -1.918 . . . . 0.96 109.571 -177.552 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -109.53 155.18 41.73 Favored Pre-proline 0 N--CA 1.429 -1.485 0 N-CA-C 109.38 -0.6 . . . . 2.35 109.38 162.421 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -73.56 -11.87 24.5 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 O-C-N 117.134 -2.087 . . . . 0.95 111.326 -173.01 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.6 p -89.13 0.21 56.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.943 2.897 . . . . 1.45 113.475 178.353 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -76.22 150.12 37.12 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 126.121 2.867 . . . . 1.69 114.456 170.361 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.3 p -85.11 153.12 22.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.232 -2.167 . . . . 0.75 112.567 176.081 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.2 mm -65.45 -36.15 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 120.512 1.506 . . . . 0.73 114.071 -178.954 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -58.28 -39.98 80.69 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.069 -2.269 . . . . 1.62 116.923 173.669 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.323 70.1 m-80 -66.03 -26.04 67.33 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 116.1 1.889 . . . . 2.13 116.1 170.524 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -72.04 -33.3 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-N 120.135 1.334 . . . . 0.62 111.854 170.838 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -83.14 -20.34 34.95 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.381 -2.699 . . . . 1.22 111.175 177.842 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.67 67.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 121.197 1.817 . . . . 0.51 114.012 171.476 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -72.32 -48.86 38.83 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 125.452 1.72 . . . . 1.44 111.261 175.277 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.5 mt -60.79 -33.25 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 125.695 1.598 . . . . 1.32 111.258 176.284 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -64.66 -60.04 3.58 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.644 1.212 . . . . 1.7 110.659 177.624 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -42.43 -56.67 2.93 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 115.368 1.618 . . . . 1.55 115.368 174.698 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -67.69 -59.91 2.95 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 113.977 1.103 . . . . 2.62 113.977 177.359 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -92.37 -58.52 2.35 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.354 -1.466 . . . . 1.48 111.66 -166.414 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.16 16.69 0.64 Allowed Glycine 0 N--CA 1.43 -1.746 0 O-C-N 119.814 -1.804 . . . . 1.12 115.579 175.049 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.415 HG21 HD22 ' A' ' 71' ' ' LEU . 2.4 mp -96.59 133.76 24.21 Favored Pre-proline 0 N--CA 1.43 -1.464 0 C-N-CA 119.291 -0.964 . . . . 1.55 110.903 -175.31 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.39 149.16 91.9 Favored 'Trans proline' 0 N--CA 1.435 -1.965 0 CA-C-N 125.036 2.834 . . . . 1.02 112.933 176.004 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -80.08 -11.25 13.62 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-O 115.702 -1.874 . . . . 1.25 108.9 -168.653 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -77.99 -24.49 48.0 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.871 2.123 . . . . 2.25 114.999 166.914 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -84.35 -34.28 23.68 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 124.244 1.973 . . . . 2.02 109.952 -177.773 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -72.38 100.06 2.58 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.437 -3.29 . . . . 0.69 112.069 179.797 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -86.65 135.37 33.43 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 121.558 1.981 . . . . 2.78 108.05 166.393 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 43' ' ' LEU 0.274 80.0 mt -104.17 125.82 50.78 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.631 3.586 . . . . 1.17 108.226 175.572 . . . . . . . . 3 3 . 1 . 111 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 29.8 mm -103.13 140.93 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 118.976 -2.327 . . . . 1.38 110.358 171.699 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -130.14 107.98 9.72 Favored 'General case' 0 N--CA 1.429 -1.479 1 N-CA-C 98.835 -4.505 . . . . 1.5 98.835 170.506 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.07 -84.89 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.246 1.818 . . . . 1.21 115.14 179.87 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.01 13.25 0.74 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 130.473 3.892 . . . . 1.3 111.338 -175.583 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -109.6 151.36 26.93 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 121.189 2.495 . . . . 2.55 104.439 168.268 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -94.42 132.81 38.67 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 130.031 3.332 . . . . 2.48 102.726 171.071 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.9 mt -91.38 133.2 35.65 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.481 -2.012 . . . . 0.9 107.011 -170.387 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -71.88 151.73 43.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.19 -3.443 . . . . 1.94 108.605 171.572 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.25 -40.81 36.06 Favored 'General case' 0 N--CA 1.429 -1.523 0 O-C-N 116.865 -3.647 . . . . 1.56 110.137 -168.81 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.04 45.45 3.42 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 118.193 -2.817 . . . . 0.97 117.149 172.265 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -116.25 167.5 10.96 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 118.417 -0.802 . . . . 2.49 109.778 163.007 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.6 p -96.9 175.84 6.19 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 127.398 3.475 . . . . 0.76 108.286 167.941 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.8 mt -72.45 -43.75 63.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.742 -3.099 . . . . 1.05 108.607 176.514 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.2 p -72.9 1.41 8.77 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 119.969 3.322 . . . . 1.19 119.969 179.301 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -82.45 -40.59 20.95 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.47 -2.644 . . . . 1.9 112.27 169.593 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -77.87 -7.3 56.51 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.072 2.549 . . . . 0.89 110.621 172.161 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.312 42.8 m-80 68.46 33.32 4.11 Favored 'General case' 0 N--CA 1.428 -1.539 0 O-C-N 116.669 -3.769 . . . . 1.84 115.829 -177.273 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.6 mt -81.31 125.29 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 CA-C-N 114.011 -1.45 . . . . 0.82 111.657 -179.573 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -108.1 -164.11 0.94 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 121.28 3.808 . . . . 2.16 121.28 -176.535 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -74.4 146.63 42.78 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 120.438 -1.414 . . . . 2.12 112.853 171.946 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.261 43.4 mt-10 68.59 18.17 8.89 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 126.901 2.08 . . . . 1.71 115.436 178.182 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -77.04 124.66 28.12 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.413 2.685 . . . . 1.04 113.482 -174.749 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.29 3.8 m -80.97 105.16 11.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 127.418 2.287 . . . . 0.79 115.143 175.845 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -103.52 166.76 10.23 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 125.58 2.61 . . . . 1.4 106.044 175.249 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.42 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 73.6 m80 -128.72 133.1 48.05 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.829 -4.295 . . . . 1.51 110.108 -172.12 . . . . . . . . 3 3 . 1 . 111 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.493 HD23 HG22 ' A' ' 7' ' ' THR . 36.6 tp -99.29 129.72 45.53 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.217 -0.927 . . . . 1.14 112.551 -176.368 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -131.05 123.4 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 122.074 2.216 . . . . 1.23 112.26 175.743 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.415 HD22 HG21 ' A' ' 36' ' ' ILE . 18.7 mt -90.42 110.47 21.57 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.65 2.463 . . . . 2.78 117.65 -178.397 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -123.52 -152.74 0.52 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.667 1.987 . . . . 3.75 106.778 -179.325 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.9 mt -122.78 165.7 16.17 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.238 2.215 . . . . 3.14 109.884 170.237 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -57.21 155.42 8.74 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.29 2.329 . . . . 6.8 117.29 -178.661 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.65 -20.25 0.6 Allowed Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 116.583 -2.722 . . . . 3.57 119.307 -160.732 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.76 1 N-CA-C 101.977 -4.449 . . . . 3.87 101.977 -176.736 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 113.311 0.856 . . . . 1.1 113.311 . . . . . . . . . 0 0 . 1 . 112 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -91.7 142.7 27.33 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.826 -1.916 . . . . 1.87 105.826 -178.046 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.0 pt -132.01 176.69 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 105.166 -2.161 . . . . 0.72 105.166 167.701 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -127.13 130.14 49.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.402 1.573 . . . . 1.4 109.079 176.299 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -109.49 110.09 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 126.231 2.919 . . . . 0.58 104.481 175.158 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 12' ' ' THR 0.27 23.7 ttmm -103.98 142.55 34.24 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 114.843 -4.911 . . . . 2.09 109.656 -178.422 . . . . . . . . 4 3 . 1 . 112 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.7 p -91.76 142.52 27.5 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 114.284 -2.77 . . . . 0.99 111.885 179.668 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.3 tp -59.97 -37.78 80.61 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.605 2.362 . . . . 2.53 109.532 165.711 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.9 -27.01 57.51 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 122.754 2.525 . . . . 2.08 110.192 -178.357 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.07 -77.38 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.739 1 N-CA-C 123.187 4.035 . . . . 1.31 123.187 176.297 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -72.59 157.51 37.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 129.266 3.568 . . . . 1.4 117.881 -174.694 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 3.3 m -105.11 133.88 49.15 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.944 2.497 . . . . 0.78 107.713 162.499 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 pt -113.18 143.88 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 101.584 -3.487 . . . . 1.55 101.584 176.319 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.3 m -99.85 128.65 45.93 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 114.753 -4.967 . . . . 1.08 104.159 174.397 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.7 mt -114.87 148.86 38.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.145 -3.472 . . . . 1.55 102.892 178.542 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -109.44 122.07 46.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.635 -1.987 . . . . 1.95 105.635 171.164 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.79 175.16 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-O 121.862 0.839 . . . . 0.96 111.136 -176.984 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.268 81.3 mt-10 -112.77 167.04 9.8 Favored Pre-proline 0 N--CA 1.431 -1.403 0 O-C-N 117.614 -3.178 . . . . 2.35 110.268 168.222 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -88.43 -8.75 5.27 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 CA-C-N 124.692 2.711 . . . . 0.95 110.513 -169.739 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 p -81.63 1.16 35.26 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 128.146 2.578 . . . . 1.45 115.897 172.958 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -77.52 137.74 38.79 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.058 -0.974 . . . . 1.69 108.507 175.25 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.3 p -79.29 156.36 28.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 128.198 2.599 . . . . 0.75 108.873 172.69 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.352 8.0 mm -61.64 -45.44 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 128.062 2.545 . . . . 0.73 114.764 -177.856 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.299 31.8 tt0 -48.83 -39.55 25.99 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 116.313 1.968 . . . . 1.62 116.313 167.292 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -73.55 -28.26 61.77 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 124.326 1.05 . . . . 2.13 111.575 179.793 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.2 t -69.06 -46.42 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 125.502 1.521 . . . . 0.62 109.262 171.297 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -62.21 -16.07 50.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 117.984 2.587 . . . . 1.22 117.984 176.878 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.82 -35.63 38.06 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 127.582 2.353 . . . . 0.51 109.574 171.465 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -70.02 -33.4 71.95 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.413 -1.429 . . . . 1.44 110.28 172.653 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.25 42.4 mt -63.63 -37.3 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 116.465 -3.897 . . . . 1.32 115.541 168.903 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.447 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 50.2 tt0 -69.62 -31.59 69.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 117.315 -1.326 . . . . 1.7 114.444 170.806 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.52 -45.48 65.47 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.393 1.451 . . . . 1.55 109.551 172.241 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -78.02 -64.78 1.08 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.049 -2.282 . . . . 2.62 114.41 -171.007 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.287 21.7 mm-40 -93.54 -45.78 7.59 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.716 1.246 . . . . 1.48 109.851 -172.745 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.88 64.15 0.34 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 106.067 -2.813 . . . . 1.12 106.067 167.069 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.447 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 8.8 mt -120.37 127.9 26.08 Favored Pre-proline 0 N--CA 1.43 -1.433 0 O-C-N 126.837 2.14 . . . . 1.55 111.448 -177.977 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -63.0 129.64 26.53 Favored 'Trans proline' 0 C--N 1.3 -2.023 1 CA-C-O 110.002 -4.249 . . . . 1.02 121.654 179.797 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -33.16 87.19 Favored 'Trans proline' 0 N--CA 1.434 -2.006 1 CA-C-N 129.243 4.337 . . . . 1.25 121.947 -175.142 . . . . . . . . 3 3 . 1 . 112 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -60.77 -37.81 83.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 125.243 3.656 . . . . 2.25 114.21 174.099 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -71.62 -28.05 63.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.107 -1.442 . . . . 2.02 107.107 -172.862 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -79.96 119.48 22.86 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.401 1.91 . . . . 0.69 115.382 -170.092 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.483 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 92.6 mtt180 -103.81 112.14 24.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 114.171 1.174 . . . . 2.78 114.171 166.821 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.6 mt -94.5 119.14 32.74 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.635 -3.166 . . . . 1.17 110.863 177.165 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.21 130.91 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 122.074 2.216 . . . . 1.38 108.152 174.484 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -118.3 114.94 23.72 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 102.953 -2.98 . . . . 1.5 102.953 171.445 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.383 . . 77.62 -63.9 0.32 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 125.961 2.791 . . . . 1.21 116.296 179.409 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.3 -60.66 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 127.213 2.339 . . . . 1.3 117.263 -172.55 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -68.26 125.41 26.31 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.971 2.908 . . . . 2.55 111.687 172.964 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -71.88 143.17 49.47 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 112.82 -1.991 . . . . 2.48 109.728 173.882 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.2 mt -80.05 128.57 33.65 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.875 1.67 . . . . 0.9 110.79 -178.04 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -86.07 148.31 25.77 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.445 -0.785 . . . . 1.94 109.107 176.002 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -59.41 -47.68 84.54 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 127.481 3.515 . . . . 1.56 117.16 -171.431 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.18 39.47 2.88 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 117.717 -3.114 . . . . 0.97 120.34 170.39 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.353 14.5 mmt180 -116.47 173.39 6.64 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 119.395 -0.922 . . . . 2.49 109.86 163.541 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.5 p -96.84 165.96 11.86 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 115.587 1.699 . . . . 0.76 115.587 168.754 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.0 mt -67.78 -32.55 73.2 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 123.04 1.4 . . . . 1.05 111.901 171.2 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.3 p -67.21 -16.19 64.15 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.256 -2.777 . . . . 1.19 112.895 174.909 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -69.81 -41.25 75.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 122.014 2.188 . . . . 1.9 115.236 177.467 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -90.35 -9.62 47.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.762 2.425 . . . . 0.89 109.724 -179.497 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.287 41.8 m-80 58.76 50.47 8.7 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 117.441 2.386 . . . . 1.84 117.441 -176.461 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.43 HG21 HD11 ' A' ' 67' ' ' LEU . 71.9 mt -86.42 118.2 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 126.409 3.004 . . . . 0.82 113.145 170.085 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -98.92 -178.16 3.86 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.638 -2.539 . . . . 2.16 111.277 -179.011 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -54.32 144.4 20.6 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.584 -2.573 . . . . 2.12 117.385 173.596 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.314 22.5 mt-10 66.66 27.39 9.44 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.737 -2.477 . . . . 1.71 117.068 174.825 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -101.09 153.46 19.55 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.232 -1.349 . . . . 1.04 108.877 -174.52 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.6 m -111.17 117.17 32.5 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.681 -3.137 . . . . 0.79 106.605 -175.125 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.43 HD11 HG21 ' A' ' 61' ' ' ILE . 7.7 mp -100.73 135.6 41.91 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.225 2.21 . . . . 1.4 106.047 176.798 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -99.57 117.44 33.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.403 -2.061 . . . . 1.51 110.178 -176.707 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.8 tp -86.96 119.44 27.17 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.465 3.506 . . . . 1.14 111.4 176.952 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 44.7 t -107.63 151.33 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 115.208 -2.33 . . . . 1.23 106.623 174.718 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.0 tp -123.75 131.66 53.64 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 115.26 -2.576 . . . . 2.78 107.465 179.667 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -93.33 136.69 33.36 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 114.965 -4.835 . . . . 3.75 103.855 178.753 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.3 mt -70.24 143.19 52.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.022 2.82 . . . . 3.14 110.69 173.7 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -101.08 -44.68 5.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 112.187 -2.279 . . . . 6.8 109.84 167.884 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.69 64.8 0.7 Allowed Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 115.945 1.138 . . . . 3.57 115.945 -170.97 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.763 1 C-N-CA 132.228 4.728 . . . . 3.87 113.337 174.164 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 ttp . . . . . 0 CA--C 1.491 -1.318 0 CA-C-O 115.598 -2.144 . . . . 1.1 110.758 . . . . . . . . . 0 0 . 1 . 113 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -90.9 132.36 35.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.766 2.53 . . . . 1.87 112.547 -178.36 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.1 pt -111.68 149.18 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 122.077 2.217 . . . . 0.72 110.543 172.282 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -108.95 115.52 30.24 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.919 -1.882 . . . . 1.4 105.919 178.694 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.427 HG21 HD11 ' A' ' 30' ' ' ILE . 77.5 t -100.34 120.0 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 115.179 -2.343 . . . . 0.58 105.017 175.885 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.251 89.1 mttt -101.79 130.59 48.26 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 116.893 -1.527 . . . . 2.09 106.892 176.489 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.2 p -82.57 170.62 14.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 120.418 1.463 . . . . 0.99 111.621 176.039 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.2 tp -79.62 -28.02 40.97 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 125.712 2.673 . . . . 2.53 111.535 170.277 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.296 38.9 p -75.5 -50.1 16.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.339 -3.35 . . . . 2.08 113.38 -177.195 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.15 32.2 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 122.75 3.86 . . . . 1.31 122.75 167.182 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -135.71 147.45 48.49 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 121.405 2.603 . . . . 1.4 112.043 -175.059 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.8 m -97.09 122.8 40.5 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.882 -1.508 . . . . 0.78 107.956 173.265 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.9 mt -117.28 115.93 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 103.939 -2.615 . . . . 1.55 103.939 -175.155 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.4 m -94.72 104.6 16.52 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.961 1.362 . . . . 1.08 114.226 179.52 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.6 mt -97.27 140.43 31.75 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 119.113 -2.242 . . . . 1.55 111.116 -176.425 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -91.3 115.43 28.02 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 115.538 -4.476 . . . . 1.95 113.236 165.118 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -133.3 152.61 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 126.773 2.546 . . . . 0.96 107.762 -179.189 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -90.71 153.67 45.62 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 115.859 -2.02 . . . . 2.35 110.843 163.452 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -84.07 0.91 9.07 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 CA-C-N 126.07 3.204 . . . . 0.95 116.473 -171.749 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.8 p -85.94 -14.79 43.66 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.614 3.166 . . . . 1.45 111.051 174.612 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.284 18.7 m-20 -82.34 156.02 24.46 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.102 2.161 . . . . 1.69 112.359 177.823 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 60.0 p -78.07 171.15 15.45 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 127.284 3.421 . . . . 0.75 116.759 175.35 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.443 HD13 ' HG ' ' A' ' 56' ' ' LEU . 14.4 mm -74.76 -27.75 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 1 O-C-N 114.968 -4.833 . . . . 0.73 111.524 174.415 . . . . . . . . 3 3 . 1 . 113 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -54.43 -41.34 69.25 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 125.652 1.581 . . . . 1.62 108.964 165.536 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.263 18.1 t-20 -60.71 -44.3 96.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 124.483 2.087 . . . . 2.13 113.423 175.539 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.08 -50.13 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 113.143 -1.844 . . . . 0.62 111.53 174.194 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.404 ' HD2' ' OD2' ' A' ' 52' ' ' ASP . 94.0 mttt -64.64 -41.57 96.05 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.332 2.345 . . . . 1.22 117.332 174.588 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.99 -45.15 41.84 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.158 2.183 . . . . 0.51 115.431 168.375 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -62.72 -39.61 94.61 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 116.182 1.919 . . . . 1.44 116.182 170.652 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.427 HD11 HG21 ' A' ' 5' ' ' VAL 0.257 21.2 mt -63.51 -25.82 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 C-N-CA 125.296 1.438 . . . . 1.32 112.57 173.155 . . . . . . . . 3 3 . 1 . 113 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -77.61 -35.55 52.64 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.561 -0.745 . . . . 1.7 112.58 174.307 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.36 -44.14 95.85 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.139 1.447 . . . . 1.55 113.378 167.975 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -73.29 -66.65 0.66 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 119.783 3.253 . . . . 2.62 119.783 -176.821 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -95.14 -48.6 5.87 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 128.377 2.671 . . . . 1.48 110.348 -174.725 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.91 -10.82 6.64 Favored Glycine 0 N--CA 1.43 -1.757 0 O-C-N 127.049 2.718 . . . . 1.12 117.104 173.362 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mm -71.68 132.19 85.48 Favored Pre-proline 0 N--CA 1.43 -1.428 0 O-C-N 119.367 -2.255 . . . . 1.55 109.178 -173.271 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 43.2 Cg_endo -68.36 151.61 76.04 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 O-C-N 117.343 -1.978 . . . . 1.02 115.117 178.802 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -62.79 -25.49 74.74 Favored 'Trans proline' 0 N--CA 1.433 -2.035 1 C-N-CA 126.68 4.92 . . . . 1.25 112.703 -173.525 . . . . . . . . 4 4 . 1 . 113 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.85 -42.54 98.01 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 129.446 3.098 . . . . 2.25 108.38 -179.296 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -78.97 -22.72 45.21 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 117.469 2.396 . . . . 2.02 117.469 -177.998 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -85.89 129.0 34.96 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.205 1.479 . . . . 0.69 110.221 -169.567 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.43 ' HB2' HG23 ' A' ' 70' ' ' VAL . 92.2 mtt180 -116.29 117.33 29.71 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 125.156 2.407 . . . . 2.78 110.103 173.289 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.6 mt -96.27 128.16 42.93 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 114.336 -5.227 . . . . 1.17 105.936 179.098 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.447 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 15.3 mm -107.26 141.36 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 103.095 -2.928 . . . . 1.38 103.095 178.649 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.452 ' HB3' HD21 ' A' ' 50' ' ' LEU 0.296 26.1 t80 -140.58 109.46 6.04 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.53 1.932 . . . . 1.5 108.137 176.894 . . . . . . . . 3 3 . 1 . 113 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.371 . . 64.8 -75.46 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.51 2.324 . . . . 1.21 112.079 -172.101 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -137.44 -34.97 0.19 Allowed Glycine 0 N--CA 1.429 -1.824 0 O-C-N 123.999 0.812 . . . . 1.3 114.686 178.847 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -89.44 150.78 22.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.221 1.934 . . . . 2.55 116.221 -176.077 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -84.71 127.34 34.05 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 111.903 -2.408 . . . . 2.48 112.183 174.552 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 45' ' ' PHE . 39.1 mt -81.91 148.44 28.75 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 121.057 1.753 . . . . 0.9 112.492 -168.548 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -98.27 148.67 23.39 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 118.605 -1.238 . . . . 1.94 113.697 179.765 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' OD2' ' HD2' ' A' ' 27' ' ' LYS . 4.6 m-20 -60.69 -66.62 0.5 Allowed 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 116.197 -4.064 . . . . 1.56 117.288 -170.962 . . . . . . . . 3 3 . 1 . 113 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.27 32.25 0.32 Allowed Glycine 0 N--CA 1.432 -1.632 0 N-CA-C 122.607 3.803 . . . . 0.97 122.607 172.977 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -115.24 161.97 17.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.469 -2.049 . . . . 2.49 105.469 166.026 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 26.7 p -81.23 158.65 24.77 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.707 -1.871 . . . . 0.76 113.767 175.279 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.443 ' HG ' HD13 ' A' ' 23' ' ' ILE . 5.1 mt -65.78 -24.8 67.01 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.277 2.231 . . . . 1.05 114.591 175.757 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.4 p -83.46 -11.28 57.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.9 2.48 . . . . 1.19 111.467 178.667 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -61.85 -55.83 25.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.483 3.113 . . . . 1.9 108.089 167.26 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -76.81 -13.59 60.0 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 130.13 4.643 . . . . 0.89 113.713 -176.236 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 57.23 64.67 1.55 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 116.678 2.103 . . . . 1.84 116.678 -176.059 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.8 mm -78.54 104.53 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 105.549 -2.019 . . . . 0.82 105.549 174.892 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -73.32 169.94 16.07 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.056 1.342 . . . . 2.16 112.64 175.418 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -55.66 136.3 50.68 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.188 -3.445 . . . . 2.12 112.822 163.115 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 70.3 38.83 1.35 Allowed 'General case' 0 N--CA 1.429 -1.49 1 C-N-CA 135.946 5.698 . . . . 1.71 112.686 175.65 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.6 m -90.73 142.26 27.94 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 116.657 2.095 . . . . 1.04 116.657 -172.595 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.7 m -100.25 116.61 32.65 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 126.169 2.168 . . . . 0.79 107.224 -178.399 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -100.62 152.67 20.16 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.352 1.549 . . . . 1.4 111.362 168.875 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.447 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 33.8 m80 -120.93 130.53 53.9 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.086 -2.259 . . . . 1.51 107.511 -174.218 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 tp -112.14 118.2 34.7 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 116.574 2.064 . . . . 1.14 116.574 177.924 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.43 HG23 ' HB2' ' A' ' 42' ' ' ARG . 6.6 m -112.77 172.08 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 103.325 -2.843 . . . . 1.23 103.325 173.1 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.255 10.8 mt -127.83 150.21 49.94 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 113.857 -1.52 . . . . 2.78 112.428 178.111 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -98.39 111.23 23.64 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 125.185 1.394 . . . . 3.75 107.408 178.842 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.5 mp -79.03 159.41 27.61 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 104.622 -2.362 . . . . 3.14 104.622 176.812 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.0 mtm-85 -71.59 -50.76 27.91 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.762 -1.108 . . . . 6.8 111.855 178.412 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.41 70.28 1.7 Allowed Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 108.743 -1.743 . . . . 3.57 108.743 -173.062 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.775 0 C-N-CA 116.994 -2.527 . . . . 3.87 113.759 -175.764 . . . . . . . . 0 0 . 1 . 114 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 ptt? . . . . . 0 CA--C 1.489 -1.372 0 CA-C-O 116.273 -1.822 . . . . 1.1 111.64 . . . . . . . . . 0 0 . 1 . 114 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -99.6 138.85 36.11 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 125.214 1.571 . . . . 1.87 109.824 -173.49 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.5 pt -123.28 160.81 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 128.37 3.938 . . . . 0.72 108.281 173.641 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -119.07 133.22 55.93 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 115.195 -4.69 . . . . 1.4 106.61 -176.556 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.97 119.48 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 106.204 -1.776 . . . . 0.58 106.204 175.973 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -106.34 133.94 50.25 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 115.79 -4.318 . . . . 2.09 111.354 178.568 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.1 p -89.19 178.99 6.22 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.452 -2.03 . . . . 0.99 115.599 -174.144 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.404 HD11 ' H ' ' A' ' 71' ' ' LEU . 5.8 mt -78.11 -22.42 48.94 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 121.727 2.058 . . . . 2.53 109.985 173.379 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.3 p -80.54 -36.27 33.3 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.357 -2.714 . . . . 2.08 109.666 -178.921 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.67 53.82 0.66 Allowed Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 130.088 3.709 . . . . 1.31 119.824 175.957 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -122.74 137.24 54.98 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.102 3.361 . . . . 1.4 105.005 -176.696 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.8 m -105.68 121.54 44.21 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-O 124.42 2.057 . . . . 0.78 108.46 179.823 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.5 mt -99.32 140.5 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.357 -2.714 . . . . 1.55 107.882 174.852 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.8 m -106.75 98.61 8.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.096 -2.252 . . . . 1.08 110.835 -178.606 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.7 mt -95.18 140.84 29.53 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 121.521 1.964 . . . . 1.55 112.933 179.942 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -97.29 134.41 40.62 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.989 -2.319 . . . . 1.95 109.16 169.772 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 m -138.87 156.66 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 127.042 2.137 . . . . 0.96 107.063 -174.141 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -106.37 160.75 25.11 Favored Pre-proline 0 N--CA 1.43 -1.446 0 O-C-N 118.197 -2.815 . . . . 2.35 107.317 162.671 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -71.25 -7.85 22.19 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 CA-C-N 124.394 2.605 . . . . 0.95 112.235 -172.136 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.3 p -93.89 -14.37 26.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.037 2.135 . . . . 1.45 111.894 -174.141 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -65.39 149.29 50.26 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 130.16 3.384 . . . . 1.69 105.635 174.246 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.509 HG22 HG22 ' A' ' 55' ' ' THR . 68.6 p -96.44 170.93 8.89 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 117.235 -1.364 . . . . 0.75 111.097 178.568 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.404 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 32.7 mm -62.16 -32.6 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.413 0 C-N-CA 126.658 1.983 . . . . 0.73 111.366 170.508 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.295 35.5 tt0 -54.15 -51.35 64.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.581 3.552 . . . . 1.62 108.86 169.453 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -57.22 -37.69 72.63 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.557 -2.59 . . . . 2.13 114.918 174.354 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 88.3 t -62.79 -44.82 99.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 114.803 1.408 . . . . 0.62 114.803 175.091 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -65.86 -30.2 70.78 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 129.539 3.136 . . . . 1.22 113.465 173.451 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.19 83.18 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.864 -3.648 . . . . 0.51 111.101 179.738 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -61.96 -42.37 99.04 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.529 -3.232 . . . . 1.44 115.203 174.0 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.1 mt -72.95 -23.75 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 123.439 1.59 . . . . 1.32 110.513 175.995 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -70.12 -35.01 73.8 Favored 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 114.517 -5.114 . . . . 1.7 112.623 169.559 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.69 -48.7 78.16 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.783 2.706 . . . . 1.55 112.558 175.412 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -82.55 -63.04 1.45 Allowed 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 114.406 -5.184 . . . . 2.62 114.88 -178.975 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -85.49 -15.4 42.95 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.948 -3.595 . . . . 1.48 116.918 -168.658 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.37 31.45 54.61 Favored Glycine 0 N--CA 1.429 -1.776 0 O-C-N 119.725 -1.859 . . . . 1.12 114.617 176.543 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mt -101.25 135.43 19.89 Favored Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 108.452 -0.944 . . . . 1.55 108.452 -173.702 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -68.1 151.26 77.44 Favored 'Trans proline' 0 N--CA 1.433 -2.03 0 CA-C-N 123.884 2.423 . . . . 1.02 111.608 179.901 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -73.17 -20.63 21.27 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-N 126.515 3.362 . . . . 1.25 111.242 -173.478 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -65.7 -29.99 70.61 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 126.191 2.9 . . . . 2.25 112.805 174.463 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -81.74 -25.7 35.15 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 114.667 -5.021 . . . . 2.02 107.944 -177.566 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -82.92 119.3 24.24 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.839 -2.413 . . . . 0.69 110.991 -169.775 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.358 80.2 mtp180 -108.18 124.98 51.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.519 -1.219 . . . . 2.78 110.229 163.942 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -107.2 116.73 32.44 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.431 2.539 . . . . 1.17 104.554 -177.771 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.3 mt -111.44 137.28 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 O-C-N 119.939 -1.726 . . . . 1.38 112.982 176.552 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -148.98 132.67 16.87 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 124.15 0.98 . . . . 1.5 111.089 174.249 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.354 . . 49.38 25.03 1.18 Allowed 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 120.256 3.428 . . . . 1.21 120.256 171.199 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.11 7.55 26.73 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 121.477 -0.765 . . . . 1.3 114.591 -177.881 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -149.0 153.53 38.06 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.442 -2.799 . . . . 2.55 110.632 -176.813 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -96.64 128.34 43.48 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 113.912 -1.495 . . . . 2.48 111.662 171.224 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.2 mt -81.49 121.21 25.99 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.648 2.468 . . . . 0.9 115.691 -174.593 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -73.72 137.32 43.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.094 2.627 . . . . 1.94 118.094 177.098 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -40.27 -64.49 0.5 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 131.431 3.892 . . . . 1.56 117.397 -171.319 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.31 16.64 12.5 Favored Glycine 0 N--CA 1.429 -1.798 1 CA-C-O 112.011 -4.772 . . . . 0.97 118.745 175.275 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.0 mtt180 -95.46 161.56 14.02 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 121.155 2.478 . . . . 2.49 110.163 171.632 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.509 HG22 HG22 ' A' ' 22' ' ' THR . 19.3 p -97.56 170.63 8.9 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 117.179 -1.809 . . . . 0.76 114.596 172.94 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.85 -39.79 82.36 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.274 -2.239 . . . . 1.05 111.828 176.506 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.3 t -61.75 -44.24 97.29 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 130.118 3.367 . . . . 1.19 113.56 175.067 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -59.57 -24.83 64.08 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 115.224 1.565 . . . . 1.9 115.224 174.201 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -106.36 9.45 31.85 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.069 -2.895 . . . . 0.89 112.601 175.08 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.6 m120 44.68 62.77 1.93 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 128.163 2.585 . . . . 1.84 114.155 -177.579 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.7 mt -108.35 127.55 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 129.398 3.079 . . . . 0.82 107.183 176.511 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -106.71 -174.11 2.46 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.541 2.336 . . . . 2.16 110.979 -172.978 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.2 ptmm? -61.2 148.16 41.81 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 114.73 1.382 . . . . 2.12 114.73 174.811 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 62.75 37.89 12.21 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 126.51 3.053 . . . . 1.71 112.921 169.957 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.7 m -84.03 133.06 34.68 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.924 2.297 . . . . 1.04 110.665 178.079 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.7 m -93.39 104.82 16.95 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.202 -2.186 . . . . 0.79 109.3 176.344 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.6 mt -88.1 147.38 24.97 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 123.184 0.593 . . . . 1.4 110.066 174.296 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -97.68 121.52 39.69 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 116.917 -1.516 . . . . 1.51 113.815 173.622 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.9 tp -91.01 111.97 23.66 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.591 2.756 . . . . 1.14 108.491 175.942 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.7 t -112.11 141.83 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 114.579 -1.192 . . . . 1.23 109.151 172.156 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.404 ' H ' HD11 ' A' ' 8' ' ' LEU . 64.4 mt -110.89 132.99 53.74 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 119.61 3.189 . . . . 2.78 119.61 179.639 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -85.39 153.65 22.38 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.391 1.476 . . . . 3.75 109.185 -178.29 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.1 tp -116.7 109.58 17.34 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.512 -1.676 . . . . 3.14 115.436 179.529 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -82.14 -53.99 5.64 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 124.873 1.269 . . . . 6.8 108.03 173.785 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 131.2 -65.82 0.59 Allowed Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 105.62 -2.992 . . . . 3.57 105.62 -166.448 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.704 0 CA-C-O 115.875 -2.625 . . . . 3.87 114.065 -179.362 . . . . . . . . 0 0 . 1 . 115 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ptt? . . . . . 0 CA--C 1.489 -1.371 0 N-CA-C 112.624 0.601 . . . . 1.1 112.624 . . . . . . . . . 0 0 . 1 . 115 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.338 0.0 OUTLIER -97.83 133.72 41.95 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.129 -1.607 . . . . 1.87 111.446 179.286 . . . . . . . . 3 3 . 1 . 115 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.3 pt -115.74 158.88 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 103.637 -2.727 . . . . 0.72 103.637 169.74 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -112.34 137.89 49.85 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.452 2.701 . . . . 1.4 107.302 178.92 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.9 t -118.15 123.15 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 102.226 -3.25 . . . . 0.58 102.226 174.291 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.7 tppt? -100.36 126.96 46.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 126.144 2.878 . . . . 2.09 105.33 175.687 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 p -78.3 -162.91 0.39 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 120.253 3.427 . . . . 0.99 120.253 173.463 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 mt -88.31 -34.73 17.56 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 117.294 -1.336 . . . . 2.53 112.831 173.66 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 p -68.38 -32.74 73.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 127.536 2.334 . . . . 2.08 106.999 173.266 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.67 35.29 2.26 Favored Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 127.592 2.52 . . . . 1.31 107.744 168.367 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -80.57 134.36 35.91 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.258 -2.867 . . . . 1.4 103.258 178.876 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.9 m -95.02 91.49 6.39 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.855 -1.521 . . . . 0.78 114.341 175.042 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.4 mt -88.38 119.13 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 123.848 1.785 . . . . 1.55 106.714 -175.449 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.1 m -90.44 126.88 36.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.062 -2.273 . . . . 1.08 110.37 -177.268 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.5 mt -128.18 134.12 49.0 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.221 -3.424 . . . . 1.55 106.246 -175.238 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -98.15 132.24 43.84 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.615 -1.624 . . . . 1.95 106.615 171.87 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 m -140.61 164.79 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 126.962 2.105 . . . . 0.96 109.621 -173.938 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -109.58 151.92 42.5 Favored Pre-proline 0 N--CA 1.43 -1.454 0 CA-C-O 114.486 -2.673 . . . . 2.35 112.651 160.373 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 96.4 Cg_endo -70.52 -14.93 34.14 Favored 'Trans proline' 0 N--CA 1.433 -2.058 0 C-N-CA 125.09 3.86 . . . . 0.95 109.715 -165.29 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.1 m -82.93 -9.95 59.05 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 122.346 2.339 . . . . 1.45 108.974 176.919 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -66.74 142.5 57.37 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.443 3.497 . . . . 1.69 112.43 172.732 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 p -83.19 171.58 13.51 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 113.121 -5.987 . . . . 0.75 110.142 -174.632 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.1 mm -75.57 -30.55 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 122.949 1.357 . . . . 0.73 109.783 179.098 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.253 38.2 tt0 -45.34 -42.85 10.38 Favored 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 117.977 -2.952 . . . . 1.62 117.49 157.925 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -68.35 -38.52 81.55 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 125.336 1.648 . . . . 2.13 110.968 176.49 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.1 t -62.67 -35.28 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 125.156 2.408 . . . . 0.62 115.094 177.844 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HD3' ' HB2' ' A' ' 41' ' ' GLN . 90.1 mttt -68.31 -38.42 81.58 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.163 -1.586 . . . . 1.22 115.093 166.269 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.68 -22.42 66.63 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 118.465 2.765 . . . . 0.51 118.465 169.796 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -84.45 -29.48 26.06 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.675 -1.891 . . . . 1.44 111.901 173.947 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.8 mt -70.49 -38.06 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 124.164 1.935 . . . . 1.32 114.752 170.662 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.45 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 10.8 tt0 -65.51 -42.53 91.96 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 128.208 2.603 . . . . 1.7 109.66 171.926 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -58.09 -52.48 65.35 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.348 -3.345 . . . . 1.55 113.116 172.469 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -64.09 -66.32 0.56 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.618 3.58 . . . . 2.62 111.818 -176.179 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -89.84 -44.59 9.84 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 110.654 -2.976 . . . . 1.48 112.956 -172.119 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 113.42 0.69 24.89 Favored Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 117.649 1.82 . . . . 1.12 117.649 -177.899 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 mt -68.49 121.26 80.08 Favored Pre-proline 0 N--CA 1.429 -1.488 0 O-C-N 118.77 -2.606 . . . . 1.55 107.003 -176.549 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -67.88 164.68 30.7 Favored 'Trans proline' 0 N--CA 1.434 -1.989 1 C-N-CA 125.739 4.293 . . . . 1.02 112.126 -176.459 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -67.45 -34.16 27.2 Favored 'Trans proline' 0 N--CA 1.433 -2.05 1 C-N-CA 125.758 4.305 . . . . 1.25 113.173 -175.223 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -44.17 -48.94 9.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 126.604 3.097 . . . . 2.25 114.211 173.762 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -83.98 -17.0 41.99 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.146 -2.846 . . . . 2.02 115.951 -170.93 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.407 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 79.1 mt-30 -85.49 134.29 34.05 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.439 1.896 . . . . 0.69 111.218 -168.875 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -121.14 114.64 21.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 130.388 3.475 . . . . 2.78 108.606 167.467 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.4 mt -88.9 116.97 27.57 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.627 -1.921 . . . . 1.17 112.578 173.866 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.6 mm -106.4 141.1 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 102.652 -3.092 . . . . 1.38 102.652 -178.431 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -132.24 97.58 4.16 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 100.378 -3.934 . . . . 1.5 100.378 174.976 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.36 . . 79.5 -86.62 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.096 2.159 . . . . 1.21 106.858 -179.309 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.57 -6.55 1.8 Allowed Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 128.668 3.032 . . . . 1.3 111.179 -178.017 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -92.87 131.1 38.2 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.403 2.681 . . . . 2.55 109.135 -177.114 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -81.66 114.59 20.44 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 112.364 -2.198 . . . . 2.48 110.776 175.234 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.8 mt -83.23 148.62 27.3 Favored 'General case' 0 N--CA 1.431 -1.407 1 O-C-N 115.198 -4.689 . . . . 0.9 112.267 -174.521 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -100.3 149.36 23.68 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.499 1.919 . . . . 1.94 113.291 172.852 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -61.67 -61.15 2.72 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 130.49 3.516 . . . . 1.56 112.222 -169.525 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.82 20.52 0.2 Allowed Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 122.285 3.674 . . . . 0.97 122.285 171.705 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -107.67 154.13 21.92 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.135 -1.803 . . . . 2.49 113.042 167.02 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.3 p -94.21 168.45 10.91 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.805 2.891 . . . . 0.76 118.805 177.999 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 56.4 mt -62.77 -43.05 99.82 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.887 -1.758 . . . . 1.05 109.916 174.316 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 t -55.36 -43.66 75.27 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 120.342 3.46 . . . . 1.19 120.342 174.719 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -54.45 -42.2 70.34 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 128.287 2.635 . . . . 1.9 110.87 177.687 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -95.03 11.39 32.2 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 115.289 1.589 . . . . 0.89 115.289 -178.65 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 52.45 50.0 19.22 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 129.038 2.935 . . . . 1.84 110.98 -177.798 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.0 mt -91.94 114.19 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 N-CA-C 106.621 -1.622 . . . . 0.82 106.621 -179.068 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -94.16 -170.67 2.35 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 125.197 2.427 . . . . 2.16 109.494 -177.153 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.321 17.8 pttp -67.39 150.82 48.44 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 111.695 -2.502 . . . . 2.12 117.416 168.769 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.343 17.2 mt-10 68.38 9.52 7.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.942 2.201 . . . . 1.71 116.942 170.156 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.3 t -94.36 138.76 31.94 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 131.034 3.734 . . . . 1.04 107.855 -175.82 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.2 m -85.99 122.95 30.74 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 115.969 1.84 . . . . 0.79 115.969 179.225 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mp -99.78 157.45 16.49 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 101.472 -3.529 . . . . 1.4 101.472 169.674 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -121.04 117.27 26.81 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 113.995 1.109 . . . . 1.51 113.995 179.956 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.7 tp -88.85 110.37 21.0 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.413 2.054 . . . . 1.14 113.185 -178.713 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.7 t -107.04 147.82 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 117.981 -2.949 . . . . 1.23 106.124 171.605 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.0 mt -109.0 154.37 22.28 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.159 -2.213 . . . . 2.78 109.437 -179.532 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -115.33 131.04 57.05 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.47 -2.018 . . . . 3.75 108.737 179.302 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.19 142.92 27.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.109 -3.495 . . . . 3.14 108.452 178.784 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -62.4 92.42 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 118.151 2.649 . . . . 6.8 118.151 174.101 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.75 59.73 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.706 0 O-C-N 119.46 -2.025 . . . . 3.57 108.831 -163.857 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.792 0 N-CA-C 119.267 2.467 . . . . 3.87 119.267 -177.378 . . . . . . . . 0 0 . 1 . 116 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 119.322 -0.37 . . . . 1.1 110.208 . . . . . . . . . 0 0 . 1 . 116 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -102.7 132.42 48.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.66 -2.525 . . . . 1.87 106.83 -179.249 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.0 pt -132.42 167.02 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-O 116.376 -1.773 . . . . 0.72 108.001 173.923 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -124.1 149.08 46.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 122.349 2.34 . . . . 1.4 115.282 176.75 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 t -128.42 119.48 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 102.858 -3.016 . . . . 0.58 102.858 171.024 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -109.82 129.1 55.67 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 111.329 -2.669 . . . . 2.09 109.595 176.258 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 p -89.89 -173.87 4.05 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 126.546 3.069 . . . . 0.99 109.205 178.555 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.6 mt -91.48 3.66 54.43 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.678 -3.764 . . . . 2.53 117.739 169.51 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.2 p -76.6 -31.14 57.27 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.861 2.465 . . . . 2.08 108.578 177.899 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.22 -29.35 3.69 Favored Glycine 0 N--CA 1.43 -1.739 1 N-CA-C 102.78 -4.128 . . . . 1.31 102.78 179.904 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -63.58 131.21 47.33 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.406 2.002 . . . . 1.4 116.406 -170.898 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.9 m -102.1 117.48 34.89 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.345 -1.298 . . . . 0.78 108.895 169.112 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.283 7.7 mt -103.83 109.69 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 129.047 2.939 . . . . 1.55 106.243 -177.2 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.6 m -83.36 131.6 35.05 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.479 1.133 . . . . 1.08 110.21 177.559 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.3 mt -134.06 140.56 46.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.037 -2.289 . . . . 1.55 108.61 -175.759 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -84.3 124.14 30.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.487 2.715 . . . . 1.95 108.583 174.175 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.344 4.1 m -134.42 149.3 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 O-C-N 118.353 -2.717 . . . . 0.96 113.258 -176.423 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -95.73 141.72 23.57 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 115.233 -2.318 . . . . 2.35 105.331 165.291 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -81.98 -15.54 9.22 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 CA-C-N 126.484 3.351 . . . . 0.95 111.512 -167.899 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.8 m -71.56 -11.78 61.03 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 120.734 -1.229 . . . . 1.45 114.08 174.948 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -67.49 159.04 30.47 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.471 2.082 . . . . 1.69 112.235 177.455 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.6 p -87.12 177.37 7.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.323 -2.736 . . . . 0.75 109.1 -177.699 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.1 mt -84.12 -24.0 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 1 O-C-N 114.307 -5.246 . . . . 0.73 114.899 171.671 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.08 -28.39 69.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.153 1.908 . . . . 1.62 116.153 163.049 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -73.29 -36.27 66.26 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 121.221 1.828 . . . . 2.13 111.888 173.889 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.8 t -63.01 -48.8 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 128.504 2.722 . . . . 0.62 114.243 176.421 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -57.91 -33.96 69.32 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.633 2.086 . . . . 1.22 116.633 176.353 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.21 -24.16 67.75 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.227 1.936 . . . . 0.51 116.227 169.827 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -72.86 -31.66 64.89 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 126.397 2.999 . . . . 1.44 116.355 172.947 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.5 mm -68.37 -27.95 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 O-C-N 117.678 -3.139 . . . . 1.32 106.702 169.758 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.424 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 41.6 tt0 -71.49 -39.0 71.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.924 -2.36 . . . . 1.7 112.277 172.283 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -63.04 -41.43 99.51 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 118.227 2.677 . . . . 1.55 118.227 171.603 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -83.96 -58.16 2.9 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.824 2.05 . . . . 2.62 111.941 -174.878 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -97.99 -42.64 7.42 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.491 1.516 . . . . 1.48 109.698 -173.905 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 94.62 57.33 1.27 Allowed Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 128.142 2.782 . . . . 1.12 111.899 179.387 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.1 mt -115.23 122.31 33.47 Favored Pre-proline 0 N--CA 1.431 -1.423 0 N-CA-C 101.927 -3.36 . . . . 1.55 101.927 -177.957 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -66.94 149.29 82.99 Favored 'Trans proline' 0 C--N 1.3 -2.024 1 CA-C-O 108.871 -4.72 . . . . 1.02 108.283 -174.134 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -66.48 -8.54 21.13 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 CA-C-N 127.15 3.589 . . . . 1.25 116.496 -174.645 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.95 -35.16 62.14 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.234 1.969 . . . . 2.25 115.134 175.771 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -81.11 -15.68 55.24 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.214 -3.429 . . . . 2.02 111.753 -177.573 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -70.65 116.49 11.02 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.649 1.98 . . . . 0.69 112.875 -175.202 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.456 HH12 ' C ' ' A' ' 76' ' ' GLY . 64.2 mtt180 -106.35 124.84 50.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.885 -3.009 . . . . 2.78 105.537 175.561 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.0 tp -112.46 125.58 54.38 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 123.987 1.851 . . . . 1.17 107.085 -175.674 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.1 mm -114.74 125.99 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 O-C-N 120.283 -1.511 . . . . 1.38 110.01 -175.733 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -138.22 118.73 13.86 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.987 -1.857 . . . . 1.5 105.987 171.512 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.6 35.99 1.75 Allowed 'General case' 0 N--CA 1.431 -1.421 1 CA-C-O 129.417 4.437 . . . . 1.21 115.946 175.195 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.29 -21.47 28.28 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 110.423 -3.081 . . . . 1.3 115.052 -175.925 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -100.43 148.38 24.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.138 2.273 . . . . 2.55 117.138 -178.524 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -76.49 119.33 20.19 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 129.901 3.281 . . . . 2.48 109.43 169.819 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.514 HD22 ' CG ' ' A' ' 59' ' ' TYR . 20.5 mt -85.92 147.04 26.43 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.675 2.179 . . . . 0.9 116.85 -177.073 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -92.21 136.65 33.02 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 117.382 -3.324 . . . . 1.94 115.087 176.297 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -66.1 -42.54 89.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.884 -3.01 . . . . 1.56 116.258 -173.19 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.88 -13.95 62.39 Favored Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 125.32 1.438 . . . . 0.97 116.673 169.317 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -77.99 160.55 28.1 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 121.027 2.414 . . . . 2.49 112.306 174.115 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.261 60.8 p -91.15 159.5 16.05 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 116.41 -3.931 . . . . 0.76 110.805 177.331 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mt -70.05 -26.25 63.94 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.285 -1.78 . . . . 1.05 110.095 179.852 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.5 p -77.07 -30.85 55.66 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.079 2.552 . . . . 1.19 111.799 176.527 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.284 3.5 t70 -60.89 -43.18 98.83 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.051 -3.53 . . . . 1.9 114.31 172.35 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.514 ' CG ' HD22 ' A' ' 50' ' ' LEU . 35.6 m-85 -85.27 -6.0 59.28 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 116.743 -1.599 . . . . 0.89 113.293 170.734 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.37 55.6 t30 68.9 50.54 0.61 Allowed 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 123.455 2.843 . . . . 1.84 113.11 175.79 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.46 HD13 HD21 ' A' ' 67' ' ' LEU . 68.2 mt -100.42 124.11 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 105.605 -1.998 . . . . 0.82 105.605 176.169 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -110.82 -173.1 2.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 129.337 3.055 . . . . 2.16 113.504 -177.832 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.314 26.2 tttm -46.4 124.05 5.43 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.961 2.505 . . . . 2.12 112.726 174.568 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.399 44.1 mt-10 61.9 43.16 9.53 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.235 3.014 . . . . 1.71 117.522 174.203 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 t -99.36 153.41 19.0 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.527 2.108 . . . . 1.04 109.876 -175.424 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.287 11.8 m -97.25 107.41 19.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.721 -1.862 . . . . 0.79 113.81 178.465 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.46 HD21 HD13 ' A' ' 61' ' ' ILE . 50.8 mt -88.34 139.8 30.12 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.414 -1.328 . . . . 1.4 107.414 170.196 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -107.38 133.55 51.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 124.628 1.205 . . . . 1.51 109.069 -177.972 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.329 36.9 tp -111.33 121.1 44.36 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 127.161 2.788 . . . . 1.14 109.473 -178.802 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.409 HG23 ' HB2' ' A' ' 42' ' ' ARG . 9.9 m -117.78 164.99 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 116.923 -1.513 . . . . 1.23 111.03 168.787 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.6 mt -105.02 159.66 15.65 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 122.223 2.283 . . . . 2.78 113.972 176.19 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -73.68 136.12 43.77 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 119.8 -1.813 . . . . 3.75 114.804 -174.646 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.5 mt -112.8 154.03 26.89 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.288 2.635 . . . . 3.14 110.512 166.959 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -81.48 150.45 28.28 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 126.051 2.834 . . . . 6.8 114.716 167.734 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.75 -87.54 1.08 Allowed Glycine 0 N--CA 1.431 -1.688 0 O-C-N 118.286 -2.758 . . . . 3.57 115.539 -164.73 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.456 ' C ' HH12 ' A' ' 42' ' ' ARG . . . . . . . . 0 N--CA 1.43 -1.731 0 O-C-N 117.583 -3.304 . . . . 3.87 113.69 -179.822 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 114.926 1.454 . . . . 1.1 114.926 . . . . . . . . . 0 0 . 1 . 117 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -101.39 112.77 25.39 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.226 1.81 . . . . 1.87 107.537 -179.504 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -100.42 174.43 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 127.168 2.187 . . . . 0.72 114.183 166.908 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -123.83 141.37 52.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.969 -2.332 . . . . 1.4 110.869 -175.0 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.0 t -106.03 119.37 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 118.026 -2.921 . . . . 0.58 112.372 166.676 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -98.37 119.14 36.54 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 116.468 -3.895 . . . . 2.09 108.716 176.723 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p -73.57 173.26 9.96 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.601 -3.187 . . . . 0.99 119.599 174.036 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.2 mt -53.41 -54.06 42.28 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 118.157 2.651 . . . . 2.53 118.157 170.401 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.4 p -69.23 -24.59 64.03 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 126.393 2.308 . . . . 2.08 111.015 -177.748 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.21 38.07 0.97 Allowed Glycine 0 N--CA 1.43 -1.712 0 O-C-N 119.526 -1.984 . . . . 1.31 112.707 170.25 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -109.98 131.07 55.39 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.867 -3.137 . . . . 1.4 107.023 -173.149 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -89.68 106.62 18.58 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.857 2.063 . . . . 0.78 114.316 177.841 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.4 mt -104.99 120.37 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 103.502 -2.777 . . . . 1.55 103.502 -178.128 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -86.33 132.95 33.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.761 -1.109 . . . . 1.08 111.978 178.971 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.3 mt -136.53 132.9 35.87 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 115.208 -2.33 . . . . 1.55 114.893 -175.698 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -84.39 114.32 21.81 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 131.258 3.823 . . . . 1.95 111.48 173.974 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.5 m -140.77 167.1 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-O 125.097 2.38 . . . . 0.96 106.131 178.763 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -121.07 158.28 53.08 Favored Pre-proline 0 N--CA 1.431 -1.425 0 O-C-N 118.518 -2.613 . . . . 2.35 111.571 168.26 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -59.14 -16.53 33.95 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 O-C-N 111.538 -5.032 . . . . 0.95 116.41 -176.45 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.7 p -79.14 -5.29 53.82 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.086 1.513 . . . . 1.45 115.086 171.691 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.27 46.5 m-20 -76.93 142.62 40.0 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.779 -1.201 . . . . 1.69 109.743 -178.395 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.3 p -86.35 161.08 18.89 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.073 -1.084 . . . . 0.75 108.073 179.761 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.447 HG23 HD12 ' A' ' 43' ' ' LEU . 27.8 mm -58.03 -42.24 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 122.324 1.059 . . . . 0.73 110.727 176.291 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -37.66 -54.01 1.21 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 119.142 3.015 . . . . 1.62 119.142 160.864 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -55.77 -41.9 74.72 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.591 2.756 . . . . 2.13 113.315 176.905 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.6 t -61.66 -50.96 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 126.282 1.833 . . . . 0.62 111.742 173.55 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.4 mttt -61.47 -27.9 68.9 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.458 -3.276 . . . . 1.22 118.237 175.248 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.53 -27.57 64.27 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.56 2.124 . . . . 0.51 113.943 178.0 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -76.47 -36.51 57.82 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.803 -2.436 . . . . 1.44 112.479 176.044 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.56 -30.05 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.908 -1.496 . . . . 1.32 114.808 161.574 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -68.6 -33.36 73.91 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.448 1.476 . . . . 1.7 113.627 179.003 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -78.3 -53.85 6.85 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 117.235 -1.786 . . . . 1.55 115.092 166.354 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -59.19 -43.51 92.19 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 115.153 -2.356 . . . . 2.62 117.309 -174.925 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -108.14 -26.65 10.51 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 126.702 2.501 . . . . 1.48 110.524 -172.713 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.52 48.89 3.83 Favored Glycine 0 N--CA 1.43 -1.767 0 O-C-N 119.987 -1.695 . . . . 1.12 111.914 171.212 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.4 mt -128.57 125.37 23.11 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-O 115.622 -2.133 . . . . 1.55 109.822 -177.876 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 75.5 Cg_exo -66.85 148.76 82.92 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-N 125.484 2.994 . . . . 1.02 114.094 178.16 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 52.1 Cg_exo -69.33 -14.1 36.85 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 N-CA-C 116.63 1.742 . . . . 1.25 116.63 -170.933 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.56 -29.67 70.75 Favored 'General case' 0 N--CA 1.43 -1.449 1 C-N-CA 132.514 4.326 . . . . 2.25 109.029 169.788 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -90.87 -31.1 16.56 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.482 1.66 . . . . 2.02 115.482 -178.697 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.281 77.4 mt-30 -81.08 134.3 35.63 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.856 -1.164 . . . . 0.69 107.856 -175.012 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -121.15 133.4 55.2 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.914 -2.991 . . . . 2.78 105.98 168.898 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 43' ' ' LEU . 98.2 mt -98.01 126.49 43.46 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 105.781 -1.933 . . . . 1.17 105.781 -177.905 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 mm -110.84 138.86 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-N 122.466 2.393 . . . . 1.38 104.616 -178.407 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -144.48 130.15 19.11 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 106.376 -1.713 . . . . 1.5 106.376 163.49 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.05 24.78 14.86 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 120.381 3.474 . . . . 1.21 120.381 177.771 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.86 -18.51 57.39 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 115.72 -2.711 . . . . 1.3 108.439 -179.785 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -101.22 156.72 17.27 Favored 'General case' 0 N--CA 1.431 -1.422 1 CA-C-N 124.847 4.323 . . . . 2.55 111.028 177.382 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.291 39.9 tt0 -96.74 144.57 26.61 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.858 2.742 . . . . 2.48 107.95 175.185 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.6 mt -92.45 148.09 22.38 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.472 -3.268 . . . . 0.9 109.129 -178.727 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -92.93 144.45 25.25 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 130.611 3.564 . . . . 1.94 112.813 -179.522 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -63.64 -54.91 28.34 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.284 -3.385 . . . . 1.56 115.665 -167.479 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.86 42.36 3.05 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-O 123.299 1.5 . . . . 0.97 115.51 173.036 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -110.43 152.95 25.69 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.362 -2.257 . . . . 2.49 105.253 165.281 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.7 p -103.1 158.82 16.04 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.86 2.064 . . . . 0.76 108.256 -177.99 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.0 mt -65.44 -28.31 69.14 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 128.484 2.714 . . . . 1.05 108.378 176.042 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 p -64.59 -40.99 96.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.285 2.634 . . . . 1.19 115.461 171.874 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -65.24 -35.24 80.43 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 124.235 0.959 . . . . 1.9 113.411 176.623 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -85.43 3.1 41.67 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.336 1.606 . . . . 0.89 115.336 179.595 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.0 m120 56.02 32.27 19.62 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 110.698 -2.956 . . . . 1.84 117.895 -174.232 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.6 mm -72.17 130.02 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 1 O-C-N 115.325 -4.609 . . . . 0.82 116.582 176.594 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -117.61 174.81 5.95 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 128.115 2.566 . . . . 2.16 107.049 -168.106 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -54.32 152.8 5.96 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.058 1.503 . . . . 2.12 115.058 172.858 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.37 35.0 mt-10 73.55 14.03 4.37 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 125.554 2.597 . . . . 1.71 115.282 172.112 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.327 27.3 m -78.51 124.39 28.1 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 116.303 1.964 . . . . 1.04 116.303 -175.019 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.6 m -89.59 99.87 12.78 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 118.134 2.642 . . . . 0.79 118.134 177.913 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.5 mt -86.52 139.06 31.23 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.302 -2.481 . . . . 1.4 104.302 176.547 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -97.29 141.5 30.32 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.747 -3.096 . . . . 1.51 108.832 174.685 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.0 tp -106.62 125.62 51.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.11 1.909 . . . . 1.14 111.382 179.954 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.12 163.89 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 105.063 -2.199 . . . . 1.23 105.063 174.695 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.9 mt -127.61 129.57 47.49 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 101.799 -3.408 . . . . 2.78 101.799 -176.672 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.1 ptt85 -81.23 166.89 20.18 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.976 -2.952 . . . . 3.75 108.372 173.603 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.7 mt -84.39 157.52 21.4 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 116.336 -3.978 . . . . 3.14 107.752 170.473 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -114.79 -120.87 0.3 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.559 -1.655 . . . . 6.8 110.009 -177.605 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.91 -22.69 6.02 Favored Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 106.264 -2.735 . . . . 3.57 106.264 -161.492 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.792 0 N-CA-C 107.929 -2.068 . . . . 3.87 107.929 -179.16 . . . . . . . . 0 0 . 1 . 118 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 ttp . . . . . 0 CA--C 1.491 -1.326 0 CA-C-O 118.61 -0.709 . . . . 1.1 112.597 . . . . . . . . . 0 0 . 1 . 118 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -94.31 133.54 37.75 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.562 -2.586 . . . . 1.87 111.716 178.576 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -123.37 159.34 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.269 2.628 . . . . 0.72 106.859 175.278 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.297 44.3 m-85 -128.96 121.71 28.6 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 123.887 1.803 . . . . 1.4 110.679 -177.604 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -100.52 105.01 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 125.851 2.739 . . . . 0.58 110.757 175.308 . . . . . . . . 3 3 . 1 . 118 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -88.13 138.59 31.31 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.547 -3.221 . . . . 2.09 110.066 176.241 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.9 p -90.52 -177.67 5.11 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 127.989 3.306 . . . . 0.99 116.18 -174.405 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.7 mt -82.74 -26.18 32.16 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.564 -1.96 . . . . 2.53 113.169 163.674 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.1 p -64.35 -62.58 1.52 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.507 1.923 . . . . 2.08 114.758 -174.262 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.49 31.61 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.757 0 N-CA-C 105.234 -3.147 . . . . 1.31 105.234 174.826 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -117.61 128.42 54.92 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 123.618 1.675 . . . . 1.4 109.025 -172.493 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.6 m -107.08 102.32 11.67 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 104.526 -2.398 . . . . 0.78 104.526 176.412 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.8 pt -91.27 133.06 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 120.778 1.626 . . . . 1.55 109.998 176.924 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.9 m -91.53 151.19 20.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 121.183 -0.948 . . . . 1.08 108.565 175.544 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.1 mt -144.31 139.39 28.52 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.106 -1.813 . . . . 1.55 106.106 176.48 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -78.0 116.19 18.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.101 1.519 . . . . 1.95 115.101 165.085 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.277 11.3 m -127.75 151.22 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 127.672 2.389 . . . . 0.96 106.839 178.49 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -94.87 161.96 26.8 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 118.107 -2.871 . . . . 2.35 112.622 157.828 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -73.45 -20.95 20.21 Favored 'Trans proline' 0 N--CA 1.433 -2.072 0 CA-C-N 126.69 3.425 . . . . 0.95 115.743 -174.895 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 p -72.59 5.32 3.14 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.488 3.915 . . . . 1.45 114.039 169.011 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -95.82 135.16 37.9 Favored 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 117.775 -3.078 . . . . 1.69 112.909 -179.604 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 26.6 p -67.79 173.98 3.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.21 -2.268 . . . . 0.75 114.225 177.414 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.6 mm -84.88 -29.7 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 118.143 -2.848 . . . . 0.73 105.156 176.861 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -48.95 -48.34 43.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.228 -2.795 . . . . 1.62 116.55 163.622 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -51.87 -50.27 61.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.861 -2.399 . . . . 2.13 115.148 167.369 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.2 t -55.97 -42.75 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 114.73 -2.557 . . . . 0.62 115.246 177.409 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -64.15 -41.11 97.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 125.101 2.382 . . . . 1.22 116.337 174.896 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.85 -43.73 81.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.51 3.124 . . . . 0.51 115.893 166.983 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.41 ' HB2' ' HE2' ' A' ' 29' ' ' LYS . 2.3 ttmm -58.86 -33.29 70.29 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 116.248 -4.033 . . . . 1.44 113.835 170.616 . . . . . . . . 3 3 . 1 . 118 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.9 mt -78.79 -31.09 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 112.907 -1.951 . . . . 1.32 108.969 176.521 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -71.15 -40.35 71.4 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 115.53 1.678 . . . . 1.7 115.53 177.868 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -58.01 -52.11 66.88 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.932 1.456 . . . . 1.55 114.932 168.001 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.2 tttp -70.23 -71.66 0.23 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.579 2.751 . . . . 2.62 113.361 -172.374 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -90.58 -34.24 15.57 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.048 -1.658 . . . . 1.48 111.616 -162.798 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.47 5.55 22.59 Favored Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 105.089 -3.204 . . . . 1.12 105.089 175.593 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 30.9 mt -80.17 122.37 82.86 Favored Pre-proline 0 N--CA 1.431 -1.41 0 CA-C-N 119.087 1.443 . . . . 1.55 108.475 -175.799 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 24.3 Cg_exo -68.31 150.75 76.52 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 C-N-CA 124.58 3.52 . . . . 1.02 110.653 -175.883 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.263 39.0 Cg_endo -62.91 -43.8 18.61 Favored 'Trans proline' 0 N--CA 1.433 -2.039 1 C-N-CA 126.963 5.109 . . . . 1.25 116.469 -168.904 . . . . . . . . 3 2 . 1 . 118 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -55.86 -26.56 47.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 121.792 3.997 . . . . 2.25 121.792 171.945 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -71.17 -34.89 71.36 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.585 1.954 . . . . 2.02 110.691 -179.322 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -70.62 97.71 1.38 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.165 2.283 . . . . 0.69 117.165 -175.299 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -87.44 126.14 34.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 118.341 -0.838 . . . . 2.78 108.96 161.957 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.0 mt -117.8 119.54 35.2 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 121.478 1.945 . . . . 1.17 108.431 -178.639 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 27.4 mt -108.3 128.94 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 128.53 2.732 . . . . 1.38 113.818 -172.426 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.429 ' CE2' HG12 ' A' ' 61' ' ' ILE 0.288 72.1 t80 -144.95 110.92 5.46 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 105.581 -2.007 . . . . 1.5 105.581 178.648 . . . . . . . . 3 3 . 1 . 118 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.82 45.25 7.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.867 1.802 . . . . 1.21 115.867 178.974 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.02 -4.85 36.25 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 120.681 3.032 . . . . 1.3 120.681 -171.534 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -96.3 119.72 35.31 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 130.155 4.091 . . . . 2.55 115.642 177.441 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -79.76 110.29 14.97 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 114.922 -4.861 . . . . 2.48 109.593 168.899 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.2 mt -82.12 146.35 29.66 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.041 -2.287 . . . . 0.9 110.827 -163.765 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -85.3 145.22 27.63 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.836 2.055 . . . . 1.94 114.004 173.536 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.39 -59.07 4.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.594 2.072 . . . . 1.56 116.594 -168.703 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.64 49.82 3.7 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-O 123.943 1.857 . . . . 0.97 116.905 173.744 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -118.25 156.48 28.75 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 101.489 -3.522 . . . . 2.49 101.489 165.443 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 16.9 p -100.07 162.48 12.95 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.686 -3.133 . . . . 0.76 112.784 174.005 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.4 mt -54.87 -48.27 73.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.777 2.831 . . . . 1.05 109.2 174.813 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 p -60.72 -37.92 83.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.07 2.148 . . . . 1.19 113.856 179.085 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -61.31 -33.93 74.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 122.637 2.471 . . . . 1.9 113.375 174.276 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -85.96 -14.34 44.94 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 127.002 2.121 . . . . 0.89 114.055 178.836 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.6 m120 66.84 50.34 1.11 Allowed 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 124.242 1.972 . . . . 1.84 111.739 -177.661 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.429 HG12 ' CE2' ' A' ' 45' ' ' PHE . 70.8 mt -95.78 128.71 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 119.951 -1.718 . . . . 0.82 108.457 174.629 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -100.1 175.98 5.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 112.159 -2.291 . . . . 2.16 111.07 -174.171 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -46.37 137.43 6.43 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.819 -3.05 . . . . 2.12 117.639 166.811 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.253 73.8 mt-10 69.57 14.04 8.27 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.287 -2.758 . . . . 1.71 117.682 175.455 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 m -76.1 148.95 37.53 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 120.438 -1.414 . . . . 1.04 112.826 -175.364 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.1 m -97.28 119.0 34.98 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 126.177 2.173 . . . . 0.79 111.258 -179.365 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.449 ' HB2' HG13 ' A' ' 5' ' ' VAL . 33.3 mt -103.8 136.68 43.03 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.053 -1.655 . . . . 1.4 107.851 170.235 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.431 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 63.5 m80 -91.64 107.5 19.25 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.298 2.332 . . . . 1.51 117.298 174.181 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.449 ' HB2' HG12 ' A' ' 5' ' ' VAL . 15.2 tp -88.09 117.04 26.7 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 124.835 1.254 . . . . 1.14 110.184 -179.334 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.2 t -120.84 143.25 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 126.493 3.044 . . . . 1.23 103.723 178.431 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.9 mt -118.12 110.51 17.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.149 -2.845 . . . . 2.78 109.126 -175.422 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -136.66 158.77 43.68 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 105.767 -1.938 . . . . 3.75 105.767 178.745 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -64.53 137.1 57.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 125.421 1.701 . . . . 3.14 115.374 167.969 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -69.33 123.94 22.53 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.713 -0.676 . . . . 6.8 111.394 172.058 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.32 94.29 0.1 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 117.622 -1.655 . . . . 3.57 114.083 -176.857 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.79 0 CA-C-O 115.938 -2.59 . . . . 3.87 112.213 168.345 . . . . . . . . 0 0 . 1 . 119 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.27 0.2 OUTLIER . . . . . 0 CA--C 1.491 -1.321 0 N-CA-C 107.138 -1.43 . . . . 1.1 107.138 . . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -115.38 119.96 38.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.765 2.026 . . . . 1.87 109.359 -178.41 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 pt -120.74 158.44 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 122.031 0.919 . . . . 0.72 112.716 -179.905 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -114.37 148.14 38.1 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.878 -2.389 . . . . 1.4 106.299 176.028 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.4 t -124.16 121.86 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 129.385 3.074 . . . . 0.58 105.51 173.118 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -107.16 137.69 44.75 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.305 2.642 . . . . 2.09 112.342 177.004 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.6 p -95.65 -176.83 3.86 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 123.376 1.56 . . . . 0.99 114.329 179.935 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.374 66.4 tp -57.54 -45.81 84.62 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 116.01 -4.181 . . . . 2.53 113.11 172.222 . . . . . . . . 3 2 . 1 . 119 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.5 p -80.11 -35.56 36.65 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 121.579 1.99 . . . . 2.08 111.844 -175.555 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.07 7.16 1.36 Allowed Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 119.524 1.057 . . . . 1.31 113.498 178.14 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.3 mtpt -76.6 130.65 38.15 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.676 -2.661 . . . . 1.4 111.65 -176.555 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.0 m -97.96 113.57 25.44 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 125.22 2.438 . . . . 0.78 113.203 -179.184 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.0 mt -92.4 95.15 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 119.101 -2.249 . . . . 1.55 110.369 178.327 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.6 m -81.48 118.82 23.03 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 120.473 1.488 . . . . 1.08 110.432 175.324 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.4 mt -119.85 153.64 35.51 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.567 -2.382 . . . . 1.55 104.567 178.275 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -110.44 120.17 41.57 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 111.558 -2.565 . . . . 1.95 107.493 174.25 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.87 -176.76 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.457 -2.652 . . . . 0.96 106.287 175.2 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -105.48 163.06 17.88 Favored Pre-proline 0 N--CA 1.431 -1.408 0 O-C-N 116.631 -3.793 . . . . 2.35 104.64 169.693 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -71.1 -14.74 32.03 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 124.012 2.468 . . . . 0.95 112.82 179.055 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.263 18.9 m -92.76 5.82 49.77 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 123.766 2.985 . . . . 1.45 111.572 -179.64 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -82.4 151.09 26.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 127.892 3.71 . . . . 1.69 108.706 176.445 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 68.7 p -79.49 170.57 16.38 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 113.586 -5.696 . . . . 0.75 113.596 179.322 . . . . . . . . 3 3 . 1 . 119 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.41 -30.57 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-N 113.561 -1.654 . . . . 0.73 110.873 178.572 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -54.82 -41.55 70.81 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.922 2.089 . . . . 1.62 113.724 169.36 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -61.9 -45.5 93.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.248 1.944 . . . . 2.13 116.248 171.252 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 56.4 t -51.51 -48.85 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 128.583 2.753 . . . . 0.62 107.896 175.445 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -67.42 -36.12 80.61 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 122.402 2.365 . . . . 1.22 117.384 175.197 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.02 -32.48 73.85 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 116.037 -4.164 . . . . 0.51 118.402 169.008 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -67.19 -31.05 71.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 112.483 -2.144 . . . . 1.44 114.839 170.142 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.293 57.3 mt -68.31 -25.43 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 CA-C-O 125.969 2.795 . . . . 1.32 113.683 172.339 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -85.47 -27.51 25.63 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.84 -4.287 . . . . 1.7 106.835 -174.32 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -78.09 -38.14 44.88 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 114.095 -3.042 . . . . 1.55 111.032 168.92 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -65.08 -61.46 2.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 112.986 0.736 . . . . 2.62 112.986 -172.243 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -106.09 -52.64 2.77 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.209 3.004 . . . . 1.48 108.969 -167.403 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.93 -15.8 5.86 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 119.096 2.398 . . . . 1.12 119.096 176.491 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mt -65.1 131.83 95.24 Favored Pre-proline 0 N--CA 1.43 -1.469 0 CA-C-O 116.499 -1.715 . . . . 1.55 110.337 -175.156 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 93.6 Cg_endo -74.93 155.36 43.25 Favored 'Trans proline' 0 N--CA 1.433 -2.038 0 C-N-CA 125.219 3.946 . . . . 1.02 112.814 -177.136 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.9 Cg_exo -63.84 -27.41 67.4 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 123.663 2.909 . . . . 1.25 119.056 -174.364 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.272 2.6 m-20 -62.08 -32.46 73.01 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.072 1.415 . . . . 2.25 113.39 177.268 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -87.81 -16.91 32.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.159 1.457 . . . . 2.02 114.085 -171.436 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -87.31 127.17 35.19 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 117.148 -1.406 . . . . 0.69 109.698 -174.909 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -118.44 128.18 54.37 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.441 -1.689 . . . . 2.78 106.441 170.421 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.2 mt -95.05 136.76 34.98 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.103 -2.873 . . . . 1.17 112.678 174.565 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 73.0 mt -125.38 117.92 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 124.415 2.055 . . . . 1.38 110.775 178.401 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -109.0 107.82 18.32 Favored 'General case' 0 N--CA 1.43 -1.439 1 N-CA-C 99.77 -4.159 . . . . 1.5 99.77 -178.534 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.88 -74.32 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.477 2.311 . . . . 1.21 113.716 -172.555 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.92 6.11 1.13 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 105.709 -2.956 . . . . 1.3 105.709 178.095 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -94.98 119.04 32.82 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.327 -3.455 . . . . 2.55 110.17 177.747 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -89.08 121.64 31.61 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.862 -2.399 . . . . 2.48 108.642 175.599 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.0 mt -80.08 164.67 23.19 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.158 -1.383 . . . . 0.9 111.599 -164.131 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -115.66 137.05 52.46 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 127.012 3.291 . . . . 1.94 111.396 174.552 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.28 -40.77 97.35 Favored 'General case' 0 N--CA 1.429 -1.483 1 N-CA-C 122.274 4.175 . . . . 1.56 122.274 -166.842 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.42 30.44 5.25 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 118.079 1.991 . . . . 0.97 118.079 171.385 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -105.86 162.61 13.41 Favored 'General case' 0 N--CA 1.43 -1.439 1 CA-C-O 130.099 4.762 . . . . 2.49 107.959 163.073 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 63.0 p -84.25 163.82 19.44 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 113.02 -6.05 . . . . 0.76 109.648 172.279 . . . . . . . . 3 3 . 1 . 119 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.2 mt -64.76 -42.7 94.92 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 121.0 -1.063 . . . . 1.05 109.086 172.432 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.3 p -66.32 -21.56 66.26 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.406 -3.309 . . . . 1.19 115.092 -179.22 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -59.34 -17.69 31.82 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 118.123 2.638 . . . . 1.9 118.123 167.017 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -115.79 11.22 15.56 Favored 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 114.561 -5.087 . . . . 0.89 109.189 178.835 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.334 1.3 t-20 67.01 33.97 5.42 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.568 1.947 . . . . 1.84 114.111 179.044 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.4 mt -92.03 126.37 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 104.759 -2.311 . . . . 0.82 104.759 -174.688 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -125.17 -171.46 2.37 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 119.488 1.04 . . . . 2.16 109.458 -169.25 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -52.68 141.7 20.26 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 118.452 -2.655 . . . . 2.12 112.842 165.722 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.316 4.2 mt-10 60.71 36.46 19.44 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.298 2.873 . . . . 1.71 115.926 175.066 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.4 t -109.49 140.82 42.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 111.562 -2.563 . . . . 1.04 106.74 -167.107 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.3 m -114.18 120.37 40.27 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.782 -1.192 . . . . 0.79 107.782 -167.759 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.7 mt -100.52 161.58 13.51 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.518 2.727 . . . . 1.4 111.186 173.795 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -123.79 109.65 13.92 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.122 2.169 . . . . 1.51 111.196 -177.616 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.9 tp -92.12 122.87 35.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 111.812 -2.449 . . . . 1.14 108.073 -175.008 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.327 4.7 m -118.4 141.03 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 118.802 -2.436 . . . . 1.23 110.953 175.63 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.9 mt -104.37 135.09 46.47 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.926 -2.984 . . . . 2.78 110.145 177.226 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.411 HH21 ' C ' ' A' ' 76' ' ' GLY . 9.8 ttt180 -150.13 150.13 31.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 101.095 -3.669 . . . . 3.75 101.095 -177.099 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.0 mt -68.59 132.83 47.59 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.045 -2.285 . . . . 3.14 112.015 171.767 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -65.31 123.43 19.57 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.114 0.959 . . . . 6.8 111.825 169.837 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.13 -63.94 0.31 Allowed Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 103.158 -3.977 . . . . 3.57 103.158 -171.207 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.411 ' C ' HH21 ' A' ' 72' ' ' ARG . . . . . . . . 0 N--CA 1.429 -1.796 0 O-C-N 120.472 -1.605 . . . . 3.87 109.622 178.942 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 ptt? . . . . . 0 CA--C 1.491 -1.301 0 CA-C-O 120.957 0.408 . . . . 1.1 110.23 . . . . . . . . . 0 0 . 1 . 120 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -107.65 147.38 30.77 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.537 -0.727 . . . . 1.87 112.3 -176.681 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.3 pt -134.09 152.41 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 124.174 1.94 . . . . 0.72 106.385 172.935 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -109.7 134.37 52.05 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 127.019 2.128 . . . . 1.4 114.298 178.619 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -114.14 109.57 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 118.015 -2.928 . . . . 0.58 106.062 178.338 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 6' ' ' LYS . 17.9 tptm -93.61 131.38 38.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.219 -1.551 . . . . 2.09 111.83 178.673 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.1 p -89.07 -178.67 5.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.211 -2.806 . . . . 0.99 113.782 -178.428 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.263 35.4 tp -85.31 -33.47 22.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 119.292 -2.13 . . . . 2.53 108.198 171.85 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.259 59.9 p -68.33 -34.32 75.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.678 -1.889 . . . . 2.08 109.015 -174.095 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.0 44.54 0.44 Allowed Glycine 0 N--CA 1.431 -1.673 0 CA-C-O 115.376 -2.902 . . . . 1.31 113.513 178.378 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -127.55 148.69 50.34 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 114.076 -2.868 . . . . 1.4 110.853 -177.838 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.8 m -122.89 121.76 36.97 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 124.69 3.405 . . . . 0.78 103.626 177.126 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mt -98.13 124.54 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 1 O-C-N 115.971 -4.206 . . . . 1.55 104.355 179.1 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.0 m -101.29 118.2 36.51 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.261 -2.15 . . . . 1.08 107.876 179.912 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.7 mt -117.46 162.3 18.18 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.5 -2.625 . . . . 1.55 109.683 178.3 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -101.26 136.11 41.64 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 127.144 2.777 . . . . 1.95 112.656 166.545 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -142.36 171.26 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 128.085 2.554 . . . . 0.96 107.48 -176.236 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -118.53 148.22 43.65 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 101.904 -3.369 . . . . 2.35 101.904 163.139 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.97 -6.12 17.39 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 O-C-N 115.809 -2.785 . . . . 0.95 118.35 178.07 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.8 p -80.57 -5.77 57.28 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.475 2.71 . . . . 1.45 112.401 169.131 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -70.01 143.17 52.65 Favored 'General case' 0 N--CA 1.431 -1.413 1 CA-C-O 128.515 4.007 . . . . 1.69 111.706 171.129 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.395 53.6 p -75.09 157.05 35.38 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.02 -2.925 . . . . 0.75 112.848 176.493 . . . . . . . . 3 3 . 1 . 120 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.9 mm -71.53 -29.97 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 122.95 1.357 . . . . 0.73 109.634 179.131 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -46.57 -57.9 4.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.561 3.077 . . . . 1.62 115.538 164.661 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -54.48 -34.24 61.22 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 119.849 3.277 . . . . 2.13 119.849 178.017 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 68.9 t -71.05 -35.73 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 112.185 -2.28 . . . . 0.62 111.208 176.109 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -72.96 -34.11 66.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.011 -2.931 . . . . 1.22 113.456 171.76 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.98 -32.63 74.22 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 117.992 -2.943 . . . . 0.51 113.067 174.335 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt -72.42 -33.55 67.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 123.35 1.547 . . . . 1.44 114.853 174.279 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 30' ' ' ILE . 47.2 mt -72.39 -29.99 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 120.399 -1.438 . . . . 1.32 108.309 176.26 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.494 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 7.7 tt0 -64.0 -51.28 64.99 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.809 1.644 . . . . 1.7 112.549 171.803 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -60.75 -39.47 88.85 Favored 'General case' 0 N--CA 1.432 -1.368 0 O-C-N 120.121 -1.612 . . . . 1.55 113.509 175.549 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.6 tptt -67.83 -56.44 9.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.427 -1.421 . . . . 2.62 114.781 -173.818 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.307 71.4 mm-40 -113.71 -15.23 12.49 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 115.755 1.761 . . . . 1.48 115.755 -171.995 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.21 64.31 1.6 Allowed Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 125.169 1.366 . . . . 1.12 110.338 171.303 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.494 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 16.9 mt -141.53 117.07 7.13 Favored Pre-proline 0 N--CA 1.429 -1.485 0 N-CA-C 101.947 -3.353 . . . . 1.55 101.947 -176.436 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.472 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 57.3 Cg_exo -58.01 153.64 43.79 Favored 'Trans proline' 0 C--N 1.3 -2.002 1 C-N-CA 128.218 5.945 . . . . 1.02 111.93 178.149 . . . . . . . . 3 3 . 1 . 120 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 95.2 Cg_exo -71.73 -27.75 17.84 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 CA-C-N 125.454 2.984 . . . . 1.25 115.37 -171.825 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -61.36 -31.62 71.5 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.354 3.062 . . . . 2.25 113.912 178.007 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -92.57 -10.36 37.84 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 116.462 -3.899 . . . . 2.02 105.546 -172.332 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -92.87 132.47 36.98 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 124.062 3.119 . . . . 0.69 109.818 -172.041 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -103.52 125.56 50.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.762 -1.837 . . . . 2.78 109.369 163.811 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.6 mt -113.81 118.51 34.47 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.64 -2.537 . . . . 1.17 109.388 179.16 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mt -110.83 125.36 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 126.824 2.049 . . . . 1.38 109.794 -177.446 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -125.23 130.78 52.76 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.17 -1.789 . . . . 1.5 106.17 168.403 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.78 -76.44 0.07 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.804 1.242 . . . . 1.21 112.0 179.259 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -177.4 33.8 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.649 0 O-C-N 117.258 -3.401 . . . . 1.3 104.809 -175.482 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.32 122.29 16.69 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.644 1.978 . . . . 2.55 107.277 179.444 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -70.85 143.14 51.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.425 -2.672 . . . . 2.48 107.228 166.186 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.1 mt -99.97 139.99 34.83 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 125.268 1.605 . . . . 0.9 110.183 -173.107 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -83.05 161.64 21.63 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 117.767 -1.111 . . . . 1.94 108.886 176.44 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -73.49 -57.15 4.2 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 129.03 2.932 . . . . 1.56 117.131 -169.237 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.04 54.47 3.64 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 126.607 3.337 . . . . 0.97 120.048 172.631 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.253 79.2 mmt-85 -122.58 169.18 11.29 Favored 'General case' 0 N--CA 1.43 -1.444 1 C-N-CA 132.122 4.169 . . . . 2.49 103.306 169.257 . . . . . . . . 3 2 . 1 . 120 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 62.5 p -109.29 -179.72 3.92 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.409 -3.932 . . . . 0.76 108.464 170.561 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 79.8 mt -72.64 -33.67 66.77 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 130.825 3.65 . . . . 1.05 109.738 172.295 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.4 t -73.9 -37.74 64.57 Favored 'General case' 0 N--CA 1.43 -1.468 1 C-N-CA 131.976 4.111 . . . . 1.19 110.688 -176.214 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -64.08 -38.14 89.98 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 113.209 -1.814 . . . . 1.9 113.956 173.509 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -84.0 -2.83 57.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 113.945 -2.931 . . . . 0.89 112.47 170.463 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.417 8.1 t-20 56.9 46.34 19.8 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 121.24 1.836 . . . . 1.84 114.245 -177.043 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.2 mt -88.18 107.31 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 130.713 3.605 . . . . 0.82 108.212 176.621 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -79.33 -175.88 4.92 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.567 -2.583 . . . . 2.16 111.556 -177.131 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -72.88 149.1 43.78 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 118.382 -2.699 . . . . 2.12 108.305 172.98 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 71.51 18.32 5.46 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 126.615 3.102 . . . . 1.71 116.88 174.915 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -83.33 151.64 25.46 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.289 -3.382 . . . . 1.04 117.223 178.951 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.6 m -108.89 110.29 21.58 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.753 -1.203 . . . . 0.79 107.753 -173.604 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.7 mt -87.94 147.58 24.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 102.162 -3.273 . . . . 1.4 102.162 170.878 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -108.41 112.87 25.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.382 -1.34 . . . . 1.51 107.382 -175.761 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.7 tp -87.68 112.0 21.89 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.898 -2.376 . . . . 1.14 110.226 -178.81 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.7 t -111.13 120.23 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 103.055 -2.943 . . . . 1.23 103.055 178.368 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.5 mt -109.98 141.15 43.17 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.732 1.73 . . . . 2.78 114.435 -178.312 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -91.55 130.02 37.44 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.894 2.553 . . . . 3.75 117.894 -176.091 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.4 mt -83.98 153.49 23.85 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.077 -3.514 . . . . 3.14 114.399 168.85 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -93.82 160.79 14.59 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 104.244 -2.502 . . . . 6.8 104.244 179.543 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.29 -50.04 1.6 Allowed Glycine 0 N--CA 1.431 -1.689 0 CA-C-O 115.099 -3.056 . . . . 3.57 113.929 -171.321 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.737 0 CA-C-N 120.942 2.371 . . . . 3.87 114.714 178.837 . . . . . . . . 0 0 . 1 . 121 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 CA--C 1.49 -1.329 0 CA-C-O 125.53 2.586 . . . . 1.1 113.826 . . . . . . . . . 0 0 . 1 . 121 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -115.59 108.82 16.92 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.881 -2.387 . . . . 1.87 106.272 -173.861 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.3 pt -114.08 164.49 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 105.733 -1.951 . . . . 0.72 105.733 171.942 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -124.35 151.68 44.05 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.573 -2.01 . . . . 1.4 105.573 -172.09 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 t -134.1 118.52 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 102.86 -3.015 . . . . 0.58 102.86 174.545 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -90.83 141.4 28.85 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.434 -1.321 . . . . 2.09 107.434 171.055 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.2 p -91.49 -162.46 0.92 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.803 2.841 . . . . 0.99 111.45 -178.715 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.5 mt -83.2 -30.89 27.39 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 126.138 2.875 . . . . 2.53 110.132 178.493 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.8 p -82.09 -60.73 2.12 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 113.977 -5.452 . . . . 2.08 110.01 -171.615 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.93 31.41 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 125.03 1.3 . . . . 1.31 111.101 175.101 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -103.76 134.81 46.45 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.949 -4.265 . . . . 1.4 104.676 -174.609 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 m -80.98 119.63 23.75 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 112.779 -2.01 . . . . 0.78 109.908 167.675 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 mt -94.84 117.51 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 104.168 -2.531 . . . . 1.55 104.168 172.468 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.266 99.3 m -86.42 122.0 29.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 124.98 1.312 . . . . 1.08 109.683 179.227 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.492 HD11 HG13 ' A' ' 30' ' ' ILE . 89.3 mt -129.3 112.66 14.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 126.554 3.073 . . . . 1.55 109.146 -174.026 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -79.63 120.79 24.45 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 110.668 -2.969 . . . . 1.95 113.393 174.561 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.1 162.43 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 113.427 -1.715 . . . . 0.96 108.487 -175.235 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -118.54 170.53 6.32 Favored Pre-proline 0 N--CA 1.43 -1.435 0 O-C-N 116.836 -3.665 . . . . 2.35 108.85 168.13 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -62.9 -18.86 66.98 Favored 'Trans proline' 0 C--N 1.3 -1.982 1 C-N-CA 125.42 4.08 . . . . 0.95 120.813 -173.109 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.7 m -95.49 16.19 17.69 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 118.448 2.759 . . . . 1.45 118.448 171.049 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -77.25 148.45 35.77 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 124.746 2.212 . . . . 1.69 106.966 167.421 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.418 ' HB ' ' H ' ' A' ' 23' ' ' ILE . 71.4 p -97.73 -168.26 1.65 Allowed 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.028 -4.795 . . . . 0.75 114.109 175.791 . . . . . . . . 3 3 . 1 . 121 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.418 ' H ' ' HB ' ' A' ' 22' ' ' THR . 33.3 mm -89.1 -30.3 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 119.631 -1.918 . . . . 0.73 110.488 175.114 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -59.41 -32.19 69.95 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 128.0 2.52 . . . . 1.62 114.038 167.118 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.265 71.1 m-20 -64.23 -44.41 91.95 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 130.411 3.484 . . . . 2.13 115.348 161.709 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.9 t -65.91 -33.37 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 114.268 -2.973 . . . . 0.62 117.683 175.305 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.275 53.1 mtmt -73.11 -36.55 66.78 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.261 2.625 . . . . 1.22 109.227 -176.73 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.11 -32.84 71.06 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.631 -2.543 . . . . 0.51 111.197 174.569 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -74.95 -25.35 58.81 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 116.367 -3.958 . . . . 1.44 115.747 176.206 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.492 HG13 HD11 ' A' ' 15' ' ' LEU . 18.4 mt -80.83 -27.53 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 C-N-CA 117.181 -1.808 . . . . 1.32 113.88 172.933 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -64.09 -36.4 83.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.625 1.97 . . . . 1.7 114.351 169.997 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -60.54 -65.07 0.75 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 128.978 3.924 . . . . 1.55 109.786 167.859 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -67.6 -54.07 22.81 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 115.384 1.624 . . . . 2.62 115.384 -172.343 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -113.08 -25.1 9.1 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.951 -2.343 . . . . 1.48 115.001 -164.646 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.69 50.27 2.75 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 118.06 -2.019 . . . . 1.12 116.115 168.651 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.5 mt -120.72 128.4 25.8 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 130.389 3.476 . . . . 1.55 105.021 -178.623 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -63.98 146.73 91.6 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 124.403 3.402 . . . . 1.02 115.839 177.183 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -73.71 -9.05 22.25 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 124.356 3.37 . . . . 1.25 113.315 -171.268 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -87.86 -17.43 31.47 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 115.948 -2.301 . . . . 2.25 112.522 170.404 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -78.97 -25.21 43.48 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 120.179 1.354 . . . . 2.02 114.39 178.587 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -82.22 103.19 11.64 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.37 1.468 . . . . 0.69 113.131 -170.469 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 70' ' ' VAL . 93.9 mtt180 -90.89 118.33 30.2 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.934 -2.354 . . . . 2.78 112.677 170.553 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.409 HD12 HG23 ' A' ' 23' ' ' ILE . 76.9 mt -103.06 114.07 28.05 Favored 'General case' 0 N--CA 1.431 -1.392 1 CA-C-N 126.431 4.196 . . . . 1.17 113.698 -178.151 . . . . . . . . 3 3 . 1 . 121 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.8 mm -97.32 138.71 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 117.062 -1.447 . . . . 1.38 109.622 -177.13 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -157.35 129.46 7.2 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.596 -1.631 . . . . 1.5 106.596 176.251 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.06 9.12 2.91 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.181 1.792 . . . . 1.21 114.187 -174.483 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.57 -28.66 9.3 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 117.641 -1.644 . . . . 1.3 116.865 -176.092 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -96.47 153.8 17.63 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.417 2.377 . . . . 2.55 117.417 179.405 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -82.77 103.72 12.47 Favored 'General case' 0 N--CA 1.43 -1.433 1 C-N-CA 134.336 5.054 . . . . 2.48 112.911 178.017 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.9 mt -69.9 141.89 53.07 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.736 3.16 . . . . 0.9 115.219 -174.979 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.259 34.7 mt-10 -80.41 141.82 34.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.191 2.596 . . . . 1.94 114.381 176.831 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -53.03 -65.15 0.61 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 120.771 3.619 . . . . 1.56 120.771 -177.524 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.25 49.22 3.48 Favored Glycine 0 N--CA 1.43 -1.751 0 O-C-N 127.293 2.871 . . . . 0.97 111.807 178.799 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -118.86 147.63 43.75 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.544 -2.739 . . . . 2.49 104.825 168.873 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -79.66 173.4 12.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 117.125 -1.83 . . . . 0.76 115.16 175.74 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.29 -20.5 60.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.612 -2.555 . . . . 1.05 111.89 172.048 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 t -70.04 -49.03 55.38 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.207 -2.808 . . . . 1.19 110.952 177.6 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -57.04 -36.38 70.42 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.764 1.626 . . . . 1.9 114.02 175.824 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -92.83 5.73 50.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.097 2.159 . . . . 0.89 115.336 177.671 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.447 26.4 m120 44.82 43.25 6.79 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.247 2.619 . . . . 1.84 117.842 -176.796 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.8 mt -81.71 128.27 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 104.914 -2.254 . . . . 0.82 104.914 -176.339 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.268 10.2 mt-30 -105.85 179.94 4.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 127.774 3.171 . . . . 2.16 111.505 -174.155 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 pttp -69.02 129.02 38.73 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 124.807 1.243 . . . . 2.12 112.42 170.168 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 87.24 10.02 0.16 Allowed 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 126.837 2.055 . . . . 1.71 111.611 177.4 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.6 t -85.07 134.83 34.19 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 114.534 -5.104 . . . . 1.04 111.601 -173.542 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.8 m -99.97 120.93 40.57 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 123.697 1.713 . . . . 0.79 110.615 -177.811 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.0 mt -95.84 169.5 9.96 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.619 -1.628 . . . . 1.4 111.354 172.175 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -126.52 110.71 13.56 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.567 -1.958 . . . . 1.51 113.634 -173.281 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.7 tp -87.37 112.23 21.91 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.203 -1.56 . . . . 1.14 108.783 -175.824 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 42' ' ' ARG . 49.4 t -107.46 131.36 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 129.519 3.128 . . . . 1.23 112.068 170.881 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.6 mt -109.09 176.06 5.23 Favored 'General case' 0 N--CA 1.431 -1.381 0 O-C-N 120.056 -1.653 . . . . 2.78 111.289 -176.886 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -140.2 176.99 8.3 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.433 -2.062 . . . . 3.75 105.433 -177.518 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.3 mt -103.86 159.87 15.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.764 -1.835 . . . . 3.14 113.523 167.069 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.274 25.9 ptt180 -92.93 148.05 22.33 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.18 -3.45 . . . . 6.8 114.673 176.512 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.47 -108.8 0.22 Allowed Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 118.16 -1.971 . . . . 3.57 111.701 -169.008 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.75 0 O-C-N 120.044 -1.857 . . . . 3.87 109.273 175.184 . . . . . . . . 0 0 . 1 . 122 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 CA--C 1.491 -1.315 0 CA-C-O 118.85 -0.595 . . . . 1.1 110.761 . . . . . . . . . 0 0 . 1 . 122 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -97.25 118.96 34.86 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 113.633 0.975 . . . . 1.87 113.633 -169.553 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.8 pt -125.59 169.62 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 120.504 1.502 . . . . 0.72 112.725 172.404 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -120.87 154.02 36.39 Favored 'General case' 0 N--CA 1.431 -1.407 1 O-C-N 114.913 -4.867 . . . . 1.4 110.628 -178.211 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.3 t -125.39 135.25 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 103.237 -2.875 . . . . 0.58 103.237 172.901 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -114.22 143.38 44.92 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.837 -3.039 . . . . 2.09 107.579 176.803 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -96.75 170.08 9.43 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.414 1.486 . . . . 0.99 114.566 176.552 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.3 mt -55.7 -45.53 77.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.554 -2.591 . . . . 2.53 110.246 174.355 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 p -73.64 -57.46 3.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 116.66 -1.638 . . . . 2.08 111.936 -177.001 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.11 19.25 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.7 0 CA-C-O 125.549 2.75 . . . . 1.31 117.485 179.156 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -102.99 122.33 44.39 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 111.659 -2.27 . . . . 1.4 109.004 -168.707 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.0 m -95.6 124.62 39.71 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.395 2.521 . . . . 0.78 110.96 177.305 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 mm -100.44 129.7 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 115.034 -2.412 . . . . 1.55 106.824 -179.097 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.4 m -89.72 104.84 17.36 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 124.133 3.152 . . . . 1.08 108.319 179.49 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.4 mt -108.73 146.52 33.39 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 125.455 3.752 . . . . 1.55 120.975 -178.845 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -98.33 131.83 44.31 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 114.245 -1.343 . . . . 1.95 109.44 169.682 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.7 m -144.5 162.47 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 1 C-N-CA 132.127 4.171 . . . . 0.96 108.214 177.831 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -114.13 150.8 44.22 Favored Pre-proline 0 N--CA 1.429 -1.477 0 C-N-CA 126.487 1.915 . . . . 2.35 108.452 166.428 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -62.47 -21.92 73.38 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-O 125.182 2.076 . . . . 0.95 114.59 -168.104 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.8 p -83.26 0.1 47.1 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.273 3.429 . . . . 1.45 111.193 178.923 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -79.99 151.97 29.71 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 115.974 -4.204 . . . . 1.69 105.473 172.525 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 35.0 p -93.57 173.48 7.67 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 112.721 -2.036 . . . . 0.75 113.372 177.865 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 42.2 mm -72.05 -33.13 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 O-C-N 120.542 -1.349 . . . . 0.73 108.276 -179.076 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -55.45 -44.96 76.85 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 125.516 2.579 . . . . 1.62 115.806 167.004 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 -60.09 -42.47 94.69 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 116.075 -4.141 . . . . 2.13 112.595 176.488 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.9 t -69.78 -42.04 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 C-N-CA 129.485 3.114 . . . . 0.62 109.737 172.152 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -64.85 -37.44 87.65 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 125.825 3.92 . . . . 1.22 112.267 -178.668 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.5 -31.59 56.29 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 119.926 3.306 . . . . 0.51 119.926 169.739 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.265 15.9 tppt? -80.15 -35.04 37.16 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 121.543 0.687 . . . . 1.44 111.977 174.087 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.8 mt -60.81 -42.49 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.371 -1.455 . . . . 1.32 114.289 171.215 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -56.11 -39.5 72.27 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.878 2.871 . . . . 1.7 111.622 173.845 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -70.57 -45.47 65.35 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 124.71 1.256 . . . . 1.55 113.718 176.698 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -70.67 -51.69 26.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 115.04 1.496 . . . . 2.62 115.04 -176.643 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -104.48 -14.14 15.8 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.682 1.993 . . . . 1.48 113.903 -168.66 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.21 49.23 34.22 Favored Glycine 0 N--CA 1.431 -1.648 0 O-C-N 118.238 -2.789 . . . . 1.12 112.987 175.438 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.407 ' CD1' HD21 ' A' ' 69' ' ' LEU . 56.9 mt -125.25 126.38 25.14 Favored Pre-proline 0 N--CA 1.429 -1.478 0 N-CA-C 105.047 -2.205 . . . . 1.55 105.047 178.735 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -66.84 150.29 83.24 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 125.237 3.958 . . . . 1.02 111.79 179.983 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -60.08 -31.51 93.47 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 C-N-CA 125.169 3.913 . . . . 1.25 114.721 -173.689 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -56.96 -41.4 78.27 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 130.33 3.452 . . . . 2.25 110.096 176.285 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -89.19 2.72 53.8 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.601 -1.312 . . . . 2.02 113.714 -178.307 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -90.01 116.51 28.1 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.429 2.692 . . . . 0.69 116.678 -173.697 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -111.96 109.03 18.58 Favored 'General case' 0 N--CA 1.429 -1.5 1 O-C-N 115.623 -4.423 . . . . 2.78 111.777 169.2 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 43' ' ' LEU . 51.8 mt -89.4 122.04 32.23 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.943 -1.723 . . . . 1.17 108.537 -178.879 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.3 mm -111.47 123.43 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 126.941 3.258 . . . . 1.38 111.474 177.316 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.276 69.6 t80 -132.31 134.7 45.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 116.531 -3.856 . . . . 1.5 104.533 173.104 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.99 28.22 0.59 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 119.77 3.248 . . . . 1.21 119.77 -177.62 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.8 -12.1 69.83 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 126.033 1.778 . . . . 1.3 111.598 -177.757 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -86.59 145.04 26.91 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.621 -1.517 . . . . 2.55 114.396 -179.347 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -87.09 109.76 19.64 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.033 -2.292 . . . . 2.48 109.615 171.893 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.7 mt -71.16 133.14 45.96 Favored 'General case' 0 N--CA 1.431 -1.423 1 CA-C-O 128.778 4.132 . . . . 0.9 109.303 -170.017 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -89.94 135.69 33.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.363 -3.961 . . . . 1.94 118.123 -179.791 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.407 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 9.0 m-20 -55.05 -54.22 45.83 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 116.864 -3.648 . . . . 1.56 119.332 -168.492 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.55 23.27 16.74 Favored Glycine 0 N--CA 1.429 -1.785 0 CA-C-O 118.424 -1.209 . . . . 0.97 112.026 177.298 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.4 mtt-85 -104.27 161.56 13.94 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 121.679 2.74 . . . . 2.49 108.624 165.981 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.1 p -97.89 156.63 16.51 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.557 2.743 . . . . 0.76 112.993 178.005 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.3 mt -58.86 -32.48 69.48 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.243 2.449 . . . . 1.05 114.878 179.712 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.5 p -69.03 -26.65 65.1 Favored 'General case' 0 N--CA 1.429 -1.52 0 O-C-N 116.627 -3.795 . . . . 1.19 117.558 176.376 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -68.61 -37.18 79.58 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.53 -1.981 . . . . 1.9 110.628 174.974 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -82.0 -13.57 57.21 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 115.262 -2.304 . . . . 0.89 106.779 -178.403 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.3 m120 65.82 56.44 0.89 Allowed 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 126.295 2.247 . . . . 1.84 108.437 -177.174 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.8 mt -99.32 136.17 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 103.922 -2.622 . . . . 0.82 103.922 179.545 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -109.69 178.16 4.51 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 126.318 2.961 . . . . 2.16 109.932 -178.799 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -60.8 152.32 27.38 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 112.4 -2.182 . . . . 2.12 116.212 167.778 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.277 53.4 mt-10 67.04 11.99 8.71 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 114.937 1.458 . . . . 1.71 114.937 -177.899 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -89.16 150.0 22.89 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.067 2.365 . . . . 1.04 109.485 -175.883 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.1 m -104.38 120.28 40.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.175 -1.578 . . . . 0.79 111.757 -176.918 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.3 mt -89.51 135.7 33.45 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.695 -1.878 . . . . 1.4 112.399 172.988 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -105.53 122.5 46.13 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.581 -2.574 . . . . 1.51 104.998 -174.792 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.407 HD21 ' CD1' ' A' ' 36' ' ' ILE . 60.0 tp -93.63 108.51 20.22 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.445 2.298 . . . . 1.14 110.803 -177.084 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.278 28.8 t -98.88 140.29 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 128.179 3.847 . . . . 1.23 105.07 173.216 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.0 mt -87.72 134.23 33.7 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 118.621 -2.55 . . . . 2.78 106.756 170.643 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -90.41 117.07 28.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.369 1.868 . . . . 3.75 110.692 178.347 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.0 mt -95.17 112.2 23.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 127.059 2.725 . . . . 3.14 107.855 173.769 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.319 13.7 ptm180 -63.89 161.27 15.88 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 117.568 2.432 . . . . 6.8 117.568 177.023 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -143.29 35.28 1.67 Allowed Glycine 0 N--CA 1.43 -1.731 0 CA-C-O 118.156 -1.358 . . . . 3.57 110.508 -170.482 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.754 0 CA-C-O 123.966 1.87 . . . . 3.87 111.868 -175.09 . . . . . . . . 0 0 . 1 . 123 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.4 ttp . . . . . 0 CA--C 1.489 -1.388 0 CA-C-O 117.375 -1.298 . . . . 1.1 109.681 . . . . . . . . . 0 0 . 1 . 123 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -87.8 133.05 33.95 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 120.314 1.415 . . . . 1.87 114.681 -178.704 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pt -138.98 164.54 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 118.582 -2.574 . . . . 0.72 109.332 174.443 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -113.21 146.71 38.84 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 127.053 2.141 . . . . 1.4 110.852 -177.397 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.1 t -126.98 105.61 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 105.886 -1.894 . . . . 0.58 105.886 175.076 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -84.03 120.96 26.76 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 131.631 3.972 . . . . 2.09 115.293 173.761 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.2 p -104.41 -121.96 0.21 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.677 1.362 . . . . 0.99 114.677 -174.163 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.0 tp -159.98 -63.53 0.07 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 103.284 -2.858 . . . . 2.53 103.284 173.585 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.5 p -97.14 93.94 6.84 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 120.418 1.463 . . . . 2.08 111.901 -178.215 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.49 -146.93 17.63 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 127.842 2.639 . . . . 1.31 110.415 176.96 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -90.88 168.33 11.78 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 122.545 1.164 . . . . 1.4 112.154 -174.853 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -102.61 116.91 33.54 Favored 'General case' 0 N--CA 1.431 -1.383 1 N-CA-C 99.382 -4.303 . . . . 0.78 99.382 175.65 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.28 16.4 pt -84.33 152.17 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 128.097 2.559 . . . . 1.55 112.578 178.159 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 m -116.77 128.67 55.52 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 128.345 2.658 . . . . 1.08 106.263 176.617 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.6 mt -122.06 157.43 31.43 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.393 -2.692 . . . . 1.55 108.447 179.663 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -107.65 120.88 43.45 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.019 -2.301 . . . . 1.95 104.983 170.996 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.1 m -131.03 172.55 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 125.435 1.494 . . . . 0.96 109.806 -175.263 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -112.94 152.7 45.1 Favored Pre-proline 0 N--CA 1.43 -1.441 0 CA-C-O 116.304 -1.808 . . . . 2.35 111.136 164.911 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.76 -22.32 32.26 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 126.335 3.298 . . . . 0.95 114.118 -176.345 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.0 m -72.45 -12.88 61.28 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 116.137 -1.887 . . . . 1.45 110.251 176.073 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -66.08 135.54 54.76 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 123.4 2.818 . . . . 1.69 117.842 177.276 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.5 p -69.83 160.91 30.89 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 117.547 -3.221 . . . . 0.75 112.873 176.795 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 mm -66.58 -42.28 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 128.025 2.53 . . . . 0.73 108.279 175.366 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -45.93 -49.62 15.52 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.084 2.624 . . . . 1.62 118.084 161.275 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -68.31 -45.53 72.72 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 127.547 3.029 . . . . 2.13 111.447 178.997 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.453 HG21 HD11 ' A' ' 56' ' ' LEU . 58.5 t -59.02 -30.1 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 115.209 1.559 . . . . 0.62 115.209 173.936 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -68.38 -35.56 77.88 Favored 'General case' 0 N--CA 1.43 -1.475 1 O-C-N 113.871 -5.518 . . . . 1.22 111.671 169.657 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.2 -46.76 82.6 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 124.106 1.908 . . . . 0.51 115.506 169.6 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -47.98 -49.84 29.41 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 127.0 2.12 . . . . 1.44 109.046 169.727 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.2 mt -62.63 -30.34 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 123.653 2.933 . . . . 1.32 116.856 175.462 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -68.48 -34.64 76.29 Favored 'General case' 0 N--CA 1.431 -1.414 1 CA-C-O 128.821 4.153 . . . . 1.7 114.52 -174.181 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -61.74 -41.41 97.62 Favored 'General case' 0 N--CA 1.432 -1.369 2 O-C-N 115.043 -4.786 . . . . 1.55 112.178 172.286 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -91.74 -65.65 0.99 Allowed 'General case' 0 N--CA 1.429 -1.495 1 O-C-N 115.556 -4.465 . . . . 2.62 107.467 -172.801 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -88.36 -17.77 29.85 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 126.111 2.862 . . . . 1.48 116.158 -165.241 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.75 34.31 28.12 Favored Glycine 0 N--CA 1.43 -1.747 0 O-C-N 117.648 -3.158 . . . . 1.12 116.248 176.629 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.8 mt -107.85 121.92 42.49 Favored Pre-proline 0 N--CA 1.429 -1.492 0 N-CA-C 107.011 -1.477 . . . . 1.55 107.011 -178.354 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.288 52.8 Cg_exo -51.36 146.8 23.54 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-O 113.875 -2.635 . . . . 1.02 116.357 175.78 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -68.67 -23.1 36.68 Favored 'Trans proline' 0 C--N 1.299 -2.058 1 C-N-CA 125.761 4.307 . . . . 1.25 110.249 -175.623 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -84.44 -18.48 35.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.555 2.428 . . . . 2.25 117.555 176.573 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -88.34 -24.15 23.21 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 115.465 1.654 . . . . 2.02 115.465 -177.59 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -100.57 139.25 36.52 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.568 1.547 . . . . 0.69 112.528 -177.201 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -118.4 133.14 56.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 107.89 -1.152 . . . . 2.78 107.89 175.172 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.6 mt -99.5 127.0 45.54 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.733 1.606 . . . . 1.17 114.762 -179.441 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.0 mm -107.86 138.41 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 1 O-C-N 130.357 4.786 . . . . 1.38 107.121 -177.09 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -145.72 140.05 26.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.441 -3.912 . . . . 1.5 102.274 171.552 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.301 . . 62.5 -96.13 0.05 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.604 1.561 . . . . 1.21 109.079 -174.66 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.61 24.59 1.2 Allowed Glycine 0 N--CA 1.429 -1.817 0 O-C-N 127.744 3.153 . . . . 1.3 110.217 -179.291 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -121.34 147.87 45.11 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.2 1.8 . . . . 2.55 107.793 -177.37 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -95.98 130.97 42.82 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.897 -1.956 . . . . 2.48 107.58 173.306 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mt -96.15 124.79 40.29 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.805 3.261 . . . . 0.9 119.805 -172.813 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -66.14 132.75 49.2 Favored 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 132.549 4.34 . . . . 1.94 114.024 177.429 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -63.64 -32.87 74.48 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.297 -3.377 . . . . 1.56 114.737 -169.239 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.84 25.71 7.28 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 116.374 -3.953 . . . . 0.97 115.362 173.662 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -121.47 168.28 11.88 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 120.766 2.283 . . . . 2.49 111.134 173.614 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 p -104.83 154.6 19.83 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.185 1.469 . . . . 0.76 111.262 -178.39 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.453 HD11 HG21 ' A' ' 26' ' ' VAL . 24.8 mt -51.48 -37.96 51.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.046 1.879 . . . . 1.05 113.268 173.444 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -59.16 -50.1 75.33 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.48 -3.263 . . . . 1.19 117.057 171.391 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -43.04 -47.72 5.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.986 -3.571 . . . . 1.9 113.882 168.046 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -77.97 -13.61 59.82 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 117.762 2.504 . . . . 0.89 117.762 177.415 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.5 m120 69.08 63.9 0.29 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.631 1.972 . . . . 1.84 112.723 178.523 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.4 mt -98.33 137.1 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 117.43 -3.293 . . . . 0.82 106.837 176.22 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -117.58 -179.47 3.74 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 106.32 -1.733 . . . . 2.16 106.32 -174.659 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -71.3 140.45 50.31 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 126.77 2.544 . . . . 2.12 115.363 176.712 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 22.9 mt-10 70.83 46.53 0.49 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 126.133 2.873 . . . . 1.71 114.099 177.308 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.3 m -109.42 135.46 50.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 112.076 -2.329 . . . . 1.04 113.298 -173.643 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.3 m -92.47 99.81 12.48 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.788 -3.07 . . . . 0.79 112.392 -173.985 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mp -81.95 146.35 29.82 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.168 -1.79 . . . . 1.4 106.168 176.344 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -107.91 138.44 44.16 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.934 -1.506 . . . . 1.51 106.934 -175.363 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 tt -106.56 122.07 45.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 119.983 1.265 . . . . 1.14 111.435 -177.606 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.6 m -107.84 122.45 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 104.922 -2.251 . . . . 1.23 104.922 175.5 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.8 tp -100.42 127.15 46.84 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.707 2.803 . . . . 2.78 116.863 -173.385 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -82.19 118.45 23.1 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.596 -2.565 . . . . 3.75 110.925 -179.564 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.1 mt -105.84 -51.3 3.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 126.328 2.267 . . . . 3.14 105.392 178.974 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.6 mtt85 -106.74 -72.8 0.71 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.275 -2.861 . . . . 6.8 103.275 173.782 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.85 151.9 5.58 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-O 125.577 2.765 . . . . 3.57 111.048 -169.324 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.815 0 O-C-N 117.356 -3.438 . . . . 3.87 109.423 -177.444 . . . . . . . . 0 0 . 1 . 124 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.3 ttp . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 117.391 2.367 . . . . 1.1 117.391 . . . . . . . . . 0 0 . 1 . 124 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -109.58 113.48 26.3 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.492 1.293 . . . . 1.87 114.492 -173.499 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.51 HD12 HD13 ' A' ' 67' ' ' LEU . 20.3 pt -111.41 171.15 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 119.597 -1.94 . . . . 0.72 110.062 174.246 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -124.65 122.67 38.17 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.869 2.068 . . . . 1.4 108.07 -176.617 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.507 HG22 ' HB2' ' A' ' 67' ' ' LEU . 45.6 t -104.41 114.17 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 118.549 -2.594 . . . . 0.58 110.091 171.169 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -93.37 158.22 15.84 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.06 -3.525 . . . . 2.09 108.909 178.063 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.9 p -119.27 172.91 7.27 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.533 -3.23 . . . . 0.99 114.369 -178.945 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.2 tp -72.55 -47.3 49.3 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.572 1.653 . . . . 2.53 110.97 178.647 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.9 p -73.65 -30.67 63.07 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.479 -1.388 . . . . 2.08 113.271 -176.398 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.07 2.07 0.65 Allowed Glycine 0 N--CA 1.43 -1.724 0 O-C-N 117.021 -3.55 . . . . 1.31 117.203 176.995 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -91.28 149.84 21.58 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 122.667 3.234 . . . . 1.4 108.57 -179.664 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.2 m -134.95 112.8 10.92 Favored 'General case' 0 N--CA 1.431 -1.398 1 N-CA-C 100.138 -4.023 . . . . 0.78 100.138 -179.806 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 mt -106.31 113.35 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 129.741 3.217 . . . . 1.55 114.231 -171.682 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.6 m -74.75 114.98 13.81 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.662 -2.524 . . . . 1.08 115.542 173.445 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.1 mt -113.66 129.11 56.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.515 1.507 . . . . 1.55 109.088 -176.791 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -97.72 113.86 25.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.618 -1.301 . . . . 1.95 111.714 174.704 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -116.5 166.62 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 126.395 2.309 . . . . 0.96 110.569 -170.599 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -112.19 155.34 43.66 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 113.252 -3.261 . . . . 2.35 105.69 164.641 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.9 -21.73 63.81 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 CA-C-N 124.207 2.538 . . . . 0.95 117.433 -175.957 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.5 p -73.89 -17.31 61.06 Favored 'General case' 0 N--CA 1.431 -1.41 1 C-N-CA 134.307 5.043 . . . . 1.45 118.927 173.024 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -69.14 143.47 54.11 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 125.475 2.56 . . . . 1.69 109.301 174.083 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 3.3 p -94.74 164.12 13.07 Favored 'General case' 0 N--CA 1.431 -1.408 1 O-C-N 116.197 -4.064 . . . . 0.75 105.154 -177.43 . . . . . . . . 3 3 . 1 . 124 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.1 mm -56.27 -42.91 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 126.666 2.479 . . . . 0.73 111.605 176.651 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -46.77 -50.55 18.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 116.213 1.931 . . . . 1.62 116.213 164.559 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -74.02 -24.97 59.63 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 121.919 2.145 . . . . 2.13 111.166 178.45 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.2 t -74.06 -33.27 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 116.867 -3.646 . . . . 0.62 111.322 176.44 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -71.16 -28.84 64.55 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.347 -3.971 . . . . 1.22 109.231 172.366 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.57 -28.13 69.66 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 115.914 -4.241 . . . . 0.51 117.377 168.192 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -74.16 -30.87 62.47 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 122.593 2.452 . . . . 1.44 109.021 -178.134 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.0 mt -67.69 -35.71 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 O-C-N 127.216 2.822 . . . . 1.32 114.813 172.284 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -73.33 -15.8 61.38 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 118.993 2.96 . . . . 1.7 118.993 178.157 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -69.07 -43.0 75.48 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.436 1.273 . . . . 1.55 114.436 162.721 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -73.06 -61.07 1.94 Allowed 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 126.893 3.235 . . . . 2.62 112.348 -175.405 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -100.15 -30.34 11.99 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.133 -2.854 . . . . 1.48 110.16 -164.564 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.43 33.11 7.75 Favored Glycine 0 N--CA 1.431 -1.674 0 O-C-N 128.116 3.385 . . . . 1.12 115.729 173.239 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.3 mt -106.05 129.21 24.93 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 116.566 -1.683 . . . . 1.55 107.291 -177.975 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -62.82 142.65 89.57 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 124.405 3.404 . . . . 1.02 119.747 175.98 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.28 -17.65 35.07 Favored 'Trans proline' 0 C--N 1.299 -2.057 0 N-CA-C 118.445 2.441 . . . . 1.25 118.445 -178.111 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -68.15 -24.87 65.04 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.72 -1.237 . . . . 2.25 113.728 173.144 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -93.69 -18.11 22.48 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.746 1.736 . . . . 2.02 111.184 -179.493 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -95.02 154.15 17.3 Favored 'General case' 0 N--CA 1.431 -1.378 0 O-C-N 118.419 -2.676 . . . . 0.69 110.82 -176.264 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -141.32 151.35 43.53 Favored 'General case' 0 N--CA 1.43 -1.465 1 C-N-CA 133.284 4.633 . . . . 2.78 113.257 171.136 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.5 mt -115.99 132.61 56.6 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.211 -2.806 . . . . 1.17 111.035 177.404 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.1 mt -109.73 123.1 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.354 -1.35 . . . . 1.38 107.354 -178.529 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -145.72 140.92 27.57 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.382 -2.699 . . . . 1.5 103.976 175.712 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.85 14.21 7.99 Favored 'General case' 0 N--CA 1.43 -1.434 1 C-N-CA 131.717 4.007 . . . . 1.21 114.53 -176.555 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.95 -30.39 10.52 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 125.74 1.638 . . . . 1.3 115.441 -171.796 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -101.25 156.16 17.6 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 120.73 2.265 . . . . 2.55 115.422 -177.974 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -72.29 135.62 46.02 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 116.897 -1.525 . . . . 2.48 113.416 167.797 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.6 mt -89.05 145.57 25.39 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.102 2.228 . . . . 0.9 112.716 -176.119 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -72.55 139.24 47.4 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.203 -2.186 . . . . 1.94 111.549 173.418 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -66.99 -56.25 10.96 Favored 'General case' 0 N--CA 1.431 -1.409 1 C-N-CA 131.826 4.05 . . . . 1.56 119.49 -168.519 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.6 37.14 2.78 Favored Glycine 0 N--CA 1.43 -1.757 0 O-C-N 117.936 -2.977 . . . . 0.97 116.775 175.564 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -114.13 160.49 18.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.866 -2.549 . . . . 2.49 108.576 171.266 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.452 54.7 p -87.49 146.27 25.89 Favored 'General case' 0 N--CA 1.43 -1.47 1 C-N-CA 132.103 4.161 . . . . 0.76 111.571 179.711 . . . . . . . . 4 3 . 1 . 124 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mt -55.46 -34.87 64.9 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 114.694 1.368 . . . . 1.05 114.694 172.026 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 p -64.11 -33.81 76.62 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.238 3.015 . . . . 1.19 112.975 178.567 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -66.62 -37.12 84.19 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 125.047 1.339 . . . . 1.9 113.74 178.226 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -85.92 -5.13 59.28 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.06 1.344 . . . . 0.89 110.038 175.152 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.4 t30 60.74 38.45 18.25 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 127.053 3.311 . . . . 1.84 116.257 179.139 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.0 mt -74.82 125.24 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 O-C-N 116.892 -3.63 . . . . 0.82 109.611 -177.405 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -99.19 -175.84 3.14 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.217 -2.802 . . . . 2.16 111.854 -176.982 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -70.68 160.67 32.18 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 124.116 1.912 . . . . 2.12 111.233 177.165 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.384 16.4 mt-10 44.83 48.54 9.1 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 118.133 2.642 . . . . 1.71 118.133 179.626 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.6 m -107.28 144.05 34.66 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 127.34 2.9 . . . . 1.04 106.028 -175.941 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.6 m -108.75 103.81 12.96 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.586 -1.188 . . . . 0.79 108.118 -178.205 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.51 HD13 HD12 ' A' ' 3' ' ' ILE . 4.1 mp -87.62 158.51 18.85 Favored 'General case' 0 N--CA 1.429 -1.475 1 C-N-CA 132.52 4.328 . . . . 1.4 106.377 173.339 . . . . . . . . 3 3 . 1 . 124 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -121.28 142.89 49.51 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 102.079 -3.304 . . . . 1.51 102.079 -174.085 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.5 tp -97.99 129.35 44.87 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 114.669 -2.586 . . . . 1.14 108.975 -179.784 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 m -129.72 168.05 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 121.642 2.019 . . . . 1.23 106.632 171.092 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.9 mt -112.49 143.9 42.85 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.384 -2.073 . . . . 2.78 106.772 -177.147 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -102.96 94.82 5.77 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.489 -0.778 . . . . 3.75 109.666 177.175 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.56 -176.83 3.19 Favored 'General case' 0 N--CA 1.43 -1.437 1 C-N-CA 134.083 4.953 . . . . 3.14 110.438 174.071 . . . . . . . . 3 3 . 1 . 124 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.8 mtm105 -81.02 132.63 35.38 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.596 2.617 . . . . 6.8 110.375 166.345 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.53 -133.72 11.46 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 119.287 -2.133 . . . . 3.57 115.036 -161.391 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.743 1 CA-C-O 112.132 -4.705 . . . . 3.87 113.841 -174.715 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptt? . . . . . 0 CA--C 1.489 -1.389 0 N-CA-C 108.363 -0.977 . . . . 1.1 108.363 . . . . . . . . . 0 0 . 1 . 125 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -102.39 131.58 48.94 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.009 2.124 . . . . 1.87 112.365 -172.147 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.1 pt -139.07 157.17 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-O 125.606 2.622 . . . . 0.72 106.625 176.651 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -109.01 121.7 45.69 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.834 -2.416 . . . . 1.4 112.764 -176.954 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.1 t -96.85 103.42 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 116.854 -3.654 . . . . 0.58 107.166 175.073 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -76.43 136.43 39.44 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 118.567 2.803 . . . . 2.09 118.567 168.272 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -83.33 169.96 15.08 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.065 -4.147 . . . . 0.99 109.847 177.622 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.512 HD11 HG13 ' A' ' 70' ' ' VAL . 19.2 mt -60.71 -42.64 97.64 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.419 -2.676 . . . . 2.53 115.455 170.324 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -75.44 -51.2 13.61 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 127.145 2.778 . . . . 2.08 116.148 -176.706 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.21 -44.84 0.19 Allowed Glycine 0 N--CA 1.431 -1.695 0 CA-C-O 113.956 -3.691 . . . . 1.31 114.161 -177.845 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -53.51 136.18 38.7 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 122.62 3.21 . . . . 1.4 118.625 -177.445 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.266 88.5 m -107.72 98.7 8.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.79 1.757 . . . . 0.78 107.818 178.4 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -80.72 98.64 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 125.695 2.664 . . . . 1.55 110.195 177.231 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.5 m -82.12 122.85 28.38 Favored 'General case' 0 N--CA 1.429 -1.498 1 O-C-N 115.153 -4.717 . . . . 1.08 110.722 178.269 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.5 mt -122.28 144.32 49.07 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.175 1.917 . . . . 1.55 116.175 -178.494 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -103.86 124.83 49.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 116.42 -2.112 . . . . 1.95 108.749 174.905 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.8 m -140.98 165.08 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.041 -1.662 . . . . 0.96 108.094 -171.122 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.293 4.6 mm-40 -102.75 150.19 37.49 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-O 114.538 -2.649 . . . . 2.35 110.518 163.578 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.41 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 33.3 Cg_endo -75.96 -14.9 18.95 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 125.877 3.135 . . . . 0.95 109.12 -171.963 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.1 p -81.18 -1.31 44.16 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 123.836 1.779 . . . . 1.45 114.129 174.202 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -75.02 147.92 40.31 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 118.315 -2.74 . . . . 1.69 113.021 172.309 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.649 ' O ' HG23 ' A' ' 26' ' ' VAL . 41.0 p -85.82 176.42 8.12 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 124.287 1.994 . . . . 0.75 112.894 -175.349 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.252 20.8 mm -76.85 -37.23 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 116.345 -3.972 . . . . 0.73 106.278 177.832 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -53.33 -36.36 61.2 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.282 -3.386 . . . . 1.62 112.027 169.027 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -74.83 -46.08 38.96 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 120.629 1.559 . . . . 2.13 112.281 177.365 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 22' ' ' THR . 26.1 t -57.3 -43.26 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 C-N-CA 128.829 2.852 . . . . 0.62 112.02 175.538 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -70.26 -34.26 72.6 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.661 2.467 . . . . 1.22 117.661 171.509 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.94 89.29 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.598 -1.939 . . . . 0.51 106.855 178.057 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -57.97 -41.52 83.1 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 119.292 3.071 . . . . 1.44 119.292 167.567 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.268 65.3 mt -63.22 -35.91 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.242 -2.786 . . . . 1.32 113.66 170.635 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -61.37 -41.26 96.81 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 130.747 3.619 . . . . 1.7 109.389 172.074 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -58.15 -57.53 12.45 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 114.45 1.278 . . . . 1.55 114.45 177.195 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -73.13 -63.59 1.15 Allowed 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 117.731 2.493 . . . . 2.62 117.731 -174.284 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -101.35 -19.06 15.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.071 -1.643 . . . . 1.48 111.566 -168.529 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.76 30.3 6.88 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 118.215 2.046 . . . . 1.12 118.215 173.696 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.9 mt -106.15 119.2 52.86 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-N 121.35 2.575 . . . . 1.55 109.104 -176.018 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -56.28 145.89 75.19 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 CA-C-N 127.263 3.629 . . . . 1.02 114.363 174.946 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -82.72 -5.31 11.56 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 124.499 3.466 . . . . 1.25 108.493 -166.214 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -80.93 -23.74 38.67 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.516 1.507 . . . . 2.25 111.384 176.389 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -90.07 -12.75 37.56 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.051 -2.281 . . . . 2.02 111.657 -178.192 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -87.21 123.49 32.28 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 130.167 3.387 . . . . 0.69 111.647 -174.682 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -123.47 114.13 19.69 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-O 125.107 2.384 . . . . 2.78 109.472 161.777 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.9 mt -87.18 138.6 31.35 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 124.346 2.022 . . . . 1.17 106.486 -178.553 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.6 mt -135.37 128.54 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 128.006 2.523 . . . . 1.38 110.209 -178.54 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -127.17 115.32 18.92 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 115.291 -4.631 . . . . 1.5 104.603 177.931 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 73.15 -58.52 0.6 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.729 2.812 . . . . 1.21 110.605 177.082 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.412 ' H ' ' H ' ' A' ' 48' ' ' LYS . . . -162.66 -13.73 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 O-C-N 120.502 -1.374 . . . . 1.3 111.849 -178.365 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.412 ' H ' ' H ' ' A' ' 47' ' ' GLY . 48.4 mttt -98.62 134.0 42.17 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.127 -1.536 . . . . 2.55 109.502 -177.163 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -73.27 140.61 46.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.838 2.055 . . . . 2.48 108.856 166.828 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.0 mt -97.56 123.28 41.39 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.204 -1.776 . . . . 0.9 106.204 -170.853 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -91.46 145.68 24.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.747 -2.471 . . . . 1.94 110.26 178.955 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -43.26 -57.59 2.92 Favored 'General case' 0 N--CA 1.43 -1.439 1 C-N-CA 131.993 4.117 . . . . 1.56 119.818 -175.757 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.15 7.29 8.13 Favored Glycine 0 N--CA 1.43 -1.728 1 N-CA-C 123.149 4.02 . . . . 0.97 123.149 168.524 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -98.23 167.07 11.09 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 120.656 2.228 . . . . 2.49 112.158 167.738 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.341 18.6 p -109.81 166.61 10.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.828 2.159 . . . . 0.76 116.828 -179.137 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.6 mt -61.98 -35.36 78.28 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.029 2.347 . . . . 1.05 111.62 172.21 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 5.8 t -75.84 -33.03 60.02 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.601 -2.562 . . . . 1.19 113.477 -179.997 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -56.42 -46.4 80.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.834 2.054 . . . . 1.9 114.116 166.248 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -84.77 -9.22 58.4 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 121.817 2.099 . . . . 0.89 112.756 -179.617 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.522 12.8 m120 81.68 46.52 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 125.867 1.667 . . . . 1.84 113.591 175.403 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.1 mt -96.8 118.81 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 113.495 -1.684 . . . . 0.82 114.012 179.931 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -115.1 -179.02 3.51 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 106.319 -1.734 . . . . 2.16 106.319 -174.964 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -62.05 151.87 34.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 127.801 2.441 . . . . 2.12 114.405 -178.675 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 66.2 29.55 9.66 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.797 2.237 . . . . 1.71 110.746 177.495 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.6 p -106.71 150.95 25.75 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 113.982 -5.449 . . . . 1.04 109.298 -176.158 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.4 m -103.14 122.18 44.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.329 2.49 . . . . 0.79 109.668 179.713 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -110.57 145.21 38.22 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 118.615 -2.553 . . . . 1.4 105.539 176.559 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -100.67 136.12 41.03 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 118.58 -2.575 . . . . 1.51 107.189 179.859 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.5 tp -113.96 123.96 50.99 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.961 -1.712 . . . . 1.14 108.21 174.691 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.512 HG13 HD11 ' A' ' 8' ' ' LEU . 48.8 t -105.85 134.51 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 103.083 -2.932 . . . . 1.23 103.083 176.04 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.8 tp -96.05 143.17 27.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.339 2.495 . . . . 2.78 111.985 174.825 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -117.05 148.7 41.27 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.348 -3.345 . . . . 3.75 105.781 174.839 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.463 4.6 mt -77.38 127.72 33.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 121.095 -0.242 . . . . 3.14 110.68 173.548 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.407 30.1 ttm180 -129.87 -73.93 0.56 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 123.169 0.587 . . . . 6.8 111.602 163.442 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.95 20.75 1.43 Allowed Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 120.208 2.843 . . . . 3.57 120.208 -166.305 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.728 1 O-C-N 116.176 -4.132 . . . . 3.87 108.317 177.04 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.4 ttp . . . . . 0 CA--C 1.49 -1.335 0 CA-C-O 117.396 -1.288 . . . . 1.1 110.935 . . . . . . . . . 0 0 . 1 . 126 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -81.34 133.1 35.37 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 120.405 1.457 . . . . 1.87 111.21 -179.136 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 pt -140.25 162.73 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 123.981 1.848 . . . . 0.72 108.072 173.565 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -120.66 133.31 55.37 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 102.226 -3.25 . . . . 1.4 102.226 -177.148 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.0 t -109.48 123.83 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 127.994 2.517 . . . . 0.58 104.831 167.829 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -101.06 124.16 46.34 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.787 -1.821 . . . . 2.09 111.43 176.74 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.423 HG22 HD23 ' A' ' 69' ' ' LEU . 1.3 p -85.84 151.81 23.5 Favored 'General case' 0 N--CA 1.431 -1.41 1 O-C-N 115.448 -4.533 . . . . 0.99 114.041 175.032 . . . . . . . . 3 3 . 1 . 126 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.5 tp -34.56 -54.1 0.54 Allowed 'General case' 0 N--CA 1.43 -1.434 1 C-N-CA 133.018 4.527 . . . . 2.53 115.404 169.83 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.4 p -81.88 -31.78 31.32 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 125.872 1.982 . . . . 2.08 110.644 -170.93 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.78 17.28 0.11 Allowed Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 118.444 -1.836 . . . . 1.31 117.048 178.862 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -114.79 141.91 47.23 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 115.68 -4.423 . . . . 1.4 105.404 -177.685 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.5 m -105.77 124.79 50.13 Favored 'General case' 0 N--CA 1.429 -1.522 0 O-C-N 123.358 0.411 . . . . 0.78 109.944 173.473 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.402 HD13 HG23 ' A' ' 30' ' ' ILE . 2.4 mt -93.46 116.09 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 125.577 2.608 . . . . 1.55 105.933 179.889 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.2 m -92.26 102.45 14.95 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 115.507 -4.495 . . . . 1.08 107.323 174.72 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.5 mt -90.96 160.21 15.77 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.526 -1.359 . . . . 1.55 110.54 178.616 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -125.3 114.06 18.41 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 119.854 -1.779 . . . . 1.95 108.008 165.715 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.01 -176.2 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 119.205 -2.185 . . . . 0.96 110.382 -173.318 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -107.08 149.12 38.22 Favored Pre-proline 0 N--CA 1.43 -1.432 0 CA-C-O 114.096 -2.859 . . . . 2.35 109.622 167.145 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.39 -24.15 19.68 Favored 'Trans proline' 0 N--CA 1.433 -2.054 1 CA-C-N 128.661 4.129 . . . . 0.95 111.807 -171.561 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.8 m -102.03 16.29 26.47 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 126.318 2.261 . . . . 1.45 116.873 -179.352 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.83 157.56 25.68 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.306 1.527 . . . . 1.69 112.446 173.227 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 1.8 p -86.68 162.58 17.84 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.51 3.052 . . . . 0.75 116.204 -176.903 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mm -70.45 -38.96 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 1 O-C-N 115.124 -4.735 . . . . 0.73 107.512 -179.289 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -47.58 -54.11 12.7 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.346 3.058 . . . . 1.62 111.592 167.937 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -62.22 -36.98 83.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.945 2.898 . . . . 2.13 118.178 171.375 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.372 4.2 t -63.3 -39.31 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 116.57 -3.831 . . . . 0.62 112.52 174.847 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -65.91 -32.39 73.87 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.844 2.165 . . . . 1.22 116.844 172.089 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.82 -31.62 72.36 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.636 -1.915 . . . . 0.51 114.1 170.472 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -68.24 -26.88 65.91 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.276 1.988 . . . . 1.44 115.217 170.199 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.402 HG23 HD13 ' A' ' 13' ' ' ILE . 84.4 mt -75.2 -28.25 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 117.385 -3.322 . . . . 1.32 114.174 170.489 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -70.81 -38.39 73.29 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.352 2.501 . . . . 1.7 115.062 170.3 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.83 -36.84 85.23 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 116.748 -3.72 . . . . 1.55 111.917 172.513 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -85.35 -53.39 5.25 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.478 1.609 . . . . 2.62 110.919 -176.69 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -100.73 -43.98 5.96 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.882 -3.011 . . . . 1.48 117.141 -174.069 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.66 -0.73 18.03 Favored Glycine 0 N--CA 1.429 -1.806 0 CA-C-O 117.01 -1.994 . . . . 1.12 111.599 178.194 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.0 mt -70.22 130.72 89.23 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-N 121.099 2.45 . . . . 1.55 112.733 -178.805 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -76.32 154.3 36.29 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 O-C-N 115.556 -2.918 . . . . 1.02 116.023 174.788 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -71.8 -6.81 19.89 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 124.009 3.139 . . . . 1.25 113.039 -169.13 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -67.58 -35.03 78.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.345 3.058 . . . . 2.25 109.132 175.116 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -85.28 -22.32 28.64 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.384 -1.448 . . . . 2.02 113.396 178.708 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -83.19 119.16 24.19 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.028 -2.92 . . . . 0.69 117.622 -168.654 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.425 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 51.4 ttt180 -107.83 118.78 37.63 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 105.297 -2.112 . . . . 2.78 105.297 172.758 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.5 mt -113.73 122.51 47.33 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 116.375 -1.774 . . . . 1.17 108.671 -177.092 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.3 mt -120.19 136.2 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 124.574 2.13 . . . . 1.38 107.702 177.483 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.447 ' HB3' HD21 ' A' ' 50' ' ' LEU . 84.9 t80 -130.4 112.2 13.03 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.056 1.884 . . . . 1.5 109.496 171.45 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.65 -72.58 0.09 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.468 2.307 . . . . 1.21 114.021 177.968 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.7 -62.18 0.19 Allowed Glycine 0 N--CA 1.43 -1.751 0 O-C-N 120.835 -1.165 . . . . 1.3 112.675 -178.28 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -79.85 153.51 29.04 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 115.085 1.513 . . . . 2.55 115.085 -173.455 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -82.95 137.66 34.11 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.321 -2.737 . . . . 2.48 111.052 171.503 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.447 HD21 ' HB3' ' A' ' 45' ' ' PHE . 11.8 mt -84.87 121.57 27.92 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.488 -2.007 . . . . 0.9 114.835 -169.217 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.316 10.7 pt-20 -78.63 173.25 12.62 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 118.463 -2.648 . . . . 1.94 115.669 175.152 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -68.08 -58.68 4.09 Favored 'General case' 0 N--CA 1.429 -1.478 1 N-CA-C 125.054 5.205 . . . . 1.56 125.054 -177.023 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.65 56.59 1.37 Allowed Glycine 0 N--CA 1.43 -1.711 0 O-C-N 118.502 -2.624 . . . . 0.97 111.143 170.81 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -123.24 168.65 12.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.224 -2.139 . . . . 2.49 105.224 160.722 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.0 p -101.65 169.29 8.93 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.469 -1.394 . . . . 0.76 112.279 179.494 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mt -54.61 -44.9 73.51 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 114.717 1.377 . . . . 1.05 114.717 166.98 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.262 41.7 p -67.88 -24.38 65.22 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.258 2.623 . . . . 1.19 115.078 -176.651 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -70.59 -25.18 62.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.124 2.869 . . . . 1.9 115.793 176.195 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -95.81 -6.71 38.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.123 -2.308 . . . . 0.89 114.18 175.157 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.26 7.6 t30 76.53 43.16 0.15 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.864 -2.397 . . . . 1.84 110.166 179.56 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 61' ' ' ILE . 77.7 mt -91.91 107.3 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.733 -1.229 . . . . 0.82 108.261 177.325 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -101.08 -170.82 1.89 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 126.184 2.897 . . . . 2.16 107.749 -174.304 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -63.69 141.91 58.59 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 111.318 -2.674 . . . . 2.12 110.693 171.822 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 69.05 20.84 7.59 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 110.734 -2.939 . . . . 1.71 116.877 177.008 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.6 m -88.88 159.37 17.72 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 116.165 1.913 . . . . 1.04 116.165 -170.899 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.2 m -101.32 115.79 31.3 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 117.007 -3.558 . . . . 0.79 110.49 -178.97 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -105.37 146.82 28.92 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.674 -1.232 . . . . 1.4 107.674 171.181 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -101.58 130.63 47.94 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 116.132 -1.89 . . . . 1.51 110.736 177.05 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.423 HD23 HG22 ' A' ' 7' ' ' THR . 25.1 tp -115.12 108.29 16.44 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.205 1.366 . . . . 1.14 107.551 177.172 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 74.6 t -96.2 130.19 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 119.131 -2.23 . . . . 1.23 105.784 171.801 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.9 mt -92.76 130.69 38.3 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 120.275 1.398 . . . . 2.78 111.087 178.896 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -115.29 -166.27 1.11 Allowed 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 120.141 -1.6 . . . . 3.75 110.06 174.773 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mp -117.79 -59.01 1.96 Allowed 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.751 2.215 . . . . 3.14 107.592 -179.966 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -99.6 -74.55 0.59 Allowed 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.01 -4.806 . . . . 6.8 106.115 172.128 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.81 172.05 41.88 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 126.437 3.243 . . . . 3.57 111.849 -162.215 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.749 0 C-N-CA 128.444 2.926 . . . . 3.87 109.087 -170.418 . . . . . . . . 0 0 . 1 . 127 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 ptt? . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 104.575 -2.379 . . . . 1.1 104.575 . . . . . . . . . 0 0 . 1 . 127 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -119.08 154.54 33.02 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 124.53 3.332 . . . . 1.87 106.291 175.994 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -136.37 167.36 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 105.425 -2.065 . . . . 0.72 105.425 167.491 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -120.96 125.84 48.44 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.046 2.138 . . . . 1.4 108.129 -176.835 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.6 t -104.45 130.72 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.708 -3.12 . . . . 0.58 105.283 170.751 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.287 12.4 ttpt -127.03 122.08 33.39 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 129.715 4.384 . . . . 2.09 119.645 -177.12 . . . . . . . . 3 2 . 1 . 127 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 p -70.89 161.73 30.53 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 112.671 -2.059 . . . . 0.99 115.106 177.963 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.7 tp -54.31 -48.34 71.44 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.783 2.433 . . . . 2.53 115.465 174.058 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.31 -31.95 70.76 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.522 2.729 . . . . 2.08 115.582 -177.728 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.94 27.68 0.7 Allowed Glycine 0 N--CA 1.429 -1.775 0 CA-C-O 117.641 -1.644 . . . . 1.31 109.817 176.1 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -97.46 122.98 41.15 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.449 3.125 . . . . 1.4 108.318 -178.093 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.4 m -96.45 117.48 30.97 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 127.309 3.433 . . . . 0.78 107.156 172.661 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.8 mt -93.6 122.05 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 117.668 -3.145 . . . . 1.55 102.529 174.944 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -108.91 106.5 16.5 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 123.657 1.694 . . . . 1.08 109.943 174.256 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.4 mt -102.6 152.58 21.01 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 116.475 -3.89 . . . . 1.55 109.445 -178.033 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.68 130.44 42.58 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.382 -1.449 . . . . 1.95 110.869 169.299 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.66 163.01 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 114.196 -1.365 . . . . 0.96 110.232 -173.969 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -104.06 151.25 38.94 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 117.963 -2.961 . . . . 2.35 112.427 158.476 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -75.99 -7.29 18.16 Favored 'Trans proline' 0 N--CA 1.434 -1.998 1 CA-C-N 129.621 4.472 . . . . 0.95 117.359 -176.262 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.3 m -82.34 -9.95 59.27 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 128.36 2.664 . . . . 1.45 113.515 173.565 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -76.27 158.2 31.81 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 116.195 -2.202 . . . . 1.69 109.774 177.918 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.2 p -87.36 158.46 19.02 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 116.304 1.964 . . . . 0.75 116.304 177.307 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.0 mp -55.13 -46.02 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 118.402 -0.808 . . . . 0.73 111.428 172.187 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.264 42.9 tt0 -41.39 -44.41 2.81 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 120.11 3.374 . . . . 1.62 120.11 163.586 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -83.36 -34.26 25.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.346 -3.346 . . . . 2.13 110.524 -177.077 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.0 t -62.44 -37.82 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 O-C-N 117.016 -3.553 . . . . 0.62 108.076 170.727 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -67.17 -24.63 65.89 Favored 'General case' 0 N--CA 1.431 -1.412 1 CA-C-O 128.715 4.102 . . . . 1.22 119.518 175.64 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.6 -16.39 62.62 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 117.974 -2.954 . . . . 0.51 113.403 169.105 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -87.48 -30.94 20.27 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 116.008 -4.182 . . . . 1.44 112.429 179.01 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.287 51.3 mt -66.16 -19.01 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-O 124.519 2.104 . . . . 1.32 108.518 173.155 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -75.05 -43.97 50.35 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.681 -2.512 . . . . 1.7 112.295 178.458 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -65.81 -53.8 35.29 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.668 1.187 . . . . 1.55 110.143 168.948 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -59.89 -69.71 0.2 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.209 1.48 . . . . 2.62 112.64 -173.179 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -90.13 -40.82 12.0 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 128.672 2.789 . . . . 1.48 113.517 -166.848 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.22 31.6 3.75 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 116.244 -2.884 . . . . 1.12 111.849 172.53 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.1 mt -113.17 119.11 43.04 Favored Pre-proline 0 N--CA 1.429 -1.48 0 C-N-CA 126.939 2.096 . . . . 1.55 109.816 -177.001 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -63.1 156.24 56.26 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 125.276 3.984 . . . . 1.02 116.48 175.754 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.88 -21.05 16.55 Favored 'Trans proline' 0 N--CA 1.433 -2.072 0 CA-C-N 128.114 3.934 . . . . 1.25 115.945 -170.171 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.17 -34.08 69.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.777 2.431 . . . . 2.25 115.691 167.369 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -84.8 -1.9 56.99 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 125.743 2.687 . . . . 2.02 112.974 177.952 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -114.87 129.05 56.63 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 115.342 -4.599 . . . . 0.69 111.26 -171.895 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -129.04 134.81 48.27 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 104.638 -2.356 . . . . 2.78 104.638 171.562 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.3 mt -107.38 129.04 54.96 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 128.14 2.576 . . . . 1.17 108.39 -177.77 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.7 mm -105.99 125.44 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 131.282 3.833 . . . . 1.38 102.915 -174.433 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.405 ' HB3' HD21 ' A' ' 50' ' ' LEU . 41.8 t80 -116.56 110.79 19.02 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 120.651 1.569 . . . . 1.5 107.069 170.53 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.36 -101.61 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 104.826 -2.287 . . . . 1.21 104.826 177.467 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.63 2.98 15.4 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 125.881 1.988 . . . . 1.3 113.831 -179.578 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -115.45 157.07 24.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.214 1.483 . . . . 2.55 109.274 -179.096 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -94.02 144.42 25.48 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.766 -2.679 . . . . 2.48 103.766 179.512 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.405 HD21 ' HB3' ' A' ' 45' ' ' PHE . 27.8 mt -97.12 140.4 31.69 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.769 -3.082 . . . . 0.9 109.983 -175.441 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -79.39 149.02 31.77 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.294 -1.504 . . . . 1.94 113.184 172.923 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -76.81 -37.12 56.33 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 115.655 1.724 . . . . 1.56 115.655 -173.231 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.43 44.71 2.6 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-O 116.655 -2.192 . . . . 0.97 108.0 179.55 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -126.93 160.05 32.2 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 121.315 2.558 . . . . 2.49 106.07 168.343 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -84.19 175.62 9.33 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 126.553 3.073 . . . . 0.76 112.506 169.448 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.7 mt -71.54 -42.42 67.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.929 -3.607 . . . . 1.05 110.064 171.381 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 m -60.19 -38.85 84.52 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 128.823 2.849 . . . . 1.19 114.094 171.875 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -52.59 -36.6 56.45 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.973 2.953 . . . . 1.9 118.973 171.425 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -90.53 3.05 55.1 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 116.505 2.039 . . . . 0.89 116.505 176.442 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 64.31 27.33 13.77 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.751 2.42 . . . . 1.84 114.64 -173.944 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.257 75.7 mt -69.82 140.8 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 118.943 -2.348 . . . . 0.82 108.185 178.027 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -111.41 175.6 5.36 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.475 -2.016 . . . . 2.16 111.777 -174.441 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -64.0 148.28 50.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.411 -1.431 . . . . 2.12 111.713 166.15 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.338 35.9 mt-10 77.13 21.24 1.12 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.425 -2.047 . . . . 1.71 113.41 169.175 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.95 140.91 30.02 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.982 3.313 . . . . 1.04 112.949 -173.622 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.8 m -89.62 114.83 26.49 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.911 2.884 . . . . 0.79 111.746 -178.856 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -113.52 151.8 31.06 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.851 -3.031 . . . . 1.4 104.789 175.246 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -107.57 123.75 48.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 123.505 1.621 . . . . 1.51 109.854 -169.748 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.5 tp -90.96 110.63 21.88 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.148 -2.845 . . . . 1.14 113.275 -178.034 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.9 t -105.08 128.9 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 1 N-CA-C 99.468 -4.271 . . . . 1.23 99.468 176.67 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.0 tp -97.89 127.49 43.87 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 113.357 -1.747 . . . . 2.78 109.337 177.147 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -89.75 109.62 20.59 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.495 -1.684 . . . . 3.75 111.398 174.805 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.1 tp -127.45 -41.45 1.72 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 120.794 1.634 . . . . 3.14 109.708 173.103 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.9 ttp-105 -76.09 -52.66 9.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.466 -1.396 . . . . 6.8 111.783 171.127 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.48 -56.18 0.11 Allowed Glycine 0 N--CA 1.429 -1.77 1 CA-C-O 113.144 -4.142 . . . . 3.57 112.148 -172.964 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.769 0 N-CA-C 107.576 -2.21 . . . . 3.87 107.576 -179.844 . . . . . . . . 0 0 . 1 . 128 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 CA--C 1.489 -1.37 0 CA-C-O 122.74 1.257 . . . . 1.1 113.344 . . . . . . . . . 0 0 . 1 . 128 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -114.58 130.03 56.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 115.738 1.755 . . . . 1.87 115.738 -171.508 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.7 pt -120.46 151.67 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-O 115.244 -2.313 . . . . 0.72 111.686 177.693 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -110.66 118.83 37.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.674 -1.973 . . . . 1.4 105.674 -174.298 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.35 116.04 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 O-C-N 118.926 -2.359 . . . . 0.58 111.052 171.983 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.314 42.1 mtpt -104.32 136.3 44.17 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 127.997 3.76 . . . . 2.09 117.599 178.325 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 p -89.82 156.15 18.69 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.522 -2.611 . . . . 0.99 111.07 172.857 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.5 mt -63.6 -44.5 93.82 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.266 -3.396 . . . . 2.53 112.267 168.141 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.337 69.4 p -65.22 -38.47 90.5 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 116.453 -1.737 . . . . 2.08 114.009 -169.7 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.13 1.88 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 123.358 2.799 . . . . 1.31 116.009 167.802 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -98.68 144.82 27.53 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.304 3.052 . . . . 1.4 111.064 -179.587 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -131.07 139.69 49.93 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 118.028 -2.92 . . . . 0.78 106.51 168.084 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.465 HG21 HD13 ' A' ' 13' ' ' ILE . 28.4 pt -130.4 150.99 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 130.098 3.359 . . . . 1.55 106.558 179.165 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 m -107.05 127.15 53.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.946 -1.479 . . . . 1.08 108.022 175.247 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.3 mt -106.8 137.0 45.66 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 125.088 2.375 . . . . 1.55 109.81 169.754 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -89.99 126.47 35.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 128.414 3.959 . . . . 1.95 107.831 162.035 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -132.09 152.33 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 109.585 -3.461 . . . . 0.96 113.358 -173.186 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -99.99 146.18 31.47 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-O 114.776 -2.535 . . . . 2.35 106.459 168.083 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -80.42 -4.8 13.21 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 CA-C-N 128.087 3.924 . . . . 0.95 106.661 -171.302 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.4 p -85.56 -17.63 35.75 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 120.0 -1.687 . . . . 1.45 111.851 175.659 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -61.44 136.26 57.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.826 -2.421 . . . . 1.69 111.733 174.992 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.7 p -78.26 162.23 26.69 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.588 -3.195 . . . . 0.75 112.473 178.655 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.4 mm -64.35 -44.23 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-N 113.09 -1.868 . . . . 0.73 112.093 172.283 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.434 76.2 tt0 -35.26 -58.66 0.55 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.349 -3.344 . . . . 1.62 117.1 158.914 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -68.75 -34.27 75.32 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.018 -3.551 . . . . 2.13 116.253 -177.967 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.7 t -55.3 -44.6 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 118.143 -2.848 . . . . 0.62 116.907 164.518 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 43.3 mtmt -54.18 -49.82 68.44 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.045 3.338 . . . . 1.22 110.018 175.704 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.95 -26.67 67.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.875 -3.016 . . . . 0.51 112.898 178.706 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -67.83 -35.34 78.42 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.218 -2.801 . . . . 1.44 111.604 173.115 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.7 mt -71.36 -26.7 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 117.851 -1.54 . . . . 1.32 112.246 172.934 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -68.15 -37.96 81.6 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 118.854 -0.593 . . . . 1.7 110.889 -179.646 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -58.29 -44.62 88.58 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 123.45 1.595 . . . . 1.55 111.463 175.819 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -84.49 -80.55 0.2 Allowed 'General case' 0 N--CA 1.43 -1.446 1 C-N-CA 132.043 4.137 . . . . 2.62 114.302 -171.197 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -78.4 -27.13 46.69 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 123.742 1.734 . . . . 1.48 110.295 -171.965 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.23 28.63 16.89 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 118.73 -2.481 . . . . 1.12 108.262 170.395 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.9 mt -94.66 123.98 56.38 Favored Pre-proline 0 N--CA 1.431 -1.421 0 N-CA-C 103.98 -2.6 . . . . 1.55 103.98 179.961 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 9.3 Cg_exo -62.13 145.64 96.33 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 C-N-CA 116.272 -2.018 . . . . 1.02 114.249 175.685 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 88.4 Cg_exo -66.32 -22.36 53.09 Favored 'Trans proline' 0 N--CA 1.433 -2.038 1 C-N-CA 126.201 4.6 . . . . 1.25 112.751 -175.653 . . . . . . . . 3 3 . 1 . 128 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -60.3 -31.98 70.77 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 131.544 3.938 . . . . 2.25 111.375 171.264 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -97.31 1.81 49.94 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 112.76 -2.018 . . . . 2.02 112.245 -178.617 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -100.56 100.14 10.83 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.659 -2.526 . . . . 0.69 111.793 -177.331 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.491 ' HG3' ' HB2' ' A' ' 72' ' ' ARG . 10.8 mtp180 -96.2 95.19 7.96 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.808 -1.807 . . . . 2.78 110.371 168.489 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.1 mt -72.73 127.34 32.26 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.448 1.499 . . . . 1.17 112.891 179.358 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.9 mm -118.36 135.51 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 123.483 2.856 . . . . 1.38 109.598 175.636 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -122.42 101.23 7.38 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.958 -2.339 . . . . 1.5 107.148 175.95 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.3 . . 78.04 -91.72 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.906 1.282 . . . . 1.21 109.935 179.027 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.18 21.09 2.63 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 104.595 -3.402 . . . . 1.3 104.595 -177.567 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -112.08 120.74 42.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.051 -1.852 . . . . 2.55 111.666 178.562 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -76.22 113.7 14.07 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.637 2.375 . . . . 2.48 108.563 166.416 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.6 mt -90.82 146.06 24.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.154 2.407 . . . . 0.9 109.329 -164.04 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -83.98 164.68 19.19 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.258 1.823 . . . . 1.94 112.284 175.281 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -89.32 -53.02 4.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 116.391 -3.943 . . . . 1.56 114.048 -167.691 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.84 18.58 4.81 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 120.118 2.807 . . . . 0.97 120.118 176.046 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.285 0.0 OUTLIER -79.43 152.3 30.39 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.731 1.752 . . . . 2.49 115.731 168.596 . . . . . . . . 3 3 . 1 . 128 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.9 p -89.37 170.48 10.52 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.558 -1.201 . . . . 0.76 111.513 168.523 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.8 mt -75.6 -32.09 60.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.457 -2.027 . . . . 1.05 109.138 177.374 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.294 1.1 t -62.89 -49.4 74.99 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.728 1.611 . . . . 1.19 109.619 -179.199 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -47.2 -50.59 20.54 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.511 2.324 . . . . 1.9 111.776 172.225 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -76.71 -6.53 52.55 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 119.637 3.199 . . . . 0.89 119.637 176.118 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 65.41 41.17 4.37 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.521 2.045 . . . . 1.84 116.521 -179.693 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.406 HG23 ' HB2' ' A' ' 65' ' ' SER . 55.8 mt -95.05 114.89 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 101.71 -3.441 . . . . 0.82 101.71 179.146 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -102.26 -175.6 2.88 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.345 -1.298 . . . . 2.16 107.878 -178.072 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -61.03 142.91 56.26 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 117.448 2.388 . . . . 2.12 117.448 169.711 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.379 13.8 mt-10 75.17 19.71 2.22 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 129.965 4.541 . . . . 1.71 118.411 177.569 . . . . . . . . 3 2 . 1 . 128 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.406 ' HB2' HG23 ' A' ' 61' ' ' ILE . 19.2 m -92.74 153.52 18.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.538 2.399 . . . . 1.04 105.669 -173.445 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.8 m -106.09 103.52 13.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 131.207 3.803 . . . . 0.79 111.101 -176.358 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -94.47 168.52 10.82 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 105.045 -2.206 . . . . 1.4 105.045 174.405 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.97 162.84 32.17 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 105.499 -2.037 . . . . 1.51 105.499 -174.258 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.265 0.5 OUTLIER -144.77 121.91 11.47 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.983 -1.858 . . . . 1.14 105.983 -172.805 . . . . . . . . 3 3 . 1 . 128 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -115.69 125.65 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 129.416 3.086 . . . . 1.23 106.85 178.713 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.1 mt -80.43 125.09 29.5 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 119.594 -1.941 . . . . 2.78 114.783 -175.649 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.491 ' HB2' ' HG3' ' A' ' 42' ' ' ARG . 53.7 ttt180 -96.12 80.84 3.3 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.886 -1.052 . . . . 3.75 109.126 176.171 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.0 mt -98.3 -151.86 0.39 Allowed 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.265 -1.522 . . . . 3.14 109.487 169.97 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.4 mtm-85 -106.99 -62.73 1.37 Allowed 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 100.507 -3.886 . . . . 6.8 100.507 174.633 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.13 81.46 0.78 Allowed Glycine 0 N--CA 1.43 -1.755 0 CA-C-O 115.179 -3.012 . . . . 3.57 112.739 -171.788 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.769 0 CA-C-O 115.303 -2.943 . . . . 3.87 117.811 179.031 . . . . . . . . 0 0 . 1 . 129 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.7 ttp . . . . . 0 CA--C 1.491 -1.318 0 N-CA-C 118.974 2.953 . . . . 1.1 118.974 . . . . . . . . . 0 0 . 1 . 129 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.11 127.12 35.41 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 119.417 -2.052 . . . . 1.87 115.091 174.045 . . . . . . . . 2 2 . 1 . 129 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 pt -122.06 163.92 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.612 2.365 . . . . 0.72 114.598 166.534 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -112.0 123.62 50.65 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 116.108 -4.12 . . . . 1.4 113.835 176.169 . . . . . . . . 2 2 . 1 . 129 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.8 t -110.41 113.15 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 118.622 -2.549 . . . . 0.58 108.502 171.052 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -86.37 139.92 30.51 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.894 -1.503 . . . . 2.09 110.503 -178.719 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 p -100.25 175.37 5.74 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.453 2.073 . . . . 0.99 110.412 174.815 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.6 mt -80.56 -25.19 38.74 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 114.876 -4.89 . . . . 2.53 108.892 171.599 . . . . . . . . 2 2 . 1 . 129 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 p -65.88 -46.09 79.67 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.275 -3.39 . . . . 2.08 113.717 -176.092 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.2 6.56 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 112.134 -2.303 . . . . 1.31 117.345 173.765 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -98.85 150.62 21.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 128.157 3.837 . . . . 1.4 114.187 -173.199 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.2 m -114.98 90.93 3.46 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.722 -3.111 . . . . 0.78 105.578 169.822 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mt -80.9 111.15 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 O-C-N 120.805 -1.184 . . . . 1.55 109.36 -179.807 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.4 m -77.17 107.22 9.4 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.144 -2.223 . . . . 1.08 109.584 170.936 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.6 mt -103.64 148.6 25.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 126.764 3.173 . . . . 1.55 104.912 173.828 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -120.44 129.35 53.85 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.172 2.189 . . . . 1.95 113.1 166.703 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.0 m -143.02 174.07 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.486 -2.413 . . . . 0.96 104.486 -178.937 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -96.82 154.03 38.46 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 104.699 -2.334 . . . . 2.35 104.699 165.06 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -73.79 -15.56 23.92 Favored 'Trans proline' 0 C--N 1.3 -2.003 1 C-N-CA 125.871 4.381 . . . . 0.95 112.239 -176.252 . . . . . . . . 2 2 . 1 . 129 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.1 p -94.34 5.57 51.37 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.758 -3.089 . . . . 1.45 115.236 172.225 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -71.39 154.91 41.21 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.85 -1.157 . . . . 1.69 110.426 168.112 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 65.7 p -92.12 159.5 15.64 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.185 -1.043 . . . . 0.75 108.185 176.752 . . . . . . . . 2 2 . 1 . 129 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -63.53 -16.49 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.463 1.905 . . . . 0.73 113.27 -179.543 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -62.93 -32.58 73.91 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.316 1.846 . . . . 1.62 115.781 166.68 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -72.78 -35.99 67.52 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.887 2.075 . . . . 2.13 111.788 168.765 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.9 t -57.53 -51.53 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 118.945 -2.347 . . . . 0.62 114.381 169.66 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -65.38 -35.99 82.64 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 129.152 2.981 . . . . 1.22 111.339 176.363 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.37 -45.54 69.26 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 116.045 1.868 . . . . 0.51 116.045 174.021 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -74.58 -28.56 60.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.599 1.559 . . . . 1.44 110.256 -179.837 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.6 mt -78.82 -29.17 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 1 O-C-N 115.457 -4.527 . . . . 1.32 114.083 172.669 . . . . . . . . 2 2 . 1 . 129 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -67.31 -32.29 73.17 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.523 -3.236 . . . . 1.7 113.061 170.022 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -61.0 -49.11 78.77 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.247 2.314 . . . . 1.55 117.247 169.666 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -89.23 -43.99 10.6 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.123 2.268 . . . . 2.62 117.123 -176.897 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -99.66 -36.87 9.35 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.434 -2.666 . . . . 1.48 113.182 -172.289 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.83 68.09 1.3 Allowed Glycine 0 N--CA 1.43 -1.704 0 CA-C-N 110.81 -2.905 . . . . 1.12 111.775 172.144 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 mt -126.85 119.2 22.49 Favored Pre-proline 0 N--CA 1.429 -1.508 0 O-C-N 126.637 2.022 . . . . 1.55 108.343 174.32 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 9.1 Cg_exo -55.87 145.48 72.83 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-O 113.104 -2.956 . . . . 1.02 117.637 176.174 . . . . . . . . 2 2 . 1 . 129 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 27.6 Cg_exo -58.66 -22.52 61.12 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 123.418 2.746 . . . . 1.25 115.142 -175.025 . . . . . . . . 2 2 . 1 . 129 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.02 -43.15 99.46 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 131.109 3.764 . . . . 2.25 109.357 173.887 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -83.79 -14.79 50.57 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 117.152 2.279 . . . . 2.02 117.152 -176.962 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -85.45 104.57 15.36 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 118.871 -2.393 . . . . 0.69 113.131 -175.726 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -96.23 101.04 12.63 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 106.327 -1.731 . . . . 2.78 106.327 175.16 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.4 mt -87.16 125.43 34.16 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.965 -2.334 . . . . 1.17 116.554 173.387 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.5 mm -108.57 106.36 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 118.853 -2.404 . . . . 1.38 109.114 178.226 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -92.99 91.97 7.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 118.977 -1.089 . . . . 1.5 110.578 171.149 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.49 -65.93 0.25 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.719 2.408 . . . . 1.21 112.811 -172.657 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.91 -14.82 0.4 Allowed Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 126.718 2.104 . . . . 1.3 112.923 -178.954 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -90.59 129.03 36.76 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 115.299 -2.56 . . . . 2.55 109.926 -176.83 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -83.17 117.24 22.77 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.302 -2.124 . . . . 2.48 112.309 165.934 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.7 mt -79.05 163.53 25.08 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 120.925 -1.109 . . . . 0.9 109.586 -166.181 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -125.64 128.53 47.99 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.329 1.852 . . . . 1.94 108.793 176.354 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.345 30.4 m-20 -45.62 -50.61 13.15 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.079 2.952 . . . . 1.56 115.489 -174.795 . . . . . . . . 2 2 . 1 . 129 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.15 20.59 15.7 Favored Glycine 0 N--CA 1.43 -1.765 1 O-C-N 115.535 -4.478 . . . . 0.97 114.343 175.675 . . . . . . . . 2 2 . 1 . 129 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -107.22 142.89 36.24 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 116.147 -4.149 . . . . 2.49 105.723 168.692 . . . . . . . . 2 2 . 1 . 129 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 17.5 p -70.09 168.51 15.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.949 -1.023 . . . . 0.76 113.136 175.803 . . . . . . . . 2 2 . 1 . 129 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.455 ' HG ' HD12 ' A' ' 61' ' ' ILE . 6.3 mp -67.09 -42.32 84.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.683 1.993 . . . . 1.05 112.984 173.73 . . . . . . . . 2 2 . 1 . 129 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.2 p -52.79 -26.57 14.75 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 131.515 3.926 . . . . 1.19 112.216 179.455 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -75.77 -51.45 12.62 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-O 126.571 3.081 . . . . 1.9 116.922 175.697 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.272 35.3 m-85 -83.31 9.32 11.12 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.831 -3.043 . . . . 0.89 114.691 174.119 . . . . . . . . 2 2 . 1 . 129 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.7 t30 47.31 59.18 4.24 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 118.801 2.889 . . . . 1.84 118.801 -176.379 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.455 HD12 ' HG ' ' A' ' 56' ' ' LEU . 78.8 mt -93.95 122.3 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 104.489 -2.411 . . . . 0.82 104.489 179.523 . . . . . . . . 2 2 . 1 . 129 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -121.35 -160.99 0.88 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 122.217 2.28 . . . . 2.16 111.742 -173.12 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -59.44 136.06 57.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 119.173 3.027 . . . . 2.12 119.173 175.649 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.295 42.8 mt-10 64.04 25.65 13.86 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.206 -2.184 . . . . 1.71 114.738 172.914 . . . . . . . . 2 2 . 1 . 129 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.7 m -75.18 137.55 41.37 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 128.005 2.522 . . . . 1.04 114.817 179.862 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.2 m -91.66 104.79 17.22 Favored 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 127.105 2.753 . . . . 0.79 114.62 -176.632 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -92.62 128.6 38.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 116.785 -1.579 . . . . 1.4 111.588 171.551 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -96.47 114.73 26.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 104.407 -2.442 . . . . 1.51 104.407 -177.803 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.4 tp -92.38 120.55 33.01 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.584 -3.197 . . . . 1.14 106.91 -177.424 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.84 153.74 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 126.251 2.22 . . . . 1.23 106.159 174.956 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.9 tp -96.21 134.08 39.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 116.056 -2.258 . . . . 2.78 105.586 175.978 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -86.9 124.12 32.76 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.328 1.851 . . . . 3.75 110.925 179.946 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.8 mt -96.98 -173.83 2.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.307 1.443 . . . . 3.14 110.061 170.293 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.6 mtt85 -93.21 102.53 14.82 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 118.504 -2.623 . . . . 6.8 112.034 169.455 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.68 153.19 29.47 Favored Glycine 0 N--CA 1.43 -1.742 0 CA-C-O 126.183 3.102 . . . . 3.57 110.848 -165.886 . . . . . . . . 1 1 . 1 . 129 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.768 1 O-C-N 116.323 -4.045 . . . . 3.87 114.184 174.829 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.418 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 5.5 ttt . . . . . 0 CA--C 1.49 -1.35 0 CA-C-O 117.206 -1.378 . . . . 1.1 109.387 . . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -86.33 135.17 33.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 115.895 -2.002 . . . . 1.87 113.301 -171.833 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 pt -129.91 153.06 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 122.105 2.23 . . . . 0.72 107.238 170.577 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.331 11.6 m-85 -115.82 122.62 45.94 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 116.876 -1.93 . . . . 1.4 110.974 177.298 . . . . . . . . 2 2 . 1 . 130 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.05 108.48 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 117.749 -3.094 . . . . 0.58 111.548 177.463 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -87.79 120.43 29.1 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.931 1.825 . . . . 2.09 108.537 -173.487 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.2 p -79.4 169.37 18.18 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 115.484 -4.51 . . . . 0.99 113.165 174.686 . . . . . . . . 2 2 . 1 . 130 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.3 mt -73.79 -26.35 60.58 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.004 -3.56 . . . . 2.53 112.222 164.851 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.5 p -75.25 -34.16 61.38 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 124.216 1.006 . . . . 2.08 111.824 -171.197 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.97 -8.0 2.44 Favored Glycine 0 N--CA 1.431 -1.678 0 CA-C-O 115.829 -2.651 . . . . 1.31 116.635 177.384 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -97.89 136.29 38.4 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 126.318 1.834 . . . . 1.4 109.983 -174.122 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -111.94 96.14 5.88 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.433 1.111 . . . . 0.78 109.363 169.759 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.7 pt -91.85 125.31 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 113.852 -1.522 . . . . 1.55 113.366 -175.149 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.8 m -91.22 109.6 20.87 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.424 -2.673 . . . . 1.08 105.443 -171.734 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.7 mt -93.34 153.16 18.7 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.371 -2.705 . . . . 1.55 108.306 176.826 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -92.78 121.56 34.28 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.524 1.929 . . . . 1.95 113.219 165.396 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 1' ' ' MET . 28.9 m -137.26 173.21 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 123.634 1.683 . . . . 0.96 108.082 176.741 . . . . . . . . 2 2 . 1 . 130 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -121.8 154.97 60.77 Favored Pre-proline 0 N--CA 1.43 -1.439 0 O-C-N 117.999 -2.938 . . . . 2.35 108.529 162.869 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.287 40.1 Cg_endo -64.4 -18.6 63.63 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 C-N-CA 123.133 2.555 . . . . 0.95 117.493 -172.611 . . . . . . . . 2 2 . 1 . 130 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.2 m -89.31 7.78 33.85 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.397 2.046 . . . . 1.45 115.596 178.58 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -81.05 146.68 30.51 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 130.037 3.335 . . . . 1.69 108.238 173.984 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.308 30.3 p -75.39 164.83 26.0 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 118.324 -1.351 . . . . 0.75 113.073 172.986 . . . . . . . . 2 2 . 1 . 130 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.5 mt -78.97 -35.7 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 108.063 -1.088 . . . . 0.73 108.063 178.859 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -47.07 -41.68 17.43 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.918 2.192 . . . . 1.62 116.918 162.796 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -64.95 -38.31 90.53 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.671 -4.393 . . . . 2.13 112.235 175.41 . . . . . . . . 2 2 . 1 . 130 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.413 HG22 HG11 ' A' ' 17' ' ' VAL . 68.3 t -69.49 -28.21 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 114.703 1.372 . . . . 0.62 114.703 174.489 . . . . . . . . 2 2 . 1 . 130 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -69.8 -30.24 67.72 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.712 -2.492 . . . . 1.22 112.117 169.247 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.47 -27.23 65.05 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.56 -1.963 . . . . 0.51 110.909 174.418 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? -72.61 -35.86 67.95 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 120.748 1.613 . . . . 1.44 111.399 172.745 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.9 mt -60.54 -46.22 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 O-C-N 116.381 -3.949 . . . . 1.32 112.486 167.515 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -57.26 -45.73 83.73 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 117.968 -2.957 . . . . 1.7 116.449 175.016 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -45.31 -40.87 8.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 125.455 2.55 . . . . 1.55 114.804 166.907 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -87.5 -59.24 2.3 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.691 -3.13 . . . . 2.62 114.824 -173.966 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -97.4 -25.59 15.16 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.954 1.835 . . . . 1.48 109.009 -165.921 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.29 52.77 4.11 Favored Glycine 0 N--CA 1.429 -1.809 1 O-C-N 115.136 -4.727 . . . . 1.12 116.287 -178.175 . . . . . . . . 2 2 . 1 . 130 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.2 mt -130.57 109.81 16.07 Favored Pre-proline 0 N--CA 1.429 -1.505 0 CA-C-N 112.223 -1.988 . . . . 1.55 109.738 -176.81 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -60.59 139.09 84.12 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 N-CA-C 120.948 3.403 . . . . 1.02 120.948 -179.919 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.85 -27.92 29.16 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 C-N-CA 124.948 3.765 . . . . 1.25 117.088 -176.197 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.58 -34.63 72.95 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 123.211 2.732 . . . . 2.25 115.954 171.488 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -80.0 4.32 17.36 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 113.639 -3.077 . . . . 2.02 108.899 -175.057 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -141.98 150.6 41.59 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 125.118 3.599 . . . . 0.69 108.897 -176.832 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -130.46 149.91 51.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.195 -2.816 . . . . 2.78 105.317 168.601 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.3 mt -106.47 149.74 26.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.951 2.159 . . . . 1.17 112.657 174.859 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.5 mt -128.52 132.79 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 108.452 -0.944 . . . . 1.38 108.452 178.911 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.264 50.4 t80 -117.07 121.05 40.21 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.537 1.637 . . . . 1.5 106.705 178.358 . . . . . . . . 2 2 . 1 . 130 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.52 -82.27 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.001 -3.562 . . . . 1.21 113.479 174.826 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.77 -26.02 1.47 Allowed Glycine 0 N--CA 1.43 -1.731 0 CA-C-N 122.356 2.344 . . . . 1.3 113.459 176.181 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -100.49 150.2 22.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.991 3.757 . . . . 2.55 117.466 178.875 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -74.48 133.51 42.34 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.982 -2.949 . . . . 2.48 112.718 172.601 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.0 mt -84.4 126.07 32.9 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.939 -2.975 . . . . 0.9 115.27 -171.856 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.18 125.57 24.94 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 125.953 2.787 . . . . 1.94 109.18 173.919 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -63.59 -45.7 89.2 Favored 'General case' 0 N--CA 1.429 -1.491 1 O-C-N 114.466 -5.146 . . . . 1.56 116.957 -172.81 . . . . . . . . 2 2 . 1 . 130 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.22 33.57 3.37 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-O 124.799 2.333 . . . . 0.97 118.504 177.226 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -110.83 167.14 10.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.878 -2.542 . . . . 2.49 112.134 167.071 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.9 p -87.4 176.83 7.32 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.802 2.841 . . . . 0.76 111.898 170.761 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.5 mt -82.25 -41.39 20.27 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 127.135 2.174 . . . . 1.05 108.645 -178.72 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.0 p -59.35 -41.56 89.51 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 129.205 3.002 . . . . 1.19 111.353 176.189 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -48.72 -52.01 25.81 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 128.704 2.802 . . . . 1.9 112.626 172.725 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -86.81 -3.69 59.09 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 115.606 1.706 . . . . 0.89 115.606 179.584 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.6 m120 73.47 37.87 0.68 Allowed 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.696 -1.138 . . . . 1.84 112.167 177.036 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.3 mt -84.97 129.08 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 119.713 -1.867 . . . . 0.82 113.17 173.614 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -116.53 -175.83 2.84 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.996 2.808 . . . . 2.16 113.2 -176.361 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -40.66 121.63 1.5 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 112.214 -2.266 . . . . 2.12 116.06 172.949 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 59.89 50.86 6.44 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 119.261 3.06 . . . . 1.71 119.261 179.06 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.1 m -89.79 133.92 34.46 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 116.479 -1.724 . . . . 1.04 112.207 -178.721 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.4 m -81.48 109.08 15.61 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 126.986 2.678 . . . . 0.79 110.538 179.087 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.58 169.71 8.36 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.465 1.939 . . . . 1.4 110.247 176.652 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -125.3 146.64 49.47 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.217 1.007 . . . . 1.51 108.887 -176.372 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.99 132.11 56.1 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 115.008 -2.425 . . . . 1.14 107.723 172.916 . . . . . . . . 2 2 . 1 . 130 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.6 m -121.26 164.24 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 121.889 2.131 . . . . 1.23 114.797 171.526 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.2 tp -75.2 139.85 42.9 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.076 -2.89 . . . . 2.78 110.899 -179.484 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.1 ttt-85 -134.41 138.25 44.68 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 127.328 2.251 . . . . 3.75 113.036 177.618 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.3 mt -88.23 143.47 27.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.909 2.483 . . . . 3.14 110.473 170.658 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -76.59 139.21 40.58 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 117.824 -3.047 . . . . 6.8 115.372 172.881 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.41 86.86 1.95 Allowed Glycine 0 N--CA 1.431 -1.676 0 CA-C-N 111.73 -2.487 . . . . 3.57 113.371 -174.248 . . . . . . . . 1 1 . 1 . 130 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.756 0 O-C-N 120.137 -1.801 . . . . 3.87 111.46 -177.224 . . . . . . . . 0 0 . 1 . 131 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.6 ttp . . . . . 0 CA--C 1.49 -1.354 0 CA-C-O 125.828 2.728 . . . . 1.1 109.936 . . . . . . . . . 0 0 . 1 . 131 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -69.56 127.98 34.88 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 115.409 -2.234 . . . . 1.87 112.559 178.167 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.318 7.4 pt -133.27 150.03 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 107.151 -1.426 . . . . 0.72 107.151 172.511 . . . . . . . . 2 2 . 1 . 131 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -118.74 118.7 32.31 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.798 2.237 . . . . 1.4 112.942 -176.099 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -102.7 112.21 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.786 -3.071 . . . . 0.58 108.489 -179.993 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.506 ' HE3' HG21 ' A' ' 66' ' ' THR . 75.9 mttt -96.1 138.31 33.9 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.021 -3.549 . . . . 2.09 111.334 177.699 . . . . . . . . 2 2 . 1 . 131 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 p -89.25 -176.4 5.09 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 122.789 1.28 . . . . 0.99 112.602 178.551 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.4 tp -86.03 -34.59 20.72 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.2 -2.188 . . . . 2.53 110.311 170.4 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.7 p -56.6 -57.28 13.07 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.145 2.578 . . . . 2.08 113.327 -178.753 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.36 24.32 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.701 0 O-C-N 117.816 -3.052 . . . . 1.31 114.254 171.745 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -106.92 146.43 31.02 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.729 2.411 . . . . 1.4 105.705 -178.001 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.7 m -116.98 97.38 5.92 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.537 3.135 . . . . 0.78 103.054 171.154 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -80.41 116.77 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 106.44 -1.689 . . . . 1.55 106.44 -176.785 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 m -88.07 114.76 25.0 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.597 -4.439 . . . . 1.08 109.613 175.21 . . . . . . . . 2 2 . 1 . 131 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.8 mt -113.75 161.43 17.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 128.128 3.392 . . . . 1.55 108.829 178.127 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -118.01 112.66 20.56 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.386 2.993 . . . . 1.95 108.256 170.313 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.6 m -107.48 160.14 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.191 -2.818 . . . . 0.96 112.954 176.529 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -105.2 143.32 26.51 Favored Pre-proline 0 N--CA 1.43 -1.43 0 O-C-N 118.925 -2.359 . . . . 2.35 107.923 164.705 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -76.51 -13.53 18.33 Favored 'Trans proline' 0 C--N 1.299 -2.044 1 C-N-CA 127.476 5.45 . . . . 0.95 116.079 -166.118 . . . . . . . . 2 2 . 1 . 131 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -85.79 -2.16 57.95 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 121.413 1.915 . . . . 1.45 109.175 176.889 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -73.73 159.72 32.57 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 120.344 3.461 . . . . 1.69 120.344 169.68 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 30.3 p -79.75 163.53 24.4 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.869 -1.77 . . . . 0.75 114.988 177.521 . . . . . . . . 2 2 . 1 . 131 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.7 mm -73.04 -25.23 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 118.344 -1.343 . . . . 0.73 111.421 177.307 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -50.93 -36.67 39.76 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.752 -2.467 . . . . 1.62 116.566 162.818 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -69.05 -24.67 64.2 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.671 2.789 . . . . 2.13 109.104 -177.825 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.34 -59.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 104.539 -2.393 . . . . 0.62 104.539 175.699 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -49.76 -38.57 34.52 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.123 2.569 . . . . 1.22 113.512 173.441 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.89 -30.93 71.22 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 123.097 2.68 . . . . 0.51 114.893 178.78 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -71.75 -29.12 64.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.865 -1.147 . . . . 1.44 112.477 175.202 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.5 mt -73.06 -33.28 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-O 125.912 2.768 . . . . 1.32 111.685 171.157 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -73.81 -41.93 61.65 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.113 -3.492 . . . . 1.7 105.927 177.04 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -61.64 -36.51 80.99 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.649 -2.532 . . . . 1.55 115.923 174.645 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -84.18 -51.22 7.21 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.04 -3.538 . . . . 2.62 113.085 -175.082 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -104.68 -36.83 7.31 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.271 -2.143 . . . . 1.48 114.574 -169.994 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.05 16.83 17.8 Favored Glycine 0 N--CA 1.429 -1.81 0 C-N-CA 115.381 -3.295 . . . . 1.12 110.249 175.263 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.9 mt -95.92 134.84 23.34 Favored Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 102.44 -3.17 . . . . 1.55 102.44 -175.073 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.428 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 17.2 Cg_exo -67.05 156.9 64.3 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 125.924 3.152 . . . . 1.02 114.904 174.558 . . . . . . . . 2 2 . 1 . 131 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -85.9 -14.96 4.99 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 CA-C-N 124.728 2.724 . . . . 1.25 115.586 -174.16 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -67.25 -29.96 69.72 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 114.808 -2.52 . . . . 2.25 108.954 169.044 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -83.05 -19.9 35.99 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 123.238 2.745 . . . . 2.02 113.183 -176.856 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 37' ' ' PRO . 77.7 mt-30 -87.8 107.59 18.73 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.7 2.0 . . . . 0.69 110.264 -170.709 . . . . . . . . 2 2 . 1 . 131 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -99.08 122.84 42.85 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.446 -1.687 . . . . 2.78 106.446 171.525 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.4 mt -104.0 127.31 51.55 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 124.846 1.341 . . . . 1.17 110.568 176.417 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.1 mt -115.16 115.4 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 119.388 -2.07 . . . . 1.38 108.314 179.847 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -104.07 102.76 12.5 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 113.456 -1.702 . . . . 1.5 107.477 175.002 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.02 -94.05 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.189 1.796 . . . . 1.21 110.353 -178.478 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.4 -19.08 6.35 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 128.25 2.833 . . . . 1.3 114.406 -177.443 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -98.55 137.08 37.72 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 125.946 2.784 . . . . 2.55 105.304 -175.876 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.4 113.97 26.26 Favored 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 119.224 -2.173 . . . . 2.48 107.168 172.972 . . . . . . . . 2 2 . 1 . 131 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.4 mt -77.36 144.43 37.98 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 121.524 1.966 . . . . 0.9 115.195 -163.134 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -90.24 150.39 21.98 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.878 2.471 . . . . 1.94 113.812 173.018 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -70.47 -59.77 2.66 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.755 2.422 . . . . 1.56 115.543 -168.086 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.92 22.55 0.9 Allowed Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 122.155 3.622 . . . . 0.97 122.155 169.987 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -97.91 162.72 13.1 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.137 -2.978 . . . . 2.49 109.06 168.633 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 44.6 p -100.12 176.79 5.28 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 124.007 3.094 . . . . 0.76 112.712 178.094 . . . . . . . . 2 2 . 1 . 131 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 mt -65.75 -34.47 78.25 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.34 -2.1 . . . . 1.05 109.133 172.961 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -57.82 -42.78 84.99 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.814 1.783 . . . . 1.19 115.814 174.318 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -71.64 -30.32 65.62 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.609 -3.182 . . . . 1.9 115.129 -177.272 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -93.11 2.62 56.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 119.132 0.878 . . . . 0.89 113.063 176.017 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.9 m120 51.17 70.76 0.5 Allowed 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 130.705 3.602 . . . . 1.84 113.06 -176.009 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.6 mt -104.84 120.48 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 118.715 -2.491 . . . . 0.82 111.654 -179.344 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -110.85 176.53 4.99 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 111.053 -2.794 . . . . 2.16 115.743 -176.618 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -51.79 118.43 3.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 120.028 3.344 . . . . 2.12 120.028 173.74 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.386 26.2 mt-10 84.56 35.75 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.302 2.001 . . . . 1.71 111.657 171.109 . . . . . . . . 2 2 . 1 . 131 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.8 m -89.64 146.62 24.42 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.618 -2.552 . . . . 1.04 114.145 -174.633 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.506 HG21 ' HE3' ' A' ' 6' ' ' LYS . 5.3 m -108.1 107.96 18.84 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.672 -1.268 . . . . 0.79 112.341 -177.637 . . . . . . . . 2 2 . 1 . 131 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -103.39 143.6 32.47 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 103.466 -2.79 . . . . 1.4 103.466 178.964 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.294 62.3 m80 -104.5 131.64 51.65 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 104.754 -2.313 . . . . 1.51 104.754 -177.095 . . . . . . . . 2 2 . 1 . 131 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.5 tp -95.83 110.56 22.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.943 2.306 . . . . 1.14 108.112 178.899 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 t -110.74 131.91 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 119.108 -2.245 . . . . 1.23 107.855 172.345 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.0 mt -97.74 138.0 35.78 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.153 -0.93 . . . . 2.78 112.329 176.035 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -149.9 126.25 10.79 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.137 -3.477 . . . . 3.75 105.751 -175.936 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.2 mt -72.55 159.21 34.29 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.366 1.866 . . . . 3.14 108.904 178.8 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -88.68 122.83 32.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.108 -2.87 . . . . 6.8 109.702 177.675 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.97 47.15 6.33 Favored Glycine 0 N--CA 1.428 -1.839 0 C-N-CA 120.217 -0.992 . . . . 3.57 113.779 -164.49 . . . . . . . . 1 1 . 1 . 131 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.792 0 CA-C-O 116.256 -2.413 . . . . 3.87 118.772 178.645 . . . . . . . . 0 0 . 1 . 132 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 ptt? . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 111.909 0.337 . . . . 1.1 111.909 . . . . . . . . . 0 0 . 1 . 132 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -98.59 144.16 28.19 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 126.569 3.08 . . . . 1.87 106.144 -178.518 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.7 pt -130.62 152.91 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 1 N-CA-C 99.206 -4.368 . . . . 0.72 99.206 178.136 . . . . . . . . 2 2 . 1 . 132 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -109.79 126.29 53.62 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.532 -2.605 . . . . 1.4 110.496 179.666 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.4 t -96.26 115.7 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 120.599 -1.313 . . . . 0.58 108.147 168.952 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -91.77 137.95 31.95 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 106.044 -1.836 . . . . 2.09 106.044 177.162 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -87.82 -164.59 1.13 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.68 -1.263 . . . . 0.99 113.348 178.627 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.9 mt -82.09 -39.03 23.98 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 124.344 1.027 . . . . 2.53 110.359 176.216 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.289 44.9 p -75.41 -10.96 59.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.701 2.4 . . . . 2.08 108.946 -177.329 . . . . . . . . 2 2 . 1 . 132 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.28 39.42 5.69 Favored Glycine 0 N--CA 1.431 -1.664 1 C-N-CA 135.1 6.095 . . . . 1.31 114.094 172.473 . . . . . . . . 2 2 . 1 . 132 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -90.05 132.4 35.41 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.099 1.95 . . . . 1.4 106.788 -171.309 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.8 m -88.87 111.43 22.06 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.18 -2.2 . . . . 0.78 108.357 -174.627 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.8 mt -104.47 115.49 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 115.569 1.692 . . . . 1.55 115.569 176.429 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 m -81.66 115.85 21.12 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 120.719 -1.238 . . . . 1.08 110.585 -179.129 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.0 mt -121.67 147.89 45.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 115.249 -2.31 . . . . 1.55 111.902 177.625 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -99.69 119.31 37.91 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 120.877 1.671 . . . . 1.95 115.48 171.63 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.82 167.75 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 130.403 3.481 . . . . 0.96 108.779 -177.598 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -118.62 167.44 11.63 Favored Pre-proline 0 N--CA 1.43 -1.47 0 O-C-N 118.477 -2.639 . . . . 2.35 106.953 162.41 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -67.54 -16.54 47.37 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 CA-C-N 125.248 2.91 . . . . 0.95 115.532 -170.654 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -74.86 -15.59 60.71 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 131.265 3.826 . . . . 1.45 117.905 174.41 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -69.66 138.34 52.93 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.061 -2.275 . . . . 1.69 115.09 171.024 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 26' ' ' VAL . 36.1 p -79.16 179.52 7.32 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.187 -1.824 . . . . 0.75 114.76 -175.842 . . . . . . . . 2 2 . 1 . 132 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -78.42 -33.75 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 118.934 -2.354 . . . . 0.73 110.799 176.513 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -49.9 -41.96 46.96 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.74 -3.1 . . . . 1.62 116.856 159.182 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.263 40.6 m-20 -76.48 -32.77 58.55 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 112.9 -3.429 . . . . 2.13 113.212 177.677 . . . . . . . . 2 2 . 1 . 132 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 22' ' ' THR . 1.9 t -66.44 -50.5 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 126.954 2.659 . . . . 0.62 113.363 167.855 . . . . . . . . 2 2 . 1 . 132 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.6 mtmt -60.01 -31.17 69.69 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.078 -2.889 . . . . 1.22 116.601 169.109 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.78 -45.38 78.2 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.781 2.141 . . . . 0.51 116.781 170.307 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -65.71 -41.25 92.52 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.383 -3.948 . . . . 1.44 115.374 179.481 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.6 mm -56.83 -40.51 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.147 1.779 . . . . 1.32 113.685 166.773 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -59.81 -55.5 33.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.577 1.951 . . . . 1.7 115.168 171.693 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -46.82 -57.37 4.97 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 130.271 3.428 . . . . 1.55 112.528 175.26 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -85.89 -62.14 1.59 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.371 1.868 . . . . 2.62 112.525 -166.847 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -76.68 -23.01 53.2 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.406 2.002 . . . . 1.48 116.406 -175.459 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.59 20.11 38.72 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 118.556 2.182 . . . . 1.12 118.556 172.876 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.1 mt -101.51 134.79 20.04 Favored Pre-proline 0 N--CA 1.43 -1.465 0 CA-C-O 113.491 -3.147 . . . . 1.55 116.75 -174.564 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -64.52 132.56 33.7 Favored 'Trans proline' 0 C--N 1.3 -2.009 1 C-N-CA 126.319 4.679 . . . . 1.02 116.819 -179.046 . . . . . . . . 2 2 . 1 . 132 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -63.36 -14.71 43.83 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 CA-C-N 127.792 3.819 . . . . 1.25 116.467 -179.026 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -60.31 -27.91 67.69 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 117.758 2.503 . . . . 2.25 117.758 168.615 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -93.12 -29.52 15.72 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.599 -1.313 . . . . 2.02 108.669 -176.951 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -72.77 126.33 29.65 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 126.341 2.972 . . . . 0.69 112.972 -171.759 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -126.78 146.94 50.05 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 111.52 -2.582 . . . . 2.78 109.478 167.328 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 mt -117.28 127.64 54.28 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 114.158 1.17 . . . . 1.17 114.158 175.429 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mm -119.52 126.72 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 118.848 -2.407 . . . . 1.38 106.151 -175.999 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.496 ' CD2' HG12 ' A' ' 61' ' ' ILE . 49.0 t80 -137.79 121.17 17.06 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.865 -3.022 . . . . 1.5 103.328 176.038 . . . . . . . . 2 2 . 1 . 132 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.25 . . 43.51 62.54 1.85 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.216 3.006 . . . . 1.21 113.35 179.942 . . . . . . . . 2 2 . 1 . 132 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.72 -31.96 2.7 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 120.346 2.898 . . . . 1.3 120.346 177.863 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -89.79 127.02 35.9 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.568 1.947 . . . . 2.55 114.261 -178.31 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -73.68 116.38 14.2 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 115.708 -2.091 . . . . 2.48 108.521 173.156 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 mt -76.96 136.43 38.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 116.761 2.134 . . . . 0.9 116.761 -168.648 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -87.73 139.35 30.62 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 121.376 3.843 . . . . 1.94 121.376 179.826 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -47.01 -55.33 8.37 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 121.25 3.796 . . . . 1.56 121.25 -166.403 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.05 35.5 4.74 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 125.94 1.733 . . . . 0.97 116.902 179.433 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.3 mtt-85 -114.47 172.6 6.92 Favored 'General case' 0 N--CA 1.429 -1.482 1 O-C-N 116.0 -4.235 . . . . 2.49 100.864 168.496 . . . . . . . . 2 2 . 1 . 132 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.6 p -104.73 170.0 8.13 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.061 3.344 . . . . 0.76 114.282 179.07 . . . . . . . . 2 2 . 1 . 132 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.8 mt -60.75 -41.62 95.77 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.813 1.412 . . . . 1.05 114.813 169.247 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.0 t -64.41 -28.26 69.56 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.575 2.131 . . . . 1.19 116.259 -178.46 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -59.17 -37.51 77.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.772 -3.705 . . . . 1.9 110.741 173.563 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -94.51 1.2 55.72 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.678 -1.264 . . . . 0.89 109.873 -179.301 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.303 32.8 m120 53.82 51.3 15.14 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 126.946 2.098 . . . . 1.84 111.032 -177.716 . . . . . . . . 2 2 . 1 . 132 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.496 HG12 ' CD2' ' A' ' 45' ' ' PHE . 76.8 mt -94.36 107.96 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 104.906 -2.257 . . . . 0.82 104.906 179.985 . . . . . . . . 2 2 . 1 . 132 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -81.79 -171.72 3.5 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 125.864 2.745 . . . . 2.16 111.773 -179.69 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -70.04 165.53 21.66 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 113.437 -5.789 . . . . 2.12 111.319 168.298 . . . . . . . . 2 2 . 1 . 132 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 63.57 22.96 13.41 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.239 1.971 . . . . 1.71 110.801 177.127 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -98.86 125.57 44.29 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 125.434 1.494 . . . . 1.04 107.285 -170.693 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.1 m -93.55 113.95 26.19 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 122.165 0.983 . . . . 0.79 111.029 -178.121 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -101.71 129.5 47.89 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 129.327 3.051 . . . . 1.4 113.06 -179.633 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -86.82 111.44 20.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 127.331 3.443 . . . . 1.51 111.652 -171.352 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 tp -87.68 111.39 21.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 116.874 -3.641 . . . . 1.14 108.564 -177.918 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 37.7 t -106.16 120.66 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 128.209 2.604 . . . . 1.23 109.098 -177.191 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.9 mt -108.94 105.33 14.82 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.823 1.649 . . . . 2.78 106.82 -179.523 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -99.33 123.07 43.31 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 124.683 2.182 . . . . 3.75 110.745 -177.601 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.8 mt -80.29 144.47 32.8 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.341 -3.975 . . . . 3.14 111.68 177.832 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -141.16 -82.64 0.22 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.041 -2.912 . . . . 6.8 109.083 179.048 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.29 -76.47 1.14 Allowed Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 110.78 -0.928 . . . . 3.57 110.78 -164.67 . . . . . . . . 1 1 . 1 . 132 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.775 1 CA-C-O 112.897 -4.279 . . . . 3.87 106.938 -179.55 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptt? . . . . . 0 CA--C 1.49 -1.352 0 CA-C-O 122.833 1.301 . . . . 1.1 114.384 . . . . . . . . . 0 0 . 1 . 133 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -108.86 130.31 55.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.54 -3.85 . . . . 1.87 107.148 -168.644 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -128.7 163.84 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 127.396 2.278 . . . . 0.72 110.711 173.728 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -123.33 129.26 51.07 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 112.714 -2.039 . . . . 1.4 113.717 179.91 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -111.96 118.61 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 118.917 -1.113 . . . . 0.58 108.607 172.191 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -89.28 134.25 34.13 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.073 -2.267 . . . . 2.09 113.74 171.089 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.403 HG22 HD23 ' A' ' 69' ' ' LEU . 81.4 p -85.82 167.73 14.92 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.833 2.16 . . . . 0.99 116.833 177.916 . . . . . . . . 2 2 . 1 . 133 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.2 mt -69.07 -40.41 78.5 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 127.145 3.355 . . . . 2.53 109.793 175.348 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.274 17.2 p -57.1 -60.68 3.24 Favored 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 114.878 -4.889 . . . . 2.08 119.021 174.85 . . . . . . . . 3 2 . 1 . 133 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.67 6.33 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.768 0 CA-C-N 119.879 1.218 . . . . 1.31 112.642 177.811 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.2 ttpt -95.63 142.63 27.72 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 121.55 2.675 . . . . 1.4 109.769 -174.937 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.0 m -112.3 120.91 43.35 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.616 -1.624 . . . . 0.78 106.616 174.496 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 mt -102.09 123.91 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 116.494 -1.717 . . . . 1.55 106.933 -177.676 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.1 m -90.37 119.6 30.8 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 124.763 1.29 . . . . 1.08 111.002 175.726 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.0 mt -111.76 137.22 49.98 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 115.358 1.614 . . . . 1.55 115.358 178.713 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -91.49 119.63 31.61 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 117.95 2.574 . . . . 1.95 117.95 165.586 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.8 m -139.3 -178.25 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.414 1 N-CA-C 99.64 -4.207 . . . . 0.96 99.64 -175.303 . . . . . . . . 2 2 . 1 . 133 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -123.29 159.81 53.02 Favored Pre-proline 0 N--CA 1.43 -1.43 1 O-C-N 115.779 -4.326 . . . . 2.35 104.456 163.234 . . . . . . . . 2 2 . 1 . 133 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 48.3 Cg_endo -69.47 -7.96 22.34 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 125.026 3.817 . . . . 0.95 112.802 -173.273 . . . . . . . . 2 2 . 1 . 133 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.2 p -80.52 -7.1 59.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.541 2.736 . . . . 1.45 114.528 171.405 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -83.4 145.04 29.22 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.965 -2.334 . . . . 1.69 109.997 175.875 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.35 41.4 p -75.17 154.75 37.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 118.282 2.697 . . . . 0.75 118.282 176.143 . . . . . . . . 2 2 . 1 . 133 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.6 mm -58.36 -29.78 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 127.07 2.148 . . . . 0.73 113.765 171.486 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.62 -32.87 74.68 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.197 2.599 . . . . 1.62 110.815 167.465 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -72.53 -28.66 62.99 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 126.078 1.751 . . . . 2.13 111.541 179.758 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.42 -50.23 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 131.39 3.876 . . . . 0.62 110.605 168.496 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -69.18 -27.64 65.69 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 115.361 1.615 . . . . 1.22 115.361 173.045 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.25 . . -72.79 -39.36 66.77 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.411 -1.431 . . . . 0.51 109.328 -178.945 . . . . . . . . 2 2 . 1 . 133 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -66.49 -39.61 88.82 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.326 3.05 . . . . 1.44 112.62 169.445 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.63 -30.85 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 117.674 -3.141 . . . . 1.32 114.796 169.478 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -65.09 -60.86 2.56 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.814 -1.804 . . . . 1.7 109.444 174.053 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -45.7 -39.57 8.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.929 2.937 . . . . 1.55 118.929 172.02 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -91.81 -63.2 1.28 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.582 2.753 . . . . 2.62 107.481 -172.282 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -93.11 -17.79 23.37 Favored 'General case' 0 N--CA 1.429 -1.521 0 O-C-N 117.272 -3.393 . . . . 1.48 115.541 -169.233 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.55 -4.84 62.06 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 108.712 -1.755 . . . . 1.12 108.712 170.793 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.2 mt -75.06 133.84 75.09 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 125.077 1.351 . . . . 1.55 112.785 -176.879 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -75.9 138.29 20.77 Favored 'Trans proline' 0 N--CA 1.433 -2.043 0 CA-C-O 114.122 -2.532 . . . . 1.02 115.766 -178.597 . . . . . . . . 2 2 . 1 . 133 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -64.67 -24.66 62.23 Favored 'Trans proline' 0 N--CA 1.433 -2.031 1 C-N-CA 125.996 4.464 . . . . 1.25 118.572 -172.176 . . . . . . . . 2 2 . 1 . 133 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -55.76 -36.05 66.88 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.212 3.445 . . . . 2.25 116.176 173.299 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -79.9 -11.89 59.78 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.025 1.73 . . . . 2.02 109.928 -178.842 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -86.58 121.21 28.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 118.737 2.865 . . . . 0.69 118.737 -169.172 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -110.44 110.55 21.34 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.211 1.368 . . . . 2.78 111.678 172.458 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.2 mt -97.93 119.43 36.53 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 123.675 2.943 . . . . 1.17 109.7 -176.001 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.6 mm -108.45 137.8 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 119.175 -2.203 . . . . 1.38 110.96 178.301 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -130.06 121.67 26.87 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 104.604 -2.369 . . . . 1.5 104.604 173.121 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.26 -100.47 0.06 Allowed 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 120.909 -1.12 . . . . 1.21 110.129 -178.793 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.69 10.39 6.75 Favored Glycine 0 N--CA 1.429 -1.817 0 C-N-CA 126.176 1.846 . . . . 1.3 115.348 174.186 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -110.38 137.66 47.8 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.729 -1.235 . . . . 2.55 112.72 -173.857 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -95.24 129.13 42.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 126.643 2.464 . . . . 2.48 109.421 176.826 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.2 mt -100.35 136.86 39.59 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 117.263 2.32 . . . . 0.9 117.263 -166.804 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -79.54 138.74 37.6 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.79 -2.444 . . . . 1.94 116.614 -178.164 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.97 -47.18 87.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.367 -2.708 . . . . 1.56 114.78 -168.869 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.76 35.86 3.45 Favored Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 119.677 2.631 . . . . 0.97 119.677 173.058 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -114.97 160.51 19.48 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 123.102 1.429 . . . . 2.49 108.463 163.152 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.4 p -100.58 171.4 7.75 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.006 -3.559 . . . . 0.76 117.235 177.953 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 3.2 mt -64.71 -23.61 67.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.712 1.72 . . . . 1.05 113.088 172.25 . . . . . . . . 2 2 . 1 . 133 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.271 19.2 t -60.4 -59.59 5.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.266 3.426 . . . . 1.19 116.111 174.993 . . . . . . . . 2 2 . 1 . 133 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -39.29 -41.27 0.87 Allowed 'General case' 0 N--CA 1.43 -1.458 1 C-N-CA 132.928 4.491 . . . . 1.9 118.74 165.632 . . . . . . . . 2 2 . 1 . 133 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -97.57 9.84 41.42 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 112.508 -3.615 . . . . 0.89 116.436 175.214 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.1 t30 52.84 51.22 16.36 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 131.213 5.321 . . . . 1.84 115.44 -175.486 . . . . . . . . 2 2 . 1 . 133 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.0 mt -101.79 116.94 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 125.574 2.607 . . . . 0.82 111.011 177.394 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -100.86 -153.59 0.45 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.15 -1.594 . . . . 2.16 109.824 -173.277 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -74.31 142.5 45.18 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 128.157 2.583 . . . . 2.12 116.422 175.74 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.252 49.0 mt-10 68.89 33.88 3.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.937 2.095 . . . . 1.71 108.072 176.782 . . . . . . . . 2 2 . 1 . 133 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.0 m -91.67 137.03 32.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 130.004 3.322 . . . . 1.04 113.969 -175.465 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.1 m -107.94 117.26 33.65 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 126.673 1.989 . . . . 0.79 114.962 -174.125 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.64 156.86 17.47 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 125.629 1.571 . . . . 1.4 108.332 177.08 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -117.37 123.14 45.74 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 125.546 2.594 . . . . 1.51 108.13 -178.661 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.403 HD23 HG22 ' A' ' 7' ' ' THR . 60.2 tp -97.13 93.4 6.54 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.633 -2.542 . . . . 1.14 112.433 -179.916 . . . . . . . . 2 2 . 1 . 133 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.5 t -91.46 136.27 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 127.831 2.452 . . . . 1.23 106.154 174.569 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.5 mt -109.47 164.04 12.87 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 124.506 2.098 . . . . 2.78 111.198 178.582 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -88.61 154.24 20.48 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 130.569 3.548 . . . . 3.75 108.309 168.528 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.2 mt -64.79 130.6 44.1 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 128.158 2.583 . . . . 3.14 113.198 171.965 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -79.66 115.76 19.46 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 116.668 2.099 . . . . 6.8 116.668 174.082 . . . . . . . . 1 1 . 1 . 133 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.65 -58.72 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.722 1 N-CA-C 101.887 -4.485 . . . . 3.57 101.887 -169.894 . . . . . . . . 2 2 . 1 . 133 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.782 0 N-CA-C 103.158 -3.977 . . . . 3.87 103.158 -178.022 . . . . . . . . 0 0 . 1 . 134 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.263 16.0 ptt? . . . . . 0 CA--C 1.49 -1.333 0 N-CA-C 114.366 1.247 . . . . 1.1 114.366 . . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -106.78 135.35 48.46 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 116.088 1.884 . . . . 1.87 116.088 -177.109 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.1 pt -120.42 165.11 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 101.514 -3.514 . . . . 0.72 101.514 176.657 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -116.83 147.53 42.04 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 121.989 0.9 . . . . 1.4 111.74 -179.732 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.347 65.0 t -123.34 113.79 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-O 123.703 1.716 . . . . 0.58 107.802 174.856 . . . . . . . . 2 2 . 1 . 134 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -99.2 130.48 45.5 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.737 -2.477 . . . . 2.09 108.545 -178.618 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.7 p -98.65 175.82 5.86 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.93 -1.731 . . . . 0.99 111.847 176.502 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.7 tp -77.32 -31.71 54.78 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 118.211 -1.396 . . . . 2.53 111.097 169.798 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.8 p -59.62 -27.31 66.21 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 131.62 3.968 . . . . 2.08 115.679 -177.425 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.01 56.6 0.62 Allowed Glycine 0 N--CA 1.43 -1.766 1 C-N-CA 135.417 6.246 . . . . 1.31 104.909 165.608 . . . . . . . . 2 2 . 1 . 134 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -125.73 141.96 51.75 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.306 -2.879 . . . . 1.4 107.807 177.642 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 100.0 m -120.53 112.69 19.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.556 -1.276 . . . . 0.78 107.556 175.921 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 13' ' ' ILE . 15.3 mt -93.97 141.07 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 118.212 -2.805 . . . . 1.55 106.838 -178.634 . . . . . . . . 2 2 . 1 . 134 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -104.42 117.74 34.9 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 124.551 2.12 . . . . 1.08 107.868 177.585 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.9 mt -116.06 128.7 55.9 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 111.75 -2.477 . . . . 1.55 107.735 -178.878 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -87.47 117.01 25.97 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 104.598 -2.371 . . . . 1.95 104.598 175.763 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.26 159.34 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 125.213 1.57 . . . . 0.96 107.591 -174.766 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 26.1 mt-10 -106.34 165.04 13.68 Favored Pre-proline 0 N--CA 1.429 -1.484 0 C-N-CA 125.502 1.521 . . . . 2.35 108.208 165.226 . . . . . . . . 2 2 . 1 . 134 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 95.7 Cg_exo -72.76 -22.38 20.44 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 125.073 3.849 . . . . 0.95 115.381 -173.18 . . . . . . . . 2 2 . 1 . 134 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.8 m -88.88 -1.33 58.04 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.796 -0.638 . . . . 1.45 112.32 -179.833 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -74.32 140.7 45.05 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.023 -2.923 . . . . 1.69 112.935 -179.318 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.0 p -76.5 162.39 27.85 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.772 -4.33 . . . . 0.75 113.499 177.873 . . . . . . . . 2 2 . 1 . 134 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mm -64.86 -29.05 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.29 -2.756 . . . . 0.73 114.325 175.48 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -61.28 -31.75 71.58 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 116.943 2.201 . . . . 1.62 116.943 164.921 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -75.43 -39.85 58.4 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.915 -1.116 . . . . 2.13 109.212 -179.344 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.0 t -63.67 -39.89 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 117.398 2.37 . . . . 0.62 117.398 171.535 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.257 66.4 mttt -61.22 -40.45 94.04 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 124.649 2.166 . . . . 1.22 114.934 172.529 . . . . . . . . 2 2 . 1 . 134 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.37 -39.77 67.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.974 -3.579 . . . . 0.51 113.6 172.506 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -68.76 -28.66 66.99 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 120.75 1.614 . . . . 1.44 109.855 172.519 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.1 mt -70.87 -24.8 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 116.95 -3.594 . . . . 1.32 115.402 174.381 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -62.11 -30.15 70.81 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.035 -2.916 . . . . 1.7 112.392 173.254 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -71.83 -20.04 61.89 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.896 -2.378 . . . . 1.55 113.205 175.801 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -103.11 -59.43 1.71 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.506 -1.664 . . . . 2.62 106.506 -173.907 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -105.57 -10.2 16.99 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.249 -1.341 . . . . 1.48 111.401 -164.45 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 56.3 54.0 38.97 Favored Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 125.757 1.646 . . . . 1.12 112.801 175.906 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.0 mt -118.49 127.55 26.5 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 127.236 2.214 . . . . 1.55 105.433 178.586 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 37.2 Cg_endo -75.6 163.91 33.19 Favored 'Trans proline' 0 N--CA 1.432 -2.124 2 O-C-N 112.669 -4.438 . . . . 1.02 115.553 179.499 . . . . . . . . 3 3 . 1 . 134 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 71.3 Cg_exo -70.63 -12.23 30.93 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 CA-C-N 123.622 2.329 . . . . 1.25 117.053 -177.238 . . . . . . . . 2 2 . 1 . 134 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -75.2 -16.25 60.5 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 115.603 -4.436 . . . . 2.25 112.533 172.642 . . . . . . . . 2 2 . 1 . 134 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -90.26 -10.68 43.34 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 119.668 1.122 . . . . 2.02 109.773 -177.071 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -103.32 132.04 49.9 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 123.931 1.824 . . . . 0.69 106.1 -160.301 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -121.41 111.25 17.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 114.207 -1.361 . . . . 2.78 112.428 168.506 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.3 mt -90.13 132.37 35.48 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.552 -1.967 . . . . 1.17 115.751 179.362 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 mm -123.73 124.82 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-O 126.316 2.96 . . . . 1.38 112.331 -179.587 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -124.48 108.16 11.84 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 127.612 2.365 . . . . 1.5 108.529 177.15 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.53 -74.3 0.09 Allowed 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 110.592 -3.003 . . . . 1.21 114.066 -178.056 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -147.67 -10.98 0.17 Allowed Glycine 0 N--CA 1.431 -1.679 1 C-N-CA 131.178 4.228 . . . . 1.3 114.631 -177.886 . . . . . . . . 2 2 . 1 . 134 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -94.93 122.43 37.56 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.515 -2.756 . . . . 2.55 113.909 -173.032 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -73.26 117.96 15.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.751 1.62 . . . . 2.48 111.273 168.76 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.8 mt -92.17 128.68 38.1 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 123.429 2.831 . . . . 0.9 113.186 -171.842 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -73.8 146.64 44.07 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.415 1.579 . . . . 1.94 112.963 178.956 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -66.1 -50.1 65.22 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.817 -2.427 . . . . 1.56 115.554 -170.288 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.92 52.85 1.93 Allowed Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 117.234 -2.412 . . . . 0.97 118.082 168.527 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -114.55 161.64 17.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.848 -1.908 . . . . 2.49 105.848 161.553 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.3 p -108.05 175.6 5.42 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 116.749 2.129 . . . . 0.76 116.749 178.11 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.3 mt -65.49 -31.62 72.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.158 2.885 . . . . 1.05 114.563 172.301 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 t -63.06 -44.41 95.89 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.879 -3.638 . . . . 1.19 118.011 171.511 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -64.74 -37.2 86.81 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 129.602 3.161 . . . . 1.9 110.269 -175.597 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -98.4 -10.16 24.13 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.788 2.835 . . . . 0.89 110.085 -174.305 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.1 m120 60.66 54.89 3.5 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 128.487 3.994 . . . . 1.84 113.003 178.715 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.9 mt -106.59 101.35 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-N 108.768 -3.833 . . . . 0.82 106.644 179.607 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -104.01 174.49 5.85 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 129.988 3.315 . . . . 2.16 111.583 -167.012 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -55.67 138.81 46.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.815 -3.053 . . . . 2.12 114.486 179.813 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 67.71 39.07 2.8 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 129.837 3.255 . . . . 1.71 112.783 -178.89 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.3 t -109.9 137.28 47.9 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.22 -1.77 . . . . 1.04 106.22 -169.494 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.6 m -96.81 110.0 22.57 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 129.148 2.979 . . . . 0.79 114.114 -176.031 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.1 mt -95.06 147.28 23.59 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 127.647 2.379 . . . . 1.4 107.742 169.342 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -109.31 123.43 49.28 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 103.735 -2.691 . . . . 1.51 103.735 -173.207 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.6 tp -81.9 107.23 14.45 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.246 -2.784 . . . . 1.14 109.011 173.706 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.4 t -98.37 144.69 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 127.923 3.264 . . . . 1.23 104.692 167.809 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.9 mt -109.19 137.08 47.63 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 117.841 -3.037 . . . . 2.78 110.593 178.755 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -85.11 -174.65 5.36 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 129.389 3.076 . . . . 3.75 112.151 177.486 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.0 mt -124.52 173.66 8.32 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 102.701 -3.074 . . . . 3.14 102.701 172.362 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.1 ttp180 -93.11 150.84 20.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.054 2.835 . . . . 6.8 118.267 175.045 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 134.6 -90.22 0.24 Allowed Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 112.548 -2.114 . . . . 3.57 112.472 -165.387 . . . . . . . . 1 1 . 1 . 134 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.727 0 N-CA-C 106.235 -2.746 . . . . 3.87 106.235 175.836 . . . . . . . . 0 0 . 1 . 135 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ptt? . . . . . 0 CA--C 1.489 -1.381 0 N-CA-C 112.017 0.377 . . . . 1.1 112.017 . . . . . . . . . 0 0 . 1 . 135 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -92.0 136.16 33.38 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.191 -2.193 . . . . 1.87 115.964 173.659 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.373 27.5 pt -116.61 161.66 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-O 114.541 -2.647 . . . . 0.72 112.378 165.839 . . . . . . . . 2 2 . 1 . 135 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -120.13 143.52 48.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 121.383 1.901 . . . . 1.4 110.91 177.226 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.83 127.55 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 112.33 -2.213 . . . . 0.58 108.198 175.654 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -97.4 138.83 34.26 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.343 -1.725 . . . . 2.09 106.343 177.256 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 p -97.57 -179.45 4.47 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 127.609 3.576 . . . . 0.99 110.867 173.027 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.8 mt -77.79 -51.33 10.68 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.208 -4.683 . . . . 2.53 112.624 175.315 . . . . . . . . 2 2 . 1 . 135 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.0 p -56.83 -43.87 81.48 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.464 2.024 . . . . 2.08 116.464 177.602 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.08 61.08 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 127.106 2.289 . . . . 1.31 111.118 177.978 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.38 156.48 48.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 103.1 -2.926 . . . . 1.4 103.1 178.38 . . . . . . . . 2 2 . 1 . 135 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.9 m -133.04 121.81 23.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.715 2.674 . . . . 0.78 110.805 -176.95 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mt -102.23 115.27 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 118.627 -2.546 . . . . 1.55 106.896 -175.998 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.2 m -93.19 115.73 28.34 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.163 -1.586 . . . . 1.08 106.784 174.867 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.3 mt -117.63 147.87 42.47 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 125.726 2.679 . . . . 1.55 112.022 -178.787 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -90.61 121.13 32.26 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.378 1.871 . . . . 1.95 110.525 177.346 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.6 m -140.99 167.38 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 116.534 -1.698 . . . . 0.96 111.829 -176.735 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -118.86 173.46 3.4 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-N 122.739 2.518 . . . . 2.35 114.182 156.96 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -75.7 -11.31 20.24 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 115.224 -2.717 . . . . 0.95 118.861 -179.479 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.6 m -79.57 -3.02 45.06 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.359 1.064 . . . . 1.45 112.062 170.493 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -81.33 151.57 27.95 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.517 -1.99 . . . . 1.69 107.884 178.781 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.269 17.3 p -92.52 164.03 13.6 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 115.088 1.514 . . . . 0.75 115.088 178.796 . . . . . . . . 2 2 . 1 . 135 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.9 mm -63.33 -22.38 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 116.267 1.951 . . . . 0.73 116.267 171.999 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -66.72 -45.34 79.01 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.149 3.379 . . . . 1.62 111.764 166.114 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -56.89 -38.16 72.39 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.343 -2.098 . . . . 2.13 114.504 178.133 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.1 t -66.26 -36.03 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 127.914 2.485 . . . . 0.62 114.245 174.979 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -67.4 -39.56 85.58 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.97 2.952 . . . . 1.22 118.97 173.582 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.28 -36.55 66.25 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 116.847 2.166 . . . . 0.51 116.847 170.547 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -60.42 -40.25 90.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.913 1.285 . . . . 1.44 114.224 170.048 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.3 mt -76.4 -31.42 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.438 1.495 . . . . 1.32 108.654 179.367 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -67.26 -43.55 81.59 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.171 -2.205 . . . . 1.7 113.904 174.851 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -58.13 -65.57 0.62 Allowed 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 130.386 3.474 . . . . 1.55 110.805 168.783 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -56.63 -53.55 56.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.926 3.306 . . . . 2.62 119.926 -175.252 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -120.87 -3.63 9.68 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.681 -1.6 . . . . 1.48 112.826 -164.845 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.83 -6.34 81.95 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 118.493 2.157 . . . . 1.12 118.493 169.527 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.7 mp -73.97 113.63 25.1 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 118.288 -2.889 . . . . 1.55 115.451 -170.665 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 14.5 Cg_exo -60.23 146.44 96.39 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 124.974 3.783 . . . . 1.02 114.009 179.718 . . . . . . . . 2 2 . 1 . 135 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -58.18 -24.91 69.26 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 C-N-CA 123.437 2.758 . . . . 1.25 117.224 -177.534 . . . . . . . . 3 3 . 1 . 135 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -70.8 -26.2 63.21 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 130.176 4.672 . . . . 2.25 112.702 179.296 . . . . . . . . 2 2 . 1 . 135 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -89.89 -16.26 30.4 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.21 -3.431 . . . . 2.02 112.492 -174.974 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -87.25 126.87 35.09 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 117.313 2.338 . . . . 0.69 117.313 -177.759 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -120.74 126.27 49.73 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.127 2.571 . . . . 2.78 108.099 164.883 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.9 mt -109.51 115.03 29.17 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.774 -3.079 . . . . 1.17 109.391 -174.993 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.3 mm -101.18 134.72 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 125.943 1.697 . . . . 1.38 108.581 -177.028 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -154.42 126.54 7.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.565 -2.383 . . . . 1.5 104.565 174.976 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.52 45.12 16.85 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 125.958 2.789 . . . . 1.21 113.788 -177.264 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.49 2.27 20.08 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 111.97 -2.377 . . . . 1.3 118.737 -173.506 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -103.88 125.9 50.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.283 -3.481 . . . . 2.55 107.19 -175.523 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -74.0 122.01 21.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.083 -2.261 . . . . 2.48 107.258 163.707 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.9 mt -78.24 127.02 31.64 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 130.459 3.504 . . . . 0.9 116.855 -177.396 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -89.29 130.55 35.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 116.421 2.008 . . . . 1.94 116.421 173.871 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.53 -61.41 1.7 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 130.275 3.43 . . . . 1.56 115.898 -170.269 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.68 23.8 3.45 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 123.066 3.986 . . . . 0.97 123.066 173.199 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -99.73 165.44 11.59 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.363 1.465 . . . . 2.49 107.347 163.862 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.391 18.6 p -92.6 171.19 9.17 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 117.09 2.256 . . . . 0.76 117.09 177.097 . . . . . . . . 2 2 . 1 . 135 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.72 -33.79 64.52 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 114.897 -2.478 . . . . 1.05 107.374 170.987 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -73.46 -35.68 65.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.42 1.888 . . . . 1.19 107.94 -175.256 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.39 3.0 t0 -63.32 -53.98 44.25 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.941 1.353 . . . . 1.9 111.859 171.005 . . . . . . . . 2 2 . 1 . 135 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -73.19 -7.98 53.79 Favored 'General case' 0 N--CA 1.43 -1.454 2 O-C-N 115.318 -4.613 . . . . 0.89 122.295 177.112 . . . . . . . . 2 2 . 1 . 135 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.0 m120 70.2 56.42 0.29 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.568 1.692 . . . . 1.84 115.568 179.137 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.1 mt -104.71 108.29 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 128.097 3.373 . . . . 0.82 109.008 177.485 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -87.95 -175.39 5.09 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 125.265 2.46 . . . . 2.16 109.49 177.807 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -63.2 131.0 47.0 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 115.276 -4.64 . . . . 2.12 115.62 174.522 . . . . . . . . 2 2 . 1 . 135 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.662 17.9 mt-10 97.69 -5.31 0.05 Allowed 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 124.622 1.201 . . . . 1.71 112.284 174.315 . . . . . . . . 2 2 . 1 . 135 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -66.71 122.69 18.2 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.807 2.043 . . . . 1.04 115.455 -176.265 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.5 m -91.2 115.59 28.14 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 103.803 -2.666 . . . . 0.79 103.803 -178.682 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.4 mt -79.34 139.74 37.7 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.079 2.952 . . . . 1.4 112.245 165.343 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -108.7 117.08 33.25 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.95 -2.969 . . . . 1.51 114.702 -179.059 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.9 tp -83.17 115.14 21.79 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 128.577 2.751 . . . . 1.14 111.746 -174.916 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.2 t -104.25 133.27 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 105.354 -2.091 . . . . 1.23 105.354 174.498 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.8 mt -114.57 165.74 12.45 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 125.345 1.653 . . . . 2.78 110.036 -178.231 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -106.19 140.19 39.53 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 102.121 -3.289 . . . . 3.75 102.121 176.981 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.5 mt -86.26 170.71 11.85 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 116.288 -1.815 . . . . 3.14 112.298 178.89 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -79.06 85.0 5.01 Favored 'General case' 0 N--CA 1.431 -1.418 1 O-C-N 129.586 4.304 . . . . 6.8 115.443 171.567 . . . . . . . . 2 2 . 1 . 135 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.22 -94.58 0.1 OUTLIER Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 117.173 1.629 . . . . 3.57 117.173 -169.902 . . . . . . . . 1 1 . 1 . 135 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.725 0 CA-C-N 121.324 2.562 . . . . 3.87 112.447 179.053 . . . . . . . . 0 0 . 1 . 136 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 ptt? . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 122.104 0.954 . . . . 1.1 109.965 . . . . . . . . . 0 0 . 1 . 136 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -103.08 144.02 31.83 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.336 -1.302 . . . . 1.87 107.966 -177.381 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.2 pt -132.35 159.68 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 C-N-CA 127.341 2.256 . . . . 0.72 107.182 175.71 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -103.39 153.09 20.85 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 128.581 2.753 . . . . 1.4 111.574 178.752 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.5 t -137.7 104.68 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 106.636 -1.616 . . . . 0.58 106.636 177.546 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -90.59 117.62 29.4 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 127.062 3.315 . . . . 2.09 111.13 -179.791 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.1 p -80.22 174.5 11.53 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.137 -3.477 . . . . 0.99 115.567 179.303 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.2 mt -61.47 -52.74 63.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 124.875 1.359 . . . . 2.53 111.573 170.235 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.276 72.6 p -66.5 -38.17 86.65 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 119.465 -2.022 . . . . 2.08 115.625 -173.189 . . . . . . . . 2 2 . 1 . 136 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.75 52.12 0.17 Allowed Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 125.542 1.544 . . . . 1.31 116.49 173.578 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -119.3 149.27 42.06 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 103.475 -2.787 . . . . 1.4 103.475 174.773 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.3 m -119.28 115.05 23.36 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 125.497 1.748 . . . . 0.78 106.636 174.633 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mt -95.69 135.63 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.189 -2.195 . . . . 1.55 105.33 179.744 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.8 m -96.14 129.52 43.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.961 -2.977 . . . . 1.08 102.961 172.122 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.0 mt -124.29 133.89 53.36 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.104 -1.813 . . . . 1.55 106.104 -179.102 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -92.3 107.24 19.07 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.07 -2.268 . . . . 1.95 111.098 169.413 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 m -113.67 179.04 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 C-N-CA 127.734 2.414 . . . . 0.96 114.113 174.669 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -125.73 154.75 73.2 Favored Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 103.84 -2.652 . . . . 2.35 103.84 166.317 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.294 25.6 Cg_endo -66.74 -30.73 41.04 Favored 'Trans proline' 0 N--CA 1.434 -2.001 1 C-N-CA 125.577 4.185 . . . . 0.95 110.234 -172.031 . . . . . . . . 3 2 . 1 . 136 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.2 p -64.51 -16.94 63.39 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.552 3.141 . . . . 1.45 116.646 173.549 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -70.07 142.47 52.66 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.376 -2.077 . . . . 1.69 109.39 177.137 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.0 p -78.26 164.56 24.79 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 126.247 2.217 . . . . 0.75 112.941 174.237 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.4 mm -65.2 -32.6 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 117.142 2.275 . . . . 0.73 117.142 174.114 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -50.03 -49.88 49.44 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 126.386 2.993 . . . . 1.62 109.688 164.533 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -65.36 -37.21 86.35 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.407 -2.683 . . . . 2.13 116.295 -178.127 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.4 t -67.53 -27.89 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 121.254 1.843 . . . . 0.62 108.221 174.812 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -75.0 -27.32 60.09 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 121.005 1.729 . . . . 1.22 112.526 178.343 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.18 -31.74 69.35 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 117.3 -1.333 . . . . 0.51 111.457 173.844 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -69.05 -35.64 76.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.515 2.726 . . . . 1.44 109.914 175.033 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.8 mt -69.03 -43.66 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-N 113.789 -1.55 . . . . 1.32 111.359 171.134 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -62.68 -38.07 88.92 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.103 -2.248 . . . . 1.7 113.389 179.206 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -49.67 -49.5 47.2 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 130.272 3.429 . . . . 1.55 114.474 168.943 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -87.96 -58.45 2.56 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.106 -3.496 . . . . 2.62 117.002 -179.557 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -81.88 -43.97 17.47 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.695 1.712 . . . . 1.48 112.546 -166.086 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.1 63.35 1.14 Allowed Glycine 0 N--CA 1.431 -1.689 0 CA-C-N 111.946 -2.388 . . . . 1.12 112.586 176.001 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.2 mt -129.81 117.9 18.52 Favored Pre-proline 0 N--CA 1.429 -1.505 0 CA-C-O 115.789 -2.053 . . . . 1.55 106.074 -177.599 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -67.4 140.63 53.35 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 CA-C-N 127.493 3.712 . . . . 1.02 112.114 -179.904 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -51.9 -20.17 9.57 Favored 'Trans proline' 0 N--CA 1.433 -2.073 1 N-CA-C 122.719 4.084 . . . . 1.25 122.719 -175.958 . . . . . . . . 3 3 . 1 . 136 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.96 -39.55 72.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.805 2.842 . . . . 2.25 111.02 172.523 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -75.75 -36.0 60.01 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 116.706 -3.746 . . . . 2.02 111.496 179.878 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -93.52 142.45 27.33 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 119.951 -1.718 . . . . 0.69 107.036 -166.136 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -124.13 151.54 43.82 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.993 -1.692 . . . . 2.78 106.535 166.599 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.6 mt -121.64 123.9 43.02 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.084 1.421 . . . . 1.17 108.868 -179.559 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.4 mt -105.53 128.43 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 129.719 3.208 . . . . 1.38 110.664 -176.101 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.416 ' C ' ' H ' ' A' ' 47' ' ' GLY . 2.4 t80 -139.13 133.11 31.04 Favored 'General case' 0 N--CA 1.43 -1.473 1 N-CA-C 99.256 -4.35 . . . . 1.5 99.256 179.835 . . . . . . . . 3 3 . 1 . 136 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.57 -36.01 0.18 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 131.418 3.887 . . . . 1.21 113.557 179.504 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 164.91 -26.06 0.18 Allowed Glycine 0 N--CA 1.429 -1.781 0 O-C-N 116.964 -3.585 . . . . 1.3 111.245 178.297 . . . . . . . . 2 2 . 1 . 136 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -83.22 137.67 33.92 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.703 2.668 . . . . 2.55 111.611 -178.974 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 pm0 -92.4 126.99 37.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.26 -2.15 . . . . 2.48 109.514 177.019 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.293 34.8 mt -81.87 122.84 28.24 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.378 2.513 . . . . 0.9 109.899 -161.683 . . . . . . . . 2 2 . 1 . 136 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -77.99 130.64 36.75 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 116.801 -3.687 . . . . 1.94 108.119 178.601 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -46.57 -48.18 19.58 Favored 'General case' 0 N--CA 1.43 -1.472 1 C-N-CA 132.34 4.256 . . . . 1.56 115.028 -173.34 . . . . . . . . 2 2 . 1 . 136 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.65 49.61 3.89 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 128.425 2.917 . . . . 0.97 116.077 172.983 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -135.78 172.86 12.39 Favored 'General case' 0 N--CA 1.43 -1.464 1 N-CA-C 97.606 -4.961 . . . . 2.49 97.606 169.47 . . . . . . . . 2 2 . 1 . 136 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.5 p -99.14 169.21 9.56 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.232 -1.804 . . . . 0.76 114.56 170.3 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.5 mt -76.02 -21.68 56.59 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 112.324 -2.216 . . . . 1.05 109.161 176.907 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 t -73.86 -39.78 63.73 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.893 -0.594 . . . . 1.19 109.798 176.862 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -54.84 -40.8 69.98 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 120.442 3.497 . . . . 1.9 120.442 174.508 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -78.84 -15.03 58.89 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 128.121 2.568 . . . . 0.89 116.992 175.966 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 m120 68.74 51.54 0.59 Allowed 'General case' 0 N--CA 1.43 -1.445 1 C-N-CA 132.932 4.493 . . . . 1.84 113.88 -178.311 . . . . . . . . 2 2 . 1 . 136 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mp -82.15 116.86 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 117.39 -3.318 . . . . 0.82 108.976 175.516 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -95.95 165.07 12.44 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 111.884 -2.417 . . . . 2.16 115.531 177.309 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -53.49 135.23 40.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.359 -1.291 . . . . 2.12 113.576 176.269 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 63.84 34.29 11.96 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 118.674 2.842 . . . . 1.71 118.674 178.241 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.7 m -92.12 154.46 18.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.1 2.16 . . . . 1.04 114.277 -177.314 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.0 m -102.36 114.14 28.07 Favored 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 117.516 -3.24 . . . . 0.79 116.348 -179.957 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -87.15 147.7 25.51 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.651 -0.656 . . . . 1.4 109.855 165.806 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -114.92 120.77 41.06 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 123.797 0.839 . . . . 1.51 109.137 -178.692 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.4 tp -97.69 129.16 44.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.932 -2.355 . . . . 1.14 109.472 -175.565 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.83 164.52 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 129.887 3.275 . . . . 1.23 105.555 177.796 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.7 mt -119.08 175.73 5.64 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 116.794 -3.691 . . . . 2.78 109.364 179.553 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -106.75 177.65 4.79 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.845 -1.07 . . . . 3.75 111.994 172.505 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.297 92.9 mt -83.65 114.69 21.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.071 1.878 . . . . 3.14 116.071 169.57 . . . . . . . . 2 2 . 1 . 136 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -75.7 120.16 20.72 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.043 2.537 . . . . 6.8 117.147 179.308 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.93 -13.12 1.92 Allowed Glycine 0 N--CA 1.43 -1.759 0 CA-C-N 112.384 -2.189 . . . . 3.57 116.433 -175.031 . . . . . . . . 1 1 . 1 . 136 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.79 0 CA-C-N 119.724 1.762 . . . . 3.87 112.845 175.41 . . . . . . . . 0 0 . 1 . 137 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 ptt? . . . . . 0 CA--C 1.49 -1.339 0 CA-C-O 115.847 -2.025 . . . . 1.1 116.247 . . . . . . . . . 0 0 . 1 . 137 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.62 138.13 34.66 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 122.809 2.55 . . . . 1.87 109.978 -179.096 . . . . . . . . 2 2 . 1 . 137 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.8 pt -124.33 170.85 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 104.232 -2.507 . . . . 0.72 104.232 167.991 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.463 ' HB3' HG23 ' A' ' 12' ' ' THR . 22.2 m-85 -119.1 147.25 44.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.811 3.245 . . . . 1.4 107.051 -176.586 . . . . . . . . 2 2 . 1 . 137 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.5 t -133.93 138.08 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 102.832 -3.025 . . . . 0.58 102.832 170.755 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -110.6 130.31 55.6 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.082 2.153 . . . . 2.09 107.328 177.768 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -81.8 -176.73 6.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 123.898 0.749 . . . . 0.99 111.966 174.977 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.7 mt -58.49 -47.51 83.84 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.171 2.988 . . . . 2.53 112.331 179.494 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.0 p -89.04 -35.73 16.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.161 -2.837 . . . . 2.08 106.529 -172.338 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.74 5.54 0.25 Allowed Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 119.938 2.735 . . . . 1.31 119.938 -178.497 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.1 ttpt -85.17 126.03 33.31 Favored 'General case' 0 N--CA 1.43 -1.443 2 O-C-N 113.803 -5.528 . . . . 1.4 108.895 -174.482 . . . . . . . . 2 2 . 1 . 137 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.463 HG23 ' HB3' ' A' ' 4' ' ' PHE 0.293 66.0 m -83.77 114.9 21.94 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.058 2.361 . . . . 0.78 109.362 173.966 . . . . . . . . 3 3 . 1 . 137 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mt -98.25 116.7 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 124.553 2.121 . . . . 1.55 105.654 177.051 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.6 m -86.59 105.89 17.18 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.812 -3.055 . . . . 1.08 116.436 173.371 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.0 mt -113.41 115.99 28.93 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 117.199 -1.381 . . . . 1.55 113.319 -179.495 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.368 0.8 OUTLIER -67.94 111.71 4.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.811 1.291 . . . . 1.95 111.211 171.081 . . . . . . . . 3 3 . 1 . 137 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 m -117.0 169.81 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 117.039 -3.538 . . . . 0.96 112.678 179.334 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -112.82 165.57 12.83 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-N 121.512 1.96 . . . . 2.35 108.382 160.25 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -66.47 -28.31 46.01 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 CA-C-N 124.27 2.561 . . . . 0.95 114.313 -172.587 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.293 24.0 p -77.65 1.01 21.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 130.953 3.701 . . . . 1.45 119.475 177.143 . . . . . . . . 2 2 . 1 . 137 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -80.78 143.49 32.83 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.254 -1.529 . . . . 1.69 107.654 175.377 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.3 p -75.56 167.79 21.24 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.439 -0.578 . . . . 0.75 109.439 179.174 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -68.4 -37.18 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.672 -1.893 . . . . 0.73 115.158 175.849 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -49.74 -43.68 48.07 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 112.164 -2.289 . . . . 1.62 114.141 162.817 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -72.42 -28.42 62.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.852 -1.155 . . . . 2.13 113.868 176.104 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.7 t -71.56 -35.42 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 117.366 -3.334 . . . . 0.62 112.042 170.556 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -68.91 -35.66 77.1 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 124.45 1.094 . . . . 1.22 109.146 172.704 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.27 -40.65 96.94 Favored 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 118.78 -2.45 . . . . 0.51 112.97 172.485 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -61.09 -42.35 98.35 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 119.031 -2.293 . . . . 1.44 115.542 171.003 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.0 mt -58.89 -36.29 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 119.077 -2.264 . . . . 1.32 112.796 167.583 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -61.44 -40.21 93.65 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.49 -1.381 . . . . 1.7 113.501 176.44 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.45 -40.37 94.23 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 119.697 3.221 . . . . 1.55 119.697 162.931 . . . . . . . . 2 2 . 1 . 137 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt -78.68 -68.2 0.67 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.167 2.187 . . . . 2.62 107.935 -176.88 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -101.44 -19.19 15.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 116.857 -1.937 . . . . 1.48 111.238 -169.364 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.57 9.84 45.71 Favored Glycine 0 N--CA 1.431 -1.679 0 CA-C-O 114.748 -3.251 . . . . 1.12 115.877 176.156 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.581 HG22 ' HG3' ' A' ' 41' ' ' GLN . 19.1 mt -85.97 128.39 58.33 Favored Pre-proline 0 N--CA 1.429 -1.49 1 CA-C-O 110.901 -4.38 . . . . 1.55 106.797 -178.953 . . . . . . . . 3 3 . 1 . 137 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -80.65 153.12 20.11 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 CA-C-N 127.561 3.736 . . . . 1.02 110.671 -179.03 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.64 -19.95 41.24 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 124.829 3.686 . . . . 1.25 111.84 -165.768 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -68.16 -39.52 82.56 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 124.283 1.992 . . . . 2.25 116.276 173.009 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -73.04 -43.62 61.77 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 131.221 3.808 . . . . 2.02 115.119 174.091 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.581 ' HG3' HG22 ' A' ' 36' ' ' ILE . 55.7 mt-30 -60.75 137.22 58.22 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.584 -2.573 . . . . 0.69 111.094 -174.591 . . . . . . . . 2 2 . 1 . 137 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -116.51 142.78 46.43 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 125.021 3.555 . . . . 2.78 107.402 167.294 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.483 HD13 HD13 ' A' ' 67' ' ' LEU . 74.9 mt -127.52 119.67 26.56 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.251 -2.129 . . . . 1.17 105.251 178.297 . . . . . . . . 2 2 . 1 . 137 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.5 HD12 HG21 ' A' ' 70' ' ' VAL . 21.3 mt -111.55 132.9 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 129.093 2.957 . . . . 1.38 110.672 -179.995 . . . . . . . . 2 2 . 1 . 137 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -139.23 141.04 37.89 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.394 -2.076 . . . . 1.5 105.394 170.413 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.43 20.71 0.32 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.123 -2.861 . . . . 1.21 117.712 177.667 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.59 6.19 80.78 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 116.807 -3.683 . . . . 1.3 113.287 179.677 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -98.09 121.71 40.35 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 115.382 -2.247 . . . . 2.55 110.841 174.795 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -77.68 125.13 28.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.506 2.323 . . . . 2.48 105.897 171.945 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.288 22.2 mt -79.99 136.41 36.6 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.908 1.814 . . . . 0.9 112.402 -167.684 . . . . . . . . 2 2 . 1 . 137 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.32 46.1 mt-10 -81.19 129.65 34.68 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.113 -3.492 . . . . 1.94 113.574 173.039 . . . . . . . . 2 2 . 1 . 137 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -59.83 -46.05 90.46 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.807 2.521 . . . . 1.56 117.807 -172.211 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.9 49.02 2.25 Favored Glycine 0 N--CA 1.43 -1.704 1 O-C-N 113.098 -6.001 . . . . 0.97 110.149 173.14 . . . . . . . . 2 2 . 1 . 137 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -119.5 176.25 5.45 Favored 'General case' 0 N--CA 1.429 -1.477 1 O-C-N 116.232 -4.099 . . . . 2.49 105.388 161.561 . . . . . . . . 2 2 . 1 . 137 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.3 p -104.29 -175.54 2.82 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 117.904 -1.518 . . . . 0.76 114.245 175.385 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.0 mt -77.97 -29.27 49.65 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.783 -1.198 . . . . 1.05 110.818 173.888 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.9 t -73.58 -29.47 62.43 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.576 -1.328 . . . . 1.19 113.261 176.584 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -58.88 -28.91 66.6 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.833 2.901 . . . . 1.9 118.833 172.252 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.356 26.6 m-85 -100.18 8.96 43.47 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 115.671 1.73 . . . . 0.89 115.671 173.022 . . . . . . . . 2 2 . 1 . 137 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.7 m120 46.69 64.14 1.64 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.553 2.341 . . . . 1.84 113.019 -173.514 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.4 mt -104.5 121.87 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 103.213 -2.884 . . . . 0.82 103.213 177.218 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -96.84 -172.66 2.52 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.994 2.118 . . . . 2.16 106.494 -168.681 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.17 153.61 40.64 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 116.49 -2.084 . . . . 2.12 110.685 173.131 . . . . . . . . 2 2 . 1 . 137 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.301 41.5 mt-10 59.53 46.65 11.86 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 115.117 1.525 . . . . 1.71 115.117 177.729 . . . . . . . . 2 2 . 1 . 137 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -104.17 142.94 33.63 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 131.469 3.908 . . . . 1.04 106.305 178.75 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.4 m -108.77 118.02 35.71 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.176 1.941 . . . . 0.79 106.76 -179.832 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.483 HD13 HD13 ' A' ' 43' ' ' LEU . 74.4 mt -92.44 146.53 23.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 113.202 -1.817 . . . . 1.4 110.242 167.381 . . . . . . . . 2 2 . 1 . 137 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -105.33 115.45 30.27 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.691 2.186 . . . . 1.51 107.036 -179.771 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 tt -88.22 116.3 26.32 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 111.863 -2.426 . . . . 1.14 110.844 -179.625 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.5 HG21 HD12 ' A' ' 44' ' ' ILE . 1.9 t -119.75 -178.51 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.259 -2.126 . . . . 1.23 105.259 176.795 . . . . . . . . 2 2 . 1 . 137 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.0 mt -126.97 146.38 50.35 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.173 -3.454 . . . . 2.78 113.354 177.889 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -75.03 144.37 43.08 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 130.139 4.649 . . . . 3.75 115.821 -175.638 . . . . . . . . 2 2 . 1 . 137 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.7 tp -103.59 148.47 25.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 101.78 -3.415 . . . . 3.14 101.78 174.605 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -130.85 147.02 52.45 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.849 -1.523 . . . . 6.8 112.676 174.102 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.82 -50.97 0.78 Allowed Glycine 0 N--CA 1.43 -1.743 0 O-C-N 119.404 -2.06 . . . . 3.57 112.899 -169.251 . . . . . . . . 1 1 . 1 . 137 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.81 0 C-N-CA 125.088 1.328 . . . . 3.87 110.892 179.344 . . . . . . . . 0 0 . 1 . 138 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ptt? . . . . . 0 CA--C 1.49 -1.344 0 N-CA-C 115.568 1.692 . . . . 1.1 115.568 . . . . . . . . . 0 0 . 1 . 138 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -99.16 142.45 30.63 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.173 -2.158 . . . . 1.87 105.173 179.508 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.431 HG13 ' HB2' ' A' ' 15' ' ' LEU . 3.1 pt -117.6 165.08 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 106.569 -1.641 . . . . 0.72 106.569 169.282 . . . . . . . . 2 2 . 1 . 138 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -118.35 121.14 39.66 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.559 -1.338 . . . . 1.4 108.49 179.053 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.3 t -103.37 138.76 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 104.685 -2.339 . . . . 0.58 104.685 171.369 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -111.94 143.58 42.68 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 113.427 -3.178 . . . . 2.09 112.248 173.228 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.5 p -88.61 -172.41 3.73 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.452 3.595 . . . . 0.99 112.915 179.243 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.1 mt -54.14 -38.83 65.91 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 127.028 3.299 . . . . 2.53 116.169 167.282 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -88.81 -35.58 16.53 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 114.297 -5.252 . . . . 2.08 113.002 179.842 . . . . . . . . 2 2 . 1 . 138 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.92 27.37 0.94 Allowed Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 117.745 -1.586 . . . . 1.31 114.541 -179.804 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.8 124.9 29.04 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 120.73 2.265 . . . . 1.4 109.784 -173.929 . . . . . . . . 2 2 . 1 . 138 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.528 1.7 m -78.64 118.63 20.93 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 113.835 -5.54 . . . . 0.78 118.25 176.98 . . . . . . . . 3 2 . 1 . 138 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mt -106.04 121.36 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 125.736 1.615 . . . . 1.55 110.099 172.873 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.251 6.4 m -92.51 108.93 20.34 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 116.854 2.168 . . . . 1.08 116.854 179.55 . . . . . . . . 2 2 . 1 . 138 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.431 ' HB2' HG13 ' A' ' 3' ' ' ILE . 21.5 mt -113.9 130.64 56.48 Favored 'General case' 0 N--CA 1.431 -1.409 1 O-C-N 115.141 -4.724 . . . . 1.55 110.651 -173.627 . . . . . . . . 3 3 . 1 . 138 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -84.81 101.06 11.97 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 116.688 -3.757 . . . . 1.95 111.184 169.61 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.0 m -114.18 164.26 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 121.154 -0.967 . . . . 0.96 110.089 -179.064 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.403 ' O ' HD12 ' A' ' 56' ' ' LEU . 32.9 mt-10 -102.14 161.4 23.51 Favored Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 127.395 2.278 . . . . 2.35 104.941 159.058 . . . . . . . . 2 2 . 1 . 138 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -77.16 -7.65 17.25 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 CA-C-N 122.655 1.984 . . . . 0.95 107.523 -179.616 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 m -79.31 -14.92 58.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.692 1.597 . . . . 1.45 111.825 177.174 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -65.99 144.8 56.52 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.923 2.297 . . . . 1.69 105.948 -179.888 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.4 p -89.34 158.28 17.85 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.415 -1.72 . . . . 0.75 112.937 176.972 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.332 2.8 mp -53.53 -43.74 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 116.323 -3.985 . . . . 0.73 115.305 169.8 . . . . . . . . 2 2 . 1 . 138 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -41.18 -59.96 1.37 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.189 2.196 . . . . 1.62 114.941 165.888 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -72.24 -24.54 61.39 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 120.322 3.453 . . . . 2.13 120.322 -175.624 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -61.18 -32.22 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 120.361 -1.462 . . . . 0.62 113.198 168.777 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -60.06 -43.46 95.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 117.68 -1.152 . . . . 1.22 110.987 177.602 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.78 -27.06 63.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 125.008 1.443 . . . . 0.51 109.027 177.895 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -66.46 -30.8 71.22 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 118.273 -2.767 . . . . 1.44 110.64 173.535 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.6 mt -65.87 -31.42 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 129.686 3.194 . . . . 1.32 109.732 169.494 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.328 52.9 tt0 -69.33 -33.63 73.42 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.024 -2.922 . . . . 1.7 116.91 175.694 . . . . . . . . 2 2 . 1 . 138 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.261 11.9 m-20 -67.81 -36.87 81.17 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.422 2.289 . . . . 1.55 112.196 168.918 . . . . . . . . 2 2 . 1 . 138 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -76.49 -77.28 0.14 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.831 1.252 . . . . 2.62 110.995 -178.494 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -88.17 -66.92 0.87 Allowed 'General case' 0 N--CA 1.429 -1.487 1 C-N-CA 133.316 4.646 . . . . 1.48 114.743 -166.561 . . . . . . . . 2 2 . 1 . 138 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.76 29.66 0.74 Allowed Glycine 0 N--CA 1.43 -1.714 0 O-C-N 126.973 2.671 . . . . 1.12 110.599 166.932 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.6 mt -89.44 126.12 59.35 Favored Pre-proline 0 N--CA 1.43 -1.459 1 O-C-N 115.738 -4.39 . . . . 1.55 109.192 -179.448 . . . . . . . . 2 2 . 1 . 138 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -54.37 129.28 33.86 Favored 'Trans proline' 0 C--N 1.299 -2.035 1 C-N-CA 125.611 4.207 . . . . 1.02 116.274 175.674 . . . . . . . . 3 3 . 1 . 138 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -59.96 -14.24 26.87 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 CA-C-N 124.324 2.58 . . . . 1.25 116.511 -173.38 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -65.28 -21.92 66.79 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 128.826 2.851 . . . . 2.25 118.581 170.608 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -102.41 -9.4 20.32 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-O 116.406 -1.759 . . . . 2.02 108.715 -172.712 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -89.38 133.49 34.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.742 2.417 . . . . 0.69 114.993 -170.39 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.5 ' HB2' HG23 ' A' ' 70' ' ' VAL . 64.3 mtt180 -132.96 145.09 50.58 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.435 2.064 . . . . 2.78 106.906 169.621 . . . . . . . . 2 2 . 1 . 138 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.5 mt -122.15 143.45 49.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.414 -2.054 . . . . 1.17 114.616 -177.992 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.5 mt -118.83 129.5 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 130.166 3.386 . . . . 1.38 108.887 -179.699 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -130.28 127.3 39.25 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.199 1.8 . . . . 1.5 109.816 167.641 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.85 12.8 0.93 Allowed 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.212 2.301 . . . . 1.21 117.212 -178.379 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.49 0.19 29.35 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 118.136 -2.852 . . . . 1.3 116.837 -174.388 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.307 64.5 mttt -114.62 137.18 52.2 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.748 1.737 . . . . 2.55 114.622 179.671 . . . . . . . . 2 2 . 1 . 138 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -86.01 138.5 31.92 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 117.188 -1.805 . . . . 2.48 107.845 174.192 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.7 mt -88.98 138.74 31.13 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.151 2.278 . . . . 0.9 117.151 -171.654 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -73.11 147.71 44.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 124.107 0.879 . . . . 1.94 113.356 169.932 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.72 -53.96 13.61 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.473 -2.017 . . . . 1.56 111.731 -168.532 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.87 44.1 2.93 Favored Glycine 0 N--CA 1.431 -1.666 0 O-C-N 126.702 2.501 . . . . 0.97 115.372 172.121 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -116.91 165.37 13.41 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 125.43 2.538 . . . . 2.49 104.447 163.616 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.9 p -96.66 163.76 12.88 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 112.89 -1.959 . . . . 0.76 110.605 172.873 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 18' ' ' GLU . 96.2 mt -57.39 -40.43 78.2 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 127.345 2.258 . . . . 1.05 111.161 170.518 . . . . . . . . 2 2 . 1 . 138 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.9 t -64.92 -40.94 95.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 126.646 2.466 . . . . 1.19 114.374 -179.174 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -56.0 -40.83 73.93 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.124 -3.485 . . . . 1.9 119.409 176.822 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -84.91 3.82 36.36 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 112.882 -1.963 . . . . 0.89 110.938 170.851 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.421 26.4 m120 62.49 38.64 12.5 Favored 'General case' 0 N--CA 1.43 -1.454 1 N-CA-C 121.957 4.058 . . . . 1.84 121.957 -174.382 . . . . . . . . 3 2 . 1 . 138 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.1 mt -93.65 123.65 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 117.281 -3.387 . . . . 0.82 109.107 -175.044 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -107.69 -172.48 2.08 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.178 1.353 . . . . 2.16 111.009 -172.577 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -56.16 144.35 29.91 Favored 'General case' 0 N--CA 1.428 -1.526 0 O-C-N 126.65 2.469 . . . . 2.12 113.658 168.315 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.294 35.5 mt-10 57.23 32.34 21.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.525 3.13 . . . . 1.71 117.052 173.226 . . . . . . . . 2 2 . 1 . 138 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 t -96.14 133.86 39.91 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.719 3.208 . . . . 1.04 109.996 -174.237 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.15 116.57 21.12 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 118.119 2.637 . . . . 0.79 118.119 177.344 . . . . . . . . 2 2 . 1 . 138 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.263 54.3 mt -101.46 140.24 36.03 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.847 -3.033 . . . . 1.4 106.291 173.542 . . . . . . . . 2 2 . 1 . 138 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -104.14 121.22 42.78 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 116.081 -1.914 . . . . 1.51 110.934 -174.556 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.3 tp -89.89 128.52 36.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.869 1.795 . . . . 1.14 115.365 178.48 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.5 HG23 ' HB2' ' A' ' 42' ' ' ARG . 35.4 m -127.09 151.71 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 1 CA-C-O 128.827 4.156 . . . . 1.23 104.86 176.778 . . . . . . . . 3 3 . 1 . 138 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.8 mt -115.51 141.88 47.46 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 116.188 -4.07 . . . . 2.78 111.481 -167.571 . . . . . . . . 2 2 . 1 . 138 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -77.27 168.0 20.77 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 115.359 -4.588 . . . . 3.75 118.022 174.012 . . . . . . . . 2 2 . 1 . 138 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.8 mt -97.6 -175.03 3.07 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 118.637 -2.539 . . . . 3.14 106.818 167.006 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -70.81 -55.45 8.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 114.971 -2.442 . . . . 6.8 114.058 -179.545 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.72 88.58 0.2 Allowed Glycine 0 N--CA 1.429 -1.779 0 O-C-N 126.702 2.501 . . . . 3.57 108.835 -172.493 . . . . . . . . 1 1 . 1 . 138 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.782 0 C-N-CA 130.456 3.884 . . . . 3.87 111.456 179.979 . . . . . . . . 0 0 . 1 . 139 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.294 45.1 ttp . . . . . 0 CA--C 1.491 -1.327 0 N-CA-C 113.749 1.018 . . . . 1.1 113.749 . . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -100.73 123.47 44.98 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 119.491 -0.883 . . . . 1.87 111.541 -177.499 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.451 HG12 HG22 ' A' ' 17' ' ' VAL . 6.6 pt -120.93 163.65 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.311 -0.996 . . . . 0.72 108.311 174.258 . . . . . . . . 2 2 . 1 . 139 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -119.95 143.03 48.22 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 130.937 3.695 . . . . 1.4 109.738 -177.924 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.298 43.5 t -116.84 115.07 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 116.915 -3.616 . . . . 0.58 113.651 171.734 . . . . . . . . 2 2 . 1 . 139 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -95.53 143.8 26.54 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 115.949 -1.977 . . . . 2.09 108.374 -176.54 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.7 p -101.37 179.75 4.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 126.748 3.166 . . . . 0.99 112.213 173.058 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.3 mt -79.77 -10.42 59.78 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 111.607 -6.933 . . . . 2.53 115.062 173.218 . . . . . . . . 2 2 . 1 . 139 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.257 28.8 p -86.51 -51.64 6.06 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 126.321 2.962 . . . . 2.08 110.914 178.002 . . . . . . . . 2 2 . 1 . 139 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.7 -2.19 0.45 Allowed Glycine 0 N--CA 1.43 -1.705 0 O-C-N 118.198 -2.814 . . . . 1.31 112.343 177.891 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -78.19 142.58 37.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 123.078 3.439 . . . . 1.4 110.672 -179.627 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.6 m -107.95 132.88 53.03 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 123.863 1.792 . . . . 0.78 107.503 171.797 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -109.93 149.16 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 102.454 -3.165 . . . . 1.55 102.454 177.212 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.3 m -123.4 125.11 44.37 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.487 -3.883 . . . . 1.08 100.645 -177.256 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -126.51 159.11 34.35 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.357 2.263 . . . . 1.55 106.011 176.244 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -120.92 125.91 48.65 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.939 3.295 . . . . 1.95 108.576 169.839 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.451 HG22 HG12 ' A' ' 3' ' ' ILE . 3.4 m -132.28 158.41 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 129.843 3.257 . . . . 0.96 105.315 -173.059 . . . . . . . . 2 2 . 1 . 139 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -114.38 141.13 26.03 Favored Pre-proline 0 N--CA 1.429 -1.476 0 N-CA-C 102.409 -3.182 . . . . 2.35 102.409 167.365 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -61.96 -7.52 9.83 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 C-N-CA 124.511 3.474 . . . . 0.95 116.169 -171.295 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 p -73.36 -14.71 61.33 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.161 2.984 . . . . 1.45 112.104 172.977 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -75.34 145.36 41.79 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 117.354 -3.341 . . . . 1.69 111.652 179.538 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 60.9 p -89.83 179.19 6.05 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.875 -1.141 . . . . 0.75 113.477 178.31 . . . . . . . . 2 2 . 1 . 139 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 23' ' ' ILE . 23.3 mm -79.67 -22.59 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 121.289 1.859 . . . . 0.73 107.162 175.453 . . . . . . . . 2 2 . 1 . 139 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -70.83 -31.4 68.12 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.052 2.141 . . . . 1.62 110.499 170.233 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -77.18 -35.42 55.84 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.65 2.38 . . . . 2.13 111.788 173.493 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.0 t -55.44 -55.11 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-N 123.819 3.009 . . . . 0.62 112.32 167.043 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -50.44 -39.2 47.03 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 126.298 2.249 . . . . 1.22 116.078 173.939 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.83 -35.82 80.94 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.075 1.75 . . . . 0.51 111.139 173.499 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -74.54 -22.8 58.83 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 115.825 -2.35 . . . . 1.44 111.429 174.062 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.287 55.5 mt -70.96 -30.48 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.389 -2.07 . . . . 1.32 111.931 171.572 . . . . . . . . 2 2 . 1 . 139 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -65.4 -38.09 88.91 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.768 -1.56 . . . . 1.7 110.306 175.481 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.57 -59.9 2.8 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 115.22 -4.675 . . . . 1.55 112.497 168.951 . . . . . . . . 2 2 . 1 . 139 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -60.75 -58.4 8.61 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.767 1.627 . . . . 2.62 112.367 -172.737 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -95.34 -56.21 2.79 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.917 -2.364 . . . . 1.48 109.611 -170.542 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.94 4.48 7.22 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 105.146 -3.182 . . . . 1.12 105.146 176.779 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mt -74.16 129.51 84.35 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 114.32 -2.753 . . . . 1.55 105.826 -173.878 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -70.58 154.23 64.62 Favored 'Trans proline' 0 N--CA 1.434 -2.009 0 C-N-CA 115.388 -2.608 . . . . 1.02 116.888 178.006 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.59 -4.88 13.83 Favored 'Trans proline' 0 C--N 1.3 -2.015 1 C-N-CA 125.544 4.162 . . . . 1.25 108.068 -172.647 . . . . . . . . 2 2 . 1 . 139 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -77.45 -40.09 44.46 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 125.669 3.849 . . . . 2.25 111.55 169.334 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -60.07 -28.62 67.95 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.668 2.47 . . . . 2.02 117.668 -178.981 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -89.47 151.77 21.82 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.182 1.944 . . . . 0.69 115.396 -178.223 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.28 83.9 mtt180 -135.8 139.8 43.77 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 101.258 -3.608 . . . . 2.78 101.258 170.104 . . . . . . . . 2 2 . 1 . 139 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 39.0 mt -122.14 128.6 51.46 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 124.67 3.396 . . . . 1.17 105.793 -178.682 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 mm -119.06 139.02 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 114.704 -2.57 . . . . 1.38 107.57 -178.888 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -131.53 126.51 35.09 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 115.921 -1.99 . . . . 1.5 106.358 171.964 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 82.23 -71.95 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 126.874 2.609 . . . . 1.21 106.188 -177.83 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.18 -26.57 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.659 0 C-N-CA 126.112 1.815 . . . . 1.3 114.206 -171.491 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -85.55 160.35 19.68 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.241 1.941 . . . . 2.55 116.241 172.809 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.277 49.2 tt0 -90.76 137.43 32.36 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.24 3.052 . . . . 2.48 119.24 170.324 . . . . . . . . 2 2 . 1 . 139 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.0 mt -94.45 127.73 40.55 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.082 -3.511 . . . . 0.9 109.274 -169.472 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -75.9 158.81 31.61 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 118.225 2.676 . . . . 1.94 118.225 179.885 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -63.44 -59.82 4.16 Favored 'General case' 0 N--CA 1.43 -1.473 1 N-CA-C 122.879 4.4 . . . . 1.56 122.879 -168.018 . . . . . . . . 2 2 . 1 . 139 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.44 23.51 8.44 Favored Glycine 0 N--CA 1.429 -1.795 0 CA-C-O 116.094 -2.503 . . . . 0.97 113.836 178.75 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -98.22 154.19 17.95 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 122.787 3.294 . . . . 2.49 109.106 168.35 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 31.1 p -85.7 177.3 7.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.873 -2.392 . . . . 0.76 115.591 171.356 . . . . . . . . 2 2 . 1 . 139 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.27 -40.89 90.41 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 111.667 -2.515 . . . . 1.05 111.297 173.225 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.4 m -70.9 -25.79 62.94 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.567 3.547 . . . . 1.19 112.307 178.435 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -66.69 -55.6 14.43 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 120.762 1.619 . . . . 1.9 113.182 170.773 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -75.42 3.69 8.72 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 120.544 3.535 . . . . 0.89 120.544 173.685 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 54.43 46.78 24.3 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.023 -2.298 . . . . 1.84 117.011 178.704 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.4 mt -97.06 103.92 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 104.867 -2.271 . . . . 0.82 104.867 -179.556 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -104.67 -172.79 2.16 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 125.4 2.524 . . . . 2.16 109.296 -172.862 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -53.5 139.82 30.0 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.127 -2.858 . . . . 2.12 112.958 -179.863 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.374 30.7 mt-10 59.77 21.9 10.74 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 130.945 3.698 . . . . 1.71 113.871 -179.057 . . . . . . . . 2 2 . 1 . 139 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.11 143.32 27.14 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.152 1.908 . . . . 1.04 116.152 -176.989 . . . . . . . . 2 2 . 1 . 139 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.7 m -106.67 121.08 43.64 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 123.769 0.668 . . . . 0.79 112.552 -171.441 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.2 mt -95.41 164.64 12.73 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 106.694 -1.595 . . . . 1.4 106.694 173.063 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -115.48 116.64 28.54 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.486 1.915 . . . . 1.51 110.733 -179.58 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.5 tp -92.76 125.6 37.45 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.682 1.706 . . . . 1.14 112.889 179.683 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.1 t -120.08 126.08 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 101.89 -3.374 . . . . 1.23 101.89 178.252 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.8 mt -101.85 153.85 19.46 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 126.229 2.918 . . . . 2.78 113.709 178.394 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -91.75 125.06 36.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.183 -2.198 . . . . 3.75 108.217 177.421 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.2 tp -120.01 -37.94 3.02 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 129.174 4.046 . . . . 3.14 111.246 170.205 . . . . . . . . 2 2 . 1 . 139 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.313 24.1 mtm-85 -107.43 -97.98 0.36 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.697 -1.223 . . . . 6.8 107.697 171.283 . . . . . . . . 2 2 . 1 . 139 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.2 123.69 0.78 Allowed Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 104.785 -3.326 . . . . 3.57 104.785 -161.392 . . . . . . . . 1 1 . 1 . 139 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.793 0 N-CA-C 105.098 -3.201 . . . . 3.87 105.098 -179.081 . . . . . . . . 0 0 . 1 . 140 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptt? . . . . . 0 CA--C 1.49 -1.355 0 N-CA-C 118.619 2.822 . . . . 1.1 118.619 . . . . . . . . . 0 0 . 1 . 140 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -85.78 146.83 26.6 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 117.823 -1.551 . . . . 1.87 110.191 179.722 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.2 pt -140.76 158.41 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 101.07 -3.678 . . . . 0.72 101.07 175.722 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -112.15 115.89 29.58 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 113.619 -1.628 . . . . 1.4 111.047 -176.816 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -85.84 113.69 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 118.942 -2.349 . . . . 0.58 107.749 171.594 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -104.06 122.23 44.85 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.13 -3.481 . . . . 2.09 111.868 177.688 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.2 p -83.47 158.05 22.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 123.481 1.61 . . . . 0.99 112.902 174.767 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.6 mt -88.52 -23.92 23.06 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.606 -4.434 . . . . 2.53 109.173 176.36 . . . . . . . . 2 2 . 1 . 140 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -61.37 -37.89 85.0 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.199 -3.438 . . . . 2.08 110.699 174.415 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.23 -58.09 0.38 Allowed Glycine 0 N--CA 1.43 -1.76 0 O-C-N 121.75 -0.594 . . . . 1.31 112.896 176.272 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.261 19.3 ptmt -61.69 150.34 36.93 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.567 -3.314 . . . . 1.4 116.312 -170.675 . . . . . . . . 2 2 . 1 . 140 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.3 m -114.66 123.55 49.57 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.488 1.515 . . . . 0.78 108.237 169.811 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.2 mt -114.41 126.97 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.211 -3.43 . . . . 1.55 110.821 179.766 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.6 m -89.49 109.81 20.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.611 -2.556 . . . . 1.08 108.514 -177.256 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -107.12 157.51 17.8 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.92 -1.881 . . . . 1.55 105.92 179.629 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -106.68 133.6 51.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.069 1.748 . . . . 1.95 108.296 171.199 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.462 HG21 HD13 ' A' ' 56' ' ' LEU . 30.1 m -145.23 160.81 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 117.274 -1.346 . . . . 0.96 107.881 -178.484 . . . . . . . . 2 2 . 1 . 140 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -95.98 155.59 38.12 Favored Pre-proline 0 N--CA 1.43 -1.462 0 N-CA-C 106.225 -1.768 . . . . 2.35 106.225 168.308 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.265 39.7 Cg_exo -66.28 -13.99 42.27 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 123.129 2.552 . . . . 0.95 115.456 -176.371 . . . . . . . . 2 2 . 1 . 140 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -111.2 25.59 11.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 122.658 1.218 . . . . 1.45 108.538 -179.751 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -84.17 137.14 33.67 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 116.841 -3.662 . . . . 1.69 104.613 174.388 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.335 80.4 p -67.05 165.21 16.2 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 117.773 2.509 . . . . 0.75 117.773 176.627 . . . . . . . . 3 3 . 1 . 140 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.2 mm -67.95 -38.05 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 116.966 -3.584 . . . . 0.73 109.517 175.269 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -46.87 -42.21 17.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 128.651 2.781 . . . . 1.62 113.688 168.596 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -80.08 -29.13 39.05 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.449 -2.657 . . . . 2.13 110.771 -178.268 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.5 HG21 HD21 ' A' ' 56' ' ' LEU 0.274 12.0 t -67.81 -41.15 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 119.764 -1.835 . . . . 0.62 113.239 167.606 . . . . . . . . 3 3 . 1 . 140 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -65.04 -26.5 68.29 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.552 -2.593 . . . . 1.22 116.463 170.771 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.23 -31.2 68.51 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.429 -3.294 . . . . 0.51 112.51 172.184 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -73.45 -37.31 65.86 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 123.686 0.616 . . . . 1.44 111.651 174.584 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.5 mt -65.3 -35.09 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-O 124.442 2.068 . . . . 1.32 112.064 175.322 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -61.45 -41.82 97.8 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.045 3.738 . . . . 1.7 112.493 -178.783 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -68.47 -32.74 72.96 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 126.759 2.537 . . . . 1.55 115.347 167.943 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -79.13 -60.09 2.51 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 119.17 0.896 . . . . 2.62 112.497 -179.415 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -102.71 -20.84 14.22 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 118.246 -2.784 . . . . 1.48 112.545 -167.388 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.2 30.49 10.9 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 117.59 -2.243 . . . . 1.12 112.643 178.73 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.8 mt -109.56 111.49 59.34 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 116.544 -1.694 . . . . 1.55 108.435 -178.589 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -61.77 153.1 70.04 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 122.973 2.449 . . . . 1.02 113.362 179.816 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -70.96 -15.14 32.63 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-N 126.631 3.404 . . . . 1.25 118.961 -177.005 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -51.83 -46.0 64.17 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 126.301 2.251 . . . . 2.25 113.784 170.48 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -76.97 -5.43 48.58 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 116.988 -1.482 . . . . 2.02 111.424 -177.701 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -99.26 126.42 45.09 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 120.013 1.279 . . . . 0.69 109.842 -172.374 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -116.8 130.84 56.96 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 128.626 2.77 . . . . 2.78 104.443 164.508 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -107.54 132.43 53.26 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.309 -2.744 . . . . 1.17 111.669 173.74 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.4 mm -109.63 141.96 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 119.881 -1.762 . . . . 1.38 108.74 179.556 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -140.7 117.66 11.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.575 -1.268 . . . . 1.5 107.575 170.636 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.377 . . 72.98 -44.19 0.59 Allowed 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 129.594 3.157 . . . . 1.21 112.048 -175.827 . . . . . . . . 2 2 . 1 . 140 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 173.38 -42.45 0.15 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 128.039 2.733 . . . . 1.3 115.253 -171.947 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -74.13 157.5 35.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 118.584 -1.246 . . . . 2.55 110.262 178.663 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -87.58 143.59 27.12 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 126.319 1.848 . . . . 2.48 110.283 176.273 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.3 mt -93.64 151.79 19.43 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 116.288 -4.008 . . . . 0.9 112.216 -176.655 . . . . . . . . 2 2 . 1 . 140 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -93.49 147.66 22.77 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 104.403 -2.443 . . . . 1.94 104.403 174.05 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -66.37 -52.68 44.39 Favored 'General case' 0 N--CA 1.43 -1.426 1 CA-C-O 128.599 4.047 . . . . 1.56 116.194 -170.938 . . . . . . . . 2 2 . 1 . 140 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.61 48.34 3.66 Favored Glycine 0 N--CA 1.43 -1.743 1 O-C-N 114.511 -5.118 . . . . 0.97 111.838 173.962 . . . . . . . . 2 2 . 1 . 140 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -130.67 161.84 30.74 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.547 -2.737 . . . . 2.49 105.742 162.071 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 14.0 p -95.7 179.72 5.02 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 117.036 -1.866 . . . . 0.76 110.076 -173.174 . . . . . . . . 2 2 . 1 . 140 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.5 HD21 HG21 ' A' ' 26' ' ' VAL . 2.9 mt -72.24 -41.68 66.54 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 116.783 -1.579 . . . . 1.05 113.082 172.378 . . . . . . . . 2 2 . 1 . 140 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 t -68.34 -11.96 60.34 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 121.769 2.077 . . . . 1.19 114.869 172.617 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -79.92 -29.44 39.77 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 125.445 3.748 . . . . 1.9 110.405 177.826 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -90.68 -6.04 55.02 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.056 -3.528 . . . . 0.89 112.304 174.258 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 75.7 34.19 0.59 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.684 3.74 . . . . 1.84 113.174 175.889 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.705 HD13 HD21 ' A' ' 67' ' ' LEU . 37.7 mt -74.7 107.66 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 127.476 2.31 . . . . 0.82 111.917 175.685 . . . . . . . . 2 2 . 1 . 140 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -84.74 178.51 7.62 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 126.728 2.517 . . . . 2.16 110.509 177.624 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -62.05 146.94 48.82 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 115.031 1.493 . . . . 2.12 115.031 172.451 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 64.29 39.41 7.32 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 122.827 1.299 . . . . 1.71 111.477 173.144 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 t -113.94 147.56 38.34 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.806 -1.543 . . . . 1.04 112.949 -173.806 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.2 m -93.96 130.14 40.18 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.726 -1.858 . . . . 0.79 113.777 178.446 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.705 HD21 HD13 ' A' ' 61' ' ' ILE . 96.7 mt -115.01 132.92 56.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.918 -1.882 . . . . 1.4 105.918 173.808 . . . . . . . . 2 2 . 1 . 140 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -94.05 125.34 38.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.756 3.169 . . . . 1.51 111.278 -174.469 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 tp -92.94 116.1 28.73 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 113.345 -5.847 . . . . 1.14 110.57 176.735 . . . . . . . . 2 2 . 1 . 140 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.0 t -111.77 126.03 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 128.474 2.709 . . . . 1.23 106.332 179.23 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mp -93.39 139.24 30.9 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.216 -2.802 . . . . 2.78 107.015 178.948 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -59.67 133.59 56.23 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 128.255 2.622 . . . . 3.75 116.549 -171.066 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.8 mt -102.88 160.08 14.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.032 -1.668 . . . . 3.14 106.836 168.125 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -124.36 140.7 52.71 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.173 -1.579 . . . . 6.8 111.798 168.07 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.86 40.81 1.05 Allowed Glycine 0 N--CA 1.429 -1.777 0 CA-C-O 114.372 -3.46 . . . . 3.57 107.386 -165.662 . . . . . . . . 1 1 . 1 . 140 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.812 0 C-N-CA 129.209 3.29 . . . . 3.87 115.133 -176.256 . . . . . . . . 0 0 . 1 . 141 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 ttp . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 123.405 1.574 . . . . 1.1 109.537 . . . . . . . . . 0 0 . 1 . 141 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -91.53 144.43 25.56 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.235 -4.666 . . . . 1.87 106.781 178.357 . . . . . . . . 2 2 . 1 . 141 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.3 pt -140.12 175.35 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 124.195 1.95 . . . . 0.72 106.974 169.008 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -116.29 143.54 45.4 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 104.736 -2.32 . . . . 1.4 104.736 176.557 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.92 117.74 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 1 O-C-N 129.425 4.203 . . . . 0.58 103.805 167.315 . . . . . . . . 2 2 . 1 . 141 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -105.75 141.3 37.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.411 -2.68 . . . . 2.09 114.13 173.582 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.1 p -84.25 171.34 12.83 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.35 -1.468 . . . . 0.99 112.658 177.058 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.258 13.1 tp -57.53 -44.09 84.84 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.754 2.822 . . . . 2.53 114.854 168.142 . . . . . . . . 2 2 . 1 . 141 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 p -75.83 -65.58 0.89 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.752 1.621 . . . . 2.08 112.844 -173.72 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.09 53.28 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.696 0 CA-C-O 117.574 -1.681 . . . . 1.31 116.585 175.599 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -128.6 124.52 36.07 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.29 -1.744 . . . . 1.4 106.29 -179.374 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.9 m -104.14 133.86 48.36 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 102.906 -2.998 . . . . 0.78 102.906 -178.778 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.8 mt -106.85 135.01 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 103.182 -2.896 . . . . 1.55 103.182 178.703 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.9 m -97.35 122.71 40.7 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.158 -2.214 . . . . 1.08 106.821 178.351 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.8 tp -129.02 124.18 34.28 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 117.217 2.303 . . . . 1.55 117.217 -175.379 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -79.86 124.63 28.82 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 117.166 -1.397 . . . . 1.95 107.443 174.47 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.0 m -134.77 177.57 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 128.668 2.787 . . . . 0.96 106.655 178.95 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.4 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 44.4 mt-10 -123.36 166.57 17.81 Favored Pre-proline 0 N--CA 1.43 -1.448 0 C-N-CA 127.187 2.195 . . . . 2.35 106.735 163.092 . . . . . . . . 2 2 . 1 . 141 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 58.2 Cg_endo -82.2 -17.31 7.95 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 122.915 2.41 . . . . 0.95 109.681 -174.37 . . . . . . . . 2 2 . 1 . 141 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 m -90.35 5.19 48.4 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.255 -2.153 . . . . 1.45 110.318 178.156 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -84.2 158.55 21.26 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.112 -1.81 . . . . 1.69 106.112 177.324 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -92.78 163.94 13.54 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 123.579 1.657 . . . . 0.75 110.202 178.767 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mp -68.08 -34.82 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 127.272 3.415 . . . . 0.73 116.363 174.548 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -53.36 -44.07 68.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.724 -2.485 . . . . 1.62 117.59 161.699 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -66.37 -31.97 73.07 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.583 1.953 . . . . 2.13 109.801 175.847 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.51 -47.98 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 117.848 -3.032 . . . . 0.62 113.497 175.899 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.302 95.8 mttt -49.63 -40.82 40.64 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 130.275 3.43 . . . . 1.22 115.229 167.664 . . . . . . . . 2 2 . 1 . 141 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.89 -39.66 87.54 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.941 1.696 . . . . 0.51 113.494 177.923 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -66.03 -29.78 70.2 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 118.346 2.721 . . . . 1.44 118.346 167.929 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.1 mt -76.02 -33.65 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 118.496 -2.627 . . . . 1.32 114.827 171.841 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -69.6 -33.4 72.64 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.268 -1.333 . . . . 1.7 109.951 172.931 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.3 -59.54 4.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.078 1.751 . . . . 1.55 110.069 170.37 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -65.62 -60.52 2.83 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 130.463 3.505 . . . . 2.62 112.029 -168.478 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -102.85 -53.15 2.91 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.623 -3.173 . . . . 1.48 111.885 -175.521 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.05 38.02 0.4 Allowed Glycine 0 N--CA 1.43 -1.721 0 O-C-N 120.466 -1.396 . . . . 1.12 115.309 172.325 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.7 mt -110.24 126.43 28.95 Favored Pre-proline 0 N--CA 1.43 -1.435 0 C-N-CA 126.26 1.824 . . . . 1.55 108.695 -174.974 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.47 143.54 97.45 Favored 'Trans proline' 0 N--CA 1.434 -2.006 1 O-C-N 112.743 -4.398 . . . . 1.02 115.701 -178.411 . . . . . . . . 2 2 . 1 . 141 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -67.61 -14.15 41.17 Favored 'Trans proline' 0 N--CA 1.434 -2.029 0 N-CA-C 118.897 2.614 . . . . 1.25 118.897 -173.179 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -79.78 -36.71 36.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 125.37 1.669 . . . . 2.25 107.951 179.364 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -74.98 -30.2 61.12 Favored 'General case' 0 N--CA 1.431 -1.402 1 C-N-CA 133.634 4.773 . . . . 2.02 111.363 -169.035 . . . . . . . . 2 2 . 1 . 141 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -87.92 134.14 33.77 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.566 -2.584 . . . . 0.69 112.519 -173.41 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.617 ' HB2' HG23 ' A' ' 70' ' ' VAL . 84.5 mtt180 -112.71 142.84 44.86 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 116.74 -3.725 . . . . 2.78 107.012 168.408 . . . . . . . . 2 2 . 1 . 141 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.3 mt -119.86 116.49 25.95 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 118.896 -2.378 . . . . 1.17 113.393 174.958 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.3 mt -88.87 137.01 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 127.875 2.47 . . . . 1.38 110.967 -178.901 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -154.9 131.18 10.36 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.685 2.184 . . . . 1.5 105.439 173.286 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.74 -64.75 0.1 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 119.395 3.109 . . . . 1.21 119.395 178.998 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -158.34 11.47 0.22 Allowed Glycine 0 N--CA 1.43 -1.703 0 CA-C-O 122.776 1.209 . . . . 1.3 112.914 177.835 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.5 pttt -144.94 177.23 8.9 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 111.964 -2.118 . . . . 2.55 111.486 -174.411 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -110.39 157.3 19.69 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.533 1.933 . . . . 2.48 108.707 171.982 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.6 mt -102.86 137.7 40.71 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 117.953 -1.022 . . . . 0.9 113.02 -173.837 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.472 ' HB2' ' HG2' ' A' ' 54' ' ' ARG . 49.8 mt-10 -75.44 141.82 43.09 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.89 2.876 . . . . 1.94 111.003 177.512 . . . . . . . . 2 2 . 1 . 141 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -69.21 -53.07 21.84 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 123.3 2.773 . . . . 1.56 116.005 -162.977 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.95 42.04 3.12 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 119.078 -2.264 . . . . 0.97 114.714 175.121 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.472 ' HG2' ' HB2' ' A' ' 51' ' ' GLU . 28.6 mmt180 -112.14 161.31 16.67 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 121.415 2.607 . . . . 2.49 104.142 166.766 . . . . . . . . 2 2 . 1 . 141 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.1 p -90.9 162.26 14.86 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 116.807 -3.683 . . . . 0.76 111.546 178.879 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.2 mt -63.86 -33.13 75.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.488 2.315 . . . . 1.05 110.573 169.566 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.5 p -63.57 -53.6 49.21 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.369 -2.707 . . . . 1.19 114.978 179.339 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -56.16 -34.19 65.92 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.424 -1.262 . . . . 1.9 114.385 173.875 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -82.01 -4.17 56.14 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.906 -1.121 . . . . 0.89 112.571 -176.896 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.261 19.4 m-80 58.42 41.89 22.13 Favored 'General case' 0 N--CA 1.431 -1.415 1 C-N-CA 133.043 4.537 . . . . 1.84 115.861 -174.418 . . . . . . . . 3 2 . 1 . 141 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.1 mt -85.32 122.51 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 117.607 -3.183 . . . . 0.82 112.576 178.188 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -97.54 -174.04 2.81 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 125.404 2.526 . . . . 2.16 113.251 -175.141 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -59.52 131.82 52.11 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 127.348 3.452 . . . . 2.12 116.702 170.82 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.308 13.6 mt-10 73.02 31.46 1.48 Allowed 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 127.04 3.305 . . . . 1.71 114.127 173.797 . . . . . . . . 2 2 . 1 . 141 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.5 m -88.84 160.98 16.97 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 118.523 -2.611 . . . . 1.04 108.68 -173.48 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.253 4.3 m -114.38 114.16 25.51 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 116.41 -3.931 . . . . 0.79 112.307 -178.424 . . . . . . . . 2 2 . 1 . 141 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.9 mt -93.87 128.24 40.05 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 129.909 3.284 . . . . 1.4 108.158 170.337 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -111.51 116.81 31.49 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 126.128 2.871 . . . . 1.51 115.184 -175.85 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.9 tp -84.53 116.98 23.42 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.852 -2.405 . . . . 1.14 113.852 -173.622 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.617 HG23 ' HB2' ' A' ' 42' ' ' ARG . 31.4 m -122.0 161.24 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 114.415 -1.266 . . . . 1.23 111.082 168.7 . . . . . . . . 2 2 . 1 . 141 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.4 mt -92.14 170.09 10.1 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.055 -1.653 . . . . 2.78 107.598 178.981 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -119.51 144.87 46.79 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 101.061 -3.681 . . . . 3.75 101.061 -171.698 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.6 mt -104.34 171.51 7.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.414 -0.804 . . . . 3.14 109.186 176.993 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -83.21 117.72 23.12 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.101 -2.25 . . . . 6.8 116.228 177.236 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.55 80.99 0.17 Allowed Glycine 0 N--CA 1.429 -1.792 0 CA-C-O 116.454 -2.303 . . . . 3.57 113.278 -166.747 . . . . . . . . 1 1 . 1 . 141 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.789 0 CA-C-N 119.958 1.879 . . . . 3.87 112.402 174.861 . . . . . . . . 0 0 . 1 . 142 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 ptt? . . . . . 0 CA--C 1.489 -1.373 0 N-CA-C 113.809 1.04 . . . . 1.1 113.809 . . . . . . . . . 0 0 . 1 . 142 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -88.52 127.92 35.54 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.466 -1.396 . . . . 1.87 109.379 -176.449 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.424 HD12 HD13 ' A' ' 67' ' ' LEU . 8.8 pt -121.97 161.07 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 104.891 -2.262 . . . . 0.72 104.891 164.798 . . . . . . . . 2 2 . 1 . 142 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -120.69 137.01 54.69 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.182 2.193 . . . . 1.4 106.865 176.449 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -119.07 125.31 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 128.281 2.632 . . . . 0.58 110.253 173.402 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -99.48 141.9 31.66 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.515 -1.991 . . . . 2.09 113.894 -178.215 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 p -102.19 175.63 5.46 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 121.165 1.802 . . . . 0.99 109.908 179.136 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.2 tp -44.6 -47.76 10.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.461 1.652 . . . . 2.53 115.461 167.996 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.8 p -80.55 -0.56 38.23 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 123.547 0.739 . . . . 2.08 112.401 -178.662 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.8 25.57 57.95 Favored Glycine 0 N--CA 1.43 -1.76 1 C-N-CA 134.18 5.657 . . . . 1.31 112.533 178.651 . . . . . . . . 2 2 . 1 . 142 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -71.01 127.1 31.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.862 -1.533 . . . . 1.4 106.862 -173.145 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.1 m -84.79 122.23 28.83 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 113.076 -3.45 . . . . 0.78 114.55 173.957 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.0 mt -98.99 119.64 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 105.323 -2.103 . . . . 1.55 105.323 173.086 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.5 m -90.63 111.47 22.81 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.312 2.258 . . . . 1.08 113.148 -178.986 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.0 mt -116.28 155.1 28.98 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 120.254 1.388 . . . . 1.55 111.45 -174.882 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -107.34 114.58 28.7 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 128.396 2.678 . . . . 1.95 105.134 172.377 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -124.68 164.12 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 118.185 -2.822 . . . . 0.96 106.831 179.117 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -102.84 147.84 34.68 Favored Pre-proline 0 N--CA 1.43 -1.453 1 C-N-CA 133.06 4.544 . . . . 2.35 114.308 159.792 . . . . . . . . 2 2 . 1 . 142 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -77.58 -12.67 16.72 Favored 'Trans proline' 0 C--N 1.3 -2.008 1 CA-C-N 129.347 4.374 . . . . 0.95 110.929 -166.521 . . . . . . . . 2 2 . 1 . 142 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 p -88.88 -0.51 57.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 115.311 -2.281 . . . . 1.45 113.295 178.342 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -74.31 149.67 40.54 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 125.276 1.61 . . . . 1.69 114.6 177.233 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.259 57.8 p -85.04 157.33 20.77 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 125.632 2.634 . . . . 0.75 110.153 -178.505 . . . . . . . . 2 2 . 1 . 142 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.3 mm -67.72 -32.03 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.492 -2.63 . . . . 0.73 109.783 175.665 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -61.89 -32.72 73.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.224 2.21 . . . . 1.62 116.096 165.086 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -81.17 -29.47 34.66 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 122.428 2.376 . . . . 2.13 113.162 176.023 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.8 -32.2 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.401 -1.333 . . . . 0.62 107.401 174.488 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.319 48.8 mttt -51.69 -41.29 61.33 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 118.889 2.922 . . . . 1.22 118.889 172.95 . . . . . . . . 2 2 . 1 . 142 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.1 -40.73 59.11 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 117.512 2.412 . . . . 0.51 117.512 166.179 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -68.7 -48.99 62.47 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.405 2.526 . . . . 1.44 114.228 -178.933 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 30' ' ' ILE . 4.2 mt -54.74 -39.67 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 O-C-N 118.144 -2.848 . . . . 1.32 117.714 166.621 . . . . . . . . 2 2 . 1 . 142 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -68.52 -32.11 71.84 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.032 -2.917 . . . . 1.7 112.152 -179.801 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -59.93 -38.17 81.6 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.167 -2.833 . . . . 1.55 114.76 168.411 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -75.13 -66.24 0.78 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 127.586 2.354 . . . . 2.62 109.676 -178.761 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -106.41 -20.88 13.24 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 128.403 2.681 . . . . 1.48 111.824 -159.988 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.31 -2.27 70.89 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 121.773 3.469 . . . . 1.12 121.773 177.901 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.8 mt -68.93 129.37 92.34 Favored Pre-proline 0 N--CA 1.431 -1.41 0 C-N-CA 127.473 2.309 . . . . 1.55 113.561 -179.584 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.251 0.3 OUTLIER -72.52 143.74 38.97 Favored 'Trans proline' 0 C--N 1.299 -2.042 1 C-N-CA 125.496 4.131 . . . . 1.02 112.995 -173.285 . . . . . . . . 4 3 . 1 . 142 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.53 -11.95 33.79 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 121.813 1.683 . . . . 1.25 114.151 -178.53 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.48 -31.86 67.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.832 -1.168 . . . . 2.25 112.054 173.99 . . . . . . . . 2 2 . 1 . 142 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -96.88 -22.19 17.04 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 125.227 1.58 . . . . 2.02 113.903 -173.373 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -75.86 122.65 24.43 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 123.674 1.702 . . . . 0.69 111.921 178.705 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -121.99 143.76 49.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 117.721 -3.112 . . . . 2.78 106.134 168.653 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.45 150.53 29.73 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.181 -3.449 . . . . 1.17 110.999 178.972 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mt -129.69 140.04 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 N-CA-C 97.291 -5.077 . . . . 1.38 97.291 -179.583 . . . . . . . . 2 2 . 1 . 142 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -154.98 137.78 15.33 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.793 2.437 . . . . 1.5 105.448 169.492 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.406 . . 74.46 -49.52 0.67 Allowed 'General case' 0 N--CA 1.431 -1.385 1 C-N-CA 134.917 5.287 . . . . 1.21 115.425 178.999 . . . . . . . . 3 2 . 1 . 142 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -173.43 -23.92 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 106.095 -2.802 . . . . 1.3 106.095 -177.497 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -118.53 158.3 25.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.626 2.631 . . . . 2.55 113.281 -170.819 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -71.66 126.29 29.3 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.7 -1.963 . . . . 2.48 105.7 169.715 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.1 mt -82.97 141.66 31.96 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.861 2.464 . . . . 0.9 108.887 -175.962 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -81.42 152.69 27.3 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.491 -4.506 . . . . 1.94 106.589 171.889 . . . . . . . . 2 2 . 1 . 142 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -77.59 -57.22 3.93 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.287 -1.779 . . . . 1.56 111.654 -167.843 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.34 17.59 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.752 0 CA-C-O 114.002 -3.666 . . . . 0.97 120.37 168.689 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -110.21 175.15 5.54 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 123.609 3.704 . . . . 2.49 105.122 176.307 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.0 p -102.41 171.9 7.19 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 128.242 3.877 . . . . 0.76 117.012 171.003 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.2 mt -65.32 -33.18 75.37 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 112.241 -2.254 . . . . 1.05 112.923 173.848 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 m -64.23 -36.25 83.47 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.142 2.645 . . . . 1.19 118.142 177.099 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -56.88 -42.89 80.62 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.493 2.717 . . . . 1.9 109.045 173.097 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -93.4 3.81 54.99 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.175 -3.453 . . . . 0.89 116.981 -177.905 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.321 69.9 m-80 71.48 29.96 2.58 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 125.936 2.779 . . . . 1.84 112.162 171.313 . . . . . . . . 2 2 . 1 . 142 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.3 mt -80.97 119.71 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 111.842 -2.436 . . . . 0.82 110.408 -178.071 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -115.59 -176.58 2.96 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.324 -3.36 . . . . 2.16 107.322 -173.386 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -64.2 153.49 37.79 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 117.728 -3.108 . . . . 2.12 117.433 177.322 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 64.0 20.27 12.12 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 130.506 3.522 . . . . 1.71 113.157 168.578 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.2 m -88.79 160.28 17.35 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 115.356 -2.259 . . . . 1.04 113.69 -172.286 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.0 m -101.92 95.93 6.71 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 115.573 -2.156 . . . . 0.79 111.163 -172.389 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.424 HD13 HD12 ' A' ' 3' ' ' ILE . 5.3 mp -91.4 163.38 14.21 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 124.355 3.252 . . . . 1.4 106.819 179.373 . . . . . . . . 2 2 . 1 . 142 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -123.04 152.31 41.1 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 124.584 2.135 . . . . 1.51 113.465 -178.173 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.6 tp -127.93 136.96 52.06 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.888 -1.758 . . . . 1.14 108.393 -176.694 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.4 m -135.14 156.76 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 104.003 -2.592 . . . . 1.23 104.003 178.94 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.3 mt -100.95 108.95 20.82 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.928 1.347 . . . . 2.78 113.71 179.357 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.97 88.17 6.85 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.226 2.21 . . . . 3.75 106.935 -179.247 . . . . . . . . 2 2 . 1 . 142 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.3 mt -105.04 -83.8 0.5 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.59 -1.633 . . . . 3.14 106.59 176.143 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 50.8 ttm-85 -145.28 -61.2 0.35 Allowed 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 125.928 1.691 . . . . 6.8 111.181 176.459 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.67 90.69 1.11 Allowed Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.268 -1.933 . . . . 3.57 108.268 -167.443 . . . . . . . . 1 1 . 1 . 142 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.757 0 CA-C-N 120.949 2.375 . . . . 3.87 107.809 -176.995 . . . . . . . . 0 0 . 1 . 143 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.368 0 N-CA-C 112.64 0.608 . . . . 1.1 112.64 . . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.04 146.72 23.51 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.8 -1.813 . . . . 1.87 110.467 179.078 . . . . . . . . 2 2 . 1 . 143 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 pt -127.99 170.03 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 103.997 -2.594 . . . . 0.72 103.997 168.147 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -124.28 142.22 51.43 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.505 -3.247 . . . . 1.4 106.327 -178.809 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.1 t -130.79 118.98 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-O 116.953 -1.499 . . . . 0.58 107.211 179.741 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -97.29 133.3 42.1 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 125.957 2.036 . . . . 2.09 112.782 176.859 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.4 ' HB ' ' H ' ' A' ' 8' ' ' LEU . 46.9 p -74.29 -161.78 0.13 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.527 -2.608 . . . . 0.99 117.697 171.665 . . . . . . . . 2 2 . 1 . 143 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.4 ' H ' ' HB ' ' A' ' 7' ' ' THR . 84.5 mt -71.0 -63.95 1.0 Allowed 'General case' 0 N--CA 1.429 -1.492 2 C-N-CA 134.428 5.091 . . . . 2.53 113.111 174.606 . . . . . . . . 3 3 . 1 . 143 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.5 p -69.09 -47.18 65.88 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 118.921 -2.362 . . . . 2.08 116.31 -176.405 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.06 1.22 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 121.594 3.398 . . . . 1.31 121.594 177.458 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -86.47 126.21 34.26 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 118.51 -2.759 . . . . 1.4 111.103 -173.494 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.259 80.1 m -102.89 116.84 33.33 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 105.101 -2.185 . . . . 0.78 105.101 174.947 . . . . . . . . 2 2 . 1 . 143 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.5 pt -99.68 148.94 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 122.543 1.163 . . . . 1.55 111.101 173.102 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.251 37.5 m -106.66 101.97 11.38 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 127.05 2.14 . . . . 1.08 109.161 178.147 . . . . . . . . 2 2 . 1 . 143 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.6 mt -96.98 140.26 31.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 113.809 1.04 . . . . 1.55 113.809 179.376 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -104.13 130.92 51.87 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 126.247 2.927 . . . . 1.95 110.96 172.643 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.6 m -135.24 158.92 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 118.292 -2.755 . . . . 0.96 110.096 -169.49 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -103.93 147.0 33.61 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 106.337 -1.727 . . . . 2.35 106.337 160.397 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.364 43.9 Cg_endo -72.07 -0.89 9.21 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 124.937 2.799 . . . . 0.95 117.548 -176.554 . . . . . . . . 2 2 . 1 . 143 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.6 p -108.59 2.06 21.8 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.792 2.437 . . . . 1.45 106.146 -176.2 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.76 139.96 43.71 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 119.815 1.189 . . . . 1.69 113.514 171.393 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 5.8 p -79.11 167.36 21.15 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.227 2.441 . . . . 0.75 106.74 -179.046 . . . . . . . . 2 2 . 1 . 143 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.2 mm -66.68 -33.6 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 115.358 -2.258 . . . . 0.73 111.104 176.624 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -54.46 -46.43 73.32 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 126.01 2.069 . . . . 1.62 111.79 171.593 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -70.24 -42.11 72.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 112.877 -3.44 . . . . 2.13 115.278 174.825 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.1 t -52.47 -32.76 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 122.266 2.303 . . . . 0.62 112.894 168.71 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 27.6 mttt -73.11 -31.49 64.36 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.407 -3.308 . . . . 1.22 113.447 178.454 . . . . . . . . 2 2 . 1 . 143 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.27 -33.81 75.34 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.282 1.433 . . . . 0.51 110.683 167.432 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -73.23 -34.8 66.1 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.119 -4.113 . . . . 1.44 113.55 176.563 . . . . . . . . 2 2 . 1 . 143 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 99.6 mt -67.75 -31.02 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 127.777 2.431 . . . . 1.32 106.252 172.638 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -39.36 80.02 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 120.468 1.485 . . . . 1.7 114.014 174.214 . . . . . . . . 2 2 . 1 . 143 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -69.79 -47.12 64.06 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 116.77 -1.586 . . . . 1.55 108.846 175.633 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -75.82 -56.38 4.73 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 125.827 1.651 . . . . 2.62 114.237 -174.442 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -103.3 -25.09 13.45 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 117.428 -3.295 . . . . 1.48 110.603 -165.045 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.41 32.95 8.98 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 115.769 -2.684 . . . . 1.12 111.796 -179.893 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mt -110.44 123.1 36.67 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 113.016 -3.373 . . . . 1.55 105.881 -176.403 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -62.16 144.82 96.23 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 124.072 3.181 . . . . 1.02 117.805 177.196 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 94.0 Cg_endo -72.75 -2.04 11.29 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 123.821 3.014 . . . . 1.25 116.134 -170.193 . . . . . . . . 2 2 . 1 . 143 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -73.06 -43.64 61.67 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.686 2.394 . . . . 2.25 109.276 169.076 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.292 31.1 mt-30 -66.35 -55.57 15.29 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.179 -1.576 . . . . 2.02 110.915 -172.667 . . . . . . . . 2 2 . 1 . 143 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.408 70.7 mt-30 -63.89 130.18 43.08 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 128.919 2.888 . . . . 0.69 112.595 -175.874 . . . . . . . . 2 2 . 1 . 143 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -120.31 115.63 23.95 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 103.25 -2.87 . . . . 2.78 103.25 174.026 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.2 mt -97.91 142.52 29.54 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.317 -1.734 . . . . 1.17 106.317 179.557 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.7 mt -136.85 144.88 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 100.597 -3.853 . . . . 1.38 100.597 177.291 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -127.9 104.8 8.01 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 124.389 2.042 . . . . 1.5 106.944 173.736 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.3 . . 71.27 -75.28 0.08 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 112.454 -2.157 . . . . 1.21 113.747 -179.694 . . . . . . . . 2 2 . 1 . 143 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.75 -17.48 1.06 Allowed Glycine 0 N--CA 1.43 -1.71 0 CA-C-O 114.351 -3.472 . . . . 1.3 113.844 174.787 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -96.64 131.3 43.44 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 105.914 -1.884 . . . . 2.55 105.914 -174.378 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -83.28 132.51 35.03 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 131.369 3.867 . . . . 2.48 105.226 172.56 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.286 56.1 mt -85.93 146.37 26.73 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 115.585 -2.15 . . . . 0.9 105.782 -170.556 . . . . . . . . 2 2 . 1 . 143 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -109.15 165.29 11.72 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 125.631 3.832 . . . . 1.94 104.433 169.919 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -76.77 -44.3 33.49 Favored 'General case' 0 N--CA 1.43 -1.434 2 C-N-CA 133.1 4.56 . . . . 1.56 122.423 -171.444 . . . . . . . . 2 2 . 1 . 143 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.68 43.13 2.76 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 126.428 1.966 . . . . 0.97 113.487 169.404 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -122.18 152.91 39.46 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.444 2.297 . . . . 2.49 111.231 170.491 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 77.6 p -95.91 168.68 10.49 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 127.899 3.249 . . . . 0.76 112.221 177.934 . . . . . . . . 2 2 . 1 . 143 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.3 mt -69.95 -33.12 71.69 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 116.735 -3.728 . . . . 1.05 109.837 176.952 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.2 t -68.86 -36.59 78.32 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.435 -3.29 . . . . 1.19 112.213 178.753 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -51.59 -49.5 62.0 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.233 -2.792 . . . . 1.9 112.504 176.391 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -87.53 -4.95 58.97 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 115.785 -4.322 . . . . 0.89 111.087 -179.163 . . . . . . . . 2 2 . 1 . 143 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.3 t30 54.26 53.45 10.93 Favored 'General case' 0 N--CA 1.43 -1.467 1 C-N-CA 132.597 4.359 . . . . 1.84 117.392 176.754 . . . . . . . . 2 2 . 1 . 143 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.0 mt -73.42 126.18 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 126.783 3.182 . . . . 0.82 112.559 -175.617 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -92.66 171.34 9.07 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 114.884 -4.885 . . . . 2.16 114.182 -176.603 . . . . . . . . 2 2 . 1 . 143 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -64.09 143.26 58.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 118.27 -2.769 . . . . 2.12 109.048 174.727 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 55.92 19.2 3.44 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 118.389 2.737 . . . . 1.71 118.389 -178.593 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -74.96 147.32 40.97 Favored 'General case' 0 N--CA 1.428 -1.54 0 O-C-N 120.028 -1.67 . . . . 1.04 106.941 -173.947 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.7 m -93.41 113.28 25.39 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.628 -1.92 . . . . 0.79 106.425 -176.981 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 mp -110.59 156.69 20.59 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 123.125 2.693 . . . . 1.4 104.041 175.558 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -106.35 144.14 33.46 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.136 -2.852 . . . . 1.51 110.155 -179.622 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.6 tp -128.01 115.9 19.21 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 102.947 -2.983 . . . . 1.14 102.947 179.369 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.89 138.22 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 119.18 -2.2 . . . . 1.23 106.218 177.334 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.4 mt -128.47 127.38 42.36 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.814 1.768 . . . . 2.78 113.51 -175.474 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.4 ttt85 -96.66 137.01 36.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 131.133 3.773 . . . . 3.75 103.301 178.236 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.0 mt -98.32 157.13 16.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 112.039 -2.346 . . . . 3.14 112.28 173.651 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.5 mtm180 -96.2 -37.24 10.64 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.196 -2.815 . . . . 6.8 108.596 173.725 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.96 -96.31 0.14 Allowed Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 119.226 -1.464 . . . . 3.57 110.282 -164.994 . . . . . . . . 1 1 . 1 . 143 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.748 0 C-N-CA 129.904 3.621 . . . . 3.87 112.081 -179.064 . . . . . . . . 0 0 . 1 . 144 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 CA--C 1.489 -1.375 0 CA-C-O 123.218 1.485 . . . . 1.1 110.811 . . . . . . . . . 0 0 . 1 . 144 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -100.93 94.17 5.89 Favored 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 115.028 -4.795 . . . . 1.87 106.864 -173.984 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.266 18.9 pt -85.35 149.84 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 1 O-C-N 129.244 4.09 . . . . 0.72 114.227 172.913 . . . . . . . . 3 2 . 1 . 144 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -107.75 108.13 19.21 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.09 2.556 . . . . 1.4 114.707 -179.358 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -94.55 116.27 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-N 119.91 1.232 . . . . 0.58 110.073 176.232 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -95.74 129.86 42.83 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 124.941 2.305 . . . . 2.09 110.232 176.357 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.0 p -74.03 -173.78 1.7 Allowed 'General case' 0 N--CA 1.431 -1.393 1 O-C-N 114.808 -4.932 . . . . 0.99 112.829 166.486 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.1 mt -81.12 -49.53 10.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 125.959 2.037 . . . . 2.53 116.421 170.271 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 p -63.56 -56.02 19.21 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.858 -4.276 . . . . 2.08 111.87 -173.392 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.22 53.7 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 116.778 -2.63 . . . . 1.31 111.745 173.098 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -136.7 125.16 23.48 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 121.491 2.646 . . . . 1.4 104.566 -174.193 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.8 m -107.04 113.35 26.77 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 118.668 -2.52 . . . . 0.78 114.431 175.876 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.419 ' CG2' ' HG2' ' A' ' 33' ' ' LYS . 15.6 mt -96.49 125.71 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 122.784 1.278 . . . . 1.55 111.96 -176.043 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 m -89.84 119.03 29.87 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.05 -2.906 . . . . 1.08 111.244 177.768 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.8 mt -116.53 153.07 32.85 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.309 -1.494 . . . . 1.55 109.013 -179.324 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -109.29 130.7 55.49 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.262 -3.399 . . . . 1.95 107.561 172.198 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -144.42 173.61 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 123.31 1.529 . . . . 0.96 109.685 179.709 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.434 ' O ' HD12 ' A' ' 56' ' ' LEU . 18.9 mm-40 -106.44 159.68 28.91 Favored Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 105.244 -2.132 . . . . 2.35 105.244 167.164 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -84.5 -11.33 8.27 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 O-C-N 113.87 -3.805 . . . . 0.95 106.486 -173.71 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.9 p -93.32 -3.37 53.59 Favored 'General case' 0 N--CA 1.43 -1.439 1 C-N-CA 131.769 4.028 . . . . 1.45 110.818 -174.154 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -73.76 152.05 40.45 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.253 2.221 . . . . 1.69 107.22 177.269 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.6 p -86.35 156.5 20.19 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 116.906 -3.621 . . . . 0.75 106.73 175.09 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 mm -44.23 -48.55 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 1 C-N-CA 131.764 4.026 . . . . 0.73 112.12 174.842 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -35.46 -57.72 0.61 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 119.019 2.97 . . . . 1.62 119.019 166.831 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -71.16 -27.77 63.78 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 113.367 -1.742 . . . . 2.13 113.848 179.461 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.37 -48.54 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 125.862 2.744 . . . . 0.62 114.085 170.868 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -60.22 -37.36 80.06 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.904 -3.623 . . . . 1.22 115.239 175.879 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.45 -14.35 61.23 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.304 -2.747 . . . . 0.51 112.694 179.509 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 32' ' ' ASP . 10.5 ttmt -74.18 -41.61 61.18 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.097 -1.627 . . . . 1.44 114.233 170.261 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.3 mt -58.51 -46.29 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 123.234 1.492 . . . . 1.32 111.439 166.741 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -49.03 -42.83 39.6 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 125.194 2.426 . . . . 1.7 112.856 171.738 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 29' ' ' LYS . 34.0 t70 -60.53 -58.91 6.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.869 -3.644 . . . . 1.55 113.787 168.827 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.419 ' HG2' ' CG2' ' A' ' 13' ' ' ILE . 33.9 tptt -68.82 -62.04 1.55 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.541 2.336 . . . . 2.62 113.429 -170.079 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -87.22 -45.2 10.85 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 128.061 2.545 . . . . 1.48 113.142 -168.57 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.11 39.89 3.91 Favored Glycine 0 N--CA 1.43 -1.751 0 CA-C-N 112.659 -2.064 . . . . 1.12 114.92 177.691 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.3 mt -106.7 134.16 19.95 Favored Pre-proline 0 N--CA 1.43 -1.466 0 C-N-CA 126.374 1.87 . . . . 1.55 107.01 -178.043 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.69 143.44 99.41 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-O 113.684 -2.715 . . . . 1.02 117.513 175.692 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -80.84 -2.31 11.75 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 126.497 3.356 . . . . 1.25 112.012 -168.331 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.74 -26.21 32.13 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 124.829 2.252 . . . . 2.25 111.66 170.393 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -84.86 -20.26 31.09 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.235 -2.791 . . . . 2.02 114.773 -176.065 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -85.85 117.93 25.02 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 114.944 -1.025 . . . . 0.69 111.266 -176.221 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.404 ' HB2' HG23 ' A' ' 70' ' ' VAL . 13.8 mtt-85 -113.22 116.01 29.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.669 -1.269 . . . . 2.78 108.706 169.772 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.5 mt -88.41 136.84 32.79 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.858 -1.151 . . . . 1.17 112.559 176.181 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -113.49 117.63 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 O-C-N 117.682 -3.136 . . . . 1.38 104.886 179.904 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.417 ' HB3' HD21 ' A' ' 50' ' ' LEU . 50.0 t80 -107.21 123.13 47.84 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 116.675 -3.766 . . . . 1.5 108.05 165.916 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.305 . . 64.29 -82.84 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 131.314 3.846 . . . . 1.21 114.215 -173.991 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.66 3.06 2.03 Favored Glycine 0 N--CA 1.43 -1.719 0 O-C-N 116.65 -3.781 . . . . 1.3 105.466 -176.919 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -127.0 141.72 51.72 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 115.658 -4.436 . . . . 2.55 113.913 178.454 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -65.38 142.98 58.03 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.246 2.219 . . . . 2.48 113.589 171.439 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.417 HD21 ' HB3' ' A' ' 45' ' ' PHE . 34.6 mt -96.36 123.46 40.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.765 -3.084 . . . . 0.9 113.493 -176.519 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -81.47 144.26 31.49 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 130.012 3.325 . . . . 1.94 112.959 -178.54 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.6 150.72 28.0 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.453 2.701 . . . . 1.56 107.385 -169.113 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.97 -4.44 78.28 Favored Glycine 0 N--CA 1.429 -1.77 0 O-C-N 119.454 -2.029 . . . . 0.97 109.409 174.194 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -97.34 172.34 7.84 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.087 2.286 . . . . 2.49 110.392 171.433 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.6 p -110.83 174.32 5.91 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.504 -1.372 . . . . 0.76 112.57 173.282 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 18' ' ' GLU . 67.1 mt -52.16 -34.67 46.0 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.844 2.458 . . . . 1.05 112.427 170.185 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.1 m -75.11 -34.56 61.72 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.701 2.501 . . . . 1.19 114.179 -172.579 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -51.31 -34.68 34.4 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 119.985 3.328 . . . . 1.9 119.985 170.442 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -92.56 -5.91 50.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 109.712 -3.404 . . . . 0.89 114.195 178.892 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.25 8.9 m120 64.92 50.3 1.96 Allowed 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.057 -2.902 . . . . 1.84 113.516 179.583 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.8 mt -92.64 107.84 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 126.004 2.811 . . . . 0.82 110.903 178.409 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -89.49 172.61 8.86 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.207 -2.269 . . . . 2.16 106.231 -171.288 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -14.42 -89.35 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.007 3.323 . . . . 2.12 119.613 167.473 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -91.44 74.95 6.01 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.537 -4.477 . . . . 1.71 114.309 179.028 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -94.41 144.85 25.21 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.89 -4.256 . . . . 1.04 119.657 177.024 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.1 m -101.13 110.11 22.09 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.284 3.434 . . . . 0.79 106.472 -177.026 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -108.81 152.37 24.98 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.695 -1.965 . . . . 1.4 105.695 -177.672 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -116.53 133.24 56.25 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.618 -4.426 . . . . 1.51 110.0 -179.788 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.0 tp -107.75 115.42 30.11 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 115.183 -2.341 . . . . 1.14 110.905 -174.173 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 42' ' ' ARG . 15.7 m -111.75 146.93 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 126.059 2.837 . . . . 1.23 106.373 173.967 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.417 HD21 HD21 ' A' ' 73' ' ' LEU . 9.0 tp -93.72 120.54 34.11 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.935 -1.728 . . . . 2.78 111.877 -174.124 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.81 114.4 28.32 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.86 -1.163 . . . . 3.75 107.86 -177.365 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.417 HD21 HD21 ' A' ' 71' ' ' LEU . 77.2 mt -103.51 -66.69 0.93 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 104.247 -2.501 . . . . 3.14 104.247 174.401 . . . . . . . . 2 2 . 1 . 144 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -120.96 -147.09 0.38 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 116.73 -1.988 . . . . 6.8 107.367 164.649 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.39 -90.5 1.33 Allowed Glycine 0 N--CA 1.43 -1.725 0 CA-C-O 119.369 -0.684 . . . . 3.57 112.273 -163.254 . . . . . . . . 1 1 . 1 . 144 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.745 0 CA-C-N 119.839 1.82 . . . . 3.87 111.7 -172.036 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.5 ttp . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 113.994 1.109 . . . . 1.1 113.994 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -105.36 140.03 39.1 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.306 -3.371 . . . . 1.87 113.49 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 pt -125.88 153.02 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 114.933 -1.03 . . . . 0.72 109.672 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -99.88 135.54 41.15 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.802 2.041 . . . . 1.4 109.247 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.7 t -114.81 104.07 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 104.32 -2.474 . . . . 0.58 104.32 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -82.16 126.05 31.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.31 2.005 . . . . 2.09 111.962 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.3 p -83.94 -169.05 2.39 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 117.171 -3.455 . . . . 0.99 113.019 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.8 tp -73.46 -57.93 3.66 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.844 1.783 . . . . 2.53 113.103 170.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.4 p -67.86 -22.9 65.1 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.256 -3.402 . . . . 2.08 118.191 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.93 22.36 1.03 Allowed Glycine 0 N--CA 1.429 -1.774 0 C-N-CA 125.848 1.689 . . . . 1.31 115.111 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -88.31 131.02 34.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.031 2.133 . . . . 1.4 105.985 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -109.59 124.39 51.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 123.603 2.911 . . . . 0.78 104.382 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.1 mt -111.72 128.23 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 107.436 -1.32 . . . . 1.55 107.436 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.8 m -102.83 115.83 31.36 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.11 -0.994 . . . . 1.08 108.928 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -105.49 157.28 17.48 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.971 -1.081 . . . . 1.55 111.568 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.39 110.82 21.46 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.358 2.263 . . . . 1.95 106.524 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.0 m -118.84 159.02 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 126.791 2.557 . . . . 0.96 109.01 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -89.82 146.3 35.09 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-O 111.762 -3.97 . . . . 2.35 106.769 160.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -73.47 -5.61 17.4 Favored 'Trans proline' 0 N--CA 1.433 -2.05 0 CA-C-N 127.547 3.731 . . . . 0.95 115.142 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 m -90.08 7.58 37.03 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 125.228 1.58 . . . . 1.45 109.444 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -85.19 144.14 28.34 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.19 1.922 . . . . 1.69 116.19 172.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 37.6 p -82.9 160.5 22.11 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.323 -2.736 . . . . 0.75 115.657 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.454 15.5 mm -57.79 -38.99 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 123.419 1.581 . . . . 0.73 115.252 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -47.49 -45.05 25.88 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.357 1.984 . . . . 1.62 116.357 161.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -72.58 -20.8 61.25 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 126.533 1.933 . . . . 2.13 113.4 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.23 -39.37 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.99 -2.319 . . . . 0.62 108.394 172.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -66.05 -41.69 90.5 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.974 -2.329 . . . . 1.22 110.183 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.75 -43.79 66.02 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.956 -2.34 . . . . 0.51 116.033 173.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -61.7 -32.15 72.34 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 125.966 2.041 . . . . 1.44 113.593 170.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -81.81 -32.13 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 118.018 -2.927 . . . . 1.32 115.093 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -56.2 -38.71 71.36 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.868 1.794 . . . . 1.7 113.879 166.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -64.56 -50.39 67.47 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.903 2.881 . . . . 1.55 111.101 167.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -71.5 -62.84 1.26 Allowed 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 126.827 2.051 . . . . 2.62 111.569 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -101.25 -35.31 9.31 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 118.45 -2.656 . . . . 1.48 115.81 -170.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.93 11.06 29.07 Favored Glycine 0 N--CA 1.43 -1.751 0 CA-C-O 124.106 1.948 . . . . 1.12 113.188 175.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.5 mm -76.1 125.97 87.31 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-O 114.418 -2.706 . . . . 1.55 112.842 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.0 154.35 74.39 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 CA-C-N 128.252 3.983 . . . . 1.02 118.169 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -74.08 -9.6 22.17 Favored 'Trans proline' 0 C--N 1.299 -2.066 0 CA-C-N 123.844 2.409 . . . . 1.25 116.52 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -59.99 -44.38 94.56 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 118.378 -0.82 . . . . 2.25 111.254 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -79.6 -29.56 41.21 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.228 0.955 . . . . 2.02 110.604 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -66.66 107.68 2.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 121.044 3.72 . . . . 0.69 121.044 -172.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.427 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 29.5 mtt180 -101.38 139.31 37.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.075 -3.516 . . . . 2.78 110.478 171.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.6 mt -113.3 141.25 47.23 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.677 -2.514 . . . . 1.17 111.891 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mm -128.72 137.58 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 115.184 -2.341 . . . . 1.38 110.899 172.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.499 ' CE2' HG12 ' A' ' 61' ' ' ILE 0.293 10.9 t80 -115.67 -54.62 2.5 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.068 1.48 . . . . 1.5 107.766 176.098 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -121.46 -75.96 0.59 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 115.276 1.584 . . . . 1.21 115.276 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.96 -44.14 0.28 Allowed Glycine 0 N--CA 1.429 -1.767 0 O-C-N 119.412 -2.055 . . . . 1.3 114.166 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 mttm -91.93 151.37 20.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 120.784 2.292 . . . . 2.55 114.459 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -83.56 121.91 27.85 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 111.959 -2.382 . . . . 2.48 111.732 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mt -78.21 132.16 37.45 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.501 -1.681 . . . . 0.9 114.197 -162.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -87.62 155.87 19.75 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 115.986 -1.959 . . . . 1.94 115.002 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -66.77 -48.21 69.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.199 2.6 . . . . 1.56 116.099 -172.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.97 38.85 1.12 Allowed Glycine 0 N--CA 1.43 -1.737 1 N-CA-C 124.923 4.729 . . . . 0.97 124.923 174.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -139.59 150.65 45.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.099 -2.412 . . . . 2.49 109.337 171.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 24.5 p -91.28 158.81 16.36 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 111.901 -2.409 . . . . 0.76 113.437 -177.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.402 HD23 HD12 ' A' ' 61' ' ' ILE . 1.5 mt -48.93 -48.73 42.54 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.875 -4.265 . . . . 1.05 107.763 170.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.4 p -56.44 -39.57 73.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.874 2.546 . . . . 1.19 117.874 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -53.56 -57.36 11.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.884 -2.385 . . . . 1.9 112.807 171.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -63.49 -16.16 59.87 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 128.124 2.57 . . . . 0.89 115.149 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.2 t30 69.23 51.56 0.51 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.356 2.662 . . . . 1.84 112.593 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.499 HG12 ' CE2' ' A' ' 45' ' ' PHE . 34.6 mt -91.73 122.88 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 118.245 -2.784 . . . . 0.82 108.06 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -89.48 -167.6 1.91 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 125.192 1.557 . . . . 2.16 109.682 -174.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.296 40.2 tttm -75.7 138.16 41.13 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.478 -2.045 . . . . 2.12 105.478 172.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 55.3 51.88 12.36 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 130.925 3.69 . . . . 1.71 109.607 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.6 m -103.02 149.87 24.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.159 -2.163 . . . . 1.04 105.159 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.0 m -100.65 118.3 36.51 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 123.138 1.447 . . . . 0.79 112.613 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 61' ' ' ILE . 9.4 mp -102.2 148.19 25.73 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 105.782 -1.933 . . . . 1.4 105.782 170.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -99.38 130.12 45.63 Favored 'General case' 0 N--CA 1.43 -1.429 1 C-N-CA 131.932 4.093 . . . . 1.51 110.96 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.2 tp -108.86 116.06 31.27 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 115.075 -2.65 . . . . 1.14 105.964 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 98.6 t -99.92 130.92 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 108.516 -0.92 . . . . 1.23 108.516 173.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 71' ' ' LEU . 61.7 mt . . . . . 0 N--CA 1.43 -1.465 0 C-N-CA 129.232 3.013 . . . . 2.78 108.371 175.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.3 ttp . . . . . 0 CA--C 1.489 -1.376 0 CA-C-O 121.788 0.804 . . . . 1.1 111.326 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -96.06 140.75 30.34 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.327 -1.483 . . . . 1.87 113.769 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.6 pt -139.34 165.14 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 125.994 2.807 . . . . 0.72 105.823 171.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -124.64 140.86 52.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 112.715 -2.038 . . . . 1.4 111.08 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -109.67 120.83 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 O-C-N 120.307 -1.495 . . . . 0.58 113.05 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -94.75 137.92 33.23 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.195 -3.441 . . . . 2.09 112.126 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.258 74.8 p -81.32 -165.02 0.85 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.626 2.631 . . . . 0.99 110.815 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.8 tp -77.19 -44.69 29.22 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.083 -2.886 . . . . 2.53 113.835 169.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.49 -53.63 7.4 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.503 1.62 . . . . 2.08 107.863 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.82 21.71 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.706 1 O-C-N 115.673 -4.392 . . . . 1.31 113.018 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -85.9 139.75 30.97 Favored 'General case' 0 N--CA 1.431 -1.412 1 CA-C-N 125.283 4.541 . . . . 1.4 106.546 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 38.2 m -101.8 114.15 27.96 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.995 1.318 . . . . 0.78 110.345 171.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.0 mt -96.21 122.9 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 117.033 -3.542 . . . . 1.55 110.192 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.3 m -87.21 125.55 34.25 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.186 -1.571 . . . . 1.08 110.73 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.1 mt -126.69 152.46 46.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.615 -1.303 . . . . 1.55 112.084 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -123.36 105.57 9.94 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 111.781 -2.463 . . . . 1.95 110.07 173.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.1 m -121.64 -167.83 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 102.107 -3.294 . . . . 0.96 102.107 -176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -122.07 162.42 37.39 Favored Pre-proline 0 N--CA 1.431 -1.388 0 C-N-CA 126.982 2.113 . . . . 2.35 106.477 167.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -83.81 -14.65 7.49 Favored 'Trans proline' 0 N--CA 1.433 -2.064 0 CA-C-O 116.845 -1.398 . . . . 0.95 108.83 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.3 p -80.94 0.99 32.98 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 124.345 1.028 . . . . 1.45 112.648 171.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -83.54 157.03 22.5 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 125.466 2.555 . . . . 1.69 111.772 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.9 p -88.6 163.35 15.88 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 112.939 -1.937 . . . . 0.75 112.169 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.0 mm -63.29 -34.37 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-O 115.31 -2.281 . . . . 0.73 110.037 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -55.48 -46.94 76.83 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 122.215 2.279 . . . . 1.62 114.788 170.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -56.03 -37.73 69.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.267 1.58 . . . . 2.13 115.267 174.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -62.44 -40.46 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 119.7 -1.875 . . . . 0.62 113.864 172.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -61.85 -28.66 69.65 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.477 -1.39 . . . . 1.22 113.803 173.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.82 -28.11 61.46 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.3 2.24 . . . . 0.51 110.156 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -74.12 -36.13 64.17 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.907 -3.621 . . . . 1.44 111.162 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.6 mt -70.61 -39.9 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 123.157 1.456 . . . . 1.32 113.648 175.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -53.03 -38.7 62.62 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.079 -2.263 . . . . 1.7 115.779 169.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -68.88 -46.66 67.83 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.488 -2.008 . . . . 1.55 113.839 173.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -80.04 -55.78 4.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.58 1.552 . . . . 2.62 114.783 -174.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -94.06 -45.51 7.54 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 127.864 3.697 . . . . 1.48 110.928 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.27 56.34 0.7 Allowed Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 111.888 -2.415 . . . . 1.12 111.211 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.5 mt -124.86 127.78 25.04 Favored Pre-proline 0 N--CA 1.43 -1.434 0 N-CA-C 103.268 -2.864 . . . . 1.55 103.268 -167.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.28 32.2 Cg_exo -66.07 138.55 52.56 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 124.625 3.55 . . . . 1.02 109.314 -171.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -64.86 -14.19 43.66 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-O 114.219 -2.492 . . . . 1.25 114.321 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -74.04 -16.34 61.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 122.455 2.389 . . . . 2.25 114.427 164.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -92.06 4.2 53.6 Favored 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 118.756 -2.465 . . . . 2.02 112.168 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -113.48 101.01 8.96 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 127.832 3.682 . . . . 0.69 119.009 -172.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -94.06 122.67 36.8 Favored 'General case' 0 N--CA 1.431 -1.409 1 O-C-N 115.266 -4.646 . . . . 2.78 110.435 173.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.2 mt -112.11 124.81 53.22 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.706 -1.59 . . . . 1.17 106.706 -170.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 1.6 mm -111.0 144.48 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 129.345 3.058 . . . . 1.38 108.912 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -143.0 116.46 9.11 Favored 'General case' 0 N--CA 1.43 -1.442 1 N-CA-C 97.629 -4.952 . . . . 1.5 97.629 175.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 42.83 39.64 1.79 Allowed 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.1 -3.5 . . . . 1.21 120.349 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.21 -25.98 26.26 Favored Glycine 0 N--CA 1.431 -1.657 0 O-C-N 118.042 -2.911 . . . . 1.3 111.039 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -77.35 130.9 37.74 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.74 -3.8 . . . . 2.55 106.378 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -91.6 135.65 33.71 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.297 1.046 . . . . 2.48 112.764 165.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.1 mt -97.81 144.03 27.82 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.069 -2.269 . . . . 0.9 113.29 -166.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -86.45 147.33 26.04 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 119.533 -1.98 . . . . 1.94 115.563 174.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -55.88 -64.26 0.91 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 118.504 2.779 . . . . 1.56 118.504 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.51 22.1 9.5 Favored Glycine 0 N--CA 1.431 -1.693 1 N-CA-C 123.162 4.025 . . . . 0.97 123.162 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -86.14 156.27 20.42 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.92 2.888 . . . . 2.49 109.624 161.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.251 40.5 p -95.44 157.5 15.87 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 126.563 3.077 . . . . 0.76 112.426 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.8 mt -63.38 -31.85 73.11 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 117.422 -3.299 . . . . 1.05 111.769 168.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.4 t -67.61 -40.21 84.71 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.914 -4.241 . . . . 1.19 113.718 174.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -46.67 -53.61 11.3 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 116.743 2.127 . . . . 1.9 116.743 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.337 86.1 m-85 -60.21 -34.87 74.25 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 118.033 2.605 . . . . 0.89 118.033 175.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.294 67.1 m-80 91.84 66.19 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.66 2.384 . . . . 1.84 106.04 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.3 mt -108.68 118.01 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 125.441 2.543 . . . . 0.82 109.654 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -100.75 -179.66 4.14 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 109.94 -3.3 . . . . 2.16 107.27 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -56.93 149.68 18.25 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.89 2.182 . . . . 2.12 116.89 174.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 64.3 26.4 13.67 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 128.966 2.907 . . . . 1.71 110.478 170.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 m -81.7 136.96 35.46 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 116.404 -1.76 . . . . 1.04 107.839 -173.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.6 m -101.95 112.63 25.34 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 101.056 -3.683 . . . . 0.79 101.056 -172.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mp -103.05 156.91 17.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.71 3.204 . . . . 1.4 109.136 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.442 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 36.5 m80 -113.92 144.06 43.68 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 123.867 0.867 . . . . 1.51 109.326 -174.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.7 tp -115.42 111.68 21.17 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 130.593 3.557 . . . . 1.14 114.271 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.5 t -103.22 125.42 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 1 C-N-CA 132.41 4.284 . . . . 1.23 110.946 173.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 N--CA 1.43 -1.441 0 CA-C-O 124.731 2.205 . . . . 2.78 113.792 -179.721 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttp . . . . . 0 CA--C 1.49 -1.343 0 CA-C-O 124.335 2.017 . . . . 1.1 110.789 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -76.54 123.96 26.86 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.508 -3.245 . . . . 1.87 117.176 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -138.22 152.15 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 O-C-N 120.305 -1.497 . . . . 0.72 107.103 174.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -108.61 141.18 40.93 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 128.195 2.598 . . . . 1.4 111.616 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.555 HG21 HD11 ' A' ' 30' ' ' ILE . 17.5 t -121.9 128.76 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 114.242 -2.79 . . . . 0.58 107.883 171.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -120.49 133.28 55.43 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 124.535 3.334 . . . . 2.09 111.472 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.45 HG22 HD23 ' A' ' 69' ' ' LEU . 27.2 p -70.88 175.35 5.14 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.514 -1.366 . . . . 0.99 112.293 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.0 tp -65.57 -41.85 92.44 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 126.194 1.798 . . . . 2.53 115.193 169.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.5 m -66.49 -47.44 73.02 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.908 1.337 . . . . 2.08 108.197 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.38 42.79 0.11 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 117.957 -2.964 . . . . 1.31 114.029 169.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -97.18 117.66 31.89 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 115.565 -2.159 . . . . 1.4 108.024 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.5 m -92.14 125.74 36.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 122.396 2.362 . . . . 0.78 113.268 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mt -112.94 126.5 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 100.524 -3.88 . . . . 1.55 100.524 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.1 m -101.39 125.51 48.04 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 119.971 -1.705 . . . . 1.08 111.301 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.9 mt -126.2 159.42 33.03 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.453 2.073 . . . . 1.55 107.074 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -119.25 138.61 52.87 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 111.722 -2.49 . . . . 1.95 104.292 170.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.273 17.3 m -145.3 164.26 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 104.713 -2.329 . . . . 0.96 104.713 -176.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -98.8 145.02 29.23 Favored Pre-proline 0 N--CA 1.43 -1.468 0 O-C-N 125.828 1.955 . . . . 2.35 107.363 160.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.37 -14.27 31.0 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 CA-C-N 122.898 2.071 . . . . 0.95 112.017 -169.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.339 6.2 t -87.29 -7.66 57.59 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 125.181 3.628 . . . . 1.45 110.692 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -74.59 151.44 39.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.086 -2.259 . . . . 1.69 111.977 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.253 77.1 p -74.16 170.03 16.36 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 117.348 -3.345 . . . . 0.75 117.096 -172.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.415 HD12 HD13 ' A' ' 50' ' ' LEU . 21.5 mm -77.1 -38.14 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 103.755 -2.684 . . . . 0.73 103.755 173.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -42.12 -53.15 4.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.17 2.588 . . . . 1.62 113.427 161.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -59.87 -44.5 94.13 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.222 1.409 . . . . 2.13 112.779 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.6 t -64.49 -42.92 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 120.505 -1.372 . . . . 0.62 110.673 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -58.54 -40.91 84.32 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.575 1.95 . . . . 1.22 113.223 172.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.3 -37.06 84.1 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.188 -3.445 . . . . 0.51 110.246 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -67.43 -39.83 85.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.277 2.325 . . . . 1.44 117.277 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.555 HD11 HG21 ' A' ' 5' ' ' VAL . 9.9 mt -62.47 -48.02 90.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-O 127.066 3.317 . . . . 1.32 113.342 169.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -48.51 -39.66 24.04 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 113.923 -5.485 . . . . 1.7 115.678 167.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -59.56 -45.11 92.78 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.883 -3.011 . . . . 1.55 113.272 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -82.66 -83.18 0.13 Allowed 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.432 -1.321 . . . . 2.62 107.432 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.297 58.1 mm-40 -76.25 -28.19 57.01 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.6 -3.812 . . . . 1.48 114.654 -166.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.31 -8.19 22.74 Favored Glycine 0 N--CA 1.431 -1.652 0 O-C-N 120.718 -1.239 . . . . 1.12 112.693 167.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.1 mt -62.19 115.29 15.12 Favored Pre-proline 0 N--CA 1.43 -1.462 0 N-CA-C 116.993 2.22 . . . . 1.55 116.993 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -67.61 148.43 78.19 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 N-CA-C 119.573 2.874 . . . . 1.02 119.573 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -61.78 -32.91 86.21 Favored 'Trans proline' 0 N--CA 1.433 -2.038 1 C-N-CA 125.876 4.384 . . . . 1.25 113.068 -173.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -62.05 -30.89 71.29 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.769 1.766 . . . . 2.25 115.769 171.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -86.32 -24.68 25.79 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.797 1.639 . . . . 2.02 112.053 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -81.77 117.65 22.24 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 104.35 -2.463 . . . . 0.69 104.35 -176.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -109.19 124.97 51.71 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 103.845 -2.65 . . . . 2.78 103.845 169.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.8 mt -119.47 125.07 48.01 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 106.248 -1.76 . . . . 1.17 106.248 -172.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.8 mm -114.55 117.38 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 C-N-CA 127.905 2.482 . . . . 1.38 114.879 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -102.95 108.18 19.27 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.357 -1.349 . . . . 1.5 107.357 173.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.4 -98.78 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.517 -1.989 . . . . 1.21 110.397 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.91 30.62 3.34 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-O 125.38 2.655 . . . . 1.3 113.273 173.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -118.58 131.0 56.2 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.727 -2.043 . . . . 2.55 112.007 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -96.06 114.8 26.54 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.802 1.641 . . . . 2.48 108.994 171.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.415 HD13 HD12 ' A' ' 23' ' ' ILE . 1.6 mt -83.13 138.78 33.53 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.776 -3.078 . . . . 0.9 111.414 -166.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -92.08 138.77 31.26 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.32 -1.487 . . . . 1.94 108.691 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.39 -46.83 83.0 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.148 2.579 . . . . 1.56 115.547 -173.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.13 -5.23 58.29 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 120.51 2.964 . . . . 0.97 120.51 176.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 -88.99 169.8 11.22 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.137 -3.567 . . . . 2.49 111.283 162.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.7 p -92.81 171.2 9.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.582 2.067 . . . . 0.76 116.582 169.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 mt -59.18 -42.52 91.04 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 115.921 -1.99 . . . . 1.05 113.616 165.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.0 t -63.14 -36.46 83.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 125.497 1.748 . . . . 1.19 112.848 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -57.06 -35.28 69.15 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 117.855 2.539 . . . . 1.9 117.855 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -90.87 -0.58 57.76 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 125.767 1.627 . . . . 0.89 110.206 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 67.68 26.1 7.98 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 121.895 2.134 . . . . 1.84 112.679 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.7 mt -68.41 123.08 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 128.529 2.732 . . . . 0.82 106.253 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -124.5 -168.83 1.87 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.944 -2.973 . . . . 2.16 107.139 -171.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -53.31 134.8 39.58 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.363 3.465 . . . . 2.12 112.534 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.536 21.5 pt-20 64.65 15.96 10.04 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 129.214 3.005 . . . . 1.71 114.032 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.256 18.2 m -73.3 138.58 45.53 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.515 -3.241 . . . . 1.04 108.456 -173.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.7 m -109.62 98.2 7.61 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 127.924 3.265 . . . . 0.79 114.603 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.1 mp -74.48 148.78 40.7 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 112.334 -2.212 . . . . 1.4 109.716 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -112.27 115.46 28.82 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.615 -2.553 . . . . 1.51 109.423 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.45 HD23 HG22 ' A' ' 7' ' ' THR . 33.9 tp -101.7 113.97 27.61 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.477 1.608 . . . . 1.14 112.749 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -108.11 146.74 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 113.764 -1.562 . . . . 1.23 112.298 173.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.0 tp . . . . . 0 N--CA 1.43 -1.47 0 O-C-N 119.384 -2.072 . . . . 2.78 111.231 -176.401 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 ptt? . . . . . 0 CA--C 1.491 -1.316 0 CA-C-O 123.706 1.717 . . . . 1.1 111.274 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -100.76 133.41 45.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 126.859 3.219 . . . . 1.87 109.953 -174.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.2 pt -123.44 155.36 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 118.01 -2.931 . . . . 0.72 105.86 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -119.81 124.3 45.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.982 1.849 . . . . 1.4 110.26 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.406 HG21 HD11 ' A' ' 30' ' ' ILE . 2.5 t -100.56 95.74 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 126.846 3.212 . . . . 0.58 114.838 173.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -75.1 124.33 26.82 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.19 -2.194 . . . . 2.09 109.708 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.1 p -100.21 178.25 4.83 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 112.933 0.716 . . . . 0.99 112.933 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.5 tp -64.57 -64.29 0.91 Allowed 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 118.368 -2.708 . . . . 2.53 112.876 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.454 22.9 p -63.27 -36.83 84.98 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 119.502 3.149 . . . . 2.08 119.502 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.22 -52.82 0.12 Allowed Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 115.015 -3.469 . . . . 1.31 114.3 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -60.6 132.39 53.75 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 124.669 2.176 . . . . 1.4 116.412 -168.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.1 m -99.76 112.91 25.12 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.067 -3.521 . . . . 0.78 104.529 168.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mt -90.81 119.66 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 120.211 -0.595 . . . . 1.55 110.973 -173.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.6 m -85.69 112.17 20.78 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.048 -2.282 . . . . 1.08 108.222 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.4 mt -116.03 116.27 27.6 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 125.335 1.647 . . . . 1.55 112.724 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -84.93 124.09 31.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.502 -3.874 . . . . 1.95 115.778 167.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.03 163.15 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 125.779 2.704 . . . . 0.96 109.147 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -97.88 152.13 37.93 Favored Pre-proline 0 N--CA 1.431 -1.391 1 O-C-N 114.493 -5.13 . . . . 2.35 104.757 164.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -73.39 -3.07 13.06 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 125.273 3.982 . . . . 0.95 120.995 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.8 m -97.35 -4.82 37.79 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.539 -1.976 . . . . 1.45 109.227 172.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -71.44 146.22 48.78 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.756 -2.465 . . . . 1.69 111.16 173.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.4 p -79.59 154.67 28.57 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 118.757 2.873 . . . . 0.75 118.757 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.9 mm -57.7 -37.27 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 121.977 2.171 . . . . 0.73 113.125 175.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.436 30.6 tt0 -38.65 -52.43 1.66 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 119.497 3.147 . . . . 1.62 119.497 165.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -56.9 -45.06 82.85 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.166 1.913 . . . . 2.13 116.166 172.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.4 t -59.29 -43.4 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-O 124.771 2.224 . . . . 0.62 115.189 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -62.21 -45.97 90.96 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.947 2.499 . . . . 1.22 108.518 172.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.56 -30.5 69.82 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.618 2.822 . . . . 0.51 118.618 172.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -80.81 -29.38 36.0 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 116.235 -4.041 . . . . 1.44 106.627 172.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.406 HD11 HG21 ' A' ' 5' ' ' VAL . 95.1 mt -72.45 -34.4 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 116.503 -3.873 . . . . 1.32 112.621 174.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -52.1 -50.94 60.62 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 116.889 -3.632 . . . . 1.7 112.958 162.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -53.48 -45.31 69.54 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 128.238 2.615 . . . . 1.55 114.188 171.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -72.96 -70.12 0.38 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.053 -2.905 . . . . 2.62 111.214 -174.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -93.36 -43.61 8.69 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 128.455 2.702 . . . . 1.48 110.951 -165.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.18 50.37 2.25 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 125.862 1.696 . . . . 1.12 114.814 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.438 HD13 HD11 ' A' ' 71' ' ' LEU . 46.5 mt -118.05 137.99 25.04 Favored Pre-proline 0 N--CA 1.43 -1.463 1 N-CA-C 98.105 -4.776 . . . . 1.55 98.105 -176.051 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -65.35 154.79 71.99 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 C-N-CA 124.244 3.296 . . . . 1.02 115.783 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.55 -10.9 24.1 Favored 'Trans proline' 0 N--CA 1.434 -1.979 0 CA-C-O 114.047 -2.564 . . . . 1.25 117.107 -174.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.31 -50.54 38.28 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.729 2.518 . . . . 2.25 114.393 169.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -60.71 -33.78 73.39 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 128.197 2.599 . . . . 2.02 106.467 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -74.07 128.43 35.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 114.494 -2.669 . . . . 0.69 107.477 -170.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.555 ' HB2' HG23 ' A' ' 70' ' ' VAL . 61.5 mtp180 -111.53 115.26 28.89 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 127.093 2.745 . . . . 2.78 105.312 166.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.7 mt -97.14 129.49 44.52 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 120.543 -0.463 . . . . 1.17 112.226 173.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.59 138.83 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 128.118 2.567 . . . . 1.38 113.3 175.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -127.51 87.6 2.65 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.445 -2.035 . . . . 1.5 113.347 172.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.388 . . 84.97 -73.52 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.676 1.99 . . . . 1.21 108.444 -175.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.02 -21.48 0.28 Allowed Glycine 0 N--CA 1.431 -1.7 0 N-CA-C 109.439 -1.464 . . . . 1.3 109.439 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -80.02 128.22 33.23 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.309 1.444 . . . . 2.55 109.681 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -87.49 126.33 34.84 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 102.195 -3.261 . . . . 2.48 102.195 170.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.9 mt -89.19 127.37 35.74 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.847 1.308 . . . . 0.9 111.208 -164.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -77.17 142.25 39.73 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.153 -2.842 . . . . 1.94 115.664 174.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -56.68 -55.59 32.14 Favored 'General case' 0 N--CA 1.43 -1.456 1 C-N-CA 132.623 4.369 . . . . 1.56 115.402 -170.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.23 14.19 29.28 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 128.933 3.158 . . . . 0.97 112.773 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -109.51 164.45 12.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.326 3.563 . . . . 2.49 110.926 168.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.3 p -90.77 152.98 20.58 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 126.162 2.887 . . . . 0.76 115.109 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mt -56.4 -45.93 80.38 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.538 -3.226 . . . . 1.05 118.142 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.0 p -68.63 -13.4 62.33 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 118.095 2.628 . . . . 1.19 118.095 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -75.64 -34.28 60.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.291 -1.374 . . . . 1.9 107.291 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -85.35 1.83 46.85 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 117.581 -1.199 . . . . 0.89 111.787 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 65.83 36.77 5.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.563 2.745 . . . . 1.84 112.031 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.6 mt -87.64 121.45 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.149 -3.469 . . . . 0.82 111.532 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -122.11 -168.17 1.67 Allowed 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 105.829 -1.915 . . . . 2.16 105.829 -173.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -56.25 140.5 44.53 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 116.128 1.899 . . . . 2.12 116.128 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.307 98.5 mt-10 69.8 15.56 7.94 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 112.768 -2.015 . . . . 1.71 114.098 176.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.329 44.8 m -78.75 156.64 28.76 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 121.72 2.055 . . . . 1.04 111.107 -177.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.8 m -102.57 126.65 49.71 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 112.57 -2.105 . . . . 0.79 106.852 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -116.68 150.78 37.61 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 104.26 -2.496 . . . . 1.4 104.26 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -116.64 112.02 20.68 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 126.495 1.918 . . . . 1.51 106.403 -171.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.9 tp -98.22 122.18 41.06 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.103 -1.814 . . . . 1.14 106.103 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.555 HG23 ' HB2' ' A' ' 42' ' ' ARG . 4.5 m -126.74 150.93 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 113.368 -1.742 . . . . 1.23 107.466 173.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.438 HD11 HD13 ' A' ' 36' ' ' ILE . 42.3 mt . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 117.811 2.523 . . . . 2.78 117.811 -175.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.49 -1.336 0 N-CA-C 111.807 0.299 . . . . 1.1 111.807 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -97.48 136.67 37.57 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 124.012 0.82 . . . . 1.87 110.557 -172.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.433 HD12 HD13 ' A' ' 67' ' ' LEU . 19.2 pt -130.17 160.62 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 105.088 -2.19 . . . . 0.72 105.088 172.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -118.01 150.09 39.87 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 120.54 1.518 . . . . 1.4 109.826 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.4 t -132.47 122.87 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 105.913 -1.884 . . . . 0.58 105.913 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -97.31 147.83 23.75 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.863 1.792 . . . . 2.09 107.446 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.441 8.9 p -101.92 175.39 5.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.498 -3.876 . . . . 0.99 112.007 174.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.0 tp -58.34 -58.39 8.72 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.629 -1.919 . . . . 2.53 114.772 169.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.277 62.5 p -78.35 -14.53 59.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 119.26 3.059 . . . . 2.08 119.26 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.63 17.01 2.18 Favored Glycine 0 N--CA 1.429 -1.796 0 CA-C-O 115.003 -3.11 . . . . 1.31 117.905 173.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -94.8 122.07 37.05 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 101.699 -3.445 . . . . 1.4 101.699 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.265 10.7 m -92.59 116.19 28.78 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.462 -3.273 . . . . 0.78 111.06 169.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -102.22 135.47 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 118.335 -2.728 . . . . 1.55 117.206 172.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.2 m -103.62 137.74 41.25 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 101.367 -3.568 . . . . 1.08 101.367 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.4 mt -129.24 142.65 50.79 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 120.847 1.658 . . . . 1.55 111.704 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -101.57 117.4 34.84 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.852 2.861 . . . . 1.95 103.791 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -134.28 164.41 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 101.823 -3.399 . . . . 0.96 101.823 -172.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -109.16 159.56 30.76 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-N 110.169 -3.196 . . . . 2.35 107.402 166.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -81.24 -11.75 11.92 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 CA-C-N 124.734 2.727 . . . . 0.95 109.677 -172.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.1 m -86.83 -7.98 57.74 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 116.09 -4.132 . . . . 1.45 110.536 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -66.45 148.82 51.32 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 128.813 2.845 . . . . 1.69 107.848 170.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.1 p -93.12 -173.45 3.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.486 1.291 . . . . 0.75 114.486 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.6 mm -79.54 -37.88 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 125.431 1.492 . . . . 0.73 107.784 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -51.15 -48.24 61.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.599 1.96 . . . . 1.62 116.047 166.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -58.0 -48.99 78.38 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 122.821 1.296 . . . . 2.13 112.34 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.9 t -56.31 -52.5 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 114.785 1.402 . . . . 0.62 114.785 174.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -62.16 -22.56 65.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 128.22 3.867 . . . . 1.22 114.516 174.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.14 -35.9 61.62 Favored 'General case' 0 N--CA 1.429 -1.5 1 O-C-N 113.04 -6.037 . . . . 0.51 112.596 171.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -68.9 -30.88 69.45 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.972 -2.33 . . . . 1.44 108.945 171.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.0 mt -69.73 -31.69 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 1 O-C-N 112.779 -6.201 . . . . 1.32 112.474 176.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -64.37 -42.09 96.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.865 -1.772 . . . . 1.7 108.654 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -52.8 -49.66 65.18 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 114.611 1.337 . . . . 1.55 114.611 169.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -70.56 -73.7 0.16 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.822 -2.424 . . . . 2.62 115.797 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -90.95 -28.98 17.7 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.443 2.297 . . . . 1.48 113.898 -169.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.06 54.62 1.98 Allowed Glycine 0 N--CA 1.43 -1.732 1 O-C-N 115.244 -4.66 . . . . 1.12 114.614 173.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.4 mt -118.27 132.36 23.8 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 104.888 -2.264 . . . . 1.55 104.888 -173.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -63.17 150.84 87.47 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 O-C-N 114.09 -3.689 . . . . 1.02 117.132 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -67.75 -15.51 44.41 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 C-N-CA 124.376 3.384 . . . . 1.25 112.935 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.63 -30.97 61.83 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.831 2.53 . . . . 2.25 117.831 173.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -92.27 -26.65 18.05 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 123.419 1.58 . . . . 2.02 111.607 -172.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -75.44 112.1 11.41 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.763 1.625 . . . . 0.69 112.846 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -103.59 119.6 39.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.693 -3.754 . . . . 2.78 105.798 168.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.9 mt -96.16 129.73 43.39 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.852 -1.976 . . . . 1.17 107.051 173.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mm -104.68 135.68 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 128.679 2.792 . . . . 1.38 108.663 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -154.97 127.25 7.79 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 114.384 1.253 . . . . 1.5 114.384 170.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.43 27.8 3.87 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 115.935 1.828 . . . . 1.21 115.935 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.37 -12.32 61.68 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 115.992 1.157 . . . . 1.3 115.992 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -135.45 143.81 46.1 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.465 1.602 . . . . 2.55 114.578 -167.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -71.61 149.13 45.9 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 118.771 -2.456 . . . . 2.48 114.44 171.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.478 HD22 ' CD1' ' A' ' 59' ' ' TYR 0.308 55.1 mt -113.67 147.99 37.14 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 122.18 0.991 . . . . 0.9 113.106 -165.497 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -75.89 152.6 37.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 113.807 1.039 . . . . 1.94 113.807 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.351 0.9 OUTLIER -73.95 -51.07 17.23 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 116.099 1.888 . . . . 1.56 116.099 -169.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.34 32.77 3.03 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 119.678 2.631 . . . . 0.97 119.678 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -95.22 155.51 16.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.974 -3.074 . . . . 2.49 110.756 162.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.275 14.3 p -87.2 165.76 15.46 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 126.426 3.013 . . . . 0.76 111.163 175.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 37.6 mt -78.93 -20.51 49.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.823 -3.048 . . . . 1.05 109.698 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -70.96 -29.04 64.94 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 127.511 2.324 . . . . 1.19 112.375 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -68.28 -35.64 78.16 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.279 1.832 . . . . 1.9 114.628 170.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.478 ' CD1' HD22 ' A' ' 50' ' ' LEU . 60.2 m-85 -95.43 7.79 45.17 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.156 1.383 . . . . 0.89 109.709 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.2 m120 45.47 39.9 5.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.266 3.027 . . . . 1.84 114.687 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mt -78.02 105.44 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 105.667 -1.975 . . . . 0.82 105.667 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -78.08 -169.42 1.58 Allowed 'General case' 0 N--CA 1.43 -1.466 1 C-N-CA 131.964 4.106 . . . . 2.16 113.186 175.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -76.34 157.15 32.71 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.996 -2.94 . . . . 2.12 113.821 172.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.289 52.9 mt-10 68.35 22.8 7.85 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 111.852 -2.431 . . . . 1.71 111.949 171.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.0 m -86.14 125.8 33.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.059 2.944 . . . . 1.04 111.417 -174.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.6 m -92.14 120.27 32.57 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.96 -3.587 . . . . 0.79 106.218 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.433 HD13 HD12 ' A' ' 3' ' ' ILE . 9.3 mp -103.67 137.51 41.62 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 104.609 -2.367 . . . . 1.4 104.609 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -107.79 137.85 45.07 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 123.641 2.928 . . . . 1.51 115.008 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.4 tt -98.35 108.59 21.32 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.412 2.053 . . . . 1.14 111.422 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -110.9 130.2 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 C-N-CA 129.483 3.113 . . . . 1.23 111.612 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.6 mt . . . . . 0 N--CA 1.43 -1.473 0 O-C-N 116.333 -3.979 . . . . 2.78 115.46 -179.154 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptt? . . . . . 0 CA--C 1.489 -1.367 1 CA-C-O 109.231 -5.176 . . . . 1.1 110.82 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -117.56 145.05 44.53 Favored 'General case' 0 N--CA 1.43 -1.45 2 O-C-N 130.148 4.655 . . . . 1.87 122.534 174.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.336 15.5 pt -128.21 153.82 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 125.741 1.901 . . . . 0.72 109.176 175.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -112.15 121.07 43.93 Favored 'General case' 0 N--CA 1.429 -1.484 1 N-CA-C 99.583 -4.228 . . . . 1.4 99.583 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.2 t -113.51 112.12 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-O 124.973 2.32 . . . . 0.58 105.389 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -88.52 145.51 25.69 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.549 -3.219 . . . . 2.09 115.474 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.318 22.1 p -93.58 162.62 13.88 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.094 2.158 . . . . 0.99 108.762 177.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.37 -29.07 70.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.185 2.194 . . . . 2.53 111.552 176.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.315 28.4 p -83.25 -45.4 13.88 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 126.51 3.052 . . . . 2.08 113.145 -176.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.64 23.79 0.06 OUTLIER Glycine 0 N--CA 1.429 -1.773 1 O-C-N 114.769 -4.957 . . . . 1.31 116.653 172.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -103.67 135.86 44.45 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 103.603 -2.74 . . . . 1.4 103.603 -172.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.0 m -97.41 112.6 24.37 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 115.537 -2.173 . . . . 0.78 109.774 169.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -95.24 120.26 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 123.525 2.875 . . . . 1.55 105.188 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.4 m -92.37 124.7 36.62 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 105.271 -2.122 . . . . 1.08 105.271 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.1 mt -119.67 130.14 54.9 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.471 1.508 . . . . 1.55 111.573 -174.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -85.05 126.5 33.62 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 104.907 -2.257 . . . . 1.95 104.907 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.8 m -143.48 167.34 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 126.8 2.04 . . . . 0.96 112.479 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -120.9 160.67 43.84 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-O 115.231 -2.319 . . . . 2.35 112.329 163.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -60.12 -25.12 79.04 Favored 'Trans proline' 0 N--CA 1.433 -2.056 2 CA-C-N 128.948 4.231 . . . . 0.95 113.597 -176.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m -74.7 -20.9 59.67 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.277 2.231 . . . . 1.45 113.32 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -62.44 141.79 58.19 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.942 -2.973 . . . . 1.69 110.998 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 72.3 p -82.6 167.09 18.65 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.528 -1.669 . . . . 0.75 108.235 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.524 ' CG2' HD23 ' A' ' 43' ' ' LEU . 22.5 mm -66.28 -33.6 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 116.22 -1.848 . . . . 0.73 109.781 172.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -54.39 -33.31 59.03 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.658 2.096 . . . . 1.62 116.658 166.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -73.23 -35.19 66.22 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 120.881 1.673 . . . . 2.13 109.947 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.18 -51.66 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 125.016 1.326 . . . . 0.62 110.038 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -66.69 -25.87 66.76 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 117.58 -1.648 . . . . 1.22 115.141 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.91 -35.48 72.29 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.667 -2.52 . . . . 0.51 114.599 172.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -64.49 -29.87 70.9 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.447 -2.658 . . . . 1.44 113.001 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.03 -36.57 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 119.553 -1.967 . . . . 1.32 111.069 170.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -67.71 -41.32 83.77 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.947 -1.721 . . . . 1.7 109.488 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.56 -53.01 63.01 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.671 -1.893 . . . . 1.55 111.931 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -69.99 -59.63 2.8 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 123.646 1.688 . . . . 2.62 112.164 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -103.24 -28.85 11.64 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 118.815 -2.428 . . . . 1.48 110.312 -160.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.7 40.67 5.57 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 122.257 2.299 . . . . 1.12 115.579 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.7 mm -115.1 118.51 40.15 Favored Pre-proline 0 N--CA 1.43 -1.469 0 N-CA-C 104.445 -2.428 . . . . 1.55 104.445 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -74.5 144.81 32.68 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 124.196 2.534 . . . . 1.02 114.089 -175.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.96 -20.84 44.36 Favored 'Trans proline' 0 N--CA 1.433 -2.041 1 C-N-CA 125.923 4.416 . . . . 1.25 114.183 -175.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -48.48 -53.07 19.38 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.482 1.611 . . . . 2.25 111.331 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -78.18 -24.76 47.08 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 119.273 3.064 . . . . 2.02 119.273 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -66.5 141.49 57.86 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.83 -1.794 . . . . 0.69 112.928 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -135.38 124.47 24.37 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.684 -2.51 . . . . 2.78 110.245 171.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.524 HD23 ' CG2' ' A' ' 23' ' ' ILE 0.288 0.3 OUTLIER -92.51 123.94 36.18 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 120.726 1.603 . . . . 1.17 112.163 175.277 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.1 mm -107.33 128.87 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-O 122.273 1.035 . . . . 1.38 108.704 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.416 ' HB3' HD21 ' A' ' 50' ' ' LEU . 76.4 t80 -140.4 128.5 22.23 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.626 -1.296 . . . . 1.5 112.074 169.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.29 17.21 2.72 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 111.509 -2.587 . . . . 1.21 112.567 -174.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.31 -7.92 56.76 Favored Glycine 0 N--CA 1.43 -1.743 1 CA-C-O 111.724 -4.931 . . . . 1.3 115.41 -170.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -102.16 131.4 48.69 Favored 'General case' 0 N--CA 1.43 -1.443 1 CA-C-N 125.342 4.571 . . . . 2.55 112.057 177.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -79.09 125.31 29.25 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 125.714 2.673 . . . . 2.48 105.926 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 45' ' ' PHE 0.288 12.5 mt -84.77 129.9 34.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.004 -1.907 . . . . 0.9 109.091 -171.392 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -88.72 143.85 26.65 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 116.642 2.09 . . . . 1.94 116.642 -176.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.67 -36.92 85.82 Favored 'General case' 0 N--CA 1.431 -1.419 1 N-CA-C 122.967 4.432 . . . . 1.56 122.967 -169.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.92 10.25 63.41 Favored Glycine 0 N--CA 1.43 -1.726 1 O-C-N 115.626 -4.421 . . . . 0.97 117.952 169.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.25 24.1 mtt180 -107.47 152.07 24.71 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.126 1.917 . . . . 2.49 110.347 172.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 7.0 p -92.75 167.2 12.03 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 126.5 3.048 . . . . 0.76 118.895 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.1 mt -63.02 -22.96 67.22 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 116.114 -4.116 . . . . 1.05 118.382 170.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.3 t -79.75 -31.99 41.0 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.146 1.927 . . . . 1.19 114.128 171.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -60.13 -35.77 76.01 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.205 -2.184 . . . . 1.9 112.7 172.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -94.78 18.81 11.02 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 123.666 2.939 . . . . 0.89 111.194 170.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.56 3.1 p-10 43.61 48.04 6.4 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 129.547 3.139 . . . . 1.84 118.336 -177.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.7 mt -90.17 115.93 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 118.627 -2.546 . . . . 0.82 115.898 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -100.37 -176.5 3.23 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 131.583 3.953 . . . . 2.16 107.808 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -58.7 158.93 7.25 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.388 -2.695 . . . . 2.12 114.812 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 71.92 27.65 2.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.397 1.879 . . . . 1.71 110.671 168.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.2 m -96.1 135.86 37.33 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 125.683 2.659 . . . . 1.04 114.07 -173.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.3 m -94.67 108.93 20.91 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 113.541 -5.724 . . . . 0.79 105.248 -173.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 mp -97.73 159.0 15.2 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 127.278 3.418 . . . . 1.4 106.512 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -133.69 121.46 21.99 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.564 -2.585 . . . . 1.51 104.631 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.3 tp -89.52 132.14 35.21 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.299 -1.741 . . . . 1.14 106.299 -176.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -116.37 135.39 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 1 N-CA-C 99.32 -4.326 . . . . 1.23 99.32 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.6 mt . . . . . 0 N--CA 1.43 -1.466 0 O-C-N 119.811 -1.805 . . . . 2.78 109.182 -178.262 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 ttp . . . . . 0 CA--C 1.489 -1.376 0 CA-C-O 115.842 -2.028 . . . . 1.1 109.883 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -91.96 123.4 35.3 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 124.699 1.249 . . . . 1.87 110.939 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -124.9 159.51 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.455 -1.403 . . . . 0.72 110.855 172.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -108.12 128.21 54.48 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.729 0.811 . . . . 1.4 110.663 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.3 t -105.93 108.41 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 C-N-CA 128.722 2.809 . . . . 0.58 106.926 171.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -104.48 132.04 51.18 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 127.669 3.604 . . . . 2.09 110.332 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.8 p -100.28 164.36 11.98 Favored 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 115.603 -4.436 . . . . 0.99 107.818 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.1 mt -84.51 -3.8 58.6 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 109.339 -0.615 . . . . 2.53 109.339 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.3 p -90.11 -29.88 18.03 Favored 'General case' 0 N--CA 1.429 -1.505 1 O-C-N 116.191 -4.068 . . . . 2.08 111.333 -175.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.2 54.07 0.17 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 124.725 2.292 . . . . 1.31 115.317 175.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -153.68 138.43 17.03 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 115.028 -2.415 . . . . 1.4 107.461 -173.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.3 m -136.58 131.05 33.26 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 127.806 3.191 . . . . 0.78 103.616 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 pt -127.01 153.76 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 123.789 1.757 . . . . 1.55 108.506 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.6 m -109.62 109.19 19.87 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 112.871 -1.968 . . . . 1.08 111.743 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.251 41.3 mt -89.09 153.31 21.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.87 2.748 . . . . 1.55 106.278 175.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -126.59 113.46 16.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.888 -2.382 . . . . 1.95 107.342 174.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 m -130.09 -164.31 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 127.576 2.35 . . . . 0.96 108.14 -173.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -129.12 171.0 9.48 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 126.159 2.162 . . . . 2.35 107.588 163.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -70.61 -17.48 33.7 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 CA-C-O 123.254 1.272 . . . . 0.95 110.882 -173.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.15 2.57 53.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.145 1.165 . . . . 1.45 114.145 176.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.37 141.11 43.35 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.667 -2.52 . . . . 1.69 109.94 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 21.9 p -75.14 163.99 26.96 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.773 2.829 . . . . 0.75 109.605 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.1 mm -67.39 -33.73 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 124.092 1.901 . . . . 0.73 110.245 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -51.73 -45.94 63.82 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.981 -2.324 . . . . 1.62 116.822 163.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -67.07 -29.05 68.71 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 118.312 2.708 . . . . 2.13 118.312 173.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.0 t -74.31 -44.9 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 127.419 2.287 . . . . 0.62 108.892 176.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -62.86 -38.88 92.6 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 126.989 2.116 . . . . 1.22 112.864 174.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.83 -32.75 72.67 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.557 1.543 . . . . 0.51 113.313 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -61.37 -55.14 34.92 Favored 'General case' 0 N--CA 1.428 -1.532 0 O-C-N 118.201 -2.812 . . . . 1.44 111.989 165.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -53.7 -39.98 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 117.802 -3.061 . . . . 1.32 114.642 173.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -58.94 -38.99 80.29 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.868 1.318 . . . . 1.7 114.237 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -69.89 -55.03 10.79 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.151 -0.968 . . . . 1.55 110.67 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -65.89 -75.67 0.09 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.709 -3.12 . . . . 2.62 106.718 -175.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -78.5 -25.7 45.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.306 2.242 . . . . 1.48 113.356 -163.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.99 12.11 55.69 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 116.332 -2.371 . . . . 1.12 110.303 168.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.404 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 5.7 mt -88.84 126.33 59.8 Favored Pre-proline 0 N--CA 1.43 -1.454 0 CA-C-N 122.738 3.269 . . . . 1.55 108.453 -175.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 36' ' ' ILE . 19.5 Cg_endo -68.21 160.31 49.44 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 124.082 3.188 . . . . 1.02 109.894 -177.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.61 -7.64 13.61 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 115.105 -2.796 . . . . 1.25 116.277 -171.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -82.77 -22.25 34.37 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.767 -1.833 . . . . 2.25 108.267 175.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -80.6 -21.36 41.67 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.726 -2.484 . . . . 2.02 113.432 -175.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -113.65 137.44 51.6 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 118.131 0.423 . . . . 0.69 109.958 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -120.04 133.44 55.53 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.251 -1.531 . . . . 2.78 108.446 171.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.1 mt -105.31 121.35 43.69 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.393 2.997 . . . . 1.17 108.175 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.4 mm -111.3 131.0 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 116.555 -3.841 . . . . 1.38 107.194 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -124.26 118.57 27.09 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 105.114 -2.18 . . . . 1.5 105.114 170.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.304 . . 64.76 -89.23 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 130.154 3.382 . . . . 1.21 111.218 -171.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.76 -21.15 3.98 Favored Glycine 0 N--CA 1.429 -1.794 0 C-N-CA 127.025 2.25 . . . . 1.3 117.903 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.253 29.5 mttm -104.93 132.53 51.06 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 127.313 2.245 . . . . 2.55 114.777 -172.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -75.94 145.1 40.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.878 -1.056 . . . . 2.48 111.92 170.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 mt -98.06 143.5 28.55 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 125.478 1.736 . . . . 0.9 112.989 -172.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -95.95 135.84 37.17 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.883 -2.386 . . . . 1.94 116.068 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -47.24 -66.4 0.41 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 120.163 3.394 . . . . 1.56 120.163 -173.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.15 52.67 2.59 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 118.724 2.25 . . . . 0.97 118.724 169.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 22' ' ' THR . 40.0 mmt180 -134.95 157.86 45.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 116.408 -1.758 . . . . 2.49 107.964 172.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.287 6.5 p -88.65 172.92 8.92 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.486 1.612 . . . . 0.76 114.9 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.5 mt -72.46 -38.38 68.26 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 116.222 -4.049 . . . . 1.05 111.919 168.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.1 t -57.49 -38.96 75.42 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 129.486 3.114 . . . . 1.19 112.951 173.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -59.64 -32.85 70.83 Favored 'General case' 0 N--CA 1.43 -1.471 1 O-C-N 115.439 -4.538 . . . . 1.9 112.348 174.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -96.19 9.1 42.06 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 126.134 2.873 . . . . 0.89 112.412 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.6 m120 49.21 47.14 22.45 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 129.729 3.212 . . . . 1.84 109.327 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.1 mt -91.6 114.65 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 124.083 1.897 . . . . 0.82 109.722 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -97.05 -172.31 2.42 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.696 -1.594 . . . . 2.16 106.696 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -65.97 143.8 57.16 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.571 2.129 . . . . 2.12 113.77 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.279 70.5 mt-10 71.09 18.62 5.8 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 116.905 -3.622 . . . . 1.71 114.774 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.3 m -79.33 139.76 37.7 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.161 2.185 . . . . 1.04 115.513 -175.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.6 m -90.74 101.39 14.14 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 124.329 2.014 . . . . 0.79 115.416 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.6 143.96 34.27 Favored 'General case' 0 N--CA 1.429 -1.505 1 O-C-N 114.468 -5.145 . . . . 1.4 108.153 165.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -108.2 115.69 30.59 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.088 -3.508 . . . . 1.51 111.457 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tt -91.6 119.87 31.88 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 126.303 2.252 . . . . 1.14 111.429 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.88 147.39 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 126.403 3.001 . . . . 1.23 103.122 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.7 mt . . . . . 0 N--CA 1.429 -1.488 1 O-C-N 115.811 -4.306 . . . . 2.78 112.782 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 121.675 0.75 . . . . 1.1 112.74 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -107.79 135.69 48.78 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.331 -3.355 . . . . 1.87 111.42 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.1 pt -130.69 171.59 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 O-C-N 120.5 -1.375 . . . . 0.72 110.051 173.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -120.4 148.39 43.84 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 124.765 1.226 . . . . 1.4 113.749 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 67' ' ' LEU . 68.6 t -133.91 124.36 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 N-CA-C 104.775 -2.306 . . . . 0.58 104.775 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 tptt -92.27 135.83 33.69 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 109.659 -3.428 . . . . 2.09 114.954 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.289 38.0 p -83.24 -171.52 3.62 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.315 3.436 . . . . 0.99 110.58 -174.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.22 -49.65 73.35 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 125.325 2.488 . . . . 2.53 113.333 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.7 p -88.25 -43.4 11.61 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.591 -1.64 . . . . 2.08 113.522 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.04 -3.94 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.762 0 O-C-N 116.981 -3.574 . . . . 1.31 121.158 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -71.59 133.8 45.98 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 120.535 2.167 . . . . 1.4 114.016 -173.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.4 m -90.88 110.61 21.84 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 117.969 -1.493 . . . . 0.78 109.151 176.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 mt -93.41 135.54 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 125.234 1.414 . . . . 1.55 107.324 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.3 m -102.51 127.51 49.54 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.259 1.424 . . . . 1.08 111.295 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.5 mt -124.57 156.39 37.46 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 107.293 -1.373 . . . . 1.55 107.293 -177.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -104.57 123.11 46.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.149 2.18 . . . . 1.95 114.296 167.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.1 m -141.15 161.46 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 124.614 3.37 . . . . 0.96 103.227 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -111.86 157.28 39.99 Favored Pre-proline 0 N--CA 1.43 -1.466 0 N-CA-C 103.725 -2.694 . . . . 2.35 103.725 166.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.13 -9.83 19.29 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 C-N-CA 124.009 3.139 . . . . 0.95 111.686 -171.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.0 p -83.68 -9.93 58.52 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 114.807 -2.52 . . . . 1.45 112.426 171.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -67.44 145.62 54.82 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 124.353 3.251 . . . . 1.69 111.403 174.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.1 p -88.12 158.82 18.45 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 113.231 -5.918 . . . . 0.75 110.844 178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.4 mm -59.83 -32.33 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 119.786 3.254 . . . . 0.73 119.786 174.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -50.74 -47.56 59.36 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.264 1.95 . . . . 1.62 116.264 159.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -60.65 -38.22 84.13 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 125.51 1.524 . . . . 2.13 112.148 174.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.63 -43.61 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 124.798 1.239 . . . . 0.62 108.984 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -62.04 -33.03 73.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 118.434 2.753 . . . . 1.22 118.434 169.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.82 -33.65 76.35 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.349 1.46 . . . . 0.51 114.615 173.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -74.17 -18.13 60.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.287 3.035 . . . . 1.44 111.593 171.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.0 mt -82.46 -32.05 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 116.932 -3.605 . . . . 1.32 105.854 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -67.73 -33.97 75.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.458 -3.276 . . . . 1.7 113.245 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -56.77 -45.16 82.28 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.199 -1.563 . . . . 1.55 112.86 166.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -74.92 -67.82 0.61 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.945 -1.097 . . . . 2.62 112.721 -176.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -84.75 -45.76 12.07 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.679 2.791 . . . . 1.48 111.619 -167.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.97 -7.2 17.14 Favored Glycine 0 N--CA 1.429 -1.824 0 CA-C-O 123.228 1.46 . . . . 1.12 111.988 175.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.1 mt -71.99 122.81 88.31 Favored Pre-proline 0 N--CA 1.431 -1.418 0 C-N-CA 126.947 2.099 . . . . 1.55 110.597 -172.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.9 145.38 68.1 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 125.092 3.861 . . . . 1.02 112.06 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -63.32 -27.72 71.76 Favored 'Trans proline' 0 C--N 1.3 -2.006 1 C-N-CA 125.567 4.178 . . . . 1.25 111.425 -174.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -53.07 -50.81 63.62 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 122.612 2.46 . . . . 2.25 111.64 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -68.86 -26.92 65.38 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.541 2.336 . . . . 2.02 114.108 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -71.83 153.45 41.92 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.046 -2.909 . . . . 0.69 116.343 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -141.46 120.8 13.11 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.083 2.153 . . . . 2.78 106.421 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.1 mt -105.61 137.36 43.58 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 121.139 1.79 . . . . 1.17 111.542 174.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 mp -123.37 136.58 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 127.904 3.252 . . . . 1.38 110.784 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -156.31 131.28 9.13 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 115.743 -4.348 . . . . 1.5 112.747 174.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.447 . . 67.99 35.56 3.7 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.765 2.826 . . . . 1.21 116.563 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.04 -28.68 4.04 Favored Glycine 0 N--CA 1.431 -1.684 0 CA-C-O 124.745 2.303 . . . . 1.3 112.205 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -90.04 165.34 14.08 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.707 -3.819 . . . . 2.55 111.944 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -108.79 137.63 46.41 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 103.523 -2.769 . . . . 2.48 103.523 172.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.3 mt -78.9 153.27 30.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.15 -2.844 . . . . 0.9 112.605 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.318 10.0 tp10 -98.77 141.91 30.97 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.337 -1.477 . . . . 1.94 109.968 171.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.59 -57.35 10.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.256 2.455 . . . . 1.56 117.485 -166.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.81 39.68 2.85 Favored Glycine 0 N--CA 1.43 -1.762 1 O-C-N 114.254 -5.279 . . . . 0.97 118.949 165.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -113.63 160.83 18.16 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.001 1.72 . . . . 2.49 107.751 166.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.4 p -106.36 161.62 14.4 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.479 1.609 . . . . 0.76 113.694 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.45 -37.67 86.79 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.16 2.184 . . . . 1.05 113.881 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 t -63.82 -39.25 93.78 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 113.341 -3.219 . . . . 1.19 113.654 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.257 9.7 t70 -49.18 -71.03 0.07 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 127.89 3.244 . . . . 1.9 109.985 173.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -50.84 -27.33 7.14 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 130.051 3.34 . . . . 0.89 119.541 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m120 79.3 47.06 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 129.855 3.262 . . . . 1.84 114.487 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.2 mt -99.86 126.65 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 124.724 2.202 . . . . 0.82 108.372 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -102.09 -173.56 2.37 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 116.254 -4.028 . . . . 2.16 111.746 -173.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -68.43 149.62 49.1 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.964 2.316 . . . . 2.12 116.942 169.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 59.98 26.68 15.99 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.459 3.103 . . . . 1.71 113.262 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -88.74 131.87 34.85 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 128.814 2.845 . . . . 1.04 106.43 -174.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.7 m -99.8 111.86 24.15 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 105.446 -2.057 . . . . 0.79 105.446 -174.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.415 ' HB2' HG22 ' A' ' 5' ' ' VAL . 7.6 mp -83.09 159.93 22.01 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 106.307 -1.738 . . . . 1.4 106.307 168.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -110.86 132.4 54.23 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 117.498 -1.239 . . . . 1.51 110.049 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -98.6 132.52 43.94 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 103.225 -2.879 . . . . 1.14 103.225 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.2 t -126.12 156.81 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 129.952 3.301 . . . . 1.23 103.839 174.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.2 mt . . . . . 0 N--CA 1.43 -1.446 0 CA-C-O 125.525 2.583 . . . . 2.78 107.258 179.15 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ttt . . . . . 0 CA--C 1.491 -1.32 0 CA-C-O 121.045 0.45 . . . . 1.1 111.65 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -87.15 134.75 33.49 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.701 -2.499 . . . . 1.87 109.493 -172.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.404 HG12 HG22 ' A' ' 17' ' ' VAL . 6.0 pt -131.8 169.62 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 121.545 1.975 . . . . 0.72 108.017 174.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -121.56 157.58 30.42 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.88 -1.763 . . . . 1.4 107.558 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.7 t -123.17 132.74 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 125.657 1.848 . . . . 0.58 109.328 163.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.48 ' HB2' ' CG2' ' A' ' 66' ' ' THR . 26.3 tptt -98.98 134.79 41.31 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.359 -2.713 . . . . 2.09 107.856 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.6 p -85.95 -166.29 1.49 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.793 1.758 . . . . 0.99 114.962 176.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.9 mt -74.22 -47.5 34.91 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.704 -1.135 . . . . 2.53 112.171 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 p -77.61 -29.88 52.08 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 114.87 1.433 . . . . 2.08 114.87 -174.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.31 11.39 0.66 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 125.371 1.462 . . . . 1.31 115.3 172.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -81.42 140.82 34.44 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.806 -1.997 . . . . 1.4 107.626 -172.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.9 m -97.96 107.94 20.53 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.98 -1.464 . . . . 0.78 109.805 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -82.7 122.36 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 119.969 1.259 . . . . 1.55 108.563 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.2 m -95.0 114.22 26.0 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.925 -1.109 . . . . 1.08 113.786 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mp -116.33 160.45 20.49 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.358 1.614 . . . . 1.55 115.358 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.261 7.0 pt-20 -128.74 124.9 36.74 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 117.013 -1.875 . . . . 1.95 112.418 177.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.404 HG22 HG12 ' A' ' 3' ' ' ILE . 12.5 m -129.2 -167.42 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 113.765 -1.562 . . . . 0.96 110.454 -176.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -136.76 173.89 5.05 Favored Pre-proline 0 N--CA 1.431 -1.399 0 O-C-N 117.386 -3.321 . . . . 2.35 103.446 162.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -80.57 -8.36 13.64 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 CA-C-N 123.393 2.248 . . . . 0.95 117.751 -170.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.274 21.0 m -87.9 -19.85 26.77 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 126.812 2.57 . . . . 1.45 114.567 174.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -62.02 152.48 32.35 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.972 -2.955 . . . . 1.69 113.314 174.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 31.9 p -90.11 168.99 11.54 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.662 -2.523 . . . . 0.75 117.507 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.5 mm -64.92 -36.3 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 120.307 -1.496 . . . . 0.73 109.979 171.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -57.41 -30.5 65.01 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.498 2.719 . . . . 1.62 113.495 168.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -73.66 -32.71 64.14 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 114.338 -5.226 . . . . 2.13 111.235 176.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.6 t -63.11 -49.68 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.026 2.13 . . . . 0.62 111.688 174.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.495 ' HD3' ' HB3' ' A' ' 38' ' ' PRO . 55.9 mttt -58.56 -39.58 80.67 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 127.855 3.222 . . . . 1.22 114.083 176.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.71 -33.47 75.71 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 118.52 2.785 . . . . 0.51 118.52 173.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -75.0 -35.57 62.01 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 125.077 1.485 . . . . 1.44 111.464 170.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.68 -39.54 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 1 O-C-N 115.69 -4.381 . . . . 1.32 112.449 166.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -63.84 -41.47 97.81 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.614 -3.804 . . . . 1.7 113.833 172.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -55.37 -69.25 0.14 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 115.821 1.785 . . . . 1.55 115.821 170.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -68.44 -59.81 2.89 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.611 -3.806 . . . . 2.62 113.875 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -83.53 -43.24 15.95 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.208 -2.807 . . . . 1.48 111.196 -163.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.7 30.28 3.56 Favored Glycine 0 N--CA 1.43 -1.76 0 CA-C-O 124.386 2.103 . . . . 1.12 111.894 169.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 88.1 mt -105.95 134.77 19.59 Favored Pre-proline 0 N--CA 1.431 -1.41 0 O-C-N 117.661 -3.259 . . . . 1.55 104.876 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -72.98 158.66 49.38 Favored 'Trans proline' 0 C--N 1.3 -2.003 1 CA-C-N 129.411 4.397 . . . . 1.02 113.699 174.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.495 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 70.4 Cg_exo -73.44 -19.7 21.65 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 CA-C-O 114.455 -2.394 . . . . 1.25 117.939 -175.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -72.19 -12.08 61.02 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 127.334 2.896 . . . . 2.25 111.39 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -100.27 -15.83 17.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 116.239 -1.839 . . . . 2.02 112.226 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -88.37 139.49 30.43 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 130.031 3.333 . . . . 0.69 111.296 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -123.23 120.73 34.02 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 128.854 2.862 . . . . 2.78 107.583 165.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.5 mt -103.01 130.67 50.19 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 124.877 2.275 . . . . 1.17 108.92 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.7 mm -117.12 139.77 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 125.068 2.366 . . . . 1.38 107.287 -172.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -146.62 148.81 32.47 Favored 'General case' 0 N--CA 1.429 -1.497 1 O-C-N 113.693 -5.629 . . . . 1.5 108.157 168.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.66 30.3 8.54 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.217 1.932 . . . . 1.21 116.217 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.67 -29.8 5.64 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 124.887 1.232 . . . . 1.3 115.039 -173.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -82.1 142.96 31.82 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 128.706 2.802 . . . . 2.55 114.787 -174.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -90.56 132.46 35.7 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.006 1.73 . . . . 2.48 108.382 168.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mt -86.74 146.89 26.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.892 1.677 . . . . 0.9 111.845 -172.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -92.42 154.7 18.35 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 123.324 1.535 . . . . 1.94 111.043 171.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.64 -66.37 0.6 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 112.987 -1.915 . . . . 1.56 113.619 -163.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.31 64.48 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.723 0 O-C-N 118.763 -2.46 . . . . 0.97 113.916 162.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -140.94 151.04 43.89 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.228 -1.767 . . . . 2.49 106.228 168.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.25 18.5 p -85.14 169.83 13.49 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 121.747 2.067 . . . . 0.76 111.146 -178.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mt -69.83 -43.98 70.86 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 123.959 1.837 . . . . 1.05 113.859 173.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.1 t -57.89 -38.63 76.14 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.615 2.366 . . . . 1.19 114.271 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -57.36 -43.85 83.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.907 -1.746 . . . . 1.9 114.115 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -85.58 3.41 40.78 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.991 2.329 . . . . 0.89 114.033 172.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.4 m120 59.75 37.85 21.9 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.801 -3.062 . . . . 1.84 113.798 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.0 mt -74.15 116.4 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 125.527 1.531 . . . . 0.82 108.496 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -89.3 -174.62 4.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 117.364 2.357 . . . . 2.16 117.364 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -60.17 133.07 55.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.285 -2.134 . . . . 2.12 115.677 169.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.41 50.1 mt-10 64.33 41.96 5.56 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.684 -1.26 . . . . 1.71 112.678 174.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.257 62.6 m -106.55 163.81 12.58 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 103.25 -2.87 . . . . 1.04 103.25 -175.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.48 ' CG2' ' HB2' ' A' ' 6' ' ' LYS . 89.5 m -128.79 124.31 35.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.608 3.099 . . . . 0.79 109.39 -176.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.3 mt -91.49 162.46 14.54 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 110.385 -3.098 . . . . 1.4 108.926 172.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -127.57 119.88 26.97 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 117.351 -1.74 . . . . 1.51 109.596 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.1 tp -75.78 125.44 29.07 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.957 1.836 . . . . 1.14 115.957 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 t -123.59 148.36 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 103.277 -2.86 . . . . 1.23 103.277 171.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.7 mt . . . . . 0 N--CA 1.431 -1.422 0 CA-C-O 124.397 2.046 . . . . 2.78 110.603 -178.822 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 CA--C 1.491 -1.313 0 CA-C-O 124.834 2.254 . . . . 1.1 114.101 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -74.11 132.37 42.21 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 128.85 2.86 . . . . 1.87 107.971 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.0 pt -136.86 152.32 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 125.983 1.713 . . . . 0.72 109.452 171.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -117.26 148.23 41.85 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.269 -2.144 . . . . 1.4 115.809 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -125.11 107.46 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 104.673 -2.343 . . . . 0.58 104.673 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 tttp -91.3 132.52 36.1 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.59 -1.944 . . . . 2.09 110.681 176.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.3 p -87.49 176.21 7.59 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.609 2.448 . . . . 0.99 117.609 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.418 HD21 HG22 ' A' ' 70' ' ' VAL . 87.2 mt -60.99 -29.63 69.8 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.143 -3.473 . . . . 2.53 119.946 166.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 p -83.79 -87.4 0.11 Allowed 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 113.702 -1.59 . . . . 2.08 107.279 -175.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.74 48.74 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.732 0 O-C-N 118.911 -2.368 . . . . 1.31 107.956 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -128.24 135.32 49.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.512 2.325 . . . . 1.4 107.478 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.6 m -118.32 119.68 35.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.937 2.304 . . . . 0.78 105.857 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.1 mt -91.99 113.97 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 O-C-N 117.513 -3.242 . . . . 1.55 103.354 -172.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.3 m -86.5 113.33 22.34 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.022 -3.549 . . . . 1.08 109.157 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.6 mt -111.56 171.19 7.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 114.946 1.461 . . . . 1.55 114.946 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -125.48 121.87 34.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.101 -3.5 . . . . 1.95 115.609 168.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -130.23 175.67 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 118.987 -2.32 . . . . 0.96 106.942 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HG3' ' H ' ' A' ' 20' ' ' SER . 11.6 pt-20 -104.21 157.36 34.2 Favored Pre-proline 0 N--CA 1.431 -1.419 0 O-C-N 118.72 -2.487 . . . . 2.35 116.061 160.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -64.33 -9.1 18.7 Favored 'Trans proline' 0 N--CA 1.434 -2.012 2 CA-C-N 129.141 4.3 . . . . 0.95 114.443 -175.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.427 ' H ' ' HG3' ' A' ' 18' ' ' GLU 0.257 15.0 m -94.42 11.51 30.39 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 123.578 2.899 . . . . 1.45 117.481 171.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.98 138.54 36.07 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.97 -2.331 . . . . 1.69 115.221 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 p -76.07 159.4 30.81 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 114.325 1.231 . . . . 0.75 114.325 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.2 mm -68.13 -36.75 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 127.456 2.302 . . . . 0.73 107.762 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -59.36 -33.45 71.18 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.668 1.729 . . . . 1.62 115.668 165.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -69.6 -39.09 77.48 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.076 -3.515 . . . . 2.13 118.94 171.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.38 -39.8 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 126.346 2.974 . . . . 0.62 113.329 167.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -63.3 -37.59 87.86 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 116.251 -4.031 . . . . 1.22 112.459 -176.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.49 -19.04 63.74 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 128.284 2.634 . . . . 0.51 112.63 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -84.79 -30.91 24.22 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 117.66 -3.15 . . . . 1.44 110.365 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.4 mt -73.65 -35.84 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 123.831 1.777 . . . . 1.32 109.479 172.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -56.4 -50.76 70.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.547 -3.846 . . . . 1.7 111.397 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -53.89 -42.63 68.87 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 128.98 2.912 . . . . 1.55 112.144 174.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -83.2 -60.04 2.27 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.921 -2.987 . . . . 2.62 111.854 -174.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -97.66 -16.81 19.81 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 122.349 2.34 . . . . 1.48 112.243 -169.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.78 30.19 24.42 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 108.087 -2.005 . . . . 1.12 108.087 171.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.6 mt -102.23 133.7 20.46 Favored Pre-proline 0 N--CA 1.431 -1.401 0 N-CA-C 104.838 -2.282 . . . . 1.55 104.838 -174.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -76.07 161.87 35.09 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 O-C-N 115.105 -3.156 . . . . 1.02 114.21 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -70.76 -25.2 24.23 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 C-N-CA 122.867 2.378 . . . . 1.25 114.559 -170.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -74.03 -26.45 60.42 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.439 1.59 . . . . 2.25 112.247 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -84.31 -12.03 55.34 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.371 -1.456 . . . . 2.02 113.684 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -91.01 122.22 33.48 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 122.178 0.989 . . . . 0.69 110.849 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -101.06 102.64 13.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.603 1.192 . . . . 2.78 112.152 166.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.0 mt -84.73 125.43 32.54 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 115.925 1.824 . . . . 1.17 115.925 171.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.61 125.48 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 127.979 2.512 . . . . 1.38 108.461 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -132.52 126.9 33.97 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.96 -1.088 . . . . 1.5 110.572 173.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.21 -40.19 0.24 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.264 2.626 . . . . 1.21 116.56 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.44 -7.46 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.668 0 C-N-CA 128.812 3.101 . . . . 1.3 111.286 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -94.34 132.37 39.01 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 126.42 1.888 . . . . 2.55 110.82 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -87.75 148.24 24.82 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 107.347 -1.353 . . . . 2.48 107.347 172.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.35 6.9 mt -107.26 120.65 42.71 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.916 2.886 . . . . 0.9 110.41 -159.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.405 ' CD ' ' HE ' ' A' ' 54' ' ' ARG . 80.3 tt0 -88.32 136.95 32.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 129.027 3.954 . . . . 1.94 111.912 178.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -57.47 -59.94 4.4 Favored 'General case' 0 N--CA 1.431 -1.422 2 C-N-CA 134.983 5.313 . . . . 1.56 116.131 -168.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.11 29.11 2.81 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 119.687 -1.883 . . . . 0.97 115.998 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.405 ' HE ' ' CD ' ' A' ' 51' ' ' GLU . 28.8 mmt180 -105.47 156.12 18.51 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.283 -2.304 . . . . 2.49 108.489 165.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.3 p -93.05 170.35 9.72 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 119.918 -1.738 . . . . 0.76 109.267 172.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.0 mt -56.94 -41.49 78.34 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.711 2.805 . . . . 1.05 115.337 167.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.9 t -64.6 -32.15 73.68 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 128.504 2.722 . . . . 1.19 115.289 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -81.88 -21.02 37.69 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.378 2.671 . . . . 1.9 112.27 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -98.01 -11.96 22.44 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.595 -1.261 . . . . 0.89 107.595 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 67.63 42.92 1.95 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 128.122 3.82 . . . . 1.84 111.242 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.9 mt -89.75 114.05 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 126.836 3.208 . . . . 0.82 113.627 172.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -101.84 -165.93 1.24 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.524 -1.985 . . . . 2.16 105.777 -172.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -73.47 166.06 23.92 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 118.742 2.867 . . . . 2.12 118.742 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.554 13.5 pt-20 63.53 18.07 10.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.758 -2.464 . . . . 1.71 115.976 176.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.7 p -90.82 151.14 21.29 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.735 -1.575 . . . . 1.04 109.36 -175.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.0 m -118.74 92.84 3.91 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.465 1.602 . . . . 0.79 112.249 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.0 mt -75.0 136.79 41.25 Favored 'General case' 0 N--CA 1.43 -1.475 1 C-N-CA 132.851 4.46 . . . . 1.4 109.473 174.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -107.04 132.06 53.38 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.469 -2.019 . . . . 1.51 111.562 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.4 tp -113.15 112.54 23.97 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 128.273 3.892 . . . . 1.14 106.831 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.418 HG22 HD21 ' A' ' 8' ' ' LEU . 18.3 t -107.66 146.15 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 129.256 3.022 . . . . 1.23 105.357 174.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tm? . . . . . 0 N--CA 1.43 -1.435 0 N-CA-C 106.12 -1.807 . . . . 2.78 106.12 177.483 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 CA--C 1.49 -1.329 0 N-CA-C 114.211 1.189 . . . . 1.1 114.211 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.385 2.4 mp0 -94.27 130.89 40.37 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 116.518 -1.706 . . . . 1.87 113.96 -174.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.2 pt -123.35 159.61 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 119.266 0.939 . . . . 0.72 110.828 172.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -111.75 135.73 51.96 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.527 -2.608 . . . . 1.4 112.688 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.01 125.11 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 119.509 -1.994 . . . . 0.58 106.308 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -102.9 148.55 25.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.105 2.128 . . . . 2.09 112.916 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.261 6.4 p -98.55 159.05 15.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 125.377 1.673 . . . . 0.99 114.546 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.1 mt -49.82 -38.63 35.56 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.543 -2.598 . . . . 2.53 117.619 171.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.0 p -83.63 -12.33 56.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.481 2.562 . . . . 2.08 112.313 -171.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.42 7.09 26.7 Favored Glycine 0 N--CA 1.43 -1.754 0 CA-C-N 112.426 -2.17 . . . . 1.31 116.722 174.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -80.46 144.18 32.79 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 123.205 3.502 . . . . 1.4 109.053 -179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.9 m -125.94 94.44 4.11 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 106.982 -1.488 . . . . 0.78 106.982 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.4 4.4 pt -76.53 142.41 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 128.374 2.67 . . . . 1.55 112.427 174.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -108.32 129.7 55.22 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.545 -2.391 . . . . 1.08 104.545 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.8 mt -117.0 165.11 13.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 126.425 2.328 . . . . 1.55 107.307 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.296 66.1 tt0 -116.1 121.54 42.46 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.519 -2.613 . . . . 1.95 106.352 178.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.431 HG12 ' HE3' ' A' ' 29' ' ' LYS . 21.8 m -132.34 168.83 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 116.516 -1.707 . . . . 0.96 115.396 176.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -116.54 160.04 37.84 Favored Pre-proline 0 N--CA 1.43 -1.448 0 O-C-N 127.56 3.037 . . . . 2.35 107.21 167.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -65.42 -25.78 55.82 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 123.714 2.943 . . . . 0.95 112.62 -177.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 m -81.75 3.93 23.87 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 117.361 2.356 . . . . 1.45 117.361 172.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.58 137.56 40.87 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.543 -1.973 . . . . 1.69 109.673 173.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 p -73.92 157.3 36.52 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.96 -2.962 . . . . 0.75 112.523 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.7 mm -56.45 -32.66 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 123.984 1.849 . . . . 0.73 114.493 170.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -59.28 -44.1 92.48 Favored 'General case' 0 N--CA 1.43 -1.469 1 O-C-N 115.718 -4.364 . . . . 1.62 110.399 165.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -66.66 -32.09 73.18 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 116.978 -3.576 . . . . 2.13 110.344 175.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.559 HG21 HD21 ' A' ' 56' ' ' LEU . 34.4 t -66.09 -51.25 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 121.125 1.784 . . . . 0.62 107.811 175.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -59.4 -33.26 71.0 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.118 -3.489 . . . . 1.22 112.076 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.33 -19.31 65.9 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 116.648 2.092 . . . . 0.51 116.648 171.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.431 ' HE3' HG12 ' A' ' 17' ' ' VAL . 39.8 mttm -85.2 -18.81 32.95 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 123.488 2.858 . . . . 1.44 107.155 176.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.9 mt -87.46 -24.43 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 108.129 -1.063 . . . . 1.32 108.129 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -65.66 -44.05 87.47 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.464 2.764 . . . . 1.7 118.464 166.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -60.13 -62.2 2.04 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 113.701 -1.59 . . . . 1.55 110.37 168.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -69.58 -63.99 0.97 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.62 2.082 . . . . 2.62 116.62 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -87.41 -33.38 19.11 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.613 2.149 . . . . 1.48 114.944 -170.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.68 34.18 2.11 Favored Glycine 0 N--CA 1.43 -1.743 0 O-C-N 118.767 -2.458 . . . . 1.12 113.744 169.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.2 mt -108.8 123.11 38.05 Favored Pre-proline 0 N--CA 1.431 -1.424 0 O-C-N 119.884 -1.95 . . . . 1.55 105.786 -170.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -68.63 145.42 63.74 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 114.746 -3.344 . . . . 1.02 112.711 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.254 18.0 Cg_exo -66.18 -28.1 48.42 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 124.474 3.449 . . . . 1.25 117.295 -171.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.254 8.8 p-10 -56.94 -31.99 65.53 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.307 -3.995 . . . . 2.25 116.091 168.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -78.13 -25.38 47.36 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.725 2.01 . . . . 2.02 113.182 -176.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -90.91 147.9 22.82 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.767 1.627 . . . . 0.69 112.614 -173.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.272 91.8 mtt180 -122.71 146.75 47.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.982 -1.699 . . . . 2.78 108.131 162.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.0 mt -121.7 114.74 21.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.965 -1.71 . . . . 1.17 111.002 172.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.9 mt -104.22 116.2 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 117.771 -1.109 . . . . 1.38 111.312 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -112.9 131.79 55.58 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.009 -1.849 . . . . 1.5 106.009 170.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 82.48 -43.29 0.13 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.064 1.346 . . . . 1.21 111.189 172.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.28 -5.63 0.18 Allowed Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 114.423 -3.431 . . . . 1.3 107.05 -173.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -123.82 143.71 50.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 121.762 2.781 . . . . 2.55 113.258 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -69.17 138.85 54.46 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.026 -2.921 . . . . 2.48 115.407 173.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.7 mt -98.87 122.39 42.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.32 2.009 . . . . 0.9 105.848 -175.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -71.6 120.63 17.46 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 123.852 1.786 . . . . 1.94 115.111 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -44.78 -53.78 7.04 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.999 2.519 . . . . 1.56 114.536 -171.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.05 39.67 1.85 Allowed Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 118.471 2.149 . . . . 0.97 118.471 173.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -124.94 167.95 13.97 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 116.664 -3.844 . . . . 2.49 106.601 168.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.6 p -97.03 175.64 6.25 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.916 1.821 . . . . 0.76 115.916 169.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.559 HD21 HG21 ' A' ' 26' ' ' VAL . 5.5 mt -73.16 -22.65 60.46 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 127.037 3.303 . . . . 1.05 110.161 174.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -78.21 -41.33 34.8 Favored 'General case' 0 N--CA 1.43 -1.453 2 C-N-CA 133.464 4.706 . . . . 1.19 116.346 175.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -63.16 -32.68 74.12 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.801 1.762 . . . . 1.9 111.516 168.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -92.93 -0.45 57.22 Favored 'General case' 0 N--CA 1.431 -1.398 1 O-C-N 116.063 -4.148 . . . . 0.89 112.884 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 48.43 53.87 11.33 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.49 2.033 . . . . 1.84 116.49 -174.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.5 mt -97.06 129.42 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 129.155 2.982 . . . . 0.82 108.377 175.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -103.29 -167.97 1.45 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 115.536 1.68 . . . . 2.16 115.536 -172.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -55.63 139.53 44.21 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.022 1.119 . . . . 2.12 114.022 160.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.279 93.0 mt-10 60.0 52.22 5.35 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 120.097 3.369 . . . . 1.71 120.097 173.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.1 p -103.53 135.28 45.42 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.531 3.532 . . . . 1.04 109.399 -175.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 m -96.54 107.42 19.84 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 104.816 -2.29 . . . . 0.79 104.816 -176.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.0 mt -93.99 145.94 24.29 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 126.623 3.106 . . . . 1.4 104.122 170.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -111.15 118.93 37.33 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 112.996 -1.911 . . . . 1.51 107.766 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.0 tp -86.09 118.43 25.56 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.252 1.501 . . . . 1.14 109.003 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.13 129.74 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 124.862 2.267 . . . . 1.23 107.781 172.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.3 mt . . . . . 0 N--CA 1.43 -1.449 1 O-C-N 113.831 -5.543 . . . . 2.78 109.105 -178.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.342 0 N-CA-C 117.298 2.333 . . . . 1.1 117.298 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -93.19 115.39 28.01 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 119.991 3.33 . . . . 1.87 119.991 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.523 HG22 ' HB2' ' A' ' 65' ' ' SER . 8.9 pt -113.17 163.09 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-N 122.904 2.593 . . . . 0.72 109.842 173.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.298 79.6 m-85 -121.01 134.22 55.29 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.07 -1.456 . . . . 1.4 107.07 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.2 t -119.16 130.24 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 119.578 -1.951 . . . . 0.58 110.021 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -95.26 119.8 34.4 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.646 3.178 . . . . 2.09 106.511 -173.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -86.84 -173.71 4.6 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 115.914 -1.993 . . . . 0.99 108.204 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.7 mt -87.01 -29.27 22.1 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.423 2.689 . . . . 2.53 108.901 173.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -77.52 -7.71 56.69 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.618 2.451 . . . . 2.08 117.618 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.28 5.56 37.25 Favored Glycine 0 N--CA 1.43 -1.745 0 CA-C-O 124.183 1.991 . . . . 1.31 112.578 174.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -96.22 144.63 26.25 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.968 -2.489 . . . . 1.4 110.605 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -106.22 115.54 30.4 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 106.025 -1.843 . . . . 0.78 106.025 173.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -91.6 126.45 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 125.753 2.692 . . . . 1.55 107.606 173.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.5 m -96.94 113.59 25.14 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 116.536 -3.853 . . . . 1.08 111.051 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.0 mt -120.29 154.42 34.99 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 114.208 1.188 . . . . 1.55 114.208 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.444 ' O ' ' HE3' ' A' ' 29' ' ' LYS . 29.7 mt-10 -109.72 145.22 36.95 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.646 -0.872 . . . . 1.95 108.646 172.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -152.22 156.31 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 126.17 1.788 . . . . 0.96 108.874 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -95.51 154.13 39.35 Favored Pre-proline 0 N--CA 1.43 -1.465 0 CA-C-O 114.364 -2.732 . . . . 2.35 108.561 171.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 57.5 Cg_endo -74.31 -11.87 22.93 Favored 'Trans proline' 0 N--CA 1.433 -2.03 0 CA-C-N 126.902 3.501 . . . . 0.95 112.218 -172.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -78.96 4.78 13.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.946 2.499 . . . . 1.45 112.596 173.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -93.56 151.76 19.48 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 126.957 2.103 . . . . 1.69 115.584 173.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.5 p -82.55 161.07 22.43 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.24 -2.788 . . . . 0.75 115.933 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mm -60.8 -34.82 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.079 -2.888 . . . . 0.73 115.387 170.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -48.27 -36.29 13.78 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 120.402 3.482 . . . . 1.62 120.402 158.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -62.0 -33.37 74.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.715 -2.491 . . . . 2.13 113.955 175.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.91 -41.25 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 127.159 2.183 . . . . 0.62 112.752 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -67.54 -34.23 76.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 113.878 -1.51 . . . . 1.22 112.32 174.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.6 -41.32 98.34 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.773 -1.829 . . . . 0.51 115.814 170.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HE3' ' O ' ' A' ' 16' ' ' GLU . 58.9 mttm -62.59 -38.26 89.46 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.1 -2.25 . . . . 1.44 114.367 168.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.41 92.7 mt -62.23 -35.52 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-O 126.888 3.233 . . . . 1.32 113.836 174.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -66.56 -31.54 72.31 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.23 -2.169 . . . . 1.7 115.057 174.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -73.22 -53.78 10.07 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.236 -1.024 . . . . 1.55 108.236 171.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -65.41 -50.23 66.25 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.917 1.451 . . . . 2.62 114.917 -174.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -108.19 -48.95 3.27 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 126.269 1.828 . . . . 1.48 113.405 -172.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.27 16.66 3.83 Favored Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 119.445 -1.36 . . . . 1.12 114.863 175.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 mt -88.88 131.01 42.7 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 115.495 -2.193 . . . . 1.55 110.052 -174.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -69.21 161.68 44.85 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 CA-C-N 126.453 3.34 . . . . 1.02 117.924 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.96 -1.86 8.78 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 CA-C-N 122.574 1.955 . . . . 1.25 113.287 -167.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -84.47 -26.27 28.32 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 116.137 -4.102 . . . . 2.25 111.998 176.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -83.92 -34.49 24.48 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.676 -2.515 . . . . 2.02 111.006 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -76.42 121.0 22.43 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 117.8 2.519 . . . . 0.69 117.8 -175.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.6 mtt85 -103.0 164.51 11.57 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 125.574 1.796 . . . . 2.78 106.365 167.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.1 mp -129.85 134.02 47.28 Favored 'General case' 0 CA--C 1.489 -1.387 0 O-C-N 117.636 -3.165 . . . . 1.17 112.026 170.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.2 mt -125.21 124.92 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 CA-C-O 128.564 4.03 . . . . 1.38 109.524 177.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -127.99 139.74 52.39 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 115.379 -4.576 . . . . 1.5 107.072 171.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.302 . . 52.35 25.83 3.71 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.632 2.773 . . . . 1.21 115.764 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.99 13.1 72.62 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-O 114.17 -3.572 . . . . 1.3 110.906 -176.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -125.17 129.66 50.58 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.639 2.22 . . . . 2.55 105.211 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.288 16.7 tt0 -83.33 125.56 31.77 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.153 2.981 . . . . 2.48 111.022 173.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.438 HD22 ' CE1' ' A' ' 59' ' ' TYR . 53.4 mt -79.26 164.47 24.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.294 -1.775 . . . . 0.9 112.58 -167.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -95.3 153.36 17.71 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.622 -1.992 . . . . 1.94 105.622 175.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -79.76 -50.69 10.19 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.665 -1.272 . . . . 1.56 111.943 -167.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.62 60.23 3.62 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 120.562 2.985 . . . . 0.97 120.562 171.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -126.19 166.96 16.1 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 104.86 -2.274 . . . . 2.49 104.86 165.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.3 p -97.8 162.0 13.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.872 -2.64 . . . . 0.76 103.872 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 5.0 mt -63.99 -27.94 69.47 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 112.762 -2.017 . . . . 1.05 115.794 174.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.9 t -59.89 -45.78 91.44 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.817 2.447 . . . . 1.19 109.001 176.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -55.46 -31.93 62.36 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.867 -2.396 . . . . 1.9 116.257 175.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.438 ' CE1' HD22 ' A' ' 50' ' ' LEU . 88.2 m-85 -85.2 -0.42 54.56 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.195 1.798 . . . . 0.89 112.029 174.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.289 18.7 m120 49.26 50.91 17.25 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.935 -3.603 . . . . 1.84 115.512 -171.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.274 83.7 mt -93.38 125.02 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 127.545 2.338 . . . . 0.82 105.308 -173.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -105.77 -175.96 2.94 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.556 3.142 . . . . 2.16 107.411 -172.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -72.21 159.31 34.31 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.417 -1.427 . . . . 2.12 110.141 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 59.53 48.53 9.58 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.685 1.994 . . . . 1.71 112.828 174.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.523 ' HB2' HG22 ' A' ' 3' ' ' ILE . 34.6 m -111.85 137.57 49.63 Favored 'General case' 0 N--CA 1.429 -1.476 1 N-CA-C 99.314 -4.328 . . . . 1.04 99.314 -169.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.6 m -102.53 108.51 19.84 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.608 1.963 . . . . 0.79 109.861 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.8 mt -105.01 148.77 26.38 Favored 'General case' 0 CA--C 1.489 -1.39 0 CA-C-O 123.559 1.647 . . . . 1.4 113.897 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -102.39 132.35 48.45 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.204 -3.435 . . . . 1.51 109.764 -173.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.1 tp -91.66 119.36 31.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.224 -2.797 . . . . 1.14 109.507 175.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.21 137.26 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 O-C-N 118.11 -2.869 . . . . 1.23 107.041 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.431 -1.399 0 C-N-CA 116.804 -1.958 . . . . 2.78 110.769 172.956 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 115.436 1.643 . . . . 1.1 115.436 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -83.83 148.04 27.22 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 114.806 -2.521 . . . . 1.87 109.561 -176.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -142.43 168.43 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 1 O-C-N 130.8 5.062 . . . . 0.72 107.97 170.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -117.88 156.68 28.01 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 114.455 1.28 . . . . 1.4 114.455 171.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.9 t -134.36 128.04 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 101.381 -3.563 . . . . 0.58 101.381 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -98.92 106.88 19.19 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.905 2.187 . . . . 2.09 116.905 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.262 4.8 p -58.13 165.43 1.93 Allowed 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 125.508 1.523 . . . . 0.99 112.571 176.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.3 94.7 mt -60.18 -54.89 40.42 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 130.867 3.667 . . . . 2.53 110.995 176.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 p -76.8 -12.23 59.95 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 117.84 -3.038 . . . . 2.08 113.264 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.65 2.21 5.36 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 122.285 2.311 . . . . 1.31 113.448 166.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -77.02 143.23 39.49 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 116.241 -4.093 . . . . 1.4 114.027 -175.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.0 m -85.44 125.92 33.39 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.144 0.977 . . . . 0.78 112.446 166.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.3 mt -100.51 112.89 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 104.999 -2.223 . . . . 1.55 104.999 171.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 m -87.99 145.49 25.98 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 116.031 -2.267 . . . . 1.08 108.479 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.3 mt -141.17 174.89 10.1 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 120.427 1.467 . . . . 1.55 109.308 175.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -126.18 119.66 28.08 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.682 1.993 . . . . 1.95 110.288 167.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 m -121.19 153.49 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 126.447 1.899 . . . . 0.96 110.702 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.278 17.7 mm-40 -101.84 175.84 2.13 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-N 125.2 3.636 . . . . 2.35 110.957 155.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -74.76 -20.17 17.74 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 121.23 1.475 . . . . 0.95 110.106 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.8 m -76.21 -8.93 58.13 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 120.328 3.455 . . . . 1.45 120.328 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -80.45 142.5 34.23 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 116.772 -3.705 . . . . 1.69 110.198 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 38.4 p -82.99 179.98 7.61 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 123.275 1.512 . . . . 0.75 111.703 -176.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.9 mm -82.62 -31.12 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 116.657 -3.777 . . . . 0.73 109.201 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -63.41 -28.76 70.2 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.18 -2.2 . . . . 1.62 115.404 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -66.71 -46.08 76.67 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.005 1.722 . . . . 2.13 113.414 172.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.2 t -62.67 -42.11 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 119.148 -2.22 . . . . 0.62 109.554 176.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -71.46 -8.31 53.06 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 118.222 2.675 . . . . 1.22 118.222 169.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.03 -39.76 19.22 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.369 1.08 . . . . 0.51 112.828 169.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -59.24 -40.84 87.18 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.324 1.85 . . . . 1.44 111.186 174.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.7 mt -74.67 -26.35 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 115.588 1.699 . . . . 1.32 115.588 170.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -62.18 -39.23 92.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.481 -2.012 . . . . 1.7 113.49 167.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -55.8 -47.66 76.74 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 116.277 1.955 . . . . 1.55 116.277 165.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -90.06 -51.42 5.47 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 115.735 1.754 . . . . 2.62 115.735 -167.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -98.54 -39.44 8.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 106.038 -1.838 . . . . 1.48 106.038 -171.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.47 18.16 6.29 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 120.933 3.133 . . . . 1.12 120.933 174.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.2 mt -103.71 120.75 50.47 Favored Pre-proline 0 N--CA 1.43 -1.437 1 C-N-CA 134.775 5.23 . . . . 1.55 108.374 -163.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -57.28 137.17 80.43 Favored 'Trans proline' 0 C--N 1.299 -2.052 2 C-N-CA 125.726 4.284 . . . . 1.02 116.749 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -67.59 -12.58 36.12 Favored 'Trans proline' 0 N--CA 1.434 -2.027 0 CA-C-N 127.978 3.885 . . . . 1.25 120.197 -172.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -78.41 -16.1 57.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.633 1.973 . . . . 2.25 112.483 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -92.01 -37.41 12.84 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.407 -2.058 . . . . 2.02 110.979 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -69.47 126.99 31.43 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.68 2.392 . . . . 0.69 112.051 -171.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.44 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 29.9 mtt180 -103.99 126.73 51.33 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 120.303 -1.498 . . . . 2.78 110.952 158.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 43' ' ' LEU . 83.0 mt -104.84 118.12 35.75 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.356 -2.715 . . . . 1.17 106.427 175.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.5 mm -112.8 141.44 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.669 1.988 . . . . 1.38 105.831 -174.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -154.8 124.26 6.45 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.535 -1.654 . . . . 1.5 106.535 169.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.47 37.83 2.55 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 126.703 2.502 . . . . 1.21 110.383 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.13 -23.51 4.5 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 118.031 -2.033 . . . . 1.3 116.131 -175.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -87.23 142.07 28.17 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.554 -1.556 . . . . 2.55 114.831 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -87.0 135.03 33.42 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.354 -2.716 . . . . 2.48 108.864 172.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.6 mt -93.09 128.77 39.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.887 -1.133 . . . . 0.9 112.54 -175.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -84.32 132.01 34.65 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 117.604 2.446 . . . . 1.94 117.604 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -40.53 -67.93 0.21 Allowed 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 121.22 3.785 . . . . 1.56 121.22 -165.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.25 58.03 5.05 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 118.011 1.964 . . . . 0.97 118.011 171.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -129.09 157.85 40.6 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 103.562 -2.755 . . . . 2.49 103.562 168.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 68.2 p -98.92 167.51 10.7 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.955 -1.716 . . . . 0.76 113.603 175.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.87 -24.81 66.94 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.993 -1.692 . . . . 1.05 115.305 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.5 t -69.4 -39.7 77.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.586 1.954 . . . . 1.19 109.654 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -55.28 -40.01 70.53 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 115.446 1.647 . . . . 1.9 115.446 171.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -88.67 -2.03 58.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.046 1.738 . . . . 0.89 113.296 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 59.08 50.75 7.77 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 123.14 1.448 . . . . 1.84 110.853 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.7 mm -85.97 126.66 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-O 125.687 2.66 . . . . 0.82 105.699 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -91.92 174.21 7.45 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.572 -2.58 . . . . 2.16 113.476 -176.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.3 pttt -70.13 147.02 50.43 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.164 1.459 . . . . 2.12 113.65 173.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.322 41.1 mt-10 61.97 35.58 16.08 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 119.139 -2.225 . . . . 1.71 114.674 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 t -102.62 149.42 24.45 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 124.326 1.05 . . . . 1.04 110.505 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.5 m -96.95 110.68 23.16 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.058 2.543 . . . . 0.79 113.031 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.8 mt -90.03 153.13 20.8 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 118.065 -1.454 . . . . 1.4 109.966 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -104.19 123.82 48.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.125 1.44 . . . . 1.51 112.599 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.1 tp -94.46 128.79 41.25 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.126 -4.109 . . . . 1.14 108.282 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 89.0 t -120.87 154.21 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 102.239 -3.245 . . . . 1.23 102.239 172.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 N--CA 1.429 -1.515 0 O-C-N 120.594 -1.316 . . . . 2.78 108.587 -175.784 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 CA--C 1.491 -1.324 0 CA-C-O 118.376 -0.821 . . . . 1.1 112.089 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -99.27 126.98 45.21 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.727 0.775 . . . . 1.87 111.232 -176.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.6 pt -114.69 164.45 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 105.663 -1.977 . . . . 0.72 105.663 173.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -119.2 135.01 54.88 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 105.26 -2.126 . . . . 1.4 105.26 -175.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.5 t -117.79 118.22 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 102.98 -2.97 . . . . 0.58 102.98 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -108.98 135.92 49.36 Favored 'General case' 0 N--CA 1.429 -1.485 2 O-C-N 115.639 -4.413 . . . . 2.09 108.05 175.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.56 HG22 HD23 ' A' ' 69' ' ' LEU . 59.1 p -87.32 -177.05 5.86 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 125.119 2.39 . . . . 0.99 115.752 176.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.78 -30.31 64.0 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 124.733 2.206 . . . . 2.53 114.794 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p -77.94 -51.04 11.02 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 114.549 -5.094 . . . . 2.08 110.526 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.61 35.68 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.748 0 O-C-N 118.552 -2.593 . . . . 1.31 111.777 173.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -102.42 108.46 19.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.931 -2.248 . . . . 1.4 104.931 -170.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.9 m -83.7 114.9 21.9 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.535 2.734 . . . . 0.78 106.694 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.4 mt -101.54 146.43 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 100.522 -3.881 . . . . 1.55 100.522 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.7 m -118.21 130.82 56.3 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.851 2.739 . . . . 1.08 103.853 174.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.3 mt -125.75 139.98 53.07 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 113.275 -1.784 . . . . 1.55 108.283 -177.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.27 48.0 mt-10 -103.32 129.91 50.47 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 123.929 1.823 . . . . 1.95 111.341 170.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 m -137.31 166.22 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 113.929 -1.487 . . . . 0.96 110.669 -169.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -105.55 167.23 10.03 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 119.25 -2.156 . . . . 2.35 109.679 161.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -70.89 -13.1 31.6 Favored 'Trans proline' 0 N--CA 1.434 -1.99 0 N-CA-C 118.999 2.653 . . . . 0.95 118.999 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.8 p -93.11 4.22 54.38 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.499 1.92 . . . . 1.45 115.5 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -80.2 144.27 33.09 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 126.378 2.99 . . . . 1.69 111.929 170.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.3 p -80.27 158.62 26.12 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 128.335 2.654 . . . . 0.75 108.108 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.6 mm -64.99 -36.75 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 103.031 -2.951 . . . . 0.73 103.031 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -55.16 -46.26 75.73 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.353 -3.342 . . . . 1.62 117.259 170.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -64.28 -37.98 89.43 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 115.785 1.772 . . . . 2.13 115.785 171.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.5 t -53.2 -44.55 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 118.418 -2.676 . . . . 0.62 114.684 167.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt -62.56 -46.63 87.48 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.318 -1.489 . . . . 1.22 114.57 173.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.1 -37.4 69.32 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.782 1.633 . . . . 0.51 112.281 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -68.37 -31.2 70.4 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 117.052 -1.451 . . . . 1.44 112.865 173.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.1 mt -68.68 -41.69 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 120.153 1.342 . . . . 1.32 108.337 173.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -53.57 -45.47 69.93 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 117.575 -3.203 . . . . 1.7 114.148 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.27 20.9 t70 -55.49 -68.06 0.23 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.074 -1.642 . . . . 1.55 109.761 167.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -59.82 -55.4 34.68 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 119.436 3.124 . . . . 2.62 119.436 -173.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -95.03 -51.23 4.74 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.092 2.557 . . . . 1.48 113.449 -169.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.56 24.7 2.81 Favored Glycine 0 N--CA 1.43 -1.733 0 CA-C-O 116.942 -2.032 . . . . 1.12 115.771 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.9 mm -103.62 135.12 19.42 Favored Pre-proline 0 N--CA 1.429 -1.484 0 CA-C-N 121.63 2.715 . . . . 1.55 108.777 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -67.48 137.64 43.53 Favored 'Trans proline' 0 C--N 1.3 -1.998 3 C-N-CA 126.452 4.768 . . . . 1.02 115.355 178.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -59.14 -21.13 57.93 Favored 'Trans proline' 0 C--N 1.299 -2.047 1 C-N-CA 129.349 6.699 . . . . 1.25 111.461 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -62.59 -39.11 92.68 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 126.299 2.952 . . . . 2.25 114.292 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -77.75 -30.68 51.66 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 114.613 -5.054 . . . . 2.02 110.026 -173.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -79.44 151.02 31.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.703 -1.248 . . . . 0.69 112.495 -164.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -139.82 156.09 46.92 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 106.341 -1.725 . . . . 2.78 106.341 168.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 42.1 mt -136.59 126.43 25.74 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 118.86 0.754 . . . . 1.17 111.322 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.8 mm -104.62 145.93 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 O-C-N 126.471 2.357 . . . . 1.38 106.257 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -134.42 126.45 29.55 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 116.893 -3.629 . . . . 1.5 102.288 165.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.22 -55.9 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.45 1 C-N-CA 135.027 5.331 . . . . 1.21 118.945 -175.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.85 -16.8 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.723 0 O-C-N 120.132 -1.605 . . . . 1.3 113.757 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -95.29 162.36 13.71 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.542 1.537 . . . . 2.55 111.063 -178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -116.58 126.33 53.13 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.623 1.569 . . . . 2.48 107.139 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.3 mt -90.42 132.3 35.7 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 125.706 1.879 . . . . 0.9 108.748 -162.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -60.12 143.76 51.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.181 -2.825 . . . . 1.94 113.074 172.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -70.21 -43.21 71.14 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 112.899 -6.126 . . . . 1.56 113.92 -169.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.62 53.25 1.29 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 125.949 2.971 . . . . 0.97 109.718 174.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.5 mtt-85 -120.87 155.21 34.64 Favored 'General case' 0 N--CA 1.43 -1.468 1 N-CA-C 100.069 -4.049 . . . . 2.49 100.069 165.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.4 p -90.56 167.41 12.58 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 124.68 1.237 . . . . 0.76 113.346 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 mt -65.22 -42.93 92.97 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 127.299 2.874 . . . . 1.05 112.735 169.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.2 t -59.0 -40.11 83.91 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 120.041 1.291 . . . . 1.19 114.34 175.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.1 -40.96 95.71 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.726 2.121 . . . . 1.9 116.726 175.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -79.04 -10.1 59.73 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.77 1.294 . . . . 0.89 113.661 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.9 m120 68.33 40.19 2.11 Favored 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 135.507 5.523 . . . . 1.84 114.661 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.9 mt -72.33 139.6 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 127.328 2.251 . . . . 0.82 106.974 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -119.21 -178.48 3.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.942 2.306 . . . . 2.16 106.857 -175.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -65.43 147.66 53.04 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.117 2.389 . . . . 2.12 116.125 167.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.272 34.8 mt-10 70.31 21.57 5.73 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.673 1.989 . . . . 1.71 113.852 173.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -92.92 141.15 28.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.621 1.677 . . . . 1.04 108.778 -175.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.2 m -96.22 100.56 12.19 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 129.266 3.026 . . . . 0.79 112.721 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.326 18.6 mt -83.13 150.88 25.99 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 128.421 3.962 . . . . 1.4 103.699 170.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -106.92 98.93 8.53 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 110.365 -3.107 . . . . 1.51 116.919 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.56 HD23 HG22 ' A' ' 7' ' ' THR . 24.9 tp -63.65 116.69 5.91 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 116.914 2.19 . . . . 1.14 116.914 169.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.9 m -131.69 -178.78 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 102.779 -3.045 . . . . 1.23 102.779 175.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.9 mt . . . . . 0 N--CA 1.43 -1.46 0 N-CA-C 105.256 -2.127 . . . . 2.78 105.256 179.044 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.344 0 CA-C-O 118.34 -0.838 . . . . 1.1 111.149 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -95.66 131.4 41.94 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 116.302 1.964 . . . . 1.87 116.302 -171.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.9 pt -126.92 165.93 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 115.093 -2.385 . . . . 0.72 111.742 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -125.88 127.68 46.41 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 125.946 2.029 . . . . 1.4 106.321 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.9 t -112.83 111.9 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 CA-C-N 115.503 -0.771 . . . . 0.58 109.633 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -93.63 135.67 34.68 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 116.852 -3.655 . . . . 2.09 111.496 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.3 p -84.2 -167.64 1.84 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.844 -1.785 . . . . 0.99 109.559 173.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.0 mt -91.96 -23.48 19.56 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.107 -2.245 . . . . 2.53 112.226 171.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.1 p -80.96 -47.64 13.38 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.035 1.124 . . . . 2.08 114.035 -173.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.17 25.3 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 116.615 -2.707 . . . . 1.31 111.686 176.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -118.47 124.45 47.64 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.492 -0.929 . . . . 1.4 108.492 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -102.41 118.56 37.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 124.579 1.175 . . . . 0.78 110.231 167.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mt -105.22 129.45 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 127.832 2.453 . . . . 1.55 110.128 -170.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.4 m -99.34 110.06 22.61 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 127.427 2.954 . . . . 1.08 108.318 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.1 mt -121.49 147.07 46.26 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.059 2.838 . . . . 1.55 109.728 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -99.3 125.71 44.99 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.509 -3.869 . . . . 1.95 114.495 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.48 HG12 ' HE3' ' A' ' 29' ' ' LYS . 32.6 m -124.9 150.38 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 117.8 -3.063 . . . . 0.96 106.134 -176.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -86.21 140.23 34.49 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 112.907 -3.425 . . . . 2.35 113.018 166.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -77.44 5.14 5.35 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 CA-C-N 126.878 3.492 . . . . 0.95 112.69 -166.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 p -106.17 9.63 32.17 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.939 -2.976 . . . . 1.45 111.841 173.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -91.23 157.26 17.27 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 124.64 2.162 . . . . 1.69 110.253 171.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.422 ' O ' HG23 ' A' ' 26' ' ' VAL . 43.9 p -83.37 165.7 19.04 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.679 -2.513 . . . . 0.75 107.392 -175.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.412 11.3 mm -68.42 -37.49 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 C-N-CA 128.101 2.56 . . . . 0.73 110.51 176.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -56.96 -34.1 67.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 126.789 3.185 . . . . 1.62 115.966 169.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -83.05 -26.42 31.17 Favored 'General case' 0 N--CA 1.432 -1.374 1 O-C-N 111.808 -6.807 . . . . 2.13 113.405 177.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 22' ' ' THR . 44.3 t -52.66 -44.61 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.384 1.873 . . . . 0.62 113.436 165.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -67.38 -40.28 85.69 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.973 -2.329 . . . . 1.22 111.371 175.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.43 76.58 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.321 2.01 . . . . 0.51 113.808 175.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HE3' HG12 ' A' ' 17' ' ' VAL . 14.3 ttmm -64.66 -46.76 81.08 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 118.93 -2.356 . . . . 1.44 116.522 163.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.6 mt -61.51 -26.96 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 117.299 -3.376 . . . . 1.32 114.588 167.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -67.43 -45.47 75.98 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.851 -3.655 . . . . 1.7 109.905 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.26 -36.94 76.43 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 118.796 -2.44 . . . . 1.55 106.338 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -76.02 -55.94 5.13 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 123.585 2.902 . . . . 2.62 113.073 -171.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -112.32 -15.9 13.06 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 126.097 2.123 . . . . 1.48 115.146 -164.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.79 21.2 40.61 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-O 123.048 1.36 . . . . 1.12 115.375 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 mt -101.55 131.98 22.33 Favored Pre-proline 0 N--CA 1.43 -1.467 0 O-C-N 121.013 -1.287 . . . . 1.55 111.059 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.408 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 30.7 Cg_exo -70.47 145.0 51.84 Favored 'Trans proline' 0 C--N 1.3 -2.003 1 C-N-CA 126.302 4.668 . . . . 1.02 115.27 178.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -72.58 -6.52 19.2 Favored 'Trans proline' 0 N--CA 1.433 -2.03 1 C-N-CA 127.45 5.434 . . . . 1.25 117.21 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.98 -39.45 30.08 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.851 -1.781 . . . . 2.25 108.669 169.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -73.65 -36.46 65.39 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 125.163 1.539 . . . . 2.02 113.422 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 37' ' ' PRO . 74.3 mt-30 -74.04 135.06 43.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.322 1.23 . . . . 0.69 114.322 -175.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.1 ttt180 -122.13 117.68 26.84 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 114.859 -2.496 . . . . 2.78 107.901 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.1 mt -100.77 125.55 47.26 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 125.291 2.472 . . . . 1.17 105.935 -176.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.1 mt -106.05 142.71 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 1 O-C-N 115.903 -4.248 . . . . 1.38 101.904 176.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -153.8 133.56 13.03 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 127.486 3.517 . . . . 1.5 106.252 172.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.22 -57.99 0.28 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.064 2.546 . . . . 1.21 115.244 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -159.84 -18.59 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 108.616 -1.794 . . . . 1.3 108.616 -173.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -134.88 163.41 29.88 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.317 -3.461 . . . . 2.55 112.223 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.3 pm0 -71.16 152.7 43.14 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 117.81 -1.091 . . . . 2.48 111.885 170.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.2 mt -97.89 172.57 7.57 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.894 2.134 . . . . 0.9 114.538 -171.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -104.68 153.57 21.09 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.037 -2.914 . . . . 1.94 110.591 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -89.47 -52.05 5.23 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.284 -2.76 . . . . 1.56 109.085 -163.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.84 46.1 1.7 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 117.233 1.653 . . . . 0.97 117.233 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.353 17.7 mmt180 -128.22 165.92 19.56 Favored 'General case' 0 CA--C 1.489 -1.38 0 O-C-N 119.499 -2.177 . . . . 2.49 106.643 168.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.288 27.2 p -99.36 170.55 8.56 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.233 1.568 . . . . 0.76 115.233 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' A' ' 61' ' ' ILE . 11.3 mt -63.15 -40.32 97.22 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 127.2 2.2 . . . . 1.05 107.926 171.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 m -65.47 -48.85 71.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.634 3.174 . . . . 1.19 110.891 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -52.49 -41.82 63.72 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.427 1.584 . . . . 1.9 114.334 174.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -82.33 -7.23 59.63 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.424 -2.047 . . . . 0.89 114.062 175.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.1 t30 56.44 43.83 25.37 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.414 3.485 . . . . 1.84 112.535 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' A' ' 56' ' ' LEU . 62.9 mt -75.59 109.87 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-N 111.927 -2.397 . . . . 0.82 113.1 177.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -82.78 -178.19 7.01 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 120.435 -1.416 . . . . 2.16 107.855 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -66.5 149.3 50.64 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 125.083 1.353 . . . . 2.12 111.075 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 69.09 33.75 3.28 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 131.557 3.943 . . . . 1.71 107.668 168.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m -96.42 139.6 32.29 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 121.507 1.958 . . . . 1.04 111.713 -176.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 m -99.98 115.96 30.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.43 1.468 . . . . 0.79 110.939 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mp -104.47 155.33 18.89 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 112.194 -2.276 . . . . 1.4 106.29 173.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -107.34 122.92 47.55 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.885 3.274 . . . . 1.51 113.666 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.9 tp -101.42 102.09 12.82 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.243 -3.411 . . . . 1.14 106.06 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.4 m -111.96 -177.05 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 126.685 2.491 . . . . 1.23 105.686 172.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.373 18.0 mt . . . . . 0 N--CA 1.43 -1.473 0 C-N-CA 119.473 -0.891 . . . . 2.78 109.319 -176.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ptt? . . . . . 0 CA--C 1.49 -1.341 0 CA-C-O 124.85 2.262 . . . . 1.1 110.814 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -109.81 123.75 50.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 112.496 -2.138 . . . . 1.87 111.779 -173.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.404 HD11 HD12 ' A' ' 15' ' ' LEU . 2.2 pp -123.83 162.1 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 129.932 3.293 . . . . 0.72 111.344 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -123.52 136.76 54.74 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 122.782 1.277 . . . . 1.4 107.812 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.4 t -110.34 124.64 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-N 112.053 -2.34 . . . . 0.58 110.346 174.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 mmtt -95.9 117.53 30.77 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.35 1.06 . . . . 2.09 109.617 174.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.404 HG22 HD23 ' A' ' 69' ' ' LEU . 64.2 p -77.65 -177.55 4.87 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.359 2.028 . . . . 0.99 109.556 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.7 tp -58.49 -50.76 72.56 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 114.656 -5.028 . . . . 2.53 116.736 174.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.7 p -68.86 -6.31 26.32 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 111.624 -2.535 . . . . 2.08 114.763 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.17 9.68 44.25 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 117.518 -3.239 . . . . 1.31 110.434 173.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -84.03 126.87 33.47 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 107.503 -1.295 . . . . 1.4 107.503 -171.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 m -93.72 121.71 35.44 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.259 -0.882 . . . . 0.78 112.368 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.0 mt -115.13 126.53 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 107.055 -1.461 . . . . 1.55 107.055 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.8 m -102.36 121.72 42.86 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.604 -1.31 . . . . 1.08 113.529 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.404 HD12 HD11 ' A' ' 3' ' ' ILE . 83.0 mt -115.52 155.13 28.09 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.351 -2.718 . . . . 1.55 110.517 -174.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -110.18 109.32 19.78 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 125.051 1.469 . . . . 1.95 110.306 171.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -123.64 173.41 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 126.192 1.797 . . . . 0.96 109.876 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -115.68 157.27 44.86 Favored Pre-proline 0 N--CA 1.429 -1.494 0 CA-C-O 115.18 -2.343 . . . . 2.35 113.42 166.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.23 2.26 8.7 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 C-N-CA 124.441 3.427 . . . . 0.95 115.472 -176.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.6 p -95.61 -25.71 16.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.086 1.513 . . . . 1.45 115.086 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -69.72 154.8 41.47 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.163 2.985 . . . . 1.69 112.607 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.269 71.7 p -81.77 149.16 28.54 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 112.281 -2.236 . . . . 0.75 112.91 -175.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 35.2 mm -52.85 -44.01 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 117.592 -1.194 . . . . 0.73 112.676 171.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -43.39 -50.96 6.72 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.427 2.691 . . . . 1.62 111.501 162.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -66.35 -36.89 84.02 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 115.999 1.851 . . . . 2.13 115.999 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.24 -45.93 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-O 125.901 2.762 . . . . 0.62 113.779 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.2 mtmt -53.24 -31.25 42.5 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.395 -2.066 . . . . 1.22 115.445 166.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.88 -20.64 60.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 120.015 -0.674 . . . . 0.51 112.366 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -70.37 -38.29 74.71 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.98 -2.325 . . . . 1.44 114.428 173.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.6 mt -68.98 -31.95 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 127.085 2.154 . . . . 1.32 111.977 169.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -65.89 -52.85 46.54 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 115.654 -4.404 . . . . 1.7 110.102 174.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -56.77 -47.68 79.56 Favored 'General case' 0 N--CA 1.431 -1.391 1 O-C-N 114.511 -5.118 . . . . 1.55 108.767 170.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -65.99 -63.32 1.11 Allowed 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 123.315 2.779 . . . . 2.62 117.244 -176.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -93.46 -43.61 8.65 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.666 -1.896 . . . . 1.48 111.631 -174.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.05 81.06 1.5 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 125.899 2.944 . . . . 1.12 106.357 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.7 mt -155.78 126.44 3.47 Favored Pre-proline 0 N--CA 1.43 -1.472 1 N-CA-C 99.03 -4.433 . . . . 1.55 99.03 -170.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -70.0 148.7 64.09 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 CA-C-N 122.725 2.009 . . . . 1.02 112.247 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.335 36.2 Cg_endo -67.64 -20.87 46.37 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 CA-C-N 125.994 3.177 . . . . 1.25 115.697 -175.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -63.79 -31.35 72.5 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 129.832 3.253 . . . . 2.25 113.733 175.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -89.06 -16.99 30.23 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 119.532 -1.98 . . . . 2.02 106.934 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -88.37 124.64 34.13 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.117 -4.739 . . . . 0.69 111.621 -176.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -116.72 133.74 55.65 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.537 -0.912 . . . . 2.78 108.537 171.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.4 mt -112.06 125.34 53.99 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 126.23 2.919 . . . . 1.17 108.861 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.6 mt -111.1 145.61 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 127.485 2.314 . . . . 1.38 104.778 176.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -150.71 135.62 17.5 Favored 'General case' 0 N--CA 1.43 -1.448 1 N-CA-C 99.878 -4.119 . . . . 1.5 99.878 178.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.24 47.6 21.97 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.893 2.758 . . . . 1.21 114.02 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.74 -2.34 54.79 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 127.633 2.54 . . . . 1.3 116.017 175.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm -123.75 143.82 50.06 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.524 -2.163 . . . . 2.55 114.249 -174.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -66.37 127.18 31.24 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 111.411 -2.631 . . . . 2.48 114.906 171.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 mt -92.27 119.89 32.3 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 110.258 -3.156 . . . . 0.9 108.389 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -77.38 151.12 34.98 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 117.127 -1.415 . . . . 1.94 113.375 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.432 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 7.1 m-20 -72.35 -53.48 12.23 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.932 2.197 . . . . 1.56 116.932 -169.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.73 29.33 0.62 Allowed Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 120.266 2.866 . . . . 0.97 120.266 169.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -118.17 174.98 5.9 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 120.213 2.007 . . . . 2.49 108.327 170.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.4 p -104.08 179.19 4.34 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 126.099 2.856 . . . . 0.76 111.624 175.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.8 mt -71.4 -33.89 69.87 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 116.464 -3.898 . . . . 1.05 113.213 171.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -57.25 -44.83 84.21 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 125.269 2.461 . . . . 1.19 110.159 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -54.95 -33.52 62.4 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.332 -2.73 . . . . 1.9 117.218 176.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -101.05 -2.41 31.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.165 -1.584 . . . . 0.89 109.148 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.257 6.6 m120 64.39 55.17 1.43 Allowed 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 116.825 2.157 . . . . 1.84 116.825 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.5 mt -100.16 132.27 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 110.568 -3.014 . . . . 0.82 107.5 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -115.65 -164.16 0.94 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 123.469 0.707 . . . . 2.16 111.621 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -67.6 153.36 43.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.952 2.501 . . . . 2.12 108.531 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 54.47 26.96 7.67 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.478 2.711 . . . . 1.71 117.089 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.252 47.2 m -94.08 144.85 25.12 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.358 -1.464 . . . . 1.04 109.971 -173.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.4 m -102.41 103.53 13.93 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 126.549 1.94 . . . . 0.79 111.661 -171.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 mt -84.22 160.52 20.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.322 1.849 . . . . 1.4 111.758 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -123.43 123.96 41.83 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.529 -2.607 . . . . 1.51 104.114 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.404 HD23 HG22 ' A' ' 7' ' ' THR . 23.1 tp -95.63 120.93 36.74 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.295 2.638 . . . . 1.14 109.318 176.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.296 14.1 m -116.94 163.13 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 127.899 2.48 . . . . 1.23 111.425 168.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.3 mt . . . . . 0 N--CA 1.431 -1.421 0 C-N-CA 117.48 -1.688 . . . . 2.78 111.914 179.852 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 tmm? . . . . . 0 CA--C 1.491 -1.299 0 CA-C-O 116.791 -1.576 . . . . 1.1 114.134 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -91.64 115.38 28.0 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.827 2.558 . . . . 1.87 113.149 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.9 pt -104.88 152.57 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 124.376 2.036 . . . . 0.72 113.015 165.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -111.46 113.74 26.39 Favored 'General case' 0 N--CA 1.429 -1.49 1 O-C-N 114.825 -4.922 . . . . 1.4 108.697 -174.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.7 t -98.13 106.5 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-O 124.082 1.896 . . . . 0.58 106.067 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -94.62 121.3 36.04 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.791 -2.443 . . . . 2.09 112.779 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 p -89.24 163.82 15.22 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.543 -1.348 . . . . 0.99 108.203 174.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.9 tp -44.8 -56.88 4.11 Favored 'General case' 0 N--CA 1.43 -1.433 1 C-N-CA 133.229 4.611 . . . . 2.53 110.842 174.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.7 p -72.59 -19.73 61.42 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 113.061 -1.881 . . . . 2.08 115.275 -174.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.4 -14.86 4.22 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 117.293 -1.837 . . . . 1.31 116.689 166.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -75.04 133.21 41.67 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 120.343 2.072 . . . . 1.4 108.748 -168.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -105.15 118.89 37.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.028 -0.73 . . . . 0.78 109.028 172.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.12 112.31 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-O 126.112 2.863 . . . . 1.55 105.226 -178.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.7 m -88.72 131.52 34.99 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.186 -2.821 . . . . 1.08 106.862 -176.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.4 mt -135.32 131.21 36.18 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 124.642 1.213 . . . . 1.55 109.788 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -88.48 94.13 9.77 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.007 -2.308 . . . . 1.95 112.481 176.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.284 30.9 m -110.79 178.35 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 105.493 -2.04 . . . . 0.96 105.493 -177.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.41 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 22.7 mm-40 -122.34 155.5 61.88 Favored Pre-proline 0 N--CA 1.431 -1.412 0 O-C-N 119.532 -1.98 . . . . 2.35 109.786 161.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 94.3 Cg_endo -72.32 -23.09 21.09 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 C-N-CA 124.126 3.217 . . . . 0.95 112.975 -166.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.1 m -74.32 -11.21 60.2 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 116.17 1.915 . . . . 1.45 116.17 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -81.73 159.48 23.87 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 119.359 3.096 . . . . 1.69 119.359 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.257 7.3 p -78.07 147.71 34.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 119.067 2.988 . . . . 0.75 119.067 -177.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.1 mm -53.68 -38.36 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 123.86 3.027 . . . . 0.73 115.849 173.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -45.85 -38.12 6.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.86 2.911 . . . . 1.62 118.86 162.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -85.4 -23.7 27.84 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.86 -1.775 . . . . 2.13 113.719 175.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.94 -48.01 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 118.583 -2.573 . . . . 0.62 109.581 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -47.7 -37.4 13.01 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.761 3.245 . . . . 1.22 119.761 174.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.08 -33.12 71.5 Favored 'General case' 0 N--CA 1.43 -1.43 2 C-N-CA 133.53 4.732 . . . . 0.51 110.731 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -62.28 -26.42 68.4 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.133 3.012 . . . . 1.44 119.133 173.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.7 mt -82.67 -16.41 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 126.541 2.401 . . . . 1.32 114.292 175.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -82.17 -49.53 10.03 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.793 -1.929 . . . . 1.7 105.793 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -48.86 -61.28 2.13 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.874 2.47 . . . . 1.55 111.305 167.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -76.88 -62.57 1.6 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.968 -1.708 . . . . 2.62 112.959 -167.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -98.5 -42.77 7.15 Favored 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 115.247 -4.658 . . . . 1.48 110.806 -166.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.34 20.47 2.19 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 121.891 3.516 . . . . 1.12 121.891 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.1 mm -99.82 118.86 61.08 Favored Pre-proline 0 N--CA 1.43 -1.471 0 C-N-CA 126.337 1.855 . . . . 1.55 109.75 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -69.3 157.44 61.27 Favored 'Trans proline' 0 C--N 1.299 -2.064 0 CA-C-N 123.116 2.148 . . . . 1.02 115.795 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -73.15 -16.14 25.36 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 C-N-CA 124.343 3.362 . . . . 1.25 112.717 -173.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -85.87 -34.54 20.97 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.898 2.479 . . . . 2.25 112.409 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -79.44 3.66 17.86 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.332 2.653 . . . . 2.02 111.269 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -122.92 147.72 46.27 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 120.799 3.629 . . . . 0.69 120.799 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -125.19 129.21 49.65 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 124.011 3.096 . . . . 2.78 103.613 176.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.4 mt -105.92 132.91 51.45 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.128 -4.732 . . . . 1.17 109.274 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.4 mt -119.7 135.36 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 106.366 -1.716 . . . . 1.38 106.366 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -124.31 131.95 53.54 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.844 2.458 . . . . 1.5 104.434 169.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.16 -57.59 0.52 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.889 2.876 . . . . 1.21 113.799 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -169.09 -32.45 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.749 0 CA-C-O 125.67 2.816 . . . . 1.3 115.439 -173.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -95.79 162.78 13.45 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.645 -2.679 . . . . 2.55 114.078 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -90.3 145.45 24.97 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 121.514 3.894 . . . . 2.48 121.514 173.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.6 mt -92.33 128.28 38.12 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 124.505 2.098 . . . . 0.9 112.605 -170.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -75.96 134.93 40.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 130.257 3.423 . . . . 1.94 110.144 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.55 -49.93 74.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.417 2.687 . . . . 1.56 115.206 -172.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.31 34.59 3.93 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 119.681 2.633 . . . . 0.97 119.681 173.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -103.83 166.13 10.61 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 114.549 -2.861 . . . . 2.49 106.789 167.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.8 p -89.97 159.82 16.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.974 -2.953 . . . . 0.76 110.127 169.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.299 81.0 mt -60.16 -33.27 71.95 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.688 1.736 . . . . 1.05 115.688 168.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.6 t -76.76 -20.78 56.09 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.457 -3.277 . . . . 1.19 115.804 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.88 -36.14 82.94 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.486 1.115 . . . . 1.9 109.326 169.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -82.54 3.21 29.45 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.553 -1.967 . . . . 0.89 112.733 172.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.312 21.7 m120 51.92 34.75 14.2 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.594 -2.566 . . . . 1.84 115.822 -176.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.4 mt -68.81 105.52 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 120.581 -1.324 . . . . 0.82 109.009 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -97.23 167.25 11.15 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 128.437 2.695 . . . . 2.16 107.953 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -62.42 145.77 53.18 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 118.215 -2.803 . . . . 2.12 118.059 175.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.33 29.3 mt-10 71.37 28.7 2.89 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 113.156 -1.838 . . . . 1.71 112.149 -172.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 m -84.42 141.44 30.83 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 121.032 1.742 . . . . 1.04 115.242 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.3 m -94.87 109.03 21.06 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.967 -1.494 . . . . 0.79 106.967 -171.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.7 mt -95.04 130.59 41.66 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.979 2.172 . . . . 1.4 106.628 171.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.272 32.1 m80 -100.33 114.1 27.34 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.032 -1.47 . . . . 1.51 107.032 -175.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -87.71 110.12 20.2 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.017 1.727 . . . . 1.14 112.266 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.7 t -98.62 133.92 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 1 N-CA-C 99.212 -4.366 . . . . 1.23 99.212 169.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.265 13.5 tp . . . . . 0 N--CA 1.43 -1.449 0 O-C-N 119.25 -2.156 . . . . 2.78 107.983 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 CA--C 1.491 -1.299 0 CA-C-O 118.176 -0.916 . . . . 1.1 111.647 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -107.03 137.81 44.39 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.127 3.371 . . . . 1.87 106.103 -178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 pt -131.2 167.45 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.604 -3.185 . . . . 0.72 104.863 168.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.252 63.4 m-85 -121.88 125.18 45.84 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.469 1.108 . . . . 1.4 108.658 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.79 112.07 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 112.693 0.627 . . . . 0.58 112.693 172.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.4 ttmm -102.42 142.77 33.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.463 -1.31 . . . . 2.09 107.463 -172.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.1 p -93.06 167.21 11.94 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 127.392 3.472 . . . . 0.99 112.975 165.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.257 21.0 tp -71.89 -25.58 61.98 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.242 -3.411 . . . . 2.53 114.382 175.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.8 p -88.24 -36.7 16.6 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.344 -2.097 . . . . 2.08 112.631 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.66 8.95 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 116.768 -2.634 . . . . 1.31 118.933 166.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -104.48 133.28 49.61 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 122.721 3.26 . . . . 1.4 109.923 -171.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.1 m -117.22 112.74 21.23 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 118.514 -1.275 . . . . 0.78 112.635 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.31 19.7 pt -97.02 136.0 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 124.178 1.942 . . . . 1.55 111.882 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.1 m -97.65 126.75 43.15 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 116.931 -3.606 . . . . 1.08 108.415 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.3 mt -131.41 141.48 49.85 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 127.4 3.476 . . . . 1.55 109.632 -173.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -97.54 118.67 34.56 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 113.562 -5.711 . . . . 1.95 109.59 171.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.97 174.99 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 119.859 -1.775 . . . . 0.96 109.138 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -116.02 147.96 40.37 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-O 116.342 -1.789 . . . . 2.35 107.084 157.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.03 -18.06 35.98 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-O 113.741 -2.691 . . . . 0.95 109.557 -174.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.2 p -71.0 -9.47 58.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 122.892 2.587 . . . . 1.45 115.057 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -80.02 166.66 21.33 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 114.629 -5.044 . . . . 1.69 110.37 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.5 p -93.82 152.0 19.21 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 121.903 0.858 . . . . 0.75 110.699 -177.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.439 HD13 ' HB3' ' A' ' 50' ' ' LEU . 4.1 mt -59.65 -36.39 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 115.913 1.82 . . . . 0.73 115.913 173.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -44.18 -56.32 4.17 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 126.304 1.842 . . . . 1.62 115.357 162.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -61.54 -39.16 90.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 112.87 -3.443 . . . . 2.13 111.683 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.3 t -63.12 -38.63 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 122.247 2.294 . . . . 0.62 108.05 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -71.45 -26.77 62.87 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.81 2.893 . . . . 1.22 118.81 171.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.98 -24.5 65.15 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.897 -2.377 . . . . 0.51 111.107 168.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -70.23 -37.33 74.97 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.119 -2.238 . . . . 1.44 112.561 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.3 mt -58.55 -35.41 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 128.787 2.835 . . . . 1.32 109.903 167.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -65.24 -42.72 93.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.175 -2.345 . . . . 1.7 113.862 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -63.71 -32.07 73.44 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 126.515 2.384 . . . . 1.55 114.82 165.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -88.41 -65.84 0.98 Allowed 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.115 -2.24 . . . . 2.62 110.224 -167.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -99.42 -24.39 14.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.246 1.818 . . . . 1.48 110.863 -169.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.43 43.67 2.91 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-O 125.298 2.61 . . . . 1.12 111.066 170.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.3 mt -120.74 129.49 25.29 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 120.288 -1.713 . . . . 1.55 106.542 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.4 Cg_exo -71.61 150.69 57.44 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-N 124.82 2.757 . . . . 1.02 109.725 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -72.89 -12.29 26.13 Favored 'Trans proline' 0 C--N 1.298 -2.08 0 C-N-CA 122.511 2.141 . . . . 1.25 116.948 -173.263 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -81.12 -32.08 33.97 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 114.375 -5.203 . . . . 2.25 105.579 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -79.66 6.03 11.72 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 114.445 1.276 . . . . 2.02 114.445 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -149.51 147.42 28.18 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.804 -2.435 . . . . 0.69 114.253 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.277 60.2 mtt180 -129.78 162.12 29.16 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.051 -2.906 . . . . 2.78 108.563 171.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.9 mt -120.32 148.75 43.33 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 119.28 -2.138 . . . . 1.17 109.633 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.7 mt -127.61 129.04 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 124.87 2.271 . . . . 1.38 109.006 -172.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -118.08 125.72 50.86 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 104.785 -2.302 . . . . 1.5 104.785 170.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.268 . . 79.84 -54.26 0.39 Allowed 'General case' 0 N--CA 1.428 -1.535 0 O-C-N 118.446 -2.659 . . . . 1.21 111.876 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.72 -24.32 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.675 0 O-C-N 118.119 -2.863 . . . . 1.3 115.099 -170.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -97.35 141.35 30.55 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.337 -1.684 . . . . 2.55 107.524 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -76.77 120.3 21.73 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.464 3.106 . . . . 2.48 111.649 177.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.439 ' HB3' HD13 ' A' ' 23' ' ' ILE . 43.2 mt -80.85 144.99 31.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.095 -1.628 . . . . 0.9 109.656 -166.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -74.87 121.5 21.95 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.716 2.406 . . . . 1.94 112.117 175.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -65.05 -29.36 70.25 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 113.382 -1.735 . . . . 1.56 112.463 -171.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.16 33.15 4.6 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 120.79 3.076 . . . . 0.97 120.79 168.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.9 mtt-85 -132.67 176.07 8.77 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 101.037 -3.69 . . . . 2.49 101.037 166.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.6 p -108.63 175.33 5.51 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.299 1.439 . . . . 0.76 109.962 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.6 mt -68.3 -23.7 64.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.539 1.681 . . . . 1.05 115.539 173.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 t -65.25 -40.09 93.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.678 2.791 . . . . 1.19 111.486 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -70.62 -21.89 62.59 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.262 1.578 . . . . 1.9 115.262 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -96.39 -3.24 43.99 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.81 -3.056 . . . . 0.89 108.582 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 58.84 40.88 22.3 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 127.575 2.35 . . . . 1.84 112.987 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.9 mt -80.53 127.08 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 1 O-C-N 131.022 5.201 . . . . 0.82 104.949 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -93.71 -174.85 3.58 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 128.079 2.552 . . . . 2.16 111.243 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.7 pttp -72.35 151.27 42.8 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.432 -1.258 . . . . 2.12 111.536 174.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.375 11.7 mt-10 56.65 42.23 27.28 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.443 2.757 . . . . 1.71 118.443 176.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.5 m -100.65 143.53 30.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.593 -2.743 . . . . 1.04 103.593 -175.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -103.04 110.4 22.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 125.183 2.421 . . . . 0.79 108.202 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -96.04 115.33 27.27 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.074 3.35 . . . . 1.4 112.538 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -86.71 121.37 29.12 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.445 -2.035 . . . . 1.51 115.977 -171.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.2 tt -89.39 138.34 31.53 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.355 -2.716 . . . . 1.14 108.764 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -125.45 162.75 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 O-C-N 128.408 3.568 . . . . 1.23 111.702 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.6 mt . . . . . 0 N--CA 1.431 -1.408 0 CA-C-O 124.031 1.872 . . . . 2.78 109.45 -179.801 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ptt? . . . . . 0 CA--C 1.489 -1.373 0 CA-C-O 123.198 1.475 . . . . 1.1 109.361 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -118.03 139.42 51.22 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.618 -3.176 . . . . 1.87 108.621 -176.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.1 pt -125.13 144.6 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 CA-C-O 115.826 -2.035 . . . . 0.72 106.251 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -102.31 101.02 11.24 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 126.419 2.324 . . . . 1.4 108.705 -174.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 21.7 t -82.2 110.99 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 116.699 -3.751 . . . . 0.58 106.779 175.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -98.58 136.38 38.76 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 109.247 -0.649 . . . . 2.09 109.247 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 p -90.81 -155.42 0.39 Allowed 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.704 1.602 . . . . 0.99 108.15 175.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.4 mt -103.47 -60.78 1.51 Allowed 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 113.739 -3.029 . . . . 2.53 110.428 175.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 p -51.37 -41.68 60.82 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 133.894 6.996 . . . . 2.08 116.672 -174.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.46 -19.77 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 126.262 3.146 . . . . 1.31 120.398 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -71.67 151.48 43.64 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.169 -2.371 . . . . 1.4 110.805 -174.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.4 m -130.32 110.23 11.36 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.147 1.779 . . . . 0.78 110.635 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.47 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 4.8 mm -85.92 101.75 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 115.539 -2.172 . . . . 1.55 105.752 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.8 m -78.42 89.63 4.41 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 125.489 1.743 . . . . 1.08 111.119 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.8 mt -85.3 124.15 31.6 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.592 -3.193 . . . . 1.55 113.207 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -71.48 114.87 10.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 125.493 1.746 . . . . 1.95 112.431 161.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 m -134.18 165.43 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 120.253 -1.529 . . . . 0.96 108.851 -176.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -104.91 156.41 36.06 Favored Pre-proline 0 N--CA 1.429 -1.488 0 CA-C-O 116.401 -1.762 . . . . 2.35 106.879 167.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -79.5 -11.9 14.13 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 CA-C-N 126.047 3.195 . . . . 0.95 106.22 -170.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.9 p -73.35 -21.8 60.45 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.898 2.555 . . . . 1.45 117.898 173.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -63.54 147.18 52.1 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 125.441 1.713 . . . . 1.69 112.159 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.8 p -83.6 168.74 16.08 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.662 -1.274 . . . . 0.75 110.51 170.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.1 mm -68.77 -30.06 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 128.684 2.794 . . . . 0.73 108.91 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -48.8 -47.78 41.89 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.301 1.84 . . . . 1.62 113.73 166.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -63.87 -41.49 97.75 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.959 2.504 . . . . 2.13 111.516 173.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.9 t -67.75 -45.0 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 1 O-C-N 116.231 -4.043 . . . . 0.62 112.807 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -68.66 -22.32 64.39 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.274 1.511 . . . . 1.22 114.034 175.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.32 83.42 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.35 -3.969 . . . . 0.51 117.356 170.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -64.01 -29.49 70.64 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.285 -2.134 . . . . 1.44 113.991 165.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.456 HD13 HD13 ' A' ' 69' ' ' LEU 0.3 76.7 mt -72.89 -40.08 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 117.042 -3.536 . . . . 1.32 111.108 176.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -64.47 -46.86 81.26 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.819 2.048 . . . . 1.7 111.474 173.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.07 -54.38 25.38 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.434 -2.666 . . . . 1.55 116.974 167.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -73.61 -68.58 0.49 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.529 2.048 . . . . 2.62 116.529 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -84.19 -23.23 30.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.362 -1.29 . . . . 1.48 113.557 -167.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.25 24.56 14.21 Favored Glycine 0 N--CA 1.429 -1.769 1 CA-C-O 128.144 4.191 . . . . 1.12 114.301 170.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.7 mt -105.37 133.71 20.03 Favored Pre-proline 0 N--CA 1.429 -1.482 0 O-C-N 116.758 -3.789 . . . . 1.55 106.622 -170.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -65.55 146.6 85.14 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 CA-C-O 114.733 -2.278 . . . . 1.02 115.304 172.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -81.16 -9.49 12.76 Favored 'Trans proline' 0 N--CA 1.433 -2.058 0 CA-C-N 125.928 3.153 . . . . 1.25 108.462 -171.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -71.19 -23.79 62.1 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.482 -2.011 . . . . 2.25 111.344 168.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -92.15 -22.53 19.81 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 120.351 1.432 . . . . 2.02 107.848 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.307 74.5 mt-30 -79.31 152.66 30.37 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 125.324 2.488 . . . . 0.69 110.449 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -125.45 138.29 54.0 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.063 -4.148 . . . . 2.78 108.756 158.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.9 mt -116.47 111.56 20.17 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.424 -3.298 . . . . 1.17 104.405 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.6 mm -98.25 141.73 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 103.824 -2.658 . . . . 1.38 103.824 174.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -115.6 -109.44 0.36 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 114.877 -2.487 . . . . 1.5 109.372 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.99 -32.15 16.04 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 124.418 3.281 . . . . 1.21 112.912 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.81 -41.23 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 127.756 2.598 . . . . 1.3 114.086 -175.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -80.69 136.02 36.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.706 2.669 . . . . 2.55 110.56 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -89.95 95.53 10.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.704 2.802 . . . . 2.48 108.208 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 mt -57.01 140.93 47.49 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.988 -2.32 . . . . 0.9 115.32 -164.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.257 42.4 mt-10 -83.14 150.19 26.41 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.456 -1.402 . . . . 1.94 114.721 173.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -65.71 -52.3 52.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.235 2.309 . . . . 1.56 117.235 -169.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.15 56.97 1.76 Allowed Glycine 0 N--CA 1.43 -1.758 0 CA-C-N 108.533 -3.939 . . . . 0.97 113.6 173.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 54' ' ' ARG . 49.0 mmt-85 -132.45 168.54 18.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 129.162 3.507 . . . . 2.49 105.34 163.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -107.18 164.83 11.83 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.439 -1.71 . . . . 0.76 113.487 173.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.8 mt -66.53 -24.68 66.41 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.504 -1.373 . . . . 1.05 113.609 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.3 t -64.59 -39.79 94.36 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 128.749 2.82 . . . . 1.19 111.063 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -66.55 -31.39 72.08 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.082 -2.886 . . . . 1.9 116.211 173.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -90.5 2.65 55.52 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 115.439 1.644 . . . . 0.89 115.439 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 69.35 27.15 5.12 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 117.452 -1.261 . . . . 1.84 109.872 178.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.4 mt -79.65 128.02 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 126.149 2.88 . . . . 0.82 110.848 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -130.82 171.51 13.06 Favored 'General case' 0 N--CA 1.429 -1.494 1 O-C-N 115.043 -4.786 . . . . 2.16 108.469 -167.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -54.16 130.74 39.43 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.818 2.723 . . . . 2.12 115.641 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 65.94 34.9 6.81 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 130.032 3.333 . . . . 1.71 112.116 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.6 t -90.91 141.48 28.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.965 1.364 . . . . 1.04 112.217 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.0 m -83.99 111.85 19.64 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.989 1.716 . . . . 0.79 114.464 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -108.45 166.44 10.77 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.715 2.006 . . . . 1.4 112.058 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -123.21 132.16 53.94 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.328 -4.608 . . . . 1.51 110.879 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.456 HD13 HD13 ' A' ' 30' ' ' ILE . 22.0 tp -98.89 108.79 21.57 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.65 1.214 . . . . 1.14 108.484 174.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.5 t -105.88 143.12 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 128.926 2.891 . . . . 1.23 108.015 -178.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.8 mt . . . . . 0 N--CA 1.43 -1.473 0 CA-C-N 125.986 3.993 . . . . 2.78 108.848 -178.626 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ptt? . . . . . 0 CA--C 1.491 -1.314 0 CA-C-O 122.655 1.217 . . . . 1.1 112.804 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -96.0 139.97 31.42 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 107.45 -1.315 . . . . 1.87 107.45 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.256 16.3 pt -132.08 169.49 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 107.312 -1.366 . . . . 0.72 107.312 172.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -134.07 142.61 47.62 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.132 0.967 . . . . 1.4 113.02 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.57 134.13 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 O-C-N 118.837 -2.415 . . . . 0.58 110.416 168.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -96.79 149.11 22.21 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 117.419 -1.276 . . . . 2.09 109.63 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.321 4.8 p -103.85 -166.35 1.25 Allowed 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.501 2.375 . . . . 0.99 114.928 176.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.2 tp -76.18 -57.93 3.58 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 114.839 1.422 . . . . 2.53 114.839 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.2 p -70.5 -32.8 70.43 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 116.871 2.175 . . . . 2.08 116.871 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.07 58.32 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 118.757 -1.687 . . . . 1.31 115.597 172.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -118.18 138.2 52.47 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 121.109 2.455 . . . . 1.4 107.775 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.5 m -100.6 117.33 34.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 104.889 -2.263 . . . . 0.78 104.889 174.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.6 mt -96.47 116.54 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 106.219 -1.771 . . . . 1.55 106.219 174.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.406 3.6 m -83.08 121.53 27.16 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 126.039 1.736 . . . . 1.08 113.551 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.679 HD22 ' HB3' ' A' ' 29' ' ' LYS . 83.5 mt -123.03 143.16 50.13 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.635 -1.915 . . . . 1.55 112.201 -175.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -104.07 141.99 35.25 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 104.49 -2.411 . . . . 1.95 104.49 170.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.3 m -161.07 161.9 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 106.966 -1.494 . . . . 0.96 106.966 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 20' ' ' SER . 13.2 pt-20 -105.52 162.44 19.71 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-O 115.828 -2.034 . . . . 2.35 106.868 157.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.414 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 97.5 Cg_endo -74.33 -1.79 11.47 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 CA-C-N 124.592 2.676 . . . . 0.95 113.714 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.456 ' H ' ' HG3' ' A' ' 18' ' ' GLU . 67.1 m -90.72 -2.51 57.81 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 115.359 1.615 . . . . 1.45 115.359 171.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -66.73 131.07 45.18 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.146 2.403 . . . . 1.69 107.121 168.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 17.6 p -68.47 175.16 3.56 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 112.954 -1.93 . . . . 0.75 112.205 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.5 mm -74.66 -35.48 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 116.528 -3.858 . . . . 0.73 108.018 176.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -54.3 -46.66 72.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.213 -3.43 . . . . 1.62 115.351 165.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -56.86 -37.16 70.93 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 125.577 2.608 . . . . 2.13 112.79 171.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.56 -39.8 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 116.463 -3.898 . . . . 0.62 114.34 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -65.88 -33.3 75.52 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 117.621 2.452 . . . . 1.22 117.621 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.68 -23.75 61.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 111.598 -2.546 . . . . 0.51 110.691 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.679 ' HB3' HD22 ' A' ' 15' ' ' LEU . 42.2 mttm -75.72 -29.64 59.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 122.579 2.445 . . . . 1.44 113.564 168.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.6 mt -66.44 -42.29 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.908 -1.745 . . . . 1.32 110.195 171.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -58.54 -38.36 77.61 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.314 -3.366 . . . . 1.7 118.216 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -59.96 -32.83 71.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.989 2.218 . . . . 1.55 116.989 172.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.327 53.8 mmtt -89.15 -48.74 7.19 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.924 -3.61 . . . . 2.62 110.009 -174.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -112.39 -19.16 12.27 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 123.096 1.426 . . . . 1.48 114.164 -165.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.33 9.42 79.55 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 118.984 -2.323 . . . . 1.12 113.907 167.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.5 mt -81.58 133.26 53.04 Favored Pre-proline 0 N--CA 1.43 -1.457 0 O-C-N 120.951 -1.323 . . . . 1.55 112.237 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -69.17 148.78 69.63 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 CA-C-N 122.517 1.935 . . . . 1.02 113.681 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -71.14 -25.03 22.87 Favored 'Trans proline' 0 C--N 1.301 -1.953 1 C-N-CA 125.893 4.395 . . . . 1.25 115.211 -170.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -70.65 -27.13 63.81 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 128.348 2.659 . . . . 2.25 113.881 175.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -91.77 -1.94 57.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.432 2.293 . . . . 2.02 110.472 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -100.86 135.19 42.69 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.658 -1.901 . . . . 0.69 109.813 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 62.4 mtm180 -117.87 114.28 23.0 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.585 2.448 . . . . 2.78 110.191 173.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.516 ' HB3' HD12 ' A' ' 50' ' ' LEU . 76.6 mt -100.32 129.17 46.28 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 120.762 1.619 . . . . 1.17 110.515 -176.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.8 mm -110.77 128.17 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 125.638 1.575 . . . . 1.38 108.639 177.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -109.12 102.72 11.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.145 1.45 . . . . 1.5 107.155 170.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.312 . . 65.41 -63.62 0.2 Allowed 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.064 -2.897 . . . . 1.21 118.084 -173.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.429 ' H ' ' H ' ' A' ' 48' ' ' LYS . . . -162.6 -5.85 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.709 0 O-C-N 118.194 -2.816 . . . . 1.3 111.914 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.429 ' H ' ' H ' ' A' ' 47' ' ' GLY . 37.7 mtmt -95.38 143.08 27.03 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 125.843 1.555 . . . . 2.55 107.609 173.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -93.59 143.55 26.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.944 2.783 . . . . 2.48 111.37 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 43' ' ' LEU . 88.0 mt -94.76 132.05 39.94 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 113.857 -5.527 . . . . 0.9 108.217 -167.27 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -83.81 139.24 32.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.395 1.478 . . . . 1.94 109.292 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.287 8.5 m-20 -62.95 -50.11 72.09 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.499 -3.251 . . . . 1.56 119.701 -171.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.23 9.44 63.92 Favored Glycine 0 N--CA 1.43 -1.704 1 N-CA-C 123.183 4.033 . . . . 0.97 123.183 174.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -78.39 161.23 27.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 113.621 0.971 . . . . 2.49 113.621 168.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 81.1 p -89.39 164.9 14.67 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 118.955 2.946 . . . . 0.76 118.955 164.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 89.5 mt -64.32 -36.56 84.51 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.599 -3.188 . . . . 1.05 116.86 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.2 p -58.41 -29.0 65.74 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 128.1 2.56 . . . . 1.19 113.362 166.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -59.6 -47.5 85.35 Favored 'General case' 0 N--CA 1.43 -1.431 1 CA-C-N 127.312 4.596 . . . . 1.9 110.892 173.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -83.36 0.98 43.56 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.123 3.369 . . . . 0.89 114.056 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.3 m120 58.32 45.85 16.4 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.996 2.221 . . . . 1.84 116.996 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.4 mt -87.76 118.04 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 104.765 -2.309 . . . . 0.82 104.765 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -85.23 -163.21 0.81 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.737 -2.477 . . . . 2.16 109.029 -174.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 pttt -74.43 147.02 42.39 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.085 -2.259 . . . . 2.12 110.217 174.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 62.73 48.74 4.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.172 0.986 . . . . 1.71 109.622 170.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.1 m -108.59 141.29 40.73 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.853 -1.779 . . . . 1.04 110.203 -169.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.8 m -103.81 108.68 20.1 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 125.568 2.604 . . . . 0.79 108.656 -172.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mp -96.52 163.88 12.85 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 112.425 -2.17 . . . . 1.4 107.875 171.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -118.05 140.28 49.98 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.197 1.799 . . . . 1.51 111.937 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.7 tp -108.97 120.59 42.99 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.399 -3.313 . . . . 1.14 109.667 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.4 t -116.93 150.31 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 105.418 -2.067 . . . . 1.23 105.418 174.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 N--CA 1.43 -1.472 0 O-C-N 117.09 -3.506 . . . . 2.78 113.211 -177.049 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 ttp . . . . . 0 CA--C 1.49 -1.33 0 N-CA-C 116.563 2.061 . . . . 1.1 116.563 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -92.84 123.74 36.33 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.233 -2.792 . . . . 1.87 108.46 -170.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.335 50.4 pt -116.22 137.66 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.495 1.918 . . . . 0.72 112.73 176.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -104.83 100.05 9.69 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 116.58 2.067 . . . . 1.4 116.58 -176.371 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.3 t -84.53 96.9 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 124.537 2.113 . . . . 0.58 111.89 178.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -95.74 122.75 38.85 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.48 1.61 . . . . 2.09 109.423 -174.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 69' ' ' LEU 0.29 20.2 p -89.99 167.27 12.92 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.787 2.035 . . . . 0.99 114.19 -176.475 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.8 tp -66.24 -32.19 73.46 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 126.009 2.814 . . . . 2.53 115.455 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.6 p -77.44 -48.24 17.67 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.428 1.891 . . . . 2.08 111.854 -178.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.3 -1.21 0.53 Allowed Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 117.174 1.63 . . . . 1.31 117.174 173.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -78.11 139.66 39.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 119.372 1.586 . . . . 1.4 109.133 -177.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -104.17 112.09 24.95 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.644 -2.535 . . . . 0.78 105.435 169.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -93.06 105.51 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 103.413 -2.81 . . . . 1.55 103.413 178.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -84.74 107.08 16.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.006 2.224 . . . . 1.08 117.006 177.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.2 mt -105.27 136.72 44.27 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 121.122 1.783 . . . . 1.55 107.518 -175.076 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -87.99 90.9 8.57 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 124.154 1.931 . . . . 1.95 108.625 168.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.21 176.27 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 128.571 2.749 . . . . 0.96 109.11 -176.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -117.88 151.37 48.68 Favored Pre-proline 0 N--CA 1.431 -1.413 0 O-C-N 124.917 1.386 . . . . 2.35 108.638 161.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -74.26 -11.96 23.06 Favored 'Trans proline' 0 N--CA 1.434 -2.004 1 O-C-N 112.794 -4.371 . . . . 0.95 115.208 -170.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.4 p -81.98 -15.35 54.04 Favored 'General case' 0 N--CA 1.429 -1.476 1 C-N-CA 132.297 4.239 . . . . 1.45 110.315 174.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -68.62 153.38 43.88 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 120.756 1.616 . . . . 1.69 110.942 172.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 25.2 p -87.6 166.87 14.4 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.353 1.861 . . . . 0.75 108.93 -179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.2 mm -71.61 -36.0 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 124.455 2.074 . . . . 0.73 113.188 175.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -38.82 -42.97 0.88 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.853 -3.03 . . . . 1.62 117.047 159.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -76.94 -38.18 53.86 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.226 -2.796 . . . . 2.13 108.489 179.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.462 HG21 HD21 ' A' ' 56' ' ' LEU . 76.9 t -55.89 -39.09 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 127.354 2.261 . . . . 0.62 114.269 172.355 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 86.3 mttt -81.05 -19.34 44.0 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.612 -2.555 . . . . 1.22 115.88 173.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.07 -38.59 63.88 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 122.819 1.295 . . . . 0.51 109.486 174.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -63.24 -29.29 70.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.633 -2.542 . . . . 1.44 113.864 174.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.3 mt -77.88 -24.34 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 116.661 2.097 . . . . 1.32 116.661 169.156 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -76.42 -30.48 57.46 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.27 -3.394 . . . . 1.7 110.025 173.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -76.5 -43.33 40.02 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.805 1.288 . . . . 1.55 112.129 173.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -77.4 -69.36 0.54 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.347 -2.096 . . . . 2.62 114.506 -173.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -80.46 -51.17 9.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.677 -1.147 . . . . 1.48 113.153 -172.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.09 43.03 1.13 Allowed Glycine 0 N--CA 1.429 -1.796 0 O-C-N 125.508 1.755 . . . . 1.12 111.232 175.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.3 mt -104.3 132.99 20.45 Favored Pre-proline 0 N--CA 1.431 -1.386 0 C-N-CA 125.557 1.543 . . . . 1.55 107.377 -178.16 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -70.85 138.96 35.42 Favored 'Trans proline' 0 N--CA 1.433 -2.067 1 C-N-CA 126.054 4.502 . . . . 1.02 111.54 -178.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.431 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 36.3 Cg_exo -71.52 -19.47 28.33 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 O-C-N 117.924 -1.671 . . . . 1.25 112.434 -169.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -62.4 -35.02 77.9 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 114.83 1.418 . . . . 2.25 114.83 165.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -87.57 -13.93 41.55 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 124.037 0.935 . . . . 2.02 112.628 -179.173 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.329 71.3 mt-30 -84.78 113.01 21.02 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 120.957 1.708 . . . . 0.69 107.701 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -92.34 134.5 34.86 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 116.676 -1.63 . . . . 2.78 106.712 165.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.8 mt -127.79 125.42 39.81 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 102.629 -3.1 . . . . 1.17 102.629 177.138 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -115.13 137.3 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 115.947 -1.978 . . . . 1.38 105.788 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -124.06 107.4 11.25 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.227 2.285 . . . . 1.5 107.628 171.172 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.363 . . 74.55 -77.07 0.06 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.517 2.58 . . . . 1.21 114.922 -173.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.3 -0.67 0.24 Allowed Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 129.917 3.627 . . . . 1.3 115.42 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -111.56 114.01 26.8 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 124.663 1.185 . . . . 2.55 110.565 -179.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -81.13 127.94 33.19 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 124.56 1.144 . . . . 2.48 111.885 176.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.44 HD22 ' CD2' ' A' ' 59' ' ' TYR . 69.7 mt -79.82 120.36 23.97 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 120.338 3.458 . . . . 0.9 120.338 -162.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.288 37.1 mt-10 -78.22 138.63 38.74 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.216 -2.177 . . . . 1.94 113.758 -176.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.66 -45.33 92.36 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 112.616 -2.084 . . . . 1.56 113.072 -171.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.59 25.14 9.88 Favored Glycine 0 N--CA 1.43 -1.713 0 C-N-CA 125.763 1.649 . . . . 0.97 116.601 175.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -112.7 166.36 11.43 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.99 1.852 . . . . 2.49 110.309 165.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 12.2 p -101.28 169.17 9.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.134 -2.854 . . . . 0.76 106.424 176.369 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.462 HD21 HG21 ' A' ' 26' ' ' VAL . 62.6 mt -65.95 -38.19 87.96 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.576 2.608 . . . . 1.05 112.304 172.185 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.0 p -60.34 -41.1 92.89 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.923 -4.236 . . . . 1.19 116.067 -178.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -53.47 -49.7 66.88 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 117.715 2.487 . . . . 1.9 117.715 169.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.44 ' CD2' HD22 ' A' ' 50' ' ' LEU . 59.9 m-85 -67.26 -10.41 50.44 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.659 2.466 . . . . 0.89 117.659 173.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.309 64.8 t30 73.93 47.62 0.15 Allowed 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.573 -2.58 . . . . 1.84 105.167 -177.402 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.6 mt -100.59 119.82 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 102.829 -3.026 . . . . 0.82 102.829 177.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -115.09 -167.8 1.29 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 114.219 -1.355 . . . . 2.16 112.274 -176.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -60.27 138.86 57.87 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.611 2.448 . . . . 2.12 117.611 169.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.432 20.8 mt-10 69.19 22.97 6.54 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.007 2.225 . . . . 1.71 117.007 174.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.4 m -83.16 141.06 32.22 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.209 2.604 . . . . 1.04 113.913 -175.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.4 m -94.65 116.1 28.34 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.3 -3.375 . . . . 0.79 107.464 -174.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -109.68 128.38 55.22 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 104.87 -2.27 . . . . 1.4 104.87 174.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -88.8 121.53 31.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 114.531 -2.652 . . . . 1.51 115.085 -177.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.412 ' HB3' HG22 ' A' ' 7' ' ' THR . 9.8 tp -89.14 120.27 30.38 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 123.827 3.012 . . . . 1.14 114.376 175.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.45 169.23 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 120.651 -1.281 . . . . 1.23 107.852 172.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 N--CA 1.43 -1.462 0 O-C-N 117.89 -3.007 . . . . 2.78 107.528 177.783 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.316 0 N-CA-C 114.325 1.231 . . . . 1.1 114.325 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.267 0.7 OUTLIER -97.39 131.96 43.56 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.023 1.49 . . . . 1.87 115.023 -175.607 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -112.5 145.14 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 117.896 -3.002 . . . . 0.72 110.131 172.114 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -109.87 112.83 25.1 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 103.984 -2.599 . . . . 1.4 103.984 -173.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.52 103.1 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 104.071 -2.566 . . . . 0.58 104.071 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -102.76 131.11 49.83 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 112.58 0.585 . . . . 2.09 112.58 -179.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.4 p -93.16 176.81 6.27 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 128.155 3.409 . . . . 0.99 119.39 -177.157 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.3 tp -67.03 -37.57 84.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 124.92 3.509 . . . . 2.53 112.047 170.206 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.8 p -78.87 6.63 8.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 129.926 3.29 . . . . 2.08 111.313 -171.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.68 5.25 57.76 Favored Glycine 0 N--CA 1.43 -1.716 0 CA-C-N 125.001 3.546 . . . . 1.31 113.671 169.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -93.99 133.66 37.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.317 2.247 . . . . 1.4 115.719 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.5 m -108.39 117.18 33.48 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.277 -1.009 . . . . 0.78 108.277 171.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 mt -105.02 113.7 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 101.238 -3.615 . . . . 1.55 101.238 -179.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.4 m -101.19 117.33 34.79 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 120.819 1.645 . . . . 1.08 107.426 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.7 mt -102.06 151.38 22.23 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.985 3.314 . . . . 1.55 114.677 178.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -105.48 104.72 14.5 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 121.636 3.939 . . . . 1.95 121.636 168.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.432 HG12 ' HE2' ' A' ' 29' ' ' LYS . 14.3 m -119.91 168.36 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 112.452 -2.158 . . . . 0.96 109.528 -177.528 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -105.44 159.88 27.96 Favored Pre-proline 0 N--CA 1.431 -1.409 0 C-N-CA 125.713 1.605 . . . . 2.35 108.772 164.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.89 -18.44 16.88 Favored 'Trans proline' 0 N--CA 1.435 -1.967 0 O-C-N 115.767 -2.807 . . . . 0.95 113.537 -170.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.4 m -86.67 2.72 47.51 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.438 -2.039 . . . . 1.45 115.989 174.482 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -79.27 148.13 32.27 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 127.463 2.305 . . . . 1.69 109.766 172.124 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.5 p -76.99 161.04 28.67 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 127.147 2.179 . . . . 0.75 116.197 175.306 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.8 mm -71.56 -31.36 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 125.738 1.615 . . . . 0.73 111.944 173.546 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -50.87 -46.65 60.44 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.142 2.401 . . . . 1.62 114.562 162.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.282 6.3 t-20 -63.4 -45.13 92.45 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 116.226 -4.046 . . . . 2.13 114.949 176.755 . . . . . . . . 3 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -48.11 -38.81 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 127.893 2.477 . . . . 0.62 115.816 168.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -66.82 -34.58 78.13 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.392 -2.692 . . . . 1.22 113.603 173.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.0 -32.43 61.65 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.583 -2.573 . . . . 0.51 112.345 176.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HE2' HG12 ' A' ' 17' ' ' VAL . 38.4 mttp -58.5 -38.73 78.26 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 120.688 1.585 . . . . 1.44 115.199 165.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.7 mt -71.55 -37.34 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 130.766 3.626 . . . . 1.32 111.902 177.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -59.81 -47.43 85.73 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 129.027 2.931 . . . . 1.7 109.364 169.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.4 -54.9 41.41 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.613 2.625 . . . . 1.55 115.127 171.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -72.49 -67.51 0.55 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.712 -3.118 . . . . 2.62 112.696 -175.564 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -77.53 -55.37 5.43 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 120.035 -1.666 . . . . 1.48 114.639 -174.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.94 25.98 0.65 Allowed Glycine 0 N--CA 1.43 -1.716 0 O-C-N 118.136 -2.853 . . . . 1.12 110.326 174.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.0 mt -99.95 140.09 21.26 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-N 123.344 3.572 . . . . 1.55 105.365 -167.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 12.8 Cg_exo -66.85 159.04 53.47 Favored 'Trans proline' 0 N--CA 1.433 -2.066 0 CA-C-N 125.128 2.867 . . . . 1.02 111.053 176.131 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 73.7 Cg_exo -78.23 -3.52 13.49 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 CA-C-N 122.635 1.977 . . . . 1.25 111.907 -175.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.271 96.0 m-20 -88.22 -29.65 20.3 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 125.813 2.72 . . . . 2.25 112.727 174.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -84.51 16.04 3.38 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 116.351 1.982 . . . . 2.02 116.351 -179.079 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -126.08 129.72 49.69 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.93 1.292 . . . . 0.69 109.78 -176.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -118.7 134.78 54.88 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.443 2.697 . . . . 2.78 108.973 167.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.5 mt -120.01 123.98 44.78 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 113.715 -1.584 . . . . 1.17 114.303 178.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 23.7 mm -99.9 145.59 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 101.397 -3.557 . . . . 1.38 101.397 175.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.438 ' HB3' HD21 ' A' ' 50' ' ' LEU . 27.3 t80 -139.16 123.82 18.49 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 101.404 -3.554 . . . . 1.5 101.404 168.153 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.07 -68.59 0.21 Allowed 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 127.487 2.992 . . . . 1.21 112.402 -172.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.25 -32.03 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 114.412 -1.267 . . . . 1.3 115.117 -179.112 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.276 12.4 ptpt -74.93 151.15 38.9 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.174 1.175 . . . . 2.55 114.174 177.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -87.16 105.34 17.13 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 131.066 3.746 . . . . 2.48 113.326 174.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.452 HD22 ' CD2' ' A' ' 59' ' ' TYR . 61.9 mt -66.77 158.37 30.51 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.074 -2.266 . . . . 0.9 109.536 -161.285 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -91.27 156.18 18.0 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 124.855 2.264 . . . . 1.94 108.862 170.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -74.53 -66.37 0.75 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.504 -1.997 . . . . 1.56 114.186 -178.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.46 50.21 1.69 Allowed Glycine 0 N--CA 1.43 -1.761 0 O-C-N 118.057 -2.902 . . . . 0.97 115.177 168.245 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -122.7 160.38 25.99 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.346 -1.679 . . . . 2.49 106.962 159.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.2 p -85.68 169.17 13.72 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.675 -1.891 . . . . 0.76 113.325 176.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.1 mt -66.05 -33.12 75.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.844 2.458 . . . . 1.05 115.185 171.037 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.7 p -70.25 -32.91 70.96 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.408 -2.682 . . . . 1.19 114.784 176.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -67.59 -27.46 66.94 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.721 1.608 . . . . 1.9 115.252 177.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.452 ' CD2' HD22 ' A' ' 50' ' ' LEU . 59.8 m-85 -89.15 -14.8 35.33 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.074 2.25 . . . . 0.89 117.074 170.045 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.3 22.1 m120 75.77 45.68 0.12 Allowed 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.016 2.969 . . . . 1.84 119.016 -174.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.442 HG23 ' HB2' ' A' ' 65' ' ' SER . 16.1 mt -91.32 107.9 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 129.833 3.253 . . . . 0.82 107.576 172.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -99.73 -165.11 1.19 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.53 1.932 . . . . 2.16 108.359 179.279 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -56.7 144.41 32.58 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.35 -2.719 . . . . 2.12 114.887 170.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 68.46 17.98 9.04 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.269 2.462 . . . . 1.71 114.97 171.436 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.442 ' HB2' HG23 ' A' ' 61' ' ' ILE . 69.7 m -80.89 131.43 35.36 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 125.675 2.655 . . . . 1.04 110.938 -169.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.0 m -80.61 110.38 16.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.758 -1.565 . . . . 0.79 115.109 176.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.46 155.17 17.98 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.476 2.71 . . . . 1.4 106.148 172.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.505 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 60.8 m80 -119.14 109.63 16.11 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.44 -2.037 . . . . 1.51 112.722 -170.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.1 tp -93.48 112.3 24.17 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 125.125 1.516 . . . . 1.14 112.338 -172.7 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.68 125.5 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 127.921 2.488 . . . . 1.23 110.266 179.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.8 tp . . . . . 0 N--CA 1.43 -1.46 0 O-C-N 117.679 -3.138 . . . . 2.78 106.623 -175.133 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptt? . . . . . 0 CA--C 1.489 -1.398 0 CA-C-O 126.429 3.014 . . . . 1.1 113.551 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -89.03 125.4 34.99 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.444 -1.707 . . . . 1.87 110.888 -174.506 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 pt -121.05 146.61 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 104.773 -2.306 . . . . 0.72 104.773 166.33 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -97.17 134.69 40.16 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 131.618 3.967 . . . . 1.4 103.677 -179.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.5 t -130.4 106.18 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 124.488 2.09 . . . . 0.58 106.947 172.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -96.65 142.93 28.1 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.185 1.469 . . . . 2.09 112.914 -176.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.1 p -82.02 179.32 7.86 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 118.339 -2.725 . . . . 0.99 114.345 175.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.7 tp -81.08 -30.73 34.65 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.661 2.384 . . . . 2.53 107.12 175.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -75.01 -44.91 45.39 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.614 -3.804 . . . . 2.08 112.36 -170.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.98 -3.59 0.16 Allowed Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 117.577 -2.249 . . . . 1.31 114.732 173.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -110.99 138.89 46.84 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 114.574 1.324 . . . . 1.4 114.574 -172.245 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -102.21 128.86 48.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 115.138 -2.363 . . . . 0.78 112.936 177.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.294 30.6 pt -107.14 145.8 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 106.773 -1.566 . . . . 1.55 106.773 176.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.9 m -97.51 134.4 40.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 111.802 -2.454 . . . . 1.08 112.639 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.64 142.43 50.66 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.701 1.715 . . . . 1.55 109.728 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -108.75 122.79 47.89 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 116.479 -3.888 . . . . 1.95 109.012 169.015 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.6 m -136.29 154.54 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 125.38 1.472 . . . . 0.96 107.887 -171.135 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -95.26 152.63 39.52 Favored Pre-proline 0 N--CA 1.43 -1.437 0 C-N-CA 130.896 3.679 . . . . 2.35 108.397 160.117 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -76.27 -7.28 17.9 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 C-N-CA 123.769 2.979 . . . . 0.95 111.322 -174.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.5 m -94.91 0.51 54.8 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.125 1.77 . . . . 1.45 111.524 175.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.53 142.65 38.94 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.178 -2.826 . . . . 1.69 108.794 174.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 p -84.58 173.29 10.9 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 124.498 1.119 . . . . 0.75 113.393 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.2 mm -65.29 -36.41 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 118.766 -2.459 . . . . 0.73 112.682 170.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.307 3.1 mp0 -54.11 -48.49 70.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.874 -2.391 . . . . 1.62 116.084 165.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -63.24 -36.13 82.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 112.628 0.603 . . . . 2.13 112.628 175.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.9 t -62.11 -52.13 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 126.681 1.992 . . . . 0.62 111.932 175.404 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -57.71 -40.39 79.44 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.848 1.259 . . . . 1.22 111.82 176.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.312 . . -50.9 -38.93 52.87 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 120.458 3.503 . . . . 0.51 120.458 167.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -74.65 -24.1 58.77 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.424 -2.048 . . . . 1.44 115.277 177.034 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.9 mt -78.51 -35.65 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 129.313 3.045 . . . . 1.32 106.012 177.034 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -75.98 -36.56 59.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.823 -1.798 . . . . 1.7 111.972 -179.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -55.56 -48.04 75.41 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 128.55 2.74 . . . . 1.55 108.625 174.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -87.66 -59.49 2.23 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.125 -2.234 . . . . 2.62 114.478 -177.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -86.55 -25.4 25.06 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 115.11 1.522 . . . . 1.48 115.11 -172.043 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.14 26.55 33.63 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 119.441 -1.361 . . . . 1.12 113.156 175.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.7 mt -96.05 115.67 65.72 Favored Pre-proline 0 N--CA 1.43 -1.454 1 CA-C-O 111.631 -4.033 . . . . 1.55 110.103 -177.179 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.29 164.81 34.47 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 CA-C-N 126.975 3.527 . . . . 1.02 115.142 -177.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -65.37 -34.27 44.63 Favored 'Trans proline' 0 N--CA 1.434 -1.982 0 CA-C-O 115.833 -1.82 . . . . 1.25 116.717 -165.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -45.46 -38.74 6.44 Favored 'General case' 0 N--CA 1.43 -1.461 1 C-N-CA 132.382 4.273 . . . . 2.25 116.171 170.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -96.94 2.27 51.4 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.608 2.363 . . . . 2.02 113.856 -176.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -88.1 99.61 12.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 116.751 -3.718 . . . . 0.69 107.811 -173.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -90.66 112.02 23.59 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 118.384 -2.697 . . . . 2.78 109.88 163.247 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.8 mt -105.3 129.84 53.56 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.154 1.781 . . . . 1.17 109.805 175.087 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 3.4 mp -123.9 129.27 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 127.571 2.348 . . . . 1.38 109.136 177.201 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.46 ' HB3' HD21 ' A' ' 50' ' ' LEU . 73.1 t80 -123.14 114.29 20.12 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 104.438 -2.43 . . . . 1.5 104.438 171.478 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.37 -110.48 0.54 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 110.224 -3.171 . . . . 1.21 112.545 -170.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.13 4.27 35.59 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 126.492 1.996 . . . . 1.3 114.204 177.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -105.76 129.1 54.03 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.91 1.684 . . . . 2.55 114.739 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -82.5 126.6 32.43 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 126.558 1.943 . . . . 2.48 109.129 170.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.46 HD21 ' HB3' ' A' ' 45' ' ' PHE . 18.3 mt -79.5 128.89 33.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.501 1.92 . . . . 0.9 109.756 -173.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -112.68 179.13 4.06 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.207 2.432 . . . . 1.94 110.874 178.261 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -79.77 151.87 30.12 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 117.197 -1.801 . . . . 1.56 112.763 -171.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.71 -0.57 81.47 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 119.524 -1.985 . . . . 0.97 116.914 170.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -87.54 159.42 18.62 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 125.575 1.397 . . . . 2.49 110.505 169.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.266 70.4 p -100.08 167.52 10.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.937 2.303 . . . . 0.76 112.397 173.357 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.21 -29.75 70.85 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 117.086 -3.509 . . . . 1.05 112.221 164.484 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 t -68.8 -30.95 69.63 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.156 -1.59 . . . . 1.19 112.111 178.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -62.84 -50.34 71.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 114.904 1.446 . . . . 1.9 114.904 172.351 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -81.87 11.9 4.55 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 115.927 -1.987 . . . . 0.89 111.788 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 m120 56.96 46.08 20.1 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 125.559 2.6 . . . . 1.84 115.04 178.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.3 mt -91.82 122.61 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 112.354 -2.203 . . . . 0.82 110.154 178.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -108.58 173.53 6.28 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 127.176 2.797 . . . . 2.16 109.477 -173.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -59.53 142.7 52.06 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.482 1.66 . . . . 2.12 115.482 173.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 5.7 tt0 75.71 15.2 2.64 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 126.271 2.939 . . . . 1.71 116.32 174.07 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 m -77.35 139.97 39.86 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 113.605 -1.634 . . . . 1.04 108.048 -175.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -109.51 90.94 3.45 Favored 'General case' 0 N--CA 1.429 -1.497 1 O-C-N 116.016 -4.177 . . . . 0.79 114.772 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -65.45 153.13 42.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.904 2.288 . . . . 1.4 112.82 173.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.415 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 18.5 m80 -105.53 101.51 11.03 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 115.815 -4.303 . . . . 1.51 109.326 -178.864 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.0 tp -91.89 108.74 20.14 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 121.018 1.736 . . . . 1.14 110.116 173.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -98.69 129.98 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 1 C-N-CA 134.069 4.947 . . . . 1.23 106.804 173.479 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.4 tp . . . . . 0 N--CA 1.43 -1.45 0 CA-C-N 111.911 -2.404 . . . . 2.78 112.861 174.179 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptt? . . . . . 0 CA--C 1.49 -1.34 0 N-CA-C 113.533 0.938 . . . . 1.1 113.533 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -105.38 124.33 49.37 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.371 3.068 . . . . 1.87 112.688 -175.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.1 pt -123.8 155.36 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 C-N-CA 129.349 3.06 . . . . 0.72 110.645 175.166 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -114.42 132.8 56.12 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 112.305 -2.225 . . . . 1.4 112.007 -171.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.86 97.22 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 103.192 -2.892 . . . . 0.58 103.192 178.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -90.62 141.09 29.14 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.529 -1.982 . . . . 2.09 112.403 174.552 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.7 p -107.31 165.39 11.42 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 120.126 1.33 . . . . 0.99 110.406 176.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.3 tp -52.7 -36.18 56.84 Favored 'General case' 0 N--CA 1.43 -1.435 1 C-N-CA 134.79 5.236 . . . . 2.53 116.974 177.65 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.4 p -90.08 -19.81 23.91 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.789 -3.07 . . . . 2.08 111.195 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.56 12.38 2.5 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 118.878 -2.389 . . . . 1.31 114.592 169.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -94.21 135.4 35.64 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 119.809 1.805 . . . . 1.4 110.433 -176.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.1 m -115.41 108.7 16.85 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.625 -4.422 . . . . 0.78 108.506 178.45 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -81.48 124.01 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.455 2.302 . . . . 1.55 108.594 175.076 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.6 m -101.32 98.27 8.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.435 -2.666 . . . . 1.08 108.518 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 mt -100.07 139.91 35.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 127.821 3.676 . . . . 1.55 108.829 179.108 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -96.35 132.1 42.19 Favored 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 114.532 -5.105 . . . . 1.95 107.882 172.494 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.82 168.33 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 126.886 2.074 . . . . 0.96 109.763 179.007 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -105.43 160.61 25.44 Favored Pre-proline 0 N--CA 1.429 -1.477 0 O-C-N 119.457 -2.027 . . . . 2.35 105.927 165.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -79.59 -16.6 11.69 Favored 'Trans proline' 0 N--CA 1.434 -2.004 1 CA-C-N 129.395 4.391 . . . . 0.95 112.027 -168.437 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.8 p -85.32 2.9 42.14 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.681 -2.512 . . . . 1.45 116.272 173.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -71.12 140.04 50.48 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 125.44 1.713 . . . . 1.69 109.98 173.3 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.444 42.7 p -84.46 161.02 20.45 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.848 -1.782 . . . . 0.75 110.646 -178.624 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.9 mm -52.98 -27.86 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 C-N-CA 126.46 1.904 . . . . 0.73 115.124 170.471 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -57.65 -44.87 85.95 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.292 2.637 . . . . 1.62 115.687 167.278 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -65.13 -37.35 87.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.787 2.708 . . . . 2.13 115.598 178.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.417 HG21 HD21 ' A' ' 56' ' ' LEU . 21.3 t -72.75 -47.63 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 112.333 -2.212 . . . . 0.62 115.086 177.517 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -65.75 -17.05 64.35 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 114.581 1.326 . . . . 1.22 114.581 169.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.28 -41.28 17.02 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 119.958 1.253 . . . . 0.51 108.198 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -59.64 -31.83 69.89 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.143 1.905 . . . . 1.44 116.143 170.413 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.77 -49.73 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.453 1.597 . . . . 1.32 114.706 170.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -59.56 -37.51 78.65 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 113.662 0.986 . . . . 1.7 113.662 177.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.7 -37.95 77.21 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.62 -3.175 . . . . 1.55 113.684 176.357 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -92.56 -59.64 2.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.265 1.983 . . . . 2.62 114.364 -177.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -84.97 -27.45 26.49 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 118.622 -2.549 . . . . 1.48 113.074 -169.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.32 24.43 26.56 Favored Glycine 0 N--CA 1.431 -1.684 0 CA-C-O 124.497 2.165 . . . . 1.12 109.423 169.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.3 mt -91.82 112.79 56.41 Favored Pre-proline 0 N--CA 1.431 -1.411 0 CA-C-N 113.225 -1.487 . . . . 1.55 110.461 -171.365 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.255 18.4 Cg_exo -55.37 139.68 81.75 Favored 'Trans proline' 0 N--CA 1.433 -2.058 1 N-CA-C 123.69 4.458 . . . . 1.02 123.69 174.821 . . . . . . . . 3 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -62.01 -22.26 73.91 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 C-N-CA 123.659 2.906 . . . . 1.25 111.013 -175.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.63 -31.32 71.92 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.883 1.801 . . . . 2.25 110.864 173.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -88.09 -14.84 37.81 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 116.413 -3.929 . . . . 2.02 115.562 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -78.98 98.94 6.62 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 112.139 -2.301 . . . . 0.69 106.659 -173.102 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -102.8 107.48 18.36 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.097 -2.927 . . . . 2.78 103.097 169.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.4 mt -105.28 148.12 27.35 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 114.597 -2.841 . . . . 1.17 105.049 -175.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 mm -125.1 131.78 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 109.38 -0.6 . . . . 1.38 109.38 -179.258 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -122.23 108.79 13.69 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.888 -2.382 . . . . 1.5 104.799 168.432 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.87 -92.67 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.18 2.192 . . . . 1.21 110.01 179.051 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.4 -26.69 4.74 Favored Glycine 0 N--CA 1.429 -1.811 0 CA-C-N 113.68 -1.6 . . . . 1.3 109.974 -173.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.383 51.2 mttm -99.07 134.97 41.15 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.018 -3.048 . . . . 2.55 118.26 -176.304 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -90.08 116.04 27.8 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 105.836 -1.912 . . . . 2.48 105.836 176.206 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.3 118.97 10.09 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 123.607 1.67 . . . . 0.9 111.521 -169.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.12 154.13 20.41 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 116.531 -3.856 . . . . 1.94 110.682 -179.308 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -68.98 152.73 44.89 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.59 -1.943 . . . . 1.56 114.178 -173.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.47 10.55 85.65 Favored Glycine 0 N--CA 1.43 -1.709 0 O-C-N 119.454 -2.029 . . . . 0.97 112.57 173.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -104.24 171.3 7.41 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.992 2.33 . . . . 2.49 110.245 170.253 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.1 p -106.32 -174.09 2.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.524 -3.86 . . . . 0.76 104.876 174.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.417 HD21 HG21 ' A' ' 26' ' ' VAL . 80.8 mt -83.02 -35.56 25.69 Favored 'General case' 0 N--CA 1.431 -1.423 1 C-N-CA 133.367 4.667 . . . . 1.05 110.477 174.882 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -70.41 -25.88 63.42 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.221 -3.425 . . . . 1.19 114.938 175.726 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -59.9 -34.06 72.67 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.894 -3.004 . . . . 1.9 111.81 168.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -92.76 11.53 26.59 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 121.42 1.918 . . . . 0.89 111.177 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.33 10.9 m120 53.26 36.29 22.28 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 127.47 2.308 . . . . 1.84 116.34 -175.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.4 mt -85.9 129.2 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 127.625 2.37 . . . . 0.82 108.464 -176.713 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -123.66 -167.01 1.55 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.253 -2.779 . . . . 2.16 110.91 -173.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -58.44 141.42 51.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.651 0.982 . . . . 2.12 113.651 178.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 69.28 33.71 3.17 Favored 'General case' 0 N--CA 1.43 -1.465 1 C-N-CA 132.199 4.199 . . . . 1.71 109.316 175.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 m -101.24 142.93 31.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 123.075 2.671 . . . . 1.04 107.562 -172.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.3 m -102.4 102.74 13.1 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 116.083 -1.913 . . . . 0.79 110.65 -171.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.317 57.6 mt -78.69 147.37 33.52 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.767 -1.197 . . . . 1.4 107.767 169.26 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -101.73 128.12 48.2 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.998 -1.064 . . . . 1.51 109.006 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.2 tt -93.61 104.33 16.45 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 118.661 -2.525 . . . . 1.14 110.391 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.0 t -107.67 129.48 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 O-C-N 117.157 -3.464 . . . . 1.23 109.408 -179.09 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.4 mt . . . . . 0 N--CA 1.43 -1.444 0 O-C-N 118.201 -2.812 . . . . 2.78 111.651 -177.88 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.351 19.0 ptt? . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 118.131 -0.938 . . . . 1.1 111.139 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -100.69 132.9 45.85 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 125.965 1.706 . . . . 1.87 106.972 -171.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.04 157.5 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 115.181 -2.342 . . . . 0.72 109.525 166.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -107.59 143.95 35.31 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.161 1.458 . . . . 1.4 111.782 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 t -123.44 124.44 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 105.583 -2.006 . . . . 0.58 105.583 171.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -114.69 135.89 53.66 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 117.15 2.278 . . . . 2.09 117.15 178.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.515 21.3 p -69.59 -175.59 0.88 Allowed 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.82 2.247 . . . . 0.99 113.707 179.386 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.3 mt -89.99 -33.67 16.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.482 -3.261 . . . . 2.53 113.913 165.589 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 p -74.49 -56.08 5.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.865 -1.772 . . . . 2.08 114.606 -176.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.07 31.16 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 119.997 2.759 . . . . 1.31 119.997 174.412 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -121.8 128.48 51.74 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.507 2.099 . . . . 1.4 111.423 -175.467 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.278 32.3 m -103.5 130.55 50.9 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.271 -2.143 . . . . 0.78 111.541 172.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -100.67 149.83 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 129.682 3.193 . . . . 1.55 107.912 176.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.5 m -123.46 131.17 53.56 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 122.22 2.282 . . . . 1.08 105.468 172.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.8 mt -119.4 128.57 54.17 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 116.047 -1.93 . . . . 1.55 114.048 -179.6 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -80.0 112.43 17.29 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 115.138 1.533 . . . . 1.95 115.138 165.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.86 174.93 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.578 -2.576 . . . . 0.96 104.701 -171.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -124.02 171.67 6.76 Favored Pre-proline 0 N--CA 1.43 -1.475 0 CA-C-O 114.233 -2.794 . . . . 2.35 104.979 165.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -76.11 -7.75 18.34 Favored 'Trans proline' 0 N--CA 1.434 -1.996 1 CA-C-N 130.02 4.614 . . . . 0.95 114.093 -177.369 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.5 p -83.24 -15.92 48.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 129.922 3.289 . . . . 1.45 109.959 179.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.69 139.96 58.24 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 114.542 1.312 . . . . 1.69 114.542 174.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 p -85.3 164.45 18.0 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 118.109 -2.869 . . . . 0.75 115.929 172.594 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.4 mm -64.56 -24.92 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 119.152 -2.218 . . . . 0.73 115.611 173.269 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -74.98 -31.7 61.51 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 116.053 -1.927 . . . . 1.62 114.901 165.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -66.68 -41.23 88.45 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 120.4 1.455 . . . . 2.13 110.194 174.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.68 -48.43 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 114.29 -2.767 . . . . 0.62 111.135 174.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -54.86 -45.2 74.55 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 122.144 2.247 . . . . 1.22 114.002 176.219 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.05 -41.16 87.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.174 1.916 . . . . 0.51 116.174 168.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -61.06 -41.36 96.47 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.292 2.237 . . . . 1.44 110.435 173.36 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.4 mt -64.37 -32.91 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 121.096 1.771 . . . . 1.32 114.474 169.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -62.69 -43.07 99.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.431 1.092 . . . . 1.7 112.503 175.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -56.1 -42.5 76.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.391 -2.693 . . . . 1.55 113.567 174.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -74.99 -66.64 0.73 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.626 1.343 . . . . 2.62 114.626 -178.117 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -95.29 -21.23 18.55 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.241 2.617 . . . . 1.48 115.389 -166.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.37 1.78 68.74 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 127.954 3.284 . . . . 1.12 113.704 175.783 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 mt -72.1 126.63 91.14 Favored Pre-proline 0 N--CA 1.429 -1.481 0 C-N-CA 125.538 1.535 . . . . 1.55 113.44 -177.075 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.524 ' HG2' ' HG3' ' A' ' 40' ' ' GLN . 18.3 Cg_endo -72.67 150.62 50.92 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 O-C-N 113.651 -3.921 . . . . 1.02 116.341 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -63.59 -32.16 69.8 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 CA-C-N 124.045 2.48 . . . . 1.25 111.48 -171.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -57.61 -29.7 64.73 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 114.939 -4.851 . . . . 2.25 114.775 176.594 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.524 ' HG3' ' HG2' ' A' ' 37' ' ' PRO . 88.7 mt-30 -90.73 -21.0 21.79 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 119.108 -1.037 . . . . 2.02 111.138 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.279 57.9 mt-30 -78.68 140.0 38.42 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 120.328 -1.483 . . . . 0.69 114.134 -174.623 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -126.44 126.44 43.8 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.771 1.748 . . . . 2.78 106.741 170.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.305 29.3 mt -98.21 111.74 23.96 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 118.868 -2.395 . . . . 1.17 111.203 178.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mm -105.95 121.02 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 124.327 1.051 . . . . 1.38 111.846 -178.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -114.36 98.31 6.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 129.06 2.944 . . . . 1.5 112.638 168.135 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.1 -106.22 0.21 Allowed 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.335 -2.728 . . . . 1.21 113.837 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.94 -12.44 55.37 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 128.704 3.05 . . . . 1.3 112.867 -179.28 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -114.06 149.3 35.68 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 123.28 3.54 . . . . 2.55 106.403 -173.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -106.83 142.87 35.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 100.673 -3.825 . . . . 2.48 100.673 169.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 mt -103.24 130.19 50.41 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 116.434 -2.106 . . . . 0.9 111.655 -172.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -81.19 141.32 34.3 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 118.028 2.603 . . . . 1.94 118.028 -174.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -60.66 132.0 52.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.609 1.818 . . . . 1.56 108.94 -176.127 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.02 -19.13 44.52 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 126.159 1.838 . . . . 0.97 116.149 171.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.8 mtt180 -82.24 164.9 20.88 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 123.094 1.426 . . . . 2.49 113.5 170.25 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.2 p -87.99 162.99 16.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.487 3.041 . . . . 0.76 112.707 174.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.6 mt -61.11 -26.46 67.69 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 114.218 -5.301 . . . . 1.05 119.552 167.457 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.7 t -67.08 -35.03 78.94 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 112.925 -1.943 . . . . 1.19 112.729 176.242 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -56.7 -41.99 78.33 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.812 -3.055 . . . . 1.9 112.402 175.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -88.96 4.46 48.03 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 119.284 -2.135 . . . . 0.89 112.584 177.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.1 m120 58.33 47.34 14.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.801 2.889 . . . . 1.84 118.801 -178.227 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mt -96.17 130.05 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 124.789 1.306 . . . . 0.82 108.69 -178.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -114.23 -159.62 0.7 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 115.504 -2.479 . . . . 2.16 105.734 176.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -56.0 153.45 8.82 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 115.551 -4.468 . . . . 2.12 116.925 171.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 55.23 33.18 20.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.341 2.972 . . . . 1.71 110.987 173.213 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 m -89.52 143.08 27.1 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 113.962 -5.461 . . . . 1.04 110.584 -179.614 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.2 m -96.02 113.08 24.66 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.282 -2.118 . . . . 0.79 105.282 178.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mp -104.57 169.82 8.24 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 104.263 -2.495 . . . . 1.4 104.263 165.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -125.84 139.21 53.67 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 127.831 3.207 . . . . 1.51 112.827 -172.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.0 tp -98.67 123.38 42.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.789 -2.444 . . . . 1.14 112.038 177.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.16 162.25 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.849 -2.278 . . . . 1.23 104.849 174.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.5 mt . . . . . 0 N--CA 1.429 -1.486 0 CA-C-O 125.085 2.374 . . . . 2.78 109.947 -179.478 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ttp . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 123.506 1.622 . . . . 1.1 113.285 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -83.15 130.11 35.08 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 115.41 -4.556 . . . . 1.87 114.049 -178.28 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -126.17 161.83 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 115.704 -2.094 . . . . 0.72 108.516 168.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -112.76 137.61 50.81 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 104.865 -2.272 . . . . 1.4 104.865 -177.192 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 t -107.46 120.59 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 114.106 -1.406 . . . . 0.58 108.015 173.249 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -96.01 115.45 27.45 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.828 -2.42 . . . . 2.09 111.381 179.327 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.9 p -80.42 175.14 10.92 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 115.982 -4.199 . . . . 0.99 116.223 173.491 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.0 mt -80.5 -24.55 39.32 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.672 -1.232 . . . . 2.53 107.672 176.586 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.3 p -70.93 -39.93 72.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.332 -2.73 . . . . 2.08 108.96 175.508 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.86 50.63 0.55 Allowed Glycine 0 N--CA 1.429 -1.827 0 C-N-CA 126.36 1.933 . . . . 1.31 113.708 -177.568 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -124.21 136.93 54.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 101.556 -3.498 . . . . 1.4 101.556 -179.116 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.4 m -100.22 116.74 32.93 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.777 -3.077 . . . . 0.78 104.767 178.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mt -99.15 141.26 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 104.821 -2.288 . . . . 1.55 104.821 178.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.5 m -109.88 108.2 18.4 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 103.893 -2.632 . . . . 1.08 103.893 -175.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.8 mt -102.74 160.59 14.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.415 -2.678 . . . . 1.55 108.46 177.699 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -119.69 107.19 12.92 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 130.553 3.541 . . . . 1.95 107.919 172.227 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.267 23.2 m -121.58 -171.61 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.696 1.598 . . . . 0.96 109.391 -174.107 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -143.84 179.89 1.09 Allowed Pre-proline 0 N--CA 1.43 -1.428 0 C-N-CA 126.114 1.765 . . . . 2.35 112.672 167.769 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 57' ' ' SER . 11.4 Cg_exo -76.5 -28.0 7.18 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 125.317 2.935 . . . . 0.95 115.669 -176.504 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 p -77.8 -20.33 53.43 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.062 2.545 . . . . 1.45 113.43 -177.68 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.34 139.86 41.51 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 122.989 2.631 . . . . 1.69 112.813 172.531 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.1 p -84.17 175.37 9.51 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 124.295 1.038 . . . . 0.75 112.073 174.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.6 mm -74.8 -34.35 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-O 116.241 -1.838 . . . . 0.73 107.573 177.831 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -49.32 -41.7 39.28 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 129.008 2.923 . . . . 1.62 113.131 166.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -78.19 -28.61 48.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.394 -2.066 . . . . 2.13 113.075 177.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.39 -43.16 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 125.223 1.409 . . . . 0.62 107.459 171.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -55.06 -39.86 69.69 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 123.179 2.718 . . . . 1.22 113.178 169.11 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.61 -40.08 76.84 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 126.925 2.09 . . . . 0.51 110.774 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -68.51 -23.28 64.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.353 -2.092 . . . . 1.44 113.109 176.177 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.4 mt -82.81 -28.1 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 117.208 -1.797 . . . . 1.32 110.896 172.615 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -63.33 -44.52 94.7 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.976 -1.702 . . . . 1.7 110.98 177.373 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -56.28 -50.06 72.46 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.809 2.043 . . . . 1.55 111.225 173.193 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -66.08 -59.81 3.43 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 118.951 2.945 . . . . 2.62 118.951 -178.581 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -108.84 -25.58 10.71 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 128.828 2.851 . . . . 1.48 113.544 -165.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.02 47.91 7.31 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 123.908 0.755 . . . . 1.12 112.626 -177.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.9 mt -104.82 114.39 63.91 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 105.663 -1.977 . . . . 1.55 105.663 177.115 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -55.83 151.45 40.43 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 123.456 2.771 . . . . 1.02 116.154 175.396 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 16.3 Cg_exo -70.51 -22.81 28.15 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 126.099 3.214 . . . . 1.25 119.904 -173.882 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.59 -17.94 62.9 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.459 1.903 . . . . 2.25 110.977 171.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -79.51 -29.44 41.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 121.162 1.801 . . . . 2.02 109.472 175.704 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.417 ' HG2' HD11 ' A' ' 69' ' ' LEU . 76.2 mt-30 -84.51 140.08 31.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 118.744 2.868 . . . . 0.69 118.744 -167.803 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -129.99 116.61 18.83 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 104.65 -2.352 . . . . 2.78 104.65 167.412 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.8 mt -96.04 105.65 17.71 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.071 2.549 . . . . 1.17 114.58 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.5 mm -98.04 134.94 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 106.24 -1.763 . . . . 1.38 106.24 -172.692 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -130.08 95.14 3.86 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 116.089 -2.244 . . . . 1.5 107.277 171.305 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 74.33 -107.38 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.325 1.85 . . . . 1.21 111.098 -173.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.79 -12.5 24.2 Favored Glycine 0 N--CA 1.429 -1.768 0 O-C-N 118.482 -2.636 . . . . 1.3 109.029 -175.43 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -100.08 134.17 43.39 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.213 -1.757 . . . . 2.55 110.032 -174.51 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -84.37 132.87 34.55 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 103.146 -2.909 . . . . 2.48 103.146 167.383 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 mt -88.5 136.58 32.92 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.911 -2.368 . . . . 0.9 113.75 -179.101 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -73.52 138.65 45.15 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 126.134 2.146 . . . . 1.94 111.731 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -62.96 -39.72 95.52 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 117.599 2.444 . . . . 1.56 117.599 -166.761 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.21 16.43 55.83 Favored Glycine 0 N--CA 1.43 -1.708 0 O-C-N 117.575 -3.203 . . . . 0.97 111.779 175.837 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -95.34 174.4 7.05 Favored 'General case' 0 N--CA 1.429 -1.5 1 CA-C-N 125.407 4.604 . . . . 2.49 108.93 167.224 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.1 p -107.84 176.66 5.07 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 115.397 -2.521 . . . . 0.76 113.979 177.19 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.8 mt -57.91 -46.44 84.98 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 126.773 3.178 . . . . 1.05 113.162 169.627 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 2.1 t -62.27 -37.28 84.86 Favored 'General case' 0 N--CA 1.43 -1.435 1 CA-C-N 108.005 -4.18 . . . . 1.19 116.54 178.669 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -62.07 -36.4 81.55 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 120.389 1.45 . . . . 1.9 114.801 176.451 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -89.9 0.92 56.78 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 116.795 2.146 . . . . 0.89 116.795 177.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 m120 74.5 24.79 1.71 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.713 3.205 . . . . 1.84 114.849 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.3 mt -68.94 112.71 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 115.244 1.572 . . . . 0.82 115.244 174.577 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -107.04 -165.54 1.08 Allowed 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 125.007 1.323 . . . . 2.16 112.081 -177.42 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -67.72 153.23 44.17 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.483 1.66 . . . . 2.12 115.483 177.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 60.83 24.31 14.26 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 128.283 2.633 . . . . 1.71 116.056 179.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.3 m -89.3 148.34 23.61 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.056 -2.278 . . . . 1.04 110.404 -170.722 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.8 m -111.82 110.11 20.29 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.065 -2.897 . . . . 0.79 110.664 -173.904 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.3 mp -90.23 151.89 21.32 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 100.792 -3.781 . . . . 1.4 100.792 172.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -116.36 123.08 46.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.463 -2.023 . . . . 1.51 110.8 175.227 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.417 HD11 ' HG2' ' A' ' 41' ' ' GLN . 45.9 tp -95.04 101.97 13.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.653 -2.067 . . . . 1.14 108.651 -174.507 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.6 t -102.41 138.38 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 105.669 -1.975 . . . . 1.23 105.669 178.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.3 mt . . . . . 0 N--CA 1.43 -1.442 0 CA-C-O 123.432 1.587 . . . . 2.78 107.702 -179.73 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptt? . . . . . 0 CA--C 1.49 -1.364 0 CA-C-O 118.977 -0.535 . . . . 1.1 111.39 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -98.57 121.59 40.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.28 1.038 . . . . 1.87 109.442 -175.244 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.0 pt -119.44 155.04 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 123.317 1.532 . . . . 0.72 109.433 174.604 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -113.78 126.03 54.76 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.732 -1.855 . . . . 1.4 112.712 -179.127 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.506 HG21 HD11 ' A' ' 30' ' ' ILE . 40.5 t -104.88 114.25 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 105.259 -2.126 . . . . 0.58 105.259 178.601 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -103.74 121.5 43.13 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 129.232 3.013 . . . . 2.09 107.682 -175.676 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 p -86.49 -179.24 6.6 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 127.93 3.729 . . . . 0.99 117.797 179.248 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 8' ' ' LEU . 47.2 mt -83.06 -29.22 28.99 Favored 'General case' 0 N--CA 1.429 -1.505 1 O-C-N 110.91 -7.369 . . . . 2.53 111.913 168.774 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.9 p -64.7 -41.3 96.11 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 117.035 -3.54 . . . . 2.08 110.141 171.443 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.08 4.88 3.19 Favored Glycine 0 N--CA 1.431 -1.692 0 O-C-N 119.962 -1.711 . . . . 1.31 114.248 173.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -75.9 122.28 23.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 125.959 1.704 . . . . 1.4 111.23 -171.547 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.307 23.8 m -80.15 88.25 5.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.842 -3.661 . . . . 0.78 114.056 167.106 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.462 HD13 ' HG3' ' A' ' 34' ' ' GLU . 57.5 mt -82.71 130.34 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 103.067 -2.938 . . . . 1.55 103.067 -176.834 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.3 m -101.89 117.48 34.93 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.957 3.303 . . . . 1.08 107.196 -174.287 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.5 mt -131.21 152.43 50.5 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 124.925 3.511 . . . . 1.55 111.642 -178.396 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -106.64 105.13 15.01 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 126.586 1.955 . . . . 1.95 113.285 175.289 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 26' ' ' VAL . 12.4 m -118.09 174.45 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 126.476 1.91 . . . . 0.96 107.615 -175.446 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -126.43 165.62 26.91 Favored Pre-proline 0 N--CA 1.431 -1.39 0 O-C-N 118.638 -2.538 . . . . 2.35 106.203 166.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -75.77 -22.57 13.38 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 CA-C-N 124.639 2.693 . . . . 0.95 114.581 -171.305 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.0 m -85.44 15.49 4.43 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 116.354 -2.138 . . . . 1.45 112.591 174.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -91.39 167.35 12.34 Favored 'General case' 0 N--CA 1.431 -1.425 1 O-C-N 116.141 -4.1 . . . . 1.69 109.48 169.025 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 36.4 p -104.0 174.57 5.82 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.704 -1.135 . . . . 0.75 108.339 -175.382 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.417 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 27.9 mm -74.76 -31.71 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 127.854 2.462 . . . . 0.73 107.958 175.102 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -57.72 -40.5 79.7 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.633 1.716 . . . . 1.62 115.633 169.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -65.29 -48.77 71.99 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 124.23 1.967 . . . . 2.13 111.881 171.472 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.46 HG22 HG11 ' A' ' 17' ' ' VAL 0.28 47.5 t -54.17 -41.71 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 117.19 -3.444 . . . . 0.62 115.333 172.455 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 85.7 mttt -59.26 -46.72 87.75 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 118.046 2.61 . . . . 1.22 118.046 167.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.01 -38.93 80.36 Favored 'General case' 0 N--CA 1.432 -1.369 1 C-N-CA 131.714 4.006 . . . . 0.51 114.037 172.845 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.23 -42.93 99.29 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.908 1.683 . . . . 1.44 113.148 167.473 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.506 HD11 HG21 ' A' ' 5' ' ' VAL . 65.8 mt -69.16 -32.32 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 125.945 1.698 . . . . 1.32 110.109 179.14 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -69.92 -47.92 60.54 Favored 'General case' 0 N--CA 1.431 -1.404 1 O-C-N 115.853 -4.279 . . . . 1.7 114.248 175.013 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.27 16.4 t70 -44.53 -59.48 2.43 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 130.53 3.532 . . . . 1.55 110.132 166.297 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -67.81 -53.34 27.79 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.942 2.097 . . . . 2.62 112.557 -172.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HG3' HD13 ' A' ' 13' ' ' ILE . 19.4 mm-40 -102.06 -75.04 0.61 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.76 3.171 . . . . 1.48 112.184 -170.185 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.66 22.84 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.714 0 CA-C-O 124.309 2.061 . . . . 1.12 115.101 177.709 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mt -97.79 128.64 33.49 Favored Pre-proline 0 N--CA 1.43 -1.434 0 O-C-N 117.95 -3.088 . . . . 1.55 117.281 -172.319 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -63.03 137.88 64.55 Favored 'Trans proline' 0 N--CA 1.433 -2.032 0 O-C-N 114.65 -3.395 . . . . 1.02 113.309 178.473 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -59.92 -17.72 45.72 Favored 'Trans proline' 0 N--CA 1.434 -2.009 1 C-N-CA 125.474 4.116 . . . . 1.25 115.135 178.747 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -75.33 -28.42 59.64 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.028 -2.295 . . . . 2.25 112.289 169.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -82.01 -26.0 34.21 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.781 -2.449 . . . . 2.02 110.196 -173.866 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -87.58 124.22 33.27 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.451 -2.031 . . . . 0.69 114.475 -174.157 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -113.07 115.4 28.28 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 124.329 2.014 . . . . 2.78 109.291 170.098 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.252 4.2 mm? -95.97 116.34 28.79 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 125.544 2.592 . . . . 1.17 112.215 178.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 2.3 mm -98.23 122.85 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 1 O-C-N 114.918 -4.864 . . . . 1.38 108.655 178.956 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -138.22 142.32 39.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 116.755 -3.715 . . . . 1.5 103.143 168.245 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.317 . . 62.53 22.37 13.24 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.352 2.352 . . . . 1.21 117.352 177.609 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.04 -14.56 43.16 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 116.947 -3.595 . . . . 1.3 114.229 -175.104 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -100.2 161.36 13.66 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 128.479 2.712 . . . . 2.55 111.707 176.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -94.92 140.84 29.37 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 117.535 -3.228 . . . . 2.48 114.854 169.962 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.323 19.7 mt -80.04 135.61 36.4 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 126.426 3.012 . . . . 0.9 113.252 -176.48 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -89.02 144.15 26.35 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.976 -3.577 . . . . 1.94 115.47 175.348 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.269 16.5 m-20 -53.59 -65.78 0.51 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.715 -2.49 . . . . 1.56 116.281 -170.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.3 58.79 2.81 Favored Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 127.186 2.327 . . . . 0.97 116.816 167.196 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -139.37 144.98 38.43 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 102.734 -3.062 . . . . 2.49 102.734 166.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 60.8 p -79.72 160.98 26.03 Favored 'General case' 0 N--CA 1.429 -1.477 1 CA-C-O 128.785 4.136 . . . . 0.76 114.643 170.937 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.1 mt -71.28 -32.61 68.88 Favored 'General case' 0 N--CA 1.431 -1.391 1 O-C-N 114.351 -5.218 . . . . 1.05 107.066 -176.263 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.8 p -64.76 -35.97 82.8 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.489 2.403 . . . . 1.19 117.489 171.575 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.252 7.9 t70 -60.54 -44.5 96.02 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.048 2.832 . . . . 1.9 113.653 171.726 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -74.64 -22.62 58.82 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 117.788 -3.07 . . . . 0.89 113.936 176.412 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.322 63.6 m-80 68.24 54.32 0.57 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 126.083 2.849 . . . . 1.84 111.597 -178.629 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.9 mm -98.64 124.92 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 102.333 -3.21 . . . . 0.82 102.333 174.226 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -105.28 -174.99 2.67 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.529 -0.732 . . . . 2.16 110.183 -175.45 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -65.12 149.67 49.49 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 116.289 1.959 . . . . 2.12 116.289 169.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 77.11 11.42 2.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.87 1.268 . . . . 1.71 113.674 172.111 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.346 5.4 t -78.55 134.84 37.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.971 3.708 . . . . 1.04 120.909 -174.112 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.9 m -101.2 106.47 17.7 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.928 1.694 . . . . 0.79 108.918 -177.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.6 mt -88.8 138.56 31.3 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 118.561 -1.255 . . . . 1.4 108.496 170.073 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 40.8 m80 -94.56 125.36 39.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 123.958 1.837 . . . . 1.51 113.312 -176.677 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.7 tp -103.46 126.78 50.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.468 -3.27 . . . . 1.14 111.446 -173.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.3 t -118.16 147.07 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 102.258 -3.238 . . . . 1.23 102.258 173.143 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.5 mt . . . . . 0 N--CA 1.43 -1.439 0 CA-C-N 113.031 -1.895 . . . . 2.78 110.029 179.081 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 ptt? . . . . . 0 CA--C 1.49 -1.364 0 CA-C-O 124.246 1.974 . . . . 1.1 110.713 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -111.79 132.78 54.44 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 117.829 -3.044 . . . . 1.87 115.553 -171.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.2 pt -135.88 161.83 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 105.592 -2.003 . . . . 0.72 105.592 176.17 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -119.32 145.92 45.73 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 123.611 1.672 . . . . 1.4 109.847 -179.184 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.5 t -119.37 123.62 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 114.528 -1.214 . . . . 0.58 112.464 176.207 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -93.67 111.97 23.76 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 119.339 -0.945 . . . . 2.09 110.665 177.826 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.2 p -69.52 169.37 12.7 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.559 -1.963 . . . . 0.99 115.224 176.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.39 -25.87 61.66 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 118.552 -2.592 . . . . 2.53 112.723 178.482 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.9 p -74.6 -22.18 59.09 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 128.012 2.525 . . . . 2.08 115.175 177.317 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.76 52.53 2.43 Favored Glycine 0 N--CA 1.43 -1.712 0 C-N-CA 130.35 3.833 . . . . 1.31 111.71 175.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -116.68 140.88 48.91 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 102.432 -3.173 . . . . 1.4 102.432 -178.497 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.5 m -107.38 117.75 34.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 101.579 -3.489 . . . . 0.78 101.579 167.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.2 pt -96.04 166.83 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 118.131 -2.855 . . . . 1.55 105.258 173.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.0 m -122.28 141.41 51.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 116.712 -1.613 . . . . 1.08 107.925 175.228 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.0 mt -129.81 158.41 39.51 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 127.842 2.457 . . . . 1.55 110.29 173.603 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -111.99 136.53 51.21 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 106.45 -1.685 . . . . 1.95 106.45 167.546 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.7 m -136.17 166.11 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 125.553 1.541 . . . . 0.96 113.976 178.017 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -104.78 156.55 35.8 Favored Pre-proline 0 N--CA 1.43 -1.437 0 O-C-N 120.403 -1.436 . . . . 2.35 109.819 155.531 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -80.34 -5.53 13.51 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 O-C-N 114.624 -3.408 . . . . 0.95 109.908 -171.792 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.284 67.9 m -77.13 -17.77 58.38 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 116.951 -1.499 . . . . 1.45 110.028 171.135 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -60.98 134.47 57.13 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 120.681 1.582 . . . . 1.69 112.843 173.451 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 26' ' ' VAL . 61.7 p -71.58 159.68 34.02 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.286 1.517 . . . . 0.75 109.614 176.714 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.0 mm -69.87 -38.54 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 124.633 2.159 . . . . 0.73 111.285 -176.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -48.13 -42.63 29.78 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 128.794 2.837 . . . . 1.62 115.389 162.626 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -67.12 -32.79 74.16 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.201 -1.562 . . . . 2.13 109.194 178.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 22' ' ' THR . 4.4 t -71.3 -29.14 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 O-C-N 118.386 -2.696 . . . . 0.62 113.614 174.346 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -75.25 -35.76 61.36 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.23 -0.919 . . . . 1.22 108.787 176.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.05 -44.33 74.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.681 1.993 . . . . 0.51 111.788 170.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -58.45 -49.22 78.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 116.836 2.161 . . . . 1.44 116.836 173.424 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.418 3.3 mt -58.27 -37.38 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 118.383 2.734 . . . . 1.32 118.383 170.668 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.415 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 64.5 tt0 -63.71 -39.79 95.17 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 118.663 -1.215 . . . . 1.7 113.623 173.11 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -59.67 -58.92 6.49 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.935 1.694 . . . . 1.55 110.555 171.636 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -57.51 -65.66 0.59 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 125.919 1.687 . . . . 2.62 115.288 -179.304 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -106.72 -3.1 20.9 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 129.152 2.981 . . . . 1.48 111.971 -167.161 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.6 54.25 8.87 Favored Glycine 0 N--CA 1.431 -1.696 1 O-C-N 114.469 -5.144 . . . . 1.12 119.29 173.449 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.415 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 81.9 mt -132.27 135.29 26.15 Favored Pre-proline 0 N--CA 1.43 -1.439 0 N-CA-C 102.096 -3.298 . . . . 1.55 102.096 -174.527 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.69 152.27 58.8 Favored 'Trans proline' 0 N--CA 1.434 -2.005 2 C-N-CA 126.379 4.719 . . . . 1.02 108.664 177.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.44 -20.93 54.18 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 122.473 2.115 . . . . 1.25 111.449 -177.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -54.45 -50.02 68.69 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 131.497 3.919 . . . . 2.25 111.513 176.592 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -73.55 -35.06 65.44 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.307 -1.315 . . . . 2.02 112.293 177.731 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -71.67 123.75 23.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.939 2.199 . . . . 0.69 116.939 -172.663 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -113.38 126.05 54.93 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 122.771 2.532 . . . . 2.78 109.481 166.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.3 mt -97.76 132.69 43.16 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.721 -1.237 . . . . 1.17 112.803 178.706 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 mt -119.48 146.44 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 2 C-N-CA 135.113 5.365 . . . . 1.38 104.8 179.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.304 68.4 t80 -151.26 128.88 11.48 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 102.631 -3.099 . . . . 1.5 102.631 173.382 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.354 . . 52.1 42.56 30.62 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 121.471 3.878 . . . . 1.21 121.471 -178.368 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.38 -30.7 5.49 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-N 120.54 1.518 . . . . 1.3 116.329 179.472 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.331 16.3 pttm -94.55 148.38 22.31 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 129.934 3.294 . . . . 2.55 112.009 178.147 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -87.58 148.98 24.62 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 127.353 3.454 . . . . 2.48 112.8 169.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.424 HD22 ' CD2' ' A' ' 59' ' ' TYR . 55.8 mt -108.45 134.78 50.76 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.36 -2.2 . . . . 0.9 105.333 -175.478 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -88.57 153.72 20.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 126.281 1.832 . . . . 1.94 113.717 178.015 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -63.41 -55.27 25.74 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 117.228 2.307 . . . . 1.56 117.228 -169.527 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.03 62.11 4.59 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 125.825 2.903 . . . . 0.97 119.831 173.517 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.5 mmt-85 -140.5 171.5 14.04 Favored 'General case' 0 N--CA 1.429 -1.479 1 N-CA-C 99.238 -4.356 . . . . 2.49 99.238 171.641 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.8 p -111.36 168.62 9.38 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.747 -1.845 . . . . 0.76 115.476 166.359 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mt -64.11 -37.33 87.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 116.528 -3.858 . . . . 1.05 107.158 174.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -65.69 -34.91 79.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 125.973 3.988 . . . . 1.19 116.751 178.356 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -57.35 -45.63 84.16 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 117.322 2.342 . . . . 1.9 117.322 167.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.424 ' CD2' HD22 ' A' ' 50' ' ' LEU . 43.0 m-85 -87.14 -2.09 58.37 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.462 2.023 . . . . 0.89 116.462 174.586 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 54.63 74.98 0.32 Allowed 'General case' 0 N--CA 1.43 -1.43 1 C-N-CA 132.075 4.15 . . . . 1.84 110.83 -179.465 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.8 mt -116.99 113.41 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 103.005 -2.961 . . . . 0.82 103.005 -177.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -86.48 177.06 7.53 Favored 'General case' 0 N--CA 1.43 -1.452 1 CA-C-O 128.93 4.205 . . . . 2.16 107.908 -174.527 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -63.25 144.74 56.68 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 110.906 -2.861 . . . . 2.12 116.527 172.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.314 43.0 mt-10 73.83 26.05 1.87 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.811 3.196 . . . . 1.71 112.886 173.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.284 70.0 m -96.26 151.74 19.23 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.721 -3.112 . . . . 1.04 105.445 -177.196 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.0 m -109.44 120.08 41.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 120.959 1.709 . . . . 0.79 111.236 176.788 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mt -95.72 136.0 36.69 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 125.569 1.547 . . . . 1.4 109.973 176.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -98.64 118.53 35.56 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.435 -1.415 . . . . 1.51 112.806 -175.299 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.3 tp -99.55 118.01 35.19 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.21 2.204 . . . . 1.14 111.926 178.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.23 165.22 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 105.614 -1.995 . . . . 1.23 105.614 172.61 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.6 mt . . . . . 0 N--CA 1.43 -1.435 0 N-CA-C 114.436 1.273 . . . . 2.78 114.436 -176.122 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.315 0 N-CA-C 114.134 1.161 . . . . 1.1 114.134 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -86.62 146.23 26.41 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 123.301 1.524 . . . . 1.87 110.425 -176.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.5 pt -139.46 150.03 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 128.254 2.621 . . . . 0.72 109.483 174.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -103.53 118.28 36.37 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.452 -1.704 . . . . 1.4 111.753 177.18 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.3 t -94.31 110.7 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 117.735 -1.126 . . . . 0.58 109.047 170.341 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.3 tttp -110.17 139.25 45.52 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 122.574 2.443 . . . . 2.09 112.296 -176.529 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.358 58.0 p -85.05 165.67 17.32 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.859 -1.519 . . . . 0.99 108.793 -178.193 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.455 HD11 HG22 ' A' ' 70' ' ' VAL . 62.1 mt -78.23 -19.31 54.02 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 123.96 1.838 . . . . 2.53 112.157 170.584 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.06 -45.04 13.48 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 114.058 -1.428 . . . . 2.08 107.88 -173.702 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.47 1.31 0.21 Allowed Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 120.262 2.865 . . . . 1.31 120.262 167.249 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -86.55 146.78 26.23 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 119.256 1.528 . . . . 1.4 113.555 -176.751 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.4 m -114.04 110.49 20.12 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.957 2.789 . . . . 0.78 109.195 171.005 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.5 mt -91.83 109.65 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 124.513 2.102 . . . . 1.55 106.403 177.32 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 m -83.44 115.04 21.88 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.69 -3.756 . . . . 1.08 106.085 176.063 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mp -108.39 156.51 19.34 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 129.089 2.956 . . . . 1.55 109.856 175.138 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -118.61 131.73 56.19 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.149 -2.219 . . . . 1.95 111.184 166.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -138.67 171.36 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 125.807 1.643 . . . . 0.96 113.233 -175.462 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -102.54 156.1 35.69 Favored Pre-proline 0 N--CA 1.429 -1.48 0 N-CA-C 103.738 -2.69 . . . . 2.35 103.738 166.717 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.9 0.98 9.39 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 124.002 3.135 . . . . 0.95 109.891 179.835 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.4 p -84.03 -18.57 36.61 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.545 -1.972 . . . . 1.45 112.151 171.155 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -66.31 140.9 58.14 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 125.451 2.548 . . . . 1.69 110.917 173.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 3.0 p -80.34 163.97 23.49 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 114.95 -2.452 . . . . 0.75 116.055 179.003 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.492 HG13 ' HB3' ' A' ' 50' ' ' LEU . 19.4 mm -64.16 -36.49 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 123.412 2.824 . . . . 0.73 110.735 176.837 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -58.05 -32.84 68.4 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.86 1.664 . . . . 1.62 113.257 168.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.383 20.0 t-20 -64.18 -39.73 94.6 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.476 2.084 . . . . 2.13 114.322 174.184 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.5 t -64.55 -46.34 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 124.781 2.229 . . . . 0.62 113.761 174.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -66.63 -25.22 66.49 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 125.57 2.605 . . . . 1.22 117.139 -179.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.37 -43.25 81.87 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.569 3.556 . . . . 0.51 109.115 174.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -63.3 -39.17 93.82 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 116.02 -4.175 . . . . 1.44 113.789 173.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.8 mt -69.79 -30.29 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-O 122.837 1.304 . . . . 1.32 111.625 173.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.421 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 59.1 tt0 -75.15 -41.98 57.11 Favored 'General case' 0 N--CA 1.431 -1.401 1 O-C-N 113.66 -5.65 . . . . 1.7 106.757 175.87 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -54.62 -46.98 73.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.713 2.673 . . . . 1.55 118.191 168.207 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.282 26.4 tttp -89.49 -43.4 10.86 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 117.168 -3.457 . . . . 2.62 117.301 -174.008 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -101.57 -35.89 8.97 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 126.755 2.534 . . . . 1.48 108.919 -172.378 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.23 56.25 1.22 Allowed Glycine 0 N--CA 1.431 -1.663 0 C-N-CA 117.926 -2.083 . . . . 1.12 113.508 176.094 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.421 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 8.7 mt -134.31 130.62 20.22 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 103.436 -2.801 . . . . 1.55 103.436 -175.49 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -66.85 154.01 76.0 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 CA-C-N 124.387 2.603 . . . . 1.02 116.714 177.664 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -59.33 -31.96 95.89 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 124.051 3.167 . . . . 1.25 110.13 -176.528 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -55.22 -57.95 9.69 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 126.023 2.821 . . . . 2.25 114.741 177.043 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -61.64 -26.88 68.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.298 2.639 . . . . 2.02 110.395 -177.661 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.272 75.2 mt-30 -96.06 131.13 42.79 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.015 1.388 . . . . 0.69 107.41 -173.642 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -118.83 131.87 56.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.107 -1.406 . . . . 2.78 109.954 167.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 tp -110.06 119.88 40.68 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 104.679 -2.341 . . . . 1.17 104.679 179.123 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.308 1.7 mt -104.95 143.02 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 128.046 2.539 . . . . 1.38 115.106 179.23 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -155.85 123.08 5.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 125.37 3.713 . . . . 1.5 102.642 179.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.257 . . 62.97 30.1 16.43 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.445 2.387 . . . . 1.21 117.445 169.314 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.29 -22.82 32.82 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 125.294 1.621 . . . . 1.3 116.108 -174.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -99.36 130.97 45.68 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 118.174 -1.41 . . . . 2.55 114.033 -176.749 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -75.1 130.42 39.24 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 117.254 -1.778 . . . . 2.48 112.988 173.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.492 ' HB3' HG13 ' A' ' 23' ' ' ILE . 42.1 mt -76.53 140.95 41.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.699 2.481 . . . . 0.9 117.699 -170.83 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -82.78 135.6 34.93 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.631 -3.168 . . . . 1.94 110.59 177.609 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -54.99 -64.99 0.66 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.766 2.426 . . . . 1.56 112.435 -171.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.26 54.54 3.95 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 119.643 -1.91 . . . . 0.97 113.352 172.076 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.9 tpp85 -131.29 161.99 31.06 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 115.296 -2.288 . . . . 2.49 111.126 161.059 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 63.9 p -96.52 155.83 16.6 Favored 'General case' 0 N--CA 1.43 -1.456 1 CA-C-N 127.759 4.799 . . . . 0.76 112.445 178.554 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.1 mt -57.78 -24.24 56.19 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.146 1.778 . . . . 1.05 113.941 173.601 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.7 p -78.4 -27.93 46.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.099 -2.876 . . . . 1.19 115.499 177.404 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -67.73 -34.71 77.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.827 -3.046 . . . . 1.9 115.787 172.332 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.418 ' CE2' HD22 ' A' ' 50' ' ' LEU . 12.7 m-85 -85.94 -8.88 57.71 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.476 1.11 . . . . 0.89 109.381 175.249 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 59.0 54.13 5.19 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.528 -1.983 . . . . 1.84 112.438 178.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.1 mt -85.8 114.47 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 126.727 3.156 . . . . 0.82 108.227 174.299 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.283 83.6 mt-30 -91.18 177.6 6.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.369 -3.332 . . . . 2.16 111.409 178.339 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -72.65 160.8 31.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 115.724 -2.391 . . . . 2.12 113.563 178.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.433 30.5 mt-10 64.51 32.33 11.79 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 110.582 -3.008 . . . . 1.71 116.005 176.765 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.9 t -100.2 128.65 46.23 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 112.973 -1.921 . . . . 1.04 110.586 -166.26 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.37 2.4 m -75.87 93.74 3.24 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 121.88 2.127 . . . . 0.79 116.313 178.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 60.0 mt -81.39 156.8 25.25 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 130.663 3.585 . . . . 1.4 103.282 174.053 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -125.5 121.34 33.45 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 120.56 1.527 . . . . 1.51 113.035 -174.092 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.1 tp -96.64 110.69 23.07 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 105.812 -1.921 . . . . 1.14 105.812 -178.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.455 HG22 HD11 ' A' ' 8' ' ' LEU . 99.0 t -107.04 138.81 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 122.863 1.316 . . . . 1.23 111.457 172.474 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.4 mt . . . . . 0 N--CA 1.431 -1.414 0 O-C-N 120.46 -1.4 . . . . 2.78 113.117 -177.191 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 CA--C 1.491 -1.321 0 CA-C-O 118.985 -0.531 . . . . 1.1 110.664 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -84.95 134.24 34.25 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.49 1.116 . . . . 1.87 112.898 -178.551 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.5 pt -131.83 159.84 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 123.643 1.687 . . . . 0.72 109.666 166.453 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -120.84 149.53 42.44 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 102.492 -3.151 . . . . 1.4 102.492 -173.544 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.4 t -136.2 119.07 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.494 -1.379 . . . . 0.58 109.427 174.409 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -92.23 127.36 37.68 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.816 -1.084 . . . . 2.09 112.079 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.2 p -83.63 165.03 19.33 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.171 1.463 . . . . 0.99 112.111 -178.862 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.68 -31.42 72.63 Favored 'General case' 0 N--CA 1.429 -1.512 1 O-C-N 116.053 -4.154 . . . . 2.53 114.723 167.324 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.0 p -71.62 -48.64 46.68 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 124.285 0.991 . . . . 2.08 111.626 -175.217 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.52 41.64 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 119.273 -1.442 . . . . 1.31 110.674 -179.21 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.29 33.7 ttpt -133.57 149.89 51.65 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.07 -2.43 . . . . 1.4 106.775 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.9 m -95.41 113.94 25.66 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.161 2.584 . . . . 0.78 114.674 167.234 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 mt -82.39 119.25 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 117.645 -3.16 . . . . 1.55 110.305 172.215 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.8 m -104.32 111.27 23.84 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.874 -2.391 . . . . 1.08 107.896 178.093 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.8 mt -110.1 156.06 21.08 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 119.395 3.109 . . . . 1.55 119.395 -177.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 tp10 -103.39 107.23 17.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.206 -1.559 . . . . 1.95 113.307 168.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.7 m -121.17 164.77 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 115.879 -2.01 . . . . 0.96 112.944 174.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 9.3 mm-40 -111.69 169.51 6.25 Favored Pre-proline 0 N--CA 1.43 -1.439 0 O-C-N 125.055 1.472 . . . . 2.35 109.993 163.381 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 46.0 Cg_exo -77.38 -20.59 12.38 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 C-N-CA 122.808 2.339 . . . . 0.95 116.103 -174.122 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.7 m -82.99 3.26 30.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.8 1.64 . . . . 1.45 111.473 174.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -82.5 147.13 28.86 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.185 -2.822 . . . . 1.69 111.266 172.796 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.1 p -75.86 164.48 26.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.291 2.701 . . . . 0.75 118.291 174.215 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.4 mm -74.94 -29.12 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 118.279 -2.763 . . . . 0.73 110.687 178.402 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -53.37 -39.65 64.36 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 126.037 1.735 . . . . 1.62 112.529 163.708 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -60.1 -47.89 84.0 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.548 2.339 . . . . 2.13 114.793 173.206 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.7 t -60.61 -48.78 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 130.144 3.378 . . . . 0.62 112.237 177.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -60.09 -38.36 82.7 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 124.543 2.116 . . . . 1.22 115.083 173.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.85 -31.98 71.32 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 119.198 -2.189 . . . . 0.51 115.767 176.237 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -71.29 -37.44 71.86 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.498 2.094 . . . . 1.44 110.866 170.582 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.0 mt -67.14 -41.77 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 116.639 -3.788 . . . . 1.32 110.984 172.29 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -51.77 -33.06 33.47 Favored 'General case' 0 N--CA 1.43 -1.466 1 N-CA-C 122.31 4.189 . . . . 1.7 122.31 169.757 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -63.51 -42.18 98.49 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 117.04 -1.457 . . . . 1.55 110.057 174.132 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -85.13 -50.9 7.03 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 125.894 1.996 . . . . 2.62 110.414 -172.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -94.35 -27.18 16.22 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 113.567 0.951 . . . . 1.48 113.567 -168.517 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.31 -23.29 29.03 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-O 126.223 3.124 . . . . 1.12 113.759 168.025 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.2 mt -63.77 123.0 80.1 Favored Pre-proline 0 N--CA 1.431 -1.41 0 C-N-CA 128.461 2.704 . . . . 1.55 114.498 -172.691 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 59.0 Cg_endo -76.35 158.35 36.92 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 CA-C-N 126.387 3.317 . . . . 1.02 111.536 -172.025 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -54.91 -31.51 73.78 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 123.359 2.706 . . . . 1.25 116.597 -174.017 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -55.37 -42.87 74.54 Favored 'General case' 0 N--CA 1.43 -1.457 1 CA-C-O 129.263 4.363 . . . . 2.25 117.761 174.019 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -88.15 -25.54 22.91 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.94 -4.225 . . . . 2.02 112.503 -177.635 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -64.73 134.3 53.9 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.931 -1.731 . . . . 0.69 110.068 179.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -126.21 140.92 52.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.173 -2.829 . . . . 2.78 106.151 165.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 67' ' ' LEU . 85.9 mt -121.95 114.93 21.68 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.689 -2.05 . . . . 1.17 110.553 -178.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 mt -104.23 127.04 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 117.63 -3.168 . . . . 1.38 110.612 178.421 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -136.02 120.34 17.95 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.12 2.568 . . . . 1.5 107.196 176.317 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.313 . . 76.68 6.7 3.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.983 -1.698 . . . . 1.21 114.915 -177.438 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.78 -10.56 74.31 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 117.796 -3.065 . . . . 1.3 111.83 -175.267 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -92.17 146.42 23.73 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 105.978 -1.86 . . . . 2.55 105.978 170.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -94.43 141.89 28.06 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.162 1.385 . . . . 2.48 111.376 170.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -105.52 123.62 48.2 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 119.245 0.93 . . . . 0.9 109.196 -166.604 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -69.1 144.1 54.02 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.145 1.778 . . . . 1.94 111.85 174.509 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -60.6 -63.12 1.41 Allowed 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 130.975 3.71 . . . . 1.56 115.742 -169.179 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.75 23.12 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.714 1 C-N-CA 131.056 4.169 . . . . 0.97 121.317 170.85 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.296 65.1 mtt180 -123.61 162.91 22.06 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.053 -2.439 . . . . 2.49 111.598 165.467 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.0 p -84.12 154.44 23.15 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 125.543 2.592 . . . . 0.76 113.579 168.694 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mt -51.3 -34.12 31.84 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.759 -4.338 . . . . 1.05 113.883 175.529 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.7 p -79.44 -12.21 59.89 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 117.583 2.438 . . . . 1.19 117.583 179.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.85 -51.49 47.71 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 127.033 3.301 . . . . 1.9 108.481 171.247 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -66.75 -21.18 66.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.963 -2.961 . . . . 0.89 117.137 172.751 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.26 2.5 m-80 70.34 47.28 0.54 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.963 3.305 . . . . 1.84 111.997 -177.279 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.2 mm -78.72 113.63 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 117.907 -2.996 . . . . 0.82 106.695 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -97.89 175.15 6.25 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 126.049 1.739 . . . . 2.16 112.847 -177.644 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -59.62 132.75 54.93 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 114.59 1.33 . . . . 2.12 114.59 172.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.401 48.4 mt-10 85.57 17.01 0.13 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.554 1.645 . . . . 1.71 111.664 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.277 6.8 m -81.47 129.88 34.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.053 -2.28 . . . . 1.04 113.362 -173.928 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.8 m -103.45 106.4 16.91 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 127.923 3.265 . . . . 0.79 109.892 -175.617 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 43' ' ' LEU . 2.7 mt -87.07 155.62 20.07 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 126.045 2.831 . . . . 1.4 111.907 172.151 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -118.9 120.84 38.5 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 115.86 -2.019 . . . . 1.51 111.457 -179.103 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.8 tp -82.82 133.68 35.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.144 1.778 . . . . 1.14 107.652 179.007 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.08 157.66 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 102.527 -3.138 . . . . 1.23 102.527 175.483 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.5 mt . . . . . 0 N--CA 1.43 -1.456 0 CA-C-O 126.228 2.918 . . . . 2.78 111.061 -169.49 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 CA--C 1.49 -1.345 0 N-CA-C 106.879 -1.526 . . . . 1.1 106.879 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -104.04 124.96 49.99 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 118.695 -2.503 . . . . 1.87 108.695 -173.554 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.9 pt -116.2 160.9 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 118.163 -2.835 . . . . 0.72 109.177 170.176 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -103.61 134.57 46.72 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 125.967 1.707 . . . . 1.4 111.057 176.475 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.2 t -112.59 125.99 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 103.939 -2.615 . . . . 0.58 103.939 172.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -103.18 144.51 31.23 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.032 -3.543 . . . . 2.09 112.438 169.543 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.5 p -93.99 -177.51 4.35 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 124.7 1.25 . . . . 0.99 114.082 -178.839 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.482 HD11 ' H ' ' A' ' 71' ' ' LEU . 46.4 mt -72.29 -27.58 62.55 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 116.442 -1.742 . . . . 2.53 113.088 174.167 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 p -88.13 -62.41 1.5 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.914 1.34 . . . . 2.08 111.672 -172.169 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.86 36.61 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.7 0 CA-C-N 113.721 -1.581 . . . . 1.31 110.153 177.492 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -99.0 148.19 24.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 106.233 -1.766 . . . . 1.4 106.233 -179.468 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.6 m -114.04 127.28 55.87 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 122.373 2.351 . . . . 0.78 106.966 169.158 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mt -108.53 133.3 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.507 -1.996 . . . . 1.55 110.707 173.475 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.0 m -93.88 112.88 24.8 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.325 1.85 . . . . 1.08 109.705 174.101 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -110.29 143.64 40.18 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 121.607 2.003 . . . . 1.55 112.711 174.659 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -114.11 115.11 27.01 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.709 -2.495 . . . . 1.95 110.178 175.199 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.77 177.36 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 127.324 2.25 . . . . 0.96 108.871 -176.521 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -120.11 155.65 55.46 Favored Pre-proline 0 N--CA 1.43 -1.443 0 O-C-N 119.079 -2.263 . . . . 2.35 105.903 162.067 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -73.57 -10.41 23.62 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 124.351 2.59 . . . . 0.95 114.376 -170.232 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.273 48.9 m -87.19 -0.8 57.26 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 127.403 2.939 . . . . 1.45 112.556 175.098 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -68.58 150.28 48.2 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 117.044 -1.455 . . . . 1.69 109.583 179.128 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.3 p -87.59 170.94 10.86 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 125.522 2.582 . . . . 0.75 109.476 176.815 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.407 7.4 mm -61.36 -48.31 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 111.295 -2.684 . . . . 0.73 112.627 173.908 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -41.8 -51.43 4.23 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 119.97 3.322 . . . . 1.62 119.97 164.506 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -61.48 -24.6 66.69 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 119.055 2.983 . . . . 2.13 119.055 174.873 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.0 t -75.65 -39.42 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 125.465 2.555 . . . . 0.62 108.988 175.718 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.3 51.5 mtmt -65.24 -36.71 84.97 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.773 -1.83 . . . . 1.22 111.557 177.784 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.19 -24.1 66.56 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 128.32 2.648 . . . . 0.51 113.965 175.966 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -78.16 -38.63 43.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 126.838 2.586 . . . . 1.44 112.951 170.503 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.363 68.8 mt -65.84 -42.99 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-O 126.391 2.996 . . . . 1.32 111.915 172.304 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -57.79 -55.03 40.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 111.474 -2.603 . . . . 1.7 111.011 172.555 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.298 33.5 t70 -29.13 -56.64 0.14 Allowed 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 119.727 3.232 . . . . 1.55 119.727 170.898 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -81.45 -53.16 6.53 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 117.563 2.431 . . . . 2.62 117.563 -178.798 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -92.72 -22.62 19.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.178 -2.826 . . . . 1.48 106.525 -163.854 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.56 10.58 59.04 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 130.239 3.78 . . . . 1.12 114.701 177.042 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.5 mt -86.73 125.09 68.13 Favored Pre-proline 0 N--CA 1.43 -1.463 0 O-C-N 116.495 -3.944 . . . . 1.55 109.305 -174.231 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.465 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 29.9 Cg_exo -64.24 149.67 89.79 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 N-CA-C 120.86 3.369 . . . . 1.02 120.86 176.741 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 47.5 Cg_exo -69.32 -14.9 38.27 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 CA-C-N 124.966 2.809 . . . . 1.25 117.808 -175.714 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -83.09 -10.65 58.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.704 1.593 . . . . 2.25 110.784 176.714 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.16 -15.74 23.09 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.299 -1.501 . . . . 2.02 108.843 -179.664 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -93.44 124.32 37.35 Favored 'General case' 0 N--CA 1.43 -1.465 1 CA-C-O 129.352 4.406 . . . . 0.69 110.529 -179.324 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -106.65 110.07 22.15 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 114.009 -5.432 . . . . 2.78 104.205 169.963 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.6 mt -89.77 124.66 34.84 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 115.518 -2.182 . . . . 1.17 107.48 172.836 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.44 HD12 HG21 ' A' ' 70' ' ' VAL . 32.4 mt -121.62 136.76 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 128.005 3.316 . . . . 1.38 106.747 -178.255 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -147.44 123.7 10.89 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.718 -1.583 . . . . 1.5 108.245 -176.349 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.304 . . 82.35 -51.09 0.21 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 114.654 1.353 . . . . 1.21 114.654 173.365 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.61 -34.84 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 128.179 2.799 . . . . 1.3 113.739 -178.405 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -89.29 164.11 15.07 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 126.228 2.918 . . . . 2.55 112.24 -179.695 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -98.23 133.45 42.64 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.592 -1.943 . . . . 2.48 110.727 171.09 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.2 mt -88.71 129.56 35.51 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 118.774 -2.454 . . . . 0.9 114.827 -167.356 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.341 26.9 mt-10 -65.0 131.53 46.84 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.727 -1.858 . . . . 1.94 115.571 174.381 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -43.58 -63.75 0.78 Allowed 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 131.188 3.795 . . . . 1.56 114.716 -171.609 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.22 61.15 1.88 Allowed Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 112.364 -2.198 . . . . 0.97 117.323 174.202 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 -126.03 172.85 9.62 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.36 -2.089 . . . . 2.49 105.36 156.393 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.0 p -97.78 177.94 5.3 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 117.315 2.339 . . . . 0.76 117.315 169.557 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.8 mt -77.3 -32.28 55.29 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.247 -2.158 . . . . 1.05 109.77 173.702 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -66.6 -37.02 84.02 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 123.814 3.006 . . . . 1.19 114.136 171.484 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -54.24 -64.1 0.94 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 131.668 3.987 . . . . 1.9 115.022 169.921 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -62.99 -14.15 44.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.913 1.819 . . . . 0.89 115.913 173.901 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.345 29.0 m120 78.02 36.83 0.23 Allowed 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 116.794 -1.574 . . . . 1.84 114.79 179.329 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.9 mt -96.22 125.54 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 122.182 2.264 . . . . 0.82 110.96 -177.147 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -98.34 -179.91 4.51 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 118.095 2.628 . . . . 2.16 118.095 -171.498 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.304 21.7 pttp -65.87 145.83 55.46 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 118.749 -1.18 . . . . 2.12 109.328 170.373 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.269 19.4 mt-10 69.99 20.13 6.66 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 126.227 2.204 . . . . 1.71 113.142 171.815 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.2 m -87.13 148.13 25.34 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 118.027 -2.92 . . . . 1.04 111.239 179.668 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.6 m -92.89 98.4 11.35 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.829 2.159 . . . . 0.79 116.829 -177.31 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -84.82 145.53 27.81 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 113.987 -5.446 . . . . 1.4 113.744 172.072 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -117.03 119.5 35.47 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 118.918 -2.364 . . . . 1.51 109.702 -176.043 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.0 tp -84.88 102.44 13.11 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.967 3.307 . . . . 1.14 109.625 178.092 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 44' ' ' ILE 0.32 98.7 t -94.02 130.48 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 130.513 3.525 . . . . 1.23 107.28 170.814 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.482 ' H ' HD11 ' A' ' 8' ' ' LEU . 66.4 mt . . . . . 0 N--CA 1.429 -1.487 0 O-C-N 117.441 -3.287 . . . . 2.78 108.589 179.106 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttp . . . . . 0 CA--C 1.491 -1.324 0 CA-C-O 124.177 1.942 . . . . 1.1 114.399 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -106.25 141.41 37.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.808 -3.057 . . . . 1.87 111.692 -176.05 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 pt -127.35 173.16 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 131.566 3.947 . . . . 0.72 113.337 175.691 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -135.32 126.02 27.2 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.569 -2.582 . . . . 1.4 105.953 -178.544 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -115.24 118.74 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 106.25 -1.759 . . . . 0.58 106.25 173.443 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -100.28 145.24 28.35 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 118.202 -1.399 . . . . 2.09 111.525 175.383 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.2 p -101.2 160.53 14.32 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 128.931 2.892 . . . . 0.99 112.766 179.939 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 mt -71.14 -28.72 64.48 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.718 -1.864 . . . . 2.53 112.862 175.053 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 t -72.76 -38.6 67.28 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 121.744 2.066 . . . . 2.08 110.142 -177.782 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.27 -10.42 0.54 Allowed Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 125.347 1.451 . . . . 1.31 112.918 166.039 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -80.02 135.02 36.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.75 2.02 . . . . 1.4 113.735 -167.731 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.2 m -108.0 117.38 33.97 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.855 2.462 . . . . 0.78 109.484 176.204 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 mt -104.8 105.61 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 113.361 0.874 . . . . 1.55 113.361 178.332 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.8 m -79.31 118.19 21.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.347 -3.345 . . . . 1.08 108.819 -178.762 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.401 HD22 ' HB3' ' A' ' 29' ' ' LYS . 83.8 mt -120.78 153.58 36.86 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 116.803 -3.686 . . . . 1.55 111.605 -179.8 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -116.33 120.37 38.68 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.059 2.544 . . . . 1.95 110.256 168.382 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -131.92 167.82 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 105.894 -1.891 . . . . 0.96 105.894 -170.575 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -109.45 147.91 37.0 Favored Pre-proline 0 N--CA 1.43 -1.45 0 O-C-N 118.485 -2.635 . . . . 2.35 109.831 160.653 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.254 2.2 Cg_endo -57.11 -18.6 29.78 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 N-CA-C 120.619 3.277 . . . . 0.95 120.619 -173.18 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.9 m -91.05 3.64 54.2 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 125.92 1.688 . . . . 1.45 112.37 -178.709 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -71.78 161.73 30.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.481 2.312 . . . . 1.69 108.54 172.405 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.7 p -98.37 163.8 12.55 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 123.306 1.527 . . . . 0.75 107.657 178.471 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mm -54.38 -41.18 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 118.32 -2.738 . . . . 0.73 114.031 174.25 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.328 16.6 tt0 -54.86 -32.18 60.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.057 -2.277 . . . . 1.62 117.09 166.955 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -64.81 -38.49 91.17 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 129.483 3.113 . . . . 2.13 111.75 176.494 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.3 t -69.18 -40.68 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 119.523 -1.985 . . . . 0.62 107.629 179.254 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.517 ' HD3' ' HB2' ' A' ' 41' ' ' GLN . 74.1 mttt -61.19 -35.64 77.69 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.042 -2.911 . . . . 1.22 114.906 170.734 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.16 -25.21 65.15 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 114.539 -2.864 . . . . 0.51 118.701 177.963 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.401 ' HB3' HD22 ' A' ' 15' ' ' LEU . 54.2 mttp -67.92 -35.53 78.6 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 130.383 3.473 . . . . 1.44 107.201 168.654 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mt -74.07 -39.36 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 1 O-C-N 116.083 -4.136 . . . . 1.32 108.671 178.953 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -64.29 -37.12 86.35 Favored 'General case' 0 N--CA 1.428 -1.547 0 O-C-N 117.12 -3.488 . . . . 1.7 111.556 178.766 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -69.85 -43.6 71.58 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.417 1.103 . . . . 1.55 112.72 172.517 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -72.73 -48.19 40.73 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 120.399 3.481 . . . . 2.62 120.399 178.943 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -108.66 -30.85 7.99 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.467 -2.645 . . . . 1.48 112.489 -165.715 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.67 37.24 5.58 Favored Glycine 0 N--CA 1.43 -1.702 0 O-C-N 118.917 -2.364 . . . . 1.12 116.133 176.467 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.3 mt -113.89 126.18 28.42 Favored Pre-proline 0 N--CA 1.431 -1.412 0 CA-C-O 111.83 -3.938 . . . . 1.55 105.368 177.622 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.84 151.06 35.45 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-N 126.379 3.314 . . . . 1.02 110.77 -176.095 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -55.87 -31.85 82.83 Favored 'Trans proline' 0 N--CA 1.433 -2.047 1 C-N-CA 126.121 4.547 . . . . 1.25 112.806 -178.897 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -41.78 -49.11 4.38 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 113.229 -3.272 . . . . 2.25 117.372 165.935 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -80.55 -20.82 42.58 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 122.664 2.484 . . . . 2.02 117.279 177.514 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.517 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 72.1 mt-30 -76.82 130.86 38.21 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.999 1.32 . . . . 0.69 111.868 -172.086 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.523 ' HB2' HG23 ' A' ' 70' ' ' VAL . 70.0 mtt180 -120.33 131.01 54.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.432 -2.668 . . . . 2.78 108.561 169.653 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.7 mt -107.55 130.52 54.86 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 120.521 1.51 . . . . 1.17 110.795 179.663 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -105.03 127.92 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 125.742 1.617 . . . . 1.38 113.046 178.373 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -152.2 141.91 21.88 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.494 -2.78 . . . . 1.5 103.494 173.163 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.27 . . 64.71 14.38 9.06 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.124 2.392 . . . . 1.21 115.024 -179.013 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.49 18.51 75.71 Favored Glycine 0 N--CA 1.431 -1.674 0 O-C-N 117.511 -3.243 . . . . 1.3 118.23 179.295 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -126.18 150.18 48.5 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.277 3.031 . . . . 2.55 111.047 176.503 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -80.15 132.75 35.97 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 121.646 2.021 . . . . 2.48 112.129 169.705 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.404 HD22 ' CD1' ' A' ' 59' ' ' TYR . 21.3 mt -88.45 135.77 33.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.453 -3.904 . . . . 0.9 114.297 -173.248 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.93 125.84 27.58 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.034 2.934 . . . . 1.94 108.739 -179.76 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.32 1.0 OUTLIER -47.23 -47.4 24.57 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 120.829 3.64 . . . . 1.56 120.829 -174.12 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.84 32.11 7.18 Favored Glycine 0 N--CA 1.43 -1.712 0 CA-C-O 125.652 2.807 . . . . 0.97 118.795 -179.834 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -101.98 157.87 16.56 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.404 -3.409 . . . . 2.49 108.951 159.685 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -85.09 168.17 15.11 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.59 -1.186 . . . . 0.76 110.048 -179.337 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.6 mt -69.64 -41.01 76.16 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 124.86 1.35 . . . . 1.05 109.869 179.289 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.264 48.3 p -58.99 -18.75 37.05 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 117.32 2.341 . . . . 1.19 117.32 175.8 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -69.79 -45.04 68.86 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.657 2.383 . . . . 1.9 111.567 173.023 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.404 ' CD1' HD22 ' A' ' 50' ' ' LEU . 61.2 m-85 -83.5 2.96 34.35 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.399 -2.688 . . . . 0.89 113.309 174.19 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.4 m120 57.56 49.02 13.34 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 129.11 2.964 . . . . 1.84 117.203 177.394 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -85.14 114.29 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 128.564 2.746 . . . . 0.82 111.791 -175.96 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -93.14 -173.73 3.34 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.005 2.336 . . . . 2.16 112.633 -176.488 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -62.54 137.72 58.32 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 112.574 -2.103 . . . . 2.12 113.456 176.673 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 64.15 29.7 13.93 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 114.029 1.122 . . . . 1.71 114.029 170.143 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.6 m -81.43 143.24 32.26 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 123.288 1.518 . . . . 1.04 114.368 -178.753 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 m -99.16 117.06 32.79 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.58 -2.575 . . . . 0.79 111.382 -179.62 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -104.24 160.23 15.05 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.088 2.555 . . . . 1.4 106.261 174.439 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -124.94 135.56 52.95 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.211 -1.774 . . . . 1.51 106.211 -176.824 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.1 tp -99.57 128.75 45.68 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 105.449 -2.056 . . . . 1.14 105.449 -176.411 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.523 HG23 ' HB2' ' A' ' 42' ' ' ARG . 20.3 m -122.0 170.13 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 104.037 -2.579 . . . . 1.23 104.037 168.771 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 71' ' ' LEU . 89.5 mt . . . . . 0 N--CA 1.43 -1.429 0 CA-C-O 117.469 -1.253 . . . . 2.78 111.4 177.39 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tmm? . . . . . 0 CA--C 1.49 -1.352 0 CA-C-O 121.05 0.452 . . . . 1.1 110.579 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -108.72 129.31 55.36 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 117.228 2.307 . . . . 1.87 117.228 -177.537 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -129.28 170.62 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 106.28 -1.748 . . . . 0.72 106.28 175.544 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -121.94 140.15 52.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.921 -2.252 . . . . 1.4 104.921 -177.203 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.453 HG22 ' HB2' ' A' ' 67' ' ' LEU . 92.6 t -123.96 131.51 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 118.069 -2.894 . . . . 0.58 106.771 170.52 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -88.68 118.81 28.62 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.857 2.063 . . . . 2.09 115.352 171.454 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.5 p -83.49 176.06 9.34 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.238 -3.414 . . . . 0.99 111.619 173.775 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.3 mt -78.9 -17.17 56.0 Favored 'General case' 0 N--CA 1.43 -1.432 1 CA-C-O 129.617 4.532 . . . . 2.53 116.066 -179.762 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 p -95.27 -56.74 2.62 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.367 -3.333 . . . . 2.08 107.119 -170.601 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.4 23.65 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.728 0 CA-C-O 114.969 -3.128 . . . . 1.31 115.453 176.124 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -109.68 139.82 44.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 121.67 2.735 . . . . 1.4 108.467 -173.255 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.1 m -106.84 124.33 49.46 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 100.61 -3.848 . . . . 0.78 100.61 175.577 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.7 mt -94.62 123.14 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 N-CA-C 104.776 -2.305 . . . . 1.55 104.776 179.553 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.3 m -90.21 106.7 18.66 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.529 2.331 . . . . 1.08 109.369 176.617 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.3 mt -103.83 128.62 51.27 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.715 1.721 . . . . 1.55 108.396 -176.811 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -90.6 116.32 28.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.807 -3.058 . . . . 1.95 111.803 165.993 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.2 m -130.22 159.59 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.731 -2.481 . . . . 0.96 111.108 -171.358 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -99.68 146.07 31.21 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 118.591 -2.568 . . . . 2.35 108.209 170.875 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -73.44 -17.44 23.81 Favored 'Trans proline' 0 C--N 1.299 -2.059 0 CA-C-N 127.744 3.802 . . . . 0.95 113.52 -177.547 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -77.34 -2.55 35.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 123.206 2.73 . . . . 1.45 111.479 172.431 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -73.97 139.65 44.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 122.415 2.37 . . . . 1.69 109.03 178.588 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 p -74.51 158.65 33.41 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 111.015 -2.811 . . . . 0.75 110.847 170.257 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.403 HG12 ' H ' ' A' ' 23' ' ' ILE . 6.6 mm -61.78 -30.98 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 125.062 1.476 . . . . 0.73 113.388 174.484 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -52.0 -33.33 37.76 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.51 3.124 . . . . 1.62 116.162 165.766 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -85.45 -29.62 24.19 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.301 -2.749 . . . . 2.13 108.699 176.258 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.1 t -70.2 -42.1 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 117.126 -3.483 . . . . 0.62 110.898 178.886 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -63.3 -27.57 69.42 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.347 2.659 . . . . 1.22 113.14 170.194 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.43 -21.64 41.96 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 123.373 1.559 . . . . 0.51 110.933 175.504 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -75.56 -30.16 59.59 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.749 -3.094 . . . . 1.44 114.574 170.054 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.8 mt -66.88 -38.19 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 O-C-N 120.383 -1.448 . . . . 1.32 109.401 169.905 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.424 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 14.4 tt0 -57.43 -58.43 8.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.506 0.67 . . . . 1.7 112.624 170.819 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -47.61 -49.78 26.06 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.854 2.062 . . . . 1.55 110.438 178.638 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -65.13 -66.26 0.57 Allowed 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.969 2.908 . . . . 2.62 112.06 -176.375 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -95.62 -53.75 3.61 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 127.86 2.464 . . . . 1.48 113.351 -164.056 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.98 -43.6 0.6 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 106.693 -2.563 . . . . 1.12 106.693 -179.365 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.481 HG13 ' H ' ' A' ' 36' ' ' ILE . 7.8 mt -40.69 115.2 1.19 Allowed Pre-proline 0 N--CA 1.43 -1.452 1 N-CA-C 123.715 4.709 . . . . 1.55 123.715 -171.479 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -69.38 157.58 60.61 Favored 'Trans proline' 0 C--N 1.3 -1.993 2 CA-C-N 129.712 4.504 . . . . 1.02 108.448 -174.444 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.424 ' HD3' ' HB2' ' A' ' 31' ' ' GLN . 38.0 Cg_exo -65.65 -23.79 56.19 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 N-CA-C 117.522 2.085 . . . . 1.25 117.522 177.099 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.3 -12.98 47.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.624 -3.173 . . . . 2.25 118.46 174.873 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -97.39 -22.4 16.63 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 124.044 0.938 . . . . 2.02 108.977 -178.546 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -90.46 136.2 33.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 118.687 2.847 . . . . 0.69 118.687 -168.246 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -126.03 118.33 25.11 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.329 -2.1 . . . . 2.78 105.329 169.955 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.3 mt -96.94 122.34 39.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 123.962 0.905 . . . . 1.17 111.462 177.88 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 22.9 mm -105.58 141.6 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 128.326 2.651 . . . . 1.38 104.183 -176.961 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -140.71 132.74 27.82 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 116.82 -3.675 . . . . 1.5 103.622 168.054 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.42 . . 56.13 32.48 20.2 Favored 'General case' 0 N--CA 1.429 -1.48 1 CA-C-O 132.335 5.826 . . . . 1.21 121.617 174.25 . . . . . . . . 3 2 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.99 -15.21 39.34 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 108.461 -3.972 . . . . 1.3 109.793 179.206 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -87.16 129.49 34.92 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 128.549 2.74 . . . . 2.55 116.931 -178.106 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -74.4 114.91 13.33 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 128.692 2.797 . . . . 2.48 112.43 173.022 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.1 mt -85.58 147.65 26.31 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 115.922 1.823 . . . . 0.9 115.922 -174.273 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -93.16 138.38 31.63 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.592 -0.892 . . . . 1.94 108.592 179.937 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -66.79 -41.48 87.54 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 118.479 0.581 . . . . 1.56 112.028 -165.623 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.95 47.51 3.39 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 118.454 2.142 . . . . 0.97 118.454 176.498 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -134.49 171.65 14.01 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 102.312 -3.218 . . . . 2.49 102.312 171.409 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.2 p -113.81 177.83 4.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 125.275 2.464 . . . . 0.76 116.799 178.818 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.54 HD23 HD12 ' A' ' 61' ' ' ILE . 84.8 mt -66.91 -42.24 85.77 Favored 'General case' 0 N--CA 1.43 -1.427 1 C-N-CA 131.816 4.046 . . . . 1.05 109.084 173.9 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 t -59.56 -32.97 70.84 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 116.277 -4.014 . . . . 1.19 111.704 173.698 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.271 54.3 m-20 -81.39 -39.91 24.27 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.127 1.899 . . . . 1.9 116.127 179.629 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -84.05 -3.72 58.25 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.31 1.596 . . . . 0.89 115.31 176.72 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 74.12 36.72 0.66 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.079 2.552 . . . . 1.84 114.101 -177.744 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.54 HD12 HD23 ' A' ' 56' ' ' LEU . 11.7 mt -88.16 118.28 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 1 O-C-N 115.581 -4.449 . . . . 0.82 106.68 179.713 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -115.12 -164.9 0.97 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.272 -1.517 . . . . 2.16 115.023 -171.01 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -57.69 127.59 32.78 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 117.708 2.485 . . . . 2.12 117.708 174.927 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 69.69 34.57 2.65 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.449 3.023 . . . . 1.71 113.668 172.854 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m -88.1 129.57 35.26 Favored 'General case' 0 N--CA 1.429 -1.491 1 O-C-N 114.076 -5.39 . . . . 1.04 115.584 -177.955 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.0 m -85.09 88.68 7.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 118.533 2.79 . . . . 0.79 118.533 -175.671 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.518 HD11 HG21 ' A' ' 61' ' ' ILE . 10.3 mp -77.69 158.75 29.54 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 124.031 1.872 . . . . 1.4 107.147 179.332 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.466 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 72.3 m80 -119.62 140.88 49.9 Favored 'General case' 0 N--CA 1.43 -1.429 1 O-C-N 115.282 -4.636 . . . . 1.51 110.707 -179.746 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 tp -115.11 107.24 15.07 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 114.525 1.306 . . . . 1.14 114.525 -178.256 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.8 t -100.9 114.8 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 118.965 -2.335 . . . . 1.23 106.206 175.995 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.5 mt . . . . . 0 N--CA 1.43 -1.444 0 CA-C-O 124.362 2.029 . . . . 2.78 108.696 177.138 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.461 ' HG3' HG23 ' A' ' 17' ' ' VAL . 12.4 ptm . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 116.972 2.212 . . . . 1.1 116.972 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -108.66 163.74 12.98 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 127.464 2.306 . . . . 1.87 105.285 -179.593 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.7 pt -142.72 163.29 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 126.96 2.104 . . . . 0.72 106.085 168.865 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -126.03 110.14 13.22 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 124.517 1.135 . . . . 1.4 111.635 178.105 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.2 t -93.93 118.62 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 106.92 -1.511 . . . . 0.58 106.92 178.48 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -103.86 128.11 51.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.394 1.077 . . . . 2.09 109.619 177.236 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.5 p -85.21 165.7 17.16 Favored 'General case' 0 N--CA 1.429 -1.505 1 CA-C-O 128.979 4.228 . . . . 0.99 109.972 173.404 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.9 mt -59.35 -46.68 87.96 Favored 'General case' 0 N--CA 1.429 -1.502 1 O-C-N 115.269 -4.644 . . . . 2.53 113.113 166.153 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 p -55.99 -34.68 65.99 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 125.383 1.473 . . . . 2.08 111.952 -177.666 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.5 27.72 1.28 Allowed Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 117.718 -1.601 . . . . 1.31 112.533 174.55 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -106.83 151.46 25.17 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 117.242 -1.783 . . . . 1.4 110.028 -176.83 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.0 m -125.73 117.88 24.39 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.27 3.414 . . . . 0.78 108.343 174.055 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.365 11.5 pt -106.1 137.65 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.605 -2.56 . . . . 1.55 105.785 174.306 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.5 m -104.03 107.35 18.21 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.306 -1.316 . . . . 1.08 109.948 173.731 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.4 mt -102.52 149.6 24.23 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.262 2.225 . . . . 1.55 109.882 -175.8 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -103.25 132.12 49.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.176 -3.453 . . . . 1.95 110.979 177.479 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.461 HG23 ' HG3' ' A' ' 1' ' ' MET . 12.6 m -137.43 160.96 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 104.97 -2.233 . . . . 0.96 104.97 -169.078 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -107.5 155.97 38.66 Favored Pre-proline 0 N--CA 1.431 -1.392 0 O-C-N 120.484 -1.385 . . . . 2.35 108.872 166.352 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.67 -27.53 38.35 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 C-N-CA 124.274 3.316 . . . . 0.95 113.24 -166.715 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.6 m -92.17 3.74 54.69 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 116.014 -1.946 . . . . 1.45 113.626 -179.796 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -59.14 145.91 40.72 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 120.206 1.366 . . . . 1.69 113.284 171.824 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -79.73 159.45 26.61 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 104.873 -2.269 . . . . 0.75 104.873 175.462 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.3 mm -65.45 -37.81 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 119.399 -2.063 . . . . 0.73 110.159 177.095 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -49.49 -41.49 40.83 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 130.21 3.404 . . . . 1.62 117.69 164.571 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -77.64 -3.79 42.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 124.149 0.905 . . . . 2.13 113.184 174.79 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.04 -36.81 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 105.159 -2.163 . . . . 0.62 105.159 175.948 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -61.07 -38.17 85.28 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.496 2.093 . . . . 1.22 109.919 175.405 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.42 -36.3 68.8 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.402 -2.686 . . . . 0.51 117.856 167.029 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -69.0 -33.63 73.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.3 -4.0 . . . . 1.44 112.886 172.071 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.0 mt -66.16 -34.77 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 114.225 -2.798 . . . . 1.32 113.974 172.589 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -68.11 -39.24 82.82 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 122.359 2.345 . . . . 1.7 107.07 178.51 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -62.57 -47.06 85.5 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.468 -2.02 . . . . 1.55 110.246 178.718 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -75.52 -63.0 1.38 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.287 -2.133 . . . . 2.62 116.549 -177.389 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -94.41 -47.92 6.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.252 1.821 . . . . 1.48 115.432 -173.478 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.31 -2.4 6.19 Favored Glycine 0 N--CA 1.431 -1.698 0 CA-C-O 127.651 3.917 . . . . 1.12 112.862 174.523 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 21.2 mt -71.29 131.69 86.58 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 117.464 -3.374 . . . . 1.55 111.016 -175.085 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 17.2 Cg_exo -88.26 165.71 6.79 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 125.249 2.911 . . . . 1.02 110.371 -176.889 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.42 -14.76 28.02 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 C-N-CA 122.037 1.825 . . . . 1.25 115.265 -173.341 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -61.36 -36.64 80.75 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.882 3.273 . . . . 2.25 112.479 172.356 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -106.07 -9.83 16.81 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 126.5 1.92 . . . . 2.02 110.095 -172.474 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -82.27 103.34 11.79 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.258 -2.151 . . . . 0.69 112.213 -175.19 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -114.71 137.41 51.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.514 2.578 . . . . 2.78 105.392 164.851 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 mt -108.66 134.42 51.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.391 -3.943 . . . . 1.17 112.24 172.132 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 93.3 mt -116.44 128.92 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 125.923 2.773 . . . . 1.38 107.172 177.712 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -137.19 142.19 42.13 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.506 -2.622 . . . . 1.5 106.455 173.754 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.26 13.9 3.33 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.294 2.638 . . . . 1.21 117.121 -176.706 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.01 -16.85 57.95 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-O 122.78 1.211 . . . . 1.3 112.384 -178.324 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -101.47 154.22 19.02 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.759 -3.789 . . . . 2.55 108.631 -178.892 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -82.19 132.69 35.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 124.999 1.437 . . . . 2.48 111.674 170.265 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 mt -89.27 140.79 29.13 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 122.041 2.2 . . . . 0.9 114.301 -176.184 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -81.91 142.91 32.06 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 128.032 2.533 . . . . 1.94 110.943 178.265 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.02 -56.31 22.58 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.916 2.086 . . . . 1.56 113.352 -174.531 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.37 37.58 2.59 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 116.021 -2.544 . . . . 0.97 114.359 176.51 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -114.91 164.36 14.25 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.192 -1.781 . . . . 2.49 106.192 166.922 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -114.0 167.18 10.88 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.169 -2.207 . . . . 0.76 112.702 -176.932 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.9 mp -64.25 -42.12 96.65 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.514 2.726 . . . . 1.05 111.672 177.482 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.1 p -70.02 -37.46 75.64 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 117.81 -1.09 . . . . 1.19 113.081 -179.629 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.19 -40.76 98.44 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.004 1.722 . . . . 1.9 115.627 174.198 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -75.21 -16.47 60.48 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.987 -3.57 . . . . 0.89 107.557 177.398 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 70.97 48.64 0.38 Allowed 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.542 1.137 . . . . 1.84 112.421 -174.361 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.8 mt -86.5 107.88 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 113.56 -1.654 . . . . 0.82 110.216 175.831 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -95.38 -160.76 0.81 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.058 2.543 . . . . 2.16 112.071 -174.967 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -76.21 138.37 40.6 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 116.997 -3.564 . . . . 2.12 111.762 174.565 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.309 5.4 tt0 71.37 69.81 0.17 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 127.866 3.229 . . . . 1.71 110.991 174.529 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.397 55.2 m -116.01 144.61 43.86 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.423 -2.673 . . . . 1.04 109.287 -174.817 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.4 m -104.07 102.72 12.47 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.94 -1.504 . . . . 0.79 106.94 175.375 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.0 mt -91.31 123.93 35.12 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.518 -2.614 . . . . 1.4 108.023 170.757 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -92.65 109.14 20.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.645 0.778 . . . . 1.51 110.59 -178.093 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 tp -91.07 113.77 26.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.321 1.534 . . . . 1.14 112.378 -179.752 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.4 m -102.78 160.63 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 124.808 2.242 . . . . 1.23 106.43 178.548 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.6 tp . . . . . 0 N--CA 1.43 -1.435 0 CA-C-N 113.837 -1.529 . . . . 2.78 114.24 176.397 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptt? . . . . . 0 CA--C 1.49 -1.349 1 CA-C-O 129.473 4.463 . . . . 1.1 110.689 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -91.03 146.75 23.59 Favored 'General case' 0 N--CA 1.431 -1.41 1 O-C-N 113.862 -5.524 . . . . 1.87 110.089 -176.555 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.329 13.9 pt -135.97 153.0 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 129.346 3.058 . . . . 0.72 109.109 178.526 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -112.95 141.98 46.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 126.459 3.028 . . . . 1.4 107.755 176.096 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -134.56 122.02 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 118.263 -2.773 . . . . 0.58 107.842 170.238 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -96.23 137.26 35.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.771 -1.559 . . . . 2.09 111.027 175.41 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.415 HG22 HD23 ' A' ' 69' ' ' LEU 0.289 44.8 p -77.15 172.67 12.88 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 126.27 2.938 . . . . 0.99 110.363 175.035 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 tp -64.17 -51.34 64.28 Favored 'General case' 0 N--CA 1.429 -1.494 1 O-C-N 115.849 -4.282 . . . . 2.53 113.622 174.965 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.379 75.4 p -61.06 -41.7 97.09 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.563 1.69 . . . . 2.08 115.563 174.552 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.34 9.97 0.2 Allowed Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 116.945 1.538 . . . . 1.31 116.945 175.005 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -84.37 118.5 24.27 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.427 -2.219 . . . . 1.4 114.165 -174.353 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.6 m -93.47 126.77 38.79 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 121.785 2.084 . . . . 0.78 109.415 179.485 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mt -116.87 111.73 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 127.179 2.192 . . . . 1.55 113.153 -178.191 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.1 m -81.2 121.31 25.99 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 126.519 1.928 . . . . 1.08 107.596 177.087 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.5 mt -124.9 146.86 49.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 100.712 -3.81 . . . . 1.55 100.712 -179.475 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -106.18 122.68 46.69 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 118.393 -2.692 . . . . 1.95 108.371 169.909 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.9 m -129.74 152.04 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 126.584 3.087 . . . . 0.96 107.247 -172.99 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -94.1 151.05 39.35 Favored Pre-proline 0 N--CA 1.429 -1.507 1 O-C-N 114.869 -4.894 . . . . 2.35 106.254 156.273 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -76.53 -6.68 17.24 Favored 'Trans proline' 0 N--CA 1.433 -2.05 0 CA-C-N 125.72 3.078 . . . . 0.95 113.525 -174.756 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -87.01 -3.02 59.05 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 125.632 1.833 . . . . 1.45 111.913 -178.466 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -76.37 156.63 33.09 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 129.515 3.126 . . . . 1.69 109.334 171.383 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 4.5 p -84.98 166.61 16.61 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.402 -2.686 . . . . 0.75 111.794 177.529 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.22 -42.81 97.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 126.419 1.888 . . . . 0.73 109.395 174.939 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -46.35 -44.28 16.77 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.624 3.194 . . . . 1.62 119.624 164.812 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -67.17 -32.97 74.43 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.306 1.595 . . . . 2.13 115.306 173.522 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.3 t -64.15 -39.05 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 126.933 3.254 . . . . 0.62 111.966 169.771 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -59.15 -44.05 92.09 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.324 -2.735 . . . . 1.22 115.268 173.876 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.3 -33.0 65.13 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.056 -2.278 . . . . 0.51 111.401 173.788 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -76.54 -26.39 55.13 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 115.342 1.608 . . . . 1.44 115.342 173.96 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.7 mt -70.96 -28.25 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 119.739 -1.851 . . . . 1.32 114.558 169.146 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -70.92 -33.55 70.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.81 3.244 . . . . 1.7 108.111 179.559 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -74.95 -34.26 62.03 Favored 'General case' 0 N--CA 1.431 -1.408 1 C-N-CA 132.998 4.519 . . . . 1.55 112.356 175.47 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.9 mmtm -89.33 -64.72 1.1 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 127.959 3.742 . . . . 2.62 110.099 -171.078 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -93.93 -42.08 9.26 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.04 -2.287 . . . . 1.48 113.621 -170.533 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.73 5.74 21.93 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 121.254 3.261 . . . . 1.12 121.254 175.638 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.1 mt -74.92 129.69 82.68 Favored Pre-proline 0 N--CA 1.431 -1.414 0 C-N-CA 128.747 2.819 . . . . 1.55 110.436 -178.186 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.527 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 8.8 Cg_endo -77.3 141.93 20.84 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 126.077 3.206 . . . . 1.02 111.998 -177.244 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 32.8 Cg_exo -58.27 -17.53 33.28 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 N-CA-C 118.739 2.554 . . . . 1.25 118.739 -173.061 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -79.04 -23.2 44.43 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 114.863 1.431 . . . . 2.25 114.863 171.349 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -88.66 -13.75 39.06 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.351 -2.093 . . . . 2.02 108.111 176.765 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.329 69.2 mt-30 -98.12 143.76 28.31 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 121.163 1.802 . . . . 0.69 110.9 -174.316 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -135.87 135.79 40.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 121.398 0.618 . . . . 2.78 111.037 171.301 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.0 mt -102.84 134.75 45.72 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 117.254 -3.404 . . . . 1.17 115.702 172.139 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.3 mt -118.53 130.28 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 114.724 -1.125 . . . . 1.38 108.322 -179.484 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -136.29 123.15 21.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.139 -2.85 . . . . 1.5 118.009 176.167 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.54 40.44 23.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.046 1.738 . . . . 1.21 110.631 -171.445 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.92 -8.45 50.5 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-O 114.465 -3.408 . . . . 1.3 114.922 179.537 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -85.39 135.5 33.85 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 120.002 1.901 . . . . 2.55 110.706 175.348 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -84.69 120.69 26.69 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.748 2.689 . . . . 2.48 108.475 164.927 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.1 mt -80.25 107.99 13.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 118.204 2.668 . . . . 0.9 118.204 -173.726 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.269 33.2 mt-10 -52.9 121.98 8.36 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 121.525 3.898 . . . . 1.94 121.525 170.434 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.12 -57.82 1.25 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 131.158 3.783 . . . . 1.56 115.756 -174.075 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.89 39.19 2.84 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 127.73 2.586 . . . . 0.97 116.613 175.186 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -121.35 172.37 8.08 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.081 1.896 . . . . 2.49 106.142 167.385 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.301 62.2 p -87.83 176.67 7.27 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 118.944 -2.348 . . . . 0.76 113.959 168.663 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.4 mt -80.53 -25.78 38.47 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.446 1.899 . . . . 1.05 109.409 165.771 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.56 -39.55 62.21 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 107.657 -1.238 . . . . 1.19 107.657 -170.641 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -43.61 -57.79 2.98 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 126.783 2.033 . . . . 1.9 116.078 169.351 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -71.49 -1.31 12.87 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 119.279 3.066 . . . . 0.89 119.279 -178.588 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.396 23.1 m120 62.2 49.9 4.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 131.003 3.721 . . . . 1.84 113.083 -170.198 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.4 mt -87.64 137.31 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 123.508 2.867 . . . . 0.82 109.247 174.988 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -122.51 -176.56 3.41 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.833 2.254 . . . . 2.16 110.528 -175.762 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 ptmm? -62.59 139.55 58.63 Favored 'General case' 0 N--CA 1.429 -1.487 1 O-C-N 116.206 -4.059 . . . . 2.12 111.898 -177.513 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 62.61 31.52 16.79 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.856 2.862 . . . . 1.71 109.15 175.307 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 t -95.01 137.45 34.05 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.458 -2.651 . . . . 1.04 109.994 -179.897 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.2 m -88.07 121.58 30.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 126.929 2.643 . . . . 0.79 112.035 -177.767 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 72.2 mt -105.28 152.79 22.46 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 128.631 2.772 . . . . 1.4 105.871 176.9 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -101.82 125.32 48.47 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.439 -2.663 . . . . 1.51 107.261 -177.48 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.415 HD23 HG22 ' A' ' 7' ' ' THR . 27.2 tp -96.93 126.28 41.96 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 124.296 3.225 . . . . 1.14 110.949 178.131 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.9 m -131.1 176.98 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 118.366 -2.709 . . . . 1.23 111.162 172.012 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 N--CA 1.43 -1.46 0 O-C-N 119.724 -1.86 . . . . 2.78 114.064 178.431 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 112.157 0.429 . . . . 1.1 112.157 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -108.96 140.73 42.07 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.316 -2.74 . . . . 1.87 105.678 177.588 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.4 pt -128.86 153.17 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 106.486 -1.672 . . . . 0.72 106.486 173.477 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -109.75 105.82 15.21 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.501 -2.0 . . . . 1.4 115.226 179.188 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.0 t -94.58 115.95 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 117.801 -3.062 . . . . 0.58 105.762 176.565 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -95.39 156.91 16.12 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.689 2.185 . . . . 2.09 108.013 175.502 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.2 p -105.06 -171.61 1.95 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.994 1.318 . . . . 0.99 110.252 -178.404 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.9 mt -85.88 -36.84 19.71 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 115.701 -4.375 . . . . 2.53 114.242 172.477 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.251 38.6 p -80.06 -54.84 5.41 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.589 -2.004 . . . . 2.08 105.589 -175.339 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.02 23.77 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 120.241 2.856 . . . . 1.31 120.241 171.541 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -88.18 135.83 33.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 117.684 -1.15 . . . . 1.4 111.058 -179.917 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.8 m -109.79 111.65 23.23 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.359 -1.349 . . . . 0.78 107.359 169.851 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 mt -92.3 105.54 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 104.835 -2.283 . . . . 1.55 104.835 -177.315 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.8 m -85.36 107.6 17.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.673 -3.142 . . . . 1.08 106.174 178.159 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.8 mt -101.13 144.17 30.35 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 114.318 1.229 . . . . 1.55 114.318 -177.973 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -101.05 118.88 37.88 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.678 2.656 . . . . 1.95 110.875 174.952 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 m -130.26 158.57 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 123.863 1.792 . . . . 0.96 110.614 -172.412 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -113.26 170.73 4.99 Favored Pre-proline 0 N--CA 1.43 -1.45 0 O-C-N 117.772 -3.08 . . . . 2.35 105.408 159.358 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -87.21 -9.55 6.05 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 C-N-CA 122.342 2.028 . . . . 0.95 114.006 -167.836 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.261 81.5 p -85.04 0.85 50.14 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 131.284 3.833 . . . . 1.45 116.079 173.445 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -86.7 145.33 26.72 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.673 -3.142 . . . . 1.69 111.552 169.098 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.5 p -59.75 155.41 16.04 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.718 2.199 . . . . 0.75 112.559 168.979 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.253 3.3 mt -63.19 -37.13 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 119.654 -1.904 . . . . 0.73 112.551 170.332 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -53.09 -40.55 64.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.075 1.509 . . . . 1.62 115.075 165.655 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -61.02 -32.98 72.57 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 118.275 2.695 . . . . 2.13 118.275 174.186 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.318 45.6 t -71.2 -35.85 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 122.387 1.089 . . . . 0.62 110.196 -178.42 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -70.08 -24.37 63.22 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 132.042 4.137 . . . . 1.22 113.593 174.442 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.56 -33.99 62.82 Favored 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 116.298 -4.001 . . . . 0.51 111.644 174.941 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -69.1 -25.93 64.66 Favored 'General case' 0 N--CA 1.431 -1.395 1 O-C-N 114.972 -4.83 . . . . 1.44 115.522 178.429 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 mt -68.01 -39.64 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 1 C-N-CA 132.499 4.32 . . . . 1.32 112.397 170.594 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.11 -36.68 77.99 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.718 2.488 . . . . 1.7 117.718 178.332 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.03 -57.9 10.88 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 116.544 -1.693 . . . . 1.55 114.127 163.242 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -62.78 -61.84 2.13 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 118.284 2.698 . . . . 2.62 118.284 -177.722 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -93.79 -32.34 14.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.9 -3.0 . . . . 1.48 109.584 -171.81 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.88 16.78 22.86 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 116.92 -2.562 . . . . 1.12 115.629 172.699 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.4 mt -90.58 131.96 36.54 Favored Pre-proline 0 N--CA 1.43 -1.455 1 CA-C-O 110.889 -4.386 . . . . 1.55 110.66 179.237 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -57.68 146.67 83.96 Favored 'Trans proline' 0 C--N 1.299 -2.056 0 CA-C-N 127.664 3.773 . . . . 1.02 116.954 171.767 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.66 -13.38 13.28 Favored 'Trans proline' 0 N--CA 1.434 -2.027 1 C-N-CA 125.674 4.249 . . . . 1.25 113.985 -175.077 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.391 9.6 p-10 -62.83 -31.78 72.86 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 119.724 1.147 . . . . 2.25 113.708 166.325 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -80.75 -26.89 37.03 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 123.813 1.768 . . . . 2.02 113.284 -176.398 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -84.67 142.78 29.65 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 111.711 -2.495 . . . . 0.69 111.252 -173.651 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -143.35 142.6 31.35 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.921 -1.49 . . . . 2.78 111.845 171.644 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.6 mt -105.19 146.63 28.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.92 2.295 . . . . 1.17 106.387 -178.38 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 mt -118.76 138.93 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 128.582 2.753 . . . . 1.38 104.51 174.29 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -144.58 120.44 10.6 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 124.971 2.32 . . . . 1.5 104.789 177.109 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.38 13.58 5.52 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 127.865 2.466 . . . . 1.21 114.912 175.435 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.29 -22.57 38.58 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 127.487 2.47 . . . . 1.3 113.991 -171.571 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -80.57 134.96 36.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 126.548 3.07 . . . . 2.55 111.676 -177.267 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -77.8 128.79 34.57 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 117.195 -3.441 . . . . 2.48 111.942 176.778 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.6 mt -92.97 142.65 27.07 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.188 -2.195 . . . . 0.9 113.438 -172.356 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -79.86 148.01 31.5 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.077 2.951 . . . . 1.94 110.849 175.242 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -89.18 -34.27 16.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.167 1.914 . . . . 1.56 116.167 -168.468 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.36 21.03 6.42 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 128.488 2.947 . . . . 0.97 117.698 171.979 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -105.55 178.2 4.63 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 119.698 1.749 . . . . 2.49 108.187 169.311 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -108.84 -172.94 2.15 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 124.905 2.288 . . . . 0.76 107.274 167.164 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.6 mt -66.06 -43.87 86.2 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 128.436 3.97 . . . . 1.05 112.889 171.089 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.4 m -53.27 -25.97 16.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.179 -3.451 . . . . 1.19 118.291 -179.734 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -78.37 -44.83 23.99 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.115 2.966 . . . . 1.9 111.841 177.386 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -80.76 9.87 5.7 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 129.949 3.3 . . . . 0.89 114.648 174.949 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.27 10.2 p30 47.93 39.8 11.68 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 129.044 2.938 . . . . 1.84 114.176 -178.888 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.304 12.7 mt -77.92 127.56 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 116.856 -3.652 . . . . 0.82 109.555 179.966 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 -107.58 -178.37 3.61 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 125.655 2.645 . . . . 2.16 106.369 178.427 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -64.22 159.22 21.19 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 115.74 -4.35 . . . . 2.12 110.467 -177.484 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.421 19.9 mt-10 59.41 41.53 19.34 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 116.966 -3.583 . . . . 1.71 112.657 169.389 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.2 p -106.36 135.14 48.38 Favored 'General case' 0 N--CA 1.431 -1.397 1 O-C-N 114.857 -4.902 . . . . 1.04 109.9 -173.373 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.5 m -86.44 116.55 24.66 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.477 -2.64 . . . . 0.79 107.163 175.808 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.6 mp -109.45 160.57 16.09 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 112.862 -1.972 . . . . 1.4 110.29 172.594 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -127.39 139.53 52.78 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.949 -2.344 . . . . 1.51 112.046 -176.681 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.6 tp -103.46 127.13 50.91 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 130.695 3.598 . . . . 1.14 109.16 -177.495 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.0 m -135.15 163.95 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 O-C-N 116.351 -3.968 . . . . 1.23 110.557 166.476 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.6 mt . . . . . 0 N--CA 1.43 -1.466 0 CA-C-O 117.024 -1.465 . . . . 2.78 113.278 170.77 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 CA--C 1.49 -1.36 0 CA-C-O 125.998 2.809 . . . . 1.1 103.709 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -90.28 125.75 35.61 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.969 -3.582 . . . . 1.87 109.432 -179.328 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -127.65 150.49 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 118.926 -1.109 . . . . 0.72 109.092 170.148 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.262 33.3 m-85 -115.03 121.86 44.4 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 124.28 1.99 . . . . 1.4 112.314 -172.027 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -103.12 107.97 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 119.677 -1.889 . . . . 0.58 110.903 178.309 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -85.61 158.66 20.05 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 118.806 -2.434 . . . . 2.09 107.474 177.781 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.3 p -108.43 -167.52 1.24 Allowed 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 106.824 -1.547 . . . . 0.99 106.824 175.3 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.6 mt -88.69 -30.75 18.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 119.865 1.211 . . . . 2.53 109.171 178.592 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.9 p -70.57 -27.65 64.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.055 -2.278 . . . . 2.08 106.542 -179.478 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.34 18.66 6.13 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-O 122.432 1.018 . . . . 1.31 115.592 173.362 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -82.63 117.86 22.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 117.041 -1.457 . . . . 1.4 113.375 -177.463 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.288 89.2 m -85.35 115.41 23.08 Favored 'General case' 0 N--CA 1.431 -1.389 1 CA-C-N 126.202 4.092 . . . . 0.78 114.115 175.396 . . . . . . . . 3 2 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 13' ' ' ILE . 53.2 mt -100.56 107.31 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 1 O-C-N 114.963 -4.836 . . . . 1.55 110.6 178.629 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.7 m -80.68 116.3 20.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.954 -2.341 . . . . 1.08 114.057 175.562 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.9 mt -107.6 127.98 54.12 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.55 -1.969 . . . . 1.55 107.717 178.009 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -96.15 99.83 11.53 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.376 -2.702 . . . . 1.95 104.619 170.69 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.3 m -112.38 164.63 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 105.681 -1.97 . . . . 0.96 105.681 -176.406 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -104.78 163.73 16.61 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 105.618 -1.993 . . . . 2.35 105.618 165.663 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -86.82 -8.93 6.72 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 O-C-N 113.932 -3.773 . . . . 0.95 108.759 -166.402 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.25 4.9 p -90.72 1.14 57.12 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 119.763 -0.775 . . . . 1.45 111.674 177.149 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.27 36.2 m-20 -63.01 148.7 46.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 129.694 3.198 . . . . 1.69 108.737 172.173 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 23.5 p -97.99 163.87 12.59 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 118.846 -2.409 . . . . 0.75 112.632 173.893 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.417 HD12 HD13 ' A' ' 50' ' ' LEU 0.298 24.1 mm -63.41 -34.98 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 120.062 1.301 . . . . 0.73 111.099 -179.581 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -48.77 -39.95 27.04 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 117.948 -2.97 . . . . 1.62 115.243 160.279 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -75.84 -48.65 20.66 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.508 -2.62 . . . . 2.13 107.905 -176.741 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.401 ' CG2' HD11 ' A' ' 56' ' ' LEU . 52.6 t -49.1 -54.25 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.989 2.916 . . . . 0.62 116.334 172.56 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -50.97 -32.75 22.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.427 -1.421 . . . . 1.22 113.876 175.983 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.88 -40.02 91.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.181 3.372 . . . . 0.51 114.068 178.789 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -58.79 -40.94 85.49 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.78 -3.075 . . . . 1.44 112.378 176.245 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.4 mt -70.5 -31.6 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 116.487 -3.883 . . . . 1.32 112.061 176.139 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -69.13 -33.39 73.38 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 119.434 -2.041 . . . . 1.7 111.453 171.929 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.355 17.5 t70 -77.13 -44.3 30.87 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.43 2.011 . . . . 1.55 116.43 167.814 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -65.33 -60.56 2.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.194 -3.441 . . . . 2.62 111.092 -171.099 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -105.13 -37.16 7.02 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 124.283 1.992 . . . . 1.48 109.355 -166.251 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.92 38.39 2.35 Favored Glycine 0 N--CA 1.43 -1.752 0 O-C-N 117.56 -3.213 . . . . 1.12 111.575 168.752 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.5 mt -111.08 122.23 38.48 Favored Pre-proline 0 N--CA 1.43 -1.465 0 O-C-N 118.577 -2.719 . . . . 1.55 106.395 -174.441 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 18.5 Cg_endo -57.76 141.73 95.79 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 O-C-N 115.65 -2.868 . . . . 1.02 116.819 175.448 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 67.6 Cg_exo -64.83 -32.96 54.87 Favored 'Trans proline' 0 N--CA 1.433 -2.03 1 C-N-CA 127.54 5.493 . . . . 1.25 111.797 -174.136 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -51.14 -39.35 56.09 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 129.871 3.268 . . . . 2.25 113.996 168.158 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -82.19 -5.22 58.33 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.11 1.909 . . . . 2.02 112.688 178.248 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -99.6 113.76 26.38 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 116.333 -3.98 . . . . 0.69 108.27 -166.933 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -89.29 123.02 33.11 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 125.31 2.481 . . . . 2.78 104.823 163.017 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.2 mt -109.29 119.67 40.2 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.039 -5.413 . . . . 1.17 105.267 175.385 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.3 mm -108.51 133.16 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 128.306 2.643 . . . . 1.38 113.037 179.57 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -130.93 114.31 15.09 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 129.298 4.124 . . . . 1.5 111.05 174.074 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.01 -92.14 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.162 2.185 . . . . 1.21 113.306 -178.437 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.79 23.0 4.01 Favored Glycine 0 N--CA 1.431 -1.696 0 C-N-CA 127.676 2.56 . . . . 1.3 112.536 174.106 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.9 mmtt -123.33 129.95 52.04 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.09 -1.829 . . . . 2.55 110.212 -179.36 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -87.55 125.13 34.15 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 117.185 -3.447 . . . . 2.48 105.274 172.014 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.417 HD13 HD12 ' A' ' 23' ' ' ILE . 99.3 mt -82.11 126.69 32.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.082 -1.636 . . . . 0.9 111.906 -162.104 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -76.13 147.97 38.16 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.644 -2.535 . . . . 1.94 111.938 168.772 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.276 42.6 m-20 -61.11 -65.65 0.66 Allowed 'General case' 0 N--CA 1.431 -1.419 1 N-CA-C 123.201 4.519 . . . . 1.56 123.201 -171.271 . . . . . . . . 3 2 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.82 32.92 3.36 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 122.045 3.578 . . . . 0.97 122.045 178.886 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.7 mtt-85 -102.7 153.65 19.93 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 103.697 -2.705 . . . . 2.49 103.697 169.875 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.268 8.1 p -77.43 153.56 33.48 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 131.043 3.737 . . . . 0.76 110.328 171.733 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.401 HD11 ' CG2' ' A' ' 26' ' ' VAL . 1.5 mt -59.74 -42.15 92.52 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.017 -0.992 . . . . 1.05 111.847 172.118 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.6 p -56.81 -36.56 70.06 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.564 2.346 . . . . 1.19 111.725 179.067 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -66.41 -45.7 79.04 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.871 1.669 . . . . 1.9 111.7 -177.197 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -72.19 -9.16 58.08 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 116.966 2.21 . . . . 0.89 116.966 170.62 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 61.46 53.01 3.51 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.496 1.518 . . . . 1.84 112.504 -177.68 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.8 mt -89.05 113.78 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 130.791 3.637 . . . . 0.82 105.038 176.079 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -99.52 -169.9 1.82 Allowed 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.301 1.593 . . . . 2.16 115.301 178.504 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -66.32 141.25 58.06 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.765 1.745 . . . . 2.12 110.791 176.38 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 67.23 24.98 9.01 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 112.437 -2.165 . . . . 1.71 113.272 172.918 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.3 m -75.58 144.6 41.75 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.855 1.312 . . . . 1.04 112.732 -175.874 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 m -97.57 123.46 41.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 118.071 -1.451 . . . . 0.79 108.518 -176.081 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 mp -122.26 163.38 19.74 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 104.508 -2.404 . . . . 1.4 104.508 178.195 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.263 43.6 m80 -134.63 112.03 10.49 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.46 2.552 . . . . 1.51 110.822 -172.302 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.05 122.74 22.26 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.695 2.398 . . . . 1.14 111.605 175.397 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.5 t -123.01 136.27 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 102.506 -3.146 . . . . 1.23 102.506 175.202 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.7 tp . . . . . 0 N--CA 1.429 -1.487 1 O-C-N 114.822 -4.924 . . . . 2.78 111.027 -174.45 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 ptt? . . . . . 0 CA--C 1.491 -1.325 0 N-CA-C 118.225 2.676 . . . . 1.1 118.225 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.257 7.1 tt0 -117.83 123.27 45.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.677 2.791 . . . . 1.87 114.206 -178.498 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.4 pt -127.94 160.47 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 117.774 -3.079 . . . . 0.72 106.922 174.457 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -118.71 132.79 56.16 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.38 3.472 . . . . 1.4 106.231 -173.355 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 t -122.97 125.59 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 123.447 0.699 . . . . 0.58 110.772 170.851 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.344 19.4 mttm -103.05 145.41 29.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.967 2.794 . . . . 2.09 115.067 179.598 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.301 22.9 p -91.45 168.68 11.37 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.722 -4.362 . . . . 0.99 116.291 173.653 . . . . . . . . 3 2 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.342 31.6 tp -59.31 -56.65 19.4 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.673 2.101 . . . . 2.53 116.673 169.603 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 p -61.89 -60.85 3.03 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 114.35 -1.295 . . . . 2.08 112.002 -176.075 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.86 30.53 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 117.964 -2.065 . . . . 1.31 117.214 173.105 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -111.36 146.3 37.35 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.696 -2.061 . . . . 1.4 111.305 -178.509 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.8 m -112.69 104.61 12.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 104.065 -2.568 . . . . 0.78 104.065 167.602 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.2 mt -91.0 123.53 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 122.213 1.006 . . . . 1.55 108.379 -176.447 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 m -94.31 120.89 35.21 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 118.488 -2.632 . . . . 1.08 109.318 -179.957 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.6 mt -113.14 143.51 44.25 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 126.929 3.252 . . . . 1.55 112.215 179.551 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -86.2 112.35 21.26 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 111.805 -2.452 . . . . 1.95 107.004 171.237 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.13 149.86 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.989 1.716 . . . . 0.96 114.922 -177.613 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -108.79 149.54 39.65 Favored Pre-proline 0 N--CA 1.43 -1.438 0 N-CA-C 103.651 -2.722 . . . . 2.35 103.651 172.418 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -63.94 -19.7 67.0 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 123.428 2.752 . . . . 0.95 113.178 -173.84 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.4 p -80.73 -16.77 53.04 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 130.08 3.352 . . . . 1.45 110.683 -177.51 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -60.24 145.63 46.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 116.779 -1.968 . . . . 1.69 113.892 172.428 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.9 p -80.25 162.62 24.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.537 2.113 . . . . 0.75 108.905 176.461 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.491 HG23 HD12 ' A' ' 43' ' ' LEU . 24.3 mm -64.87 -30.5 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 126.833 3.206 . . . . 0.73 112.016 177.125 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.6 -39.17 91.27 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 114.693 -5.004 . . . . 1.62 112.217 167.059 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.253 15.8 m-80 -70.39 -32.73 70.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 119.892 1.224 . . . . 2.13 112.552 171.683 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.35 43.4 t -53.57 -48.67 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 1 O-C-N 114.287 -5.258 . . . . 0.62 112.72 167.825 . . . . . . . . 3 2 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -56.06 -41.25 74.78 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.187 1.921 . . . . 1.22 116.187 174.531 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.3 -31.74 72.96 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.431 1.493 . . . . 0.51 112.637 172.275 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -66.22 -38.59 88.3 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 127.494 3.521 . . . . 1.44 115.673 176.119 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.7 mt -73.07 -36.99 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 117.636 -3.165 . . . . 1.32 107.596 172.911 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.454 ' HG3' ' HD3' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -62.64 -35.2 78.85 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 123.851 3.023 . . . . 1.7 113.844 179.431 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.45 -54.72 24.39 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.461 1.904 . . . . 1.55 109.726 175.188 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.5 mmtt -57.83 -77.64 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.479 3.038 . . . . 2.62 115.638 -179.08 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -101.68 -20.78 14.85 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.166 -3.458 . . . . 1.48 110.142 -161.895 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.77 53.81 2.48 Favored Glycine 0 N--CA 1.431 -1.682 0 O-C-N 120.412 -1.43 . . . . 1.12 115.165 172.524 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.417 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 6.1 mt -108.05 117.04 55.99 Favored Pre-proline 0 N--CA 1.43 -1.436 0 CA-C-O 113.51 -3.138 . . . . 1.55 110.153 -175.773 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.499 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 50.3 Cg_exo -67.32 127.24 16.26 Favored 'Trans proline' 0 C--N 1.299 -2.054 0 CA-C-N 126.241 3.265 . . . . 1.02 117.292 -179.654 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 27.5 Cg_exo -59.49 -31.13 94.15 Favored 'Trans proline' 0 N--CA 1.434 -2.016 1 C-N-CA 127.527 5.485 . . . . 1.25 118.406 -172.402 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -64.9 -24.68 67.6 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.753 2.821 . . . . 2.25 108.445 178.721 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -94.02 12.71 25.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.912 -2.368 . . . . 2.02 116.53 173.733 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.275 9.6 mt-30 -115.29 147.21 40.69 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.217 2.437 . . . . 0.69 110.675 -178.893 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.6 ptt85 -135.02 134.65 40.66 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 112.907 -1.951 . . . . 2.78 106.048 163.853 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.491 HD12 HG23 ' A' ' 23' ' ' ILE . 44.3 mt -103.69 133.48 48.63 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 119.823 1.192 . . . . 1.17 113.203 179.64 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.4 mm -118.64 145.49 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 125.059 2.361 . . . . 1.38 108.553 177.9 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -134.54 108.79 8.29 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.013 -2.93 . . . . 1.5 103.92 172.295 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.519 . . 72.77 -97.33 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 116.666 2.099 . . . . 1.21 116.666 -176.961 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.9 17.52 1.97 Allowed Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 127.603 2.525 . . . . 1.3 108.532 -175.639 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.2 mttm -106.49 144.79 32.66 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.204 -2.35 . . . . 2.55 110.06 170.664 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -107.75 129.29 55.05 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.587 3.089 . . . . 2.48 115.345 169.649 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.7 mt -97.19 122.84 40.66 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.394 -3.941 . . . . 0.9 104.433 -160.342 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -77.09 138.66 39.67 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 117.633 -3.167 . . . . 1.94 111.72 172.397 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -54.91 -41.14 70.6 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 130.489 3.515 . . . . 1.56 115.978 -170.131 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.38 31.24 6.9 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 126.537 2.018 . . . . 0.97 115.051 174.935 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.87 165.28 11.83 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.224 -1.399 . . . . 2.49 107.224 166.426 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 5.4 p -95.62 171.52 8.62 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 119.034 2.976 . . . . 0.76 119.034 169.179 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -59.35 -39.1 82.16 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 121.59 1.995 . . . . 1.05 112.171 169.772 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 t -64.3 -37.86 88.98 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 116.944 2.202 . . . . 1.19 116.944 -179.151 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -61.19 -21.59 63.96 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.657 -1.902 . . . . 1.9 113.851 174.071 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -109.52 12.35 24.48 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.659 2.936 . . . . 0.89 115.685 -178.962 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.401 6.4 t-20 62.6 39.24 11.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.683 2.793 . . . . 1.84 116.71 -177.093 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.7 mt -90.84 105.5 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 112.661 -2.063 . . . . 0.82 112.556 178.046 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -98.9 -171.59 2.13 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 122.23 2.286 . . . . 2.16 107.111 -174.551 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.253 21.8 pttp -61.54 149.01 40.26 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 126.698 1.999 . . . . 2.12 115.604 176.354 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.317 36.1 mt-10 67.19 13.18 9.32 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.804 1.779 . . . . 1.71 115.804 175.123 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.6 m -66.44 148.74 51.45 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.477 -2.014 . . . . 1.04 112.271 -177.835 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.6 m -103.45 97.92 7.9 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.808 1.766 . . . . 0.79 115.494 173.751 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 mp -87.26 152.43 22.31 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.526 -1.984 . . . . 1.4 113.993 -178.924 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.6 m170 -120.79 129.07 53.44 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.158 -1.589 . . . . 1.51 109.87 -173.788 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.4 tp -95.34 128.82 42.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.576 -1.327 . . . . 1.14 114.374 -176.175 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.4 159.0 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 124.163 1.935 . . . . 1.23 113.669 177.371 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 tp . . . . . 0 N--CA 1.43 -1.433 0 O-C-N 120.786 -1.196 . . . . 2.78 110.852 -174.439 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.2 ttp . . . . . 0 CA--C 1.49 -1.355 0 CA-C-O 116.443 -1.741 . . . . 1.1 109.537 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -96.13 134.29 39.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.114 1.779 . . . . 1.87 109.064 176.69 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 pt -130.22 162.58 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 106.289 -1.745 . . . . 0.72 106.289 163.566 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -115.01 143.32 45.37 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.038 -1.664 . . . . 1.4 113.952 178.088 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.3 t -113.73 120.29 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 118.098 -2.876 . . . . 0.58 104.05 171.106 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -107.78 119.38 39.27 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 126.973 2.109 . . . . 2.09 106.641 177.547 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.3 p -84.13 163.55 19.73 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 121.165 -0.959 . . . . 0.99 111.724 -176.746 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.4 tp -39.56 -43.05 1.24 Allowed 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 118.713 2.857 . . . . 2.53 118.713 172.755 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.5 p -81.2 -24.86 37.16 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.892 1.995 . . . . 2.08 108.419 -176.7 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.44 31.24 3.3 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-O 125.402 2.668 . . . . 1.31 115.245 178.843 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -92.78 124.48 36.81 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.636 -2.685 . . . . 1.4 106.723 178.548 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -109.49 111.73 23.43 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.722 2.677 . . . . 0.78 112.026 175.315 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.262 36.1 pt -100.24 132.57 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 1 CA-C-O 128.847 4.165 . . . . 1.55 106.752 -178.691 . . . . . . . . 3 2 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 95.9 m -90.5 122.11 33.04 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.04 -2.913 . . . . 1.08 110.834 177.584 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.46 142.55 35.94 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.436 2.294 . . . . 1.55 112.675 176.547 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -110.57 118.61 36.68 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.548 2.339 . . . . 1.95 109.667 169.339 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.89 159.92 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 C-N-CA 124.016 0.926 . . . . 0.96 112.006 -178.676 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -92.05 156.26 42.36 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-O 116.424 -1.751 . . . . 2.35 112.693 159.57 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -73.11 -9.13 23.1 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 CA-C-N 126.139 3.228 . . . . 0.95 111.477 -177.285 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.4 m -79.04 -19.15 52.14 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 129.772 3.229 . . . . 1.45 108.545 177.934 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -61.04 137.45 58.23 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.488 2.774 . . . . 1.69 118.488 177.076 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.9 p -86.59 171.42 11.04 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 111.74 0.274 . . . . 0.75 111.74 177.193 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.402 HG13 ' HB3' ' A' ' 50' ' ' LEU . 10.0 mm -68.71 -33.79 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 114.588 1.329 . . . . 0.73 114.588 175.796 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -53.15 -43.44 67.0 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 117.551 2.426 . . . . 1.62 117.551 161.085 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -62.55 -42.53 99.59 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 120.553 1.524 . . . . 2.13 110.615 171.365 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 t -57.02 -48.84 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.449 1.5 . . . . 0.62 111.553 172.915 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -56.7 -34.53 67.52 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 116.953 -3.592 . . . . 1.22 117.627 172.977 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.85 -42.68 81.01 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 125.674 2.654 . . . . 0.51 112.922 176.819 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.27 13.6 mttm -60.02 -34.54 73.5 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 130.382 3.473 . . . . 1.44 115.174 173.584 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.0 mt -74.02 -35.44 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 129.395 3.078 . . . . 1.32 108.13 174.9 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -63.34 -32.03 73.35 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 119.705 3.224 . . . . 1.7 119.705 173.854 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -76.31 -20.41 57.31 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.631 1.973 . . . . 1.55 113.702 169.138 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -84.0 -47.44 10.97 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.657 -2.527 . . . . 2.62 109.942 177.42 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -131.86 -31.69 1.5 Allowed 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 118.453 2.76 . . . . 1.48 118.453 -167.421 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.57 60.99 1.07 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 104.248 -3.541 . . . . 1.12 104.248 169.997 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.1 mt -129.52 115.15 18.25 Favored Pre-proline 0 N--CA 1.43 -1.463 0 N-CA-C 104.699 -2.334 . . . . 1.55 104.699 178.077 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -70.57 160.2 50.27 Favored 'Trans proline' 0 N--CA 1.433 -2.053 1 CA-C-N 129.081 4.279 . . . . 1.02 116.19 -173.347 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.64 -35.13 99.08 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-N 123.682 2.351 . . . . 1.25 116.965 -176.551 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -55.7 -37.0 67.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.986 1.476 . . . . 2.25 114.986 171.635 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -84.32 -12.41 54.64 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 119.56 1.073 . . . . 2.02 111.657 -175.7 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -83.85 115.98 22.52 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.875 -1.528 . . . . 0.69 106.875 -178.561 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -109.2 95.41 5.62 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.525 1.766 . . . . 2.78 107.623 168.266 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.3 mt -87.57 132.53 34.02 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.184 -1.413 . . . . 1.17 107.184 -174.282 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.5 mm -117.19 133.83 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 126.77 2.028 . . . . 1.38 106.166 178.95 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.49 ' HB3' HD21 ' A' ' 50' ' ' LEU . 33.5 t80 -112.34 108.24 17.35 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.977 -1.86 . . . . 1.5 105.977 165.055 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.13 -83.31 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.924 2.89 . . . . 1.21 109.645 -177.474 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.15 -27.3 2.07 Favored Glycine 0 N--CA 1.43 -1.74 0 O-C-N 118.822 -2.424 . . . . 1.3 116.082 -176.019 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -95.59 155.23 16.83 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 126.353 2.978 . . . . 2.55 113.262 -178.572 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -93.91 129.09 40.48 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.77 -3.081 . . . . 2.48 107.764 178.766 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.49 HD21 ' HB3' ' A' ' 45' ' ' PHE . 29.2 mt -80.49 140.57 35.83 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.026 1.393 . . . . 0.9 112.469 -170.373 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -88.54 159.25 18.01 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.282 -4.011 . . . . 1.94 110.703 170.613 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.16 -50.79 15.16 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 127.207 2.203 . . . . 1.56 114.575 -171.264 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.83 62.82 0.78 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 119.058 -2.276 . . . . 0.97 117.14 171.499 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.25 31.4 mmt180 -122.66 153.62 39.12 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.956 -2.239 . . . . 2.49 104.956 164.728 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.1 p -89.62 171.94 9.31 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 119.488 1.04 . . . . 0.76 109.963 174.232 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 29.6 mt -81.18 -29.31 34.67 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.29 -0.881 . . . . 1.05 108.781 175.757 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 t -68.86 -35.76 77.3 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.101 -2.249 . . . . 1.19 112.272 179.053 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.84 -28.27 69.44 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.212 -2.805 . . . . 1.9 112.748 176.385 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -81.59 -13.12 58.4 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.162 -4.086 . . . . 0.89 115.432 179.578 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 77.81 26.75 0.62 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 126.609 2.443 . . . . 1.84 111.152 178.688 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.8 mt -70.0 113.2 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 127.205 3.383 . . . . 0.82 114.79 -179.26 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -95.03 171.97 8.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 114.932 -2.707 . . . . 2.16 110.911 -178.329 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -62.64 145.9 53.43 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.297 -2.752 . . . . 2.12 110.062 176.769 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 58.37 38.53 25.82 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 125.663 2.649 . . . . 1.71 112.379 175.462 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.2 t -98.97 141.79 31.29 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 104.082 -2.562 . . . . 1.04 104.082 179.51 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -96.57 121.11 38.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 127.404 2.282 . . . . 0.79 110.34 178.185 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -101.85 158.89 15.8 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 102.307 -3.22 . . . . 1.4 102.307 174.912 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -114.42 127.79 56.01 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.033 1.733 . . . . 1.51 114.348 -176.19 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.465 ' C ' HD23 ' A' ' 69' ' ' LEU . 4.2 tt -108.48 123.77 49.4 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 106.635 -1.616 . . . . 1.14 106.635 -178.278 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 t -104.37 142.94 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 104.92 -2.252 . . . . 1.23 104.92 173.702 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.49 HD12 ' HA ' ' A' ' 71' ' ' LEU . 7.9 tp . . . . . 0 N--CA 1.43 -1.443 0 CA-C-O 116.375 -1.774 . . . . 2.78 110.939 174.334 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 124.2 1.952 . . . . 1.1 108.461 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -104.65 132.13 51.25 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.135 -1.603 . . . . 1.87 108.301 -174.981 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.434 HD12 HD22 ' A' ' 67' ' ' LEU . 8.4 pt -127.38 140.89 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 126.027 2.822 . . . . 0.72 107.526 175.333 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -101.75 131.69 47.89 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.397 -2.064 . . . . 1.4 111.3 -178.939 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.3 t -109.41 111.52 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 116.876 -3.64 . . . . 0.58 108.789 177.965 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.5 mtpt -93.36 139.29 30.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.612 -3.18 . . . . 2.09 106.93 175.912 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p -93.25 164.94 13.04 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 116.918 -1.515 . . . . 0.99 112.301 179.904 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.9 tp -65.87 -30.88 71.56 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.246 3.403 . . . . 2.53 113.379 166.339 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.315 70.2 p -61.61 -38.4 87.46 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.124 -4.11 . . . . 2.08 114.271 -178.815 . . . . . . . . 3 2 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.87 24.42 1.69 Allowed Glycine 0 N--CA 1.43 -1.726 1 C-N-CA 131.031 4.158 . . . . 1.31 114.416 174.191 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -101.6 153.15 20.01 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.054 -1.461 . . . . 1.4 107.054 -177.994 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -108.6 110.47 21.94 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 113.078 -1.874 . . . . 0.78 109.99 168.079 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 mt -92.35 119.91 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 121.129 1.786 . . . . 1.55 115.122 177.362 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.259 8.7 m -89.37 130.06 35.8 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 116.741 -3.725 . . . . 1.08 106.894 179.079 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.0 mt -133.08 156.41 47.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 118.605 -1.238 . . . . 1.55 107.967 177.898 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -112.74 129.37 56.44 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 117.52 -1.228 . . . . 1.95 109.594 165.833 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 m -127.31 177.55 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 126.645 1.978 . . . . 0.96 114.89 177.872 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -120.11 161.64 37.6 Favored Pre-proline 0 N--CA 1.43 -1.432 0 CA-C-O 115.119 -2.372 . . . . 2.35 110.878 164.261 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.256 33.8 Cg_endo -74.81 -12.63 21.95 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 C-N-CA 122.987 2.458 . . . . 0.95 112.649 -176.744 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.255 70.0 m -92.4 9.7 33.09 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.75 2.82 . . . . 1.45 111.724 173.253 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -84.96 139.0 32.14 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 121.67 2.032 . . . . 1.69 109.906 176.864 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.5 p -84.43 156.42 21.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.305 2.955 . . . . 0.75 112.342 176.113 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mm -64.48 -20.71 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 O-C-N 116.372 -3.955 . . . . 0.73 115.086 176.464 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -56.92 -51.87 67.43 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.367 2.508 . . . . 1.62 117.162 163.079 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -60.45 -31.99 70.96 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 111.048 -2.796 . . . . 2.13 116.571 170.535 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.2 t -65.78 -32.89 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 124.098 3.135 . . . . 0.62 112.202 175.804 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -71.71 -27.48 63.05 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.335 1.854 . . . . 1.22 112.082 175.882 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.04 -21.67 58.9 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.803 -2.436 . . . . 0.51 114.82 173.365 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -78.3 -30.5 48.4 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.608 -3.183 . . . . 1.44 108.206 178.584 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.4 mt -68.54 -33.3 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 129.309 3.044 . . . . 1.32 110.189 168.838 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -66.93 -29.47 69.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.712 -3.117 . . . . 1.7 113.885 167.324 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -74.58 -58.22 3.43 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 120.986 1.721 . . . . 1.55 110.464 172.162 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.2 tptt -57.79 -55.86 29.46 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.574 2.435 . . . . 2.62 117.574 -172.915 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -110.84 -36.43 5.69 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.473 2.082 . . . . 1.48 108.756 -164.905 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.85 66.34 1.0 Allowed Glycine 0 N--CA 1.429 -1.788 0 O-C-N 119.576 -1.953 . . . . 1.12 110.583 169.979 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.6 mt -126.93 130.12 23.86 Favored Pre-proline 0 N--CA 1.429 -1.488 0 CA-C-O 114.452 -2.689 . . . . 1.55 105.552 -178.341 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -62.11 150.42 86.68 Favored 'Trans proline' 0 N--CA 1.433 -2.056 0 C-N-CA 124.167 3.245 . . . . 1.02 111.582 178.82 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -87.13 -0.22 7.69 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 CA-C-N 120.853 1.341 . . . . 1.25 110.319 -162.535 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -71.47 -46.83 58.87 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.372 2.269 . . . . 2.25 112.719 170.719 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -69.41 -19.52 63.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.805 2.842 . . . . 2.02 115.599 -175.055 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -86.83 139.43 30.68 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 124.126 1.917 . . . . 0.69 111.053 -168.82 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.9 mtt180 -131.38 134.07 45.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.731 -3.731 . . . . 2.78 104.19 170.556 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.3 mt -114.21 117.03 30.04 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 114.038 -5.414 . . . . 1.17 112.826 175.296 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 mm -99.3 138.28 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 128.489 3.618 . . . . 1.38 114.439 178.684 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -129.5 96.27 4.23 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 120.836 1.653 . . . . 1.5 109.208 170.358 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.26 26.45 2.7 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 111.854 -3.927 . . . . 1.21 117.246 -179.608 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.39 -24.18 23.04 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 122.991 2.632 . . . . 1.3 112.731 -174.408 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -96.56 132.43 42.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.718 -2.636 . . . . 2.55 106.709 175.351 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.79 131.3 35.26 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.893 -2.379 . . . . 2.48 111.784 166.327 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.0 mt -79.01 128.85 33.78 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.033 1.333 . . . . 0.9 108.689 -173.088 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -80.26 138.93 36.86 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 121.564 1.984 . . . . 1.94 111.034 176.437 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.85 -55.38 14.46 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.525 3.157 . . . . 1.56 119.525 -173.254 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.23 39.96 2.12 Favored Glycine 0 N--CA 1.43 -1.733 0 O-C-N 124.662 1.226 . . . . 0.97 115.889 173.059 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.423 HH21 ' CG ' ' A' ' 58' ' ' ASP . 44.1 mmm-85 -117.73 161.07 20.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 124.814 0.949 . . . . 2.49 112.151 158.168 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -96.52 172.38 7.96 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 115.574 1.694 . . . . 0.76 115.574 173.301 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.1 mt -77.26 -25.4 51.44 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.014 1.116 . . . . 1.05 114.014 176.859 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.8 t -78.8 -33.43 46.26 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.106 -1.442 . . . . 1.19 107.106 -179.495 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.423 ' CG ' HH21 ' A' ' 54' ' ' ARG . 38.1 t0 -61.44 -52.82 62.97 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.365 2.666 . . . . 1.9 112.023 178.183 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -74.42 -7.49 53.11 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 126.813 3.197 . . . . 0.89 117.882 177.993 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.3 m120 62.8 46.15 5.29 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.2 -2.812 . . . . 1.84 115.509 179.702 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.4 mt -96.25 124.24 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 103.729 -2.693 . . . . 0.82 103.729 -177.699 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -112.44 -176.2 2.86 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 118.364 -1.334 . . . . 2.16 112.147 -175.055 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -55.06 137.52 46.23 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 126.768 3.175 . . . . 2.12 110.092 174.812 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 57.3 mt-10 76.3 12.98 2.6 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 126.116 2.865 . . . . 1.71 113.534 170.46 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -79.39 133.22 36.57 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 117.593 -3.192 . . . . 1.04 107.475 -170.813 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.1 m -86.07 113.79 22.42 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.85 -3.656 . . . . 0.79 113.848 178.58 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.434 HD22 HD12 ' A' ' 3' ' ' ILE . 9.7 mp -92.46 160.4 15.09 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.625 -1.922 . . . . 1.4 110.895 174.271 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -129.32 123.16 31.1 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.438 2.066 . . . . 1.51 108.351 -175.243 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.5 tp -93.65 125.23 38.15 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 130.892 3.677 . . . . 1.14 108.317 176.59 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.14 159.34 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 104.126 -2.546 . . . . 1.23 104.126 167.201 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.4 mt . . . . . 0 N--CA 1.429 -1.485 0 CA-C-O 122.653 1.216 . . . . 2.78 108.042 -179.668 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptt? . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 123.259 1.504 . . . . 1.1 109.188 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -101.23 129.44 47.17 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.848 1.659 . . . . 1.87 111.038 -172.304 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.1 pt -125.44 174.48 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.775 -2.453 . . . . 0.72 110.007 176.196 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -119.77 140.91 50.01 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 116.055 1.872 . . . . 1.4 116.055 179.767 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.7 t -124.96 119.63 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 124.196 1.951 . . . . 0.58 105.898 171.606 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -95.44 127.32 41.38 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.627 -3.795 . . . . 2.09 111.68 179.441 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.0 p -73.39 -168.92 0.58 Allowed 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 125.031 2.348 . . . . 0.99 110.953 -176.069 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.536 HD11 ' H ' ' A' ' 71' ' ' LEU . 86.1 mt -86.9 -38.6 16.56 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 111.825 -2.443 . . . . 2.53 111.597 171.492 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.9 p -65.44 -27.35 68.46 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.427 1.891 . . . . 2.08 112.885 -175.9 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.57 22.97 5.25 Favored Glycine 0 N--CA 1.431 -1.669 0 O-C-N 118.151 -2.843 . . . . 1.31 119.108 177.845 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -108.04 138.53 44.14 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 105.602 -1.999 . . . . 1.4 105.602 -175.348 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.0 m -92.91 111.08 22.57 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.595 2.758 . . . . 0.78 108.044 177.149 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -89.85 137.16 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 116.48 -3.888 . . . . 1.55 105.075 -179.268 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.1 m -100.34 129.5 46.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.599 1.959 . . . . 1.08 110.36 -178.653 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.4 mt -129.36 155.38 45.75 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 119.651 1.114 . . . . 1.55 112.673 -175.923 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -116.22 112.25 21.35 Favored 'General case' 0 N--CA 1.429 -1.477 1 O-C-N 115.186 -4.696 . . . . 1.95 105.792 173.253 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.5 m -126.37 155.48 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 110.974 -2.83 . . . . 0.96 112.101 -179.0 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -103.28 159.5 29.1 Favored Pre-proline 0 N--CA 1.431 -1.392 1 O-C-N 114.639 -5.038 . . . . 2.35 109.644 165.485 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.66 -20.78 46.34 Favored 'Trans proline' 0 C--N 1.299 -2.039 1 O-C-N 113.297 -4.107 . . . . 0.95 115.455 -170.993 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 p -84.76 4.52 32.48 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.133 2.173 . . . . 1.45 112.121 175.543 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -75.58 138.2 41.3 Favored 'General case' 0 N--CA 1.431 -1.419 1 O-C-N 115.496 -4.502 . . . . 1.69 106.424 170.473 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.563 HG22 HG22 ' A' ' 55' ' ' THR . 64.6 p -87.02 159.76 18.85 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 125.935 2.022 . . . . 0.75 108.074 -179.225 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.7 mm -60.24 -37.02 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 124.168 0.987 . . . . 0.73 109.692 177.415 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.302 25.5 tt0 -47.12 -50.59 19.91 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.664 1.986 . . . . 1.62 113.385 164.465 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -68.86 -32.74 72.64 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 125.934 2.021 . . . . 2.13 109.745 -179.706 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.55 -38.94 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 120.642 1.565 . . . . 0.62 113.315 175.105 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -61.56 -38.67 88.34 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 122.605 1.193 . . . . 1.22 112.83 169.701 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.65 -25.86 57.22 Favored 'General case' 0 N--CA 1.43 -1.428 1 CA-C-O 129.274 4.368 . . . . 0.51 113.694 179.332 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -72.63 -34.05 67.06 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 114.856 -4.903 . . . . 1.44 111.647 171.703 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.253 97.1 mt -64.73 -48.57 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 O-C-N 120.015 -1.678 . . . . 1.32 109.401 171.126 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -56.63 -42.83 79.51 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 116.446 -3.909 . . . . 1.7 113.265 177.145 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -53.95 -47.26 71.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.815 3.197 . . . . 1.55 117.079 166.522 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.265 14.2 tppt? -73.24 -53.49 10.75 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.04 2.352 . . . . 2.62 114.144 -171.844 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -111.42 -30.1 7.53 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.738 -3.101 . . . . 1.48 109.993 -171.431 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.28 38.36 4.56 Favored Glycine 0 N--CA 1.429 -1.787 0 C-N-CA 125.465 1.507 . . . . 1.12 114.056 -179.586 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.4 mt -97.77 130.38 29.13 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-O 114.749 -2.548 . . . . 1.55 112.117 179.509 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -66.18 154.0 75.86 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 CA-C-N 125.356 2.948 . . . . 1.02 113.487 -173.475 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -65.62 -23.32 56.94 Favored 'Trans proline' 0 N--CA 1.432 -2.094 1 CA-C-N 129.094 4.283 . . . . 1.25 116.373 -177.668 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -69.0 -34.62 75.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.77 -2.456 . . . . 2.25 115.546 178.06 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -73.75 -12.79 60.82 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 124.38 1.05 . . . . 2.02 111.279 179.597 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -98.64 118.06 34.5 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 118.214 -2.804 . . . . 0.69 112.572 -167.951 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -106.51 114.64 28.87 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 126.259 2.224 . . . . 2.78 106.378 170.674 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.1 mt -98.03 109.42 22.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.99 1.853 . . . . 1.17 113.607 175.343 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.3 mt -100.48 112.2 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 128.356 2.662 . . . . 1.38 112.617 180.0 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -105.67 123.76 48.46 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.5 -2.625 . . . . 1.5 107.446 172.008 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.362 . . 69.46 -63.81 0.36 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.128 2.171 . . . . 1.21 110.694 -176.459 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.59 -16.81 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.791 0 N-CA-C 106.122 -2.791 . . . . 1.3 106.122 179.378 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -83.6 125.1 31.46 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.611 3.164 . . . . 2.55 106.848 -172.557 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.3 17.4 tt0 -83.96 115.48 22.33 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.176 1.547 . . . . 2.48 115.176 175.849 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.8 mt -75.58 133.85 40.84 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.173 1.789 . . . . 0.9 112.047 -171.018 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -87.15 151.43 23.21 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 127.859 2.464 . . . . 1.94 115.719 172.743 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -66.24 -44.65 83.12 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 128.364 2.665 . . . . 1.56 113.434 -160.147 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.15 51.25 1.29 Allowed Glycine 0 N--CA 1.43 -1.705 0 O-C-N 118.813 -2.43 . . . . 0.97 110.866 176.332 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -123.56 161.88 24.06 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.889 -1.948 . . . . 2.49 107.377 162.582 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.563 HG22 HG22 ' A' ' 22' ' ' THR . 18.7 p -107.89 172.61 6.73 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.084 -2.26 . . . . 0.76 110.741 179.693 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.407 HD23 HD12 ' A' ' 61' ' ' ILE . 20.8 mt -62.17 -38.41 88.95 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 126.758 2.536 . . . . 1.05 114.077 172.855 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -66.52 -30.8 71.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.916 2.486 . . . . 1.19 115.256 174.284 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -71.49 -43.9 65.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.752 -3.093 . . . . 1.9 111.393 171.222 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -91.55 8.26 37.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 124.964 1.415 . . . . 0.89 114.154 -177.877 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 47.23 49.24 15.54 Favored 'General case' 0 N--CA 1.43 -1.438 1 C-N-CA 132.459 4.304 . . . . 1.84 116.613 -179.462 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.567 HG21 HD21 ' A' ' 67' ' ' LEU . 76.8 mt -89.81 115.04 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 114.191 -2.814 . . . . 0.82 105.48 176.912 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -107.22 -166.66 1.18 Allowed 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 126.291 2.244 . . . . 2.16 112.88 -175.754 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -63.27 144.87 56.57 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 125.128 1.517 . . . . 2.12 113.586 -179.682 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.294 32.2 mt-10 67.28 15.13 9.91 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.629 1.971 . . . . 1.71 114.686 -179.766 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 t -90.17 135.94 33.35 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 123.537 1.636 . . . . 1.04 111.07 -173.903 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.2 m -96.09 113.84 25.49 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.821 3.648 . . . . 0.79 112.213 -172.397 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.567 HD21 HG21 ' A' ' 61' ' ' ILE . 10.5 mt -95.98 152.85 18.14 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 115.604 -4.435 . . . . 1.4 108.883 169.762 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -112.2 119.36 38.11 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 115.873 -2.331 . . . . 1.51 109.463 -174.488 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.6 tp -86.45 116.55 24.67 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.346 1.858 . . . . 1.14 111.454 -178.87 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.8 t -111.73 119.87 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 115.167 -2.349 . . . . 1.23 109.402 177.502 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.536 ' H ' HD11 ' A' ' 8' ' ' LEU 0.296 93.3 mt . . . . . 0 N--CA 1.431 -1.405 0 CA-C-N 121.211 1.823 . . . . 2.78 108.85 -173.482 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 CA--C 1.49 -1.327 0 N-CA-C 104.728 -2.323 . . . . 1.1 104.728 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -100.96 128.68 46.88 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.574 -1.954 . . . . 1.87 110.418 -173.675 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.8 pt -137.04 155.75 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 O-C-N 117.315 -3.365 . . . . 0.72 106.709 172.493 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -103.06 140.43 37.32 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.393 1.877 . . . . 1.4 106.716 -175.921 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.8 t -120.73 109.84 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 118.711 -2.493 . . . . 0.58 106.299 171.591 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.7 tttt -96.12 128.75 43.3 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 118.001 2.593 . . . . 2.09 118.001 -178.55 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.7 p -86.12 176.25 8.09 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 115.166 1.543 . . . . 0.99 115.166 174.07 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.8 mt -74.47 -22.85 58.89 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.699 -1.876 . . . . 2.53 115.558 172.76 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 p -67.34 -25.97 66.26 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.808 2.043 . . . . 2.08 113.103 176.602 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.27 28.61 5.74 Favored Glycine 0 N--CA 1.429 -1.803 0 C-N-CA 128.6 3.0 . . . . 1.31 114.29 179.743 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -111.55 141.13 45.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.895 3.712 . . . . 1.4 112.476 -173.014 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.2 m -96.34 116.68 29.43 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 127.891 3.71 . . . . 0.78 116.907 176.084 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mt -96.86 125.35 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 1 O-C-N 114.042 -5.411 . . . . 1.55 110.556 168.299 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.1 m -97.66 118.58 34.51 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 124.903 2.287 . . . . 1.08 106.039 -174.49 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.1 mt -105.48 145.6 30.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.506 -3.871 . . . . 1.55 111.279 -178.163 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -103.79 126.05 50.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.469 1.604 . . . . 1.95 107.219 167.987 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 m -144.43 161.67 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 117.249 -3.407 . . . . 0.96 112.481 -176.006 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -99.33 155.01 37.0 Favored Pre-proline 0 N--CA 1.431 -1.421 0 O-C-N 119.132 -2.23 . . . . 2.35 106.462 157.737 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -72.8 -9.65 24.02 Favored 'Trans proline' 0 N--CA 1.433 -2.064 0 C-N-CA 124.625 3.55 . . . . 0.95 111.755 173.907 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.5 m -87.93 0.71 55.53 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 131.109 3.763 . . . . 1.45 114.584 173.303 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -94.08 143.58 26.24 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 117.729 -3.107 . . . . 1.69 107.809 -179.315 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p -80.58 164.02 23.23 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 128.117 3.818 . . . . 0.75 110.165 176.973 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mm -59.22 -33.83 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 112.264 -2.244 . . . . 0.73 112.295 175.598 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -59.81 -30.99 69.3 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.585 -1.947 . . . . 1.62 111.627 175.733 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -74.9 -39.12 61.65 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.974 -3.579 . . . . 2.13 111.771 175.9 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.283 57.3 t -57.09 -60.48 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 O-C-N 118.07 -2.894 . . . . 0.62 110.233 172.368 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -53.51 -41.6 66.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 120.579 3.548 . . . . 1.22 120.579 177.318 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.14 -40.71 94.87 Favored 'General case' 0 CA--C 1.489 -1.394 0 O-C-N 119.412 -2.055 . . . . 0.51 111.794 169.932 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -63.95 -32.29 73.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.397 3.11 . . . . 1.44 119.397 170.488 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.2 mt -68.56 -39.04 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 O-C-N 124.871 1.357 . . . . 1.32 108.669 170.585 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -61.31 -43.92 98.07 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.12 2.39 . . . . 1.7 115.881 176.097 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.56 -46.2 91.06 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.122 -2.861 . . . . 1.55 113.933 174.105 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -68.41 -54.84 14.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.873 -3.642 . . . . 2.62 113.738 -179.828 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -104.78 -35.24 7.83 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.928 2.299 . . . . 1.48 116.82 -165.412 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.88 36.66 5.71 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-O 117.236 -1.869 . . . . 1.12 113.236 -179.645 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.8 mt -104.02 119.01 55.69 Favored Pre-proline 0 CA--C 1.489 -1.398 0 CA-C-O 113.78 -3.009 . . . . 1.55 103.585 -176.605 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.25 9.2 Cg_exo -62.81 161.68 28.08 Favored 'Trans proline' 0 N--CA 1.433 -2.031 1 C-N-CA 125.988 4.458 . . . . 1.02 116.611 176.147 . . . . . . . . 3 2 . 1 . 042 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.45 -25.13 11.47 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 CA-C-N 124.941 2.8 . . . . 1.25 117.904 -170.097 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -60.99 -49.13 78.69 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 125.968 2.794 . . . . 2.25 113.098 -179.416 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -62.26 -31.81 72.43 Favored 'General case' 0 N--CA 1.43 -1.45 1 C-N-CA 133.812 4.845 . . . . 2.02 112.727 176.225 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -75.73 130.81 39.26 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 117.736 -3.103 . . . . 0.69 114.413 -174.909 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.421 ' HB3' HG23 ' A' ' 70' ' ' VAL . 29.4 ttt180 -120.57 106.68 12.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.73 -1.211 . . . . 2.78 107.73 175.431 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.4 mt -91.41 129.65 37.37 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.17 2.588 . . . . 1.17 109.838 179.147 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.504 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 13.6 mt -121.79 146.26 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 127.013 2.125 . . . . 1.38 107.939 177.808 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.42 ' HB3' HD21 ' A' ' 50' ' ' LEU . 20.7 t80 -135.7 117.49 15.1 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 105.129 -2.174 . . . . 1.5 105.129 171.615 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.98 -68.88 0.12 Allowed 'General case' 0 N--CA 1.43 -1.464 1 C-N-CA 132.015 4.126 . . . . 1.21 107.612 179.943 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.4 14.11 0.45 Allowed Glycine 0 N--CA 1.43 -1.728 0 O-C-N 117.364 -3.335 . . . . 1.3 113.983 176.967 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -121.53 128.18 51.76 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 123.562 1.649 . . . . 2.55 108.208 -178.686 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -72.0 126.63 30.26 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.399 2.523 . . . . 2.48 109.234 169.47 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 45' ' ' PHE . 31.4 mt -83.27 145.43 29.11 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.261 -1.791 . . . . 0.9 107.464 -171.262 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -106.91 155.82 19.36 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-O 123.985 1.85 . . . . 1.94 113.327 -179.018 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -52.44 -60.28 3.42 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 121.12 3.748 . . . . 1.56 121.12 -168.071 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.9 37.69 2.68 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 129.82 3.581 . . . . 0.97 112.956 174.085 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -120.25 153.54 36.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 116.67 -1.634 . . . . 2.49 107.649 170.759 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.4 p -88.18 168.43 12.76 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 125.364 1.665 . . . . 0.76 113.72 164.918 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.7 mt -74.22 -27.78 60.95 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 116.183 -1.865 . . . . 1.05 109.659 178.031 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.1 p -64.66 -31.65 72.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 126.246 2.216 . . . . 1.19 115.115 174.582 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -55.05 -41.7 71.79 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 127.819 3.676 . . . . 1.9 114.772 171.306 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -84.16 -1.39 54.96 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 117.594 -3.191 . . . . 0.89 116.852 176.946 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.299 7.5 m120 65.85 40.96 4.0 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 125.854 2.74 . . . . 1.84 115.93 -176.927 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.6 mt -92.43 121.36 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 126.701 3.143 . . . . 0.82 111.032 177.969 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -110.64 179.34 4.1 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 111.374 -2.648 . . . . 2.16 108.71 -176.065 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -63.52 156.49 26.22 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 124.767 1.227 . . . . 2.12 113.961 179.22 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.451 65.6 mt-10 79.44 -4.03 2.05 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.323 -2.11 . . . . 1.71 113.485 172.793 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.298 49.7 m -73.14 154.08 40.49 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 117.699 2.481 . . . . 1.04 117.699 -174.578 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.7 m -112.73 124.02 51.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.58 -1.637 . . . . 0.79 106.58 178.247 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.2 mt -103.81 164.25 11.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.869 -1.16 . . . . 1.4 107.869 168.932 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.504 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 44.0 m170 -113.97 129.68 56.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 116.555 -1.688 . . . . 1.51 111.887 -176.902 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.7 tp -117.34 115.6 25.55 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 102.219 -3.252 . . . . 1.14 102.219 -176.125 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 42' ' ' ARG . 24.6 m -115.33 159.76 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 127.33 3.443 . . . . 1.23 102.747 173.909 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.43 -1.445 1 O-C-N 111.015 -7.303 . . . . 2.78 109.562 173.764 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.253 6.2 ptt? . . . . . 0 CA--C 1.49 -1.342 0 N-CA-C 113.775 1.028 . . . . 1.1 113.775 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.264 34.5 mt-30 -115.18 147.69 39.98 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 116.155 -4.091 . . . . 1.87 110.916 177.08 . . . . . . . . 3 2 . 1 . 043 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.8 pt -134.35 156.67 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 116.904 -3.623 . . . . 0.72 103.436 177.518 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -116.65 139.06 50.95 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.156 -1.59 . . . . 1.4 110.738 178.221 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.0 t -120.43 116.41 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-O 116.98 -1.486 . . . . 0.58 108.553 177.471 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -100.21 139.44 35.87 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 117.081 -1.848 . . . . 2.09 114.707 177.469 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 p -83.49 157.67 22.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.614 2.766 . . . . 0.99 113.234 174.205 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.1 tp -49.12 -41.1 34.79 Favored 'General case' 0 N--CA 1.43 -1.466 2 O-C-N 114.045 -5.41 . . . . 2.53 110.855 166.46 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.1 p -67.83 -28.26 67.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.948 1.832 . . . . 2.08 115.948 179.385 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.11 31.19 3.16 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 125.238 2.577 . . . . 1.31 113.849 173.454 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -109.6 133.39 53.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.743 -3.21 . . . . 1.4 104.181 -176.628 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.4 m -99.51 119.06 37.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.301 -3.374 . . . . 0.78 106.69 175.735 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mt -97.01 98.42 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.823 2.049 . . . . 1.55 106.836 175.997 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.6 m -87.35 125.86 34.51 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 125.401 2.524 . . . . 1.08 107.942 177.851 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.4 mt -116.94 162.59 17.52 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.542 -2.599 . . . . 1.55 107.272 -173.641 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -121.12 112.68 18.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.759 -2.463 . . . . 1.95 110.402 179.718 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -132.45 164.47 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 125.479 1.512 . . . . 0.96 114.356 -176.816 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -111.86 155.68 42.85 Favored Pre-proline 0 N--CA 1.43 -1.438 1 CA-C-O 110.828 -4.415 . . . . 2.35 104.471 164.806 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -69.92 -4.78 14.83 Favored 'Trans proline' 0 C--N 1.3 -2.023 1 CA-C-N 129.049 4.268 . . . . 0.95 114.808 -175.272 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 p -86.09 6.89 26.97 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.662 2.785 . . . . 1.45 111.633 170.714 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.5 133.33 47.56 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.973 -0.751 . . . . 1.69 108.973 169.008 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.7 p -79.96 167.63 20.24 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.731 -2.322 . . . . 0.75 104.731 177.412 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.3 mm -81.5 -21.64 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 117.536 -3.227 . . . . 0.73 109.302 176.849 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -55.1 -49.67 71.11 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 122.02 2.191 . . . . 1.62 109.59 161.348 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -59.14 -59.39 5.54 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 114.578 1.325 . . . . 2.13 114.578 -179.617 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.419 ' H ' HG23 ' A' ' 26' ' ' VAL . 15.2 t -45.1 -43.9 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 127.067 2.147 . . . . 0.62 114.483 172.167 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.454 ' HD2' ' HB2' ' A' ' 41' ' ' GLN 0.349 36.2 mtmt -60.17 -38.95 84.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 118.716 2.858 . . . . 1.22 118.716 171.491 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.57 -19.89 61.41 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.002 2.334 . . . . 0.51 117.024 179.584 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -78.71 -16.33 57.39 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 119.311 -2.118 . . . . 1.44 112.144 171.516 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.332 73.0 mt -78.32 -44.56 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 128.368 3.937 . . . . 1.32 108.751 172.179 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -57.4 -45.24 84.74 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 110.842 -2.89 . . . . 1.7 117.483 172.098 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -45.42 -45.25 12.68 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.872 1.669 . . . . 1.55 114.366 166.761 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -82.38 -68.8 0.67 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.364 -0.834 . . . . 2.62 111.741 -171.33 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -93.99 -20.75 19.69 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 125.789 1.931 . . . . 1.48 113.946 -169.667 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.23 -0.62 64.03 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 118.355 2.102 . . . . 1.12 118.355 175.753 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.9 mt -70.8 122.58 87.23 Favored Pre-proline 0 N--CA 1.429 -1.484 0 CA-C-O 113.955 -2.926 . . . . 1.55 105.303 -178.311 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.37 146.11 61.55 Favored 'Trans proline' 0 N--CA 1.433 -2.033 1 CA-C-O 106.609 -5.663 . . . . 1.02 116.565 177.873 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -55.63 -13.49 8.23 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 128.013 3.898 . . . . 1.25 122.196 -177.847 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -57.04 -41.54 78.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.991 2.517 . . . . 2.25 113.259 176.975 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.281 68.9 mt-30 -84.77 -27.0 27.18 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 126.331 1.852 . . . . 2.02 108.993 -170.437 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.454 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 61.1 mt-30 -71.23 139.92 50.24 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.509 2.781 . . . . 0.69 118.509 -171.496 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -133.83 129.24 36.21 Favored 'General case' 0 N--CA 1.43 -1.435 1 N-CA-C 99.126 -4.398 . . . . 2.78 99.126 172.493 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.46 ' HA ' HD23 ' A' ' 43' ' ' LEU . 23.9 mt -111.24 107.92 17.38 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 112.189 -2.278 . . . . 1.17 106.889 177.426 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 mm -97.26 133.98 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 115.003 -0.999 . . . . 1.38 108.699 176.227 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -122.32 100.6 7.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 101.772 -3.418 . . . . 1.5 101.772 176.794 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 81.65 -100.92 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 105.259 -2.126 . . . . 1.21 105.259 172.61 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.31 -10.16 7.49 Favored Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 107.033 -2.427 . . . . 1.3 107.033 179.284 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -100.94 148.32 25.14 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 119.96 1.88 . . . . 2.55 108.916 -173.478 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -105.4 129.04 53.8 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.795 -2.002 . . . . 2.48 113.661 178.284 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.4 mt -92.72 146.47 23.63 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 116.933 -1.508 . . . . 0.9 109.818 -167.058 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.1 148.94 21.69 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 128.786 3.804 . . . . 1.94 117.667 174.778 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.65 -59.73 4.76 Favored 'General case' 0 CA--C 1.488 -1.41 1 C-N-CA 133.241 4.617 . . . . 1.56 113.295 -169.527 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.66 46.7 3.49 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 119.508 -1.995 . . . . 0.97 116.515 175.458 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -127.75 -179.8 5.13 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 120.553 2.177 . . . . 2.49 112.043 166.805 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.2 p -104.53 172.47 6.77 Favored 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 116.011 -4.181 . . . . 0.76 117.835 178.715 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.5 mt -66.32 -29.63 69.87 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.704 -2.497 . . . . 1.05 111.006 173.105 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -71.69 -29.31 64.44 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 130.019 3.328 . . . . 1.19 117.453 178.367 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.327 23.6 m-20 -63.65 -36.58 84.29 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 119.231 -0.988 . . . . 1.9 112.709 170.118 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -93.42 12.85 23.49 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 117.166 2.284 . . . . 0.89 117.166 -174.996 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 50.08 32.62 6.02 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 118.137 2.643 . . . . 1.84 118.137 -175.304 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.8 mt -89.88 111.59 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 125.11 1.364 . . . . 0.82 110.498 -178.352 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -100.99 -165.68 1.23 Allowed 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 113.868 -1.514 . . . . 2.16 109.286 -173.768 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.5 pttp -68.78 149.81 48.58 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.534 2.111 . . . . 2.12 112.548 179.667 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.281 10.8 mt-10 66.66 30.13 8.39 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 125.619 2.628 . . . . 1.71 116.259 172.71 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.1 m -89.29 135.7 33.43 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.869 -2.394 . . . . 1.04 107.926 -170.697 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.6 m -105.06 106.36 16.81 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.913 -2.367 . . . . 0.79 108.818 -177.006 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -96.61 167.28 11.23 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.448 -2.032 . . . . 1.4 109.586 171.842 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -118.86 121.8 40.84 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 113.662 -1.608 . . . . 1.51 111.138 -170.338 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.9 tp -88.31 121.85 31.16 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.816 -1.549 . . . . 1.14 106.816 -177.449 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.6 t -114.26 124.51 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 106.487 -1.671 . . . . 1.23 106.487 179.308 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.0 mt . . . . . 0 N--CA 1.429 -1.479 0 O-C-N 116.366 -3.959 . . . . 2.78 111.763 179.673 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptt? . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 121.808 0.813 . . . . 1.1 109.507 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -104.57 120.24 40.84 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 113.129 -3.32 . . . . 1.87 108.717 -175.829 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.265 9.2 pt -116.74 174.01 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 127.007 2.692 . . . . 0.72 114.281 171.365 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -125.68 140.22 52.89 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.897 2.879 . . . . 1.4 106.71 -178.278 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 67' ' ' LEU . 95.8 t -129.07 114.81 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.499 -2.001 . . . . 0.58 107.051 171.405 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -86.23 143.14 28.1 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.678 0.751 . . . . 2.09 111.339 -176.129 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.3 p -88.01 169.36 12.04 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.043 -2.286 . . . . 0.99 111.995 176.408 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.8 mt -56.42 -33.71 66.09 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 114.001 -5.437 . . . . 2.53 113.023 172.609 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.2 p -90.18 -34.9 15.66 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 114.835 1.42 . . . . 2.08 114.835 -172.69 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.71 -17.01 0.4 Allowed Glycine 0 N--CA 1.429 -1.771 0 C-N-CA 116.27 -2.872 . . . . 1.31 112.15 177.46 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -84.84 147.91 26.56 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 124.743 2.211 . . . . 1.4 111.326 -170.743 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.6 m -115.65 128.22 55.76 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.745 -3.722 . . . . 0.78 108.752 178.905 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 mt -95.32 137.92 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 119.662 -1.899 . . . . 1.55 107.02 177.055 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.7 m -95.31 111.43 23.29 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.526 -1.984 . . . . 1.08 112.945 175.623 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.7 mt -115.42 148.87 38.86 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.01 -1.681 . . . . 1.55 111.891 -177.831 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -115.29 109.78 18.45 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 103.449 -2.797 . . . . 1.95 103.449 179.49 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.6 m -120.78 170.2 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 124.993 2.33 . . . . 0.96 105.075 177.36 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -126.75 155.4 75.21 Favored Pre-proline 0 N--CA 1.43 -1.429 0 N-CA-C 104.814 -2.291 . . . . 2.35 104.814 168.818 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.45 -29.34 39.36 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 N-CA-C 120.924 3.394 . . . . 0.95 120.924 -176.679 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 m -76.13 4.37 8.7 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.424 2.379 . . . . 1.45 117.424 177.176 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -85.1 148.74 25.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 125.74 1.9 . . . . 1.69 114.878 177.637 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.3 p -90.1 169.96 10.73 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.35 -2.094 . . . . 0.75 114.225 175.595 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.8 mm -63.64 -41.31 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 1 O-C-N 115.867 -4.27 . . . . 0.73 114.462 176.255 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.382 76.8 tt0 -35.75 -55.73 0.71 Allowed 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 118.624 2.824 . . . . 1.62 118.624 155.583 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -56.83 -28.15 61.13 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.734 -1.854 . . . . 2.13 115.718 176.187 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.2 t -69.98 -42.63 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 117.988 -2.945 . . . . 0.62 108.998 175.208 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -56.29 -39.53 72.84 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.437 -2.039 . . . . 1.22 116.404 171.777 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.0 -49.48 72.3 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.073 -2.892 . . . . 0.51 115.659 174.469 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -52.83 -45.11 67.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.248 1.419 . . . . 1.44 113.131 170.715 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 30' ' ' ILE . 56.4 mt -69.29 -30.9 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 O-C-N 115.722 -4.361 . . . . 1.32 112.169 175.125 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.31 -40.04 71.06 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.119 -1.613 . . . . 1.7 111.041 173.369 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.02 -54.7 44.12 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 123.358 1.551 . . . . 1.55 112.304 170.117 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -72.94 -57.89 3.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 116.55 -3.844 . . . . 2.62 115.628 -174.617 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -94.28 -27.33 16.19 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.364 1.987 . . . . 1.48 116.364 -174.188 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.35 23.67 21.17 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 117.47 1.748 . . . . 1.12 117.47 178.614 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.1 mt -89.77 138.84 27.77 Favored Pre-proline 0 N--CA 1.431 -1.402 0 O-C-N 118.188 -2.948 . . . . 1.55 103.827 -173.194 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.57 151.37 64.38 Favored 'Trans proline' 0 C--N 1.299 -2.052 1 CA-C-N 130.675 4.848 . . . . 1.02 111.712 176.761 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -73.03 -19.0 23.55 Favored 'Trans proline' 0 C--N 1.3 -2.004 3 C-N-CA 126.53 4.82 . . . . 1.25 115.676 -176.729 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.27 -39.03 66.5 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 115.686 1.736 . . . . 2.25 115.686 177.421 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -89.71 -18.61 26.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.342 -1.355 . . . . 2.02 107.342 -173.071 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.454 ' HG2' HD11 ' A' ' 69' ' ' LEU . 67.9 mt-30 -78.35 100.2 6.67 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 117.728 2.492 . . . . 0.69 117.728 -167.639 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -97.85 122.99 41.61 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 119.292 0.951 . . . . 2.78 110.867 171.009 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.1 mt -92.76 105.72 17.81 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.214 2.911 . . . . 1.17 112.896 179.146 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mm -90.66 130.57 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 128.615 2.766 . . . . 1.38 109.783 -177.521 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -138.89 114.8 10.08 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 106.344 -1.724 . . . . 1.5 106.344 176.364 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.458 . . 68.16 24.98 7.45 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.098 -1.626 . . . . 1.21 113.405 173.605 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.24 -24.87 28.33 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 117.827 -1.54 . . . . 1.3 112.151 -173.189 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.5 tttt -106.44 128.99 54.49 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 122.239 3.02 . . . . 2.55 112.618 -179.685 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -78.48 138.22 38.33 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 112.124 -2.307 . . . . 2.48 112.865 168.964 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.1 mt -93.38 137.89 32.24 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 129.305 3.042 . . . . 0.9 108.959 -166.816 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -68.37 144.8 54.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.995 1.85 . . . . 1.94 115.995 173.11 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.15 -38.81 82.53 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 118.751 2.871 . . . . 1.56 118.751 -165.799 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.39 23.47 31.83 Favored Glycine 0 N--CA 1.43 -1.753 0 O-C-N 119.147 -2.221 . . . . 0.97 115.788 173.486 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -99.07 143.82 28.91 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 118.562 1.181 . . . . 2.49 109.104 166.416 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.251 72.1 p -80.9 162.57 23.87 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 126.277 2.235 . . . . 0.76 112.857 -179.76 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.9 -24.26 67.75 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.307 -2.746 . . . . 1.05 110.467 172.622 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.6 t -88.02 -11.08 48.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.936 -1.728 . . . . 1.19 110.431 -176.997 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -75.8 -42.75 49.1 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.659 -1.9 . . . . 1.9 109.526 173.08 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -79.63 -0.05 32.19 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.41 2.374 . . . . 0.89 117.41 176.13 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 64.01 39.76 7.68 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 115.733 1.753 . . . . 1.84 115.733 -179.48 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.1 mm -75.43 118.4 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 119.273 -2.142 . . . . 0.82 110.081 178.085 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -91.84 172.71 8.29 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.322 2.487 . . . . 2.16 114.394 177.373 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -66.98 140.28 57.72 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.451 -3.28 . . . . 2.12 107.607 179.635 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.386 6.3 tt0 85.71 12.7 0.2 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.812 1.645 . . . . 1.71 113.365 177.2 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.8 m -80.15 152.55 29.18 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 116.856 -3.652 . . . . 1.04 112.52 -172.687 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.83 115.48 30.17 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.76 2.219 . . . . 0.79 109.599 -178.006 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.451 ' HB2' HG22 ' A' ' 5' ' ' VAL . 10.5 mp -102.52 163.19 12.37 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 114.118 -5.364 . . . . 1.4 104.86 174.183 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -122.67 123.46 41.18 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.866 1.666 . . . . 1.51 109.942 176.496 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.454 HD11 ' HG2' ' A' ' 41' ' ' GLN . 24.1 tp -84.8 122.14 28.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.719 1.608 . . . . 1.14 114.144 179.067 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.1 t -117.82 138.47 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 102.156 -3.276 . . . . 1.23 102.156 177.737 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 71' ' ' LEU . 36.0 mt . . . . . 0 N--CA 1.43 -1.438 0 CA-C-O 123.057 1.408 . . . . 2.78 108.495 -177.156 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 3.3 ptt? . . . . . 0 CA--C 1.491 -1.32 0 N-CA-C 116.566 2.061 . . . . 1.1 116.566 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -103.05 112.52 25.41 Favored 'General case' 0 N--CA 1.429 -1.486 1 O-C-N 116.03 -4.169 . . . . 1.87 107.153 -168.571 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.3 pt -117.71 154.07 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 117.333 -1.318 . . . . 0.72 111.425 169.724 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -118.0 134.63 54.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 125.589 1.805 . . . . 1.4 113.815 -179.195 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -104.14 127.16 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 104.509 -2.404 . . . . 0.58 104.509 173.851 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -104.1 147.69 27.13 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.806 -1.553 . . . . 2.09 106.806 176.208 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.337 7.8 p -97.8 154.09 17.85 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 128.228 3.455 . . . . 0.99 113.378 174.119 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.5 mt -55.14 -36.85 66.23 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.87 2.468 . . . . 2.53 113.389 168.044 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.6 p -78.25 -47.31 18.2 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.592 -1.942 . . . . 2.08 112.489 -173.567 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.85 25.6 0.06 OUTLIER Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 117.3 1.68 . . . . 1.31 117.3 167.916 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -103.74 153.24 20.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 116.121 -1.895 . . . . 1.4 111.668 -179.115 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.3 m -116.24 124.59 50.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 106.716 -1.587 . . . . 0.78 106.716 173.67 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.8 mt -99.08 117.65 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 123.413 2.824 . . . . 1.55 104.042 179.768 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.0 m -98.18 112.58 24.5 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.971 -2.956 . . . . 1.08 107.958 -176.107 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.8 mt -96.6 143.98 27.07 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.766 -1.209 . . . . 1.55 109.491 -174.384 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -98.41 119.17 36.64 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 126.284 2.24 . . . . 1.95 106.727 166.211 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.15 172.27 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 CA-C-N 121.231 1.832 . . . . 0.96 110.433 -175.823 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -126.2 152.53 73.67 Favored Pre-proline 0 N--CA 1.429 -1.483 0 C-N-CA 127.873 2.469 . . . . 2.35 107.246 172.409 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -75.69 -26.63 9.67 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 N-CA-C 107.056 -1.94 . . . . 0.95 107.056 -170.626 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.8 p -78.9 -5.76 54.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.672 -2.517 . . . . 1.45 115.557 -179.241 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -70.0 157.87 36.7 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 124.197 0.935 . . . . 1.69 111.852 168.945 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.7 p -88.75 166.72 13.85 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.649 2.092 . . . . 0.75 116.649 175.373 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.5 mm -67.13 -38.88 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.39 -2.069 . . . . 0.73 107.588 175.017 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -49.07 -44.82 42.24 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 118.31 -2.744 . . . . 1.62 114.077 167.676 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -64.71 -22.33 66.96 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.898 2.079 . . . . 2.13 111.8 175.956 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.36 98.5 t -73.67 -39.53 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 124.055 1.883 . . . . 0.62 110.792 176.543 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -70.88 -38.95 73.08 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.91 2.484 . . . . 1.22 110.487 178.449 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.46 -38.16 63.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.692 2.797 . . . . 0.51 114.193 169.853 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -77.23 -38.36 51.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.815 -1.803 . . . . 1.44 112.109 177.164 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.1 mt -61.08 -36.55 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 124.451 1.101 . . . . 1.32 111.42 172.219 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -65.51 -38.2 88.99 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 123.743 1.735 . . . . 1.7 110.936 178.777 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.53 -41.1 98.64 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 117.822 -3.049 . . . . 1.55 113.023 176.6 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -81.59 -59.09 2.73 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 116.423 -1.751 . . . . 2.62 112.064 -176.766 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -98.72 -39.17 8.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.989 2.515 . . . . 1.48 114.119 -164.825 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.21 26.59 7.31 Favored Glycine 0 N--CA 1.431 -1.693 0 O-C-N 125.733 1.896 . . . . 1.12 111.753 173.503 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 36' ' ' ILE . 39.2 mt -102.31 128.39 28.44 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 118.712 -2.64 . . . . 1.55 105.923 -176.809 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.305 80.1 Cg_endo -68.54 158.48 57.52 Favored 'Trans proline' 0 C--N 1.299 -2.051 2 C-N-CA 128.958 6.438 . . . . 1.02 112.75 -175.937 . . . . . . . . 3 2 . 1 . 045 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -66.52 -31.68 41.12 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 CA-C-N 124.389 2.603 . . . . 1.25 112.364 -178.514 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -50.14 -47.55 54.13 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.755 2.872 . . . . 2.25 118.755 175.271 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -70.27 -19.77 63.09 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.32 2.341 . . . . 2.02 117.32 176.199 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -96.41 135.97 37.55 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 120.011 1.278 . . . . 0.69 110.398 -173.484 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -128.01 124.23 36.65 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 100.817 -3.771 . . . . 2.78 100.817 173.279 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.8 mt -104.88 129.51 53.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.451 -2.159 . . . . 1.17 110.735 178.21 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.5 mm -108.59 129.21 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 125.588 2.613 . . . . 1.38 110.198 178.473 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -130.15 130.82 45.25 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.939 -2.976 . . . . 1.5 109.502 172.068 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.255 . . 67.51 -75.23 0.06 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.21 1.481 . . . . 1.21 109.089 -173.08 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.428 ' H ' ' H ' ' A' ' 48' ' ' LYS . . . -161.38 -7.9 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 129.912 3.625 . . . . 1.3 112.3 -175.937 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.428 ' H ' ' H ' ' A' ' 47' ' ' GLY . 44.2 mttp -81.3 130.85 35.2 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.569 -1.548 . . . . 2.55 112.427 -177.467 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -91.2 106.87 18.82 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 114.905 -4.872 . . . . 2.48 104.003 169.671 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.4 mt -71.21 133.17 45.93 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 117.316 2.339 . . . . 0.9 117.316 -169.583 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -83.87 141.97 30.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 111.562 -2.563 . . . . 1.94 114.031 -178.795 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.6 -65.68 0.64 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.469 -2.644 . . . . 1.56 117.989 -161.573 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.3 54.26 4.92 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-O 126.339 3.189 . . . . 0.97 117.33 168.701 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -117.14 146.69 43.02 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 111.585 -2.307 . . . . 2.49 108.987 159.657 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.6 p -72.79 152.93 41.33 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.905 1.446 . . . . 0.76 114.905 169.351 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.6 mt -59.72 -36.8 77.31 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.708 2.803 . . . . 1.05 108.161 175.109 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.263 1.7 t -71.38 -26.11 62.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 127.333 2.896 . . . . 1.19 112.836 175.078 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -67.88 -47.57 68.48 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 123.805 3.002 . . . . 1.9 111.183 168.74 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -69.8 -23.15 63.29 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.732 -1.855 . . . . 0.89 114.692 176.963 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.7 t30 73.79 53.11 0.11 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 127.414 2.286 . . . . 1.84 109.668 -171.672 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.8 mt -95.91 119.79 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 103.524 -2.769 . . . . 0.82 103.524 174.163 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -105.18 -178.06 3.54 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.282 -2.136 . . . . 2.16 111.869 -179.038 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.362 14.1 ptmt -49.18 137.42 13.77 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 127.326 2.25 . . . . 2.12 115.668 172.852 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 77.91 11.31 2.0 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.714 1.605 . . . . 1.71 114.421 173.163 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.3 m -82.59 147.19 28.74 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 124.395 1.059 . . . . 1.04 113.188 -175.165 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.5 m -105.19 116.48 32.02 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.732 2.206 . . . . 0.79 110.625 179.635 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.8 mt -88.4 141.46 28.52 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.323 -2.736 . . . . 1.4 110.804 172.15 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -100.69 123.61 45.14 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.714 1.721 . . . . 1.51 107.448 173.75 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.8 tp -85.89 111.99 20.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.916 1.686 . . . . 1.14 113.745 176.86 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.7 t -111.51 134.3 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 2 CA-C-O 129.965 4.698 . . . . 1.23 99.757 178.947 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.6 mt . . . . . 0 N--CA 1.43 -1.473 0 O-C-N 118.023 -2.923 . . . . 2.78 115.687 -177.549 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 CA--C 1.489 -1.371 0 CA-C-O 117.439 -1.267 . . . . 1.1 111.138 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -94.7 134.57 37.15 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.774 1.75 . . . . 1.87 111.374 -171.633 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -120.61 136.6 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.855 -3.028 . . . . 0.72 106.26 169.037 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -101.66 90.66 4.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 125.312 2.482 . . . . 1.4 111.701 -173.443 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.99 100.08 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.49 1 O-C-N 112.216 -6.553 . . . . 0.58 113.367 177.238 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -96.12 134.89 38.64 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.84 -1.163 . . . . 2.09 110.568 178.452 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.5 p -84.52 -178.78 6.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 131.049 3.74 . . . . 0.99 116.102 174.612 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.3 tp -79.01 -26.58 43.24 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.97 -4.206 . . . . 2.53 116.336 171.395 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.5 p -77.32 -34.01 55.41 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.253 2.93 . . . . 2.08 114.335 -179.167 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.32 4.16 2.6 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 119.27 -2.144 . . . . 1.31 111.455 174.464 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -82.4 122.74 28.39 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.82 -1.988 . . . . 1.4 111.531 -176.174 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 m -99.26 112.23 24.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.394 -2.691 . . . . 0.78 113.362 170.041 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.52 117.63 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 120.021 -1.674 . . . . 1.55 106.59 171.049 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.6 m -99.07 98.04 9.11 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.495 -1.669 . . . . 1.08 106.495 -178.362 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.1 mt -76.51 126.09 30.37 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.436 1.894 . . . . 1.55 111.294 -176.928 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -81.26 104.07 11.47 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.904 -2.997 . . . . 1.95 113.363 166.662 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 m -110.49 171.62 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 123.983 0.913 . . . . 0.96 111.596 -179.739 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -123.32 169.73 9.6 Favored Pre-proline 0 N--CA 1.43 -1.472 0 CA-C-O 116.278 -1.82 . . . . 2.35 107.387 158.22 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -78.66 -16.08 13.3 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 124.127 2.51 . . . . 0.95 112.719 -167.905 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.83 -19.21 65.8 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 114.886 -2.483 . . . . 1.45 113.886 174.537 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -72.18 143.63 48.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 125.189 1.555 . . . . 1.69 113.073 -174.863 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 26' ' ' VAL . 13.5 p -86.89 167.42 14.34 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.568 -1.958 . . . . 0.75 113.361 178.798 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 23' ' ' ILE . 42.4 mm -64.08 -37.16 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.536 -1.353 . . . . 0.73 111.84 172.962 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -53.03 -42.18 65.43 Favored 'General case' 0 N--CA 1.429 -1.492 1 O-C-N 115.458 -4.526 . . . . 1.62 114.866 163.639 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -72.72 -32.94 66.09 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.407 -2.683 . . . . 2.13 111.756 -178.621 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 55.1 t -62.56 -50.38 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 119.019 -2.3 . . . . 0.62 109.927 171.724 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -66.82 -18.59 65.45 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.142 1.377 . . . . 1.22 111.168 -179.227 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.0 -35.51 31.86 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 113.292 0.849 . . . . 0.51 113.292 169.816 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 55.1 mttp -63.46 -52.47 61.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.153 -2.217 . . . . 1.44 108.542 171.203 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.8 mt -53.92 -32.54 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 123.96 3.073 . . . . 1.32 117.397 174.83 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -71.1 -40.06 71.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.088 -2.883 . . . . 1.7 114.901 173.568 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.64 -56.85 16.16 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.09 -2.881 . . . . 1.55 107.428 168.836 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -71.22 -56.48 5.97 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.485 1.291 . . . . 2.62 114.485 -170.103 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -96.15 -24.79 16.12 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.151 2.58 . . . . 1.48 112.11 -168.972 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.55 37.53 13.99 Favored Glycine 0 N--CA 1.43 -1.751 0 CA-C-O 127.6 3.889 . . . . 1.12 113.71 173.853 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.7 mt -108.86 132.72 21.0 Favored Pre-proline 0 N--CA 1.429 -1.494 1 O-C-N 116.262 -4.081 . . . . 1.55 108.268 -178.539 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -68.51 142.88 55.29 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 C-N-CA 125.05 3.833 . . . . 1.02 120.817 -179.574 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.47 -9.11 21.32 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 123.731 2.954 . . . . 1.25 117.745 -171.376 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.74 -23.39 36.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.906 1.683 . . . . 2.25 112.697 166.85 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -86.15 -41.08 15.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 129.122 2.969 . . . . 2.02 111.123 -177.762 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.257 58.0 mt-30 -70.0 134.54 48.42 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 111.056 -2.793 . . . . 0.69 113.168 179.978 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -133.11 120.13 20.85 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.322 1.601 . . . . 2.78 115.322 175.074 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.6 mt -100.02 117.42 34.25 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 121.223 -0.923 . . . . 1.17 111.167 -177.214 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 44' ' ' ILE . 80.8 mt -110.33 129.19 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 126.964 2.106 . . . . 1.38 108.097 179.472 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -142.83 137.52 29.68 Favored 'General case' 0 N--CA 1.43 -1.463 1 N-CA-C 99.092 -4.41 . . . . 1.5 99.092 173.002 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.16 33.4 23.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 117.078 2.251 . . . . 1.21 117.078 175.695 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.57 9.18 73.53 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 116.198 -2.906 . . . . 1.3 115.459 -174.023 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -121.33 137.9 54.49 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.694 2.187 . . . . 2.55 109.732 -176.459 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -89.37 118.22 28.88 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 127.261 3.41 . . . . 2.48 102.155 179.281 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.1 mt -87.22 152.59 22.18 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.771 -3.706 . . . . 0.9 112.82 -170.715 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -97.4 163.9 12.68 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.104 -3.498 . . . . 1.94 109.535 179.633 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -72.88 -69.04 0.44 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.458 2.303 . . . . 1.56 114.168 -168.314 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.08 59.77 2.25 Favored Glycine 0 N--CA 1.43 -1.728 1 C-N-CA 131.455 4.359 . . . . 0.97 110.76 176.919 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.5 mmt-85 -142.74 148.46 37.28 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.073 -1.825 . . . . 2.49 106.073 169.7 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 72.6 p -86.43 170.24 12.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.217 -3.427 . . . . 0.76 108.617 178.72 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 31.3 mt -65.89 -39.1 90.32 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.794 2.838 . . . . 1.05 110.648 169.078 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 t -64.88 -37.03 86.26 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.825 -3.047 . . . . 1.19 114.966 177.726 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -60.48 -40.67 92.14 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 115.925 1.824 . . . . 1.9 115.925 177.486 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -77.25 -9.92 59.1 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.797 2.839 . . . . 0.89 114.246 171.809 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.258 9.6 t30 63.18 48.39 3.73 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 125.787 2.708 . . . . 1.84 113.368 -176.698 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.1 mt -96.47 100.24 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 1 C-N-CA 132.25 4.22 . . . . 0.82 104.843 179.352 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -90.75 -174.45 4.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 121.959 2.163 . . . . 2.16 106.591 -175.955 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -62.37 151.66 36.2 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.58 -1.646 . . . . 2.12 109.76 173.088 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.344 43.7 mt-10 67.4 21.88 9.57 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 128.983 2.913 . . . . 1.71 111.078 171.106 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.1 m -85.59 136.7 33.28 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 115.617 -2.135 . . . . 1.04 112.64 -178.396 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.0 m -90.72 111.13 22.36 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 120.234 1.379 . . . . 0.79 108.623 -178.764 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.3 mt -88.91 137.67 32.11 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.259 -3.4 . . . . 1.4 107.313 173.326 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -94.06 116.65 29.1 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.78 -2.45 . . . . 1.51 106.527 -174.046 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.1 tp -99.63 108.68 21.12 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.749 -1.844 . . . . 1.14 110.005 -176.909 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.3 t -98.52 132.73 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 131.262 3.825 . . . . 1.23 107.691 178.307 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.8 mt . . . . . 0 N--CA 1.43 -1.44 0 CA-C-O 127.458 3.504 . . . . 2.78 105.354 177.565 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ptt? . . . . . 0 CA--C 1.489 -1.392 0 CA-C-O 121.792 0.806 . . . . 1.1 111.739 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -110.81 142.21 43.12 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.645 -1.909 . . . . 1.87 110.301 -169.694 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.2 pt -136.64 146.2 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 129.073 2.949 . . . . 0.72 109.809 178.42 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.422 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 25.3 m-85 -105.29 109.55 21.58 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 113.384 -1.735 . . . . 1.4 112.933 -178.497 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -100.49 103.06 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 117.601 -3.187 . . . . 0.58 108.703 176.227 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -91.76 131.57 37.03 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.73 -1.605 . . . . 2.09 113.049 176.486 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.351 0.0 OUTLIER -98.4 168.83 9.96 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.455 2.302 . . . . 0.99 109.32 -177.976 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.5 mt -67.67 -35.29 78.58 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 126.404 2.315 . . . . 2.53 112.686 -175.611 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.319 17.8 p -71.31 -35.66 71.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.893 1.679 . . . . 2.08 109.197 -176.388 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.29 -12.68 1.83 Allowed Glycine 0 N--CA 1.429 -1.805 0 O-C-N 118.949 -2.344 . . . . 1.31 115.758 178.031 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -80.29 134.45 36.08 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 124.946 2.308 . . . . 1.4 114.064 -175.654 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -99.82 127.3 45.99 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.197 -2.19 . . . . 0.78 109.518 173.813 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 mt -102.48 117.61 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 118.136 -2.853 . . . . 1.55 108.66 174.699 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.1 m -95.92 117.69 31.1 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 119.534 -0.866 . . . . 1.08 109.194 178.629 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.5 mt -119.21 150.27 40.35 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 121.212 -0.93 . . . . 1.55 112.627 177.371 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -101.07 139.91 36.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 127.762 3.164 . . . . 1.95 108.547 167.657 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.9 m -150.93 170.47 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 C-N-CA 129.969 3.307 . . . . 0.96 112.981 -178.383 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -108.47 156.9 37.84 Favored Pre-proline 0 CA--C 1.489 -1.383 0 CA-C-O 114.071 -2.871 . . . . 2.35 110.264 167.054 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -67.84 -21.27 44.51 Favored 'Trans proline' 0 N--CA 1.433 -2.065 0 C-N-CA 124.525 3.483 . . . . 0.95 111.827 -174.643 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.2 p -71.4 -6.64 41.74 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 130.511 3.525 . . . . 1.45 115.944 169.713 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.74 156.19 30.75 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.473 -2.017 . . . . 1.69 112.928 176.021 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.6 p -92.64 169.63 10.36 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.085 1.754 . . . . 0.75 113.128 176.512 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.5 mm -66.93 -30.97 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.806 -2.434 . . . . 0.73 114.975 173.579 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -57.25 -40.44 77.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.883 -3.01 . . . . 1.62 112.176 168.827 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -69.42 -23.65 63.73 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 113.217 0.821 . . . . 2.13 113.217 177.912 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.9 t -79.69 -46.54 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 119.647 -1.908 . . . . 0.62 113.48 176.38 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -68.85 -23.6 64.26 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 125.761 2.696 . . . . 1.22 115.017 176.614 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.84 -19.75 57.15 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.24 -3.412 . . . . 0.51 111.105 173.561 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -84.64 -34.85 22.99 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.173 2.416 . . . . 1.44 110.3 -179.838 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.7 mt -75.95 -22.13 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 117.965 -2.96 . . . . 1.32 107.767 175.822 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -70.23 -37.27 74.95 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 117.968 -2.958 . . . . 1.7 110.883 170.818 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.97 -59.33 3.58 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 120.467 -1.396 . . . . 1.55 110.873 172.438 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.256 32.6 tttp -59.18 -58.83 6.93 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.266 2.626 . . . . 2.62 111.25 -172.266 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -92.99 -74.7 0.51 Allowed 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.4 1.88 . . . . 1.48 109.612 -174.065 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 156.6 -14.23 0.35 Allowed Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 125.31 3.687 . . . . 1.12 110.274 177.186 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.6 mt -57.59 119.41 32.61 Favored Pre-proline 0 N--CA 1.43 -1.433 0 C-N-CA 128.929 2.892 . . . . 1.55 113.476 -172.891 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -60.22 147.09 94.85 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 CA-C-N 125.168 2.882 . . . . 1.02 117.534 171.789 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.304 73.6 Cg_endo -72.35 -18.25 26.57 Favored 'Trans proline' 0 N--CA 1.433 -2.031 1 C-N-CA 126.691 4.927 . . . . 1.25 114.615 -172.327 . . . . . . . . 3 2 . 1 . 047 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -73.36 -22.03 60.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 124.176 3.171 . . . . 2.25 109.373 174.799 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -87.4 -18.38 30.13 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.918 -2.364 . . . . 2.02 110.0 -178.724 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -96.12 116.27 28.72 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.726 -1.953 . . . . 0.69 105.726 -172.043 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -103.57 119.79 39.59 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 131.472 3.909 . . . . 2.78 107.851 168.695 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.5 mt -109.53 120.82 43.67 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.047 1.403 . . . . 1.17 110.916 179.631 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.414 HD11 HG21 ' A' ' 70' ' ' VAL . 1.4 mt -104.98 126.81 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 O-C-N 119.871 -1.768 . . . . 1.38 109.843 -179.614 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.498 ' CE2' HG12 ' A' ' 61' ' ' ILE . 49.3 t80 -134.12 127.79 32.82 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 116.881 -3.637 . . . . 1.5 112.936 173.762 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 35.39 38.75 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.843 1.657 . . . . 1.21 114.508 -171.51 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.27 -43.12 1.76 Allowed Glycine 0 N--CA 1.431 -1.699 0 O-C-N 118.012 -2.93 . . . . 1.3 113.096 175.752 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -72.46 144.03 48.22 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 119.374 1.587 . . . . 2.55 113.522 176.47 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.445 1.1 mp0 -99.14 112.8 24.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.325 -2.109 . . . . 2.48 112.101 169.742 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.8 mt -78.27 139.28 38.89 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 116.715 -3.741 . . . . 0.9 113.964 -158.393 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -82.05 141.8 32.87 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.747 2.419 . . . . 1.94 109.673 178.262 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.31 -48.46 71.32 Favored 'General case' 0 N--CA 1.43 -1.433 1 N-CA-C 121.91 4.041 . . . . 1.56 121.91 -173.378 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.92 63.25 1.52 Allowed Glycine 0 N--CA 1.431 -1.649 0 O-C-N 118.378 -2.701 . . . . 0.97 114.216 171.228 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -129.65 150.39 50.99 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.371 3.069 . . . . 2.49 105.932 167.62 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.7 p -87.41 170.15 11.63 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 119.071 -1.052 . . . . 0.76 110.048 177.662 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.6 mt -70.67 -30.11 66.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.591 1.956 . . . . 1.05 107.943 173.39 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.3 p -73.03 -43.0 62.56 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 116.241 -4.037 . . . . 1.19 118.036 175.382 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -44.05 -60.45 1.86 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.256 2.222 . . . . 1.9 116.584 167.058 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -73.25 3.78 5.34 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.424 -1.262 . . . . 0.89 112.054 179.61 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.2 t30 52.76 48.76 21.77 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.612 3.165 . . . . 1.84 114.654 -175.308 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.498 HG12 ' CE2' ' A' ' 45' ' ' PHE . 19.5 mt -94.92 124.74 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 116.528 -3.857 . . . . 0.82 108.281 175.785 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -114.33 -162.64 0.82 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 116.794 -3.691 . . . . 2.16 105.809 -165.299 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -67.87 139.59 56.51 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 124.935 2.302 . . . . 2.12 113.371 167.347 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.438 84.5 mt-10 70.81 38.3 1.22 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.912 -2.368 . . . . 1.71 111.191 171.043 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 m -95.53 115.24 27.16 Favored 'General case' 0 N--CA 1.43 -1.453 1 C-N-CA 133.734 4.813 . . . . 1.04 107.779 -170.31 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.422 ' HA ' ' HB2' ' A' ' 4' ' ' PHE 0.256 87.5 m -80.46 102.47 9.7 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.723 -1.236 . . . . 0.79 114.263 175.414 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.308 8.8 mt -89.21 135.61 33.48 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-O 123.904 1.812 . . . . 1.4 107.494 174.033 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -97.39 104.98 17.05 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.084 1.354 . . . . 1.51 107.586 -174.276 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.362 16.6 tp -76.43 115.42 16.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.371 -3.331 . . . . 1.14 114.335 174.906 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.414 HG21 HD11 ' A' ' 44' ' ' ILE . 66.0 t -108.48 128.77 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 115.554 -2.165 . . . . 1.23 106.508 172.212 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.8 mt . . . . . 0 N--CA 1.429 -1.486 0 CA-C-N 123.968 3.076 . . . . 2.78 109.019 176.285 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.458 ' SD ' ' HA ' ' A' ' 63' ' ' LYS . 11.0 ptt? . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 117.878 -1.058 . . . . 1.1 112.834 . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -86.4 129.43 34.86 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 120.878 1.672 . . . . 1.87 112.013 -179.881 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.261 32.5 pt -130.91 150.68 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.129 -3.482 . . . . 0.72 108.642 175.459 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -110.88 142.73 42.55 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 117.897 -3.002 . . . . 1.4 104.819 -178.653 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.4 t -124.1 108.49 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 107.082 -1.451 . . . . 0.58 107.082 172.748 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -98.28 132.1 44.05 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.89 -2.381 . . . . 2.09 110.633 -178.872 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.555 HG22 HD23 ' A' ' 69' ' ' LEU . 2.6 p -86.53 177.48 7.38 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.805 2.241 . . . . 0.99 113.682 178.797 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.317 43.0 mt -83.2 -38.99 21.56 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 119.153 -2.217 . . . . 2.53 109.828 170.073 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 p -63.71 -52.28 61.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.452 3.101 . . . . 2.08 113.963 179.69 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.84 11.31 0.04 OUTLIER Glycine 0 N--CA 1.429 -1.783 0 O-C-N 118.465 -2.647 . . . . 1.31 118.008 -175.136 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -115.59 150.95 35.83 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 105.824 -1.917 . . . . 1.4 105.824 -167.445 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.3 m -122.29 111.23 16.66 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 116.393 -1.765 . . . . 0.78 109.377 166.963 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -91.58 121.79 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 123.605 2.911 . . . . 1.55 109.952 177.622 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 m -87.55 114.18 23.92 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 127.189 3.376 . . . . 1.08 113.286 173.008 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.4 mt -110.8 154.74 23.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.918 -2.989 . . . . 1.55 112.88 -179.712 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -110.09 123.14 49.17 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 124.259 1.981 . . . . 1.95 108.028 166.283 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.96 170.59 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 118.672 -2.517 . . . . 0.96 107.116 -174.528 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -118.91 154.65 53.12 Favored Pre-proline 0 N--CA 1.43 -1.463 0 O-C-N 119.151 -2.218 . . . . 2.35 105.825 165.331 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -68.17 -16.54 44.53 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 O-C-N 114.683 -3.377 . . . . 0.95 114.276 -175.253 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.4 m -91.15 12.03 21.35 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 114.045 -5.409 . . . . 1.45 113.378 175.836 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -88.54 144.86 26.06 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 113.31 -3.356 . . . . 1.69 108.463 179.707 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.278 53.7 p -71.28 153.24 42.55 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.473 1.909 . . . . 0.75 109.758 -179.945 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.6 mm -54.09 -40.58 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 118.403 -2.685 . . . . 0.73 114.598 168.645 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -42.59 -46.29 4.88 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 117.675 2.472 . . . . 1.62 117.675 164.983 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.61 -46.03 84.38 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 111.625 -2.534 . . . . 2.13 112.478 178.151 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.6 t -59.01 -44.32 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 C-N-CA 126.743 2.017 . . . . 0.62 106.155 178.034 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.254 84.2 mttt -60.8 -42.61 97.97 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 116.203 -4.061 . . . . 1.22 114.124 177.473 . . . . . . . . 3 2 . 1 . 048 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.34 -20.68 62.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.448 -3.283 . . . . 0.51 116.379 175.091 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -72.68 -45.24 59.83 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.095 1.758 . . . . 1.44 112.359 170.442 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -48.69 -43.91 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.532 1.533 . . . . 1.32 112.756 163.264 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -66.05 -43.38 87.65 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.855 -3.653 . . . . 1.7 112.622 -179.537 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -53.77 -49.59 67.91 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.323 1.449 . . . . 1.55 110.339 168.26 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -80.97 -54.79 5.27 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.071 -2.893 . . . . 2.62 112.627 -174.815 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -99.62 -26.62 14.02 Favored 'General case' 0 N--CA 1.431 -1.401 1 O-C-N 112.694 -6.254 . . . . 1.48 109.03 -168.309 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.2 17.4 40.23 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 117.918 -2.989 . . . . 1.12 115.158 179.929 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.8 mt -84.83 123.28 74.17 Favored Pre-proline 0 N--CA 1.43 -1.471 0 CA-C-O 113.678 -3.058 . . . . 1.55 107.972 -177.404 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -69.81 144.4 53.61 Favored 'Trans proline' 0 N--CA 1.433 -2.037 1 CA-C-N 129.548 4.446 . . . . 1.02 114.205 -178.142 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_exo -62.08 -20.05 68.42 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 N-CA-C 121.185 3.494 . . . . 1.25 121.185 -165.425 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -66.79 -28.17 68.17 Favored 'General case' 0 N--CA 1.429 -1.49 1 O-C-N 129.998 4.561 . . . . 2.25 111.773 173.542 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -85.62 -24.59 27.05 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 116.296 -1.812 . . . . 2.02 110.457 -176.412 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.251 60.1 mt-30 -79.49 129.8 34.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 127.899 3.249 . . . . 0.69 110.959 -169.107 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -115.1 129.87 56.79 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.457 -2.053 . . . . 2.78 105.457 168.993 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.3 mt -114.1 126.96 55.68 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.139 -2.85 . . . . 1.17 111.093 179.647 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 59.8 mt -117.73 124.23 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-O 126.969 3.271 . . . . 1.38 111.245 -175.47 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -135.66 139.3 43.63 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 115.965 -4.21 . . . . 1.5 109.049 172.192 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.362 . . 58.68 25.21 13.05 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 123.779 2.991 . . . . 1.21 115.673 173.469 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.11 2.92 90.7 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 117.077 1.591 . . . . 1.3 117.077 -177.055 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -113.26 157.21 22.05 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.382 2.273 . . . . 2.55 115.61 176.773 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -97.54 139.66 33.12 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.431 -2.668 . . . . 2.48 109.674 173.079 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.3 mt -102.2 120.66 40.82 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.978 -2.951 . . . . 0.9 111.329 -170.362 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -67.28 148.01 52.25 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.191 1.552 . . . . 1.94 115.191 175.283 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.65 -47.11 76.67 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 120.75 3.611 . . . . 1.56 120.75 -174.37 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.39 18.01 21.03 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 115.372 -2.904 . . . . 0.97 118.766 173.684 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -102.79 156.74 17.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.77 2.785 . . . . 2.49 110.974 171.643 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 39.1 p -88.55 169.65 11.55 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 123.329 1.538 . . . . 0.76 115.008 172.817 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.333 77.3 mt -69.22 -23.96 63.95 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 116.011 -4.181 . . . . 1.05 110.809 170.713 . . . . . . . . 3 2 . 1 . 048 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -65.72 -36.4 83.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.8 2.44 . . . . 1.19 115.489 171.806 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -65.41 -38.59 90.38 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.698 1.599 . . . . 1.9 113.911 173.881 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -78.9 -25.28 43.79 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 115.328 -2.272 . . . . 0.89 113.901 175.323 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.279 1.9 m-80 70.8 58.46 0.21 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.107 1.763 . . . . 1.84 109.909 -171.299 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 mt -105.25 117.12 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 105.022 -2.214 . . . . 0.82 105.022 174.034 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -84.83 -175.16 5.65 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 124.837 2.256 . . . . 2.16 111.374 -169.216 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.458 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 59.7 tttt -20.98 -87.87 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.422 1 C-N-CA 134.351 5.06 . . . . 2.12 118.208 169.086 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -103.17 69.3 1.01 Allowed 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 122.408 2.367 . . . . 1.71 116.226 -179.97 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.3 m -91.85 152.38 20.12 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 114.797 -1.092 . . . . 1.04 112.762 -179.99 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.5 m -113.52 115.69 28.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.136 1.374 . . . . 0.79 109.851 174.024 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.3 mt -96.93 156.63 16.27 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.545 1.938 . . . . 1.4 110.83 -179.674 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.405 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 98.2 m-70 -110.9 129.65 55.81 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 100.991 -3.707 . . . . 1.51 100.991 -175.815 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.555 HD23 HG22 ' A' ' 7' ' ' THR . 29.0 tp -102.53 113.89 27.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 125.328 1.643 . . . . 1.14 108.441 178.509 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.96 148.79 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 125.497 2.57 . . . . 1.23 109.464 172.845 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.9 mt . . . . . 0 N--CA 1.43 -1.464 1 O-C-N 115.728 -4.358 . . . . 2.78 111.985 -177.708 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 ptt? . . . . . 0 CA--C 1.491 -1.316 0 N-CA-C 116.773 2.138 . . . . 1.1 116.773 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -87.62 121.17 29.72 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 122.566 2.439 . . . . 1.87 110.489 178.904 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 pt -108.42 153.09 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 127.699 2.4 . . . . 0.72 108.577 173.777 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -104.18 131.08 51.85 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.868 -1.16 . . . . 1.4 107.868 -179.744 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.5 t -121.01 121.47 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 104.481 -2.414 . . . . 0.58 104.481 168.054 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -100.25 128.18 46.37 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 126.632 1.973 . . . . 2.09 111.727 -176.971 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.353 30.5 p -77.41 -164.07 0.44 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.602 1.668 . . . . 0.99 114.42 179.201 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.308 10.3 mt -90.97 -40.6 11.59 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.704 -1.872 . . . . 2.53 112.911 169.159 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.0 p -64.75 -37.09 86.42 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.548 -2.595 . . . . 2.08 107.616 -176.409 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.35 51.97 0.31 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 128.067 2.746 . . . . 1.31 111.312 175.92 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -114.1 130.27 56.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 101.972 -3.344 . . . . 1.4 101.972 177.425 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.3 m -102.67 103.76 14.05 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 118.016 -2.927 . . . . 0.78 110.399 177.146 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.81 136.51 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 118.755 -2.465 . . . . 1.55 108.418 179.541 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.7 m -103.29 111.93 24.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 118.733 -0.651 . . . . 1.08 109.265 179.602 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.38 142.23 28.01 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 127.992 3.307 . . . . 1.55 109.253 -178.97 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -105.81 116.28 31.67 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 123.395 1.569 . . . . 1.95 113.044 164.407 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.78 179.46 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.039 -1.437 . . . . 0.96 109.635 -178.808 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 89.8 mt-10 -115.89 163.35 21.46 Favored Pre-proline 0 N--CA 1.432 -1.373 0 O-C-N 117.1 -3.5 . . . . 2.35 107.888 164.189 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 56.1 Cg_exo -70.51 -14.46 33.73 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 C-N-CA 122.603 2.202 . . . . 0.95 112.444 -177.688 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.0 p -90.6 -0.99 57.88 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.165 2.186 . . . . 1.45 112.675 179.335 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -75.89 137.51 40.46 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.602 -1.936 . . . . 1.69 112.321 174.284 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 17.2 p -78.87 170.84 16.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.902 1.81 . . . . 0.75 111.625 174.297 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.284 3.5 mp -64.43 -41.07 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.267 -3.396 . . . . 0.73 112.721 168.106 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -43.5 -50.97 6.96 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 117.133 2.271 . . . . 1.62 117.133 163.694 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -67.01 -34.58 78.04 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.234 -2.166 . . . . 2.13 110.743 179.11 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.25 -42.1 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 118.253 2.686 . . . . 0.62 118.253 170.548 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.413 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 40.1 mtmt -71.86 -34.96 69.65 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 117.621 -3.175 . . . . 1.22 117.091 174.337 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.39 -28.38 63.99 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.733 2.413 . . . . 0.51 113.116 179.254 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -71.53 -37.89 71.11 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.689 2.395 . . . . 1.44 110.345 168.616 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.1 mt -68.31 -38.81 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 125.282 1.433 . . . . 1.32 107.996 175.872 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.342 40.3 tt0 -56.44 -41.8 77.04 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 128.788 2.835 . . . . 1.7 114.057 171.035 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -60.51 -41.73 94.95 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 118.236 2.68 . . . . 1.55 118.236 162.013 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -76.28 -52.4 10.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.719 -3.113 . . . . 2.62 116.431 -173.748 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -100.31 -26.77 13.79 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.714 2.406 . . . . 1.48 111.152 -168.585 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.75 13.88 56.04 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 118.12 -2.862 . . . . 1.12 117.289 176.048 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.9 mt -98.7 117.86 63.89 Favored Pre-proline 0 N--CA 1.43 -1.431 0 C-N-CA 127.439 2.295 . . . . 1.55 110.094 -170.799 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.39 152.71 70.94 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 CA-C-N 125.273 2.919 . . . . 1.02 116.932 -178.593 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -81.8 8.73 4.28 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 CA-C-O 113.582 -2.757 . . . . 1.25 107.919 -165.808 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -73.37 -44.13 59.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 125.272 3.669 . . . . 2.25 113.167 168.939 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -72.61 -26.36 61.66 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.783 2.833 . . . . 2.02 107.926 -172.466 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.413 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 73.3 mt-30 -87.25 133.18 33.7 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 123.455 0.702 . . . . 0.69 111.518 -165.932 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -124.6 146.89 48.81 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.182 2.593 . . . . 2.78 105.167 166.01 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 69' ' ' LEU . 32.5 mt -129.33 128.06 42.36 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 129.168 2.987 . . . . 1.17 105.933 -177.709 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -121.01 115.66 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 105.339 -2.097 . . . . 1.38 105.339 -178.165 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.414 ' HB2' HD22 ' A' ' 67' ' ' LEU 0.262 23.8 t80 -101.45 117.37 34.8 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.736 -1.852 . . . . 1.5 106.397 171.127 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.54 -46.31 0.62 Allowed 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.45 2.7 . . . . 1.21 114.806 -177.086 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.04 -32.81 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 126.938 2.209 . . . . 1.3 110.186 -171.712 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.27 52.8 mttm -73.29 125.96 29.01 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 126.657 2.034 . . . . 2.55 114.685 175.272 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -82.79 136.36 34.69 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 128.382 3.944 . . . . 2.48 112.825 172.309 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.4 mt -99.89 132.53 45.19 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.125 -2.86 . . . . 0.9 111.628 -165.171 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -79.17 141.28 37.35 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 122.175 0.988 . . . . 1.94 112.426 174.728 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.82 -57.74 8.45 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 126.031 2.824 . . . . 1.56 116.273 -174.135 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.43 16.43 13.84 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 122.6 3.8 . . . . 0.97 122.6 174.502 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 -85.41 163.87 18.25 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.8 1.8 . . . . 2.49 111.14 161.17 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.7 p -89.66 169.66 11.13 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 115.365 1.617 . . . . 0.76 115.365 165.287 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.491 ' HA ' HD12 ' A' ' 61' ' ' ILE . 58.5 mt -64.6 -47.8 77.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 129.086 2.954 . . . . 1.05 108.666 172.147 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.7 m -57.65 -37.06 72.72 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.038 -2.289 . . . . 1.19 114.481 175.675 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -62.79 -54.37 39.99 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 129.764 3.226 . . . . 1.9 115.913 175.365 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -64.42 -12.38 42.65 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.564 -2.16 . . . . 0.89 116.294 169.404 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.2 m120 69.67 56.24 0.35 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 126.615 2.447 . . . . 1.84 113.175 -179.583 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 56' ' ' LEU . 65.9 mt -95.66 128.44 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 128.885 2.874 . . . . 0.82 106.433 -176.731 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -75.76 159.42 31.07 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 125.708 1.603 . . . . 2.16 109.875 -171.943 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -52.27 -35.26 49.57 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 120.448 3.499 . . . . 2.12 120.448 167.519 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -128.39 86.44 2.46 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 130.086 4.616 . . . . 1.71 105.011 174.437 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.44 172.76 11.2 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 117.895 -1.05 . . . . 1.04 110.997 -176.697 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.4 m -130.48 125.79 35.27 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 117.807 -1.092 . . . . 0.79 108.727 176.381 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.414 HD22 ' HB2' ' A' ' 45' ' ' PHE . 15.0 mt -104.12 145.64 29.89 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 128.773 2.829 . . . . 1.4 111.671 170.492 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -106.15 122.13 45.56 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.171 -1.58 . . . . 1.51 111.416 -172.277 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 43' ' ' LEU . 57.2 tp -90.22 118.69 29.93 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.208 -1.775 . . . . 1.14 106.208 -173.574 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.5 t -119.29 148.9 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 103.69 -2.707 . . . . 1.23 103.69 173.722 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 N--CA 1.431 -1.422 0 O-C-N 125.933 2.02 . . . . 2.78 108.401 -175.459 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.368 0 CA-C-O 125.902 2.763 . . . . 1.1 115.991 . . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -82.21 99.19 9.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.174 -3.454 . . . . 1.87 107.851 172.029 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -92.92 134.42 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 120.7 -1.25 . . . . 0.72 113.827 168.944 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -94.77 109.45 21.41 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 129.554 3.142 . . . . 1.4 111.328 -176.497 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 t -90.18 102.54 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 123.747 0.819 . . . . 0.58 111.963 173.352 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -75.87 140.57 42.28 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.137 2.399 . . . . 2.09 108.838 172.869 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 p -108.94 162.39 14.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.809 -1.807 . . . . 0.99 108.424 176.786 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.486 HD11 HG13 ' A' ' 70' ' ' VAL . 5.2 mt -69.63 -32.76 71.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 128.278 3.894 . . . . 2.53 112.531 177.951 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.0 p -70.86 -35.73 72.52 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 130.405 3.482 . . . . 2.08 115.975 -174.707 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.58 15.66 0.95 Allowed Glycine 0 N--CA 1.431 -1.692 0 CA-C-O 116.954 -2.025 . . . . 1.31 117.263 170.468 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -116.87 172.28 7.36 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 120.333 2.066 . . . . 1.4 110.141 -178.26 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.4 m -123.87 106.6 10.58 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 128.134 2.574 . . . . 0.78 113.392 177.259 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -90.58 107.65 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 117.272 -1.347 . . . . 1.55 109.878 178.731 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.3 m -98.63 101.02 12.32 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.852 2.739 . . . . 1.08 106.907 -175.374 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.2 mt -102.15 141.62 34.7 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.284 -1.78 . . . . 1.55 111.658 -179.149 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -89.09 115.96 27.01 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.918 2.192 . . . . 1.95 116.918 163.599 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.407 HG12 ' HE3' ' A' ' 29' ' ' LYS . 15.1 m -127.32 170.26 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 128.79 2.836 . . . . 0.96 110.274 176.959 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -124.17 165.32 24.78 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 127.355 2.262 . . . . 2.35 109.527 167.417 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -69.1 -28.73 28.06 Favored 'Trans proline' 0 N--CA 1.434 -2.012 1 O-C-N 113.487 -4.007 . . . . 0.95 113.468 -168.062 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.7 m -83.93 6.07 23.1 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 114.565 -2.854 . . . . 1.45 111.2 -177.692 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -72.86 142.67 47.96 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.405 2.526 . . . . 1.69 108.168 173.432 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 38.2 p -84.41 164.83 18.65 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.668 -2.52 . . . . 0.75 109.249 -178.619 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.335 1.4 mp -70.25 -29.4 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.192 -2.193 . . . . 0.73 112.128 176.718 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -53.31 -46.68 69.52 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.797 -1.19 . . . . 1.62 113.536 165.649 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -62.05 -38.41 88.66 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 116.875 2.176 . . . . 2.13 116.875 177.496 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.1 -46.73 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 131.163 3.785 . . . . 0.62 111.294 173.028 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -65.63 -35.86 82.02 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.282 1.433 . . . . 1.22 111.127 179.043 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.24 74.7 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 115.739 -2.077 . . . . 0.51 113.775 174.446 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.407 ' HE3' HG12 ' A' ' 17' ' ' VAL . 25.7 mttm -72.79 -20.49 61.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.442 2.756 . . . . 1.44 118.442 175.327 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.0 mt -79.57 -34.13 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.98 2.112 . . . . 1.32 111.475 173.44 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -53.79 -41.88 67.71 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.494 -2.629 . . . . 1.7 112.687 175.09 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -67.49 -55.45 13.5 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.164 2.283 . . . . 1.55 117.164 170.028 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -66.46 -71.71 0.19 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.152 -2.218 . . . . 2.62 112.743 -174.461 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -74.19 -38.23 63.7 Favored 'General case' 0 N--CA 1.428 -1.527 0 O-C-N 118.095 -2.878 . . . . 1.48 113.535 -174.734 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.63 32.69 7.13 Favored Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 126.031 3.017 . . . . 1.12 113.267 -179.372 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.4 mt -101.11 125.14 39.1 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-N 111.144 -2.528 . . . . 1.55 107.812 -179.916 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -66.51 163.5 32.34 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 CA-C-O 112.374 -3.261 . . . . 1.02 114.773 -178.735 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -77.7 -16.52 14.7 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 CA-C-N 122.759 2.021 . . . . 1.25 113.444 -177.941 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -68.14 -35.83 78.71 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.77 -2.456 . . . . 2.25 109.935 168.54 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -76.82 -16.79 59.34 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.165 1.386 . . . . 2.02 114.62 -178.214 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -93.31 120.88 34.1 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.635 -3.79 . . . . 0.69 110.161 -173.31 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -103.58 116.27 32.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.503 -2.776 . . . . 2.78 103.503 167.842 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.5 mt -104.98 112.51 25.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 102.159 -3.274 . . . . 1.17 102.159 177.807 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.6 mm -103.23 137.39 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 105.45 -2.055 . . . . 1.38 105.45 177.379 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -129.33 109.34 11.02 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 103.749 -2.686 . . . . 1.5 103.749 176.855 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.402 . . 74.71 -86.58 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.144 -2.223 . . . . 1.21 112.37 177.855 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.28 1.09 1.85 Allowed Glycine 0 N--CA 1.43 -1.765 0 O-C-N 118.929 -2.357 . . . . 1.3 113.914 179.8 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -115.39 141.58 47.85 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 109.468 -0.567 . . . . 2.55 109.468 -178.707 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -86.06 134.25 33.84 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.742 2.417 . . . . 2.48 109.335 173.002 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.7 mt -85.14 121.81 28.43 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.63 2.826 . . . . 0.9 118.63 -179.601 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -81.5 142.19 33.13 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 116.336 1.976 . . . . 1.94 116.336 173.884 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.28 -54.53 19.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.224 1.409 . . . . 1.56 114.579 -167.81 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.0 15.89 2.96 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 120.043 2.777 . . . . 0.97 120.043 172.851 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.498 HH21 ' CG ' ' A' ' 58' ' ' ASP . 79.0 mtp180 -102.83 156.4 17.68 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 121.225 2.512 . . . . 2.49 107.772 165.722 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 16.7 p -82.59 161.73 22.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.321 2.249 . . . . 0.76 114.462 175.874 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -65.48 -28.72 69.41 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.403 2.001 . . . . 1.05 116.403 167.216 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.0 p -74.44 -21.92 59.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 117.08 2.252 . . . . 1.19 117.08 173.052 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.498 ' CG ' HH21 ' A' ' 54' ' ' ARG . 48.6 t0 -67.26 -40.97 86.28 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 118.296 -0.859 . . . . 1.9 110.999 172.346 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -77.53 -17.77 57.62 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 114.911 -2.471 . . . . 0.89 115.17 169.286 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 73.34 34.55 0.99 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.497 2.57 . . . . 1.84 116.367 -179.997 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.5 mt -65.38 124.58 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 116.384 -3.947 . . . . 0.82 115.528 179.618 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -61.43 164.55 5.57 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 119.987 3.328 . . . . 2.16 119.987 -178.082 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -60.08 -61.16 2.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.698 -3.126 . . . . 2.12 110.421 174.178 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -93.35 81.28 4.42 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 116.521 -2.071 . . . . 1.71 113.579 172.784 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.282 19.1 m -108.83 139.72 43.27 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 118.962 2.949 . . . . 1.04 118.962 -178.835 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.2 m -115.08 130.01 56.83 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.164 -1.421 . . . . 0.79 107.164 178.641 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -115.17 168.72 9.69 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 116.513 -1.708 . . . . 1.4 111.245 -179.345 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -122.88 122.84 39.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.29 1.436 . . . . 1.51 112.92 -179.22 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 tp -94.77 101.21 13.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.243 -1.536 . . . . 1.14 111.77 177.34 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.486 HG13 HD11 ' A' ' 8' ' ' LEU . 2.8 t -88.45 128.92 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 104.344 -2.465 . . . . 1.23 104.344 173.217 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.8 tp . . . . . 0 N--CA 1.43 -1.434 0 CA-C-O 115.585 -2.15 . . . . 2.78 113.074 175.185 . . . . . . . . 0 0 . 1 . 051 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 ptt? . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 123.773 1.749 . . . . 1.1 110.914 . . . . . . . . . 0 0 . 1 . 051 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -88.11 107.24 18.66 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 113.773 -5.579 . . . . 1.87 115.316 -178.687 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.3 pt -111.83 164.28 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 117.743 -3.098 . . . . 0.72 109.257 178.564 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -120.39 125.89 49.12 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 116.766 -3.709 . . . . 1.4 112.128 178.703 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 t -109.78 111.4 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 1 O-C-N 113.228 -5.92 . . . . 0.58 109.116 167.686 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -71.68 140.4 49.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.268 2.937 . . . . 2.09 111.124 175.097 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.1 p -87.93 177.75 6.88 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 113.25 -5.906 . . . . 0.99 110.769 169.744 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 tp -79.49 -51.28 9.54 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.334 -1.478 . . . . 2.53 108.422 179.631 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.1 p -65.7 -58.02 6.68 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.758 2.133 . . . . 2.08 116.758 -174.385 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.43 39.99 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.67 0 CA-C-O 115.054 -3.081 . . . . 1.31 110.546 -179.918 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -135.94 156.72 48.34 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 124.192 3.996 . . . . 1.4 110.571 -175.092 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.2 m -127.29 111.51 14.0 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 130.346 3.458 . . . . 0.78 107.514 177.814 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mt -88.28 118.92 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 123.924 3.056 . . . . 1.55 104.566 -177.94 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.9 m -98.73 122.09 41.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.224 -1.398 . . . . 1.08 107.224 178.229 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.8 mt -123.93 154.28 39.98 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 113.534 0.938 . . . . 1.55 113.534 -176.461 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -110.01 111.57 23.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 104.449 -2.426 . . . . 1.95 104.449 171.287 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.25 170.31 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 C-N-CA 127.443 2.297 . . . . 0.96 106.961 -179.91 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -117.97 156.59 49.99 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 105.209 -2.145 . . . . 2.35 105.209 167.035 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.421 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 18.4 Cg_endo -68.49 -16.28 42.77 Favored 'Trans proline' 0 C--N 1.299 -2.069 0 N-CA-C 116.386 1.648 . . . . 0.95 116.386 -177.786 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.2 m -85.02 -11.51 55.24 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-O 115.731 -2.08 . . . . 1.45 110.763 179.699 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.07 139.51 54.83 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 126.262 1.825 . . . . 1.69 109.691 173.379 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.36 35.8 p -71.25 150.89 44.8 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 128.552 2.741 . . . . 0.75 110.021 176.091 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 mt -62.1 -35.1 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 104.869 -2.271 . . . . 0.73 104.869 178.795 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.291 30.1 tt0 -52.95 -46.39 68.15 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 116.262 -4.024 . . . . 1.62 118.548 165.812 . . . . . . . . 3 2 . 1 . 051 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.338 83.9 m-20 -61.77 -35.62 78.67 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.439 1.496 . . . . 2.13 113.95 173.613 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.5 t -68.94 -36.21 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 123.482 1.611 . . . . 0.62 112.01 175.101 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -59.04 -30.44 68.04 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 119.125 -2.234 . . . . 1.22 115.252 163.84 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.21 -38.6 63.54 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 114.634 -5.042 . . . . 0.51 111.591 172.62 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.277 12.4 ttmm -57.32 -39.37 75.69 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.092 -2.88 . . . . 1.44 116.064 166.751 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.0 mt -57.34 -39.96 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 125.132 3.606 . . . . 1.32 114.57 166.945 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 37' ' ' PRO . 21.1 tt0 -66.85 -39.9 87.75 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.898 -1.751 . . . . 1.7 111.315 177.257 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -52.95 -43.51 66.38 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.579 2.066 . . . . 1.55 116.579 172.292 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -87.02 -47.57 8.83 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.664 -1.273 . . . . 2.62 113.289 -175.801 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -99.97 -55.68 2.57 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 116.941 -1.504 . . . . 1.48 107.214 -167.259 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.36 52.26 0.83 Allowed Glycine 0 N--CA 1.431 -1.695 0 CA-C-N 120.719 1.6 . . . . 1.12 112.607 -176.479 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.4 mt -130.74 126.29 21.79 Favored Pre-proline 0 N--CA 1.429 -1.48 0 N-CA-C 101.4 -3.556 . . . . 1.55 101.4 177.817 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 0.5 OUTLIER -60.8 140.75 92.27 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 CA-C-O 111.082 -3.799 . . . . 1.02 111.648 -177.698 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -55.05 -23.8 37.17 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-N 124.925 2.795 . . . . 1.25 117.929 175.416 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -68.89 -23.13 64.16 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.309 1.226 . . . . 2.25 114.309 173.849 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -81.74 -20.96 38.23 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.877 1.323 . . . . 2.02 109.293 176.612 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -97.4 136.7 37.47 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.113 -2.867 . . . . 0.69 118.256 -173.849 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -123.77 108.09 12.14 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.185 -2.28 . . . . 2.78 111.533 173.595 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.406 ' HB3' HD12 ' A' ' 50' ' ' LEU . 16.5 mt -71.5 138.93 49.32 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 123.739 1.733 . . . . 1.17 112.053 176.903 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.316 47.0 mm -127.44 146.85 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 106.252 -1.759 . . . . 1.38 106.252 179.488 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -143.39 133.3 24.06 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.642 -1.911 . . . . 1.5 109.864 177.49 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.69 -83.91 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.412 2.285 . . . . 1.21 111.683 174.544 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -156.03 16.88 0.45 Allowed Glycine 0 N--CA 1.43 -1.759 0 O-C-N 125.647 1.842 . . . . 1.3 109.164 -178.215 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -126.7 167.0 16.33 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 126.077 2.846 . . . . 2.55 109.336 -177.984 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -93.0 162.68 13.95 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 114.607 -5.058 . . . . 2.48 105.874 170.521 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.406 HD12 ' HB3' ' A' ' 43' ' ' LEU . 98.0 mt -109.64 148.06 31.98 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.519 -3.238 . . . . 0.9 109.345 179.011 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -96.68 144.64 26.51 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.511 1.924 . . . . 1.94 110.909 171.681 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -85.88 -40.0 16.42 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 116.153 1.908 . . . . 1.56 116.153 -162.936 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.86 47.22 3.67 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-N 122.823 2.556 . . . . 0.97 113.657 171.505 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -131.84 164.28 26.4 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 104.175 -2.528 . . . . 2.49 104.175 170.353 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.363 20.4 p -90.93 174.74 7.27 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 118.717 -2.489 . . . . 0.76 115.147 -178.777 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 35.2 mt -73.04 -23.98 60.65 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.239 -1.538 . . . . 1.05 110.025 171.874 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -85.57 -41.12 15.55 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.69 1.367 . . . . 1.19 114.69 -177.27 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -53.05 -46.67 68.62 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.875 2.47 . . . . 1.9 111.815 168.881 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -75.06 -9.24 58.35 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 117.64 -3.162 . . . . 0.89 113.769 175.991 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.295 35.2 t-20 59.8 47.91 9.7 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 124.236 1.97 . . . . 1.84 114.896 -177.217 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.5 mm -74.75 130.91 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 128.102 2.561 . . . . 0.82 108.812 178.292 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -69.63 171.07 9.55 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.424 -3.298 . . . . 2.16 115.894 -176.691 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -57.36 -56.12 26.01 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 116.295 -4.003 . . . . 2.12 110.2 172.308 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -103.35 92.55 4.54 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.574 1.15 . . . . 1.71 109.389 171.733 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.3 t -115.14 144.69 43.28 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.644 2.09 . . . . 1.04 116.644 176.397 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.2 m -102.95 102.17 12.21 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.495 1.918 . . . . 0.79 110.875 179.695 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -106.69 172.88 6.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.893 -1.754 . . . . 1.4 109.304 178.292 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -123.7 137.35 54.72 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 118.151 2.648 . . . . 1.51 118.151 178.453 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.5 tp -95.64 118.69 32.8 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 112.744 -2.025 . . . . 1.14 111.282 177.064 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.2 t -122.53 121.67 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 125.862 1.665 . . . . 1.23 112.999 174.854 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 N--CA 1.431 -1.388 0 CA-C-O 126.974 3.273 . . . . 2.78 115.61 178.792 . . . . . . . . 0 0 . 1 . 052 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ttp . . . . . 0 CA--C 1.49 -1.335 0 N-CA-C 118.428 2.751 . . . . 1.1 118.428 . . . . . . . . . 0 0 . 1 . 052 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -75.05 124.49 27.08 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 115.078 1.51 . . . . 1.87 115.078 -177.991 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.1 pt -136.14 159.0 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 117.248 -3.408 . . . . 0.72 103.218 175.752 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -116.64 149.5 39.64 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 124.477 1.111 . . . . 1.4 108.607 176.65 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.71 113.31 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-N 111.298 -2.683 . . . . 0.58 107.854 170.458 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -101.68 132.03 47.6 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 103.516 -2.772 . . . . 2.09 103.516 -176.048 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.1 p -86.48 165.86 15.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.986 -3.571 . . . . 0.99 113.508 173.66 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.9 mt -81.95 -29.77 32.04 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.841 -2.412 . . . . 2.53 108.78 174.097 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.9 p -68.1 -48.24 66.03 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 125.185 1.553 . . . . 2.08 111.692 -174.85 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.34 44.63 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.772 0 CA-C-N 119.523 1.056 . . . . 1.31 114.815 168.014 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -143.43 147.17 34.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.684 2.183 . . . . 1.4 110.061 -162.53 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.3 m -112.84 135.04 54.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.48 -2.638 . . . . 0.78 105.038 171.427 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mt -111.57 107.54 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 126.585 1.954 . . . . 1.55 105.916 176.433 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.3 m -89.74 115.94 27.47 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.656 1.693 . . . . 1.08 108.789 -178.16 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.8 mt -115.31 154.99 28.13 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 125.421 2.534 . . . . 1.55 106.974 -170.348 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -112.06 117.68 33.33 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 115.382 -2.247 . . . . 1.95 108.044 166.191 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.413 HG12 ' HE3' ' A' ' 29' ' ' LYS . 23.0 m -129.73 177.47 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 101.859 -3.385 . . . . 0.96 101.859 -178.869 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -111.79 154.23 44.12 Favored Pre-proline 0 N--CA 1.43 -1.462 1 C-N-CA 133.196 4.598 . . . . 2.35 107.603 164.305 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -77.89 -5.46 15.3 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 125.078 3.852 . . . . 0.95 110.733 -172.404 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 m -101.57 3.25 39.83 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 123.529 1.633 . . . . 1.45 108.008 -175.53 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -81.91 149.84 28.04 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.394 1.257 . . . . 1.69 114.394 170.945 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 p -75.66 159.43 31.17 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 123.777 0.831 . . . . 0.75 111.075 -177.835 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.1 mm -67.65 -26.51 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.559 -1.338 . . . . 0.73 108.53 173.454 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -62.03 -34.61 76.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.143 1.792 . . . . 1.62 112.639 168.821 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -65.68 -40.8 92.72 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.748 1.619 . . . . 2.13 108.652 -179.08 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.7 t -64.8 -37.63 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-O 122.382 1.087 . . . . 0.62 113.278 175.947 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -59.97 -40.23 88.37 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 118.395 2.739 . . . . 1.22 118.395 166.292 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.56 -36.86 85.58 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.548 -1.97 . . . . 0.51 113.417 176.16 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.413 ' HE3' HG12 ' A' ' 17' ' ' VAL . 46.2 mttm -59.85 -48.01 83.41 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.577 -1.952 . . . . 1.44 114.805 170.628 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.8 mt -64.91 -32.81 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 119.22 -2.175 . . . . 1.32 112.976 172.029 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -62.98 -38.94 93.15 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.221 -1.55 . . . . 1.7 115.123 169.388 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -62.12 -44.06 97.47 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 123.423 1.582 . . . . 1.55 112.214 172.186 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -66.83 -55.79 13.26 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.572 -2.58 . . . . 2.62 116.002 178.555 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -100.03 -55.84 2.53 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.848 2.859 . . . . 1.48 108.952 -166.713 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.22 -9.56 9.51 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-O 123.443 1.579 . . . . 1.12 113.633 -176.154 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.9 mt -72.44 126.4 90.94 Favored Pre-proline 0 N--CA 1.43 -1.452 0 O-C-N 116.779 -3.777 . . . . 1.55 102.287 -175.635 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 72.6 Cg_endo -70.85 161.38 46.27 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.667 2.245 . . . . 1.02 112.511 175.105 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 20.4 Cg_exo -70.05 -12.17 31.84 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 C-N-CA 121.745 1.63 . . . . 1.25 113.477 -172.593 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -75.67 -27.08 58.17 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.422 2.058 . . . . 2.25 109.63 176.436 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -90.61 -20.07 22.98 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.091 -2.881 . . . . 2.02 108.022 -174.979 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -85.78 124.94 32.85 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.595 3.183 . . . . 0.69 119.595 178.911 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.4 ttm105 -109.31 118.71 37.4 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.467 -2.02 . . . . 2.78 110.538 171.654 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.267 66.9 mt -99.06 105.32 17.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 109.257 -0.645 . . . . 1.17 109.257 -178.944 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.554 HD12 HG21 ' A' ' 70' ' ' VAL . 40.7 mt -93.75 118.81 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-N 113.719 -1.582 . . . . 1.38 108.59 -179.343 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -138.54 138.26 37.83 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.158 -1.589 . . . . 1.5 110.772 173.865 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.16 41.61 26.86 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.053 2.941 . . . . 1.21 113.527 173.417 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.63 -18.01 22.21 Favored Glycine 0 N--CA 1.429 -1.789 1 CA-C-O 112.334 -4.592 . . . . 1.3 113.16 -179.832 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 172.3 7.3 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 123.534 3.667 . . . . 2.55 113.595 -178.544 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -104.57 134.84 47.06 Favored 'General case' 0 N--CA 1.431 -1.401 1 O-C-N 115.353 -4.592 . . . . 2.48 109.03 173.863 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.4 mt -76.3 155.05 34.59 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 123.842 1.782 . . . . 0.9 114.737 -173.661 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -98.85 141.99 30.94 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 124.78 2.229 . . . . 1.94 107.211 178.737 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -75.81 -41.93 51.34 Favored 'General case' 0 N--CA 1.43 -1.454 1 N-CA-C 124.093 4.849 . . . . 1.56 124.093 -167.018 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.04 0.5 89.02 Favored Glycine 0 N--CA 1.431 -1.665 0 O-C-N 116.563 -3.836 . . . . 0.97 110.856 170.232 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -71.55 151.22 44.03 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 122.465 3.132 . . . . 2.49 111.538 169.542 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.7 p -97.83 167.55 10.86 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.101 1.905 . . . . 0.76 111.684 -177.199 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.5 mt -69.37 -25.41 64.16 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.407 -3.308 . . . . 1.05 111.29 178.038 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.2 t -70.81 -39.56 73.01 Favored 'General case' 0 N--CA 1.431 -1.406 1 C-N-CA 132.845 4.458 . . . . 1.19 112.816 175.7 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -57.92 -34.61 70.05 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 124.858 2.266 . . . . 1.9 113.913 172.826 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -94.53 0.09 55.01 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 114.309 -5.244 . . . . 0.89 112.03 -178.208 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.0 m120 58.66 47.52 12.96 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 119.865 3.283 . . . . 1.84 119.865 -175.15 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.0 mt -83.21 105.91 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 126.336 1.854 . . . . 0.82 109.886 171.28 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -121.9 -48.23 2.14 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 124.213 1.958 . . . . 2.16 112.332 -179.246 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.2 mmtt -78.34 -173.95 3.52 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 112.739 -2.028 . . . . 2.12 115.728 176.907 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -71.44 69.79 0.6 Allowed 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 129.964 3.306 . . . . 1.71 112.796 177.267 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -90.59 158.4 16.99 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.511 3.124 . . . . 1.04 111.639 -175.364 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.8 m -118.66 118.36 31.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 104.496 -2.409 . . . . 0.79 104.496 -173.843 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.1 mt -94.57 148.61 22.08 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 103.33 -2.841 . . . . 1.4 103.33 172.105 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -108.63 112.87 25.44 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 126.032 2.825 . . . . 1.51 106.026 -176.489 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.0 tp -89.65 122.26 32.61 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.993 -3.567 . . . . 1.14 113.507 179.264 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.554 HG21 HD12 ' A' ' 44' ' ' ILE 0.33 3.2 t -125.52 145.85 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 114.23 -1.35 . . . . 1.23 108.148 -177.067 . . . . . . . . 3 3 . 1 . 052 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.8 tp . . . . . 0 N--CA 1.429 -1.491 0 C-N-CA 130.853 3.661 . . . . 2.78 106.567 -179.954 . . . . . . . . 0 0 . 1 . 053 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ptt? . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 123.816 1.77 . . . . 1.1 107.903 . . . . . . . . . 0 0 . 1 . 053 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -93.44 136.51 33.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 117.067 -3.521 . . . . 1.87 111.523 -179.252 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.2 pt -131.7 161.79 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 117.005 -3.559 . . . . 0.72 104.707 173.771 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -122.04 141.94 50.85 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.767 -1.561 . . . . 1.4 107.888 -170.615 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 t -117.21 120.66 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 103.311 -2.848 . . . . 0.58 103.311 175.748 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -95.81 130.38 42.76 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 119.067 -1.053 . . . . 2.09 108.28 175.409 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.9 p -84.2 -176.13 6.11 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.708 -2.495 . . . . 0.99 115.199 176.788 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mt -68.55 -41.16 80.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 119.805 1.184 . . . . 2.53 109.328 172.086 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -72.59 -13.92 61.5 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 127.972 2.509 . . . . 2.08 107.824 -178.764 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.28 30.53 9.17 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 120.734 1.606 . . . . 1.31 113.577 175.857 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -95.71 134.1 39.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 117.908 -3.113 . . . . 1.4 107.286 -171.412 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.1 m -86.66 90.45 8.27 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 118.537 2.791 . . . . 0.78 118.537 175.449 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.7 mm -79.77 112.01 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 126.977 2.673 . . . . 1.55 109.542 176.204 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.5 m -103.67 113.83 27.65 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 123.279 2.763 . . . . 1.08 109.854 179.788 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -106.63 143.39 34.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.137 -1.602 . . . . 1.55 109.325 -179.511 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -93.3 123.89 36.9 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 104.037 -2.579 . . . . 1.95 104.037 170.246 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 m -133.76 160.44 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-O 115.471 -2.204 . . . . 0.96 108.468 -175.716 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -109.25 160.59 27.03 Favored Pre-proline 0 N--CA 1.43 -1.466 0 N-CA-C 104.899 -2.26 . . . . 2.35 104.899 160.259 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.74 -14.3 24.37 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 C-N-CA 121.788 1.659 . . . . 0.95 113.887 -179.0 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.1 p -75.59 -25.76 57.29 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 114.0 1.111 . . . . 1.45 114.0 173.481 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -62.67 160.53 13.96 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.976 -1.703 . . . . 1.69 114.549 -179.524 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.334 20.4 p -93.67 166.62 12.13 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.939 2.94 . . . . 0.75 118.939 -179.828 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.436 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 32.6 mm -71.3 -34.1 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.311 1.445 . . . . 0.73 111.152 177.386 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -60.04 -34.75 73.82 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.156 2.28 . . . . 1.62 117.156 165.999 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -71.69 -40.42 69.57 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.745 -1.847 . . . . 2.13 113.783 173.67 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.8 t -60.3 -38.81 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 123.709 0.804 . . . . 0.62 111.728 174.228 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -60.74 -40.51 92.69 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.545 -3.222 . . . . 1.22 114.725 164.618 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.75 -33.62 76.29 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.412 1.577 . . . . 0.51 113.634 173.413 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -56.67 -46.89 80.84 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.997 -2.939 . . . . 1.44 117.461 173.22 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.8 mt -67.85 -39.09 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 125.422 2.534 . . . . 1.32 114.333 173.826 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -57.63 -37.93 74.15 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.16 -4.713 . . . . 1.7 111.991 172.256 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -67.05 -35.98 81.04 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.349 2.976 . . . . 1.55 114.045 177.535 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -82.82 -44.49 15.44 Favored 'General case' 0 N--CA 1.429 -1.499 1 O-C-N 115.389 -4.57 . . . . 2.62 108.614 -176.554 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -125.92 -17.13 5.44 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 122.045 2.202 . . . . 1.48 113.186 -166.866 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.05 27.97 7.54 Favored Glycine 0 N--CA 1.43 -1.713 0 CA-C-N 120.861 1.664 . . . . 1.12 113.703 173.171 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.6 mt -99.81 120.4 57.31 Favored Pre-proline 0 N--CA 1.43 -1.467 0 O-C-N 120.014 -1.874 . . . . 1.55 109.104 -172.0 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.74 136.25 61.13 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 C-N-CA 124.899 3.733 . . . . 1.02 112.252 179.624 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -55.94 -15.46 13.58 Favored 'Trans proline' 0 C--N 1.3 -2.008 1 C-N-CA 126.399 4.733 . . . . 1.25 118.219 -177.181 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -76.07 -26.41 56.5 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.735 0.779 . . . . 2.25 111.527 173.748 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -85.2 -30.03 24.23 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.391 2.043 . . . . 2.02 107.63 -177.79 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -74.71 118.18 17.39 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.783 -4.323 . . . . 0.69 112.092 -176.807 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.1 ttm-85 -121.7 116.33 24.33 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.685 -1.969 . . . . 2.78 105.685 170.56 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.5 mt -99.52 130.38 45.77 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.183 -1.043 . . . . 1.17 108.183 -179.772 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.3 mt -113.71 119.54 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 126.818 2.047 . . . . 1.38 112.085 174.715 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.528 ' HB3' HD21 ' A' ' 50' ' ' LEU . 51.6 t80 -114.72 132.11 56.54 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 102.865 -3.013 . . . . 1.5 102.865 174.653 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.39 -94.43 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.417 1 C-N-CA 132.138 4.175 . . . . 1.21 110.079 177.015 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.66 8.61 7.75 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 129.003 3.192 . . . . 1.3 113.059 176.217 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -106.04 137.9 43.16 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 129.5 3.12 . . . . 2.55 111.179 -178.527 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -103.47 113.92 27.79 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 125.543 2.592 . . . . 2.48 106.927 169.863 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.528 HD21 ' HB3' ' A' ' 45' ' ' PHE . 13.6 mt -67.75 126.15 28.48 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.358 -3.338 . . . . 0.9 113.67 -170.707 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -91.06 134.29 34.63 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 114.645 1.35 . . . . 1.94 114.645 174.446 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.436 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 4.6 m-20 -47.1 -52.39 15.42 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 119.893 3.294 . . . . 1.56 119.893 -171.785 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.23 68.78 0.96 Allowed Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 113.962 -3.688 . . . . 0.97 111.668 174.86 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.253 84.1 mmt-85 -139.55 164.74 29.11 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 102.53 -3.137 . . . . 2.49 102.53 167.851 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.9 p -93.54 166.34 12.3 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.188 2.423 . . . . 0.76 108.086 173.828 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 mt -59.91 -40.33 88.44 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.444 2.698 . . . . 1.05 108.961 171.079 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.2 t -54.88 -48.61 72.75 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.285 2.234 . . . . 1.19 113.465 176.158 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -50.77 -34.1 25.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 118.595 2.813 . . . . 1.9 118.595 170.791 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -90.48 1.19 56.91 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.151 1.38 . . . . 0.89 110.253 178.203 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.257 4.3 m120 52.08 43.56 30.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.093 2.557 . . . . 1.84 115.157 -174.231 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.4 mt -91.49 115.01 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 127.177 3.37 . . . . 0.82 113.487 177.574 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -95.47 -177.02 3.94 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.213 -2.804 . . . . 2.16 114.805 -176.214 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -62.62 152.45 35.1 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 115.049 -4.782 . . . . 2.12 116.722 169.723 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.331 31.4 mt-10 66.47 18.36 10.81 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.112 -2.243 . . . . 1.71 113.203 174.371 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.3 p -89.96 165.12 14.26 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 127.382 3.468 . . . . 1.04 111.517 -172.87 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.1 m -120.92 108.74 14.26 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 113.337 -5.852 . . . . 0.79 113.177 -177.807 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.0 mt -81.75 137.51 35.34 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 124.905 1.282 . . . . 1.4 113.238 166.794 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -98.33 115.25 28.03 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.904 -0.497 . . . . 1.51 110.323 -177.826 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.9 tp -93.72 112.37 24.23 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 126.197 2.186 . . . . 1.14 106.874 -177.12 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.27 143.42 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 128.468 2.707 . . . . 1.23 104.204 174.972 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.6 mt . . . . . 0 N--CA 1.43 -1.446 0 O-C-N 121.112 -0.992 . . . . 2.78 108.658 175.367 . . . . . . . . 0 0 . 1 . 054 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 108.268 -1.012 . . . . 1.1 108.268 . . . . . . . . . 0 0 . 1 . 054 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -100.62 130.13 46.64 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 115.698 -2.096 . . . . 1.87 112.199 179.766 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.3 pt -129.03 159.33 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 120.099 1.318 . . . . 0.72 107.948 171.798 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -106.81 143.35 35.03 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.341 -1.754 . . . . 1.4 110.456 -176.516 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.2 t -119.35 120.04 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 129.43 3.092 . . . . 0.58 108.328 177.715 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.0 mttp -105.28 141.54 36.63 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 116.06 1.874 . . . . 2.09 116.06 169.87 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 p -95.76 177.72 5.69 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.513 2.325 . . . . 0.99 113.195 177.929 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.6 tp -57.74 -45.74 85.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.052 0.941 . . . . 2.53 113.279 178.278 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.2 p -78.01 -14.13 59.62 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.022 2.344 . . . . 2.08 112.879 -175.148 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.15 30.3 4.82 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 117.148 -3.47 . . . . 1.31 114.997 172.882 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -91.91 111.3 22.78 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.049 -1.575 . . . . 1.4 108.782 -176.317 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 m -83.8 115.24 22.14 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.92 -2.988 . . . . 0.78 109.152 177.201 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.44 HG21 HD13 ' A' ' 13' ' ' ILE . 46.9 mt -101.33 126.73 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 106.85 -1.537 . . . . 1.55 106.85 175.297 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.6 m -104.55 125.39 50.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 102.587 -3.116 . . . . 1.08 102.587 -170.338 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.2 mt -128.35 150.73 49.96 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 126.706 2.002 . . . . 1.55 109.239 -173.83 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -115.93 131.5 56.92 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.844 -0.616 . . . . 1.95 112.074 170.245 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.451 HG21 HD13 ' A' ' 56' ' ' LEU . 10.3 m -144.29 165.78 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 125.363 1.665 . . . . 0.96 108.919 -174.433 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -101.07 153.02 37.99 Favored Pre-proline 0 N--CA 1.43 -1.475 0 O-C-N 117.63 -3.169 . . . . 2.35 111.442 165.294 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -67.74 -13.52 38.95 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 CA-C-N 126.932 3.511 . . . . 0.95 115.795 -173.437 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.1 p -84.22 0.86 47.18 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 131.553 3.941 . . . . 1.45 116.059 171.494 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -76.46 136.45 39.4 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 118.892 -2.38 . . . . 1.69 113.407 170.558 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 p -70.13 152.96 43.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.526 -3.233 . . . . 0.75 108.125 179.419 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.6 mm -57.53 -23.1 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 118.039 2.607 . . . . 0.73 118.039 167.858 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -53.74 -43.65 69.3 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.267 -3.396 . . . . 1.62 115.346 159.443 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.4 m-20 -66.54 -28.94 68.94 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.526 2.584 . . . . 2.13 117.746 177.686 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.3 -41.7 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 113.809 -1.541 . . . . 0.62 111.258 171.017 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.68 -33.8 69.14 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 126.512 1.925 . . . . 1.22 112.628 174.615 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.52 -44.25 84.94 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.051 2.14 . . . . 0.51 111.497 170.02 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -61.49 -38.49 87.5 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.692 2.397 . . . . 1.44 110.937 172.222 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.7 mt -70.48 -37.32 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 O-C-N 117.954 -2.966 . . . . 1.32 115.205 170.336 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -52.92 -46.51 68.11 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.632 2.634 . . . . 1.7 110.991 172.388 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -55.03 -59.76 4.3 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 116.181 -4.075 . . . . 1.55 114.713 172.913 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -69.65 -60.23 2.45 Favored 'General case' 0 N--CA 1.43 -1.461 1 CA-C-O 129.579 4.514 . . . . 2.62 110.592 -174.635 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -80.36 -59.93 2.51 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.672 -4.392 . . . . 1.48 114.046 -172.96 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.57 -16.23 6.26 Favored Glycine 0 N--CA 1.431 -1.695 0 CA-C-O 115.427 -2.874 . . . . 1.12 109.105 -179.483 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.9 mt -60.92 122.09 66.64 Favored Pre-proline 0 N--CA 1.431 -1.38 0 C-N-CA 126.877 2.071 . . . . 1.55 112.826 -170.363 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.67 142.98 99.3 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 N-CA-C 119.236 2.744 . . . . 1.02 119.236 -176.33 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -80.49 -9.92 13.46 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 115.82 -2.779 . . . . 1.25 115.072 -166.604 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.55 -14.99 57.75 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.116 2.566 . . . . 2.25 113.469 167.635 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -94.68 -32.31 13.43 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.509 -3.245 . . . . 2.02 110.364 178.522 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -62.93 145.29 55.57 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 113.407 -1.724 . . . . 0.69 113.432 179.521 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.428 ' HB2' HG23 ' A' ' 70' ' ' VAL . 92.5 mtt180 -134.91 130.31 35.69 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.534 -2.604 . . . . 2.78 106.127 164.154 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.4 mt -100.4 131.55 46.26 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.944 2.307 . . . . 1.17 108.21 172.902 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.4 mt -120.24 139.98 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 112.081 -2.327 . . . . 1.38 107.111 176.056 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -135.28 134.43 39.93 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 102.447 -3.168 . . . . 1.5 102.447 168.187 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.83 -68.5 0.22 Allowed 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.196 2.903 . . . . 1.21 113.511 177.171 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.69 -47.26 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.763 0 CA-C-O 127.433 3.796 . . . . 1.3 113.702 -174.692 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -73.85 138.86 44.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 127.59 3.567 . . . . 2.55 113.549 -178.021 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -73.58 124.33 25.7 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.905 -2.997 . . . . 2.48 115.032 166.771 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.6 mt -85.51 161.58 19.3 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.955 -1.716 . . . . 0.9 115.1 -178.016 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.282 27.8 mt-10 -104.77 143.45 33.1 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 120.554 3.538 . . . . 1.94 120.554 174.084 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -67.23 -43.57 81.63 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 116.338 -3.976 . . . . 1.56 116.304 -170.182 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.98 15.91 0.65 Allowed Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 130.437 3.875 . . . . 0.97 114.86 173.947 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -120.71 170.93 8.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.13 1.965 . . . . 2.49 111.738 166.557 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.3 p -107.21 177.51 4.83 Favored 'General case' 0 N--CA 1.429 -1.514 1 CA-C-O 128.554 4.026 . . . . 0.76 111.687 176.374 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.451 HD13 HG21 ' A' ' 17' ' ' VAL . 30.7 mt -70.32 -31.75 69.2 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.444 -2.66 . . . . 1.05 108.329 176.377 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -66.7 -41.05 88.63 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.964 -2.335 . . . . 1.19 115.126 -177.823 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -49.61 -45.98 48.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.077 2.151 . . . . 1.9 110.907 173.638 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -85.25 -0.67 55.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.027 2.346 . . . . 0.89 116.272 -178.174 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 56.78 37.42 28.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.04 2.936 . . . . 1.84 115.921 -178.527 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.2 mt -70.39 116.53 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 C-N-CA 128.681 2.792 . . . . 0.82 111.564 173.769 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -89.98 178.01 6.32 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.055 2.142 . . . . 2.16 108.411 174.21 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -67.51 152.89 44.88 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.12 1.914 . . . . 2.12 112.623 177.519 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.268 51.4 mt-10 67.31 27.43 8.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.989 -1.069 . . . . 1.71 113.68 169.434 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.9 m -98.91 144.49 28.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.684 3.194 . . . . 1.04 108.196 -175.253 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.6 m -108.93 120.79 43.56 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.143 -2.848 . . . . 0.79 109.393 -172.29 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -93.07 162.91 13.85 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.416 -1.327 . . . . 1.4 107.416 177.692 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -119.77 132.83 55.73 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.149 1.38 . . . . 1.51 112.968 -179.601 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.0 tp -118.5 116.57 26.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.529 -1.982 . . . . 1.14 109.854 -174.854 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' A' ' 42' ' ' ARG . 3.2 m -117.66 170.36 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 123.351 1.548 . . . . 1.23 110.902 172.516 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.1 mt . . . . . 0 N--CA 1.431 -1.423 0 CA-C-O 124.029 1.871 . . . . 2.78 115.072 174.11 . . . . . . . . 0 0 . 1 . 055 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.49 -1.361 0 CA-C-O 123.375 1.559 . . . . 1.1 109.497 . . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -104.96 142.32 34.99 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.555 -1.341 . . . . 1.87 109.446 -172.335 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.0 pt -131.81 155.05 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 124.723 1.209 . . . . 0.72 107.997 174.557 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.271 64.2 m-85 -108.33 125.27 51.51 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 112.957 0.725 . . . . 1.4 112.957 177.8 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -105.67 122.77 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 119.03 0.832 . . . . 0.58 109.625 173.257 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -94.61 124.57 38.73 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 128.712 2.805 . . . . 2.09 109.707 175.913 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.8 p -77.56 -173.52 2.99 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 127.627 2.371 . . . . 0.99 105.583 -178.55 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.7 mt -59.86 -48.11 83.0 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 129.802 3.241 . . . . 2.53 117.859 169.564 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.1 p -79.36 -15.43 57.91 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.626 3.571 . . . . 2.08 110.627 -179.202 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.14 44.53 5.62 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 126.914 2.197 . . . . 1.31 114.031 176.067 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -95.4 151.52 19.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 104.697 -2.334 . . . . 1.4 104.697 174.788 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.2 m -101.21 112.36 24.83 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 125.764 1.915 . . . . 0.78 112.08 179.795 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 mm -94.76 124.62 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 103.018 -2.956 . . . . 1.55 103.018 172.032 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.7 m -106.44 115.41 30.16 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.337 -3.352 . . . . 1.08 114.678 -178.999 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.259 34.6 mt -112.71 135.5 53.38 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.87 -2.394 . . . . 1.55 110.895 -175.957 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -75.8 116.39 16.45 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.142 -1.429 . . . . 1.95 107.142 161.085 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -127.85 175.74 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.241 1.417 . . . . 0.96 109.76 174.339 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -118.23 156.71 50.4 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-O 124.614 2.15 . . . . 2.35 109.629 167.064 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -71.79 -20.14 26.55 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 O-C-N 113.246 -4.134 . . . . 0.95 111.767 -175.72 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 p -87.36 3.58 46.39 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 130.788 3.635 . . . . 1.45 115.831 175.732 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -83.63 149.21 26.68 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.497 -2.627 . . . . 1.69 106.168 177.36 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 44.2 p -90.8 168.21 11.9 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 118.006 -0.997 . . . . 0.75 108.464 -177.789 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.324 40.9 mm -65.78 -24.61 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 N-CA-C 114.494 1.294 . . . . 0.73 114.494 173.937 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -69.07 -30.41 68.73 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 113.772 -3.013 . . . . 1.62 116.278 163.62 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -76.37 -25.66 54.85 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.207 1.821 . . . . 2.13 108.602 170.687 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.7 -50.25 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 121.879 2.127 . . . . 0.62 114.565 170.822 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -65.72 -34.67 78.73 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 118.454 2.761 . . . . 1.22 118.454 179.75 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.05 -38.87 73.85 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 114.177 -2.821 . . . . 0.51 111.736 168.555 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -66.59 -35.72 80.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 120.709 1.595 . . . . 1.44 114.013 174.28 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 53.8 mt -73.58 -24.28 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 119.777 -1.827 . . . . 1.32 114.803 173.159 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -75.73 -29.98 59.08 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.076 1.762 . . . . 1.7 111.773 172.066 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -72.1 -46.27 57.36 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.468 1.127 . . . . 1.55 112.996 175.831 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -65.17 -75.44 0.09 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 126.176 1.791 . . . . 2.62 111.935 -178.913 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -86.91 -42.31 13.29 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.588 2.355 . . . . 1.48 114.813 -169.532 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.96 31.67 2.22 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 118.277 -1.916 . . . . 1.12 111.948 174.574 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 36' ' ' ILE . 26.8 mt -102.09 124.4 40.11 Favored Pre-proline 0 N--CA 1.43 -1.426 0 CA-C-O 114.6 -2.619 . . . . 1.55 113.436 -175.509 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -60.79 138.7 81.03 Favored 'Trans proline' 0 N--CA 1.433 -2.064 0 CA-C-O 114.05 -2.562 . . . . 1.02 114.38 -176.715 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -62.83 -29.17 76.34 Favored 'Trans proline' 0 N--CA 1.434 -2.009 1 C-N-CA 127.49 5.46 . . . . 1.25 114.273 -171.947 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -62.76 -28.95 70.33 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.849 -2.407 . . . . 2.25 112.056 173.057 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -76.36 -13.18 60.15 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 116.785 2.143 . . . . 2.02 116.785 179.092 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -95.39 117.18 29.89 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.013 -3.555 . . . . 0.69 115.26 -172.361 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -107.27 127.09 53.24 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 127.2 2.2 . . . . 2.78 107.946 169.343 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.284 65.6 mt -109.49 138.69 45.48 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 105.263 -2.125 . . . . 1.17 105.263 -175.788 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.7 mm -122.37 126.23 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 109.74 -3.391 . . . . 1.38 107.325 179.801 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.42 ' HB2' HD11 ' A' ' 50' ' ' LEU . 67.4 t80 -120.46 108.93 14.7 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.652 -1.981 . . . . 1.5 105.652 172.317 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.92 -73.22 0.09 Allowed 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 126.526 1.93 . . . . 1.21 109.106 -179.443 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.41 ' H ' ' H ' ' A' ' 48' ' ' LYS . . . -160.73 7.84 0.11 Allowed Glycine 0 N--CA 1.43 -1.709 0 CA-C-O 124.898 2.388 . . . . 1.3 114.915 -174.039 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.41 ' H ' ' H ' ' A' ' 47' ' ' GLY . 12.4 tppt? -105.78 128.61 53.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 111.585 -2.307 . . . . 2.55 105.842 177.311 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -79.47 138.89 37.72 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.176 -0.952 . . . . 2.48 109.573 170.499 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' A' ' 45' ' ' PHE . 21.3 mt -101.73 126.44 48.59 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 121.649 2.022 . . . . 0.9 111.967 -165.966 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -88.56 156.3 19.14 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.285 -1.746 . . . . 1.94 106.285 178.73 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -76.04 -40.2 53.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 118.748 2.869 . . . . 1.56 118.748 -168.613 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.25 22.85 9.11 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 117.798 -3.064 . . . . 0.97 112.868 177.559 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -108.13 164.37 12.36 Favored 'General case' 0 N--CA 1.431 -1.397 1 O-C-N 116.294 -4.062 . . . . 2.49 106.918 164.786 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 37.0 p -101.1 168.78 9.37 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.989 2.116 . . . . 0.76 111.662 179.129 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -58.5 -42.86 88.59 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 112.119 -2.31 . . . . 1.05 110.275 169.926 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.388 5.6 t -64.03 -33.39 75.64 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.499 1.954 . . . . 1.19 112.973 -179.013 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -61.18 -34.42 75.04 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 119.834 3.272 . . . . 1.9 119.834 175.016 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -90.74 10.72 24.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 111.957 -2.383 . . . . 0.89 114.169 174.934 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.279 46.7 m-80 65.09 21.45 12.21 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 113.379 -5.825 . . . . 1.84 115.263 -178.878 . . . . . . . . 3 2 . 1 . 055 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.0 mt -75.9 106.74 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 124.777 1.231 . . . . 0.82 112.298 -178.326 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -98.45 -164.91 1.18 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.264 2.226 . . . . 2.16 106.465 -169.655 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.264 44.8 mttp -72.25 141.21 48.94 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.641 -2.537 . . . . 2.12 110.867 173.826 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.254 31.9 mt-10 74.32 15.48 3.53 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 125.956 2.035 . . . . 1.71 112.872 172.192 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.32 50.1 m -84.16 145.79 28.2 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.162 -3.461 . . . . 1.04 110.819 -172.165 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.0 m -97.35 118.9 34.86 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.161 2.184 . . . . 0.79 106.14 -175.552 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.3 mp -107.06 145.51 32.31 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.225 2.61 . . . . 1.4 111.854 171.902 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -119.36 139.28 52.23 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.455 -2.054 . . . . 1.51 105.455 -174.989 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tt -107.67 124.48 50.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 113.82 -1.536 . . . . 1.14 107.979 -173.948 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.2 t -116.68 132.53 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 CA-C-O 129.171 4.32 . . . . 1.23 105.035 174.345 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.431 -1.423 0 O-C-N 116.633 -3.792 . . . . 2.78 108.994 175.746 . . . . . . . . 0 0 . 1 . 056 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 CA--C 1.49 -1.327 0 CA-C-O 122.367 1.08 . . . . 1.1 110.552 . . . . . . . . . 0 0 . 1 . 056 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -111.65 136.91 50.23 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 117.477 -1.249 . . . . 1.87 109.831 -169.467 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.437 HD12 HD13 ' A' ' 67' ' ' LEU . 5.6 pt -135.56 159.39 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 122.489 2.404 . . . . 0.72 105.806 171.526 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -109.49 145.1 36.81 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.372 2.269 . . . . 1.4 107.781 -173.616 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.3 t -124.64 132.53 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.206 -1.776 . . . . 0.58 106.206 168.613 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 mmtm -97.09 143.59 27.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 104.975 -2.231 . . . . 2.09 104.975 169.472 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.7 p -90.36 -165.04 1.26 Allowed 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 130.272 3.429 . . . . 0.99 111.192 176.128 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.353 0.6 OUTLIER -64.63 -46.98 80.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 130.298 3.439 . . . . 2.53 113.042 175.992 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.3 p -92.84 -37.34 12.35 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 126.381 2.991 . . . . 2.08 115.634 -178.6 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.05 -2.52 1.01 Allowed Glycine 0 N--CA 1.43 -1.721 0 O-C-N 116.301 -3.999 . . . . 1.31 117.701 178.215 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -74.92 120.97 21.19 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 122.7 3.25 . . . . 1.4 105.022 -166.905 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.7 m -71.17 117.23 12.42 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 126.56 2.413 . . . . 0.78 113.91 176.591 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.3 mm -98.84 138.68 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 117.08 -1.848 . . . . 1.55 107.78 173.522 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.4 m -106.3 112.81 25.99 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.702 2.001 . . . . 1.08 111.911 179.692 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.7 mt -108.57 144.26 36.5 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 116.177 -4.077 . . . . 1.55 115.268 175.141 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -90.85 123.71 34.6 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.172 1.789 . . . . 1.95 107.85 166.858 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 m -138.53 154.0 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 121.605 0.717 . . . . 0.96 109.639 -179.165 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -101.55 162.36 20.69 Favored Pre-proline 0 N--CA 1.429 -1.489 0 CA-C-O 115.597 -2.144 . . . . 2.35 109.603 167.365 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -81.7 -8.05 12.43 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 125.846 3.124 . . . . 0.95 112.089 178.694 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 p -81.13 -15.68 55.18 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.613 -0.721 . . . . 1.45 111.902 176.165 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -61.77 143.71 55.85 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 124.964 2.316 . . . . 1.69 115.376 178.933 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 25.0 p -90.58 165.25 13.86 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 115.759 -4.338 . . . . 0.75 108.664 178.5 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.5 mm -71.98 -22.03 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-O 122.76 1.266 . . . . 0.73 109.961 -178.933 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -61.48 -35.36 77.44 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.075 -2.891 . . . . 1.62 118.07 160.681 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -76.53 -30.87 57.33 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 116.83 -3.669 . . . . 2.13 111.697 172.634 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.98 -41.92 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 O-C-N 120.156 -1.59 . . . . 0.62 111.809 179.982 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -61.35 -41.3 96.82 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.118 -2.239 . . . . 1.22 111.783 176.888 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.71 -39.6 81.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 126.538 2.399 . . . . 0.51 111.731 178.871 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.265 51.8 mttm -57.82 -53.94 52.48 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.102 -2.248 . . . . 1.44 110.333 173.465 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.253 64.8 mt -52.15 -41.4 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 130.122 3.369 . . . . 1.32 109.241 178.309 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -66.52 -50.82 61.93 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 130.261 3.424 . . . . 1.7 111.372 174.975 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -49.28 -45.54 45.17 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 124.13 3.15 . . . . 1.55 114.009 169.423 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -75.46 -66.56 0.76 Allowed 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 127.607 2.363 . . . . 2.62 114.137 -177.52 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -96.47 -18.46 19.84 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 117.508 2.41 . . . . 1.48 117.508 -173.042 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.51 46.84 5.36 Favored Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 118.696 2.238 . . . . 1.12 118.696 -177.731 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.8 mt -119.14 129.09 25.58 Favored Pre-proline 0 N--CA 1.43 -1.465 0 CA-C-O 111.704 -3.998 . . . . 1.55 106.376 -174.14 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -64.1 152.14 82.34 Favored 'Trans proline' 0 N--CA 1.433 -2.059 0 CA-C-O 112.132 -3.362 . . . . 1.02 119.896 172.122 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -81.4 -23.53 5.01 Favored 'Trans proline' 0 N--CA 1.433 -2.046 0 CA-C-N 127.253 3.626 . . . . 1.25 112.466 -166.484 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -56.43 -31.67 64.15 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.448 2.699 . . . . 2.25 110.663 175.126 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -93.52 6.97 46.44 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 111.184 -2.735 . . . . 2.02 108.44 -170.09 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -122.11 126.67 48.88 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 122.536 2.426 . . . . 0.69 109.4 -174.285 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -109.47 150.27 28.36 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 116.856 -1.545 . . . . 2.78 110.117 158.975 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.4 mt -125.8 136.06 52.7 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 107.468 -1.308 . . . . 1.17 107.468 176.295 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.9 mm -112.43 124.44 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 128.054 2.541 . . . . 1.38 111.397 -178.787 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -114.31 128.09 56.18 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 122.517 2.417 . . . . 1.5 108.901 168.673 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.66 -85.06 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.56 1.544 . . . . 1.21 110.125 -171.574 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -164.19 43.55 0.31 Allowed Glycine 0 N--CA 1.429 -1.78 0 O-C-N 121.091 -1.006 . . . . 1.3 111.929 178.079 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -135.26 135.83 41.2 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.16 2.184 . . . . 2.55 110.253 -179.768 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -89.32 116.08 27.27 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 114.505 1.298 . . . . 2.48 114.505 175.886 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.5 mt -67.88 160.51 28.3 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.981 2.324 . . . . 0.9 113.308 -168.447 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -103.98 135.11 46.11 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.863 -2.426 . . . . 1.94 109.868 172.519 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.261 2.9 m-20 -56.17 -49.38 74.16 Favored 'General case' 0 N--CA 1.43 -1.439 1 C-N-CA 132.311 4.244 . . . . 1.56 113.528 -172.913 . . . . . . . . 3 2 . 1 . 056 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.2 50.63 2.76 Favored Glycine 0 N--CA 1.43 -1.767 0 N-CA-C 119.689 2.636 . . . . 0.97 119.689 171.226 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -124.03 164.1 20.06 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.233 1.968 . . . . 2.49 106.136 163.062 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 66.6 p -106.12 164.01 12.33 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.211 -2.268 . . . . 0.76 113.859 175.117 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.4 mt -50.08 -37.52 34.13 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.712 -3.742 . . . . 1.05 114.518 168.566 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -64.25 -26.33 68.45 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.257 2.317 . . . . 1.19 117.257 176.703 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -70.15 -51.4 31.62 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.387 1.475 . . . . 1.9 108.036 177.805 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -76.89 2.7 13.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.057 2.143 . . . . 0.89 113.05 179.753 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.508 1.1 m-80 60.42 39.62 18.28 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.334 1.646 . . . . 1.84 114.096 179.778 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.4 mt -90.85 118.87 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 126.054 2.835 . . . . 0.82 113.241 -177.267 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -101.5 -167.37 1.41 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.159 -3.463 . . . . 2.16 113.8 -177.068 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.256 13.7 ptmt -58.5 153.97 14.95 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.851 -2.405 . . . . 2.12 116.329 174.759 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 49.0 42.49 20.87 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 129.745 3.218 . . . . 1.71 113.741 173.149 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.6 m -92.47 142.72 27.1 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 130.749 3.619 . . . . 1.04 105.535 -179.095 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.2 m -104.73 117.41 34.02 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.142 -2.17 . . . . 0.79 105.142 -175.012 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.437 HD13 HD12 ' A' ' 3' ' ' ILE . 5.1 mp -98.34 162.91 12.93 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 131.521 3.928 . . . . 1.4 110.045 171.05 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -123.08 126.36 46.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.083 -3.511 . . . . 1.51 111.472 -178.939 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.4 tp -95.9 113.92 25.59 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 107.07 -1.455 . . . . 1.14 107.07 -176.415 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.0 t -104.58 143.66 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 101.197 -3.631 . . . . 1.23 101.197 176.526 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.4 mt . . . . . 0 N--CA 1.43 -1.446 0 C-N-CA 113.181 -3.408 . . . . 2.78 110.927 -179.925 . . . . . . . . 0 0 . 1 . 057 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 116.883 -1.532 . . . . 1.1 111.724 . . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -97.17 140.67 31.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 127.273 3.416 . . . . 1.87 109.416 -174.66 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.0 pt -123.44 160.73 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 124.814 2.245 . . . . 0.72 110.996 171.323 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -108.91 143.08 38.62 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.234 -4.041 . . . . 1.4 111.419 -179.265 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.42 HG21 HD11 ' A' ' 30' ' ' ILE . 2.8 t -110.91 123.79 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.243 -3.411 . . . . 0.58 108.043 174.199 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 11' ' ' LYS . 73.9 tttt -119.45 138.89 52.83 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.033 1.397 . . . . 2.09 108.563 -178.618 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.0 p -103.69 168.98 8.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.438 -1.414 . . . . 0.99 108.176 -178.067 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.2 tp -66.34 -42.46 88.11 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.955 1.302 . . . . 2.53 112.285 172.464 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.6 p -76.89 -18.52 58.27 Favored 'General case' 0 N--CA 1.43 -1.463 1 CA-C-O 128.968 4.223 . . . . 2.08 110.064 -171.35 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.15 26.95 1.28 Allowed Glycine 0 N--CA 1.43 -1.727 1 O-C-N 116.004 -4.185 . . . . 1.31 118.002 166.285 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 63.4 tttt -91.98 133.87 35.32 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 117.258 -1.353 . . . . 1.4 110.241 -179.814 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m -122.43 105.94 10.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 125.627 1.83 . . . . 0.78 115.762 168.966 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 pt -114.79 164.92 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 125.92 2.771 . . . . 1.55 105.191 179.778 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.7 m -112.37 135.18 53.37 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.875 -3.015 . . . . 1.08 112.544 -178.37 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.8 mt -115.78 154.74 29.09 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.888 -1.758 . . . . 1.55 109.887 172.393 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -112.73 120.52 41.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.333 -1.48 . . . . 1.95 110.864 167.273 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.4 m -125.28 175.11 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 124.354 2.026 . . . . 0.96 108.427 178.508 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -114.29 171.96 3.98 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 104.7 -2.333 . . . . 2.35 104.7 164.075 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -83.38 -9.51 10.29 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 N-CA-C 107.174 -1.895 . . . . 0.95 107.174 -176.314 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.4 m -95.82 6.35 49.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.608 1.963 . . . . 1.45 115.415 173.48 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -77.09 153.8 33.96 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 104.727 -2.323 . . . . 1.69 104.727 170.296 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.5 p -86.95 162.1 17.87 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 116.158 -4.089 . . . . 0.75 110.218 168.904 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.306 23.1 mm -65.97 -38.89 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 118.159 -2.838 . . . . 0.73 111.31 179.17 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -50.79 -38.12 46.38 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 127.182 3.373 . . . . 1.62 117.597 166.941 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -75.07 -26.38 59.31 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.519 3.128 . . . . 2.13 110.915 172.792 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.38 -34.33 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 123.334 2.788 . . . . 0.62 109.547 170.831 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -70.49 -36.52 73.88 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.528 -1.983 . . . . 1.22 113.838 175.982 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.84 76.91 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 115.724 1.75 . . . . 0.51 115.724 173.278 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -58.26 -37.36 74.8 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.981 2.113 . . . . 1.44 111.964 175.018 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 5' ' ' VAL . 94.3 mt -75.94 -29.12 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 1 O-C-N 115.676 -4.39 . . . . 1.32 110.357 174.717 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -69.05 -42.3 76.46 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 116.797 -3.689 . . . . 1.7 115.155 168.885 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.337 23.2 t70 -55.03 -49.18 72.2 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.238 -2.164 . . . . 1.55 112.396 168.811 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -70.49 -69.04 0.38 Allowed 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.011 -1.681 . . . . 2.62 113.753 -177.388 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -91.44 -48.71 6.73 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 112.287 -2.233 . . . . 1.48 110.187 -167.387 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.1 32.63 3.21 Favored Glycine 0 N--CA 1.429 -1.773 0 CA-C-O 125.183 2.546 . . . . 1.12 114.837 -179.037 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.8 mt -92.65 129.22 41.14 Favored Pre-proline 0 N--CA 1.43 -1.444 0 N-CA-C 102.49 -3.152 . . . . 1.55 102.49 -177.222 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -76.74 139.37 19.86 Favored 'Trans proline' 0 N--CA 1.433 -2.053 0 CA-C-O 114.156 -2.518 . . . . 1.02 112.737 -178.954 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -68.57 0.04 5.31 Favored 'Trans proline' 0 N--CA 1.433 -2.058 1 C-N-CA 125.624 4.216 . . . . 1.25 112.014 -169.501 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -64.92 -42.81 94.4 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.806 1.289 . . . . 2.25 113.097 166.36 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -75.49 -27.07 58.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.132 2.396 . . . . 2.02 111.034 -176.243 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -81.88 122.26 27.51 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 119.995 3.331 . . . . 0.69 119.995 -169.088 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -116.41 136.68 52.78 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 131.242 3.817 . . . . 2.78 108.976 170.453 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.9 mt -120.13 113.58 20.68 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.425 -4.547 . . . . 1.17 113.513 178.392 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.1 mm -102.19 143.01 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 126.889 3.233 . . . . 1.38 105.765 173.425 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.446 ' HB3' HD21 ' A' ' 50' ' ' LEU . 59.1 t80 -132.66 125.3 30.02 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 115.3 -4.625 . . . . 1.5 110.111 162.866 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.63 -95.15 0.05 OUTLIER 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 124.171 1.938 . . . . 1.21 112.615 -172.428 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.74 20.16 3.1 Favored Glycine 0 N--CA 1.43 -1.757 0 O-C-N 119.208 -2.182 . . . . 1.3 111.3 176.352 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -111.85 135.35 52.59 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 128.675 2.79 . . . . 2.55 109.887 175.752 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -86.76 101.01 12.91 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 129.667 3.187 . . . . 2.48 109.591 168.921 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.446 HD21 ' HB3' ' A' ' 45' ' ' PHE . 21.1 mt -72.11 122.08 20.36 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.397 2.679 . . . . 0.9 112.781 -169.194 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -75.11 133.55 41.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 116.414 2.005 . . . . 1.94 116.414 174.786 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -45.52 -55.1 6.59 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 131.252 3.821 . . . . 1.56 116.298 -174.484 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.68 9.61 58.73 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 118.171 2.028 . . . . 0.97 118.171 173.491 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -91.58 165.51 13.3 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 121.836 2.818 . . . . 2.49 109.496 164.712 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.268 30.3 p -94.02 177.64 5.91 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.785 -1.197 . . . . 0.76 113.059 178.411 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mt -75.03 -27.95 60.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.65 2.643 . . . . 1.05 115.289 171.635 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.4 t -68.07 -39.94 82.83 Favored 'General case' 0 N--CA 1.429 -1.481 1 C-N-CA 132.575 4.35 . . . . 1.19 117.13 175.588 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.288 2.5 m-20 -55.52 -46.91 76.96 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.741 2.816 . . . . 1.9 109.567 175.955 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -83.34 -1.07 52.43 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 126.549 1.94 . . . . 0.89 116.105 176.155 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 63.26 47.34 4.09 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 128.877 2.871 . . . . 1.84 112.36 175.503 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.8 mt -85.52 130.25 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 127.676 2.39 . . . . 0.82 110.799 178.762 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -115.84 175.37 5.57 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 116.267 -4.021 . . . . 2.16 112.061 -173.632 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -50.38 146.65 5.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.899 -2.376 . . . . 2.12 114.423 169.116 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 63.43 23.02 13.52 Favored 'General case' 0 N--CA 1.43 -1.461 2 C-N-CA 132.773 4.429 . . . . 1.71 111.757 176.927 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -91.15 155.21 18.79 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 116.927 -3.608 . . . . 1.04 107.034 -178.588 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.4 m -103.41 116.12 31.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.123 -1.399 . . . . 0.79 112.062 -177.753 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -97.11 136.15 38.06 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 102.65 -3.093 . . . . 1.4 102.65 172.848 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -101.72 101.82 12.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.521 1.928 . . . . 1.51 110.377 -175.233 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.1 tp -80.18 124.85 29.15 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 125.93 2.019 . . . . 1.14 110.323 -179.242 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.9 t -126.58 124.14 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.183 -1.826 . . . . 1.23 107.249 -169.471 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.3 mt . . . . . 0 N--CA 1.43 -1.443 0 C-N-CA 117.943 -1.503 . . . . 2.78 114.709 -177.484 . . . . . . . . 0 0 . 1 . 058 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 123.649 1.69 . . . . 1.1 110.639 . . . . . . . . . 0 0 . 1 . 058 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -85.19 121.68 28.29 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.05 -2.906 . . . . 1.87 109.691 -176.817 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -118.83 171.59 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 125.392 2.52 . . . . 0.72 107.848 168.272 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -129.42 129.68 45.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 111.706 -2.497 . . . . 1.4 111.808 179.938 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.6 t -110.94 115.96 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 113.254 -1.794 . . . . 0.58 107.113 169.497 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -97.19 140.98 30.87 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 125.125 2.393 . . . . 2.09 107.786 175.464 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.0 p -82.17 178.64 8.16 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.973 -1.704 . . . . 0.99 114.494 179.796 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.2 tp -54.33 -47.0 73.01 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 116.169 -4.082 . . . . 2.53 112.423 167.556 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 p -71.65 -26.89 62.73 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.729 -3.732 . . . . 2.08 111.374 -178.424 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.1 26.93 6.09 Favored Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 126.491 1.996 . . . . 1.31 112.033 -178.02 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -83.19 128.38 34.44 Favored 'General case' 0 N--CA 1.43 -1.474 2 O-C-N 116.287 -4.067 . . . . 1.4 108.386 176.441 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -99.02 113.29 25.4 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 128.333 3.921 . . . . 0.78 109.979 -176.377 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mt -91.95 126.71 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 111.11 -2.768 . . . . 1.55 108.996 176.111 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.6 t -98.89 143.31 29.34 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 119.95 1.25 . . . . 1.08 111.174 172.958 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.9 mt -136.97 158.1 45.24 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.587 2.755 . . . . 1.55 108.592 -177.828 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -111.33 121.1 44.36 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.479 -1.388 . . . . 1.95 107.819 166.057 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.03 159.32 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 126.491 3.043 . . . . 0.96 106.488 -172.724 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -112.01 149.17 40.47 Favored Pre-proline 0 N--CA 1.43 -1.475 1 O-C-N 116.067 -4.145 . . . . 2.35 108.186 165.239 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -72.31 -9.42 24.28 Favored 'Trans proline' 0 C--N 1.299 -2.031 2 O-C-N 112.925 -4.303 . . . . 0.95 115.671 -173.526 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.7 p -89.03 2.98 53.2 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 111.656 -2.52 . . . . 1.45 111.364 177.795 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -78.3 157.95 29.03 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.65 2.092 . . . . 1.69 116.65 172.864 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 67.2 p -95.87 160.12 14.63 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.015 2.816 . . . . 0.75 110.184 169.844 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 mm -54.83 -32.03 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 117.447 -3.283 . . . . 0.73 115.561 166.385 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -51.29 -59.86 3.75 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 116.692 2.108 . . . . 1.62 116.692 160.901 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -54.26 -37.44 64.7 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 117.768 2.507 . . . . 2.13 117.768 174.476 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.4 t -56.54 -42.34 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 126.86 2.064 . . . . 0.62 115.1 167.46 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -68.82 -24.2 64.35 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 115.577 1.695 . . . . 1.22 115.577 174.915 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.34 83.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 116.795 -1.574 . . . . 0.51 112.901 166.349 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -68.23 -35.45 77.96 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 128.726 3.766 . . . . 1.44 115.999 -179.573 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.2 mt -79.98 -32.25 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 C-N-CA 128.634 2.773 . . . . 1.32 113.535 170.931 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -62.96 -51.53 66.53 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 115.781 -4.324 . . . . 1.7 114.058 167.155 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -52.18 -43.85 64.36 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.34 1.978 . . . . 1.55 116.34 169.145 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -84.83 -63.82 1.27 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.066 -1.646 . . . . 2.62 113.944 -177.898 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -96.62 -39.19 9.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.752 2.215 . . . . 1.48 115.86 -174.151 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.61 44.92 2.4 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 116.79 -3.694 . . . . 1.12 113.626 169.604 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.7 mt -103.95 130.84 22.67 Favored Pre-proline 0 N--CA 1.43 -1.451 1 N-CA-C 99.775 -4.157 . . . . 1.55 99.775 -174.489 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -54.16 135.15 63.54 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-O 112.205 -3.331 . . . . 1.02 116.058 -179.571 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.64 -26.12 63.33 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 CA-C-N 127.052 3.554 . . . . 1.25 119.863 -178.988 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -68.67 -37.29 79.5 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.378 -1.283 . . . . 2.25 113.727 177.634 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -73.1 -27.48 61.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.609 -3.182 . . . . 2.02 115.105 178.307 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -68.49 129.49 40.08 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.377 3.473 . . . . 0.69 120.377 177.526 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -127.92 114.99 17.87 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.66 1.984 . . . . 2.78 111.715 168.9 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.565 HD12 HD23 ' A' ' 67' ' ' LEU . 3.8 mm? -86.71 130.16 34.59 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 125.881 1.988 . . . . 1.17 108.248 176.949 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.1 mm -127.41 123.3 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 125.985 2.053 . . . . 1.38 108.131 177.101 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -123.3 124.06 42.14 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.648 1.69 . . . . 1.5 108.945 171.948 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.89 -92.85 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.503 2.721 . . . . 1.21 116.05 -172.886 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.31 -38.18 1.68 Allowed Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 126.462 1.982 . . . . 1.3 113.505 -177.854 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -82.39 146.83 29.13 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 129.897 3.279 . . . . 2.55 116.039 -172.304 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -92.49 141.09 28.89 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 118.966 -2.334 . . . . 2.48 108.953 171.801 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 43' ' ' LEU . 27.7 mt -98.4 128.43 44.78 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 104.418 -2.438 . . . . 0.9 104.418 -168.922 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.55 140.63 32.14 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.672 2.389 . . . . 1.94 112.936 173.396 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -56.57 -54.44 45.88 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.34 3.089 . . . . 1.56 119.34 -172.179 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.02 8.44 63.33 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 115.278 -2.957 . . . . 0.97 117.505 175.106 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 22' ' ' THR . 31.0 mmt180 -78.88 158.21 28.14 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 122.732 3.266 . . . . 2.49 115.124 163.041 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.7 p -89.4 156.59 18.58 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 122.758 2.526 . . . . 0.76 113.351 173.141 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.0 mt -53.8 -36.86 62.92 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.104 -0.953 . . . . 1.05 111.675 166.361 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -54.19 -48.05 71.39 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.232 -2.168 . . . . 1.19 113.863 -178.841 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -45.69 -43.93 13.07 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 119.984 3.327 . . . . 1.9 119.984 171.786 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -96.75 3.54 52.29 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.203 2.601 . . . . 0.89 111.176 178.944 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.4 m120 54.88 47.29 22.6 Favored 'General case' 0 N--CA 1.431 -1.384 0 O-C-N 119.32 -2.113 . . . . 1.84 112.862 -176.092 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.3 mt -80.5 117.5 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 122.184 2.265 . . . . 0.82 110.274 177.481 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -110.32 176.86 4.89 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 120.13 1.332 . . . . 2.16 108.423 -168.43 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.377 45.5 pttt -54.27 128.46 31.4 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 131.555 3.942 . . . . 2.12 115.172 174.191 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 64.17 48.18 3.02 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 128.021 2.528 . . . . 1.71 109.269 175.758 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.2 p -92.12 173.45 7.83 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.806 -3.059 . . . . 1.04 113.35 178.117 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.1 m -120.88 114.86 22.18 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.281 -2.137 . . . . 0.79 112.317 173.201 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.565 HD23 HD12 ' A' ' 43' ' ' LEU . 6.3 mp -105.11 155.1 19.32 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.062 1.745 . . . . 1.4 108.522 175.575 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -118.42 130.64 56.09 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 126.543 2.402 . . . . 1.51 105.179 -174.763 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.2 tp -99.38 117.77 34.53 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.411 1.084 . . . . 1.14 112.981 175.524 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.8 t -102.97 129.85 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-O 123.896 1.808 . . . . 1.23 109.134 172.6 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.4 mt . . . . . 0 N--CA 1.43 -1.471 0 O-C-N 117.939 -2.976 . . . . 2.78 108.522 178.087 . . . . . . . . 0 0 . 1 . 059 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 CA--C 1.491 -1.319 0 CA-C-O 122.992 1.377 . . . . 1.1 113.882 . . . . . . . . . 0 0 . 1 . 059 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -85.9 135.18 33.79 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.21 1.804 . . . . 1.87 110.175 -174.565 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 pt -135.97 161.01 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 120.003 -1.686 . . . . 0.72 111.815 174.199 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -118.04 141.43 48.47 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.161 -2.212 . . . . 1.4 107.819 -179.268 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 t -116.88 130.11 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 126.064 2.102 . . . . 0.58 107.185 173.566 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -115.06 123.44 49.02 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.133 -3.479 . . . . 2.09 113.722 179.02 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.3 p -68.0 171.22 7.08 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 124.522 2.106 . . . . 0.99 112.038 178.161 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 tp -71.77 -27.37 62.91 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 117.912 -2.993 . . . . 2.53 110.403 174.622 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 p -73.6 -30.32 62.92 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.758 -3.714 . . . . 2.08 106.46 178.546 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.26 -21.22 2.96 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 125.289 3.677 . . . . 1.31 113.041 -179.433 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -57.11 117.41 4.0 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 126.874 2.07 . . . . 1.4 114.185 -177.159 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.8 m -107.64 114.82 29.06 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.169 -1.789 . . . . 0.78 106.169 -179.798 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.516 HD12 ' CE ' ' A' ' 33' ' ' LYS . 26.9 pt -104.61 161.64 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 125.839 1.962 . . . . 1.55 105.883 -178.162 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -117.24 121.13 40.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.711 2.004 . . . . 1.08 108.861 -174.48 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.6 mt -122.99 164.42 18.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 126.289 2.947 . . . . 1.55 110.974 -177.657 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -129.0 132.4 47.52 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 116.406 -3.934 . . . . 1.95 110.884 174.828 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.7 m -137.59 -175.45 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-O 128.377 3.942 . . . . 0.96 112.047 -179.818 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -122.88 147.32 50.83 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-N 112.157 -2.292 . . . . 2.35 110.572 166.084 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -65.6 -20.09 60.07 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 O-C-N 114.036 -3.718 . . . . 0.95 115.276 -178.783 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.6 p -70.64 -21.92 62.57 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 117.45 -3.281 . . . . 1.45 112.154 177.862 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -62.86 146.7 52.16 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.994 2.961 . . . . 1.69 118.994 178.395 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.8 p -85.58 151.64 23.76 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 124.895 1.278 . . . . 0.75 108.191 177.358 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.2 mm -54.0 -41.34 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 129.225 3.01 . . . . 0.73 113.063 -179.884 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -44.56 -53.17 7.36 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 118.612 2.819 . . . . 1.62 118.612 161.777 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -50.8 -32.15 19.15 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 126.537 1.935 . . . . 2.13 113.693 174.096 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.9 t -77.44 -42.7 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 107.243 -1.391 . . . . 0.62 107.243 -177.305 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.496 ' HA ' HD12 ' A' ' 30' ' ' ILE . 40.8 mtmt -60.16 -42.3 94.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 120.393 1.451 . . . . 1.22 112.79 174.744 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.85 -20.53 65.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.594 1.558 . . . . 0.51 110.227 177.915 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -80.11 -40.79 26.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.969 2.319 . . . . 1.44 112.878 174.545 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 27' ' ' LYS . 33.2 mt -51.52 -42.57 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.551 -2.593 . . . . 1.32 113.65 165.68 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -54.17 -47.76 71.64 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.339 2.656 . . . . 1.7 113.613 177.559 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -56.71 -42.51 79.3 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.816 2.046 . . . . 1.55 115.058 170.884 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.516 ' CE ' HD12 ' A' ' 13' ' ' ILE . 52.3 tttp -74.26 -48.56 27.9 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.671 1.988 . . . . 2.62 114.654 -179.213 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -115.85 -15.09 11.3 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 123.911 1.815 . . . . 1.48 114.264 -171.061 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.17 21.67 32.1 Favored Glycine 0 N--CA 1.429 -1.789 1 O-C-N 113.848 -5.533 . . . . 1.12 113.012 171.394 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 mt -98.69 124.02 47.67 Favored Pre-proline 0 N--CA 1.431 -1.42 0 O-C-N 120.626 -1.514 . . . . 1.55 107.009 -175.328 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -67.97 152.54 76.77 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 C-N-CA 124.302 3.335 . . . . 1.02 113.779 178.043 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -82.47 -15.84 8.45 Favored 'Trans proline' 0 N--CA 1.433 -2.052 0 C-N-CA 123.704 2.936 . . . . 1.25 113.321 -163.304 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -72.7 -27.76 62.26 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 129.981 4.551 . . . . 2.25 113.889 175.333 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -82.03 -20.54 38.13 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.046 2.355 . . . . 2.02 112.522 179.132 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.276 76.8 mt-30 -97.11 145.39 26.04 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 127.805 3.669 . . . . 0.69 109.786 -171.867 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -139.18 122.58 17.18 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.101 -2.249 . . . . 2.78 113.903 172.539 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.2 mt -92.44 120.85 33.34 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.414 -1.428 . . . . 1.17 112.866 -176.299 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.5 mt -112.7 130.15 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 129.981 3.313 . . . . 1.38 107.92 -175.537 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -138.3 135.15 35.16 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.744 -1.222 . . . . 1.5 110.206 177.872 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.01 46.96 25.71 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.824 3.202 . . . . 1.21 116.675 179.592 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.17 -44.28 3.35 Favored Glycine 0 N--CA 1.43 -1.717 0 O-C-N 118.617 -2.552 . . . . 1.3 117.479 -177.147 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -86.67 159.5 19.17 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 118.89 1.345 . . . . 2.55 114.498 -176.228 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -83.54 135.01 34.8 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.411 -0.813 . . . . 2.48 109.501 174.497 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 mt -87.7 148.1 24.92 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.759 -1.2 . . . . 0.9 107.759 -179.011 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -99.69 134.54 42.44 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.26 -2.775 . . . . 1.94 110.027 -179.619 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -68.36 -25.86 65.29 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 117.692 2.478 . . . . 1.56 117.692 -167.626 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.05 14.76 64.13 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 115.617 -3.183 . . . . 0.97 117.662 169.091 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -96.84 176.51 5.95 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.991 1.377 . . . . 2.49 108.157 170.005 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.5 p -102.6 -174.72 2.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 116.328 -3.982 . . . . 0.76 117.182 177.648 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.259 60.2 mt -77.33 -38.54 50.17 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.632 -2.542 . . . . 1.05 111.255 174.301 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.1 p -72.28 -15.12 61.9 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 128.369 3.543 . . . . 1.19 118.387 179.012 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -66.09 -29.66 70.02 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.127 -1.608 . . . . 1.9 113.672 168.921 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -102.96 6.46 38.92 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 122.851 1.31 . . . . 0.89 109.83 -177.231 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.8 m120 55.45 35.41 25.01 Favored 'General case' 0 N--CA 1.431 -1.38 1 O-C-N 116.279 -4.013 . . . . 1.84 114.746 -173.507 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.9 mt -68.72 118.03 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.943 1.297 . . . . 0.82 113.475 175.073 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -115.55 -175.85 2.8 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 130.97 3.708 . . . . 2.16 112.859 -178.864 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -67.07 139.12 57.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.247 2.927 . . . . 2.12 110.894 -176.224 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.446 25.3 mt-10 85.38 9.07 0.35 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 111.439 -2.619 . . . . 1.71 116.015 176.652 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.0 m -74.23 133.43 42.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.859 -1.776 . . . . 1.04 114.371 -173.282 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.5 m -99.99 109.99 22.32 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 104.651 -2.351 . . . . 0.79 104.651 -169.595 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.19 151.47 19.44 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.274 2.23 . . . . 1.4 109.134 172.306 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -109.34 108.18 18.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 123.598 1.666 . . . . 1.51 112.228 -179.06 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.4 tp -85.08 120.38 26.52 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.516 2.103 . . . . 1.14 109.412 178.178 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.366 31.3 m -114.67 148.25 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 117.17 -3.456 . . . . 1.23 112.611 171.702 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.286 62.1 mt . . . . . 0 N--CA 1.43 -1.455 0 CA-C-O 125.986 2.803 . . . . 2.78 108.829 -179.076 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.295 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.359 0 CA-C-O 125.099 2.381 . . . . 1.1 115.096 . . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -87.78 128.5 35.32 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.46 -3.9 . . . . 1.87 111.475 179.317 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.7 pt -126.66 172.96 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 117.07 -3.519 . . . . 0.72 106.603 169.612 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -127.17 135.65 50.99 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 123.519 0.728 . . . . 1.4 110.861 -176.864 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.2 t -117.37 117.94 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 101.342 -3.577 . . . . 0.58 101.342 176.774 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.7 tttp -101.73 148.2 25.56 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.625 -3.797 . . . . 2.09 113.54 174.84 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.4 HG22 HD23 ' A' ' 69' ' ' LEU . 31.1 p -97.28 171.59 8.33 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.542 2.591 . . . . 0.99 108.751 176.946 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.6 mt -83.47 -4.79 58.84 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.811 -2.43 . . . . 2.53 114.205 172.544 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.2 p -88.83 -30.44 18.94 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 115.723 -2.084 . . . . 2.08 105.467 178.947 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.11 -2.17 10.69 Favored Glycine 0 N--CA 1.43 -1.754 1 O-C-N 129.471 4.232 . . . . 1.31 115.89 170.941 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -72.47 140.61 48.36 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.859 -1.163 . . . . 1.4 107.859 -176.421 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.6 m -108.3 124.58 50.55 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.848 -2.649 . . . . 0.78 103.848 177.419 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.3 mm -101.55 116.81 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 119.237 -2.165 . . . . 1.55 109.769 176.209 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.2 m -92.85 120.8 33.57 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 121.351 1.887 . . . . 1.08 107.891 -179.162 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 15' ' ' LEU . 39.4 mt -125.88 127.23 45.7 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.048 2.939 . . . . 1.55 110.261 -173.731 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -86.29 114.26 22.95 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 126.72 2.513 . . . . 1.95 113.075 166.409 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.1 m -129.28 167.11 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 118.044 -2.91 . . . . 0.96 109.103 -179.407 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.271 69.1 mm-40 -110.4 156.08 40.93 Favored Pre-proline 0 N--CA 1.431 -1.408 0 CA-C-O 117.839 -1.077 . . . . 2.35 108.573 164.851 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -71.08 -8.22 23.09 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 CA-C-N 123.217 2.185 . . . . 0.95 113.853 -175.175 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.1 p -81.49 -24.91 36.41 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.049 2.94 . . . . 1.45 113.284 178.535 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -66.74 154.55 40.44 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 117.687 -1.149 . . . . 1.69 111.985 178.97 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 19.0 p -87.13 175.94 7.83 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 106.303 -1.74 . . . . 0.75 106.303 -177.872 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.4 mm -73.31 -33.96 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 C-N-CA 123.889 0.876 . . . . 0.73 111.792 175.848 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -46.2 -41.14 12.35 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.678 3.191 . . . . 1.62 113.751 167.41 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -73.39 -22.13 60.33 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 115.513 -4.492 . . . . 2.13 114.205 179.275 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -74.51 -47.02 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 113.709 -1.587 . . . . 0.62 109.047 175.589 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -52.69 -27.77 18.89 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 128.419 3.574 . . . . 1.22 119.817 167.116 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.21 -37.38 57.84 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.461 -3.899 . . . . 0.51 110.781 172.54 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -70.22 -39.83 74.88 Favored 'General case' 0 N--CA 1.43 -1.444 2 O-C-N 111.372 -7.08 . . . . 1.44 110.68 177.269 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 53.5 mt -59.28 -42.29 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 1 O-C-N 115.989 -4.194 . . . . 1.32 111.05 173.038 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -65.55 -46.5 79.3 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.215 -3.428 . . . . 1.7 107.671 177.755 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -55.15 -64.99 0.66 Allowed 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.081 -4.762 . . . . 1.55 117.003 169.91 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -61.37 -57.18 13.32 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.226 -2.796 . . . . 2.62 113.215 -176.021 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -100.93 -46.1 5.22 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.957 2.903 . . . . 1.48 111.315 -165.639 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.01 22.75 5.18 Favored Glycine 0 N--CA 1.429 -1.79 0 O-C-N 116.649 -3.782 . . . . 1.12 113.781 170.61 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.9 mt -92.43 128.24 45.44 Favored Pre-proline 0 N--CA 1.432 -1.374 0 N-CA-C 101.666 -3.457 . . . . 1.55 101.666 -173.11 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -71.26 155.78 60.12 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 CA-C-O 112.67 -3.137 . . . . 1.02 114.961 175.681 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -65.61 -24.15 56.05 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 CA-C-N 124.861 2.772 . . . . 1.25 118.274 -179.163 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.83 -33.85 76.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.548 2.055 . . . . 2.25 116.548 172.866 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -83.41 -35.28 25.16 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 126.321 2.962 . . . . 2.02 112.603 -177.916 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -79.05 130.09 35.15 Favored 'General case' 0 N--CA 1.429 -1.482 1 O-C-N 115.575 -4.453 . . . . 0.69 111.816 -176.103 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -123.91 129.73 51.44 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.696 1.599 . . . . 2.78 106.686 166.776 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 mt -96.19 139.42 32.36 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 124.657 1.223 . . . . 1.17 113.595 173.692 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 60.1 mt -114.63 138.5 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.899 -3.0 . . . . 1.38 107.607 174.141 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -147.13 136.74 22.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.797 -3.064 . . . . 1.5 112.062 169.46 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.374 . . 63.53 -2.21 0.51 Allowed 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 116.677 2.103 . . . . 1.21 116.677 -178.426 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.21 -11.28 33.84 Favored Glycine 0 N--CA 1.429 -1.776 0 CA-C-O 126.648 3.36 . . . . 1.3 113.52 -173.862 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -90.23 128.98 36.53 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 117.592 -3.299 . . . . 2.55 108.795 -179.548 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -77.03 126.44 30.97 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.084 -3.51 . . . . 2.48 108.099 171.565 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.289 26.5 mt -79.17 127.96 32.7 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 118.136 2.643 . . . . 0.9 118.136 -170.519 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -83.43 149.49 26.64 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.584 2.068 . . . . 1.94 116.584 174.441 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.76 -36.11 72.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.142 2.577 . . . . 1.56 114.15 -171.782 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.46 10.59 68.81 Favored Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 114.572 -3.68 . . . . 0.97 119.141 171.233 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -80.06 154.3 28.21 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 126.594 1.996 . . . . 2.49 113.225 170.701 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 32.5 p -82.77 164.32 20.7 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 124.886 2.279 . . . . 0.76 111.098 167.902 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mt -75.43 -29.04 59.59 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 116.791 -3.693 . . . . 1.05 112.481 173.098 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 p -62.92 -40.6 98.1 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.39 -2.069 . . . . 1.19 112.491 173.9 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.278 2.0 t70 -53.62 -40.87 66.11 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 118.535 2.791 . . . . 1.9 118.535 172.833 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -79.66 -9.07 59.58 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 126.009 2.068 . . . . 0.89 116.077 172.184 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.4 m120 70.8 65.82 0.18 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 130.1 3.36 . . . . 1.84 108.557 -177.521 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.5 mt -108.78 124.18 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 O-C-N 117.068 -3.52 . . . . 0.82 111.009 -178.145 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -107.42 -173.83 2.38 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.53 1.532 . . . . 2.16 115.032 -178.045 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -70.87 145.83 49.99 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 119.086 -2.259 . . . . 2.12 113.006 176.709 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.35 31.7 mt-10 78.4 15.05 1.33 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.297 2.639 . . . . 1.71 112.333 165.847 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.5 m -86.61 146.0 26.51 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.314 -2.221 . . . . 1.04 110.265 -169.42 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.7 m -93.79 110.41 22.06 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.547 1.976 . . . . 0.79 116.007 179.406 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -87.29 151.52 23.06 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.497 -2.002 . . . . 1.4 110.184 172.511 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.426 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 39.7 m80 -109.57 100.8 9.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.785 -1.822 . . . . 1.51 114.62 -179.562 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.4 HD23 HG22 ' A' ' 7' ' ' THR 0.259 36.0 tp -84.96 115.73 22.97 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.386 -2.071 . . . . 1.14 108.489 -173.122 . . . . . . . . 3 3 . 1 . 060 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 m -107.74 153.16 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 126.238 1.815 . . . . 1.23 110.792 174.817 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.1 mt . . . . . 0 N--CA 1.43 -1.474 0 O-C-N 118.802 -2.436 . . . . 2.78 107.788 179.281 . . . . . . . . 0 0 . 1 . 061 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 ptt? . . . . . 0 CA--C 1.491 -1.294 0 N-CA-C 115.138 1.533 . . . . 1.1 115.138 . . . . . . . . . 0 0 . 1 . 061 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -87.45 135.12 33.46 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 124.835 1.334 . . . . 1.87 110.435 179.439 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -126.66 138.39 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 105.894 -1.891 . . . . 0.72 105.894 175.073 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -104.19 77.03 1.38 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.791 -1.095 . . . . 1.4 108.91 -176.105 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 t -63.42 105.29 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 116.213 1.931 . . . . 0.58 116.213 168.95 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.257 35.7 tptt -90.46 139.8 30.33 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 124.151 1.929 . . . . 2.09 112.652 179.095 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.3 p -91.17 -179.39 5.42 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.556 -1.965 . . . . 0.99 108.513 179.544 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.4 tp -66.23 -50.88 62.28 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 123.218 1.485 . . . . 2.53 113.903 179.997 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 p -74.69 -22.07 59.06 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.113 1.523 . . . . 2.08 115.113 -172.577 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.05 -2.53 2.96 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 117.679 -2.201 . . . . 1.31 114.817 172.49 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -78.86 131.09 36.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.165 -2.962 . . . . 1.4 112.146 -175.18 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.271 85.8 m -98.83 118.1 34.82 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.147 -2.221 . . . . 0.78 108.97 175.452 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.1 mm -102.39 118.68 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 125.175 1.547 . . . . 1.55 110.201 179.698 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.2 m -81.02 98.33 7.91 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.447 -1.251 . . . . 1.08 110.549 174.862 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.3 tp -100.69 158.08 16.21 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.016 -2.303 . . . . 1.55 110.118 -176.394 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -121.55 118.74 30.03 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.284 -1.006 . . . . 1.95 108.284 174.956 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 m -135.58 176.67 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 107.619 -1.252 . . . . 0.96 107.619 -177.581 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -124.25 166.7 18.2 Favored Pre-proline 0 N--CA 1.429 -1.482 0 O-C-N 118.547 -2.596 . . . . 2.35 109.644 170.275 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.359 14.5 Cg_endo -75.68 -16.27 18.83 Favored 'Trans proline' 0 C--N 1.299 -2.075 0 O-C-N 114.7 -3.368 . . . . 0.95 114.502 -175.99 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.9 p -90.87 2.57 56.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.206 -2.184 . . . . 1.45 107.334 -178.804 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -80.51 142.59 34.04 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.923 -1.736 . . . . 1.69 113.544 179.433 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.6 p -85.71 164.71 17.47 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 117.029 2.233 . . . . 0.75 117.029 177.783 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.5 HD11 HD23 ' A' ' 56' ' ' LEU . 42.9 mm -76.48 -31.06 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 101.738 -3.43 . . . . 0.73 101.738 -172.979 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -49.76 -47.01 51.21 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 115.641 1.719 . . . . 1.62 115.641 167.298 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -76.72 -30.82 56.81 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 115.87 -2.014 . . . . 2.13 112.533 177.328 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.31 -29.7 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 121.592 1.996 . . . . 0.62 114.463 177.551 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -74.55 -35.39 63.08 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 117.607 -1.187 . . . . 1.22 109.213 171.232 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -36.93 83.99 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 123.389 2.813 . . . . 0.51 112.619 171.007 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.6 mttm -63.94 -47.38 80.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 126.842 2.589 . . . . 1.44 114.804 170.364 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.43 HG21 HD13 ' A' ' 30' ' ' ILE . 60.9 mt -61.48 -36.38 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 1 O-C-N 114.462 -5.149 . . . . 1.32 109.756 171.066 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -57.52 -54.27 48.71 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 117.14 -3.475 . . . . 1.7 113.152 172.734 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -52.75 -44.64 66.61 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.767 -1.208 . . . . 1.55 111.98 171.92 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -65.18 -57.41 8.6 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 127.612 2.365 . . . . 2.62 110.464 -173.369 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -105.75 -47.64 3.84 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 118.128 -2.857 . . . . 1.48 115.705 -169.611 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.42 4.63 8.96 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 119.547 -1.971 . . . . 1.12 114.17 -176.445 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.9 mt -83.5 127.37 68.48 Favored Pre-proline 0 N--CA 1.43 -1.462 0 O-C-N 119.026 -2.455 . . . . 1.55 110.478 -176.108 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -73.35 146.57 40.27 Favored 'Trans proline' 0 C--N 1.3 -2.014 2 O-C-N 110.895 -5.371 . . . . 1.02 113.389 179.135 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.06 -5.69 16.4 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 C-N-CA 126.107 4.538 . . . . 1.25 116.672 -176.931 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.53 -37.61 84.38 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.815 2.245 . . . . 2.25 110.782 169.343 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -85.17 -31.9 22.99 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 115.937 -1.982 . . . . 2.02 115.022 -177.411 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.359 46.7 mt-30 -67.58 113.47 5.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.388 2.675 . . . . 0.69 117.698 -172.089 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -122.01 115.47 22.58 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.327 -2.733 . . . . 2.78 109.551 172.765 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.9 mt -96.53 143.11 27.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.51 -1.369 . . . . 1.17 110.256 179.427 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.2 mm -124.6 148.64 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 102.679 -3.082 . . . . 1.38 102.679 175.423 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.407 ' HB3' HD21 ' A' ' 50' ' ' LEU . 69.4 t80 -139.53 112.86 8.27 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 101.156 -3.646 . . . . 1.5 101.156 173.982 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.96 28.76 14.49 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 126.286 2.241 . . . . 1.21 114.119 172.662 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.91 -17.1 56.68 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 124.938 1.256 . . . . 1.3 114.31 -175.168 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.316 34.7 ttmt -87.63 122.51 31.41 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.766 -2.608 . . . . 2.55 115.756 178.417 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -64.46 138.12 58.24 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 118.193 2.664 . . . . 2.48 118.193 171.718 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.407 HD21 ' HB3' ' A' ' 45' ' ' PHE . 39.7 mt -95.9 113.2 24.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.951 -1.022 . . . . 0.9 111.126 -172.326 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -77.5 142.56 39.03 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.873 -1.158 . . . . 1.94 107.873 -178.973 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.472 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 7.0 m-20 -56.96 -65.47 0.61 Allowed 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 119.29 3.071 . . . . 1.56 119.29 -168.723 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.1 25.5 0.15 Allowed Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 119.38 2.512 . . . . 0.97 119.38 171.943 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -105.97 158.0 17.1 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 119.773 1.786 . . . . 2.49 109.926 164.821 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.7 p -84.91 169.1 14.41 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 112.735 -2.03 . . . . 0.76 111.602 170.708 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.5 HD23 HD11 ' A' ' 23' ' ' ILE . 94.0 mt -66.02 -37.16 85.18 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 127.384 2.274 . . . . 1.05 111.739 171.543 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.9 p -69.39 -10.4 57.79 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 129.23 3.012 . . . . 1.19 115.016 173.806 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.99 -48.21 31.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.876 1.67 . . . . 1.9 110.362 169.84 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -85.63 -1.11 56.8 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 130.476 3.51 . . . . 0.89 113.775 -177.924 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.0 m120 57.21 54.32 6.9 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.604 2.361 . . . . 1.84 116.646 179.517 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 88.9 mt -100.27 109.8 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 126.846 2.058 . . . . 0.82 108.797 -179.194 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -93.74 -178.62 4.74 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.052 2.358 . . . . 2.16 110.422 -178.902 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -58.28 140.18 53.77 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.108 -3.495 . . . . 2.12 119.885 175.735 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.327 12.7 mt-10 67.98 40.56 2.26 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 123.778 0.674 . . . . 1.71 110.557 174.913 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 p -96.22 155.43 16.76 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 126.667 1.987 . . . . 1.04 108.547 176.106 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.4 m -104.68 85.75 2.37 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.689 -2.337 . . . . 0.79 104.689 -177.079 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -63.6 159.78 18.15 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 114.539 -5.1 . . . . 1.4 113.884 169.01 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -118.2 129.86 55.75 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.39 2.043 . . . . 1.51 108.584 -178.96 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.6 tp -116.67 131.27 56.99 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 116.065 -4.147 . . . . 1.14 113.242 175.351 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 m -135.1 167.9 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 103.437 -2.801 . . . . 1.23 103.437 175.727 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 66.4 mt . . . . . 0 N--CA 1.43 -1.428 0 CA-C-O 126.446 3.022 . . . . 2.78 113.958 179.596 . . . . . . . . 0 0 . 1 . 062 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 ttp . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 117.484 2.401 . . . . 1.1 117.484 . . . . . . . . . 0 0 . 1 . 062 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -100.03 124.01 44.91 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 124.53 1.144 . . . . 1.87 110.852 -176.337 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 17' ' ' VAL . 3.1 pt -129.11 157.89 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 105.571 -2.011 . . . . 0.72 105.571 172.003 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -108.79 134.67 51.17 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.023 1.729 . . . . 1.4 112.117 -174.854 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.491 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 42.1 t -111.85 115.01 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 122.15 0.976 . . . . 0.58 108.852 173.612 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -96.57 149.94 21.2 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.948 -2.345 . . . . 2.09 107.544 176.979 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.6 p -109.78 -149.21 0.44 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 116.275 -1.821 . . . . 0.99 107.462 176.464 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.2 tp -91.77 -58.12 2.52 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-N 122.809 2.55 . . . . 2.53 110.92 167.121 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.4 p -127.19 133.83 50.23 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 113.755 -3.022 . . . . 2.08 117.946 178.877 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.21 -116.97 2.71 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 103.307 -3.917 . . . . 1.31 103.307 173.983 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -119.67 164.62 15.62 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 121.831 -0.805 . . . . 1.4 108.87 -170.17 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.5 m -88.65 120.26 29.88 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 125.853 1.97 . . . . 0.78 109.652 168.958 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 15.6 mt -79.9 122.62 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-N 122.122 2.237 . . . . 1.55 114.983 -179.627 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.8 m -78.83 100.95 7.39 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.767 -1.833 . . . . 1.08 109.973 176.882 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tp -102.8 119.52 38.98 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 113.709 1.003 . . . . 1.55 113.709 -178.302 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -91.71 126.3 36.74 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.396 2.522 . . . . 1.95 112.983 168.574 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.401 HG21 HD13 ' A' ' 3' ' ' ILE . 19.7 m -142.89 171.46 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 1 C-N-CA 131.737 4.015 . . . . 0.96 110.868 -174.331 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 41.5 mt-10 -114.24 169.14 6.9 Favored Pre-proline 0 N--CA 1.43 -1.462 0 C-N-CA 129.163 2.985 . . . . 2.35 106.737 166.428 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 82.1 Cg_exo -73.16 -18.11 24.01 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 N-CA-C 120.11 3.081 . . . . 0.95 120.11 -177.1 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.4 m -84.69 10.15 12.02 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 112.036 -2.347 . . . . 1.45 116.171 174.574 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.69 130.49 35.08 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 116.688 -3.757 . . . . 1.69 106.007 177.464 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 23.9 p -71.05 163.59 27.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.712 2.196 . . . . 0.75 108.493 171.18 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.5 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 49.1 mm -66.41 -34.07 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 113.625 -3.083 . . . . 0.73 105.381 175.951 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -61.65 -40.02 93.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 122.883 2.583 . . . . 1.62 116.207 171.731 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -69.59 -41.02 76.32 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 125.144 1.528 . . . . 2.13 112.476 177.653 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.5 t -49.85 -50.12 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 120.858 -1.151 . . . . 0.62 113.569 169.872 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -58.77 -37.32 76.02 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.152 -1.592 . . . . 1.22 113.735 170.319 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.59 -37.84 85.75 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.648 -2.533 . . . . 0.51 108.908 178.945 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -69.32 -38.29 78.14 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 129.087 2.955 . . . . 1.44 112.813 179.303 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.8 mt -69.1 -28.66 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 117.431 -3.293 . . . . 1.32 110.959 170.99 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -66.31 -47.19 74.36 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.519 1.528 . . . . 1.7 110.761 172.235 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -64.3 -28.81 69.97 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 114.519 1.303 . . . . 1.55 114.519 173.058 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -87.89 -46.89 9.01 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.087 -2.258 . . . . 2.62 115.12 -173.839 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -113.58 -29.35 7.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.056 1.742 . . . . 1.48 115.262 -175.486 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.19 4.03 38.42 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 119.305 -2.122 . . . . 1.12 118.165 175.074 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.9 mt -85.06 132.48 45.46 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 119.262 1.531 . . . . 1.55 110.771 -173.934 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -61.32 144.04 98.31 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 C-N-CA 123.464 2.776 . . . . 1.02 116.72 -179.721 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -59.43 -32.52 96.59 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 123.379 2.719 . . . . 1.25 114.141 -178.627 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -63.24 -18.11 63.19 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.928 2.936 . . . . 2.25 118.928 171.59 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -91.89 -23.19 19.71 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 116.295 -1.812 . . . . 2.02 107.1 -177.162 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -89.49 141.09 28.89 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 117.406 2.373 . . . . 0.69 117.406 -172.932 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -123.23 137.72 54.81 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.486 -2.008 . . . . 2.78 110.143 163.496 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.2 mt -112.25 140.0 47.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.882 -1.896 . . . . 1.17 105.882 179.742 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.7 mm -120.92 127.58 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 130.108 3.363 . . . . 1.38 108.668 177.985 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -139.27 126.02 20.77 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 104.721 -2.325 . . . . 1.5 104.721 172.16 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.97 41.27 10.65 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 121.037 3.717 . . . . 1.21 121.037 173.921 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.1 -17.59 58.43 Favored Glycine 0 N--CA 1.43 -1.71 0 O-C-N 117.659 -3.151 . . . . 1.3 113.267 -178.772 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -108.81 135.5 49.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.477 -2.778 . . . . 2.55 115.279 -178.866 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -87.6 127.06 35.27 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.114 0.959 . . . . 2.48 109.248 170.805 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.0 mt -89.41 144.99 25.63 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 126.576 3.084 . . . . 0.9 112.325 -163.638 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -95.09 125.16 39.56 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.428 -3.295 . . . . 1.94 114.806 -179.781 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.5 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 5.9 m-20 -48.05 -49.86 29.96 Favored 'General case' 0 N--CA 1.429 -1.491 1 C-N-CA 132.406 4.282 . . . . 1.56 119.766 -169.006 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.42 46.2 3.18 Favored Glycine 0 N--CA 1.431 -1.673 0 CA-C-O 114.538 -3.368 . . . . 0.97 119.174 168.354 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -125.32 152.72 44.33 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.593 -2.743 . . . . 2.49 103.593 165.659 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 55.8 p -94.84 159.75 14.9 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.547 3.654 . . . . 0.76 116.039 176.857 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.6 mt -55.21 -40.49 70.84 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 115.682 1.734 . . . . 1.05 115.682 175.483 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 p -73.43 -9.28 58.53 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.181 -3.449 . . . . 1.19 118.41 179.506 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -93.21 -31.9 14.57 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 114.648 -2.596 . . . . 1.9 107.354 174.585 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -80.0 -5.51 55.87 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 125.892 1.995 . . . . 0.89 106.937 177.049 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 56.18 71.74 0.54 Allowed 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 115.053 -4.78 . . . . 1.84 111.813 -175.38 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.1 mt -115.87 111.9 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 105.001 -2.222 . . . . 0.82 105.001 178.619 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -95.34 -175.08 3.38 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.431 3.015 . . . . 2.16 109.621 -174.232 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -57.73 140.23 51.94 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 111.471 -2.604 . . . . 2.12 112.116 177.162 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.338 51.0 mt-10 69.38 20.85 7.17 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 125.214 1.406 . . . . 1.71 113.309 174.486 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.2 m -85.4 147.72 26.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 121.617 -0.677 . . . . 1.04 112.032 -172.459 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.2 m -104.5 111.07 23.6 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.052 -1.655 . . . . 0.79 112.921 -175.509 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -93.8 147.4 23.09 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.45 -1.406 . . . . 1.4 110.9 174.456 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -113.96 128.1 56.25 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.102 -2.874 . . . . 1.51 110.404 -177.367 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.0 tp -102.49 124.48 48.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 124.834 1.334 . . . . 1.14 112.995 -172.059 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.255 6.2 m -138.3 133.37 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.606 2.763 . . . . 1.23 107.662 -175.408 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 N--CA 1.43 -1.456 0 CA-C-O 125.144 2.402 . . . . 2.78 117.412 -175.995 . . . . . . . . 0 0 . 1 . 063 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ttp . . . . . 0 CA--C 1.49 -1.347 0 CA-C-O 116.447 -1.74 . . . . 1.1 107.145 . . . . . . . . . 0 0 . 1 . 063 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -116.55 128.91 55.85 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 124.665 1.228 . . . . 1.87 112.323 171.869 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.6 pt -121.06 173.55 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 119.116 -2.24 . . . . 0.72 107.648 169.521 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -128.3 150.93 49.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.98 -2.23 . . . . 1.4 104.98 -179.328 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.6 t -138.8 112.64 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 126.515 3.055 . . . . 0.58 112.627 174.469 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -89.51 153.25 20.95 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 111.072 -2.786 . . . . 2.09 115.509 -176.831 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 t -127.68 -160.55 1.02 Allowed 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 124.483 2.087 . . . . 0.99 107.853 170.864 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.8 mt -81.19 -85.53 0.1 Allowed 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 114.563 -5.086 . . . . 2.53 113.74 175.383 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.1 p -80.71 -41.34 23.8 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 128.764 2.826 . . . . 2.08 117.287 179.239 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.36 -168.31 11.16 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 118.696 -2.503 . . . . 1.31 118.622 176.181 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -60.34 151.31 28.1 Favored 'General case' 0 N--CA 1.43 -1.461 1 C-N-CA 131.735 4.014 . . . . 1.4 114.068 -172.808 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.8 m -98.18 117.23 32.09 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.453 -2.655 . . . . 0.78 104.216 163.659 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 pt -99.86 153.91 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 116.76 -3.713 . . . . 1.55 108.168 179.991 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.7 m -107.55 126.32 52.39 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 104.404 -2.443 . . . . 1.08 104.404 175.852 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.2 mt -117.38 129.04 55.61 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 123.388 1.566 . . . . 1.55 110.519 -179.263 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -96.73 125.99 41.57 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 116.641 -3.787 . . . . 1.95 104.343 174.305 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.25 27.4 m -136.8 170.42 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 129.264 3.025 . . . . 0.96 111.191 -170.871 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -109.7 156.0 40.47 Favored Pre-proline 0 N--CA 1.43 -1.442 0 CA-C-N 124.384 3.266 . . . . 2.35 107.324 166.728 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.86 -16.52 29.46 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 124.991 3.794 . . . . 0.95 114.787 -168.197 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.3 m -107.34 17.5 22.75 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 120.219 1.372 . . . . 1.45 110.21 177.574 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -73.75 151.09 40.74 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.306 -3.371 . . . . 1.69 113.164 171.053 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -91.53 160.07 15.6 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.913 1.816 . . . . 0.75 113.31 -178.525 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.315 26.0 mm -56.51 -37.9 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 116.381 1.993 . . . . 0.73 116.381 176.069 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -52.54 -43.39 65.13 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.844 2.165 . . . . 1.62 116.844 170.206 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -76.93 -42.4 39.51 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.229 -2.794 . . . . 2.13 108.346 -177.949 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.0 t -57.06 -45.62 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 118.177 2.658 . . . . 0.62 118.177 169.619 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -56.25 -40.71 74.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.021 1.328 . . . . 1.22 112.988 170.116 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.55 -33.55 75.27 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.779 2.432 . . . . 0.51 113.346 175.501 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -67.93 -40.19 83.37 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.474 2.709 . . . . 1.44 106.926 170.369 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.5 mt -62.31 -40.89 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 123.448 2.84 . . . . 1.32 113.117 173.092 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -55.64 -48.88 74.23 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.842 2.457 . . . . 1.7 114.503 170.503 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -58.03 -46.55 85.15 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.61 2.078 . . . . 1.55 116.61 170.853 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -76.71 -58.87 3.03 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 117.889 -3.007 . . . . 2.62 114.611 -177.353 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -88.51 -47.15 8.53 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.257 -1.527 . . . . 1.48 110.531 -170.294 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.85 34.84 1.95 Allowed Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 124.006 1.892 . . . . 1.12 113.72 177.367 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 mt -108.75 128.55 25.33 Favored Pre-proline 0 N--CA 1.431 -1.418 0 O-C-N 120.512 -1.581 . . . . 1.55 111.027 -176.935 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -63.36 141.13 80.2 Favored 'Trans proline' 0 N--CA 1.434 -1.98 0 CA-C-N 125.305 2.93 . . . . 1.02 114.111 173.694 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -75.07 -1.8 11.72 Favored 'Trans proline' 0 C--N 1.3 -1.994 1 C-N-CA 127.188 5.259 . . . . 1.25 113.904 -174.868 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -76.13 -34.2 59.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.905 2.482 . . . . 2.25 109.076 171.381 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -82.01 -25.97 34.25 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.056 2.36 . . . . 2.02 110.108 -175.591 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -82.22 125.02 30.44 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.766 2.698 . . . . 0.69 111.038 -171.746 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -114.99 98.07 6.6 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 109.335 -3.575 . . . . 2.78 109.694 167.837 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.3 mt -79.28 125.47 29.53 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 119.244 -2.16 . . . . 1.17 113.114 176.024 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.9 mm -112.92 123.33 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 O-C-N 119.469 -2.019 . . . . 1.38 106.04 176.18 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.439 ' HB2' HD23 ' A' ' 67' ' ' LEU . 10.9 t80 -91.03 -73.76 0.52 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 117.56 -1.656 . . . . 1.5 111.88 168.911 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.72 -69.32 0.65 Allowed 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 128.147 2.579 . . . . 1.21 114.035 179.895 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.47 17.48 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.72 1 O-C-N 112.9 -6.125 . . . . 1.3 115.914 -177.006 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -141.85 162.9 34.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 112.509 -1.845 . . . . 2.55 107.694 178.418 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -64.31 168.34 5.74 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 118.175 2.657 . . . . 2.48 118.175 168.146 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.458 HD22 ' CD2' ' A' ' 59' ' ' TYR . 91.4 mt -123.22 128.18 49.66 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.188 -2.195 . . . . 0.9 107.252 -172.622 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -90.06 152.86 20.96 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.796 1.776 . . . . 1.94 115.796 179.565 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.93 -37.82 79.13 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 129.731 3.212 . . . . 1.56 115.379 -165.375 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.88 43.84 1.8 Allowed Glycine 0 N--CA 1.43 -1.721 1 CA-C-O 113.096 -4.169 . . . . 0.97 109.616 169.913 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -122.12 162.0 22.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.524 3.162 . . . . 2.49 104.758 166.088 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.256 20.7 p -95.79 168.41 10.67 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 113.34 -1.755 . . . . 0.76 113.824 -177.551 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -56.96 -46.98 81.76 Favored 'General case' 0 N--CA 1.43 -1.468 1 C-N-CA 132.298 4.239 . . . . 1.05 115.768 168.666 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 t -60.94 -37.85 83.8 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 117.221 2.304 . . . . 1.19 117.221 173.73 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.276 11.7 t0 -46.19 -60.65 2.17 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 129.624 3.169 . . . . 1.9 111.869 178.171 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.458 ' CD2' HD22 ' A' ' 50' ' ' LEU . 60.6 m-85 -79.68 -1.66 39.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 112.57 -2.105 . . . . 0.89 116.397 -175.368 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.357 33.1 m120 73.89 52.22 0.11 Allowed 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 127.857 2.463 . . . . 1.84 114.176 -178.825 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.1 mt -96.31 117.44 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 103.901 -2.629 . . . . 0.82 103.901 -177.944 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -113.45 178.51 4.25 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 125.058 2.361 . . . . 2.16 111.578 -173.395 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -64.87 129.1 38.48 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 114.918 -4.864 . . . . 2.12 110.844 172.714 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.313 18.1 mt-10 80.03 36.18 0.13 Allowed 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 123.509 1.623 . . . . 1.71 114.558 178.108 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -107.18 125.18 50.78 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.203 2.201 . . . . 1.04 114.808 -176.205 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.9 m -97.32 117.69 32.11 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 121.323 -0.861 . . . . 0.79 111.029 -177.867 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.439 HD23 ' HB2' ' A' ' 45' ' ' PHE . 2.9 mp -101.88 164.7 11.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.479 1.133 . . . . 1.4 109.536 179.361 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -119.69 113.13 20.19 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 116.992 -1.48 . . . . 1.51 111.856 -176.496 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -80.55 131.97 35.6 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 124.654 1.221 . . . . 1.14 108.328 176.197 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.5 t -113.0 129.36 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 105.572 -2.01 . . . . 1.23 105.572 166.274 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 N--CA 1.431 -1.397 0 N-CA-C 108.555 -0.906 . . . . 2.78 108.555 179.644 . . . . . . . . 0 0 . 1 . 064 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ptt? . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 115.963 1.838 . . . . 1.1 115.963 . . . . . . . . . 0 0 . 1 . 064 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -102.91 127.71 50.01 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 114.923 -2.465 . . . . 1.87 112.592 -175.968 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.4 pt -124.54 176.53 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 123.104 2.683 . . . . 0.72 109.303 176.246 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -120.51 152.72 37.66 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.496 -2.627 . . . . 1.4 111.078 172.992 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.9 t -135.67 124.39 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 105.627 -1.99 . . . . 0.58 105.627 173.72 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -106.69 133.4 51.41 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 114.203 1.186 . . . . 2.09 114.203 175.67 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -95.99 165.39 12.29 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.669 1.588 . . . . 0.99 111.559 -179.588 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.258 43.2 mt -72.28 -28.58 63.19 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 118.037 2.606 . . . . 2.53 118.037 175.939 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 p -76.71 -26.98 55.27 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 126.805 2.042 . . . . 2.08 109.095 -179.362 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.6 46.46 0.48 Allowed Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 129.61 3.481 . . . . 1.31 114.951 167.07 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -109.82 133.83 52.72 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.707 3.203 . . . . 1.4 106.448 177.091 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 m -117.02 106.97 13.97 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 124.192 0.933 . . . . 0.78 109.34 167.521 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mt -85.49 136.95 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.358 1.863 . . . . 1.55 113.919 179.042 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.9 m -95.72 117.37 30.38 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 114.921 -2.466 . . . . 1.08 105.56 176.581 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.3 mt -129.08 137.83 51.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 124.651 3.387 . . . . 1.55 111.175 178.512 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -99.48 128.8 45.62 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 126.739 3.161 . . . . 1.95 110.082 172.379 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.69 172.76 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 101.922 -3.362 . . . . 0.96 101.922 -174.426 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -117.9 155.92 50.53 Favored Pre-proline 0 N--CA 1.43 -1.451 0 N-CA-C 104.276 -2.49 . . . . 2.35 104.276 163.392 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -73.73 -7.22 19.84 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 N-CA-C 115.702 1.385 . . . . 0.95 115.702 -170.414 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.1 p -97.57 -0.75 45.27 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 126.199 1.799 . . . . 1.45 109.188 178.179 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -76.89 148.88 36.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.482 -2.636 . . . . 1.69 108.287 173.785 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 72.5 p -85.91 165.13 17.02 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.938 2.495 . . . . 0.75 116.722 176.092 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.9 mm -70.27 -28.74 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 117.435 -3.291 . . . . 0.73 114.776 -178.146 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.25 75.3 tt0 -56.7 -46.56 81.15 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.015 1.388 . . . . 1.62 114.622 167.925 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -67.27 -37.32 83.27 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.362 -2.711 . . . . 2.13 110.798 179.688 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -66.72 -46.66 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 119.77 -1.831 . . . . 0.62 109.109 178.161 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -60.52 -39.22 87.03 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.903 -1.044 . . . . 1.22 112.446 174.724 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.46 -15.16 62.36 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 116.972 2.212 . . . . 0.51 116.972 175.532 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 29' ' ' LYS . 20.2 ttmm -85.3 -33.75 22.04 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.152 1.781 . . . . 1.44 114.316 177.735 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.3 mt -66.99 -47.43 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 1 C-N-CA 131.702 4.001 . . . . 1.32 106.718 166.634 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -47.8 -55.58 9.36 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 121.266 3.802 . . . . 1.7 121.266 173.534 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -34.21 -59.85 0.42 Allowed 'General case' 0 N--CA 1.431 -1.41 1 C-N-CA 131.777 4.031 . . . . 1.55 112.928 164.605 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -66.39 -57.61 7.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 118.488 2.773 . . . . 2.62 118.488 179.817 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -82.81 -45.64 14.07 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 130.411 3.484 . . . . 1.48 110.874 -171.093 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.18 47.27 1.74 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 107.6 -2.2 . . . . 1.12 107.6 174.178 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.7 mt -120.33 129.15 25.47 Favored Pre-proline 0 N--CA 1.431 -1.413 0 C-N-CA 127.504 2.322 . . . . 1.55 107.825 -169.143 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -72.65 145.69 42.1 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 114.007 -3.733 . . . . 1.02 112.375 175.691 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -65.18 -13.88 42.17 Favored 'Trans proline' 0 N--CA 1.433 -2.062 0 CA-C-N 126.668 3.417 . . . . 1.25 118.463 -177.392 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -56.24 -44.39 79.59 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 124.818 2.246 . . . . 2.25 114.227 175.088 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -90.27 -6.36 55.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 110.535 -3.03 . . . . 2.02 114.09 -177.678 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.415 ' HA ' HD23 ' A' ' 71' ' ' LEU . 66.5 mt-30 -103.77 139.63 38.73 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.353 -2.462 . . . . 0.69 104.353 -177.501 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -130.88 145.48 52.02 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.141 1.924 . . . . 2.78 108.711 167.962 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 mt -107.47 130.34 54.85 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.727 -1.583 . . . . 1.17 106.727 178.931 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 7.1 mm -112.28 140.14 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 105.293 -2.114 . . . . 1.38 105.293 177.925 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -155.07 126.99 7.58 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 125.07 2.367 . . . . 1.5 108.512 175.275 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.358 . . 61.86 34.05 17.27 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 127.747 3.641 . . . . 1.21 118.722 -175.885 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.31 -18.1 11.48 Favored Glycine 0 N--CA 1.429 -1.804 0 O-C-N 118.442 -2.661 . . . . 1.3 114.375 -178.495 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.263 30.0 mtmt -95.77 148.7 22.31 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.607 -3.29 . . . . 2.55 110.278 -177.393 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -88.09 122.1 31.27 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.26 2.225 . . . . 2.48 107.791 172.67 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.2 mt -74.04 162.07 29.4 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 110.06 -3.245 . . . . 0.9 112.433 -176.803 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -109.12 159.18 17.09 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.511 -3.243 . . . . 1.94 106.386 172.869 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.56 -58.56 3.22 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.829 2.852 . . . . 1.56 116.246 -169.93 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.94 43.13 2.59 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 127.356 2.407 . . . . 0.97 113.74 172.999 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -120.87 148.3 44.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.535 -3.332 . . . . 2.49 103.991 164.135 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.9 p -76.69 163.44 26.83 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 118.204 2.668 . . . . 0.76 118.204 170.609 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mt -55.55 -44.53 76.87 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.983 2.913 . . . . 1.05 109.9 170.461 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 p -59.44 -32.11 69.91 Favored 'General case' 0 N--CA 1.431 -1.412 1 O-C-N 129.813 4.446 . . . . 1.19 116.563 174.675 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -69.08 -34.8 75.71 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.609 1.671 . . . . 1.9 112.63 172.62 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -82.97 0.1 46.18 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.898 -3.626 . . . . 0.89 117.684 177.709 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.4 t30 48.96 43.7 22.0 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 131.661 3.984 . . . . 1.84 115.104 -176.535 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.2 mt -82.33 130.46 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 112.845 -1.98 . . . . 0.82 111.959 179.91 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -127.14 178.47 6.0 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 120.089 -1.632 . . . . 2.16 109.798 -173.446 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -57.56 154.72 10.8 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 115.412 1.634 . . . . 2.12 115.412 -178.281 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 61.33 11.02 3.39 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 126.277 1.831 . . . . 1.71 112.461 171.456 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.0 t -89.51 131.07 35.72 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 104.962 -2.236 . . . . 1.04 104.962 -174.069 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.0 m -96.32 114.14 25.79 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 102.761 -3.051 . . . . 0.79 102.761 -174.413 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mt -90.96 161.93 14.95 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.21 -2.806 . . . . 1.4 111.673 167.648 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.419 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 80.6 m80 -112.58 127.03 55.97 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 117.564 -1.208 . . . . 1.51 113.3 -177.54 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.4 tp -93.79 134.63 35.93 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 124.639 1.175 . . . . 1.14 110.635 176.805 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.0 m -129.92 156.47 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 103.823 -2.658 . . . . 1.23 103.823 174.503 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 41' ' ' GLN . 86.1 mt . . . . . 0 N--CA 1.431 -1.415 0 CA-C-O 125.059 2.361 . . . . 2.78 113.108 -179.755 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ptt? . . . . . 0 CA--C 1.49 -1.347 0 CA-C-O 123.032 1.396 . . . . 1.1 114.107 . . . . . . . . . 0 0 . 1 . 065 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -94.27 133.52 37.72 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 115.876 1.806 . . . . 1.87 115.876 -174.303 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.9 pt -127.44 153.78 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 120.727 -1.233 . . . . 0.72 109.627 173.993 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.304 58.2 m-85 -112.74 119.1 36.91 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 125.237 1.586 . . . . 1.4 113.099 -179.858 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.442 HG21 HD11 ' A' ' 30' ' ' ILE . 15.5 t -105.53 120.03 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 116.043 -2.263 . . . . 0.58 113.536 177.094 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -88.36 116.99 26.97 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.872 -2.392 . . . . 2.09 114.477 178.318 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.295 19.9 p -72.84 168.2 19.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.001 1.72 . . . . 0.99 112.988 178.774 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.417 HD21 HG12 ' A' ' 70' ' ' VAL 0.291 19.0 mt -66.15 -45.64 80.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.416 1.462 . . . . 2.53 113.862 173.981 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -65.14 -67.24 0.45 Allowed 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 117.379 2.362 . . . . 2.08 117.379 176.555 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.75 22.57 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 117.967 -2.063 . . . . 1.31 115.502 177.893 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -106.37 130.48 54.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.44 -1.319 . . . . 1.4 107.44 -176.831 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.9 m -99.34 107.69 20.02 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 105.722 -1.955 . . . . 0.78 105.722 172.165 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.1 mt -78.57 119.27 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 118.948 -2.345 . . . . 1.55 110.661 -179.967 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.6 m -83.1 117.98 23.24 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.394 -1.442 . . . . 1.08 108.736 174.163 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.2 mt -111.79 164.15 13.38 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 118.841 0.746 . . . . 1.55 111.58 179.136 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.75 129.54 56.38 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.351 1.06 . . . . 1.95 109.05 167.539 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.09 161.53 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 104.307 -2.479 . . . . 0.96 104.307 178.046 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -106.71 137.43 19.47 Favored Pre-proline 0 N--CA 1.43 -1.437 0 C-N-CA 128.172 2.589 . . . . 2.35 108.647 163.162 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -68.0 -8.42 22.6 Favored 'Trans proline' 0 N--CA 1.433 -2.04 0 C-N-CA 122.672 2.248 . . . . 0.95 114.586 -174.023 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.6 p -101.35 10.59 40.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.458 2.39 . . . . 1.45 111.697 175.676 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -91.35 165.06 13.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.503 1.62 . . . . 1.69 108.692 -176.7 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -90.4 161.2 15.68 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.777 -4.327 . . . . 0.75 110.093 -178.56 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.3 mt -72.22 -34.29 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.438 -2.663 . . . . 0.73 115.703 -177.156 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -52.47 -45.14 65.97 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.418 2.377 . . . . 1.62 117.418 157.14 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -58.29 -38.73 77.62 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 116.364 -3.96 . . . . 2.13 110.919 175.093 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.74 -49.2 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 122.828 1.299 . . . . 0.62 112.217 170.75 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -55.81 -39.58 71.53 Favored 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 115.786 -4.321 . . . . 1.22 114.658 175.945 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.258 . . -55.86 -31.23 62.59 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.334 2.654 . . . . 0.51 113.2 168.562 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 30.1 mmmt -65.69 -36.25 83.08 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 116.51 -3.868 . . . . 1.44 114.797 173.839 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.442 HD11 HG21 ' A' ' 5' ' ' VAL . 19.0 mt -66.47 -34.41 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 114.932 1.456 . . . . 1.32 114.932 170.266 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -59.86 -38.94 83.58 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 130.106 3.362 . . . . 1.7 109.255 178.148 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -50.42 -46.64 56.56 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 119.452 3.13 . . . . 1.55 119.452 163.837 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -80.54 -45.65 17.08 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 124.884 1.274 . . . . 2.62 111.747 -177.728 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -100.89 -44.29 5.81 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.738 -1.208 . . . . 1.48 107.738 -166.923 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.37 16.99 47.91 Favored Glycine 0 N--CA 1.43 -1.707 0 O-C-N 118.296 -2.752 . . . . 1.12 114.725 177.742 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.1 mt -98.26 127.46 36.4 Favored Pre-proline 0 N--CA 1.43 -1.461 1 C-N-CA 132.235 4.214 . . . . 1.55 104.114 174.583 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.91 151.57 81.97 Favored 'Trans proline' 0 N--CA 1.432 -2.093 1 O-C-N 112.363 -4.599 . . . . 1.02 114.289 -177.928 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.2 -19.29 20.11 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 CA-C-N 124.288 2.567 . . . . 1.25 112.28 -169.633 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -57.84 -30.27 65.63 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 120.615 1.552 . . . . 2.25 114.103 168.033 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.272 10.6 tt0 -77.17 -33.36 56.48 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 118.044 -2.91 . . . . 2.02 112.809 178.799 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -80.57 148.18 30.46 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 117.391 2.367 . . . . 0.69 117.391 -172.97 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -146.64 139.41 25.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.662 -1.607 . . . . 2.78 106.662 173.736 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.1 mt -105.06 145.15 30.89 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.067 -3.521 . . . . 1.17 109.694 -178.634 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.5 mm -119.76 140.67 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 105.456 -2.053 . . . . 1.38 105.456 -178.322 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -147.57 135.04 20.79 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.985 -1.697 . . . . 1.5 110.401 170.919 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.87 8.46 0.16 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 130.213 3.405 . . . . 1.21 116.532 -177.158 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.36 -25.79 9.01 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 129.684 3.516 . . . . 1.3 113.738 -174.498 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -79.61 146.52 32.5 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 121.202 2.501 . . . . 2.55 111.147 179.01 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -89.47 123.46 33.61 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 101.259 -3.608 . . . . 2.48 101.259 172.648 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.7 mt -85.42 145.41 27.46 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 105.709 -1.96 . . . . 0.9 105.709 -172.208 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -79.56 154.88 28.46 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 115.886 1.81 . . . . 1.94 115.886 173.8 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -82.74 -47.36 12.05 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.43 -3.294 . . . . 1.56 117.595 -171.359 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.21 57.34 1.73 Allowed Glycine 0 N--CA 1.43 -1.737 1 O-C-N 116.286 -4.009 . . . . 0.97 111.447 178.432 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.0 ttt85 -138.08 164.37 29.27 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.815 -1.92 . . . . 2.49 105.815 171.822 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.7 p -101.76 153.84 19.44 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 116.495 2.035 . . . . 0.76 116.495 175.366 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.8 mt -53.0 -47.34 68.35 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 126.293 2.949 . . . . 1.05 113.996 177.948 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.4 p -60.86 -24.65 66.07 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.061 -4.15 . . . . 1.19 120.384 174.38 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.28 -30.18 70.55 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 123.147 2.703 . . . . 1.9 114.798 172.946 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -86.87 -12.79 46.76 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.733 2.813 . . . . 0.89 114.646 177.611 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 66.47 45.03 2.21 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.472 -1.695 . . . . 1.84 114.582 -174.311 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.9 mt -98.32 106.71 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 128.327 3.917 . . . . 0.82 110.298 179.01 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -89.45 171.8 9.46 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 110.718 -2.947 . . . . 2.16 116.321 -170.933 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -52.53 137.7 29.55 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.536 1.935 . . . . 2.12 112.403 170.168 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.275 37.0 mt-10 56.4 41.56 28.76 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 119.926 3.306 . . . . 1.71 119.926 178.65 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.8 m -98.62 156.45 16.81 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.184 2.193 . . . . 1.04 110.166 -179.592 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.4 m -106.95 106.48 17.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.914 2.769 . . . . 0.79 111.746 -175.329 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -94.82 164.36 12.96 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.351 2.024 . . . . 1.4 109.298 176.343 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -137.5 122.08 18.5 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 126.235 2.921 . . . . 1.51 107.6 -179.386 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.5 tp -87.92 133.8 33.85 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 111.455 -2.611 . . . . 1.14 117.067 178.185 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.417 HG12 HD21 ' A' ' 8' ' ' LEU . 28.6 m -130.02 173.23 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.184 -2.822 . . . . 1.23 106.008 173.487 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.7 mt . . . . . 0 N--CA 1.429 -1.49 0 O-C-N 118.422 -2.673 . . . . 2.78 108.846 -173.954 . . . . . . . . 0 0 . 1 . 066 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 CA--C 1.49 -1.361 0 N-CA-C 120.207 3.41 . . . . 1.1 120.207 . . . . . . . . . 0 0 . 1 . 066 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -96.62 140.17 31.62 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 105.82 -1.919 . . . . 1.87 105.82 179.862 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.7 pt -136.43 165.16 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 129.928 3.291 . . . . 0.72 108.868 167.877 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -118.95 132.75 56.09 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.28 -2.138 . . . . 1.4 115.476 -175.812 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.7 t -118.29 121.64 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 1 O-C-N 116.056 -4.152 . . . . 0.58 112.825 176.634 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -91.15 128.11 36.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 118.456 2.762 . . . . 2.09 118.456 178.455 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.491 HG22 HD23 ' A' ' 69' ' ' LEU . 39.4 p -79.53 -177.83 6.01 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.069 2.366 . . . . 0.99 113.232 -177.293 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.3 mt -68.04 -43.6 78.34 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 113.939 -1.482 . . . . 2.53 113.203 166.506 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.6 p -73.89 -21.0 60.24 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 123.005 1.383 . . . . 2.08 108.919 -175.861 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.38 23.68 4.38 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 116.539 -3.851 . . . . 1.31 113.281 171.047 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -82.87 136.25 34.67 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 112.664 -3.541 . . . . 1.4 113.059 -176.932 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.4 m -95.69 118.86 33.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 123.916 3.053 . . . . 0.78 109.343 170.588 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.1 mt -90.74 123.58 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 130.509 3.524 . . . . 1.55 108.119 174.766 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 m -97.6 112.26 24.2 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 116.666 -3.771 . . . . 1.08 107.048 -179.67 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.4 mt -126.75 152.73 46.47 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.425 1.09 . . . . 1.55 113.469 -178.619 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -107.26 146.47 31.42 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.74 -1.207 . . . . 1.95 107.74 172.046 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 m -149.25 178.4 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 102.236 -3.246 . . . . 0.96 102.236 -177.479 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -138.55 157.57 71.95 Favored Pre-proline 0 N--CA 1.43 -1.47 0 CA-C-O 124.076 1.893 . . . . 2.35 106.196 158.996 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 47.6 Cg_exo -52.92 -23.7 22.03 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 124.943 3.762 . . . . 0.95 118.019 -175.221 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.1 m -79.26 -13.15 59.86 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 120.179 1.354 . . . . 1.45 114.107 178.775 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -72.57 153.87 41.07 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 112.73 0.641 . . . . 1.69 112.73 -179.943 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.2 p -87.41 167.42 14.03 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 126.403 3.001 . . . . 0.75 109.906 174.742 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 43' ' ' LEU . 26.7 mm -70.58 -34.19 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 1 O-C-N 116.236 -4.04 . . . . 0.73 109.107 174.202 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.313 29.1 tt0 -51.89 -44.32 63.71 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 116.872 2.175 . . . . 1.62 116.872 168.088 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -71.15 -9.28 57.81 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 119.549 3.166 . . . . 2.13 119.549 179.642 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -87.12 -38.98 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 C-N-CA 126.208 1.803 . . . . 0.62 108.205 167.384 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -75.53 -24.28 56.74 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 117.462 2.393 . . . . 1.22 117.462 177.853 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.07 -45.24 89.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.822 2.449 . . . . 0.51 108.259 165.335 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -57.74 -31.95 66.97 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 118.01 2.596 . . . . 1.44 118.01 164.3 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.447 HD13 HD22 ' A' ' 69' ' ' LEU . 46.8 mt -78.14 -20.79 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 118.816 -2.428 . . . . 1.32 115.859 177.742 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -59.99 -30.13 68.92 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.891 -1.755 . . . . 1.7 112.725 165.606 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -74.06 -51.18 16.57 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.435 -2.041 . . . . 1.55 114.844 168.634 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -56.48 -55.34 34.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.675 -1.148 . . . . 2.62 111.573 -172.474 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -107.65 -57.71 2.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 126.134 2.147 . . . . 1.48 113.468 -173.188 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.16 9.5 2.12 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 127.05 2.719 . . . . 1.12 116.135 173.849 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.8 mt -88.96 139.19 29.0 Favored Pre-proline 0 N--CA 1.43 -1.467 1 CA-C-O 111.678 -4.01 . . . . 1.55 111.379 -174.665 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -77.81 151.53 28.11 Favored 'Trans proline' 0 C--N 1.3 -2.0 1 CA-C-N 133.151 5.732 . . . . 1.02 110.936 -171.945 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.45 -17.04 43.9 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 O-C-N 125.453 2.291 . . . . 1.25 112.641 -176.011 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -54.41 -59.95 3.99 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 114.807 -2.52 . . . . 2.25 110.998 167.628 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -70.39 -17.33 63.03 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.394 3.878 . . . . 2.02 117.55 -176.525 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -95.8 147.18 23.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.431 -0.793 . . . . 0.69 111.912 -178.984 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -136.59 139.56 42.21 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.604 -3.185 . . . . 2.78 113.186 170.674 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.402 HD12 HG23 ' A' ' 23' ' ' ILE . 18.8 mt -96.49 143.44 27.5 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.065 -3.522 . . . . 1.17 118.901 174.371 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.8 mt -119.53 139.84 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 102.409 -3.182 . . . . 1.38 102.409 179.317 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -145.58 120.57 10.03 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 101.47 -3.53 . . . . 1.5 101.47 168.673 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.8 52.08 1.71 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 120.05 3.352 . . . . 1.21 120.05 173.874 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.75 2.59 6.38 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 129.094 3.235 . . . . 1.3 116.939 177.818 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -120.93 152.9 37.94 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.609 -2.701 . . . . 2.55 109.56 174.873 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -84.96 138.33 32.55 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.337 2.494 . . . . 2.48 109.119 174.629 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.3 mt -94.69 145.21 25.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.239 2.216 . . . . 0.9 109.153 -175.913 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -85.97 142.67 28.63 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.932 -2.355 . . . . 1.94 113.869 170.432 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -59.05 -58.62 7.84 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.821 3.649 . . . . 1.56 112.64 -175.227 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.23 39.39 3.05 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 127.826 2.632 . . . . 0.97 115.301 172.474 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.483 ' HD2' ' HA ' ' A' ' 54' ' ' ARG . 18.7 mmm-85 -110.35 150.62 28.52 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.811 2.719 . . . . 2.49 107.333 155.232 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.1 p -76.28 155.98 33.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.322 -3.361 . . . . 0.76 109.841 172.632 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.519 HD22 HD12 ' A' ' 61' ' ' ILE . 46.8 mt -60.36 -39.4 87.05 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 114.309 1.225 . . . . 1.05 114.309 172.093 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.288 82.7 p -50.62 -42.4 56.03 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.306 -3.371 . . . . 1.19 112.504 175.347 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -56.49 -42.17 77.86 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.537 -3.227 . . . . 1.9 111.804 176.175 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -87.12 -13.57 43.8 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 114.5 -2.667 . . . . 0.89 112.769 177.125 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 70.23 24.71 4.77 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.704 2.669 . . . . 1.84 117.05 -178.971 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.519 HD12 HD22 ' A' ' 56' ' ' LEU . 7.0 mt -70.37 112.54 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 113.064 -1.88 . . . . 0.82 111.531 179.061 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -87.95 179.52 6.42 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.123 -1.611 . . . . 2.16 108.658 178.209 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -55.7 142.25 34.93 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 130.911 3.684 . . . . 2.12 117.796 173.251 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.46 37.6 mt-10 77.21 10.84 2.4 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.499 -2.001 . . . . 1.71 113.769 170.029 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.1 m -75.08 146.13 41.72 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.648 3.179 . . . . 1.04 111.717 177.773 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.2 m -111.02 113.22 25.6 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 125.323 2.487 . . . . 0.79 105.241 -179.294 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.4 mt -96.73 127.19 42.48 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 125.968 1.707 . . . . 1.4 111.39 175.883 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -84.89 136.84 33.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.987 -1.695 . . . . 1.51 109.842 -177.4 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.491 HD23 HG22 ' A' ' 7' ' ' THR . 1.7 tp -104.75 121.01 42.72 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.457 2.348 . . . . 1.14 105.26 178.792 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 m -123.65 163.95 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 119.59 -1.944 . . . . 1.23 106.299 172.847 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.6 mt . . . . . 0 N--CA 1.431 -1.397 0 O-C-N 119.389 -2.07 . . . . 2.78 112.019 176.281 . . . . . . . . 0 0 . 1 . 067 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 ptt? . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 114.284 1.216 . . . . 1.1 114.284 . . . . . . . . . 0 0 . 1 . 067 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -112.77 122.94 49.14 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 125.828 1.955 . . . . 1.87 112.229 -171.052 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.684 HG22 ' H ' ' A' ' 65' ' ' SER . 5.7 pt -113.07 157.61 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 126.324 2.265 . . . . 0.72 116.175 167.348 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -103.66 125.39 50.13 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.672 1.589 . . . . 1.4 110.165 -174.818 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 t -103.0 125.61 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.109 -2.245 . . . . 0.58 110.974 173.887 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -93.4 118.05 30.83 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.679 2.487 . . . . 2.09 113.009 176.097 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -94.84 171.53 8.72 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.566 -1.959 . . . . 0.99 109.749 -174.421 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.4 mt -83.19 -5.59 59.18 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 117.713 2.486 . . . . 2.53 117.713 171.613 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -88.64 -32.57 17.98 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 104.941 -2.244 . . . . 2.08 104.941 179.88 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.8 37.61 1.04 Allowed Glycine 0 N--CA 1.429 -1.777 0 C-N-CA 126.56 2.028 . . . . 1.31 110.853 -179.952 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -106.7 144.92 32.66 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.764 -1.433 . . . . 1.4 109.798 -179.94 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.5 m -104.84 114.41 28.61 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.564 2.746 . . . . 0.78 108.002 168.462 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.4 mt -109.96 116.66 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 118.55 -2.594 . . . . 1.55 105.062 -168.712 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 m -89.84 97.07 10.98 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.387 1.875 . . . . 1.08 109.944 179.005 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.2 mt -96.5 131.78 42.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 112.531 -2.122 . . . . 1.55 116.383 177.632 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -88.23 111.22 21.4 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.967 2.907 . . . . 1.95 109.787 172.461 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.54 158.26 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 116.565 -3.835 . . . . 0.96 104.447 -172.543 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -103.01 161.23 23.74 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 117.348 -1.311 . . . . 2.35 111.716 169.064 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -75.67 -11.95 20.27 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 CA-C-N 121.008 1.396 . . . . 0.95 113.731 -168.252 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.4 p -85.75 -6.3 59.13 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 125.611 1.819 . . . . 1.45 110.733 175.785 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -76.46 149.69 36.77 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 123.851 1.786 . . . . 1.69 109.138 172.574 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.299 63.3 p -90.17 166.54 13.32 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.881 2.277 . . . . 0.75 108.967 -179.578 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.461 HG23 HD12 ' A' ' 43' ' ' LEU . 19.8 mm -63.79 -36.69 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 111.933 -2.394 . . . . 0.73 110.1 179.956 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -53.14 -42.12 65.76 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 121.509 3.892 . . . . 1.62 121.509 163.142 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 -59.97 -27.51 66.89 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.406 2.373 . . . . 2.13 117.406 173.302 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.9 t -72.23 -47.14 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 C-N-CA 127.112 2.165 . . . . 0.62 114.331 169.302 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 79.5 mttt -60.37 -29.4 68.9 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 113.972 -1.467 . . . . 1.22 112.593 172.5 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.26 -25.58 65.25 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 116.002 -4.186 . . . . 0.51 117.295 -179.556 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -76.77 -35.1 57.93 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 127.156 2.182 . . . . 1.44 109.533 179.471 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.4 mt -71.64 -32.96 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 126.311 1.845 . . . . 1.32 108.88 174.344 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -62.84 -45.42 92.67 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.736 -4.353 . . . . 1.7 111.887 173.376 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -50.73 -60.91 2.56 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 116.206 1.928 . . . . 1.55 116.206 168.063 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -65.14 -62.28 1.64 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.067 2.547 . . . . 2.62 111.45 -174.472 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -105.41 -38.39 6.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.458 -1.401 . . . . 1.48 109.933 -160.596 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.7 -11.2 7.49 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 117.575 -3.203 . . . . 1.12 114.063 168.152 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.0 mt -67.1 124.18 88.21 Favored Pre-proline 0 N--CA 1.429 -1.497 0 O-C-N 119.814 -1.992 . . . . 1.55 108.549 -174.451 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.83 145.05 35.75 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 CA-C-N 120.847 1.338 . . . . 1.02 109.578 172.976 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.03 -0.39 3.99 Favored 'Trans proline' 0 C--N 1.3 -2.009 1 C-N-CA 127.634 5.556 . . . . 1.25 115.975 -169.732 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -91.36 -13.91 31.64 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.117 1.78 . . . . 2.25 113.028 169.99 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -87.94 -45.65 10.06 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 121.47 1.941 . . . . 2.02 111.793 178.815 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -79.33 126.69 31.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.375 2.512 . . . . 0.69 110.963 -176.384 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -113.35 151.15 31.61 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 117.538 -3.226 . . . . 2.78 107.683 171.537 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.461 HD12 HG23 ' A' ' 23' ' ' ILE . 85.1 mt -114.58 120.53 40.49 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 126.223 2.202 . . . . 1.17 111.676 176.817 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.269 82.7 mt -105.49 132.32 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 N-CA-C 115.195 1.554 . . . . 1.38 115.195 175.734 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -148.18 126.36 12.17 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 119.008 -2.308 . . . . 1.5 112.57 173.916 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.17 21.56 7.15 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.874 1.805 . . . . 1.21 115.874 -175.645 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.7 8.48 77.04 Favored Glycine 0 N--CA 1.429 -1.774 1 C-N-CA 131.967 4.603 . . . . 1.3 113.575 -173.451 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -101.38 128.99 47.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.858 -1.534 . . . . 2.55 106.858 179.14 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -74.21 112.03 9.95 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 127.893 2.477 . . . . 2.48 114.02 170.365 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 mt -83.11 124.27 30.32 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 117.741 -1.584 . . . . 0.9 114.725 -163.317 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -75.73 135.36 40.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.344 -3.347 . . . . 1.94 110.849 -178.976 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.413 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -63.05 -45.17 93.5 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 109.144 -3.662 . . . . 1.56 115.941 -168.317 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.18 29.82 1.63 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 118.246 2.058 . . . . 0.97 118.246 166.703 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.5 mtp180 -120.53 158.16 27.89 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 124.21 1.957 . . . . 2.49 111.72 163.452 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.3 p -89.16 168.58 12.18 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 124.216 1.96 . . . . 0.76 114.312 171.585 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.331 8.4 mt -66.7 -38.52 86.9 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 110.845 -2.888 . . . . 1.05 105.25 174.603 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -68.09 -32.53 72.91 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.896 -3.002 . . . . 1.19 111.919 -179.021 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.32 38.0 t0 -63.08 -47.73 81.63 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.484 2.031 . . . . 1.9 116.484 174.219 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -73.86 -9.47 58.68 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.444 -3.91 . . . . 0.89 114.97 168.777 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.4 t30 66.63 58.37 0.64 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.662 2.385 . . . . 1.84 113.804 -178.883 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mt -100.67 120.78 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 126.253 1.821 . . . . 0.82 110.087 -178.15 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.23 174.78 5.98 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.539 1.638 . . . . 2.16 111.792 -174.521 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -53.66 148.51 9.62 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.876 -3.64 . . . . 2.12 114.959 169.199 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.251 86.3 mt-10 67.79 25.18 8.03 Favored 'General case' 0 N--CA 1.431 -1.378 1 C-N-CA 132.699 4.4 . . . . 1.71 110.372 178.495 . . . . . . . . 3 2 . 1 . 067 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.684 ' H ' HG22 ' A' ' 3' ' ' ILE . 69.0 m -75.86 143.9 41.52 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.58 2.61 . . . . 1.04 110.481 -177.496 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.6 m -100.64 97.16 7.86 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.949 -3.594 . . . . 0.79 110.209 -179.519 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.408 HD11 HD12 ' A' ' 3' ' ' ILE . 16.4 mt -91.64 128.76 37.59 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 126.033 2.083 . . . . 1.4 111.54 -178.676 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -89.09 116.12 27.13 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.93 -3.606 . . . . 1.51 113.09 177.34 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 tt -97.54 123.05 41.28 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 104.935 -2.246 . . . . 1.14 104.935 -177.737 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.52 176.41 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 O-C-N 118.686 -2.508 . . . . 1.23 106.135 174.677 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 N--CA 1.431 -1.39 0 CA-C-O 125.121 2.391 . . . . 2.78 105.58 173.385 . . . . . . . . 0 0 . 1 . 068 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 CA--C 1.49 -1.338 0 CA-C-O 118.662 -0.685 . . . . 1.1 112.825 . . . . . . . . . 0 0 . 1 . 068 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -97.96 148.74 23.16 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 120.316 1.416 . . . . 1.87 112.784 -176.492 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.0 pt -130.51 169.05 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.896 -2.377 . . . . 0.72 106.647 171.85 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -112.82 125.93 54.88 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.862 1.43 . . . . 1.4 114.862 179.585 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 t -114.76 116.64 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 126.782 3.182 . . . . 0.58 110.26 173.922 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -92.1 119.03 31.4 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 111.202 -2.726 . . . . 2.09 112.057 179.093 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.1 p -75.1 179.41 5.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.885 2.074 . . . . 0.99 111.488 -178.815 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.4 mt -60.59 -41.15 94.12 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.991 -1.068 . . . . 2.53 113.321 177.384 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.5 p -84.85 -38.21 19.76 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 115.491 -2.195 . . . . 2.08 116.9 178.434 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.92 29.57 0.22 Allowed Glycine 0 N--CA 1.429 -1.826 0 O-C-N 126.991 2.682 . . . . 1.31 111.91 175.571 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -86.76 131.49 34.12 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 119.99 1.895 . . . . 1.4 110.03 175.466 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.5 m -90.93 112.15 23.9 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 117.694 -1.603 . . . . 0.78 109.312 177.188 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.3 mm -95.43 117.21 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 102.666 -3.087 . . . . 1.55 102.666 178.72 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.7 m -100.32 105.13 16.63 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.176 -1.787 . . . . 1.08 106.176 -178.049 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.4 mt -103.12 146.24 28.69 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 118.592 -0.718 . . . . 1.55 109.881 -177.835 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -92.4 139.15 30.89 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 106.407 -1.701 . . . . 1.95 106.407 170.232 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.6 m -142.98 -177.58 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 100.204 -3.999 . . . . 0.96 100.204 -176.831 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -125.94 161.04 53.77 Favored Pre-proline 0 N--CA 1.43 -1.456 0 C-N-CA 128.28 2.632 . . . . 2.35 105.486 169.196 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -62.74 -21.99 73.51 Favored 'Trans proline' 0 C--N 1.3 -2.009 1 C-N-CA 127.832 5.688 . . . . 0.95 111.115 174.792 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 p -83.56 -5.59 59.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 125.898 1.999 . . . . 1.45 113.13 179.936 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -81.29 142.41 33.14 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 120.906 1.685 . . . . 1.69 112.533 179.18 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 61.2 p -87.88 165.28 15.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 128.143 3.402 . . . . 0.75 113.925 175.376 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.2 mm -62.67 -37.19 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 124.697 1.199 . . . . 0.73 111.643 177.957 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -54.94 -42.39 72.22 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 118.656 2.836 . . . . 1.62 118.656 168.515 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -62.88 -36.46 83.37 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 116.873 -3.642 . . . . 2.13 111.774 -178.998 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.3 t -59.83 -48.29 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 C-N-CA 128.84 2.856 . . . . 0.62 114.112 171.229 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -55.85 -43.68 77.31 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 115.242 1.571 . . . . 1.22 115.242 169.689 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.62 -36.69 85.06 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.585 -3.197 . . . . 0.51 115.939 172.467 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.281 41.2 mttm -54.42 -53.87 48.3 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.425 1.89 . . . . 1.44 112.566 167.867 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.9 mt -59.14 -34.79 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 O-C-N 118.198 -2.814 . . . . 1.32 117.751 176.373 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -69.14 -37.25 78.2 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 113.008 -1.906 . . . . 1.7 110.576 178.05 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -65.52 -41.85 92.65 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.988 2.327 . . . . 1.55 115.861 167.661 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -58.97 -82.12 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 125.779 2.704 . . . . 2.62 115.704 -177.73 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -95.56 -23.25 17.16 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.633 2.773 . . . . 1.48 112.939 -171.596 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.14 46.25 3.9 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 117.577 -2.249 . . . . 1.12 113.549 176.165 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.4 mt -105.38 132.09 21.18 Favored Pre-proline 0 N--CA 1.429 -1.475 0 CA-C-O 114.337 -2.744 . . . . 1.55 104.448 178.911 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -67.75 140.55 51.53 Favored 'Trans proline' 0 N--CA 1.434 -1.999 0 CA-C-N 125.439 2.978 . . . . 1.02 117.773 -178.402 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -75.27 -10.59 20.83 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 N-CA-C 120.835 3.359 . . . . 1.25 120.835 -174.173 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -88.7 17.77 5.25 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.35 1.46 . . . . 2.25 108.587 168.507 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -115.24 -31.68 5.91 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.927 -2.983 . . . . 2.02 107.167 -177.686 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -84.09 121.89 28.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 131.457 3.903 . . . . 0.69 117.315 -165.751 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -116.72 122.15 43.66 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.862 1.665 . . . . 2.78 107.545 -179.19 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -95.45 117.7 30.85 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 116.099 -1.905 . . . . 1.17 108.575 -178.427 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mm -101.62 125.11 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 129.308 3.043 . . . . 1.38 111.294 176.888 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -150.9 115.59 5.2 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 127.892 3.71 . . . . 1.5 106.886 174.694 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 46.34 0.77 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 109.098 -3.683 . . . . 1.21 113.939 178.872 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.02 -16.29 0.88 Allowed Glycine 0 N--CA 1.43 -1.712 0 CA-C-O 116.558 -2.246 . . . . 1.3 118.398 -171.189 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -101.5 157.13 17.04 Favored 'General case' 0 N--CA 1.43 -1.464 1 CA-C-N 125.797 4.799 . . . . 2.55 103.326 -175.047 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -95.44 141.86 28.49 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.517 2.103 . . . . 2.48 106.3 172.779 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.7 mt -89.84 136.58 32.96 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.65 -2.531 . . . . 0.9 116.658 -169.909 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -65.29 133.05 50.6 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 120.999 3.703 . . . . 1.94 120.999 175.501 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -60.07 -49.67 76.75 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.759 2.695 . . . . 1.56 114.436 -170.567 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.76 45.61 1.41 Allowed Glycine 0 N--CA 1.43 -1.733 0 CA-C-N 111.374 -2.648 . . . . 0.97 116.653 179.303 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.412 ' HD3' ' CE2' ' A' ' 59' ' ' TYR . 62.3 ttt180 -130.54 127.41 39.05 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 128.271 2.983 . . . . 2.49 112.769 169.576 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.375 2.6 p -63.04 167.04 5.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 121.038 3.718 . . . . 0.76 121.038 173.738 . . . . . . . . 3 3 . 1 . 068 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.4 mt -74.0 -43.28 58.59 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.662 -1.899 . . . . 1.05 110.935 176.464 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 t -60.59 -42.26 96.38 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 122.491 1.139 . . . . 1.19 114.035 176.053 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -56.03 -38.21 70.25 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 121.055 3.724 . . . . 1.9 121.055 173.575 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CE2' ' HD3' ' A' ' 54' ' ' ARG . 21.8 m-85 -80.99 -15.87 55.0 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.282 -2.137 . . . . 0.89 111.158 175.242 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.3 m120 77.94 34.63 0.31 Allowed 'General case' 0 N--CA 1.43 -1.462 1 C-N-CA 132.998 4.519 . . . . 1.84 114.067 -177.732 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -89.69 117.48 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 130.295 3.438 . . . . 0.82 114.901 176.61 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -110.34 -178.23 3.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.031 1.872 . . . . 2.16 108.536 -174.869 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -59.11 153.5 17.88 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.4 -3.313 . . . . 2.12 116.251 179.128 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.3 32.2 mt-10 65.11 31.45 10.99 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 125.223 1.409 . . . . 1.71 110.817 175.115 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.2 t -96.67 152.06 19.02 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 104.06 -2.57 . . . . 1.04 104.06 -175.458 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.3 m -109.95 109.53 20.17 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.781 -1.824 . . . . 0.79 113.84 178.515 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.1 mt -106.39 145.33 31.86 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 128.943 2.897 . . . . 1.4 109.384 176.407 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -109.41 127.52 54.44 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 114.239 -2.791 . . . . 1.51 112.72 -175.207 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.3 tp -93.81 120.89 34.67 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 123.444 2.838 . . . . 1.14 113.0 -175.517 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.9 t -110.62 149.42 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 108.101 -1.074 . . . . 1.23 108.101 175.923 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.2 mt . . . . . 0 N--CA 1.429 -1.478 0 CA-C-O 123.161 1.458 . . . . 2.78 114.531 -179.624 . . . . . . . . 0 0 . 1 . 069 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 CA--C 1.49 -1.331 0 CA-C-O 123.532 1.634 . . . . 1.1 113.204 . . . . . . . . . 0 0 . 1 . 069 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -106.29 125.48 51.05 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.886 -2.384 . . . . 1.87 111.088 -173.702 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.1 pt -120.82 165.58 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 106.266 -1.753 . . . . 0.72 106.266 169.584 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -120.11 139.54 52.43 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.27 -2.769 . . . . 1.4 114.814 -177.02 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.1 t -124.22 125.85 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 118.456 -2.652 . . . . 0.58 108.58 174.029 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -90.6 122.92 33.82 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.798 -4.314 . . . . 2.09 109.695 176.567 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.0 p -91.0 167.32 12.48 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 126.905 2.082 . . . . 0.99 114.828 -179.758 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.521 HD12 HD12 ' A' ' 71' ' ' LEU . 90.3 mt -69.64 -36.8 76.41 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 113.961 1.097 . . . . 2.53 113.961 179.607 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.2 p -74.39 -67.63 0.6 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 130.637 3.575 . . . . 2.08 111.808 -176.881 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.95 62.78 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.638 0 CA-C-O 115.37 -2.906 . . . . 1.31 117.596 171.644 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -150.71 139.16 20.47 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 125.725 2.679 . . . . 1.4 113.818 179.91 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.7 m -102.6 97.42 7.62 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 103.861 -2.644 . . . . 0.78 103.861 174.994 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 13' ' ' ILE . 2.6 mt -65.21 121.57 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 116.763 2.135 . . . . 1.55 116.763 176.184 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.4 m -84.94 105.94 16.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 122.572 2.442 . . . . 1.08 110.119 177.235 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.48 HD23 ' HE3' ' A' ' 33' ' ' LYS . 25.4 mt -101.11 133.77 45.13 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 123.44 1.591 . . . . 1.55 110.193 178.875 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -98.12 110.85 23.36 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 114.652 1.353 . . . . 1.95 114.652 166.909 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.9 m -127.08 176.36 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 128.169 2.588 . . . . 0.96 108.896 -174.8 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.417 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 79.1 mm-40 -116.18 163.76 20.42 Favored Pre-proline 0 N--CA 1.43 -1.455 0 C-N-CA 127.861 2.465 . . . . 2.35 106.56 161.777 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 17.7 Cg_endo -84.58 -6.91 9.82 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 O-C-N 116.569 -2.385 . . . . 0.95 109.751 -166.474 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.4 m -93.23 -6.28 48.0 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.501 2.037 . . . . 1.45 116.501 174.626 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -69.18 147.17 51.71 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 118.801 -1.16 . . . . 1.69 109.639 174.523 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 75.7 p -82.88 175.51 10.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.432 -2.043 . . . . 0.75 112.128 -178.72 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.8 mm -70.24 -42.89 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-O 123.918 1.818 . . . . 0.73 109.316 173.646 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -47.03 -47.77 22.29 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 119.022 2.971 . . . . 1.62 119.022 162.706 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -65.75 -38.18 88.38 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 116.174 -4.079 . . . . 2.13 114.132 174.958 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 56' ' ' LEU . 53.5 t -62.52 -39.31 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 126.758 3.171 . . . . 0.62 111.103 176.012 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -65.99 -33.43 75.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.586 -2.571 . . . . 1.22 114.094 174.131 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.59 -34.1 77.13 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.308 2.255 . . . . 0.51 115.004 173.739 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -74.67 -16.28 60.77 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.309 -2.744 . . . . 1.44 114.811 174.995 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.3 mt -87.0 -36.17 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 127.102 3.334 . . . . 1.32 107.487 171.657 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.97 -38.52 88.77 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.203 -2.811 . . . . 1.7 109.099 -178.274 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -55.93 -48.08 76.36 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.913 -2.992 . . . . 1.55 115.647 170.469 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HE3' HD23 ' A' ' 15' ' ' LEU . 61.9 mttm -79.37 -52.16 8.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.141 -1.6 . . . . 2.62 113.446 -176.243 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -112.44 -8.84 13.87 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.83 1.3 . . . . 1.48 110.386 -161.67 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.98 21.72 60.68 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 118.223 -2.798 . . . . 1.12 113.995 173.601 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mt -83.7 123.38 76.31 Favored Pre-proline 0 N--CA 1.431 -1.386 0 CA-C-O 112.655 -3.545 . . . . 1.55 115.342 -174.555 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -65.81 136.45 45.5 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 CA-C-N 127.199 3.607 . . . . 1.02 116.269 -179.69 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -60.71 -23.0 75.09 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 N-CA-C 117.383 2.032 . . . . 1.25 117.383 -177.286 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.17 -19.5 61.1 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.233 2.213 . . . . 2.25 109.9 177.716 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.418 ' HG2' HD22 ' A' ' 71' ' ' LEU . 17.4 tt0 -92.22 -39.84 11.32 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 130.271 3.428 . . . . 2.02 109.963 -170.654 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -74.45 123.77 25.32 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 113.458 -1.701 . . . . 0.69 113.863 -171.216 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -117.61 123.48 46.28 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 124.379 1.049 . . . . 2.78 109.216 167.792 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.5 mt -105.49 131.34 53.02 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.117 2.389 . . . . 1.17 106.264 -175.965 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.2 mm -116.9 145.57 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 120.349 -1.469 . . . . 1.38 113.49 -178.888 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -161.06 105.07 1.32 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.686 1.736 . . . . 1.5 115.686 174.821 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.468 . . 61.68 32.37 18.41 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 118.003 2.594 . . . . 1.21 118.003 -179.87 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.48 -15.55 45.86 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 119.163 0.892 . . . . 1.3 112.173 -177.497 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -102.46 124.71 48.51 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.732 -2.628 . . . . 2.55 115.277 174.694 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -81.3 145.97 30.63 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 102.714 -3.069 . . . . 2.48 102.714 165.129 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.3 mt -101.75 123.33 45.54 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 114.809 1.411 . . . . 0.9 114.809 -172.954 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.56 157.49 18.59 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 116.489 -2.085 . . . . 1.94 115.174 175.289 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.26 -63.55 1.19 Allowed 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 118.509 2.781 . . . . 1.56 118.509 -165.106 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.68 30.83 4.07 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 116.943 1.537 . . . . 0.97 116.943 176.418 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.7 mmt-85 -99.21 159.0 15.3 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 119.052 -1.059 . . . . 2.49 110.046 162.384 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.8 p -97.19 162.87 13.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.692 -3.755 . . . . 0.76 114.163 178.949 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.483 HD11 HG21 ' A' ' 26' ' ' VAL . 62.5 mt -58.24 -14.82 8.0 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 126.367 2.984 . . . . 1.05 113.864 170.436 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 t -85.12 -42.34 14.87 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.388 -2.695 . . . . 1.19 116.089 172.543 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -63.82 -39.48 94.34 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 127.833 2.453 . . . . 1.9 110.929 175.426 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -80.0 -8.7 59.49 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.784 2.034 . . . . 0.89 110.925 174.923 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.337 57.1 m-80 54.44 45.43 27.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.196 3.406 . . . . 1.84 120.196 -175.979 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.4 mm -78.68 123.99 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 126.132 1.773 . . . . 0.82 113.159 174.65 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -101.89 175.88 5.4 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 114.58 1.326 . . . . 2.16 114.58 -172.333 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -70.45 129.85 40.34 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 126.691 3.139 . . . . 2.12 112.537 -179.603 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.477 7.0 mt-10 67.7 35.99 3.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 125.499 2.571 . . . . 1.71 112.551 -179.858 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.301 4.4 t -94.63 126.94 40.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 109.559 -3.473 . . . . 1.04 110.29 -176.537 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.7 m -96.14 119.55 34.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.948 -1.72 . . . . 0.79 111.061 -169.845 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.5 mt -97.75 148.02 23.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 129.01 2.924 . . . . 1.4 108.745 175.249 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -106.71 137.42 44.76 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.744 -4.348 . . . . 1.51 106.264 178.566 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.5 tp -108.73 121.03 44.19 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.754 -3.091 . . . . 1.14 110.526 -178.106 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.0 t -109.85 153.6 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 130.969 3.707 . . . . 1.23 107.707 178.991 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.521 HD12 HD12 ' A' ' 8' ' ' LEU . 96.3 mt . . . . . 0 N--CA 1.429 -1.496 0 O-C-N 119.079 -2.263 . . . . 2.78 115.251 178.427 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 ptt? . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 115.09 1.515 . . . . 1.1 115.09 . . . . . . . . . 0 0 . 1 . 070 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -101.86 133.87 45.93 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.056 -1.652 . . . . 1.87 113.973 -172.652 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -130.77 159.93 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 104.321 -2.474 . . . . 0.72 104.321 174.275 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -119.55 120.87 38.0 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.065 2.946 . . . . 1.4 110.053 -174.111 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.421 HG21 HD11 ' A' ' 30' ' ' ILE . 94.9 t -105.69 115.19 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 119.889 -1.757 . . . . 0.58 110.439 172.979 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -96.37 134.21 39.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 103.639 -2.726 . . . . 2.09 103.639 179.626 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.269 28.0 p -80.86 169.85 17.04 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 118.044 -2.91 . . . . 0.99 112.665 171.813 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.4 mt -54.81 -49.64 70.52 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.961 3.305 . . . . 2.53 116.951 167.916 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.49 -62.26 1.47 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.408 3.004 . . . . 2.08 107.993 -172.029 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.78 12.27 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 116.929 -2.558 . . . . 1.31 116.78 179.618 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -101.01 154.43 18.71 Favored 'General case' 0 N--CA 1.429 -1.504 1 CA-C-N 126.147 4.974 . . . . 1.4 106.895 -169.148 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -113.04 108.91 17.97 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.426 -1.421 . . . . 0.78 108.928 167.063 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.405 ' CD1' HG23 ' A' ' 30' ' ' ILE . 46.9 mt -88.36 124.5 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 105.823 -1.918 . . . . 1.55 105.823 177.999 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.0 m -91.44 130.52 37.27 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 104.721 -2.325 . . . . 1.08 104.721 179.298 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mt -118.56 155.4 30.97 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 112.969 0.729 . . . . 1.55 112.969 179.685 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -113.03 130.14 56.25 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 100.596 -3.853 . . . . 1.95 100.596 167.765 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.1 m -143.95 156.35 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 126.39 1.876 . . . . 0.96 107.506 -176.805 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 36.1 mm-40 -114.21 154.46 46.26 Favored Pre-proline 0 N--CA 1.431 -1.416 0 C-N-CA 126.141 1.776 . . . . 2.35 110.036 168.042 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 53.4 Cg_exo -73.72 -25.7 14.4 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 CA-C-N 125.672 3.062 . . . . 0.95 117.195 -165.355 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -91.24 4.58 51.95 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 122.575 1.179 . . . . 1.45 113.657 177.984 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -64.77 149.43 49.3 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 115.018 -2.673 . . . . 1.69 112.649 165.995 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.319 21.6 p -87.03 169.45 12.41 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 116.049 -2.26 . . . . 0.75 112.743 177.656 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.91 -37.06 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 113.16 0.8 . . . . 0.73 113.16 171.185 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -57.42 -37.57 72.97 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.656 -3.152 . . . . 1.62 110.663 172.059 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -75.42 -28.12 59.27 Favored 'General case' 0 N--CA 1.43 -1.473 1 O-C-N 115.174 -4.704 . . . . 2.13 111.448 -179.217 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.9 t -71.07 -39.51 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.122 1.369 . . . . 0.62 112.474 172.239 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -63.83 -39.91 95.34 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 118.958 0.799 . . . . 1.22 111.97 170.966 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.14 68.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 119.977 3.325 . . . . 0.51 119.977 172.068 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -63.35 -35.44 80.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 115.32 -2.276 . . . . 1.44 112.91 165.856 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.421 HD11 HG21 ' A' ' 5' ' ' VAL . 15.3 mt -73.8 -40.17 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 123.138 2.699 . . . . 1.32 110.608 171.112 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -51.47 -45.89 62.92 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.671 2.788 . . . . 1.7 117.28 176.425 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -60.57 -28.83 68.77 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.433 -2.667 . . . . 1.55 116.279 174.957 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -94.93 -61.83 1.42 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 104.893 -2.262 . . . . 2.62 104.893 -173.139 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -98.87 -8.43 25.71 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 118.894 -2.378 . . . . 1.48 113.486 -169.744 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.76 5.64 89.68 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 118.389 -2.694 . . . . 1.12 113.365 174.695 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.1 mt -88.02 131.75 41.99 Favored Pre-proline 0 N--CA 1.429 -1.505 0 CA-C-N 121.523 2.662 . . . . 1.55 111.742 -175.086 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 74.0 Cg_exo -64.58 146.57 89.29 Favored 'Trans proline' 0 C--N 1.3 -1.993 1 CA-C-N 129.058 4.271 . . . . 1.02 118.274 -177.359 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 34.5 Cg_exo -68.33 -11.86 33.23 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 C-N-CA 123.029 2.486 . . . . 1.25 113.696 -177.581 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -77.87 -24.98 48.32 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.787 -3.696 . . . . 2.25 110.757 170.787 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -83.16 -39.71 20.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 116.352 -2.139 . . . . 2.02 108.49 176.67 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -63.93 125.8 25.6 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 126.611 1.965 . . . . 0.69 113.604 -172.171 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -118.9 118.52 31.75 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.158 -2.839 . . . . 2.78 108.19 170.708 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' A' ' 43' ' ' LEU . 68.6 mt -98.4 128.81 44.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.139 -2.225 . . . . 1.17 112.243 -174.788 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mm -110.05 137.57 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 125.386 1.474 . . . . 1.38 107.543 -179.812 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -146.61 144.59 29.64 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 125.963 1.705 . . . . 1.5 108.392 165.806 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.24 -107.53 0.15 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 123.832 0.707 . . . . 1.21 112.014 172.496 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.2 18.11 4.75 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 108.134 -1.987 . . . . 1.3 108.134 177.333 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -133.45 149.28 51.78 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.606 1.669 . . . . 2.55 114.455 177.114 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -93.67 130.65 39.54 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.238 -4.039 . . . . 2.48 103.831 174.271 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.336 79.4 mt -87.24 138.06 31.81 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.589 -1.944 . . . . 0.9 113.743 -168.485 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -85.8 164.08 17.77 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 117.85 -3.031 . . . . 1.94 111.671 -179.4 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -67.44 -62.89 1.2 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.315 -3.99 . . . . 1.56 118.931 -170.45 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.93 40.17 0.82 Allowed Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 129.495 3.426 . . . . 0.97 114.03 172.04 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -119.51 158.9 25.34 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.484 3.142 . . . . 2.49 105.605 168.179 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.4 p -100.09 164.17 12.1 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 125.76 1.912 . . . . 0.76 115.356 176.714 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.18 -43.95 97.68 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 117.851 -3.031 . . . . 1.05 109.947 178.667 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.0 m -53.6 -49.51 67.65 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.424 -3.297 . . . . 1.19 116.405 170.759 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -51.82 -39.29 58.54 Favored 'General case' 0 N--CA 1.429 -1.475 1 O-C-N 116.225 -4.047 . . . . 1.9 114.764 172.317 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -85.87 -13.01 49.24 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.325 1.972 . . . . 0.89 116.325 177.006 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.416 27.9 m120 75.03 23.39 1.65 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 124.163 1.935 . . . . 1.84 115.712 -177.772 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.9 mt -77.07 102.06 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 118.34 -2.725 . . . . 0.82 111.77 179.112 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -90.53 -178.99 5.46 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 125.814 2.721 . . . . 2.16 110.398 -176.389 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.4 pttp -66.46 151.69 46.68 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.163 -3.461 . . . . 2.12 113.007 174.396 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.522 90.5 mt-10 90.71 -15.55 0.22 Allowed 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.995 2.918 . . . . 1.71 115.356 -179.102 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.6 m -68.54 137.38 54.3 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.643 2.831 . . . . 1.04 118.643 -171.244 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.5 m -96.6 109.18 21.84 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 119.795 -1.816 . . . . 0.79 113.533 -179.468 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -92.79 163.66 13.64 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.74 3.15 . . . . 1.4 109.92 174.43 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.279 39.1 m80 -124.56 119.82 30.17 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.35 -1.295 . . . . 1.51 107.678 -173.347 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.492 HD21 HD21 ' A' ' 71' ' ' LEU 0.263 3.4 tt -91.71 104.67 17.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.496 -3.253 . . . . 1.14 115.567 -177.05 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.2 t -93.44 144.46 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 105.674 -1.973 . . . . 1.23 105.674 177.529 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.492 HD21 HD21 ' A' ' 69' ' ' LEU . 81.3 mt . . . . . 0 N--CA 1.431 -1.424 0 CA-C-O 125.601 2.62 . . . . 2.78 111.766 177.623 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptt? . . . . . 0 CA--C 1.49 -1.354 0 N-CA-C 107.393 -1.336 . . . . 1.1 107.393 . . . . . . . . . 0 0 . 1 . 071 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -94.23 126.92 39.77 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 114.134 1.161 . . . . 1.87 114.134 178.649 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.5 pt -115.91 163.08 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 107.628 -1.249 . . . . 0.72 107.628 165.886 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -125.05 132.65 53.16 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.984 -1.073 . . . . 1.4 108.111 -178.196 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.5 t -109.45 130.47 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 105.246 -2.131 . . . . 0.58 105.246 174.736 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -118.31 136.1 53.91 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.826 -2.421 . . . . 2.09 108.258 173.581 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.6 p -87.75 174.02 8.64 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 116.393 -3.942 . . . . 0.99 109.554 177.021 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.448 HD11 ' HA ' ' A' ' 70' ' ' VAL . 5.2 mt -73.43 -23.85 60.17 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 127.677 3.608 . . . . 2.53 117.802 172.193 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 p -88.98 -12.91 40.16 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.517 -3.239 . . . . 2.08 107.786 -175.08 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.4 32.53 3.93 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 115.519 0.968 . . . . 1.31 115.519 167.922 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -113.14 137.9 50.75 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 114.279 -2.968 . . . . 1.4 103.493 -178.228 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.271 32.9 m -109.01 125.2 51.82 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.484 2.088 . . . . 0.78 110.783 -179.129 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.7 mt -109.52 121.97 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.828 -3.045 . . . . 1.55 109.629 179.347 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.3 m -95.84 119.4 34.27 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 114.604 -5.06 . . . . 1.08 110.734 176.966 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.7 mt -126.99 138.97 53.35 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 116.953 -3.592 . . . . 1.55 117.49 -176.27 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -97.83 108.8 21.59 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.709 2.003 . . . . 1.95 109.683 178.781 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -120.11 157.23 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 128.283 2.633 . . . . 0.96 108.908 178.514 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -98.06 148.79 34.98 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-O 115.069 -2.396 . . . . 2.35 113.108 156.522 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.88 -13.77 34.83 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 125.29 3.993 . . . . 0.95 113.112 -172.459 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m -74.08 -25.76 60.0 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.705 1.878 . . . . 1.45 106.1 174.354 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -67.19 140.34 57.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.513 -2.617 . . . . 1.69 116.166 -179.828 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 50.7 p -83.28 161.16 21.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 111.397 -2.638 . . . . 0.75 113.094 -172.398 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.7 mm -59.09 -46.8 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 1 C-N-CA 134.742 5.217 . . . . 0.73 109.505 176.065 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -47.8 -40.08 19.99 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 127.084 2.154 . . . . 1.62 114.283 163.124 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -76.56 -24.64 53.57 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.765 -3.084 . . . . 2.13 116.71 176.304 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.3 t -74.63 -40.43 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 124.151 0.98 . . . . 0.62 111.733 173.996 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -61.38 -29.23 69.79 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.193 1.797 . . . . 1.22 113.249 173.357 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.22 -33.72 76.39 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.513 -1.992 . . . . 0.51 111.095 175.747 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.271 56.2 mttm -61.74 -43.05 99.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.475 -2.641 . . . . 1.44 114.985 176.287 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.0 mt -70.3 -33.87 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 C-N-CA 127.874 2.469 . . . . 1.32 109.364 175.402 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -64.14 -50.59 67.62 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 116.554 -3.841 . . . . 1.7 112.624 179.805 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -54.04 -49.7 68.38 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.293 2.637 . . . . 1.55 111.403 171.668 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -79.63 -61.23 2.06 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.55 2.426 . . . . 2.62 117.55 -178.478 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -87.3 -29.17 21.81 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.056 2.243 . . . . 1.48 117.056 -167.31 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.07 13.8 14.88 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 119.55 -1.309 . . . . 1.12 113.677 171.823 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.9 mt -96.14 119.67 64.08 Favored Pre-proline 0 N--CA 1.43 -1.434 1 CA-C-O 111.533 -4.079 . . . . 1.55 107.001 -171.053 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 67.8 Cg_endo -70.57 159.11 53.89 Favored 'Trans proline' 0 N--CA 1.433 -2.035 1 CA-C-N 129.31 4.361 . . . . 1.02 113.831 172.996 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 52.9 Cg_exo -68.37 -26.37 35.08 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 C-N-CA 122.784 2.323 . . . . 1.25 113.759 -173.131 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -56.47 -33.34 65.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.985 2.514 . . . . 2.25 110.151 174.108 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -98.65 19.79 14.07 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.248 1.944 . . . . 2.02 116.248 175.972 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -127.44 113.15 15.81 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.985 -1.117 . . . . 0.69 107.985 -175.501 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.416 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 14.0 tpp180 -110.28 127.74 55.16 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.797 -0.816 . . . . 2.78 108.797 173.857 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.5 mt -110.3 143.01 41.14 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 112.791 -3.48 . . . . 1.17 114.566 179.419 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.2 mt -128.65 143.24 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 129.031 3.957 . . . . 1.38 105.165 -174.28 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -155.1 136.3 13.95 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.162 -2.211 . . . . 1.5 105.779 168.912 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.251 . . 61.81 26.17 15.84 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 118.556 2.798 . . . . 1.21 118.556 175.837 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.2 -14.13 63.12 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-O 117.557 -1.691 . . . . 1.3 110.604 -173.867 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -97.66 126.95 43.26 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 125.602 1.413 . . . . 2.55 112.794 -171.599 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -80.67 112.31 17.92 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 124.811 2.243 . . . . 2.48 106.448 170.54 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.5 mt -74.67 124.85 27.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.92 2.888 . . . . 0.9 115.664 -176.222 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -87.68 142.11 28.08 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 118.733 2.864 . . . . 1.94 118.733 178.772 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -46.83 -66.77 0.36 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.948 2.499 . . . . 1.56 117.692 -173.072 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.56 35.87 0.84 Allowed Glycine 0 N--CA 1.43 -1.723 0 CA-C-O 125.033 2.463 . . . . 0.97 116.871 171.023 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -115.81 175.64 5.44 Favored 'General case' 0 N--CA 1.429 -1.507 1 O-C-N 113.785 -5.538 . . . . 2.49 107.956 166.299 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 60.0 p -106.95 -174.68 2.59 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.515 -1.99 . . . . 0.76 110.759 175.665 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mt -80.91 -37.01 30.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.877 2.071 . . . . 1.05 108.995 176.449 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.8 t -57.14 -48.4 78.78 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 128.235 3.459 . . . . 1.19 110.884 174.538 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -49.62 -29.7 7.62 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.203 3.038 . . . . 1.9 119.203 175.665 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -111.33 1.55 17.15 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.621 -1.299 . . . . 0.89 109.315 -179.577 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 61.77 40.05 13.36 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.954 2.902 . . . . 1.84 109.324 -178.176 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.9 mt -78.59 114.82 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 124.257 1.98 . . . . 0.82 107.489 172.852 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.473 ' HB3' ' H ' ' A' ' 63' ' ' LYS . 35.5 mt-30 -108.59 -158.58 0.65 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.049 -2.907 . . . . 2.16 115.608 -179.325 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.473 ' H ' ' HB3' ' A' ' 62' ' ' GLN 0.273 25.3 pttt -74.67 138.74 43.04 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.72 -2.487 . . . . 2.12 113.822 -179.235 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 71.87 31.2 2.13 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 124.723 2.201 . . . . 1.71 114.821 178.852 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.3 m -86.59 121.46 29.15 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 113.161 -1.836 . . . . 1.04 115.138 -178.786 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.1 m -92.88 120.48 33.27 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 118.0 -2.937 . . . . 0.79 107.382 176.028 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.1 mt -94.35 147.8 22.86 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.159 -1.837 . . . . 1.4 107.582 171.832 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -92.35 123.6 35.79 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.85 2.46 . . . . 1.51 108.34 176.941 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.47 117.54 31.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 122.257 2.299 . . . . 1.14 107.601 175.244 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.448 ' HA ' HD11 ' A' ' 8' ' ' LEU . 78.0 t -106.61 129.91 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 130.77 3.628 . . . . 1.23 102.672 -176.191 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.43 -1.443 0 O-C-N 118.446 -2.659 . . . . 2.78 114.129 171.266 . . . . . . . . 0 0 . 1 . 072 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ptt? . . . . . 0 CA--C 1.491 -1.323 0 N-CA-C 116.767 2.136 . . . . 1.1 116.767 . . . . . . . . . 0 0 . 1 . 072 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.293 19.6 mt-30 -107.47 129.52 54.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 103.941 -2.615 . . . . 1.87 103.941 -176.717 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.9 pt -113.79 153.89 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 117.524 -1.226 . . . . 0.72 110.795 165.623 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -107.02 147.64 29.68 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 122.389 1.09 . . . . 1.4 112.528 174.879 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.2 t -124.05 128.22 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.828 2.051 . . . . 0.58 108.105 176.488 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -107.31 144.93 33.45 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.319 -2.113 . . . . 2.09 106.432 178.822 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 p -89.19 -168.17 2.09 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.291 2.7 . . . . 0.99 118.291 179.796 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 mt -65.87 -52.89 46.35 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.956 1.703 . . . . 2.53 111.721 174.696 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.4 p -70.77 -52.59 19.69 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.081 -2.262 . . . . 2.08 115.428 -178.235 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.27 50.49 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 104.529 -3.428 . . . . 1.31 104.529 171.626 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -107.29 147.88 29.69 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.522 -2.752 . . . . 1.4 107.303 175.598 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.0 m -102.21 136.19 42.48 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 103.131 -2.915 . . . . 0.78 103.131 179.034 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.2 mt -122.75 120.75 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-O 125.371 2.51 . . . . 1.55 108.297 176.659 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.1 m -92.75 125.5 37.4 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.391 -2.693 . . . . 1.08 106.398 177.393 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 29' ' ' LYS . 68.5 mt -116.03 142.4 46.85 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 129.1 4.0 . . . . 1.55 112.657 170.452 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -98.73 123.73 43.13 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 120.656 1.571 . . . . 1.95 109.259 172.026 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.466 HG21 ' CD1' ' A' ' 56' ' ' LEU . 27.8 m -139.67 171.71 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 O-C-N 118.486 -2.634 . . . . 0.96 106.659 -177.788 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -121.47 162.15 37.66 Favored Pre-proline 0 N--CA 1.43 -1.468 0 N-CA-C 103.21 -2.885 . . . . 2.35 103.21 156.773 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -76.39 -3.4 13.77 Favored 'Trans proline' 0 N--CA 1.434 -1.971 0 C-N-CA 124.595 3.53 . . . . 0.95 111.192 -168.819 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.1 m -86.84 -5.25 59.16 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.614 3.102 . . . . 1.45 113.084 178.543 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -78.79 147.36 33.33 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.873 -3.642 . . . . 1.69 116.919 175.996 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 35.1 p -72.46 158.96 34.76 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 118.183 -0.913 . . . . 0.75 112.814 177.701 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.6 mm -67.87 -31.37 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 126.852 2.595 . . . . 0.73 112.813 173.713 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -60.47 -30.98 70.02 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.352 -2.718 . . . . 1.62 114.353 170.966 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -76.74 -35.82 57.52 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.846 -1.784 . . . . 2.13 109.41 176.037 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -69.82 -34.21 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 119.105 -2.247 . . . . 0.62 113.099 178.294 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -69.85 -18.18 63.42 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.114 -2.241 . . . . 1.22 115.869 170.783 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.07 -19.47 43.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.303 1.441 . . . . 0.51 112.474 -179.585 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.513 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.5 mttm -78.68 -33.4 47.02 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.171 1.788 . . . . 1.44 111.469 172.173 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.3 mt -76.53 -24.08 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 107.603 -1.258 . . . . 1.32 107.603 173.707 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -67.14 -32.08 72.95 Favored 'General case' 0 N--CA 1.429 -1.491 2 O-C-N 114.999 -4.813 . . . . 1.7 115.89 175.042 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -73.59 -31.12 63.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.836 -1.165 . . . . 1.55 112.09 166.795 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -83.66 -72.86 0.44 Allowed 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.45 -2.056 . . . . 2.62 105.45 -170.321 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -93.86 -7.62 42.7 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 115.574 1.694 . . . . 1.48 115.574 -167.309 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.76 16.22 77.98 Favored Glycine 0 N--CA 1.429 -1.782 0 O-C-N 117.679 -3.138 . . . . 1.12 115.74 176.729 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.1 mt -89.03 128.44 51.88 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 116.99 -3.653 . . . . 1.55 104.369 -178.977 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 17.0 Cg_exo -70.15 142.31 45.88 Favored 'Trans proline' 0 N--CA 1.433 -2.044 0 CA-C-N 126.671 3.418 . . . . 1.02 114.565 179.311 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 8.0 Cg_exo -58.1 -17.28 30.94 Favored 'Trans proline' 0 N--CA 1.434 -2.022 1 C-N-CA 126.345 4.696 . . . . 1.25 115.905 -176.942 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -75.82 -18.98 59.28 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.346 2.339 . . . . 2.25 116.33 170.337 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -97.37 2.37 50.44 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 121.272 1.851 . . . . 2.02 115.94 179.885 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -105.79 139.75 39.88 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 111.058 -2.792 . . . . 0.69 111.408 -172.225 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -132.73 122.5 24.67 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.174 2.19 . . . . 2.78 112.536 167.59 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.2 mt -88.11 138.86 31.07 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 106.459 -1.682 . . . . 1.17 106.459 174.082 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mt -119.96 132.68 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 127.424 2.29 . . . . 1.38 105.209 178.344 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -155.16 123.1 5.78 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.165 2.257 . . . . 1.5 110.39 170.54 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.284 . . 75.41 37.01 0.46 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.623 3.569 . . . . 1.21 114.152 176.449 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.05 -24.05 6.43 Favored Glycine 0 N--CA 1.43 -1.749 0 CA-C-O 115.777 -2.679 . . . . 1.3 112.412 -173.929 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -102.94 148.1 26.08 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 120.66 2.23 . . . . 2.55 112.102 -175.834 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -88.15 150.46 23.32 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 122.068 0.937 . . . . 2.48 109.542 171.926 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.1 mt -97.02 133.42 41.72 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.251 1.82 . . . . 0.9 108.715 -169.561 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -80.73 146.09 31.21 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.393 -1.276 . . . . 1.94 109.754 177.166 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -65.39 -59.21 4.26 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.211 -3.43 . . . . 1.56 120.092 -169.542 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.98 32.06 1.51 Allowed Glycine 0 N--CA 1.431 -1.692 0 CA-C-N 111.479 -2.601 . . . . 0.97 119.171 173.079 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -105.12 176.69 5.08 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 104.2 -2.518 . . . . 2.49 104.2 164.676 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 67.3 p -107.26 167.22 10.07 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 112.612 -2.085 . . . . 0.76 112.022 171.462 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.466 ' CD1' HG21 ' A' ' 17' ' ' VAL . 66.9 mt -67.07 -38.31 85.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.058 2.837 . . . . 1.05 113.637 175.678 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.9 t -69.01 -19.2 64.12 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 119.666 3.21 . . . . 1.19 119.666 173.842 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -58.7 -51.99 67.6 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 114.875 -2.488 . . . . 1.9 104.658 172.844 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -81.69 -8.57 59.72 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 129.404 3.081 . . . . 0.89 113.488 -176.053 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 m120 59.98 56.68 3.32 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 116.589 -3.819 . . . . 1.84 117.677 -173.461 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.418 HG21 HD11 ' A' ' 67' ' ' LEU . 62.2 mt -96.54 117.71 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 104.968 -2.234 . . . . 0.82 104.968 -178.284 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -97.71 -176.57 3.51 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.037 -2.289 . . . . 2.16 105.755 -171.85 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.5 pttt -65.85 151.69 46.11 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.644 2.64 . . . . 2.12 116.471 174.521 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 60.98 15.26 5.95 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 131.654 3.981 . . . . 1.71 114.213 176.02 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 t -76.16 150.22 37.19 Favored 'General case' 0 N--CA 1.429 -1.486 1 C-N-CA 132.318 4.247 . . . . 1.04 109.134 -177.541 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.6 m -103.49 105.47 15.74 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.587 -3.196 . . . . 0.79 113.19 -179.417 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.418 HD11 HG21 ' A' ' 61' ' ' ILE . 6.2 mp -82.77 168.38 17.24 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 106.126 -1.805 . . . . 1.4 106.126 170.902 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -121.56 135.57 55.0 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.31 -2.744 . . . . 1.51 108.867 -179.271 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.4 tp -109.16 117.37 33.95 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.08 2.848 . . . . 1.14 111.386 -177.594 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 t -105.96 146.28 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 1 O-C-N 115.932 -4.23 . . . . 1.23 112.22 174.474 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.9 mt . . . . . 0 N--CA 1.43 -1.452 0 N-CA-C 117.847 2.536 . . . . 2.78 117.847 178.512 . . . . . . . . 0 0 . 1 . 073 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.269 0.7 OUTLIER . . . . . 0 CA--C 1.491 -1.312 0 N-CA-C 104.38 -2.452 . . . . 1.1 104.38 . . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -89.86 127.73 36.05 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 117.263 -1.351 . . . . 1.87 107.557 -179.114 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.522 HD12 HD22 ' A' ' 67' ' ' LEU . 40.3 pt -115.11 138.83 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 122.105 2.23 . . . . 0.72 106.658 165.764 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -97.88 118.23 33.98 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.13 0.972 . . . . 1.4 109.794 -178.008 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.5 t -99.56 124.38 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.613 1.965 . . . . 0.58 106.289 174.069 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -117.62 126.92 53.38 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 125.189 1.396 . . . . 2.09 110.155 -175.395 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.289 7.3 p -74.49 176.01 7.23 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 128.485 2.714 . . . . 0.99 117.344 -179.364 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.9 tp -67.99 -56.11 10.19 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.95 1.705 . . . . 2.53 113.219 166.224 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 p -62.52 -53.02 61.01 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 118.462 2.764 . . . . 2.08 118.462 -176.378 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.79 30.09 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 119.122 2.409 . . . . 1.31 119.122 176.87 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -103.58 138.48 40.2 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 119.061 1.43 . . . . 1.4 107.89 176.697 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.1 m -105.09 118.93 37.78 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.194 -2.15 . . . . 0.78 105.194 169.019 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.6 mt -101.49 115.22 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 106.741 -1.577 . . . . 1.55 106.741 176.592 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.9 m -96.52 124.35 40.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 120.804 1.638 . . . . 1.08 112.493 176.004 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.268 84.0 mt -116.03 127.71 55.12 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 127.959 3.743 . . . . 1.55 109.688 -173.217 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -80.02 108.21 13.43 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.1 -3.5 . . . . 1.95 114.68 168.723 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.87 160.87 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 125.373 1.469 . . . . 0.96 111.982 -179.082 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -97.46 161.44 25.96 Favored Pre-proline 0 N--CA 1.431 -1.388 0 C-N-CA 127.794 2.437 . . . . 2.35 107.065 159.852 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -71.14 -15.77 31.98 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 C-N-CA 124.164 3.243 . . . . 0.95 112.29 179.064 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 p -83.38 -2.6 56.16 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.347 1.459 . . . . 1.45 112.503 174.746 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -77.82 140.89 39.44 Favored 'General case' 0 N--CA 1.431 -1.4 1 O-C-N 116.216 -4.053 . . . . 1.69 110.579 169.805 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.361 22.9 p -81.05 176.23 9.99 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 110.759 -2.928 . . . . 0.75 114.892 179.717 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -85.76 -20.77 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 CA-C-N 121.252 1.842 . . . . 0.73 108.526 175.581 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -56.01 -38.27 70.28 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.103 2.561 . . . . 1.62 113.058 165.37 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -71.88 -33.23 68.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.05 2.14 . . . . 2.13 114.961 176.348 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.327 79.1 t -65.33 -48.23 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 C-N-CA 128.065 2.546 . . . . 0.62 110.067 173.841 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -69.96 -26.81 64.28 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.945 -2.347 . . . . 1.22 115.552 174.703 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.75 -37.07 83.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.282 -2.761 . . . . 0.51 113.37 171.445 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.1 mttm -65.37 -51.61 59.26 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.91 -1.744 . . . . 1.44 114.356 176.2 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.7 mt -51.81 -37.43 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 128.064 3.792 . . . . 1.32 113.549 170.723 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -63.24 -44.56 94.86 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 114.748 -4.97 . . . . 1.7 118.308 170.001 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -55.57 -49.55 72.41 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 114.736 1.384 . . . . 1.55 114.736 167.831 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -74.71 -65.58 0.85 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.763 -2.017 . . . . 2.62 107.572 -170.075 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.261 13.8 mm-40 -85.21 -51.75 6.39 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.87 1.804 . . . . 1.48 115.87 -171.119 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.91 9.51 5.2 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 117.628 1.811 . . . . 1.12 117.628 -178.706 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.0 mt -87.82 135.35 33.86 Favored Pre-proline 0 N--CA 1.429 -1.5 0 CA-C-O 113.967 -2.92 . . . . 1.55 112.018 -173.224 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 51.4 Cg_endo -78.32 157.71 29.51 Favored 'Trans proline' 0 N--CA 1.434 -1.991 0 CA-C-N 124.632 2.69 . . . . 1.02 108.71 -178.944 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 29.0 Cg_exo -64.02 -17.09 58.45 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 125.08 3.854 . . . . 1.25 114.257 -178.235 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -67.21 -49.17 65.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 129.879 3.272 . . . . 2.25 111.868 175.768 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -70.95 -31.67 68.32 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.647 -2.533 . . . . 2.02 110.495 -175.951 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -80.01 120.12 23.76 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 130.025 3.33 . . . . 0.69 113.902 -175.095 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -113.63 123.67 50.48 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.221 -2.14 . . . . 2.78 105.221 167.507 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -108.34 126.3 52.69 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 102.984 -2.969 . . . . 1.17 102.984 178.822 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 68' ' ' HIS 0.253 37.8 mm -112.71 154.21 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 131.549 3.94 . . . . 1.38 106.255 177.592 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -114.4 -94.01 0.48 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.535 -3.228 . . . . 1.5 102.744 175.307 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.38 -65.78 0.98 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 119.656 -0.818 . . . . 1.21 109.95 177.254 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.63 -13.43 0.73 Allowed Glycine 0 N--CA 1.429 -1.802 0 O-C-N 117.534 -3.229 . . . . 1.3 114.789 -173.705 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -105.95 150.44 25.67 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.828 2.051 . . . . 2.55 110.988 175.789 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -77.16 138.3 39.4 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 130.83 3.652 . . . . 2.48 110.033 178.774 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.4 mt -82.9 160.14 22.18 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.138 -1.601 . . . . 0.9 113.796 -176.478 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -102.99 151.51 22.39 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.981 1.712 . . . . 1.94 109.967 176.755 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.377 30.1 m-20 -75.02 -63.29 1.3 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 112.988 0.736 . . . . 1.56 112.988 -167.294 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.45 55.97 4.72 Favored Glycine 0 N--CA 1.431 -1.665 0 O-C-N 118.631 -2.543 . . . . 0.97 112.3 178.641 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -120.58 161.08 21.94 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 102.62 -3.104 . . . . 2.49 102.62 162.259 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 81.0 p -90.67 164.19 14.25 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.351 2.5 . . . . 0.76 109.23 168.251 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.9 mt -59.03 -34.43 71.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.658 2.783 . . . . 1.05 115.15 167.309 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.8 p -70.99 -21.51 62.3 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 114.606 1.335 . . . . 1.19 114.606 179.221 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -69.99 -34.54 73.47 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.8 2.84 . . . . 1.9 108.969 175.69 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -96.74 15.88 20.67 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.182 2.896 . . . . 0.89 112.964 176.458 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 m120 57.29 25.19 10.84 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 111.298 -2.683 . . . . 1.84 116.97 174.028 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.8 mt -81.63 98.97 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 106.043 -1.836 . . . . 0.82 106.043 178.629 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -112.92 -39.06 4.34 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.795 2.838 . . . . 2.16 104.569 -174.83 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -101.16 171.83 7.38 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.324 1.601 . . . . 2.12 115.324 167.294 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -45.11 103.05 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 129.953 3.301 . . . . 1.71 116.12 168.581 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.6 m -123.13 159.53 28.37 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.469 -4.519 . . . . 1.04 116.75 -175.952 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.2 m -101.88 126.79 48.85 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.843 -1.786 . . . . 0.79 111.822 -175.552 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.522 HD22 HD12 ' A' ' 3' ' ' ILE . 8.5 mp -107.56 142.6 37.22 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.847 3.659 . . . . 1.4 112.327 176.814 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.405 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 49.6 m80 -116.03 117.69 30.8 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.634 -1.917 . . . . 1.51 109.404 -175.469 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.1 tp -87.62 123.43 32.47 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.971 1.367 . . . . 1.14 111.057 -176.894 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.0 t -122.84 136.66 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.181 -2.2 . . . . 1.23 108.488 176.416 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.1 mt . . . . . 0 N--CA 1.43 -1.448 0 O-C-N 118.37 -2.706 . . . . 2.78 113.007 -174.165 . . . . . . . . 0 0 . 1 . 074 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.351 0 CA-C-O 116.147 -1.882 . . . . 1.1 113.619 . . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -119.22 125.92 50.3 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 120.403 1.456 . . . . 1.87 112.87 -178.028 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.9 pt -121.95 162.75 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 125.89 2.757 . . . . 0.72 107.241 170.582 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -103.89 149.04 25.45 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.5 2.32 . . . . 1.4 110.737 178.064 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.283 49.4 t -119.0 121.97 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 126.792 2.558 . . . . 0.58 106.071 171.067 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.7 tttt -101.9 140.13 36.6 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 126.53 2.394 . . . . 2.09 112.88 177.708 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.9 p -96.97 173.67 7.16 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.327 -2.733 . . . . 0.99 108.092 174.328 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.8 mt -56.61 -57.62 11.6 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.692 -1.88 . . . . 2.53 112.649 167.279 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.1 p -61.46 -30.69 70.75 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 117.66 2.467 . . . . 2.08 117.66 -179.244 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.87 15.91 1.31 Allowed Glycine 0 N--CA 1.429 -1.817 0 CA-C-O 114.784 -3.231 . . . . 1.31 114.715 170.004 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.0 tttt -90.13 115.23 27.22 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 122.768 3.284 . . . . 1.4 106.874 -173.573 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 m -87.16 115.35 24.49 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 113.926 -1.488 . . . . 0.78 113.543 175.454 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mt -103.07 127.46 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 116.533 2.049 . . . . 1.55 116.533 176.302 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.4 m -89.09 105.58 17.88 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 116.687 -3.758 . . . . 1.08 111.456 -174.974 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.9 mt -112.38 127.6 56.06 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 125.186 2.422 . . . . 1.55 110.378 178.537 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -92.74 117.14 29.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.543 3.068 . . . . 1.95 108.422 170.47 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 m -127.1 178.32 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 111.962 -2.381 . . . . 0.96 112.5 -179.444 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -105.38 154.14 39.21 Favored Pre-proline 0 N--CA 1.43 -1.441 0 C-N-CA 126.963 2.105 . . . . 2.35 109.846 165.241 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.11 -14.2 23.45 Favored 'Trans proline' 0 C--N 1.299 -2.028 1 CA-C-N 128.307 4.003 . . . . 0.95 107.157 -177.462 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 m -86.69 -4.88 59.23 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 115.08 1.511 . . . . 1.45 115.08 177.728 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -64.09 146.8 53.56 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.15 -2.219 . . . . 1.69 112.451 174.259 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 15.8 p -89.77 161.86 15.82 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 119.731 -1.855 . . . . 0.75 112.793 172.963 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.7 mm -58.51 -22.64 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.287 -3.383 . . . . 0.73 117.772 174.679 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.09 -59.13 5.54 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 117.857 -3.027 . . . . 1.62 110.985 161.745 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -51.98 -50.24 61.66 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.077 2.151 . . . . 2.13 111.687 176.616 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -61.51 -49.4 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 119.816 -1.802 . . . . 0.62 111.88 -177.9 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -68.53 -19.7 64.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 124.064 3.12 . . . . 1.22 112.238 175.585 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.12 -27.3 63.48 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.394 -2.066 . . . . 0.51 109.293 173.923 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -68.12 -48.18 66.13 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.835 2.054 . . . . 1.44 110.628 171.823 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mt -59.91 -36.06 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 113.794 1.035 . . . . 1.32 113.794 173.033 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -60.22 -43.65 95.84 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.633 -3.167 . . . . 1.7 114.496 175.121 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -47.06 -58.91 3.51 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.635 -3.791 . . . . 1.55 115.758 166.861 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -71.29 -53.56 13.84 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.707 -1.87 . . . . 2.62 113.257 -176.57 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -92.4 -58.89 2.23 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 125.002 1.439 . . . . 1.48 108.385 -167.091 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.53 -0.16 2.74 Favored Glycine 0 N--CA 1.429 -1.782 0 O-C-N 119.698 -1.877 . . . . 1.12 111.72 176.191 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.0 mt -74.46 128.78 85.24 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 114.094 -2.86 . . . . 1.55 113.29 -169.277 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -63.61 151.04 86.92 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 CA-C-N 122.618 1.971 . . . . 1.02 113.856 175.037 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.29 -4.46 15.1 Favored 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 124.188 3.259 . . . . 1.25 118.704 -178.883 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -80.55 -29.53 37.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 126.264 2.228 . . . . 2.25 114.799 170.751 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -79.37 -40.26 30.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.723 2.202 . . . . 2.02 111.784 177.593 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -70.04 95.94 1.01 Allowed 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 114.743 -4.973 . . . . 0.69 115.616 -171.186 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -90.66 132.22 35.9 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 118.526 -2.609 . . . . 2.78 107.589 172.219 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.5 mt -111.06 120.4 42.24 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.813 1.768 . . . . 1.17 110.589 178.449 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.9 mt -102.83 128.64 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 120.476 -1.39 . . . . 1.38 108.919 172.936 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -82.14 -76.85 0.24 Allowed 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.13 2.395 . . . . 1.5 108.673 174.245 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -96.04 -60.07 1.71 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.53 1.532 . . . . 1.21 110.565 -179.004 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.91 -48.01 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.806 0 CA-C-O 122.379 0.989 . . . . 1.3 112.377 -172.522 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -81.09 141.98 33.76 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.246 -1.149 . . . . 2.55 111.037 179.927 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 pm0 -77.38 152.19 34.51 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 117.285 -1.766 . . . . 2.48 111.915 176.761 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.0 mt -98.39 136.96 37.8 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 116.649 -2.02 . . . . 0.9 113.929 -167.047 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.03 144.71 48.71 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.538 2.335 . . . . 1.94 115.499 172.461 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -64.55 -56.19 15.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.805 3.642 . . . . 1.56 114.752 -175.578 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.47 64.37 3.99 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 121.072 3.189 . . . . 0.97 121.072 170.31 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -135.35 158.39 44.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.17 1.788 . . . . 2.49 106.651 161.651 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.259 17.0 p -80.72 164.94 22.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 117.659 2.466 . . . . 0.76 117.659 174.478 . . . . . . . . 3 3 . 1 . 074 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.2 mt -64.56 -33.8 76.76 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.388 -2.07 . . . . 1.05 113.118 175.791 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 t -68.79 -31.37 70.34 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.079 2.152 . . . . 1.19 116.337 177.096 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -57.24 -37.07 71.74 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 120.86 -1.15 . . . . 1.9 111.774 171.369 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -77.59 3.81 12.83 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 118.305 2.706 . . . . 0.89 118.305 174.63 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.66 17.3 m-80 81.76 12.01 0.69 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.034 2.605 . . . . 1.84 118.034 178.686 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.43 HG23 ' HB2' ' A' ' 65' ' ' SER . 9.2 mt -91.51 102.84 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 118.949 -2.344 . . . . 0.82 111.827 178.135 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -106.49 -26.21 11.52 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.739 1.615 . . . . 2.16 108.294 -171.555 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.5 tttp -137.66 -91.99 0.22 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 117.317 2.339 . . . . 2.12 117.317 175.918 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.14 126.09 49.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 121.284 -0.885 . . . . 1.71 111.518 -176.125 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.43 ' HB2' HG23 ' A' ' 61' ' ' ILE . 21.3 t -146.8 145.48 29.92 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.587 -1.188 . . . . 1.04 114.09 -173.714 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.9 m -118.43 109.09 15.83 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.714 -3.116 . . . . 0.79 103.673 179.752 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.6 mt -93.36 154.87 17.72 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.23 -2.137 . . . . 1.4 105.23 173.336 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -118.49 117.05 27.98 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.394 1.092 . . . . 1.51 113.472 -175.258 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.3 tp -79.59 94.62 5.69 Favored 'General case' 0 N--CA 1.43 -1.428 1 C-N-CA 132.904 4.481 . . . . 1.14 107.974 -171.728 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.27 121.44 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 C-N-CA 127.981 2.512 . . . . 1.23 108.613 175.716 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 N--CA 1.429 -1.48 0 CA-C-O 116.499 -1.715 . . . . 2.78 111.665 176.61 . . . . . . . . 0 0 . 1 . 075 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.491 -1.311 0 CA-C-O 118.621 -0.704 . . . . 1.1 110.359 . . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -100.56 122.37 43.14 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 119.57 1.077 . . . . 1.87 112.678 177.176 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.258 21.6 pt -106.97 147.57 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 118.188 -2.82 . . . . 0.72 109.551 -179.341 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -105.17 117.94 35.28 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 117.746 -3.096 . . . . 1.4 107.412 -177.683 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.3 t -99.55 96.41 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 120.09 -1.631 . . . . 0.58 108.825 173.219 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -78.99 112.23 15.98 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.762 2.425 . . . . 2.09 107.051 176.409 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.479 HG22 HD23 ' A' ' 69' ' ' LEU . 80.8 p -75.99 166.45 23.48 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 116.315 1.969 . . . . 0.99 116.315 -179.382 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.8 tp -54.54 -39.86 68.1 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 127.393 2.277 . . . . 2.53 110.336 161.753 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.0 p -75.82 -30.17 58.92 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.114 -1.616 . . . . 2.08 111.64 -178.985 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.32 38.78 1.59 Allowed Glycine 0 N--CA 1.43 -1.721 0 CA-C-O 124.385 2.103 . . . . 1.31 113.657 177.571 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -120.53 121.26 38.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 104.671 -2.344 . . . . 1.4 104.671 178.132 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.284 85.6 m -73.0 101.95 3.36 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 112.849 -1.978 . . . . 0.78 112.909 171.16 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 mt -96.62 128.34 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 105.33 -2.1 . . . . 1.55 105.33 -179.08 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.8 m -99.73 119.47 38.19 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.133 -1.062 . . . . 1.08 108.133 175.185 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.8 mt -120.29 128.93 53.75 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 127.837 2.455 . . . . 1.55 109.586 176.207 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -74.48 131.69 41.24 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.713 3.227 . . . . 1.95 119.713 162.939 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.2 m -139.26 176.69 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.718 -1.239 . . . . 0.96 113.62 174.193 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -101.84 163.33 18.0 Favored Pre-proline 0 N--CA 1.429 -1.494 0 O-C-N 116.98 -3.575 . . . . 2.35 104.781 160.123 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -77.83 -10.36 16.89 Favored 'Trans proline' 0 N--CA 1.433 -2.043 0 O-C-N 116.802 -2.262 . . . . 0.95 109.325 -179.582 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -79.9 -12.26 59.75 Favored 'General case' 0 N--CA 1.428 -1.531 1 O-C-N 116.002 -4.187 . . . . 1.45 116.882 174.55 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -76.16 151.59 36.91 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.559 1.647 . . . . 1.69 114.3 176.516 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.2 p -80.77 161.25 24.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.908 -1.745 . . . . 0.75 114.13 -177.79 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.0 mt -70.99 -35.99 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 120.428 -1.42 . . . . 0.73 109.374 174.35 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -49.31 -38.81 29.0 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.463 2.705 . . . . 1.62 112.374 162.255 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -70.79 -52.14 22.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.905 -2.997 . . . . 2.13 105.41 179.142 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.284 42.2 t -47.68 -57.56 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-N 121.797 2.09 . . . . 0.62 115.446 166.945 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -60.28 -31.19 70.0 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.103 -3.498 . . . . 1.22 112.307 179.094 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.7 -27.76 58.36 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 124.482 3.31 . . . . 0.51 111.343 -179.404 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.268 35.1 mttm -74.97 -26.84 59.88 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.592 2.757 . . . . 1.44 111.169 173.394 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.2 mt -69.41 -45.53 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 C-N-CA 128.9 2.88 . . . . 1.32 104.911 171.862 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -58.05 -39.35 78.23 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.484 2.313 . . . . 1.7 113.265 176.595 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.53 -56.07 21.44 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 127.203 3.382 . . . . 1.55 111.676 173.265 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -80.81 -58.84 2.91 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.604 -3.81 . . . . 2.62 113.332 -174.038 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -83.62 -50.61 8.04 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.595 -3.191 . . . . 1.48 111.786 -172.535 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.64 73.04 1.27 Allowed Glycine 0 N--CA 1.43 -1.701 0 CA-C-O 125.649 2.805 . . . . 1.12 110.203 179.963 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.9 mt -132.72 128.77 21.0 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-O 113.435 -3.174 . . . . 1.55 103.347 178.341 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -64.54 160.55 39.24 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 125.742 3.087 . . . . 1.02 117.115 179.944 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.01 -26.65 12.82 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 123.058 2.128 . . . . 1.25 111.018 -174.552 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.18 -39.15 81.63 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 117.882 -1.056 . . . . 2.25 112.766 171.203 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -83.78 -1.89 55.2 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 123.011 2.641 . . . . 2.02 112.593 -179.849 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -93.06 122.75 35.74 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 120.938 1.699 . . . . 0.69 108.712 -176.032 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -115.3 114.78 25.63 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 114.347 -1.297 . . . . 2.78 108.035 165.607 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.5 mt -98.63 122.59 42.03 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 123.774 1.749 . . . . 1.17 107.57 -179.264 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.3 mm -106.2 139.24 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 118.614 -2.554 . . . . 1.38 104.708 179.314 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -103.43 -92.67 0.34 Allowed 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 119.61 -1.931 . . . . 1.5 110.234 173.992 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.96 -84.29 0.51 Allowed 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.843 -1.91 . . . . 1.21 105.843 179.844 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.74 7.59 22.05 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 126.809 2.568 . . . . 1.3 112.361 -170.352 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -139.38 155.99 47.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.167 -1.784 . . . . 2.55 110.438 178.28 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -83.23 148.58 27.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.814 -1.178 . . . . 2.48 111.756 166.76 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.1 mt -86.75 131.14 34.21 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 119.26 -2.15 . . . . 0.9 110.806 -176.486 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -84.82 136.88 33.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.417 2.687 . . . . 1.94 110.405 175.016 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.39 -51.56 59.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.366 -3.334 . . . . 1.56 114.398 -167.088 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.61 26.38 2.71 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 123.293 2.769 . . . . 0.97 115.387 171.87 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -105.46 171.69 7.19 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.489 1.138 . . . . 2.49 110.813 165.539 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.6 p -98.82 172.43 7.45 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 127.852 3.691 . . . . 0.76 111.365 167.701 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.6 mt -64.0 -44.45 92.58 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 111.99 -2.368 . . . . 1.05 109.779 171.397 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 t -57.88 -37.45 73.98 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 116.851 2.167 . . . . 1.19 116.851 176.879 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -53.36 -21.66 6.14 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.741 -2.474 . . . . 1.9 113.497 175.687 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -112.27 22.14 15.04 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.5 -2.625 . . . . 0.89 113.206 177.334 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.504 1.0 OUTLIER 61.37 31.95 19.16 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 119.705 3.224 . . . . 1.84 119.705 177.968 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.317 57.4 mt -86.2 125.8 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 118.322 -2.736 . . . . 0.82 105.009 177.968 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -148.77 -51.06 0.16 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.792 -2.442 . . . . 2.16 110.08 -170.831 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.4 tptp -79.47 -173.17 3.6 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 113.633 0.975 . . . . 2.12 113.633 169.352 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -73.05 95.88 2.09 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.123 2.392 . . . . 1.71 116.304 175.84 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.5 m -94.27 160.12 14.82 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 120.922 3.675 . . . . 1.04 120.922 -169.991 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.9 m -106.92 119.19 38.68 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 117.185 -1.388 . . . . 0.79 110.104 177.91 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -105.32 160.95 14.72 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 125.651 1.844 . . . . 1.4 106.61 168.471 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -127.08 124.47 39.31 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.273 -2.142 . . . . 1.51 108.864 -177.946 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 7' ' ' THR . 45.4 tp -99.55 112.17 24.42 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.059 1.344 . . . . 1.14 110.63 -174.42 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.1 t -97.6 120.56 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 C-N-CA 130.497 3.519 . . . . 1.23 112.737 174.018 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.4 mt . . . . . 0 N--CA 1.43 -1.437 0 C-N-CA 118.21 -1.396 . . . . 2.78 107.758 -177.787 . . . . . . . . 0 0 . 1 . 076 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ttp . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 118.662 2.838 . . . . 1.1 118.662 . . . . . . . . . 0 0 . 1 . 076 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -97.71 112.91 24.61 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.138 1.923 . . . . 1.87 109.623 -178.172 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.463 HG12 HG22 ' A' ' 17' ' ' VAL . 5.0 pt -109.14 146.77 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.038 -2.914 . . . . 0.72 109.368 175.083 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -106.32 124.06 49.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.091 2.956 . . . . 1.4 113.38 175.33 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.412 HG22 ' HB2' ' A' ' 67' ' ' LEU . 85.3 t -105.45 113.58 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 114.76 -1.109 . . . . 0.58 111.375 178.819 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -85.95 135.56 33.62 Favored 'General case' 0 N--CA 1.431 -1.423 2 O-C-N 113.041 -6.037 . . . . 2.09 115.826 179.038 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 p -99.1 173.11 6.97 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.653 -1.28 . . . . 0.99 109.708 178.797 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 tt -56.14 -49.14 74.77 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.22 1.008 . . . . 2.53 111.576 174.686 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -77.29 4.33 10.91 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.04 -2.287 . . . . 2.08 115.261 -177.425 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.16 17.63 46.17 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 119.497 2.559 . . . . 1.31 119.497 177.523 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -99.63 145.55 27.45 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 120.413 2.106 . . . . 1.4 109.939 -177.767 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.3 m -105.43 126.55 52.25 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.755 -1.216 . . . . 0.78 108.019 -173.036 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.9 mt -100.9 107.1 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.814 -3.054 . . . . 1.55 106.265 178.645 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 m -91.19 126.34 36.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.1 1.905 . . . . 1.08 108.021 -175.444 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.0 mt -126.63 160.75 29.81 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.867 2.867 . . . . 1.55 109.241 -178.473 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.342 43.6 mt-10 -122.85 115.62 22.29 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 125.658 2.647 . . . . 1.95 108.922 170.094 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.463 HG22 HG12 ' A' ' 3' ' ' ILE . 27.6 m -123.21 163.6 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 117.242 -3.411 . . . . 0.96 113.619 -178.591 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -98.2 145.45 29.85 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-O 116.634 -1.65 . . . . 2.35 112.816 162.735 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.49 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 21.1 Cg_exo -63.91 -9.87 20.67 Favored 'Trans proline' 0 N--CA 1.434 -1.999 2 CA-C-N 129.993 4.605 . . . . 0.95 114.149 -179.495 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.6 p -84.57 -0.2 52.36 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 127.189 3.376 . . . . 1.45 116.099 173.526 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -80.67 156.01 26.53 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.816 -2.428 . . . . 1.69 106.356 176.0 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 p -104.37 165.77 10.84 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.52 -1.218 . . . . 0.75 113.245 176.292 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -58.43 -41.4 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.183 2.193 . . . . 0.73 112.496 176.695 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -44.17 -60.59 1.82 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.491 3.145 . . . . 1.62 119.491 162.024 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -58.96 -33.31 70.5 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 115.059 1.503 . . . . 2.13 115.059 177.85 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.23 -47.83 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 131.626 3.97 . . . . 0.62 115.406 172.478 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.33 27.1 mtmt -69.45 -32.43 71.37 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 111.561 -2.563 . . . . 1.22 110.944 177.946 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.66 -26.32 65.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.255 1.822 . . . . 0.51 113.537 171.79 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -75.97 -42.71 47.58 Favored 'General case' 0 N--CA 1.431 -1.411 1 C-N-CA 131.972 4.109 . . . . 1.44 108.427 -179.859 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt -61.08 -36.0 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 1 O-C-N 116.207 -4.058 . . . . 1.32 113.524 169.068 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -62.44 -37.54 86.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.052 2.541 . . . . 1.7 111.88 172.54 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.6 -52.18 41.48 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 119.548 3.166 . . . . 1.55 119.548 166.928 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -69.4 -51.5 35.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.662 1.185 . . . . 2.62 112.193 -176.546 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -110.34 -25.38 10.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.161 1.784 . . . . 1.48 112.159 -169.453 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.26 39.94 5.26 Favored Glycine 0 N--CA 1.429 -1.773 0 O-C-N 118.363 -2.711 . . . . 1.12 115.255 175.985 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.5 mt -117.97 126.65 27.14 Favored Pre-proline 0 N--CA 1.429 -1.483 0 CA-C-O 116.836 -1.554 . . . . 1.55 111.775 -174.111 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -63.78 145.39 90.78 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 CA-C-N 127.145 3.588 . . . . 1.02 116.932 178.283 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -66.72 -25.23 46.59 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 CA-C-N 120.686 1.281 . . . . 1.25 113.279 -175.137 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -70.78 -13.8 62.19 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 120.398 3.481 . . . . 2.25 120.398 177.476 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -84.76 -36.88 21.46 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 127.866 3.229 . . . . 2.02 108.165 174.043 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -76.91 108.88 10.27 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.067 2.365 . . . . 0.69 113.422 -173.378 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.425 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 56.2 mtt180 -102.19 114.76 29.18 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 114.611 -5.055 . . . . 2.78 110.756 162.725 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 43' ' ' LEU . 64.9 mt -100.53 123.43 44.74 Favored 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 116.035 -4.166 . . . . 1.17 111.922 -177.687 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.496 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 33.9 mm -109.4 136.33 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 112.255 -2.248 . . . . 1.38 110.635 -177.654 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -99.42 -88.05 0.35 Allowed 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.742 -1.849 . . . . 1.5 109.571 172.404 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -113.02 -8.63 13.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 126.595 3.093 . . . . 1.21 113.151 -176.186 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.14 -40.04 0.17 Allowed Glycine 0 N--CA 1.429 -1.816 1 N-CA-C 102.958 -4.057 . . . . 1.3 102.958 -178.37 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -75.96 150.57 37.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.47 1.605 . . . . 2.55 114.39 175.424 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -84.25 134.06 34.55 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.858 -3.026 . . . . 2.48 107.532 170.67 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.2 mt -82.38 124.94 30.47 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 129.208 4.068 . . . . 0.9 105.448 -173.715 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -80.25 140.86 36.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.364 3.468 . . . . 1.94 120.364 174.082 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.94 -62.82 1.39 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 116.479 2.029 . . . . 1.56 116.479 -170.723 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.1 56.68 4.97 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 118.512 2.165 . . . . 0.97 118.512 173.056 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.266 50.5 mmt-85 -133.35 151.57 51.86 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 107.623 -1.251 . . . . 2.49 107.623 169.108 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 4.5 p -74.2 169.04 18.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 127.027 3.299 . . . . 0.76 118.141 174.172 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.49 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 94.3 mt -74.4 -34.93 63.42 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.536 -4.477 . . . . 1.05 113.279 173.764 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -66.52 -49.19 67.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.127 -2.76 . . . . 1.19 108.891 178.529 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -42.1 -45.16 3.89 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 120.258 3.429 . . . . 1.9 120.258 173.788 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -82.25 -20.81 36.86 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 115.988 1.847 . . . . 0.89 115.988 179.472 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 80.26 50.16 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 128.001 2.521 . . . . 1.84 111.057 -175.022 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.2 mt -93.2 115.94 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 124.809 1.244 . . . . 0.82 109.519 170.814 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -108.18 -174.86 2.62 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.991 2.116 . . . . 2.16 111.577 -167.197 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -65.58 -34.75 78.96 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.819 1.295 . . . . 2.12 112.821 172.066 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.258 13.5 pt-20 -77.04 -12.14 59.9 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.067 -2.896 . . . . 1.71 115.957 178.455 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.314 19.0 m -82.01 139.86 34.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 114.827 1.417 . . . . 1.04 114.827 -167.437 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.4 m -107.11 124.15 49.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.218 1.807 . . . . 0.79 111.609 -179.495 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.412 ' HB2' HG22 ' A' ' 5' ' ' VAL . 8.6 mp -96.85 149.5 21.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 123.198 2.726 . . . . 1.4 106.269 178.13 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.496 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 57.9 m80 -110.34 131.05 55.4 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.48 1.609 . . . . 1.51 113.413 176.735 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 43' ' ' LEU . 51.8 tp -110.14 135.57 50.72 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 125.527 2.584 . . . . 1.14 105.658 -174.93 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 53.1 t -125.54 123.85 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.082 -2.562 . . . . 1.23 104.082 175.826 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 N--CA 1.43 -1.465 0 O-C-N 120.77 -1.206 . . . . 2.78 111.821 177.623 . . . . . . . . 0 0 . 1 . 077 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ttp . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 116.743 -1.599 . . . . 1.1 112.034 . . . . . . . . . 0 0 . 1 . 077 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -93.5 111.62 23.33 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 115.316 -2.278 . . . . 1.87 111.185 -177.274 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.7 pt -106.47 167.98 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-O 125.992 2.806 . . . . 0.72 107.824 172.872 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -126.1 114.8 18.87 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.403 2.049 . . . . 1.4 113.129 -176.727 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.0 t -107.6 113.59 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 116.404 -3.935 . . . . 0.58 102.174 -179.002 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -82.74 143.93 30.55 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 116.103 -4.123 . . . . 2.09 116.49 177.166 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.569 HG21 ' HE2' ' A' ' 11' ' ' LYS . 20.2 p -93.85 158.46 15.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.558 1.943 . . . . 0.99 116.126 176.179 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.25 80.1 mt -64.44 -32.53 74.2 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.246 1.818 . . . . 2.53 114.648 175.906 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.7 p -71.61 -44.31 64.64 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.542 -1.349 . . . . 2.08 112.172 178.33 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.79 -33.75 0.44 Allowed Glycine 0 N--CA 1.43 -1.762 0 CA-C-O 125.516 2.731 . . . . 1.31 115.072 172.036 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.569 ' HE2' HG21 ' A' ' 7' ' ' THR 0.362 0.0 OUTLIER -70.9 153.41 42.72 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 110.879 -2.661 . . . . 1.4 115.434 -176.285 . . . . . . . . 4 4 . 1 . 077 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.9 m -103.21 136.38 43.11 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.051 -1.655 . . . . 0.78 110.432 177.642 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 69.7 mt -98.78 115.48 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 116.517 -1.706 . . . . 1.55 108.768 177.597 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 m -92.44 110.83 22.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.242 1.817 . . . . 1.08 111.767 179.95 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.9 mt -112.89 133.85 54.67 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 125.332 2.491 . . . . 1.55 110.803 -174.742 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -91.0 113.15 25.34 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 116.28 -4.012 . . . . 1.95 109.64 168.255 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.7 163.14 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 113.502 -1.681 . . . . 0.96 108.688 -177.378 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -104.55 131.0 22.26 Favored Pre-proline 0 N--CA 1.43 -1.434 0 O-C-N 125.792 1.933 . . . . 2.35 106.102 163.449 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.71 -14.04 24.77 Favored 'Trans proline' 0 C--N 1.3 -1.993 1 C-N-CA 127.827 5.684 . . . . 0.95 114.788 -178.542 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -85.96 -17.04 36.46 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.895 2.878 . . . . 1.45 114.858 -179.771 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -68.17 144.46 54.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 116.997 -1.478 . . . . 1.69 113.704 176.007 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.3 p -76.61 164.11 26.23 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 122.959 2.618 . . . . 0.75 110.332 -178.266 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.881 HD13 ' HB3' ' A' ' 50' ' ' LEU . 52.0 mt -67.86 -35.38 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 118.158 -2.838 . . . . 0.73 114.594 176.165 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -47.89 -37.65 14.59 Favored 'General case' 0 N--CA 1.431 -1.409 1 O-C-N 115.665 -4.397 . . . . 1.62 116.873 156.659 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -78.97 -30.22 44.35 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.43 -2.669 . . . . 2.13 111.087 177.094 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.7 t -61.83 -52.98 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 O-C-N 119.554 -1.966 . . . . 0.62 113.305 170.961 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -50.05 -40.73 45.97 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 127.892 3.245 . . . . 1.22 114.771 176.457 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.97 -37.37 68.96 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.839 -1.163 . . . . 0.51 112.432 173.388 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -70.16 -24.92 63.23 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 118.801 2.889 . . . . 1.44 118.801 174.548 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.8 mt -77.33 -42.37 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 129.051 2.94 . . . . 1.32 104.38 179.693 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -61.38 -47.9 83.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.418 -1.426 . . . . 1.7 110.585 179.947 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -41.71 -48.68 4.22 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 118.076 2.621 . . . . 1.55 118.076 170.329 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -79.0 -60.76 2.25 Favored 'General case' 0 N--CA 1.432 -1.372 0 O-C-N 119.192 -2.193 . . . . 2.62 108.607 -174.031 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -101.85 -17.37 16.22 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 119.862 1.21 . . . . 1.48 111.535 -163.922 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.98 46.89 5.77 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 123.844 1.802 . . . . 1.12 116.852 173.444 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.4 mt -129.3 129.1 23.27 Favored Pre-proline 0 N--CA 1.431 -1.395 0 O-C-N 120.211 -1.758 . . . . 1.55 112.162 -174.112 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -62.72 162.16 26.01 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 O-C-N 114.574 -3.435 . . . . 1.02 120.881 -177.278 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.7 -14.92 19.51 Favored 'Trans proline' 0 N--CA 1.433 -2.038 0 CA-C-N 127.825 3.83 . . . . 1.25 112.824 -178.398 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -60.47 -46.21 90.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.919 2.488 . . . . 2.25 109.398 173.41 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -83.77 -27.57 28.77 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 123.503 0.721 . . . . 2.02 112.473 -174.417 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -76.87 108.32 9.83 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.344 2.021 . . . . 0.69 110.731 -177.582 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -93.8 119.13 32.36 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.971 -3.581 . . . . 2.78 104.564 167.542 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.3 mt -98.41 138.38 35.73 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.278 -2.139 . . . . 1.17 108.688 174.277 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.41 134.1 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 101.735 -3.432 . . . . 1.38 101.735 -178.404 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -98.11 -107.23 0.18 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.187 -1.571 . . . . 1.5 109.736 170.171 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.66 -51.38 5.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.079 -2.263 . . . . 1.21 110.752 177.582 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.25 -40.17 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 128.955 3.169 . . . . 1.3 106.343 -171.074 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -74.5 146.77 42.44 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 112.878 0.696 . . . . 2.55 112.878 178.348 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.276 3.6 mp0 -97.92 145.65 26.25 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 100.308 -3.96 . . . . 2.48 100.308 171.879 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.881 ' HB3' HD13 ' A' ' 23' ' ' ILE . 78.8 mt -99.75 121.02 40.65 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 127.733 3.635 . . . . 0.9 108.437 -169.496 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -71.35 129.15 38.12 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.519 -2.613 . . . . 1.94 114.189 170.638 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.41 -48.04 47.46 Favored 'General case' 0 N--CA 1.431 -1.417 1 C-N-CA 131.966 4.106 . . . . 1.56 117.412 -175.071 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.62 -9.58 62.19 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 119.157 2.423 . . . . 0.97 119.157 176.663 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -90.39 177.02 6.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 118.386 1.093 . . . . 2.49 109.247 179.412 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.5 p -108.23 164.36 12.38 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.184 1.393 . . . . 0.76 108.46 173.873 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.0 mt -58.4 -33.24 69.42 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.478 1.511 . . . . 1.05 111.421 171.629 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -64.27 -34.72 78.78 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 118.788 2.884 . . . . 1.19 118.788 176.728 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.284 64.6 m-20 -67.47 -29.79 69.33 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.42 -2.675 . . . . 1.9 111.785 178.429 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -92.53 -7.16 48.07 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 130.402 3.481 . . . . 0.89 112.088 178.664 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.268 71.6 m-80 61.96 60.82 1.47 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.213 1.482 . . . . 1.84 110.06 176.479 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.282 12.8 mt -83.69 130.43 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 128.054 2.542 . . . . 0.82 109.665 173.431 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -100.7 178.38 4.72 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 117.576 -1.202 . . . . 2.16 114.003 -171.453 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -44.19 -80.86 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.248 2.219 . . . . 2.12 116.684 173.627 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.341 0.8 OUTLIER -93.05 58.29 2.91 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 123.214 1.483 . . . . 1.71 113.622 -177.666 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 p -92.3 139.87 30.17 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.952 2.501 . . . . 1.04 113.514 -175.039 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.4 m -109.79 124.12 50.74 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 104.122 -2.547 . . . . 0.79 104.122 -176.223 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -97.91 170.33 9.03 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 126.531 3.063 . . . . 1.4 104.815 172.361 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -120.76 125.51 47.77 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 118.037 -2.914 . . . . 1.51 105.09 -177.998 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.0 tp -95.17 107.16 19.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.471 2.081 . . . . 1.14 111.608 169.069 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -112.49 150.3 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 118.609 -2.557 . . . . 1.23 107.819 173.964 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.5 mt . . . . . 0 N--CA 1.43 -1.43 0 O-C-N 118.6 -2.563 . . . . 2.78 111.516 -178.788 . . . . . . . . 0 0 . 1 . 078 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tmm? . . . . . 0 CA--C 1.491 -1.32 0 N-CA-C 105.25 -2.13 . . . . 1.1 105.25 . . . . . . . . . 0 0 . 1 . 078 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.83 131.64 36.56 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.095 -3.503 . . . . 1.87 113.372 179.762 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.2 pt -116.48 148.15 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 129.245 3.018 . . . . 0.72 105.305 174.867 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -104.42 131.11 52.14 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.24 -1.538 . . . . 1.4 107.275 -179.546 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.0 t -109.79 118.66 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 105.185 -2.154 . . . . 0.58 105.185 177.083 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -105.08 130.39 53.28 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.475 -1.391 . . . . 2.09 110.066 176.277 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.8 p -69.93 167.02 18.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.549 2.118 . . . . 0.99 113.71 176.883 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.2 tp -56.01 -46.18 78.84 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 112.122 -2.308 . . . . 2.53 114.11 173.427 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 p -81.22 -21.15 39.75 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.299 2.333 . . . . 2.08 117.299 -176.248 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.76 1.69 4.1 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 122.686 3.834 . . . . 1.31 122.686 177.78 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -88.25 131.27 34.84 Favored 'General case' 0 N--CA 1.431 -1.397 1 O-C-N 115.855 -4.321 . . . . 1.4 109.978 -174.306 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.5 m -119.53 112.99 20.04 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 120.171 1.35 . . . . 0.78 113.384 179.626 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.9 pt -101.78 151.94 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 125.691 1.869 . . . . 1.55 107.61 -177.476 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.1 m -116.68 118.68 33.25 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 126.61 2.444 . . . . 1.08 110.012 -175.122 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.7 mt -102.96 149.22 24.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.518 -3.239 . . . . 1.55 107.247 177.977 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -102.48 123.36 46.1 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.225 -1.398 . . . . 1.95 107.225 165.762 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 m -131.77 147.66 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 106.67 -1.604 . . . . 0.96 106.67 -176.558 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -87.01 129.68 51.12 Favored Pre-proline 0 N--CA 1.429 -1.523 1 CA-C-O 111.438 -4.125 . . . . 2.35 110.132 163.875 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.31 -1.94 12.06 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 CA-C-N 127.809 3.825 . . . . 0.95 115.517 -166.246 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.2 m -84.19 2.66 38.72 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 116.301 -3.999 . . . . 1.45 116.513 172.917 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -81.36 163.32 22.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.514 -3.241 . . . . 1.69 113.174 174.952 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -90.98 157.95 16.99 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 125.729 2.68 . . . . 0.75 112.73 -178.538 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.44 -37.67 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.004 -2.935 . . . . 0.73 115.814 171.22 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -48.27 -41.21 27.22 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.647 -3.158 . . . . 1.62 117.879 167.811 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -73.8 -33.56 64.26 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.406 1.262 . . . . 2.13 114.406 172.568 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.5 -40.26 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 116.791 -3.693 . . . . 0.62 111.572 174.665 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -66.32 -35.74 81.14 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.288 -2.132 . . . . 1.22 110.115 177.58 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.439 . . -69.62 -27.02 64.72 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.883 2.473 . . . . 0.51 116.148 173.369 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -75.09 -34.84 61.8 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 120.702 -1.249 . . . . 1.44 111.698 172.391 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.1 mt -69.0 -33.73 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 117.425 -1.274 . . . . 1.32 112.666 168.38 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -65.2 -35.21 80.35 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.435 -1.32 . . . . 1.7 107.435 176.53 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.32 -26.9 68.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.041 2.237 . . . . 1.55 117.041 173.892 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -99.37 -69.71 0.76 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.522 1.629 . . . . 2.62 113.332 -172.734 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -84.8 -25.36 28.21 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.058 -2.901 . . . . 1.48 105.475 -169.314 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.88 58.88 2.56 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 107.928 -2.069 . . . . 1.12 107.928 178.948 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.3 mt -115.25 120.31 36.9 Favored Pre-proline 0 N--CA 1.43 -1.443 1 CA-C-O 110.705 -4.474 . . . . 1.55 107.411 -179.25 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -63.56 143.95 88.86 Favored 'Trans proline' 0 N--CA 1.434 -2.028 1 CA-C-N 128.555 4.091 . . . . 1.02 116.801 177.681 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -68.87 -18.37 41.33 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 CA-C-N 125.763 3.094 . . . . 1.25 115.015 -172.925 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.257 11.3 p-10 -77.51 -18.67 56.83 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 127.69 3.614 . . . . 2.25 113.729 178.413 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -90.32 -16.51 29.1 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 114.903 -4.873 . . . . 2.02 110.524 178.831 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -87.46 131.07 34.46 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 126.088 2.852 . . . . 0.69 116.638 -177.614 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -111.85 114.38 27.29 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.171 2.988 . . . . 2.78 111.304 172.361 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 39.5 mt -104.5 126.01 51.2 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 118.455 -2.653 . . . . 1.17 108.253 178.106 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.8 mt -119.72 153.76 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 N-CA-C 101.28 -3.6 . . . . 1.38 101.28 -179.185 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.567 ' HB3' HD21 ' A' ' 50' ' ' LEU 0.429 26.7 t80 -126.03 -73.15 0.63 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 119.052 -1.059 . . . . 1.5 112.738 167.964 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.11 -40.12 8.57 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 114.115 -2.85 . . . . 1.21 115.29 178.768 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.89 -52.69 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 108.452 -1.859 . . . . 1.3 108.452 -175.873 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -89.12 163.46 15.45 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 122.084 2.942 . . . . 2.55 112.787 177.677 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -68.63 147.98 51.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 125.623 1.827 . . . . 2.48 112.053 170.669 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.567 HD21 ' HB3' ' A' ' 45' ' ' PHE . 24.1 mt -84.64 144.73 28.41 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 115.925 -1.988 . . . . 0.9 107.481 -175.436 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -90.97 155.38 18.76 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 125.799 3.908 . . . . 1.94 109.372 178.252 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -65.44 -57.85 7.27 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.87 3.268 . . . . 1.56 112.858 -172.81 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.67 62.62 1.64 Allowed Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 121.385 3.314 . . . . 0.97 121.385 168.506 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 ttm-85 -139.92 163.26 33.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 113.545 -1.328 . . . . 2.49 107.442 164.938 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.254 24.4 p -91.75 172.41 8.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.269 1.985 . . . . 0.76 112.149 -174.93 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.55 -46.0 64.38 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.322 -1.763 . . . . 1.05 111.065 168.594 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.273 1.2 t -63.51 -17.2 62.51 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.127 2.171 . . . . 1.19 114.747 175.733 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -77.73 -36.08 51.23 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 115.596 1.702 . . . . 1.9 115.596 170.268 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -87.22 7.08 29.98 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.289 1.995 . . . . 0.89 112.233 173.08 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 m120 44.06 59.83 3.02 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.887 3.675 . . . . 1.84 115.86 -174.649 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.449 HG12 ' CE2' ' A' ' 45' ' ' PHE . 46.8 mt -87.07 106.98 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 119.411 -2.055 . . . . 0.82 105.811 179.294 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -104.03 -170.31 1.76 Allowed 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 116.269 -0.423 . . . . 2.16 110.364 -179.97 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -27.99 137.46 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 130.16 3.384 . . . . 2.12 118.934 169.124 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 48.42 56.2 7.83 Favored 'General case' 0 N--CA 1.431 -1.385 1 C-N-CA 132.402 4.281 . . . . 1.71 114.948 176.679 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.4 m -116.91 135.45 53.71 Favored 'General case' 0 N--CA 1.432 -1.37 0 O-C-N 119.756 -1.84 . . . . 1.04 113.859 -173.938 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.2 m -102.35 99.87 9.98 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.195 2.998 . . . . 0.79 109.299 -176.471 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.61 135.35 48.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 116.339 -1.791 . . . . 1.4 111.968 169.465 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.6 m170 -91.11 100.37 13.22 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 127.864 2.466 . . . . 1.51 113.15 -176.898 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.2 tp -91.48 135.6 33.73 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 126.9 2.625 . . . . 1.14 114.083 177.681 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.6 t -135.16 120.46 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 129.841 3.256 . . . . 1.23 109.37 170.63 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.0 pp . . . . . 0 N--CA 1.429 -1.489 0 CA-C-N 124.366 3.257 . . . . 2.78 107.526 172.264 . . . . . . . . 0 0 . 1 . 079 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ptt? . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 114.363 1.246 . . . . 1.1 114.363 . . . . . . . . . 0 0 . 1 . 079 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -89.05 127.82 35.71 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.281 -2.762 . . . . 1.87 107.456 -175.778 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.8 pt -114.73 162.53 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 115.254 1.575 . . . . 0.72 115.254 171.67 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 64' ' ' GLU . 36.1 m-85 -116.15 121.34 41.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.538 -3.226 . . . . 1.4 110.962 -175.883 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.0 t -103.2 124.45 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 1 O-C-N 116.009 -4.182 . . . . 0.58 110.592 176.49 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -99.62 135.98 40.23 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.38 1.446 . . . . 2.09 109.407 179.744 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.1 p -88.17 -175.49 5.07 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 117.235 -1.364 . . . . 0.99 113.665 176.053 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.3 mt -62.47 -52.52 63.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 124.724 1.265 . . . . 2.53 112.308 170.232 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.5 p -74.53 -12.98 60.61 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 115.591 -2.147 . . . . 2.08 110.472 -178.327 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.54 9.23 25.53 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 122.14 3.616 . . . . 1.31 122.14 173.291 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.49 140.87 54.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.493 2.092 . . . . 1.4 107.659 -177.006 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.7 m -108.33 104.83 14.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.498 -3.251 . . . . 0.78 112.458 177.128 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.7 mt -98.12 120.57 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 125.046 1.466 . . . . 1.55 107.8 -176.13 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 m -90.99 115.92 28.38 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 127.332 2.895 . . . . 1.08 108.708 178.357 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 mt -123.35 137.45 54.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.26 1.824 . . . . 1.55 107.83 -178.261 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.89 130.93 35.33 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 101.997 -3.335 . . . . 1.95 101.997 170.146 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -138.27 158.78 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 126.022 2.82 . . . . 0.96 108.968 174.472 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -102.6 153.35 38.23 Favored Pre-proline 0 N--CA 1.43 -1.433 1 O-C-N 115.211 -4.681 . . . . 2.35 107.034 161.105 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -76.67 -7.66 17.74 Favored 'Trans proline' 0 N--CA 1.433 -2.037 1 CA-C-N 128.475 4.063 . . . . 0.95 112.567 -167.753 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -80.95 -8.92 59.87 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 126.037 1.735 . . . . 1.45 108.776 -179.01 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -66.7 141.17 57.86 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.661 1.984 . . . . 1.69 113.063 171.001 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 82.3 p -82.66 168.01 17.69 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.875 -2.391 . . . . 0.75 114.557 173.435 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.1 mm -64.41 -32.31 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 117.795 -3.065 . . . . 0.73 112.437 173.107 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -58.65 -39.35 80.35 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 115.957 -4.214 . . . . 1.62 115.02 169.539 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -63.48 -43.44 97.28 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 127.837 2.455 . . . . 2.13 111.728 174.874 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.6 t -61.81 -47.05 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 126.814 2.046 . . . . 0.62 110.554 175.255 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -62.68 -30.61 71.52 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 119.559 3.17 . . . . 1.22 119.559 170.838 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.76 -28.66 61.79 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 123.075 1.416 . . . . 0.51 112.836 175.819 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.289 18.5 ttmm -80.18 -36.45 34.99 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 129.551 3.14 . . . . 1.44 114.041 173.317 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.443 68.7 mt -62.68 -44.75 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 127.796 2.438 . . . . 1.32 112.368 168.093 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -55.92 -52.19 65.0 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.518 -3.239 . . . . 1.7 114.251 169.872 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -60.58 -42.95 97.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.625 2.083 . . . . 1.55 116.625 175.058 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -86.22 -50.16 7.18 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.776 1.274 . . . . 2.62 110.516 -173.435 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -94.82 -41.97 8.95 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 116.643 -3.786 . . . . 1.48 114.003 -171.691 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.94 22.65 6.81 Favored Glycine 0 N--CA 1.431 -1.699 0 CA-C-O 124.279 2.044 . . . . 1.12 111.836 174.02 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.4 mt -94.89 131.9 29.43 Favored Pre-proline 0 N--CA 1.43 -1.442 0 O-C-N 118.891 -2.535 . . . . 1.55 104.856 -173.168 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -64.72 144.62 84.5 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 C-N-CA 124.685 3.59 . . . . 1.02 119.293 -179.931 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -71.65 -15.46 30.38 Favored 'Trans proline' 0 N--CA 1.433 -2.085 0 C-N-CA 114.745 -3.036 . . . . 1.25 113.757 -172.124 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -65.43 -25.29 67.46 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 118.395 2.739 . . . . 2.25 118.395 175.261 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -96.68 -25.22 15.63 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 116.13 -4.106 . . . . 2.02 105.472 -172.044 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -75.38 103.42 5.51 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.396 -3.94 . . . . 0.69 114.533 -177.382 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -94.77 129.57 41.66 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.425 -2.047 . . . . 2.78 109.203 165.605 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' A' ' 43' ' ' LEU . 42.9 mt -115.08 127.32 55.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.5 -2.0 . . . . 1.17 108.694 -179.494 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 9.5 mm -116.31 155.37 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 127.994 2.518 . . . . 1.38 104.597 173.958 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -104.73 -83.32 0.5 Allowed 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.88 -2.637 . . . . 1.5 103.88 174.218 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.99 -43.69 6.6 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 113.95 -1.477 . . . . 1.21 110.787 179.199 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -173.81 -16.9 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 127.254 2.359 . . . . 1.3 114.23 -179.007 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -82.2 124.73 30.17 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 102.758 -3.053 . . . . 2.55 102.758 178.864 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.04 130.69 45.03 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.349 -2.719 . . . . 2.48 112.166 173.73 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.1 mt -87.41 132.32 34.02 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.108 -2.87 . . . . 0.9 107.432 -175.094 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -94.25 138.18 32.55 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 117.704 -1.141 . . . . 1.94 113.122 177.75 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -50.6 -56.07 13.44 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 130.866 3.666 . . . . 1.56 113.339 -166.813 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.85 52.98 4.48 Favored Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 118.024 1.969 . . . . 0.97 118.024 172.963 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.0 mmt-85 -126.94 159.23 34.65 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 105.942 -1.873 . . . . 2.49 105.942 165.438 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.299 35.6 p -89.7 170.78 10.16 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.566 -2.583 . . . . 0.76 113.277 175.808 . . . . . . . . 3 3 . 1 . 079 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mt -73.3 -32.55 64.69 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 106.416 -1.698 . . . . 1.05 106.416 173.381 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -64.38 -43.56 94.12 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 117.079 -1.439 . . . . 1.19 110.195 177.959 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -46.02 -45.79 16.13 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 122.383 2.356 . . . . 1.9 113.801 173.791 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -82.42 6.68 16.43 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.338 -1.476 . . . . 0.89 114.946 178.45 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.4 m120 61.79 37.96 15.18 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 131.25 3.82 . . . . 1.84 116.684 176.09 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -86.65 128.01 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 127.043 2.137 . . . . 0.82 105.761 -177.57 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -142.94 -47.31 0.31 Allowed 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.243 -1.536 . . . . 2.16 113.333 -172.318 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -88.6 -162.36 0.84 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.333 1.453 . . . . 2.12 114.465 179.917 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.44 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 24.8 mt-10 -84.51 75.45 10.27 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.002 -2.937 . . . . 1.71 111.74 179.598 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 m -82.42 144.09 30.73 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 119.985 3.328 . . . . 1.04 119.985 -175.834 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.3 m -91.7 106.47 18.5 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.2 -1.364 . . . . 0.79 111.44 179.63 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -85.26 154.96 21.59 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 128.317 3.913 . . . . 1.4 105.963 166.126 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.425 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 69.9 m80 -115.17 119.04 35.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 111.791 -2.458 . . . . 1.51 106.637 -176.525 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.5 tp -105.08 99.7 9.31 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 105.118 -2.178 . . . . 1.14 105.118 178.096 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.6 t -86.88 125.39 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 113.478 -1.692 . . . . 1.23 111.017 171.283 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.3 mt . . . . . 0 N--CA 1.43 -1.468 0 O-C-N 119.191 -2.193 . . . . 2.78 114.635 -179.111 . . . . . . . . 0 0 . 1 . 080 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.329 0 CA-C-O 119.556 -0.259 . . . . 1.1 111.252 . . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -114.0 113.26 24.54 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 101.531 -3.507 . . . . 1.87 101.531 -174.581 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.7 pt -92.52 166.66 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 122.601 2.455 . . . . 0.72 111.835 170.611 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -122.61 94.12 4.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.895 1.678 . . . . 1.4 110.831 176.142 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.4 t -77.05 115.11 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 O-C-N 118.035 -2.915 . . . . 0.58 113.557 174.742 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -94.84 128.89 41.91 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 117.083 -1.847 . . . . 2.09 113.74 -178.288 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 p -85.67 173.24 10.26 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 124.463 2.078 . . . . 0.99 109.914 177.126 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 mt -79.96 -33.97 39.13 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.242 -2.786 . . . . 2.53 108.406 172.845 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.9 p -71.77 -35.06 69.94 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 123.769 2.986 . . . . 2.08 113.568 179.898 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.81 8.41 0.92 Allowed Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 119.162 2.425 . . . . 1.31 119.162 176.957 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.0 tptt -96.94 144.55 26.75 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.898 -1.519 . . . . 1.4 106.898 -172.309 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.4 m -111.73 108.25 17.62 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.318 -2.845 . . . . 0.78 103.318 174.241 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.9 mt -82.27 111.1 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 113.526 -1.67 . . . . 1.55 108.276 179.472 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.5 m -85.23 106.84 16.95 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.194 1.398 . . . . 1.08 112.665 -178.756 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.4 mt -123.36 133.28 54.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 124.833 1.333 . . . . 1.55 107.871 -172.849 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -94.21 133.59 37.57 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.748 -1.845 . . . . 1.95 110.672 162.902 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.3 m -133.3 173.54 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 125.964 2.792 . . . . 0.96 108.997 176.744 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.267 39.5 mt-10 -123.42 167.08 15.79 Favored Pre-proline 0 N--CA 1.43 -1.451 0 N-CA-C 103.595 -2.743 . . . . 2.35 103.595 162.911 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -69.06 -11.54 32.0 Favored 'Trans proline' 0 N--CA 1.433 -2.065 0 N-CA-C 117.184 1.955 . . . . 0.95 117.184 179.395 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -79.27 -11.73 59.95 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 129.066 2.946 . . . . 1.45 112.07 179.001 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -74.76 141.22 44.42 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.16 -1.588 . . . . 1.69 113.098 175.425 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 57.2 p -84.46 164.35 18.89 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.865 -1.772 . . . . 0.75 107.957 174.875 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.275 1.9 mp -69.95 -27.77 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 119.232 -2.168 . . . . 0.73 113.429 178.86 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -53.34 -46.72 69.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.07 -2.269 . . . . 1.62 114.69 164.436 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -53.3 -40.8 65.04 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.532 -3.23 . . . . 2.13 113.714 172.633 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.06 -42.0 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 O-C-N 121.045 -1.034 . . . . 0.62 111.682 177.546 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -59.56 -36.89 77.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.057 -2.277 . . . . 1.22 115.03 173.634 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.17 73.64 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.052 2.095 . . . . 0.51 115.034 174.883 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -72.81 -37.19 67.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 131.418 3.887 . . . . 1.44 112.748 173.823 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.6 mt -73.6 -28.02 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 117.825 -3.047 . . . . 1.32 109.106 170.596 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -71.2 -35.22 71.47 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.859 -1.776 . . . . 1.7 110.228 176.613 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -69.64 -57.39 5.22 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.098 2.559 . . . . 1.55 109.066 176.41 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.254 22.6 mmtt -57.58 -73.44 0.07 Allowed 'General case' 0 CA--C 1.489 -1.384 0 C-N-CA 131.068 3.747 . . . . 2.62 115.104 178.449 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.276 47.0 mm-40 -88.73 -41.14 12.74 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.727 -2.483 . . . . 1.48 114.52 -168.105 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.62 34.43 2.86 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 126.421 1.962 . . . . 1.12 111.427 173.97 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.8 mm -92.93 135.31 26.15 Favored Pre-proline 0 N--CA 1.429 -1.488 0 CA-C-O 112.456 -3.64 . . . . 1.55 109.52 -177.586 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -75.48 136.02 18.93 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 CA-C-N 127.342 3.658 . . . . 1.02 112.638 176.75 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -60.9 -21.14 69.89 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 C-N-CA 123.574 2.85 . . . . 1.25 116.909 -173.629 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.55 -28.68 68.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 130.094 3.358 . . . . 2.25 113.135 172.814 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -80.98 -34.82 32.77 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 131.066 3.746 . . . . 2.02 113.663 -177.518 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -88.59 115.47 26.14 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 116.266 1.95 . . . . 0.69 116.266 -163.587 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -95.71 120.04 35.27 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.898 -2.376 . . . . 2.78 110.092 173.46 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 43' ' ' LEU 0.264 68.0 mt -97.43 99.17 10.6 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.132 1.787 . . . . 1.17 113.109 175.835 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mm -95.05 130.65 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 128.857 2.863 . . . . 1.38 107.432 -174.788 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -111.7 -80.96 0.59 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 105.326 -2.102 . . . . 1.5 105.326 174.889 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.99 -95.67 0.35 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.777 -2.452 . . . . 1.21 111.016 -179.168 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.58 -4.12 54.91 Favored Glycine 0 N--CA 1.429 -1.772 0 O-C-N 119.551 -1.968 . . . . 1.3 113.634 -178.977 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -133.25 153.87 51.18 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.178 -2.366 . . . . 2.55 113.458 -177.581 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -82.31 141.41 32.91 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.045 -3.535 . . . . 2.48 109.483 162.948 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.8 mt -75.68 141.1 42.81 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.631 -2.543 . . . . 0.9 106.157 -178.909 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -86.42 137.34 32.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.204 -3.435 . . . . 1.94 115.077 176.773 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -53.03 -60.86 2.75 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 120.742 3.608 . . . . 1.56 120.742 -166.372 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.87 25.62 1.18 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 120.81 3.084 . . . . 0.97 120.81 170.128 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -113.87 159.82 19.43 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 127.325 2.427 . . . . 2.49 106.241 173.161 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 29.1 p -87.21 156.84 19.5 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.384 2.364 . . . . 0.76 117.384 -176.462 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.8 mt -53.62 -40.24 65.6 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 118.576 -2.577 . . . . 1.05 114.064 167.824 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.1 t -56.23 -36.69 68.76 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 115.573 1.694 . . . . 1.19 115.573 174.777 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -55.31 -30.49 60.32 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 120.795 3.628 . . . . 1.9 120.795 175.015 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -96.91 -1.24 46.22 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.843 -1.526 . . . . 0.89 109.906 -179.221 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.308 33.8 m-80 64.74 67.86 0.54 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.999 2.92 . . . . 1.84 109.44 -177.978 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.4 mt -124.34 114.02 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 1 C-N-CA 132.614 4.365 . . . . 0.82 101.794 179.851 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.25 57.0 mm-40 -139.77 -25.32 0.82 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 116.448 -1.739 . . . . 2.16 109.083 -176.104 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -107.45 -173.35 2.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 129.555 3.142 . . . . 2.12 110.977 -179.481 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -73.51 77.5 1.44 Allowed 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.938 1.295 . . . . 1.71 113.719 177.597 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.379 54.3 p -80.06 158.56 26.43 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.046 1.339 . . . . 1.04 113.772 -170.386 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.48 HG22 ' CE1' ' A' ' 68' ' ' HIS . 2.9 m -107.96 115.46 30.17 Favored 'General case' 0 N--CA 1.431 -1.424 1 N-CA-C 99.636 -4.209 . . . . 0.79 99.636 179.097 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mp -108.27 168.01 9.61 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 116.66 -3.775 . . . . 1.4 106.292 175.706 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.48 ' CE1' HG22 ' A' ' 66' ' ' THR . 86.3 m-70 -127.33 135.41 50.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.978 -1.701 . . . . 1.51 113.002 -178.554 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.259 42.0 tp -106.08 107.08 17.9 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.655 -2.528 . . . . 1.14 107.393 179.738 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 37.1 t -98.16 143.57 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 103.382 -2.821 . . . . 1.23 103.382 176.543 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.5 mt . . . . . 0 N--CA 1.43 -1.426 1 O-C-N 115.404 -4.56 . . . . 2.78 112.227 178.022 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ptt? . . . . . 0 CA--C 1.489 -1.387 0 CA-C-O 121.672 0.748 . . . . 1.1 112.948 . . . . . . . . . 0 0 . 1 . 081 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -95.54 137.88 33.99 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.939 -2.245 . . . . 1.87 104.939 -179.287 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.444 HD12 HD22 ' A' ' 67' ' ' LEU . 38.2 pt -123.14 155.95 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 124.398 2.047 . . . . 0.72 109.756 161.946 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -115.88 119.07 34.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.469 -3.269 . . . . 1.4 107.433 -172.363 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.495 HG22 ' HB2' ' A' ' 67' ' ' LEU . 40.0 t -110.83 117.89 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 119.032 -2.292 . . . . 0.58 106.028 -179.092 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -108.62 168.77 9.09 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 119.634 -0.827 . . . . 2.09 111.292 177.05 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -103.9 -165.93 1.2 Allowed 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 122.663 1.22 . . . . 0.99 109.743 173.979 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.0 tp -75.29 -49.99 17.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.136 2.174 . . . . 2.53 113.494 173.681 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.8 p -89.43 -37.68 14.64 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.122 -2.236 . . . . 2.08 114.445 -172.548 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.73 28.21 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.713 0 N-CA-C 121.981 3.552 . . . . 1.31 121.981 179.28 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -104.95 95.76 6.08 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 126.478 1.911 . . . . 1.4 114.366 -177.506 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.9 m -89.77 124.19 34.42 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 115.54 -2.464 . . . . 0.78 109.149 178.847 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 pt -119.32 128.57 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 117.688 -3.132 . . . . 1.55 107.5 172.675 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.3 m -95.76 122.94 39.07 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 116.133 -1.889 . . . . 1.08 110.016 -177.565 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.278 76.9 mt -119.89 128.17 53.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 121.925 2.148 . . . . 1.55 111.465 -177.502 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -80.03 122.23 26.49 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 125.487 1.742 . . . . 1.95 108.031 171.608 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 m -136.54 178.72 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 1 C-N-CA 131.797 4.039 . . . . 0.96 111.663 -173.963 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -125.84 162.55 44.65 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 113.046 -3.359 . . . . 2.35 107.303 166.411 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -74.16 -19.46 20.03 Favored 'Trans proline' 0 C--N 1.3 -2.013 1 CA-C-N 130.026 4.616 . . . . 0.95 111.886 -170.622 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.15 10.85 27.65 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 131.056 3.742 . . . . 1.45 110.925 -173.96 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -88.37 148.15 24.39 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.813 -3.679 . . . . 1.69 110.086 176.368 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 p -87.0 162.55 17.58 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.829 1.789 . . . . 0.75 115.829 -177.488 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.442 HD12 HD13 ' A' ' 50' ' ' LEU . 19.6 mm -66.47 -29.39 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 127.817 3.675 . . . . 0.73 114.859 173.389 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -58.51 -51.33 70.35 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 113.574 -5.704 . . . . 1.62 113.358 173.173 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -63.25 -40.02 96.24 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.69 1.596 . . . . 2.13 110.62 176.711 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.6 t -63.38 -33.91 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 117.729 -3.107 . . . . 0.62 116.077 176.455 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.487 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 37.4 mtmt -65.33 -32.18 73.7 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.17 -4.081 . . . . 1.22 111.8 174.386 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.14 -23.35 62.99 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.191 1.796 . . . . 0.51 113.271 172.914 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -76.45 -41.18 48.28 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 126.307 2.955 . . . . 1.44 115.366 170.908 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.9 -35.13 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 118.608 -2.558 . . . . 1.32 109.672 171.139 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -62.81 -54.48 38.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.169 -3.457 . . . . 1.7 110.782 177.343 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -40.17 -52.44 2.59 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 125.619 1.567 . . . . 1.55 113.642 170.362 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -72.15 -67.05 0.57 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 115.958 1.836 . . . . 2.62 115.958 -176.818 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -101.38 -21.19 14.89 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.788 2.709 . . . . 1.48 113.829 -167.08 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.64 7.85 50.24 Favored Glycine 0 N--CA 1.43 -1.715 0 O-C-N 119.138 -2.226 . . . . 1.12 114.426 168.321 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.7 mt -81.46 117.8 69.65 Favored Pre-proline 0 N--CA 1.43 -1.433 0 N-CA-C 103.469 -2.789 . . . . 1.55 103.469 -166.614 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.91 137.28 61.73 Favored 'Trans proline' 0 N--CA 1.433 -2.066 0 C-N-CA 121.871 1.714 . . . . 1.02 114.231 -176.505 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -63.23 -8.82 15.35 Favored 'Trans proline' 0 N--CA 1.434 -1.999 0 N-CA-C 122.05 3.827 . . . . 1.25 122.05 -172.301 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -81.75 -14.35 56.58 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 119.929 -0.709 . . . . 2.25 112.0 168.668 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -90.77 -27.09 19.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.912 2.885 . . . . 2.02 110.38 -175.601 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.487 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 76.2 mt-30 -75.66 128.35 35.02 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 126.294 2.246 . . . . 0.69 114.76 -176.423 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -116.82 100.78 8.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.53 -3.856 . . . . 2.78 101.167 175.176 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 43' ' ' LEU . 94.4 mt -91.11 125.6 35.94 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 103.796 -2.668 . . . . 1.17 103.796 177.822 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 mm -120.76 130.97 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 103.888 -2.634 . . . . 1.38 103.888 178.907 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.667 ' HB2' HD21 ' A' ' 50' ' ' LEU . 1.8 t80 -84.32 -75.44 0.34 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 118.117 -0.945 . . . . 1.5 109.979 170.164 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.0 -77.63 0.59 Allowed 'General case' 0 N--CA 1.43 -1.429 2 O-C-N 115.822 -4.299 . . . . 1.21 104.909 173.589 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.8 -25.26 3.4 Favored Glycine 0 N--CA 1.429 -1.779 0 O-C-N 118.564 -2.585 . . . . 1.3 113.646 -177.971 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -84.43 138.08 33.03 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.835 -2.568 . . . . 2.55 117.503 176.66 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -71.0 142.37 50.96 Favored 'General case' 0 N--CA 1.431 -1.405 1 O-C-N 115.932 -4.23 . . . . 2.48 111.362 174.422 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' A' ' 45' ' ' PHE . 83.8 mt -90.98 141.85 28.4 Favored 'General case' 0 N--CA 1.429 -1.495 1 O-C-N 115.983 -4.198 . . . . 0.9 109.988 -175.835 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -92.66 145.08 24.7 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 125.44 1.713 . . . . 1.94 111.935 -178.069 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.74 -63.36 1.33 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.383 2.04 . . . . 1.56 112.591 -167.619 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.4 39.37 2.49 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 116.745 -3.722 . . . . 0.97 116.106 177.184 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -115.56 159.38 21.33 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 121.511 2.656 . . . . 2.49 107.381 166.399 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.319 33.5 p -84.46 156.45 21.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 126.898 3.237 . . . . 0.76 110.754 176.777 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.1 mt -68.5 -25.94 65.21 Favored 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 111.544 -6.972 . . . . 1.05 115.287 171.776 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -66.65 -32.98 74.65 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.113 -3.492 . . . . 1.19 110.014 172.538 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -64.04 -34.08 77.2 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.075 -1.641 . . . . 1.9 114.47 171.382 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -89.42 -3.44 58.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.146 1.339 . . . . 0.89 111.892 177.025 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.6 m120 55.12 50.0 16.22 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 127.415 2.286 . . . . 1.84 115.948 -174.964 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.9 mt -77.88 126.99 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 113.161 -1.836 . . . . 0.82 108.6 178.474 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -102.46 175.35 5.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.111 1.764 . . . . 2.16 110.825 -176.28 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -72.97 -8.95 58.03 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 119.308 3.077 . . . . 2.12 119.308 177.604 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -106.85 7.48 30.19 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 125.707 1.879 . . . . 1.71 109.739 177.202 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 m -84.36 144.75 28.62 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.872 -1.768 . . . . 1.04 112.766 -171.635 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.3 m -110.32 120.04 41.14 Favored 'General case' 0 N--CA 1.431 -1.384 1 C-N-CA 133.065 4.546 . . . . 0.79 104.516 -177.007 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.495 ' HB2' HG22 ' A' ' 5' ' ' VAL . 7.9 mp -104.77 158.73 16.32 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.374 -2.825 . . . . 1.4 103.374 174.519 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -121.04 124.89 45.92 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.115 1.766 . . . . 1.51 109.413 -176.505 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.1 tp -105.7 99.73 9.32 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.897 1.681 . . . . 1.14 107.058 -177.812 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.7 152.04 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 105.682 -1.97 . . . . 1.23 105.682 171.247 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 N--CA 1.43 -1.474 0 O-C-N 119.164 -2.21 . . . . 2.78 107.001 176.377 . . . . . . . . 0 0 . 1 . 082 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 ptt? . . . . . 0 CA--C 1.489 -1.37 0 CA-C-O 124.694 2.188 . . . . 1.1 115.184 . . . . . . . . . 0 0 . 1 . 082 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -94.25 125.0 38.62 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.673 -2.517 . . . . 1.87 110.772 -179.715 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.6 pt -124.89 163.79 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 124.902 1.281 . . . . 0.72 112.339 171.696 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -114.42 159.18 20.59 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.137 2.875 . . . . 1.4 107.43 -178.248 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 60.0 t -143.05 134.34 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 102.539 -3.134 . . . . 0.58 102.539 177.283 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -113.73 131.78 56.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.856 1.312 . . . . 2.09 109.324 177.856 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.5 p -87.26 164.77 16.12 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 126.122 2.867 . . . . 0.99 107.801 179.845 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.1 mt -52.36 -56.71 13.09 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 116.173 -4.08 . . . . 2.53 114.696 170.647 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.4 p -69.51 -14.07 62.67 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.202 2.601 . . . . 2.08 114.142 -173.367 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.38 32.18 1.69 Allowed Glycine 0 N--CA 1.43 -1.745 1 N-CA-C 123.26 4.064 . . . . 1.31 123.26 169.246 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -111.6 148.43 33.33 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 115.217 -2.325 . . . . 1.4 114.955 -178.414 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.1 m -98.95 127.0 44.77 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 120.636 1.562 . . . . 0.78 108.067 175.712 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -103.73 123.6 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 125.991 2.805 . . . . 1.55 106.665 175.57 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.9 m -97.86 128.55 44.55 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.494 -3.879 . . . . 1.08 103.971 -178.096 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -125.61 133.08 52.36 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 121.688 2.04 . . . . 1.55 115.897 178.75 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -80.54 104.0 10.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 113.369 0.878 . . . . 1.95 113.369 162.318 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -114.9 154.1 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 119.211 -2.18 . . . . 0.96 109.583 177.967 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -113.86 151.39 44.7 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 102.923 -2.991 . . . . 2.35 102.923 164.261 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -68.29 -4.17 12.26 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-O 116.907 -1.372 . . . . 0.95 114.911 -173.39 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.2 p -93.11 -5.09 51.07 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.497 3.119 . . . . 1.45 113.065 -179.547 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -79.93 138.39 37.1 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.864 2.066 . . . . 1.69 108.132 174.599 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 39.3 p -76.22 173.78 10.95 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 128.392 3.949 . . . . 0.75 108.443 176.803 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.516 HG22 ' HE3' ' A' ' 27' ' ' LYS . 31.0 mm -74.67 -27.45 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 1 O-C-N 113.348 -5.845 . . . . 0.73 106.925 175.037 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -65.6 -33.68 76.46 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 129.268 3.027 . . . . 1.62 111.433 172.079 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -83.96 -33.92 24.52 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.541 1.162 . . . . 2.13 111.825 172.867 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.26 29.0 t -64.62 -39.03 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 1 O-C-N 114.449 -5.157 . . . . 0.62 108.206 178.544 . . . . . . . . 3 2 . 1 . 082 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.516 ' HE3' HG22 ' A' ' 23' ' ' ILE 0.328 91.0 mttt -61.02 -47.87 84.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.23 -3.419 . . . . 1.22 113.528 173.486 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.0 -39.65 63.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.849 -2.407 . . . . 0.51 109.648 170.961 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -61.22 -37.71 84.01 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.662 -4.398 . . . . 1.44 114.224 176.098 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.6 mt -77.7 -33.2 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 127.309 2.244 . . . . 1.32 112.101 171.851 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -60.77 -34.6 74.72 Favored 'General case' 0 N--CA 1.431 -1.384 1 O-C-N 115.647 -4.408 . . . . 1.7 118.452 171.902 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -67.83 -26.03 65.85 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 110.523 -3.035 . . . . 1.55 113.728 168.879 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -96.44 -58.52 2.04 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 104.633 -2.358 . . . . 2.62 104.633 -172.94 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -92.45 -44.38 8.69 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.776 -2.453 . . . . 1.48 115.145 -169.817 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.8 -11.0 10.24 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 119.299 -2.126 . . . . 1.12 111.402 176.718 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.0 mt -68.64 129.12 92.75 Favored Pre-proline 0 N--CA 1.429 -1.49 0 CA-C-O 112.896 -3.43 . . . . 1.55 109.165 -174.627 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -73.87 154.95 48.64 Favored 'Trans proline' 0 N--CA 1.433 -2.049 0 CA-C-N 126.783 3.458 . . . . 1.02 109.959 -174.667 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.39 -11.27 19.05 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 123.942 3.095 . . . . 1.25 111.654 -171.779 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -53.79 -59.14 5.0 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.906 2.482 . . . . 2.25 114.768 165.417 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -66.96 -23.79 65.99 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 118.911 2.93 . . . . 2.02 118.911 -177.871 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -83.97 134.69 34.64 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.415 1.886 . . . . 0.69 113.52 -170.311 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.255 47.8 mtt180 -119.34 114.44 22.36 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.382 -1.449 . . . . 2.78 109.847 172.11 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.0 mt -95.73 137.62 34.53 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.036 -1.839 . . . . 1.17 106.036 178.247 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.4 mt -135.37 136.78 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 128.261 2.625 . . . . 1.38 109.186 179.571 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -139.08 143.93 38.53 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 121.478 -0.764 . . . . 1.5 110.941 168.696 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.344 . . 54.4 27.57 8.35 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.712 -2.493 . . . . 1.21 115.499 176.658 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.88 -7.21 35.98 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-O 119.054 -0.859 . . . . 1.3 112.649 -170.583 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -87.2 139.93 30.06 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 123.032 3.416 . . . . 2.55 111.815 173.537 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -98.09 115.49 28.36 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.493 -2.004 . . . . 2.48 109.03 174.825 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 mt -83.24 159.42 21.97 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.425 -1.261 . . . . 0.9 112.961 -173.532 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -112.47 155.17 24.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 118.486 2.773 . . . . 1.94 118.486 172.471 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.51 -54.03 38.76 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 119.483 3.142 . . . . 1.56 119.483 -167.666 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.78 63.69 4.41 Favored Glycine 0 N--CA 1.431 -1.679 0 O-C-N 119.613 -1.929 . . . . 0.97 116.387 170.952 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -139.48 155.17 47.72 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.006 -2.22 . . . . 2.49 105.006 168.121 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 40.7 p -87.81 171.34 10.46 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.68 2.181 . . . . 0.76 109.481 176.274 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.0 mt -70.46 -37.69 74.34 Favored 'General case' 0 N--CA 1.43 -1.433 1 O-C-N 116.179 -4.076 . . . . 1.05 107.448 172.529 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.8 t -52.61 -45.83 66.74 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 118.5 2.778 . . . . 1.19 118.5 173.802 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -58.34 -53.74 54.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 130.7 3.6 . . . . 1.9 112.184 173.098 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -76.67 -2.1 31.11 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.863 -3.648 . . . . 0.89 115.876 -175.461 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.269 17.6 m120 60.93 55.44 3.14 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.569 1.947 . . . . 1.84 116.036 -178.825 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.0 mt -106.76 128.01 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-O 115.586 -2.149 . . . . 0.82 108.925 174.872 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -107.39 -176.2 3.0 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 114.446 -2.692 . . . . 2.16 111.983 -170.024 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.1 ptmm? -59.14 146.48 38.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 126.706 2.504 . . . . 2.12 114.462 171.717 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.285 50.8 mt-10 69.87 20.5 6.68 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.281 1.515 . . . . 1.71 114.984 174.767 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.8 t -102.77 161.95 13.32 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 114.249 -1.341 . . . . 1.04 110.912 -171.917 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.2 m -121.18 120.12 34.31 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.629 -1.92 . . . . 0.79 114.144 -172.205 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 8.1 mt -92.15 164.06 13.71 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 122.749 1.262 . . . . 1.4 110.381 172.694 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -121.96 112.29 18.11 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.819 -3.051 . . . . 1.51 112.324 -179.234 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.5 tp -87.55 122.29 31.07 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 118.211 -2.806 . . . . 1.14 113.361 179.14 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.94 168.33 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 105.145 -2.169 . . . . 1.23 105.145 175.107 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.1 mt . . . . . 0 N--CA 1.43 -1.43 1 O-C-N 116.24 -4.037 . . . . 2.78 108.782 -176.533 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 CA--C 1.491 -1.312 0 CA-C-O 127.519 3.533 . . . . 1.1 115.955 . . . . . . . . . 0 0 . 1 . 083 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -81.77 140.2 34.38 Favored 'General case' 0 N--CA 1.431 -1.407 1 O-C-N 113.473 -5.767 . . . . 1.87 110.601 -175.387 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.5 pt -131.47 159.47 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 119.818 -1.801 . . . . 0.72 106.606 177.136 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -120.08 100.12 7.01 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.949 1.833 . . . . 1.4 112.048 -175.532 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -91.09 111.99 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 103.968 -2.605 . . . . 0.58 103.968 177.195 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.254 68.2 mmtt -90.68 141.09 29.15 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.232 -2.792 . . . . 2.09 110.85 177.666 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.5 p -93.96 176.29 6.39 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 120.586 3.55 . . . . 0.99 120.586 172.229 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.6 tp -66.11 -43.83 86.07 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 126.35 1.86 . . . . 2.53 110.497 -177.559 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.8 p -78.36 -49.55 13.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.063 3.357 . . . . 2.08 120.063 -171.641 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.9 32.59 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 128.321 2.867 . . . . 1.31 120.073 174.565 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.35 149.44 31.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.373 -0.973 . . . . 1.4 108.373 178.482 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -104.59 138.06 41.5 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.667 -2.521 . . . . 0.78 106.752 171.835 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.265 3.2 mt -106.12 92.91 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 122.793 1.282 . . . . 1.55 109.391 175.177 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.8 m -78.81 116.58 19.23 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 119.97 -1.706 . . . . 1.08 109.709 174.812 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.7 mt -125.51 149.26 48.45 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 106.849 -1.537 . . . . 1.55 106.849 -179.773 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -85.2 109.81 18.58 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 127.31 2.881 . . . . 1.95 117.386 165.227 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -121.88 164.07 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 121.879 2.127 . . . . 0.96 110.008 -178.799 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -112.06 157.75 38.85 Favored Pre-proline 0 N--CA 1.43 -1.435 0 C-N-CA 125.529 1.532 . . . . 2.35 109.482 164.858 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -86.48 -0.29 8.15 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 CA-C-N 125.658 3.057 . . . . 0.95 110.902 -170.281 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.1 p -89.82 -14.82 33.62 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 129.657 3.183 . . . . 1.45 111.251 175.205 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -68.03 142.37 55.91 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 127.086 3.327 . . . . 1.69 107.816 173.934 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.2 p -79.69 160.95 26.1 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.795 -2.441 . . . . 0.75 111.429 174.003 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mm -66.58 -27.17 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 1 O-C-N 115.628 -4.42 . . . . 0.73 111.743 171.513 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -56.98 -45.57 82.85 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 129.056 2.942 . . . . 1.62 109.836 167.913 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -65.45 -52.1 55.46 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.146 2.578 . . . . 2.13 111.752 176.626 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.82 -37.36 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 128.866 2.866 . . . . 0.62 109.404 177.046 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.84 -36.42 82.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 121.292 1.86 . . . . 1.22 115.467 174.81 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -24.81 67.78 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.257 1.206 . . . . 0.51 114.257 166.406 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -82.52 -25.57 33.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.756 -3.715 . . . . 1.44 111.618 173.747 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.8 mt -77.53 -29.09 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 117.915 -2.991 . . . . 1.32 111.103 175.093 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -66.61 -43.31 85.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 127.462 2.976 . . . . 1.7 111.567 173.536 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.263 31.6 t70 -49.6 -39.77 36.64 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 116.752 2.13 . . . . 1.55 116.752 168.03 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -86.07 -61.69 1.69 Allowed 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 118.289 2.7 . . . . 2.62 118.289 -178.153 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -95.19 -11.74 27.56 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.088 1.355 . . . . 1.48 113.052 -174.083 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.65 24.77 71.63 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 117.257 -3.402 . . . . 1.12 118.334 179.696 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.5 mt -99.62 132.37 23.21 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 116.852 -3.734 . . . . 1.55 110.218 -169.848 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 11.1 Cg_endo -72.91 152.51 52.11 Favored 'Trans proline' 0 C--N 1.299 -2.038 1 C-N-CA 125.518 4.145 . . . . 1.02 113.536 -175.255 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 64.9 Cg_exo -66.92 -36.61 22.38 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 O-C-N 115.322 -3.041 . . . . 1.25 112.947 -175.046 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.26 -25.74 67.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 124.715 2.198 . . . . 2.25 115.774 178.405 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -91.24 -22.91 20.36 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.29 -1.506 . . . . 2.02 109.811 179.783 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -78.84 135.89 37.17 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.831 -3.043 . . . . 0.69 112.239 -177.517 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.346 38.2 ttt180 -124.25 123.51 40.39 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 116.973 -3.579 . . . . 2.78 109.288 167.948 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mt -105.63 127.17 52.9 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.672 2.177 . . . . 1.17 108.885 179.682 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.3 mm -114.37 143.17 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 131.273 3.829 . . . . 1.38 106.816 -177.683 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -131.07 100.05 5.09 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.723 -3.111 . . . . 1.5 107.973 175.998 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.351 . . 66.76 -61.53 0.32 Allowed 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 129.22 3.008 . . . . 1.21 114.856 -173.031 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.09 -24.31 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 106.538 -2.625 . . . . 1.3 106.538 -176.079 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -90.08 153.41 20.57 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.094 -2.416 . . . . 2.55 110.481 177.237 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -97.73 140.59 31.9 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 102.072 -3.307 . . . . 2.48 102.072 179.184 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.2 mt -116.47 127.08 54.25 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 115.961 -1.971 . . . . 0.9 110.767 -173.023 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -83.31 157.1 22.73 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 118.635 2.828 . . . . 1.94 118.635 -179.419 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -59.87 -63.85 1.16 Allowed 'General case' 0 N--CA 1.43 -1.444 1 N-CA-C 121.829 4.011 . . . . 1.56 121.829 -167.02 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.21 31.79 2.58 Favored Glycine 0 N--CA 1.43 -1.754 0 CA-C-N 113.572 -1.649 . . . . 0.97 117.114 172.05 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -98.25 164.77 12.17 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.486 -3.361 . . . . 2.49 109.04 159.616 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.455 11.9 p -95.69 172.83 7.8 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.65 2.38 . . . . 0.76 109.855 172.615 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.6 mp -76.01 -37.96 57.86 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.979 -1.009 . . . . 1.05 109.607 171.098 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -48.97 -50.03 37.62 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 116.588 2.07 . . . . 1.19 116.588 175.433 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -56.28 -35.44 67.49 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.352 2.661 . . . . 1.9 115.367 176.126 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -99.45 6.72 45.89 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.835 1.654 . . . . 0.89 112.849 178.342 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.9 m120 53.87 37.89 27.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.53 2.048 . . . . 1.84 116.53 -178.811 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.2 mm -82.27 114.69 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 126.691 1.996 . . . . 0.82 107.88 -173.896 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -103.61 -177.22 3.31 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.779 -2.451 . . . . 2.16 110.731 -173.61 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -58.45 146.29 35.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 127.143 2.177 . . . . 2.12 113.08 179.425 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.276 72.9 mt-10 64.03 19.42 11.75 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 128.325 3.516 . . . . 1.71 118.119 172.957 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.6 m -88.48 151.33 22.62 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.91 -1.885 . . . . 1.04 105.91 -168.778 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.0 m -90.12 110.38 21.39 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.269 2.228 . . . . 0.79 107.716 -179.364 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -102.34 155.76 18.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 102.214 -3.254 . . . . 1.4 102.214 174.055 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -129.16 128.24 43.01 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.974 -4.204 . . . . 1.51 115.34 -176.781 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.0 tp -108.34 124.21 50.0 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 124.749 1.281 . . . . 1.14 112.28 -174.686 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.431 15.6 m -118.17 -179.3 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 130.481 3.512 . . . . 1.23 108.812 170.202 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 N--CA 1.43 -1.442 0 O-C-N 116.398 -3.938 . . . . 2.78 113.099 179.038 . . . . . . . . 0 0 . 1 . 084 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 CA--C 1.489 -1.382 0 N-CA-C 115.709 1.744 . . . . 1.1 115.709 . . . . . . . . . 0 0 . 1 . 084 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -74.82 134.64 41.71 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 118.079 -0.962 . . . . 1.87 111.048 -177.683 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.445 HD12 HD12 ' A' ' 67' ' ' LEU . 45.5 pt -131.15 173.38 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-O 127.385 3.469 . . . . 0.72 108.341 174.769 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.439 ' HB2' ' HA ' ' A' ' 66' ' ' THR 0.251 22.9 m-85 -127.41 134.83 49.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.519 -3.238 . . . . 1.4 105.653 -171.465 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -116.69 114.59 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.545 -2.021 . . . . 0.58 105.545 178.554 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -107.98 137.02 46.7 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 116.18 -4.075 . . . . 2.09 109.779 178.367 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.2 p -83.69 166.77 17.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.531 -1.981 . . . . 0.99 115.157 173.167 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.8 mt -39.14 -51.9 1.9 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 120.903 3.668 . . . . 2.53 120.903 167.021 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.8 p -82.99 -32.28 27.06 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 116.697 -3.752 . . . . 2.08 110.061 -175.544 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.44 24.66 0.16 Allowed Glycine 0 N--CA 1.43 -1.717 0 O-C-N 119.407 -2.058 . . . . 1.31 116.758 172.066 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -88.41 123.18 32.71 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.207 1.504 . . . . 1.4 112.707 -175.791 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -83.93 115.84 22.49 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 120.726 3.602 . . . . 0.78 120.726 172.939 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.4 mt -108.24 141.08 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 124.911 1.284 . . . . 1.55 111.136 176.352 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.8 m -116.97 137.21 52.37 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.523 -1.986 . . . . 1.08 107.152 178.419 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.8 mt -135.96 144.11 45.23 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.219 1.407 . . . . 1.55 112.007 -179.435 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -93.59 115.83 28.33 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.004 0.82 . . . . 1.95 111.168 169.283 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.53 HG11 HG22 ' A' ' 26' ' ' VAL . 11.5 m -118.57 173.4 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 101.914 -3.365 . . . . 0.96 101.914 178.377 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -118.25 160.24 40.19 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 103.488 -2.782 . . . . 2.35 103.488 167.435 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -64.71 -18.28 62.1 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 C-N-CA 124.558 3.505 . . . . 0.95 117.25 -173.183 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 m -104.08 19.72 19.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 126.622 2.451 . . . . 1.45 107.563 -178.346 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -82.03 140.96 33.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 113.449 0.907 . . . . 1.69 113.449 171.168 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.264 68.2 p -80.02 156.22 27.25 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.563 2.125 . . . . 0.75 113.491 174.99 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.3 mm -58.62 -41.12 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.663 1.585 . . . . 0.73 111.621 175.074 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -46.54 -44.72 18.14 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.701 -1.875 . . . . 1.62 114.992 168.276 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -71.21 -35.58 71.57 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 125.658 1.583 . . . . 2.13 111.276 179.678 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.53 HG22 HG11 ' A' ' 17' ' ' VAL . 5.5 t -58.38 -45.69 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 117.587 -3.196 . . . . 0.62 114.199 167.989 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -65.77 -35.49 80.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 114.169 -2.824 . . . . 1.22 111.353 170.0 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.04 -29.21 68.13 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 123.365 2.802 . . . . 0.51 111.539 175.085 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.6 mttm -65.71 -21.98 66.57 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.571 -1.331 . . . . 1.44 114.049 171.752 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.2 mm -85.94 -23.92 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 127.252 2.221 . . . . 1.32 105.911 170.073 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.426 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 50.4 tt0 -77.04 -23.03 52.11 Favored 'General case' 0 N--CA 1.429 -1.482 2 O-C-N 114.538 -5.101 . . . . 1.7 111.265 173.717 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -74.51 -40.45 61.77 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 114.716 1.376 . . . . 1.55 114.716 167.571 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -87.35 -66.31 0.92 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 116.592 2.071 . . . . 2.62 116.592 179.093 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -82.52 -32.11 28.85 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 118.057 -1.457 . . . . 1.48 109.625 -172.101 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.75 43.05 3.45 Favored Glycine 0 N--CA 1.429 -1.776 0 O-C-N 116.78 -3.7 . . . . 1.12 114.155 -176.193 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.4 mt -120.38 136.78 25.46 Favored Pre-proline 0 N--CA 1.429 -1.5 1 N-CA-C 99.808 -4.145 . . . . 1.55 99.808 -174.721 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -67.84 152.66 77.08 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 O-C-N 115.767 -2.807 . . . . 1.02 113.845 176.798 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.426 ' HD3' ' OE1' ' A' ' 31' ' ' GLN . 63.1 Cg_endo -78.41 -12.93 15.31 Favored 'Trans proline' 0 N--CA 1.433 -2.079 0 C-N-CA 117.529 -1.181 . . . . 1.25 110.713 -173.277 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -72.6 -38.5 67.82 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.347 -2.095 . . . . 2.25 113.89 170.885 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -69.97 -25.67 63.74 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.327 -2.733 . . . . 2.02 111.085 178.308 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -89.35 143.62 26.69 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.384 2.673 . . . . 0.69 115.873 -171.817 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -132.0 150.38 52.17 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 115.709 -2.091 . . . . 2.78 107.966 167.503 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.9 mt -106.14 138.85 41.6 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 124.553 3.342 . . . . 1.17 110.017 174.355 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 mt -112.67 146.12 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-O 125.03 2.347 . . . . 1.38 106.372 172.251 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.45 ' HB3' HD11 ' A' ' 50' ' ' LEU . 83.8 t80 -165.36 137.08 4.09 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 127.756 3.646 . . . . 1.5 105.166 174.653 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.53 19.51 11.53 Favored 'General case' 0 N--CA 1.431 -1.4 1 O-C-N 116.052 -4.155 . . . . 1.21 113.775 -176.622 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.13 -22.8 32.61 Favored Glycine 0 N--CA 1.431 -1.669 0 O-C-N 119.177 -2.202 . . . . 1.3 113.826 -175.5 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -93.0 157.54 16.26 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 121.539 3.903 . . . . 2.55 121.539 176.403 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -94.45 133.91 37.53 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 116.973 -1.891 . . . . 2.48 111.106 174.226 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 45' ' ' PHE . 19.9 mt -81.13 133.23 35.43 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.106 1.362 . . . . 0.9 113.069 -172.927 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -67.3 142.98 56.67 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.273 1.035 . . . . 1.94 109.725 170.136 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -77.0 -56.43 4.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.154 1.454 . . . . 1.56 110.381 -168.553 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.16 40.87 1.74 Allowed Glycine 0 N--CA 1.43 -1.765 1 O-C-N 116.225 -4.047 . . . . 0.97 118.198 171.33 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -117.73 161.2 20.08 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.626 -3.279 . . . . 2.49 106.555 167.745 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.5 p -86.23 177.19 7.58 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.094 -1.629 . . . . 0.76 114.233 176.11 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.0 mt -70.45 -44.69 67.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.672 -1.893 . . . . 1.05 110.4 176.106 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 t -63.01 -30.54 71.68 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.239 1.57 . . . . 1.19 115.239 -178.811 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -57.26 -46.7 82.81 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.806 2.442 . . . . 1.9 107.269 177.596 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.263 24.2 m-85 -87.15 -1.86 58.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.208 -3.432 . . . . 0.89 116.515 177.121 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 71.88 52.8 0.21 Allowed 'General case' 0 N--CA 1.43 -1.459 1 C-N-CA 133.87 4.868 . . . . 1.84 107.268 178.047 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 mt -96.7 126.27 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.123 -2.236 . . . . 0.82 107.747 -179.455 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.408 31.0 mt-30 -96.76 -167.49 1.56 Allowed 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 121.153 -0.967 . . . . 2.16 110.127 -171.582 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -75.05 151.32 38.7 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.699 1.6 . . . . 2.12 112.79 167.848 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.295 8.8 mt-10 66.6 27.31 9.59 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.579 2.351 . . . . 1.71 114.053 172.856 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.9 t -108.98 134.82 51.12 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 117.183 -3.448 . . . . 1.04 110.648 -172.961 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 97.9 m -82.11 104.21 12.28 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.449 2.547 . . . . 0.79 115.324 -178.346 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.445 HD12 HD12 ' A' ' 3' ' ' ILE . 93.6 mt -91.58 129.23 37.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.142 -2.849 . . . . 1.4 108.922 177.953 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -92.19 115.54 28.17 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.348 -2.72 . . . . 1.51 108.666 -173.22 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.4 tp -86.52 134.2 33.68 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 113.558 -3.115 . . . . 1.14 115.742 179.946 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 m -132.11 -172.63 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 127.892 3.245 . . . . 1.23 108.78 170.427 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.0 mt . . . . . 0 N--CA 1.43 -1.431 0 C-N-CA 126.317 1.847 . . . . 2.78 110.279 176.315 . . . . . . . . 0 0 . 1 . 085 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptt? . . . . . 0 CA--C 1.49 -1.328 0 N-CA-C 107.841 -1.17 . . . . 1.1 107.841 . . . . . . . . . 0 0 . 1 . 085 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -121.55 144.81 48.51 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 119.941 -0.704 . . . . 1.87 111.656 -176.02 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.2 pt -129.06 163.74 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 120.042 -1.661 . . . . 0.72 110.038 175.167 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -111.42 114.31 27.35 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.366 2.508 . . . . 1.4 108.539 -178.647 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 81.4 t -103.76 126.33 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 118.252 -2.78 . . . . 0.58 105.985 169.347 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -107.16 127.49 53.56 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 125.638 1.836 . . . . 2.09 110.385 174.109 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.3 p -81.15 170.31 16.3 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 129.805 3.242 . . . . 0.99 113.154 173.09 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.9 mt -67.2 -30.6 70.58 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.271 -2.143 . . . . 2.53 114.086 174.701 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 p -85.7 -5.42 59.26 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.556 -1.275 . . . . 2.08 107.556 -174.677 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.92 1.49 36.36 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 115.225 0.85 . . . . 1.31 115.225 170.592 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -78.64 114.57 17.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 118.54 1.17 . . . . 1.4 112.518 -178.123 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 m -79.64 130.44 35.37 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 120.708 1.595 . . . . 0.78 110.497 170.052 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mt -109.19 119.15 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 131.541 3.936 . . . . 1.55 106.554 174.528 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.2 m -92.41 95.66 9.79 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 107.143 -1.429 . . . . 1.08 107.143 178.765 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.3 mt -96.2 139.07 32.89 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 117.937 2.569 . . . . 1.55 117.937 -177.149 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -59.76 114.49 2.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 111.127 -2.761 . . . . 1.95 109.289 163.56 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.298 13.7 m -136.6 166.19 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 126.983 2.113 . . . . 0.96 109.708 173.795 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -125.28 162.42 44.18 Favored Pre-proline 0 N--CA 1.43 -1.473 0 N-CA-C 101.258 -3.608 . . . . 2.35 101.258 171.892 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -81.93 -6.55 12.29 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 O-C-N 117.739 -1.769 . . . . 0.95 107.909 -175.79 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.7 p -99.82 16.98 21.93 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.247 1.573 . . . . 1.45 115.247 176.445 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -78.14 144.29 36.54 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 129.56 3.144 . . . . 1.69 106.123 172.952 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.0 p -83.4 154.53 23.95 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.01 1.724 . . . . 0.75 111.586 175.548 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.0 mm -67.72 -36.3 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 124.897 1.373 . . . . 0.73 110.145 -179.523 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -59.95 -41.97 93.02 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.573 -1.955 . . . . 1.62 111.92 169.977 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.3 28.4 t-20 -61.55 -37.16 82.77 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.75 -3.094 . . . . 2.13 114.738 177.256 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.9 t -53.33 -51.39 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 124.522 1.138 . . . . 0.62 113.329 169.676 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -59.96 -31.86 70.27 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 114.071 1.137 . . . . 1.22 114.071 174.38 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.22 -33.45 73.32 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.168 -2.207 . . . . 0.51 113.376 170.893 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -71.2 -26.04 62.77 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 122.397 2.362 . . . . 1.44 110.247 173.544 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.3 mt -76.99 -26.54 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-N 121.28 1.855 . . . . 1.32 106.585 173.786 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -68.9 -48.51 63.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 121.194 1.816 . . . . 1.7 109.755 176.75 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -51.18 -39.08 55.63 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.071 -2.893 . . . . 1.55 113.616 174.184 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -82.92 -71.11 0.51 Allowed 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.877 2.471 . . . . 2.62 106.221 -174.978 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -100.42 -45.14 5.66 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.051 2.982 . . . . 1.48 119.051 -166.292 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.78 74.25 0.85 Allowed Glycine 0 N--CA 1.431 -1.694 0 CA-C-O 124.748 2.305 . . . . 1.12 115.946 166.37 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.89 127.24 23.94 Favored Pre-proline 0 N--CA 1.43 -1.466 0 CA-C-N 110.804 -2.698 . . . . 1.55 105.54 -178.724 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -58.42 134.92 64.48 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 CA-C-O 112.481 -3.216 . . . . 1.02 118.075 176.851 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -65.44 -14.97 47.68 Favored 'Trans proline' 0 C--N 1.299 -2.046 1 C-N-CA 126.51 4.807 . . . . 1.25 120.528 -174.407 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.85 -20.34 35.79 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.338 -2.101 . . . . 2.25 111.06 167.44 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -87.11 -29.02 22.15 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.517 1.962 . . . . 2.02 114.438 -175.476 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.329 1.5 pt20 -78.95 135.62 37.0 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 115.067 -2.397 . . . . 0.69 110.041 -176.468 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.31 65.9 mtt180 -104.15 136.44 43.77 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 128.482 3.614 . . . . 2.78 110.047 164.834 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.5 mt -108.89 132.83 53.67 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 126.67 3.128 . . . . 1.17 110.072 172.116 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 53.7 mt -119.58 142.06 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 118.822 -2.423 . . . . 1.38 106.51 -178.831 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -157.89 141.15 15.24 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 100.603 -3.851 . . . . 1.5 100.603 171.98 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.56 -44.96 0.61 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.385 3.074 . . . . 1.21 116.394 -173.948 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 166.78 -48.42 0.26 Allowed Glycine 0 N--CA 1.43 -1.731 0 CA-C-O 124.646 2.248 . . . . 1.3 109.598 -170.923 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -83.09 -179.97 7.58 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.443 2.016 . . . . 2.55 116.443 178.752 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -96.53 147.7 23.58 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.433 -2.042 . . . . 2.48 111.502 170.87 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.6 mt -94.54 134.11 37.45 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 104.583 -2.377 . . . . 0.9 104.583 -176.105 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -86.09 137.34 32.75 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.717 0.77 . . . . 1.94 111.436 176.478 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.13 -57.99 5.73 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.935 3.694 . . . . 1.56 117.746 -168.95 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.98 44.16 3.28 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 124.639 3.381 . . . . 0.97 120.041 176.318 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 -115.65 173.26 6.63 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.733 2.682 . . . . 2.49 104.479 165.685 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.7 p -108.88 173.8 6.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.534 -1.666 . . . . 0.76 112.258 176.406 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.15 -37.28 72.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 114.856 1.428 . . . . 1.05 114.856 170.062 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -57.51 -42.0 81.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.397 -2.689 . . . . 1.19 113.73 174.539 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -52.21 -41.22 62.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.185 2.661 . . . . 1.9 118.185 173.461 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -88.99 -16.06 32.64 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 128.366 2.667 . . . . 0.89 108.251 178.139 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.419 12.0 m-80 72.83 48.56 0.19 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.776 -1.203 . . . . 1.84 111.395 179.434 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.6 mt -87.92 122.22 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.97 -2.331 . . . . 0.82 107.954 -172.993 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -87.39 -177.12 5.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 117.38 -1.728 . . . . 2.16 114.373 -173.543 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.256 14.8 pttp -63.43 140.37 58.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.952 -3.593 . . . . 2.12 110.969 167.358 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 68.42 30.18 5.47 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 127.937 2.495 . . . . 1.71 111.642 177.908 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.1 m -88.02 145.24 26.08 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 119.097 -2.252 . . . . 1.04 113.278 -172.79 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.3 m -92.27 119.68 32.1 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 118.302 -2.749 . . . . 0.79 112.953 -179.923 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mt -104.95 131.36 52.55 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 119.7 -1.875 . . . . 1.4 107.718 165.3 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -94.92 135.51 36.35 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 103.701 -2.703 . . . . 1.51 103.701 -178.719 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.7 tp -106.96 123.17 47.79 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 127.226 2.211 . . . . 1.14 110.666 -172.18 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.329 0.1 OUTLIER -121.63 167.89 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.578 1.951 . . . . 1.23 112.596 176.499 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 N--CA 1.431 -1.42 0 O-C-N 125.66 1.85 . . . . 2.78 108.697 177.979 . . . . . . . . 0 0 . 1 . 086 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 CA--C 1.491 -1.321 0 CA-C-O 116.583 -1.675 . . . . 1.1 114.993 . . . . . . . . . 0 0 . 1 . 086 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -93.35 122.81 36.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 128.69 2.796 . . . . 1.87 106.769 -177.367 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 pt -119.65 170.17 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 124.553 2.121 . . . . 0.72 108.124 169.539 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.263 72.7 m-85 -122.09 144.56 48.85 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.185 -3.447 . . . . 1.4 110.645 -179.652 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.83 128.9 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 120.482 -1.386 . . . . 0.58 108.045 173.327 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -93.28 132.36 37.54 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.753 -3.092 . . . . 2.09 108.573 171.206 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.9 p -74.16 -169.99 0.88 Allowed 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 117.338 2.347 . . . . 0.99 117.338 177.105 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.2 mt -72.69 -62.44 1.45 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.225 2.61 . . . . 2.53 106.377 173.743 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.8 p -56.76 -56.34 22.76 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 120.383 3.475 . . . . 2.08 120.383 -175.178 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.38 43.55 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.764 0 CA-C-O 119.219 -0.767 . . . . 1.31 111.35 177.968 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -126.49 155.56 42.12 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 130.279 3.432 . . . . 1.4 104.334 -179.002 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.9 m -125.32 119.05 27.3 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 104.839 -2.282 . . . . 0.78 104.839 -178.94 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -95.52 148.88 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 103.483 -2.784 . . . . 1.55 103.483 -176.421 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.3 m -117.41 117.85 30.6 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.452 2.548 . . . . 1.08 106.231 177.296 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.2 mt -116.37 138.19 51.54 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.7 -2.5 . . . . 1.55 111.179 -174.517 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.12 106.15 18.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.724 2.009 . . . . 1.95 115.143 170.713 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 m -127.87 167.79 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 125.538 2.589 . . . . 0.96 108.549 -172.937 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -110.1 161.78 23.03 Favored Pre-proline 0 N--CA 1.43 -1.453 0 O-C-N 116.584 -3.823 . . . . 2.35 108.257 162.682 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -73.06 -12.12 25.67 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-N 124.72 2.721 . . . . 0.95 113.275 -177.245 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 m -83.7 -9.14 59.05 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 115.124 -2.369 . . . . 1.45 109.339 175.523 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -74.0 155.86 38.15 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 124.391 3.269 . . . . 1.69 111.138 178.251 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.6 p -95.73 164.44 12.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.5 -1.375 . . . . 0.75 110.411 -177.19 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.6 mm -62.47 -31.11 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 124.581 1.153 . . . . 0.73 112.032 175.934 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -58.71 -47.52 84.29 Favored 'General case' 0 N--CA 1.429 -1.499 1 C-N-CA 134.097 4.959 . . . . 1.62 114.611 162.383 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.281 29.4 m120 -66.21 -37.95 86.8 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.483 -3.26 . . . . 2.13 106.93 178.947 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.4 t -71.2 -25.95 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 1 O-C-N 115.045 -4.784 . . . . 0.62 117.875 176.415 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -81.96 -32.92 30.49 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 104.635 -2.357 . . . . 1.22 104.635 178.994 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.4 68.0 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.872 -3.642 . . . . 0.51 111.407 172.715 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -67.15 -28.19 67.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 125.867 1.979 . . . . 1.44 109.921 171.595 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.1 mt -75.39 -18.04 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 116.514 -3.866 . . . . 1.32 113.93 170.138 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -68.35 -27.75 66.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 119.715 1.143 . . . . 1.7 111.694 167.667 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -68.57 -51.74 39.39 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.385 -3.322 . . . . 1.55 112.338 165.638 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -68.81 -74.81 0.12 Allowed 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.926 -2.359 . . . . 2.62 117.256 -175.603 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -90.73 -15.24 30.58 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 124.389 1.055 . . . . 1.48 113.122 -176.6 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.38 48.47 5.94 Favored Glycine 0 N--CA 1.43 -1.723 0 C-N-CA 119.276 -1.44 . . . . 1.12 115.967 168.046 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.4 mt -125.66 140.07 35.62 Favored Pre-proline 0 N--CA 1.429 -1.488 0 C-N-CA 126.781 2.033 . . . . 1.55 107.786 -175.51 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -67.83 149.9 78.4 Favored 'Trans proline' 0 N--CA 1.433 -2.055 2 C-N-CA 125.938 4.425 . . . . 1.02 112.285 -174.381 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.472 58.0 Cg_endo -61.22 -38.35 66.87 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 CA-C-N 127.293 3.64 . . . . 1.25 119.213 -179.972 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -57.44 -36.65 71.67 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 127.003 2.69 . . . . 2.25 114.178 -179.316 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -81.22 -13.11 58.88 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.576 2.065 . . . . 2.02 116.576 -177.021 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -92.19 141.94 28.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.94 -1.725 . . . . 0.69 110.822 -175.445 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -113.52 134.78 54.5 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 125.775 1.922 . . . . 2.78 110.702 167.515 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 69' ' ' LEU . 34.8 mt -116.73 111.96 20.52 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.022 -1.844 . . . . 1.17 106.022 -178.618 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.569 HD13 ' HA ' ' A' ' 49' ' ' GLN . 24.3 mm -102.46 135.58 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 118.626 -2.546 . . . . 1.38 108.063 -173.318 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -154.44 122.89 6.1 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 124.249 1.02 . . . . 1.5 111.166 171.687 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.92 46.64 4.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.801 2.239 . . . . 1.21 116.525 -177.448 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.24 -31.01 4.21 Favored Glycine 0 N--CA 1.43 -1.734 0 CA-C-N 113.875 -1.511 . . . . 1.3 114.505 175.528 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -96.68 156.74 16.22 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 124.867 2.27 . . . . 2.55 114.415 -177.299 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.569 ' HA ' HD13 ' A' ' 44' ' ' ILE . 39.3 tt0 -93.05 121.51 34.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 127.492 3.52 . . . . 2.48 109.867 175.349 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.3 mt -79.07 122.6 26.42 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 113.55 -5.719 . . . . 0.9 114.864 -172.901 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.259 53.4 mt-10 -70.59 139.67 51.49 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 121.171 3.767 . . . . 1.94 121.171 -178.222 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -52.54 -63.09 1.25 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.327 3.051 . . . . 1.56 116.74 -169.323 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.74 43.3 3.06 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 125.784 1.659 . . . . 0.97 113.12 172.296 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.5 mtt-85 -121.91 162.02 21.76 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.642 -2.681 . . . . 2.49 109.543 165.686 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.26 70.2 p -92.63 151.17 20.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.368 2.667 . . . . 0.76 110.372 178.519 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -50.96 -50.59 57.71 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 125.514 2.578 . . . . 1.05 110.9 167.438 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -48.36 -42.69 32.24 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 114.605 -5.059 . . . . 1.19 118.006 174.668 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -71.5 -16.85 62.36 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.938 2.199 . . . . 1.9 116.938 173.538 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -94.15 -2.91 51.92 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 126.167 1.787 . . . . 0.89 106.359 177.096 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.5 m120 66.03 32.3 8.44 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.922 1.689 . . . . 1.84 112.735 176.341 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.7 mt -91.03 121.55 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 126.842 3.211 . . . . 0.82 107.771 -177.537 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -113.1 -170.46 1.68 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.66 -3.15 . . . . 2.16 114.044 178.531 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -61.73 135.63 57.68 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 112.348 -2.206 . . . . 2.12 112.279 -179.689 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.272 12.9 mt-10 83.67 13.58 0.35 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.791 2.036 . . . . 1.71 116.086 173.119 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.8 t -88.11 145.34 25.99 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.843 2.057 . . . . 1.04 105.873 -170.364 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.2 m -108.31 110.16 21.67 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.7 -1.25 . . . . 0.79 110.497 -176.678 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.4 mt -90.34 150.83 21.73 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 127.424 3.488 . . . . 1.4 107.247 172.582 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -111.73 129.39 56.13 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.083 -4.761 . . . . 1.51 110.993 -179.48 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 43' ' ' LEU . 47.3 tp -98.28 133.13 43.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 128.106 3.812 . . . . 1.14 101.559 -171.234 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.55 163.06 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.986 -2.946 . . . . 1.23 106.668 172.516 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 71' ' ' LEU . 33.1 mt . . . . . 0 N--CA 1.431 -1.41 0 CA-C-O 125.643 2.64 . . . . 2.78 114.646 176.034 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 ptt? . . . . . 0 CA--C 1.491 -1.315 0 N-CA-C 115.303 1.594 . . . . 1.1 115.303 . . . . . . . . . 0 0 . 1 . 087 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.278 4.8 pt20 -127.02 138.93 53.33 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 129.042 3.963 . . . . 1.87 112.984 175.064 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.5 pt -127.2 151.05 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 130.794 3.638 . . . . 0.72 109.989 175.987 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -98.26 136.83 37.89 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 111.898 -2.41 . . . . 1.4 110.438 -179.056 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 89.2 t -112.66 125.84 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-O 114.692 -2.575 . . . . 0.58 111.397 171.982 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -105.29 128.43 53.45 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 123.122 2.692 . . . . 2.09 113.611 176.263 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.286 3.5 p -84.56 173.91 10.42 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 120.036 3.347 . . . . 0.99 120.036 177.576 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.77 -38.08 82.93 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 130.548 3.539 . . . . 2.53 111.302 -179.821 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.7 p -74.95 -45.42 42.42 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.485 1.514 . . . . 2.08 109.713 177.408 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.25 42.67 0.31 Allowed Glycine 0 N--CA 1.43 -1.728 0 O-C-N 125.944 2.027 . . . . 1.31 110.603 169.154 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -105.69 157.98 17.04 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.076 2.15 . . . . 1.4 106.279 -173.266 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -111.25 124.53 52.4 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 121.024 1.738 . . . . 0.78 106.33 175.414 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.472 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 20.0 mt -100.04 121.51 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 100.807 -3.775 . . . . 1.55 100.807 173.795 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.0 m -104.89 114.07 28.05 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.176 2.893 . . . . 1.08 105.675 175.087 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.6 mt -101.11 145.16 29.12 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 128.171 2.588 . . . . 1.55 112.772 -177.046 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -97.18 112.69 24.37 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 117.02 -1.467 . . . . 1.95 113.892 173.475 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.8 169.93 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 116.032 1.864 . . . . 0.96 116.032 -179.815 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -114.37 160.74 31.71 Favored Pre-proline 0 N--CA 1.43 -1.449 0 O-C-N 127.968 3.293 . . . . 2.35 109.424 165.954 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.34 -10.66 29.64 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 O-C-N 114.521 -3.463 . . . . 0.95 114.792 -173.687 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.8 p -85.87 -16.18 39.45 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.792 3.808 . . . . 1.45 111.468 177.881 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -70.19 147.8 49.41 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.408 -3.308 . . . . 1.69 114.064 -175.845 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.8 p -95.67 166.24 11.92 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 116.197 -4.064 . . . . 0.75 112.494 -177.299 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.331 29.7 mm -65.42 -31.79 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 116.81 2.152 . . . . 0.73 116.81 179.203 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -46.83 -52.08 15.08 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.19 2.196 . . . . 1.62 116.608 160.965 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -70.72 -35.81 72.9 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.704 2.002 . . . . 2.13 109.11 -177.974 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.9 t -70.04 -49.69 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 119.044 -2.285 . . . . 0.62 111.459 -179.489 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -62.56 -27.7 69.36 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.164 -2.21 . . . . 1.22 115.749 175.984 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.58 -40.53 97.18 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 128.661 2.785 . . . . 0.51 114.422 173.67 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -62.25 -26.93 68.66 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.303 2.241 . . . . 1.44 116.565 171.629 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.9 mt -74.09 -42.89 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 126.997 2.119 . . . . 1.32 111.701 171.913 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -62.68 -34.04 76.31 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.496 -1.229 . . . . 1.7 112.519 178.36 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.24 -47.04 81.2 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.437 -2.039 . . . . 1.55 115.643 171.831 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -78.9 -59.59 2.72 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.27 -1.786 . . . . 2.62 113.725 -177.343 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -101.28 -30.84 11.28 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 128.905 2.882 . . . . 1.48 109.989 -165.258 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.74 19.86 30.56 Favored Glycine 0 N--CA 1.429 -1.77 0 O-C-N 121.098 -1.001 . . . . 1.12 113.993 170.428 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.5 mt -91.3 123.42 64.2 Favored Pre-proline 0 N--CA 1.431 -1.409 0 CA-C-O 114.466 -2.683 . . . . 1.55 110.039 178.219 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -67.66 144.08 64.67 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 124.386 3.391 . . . . 1.02 110.187 -174.009 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.77 -24.41 47.15 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 C-N-CA 125.053 3.836 . . . . 1.25 113.03 -167.831 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -68.01 -26.05 65.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.892 2.477 . . . . 2.25 109.871 178.496 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -89.32 -18.69 26.45 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 125.427 2.537 . . . . 2.02 110.894 -176.275 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -82.18 125.87 31.41 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.621 -2.55 . . . . 0.69 112.059 -177.868 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.573 ' HB2' HG23 ' A' ' 70' ' ' VAL . 94.7 mtt180 -119.54 129.38 54.65 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 104.903 -2.258 . . . . 2.78 104.903 168.759 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.1 mt -103.01 139.48 38.52 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.63 -3.169 . . . . 1.17 111.022 176.69 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.456 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 17.8 mm -121.14 146.97 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 103.154 -2.906 . . . . 1.38 103.154 176.901 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -135.94 105.21 5.99 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 101.365 -3.569 . . . . 1.5 101.365 173.208 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.309 . . 70.65 -75.13 0.08 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.921 2.088 . . . . 1.21 115.054 179.283 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.34 -4.66 0.9 Allowed Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 113.481 -1.691 . . . . 1.3 115.101 -175.385 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.27 65.6 mttm -106.82 143.2 35.26 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.765 -0.828 . . . . 2.55 108.765 -178.85 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -86.44 128.51 34.96 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 117.375 -1.298 . . . . 2.48 108.371 164.775 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 mt -83.66 134.92 34.76 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 116.349 1.981 . . . . 0.9 116.349 -173.815 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -75.86 147.98 38.67 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.576 1.151 . . . . 1.94 111.56 175.182 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -68.53 -38.03 80.51 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 118.559 2.8 . . . . 1.56 118.559 -171.133 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.8 28.25 14.46 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 126.078 1.799 . . . . 0.97 113.49 176.703 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -100.34 163.97 12.15 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 121.234 -1.156 . . . . 2.49 111.671 167.222 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.8 p -96.5 -172.03 2.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.516 -1.99 . . . . 0.76 111.368 175.509 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.3 mt -87.83 -29.25 21.08 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 119.107 -2.245 . . . . 1.05 111.436 172.362 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.282 8.2 t -63.08 -37.49 87.43 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 120.916 3.673 . . . . 1.19 120.916 171.057 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -52.97 -40.38 63.69 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 113.458 -1.701 . . . . 1.9 113.923 170.249 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -93.76 -3.38 52.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.532 2.333 . . . . 0.89 112.485 -177.695 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.286 13.7 m120 66.35 33.05 7.27 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.714 1.721 . . . . 1.84 114.232 -174.046 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.279 33.7 mt -73.59 104.19 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 114.843 -2.503 . . . . 0.82 107.837 172.91 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -92.04 -164.04 1.12 Allowed 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 124.673 1.233 . . . . 2.16 110.101 179.772 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -72.0 156.5 39.16 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.04 1.4 . . . . 2.12 112.094 171.28 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.326 26.9 mt-10 61.26 28.7 18.2 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.033 -2.292 . . . . 1.71 115.628 175.956 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.0 t -101.18 154.89 18.36 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.951 -2.968 . . . . 1.04 109.597 -173.71 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.7 m -110.42 111.81 23.32 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.854 2.74 . . . . 0.79 112.5 -174.783 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.1 mt -93.02 147.52 22.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.308 -3.37 . . . . 1.4 108.008 170.526 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.456 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 5.5 m-70 -102.11 122.89 44.99 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 126.834 2.584 . . . . 1.51 104.721 -175.604 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.8 tp -93.96 137.92 32.65 Favored 'General case' 0 N--CA 1.428 -1.542 0 O-C-N 118.732 -2.48 . . . . 1.14 111.59 178.678 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' A' ' 42' ' ' ARG . 2.7 m -135.93 150.05 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 105.868 -1.901 . . . . 1.23 105.868 168.376 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.8 mt . . . . . 0 N--CA 1.43 -1.438 0 O-C-N 118.803 -2.436 . . . . 2.78 112.812 -175.054 . . . . . . . . 0 0 . 1 . 088 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ptt? . . . . . 0 CA--C 1.49 -1.357 0 CA-C-O 123.049 1.404 . . . . 1.1 114.281 . . . . . . . . . 0 0 . 1 . 088 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -77.89 124.3 27.83 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.224 3.01 . . . . 1.87 114.453 -179.402 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.277 9.8 pt -128.48 153.12 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.301 -2.749 . . . . 0.72 111.139 171.286 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -117.59 130.49 56.43 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.526 1.967 . . . . 1.4 110.666 -178.89 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.51 111.16 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 102.908 -2.997 . . . . 0.58 102.908 -179.749 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -93.13 133.4 36.34 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 124.153 1.93 . . . . 2.09 111.774 -178.231 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.307 3.9 p -102.3 161.48 13.66 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 117.376 2.362 . . . . 0.99 117.376 169.166 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.4 tp -78.78 -35.72 43.99 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 112.22 -2.264 . . . . 2.53 111.449 168.75 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.273 0.8 OUTLIER -63.91 -58.41 6.85 Favored 'General case' 0 N--CA 1.431 -1.412 1 C-N-CA 133.323 4.649 . . . . 2.08 111.716 -169.983 . . . . . . . . 4 3 . 1 . 088 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.85 -79.23 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 129.456 3.407 . . . . 1.31 120.515 176.422 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -77.92 165.4 24.14 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 129.831 3.252 . . . . 1.4 116.197 -170.281 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.8 m -115.66 120.58 39.85 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 103.452 -2.796 . . . . 0.78 103.452 168.315 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.4 mt -89.18 107.03 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.859 2.463 . . . . 1.55 105.93 -176.522 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.7 m -82.54 100.0 9.85 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 124.282 0.989 . . . . 1.08 113.434 178.944 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.1 mt -88.13 154.52 20.39 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.7 2.19 . . . . 1.55 115.911 -179.98 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -104.27 114.78 29.24 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 102.399 -3.186 . . . . 1.95 102.399 163.616 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.8 m -117.36 177.39 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.069 -2.269 . . . . 0.96 109.426 173.081 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -115.57 156.65 45.82 Favored Pre-proline 0 N--CA 1.429 -1.476 0 N-CA-C 104.623 -2.362 . . . . 2.35 104.623 154.913 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -78.53 -9.09 16.12 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 CA-C-N 127.334 3.655 . . . . 0.95 109.197 -171.589 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.1 p -81.45 -9.65 59.67 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.884 -2.385 . . . . 1.45 113.911 174.838 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -66.82 141.85 57.55 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 125.855 1.972 . . . . 1.69 111.83 172.704 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.647 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 52.6 p -81.35 170.34 16.13 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.795 -2.441 . . . . 0.75 112.699 176.852 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.462 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 25.2 mm -66.01 -26.18 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 129.179 2.991 . . . . 0.73 109.37 170.563 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -70.97 -33.85 70.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.164 1.935 . . . . 1.62 115.546 173.999 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.434 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 83.5 m-20 -66.02 -43.38 87.8 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.193 2.597 . . . . 2.13 111.878 169.723 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.25 -45.21 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 115.224 1.564 . . . . 0.62 115.224 174.059 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -67.11 -36.03 81.03 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 117.348 -3.345 . . . . 1.22 113.277 169.769 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.71 -25.02 62.48 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 118.501 -2.624 . . . . 0.51 117.454 172.122 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 25' ' ' ASN 0.356 44.5 mttm -69.63 -55.14 10.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.41 -2.681 . . . . 1.44 117.247 174.537 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.2 mt -52.62 -47.07 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 1 C-N-CA 135.202 5.401 . . . . 1.32 106.419 173.615 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -50.02 -40.82 45.84 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 120.825 3.639 . . . . 1.7 120.825 177.129 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -66.56 -43.4 85.11 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.958 -3.589 . . . . 1.55 114.807 164.444 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -70.19 -49.98 44.83 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 127.656 3.598 . . . . 2.62 110.322 -169.95 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.264 28.7 mm-40 -120.3 4.72 10.76 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 111.286 -2.688 . . . . 1.48 112.726 -165.858 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.6 0.38 47.95 Favored Glycine 0 N--CA 1.431 -1.662 0 C-N-CA 115.678 -3.153 . . . . 1.12 119.222 173.605 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.5 mt -86.42 116.29 65.34 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 103.445 -2.798 . . . . 1.55 103.445 -169.202 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 36.9 Cg_endo -66.1 165.26 24.72 Favored 'Trans proline' 0 C--N 1.3 -2.016 1 C-N-CA 126.54 4.827 . . . . 1.02 115.695 176.389 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.2 Cg_exo -79.38 -17.43 11.51 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 124.524 2.651 . . . . 1.25 112.994 -172.235 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -67.54 -27.49 67.0 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.373 2.035 . . . . 2.25 115.436 175.458 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -104.87 24.02 12.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.813 -2.429 . . . . 2.02 114.308 -178.032 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -123.53 119.0 28.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.987 2.515 . . . . 0.69 113.392 179.66 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.53 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 90.5 mtt-85 -113.94 120.8 41.9 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.806 1.642 . . . . 2.78 108.288 169.466 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.6 mt -104.51 126.62 51.77 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.143 -1.598 . . . . 1.17 111.219 -178.103 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mm -117.61 140.4 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 124.206 3.185 . . . . 1.38 112.755 177.131 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -152.56 132.57 13.4 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 104.752 -2.314 . . . . 1.5 104.752 175.959 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.91 21.92 11.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 115.968 -1.968 . . . . 1.21 115.178 179.64 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.66 -2.34 83.16 Favored Glycine 0 N--CA 1.431 -1.688 1 C-N-CA 132.379 4.8 . . . . 1.3 113.286 -179.38 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -101.01 137.57 39.2 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.842 0.829 . . . . 2.55 112.841 -178.983 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -70.68 127.13 31.62 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 117.194 -3.442 . . . . 2.48 115.808 166.627 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.405 ' HB3' HG13 ' A' ' 23' ' ' ILE . 36.9 mt -81.62 136.9 35.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.705 -1.872 . . . . 0.9 113.647 -176.075 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -85.74 144.14 27.94 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 119.031 2.974 . . . . 1.94 119.031 172.467 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.462 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 1.8 m-20 -67.12 -43.26 82.87 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 121.763 3.986 . . . . 1.56 121.763 -168.362 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.23 8.84 50.82 Favored Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 118.123 2.009 . . . . 0.97 118.123 170.446 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -101.59 149.55 24.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.679 1.704 . . . . 2.49 110.233 170.289 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.647 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.283 32.2 p -81.7 170.65 15.52 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.069 -2.894 . . . . 0.76 110.547 -178.211 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.7 mt -67.8 -37.04 81.47 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 127.031 2.132 . . . . 1.05 110.062 167.672 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.382 4.9 t -59.4 -43.64 92.95 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.525 -3.234 . . . . 1.19 114.234 176.72 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -60.82 -44.63 96.64 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.113 2.863 . . . . 1.9 111.042 179.995 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -77.92 -6.76 55.37 Favored 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 114.939 -4.85 . . . . 0.89 115.883 178.416 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.304 13.1 m120 68.95 36.79 2.42 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.605 -2.559 . . . . 1.84 115.412 -178.206 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.2 mt -85.24 113.96 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 125.905 1.682 . . . . 0.82 111.968 177.635 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -103.64 -173.96 2.43 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 118.411 -1.316 . . . . 2.16 108.824 -174.933 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -53.42 147.48 10.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.419 3.009 . . . . 2.12 114.4 171.082 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 56.09 33.51 22.08 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 120.441 3.497 . . . . 1.71 120.441 -178.969 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.7 m -103.51 149.1 25.18 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.777 -1.556 . . . . 1.04 109.96 -177.151 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -103.58 112.06 24.8 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 126.132 1.773 . . . . 0.79 109.106 -170.452 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mt -90.24 140.72 29.41 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.458 -1.312 . . . . 1.4 107.458 174.15 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.375 66.9 m80 -107.28 118.1 35.82 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.665 -1.272 . . . . 1.51 108.116 178.308 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -88.02 121.44 30.43 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 121.378 -0.826 . . . . 1.14 109.761 179.875 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 59.6 t -105.69 135.46 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 104.473 -2.417 . . . . 1.23 104.473 174.242 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.428 0 N-CA-C 107.402 -1.332 . . . . 2.78 107.402 -179.5 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 CA--C 1.49 -1.34 0 N-CA-C 106.721 -1.585 . . . . 1.1 106.721 . . . . . . . . . 0 0 . 1 . 089 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -93.71 126.5 38.93 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.138 1.375 . . . . 1.87 112.692 179.698 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -127.25 166.98 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 105.002 -2.222 . . . . 0.72 105.002 167.759 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -123.27 145.05 49.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.076 2.95 . . . . 1.4 110.268 -177.716 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.2 t -124.91 124.18 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 106.691 -1.596 . . . . 0.58 106.691 173.677 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -106.41 128.59 54.16 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.601 2.36 . . . . 2.09 108.406 -178.73 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 p -87.4 179.44 6.58 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.02 2.343 . . . . 0.99 110.03 -179.399 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.331 14.2 tp -65.94 -41.95 90.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.918 2.487 . . . . 2.53 114.61 168.462 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.8 p -75.42 -38.54 59.75 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 120.817 -1.177 . . . . 2.08 108.307 -177.778 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.73 28.32 0.3 Allowed Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 123.652 0.644 . . . . 1.31 113.226 169.783 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -94.48 129.22 41.34 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.082 -2.422 . . . . 1.4 110.863 -177.134 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.8 m -116.36 90.21 3.28 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.937 2.78 . . . . 0.78 107.489 -174.345 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 pt -92.94 136.97 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 112.224 -2.262 . . . . 1.55 106.099 -178.876 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -94.86 128.37 41.57 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 130.22 3.408 . . . . 1.08 113.287 -178.801 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.9 mt -122.32 151.06 41.53 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.882 1.801 . . . . 1.55 112.88 178.184 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -114.54 112.7 23.36 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.657 1.218 . . . . 1.95 108.689 174.464 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m -118.27 175.11 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 118.715 -2.491 . . . . 0.96 111.548 -176.751 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -108.15 147.93 36.53 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-N 122.186 2.266 . . . . 2.35 106.784 160.498 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.13 -18.88 26.83 Favored 'Trans proline' 0 N--CA 1.433 -2.058 0 C-N-CA 123.718 2.945 . . . . 0.95 112.533 -174.548 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.3 p -90.57 9.92 27.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 121.725 2.057 . . . . 1.45 113.329 178.097 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -89.59 158.42 17.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.331 -3.355 . . . . 1.69 107.333 -179.865 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 69.6 p -80.6 171.11 15.46 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.297 1.221 . . . . 0.75 114.297 178.832 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.6 mm -69.77 -39.79 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 125.679 1.592 . . . . 0.73 108.91 175.993 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.26 86.7 tt0 -45.77 -45.75 14.84 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 117.613 2.449 . . . . 1.62 117.613 169.117 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -68.09 -35.66 78.54 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 118.058 2.614 . . . . 2.13 118.058 175.703 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 26' ' ' VAL . 10.8 t -62.96 -31.22 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 112.971 0.73 . . . . 0.62 112.971 170.783 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -71.5 -25.58 62.32 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 118.802 2.89 . . . . 1.22 118.802 167.327 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.87 -20.3 53.26 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 119.582 -1.949 . . . . 0.51 108.476 170.893 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -80.54 -23.51 39.94 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 120.419 1.463 . . . . 1.44 107.993 177.626 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.1 mt -81.85 -28.26 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.784 -2.447 . . . . 1.32 112.802 167.616 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 67.0 tt0 -65.74 -36.75 84.46 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 123.552 2.887 . . . . 1.7 113.362 173.655 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -60.05 -56.79 17.35 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 124.285 1.034 . . . . 1.55 111.781 170.118 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -77.34 -52.75 8.64 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 116.272 1.953 . . . . 2.62 116.272 -172.807 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -99.08 -25.1 14.66 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 119.348 -2.095 . . . . 1.48 108.407 -165.911 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.4 37.33 11.0 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 122.017 2.189 . . . . 1.12 113.161 175.668 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 mt -106.92 126.96 28.96 Favored Pre-proline 0 N--CA 1.43 -1.433 0 C-N-CA 127.671 2.388 . . . . 1.55 107.472 -178.752 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -68.82 150.2 73.49 Favored 'Trans proline' 0 N--CA 1.434 -1.977 0 O-C-N 115.28 -3.063 . . . . 1.02 116.585 -178.653 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -69.39 -14.5 37.37 Favored 'Trans proline' 0 N--CA 1.433 -2.061 0 CA-C-N 124.447 2.624 . . . . 1.25 117.886 -172.557 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -74.86 -34.09 62.22 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.993 1.854 . . . . 2.25 111.069 172.314 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -72.56 -28.41 62.81 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 115.165 -4.709 . . . . 2.02 114.523 -178.895 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -78.99 147.19 33.0 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.353 -1.467 . . . . 0.69 110.419 -173.382 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.277 12.1 tpt180 -133.35 120.12 20.58 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.07 -2.567 . . . . 2.78 104.07 170.773 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.2 mt -96.51 125.85 41.28 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.546 -1.346 . . . . 1.17 108.708 -177.899 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.278 6.2 mt -118.91 115.07 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 116.422 2.008 . . . . 1.38 116.422 -179.865 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -130.54 137.99 49.97 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 117.076 2.25 . . . . 1.5 117.076 164.97 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.291 . . 51.26 45.73 27.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.404 -3.31 . . . . 1.21 118.806 -175.487 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.6 -22.12 1.43 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 125.335 1.445 . . . . 1.3 113.646 -175.471 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -90.22 133.09 35.14 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 118.526 2.787 . . . . 2.55 118.526 -173.828 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -74.19 133.68 42.73 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 116.785 -3.697 . . . . 2.48 104.365 171.016 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.7 mt -91.17 123.69 34.81 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 127.07 3.319 . . . . 0.9 110.869 -175.741 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -85.19 135.5 33.92 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.165 -2.834 . . . . 1.94 116.105 175.966 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.488 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 3.4 m-20 -57.11 -53.04 62.6 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 129.973 3.309 . . . . 1.56 117.38 -160.958 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.09 21.51 1.35 Allowed Glycine 0 N--CA 1.43 -1.737 0 O-C-N 118.952 -2.342 . . . . 0.97 115.88 170.263 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -113.79 166.28 11.72 Favored 'General case' 0 N--CA 1.43 -1.451 1 CA-C-N 124.531 4.165 . . . . 2.49 108.251 168.979 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.8 p -97.78 173.47 7.09 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 123.551 1.644 . . . . 0.76 110.061 -179.173 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.9 mt -67.77 -31.91 72.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 114.317 1.229 . . . . 1.05 114.317 177.065 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.8 t -62.18 -44.73 95.94 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.043 3.337 . . . . 1.19 113.941 178.377 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -52.86 -38.54 61.68 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 125.141 1.526 . . . . 1.9 112.112 175.571 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -91.23 -1.0 57.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.335 1.854 . . . . 0.89 111.984 178.488 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.311 3.4 m120 61.72 31.26 18.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 119.446 3.128 . . . . 1.84 119.446 -179.526 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.4 mt -88.11 110.36 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 128.7 2.8 . . . . 0.82 104.469 -173.41 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -95.82 -169.91 2.03 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 112.373 -2.194 . . . . 2.16 106.288 -174.434 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -57.83 147.9 26.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 130.239 3.416 . . . . 2.12 117.797 172.894 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 55.89 49.33 16.19 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 115.817 1.784 . . . . 1.71 115.817 178.102 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 m -117.53 147.91 42.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.774 -1.195 . . . . 1.04 107.774 -174.62 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.4 m -99.2 105.41 17.45 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.355 3.462 . . . . 0.79 111.209 177.394 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.69 132.54 39.32 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.778 1.631 . . . . 1.4 108.505 178.072 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -89.13 124.88 34.74 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.95 -4.219 . . . . 1.51 106.395 -178.734 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.8 tp -95.13 122.09 37.44 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.716 -2.49 . . . . 1.14 105.842 171.214 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.1 t -115.14 151.4 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 127.872 2.469 . . . . 1.23 108.829 168.537 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.0 mt . . . . . 0 N--CA 1.429 -1.482 0 O-C-N 117.601 -3.187 . . . . 2.78 110.659 174.637 . . . . . . . . 0 0 . 1 . 090 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 CA--C 1.491 -1.304 0 CA-C-O 121.188 0.518 . . . . 1.1 110.677 . . . . . . . . . 0 0 . 1 . 090 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -110.6 121.31 45.02 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.489 -2.632 . . . . 1.87 111.44 -179.691 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.3 pt -108.73 172.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 114.588 -1.187 . . . . 0.72 111.792 169.621 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -120.4 160.08 23.81 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.76 -0.829 . . . . 1.4 108.76 178.879 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.7 t -139.56 133.46 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 117.381 -3.325 . . . . 0.58 106.815 168.851 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -110.76 137.57 48.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.551 -3.218 . . . . 2.09 109.415 177.323 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.275 11.1 p -81.67 -169.63 2.42 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 114.824 -4.923 . . . . 0.99 115.74 176.858 . . . . . . . . 3 2 . 1 . 090 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.322 13.1 mt -77.46 -37.34 51.69 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 113.656 0.984 . . . . 2.53 113.656 174.963 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.76 -37.72 22.26 Favored 'General case' 0 N--CA 1.429 -1.504 1 C-N-CA 133.61 4.764 . . . . 2.08 110.019 -169.501 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.67 33.66 0.64 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 115.04 -3.089 . . . . 1.31 111.842 173.175 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -97.54 137.48 36.41 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.513 2.156 . . . . 1.4 106.572 -178.953 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 m -108.27 121.42 44.86 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 118.897 -0.573 . . . . 0.78 109.9 176.687 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mt -104.77 106.87 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 125.498 1.749 . . . . 1.55 111.444 179.081 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.9 m -80.78 94.72 6.46 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 130.485 3.514 . . . . 1.08 111.67 178.024 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.8 mt -98.02 130.99 44.82 Favored 'General case' 0 N--CA 1.429 -1.482 1 O-C-N 115.781 -4.324 . . . . 1.55 112.907 -174.898 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -92.08 125.92 36.96 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.182 1.81 . . . . 1.95 107.18 174.836 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.9 m -133.89 174.95 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 107.401 -1.333 . . . . 0.96 107.401 -173.569 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -126.26 159.99 59.83 Favored Pre-proline 0 N--CA 1.43 -1.443 0 O-C-N 120.378 -1.451 . . . . 2.35 108.09 163.694 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -78.02 -10.06 16.66 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 CA-C-N 126.29 3.282 . . . . 0.95 109.919 -172.561 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.9 p -78.34 -22.54 47.85 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 130.369 3.468 . . . . 1.45 113.951 174.598 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -68.08 142.39 55.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.104 2.162 . . . . 1.69 110.655 176.21 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 22.9 p -78.08 164.25 25.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.659 2.171 . . . . 0.75 113.424 175.346 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -59.91 -33.18 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.515 1.926 . . . . 0.73 111.189 173.127 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -63.32 -44.48 94.83 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.582 1.553 . . . . 1.62 113.196 172.141 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -60.83 -26.45 67.35 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 115.517 -2.183 . . . . 2.13 114.083 170.037 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.338 46.6 t -84.43 -25.97 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 CA-C-N 127.243 4.565 . . . . 0.62 109.658 179.146 . . . . . . . . 3 2 . 1 . 090 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -75.74 -30.71 59.32 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.575 -3.203 . . . . 1.22 110.766 173.676 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.61 93.06 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.248 -1.532 . . . . 0.51 112.123 174.872 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -58.95 -45.44 90.46 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.436 -3.29 . . . . 1.44 111.074 174.883 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.4 mt -58.48 -33.61 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.292 -3.38 . . . . 1.32 114.652 173.229 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -70.07 -34.85 73.71 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.507 2.41 . . . . 1.7 117.507 -179.673 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -72.82 -47.74 43.75 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 125.016 2.341 . . . . 1.55 116.387 164.506 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -63.86 -65.85 0.62 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.12 -3.488 . . . . 2.62 109.639 -173.673 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -94.23 -51.93 4.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.439 -2.663 . . . . 1.48 110.96 -168.406 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.56 73.19 0.97 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-N 115.489 -0.778 . . . . 1.12 112.276 179.374 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 mt -138.53 117.4 9.46 Favored Pre-proline 0 N--CA 1.429 -1.487 0 N-CA-C 102.427 -3.175 . . . . 1.55 102.427 -174.695 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -57.83 143.13 96.23 Favored 'Trans proline' 0 C--N 1.299 -2.059 0 CA-C-O 112.559 -3.184 . . . . 1.02 114.219 177.838 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -62.21 -15.92 47.52 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 CA-C-N 124.961 2.807 . . . . 1.25 115.926 178.404 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -63.73 -34.99 79.1 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 124.784 2.231 . . . . 2.25 115.907 173.976 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -81.81 -21.87 37.43 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.418 -2.676 . . . . 2.02 109.705 -177.86 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -82.06 104.53 12.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.642 1.686 . . . . 0.69 114.975 -173.767 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.5 tpp85 -100.59 123.37 44.7 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 112.455 -2.157 . . . . 2.78 107.282 162.54 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.0 mt -111.43 137.1 49.65 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.758 2.694 . . . . 1.17 106.531 178.713 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.0 mt -125.36 149.77 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 117.266 -3.396 . . . . 1.38 104.211 -179.654 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.31 84.1 t80 -146.84 135.58 22.17 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 116.564 2.061 . . . . 1.5 116.564 168.541 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.59 -67.3 0.21 Allowed 'General case' 0 N--CA 1.43 -1.45 1 C-N-CA 131.942 4.097 . . . . 1.21 112.317 179.464 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.59 15.42 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.648 0 C-N-CA 128.042 2.734 . . . . 1.3 107.861 174.441 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.1 mttp -123.11 134.14 54.24 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.6 -2.117 . . . . 2.55 107.269 -176.706 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -73.17 140.48 47.05 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 116.857 -1.937 . . . . 2.48 115.237 169.003 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 mt -94.89 133.34 38.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 116.703 -3.748 . . . . 0.9 108.33 -164.558 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -96.67 118.85 34.02 Favored 'General case' 0 N--CA 1.431 -1.393 1 O-C-N 115.46 -4.525 . . . . 1.94 109.46 -176.521 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -39.88 -51.31 2.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 117.797 2.517 . . . . 1.56 117.797 -175.817 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.53 39.54 0.22 Allowed Glycine 0 N--CA 1.429 -1.787 0 C-N-CA 128.04 2.733 . . . . 0.97 114.331 170.411 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -137.1 169.49 17.7 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 119.723 1.762 . . . . 2.49 111.619 164.847 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 44.8 p -98.51 166.36 11.39 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.45 1.9 . . . . 0.76 115.858 175.702 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mt -62.51 -36.47 82.66 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.379 -2.076 . . . . 1.05 112.227 172.167 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -60.64 -44.98 95.75 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.687 1.995 . . . . 1.19 116.336 175.359 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -60.62 -45.82 92.59 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 119.551 1.068 . . . . 1.9 111.8 179.951 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -77.65 -8.86 58.52 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 113.52 0.933 . . . . 0.89 113.52 179.242 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.29 71.4 m-80 62.26 51.29 3.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.048 2.139 . . . . 1.84 116.691 -174.749 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.0 mt -92.7 121.99 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 101.418 -3.549 . . . . 0.82 101.418 178.069 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.6 mm-40 -110.33 -168.49 1.32 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.197 -1.564 . . . . 2.16 112.676 178.923 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -68.74 155.93 39.22 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.586 -3.196 . . . . 2.12 107.83 -179.929 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 64.2 20.59 12.24 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 112.641 -2.072 . . . . 1.71 114.724 178.433 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.278 50.6 m -84.39 148.09 26.8 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-O 114.661 -2.59 . . . . 1.04 114.51 -174.068 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.0 m -109.59 113.62 26.56 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 115.963 -2.295 . . . . 0.79 109.993 176.657 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.6 mt -84.69 155.4 21.96 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.208 -1.558 . . . . 1.4 107.417 175.732 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -107.09 109.95 21.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 118.027 -0.987 . . . . 1.51 111.932 -174.699 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 tt -80.59 112.58 18.08 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.366 1.066 . . . . 1.14 113.065 174.348 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.4 t -109.77 122.06 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 127.267 2.227 . . . . 1.23 105.382 171.622 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 71' ' ' LEU . 53.9 mt . . . . . 0 N--CA 1.431 -1.391 0 N-CA-C 104.142 -2.54 . . . . 2.78 104.142 177.131 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptt? . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 117.885 2.55 . . . . 1.1 117.885 . . . . . . . . . 0 0 . 1 . 091 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -89.29 121.35 31.48 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.997 -1.064 . . . . 1.87 111.818 -173.585 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.8 pt -116.46 154.7 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 101.025 -3.695 . . . . 0.72 101.025 173.265 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -113.18 151.94 30.32 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 124.783 1.233 . . . . 1.4 111.623 179.943 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.1 t -134.58 127.64 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 122.745 2.521 . . . . 0.58 105.582 175.456 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -92.86 140.6 29.33 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.716 -1.865 . . . . 2.09 110.743 -179.793 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.0 p -87.13 -177.9 6.12 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.365 -0.976 . . . . 0.99 108.365 178.133 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 tp -64.7 -46.52 82.01 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.09 -4.131 . . . . 2.53 115.346 171.126 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -77.23 -21.45 53.76 Favored 'General case' 0 N--CA 1.43 -1.433 1 O-C-N 115.988 -4.195 . . . . 2.08 117.066 178.056 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.59 37.98 0.87 Allowed Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 121.037 3.175 . . . . 1.31 121.037 174.98 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -98.31 127.05 44.06 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 102.006 -3.331 . . . . 1.4 102.006 -177.358 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.0 m -91.68 118.18 30.42 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.134 -1.604 . . . . 0.78 113.871 175.841 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.293 10.4 mt -90.92 126.46 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 103.614 -2.736 . . . . 1.55 103.614 -179.855 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.2 m -98.84 120.16 38.81 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 123.527 2.876 . . . . 1.08 107.127 173.083 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.4 mt -118.38 117.11 28.16 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 125.095 2.379 . . . . 1.55 113.996 177.856 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -79.63 97.37 6.49 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.108 -1.62 . . . . 1.95 113.36 172.258 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -113.84 166.72 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 128.299 2.64 . . . . 0.96 110.915 -175.669 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -107.36 163.71 16.36 Favored Pre-proline 0 N--CA 1.429 -1.5 0 O-C-N 125.017 1.448 . . . . 2.35 111.79 162.02 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.43 -19.67 10.1 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 O-C-N 113.594 -3.951 . . . . 0.95 109.877 -175.172 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 m -81.56 -3.07 52.26 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 116.616 -1.659 . . . . 1.45 114.07 -179.573 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -72.72 142.78 48.19 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.498 1.519 . . . . 1.69 112.576 176.846 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 p -81.82 165.25 21.04 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 124.606 1.191 . . . . 0.75 110.52 176.319 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.422 ' CG2' HD12 ' A' ' 43' ' ' LEU . 4.4 mm -68.79 -24.64 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 1 O-C-N 115.285 -4.634 . . . . 0.73 113.122 178.882 . . . . . . . . 3 3 . 1 . 091 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -51.91 -45.84 64.38 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 129.661 3.185 . . . . 1.62 113.59 164.062 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -62.96 -36.98 85.27 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 115.624 1.713 . . . . 2.13 115.624 174.064 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.75 -48.4 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 127.177 2.191 . . . . 0.62 111.735 175.391 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.5 mttt -55.1 -34.06 63.35 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.339 1.977 . . . . 1.22 116.339 170.033 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.69 -23.79 61.71 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 116.011 1.856 . . . . 0.51 116.011 172.615 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -75.44 -33.49 60.9 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.955 2.902 . . . . 1.44 114.128 168.599 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.4 mt -76.41 -26.68 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 1 O-C-N 113.791 -5.568 . . . . 1.32 110.402 174.861 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -74.01 -25.3 59.82 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.964 -2.335 . . . . 1.7 106.475 178.808 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -86.13 -41.95 14.3 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.172 1.463 . . . . 1.55 114.483 171.122 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.3 mmtt -57.47 -65.7 0.58 Allowed 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 113.999 -5.438 . . . . 2.62 111.36 172.316 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -97.16 -35.53 10.75 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.023 2.529 . . . . 1.48 115.08 -168.067 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.18 44.98 3.65 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 119.896 -1.753 . . . . 1.12 114.093 179.162 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.3 mt -114.18 126.67 27.71 Favored Pre-proline 0 N--CA 1.43 -1.429 1 C-N-CA 134.79 5.236 . . . . 1.55 111.32 -178.76 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.78 156.16 43.97 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 CA-C-N 125.962 3.165 . . . . 1.02 113.442 179.372 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -65.31 -12.11 33.31 Favored 'Trans proline' 0 N--CA 1.433 -2.032 2 CA-C-N 131.235 5.048 . . . . 1.25 118.198 -173.021 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -63.95 -45.14 90.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 127.128 2.768 . . . . 2.25 113.132 175.231 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -84.37 -7.86 59.17 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.9 -3.0 . . . . 2.02 108.465 -175.831 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -92.01 129.74 37.9 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 115.71 -4.368 . . . . 0.69 109.457 -171.684 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -130.64 120.85 24.56 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 129.424 3.09 . . . . 2.78 105.925 172.511 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.422 HD12 ' CG2' ' A' ' 23' ' ' ILE . 82.5 mt -107.01 122.71 46.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.602 3.096 . . . . 1.17 113.474 -176.719 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 29.0 mm -109.9 123.32 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 111.786 -2.461 . . . . 1.38 109.087 177.549 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -101.83 111.41 23.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.53 -2.767 . . . . 1.5 103.53 167.919 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.05 -93.48 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 125.48 1.738 . . . . 1.21 108.905 172.901 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.37 14.04 3.48 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-O 116.208 -2.44 . . . . 1.3 114.15 176.583 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp -107.82 133.63 51.93 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 128.496 3.115 . . . . 2.55 112.858 179.904 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -86.94 115.98 24.7 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 126.018 2.818 . . . . 2.48 114.819 173.681 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.0 mt -73.79 143.88 45.81 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.898 -1.751 . . . . 0.9 112.214 -171.561 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -100.1 138.72 36.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 125.23 2.443 . . . . 1.94 115.568 174.236 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -48.46 -46.86 38.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.422 3.489 . . . . 1.56 119.847 -175.985 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.54 44.91 1.39 Allowed Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 127.105 2.288 . . . . 0.97 116.691 170.928 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.25 20.7 mmt85 -117.25 163.61 16.05 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 117.703 -3.234 . . . . 2.49 103.659 166.332 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.5 p -99.61 163.63 12.41 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.081 -3.512 . . . . 0.76 115.964 169.064 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.7 mt -57.54 -36.17 71.28 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 113.646 -1.615 . . . . 1.05 112.198 174.402 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 t -66.4 -37.75 85.94 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 116.132 1.901 . . . . 1.19 116.132 178.825 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -55.92 -32.15 63.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.37 1.868 . . . . 1.9 114.513 173.065 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -94.86 -8.01 38.54 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 122.951 1.358 . . . . 0.89 110.73 -178.936 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.8 m120 69.0 43.13 1.17 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.356 2.662 . . . . 1.84 114.668 -173.169 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.8 mt -84.9 128.82 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 126.014 2.816 . . . . 0.82 106.379 -179.127 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -109.06 179.99 4.01 Favored 'General case' 0 N--CA 1.431 -1.425 1 O-C-N 115.893 -4.255 . . . . 2.16 108.22 -176.86 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 35.2 ttpt -53.73 138.76 34.57 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 130.943 3.697 . . . . 2.12 115.41 167.005 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 63' ' ' LYS 0.343 9.7 pt-20 77.04 3.2 3.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.598 2.359 . . . . 1.71 117.145 171.828 . . . . . . . . 3 3 . 1 . 091 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.41 164.07 25.37 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 112.818 -1.992 . . . . 1.04 112.849 -176.661 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.3 m -120.0 121.1 38.18 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 124.34 2.019 . . . . 0.79 108.432 175.321 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.29 174.18 5.98 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 104.642 -2.355 . . . . 1.4 104.642 175.117 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 31.3 m170 -130.63 141.53 50.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.962 -1.496 . . . . 1.51 106.962 179.232 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.6 tp -112.23 110.78 21.23 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 129.993 3.317 . . . . 1.14 106.849 -174.259 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.1 t -112.83 123.05 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 C-N-CA 125.222 1.409 . . . . 1.23 109.676 176.93 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 N--CA 1.43 -1.466 0 CA-C-O 122.704 1.24 . . . . 2.78 111.63 178.036 . . . . . . . . 0 0 . 1 . 092 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ptt? . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 116.565 2.061 . . . . 1.1 116.565 . . . . . . . . . 0 0 . 1 . 092 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -106.88 123.09 47.66 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.133 -2.854 . . . . 1.87 111.887 -177.31 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.0 pt -127.19 155.61 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 112.028 -2.351 . . . . 0.72 108.535 170.05 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -124.55 137.22 54.42 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.384 1.073 . . . . 1.4 110.282 -176.014 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.1 t -116.6 101.49 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 129.422 3.089 . . . . 0.58 106.371 178.199 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -81.9 139.59 34.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.711 1.243 . . . . 2.09 112.653 178.769 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.2 p -100.43 -175.96 3.07 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 120.191 -1.568 . . . . 0.99 112.61 -179.147 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.2 mt -77.35 -43.19 33.82 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 112.82 -6.175 . . . . 2.53 111.185 178.205 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.8 p -70.05 -17.49 63.25 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.89 2.076 . . . . 2.08 111.526 -168.352 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.52 33.65 3.3 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 126.091 1.805 . . . . 1.31 116.15 170.317 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -108.56 148.44 30.29 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 103.226 -2.879 . . . . 1.4 103.226 -178.557 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 80.5 m -117.38 120.18 37.38 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 126.247 2.217 . . . . 0.78 109.007 -179.212 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.0 mm -98.72 108.7 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 126.48 3.038 . . . . 1.55 112.204 179.904 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.268 47.4 m -85.18 139.49 31.64 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.131 -3.48 . . . . 1.08 106.704 -175.377 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.1 mt -125.47 146.58 49.57 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.688 -2.507 . . . . 1.55 109.497 176.159 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -99.61 104.21 15.97 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 127.651 2.381 . . . . 1.95 110.726 163.95 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.478 HG21 ' CD1' ' A' ' 56' ' ' LEU . 33.7 m -124.8 176.3 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 119.069 -2.269 . . . . 0.96 111.037 177.728 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -115.47 155.65 46.92 Favored Pre-proline 0 N--CA 1.429 -1.508 0 N-CA-C 103.308 -2.849 . . . . 2.35 103.308 162.487 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -74.95 5.73 3.79 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 127.167 3.595 . . . . 0.95 112.026 -174.61 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.7 p -94.97 -8.73 36.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 130.405 3.482 . . . . 1.45 109.434 179.613 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -72.05 134.1 45.65 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.784 -2.448 . . . . 1.69 107.477 175.412 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.6 p -78.62 160.46 27.54 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 111.004 -2.816 . . . . 0.75 110.926 174.154 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -65.57 -31.39 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 117.176 -3.452 . . . . 0.73 116.246 177.692 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -40.16 -53.43 2.47 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.576 -3.828 . . . . 1.62 114.982 159.78 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -58.75 -39.29 80.51 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 125.117 2.389 . . . . 2.13 116.5 173.259 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.29 -42.57 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 129.909 3.284 . . . . 0.62 113.872 -179.346 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.28 39.0 mtmt -70.03 -33.5 72.05 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 126.469 2.355 . . . . 1.22 114.895 174.256 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.27 -34.03 76.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.221 1.563 . . . . 0.51 115.221 169.857 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -58.35 -31.41 67.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 127.986 3.755 . . . . 1.44 118.293 172.046 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.2 mt -84.41 -32.42 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 1 CA-C-N 108.299 -4.046 . . . . 1.32 110.151 179.256 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -63.63 -33.97 76.81 Favored 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 116.201 -4.062 . . . . 1.7 114.62 176.863 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -64.34 -47.09 80.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.616 1.566 . . . . 1.55 113.332 168.139 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -75.9 -62.29 1.64 Allowed 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 121.267 1.849 . . . . 2.62 114.101 -178.773 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -89.97 -18.25 26.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.952 1.251 . . . . 1.48 114.035 -171.477 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.62 13.85 46.0 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 120.469 -1.394 . . . . 1.12 111.264 167.534 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.7 mt -98.35 133.46 22.83 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 118.936 -2.508 . . . . 1.55 113.837 -173.93 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 72.3 Cg_exo -64.65 143.61 81.59 Favored 'Trans proline' 0 N--CA 1.433 -2.045 1 N-CA-C 124.499 4.769 . . . . 1.02 124.499 170.563 . . . . . . . . 3 3 . 1 . 092 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 13.4 Cg_exo -62.69 -21.01 72.54 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 124.435 3.423 . . . . 1.25 114.772 179.807 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -63.65 -21.61 66.46 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.517 2.043 . . . . 2.25 116.517 168.381 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -94.94 -38.62 10.61 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 103.994 -2.595 . . . . 2.02 103.994 179.127 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.331 76.5 mt-30 -80.23 132.2 35.82 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 114.255 1.206 . . . . 0.69 114.255 -171.696 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -123.33 151.59 42.31 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.295 2.638 . . . . 2.78 104.822 170.219 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.2 mt -127.84 127.47 43.52 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 124.444 2.069 . . . . 1.17 106.929 176.521 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.6 mt -104.72 137.66 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 101.48 -3.526 . . . . 1.38 101.48 171.107 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.281 2.8 t80 -130.14 103.94 7.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.802 -3.061 . . . . 1.5 103.669 170.401 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.391 . . 80.58 -98.44 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 123.812 1.767 . . . . 1.21 110.844 -178.18 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.6 -5.78 3.95 Favored Glycine 0 N--CA 1.429 -1.79 1 CA-C-O 113.243 -4.087 . . . . 1.3 109.043 -176.995 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -101.77 128.61 48.03 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 122.093 2.947 . . . . 2.55 111.136 177.067 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -88.19 117.84 27.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.638 3.575 . . . . 2.48 111.286 177.803 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 mt -75.9 148.14 38.48 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.289 1.995 . . . . 0.9 113.576 -166.947 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -99.0 153.0 19.19 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 111.586 -2.552 . . . . 1.94 111.436 175.604 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.22 -54.33 8.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.466 1.507 . . . . 1.56 114.832 -168.418 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.06 47.31 3.68 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-O 114.787 -3.229 . . . . 0.97 115.672 176.104 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -130.47 158.15 40.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.756 2.278 . . . . 2.49 110.224 165.82 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.328 27.1 p -84.85 169.11 14.47 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 113.67 -5.644 . . . . 0.76 114.557 179.704 . . . . . . . . 3 2 . 1 . 092 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.478 ' CD1' HG21 ' A' ' 17' ' ' VAL . 36.7 mt -65.73 -34.08 77.36 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 113.326 0.861 . . . . 1.05 113.326 172.251 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.6 t -70.95 -25.42 62.72 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 127.416 2.287 . . . . 1.19 111.231 179.57 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -68.03 -29.31 68.27 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 117.728 -1.13 . . . . 1.9 113.298 169.427 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -96.18 18.2 14.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.578 2.351 . . . . 0.89 105.67 176.158 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.6 m120 45.07 41.19 5.34 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 129.097 2.959 . . . . 1.84 118.727 -179.763 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.9 mt -92.65 131.01 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 118.915 -2.366 . . . . 0.82 105.113 -176.864 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -148.1 -34.91 0.22 Allowed 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.259 2.457 . . . . 2.16 110.022 -175.214 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -95.96 -179.6 4.75 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 118.934 -2.354 . . . . 2.12 109.526 174.544 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -68.31 97.56 0.75 Allowed 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 124.404 2.05 . . . . 1.71 116.202 175.745 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 98.2 p -91.85 138.97 31.12 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.362 -1.29 . . . . 1.04 109.739 -167.371 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.1 m -89.57 104.07 16.66 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 115.807 -2.357 . . . . 0.79 112.894 175.483 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mp -88.54 158.1 18.41 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.482 -1.386 . . . . 1.4 107.498 176.181 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -122.87 121.94 37.44 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 118.261 -2.774 . . . . 1.51 114.81 176.331 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 tt -82.57 117.99 22.96 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 116.962 -1.895 . . . . 1.14 115.301 -178.793 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.5 t -114.96 133.67 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 CA-C-O 126.368 2.985 . . . . 1.23 112.466 175.321 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.6 mt . . . . . 0 N--CA 1.429 -1.484 0 O-C-N 116.752 -3.718 . . . . 2.78 107.735 175.87 . . . . . . . . 0 0 . 1 . 093 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 ttp . . . . . 0 CA--C 1.491 -1.318 0 N-CA-C 113.991 1.108 . . . . 1.1 113.991 . . . . . . . . . 0 0 . 1 . 093 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -106.29 95.0 5.46 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.752 -2.467 . . . . 1.87 111.004 -166.316 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.9 pt -90.44 165.58 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 125.762 1.914 . . . . 0.72 111.842 177.855 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -121.41 130.86 53.84 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.393 -1.442 . . . . 1.4 107.338 178.388 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.62 108.45 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 O-C-N 119.816 -1.802 . . . . 0.58 108.44 174.41 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -99.63 133.59 43.74 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.214 1.405 . . . . 2.09 111.059 179.707 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.9 p -101.08 163.58 12.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 115.742 1.756 . . . . 0.99 115.742 -179.31 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 tp -51.58 -49.06 62.85 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.802 3.241 . . . . 2.53 114.303 170.058 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 p -74.86 -40.01 61.23 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.702 1.715 . . . . 2.08 114.201 -165.975 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.37 15.73 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.709 0 O-C-N 118.283 -2.761 . . . . 1.31 114.134 174.323 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -108.03 134.41 50.96 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 126.02 2.819 . . . . 1.4 114.864 -178.367 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.0 m -108.66 107.15 17.51 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 130.02 3.328 . . . . 0.78 105.089 174.059 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -88.4 131.79 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 1 O-C-N 116.066 -4.146 . . . . 1.55 107.318 174.828 . . . . . . . . 3 3 . 1 . 093 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 m -100.1 103.08 14.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 100.416 -3.92 . . . . 1.08 100.416 178.523 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.9 mt -102.97 130.72 50.15 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.055 1.883 . . . . 1.55 112.347 177.398 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -97.17 113.84 25.48 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.411 -2.681 . . . . 1.95 110.689 169.024 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.55 155.76 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 107.273 -1.38 . . . . 0.96 107.273 -177.443 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.325 19.5 mm-40 -86.61 152.8 55.02 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-N 121.644 2.02 . . . . 2.35 107.026 163.669 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -71.25 -16.71 31.45 Favored 'Trans proline' 0 C--N 1.3 -1.996 3 CA-C-N 129.823 4.544 . . . . 0.95 113.537 179.715 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 m -74.95 -6.07 47.26 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 126.042 2.089 . . . . 1.45 113.312 168.652 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -74.3 153.59 39.29 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.64 -2.537 . . . . 1.69 109.276 175.997 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 p -87.28 177.03 7.27 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.196 -2.815 . . . . 0.75 115.283 178.901 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.49 HD12 HD13 ' A' ' 50' ' ' LEU . 47.3 mm -76.79 -32.03 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 124.997 1.319 . . . . 0.73 108.758 174.179 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -53.39 -52.81 58.12 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.89 2.476 . . . . 1.62 113.256 170.488 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -62.58 -38.59 90.71 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 114.79 -2.528 . . . . 2.13 116.234 172.426 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.06 -44.71 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 123.265 2.757 . . . . 0.62 111.706 171.587 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -59.9 -32.79 71.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.77 -3.081 . . . . 1.22 112.181 175.482 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.57 -35.2 79.63 Favored 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.731 -4.355 . . . . 0.51 117.727 172.249 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -71.54 -27.03 62.9 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.576 -2.577 . . . . 1.44 114.281 176.053 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.3 mt -75.45 -36.82 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 117.372 -3.33 . . . . 1.32 109.103 173.67 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -63.09 -53.14 58.29 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.21 -1.556 . . . . 1.7 109.963 177.392 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -41.34 -63.5 0.69 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.688 2.847 . . . . 1.55 118.688 166.53 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -81.9 -36.47 28.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 117.08 2.252 . . . . 2.62 117.08 -166.112 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -103.09 -46.97 4.48 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.848 -1.782 . . . . 1.48 111.315 -175.223 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.96 25.36 2.31 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 123.913 0.768 . . . . 1.12 114.668 170.831 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.4 mt -107.09 127.36 28.12 Favored Pre-proline 0 N--CA 1.429 -1.493 0 O-C-N 118.575 -2.72 . . . . 1.55 109.445 -170.465 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -67.78 138.5 45.05 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 C-N-CA 123.286 2.658 . . . . 1.02 115.809 179.344 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.14 -13.63 31.28 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 CA-C-N 121.335 1.512 . . . . 1.25 115.11 -162.025 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -55.93 -27.8 53.97 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 129.509 3.124 . . . . 2.25 113.721 168.517 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -98.08 -0.14 45.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.8 -1.813 . . . . 2.02 111.149 -173.664 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -97.79 135.82 39.01 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.563 2.601 . . . . 0.69 112.646 -175.215 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -125.05 115.45 20.54 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.756 -1.84 . . . . 2.78 107.241 169.175 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mt -94.44 126.07 39.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.681 2.392 . . . . 1.17 113.807 177.888 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.3 mm -111.04 131.7 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 108.736 -0.838 . . . . 1.38 108.736 -175.913 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -123.67 87.46 2.74 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 127.124 2.17 . . . . 1.5 106.853 168.793 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.256 . . 69.18 -98.49 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.378 -2.076 . . . . 1.21 112.176 -178.441 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.06 6.65 13.13 Favored Glycine 0 N--CA 1.431 -1.653 0 O-C-N 118.352 -2.717 . . . . 1.3 111.571 177.762 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -99.36 130.25 45.63 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.91 -1.885 . . . . 2.55 105.91 178.74 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -103.4 107.25 18.01 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 111.156 -2.747 . . . . 2.48 109.597 170.268 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.49 HD13 HD12 ' A' ' 23' ' ' ILE . 53.3 mt -76.1 131.66 39.57 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 121.111 3.745 . . . . 0.9 121.111 -166.059 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -90.5 141.38 28.82 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 119.647 3.203 . . . . 1.94 119.647 176.536 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -42.96 -68.71 0.17 Allowed 'General case' 0 N--CA 1.431 -1.418 1 N-CA-C 122.337 4.199 . . . . 1.56 122.337 -171.752 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.6 25.15 1.15 Allowed Glycine 0 N--CA 1.429 -1.774 0 C-N-CA 129.194 3.283 . . . . 0.97 119.419 171.193 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -105.99 151.95 23.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.178 -3.542 . . . . 2.49 111.845 163.659 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.7 p -76.04 171.37 14.58 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 124.781 2.229 . . . . 0.76 116.412 172.811 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.629 HD23 HD12 ' A' ' 61' ' ' ILE . 47.9 mt -73.02 -27.69 61.91 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.305 -2.122 . . . . 1.05 113.312 167.838 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.9 p -78.49 -28.39 46.35 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-O 118.148 -0.929 . . . . 1.19 110.087 -177.978 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -56.34 -59.74 4.52 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.366 1.066 . . . . 1.9 111.14 171.909 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -62.85 -28.93 70.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 126.743 2.527 . . . . 0.89 114.507 -179.063 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 82.86 51.79 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.412 1 C-N-CA 132.95 4.5 . . . . 1.84 112.048 -178.466 . . . . . . . . 3 3 . 1 . 093 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.629 HD12 HD23 ' A' ' 56' ' ' LEU . 65.5 mt -84.09 114.7 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 108.373 -0.973 . . . . 0.82 108.373 -178.547 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -95.32 159.79 14.84 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 126.256 1.823 . . . . 2.16 114.118 -170.696 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.382 6.5 tmtm? -6.35 -81.31 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 120.233 3.419 . . . . 2.12 120.233 175.165 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -105.39 71.04 0.91 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.948 2.309 . . . . 1.71 110.962 -175.141 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.283 18.7 m -107.55 141.52 38.88 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 124.392 2.044 . . . . 1.04 107.216 -177.49 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.3 m -105.4 119.19 38.47 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.767 -1.833 . . . . 0.79 107.659 174.374 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -96.34 148.92 22.27 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.527 2.331 . . . . 1.4 107.563 174.314 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -126.15 122.33 35.38 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.148 -1.797 . . . . 1.51 106.148 -174.617 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.5 tp -82.29 135.61 35.18 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 125.062 2.363 . . . . 1.14 107.095 -176.143 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.0 t -135.17 150.21 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 1 N-CA-C 99.328 -4.323 . . . . 1.23 99.328 -179.208 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.43 -1.461 1 O-C-N 115.094 -4.754 . . . . 2.78 107.76 -176.919 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 ttp . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 109.275 -0.639 . . . . 1.1 109.275 . . . . . . . . . 0 0 . 1 . 094 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -102.68 117.6 35.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.811 -3.681 . . . . 1.87 107.85 -178.052 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.0 pt -117.12 149.54 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 125.69 2.662 . . . . 0.72 110.062 174.369 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -95.26 153.76 17.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.984 -2.322 . . . . 1.4 112.223 -177.062 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.9 t -137.37 114.24 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 117.957 -2.964 . . . . 0.58 108.286 172.464 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -86.69 122.51 30.69 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.344 2.257 . . . . 2.09 112.427 179.709 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.301 17.0 p -80.89 174.89 11.17 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.451 -0.795 . . . . 0.99 112.674 -177.378 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 tp -78.03 -25.69 48.0 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 119.176 3.028 . . . . 2.53 119.176 171.357 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.9 p -74.82 -46.55 35.89 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.736 -3.102 . . . . 2.08 112.054 -178.001 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.31 6.89 0.12 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 126.629 2.062 . . . . 1.31 110.014 174.137 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -84.0 144.68 28.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 121.415 2.608 . . . . 1.4 114.137 178.371 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.335 31.3 m -102.57 137.63 40.55 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.228 2.211 . . . . 0.78 111.452 167.306 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mt -125.04 129.54 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 1 C-N-CA 132.908 4.483 . . . . 1.55 110.361 177.082 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.6 m -101.06 117.8 35.74 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 125.615 1.822 . . . . 1.08 109.651 177.096 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -111.36 137.82 48.64 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.425 1.89 . . . . 1.55 111.166 173.763 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -90.38 134.28 34.43 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.154 -2.216 . . . . 1.95 106.305 163.711 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.7 m -142.82 161.95 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 C-N-CA 129.427 3.091 . . . . 0.96 111.789 179.503 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -98.06 149.02 35.3 Favored Pre-proline 0 N--CA 1.431 -1.417 0 O-C-N 117.328 -3.358 . . . . 2.35 108.026 165.474 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -69.82 -17.58 37.21 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 CA-C-N 128.182 3.958 . . . . 0.95 112.109 -179.183 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.0 p -77.95 -16.09 58.45 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.048 1.739 . . . . 1.45 112.984 175.784 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -66.86 134.26 51.72 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.535 -1.211 . . . . 1.69 113.213 178.757 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -69.03 168.38 13.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 115.346 1.61 . . . . 0.75 115.346 174.653 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.276 15.4 mm -76.06 -29.59 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 113.642 -1.617 . . . . 0.73 112.186 176.621 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -46.82 -48.87 20.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.641 3.176 . . . . 1.62 111.703 158.84 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -63.87 -37.22 86.59 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.296 1.438 . . . . 2.13 114.859 176.459 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.3 t -59.99 -43.06 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 118.983 -2.323 . . . . 0.62 116.535 173.593 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HD3' ' HB2' ' A' ' 41' ' ' GLN . 74.4 mttt -71.7 -33.75 69.04 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.241 1.816 . . . . 1.22 114.528 179.741 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.22 -17.76 60.27 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.026 -2.921 . . . . 0.51 109.978 173.412 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -89.93 -12.68 38.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.967 1.841 . . . . 1.44 113.646 173.824 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.8 mt -88.32 -23.52 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 119.918 -1.739 . . . . 1.32 110.671 169.432 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -69.73 -49.42 53.42 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.314 1.845 . . . . 1.7 108.673 172.04 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.306 33.1 t70 -53.7 -62.86 1.38 Allowed 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 123.189 2.722 . . . . 1.55 116.405 164.078 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -63.21 -62.39 1.72 Allowed 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.818 -3.052 . . . . 2.62 113.995 -170.938 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -96.02 -56.46 2.64 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.258 -2.776 . . . . 1.48 113.23 -170.935 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.91 5.49 1.03 Allowed Glycine 0 N--CA 1.431 -1.698 0 O-C-N 124.867 1.354 . . . . 1.12 114.497 170.739 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.5 mt -78.12 135.53 62.3 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-O 114.611 -2.614 . . . . 1.55 111.969 -174.578 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 3.0 Cg_endo -77.37 153.24 31.03 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 CA-C-N 125.413 2.969 . . . . 1.02 113.469 -178.024 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 85.9 Cg_exo -64.51 -24.66 63.34 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 CA-C-N 127.664 3.773 . . . . 1.25 115.603 -172.106 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -61.24 -33.25 73.21 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.613 -2.555 . . . . 2.25 117.254 173.792 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -76.97 -24.74 52.28 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.376 -3.327 . . . . 2.02 116.746 -178.29 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.484 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 68.0 mt-30 -80.9 107.86 14.08 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.28 2.232 . . . . 0.69 110.513 -172.468 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -103.5 119.67 39.35 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.094 -2.879 . . . . 2.78 106.577 168.713 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.7 mt -102.92 123.86 47.34 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 119.67 3.211 . . . . 1.17 119.67 -178.789 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -109.58 157.68 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 115.675 -2.107 . . . . 1.38 109.751 178.356 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -140.63 114.95 9.29 Favored 'General case' 0 N--CA 1.43 -1.453 1 N-CA-C 95.64 -5.689 . . . . 1.5 95.64 173.604 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.259 . . 55.9 -110.23 0.54 Allowed 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.299 -1.501 . . . . 1.21 114.348 -176.815 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.48 -8.71 24.55 Favored Glycine 0 N--CA 1.43 -1.738 0 CA-C-O 123.062 1.368 . . . . 1.3 112.967 -176.601 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -91.61 143.86 26.13 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.388 -3.419 . . . . 2.55 114.468 171.572 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -99.83 129.05 45.89 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.236 1.014 . . . . 2.48 108.634 170.365 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.1 mt -91.36 147.13 23.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.194 1.473 . . . . 0.9 113.234 -167.86 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -91.74 143.23 26.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.719 -1.863 . . . . 1.94 115.581 175.392 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.81 -47.68 77.16 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 118.646 2.832 . . . . 1.56 118.646 -173.504 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.55 26.04 2.75 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 122.934 3.934 . . . . 0.97 122.934 171.885 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.4 mtt-85 -111.46 146.67 36.82 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 118.813 -2.581 . . . . 2.49 110.589 169.84 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.343 43.7 p -70.98 170.9 11.8 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.638 2.637 . . . . 0.76 113.264 176.404 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mt -74.87 -27.96 60.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.318 -2.739 . . . . 1.05 109.779 168.571 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.6 t -65.75 -39.87 91.52 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 127.706 2.402 . . . . 1.19 114.752 178.977 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -51.0 -50.22 58.92 Favored 'General case' 0 N--CA 1.43 -1.452 1 CA-C-O 129.135 4.302 . . . . 1.9 112.505 174.544 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -88.15 -2.1 58.4 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.822 -3.049 . . . . 0.89 114.286 -178.904 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 63.73 55.73 1.63 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.61 1.964 . . . . 1.84 113.183 -176.381 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.1 mm -85.3 118.44 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-O 116.333 -1.794 . . . . 0.82 106.308 179.288 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -82.56 -170.52 3.0 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 128.035 3.334 . . . . 2.16 109.35 -176.69 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.28 92.4 mttt -72.61 -56.3 5.55 Favored 'General case' 0 N--CA 1.429 -1.495 1 N-CA-C 123.84 4.756 . . . . 2.12 123.84 -177.981 . . . . . . . . 3 2 . 1 . 094 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -74.3 27.14 0.08 Allowed 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.783 2.706 . . . . 1.71 115.01 -176.571 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.7 m -73.83 136.41 43.51 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.722 -4.361 . . . . 1.04 116.174 -174.859 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.8 m -112.98 108.97 18.08 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.478 2.085 . . . . 0.79 107.123 178.773 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -75.77 138.97 41.56 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 112.368 -2.197 . . . . 1.4 105.843 174.395 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -106.73 109.41 21.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.744 -3.098 . . . . 1.51 107.225 -170.339 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tp -106.48 126.0 51.7 Favored 'General case' 0 N--CA 1.43 -1.455 1 CA-C-O 128.81 4.148 . . . . 1.14 107.701 -171.69 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -112.85 138.74 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 109.353 -3.567 . . . . 1.23 105.906 -179.151 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.43 -1.467 0 C-N-CA 116.579 -2.049 . . . . 2.78 108.884 -173.899 . . . . . . . . 0 0 . 1 . 095 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ptt? . . . . . 0 CA--C 1.49 -1.356 0 CA-C-O 119.635 -0.221 . . . . 1.1 111.008 . . . . . . . . . 0 0 . 1 . 095 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -111.3 117.67 33.79 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.815 -1.178 . . . . 1.87 108.517 -176.594 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.425 HG12 HG22 ' A' ' 17' ' ' VAL . 16.8 pt -114.13 159.13 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 124.586 1.154 . . . . 0.72 113.054 -178.63 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -112.17 146.61 37.77 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 104.914 -2.254 . . . . 1.4 104.914 174.916 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.8 t -117.3 114.45 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 110.927 -2.851 . . . . 0.58 109.822 174.159 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -91.96 131.5 37.21 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 120.937 1.699 . . . . 2.09 110.329 175.838 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.295 39.4 p -83.12 174.13 11.09 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 126.535 3.064 . . . . 0.99 112.379 174.914 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.3 tp -57.96 -47.32 83.28 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.488 2.566 . . . . 2.53 117.818 172.746 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.3 p -86.4 -8.0 58.0 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.241 2.216 . . . . 2.08 110.103 -173.809 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.4 30.14 5.73 Favored Glycine 0 N--CA 1.431 -1.7 1 C-N-CA 132.932 5.063 . . . . 1.31 118.84 167.613 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -106.15 133.94 50.06 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.258 -2.319 . . . . 1.4 105.54 -176.038 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.7 m -105.05 118.7 37.2 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.239 -0.891 . . . . 0.78 110.155 -173.501 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.72 129.27 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 124.783 1.233 . . . . 1.55 109.982 -176.12 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 100.0 m -88.86 122.46 32.27 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 126.813 2.571 . . . . 1.08 106.409 177.931 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.2 tp -121.63 134.69 54.99 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.379 -2.076 . . . . 1.55 108.612 -178.616 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -94.02 99.92 12.14 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 129.643 3.177 . . . . 1.95 116.561 173.197 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.425 HG22 HG12 ' A' ' 3' ' ' ILE . 16.2 m -115.29 149.58 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 127.712 2.405 . . . . 0.96 112.681 -175.456 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -103.81 165.84 12.75 Favored Pre-proline 0 N--CA 1.43 -1.448 0 N-CA-C 106.625 -1.62 . . . . 2.35 106.625 168.274 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -79.56 -20.01 9.7 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 123.18 2.587 . . . . 0.95 107.625 -172.597 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.8 p -84.8 0.49 50.59 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.244 -2.16 . . . . 1.45 115.974 177.039 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -70.65 151.65 44.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.816 1.246 . . . . 1.69 110.611 173.913 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 p -84.78 166.64 16.79 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.421 1.488 . . . . 0.75 111.028 171.293 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.4 mm -75.12 -35.87 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 116.645 2.091 . . . . 0.73 116.645 173.335 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -48.31 -49.45 33.93 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.053 2.983 . . . . 1.62 119.053 163.536 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -58.49 -35.73 72.66 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.861 2.064 . . . . 2.13 112.899 173.892 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 t -72.76 -38.9 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 121.09 -1.006 . . . . 0.62 112.797 177.685 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -64.02 -31.26 72.38 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.495 -3.253 . . . . 1.22 111.409 170.514 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.43 -32.04 70.75 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 119.144 0.884 . . . . 0.51 111.695 175.246 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -68.86 -45.16 71.79 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.0 1.481 . . . . 1.44 115.0 171.888 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mt -59.03 -35.41 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 125.621 2.629 . . . . 1.32 113.553 177.428 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.298 26.3 tt0 -69.15 -40.89 77.95 Favored 'General case' 0 N--CA 1.428 -1.535 0 O-C-N 116.331 -3.981 . . . . 1.7 111.475 172.67 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -56.05 -61.79 2.14 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 122.969 2.622 . . . . 1.55 114.362 167.429 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.439 12.0 ptpt -76.77 -50.77 12.75 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 114.8 1.407 . . . . 2.62 114.8 -173.706 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -97.28 -48.44 5.33 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 125.577 2.608 . . . . 1.48 112.98 -170.248 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.93 67.02 0.75 Allowed Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 119.936 2.734 . . . . 1.12 119.936 -179.336 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.3 mt -127.26 135.24 27.12 Favored Pre-proline 0 N--CA 1.43 -1.446 0 N-CA-C 100.563 -3.865 . . . . 1.55 100.563 -177.303 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -85.55 135.17 4.99 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 C-N-CA 115.047 -2.835 . . . . 1.02 111.76 -175.202 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.29 -11.68 6.56 Favored 'Trans proline' 0 C--N 1.3 -2.0 1 C-N-CA 126.233 4.622 . . . . 1.25 117.41 -172.91 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -73.83 -23.7 59.69 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.82 1.415 . . . . 2.25 114.82 169.329 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -99.85 -3.06 33.37 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.023 -2.923 . . . . 2.02 113.871 -176.379 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -101.13 97.59 8.11 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.466 -2.021 . . . . 0.69 113.782 -172.706 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.8 ttt-85 -87.82 122.14 31.1 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 115.856 -2.021 . . . . 2.78 110.263 166.737 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.8 mt -111.08 131.5 55.02 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.886 2.18 . . . . 1.17 116.886 -177.717 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.91 136.23 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 105.691 -1.966 . . . . 1.38 105.691 -177.927 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -93.1 -105.42 0.12 Allowed 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.882 -1.508 . . . . 1.5 107.644 168.847 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.83 -69.81 0.79 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 113.934 1.087 . . . . 1.21 113.934 170.174 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.79 -28.57 5.29 Favored Glycine 0 N--CA 1.429 -1.779 0 O-C-N 119.701 -1.874 . . . . 1.3 109.5 -179.275 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -95.25 142.75 27.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 120.423 2.112 . . . . 2.55 108.599 -179.404 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -95.3 135.68 36.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 128.634 2.774 . . . . 2.48 104.394 166.851 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.1 mt -86.68 115.85 24.4 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 126.287 2.242 . . . . 0.9 116.777 -168.769 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -84.8 134.4 34.31 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 125.636 2.636 . . . . 1.94 111.776 179.014 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.283 20.0 m-20 -59.75 -40.38 87.92 Favored 'General case' 0 N--CA 1.43 -1.44 2 N-CA-C 127.458 6.095 . . . . 1.56 127.458 -168.547 . . . . . . . . 3 2 . 1 . 095 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.52 56.88 1.98 Allowed Glycine 0 N--CA 1.43 -1.703 0 O-C-N 119.256 -2.153 . . . . 0.97 113.518 167.736 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -131.93 162.25 31.12 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 127.811 2.444 . . . . 2.49 108.733 172.012 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.3 p -95.53 169.71 9.85 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 121.049 1.75 . . . . 0.76 110.134 173.948 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.451 ' HG ' HD12 ' A' ' 61' ' ' ILE 0.262 7.5 mp -59.02 -30.25 67.87 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 119.152 3.019 . . . . 1.05 119.152 161.906 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 p -74.24 -23.62 59.18 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.909 -2.994 . . . . 1.19 109.118 177.614 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -74.63 -40.65 61.37 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 129.759 3.224 . . . . 1.9 112.696 178.784 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.254 46.8 m-85 -91.62 -0.67 57.6 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 113.469 -5.769 . . . . 0.89 109.505 177.553 . . . . . . . . 3 2 . 1 . 095 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.8 m120 63.74 56.78 1.48 Allowed 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 114.233 -2.794 . . . . 1.84 109.278 -179.029 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.451 HD12 ' HG ' ' A' ' 56' ' ' LEU 0.295 65.6 mt -84.66 126.18 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 127.886 2.474 . . . . 0.82 110.659 175.643 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -107.58 170.92 7.68 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 117.925 -1.036 . . . . 2.16 108.277 -173.473 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -71.51 -29.3 64.63 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 115.478 -2.489 . . . . 2.12 113.981 -178.963 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -80.04 10.4 4.37 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 125.603 2.621 . . . . 1.71 113.972 -179.652 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.8 m -78.84 130.94 36.24 Favored 'General case' 0 N--CA 1.431 -1.406 1 O-C-N 116.096 -4.127 . . . . 1.04 116.899 -174.631 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.8 m -106.51 115.71 30.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.937 -1.938 . . . . 0.79 111.879 170.947 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.297 8.8 mp -87.61 157.61 19.08 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.744 -1.116 . . . . 1.4 109.439 177.103 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -128.54 123.93 34.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 103.36 -2.83 . . . . 1.51 103.36 -176.088 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.305 6.8 tt -103.56 115.42 30.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.253 1.021 . . . . 1.14 111.349 179.579 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.388 4.1 m -109.66 166.71 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 118.628 -2.545 . . . . 1.23 112.446 174.283 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.4 tp . . . . . 0 N--CA 1.431 -1.404 0 N-CA-C 117.365 2.358 . . . . 2.78 117.365 -178.45 . . . . . . . . 0 0 . 1 . 096 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 ptt? . . . . . 0 CA--C 1.49 -1.355 0 N-CA-C 113.268 0.84 . . . . 1.1 113.268 . . . . . . . . . 0 0 . 1 . 096 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -101.14 107.11 18.44 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 120.414 1.461 . . . . 1.87 112.021 -178.768 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.1 pt -89.62 155.9 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 C-N-CA 124.76 1.224 . . . . 0.72 111.431 176.763 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -104.88 140.99 37.32 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 123.303 1.525 . . . . 1.4 107.93 -179.894 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.6 t -124.43 114.97 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 103.584 -2.747 . . . . 0.58 103.584 174.298 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -96.59 138.14 34.62 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.828 -1.795 . . . . 2.09 111.481 -178.322 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.65 HG22 HD23 ' A' ' 69' ' ' LEU 0.346 18.3 p -91.73 166.86 12.56 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 116.429 -1.748 . . . . 0.99 110.977 175.204 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.8 mt -68.95 -44.82 72.23 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 125.33 1.644 . . . . 2.53 111.182 171.784 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.1 p -62.17 -81.84 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 128.399 3.952 . . . . 2.08 113.299 -177.432 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.12 40.48 0.11 Allowed Glycine 0 N--CA 1.431 -1.692 1 O-C-N 116.299 -4.001 . . . . 1.31 119.243 174.819 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -122.87 142.39 50.84 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.069 1.435 . . . . 1.4 108.134 -177.206 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.6 m -120.63 118.66 30.72 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.759 2.423 . . . . 0.78 106.289 172.03 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.444 HD13 HG21 ' A' ' 13' ' ' ILE . 2.9 mt -97.59 133.2 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-O 124.978 2.323 . . . . 1.55 105.89 178.61 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 p -107.28 92.63 4.16 Favored 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 132.496 4.318 . . . . 1.08 107.091 -177.402 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.0 mt -101.31 130.36 47.46 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 125.313 1.633 . . . . 1.55 112.353 -179.198 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -74.7 107.49 6.84 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 115.269 -2.301 . . . . 1.95 109.758 171.314 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.1 m -127.57 173.32 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 105.847 -1.908 . . . . 0.96 105.847 -173.349 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -125.77 169.57 11.21 Favored Pre-proline 0 N--CA 1.431 -1.399 0 CA-C-O 112.903 -3.427 . . . . 2.35 106.285 163.849 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -74.87 -17.95 19.48 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 C-N-CA 124.028 3.152 . . . . 0.95 111.356 -175.192 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.6 p -78.17 -8.96 58.94 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.736 2.014 . . . . 1.45 115.656 176.339 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -74.29 137.88 43.19 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.69 -3.131 . . . . 1.69 112.567 176.565 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 29.6 p -76.42 154.84 34.47 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.697 1.999 . . . . 0.75 111.354 176.072 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.0 mm -54.42 -37.08 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 125.679 1.592 . . . . 0.73 112.072 173.96 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -53.32 -45.52 69.07 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.281 2.232 . . . . 1.62 116.783 162.599 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.413 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 5.5 t-20 -55.75 -42.22 75.11 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 119.09 -2.256 . . . . 2.13 115.642 171.692 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.0 t -66.33 -39.34 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 114.284 1.216 . . . . 0.62 114.284 179.204 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -63.27 -27.02 69.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.587 2.069 . . . . 1.22 116.587 168.931 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -64.71 -47.29 78.86 Favored 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 116.291 -4.005 . . . . 0.51 113.773 169.127 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -55.47 -49.95 71.17 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 126.431 3.015 . . . . 1.44 116.672 169.634 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.1 mt -59.11 -40.14 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 O-C-N 116.394 -3.941 . . . . 1.32 114.291 169.921 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -61.09 -39.87 91.56 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.77 -1.831 . . . . 1.7 113.058 173.444 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -62.7 -50.68 70.2 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.511 2.041 . . . . 1.55 116.511 172.711 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -67.6 -61.18 2.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.863 2.465 . . . . 2.62 109.665 -173.583 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -94.93 -56.27 2.81 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.622 -2.549 . . . . 1.48 112.837 -169.719 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.73 -1.1 2.84 Favored Glycine 0 N--CA 1.431 -1.667 0 O-C-N 119.615 -1.928 . . . . 1.12 116.155 176.111 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.1 mt -90.84 134.51 30.27 Favored Pre-proline 0 N--CA 1.429 -1.481 0 O-C-N 119.959 -1.906 . . . . 1.55 107.486 -167.269 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 20.4 Cg_exo -61.08 153.05 67.14 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 O-C-N 115.121 -3.147 . . . . 1.02 114.943 173.5 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 99.0 Cg_exo -73.7 -19.02 21.75 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 122.815 2.041 . . . . 1.25 110.557 -177.644 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.265 3.3 m-20 -63.42 -28.57 70.06 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.12 -2.863 . . . . 2.25 116.897 170.276 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.251 18.6 mt-30 -85.95 -23.91 26.75 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 115.164 -0.925 . . . . 2.02 111.936 -179.552 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -78.43 134.46 37.37 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 120.346 3.461 . . . . 0.69 120.346 -178.456 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -122.57 130.64 53.23 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 105.092 -2.188 . . . . 2.78 105.092 175.465 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.2 mt -114.73 147.11 40.15 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 117.238 -3.414 . . . . 1.17 113.371 175.778 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.0 mt -144.25 136.97 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 C-N-CA 128.268 2.627 . . . . 1.38 104.084 -168.674 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -117.52 123.65 46.79 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 103.289 -2.856 . . . . 1.5 103.289 170.374 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.285 . . 63.3 -89.53 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.476 -2.64 . . . . 1.21 116.75 -176.816 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.9 4.82 3.6 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 105.38 -3.088 . . . . 1.3 105.38 -177.91 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -109.12 130.03 55.48 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.029 -2.454 . . . . 2.55 115.557 -174.538 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -70.32 130.9 43.21 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.836 1.655 . . . . 2.48 110.347 171.171 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.1 mt -99.32 159.15 15.21 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 124.43 3.286 . . . . 0.9 105.094 -168.202 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.491 ' HB3' ' HG3' ' A' ' 54' ' ' ARG . 37.6 tt0 -104.25 130.2 52.05 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 125.65 1.844 . . . . 1.94 114.036 174.5 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -50.25 -50.73 49.17 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.523 3.156 . . . . 1.56 119.523 -168.848 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.6 -9.43 65.15 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 119.832 2.693 . . . . 0.97 119.832 170.68 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.491 ' HG3' ' HB3' ' A' ' 51' ' ' GLU . 37.4 mtt180 -84.92 163.22 19.1 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 115.757 -4.378 . . . . 2.49 115.066 169.687 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 43.0 p -84.02 174.66 10.12 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 118.582 2.808 . . . . 0.76 118.582 171.825 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.83 -31.29 72.41 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 117.922 2.564 . . . . 1.05 117.922 165.892 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.5 t -77.25 -25.2 51.28 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.937 2.095 . . . . 1.19 112.927 178.79 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -65.3 -33.49 76.1 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.316 -2.115 . . . . 1.9 111.898 169.45 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -91.81 4.51 52.69 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.316 -4.615 . . . . 0.89 113.439 170.059 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.663 2.9 m120 63.46 25.83 14.64 Favored 'General case' 0 N--CA 1.43 -1.439 1 N-CA-C 124.288 4.922 . . . . 1.84 124.288 -174.862 . . . . . . . . 3 2 . 1 . 096 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.4 mt -66.84 121.87 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 128.106 2.563 . . . . 0.82 110.541 -177.252 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -89.44 174.73 7.63 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.416 2.531 . . . . 2.16 112.349 -179.518 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -42.06 -56.65 2.75 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 128.023 3.773 . . . . 2.12 118.154 174.791 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -94.61 44.29 1.11 Allowed 'General case' 0 N--CA 1.429 -1.513 1 O-C-N 113.077 -6.015 . . . . 1.71 113.445 -175.269 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.31 38.8 m -92.65 133.73 35.7 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 118.73 -2.481 . . . . 1.04 115.478 -171.716 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.3 m -104.33 105.32 15.41 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 120.694 1.588 . . . . 0.79 107.448 175.004 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 67' ' ' LEU . 5.8 mp -81.74 161.85 23.17 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.299 2.0 . . . . 1.4 109.385 163.67 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.261 98.8 m-70 -118.45 130.7 56.11 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 112.493 -2.139 . . . . 1.51 108.966 -178.199 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.65 HD23 HG22 ' A' ' 7' ' ' THR . 49.8 tp -102.16 111.5 23.81 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 123.351 1.548 . . . . 1.14 110.228 179.295 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.289 40.0 t -109.48 129.79 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 118.218 2.673 . . . . 1.23 118.218 177.848 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.2 tp . . . . . 0 N--CA 1.43 -1.433 0 C-N-CA 115.889 -2.324 . . . . 2.78 113.741 -170.287 . . . . . . . . 0 0 . 1 . 097 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttp . . . . . 0 CA--C 1.491 -1.309 0 N-CA-C 116.139 1.904 . . . . 1.1 116.139 . . . . . . . . . 0 0 . 1 . 097 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -95.98 125.65 40.68 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 116.52 -3.863 . . . . 1.87 110.688 -174.312 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.6 pt -111.98 144.54 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 124.739 2.209 . . . . 0.72 110.12 169.121 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -108.34 112.67 25.24 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.131 -1.85 . . . . 1.4 110.63 -174.661 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.39 116.24 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-O 124.895 2.283 . . . . 0.58 107.262 178.564 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 tppt? -97.38 132.35 43.18 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.389 -3.945 . . . . 2.09 109.197 177.045 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.357 12.5 p -73.56 173.78 9.21 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.08 -2.262 . . . . 0.99 115.106 176.26 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.9 mt -70.92 -15.32 62.6 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.628 1.68 . . . . 2.53 114.985 172.962 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.7 p -109.24 -26.17 10.22 Favored 'General case' 0 N--CA 1.431 -1.399 1 O-C-N 116.025 -4.172 . . . . 2.08 107.264 -175.796 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.42 27.22 0.83 Allowed Glycine 0 N--CA 1.431 -1.651 0 O-C-N 118.968 -2.332 . . . . 1.31 117.12 169.383 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -100.66 118.41 36.74 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.808 2.304 . . . . 1.4 109.919 -168.712 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.4 m -81.44 122.48 27.56 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 119.557 -0.857 . . . . 0.78 110.012 178.518 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -111.14 133.77 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 102.729 -3.063 . . . . 1.55 102.729 173.518 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.8 m -111.63 125.73 54.26 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.277 -2.764 . . . . 1.08 108.815 -172.833 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.8 mt -119.01 135.45 54.62 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 120.739 1.609 . . . . 1.55 107.817 -177.369 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -91.43 112.57 24.54 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.143 -1.428 . . . . 1.95 107.143 169.966 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.7 m -127.53 165.85 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 C-N-CA 129.008 2.923 . . . . 0.96 116.02 -178.785 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -109.27 163.32 17.28 Favored Pre-proline 0 N--CA 1.43 -1.462 0 C-N-CA 119.717 -0.793 . . . . 2.35 111.601 163.876 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -82.18 -12.35 10.58 Favored 'Trans proline' 0 C--N 1.299 -2.049 0 O-C-N 114.531 -3.458 . . . . 0.95 113.729 -172.996 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.7 m -82.36 -5.92 58.93 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 124.792 1.307 . . . . 1.45 110.457 176.177 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -85.33 146.5 26.99 Favored 'General case' 0 N--CA 1.429 -1.498 1 O-C-N 114.652 -5.03 . . . . 1.69 109.776 178.783 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 68.9 p -77.55 161.78 27.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 118.289 -2.757 . . . . 0.75 112.159 178.629 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mp -68.81 -31.32 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 119.469 -2.019 . . . . 0.73 108.937 -179.818 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -46.48 -40.51 12.54 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.476 -2.015 . . . . 1.62 114.1 165.65 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -70.77 -29.55 65.8 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 117.514 2.413 . . . . 2.13 117.514 174.752 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.39 -39.61 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-N 113.428 -1.714 . . . . 0.62 109.289 176.809 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.3 84.2 mttt -60.73 -34.37 74.3 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 124.277 0.985 . . . . 1.22 111.974 169.275 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.62 -44.48 96.18 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.524 -2.61 . . . . 0.51 114.676 173.235 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -66.58 -43.55 84.64 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.425 -1.716 . . . . 1.44 115.014 172.397 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.5 mt -58.12 -31.07 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 116.652 -3.78 . . . . 1.32 113.327 170.656 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -60.34 -45.64 92.72 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 116.849 2.166 . . . . 1.7 116.849 170.69 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.87 -53.86 43.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.032 2.349 . . . . 1.55 114.151 174.92 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -56.81 -75.96 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 111.502 -2.59 . . . . 2.62 113.551 177.782 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -94.52 -21.38 18.91 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.433 3.123 . . . . 1.48 119.433 -169.068 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.75 43.38 3.63 Favored Glycine 0 N--CA 1.43 -1.755 1 O-C-N 114.802 -4.936 . . . . 1.12 113.471 175.886 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.7 mt -115.72 131.39 23.7 Favored Pre-proline 0 N--CA 1.43 -1.441 0 O-C-N 120.892 -1.357 . . . . 1.55 109.481 179.787 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -63.84 147.07 92.36 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 O-C-N 116.456 -2.444 . . . . 1.02 113.623 176.069 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.66 -22.89 64.04 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 C-N-CA 124.246 3.297 . . . . 1.25 115.991 -176.606 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.58 -24.47 65.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 128.395 2.678 . . . . 2.25 117.35 177.311 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -86.96 -33.22 19.72 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.014 -1.448 . . . . 2.02 107.257 -177.982 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -85.87 129.78 34.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.081 -1.637 . . . . 0.69 115.118 -168.642 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -115.97 142.24 47.06 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.599 1.959 . . . . 2.78 106.253 163.393 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.8 mt -117.7 125.56 50.9 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.306 -1.739 . . . . 1.17 106.306 178.89 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 39.3 mm -102.29 144.65 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 129.959 3.304 . . . . 1.38 107.259 174.222 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.315 17.4 t80 -143.0 114.83 8.18 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 105.235 -2.135 . . . . 1.5 105.235 171.57 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.5 17.73 9.03 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 127.524 3.535 . . . . 1.21 116.826 176.619 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.32 -7.55 54.31 Favored Glycine 0 N--CA 1.43 -1.712 1 O-C-N 114.323 -5.236 . . . . 1.3 111.527 -178.388 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -104.4 133.32 49.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.229 -1.748 . . . . 2.55 108.463 -175.801 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -74.42 125.64 28.97 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 112.901 -1.954 . . . . 2.48 111.372 169.033 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.1 mt -83.76 152.21 24.79 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 125.078 1.486 . . . . 0.9 108.719 -172.323 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -94.93 135.39 36.51 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 123.28 1.514 . . . . 1.94 111.073 176.074 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -54.59 -53.88 48.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 111.612 -2.54 . . . . 1.56 114.94 -171.801 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.38 63.17 2.72 Favored Glycine 0 N--CA 1.429 -1.803 0 O-C-N 119.297 -2.127 . . . . 0.97 114.554 169.347 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -133.99 158.56 43.2 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 100.794 -3.78 . . . . 2.49 100.794 161.169 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 45.8 p -88.41 171.01 10.44 Favored 'General case' 0 N--CA 1.43 -1.439 1 CA-C-O 129.288 4.375 . . . . 0.76 110.115 176.694 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.32 -36.78 71.71 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 112.07 -6.643 . . . . 1.05 111.467 175.597 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.4 t -51.59 -35.07 39.95 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 129.158 2.983 . . . . 1.19 113.89 179.432 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -62.75 -30.36 71.38 Favored 'General case' 0 N--CA 1.43 -1.455 1 C-N-CA 132.855 4.462 . . . . 1.9 110.384 174.332 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -99.68 167.94 10.25 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.946 -2.346 . . . . 0.89 110.264 179.772 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -89.39 62.81 6.17 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 118.982 -2.324 . . . . 1.84 110.356 -179.829 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.8 mm -80.82 128.61 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 124.454 1.102 . . . . 0.82 108.283 177.858 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -100.17 -119.49 0.16 Allowed 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.49 2.404 . . . . 2.16 117.49 -169.941 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -100.39 -59.55 1.69 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.983 0.897 . . . . 2.12 111.192 177.703 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.32 75.23 1.64 Allowed 'General case' 0 N--CA 1.429 -1.523 0 O-C-N 118.321 -2.737 . . . . 1.71 107.684 177.278 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.0 m -91.47 142.6 27.49 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.907 -2.995 . . . . 1.04 109.573 -167.336 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.0 m -98.4 126.95 44.12 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.67 1.7 . . . . 0.79 107.118 178.871 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mp -110.15 166.18 11.16 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.659 -1.901 . . . . 1.4 107.088 176.157 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.549 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 98.4 m-70 -124.07 127.89 48.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.68 -3.762 . . . . 1.51 112.212 -170.109 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.0 tp -103.67 116.91 33.21 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 127.053 2.721 . . . . 1.14 113.022 -178.454 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.7 128.05 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 N-CA-C 105.329 -2.101 . . . . 1.23 105.329 178.351 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 N--CA 1.43 -1.466 0 O-C-N 124.2 0.937 . . . . 2.78 111.607 174.911 . . . . . . . . 0 0 . 1 . 098 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 ttp . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 120.56 0.219 . . . . 1.1 111.2 . . . . . . . . . 0 0 . 1 . 098 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -98.99 114.44 27.09 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.9 -2.259 . . . . 1.87 104.9 -170.069 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 pt -117.83 153.97 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 113.047 -1.888 . . . . 0.72 108.712 -179.722 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -118.88 113.53 21.2 Favored 'General case' 0 N--CA 1.43 -1.44 1 C-N-CA 132.556 4.342 . . . . 1.4 109.521 -175.93 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -104.23 121.49 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 100.812 -3.773 . . . . 0.58 100.812 177.364 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt -99.54 135.77 40.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.353 2.661 . . . . 2.09 110.878 177.511 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -92.64 -176.62 4.32 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.97 1.708 . . . . 0.99 112.125 173.229 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.5 mt -95.16 -11.72 27.64 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.953 2.101 . . . . 2.53 111.227 168.955 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.3 p -82.92 -46.41 12.99 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.368 2.032 . . . . 2.08 114.534 179.658 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.31 -13.5 0.29 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 117.546 -3.221 . . . . 1.31 111.141 170.976 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -86.82 128.26 35.03 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 119.902 1.851 . . . . 1.4 113.047 -165.654 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -92.52 115.64 28.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.834 -3.041 . . . . 0.78 108.353 175.037 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mt -99.08 117.25 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 1 O-C-N 115.967 -4.208 . . . . 1.55 109.455 -179.342 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.0 m -98.07 124.38 42.56 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.406 2.527 . . . . 1.08 108.459 -178.359 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.4 mt -118.99 138.33 52.89 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.348 1.61 . . . . 1.55 115.348 -179.968 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -103.46 102.37 12.28 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.69 -3.131 . . . . 1.95 109.927 175.219 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.9 m -114.75 170.78 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 128.421 2.688 . . . . 0.96 108.458 -175.296 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -118.18 157.48 48.82 Favored Pre-proline 0 N--CA 1.43 -1.459 0 O-C-N 118.393 -2.692 . . . . 2.35 107.521 163.775 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -62.7 -20.86 72.17 Favored 'Trans proline' 0 C--N 1.299 -2.055 0 C-N-CA 124.044 3.163 . . . . 0.95 115.508 -171.605 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 m -80.91 0.93 33.1 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 118.076 2.621 . . . . 1.45 118.076 173.862 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -87.43 163.91 16.48 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 102.457 -3.164 . . . . 1.69 102.457 175.624 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.2 p -90.8 -175.26 4.32 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.132 2.396 . . . . 0.75 114.006 176.142 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.4 mm -82.63 -36.41 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 O-C-N 116.893 -3.629 . . . . 0.73 106.61 178.917 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -50.97 -45.86 61.07 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.169 2.187 . . . . 1.62 112.478 167.168 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -64.27 -38.73 92.07 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.336 2.654 . . . . 2.13 107.202 175.787 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.8 t -59.27 -48.04 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 124.264 3.211 . . . . 0.62 114.364 176.805 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.262 37.8 mtmt -64.64 -41.73 95.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.46 1.504 . . . . 1.22 112.049 174.162 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.08 -32.38 72.91 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 117.067 2.247 . . . . 0.51 117.067 176.952 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -76.46 -36.54 57.85 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 125.092 1.495 . . . . 1.44 111.694 175.437 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.2 mt -71.9 -31.29 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 116.666 -3.772 . . . . 1.32 110.089 175.557 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -59.28 -59.1 6.0 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 113.579 -3.105 . . . . 1.7 107.74 169.985 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -50.16 -52.51 34.72 Favored 'General case' 0 N--CA 1.43 -1.432 1 CA-C-N 127.925 4.875 . . . . 1.55 111.79 166.418 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -61.66 -48.48 80.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.033 -2.917 . . . . 2.62 117.61 -167.952 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -112.59 -52.04 2.8 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 118.909 -1.116 . . . . 1.48 113.308 -168.317 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.21 36.25 0.43 Allowed Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 126.382 1.944 . . . . 1.12 114.305 178.934 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.8 mt -117.92 116.7 36.02 Favored Pre-proline 0 N--CA 1.429 -1.489 0 O-C-N 118.237 -2.919 . . . . 1.55 105.692 -171.239 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -59.93 154.0 53.51 Favored 'Trans proline' 0 C--N 1.299 -2.051 2 C-N-CA 126.67 4.913 . . . . 1.02 114.877 -179.954 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -73.36 -17.76 23.76 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 C-N-CA 124.566 3.511 . . . . 1.25 113.294 -176.55 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -84.25 -16.55 42.79 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.168 2.587 . . . . 2.25 108.986 -178.814 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.329 14.8 tt0 -97.86 -24.44 15.42 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 126.076 2.11 . . . . 2.02 109.925 -177.017 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -88.07 125.0 34.34 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 113.72 1.007 . . . . 0.69 113.72 -175.761 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -110.07 124.53 51.65 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.055 -0.72 . . . . 2.78 109.055 172.806 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.3 mt -107.84 114.83 29.04 Favored 'General case' 0 N--CA 1.429 -1.516 0 O-C-N 118.933 -2.354 . . . . 1.17 110.748 -173.102 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.7 mm -91.85 124.94 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 114.949 -1.023 . . . . 1.38 109.673 177.107 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -114.15 111.28 21.33 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.072 -1.085 . . . . 1.5 108.072 163.89 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.498 . . 68.01 -44.11 0.49 Allowed 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 127.039 3.305 . . . . 1.21 118.642 174.33 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.67 -47.66 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.738 0 O-C-N 116.798 -3.689 . . . . 1.3 108.246 -172.659 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -75.34 156.59 35.36 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 124.676 2.179 . . . . 2.55 112.319 179.612 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -104.82 135.48 46.11 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.173 -2.204 . . . . 2.48 105.718 169.131 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.418 HD22 ' CE2' ' A' ' 59' ' ' TYR . 12.8 mt -96.1 143.59 27.1 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.748 -1.845 . . . . 0.9 110.395 -169.675 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -83.67 147.44 27.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 113.312 -1.767 . . . . 1.94 115.303 172.449 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.61 -63.83 1.16 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 130.909 3.684 . . . . 1.56 113.216 -165.857 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.81 36.71 2.83 Favored Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 119.785 2.674 . . . . 0.97 119.785 171.637 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -102.73 152.43 21.24 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 120.999 0.428 . . . . 2.49 111.221 161.463 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.1 p -83.67 173.27 11.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 124.781 2.229 . . . . 0.76 109.219 171.677 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -72.7 -38.27 67.58 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.955 -2.966 . . . . 1.05 106.937 172.412 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.34 59.8 p -60.87 -24.76 66.18 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.528 1.931 . . . . 1.19 115.356 178.564 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.386 4.7 t0 -62.18 -38.4 88.91 Favored 'General case' 0 N--CA 1.429 -1.524 1 CA-C-O 129.017 4.246 . . . . 1.9 114.838 172.057 . . . . . . . . 3 2 . 1 . 098 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.418 ' CE2' HD22 ' A' ' 50' ' ' LEU . 76.8 m-85 -97.83 171.12 8.51 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 110.894 -2.867 . . . . 0.89 111.125 -179.367 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -89.68 43.16 1.13 Allowed 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.373 -2.704 . . . . 1.84 116.325 -175.136 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.3 mm -71.59 124.73 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 118.47 2.767 . . . . 0.82 118.47 -179.371 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -85.28 173.76 10.11 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 125.014 2.34 . . . . 2.16 109.125 -177.42 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.47 -48.83 77.91 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.497 -3.252 . . . . 2.12 115.568 173.858 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.06 64.09 0.93 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.445 -3.285 . . . . 1.71 111.964 175.365 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.5 m -87.39 141.65 28.47 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 117.896 2.554 . . . . 1.04 117.896 178.551 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.1 m -102.02 122.47 44.14 Favored 'General case' 0 N--CA 1.431 -1.409 1 CA-C-N 108.097 -4.138 . . . . 0.79 105.032 176.536 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -112.88 154.72 25.89 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 101.84 -3.392 . . . . 1.4 101.84 177.218 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -126.22 117.32 22.84 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.111 -2.243 . . . . 1.51 111.594 -175.534 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.251 3.9 tt -86.38 115.57 23.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 127.252 2.221 . . . . 1.14 108.946 -179.561 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.9 t -101.56 157.41 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 1 C-N-CA 133.523 4.729 . . . . 1.23 105.346 172.087 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.6 mt . . . . . 0 N--CA 1.431 -1.422 0 O-C-N 120.659 -1.275 . . . . 2.78 108.199 173.676 . . . . . . . . 0 0 . 1 . 099 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttp . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 114.076 1.139 . . . . 1.1 114.076 . . . . . . . . . 0 0 . 1 . 099 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -96.95 104.3 16.3 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 114.976 -2.44 . . . . 1.87 109.313 -172.636 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.43 HD12 HD13 ' A' ' 67' ' ' LEU . 13.4 pt -95.47 165.39 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 127.459 2.975 . . . . 0.72 111.977 174.94 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -117.5 136.3 53.33 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.359 1.464 . . . . 1.4 112.742 176.618 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.447 HG21 HD12 ' A' ' 15' ' ' LEU . 18.6 t -116.19 98.58 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 131.246 3.818 . . . . 0.58 111.123 177.21 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -84.53 134.46 34.42 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 119.168 0.895 . . . . 2.09 112.935 179.396 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -83.5 -174.86 5.53 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.809 -1.087 . . . . 0.99 110.95 176.864 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.7 tp -81.75 -41.54 21.08 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.609 1.195 . . . . 2.53 112.758 171.01 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.9 p -74.39 -21.78 59.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.769 2.137 . . . . 2.08 116.769 -177.452 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.45 -0.01 1.03 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 118.415 2.126 . . . . 1.31 118.415 166.62 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.8 tttp -91.24 126.4 36.31 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.132 -1.805 . . . . 1.4 114.303 -172.957 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.5 m -95.37 109.78 21.9 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 121.398 -0.814 . . . . 0.78 110.454 176.197 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.1 mt -89.85 137.29 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 113.162 -3.304 . . . . 1.55 102.324 -174.884 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 m -110.17 129.62 55.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 126.598 2.436 . . . . 1.08 105.397 -174.508 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.447 HD12 HG21 ' A' ' 5' ' ' VAL . 43.2 mt -133.33 125.76 29.91 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.02 -2.3 . . . . 1.55 105.081 -171.596 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -85.74 113.61 22.06 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.433 -3.292 . . . . 1.95 107.875 173.48 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.9 m -123.01 172.34 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 128.031 2.532 . . . . 0.96 111.741 176.447 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -126.01 156.71 71.35 Favored Pre-proline 0 N--CA 1.431 -1.42 0 C-N-CA 124.493 1.117 . . . . 2.35 109.315 164.153 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -64.17 -8.35 16.21 Favored 'Trans proline' 0 N--CA 1.433 -2.038 0 CA-C-N 126.678 3.421 . . . . 0.95 116.551 -174.761 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 p -93.77 -1.93 54.37 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.179 1.809 . . . . 1.45 111.966 178.635 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -73.38 156.0 38.78 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.519 -1.988 . . . . 1.69 110.672 172.569 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 58.3 p -95.63 173.47 7.47 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 114.842 1.423 . . . . 0.75 114.842 176.872 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.9 mm -67.05 -44.79 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 116.307 -1.806 . . . . 0.73 108.479 169.418 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -52.12 -33.54 40.3 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 117.287 2.328 . . . . 1.62 117.287 169.285 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -66.79 -42.72 85.55 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.868 -3.645 . . . . 2.13 113.186 174.463 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 t -53.32 -47.88 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 115.328 1.603 . . . . 0.62 115.328 171.303 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -65.73 -31.16 72.0 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 126.578 2.423 . . . . 1.22 114.734 176.217 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -43.47 98.75 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 120.96 1.709 . . . . 0.51 110.775 176.793 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -57.03 -38.12 72.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.978 1.844 . . . . 1.44 115.978 172.2 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.5 mt -69.75 -34.35 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 113.911 1.078 . . . . 1.32 113.911 168.555 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -69.07 -34.02 74.49 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 130.14 3.376 . . . . 1.7 115.388 174.905 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.351 36.8 t70 -71.19 -41.92 69.68 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 123.977 0.911 . . . . 1.55 113.043 166.509 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -81.12 -44.94 17.19 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 117.527 2.417 . . . . 2.62 117.527 -176.557 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -109.42 -46.84 3.48 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.502 -1.295 . . . . 1.48 107.502 -165.273 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.89 36.13 2.25 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 119.055 2.382 . . . . 1.12 119.055 173.271 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.451 HG21 HD22 ' A' ' 71' ' ' LEU . 9.9 mt -111.18 136.76 20.86 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-O 116.687 -1.625 . . . . 1.55 109.981 -177.575 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -70.85 160.58 48.92 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 CA-C-N 125.08 2.85 . . . . 1.02 112.48 -175.379 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.82 -19.84 52.53 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 N-CA-C 118.1 2.308 . . . . 1.25 118.1 178.535 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -62.55 -37.48 86.32 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 119.702 3.223 . . . . 2.25 119.702 171.545 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.34 18.4 mm100 -80.23 -29.76 38.5 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 108.666 -3.879 . . . . 2.02 111.763 -173.21 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -81.8 133.15 35.31 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.064 -1.425 . . . . 0.69 108.484 -175.181 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -123.86 110.92 15.47 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 106.325 -1.731 . . . . 2.78 106.325 175.046 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.8 mt -99.96 118.0 35.43 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.699 2.666 . . . . 1.17 105.556 -179.008 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.8 mm -109.75 116.05 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 104.152 -2.536 . . . . 1.38 104.152 -173.244 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -121.83 110.11 15.49 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.849 -2.278 . . . . 1.5 104.849 176.147 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.27 30.87 4.11 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.627 3.171 . . . . 1.21 110.658 175.951 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.71 -33.74 5.33 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 119.867 1.212 . . . . 1.3 112.396 -175.046 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -78.29 132.94 37.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.232 1.813 . . . . 2.55 108.83 -177.972 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -91.44 122.02 33.66 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.424 2.059 . . . . 2.48 109.409 170.992 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.2 mt -70.23 136.08 49.61 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 129.553 3.141 . . . . 0.9 113.691 -174.911 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -77.88 148.42 34.62 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.202 -1.561 . . . . 1.94 114.922 174.973 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -62.95 -63.13 1.3 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.14 -2.225 . . . . 1.56 116.94 -171.943 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.5 42.7 0.24 Allowed Glycine 0 N--CA 1.43 -1.729 1 N-CA-C 123.859 4.303 . . . . 0.97 123.859 167.554 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -117.12 164.43 14.77 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 114.238 -2.791 . . . . 2.49 111.14 168.453 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.0 p -96.39 169.64 9.78 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 122.64 2.473 . . . . 0.76 110.769 169.803 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.2 mt -75.88 -23.47 55.6 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.596 -2.565 . . . . 1.05 112.976 174.916 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.4 t -71.53 -29.59 64.95 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.859 2.17 . . . . 1.19 116.859 178.709 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -58.61 -49.29 78.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 131.434 3.893 . . . . 1.9 110.991 174.236 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -80.44 164.16 23.26 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 125.664 2.65 . . . . 0.89 105.833 -177.961 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -90.92 58.18 3.72 Favored 'General case' 0 N--CA 1.43 -1.473 1 O-C-N 114.139 -5.351 . . . . 1.84 113.484 -175.877 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.4 mm -93.24 143.64 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.521 -1.218 . . . . 0.82 109.702 179.878 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -96.63 -102.65 0.17 Allowed 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.41 1.084 . . . . 2.16 108.846 -174.343 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -131.04 -73.85 0.54 Allowed 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 113.67 0.989 . . . . 2.12 113.67 -179.995 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -98.9 52.09 0.97 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.139 1.447 . . . . 1.71 111.418 177.352 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -83.46 149.3 26.73 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 128.407 2.683 . . . . 1.04 111.388 -169.561 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.7 m -101.56 122.94 44.77 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.532 -1.667 . . . . 0.79 111.79 -174.818 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.43 HD13 HD12 ' A' ' 3' ' ' ILE . 7.0 mp -111.0 156.43 21.26 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 103.749 -2.686 . . . . 1.4 103.749 176.705 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -125.1 129.38 50.08 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 125.656 2.645 . . . . 1.51 108.213 -172.29 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.3 tp -98.62 114.16 26.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.769 -2.457 . . . . 1.14 111.52 179.909 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.2 t -105.71 135.67 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 C-N-CA 127.48 2.312 . . . . 1.23 105.241 174.732 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.451 HD22 HG21 ' A' ' 36' ' ' ILE . 81.5 mt . . . . . 0 N--CA 1.431 -1.413 0 O-C-N 117.465 -3.272 . . . . 2.78 112.193 175.645 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 CA--C 1.49 -1.355 0 N-CA-C 112.965 0.728 . . . . 1.1 112.965 . . . . . . . . . 0 0 . 1 . 100 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.86 134.69 36.92 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 122.793 1.283 . . . . 1.87 108.836 174.576 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.6 pt -125.76 157.51 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 105.965 -1.865 . . . . 0.72 105.965 164.023 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.424 ' HB3' ' CG2' ' A' ' 12' ' ' THR . 55.9 m-85 -113.72 114.66 26.68 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 125.661 2.648 . . . . 1.4 109.969 -178.612 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.4 t -97.45 106.06 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 113.548 -1.66 . . . . 0.58 111.568 177.303 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.278 85.9 mttt -91.77 122.72 34.58 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 116.92 -3.612 . . . . 2.09 112.044 -177.261 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.1 p -89.81 168.42 12.09 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.036 -2.915 . . . . 0.99 111.641 -179.031 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.8 mt -75.16 -36.55 61.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.957 -2.965 . . . . 2.53 114.3 176.44 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -74.83 -22.98 58.39 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 127.392 2.277 . . . . 2.08 112.416 -177.91 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.46 54.68 0.33 Allowed Glycine 0 N--CA 1.43 -1.757 0 O-C-N 119.528 -1.983 . . . . 1.31 116.191 171.709 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -141.46 140.34 33.55 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.413 -2.227 . . . . 1.4 112.642 169.689 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.424 ' CG2' ' HB3' ' A' ' 4' ' ' PHE . 32.4 m -95.8 105.37 17.37 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 111.767 -2.469 . . . . 0.78 105.294 174.438 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 80.2 mt -89.51 123.2 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.776 -2.453 . . . . 1.55 106.281 -178.025 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -95.44 122.98 38.74 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.191 1.472 . . . . 1.08 110.574 177.095 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.269 62.3 mt -111.86 142.53 44.13 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 128.943 2.897 . . . . 1.55 113.327 -175.074 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -98.75 103.72 15.7 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.163 1.459 . . . . 1.95 108.085 169.426 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.6 172.03 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 117.823 -1.551 . . . . 0.96 111.699 176.354 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -123.2 157.47 60.95 Favored Pre-proline 0 N--CA 1.43 -1.465 0 O-C-N 119.122 -2.236 . . . . 2.35 108.81 165.58 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.75 -7.74 17.7 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 CA-C-N 127.068 3.56 . . . . 0.95 112.998 -171.175 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.5 m -78.58 -25.07 45.2 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 127.303 2.877 . . . . 1.45 108.628 176.91 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -70.3 163.37 26.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.906 2.765 . . . . 1.69 111.528 -175.129 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 38.3 p -98.22 165.04 12.07 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.912 -1.742 . . . . 0.75 109.553 -177.034 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.8 mm -66.59 -32.24 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 126.965 2.106 . . . . 0.73 114.26 172.163 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -52.81 -35.19 56.55 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 130.986 3.714 . . . . 1.62 113.113 163.347 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -80.92 -28.3 35.86 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.555 -1.966 . . . . 2.13 113.522 176.874 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.2 t -67.92 -51.27 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 104.217 -2.512 . . . . 0.62 104.217 178.982 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -64.44 -28.76 69.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 116.66 -3.775 . . . . 1.22 113.215 179.739 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.11 -29.19 66.08 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 121.187 1.812 . . . . 0.51 114.704 175.01 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.06 -30.58 63.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.441 -1.412 . . . . 1.44 114.371 172.313 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.2 mt -65.95 -36.89 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 118.559 -2.588 . . . . 1.32 113.897 167.283 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -58.16 -47.39 83.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.014 2.926 . . . . 1.7 111.457 172.782 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -60.29 -57.14 14.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 118.906 2.928 . . . . 1.55 118.906 165.827 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -66.51 -56.82 9.07 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 128.398 3.952 . . . . 2.62 116.046 -175.912 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -96.17 -44.65 7.19 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.788 -3.695 . . . . 1.48 114.715 -170.378 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.03 32.05 2.31 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 117.44 -1.755 . . . . 1.12 113.824 176.575 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.5 mm -108.55 143.81 28.27 Favored Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 101.824 -3.399 . . . . 1.55 101.824 -174.088 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -73.11 154.47 52.27 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 N-CA-C 116.239 1.592 . . . . 1.02 116.239 174.552 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -78.29 -28.49 4.61 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 CA-C-N 120.644 1.266 . . . . 1.25 112.379 -173.766 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -59.83 -35.29 74.42 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.426 1.891 . . . . 2.25 113.404 173.535 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -81.34 -33.85 32.19 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 116.507 -3.871 . . . . 2.02 111.257 179.349 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.297 71.8 mt-30 -74.66 130.95 40.45 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 116.424 -1.75 . . . . 0.69 111.855 -175.832 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -115.62 125.1 52.49 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 121.703 2.047 . . . . 2.78 110.94 163.47 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.4 mt -99.8 127.36 45.95 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.317 -2.114 . . . . 1.17 110.766 179.169 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.9 mt -118.78 134.08 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 126.981 2.112 . . . . 1.38 108.551 -178.435 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 67' ' ' LEU . 34.4 t80 -128.54 137.79 51.92 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.503 -2.406 . . . . 1.5 104.503 169.091 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 37.32 39.72 0.17 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 118.483 2.771 . . . . 1.21 118.483 -176.078 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.66 -18.0 32.28 Favored Glycine 0 N--CA 1.43 -1.713 0 N-CA-C 119.976 2.75 . . . . 1.3 119.976 -177.921 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -81.32 134.11 35.53 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.756 -2.026 . . . . 2.55 109.45 175.824 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -93.23 106.94 18.84 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 125.957 2.036 . . . . 2.48 108.848 179.182 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.4 mt -66.12 137.03 56.76 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 110.567 -3.015 . . . . 0.9 106.545 -168.542 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -84.36 159.87 20.77 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.645 2.641 . . . . 1.94 109.619 174.18 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -70.38 -55.77 8.28 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 116.383 -3.948 . . . . 1.56 114.086 -167.854 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.65 49.67 4.1 Favored Glycine 0 N--CA 1.431 -1.643 0 C-N-CA 126.348 1.928 . . . . 0.97 110.495 178.182 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 -124.47 158.74 32.12 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.773 -1.936 . . . . 2.49 105.773 164.357 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 21.7 p -89.47 163.02 15.43 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.996 1.48 . . . . 0.76 114.996 175.035 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.8 mt -66.6 -35.49 80.32 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.747 -3.095 . . . . 1.05 105.719 178.571 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 t -58.41 -34.33 70.65 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 118.367 2.729 . . . . 1.19 118.367 173.172 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -74.86 -37.41 62.21 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 113.48 -1.691 . . . . 1.9 110.286 -179.615 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -80.44 5.41 15.14 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.205 -1.56 . . . . 0.89 114.017 172.655 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.275 14.0 m-80 62.48 31.42 17.08 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.632 1.573 . . . . 1.84 113.047 179.755 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.9 mt -78.93 122.22 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 125.351 1.461 . . . . 0.82 112.32 179.904 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -96.06 177.23 5.81 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 110.402 -3.09 . . . . 2.16 114.958 -177.752 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -54.47 130.84 41.07 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 115.746 1.758 . . . . 2.12 115.746 171.229 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.361 77.5 mt-10 62.72 55.46 2.13 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.502 -1.999 . . . . 1.71 116.307 -178.046 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.3 m -104.02 151.46 23.2 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.127 2.394 . . . . 1.04 109.667 -175.173 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.0 m -102.84 113.65 27.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.085 -2.884 . . . . 0.79 105.394 177.946 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.443 HD23 ' CD1' ' A' ' 45' ' ' PHE . 31.9 mt -110.24 165.74 11.52 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 105.858 -1.904 . . . . 1.4 105.858 174.791 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -124.01 126.29 46.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.853 -1.78 . . . . 1.51 111.765 -173.732 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.0 tp -105.27 134.86 47.68 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 126.001 1.72 . . . . 1.14 111.759 -176.484 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.1 m -137.29 158.76 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 125.142 2.401 . . . . 1.23 105.007 176.131 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.1 mt . . . . . 0 N--CA 1.43 -1.452 0 O-C-N 117.906 -2.996 . . . . 2.78 115.828 -177.207 . . . . . . . . 0 0 . 1 . 101 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.6 ptt? . . . . . 0 CA--C 1.49 -1.33 0 CA-C-O 119.657 -0.211 . . . . 1.1 110.758 . . . . . . . . . 0 0 . 1 . 101 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -88.44 149.78 23.5 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 117.153 -1.403 . . . . 1.87 110.42 177.222 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.494 HD11 HG11 ' A' ' 17' ' ' VAL . 9.5 pt -140.12 144.6 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.971 -2.233 . . . . 0.72 104.971 175.131 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -103.81 139.17 39.39 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 112.629 -3.628 . . . . 1.4 109.519 177.877 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.492 HG22 ' HB2' ' A' ' 67' ' ' LEU . 12.6 t -113.25 109.67 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 117.983 -2.948 . . . . 0.58 109.526 167.41 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -91.04 137.94 31.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.504 -2.623 . . . . 2.09 111.179 -178.208 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.263 67.8 p -82.34 -175.41 5.68 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 124.787 2.232 . . . . 0.99 115.323 177.707 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.1 mt -50.31 -55.93 13.4 Favored 'General case' 0 N--CA 1.43 -1.461 2 O-C-N 114.521 -5.112 . . . . 2.53 109.426 166.044 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.253 20.4 p -72.19 -31.09 65.57 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.533 -2.604 . . . . 2.08 110.383 -175.834 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.74 25.05 1.62 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 110.773 -0.931 . . . . 1.31 110.773 172.291 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -76.53 117.64 18.38 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.041 -3.035 . . . . 1.4 109.328 -179.976 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m -74.39 90.08 2.14 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.017 2.817 . . . . 0.78 113.42 175.694 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mt -83.07 125.73 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 117.249 -3.407 . . . . 1.55 108.456 -179.718 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.3 m -101.33 128.27 47.57 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 119.487 -2.008 . . . . 1.08 113.854 177.55 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.448 HD21 HG13 ' A' ' 30' ' ' ILE . 9.3 mp -128.89 154.67 46.28 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 126.0 2.063 . . . . 1.55 105.557 -175.956 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -100.7 129.29 46.58 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.245 -1.761 . . . . 1.95 106.245 171.883 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.494 HG11 HD11 ' A' ' 3' ' ' ILE . 27.2 m -135.46 155.88 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 O-C-N 127.904 3.252 . . . . 0.96 107.566 179.821 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -106.33 153.67 40.27 Favored Pre-proline 0 N--CA 1.43 -1.474 0 N-CA-C 102.915 -2.995 . . . . 2.35 102.915 161.897 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -70.68 -12.11 30.66 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 115.255 -3.076 . . . . 0.95 116.683 -177.356 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.8 p -90.42 7.08 40.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 117.365 -1.303 . . . . 1.45 109.685 175.039 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -81.31 146.23 30.48 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.927 2.775 . . . . 1.69 109.855 174.189 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.52 159.49 18.61 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.737 -3.102 . . . . 0.75 111.833 -174.289 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.1 mm -59.07 -43.03 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 124.472 1.109 . . . . 0.73 113.067 175.336 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -39.91 -41.66 1.21 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.725 3.602 . . . . 1.62 120.725 161.084 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -79.38 -25.1 42.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 114.721 -2.561 . . . . 2.13 111.716 173.268 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -68.37 -45.92 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 122.856 2.571 . . . . 0.62 110.668 173.417 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -58.73 -38.37 78.24 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.435 1.642 . . . . 1.22 115.435 174.18 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.27 -37.77 72.89 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.301 -2.124 . . . . 0.51 114.598 173.671 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.8 mttm -60.98 -44.77 96.88 Favored 'General case' 0 N--CA 1.431 -1.392 1 C-N-CA 131.884 4.073 . . . . 1.44 111.325 175.463 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.448 HG13 HD21 ' A' ' 15' ' ' LEU . 93.7 mt -66.54 -44.8 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 126.641 3.115 . . . . 1.32 114.602 172.022 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -50.27 -44.41 53.69 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.158 -2.839 . . . . 1.7 114.977 166.899 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -60.61 -59.2 5.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 115.74 -2.076 . . . . 1.55 108.6 175.544 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -68.01 -47.21 69.09 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 116.607 2.077 . . . . 2.62 116.607 -172.917 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -99.7 -46.36 5.45 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.972 2.509 . . . . 1.48 109.902 -165.58 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.92 22.59 5.9 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 126.484 2.365 . . . . 1.12 114.532 175.014 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mt -97.46 119.82 62.05 Favored Pre-proline 0 N--CA 1.43 -1.44 0 C-N-CA 125.628 1.571 . . . . 1.55 114.355 -174.432 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.74 161.01 30.9 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 116.854 -1.631 . . . . 1.02 113.728 -173.672 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -62.81 -19.68 69.2 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 123.809 3.006 . . . . 1.25 118.546 -171.186 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -67.82 -27.77 67.0 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.078 2.151 . . . . 2.25 114.194 177.338 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -94.34 -38.4 11.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.742 2.017 . . . . 2.02 113.568 -173.062 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -102.17 135.94 42.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.582 2.611 . . . . 0.69 115.156 -170.566 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -121.8 143.53 49.34 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.08 -2.263 . . . . 2.78 111.147 170.813 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -110.62 130.84 55.47 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.21 2.433 . . . . 1.17 112.313 178.72 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.0 mm -109.34 138.66 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 110.581 -3.009 . . . . 1.38 106.537 178.828 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.477 ' HB3' HD21 ' A' ' 50' ' ' LEU . 48.2 t80 -120.77 107.0 12.22 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.995 2.918 . . . . 1.5 109.144 163.558 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.371 . . 69.29 -93.64 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.881 3.229 . . . . 1.21 113.685 179.987 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.61 8.62 6.17 Favored Glycine 0 N--CA 1.43 -1.746 0 O-C-N 116.959 -3.588 . . . . 1.3 111.693 -177.773 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -117.65 138.54 51.9 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 119.61 -2.112 . . . . 2.55 107.462 -177.796 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -76.77 111.16 11.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 112.609 -2.087 . . . . 2.48 113.073 164.812 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.477 HD21 ' HB3' ' A' ' 45' ' ' PHE . 36.5 mt -66.25 113.89 4.92 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 118.423 0.556 . . . . 0.9 111.565 -174.418 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -76.21 129.26 36.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 127.52 3.534 . . . . 1.94 113.03 176.462 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -43.9 -53.43 6.11 Favored 'General case' 0 N--CA 1.43 -1.433 2 N-CA-C 124.061 4.837 . . . . 1.56 124.061 -173.163 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.35 43.97 3.15 Favored Glycine 0 N--CA 1.429 -1.797 0 O-C-N 119.861 -1.774 . . . . 0.97 115.338 175.996 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.311 33.6 mmt180 -118.29 171.79 7.89 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.953 2.311 . . . . 2.49 112.07 159.655 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.7 p -93.37 174.14 7.36 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.497 -2.627 . . . . 0.76 117.748 163.682 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.8 mt -67.16 -33.89 76.39 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 130.231 3.412 . . . . 1.05 114.845 165.057 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 t -65.43 -35.28 80.44 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.86 2.864 . . . . 1.19 114.288 173.315 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -68.41 -44.33 75.26 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 117.673 -1.156 . . . . 1.9 109.899 177.293 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -82.59 3.45 28.66 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 116.196 -1.859 . . . . 0.89 113.311 176.732 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.5 t30 58.27 50.61 9.45 Favored 'General case' 0 N--CA 1.43 -1.434 1 CA-C-O 129.264 4.364 . . . . 1.84 114.564 174.85 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.251 24.6 mt -105.1 115.48 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 C-N-CA 131.87 4.068 . . . . 0.82 108.59 177.641 . . . . . . . . 3 2 . 1 . 101 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -93.46 172.68 8.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 130.798 3.639 . . . . 2.16 112.167 -176.507 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -72.04 144.83 48.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 115.546 -2.462 . . . . 2.12 114.175 169.897 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.384 54.3 mt-10 72.06 23.42 3.45 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.759 1.266 . . . . 1.71 114.153 177.275 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.281 17.4 m -88.75 153.46 21.07 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.02 -2.585 . . . . 1.04 104.02 -172.424 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.5 m -103.12 115.05 29.85 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 125.818 2.723 . . . . 0.79 106.788 -178.819 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.492 ' HB2' HG22 ' A' ' 5' ' ' VAL . 8.1 mp -103.38 164.63 11.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 103.027 -2.953 . . . . 1.4 103.027 174.11 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -131.2 138.02 49.21 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.532 -1.355 . . . . 1.51 111.918 177.981 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.1 tp -106.93 117.78 34.96 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 129.221 3.008 . . . . 1.14 108.195 -177.849 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.7 m -115.5 175.06 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 107.119 -1.437 . . . . 1.23 107.119 165.803 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 N--CA 1.431 -1.406 0 O-C-N 120.914 -1.116 . . . . 2.78 109.412 -174.197 . . . . . . . . 0 0 . 1 . 102 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.1 ttp . . . . . 0 CA--C 1.491 -1.318 1 CA-C-O 129.664 4.554 . . . . 1.1 110.065 . . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.271 20.5 tt0 -93.81 113.44 25.48 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 114.487 -5.133 . . . . 1.87 110.305 -176.17 . . . . . . . . 3 2 . 1 . 102 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.481 HG12 HG22 ' A' ' 17' ' ' VAL . 15.0 pt -119.93 168.18 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.735 1.731 . . . . 0.72 107.119 170.348 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -131.4 157.61 42.99 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 103.268 -2.864 . . . . 1.4 103.268 -178.838 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.6 t -133.12 128.34 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 101.818 -3.401 . . . . 0.58 101.818 -178.34 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -119.39 119.38 33.77 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 122.591 1.186 . . . . 2.09 108.549 178.98 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.402 HG22 HD23 ' A' ' 69' ' ' LEU . 46.9 p -77.5 174.98 10.26 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 121.654 3.946 . . . . 0.99 121.654 -174.74 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.6 mt -52.02 -52.25 52.04 Favored 'General case' 0 N--CA 1.43 -1.443 1 CA-C-O 129.104 4.288 . . . . 2.53 115.218 169.082 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -72.2 -25.15 61.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.172 -2.83 . . . . 2.08 115.469 -178.066 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.33 19.25 4.29 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 124.778 3.444 . . . . 1.31 111.386 169.303 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -89.57 143.02 27.14 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 104.801 -2.296 . . . . 1.4 104.801 -176.638 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -110.28 119.74 40.22 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.361 1.553 . . . . 0.78 109.942 173.119 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.2 mt -98.8 122.25 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 125.631 2.634 . . . . 1.55 109.812 176.033 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.3 m -91.3 121.69 33.27 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.483 -3.26 . . . . 1.08 108.621 -179.74 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mt -116.92 163.5 16.11 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.028 -1.842 . . . . 1.55 106.028 -173.527 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -121.44 104.57 9.78 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.334 1.453 . . . . 1.95 107.305 169.983 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.481 HG22 HG12 ' A' ' 3' ' ' ILE . 27.2 m -106.11 -174.13 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 103.912 -2.625 . . . . 0.96 103.912 179.528 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -138.2 155.24 74.32 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 103.004 -2.962 . . . . 2.35 103.004 165.709 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -62.25 -11.88 24.43 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 126.529 3.368 . . . . 0.95 117.382 -173.384 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.9 m -85.22 -0.14 53.69 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.874 1.67 . . . . 1.45 113.025 -175.564 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -84.23 144.04 29.19 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 126.095 2.122 . . . . 1.69 110.735 -179.588 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 67.4 p -83.71 164.1 19.84 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.02 -1.9 . . . . 0.75 110.339 178.159 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.2 mm -68.32 -35.33 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 O-C-N 120.025 -1.672 . . . . 0.73 110.699 -179.912 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -45.8 -49.31 15.25 Favored 'General case' 0 N--CA 1.43 -1.446 1 C-N-CA 133.446 4.699 . . . . 1.62 110.773 163.424 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -73.78 -41.65 62.11 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.153 -2.217 . . . . 2.13 110.746 -176.486 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.1 t -61.56 -37.19 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 116.713 2.116 . . . . 0.62 116.713 170.856 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -56.88 -36.58 70.26 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 118.127 2.64 . . . . 1.22 118.127 170.762 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.56 80.78 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 118.68 -2.512 . . . . 0.51 111.196 166.437 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -68.32 -29.65 68.45 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 115.04 -4.788 . . . . 1.44 115.59 170.323 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.307 56.7 mt -70.09 -30.24 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-O 123.672 1.701 . . . . 1.32 106.816 175.281 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -69.34 -37.52 77.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.245 -1.534 . . . . 1.7 109.173 179.257 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -67.89 -54.63 17.32 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 126.876 2.61 . . . . 1.55 108.735 174.984 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -69.18 -54.63 13.82 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 118.579 -2.576 . . . . 2.62 111.833 -169.652 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -93.26 -59.54 2.0 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.157 -2.214 . . . . 1.48 112.31 -169.978 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.64 45.93 0.37 Allowed Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 107.03 -2.428 . . . . 1.12 107.03 176.444 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.4 mt -118.56 134.61 23.47 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 103.245 -2.872 . . . . 1.55 103.245 -176.662 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 76.4 Cg_exo -75.12 152.05 39.73 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-O 114.939 -2.192 . . . . 1.02 116.354 -177.618 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 81.0 Cg_exo -71.94 -14.3 29.33 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 CA-C-N 121.685 1.638 . . . . 1.25 115.769 -172.938 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.393 2.6 p30 -67.41 -48.64 66.72 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.959 1.704 . . . . 2.25 108.393 172.567 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -68.85 -16.74 63.86 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 116.35 -1.786 . . . . 2.02 113.574 -177.242 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -88.2 110.47 20.73 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 123.366 1.555 . . . . 0.69 108.347 -178.073 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -101.19 112.55 25.07 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.28 -2.118 . . . . 2.78 105.28 170.48 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.5 mt -107.79 128.56 54.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.091 -2.88 . . . . 1.17 111.647 -178.203 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 mt -107.74 136.7 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 1 C-N-CA 135.187 5.395 . . . . 1.38 105.752 -177.892 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.329 73.3 t80 -149.22 114.62 5.54 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 127.753 2.421 . . . . 1.5 105.42 173.624 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.59 30.45 15.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.863 2.465 . . . . 1.21 116.615 -178.839 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.67 -9.08 53.04 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-O 114.689 -3.284 . . . . 1.3 112.266 -176.385 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -92.11 134.3 34.97 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 115.692 -2.403 . . . . 2.55 114.305 167.868 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -86.93 123.58 32.21 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 118.956 -2.34 . . . . 2.48 109.174 173.473 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.8 mt -78.8 154.85 29.57 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.115 -2.241 . . . . 0.9 111.759 -159.29 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -91.47 150.66 21.13 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.43 -2.044 . . . . 1.94 110.468 173.898 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -71.99 -41.14 67.98 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 121.667 2.031 . . . . 1.56 115.481 -173.086 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.66 45.31 3.42 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 121.726 3.45 . . . . 0.97 121.726 170.291 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 mmt-85 -122.78 143.99 49.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 128.207 3.86 . . . . 2.49 101.473 168.748 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.312 80.8 p -82.63 167.08 18.62 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.257 -4.027 . . . . 0.76 114.591 168.543 . . . . . . . . 4 3 . 1 . 102 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -57.58 -46.68 83.69 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 126.955 2.102 . . . . 1.05 108.956 172.496 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.255 10.6 t -56.4 -38.61 71.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 130.131 3.372 . . . . 1.19 114.805 178.22 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -63.78 -61.72 2.11 Favored 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.411 -4.556 . . . . 1.9 115.172 172.766 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -64.55 -4.05 3.7 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.707 -1.87 . . . . 0.89 116.009 170.924 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.276 73.9 m-80 66.36 39.31 4.06 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.977 -2.952 . . . . 1.84 112.65 -175.701 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.0 mt -87.05 103.17 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.558 -2.589 . . . . 0.82 104.396 175.266 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -100.15 -172.42 2.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.306 1.842 . . . . 2.16 110.093 -172.454 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -58.99 140.31 55.84 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 127.613 3.578 . . . . 2.12 112.271 177.369 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 65.51 36.8 6.41 Favored 'General case' 0 N--CA 1.43 -1.438 1 C-N-CA 132.124 4.169 . . . . 1.71 112.089 175.75 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 m -88.22 159.64 18.06 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 114.473 -2.679 . . . . 1.04 111.435 -170.969 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.5 m -111.32 113.49 26.0 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 123.921 3.055 . . . . 0.79 108.645 172.887 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.3 mt -88.66 134.48 33.88 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 115.638 -2.425 . . . . 1.4 107.314 167.013 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -101.1 112.84 25.41 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.293 -3.38 . . . . 1.51 108.446 -171.952 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.402 HD23 HG22 ' A' ' 7' ' ' THR . 46.4 tp -92.69 117.87 30.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.894 3.277 . . . . 1.14 119.564 -173.75 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.89 124.65 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 102.384 -3.191 . . . . 1.23 102.384 172.941 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.7 tp . . . . . 0 N--CA 1.429 -1.48 0 O-C-N 116.882 -3.636 . . . . 2.78 109.012 171.51 . . . . . . . . 0 0 . 1 . 103 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 ptt? . . . . . 0 CA--C 1.491 -1.313 0 N-CA-C 119.601 3.185 . . . . 1.1 119.601 . . . . . . . . . 0 0 . 1 . 103 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -95.98 139.14 32.6 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.096 -2.253 . . . . 1.87 106.889 -174.616 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.0 pt -143.03 150.35 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 122.541 2.428 . . . . 0.72 109.983 169.654 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -108.77 134.02 52.04 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.4 -1.333 . . . . 1.4 107.4 -172.08 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -120.43 122.66 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 116.08 1.882 . . . . 0.58 116.08 166.553 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -94.33 130.1 40.76 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.978 2.511 . . . . 2.09 113.365 -176.013 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.6 p -97.14 153.28 18.07 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.958 -3.589 . . . . 0.99 107.853 -178.57 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.6 mt -61.91 -23.44 66.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 130.978 3.711 . . . . 2.53 112.841 174.095 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.8 p -77.78 -52.4 8.99 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 120.001 1.273 . . . . 2.08 113.754 178.872 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.05 11.51 0.03 OUTLIER Glycine 0 N--CA 1.429 -1.785 0 O-C-N 120.633 -1.292 . . . . 1.31 114.802 169.921 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -107.29 147.83 29.75 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 117.456 -3.379 . . . . 1.4 114.707 -173.276 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.7 m -112.69 116.96 30.96 Favored 'General case' 0 N--CA 1.43 -1.469 1 O-C-N 115.453 -4.529 . . . . 0.78 108.573 173.383 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mt -86.22 128.36 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 128.983 2.913 . . . . 1.55 105.93 -179.279 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.8 m -99.91 99.91 10.76 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.327 -3.358 . . . . 1.08 107.859 174.739 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.9 mt -97.09 145.39 26.03 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 115.973 -4.204 . . . . 1.55 109.721 177.219 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -97.2 132.14 43.26 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 125.32 2.486 . . . . 1.95 114.351 159.407 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -135.48 168.75 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 113.896 -1.502 . . . . 0.96 108.181 -176.148 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -116.08 152.27 47.55 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-O 116.147 -1.882 . . . . 2.35 106.539 166.914 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -76.33 -3.89 14.38 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-N 126.691 3.425 . . . . 0.95 112.999 -172.938 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -88.78 0.34 56.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 123.895 0.878 . . . . 1.45 111.988 173.525 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -82.07 147.33 29.17 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 125.042 1.337 . . . . 1.69 110.921 178.26 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 68.0 p -87.04 160.64 18.54 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.452 1.901 . . . . 0.75 112.349 -179.161 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.0 mm -75.99 -18.66 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 124.888 2.28 . . . . 0.73 114.441 -178.029 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.33 -44.58 94.5 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.37 -3.956 . . . . 1.62 111.298 158.407 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.307 18.3 m120 -50.82 -53.58 30.9 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 123.007 2.639 . . . . 2.13 114.18 169.054 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.501 HG21 HD21 ' A' ' 56' ' ' LEU 0.293 2.4 t -50.46 -43.89 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 119.272 3.064 . . . . 0.62 119.272 171.758 . . . . . . . . 3 3 . 1 . 103 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -74.54 -14.57 60.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.909 3.718 . . . . 1.22 114.515 174.245 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.262 . . -74.16 -34.35 63.8 Favored 'General case' 0 N--CA 1.431 -1.405 1 O-C-N 115.05 -4.781 . . . . 0.51 112.898 169.885 . . . . . . . . 3 2 . 1 . 103 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -64.09 -34.12 77.31 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.223 -1.353 . . . . 1.44 111.937 176.06 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.466 HD13 HD22 ' A' ' 69' ' ' LEU 0.46 36.5 mt -68.86 -38.47 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.877 1.799 . . . . 1.32 110.584 177.158 . . . . . . . . 3 3 . 1 . 103 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -64.81 -40.77 95.76 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.898 -2.376 . . . . 1.7 108.696 178.001 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -60.24 -40.85 91.68 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.684 1.735 . . . . 1.55 115.684 171.715 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -76.42 -67.68 0.67 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.886 -1.134 . . . . 2.62 112.748 -176.909 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -95.95 -45.1 7.07 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 116.645 -1.645 . . . . 1.48 111.027 -172.52 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.09 43.68 0.99 Allowed Glycine 0 N--CA 1.429 -1.78 0 CA-C-O 124.677 2.265 . . . . 1.12 117.237 174.852 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 mt -108.59 134.99 20.08 Favored Pre-proline 0 N--CA 1.43 -1.434 1 CA-C-O 111.536 -4.078 . . . . 1.55 102.736 -177.663 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -63.18 153.86 71.32 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 N-CA-C 120.024 3.048 . . . . 1.02 120.024 174.715 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -73.7 -24.75 15.44 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 CA-C-N 126.677 3.42 . . . . 1.25 113.014 -176.83 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.342 10.2 p-10 -65.86 -32.34 73.8 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 121.986 2.176 . . . . 2.25 111.951 170.528 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -73.84 -24.62 59.79 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.813 -2.429 . . . . 2.02 114.354 -179.174 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -92.11 145.59 24.39 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.929 -2.982 . . . . 0.69 110.225 -173.417 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.4 mtm180 -126.81 135.05 50.5 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 117.282 -1.342 . . . . 2.78 110.843 168.836 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.7 mt -103.42 124.99 49.75 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 123.715 2.962 . . . . 1.17 109.122 177.007 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.7 mm -114.88 120.48 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 104.749 -2.315 . . . . 1.38 104.749 177.908 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.457 ' HB3' HD21 ' A' ' 50' ' ' LEU . 35.7 t80 -130.02 136.28 49.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 129.277 3.031 . . . . 1.5 108.843 169.007 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.306 . . 54.6 31.58 15.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.278 1.584 . . . . 1.21 115.278 175.466 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.48 -20.82 6.83 Favored Glycine 0 N--CA 1.429 -1.805 0 O-C-N 119.176 -2.203 . . . . 1.3 115.438 -174.849 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.0 mttt -85.6 136.68 33.29 Favored 'General case' 0 N--CA 1.43 -1.468 2 C-N-CA 133.535 4.734 . . . . 2.55 110.802 -179.211 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -86.57 128.56 34.99 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.095 -1.866 . . . . 2.48 111.345 168.941 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' A' ' 45' ' ' PHE . 17.4 mt -83.76 127.24 33.66 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 104.927 -2.249 . . . . 0.9 104.927 -176.224 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -82.91 137.8 34.1 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.799 -3.063 . . . . 1.94 114.325 175.116 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -37.74 -72.8 0.05 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 131.087 3.755 . . . . 1.56 117.976 -177.676 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.86 51.79 4.6 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 120.696 3.038 . . . . 0.97 120.696 176.566 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.268 10.7 mmt180 -131.34 156.32 45.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.569 -3.313 . . . . 2.49 107.324 172.121 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.253 24.7 p -80.84 169.98 16.87 Favored 'General case' 0 N--CA 1.43 -1.442 2 O-C-N 114.123 -5.361 . . . . 0.76 116.647 176.733 . . . . . . . . 4 3 . 1 . 103 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.501 HD21 HG21 ' A' ' 26' ' ' VAL . 6.8 mt -63.87 -49.47 72.61 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.596 1.958 . . . . 1.05 109.186 171.663 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 t -57.29 -40.33 77.57 Favored 'General case' 0 N--CA 1.432 -1.363 0 O-C-N 118.774 -2.454 . . . . 1.19 111.632 177.137 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.4 -29.97 17.59 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 116.414 2.005 . . . . 1.9 116.414 167.876 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -99.95 7.86 44.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.069 -2.269 . . . . 0.89 115.373 171.846 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.294 7.7 m120 52.17 57.77 6.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 126.576 2.422 . . . . 1.84 117.433 -171.144 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mt -96.57 131.08 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 120.045 -1.659 . . . . 0.82 110.635 -177.876 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -97.68 -171.78 2.25 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 127.023 2.129 . . . . 2.16 114.339 -169.189 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -81.98 143.48 31.57 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.25 -1.531 . . . . 2.12 114.622 175.349 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.254 32.3 mt-10 65.43 21.32 11.86 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.426 2.01 . . . . 1.71 116.426 178.461 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.4 t -85.2 150.22 24.96 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 125.682 1.593 . . . . 1.04 112.741 -174.427 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.311 8.8 m -106.07 115.63 30.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 121.599 1.999 . . . . 0.79 113.648 -176.771 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 mt -101.36 164.15 11.92 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.105 -2.554 . . . . 1.4 104.105 173.759 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.293 74.1 m80 -123.73 135.54 53.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.833 -3.042 . . . . 1.51 107.392 178.431 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.466 HD22 HD13 ' A' ' 30' ' ' ILE . 36.4 tp -97.5 132.41 43.21 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 112.293 -2.231 . . . . 1.14 111.323 178.381 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.9 m -143.65 161.26 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 103.707 -2.701 . . . . 1.23 103.707 176.659 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.43 -1.463 0 CA-C-O 125.713 2.673 . . . . 2.78 112.846 -174.402 . . . . . . . . 0 0 . 1 . 104 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 CA--C 1.491 -1.324 0 CA-C-O 117.582 -1.199 . . . . 1.1 111.118 . . . . . . . . . 0 0 . 1 . 104 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -103.51 143.29 32.92 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 120.119 1.327 . . . . 1.87 110.979 179.837 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.9 pt -131.31 168.46 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 116.635 -1.65 . . . . 0.72 109.28 176.657 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -122.17 137.81 54.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 120.927 1.694 . . . . 1.4 113.163 177.283 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.407 HG22 ' HB2' ' A' ' 67' ' ' LEU . 4.3 t -122.22 131.3 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-O 125.842 2.734 . . . . 0.58 118.172 165.706 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -89.21 123.25 33.27 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 112.152 -2.294 . . . . 2.09 108.676 177.932 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.0 p -80.05 177.18 9.12 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.444 1.592 . . . . 0.99 112.758 169.455 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.0 mt -66.0 -46.31 78.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.299 -2.75 . . . . 2.53 113.909 176.165 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -65.04 -68.57 0.35 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.08 1.352 . . . . 2.08 108.488 179.379 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.67 -6.24 0.03 OUTLIER Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 117.454 1.742 . . . . 1.31 117.454 -176.203 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -71.62 141.73 49.96 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.304 -1.704 . . . . 1.4 114.664 -175.573 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.3 m -108.27 104.57 13.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 127.915 3.722 . . . . 0.78 111.183 172.435 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -88.59 115.57 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 1 O-C-N 115.874 -4.266 . . . . 1.55 109.743 179.248 . . . . . . . . 4 4 . 1 . 104 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.5 m -91.48 119.22 31.25 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.124 -2.176 . . . . 1.08 105.124 177.719 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 mt -115.42 139.51 49.96 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 125.102 2.382 . . . . 1.55 110.592 -171.378 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -87.97 120.75 29.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.201 -2.187 . . . . 1.95 108.038 174.852 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.9 177.02 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 125.741 1.901 . . . . 0.96 114.095 179.397 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -129.14 148.0 67.26 Favored Pre-proline 0 N--CA 1.43 -1.465 3 CA-C-O 108.292 -5.623 . . . . 2.35 110.668 166.82 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -61.35 -24.39 78.55 Favored 'Trans proline' 0 N--CA 1.434 -2.004 1 CA-C-N 128.843 4.194 . . . . 0.95 115.22 -174.216 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.4 p -69.75 -10.78 59.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.837 2.455 . . . . 1.45 116.072 177.045 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.305 36.4 m-20 -78.75 147.55 33.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 128.044 3.783 . . . . 1.69 108.576 -178.878 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 p -82.82 165.79 19.53 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 114.514 -2.66 . . . . 0.75 115.913 174.55 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.2 mm -66.08 -20.03 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-N 122.071 2.214 . . . . 0.73 111.18 178.289 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -64.68 -39.38 93.58 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 117.522 2.416 . . . . 1.62 117.522 169.51 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -72.74 -33.05 66.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.416 3.008 . . . . 2.13 108.665 179.591 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.6 t -69.09 -48.28 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 112.289 -2.232 . . . . 0.62 112.844 176.86 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.502 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 52.6 mtmt -55.84 -30.82 62.06 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 119.558 3.17 . . . . 1.22 119.558 160.052 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -31.96 72.76 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 124.312 3.233 . . . . 0.51 113.132 172.419 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -70.12 -29.13 66.0 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.544 -3.222 . . . . 1.44 113.342 172.562 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.9 mt -73.09 -39.17 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 120.017 -1.677 . . . . 1.32 112.544 176.255 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -58.21 -35.38 71.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 114.435 -2.698 . . . . 1.7 109.425 171.854 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -66.3 -50.66 62.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 123.355 2.798 . . . . 1.55 117.176 170.797 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -59.75 -61.01 2.94 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 116.949 -3.595 . . . . 2.62 111.616 -172.333 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -101.47 -44.9 5.47 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.449 -1.705 . . . . 1.48 108.893 -168.795 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.01 57.05 1.17 Allowed Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 118.502 -1.808 . . . . 1.12 111.383 178.821 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.0 mt -122.49 125.13 26.57 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 112.381 -3.675 . . . . 1.55 104.637 -177.58 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -57.64 138.42 86.04 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 CA-C-N 129.358 4.378 . . . . 1.02 116.708 177.276 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -54.39 -27.67 50.0 Favored 'Trans proline' 0 C--N 1.299 -2.076 1 C-N-CA 127.208 5.272 . . . . 1.25 117.414 -178.329 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -69.89 -39.41 76.26 Favored 'General case' 0 N--CA 1.431 -1.422 1 CA-C-O 111.334 -4.174 . . . . 2.25 110.086 171.663 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -61.65 -31.33 71.43 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 124.176 3.171 . . . . 2.02 114.326 177.701 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.502 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 63.0 mt-30 -78.13 135.27 37.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 120.354 3.464 . . . . 0.69 120.354 -177.447 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -135.05 146.98 49.48 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 102.512 -3.144 . . . . 2.78 102.512 173.23 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.5 mt -113.0 137.05 52.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.76 -2.462 . . . . 1.17 110.173 179.17 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.7 mm -117.47 133.9 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 124.994 2.33 . . . . 1.38 108.209 -178.551 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.444 ' HB3' HD21 ' A' ' 50' ' ' LEU . 7.7 t80 -147.47 138.02 23.32 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.29 -3.381 . . . . 1.5 112.338 169.787 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.76 43.27 30.33 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.412 3.085 . . . . 1.21 115.166 -178.525 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.55 -23.66 15.2 Favored Glycine 0 N--CA 1.429 -1.781 0 O-C-N 118.06 -2.9 . . . . 1.3 116.801 -176.373 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -119.03 166.81 12.42 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.056 -3.026 . . . . 2.55 112.841 -171.791 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.345 33.3 tt0 -98.78 153.41 18.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.126 -0.943 . . . . 2.48 112.435 178.192 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 45' ' ' PHE . 8.1 mt -110.56 126.58 54.57 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.675 1.59 . . . . 0.9 110.353 -173.302 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.493 ' HB2' ' HG3' ' A' ' 54' ' ' ARG . 28.2 mt-10 -73.73 141.63 46.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.19 2.596 . . . . 1.94 113.725 -178.1 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -46.98 -54.44 10.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 118.476 2.769 . . . . 1.56 118.476 -177.254 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.94 5.76 61.25 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 127.265 2.853 . . . . 0.97 120.088 172.893 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.493 ' HG3' ' HB2' ' A' ' 51' ' ' GLU . 6.3 mtt180 -87.92 154.33 20.6 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 120.092 1.946 . . . . 2.49 106.54 171.903 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.0 p -97.79 162.09 13.43 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.094 1.902 . . . . 0.76 115.79 172.038 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.38 -20.2 65.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.901 -2.999 . . . . 1.05 114.15 174.748 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.0 p -80.28 -31.86 38.26 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.541 3.137 . . . . 1.19 110.805 178.856 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.68 -46.22 39.26 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 112.834 -3.46 . . . . 1.9 111.799 175.483 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -76.52 -18.82 58.51 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 127.117 2.76 . . . . 0.89 110.654 178.095 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.7 t30 65.96 53.88 1.07 Allowed 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 127.073 2.149 . . . . 1.84 109.599 -176.264 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 mt -84.39 106.67 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 101.192 -3.633 . . . . 0.82 101.192 172.186 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -89.26 -174.43 4.4 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 122.248 2.295 . . . . 2.16 112.017 -178.713 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -60.53 137.55 58.15 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 123.638 1.685 . . . . 2.12 114.35 174.584 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 74.42 26.75 1.49 Allowed 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 131.492 3.917 . . . . 1.71 114.476 169.627 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.89 151.93 20.31 Favored 'General case' 0 N--CA 1.429 -1.491 1 C-N-CA 131.892 4.077 . . . . 1.04 105.613 -177.22 . . . . . . . . 3 3 . 1 . 104 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.4 m -107.3 126.25 52.21 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.57 -1.956 . . . . 0.79 112.411 178.364 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.407 ' HB2' HG22 ' A' ' 5' ' ' VAL . 66.4 mt -100.07 151.9 20.85 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 126.259 2.933 . . . . 1.4 106.532 169.561 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -113.35 116.58 29.92 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 116.035 -4.166 . . . . 1.51 112.584 179.083 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.7 tp -92.58 125.93 37.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.314 2.959 . . . . 1.14 107.826 -176.906 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.7 t -118.81 147.97 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 C-N-CA 127.216 2.206 . . . . 1.23 106.255 176.64 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.9 mt . . . . . 0 N--CA 1.429 -1.494 0 O-C-N 117.797 -3.064 . . . . 2.78 114.205 175.404 . . . . . . . . 0 0 . 1 . 105 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 ptt? . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 117.633 -1.175 . . . . 1.1 113.744 . . . . . . . . . 0 0 . 1 . 105 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -90.03 140.3 29.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 123.054 2.661 . . . . 1.87 112.907 175.357 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.2 pt -130.72 161.97 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 108.066 -1.087 . . . . 0.72 108.066 166.062 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -119.62 130.13 54.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.315 3.046 . . . . 1.4 111.245 172.656 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.0 t -109.56 121.4 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 111.677 -2.511 . . . . 0.58 108.554 172.954 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -97.24 123.36 41.0 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 117.784 -3.073 . . . . 2.09 112.595 174.637 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.6 p -78.78 174.53 11.36 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.148 3.356 . . . . 0.99 115.214 170.062 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.12 -43.18 74.93 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 116.416 -3.927 . . . . 2.53 115.935 178.412 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 p -73.36 -41.22 63.69 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.119 2.568 . . . . 2.08 110.957 -177.334 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.57 8.18 0.42 Allowed Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 115.514 -3.231 . . . . 1.31 116.178 170.766 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.23 133.96 35.91 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 104.583 -2.377 . . . . 1.4 104.583 -176.137 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.6 m -98.73 123.39 42.92 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.301 -1.5 . . . . 0.78 107.156 171.274 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -100.59 95.41 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 124.437 2.065 . . . . 1.55 109.871 175.676 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.4 m -76.53 115.42 16.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 105.256 -2.127 . . . . 1.08 105.256 177.923 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.5 mt -120.24 171.69 8.32 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.001 2.12 . . . . 1.55 112.215 -176.712 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -127.61 132.39 49.79 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 105.304 -2.11 . . . . 1.95 105.304 169.505 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.8 m -140.25 169.49 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 128.286 2.634 . . . . 0.96 108.549 -178.471 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -104.81 159.93 27.69 Favored Pre-proline 0 N--CA 1.43 -1.433 0 O-C-N 119.269 -2.144 . . . . 2.35 108.774 162.897 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -70.23 -19.06 34.37 Favored 'Trans proline' 0 N--CA 1.434 -2.01 1 O-C-N 112.146 -4.713 . . . . 0.95 106.999 -174.911 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -91.57 9.01 33.91 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.474 2.398 . . . . 1.45 117.474 -176.481 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -85.66 150.19 24.79 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 113.082 0.771 . . . . 1.69 113.082 173.098 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.8 p -78.35 160.14 27.99 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 123.395 1.569 . . . . 0.75 113.176 173.559 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -60.59 -33.86 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 126.615 1.966 . . . . 0.73 109.92 169.884 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.303 3.4 tt0 -47.03 -46.56 22.16 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.526 2.047 . . . . 1.62 116.526 158.766 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -75.53 -35.73 60.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 116.83 2.159 . . . . 2.13 116.83 -178.021 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.4 t -57.92 -47.18 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 111.683 -2.508 . . . . 0.62 111.374 173.417 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.286 37.6 mtmt -57.91 -29.83 65.42 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 121.692 3.96 . . . . 1.22 121.692 170.628 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.38 -33.06 62.95 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.892 -2.38 . . . . 0.51 112.872 169.645 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -61.5 -17.17 53.43 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.706 1.602 . . . . 1.44 113.735 167.677 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.9 mt -98.61 -36.15 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 125.636 2.636 . . . . 1.32 108.945 178.777 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.307 24.7 tt0 -45.18 -50.01 11.74 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 117.815 -3.053 . . . . 1.7 113.825 173.752 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.397 0.6 OUTLIER -62.01 -26.4 68.21 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.92 2.933 . . . . 1.55 118.92 174.879 . . . . . . . . 3 3 . 1 . 105 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -86.17 -78.7 0.27 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.182 2.593 . . . . 2.62 109.212 -178.61 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -89.21 -12.36 41.04 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 119.03 2.974 . . . . 1.48 119.03 -172.529 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.66 24.08 26.71 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 120.92 -1.112 . . . . 1.12 115.419 172.962 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.4 mt -104.28 133.88 19.98 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-O 112.594 -3.574 . . . . 1.55 107.765 -169.549 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 41.2 Cg_endo -77.51 158.95 32.49 Favored 'Trans proline' 0 N--CA 1.434 -1.974 0 CA-C-N 125.037 2.835 . . . . 1.02 115.397 -179.377 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 14.7 Cg_exo -61.92 -26.73 79.21 Favored 'Trans proline' 0 C--N 1.299 -2.03 1 C-N-CA 127.002 5.135 . . . . 1.25 117.358 -178.329 . . . . . . . . 3 3 . 1 . 105 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.342 0.2 OUTLIER -61.02 -51.2 70.2 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 130.275 3.43 . . . . 2.25 110.259 179.303 . . . . . . . . 3 3 . 1 . 105 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -74.71 -43.65 54.01 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.597 -1.26 . . . . 2.02 107.597 178.284 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -60.21 137.8 58.05 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 116.792 2.145 . . . . 0.69 116.792 -174.35 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -138.17 128.68 26.37 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 125.875 1.67 . . . . 2.78 109.955 175.351 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.261 85.2 mt -95.64 135.67 37.03 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.648 1.69 . . . . 1.17 110.488 174.608 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.251 37.2 mm -123.17 120.23 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 109.565 -3.47 . . . . 1.38 106.501 173.748 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -134.62 131.81 38.26 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.615 2.626 . . . . 1.5 108.886 171.127 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.58 45.52 24.17 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.405 2.743 . . . . 1.21 118.405 179.848 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.54 -45.98 1.99 Allowed Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 120.574 -0.822 . . . . 1.3 114.895 179.456 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -82.73 149.04 27.51 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.083 2.553 . . . . 2.55 116.252 179.372 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -81.27 125.71 30.66 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 129.041 2.936 . . . . 2.48 107.988 172.464 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 mt -88.09 146.53 25.39 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.74 1.257 . . . . 0.9 109.702 -173.437 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -98.07 146.54 25.44 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 126.087 2.851 . . . . 1.94 107.41 177.207 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.7 -61.49 2.57 Favored 'General case' 0 N--CA 1.43 -1.473 1 C-N-CA 133.675 4.79 . . . . 1.56 117.042 -168.753 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.41 12.63 1.8 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 120.088 2.795 . . . . 0.97 120.088 172.985 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -106.15 159.35 16.15 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.702 1.715 . . . . 2.49 113.274 178.06 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -95.48 162.98 13.42 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.878 -4.264 . . . . 0.76 110.945 -179.639 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.3 mt -64.28 -43.21 95.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.957 3.303 . . . . 1.05 108.242 178.538 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 p -60.8 -34.23 74.2 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 114.479 1.288 . . . . 1.19 114.479 -179.992 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -64.09 -37.24 86.72 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 129.774 3.23 . . . . 1.9 113.807 173.04 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -92.9 7.82 42.29 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.947 -2.971 . . . . 0.89 110.97 177.639 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.2 m120 55.5 39.15 31.02 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 130.917 3.687 . . . . 1.84 114.459 -175.897 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.427 HG21 HD21 ' A' ' 67' ' ' LEU . 33.2 mt -82.56 115.99 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 103.999 -2.593 . . . . 0.82 103.999 179.064 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -100.99 -179.94 4.19 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.917 2.294 . . . . 2.16 110.54 -176.655 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.284 32.7 pttt -54.41 137.07 43.14 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.674 -3.141 . . . . 2.12 119.085 169.232 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.292 59.3 mt-10 71.31 24.28 3.79 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.061 1.744 . . . . 1.71 113.748 171.919 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.7 p -91.23 159.32 16.11 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.256 2.622 . . . . 1.04 115.431 -174.827 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.1 m -105.97 100.32 9.87 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.201 3.0 . . . . 0.79 114.321 176.952 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.427 HD21 HG21 ' A' ' 61' ' ' ILE . 3.9 mp -97.9 146.84 25.05 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 103.31 -2.848 . . . . 1.4 103.31 170.893 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -109.31 145.65 35.64 Favored 'General case' 0 CA--C 1.489 -1.37 0 CA-C-O 114.498 -2.668 . . . . 1.51 110.299 -179.009 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.2 tp -111.7 119.88 40.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 127.347 2.904 . . . . 1.14 110.592 -173.582 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 m -113.31 151.58 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 118.968 -2.332 . . . . 1.23 111.326 172.959 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.2 mt . . . . . 0 N--CA 1.43 -1.463 0 C-N-CA 116.966 -1.894 . . . . 2.78 108.846 -179.624 . . . . . . . . 0 0 . 1 . 106 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.37 15.3 ptt? . . . . . 0 CA--C 1.489 -1.382 0 N-CA-C 115.006 1.484 . . . . 1.1 115.006 . . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -97.74 130.07 44.73 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 117.168 -1.813 . . . . 1.87 111.79 179.799 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.2 pt -121.15 169.06 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 103.247 -2.872 . . . . 0.72 103.247 175.953 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -128.4 126.39 40.53 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.691 -1.226 . . . . 1.4 107.691 -171.442 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.42 HG23 HD23 ' A' ' 15' ' ' LEU . 76.0 t -107.91 121.96 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 114.494 -1.23 . . . . 0.58 108.406 172.462 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -99.04 126.88 44.86 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.313 1.445 . . . . 2.09 108.902 175.903 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 p -69.69 -178.63 1.53 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.643 2.09 . . . . 0.99 116.643 175.024 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.7 tp -74.73 -38.55 62.25 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.943 -1.098 . . . . 2.53 112.126 173.529 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.2 p -79.33 -53.25 7.11 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.987 2.588 . . . . 2.08 117.987 176.697 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.99 7.89 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.778 0 CA-C-N 125.772 3.897 . . . . 1.31 115.096 179.988 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -99.77 139.6 35.19 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 115.198 -2.601 . . . . 1.4 113.695 -175.603 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.4 m -103.28 128.19 50.39 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 116.53 -2.068 . . . . 0.78 105.534 174.787 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.4 mt -116.32 123.98 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.661 2.784 . . . . 1.55 111.265 -177.72 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.8 m -96.64 126.41 41.79 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 105.847 -1.908 . . . . 1.08 105.847 -174.891 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.42 HD23 HG23 ' A' ' 5' ' ' VAL . 1.9 mm? -121.35 120.31 34.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.399 2.28 . . . . 1.55 111.222 -178.056 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -82.48 111.65 18.69 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.114 1.765 . . . . 1.95 108.16 172.667 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.263 23.8 m -134.97 -178.43 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 O-C-N 120.163 -1.586 . . . . 0.96 107.25 177.579 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -117.31 174.68 2.38 Favored Pre-proline 0 N--CA 1.43 -1.451 0 O-C-N 117.237 -3.414 . . . . 2.35 108.304 163.817 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -77.56 -19.04 13.28 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 117.377 -1.96 . . . . 0.95 113.215 -175.124 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.333 4.5 m -82.94 3.95 27.79 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 122.755 2.525 . . . . 1.45 115.387 176.816 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.269 2.8 m-20 -72.59 153.74 41.12 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 115.917 1.821 . . . . 1.69 115.917 172.114 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.5 p -89.85 153.86 20.32 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 117.481 -3.262 . . . . 0.75 111.424 -179.61 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.5 mm -47.63 -49.01 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 118.832 -2.417 . . . . 0.73 116.497 172.354 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -45.31 -35.71 3.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 117.101 2.26 . . . . 1.62 117.101 167.828 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -65.48 -32.42 74.01 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 122.02 2.191 . . . . 2.13 114.515 174.836 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.9 t -75.75 -40.19 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 120.112 -1.618 . . . . 0.62 109.772 -174.93 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -59.37 -32.07 69.8 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 113.251 -1.795 . . . . 1.22 114.957 167.556 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.17 84.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 114.98 -2.438 . . . . 0.51 112.905 171.748 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -70.2 -22.16 62.96 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 127.635 3.084 . . . . 1.44 115.023 -179.648 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.1 mm -79.38 -35.66 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 127.262 2.225 . . . . 1.32 109.513 175.446 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.35 8.7 tt0 -58.39 -48.78 79.54 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 126.539 2.399 . . . . 1.7 113.459 172.867 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -54.05 -53.04 58.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 111.647 -2.524 . . . . 1.55 113.145 168.949 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -87.53 -49.21 7.34 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.488 -3.258 . . . . 2.62 114.102 -167.522 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -96.36 -44.45 7.22 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 113.472 -1.695 . . . . 1.48 113.832 -172.202 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.74 -28.28 3.98 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 117.226 1.65 . . . . 1.12 117.226 169.56 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.494 HD12 ' H ' ' A' ' 36' ' ' ILE . 2.8 mp -57.45 138.17 81.43 Favored Pre-proline 0 N--CA 1.429 -1.496 0 N-CA-C 115.754 1.761 . . . . 1.55 115.754 -174.57 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -59.92 134.39 56.49 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 C-N-CA 123.872 3.048 . . . . 1.02 114.445 174.772 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -73.95 -16.75 22.93 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-O 112.004 -3.415 . . . . 1.25 112.74 -169.72 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.03 -38.33 90.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.596 2.617 . . . . 2.25 111.616 171.584 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -78.4 -18.29 55.23 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.765 -2.459 . . . . 2.02 114.739 178.521 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -88.66 138.64 31.24 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.781 2.229 . . . . 0.69 116.09 177.766 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -121.77 158.04 29.68 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.908 -3.62 . . . . 2.78 110.976 165.408 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.276 12.8 mt -119.26 125.16 48.47 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 126.285 1.834 . . . . 1.17 111.387 179.324 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.1 mt -113.08 136.88 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 106.932 -1.507 . . . . 1.38 106.932 -174.149 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -142.04 129.59 21.4 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.588 -1.32 . . . . 1.5 111.106 173.214 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.43 18.3 6.72 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 130.322 3.449 . . . . 1.21 116.334 -179.288 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.54 -3.76 57.89 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 126.561 2.029 . . . . 1.3 115.049 -175.624 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -108.0 133.3 52.51 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 126.421 3.01 . . . . 2.55 113.785 177.215 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -77.41 127.62 32.85 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.251 -4.031 . . . . 2.48 104.735 172.564 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.5 mt -89.61 147.33 23.98 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.283 -2.136 . . . . 0.9 116.73 -173.927 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -82.83 132.87 35.15 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.366 2.031 . . . . 1.94 112.572 171.435 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -60.9 -51.45 69.23 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 111.008 -2.814 . . . . 1.56 115.213 -172.671 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.19 46.95 3.62 Favored Glycine 0 N--CA 1.43 -1.747 0 CA-C-O 118.347 -1.252 . . . . 0.97 114.293 173.726 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -128.21 155.6 44.26 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.085 2.154 . . . . 2.49 113.152 168.8 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.342 70.1 p -82.04 164.01 21.7 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 121.692 2.042 . . . . 0.76 111.116 173.951 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mt -70.41 -26.98 63.93 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 111.302 -2.681 . . . . 1.05 111.698 170.314 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.254 23.2 t -65.74 -46.28 79.45 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 115.572 -2.156 . . . . 1.19 111.681 171.515 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -52.27 -28.36 18.56 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 117.999 2.592 . . . . 1.9 117.999 176.397 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -93.39 -11.46 32.19 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 117.593 -3.192 . . . . 0.89 111.31 -179.693 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.1 m120 67.23 50.5 0.98 Allowed 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 128.728 2.811 . . . . 1.84 113.308 -175.087 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.8 mt -95.46 110.54 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 1 CA-C-O 128.857 4.17 . . . . 0.82 107.674 177.366 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -89.84 -173.15 3.8 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 114.081 -5.387 . . . . 2.16 112.563 -179.589 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -61.73 166.48 4.3 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.118 -2.239 . . . . 2.12 111.329 175.1 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 49.79 28.82 2.9 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 118.471 2.767 . . . . 1.71 118.471 172.703 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.9 p -90.88 147.33 23.23 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.074 2.55 . . . . 1.04 113.054 -174.848 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.9 m -107.98 98.6 8.15 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 115.305 1.594 . . . . 0.79 115.305 -179.205 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.297 2.7 mp -84.01 156.22 22.38 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 129.176 2.99 . . . . 1.4 107.945 175.123 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -126.05 120.23 29.69 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 118.281 -1.368 . . . . 1.51 109.873 -176.614 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.9 tp -84.58 130.81 34.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.903 -2.373 . . . . 1.14 107.636 -179.879 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.5 m -125.04 140.47 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 126.388 2.994 . . . . 1.23 113.066 166.065 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.335 4.9 mt . . . . . 0 N--CA 1.43 -1.446 0 O-C-N 118.023 -2.923 . . . . 2.78 112.553 176.919 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptt? . . . . . 0 CA--C 1.491 -1.319 0 CA-C-O 117.99 -1.005 . . . . 1.1 111.215 . . . . . . . . . 0 0 . 1 . 107 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -115.42 135.05 54.51 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 127.476 2.985 . . . . 1.87 109.275 175.997 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt -117.25 163.54 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 106.832 -1.544 . . . . 0.72 106.832 171.25 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -109.53 136.08 49.49 Favored 'General case' 0 N--CA 1.431 -1.409 1 C-N-CA 132.429 4.292 . . . . 1.4 109.703 174.998 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.9 t -130.01 123.46 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 O-C-N 118.099 -2.876 . . . . 0.58 104.861 178.769 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -98.03 139.49 33.77 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.299 -3.376 . . . . 2.09 112.391 176.531 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.323 32.7 p -82.59 -171.67 3.62 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.831 -1.168 . . . . 0.99 111.676 176.319 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 71' ' ' LEU . 83.9 mt -61.71 -47.77 83.78 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.389 -1.444 . . . . 2.53 112.544 172.14 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.3 p -81.02 -22.84 39.06 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.969 -1.707 . . . . 2.08 109.1 -178.672 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.93 23.89 4.46 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 118.969 2.347 . . . . 1.31 118.969 172.375 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -77.73 134.4 38.1 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 120.054 1.927 . . . . 1.4 108.276 179.039 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.9 m -91.66 110.75 22.08 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.409 -2.057 . . . . 0.78 109.31 -173.272 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mt -100.86 125.91 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 125.742 1.617 . . . . 1.55 106.723 178.153 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.0 m -103.79 121.42 42.99 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.781 2.032 . . . . 1.08 108.207 179.613 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.5 mt -120.45 125.01 46.85 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.774 -2.454 . . . . 1.55 117.268 -178.621 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -70.69 117.56 12.36 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 124.774 1.296 . . . . 1.95 110.235 170.461 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.0 m -142.84 171.97 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 126.2 2.905 . . . . 0.96 109.064 178.231 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -118.58 158.62 46.7 Favored Pre-proline 0 N--CA 1.43 -1.428 1 O-C-N 114.087 -5.383 . . . . 2.35 106.484 163.509 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.08 -14.1 26.06 Favored 'Trans proline' 0 C--N 1.299 -2.048 1 C-N-CA 125.581 4.188 . . . . 0.95 110.235 -171.379 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 m -90.25 8.21 34.33 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 122.125 2.239 . . . . 1.45 110.24 177.773 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.35 147.03 28.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.593 -2.567 . . . . 1.69 110.285 171.388 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 47.0 p -86.71 161.35 18.47 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.663 -1.606 . . . . 0.75 106.663 -177.395 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 23' ' ' ILE 0.3 26.1 mm -64.98 -29.32 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 O-C-N 116.205 -4.06 . . . . 0.73 110.991 -178.374 . . . . . . . . 4 3 . 1 . 107 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -52.98 -47.49 68.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 129.009 2.924 . . . . 1.62 111.773 167.963 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.258 26.3 t30 -71.31 -32.85 69.1 Favored 'General case' 0 N--CA 1.431 -1.41 1 O-C-N 116.229 -4.044 . . . . 2.13 112.997 177.789 . . . . . . . . 3 2 . 1 . 107 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.0 t -63.15 -45.09 99.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 1 O-C-N 113.509 -5.744 . . . . 0.62 113.931 174.482 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.5 mttt -60.37 -38.71 84.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 128.006 3.316 . . . . 1.22 117.267 167.859 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.51 -41.6 85.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 123.901 1.81 . . . . 0.51 113.335 172.442 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -68.33 -29.46 68.21 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.545 -3.222 . . . . 1.44 117.156 171.107 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.8 mt -71.98 -43.92 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-N 120.898 1.681 . . . . 1.32 110.602 172.487 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -49.34 -45.84 46.13 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.575 2.35 . . . . 1.7 115.375 170.951 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -51.58 -46.53 63.53 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.751 2.215 . . . . 1.55 115.023 175.342 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 tttp -85.03 -57.73 2.98 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.681 -3.137 . . . . 2.62 113.008 -174.767 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -89.12 -46.81 8.54 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 129.824 3.25 . . . . 1.48 114.636 -168.274 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.88 27.08 3.35 Favored Glycine 0 N--CA 1.429 -1.798 1 O-C-N 114.637 -5.04 . . . . 1.12 110.455 169.981 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.0 mt -104.97 124.24 37.31 Favored Pre-proline 0 N--CA 1.429 -1.484 0 CA-C-O 113.883 -2.96 . . . . 1.55 107.087 -178.256 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -64.39 164.51 22.95 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 CA-C-N 127.969 3.882 . . . . 1.02 118.413 174.677 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -65.33 -26.65 55.91 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 123.815 3.01 . . . . 1.25 118.593 -176.847 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -55.96 -43.34 77.44 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 127.344 2.902 . . . . 2.25 113.062 173.774 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -85.38 -1.51 57.09 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 113.147 -1.842 . . . . 2.02 114.321 -170.317 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -107.6 103.62 12.97 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.146 1.378 . . . . 0.69 112.451 -171.946 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.257 72.6 mtt180 -96.39 116.74 29.53 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.286 -2.759 . . . . 2.78 107.849 167.74 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.1 mt -99.46 126.86 45.46 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.583 -3.198 . . . . 1.17 105.089 177.559 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -114.31 143.36 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 125.298 2.475 . . . . 1.38 107.966 176.481 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.515 ' C ' ' H ' ' A' ' 47' ' ' GLY . 34.9 t80 -141.2 127.37 19.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.346 -3.971 . . . . 1.5 108.888 171.964 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 75.93 -27.39 0.18 Allowed 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 127.953 2.501 . . . . 1.21 109.624 174.155 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 143.48 -13.02 2.25 Favored Glycine 0 N--CA 1.431 -1.694 0 CA-C-O 125.162 2.535 . . . . 1.3 113.55 -175.887 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -86.22 137.1 32.89 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 111.806 -2.197 . . . . 2.55 109.473 178.781 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -77.59 109.66 11.75 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.796 3.638 . . . . 2.48 110.508 169.092 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.8 mt -68.46 130.97 44.44 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 114.858 1.429 . . . . 0.9 114.858 -177.393 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -89.8 144.52 25.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.654 1.582 . . . . 1.94 113.285 177.891 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -60.87 -54.87 39.81 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.718 -3.114 . . . . 1.56 115.862 -171.933 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.42 28.86 0.85 Allowed Glycine 0 N--CA 1.43 -1.763 1 N-CA-C 123.754 4.262 . . . . 0.97 123.754 171.357 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -127.87 160.01 33.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.548 -1.56 . . . . 2.49 112.139 173.01 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.26 44.2 p -89.15 167.07 13.41 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.356 1.551 . . . . 0.76 109.974 -177.703 . . . . . . . . 3 3 . 1 . 107 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mt -64.81 -34.73 79.06 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 113.892 -1.503 . . . . 1.05 109.854 169.938 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.9 t -61.16 -41.81 97.43 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 122.598 1.189 . . . . 1.19 109.613 179.397 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -55.23 -41.87 72.63 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.569 -2.582 . . . . 1.9 117.56 176.309 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -84.9 -6.69 59.34 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 117.75 2.5 . . . . 0.89 117.75 -179.441 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.318 35.9 m120 68.62 50.57 0.67 Allowed 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 119.399 1.0 . . . . 1.84 111.999 -176.204 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.6 mt -103.44 108.73 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 121.704 0.764 . . . . 0.82 111.451 172.838 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -93.78 -175.8 3.85 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.297 2.639 . . . . 2.16 107.627 177.886 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -68.59 149.35 49.28 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 125.932 2.777 . . . . 2.12 113.747 171.275 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.429 75.3 mt-10 64.97 22.39 12.44 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 109.99 -3.277 . . . . 1.71 115.375 174.687 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.5 m -92.23 156.42 17.31 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.776 -3.077 . . . . 1.04 110.812 -176.883 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.2 m -106.89 110.19 22.28 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 126.521 2.388 . . . . 0.79 108.211 -173.005 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -93.22 141.33 28.54 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.59 1.556 . . . . 1.4 106.869 172.31 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -101.9 117.99 35.99 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.015 -2.928 . . . . 1.51 106.773 -177.902 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.8 tp -93.1 121.4 34.42 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.697 -2.502 . . . . 1.14 111.163 173.868 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.1 t -111.36 140.77 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 O-C-N 117.8 -3.062 . . . . 1.23 108.084 177.561 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.413 ' HB3' HD11 ' A' ' 8' ' ' LEU . 10.5 tp . . . . . 0 N--CA 1.43 -1.474 0 N-CA-C 116.39 1.996 . . . . 2.78 116.39 174.567 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ptt? . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 106.733 -1.58 . . . . 1.1 106.733 . . . . . . . . . 0 0 . 1 . 108 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.1 pm0 -107.15 131.6 53.96 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 114.28 1.215 . . . . 1.87 114.28 -178.863 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 pt -121.32 152.7 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 105.867 -1.901 . . . . 0.72 105.867 169.67 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.252 75.0 m-85 -113.89 135.34 54.08 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.035 -1.439 . . . . 1.4 108.88 -176.58 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.0 t -118.07 107.47 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 123.191 1.472 . . . . 0.58 111.405 178.709 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -89.02 138.23 31.59 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 118.239 -2.788 . . . . 2.09 118.278 174.686 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.329 27.8 p -94.81 154.35 17.3 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 110.725 -2.943 . . . . 0.99 110.013 178.309 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.282 43.1 mt -65.6 -41.64 92.57 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 131.012 3.725 . . . . 2.53 107.611 178.367 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 p -67.57 -46.17 73.45 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.138 1.375 . . . . 2.08 114.001 -176.7 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.05 50.57 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 125.406 1.479 . . . . 1.31 114.953 166.417 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -127.87 137.94 52.51 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.505 2.574 . . . . 1.4 107.652 -179.798 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.0 m -103.07 110.89 22.99 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 120.192 -1.567 . . . . 0.78 111.634 167.492 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.9 mm -97.54 112.72 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 104.545 -2.391 . . . . 1.55 104.545 -179.475 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.7 m -87.58 104.0 16.09 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.795 -1.191 . . . . 1.08 110.067 176.922 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.422 HD11 HG12 ' A' ' 30' ' ' ILE . 24.0 mt -101.54 134.76 44.16 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 105.598 -2.001 . . . . 1.55 105.598 -170.646 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -81.72 99.37 8.9 Favored 'General case' 0 N--CA 1.429 -1.492 1 O-C-N 116.116 -4.115 . . . . 1.95 116.395 165.233 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.5 m -109.22 -177.66 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.457 1 O-C-N 116.295 -4.003 . . . . 0.96 109.964 -179.693 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -124.11 158.5 60.42 Favored Pre-proline 0 N--CA 1.431 -1.417 0 CA-C-O 114.885 -2.483 . . . . 2.35 105.823 161.55 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -79.03 -6.82 15.18 Favored 'Trans proline' 0 N--CA 1.434 -2.019 1 CA-C-N 129.825 4.544 . . . . 0.95 111.894 -173.347 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.275 1.0 OUTLIER -82.79 2.2 35.22 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 116.448 2.018 . . . . 1.45 116.448 172.01 . . . . . . . . 3 3 . 1 . 108 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -78.02 134.63 37.76 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 116.566 2.062 . . . . 1.69 116.566 172.552 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.7 p -73.63 157.93 35.71 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.139 2.4 . . . . 0.75 110.134 174.569 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.266 35.4 mm -68.64 -37.31 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 112.392 -2.186 . . . . 0.73 110.075 -177.545 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -44.67 -46.53 10.3 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 128.329 2.652 . . . . 1.62 112.463 162.762 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -74.51 -38.63 62.79 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.748 2.69 . . . . 2.13 117.015 -179.679 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.7 t -65.11 -37.86 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 O-C-N 115.188 -4.695 . . . . 0.62 110.196 175.2 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -60.89 -29.72 69.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.838 -2.414 . . . . 1.22 115.334 172.34 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.48 -32.86 66.56 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.097 1.359 . . . . 0.51 112.162 174.325 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.28 0.4 OUTLIER -64.82 -32.95 74.89 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 130.371 3.469 . . . . 1.44 112.822 171.724 . . . . . . . . 3 3 . 1 . 108 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.422 HG12 HD11 ' A' ' 15' ' ' LEU . 15.3 mt -70.82 -41.15 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.579 2.351 . . . . 1.32 108.761 167.495 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.369 13.6 tt0 -57.83 -45.5 86.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 127.754 3.645 . . . . 1.7 117.259 170.065 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -52.45 -56.88 12.05 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.41 -3.306 . . . . 1.55 116.004 170.772 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -78.17 -51.12 10.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.92 -2.362 . . . . 2.62 113.074 -177.992 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -93.91 -62.19 1.4 Allowed 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.982 -2.949 . . . . 1.48 110.386 -170.973 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.15 53.68 0.35 Allowed Glycine 0 N--CA 1.431 -1.663 1 O-C-N 114.13 -5.356 . . . . 1.12 114.829 -179.489 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.9 mt -123.11 127.97 25.48 Favored Pre-proline 0 N--CA 1.43 -1.432 1 N-CA-C 99.661 -4.2 . . . . 1.55 99.661 -177.172 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.02 135.18 39.73 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 C-N-CA 123.022 2.482 . . . . 1.02 112.022 -179.319 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -46.47 -21.51 1.33 Allowed 'Trans proline' 0 N--CA 1.434 -1.999 1 C-N-CA 128.968 6.445 . . . . 1.25 121.96 179.612 . . . . . . . . 3 3 . 1 . 108 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -72.87 -50.41 24.06 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.881 2.472 . . . . 2.25 110.334 177.416 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -77.66 -7.22 56.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.551 3.072 . . . . 2.02 108.51 -172.977 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -91.72 124.02 35.55 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.387 -3.321 . . . . 0.69 113.424 -178.705 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -121.18 147.93 44.92 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.565 2.126 . . . . 2.78 105.467 169.008 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.262 29.5 mt -127.07 133.95 50.36 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 117.912 -1.515 . . . . 1.17 107.013 178.587 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.5 mt -106.39 147.98 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 127.948 3.28 . . . . 1.38 107.569 171.57 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -128.59 107.3 9.59 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.416 -2.068 . . . . 1.5 105.416 177.164 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.43 -42.13 0.49 Allowed 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 132.225 4.21 . . . . 1.21 113.216 177.38 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -172.23 -25.44 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 127.747 2.594 . . . . 1.3 109.435 -176.811 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -104.43 147.77 27.18 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.278 1.539 . . . . 2.55 113.48 -175.489 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -81.59 140.63 34.35 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.012 -1.449 . . . . 2.48 113.232 172.266 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.5 mt -98.44 144.76 27.45 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.378 1.561 . . . . 0.9 113.482 -177.883 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -99.04 144.82 27.75 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.601 -2.562 . . . . 1.94 108.277 170.501 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.92 -43.93 94.45 Favored 'General case' 0 CA--C 1.489 -1.391 1 C-N-CA 137.864 6.465 . . . . 1.56 114.513 -167.668 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.31 22.87 13.54 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 129.14 3.257 . . . . 0.97 111.847 168.605 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -98.57 168.34 10.23 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.812 2.244 . . . . 2.49 109.25 161.234 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.3 p -102.68 173.09 6.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.586 -2.571 . . . . 0.76 111.27 170.741 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.321 16.7 mt -76.68 -31.51 57.31 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.442 -2.036 . . . . 1.05 106.579 176.951 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 t -64.05 -41.77 97.27 Favored 'General case' 0 CA--C 1.489 -1.39 0 C-N-CA 124.796 1.238 . . . . 1.19 111.093 179.703 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -56.14 -41.01 74.7 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.843 2.164 . . . . 1.9 116.843 174.552 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -87.67 7.36 30.35 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.004 2.122 . . . . 0.89 112.781 179.456 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.277 35.0 m120 56.67 40.49 29.23 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.721 -2.487 . . . . 1.84 115.455 -179.855 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.2 mt -79.03 108.18 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 124.082 1.896 . . . . 0.82 112.116 171.916 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -95.01 -175.27 3.48 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.927 -1.733 . . . . 2.16 113.009 179.131 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -69.02 146.36 52.76 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 115.858 -2.02 . . . . 2.12 114.901 170.774 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 69.57 42.94 1.06 Allowed 'General case' 0 N--CA 1.431 -1.409 1 CA-C-O 130.943 5.163 . . . . 1.71 108.193 177.372 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.256 37.9 m -107.11 129.48 54.82 Favored 'General case' 0 N--CA 1.431 -1.411 1 O-C-N 113.693 -5.629 . . . . 1.04 115.809 176.943 . . . . . . . . 3 2 . 1 . 108 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.3 m -88.33 126.12 35.03 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 125.686 1.866 . . . . 0.79 111.815 177.53 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -112.57 151.7 29.75 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.67 2.788 . . . . 1.4 108.271 173.607 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -110.26 113.45 26.13 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.224 1.935 . . . . 1.51 116.224 -174.967 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.3 tp -82.21 112.97 19.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.203 -2.811 . . . . 1.14 113.39 -178.64 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.39 112.56 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 125.04 2.352 . . . . 1.23 112.593 179.408 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.7 tp . . . . . 0 N--CA 1.43 -1.426 0 O-C-N 118.935 -2.353 . . . . 2.78 107.644 -175.301 . . . . . . . . 0 0 . 1 . 109 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.324 0 N-CA-C 107.442 -1.318 . . . . 1.1 107.442 . . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -99.16 144.45 28.28 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.288 1.994 . . . . 1.87 108.857 -173.913 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 pt -118.7 145.52 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 120.201 -1.562 . . . . 0.72 110.818 169.946 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -100.86 104.13 15.34 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.714 -0.676 . . . . 1.4 110.965 -179.567 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.8 t -88.29 117.62 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.446 -2.034 . . . . 0.58 107.299 174.651 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -101.88 145.12 29.66 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 125.288 1.618 . . . . 2.09 107.264 -179.529 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -103.9 -166.54 1.26 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.582 2.134 . . . . 0.99 112.186 178.532 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.5 tp -61.14 -51.29 69.68 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.539 -4.476 . . . . 2.53 114.15 176.233 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 p -72.24 -24.69 61.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.443 -3.286 . . . . 2.08 110.458 178.523 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.25 38.1 2.73 Favored Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 115.043 -3.087 . . . . 1.31 112.167 179.261 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -95.67 130.06 42.67 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 121.492 2.646 . . . . 1.4 110.956 -178.74 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.1 m -80.0 120.74 24.6 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.091 2.956 . . . . 0.78 112.786 178.972 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mt -107.8 118.1 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 101.786 -3.413 . . . . 1.55 101.786 171.523 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.6 m -102.0 113.33 26.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 123.723 2.965 . . . . 1.08 107.462 -172.23 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.8 mt -108.58 137.05 47.17 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.231 -0.918 . . . . 1.55 110.924 177.543 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -80.94 112.86 18.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.872 1.269 . . . . 1.95 110.635 165.516 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -121.48 171.86 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 116.648 2.092 . . . . 0.96 116.648 174.866 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -106.14 158.05 33.44 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 104.115 -2.55 . . . . 2.35 104.115 164.712 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -82.51 4.61 6.95 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 O-C-N 114.656 -3.391 . . . . 0.95 109.095 179.926 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.6 p -92.66 -13.61 29.25 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.329 1.452 . . . . 1.45 114.561 175.661 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -66.67 135.88 54.72 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 126.109 2.861 . . . . 1.69 109.041 -179.416 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.263 23.8 p -68.96 158.33 34.91 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 116.451 -3.906 . . . . 0.75 113.534 177.881 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.401 7.9 mm -55.85 -41.77 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 124.623 2.154 . . . . 0.73 116.416 171.953 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -56.53 -39.65 73.72 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 119.546 3.165 . . . . 1.62 119.546 167.933 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -29.21 64.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.552 2.056 . . . . 2.13 116.552 172.321 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.44 -37.09 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 130.373 3.469 . . . . 0.62 109.635 168.732 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -81.44 -18.74 44.29 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 122.538 1.161 . . . . 1.22 109.793 -179.427 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.38 -17.34 58.28 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.651 -1.906 . . . . 0.51 111.532 168.242 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -83.64 -30.61 26.74 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 119.831 -1.793 . . . . 1.44 111.522 173.22 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.258 13.6 mt -73.01 -26.56 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 117.167 -3.458 . . . . 1.32 113.213 171.561 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -70.65 -51.36 28.46 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.492 3.517 . . . . 1.7 109.446 174.305 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -50.28 -45.16 54.22 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.608 2.763 . . . . 1.55 117.005 165.708 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -81.59 -60.15 2.36 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 113.869 1.063 . . . . 2.62 113.869 -179.646 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -95.13 -48.35 5.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.041 1.497 . . . . 1.48 115.041 -171.396 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.07 -2.0 6.25 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-O 124.222 2.012 . . . . 1.12 114.614 169.922 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.7 mt -74.03 117.61 62.76 Favored Pre-proline 0 N--CA 1.431 -1.409 0 C-N-CA 127.899 2.48 . . . . 1.55 105.039 -174.732 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -69.14 166.88 25.29 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 CA-C-O 111.815 -3.494 . . . . 1.02 117.074 178.03 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -66.19 -32.72 41.98 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 N-CA-C 120.133 3.09 . . . . 1.25 120.133 -174.64 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.379 38.0 m-20 -47.95 -36.63 12.83 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.974 2.109 . . . . 2.25 113.173 169.102 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -98.59 -4.74 33.35 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.964 -0.46 . . . . 2.02 111.802 -172.172 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -97.58 126.17 42.73 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.459 -2.025 . . . . 0.69 110.839 -179.685 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -106.83 116.82 32.59 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.08 2.152 . . . . 2.78 108.826 168.691 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.5 mt -104.84 115.73 30.79 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.8 -1.188 . . . . 1.17 112.037 -179.086 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.9 mm -110.65 126.17 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 127.129 2.172 . . . . 1.38 116.589 -179.779 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -127.92 104.0 7.56 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 104.792 -2.299 . . . . 1.5 104.792 174.97 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.284 . . 61.88 -117.03 0.62 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 110.641 -2.982 . . . . 1.21 110.976 -179.655 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.08 -27.12 29.28 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 119.876 -1.765 . . . . 1.3 110.634 -168.513 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -96.28 139.55 32.26 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 126.86 2.153 . . . . 2.55 115.36 -179.224 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -90.46 127.73 36.3 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 111.919 -2.4 . . . . 2.48 105.836 173.408 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.4 mt -83.85 117.17 23.13 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.363 -1.461 . . . . 0.9 112.445 -171.424 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -68.7 139.7 55.4 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 119.936 3.31 . . . . 1.94 119.936 172.381 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.52 -59.43 4.84 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 118.566 2.802 . . . . 1.56 118.566 -174.611 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.76 60.19 4.83 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-N 113.118 -1.855 . . . . 0.97 114.805 172.362 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -136.8 178.48 7.04 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.418 2.532 . . . . 2.49 106.038 164.521 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.6 p -110.38 176.6 4.98 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 116.604 -3.81 . . . . 0.76 106.961 170.241 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.6 mt -75.2 -33.92 61.46 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.32 -2.737 . . . . 1.05 109.024 177.302 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.6 t -56.01 -44.24 78.47 Favored 'General case' 0 N--CA 1.43 -1.436 1 C-N-CA 134.34 5.056 . . . . 1.19 109.685 176.84 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.251 33.6 m-20 -57.27 -39.79 76.36 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.542 -3.849 . . . . 1.9 118.25 175.653 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -96.67 -2.25 45.02 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 127.469 2.308 . . . . 0.89 112.76 179.476 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.9 m120 58.21 42.53 21.84 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.916 2.886 . . . . 1.84 118.713 -179.165 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.1 mt -94.36 114.38 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 119.439 -2.038 . . . . 0.82 108.596 -179.695 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -101.13 -172.77 2.23 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.742 2.417 . . . . 2.16 112.776 -179.85 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -45.56 151.55 0.39 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.492 -3.88 . . . . 2.12 120.577 174.056 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 50.96 34.93 11.45 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.694 1.368 . . . . 1.71 114.694 174.548 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.0 m -91.84 137.38 32.41 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.697 -1.592 . . . . 1.04 109.294 -176.257 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.2 m -86.7 111.45 20.69 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 124.981 1.425 . . . . 0.79 110.831 177.003 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -92.13 163.97 13.75 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 117.461 -3.274 . . . . 1.4 107.428 171.405 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -128.95 116.28 19.13 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 124.232 1.968 . . . . 1.51 110.031 179.93 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.7 tp -82.36 110.26 17.35 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.677 3.214 . . . . 1.14 119.677 174.548 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.6 t -113.19 142.8 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.686 -1.227 . . . . 1.23 107.686 -178.919 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.9 tp . . . . . 0 N--CA 1.429 -1.48 0 CA-C-N 122.919 2.6 . . . . 2.78 108.851 178.37 . . . . . . . . 0 0 . 1 . 110 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 114.307 1.225 . . . . 1.1 114.307 . . . . . . . . . 0 0 . 1 . 110 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -93.31 130.16 39.16 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.646 -2.534 . . . . 1.87 112.898 -175.967 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.5 pt -129.85 149.64 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 128.561 3.663 . . . . 0.72 110.614 176.149 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -109.0 130.69 55.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 113.052 -1.886 . . . . 1.4 107.854 -176.106 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.48 130.58 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 103.076 -2.935 . . . . 0.58 103.076 173.589 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -110.24 146.13 36.14 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 116.21 -4.056 . . . . 2.09 115.691 174.137 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.482 HG22 HD23 ' A' ' 69' ' ' LEU 0.251 2.9 p -104.34 171.63 7.23 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 119.727 1.149 . . . . 0.99 108.4 173.704 . . . . . . . . 3 3 . 1 . 110 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.9 mt -73.41 -40.26 64.42 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 117.242 -3.411 . . . . 2.53 114.962 174.592 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.0 p -80.72 -37.29 30.86 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.62 2.452 . . . . 2.08 117.62 -175.549 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.57 -55.14 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 116.252 -2.88 . . . . 1.31 119.801 174.973 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -54.18 129.62 35.52 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 121.102 3.742 . . . . 1.4 121.102 -178.311 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.7 m -112.6 115.23 28.27 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 104.498 -2.408 . . . . 0.78 104.498 168.261 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mt -95.03 129.06 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 107.474 -1.306 . . . . 1.55 107.474 -173.005 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.9 m -89.23 111.09 21.8 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.879 2.276 . . . . 1.08 106.634 172.832 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.8 mt -111.44 141.48 44.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 117.408 2.373 . . . . 1.55 117.408 174.527 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -103.37 115.94 31.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 130.64 3.576 . . . . 1.95 109.283 168.251 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.0 m -131.45 155.89 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.223 1.809 . . . . 0.96 112.994 -176.938 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -97.02 142.58 24.75 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-O 112.675 -3.536 . . . . 2.35 117.07 164.356 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' A' ' 56' ' ' LEU 0.267 18.8 Cg_endo -70.7 -24.68 25.11 Favored 'Trans proline' 0 C--N 1.299 -2.055 2 C-N-CA 127.502 5.468 . . . . 0.95 111.705 -170.373 . . . . . . . . 4 3 . 1 . 110 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.329 25.5 m -84.56 8.13 17.73 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 114.216 1.191 . . . . 1.45 114.216 173.916 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -78.13 149.0 33.89 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.992 2.517 . . . . 1.69 104.859 174.637 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.2 p -74.36 163.83 27.33 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.516 2.413 . . . . 0.75 117.516 169.907 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.2 mm -66.26 -36.22 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 121.673 2.033 . . . . 0.73 110.264 171.027 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -52.27 -43.55 64.47 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.391 -2.693 . . . . 1.62 116.709 171.839 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -57.44 -46.49 83.54 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.323 -2.11 . . . . 2.13 113.006 171.765 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.63 -39.23 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 120.408 1.458 . . . . 0.62 113.18 177.106 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.03 -33.0 74.75 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.113 1.153 . . . . 1.22 114.113 173.295 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.25 -27.8 66.66 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.476 1.11 . . . . 0.51 112.548 175.001 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -81.61 -26.34 34.95 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.699 -2.5 . . . . 1.44 109.221 176.913 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.4 mt -75.02 -30.44 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 122.213 2.278 . . . . 1.32 109.485 174.918 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -57.13 -48.81 77.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 130.17 3.388 . . . . 1.7 108.74 169.44 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.29 4.4 t70 -52.29 -58.63 6.05 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.015 1.726 . . . . 1.55 111.478 171.227 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -75.93 -62.47 1.58 Allowed 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 116.02 -4.175 . . . . 2.62 113.296 -172.553 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -96.37 -20.27 18.59 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 116.513 2.042 . . . . 1.48 116.513 -170.221 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.68 20.73 21.07 Favored Glycine 0 N--CA 1.429 -1.803 0 CA-C-O 125.24 2.578 . . . . 1.12 114.736 169.91 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.95 127.46 36.96 Favored Pre-proline 0 N--CA 1.43 -1.445 1 O-C-N 115.801 -4.353 . . . . 1.55 107.707 -174.385 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 52.7 Cg_exo -64.61 147.76 90.21 Favored 'Trans proline' 0 C--N 1.3 -2.016 1 CA-C-N 129.276 4.349 . . . . 1.02 115.017 -178.966 . . . . . . . . 3 3 . 1 . 110 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.1 Cg_exo -62.07 -12.43 26.38 Favored 'Trans proline' 0 N--CA 1.433 -2.049 0 C-N-CA 124.386 3.391 . . . . 1.25 111.672 -178.778 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -73.68 -30.4 62.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 124.629 3.377 . . . . 2.25 115.253 172.382 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -78.66 -32.49 47.2 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 119.181 -2.2 . . . . 2.02 115.498 -176.47 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -71.2 124.52 24.68 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 124.499 1.124 . . . . 0.69 111.326 -172.129 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -120.93 109.78 15.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 114.785 -1.098 . . . . 2.78 109.82 167.537 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.8 mt -90.3 124.43 34.89 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 106.224 -1.769 . . . . 1.17 106.224 -175.997 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.0 mm -102.6 121.1 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 129.685 3.194 . . . . 1.38 113.582 172.107 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -136.49 136.13 39.16 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.902 -1.749 . . . . 1.5 108.773 171.756 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.12 27.01 7.12 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 120.101 3.371 . . . . 1.21 120.101 -178.963 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.73 5.53 84.0 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 119.025 -1.56 . . . . 1.3 116.713 -175.05 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -114.48 143.03 45.6 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.246 1.819 . . . . 2.55 113.818 -178.609 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -97.45 116.18 29.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.674 -1.232 . . . . 2.48 107.674 176.898 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.49 120.91 25.1 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.679 -2.513 . . . . 0.9 108.498 -164.491 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -66.69 157.61 32.2 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 113.849 1.055 . . . . 1.94 113.849 173.659 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -69.72 -55.53 9.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 114.398 1.258 . . . . 1.56 114.398 -176.305 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.27 46.8 2.81 Favored Glycine 0 N--CA 1.43 -1.766 0 CA-C-N 120.202 1.365 . . . . 0.97 115.075 173.538 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -112.88 156.39 23.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 119.913 -1.934 . . . . 2.49 108.212 162.778 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.2 p -99.13 168.78 9.85 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 115.428 -4.545 . . . . 0.76 113.185 169.32 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.403 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 6.6 mt -63.81 -37.58 87.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 125.273 1.608 . . . . 1.05 112.367 173.291 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.6 t -71.89 -36.43 70.04 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 122.229 1.014 . . . . 1.19 113.355 -179.943 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -54.6 -36.73 64.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.5 3.519 . . . . 1.9 120.5 168.284 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -92.02 9.52 32.91 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.087 -1.449 . . . . 0.89 107.087 -179.964 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 46.42 44.03 12.49 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 117.068 2.247 . . . . 1.84 117.068 -169.65 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.4 mt -86.4 121.04 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 106.5 -1.667 . . . . 0.82 106.5 175.988 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -104.71 179.31 4.31 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 123.296 1.522 . . . . 2.16 107.67 179.632 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -48.84 155.01 0.63 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 117.584 2.439 . . . . 2.12 117.584 173.064 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.305 20.0 mt-10 62.46 25.47 15.18 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 119.068 2.988 . . . . 1.71 119.068 172.075 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -93.25 145.64 24.29 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.721 1.608 . . . . 1.04 113.213 -173.178 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.253 3.2 m -94.02 104.29 16.34 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.3 -4.0 . . . . 0.79 113.666 176.229 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -89.25 142.69 27.43 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 124.394 1.059 . . . . 1.4 109.638 172.645 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -105.05 119.66 39.58 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 116.448 -3.908 . . . . 1.51 108.607 -178.89 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.482 HD23 HG22 ' A' ' 7' ' ' THR . 44.7 tp -91.54 129.86 37.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.951 -3.593 . . . . 1.14 106.374 177.359 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.14 148.45 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 128.125 2.57 . . . . 1.23 106.376 174.297 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 71.2 mt . . . . . 0 N--CA 1.43 -1.449 1 O-C-N 115.913 -4.242 . . . . 2.78 110.442 175.651 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ptt? . . . . . 0 CA--C 1.49 -1.338 0 N-CA-C 109.758 -0.46 . . . . 1.1 109.758 . . . . . . . . . 0 0 . 1 . 111 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -99.43 126.55 45.36 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.49 2.716 . . . . 1.87 111.005 -177.007 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.4 pt -116.85 142.19 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 118.386 -2.696 . . . . 0.72 106.245 168.648 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -100.3 106.33 17.96 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.444 2.698 . . . . 1.4 109.205 -178.16 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.0 t -101.66 112.14 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 O-C-N 117.403 -3.311 . . . . 0.58 106.986 173.354 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.5 mttm -89.98 146.93 24.01 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.89 -3.006 . . . . 2.09 113.375 177.964 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.493 HG22 HD23 ' A' ' 69' ' ' LEU . 82.2 p -98.69 172.05 7.72 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.472 3.034 . . . . 0.99 108.097 172.651 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.6 mt -73.39 -26.47 61.0 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.666 -2.061 . . . . 2.53 113.67 166.181 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.9 p -71.94 -69.95 0.36 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.069 2.248 . . . . 2.08 117.069 -175.67 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.02 12.67 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.809 0 CA-C-O 115.619 -2.767 . . . . 1.31 111.859 176.738 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -108.09 126.91 53.3 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 120.461 2.131 . . . . 1.4 113.225 -177.423 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.2 m -103.78 103.44 13.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.927 -2.249 . . . . 0.78 104.927 173.219 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -82.85 113.93 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 O-C-N 117.129 -3.482 . . . . 1.55 110.912 177.446 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.5 m -79.76 116.25 19.82 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.902 -2.374 . . . . 1.08 105.545 172.647 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.5 mt -114.2 134.43 54.92 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.169 -1.419 . . . . 1.55 107.169 176.185 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -86.75 106.99 18.05 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.174 2.99 . . . . 1.95 114.07 167.719 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.74 165.42 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 112.981 -1.918 . . . . 0.96 109.571 -177.552 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -109.53 155.18 41.73 Favored Pre-proline 0 N--CA 1.429 -1.485 0 N-CA-C 109.38 -0.6 . . . . 2.35 109.38 162.421 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -73.56 -11.87 24.5 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 O-C-N 117.134 -2.087 . . . . 0.95 111.326 -173.01 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.6 p -89.13 0.21 56.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.943 2.897 . . . . 1.45 113.475 178.353 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -76.22 150.12 37.12 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 126.121 2.867 . . . . 1.69 114.456 170.361 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.3 p -85.11 153.12 22.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.232 -2.167 . . . . 0.75 112.567 176.081 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.2 mm -65.45 -36.15 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 120.512 1.506 . . . . 0.73 114.071 -178.954 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -58.28 -39.98 80.69 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.069 -2.269 . . . . 1.62 116.923 173.669 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.323 70.1 m-80 -66.03 -26.04 67.33 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 116.1 1.889 . . . . 2.13 116.1 170.524 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -72.04 -33.3 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-N 120.135 1.334 . . . . 0.62 111.854 170.838 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -83.14 -20.34 34.95 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.381 -2.699 . . . . 1.22 111.175 177.842 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.67 67.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 121.197 1.817 . . . . 0.51 114.012 171.476 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -72.32 -48.86 38.83 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 125.452 1.72 . . . . 1.44 111.261 175.277 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.5 mt -60.79 -33.25 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 125.695 1.598 . . . . 1.32 111.258 176.284 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -64.66 -60.04 3.58 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.644 1.212 . . . . 1.7 110.659 177.624 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -42.43 -56.67 2.93 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 115.368 1.618 . . . . 1.55 115.368 174.698 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -67.69 -59.91 2.95 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 113.977 1.103 . . . . 2.62 113.977 177.359 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -92.37 -58.52 2.35 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.354 -1.466 . . . . 1.48 111.66 -166.414 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.16 16.69 0.64 Allowed Glycine 0 N--CA 1.43 -1.746 0 O-C-N 119.814 -1.804 . . . . 1.12 115.579 175.049 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.415 HG21 HD22 ' A' ' 71' ' ' LEU . 2.4 mp -96.59 133.76 24.21 Favored Pre-proline 0 N--CA 1.43 -1.464 0 C-N-CA 119.291 -0.964 . . . . 1.55 110.903 -175.31 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.39 149.16 91.9 Favored 'Trans proline' 0 N--CA 1.435 -1.965 0 CA-C-N 125.036 2.834 . . . . 1.02 112.933 176.004 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -80.08 -11.25 13.62 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-O 115.702 -1.874 . . . . 1.25 108.9 -168.653 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -77.99 -24.49 48.0 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.871 2.123 . . . . 2.25 114.999 166.914 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -84.35 -34.28 23.68 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 124.244 1.973 . . . . 2.02 109.952 -177.773 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -72.38 100.06 2.58 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.437 -3.29 . . . . 0.69 112.069 179.797 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -86.65 135.37 33.43 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 121.558 1.981 . . . . 2.78 108.05 166.393 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 43' ' ' LEU 0.274 80.0 mt -104.17 125.82 50.78 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.631 3.586 . . . . 1.17 108.226 175.572 . . . . . . . . 3 3 . 1 . 111 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 29.8 mm -103.13 140.93 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 118.976 -2.327 . . . . 1.38 110.358 171.699 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -130.14 107.98 9.72 Favored 'General case' 0 N--CA 1.429 -1.479 1 N-CA-C 98.835 -4.505 . . . . 1.5 98.835 170.506 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.07 -84.89 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.246 1.818 . . . . 1.21 115.14 179.87 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.01 13.25 0.74 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 130.473 3.892 . . . . 1.3 111.338 -175.583 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -109.6 151.36 26.93 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 121.189 2.495 . . . . 2.55 104.439 168.268 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -94.42 132.81 38.67 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 130.031 3.332 . . . . 2.48 102.726 171.071 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.9 mt -91.38 133.2 35.65 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.481 -2.012 . . . . 0.9 107.011 -170.387 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -71.88 151.73 43.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.19 -3.443 . . . . 1.94 108.605 171.572 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.25 -40.81 36.06 Favored 'General case' 0 N--CA 1.429 -1.523 0 O-C-N 116.865 -3.647 . . . . 1.56 110.137 -168.81 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.04 45.45 3.42 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 118.193 -2.817 . . . . 0.97 117.149 172.265 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -116.25 167.5 10.96 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 118.417 -0.802 . . . . 2.49 109.778 163.007 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.6 p -96.9 175.84 6.19 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 127.398 3.475 . . . . 0.76 108.286 167.941 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.8 mt -72.45 -43.75 63.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.742 -3.099 . . . . 1.05 108.607 176.514 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.2 p -72.9 1.41 8.77 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 119.969 3.322 . . . . 1.19 119.969 179.301 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -82.45 -40.59 20.95 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.47 -2.644 . . . . 1.9 112.27 169.593 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -77.87 -7.3 56.51 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.072 2.549 . . . . 0.89 110.621 172.161 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.312 42.8 m-80 68.46 33.32 4.11 Favored 'General case' 0 N--CA 1.428 -1.539 0 O-C-N 116.669 -3.769 . . . . 1.84 115.829 -177.273 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.6 mt -81.31 125.29 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 CA-C-N 114.011 -1.45 . . . . 0.82 111.657 -179.573 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -108.1 -164.11 0.94 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 121.28 3.808 . . . . 2.16 121.28 -176.535 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -74.4 146.63 42.78 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 120.438 -1.414 . . . . 2.12 112.853 171.946 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.261 43.4 mt-10 68.59 18.17 8.89 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 126.901 2.08 . . . . 1.71 115.436 178.182 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -77.04 124.66 28.12 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.413 2.685 . . . . 1.04 113.482 -174.749 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.29 3.8 m -80.97 105.16 11.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 127.418 2.287 . . . . 0.79 115.143 175.845 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -103.52 166.76 10.23 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 125.58 2.61 . . . . 1.4 106.044 175.249 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.42 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 73.6 m80 -128.72 133.1 48.05 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.829 -4.295 . . . . 1.51 110.108 -172.12 . . . . . . . . 3 3 . 1 . 111 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.493 HD23 HG22 ' A' ' 7' ' ' THR . 36.6 tp -99.29 129.72 45.53 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.217 -0.927 . . . . 1.14 112.551 -176.368 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -131.05 123.4 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 122.074 2.216 . . . . 1.23 112.26 175.743 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.415 HD22 HG21 ' A' ' 36' ' ' ILE . 18.7 mt . . . . . 0 N--CA 1.43 -1.462 0 N-CA-C 117.65 2.463 . . . . 2.78 117.65 -178.397 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 113.311 0.856 . . . . 1.1 113.311 . . . . . . . . . 0 0 . 1 . 112 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.408 HE21 ' HB2' ' A' ' 2' ' ' GLN . 12.0 mt-30 -91.7 142.7 27.33 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.826 -1.916 . . . . 1.87 105.826 -178.046 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.0 pt -132.01 176.69 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 105.166 -2.161 . . . . 0.72 105.166 167.701 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -127.13 130.14 49.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.402 1.573 . . . . 1.4 109.079 176.299 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -109.49 110.09 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 126.231 2.919 . . . . 0.58 104.481 175.158 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 12' ' ' THR 0.27 23.7 ttmm -103.98 142.55 34.24 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 114.843 -4.911 . . . . 2.09 109.656 -178.422 . . . . . . . . 4 3 . 1 . 112 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.7 p -91.76 142.52 27.5 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 114.284 -2.77 . . . . 0.99 111.885 179.668 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.3 tp -59.97 -37.78 80.61 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.605 2.362 . . . . 2.53 109.532 165.711 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.9 -27.01 57.51 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 122.754 2.525 . . . . 2.08 110.192 -178.357 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.07 -77.38 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.739 1 N-CA-C 123.187 4.035 . . . . 1.31 123.187 176.297 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -72.59 157.51 37.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 129.266 3.568 . . . . 1.4 117.881 -174.694 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 3.3 m -105.11 133.88 49.15 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.944 2.497 . . . . 0.78 107.713 162.499 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 pt -113.18 143.88 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 101.584 -3.487 . . . . 1.55 101.584 176.319 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.3 m -99.85 128.65 45.93 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 114.753 -4.967 . . . . 1.08 104.159 174.397 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.7 mt -114.87 148.86 38.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.145 -3.472 . . . . 1.55 102.892 178.542 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -109.44 122.07 46.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.635 -1.987 . . . . 1.95 105.635 171.164 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.79 175.16 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-O 121.862 0.839 . . . . 0.96 111.136 -176.984 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.268 81.3 mt-10 -112.77 167.04 9.8 Favored Pre-proline 0 N--CA 1.431 -1.403 0 O-C-N 117.614 -3.178 . . . . 2.35 110.268 168.222 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -88.43 -8.75 5.27 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 CA-C-N 124.692 2.711 . . . . 0.95 110.513 -169.739 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 p -81.63 1.16 35.26 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 128.146 2.578 . . . . 1.45 115.897 172.958 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -77.52 137.74 38.79 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.058 -0.974 . . . . 1.69 108.507 175.25 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.3 p -79.29 156.36 28.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 128.198 2.599 . . . . 0.75 108.873 172.69 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.352 8.0 mm -61.64 -45.44 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 128.062 2.545 . . . . 0.73 114.764 -177.856 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.299 31.8 tt0 -48.83 -39.55 25.99 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 116.313 1.968 . . . . 1.62 116.313 167.292 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -73.55 -28.26 61.77 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 124.326 1.05 . . . . 2.13 111.575 179.793 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.2 t -69.06 -46.42 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 125.502 1.521 . . . . 0.62 109.262 171.297 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -62.21 -16.07 50.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 117.984 2.587 . . . . 1.22 117.984 176.878 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.82 -35.63 38.06 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 127.582 2.353 . . . . 0.51 109.574 171.465 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -70.02 -33.4 71.95 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.413 -1.429 . . . . 1.44 110.28 172.653 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.25 42.4 mt -63.63 -37.3 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 116.465 -3.897 . . . . 1.32 115.541 168.903 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.447 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 50.2 tt0 -69.62 -31.59 69.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 117.315 -1.326 . . . . 1.7 114.444 170.806 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.52 -45.48 65.47 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.393 1.451 . . . . 1.55 109.551 172.241 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -78.02 -64.78 1.08 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.049 -2.282 . . . . 2.62 114.41 -171.007 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.287 21.7 mm-40 -93.54 -45.78 7.59 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.716 1.246 . . . . 1.48 109.851 -172.745 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.88 64.15 0.34 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 106.067 -2.813 . . . . 1.12 106.067 167.069 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.447 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 8.8 mt -120.37 127.9 26.08 Favored Pre-proline 0 N--CA 1.43 -1.433 0 O-C-N 126.837 2.14 . . . . 1.55 111.448 -177.977 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -63.0 129.64 26.53 Favored 'Trans proline' 0 C--N 1.3 -2.023 1 CA-C-O 110.002 -4.249 . . . . 1.02 121.654 179.797 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -33.16 87.19 Favored 'Trans proline' 0 N--CA 1.434 -2.006 1 CA-C-N 129.243 4.337 . . . . 1.25 121.947 -175.142 . . . . . . . . 3 3 . 1 . 112 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -60.77 -37.81 83.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 125.243 3.656 . . . . 2.25 114.21 174.099 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -71.62 -28.05 63.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.107 -1.442 . . . . 2.02 107.107 -172.862 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -79.96 119.48 22.86 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.401 1.91 . . . . 0.69 115.382 -170.092 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.483 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 92.6 mtt180 -103.81 112.14 24.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 114.171 1.174 . . . . 2.78 114.171 166.821 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.6 mt -94.5 119.14 32.74 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.635 -3.166 . . . . 1.17 110.863 177.165 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.21 130.91 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 122.074 2.216 . . . . 1.38 108.152 174.484 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -118.3 114.94 23.72 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 102.953 -2.98 . . . . 1.5 102.953 171.445 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.383 . . 77.62 -63.9 0.32 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 125.961 2.791 . . . . 1.21 116.296 179.409 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.3 -60.66 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 127.213 2.339 . . . . 1.3 117.263 -172.55 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -68.26 125.41 26.31 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.971 2.908 . . . . 2.55 111.687 172.964 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -71.88 143.17 49.47 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 112.82 -1.991 . . . . 2.48 109.728 173.882 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.2 mt -80.05 128.57 33.65 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.875 1.67 . . . . 0.9 110.79 -178.04 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -86.07 148.31 25.77 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.445 -0.785 . . . . 1.94 109.107 176.002 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -59.41 -47.68 84.54 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 127.481 3.515 . . . . 1.56 117.16 -171.431 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.18 39.47 2.88 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 117.717 -3.114 . . . . 0.97 120.34 170.39 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.353 14.5 mmt180 -116.47 173.39 6.64 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 119.395 -0.922 . . . . 2.49 109.86 163.541 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.5 p -96.84 165.96 11.86 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 115.587 1.699 . . . . 0.76 115.587 168.754 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.0 mt -67.78 -32.55 73.2 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 123.04 1.4 . . . . 1.05 111.901 171.2 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.3 p -67.21 -16.19 64.15 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.256 -2.777 . . . . 1.19 112.895 174.909 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -69.81 -41.25 75.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 122.014 2.188 . . . . 1.9 115.236 177.467 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -90.35 -9.62 47.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.762 2.425 . . . . 0.89 109.724 -179.497 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.287 41.8 m-80 58.76 50.47 8.7 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 117.441 2.386 . . . . 1.84 117.441 -176.461 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.43 HG21 HD11 ' A' ' 67' ' ' LEU . 71.9 mt -86.42 118.2 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 126.409 3.004 . . . . 0.82 113.145 170.085 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -98.92 -178.16 3.86 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.638 -2.539 . . . . 2.16 111.277 -179.011 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -54.32 144.4 20.6 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.584 -2.573 . . . . 2.12 117.385 173.596 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.314 22.5 mt-10 66.66 27.39 9.44 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.737 -2.477 . . . . 1.71 117.068 174.825 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -101.09 153.46 19.55 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.232 -1.349 . . . . 1.04 108.877 -174.52 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.6 m -111.17 117.17 32.5 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.681 -3.137 . . . . 0.79 106.605 -175.125 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.43 HD11 HG21 ' A' ' 61' ' ' ILE . 7.7 mp -100.73 135.6 41.91 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.225 2.21 . . . . 1.4 106.047 176.798 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -99.57 117.44 33.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.403 -2.061 . . . . 1.51 110.178 -176.707 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.8 tp -86.96 119.44 27.17 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.465 3.506 . . . . 1.14 111.4 176.952 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 44.7 t -107.63 151.33 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 115.208 -2.33 . . . . 1.23 106.623 174.718 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.0 tp . . . . . 0 N--CA 1.43 -1.45 0 C-N-CA 115.26 -2.576 . . . . 2.78 107.465 179.667 . . . . . . . . 0 0 . 1 . 113 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 ttp . . . . . 0 CA--C 1.491 -1.318 0 CA-C-O 115.598 -2.144 . . . . 1.1 110.758 . . . . . . . . . 0 0 . 1 . 113 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.415 HE21 HG21 ' A' ' 14' ' ' THR . 29.0 mt-30 -90.9 132.36 35.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.766 2.53 . . . . 1.87 112.547 -178.36 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.1 pt -111.68 149.18 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 122.077 2.217 . . . . 0.72 110.543 172.282 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -108.95 115.52 30.24 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.919 -1.882 . . . . 1.4 105.919 178.694 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.427 HG21 HD11 ' A' ' 30' ' ' ILE . 77.5 t -100.34 120.0 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 115.179 -2.343 . . . . 0.58 105.017 175.885 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.251 89.1 mttt -101.79 130.59 48.26 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 116.893 -1.527 . . . . 2.09 106.892 176.489 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.2 p -82.57 170.62 14.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 120.418 1.463 . . . . 0.99 111.621 176.039 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.2 tp -79.62 -28.02 40.97 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 125.712 2.673 . . . . 2.53 111.535 170.277 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.296 38.9 p -75.5 -50.1 16.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.339 -3.35 . . . . 2.08 113.38 -177.195 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.15 32.2 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 122.75 3.86 . . . . 1.31 122.75 167.182 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -135.71 147.45 48.49 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 121.405 2.603 . . . . 1.4 112.043 -175.059 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.8 m -97.09 122.8 40.5 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.882 -1.508 . . . . 0.78 107.956 173.265 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.9 mt -117.28 115.93 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 103.939 -2.615 . . . . 1.55 103.939 -175.155 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.415 HG21 HE21 ' A' ' 2' ' ' GLN . 47.4 m -94.72 104.6 16.52 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.961 1.362 . . . . 1.08 114.226 179.52 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.6 mt -97.27 140.43 31.75 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 119.113 -2.242 . . . . 1.55 111.116 -176.425 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -91.3 115.43 28.02 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 115.538 -4.476 . . . . 1.95 113.236 165.118 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -133.3 152.61 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 126.773 2.546 . . . . 0.96 107.762 -179.189 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -90.71 153.67 45.62 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 115.859 -2.02 . . . . 2.35 110.843 163.452 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -84.07 0.91 9.07 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 CA-C-N 126.07 3.204 . . . . 0.95 116.473 -171.749 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.8 p -85.94 -14.79 43.66 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.614 3.166 . . . . 1.45 111.051 174.612 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.284 18.7 m-20 -82.34 156.02 24.46 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.102 2.161 . . . . 1.69 112.359 177.823 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 60.0 p -78.07 171.15 15.45 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 127.284 3.421 . . . . 0.75 116.759 175.35 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.443 HD13 ' HG ' ' A' ' 56' ' ' LEU . 14.4 mm -74.76 -27.75 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 1 O-C-N 114.968 -4.833 . . . . 0.73 111.524 174.415 . . . . . . . . 3 3 . 1 . 113 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -54.43 -41.34 69.25 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 125.652 1.581 . . . . 1.62 108.964 165.536 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.263 18.1 t-20 -60.71 -44.3 96.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 124.483 2.087 . . . . 2.13 113.423 175.539 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.08 -50.13 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 113.143 -1.844 . . . . 0.62 111.53 174.194 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.404 ' HD2' ' OD2' ' A' ' 52' ' ' ASP . 94.0 mttt -64.64 -41.57 96.05 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.332 2.345 . . . . 1.22 117.332 174.588 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.99 -45.15 41.84 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.158 2.183 . . . . 0.51 115.431 168.375 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -62.72 -39.61 94.61 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 116.182 1.919 . . . . 1.44 116.182 170.652 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.427 HD11 HG21 ' A' ' 5' ' ' VAL 0.257 21.2 mt -63.51 -25.82 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 C-N-CA 125.296 1.438 . . . . 1.32 112.57 173.155 . . . . . . . . 3 3 . 1 . 113 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -77.61 -35.55 52.64 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.561 -0.745 . . . . 1.7 112.58 174.307 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.36 -44.14 95.85 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.139 1.447 . . . . 1.55 113.378 167.975 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -73.29 -66.65 0.66 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 119.783 3.253 . . . . 2.62 119.783 -176.821 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -95.14 -48.6 5.87 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 128.377 2.671 . . . . 1.48 110.348 -174.725 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.91 -10.82 6.64 Favored Glycine 0 N--CA 1.43 -1.757 0 O-C-N 127.049 2.718 . . . . 1.12 117.104 173.362 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mm -71.68 132.19 85.48 Favored Pre-proline 0 N--CA 1.43 -1.428 0 O-C-N 119.367 -2.255 . . . . 1.55 109.178 -173.271 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 43.2 Cg_endo -68.36 151.61 76.04 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 O-C-N 117.343 -1.978 . . . . 1.02 115.117 178.802 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -62.79 -25.49 74.74 Favored 'Trans proline' 0 N--CA 1.433 -2.035 1 C-N-CA 126.68 4.92 . . . . 1.25 112.703 -173.525 . . . . . . . . 4 4 . 1 . 113 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.85 -42.54 98.01 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 129.446 3.098 . . . . 2.25 108.38 -179.296 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -78.97 -22.72 45.21 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 117.469 2.396 . . . . 2.02 117.469 -177.998 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -85.89 129.0 34.96 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.205 1.479 . . . . 0.69 110.221 -169.567 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.43 ' HB2' HG23 ' A' ' 70' ' ' VAL . 92.2 mtt180 -116.29 117.33 29.71 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 125.156 2.407 . . . . 2.78 110.103 173.289 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.6 mt -96.27 128.16 42.93 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 114.336 -5.227 . . . . 1.17 105.936 179.098 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.447 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 15.3 mm -107.26 141.36 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 103.095 -2.928 . . . . 1.38 103.095 178.649 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.452 ' HB3' HD21 ' A' ' 50' ' ' LEU 0.296 26.1 t80 -140.58 109.46 6.04 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.53 1.932 . . . . 1.5 108.137 176.894 . . . . . . . . 3 3 . 1 . 113 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.371 . . 64.8 -75.46 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.51 2.324 . . . . 1.21 112.079 -172.101 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -137.44 -34.97 0.19 Allowed Glycine 0 N--CA 1.429 -1.824 0 O-C-N 123.999 0.812 . . . . 1.3 114.686 178.847 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -89.44 150.78 22.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.221 1.934 . . . . 2.55 116.221 -176.077 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -84.71 127.34 34.05 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 111.903 -2.408 . . . . 2.48 112.183 174.552 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 45' ' ' PHE . 39.1 mt -81.91 148.44 28.75 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 121.057 1.753 . . . . 0.9 112.492 -168.548 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -98.27 148.67 23.39 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 118.605 -1.238 . . . . 1.94 113.697 179.765 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.404 ' OD2' ' HD2' ' A' ' 27' ' ' LYS . 4.6 m-20 -60.69 -66.62 0.5 Allowed 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 116.197 -4.064 . . . . 1.56 117.288 -170.962 . . . . . . . . 3 3 . 1 . 113 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.27 32.25 0.32 Allowed Glycine 0 N--CA 1.432 -1.632 0 N-CA-C 122.607 3.803 . . . . 0.97 122.607 172.977 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -115.24 161.97 17.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.469 -2.049 . . . . 2.49 105.469 166.026 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 26.7 p -81.23 158.65 24.77 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.707 -1.871 . . . . 0.76 113.767 175.279 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.443 ' HG ' HD13 ' A' ' 23' ' ' ILE . 5.1 mt -65.78 -24.8 67.01 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.277 2.231 . . . . 1.05 114.591 175.757 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.4 p -83.46 -11.28 57.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.9 2.48 . . . . 1.19 111.467 178.667 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -61.85 -55.83 25.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.483 3.113 . . . . 1.9 108.089 167.26 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -76.81 -13.59 60.0 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 130.13 4.643 . . . . 0.89 113.713 -176.236 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 57.23 64.67 1.55 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 116.678 2.103 . . . . 1.84 116.678 -176.059 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.8 mm -78.54 104.53 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 105.549 -2.019 . . . . 0.82 105.549 174.892 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -73.32 169.94 16.07 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.056 1.342 . . . . 2.16 112.64 175.418 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -55.66 136.3 50.68 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.188 -3.445 . . . . 2.12 112.822 163.115 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 70.3 38.83 1.35 Allowed 'General case' 0 N--CA 1.429 -1.49 1 C-N-CA 135.946 5.698 . . . . 1.71 112.686 175.65 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.6 m -90.73 142.26 27.94 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 116.657 2.095 . . . . 1.04 116.657 -172.595 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.7 m -100.25 116.61 32.65 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 126.169 2.168 . . . . 0.79 107.224 -178.399 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -100.62 152.67 20.16 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.352 1.549 . . . . 1.4 111.362 168.875 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.447 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 33.8 m80 -120.93 130.53 53.9 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.086 -2.259 . . . . 1.51 107.511 -174.218 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 tp -112.14 118.2 34.7 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 116.574 2.064 . . . . 1.14 116.574 177.924 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.43 HG23 ' HB2' ' A' ' 42' ' ' ARG . 6.6 m -112.77 172.08 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 103.325 -2.843 . . . . 1.23 103.325 173.1 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.255 10.8 mt . . . . . 0 N--CA 1.43 -1.464 0 CA-C-N 113.857 -1.52 . . . . 2.78 112.428 178.111 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 ptt? . . . . . 0 CA--C 1.489 -1.372 0 CA-C-O 116.273 -1.822 . . . . 1.1 111.64 . . . . . . . . . 0 0 . 1 . 114 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -99.6 138.85 36.11 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 125.214 1.571 . . . . 1.87 109.824 -173.49 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.5 pt -123.28 160.81 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 128.37 3.938 . . . . 0.72 108.281 173.641 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -119.07 133.22 55.93 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 115.195 -4.69 . . . . 1.4 106.61 -176.556 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.97 119.48 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 106.204 -1.776 . . . . 0.58 106.204 175.973 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -106.34 133.94 50.25 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 115.79 -4.318 . . . . 2.09 111.354 178.568 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.1 p -89.19 178.99 6.22 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.452 -2.03 . . . . 0.99 115.599 -174.144 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.404 HD11 ' H ' ' A' ' 71' ' ' LEU . 5.8 mt -78.11 -22.42 48.94 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 121.727 2.058 . . . . 2.53 109.985 173.379 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.3 p -80.54 -36.27 33.3 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.357 -2.714 . . . . 2.08 109.666 -178.921 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.67 53.82 0.66 Allowed Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 130.088 3.709 . . . . 1.31 119.824 175.957 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -122.74 137.24 54.98 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.102 3.361 . . . . 1.4 105.005 -176.696 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.8 m -105.68 121.54 44.21 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-O 124.42 2.057 . . . . 0.78 108.46 179.823 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.5 mt -99.32 140.5 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.357 -2.714 . . . . 1.55 107.882 174.852 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.8 m -106.75 98.61 8.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.096 -2.252 . . . . 1.08 110.835 -178.606 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.7 mt -95.18 140.84 29.53 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 121.521 1.964 . . . . 1.55 112.933 179.942 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -97.29 134.41 40.62 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.989 -2.319 . . . . 1.95 109.16 169.772 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 m -138.87 156.66 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 127.042 2.137 . . . . 0.96 107.063 -174.141 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -106.37 160.75 25.11 Favored Pre-proline 0 N--CA 1.43 -1.446 0 O-C-N 118.197 -2.815 . . . . 2.35 107.317 162.671 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -71.25 -7.85 22.19 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 CA-C-N 124.394 2.605 . . . . 0.95 112.235 -172.136 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.3 p -93.89 -14.37 26.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.037 2.135 . . . . 1.45 111.894 -174.141 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -65.39 149.29 50.26 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 130.16 3.384 . . . . 1.69 105.635 174.246 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.509 HG22 HG22 ' A' ' 55' ' ' THR . 68.6 p -96.44 170.93 8.89 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 117.235 -1.364 . . . . 0.75 111.097 178.568 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.404 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 32.7 mm -62.16 -32.6 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.413 0 C-N-CA 126.658 1.983 . . . . 0.73 111.366 170.508 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.295 35.5 tt0 -54.15 -51.35 64.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.581 3.552 . . . . 1.62 108.86 169.453 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -57.22 -37.69 72.63 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.557 -2.59 . . . . 2.13 114.918 174.354 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 88.3 t -62.79 -44.82 99.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 114.803 1.408 . . . . 0.62 114.803 175.091 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -65.86 -30.2 70.78 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 129.539 3.136 . . . . 1.22 113.465 173.451 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.19 83.18 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.864 -3.648 . . . . 0.51 111.101 179.738 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -61.96 -42.37 99.04 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.529 -3.232 . . . . 1.44 115.203 174.0 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.1 mt -72.95 -23.75 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 123.439 1.59 . . . . 1.32 110.513 175.995 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -70.12 -35.01 73.8 Favored 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 114.517 -5.114 . . . . 1.7 112.623 169.559 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.69 -48.7 78.16 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.783 2.706 . . . . 1.55 112.558 175.412 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -82.55 -63.04 1.45 Allowed 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 114.406 -5.184 . . . . 2.62 114.88 -178.975 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -85.49 -15.4 42.95 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.948 -3.595 . . . . 1.48 116.918 -168.658 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.37 31.45 54.61 Favored Glycine 0 N--CA 1.429 -1.776 0 O-C-N 119.725 -1.859 . . . . 1.12 114.617 176.543 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mt -101.25 135.43 19.89 Favored Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 108.452 -0.944 . . . . 1.55 108.452 -173.702 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -68.1 151.26 77.44 Favored 'Trans proline' 0 N--CA 1.433 -2.03 0 CA-C-N 123.884 2.423 . . . . 1.02 111.608 179.901 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -73.17 -20.63 21.27 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-N 126.515 3.362 . . . . 1.25 111.242 -173.478 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -65.7 -29.99 70.61 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 126.191 2.9 . . . . 2.25 112.805 174.463 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -81.74 -25.7 35.15 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 114.667 -5.021 . . . . 2.02 107.944 -177.566 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -82.92 119.3 24.24 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.839 -2.413 . . . . 0.69 110.991 -169.775 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.358 80.2 mtp180 -108.18 124.98 51.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.519 -1.219 . . . . 2.78 110.229 163.942 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -107.2 116.73 32.44 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.431 2.539 . . . . 1.17 104.554 -177.771 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.3 mt -111.44 137.28 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 O-C-N 119.939 -1.726 . . . . 1.38 112.982 176.552 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -148.98 132.67 16.87 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 124.15 0.98 . . . . 1.5 111.089 174.249 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.354 . . 49.38 25.03 1.18 Allowed 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 120.256 3.428 . . . . 1.21 120.256 171.199 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.11 7.55 26.73 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 121.477 -0.765 . . . . 1.3 114.591 -177.881 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -149.0 153.53 38.06 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.442 -2.799 . . . . 2.55 110.632 -176.813 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -96.64 128.34 43.48 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 113.912 -1.495 . . . . 2.48 111.662 171.224 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.2 mt -81.49 121.21 25.99 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.648 2.468 . . . . 0.9 115.691 -174.593 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -73.72 137.32 43.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.094 2.627 . . . . 1.94 118.094 177.098 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -40.27 -64.49 0.5 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 131.431 3.892 . . . . 1.56 117.397 -171.319 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.31 16.64 12.5 Favored Glycine 0 N--CA 1.429 -1.798 1 CA-C-O 112.011 -4.772 . . . . 0.97 118.745 175.275 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.0 mtt180 -95.46 161.56 14.02 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 121.155 2.478 . . . . 2.49 110.163 171.632 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.509 HG22 HG22 ' A' ' 22' ' ' THR . 19.3 p -97.56 170.63 8.9 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 117.179 -1.809 . . . . 0.76 114.596 172.94 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.85 -39.79 82.36 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.274 -2.239 . . . . 1.05 111.828 176.506 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.3 t -61.75 -44.24 97.29 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 130.118 3.367 . . . . 1.19 113.56 175.067 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -59.57 -24.83 64.08 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 115.224 1.565 . . . . 1.9 115.224 174.201 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -106.36 9.45 31.85 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.069 -2.895 . . . . 0.89 112.601 175.08 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.6 m120 44.68 62.77 1.93 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 128.163 2.585 . . . . 1.84 114.155 -177.579 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.7 mt -108.35 127.55 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 129.398 3.079 . . . . 0.82 107.183 176.511 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -106.71 -174.11 2.46 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.541 2.336 . . . . 2.16 110.979 -172.978 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.2 ptmm? -61.2 148.16 41.81 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 114.73 1.382 . . . . 2.12 114.73 174.811 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 62.75 37.89 12.21 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 126.51 3.053 . . . . 1.71 112.921 169.957 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.7 m -84.03 133.06 34.68 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.924 2.297 . . . . 1.04 110.665 178.079 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.7 m -93.39 104.82 16.95 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.202 -2.186 . . . . 0.79 109.3 176.344 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.6 mt -88.1 147.38 24.97 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 123.184 0.593 . . . . 1.4 110.066 174.296 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -97.68 121.52 39.69 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 116.917 -1.516 . . . . 1.51 113.815 173.622 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.9 tp -91.01 111.97 23.66 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.591 2.756 . . . . 1.14 108.491 175.942 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.7 t -112.11 141.83 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 114.579 -1.192 . . . . 1.23 109.151 172.156 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.404 ' H ' HD11 ' A' ' 8' ' ' LEU . 64.4 mt . . . . . 0 N--CA 1.429 -1.504 0 N-CA-C 119.61 3.189 . . . . 2.78 119.61 179.639 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ptt? . . . . . 0 CA--C 1.489 -1.371 0 N-CA-C 112.624 0.601 . . . . 1.1 112.624 . . . . . . . . . 0 0 . 1 . 115 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.338 0.0 OUTLIER -97.83 133.72 41.95 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.129 -1.607 . . . . 1.87 111.446 179.286 . . . . . . . . 3 3 . 1 . 115 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.3 pt -115.74 158.88 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 103.637 -2.727 . . . . 0.72 103.637 169.74 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -112.34 137.89 49.85 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.452 2.701 . . . . 1.4 107.302 178.92 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.9 t -118.15 123.15 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 102.226 -3.25 . . . . 0.58 102.226 174.291 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.7 tppt? -100.36 126.96 46.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 126.144 2.878 . . . . 2.09 105.33 175.687 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 p -78.3 -162.91 0.39 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 120.253 3.427 . . . . 0.99 120.253 173.463 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 mt -88.31 -34.73 17.56 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 117.294 -1.336 . . . . 2.53 112.831 173.66 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 p -68.38 -32.74 73.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 127.536 2.334 . . . . 2.08 106.999 173.266 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.67 35.29 2.26 Favored Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 127.592 2.52 . . . . 1.31 107.744 168.367 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -80.57 134.36 35.91 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.258 -2.867 . . . . 1.4 103.258 178.876 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.9 m -95.02 91.49 6.39 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.855 -1.521 . . . . 0.78 114.341 175.042 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.4 mt -88.38 119.13 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 123.848 1.785 . . . . 1.55 106.714 -175.449 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.1 m -90.44 126.88 36.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.062 -2.273 . . . . 1.08 110.37 -177.268 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.5 mt -128.18 134.12 49.0 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.221 -3.424 . . . . 1.55 106.246 -175.238 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -98.15 132.24 43.84 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.615 -1.624 . . . . 1.95 106.615 171.87 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 m -140.61 164.79 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 126.962 2.105 . . . . 0.96 109.621 -173.938 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -109.58 151.92 42.5 Favored Pre-proline 0 N--CA 1.43 -1.454 0 CA-C-O 114.486 -2.673 . . . . 2.35 112.651 160.373 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 96.4 Cg_endo -70.52 -14.93 34.14 Favored 'Trans proline' 0 N--CA 1.433 -2.058 0 C-N-CA 125.09 3.86 . . . . 0.95 109.715 -165.29 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.1 m -82.93 -9.95 59.05 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 122.346 2.339 . . . . 1.45 108.974 176.919 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -66.74 142.5 57.37 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.443 3.497 . . . . 1.69 112.43 172.732 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 p -83.19 171.58 13.51 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 113.121 -5.987 . . . . 0.75 110.142 -174.632 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.1 mm -75.57 -30.55 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 122.949 1.357 . . . . 0.73 109.783 179.098 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.253 38.2 tt0 -45.34 -42.85 10.38 Favored 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 117.977 -2.952 . . . . 1.62 117.49 157.925 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -68.35 -38.52 81.55 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 125.336 1.648 . . . . 2.13 110.968 176.49 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.1 t -62.67 -35.28 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 125.156 2.408 . . . . 0.62 115.094 177.844 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HD3' ' HB2' ' A' ' 41' ' ' GLN . 90.1 mttt -68.31 -38.42 81.58 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.163 -1.586 . . . . 1.22 115.093 166.269 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.68 -22.42 66.63 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 118.465 2.765 . . . . 0.51 118.465 169.796 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -84.45 -29.48 26.06 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.675 -1.891 . . . . 1.44 111.901 173.947 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.8 mt -70.49 -38.06 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 124.164 1.935 . . . . 1.32 114.752 170.662 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.45 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 10.8 tt0 -65.51 -42.53 91.96 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 128.208 2.603 . . . . 1.7 109.66 171.926 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -58.09 -52.48 65.35 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.348 -3.345 . . . . 1.55 113.116 172.469 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -64.09 -66.32 0.56 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.618 3.58 . . . . 2.62 111.818 -176.179 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -89.84 -44.59 9.84 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 110.654 -2.976 . . . . 1.48 112.956 -172.119 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 113.42 0.69 24.89 Favored Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 117.649 1.82 . . . . 1.12 117.649 -177.899 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 mt -68.49 121.26 80.08 Favored Pre-proline 0 N--CA 1.429 -1.488 0 O-C-N 118.77 -2.606 . . . . 1.55 107.003 -176.549 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -67.88 164.68 30.7 Favored 'Trans proline' 0 N--CA 1.434 -1.989 1 C-N-CA 125.739 4.293 . . . . 1.02 112.126 -176.459 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -67.45 -34.16 27.2 Favored 'Trans proline' 0 N--CA 1.433 -2.05 1 C-N-CA 125.758 4.305 . . . . 1.25 113.173 -175.223 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -44.17 -48.94 9.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 126.604 3.097 . . . . 2.25 114.211 173.762 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -83.98 -17.0 41.99 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.146 -2.846 . . . . 2.02 115.951 -170.93 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.407 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 79.1 mt-30 -85.49 134.29 34.05 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.439 1.896 . . . . 0.69 111.218 -168.875 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -121.14 114.64 21.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 130.388 3.475 . . . . 2.78 108.606 167.467 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.4 mt -88.9 116.97 27.57 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.627 -1.921 . . . . 1.17 112.578 173.866 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.6 mm -106.4 141.1 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 102.652 -3.092 . . . . 1.38 102.652 -178.431 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -132.24 97.58 4.16 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 100.378 -3.934 . . . . 1.5 100.378 174.976 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.36 . . 79.5 -86.62 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.096 2.159 . . . . 1.21 106.858 -179.309 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.57 -6.55 1.8 Allowed Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 128.668 3.032 . . . . 1.3 111.179 -178.017 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -92.87 131.1 38.2 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.403 2.681 . . . . 2.55 109.135 -177.114 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -81.66 114.59 20.44 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 112.364 -2.198 . . . . 2.48 110.776 175.234 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.8 mt -83.23 148.62 27.3 Favored 'General case' 0 N--CA 1.431 -1.407 1 O-C-N 115.198 -4.689 . . . . 0.9 112.267 -174.521 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -100.3 149.36 23.68 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.499 1.919 . . . . 1.94 113.291 172.852 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -61.67 -61.15 2.72 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 130.49 3.516 . . . . 1.56 112.222 -169.525 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.82 20.52 0.2 Allowed Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 122.285 3.674 . . . . 0.97 122.285 171.705 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -107.67 154.13 21.92 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.135 -1.803 . . . . 2.49 113.042 167.02 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.3 p -94.21 168.45 10.91 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.805 2.891 . . . . 0.76 118.805 177.999 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 56.4 mt -62.77 -43.05 99.82 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.887 -1.758 . . . . 1.05 109.916 174.316 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 t -55.36 -43.66 75.27 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 120.342 3.46 . . . . 1.19 120.342 174.719 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -54.45 -42.2 70.34 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 128.287 2.635 . . . . 1.9 110.87 177.687 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -95.03 11.39 32.2 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 115.289 1.589 . . . . 0.89 115.289 -178.65 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 52.45 50.0 19.22 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 129.038 2.935 . . . . 1.84 110.98 -177.798 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.0 mt -91.94 114.19 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 N-CA-C 106.621 -1.622 . . . . 0.82 106.621 -179.068 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -94.16 -170.67 2.35 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 125.197 2.427 . . . . 2.16 109.494 -177.153 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.321 17.8 pttp -67.39 150.82 48.44 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 111.695 -2.502 . . . . 2.12 117.416 168.769 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.343 17.2 mt-10 68.38 9.52 7.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.942 2.201 . . . . 1.71 116.942 170.156 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.3 t -94.36 138.76 31.94 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 131.034 3.734 . . . . 1.04 107.855 -175.82 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.2 m -85.99 122.95 30.74 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 115.969 1.84 . . . . 0.79 115.969 179.225 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mp -99.78 157.45 16.49 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 101.472 -3.529 . . . . 1.4 101.472 169.674 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -121.04 117.27 26.81 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 113.995 1.109 . . . . 1.51 113.995 179.956 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.7 tp -88.85 110.37 21.0 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.413 2.054 . . . . 1.14 113.185 -178.713 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.7 t -107.04 147.82 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 117.981 -2.949 . . . . 1.23 106.124 171.605 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.0 mt . . . . . 0 N--CA 1.43 -1.435 0 O-C-N 119.159 -2.213 . . . . 2.78 109.437 -179.532 . . . . . . . . 0 0 . 1 . 116 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 119.322 -0.37 . . . . 1.1 110.208 . . . . . . . . . 0 0 . 1 . 116 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -102.7 132.42 48.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.66 -2.525 . . . . 1.87 106.83 -179.249 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.0 pt -132.42 167.02 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-O 116.376 -1.773 . . . . 0.72 108.001 173.923 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -124.1 149.08 46.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 122.349 2.34 . . . . 1.4 115.282 176.75 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 t -128.42 119.48 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 102.858 -3.016 . . . . 0.58 102.858 171.024 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -109.82 129.1 55.67 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 111.329 -2.669 . . . . 2.09 109.595 176.258 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 p -89.89 -173.87 4.05 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 126.546 3.069 . . . . 0.99 109.205 178.555 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.6 mt -91.48 3.66 54.43 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.678 -3.764 . . . . 2.53 117.739 169.51 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.2 p -76.6 -31.14 57.27 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.861 2.465 . . . . 2.08 108.578 177.899 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.22 -29.35 3.69 Favored Glycine 0 N--CA 1.43 -1.739 1 N-CA-C 102.78 -4.128 . . . . 1.31 102.78 179.904 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -63.58 131.21 47.33 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.406 2.002 . . . . 1.4 116.406 -170.898 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.9 m -102.1 117.48 34.89 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.345 -1.298 . . . . 0.78 108.895 169.112 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.283 7.7 mt -103.83 109.69 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 129.047 2.939 . . . . 1.55 106.243 -177.2 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.6 m -83.36 131.6 35.05 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.479 1.133 . . . . 1.08 110.21 177.559 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.3 mt -134.06 140.56 46.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.037 -2.289 . . . . 1.55 108.61 -175.759 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -84.3 124.14 30.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.487 2.715 . . . . 1.95 108.583 174.175 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.344 4.1 m -134.42 149.3 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 O-C-N 118.353 -2.717 . . . . 0.96 113.258 -176.423 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -95.73 141.72 23.57 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 115.233 -2.318 . . . . 2.35 105.331 165.291 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -81.98 -15.54 9.22 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 CA-C-N 126.484 3.351 . . . . 0.95 111.512 -167.899 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.8 m -71.56 -11.78 61.03 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 120.734 -1.229 . . . . 1.45 114.08 174.948 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -67.49 159.04 30.47 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.471 2.082 . . . . 1.69 112.235 177.455 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.6 p -87.12 177.37 7.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.323 -2.736 . . . . 0.75 109.1 -177.699 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.1 mt -84.12 -24.0 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 1 O-C-N 114.307 -5.246 . . . . 0.73 114.899 171.671 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.08 -28.39 69.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.153 1.908 . . . . 1.62 116.153 163.049 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -73.29 -36.27 66.26 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 121.221 1.828 . . . . 2.13 111.888 173.889 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.8 t -63.01 -48.8 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 128.504 2.722 . . . . 0.62 114.243 176.421 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -57.91 -33.96 69.32 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.633 2.086 . . . . 1.22 116.633 176.353 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.21 -24.16 67.75 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.227 1.936 . . . . 0.51 116.227 169.827 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -72.86 -31.66 64.89 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 126.397 2.999 . . . . 1.44 116.355 172.947 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.5 mm -68.37 -27.95 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 O-C-N 117.678 -3.139 . . . . 1.32 106.702 169.758 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.424 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 41.6 tt0 -71.49 -39.0 71.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.924 -2.36 . . . . 1.7 112.277 172.283 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -63.04 -41.43 99.51 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 118.227 2.677 . . . . 1.55 118.227 171.603 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -83.96 -58.16 2.9 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.824 2.05 . . . . 2.62 111.941 -174.878 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -97.99 -42.64 7.42 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.491 1.516 . . . . 1.48 109.698 -173.905 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 94.62 57.33 1.27 Allowed Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 128.142 2.782 . . . . 1.12 111.899 179.387 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.1 mt -115.23 122.31 33.47 Favored Pre-proline 0 N--CA 1.431 -1.423 0 N-CA-C 101.927 -3.36 . . . . 1.55 101.927 -177.957 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -66.94 149.29 82.99 Favored 'Trans proline' 0 C--N 1.3 -2.024 1 CA-C-O 108.871 -4.72 . . . . 1.02 108.283 -174.134 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -66.48 -8.54 21.13 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 CA-C-N 127.15 3.589 . . . . 1.25 116.496 -174.645 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.95 -35.16 62.14 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.234 1.969 . . . . 2.25 115.134 175.771 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -81.11 -15.68 55.24 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.214 -3.429 . . . . 2.02 111.753 -177.573 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -70.65 116.49 11.02 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.649 1.98 . . . . 0.69 112.875 -175.202 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.409 ' HB2' HG23 ' A' ' 70' ' ' VAL . 64.2 mtt180 -106.35 124.84 50.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.885 -3.009 . . . . 2.78 105.537 175.561 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.0 tp -112.46 125.58 54.38 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 123.987 1.851 . . . . 1.17 107.085 -175.674 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.1 mm -114.74 125.99 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 O-C-N 120.283 -1.511 . . . . 1.38 110.01 -175.733 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -138.22 118.73 13.86 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.987 -1.857 . . . . 1.5 105.987 171.512 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.6 35.99 1.75 Allowed 'General case' 0 N--CA 1.431 -1.421 1 CA-C-O 129.417 4.437 . . . . 1.21 115.946 175.195 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.29 -21.47 28.28 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 110.423 -3.081 . . . . 1.3 115.052 -175.925 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -100.43 148.38 24.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.138 2.273 . . . . 2.55 117.138 -178.524 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -76.49 119.33 20.19 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 129.901 3.281 . . . . 2.48 109.43 169.819 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.514 HD22 ' CG ' ' A' ' 59' ' ' TYR . 20.5 mt -85.92 147.04 26.43 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.675 2.179 . . . . 0.9 116.85 -177.073 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -92.21 136.65 33.02 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 117.382 -3.324 . . . . 1.94 115.087 176.297 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -66.1 -42.54 89.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.884 -3.01 . . . . 1.56 116.258 -173.19 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.88 -13.95 62.39 Favored Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 125.32 1.438 . . . . 0.97 116.673 169.317 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -77.99 160.55 28.1 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 121.027 2.414 . . . . 2.49 112.306 174.115 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.261 60.8 p -91.15 159.5 16.05 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 116.41 -3.931 . . . . 0.76 110.805 177.331 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mt -70.05 -26.25 63.94 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.285 -1.78 . . . . 1.05 110.095 179.852 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.5 p -77.07 -30.85 55.66 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.079 2.552 . . . . 1.19 111.799 176.527 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.284 3.5 t70 -60.89 -43.18 98.83 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.051 -3.53 . . . . 1.9 114.31 172.35 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.514 ' CG ' HD22 ' A' ' 50' ' ' LEU . 35.6 m-85 -85.27 -6.0 59.28 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 116.743 -1.599 . . . . 0.89 113.293 170.734 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.37 55.6 t30 68.9 50.54 0.61 Allowed 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 123.455 2.843 . . . . 1.84 113.11 175.79 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.46 HD13 HD21 ' A' ' 67' ' ' LEU . 68.2 mt -100.42 124.11 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 105.605 -1.998 . . . . 0.82 105.605 176.169 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -110.82 -173.1 2.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 129.337 3.055 . . . . 2.16 113.504 -177.832 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.314 26.2 tttm -46.4 124.05 5.43 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.961 2.505 . . . . 2.12 112.726 174.568 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.399 44.1 mt-10 61.9 43.16 9.53 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.235 3.014 . . . . 1.71 117.522 174.203 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 t -99.36 153.41 19.0 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.527 2.108 . . . . 1.04 109.876 -175.424 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.287 11.8 m -97.25 107.41 19.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.721 -1.862 . . . . 0.79 113.81 178.465 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.46 HD21 HD13 ' A' ' 61' ' ' ILE . 50.8 mt -88.34 139.8 30.12 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.414 -1.328 . . . . 1.4 107.414 170.196 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -107.38 133.55 51.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 124.628 1.205 . . . . 1.51 109.069 -177.972 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.329 36.9 tp -111.33 121.1 44.36 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 127.161 2.788 . . . . 1.14 109.473 -178.802 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.409 HG23 ' HB2' ' A' ' 42' ' ' ARG . 9.9 m -117.78 164.99 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 116.923 -1.513 . . . . 1.23 111.03 168.787 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.6 mt . . . . . 0 N--CA 1.431 -1.402 0 CA-C-N 122.223 2.283 . . . . 2.78 113.972 176.19 . . . . . . . . 0 0 . 1 . 117 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 114.926 1.454 . . . . 1.1 114.926 . . . . . . . . . 0 0 . 1 . 117 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -101.39 112.77 25.39 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.226 1.81 . . . . 1.87 107.537 -179.504 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -100.42 174.43 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 127.168 2.187 . . . . 0.72 114.183 166.908 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -123.83 141.37 52.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.969 -2.332 . . . . 1.4 110.869 -175.0 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.0 t -106.03 119.37 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 118.026 -2.921 . . . . 0.58 112.372 166.676 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -98.37 119.14 36.54 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 116.468 -3.895 . . . . 2.09 108.716 176.723 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p -73.57 173.26 9.96 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.601 -3.187 . . . . 0.99 119.599 174.036 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.2 mt -53.41 -54.06 42.28 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 118.157 2.651 . . . . 2.53 118.157 170.401 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.4 p -69.23 -24.59 64.03 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 126.393 2.308 . . . . 2.08 111.015 -177.748 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.21 38.07 0.97 Allowed Glycine 0 N--CA 1.43 -1.712 0 O-C-N 119.526 -1.984 . . . . 1.31 112.707 170.25 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -109.98 131.07 55.39 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.867 -3.137 . . . . 1.4 107.023 -173.149 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -89.68 106.62 18.58 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.857 2.063 . . . . 0.78 114.316 177.841 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.4 mt -104.99 120.37 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 103.502 -2.777 . . . . 1.55 103.502 -178.128 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -86.33 132.95 33.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.761 -1.109 . . . . 1.08 111.978 178.971 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.3 mt -136.53 132.9 35.87 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 115.208 -2.33 . . . . 1.55 114.893 -175.698 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -84.39 114.32 21.81 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 131.258 3.823 . . . . 1.95 111.48 173.974 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.5 m -140.77 167.1 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-O 125.097 2.38 . . . . 0.96 106.131 178.763 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -121.07 158.28 53.08 Favored Pre-proline 0 N--CA 1.431 -1.425 0 O-C-N 118.518 -2.613 . . . . 2.35 111.571 168.26 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -59.14 -16.53 33.95 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 O-C-N 111.538 -5.032 . . . . 0.95 116.41 -176.45 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.7 p -79.14 -5.29 53.82 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.086 1.513 . . . . 1.45 115.086 171.691 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.27 46.5 m-20 -76.93 142.62 40.0 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.779 -1.201 . . . . 1.69 109.743 -178.395 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.3 p -86.35 161.08 18.89 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.073 -1.084 . . . . 0.75 108.073 179.761 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.447 HG23 HD12 ' A' ' 43' ' ' LEU . 27.8 mm -58.03 -42.24 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 122.324 1.059 . . . . 0.73 110.727 176.291 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -37.66 -54.01 1.21 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 119.142 3.015 . . . . 1.62 119.142 160.864 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -55.77 -41.9 74.72 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.591 2.756 . . . . 2.13 113.315 176.905 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.6 t -61.66 -50.96 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 126.282 1.833 . . . . 0.62 111.742 173.55 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.4 mttt -61.47 -27.9 68.9 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.458 -3.276 . . . . 1.22 118.237 175.248 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.53 -27.57 64.27 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.56 2.124 . . . . 0.51 113.943 178.0 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -76.47 -36.51 57.82 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.803 -2.436 . . . . 1.44 112.479 176.044 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.56 -30.05 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.908 -1.496 . . . . 1.32 114.808 161.574 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -68.6 -33.36 73.91 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.448 1.476 . . . . 1.7 113.627 179.003 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -78.3 -53.85 6.85 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 117.235 -1.786 . . . . 1.55 115.092 166.354 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -59.19 -43.51 92.19 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 115.153 -2.356 . . . . 2.62 117.309 -174.925 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -108.14 -26.65 10.51 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 126.702 2.501 . . . . 1.48 110.524 -172.713 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.52 48.89 3.83 Favored Glycine 0 N--CA 1.43 -1.767 0 O-C-N 119.987 -1.695 . . . . 1.12 111.914 171.212 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.4 mt -128.57 125.37 23.11 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-O 115.622 -2.133 . . . . 1.55 109.822 -177.876 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 75.5 Cg_exo -66.85 148.76 82.92 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-N 125.484 2.994 . . . . 1.02 114.094 178.16 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 52.1 Cg_exo -69.33 -14.1 36.85 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 N-CA-C 116.63 1.742 . . . . 1.25 116.63 -170.933 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.56 -29.67 70.75 Favored 'General case' 0 N--CA 1.43 -1.449 1 C-N-CA 132.514 4.326 . . . . 2.25 109.029 169.788 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -90.87 -31.1 16.56 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.482 1.66 . . . . 2.02 115.482 -178.697 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.281 77.4 mt-30 -81.08 134.3 35.63 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.856 -1.164 . . . . 0.69 107.856 -175.012 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -121.15 133.4 55.2 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.914 -2.991 . . . . 2.78 105.98 168.898 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 43' ' ' LEU . 98.2 mt -98.01 126.49 43.46 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 105.781 -1.933 . . . . 1.17 105.781 -177.905 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 mm -110.84 138.86 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-N 122.466 2.393 . . . . 1.38 104.616 -178.407 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -144.48 130.15 19.11 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 106.376 -1.713 . . . . 1.5 106.376 163.49 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.05 24.78 14.86 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 120.381 3.474 . . . . 1.21 120.381 177.771 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.86 -18.51 57.39 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 115.72 -2.711 . . . . 1.3 108.439 -179.785 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -101.22 156.72 17.27 Favored 'General case' 0 N--CA 1.431 -1.422 1 CA-C-N 124.847 4.323 . . . . 2.55 111.028 177.382 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.291 39.9 tt0 -96.74 144.57 26.61 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.858 2.742 . . . . 2.48 107.95 175.185 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.6 mt -92.45 148.09 22.38 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.472 -3.268 . . . . 0.9 109.129 -178.727 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -92.93 144.45 25.25 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 130.611 3.564 . . . . 1.94 112.813 -179.522 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -63.64 -54.91 28.34 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.284 -3.385 . . . . 1.56 115.665 -167.479 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.86 42.36 3.05 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-O 123.299 1.5 . . . . 0.97 115.51 173.036 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -110.43 152.95 25.69 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.362 -2.257 . . . . 2.49 105.253 165.281 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.7 p -103.1 158.82 16.04 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.86 2.064 . . . . 0.76 108.256 -177.99 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.0 mt -65.44 -28.31 69.14 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 128.484 2.714 . . . . 1.05 108.378 176.042 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 p -64.59 -40.99 96.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.285 2.634 . . . . 1.19 115.461 171.874 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -65.24 -35.24 80.43 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 124.235 0.959 . . . . 1.9 113.411 176.623 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -85.43 3.1 41.67 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.336 1.606 . . . . 0.89 115.336 179.595 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.0 m120 56.02 32.27 19.62 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 110.698 -2.956 . . . . 1.84 117.895 -174.232 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.6 mm -72.17 130.02 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 1 O-C-N 115.325 -4.609 . . . . 0.82 116.582 176.594 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -117.61 174.81 5.95 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 128.115 2.566 . . . . 2.16 107.049 -168.106 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -54.32 152.8 5.96 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.058 1.503 . . . . 2.12 115.058 172.858 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.37 35.0 mt-10 73.55 14.03 4.37 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 125.554 2.597 . . . . 1.71 115.282 172.112 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.327 27.3 m -78.51 124.39 28.1 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 116.303 1.964 . . . . 1.04 116.303 -175.019 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.6 m -89.59 99.87 12.78 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 118.134 2.642 . . . . 0.79 118.134 177.913 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.5 mt -86.52 139.06 31.23 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.302 -2.481 . . . . 1.4 104.302 176.547 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -97.29 141.5 30.32 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.747 -3.096 . . . . 1.51 108.832 174.685 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.0 tp -106.62 125.62 51.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.11 1.909 . . . . 1.14 111.382 179.954 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.12 163.89 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 105.063 -2.199 . . . . 1.23 105.063 174.695 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.9 mt . . . . . 0 N--CA 1.43 -1.436 0 N-CA-C 101.799 -3.408 . . . . 2.78 101.799 -176.672 . . . . . . . . 0 0 . 1 . 118 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 ttp . . . . . 0 CA--C 1.491 -1.326 0 CA-C-O 118.61 -0.709 . . . . 1.1 112.597 . . . . . . . . . 0 0 . 1 . 118 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -94.31 133.54 37.75 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.562 -2.586 . . . . 1.87 111.716 178.576 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -123.37 159.34 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.269 2.628 . . . . 0.72 106.859 175.278 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.297 44.3 m-85 -128.96 121.71 28.6 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 123.887 1.803 . . . . 1.4 110.679 -177.604 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -100.52 105.01 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 125.851 2.739 . . . . 0.58 110.757 175.308 . . . . . . . . 3 3 . 1 . 118 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -88.13 138.59 31.31 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.547 -3.221 . . . . 2.09 110.066 176.241 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.9 p -90.52 -177.67 5.11 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 127.989 3.306 . . . . 0.99 116.18 -174.405 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.7 mt -82.74 -26.18 32.16 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.564 -1.96 . . . . 2.53 113.169 163.674 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.1 p -64.35 -62.58 1.52 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.507 1.923 . . . . 2.08 114.758 -174.262 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.49 31.61 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.757 0 N-CA-C 105.234 -3.147 . . . . 1.31 105.234 174.826 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -117.61 128.42 54.92 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 123.618 1.675 . . . . 1.4 109.025 -172.493 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.6 m -107.08 102.32 11.67 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 104.526 -2.398 . . . . 0.78 104.526 176.412 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.8 pt -91.27 133.06 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 120.778 1.626 . . . . 1.55 109.998 176.924 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.9 m -91.53 151.19 20.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 121.183 -0.948 . . . . 1.08 108.565 175.544 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.1 mt -144.31 139.39 28.52 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.106 -1.813 . . . . 1.55 106.106 176.48 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -78.0 116.19 18.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.101 1.519 . . . . 1.95 115.101 165.085 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.277 11.3 m -127.75 151.22 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 127.672 2.389 . . . . 0.96 106.839 178.49 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -94.87 161.96 26.8 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 118.107 -2.871 . . . . 2.35 112.622 157.828 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -73.45 -20.95 20.21 Favored 'Trans proline' 0 N--CA 1.433 -2.072 0 CA-C-N 126.69 3.425 . . . . 0.95 115.743 -174.895 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 p -72.59 5.32 3.14 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.488 3.915 . . . . 1.45 114.039 169.011 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -95.82 135.16 37.9 Favored 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 117.775 -3.078 . . . . 1.69 112.909 -179.604 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 26.6 p -67.79 173.98 3.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.21 -2.268 . . . . 0.75 114.225 177.414 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.6 mm -84.88 -29.7 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 118.143 -2.848 . . . . 0.73 105.156 176.861 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -48.95 -48.34 43.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.228 -2.795 . . . . 1.62 116.55 163.622 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -51.87 -50.27 61.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.861 -2.399 . . . . 2.13 115.148 167.369 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.2 t -55.97 -42.75 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 114.73 -2.557 . . . . 0.62 115.246 177.409 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -64.15 -41.11 97.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 125.101 2.382 . . . . 1.22 116.337 174.896 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.85 -43.73 81.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.51 3.124 . . . . 0.51 115.893 166.983 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.41 ' HB2' ' HE2' ' A' ' 29' ' ' LYS . 2.3 ttmm -58.86 -33.29 70.29 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 116.248 -4.033 . . . . 1.44 113.835 170.616 . . . . . . . . 3 3 . 1 . 118 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.9 mt -78.79 -31.09 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 112.907 -1.951 . . . . 1.32 108.969 176.521 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -71.15 -40.35 71.4 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 115.53 1.678 . . . . 1.7 115.53 177.868 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -58.01 -52.11 66.88 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.932 1.456 . . . . 1.55 114.932 168.001 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.2 tttp -70.23 -71.66 0.23 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.579 2.751 . . . . 2.62 113.361 -172.374 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -90.58 -34.24 15.57 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.048 -1.658 . . . . 1.48 111.616 -162.798 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.47 5.55 22.59 Favored Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 105.089 -3.204 . . . . 1.12 105.089 175.593 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 30.9 mt -80.17 122.37 82.86 Favored Pre-proline 0 N--CA 1.431 -1.41 0 CA-C-N 119.087 1.443 . . . . 1.55 108.475 -175.799 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 24.3 Cg_exo -68.31 150.75 76.52 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 C-N-CA 124.58 3.52 . . . . 1.02 110.653 -175.883 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.263 39.0 Cg_endo -62.91 -43.8 18.61 Favored 'Trans proline' 0 N--CA 1.433 -2.039 1 C-N-CA 126.963 5.109 . . . . 1.25 116.469 -168.904 . . . . . . . . 3 2 . 1 . 118 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -55.86 -26.56 47.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 121.792 3.997 . . . . 2.25 121.792 171.945 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -71.17 -34.89 71.36 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.585 1.954 . . . . 2.02 110.691 -179.322 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -70.62 97.71 1.38 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.165 2.283 . . . . 0.69 117.165 -175.299 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -87.44 126.14 34.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 118.341 -0.838 . . . . 2.78 108.96 161.957 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.0 mt -117.8 119.54 35.2 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 121.478 1.945 . . . . 1.17 108.431 -178.639 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 27.4 mt -108.3 128.94 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 128.53 2.732 . . . . 1.38 113.818 -172.426 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.429 ' CE2' HG12 ' A' ' 61' ' ' ILE 0.288 72.1 t80 -144.95 110.92 5.46 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 105.581 -2.007 . . . . 1.5 105.581 178.648 . . . . . . . . 3 3 . 1 . 118 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.82 45.25 7.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.867 1.802 . . . . 1.21 115.867 178.974 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.02 -4.85 36.25 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 120.681 3.032 . . . . 1.3 120.681 -171.534 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -96.3 119.72 35.31 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 130.155 4.091 . . . . 2.55 115.642 177.441 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -79.76 110.29 14.97 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 114.922 -4.861 . . . . 2.48 109.593 168.899 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.2 mt -82.12 146.35 29.66 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.041 -2.287 . . . . 0.9 110.827 -163.765 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -85.3 145.22 27.63 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.836 2.055 . . . . 1.94 114.004 173.536 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.39 -59.07 4.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.594 2.072 . . . . 1.56 116.594 -168.703 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.64 49.82 3.7 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-O 123.943 1.857 . . . . 0.97 116.905 173.744 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -118.25 156.48 28.75 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 101.489 -3.522 . . . . 2.49 101.489 165.443 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 16.9 p -100.07 162.48 12.95 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.686 -3.133 . . . . 0.76 112.784 174.005 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.4 mt -54.87 -48.27 73.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.777 2.831 . . . . 1.05 109.2 174.813 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 p -60.72 -37.92 83.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.07 2.148 . . . . 1.19 113.856 179.085 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -61.31 -33.93 74.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 122.637 2.471 . . . . 1.9 113.375 174.276 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -85.96 -14.34 44.94 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 127.002 2.121 . . . . 0.89 114.055 178.836 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.6 m120 66.84 50.34 1.11 Allowed 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 124.242 1.972 . . . . 1.84 111.739 -177.661 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.429 HG12 ' CE2' ' A' ' 45' ' ' PHE . 70.8 mt -95.78 128.71 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 119.951 -1.718 . . . . 0.82 108.457 174.629 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -100.1 175.98 5.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 112.159 -2.291 . . . . 2.16 111.07 -174.171 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -46.37 137.43 6.43 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.819 -3.05 . . . . 2.12 117.639 166.811 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.253 73.8 mt-10 69.57 14.04 8.27 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.287 -2.758 . . . . 1.71 117.682 175.455 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 m -76.1 148.95 37.53 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 120.438 -1.414 . . . . 1.04 112.826 -175.364 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.1 m -97.28 119.0 34.98 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 126.177 2.173 . . . . 0.79 111.258 -179.365 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.449 ' HB2' HG13 ' A' ' 5' ' ' VAL . 33.3 mt -103.8 136.68 43.03 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.053 -1.655 . . . . 1.4 107.851 170.235 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.431 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 63.5 m80 -91.64 107.5 19.25 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.298 2.332 . . . . 1.51 117.298 174.181 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.449 ' HB2' HG12 ' A' ' 5' ' ' VAL . 15.2 tp -88.09 117.04 26.7 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 124.835 1.254 . . . . 1.14 110.184 -179.334 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.2 t -120.84 143.25 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 126.493 3.044 . . . . 1.23 103.723 178.431 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 N--CA 1.43 -1.456 0 O-C-N 118.149 -2.845 . . . . 2.78 109.126 -175.422 . . . . . . . . 0 0 . 1 . 119 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.27 0.2 OUTLIER . . . . . 0 CA--C 1.491 -1.321 0 N-CA-C 107.138 -1.43 . . . . 1.1 107.138 . . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -115.38 119.96 38.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.765 2.026 . . . . 1.87 109.359 -178.41 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 pt -120.74 158.44 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 122.031 0.919 . . . . 0.72 112.716 -179.905 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -114.37 148.14 38.1 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.878 -2.389 . . . . 1.4 106.299 176.028 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.4 t -124.16 121.86 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 129.385 3.074 . . . . 0.58 105.51 173.118 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -107.16 137.69 44.75 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.305 2.642 . . . . 2.09 112.342 177.004 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.6 p -95.65 -176.83 3.86 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 123.376 1.56 . . . . 0.99 114.329 179.935 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.374 66.4 tp -57.54 -45.81 84.62 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 116.01 -4.181 . . . . 2.53 113.11 172.222 . . . . . . . . 3 2 . 1 . 119 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.5 p -80.11 -35.56 36.65 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 121.579 1.99 . . . . 2.08 111.844 -175.555 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.07 7.16 1.36 Allowed Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 119.524 1.057 . . . . 1.31 113.498 178.14 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.3 mtpt -76.6 130.65 38.15 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.676 -2.661 . . . . 1.4 111.65 -176.555 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.0 m -97.96 113.57 25.44 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 125.22 2.438 . . . . 0.78 113.203 -179.184 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.0 mt -92.4 95.15 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 119.101 -2.249 . . . . 1.55 110.369 178.327 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.6 m -81.48 118.82 23.03 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 120.473 1.488 . . . . 1.08 110.432 175.324 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.4 mt -119.85 153.64 35.51 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.567 -2.382 . . . . 1.55 104.567 178.275 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -110.44 120.17 41.57 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 111.558 -2.565 . . . . 1.95 107.493 174.25 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.87 -176.76 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.457 -2.652 . . . . 0.96 106.287 175.2 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -105.48 163.06 17.88 Favored Pre-proline 0 N--CA 1.431 -1.408 0 O-C-N 116.631 -3.793 . . . . 2.35 104.64 169.693 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -71.1 -14.74 32.03 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 124.012 2.468 . . . . 0.95 112.82 179.055 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.263 18.9 m -92.76 5.82 49.77 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 123.766 2.985 . . . . 1.45 111.572 -179.64 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -82.4 151.09 26.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 127.892 3.71 . . . . 1.69 108.706 176.445 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 68.7 p -79.49 170.57 16.38 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 113.586 -5.696 . . . . 0.75 113.596 179.322 . . . . . . . . 3 3 . 1 . 119 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.41 -30.57 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-N 113.561 -1.654 . . . . 0.73 110.873 178.572 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -54.82 -41.55 70.81 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.922 2.089 . . . . 1.62 113.724 169.36 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -61.9 -45.5 93.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.248 1.944 . . . . 2.13 116.248 171.252 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 56.4 t -51.51 -48.85 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 128.583 2.753 . . . . 0.62 107.896 175.445 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -67.42 -36.12 80.61 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 122.402 2.365 . . . . 1.22 117.384 175.197 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.02 -32.48 73.85 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 116.037 -4.164 . . . . 0.51 118.402 169.008 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -67.19 -31.05 71.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 112.483 -2.144 . . . . 1.44 114.839 170.142 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.293 57.3 mt -68.31 -25.43 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 CA-C-O 125.969 2.795 . . . . 1.32 113.683 172.339 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -85.47 -27.51 25.63 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.84 -4.287 . . . . 1.7 106.835 -174.32 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -78.09 -38.14 44.88 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 114.095 -3.042 . . . . 1.55 111.032 168.92 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -65.08 -61.46 2.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 112.986 0.736 . . . . 2.62 112.986 -172.243 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -106.09 -52.64 2.77 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.209 3.004 . . . . 1.48 108.969 -167.403 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.93 -15.8 5.86 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 119.096 2.398 . . . . 1.12 119.096 176.491 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mt -65.1 131.83 95.24 Favored Pre-proline 0 N--CA 1.43 -1.469 0 CA-C-O 116.499 -1.715 . . . . 1.55 110.337 -175.156 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 93.6 Cg_endo -74.93 155.36 43.25 Favored 'Trans proline' 0 N--CA 1.433 -2.038 0 C-N-CA 125.219 3.946 . . . . 1.02 112.814 -177.136 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.9 Cg_exo -63.84 -27.41 67.4 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 123.663 2.909 . . . . 1.25 119.056 -174.364 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.272 2.6 m-20 -62.08 -32.46 73.01 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.072 1.415 . . . . 2.25 113.39 177.268 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -87.81 -16.91 32.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.159 1.457 . . . . 2.02 114.085 -171.436 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -87.31 127.17 35.19 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 117.148 -1.406 . . . . 0.69 109.698 -174.909 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -118.44 128.18 54.37 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.441 -1.689 . . . . 2.78 106.441 170.421 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.2 mt -95.05 136.76 34.98 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.103 -2.873 . . . . 1.17 112.678 174.565 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 73.0 mt -125.38 117.92 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 124.415 2.055 . . . . 1.38 110.775 178.401 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -109.0 107.82 18.32 Favored 'General case' 0 N--CA 1.43 -1.439 1 N-CA-C 99.77 -4.159 . . . . 1.5 99.77 -178.534 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.88 -74.32 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.477 2.311 . . . . 1.21 113.716 -172.555 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.92 6.11 1.13 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 105.709 -2.956 . . . . 1.3 105.709 178.095 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -94.98 119.04 32.82 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.327 -3.455 . . . . 2.55 110.17 177.747 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -89.08 121.64 31.61 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.862 -2.399 . . . . 2.48 108.642 175.599 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.0 mt -80.08 164.67 23.19 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.158 -1.383 . . . . 0.9 111.599 -164.131 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -115.66 137.05 52.46 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 127.012 3.291 . . . . 1.94 111.396 174.552 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.28 -40.77 97.35 Favored 'General case' 0 N--CA 1.429 -1.483 1 N-CA-C 122.274 4.175 . . . . 1.56 122.274 -166.842 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.42 30.44 5.25 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 118.079 1.991 . . . . 0.97 118.079 171.385 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -105.86 162.61 13.41 Favored 'General case' 0 N--CA 1.43 -1.439 1 CA-C-O 130.099 4.762 . . . . 2.49 107.959 163.073 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 63.0 p -84.25 163.82 19.44 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 113.02 -6.05 . . . . 0.76 109.648 172.279 . . . . . . . . 3 3 . 1 . 119 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.2 mt -64.76 -42.7 94.92 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 121.0 -1.063 . . . . 1.05 109.086 172.432 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.3 p -66.32 -21.56 66.26 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.406 -3.309 . . . . 1.19 115.092 -179.22 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -59.34 -17.69 31.82 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 118.123 2.638 . . . . 1.9 118.123 167.017 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -115.79 11.22 15.56 Favored 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 114.561 -5.087 . . . . 0.89 109.189 178.835 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.334 1.3 t-20 67.01 33.97 5.42 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.568 1.947 . . . . 1.84 114.111 179.044 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.4 mt -92.03 126.37 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 104.759 -2.311 . . . . 0.82 104.759 -174.688 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -125.17 -171.46 2.37 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 119.488 1.04 . . . . 2.16 109.458 -169.25 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -52.68 141.7 20.26 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 118.452 -2.655 . . . . 2.12 112.842 165.722 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.316 4.2 mt-10 60.71 36.46 19.44 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.298 2.873 . . . . 1.71 115.926 175.066 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.4 t -109.49 140.82 42.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 111.562 -2.563 . . . . 1.04 106.74 -167.107 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.3 m -114.18 120.37 40.27 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.782 -1.192 . . . . 0.79 107.782 -167.759 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.7 mt -100.52 161.58 13.51 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.518 2.727 . . . . 1.4 111.186 173.795 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -123.79 109.65 13.92 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.122 2.169 . . . . 1.51 111.196 -177.616 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.9 tp -92.12 122.87 35.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 111.812 -2.449 . . . . 1.14 108.073 -175.008 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.327 4.7 m -118.4 141.03 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 118.802 -2.436 . . . . 1.23 110.953 175.63 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.9 mt . . . . . 0 N--CA 1.431 -1.414 0 O-C-N 117.926 -2.984 . . . . 2.78 110.145 177.226 . . . . . . . . 0 0 . 1 . 120 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 ptt? . . . . . 0 CA--C 1.491 -1.301 0 CA-C-O 120.957 0.408 . . . . 1.1 110.23 . . . . . . . . . 0 0 . 1 . 120 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -107.65 147.38 30.77 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.537 -0.727 . . . . 1.87 112.3 -176.681 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.3 pt -134.09 152.41 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 124.174 1.94 . . . . 0.72 106.385 172.935 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -109.7 134.37 52.05 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 127.019 2.128 . . . . 1.4 114.298 178.619 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -114.14 109.57 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 118.015 -2.928 . . . . 0.58 106.062 178.338 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 6' ' ' LYS . 17.9 tptm -93.61 131.38 38.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.219 -1.551 . . . . 2.09 111.83 178.673 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.1 p -89.07 -178.67 5.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.211 -2.806 . . . . 0.99 113.782 -178.428 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.263 35.4 tp -85.31 -33.47 22.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 119.292 -2.13 . . . . 2.53 108.198 171.85 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.259 59.9 p -68.33 -34.32 75.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.678 -1.889 . . . . 2.08 109.015 -174.095 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.0 44.54 0.44 Allowed Glycine 0 N--CA 1.431 -1.673 0 CA-C-O 115.376 -2.902 . . . . 1.31 113.513 178.378 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -127.55 148.69 50.34 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 114.076 -2.868 . . . . 1.4 110.853 -177.838 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.8 m -122.89 121.76 36.97 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 124.69 3.405 . . . . 0.78 103.626 177.126 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mt -98.13 124.54 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 1 O-C-N 115.971 -4.206 . . . . 1.55 104.355 179.1 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.0 m -101.29 118.2 36.51 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.261 -2.15 . . . . 1.08 107.876 179.912 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.7 mt -117.46 162.3 18.18 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.5 -2.625 . . . . 1.55 109.683 178.3 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -101.26 136.11 41.64 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 127.144 2.777 . . . . 1.95 112.656 166.545 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -142.36 171.26 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 128.085 2.554 . . . . 0.96 107.48 -176.236 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -118.53 148.22 43.65 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 101.904 -3.369 . . . . 2.35 101.904 163.139 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.97 -6.12 17.39 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 O-C-N 115.809 -2.785 . . . . 0.95 118.35 178.07 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.8 p -80.57 -5.77 57.28 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.475 2.71 . . . . 1.45 112.401 169.131 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -70.01 143.17 52.65 Favored 'General case' 0 N--CA 1.431 -1.413 1 CA-C-O 128.515 4.007 . . . . 1.69 111.706 171.129 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.395 53.6 p -75.09 157.05 35.38 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.02 -2.925 . . . . 0.75 112.848 176.493 . . . . . . . . 3 3 . 1 . 120 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.9 mm -71.53 -29.97 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 122.95 1.357 . . . . 0.73 109.634 179.131 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -46.57 -57.9 4.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.561 3.077 . . . . 1.62 115.538 164.661 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -54.48 -34.24 61.22 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 119.849 3.277 . . . . 2.13 119.849 178.017 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 68.9 t -71.05 -35.73 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 112.185 -2.28 . . . . 0.62 111.208 176.109 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -72.96 -34.11 66.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.011 -2.931 . . . . 1.22 113.456 171.76 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.98 -32.63 74.22 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 117.992 -2.943 . . . . 0.51 113.067 174.335 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt -72.42 -33.55 67.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 123.35 1.547 . . . . 1.44 114.853 174.279 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 30' ' ' ILE . 47.2 mt -72.39 -29.99 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 120.399 -1.438 . . . . 1.32 108.309 176.26 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.494 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 7.7 tt0 -64.0 -51.28 64.99 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.809 1.644 . . . . 1.7 112.549 171.803 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -60.75 -39.47 88.85 Favored 'General case' 0 N--CA 1.432 -1.368 0 O-C-N 120.121 -1.612 . . . . 1.55 113.509 175.549 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.6 tptt -67.83 -56.44 9.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.427 -1.421 . . . . 2.62 114.781 -173.818 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.307 71.4 mm-40 -113.71 -15.23 12.49 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 115.755 1.761 . . . . 1.48 115.755 -171.995 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.21 64.31 1.6 Allowed Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 125.169 1.366 . . . . 1.12 110.338 171.303 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.494 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 16.9 mt -141.53 117.07 7.13 Favored Pre-proline 0 N--CA 1.429 -1.485 0 N-CA-C 101.947 -3.353 . . . . 1.55 101.947 -176.436 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.472 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 57.3 Cg_exo -58.01 153.64 43.79 Favored 'Trans proline' 0 C--N 1.3 -2.002 1 C-N-CA 128.218 5.945 . . . . 1.02 111.93 178.149 . . . . . . . . 3 3 . 1 . 120 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 95.2 Cg_exo -71.73 -27.75 17.84 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 CA-C-N 125.454 2.984 . . . . 1.25 115.37 -171.825 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -61.36 -31.62 71.5 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.354 3.062 . . . . 2.25 113.912 178.007 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -92.57 -10.36 37.84 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 116.462 -3.899 . . . . 2.02 105.546 -172.332 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -92.87 132.47 36.98 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 124.062 3.119 . . . . 0.69 109.818 -172.041 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -103.52 125.56 50.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.762 -1.837 . . . . 2.78 109.369 163.811 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.6 mt -113.81 118.51 34.47 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.64 -2.537 . . . . 1.17 109.388 179.16 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mt -110.83 125.36 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 126.824 2.049 . . . . 1.38 109.794 -177.446 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -125.23 130.78 52.76 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.17 -1.789 . . . . 1.5 106.17 168.403 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.78 -76.44 0.07 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.804 1.242 . . . . 1.21 112.0 179.259 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -177.4 33.8 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.649 0 O-C-N 117.258 -3.401 . . . . 1.3 104.809 -175.482 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.32 122.29 16.69 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.644 1.978 . . . . 2.55 107.277 179.444 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -70.85 143.14 51.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.425 -2.672 . . . . 2.48 107.228 166.186 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.1 mt -99.97 139.99 34.83 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 125.268 1.605 . . . . 0.9 110.183 -173.107 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -83.05 161.64 21.63 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 117.767 -1.111 . . . . 1.94 108.886 176.44 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -73.49 -57.15 4.2 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 129.03 2.932 . . . . 1.56 117.131 -169.237 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.04 54.47 3.64 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 126.607 3.337 . . . . 0.97 120.048 172.631 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.253 79.2 mmt-85 -122.58 169.18 11.29 Favored 'General case' 0 N--CA 1.43 -1.444 1 C-N-CA 132.122 4.169 . . . . 2.49 103.306 169.257 . . . . . . . . 3 2 . 1 . 120 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 62.5 p -109.29 -179.72 3.92 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.409 -3.932 . . . . 0.76 108.464 170.561 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 79.8 mt -72.64 -33.67 66.77 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 130.825 3.65 . . . . 1.05 109.738 172.295 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.4 t -73.9 -37.74 64.57 Favored 'General case' 0 N--CA 1.43 -1.468 1 C-N-CA 131.976 4.111 . . . . 1.19 110.688 -176.214 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -64.08 -38.14 89.98 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 113.209 -1.814 . . . . 1.9 113.956 173.509 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -84.0 -2.83 57.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 113.945 -2.931 . . . . 0.89 112.47 170.463 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.417 8.1 t-20 56.9 46.34 19.8 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 121.24 1.836 . . . . 1.84 114.245 -177.043 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.2 mt -88.18 107.31 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 130.713 3.605 . . . . 0.82 108.212 176.621 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -79.33 -175.88 4.92 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.567 -2.583 . . . . 2.16 111.556 -177.131 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -72.88 149.1 43.78 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 118.382 -2.699 . . . . 2.12 108.305 172.98 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 71.51 18.32 5.46 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 126.615 3.102 . . . . 1.71 116.88 174.915 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -83.33 151.64 25.46 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.289 -3.382 . . . . 1.04 117.223 178.951 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.6 m -108.89 110.29 21.58 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.753 -1.203 . . . . 0.79 107.753 -173.604 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.7 mt -87.94 147.58 24.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 102.162 -3.273 . . . . 1.4 102.162 170.878 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -108.41 112.87 25.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.382 -1.34 . . . . 1.51 107.382 -175.761 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.7 tp -87.68 112.0 21.89 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.898 -2.376 . . . . 1.14 110.226 -178.81 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.7 t -111.13 120.23 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 103.055 -2.943 . . . . 1.23 103.055 178.368 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 123.732 1.73 . . . . 2.78 114.435 -178.312 . . . . . . . . 0 0 . 1 . 121 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 CA--C 1.49 -1.329 0 CA-C-O 125.53 2.586 . . . . 1.1 113.826 . . . . . . . . . 0 0 . 1 . 121 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -115.59 108.82 16.92 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.881 -2.387 . . . . 1.87 106.272 -173.861 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.3 pt -114.08 164.49 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 105.733 -1.951 . . . . 0.72 105.733 171.942 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -124.35 151.68 44.05 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.573 -2.01 . . . . 1.4 105.573 -172.09 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 t -134.1 118.52 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 102.86 -3.015 . . . . 0.58 102.86 174.545 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -90.83 141.4 28.85 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.434 -1.321 . . . . 2.09 107.434 171.055 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.2 p -91.49 -162.46 0.92 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.803 2.841 . . . . 0.99 111.45 -178.715 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.5 mt -83.2 -30.89 27.39 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 126.138 2.875 . . . . 2.53 110.132 178.493 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.8 p -82.09 -60.73 2.12 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 113.977 -5.452 . . . . 2.08 110.01 -171.615 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.93 31.41 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 125.03 1.3 . . . . 1.31 111.101 175.101 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -103.76 134.81 46.45 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.949 -4.265 . . . . 1.4 104.676 -174.609 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 m -80.98 119.63 23.75 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 112.779 -2.01 . . . . 0.78 109.908 167.675 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 mt -94.84 117.51 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 104.168 -2.531 . . . . 1.55 104.168 172.468 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.266 99.3 m -86.42 122.0 29.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 124.98 1.312 . . . . 1.08 109.683 179.227 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.492 HD11 HG13 ' A' ' 30' ' ' ILE . 89.3 mt -129.3 112.66 14.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 126.554 3.073 . . . . 1.55 109.146 -174.026 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -79.63 120.79 24.45 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 110.668 -2.969 . . . . 1.95 113.393 174.561 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.1 162.43 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 113.427 -1.715 . . . . 0.96 108.487 -175.235 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -118.54 170.53 6.32 Favored Pre-proline 0 N--CA 1.43 -1.435 0 O-C-N 116.836 -3.665 . . . . 2.35 108.85 168.13 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -62.9 -18.86 66.98 Favored 'Trans proline' 0 C--N 1.3 -1.982 1 C-N-CA 125.42 4.08 . . . . 0.95 120.813 -173.109 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.7 m -95.49 16.19 17.69 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 118.448 2.759 . . . . 1.45 118.448 171.049 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -77.25 148.45 35.77 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 124.746 2.212 . . . . 1.69 106.966 167.421 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.418 ' HB ' ' H ' ' A' ' 23' ' ' ILE . 71.4 p -97.73 -168.26 1.65 Allowed 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.028 -4.795 . . . . 0.75 114.109 175.791 . . . . . . . . 3 3 . 1 . 121 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.418 ' H ' ' HB ' ' A' ' 22' ' ' THR . 33.3 mm -89.1 -30.3 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 119.631 -1.918 . . . . 0.73 110.488 175.114 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -59.41 -32.19 69.95 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 128.0 2.52 . . . . 1.62 114.038 167.118 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.265 71.1 m-20 -64.23 -44.41 91.95 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 130.411 3.484 . . . . 2.13 115.348 161.709 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.9 t -65.91 -33.37 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 114.268 -2.973 . . . . 0.62 117.683 175.305 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.275 53.1 mtmt -73.11 -36.55 66.78 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.261 2.625 . . . . 1.22 109.227 -176.73 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.11 -32.84 71.06 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.631 -2.543 . . . . 0.51 111.197 174.569 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -74.95 -25.35 58.81 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 116.367 -3.958 . . . . 1.44 115.747 176.206 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.492 HG13 HD11 ' A' ' 15' ' ' LEU . 18.4 mt -80.83 -27.53 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 C-N-CA 117.181 -1.808 . . . . 1.32 113.88 172.933 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -64.09 -36.4 83.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.625 1.97 . . . . 1.7 114.351 169.997 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -60.54 -65.07 0.75 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 128.978 3.924 . . . . 1.55 109.786 167.859 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -67.6 -54.07 22.81 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 115.384 1.624 . . . . 2.62 115.384 -172.343 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -113.08 -25.1 9.1 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.951 -2.343 . . . . 1.48 115.001 -164.646 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.69 50.27 2.75 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 118.06 -2.019 . . . . 1.12 116.115 168.651 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.5 mt -120.72 128.4 25.8 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 130.389 3.476 . . . . 1.55 105.021 -178.623 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -63.98 146.73 91.6 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 124.403 3.402 . . . . 1.02 115.839 177.183 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -73.71 -9.05 22.25 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 124.356 3.37 . . . . 1.25 113.315 -171.268 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -87.86 -17.43 31.47 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 115.948 -2.301 . . . . 2.25 112.522 170.404 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -78.97 -25.21 43.48 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 120.179 1.354 . . . . 2.02 114.39 178.587 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -82.22 103.19 11.64 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.37 1.468 . . . . 0.69 113.131 -170.469 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 70' ' ' VAL . 93.9 mtt180 -90.89 118.33 30.2 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.934 -2.354 . . . . 2.78 112.677 170.553 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.409 HD12 HG23 ' A' ' 23' ' ' ILE . 76.9 mt -103.06 114.07 28.05 Favored 'General case' 0 N--CA 1.431 -1.392 1 CA-C-N 126.431 4.196 . . . . 1.17 113.698 -178.151 . . . . . . . . 3 3 . 1 . 121 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.8 mm -97.32 138.71 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 117.062 -1.447 . . . . 1.38 109.622 -177.13 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -157.35 129.46 7.2 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.596 -1.631 . . . . 1.5 106.596 176.251 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.06 9.12 2.91 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.181 1.792 . . . . 1.21 114.187 -174.483 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.57 -28.66 9.3 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 117.641 -1.644 . . . . 1.3 116.865 -176.092 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -96.47 153.8 17.63 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.417 2.377 . . . . 2.55 117.417 179.405 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -82.77 103.72 12.47 Favored 'General case' 0 N--CA 1.43 -1.433 1 C-N-CA 134.336 5.054 . . . . 2.48 112.911 178.017 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.9 mt -69.9 141.89 53.07 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.736 3.16 . . . . 0.9 115.219 -174.979 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.259 34.7 mt-10 -80.41 141.82 34.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.191 2.596 . . . . 1.94 114.381 176.831 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -53.03 -65.15 0.61 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 120.771 3.619 . . . . 1.56 120.771 -177.524 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.25 49.22 3.48 Favored Glycine 0 N--CA 1.43 -1.751 0 O-C-N 127.293 2.871 . . . . 0.97 111.807 178.799 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -118.86 147.63 43.75 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.544 -2.739 . . . . 2.49 104.825 168.873 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -79.66 173.4 12.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 117.125 -1.83 . . . . 0.76 115.16 175.74 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.29 -20.5 60.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.612 -2.555 . . . . 1.05 111.89 172.048 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 t -70.04 -49.03 55.38 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.207 -2.808 . . . . 1.19 110.952 177.6 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -57.04 -36.38 70.42 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.764 1.626 . . . . 1.9 114.02 175.824 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -92.83 5.73 50.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.097 2.159 . . . . 0.89 115.336 177.671 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.447 26.4 m120 44.82 43.25 6.79 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.247 2.619 . . . . 1.84 117.842 -176.796 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.8 mt -81.71 128.27 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 104.914 -2.254 . . . . 0.82 104.914 -176.339 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.268 10.2 mt-30 -105.85 179.94 4.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 127.774 3.171 . . . . 2.16 111.505 -174.155 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 pttp -69.02 129.02 38.73 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 124.807 1.243 . . . . 2.12 112.42 170.168 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 87.24 10.02 0.16 Allowed 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 126.837 2.055 . . . . 1.71 111.611 177.4 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.6 t -85.07 134.83 34.19 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 114.534 -5.104 . . . . 1.04 111.601 -173.542 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.8 m -99.97 120.93 40.57 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 123.697 1.713 . . . . 0.79 110.615 -177.811 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.0 mt -95.84 169.5 9.96 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.619 -1.628 . . . . 1.4 111.354 172.175 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -126.52 110.71 13.56 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.567 -1.958 . . . . 1.51 113.634 -173.281 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.7 tp -87.37 112.23 21.91 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.203 -1.56 . . . . 1.14 108.783 -175.824 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 42' ' ' ARG . 49.4 t -107.46 131.36 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 129.519 3.128 . . . . 1.23 112.068 170.881 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.6 mt . . . . . 0 N--CA 1.431 -1.381 0 O-C-N 120.056 -1.653 . . . . 2.78 111.289 -176.886 . . . . . . . . 0 0 . 1 . 122 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 CA--C 1.491 -1.315 0 CA-C-O 118.85 -0.595 . . . . 1.1 110.761 . . . . . . . . . 0 0 . 1 . 122 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -97.25 118.96 34.86 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 113.633 0.975 . . . . 1.87 113.633 -169.553 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.8 pt -125.59 169.62 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 120.504 1.502 . . . . 0.72 112.725 172.404 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -120.87 154.02 36.39 Favored 'General case' 0 N--CA 1.431 -1.407 1 O-C-N 114.913 -4.867 . . . . 1.4 110.628 -178.211 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.3 t -125.39 135.25 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 103.237 -2.875 . . . . 0.58 103.237 172.901 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -114.22 143.38 44.92 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.837 -3.039 . . . . 2.09 107.579 176.803 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -96.75 170.08 9.43 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.414 1.486 . . . . 0.99 114.566 176.552 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.3 mt -55.7 -45.53 77.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.554 -2.591 . . . . 2.53 110.246 174.355 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 p -73.64 -57.46 3.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 116.66 -1.638 . . . . 2.08 111.936 -177.001 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.11 19.25 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.7 0 CA-C-O 125.549 2.75 . . . . 1.31 117.485 179.156 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -102.99 122.33 44.39 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 111.659 -2.27 . . . . 1.4 109.004 -168.707 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.0 m -95.6 124.62 39.71 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.395 2.521 . . . . 0.78 110.96 177.305 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 mm -100.44 129.7 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 115.034 -2.412 . . . . 1.55 106.824 -179.097 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.4 m -89.72 104.84 17.36 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 124.133 3.152 . . . . 1.08 108.319 179.49 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.4 mt -108.73 146.52 33.39 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 125.455 3.752 . . . . 1.55 120.975 -178.845 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -98.33 131.83 44.31 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 114.245 -1.343 . . . . 1.95 109.44 169.682 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.7 m -144.5 162.47 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 1 C-N-CA 132.127 4.171 . . . . 0.96 108.214 177.831 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -114.13 150.8 44.22 Favored Pre-proline 0 N--CA 1.429 -1.477 0 C-N-CA 126.487 1.915 . . . . 2.35 108.452 166.428 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -62.47 -21.92 73.38 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-O 125.182 2.076 . . . . 0.95 114.59 -168.104 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.8 p -83.26 0.1 47.1 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.273 3.429 . . . . 1.45 111.193 178.923 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -79.99 151.97 29.71 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 115.974 -4.204 . . . . 1.69 105.473 172.525 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 35.0 p -93.57 173.48 7.67 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 112.721 -2.036 . . . . 0.75 113.372 177.865 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 42.2 mm -72.05 -33.13 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 O-C-N 120.542 -1.349 . . . . 0.73 108.276 -179.076 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -55.45 -44.96 76.85 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 125.516 2.579 . . . . 1.62 115.806 167.004 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 -60.09 -42.47 94.69 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 116.075 -4.141 . . . . 2.13 112.595 176.488 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.9 t -69.78 -42.04 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 C-N-CA 129.485 3.114 . . . . 0.62 109.737 172.152 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -64.85 -37.44 87.65 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 125.825 3.92 . . . . 1.22 112.267 -178.668 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.5 -31.59 56.29 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 119.926 3.306 . . . . 0.51 119.926 169.739 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.265 15.9 tppt? -80.15 -35.04 37.16 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 121.543 0.687 . . . . 1.44 111.977 174.087 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.8 mt -60.81 -42.49 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.371 -1.455 . . . . 1.32 114.289 171.215 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -56.11 -39.5 72.27 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.878 2.871 . . . . 1.7 111.622 173.845 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -70.57 -45.47 65.35 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 124.71 1.256 . . . . 1.55 113.718 176.698 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -70.67 -51.69 26.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 115.04 1.496 . . . . 2.62 115.04 -176.643 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -104.48 -14.14 15.8 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.682 1.993 . . . . 1.48 113.903 -168.66 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.21 49.23 34.22 Favored Glycine 0 N--CA 1.431 -1.648 0 O-C-N 118.238 -2.789 . . . . 1.12 112.987 175.438 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.407 ' CD1' HD21 ' A' ' 69' ' ' LEU . 56.9 mt -125.25 126.38 25.14 Favored Pre-proline 0 N--CA 1.429 -1.478 0 N-CA-C 105.047 -2.205 . . . . 1.55 105.047 178.735 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -66.84 150.29 83.24 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 125.237 3.958 . . . . 1.02 111.79 179.983 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -60.08 -31.51 93.47 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 C-N-CA 125.169 3.913 . . . . 1.25 114.721 -173.689 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -56.96 -41.4 78.27 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 130.33 3.452 . . . . 2.25 110.096 176.285 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -89.19 2.72 53.8 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.601 -1.312 . . . . 2.02 113.714 -178.307 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -90.01 116.51 28.1 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.429 2.692 . . . . 0.69 116.678 -173.697 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -111.96 109.03 18.58 Favored 'General case' 0 N--CA 1.429 -1.5 1 O-C-N 115.623 -4.423 . . . . 2.78 111.777 169.2 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 43' ' ' LEU . 51.8 mt -89.4 122.04 32.23 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.943 -1.723 . . . . 1.17 108.537 -178.879 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.3 mm -111.47 123.43 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 126.941 3.258 . . . . 1.38 111.474 177.316 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.276 69.6 t80 -132.31 134.7 45.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 116.531 -3.856 . . . . 1.5 104.533 173.104 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.99 28.22 0.59 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 119.77 3.248 . . . . 1.21 119.77 -177.62 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.8 -12.1 69.83 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 126.033 1.778 . . . . 1.3 111.598 -177.757 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -86.59 145.04 26.91 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.621 -1.517 . . . . 2.55 114.396 -179.347 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -87.09 109.76 19.64 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.033 -2.292 . . . . 2.48 109.615 171.893 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.7 mt -71.16 133.14 45.96 Favored 'General case' 0 N--CA 1.431 -1.423 1 CA-C-O 128.778 4.132 . . . . 0.9 109.303 -170.017 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -89.94 135.69 33.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.363 -3.961 . . . . 1.94 118.123 -179.791 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.407 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 9.0 m-20 -55.05 -54.22 45.83 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 116.864 -3.648 . . . . 1.56 119.332 -168.492 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.55 23.27 16.74 Favored Glycine 0 N--CA 1.429 -1.785 0 CA-C-O 118.424 -1.209 . . . . 0.97 112.026 177.298 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.4 mtt-85 -104.27 161.56 13.94 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 121.679 2.74 . . . . 2.49 108.624 165.981 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.1 p -97.89 156.63 16.51 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.557 2.743 . . . . 0.76 112.993 178.005 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.3 mt -58.86 -32.48 69.48 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.243 2.449 . . . . 1.05 114.878 179.712 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.5 p -69.03 -26.65 65.1 Favored 'General case' 0 N--CA 1.429 -1.52 0 O-C-N 116.627 -3.795 . . . . 1.19 117.558 176.376 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -68.61 -37.18 79.58 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.53 -1.981 . . . . 1.9 110.628 174.974 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -82.0 -13.57 57.21 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 115.262 -2.304 . . . . 0.89 106.779 -178.403 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.3 m120 65.82 56.44 0.89 Allowed 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 126.295 2.247 . . . . 1.84 108.437 -177.174 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.8 mt -99.32 136.17 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 103.922 -2.622 . . . . 0.82 103.922 179.545 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -109.69 178.16 4.51 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 126.318 2.961 . . . . 2.16 109.932 -178.799 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -60.8 152.32 27.38 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 112.4 -2.182 . . . . 2.12 116.212 167.778 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.277 53.4 mt-10 67.04 11.99 8.71 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 114.937 1.458 . . . . 1.71 114.937 -177.899 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -89.16 150.0 22.89 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.067 2.365 . . . . 1.04 109.485 -175.883 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.1 m -104.38 120.28 40.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.175 -1.578 . . . . 0.79 111.757 -176.918 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.3 mt -89.51 135.7 33.45 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.695 -1.878 . . . . 1.4 112.399 172.988 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -105.53 122.5 46.13 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.581 -2.574 . . . . 1.51 104.998 -174.792 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.407 HD21 ' CD1' ' A' ' 36' ' ' ILE . 60.0 tp -93.63 108.51 20.22 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.445 2.298 . . . . 1.14 110.803 -177.084 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.278 28.8 t -98.88 140.29 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 128.179 3.847 . . . . 1.23 105.07 173.216 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 N--CA 1.431 -1.388 0 O-C-N 118.621 -2.55 . . . . 2.78 106.756 170.643 . . . . . . . . 0 0 . 1 . 123 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.4 ttp . . . . . 0 CA--C 1.489 -1.388 0 CA-C-O 117.375 -1.298 . . . . 1.1 109.681 . . . . . . . . . 0 0 . 1 . 123 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -87.8 133.05 33.95 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 120.314 1.415 . . . . 1.87 114.681 -178.704 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pt -138.98 164.54 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 118.582 -2.574 . . . . 0.72 109.332 174.443 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -113.21 146.71 38.84 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 127.053 2.141 . . . . 1.4 110.852 -177.397 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.1 t -126.98 105.61 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 105.886 -1.894 . . . . 0.58 105.886 175.076 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -84.03 120.96 26.76 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 131.631 3.972 . . . . 2.09 115.293 173.761 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.2 p -104.41 -121.96 0.21 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.677 1.362 . . . . 0.99 114.677 -174.163 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.0 tp -159.98 -63.53 0.07 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 103.284 -2.858 . . . . 2.53 103.284 173.585 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.5 p -97.14 93.94 6.84 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 120.418 1.463 . . . . 2.08 111.901 -178.215 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.49 -146.93 17.63 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 127.842 2.639 . . . . 1.31 110.415 176.96 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -90.88 168.33 11.78 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 122.545 1.164 . . . . 1.4 112.154 -174.853 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -102.61 116.91 33.54 Favored 'General case' 0 N--CA 1.431 -1.383 1 N-CA-C 99.382 -4.303 . . . . 0.78 99.382 175.65 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.28 16.4 pt -84.33 152.17 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 128.097 2.559 . . . . 1.55 112.578 178.159 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 m -116.77 128.67 55.52 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 128.345 2.658 . . . . 1.08 106.263 176.617 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.6 mt -122.06 157.43 31.43 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.393 -2.692 . . . . 1.55 108.447 179.663 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -107.65 120.88 43.45 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.019 -2.301 . . . . 1.95 104.983 170.996 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.1 m -131.03 172.55 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 125.435 1.494 . . . . 0.96 109.806 -175.263 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -112.94 152.7 45.1 Favored Pre-proline 0 N--CA 1.43 -1.441 0 CA-C-O 116.304 -1.808 . . . . 2.35 111.136 164.911 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.76 -22.32 32.26 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 126.335 3.298 . . . . 0.95 114.118 -176.345 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.0 m -72.45 -12.88 61.28 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 116.137 -1.887 . . . . 1.45 110.251 176.073 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -66.08 135.54 54.76 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 123.4 2.818 . . . . 1.69 117.842 177.276 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.5 p -69.83 160.91 30.89 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 117.547 -3.221 . . . . 0.75 112.873 176.795 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 mm -66.58 -42.28 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 128.025 2.53 . . . . 0.73 108.279 175.366 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -45.93 -49.62 15.52 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.084 2.624 . . . . 1.62 118.084 161.275 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -68.31 -45.53 72.72 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 127.547 3.029 . . . . 2.13 111.447 178.997 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.453 HG21 HD11 ' A' ' 56' ' ' LEU . 58.5 t -59.02 -30.1 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 115.209 1.559 . . . . 0.62 115.209 173.936 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -68.38 -35.56 77.88 Favored 'General case' 0 N--CA 1.43 -1.475 1 O-C-N 113.871 -5.518 . . . . 1.22 111.671 169.657 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.2 -46.76 82.6 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 124.106 1.908 . . . . 0.51 115.506 169.6 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -47.98 -49.84 29.41 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 127.0 2.12 . . . . 1.44 109.046 169.727 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.2 mt -62.63 -30.34 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 123.653 2.933 . . . . 1.32 116.856 175.462 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -68.48 -34.64 76.29 Favored 'General case' 0 N--CA 1.431 -1.414 1 CA-C-O 128.821 4.153 . . . . 1.7 114.52 -174.181 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -61.74 -41.41 97.62 Favored 'General case' 0 N--CA 1.432 -1.369 2 O-C-N 115.043 -4.786 . . . . 1.55 112.178 172.286 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -91.74 -65.65 0.99 Allowed 'General case' 0 N--CA 1.429 -1.495 1 O-C-N 115.556 -4.465 . . . . 2.62 107.467 -172.801 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -88.36 -17.77 29.85 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 126.111 2.862 . . . . 1.48 116.158 -165.241 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.75 34.31 28.12 Favored Glycine 0 N--CA 1.43 -1.747 0 O-C-N 117.648 -3.158 . . . . 1.12 116.248 176.629 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.8 mt -107.85 121.92 42.49 Favored Pre-proline 0 N--CA 1.429 -1.492 0 N-CA-C 107.011 -1.477 . . . . 1.55 107.011 -178.354 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.288 52.8 Cg_exo -51.36 146.8 23.54 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-O 113.875 -2.635 . . . . 1.02 116.357 175.78 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -68.67 -23.1 36.68 Favored 'Trans proline' 0 C--N 1.299 -2.058 1 C-N-CA 125.761 4.307 . . . . 1.25 110.249 -175.623 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -84.44 -18.48 35.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.555 2.428 . . . . 2.25 117.555 176.573 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -88.34 -24.15 23.21 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 115.465 1.654 . . . . 2.02 115.465 -177.59 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -100.57 139.25 36.52 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.568 1.547 . . . . 0.69 112.528 -177.201 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -118.4 133.14 56.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 107.89 -1.152 . . . . 2.78 107.89 175.172 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.6 mt -99.5 127.0 45.54 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.733 1.606 . . . . 1.17 114.762 -179.441 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.0 mm -107.86 138.41 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 1 O-C-N 130.357 4.786 . . . . 1.38 107.121 -177.09 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -145.72 140.05 26.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.441 -3.912 . . . . 1.5 102.274 171.552 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.301 . . 62.5 -96.13 0.05 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.604 1.561 . . . . 1.21 109.079 -174.66 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.61 24.59 1.2 Allowed Glycine 0 N--CA 1.429 -1.817 0 O-C-N 127.744 3.153 . . . . 1.3 110.217 -179.291 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -121.34 147.87 45.11 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.2 1.8 . . . . 2.55 107.793 -177.37 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -95.98 130.97 42.82 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.897 -1.956 . . . . 2.48 107.58 173.306 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mt -96.15 124.79 40.29 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.805 3.261 . . . . 0.9 119.805 -172.813 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -66.14 132.75 49.2 Favored 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 132.549 4.34 . . . . 1.94 114.024 177.429 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -63.64 -32.87 74.48 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.297 -3.377 . . . . 1.56 114.737 -169.239 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.84 25.71 7.28 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 116.374 -3.953 . . . . 0.97 115.362 173.662 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -121.47 168.28 11.88 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 120.766 2.283 . . . . 2.49 111.134 173.614 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 p -104.83 154.6 19.83 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.185 1.469 . . . . 0.76 111.262 -178.39 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.453 HD11 HG21 ' A' ' 26' ' ' VAL . 24.8 mt -51.48 -37.96 51.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.046 1.879 . . . . 1.05 113.268 173.444 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -59.16 -50.1 75.33 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.48 -3.263 . . . . 1.19 117.057 171.391 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -43.04 -47.72 5.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.986 -3.571 . . . . 1.9 113.882 168.046 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -77.97 -13.61 59.82 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 117.762 2.504 . . . . 0.89 117.762 177.415 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.5 m120 69.08 63.9 0.29 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.631 1.972 . . . . 1.84 112.723 178.523 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.4 mt -98.33 137.1 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 117.43 -3.293 . . . . 0.82 106.837 176.22 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -117.58 -179.47 3.74 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 106.32 -1.733 . . . . 2.16 106.32 -174.659 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -71.3 140.45 50.31 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 126.77 2.544 . . . . 2.12 115.363 176.712 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 22.9 mt-10 70.83 46.53 0.49 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 126.133 2.873 . . . . 1.71 114.099 177.308 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.3 m -109.42 135.46 50.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 112.076 -2.329 . . . . 1.04 113.298 -173.643 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.3 m -92.47 99.81 12.48 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.788 -3.07 . . . . 0.79 112.392 -173.985 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mp -81.95 146.35 29.82 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.168 -1.79 . . . . 1.4 106.168 176.344 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -107.91 138.44 44.16 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.934 -1.506 . . . . 1.51 106.934 -175.363 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 tt -106.56 122.07 45.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 119.983 1.265 . . . . 1.14 111.435 -177.606 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.6 m -107.84 122.45 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 104.922 -2.251 . . . . 1.23 104.922 175.5 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 N--CA 1.429 -1.479 0 C-N-CA 128.707 2.803 . . . . 2.78 116.863 -173.385 . . . . . . . . 0 0 . 1 . 124 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.3 ttp . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 117.391 2.367 . . . . 1.1 117.391 . . . . . . . . . 0 0 . 1 . 124 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -109.58 113.48 26.3 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.492 1.293 . . . . 1.87 114.492 -173.499 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.51 HD12 HD13 ' A' ' 67' ' ' LEU . 20.3 pt -111.41 171.15 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 119.597 -1.94 . . . . 0.72 110.062 174.246 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -124.65 122.67 38.17 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.869 2.068 . . . . 1.4 108.07 -176.617 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.507 HG22 ' HB2' ' A' ' 67' ' ' LEU . 45.6 t -104.41 114.17 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 118.549 -2.594 . . . . 0.58 110.091 171.169 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -93.37 158.22 15.84 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.06 -3.525 . . . . 2.09 108.909 178.063 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.9 p -119.27 172.91 7.27 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.533 -3.23 . . . . 0.99 114.369 -178.945 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.2 tp -72.55 -47.3 49.3 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.572 1.653 . . . . 2.53 110.97 178.647 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.9 p -73.65 -30.67 63.07 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.479 -1.388 . . . . 2.08 113.271 -176.398 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.07 2.07 0.65 Allowed Glycine 0 N--CA 1.43 -1.724 0 O-C-N 117.021 -3.55 . . . . 1.31 117.203 176.995 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -91.28 149.84 21.58 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 122.667 3.234 . . . . 1.4 108.57 -179.664 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.2 m -134.95 112.8 10.92 Favored 'General case' 0 N--CA 1.431 -1.398 1 N-CA-C 100.138 -4.023 . . . . 0.78 100.138 -179.806 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 mt -106.31 113.35 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 129.741 3.217 . . . . 1.55 114.231 -171.682 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.6 m -74.75 114.98 13.81 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.662 -2.524 . . . . 1.08 115.542 173.445 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.1 mt -113.66 129.11 56.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.515 1.507 . . . . 1.55 109.088 -176.791 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -97.72 113.86 25.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.618 -1.301 . . . . 1.95 111.714 174.704 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -116.5 166.62 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 126.395 2.309 . . . . 0.96 110.569 -170.599 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -112.19 155.34 43.66 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 113.252 -3.261 . . . . 2.35 105.69 164.641 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.9 -21.73 63.81 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 CA-C-N 124.207 2.538 . . . . 0.95 117.433 -175.957 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.5 p -73.89 -17.31 61.06 Favored 'General case' 0 N--CA 1.431 -1.41 1 C-N-CA 134.307 5.043 . . . . 1.45 118.927 173.024 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -69.14 143.47 54.11 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 125.475 2.56 . . . . 1.69 109.301 174.083 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 3.3 p -94.74 164.12 13.07 Favored 'General case' 0 N--CA 1.431 -1.408 1 O-C-N 116.197 -4.064 . . . . 0.75 105.154 -177.43 . . . . . . . . 3 3 . 1 . 124 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.1 mm -56.27 -42.91 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 126.666 2.479 . . . . 0.73 111.605 176.651 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -46.77 -50.55 18.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 116.213 1.931 . . . . 1.62 116.213 164.559 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -74.02 -24.97 59.63 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 121.919 2.145 . . . . 2.13 111.166 178.45 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.2 t -74.06 -33.27 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 116.867 -3.646 . . . . 0.62 111.322 176.44 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -71.16 -28.84 64.55 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.347 -3.971 . . . . 1.22 109.231 172.366 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.57 -28.13 69.66 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 115.914 -4.241 . . . . 0.51 117.377 168.192 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -74.16 -30.87 62.47 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 122.593 2.452 . . . . 1.44 109.021 -178.134 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.0 mt -67.69 -35.71 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 O-C-N 127.216 2.822 . . . . 1.32 114.813 172.284 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -73.33 -15.8 61.38 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 118.993 2.96 . . . . 1.7 118.993 178.157 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -69.07 -43.0 75.48 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.436 1.273 . . . . 1.55 114.436 162.721 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -73.06 -61.07 1.94 Allowed 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 126.893 3.235 . . . . 2.62 112.348 -175.405 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -100.15 -30.34 11.99 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.133 -2.854 . . . . 1.48 110.16 -164.564 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.43 33.11 7.75 Favored Glycine 0 N--CA 1.431 -1.674 0 O-C-N 128.116 3.385 . . . . 1.12 115.729 173.239 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.3 mt -106.05 129.21 24.93 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 116.566 -1.683 . . . . 1.55 107.291 -177.975 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -62.82 142.65 89.57 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 124.405 3.404 . . . . 1.02 119.747 175.98 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.28 -17.65 35.07 Favored 'Trans proline' 0 C--N 1.299 -2.057 0 N-CA-C 118.445 2.441 . . . . 1.25 118.445 -178.111 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -68.15 -24.87 65.04 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.72 -1.237 . . . . 2.25 113.728 173.144 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -93.69 -18.11 22.48 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.746 1.736 . . . . 2.02 111.184 -179.493 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -95.02 154.15 17.3 Favored 'General case' 0 N--CA 1.431 -1.378 0 O-C-N 118.419 -2.676 . . . . 0.69 110.82 -176.264 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -141.32 151.35 43.53 Favored 'General case' 0 N--CA 1.43 -1.465 1 C-N-CA 133.284 4.633 . . . . 2.78 113.257 171.136 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.5 mt -115.99 132.61 56.6 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.211 -2.806 . . . . 1.17 111.035 177.404 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.1 mt -109.73 123.1 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.354 -1.35 . . . . 1.38 107.354 -178.529 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -145.72 140.92 27.57 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.382 -2.699 . . . . 1.5 103.976 175.712 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.85 14.21 7.99 Favored 'General case' 0 N--CA 1.43 -1.434 1 C-N-CA 131.717 4.007 . . . . 1.21 114.53 -176.555 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.95 -30.39 10.52 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 125.74 1.638 . . . . 1.3 115.441 -171.796 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -101.25 156.16 17.6 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 120.73 2.265 . . . . 2.55 115.422 -177.974 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -72.29 135.62 46.02 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 116.897 -1.525 . . . . 2.48 113.416 167.797 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.6 mt -89.05 145.57 25.39 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.102 2.228 . . . . 0.9 112.716 -176.119 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -72.55 139.24 47.4 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.203 -2.186 . . . . 1.94 111.549 173.418 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -66.99 -56.25 10.96 Favored 'General case' 0 N--CA 1.431 -1.409 1 C-N-CA 131.826 4.05 . . . . 1.56 119.49 -168.519 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.6 37.14 2.78 Favored Glycine 0 N--CA 1.43 -1.757 0 O-C-N 117.936 -2.977 . . . . 0.97 116.775 175.564 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -114.13 160.49 18.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.866 -2.549 . . . . 2.49 108.576 171.266 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.452 54.7 p -87.49 146.27 25.89 Favored 'General case' 0 N--CA 1.43 -1.47 1 C-N-CA 132.103 4.161 . . . . 0.76 111.571 179.711 . . . . . . . . 4 3 . 1 . 124 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mt -55.46 -34.87 64.9 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 114.694 1.368 . . . . 1.05 114.694 172.026 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 p -64.11 -33.81 76.62 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.238 3.015 . . . . 1.19 112.975 178.567 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -66.62 -37.12 84.19 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 125.047 1.339 . . . . 1.9 113.74 178.226 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -85.92 -5.13 59.28 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.06 1.344 . . . . 0.89 110.038 175.152 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.4 t30 60.74 38.45 18.25 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 127.053 3.311 . . . . 1.84 116.257 179.139 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.0 mt -74.82 125.24 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 O-C-N 116.892 -3.63 . . . . 0.82 109.611 -177.405 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -99.19 -175.84 3.14 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.217 -2.802 . . . . 2.16 111.854 -176.982 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -70.68 160.67 32.18 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 124.116 1.912 . . . . 2.12 111.233 177.165 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.384 16.4 mt-10 44.83 48.54 9.1 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 118.133 2.642 . . . . 1.71 118.133 179.626 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.6 m -107.28 144.05 34.66 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 127.34 2.9 . . . . 1.04 106.028 -175.941 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.6 m -108.75 103.81 12.96 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.586 -1.188 . . . . 0.79 108.118 -178.205 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.51 HD13 HD12 ' A' ' 3' ' ' ILE . 4.1 mp -87.62 158.51 18.85 Favored 'General case' 0 N--CA 1.429 -1.475 1 C-N-CA 132.52 4.328 . . . . 1.4 106.377 173.339 . . . . . . . . 3 3 . 1 . 124 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -121.28 142.89 49.51 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 102.079 -3.304 . . . . 1.51 102.079 -174.085 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.5 tp -97.99 129.35 44.87 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 114.669 -2.586 . . . . 1.14 108.975 -179.784 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 m -129.72 168.05 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 121.642 2.019 . . . . 1.23 106.632 171.092 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.43 -1.456 0 O-C-N 119.384 -2.073 . . . . 2.78 106.772 -177.147 . . . . . . . . 0 0 . 1 . 125 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptt? . . . . . 0 CA--C 1.489 -1.389 0 N-CA-C 108.363 -0.977 . . . . 1.1 108.363 . . . . . . . . . 0 0 . 1 . 125 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -102.39 131.58 48.94 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.009 2.124 . . . . 1.87 112.365 -172.147 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.1 pt -139.07 157.17 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-O 125.606 2.622 . . . . 0.72 106.625 176.651 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -109.01 121.7 45.69 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.834 -2.416 . . . . 1.4 112.764 -176.954 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.1 t -96.85 103.42 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 116.854 -3.654 . . . . 0.58 107.166 175.073 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -76.43 136.43 39.44 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 118.567 2.803 . . . . 2.09 118.567 168.272 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -83.33 169.96 15.08 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.065 -4.147 . . . . 0.99 109.847 177.622 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.512 HD11 HG13 ' A' ' 70' ' ' VAL . 19.2 mt -60.71 -42.64 97.64 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.419 -2.676 . . . . 2.53 115.455 170.324 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -75.44 -51.2 13.61 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 127.145 2.778 . . . . 2.08 116.148 -176.706 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.21 -44.84 0.19 Allowed Glycine 0 N--CA 1.431 -1.695 0 CA-C-O 113.956 -3.691 . . . . 1.31 114.161 -177.845 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -53.51 136.18 38.7 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 122.62 3.21 . . . . 1.4 118.625 -177.445 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.266 88.5 m -107.72 98.7 8.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.79 1.757 . . . . 0.78 107.818 178.4 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -80.72 98.64 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 125.695 2.664 . . . . 1.55 110.195 177.231 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.5 m -82.12 122.85 28.38 Favored 'General case' 0 N--CA 1.429 -1.498 1 O-C-N 115.153 -4.717 . . . . 1.08 110.722 178.269 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.5 mt -122.28 144.32 49.07 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.175 1.917 . . . . 1.55 116.175 -178.494 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -103.86 124.83 49.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 116.42 -2.112 . . . . 1.95 108.749 174.905 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.8 m -140.98 165.08 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.041 -1.662 . . . . 0.96 108.094 -171.122 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.293 4.6 mm-40 -102.75 150.19 37.49 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-O 114.538 -2.649 . . . . 2.35 110.518 163.578 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.41 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 33.3 Cg_endo -75.96 -14.9 18.95 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 125.877 3.135 . . . . 0.95 109.12 -171.963 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.1 p -81.18 -1.31 44.16 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 123.836 1.779 . . . . 1.45 114.129 174.202 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -75.02 147.92 40.31 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 118.315 -2.74 . . . . 1.69 113.021 172.309 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.649 ' O ' HG23 ' A' ' 26' ' ' VAL . 41.0 p -85.82 176.42 8.12 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 124.287 1.994 . . . . 0.75 112.894 -175.349 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.252 20.8 mm -76.85 -37.23 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 116.345 -3.972 . . . . 0.73 106.278 177.832 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -53.33 -36.36 61.2 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.282 -3.386 . . . . 1.62 112.027 169.027 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -74.83 -46.08 38.96 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 120.629 1.559 . . . . 2.13 112.281 177.365 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 22' ' ' THR . 26.1 t -57.3 -43.26 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 C-N-CA 128.829 2.852 . . . . 0.62 112.02 175.538 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -70.26 -34.26 72.6 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.661 2.467 . . . . 1.22 117.661 171.509 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.94 89.29 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.598 -1.939 . . . . 0.51 106.855 178.057 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -57.97 -41.52 83.1 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 119.292 3.071 . . . . 1.44 119.292 167.567 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.268 65.3 mt -63.22 -35.91 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.242 -2.786 . . . . 1.32 113.66 170.635 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -61.37 -41.26 96.81 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 130.747 3.619 . . . . 1.7 109.389 172.074 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -58.15 -57.53 12.45 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 114.45 1.278 . . . . 1.55 114.45 177.195 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -73.13 -63.59 1.15 Allowed 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 117.731 2.493 . . . . 2.62 117.731 -174.284 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -101.35 -19.06 15.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.071 -1.643 . . . . 1.48 111.566 -168.529 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.76 30.3 6.88 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 118.215 2.046 . . . . 1.12 118.215 173.696 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.9 mt -106.15 119.2 52.86 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-N 121.35 2.575 . . . . 1.55 109.104 -176.018 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -56.28 145.89 75.19 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 CA-C-N 127.263 3.629 . . . . 1.02 114.363 174.946 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -82.72 -5.31 11.56 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 124.499 3.466 . . . . 1.25 108.493 -166.214 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -80.93 -23.74 38.67 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.516 1.507 . . . . 2.25 111.384 176.389 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -90.07 -12.75 37.56 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.051 -2.281 . . . . 2.02 111.657 -178.192 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -87.21 123.49 32.28 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 130.167 3.387 . . . . 0.69 111.647 -174.682 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -123.47 114.13 19.69 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-O 125.107 2.384 . . . . 2.78 109.472 161.777 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.9 mt -87.18 138.6 31.35 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 124.346 2.022 . . . . 1.17 106.486 -178.553 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.6 mt -135.37 128.54 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 128.006 2.523 . . . . 1.38 110.209 -178.54 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -127.17 115.32 18.92 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 115.291 -4.631 . . . . 1.5 104.603 177.931 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 73.15 -58.52 0.6 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.729 2.812 . . . . 1.21 110.605 177.082 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.412 ' H ' ' H ' ' A' ' 48' ' ' LYS . . . -162.66 -13.73 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 O-C-N 120.502 -1.374 . . . . 1.3 111.849 -178.365 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.412 ' H ' ' H ' ' A' ' 47' ' ' GLY . 48.4 mttt -98.62 134.0 42.17 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.127 -1.536 . . . . 2.55 109.502 -177.163 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -73.27 140.61 46.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.838 2.055 . . . . 2.48 108.856 166.828 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.0 mt -97.56 123.28 41.39 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.204 -1.776 . . . . 0.9 106.204 -170.853 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -91.46 145.68 24.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.747 -2.471 . . . . 1.94 110.26 178.955 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -43.26 -57.59 2.92 Favored 'General case' 0 N--CA 1.43 -1.439 1 C-N-CA 131.993 4.117 . . . . 1.56 119.818 -175.757 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.15 7.29 8.13 Favored Glycine 0 N--CA 1.43 -1.728 1 N-CA-C 123.149 4.02 . . . . 0.97 123.149 168.524 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -98.23 167.07 11.09 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 120.656 2.228 . . . . 2.49 112.158 167.738 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.341 18.6 p -109.81 166.61 10.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.828 2.159 . . . . 0.76 116.828 -179.137 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.6 mt -61.98 -35.36 78.28 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.029 2.347 . . . . 1.05 111.62 172.21 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 5.8 t -75.84 -33.03 60.02 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.601 -2.562 . . . . 1.19 113.477 -179.997 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -56.42 -46.4 80.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.834 2.054 . . . . 1.9 114.116 166.248 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -84.77 -9.22 58.4 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 121.817 2.099 . . . . 0.89 112.756 -179.617 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.522 12.8 m120 81.68 46.52 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 125.867 1.667 . . . . 1.84 113.591 175.403 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.1 mt -96.8 118.81 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 113.495 -1.684 . . . . 0.82 114.012 179.931 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -115.1 -179.02 3.51 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 106.319 -1.734 . . . . 2.16 106.319 -174.964 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -62.05 151.87 34.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 127.801 2.441 . . . . 2.12 114.405 -178.675 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 66.2 29.55 9.66 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.797 2.237 . . . . 1.71 110.746 177.495 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.6 p -106.71 150.95 25.75 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 113.982 -5.449 . . . . 1.04 109.298 -176.158 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.4 m -103.14 122.18 44.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.329 2.49 . . . . 0.79 109.668 179.713 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -110.57 145.21 38.22 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 118.615 -2.553 . . . . 1.4 105.539 176.559 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -100.67 136.12 41.03 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 118.58 -2.575 . . . . 1.51 107.189 179.859 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.5 tp -113.96 123.96 50.99 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.961 -1.712 . . . . 1.14 108.21 174.691 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.512 HG13 HD11 ' A' ' 8' ' ' LEU . 48.8 t -105.85 134.51 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 103.083 -2.932 . . . . 1.23 103.083 176.04 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.8 tp . . . . . 0 N--CA 1.43 -1.448 0 CA-C-O 125.339 2.495 . . . . 2.78 111.985 174.825 . . . . . . . . 0 0 . 1 . 126 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.4 ttp . . . . . 0 CA--C 1.49 -1.335 0 CA-C-O 117.396 -1.288 . . . . 1.1 110.935 . . . . . . . . . 0 0 . 1 . 126 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -81.34 133.1 35.37 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 120.405 1.457 . . . . 1.87 111.21 -179.136 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 pt -140.25 162.73 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 123.981 1.848 . . . . 0.72 108.072 173.565 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -120.66 133.31 55.37 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 102.226 -3.25 . . . . 1.4 102.226 -177.148 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.0 t -109.48 123.83 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 127.994 2.517 . . . . 0.58 104.831 167.829 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -101.06 124.16 46.34 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.787 -1.821 . . . . 2.09 111.43 176.74 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.423 HG22 HD23 ' A' ' 69' ' ' LEU . 1.3 p -85.84 151.81 23.5 Favored 'General case' 0 N--CA 1.431 -1.41 1 O-C-N 115.448 -4.533 . . . . 0.99 114.041 175.032 . . . . . . . . 3 3 . 1 . 126 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.5 tp -34.56 -54.1 0.54 Allowed 'General case' 0 N--CA 1.43 -1.434 1 C-N-CA 133.018 4.527 . . . . 2.53 115.404 169.83 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.4 p -81.88 -31.78 31.32 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 125.872 1.982 . . . . 2.08 110.644 -170.93 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.78 17.28 0.11 Allowed Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 118.444 -1.836 . . . . 1.31 117.048 178.862 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -114.79 141.91 47.23 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 115.68 -4.423 . . . . 1.4 105.404 -177.685 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.5 m -105.77 124.79 50.13 Favored 'General case' 0 N--CA 1.429 -1.522 0 O-C-N 123.358 0.411 . . . . 0.78 109.944 173.473 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.402 HD13 HG23 ' A' ' 30' ' ' ILE . 2.4 mt -93.46 116.09 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 125.577 2.608 . . . . 1.55 105.933 179.889 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.2 m -92.26 102.45 14.95 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 115.507 -4.495 . . . . 1.08 107.323 174.72 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.5 mt -90.96 160.21 15.77 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.526 -1.359 . . . . 1.55 110.54 178.616 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -125.3 114.06 18.41 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 119.854 -1.779 . . . . 1.95 108.008 165.715 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.01 -176.2 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 119.205 -2.185 . . . . 0.96 110.382 -173.318 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -107.08 149.12 38.22 Favored Pre-proline 0 N--CA 1.43 -1.432 0 CA-C-O 114.096 -2.859 . . . . 2.35 109.622 167.145 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.39 -24.15 19.68 Favored 'Trans proline' 0 N--CA 1.433 -2.054 1 CA-C-N 128.661 4.129 . . . . 0.95 111.807 -171.561 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.8 m -102.03 16.29 26.47 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 126.318 2.261 . . . . 1.45 116.873 -179.352 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.83 157.56 25.68 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.306 1.527 . . . . 1.69 112.446 173.227 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 1.8 p -86.68 162.58 17.84 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.51 3.052 . . . . 0.75 116.204 -176.903 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mm -70.45 -38.96 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 1 O-C-N 115.124 -4.735 . . . . 0.73 107.512 -179.289 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -47.58 -54.11 12.7 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.346 3.058 . . . . 1.62 111.592 167.937 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -62.22 -36.98 83.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.945 2.898 . . . . 2.13 118.178 171.375 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.372 4.2 t -63.3 -39.31 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 116.57 -3.831 . . . . 0.62 112.52 174.847 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -65.91 -32.39 73.87 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.844 2.165 . . . . 1.22 116.844 172.089 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.82 -31.62 72.36 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.636 -1.915 . . . . 0.51 114.1 170.472 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -68.24 -26.88 65.91 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.276 1.988 . . . . 1.44 115.217 170.199 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.402 HG23 HD13 ' A' ' 13' ' ' ILE . 84.4 mt -75.2 -28.25 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 117.385 -3.322 . . . . 1.32 114.174 170.489 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -70.81 -38.39 73.29 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.352 2.501 . . . . 1.7 115.062 170.3 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.83 -36.84 85.23 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 116.748 -3.72 . . . . 1.55 111.917 172.513 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -85.35 -53.39 5.25 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.478 1.609 . . . . 2.62 110.919 -176.69 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -100.73 -43.98 5.96 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.882 -3.011 . . . . 1.48 117.141 -174.069 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.66 -0.73 18.03 Favored Glycine 0 N--CA 1.429 -1.806 0 CA-C-O 117.01 -1.994 . . . . 1.12 111.599 178.194 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.0 mt -70.22 130.72 89.23 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-N 121.099 2.45 . . . . 1.55 112.733 -178.805 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -76.32 154.3 36.29 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 O-C-N 115.556 -2.918 . . . . 1.02 116.023 174.788 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -71.8 -6.81 19.89 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 124.009 3.139 . . . . 1.25 113.039 -169.13 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -67.58 -35.03 78.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.345 3.058 . . . . 2.25 109.132 175.116 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -85.28 -22.32 28.64 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.384 -1.448 . . . . 2.02 113.396 178.708 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -83.19 119.16 24.19 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.028 -2.92 . . . . 0.69 117.622 -168.654 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.425 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 51.4 ttt180 -107.83 118.78 37.63 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 105.297 -2.112 . . . . 2.78 105.297 172.758 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.5 mt -113.73 122.51 47.33 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 116.375 -1.774 . . . . 1.17 108.671 -177.092 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.3 mt -120.19 136.2 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 124.574 2.13 . . . . 1.38 107.702 177.483 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.447 ' HB3' HD21 ' A' ' 50' ' ' LEU . 84.9 t80 -130.4 112.2 13.03 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.056 1.884 . . . . 1.5 109.496 171.45 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.65 -72.58 0.09 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.468 2.307 . . . . 1.21 114.021 177.968 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.7 -62.18 0.19 Allowed Glycine 0 N--CA 1.43 -1.751 0 O-C-N 120.835 -1.165 . . . . 1.3 112.675 -178.28 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -79.85 153.51 29.04 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 115.085 1.513 . . . . 2.55 115.085 -173.455 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -82.95 137.66 34.11 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.321 -2.737 . . . . 2.48 111.052 171.503 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.447 HD21 ' HB3' ' A' ' 45' ' ' PHE . 11.8 mt -84.87 121.57 27.92 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.488 -2.007 . . . . 0.9 114.835 -169.217 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.316 10.7 pt-20 -78.63 173.25 12.62 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 118.463 -2.648 . . . . 1.94 115.669 175.152 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -68.08 -58.68 4.09 Favored 'General case' 0 N--CA 1.429 -1.478 1 N-CA-C 125.054 5.205 . . . . 1.56 125.054 -177.023 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.65 56.59 1.37 Allowed Glycine 0 N--CA 1.43 -1.711 0 O-C-N 118.502 -2.624 . . . . 0.97 111.143 170.81 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -123.24 168.65 12.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.224 -2.139 . . . . 2.49 105.224 160.722 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.0 p -101.65 169.29 8.93 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.469 -1.394 . . . . 0.76 112.279 179.494 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mt -54.61 -44.9 73.51 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 114.717 1.377 . . . . 1.05 114.717 166.98 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.262 41.7 p -67.88 -24.38 65.22 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.258 2.623 . . . . 1.19 115.078 -176.651 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -70.59 -25.18 62.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.124 2.869 . . . . 1.9 115.793 176.195 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -95.81 -6.71 38.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.123 -2.308 . . . . 0.89 114.18 175.157 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.26 7.6 t30 76.53 43.16 0.15 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.864 -2.397 . . . . 1.84 110.166 179.56 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 61' ' ' ILE . 77.7 mt -91.91 107.3 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.733 -1.229 . . . . 0.82 108.261 177.325 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -101.08 -170.82 1.89 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 126.184 2.897 . . . . 2.16 107.749 -174.304 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -63.69 141.91 58.59 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 111.318 -2.674 . . . . 2.12 110.693 171.822 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 69.05 20.84 7.59 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 110.734 -2.939 . . . . 1.71 116.877 177.008 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.6 m -88.88 159.37 17.72 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 116.165 1.913 . . . . 1.04 116.165 -170.899 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.2 m -101.32 115.79 31.3 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 117.007 -3.558 . . . . 0.79 110.49 -178.97 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -105.37 146.82 28.92 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.674 -1.232 . . . . 1.4 107.674 171.181 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -101.58 130.63 47.94 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 116.132 -1.89 . . . . 1.51 110.736 177.05 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.423 HD23 HG22 ' A' ' 7' ' ' THR . 25.1 tp -115.12 108.29 16.44 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.205 1.366 . . . . 1.14 107.551 177.172 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 74.6 t -96.2 130.19 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 119.131 -2.23 . . . . 1.23 105.784 171.801 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 N--CA 1.428 -1.543 0 CA-C-N 120.275 1.398 . . . . 2.78 111.087 178.896 . . . . . . . . 0 0 . 1 . 127 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 ptt? . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 104.575 -2.379 . . . . 1.1 104.575 . . . . . . . . . 0 0 . 1 . 127 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -119.08 154.54 33.02 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 124.53 3.332 . . . . 1.87 106.291 175.994 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -136.37 167.36 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 105.425 -2.065 . . . . 0.72 105.425 167.491 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -120.96 125.84 48.44 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.046 2.138 . . . . 1.4 108.129 -176.835 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.6 t -104.45 130.72 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.708 -3.12 . . . . 0.58 105.283 170.751 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.287 12.4 ttpt -127.03 122.08 33.39 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 129.715 4.384 . . . . 2.09 119.645 -177.12 . . . . . . . . 3 2 . 1 . 127 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 p -70.89 161.73 30.53 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 112.671 -2.059 . . . . 0.99 115.106 177.963 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.7 tp -54.31 -48.34 71.44 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.783 2.433 . . . . 2.53 115.465 174.058 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.31 -31.95 70.76 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.522 2.729 . . . . 2.08 115.582 -177.728 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.94 27.68 0.7 Allowed Glycine 0 N--CA 1.429 -1.775 0 CA-C-O 117.641 -1.644 . . . . 1.31 109.817 176.1 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -97.46 122.98 41.15 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.449 3.125 . . . . 1.4 108.318 -178.093 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.4 m -96.45 117.48 30.97 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 127.309 3.433 . . . . 0.78 107.156 172.661 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.8 mt -93.6 122.05 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 117.668 -3.145 . . . . 1.55 102.529 174.944 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -108.91 106.5 16.5 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 123.657 1.694 . . . . 1.08 109.943 174.256 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.4 mt -102.6 152.58 21.01 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 116.475 -3.89 . . . . 1.55 109.445 -178.033 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.68 130.44 42.58 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.382 -1.449 . . . . 1.95 110.869 169.299 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.66 163.01 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 114.196 -1.365 . . . . 0.96 110.232 -173.969 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -104.06 151.25 38.94 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 117.963 -2.961 . . . . 2.35 112.427 158.476 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -75.99 -7.29 18.16 Favored 'Trans proline' 0 N--CA 1.434 -1.998 1 CA-C-N 129.621 4.472 . . . . 0.95 117.359 -176.262 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.3 m -82.34 -9.95 59.27 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 128.36 2.664 . . . . 1.45 113.515 173.565 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -76.27 158.2 31.81 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 116.195 -2.202 . . . . 1.69 109.774 177.918 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.2 p -87.36 158.46 19.02 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 116.304 1.964 . . . . 0.75 116.304 177.307 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.0 mp -55.13 -46.02 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 118.402 -0.808 . . . . 0.73 111.428 172.187 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.264 42.9 tt0 -41.39 -44.41 2.81 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 120.11 3.374 . . . . 1.62 120.11 163.586 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -83.36 -34.26 25.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.346 -3.346 . . . . 2.13 110.524 -177.077 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.0 t -62.44 -37.82 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 O-C-N 117.016 -3.553 . . . . 0.62 108.076 170.727 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -67.17 -24.63 65.89 Favored 'General case' 0 N--CA 1.431 -1.412 1 CA-C-O 128.715 4.102 . . . . 1.22 119.518 175.64 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.6 -16.39 62.62 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 117.974 -2.954 . . . . 0.51 113.403 169.105 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -87.48 -30.94 20.27 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 116.008 -4.182 . . . . 1.44 112.429 179.01 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.287 51.3 mt -66.16 -19.01 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-O 124.519 2.104 . . . . 1.32 108.518 173.155 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -75.05 -43.97 50.35 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.681 -2.512 . . . . 1.7 112.295 178.458 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -65.81 -53.8 35.29 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.668 1.187 . . . . 1.55 110.143 168.948 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -59.89 -69.71 0.2 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.209 1.48 . . . . 2.62 112.64 -173.179 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -90.13 -40.82 12.0 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 128.672 2.789 . . . . 1.48 113.517 -166.848 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.22 31.6 3.75 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 116.244 -2.884 . . . . 1.12 111.849 172.53 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.1 mt -113.17 119.11 43.04 Favored Pre-proline 0 N--CA 1.429 -1.48 0 C-N-CA 126.939 2.096 . . . . 1.55 109.816 -177.001 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -63.1 156.24 56.26 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 125.276 3.984 . . . . 1.02 116.48 175.754 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.88 -21.05 16.55 Favored 'Trans proline' 0 N--CA 1.433 -2.072 0 CA-C-N 128.114 3.934 . . . . 1.25 115.945 -170.171 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.17 -34.08 69.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.777 2.431 . . . . 2.25 115.691 167.369 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -84.8 -1.9 56.99 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 125.743 2.687 . . . . 2.02 112.974 177.952 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -114.87 129.05 56.63 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 115.342 -4.599 . . . . 0.69 111.26 -171.895 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -129.04 134.81 48.27 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 104.638 -2.356 . . . . 2.78 104.638 171.562 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.3 mt -107.38 129.04 54.96 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 128.14 2.576 . . . . 1.17 108.39 -177.77 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.7 mm -105.99 125.44 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 131.282 3.833 . . . . 1.38 102.915 -174.433 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.405 ' HB3' HD21 ' A' ' 50' ' ' LEU . 41.8 t80 -116.56 110.79 19.02 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 120.651 1.569 . . . . 1.5 107.069 170.53 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.36 -101.61 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 104.826 -2.287 . . . . 1.21 104.826 177.467 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.63 2.98 15.4 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 125.881 1.988 . . . . 1.3 113.831 -179.578 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -115.45 157.07 24.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.214 1.483 . . . . 2.55 109.274 -179.096 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -94.02 144.42 25.48 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.766 -2.679 . . . . 2.48 103.766 179.512 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.405 HD21 ' HB3' ' A' ' 45' ' ' PHE . 27.8 mt -97.12 140.4 31.69 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.769 -3.082 . . . . 0.9 109.983 -175.441 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -79.39 149.02 31.77 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.294 -1.504 . . . . 1.94 113.184 172.923 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -76.81 -37.12 56.33 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 115.655 1.724 . . . . 1.56 115.655 -173.231 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.43 44.71 2.6 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-O 116.655 -2.192 . . . . 0.97 108.0 179.55 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -126.93 160.05 32.2 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 121.315 2.558 . . . . 2.49 106.07 168.343 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -84.19 175.62 9.33 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 126.553 3.073 . . . . 0.76 112.506 169.448 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.7 mt -71.54 -42.42 67.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.929 -3.607 . . . . 1.05 110.064 171.381 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 m -60.19 -38.85 84.52 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 128.823 2.849 . . . . 1.19 114.094 171.875 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -52.59 -36.6 56.45 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.973 2.953 . . . . 1.9 118.973 171.425 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -90.53 3.05 55.1 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 116.505 2.039 . . . . 0.89 116.505 176.442 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 64.31 27.33 13.77 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.751 2.42 . . . . 1.84 114.64 -173.944 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.257 75.7 mt -69.82 140.8 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 118.943 -2.348 . . . . 0.82 108.185 178.027 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -111.41 175.6 5.36 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.475 -2.016 . . . . 2.16 111.777 -174.441 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -64.0 148.28 50.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.411 -1.431 . . . . 2.12 111.713 166.15 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.338 35.9 mt-10 77.13 21.24 1.12 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.425 -2.047 . . . . 1.71 113.41 169.175 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.95 140.91 30.02 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.982 3.313 . . . . 1.04 112.949 -173.622 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.8 m -89.62 114.83 26.49 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.911 2.884 . . . . 0.79 111.746 -178.856 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -113.52 151.8 31.06 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.851 -3.031 . . . . 1.4 104.789 175.246 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -107.57 123.75 48.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 123.505 1.621 . . . . 1.51 109.854 -169.748 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.5 tp -90.96 110.63 21.88 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.148 -2.845 . . . . 1.14 113.275 -178.034 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.9 t -105.08 128.9 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 1 N-CA-C 99.468 -4.271 . . . . 1.23 99.468 176.67 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.0 tp . . . . . 0 N--CA 1.431 -1.409 0 CA-C-N 113.357 -1.747 . . . . 2.78 109.337 177.147 . . . . . . . . 0 0 . 1 . 128 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 CA--C 1.489 -1.37 0 CA-C-O 122.74 1.257 . . . . 1.1 113.344 . . . . . . . . . 0 0 . 1 . 128 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -114.58 130.03 56.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 115.738 1.755 . . . . 1.87 115.738 -171.508 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.7 pt -120.46 151.67 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-O 115.244 -2.313 . . . . 0.72 111.686 177.693 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -110.66 118.83 37.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.674 -1.973 . . . . 1.4 105.674 -174.298 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.35 116.04 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 O-C-N 118.926 -2.359 . . . . 0.58 111.052 171.983 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.314 42.1 mtpt -104.32 136.3 44.17 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 127.997 3.76 . . . . 2.09 117.599 178.325 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 p -89.82 156.15 18.69 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.522 -2.611 . . . . 0.99 111.07 172.857 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.5 mt -63.6 -44.5 93.82 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.266 -3.396 . . . . 2.53 112.267 168.141 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.337 69.4 p -65.22 -38.47 90.5 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 116.453 -1.737 . . . . 2.08 114.009 -169.7 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.13 1.88 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 123.358 2.799 . . . . 1.31 116.009 167.802 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -98.68 144.82 27.53 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.304 3.052 . . . . 1.4 111.064 -179.587 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -131.07 139.69 49.93 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 118.028 -2.92 . . . . 0.78 106.51 168.084 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.465 HG21 HD13 ' A' ' 13' ' ' ILE . 28.4 pt -130.4 150.99 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 130.098 3.359 . . . . 1.55 106.558 179.165 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 m -107.05 127.15 53.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.946 -1.479 . . . . 1.08 108.022 175.247 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.3 mt -106.8 137.0 45.66 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 125.088 2.375 . . . . 1.55 109.81 169.754 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -89.99 126.47 35.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 128.414 3.959 . . . . 1.95 107.831 162.035 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -132.09 152.33 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 109.585 -3.461 . . . . 0.96 113.358 -173.186 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -99.99 146.18 31.47 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-O 114.776 -2.535 . . . . 2.35 106.459 168.083 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -80.42 -4.8 13.21 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 CA-C-N 128.087 3.924 . . . . 0.95 106.661 -171.302 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.4 p -85.56 -17.63 35.75 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 120.0 -1.687 . . . . 1.45 111.851 175.659 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -61.44 136.26 57.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.826 -2.421 . . . . 1.69 111.733 174.992 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.7 p -78.26 162.23 26.69 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.588 -3.195 . . . . 0.75 112.473 178.655 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.4 mm -64.35 -44.23 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-N 113.09 -1.868 . . . . 0.73 112.093 172.283 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.434 76.2 tt0 -35.26 -58.66 0.55 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.349 -3.344 . . . . 1.62 117.1 158.914 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -68.75 -34.27 75.32 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.018 -3.551 . . . . 2.13 116.253 -177.967 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.7 t -55.3 -44.6 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 118.143 -2.848 . . . . 0.62 116.907 164.518 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 43.3 mtmt -54.18 -49.82 68.44 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.045 3.338 . . . . 1.22 110.018 175.704 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.95 -26.67 67.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.875 -3.016 . . . . 0.51 112.898 178.706 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -67.83 -35.34 78.42 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.218 -2.801 . . . . 1.44 111.604 173.115 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.7 mt -71.36 -26.7 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 117.851 -1.54 . . . . 1.32 112.246 172.934 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -68.15 -37.96 81.6 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 118.854 -0.593 . . . . 1.7 110.889 -179.646 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -58.29 -44.62 88.58 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 123.45 1.595 . . . . 1.55 111.463 175.819 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -84.49 -80.55 0.2 Allowed 'General case' 0 N--CA 1.43 -1.446 1 C-N-CA 132.043 4.137 . . . . 2.62 114.302 -171.197 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -78.4 -27.13 46.69 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 123.742 1.734 . . . . 1.48 110.295 -171.965 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.23 28.63 16.89 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 118.73 -2.481 . . . . 1.12 108.262 170.395 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.9 mt -94.66 123.98 56.38 Favored Pre-proline 0 N--CA 1.431 -1.421 0 N-CA-C 103.98 -2.6 . . . . 1.55 103.98 179.961 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 9.3 Cg_exo -62.13 145.64 96.33 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 C-N-CA 116.272 -2.018 . . . . 1.02 114.249 175.685 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 88.4 Cg_exo -66.32 -22.36 53.09 Favored 'Trans proline' 0 N--CA 1.433 -2.038 1 C-N-CA 126.201 4.6 . . . . 1.25 112.751 -175.653 . . . . . . . . 3 3 . 1 . 128 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -60.3 -31.98 70.77 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 131.544 3.938 . . . . 2.25 111.375 171.264 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -97.31 1.81 49.94 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 112.76 -2.018 . . . . 2.02 112.245 -178.617 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -100.56 100.14 10.83 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.659 -2.526 . . . . 0.69 111.793 -177.331 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -96.2 95.19 7.96 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.808 -1.807 . . . . 2.78 110.371 168.489 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.1 mt -72.73 127.34 32.26 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.448 1.499 . . . . 1.17 112.891 179.358 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.9 mm -118.36 135.51 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 123.483 2.856 . . . . 1.38 109.598 175.636 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -122.42 101.23 7.38 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.958 -2.339 . . . . 1.5 107.148 175.95 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.3 . . 78.04 -91.72 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.906 1.282 . . . . 1.21 109.935 179.027 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.18 21.09 2.63 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 104.595 -3.402 . . . . 1.3 104.595 -177.567 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -112.08 120.74 42.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.051 -1.852 . . . . 2.55 111.666 178.562 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -76.22 113.7 14.07 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.637 2.375 . . . . 2.48 108.563 166.416 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.6 mt -90.82 146.06 24.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.154 2.407 . . . . 0.9 109.329 -164.04 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -83.98 164.68 19.19 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.258 1.823 . . . . 1.94 112.284 175.281 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -89.32 -53.02 4.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 116.391 -3.943 . . . . 1.56 114.048 -167.691 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.84 18.58 4.81 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 120.118 2.807 . . . . 0.97 120.118 176.046 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.285 0.0 OUTLIER -79.43 152.3 30.39 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.731 1.752 . . . . 2.49 115.731 168.596 . . . . . . . . 3 3 . 1 . 128 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.9 p -89.37 170.48 10.52 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.558 -1.201 . . . . 0.76 111.513 168.523 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.8 mt -75.6 -32.09 60.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.457 -2.027 . . . . 1.05 109.138 177.374 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.294 1.1 t -62.89 -49.4 74.99 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.728 1.611 . . . . 1.19 109.619 -179.199 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -47.2 -50.59 20.54 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.511 2.324 . . . . 1.9 111.776 172.225 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -76.71 -6.53 52.55 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 119.637 3.199 . . . . 0.89 119.637 176.118 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 65.41 41.17 4.37 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.521 2.045 . . . . 1.84 116.521 -179.693 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.406 HG23 ' HB2' ' A' ' 65' ' ' SER . 55.8 mt -95.05 114.89 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 101.71 -3.441 . . . . 0.82 101.71 179.146 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -102.26 -175.6 2.88 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.345 -1.298 . . . . 2.16 107.878 -178.072 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -61.03 142.91 56.26 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 117.448 2.388 . . . . 2.12 117.448 169.711 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.379 13.8 mt-10 75.17 19.71 2.22 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 129.965 4.541 . . . . 1.71 118.411 177.569 . . . . . . . . 3 2 . 1 . 128 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.406 ' HB2' HG23 ' A' ' 61' ' ' ILE . 19.2 m -92.74 153.52 18.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.538 2.399 . . . . 1.04 105.669 -173.445 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.8 m -106.09 103.52 13.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 131.207 3.803 . . . . 0.79 111.101 -176.358 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -94.47 168.52 10.82 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 105.045 -2.206 . . . . 1.4 105.045 174.405 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.97 162.84 32.17 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 105.499 -2.037 . . . . 1.51 105.499 -174.258 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.265 0.5 OUTLIER -144.77 121.91 11.47 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.983 -1.858 . . . . 1.14 105.983 -172.805 . . . . . . . . 3 3 . 1 . 128 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -115.69 125.65 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 129.416 3.086 . . . . 1.23 106.85 178.713 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.1 mt . . . . . 0 N--CA 1.431 -1.411 0 O-C-N 119.594 -1.941 . . . . 2.78 114.783 -175.649 . . . . . . . . 0 0 . 1 . 129 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.7 ttp . . . . . 0 CA--C 1.491 -1.318 0 N-CA-C 118.974 2.953 . . . . 1.1 118.974 . . . . . . . . . 0 0 . 1 . 129 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.11 127.12 35.41 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 119.417 -2.052 . . . . 1.87 115.091 174.045 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 pt -122.06 163.92 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.612 2.365 . . . . 0.72 114.598 166.534 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -112.0 123.62 50.65 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 116.108 -4.12 . . . . 1.4 113.835 176.169 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.8 t -110.41 113.15 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 118.622 -2.549 . . . . 0.58 108.502 171.052 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -86.37 139.92 30.51 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.894 -1.503 . . . . 2.09 110.503 -178.719 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 p -100.25 175.37 5.74 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.453 2.073 . . . . 0.99 110.412 174.815 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.6 mt -80.56 -25.19 38.74 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 114.876 -4.89 . . . . 2.53 108.892 171.599 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 p -65.88 -46.09 79.67 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.275 -3.39 . . . . 2.08 113.717 -176.092 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.2 6.56 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 112.134 -2.303 . . . . 1.31 117.345 173.765 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -98.85 150.62 21.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 128.157 3.837 . . . . 1.4 114.187 -173.199 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.2 m -114.98 90.93 3.46 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.722 -3.111 . . . . 0.78 105.578 169.822 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mt -80.9 111.15 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 O-C-N 120.805 -1.184 . . . . 1.55 109.36 -179.807 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.4 m -77.17 107.22 9.4 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.144 -2.223 . . . . 1.08 109.584 170.936 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.6 mt -103.64 148.6 25.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 126.764 3.173 . . . . 1.55 104.912 173.828 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -120.44 129.35 53.85 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.172 2.189 . . . . 1.95 113.1 166.703 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.0 m -143.02 174.07 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.486 -2.413 . . . . 0.96 104.486 -178.937 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -96.82 154.03 38.46 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 104.699 -2.334 . . . . 2.35 104.699 165.06 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -73.79 -15.56 23.92 Favored 'Trans proline' 0 C--N 1.3 -2.003 1 C-N-CA 125.871 4.381 . . . . 0.95 112.239 -176.252 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.1 p -94.34 5.57 51.37 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.758 -3.089 . . . . 1.45 115.236 172.225 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -71.39 154.91 41.21 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.85 -1.157 . . . . 1.69 110.426 168.112 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 65.7 p -92.12 159.5 15.64 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.185 -1.043 . . . . 0.75 108.185 176.752 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -63.53 -16.49 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.463 1.905 . . . . 0.73 113.27 -179.543 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -62.93 -32.58 73.91 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.316 1.846 . . . . 1.62 115.781 166.68 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -72.78 -35.99 67.52 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.887 2.075 . . . . 2.13 111.788 168.765 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.9 t -57.53 -51.53 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 118.945 -2.347 . . . . 0.62 114.381 169.66 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -65.38 -35.99 82.64 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 129.152 2.981 . . . . 1.22 111.339 176.363 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.37 -45.54 69.26 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 116.045 1.868 . . . . 0.51 116.045 174.021 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -74.58 -28.56 60.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.599 1.559 . . . . 1.44 110.256 -179.837 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.6 mt -78.82 -29.17 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 1 O-C-N 115.457 -4.527 . . . . 1.32 114.083 172.669 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -67.31 -32.29 73.17 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.523 -3.236 . . . . 1.7 113.061 170.022 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -61.0 -49.11 78.77 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.247 2.314 . . . . 1.55 117.247 169.666 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -89.23 -43.99 10.6 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.123 2.268 . . . . 2.62 117.123 -176.897 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -99.66 -36.87 9.35 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.434 -2.666 . . . . 1.48 113.182 -172.289 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.83 68.09 1.3 Allowed Glycine 0 N--CA 1.43 -1.704 0 CA-C-N 110.81 -2.905 . . . . 1.12 111.775 172.144 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 mt -126.85 119.2 22.49 Favored Pre-proline 0 N--CA 1.429 -1.508 0 O-C-N 126.637 2.022 . . . . 1.55 108.343 174.32 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 9.1 Cg_exo -55.87 145.48 72.83 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-O 113.104 -2.956 . . . . 1.02 117.637 176.174 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 27.6 Cg_exo -58.66 -22.52 61.12 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 123.418 2.746 . . . . 1.25 115.142 -175.025 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.02 -43.15 99.46 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 131.109 3.764 . . . . 2.25 109.357 173.887 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -83.79 -14.79 50.57 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 117.152 2.279 . . . . 2.02 117.152 -176.962 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -85.45 104.57 15.36 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 118.871 -2.393 . . . . 0.69 113.131 -175.726 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -96.23 101.04 12.63 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 106.327 -1.731 . . . . 2.78 106.327 175.16 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.4 mt -87.16 125.43 34.16 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.965 -2.334 . . . . 1.17 116.554 173.387 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.5 mm -108.57 106.36 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 118.853 -2.404 . . . . 1.38 109.114 178.226 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -92.99 91.97 7.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 118.977 -1.089 . . . . 1.5 110.578 171.149 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.49 -65.93 0.25 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.719 2.408 . . . . 1.21 112.811 -172.657 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.91 -14.82 0.4 Allowed Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 126.718 2.104 . . . . 1.3 112.923 -178.954 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -90.59 129.03 36.76 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 115.299 -2.56 . . . . 2.55 109.926 -176.83 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -83.17 117.24 22.77 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.302 -2.124 . . . . 2.48 112.309 165.934 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.7 mt -79.05 163.53 25.08 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 120.925 -1.109 . . . . 0.9 109.586 -166.181 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -125.64 128.53 47.99 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.329 1.852 . . . . 1.94 108.793 176.354 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.345 30.4 m-20 -45.62 -50.61 13.15 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.079 2.952 . . . . 1.56 115.489 -174.795 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.15 20.59 15.7 Favored Glycine 0 N--CA 1.43 -1.765 1 O-C-N 115.535 -4.478 . . . . 0.97 114.343 175.675 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -107.22 142.89 36.24 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 116.147 -4.149 . . . . 2.49 105.723 168.692 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 17.5 p -70.09 168.51 15.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.949 -1.023 . . . . 0.76 113.136 175.803 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.455 ' HG ' HD12 ' A' ' 61' ' ' ILE . 6.3 mp -67.09 -42.32 84.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.683 1.993 . . . . 1.05 112.984 173.73 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.2 p -52.79 -26.57 14.75 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 131.515 3.926 . . . . 1.19 112.216 179.455 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -75.77 -51.45 12.62 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-O 126.571 3.081 . . . . 1.9 116.922 175.697 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.272 35.3 m-85 -83.31 9.32 11.12 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.831 -3.043 . . . . 0.89 114.691 174.119 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.7 t30 47.31 59.18 4.24 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 118.801 2.889 . . . . 1.84 118.801 -176.379 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.455 HD12 ' HG ' ' A' ' 56' ' ' LEU . 78.8 mt -93.95 122.3 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 104.489 -2.411 . . . . 0.82 104.489 179.523 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -121.35 -160.99 0.88 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 122.217 2.28 . . . . 2.16 111.742 -173.12 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -59.44 136.06 57.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 119.173 3.027 . . . . 2.12 119.173 175.649 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.295 42.8 mt-10 64.04 25.65 13.86 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.206 -2.184 . . . . 1.71 114.738 172.914 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.7 m -75.18 137.55 41.37 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 128.005 2.522 . . . . 1.04 114.817 179.862 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.2 m -91.66 104.79 17.22 Favored 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 127.105 2.753 . . . . 0.79 114.62 -176.632 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -92.62 128.6 38.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 116.785 -1.579 . . . . 1.4 111.588 171.551 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -96.47 114.73 26.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 104.407 -2.442 . . . . 1.51 104.407 -177.803 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.4 tp -92.38 120.55 33.01 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.584 -3.197 . . . . 1.14 106.91 -177.424 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.84 153.74 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 126.251 2.22 . . . . 1.23 106.159 174.956 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.9 tp . . . . . 0 N--CA 1.43 -1.468 0 C-N-CA 116.056 -2.258 . . . . 2.78 105.586 175.978 . . . . . . . . 0 0 . 1 . 130 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.418 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 5.5 ttt . . . . . 0 CA--C 1.49 -1.35 0 CA-C-O 117.206 -1.378 . . . . 1.1 109.387 . . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -86.33 135.17 33.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 115.895 -2.002 . . . . 1.87 113.301 -171.833 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 pt -129.91 153.06 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 122.105 2.23 . . . . 0.72 107.238 170.577 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.331 11.6 m-85 -115.82 122.62 45.94 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 116.876 -1.93 . . . . 1.4 110.974 177.298 . . . . . . . . 2 2 . 1 . 130 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.05 108.48 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 117.749 -3.094 . . . . 0.58 111.548 177.463 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -87.79 120.43 29.1 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.931 1.825 . . . . 2.09 108.537 -173.487 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.2 p -79.4 169.37 18.18 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 115.484 -4.51 . . . . 0.99 113.165 174.686 . . . . . . . . 2 2 . 1 . 130 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.3 mt -73.79 -26.35 60.58 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.004 -3.56 . . . . 2.53 112.222 164.851 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.5 p -75.25 -34.16 61.38 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 124.216 1.006 . . . . 2.08 111.824 -171.197 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.97 -8.0 2.44 Favored Glycine 0 N--CA 1.431 -1.678 0 CA-C-O 115.829 -2.651 . . . . 1.31 116.635 177.384 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -97.89 136.29 38.4 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 126.318 1.834 . . . . 1.4 109.983 -174.122 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -111.94 96.14 5.88 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.433 1.111 . . . . 0.78 109.363 169.759 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.7 pt -91.85 125.31 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 113.852 -1.522 . . . . 1.55 113.366 -175.149 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.8 m -91.22 109.6 20.87 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.424 -2.673 . . . . 1.08 105.443 -171.734 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.7 mt -93.34 153.16 18.7 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.371 -2.705 . . . . 1.55 108.306 176.826 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -92.78 121.56 34.28 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.524 1.929 . . . . 1.95 113.219 165.396 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 1' ' ' MET . 28.9 m -137.26 173.21 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 123.634 1.683 . . . . 0.96 108.082 176.741 . . . . . . . . 2 2 . 1 . 130 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -121.8 154.97 60.77 Favored Pre-proline 0 N--CA 1.43 -1.439 0 O-C-N 117.999 -2.938 . . . . 2.35 108.529 162.869 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.287 40.1 Cg_endo -64.4 -18.6 63.63 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 C-N-CA 123.133 2.555 . . . . 0.95 117.493 -172.611 . . . . . . . . 2 2 . 1 . 130 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.2 m -89.31 7.78 33.85 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.397 2.046 . . . . 1.45 115.596 178.58 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -81.05 146.68 30.51 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 130.037 3.335 . . . . 1.69 108.238 173.984 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.308 30.3 p -75.39 164.83 26.0 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 118.324 -1.351 . . . . 0.75 113.073 172.986 . . . . . . . . 2 2 . 1 . 130 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.5 mt -78.97 -35.7 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 108.063 -1.088 . . . . 0.73 108.063 178.859 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -47.07 -41.68 17.43 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.918 2.192 . . . . 1.62 116.918 162.796 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -64.95 -38.31 90.53 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.671 -4.393 . . . . 2.13 112.235 175.41 . . . . . . . . 2 2 . 1 . 130 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.413 HG22 HG11 ' A' ' 17' ' ' VAL . 68.3 t -69.49 -28.21 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 114.703 1.372 . . . . 0.62 114.703 174.489 . . . . . . . . 2 2 . 1 . 130 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -69.8 -30.24 67.72 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.712 -2.492 . . . . 1.22 112.117 169.247 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.47 -27.23 65.05 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.56 -1.963 . . . . 0.51 110.909 174.418 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? -72.61 -35.86 67.95 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 120.748 1.613 . . . . 1.44 111.399 172.745 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.9 mt -60.54 -46.22 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 O-C-N 116.381 -3.949 . . . . 1.32 112.486 167.515 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -57.26 -45.73 83.73 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 117.968 -2.957 . . . . 1.7 116.449 175.016 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -45.31 -40.87 8.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 125.455 2.55 . . . . 1.55 114.804 166.907 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -87.5 -59.24 2.3 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.691 -3.13 . . . . 2.62 114.824 -173.966 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -97.4 -25.59 15.16 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.954 1.835 . . . . 1.48 109.009 -165.921 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.29 52.77 4.11 Favored Glycine 0 N--CA 1.429 -1.809 1 O-C-N 115.136 -4.727 . . . . 1.12 116.287 -178.175 . . . . . . . . 2 2 . 1 . 130 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.2 mt -130.57 109.81 16.07 Favored Pre-proline 0 N--CA 1.429 -1.505 0 CA-C-N 112.223 -1.988 . . . . 1.55 109.738 -176.81 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -60.59 139.09 84.12 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 N-CA-C 120.948 3.403 . . . . 1.02 120.948 -179.919 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.85 -27.92 29.16 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 C-N-CA 124.948 3.765 . . . . 1.25 117.088 -176.197 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.58 -34.63 72.95 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 123.211 2.732 . . . . 2.25 115.954 171.488 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -80.0 4.32 17.36 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 113.639 -3.077 . . . . 2.02 108.899 -175.057 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -141.98 150.6 41.59 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 125.118 3.599 . . . . 0.69 108.897 -176.832 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -130.46 149.91 51.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.195 -2.816 . . . . 2.78 105.317 168.601 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.3 mt -106.47 149.74 26.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.951 2.159 . . . . 1.17 112.657 174.859 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.5 mt -128.52 132.79 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 108.452 -0.944 . . . . 1.38 108.452 178.911 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.264 50.4 t80 -117.07 121.05 40.21 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.537 1.637 . . . . 1.5 106.705 178.358 . . . . . . . . 2 2 . 1 . 130 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.52 -82.27 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.001 -3.562 . . . . 1.21 113.479 174.826 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.77 -26.02 1.47 Allowed Glycine 0 N--CA 1.43 -1.731 0 CA-C-N 122.356 2.344 . . . . 1.3 113.459 176.181 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -100.49 150.2 22.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.991 3.757 . . . . 2.55 117.466 178.875 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -74.48 133.51 42.34 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.982 -2.949 . . . . 2.48 112.718 172.601 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.0 mt -84.4 126.07 32.9 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.939 -2.975 . . . . 0.9 115.27 -171.856 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.18 125.57 24.94 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 125.953 2.787 . . . . 1.94 109.18 173.919 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -63.59 -45.7 89.2 Favored 'General case' 0 N--CA 1.429 -1.491 1 O-C-N 114.466 -5.146 . . . . 1.56 116.957 -172.81 . . . . . . . . 2 2 . 1 . 130 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.22 33.57 3.37 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-O 124.799 2.333 . . . . 0.97 118.504 177.226 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -110.83 167.14 10.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.878 -2.542 . . . . 2.49 112.134 167.071 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.9 p -87.4 176.83 7.32 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.802 2.841 . . . . 0.76 111.898 170.761 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.5 mt -82.25 -41.39 20.27 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 127.135 2.174 . . . . 1.05 108.645 -178.72 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.0 p -59.35 -41.56 89.51 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 129.205 3.002 . . . . 1.19 111.353 176.189 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -48.72 -52.01 25.81 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 128.704 2.802 . . . . 1.9 112.626 172.725 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -86.81 -3.69 59.09 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 115.606 1.706 . . . . 0.89 115.606 179.584 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.6 m120 73.47 37.87 0.68 Allowed 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.696 -1.138 . . . . 1.84 112.167 177.036 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.3 mt -84.97 129.08 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 119.713 -1.867 . . . . 0.82 113.17 173.614 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -116.53 -175.83 2.84 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.996 2.808 . . . . 2.16 113.2 -176.361 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -40.66 121.63 1.5 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 112.214 -2.266 . . . . 2.12 116.06 172.949 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 59.89 50.86 6.44 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 119.261 3.06 . . . . 1.71 119.261 179.06 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.1 m -89.79 133.92 34.46 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 116.479 -1.724 . . . . 1.04 112.207 -178.721 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.4 m -81.48 109.08 15.61 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 126.986 2.678 . . . . 0.79 110.538 179.087 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.58 169.71 8.36 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.465 1.939 . . . . 1.4 110.247 176.652 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -125.3 146.64 49.47 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.217 1.007 . . . . 1.51 108.887 -176.372 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.99 132.11 56.1 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 115.008 -2.425 . . . . 1.14 107.723 172.916 . . . . . . . . 2 2 . 1 . 130 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.6 m -121.26 164.24 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 121.889 2.131 . . . . 1.23 114.797 171.526 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.2 tp . . . . . 0 N--CA 1.431 -1.417 0 O-C-N 118.076 -2.89 . . . . 2.78 110.899 -179.484 . . . . . . . . 0 0 . 1 . 131 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.6 ttp . . . . . 0 CA--C 1.49 -1.354 0 CA-C-O 125.828 2.728 . . . . 1.1 109.936 . . . . . . . . . 0 0 . 1 . 131 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -69.56 127.98 34.88 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 115.409 -2.234 . . . . 1.87 112.559 178.167 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.318 7.4 pt -133.27 150.03 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 107.151 -1.426 . . . . 0.72 107.151 172.511 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -118.74 118.7 32.31 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.798 2.237 . . . . 1.4 112.942 -176.099 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -102.7 112.21 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.786 -3.071 . . . . 0.58 108.489 -179.993 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.506 ' HE3' HG21 ' A' ' 66' ' ' THR . 75.9 mttt -96.1 138.31 33.9 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.021 -3.549 . . . . 2.09 111.334 177.699 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 p -89.25 -176.4 5.09 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 122.789 1.28 . . . . 0.99 112.602 178.551 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.4 tp -86.03 -34.59 20.72 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.2 -2.188 . . . . 2.53 110.311 170.4 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.7 p -56.6 -57.28 13.07 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.145 2.578 . . . . 2.08 113.327 -178.753 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.36 24.32 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.701 0 O-C-N 117.816 -3.052 . . . . 1.31 114.254 171.745 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -106.92 146.43 31.02 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.729 2.411 . . . . 1.4 105.705 -178.001 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.7 m -116.98 97.38 5.92 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.537 3.135 . . . . 0.78 103.054 171.154 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -80.41 116.77 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 106.44 -1.689 . . . . 1.55 106.44 -176.785 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 m -88.07 114.76 25.0 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.597 -4.439 . . . . 1.08 109.613 175.21 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.8 mt -113.75 161.43 17.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 128.128 3.392 . . . . 1.55 108.829 178.127 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -118.01 112.66 20.56 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.386 2.993 . . . . 1.95 108.256 170.313 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.6 m -107.48 160.14 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.191 -2.818 . . . . 0.96 112.954 176.529 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -105.2 143.32 26.51 Favored Pre-proline 0 N--CA 1.43 -1.43 0 O-C-N 118.925 -2.359 . . . . 2.35 107.923 164.705 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -76.51 -13.53 18.33 Favored 'Trans proline' 0 C--N 1.299 -2.044 1 C-N-CA 127.476 5.45 . . . . 0.95 116.079 -166.118 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -85.79 -2.16 57.95 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 121.413 1.915 . . . . 1.45 109.175 176.889 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -73.73 159.72 32.57 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 120.344 3.461 . . . . 1.69 120.344 169.68 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 30.3 p -79.75 163.53 24.4 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.869 -1.77 . . . . 0.75 114.988 177.521 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.7 mm -73.04 -25.23 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 118.344 -1.343 . . . . 0.73 111.421 177.307 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -50.93 -36.67 39.76 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.752 -2.467 . . . . 1.62 116.566 162.818 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -69.05 -24.67 64.2 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.671 2.789 . . . . 2.13 109.104 -177.825 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.34 -59.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 104.539 -2.393 . . . . 0.62 104.539 175.699 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -49.76 -38.57 34.52 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.123 2.569 . . . . 1.22 113.512 173.441 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.89 -30.93 71.22 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 123.097 2.68 . . . . 0.51 114.893 178.78 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -71.75 -29.12 64.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.865 -1.147 . . . . 1.44 112.477 175.202 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.5 mt -73.06 -33.28 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-O 125.912 2.768 . . . . 1.32 111.685 171.157 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -73.81 -41.93 61.65 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.113 -3.492 . . . . 1.7 105.927 177.04 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -61.64 -36.51 80.99 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.649 -2.532 . . . . 1.55 115.923 174.645 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -84.18 -51.22 7.21 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.04 -3.538 . . . . 2.62 113.085 -175.082 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -104.68 -36.83 7.31 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.271 -2.143 . . . . 1.48 114.574 -169.994 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.05 16.83 17.8 Favored Glycine 0 N--CA 1.429 -1.81 0 C-N-CA 115.381 -3.295 . . . . 1.12 110.249 175.263 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.9 mt -95.92 134.84 23.34 Favored Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 102.44 -3.17 . . . . 1.55 102.44 -175.073 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.428 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 17.2 Cg_exo -67.05 156.9 64.3 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 125.924 3.152 . . . . 1.02 114.904 174.558 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -85.9 -14.96 4.99 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 CA-C-N 124.728 2.724 . . . . 1.25 115.586 -174.16 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -67.25 -29.96 69.72 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 114.808 -2.52 . . . . 2.25 108.954 169.044 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -83.05 -19.9 35.99 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 123.238 2.745 . . . . 2.02 113.183 -176.856 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 37' ' ' PRO . 77.7 mt-30 -87.8 107.59 18.73 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.7 2.0 . . . . 0.69 110.264 -170.709 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -99.08 122.84 42.85 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.446 -1.687 . . . . 2.78 106.446 171.525 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.4 mt -104.0 127.31 51.55 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 124.846 1.341 . . . . 1.17 110.568 176.417 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.1 mt -115.16 115.4 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 119.388 -2.07 . . . . 1.38 108.314 179.847 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -104.07 102.76 12.5 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 113.456 -1.702 . . . . 1.5 107.477 175.002 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.02 -94.05 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.189 1.796 . . . . 1.21 110.353 -178.478 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.4 -19.08 6.35 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 128.25 2.833 . . . . 1.3 114.406 -177.443 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -98.55 137.08 37.72 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 125.946 2.784 . . . . 2.55 105.304 -175.876 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.4 113.97 26.26 Favored 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 119.224 -2.173 . . . . 2.48 107.168 172.972 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.4 mt -77.36 144.43 37.98 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 121.524 1.966 . . . . 0.9 115.195 -163.134 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -90.24 150.39 21.98 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.878 2.471 . . . . 1.94 113.812 173.018 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -70.47 -59.77 2.66 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.755 2.422 . . . . 1.56 115.543 -168.086 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.92 22.55 0.9 Allowed Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 122.155 3.622 . . . . 0.97 122.155 169.987 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -97.91 162.72 13.1 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.137 -2.978 . . . . 2.49 109.06 168.633 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 44.6 p -100.12 176.79 5.28 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 124.007 3.094 . . . . 0.76 112.712 178.094 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 mt -65.75 -34.47 78.25 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.34 -2.1 . . . . 1.05 109.133 172.961 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -57.82 -42.78 84.99 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.814 1.783 . . . . 1.19 115.814 174.318 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -71.64 -30.32 65.62 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.609 -3.182 . . . . 1.9 115.129 -177.272 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -93.11 2.62 56.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 119.132 0.878 . . . . 0.89 113.063 176.017 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.9 m120 51.17 70.76 0.5 Allowed 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 130.705 3.602 . . . . 1.84 113.06 -176.009 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.6 mt -104.84 120.48 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 118.715 -2.491 . . . . 0.82 111.654 -179.344 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -110.85 176.53 4.99 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 111.053 -2.794 . . . . 2.16 115.743 -176.618 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -51.79 118.43 3.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 120.028 3.344 . . . . 2.12 120.028 173.74 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.386 26.2 mt-10 84.56 35.75 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.302 2.001 . . . . 1.71 111.657 171.109 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.8 m -89.64 146.62 24.42 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.618 -2.552 . . . . 1.04 114.145 -174.633 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.506 HG21 ' HE3' ' A' ' 6' ' ' LYS . 5.3 m -108.1 107.96 18.84 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.672 -1.268 . . . . 0.79 112.341 -177.637 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -103.39 143.6 32.47 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 103.466 -2.79 . . . . 1.4 103.466 178.964 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.294 62.3 m80 -104.5 131.64 51.65 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 104.754 -2.313 . . . . 1.51 104.754 -177.095 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.5 tp -95.83 110.56 22.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.943 2.306 . . . . 1.14 108.112 178.899 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 t -110.74 131.91 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 119.108 -2.245 . . . . 1.23 107.855 172.345 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.0 mt . . . . . 0 N--CA 1.43 -1.439 0 CA-C-N 115.153 -0.93 . . . . 2.78 112.329 176.035 . . . . . . . . 0 0 . 1 . 132 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 ptt? . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 111.909 0.337 . . . . 1.1 111.909 . . . . . . . . . 0 0 . 1 . 132 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -98.59 144.16 28.19 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 126.569 3.08 . . . . 1.87 106.144 -178.518 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.7 pt -130.62 152.91 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 1 N-CA-C 99.206 -4.368 . . . . 0.72 99.206 178.136 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -109.79 126.29 53.62 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.532 -2.605 . . . . 1.4 110.496 179.666 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.4 t -96.26 115.7 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 120.599 -1.313 . . . . 0.58 108.147 168.952 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -91.77 137.95 31.95 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 106.044 -1.836 . . . . 2.09 106.044 177.162 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -87.82 -164.59 1.13 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.68 -1.263 . . . . 0.99 113.348 178.627 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.9 mt -82.09 -39.03 23.98 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 124.344 1.027 . . . . 2.53 110.359 176.216 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.289 44.9 p -75.41 -10.96 59.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.701 2.4 . . . . 2.08 108.946 -177.329 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.28 39.42 5.69 Favored Glycine 0 N--CA 1.431 -1.664 1 C-N-CA 135.1 6.095 . . . . 1.31 114.094 172.473 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -90.05 132.4 35.41 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.099 1.95 . . . . 1.4 106.788 -171.309 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.8 m -88.87 111.43 22.06 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.18 -2.2 . . . . 0.78 108.357 -174.627 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.8 mt -104.47 115.49 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 115.569 1.692 . . . . 1.55 115.569 176.429 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 m -81.66 115.85 21.12 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 120.719 -1.238 . . . . 1.08 110.585 -179.129 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.0 mt -121.67 147.89 45.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 115.249 -2.31 . . . . 1.55 111.902 177.625 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -99.69 119.31 37.91 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 120.877 1.671 . . . . 1.95 115.48 171.63 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.82 167.75 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 130.403 3.481 . . . . 0.96 108.779 -177.598 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -118.62 167.44 11.63 Favored Pre-proline 0 N--CA 1.43 -1.47 0 O-C-N 118.477 -2.639 . . . . 2.35 106.953 162.41 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -67.54 -16.54 47.37 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 CA-C-N 125.248 2.91 . . . . 0.95 115.532 -170.654 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -74.86 -15.59 60.71 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 131.265 3.826 . . . . 1.45 117.905 174.41 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -69.66 138.34 52.93 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.061 -2.275 . . . . 1.69 115.09 171.024 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 26' ' ' VAL . 36.1 p -79.16 179.52 7.32 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.187 -1.824 . . . . 0.75 114.76 -175.842 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -78.42 -33.75 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 118.934 -2.354 . . . . 0.73 110.799 176.513 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -49.9 -41.96 46.96 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.74 -3.1 . . . . 1.62 116.856 159.182 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.263 40.6 m-20 -76.48 -32.77 58.55 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 112.9 -3.429 . . . . 2.13 113.212 177.677 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 22' ' ' THR . 1.9 t -66.44 -50.5 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 126.954 2.659 . . . . 0.62 113.363 167.855 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.6 mtmt -60.01 -31.17 69.69 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.078 -2.889 . . . . 1.22 116.601 169.109 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.78 -45.38 78.2 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.781 2.141 . . . . 0.51 116.781 170.307 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -65.71 -41.25 92.52 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.383 -3.948 . . . . 1.44 115.374 179.481 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.6 mm -56.83 -40.51 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.147 1.779 . . . . 1.32 113.685 166.773 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -59.81 -55.5 33.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.577 1.951 . . . . 1.7 115.168 171.693 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -46.82 -57.37 4.97 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 130.271 3.428 . . . . 1.55 112.528 175.26 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -85.89 -62.14 1.59 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.371 1.868 . . . . 2.62 112.525 -166.847 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -76.68 -23.01 53.2 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.406 2.002 . . . . 1.48 116.406 -175.459 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.59 20.11 38.72 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 118.556 2.182 . . . . 1.12 118.556 172.876 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.1 mt -101.51 134.79 20.04 Favored Pre-proline 0 N--CA 1.43 -1.465 0 CA-C-O 113.491 -3.147 . . . . 1.55 116.75 -174.564 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -64.52 132.56 33.7 Favored 'Trans proline' 0 C--N 1.3 -2.009 1 C-N-CA 126.319 4.679 . . . . 1.02 116.819 -179.046 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -63.36 -14.71 43.83 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 CA-C-N 127.792 3.819 . . . . 1.25 116.467 -179.026 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -60.31 -27.91 67.69 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 117.758 2.503 . . . . 2.25 117.758 168.615 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -93.12 -29.52 15.72 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.599 -1.313 . . . . 2.02 108.669 -176.951 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -72.77 126.33 29.65 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 126.341 2.972 . . . . 0.69 112.972 -171.759 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -126.78 146.94 50.05 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 111.52 -2.582 . . . . 2.78 109.478 167.328 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 mt -117.28 127.64 54.28 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 114.158 1.17 . . . . 1.17 114.158 175.429 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mm -119.52 126.72 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 118.848 -2.407 . . . . 1.38 106.151 -175.999 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.496 ' CD2' HG12 ' A' ' 61' ' ' ILE . 49.0 t80 -137.79 121.17 17.06 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.865 -3.022 . . . . 1.5 103.328 176.038 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.25 . . 43.51 62.54 1.85 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.216 3.006 . . . . 1.21 113.35 179.942 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.72 -31.96 2.7 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 120.346 2.898 . . . . 1.3 120.346 177.863 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -89.79 127.02 35.9 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.568 1.947 . . . . 2.55 114.261 -178.31 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -73.68 116.38 14.2 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 115.708 -2.091 . . . . 2.48 108.521 173.156 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 mt -76.96 136.43 38.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 116.761 2.134 . . . . 0.9 116.761 -168.648 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -87.73 139.35 30.62 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 121.376 3.843 . . . . 1.94 121.376 179.826 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -47.01 -55.33 8.37 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 121.25 3.796 . . . . 1.56 121.25 -166.403 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.05 35.5 4.74 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 125.94 1.733 . . . . 0.97 116.902 179.433 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.3 mtt-85 -114.47 172.6 6.92 Favored 'General case' 0 N--CA 1.429 -1.482 1 O-C-N 116.0 -4.235 . . . . 2.49 100.864 168.496 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.6 p -104.73 170.0 8.13 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.061 3.344 . . . . 0.76 114.282 179.07 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.8 mt -60.75 -41.62 95.77 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.813 1.412 . . . . 1.05 114.813 169.247 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.0 t -64.41 -28.26 69.56 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.575 2.131 . . . . 1.19 116.259 -178.46 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -59.17 -37.51 77.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.772 -3.705 . . . . 1.9 110.741 173.563 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -94.51 1.2 55.72 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.678 -1.264 . . . . 0.89 109.873 -179.301 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.303 32.8 m120 53.82 51.3 15.14 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 126.946 2.098 . . . . 1.84 111.032 -177.716 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.496 HG12 ' CD2' ' A' ' 45' ' ' PHE . 76.8 mt -94.36 107.96 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 104.906 -2.257 . . . . 0.82 104.906 179.985 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -81.79 -171.72 3.5 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 125.864 2.745 . . . . 2.16 111.773 -179.69 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -70.04 165.53 21.66 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 113.437 -5.789 . . . . 2.12 111.319 168.298 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 63.57 22.96 13.41 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.239 1.971 . . . . 1.71 110.801 177.127 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -98.86 125.57 44.29 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 125.434 1.494 . . . . 1.04 107.285 -170.693 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.1 m -93.55 113.95 26.19 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 122.165 0.983 . . . . 0.79 111.029 -178.121 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -101.71 129.5 47.89 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 129.327 3.051 . . . . 1.4 113.06 -179.633 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -86.82 111.44 20.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 127.331 3.443 . . . . 1.51 111.652 -171.352 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 tp -87.68 111.39 21.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 116.874 -3.641 . . . . 1.14 108.564 -177.918 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 37.7 t -106.16 120.66 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 128.209 2.604 . . . . 1.23 109.098 -177.191 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.9 mt . . . . . 0 N--CA 1.429 -1.477 0 C-N-CA 125.823 1.649 . . . . 2.78 106.82 -179.523 . . . . . . . . 0 0 . 1 . 133 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptt? . . . . . 0 CA--C 1.49 -1.352 0 CA-C-O 122.833 1.301 . . . . 1.1 114.384 . . . . . . . . . 0 0 . 1 . 133 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -108.86 130.31 55.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.54 -3.85 . . . . 1.87 107.148 -168.644 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -128.7 163.84 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 127.396 2.278 . . . . 0.72 110.711 173.728 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -123.33 129.26 51.07 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 112.714 -2.039 . . . . 1.4 113.717 179.91 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -111.96 118.61 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 118.917 -1.113 . . . . 0.58 108.607 172.191 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -89.28 134.25 34.13 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.073 -2.267 . . . . 2.09 113.74 171.089 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.403 HG22 HD23 ' A' ' 69' ' ' LEU . 81.4 p -85.82 167.73 14.92 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.833 2.16 . . . . 0.99 116.833 177.916 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.2 mt -69.07 -40.41 78.5 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 127.145 3.355 . . . . 2.53 109.793 175.348 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.274 17.2 p -57.1 -60.68 3.24 Favored 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 114.878 -4.889 . . . . 2.08 119.021 174.85 . . . . . . . . 3 2 . 1 . 133 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.67 6.33 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.768 0 CA-C-N 119.879 1.218 . . . . 1.31 112.642 177.811 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.2 ttpt -95.63 142.63 27.72 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 121.55 2.675 . . . . 1.4 109.769 -174.937 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.0 m -112.3 120.91 43.35 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.616 -1.624 . . . . 0.78 106.616 174.496 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 mt -102.09 123.91 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 116.494 -1.717 . . . . 1.55 106.933 -177.676 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.1 m -90.37 119.6 30.8 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 124.763 1.29 . . . . 1.08 111.002 175.726 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.0 mt -111.76 137.22 49.98 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 115.358 1.614 . . . . 1.55 115.358 178.713 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -91.49 119.63 31.61 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 117.95 2.574 . . . . 1.95 117.95 165.586 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.8 m -139.3 -178.25 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.414 1 N-CA-C 99.64 -4.207 . . . . 0.96 99.64 -175.303 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -123.29 159.81 53.02 Favored Pre-proline 0 N--CA 1.43 -1.43 1 O-C-N 115.779 -4.326 . . . . 2.35 104.456 163.234 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 48.3 Cg_endo -69.47 -7.96 22.34 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 125.026 3.817 . . . . 0.95 112.802 -173.273 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.2 p -80.52 -7.1 59.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.541 2.736 . . . . 1.45 114.528 171.405 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -83.4 145.04 29.22 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.965 -2.334 . . . . 1.69 109.997 175.875 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.35 41.4 p -75.17 154.75 37.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 118.282 2.697 . . . . 0.75 118.282 176.143 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.6 mm -58.36 -29.78 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 127.07 2.148 . . . . 0.73 113.765 171.486 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.62 -32.87 74.68 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.197 2.599 . . . . 1.62 110.815 167.465 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -72.53 -28.66 62.99 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 126.078 1.751 . . . . 2.13 111.541 179.758 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.42 -50.23 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 131.39 3.876 . . . . 0.62 110.605 168.496 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -69.18 -27.64 65.69 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 115.361 1.615 . . . . 1.22 115.361 173.045 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.25 . . -72.79 -39.36 66.77 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.411 -1.431 . . . . 0.51 109.328 -178.945 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -66.49 -39.61 88.82 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.326 3.05 . . . . 1.44 112.62 169.445 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.63 -30.85 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 117.674 -3.141 . . . . 1.32 114.796 169.478 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -65.09 -60.86 2.56 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.814 -1.804 . . . . 1.7 109.444 174.053 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -45.7 -39.57 8.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.929 2.937 . . . . 1.55 118.929 172.02 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -91.81 -63.2 1.28 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.582 2.753 . . . . 2.62 107.481 -172.282 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -93.11 -17.79 23.37 Favored 'General case' 0 N--CA 1.429 -1.521 0 O-C-N 117.272 -3.393 . . . . 1.48 115.541 -169.233 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.55 -4.84 62.06 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 108.712 -1.755 . . . . 1.12 108.712 170.793 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.2 mt -75.06 133.84 75.09 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 125.077 1.351 . . . . 1.55 112.785 -176.879 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -75.9 138.29 20.77 Favored 'Trans proline' 0 N--CA 1.433 -2.043 0 CA-C-O 114.122 -2.532 . . . . 1.02 115.766 -178.597 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -64.67 -24.66 62.23 Favored 'Trans proline' 0 N--CA 1.433 -2.031 1 C-N-CA 125.996 4.464 . . . . 1.25 118.572 -172.176 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -55.76 -36.05 66.88 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.212 3.445 . . . . 2.25 116.176 173.299 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -79.9 -11.89 59.78 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.025 1.73 . . . . 2.02 109.928 -178.842 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -86.58 121.21 28.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 118.737 2.865 . . . . 0.69 118.737 -169.172 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -110.44 110.55 21.34 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.211 1.368 . . . . 2.78 111.678 172.458 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.2 mt -97.93 119.43 36.53 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 123.675 2.943 . . . . 1.17 109.7 -176.001 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.6 mm -108.45 137.8 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 119.175 -2.203 . . . . 1.38 110.96 178.301 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -130.06 121.67 26.87 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 104.604 -2.369 . . . . 1.5 104.604 173.121 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.26 -100.47 0.06 Allowed 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 120.909 -1.12 . . . . 1.21 110.129 -178.793 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.69 10.39 6.75 Favored Glycine 0 N--CA 1.429 -1.817 0 C-N-CA 126.176 1.846 . . . . 1.3 115.348 174.186 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -110.38 137.66 47.8 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.729 -1.235 . . . . 2.55 112.72 -173.857 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -95.24 129.13 42.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 126.643 2.464 . . . . 2.48 109.421 176.826 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.2 mt -100.35 136.86 39.59 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 117.263 2.32 . . . . 0.9 117.263 -166.804 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -79.54 138.74 37.6 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.79 -2.444 . . . . 1.94 116.614 -178.164 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.97 -47.18 87.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.367 -2.708 . . . . 1.56 114.78 -168.869 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.76 35.86 3.45 Favored Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 119.677 2.631 . . . . 0.97 119.677 173.058 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -114.97 160.51 19.48 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 123.102 1.429 . . . . 2.49 108.463 163.152 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.4 p -100.58 171.4 7.75 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.006 -3.559 . . . . 0.76 117.235 177.953 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 3.2 mt -64.71 -23.61 67.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.712 1.72 . . . . 1.05 113.088 172.25 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.271 19.2 t -60.4 -59.59 5.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.266 3.426 . . . . 1.19 116.111 174.993 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -39.29 -41.27 0.87 Allowed 'General case' 0 N--CA 1.43 -1.458 1 C-N-CA 132.928 4.491 . . . . 1.9 118.74 165.632 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -97.57 9.84 41.42 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 112.508 -3.615 . . . . 0.89 116.436 175.214 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.1 t30 52.84 51.22 16.36 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 131.213 5.321 . . . . 1.84 115.44 -175.486 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.0 mt -101.79 116.94 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 125.574 2.607 . . . . 0.82 111.011 177.394 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -100.86 -153.59 0.45 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.15 -1.594 . . . . 2.16 109.824 -173.277 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -74.31 142.5 45.18 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 128.157 2.583 . . . . 2.12 116.422 175.74 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.252 49.0 mt-10 68.89 33.88 3.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.937 2.095 . . . . 1.71 108.072 176.782 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.0 m -91.67 137.03 32.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 130.004 3.322 . . . . 1.04 113.969 -175.465 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.1 m -107.94 117.26 33.65 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 126.673 1.989 . . . . 0.79 114.962 -174.125 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.64 156.86 17.47 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 125.629 1.571 . . . . 1.4 108.332 177.08 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -117.37 123.14 45.74 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 125.546 2.594 . . . . 1.51 108.13 -178.661 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.403 HD23 HG22 ' A' ' 7' ' ' THR . 60.2 tp -97.13 93.4 6.54 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.633 -2.542 . . . . 1.14 112.433 -179.916 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.5 t -91.46 136.27 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 127.831 2.452 . . . . 1.23 106.154 174.569 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.5 mt . . . . . 0 N--CA 1.429 -1.501 0 CA-C-O 124.506 2.098 . . . . 2.78 111.198 178.582 . . . . . . . . 0 0 . 1 . 134 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.263 16.0 ptt? . . . . . 0 CA--C 1.49 -1.333 0 N-CA-C 114.366 1.247 . . . . 1.1 114.366 . . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -106.78 135.35 48.46 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 116.088 1.884 . . . . 1.87 116.088 -177.109 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.1 pt -120.42 165.11 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 101.514 -3.514 . . . . 0.72 101.514 176.657 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -116.83 147.53 42.04 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 121.989 0.9 . . . . 1.4 111.74 -179.732 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.347 65.0 t -123.34 113.79 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-O 123.703 1.716 . . . . 0.58 107.802 174.856 . . . . . . . . 2 2 . 1 . 134 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -99.2 130.48 45.5 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.737 -2.477 . . . . 2.09 108.545 -178.618 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.7 p -98.65 175.82 5.86 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.93 -1.731 . . . . 0.99 111.847 176.502 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.7 tp -77.32 -31.71 54.78 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 118.211 -1.396 . . . . 2.53 111.097 169.798 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.8 p -59.62 -27.31 66.21 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 131.62 3.968 . . . . 2.08 115.679 -177.425 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.01 56.6 0.62 Allowed Glycine 0 N--CA 1.43 -1.766 1 C-N-CA 135.417 6.246 . . . . 1.31 104.909 165.608 . . . . . . . . 2 2 . 1 . 134 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -125.73 141.96 51.75 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.306 -2.879 . . . . 1.4 107.807 177.642 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 100.0 m -120.53 112.69 19.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.556 -1.276 . . . . 0.78 107.556 175.921 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 13' ' ' ILE . 15.3 mt -93.97 141.07 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 118.212 -2.805 . . . . 1.55 106.838 -178.634 . . . . . . . . 2 2 . 1 . 134 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -104.42 117.74 34.9 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 124.551 2.12 . . . . 1.08 107.868 177.585 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.9 mt -116.06 128.7 55.9 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 111.75 -2.477 . . . . 1.55 107.735 -178.878 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -87.47 117.01 25.97 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 104.598 -2.371 . . . . 1.95 104.598 175.763 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.26 159.34 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 125.213 1.57 . . . . 0.96 107.591 -174.766 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 26.1 mt-10 -106.34 165.04 13.68 Favored Pre-proline 0 N--CA 1.429 -1.484 0 C-N-CA 125.502 1.521 . . . . 2.35 108.208 165.226 . . . . . . . . 2 2 . 1 . 134 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 95.7 Cg_exo -72.76 -22.38 20.44 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 125.073 3.849 . . . . 0.95 115.381 -173.18 . . . . . . . . 2 2 . 1 . 134 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.8 m -88.88 -1.33 58.04 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.796 -0.638 . . . . 1.45 112.32 -179.833 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -74.32 140.7 45.05 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.023 -2.923 . . . . 1.69 112.935 -179.318 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.0 p -76.5 162.39 27.85 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.772 -4.33 . . . . 0.75 113.499 177.873 . . . . . . . . 2 2 . 1 . 134 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mm -64.86 -29.05 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.29 -2.756 . . . . 0.73 114.325 175.48 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -61.28 -31.75 71.58 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 116.943 2.201 . . . . 1.62 116.943 164.921 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -75.43 -39.85 58.4 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.915 -1.116 . . . . 2.13 109.212 -179.344 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.0 t -63.67 -39.89 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 117.398 2.37 . . . . 0.62 117.398 171.535 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.257 66.4 mttt -61.22 -40.45 94.04 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 124.649 2.166 . . . . 1.22 114.934 172.529 . . . . . . . . 2 2 . 1 . 134 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.37 -39.77 67.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.974 -3.579 . . . . 0.51 113.6 172.506 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -68.76 -28.66 66.99 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 120.75 1.614 . . . . 1.44 109.855 172.519 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.1 mt -70.87 -24.8 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 116.95 -3.594 . . . . 1.32 115.402 174.381 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -62.11 -30.15 70.81 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.035 -2.916 . . . . 1.7 112.392 173.254 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -71.83 -20.04 61.89 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.896 -2.378 . . . . 1.55 113.205 175.801 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -103.11 -59.43 1.71 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.506 -1.664 . . . . 2.62 106.506 -173.907 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -105.57 -10.2 16.99 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.249 -1.341 . . . . 1.48 111.401 -164.45 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 56.3 54.0 38.97 Favored Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 125.757 1.646 . . . . 1.12 112.801 175.906 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.0 mt -118.49 127.55 26.5 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 127.236 2.214 . . . . 1.55 105.433 178.586 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 37.2 Cg_endo -75.6 163.91 33.19 Favored 'Trans proline' 0 N--CA 1.432 -2.124 2 O-C-N 112.669 -4.438 . . . . 1.02 115.553 179.499 . . . . . . . . 3 3 . 1 . 134 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 71.3 Cg_exo -70.63 -12.23 30.93 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 CA-C-N 123.622 2.329 . . . . 1.25 117.053 -177.238 . . . . . . . . 2 2 . 1 . 134 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -75.2 -16.25 60.5 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 115.603 -4.436 . . . . 2.25 112.533 172.642 . . . . . . . . 2 2 . 1 . 134 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -90.26 -10.68 43.34 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 119.668 1.122 . . . . 2.02 109.773 -177.071 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -103.32 132.04 49.9 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 123.931 1.824 . . . . 0.69 106.1 -160.301 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -121.41 111.25 17.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 114.207 -1.361 . . . . 2.78 112.428 168.506 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.3 mt -90.13 132.37 35.48 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.552 -1.967 . . . . 1.17 115.751 179.362 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 mm -123.73 124.82 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-O 126.316 2.96 . . . . 1.38 112.331 -179.587 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -124.48 108.16 11.84 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 127.612 2.365 . . . . 1.5 108.529 177.15 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.53 -74.3 0.09 Allowed 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 110.592 -3.003 . . . . 1.21 114.066 -178.056 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -147.67 -10.98 0.17 Allowed Glycine 0 N--CA 1.431 -1.679 1 C-N-CA 131.178 4.228 . . . . 1.3 114.631 -177.886 . . . . . . . . 2 2 . 1 . 134 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -94.93 122.43 37.56 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.515 -2.756 . . . . 2.55 113.909 -173.032 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -73.26 117.96 15.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.751 1.62 . . . . 2.48 111.273 168.76 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.8 mt -92.17 128.68 38.1 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 123.429 2.831 . . . . 0.9 113.186 -171.842 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -73.8 146.64 44.07 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.415 1.579 . . . . 1.94 112.963 178.956 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -66.1 -50.1 65.22 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.817 -2.427 . . . . 1.56 115.554 -170.288 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.92 52.85 1.93 Allowed Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 117.234 -2.412 . . . . 0.97 118.082 168.527 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -114.55 161.64 17.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.848 -1.908 . . . . 2.49 105.848 161.553 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.3 p -108.05 175.6 5.42 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 116.749 2.129 . . . . 0.76 116.749 178.11 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.3 mt -65.49 -31.62 72.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.158 2.885 . . . . 1.05 114.563 172.301 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 t -63.06 -44.41 95.89 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.879 -3.638 . . . . 1.19 118.011 171.511 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -64.74 -37.2 86.81 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 129.602 3.161 . . . . 1.9 110.269 -175.597 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -98.4 -10.16 24.13 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.788 2.835 . . . . 0.89 110.085 -174.305 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.1 m120 60.66 54.89 3.5 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 128.487 3.994 . . . . 1.84 113.003 178.715 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.9 mt -106.59 101.35 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-N 108.768 -3.833 . . . . 0.82 106.644 179.607 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -104.01 174.49 5.85 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 129.988 3.315 . . . . 2.16 111.583 -167.012 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -55.67 138.81 46.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.815 -3.053 . . . . 2.12 114.486 179.813 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 67.71 39.07 2.8 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 129.837 3.255 . . . . 1.71 112.783 -178.89 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.3 t -109.9 137.28 47.9 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.22 -1.77 . . . . 1.04 106.22 -169.494 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.6 m -96.81 110.0 22.57 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 129.148 2.979 . . . . 0.79 114.114 -176.031 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.1 mt -95.06 147.28 23.59 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 127.647 2.379 . . . . 1.4 107.742 169.342 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -109.31 123.43 49.28 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 103.735 -2.691 . . . . 1.51 103.735 -173.207 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.6 tp -81.9 107.23 14.45 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.246 -2.784 . . . . 1.14 109.011 173.706 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.4 t -98.37 144.69 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 127.923 3.264 . . . . 1.23 104.692 167.809 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 N--CA 1.431 -1.407 0 O-C-N 117.841 -3.037 . . . . 2.78 110.593 178.755 . . . . . . . . 0 0 . 1 . 135 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ptt? . . . . . 0 CA--C 1.489 -1.381 0 N-CA-C 112.017 0.377 . . . . 1.1 112.017 . . . . . . . . . 0 0 . 1 . 135 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -92.0 136.16 33.38 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.191 -2.193 . . . . 1.87 115.964 173.659 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.373 27.5 pt -116.61 161.66 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-O 114.541 -2.647 . . . . 0.72 112.378 165.839 . . . . . . . . 2 2 . 1 . 135 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -120.13 143.52 48.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 121.383 1.901 . . . . 1.4 110.91 177.226 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.83 127.55 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 112.33 -2.213 . . . . 0.58 108.198 175.654 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -97.4 138.83 34.26 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.343 -1.725 . . . . 2.09 106.343 177.256 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 p -97.57 -179.45 4.47 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 127.609 3.576 . . . . 0.99 110.867 173.027 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.8 mt -77.79 -51.33 10.68 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.208 -4.683 . . . . 2.53 112.624 175.315 . . . . . . . . 2 2 . 1 . 135 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.0 p -56.83 -43.87 81.48 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.464 2.024 . . . . 2.08 116.464 177.602 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.08 61.08 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 127.106 2.289 . . . . 1.31 111.118 177.978 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.38 156.48 48.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 103.1 -2.926 . . . . 1.4 103.1 178.38 . . . . . . . . 2 2 . 1 . 135 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.9 m -133.04 121.81 23.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.715 2.674 . . . . 0.78 110.805 -176.95 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mt -102.23 115.27 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 118.627 -2.546 . . . . 1.55 106.896 -175.998 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.2 m -93.19 115.73 28.34 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.163 -1.586 . . . . 1.08 106.784 174.867 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.3 mt -117.63 147.87 42.47 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 125.726 2.679 . . . . 1.55 112.022 -178.787 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -90.61 121.13 32.26 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.378 1.871 . . . . 1.95 110.525 177.346 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.6 m -140.99 167.38 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 116.534 -1.698 . . . . 0.96 111.829 -176.735 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -118.86 173.46 3.4 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-N 122.739 2.518 . . . . 2.35 114.182 156.96 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -75.7 -11.31 20.24 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 115.224 -2.717 . . . . 0.95 118.861 -179.479 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.6 m -79.57 -3.02 45.06 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.359 1.064 . . . . 1.45 112.062 170.493 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -81.33 151.57 27.95 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.517 -1.99 . . . . 1.69 107.884 178.781 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.269 17.3 p -92.52 164.03 13.6 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 115.088 1.514 . . . . 0.75 115.088 178.796 . . . . . . . . 2 2 . 1 . 135 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.9 mm -63.33 -22.38 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 116.267 1.951 . . . . 0.73 116.267 171.999 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -66.72 -45.34 79.01 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.149 3.379 . . . . 1.62 111.764 166.114 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -56.89 -38.16 72.39 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.343 -2.098 . . . . 2.13 114.504 178.133 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.1 t -66.26 -36.03 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 127.914 2.485 . . . . 0.62 114.245 174.979 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -67.4 -39.56 85.58 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.97 2.952 . . . . 1.22 118.97 173.582 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.28 -36.55 66.25 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 116.847 2.166 . . . . 0.51 116.847 170.547 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -60.42 -40.25 90.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.913 1.285 . . . . 1.44 114.224 170.048 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.3 mt -76.4 -31.42 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.438 1.495 . . . . 1.32 108.654 179.367 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -67.26 -43.55 81.59 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.171 -2.205 . . . . 1.7 113.904 174.851 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -58.13 -65.57 0.62 Allowed 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 130.386 3.474 . . . . 1.55 110.805 168.783 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -56.63 -53.55 56.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.926 3.306 . . . . 2.62 119.926 -175.252 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -120.87 -3.63 9.68 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.681 -1.6 . . . . 1.48 112.826 -164.845 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.83 -6.34 81.95 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 118.493 2.157 . . . . 1.12 118.493 169.527 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.7 mp -73.97 113.63 25.1 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 118.288 -2.889 . . . . 1.55 115.451 -170.665 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 14.5 Cg_exo -60.23 146.44 96.39 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 124.974 3.783 . . . . 1.02 114.009 179.718 . . . . . . . . 2 2 . 1 . 135 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -58.18 -24.91 69.26 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 C-N-CA 123.437 2.758 . . . . 1.25 117.224 -177.534 . . . . . . . . 3 3 . 1 . 135 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -70.8 -26.2 63.21 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 130.176 4.672 . . . . 2.25 112.702 179.296 . . . . . . . . 2 2 . 1 . 135 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -89.89 -16.26 30.4 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.21 -3.431 . . . . 2.02 112.492 -174.974 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -87.25 126.87 35.09 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 117.313 2.338 . . . . 0.69 117.313 -177.759 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -120.74 126.27 49.73 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.127 2.571 . . . . 2.78 108.099 164.883 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.9 mt -109.51 115.03 29.17 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.774 -3.079 . . . . 1.17 109.391 -174.993 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.3 mm -101.18 134.72 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 125.943 1.697 . . . . 1.38 108.581 -177.028 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -154.42 126.54 7.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.565 -2.383 . . . . 1.5 104.565 174.976 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.52 45.12 16.85 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 125.958 2.789 . . . . 1.21 113.788 -177.264 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.49 2.27 20.08 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 111.97 -2.377 . . . . 1.3 118.737 -173.506 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -103.88 125.9 50.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.283 -3.481 . . . . 2.55 107.19 -175.523 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -74.0 122.01 21.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.083 -2.261 . . . . 2.48 107.258 163.707 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.9 mt -78.24 127.02 31.64 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 130.459 3.504 . . . . 0.9 116.855 -177.396 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -89.29 130.55 35.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 116.421 2.008 . . . . 1.94 116.421 173.871 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.53 -61.41 1.7 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 130.275 3.43 . . . . 1.56 115.898 -170.269 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.68 23.8 3.45 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 123.066 3.986 . . . . 0.97 123.066 173.199 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -99.73 165.44 11.59 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.363 1.465 . . . . 2.49 107.347 163.862 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.391 18.6 p -92.6 171.19 9.17 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 117.09 2.256 . . . . 0.76 117.09 177.097 . . . . . . . . 2 2 . 1 . 135 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.72 -33.79 64.52 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 114.897 -2.478 . . . . 1.05 107.374 170.987 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -73.46 -35.68 65.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.42 1.888 . . . . 1.19 107.94 -175.256 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.39 3.0 t0 -63.32 -53.98 44.25 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.941 1.353 . . . . 1.9 111.859 171.005 . . . . . . . . 2 2 . 1 . 135 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -73.19 -7.98 53.79 Favored 'General case' 0 N--CA 1.43 -1.454 2 O-C-N 115.318 -4.613 . . . . 0.89 122.295 177.112 . . . . . . . . 2 2 . 1 . 135 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.0 m120 70.2 56.42 0.29 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.568 1.692 . . . . 1.84 115.568 179.137 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.1 mt -104.71 108.29 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 128.097 3.373 . . . . 0.82 109.008 177.485 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -87.95 -175.39 5.09 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 125.265 2.46 . . . . 2.16 109.49 177.807 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -63.2 131.0 47.0 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 115.276 -4.64 . . . . 2.12 115.62 174.522 . . . . . . . . 2 2 . 1 . 135 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.662 17.9 mt-10 97.69 -5.31 0.05 Allowed 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 124.622 1.201 . . . . 1.71 112.284 174.315 . . . . . . . . 2 2 . 1 . 135 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -66.71 122.69 18.2 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.807 2.043 . . . . 1.04 115.455 -176.265 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.5 m -91.2 115.59 28.14 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 103.803 -2.666 . . . . 0.79 103.803 -178.682 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.4 mt -79.34 139.74 37.7 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.079 2.952 . . . . 1.4 112.245 165.343 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -108.7 117.08 33.25 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.95 -2.969 . . . . 1.51 114.702 -179.059 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.9 tp -83.17 115.14 21.79 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 128.577 2.751 . . . . 1.14 111.746 -174.916 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.2 t -104.25 133.27 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 105.354 -2.091 . . . . 1.23 105.354 174.498 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 N--CA 1.431 -1.408 0 O-C-N 125.345 1.653 . . . . 2.78 110.036 -178.231 . . . . . . . . 0 0 . 1 . 136 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 ptt? . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 122.104 0.954 . . . . 1.1 109.965 . . . . . . . . . 0 0 . 1 . 136 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -103.08 144.02 31.83 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.336 -1.302 . . . . 1.87 107.966 -177.381 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.2 pt -132.35 159.68 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 C-N-CA 127.341 2.256 . . . . 0.72 107.182 175.71 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -103.39 153.09 20.85 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 128.581 2.753 . . . . 1.4 111.574 178.752 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.5 t -137.7 104.68 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 106.636 -1.616 . . . . 0.58 106.636 177.546 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -90.59 117.62 29.4 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 127.062 3.315 . . . . 2.09 111.13 -179.791 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.1 p -80.22 174.5 11.53 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.137 -3.477 . . . . 0.99 115.567 179.303 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.2 mt -61.47 -52.74 63.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 124.875 1.359 . . . . 2.53 111.573 170.235 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.276 72.6 p -66.5 -38.17 86.65 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 119.465 -2.022 . . . . 2.08 115.625 -173.189 . . . . . . . . 2 2 . 1 . 136 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.75 52.12 0.17 Allowed Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 125.542 1.544 . . . . 1.31 116.49 173.578 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -119.3 149.27 42.06 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 103.475 -2.787 . . . . 1.4 103.475 174.773 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.3 m -119.28 115.05 23.36 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 125.497 1.748 . . . . 0.78 106.636 174.633 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mt -95.69 135.63 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.189 -2.195 . . . . 1.55 105.33 179.744 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.8 m -96.14 129.52 43.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.961 -2.977 . . . . 1.08 102.961 172.122 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.0 mt -124.29 133.89 53.36 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.104 -1.813 . . . . 1.55 106.104 -179.102 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -92.3 107.24 19.07 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.07 -2.268 . . . . 1.95 111.098 169.413 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 m -113.67 179.04 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 C-N-CA 127.734 2.414 . . . . 0.96 114.113 174.669 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -125.73 154.75 73.2 Favored Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 103.84 -2.652 . . . . 2.35 103.84 166.317 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.294 25.6 Cg_endo -66.74 -30.73 41.04 Favored 'Trans proline' 0 N--CA 1.434 -2.001 1 C-N-CA 125.577 4.185 . . . . 0.95 110.234 -172.031 . . . . . . . . 3 2 . 1 . 136 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.2 p -64.51 -16.94 63.39 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.552 3.141 . . . . 1.45 116.646 173.549 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -70.07 142.47 52.66 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.376 -2.077 . . . . 1.69 109.39 177.137 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.0 p -78.26 164.56 24.79 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 126.247 2.217 . . . . 0.75 112.941 174.237 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.4 mm -65.2 -32.6 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 117.142 2.275 . . . . 0.73 117.142 174.114 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -50.03 -49.88 49.44 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 126.386 2.993 . . . . 1.62 109.688 164.533 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -65.36 -37.21 86.35 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.407 -2.683 . . . . 2.13 116.295 -178.127 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.4 t -67.53 -27.89 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 121.254 1.843 . . . . 0.62 108.221 174.812 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -75.0 -27.32 60.09 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 121.005 1.729 . . . . 1.22 112.526 178.343 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.18 -31.74 69.35 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 117.3 -1.333 . . . . 0.51 111.457 173.844 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -69.05 -35.64 76.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.515 2.726 . . . . 1.44 109.914 175.033 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.8 mt -69.03 -43.66 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-N 113.789 -1.55 . . . . 1.32 111.359 171.134 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -62.68 -38.07 88.92 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.103 -2.248 . . . . 1.7 113.389 179.206 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -49.67 -49.5 47.2 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 130.272 3.429 . . . . 1.55 114.474 168.943 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -87.96 -58.45 2.56 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.106 -3.496 . . . . 2.62 117.002 -179.557 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -81.88 -43.97 17.47 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.695 1.712 . . . . 1.48 112.546 -166.086 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.1 63.35 1.14 Allowed Glycine 0 N--CA 1.431 -1.689 0 CA-C-N 111.946 -2.388 . . . . 1.12 112.586 176.001 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.2 mt -129.81 117.9 18.52 Favored Pre-proline 0 N--CA 1.429 -1.505 0 CA-C-O 115.789 -2.053 . . . . 1.55 106.074 -177.599 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -67.4 140.63 53.35 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 CA-C-N 127.493 3.712 . . . . 1.02 112.114 -179.904 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -51.9 -20.17 9.57 Favored 'Trans proline' 0 N--CA 1.433 -2.073 1 N-CA-C 122.719 4.084 . . . . 1.25 122.719 -175.958 . . . . . . . . 3 3 . 1 . 136 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.96 -39.55 72.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.805 2.842 . . . . 2.25 111.02 172.523 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -75.75 -36.0 60.01 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 116.706 -3.746 . . . . 2.02 111.496 179.878 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -93.52 142.45 27.33 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 119.951 -1.718 . . . . 0.69 107.036 -166.136 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -124.13 151.54 43.82 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.993 -1.692 . . . . 2.78 106.535 166.599 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.6 mt -121.64 123.9 43.02 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.084 1.421 . . . . 1.17 108.868 -179.559 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.4 mt -105.53 128.43 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 129.719 3.208 . . . . 1.38 110.664 -176.101 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.416 ' C ' ' H ' ' A' ' 47' ' ' GLY . 2.4 t80 -139.13 133.11 31.04 Favored 'General case' 0 N--CA 1.43 -1.473 1 N-CA-C 99.256 -4.35 . . . . 1.5 99.256 179.835 . . . . . . . . 3 3 . 1 . 136 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.57 -36.01 0.18 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 131.418 3.887 . . . . 1.21 113.557 179.504 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 164.91 -26.06 0.18 Allowed Glycine 0 N--CA 1.429 -1.781 0 O-C-N 116.964 -3.585 . . . . 1.3 111.245 178.297 . . . . . . . . 2 2 . 1 . 136 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -83.22 137.67 33.92 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.703 2.668 . . . . 2.55 111.611 -178.974 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 pm0 -92.4 126.99 37.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.26 -2.15 . . . . 2.48 109.514 177.019 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.293 34.8 mt -81.87 122.84 28.24 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.378 2.513 . . . . 0.9 109.899 -161.683 . . . . . . . . 2 2 . 1 . 136 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -77.99 130.64 36.75 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 116.801 -3.687 . . . . 1.94 108.119 178.601 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -46.57 -48.18 19.58 Favored 'General case' 0 N--CA 1.43 -1.472 1 C-N-CA 132.34 4.256 . . . . 1.56 115.028 -173.34 . . . . . . . . 2 2 . 1 . 136 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.65 49.61 3.89 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 128.425 2.917 . . . . 0.97 116.077 172.983 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -135.78 172.86 12.39 Favored 'General case' 0 N--CA 1.43 -1.464 1 N-CA-C 97.606 -4.961 . . . . 2.49 97.606 169.47 . . . . . . . . 2 2 . 1 . 136 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.5 p -99.14 169.21 9.56 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.232 -1.804 . . . . 0.76 114.56 170.3 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.5 mt -76.02 -21.68 56.59 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 112.324 -2.216 . . . . 1.05 109.161 176.907 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 t -73.86 -39.78 63.73 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.893 -0.594 . . . . 1.19 109.798 176.862 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -54.84 -40.8 69.98 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 120.442 3.497 . . . . 1.9 120.442 174.508 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -78.84 -15.03 58.89 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 128.121 2.568 . . . . 0.89 116.992 175.966 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 m120 68.74 51.54 0.59 Allowed 'General case' 0 N--CA 1.43 -1.445 1 C-N-CA 132.932 4.493 . . . . 1.84 113.88 -178.311 . . . . . . . . 2 2 . 1 . 136 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mp -82.15 116.86 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 117.39 -3.318 . . . . 0.82 108.976 175.516 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -95.95 165.07 12.44 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 111.884 -2.417 . . . . 2.16 115.531 177.309 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -53.49 135.23 40.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.359 -1.291 . . . . 2.12 113.576 176.269 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 63.84 34.29 11.96 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 118.674 2.842 . . . . 1.71 118.674 178.241 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.7 m -92.12 154.46 18.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.1 2.16 . . . . 1.04 114.277 -177.314 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.0 m -102.36 114.14 28.07 Favored 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 117.516 -3.24 . . . . 0.79 116.348 -179.957 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -87.15 147.7 25.51 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.651 -0.656 . . . . 1.4 109.855 165.806 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -114.92 120.77 41.06 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 123.797 0.839 . . . . 1.51 109.137 -178.692 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.4 tp -97.69 129.16 44.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.932 -2.355 . . . . 1.14 109.472 -175.565 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.83 164.52 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 129.887 3.275 . . . . 1.23 105.555 177.796 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.7 mt . . . . . 0 N--CA 1.429 -1.501 0 O-C-N 116.794 -3.691 . . . . 2.78 109.364 179.553 . . . . . . . . 0 0 . 1 . 137 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 ptt? . . . . . 0 CA--C 1.49 -1.339 0 CA-C-O 115.847 -2.025 . . . . 1.1 116.247 . . . . . . . . . 0 0 . 1 . 137 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.62 138.13 34.66 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 122.809 2.55 . . . . 1.87 109.978 -179.096 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.8 pt -124.33 170.85 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 104.232 -2.507 . . . . 0.72 104.232 167.991 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.463 ' HB3' HG23 ' A' ' 12' ' ' THR . 22.2 m-85 -119.1 147.25 44.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.811 3.245 . . . . 1.4 107.051 -176.586 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.5 t -133.93 138.08 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 102.832 -3.025 . . . . 0.58 102.832 170.755 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -110.6 130.31 55.6 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.082 2.153 . . . . 2.09 107.328 177.768 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -81.8 -176.73 6.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 123.898 0.749 . . . . 0.99 111.966 174.977 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.7 mt -58.49 -47.51 83.84 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.171 2.988 . . . . 2.53 112.331 179.494 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.0 p -89.04 -35.73 16.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.161 -2.837 . . . . 2.08 106.529 -172.338 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.74 5.54 0.25 Allowed Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 119.938 2.735 . . . . 1.31 119.938 -178.497 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.1 ttpt -85.17 126.03 33.31 Favored 'General case' 0 N--CA 1.43 -1.443 2 O-C-N 113.803 -5.528 . . . . 1.4 108.895 -174.482 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.463 HG23 ' HB3' ' A' ' 4' ' ' PHE 0.293 66.0 m -83.77 114.9 21.94 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.058 2.361 . . . . 0.78 109.362 173.966 . . . . . . . . 3 3 . 1 . 137 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mt -98.25 116.7 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 124.553 2.121 . . . . 1.55 105.654 177.051 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.6 m -86.59 105.89 17.18 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.812 -3.055 . . . . 1.08 116.436 173.371 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.0 mt -113.41 115.99 28.93 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 117.199 -1.381 . . . . 1.55 113.319 -179.495 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.368 0.8 OUTLIER -67.94 111.71 4.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.811 1.291 . . . . 1.95 111.211 171.081 . . . . . . . . 3 3 . 1 . 137 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 m -117.0 169.81 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 117.039 -3.538 . . . . 0.96 112.678 179.334 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -112.82 165.57 12.83 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-N 121.512 1.96 . . . . 2.35 108.382 160.25 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -66.47 -28.31 46.01 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 CA-C-N 124.27 2.561 . . . . 0.95 114.313 -172.587 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.293 24.0 p -77.65 1.01 21.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 130.953 3.701 . . . . 1.45 119.475 177.143 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -80.78 143.49 32.83 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.254 -1.529 . . . . 1.69 107.654 175.377 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.3 p -75.56 167.79 21.24 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.439 -0.578 . . . . 0.75 109.439 179.174 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -68.4 -37.18 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.672 -1.893 . . . . 0.73 115.158 175.849 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -49.74 -43.68 48.07 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 112.164 -2.289 . . . . 1.62 114.141 162.817 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -72.42 -28.42 62.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.852 -1.155 . . . . 2.13 113.868 176.104 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.7 t -71.56 -35.42 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 117.366 -3.334 . . . . 0.62 112.042 170.556 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -68.91 -35.66 77.1 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 124.45 1.094 . . . . 1.22 109.146 172.704 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.27 -40.65 96.94 Favored 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 118.78 -2.45 . . . . 0.51 112.97 172.485 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -61.09 -42.35 98.35 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 119.031 -2.293 . . . . 1.44 115.542 171.003 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.0 mt -58.89 -36.29 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 119.077 -2.264 . . . . 1.32 112.796 167.583 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -61.44 -40.21 93.65 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.49 -1.381 . . . . 1.7 113.501 176.44 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.45 -40.37 94.23 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 119.697 3.221 . . . . 1.55 119.697 162.931 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt -78.68 -68.2 0.67 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.167 2.187 . . . . 2.62 107.935 -176.88 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -101.44 -19.19 15.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 116.857 -1.937 . . . . 1.48 111.238 -169.364 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.57 9.84 45.71 Favored Glycine 0 N--CA 1.431 -1.679 0 CA-C-O 114.748 -3.251 . . . . 1.12 115.877 176.156 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.581 HG22 ' HG3' ' A' ' 41' ' ' GLN . 19.1 mt -85.97 128.39 58.33 Favored Pre-proline 0 N--CA 1.429 -1.49 1 CA-C-O 110.901 -4.38 . . . . 1.55 106.797 -178.953 . . . . . . . . 3 3 . 1 . 137 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -80.65 153.12 20.11 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 CA-C-N 127.561 3.736 . . . . 1.02 110.671 -179.03 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.64 -19.95 41.24 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 124.829 3.686 . . . . 1.25 111.84 -165.768 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -68.16 -39.52 82.56 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 124.283 1.992 . . . . 2.25 116.276 173.009 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -73.04 -43.62 61.77 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 131.221 3.808 . . . . 2.02 115.119 174.091 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.581 ' HG3' HG22 ' A' ' 36' ' ' ILE . 55.7 mt-30 -60.75 137.22 58.22 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.584 -2.573 . . . . 0.69 111.094 -174.591 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -116.51 142.78 46.43 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 125.021 3.555 . . . . 2.78 107.402 167.294 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.483 HD13 HD13 ' A' ' 67' ' ' LEU . 74.9 mt -127.52 119.67 26.56 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.251 -2.129 . . . . 1.17 105.251 178.297 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.5 HD12 HG21 ' A' ' 70' ' ' VAL . 21.3 mt -111.55 132.9 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 129.093 2.957 . . . . 1.38 110.672 -179.995 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -139.23 141.04 37.89 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.394 -2.076 . . . . 1.5 105.394 170.413 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.43 20.71 0.32 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.123 -2.861 . . . . 1.21 117.712 177.667 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.59 6.19 80.78 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 116.807 -3.683 . . . . 1.3 113.287 179.677 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -98.09 121.71 40.35 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 115.382 -2.247 . . . . 2.55 110.841 174.795 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -77.68 125.13 28.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.506 2.323 . . . . 2.48 105.897 171.945 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.288 22.2 mt -79.99 136.41 36.6 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.908 1.814 . . . . 0.9 112.402 -167.684 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.32 46.1 mt-10 -81.19 129.65 34.68 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.113 -3.492 . . . . 1.94 113.574 173.039 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -59.83 -46.05 90.46 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.807 2.521 . . . . 1.56 117.807 -172.211 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.9 49.02 2.25 Favored Glycine 0 N--CA 1.43 -1.704 1 O-C-N 113.098 -6.001 . . . . 0.97 110.149 173.14 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -119.5 176.25 5.45 Favored 'General case' 0 N--CA 1.429 -1.477 1 O-C-N 116.232 -4.099 . . . . 2.49 105.388 161.561 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.3 p -104.29 -175.54 2.82 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 117.904 -1.518 . . . . 0.76 114.245 175.385 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.0 mt -77.97 -29.27 49.65 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.783 -1.198 . . . . 1.05 110.818 173.888 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.9 t -73.58 -29.47 62.43 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.576 -1.328 . . . . 1.19 113.261 176.584 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -58.88 -28.91 66.6 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.833 2.901 . . . . 1.9 118.833 172.252 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.356 26.6 m-85 -100.18 8.96 43.47 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 115.671 1.73 . . . . 0.89 115.671 173.022 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.7 m120 46.69 64.14 1.64 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.553 2.341 . . . . 1.84 113.019 -173.514 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.4 mt -104.5 121.87 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 103.213 -2.884 . . . . 0.82 103.213 177.218 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -96.84 -172.66 2.52 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.994 2.118 . . . . 2.16 106.494 -168.681 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.17 153.61 40.64 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 116.49 -2.084 . . . . 2.12 110.685 173.131 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.301 41.5 mt-10 59.53 46.65 11.86 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 115.117 1.525 . . . . 1.71 115.117 177.729 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -104.17 142.94 33.63 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 131.469 3.908 . . . . 1.04 106.305 178.75 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.4 m -108.77 118.02 35.71 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.176 1.941 . . . . 0.79 106.76 -179.832 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.483 HD13 HD13 ' A' ' 43' ' ' LEU . 74.4 mt -92.44 146.53 23.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 113.202 -1.817 . . . . 1.4 110.242 167.381 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -105.33 115.45 30.27 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.691 2.186 . . . . 1.51 107.036 -179.771 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 tt -88.22 116.3 26.32 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 111.863 -2.426 . . . . 1.14 110.844 -179.625 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.5 HG21 HD12 ' A' ' 44' ' ' ILE . 1.9 t -119.75 -178.51 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.259 -2.126 . . . . 1.23 105.259 176.795 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.0 mt . . . . . 0 N--CA 1.43 -1.458 0 O-C-N 117.173 -3.454 . . . . 2.78 113.354 177.889 . . . . . . . . 0 0 . 1 . 138 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ptt? . . . . . 0 CA--C 1.49 -1.344 0 N-CA-C 115.568 1.692 . . . . 1.1 115.568 . . . . . . . . . 0 0 . 1 . 138 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -99.16 142.45 30.63 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.173 -2.158 . . . . 1.87 105.173 179.508 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.431 HG13 ' HB2' ' A' ' 15' ' ' LEU . 3.1 pt -117.6 165.08 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 106.569 -1.641 . . . . 0.72 106.569 169.282 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -118.35 121.14 39.66 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.559 -1.338 . . . . 1.4 108.49 179.053 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.3 t -103.37 138.76 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 104.685 -2.339 . . . . 0.58 104.685 171.369 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -111.94 143.58 42.68 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 113.427 -3.178 . . . . 2.09 112.248 173.228 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.5 p -88.61 -172.41 3.73 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.452 3.595 . . . . 0.99 112.915 179.243 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.1 mt -54.14 -38.83 65.91 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 127.028 3.299 . . . . 2.53 116.169 167.282 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -88.81 -35.58 16.53 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 114.297 -5.252 . . . . 2.08 113.002 179.842 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.92 27.37 0.94 Allowed Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 117.745 -1.586 . . . . 1.31 114.541 -179.804 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.8 124.9 29.04 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 120.73 2.265 . . . . 1.4 109.784 -173.929 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.528 1.7 m -78.64 118.63 20.93 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 113.835 -5.54 . . . . 0.78 118.25 176.98 . . . . . . . . 3 2 . 1 . 138 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mt -106.04 121.36 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 125.736 1.615 . . . . 1.55 110.099 172.873 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.251 6.4 m -92.51 108.93 20.34 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 116.854 2.168 . . . . 1.08 116.854 179.55 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.431 ' HB2' HG13 ' A' ' 3' ' ' ILE . 21.5 mt -113.9 130.64 56.48 Favored 'General case' 0 N--CA 1.431 -1.409 1 O-C-N 115.141 -4.724 . . . . 1.55 110.651 -173.627 . . . . . . . . 3 3 . 1 . 138 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -84.81 101.06 11.97 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 116.688 -3.757 . . . . 1.95 111.184 169.61 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.0 m -114.18 164.26 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 121.154 -0.967 . . . . 0.96 110.089 -179.064 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.403 ' O ' HD12 ' A' ' 56' ' ' LEU . 32.9 mt-10 -102.14 161.4 23.51 Favored Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 127.395 2.278 . . . . 2.35 104.941 159.058 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -77.16 -7.65 17.25 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 CA-C-N 122.655 1.984 . . . . 0.95 107.523 -179.616 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 m -79.31 -14.92 58.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.692 1.597 . . . . 1.45 111.825 177.174 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -65.99 144.8 56.52 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.923 2.297 . . . . 1.69 105.948 -179.888 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.4 p -89.34 158.28 17.85 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.415 -1.72 . . . . 0.75 112.937 176.972 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.332 2.8 mp -53.53 -43.74 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 116.323 -3.985 . . . . 0.73 115.305 169.8 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -41.18 -59.96 1.37 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.189 2.196 . . . . 1.62 114.941 165.888 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -72.24 -24.54 61.39 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 120.322 3.453 . . . . 2.13 120.322 -175.624 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -61.18 -32.22 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 120.361 -1.462 . . . . 0.62 113.198 168.777 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -60.06 -43.46 95.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 117.68 -1.152 . . . . 1.22 110.987 177.602 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.78 -27.06 63.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 125.008 1.443 . . . . 0.51 109.027 177.895 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -66.46 -30.8 71.22 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 118.273 -2.767 . . . . 1.44 110.64 173.535 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.6 mt -65.87 -31.42 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 129.686 3.194 . . . . 1.32 109.732 169.494 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.328 52.9 tt0 -69.33 -33.63 73.42 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.024 -2.922 . . . . 1.7 116.91 175.694 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.261 11.9 m-20 -67.81 -36.87 81.17 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.422 2.289 . . . . 1.55 112.196 168.918 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -76.49 -77.28 0.14 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.831 1.252 . . . . 2.62 110.995 -178.494 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -88.17 -66.92 0.87 Allowed 'General case' 0 N--CA 1.429 -1.487 1 C-N-CA 133.316 4.646 . . . . 1.48 114.743 -166.561 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.76 29.66 0.74 Allowed Glycine 0 N--CA 1.43 -1.714 0 O-C-N 126.973 2.671 . . . . 1.12 110.599 166.932 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.6 mt -89.44 126.12 59.35 Favored Pre-proline 0 N--CA 1.43 -1.459 1 O-C-N 115.738 -4.39 . . . . 1.55 109.192 -179.448 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -54.37 129.28 33.86 Favored 'Trans proline' 0 C--N 1.299 -2.035 1 C-N-CA 125.611 4.207 . . . . 1.02 116.274 175.674 . . . . . . . . 3 3 . 1 . 138 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -59.96 -14.24 26.87 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 CA-C-N 124.324 2.58 . . . . 1.25 116.511 -173.38 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -65.28 -21.92 66.79 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 128.826 2.851 . . . . 2.25 118.581 170.608 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -102.41 -9.4 20.32 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-O 116.406 -1.759 . . . . 2.02 108.715 -172.712 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -89.38 133.49 34.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.742 2.417 . . . . 0.69 114.993 -170.39 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.5 ' HB2' HG23 ' A' ' 70' ' ' VAL . 64.3 mtt180 -132.96 145.09 50.58 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.435 2.064 . . . . 2.78 106.906 169.621 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.5 mt -122.15 143.45 49.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.414 -2.054 . . . . 1.17 114.616 -177.992 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.5 mt -118.83 129.5 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 130.166 3.386 . . . . 1.38 108.887 -179.699 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -130.28 127.3 39.25 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.199 1.8 . . . . 1.5 109.816 167.641 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.85 12.8 0.93 Allowed 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.212 2.301 . . . . 1.21 117.212 -178.379 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.49 0.19 29.35 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 118.136 -2.852 . . . . 1.3 116.837 -174.388 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.307 64.5 mttt -114.62 137.18 52.2 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.748 1.737 . . . . 2.55 114.622 179.671 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -86.01 138.5 31.92 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 117.188 -1.805 . . . . 2.48 107.845 174.192 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.7 mt -88.98 138.74 31.13 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.151 2.278 . . . . 0.9 117.151 -171.654 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -73.11 147.71 44.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 124.107 0.879 . . . . 1.94 113.356 169.932 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.72 -53.96 13.61 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.473 -2.017 . . . . 1.56 111.731 -168.532 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.87 44.1 2.93 Favored Glycine 0 N--CA 1.431 -1.666 0 O-C-N 126.702 2.501 . . . . 0.97 115.372 172.121 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -116.91 165.37 13.41 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 125.43 2.538 . . . . 2.49 104.447 163.616 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.9 p -96.66 163.76 12.88 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 112.89 -1.959 . . . . 0.76 110.605 172.873 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 18' ' ' GLU . 96.2 mt -57.39 -40.43 78.2 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 127.345 2.258 . . . . 1.05 111.161 170.518 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.9 t -64.92 -40.94 95.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 126.646 2.466 . . . . 1.19 114.374 -179.174 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -56.0 -40.83 73.93 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.124 -3.485 . . . . 1.9 119.409 176.822 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -84.91 3.82 36.36 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 112.882 -1.963 . . . . 0.89 110.938 170.851 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.421 26.4 m120 62.49 38.64 12.5 Favored 'General case' 0 N--CA 1.43 -1.454 1 N-CA-C 121.957 4.058 . . . . 1.84 121.957 -174.382 . . . . . . . . 3 2 . 1 . 138 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.1 mt -93.65 123.65 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 117.281 -3.387 . . . . 0.82 109.107 -175.044 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -107.69 -172.48 2.08 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.178 1.353 . . . . 2.16 111.009 -172.577 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -56.16 144.35 29.91 Favored 'General case' 0 N--CA 1.428 -1.526 0 O-C-N 126.65 2.469 . . . . 2.12 113.658 168.315 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.294 35.5 mt-10 57.23 32.34 21.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.525 3.13 . . . . 1.71 117.052 173.226 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 t -96.14 133.86 39.91 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.719 3.208 . . . . 1.04 109.996 -174.237 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.15 116.57 21.12 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 118.119 2.637 . . . . 0.79 118.119 177.344 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.263 54.3 mt -101.46 140.24 36.03 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.847 -3.033 . . . . 1.4 106.291 173.542 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -104.14 121.22 42.78 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 116.081 -1.914 . . . . 1.51 110.934 -174.556 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.3 tp -89.89 128.52 36.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.869 1.795 . . . . 1.14 115.365 178.48 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.5 HG23 ' HB2' ' A' ' 42' ' ' ARG . 35.4 m -127.09 151.71 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 1 CA-C-O 128.827 4.156 . . . . 1.23 104.86 176.778 . . . . . . . . 3 3 . 1 . 138 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.8 mt . . . . . 0 N--CA 1.43 -1.465 1 O-C-N 116.188 -4.07 . . . . 2.78 111.481 -167.571 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.294 45.1 ttp . . . . . 0 CA--C 1.491 -1.327 0 N-CA-C 113.749 1.018 . . . . 1.1 113.749 . . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -100.73 123.47 44.98 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 119.491 -0.883 . . . . 1.87 111.541 -177.499 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.451 HG12 HG22 ' A' ' 17' ' ' VAL . 6.6 pt -120.93 163.65 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.311 -0.996 . . . . 0.72 108.311 174.258 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -119.95 143.03 48.22 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 130.937 3.695 . . . . 1.4 109.738 -177.924 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.298 43.5 t -116.84 115.07 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 116.915 -3.616 . . . . 0.58 113.651 171.734 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -95.53 143.8 26.54 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 115.949 -1.977 . . . . 2.09 108.374 -176.54 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.7 p -101.37 179.75 4.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 126.748 3.166 . . . . 0.99 112.213 173.058 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.3 mt -79.77 -10.42 59.78 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 111.607 -6.933 . . . . 2.53 115.062 173.218 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.257 28.8 p -86.51 -51.64 6.06 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 126.321 2.962 . . . . 2.08 110.914 178.002 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.7 -2.19 0.45 Allowed Glycine 0 N--CA 1.43 -1.705 0 O-C-N 118.198 -2.814 . . . . 1.31 112.343 177.891 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -78.19 142.58 37.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 123.078 3.439 . . . . 1.4 110.672 -179.627 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.6 m -107.95 132.88 53.03 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 123.863 1.792 . . . . 0.78 107.503 171.797 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -109.93 149.16 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 102.454 -3.165 . . . . 1.55 102.454 177.212 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.3 m -123.4 125.11 44.37 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.487 -3.883 . . . . 1.08 100.645 -177.256 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -126.51 159.11 34.35 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.357 2.263 . . . . 1.55 106.011 176.244 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -120.92 125.91 48.65 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.939 3.295 . . . . 1.95 108.576 169.839 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.451 HG22 HG12 ' A' ' 3' ' ' ILE . 3.4 m -132.28 158.41 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 129.843 3.257 . . . . 0.96 105.315 -173.059 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -114.38 141.13 26.03 Favored Pre-proline 0 N--CA 1.429 -1.476 0 N-CA-C 102.409 -3.182 . . . . 2.35 102.409 167.365 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -61.96 -7.52 9.83 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 C-N-CA 124.511 3.474 . . . . 0.95 116.169 -171.295 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 p -73.36 -14.71 61.33 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.161 2.984 . . . . 1.45 112.104 172.977 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -75.34 145.36 41.79 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 117.354 -3.341 . . . . 1.69 111.652 179.538 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 60.9 p -89.83 179.19 6.05 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.875 -1.141 . . . . 0.75 113.477 178.31 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 23' ' ' ILE . 23.3 mm -79.67 -22.59 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 121.289 1.859 . . . . 0.73 107.162 175.453 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -70.83 -31.4 68.12 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.052 2.141 . . . . 1.62 110.499 170.233 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -77.18 -35.42 55.84 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.65 2.38 . . . . 2.13 111.788 173.493 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.0 t -55.44 -55.11 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-N 123.819 3.009 . . . . 0.62 112.32 167.043 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -50.44 -39.2 47.03 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 126.298 2.249 . . . . 1.22 116.078 173.939 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.83 -35.82 80.94 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.075 1.75 . . . . 0.51 111.139 173.499 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -74.54 -22.8 58.83 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 115.825 -2.35 . . . . 1.44 111.429 174.062 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.287 55.5 mt -70.96 -30.48 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.389 -2.07 . . . . 1.32 111.931 171.572 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -65.4 -38.09 88.91 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.768 -1.56 . . . . 1.7 110.306 175.481 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.57 -59.9 2.8 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 115.22 -4.675 . . . . 1.55 112.497 168.951 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -60.75 -58.4 8.61 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.767 1.627 . . . . 2.62 112.367 -172.737 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -95.34 -56.21 2.79 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.917 -2.364 . . . . 1.48 109.611 -170.542 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.94 4.48 7.22 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 105.146 -3.182 . . . . 1.12 105.146 176.779 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mt -74.16 129.51 84.35 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 114.32 -2.753 . . . . 1.55 105.826 -173.878 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -70.58 154.23 64.62 Favored 'Trans proline' 0 N--CA 1.434 -2.009 0 C-N-CA 115.388 -2.608 . . . . 1.02 116.888 178.006 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.59 -4.88 13.83 Favored 'Trans proline' 0 C--N 1.3 -2.015 1 C-N-CA 125.544 4.162 . . . . 1.25 108.068 -172.647 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -77.45 -40.09 44.46 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 125.669 3.849 . . . . 2.25 111.55 169.334 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -60.07 -28.62 67.95 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.668 2.47 . . . . 2.02 117.668 -178.981 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -89.47 151.77 21.82 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.182 1.944 . . . . 0.69 115.396 -178.223 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.28 83.9 mtt180 -135.8 139.8 43.77 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 101.258 -3.608 . . . . 2.78 101.258 170.104 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 39.0 mt -122.14 128.6 51.46 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 124.67 3.396 . . . . 1.17 105.793 -178.682 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 mm -119.06 139.02 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 114.704 -2.57 . . . . 1.38 107.57 -178.888 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -131.53 126.51 35.09 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 115.921 -1.99 . . . . 1.5 106.358 171.964 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 82.23 -71.95 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 126.874 2.609 . . . . 1.21 106.188 -177.83 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.18 -26.57 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.659 0 C-N-CA 126.112 1.815 . . . . 1.3 114.206 -171.491 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -85.55 160.35 19.68 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.241 1.941 . . . . 2.55 116.241 172.809 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.277 49.2 tt0 -90.76 137.43 32.36 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.24 3.052 . . . . 2.48 119.24 170.324 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.0 mt -94.45 127.73 40.55 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.082 -3.511 . . . . 0.9 109.274 -169.472 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -75.9 158.81 31.61 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 118.225 2.676 . . . . 1.94 118.225 179.885 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -63.44 -59.82 4.16 Favored 'General case' 0 N--CA 1.43 -1.473 1 N-CA-C 122.879 4.4 . . . . 1.56 122.879 -168.018 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.44 23.51 8.44 Favored Glycine 0 N--CA 1.429 -1.795 0 CA-C-O 116.094 -2.503 . . . . 0.97 113.836 178.75 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -98.22 154.19 17.95 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 122.787 3.294 . . . . 2.49 109.106 168.35 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 31.1 p -85.7 177.3 7.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.873 -2.392 . . . . 0.76 115.591 171.356 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.27 -40.89 90.41 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 111.667 -2.515 . . . . 1.05 111.297 173.225 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.4 m -70.9 -25.79 62.94 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.567 3.547 . . . . 1.19 112.307 178.435 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -66.69 -55.6 14.43 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 120.762 1.619 . . . . 1.9 113.182 170.773 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -75.42 3.69 8.72 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 120.544 3.535 . . . . 0.89 120.544 173.685 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 54.43 46.78 24.3 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.023 -2.298 . . . . 1.84 117.011 178.704 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.4 mt -97.06 103.92 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 104.867 -2.271 . . . . 0.82 104.867 -179.556 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -104.67 -172.79 2.16 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 125.4 2.524 . . . . 2.16 109.296 -172.862 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -53.5 139.82 30.0 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.127 -2.858 . . . . 2.12 112.958 -179.863 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.374 30.7 mt-10 59.77 21.9 10.74 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 130.945 3.698 . . . . 1.71 113.871 -179.057 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.11 143.32 27.14 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.152 1.908 . . . . 1.04 116.152 -176.989 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.7 m -106.67 121.08 43.64 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 123.769 0.668 . . . . 0.79 112.552 -171.441 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.2 mt -95.41 164.64 12.73 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 106.694 -1.595 . . . . 1.4 106.694 173.063 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -115.48 116.64 28.54 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.486 1.915 . . . . 1.51 110.733 -179.58 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.5 tp -92.76 125.6 37.45 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.682 1.706 . . . . 1.14 112.889 179.683 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.1 t -120.08 126.08 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 101.89 -3.374 . . . . 1.23 101.89 178.252 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.8 mt . . . . . 0 N--CA 1.431 -1.417 0 CA-C-O 126.229 2.918 . . . . 2.78 113.709 178.394 . . . . . . . . 0 0 . 1 . 140 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptt? . . . . . 0 CA--C 1.49 -1.355 0 N-CA-C 118.619 2.822 . . . . 1.1 118.619 . . . . . . . . . 0 0 . 1 . 140 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -85.78 146.83 26.6 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 117.823 -1.551 . . . . 1.87 110.191 179.722 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.2 pt -140.76 158.41 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 101.07 -3.678 . . . . 0.72 101.07 175.722 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -112.15 115.89 29.58 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 113.619 -1.628 . . . . 1.4 111.047 -176.816 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -85.84 113.69 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 118.942 -2.349 . . . . 0.58 107.749 171.594 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -104.06 122.23 44.85 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.13 -3.481 . . . . 2.09 111.868 177.688 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.2 p -83.47 158.05 22.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 123.481 1.61 . . . . 0.99 112.902 174.767 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.6 mt -88.52 -23.92 23.06 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.606 -4.434 . . . . 2.53 109.173 176.36 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -61.37 -37.89 85.0 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.199 -3.438 . . . . 2.08 110.699 174.415 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.23 -58.09 0.38 Allowed Glycine 0 N--CA 1.43 -1.76 0 O-C-N 121.75 -0.594 . . . . 1.31 112.896 176.272 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.261 19.3 ptmt -61.69 150.34 36.93 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.567 -3.314 . . . . 1.4 116.312 -170.675 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.3 m -114.66 123.55 49.57 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.488 1.515 . . . . 0.78 108.237 169.811 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.2 mt -114.41 126.97 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.211 -3.43 . . . . 1.55 110.821 179.766 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.6 m -89.49 109.81 20.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.611 -2.556 . . . . 1.08 108.514 -177.256 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -107.12 157.51 17.8 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.92 -1.881 . . . . 1.55 105.92 179.629 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -106.68 133.6 51.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.069 1.748 . . . . 1.95 108.296 171.199 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.462 HG21 HD13 ' A' ' 56' ' ' LEU . 30.1 m -145.23 160.81 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 117.274 -1.346 . . . . 0.96 107.881 -178.484 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -95.98 155.59 38.12 Favored Pre-proline 0 N--CA 1.43 -1.462 0 N-CA-C 106.225 -1.768 . . . . 2.35 106.225 168.308 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.265 39.7 Cg_exo -66.28 -13.99 42.27 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 123.129 2.552 . . . . 0.95 115.456 -176.371 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -111.2 25.59 11.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 122.658 1.218 . . . . 1.45 108.538 -179.751 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -84.17 137.14 33.67 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 116.841 -3.662 . . . . 1.69 104.613 174.388 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.335 80.4 p -67.05 165.21 16.2 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 117.773 2.509 . . . . 0.75 117.773 176.627 . . . . . . . . 3 3 . 1 . 140 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.2 mm -67.95 -38.05 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 116.966 -3.584 . . . . 0.73 109.517 175.269 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -46.87 -42.21 17.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 128.651 2.781 . . . . 1.62 113.688 168.596 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -80.08 -29.13 39.05 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.449 -2.657 . . . . 2.13 110.771 -178.268 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.5 HG21 HD21 ' A' ' 56' ' ' LEU 0.274 12.0 t -67.81 -41.15 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 119.764 -1.835 . . . . 0.62 113.239 167.606 . . . . . . . . 3 3 . 1 . 140 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -65.04 -26.5 68.29 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.552 -2.593 . . . . 1.22 116.463 170.771 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.23 -31.2 68.51 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.429 -3.294 . . . . 0.51 112.51 172.184 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -73.45 -37.31 65.86 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 123.686 0.616 . . . . 1.44 111.651 174.584 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.5 mt -65.3 -35.09 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-O 124.442 2.068 . . . . 1.32 112.064 175.322 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -61.45 -41.82 97.8 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.045 3.738 . . . . 1.7 112.493 -178.783 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -68.47 -32.74 72.96 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 126.759 2.537 . . . . 1.55 115.347 167.943 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -79.13 -60.09 2.51 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 119.17 0.896 . . . . 2.62 112.497 -179.415 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -102.71 -20.84 14.22 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 118.246 -2.784 . . . . 1.48 112.545 -167.388 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.2 30.49 10.9 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 117.59 -2.243 . . . . 1.12 112.643 178.73 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.8 mt -109.56 111.49 59.34 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 116.544 -1.694 . . . . 1.55 108.435 -178.589 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -61.77 153.1 70.04 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 122.973 2.449 . . . . 1.02 113.362 179.816 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -70.96 -15.14 32.63 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-N 126.631 3.404 . . . . 1.25 118.961 -177.005 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -51.83 -46.0 64.17 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 126.301 2.251 . . . . 2.25 113.784 170.48 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -76.97 -5.43 48.58 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 116.988 -1.482 . . . . 2.02 111.424 -177.701 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -99.26 126.42 45.09 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 120.013 1.279 . . . . 0.69 109.842 -172.374 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -116.8 130.84 56.96 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 128.626 2.77 . . . . 2.78 104.443 164.508 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -107.54 132.43 53.26 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.309 -2.744 . . . . 1.17 111.669 173.74 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.4 mm -109.63 141.96 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 119.881 -1.762 . . . . 1.38 108.74 179.556 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -140.7 117.66 11.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.575 -1.268 . . . . 1.5 107.575 170.636 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.377 . . 72.98 -44.19 0.59 Allowed 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 129.594 3.157 . . . . 1.21 112.048 -175.827 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 173.38 -42.45 0.15 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 128.039 2.733 . . . . 1.3 115.253 -171.947 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -74.13 157.5 35.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 118.584 -1.246 . . . . 2.55 110.262 178.663 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -87.58 143.59 27.12 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 126.319 1.848 . . . . 2.48 110.283 176.273 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.3 mt -93.64 151.79 19.43 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 116.288 -4.008 . . . . 0.9 112.216 -176.655 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -93.49 147.66 22.77 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 104.403 -2.443 . . . . 1.94 104.403 174.05 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -66.37 -52.68 44.39 Favored 'General case' 0 N--CA 1.43 -1.426 1 CA-C-O 128.599 4.047 . . . . 1.56 116.194 -170.938 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.61 48.34 3.66 Favored Glycine 0 N--CA 1.43 -1.743 1 O-C-N 114.511 -5.118 . . . . 0.97 111.838 173.962 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -130.67 161.84 30.74 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.547 -2.737 . . . . 2.49 105.742 162.071 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 14.0 p -95.7 179.72 5.02 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 117.036 -1.866 . . . . 0.76 110.076 -173.174 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.5 HD21 HG21 ' A' ' 26' ' ' VAL . 2.9 mt -72.24 -41.68 66.54 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 116.783 -1.579 . . . . 1.05 113.082 172.378 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 t -68.34 -11.96 60.34 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 121.769 2.077 . . . . 1.19 114.869 172.617 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -79.92 -29.44 39.77 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 125.445 3.748 . . . . 1.9 110.405 177.826 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -90.68 -6.04 55.02 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.056 -3.528 . . . . 0.89 112.304 174.258 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 75.7 34.19 0.59 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.684 3.74 . . . . 1.84 113.174 175.889 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.705 HD13 HD21 ' A' ' 67' ' ' LEU . 37.7 mt -74.7 107.66 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 127.476 2.31 . . . . 0.82 111.917 175.685 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -84.74 178.51 7.62 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 126.728 2.517 . . . . 2.16 110.509 177.624 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -62.05 146.94 48.82 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 115.031 1.493 . . . . 2.12 115.031 172.451 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 64.29 39.41 7.32 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 122.827 1.299 . . . . 1.71 111.477 173.144 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 t -113.94 147.56 38.34 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.806 -1.543 . . . . 1.04 112.949 -173.806 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.2 m -93.96 130.14 40.18 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.726 -1.858 . . . . 0.79 113.777 178.446 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.705 HD21 HD13 ' A' ' 61' ' ' ILE . 96.7 mt -115.01 132.92 56.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.918 -1.882 . . . . 1.4 105.918 173.808 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -94.05 125.34 38.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.756 3.169 . . . . 1.51 111.278 -174.469 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 tp -92.94 116.1 28.73 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 113.345 -5.847 . . . . 1.14 110.57 176.735 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.0 t -111.77 126.03 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 128.474 2.709 . . . . 1.23 106.332 179.23 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 N--CA 1.43 -1.444 0 O-C-N 118.216 -2.802 . . . . 2.78 107.015 178.948 . . . . . . . . 0 0 . 1 . 141 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 ttp . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 123.405 1.574 . . . . 1.1 109.537 . . . . . . . . . 0 0 . 1 . 141 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -91.53 144.43 25.56 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.235 -4.666 . . . . 1.87 106.781 178.357 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.3 pt -140.12 175.35 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 124.195 1.95 . . . . 0.72 106.974 169.008 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -116.29 143.54 45.4 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 104.736 -2.32 . . . . 1.4 104.736 176.557 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.92 117.74 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 1 O-C-N 129.425 4.203 . . . . 0.58 103.805 167.315 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -105.75 141.3 37.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.411 -2.68 . . . . 2.09 114.13 173.582 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.1 p -84.25 171.34 12.83 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.35 -1.468 . . . . 0.99 112.658 177.058 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.258 13.1 tp -57.53 -44.09 84.84 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.754 2.822 . . . . 2.53 114.854 168.142 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 p -75.83 -65.58 0.89 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.752 1.621 . . . . 2.08 112.844 -173.72 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.09 53.28 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.696 0 CA-C-O 117.574 -1.681 . . . . 1.31 116.585 175.599 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -128.6 124.52 36.07 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.29 -1.744 . . . . 1.4 106.29 -179.374 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.9 m -104.14 133.86 48.36 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 102.906 -2.998 . . . . 0.78 102.906 -178.778 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.8 mt -106.85 135.01 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 103.182 -2.896 . . . . 1.55 103.182 178.703 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.9 m -97.35 122.71 40.7 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.158 -2.214 . . . . 1.08 106.821 178.351 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.8 tp -129.02 124.18 34.28 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 117.217 2.303 . . . . 1.55 117.217 -175.379 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -79.86 124.63 28.82 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 117.166 -1.397 . . . . 1.95 107.443 174.47 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.0 m -134.77 177.57 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 128.668 2.787 . . . . 0.96 106.655 178.95 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.4 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 44.4 mt-10 -123.36 166.57 17.81 Favored Pre-proline 0 N--CA 1.43 -1.448 0 C-N-CA 127.187 2.195 . . . . 2.35 106.735 163.092 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 58.2 Cg_endo -82.2 -17.31 7.95 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 122.915 2.41 . . . . 0.95 109.681 -174.37 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 m -90.35 5.19 48.4 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.255 -2.153 . . . . 1.45 110.318 178.156 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -84.2 158.55 21.26 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.112 -1.81 . . . . 1.69 106.112 177.324 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -92.78 163.94 13.54 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 123.579 1.657 . . . . 0.75 110.202 178.767 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mp -68.08 -34.82 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 127.272 3.415 . . . . 0.73 116.363 174.548 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -53.36 -44.07 68.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.724 -2.485 . . . . 1.62 117.59 161.699 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -66.37 -31.97 73.07 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.583 1.953 . . . . 2.13 109.801 175.847 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.51 -47.98 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 117.848 -3.032 . . . . 0.62 113.497 175.899 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.302 95.8 mttt -49.63 -40.82 40.64 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 130.275 3.43 . . . . 1.22 115.229 167.664 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.89 -39.66 87.54 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.941 1.696 . . . . 0.51 113.494 177.923 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -66.03 -29.78 70.2 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 118.346 2.721 . . . . 1.44 118.346 167.929 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.1 mt -76.02 -33.65 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 118.496 -2.627 . . . . 1.32 114.827 171.841 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -69.6 -33.4 72.64 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.268 -1.333 . . . . 1.7 109.951 172.931 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.3 -59.54 4.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.078 1.751 . . . . 1.55 110.069 170.37 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -65.62 -60.52 2.83 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 130.463 3.505 . . . . 2.62 112.029 -168.478 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -102.85 -53.15 2.91 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.623 -3.173 . . . . 1.48 111.885 -175.521 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.05 38.02 0.4 Allowed Glycine 0 N--CA 1.43 -1.721 0 O-C-N 120.466 -1.396 . . . . 1.12 115.309 172.325 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.7 mt -110.24 126.43 28.95 Favored Pre-proline 0 N--CA 1.43 -1.435 0 C-N-CA 126.26 1.824 . . . . 1.55 108.695 -174.974 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.47 143.54 97.45 Favored 'Trans proline' 0 N--CA 1.434 -2.006 1 O-C-N 112.743 -4.398 . . . . 1.02 115.701 -178.411 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -67.61 -14.15 41.17 Favored 'Trans proline' 0 N--CA 1.434 -2.029 0 N-CA-C 118.897 2.614 . . . . 1.25 118.897 -173.179 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -79.78 -36.71 36.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 125.37 1.669 . . . . 2.25 107.951 179.364 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -74.98 -30.2 61.12 Favored 'General case' 0 N--CA 1.431 -1.402 1 C-N-CA 133.634 4.773 . . . . 2.02 111.363 -169.035 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -87.92 134.14 33.77 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.566 -2.584 . . . . 0.69 112.519 -173.41 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.617 ' HB2' HG23 ' A' ' 70' ' ' VAL . 84.5 mtt180 -112.71 142.84 44.86 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 116.74 -3.725 . . . . 2.78 107.012 168.408 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.3 mt -119.86 116.49 25.95 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 118.896 -2.378 . . . . 1.17 113.393 174.958 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.3 mt -88.87 137.01 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 127.875 2.47 . . . . 1.38 110.967 -178.901 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -154.9 131.18 10.36 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.685 2.184 . . . . 1.5 105.439 173.286 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.74 -64.75 0.1 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 119.395 3.109 . . . . 1.21 119.395 178.998 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -158.34 11.47 0.22 Allowed Glycine 0 N--CA 1.43 -1.703 0 CA-C-O 122.776 1.209 . . . . 1.3 112.914 177.835 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.5 pttt -144.94 177.23 8.9 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 111.964 -2.118 . . . . 2.55 111.486 -174.411 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -110.39 157.3 19.69 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.533 1.933 . . . . 2.48 108.707 171.982 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.6 mt -102.86 137.7 40.71 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 117.953 -1.022 . . . . 0.9 113.02 -173.837 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.472 ' HB2' ' HG2' ' A' ' 54' ' ' ARG . 49.8 mt-10 -75.44 141.82 43.09 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.89 2.876 . . . . 1.94 111.003 177.512 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -69.21 -53.07 21.84 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 123.3 2.773 . . . . 1.56 116.005 -162.977 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.95 42.04 3.12 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 119.078 -2.264 . . . . 0.97 114.714 175.121 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.472 ' HG2' ' HB2' ' A' ' 51' ' ' GLU . 28.6 mmt180 -112.14 161.31 16.67 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 121.415 2.607 . . . . 2.49 104.142 166.766 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.1 p -90.9 162.26 14.86 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 116.807 -3.683 . . . . 0.76 111.546 178.879 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.2 mt -63.86 -33.13 75.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.488 2.315 . . . . 1.05 110.573 169.566 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.5 p -63.57 -53.6 49.21 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.369 -2.707 . . . . 1.19 114.978 179.339 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -56.16 -34.19 65.92 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.424 -1.262 . . . . 1.9 114.385 173.875 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -82.01 -4.17 56.14 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.906 -1.121 . . . . 0.89 112.571 -176.896 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.261 19.4 m-80 58.42 41.89 22.13 Favored 'General case' 0 N--CA 1.431 -1.415 1 C-N-CA 133.043 4.537 . . . . 1.84 115.861 -174.418 . . . . . . . . 3 2 . 1 . 141 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.1 mt -85.32 122.51 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 117.607 -3.183 . . . . 0.82 112.576 178.188 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -97.54 -174.04 2.81 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 125.404 2.526 . . . . 2.16 113.251 -175.141 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -59.52 131.82 52.11 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 127.348 3.452 . . . . 2.12 116.702 170.82 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.308 13.6 mt-10 73.02 31.46 1.48 Allowed 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 127.04 3.305 . . . . 1.71 114.127 173.797 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.5 m -88.84 160.98 16.97 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 118.523 -2.611 . . . . 1.04 108.68 -173.48 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.253 4.3 m -114.38 114.16 25.51 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 116.41 -3.931 . . . . 0.79 112.307 -178.424 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.9 mt -93.87 128.24 40.05 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 129.909 3.284 . . . . 1.4 108.158 170.337 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -111.51 116.81 31.49 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 126.128 2.871 . . . . 1.51 115.184 -175.85 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.9 tp -84.53 116.98 23.42 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.852 -2.405 . . . . 1.14 113.852 -173.622 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.617 HG23 ' HB2' ' A' ' 42' ' ' ARG . 31.4 m -122.0 161.24 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 114.415 -1.266 . . . . 1.23 111.082 168.7 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.4 mt . . . . . 0 N--CA 1.429 -1.487 0 O-C-N 120.055 -1.653 . . . . 2.78 107.598 178.981 . . . . . . . . 0 0 . 1 . 142 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 ptt? . . . . . 0 CA--C 1.489 -1.373 0 N-CA-C 113.809 1.04 . . . . 1.1 113.809 . . . . . . . . . 0 0 . 1 . 142 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -88.52 127.92 35.54 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.466 -1.396 . . . . 1.87 109.379 -176.449 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.424 HD12 HD13 ' A' ' 67' ' ' LEU . 8.8 pt -121.97 161.07 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 104.891 -2.262 . . . . 0.72 104.891 164.798 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -120.69 137.01 54.69 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.182 2.193 . . . . 1.4 106.865 176.449 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -119.07 125.31 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 128.281 2.632 . . . . 0.58 110.253 173.402 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -99.48 141.9 31.66 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.515 -1.991 . . . . 2.09 113.894 -178.215 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 p -102.19 175.63 5.46 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 121.165 1.802 . . . . 0.99 109.908 179.136 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.2 tp -44.6 -47.76 10.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.461 1.652 . . . . 2.53 115.461 167.996 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.8 p -80.55 -0.56 38.23 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 123.547 0.739 . . . . 2.08 112.401 -178.662 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.8 25.57 57.95 Favored Glycine 0 N--CA 1.43 -1.76 1 C-N-CA 134.18 5.657 . . . . 1.31 112.533 178.651 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -71.01 127.1 31.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.862 -1.533 . . . . 1.4 106.862 -173.145 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.1 m -84.79 122.23 28.83 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 113.076 -3.45 . . . . 0.78 114.55 173.957 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.0 mt -98.99 119.64 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 105.323 -2.103 . . . . 1.55 105.323 173.086 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.5 m -90.63 111.47 22.81 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.312 2.258 . . . . 1.08 113.148 -178.986 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.0 mt -116.28 155.1 28.98 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 120.254 1.388 . . . . 1.55 111.45 -174.882 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -107.34 114.58 28.7 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 128.396 2.678 . . . . 1.95 105.134 172.377 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -124.68 164.12 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 118.185 -2.822 . . . . 0.96 106.831 179.117 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -102.84 147.84 34.68 Favored Pre-proline 0 N--CA 1.43 -1.453 1 C-N-CA 133.06 4.544 . . . . 2.35 114.308 159.792 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -77.58 -12.67 16.72 Favored 'Trans proline' 0 C--N 1.3 -2.008 1 CA-C-N 129.347 4.374 . . . . 0.95 110.929 -166.521 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 p -88.88 -0.51 57.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 115.311 -2.281 . . . . 1.45 113.295 178.342 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -74.31 149.67 40.54 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 125.276 1.61 . . . . 1.69 114.6 177.233 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.259 57.8 p -85.04 157.33 20.77 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 125.632 2.634 . . . . 0.75 110.153 -178.505 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.3 mm -67.72 -32.03 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.492 -2.63 . . . . 0.73 109.783 175.665 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -61.89 -32.72 73.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.224 2.21 . . . . 1.62 116.096 165.086 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -81.17 -29.47 34.66 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 122.428 2.376 . . . . 2.13 113.162 176.023 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.8 -32.2 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.401 -1.333 . . . . 0.62 107.401 174.488 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.319 48.8 mttt -51.69 -41.29 61.33 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 118.889 2.922 . . . . 1.22 118.889 172.95 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.1 -40.73 59.11 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 117.512 2.412 . . . . 0.51 117.512 166.179 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -68.7 -48.99 62.47 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.405 2.526 . . . . 1.44 114.228 -178.933 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 30' ' ' ILE . 4.2 mt -54.74 -39.67 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 O-C-N 118.144 -2.848 . . . . 1.32 117.714 166.621 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -68.52 -32.11 71.84 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.032 -2.917 . . . . 1.7 112.152 -179.801 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -59.93 -38.17 81.6 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.167 -2.833 . . . . 1.55 114.76 168.411 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -75.13 -66.24 0.78 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 127.586 2.354 . . . . 2.62 109.676 -178.761 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -106.41 -20.88 13.24 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 128.403 2.681 . . . . 1.48 111.824 -159.988 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.31 -2.27 70.89 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 121.773 3.469 . . . . 1.12 121.773 177.901 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.8 mt -68.93 129.37 92.34 Favored Pre-proline 0 N--CA 1.431 -1.41 0 C-N-CA 127.473 2.309 . . . . 1.55 113.561 -179.584 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.251 0.3 OUTLIER -72.52 143.74 38.97 Favored 'Trans proline' 0 C--N 1.299 -2.042 1 C-N-CA 125.496 4.131 . . . . 1.02 112.995 -173.285 . . . . . . . . 4 3 . 1 . 142 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.53 -11.95 33.79 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 121.813 1.683 . . . . 1.25 114.151 -178.53 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.48 -31.86 67.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.832 -1.168 . . . . 2.25 112.054 173.99 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -96.88 -22.19 17.04 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 125.227 1.58 . . . . 2.02 113.903 -173.373 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -75.86 122.65 24.43 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 123.674 1.702 . . . . 0.69 111.921 178.705 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -121.99 143.76 49.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 117.721 -3.112 . . . . 2.78 106.134 168.653 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.45 150.53 29.73 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.181 -3.449 . . . . 1.17 110.999 178.972 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mt -129.69 140.04 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 N-CA-C 97.291 -5.077 . . . . 1.38 97.291 -179.583 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -154.98 137.78 15.33 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.793 2.437 . . . . 1.5 105.448 169.492 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.406 . . 74.46 -49.52 0.67 Allowed 'General case' 0 N--CA 1.431 -1.385 1 C-N-CA 134.917 5.287 . . . . 1.21 115.425 178.999 . . . . . . . . 3 2 . 1 . 142 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -173.43 -23.92 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 106.095 -2.802 . . . . 1.3 106.095 -177.497 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -118.53 158.3 25.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.626 2.631 . . . . 2.55 113.281 -170.819 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -71.66 126.29 29.3 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.7 -1.963 . . . . 2.48 105.7 169.715 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.1 mt -82.97 141.66 31.96 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.861 2.464 . . . . 0.9 108.887 -175.962 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -81.42 152.69 27.3 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.491 -4.506 . . . . 1.94 106.589 171.889 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -77.59 -57.22 3.93 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.287 -1.779 . . . . 1.56 111.654 -167.843 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.34 17.59 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.752 0 CA-C-O 114.002 -3.666 . . . . 0.97 120.37 168.689 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -110.21 175.15 5.54 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 123.609 3.704 . . . . 2.49 105.122 176.307 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.0 p -102.41 171.9 7.19 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 128.242 3.877 . . . . 0.76 117.012 171.003 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.2 mt -65.32 -33.18 75.37 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 112.241 -2.254 . . . . 1.05 112.923 173.848 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 m -64.23 -36.25 83.47 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.142 2.645 . . . . 1.19 118.142 177.099 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -56.88 -42.89 80.62 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.493 2.717 . . . . 1.9 109.045 173.097 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -93.4 3.81 54.99 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.175 -3.453 . . . . 0.89 116.981 -177.905 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.321 69.9 m-80 71.48 29.96 2.58 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 125.936 2.779 . . . . 1.84 112.162 171.313 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.3 mt -80.97 119.71 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 111.842 -2.436 . . . . 0.82 110.408 -178.071 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -115.59 -176.58 2.96 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.324 -3.36 . . . . 2.16 107.322 -173.386 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -64.2 153.49 37.79 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 117.728 -3.108 . . . . 2.12 117.433 177.322 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 64.0 20.27 12.12 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 130.506 3.522 . . . . 1.71 113.157 168.578 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.2 m -88.79 160.28 17.35 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 115.356 -2.259 . . . . 1.04 113.69 -172.286 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.0 m -101.92 95.93 6.71 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 115.573 -2.156 . . . . 0.79 111.163 -172.389 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.424 HD13 HD12 ' A' ' 3' ' ' ILE . 5.3 mp -91.4 163.38 14.21 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 124.355 3.252 . . . . 1.4 106.819 179.373 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -123.04 152.31 41.1 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 124.584 2.135 . . . . 1.51 113.465 -178.173 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.6 tp -127.93 136.96 52.06 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.888 -1.758 . . . . 1.14 108.393 -176.694 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.4 m -135.14 156.76 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 104.003 -2.592 . . . . 1.23 104.003 178.94 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.3 mt . . . . . 0 N--CA 1.43 -1.472 0 CA-C-O 122.928 1.347 . . . . 2.78 113.71 179.357 . . . . . . . . 0 0 . 1 . 143 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.368 0 N-CA-C 112.64 0.608 . . . . 1.1 112.64 . . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.04 146.72 23.51 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.8 -1.813 . . . . 1.87 110.467 179.078 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 pt -127.99 170.03 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 103.997 -2.594 . . . . 0.72 103.997 168.147 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -124.28 142.22 51.43 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.505 -3.247 . . . . 1.4 106.327 -178.809 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.1 t -130.79 118.98 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-O 116.953 -1.499 . . . . 0.58 107.211 179.741 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -97.29 133.3 42.1 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 125.957 2.036 . . . . 2.09 112.782 176.859 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.4 ' HB ' ' H ' ' A' ' 8' ' ' LEU . 46.9 p -74.29 -161.78 0.13 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.527 -2.608 . . . . 0.99 117.697 171.665 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.4 ' H ' ' HB ' ' A' ' 7' ' ' THR . 84.5 mt -71.0 -63.95 1.0 Allowed 'General case' 0 N--CA 1.429 -1.492 2 C-N-CA 134.428 5.091 . . . . 2.53 113.111 174.606 . . . . . . . . 3 3 . 1 . 143 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.5 p -69.09 -47.18 65.88 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 118.921 -2.362 . . . . 2.08 116.31 -176.405 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.06 1.22 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 121.594 3.398 . . . . 1.31 121.594 177.458 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -86.47 126.21 34.26 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 118.51 -2.759 . . . . 1.4 111.103 -173.494 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.259 80.1 m -102.89 116.84 33.33 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 105.101 -2.185 . . . . 0.78 105.101 174.947 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.5 pt -99.68 148.94 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 122.543 1.163 . . . . 1.55 111.101 173.102 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.251 37.5 m -106.66 101.97 11.38 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 127.05 2.14 . . . . 1.08 109.161 178.147 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.6 mt -96.98 140.26 31.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 113.809 1.04 . . . . 1.55 113.809 179.376 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -104.13 130.92 51.87 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 126.247 2.927 . . . . 1.95 110.96 172.643 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.6 m -135.24 158.92 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 118.292 -2.755 . . . . 0.96 110.096 -169.49 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -103.93 147.0 33.61 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 106.337 -1.727 . . . . 2.35 106.337 160.397 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.364 43.9 Cg_endo -72.07 -0.89 9.21 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 124.937 2.799 . . . . 0.95 117.548 -176.554 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.6 p -108.59 2.06 21.8 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.792 2.437 . . . . 1.45 106.146 -176.2 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.76 139.96 43.71 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 119.815 1.189 . . . . 1.69 113.514 171.393 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 5.8 p -79.11 167.36 21.15 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.227 2.441 . . . . 0.75 106.74 -179.046 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.2 mm -66.68 -33.6 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 115.358 -2.258 . . . . 0.73 111.104 176.624 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -54.46 -46.43 73.32 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 126.01 2.069 . . . . 1.62 111.79 171.593 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -70.24 -42.11 72.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 112.877 -3.44 . . . . 2.13 115.278 174.825 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.1 t -52.47 -32.76 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 122.266 2.303 . . . . 0.62 112.894 168.71 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 27.6 mttt -73.11 -31.49 64.36 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.407 -3.308 . . . . 1.22 113.447 178.454 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.27 -33.81 75.34 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.282 1.433 . . . . 0.51 110.683 167.432 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -73.23 -34.8 66.1 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.119 -4.113 . . . . 1.44 113.55 176.563 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 99.6 mt -67.75 -31.02 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 127.777 2.431 . . . . 1.32 106.252 172.638 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -39.36 80.02 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 120.468 1.485 . . . . 1.7 114.014 174.214 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -69.79 -47.12 64.06 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 116.77 -1.586 . . . . 1.55 108.846 175.633 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -75.82 -56.38 4.73 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 125.827 1.651 . . . . 2.62 114.237 -174.442 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -103.3 -25.09 13.45 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 117.428 -3.295 . . . . 1.48 110.603 -165.045 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.41 32.95 8.98 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 115.769 -2.684 . . . . 1.12 111.796 -179.893 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mt -110.44 123.1 36.67 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 113.016 -3.373 . . . . 1.55 105.881 -176.403 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -62.16 144.82 96.23 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 124.072 3.181 . . . . 1.02 117.805 177.196 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 94.0 Cg_endo -72.75 -2.04 11.29 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 123.821 3.014 . . . . 1.25 116.134 -170.193 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -73.06 -43.64 61.67 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.686 2.394 . . . . 2.25 109.276 169.076 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.292 31.1 mt-30 -66.35 -55.57 15.29 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.179 -1.576 . . . . 2.02 110.915 -172.667 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.408 70.7 mt-30 -63.89 130.18 43.08 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 128.919 2.888 . . . . 0.69 112.595 -175.874 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -120.31 115.63 23.95 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 103.25 -2.87 . . . . 2.78 103.25 174.026 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.2 mt -97.91 142.52 29.54 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.317 -1.734 . . . . 1.17 106.317 179.557 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.7 mt -136.85 144.88 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 100.597 -3.853 . . . . 1.38 100.597 177.291 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -127.9 104.8 8.01 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 124.389 2.042 . . . . 1.5 106.944 173.736 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.3 . . 71.27 -75.28 0.08 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 112.454 -2.157 . . . . 1.21 113.747 -179.694 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.75 -17.48 1.06 Allowed Glycine 0 N--CA 1.43 -1.71 0 CA-C-O 114.351 -3.472 . . . . 1.3 113.844 174.787 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -96.64 131.3 43.44 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 105.914 -1.884 . . . . 2.55 105.914 -174.378 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -83.28 132.51 35.03 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 131.369 3.867 . . . . 2.48 105.226 172.56 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.286 56.1 mt -85.93 146.37 26.73 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 115.585 -2.15 . . . . 0.9 105.782 -170.556 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -109.15 165.29 11.72 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 125.631 3.832 . . . . 1.94 104.433 169.919 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -76.77 -44.3 33.49 Favored 'General case' 0 N--CA 1.43 -1.434 2 C-N-CA 133.1 4.56 . . . . 1.56 122.423 -171.444 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.68 43.13 2.76 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 126.428 1.966 . . . . 0.97 113.487 169.404 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -122.18 152.91 39.46 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.444 2.297 . . . . 2.49 111.231 170.491 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 77.6 p -95.91 168.68 10.49 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 127.899 3.249 . . . . 0.76 112.221 177.934 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.3 mt -69.95 -33.12 71.69 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 116.735 -3.728 . . . . 1.05 109.837 176.952 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.2 t -68.86 -36.59 78.32 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.435 -3.29 . . . . 1.19 112.213 178.753 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -51.59 -49.5 62.0 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.233 -2.792 . . . . 1.9 112.504 176.391 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -87.53 -4.95 58.97 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 115.785 -4.322 . . . . 0.89 111.087 -179.163 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.3 t30 54.26 53.45 10.93 Favored 'General case' 0 N--CA 1.43 -1.467 1 C-N-CA 132.597 4.359 . . . . 1.84 117.392 176.754 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.0 mt -73.42 126.18 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 126.783 3.182 . . . . 0.82 112.559 -175.617 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -92.66 171.34 9.07 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 114.884 -4.885 . . . . 2.16 114.182 -176.603 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -64.09 143.26 58.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 118.27 -2.769 . . . . 2.12 109.048 174.727 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 55.92 19.2 3.44 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 118.389 2.737 . . . . 1.71 118.389 -178.593 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -74.96 147.32 40.97 Favored 'General case' 0 N--CA 1.428 -1.54 0 O-C-N 120.028 -1.67 . . . . 1.04 106.941 -173.947 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.7 m -93.41 113.28 25.39 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.628 -1.92 . . . . 0.79 106.425 -176.981 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 mp -110.59 156.69 20.59 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 123.125 2.693 . . . . 1.4 104.041 175.558 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -106.35 144.14 33.46 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.136 -2.852 . . . . 1.51 110.155 -179.622 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.6 tp -128.01 115.9 19.21 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 102.947 -2.983 . . . . 1.14 102.947 179.369 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.89 138.22 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 119.18 -2.2 . . . . 1.23 106.218 177.334 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.43 -1.442 0 CA-C-O 123.814 1.768 . . . . 2.78 113.51 -175.474 . . . . . . . . 0 0 . 1 . 144 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 CA--C 1.489 -1.375 0 CA-C-O 123.218 1.485 . . . . 1.1 110.811 . . . . . . . . . 0 0 . 1 . 144 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -100.93 94.17 5.89 Favored 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 115.028 -4.795 . . . . 1.87 106.864 -173.984 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.266 18.9 pt -85.35 149.84 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 1 O-C-N 129.244 4.09 . . . . 0.72 114.227 172.913 . . . . . . . . 3 2 . 1 . 144 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -107.75 108.13 19.21 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.09 2.556 . . . . 1.4 114.707 -179.358 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -94.55 116.27 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-N 119.91 1.232 . . . . 0.58 110.073 176.232 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -95.74 129.86 42.83 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 124.941 2.305 . . . . 2.09 110.232 176.357 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.0 p -74.03 -173.78 1.7 Allowed 'General case' 0 N--CA 1.431 -1.393 1 O-C-N 114.808 -4.932 . . . . 0.99 112.829 166.486 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.1 mt -81.12 -49.53 10.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 125.959 2.037 . . . . 2.53 116.421 170.271 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 p -63.56 -56.02 19.21 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.858 -4.276 . . . . 2.08 111.87 -173.392 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.22 53.7 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 116.778 -2.63 . . . . 1.31 111.745 173.098 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -136.7 125.16 23.48 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 121.491 2.646 . . . . 1.4 104.566 -174.193 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.8 m -107.04 113.35 26.77 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 118.668 -2.52 . . . . 0.78 114.431 175.876 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.419 ' CG2' ' HG2' ' A' ' 33' ' ' LYS . 15.6 mt -96.49 125.71 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 122.784 1.278 . . . . 1.55 111.96 -176.043 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 m -89.84 119.03 29.87 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.05 -2.906 . . . . 1.08 111.244 177.768 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.8 mt -116.53 153.07 32.85 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.309 -1.494 . . . . 1.55 109.013 -179.324 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -109.29 130.7 55.49 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.262 -3.399 . . . . 1.95 107.561 172.198 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -144.42 173.61 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 123.31 1.529 . . . . 0.96 109.685 179.709 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.434 ' O ' HD12 ' A' ' 56' ' ' LEU . 18.9 mm-40 -106.44 159.68 28.91 Favored Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 105.244 -2.132 . . . . 2.35 105.244 167.164 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -84.5 -11.33 8.27 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 O-C-N 113.87 -3.805 . . . . 0.95 106.486 -173.71 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.9 p -93.32 -3.37 53.59 Favored 'General case' 0 N--CA 1.43 -1.439 1 C-N-CA 131.769 4.028 . . . . 1.45 110.818 -174.154 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -73.76 152.05 40.45 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.253 2.221 . . . . 1.69 107.22 177.269 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.6 p -86.35 156.5 20.19 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 116.906 -3.621 . . . . 0.75 106.73 175.09 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 mm -44.23 -48.55 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 1 C-N-CA 131.764 4.026 . . . . 0.73 112.12 174.842 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -35.46 -57.72 0.61 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 119.019 2.97 . . . . 1.62 119.019 166.831 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -71.16 -27.77 63.78 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 113.367 -1.742 . . . . 2.13 113.848 179.461 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.37 -48.54 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 125.862 2.744 . . . . 0.62 114.085 170.868 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -60.22 -37.36 80.06 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.904 -3.623 . . . . 1.22 115.239 175.879 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.45 -14.35 61.23 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.304 -2.747 . . . . 0.51 112.694 179.509 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 32' ' ' ASP . 10.5 ttmt -74.18 -41.61 61.18 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.097 -1.627 . . . . 1.44 114.233 170.261 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.3 mt -58.51 -46.29 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 123.234 1.492 . . . . 1.32 111.439 166.741 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -49.03 -42.83 39.6 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 125.194 2.426 . . . . 1.7 112.856 171.738 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 29' ' ' LYS . 34.0 t70 -60.53 -58.91 6.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.869 -3.644 . . . . 1.55 113.787 168.827 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.419 ' HG2' ' CG2' ' A' ' 13' ' ' ILE . 33.9 tptt -68.82 -62.04 1.55 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.541 2.336 . . . . 2.62 113.429 -170.079 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -87.22 -45.2 10.85 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 128.061 2.545 . . . . 1.48 113.142 -168.57 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.11 39.89 3.91 Favored Glycine 0 N--CA 1.43 -1.751 0 CA-C-N 112.659 -2.064 . . . . 1.12 114.92 177.691 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.3 mt -106.7 134.16 19.95 Favored Pre-proline 0 N--CA 1.43 -1.466 0 C-N-CA 126.374 1.87 . . . . 1.55 107.01 -178.043 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.69 143.44 99.41 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-O 113.684 -2.715 . . . . 1.02 117.513 175.692 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -80.84 -2.31 11.75 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 126.497 3.356 . . . . 1.25 112.012 -168.331 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.74 -26.21 32.13 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 124.829 2.252 . . . . 2.25 111.66 170.393 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -84.86 -20.26 31.09 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.235 -2.791 . . . . 2.02 114.773 -176.065 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -85.85 117.93 25.02 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 114.944 -1.025 . . . . 0.69 111.266 -176.221 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.404 ' HB2' HG23 ' A' ' 70' ' ' VAL . 13.8 mtt-85 -113.22 116.01 29.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.669 -1.269 . . . . 2.78 108.706 169.772 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.5 mt -88.41 136.84 32.79 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.858 -1.151 . . . . 1.17 112.559 176.181 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -113.49 117.63 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 O-C-N 117.682 -3.136 . . . . 1.38 104.886 179.904 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.417 ' HB3' HD21 ' A' ' 50' ' ' LEU . 50.0 t80 -107.21 123.13 47.84 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 116.675 -3.766 . . . . 1.5 108.05 165.916 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.305 . . 64.29 -82.84 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 131.314 3.846 . . . . 1.21 114.215 -173.991 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.66 3.06 2.03 Favored Glycine 0 N--CA 1.43 -1.719 0 O-C-N 116.65 -3.781 . . . . 1.3 105.466 -176.919 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -127.0 141.72 51.72 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 115.658 -4.436 . . . . 2.55 113.913 178.454 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -65.38 142.98 58.03 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.246 2.219 . . . . 2.48 113.589 171.439 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.417 HD21 ' HB3' ' A' ' 45' ' ' PHE . 34.6 mt -96.36 123.46 40.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.765 -3.084 . . . . 0.9 113.493 -176.519 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -81.47 144.26 31.49 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 130.012 3.325 . . . . 1.94 112.959 -178.54 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.6 150.72 28.0 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.453 2.701 . . . . 1.56 107.385 -169.113 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.97 -4.44 78.28 Favored Glycine 0 N--CA 1.429 -1.77 0 O-C-N 119.454 -2.029 . . . . 0.97 109.409 174.194 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -97.34 172.34 7.84 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.087 2.286 . . . . 2.49 110.392 171.433 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.6 p -110.83 174.32 5.91 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.504 -1.372 . . . . 0.76 112.57 173.282 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 18' ' ' GLU . 67.1 mt -52.16 -34.67 46.0 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.844 2.458 . . . . 1.05 112.427 170.185 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.1 m -75.11 -34.56 61.72 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.701 2.501 . . . . 1.19 114.179 -172.579 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -51.31 -34.68 34.4 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 119.985 3.328 . . . . 1.9 119.985 170.442 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -92.56 -5.91 50.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 109.712 -3.404 . . . . 0.89 114.195 178.892 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.25 8.9 m120 64.92 50.3 1.96 Allowed 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.057 -2.902 . . . . 1.84 113.516 179.583 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.8 mt -92.64 107.84 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 126.004 2.811 . . . . 0.82 110.903 178.409 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -89.49 172.61 8.86 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.207 -2.269 . . . . 2.16 106.231 -171.288 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -14.42 -89.35 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.007 3.323 . . . . 2.12 119.613 167.473 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -91.44 74.95 6.01 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.537 -4.477 . . . . 1.71 114.309 179.028 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -94.41 144.85 25.21 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.89 -4.256 . . . . 1.04 119.657 177.024 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.1 m -101.13 110.11 22.09 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.284 3.434 . . . . 0.79 106.472 -177.026 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -108.81 152.37 24.98 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.695 -1.965 . . . . 1.4 105.695 -177.672 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -116.53 133.24 56.25 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.618 -4.426 . . . . 1.51 110.0 -179.788 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.0 tp -107.75 115.42 30.11 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 115.183 -2.341 . . . . 1.14 110.905 -174.173 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 42' ' ' ARG . 15.7 m -111.75 146.93 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 126.059 2.837 . . . . 1.23 106.373 173.967 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.0 tp . . . . . 0 N--CA 1.431 -1.422 0 O-C-N 119.935 -1.728 . . . . 2.78 111.877 -174.124 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.5 ttp . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 113.994 1.109 . . . . 1.1 113.994 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -105.36 140.03 39.1 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.306 -3.371 . . . . 1.87 113.49 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 pt -125.88 153.02 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 114.933 -1.03 . . . . 0.72 109.672 175.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -99.88 135.54 41.15 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.802 2.041 . . . . 1.4 109.247 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.7 t -114.81 104.07 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 104.32 -2.474 . . . . 0.58 104.32 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -82.16 126.05 31.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.31 2.005 . . . . 2.09 111.962 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.3 p -83.94 -169.05 2.39 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 117.171 -3.455 . . . . 0.99 113.019 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.8 tp -73.46 -57.93 3.66 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.844 1.783 . . . . 2.53 113.103 170.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.4 p -67.86 -22.9 65.1 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.256 -3.402 . . . . 2.08 118.191 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.93 22.36 1.03 Allowed Glycine 0 N--CA 1.429 -1.774 0 C-N-CA 125.848 1.689 . . . . 1.31 115.111 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -88.31 131.02 34.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.031 2.133 . . . . 1.4 105.985 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -109.59 124.39 51.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 123.603 2.911 . . . . 0.78 104.382 175.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.1 mt -111.72 128.23 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 107.436 -1.32 . . . . 1.55 107.436 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.8 m -102.83 115.83 31.36 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.11 -0.994 . . . . 1.08 108.928 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -105.49 157.28 17.48 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.971 -1.081 . . . . 1.55 111.568 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.39 110.82 21.46 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.358 2.263 . . . . 1.95 106.524 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.0 m -118.84 159.02 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 126.791 2.557 . . . . 0.96 109.01 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -89.82 146.3 35.09 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-O 111.762 -3.97 . . . . 2.35 106.769 160.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -73.47 -5.61 17.4 Favored 'Trans proline' 0 N--CA 1.433 -2.05 0 CA-C-N 127.547 3.731 . . . . 0.95 115.142 178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 m -90.08 7.58 37.03 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 125.228 1.58 . . . . 1.45 109.444 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -85.19 144.14 28.34 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.19 1.922 . . . . 1.69 116.19 172.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 37.6 p -82.9 160.5 22.11 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.323 -2.736 . . . . 0.75 115.657 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.454 15.5 mm -57.79 -38.99 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 123.419 1.581 . . . . 0.73 115.252 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -47.49 -45.05 25.88 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.357 1.984 . . . . 1.62 116.357 161.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -72.58 -20.8 61.25 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 126.533 1.933 . . . . 2.13 113.4 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.23 -39.37 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.99 -2.319 . . . . 0.62 108.394 172.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -66.05 -41.69 90.5 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.974 -2.329 . . . . 1.22 110.183 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.75 -43.79 66.02 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.956 -2.34 . . . . 0.51 116.033 173.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -61.7 -32.15 72.34 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 125.966 2.041 . . . . 1.44 113.593 170.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -81.81 -32.13 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 118.018 -2.927 . . . . 1.32 115.093 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -56.2 -38.71 71.36 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.868 1.794 . . . . 1.7 113.879 166.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -64.56 -50.39 67.47 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.903 2.881 . . . . 1.55 111.101 167.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -71.5 -62.84 1.26 Allowed 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 126.827 2.051 . . . . 2.62 111.569 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -101.25 -35.31 9.31 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 118.45 -2.656 . . . . 1.48 115.81 -170.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.93 11.06 29.07 Favored Glycine 0 N--CA 1.43 -1.751 0 CA-C-O 124.106 1.948 . . . . 1.12 113.188 175.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.5 mm -76.1 125.97 87.31 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-O 114.418 -2.706 . . . . 1.55 112.842 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.0 154.35 74.39 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 CA-C-N 128.252 3.983 . . . . 1.02 118.169 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -74.08 -9.6 22.17 Favored 'Trans proline' 0 C--N 1.299 -2.066 0 CA-C-N 123.844 2.409 . . . . 1.25 116.52 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -59.99 -44.38 94.56 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 118.378 -0.82 . . . . 2.25 111.254 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -79.6 -29.56 41.21 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.228 0.955 . . . . 2.02 110.604 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -66.66 107.68 2.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 121.044 3.72 . . . . 0.69 121.044 -172.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.427 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 29.5 mtt180 -101.38 139.31 37.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.075 -3.516 . . . . 2.78 110.478 171.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.6 mt -113.3 141.25 47.23 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.677 -2.514 . . . . 1.17 111.891 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mm -128.72 137.58 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 115.184 -2.341 . . . . 1.38 110.899 172.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.499 ' CE2' HG12 ' A' ' 61' ' ' ILE 0.293 10.9 t80 -115.67 -54.62 2.5 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.068 1.48 . . . . 1.5 107.766 176.098 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -121.46 -75.96 0.59 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 115.276 1.584 . . . . 1.21 115.276 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.96 -44.14 0.28 Allowed Glycine 0 N--CA 1.429 -1.767 0 O-C-N 119.412 -2.055 . . . . 1.3 114.166 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 mttm -91.93 151.37 20.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 120.784 2.292 . . . . 2.55 114.459 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -83.56 121.91 27.85 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 111.959 -2.382 . . . . 2.48 111.732 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 mt -78.21 132.16 37.45 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.501 -1.681 . . . . 0.9 114.197 -162.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -87.62 155.87 19.75 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 115.986 -1.959 . . . . 1.94 115.002 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -66.77 -48.21 69.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.199 2.6 . . . . 1.56 116.099 -172.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.97 38.85 1.12 Allowed Glycine 0 N--CA 1.43 -1.737 1 N-CA-C 124.923 4.729 . . . . 0.97 124.923 174.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -139.59 150.65 45.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.099 -2.412 . . . . 2.49 109.337 171.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 24.5 p -91.28 158.81 16.36 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 111.901 -2.409 . . . . 0.76 113.437 -177.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.402 HD23 HD12 ' A' ' 61' ' ' ILE . 1.5 mt -48.93 -48.73 42.54 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.875 -4.265 . . . . 1.05 107.763 170.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.4 p -56.44 -39.57 73.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.874 2.546 . . . . 1.19 117.874 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -53.56 -57.36 11.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.884 -2.385 . . . . 1.9 112.807 171.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -63.49 -16.16 59.87 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 128.124 2.57 . . . . 0.89 115.149 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.2 t30 69.23 51.56 0.51 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.356 2.662 . . . . 1.84 112.593 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.499 HG12 ' CE2' ' A' ' 45' ' ' PHE . 34.6 mt -91.73 122.88 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 118.245 -2.784 . . . . 0.82 108.06 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -89.48 -167.6 1.91 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 125.192 1.557 . . . . 2.16 109.682 -174.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.296 40.2 tttm -75.7 138.16 41.13 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.478 -2.045 . . . . 2.12 105.478 172.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 55.3 51.88 12.36 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 130.925 3.69 . . . . 1.71 109.607 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.6 m -103.02 149.87 24.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.159 -2.163 . . . . 1.04 105.159 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.0 m -100.65 118.3 36.51 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 123.138 1.447 . . . . 0.79 112.613 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 61' ' ' ILE . 9.4 mp -102.2 148.19 25.73 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 105.782 -1.933 . . . . 1.4 105.782 170.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -99.38 130.12 45.63 Favored 'General case' 0 N--CA 1.43 -1.429 1 C-N-CA 131.932 4.093 . . . . 1.51 110.96 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.2 tp -108.86 116.06 31.27 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 115.075 -2.65 . . . . 1.14 105.964 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 98.6 t -99.92 130.92 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 108.516 -0.92 . . . . 1.23 108.516 173.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 71' ' ' LEU . 61.7 mt -90.06 111.85 23.09 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 129.232 3.013 . . . . 2.78 108.371 175.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -70.41 128.22 35.42 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 125.386 2.517 . . . . 3.75 111.085 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.4 mt -101.1 -70.09 0.75 Allowed 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.759 -3.088 . . . . 3.14 108.023 163.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -116.46 -58.97 2.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.137 -2.542 . . . . 6.8 104.137 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.55 119.4 0.56 Allowed Glycine 0 N--CA 1.43 -1.706 0 O-C-N 128.499 3.624 . . . . 3.57 116.723 -162.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.705 0 C-N-CA 126.564 2.031 . . . . 3.87 108.642 -178.453 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.3 ttp . . . . . 0 CA--C 1.489 -1.376 0 CA-C-O 121.788 0.804 . . . . 1.1 111.326 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -96.06 140.75 30.34 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.327 -1.483 . . . . 1.87 113.769 -176.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.6 pt -139.34 165.14 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 125.994 2.807 . . . . 0.72 105.823 171.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -124.64 140.86 52.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 112.715 -2.038 . . . . 1.4 111.08 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.5 t -109.67 120.83 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 O-C-N 120.307 -1.495 . . . . 0.58 113.05 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -94.75 137.92 33.23 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.195 -3.441 . . . . 2.09 112.126 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.258 74.8 p -81.32 -165.02 0.85 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.626 2.631 . . . . 0.99 110.815 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.8 tp -77.19 -44.69 29.22 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.083 -2.886 . . . . 2.53 113.835 169.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.49 -53.63 7.4 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.503 1.62 . . . . 2.08 107.863 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.82 21.71 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.706 1 O-C-N 115.673 -4.392 . . . . 1.31 113.018 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -85.9 139.75 30.97 Favored 'General case' 0 N--CA 1.431 -1.412 1 CA-C-N 125.283 4.541 . . . . 1.4 106.546 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 38.2 m -101.8 114.15 27.96 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.995 1.318 . . . . 0.78 110.345 171.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.0 mt -96.21 122.9 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 117.033 -3.542 . . . . 1.55 110.192 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.3 m -87.21 125.55 34.25 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.186 -1.571 . . . . 1.08 110.73 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.1 mt -126.69 152.46 46.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.615 -1.303 . . . . 1.55 112.084 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -123.36 105.57 9.94 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 111.781 -2.463 . . . . 1.95 110.07 173.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.1 m -121.64 -167.83 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 102.107 -3.294 . . . . 0.96 102.107 -176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -122.07 162.42 37.39 Favored Pre-proline 0 N--CA 1.431 -1.388 0 C-N-CA 126.982 2.113 . . . . 2.35 106.477 167.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -83.81 -14.65 7.49 Favored 'Trans proline' 0 N--CA 1.433 -2.064 0 CA-C-O 116.845 -1.398 . . . . 0.95 108.83 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.3 p -80.94 0.99 32.98 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 124.345 1.028 . . . . 1.45 112.648 171.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -83.54 157.03 22.5 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 125.466 2.555 . . . . 1.69 111.772 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.9 p -88.6 163.35 15.88 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 112.939 -1.937 . . . . 0.75 112.169 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.0 mm -63.29 -34.37 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-O 115.31 -2.281 . . . . 0.73 110.037 174.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -55.48 -46.94 76.83 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 122.215 2.279 . . . . 1.62 114.788 170.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -56.03 -37.73 69.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.267 1.58 . . . . 2.13 115.267 174.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -62.44 -40.46 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 119.7 -1.875 . . . . 0.62 113.864 172.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -61.85 -28.66 69.65 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.477 -1.39 . . . . 1.22 113.803 173.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.82 -28.11 61.46 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.3 2.24 . . . . 0.51 110.156 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -74.12 -36.13 64.17 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.907 -3.621 . . . . 1.44 111.162 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.6 mt -70.61 -39.9 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 123.157 1.456 . . . . 1.32 113.648 175.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -53.03 -38.7 62.62 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.079 -2.263 . . . . 1.7 115.779 169.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -68.88 -46.66 67.83 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.488 -2.008 . . . . 1.55 113.839 173.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -80.04 -55.78 4.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.58 1.552 . . . . 2.62 114.783 -174.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -94.06 -45.51 7.54 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 127.864 3.697 . . . . 1.48 110.928 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.27 56.34 0.7 Allowed Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 111.888 -2.415 . . . . 1.12 111.211 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.5 mt -124.86 127.78 25.04 Favored Pre-proline 0 N--CA 1.43 -1.434 0 N-CA-C 103.268 -2.864 . . . . 1.55 103.268 -167.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.28 32.2 Cg_exo -66.07 138.55 52.56 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 C-N-CA 124.625 3.55 . . . . 1.02 109.314 -171.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -64.86 -14.19 43.66 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-O 114.219 -2.492 . . . . 1.25 114.321 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -74.04 -16.34 61.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 122.455 2.389 . . . . 2.25 114.427 164.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -92.06 4.2 53.6 Favored 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 118.756 -2.465 . . . . 2.02 112.168 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -113.48 101.01 8.96 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 127.832 3.682 . . . . 0.69 119.009 -172.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -94.06 122.67 36.8 Favored 'General case' 0 N--CA 1.431 -1.409 1 O-C-N 115.266 -4.646 . . . . 2.78 110.435 173.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.2 mt -112.11 124.81 53.22 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.706 -1.59 . . . . 1.17 106.706 -170.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 1.6 mm -111.0 144.48 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 129.345 3.058 . . . . 1.38 108.912 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -143.0 116.46 9.11 Favored 'General case' 0 N--CA 1.43 -1.442 1 N-CA-C 97.629 -4.952 . . . . 1.5 97.629 175.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 42.83 39.64 1.79 Allowed 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.1 -3.5 . . . . 1.21 120.349 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.21 -25.98 26.26 Favored Glycine 0 N--CA 1.431 -1.657 0 O-C-N 118.042 -2.911 . . . . 1.3 111.039 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -77.35 130.9 37.74 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.74 -3.8 . . . . 2.55 106.378 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -91.6 135.65 33.71 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.297 1.046 . . . . 2.48 112.764 165.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.1 mt -97.81 144.03 27.82 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.069 -2.269 . . . . 0.9 113.29 -166.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -86.45 147.33 26.04 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 119.533 -1.98 . . . . 1.94 115.563 174.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -55.88 -64.26 0.91 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 118.504 2.779 . . . . 1.56 118.504 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.51 22.1 9.5 Favored Glycine 0 N--CA 1.431 -1.693 1 N-CA-C 123.162 4.025 . . . . 0.97 123.162 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -86.14 156.27 20.42 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.92 2.888 . . . . 2.49 109.624 161.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.251 40.5 p -95.44 157.5 15.87 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 126.563 3.077 . . . . 0.76 112.426 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.8 mt -63.38 -31.85 73.11 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 117.422 -3.299 . . . . 1.05 111.769 168.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.4 t -67.61 -40.21 84.71 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.914 -4.241 . . . . 1.19 113.718 174.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -46.67 -53.61 11.3 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 116.743 2.127 . . . . 1.9 116.743 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.337 86.1 m-85 -60.21 -34.87 74.25 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 118.033 2.605 . . . . 0.89 118.033 175.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.294 67.1 m-80 91.84 66.19 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.66 2.384 . . . . 1.84 106.04 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.3 mt -108.68 118.01 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 125.441 2.543 . . . . 0.82 109.654 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -100.75 -179.66 4.14 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 109.94 -3.3 . . . . 2.16 107.27 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -56.93 149.68 18.25 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.89 2.182 . . . . 2.12 116.89 174.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 64.3 26.4 13.67 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 128.966 2.907 . . . . 1.71 110.478 170.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 m -81.7 136.96 35.46 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 116.404 -1.76 . . . . 1.04 107.839 -173.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.6 m -101.95 112.63 25.34 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 101.056 -3.683 . . . . 0.79 101.056 -172.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mp -103.05 156.91 17.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.71 3.204 . . . . 1.4 109.136 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.442 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 36.5 m80 -113.92 144.06 43.68 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 123.867 0.867 . . . . 1.51 109.326 -174.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.7 tp -115.42 111.68 21.17 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 130.593 3.557 . . . . 1.14 114.271 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.5 t -103.22 125.42 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 1 C-N-CA 132.41 4.284 . . . . 1.23 110.946 173.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 tp -77.53 132.2 38.25 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.731 2.205 . . . . 2.78 113.792 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -117.01 92.9 3.99 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 116.909 -3.62 . . . . 3.75 113.954 175.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.1 mt -80.58 -179.13 7.05 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.365 2.031 . . . . 3.14 111.134 177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -69.67 -44.57 70.22 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.251 -1.531 . . . . 6.8 112.004 172.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.93 49.36 0.88 Allowed Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 127.297 2.38 . . . . 3.57 109.121 -163.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.755 0 CA-C-O 123.892 1.829 . . . . 3.87 111.321 174.291 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttp . . . . . 0 CA--C 1.49 -1.343 0 CA-C-O 124.335 2.017 . . . . 1.1 110.789 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -76.54 123.96 26.86 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.508 -3.245 . . . . 1.87 117.176 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -138.22 152.15 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 O-C-N 120.305 -1.497 . . . . 0.72 107.103 174.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -108.61 141.18 40.93 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 128.195 2.598 . . . . 1.4 111.616 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.555 HG21 HD11 ' A' ' 30' ' ' ILE . 17.5 t -121.9 128.76 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 114.242 -2.79 . . . . 0.58 107.883 171.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -120.49 133.28 55.43 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 124.535 3.334 . . . . 2.09 111.472 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.45 HG22 HD23 ' A' ' 69' ' ' LEU . 27.2 p -70.88 175.35 5.14 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.514 -1.366 . . . . 0.99 112.293 178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.0 tp -65.57 -41.85 92.44 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 126.194 1.798 . . . . 2.53 115.193 169.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.5 m -66.49 -47.44 73.02 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.908 1.337 . . . . 2.08 108.197 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.38 42.79 0.11 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 117.957 -2.964 . . . . 1.31 114.029 169.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -97.18 117.66 31.89 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 115.565 -2.159 . . . . 1.4 108.024 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.5 m -92.14 125.74 36.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 122.396 2.362 . . . . 0.78 113.268 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mt -112.94 126.5 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 100.524 -3.88 . . . . 1.55 100.524 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.1 m -101.39 125.51 48.04 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 119.971 -1.705 . . . . 1.08 111.301 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.9 mt -126.2 159.42 33.03 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.453 2.073 . . . . 1.55 107.074 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -119.25 138.61 52.87 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 111.722 -2.49 . . . . 1.95 104.292 170.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.273 17.3 m -145.3 164.26 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 104.713 -2.329 . . . . 0.96 104.713 -176.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -98.8 145.02 29.23 Favored Pre-proline 0 N--CA 1.43 -1.468 0 O-C-N 125.828 1.955 . . . . 2.35 107.363 160.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.37 -14.27 31.0 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 CA-C-N 122.898 2.071 . . . . 0.95 112.017 -169.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.339 6.2 t -87.29 -7.66 57.59 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 125.181 3.628 . . . . 1.45 110.692 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -74.59 151.44 39.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.086 -2.259 . . . . 1.69 111.977 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.253 77.1 p -74.16 170.03 16.36 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 117.348 -3.345 . . . . 0.75 117.096 -172.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.415 HD12 HD13 ' A' ' 50' ' ' LEU . 21.5 mm -77.1 -38.14 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 103.755 -2.684 . . . . 0.73 103.755 173.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -42.12 -53.15 4.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.17 2.588 . . . . 1.62 113.427 161.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -59.87 -44.5 94.13 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.222 1.409 . . . . 2.13 112.779 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.6 t -64.49 -42.92 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 120.505 -1.372 . . . . 0.62 110.673 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -58.54 -40.91 84.32 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.575 1.95 . . . . 1.22 113.223 172.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.3 -37.06 84.1 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.188 -3.445 . . . . 0.51 110.246 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -67.43 -39.83 85.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.277 2.325 . . . . 1.44 117.277 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.555 HD11 HG21 ' A' ' 5' ' ' VAL . 9.9 mt -62.47 -48.02 90.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-O 127.066 3.317 . . . . 1.32 113.342 169.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -48.51 -39.66 24.04 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 113.923 -5.485 . . . . 1.7 115.678 167.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -59.56 -45.11 92.78 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.883 -3.011 . . . . 1.55 113.272 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -82.66 -83.18 0.13 Allowed 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.432 -1.321 . . . . 2.62 107.432 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.297 58.1 mm-40 -76.25 -28.19 57.01 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.6 -3.812 . . . . 1.48 114.654 -166.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.31 -8.19 22.74 Favored Glycine 0 N--CA 1.431 -1.652 0 O-C-N 120.718 -1.239 . . . . 1.12 112.693 167.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.1 mt -62.19 115.29 15.12 Favored Pre-proline 0 N--CA 1.43 -1.462 0 N-CA-C 116.993 2.22 . . . . 1.55 116.993 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -67.61 148.43 78.19 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 N-CA-C 119.573 2.874 . . . . 1.02 119.573 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -61.78 -32.91 86.21 Favored 'Trans proline' 0 N--CA 1.433 -2.038 1 C-N-CA 125.876 4.384 . . . . 1.25 113.068 -173.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -62.05 -30.89 71.29 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.769 1.766 . . . . 2.25 115.769 171.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -86.32 -24.68 25.79 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.797 1.639 . . . . 2.02 112.053 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -81.77 117.65 22.24 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 104.35 -2.463 . . . . 0.69 104.35 -176.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -109.19 124.97 51.71 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 103.845 -2.65 . . . . 2.78 103.845 169.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.8 mt -119.47 125.07 48.01 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 106.248 -1.76 . . . . 1.17 106.248 -172.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.8 mm -114.55 117.38 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 C-N-CA 127.905 2.482 . . . . 1.38 114.879 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -102.95 108.18 19.27 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.357 -1.349 . . . . 1.5 107.357 173.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.4 -98.78 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.517 -1.989 . . . . 1.21 110.397 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.91 30.62 3.34 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-O 125.38 2.655 . . . . 1.3 113.273 173.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -118.58 131.0 56.2 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.727 -2.043 . . . . 2.55 112.007 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -96.06 114.8 26.54 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.802 1.641 . . . . 2.48 108.994 171.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.415 HD13 HD12 ' A' ' 23' ' ' ILE . 1.6 mt -83.13 138.78 33.53 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.776 -3.078 . . . . 0.9 111.414 -166.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -92.08 138.77 31.26 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.32 -1.487 . . . . 1.94 108.691 174.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.39 -46.83 83.0 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.148 2.579 . . . . 1.56 115.547 -173.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.13 -5.23 58.29 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 120.51 2.964 . . . . 0.97 120.51 176.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 -88.99 169.8 11.22 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.137 -3.567 . . . . 2.49 111.283 162.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.7 p -92.81 171.2 9.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.582 2.067 . . . . 0.76 116.582 169.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 mt -59.18 -42.52 91.04 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 115.921 -1.99 . . . . 1.05 113.616 165.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.0 t -63.14 -36.46 83.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 125.497 1.748 . . . . 1.19 112.848 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -57.06 -35.28 69.15 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 117.855 2.539 . . . . 1.9 117.855 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -90.87 -0.58 57.76 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 125.767 1.627 . . . . 0.89 110.206 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 67.68 26.1 7.98 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 121.895 2.134 . . . . 1.84 112.679 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.7 mt -68.41 123.08 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 128.529 2.732 . . . . 0.82 106.253 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -124.5 -168.83 1.87 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.944 -2.973 . . . . 2.16 107.139 -171.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -53.31 134.8 39.58 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.363 3.465 . . . . 2.12 112.534 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.536 21.5 pt-20 64.65 15.96 10.04 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 129.214 3.005 . . . . 1.71 114.032 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.256 18.2 m -73.3 138.58 45.53 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.515 -3.241 . . . . 1.04 108.456 -173.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.7 m -109.62 98.2 7.61 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 127.924 3.265 . . . . 0.79 114.603 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.1 mp -74.48 148.78 40.7 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 112.334 -2.212 . . . . 1.4 109.716 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -112.27 115.46 28.82 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.615 -2.553 . . . . 1.51 109.423 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.45 HD23 HG22 ' A' ' 7' ' ' THR . 33.9 tp -101.7 113.97 27.61 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.477 1.608 . . . . 1.14 112.749 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -108.11 146.74 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 113.764 -1.562 . . . . 1.23 112.298 173.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.0 tp -97.41 113.23 24.86 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.384 -2.072 . . . . 2.78 111.231 -176.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -79.54 116.98 20.07 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 130.509 3.524 . . . . 3.75 111.525 173.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.3 mt -95.72 164.92 12.56 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 125.772 1.92 . . . . 3.14 115.709 167.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 -69.44 -53.61 18.43 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.646 -3.159 . . . . 6.8 109.491 173.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.86 61.76 0.56 Allowed Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 125.561 2.756 . . . . 3.57 107.666 -169.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.805 0 O-C-N 116.925 -3.691 . . . . 3.87 107.834 174.694 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 ptt? . . . . . 0 CA--C 1.491 -1.316 0 CA-C-O 123.706 1.717 . . . . 1.1 111.274 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -100.76 133.41 45.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 126.859 3.219 . . . . 1.87 109.953 -174.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.2 pt -123.44 155.36 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 118.01 -2.931 . . . . 0.72 105.86 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -119.81 124.3 45.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.982 1.849 . . . . 1.4 110.26 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.406 HG21 HD11 ' A' ' 30' ' ' ILE . 2.5 t -100.56 95.74 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 126.846 3.212 . . . . 0.58 114.838 173.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -75.1 124.33 26.82 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.19 -2.194 . . . . 2.09 109.708 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.1 p -100.21 178.25 4.83 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 112.933 0.716 . . . . 0.99 112.933 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.5 tp -64.57 -64.29 0.91 Allowed 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 118.368 -2.708 . . . . 2.53 112.876 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.454 22.9 p -63.27 -36.83 84.98 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 119.502 3.149 . . . . 2.08 119.502 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.22 -52.82 0.12 Allowed Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 115.015 -3.469 . . . . 1.31 114.3 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -60.6 132.39 53.75 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 124.669 2.176 . . . . 1.4 116.412 -168.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.1 m -99.76 112.91 25.12 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.067 -3.521 . . . . 0.78 104.529 168.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mt -90.81 119.66 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 120.211 -0.595 . . . . 1.55 110.973 -173.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.6 m -85.69 112.17 20.78 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.048 -2.282 . . . . 1.08 108.222 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.4 mt -116.03 116.27 27.6 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 125.335 1.647 . . . . 1.55 112.724 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -84.93 124.09 31.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.502 -3.874 . . . . 1.95 115.778 167.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.03 163.15 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 125.779 2.704 . . . . 0.96 109.147 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -97.88 152.13 37.93 Favored Pre-proline 0 N--CA 1.431 -1.391 1 O-C-N 114.493 -5.13 . . . . 2.35 104.757 164.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -73.39 -3.07 13.06 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 125.273 3.982 . . . . 0.95 120.995 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.8 m -97.35 -4.82 37.79 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.539 -1.976 . . . . 1.45 109.227 172.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -71.44 146.22 48.78 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.756 -2.465 . . . . 1.69 111.16 173.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.4 p -79.59 154.67 28.57 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 118.757 2.873 . . . . 0.75 118.757 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.9 mm -57.7 -37.27 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 121.977 2.171 . . . . 0.73 113.125 175.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.436 30.6 tt0 -38.65 -52.43 1.66 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 119.497 3.147 . . . . 1.62 119.497 165.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -56.9 -45.06 82.85 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.166 1.913 . . . . 2.13 116.166 172.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.4 t -59.29 -43.4 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-O 124.771 2.224 . . . . 0.62 115.189 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -62.21 -45.97 90.96 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.947 2.499 . . . . 1.22 108.518 172.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.56 -30.5 69.82 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.618 2.822 . . . . 0.51 118.618 172.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -80.81 -29.38 36.0 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 116.235 -4.041 . . . . 1.44 106.627 172.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.406 HD11 HG21 ' A' ' 5' ' ' VAL . 95.1 mt -72.45 -34.4 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 116.503 -3.873 . . . . 1.32 112.621 174.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -52.1 -50.94 60.62 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 116.889 -3.632 . . . . 1.7 112.958 162.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -53.48 -45.31 69.54 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 128.238 2.615 . . . . 1.55 114.188 171.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -72.96 -70.12 0.38 Allowed 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.053 -2.905 . . . . 2.62 111.214 -174.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -93.36 -43.61 8.69 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 128.455 2.702 . . . . 1.48 110.951 -165.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.18 50.37 2.25 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 125.862 1.696 . . . . 1.12 114.814 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.438 HD13 HD11 ' A' ' 71' ' ' LEU . 46.5 mt -118.05 137.99 25.04 Favored Pre-proline 0 N--CA 1.43 -1.463 1 N-CA-C 98.105 -4.776 . . . . 1.55 98.105 -176.051 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -65.35 154.79 71.99 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 C-N-CA 124.244 3.296 . . . . 1.02 115.783 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.55 -10.9 24.1 Favored 'Trans proline' 0 N--CA 1.434 -1.979 0 CA-C-O 114.047 -2.564 . . . . 1.25 117.107 -174.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.31 -50.54 38.28 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.729 2.518 . . . . 2.25 114.393 169.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -60.71 -33.78 73.39 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 128.197 2.599 . . . . 2.02 106.467 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -74.07 128.43 35.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 114.494 -2.669 . . . . 0.69 107.477 -170.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.555 ' HB2' HG23 ' A' ' 70' ' ' VAL . 61.5 mtp180 -111.53 115.26 28.89 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 127.093 2.745 . . . . 2.78 105.312 166.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.7 mt -97.14 129.49 44.52 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 120.543 -0.463 . . . . 1.17 112.226 173.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.59 138.83 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 128.118 2.567 . . . . 1.38 113.3 175.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -127.51 87.6 2.65 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.445 -2.035 . . . . 1.5 113.347 172.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.388 . . 84.97 -73.52 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.676 1.99 . . . . 1.21 108.444 -175.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.02 -21.48 0.28 Allowed Glycine 0 N--CA 1.431 -1.7 0 N-CA-C 109.439 -1.464 . . . . 1.3 109.439 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -80.02 128.22 33.23 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.309 1.444 . . . . 2.55 109.681 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -87.49 126.33 34.84 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 102.195 -3.261 . . . . 2.48 102.195 170.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.9 mt -89.19 127.37 35.74 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.847 1.308 . . . . 0.9 111.208 -164.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -77.17 142.25 39.73 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.153 -2.842 . . . . 1.94 115.664 174.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -56.68 -55.59 32.14 Favored 'General case' 0 N--CA 1.43 -1.456 1 C-N-CA 132.623 4.369 . . . . 1.56 115.402 -170.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.23 14.19 29.28 Favored Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 128.933 3.158 . . . . 0.97 112.773 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -109.51 164.45 12.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.326 3.563 . . . . 2.49 110.926 168.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.3 p -90.77 152.98 20.58 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 126.162 2.887 . . . . 0.76 115.109 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mt -56.4 -45.93 80.38 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.538 -3.226 . . . . 1.05 118.142 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.0 p -68.63 -13.4 62.33 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 118.095 2.628 . . . . 1.19 118.095 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -75.64 -34.28 60.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.291 -1.374 . . . . 1.9 107.291 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -85.35 1.83 46.85 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 117.581 -1.199 . . . . 0.89 111.787 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 65.83 36.77 5.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.563 2.745 . . . . 1.84 112.031 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.6 mt -87.64 121.45 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.149 -3.469 . . . . 0.82 111.532 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -122.11 -168.17 1.67 Allowed 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 105.829 -1.915 . . . . 2.16 105.829 -173.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -56.25 140.5 44.53 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 116.128 1.899 . . . . 2.12 116.128 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.307 98.5 mt-10 69.8 15.56 7.94 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 112.768 -2.015 . . . . 1.71 114.098 176.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.329 44.8 m -78.75 156.64 28.76 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 121.72 2.055 . . . . 1.04 111.107 -177.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.8 m -102.57 126.65 49.71 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 112.57 -2.105 . . . . 0.79 106.852 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -116.68 150.78 37.61 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 104.26 -2.496 . . . . 1.4 104.26 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -116.64 112.02 20.68 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 126.495 1.918 . . . . 1.51 106.403 -171.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.9 tp -98.22 122.18 41.06 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.103 -1.814 . . . . 1.14 106.103 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.555 HG23 ' HB2' ' A' ' 42' ' ' ARG . 4.5 m -126.74 150.93 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 113.368 -1.742 . . . . 1.23 107.466 173.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.438 HD11 HD13 ' A' ' 36' ' ' ILE . 42.3 mt -99.32 142.61 30.58 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 117.811 2.523 . . . . 2.78 117.811 -175.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.7 ttt-85 -110.9 77.5 1.04 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 103.587 -2.746 . . . . 3.75 103.587 172.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.0 mt -75.63 171.14 14.83 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 115.943 1.831 . . . . 3.14 115.943 168.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.7 ptt-85 -84.52 155.53 22.1 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 114.547 -2.861 . . . . 6.8 112.456 169.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.71 -43.5 1.2 Allowed Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 109.123 -1.591 . . . . 3.57 109.123 -168.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.756 0 CA-C-O 117.539 -1.701 . . . . 3.87 114.898 174.306 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.49 -1.336 0 N-CA-C 111.807 0.299 . . . . 1.1 111.807 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -97.48 136.67 37.57 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 124.012 0.82 . . . . 1.87 110.557 -172.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.433 HD12 HD13 ' A' ' 67' ' ' LEU . 19.2 pt -130.17 160.62 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 105.088 -2.19 . . . . 0.72 105.088 172.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -118.01 150.09 39.87 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 120.54 1.518 . . . . 1.4 109.826 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.4 t -132.47 122.87 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 105.913 -1.884 . . . . 0.58 105.913 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -97.31 147.83 23.75 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.863 1.792 . . . . 2.09 107.446 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.441 8.9 p -101.92 175.39 5.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.498 -3.876 . . . . 0.99 112.007 174.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.0 tp -58.34 -58.39 8.72 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.629 -1.919 . . . . 2.53 114.772 169.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.277 62.5 p -78.35 -14.53 59.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 119.26 3.059 . . . . 2.08 119.26 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.63 17.01 2.18 Favored Glycine 0 N--CA 1.429 -1.796 0 CA-C-O 115.003 -3.11 . . . . 1.31 117.905 173.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -94.8 122.07 37.05 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 101.699 -3.445 . . . . 1.4 101.699 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.265 10.7 m -92.59 116.19 28.78 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.462 -3.273 . . . . 0.78 111.06 169.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -102.22 135.47 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 118.335 -2.728 . . . . 1.55 117.206 172.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.2 m -103.62 137.74 41.25 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 101.367 -3.568 . . . . 1.08 101.367 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.4 mt -129.24 142.65 50.79 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 120.847 1.658 . . . . 1.55 111.704 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -101.57 117.4 34.84 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.852 2.861 . . . . 1.95 103.791 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -134.28 164.41 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 101.823 -3.399 . . . . 0.96 101.823 -172.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -109.16 159.56 30.76 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-N 110.169 -3.196 . . . . 2.35 107.402 166.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -81.24 -11.75 11.92 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 CA-C-N 124.734 2.727 . . . . 0.95 109.677 -172.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.1 m -86.83 -7.98 57.74 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 116.09 -4.132 . . . . 1.45 110.536 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -66.45 148.82 51.32 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 128.813 2.845 . . . . 1.69 107.848 170.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.1 p -93.12 -173.45 3.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.486 1.291 . . . . 0.75 114.486 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.6 mm -79.54 -37.88 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 125.431 1.492 . . . . 0.73 107.784 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -51.15 -48.24 61.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.599 1.96 . . . . 1.62 116.047 166.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -58.0 -48.99 78.38 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 122.821 1.296 . . . . 2.13 112.34 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.9 t -56.31 -52.5 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 114.785 1.402 . . . . 0.62 114.785 174.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -62.16 -22.56 65.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 128.22 3.867 . . . . 1.22 114.516 174.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.14 -35.9 61.62 Favored 'General case' 0 N--CA 1.429 -1.5 1 O-C-N 113.04 -6.037 . . . . 0.51 112.596 171.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -68.9 -30.88 69.45 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.972 -2.33 . . . . 1.44 108.945 171.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.0 mt -69.73 -31.69 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 1 O-C-N 112.779 -6.201 . . . . 1.32 112.474 176.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -64.37 -42.09 96.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.865 -1.772 . . . . 1.7 108.654 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -52.8 -49.66 65.18 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 114.611 1.337 . . . . 1.55 114.611 169.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -70.56 -73.7 0.16 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.822 -2.424 . . . . 2.62 115.797 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -90.95 -28.98 17.7 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.443 2.297 . . . . 1.48 113.898 -169.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.06 54.62 1.98 Allowed Glycine 0 N--CA 1.43 -1.732 1 O-C-N 115.244 -4.66 . . . . 1.12 114.614 173.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.4 mt -118.27 132.36 23.8 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 104.888 -2.264 . . . . 1.55 104.888 -173.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -63.17 150.84 87.47 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 O-C-N 114.09 -3.689 . . . . 1.02 117.132 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -67.75 -15.51 44.41 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 C-N-CA 124.376 3.384 . . . . 1.25 112.935 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.63 -30.97 61.83 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.831 2.53 . . . . 2.25 117.831 173.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -92.27 -26.65 18.05 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 123.419 1.58 . . . . 2.02 111.607 -172.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -75.44 112.1 11.41 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.763 1.625 . . . . 0.69 112.846 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -103.59 119.6 39.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.693 -3.754 . . . . 2.78 105.798 168.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.9 mt -96.16 129.73 43.39 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.852 -1.976 . . . . 1.17 107.051 173.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mm -104.68 135.68 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 128.679 2.792 . . . . 1.38 108.663 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -154.97 127.25 7.79 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 114.384 1.253 . . . . 1.5 114.384 170.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.43 27.8 3.87 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 115.935 1.828 . . . . 1.21 115.935 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.37 -12.32 61.68 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 115.992 1.157 . . . . 1.3 115.992 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -135.45 143.81 46.1 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.465 1.602 . . . . 2.55 114.578 -167.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -71.61 149.13 45.9 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 118.771 -2.456 . . . . 2.48 114.44 171.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.478 HD22 ' CD1' ' A' ' 59' ' ' TYR 0.308 55.1 mt -113.67 147.99 37.14 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 122.18 0.991 . . . . 0.9 113.106 -165.497 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -75.89 152.6 37.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 113.807 1.039 . . . . 1.94 113.807 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.351 0.9 OUTLIER -73.95 -51.07 17.23 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 116.099 1.888 . . . . 1.56 116.099 -169.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.34 32.77 3.03 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 119.678 2.631 . . . . 0.97 119.678 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -95.22 155.51 16.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.974 -3.074 . . . . 2.49 110.756 162.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.275 14.3 p -87.2 165.76 15.46 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 126.426 3.013 . . . . 0.76 111.163 175.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 37.6 mt -78.93 -20.51 49.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.823 -3.048 . . . . 1.05 109.698 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -70.96 -29.04 64.94 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 127.511 2.324 . . . . 1.19 112.375 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -68.28 -35.64 78.16 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.279 1.832 . . . . 1.9 114.628 170.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.478 ' CD1' HD22 ' A' ' 50' ' ' LEU . 60.2 m-85 -95.43 7.79 45.17 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.156 1.383 . . . . 0.89 109.709 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.2 m120 45.47 39.9 5.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.266 3.027 . . . . 1.84 114.687 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mt -78.02 105.44 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 105.667 -1.975 . . . . 0.82 105.667 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -78.08 -169.42 1.58 Allowed 'General case' 0 N--CA 1.43 -1.466 1 C-N-CA 131.964 4.106 . . . . 2.16 113.186 175.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -76.34 157.15 32.71 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.996 -2.94 . . . . 2.12 113.821 172.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.289 52.9 mt-10 68.35 22.8 7.85 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 111.852 -2.431 . . . . 1.71 111.949 171.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.0 m -86.14 125.8 33.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.059 2.944 . . . . 1.04 111.417 -174.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.6 m -92.14 120.27 32.57 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.96 -3.587 . . . . 0.79 106.218 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.433 HD13 HD12 ' A' ' 3' ' ' ILE . 9.3 mp -103.67 137.51 41.62 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 104.609 -2.367 . . . . 1.4 104.609 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -107.79 137.85 45.07 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 123.641 2.928 . . . . 1.51 115.008 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.4 tt -98.35 108.59 21.32 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.412 2.053 . . . . 1.14 111.422 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.6 t -110.9 130.2 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 C-N-CA 129.483 3.113 . . . . 1.23 111.612 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.6 mt -83.33 138.81 33.38 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 116.333 -3.979 . . . . 2.78 115.46 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -95.49 94.24 7.67 Favored 'General case' 0 N--CA 1.43 -1.475 1 N-CA-C 98.343 -4.688 . . . . 3.75 98.343 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.1 mt -81.53 154.76 26.09 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.215 -2.803 . . . . 3.14 117.833 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.255 68.9 mtt180 -74.68 147.02 41.85 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.741 2.497 . . . . 6.8 117.741 175.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 135.71 -75.78 0.4 Allowed Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 104.979 -3.249 . . . . 3.57 104.979 -167.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.795 0 N-CA-C 108.924 -1.67 . . . . 3.87 108.924 -174.661 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptt? . . . . . 0 CA--C 1.489 -1.367 1 CA-C-O 109.231 -5.176 . . . . 1.1 110.82 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -117.56 145.05 44.53 Favored 'General case' 0 N--CA 1.43 -1.45 2 O-C-N 130.148 4.655 . . . . 1.87 122.534 174.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.336 15.5 pt -128.21 153.82 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 125.741 1.901 . . . . 0.72 109.176 175.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -112.15 121.07 43.93 Favored 'General case' 0 N--CA 1.429 -1.484 1 N-CA-C 99.583 -4.228 . . . . 1.4 99.583 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.2 t -113.51 112.12 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-O 124.973 2.32 . . . . 0.58 105.389 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -88.52 145.51 25.69 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.549 -3.219 . . . . 2.09 115.474 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.318 22.1 p -93.58 162.62 13.88 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.094 2.158 . . . . 0.99 108.762 177.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.37 -29.07 70.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.185 2.194 . . . . 2.53 111.552 176.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.315 28.4 p -83.25 -45.4 13.88 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 126.51 3.052 . . . . 2.08 113.145 -176.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.64 23.79 0.06 OUTLIER Glycine 0 N--CA 1.429 -1.773 1 O-C-N 114.769 -4.957 . . . . 1.31 116.653 172.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -103.67 135.86 44.45 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 103.603 -2.74 . . . . 1.4 103.603 -172.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.0 m -97.41 112.6 24.37 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 115.537 -2.173 . . . . 0.78 109.774 169.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -95.24 120.26 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 123.525 2.875 . . . . 1.55 105.188 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.4 m -92.37 124.7 36.62 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 105.271 -2.122 . . . . 1.08 105.271 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.1 mt -119.67 130.14 54.9 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.471 1.508 . . . . 1.55 111.573 -174.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -85.05 126.5 33.62 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 104.907 -2.257 . . . . 1.95 104.907 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.8 m -143.48 167.34 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 C-N-CA 126.8 2.04 . . . . 0.96 112.479 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -120.9 160.67 43.84 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-O 115.231 -2.319 . . . . 2.35 112.329 163.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -60.12 -25.12 79.04 Favored 'Trans proline' 0 N--CA 1.433 -2.056 2 CA-C-N 128.948 4.231 . . . . 0.95 113.597 -176.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m -74.7 -20.9 59.67 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.277 2.231 . . . . 1.45 113.32 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -62.44 141.79 58.19 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.942 -2.973 . . . . 1.69 110.998 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 72.3 p -82.6 167.09 18.65 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.528 -1.669 . . . . 0.75 108.235 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.524 ' CG2' HD23 ' A' ' 43' ' ' LEU . 22.5 mm -66.28 -33.6 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 116.22 -1.848 . . . . 0.73 109.781 172.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -54.39 -33.31 59.03 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.658 2.096 . . . . 1.62 116.658 166.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -73.23 -35.19 66.22 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 120.881 1.673 . . . . 2.13 109.947 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.8 t -61.18 -51.66 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 125.016 1.326 . . . . 0.62 110.038 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -66.69 -25.87 66.76 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 117.58 -1.648 . . . . 1.22 115.141 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.91 -35.48 72.29 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.667 -2.52 . . . . 0.51 114.599 172.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -64.49 -29.87 70.9 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.447 -2.658 . . . . 1.44 113.001 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.03 -36.57 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 119.553 -1.967 . . . . 1.32 111.069 170.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -67.71 -41.32 83.77 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.947 -1.721 . . . . 1.7 109.488 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.56 -53.01 63.01 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.671 -1.893 . . . . 1.55 111.931 174.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -69.99 -59.63 2.8 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 123.646 1.688 . . . . 2.62 112.164 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -103.24 -28.85 11.64 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 118.815 -2.428 . . . . 1.48 110.312 -160.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.7 40.67 5.57 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 122.257 2.299 . . . . 1.12 115.579 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.7 mm -115.1 118.51 40.15 Favored Pre-proline 0 N--CA 1.43 -1.469 0 N-CA-C 104.445 -2.428 . . . . 1.55 104.445 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -74.5 144.81 32.68 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 124.196 2.534 . . . . 1.02 114.089 -175.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.96 -20.84 44.36 Favored 'Trans proline' 0 N--CA 1.433 -2.041 1 C-N-CA 125.923 4.416 . . . . 1.25 114.183 -175.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -48.48 -53.07 19.38 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.482 1.611 . . . . 2.25 111.331 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -78.18 -24.76 47.08 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 119.273 3.064 . . . . 2.02 119.273 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -66.5 141.49 57.86 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.83 -1.794 . . . . 0.69 112.928 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -135.38 124.47 24.37 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.684 -2.51 . . . . 2.78 110.245 171.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.524 HD23 ' CG2' ' A' ' 23' ' ' ILE 0.288 0.3 OUTLIER -92.51 123.94 36.18 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 120.726 1.603 . . . . 1.17 112.163 175.277 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.1 mm -107.33 128.87 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-O 122.273 1.035 . . . . 1.38 108.704 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.416 ' HB3' HD21 ' A' ' 50' ' ' LEU . 76.4 t80 -140.4 128.5 22.23 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.626 -1.296 . . . . 1.5 112.074 169.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.29 17.21 2.72 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 111.509 -2.587 . . . . 1.21 112.567 -174.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.31 -7.92 56.76 Favored Glycine 0 N--CA 1.43 -1.743 1 CA-C-O 111.724 -4.931 . . . . 1.3 115.41 -170.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -102.16 131.4 48.69 Favored 'General case' 0 N--CA 1.43 -1.443 1 CA-C-N 125.342 4.571 . . . . 2.55 112.057 177.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -79.09 125.31 29.25 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 125.714 2.673 . . . . 2.48 105.926 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.416 HD21 ' HB3' ' A' ' 45' ' ' PHE 0.288 12.5 mt -84.77 129.9 34.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.004 -1.907 . . . . 0.9 109.091 -171.392 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -88.72 143.85 26.65 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 116.642 2.09 . . . . 1.94 116.642 -176.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.67 -36.92 85.82 Favored 'General case' 0 N--CA 1.431 -1.419 1 N-CA-C 122.967 4.432 . . . . 1.56 122.967 -169.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.92 10.25 63.41 Favored Glycine 0 N--CA 1.43 -1.726 1 O-C-N 115.626 -4.421 . . . . 0.97 117.952 169.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.25 24.1 mtt180 -107.47 152.07 24.71 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.126 1.917 . . . . 2.49 110.347 172.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 7.0 p -92.75 167.2 12.03 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 126.5 3.048 . . . . 0.76 118.895 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.1 mt -63.02 -22.96 67.22 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 116.114 -4.116 . . . . 1.05 118.382 170.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.3 t -79.75 -31.99 41.0 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.146 1.927 . . . . 1.19 114.128 171.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -60.13 -35.77 76.01 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.205 -2.184 . . . . 1.9 112.7 172.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -94.78 18.81 11.02 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 123.666 2.939 . . . . 0.89 111.194 170.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.56 3.1 p-10 43.61 48.04 6.4 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 129.547 3.139 . . . . 1.84 118.336 -177.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.7 mt -90.17 115.93 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 118.627 -2.546 . . . . 0.82 115.898 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -100.37 -176.5 3.23 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 131.583 3.953 . . . . 2.16 107.808 175.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -58.7 158.93 7.25 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.388 -2.695 . . . . 2.12 114.812 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 71.92 27.65 2.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.397 1.879 . . . . 1.71 110.671 168.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.2 m -96.1 135.86 37.33 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 125.683 2.659 . . . . 1.04 114.07 -173.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.3 m -94.67 108.93 20.91 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 113.541 -5.724 . . . . 0.79 105.248 -173.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 mp -97.73 159.0 15.2 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 127.278 3.418 . . . . 1.4 106.512 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -133.69 121.46 21.99 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.564 -2.585 . . . . 1.51 104.631 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.3 tp -89.52 132.14 35.21 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.299 -1.741 . . . . 1.14 106.299 -176.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -116.37 135.39 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 1 N-CA-C 99.32 -4.326 . . . . 1.23 99.32 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.6 mt -114.11 98.99 7.3 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.811 -1.805 . . . . 2.78 109.182 -178.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -97.7 75.44 2.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.168 -1.79 . . . . 3.75 106.168 -174.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.7 tp -94.81 -70.94 0.69 Allowed 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 109.899 -3.319 . . . . 3.14 108.839 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -74.75 -44.37 50.06 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 113.034 -1.894 . . . . 6.8 111.34 172.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.28 20.16 57.53 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 120.199 2.84 . . . . 3.57 120.199 -163.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.796 1 N-CA-C 102.622 -4.191 . . . . 3.87 102.622 -171.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 ttp . . . . . 0 CA--C 1.489 -1.376 0 CA-C-O 115.842 -2.028 . . . . 1.1 109.883 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -91.96 123.4 35.3 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 124.699 1.249 . . . . 1.87 110.939 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -124.9 159.51 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.455 -1.403 . . . . 0.72 110.855 172.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -108.12 128.21 54.48 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.729 0.811 . . . . 1.4 110.663 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.3 t -105.93 108.41 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 C-N-CA 128.722 2.809 . . . . 0.58 106.926 171.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -104.48 132.04 51.18 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 127.669 3.604 . . . . 2.09 110.332 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.8 p -100.28 164.36 11.98 Favored 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 115.603 -4.436 . . . . 0.99 107.818 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.1 mt -84.51 -3.8 58.6 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 109.339 -0.615 . . . . 2.53 109.339 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.3 p -90.11 -29.88 18.03 Favored 'General case' 0 N--CA 1.429 -1.505 1 O-C-N 116.191 -4.068 . . . . 2.08 111.333 -175.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.2 54.07 0.17 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 124.725 2.292 . . . . 1.31 115.317 175.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -153.68 138.43 17.03 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 115.028 -2.415 . . . . 1.4 107.461 -173.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.3 m -136.58 131.05 33.26 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 127.806 3.191 . . . . 0.78 103.616 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 pt -127.01 153.76 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 123.789 1.757 . . . . 1.55 108.506 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.6 m -109.62 109.19 19.87 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 112.871 -1.968 . . . . 1.08 111.743 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.251 41.3 mt -89.09 153.31 21.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.87 2.748 . . . . 1.55 106.278 175.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -126.59 113.46 16.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.888 -2.382 . . . . 1.95 107.342 174.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 m -130.09 -164.31 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 127.576 2.35 . . . . 0.96 108.14 -173.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -129.12 171.0 9.48 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 126.159 2.162 . . . . 2.35 107.588 163.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -70.61 -17.48 33.7 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 CA-C-O 123.254 1.272 . . . . 0.95 110.882 -173.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.15 2.57 53.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.145 1.165 . . . . 1.45 114.145 176.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.37 141.11 43.35 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.667 -2.52 . . . . 1.69 109.94 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 21.9 p -75.14 163.99 26.96 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.773 2.829 . . . . 0.75 109.605 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.1 mm -67.39 -33.73 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 124.092 1.901 . . . . 0.73 110.245 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -51.73 -45.94 63.82 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.981 -2.324 . . . . 1.62 116.822 163.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -67.07 -29.05 68.71 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 118.312 2.708 . . . . 2.13 118.312 173.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.0 t -74.31 -44.9 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 127.419 2.287 . . . . 0.62 108.892 176.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -62.86 -38.88 92.6 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 126.989 2.116 . . . . 1.22 112.864 174.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.83 -32.75 72.67 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.557 1.543 . . . . 0.51 113.313 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -61.37 -55.14 34.92 Favored 'General case' 0 N--CA 1.428 -1.532 0 O-C-N 118.201 -2.812 . . . . 1.44 111.989 165.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -53.7 -39.98 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 117.802 -3.061 . . . . 1.32 114.642 173.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -58.94 -38.99 80.29 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.868 1.318 . . . . 1.7 114.237 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -69.89 -55.03 10.79 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.151 -0.968 . . . . 1.55 110.67 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -65.89 -75.67 0.09 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.709 -3.12 . . . . 2.62 106.718 -175.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -78.5 -25.7 45.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.306 2.242 . . . . 1.48 113.356 -163.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.99 12.11 55.69 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 116.332 -2.371 . . . . 1.12 110.303 168.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.404 ' HA ' ' HD2' ' A' ' 37' ' ' PRO . 5.7 mt -88.84 126.33 59.8 Favored Pre-proline 0 N--CA 1.43 -1.454 0 CA-C-N 122.738 3.269 . . . . 1.55 108.453 -175.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 36' ' ' ILE . 19.5 Cg_endo -68.21 160.31 49.44 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 124.082 3.188 . . . . 1.02 109.894 -177.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.61 -7.64 13.61 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 115.105 -2.796 . . . . 1.25 116.277 -171.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -82.77 -22.25 34.37 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.767 -1.833 . . . . 2.25 108.267 175.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -80.6 -21.36 41.67 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.726 -2.484 . . . . 2.02 113.432 -175.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -113.65 137.44 51.6 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 118.131 0.423 . . . . 0.69 109.958 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -120.04 133.44 55.53 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.251 -1.531 . . . . 2.78 108.446 171.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.1 mt -105.31 121.35 43.69 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.393 2.997 . . . . 1.17 108.175 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.4 mm -111.3 131.0 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 116.555 -3.841 . . . . 1.38 107.194 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -124.26 118.57 27.09 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 105.114 -2.18 . . . . 1.5 105.114 170.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.304 . . 64.76 -89.23 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 130.154 3.382 . . . . 1.21 111.218 -171.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.76 -21.15 3.98 Favored Glycine 0 N--CA 1.429 -1.794 0 C-N-CA 127.025 2.25 . . . . 1.3 117.903 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.253 29.5 mttm -104.93 132.53 51.06 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 127.313 2.245 . . . . 2.55 114.777 -172.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -75.94 145.1 40.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.878 -1.056 . . . . 2.48 111.92 170.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 mt -98.06 143.5 28.55 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 125.478 1.736 . . . . 0.9 112.989 -172.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -95.95 135.84 37.17 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.883 -2.386 . . . . 1.94 116.068 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -47.24 -66.4 0.41 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 120.163 3.394 . . . . 1.56 120.163 -173.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.15 52.67 2.59 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 118.724 2.25 . . . . 0.97 118.724 169.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 22' ' ' THR . 40.0 mmt180 -134.95 157.86 45.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 116.408 -1.758 . . . . 2.49 107.964 172.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.287 6.5 p -88.65 172.92 8.92 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.486 1.612 . . . . 0.76 114.9 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.5 mt -72.46 -38.38 68.26 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 116.222 -4.049 . . . . 1.05 111.919 168.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.1 t -57.49 -38.96 75.42 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 129.486 3.114 . . . . 1.19 112.951 173.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -59.64 -32.85 70.83 Favored 'General case' 0 N--CA 1.43 -1.471 1 O-C-N 115.439 -4.538 . . . . 1.9 112.348 174.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -96.19 9.1 42.06 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 126.134 2.873 . . . . 0.89 112.412 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.6 m120 49.21 47.14 22.45 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 129.729 3.212 . . . . 1.84 109.327 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.1 mt -91.6 114.65 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 124.083 1.897 . . . . 0.82 109.722 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -97.05 -172.31 2.42 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.696 -1.594 . . . . 2.16 106.696 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -65.97 143.8 57.16 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.571 2.129 . . . . 2.12 113.77 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.279 70.5 mt-10 71.09 18.62 5.8 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 116.905 -3.622 . . . . 1.71 114.774 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.3 m -79.33 139.76 37.7 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.161 2.185 . . . . 1.04 115.513 -175.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.6 m -90.74 101.39 14.14 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 124.329 2.014 . . . . 0.79 115.416 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -79.6 143.96 34.27 Favored 'General case' 0 N--CA 1.429 -1.505 1 O-C-N 114.468 -5.145 . . . . 1.4 108.153 165.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -108.2 115.69 30.59 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.088 -3.508 . . . . 1.51 111.457 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tt -91.6 119.87 31.88 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 126.303 2.252 . . . . 1.14 111.429 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.88 147.39 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 126.403 3.001 . . . . 1.23 103.122 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.7 mt -103.46 156.93 17.39 Favored 'General case' 0 N--CA 1.429 -1.488 1 O-C-N 115.811 -4.306 . . . . 2.78 112.782 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -76.37 87.86 3.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 124.856 2.265 . . . . 3.75 106.913 -170.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.6 mt -118.43 -59.0 1.93 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.068 -2.895 . . . . 3.14 106.774 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -73.72 150.58 41.1 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 130.796 3.639 . . . . 6.8 111.352 166.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -52.47 -59.26 9.29 Favored Glycine 0 N--CA 1.43 -1.761 1 C-N-CA 131.571 4.415 . . . . 3.57 111.814 -169.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.732 0 N-CA-C 116.254 1.262 . . . . 3.87 116.254 -175.83 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 121.675 0.75 . . . . 1.1 112.74 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -107.79 135.69 48.78 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.331 -3.355 . . . . 1.87 111.42 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.1 pt -130.69 171.59 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 O-C-N 120.5 -1.375 . . . . 0.72 110.051 173.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -120.4 148.39 43.84 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 124.765 1.226 . . . . 1.4 113.749 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 67' ' ' LEU . 68.6 t -133.91 124.36 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 N-CA-C 104.775 -2.306 . . . . 0.58 104.775 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 tptt -92.27 135.83 33.69 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 109.659 -3.428 . . . . 2.09 114.954 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.289 38.0 p -83.24 -171.52 3.62 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.315 3.436 . . . . 0.99 110.58 -174.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.22 -49.65 73.35 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 125.325 2.488 . . . . 2.53 113.333 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.7 p -88.25 -43.4 11.61 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.591 -1.64 . . . . 2.08 113.522 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.04 -3.94 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.762 0 O-C-N 116.981 -3.574 . . . . 1.31 121.158 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -71.59 133.8 45.98 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 120.535 2.167 . . . . 1.4 114.016 -173.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.4 m -90.88 110.61 21.84 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 117.969 -1.493 . . . . 0.78 109.151 176.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 mt -93.41 135.54 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 125.234 1.414 . . . . 1.55 107.324 175.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.3 m -102.51 127.51 49.54 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.259 1.424 . . . . 1.08 111.295 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.5 mt -124.57 156.39 37.46 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 107.293 -1.373 . . . . 1.55 107.293 -177.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -104.57 123.11 46.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.149 2.18 . . . . 1.95 114.296 167.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.1 m -141.15 161.46 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 124.614 3.37 . . . . 0.96 103.227 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -111.86 157.28 39.99 Favored Pre-proline 0 N--CA 1.43 -1.466 0 N-CA-C 103.725 -2.694 . . . . 2.35 103.725 166.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.13 -9.83 19.29 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 C-N-CA 124.009 3.139 . . . . 0.95 111.686 -171.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.0 p -83.68 -9.93 58.52 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 114.807 -2.52 . . . . 1.45 112.426 171.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -67.44 145.62 54.82 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 124.353 3.251 . . . . 1.69 111.403 174.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.1 p -88.12 158.82 18.45 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 113.231 -5.918 . . . . 0.75 110.844 178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.4 mm -59.83 -32.33 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 119.786 3.254 . . . . 0.73 119.786 174.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -50.74 -47.56 59.36 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.264 1.95 . . . . 1.62 116.264 159.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -60.65 -38.22 84.13 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 125.51 1.524 . . . . 2.13 112.148 174.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.63 -43.61 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 124.798 1.239 . . . . 0.62 108.984 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -62.04 -33.03 73.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 118.434 2.753 . . . . 1.22 118.434 169.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.82 -33.65 76.35 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.349 1.46 . . . . 0.51 114.615 173.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -74.17 -18.13 60.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.287 3.035 . . . . 1.44 111.593 171.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.0 mt -82.46 -32.05 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 116.932 -3.605 . . . . 1.32 105.854 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -67.73 -33.97 75.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.458 -3.276 . . . . 1.7 113.245 175.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -56.77 -45.16 82.28 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.199 -1.563 . . . . 1.55 112.86 166.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -74.92 -67.82 0.61 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.945 -1.097 . . . . 2.62 112.721 -176.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -84.75 -45.76 12.07 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.679 2.791 . . . . 1.48 111.619 -167.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.97 -7.2 17.14 Favored Glycine 0 N--CA 1.429 -1.824 0 CA-C-O 123.228 1.46 . . . . 1.12 111.988 175.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.1 mt -71.99 122.81 88.31 Favored Pre-proline 0 N--CA 1.431 -1.418 0 C-N-CA 126.947 2.099 . . . . 1.55 110.597 -172.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.9 145.38 68.1 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 125.092 3.861 . . . . 1.02 112.06 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -63.32 -27.72 71.76 Favored 'Trans proline' 0 C--N 1.3 -2.006 1 C-N-CA 125.567 4.178 . . . . 1.25 111.425 -174.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -53.07 -50.81 63.62 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 122.612 2.46 . . . . 2.25 111.64 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -68.86 -26.92 65.38 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.541 2.336 . . . . 2.02 114.108 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -71.83 153.45 41.92 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.046 -2.909 . . . . 0.69 116.343 -177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -141.46 120.8 13.11 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.083 2.153 . . . . 2.78 106.421 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.1 mt -105.61 137.36 43.58 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 121.139 1.79 . . . . 1.17 111.542 174.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 mp -123.37 136.58 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 127.904 3.252 . . . . 1.38 110.784 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -156.31 131.28 9.13 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 115.743 -4.348 . . . . 1.5 112.747 174.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.447 . . 67.99 35.56 3.7 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.765 2.826 . . . . 1.21 116.563 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.04 -28.68 4.04 Favored Glycine 0 N--CA 1.431 -1.684 0 CA-C-O 124.745 2.303 . . . . 1.3 112.205 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.7 mtmt -90.04 165.34 14.08 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.707 -3.819 . . . . 2.55 111.944 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -108.79 137.63 46.41 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 103.523 -2.769 . . . . 2.48 103.523 172.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.3 mt -78.9 153.27 30.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.15 -2.844 . . . . 0.9 112.605 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.318 10.0 tp10 -98.77 141.91 30.97 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.337 -1.477 . . . . 1.94 109.968 171.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.59 -57.35 10.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.256 2.455 . . . . 1.56 117.485 -166.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.81 39.68 2.85 Favored Glycine 0 N--CA 1.43 -1.762 1 O-C-N 114.254 -5.279 . . . . 0.97 118.949 165.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -113.63 160.83 18.16 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.001 1.72 . . . . 2.49 107.751 166.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.4 p -106.36 161.62 14.4 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.479 1.609 . . . . 0.76 113.694 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.45 -37.67 86.79 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.16 2.184 . . . . 1.05 113.881 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 t -63.82 -39.25 93.78 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 113.341 -3.219 . . . . 1.19 113.654 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.257 9.7 t70 -49.18 -71.03 0.07 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 127.89 3.244 . . . . 1.9 109.985 173.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -50.84 -27.33 7.14 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 130.051 3.34 . . . . 0.89 119.541 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m120 79.3 47.06 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 129.855 3.262 . . . . 1.84 114.487 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.2 mt -99.86 126.65 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 124.724 2.202 . . . . 0.82 108.372 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -102.09 -173.56 2.37 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 116.254 -4.028 . . . . 2.16 111.746 -173.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -68.43 149.62 49.1 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.964 2.316 . . . . 2.12 116.942 169.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 59.98 26.68 15.99 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.459 3.103 . . . . 1.71 113.262 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -88.74 131.87 34.85 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 128.814 2.845 . . . . 1.04 106.43 -174.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.7 m -99.8 111.86 24.15 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 105.446 -2.057 . . . . 0.79 105.446 -174.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.415 ' HB2' HG22 ' A' ' 5' ' ' VAL . 7.6 mp -83.09 159.93 22.01 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 106.307 -1.738 . . . . 1.4 106.307 168.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -110.86 132.4 54.23 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 117.498 -1.239 . . . . 1.51 110.049 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -98.6 132.52 43.94 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 103.225 -2.879 . . . . 1.14 103.225 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.2 t -126.12 156.81 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 129.952 3.301 . . . . 1.23 103.839 174.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.2 mt -126.39 176.09 7.38 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.525 2.583 . . . . 2.78 107.258 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -53.9 -58.57 6.8 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 128.593 2.757 . . . . 3.75 110.756 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.7 mt -86.74 131.6 34.09 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 131.288 3.835 . . . . 3.14 109.879 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -86.13 -82.47 0.2 Allowed 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 113.786 -1.552 . . . . 6.8 111.661 170.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.26 -61.03 1.87 Allowed Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 108.218 -1.953 . . . . 3.57 108.218 -164.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.757 0 N-CA-C 107.218 -2.353 . . . . 3.87 107.218 179.477 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ttt . . . . . 0 CA--C 1.491 -1.32 0 CA-C-O 121.045 0.45 . . . . 1.1 111.65 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -87.15 134.75 33.49 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.701 -2.499 . . . . 1.87 109.493 -172.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.404 HG12 HG22 ' A' ' 17' ' ' VAL . 6.0 pt -131.8 169.62 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 121.545 1.975 . . . . 0.72 108.017 174.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -121.56 157.58 30.42 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.88 -1.763 . . . . 1.4 107.558 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.7 t -123.17 132.74 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 125.657 1.848 . . . . 0.58 109.328 163.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.48 ' HB2' ' CG2' ' A' ' 66' ' ' THR . 26.3 tptt -98.98 134.79 41.31 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.359 -2.713 . . . . 2.09 107.856 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.6 p -85.95 -166.29 1.49 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.793 1.758 . . . . 0.99 114.962 176.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.9 mt -74.22 -47.5 34.91 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.704 -1.135 . . . . 2.53 112.171 175.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.7 p -77.61 -29.88 52.08 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 114.87 1.433 . . . . 2.08 114.87 -174.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.31 11.39 0.66 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 125.371 1.462 . . . . 1.31 115.3 172.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -81.42 140.82 34.44 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.806 -1.997 . . . . 1.4 107.626 -172.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.9 m -97.96 107.94 20.53 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.98 -1.464 . . . . 0.78 109.805 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -82.7 122.36 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 119.969 1.259 . . . . 1.55 108.563 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.2 m -95.0 114.22 26.0 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.925 -1.109 . . . . 1.08 113.786 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mp -116.33 160.45 20.49 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.358 1.614 . . . . 1.55 115.358 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.261 7.0 pt-20 -128.74 124.9 36.74 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 117.013 -1.875 . . . . 1.95 112.418 177.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.404 HG22 HG12 ' A' ' 3' ' ' ILE . 12.5 m -129.2 -167.42 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 113.765 -1.562 . . . . 0.96 110.454 -176.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -136.76 173.89 5.05 Favored Pre-proline 0 N--CA 1.431 -1.399 0 O-C-N 117.386 -3.321 . . . . 2.35 103.446 162.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -80.57 -8.36 13.64 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 CA-C-N 123.393 2.248 . . . . 0.95 117.751 -170.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.274 21.0 m -87.9 -19.85 26.77 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 126.812 2.57 . . . . 1.45 114.567 174.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -62.02 152.48 32.35 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.972 -2.955 . . . . 1.69 113.314 174.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 31.9 p -90.11 168.99 11.54 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.662 -2.523 . . . . 0.75 117.507 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.5 mm -64.92 -36.3 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 120.307 -1.496 . . . . 0.73 109.979 171.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -57.41 -30.5 65.01 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.498 2.719 . . . . 1.62 113.495 168.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -73.66 -32.71 64.14 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 114.338 -5.226 . . . . 2.13 111.235 176.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.6 t -63.11 -49.68 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.026 2.13 . . . . 0.62 111.688 174.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.495 ' HD3' ' HB3' ' A' ' 38' ' ' PRO . 55.9 mttt -58.56 -39.58 80.67 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 127.855 3.222 . . . . 1.22 114.083 176.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.71 -33.47 75.71 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 118.52 2.785 . . . . 0.51 118.52 173.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -75.0 -35.57 62.01 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 125.077 1.485 . . . . 1.44 111.464 170.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.68 -39.54 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 1 O-C-N 115.69 -4.381 . . . . 1.32 112.449 166.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -63.84 -41.47 97.81 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.614 -3.804 . . . . 1.7 113.833 172.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -55.37 -69.25 0.14 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 115.821 1.785 . . . . 1.55 115.821 170.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -68.44 -59.81 2.89 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.611 -3.806 . . . . 2.62 113.875 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -83.53 -43.24 15.95 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.208 -2.807 . . . . 1.48 111.196 -163.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.7 30.28 3.56 Favored Glycine 0 N--CA 1.43 -1.76 0 CA-C-O 124.386 2.103 . . . . 1.12 111.894 169.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 88.1 mt -105.95 134.77 19.59 Favored Pre-proline 0 N--CA 1.431 -1.41 0 O-C-N 117.661 -3.259 . . . . 1.55 104.876 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -72.98 158.66 49.38 Favored 'Trans proline' 0 C--N 1.3 -2.003 1 CA-C-N 129.411 4.397 . . . . 1.02 113.699 174.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.495 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 70.4 Cg_exo -73.44 -19.7 21.65 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 CA-C-O 114.455 -2.394 . . . . 1.25 117.939 -175.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -72.19 -12.08 61.02 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 127.334 2.896 . . . . 2.25 111.39 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -100.27 -15.83 17.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 116.239 -1.839 . . . . 2.02 112.226 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -88.37 139.49 30.43 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 130.031 3.333 . . . . 0.69 111.296 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -123.23 120.73 34.02 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 128.854 2.862 . . . . 2.78 107.583 165.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.5 mt -103.01 130.67 50.19 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 124.877 2.275 . . . . 1.17 108.92 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.7 mm -117.12 139.77 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 125.068 2.366 . . . . 1.38 107.287 -172.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -146.62 148.81 32.47 Favored 'General case' 0 N--CA 1.429 -1.497 1 O-C-N 113.693 -5.629 . . . . 1.5 108.157 168.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.66 30.3 8.54 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.217 1.932 . . . . 1.21 116.217 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.67 -29.8 5.64 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 124.887 1.232 . . . . 1.3 115.039 -173.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -82.1 142.96 31.82 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 128.706 2.802 . . . . 2.55 114.787 -174.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -90.56 132.46 35.7 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.006 1.73 . . . . 2.48 108.382 168.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mt -86.74 146.89 26.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.892 1.677 . . . . 0.9 111.845 -172.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -92.42 154.7 18.35 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 123.324 1.535 . . . . 1.94 111.043 171.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.64 -66.37 0.6 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 112.987 -1.915 . . . . 1.56 113.619 -163.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.31 64.48 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.723 0 O-C-N 118.763 -2.46 . . . . 0.97 113.916 162.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -140.94 151.04 43.89 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.228 -1.767 . . . . 2.49 106.228 168.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.25 18.5 p -85.14 169.83 13.49 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 121.747 2.067 . . . . 0.76 111.146 -178.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mt -69.83 -43.98 70.86 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 123.959 1.837 . . . . 1.05 113.859 173.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.1 t -57.89 -38.63 76.14 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.615 2.366 . . . . 1.19 114.271 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -57.36 -43.85 83.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.907 -1.746 . . . . 1.9 114.115 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -85.58 3.41 40.78 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.991 2.329 . . . . 0.89 114.033 172.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.4 m120 59.75 37.85 21.9 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.801 -3.062 . . . . 1.84 113.798 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.0 mt -74.15 116.4 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 125.527 1.531 . . . . 0.82 108.496 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -89.3 -174.62 4.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 117.364 2.357 . . . . 2.16 117.364 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -60.17 133.07 55.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.285 -2.134 . . . . 2.12 115.677 169.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.41 50.1 mt-10 64.33 41.96 5.56 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.684 -1.26 . . . . 1.71 112.678 174.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.257 62.6 m -106.55 163.81 12.58 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 103.25 -2.87 . . . . 1.04 103.25 -175.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.48 ' CG2' ' HB2' ' A' ' 6' ' ' LYS . 89.5 m -128.79 124.31 35.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.608 3.099 . . . . 0.79 109.39 -176.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.3 mt -91.49 162.46 14.54 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 110.385 -3.098 . . . . 1.4 108.926 172.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -127.57 119.88 26.97 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 117.351 -1.74 . . . . 1.51 109.596 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.1 tp -75.78 125.44 29.07 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.957 1.836 . . . . 1.14 115.957 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 t -123.59 148.36 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 103.277 -2.86 . . . . 1.23 103.277 171.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.7 mt -121.53 147.01 46.36 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 124.397 2.046 . . . . 2.78 110.603 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -68.81 -51.12 44.16 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 112.485 -2.143 . . . . 3.75 116.415 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.3 mt -106.12 -158.66 0.67 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.071 -1.825 . . . . 3.14 106.071 175.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -89.14 147.57 24.13 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 117.473 -1.691 . . . . 6.8 108.208 167.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.81 87.62 0.37 Allowed Glycine 0 N--CA 1.429 -1.768 0 O-C-N 119.301 -2.124 . . . . 3.57 112.09 -172.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.732 0 CA-C-O 126.312 3.173 . . . . 3.87 115.152 177.508 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 CA--C 1.491 -1.313 0 CA-C-O 124.834 2.254 . . . . 1.1 114.101 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -74.11 132.37 42.21 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 128.85 2.86 . . . . 1.87 107.971 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.0 pt -136.86 152.32 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 125.983 1.713 . . . . 0.72 109.452 171.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -117.26 148.23 41.85 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.269 -2.144 . . . . 1.4 115.809 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -125.11 107.46 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 104.673 -2.343 . . . . 0.58 104.673 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 tttp -91.3 132.52 36.1 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.59 -1.944 . . . . 2.09 110.681 176.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.3 p -87.49 176.21 7.59 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.609 2.448 . . . . 0.99 117.609 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.418 HD21 HG22 ' A' ' 70' ' ' VAL . 87.2 mt -60.99 -29.63 69.8 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.143 -3.473 . . . . 2.53 119.946 166.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 p -83.79 -87.4 0.11 Allowed 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 113.702 -1.59 . . . . 2.08 107.279 -175.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.74 48.74 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.732 0 O-C-N 118.911 -2.368 . . . . 1.31 107.956 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -128.24 135.32 49.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.512 2.325 . . . . 1.4 107.478 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.6 m -118.32 119.68 35.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.937 2.304 . . . . 0.78 105.857 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.1 mt -91.99 113.97 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 O-C-N 117.513 -3.242 . . . . 1.55 103.354 -172.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.3 m -86.5 113.33 22.34 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.022 -3.549 . . . . 1.08 109.157 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.6 mt -111.56 171.19 7.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 114.946 1.461 . . . . 1.55 114.946 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -125.48 121.87 34.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.101 -3.5 . . . . 1.95 115.609 168.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -130.23 175.67 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 118.987 -2.32 . . . . 0.96 106.942 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HG3' ' H ' ' A' ' 20' ' ' SER . 11.6 pt-20 -104.21 157.36 34.2 Favored Pre-proline 0 N--CA 1.431 -1.419 0 O-C-N 118.72 -2.487 . . . . 2.35 116.061 160.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -64.33 -9.1 18.7 Favored 'Trans proline' 0 N--CA 1.434 -2.012 2 CA-C-N 129.141 4.3 . . . . 0.95 114.443 -175.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.427 ' H ' ' HG3' ' A' ' 18' ' ' GLU 0.257 15.0 m -94.42 11.51 30.39 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 123.578 2.899 . . . . 1.45 117.481 171.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.98 138.54 36.07 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.97 -2.331 . . . . 1.69 115.221 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 p -76.07 159.4 30.81 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 114.325 1.231 . . . . 0.75 114.325 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.2 mm -68.13 -36.75 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 127.456 2.302 . . . . 0.73 107.762 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -59.36 -33.45 71.18 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.668 1.729 . . . . 1.62 115.668 165.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -69.6 -39.09 77.48 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.076 -3.515 . . . . 2.13 118.94 171.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.38 -39.8 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 126.346 2.974 . . . . 0.62 113.329 167.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -63.3 -37.59 87.86 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 116.251 -4.031 . . . . 1.22 112.459 -176.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.49 -19.04 63.74 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 128.284 2.634 . . . . 0.51 112.63 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -84.79 -30.91 24.22 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 117.66 -3.15 . . . . 1.44 110.365 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.4 mt -73.65 -35.84 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 123.831 1.777 . . . . 1.32 109.479 172.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -56.4 -50.76 70.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.547 -3.846 . . . . 1.7 111.397 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -53.89 -42.63 68.87 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 128.98 2.912 . . . . 1.55 112.144 174.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -83.2 -60.04 2.27 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.921 -2.987 . . . . 2.62 111.854 -174.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -97.66 -16.81 19.81 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 122.349 2.34 . . . . 1.48 112.243 -169.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.78 30.19 24.42 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 108.087 -2.005 . . . . 1.12 108.087 171.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.6 mt -102.23 133.7 20.46 Favored Pre-proline 0 N--CA 1.431 -1.401 0 N-CA-C 104.838 -2.282 . . . . 1.55 104.838 -174.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -76.07 161.87 35.09 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 O-C-N 115.105 -3.156 . . . . 1.02 114.21 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -70.76 -25.2 24.23 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 C-N-CA 122.867 2.378 . . . . 1.25 114.559 -170.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -74.03 -26.45 60.42 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.439 1.59 . . . . 2.25 112.247 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -84.31 -12.03 55.34 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.371 -1.456 . . . . 2.02 113.684 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -91.01 122.22 33.48 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 122.178 0.989 . . . . 0.69 110.849 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -101.06 102.64 13.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.603 1.192 . . . . 2.78 112.152 166.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.0 mt -84.73 125.43 32.54 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 115.925 1.824 . . . . 1.17 115.925 171.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.61 125.48 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 127.979 2.512 . . . . 1.38 108.461 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -132.52 126.9 33.97 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.96 -1.088 . . . . 1.5 110.572 173.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.21 -40.19 0.24 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.264 2.626 . . . . 1.21 116.56 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.44 -7.46 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.668 0 C-N-CA 128.812 3.101 . . . . 1.3 111.286 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -94.34 132.37 39.01 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 126.42 1.888 . . . . 2.55 110.82 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -87.75 148.24 24.82 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 107.347 -1.353 . . . . 2.48 107.347 172.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.35 6.9 mt -107.26 120.65 42.71 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.916 2.886 . . . . 0.9 110.41 -159.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.405 ' CD ' ' HE ' ' A' ' 54' ' ' ARG . 80.3 tt0 -88.32 136.95 32.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 129.027 3.954 . . . . 1.94 111.912 178.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -57.47 -59.94 4.4 Favored 'General case' 0 N--CA 1.431 -1.422 2 C-N-CA 134.983 5.313 . . . . 1.56 116.131 -168.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.11 29.11 2.81 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 119.687 -1.883 . . . . 0.97 115.998 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.405 ' HE ' ' CD ' ' A' ' 51' ' ' GLU . 28.8 mmt180 -105.47 156.12 18.51 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.283 -2.304 . . . . 2.49 108.489 165.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.3 p -93.05 170.35 9.72 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 119.918 -1.738 . . . . 0.76 109.267 172.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.0 mt -56.94 -41.49 78.34 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.711 2.805 . . . . 1.05 115.337 167.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.9 t -64.6 -32.15 73.68 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 128.504 2.722 . . . . 1.19 115.289 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -81.88 -21.02 37.69 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.378 2.671 . . . . 1.9 112.27 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -98.01 -11.96 22.44 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.595 -1.261 . . . . 0.89 107.595 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 67.63 42.92 1.95 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 128.122 3.82 . . . . 1.84 111.242 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.9 mt -89.75 114.05 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 126.836 3.208 . . . . 0.82 113.627 172.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -101.84 -165.93 1.24 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.524 -1.985 . . . . 2.16 105.777 -172.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -73.47 166.06 23.92 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 118.742 2.867 . . . . 2.12 118.742 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.554 13.5 pt-20 63.53 18.07 10.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.758 -2.464 . . . . 1.71 115.976 176.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.7 p -90.82 151.14 21.29 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.735 -1.575 . . . . 1.04 109.36 -175.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.0 m -118.74 92.84 3.91 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.465 1.602 . . . . 0.79 112.249 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.0 mt -75.0 136.79 41.25 Favored 'General case' 0 N--CA 1.43 -1.475 1 C-N-CA 132.851 4.46 . . . . 1.4 109.473 174.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -107.04 132.06 53.38 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.469 -2.019 . . . . 1.51 111.562 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.4 tp -113.15 112.54 23.97 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 128.273 3.892 . . . . 1.14 106.831 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.418 HG22 HD21 ' A' ' 8' ' ' LEU . 18.3 t -107.66 146.15 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 129.256 3.022 . . . . 1.23 105.357 174.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -88.29 127.84 35.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.12 -1.807 . . . . 2.78 106.12 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -73.69 110.2 7.79 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 126.958 2.103 . . . . 3.75 112.95 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.4 mt -87.52 164.0 16.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.116 1.913 . . . . 3.14 114.99 173.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -70.0 103.09 2.16 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 111.907 -2.406 . . . . 6.8 116.771 172.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 150.51 -115.79 0.73 Allowed Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 116.271 1.269 . . . . 3.57 116.271 -166.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.793 0 CA-C-O 126.416 3.231 . . . . 3.87 109.949 -179.498 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptt? . . . . . 0 CA--C 1.49 -1.329 0 N-CA-C 114.211 1.189 . . . . 1.1 114.211 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.385 2.4 mp0 -94.27 130.89 40.37 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 116.518 -1.706 . . . . 1.87 113.96 -174.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.2 pt -123.35 159.61 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 119.266 0.939 . . . . 0.72 110.828 172.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -111.75 135.73 51.96 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.527 -2.608 . . . . 1.4 112.688 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.01 125.11 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 119.509 -1.994 . . . . 0.58 106.308 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -102.9 148.55 25.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.105 2.128 . . . . 2.09 112.916 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.261 6.4 p -98.55 159.05 15.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 125.377 1.673 . . . . 0.99 114.546 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.1 mt -49.82 -38.63 35.56 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.543 -2.598 . . . . 2.53 117.619 171.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.0 p -83.63 -12.33 56.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.481 2.562 . . . . 2.08 112.313 -171.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.42 7.09 26.7 Favored Glycine 0 N--CA 1.43 -1.754 0 CA-C-N 112.426 -2.17 . . . . 1.31 116.722 174.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -80.46 144.18 32.79 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 123.205 3.502 . . . . 1.4 109.053 -179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.9 m -125.94 94.44 4.11 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 106.982 -1.488 . . . . 0.78 106.982 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.4 4.4 pt -76.53 142.41 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 128.374 2.67 . . . . 1.55 112.427 174.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -108.32 129.7 55.22 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.545 -2.391 . . . . 1.08 104.545 173.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.8 mt -117.0 165.11 13.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 126.425 2.328 . . . . 1.55 107.307 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.296 66.1 tt0 -116.1 121.54 42.46 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.519 -2.613 . . . . 1.95 106.352 178.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.431 HG12 ' HE3' ' A' ' 29' ' ' LYS . 21.8 m -132.34 168.83 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-O 116.516 -1.707 . . . . 0.96 115.396 176.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -116.54 160.04 37.84 Favored Pre-proline 0 N--CA 1.43 -1.448 0 O-C-N 127.56 3.037 . . . . 2.35 107.21 167.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -65.42 -25.78 55.82 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 123.714 2.943 . . . . 0.95 112.62 -177.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.5 m -81.75 3.93 23.87 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 117.361 2.356 . . . . 1.45 117.361 172.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.58 137.56 40.87 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.543 -1.973 . . . . 1.69 109.673 173.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.0 p -73.92 157.3 36.52 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.96 -2.962 . . . . 0.75 112.523 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.7 mm -56.45 -32.66 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 123.984 1.849 . . . . 0.73 114.493 170.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -59.28 -44.1 92.48 Favored 'General case' 0 N--CA 1.43 -1.469 1 O-C-N 115.718 -4.364 . . . . 1.62 110.399 165.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -66.66 -32.09 73.18 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 116.978 -3.576 . . . . 2.13 110.344 175.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.559 HG21 HD21 ' A' ' 56' ' ' LEU . 34.4 t -66.09 -51.25 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 121.125 1.784 . . . . 0.62 107.811 175.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -59.4 -33.26 71.0 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.118 -3.489 . . . . 1.22 112.076 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.33 -19.31 65.9 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 116.648 2.092 . . . . 0.51 116.648 171.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.431 ' HE3' HG12 ' A' ' 17' ' ' VAL . 39.8 mttm -85.2 -18.81 32.95 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 123.488 2.858 . . . . 1.44 107.155 176.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.9 mt -87.46 -24.43 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 108.129 -1.063 . . . . 1.32 108.129 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -65.66 -44.05 87.47 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.464 2.764 . . . . 1.7 118.464 166.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -60.13 -62.2 2.04 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 113.701 -1.59 . . . . 1.55 110.37 168.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -69.58 -63.99 0.97 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.62 2.082 . . . . 2.62 116.62 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -87.41 -33.38 19.11 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.613 2.149 . . . . 1.48 114.944 -170.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.68 34.18 2.11 Favored Glycine 0 N--CA 1.43 -1.743 0 O-C-N 118.767 -2.458 . . . . 1.12 113.744 169.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.2 mt -108.8 123.11 38.05 Favored Pre-proline 0 N--CA 1.431 -1.424 0 O-C-N 119.884 -1.95 . . . . 1.55 105.786 -170.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -68.63 145.42 63.74 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 114.746 -3.344 . . . . 1.02 112.711 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.254 18.0 Cg_exo -66.18 -28.1 48.42 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 124.474 3.449 . . . . 1.25 117.295 -171.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.254 8.8 p-10 -56.94 -31.99 65.53 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.307 -3.995 . . . . 2.25 116.091 168.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -78.13 -25.38 47.36 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.725 2.01 . . . . 2.02 113.182 -176.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -90.91 147.9 22.82 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.767 1.627 . . . . 0.69 112.614 -173.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.272 91.8 mtt180 -122.71 146.75 47.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.982 -1.699 . . . . 2.78 108.131 162.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.0 mt -121.7 114.74 21.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.965 -1.71 . . . . 1.17 111.002 172.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.9 mt -104.22 116.2 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 117.771 -1.109 . . . . 1.38 111.312 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -112.9 131.79 55.58 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.009 -1.849 . . . . 1.5 106.009 170.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 82.48 -43.29 0.13 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.064 1.346 . . . . 1.21 111.189 172.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.28 -5.63 0.18 Allowed Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 114.423 -3.431 . . . . 1.3 107.05 -173.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -123.82 143.71 50.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 121.762 2.781 . . . . 2.55 113.258 -175.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -69.17 138.85 54.46 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.026 -2.921 . . . . 2.48 115.407 173.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.7 mt -98.87 122.39 42.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.32 2.009 . . . . 0.9 105.848 -175.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -71.6 120.63 17.46 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 123.852 1.786 . . . . 1.94 115.111 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -44.78 -53.78 7.04 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.999 2.519 . . . . 1.56 114.536 -171.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.05 39.67 1.85 Allowed Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 118.471 2.149 . . . . 0.97 118.471 173.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -124.94 167.95 13.97 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 116.664 -3.844 . . . . 2.49 106.601 168.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.6 p -97.03 175.64 6.25 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.916 1.821 . . . . 0.76 115.916 169.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.559 HD21 HG21 ' A' ' 26' ' ' VAL . 5.5 mt -73.16 -22.65 60.46 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 127.037 3.303 . . . . 1.05 110.161 174.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -78.21 -41.33 34.8 Favored 'General case' 0 N--CA 1.43 -1.453 2 C-N-CA 133.464 4.706 . . . . 1.19 116.346 175.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -63.16 -32.68 74.12 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.801 1.762 . . . . 1.9 111.516 168.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -92.93 -0.45 57.22 Favored 'General case' 0 N--CA 1.431 -1.398 1 O-C-N 116.063 -4.148 . . . . 0.89 112.884 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 48.43 53.87 11.33 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.49 2.033 . . . . 1.84 116.49 -174.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.5 mt -97.06 129.42 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 129.155 2.982 . . . . 0.82 108.377 175.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -103.29 -167.97 1.45 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 115.536 1.68 . . . . 2.16 115.536 -172.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -55.63 139.53 44.21 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.022 1.119 . . . . 2.12 114.022 160.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.279 93.0 mt-10 60.0 52.22 5.35 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 120.097 3.369 . . . . 1.71 120.097 173.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.1 p -103.53 135.28 45.42 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.531 3.532 . . . . 1.04 109.399 -175.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 m -96.54 107.42 19.84 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 104.816 -2.29 . . . . 0.79 104.816 -176.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.0 mt -93.99 145.94 24.29 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 126.623 3.106 . . . . 1.4 104.122 170.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -111.15 118.93 37.33 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 112.996 -1.911 . . . . 1.51 107.766 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.0 tp -86.09 118.43 25.56 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.252 1.501 . . . . 1.14 109.003 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.13 129.74 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 124.862 2.267 . . . . 1.23 107.781 172.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.3 mt -104.94 149.76 25.46 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 113.831 -5.543 . . . . 2.78 109.105 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -75.54 165.37 25.2 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 117.298 -1.761 . . . . 3.75 109.835 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.9 mt -73.89 145.51 44.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.223 2.916 . . . . 3.14 112.682 168.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -83.32 -158.44 0.29 Allowed 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.715 -2.491 . . . . 6.8 117.362 170.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -99.57 77.79 0.49 Allowed Glycine 0 N--CA 1.431 -1.696 0 O-C-N 120.774 -1.204 . . . . 3.57 112.077 -168.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.818 0 O-C-N 119.522 -2.163 . . . . 3.87 115.343 178.226 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.342 0 N-CA-C 117.298 2.333 . . . . 1.1 117.298 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -93.19 115.39 28.01 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 119.991 3.33 . . . . 1.87 119.991 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.523 HG22 ' HB2' ' A' ' 65' ' ' SER . 8.9 pt -113.17 163.09 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-N 122.904 2.593 . . . . 0.72 109.842 173.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.298 79.6 m-85 -121.01 134.22 55.29 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.07 -1.456 . . . . 1.4 107.07 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.2 t -119.16 130.24 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 119.578 -1.951 . . . . 0.58 110.021 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -95.26 119.8 34.4 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.646 3.178 . . . . 2.09 106.511 -173.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -86.84 -173.71 4.6 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 115.914 -1.993 . . . . 0.99 108.204 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.7 mt -87.01 -29.27 22.1 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.423 2.689 . . . . 2.53 108.901 173.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -77.52 -7.71 56.69 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.618 2.451 . . . . 2.08 117.618 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.28 5.56 37.25 Favored Glycine 0 N--CA 1.43 -1.745 0 CA-C-O 124.183 1.991 . . . . 1.31 112.578 174.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -96.22 144.63 26.25 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.968 -2.489 . . . . 1.4 110.605 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -106.22 115.54 30.4 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 106.025 -1.843 . . . . 0.78 106.025 173.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -91.6 126.45 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 125.753 2.692 . . . . 1.55 107.606 173.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.5 m -96.94 113.59 25.14 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 116.536 -3.853 . . . . 1.08 111.051 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.0 mt -120.29 154.42 34.99 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 114.208 1.188 . . . . 1.55 114.208 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.444 ' O ' ' HE3' ' A' ' 29' ' ' LYS . 29.7 mt-10 -109.72 145.22 36.95 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.646 -0.872 . . . . 1.95 108.646 172.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -152.22 156.31 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 126.17 1.788 . . . . 0.96 108.874 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -95.51 154.13 39.35 Favored Pre-proline 0 N--CA 1.43 -1.465 0 CA-C-O 114.364 -2.732 . . . . 2.35 108.561 171.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 57.5 Cg_endo -74.31 -11.87 22.93 Favored 'Trans proline' 0 N--CA 1.433 -2.03 0 CA-C-N 126.902 3.501 . . . . 0.95 112.218 -172.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -78.96 4.78 13.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.946 2.499 . . . . 1.45 112.596 173.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -93.56 151.76 19.48 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 126.957 2.103 . . . . 1.69 115.584 173.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.5 p -82.55 161.07 22.43 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.24 -2.788 . . . . 0.75 115.933 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mm -60.8 -34.82 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.079 -2.888 . . . . 0.73 115.387 170.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -48.27 -36.29 13.78 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 120.402 3.482 . . . . 1.62 120.402 158.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -62.0 -33.37 74.2 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.715 -2.491 . . . . 2.13 113.955 175.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.2 t -68.91 -41.25 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 127.159 2.183 . . . . 0.62 112.752 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -67.54 -34.23 76.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 113.878 -1.51 . . . . 1.22 112.32 174.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.6 -41.32 98.34 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.773 -1.829 . . . . 0.51 115.814 170.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HE3' ' O ' ' A' ' 16' ' ' GLU . 58.9 mttm -62.59 -38.26 89.46 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.1 -2.25 . . . . 1.44 114.367 168.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.41 92.7 mt -62.23 -35.52 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-O 126.888 3.233 . . . . 1.32 113.836 174.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -66.56 -31.54 72.31 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.23 -2.169 . . . . 1.7 115.057 174.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -73.22 -53.78 10.07 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.236 -1.024 . . . . 1.55 108.236 171.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -65.41 -50.23 66.25 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.917 1.451 . . . . 2.62 114.917 -174.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -108.19 -48.95 3.27 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 126.269 1.828 . . . . 1.48 113.405 -172.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.27 16.66 3.83 Favored Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 119.445 -1.36 . . . . 1.12 114.863 175.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 mt -88.88 131.01 42.7 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 115.495 -2.193 . . . . 1.55 110.052 -174.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -69.21 161.68 44.85 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 CA-C-N 126.453 3.34 . . . . 1.02 117.924 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.96 -1.86 8.78 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 CA-C-N 122.574 1.955 . . . . 1.25 113.287 -167.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -84.47 -26.27 28.32 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 116.137 -4.102 . . . . 2.25 111.998 176.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -83.92 -34.49 24.48 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.676 -2.515 . . . . 2.02 111.006 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -76.42 121.0 22.43 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 117.8 2.519 . . . . 0.69 117.8 -175.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.6 mtt85 -103.0 164.51 11.57 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 125.574 1.796 . . . . 2.78 106.365 167.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.1 mp -129.85 134.02 47.28 Favored 'General case' 0 CA--C 1.489 -1.387 0 O-C-N 117.636 -3.165 . . . . 1.17 112.026 170.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.2 mt -125.21 124.92 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 CA-C-O 128.564 4.03 . . . . 1.38 109.524 177.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -127.99 139.74 52.39 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 115.379 -4.576 . . . . 1.5 107.072 171.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.302 . . 52.35 25.83 3.71 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.632 2.773 . . . . 1.21 115.764 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.99 13.1 72.62 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-O 114.17 -3.572 . . . . 1.3 110.906 -176.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.4 ttmm -125.17 129.66 50.58 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.639 2.22 . . . . 2.55 105.211 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.288 16.7 tt0 -83.33 125.56 31.77 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.153 2.981 . . . . 2.48 111.022 173.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.438 HD22 ' CE1' ' A' ' 59' ' ' TYR . 53.4 mt -79.26 164.47 24.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.294 -1.775 . . . . 0.9 112.58 -167.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -95.3 153.36 17.71 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.622 -1.992 . . . . 1.94 105.622 175.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -79.76 -50.69 10.19 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.665 -1.272 . . . . 1.56 111.943 -167.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.62 60.23 3.62 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 120.562 2.985 . . . . 0.97 120.562 171.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -126.19 166.96 16.1 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 104.86 -2.274 . . . . 2.49 104.86 165.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.3 p -97.8 162.0 13.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.872 -2.64 . . . . 0.76 103.872 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 5.0 mt -63.99 -27.94 69.47 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 112.762 -2.017 . . . . 1.05 115.794 174.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.9 t -59.89 -45.78 91.44 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.817 2.447 . . . . 1.19 109.001 176.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -55.46 -31.93 62.36 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.867 -2.396 . . . . 1.9 116.257 175.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.438 ' CE1' HD22 ' A' ' 50' ' ' LEU . 88.2 m-85 -85.2 -0.42 54.56 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.195 1.798 . . . . 0.89 112.029 174.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.289 18.7 m120 49.26 50.91 17.25 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.935 -3.603 . . . . 1.84 115.512 -171.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.274 83.7 mt -93.38 125.02 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 127.545 2.338 . . . . 0.82 105.308 -173.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -105.77 -175.96 2.94 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.556 3.142 . . . . 2.16 107.411 -172.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -72.21 159.31 34.31 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.417 -1.427 . . . . 2.12 110.141 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 59.53 48.53 9.58 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.685 1.994 . . . . 1.71 112.828 174.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.523 ' HB2' HG22 ' A' ' 3' ' ' ILE . 34.6 m -111.85 137.57 49.63 Favored 'General case' 0 N--CA 1.429 -1.476 1 N-CA-C 99.314 -4.328 . . . . 1.04 99.314 -169.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.6 m -102.53 108.51 19.84 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.608 1.963 . . . . 0.79 109.861 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.8 mt -105.01 148.77 26.38 Favored 'General case' 0 CA--C 1.489 -1.39 0 CA-C-O 123.559 1.647 . . . . 1.4 113.897 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -102.39 132.35 48.45 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.204 -3.435 . . . . 1.51 109.764 -173.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.1 tp -91.66 119.36 31.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.224 -2.797 . . . . 1.14 109.507 175.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.21 137.26 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 O-C-N 118.11 -2.869 . . . . 1.23 107.041 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.8 mt -119.97 -165.51 1.18 Allowed 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 116.804 -1.958 . . . . 2.78 110.769 172.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.4 mmt-85 -90.98 -67.05 0.88 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.744 2.688 . . . . 3.75 105.294 170.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.6 mt -125.08 156.32 38.43 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.571 -1.956 . . . . 3.14 111.22 172.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.0 ttt180 -78.04 157.93 29.4 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.306 2.642 . . . . 6.8 108.286 171.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.15 -121.49 1.69 Allowed Glycine 0 N--CA 1.429 -1.795 0 O-C-N 118.028 -2.92 . . . . 3.57 109.296 -171.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.745 0 O-C-N 120.075 -1.838 . . . . 3.87 117.628 -179.558 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 115.436 1.643 . . . . 1.1 115.436 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -83.83 148.04 27.22 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 114.806 -2.521 . . . . 1.87 109.561 -176.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -142.43 168.43 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 1 O-C-N 130.8 5.062 . . . . 0.72 107.97 170.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -117.88 156.68 28.01 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 114.455 1.28 . . . . 1.4 114.455 171.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.9 t -134.36 128.04 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 101.381 -3.563 . . . . 0.58 101.381 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -98.92 106.88 19.19 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.905 2.187 . . . . 2.09 116.905 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.262 4.8 p -58.13 165.43 1.93 Allowed 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 125.508 1.523 . . . . 0.99 112.571 176.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.3 94.7 mt -60.18 -54.89 40.42 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 130.867 3.667 . . . . 2.53 110.995 176.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 p -76.8 -12.23 59.95 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 117.84 -3.038 . . . . 2.08 113.264 -178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.65 2.21 5.36 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 122.285 2.311 . . . . 1.31 113.448 166.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -77.02 143.23 39.49 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 116.241 -4.093 . . . . 1.4 114.027 -175.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.0 m -85.44 125.92 33.39 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 124.144 0.977 . . . . 0.78 112.446 166.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.3 mt -100.51 112.89 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 104.999 -2.223 . . . . 1.55 104.999 171.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 m -87.99 145.49 25.98 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 116.031 -2.267 . . . . 1.08 108.479 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.3 mt -141.17 174.89 10.1 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 120.427 1.467 . . . . 1.55 109.308 175.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -126.18 119.66 28.08 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.682 1.993 . . . . 1.95 110.288 167.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 m -121.19 153.49 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 126.447 1.899 . . . . 0.96 110.702 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.278 17.7 mm-40 -101.84 175.84 2.13 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-N 125.2 3.636 . . . . 2.35 110.957 155.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -74.76 -20.17 17.74 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 121.23 1.475 . . . . 0.95 110.106 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.8 m -76.21 -8.93 58.13 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 120.328 3.455 . . . . 1.45 120.328 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -80.45 142.5 34.23 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 116.772 -3.705 . . . . 1.69 110.198 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 38.4 p -82.99 179.98 7.61 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 123.275 1.512 . . . . 0.75 111.703 -176.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.9 mm -82.62 -31.12 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 116.657 -3.777 . . . . 0.73 109.201 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -63.41 -28.76 70.2 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.18 -2.2 . . . . 1.62 115.404 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -66.71 -46.08 76.67 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.005 1.722 . . . . 2.13 113.414 172.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.2 t -62.67 -42.11 94.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 119.148 -2.22 . . . . 0.62 109.554 176.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -71.46 -8.31 53.06 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 118.222 2.675 . . . . 1.22 118.222 169.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.03 -39.76 19.22 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.369 1.08 . . . . 0.51 112.828 169.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -59.24 -40.84 87.18 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.324 1.85 . . . . 1.44 111.186 174.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.7 mt -74.67 -26.35 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 115.588 1.699 . . . . 1.32 115.588 170.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -62.18 -39.23 92.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.481 -2.012 . . . . 1.7 113.49 167.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -55.8 -47.66 76.74 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 116.277 1.955 . . . . 1.55 116.277 165.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -90.06 -51.42 5.47 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 115.735 1.754 . . . . 2.62 115.735 -167.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -98.54 -39.44 8.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 106.038 -1.838 . . . . 1.48 106.038 -171.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.47 18.16 6.29 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 120.933 3.133 . . . . 1.12 120.933 174.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.2 mt -103.71 120.75 50.47 Favored Pre-proline 0 N--CA 1.43 -1.437 1 C-N-CA 134.775 5.23 . . . . 1.55 108.374 -163.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -57.28 137.17 80.43 Favored 'Trans proline' 0 C--N 1.299 -2.052 2 C-N-CA 125.726 4.284 . . . . 1.02 116.749 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -67.59 -12.58 36.12 Favored 'Trans proline' 0 N--CA 1.434 -2.027 0 CA-C-N 127.978 3.885 . . . . 1.25 120.197 -172.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -78.41 -16.1 57.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.633 1.973 . . . . 2.25 112.483 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -92.01 -37.41 12.84 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.407 -2.058 . . . . 2.02 110.979 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -69.47 126.99 31.43 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.68 2.392 . . . . 0.69 112.051 -171.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.44 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 29.9 mtt180 -103.99 126.73 51.33 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 120.303 -1.498 . . . . 2.78 110.952 158.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 43' ' ' LEU . 83.0 mt -104.84 118.12 35.75 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.356 -2.715 . . . . 1.17 106.427 175.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.5 mm -112.8 141.44 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.669 1.988 . . . . 1.38 105.831 -174.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -154.8 124.26 6.45 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.535 -1.654 . . . . 1.5 106.535 169.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.47 37.83 2.55 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 126.703 2.502 . . . . 1.21 110.383 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.13 -23.51 4.5 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 118.031 -2.033 . . . . 1.3 116.131 -175.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -87.23 142.07 28.17 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.554 -1.556 . . . . 2.55 114.831 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -87.0 135.03 33.42 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.354 -2.716 . . . . 2.48 108.864 172.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.6 mt -93.09 128.77 39.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.887 -1.133 . . . . 0.9 112.54 -175.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -84.32 132.01 34.65 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 117.604 2.446 . . . . 1.94 117.604 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -40.53 -67.93 0.21 Allowed 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 121.22 3.785 . . . . 1.56 121.22 -165.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.25 58.03 5.05 Favored Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 118.011 1.964 . . . . 0.97 118.011 171.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -129.09 157.85 40.6 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 103.562 -2.755 . . . . 2.49 103.562 168.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 68.2 p -98.92 167.51 10.7 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.955 -1.716 . . . . 0.76 113.603 175.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.87 -24.81 66.94 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.993 -1.692 . . . . 1.05 115.305 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.5 t -69.4 -39.7 77.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.586 1.954 . . . . 1.19 109.654 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -55.28 -40.01 70.53 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 115.446 1.647 . . . . 1.9 115.446 171.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -88.67 -2.03 58.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.046 1.738 . . . . 0.89 113.296 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 59.08 50.75 7.77 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 123.14 1.448 . . . . 1.84 110.853 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.7 mm -85.97 126.66 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-O 125.687 2.66 . . . . 0.82 105.699 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -91.92 174.21 7.45 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.572 -2.58 . . . . 2.16 113.476 -176.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.3 pttt -70.13 147.02 50.43 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.164 1.459 . . . . 2.12 113.65 173.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.322 41.1 mt-10 61.97 35.58 16.08 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 119.139 -2.225 . . . . 1.71 114.674 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 t -102.62 149.42 24.45 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 124.326 1.05 . . . . 1.04 110.505 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.5 m -96.95 110.68 23.16 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.058 2.543 . . . . 0.79 113.031 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.8 mt -90.03 153.13 20.8 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 118.065 -1.454 . . . . 1.4 109.966 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -104.19 123.82 48.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.125 1.44 . . . . 1.51 112.599 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.1 tp -94.46 128.79 41.25 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.126 -4.109 . . . . 1.14 108.282 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 89.0 t -120.87 154.21 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 102.239 -3.245 . . . . 1.23 102.239 172.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.0 mt -130.53 155.7 46.05 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 120.594 -1.316 . . . . 2.78 108.587 -175.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.4 ttp180 -70.8 -48.84 52.08 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 130.386 3.474 . . . . 3.75 110.34 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 55.7 mt -90.56 160.39 15.97 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.535 1.636 . . . . 3.14 110.967 170.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.329 1.0 OUTLIER -90.61 -40.97 11.61 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 116.545 -3.847 . . . . 6.8 113.08 169.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.17 -59.28 1.39 Allowed Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 125.891 1.71 . . . . 3.57 111.219 -163.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.744 1 CA-C-O 112.0 -4.778 . . . . 3.87 112.951 175.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 CA--C 1.491 -1.324 0 CA-C-O 118.376 -0.821 . . . . 1.1 112.089 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -99.27 126.98 45.21 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 121.727 0.775 . . . . 1.87 111.232 -176.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.6 pt -114.69 164.45 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 105.663 -1.977 . . . . 0.72 105.663 173.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -119.2 135.01 54.88 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 105.26 -2.126 . . . . 1.4 105.26 -175.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.5 t -117.79 118.22 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 102.98 -2.97 . . . . 0.58 102.98 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -108.98 135.92 49.36 Favored 'General case' 0 N--CA 1.429 -1.485 2 O-C-N 115.639 -4.413 . . . . 2.09 108.05 175.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.56 HG22 HD23 ' A' ' 69' ' ' LEU . 59.1 p -87.32 -177.05 5.86 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 125.119 2.39 . . . . 0.99 115.752 176.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.1 mt -72.78 -30.31 64.0 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 124.733 2.206 . . . . 2.53 114.794 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p -77.94 -51.04 11.02 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 114.549 -5.094 . . . . 2.08 110.526 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.61 35.68 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.748 0 O-C-N 118.552 -2.593 . . . . 1.31 111.777 173.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -102.42 108.46 19.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.931 -2.248 . . . . 1.4 104.931 -170.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.9 m -83.7 114.9 21.9 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.535 2.734 . . . . 0.78 106.694 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.4 mt -101.54 146.43 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 100.522 -3.881 . . . . 1.55 100.522 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.7 m -118.21 130.82 56.3 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.851 2.739 . . . . 1.08 103.853 174.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.3 mt -125.75 139.98 53.07 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 113.275 -1.784 . . . . 1.55 108.283 -177.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.27 48.0 mt-10 -103.32 129.91 50.47 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 123.929 1.823 . . . . 1.95 111.341 170.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 m -137.31 166.22 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-N 113.929 -1.487 . . . . 0.96 110.669 -169.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -105.55 167.23 10.03 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 119.25 -2.156 . . . . 2.35 109.679 161.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -70.89 -13.1 31.6 Favored 'Trans proline' 0 N--CA 1.434 -1.99 0 N-CA-C 118.999 2.653 . . . . 0.95 118.999 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.8 p -93.11 4.22 54.38 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.499 1.92 . . . . 1.45 115.5 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -80.2 144.27 33.09 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 126.378 2.99 . . . . 1.69 111.929 170.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.3 p -80.27 158.62 26.12 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 128.335 2.654 . . . . 0.75 108.108 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.6 mm -64.99 -36.75 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 103.031 -2.951 . . . . 0.73 103.031 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -55.16 -46.26 75.73 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.353 -3.342 . . . . 1.62 117.259 170.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -64.28 -37.98 89.43 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 115.785 1.772 . . . . 2.13 115.785 171.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.5 t -53.2 -44.55 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 118.418 -2.676 . . . . 0.62 114.684 167.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt -62.56 -46.63 87.48 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.318 -1.489 . . . . 1.22 114.57 173.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.1 -37.4 69.32 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.782 1.633 . . . . 0.51 112.281 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -68.37 -31.2 70.4 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 117.052 -1.451 . . . . 1.44 112.865 173.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.1 mt -68.68 -41.69 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 120.153 1.342 . . . . 1.32 108.337 173.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -53.57 -45.47 69.93 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 117.575 -3.203 . . . . 1.7 114.148 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.27 20.9 t70 -55.49 -68.06 0.23 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.074 -1.642 . . . . 1.55 109.761 167.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -59.82 -55.4 34.68 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 119.436 3.124 . . . . 2.62 119.436 -173.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -95.03 -51.23 4.74 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.092 2.557 . . . . 1.48 113.449 -169.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.56 24.7 2.81 Favored Glycine 0 N--CA 1.43 -1.733 0 CA-C-O 116.942 -2.032 . . . . 1.12 115.771 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.9 mm -103.62 135.12 19.42 Favored Pre-proline 0 N--CA 1.429 -1.484 0 CA-C-N 121.63 2.715 . . . . 1.55 108.777 -173.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -67.48 137.64 43.53 Favored 'Trans proline' 0 C--N 1.3 -1.998 3 C-N-CA 126.452 4.768 . . . . 1.02 115.355 178.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -59.14 -21.13 57.93 Favored 'Trans proline' 0 C--N 1.299 -2.047 1 C-N-CA 129.349 6.699 . . . . 1.25 111.461 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -62.59 -39.11 92.68 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 126.299 2.952 . . . . 2.25 114.292 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -77.75 -30.68 51.66 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 114.613 -5.054 . . . . 2.02 110.026 -173.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -79.44 151.02 31.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.703 -1.248 . . . . 0.69 112.495 -164.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -139.82 156.09 46.92 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 106.341 -1.725 . . . . 2.78 106.341 168.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 42.1 mt -136.59 126.43 25.74 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 118.86 0.754 . . . . 1.17 111.322 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.8 mm -104.62 145.93 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 O-C-N 126.471 2.357 . . . . 1.38 106.257 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -134.42 126.45 29.55 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 116.893 -3.629 . . . . 1.5 102.288 165.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.22 -55.9 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.45 1 C-N-CA 135.027 5.331 . . . . 1.21 118.945 -175.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.85 -16.8 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.723 0 O-C-N 120.132 -1.605 . . . . 1.3 113.757 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -95.29 162.36 13.71 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.542 1.537 . . . . 2.55 111.063 -178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -116.58 126.33 53.13 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.623 1.569 . . . . 2.48 107.139 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.3 mt -90.42 132.3 35.7 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 125.706 1.879 . . . . 0.9 108.748 -162.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -60.12 143.76 51.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.181 -2.825 . . . . 1.94 113.074 172.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -70.21 -43.21 71.14 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 112.899 -6.126 . . . . 1.56 113.92 -169.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.62 53.25 1.29 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 125.949 2.971 . . . . 0.97 109.718 174.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.5 mtt-85 -120.87 155.21 34.64 Favored 'General case' 0 N--CA 1.43 -1.468 1 N-CA-C 100.069 -4.049 . . . . 2.49 100.069 165.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.4 p -90.56 167.41 12.58 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 124.68 1.237 . . . . 0.76 113.346 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 mt -65.22 -42.93 92.97 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 127.299 2.874 . . . . 1.05 112.735 169.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.2 t -59.0 -40.11 83.91 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 120.041 1.291 . . . . 1.19 114.34 175.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.1 -40.96 95.71 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.726 2.121 . . . . 1.9 116.726 175.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -79.04 -10.1 59.73 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.77 1.294 . . . . 0.89 113.661 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.9 m120 68.33 40.19 2.11 Favored 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 135.507 5.523 . . . . 1.84 114.661 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.9 mt -72.33 139.6 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 127.328 2.251 . . . . 0.82 106.974 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -119.21 -178.48 3.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.942 2.306 . . . . 2.16 106.857 -175.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -65.43 147.66 53.04 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.117 2.389 . . . . 2.12 116.125 167.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.272 34.8 mt-10 70.31 21.57 5.73 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.673 1.989 . . . . 1.71 113.852 173.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -92.92 141.15 28.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.621 1.677 . . . . 1.04 108.778 -175.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.2 m -96.22 100.56 12.19 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 129.266 3.026 . . . . 0.79 112.721 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.326 18.6 mt -83.13 150.88 25.99 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 128.421 3.962 . . . . 1.4 103.699 170.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -106.92 98.93 8.53 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 110.365 -3.107 . . . . 1.51 116.919 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.56 HD23 HG22 ' A' ' 7' ' ' THR . 24.9 tp -63.65 116.69 5.91 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 116.914 2.19 . . . . 1.14 116.914 169.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.9 m -131.69 -178.78 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 102.779 -3.045 . . . . 1.23 102.779 175.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.9 mt -118.37 174.41 6.26 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 105.256 -2.127 . . . . 2.78 105.256 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.293 12.4 ptt180 -51.58 -48.7 63.06 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.756 1.762 . . . . 3.75 115.756 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.1 mt -79.57 120.47 23.97 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 129.285 3.034 . . . . 3.14 110.677 173.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -71.09 122.5 20.2 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.86 2.118 . . . . 6.8 106.161 170.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.53 108.85 0.3 Allowed Glycine 0 N--CA 1.429 -1.805 0 O-C-N 120.32 -1.488 . . . . 3.57 110.784 -166.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.755 0 N-CA-C 110.439 -1.064 . . . . 3.87 110.439 176.734 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.344 0 CA-C-O 118.34 -0.838 . . . . 1.1 111.149 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -95.66 131.4 41.94 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 116.302 1.964 . . . . 1.87 116.302 -171.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.9 pt -126.92 165.93 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 115.093 -2.385 . . . . 0.72 111.742 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -125.88 127.68 46.41 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 125.946 2.029 . . . . 1.4 106.321 -175.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.9 t -112.83 111.9 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 CA-C-N 115.503 -0.771 . . . . 0.58 109.633 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -93.63 135.67 34.68 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 116.852 -3.655 . . . . 2.09 111.496 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.3 p -84.2 -167.64 1.84 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.844 -1.785 . . . . 0.99 109.559 173.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.0 mt -91.96 -23.48 19.56 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.107 -2.245 . . . . 2.53 112.226 171.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.1 p -80.96 -47.64 13.38 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.035 1.124 . . . . 2.08 114.035 -173.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.17 25.3 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 116.615 -2.707 . . . . 1.31 111.686 176.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -118.47 124.45 47.64 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 108.492 -0.929 . . . . 1.4 108.492 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -102.41 118.56 37.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 124.579 1.175 . . . . 0.78 110.231 167.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mt -105.22 129.45 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 127.832 2.453 . . . . 1.55 110.128 -170.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.4 m -99.34 110.06 22.61 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 127.427 2.954 . . . . 1.08 108.318 -176.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.1 mt -121.49 147.07 46.26 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.059 2.838 . . . . 1.55 109.728 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -99.3 125.71 44.99 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.509 -3.869 . . . . 1.95 114.495 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.48 HG12 ' HE3' ' A' ' 29' ' ' LYS . 32.6 m -124.9 150.38 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 117.8 -3.063 . . . . 0.96 106.134 -176.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -86.21 140.23 34.49 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 112.907 -3.425 . . . . 2.35 113.018 166.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -77.44 5.14 5.35 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 CA-C-N 126.878 3.492 . . . . 0.95 112.69 -166.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 p -106.17 9.63 32.17 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.939 -2.976 . . . . 1.45 111.841 173.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -91.23 157.26 17.27 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 124.64 2.162 . . . . 1.69 110.253 171.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.422 ' O ' HG23 ' A' ' 26' ' ' VAL . 43.9 p -83.37 165.7 19.04 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.679 -2.513 . . . . 0.75 107.392 -175.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.412 11.3 mm -68.42 -37.49 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 C-N-CA 128.101 2.56 . . . . 0.73 110.51 176.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -56.96 -34.1 67.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 126.789 3.185 . . . . 1.62 115.966 169.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -83.05 -26.42 31.17 Favored 'General case' 0 N--CA 1.432 -1.374 1 O-C-N 111.808 -6.807 . . . . 2.13 113.405 177.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 22' ' ' THR . 44.3 t -52.66 -44.61 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.384 1.873 . . . . 0.62 113.436 165.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -67.38 -40.28 85.69 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.973 -2.329 . . . . 1.22 111.371 175.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.43 76.58 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.321 2.01 . . . . 0.51 113.808 175.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HE3' HG12 ' A' ' 17' ' ' VAL . 14.3 ttmm -64.66 -46.76 81.08 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 118.93 -2.356 . . . . 1.44 116.522 163.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.6 mt -61.51 -26.96 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 117.299 -3.376 . . . . 1.32 114.588 167.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -67.43 -45.47 75.98 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.851 -3.655 . . . . 1.7 109.905 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -59.26 -36.94 76.43 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 118.796 -2.44 . . . . 1.55 106.338 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.6 tptt -76.02 -55.94 5.13 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 123.585 2.902 . . . . 2.62 113.073 -171.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -112.32 -15.9 13.06 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 126.097 2.123 . . . . 1.48 115.146 -164.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.79 21.2 40.61 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-O 123.048 1.36 . . . . 1.12 115.375 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 mt -101.55 131.98 22.33 Favored Pre-proline 0 N--CA 1.43 -1.467 0 O-C-N 121.013 -1.287 . . . . 1.55 111.059 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.408 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 30.7 Cg_exo -70.47 145.0 51.84 Favored 'Trans proline' 0 C--N 1.3 -2.003 1 C-N-CA 126.302 4.668 . . . . 1.02 115.27 178.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -72.58 -6.52 19.2 Favored 'Trans proline' 0 N--CA 1.433 -2.03 1 C-N-CA 127.45 5.434 . . . . 1.25 117.21 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.98 -39.45 30.08 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.851 -1.781 . . . . 2.25 108.669 169.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -73.65 -36.46 65.39 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 125.163 1.539 . . . . 2.02 113.422 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 37' ' ' PRO . 74.3 mt-30 -74.04 135.06 43.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.322 1.23 . . . . 0.69 114.322 -175.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.1 ttt180 -122.13 117.68 26.84 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 114.859 -2.496 . . . . 2.78 107.901 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.1 mt -100.77 125.55 47.26 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 125.291 2.472 . . . . 1.17 105.935 -176.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.1 mt -106.05 142.71 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 1 O-C-N 115.903 -4.248 . . . . 1.38 101.904 176.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -153.8 133.56 13.03 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 127.486 3.517 . . . . 1.5 106.252 172.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.22 -57.99 0.28 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.064 2.546 . . . . 1.21 115.244 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -159.84 -18.59 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 108.616 -1.794 . . . . 1.3 108.616 -173.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -134.88 163.41 29.88 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.317 -3.461 . . . . 2.55 112.223 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.3 pm0 -71.16 152.7 43.14 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 117.81 -1.091 . . . . 2.48 111.885 170.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.2 mt -97.89 172.57 7.57 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.894 2.134 . . . . 0.9 114.538 -171.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -104.68 153.57 21.09 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.037 -2.914 . . . . 1.94 110.591 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -89.47 -52.05 5.23 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.284 -2.76 . . . . 1.56 109.085 -163.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.84 46.1 1.7 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 117.233 1.653 . . . . 0.97 117.233 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.353 17.7 mmt180 -128.22 165.92 19.56 Favored 'General case' 0 CA--C 1.489 -1.38 0 O-C-N 119.499 -2.177 . . . . 2.49 106.643 168.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.288 27.2 p -99.36 170.55 8.56 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.233 1.568 . . . . 0.76 115.233 -178.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' A' ' 61' ' ' ILE . 11.3 mt -63.15 -40.32 97.22 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 127.2 2.2 . . . . 1.05 107.926 171.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 m -65.47 -48.85 71.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.634 3.174 . . . . 1.19 110.891 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -52.49 -41.82 63.72 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.427 1.584 . . . . 1.9 114.334 174.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -82.33 -7.23 59.63 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.424 -2.047 . . . . 0.89 114.062 175.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.1 t30 56.44 43.83 25.37 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.414 3.485 . . . . 1.84 112.535 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' A' ' 56' ' ' LEU . 62.9 mt -75.59 109.87 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-N 111.927 -2.397 . . . . 0.82 113.1 177.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -82.78 -178.19 7.01 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 120.435 -1.416 . . . . 2.16 107.855 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -66.5 149.3 50.64 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 125.083 1.353 . . . . 2.12 111.075 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 69.09 33.75 3.28 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 131.557 3.943 . . . . 1.71 107.668 168.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m -96.42 139.6 32.29 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 121.507 1.958 . . . . 1.04 111.713 -176.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 m -99.98 115.96 30.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.43 1.468 . . . . 0.79 110.939 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.7 mp -104.47 155.33 18.89 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 112.194 -2.276 . . . . 1.4 106.29 173.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -107.34 122.92 47.55 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.885 3.274 . . . . 1.51 113.666 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.9 tp -101.42 102.09 12.82 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.243 -3.411 . . . . 1.14 106.06 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.4 m -111.96 -177.05 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 126.685 2.491 . . . . 1.23 105.686 172.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.373 18.0 mt -128.47 178.38 6.33 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 119.473 -0.891 . . . . 2.78 109.319 -176.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.421 HH21 ' C ' ' A' ' 76' ' ' GLY . 9.1 ptm85 -116.04 160.85 19.73 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 102.549 -3.13 . . . . 3.75 102.549 177.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.5 mt -76.12 168.55 19.84 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.716 -3.115 . . . . 3.14 105.906 172.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -86.1 126.37 34.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.641 1.576 . . . . 6.8 112.637 166.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 135.61 2.69 2.82 Favored Glycine 0 N--CA 1.429 -1.804 0 O-C-N 126.321 2.263 . . . . 3.57 113.601 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.421 ' C ' HH21 ' A' ' 72' ' ' ARG . . . . . . . . 0 C--O 1.26 1.751 0 N-CA-C 107.683 -2.167 . . . . 3.87 107.683 -173.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ptt? . . . . . 0 CA--C 1.49 -1.341 0 CA-C-O 124.85 2.262 . . . . 1.1 110.814 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -109.81 123.75 50.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 112.496 -2.138 . . . . 1.87 111.779 -173.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.404 HD11 HD12 ' A' ' 15' ' ' LEU . 2.2 pp -123.83 162.1 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 129.932 3.293 . . . . 0.72 111.344 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -123.52 136.76 54.74 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 122.782 1.277 . . . . 1.4 107.812 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.4 t -110.34 124.64 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 CA-C-N 112.053 -2.34 . . . . 0.58 110.346 174.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 mmtt -95.9 117.53 30.77 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.35 1.06 . . . . 2.09 109.617 174.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.404 HG22 HD23 ' A' ' 69' ' ' LEU . 64.2 p -77.65 -177.55 4.87 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.359 2.028 . . . . 0.99 109.556 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.7 tp -58.49 -50.76 72.56 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 114.656 -5.028 . . . . 2.53 116.736 174.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.7 p -68.86 -6.31 26.32 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 111.624 -2.535 . . . . 2.08 114.763 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.17 9.68 44.25 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 117.518 -3.239 . . . . 1.31 110.434 173.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -84.03 126.87 33.47 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 107.503 -1.295 . . . . 1.4 107.503 -171.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 m -93.72 121.71 35.44 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.259 -0.882 . . . . 0.78 112.368 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.0 mt -115.13 126.53 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 107.055 -1.461 . . . . 1.55 107.055 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.8 m -102.36 121.72 42.86 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.604 -1.31 . . . . 1.08 113.529 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.404 HD12 HD11 ' A' ' 3' ' ' ILE . 83.0 mt -115.52 155.13 28.09 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.351 -2.718 . . . . 1.55 110.517 -174.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -110.18 109.32 19.78 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 125.051 1.469 . . . . 1.95 110.306 171.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -123.64 173.41 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 126.192 1.797 . . . . 0.96 109.876 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -115.68 157.27 44.86 Favored Pre-proline 0 N--CA 1.429 -1.494 0 CA-C-O 115.18 -2.343 . . . . 2.35 113.42 166.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.23 2.26 8.7 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 C-N-CA 124.441 3.427 . . . . 0.95 115.472 -176.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.6 p -95.61 -25.71 16.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.086 1.513 . . . . 1.45 115.086 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -69.72 154.8 41.47 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.163 2.985 . . . . 1.69 112.607 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.269 71.7 p -81.77 149.16 28.54 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 112.281 -2.236 . . . . 0.75 112.91 -175.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 35.2 mm -52.85 -44.01 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 117.592 -1.194 . . . . 0.73 112.676 171.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -43.39 -50.96 6.72 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.427 2.691 . . . . 1.62 111.501 162.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -66.35 -36.89 84.02 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 115.999 1.851 . . . . 2.13 115.999 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.24 -45.93 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-O 125.901 2.762 . . . . 0.62 113.779 177.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.2 mtmt -53.24 -31.25 42.5 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.395 -2.066 . . . . 1.22 115.445 166.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.88 -20.64 60.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 120.015 -0.674 . . . . 0.51 112.366 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -70.37 -38.29 74.71 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.98 -2.325 . . . . 1.44 114.428 173.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.6 mt -68.98 -31.95 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 127.085 2.154 . . . . 1.32 111.977 169.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -65.89 -52.85 46.54 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 115.654 -4.404 . . . . 1.7 110.102 174.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -56.77 -47.68 79.56 Favored 'General case' 0 N--CA 1.431 -1.391 1 O-C-N 114.511 -5.118 . . . . 1.55 108.767 170.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -65.99 -63.32 1.11 Allowed 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 123.315 2.779 . . . . 2.62 117.244 -176.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -93.46 -43.61 8.65 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.666 -1.896 . . . . 1.48 111.631 -174.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.05 81.06 1.5 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 125.899 2.944 . . . . 1.12 106.357 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.7 mt -155.78 126.44 3.47 Favored Pre-proline 0 N--CA 1.43 -1.472 1 N-CA-C 99.03 -4.433 . . . . 1.55 99.03 -170.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -70.0 148.7 64.09 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 CA-C-N 122.725 2.009 . . . . 1.02 112.247 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.335 36.2 Cg_endo -67.64 -20.87 46.37 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 CA-C-N 125.994 3.177 . . . . 1.25 115.697 -175.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -63.79 -31.35 72.5 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 129.832 3.253 . . . . 2.25 113.733 175.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -89.06 -16.99 30.23 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 119.532 -1.98 . . . . 2.02 106.934 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -88.37 124.64 34.13 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.117 -4.739 . . . . 0.69 111.621 -176.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -116.72 133.74 55.65 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.537 -0.912 . . . . 2.78 108.537 171.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.4 mt -112.06 125.34 53.99 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 126.23 2.919 . . . . 1.17 108.861 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.6 mt -111.1 145.61 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 127.485 2.314 . . . . 1.38 104.778 176.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -150.71 135.62 17.5 Favored 'General case' 0 N--CA 1.43 -1.448 1 N-CA-C 99.878 -4.119 . . . . 1.5 99.878 178.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.24 47.6 21.97 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.893 2.758 . . . . 1.21 114.02 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.74 -2.34 54.79 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 127.633 2.54 . . . . 1.3 116.017 175.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm -123.75 143.82 50.06 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.524 -2.163 . . . . 2.55 114.249 -174.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -66.37 127.18 31.24 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 111.411 -2.631 . . . . 2.48 114.906 171.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 mt -92.27 119.89 32.3 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 110.258 -3.156 . . . . 0.9 108.389 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -77.38 151.12 34.98 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 117.127 -1.415 . . . . 1.94 113.375 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.432 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 7.1 m-20 -72.35 -53.48 12.23 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.932 2.197 . . . . 1.56 116.932 -169.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.73 29.33 0.62 Allowed Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 120.266 2.866 . . . . 0.97 120.266 169.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -118.17 174.98 5.9 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 120.213 2.007 . . . . 2.49 108.327 170.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.4 p -104.08 179.19 4.34 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 126.099 2.856 . . . . 0.76 111.624 175.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.8 mt -71.4 -33.89 69.87 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 116.464 -3.898 . . . . 1.05 113.213 171.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -57.25 -44.83 84.21 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 125.269 2.461 . . . . 1.19 110.159 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -54.95 -33.52 62.4 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.332 -2.73 . . . . 1.9 117.218 176.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -101.05 -2.41 31.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.165 -1.584 . . . . 0.89 109.148 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.257 6.6 m120 64.39 55.17 1.43 Allowed 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 116.825 2.157 . . . . 1.84 116.825 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.5 mt -100.16 132.27 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 110.568 -3.014 . . . . 0.82 107.5 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -115.65 -164.16 0.94 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 123.469 0.707 . . . . 2.16 111.621 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -67.6 153.36 43.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.952 2.501 . . . . 2.12 108.531 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 54.47 26.96 7.67 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.478 2.711 . . . . 1.71 117.089 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.252 47.2 m -94.08 144.85 25.12 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.358 -1.464 . . . . 1.04 109.971 -173.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.4 m -102.41 103.53 13.93 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 126.549 1.94 . . . . 0.79 111.661 -171.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 mt -84.22 160.52 20.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.322 1.849 . . . . 1.4 111.758 176.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -123.43 123.96 41.83 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.529 -2.607 . . . . 1.51 104.114 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.404 HD23 HG22 ' A' ' 7' ' ' THR . 23.1 tp -95.63 120.93 36.74 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.295 2.638 . . . . 1.14 109.318 176.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.296 14.1 m -116.94 163.13 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 127.899 2.48 . . . . 1.23 111.425 168.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.3 mt -115.81 134.29 55.15 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 117.48 -1.688 . . . . 2.78 111.914 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -90.34 100.48 13.31 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-O 126.005 2.812 . . . . 3.75 116.593 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.7 mt -117.29 170.97 8.28 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 123.957 1.837 . . . . 3.14 110.343 166.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -85.47 158.67 20.13 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 113.653 -1.612 . . . . 6.8 111.126 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.58 47.96 6.52 Favored Glycine 0 N--CA 1.43 -1.745 0 CA-C-O 116.815 -2.103 . . . . 3.57 116.892 -166.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.767 0 CA-C-N 121.617 2.708 . . . . 3.87 106.502 -177.404 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 tmm? . . . . . 0 CA--C 1.491 -1.299 0 CA-C-O 116.791 -1.576 . . . . 1.1 114.134 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -91.64 115.38 28.0 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.827 2.558 . . . . 1.87 113.149 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.9 pt -104.88 152.57 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 124.376 2.036 . . . . 0.72 113.015 165.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -111.46 113.74 26.39 Favored 'General case' 0 N--CA 1.429 -1.49 1 O-C-N 114.825 -4.922 . . . . 1.4 108.697 -174.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.7 t -98.13 106.5 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-O 124.082 1.896 . . . . 0.58 106.067 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -94.62 121.3 36.04 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.791 -2.443 . . . . 2.09 112.779 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 p -89.24 163.82 15.22 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.543 -1.348 . . . . 0.99 108.203 174.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.9 tp -44.8 -56.88 4.11 Favored 'General case' 0 N--CA 1.43 -1.433 1 C-N-CA 133.229 4.611 . . . . 2.53 110.842 174.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.7 p -72.59 -19.73 61.42 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 113.061 -1.881 . . . . 2.08 115.275 -174.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.4 -14.86 4.22 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 117.293 -1.837 . . . . 1.31 116.689 166.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -75.04 133.21 41.67 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 120.343 2.072 . . . . 1.4 108.748 -168.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -105.15 118.89 37.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.028 -0.73 . . . . 0.78 109.028 172.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.12 112.31 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-O 126.112 2.863 . . . . 1.55 105.226 -178.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.7 m -88.72 131.52 34.99 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.186 -2.821 . . . . 1.08 106.862 -176.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.4 mt -135.32 131.21 36.18 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 124.642 1.213 . . . . 1.55 109.788 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -88.48 94.13 9.77 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.007 -2.308 . . . . 1.95 112.481 176.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.284 30.9 m -110.79 178.35 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 105.493 -2.04 . . . . 0.96 105.493 -177.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.41 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 22.7 mm-40 -122.34 155.5 61.88 Favored Pre-proline 0 N--CA 1.431 -1.412 0 O-C-N 119.532 -1.98 . . . . 2.35 109.786 161.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 94.3 Cg_endo -72.32 -23.09 21.09 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 C-N-CA 124.126 3.217 . . . . 0.95 112.975 -166.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.1 m -74.32 -11.21 60.2 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 116.17 1.915 . . . . 1.45 116.17 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -81.73 159.48 23.87 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 119.359 3.096 . . . . 1.69 119.359 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.257 7.3 p -78.07 147.71 34.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 119.067 2.988 . . . . 0.75 119.067 -177.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.1 mm -53.68 -38.36 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 123.86 3.027 . . . . 0.73 115.849 173.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -45.85 -38.12 6.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.86 2.911 . . . . 1.62 118.86 162.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -85.4 -23.7 27.84 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.86 -1.775 . . . . 2.13 113.719 175.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.94 -48.01 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 118.583 -2.573 . . . . 0.62 109.581 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -47.7 -37.4 13.01 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.761 3.245 . . . . 1.22 119.761 174.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.08 -33.12 71.5 Favored 'General case' 0 N--CA 1.43 -1.43 2 C-N-CA 133.53 4.732 . . . . 0.51 110.731 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -62.28 -26.42 68.4 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.133 3.012 . . . . 1.44 119.133 173.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.7 mt -82.67 -16.41 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 126.541 2.401 . . . . 1.32 114.292 175.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -82.17 -49.53 10.03 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.793 -1.929 . . . . 1.7 105.793 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -48.86 -61.28 2.13 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.874 2.47 . . . . 1.55 111.305 167.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -76.88 -62.57 1.6 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.968 -1.708 . . . . 2.62 112.959 -167.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -98.5 -42.77 7.15 Favored 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 115.247 -4.658 . . . . 1.48 110.806 -166.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.34 20.47 2.19 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 121.891 3.516 . . . . 1.12 121.891 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.1 mm -99.82 118.86 61.08 Favored Pre-proline 0 N--CA 1.43 -1.471 0 C-N-CA 126.337 1.855 . . . . 1.55 109.75 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -69.3 157.44 61.27 Favored 'Trans proline' 0 C--N 1.299 -2.064 0 CA-C-N 123.116 2.148 . . . . 1.02 115.795 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -73.15 -16.14 25.36 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 C-N-CA 124.343 3.362 . . . . 1.25 112.717 -173.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -85.87 -34.54 20.97 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.898 2.479 . . . . 2.25 112.409 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -79.44 3.66 17.86 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.332 2.653 . . . . 2.02 111.269 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -122.92 147.72 46.27 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 120.799 3.629 . . . . 0.69 120.799 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -125.19 129.21 49.65 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 124.011 3.096 . . . . 2.78 103.613 176.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.4 mt -105.92 132.91 51.45 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.128 -4.732 . . . . 1.17 109.274 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.4 mt -119.7 135.36 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 106.366 -1.716 . . . . 1.38 106.366 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -124.31 131.95 53.54 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.844 2.458 . . . . 1.5 104.434 169.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.16 -57.59 0.52 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.889 2.876 . . . . 1.21 113.799 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -169.09 -32.45 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.749 0 CA-C-O 125.67 2.816 . . . . 1.3 115.439 -173.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -95.79 162.78 13.45 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.645 -2.679 . . . . 2.55 114.078 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -90.3 145.45 24.97 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 121.514 3.894 . . . . 2.48 121.514 173.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.6 mt -92.33 128.28 38.12 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 124.505 2.098 . . . . 0.9 112.605 -170.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -75.96 134.93 40.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 130.257 3.423 . . . . 1.94 110.144 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.55 -49.93 74.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.417 2.687 . . . . 1.56 115.206 -172.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.31 34.59 3.93 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 119.681 2.633 . . . . 0.97 119.681 173.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -103.83 166.13 10.61 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 114.549 -2.861 . . . . 2.49 106.789 167.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.8 p -89.97 159.82 16.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.974 -2.953 . . . . 0.76 110.127 169.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.299 81.0 mt -60.16 -33.27 71.95 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.688 1.736 . . . . 1.05 115.688 168.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.6 t -76.76 -20.78 56.09 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.457 -3.277 . . . . 1.19 115.804 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.88 -36.14 82.94 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.486 1.115 . . . . 1.9 109.326 169.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -82.54 3.21 29.45 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.553 -1.967 . . . . 0.89 112.733 172.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.312 21.7 m120 51.92 34.75 14.2 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.594 -2.566 . . . . 1.84 115.822 -176.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.4 mt -68.81 105.52 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 120.581 -1.324 . . . . 0.82 109.009 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -97.23 167.25 11.15 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 128.437 2.695 . . . . 2.16 107.953 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -62.42 145.77 53.18 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 118.215 -2.803 . . . . 2.12 118.059 175.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.33 29.3 mt-10 71.37 28.7 2.89 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 113.156 -1.838 . . . . 1.71 112.149 -172.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 m -84.42 141.44 30.83 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 121.032 1.742 . . . . 1.04 115.242 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.3 m -94.87 109.03 21.06 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.967 -1.494 . . . . 0.79 106.967 -171.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.7 mt -95.04 130.59 41.66 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.979 2.172 . . . . 1.4 106.628 171.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.272 32.1 m80 -100.33 114.1 27.34 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.032 -1.47 . . . . 1.51 107.032 -175.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -87.71 110.12 20.2 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.017 1.727 . . . . 1.14 112.266 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.7 t -98.62 133.92 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 1 N-CA-C 99.212 -4.366 . . . . 1.23 99.212 169.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.265 13.5 tp -94.04 127.35 39.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.25 -2.156 . . . . 2.78 107.983 177.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -95.77 124.25 39.7 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.292 -2.13 . . . . 3.75 111.023 -173.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.2 tp -99.36 -68.55 0.8 Allowed 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 122.843 1.306 . . . . 3.14 109.68 170.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 74' ' ' ARG . 29.0 ttm105 -103.69 -82.13 0.5 Allowed 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.838 -2.414 . . . . 6.8 109.829 175.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.29 38.33 0.23 Allowed Glycine 0 N--CA 1.43 -1.735 1 O-C-N 114.675 -5.016 . . . . 3.57 110.696 -166.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.764 0 N-CA-C 107.424 -2.27 . . . . 3.87 107.424 -175.414 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 CA--C 1.491 -1.299 0 CA-C-O 118.176 -0.916 . . . . 1.1 111.647 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -107.03 137.81 44.39 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.127 3.371 . . . . 1.87 106.103 -178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 pt -131.2 167.45 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.604 -3.185 . . . . 0.72 104.863 168.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.252 63.4 m-85 -121.88 125.18 45.84 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.469 1.108 . . . . 1.4 108.658 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.79 112.07 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 112.693 0.627 . . . . 0.58 112.693 172.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.4 ttmm -102.42 142.77 33.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.463 -1.31 . . . . 2.09 107.463 -172.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.1 p -93.06 167.21 11.94 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 127.392 3.472 . . . . 0.99 112.975 165.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.257 21.0 tp -71.89 -25.58 61.98 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.242 -3.411 . . . . 2.53 114.382 175.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.8 p -88.24 -36.7 16.6 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.344 -2.097 . . . . 2.08 112.631 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.66 8.95 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 116.768 -2.634 . . . . 1.31 118.933 166.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -104.48 133.28 49.61 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 122.721 3.26 . . . . 1.4 109.923 -171.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.1 m -117.22 112.74 21.23 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 118.514 -1.275 . . . . 0.78 112.635 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.31 19.7 pt -97.02 136.0 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 124.178 1.942 . . . . 1.55 111.882 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.1 m -97.65 126.75 43.15 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 116.931 -3.606 . . . . 1.08 108.415 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.3 mt -131.41 141.48 49.85 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 127.4 3.476 . . . . 1.55 109.632 -173.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -97.54 118.67 34.56 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 113.562 -5.711 . . . . 1.95 109.59 171.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.97 174.99 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 119.859 -1.775 . . . . 0.96 109.138 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -116.02 147.96 40.37 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-O 116.342 -1.789 . . . . 2.35 107.084 157.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.03 -18.06 35.98 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-O 113.741 -2.691 . . . . 0.95 109.557 -174.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.2 p -71.0 -9.47 58.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 122.892 2.587 . . . . 1.45 115.057 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -80.02 166.66 21.33 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 114.629 -5.044 . . . . 1.69 110.37 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.5 p -93.82 152.0 19.21 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 121.903 0.858 . . . . 0.75 110.699 -177.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.439 HD13 ' HB3' ' A' ' 50' ' ' LEU . 4.1 mt -59.65 -36.39 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 115.913 1.82 . . . . 0.73 115.913 173.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -44.18 -56.32 4.17 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 126.304 1.842 . . . . 1.62 115.357 162.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -61.54 -39.16 90.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 112.87 -3.443 . . . . 2.13 111.683 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.3 t -63.12 -38.63 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 122.247 2.294 . . . . 0.62 108.05 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt -71.45 -26.77 62.87 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.81 2.893 . . . . 1.22 118.81 171.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.98 -24.5 65.15 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.897 -2.377 . . . . 0.51 111.107 168.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -70.23 -37.33 74.97 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.119 -2.238 . . . . 1.44 112.561 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.3 mt -58.55 -35.41 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 128.787 2.835 . . . . 1.32 109.903 167.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -65.24 -42.72 93.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.175 -2.345 . . . . 1.7 113.862 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -63.71 -32.07 73.44 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 126.515 2.384 . . . . 1.55 114.82 165.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -88.41 -65.84 0.98 Allowed 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.115 -2.24 . . . . 2.62 110.224 -167.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -99.42 -24.39 14.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.246 1.818 . . . . 1.48 110.863 -169.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.43 43.67 2.91 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-O 125.298 2.61 . . . . 1.12 111.066 170.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.3 mt -120.74 129.49 25.29 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 120.288 -1.713 . . . . 1.55 106.542 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 78.4 Cg_exo -71.61 150.69 57.44 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-N 124.82 2.757 . . . . 1.02 109.725 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -72.89 -12.29 26.13 Favored 'Trans proline' 0 C--N 1.298 -2.08 0 C-N-CA 122.511 2.141 . . . . 1.25 116.948 -173.263 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -81.12 -32.08 33.97 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 114.375 -5.203 . . . . 2.25 105.579 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -79.66 6.03 11.72 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 114.445 1.276 . . . . 2.02 114.445 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -149.51 147.42 28.18 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.804 -2.435 . . . . 0.69 114.253 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.277 60.2 mtt180 -129.78 162.12 29.16 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.051 -2.906 . . . . 2.78 108.563 171.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.9 mt -120.32 148.75 43.33 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 119.28 -2.138 . . . . 1.17 109.633 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.7 mt -127.61 129.04 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 124.87 2.271 . . . . 1.38 109.006 -172.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -118.08 125.72 50.86 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 104.785 -2.302 . . . . 1.5 104.785 170.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.268 . . 79.84 -54.26 0.39 Allowed 'General case' 0 N--CA 1.428 -1.535 0 O-C-N 118.446 -2.659 . . . . 1.21 111.876 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.72 -24.32 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.675 0 O-C-N 118.119 -2.863 . . . . 1.3 115.099 -170.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -97.35 141.35 30.55 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.337 -1.684 . . . . 2.55 107.524 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -76.77 120.3 21.73 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.464 3.106 . . . . 2.48 111.649 177.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.439 ' HB3' HD13 ' A' ' 23' ' ' ILE . 43.2 mt -80.85 144.99 31.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.095 -1.628 . . . . 0.9 109.656 -166.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -74.87 121.5 21.95 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.716 2.406 . . . . 1.94 112.117 175.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -65.05 -29.36 70.25 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 113.382 -1.735 . . . . 1.56 112.463 -171.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.16 33.15 4.6 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 120.79 3.076 . . . . 0.97 120.79 168.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.9 mtt-85 -132.67 176.07 8.77 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 101.037 -3.69 . . . . 2.49 101.037 166.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.6 p -108.63 175.33 5.51 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.299 1.439 . . . . 0.76 109.962 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.6 mt -68.3 -23.7 64.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.539 1.681 . . . . 1.05 115.539 173.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 t -65.25 -40.09 93.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.678 2.791 . . . . 1.19 111.486 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -70.62 -21.89 62.59 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.262 1.578 . . . . 1.9 115.262 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -96.39 -3.24 43.99 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.81 -3.056 . . . . 0.89 108.582 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 58.84 40.88 22.3 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 127.575 2.35 . . . . 1.84 112.987 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.9 mt -80.53 127.08 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 1 O-C-N 131.022 5.201 . . . . 0.82 104.949 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -93.71 -174.85 3.58 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 128.079 2.552 . . . . 2.16 111.243 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.7 pttp -72.35 151.27 42.8 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.432 -1.258 . . . . 2.12 111.536 174.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.375 11.7 mt-10 56.65 42.23 27.28 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.443 2.757 . . . . 1.71 118.443 176.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.5 m -100.65 143.53 30.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.593 -2.743 . . . . 1.04 103.593 -175.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -103.04 110.4 22.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 125.183 2.421 . . . . 0.79 108.202 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -96.04 115.33 27.27 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.074 3.35 . . . . 1.4 112.538 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -86.71 121.37 29.12 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.445 -2.035 . . . . 1.51 115.977 -171.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.2 tt -89.39 138.34 31.53 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.355 -2.716 . . . . 1.14 108.764 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -125.45 162.75 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 O-C-N 128.408 3.568 . . . . 1.23 111.702 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.6 mt -100.09 152.51 20.15 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 124.031 1.872 . . . . 2.78 109.45 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.9 ttt-85 -137.1 140.91 42.26 Favored 'General case' 0 N--CA 1.43 -1.473 1 CA-C-O 128.864 4.173 . . . . 3.75 117.382 -177.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 73' ' ' LEU . 31.7 mt -99.35 157.01 16.7 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.654 -3.779 . . . . 3.14 107.215 175.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -77.26 94.77 4.2 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.715 2.806 . . . . 6.8 111.652 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.68 -149.95 19.02 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 107.519 -2.232 . . . . 3.57 107.519 -170.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.782 0 O-C-N 118.43 -2.806 . . . . 3.87 110.654 -177.275 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ptt? . . . . . 0 CA--C 1.489 -1.373 0 CA-C-O 123.198 1.475 . . . . 1.1 109.361 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -118.03 139.42 51.22 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.618 -3.176 . . . . 1.87 108.621 -176.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.1 pt -125.13 144.6 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 CA-C-O 115.826 -2.035 . . . . 0.72 106.251 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -102.31 101.02 11.24 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 126.419 2.324 . . . . 1.4 108.705 -174.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 21.7 t -82.2 110.99 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 116.699 -3.751 . . . . 0.58 106.779 175.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -98.58 136.38 38.76 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 109.247 -0.649 . . . . 2.09 109.247 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 p -90.81 -155.42 0.39 Allowed 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.704 1.602 . . . . 0.99 108.15 175.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.4 mt -103.47 -60.78 1.51 Allowed 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 113.739 -3.029 . . . . 2.53 110.428 175.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 p -51.37 -41.68 60.82 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 133.894 6.996 . . . . 2.08 116.672 -174.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.46 -19.77 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 126.262 3.146 . . . . 1.31 120.398 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -71.67 151.48 43.64 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.169 -2.371 . . . . 1.4 110.805 -174.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.4 m -130.32 110.23 11.36 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.147 1.779 . . . . 0.78 110.635 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.47 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 4.8 mm -85.92 101.75 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 115.539 -2.172 . . . . 1.55 105.752 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.8 m -78.42 89.63 4.41 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 125.489 1.743 . . . . 1.08 111.119 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.8 mt -85.3 124.15 31.6 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.592 -3.193 . . . . 1.55 113.207 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -71.48 114.87 10.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 125.493 1.746 . . . . 1.95 112.431 161.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 m -134.18 165.43 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 120.253 -1.529 . . . . 0.96 108.851 -176.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -104.91 156.41 36.06 Favored Pre-proline 0 N--CA 1.429 -1.488 0 CA-C-O 116.401 -1.762 . . . . 2.35 106.879 167.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -79.5 -11.9 14.13 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 CA-C-N 126.047 3.195 . . . . 0.95 106.22 -170.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.9 p -73.35 -21.8 60.45 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.898 2.555 . . . . 1.45 117.898 173.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -63.54 147.18 52.1 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 125.441 1.713 . . . . 1.69 112.159 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.8 p -83.6 168.74 16.08 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.662 -1.274 . . . . 0.75 110.51 170.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.1 mm -68.77 -30.06 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 128.684 2.794 . . . . 0.73 108.91 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -48.8 -47.78 41.89 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.301 1.84 . . . . 1.62 113.73 166.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -63.87 -41.49 97.75 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.959 2.504 . . . . 2.13 111.516 173.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.9 t -67.75 -45.0 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 1 O-C-N 116.231 -4.043 . . . . 0.62 112.807 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -68.66 -22.32 64.39 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.274 1.511 . . . . 1.22 114.034 175.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.32 83.42 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.35 -3.969 . . . . 0.51 117.356 170.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -64.01 -29.49 70.64 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.285 -2.134 . . . . 1.44 113.991 165.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.456 HD13 HD13 ' A' ' 69' ' ' LEU 0.3 76.7 mt -72.89 -40.08 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 117.042 -3.536 . . . . 1.32 111.108 176.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -64.47 -46.86 81.26 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.819 2.048 . . . . 1.7 111.474 173.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.07 -54.38 25.38 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.434 -2.666 . . . . 1.55 116.974 167.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -73.61 -68.58 0.49 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.529 2.048 . . . . 2.62 116.529 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -84.19 -23.23 30.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.362 -1.29 . . . . 1.48 113.557 -167.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.25 24.56 14.21 Favored Glycine 0 N--CA 1.429 -1.769 1 CA-C-O 128.144 4.191 . . . . 1.12 114.301 170.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.7 mt -105.37 133.71 20.03 Favored Pre-proline 0 N--CA 1.429 -1.482 0 O-C-N 116.758 -3.789 . . . . 1.55 106.622 -170.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -65.55 146.6 85.14 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 CA-C-O 114.733 -2.278 . . . . 1.02 115.304 172.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -81.16 -9.49 12.76 Favored 'Trans proline' 0 N--CA 1.433 -2.058 0 CA-C-N 125.928 3.153 . . . . 1.25 108.462 -171.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -71.19 -23.79 62.1 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.482 -2.011 . . . . 2.25 111.344 168.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -92.15 -22.53 19.81 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 120.351 1.432 . . . . 2.02 107.848 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.307 74.5 mt-30 -79.31 152.66 30.37 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 125.324 2.488 . . . . 0.69 110.449 -171.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -125.45 138.29 54.0 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.063 -4.148 . . . . 2.78 108.756 158.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.9 mt -116.47 111.56 20.17 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.424 -3.298 . . . . 1.17 104.405 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.6 mm -98.25 141.73 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 103.824 -2.658 . . . . 1.38 103.824 174.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -115.6 -109.44 0.36 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 114.877 -2.487 . . . . 1.5 109.372 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.99 -32.15 16.04 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 124.418 3.281 . . . . 1.21 112.912 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.81 -41.23 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 127.756 2.598 . . . . 1.3 114.086 -175.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -80.69 136.02 36.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.706 2.669 . . . . 2.55 110.56 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -89.95 95.53 10.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.704 2.802 . . . . 2.48 108.208 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.0 mt -57.01 140.93 47.49 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.988 -2.32 . . . . 0.9 115.32 -164.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.257 42.4 mt-10 -83.14 150.19 26.41 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.456 -1.402 . . . . 1.94 114.721 173.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -65.71 -52.3 52.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.235 2.309 . . . . 1.56 117.235 -169.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.15 56.97 1.76 Allowed Glycine 0 N--CA 1.43 -1.758 0 CA-C-N 108.533 -3.939 . . . . 0.97 113.6 173.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 54' ' ' ARG . 49.0 mmt-85 -132.45 168.54 18.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 129.162 3.507 . . . . 2.49 105.34 163.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -107.18 164.83 11.83 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.439 -1.71 . . . . 0.76 113.487 173.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.8 mt -66.53 -24.68 66.41 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.504 -1.373 . . . . 1.05 113.609 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.3 t -64.59 -39.79 94.36 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 128.749 2.82 . . . . 1.19 111.063 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -66.55 -31.39 72.08 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.082 -2.886 . . . . 1.9 116.211 173.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -90.5 2.65 55.52 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 115.439 1.644 . . . . 0.89 115.439 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 69.35 27.15 5.12 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 117.452 -1.261 . . . . 1.84 109.872 178.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.4 mt -79.65 128.02 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 126.149 2.88 . . . . 0.82 110.848 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -130.82 171.51 13.06 Favored 'General case' 0 N--CA 1.429 -1.494 1 O-C-N 115.043 -4.786 . . . . 2.16 108.469 -167.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -54.16 130.74 39.43 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.818 2.723 . . . . 2.12 115.641 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 65.94 34.9 6.81 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 130.032 3.333 . . . . 1.71 112.116 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.6 t -90.91 141.48 28.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.965 1.364 . . . . 1.04 112.217 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.0 m -83.99 111.85 19.64 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.989 1.716 . . . . 0.79 114.464 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -108.45 166.44 10.77 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.715 2.006 . . . . 1.4 112.058 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -123.21 132.16 53.94 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.328 -4.608 . . . . 1.51 110.879 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.456 HD13 HD13 ' A' ' 30' ' ' ILE . 22.0 tp -98.89 108.79 21.57 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.65 1.214 . . . . 1.14 108.484 174.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.5 t -105.88 143.12 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 128.926 2.891 . . . . 1.23 108.015 -178.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.8 mt -123.14 147.37 46.87 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 125.986 3.993 . . . . 2.78 108.848 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.7 mtp180 -95.74 -169.15 1.89 Allowed 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 126.689 3.138 . . . . 3.75 103.8 173.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.2 mt -106.13 -56.09 2.23 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 111.315 -2.675 . . . . 3.14 110.57 168.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.61 172.38 13.1 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 114.153 -2.832 . . . . 6.8 108.02 171.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.86 -169.3 42.54 Favored Glycine 0 N--CA 1.43 -1.747 0 CA-C-N 121.376 1.898 . . . . 3.57 113.318 -171.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.808 0 CA-C-O 115.495 -2.836 . . . . 3.87 107.219 -177.681 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ptt? . . . . . 0 CA--C 1.491 -1.314 0 CA-C-O 122.655 1.217 . . . . 1.1 112.804 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -96.0 139.97 31.42 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 107.45 -1.315 . . . . 1.87 107.45 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.256 16.3 pt -132.08 169.49 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 107.312 -1.366 . . . . 0.72 107.312 172.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -134.07 142.61 47.62 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.132 0.967 . . . . 1.4 113.02 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.57 134.13 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 O-C-N 118.837 -2.415 . . . . 0.58 110.416 168.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -96.79 149.11 22.21 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 117.419 -1.276 . . . . 2.09 109.63 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.321 4.8 p -103.85 -166.35 1.25 Allowed 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.501 2.375 . . . . 0.99 114.928 176.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.2 tp -76.18 -57.93 3.58 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 114.839 1.422 . . . . 2.53 114.839 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.2 p -70.5 -32.8 70.43 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 116.871 2.175 . . . . 2.08 116.871 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.07 58.32 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 118.757 -1.687 . . . . 1.31 115.597 172.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -118.18 138.2 52.47 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 121.109 2.455 . . . . 1.4 107.775 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.5 m -100.6 117.33 34.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 104.889 -2.263 . . . . 0.78 104.889 174.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.6 mt -96.47 116.54 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 106.219 -1.771 . . . . 1.55 106.219 174.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.406 3.6 m -83.08 121.53 27.16 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 126.039 1.736 . . . . 1.08 113.551 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.679 HD22 ' HB3' ' A' ' 29' ' ' LYS . 83.5 mt -123.03 143.16 50.13 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.635 -1.915 . . . . 1.55 112.201 -175.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -104.07 141.99 35.25 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 104.49 -2.411 . . . . 1.95 104.49 170.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.3 m -161.07 161.9 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 106.966 -1.494 . . . . 0.96 106.966 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 20' ' ' SER . 13.2 pt-20 -105.52 162.44 19.71 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-O 115.828 -2.034 . . . . 2.35 106.868 157.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.414 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 97.5 Cg_endo -74.33 -1.79 11.47 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 CA-C-N 124.592 2.676 . . . . 0.95 113.714 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.456 ' H ' ' HG3' ' A' ' 18' ' ' GLU . 67.1 m -90.72 -2.51 57.81 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 115.359 1.615 . . . . 1.45 115.359 171.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -66.73 131.07 45.18 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.146 2.403 . . . . 1.69 107.121 168.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 17.6 p -68.47 175.16 3.56 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 112.954 -1.93 . . . . 0.75 112.205 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.5 mm -74.66 -35.48 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 116.528 -3.858 . . . . 0.73 108.018 176.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -54.3 -46.66 72.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.213 -3.43 . . . . 1.62 115.351 165.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -56.86 -37.16 70.93 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 125.577 2.608 . . . . 2.13 112.79 171.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.56 -39.8 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 116.463 -3.898 . . . . 0.62 114.34 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -65.88 -33.3 75.52 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 117.621 2.452 . . . . 1.22 117.621 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.68 -23.75 61.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 111.598 -2.546 . . . . 0.51 110.691 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.679 ' HB3' HD22 ' A' ' 15' ' ' LEU . 42.2 mttm -75.72 -29.64 59.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 122.579 2.445 . . . . 1.44 113.564 168.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.6 mt -66.44 -42.29 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.908 -1.745 . . . . 1.32 110.195 171.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -58.54 -38.36 77.61 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.314 -3.366 . . . . 1.7 118.216 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -59.96 -32.83 71.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.989 2.218 . . . . 1.55 116.989 172.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.327 53.8 mmtt -89.15 -48.74 7.19 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.924 -3.61 . . . . 2.62 110.009 -174.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -112.39 -19.16 12.27 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 123.096 1.426 . . . . 1.48 114.164 -165.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.33 9.42 79.55 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 118.984 -2.323 . . . . 1.12 113.907 167.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.5 mt -81.58 133.26 53.04 Favored Pre-proline 0 N--CA 1.43 -1.457 0 O-C-N 120.951 -1.323 . . . . 1.55 112.237 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -69.17 148.78 69.63 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 CA-C-N 122.517 1.935 . . . . 1.02 113.681 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -71.14 -25.03 22.87 Favored 'Trans proline' 0 C--N 1.301 -1.953 1 C-N-CA 125.893 4.395 . . . . 1.25 115.211 -170.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -70.65 -27.13 63.81 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 128.348 2.659 . . . . 2.25 113.881 175.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -91.77 -1.94 57.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.432 2.293 . . . . 2.02 110.472 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -100.86 135.19 42.69 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.658 -1.901 . . . . 0.69 109.813 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 62.4 mtm180 -117.87 114.28 23.0 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.585 2.448 . . . . 2.78 110.191 173.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.516 ' HB3' HD12 ' A' ' 50' ' ' LEU . 76.6 mt -100.32 129.17 46.28 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 120.762 1.619 . . . . 1.17 110.515 -176.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.8 mm -110.77 128.17 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 125.638 1.575 . . . . 1.38 108.639 177.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -109.12 102.72 11.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.145 1.45 . . . . 1.5 107.155 170.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.312 . . 65.41 -63.62 0.2 Allowed 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.064 -2.897 . . . . 1.21 118.084 -173.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.429 ' H ' ' H ' ' A' ' 48' ' ' LYS . . . -162.6 -5.85 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.709 0 O-C-N 118.194 -2.816 . . . . 1.3 111.914 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.429 ' H ' ' H ' ' A' ' 47' ' ' GLY . 37.7 mtmt -95.38 143.08 27.03 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 125.843 1.555 . . . . 2.55 107.609 173.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -93.59 143.55 26.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.944 2.783 . . . . 2.48 111.37 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 43' ' ' LEU . 88.0 mt -94.76 132.05 39.94 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 113.857 -5.527 . . . . 0.9 108.217 -167.27 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -83.81 139.24 32.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.395 1.478 . . . . 1.94 109.292 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.287 8.5 m-20 -62.95 -50.11 72.09 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.499 -3.251 . . . . 1.56 119.701 -171.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.23 9.44 63.92 Favored Glycine 0 N--CA 1.43 -1.704 1 N-CA-C 123.183 4.033 . . . . 0.97 123.183 174.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -78.39 161.23 27.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 113.621 0.971 . . . . 2.49 113.621 168.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 81.1 p -89.39 164.9 14.67 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 118.955 2.946 . . . . 0.76 118.955 164.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 89.5 mt -64.32 -36.56 84.51 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.599 -3.188 . . . . 1.05 116.86 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.2 p -58.41 -29.0 65.74 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 128.1 2.56 . . . . 1.19 113.362 166.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -59.6 -47.5 85.35 Favored 'General case' 0 N--CA 1.43 -1.431 1 CA-C-N 127.312 4.596 . . . . 1.9 110.892 173.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -83.36 0.98 43.56 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.123 3.369 . . . . 0.89 114.056 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.3 m120 58.32 45.85 16.4 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.996 2.221 . . . . 1.84 116.996 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.4 mt -87.76 118.04 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 104.765 -2.309 . . . . 0.82 104.765 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -85.23 -163.21 0.81 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.737 -2.477 . . . . 2.16 109.029 -174.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 pttt -74.43 147.02 42.39 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.085 -2.259 . . . . 2.12 110.217 174.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 62.73 48.74 4.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.172 0.986 . . . . 1.71 109.622 170.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.1 m -108.59 141.29 40.73 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.853 -1.779 . . . . 1.04 110.203 -169.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.8 m -103.81 108.68 20.1 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 125.568 2.604 . . . . 0.79 108.656 -172.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mp -96.52 163.88 12.85 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 112.425 -2.17 . . . . 1.4 107.875 171.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -118.05 140.28 49.98 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.197 1.799 . . . . 1.51 111.937 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.7 tp -108.97 120.59 42.99 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.399 -3.313 . . . . 1.14 109.667 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 80.4 t -116.93 150.31 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 105.418 -2.067 . . . . 1.23 105.418 174.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.6 155.88 17.82 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.09 -3.506 . . . . 2.78 113.211 -177.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -136.81 127.97 27.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 116.903 -1.523 . . . . 3.75 112.031 -177.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 tp -98.64 -65.2 0.98 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.75 2.02 . . . . 3.14 111.314 169.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -146.63 -104.22 0.1 Allowed 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.521 1.153 . . . . 6.8 111.811 170.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.58 64.41 1.55 Allowed Glycine 0 N--CA 1.429 -1.797 0 O-C-N 118.394 -2.691 . . . . 3.57 116.942 -167.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.727 0 N-CA-C 106.825 -2.51 . . . . 3.87 106.825 176.678 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 ttp . . . . . 0 CA--C 1.49 -1.33 0 N-CA-C 116.563 2.061 . . . . 1.1 116.563 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -92.84 123.74 36.33 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.233 -2.792 . . . . 1.87 108.46 -170.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.335 50.4 pt -116.22 137.66 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.495 1.918 . . . . 0.72 112.73 176.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -104.83 100.05 9.69 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 116.58 2.067 . . . . 1.4 116.58 -176.371 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.3 t -84.53 96.9 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 124.537 2.113 . . . . 0.58 111.89 178.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -95.74 122.75 38.85 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.48 1.61 . . . . 2.09 109.423 -174.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.412 HG22 ' HB3' ' A' ' 69' ' ' LEU 0.29 20.2 p -89.99 167.27 12.92 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.787 2.035 . . . . 0.99 114.19 -176.475 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.8 tp -66.24 -32.19 73.46 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 126.009 2.814 . . . . 2.53 115.455 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.6 p -77.44 -48.24 17.67 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.428 1.891 . . . . 2.08 111.854 -178.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.3 -1.21 0.53 Allowed Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 117.174 1.63 . . . . 1.31 117.174 173.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -78.11 139.66 39.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 119.372 1.586 . . . . 1.4 109.133 -177.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -104.17 112.09 24.95 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.644 -2.535 . . . . 0.78 105.435 169.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -93.06 105.51 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 103.413 -2.81 . . . . 1.55 103.413 178.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -84.74 107.08 16.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.006 2.224 . . . . 1.08 117.006 177.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.2 mt -105.27 136.72 44.27 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 121.122 1.783 . . . . 1.55 107.518 -175.076 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -87.99 90.9 8.57 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 124.154 1.931 . . . . 1.95 108.625 168.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.21 176.27 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 128.571 2.749 . . . . 0.96 109.11 -176.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -117.88 151.37 48.68 Favored Pre-proline 0 N--CA 1.431 -1.413 0 O-C-N 124.917 1.386 . . . . 2.35 108.638 161.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -74.26 -11.96 23.06 Favored 'Trans proline' 0 N--CA 1.434 -2.004 1 O-C-N 112.794 -4.371 . . . . 0.95 115.208 -170.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.4 p -81.98 -15.35 54.04 Favored 'General case' 0 N--CA 1.429 -1.476 1 C-N-CA 132.297 4.239 . . . . 1.45 110.315 174.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -68.62 153.38 43.88 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 120.756 1.616 . . . . 1.69 110.942 172.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 25.2 p -87.6 166.87 14.4 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.353 1.861 . . . . 0.75 108.93 -179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.2 mm -71.61 -36.0 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 124.455 2.074 . . . . 0.73 113.188 175.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -38.82 -42.97 0.88 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.853 -3.03 . . . . 1.62 117.047 159.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -76.94 -38.18 53.86 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.226 -2.796 . . . . 2.13 108.489 179.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.462 HG21 HD21 ' A' ' 56' ' ' LEU . 76.9 t -55.89 -39.09 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 127.354 2.261 . . . . 0.62 114.269 172.355 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 86.3 mttt -81.05 -19.34 44.0 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.612 -2.555 . . . . 1.22 115.88 173.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.07 -38.59 63.88 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 122.819 1.295 . . . . 0.51 109.486 174.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -63.24 -29.29 70.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.633 -2.542 . . . . 1.44 113.864 174.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.3 mt -77.88 -24.34 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 116.661 2.097 . . . . 1.32 116.661 169.156 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -76.42 -30.48 57.46 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.27 -3.394 . . . . 1.7 110.025 173.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -76.5 -43.33 40.02 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.805 1.288 . . . . 1.55 112.129 173.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -77.4 -69.36 0.54 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.347 -2.096 . . . . 2.62 114.506 -173.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -80.46 -51.17 9.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.677 -1.147 . . . . 1.48 113.153 -172.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.09 43.03 1.13 Allowed Glycine 0 N--CA 1.429 -1.796 0 O-C-N 125.508 1.755 . . . . 1.12 111.232 175.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.3 mt -104.3 132.99 20.45 Favored Pre-proline 0 N--CA 1.431 -1.386 0 C-N-CA 125.557 1.543 . . . . 1.55 107.377 -178.16 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -70.85 138.96 35.42 Favored 'Trans proline' 0 N--CA 1.433 -2.067 1 C-N-CA 126.054 4.502 . . . . 1.02 111.54 -178.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.431 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 36.3 Cg_exo -71.52 -19.47 28.33 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 O-C-N 117.924 -1.671 . . . . 1.25 112.434 -169.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -62.4 -35.02 77.9 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 114.83 1.418 . . . . 2.25 114.83 165.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -87.57 -13.93 41.55 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 124.037 0.935 . . . . 2.02 112.628 -179.173 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.329 71.3 mt-30 -84.78 113.01 21.02 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 120.957 1.708 . . . . 0.69 107.701 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -92.34 134.5 34.86 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 116.676 -1.63 . . . . 2.78 106.712 165.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.8 mt -127.79 125.42 39.81 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 102.629 -3.1 . . . . 1.17 102.629 177.138 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -115.13 137.3 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 115.947 -1.978 . . . . 1.38 105.788 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -124.06 107.4 11.25 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.227 2.285 . . . . 1.5 107.628 171.172 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.363 . . 74.55 -77.07 0.06 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.517 2.58 . . . . 1.21 114.922 -173.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.3 -0.67 0.24 Allowed Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 129.917 3.627 . . . . 1.3 115.42 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -111.56 114.01 26.8 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 124.663 1.185 . . . . 2.55 110.565 -179.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -81.13 127.94 33.19 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 124.56 1.144 . . . . 2.48 111.885 176.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.44 HD22 ' CD2' ' A' ' 59' ' ' TYR . 69.7 mt -79.82 120.36 23.97 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 120.338 3.458 . . . . 0.9 120.338 -162.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.288 37.1 mt-10 -78.22 138.63 38.74 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.216 -2.177 . . . . 1.94 113.758 -176.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.66 -45.33 92.36 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 112.616 -2.084 . . . . 1.56 113.072 -171.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.59 25.14 9.88 Favored Glycine 0 N--CA 1.43 -1.713 0 C-N-CA 125.763 1.649 . . . . 0.97 116.601 175.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -112.7 166.36 11.43 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.99 1.852 . . . . 2.49 110.309 165.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 12.2 p -101.28 169.17 9.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.134 -2.854 . . . . 0.76 106.424 176.369 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.462 HD21 HG21 ' A' ' 26' ' ' VAL . 62.6 mt -65.95 -38.19 87.96 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.576 2.608 . . . . 1.05 112.304 172.185 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.0 p -60.34 -41.1 92.89 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.923 -4.236 . . . . 1.19 116.067 -178.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -53.47 -49.7 66.88 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 117.715 2.487 . . . . 1.9 117.715 169.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.44 ' CD2' HD22 ' A' ' 50' ' ' LEU . 59.9 m-85 -67.26 -10.41 50.44 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.659 2.466 . . . . 0.89 117.659 173.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.309 64.8 t30 73.93 47.62 0.15 Allowed 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.573 -2.58 . . . . 1.84 105.167 -177.402 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.6 mt -100.59 119.82 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 102.829 -3.026 . . . . 0.82 102.829 177.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -115.09 -167.8 1.29 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 114.219 -1.355 . . . . 2.16 112.274 -176.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -60.27 138.86 57.87 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.611 2.448 . . . . 2.12 117.611 169.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.432 20.8 mt-10 69.19 22.97 6.54 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.007 2.225 . . . . 1.71 117.007 174.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.4 m -83.16 141.06 32.22 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.209 2.604 . . . . 1.04 113.913 -175.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.4 m -94.65 116.1 28.34 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.3 -3.375 . . . . 0.79 107.464 -174.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -109.68 128.38 55.22 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 104.87 -2.27 . . . . 1.4 104.87 174.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -88.8 121.53 31.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 114.531 -2.652 . . . . 1.51 115.085 -177.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.412 ' HB3' HG22 ' A' ' 7' ' ' THR . 9.8 tp -89.14 120.27 30.38 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 123.827 3.012 . . . . 1.14 114.376 175.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.45 169.23 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 120.651 -1.281 . . . . 1.23 107.852 172.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.3 mt -112.05 159.36 18.54 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.89 -3.007 . . . . 2.78 107.528 177.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -128.9 156.22 44.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.344 -0.844 . . . . 3.75 109.212 175.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.9 mt -86.17 -107.65 0.06 Allowed 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.395 -1.44 . . . . 3.14 108.337 170.305 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -78.97 -55.63 4.99 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 128.046 3.784 . . . . 6.8 110.189 172.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.8 142.67 9.94 Favored Glycine 0 N--CA 1.429 -1.802 1 O-C-N 116.285 -4.009 . . . . 3.57 106.71 -168.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.805 0 N-CA-C 106.585 -2.606 . . . . 3.87 106.585 176.075 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.316 0 N-CA-C 114.325 1.231 . . . . 1.1 114.325 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.267 0.7 OUTLIER -97.39 131.96 43.56 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.023 1.49 . . . . 1.87 115.023 -175.607 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -112.5 145.14 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 117.896 -3.002 . . . . 0.72 110.131 172.114 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -109.87 112.83 25.1 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 103.984 -2.599 . . . . 1.4 103.984 -173.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.52 103.1 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 104.071 -2.566 . . . . 0.58 104.071 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -102.76 131.11 49.83 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 112.58 0.585 . . . . 2.09 112.58 -179.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.4 p -93.16 176.81 6.27 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 128.155 3.409 . . . . 0.99 119.39 -177.157 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.3 tp -67.03 -37.57 84.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 124.92 3.509 . . . . 2.53 112.047 170.206 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.8 p -78.87 6.63 8.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 129.926 3.29 . . . . 2.08 111.313 -171.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.68 5.25 57.76 Favored Glycine 0 N--CA 1.43 -1.716 0 CA-C-N 125.001 3.546 . . . . 1.31 113.671 169.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -93.99 133.66 37.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.317 2.247 . . . . 1.4 115.719 179.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.5 m -108.39 117.18 33.48 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.277 -1.009 . . . . 0.78 108.277 171.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 mt -105.02 113.7 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 101.238 -3.615 . . . . 1.55 101.238 -179.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.4 m -101.19 117.33 34.79 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 120.819 1.645 . . . . 1.08 107.426 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.7 mt -102.06 151.38 22.23 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.985 3.314 . . . . 1.55 114.677 178.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -105.48 104.72 14.5 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 121.636 3.939 . . . . 1.95 121.636 168.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.432 HG12 ' HE2' ' A' ' 29' ' ' LYS . 14.3 m -119.91 168.36 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 112.452 -2.158 . . . . 0.96 109.528 -177.528 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -105.44 159.88 27.96 Favored Pre-proline 0 N--CA 1.431 -1.409 0 C-N-CA 125.713 1.605 . . . . 2.35 108.772 164.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.89 -18.44 16.88 Favored 'Trans proline' 0 N--CA 1.435 -1.967 0 O-C-N 115.767 -2.807 . . . . 0.95 113.537 -170.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.4 m -86.67 2.72 47.51 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.438 -2.039 . . . . 1.45 115.989 174.482 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -79.27 148.13 32.27 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 127.463 2.305 . . . . 1.69 109.766 172.124 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.5 p -76.99 161.04 28.67 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 127.147 2.179 . . . . 0.75 116.197 175.306 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.8 mm -71.56 -31.36 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 C-N-CA 125.738 1.615 . . . . 0.73 111.944 173.546 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -50.87 -46.65 60.44 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.142 2.401 . . . . 1.62 114.562 162.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.282 6.3 t-20 -63.4 -45.13 92.45 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 116.226 -4.046 . . . . 2.13 114.949 176.755 . . . . . . . . 3 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -48.11 -38.81 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 127.893 2.477 . . . . 0.62 115.816 168.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -66.82 -34.58 78.13 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.392 -2.692 . . . . 1.22 113.603 173.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.0 -32.43 61.65 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.583 -2.573 . . . . 0.51 112.345 176.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HE2' HG12 ' A' ' 17' ' ' VAL . 38.4 mttp -58.5 -38.73 78.26 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 120.688 1.585 . . . . 1.44 115.199 165.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.7 mt -71.55 -37.34 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 130.766 3.626 . . . . 1.32 111.902 177.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -59.81 -47.43 85.73 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 129.027 2.931 . . . . 1.7 109.364 169.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.4 -54.9 41.41 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.613 2.625 . . . . 1.55 115.127 171.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -72.49 -67.51 0.55 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.712 -3.118 . . . . 2.62 112.696 -175.564 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -77.53 -55.37 5.43 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 120.035 -1.666 . . . . 1.48 114.639 -174.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.94 25.98 0.65 Allowed Glycine 0 N--CA 1.43 -1.716 0 O-C-N 118.136 -2.853 . . . . 1.12 110.326 174.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.0 mt -99.95 140.09 21.26 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-N 123.344 3.572 . . . . 1.55 105.365 -167.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 12.8 Cg_exo -66.85 159.04 53.47 Favored 'Trans proline' 0 N--CA 1.433 -2.066 0 CA-C-N 125.128 2.867 . . . . 1.02 111.053 176.131 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 73.7 Cg_exo -78.23 -3.52 13.49 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 CA-C-N 122.635 1.977 . . . . 1.25 111.907 -175.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.271 96.0 m-20 -88.22 -29.65 20.3 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 125.813 2.72 . . . . 2.25 112.727 174.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -84.51 16.04 3.38 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 116.351 1.982 . . . . 2.02 116.351 -179.079 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -126.08 129.72 49.69 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.93 1.292 . . . . 0.69 109.78 -176.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -118.7 134.78 54.88 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.443 2.697 . . . . 2.78 108.973 167.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.5 mt -120.01 123.98 44.78 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 113.715 -1.584 . . . . 1.17 114.303 178.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 23.7 mm -99.9 145.59 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 101.397 -3.557 . . . . 1.38 101.397 175.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.438 ' HB3' HD21 ' A' ' 50' ' ' LEU . 27.3 t80 -139.16 123.82 18.49 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 101.404 -3.554 . . . . 1.5 101.404 168.153 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.07 -68.59 0.21 Allowed 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 127.487 2.992 . . . . 1.21 112.402 -172.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.25 -32.03 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 114.412 -1.267 . . . . 1.3 115.117 -179.112 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.276 12.4 ptpt -74.93 151.15 38.9 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.174 1.175 . . . . 2.55 114.174 177.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -87.16 105.34 17.13 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 131.066 3.746 . . . . 2.48 113.326 174.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.452 HD22 ' CD2' ' A' ' 59' ' ' TYR . 61.9 mt -66.77 158.37 30.51 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.074 -2.266 . . . . 0.9 109.536 -161.285 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -91.27 156.18 18.0 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 124.855 2.264 . . . . 1.94 108.862 170.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -74.53 -66.37 0.75 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.504 -1.997 . . . . 1.56 114.186 -178.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.46 50.21 1.69 Allowed Glycine 0 N--CA 1.43 -1.761 0 O-C-N 118.057 -2.902 . . . . 0.97 115.177 168.245 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -122.7 160.38 25.99 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.346 -1.679 . . . . 2.49 106.962 159.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.2 p -85.68 169.17 13.72 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.675 -1.891 . . . . 0.76 113.325 176.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.1 mt -66.05 -33.12 75.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.844 2.458 . . . . 1.05 115.185 171.037 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.7 p -70.25 -32.91 70.96 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.408 -2.682 . . . . 1.19 114.784 176.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -67.59 -27.46 66.94 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.721 1.608 . . . . 1.9 115.252 177.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' CD2' HD22 ' A' ' 50' ' ' LEU . 59.8 m-85 -89.15 -14.8 35.33 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.074 2.25 . . . . 0.89 117.074 170.045 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.3 22.1 m120 75.77 45.68 0.12 Allowed 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.016 2.969 . . . . 1.84 119.016 -174.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.442 HG23 ' HB2' ' A' ' 65' ' ' SER . 16.1 mt -91.32 107.9 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 129.833 3.253 . . . . 0.82 107.576 172.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -99.73 -165.11 1.19 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.53 1.932 . . . . 2.16 108.359 179.279 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -56.7 144.41 32.58 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.35 -2.719 . . . . 2.12 114.887 170.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 68.46 17.98 9.04 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.269 2.462 . . . . 1.71 114.97 171.436 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.442 ' HB2' HG23 ' A' ' 61' ' ' ILE . 69.7 m -80.89 131.43 35.36 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 125.675 2.655 . . . . 1.04 110.938 -169.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.0 m -80.61 110.38 16.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.758 -1.565 . . . . 0.79 115.109 176.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.46 155.17 17.98 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.476 2.71 . . . . 1.4 106.148 172.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.505 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 60.8 m80 -119.14 109.63 16.11 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.44 -2.037 . . . . 1.51 112.722 -170.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.1 tp -93.48 112.3 24.17 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 125.125 1.516 . . . . 1.14 112.338 -172.7 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.68 125.5 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 127.921 2.488 . . . . 1.23 110.266 179.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.8 tp -88.54 138.58 31.3 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.679 -3.138 . . . . 2.78 106.623 -175.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -106.24 102.4 11.81 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.28 -3.388 . . . . 3.75 105.974 -179.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.9 mt -80.52 153.46 28.12 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.614 -2.554 . . . . 3.14 114.21 171.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.78 108.57 18.77 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.478 -2.639 . . . . 6.8 107.296 168.676 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.93 41.82 0.03 OUTLIER Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 116.734 -2.651 . . . . 3.57 108.957 -171.209 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.734 0 N-CA-C 108.258 -1.937 . . . . 3.87 108.258 -178.017 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptt? . . . . . 0 CA--C 1.489 -1.398 0 CA-C-O 126.429 3.014 . . . . 1.1 113.551 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -89.03 125.4 34.99 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.444 -1.707 . . . . 1.87 110.888 -174.506 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 pt -121.05 146.61 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 104.773 -2.306 . . . . 0.72 104.773 166.33 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -97.17 134.69 40.16 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 131.618 3.967 . . . . 1.4 103.677 -179.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.5 t -130.4 106.18 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 124.488 2.09 . . . . 0.58 106.947 172.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.6 tttt -96.65 142.93 28.1 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.185 1.469 . . . . 2.09 112.914 -176.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.1 p -82.02 179.32 7.86 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 118.339 -2.725 . . . . 0.99 114.345 175.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 54.7 tp -81.08 -30.73 34.65 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.661 2.384 . . . . 2.53 107.12 175.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.2 p -75.01 -44.91 45.39 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.614 -3.804 . . . . 2.08 112.36 -170.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.98 -3.59 0.16 Allowed Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 117.577 -2.249 . . . . 1.31 114.732 173.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -110.99 138.89 46.84 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 114.574 1.324 . . . . 1.4 114.574 -172.245 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -102.21 128.86 48.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 115.138 -2.363 . . . . 0.78 112.936 177.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.294 30.6 pt -107.14 145.8 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 106.773 -1.566 . . . . 1.55 106.773 176.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.9 m -97.51 134.4 40.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 111.802 -2.454 . . . . 1.08 112.639 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.64 142.43 50.66 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.701 1.715 . . . . 1.55 109.728 -179.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -108.75 122.79 47.89 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 116.479 -3.888 . . . . 1.95 109.012 169.015 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.6 m -136.29 154.54 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 125.38 1.472 . . . . 0.96 107.887 -171.135 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -95.26 152.63 39.52 Favored Pre-proline 0 N--CA 1.43 -1.437 0 C-N-CA 130.896 3.679 . . . . 2.35 108.397 160.117 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -76.27 -7.28 17.9 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 C-N-CA 123.769 2.979 . . . . 0.95 111.322 -174.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.5 m -94.91 0.51 54.8 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.125 1.77 . . . . 1.45 111.524 175.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.53 142.65 38.94 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.178 -2.826 . . . . 1.69 108.794 174.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 p -84.58 173.29 10.9 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 124.498 1.119 . . . . 0.75 113.393 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.2 mm -65.29 -36.41 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 118.766 -2.459 . . . . 0.73 112.682 170.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.307 3.1 mp0 -54.11 -48.49 70.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.874 -2.391 . . . . 1.62 116.084 165.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -63.24 -36.13 82.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 112.628 0.603 . . . . 2.13 112.628 175.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.9 t -62.11 -52.13 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 126.681 1.992 . . . . 0.62 111.932 175.404 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -57.71 -40.39 79.44 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.848 1.259 . . . . 1.22 111.82 176.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.312 . . -50.9 -38.93 52.87 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 120.458 3.503 . . . . 0.51 120.458 167.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -74.65 -24.1 58.77 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.424 -2.048 . . . . 1.44 115.277 177.034 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.9 mt -78.51 -35.65 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 129.313 3.045 . . . . 1.32 106.012 177.034 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -75.98 -36.56 59.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.823 -1.798 . . . . 1.7 111.972 -179.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -55.56 -48.04 75.41 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 128.55 2.74 . . . . 1.55 108.625 174.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -87.66 -59.49 2.23 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.125 -2.234 . . . . 2.62 114.478 -177.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -86.55 -25.4 25.06 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 115.11 1.522 . . . . 1.48 115.11 -172.043 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.14 26.55 33.63 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 119.441 -1.361 . . . . 1.12 113.156 175.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.7 mt -96.05 115.67 65.72 Favored Pre-proline 0 N--CA 1.43 -1.454 1 CA-C-O 111.631 -4.033 . . . . 1.55 110.103 -177.179 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.29 164.81 34.47 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 CA-C-N 126.975 3.527 . . . . 1.02 115.142 -177.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -65.37 -34.27 44.63 Favored 'Trans proline' 0 N--CA 1.434 -1.982 0 CA-C-O 115.833 -1.82 . . . . 1.25 116.717 -165.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -45.46 -38.74 6.44 Favored 'General case' 0 N--CA 1.43 -1.461 1 C-N-CA 132.382 4.273 . . . . 2.25 116.171 170.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -96.94 2.27 51.4 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.608 2.363 . . . . 2.02 113.856 -176.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -88.1 99.61 12.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 116.751 -3.718 . . . . 0.69 107.811 -173.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -90.66 112.02 23.59 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 118.384 -2.697 . . . . 2.78 109.88 163.247 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.8 mt -105.3 129.84 53.56 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.154 1.781 . . . . 1.17 109.805 175.087 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 3.4 mp -123.9 129.27 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 127.571 2.348 . . . . 1.38 109.136 177.201 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.46 ' HB3' HD21 ' A' ' 50' ' ' LEU . 73.1 t80 -123.14 114.29 20.12 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 104.438 -2.43 . . . . 1.5 104.438 171.478 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.37 -110.48 0.54 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 110.224 -3.171 . . . . 1.21 112.545 -170.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.13 4.27 35.59 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 126.492 1.996 . . . . 1.3 114.204 177.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -105.76 129.1 54.03 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.91 1.684 . . . . 2.55 114.739 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -82.5 126.6 32.43 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 126.558 1.943 . . . . 2.48 109.129 170.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.46 HD21 ' HB3' ' A' ' 45' ' ' PHE . 18.3 mt -79.5 128.89 33.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.501 1.92 . . . . 0.9 109.756 -173.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -112.68 179.13 4.06 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.207 2.432 . . . . 1.94 110.874 178.261 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -79.77 151.87 30.12 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 117.197 -1.801 . . . . 1.56 112.763 -171.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.71 -0.57 81.47 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 119.524 -1.985 . . . . 0.97 116.914 170.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -87.54 159.42 18.62 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 125.575 1.397 . . . . 2.49 110.505 169.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.266 70.4 p -100.08 167.52 10.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.937 2.303 . . . . 0.76 112.397 173.357 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.21 -29.75 70.85 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 117.086 -3.509 . . . . 1.05 112.221 164.484 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 t -68.8 -30.95 69.63 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.156 -1.59 . . . . 1.19 112.111 178.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -62.84 -50.34 71.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 114.904 1.446 . . . . 1.9 114.904 172.351 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -81.87 11.9 4.55 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 115.927 -1.987 . . . . 0.89 111.788 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 m120 56.96 46.08 20.1 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 125.559 2.6 . . . . 1.84 115.04 178.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.3 mt -91.82 122.61 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 112.354 -2.203 . . . . 0.82 110.154 178.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -108.58 173.53 6.28 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 127.176 2.797 . . . . 2.16 109.477 -173.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -59.53 142.7 52.06 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.482 1.66 . . . . 2.12 115.482 173.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 5.7 tt0 75.71 15.2 2.64 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 126.271 2.939 . . . . 1.71 116.32 174.07 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 m -77.35 139.97 39.86 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 113.605 -1.634 . . . . 1.04 108.048 -175.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 m -109.51 90.94 3.45 Favored 'General case' 0 N--CA 1.429 -1.497 1 O-C-N 116.016 -4.177 . . . . 0.79 114.772 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -65.45 153.13 42.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.904 2.288 . . . . 1.4 112.82 173.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.415 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 18.5 m80 -105.53 101.51 11.03 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 115.815 -4.303 . . . . 1.51 109.326 -178.864 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.0 tp -91.89 108.74 20.14 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 121.018 1.736 . . . . 1.14 110.116 173.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -98.69 129.98 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 1 C-N-CA 134.069 4.947 . . . . 1.23 106.804 173.479 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.4 tp -102.42 116.71 33.19 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 111.911 -2.404 . . . . 2.78 112.861 174.179 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.86 159.33 15.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.772 2.138 . . . . 3.75 116.772 176.56 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.9 mt -81.17 -100.22 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.443 2.544 . . . . 3.14 110.776 171.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -87.17 168.19 13.46 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 115.858 -4.276 . . . . 6.8 111.061 172.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.07 166.76 38.08 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 106.43 -2.668 . . . . 3.57 106.43 -168.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.744 1 CA-C-O 113.232 -4.094 . . . . 3.87 106.312 178.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptt? . . . . . 0 CA--C 1.49 -1.34 0 N-CA-C 113.533 0.938 . . . . 1.1 113.533 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -105.38 124.33 49.37 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.371 3.068 . . . . 1.87 112.688 -175.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.1 pt -123.8 155.36 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 C-N-CA 129.349 3.06 . . . . 0.72 110.645 175.166 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -114.42 132.8 56.12 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 112.305 -2.225 . . . . 1.4 112.007 -171.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.86 97.22 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 103.192 -2.892 . . . . 0.58 103.192 178.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -90.62 141.09 29.14 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.529 -1.982 . . . . 2.09 112.403 174.552 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.7 p -107.31 165.39 11.42 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 120.126 1.33 . . . . 0.99 110.406 176.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.3 tp -52.7 -36.18 56.84 Favored 'General case' 0 N--CA 1.43 -1.435 1 C-N-CA 134.79 5.236 . . . . 2.53 116.974 177.65 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.4 p -90.08 -19.81 23.91 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.789 -3.07 . . . . 2.08 111.195 -178.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.56 12.38 2.5 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 118.878 -2.389 . . . . 1.31 114.592 169.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -94.21 135.4 35.64 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 119.809 1.805 . . . . 1.4 110.433 -176.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.1 m -115.41 108.7 16.85 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.625 -4.422 . . . . 0.78 108.506 178.45 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -81.48 124.01 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.455 2.302 . . . . 1.55 108.594 175.076 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.6 m -101.32 98.27 8.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.435 -2.666 . . . . 1.08 108.518 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 mt -100.07 139.91 35.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 127.821 3.676 . . . . 1.55 108.829 179.108 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -96.35 132.1 42.19 Favored 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 114.532 -5.105 . . . . 1.95 107.882 172.494 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.82 168.33 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 126.886 2.074 . . . . 0.96 109.763 179.007 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -105.43 160.61 25.44 Favored Pre-proline 0 N--CA 1.429 -1.477 0 O-C-N 119.457 -2.027 . . . . 2.35 105.927 165.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -79.59 -16.6 11.69 Favored 'Trans proline' 0 N--CA 1.434 -2.004 1 CA-C-N 129.395 4.391 . . . . 0.95 112.027 -168.437 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.8 p -85.32 2.9 42.14 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.681 -2.512 . . . . 1.45 116.272 173.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -71.12 140.04 50.48 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 125.44 1.713 . . . . 1.69 109.98 173.3 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.444 42.7 p -84.46 161.02 20.45 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.848 -1.782 . . . . 0.75 110.646 -178.624 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.9 mm -52.98 -27.86 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 C-N-CA 126.46 1.904 . . . . 0.73 115.124 170.471 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -57.65 -44.87 85.95 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.292 2.637 . . . . 1.62 115.687 167.278 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -65.13 -37.35 87.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.787 2.708 . . . . 2.13 115.598 178.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.417 HG21 HD21 ' A' ' 56' ' ' LEU . 21.3 t -72.75 -47.63 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 112.333 -2.212 . . . . 0.62 115.086 177.517 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -65.75 -17.05 64.35 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 114.581 1.326 . . . . 1.22 114.581 169.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.28 -41.28 17.02 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 119.958 1.253 . . . . 0.51 108.198 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -59.64 -31.83 69.89 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.143 1.905 . . . . 1.44 116.143 170.413 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.77 -49.73 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.453 1.597 . . . . 1.32 114.706 170.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -59.56 -37.51 78.65 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 113.662 0.986 . . . . 1.7 113.662 177.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.7 -37.95 77.21 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.62 -3.175 . . . . 1.55 113.684 176.357 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -92.56 -59.64 2.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.265 1.983 . . . . 2.62 114.364 -177.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -84.97 -27.45 26.49 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 118.622 -2.549 . . . . 1.48 113.074 -169.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.32 24.43 26.56 Favored Glycine 0 N--CA 1.431 -1.684 0 CA-C-O 124.497 2.165 . . . . 1.12 109.423 169.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.3 mt -91.82 112.79 56.41 Favored Pre-proline 0 N--CA 1.431 -1.411 0 CA-C-N 113.225 -1.487 . . . . 1.55 110.461 -171.365 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.255 18.4 Cg_exo -55.37 139.68 81.75 Favored 'Trans proline' 0 N--CA 1.433 -2.058 1 N-CA-C 123.69 4.458 . . . . 1.02 123.69 174.821 . . . . . . . . 3 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -62.01 -22.26 73.91 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 C-N-CA 123.659 2.906 . . . . 1.25 111.013 -175.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.63 -31.32 71.92 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.883 1.801 . . . . 2.25 110.864 173.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -88.09 -14.84 37.81 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 116.413 -3.929 . . . . 2.02 115.562 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -78.98 98.94 6.62 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 112.139 -2.301 . . . . 0.69 106.659 -173.102 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -102.8 107.48 18.36 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.097 -2.927 . . . . 2.78 103.097 169.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.4 mt -105.28 148.12 27.35 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 114.597 -2.841 . . . . 1.17 105.049 -175.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 mm -125.1 131.78 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 109.38 -0.6 . . . . 1.38 109.38 -179.258 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -122.23 108.79 13.69 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.888 -2.382 . . . . 1.5 104.799 168.432 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.87 -92.67 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.18 2.192 . . . . 1.21 110.01 179.051 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.4 -26.69 4.74 Favored Glycine 0 N--CA 1.429 -1.811 0 CA-C-N 113.68 -1.6 . . . . 1.3 109.974 -173.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.383 51.2 mttm -99.07 134.97 41.15 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.018 -3.048 . . . . 2.55 118.26 -176.304 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -90.08 116.04 27.8 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 105.836 -1.912 . . . . 2.48 105.836 176.206 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.9 mt -65.3 118.97 10.09 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 123.607 1.67 . . . . 0.9 111.521 -169.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.12 154.13 20.41 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 116.531 -3.856 . . . . 1.94 110.682 -179.308 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -68.98 152.73 44.89 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.59 -1.943 . . . . 1.56 114.178 -173.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.47 10.55 85.65 Favored Glycine 0 N--CA 1.43 -1.709 0 O-C-N 119.454 -2.029 . . . . 0.97 112.57 173.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -104.24 171.3 7.41 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.992 2.33 . . . . 2.49 110.245 170.253 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.1 p -106.32 -174.09 2.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.524 -3.86 . . . . 0.76 104.876 174.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.417 HD21 HG21 ' A' ' 26' ' ' VAL . 80.8 mt -83.02 -35.56 25.69 Favored 'General case' 0 N--CA 1.431 -1.423 1 C-N-CA 133.367 4.667 . . . . 1.05 110.477 174.882 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -70.41 -25.88 63.42 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.221 -3.425 . . . . 1.19 114.938 175.726 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -59.9 -34.06 72.67 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.894 -3.004 . . . . 1.9 111.81 168.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -92.76 11.53 26.59 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 121.42 1.918 . . . . 0.89 111.177 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.33 10.9 m120 53.26 36.29 22.28 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 127.47 2.308 . . . . 1.84 116.34 -175.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.4 mt -85.9 129.2 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 127.625 2.37 . . . . 0.82 108.464 -176.713 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -123.66 -167.01 1.55 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.253 -2.779 . . . . 2.16 110.91 -173.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -58.44 141.42 51.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.651 0.982 . . . . 2.12 113.651 178.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 69.28 33.71 3.17 Favored 'General case' 0 N--CA 1.43 -1.465 1 C-N-CA 132.199 4.199 . . . . 1.71 109.316 175.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 m -101.24 142.93 31.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 123.075 2.671 . . . . 1.04 107.562 -172.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.3 m -102.4 102.74 13.1 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 116.083 -1.913 . . . . 0.79 110.65 -171.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.317 57.6 mt -78.69 147.37 33.52 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.767 -1.197 . . . . 1.4 107.767 169.26 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -101.73 128.12 48.2 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.998 -1.064 . . . . 1.51 109.006 178.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.2 tt -93.61 104.33 16.45 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 118.661 -2.525 . . . . 1.14 110.391 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.0 t -107.67 129.48 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 O-C-N 117.157 -3.464 . . . . 1.23 109.408 -179.09 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.4 mt -97.82 125.37 42.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.201 -2.812 . . . . 2.78 111.651 -177.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -87.17 130.02 34.71 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.665 3.586 . . . . 3.75 108.074 178.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.4 tp -97.43 -62.92 1.18 Allowed 'General case' 0 N--CA 1.432 -1.361 0 CA-C-O 123.917 1.818 . . . . 3.14 111.439 174.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -137.99 146.66 43.39 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 111.901 -2.409 . . . . 6.8 111.593 175.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.56 179.6 29.12 Favored Glycine 0 N--CA 1.43 -1.723 0 O-C-N 119.106 -2.246 . . . . 3.57 110.815 -168.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.747 1 O-C-N 115.97 -4.253 . . . . 3.87 120.793 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.351 19.0 ptt? . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 118.131 -0.938 . . . . 1.1 111.139 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -100.69 132.9 45.85 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 125.965 1.706 . . . . 1.87 106.972 -171.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.04 157.5 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 115.181 -2.342 . . . . 0.72 109.525 166.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -107.59 143.95 35.31 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.161 1.458 . . . . 1.4 111.782 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 t -123.44 124.44 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 105.583 -2.006 . . . . 0.58 105.583 171.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -114.69 135.89 53.66 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 117.15 2.278 . . . . 2.09 117.15 178.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.515 21.3 p -69.59 -175.59 0.88 Allowed 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.82 2.247 . . . . 0.99 113.707 179.386 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.3 mt -89.99 -33.67 16.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.482 -3.261 . . . . 2.53 113.913 165.589 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 p -74.49 -56.08 5.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.865 -1.772 . . . . 2.08 114.606 -176.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.07 31.16 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 119.997 2.759 . . . . 1.31 119.997 174.412 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -121.8 128.48 51.74 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.507 2.099 . . . . 1.4 111.423 -175.467 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.278 32.3 m -103.5 130.55 50.9 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.271 -2.143 . . . . 0.78 111.541 172.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -100.67 149.83 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 129.682 3.193 . . . . 1.55 107.912 176.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.5 m -123.46 131.17 53.56 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 122.22 2.282 . . . . 1.08 105.468 172.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.8 mt -119.4 128.57 54.17 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 116.047 -1.93 . . . . 1.55 114.048 -179.6 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -80.0 112.43 17.29 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 115.138 1.533 . . . . 1.95 115.138 165.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.86 174.93 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.578 -2.576 . . . . 0.96 104.701 -171.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -124.02 171.67 6.76 Favored Pre-proline 0 N--CA 1.43 -1.475 0 CA-C-O 114.233 -2.794 . . . . 2.35 104.979 165.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -76.11 -7.75 18.34 Favored 'Trans proline' 0 N--CA 1.434 -1.996 1 CA-C-N 130.02 4.614 . . . . 0.95 114.093 -177.369 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.5 p -83.24 -15.92 48.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 129.922 3.289 . . . . 1.45 109.959 179.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.69 139.96 58.24 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 114.542 1.312 . . . . 1.69 114.542 174.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 p -85.3 164.45 18.0 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 118.109 -2.869 . . . . 0.75 115.929 172.594 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.4 mm -64.56 -24.92 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 119.152 -2.218 . . . . 0.73 115.611 173.269 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -74.98 -31.7 61.51 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 116.053 -1.927 . . . . 1.62 114.901 165.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -66.68 -41.23 88.45 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 120.4 1.455 . . . . 2.13 110.194 174.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.68 -48.43 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 114.29 -2.767 . . . . 0.62 111.135 174.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -54.86 -45.2 74.55 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 122.144 2.247 . . . . 1.22 114.002 176.219 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.05 -41.16 87.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.174 1.916 . . . . 0.51 116.174 168.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -61.06 -41.36 96.47 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.292 2.237 . . . . 1.44 110.435 173.36 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.4 mt -64.37 -32.91 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 121.096 1.771 . . . . 1.32 114.474 169.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -62.69 -43.07 99.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.431 1.092 . . . . 1.7 112.503 175.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -56.1 -42.5 76.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.391 -2.693 . . . . 1.55 113.567 174.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -74.99 -66.64 0.73 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.626 1.343 . . . . 2.62 114.626 -178.117 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -95.29 -21.23 18.55 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.241 2.617 . . . . 1.48 115.389 -166.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.37 1.78 68.74 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 127.954 3.284 . . . . 1.12 113.704 175.783 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 mt -72.1 126.63 91.14 Favored Pre-proline 0 N--CA 1.429 -1.481 0 C-N-CA 125.538 1.535 . . . . 1.55 113.44 -177.075 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.524 ' HG2' ' HG3' ' A' ' 40' ' ' GLN . 18.3 Cg_endo -72.67 150.62 50.92 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 O-C-N 113.651 -3.921 . . . . 1.02 116.341 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -63.59 -32.16 69.8 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 CA-C-N 124.045 2.48 . . . . 1.25 111.48 -171.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -57.61 -29.7 64.73 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 114.939 -4.851 . . . . 2.25 114.775 176.594 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.524 ' HG3' ' HG2' ' A' ' 37' ' ' PRO . 88.7 mt-30 -90.73 -21.0 21.79 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 119.108 -1.037 . . . . 2.02 111.138 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.279 57.9 mt-30 -78.68 140.0 38.42 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 120.328 -1.483 . . . . 0.69 114.134 -174.623 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -126.44 126.44 43.8 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.771 1.748 . . . . 2.78 106.741 170.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.305 29.3 mt -98.21 111.74 23.96 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 118.868 -2.395 . . . . 1.17 111.203 178.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.4 mm -105.95 121.02 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 124.327 1.051 . . . . 1.38 111.846 -178.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -114.36 98.31 6.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 129.06 2.944 . . . . 1.5 112.638 168.135 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.1 -106.22 0.21 Allowed 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.335 -2.728 . . . . 1.21 113.837 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.94 -12.44 55.37 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 128.704 3.05 . . . . 1.3 112.867 -179.28 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -114.06 149.3 35.68 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 123.28 3.54 . . . . 2.55 106.403 -173.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -106.83 142.87 35.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 100.673 -3.825 . . . . 2.48 100.673 169.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 mt -103.24 130.19 50.41 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 116.434 -2.106 . . . . 0.9 111.655 -172.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -81.19 141.32 34.3 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 118.028 2.603 . . . . 1.94 118.028 -174.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -60.66 132.0 52.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.609 1.818 . . . . 1.56 108.94 -176.127 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.02 -19.13 44.52 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 126.159 1.838 . . . . 0.97 116.149 171.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.8 mtt180 -82.24 164.9 20.88 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 123.094 1.426 . . . . 2.49 113.5 170.25 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.2 p -87.99 162.99 16.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.487 3.041 . . . . 0.76 112.707 174.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.6 mt -61.11 -26.46 67.69 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 114.218 -5.301 . . . . 1.05 119.552 167.457 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.7 t -67.08 -35.03 78.94 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 112.925 -1.943 . . . . 1.19 112.729 176.242 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -56.7 -41.99 78.33 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.812 -3.055 . . . . 1.9 112.402 175.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -88.96 4.46 48.03 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 119.284 -2.135 . . . . 0.89 112.584 177.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.1 m120 58.33 47.34 14.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.801 2.889 . . . . 1.84 118.801 -178.227 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mt -96.17 130.05 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 124.789 1.306 . . . . 0.82 108.69 -178.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -114.23 -159.62 0.7 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 115.504 -2.479 . . . . 2.16 105.734 176.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -56.0 153.45 8.82 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 115.551 -4.468 . . . . 2.12 116.925 171.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 55.23 33.18 20.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.341 2.972 . . . . 1.71 110.987 173.213 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 m -89.52 143.08 27.1 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 113.962 -5.461 . . . . 1.04 110.584 -179.614 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.2 m -96.02 113.08 24.66 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.282 -2.118 . . . . 0.79 105.282 178.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mp -104.57 169.82 8.24 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 104.263 -2.495 . . . . 1.4 104.263 165.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -125.84 139.21 53.67 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 127.831 3.207 . . . . 1.51 112.827 -172.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.0 tp -98.67 123.38 42.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.789 -2.444 . . . . 1.14 112.038 177.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.16 162.25 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.849 -2.278 . . . . 1.23 104.849 174.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.5 mt -129.03 147.03 50.86 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.085 2.374 . . . . 2.78 109.947 -179.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.286 68.3 ttt180 -82.92 140.22 32.95 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 110.313 -3.13 . . . . 3.75 109.87 179.213 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.9 mt -106.78 74.26 0.99 Allowed 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.781 -3.075 . . . . 3.14 114.963 178.617 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -64.28 -31.92 73.31 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.49 -2.006 . . . . 6.8 112.437 169.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.81 -44.63 1.62 Allowed Glycine 0 N--CA 1.43 -1.706 0 O-C-N 117.74 -3.1 . . . . 3.57 114.556 -175.223 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.782 0 N-CA-C 107.641 -2.184 . . . . 3.87 107.641 -176.48 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ttp . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 123.506 1.622 . . . . 1.1 113.285 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -83.15 130.11 35.08 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 115.41 -4.556 . . . . 1.87 114.049 -178.28 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -126.17 161.83 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 115.704 -2.094 . . . . 0.72 108.516 168.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -112.76 137.61 50.81 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 104.865 -2.272 . . . . 1.4 104.865 -177.192 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 t -107.46 120.59 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 114.106 -1.406 . . . . 0.58 108.015 173.249 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -96.01 115.45 27.45 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.828 -2.42 . . . . 2.09 111.381 179.327 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.9 p -80.42 175.14 10.92 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 115.982 -4.199 . . . . 0.99 116.223 173.491 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 69.0 mt -80.5 -24.55 39.32 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.672 -1.232 . . . . 2.53 107.672 176.586 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.3 p -70.93 -39.93 72.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.332 -2.73 . . . . 2.08 108.96 175.508 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.86 50.63 0.55 Allowed Glycine 0 N--CA 1.429 -1.827 0 C-N-CA 126.36 1.933 . . . . 1.31 113.708 -177.568 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -124.21 136.93 54.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 101.556 -3.498 . . . . 1.4 101.556 -179.116 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.4 m -100.22 116.74 32.93 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.777 -3.077 . . . . 0.78 104.767 178.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mt -99.15 141.26 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 104.821 -2.288 . . . . 1.55 104.821 178.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.5 m -109.88 108.2 18.4 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 103.893 -2.632 . . . . 1.08 103.893 -175.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.8 mt -102.74 160.59 14.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.415 -2.678 . . . . 1.55 108.46 177.699 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -119.69 107.19 12.92 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 130.553 3.541 . . . . 1.95 107.919 172.227 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.267 23.2 m -121.58 -171.61 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.696 1.598 . . . . 0.96 109.391 -174.107 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -143.84 179.89 1.09 Allowed Pre-proline 0 N--CA 1.43 -1.428 0 C-N-CA 126.114 1.765 . . . . 2.35 112.672 167.769 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 57' ' ' SER . 11.4 Cg_exo -76.5 -28.0 7.18 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 125.317 2.935 . . . . 0.95 115.669 -176.504 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 p -77.8 -20.33 53.43 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.062 2.545 . . . . 1.45 113.43 -177.68 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.34 139.86 41.51 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 122.989 2.631 . . . . 1.69 112.813 172.531 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.1 p -84.17 175.37 9.51 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 124.295 1.038 . . . . 0.75 112.073 174.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.6 mm -74.8 -34.35 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-O 116.241 -1.838 . . . . 0.73 107.573 177.831 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -49.32 -41.7 39.28 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 129.008 2.923 . . . . 1.62 113.131 166.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -78.19 -28.61 48.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.394 -2.066 . . . . 2.13 113.075 177.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.39 -43.16 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 125.223 1.409 . . . . 0.62 107.459 171.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.7 mttt -55.06 -39.86 69.69 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 123.179 2.718 . . . . 1.22 113.178 169.11 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.61 -40.08 76.84 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 126.925 2.09 . . . . 0.51 110.774 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -68.51 -23.28 64.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.353 -2.092 . . . . 1.44 113.109 176.177 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.4 mt -82.81 -28.1 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 117.208 -1.797 . . . . 1.32 110.896 172.615 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -63.33 -44.52 94.7 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.976 -1.702 . . . . 1.7 110.98 177.373 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -56.28 -50.06 72.46 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.809 2.043 . . . . 1.55 111.225 173.193 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -66.08 -59.81 3.43 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 118.951 2.945 . . . . 2.62 118.951 -178.581 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -108.84 -25.58 10.71 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 128.828 2.851 . . . . 1.48 113.544 -165.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.02 47.91 7.31 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 123.908 0.755 . . . . 1.12 112.626 -177.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.9 mt -104.82 114.39 63.91 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 105.663 -1.977 . . . . 1.55 105.663 177.115 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -55.83 151.45 40.43 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 123.456 2.771 . . . . 1.02 116.154 175.396 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 16.3 Cg_exo -70.51 -22.81 28.15 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 126.099 3.214 . . . . 1.25 119.904 -173.882 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.59 -17.94 62.9 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.459 1.903 . . . . 2.25 110.977 171.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -79.51 -29.44 41.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 121.162 1.801 . . . . 2.02 109.472 175.704 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.417 ' HG2' HD11 ' A' ' 69' ' ' LEU . 76.2 mt-30 -84.51 140.08 31.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 118.744 2.868 . . . . 0.69 118.744 -167.803 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -129.99 116.61 18.83 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 104.65 -2.352 . . . . 2.78 104.65 167.412 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.8 mt -96.04 105.65 17.71 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.071 2.549 . . . . 1.17 114.58 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.5 mm -98.04 134.94 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 106.24 -1.763 . . . . 1.38 106.24 -172.692 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -130.08 95.14 3.86 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 116.089 -2.244 . . . . 1.5 107.277 171.305 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 74.33 -107.38 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.325 1.85 . . . . 1.21 111.098 -173.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.79 -12.5 24.2 Favored Glycine 0 N--CA 1.429 -1.768 0 O-C-N 118.482 -2.636 . . . . 1.3 109.029 -175.43 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -100.08 134.17 43.39 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.213 -1.757 . . . . 2.55 110.032 -174.51 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -84.37 132.87 34.55 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 103.146 -2.909 . . . . 2.48 103.146 167.383 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 mt -88.5 136.58 32.92 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.911 -2.368 . . . . 0.9 113.75 -179.101 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -73.52 138.65 45.15 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 126.134 2.146 . . . . 1.94 111.731 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -62.96 -39.72 95.52 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 117.599 2.444 . . . . 1.56 117.599 -166.761 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.21 16.43 55.83 Favored Glycine 0 N--CA 1.43 -1.708 0 O-C-N 117.575 -3.203 . . . . 0.97 111.779 175.837 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -95.34 174.4 7.05 Favored 'General case' 0 N--CA 1.429 -1.5 1 CA-C-N 125.407 4.604 . . . . 2.49 108.93 167.224 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.1 p -107.84 176.66 5.07 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 115.397 -2.521 . . . . 0.76 113.979 177.19 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.8 mt -57.91 -46.44 84.98 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 126.773 3.178 . . . . 1.05 113.162 169.627 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 2.1 t -62.27 -37.28 84.86 Favored 'General case' 0 N--CA 1.43 -1.435 1 CA-C-N 108.005 -4.18 . . . . 1.19 116.54 178.669 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -62.07 -36.4 81.55 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 120.389 1.45 . . . . 1.9 114.801 176.451 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -89.9 0.92 56.78 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 116.795 2.146 . . . . 0.89 116.795 177.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 m120 74.5 24.79 1.71 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.713 3.205 . . . . 1.84 114.849 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.3 mt -68.94 112.71 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 115.244 1.572 . . . . 0.82 115.244 174.577 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -107.04 -165.54 1.08 Allowed 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 125.007 1.323 . . . . 2.16 112.081 -177.42 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -67.72 153.23 44.17 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.483 1.66 . . . . 2.12 115.483 177.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 60.83 24.31 14.26 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 128.283 2.633 . . . . 1.71 116.056 179.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.3 m -89.3 148.34 23.61 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.056 -2.278 . . . . 1.04 110.404 -170.722 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.8 m -111.82 110.11 20.29 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.065 -2.897 . . . . 0.79 110.664 -173.904 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.3 mp -90.23 151.89 21.32 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 100.792 -3.781 . . . . 1.4 100.792 172.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -116.36 123.08 46.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.463 -2.023 . . . . 1.51 110.8 175.227 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.417 HD11 ' HG2' ' A' ' 41' ' ' GLN . 45.9 tp -95.04 101.97 13.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.653 -2.067 . . . . 1.14 108.651 -174.507 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.6 t -102.41 138.38 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 105.669 -1.975 . . . . 1.23 105.669 178.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.3 mt -116.48 164.16 14.99 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.432 1.587 . . . . 2.78 107.702 -179.73 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -87.5 150.46 23.72 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 111.094 -2.776 . . . . 3.75 110.243 174.453 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.0 mt -48.04 120.65 3.64 Favored 'General case' 0 N--CA 1.43 -1.442 1 N-CA-C 123.149 4.5 . . . . 3.14 123.149 177.816 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.418 ' HB3' ' H ' ' A' ' 75' ' ' GLY . 26.3 ttt180 -106.2 -79.31 0.57 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.317 2.008 . . . . 6.8 115.28 170.734 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.418 ' H ' ' HB3' ' A' ' 74' ' ' ARG . . . 142.99 82.25 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 103.951 -3.66 . . . . 3.57 103.951 -167.321 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.753 0 CA-C-N 120.283 2.041 . . . . 3.87 110.319 -171.078 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptt? . . . . . 0 CA--C 1.49 -1.364 0 CA-C-O 118.977 -0.535 . . . . 1.1 111.39 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -98.57 121.59 40.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.28 1.038 . . . . 1.87 109.442 -175.244 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.0 pt -119.44 155.04 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 123.317 1.532 . . . . 0.72 109.433 174.604 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -113.78 126.03 54.76 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.732 -1.855 . . . . 1.4 112.712 -179.127 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.506 HG21 HD11 ' A' ' 30' ' ' ILE . 40.5 t -104.88 114.25 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 105.259 -2.126 . . . . 0.58 105.259 178.601 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -103.74 121.5 43.13 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 129.232 3.013 . . . . 2.09 107.682 -175.676 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 p -86.49 -179.24 6.6 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 127.93 3.729 . . . . 0.99 117.797 179.248 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 8' ' ' LEU . 47.2 mt -83.06 -29.22 28.99 Favored 'General case' 0 N--CA 1.429 -1.505 1 O-C-N 110.91 -7.369 . . . . 2.53 111.913 168.774 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.9 p -64.7 -41.3 96.11 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 117.035 -3.54 . . . . 2.08 110.141 171.443 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.08 4.88 3.19 Favored Glycine 0 N--CA 1.431 -1.692 0 O-C-N 119.962 -1.711 . . . . 1.31 114.248 173.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -75.9 122.28 23.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 125.959 1.704 . . . . 1.4 111.23 -171.547 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.307 23.8 m -80.15 88.25 5.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.842 -3.661 . . . . 0.78 114.056 167.106 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.462 HD13 ' HG3' ' A' ' 34' ' ' GLU . 57.5 mt -82.71 130.34 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 103.067 -2.938 . . . . 1.55 103.067 -176.834 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.3 m -101.89 117.48 34.93 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.957 3.303 . . . . 1.08 107.196 -174.287 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.5 mt -131.21 152.43 50.5 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 124.925 3.511 . . . . 1.55 111.642 -178.396 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -106.64 105.13 15.01 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 126.586 1.955 . . . . 1.95 113.285 175.289 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 26' ' ' VAL . 12.4 m -118.09 174.45 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 126.476 1.91 . . . . 0.96 107.615 -175.446 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -126.43 165.62 26.91 Favored Pre-proline 0 N--CA 1.431 -1.39 0 O-C-N 118.638 -2.538 . . . . 2.35 106.203 166.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -75.77 -22.57 13.38 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 CA-C-N 124.639 2.693 . . . . 0.95 114.581 -171.305 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.0 m -85.44 15.49 4.43 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 116.354 -2.138 . . . . 1.45 112.591 174.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -91.39 167.35 12.34 Favored 'General case' 0 N--CA 1.431 -1.425 1 O-C-N 116.141 -4.1 . . . . 1.69 109.48 169.025 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 36.4 p -104.0 174.57 5.82 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.704 -1.135 . . . . 0.75 108.339 -175.382 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.417 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 27.9 mm -74.76 -31.71 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 127.854 2.462 . . . . 0.73 107.958 175.102 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -57.72 -40.5 79.7 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.633 1.716 . . . . 1.62 115.633 169.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -65.29 -48.77 71.99 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 124.23 1.967 . . . . 2.13 111.881 171.472 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.46 HG22 HG11 ' A' ' 17' ' ' VAL 0.28 47.5 t -54.17 -41.71 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 117.19 -3.444 . . . . 0.62 115.333 172.455 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 85.7 mttt -59.26 -46.72 87.75 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 118.046 2.61 . . . . 1.22 118.046 167.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.01 -38.93 80.36 Favored 'General case' 0 N--CA 1.432 -1.369 1 C-N-CA 131.714 4.006 . . . . 0.51 114.037 172.845 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.23 -42.93 99.29 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.908 1.683 . . . . 1.44 113.148 167.473 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.506 HD11 HG21 ' A' ' 5' ' ' VAL . 65.8 mt -69.16 -32.32 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 125.945 1.698 . . . . 1.32 110.109 179.14 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -69.92 -47.92 60.54 Favored 'General case' 0 N--CA 1.431 -1.404 1 O-C-N 115.853 -4.279 . . . . 1.7 114.248 175.013 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.27 16.4 t70 -44.53 -59.48 2.43 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 130.53 3.532 . . . . 1.55 110.132 166.297 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -67.81 -53.34 27.79 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.942 2.097 . . . . 2.62 112.557 -172.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HG3' HD13 ' A' ' 13' ' ' ILE . 19.4 mm-40 -102.06 -75.04 0.61 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.76 3.171 . . . . 1.48 112.184 -170.185 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.66 22.84 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.714 0 CA-C-O 124.309 2.061 . . . . 1.12 115.101 177.709 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mt -97.79 128.64 33.49 Favored Pre-proline 0 N--CA 1.43 -1.434 0 O-C-N 117.95 -3.088 . . . . 1.55 117.281 -172.319 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -63.03 137.88 64.55 Favored 'Trans proline' 0 N--CA 1.433 -2.032 0 O-C-N 114.65 -3.395 . . . . 1.02 113.309 178.473 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -59.92 -17.72 45.72 Favored 'Trans proline' 0 N--CA 1.434 -2.009 1 C-N-CA 125.474 4.116 . . . . 1.25 115.135 178.747 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -75.33 -28.42 59.64 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.028 -2.295 . . . . 2.25 112.289 169.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -82.01 -26.0 34.21 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.781 -2.449 . . . . 2.02 110.196 -173.866 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -87.58 124.22 33.27 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.451 -2.031 . . . . 0.69 114.475 -174.157 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -113.07 115.4 28.28 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 124.329 2.014 . . . . 2.78 109.291 170.098 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.252 4.2 mm? -95.97 116.34 28.79 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 125.544 2.592 . . . . 1.17 112.215 178.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 2.3 mm -98.23 122.85 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 1 O-C-N 114.918 -4.864 . . . . 1.38 108.655 178.956 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -138.22 142.32 39.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 116.755 -3.715 . . . . 1.5 103.143 168.245 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.317 . . 62.53 22.37 13.24 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.352 2.352 . . . . 1.21 117.352 177.609 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.04 -14.56 43.16 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 116.947 -3.595 . . . . 1.3 114.229 -175.104 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -100.2 161.36 13.66 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 128.479 2.712 . . . . 2.55 111.707 176.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -94.92 140.84 29.37 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 117.535 -3.228 . . . . 2.48 114.854 169.962 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.323 19.7 mt -80.04 135.61 36.4 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 126.426 3.012 . . . . 0.9 113.252 -176.48 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -89.02 144.15 26.35 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.976 -3.577 . . . . 1.94 115.47 175.348 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.269 16.5 m-20 -53.59 -65.78 0.51 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.715 -2.49 . . . . 1.56 116.281 -170.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.3 58.79 2.81 Favored Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 127.186 2.327 . . . . 0.97 116.816 167.196 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -139.37 144.98 38.43 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 102.734 -3.062 . . . . 2.49 102.734 166.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 60.8 p -79.72 160.98 26.03 Favored 'General case' 0 N--CA 1.429 -1.477 1 CA-C-O 128.785 4.136 . . . . 0.76 114.643 170.937 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.1 mt -71.28 -32.61 68.88 Favored 'General case' 0 N--CA 1.431 -1.391 1 O-C-N 114.351 -5.218 . . . . 1.05 107.066 -176.263 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.8 p -64.76 -35.97 82.8 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.489 2.403 . . . . 1.19 117.489 171.575 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.252 7.9 t70 -60.54 -44.5 96.02 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.048 2.832 . . . . 1.9 113.653 171.726 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -74.64 -22.62 58.82 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 117.788 -3.07 . . . . 0.89 113.936 176.412 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.322 63.6 m-80 68.24 54.32 0.57 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 126.083 2.849 . . . . 1.84 111.597 -178.629 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.9 mm -98.64 124.92 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 102.333 -3.21 . . . . 0.82 102.333 174.226 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -105.28 -174.99 2.67 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.529 -0.732 . . . . 2.16 110.183 -175.45 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -65.12 149.67 49.49 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 116.289 1.959 . . . . 2.12 116.289 169.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 77.11 11.42 2.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.87 1.268 . . . . 1.71 113.674 172.111 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.346 5.4 t -78.55 134.84 37.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.971 3.708 . . . . 1.04 120.909 -174.112 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.9 m -101.2 106.47 17.7 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.928 1.694 . . . . 0.79 108.918 -177.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.6 mt -88.8 138.56 31.3 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 118.561 -1.255 . . . . 1.4 108.496 170.073 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 40.8 m80 -94.56 125.36 39.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 123.958 1.837 . . . . 1.51 113.312 -176.677 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.7 tp -103.46 126.78 50.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.468 -3.27 . . . . 1.14 111.446 -173.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.3 t -118.16 147.07 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 102.258 -3.238 . . . . 1.23 102.258 173.143 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.5 mt -111.07 137.59 48.54 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 113.031 -1.895 . . . . 2.78 110.029 179.081 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -94.2 86.94 5.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.267 2.227 . . . . 3.75 106.805 179.495 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.2 mt -89.83 158.9 17.27 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 125.807 2.718 . . . . 3.14 110.473 176.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -97.02 148.49 22.94 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.867 -3.645 . . . . 6.8 108.1 171.502 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.92 -86.65 0.45 Allowed Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 108.293 -1.923 . . . . 3.57 108.293 -166.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.733 0 CA-C-N 110.562 -2.819 . . . . 3.87 108.082 -173.418 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 ptt? . . . . . 0 CA--C 1.49 -1.364 0 CA-C-O 124.246 1.974 . . . . 1.1 110.713 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -111.79 132.78 54.44 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 117.829 -3.044 . . . . 1.87 115.553 -171.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.2 pt -135.88 161.83 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 N-CA-C 105.592 -2.003 . . . . 0.72 105.592 176.17 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -119.32 145.92 45.73 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 123.611 1.672 . . . . 1.4 109.847 -179.184 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.5 t -119.37 123.62 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 114.528 -1.214 . . . . 0.58 112.464 176.207 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 mttp -93.67 111.97 23.76 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 119.339 -0.945 . . . . 2.09 110.665 177.826 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.2 p -69.52 169.37 12.7 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.559 -1.963 . . . . 0.99 115.224 176.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.39 -25.87 61.66 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 118.552 -2.592 . . . . 2.53 112.723 178.482 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.9 p -74.6 -22.18 59.09 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 128.012 2.525 . . . . 2.08 115.175 177.317 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.76 52.53 2.43 Favored Glycine 0 N--CA 1.43 -1.712 0 C-N-CA 130.35 3.833 . . . . 1.31 111.71 175.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -116.68 140.88 48.91 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 102.432 -3.173 . . . . 1.4 102.432 -178.497 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.5 m -107.38 117.75 34.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 101.579 -3.489 . . . . 0.78 101.579 167.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.2 pt -96.04 166.83 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 118.131 -2.855 . . . . 1.55 105.258 173.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.0 m -122.28 141.41 51.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 116.712 -1.613 . . . . 1.08 107.925 175.228 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.0 mt -129.81 158.41 39.51 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 127.842 2.457 . . . . 1.55 110.29 173.603 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -111.99 136.53 51.21 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 106.45 -1.685 . . . . 1.95 106.45 167.546 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.7 m -136.17 166.11 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 125.553 1.541 . . . . 0.96 113.976 178.017 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -104.78 156.55 35.8 Favored Pre-proline 0 N--CA 1.43 -1.437 0 O-C-N 120.403 -1.436 . . . . 2.35 109.819 155.531 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -80.34 -5.53 13.51 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 O-C-N 114.624 -3.408 . . . . 0.95 109.908 -171.792 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.284 67.9 m -77.13 -17.77 58.38 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 116.951 -1.499 . . . . 1.45 110.028 171.135 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -60.98 134.47 57.13 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 120.681 1.582 . . . . 1.69 112.843 173.451 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 26' ' ' VAL . 61.7 p -71.58 159.68 34.02 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.286 1.517 . . . . 0.75 109.614 176.714 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.0 mm -69.87 -38.54 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 124.633 2.159 . . . . 0.73 111.285 -176.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -48.13 -42.63 29.78 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 128.794 2.837 . . . . 1.62 115.389 162.626 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -67.12 -32.79 74.16 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.201 -1.562 . . . . 2.13 109.194 178.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 22' ' ' THR . 4.4 t -71.3 -29.14 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 O-C-N 118.386 -2.696 . . . . 0.62 113.614 174.346 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -75.25 -35.76 61.36 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.23 -0.919 . . . . 1.22 108.787 176.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.05 -44.33 74.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.681 1.993 . . . . 0.51 111.788 170.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -58.45 -49.22 78.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 116.836 2.161 . . . . 1.44 116.836 173.424 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.418 3.3 mt -58.27 -37.38 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 118.383 2.734 . . . . 1.32 118.383 170.668 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.415 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 64.5 tt0 -63.71 -39.79 95.17 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 118.663 -1.215 . . . . 1.7 113.623 173.11 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -59.67 -58.92 6.49 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.935 1.694 . . . . 1.55 110.555 171.636 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -57.51 -65.66 0.59 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 125.919 1.687 . . . . 2.62 115.288 -179.304 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -106.72 -3.1 20.9 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 129.152 2.981 . . . . 1.48 111.971 -167.161 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.6 54.25 8.87 Favored Glycine 0 N--CA 1.431 -1.696 1 O-C-N 114.469 -5.144 . . . . 1.12 119.29 173.449 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.415 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 81.9 mt -132.27 135.29 26.15 Favored Pre-proline 0 N--CA 1.43 -1.439 0 N-CA-C 102.096 -3.298 . . . . 1.55 102.096 -174.527 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.69 152.27 58.8 Favored 'Trans proline' 0 N--CA 1.434 -2.005 2 C-N-CA 126.379 4.719 . . . . 1.02 108.664 177.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.44 -20.93 54.18 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 122.473 2.115 . . . . 1.25 111.449 -177.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -54.45 -50.02 68.69 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 131.497 3.919 . . . . 2.25 111.513 176.592 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -73.55 -35.06 65.44 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.307 -1.315 . . . . 2.02 112.293 177.731 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -71.67 123.75 23.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.939 2.199 . . . . 0.69 116.939 -172.663 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -113.38 126.05 54.93 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 122.771 2.532 . . . . 2.78 109.481 166.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.3 mt -97.76 132.69 43.16 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.721 -1.237 . . . . 1.17 112.803 178.706 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 mt -119.48 146.44 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 2 C-N-CA 135.113 5.365 . . . . 1.38 104.8 179.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.304 68.4 t80 -151.26 128.88 11.48 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 102.631 -3.099 . . . . 1.5 102.631 173.382 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.354 . . 52.1 42.56 30.62 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 121.471 3.878 . . . . 1.21 121.471 -178.368 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.38 -30.7 5.49 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-N 120.54 1.518 . . . . 1.3 116.329 179.472 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.331 16.3 pttm -94.55 148.38 22.31 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 129.934 3.294 . . . . 2.55 112.009 178.147 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -87.58 148.98 24.62 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 127.353 3.454 . . . . 2.48 112.8 169.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.424 HD22 ' CD2' ' A' ' 59' ' ' TYR . 55.8 mt -108.45 134.78 50.76 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.36 -2.2 . . . . 0.9 105.333 -175.478 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -88.57 153.72 20.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 126.281 1.832 . . . . 1.94 113.717 178.015 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -63.41 -55.27 25.74 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 117.228 2.307 . . . . 1.56 117.228 -169.527 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.03 62.11 4.59 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 125.825 2.903 . . . . 0.97 119.831 173.517 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.5 mmt-85 -140.5 171.5 14.04 Favored 'General case' 0 N--CA 1.429 -1.479 1 N-CA-C 99.238 -4.356 . . . . 2.49 99.238 171.641 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.8 p -111.36 168.62 9.38 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.747 -1.845 . . . . 0.76 115.476 166.359 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mt -64.11 -37.33 87.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 116.528 -3.858 . . . . 1.05 107.158 174.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -65.69 -34.91 79.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 125.973 3.988 . . . . 1.19 116.751 178.356 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -57.35 -45.63 84.16 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 117.322 2.342 . . . . 1.9 117.322 167.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.424 ' CD2' HD22 ' A' ' 50' ' ' LEU . 43.0 m-85 -87.14 -2.09 58.37 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.462 2.023 . . . . 0.89 116.462 174.586 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 54.63 74.98 0.32 Allowed 'General case' 0 N--CA 1.43 -1.43 1 C-N-CA 132.075 4.15 . . . . 1.84 110.83 -179.465 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.8 mt -116.99 113.41 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 103.005 -2.961 . . . . 0.82 103.005 -177.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -86.48 177.06 7.53 Favored 'General case' 0 N--CA 1.43 -1.452 1 CA-C-O 128.93 4.205 . . . . 2.16 107.908 -174.527 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -63.25 144.74 56.68 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 110.906 -2.861 . . . . 2.12 116.527 172.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.314 43.0 mt-10 73.83 26.05 1.87 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.811 3.196 . . . . 1.71 112.886 173.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.284 70.0 m -96.26 151.74 19.23 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.721 -3.112 . . . . 1.04 105.445 -177.196 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.0 m -109.44 120.08 41.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 120.959 1.709 . . . . 0.79 111.236 176.788 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mt -95.72 136.0 36.69 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 125.569 1.547 . . . . 1.4 109.973 176.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -98.64 118.53 35.56 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.435 -1.415 . . . . 1.51 112.806 -175.299 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.3 tp -99.55 118.01 35.19 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.21 2.204 . . . . 1.14 111.926 178.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.23 165.22 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 105.614 -1.995 . . . . 1.23 105.614 172.61 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.6 mt -97.34 153.01 18.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 114.436 1.273 . . . . 2.78 114.436 -176.122 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -103.73 115.24 30.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 116.632 -1.652 . . . . 3.75 113.326 176.383 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.5 mt -87.54 62.32 7.03 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 121.904 2.138 . . . . 3.14 116.125 173.208 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -73.12 138.35 45.73 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.059 2.544 . . . . 6.8 111.14 171.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.13 60.52 0.48 Allowed Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 104.235 -3.546 . . . . 3.57 104.235 -173.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.794 0 N-CA-C 107.481 -2.248 . . . . 3.87 107.481 178.122 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.315 0 N-CA-C 114.134 1.161 . . . . 1.1 114.134 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -86.62 146.23 26.41 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 123.301 1.524 . . . . 1.87 110.425 -176.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.5 pt -139.46 150.03 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 128.254 2.621 . . . . 0.72 109.483 174.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -103.53 118.28 36.37 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.452 -1.704 . . . . 1.4 111.753 177.18 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.3 t -94.31 110.7 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 117.735 -1.126 . . . . 0.58 109.047 170.341 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.3 tttp -110.17 139.25 45.52 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 122.574 2.443 . . . . 2.09 112.296 -176.529 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.358 58.0 p -85.05 165.67 17.32 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.859 -1.519 . . . . 0.99 108.793 -178.193 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.455 HD11 HG22 ' A' ' 70' ' ' VAL . 62.1 mt -78.23 -19.31 54.02 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 123.96 1.838 . . . . 2.53 112.157 170.584 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.06 -45.04 13.48 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 114.058 -1.428 . . . . 2.08 107.88 -173.702 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.47 1.31 0.21 Allowed Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 120.262 2.865 . . . . 1.31 120.262 167.249 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -86.55 146.78 26.23 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 119.256 1.528 . . . . 1.4 113.555 -176.751 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.4 m -114.04 110.49 20.12 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.957 2.789 . . . . 0.78 109.195 171.005 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.5 mt -91.83 109.65 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 124.513 2.102 . . . . 1.55 106.403 177.32 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.4 m -83.44 115.04 21.88 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.69 -3.756 . . . . 1.08 106.085 176.063 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mp -108.39 156.51 19.34 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 129.089 2.956 . . . . 1.55 109.856 175.138 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -118.61 131.73 56.19 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.149 -2.219 . . . . 1.95 111.184 166.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -138.67 171.36 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 125.807 1.643 . . . . 0.96 113.233 -175.462 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -102.54 156.1 35.69 Favored Pre-proline 0 N--CA 1.429 -1.48 0 N-CA-C 103.738 -2.69 . . . . 2.35 103.738 166.717 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.9 0.98 9.39 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 124.002 3.135 . . . . 0.95 109.891 179.835 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.4 p -84.03 -18.57 36.61 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.545 -1.972 . . . . 1.45 112.151 171.155 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -66.31 140.9 58.14 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 125.451 2.548 . . . . 1.69 110.917 173.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 3.0 p -80.34 163.97 23.49 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 114.95 -2.452 . . . . 0.75 116.055 179.003 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.492 HG13 ' HB3' ' A' ' 50' ' ' LEU . 19.4 mm -64.16 -36.49 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 123.412 2.824 . . . . 0.73 110.735 176.837 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -58.05 -32.84 68.4 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.86 1.664 . . . . 1.62 113.257 168.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.383 20.0 t-20 -64.18 -39.73 94.6 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.476 2.084 . . . . 2.13 114.322 174.184 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.5 t -64.55 -46.34 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 124.781 2.229 . . . . 0.62 113.761 174.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -66.63 -25.22 66.49 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 125.57 2.605 . . . . 1.22 117.139 -179.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.37 -43.25 81.87 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.569 3.556 . . . . 0.51 109.115 174.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -63.3 -39.17 93.82 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 116.02 -4.175 . . . . 1.44 113.789 173.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.8 mt -69.79 -30.29 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-O 122.837 1.304 . . . . 1.32 111.625 173.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.421 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 59.1 tt0 -75.15 -41.98 57.11 Favored 'General case' 0 N--CA 1.431 -1.401 1 O-C-N 113.66 -5.65 . . . . 1.7 106.757 175.87 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -54.62 -46.98 73.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.713 2.673 . . . . 1.55 118.191 168.207 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.282 26.4 tttp -89.49 -43.4 10.86 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 117.168 -3.457 . . . . 2.62 117.301 -174.008 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -101.57 -35.89 8.97 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 126.755 2.534 . . . . 1.48 108.919 -172.378 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.23 56.25 1.22 Allowed Glycine 0 N--CA 1.431 -1.663 0 C-N-CA 117.926 -2.083 . . . . 1.12 113.508 176.094 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.421 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 8.7 mt -134.31 130.62 20.22 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 103.436 -2.801 . . . . 1.55 103.436 -175.49 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -66.85 154.01 76.0 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 CA-C-N 124.387 2.603 . . . . 1.02 116.714 177.664 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -59.33 -31.96 95.89 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 124.051 3.167 . . . . 1.25 110.13 -176.528 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -55.22 -57.95 9.69 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 126.023 2.821 . . . . 2.25 114.741 177.043 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -61.64 -26.88 68.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.298 2.639 . . . . 2.02 110.395 -177.661 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.272 75.2 mt-30 -96.06 131.13 42.79 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.015 1.388 . . . . 0.69 107.41 -173.642 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -118.83 131.87 56.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.107 -1.406 . . . . 2.78 109.954 167.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 tp -110.06 119.88 40.68 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 104.679 -2.341 . . . . 1.17 104.679 179.123 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.308 1.7 mt -104.95 143.02 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 128.046 2.539 . . . . 1.38 115.106 179.23 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -155.85 123.08 5.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 125.37 3.713 . . . . 1.5 102.642 179.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.257 . . 62.97 30.1 16.43 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.445 2.387 . . . . 1.21 117.445 169.314 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.29 -22.82 32.82 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 125.294 1.621 . . . . 1.3 116.108 -174.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -99.36 130.97 45.68 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 118.174 -1.41 . . . . 2.55 114.033 -176.749 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -75.1 130.42 39.24 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 117.254 -1.778 . . . . 2.48 112.988 173.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.492 ' HB3' HG13 ' A' ' 23' ' ' ILE . 42.1 mt -76.53 140.95 41.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.699 2.481 . . . . 0.9 117.699 -170.83 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -82.78 135.6 34.93 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.631 -3.168 . . . . 1.94 110.59 177.609 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -54.99 -64.99 0.66 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.766 2.426 . . . . 1.56 112.435 -171.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.26 54.54 3.95 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 119.643 -1.91 . . . . 0.97 113.352 172.076 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.9 tpp85 -131.29 161.99 31.06 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 115.296 -2.288 . . . . 2.49 111.126 161.059 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 63.9 p -96.52 155.83 16.6 Favored 'General case' 0 N--CA 1.43 -1.456 1 CA-C-N 127.759 4.799 . . . . 0.76 112.445 178.554 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.1 mt -57.78 -24.24 56.19 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.146 1.778 . . . . 1.05 113.941 173.601 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.7 p -78.4 -27.93 46.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.099 -2.876 . . . . 1.19 115.499 177.404 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -67.73 -34.71 77.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.827 -3.046 . . . . 1.9 115.787 172.332 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.418 ' CE2' HD22 ' A' ' 50' ' ' LEU . 12.7 m-85 -85.94 -8.88 57.71 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.476 1.11 . . . . 0.89 109.381 175.249 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 59.0 54.13 5.19 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.528 -1.983 . . . . 1.84 112.438 178.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.1 mt -85.8 114.47 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 126.727 3.156 . . . . 0.82 108.227 174.299 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.283 83.6 mt-30 -91.18 177.6 6.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.369 -3.332 . . . . 2.16 111.409 178.339 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -72.65 160.8 31.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 115.724 -2.391 . . . . 2.12 113.563 178.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.433 30.5 mt-10 64.51 32.33 11.79 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 110.582 -3.008 . . . . 1.71 116.005 176.765 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.9 t -100.2 128.65 46.23 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 112.973 -1.921 . . . . 1.04 110.586 -166.26 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.37 2.4 m -75.87 93.74 3.24 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 121.88 2.127 . . . . 0.79 116.313 178.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 60.0 mt -81.39 156.8 25.25 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 130.663 3.585 . . . . 1.4 103.282 174.053 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -125.5 121.34 33.45 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 120.56 1.527 . . . . 1.51 113.035 -174.092 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.1 tp -96.64 110.69 23.07 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 105.812 -1.921 . . . . 1.14 105.812 -178.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.455 HG22 HD11 ' A' ' 8' ' ' LEU . 99.0 t -107.04 138.81 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 122.863 1.316 . . . . 1.23 111.457 172.474 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.4 mt -107.64 144.38 34.78 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.46 -1.4 . . . . 2.78 113.117 -177.191 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -88.08 72.01 9.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 104.798 -2.297 . . . . 3.75 104.798 173.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.9 mt -61.21 142.47 56.75 Favored 'General case' 0 N--CA 1.43 -1.445 1 C-N-CA 132.41 4.284 . . . . 3.14 108.625 177.413 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.262 32.8 ttm180 -73.09 118.94 16.66 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 116.147 -1.883 . . . . 6.8 112.891 172.445 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.46 -83.18 0.16 Allowed Glycine 0 N--CA 1.43 -1.701 0 CA-C-O 123.115 1.397 . . . . 3.57 110.145 179.25 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.72 0 C-N-CA 129.246 3.308 . . . . 3.87 110.678 -176.604 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 CA--C 1.491 -1.321 0 CA-C-O 118.985 -0.531 . . . . 1.1 110.664 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -84.95 134.24 34.25 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.49 1.116 . . . . 1.87 112.898 -178.551 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.5 pt -131.83 159.84 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 123.643 1.687 . . . . 0.72 109.666 166.453 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -120.84 149.53 42.44 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 102.492 -3.151 . . . . 1.4 102.492 -173.544 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.4 t -136.2 119.07 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.494 -1.379 . . . . 0.58 109.427 174.409 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -92.23 127.36 37.68 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.816 -1.084 . . . . 2.09 112.079 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.2 p -83.63 165.03 19.33 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.171 1.463 . . . . 0.99 112.111 -178.862 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.68 -31.42 72.63 Favored 'General case' 0 N--CA 1.429 -1.512 1 O-C-N 116.053 -4.154 . . . . 2.53 114.723 167.324 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.0 p -71.62 -48.64 46.68 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 124.285 0.991 . . . . 2.08 111.626 -175.217 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.52 41.64 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 119.273 -1.442 . . . . 1.31 110.674 -179.21 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.29 33.7 ttpt -133.57 149.89 51.65 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.07 -2.43 . . . . 1.4 106.775 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.9 m -95.41 113.94 25.66 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.161 2.584 . . . . 0.78 114.674 167.234 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 mt -82.39 119.25 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 117.645 -3.16 . . . . 1.55 110.305 172.215 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.8 m -104.32 111.27 23.84 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.874 -2.391 . . . . 1.08 107.896 178.093 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.8 mt -110.1 156.06 21.08 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 119.395 3.109 . . . . 1.55 119.395 -177.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.9 tp10 -103.39 107.23 17.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.206 -1.559 . . . . 1.95 113.307 168.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.7 m -121.17 164.77 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 115.879 -2.01 . . . . 0.96 112.944 174.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 9.3 mm-40 -111.69 169.51 6.25 Favored Pre-proline 0 N--CA 1.43 -1.439 0 O-C-N 125.055 1.472 . . . . 2.35 109.993 163.381 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 46.0 Cg_exo -77.38 -20.59 12.38 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 C-N-CA 122.808 2.339 . . . . 0.95 116.103 -174.122 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.7 m -82.99 3.26 30.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.8 1.64 . . . . 1.45 111.473 174.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -82.5 147.13 28.86 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.185 -2.822 . . . . 1.69 111.266 172.796 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.1 p -75.86 164.48 26.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.291 2.701 . . . . 0.75 118.291 174.215 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.4 mm -74.94 -29.12 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 118.279 -2.763 . . . . 0.73 110.687 178.402 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -53.37 -39.65 64.36 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 126.037 1.735 . . . . 1.62 112.529 163.708 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -60.1 -47.89 84.0 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.548 2.339 . . . . 2.13 114.793 173.206 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.7 t -60.61 -48.78 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 130.144 3.378 . . . . 0.62 112.237 177.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -60.09 -38.36 82.7 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 124.543 2.116 . . . . 1.22 115.083 173.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.85 -31.98 71.32 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 119.198 -2.189 . . . . 0.51 115.767 176.237 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -71.29 -37.44 71.86 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.498 2.094 . . . . 1.44 110.866 170.582 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.0 mt -67.14 -41.77 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 116.639 -3.788 . . . . 1.32 110.984 172.29 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -51.77 -33.06 33.47 Favored 'General case' 0 N--CA 1.43 -1.466 1 N-CA-C 122.31 4.189 . . . . 1.7 122.31 169.757 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -63.51 -42.18 98.49 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 117.04 -1.457 . . . . 1.55 110.057 174.132 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -85.13 -50.9 7.03 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 125.894 1.996 . . . . 2.62 110.414 -172.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -94.35 -27.18 16.22 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 113.567 0.951 . . . . 1.48 113.567 -168.517 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.31 -23.29 29.03 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-O 126.223 3.124 . . . . 1.12 113.759 168.025 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.2 mt -63.77 123.0 80.1 Favored Pre-proline 0 N--CA 1.431 -1.41 0 C-N-CA 128.461 2.704 . . . . 1.55 114.498 -172.691 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 59.0 Cg_endo -76.35 158.35 36.92 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 CA-C-N 126.387 3.317 . . . . 1.02 111.536 -172.025 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -54.91 -31.51 73.78 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 123.359 2.706 . . . . 1.25 116.597 -174.017 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -55.37 -42.87 74.54 Favored 'General case' 0 N--CA 1.43 -1.457 1 CA-C-O 129.263 4.363 . . . . 2.25 117.761 174.019 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -88.15 -25.54 22.91 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.94 -4.225 . . . . 2.02 112.503 -177.635 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -64.73 134.3 53.9 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.931 -1.731 . . . . 0.69 110.068 179.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -126.21 140.92 52.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.173 -2.829 . . . . 2.78 106.151 165.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 67' ' ' LEU . 85.9 mt -121.95 114.93 21.68 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.689 -2.05 . . . . 1.17 110.553 -178.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 mt -104.23 127.04 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 117.63 -3.168 . . . . 1.38 110.612 178.421 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -136.02 120.34 17.95 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.12 2.568 . . . . 1.5 107.196 176.317 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.313 . . 76.68 6.7 3.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.983 -1.698 . . . . 1.21 114.915 -177.438 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.78 -10.56 74.31 Favored Glycine 0 N--CA 1.43 -1.711 0 O-C-N 117.796 -3.065 . . . . 1.3 111.83 -175.267 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -92.17 146.42 23.73 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 105.978 -1.86 . . . . 2.55 105.978 170.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -94.43 141.89 28.06 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.162 1.385 . . . . 2.48 111.376 170.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.3 mt -105.52 123.62 48.2 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 119.245 0.93 . . . . 0.9 109.196 -166.604 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -69.1 144.1 54.02 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.145 1.778 . . . . 1.94 111.85 174.509 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -60.6 -63.12 1.41 Allowed 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 130.975 3.71 . . . . 1.56 115.742 -169.179 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.75 23.12 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.714 1 C-N-CA 131.056 4.169 . . . . 0.97 121.317 170.85 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.296 65.1 mtt180 -123.61 162.91 22.06 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.053 -2.439 . . . . 2.49 111.598 165.467 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.0 p -84.12 154.44 23.15 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 125.543 2.592 . . . . 0.76 113.579 168.694 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mt -51.3 -34.12 31.84 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.759 -4.338 . . . . 1.05 113.883 175.529 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.7 p -79.44 -12.21 59.89 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 117.583 2.438 . . . . 1.19 117.583 179.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.85 -51.49 47.71 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 127.033 3.301 . . . . 1.9 108.481 171.247 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -66.75 -21.18 66.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.963 -2.961 . . . . 0.89 117.137 172.751 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.26 2.5 m-80 70.34 47.28 0.54 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.963 3.305 . . . . 1.84 111.997 -177.279 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.2 mm -78.72 113.63 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 117.907 -2.996 . . . . 0.82 106.695 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -97.89 175.15 6.25 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 126.049 1.739 . . . . 2.16 112.847 -177.644 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -59.62 132.75 54.93 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 114.59 1.33 . . . . 2.12 114.59 172.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.401 48.4 mt-10 85.57 17.01 0.13 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.554 1.645 . . . . 1.71 111.664 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.277 6.8 m -81.47 129.88 34.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.053 -2.28 . . . . 1.04 113.362 -173.928 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.8 m -103.45 106.4 16.91 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 127.923 3.265 . . . . 0.79 109.892 -175.617 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 43' ' ' LEU . 2.7 mt -87.07 155.62 20.07 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 126.045 2.831 . . . . 1.4 111.907 172.151 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -118.9 120.84 38.5 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 115.86 -2.019 . . . . 1.51 111.457 -179.103 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.8 tp -82.82 133.68 35.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.144 1.778 . . . . 1.14 107.652 179.007 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.08 157.66 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 102.527 -3.138 . . . . 1.23 102.527 175.483 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.5 mt -122.65 141.2 52.0 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.228 2.918 . . . . 2.78 111.061 -169.49 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -95.39 89.09 5.32 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 128.063 3.792 . . . . 3.75 109.472 -171.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.9 mt -59.89 172.71 0.7 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 111.911 -2.404 . . . . 3.14 112.032 169.562 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -81.13 143.09 32.66 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 117.67 2.47 . . . . 6.8 117.67 168.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.47 -32.61 0.22 Allowed Glycine 0 N--CA 1.43 -1.75 0 O-C-N 116.785 -3.697 . . . . 3.57 110.758 -170.225 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.698 0 N-CA-C 104.647 -3.381 . . . . 3.87 104.647 -174.986 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 CA--C 1.49 -1.345 0 N-CA-C 106.879 -1.526 . . . . 1.1 106.879 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -104.04 124.96 49.99 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 118.695 -2.503 . . . . 1.87 108.695 -173.554 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.9 pt -116.2 160.9 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 118.163 -2.835 . . . . 0.72 109.177 170.176 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -103.61 134.57 46.72 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 125.967 1.707 . . . . 1.4 111.057 176.475 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.2 t -112.59 125.99 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 103.939 -2.615 . . . . 0.58 103.939 172.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -103.18 144.51 31.23 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.032 -3.543 . . . . 2.09 112.438 169.543 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.5 p -93.99 -177.51 4.35 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 124.7 1.25 . . . . 0.99 114.082 -178.839 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.482 HD11 ' H ' ' A' ' 71' ' ' LEU . 46.4 mt -72.29 -27.58 62.55 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 116.442 -1.742 . . . . 2.53 113.088 174.167 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 p -88.13 -62.41 1.5 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.914 1.34 . . . . 2.08 111.672 -172.169 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.86 36.61 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.7 0 CA-C-N 113.721 -1.581 . . . . 1.31 110.153 177.492 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -99.0 148.19 24.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 106.233 -1.766 . . . . 1.4 106.233 -179.468 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.6 m -114.04 127.28 55.87 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 122.373 2.351 . . . . 0.78 106.966 169.158 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mt -108.53 133.3 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.507 -1.996 . . . . 1.55 110.707 173.475 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.0 m -93.88 112.88 24.8 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.325 1.85 . . . . 1.08 109.705 174.101 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -110.29 143.64 40.18 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 121.607 2.003 . . . . 1.55 112.711 174.659 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -114.11 115.11 27.01 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.709 -2.495 . . . . 1.95 110.178 175.199 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.77 177.36 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 127.324 2.25 . . . . 0.96 108.871 -176.521 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -120.11 155.65 55.46 Favored Pre-proline 0 N--CA 1.43 -1.443 0 O-C-N 119.079 -2.263 . . . . 2.35 105.903 162.067 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -73.57 -10.41 23.62 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 124.351 2.59 . . . . 0.95 114.376 -170.232 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.273 48.9 m -87.19 -0.8 57.26 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 127.403 2.939 . . . . 1.45 112.556 175.098 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -68.58 150.28 48.2 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 117.044 -1.455 . . . . 1.69 109.583 179.128 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.3 p -87.59 170.94 10.86 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 125.522 2.582 . . . . 0.75 109.476 176.815 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.407 7.4 mm -61.36 -48.31 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 111.295 -2.684 . . . . 0.73 112.627 173.908 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -41.8 -51.43 4.23 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 119.97 3.322 . . . . 1.62 119.97 164.506 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -61.48 -24.6 66.69 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 119.055 2.983 . . . . 2.13 119.055 174.873 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.0 t -75.65 -39.42 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 125.465 2.555 . . . . 0.62 108.988 175.718 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.3 51.5 mtmt -65.24 -36.71 84.97 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.773 -1.83 . . . . 1.22 111.557 177.784 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.19 -24.1 66.56 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 128.32 2.648 . . . . 0.51 113.965 175.966 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -78.16 -38.63 43.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 126.838 2.586 . . . . 1.44 112.951 170.503 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.363 68.8 mt -65.84 -42.99 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-O 126.391 2.996 . . . . 1.32 111.915 172.304 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -57.79 -55.03 40.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 111.474 -2.603 . . . . 1.7 111.011 172.555 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.298 33.5 t70 -29.13 -56.64 0.14 Allowed 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 119.727 3.232 . . . . 1.55 119.727 170.898 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -81.45 -53.16 6.53 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 117.563 2.431 . . . . 2.62 117.563 -178.798 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -92.72 -22.62 19.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.178 -2.826 . . . . 1.48 106.525 -163.854 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.56 10.58 59.04 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 130.239 3.78 . . . . 1.12 114.701 177.042 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.5 mt -86.73 125.09 68.13 Favored Pre-proline 0 N--CA 1.43 -1.463 0 O-C-N 116.495 -3.944 . . . . 1.55 109.305 -174.231 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.465 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 29.9 Cg_exo -64.24 149.67 89.79 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 N-CA-C 120.86 3.369 . . . . 1.02 120.86 176.741 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 47.5 Cg_exo -69.32 -14.9 38.27 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 CA-C-N 124.966 2.809 . . . . 1.25 117.808 -175.714 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -83.09 -10.65 58.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.704 1.593 . . . . 2.25 110.784 176.714 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.16 -15.74 23.09 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.299 -1.501 . . . . 2.02 108.843 -179.664 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -93.44 124.32 37.35 Favored 'General case' 0 N--CA 1.43 -1.465 1 CA-C-O 129.352 4.406 . . . . 0.69 110.529 -179.324 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -106.65 110.07 22.15 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 114.009 -5.432 . . . . 2.78 104.205 169.963 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.6 mt -89.77 124.66 34.84 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 115.518 -2.182 . . . . 1.17 107.48 172.836 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.44 HD12 HG21 ' A' ' 70' ' ' VAL . 32.4 mt -121.62 136.76 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 128.005 3.316 . . . . 1.38 106.747 -178.255 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -147.44 123.7 10.89 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.718 -1.583 . . . . 1.5 108.245 -176.349 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.304 . . 82.35 -51.09 0.21 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 114.654 1.353 . . . . 1.21 114.654 173.365 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.61 -34.84 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 128.179 2.799 . . . . 1.3 113.739 -178.405 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -89.29 164.11 15.07 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 126.228 2.918 . . . . 2.55 112.24 -179.695 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -98.23 133.45 42.64 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.592 -1.943 . . . . 2.48 110.727 171.09 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.2 mt -88.71 129.56 35.51 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 118.774 -2.454 . . . . 0.9 114.827 -167.356 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.341 26.9 mt-10 -65.0 131.53 46.84 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.727 -1.858 . . . . 1.94 115.571 174.381 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -43.58 -63.75 0.78 Allowed 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 131.188 3.795 . . . . 1.56 114.716 -171.609 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.22 61.15 1.88 Allowed Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 112.364 -2.198 . . . . 0.97 117.323 174.202 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 -126.03 172.85 9.62 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.36 -2.089 . . . . 2.49 105.36 156.393 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.0 p -97.78 177.94 5.3 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 117.315 2.339 . . . . 0.76 117.315 169.557 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.8 mt -77.3 -32.28 55.29 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.247 -2.158 . . . . 1.05 109.77 173.702 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.5 m -66.6 -37.02 84.02 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 123.814 3.006 . . . . 1.19 114.136 171.484 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -54.24 -64.1 0.94 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 131.668 3.987 . . . . 1.9 115.022 169.921 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -62.99 -14.15 44.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.913 1.819 . . . . 0.89 115.913 173.901 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.345 29.0 m120 78.02 36.83 0.23 Allowed 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 116.794 -1.574 . . . . 1.84 114.79 179.329 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.9 mt -96.22 125.54 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 122.182 2.264 . . . . 0.82 110.96 -177.147 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -98.34 -179.91 4.51 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 118.095 2.628 . . . . 2.16 118.095 -171.498 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.304 21.7 pttp -65.87 145.83 55.46 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 118.749 -1.18 . . . . 2.12 109.328 170.373 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.269 19.4 mt-10 69.99 20.13 6.66 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 126.227 2.204 . . . . 1.71 113.142 171.815 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.2 m -87.13 148.13 25.34 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 118.027 -2.92 . . . . 1.04 111.239 179.668 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.6 m -92.89 98.4 11.35 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.829 2.159 . . . . 0.79 116.829 -177.31 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -84.82 145.53 27.81 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 113.987 -5.446 . . . . 1.4 113.744 172.072 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -117.03 119.5 35.47 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 118.918 -2.364 . . . . 1.51 109.702 -176.043 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.0 tp -84.88 102.44 13.11 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.967 3.307 . . . . 1.14 109.625 178.092 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 44' ' ' ILE 0.32 98.7 t -94.02 130.48 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 130.513 3.525 . . . . 1.23 107.28 170.814 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.482 ' H ' HD11 ' A' ' 8' ' ' LEU . 66.4 mt -100.13 141.38 33.05 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.441 -3.287 . . . . 2.78 108.589 179.106 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -74.8 -39.81 61.5 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.628 -3.17 . . . . 3.75 114.333 176.578 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.273 17.1 mt -109.82 -163.24 0.85 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.247 3.019 . . . . 3.14 111.637 164.057 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -64.94 137.89 58.02 Favored 'General case' 0 N--CA 1.43 -1.44 2 CA-C-O 129.388 4.423 . . . . 6.8 107.897 165.364 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.78 36.46 0.19 Allowed Glycine 0 N--CA 1.43 -1.707 1 O-C-N 115.27 -4.644 . . . . 3.57 113.626 -175.834 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.788 0 CA-C-O 125.85 2.916 . . . . 3.87 113.922 179.693 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttp . . . . . 0 CA--C 1.491 -1.324 0 CA-C-O 124.177 1.942 . . . . 1.1 114.399 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -106.25 141.41 37.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.808 -3.057 . . . . 1.87 111.692 -176.05 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 pt -127.35 173.16 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 131.566 3.947 . . . . 0.72 113.337 175.691 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -135.32 126.02 27.2 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.569 -2.582 . . . . 1.4 105.953 -178.544 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -115.24 118.74 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 106.25 -1.759 . . . . 0.58 106.25 173.443 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -100.28 145.24 28.35 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 118.202 -1.399 . . . . 2.09 111.525 175.383 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.2 p -101.2 160.53 14.32 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 128.931 2.892 . . . . 0.99 112.766 179.939 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 mt -71.14 -28.72 64.48 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.718 -1.864 . . . . 2.53 112.862 175.053 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 t -72.76 -38.6 67.28 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 121.744 2.066 . . . . 2.08 110.142 -177.782 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.27 -10.42 0.54 Allowed Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 125.347 1.451 . . . . 1.31 112.918 166.039 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -80.02 135.02 36.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.75 2.02 . . . . 1.4 113.735 -167.731 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.2 m -108.0 117.38 33.97 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.855 2.462 . . . . 0.78 109.484 176.204 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 mt -104.8 105.61 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 113.361 0.874 . . . . 1.55 113.361 178.332 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.8 m -79.31 118.19 21.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.347 -3.345 . . . . 1.08 108.819 -178.762 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.401 HD22 ' HB3' ' A' ' 29' ' ' LYS . 83.8 mt -120.78 153.58 36.86 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 116.803 -3.686 . . . . 1.55 111.605 -179.8 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -116.33 120.37 38.68 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.059 2.544 . . . . 1.95 110.256 168.382 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.0 m -131.92 167.82 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 105.894 -1.891 . . . . 0.96 105.894 -170.575 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -109.45 147.91 37.0 Favored Pre-proline 0 N--CA 1.43 -1.45 0 O-C-N 118.485 -2.635 . . . . 2.35 109.831 160.653 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.254 2.2 Cg_endo -57.11 -18.6 29.78 Favored 'Trans proline' 0 N--CA 1.433 -2.068 0 N-CA-C 120.619 3.277 . . . . 0.95 120.619 -173.18 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.9 m -91.05 3.64 54.2 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 125.92 1.688 . . . . 1.45 112.37 -178.709 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -71.78 161.73 30.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.481 2.312 . . . . 1.69 108.54 172.405 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.7 p -98.37 163.8 12.55 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 123.306 1.527 . . . . 0.75 107.657 178.471 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mm -54.38 -41.18 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 118.32 -2.738 . . . . 0.73 114.031 174.25 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.328 16.6 tt0 -54.86 -32.18 60.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.057 -2.277 . . . . 1.62 117.09 166.955 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -64.81 -38.49 91.17 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 129.483 3.113 . . . . 2.13 111.75 176.494 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.3 t -69.18 -40.68 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 119.523 -1.985 . . . . 0.62 107.629 179.254 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.517 ' HD3' ' HB2' ' A' ' 41' ' ' GLN . 74.1 mttt -61.19 -35.64 77.69 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.042 -2.911 . . . . 1.22 114.906 170.734 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.16 -25.21 65.15 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 114.539 -2.864 . . . . 0.51 118.701 177.963 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.401 ' HB3' HD22 ' A' ' 15' ' ' LEU . 54.2 mttp -67.92 -35.53 78.6 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 130.383 3.473 . . . . 1.44 107.201 168.654 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mt -74.07 -39.36 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 1 O-C-N 116.083 -4.136 . . . . 1.32 108.671 178.953 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -64.29 -37.12 86.35 Favored 'General case' 0 N--CA 1.428 -1.547 0 O-C-N 117.12 -3.488 . . . . 1.7 111.556 178.766 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -69.85 -43.6 71.58 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.417 1.103 . . . . 1.55 112.72 172.517 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.9 mttm -72.73 -48.19 40.73 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 120.399 3.481 . . . . 2.62 120.399 178.943 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -108.66 -30.85 7.99 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.467 -2.645 . . . . 1.48 112.489 -165.715 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.67 37.24 5.58 Favored Glycine 0 N--CA 1.43 -1.702 0 O-C-N 118.917 -2.364 . . . . 1.12 116.133 176.467 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.3 mt -113.89 126.18 28.42 Favored Pre-proline 0 N--CA 1.431 -1.412 0 CA-C-O 111.83 -3.938 . . . . 1.55 105.368 177.622 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.84 151.06 35.45 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-N 126.379 3.314 . . . . 1.02 110.77 -176.095 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -55.87 -31.85 82.83 Favored 'Trans proline' 0 N--CA 1.433 -2.047 1 C-N-CA 126.121 4.547 . . . . 1.25 112.806 -178.897 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -41.78 -49.11 4.38 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 113.229 -3.272 . . . . 2.25 117.372 165.935 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -80.55 -20.82 42.58 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 122.664 2.484 . . . . 2.02 117.279 177.514 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.517 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 72.1 mt-30 -76.82 130.86 38.21 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.999 1.32 . . . . 0.69 111.868 -172.086 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.523 ' HB2' HG23 ' A' ' 70' ' ' VAL . 70.0 mtt180 -120.33 131.01 54.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.432 -2.668 . . . . 2.78 108.561 169.653 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.7 mt -107.55 130.52 54.86 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 120.521 1.51 . . . . 1.17 110.795 179.663 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -105.03 127.92 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 125.742 1.617 . . . . 1.38 113.046 178.373 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -152.2 141.91 21.88 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.494 -2.78 . . . . 1.5 103.494 173.163 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.27 . . 64.71 14.38 9.06 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.124 2.392 . . . . 1.21 115.024 -179.013 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.49 18.51 75.71 Favored Glycine 0 N--CA 1.431 -1.674 0 O-C-N 117.511 -3.243 . . . . 1.3 118.23 179.295 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -126.18 150.18 48.5 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.277 3.031 . . . . 2.55 111.047 176.503 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -80.15 132.75 35.97 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 121.646 2.021 . . . . 2.48 112.129 169.705 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.404 HD22 ' CD1' ' A' ' 59' ' ' TYR . 21.3 mt -88.45 135.77 33.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.453 -3.904 . . . . 0.9 114.297 -173.248 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.93 125.84 27.58 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.034 2.934 . . . . 1.94 108.739 -179.76 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.32 1.0 OUTLIER -47.23 -47.4 24.57 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 120.829 3.64 . . . . 1.56 120.829 -174.12 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.84 32.11 7.18 Favored Glycine 0 N--CA 1.43 -1.712 0 CA-C-O 125.652 2.807 . . . . 0.97 118.795 -179.834 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -101.98 157.87 16.56 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.404 -3.409 . . . . 2.49 108.951 159.685 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -85.09 168.17 15.11 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.59 -1.186 . . . . 0.76 110.048 -179.337 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.6 mt -69.64 -41.01 76.16 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 124.86 1.35 . . . . 1.05 109.869 179.289 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.264 48.3 p -58.99 -18.75 37.05 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 117.32 2.341 . . . . 1.19 117.32 175.8 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -69.79 -45.04 68.86 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.657 2.383 . . . . 1.9 111.567 173.023 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.404 ' CD1' HD22 ' A' ' 50' ' ' LEU . 61.2 m-85 -83.5 2.96 34.35 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.399 -2.688 . . . . 0.89 113.309 174.19 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.4 m120 57.56 49.02 13.34 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 129.11 2.964 . . . . 1.84 117.203 177.394 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -85.14 114.29 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 128.564 2.746 . . . . 0.82 111.791 -175.96 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -93.14 -173.73 3.34 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.005 2.336 . . . . 2.16 112.633 -176.488 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -62.54 137.72 58.32 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 112.574 -2.103 . . . . 2.12 113.456 176.673 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 64.15 29.7 13.93 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 114.029 1.122 . . . . 1.71 114.029 170.143 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.6 m -81.43 143.24 32.26 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 123.288 1.518 . . . . 1.04 114.368 -178.753 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 m -99.16 117.06 32.79 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.58 -2.575 . . . . 0.79 111.382 -179.62 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -104.24 160.23 15.05 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.088 2.555 . . . . 1.4 106.261 174.439 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -124.94 135.56 52.95 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.211 -1.774 . . . . 1.51 106.211 -176.824 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.1 tp -99.57 128.75 45.68 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 105.449 -2.056 . . . . 1.14 105.449 -176.411 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.523 HG23 ' HB2' ' A' ' 42' ' ' ARG . 20.3 m -122.0 170.13 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 104.037 -2.579 . . . . 1.23 104.037 168.771 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 71' ' ' LEU . 89.5 mt -122.44 153.51 39.0 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 117.469 -1.253 . . . . 2.78 111.4 177.39 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.274 49.1 ttp180 -60.95 123.63 18.15 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 127.412 2.945 . . . . 3.75 115.454 175.019 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.4 mt -99.87 -172.83 2.31 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 123.94 0.896 . . . . 3.14 112.822 177.495 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -88.14 86.48 7.1 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.392 2.677 . . . . 6.8 113.608 169.012 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.09 -110.56 0.41 Allowed Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 110.731 -0.948 . . . . 3.57 110.731 -169.818 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.774 0 CA-C-O 115.443 -2.865 . . . . 3.87 111.836 -174.454 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tmm? . . . . . 0 CA--C 1.49 -1.352 0 CA-C-O 121.05 0.452 . . . . 1.1 110.579 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -108.72 129.31 55.36 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 117.228 2.307 . . . . 1.87 117.228 -177.537 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -129.28 170.62 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 106.28 -1.748 . . . . 0.72 106.28 175.544 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -121.94 140.15 52.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.921 -2.252 . . . . 1.4 104.921 -177.203 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.453 HG22 ' HB2' ' A' ' 67' ' ' LEU . 92.6 t -123.96 131.51 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 118.069 -2.894 . . . . 0.58 106.771 170.52 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -88.68 118.81 28.62 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.857 2.063 . . . . 2.09 115.352 171.454 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.5 p -83.49 176.06 9.34 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.238 -3.414 . . . . 0.99 111.619 173.775 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.3 mt -78.9 -17.17 56.0 Favored 'General case' 0 N--CA 1.43 -1.432 1 CA-C-O 129.617 4.532 . . . . 2.53 116.066 -179.762 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 p -95.27 -56.74 2.62 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.367 -3.333 . . . . 2.08 107.119 -170.601 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.4 23.65 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.728 0 CA-C-O 114.969 -3.128 . . . . 1.31 115.453 176.124 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -109.68 139.82 44.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 121.67 2.735 . . . . 1.4 108.467 -173.255 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.1 m -106.84 124.33 49.46 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 100.61 -3.848 . . . . 0.78 100.61 175.577 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.7 mt -94.62 123.14 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 N-CA-C 104.776 -2.305 . . . . 1.55 104.776 179.553 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.3 m -90.21 106.7 18.66 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.529 2.331 . . . . 1.08 109.369 176.617 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.3 mt -103.83 128.62 51.27 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.715 1.721 . . . . 1.55 108.396 -176.811 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -90.6 116.32 28.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.807 -3.058 . . . . 1.95 111.803 165.993 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.2 m -130.22 159.59 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.731 -2.481 . . . . 0.96 111.108 -171.358 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -99.68 146.07 31.21 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 118.591 -2.568 . . . . 2.35 108.209 170.875 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -73.44 -17.44 23.81 Favored 'Trans proline' 0 C--N 1.299 -2.059 0 CA-C-N 127.744 3.802 . . . . 0.95 113.52 -177.547 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -77.34 -2.55 35.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 123.206 2.73 . . . . 1.45 111.479 172.431 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -73.97 139.65 44.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 122.415 2.37 . . . . 1.69 109.03 178.588 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 p -74.51 158.65 33.41 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 111.015 -2.811 . . . . 0.75 110.847 170.257 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.403 HG12 ' H ' ' A' ' 23' ' ' ILE . 6.6 mm -61.78 -30.98 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 125.062 1.476 . . . . 0.73 113.388 174.484 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -52.0 -33.33 37.76 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.51 3.124 . . . . 1.62 116.162 165.766 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -85.45 -29.62 24.19 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.301 -2.749 . . . . 2.13 108.699 176.258 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.1 t -70.2 -42.1 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 117.126 -3.483 . . . . 0.62 110.898 178.886 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -63.3 -27.57 69.42 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.347 2.659 . . . . 1.22 113.14 170.194 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.43 -21.64 41.96 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 123.373 1.559 . . . . 0.51 110.933 175.504 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -75.56 -30.16 59.59 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.749 -3.094 . . . . 1.44 114.574 170.054 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.8 mt -66.88 -38.19 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 O-C-N 120.383 -1.448 . . . . 1.32 109.401 169.905 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.424 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 14.4 tt0 -57.43 -58.43 8.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.506 0.67 . . . . 1.7 112.624 170.819 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -47.61 -49.78 26.06 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.854 2.062 . . . . 1.55 110.438 178.638 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -65.13 -66.26 0.57 Allowed 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.969 2.908 . . . . 2.62 112.06 -176.375 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -95.62 -53.75 3.61 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 127.86 2.464 . . . . 1.48 113.351 -164.056 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.98 -43.6 0.6 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 106.693 -2.563 . . . . 1.12 106.693 -179.365 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.481 HG13 ' H ' ' A' ' 36' ' ' ILE . 7.8 mt -40.69 115.2 1.19 Allowed Pre-proline 0 N--CA 1.43 -1.452 1 N-CA-C 123.715 4.709 . . . . 1.55 123.715 -171.479 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -69.38 157.58 60.61 Favored 'Trans proline' 0 C--N 1.3 -1.993 2 CA-C-N 129.712 4.504 . . . . 1.02 108.448 -174.444 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.424 ' HD3' ' HB2' ' A' ' 31' ' ' GLN . 38.0 Cg_exo -65.65 -23.79 56.19 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 N-CA-C 117.522 2.085 . . . . 1.25 117.522 177.099 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.3 -12.98 47.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.624 -3.173 . . . . 2.25 118.46 174.873 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -97.39 -22.4 16.63 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 124.044 0.938 . . . . 2.02 108.977 -178.546 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -90.46 136.2 33.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 118.687 2.847 . . . . 0.69 118.687 -168.246 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -126.03 118.33 25.11 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.329 -2.1 . . . . 2.78 105.329 169.955 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.3 mt -96.94 122.34 39.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 123.962 0.905 . . . . 1.17 111.462 177.88 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 22.9 mm -105.58 141.6 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 128.326 2.651 . . . . 1.38 104.183 -176.961 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -140.71 132.74 27.82 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 116.82 -3.675 . . . . 1.5 103.622 168.054 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.42 . . 56.13 32.48 20.2 Favored 'General case' 0 N--CA 1.429 -1.48 1 CA-C-O 132.335 5.826 . . . . 1.21 121.617 174.25 . . . . . . . . 3 2 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.99 -15.21 39.34 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 108.461 -3.972 . . . . 1.3 109.793 179.206 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -87.16 129.49 34.92 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 128.549 2.74 . . . . 2.55 116.931 -178.106 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -74.4 114.91 13.33 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 128.692 2.797 . . . . 2.48 112.43 173.022 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.1 mt -85.58 147.65 26.31 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 115.922 1.823 . . . . 0.9 115.922 -174.273 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -93.16 138.38 31.63 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 108.592 -0.892 . . . . 1.94 108.592 179.937 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -66.79 -41.48 87.54 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 118.479 0.581 . . . . 1.56 112.028 -165.623 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.95 47.51 3.39 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 118.454 2.142 . . . . 0.97 118.454 176.498 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -134.49 171.65 14.01 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 102.312 -3.218 . . . . 2.49 102.312 171.409 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.2 p -113.81 177.83 4.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 125.275 2.464 . . . . 0.76 116.799 178.818 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.54 HD23 HD12 ' A' ' 61' ' ' ILE . 84.8 mt -66.91 -42.24 85.77 Favored 'General case' 0 N--CA 1.43 -1.427 1 C-N-CA 131.816 4.046 . . . . 1.05 109.084 173.9 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 t -59.56 -32.97 70.84 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 116.277 -4.014 . . . . 1.19 111.704 173.698 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.271 54.3 m-20 -81.39 -39.91 24.27 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.127 1.899 . . . . 1.9 116.127 179.629 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -84.05 -3.72 58.25 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.31 1.596 . . . . 0.89 115.31 176.72 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 74.12 36.72 0.66 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.079 2.552 . . . . 1.84 114.101 -177.744 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.54 HD12 HD23 ' A' ' 56' ' ' LEU . 11.7 mt -88.16 118.28 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 1 O-C-N 115.581 -4.449 . . . . 0.82 106.68 179.713 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -115.12 -164.9 0.97 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.272 -1.517 . . . . 2.16 115.023 -171.01 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -57.69 127.59 32.78 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 117.708 2.485 . . . . 2.12 117.708 174.927 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 69.69 34.57 2.65 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.449 3.023 . . . . 1.71 113.668 172.854 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m -88.1 129.57 35.26 Favored 'General case' 0 N--CA 1.429 -1.491 1 O-C-N 114.076 -5.39 . . . . 1.04 115.584 -177.955 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.0 m -85.09 88.68 7.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 118.533 2.79 . . . . 0.79 118.533 -175.671 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.518 HD11 HG21 ' A' ' 61' ' ' ILE . 10.3 mp -77.69 158.75 29.54 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 124.031 1.872 . . . . 1.4 107.147 179.332 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.466 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 72.3 m80 -119.62 140.88 49.9 Favored 'General case' 0 N--CA 1.43 -1.429 1 O-C-N 115.282 -4.636 . . . . 1.51 110.707 -179.746 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 tp -115.11 107.24 15.07 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 114.525 1.306 . . . . 1.14 114.525 -178.256 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.8 t -100.9 114.8 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 118.965 -2.335 . . . . 1.23 106.206 175.995 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.5 mt -97.57 158.2 15.61 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.362 2.029 . . . . 2.78 108.696 177.138 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.4 ttt85 -100.37 159.5 15.08 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.872 2.469 . . . . 3.75 106.582 -174.906 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.4 mt -81.67 85.13 6.62 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 121.839 -0.538 . . . . 3.14 111.135 168.749 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.4 ttt85 -82.8 -63.58 1.34 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.693 1.738 . . . . 6.8 115.693 169.562 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.94 -97.41 0.2 Allowed Glycine 0 N--CA 1.431 -1.692 0 O-C-N 118.675 -2.516 . . . . 3.57 113.316 -169.105 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.767 0 N-CA-C 107.914 -2.074 . . . . 3.87 107.914 -177.654 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.461 ' HG3' HG23 ' A' ' 17' ' ' VAL . 12.4 ptm . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 116.972 2.212 . . . . 1.1 116.972 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -108.66 163.74 12.98 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 127.464 2.306 . . . . 1.87 105.285 -179.593 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.7 pt -142.72 163.29 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 126.96 2.104 . . . . 0.72 106.085 168.865 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -126.03 110.14 13.22 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 124.517 1.135 . . . . 1.4 111.635 178.105 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.2 t -93.93 118.62 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 106.92 -1.511 . . . . 0.58 106.92 178.48 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -103.86 128.11 51.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.394 1.077 . . . . 2.09 109.619 177.236 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.5 p -85.21 165.7 17.16 Favored 'General case' 0 N--CA 1.429 -1.505 1 CA-C-O 128.979 4.228 . . . . 0.99 109.972 173.404 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.9 mt -59.35 -46.68 87.96 Favored 'General case' 0 N--CA 1.429 -1.502 1 O-C-N 115.269 -4.644 . . . . 2.53 113.113 166.153 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 p -55.99 -34.68 65.99 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 125.383 1.473 . . . . 2.08 111.952 -177.666 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.5 27.72 1.28 Allowed Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 117.718 -1.601 . . . . 1.31 112.533 174.55 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -106.83 151.46 25.17 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 117.242 -1.783 . . . . 1.4 110.028 -176.83 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.0 m -125.73 117.88 24.39 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.27 3.414 . . . . 0.78 108.343 174.055 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.365 11.5 pt -106.1 137.65 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.605 -2.56 . . . . 1.55 105.785 174.306 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.5 m -104.03 107.35 18.21 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.306 -1.316 . . . . 1.08 109.948 173.731 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.4 mt -102.52 149.6 24.23 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.262 2.225 . . . . 1.55 109.882 -175.8 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -103.25 132.12 49.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.176 -3.453 . . . . 1.95 110.979 177.479 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.461 HG23 ' HG3' ' A' ' 1' ' ' MET . 12.6 m -137.43 160.96 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 104.97 -2.233 . . . . 0.96 104.97 -169.078 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -107.5 155.97 38.66 Favored Pre-proline 0 N--CA 1.431 -1.392 0 O-C-N 120.484 -1.385 . . . . 2.35 108.872 166.352 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.67 -27.53 38.35 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 C-N-CA 124.274 3.316 . . . . 0.95 113.24 -166.715 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.6 m -92.17 3.74 54.69 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 116.014 -1.946 . . . . 1.45 113.626 -179.796 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -59.14 145.91 40.72 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 120.206 1.366 . . . . 1.69 113.284 171.824 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -79.73 159.45 26.61 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 104.873 -2.269 . . . . 0.75 104.873 175.462 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.3 mm -65.45 -37.81 80.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 119.399 -2.063 . . . . 0.73 110.159 177.095 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -49.49 -41.49 40.83 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 130.21 3.404 . . . . 1.62 117.69 164.571 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -77.64 -3.79 42.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 124.149 0.905 . . . . 2.13 113.184 174.79 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.04 -36.81 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 105.159 -2.163 . . . . 0.62 105.159 175.948 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -61.07 -38.17 85.28 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.496 2.093 . . . . 1.22 109.919 175.405 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.42 -36.3 68.8 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.402 -2.686 . . . . 0.51 117.856 167.029 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -69.0 -33.63 73.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.3 -4.0 . . . . 1.44 112.886 172.071 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.0 mt -66.16 -34.77 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 114.225 -2.798 . . . . 1.32 113.974 172.589 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -68.11 -39.24 82.82 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 122.359 2.345 . . . . 1.7 107.07 178.51 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -62.57 -47.06 85.5 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.468 -2.02 . . . . 1.55 110.246 178.718 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -75.52 -63.0 1.38 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.287 -2.133 . . . . 2.62 116.549 -177.389 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -94.41 -47.92 6.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.252 1.821 . . . . 1.48 115.432 -173.478 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.31 -2.4 6.19 Favored Glycine 0 N--CA 1.431 -1.698 0 CA-C-O 127.651 3.917 . . . . 1.12 112.862 174.523 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 21.2 mt -71.29 131.69 86.58 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 117.464 -3.374 . . . . 1.55 111.016 -175.085 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 17.2 Cg_exo -88.26 165.71 6.79 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 125.249 2.911 . . . . 1.02 110.371 -176.889 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.42 -14.76 28.02 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 C-N-CA 122.037 1.825 . . . . 1.25 115.265 -173.341 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -61.36 -36.64 80.75 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.882 3.273 . . . . 2.25 112.479 172.356 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -106.07 -9.83 16.81 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 126.5 1.92 . . . . 2.02 110.095 -172.474 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -82.27 103.34 11.79 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.258 -2.151 . . . . 0.69 112.213 -175.19 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -114.71 137.41 51.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.514 2.578 . . . . 2.78 105.392 164.851 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 mt -108.66 134.42 51.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.391 -3.943 . . . . 1.17 112.24 172.132 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 93.3 mt -116.44 128.92 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 125.923 2.773 . . . . 1.38 107.172 177.712 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -137.19 142.19 42.13 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.506 -2.622 . . . . 1.5 106.455 173.754 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.26 13.9 3.33 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.294 2.638 . . . . 1.21 117.121 -176.706 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.01 -16.85 57.95 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-O 122.78 1.211 . . . . 1.3 112.384 -178.324 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -101.47 154.22 19.02 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.759 -3.789 . . . . 2.55 108.631 -178.892 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -82.19 132.69 35.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 124.999 1.437 . . . . 2.48 111.674 170.265 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 mt -89.27 140.79 29.13 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 122.041 2.2 . . . . 0.9 114.301 -176.184 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -81.91 142.91 32.06 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 128.032 2.533 . . . . 1.94 110.943 178.265 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -61.02 -56.31 22.58 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.916 2.086 . . . . 1.56 113.352 -174.531 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.37 37.58 2.59 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 116.021 -2.544 . . . . 0.97 114.359 176.51 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -114.91 164.36 14.25 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.192 -1.781 . . . . 2.49 106.192 166.922 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -114.0 167.18 10.88 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.169 -2.207 . . . . 0.76 112.702 -176.932 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.9 mp -64.25 -42.12 96.65 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.514 2.726 . . . . 1.05 111.672 177.482 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.1 p -70.02 -37.46 75.64 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 117.81 -1.09 . . . . 1.19 113.081 -179.629 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.19 -40.76 98.44 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.004 1.722 . . . . 1.9 115.627 174.198 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -75.21 -16.47 60.48 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.987 -3.57 . . . . 0.89 107.557 177.398 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 70.97 48.64 0.38 Allowed 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.542 1.137 . . . . 1.84 112.421 -174.361 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.8 mt -86.5 107.88 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 113.56 -1.654 . . . . 0.82 110.216 175.831 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -95.38 -160.76 0.81 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.058 2.543 . . . . 2.16 112.071 -174.967 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -76.21 138.37 40.6 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 116.997 -3.564 . . . . 2.12 111.762 174.565 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.309 5.4 tt0 71.37 69.81 0.17 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 127.866 3.229 . . . . 1.71 110.991 174.529 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.397 55.2 m -116.01 144.61 43.86 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.423 -2.673 . . . . 1.04 109.287 -174.817 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.4 m -104.07 102.72 12.47 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.94 -1.504 . . . . 0.79 106.94 175.375 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.0 mt -91.31 123.93 35.12 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.518 -2.614 . . . . 1.4 108.023 170.757 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -92.65 109.14 20.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.645 0.778 . . . . 1.51 110.59 -178.093 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.1 tp -91.07 113.77 26.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.321 1.534 . . . . 1.14 112.378 -179.752 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.4 m -102.78 160.63 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 124.808 2.242 . . . . 1.23 106.43 178.548 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.6 tp -96.05 115.81 28.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.837 -1.529 . . . . 2.78 114.24 176.397 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -95.94 121.9 38.17 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 105.018 -2.216 . . . . 3.75 105.018 -179.732 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.4 mt -96.28 175.91 6.26 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.26 -0.882 . . . . 3.14 112.416 172.289 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -84.7 106.05 15.95 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.413 2.054 . . . . 6.8 114.175 174.586 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.31 -165.27 37.84 Favored Glycine 0 N--CA 1.43 -1.738 0 O-C-N 119.445 -2.035 . . . . 3.57 113.706 -166.228 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.772 0 CA-C-O 115.597 -2.78 . . . . 3.87 109.993 -176.036 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptt? . . . . . 0 CA--C 1.49 -1.349 1 CA-C-O 129.473 4.463 . . . . 1.1 110.689 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -91.03 146.75 23.59 Favored 'General case' 0 N--CA 1.431 -1.41 1 O-C-N 113.862 -5.524 . . . . 1.87 110.089 -176.555 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.329 13.9 pt -135.97 153.0 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 129.346 3.058 . . . . 0.72 109.109 178.526 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -112.95 141.98 46.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 126.459 3.028 . . . . 1.4 107.755 176.096 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -134.56 122.02 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 118.263 -2.773 . . . . 0.58 107.842 170.238 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -96.23 137.26 35.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.771 -1.559 . . . . 2.09 111.027 175.41 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.415 HG22 HD23 ' A' ' 69' ' ' LEU 0.289 44.8 p -77.15 172.67 12.88 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 126.27 2.938 . . . . 0.99 110.363 175.035 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 tp -64.17 -51.34 64.28 Favored 'General case' 0 N--CA 1.429 -1.494 1 O-C-N 115.849 -4.282 . . . . 2.53 113.622 174.965 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.379 75.4 p -61.06 -41.7 97.09 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.563 1.69 . . . . 2.08 115.563 174.552 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.34 9.97 0.2 Allowed Glycine 0 N--CA 1.429 -1.787 0 N-CA-C 116.945 1.538 . . . . 1.31 116.945 175.005 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -84.37 118.5 24.27 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.427 -2.219 . . . . 1.4 114.165 -174.353 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.6 m -93.47 126.77 38.79 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 121.785 2.084 . . . . 0.78 109.415 179.485 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mt -116.87 111.73 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 127.179 2.192 . . . . 1.55 113.153 -178.191 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.1 m -81.2 121.31 25.99 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 126.519 1.928 . . . . 1.08 107.596 177.087 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.5 mt -124.9 146.86 49.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 100.712 -3.81 . . . . 1.55 100.712 -179.475 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -106.18 122.68 46.69 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 118.393 -2.692 . . . . 1.95 108.371 169.909 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.9 m -129.74 152.04 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 126.584 3.087 . . . . 0.96 107.247 -172.99 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -94.1 151.05 39.35 Favored Pre-proline 0 N--CA 1.429 -1.507 1 O-C-N 114.869 -4.894 . . . . 2.35 106.254 156.273 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -76.53 -6.68 17.24 Favored 'Trans proline' 0 N--CA 1.433 -2.05 0 CA-C-N 125.72 3.078 . . . . 0.95 113.525 -174.756 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -87.01 -3.02 59.05 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 125.632 1.833 . . . . 1.45 111.913 -178.466 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -76.37 156.63 33.09 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 129.515 3.126 . . . . 1.69 109.334 171.383 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 4.5 p -84.98 166.61 16.61 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.402 -2.686 . . . . 0.75 111.794 177.529 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.22 -42.81 97.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 126.419 1.888 . . . . 0.73 109.395 174.939 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -46.35 -44.28 16.77 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.624 3.194 . . . . 1.62 119.624 164.812 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -67.17 -32.97 74.43 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.306 1.595 . . . . 2.13 115.306 173.522 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.3 t -64.15 -39.05 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 126.933 3.254 . . . . 0.62 111.966 169.771 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -59.15 -44.05 92.09 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.324 -2.735 . . . . 1.22 115.268 173.876 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.3 -33.0 65.13 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.056 -2.278 . . . . 0.51 111.401 173.788 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -76.54 -26.39 55.13 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 115.342 1.608 . . . . 1.44 115.342 173.96 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.7 mt -70.96 -28.25 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 119.739 -1.851 . . . . 1.32 114.558 169.146 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -70.92 -33.55 70.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.81 3.244 . . . . 1.7 108.111 179.559 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -74.95 -34.26 62.03 Favored 'General case' 0 N--CA 1.431 -1.408 1 C-N-CA 132.998 4.519 . . . . 1.55 112.356 175.47 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.9 mmtm -89.33 -64.72 1.1 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 127.959 3.742 . . . . 2.62 110.099 -171.078 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -93.93 -42.08 9.26 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.04 -2.287 . . . . 1.48 113.621 -170.533 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.73 5.74 21.93 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 121.254 3.261 . . . . 1.12 121.254 175.638 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.1 mt -74.92 129.69 82.68 Favored Pre-proline 0 N--CA 1.431 -1.414 0 C-N-CA 128.747 2.819 . . . . 1.55 110.436 -178.186 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.527 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 8.8 Cg_endo -77.3 141.93 20.84 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 126.077 3.206 . . . . 1.02 111.998 -177.244 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.527 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 32.8 Cg_exo -58.27 -17.53 33.28 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 N-CA-C 118.739 2.554 . . . . 1.25 118.739 -173.061 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -79.04 -23.2 44.43 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 114.863 1.431 . . . . 2.25 114.863 171.349 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -88.66 -13.75 39.06 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.351 -2.093 . . . . 2.02 108.111 176.765 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.329 69.2 mt-30 -98.12 143.76 28.31 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 121.163 1.802 . . . . 0.69 110.9 -174.316 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -135.87 135.79 40.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 121.398 0.618 . . . . 2.78 111.037 171.301 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.0 mt -102.84 134.75 45.72 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 117.254 -3.404 . . . . 1.17 115.702 172.139 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.3 mt -118.53 130.28 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 114.724 -1.125 . . . . 1.38 108.322 -179.484 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -136.29 123.15 21.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.139 -2.85 . . . . 1.5 118.009 176.167 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.54 40.44 23.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.046 1.738 . . . . 1.21 110.631 -171.445 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.92 -8.45 50.5 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-O 114.465 -3.408 . . . . 1.3 114.922 179.537 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -85.39 135.5 33.85 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 120.002 1.901 . . . . 2.55 110.706 175.348 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -84.69 120.69 26.69 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.748 2.689 . . . . 2.48 108.475 164.927 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.1 mt -80.25 107.99 13.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 118.204 2.668 . . . . 0.9 118.204 -173.726 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.269 33.2 mt-10 -52.9 121.98 8.36 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 121.525 3.898 . . . . 1.94 121.525 170.434 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.12 -57.82 1.25 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 131.158 3.783 . . . . 1.56 115.756 -174.075 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.89 39.19 2.84 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 127.73 2.586 . . . . 0.97 116.613 175.186 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -121.35 172.37 8.08 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.081 1.896 . . . . 2.49 106.142 167.385 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.301 62.2 p -87.83 176.67 7.27 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 118.944 -2.348 . . . . 0.76 113.959 168.663 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.4 mt -80.53 -25.78 38.47 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.446 1.899 . . . . 1.05 109.409 165.771 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.56 -39.55 62.21 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 107.657 -1.238 . . . . 1.19 107.657 -170.641 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -43.61 -57.79 2.98 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 126.783 2.033 . . . . 1.9 116.078 169.351 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -71.49 -1.31 12.87 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 119.279 3.066 . . . . 0.89 119.279 -178.588 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.396 23.1 m120 62.2 49.9 4.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 131.003 3.721 . . . . 1.84 113.083 -170.198 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.4 mt -87.64 137.31 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 123.508 2.867 . . . . 0.82 109.247 174.988 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -122.51 -176.56 3.41 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.833 2.254 . . . . 2.16 110.528 -175.762 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 ptmm? -62.59 139.55 58.63 Favored 'General case' 0 N--CA 1.429 -1.487 1 O-C-N 116.206 -4.059 . . . . 2.12 111.898 -177.513 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 62.61 31.52 16.79 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.856 2.862 . . . . 1.71 109.15 175.307 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 t -95.01 137.45 34.05 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.458 -2.651 . . . . 1.04 109.994 -179.897 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.2 m -88.07 121.58 30.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 126.929 2.643 . . . . 0.79 112.035 -177.767 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 72.2 mt -105.28 152.79 22.46 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 128.631 2.772 . . . . 1.4 105.871 176.9 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -101.82 125.32 48.47 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.439 -2.663 . . . . 1.51 107.261 -177.48 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.415 HD23 HG22 ' A' ' 7' ' ' THR . 27.2 tp -96.93 126.28 41.96 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 124.296 3.225 . . . . 1.14 110.949 178.131 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.9 m -131.1 176.98 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 118.366 -2.709 . . . . 1.23 111.162 172.012 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 67.7 mt -101.39 133.49 45.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.724 -1.86 . . . . 2.78 114.064 178.431 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.3 ttt-85 -86.56 75.93 9.65 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 126.501 1.92 . . . . 3.75 110.805 170.613 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.9 mt -81.95 163.19 22.36 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 113.627 -1.624 . . . . 3.14 110.781 -178.27 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -73.04 -178.5 2.85 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 127.359 2.264 . . . . 6.8 116.683 174.464 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.24 40.65 9.02 Favored Glycine 0 N--CA 1.432 -1.619 0 N-CA-C 120.03 2.772 . . . . 3.57 120.03 -170.286 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.773 0 C-N-CA 116.604 -2.713 . . . . 3.87 111.608 -175.488 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 112.157 0.429 . . . . 1.1 112.157 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -108.96 140.73 42.07 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.316 -2.74 . . . . 1.87 105.678 177.588 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.4 pt -128.86 153.17 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 106.486 -1.672 . . . . 0.72 106.486 173.477 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -109.75 105.82 15.21 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.501 -2.0 . . . . 1.4 115.226 179.188 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.0 t -94.58 115.95 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 117.801 -3.062 . . . . 0.58 105.762 176.565 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -95.39 156.91 16.12 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.689 2.185 . . . . 2.09 108.013 175.502 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.2 p -105.06 -171.61 1.95 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.994 1.318 . . . . 0.99 110.252 -178.404 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.9 mt -85.88 -36.84 19.71 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 115.701 -4.375 . . . . 2.53 114.242 172.477 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.251 38.6 p -80.06 -54.84 5.41 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.589 -2.004 . . . . 2.08 105.589 -175.339 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.02 23.77 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 120.241 2.856 . . . . 1.31 120.241 171.541 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -88.18 135.83 33.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 117.684 -1.15 . . . . 1.4 111.058 -179.917 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.8 m -109.79 111.65 23.23 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.359 -1.349 . . . . 0.78 107.359 169.851 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 mt -92.3 105.54 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 104.835 -2.283 . . . . 1.55 104.835 -177.315 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.8 m -85.36 107.6 17.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.673 -3.142 . . . . 1.08 106.174 178.159 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.8 mt -101.13 144.17 30.35 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 114.318 1.229 . . . . 1.55 114.318 -177.973 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -101.05 118.88 37.88 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.678 2.656 . . . . 1.95 110.875 174.952 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.8 m -130.26 158.57 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 123.863 1.792 . . . . 0.96 110.614 -172.412 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -113.26 170.73 4.99 Favored Pre-proline 0 N--CA 1.43 -1.45 0 O-C-N 117.772 -3.08 . . . . 2.35 105.408 159.358 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -87.21 -9.55 6.05 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 C-N-CA 122.342 2.028 . . . . 0.95 114.006 -167.836 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.261 81.5 p -85.04 0.85 50.14 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 131.284 3.833 . . . . 1.45 116.079 173.445 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -86.7 145.33 26.72 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.673 -3.142 . . . . 1.69 111.552 169.098 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.5 p -59.75 155.41 16.04 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.718 2.199 . . . . 0.75 112.559 168.979 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.253 3.3 mt -63.19 -37.13 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 119.654 -1.904 . . . . 0.73 112.551 170.332 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -53.09 -40.55 64.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.075 1.509 . . . . 1.62 115.075 165.655 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -61.02 -32.98 72.57 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 118.275 2.695 . . . . 2.13 118.275 174.186 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.318 45.6 t -71.2 -35.85 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 122.387 1.089 . . . . 0.62 110.196 -178.42 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -70.08 -24.37 63.22 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 132.042 4.137 . . . . 1.22 113.593 174.442 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.56 -33.99 62.82 Favored 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 116.298 -4.001 . . . . 0.51 111.644 174.941 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -69.1 -25.93 64.66 Favored 'General case' 0 N--CA 1.431 -1.395 1 O-C-N 114.972 -4.83 . . . . 1.44 115.522 178.429 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 mt -68.01 -39.64 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 1 C-N-CA 132.499 4.32 . . . . 1.32 112.397 170.594 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -60.11 -36.68 77.99 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.718 2.488 . . . . 1.7 117.718 178.332 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.03 -57.9 10.88 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 116.544 -1.693 . . . . 1.55 114.127 163.242 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -62.78 -61.84 2.13 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 118.284 2.698 . . . . 2.62 118.284 -177.722 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -93.79 -32.34 14.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.9 -3.0 . . . . 1.48 109.584 -171.81 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.88 16.78 22.86 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 116.92 -2.562 . . . . 1.12 115.629 172.699 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.4 mt -90.58 131.96 36.54 Favored Pre-proline 0 N--CA 1.43 -1.455 1 CA-C-O 110.889 -4.386 . . . . 1.55 110.66 179.237 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -57.68 146.67 83.96 Favored 'Trans proline' 0 C--N 1.299 -2.056 0 CA-C-N 127.664 3.773 . . . . 1.02 116.954 171.767 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.66 -13.38 13.28 Favored 'Trans proline' 0 N--CA 1.434 -2.027 1 C-N-CA 125.674 4.249 . . . . 1.25 113.985 -175.077 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.391 9.6 p-10 -62.83 -31.78 72.86 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 119.724 1.147 . . . . 2.25 113.708 166.325 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -80.75 -26.89 37.03 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 123.813 1.768 . . . . 2.02 113.284 -176.398 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -84.67 142.78 29.65 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 111.711 -2.495 . . . . 0.69 111.252 -173.651 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -143.35 142.6 31.35 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.921 -1.49 . . . . 2.78 111.845 171.644 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.6 mt -105.19 146.63 28.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.92 2.295 . . . . 1.17 106.387 -178.38 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 mt -118.76 138.93 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 128.582 2.753 . . . . 1.38 104.51 174.29 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -144.58 120.44 10.6 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-O 124.971 2.32 . . . . 1.5 104.789 177.109 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.38 13.58 5.52 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 127.865 2.466 . . . . 1.21 114.912 175.435 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.29 -22.57 38.58 Favored Glycine 0 N--CA 1.43 -1.759 0 C-N-CA 127.487 2.47 . . . . 1.3 113.991 -171.571 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -80.57 134.96 36.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 126.548 3.07 . . . . 2.55 111.676 -177.267 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -77.8 128.79 34.57 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 117.195 -3.441 . . . . 2.48 111.942 176.778 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.6 mt -92.97 142.65 27.07 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.188 -2.195 . . . . 0.9 113.438 -172.356 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -79.86 148.01 31.5 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.077 2.951 . . . . 1.94 110.849 175.242 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -89.18 -34.27 16.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.167 1.914 . . . . 1.56 116.167 -168.468 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.36 21.03 6.42 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 128.488 2.947 . . . . 0.97 117.698 171.979 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -105.55 178.2 4.63 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 119.698 1.749 . . . . 2.49 108.187 169.311 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -108.84 -172.94 2.15 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 124.905 2.288 . . . . 0.76 107.274 167.164 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.6 mt -66.06 -43.87 86.2 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 128.436 3.97 . . . . 1.05 112.889 171.089 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.4 m -53.27 -25.97 16.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.179 -3.451 . . . . 1.19 118.291 -179.734 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -78.37 -44.83 23.99 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.115 2.966 . . . . 1.9 111.841 177.386 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -80.76 9.87 5.7 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 129.949 3.3 . . . . 0.89 114.648 174.949 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.27 10.2 p30 47.93 39.8 11.68 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 129.044 2.938 . . . . 1.84 114.176 -178.888 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.304 12.7 mt -77.92 127.56 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 116.856 -3.652 . . . . 0.82 109.555 179.966 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 -107.58 -178.37 3.61 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 125.655 2.645 . . . . 2.16 106.369 178.427 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -64.22 159.22 21.19 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 115.74 -4.35 . . . . 2.12 110.467 -177.484 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.421 19.9 mt-10 59.41 41.53 19.34 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 116.966 -3.583 . . . . 1.71 112.657 169.389 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.2 p -106.36 135.14 48.38 Favored 'General case' 0 N--CA 1.431 -1.397 1 O-C-N 114.857 -4.902 . . . . 1.04 109.9 -173.373 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.5 m -86.44 116.55 24.66 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.477 -2.64 . . . . 0.79 107.163 175.808 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.6 mp -109.45 160.57 16.09 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 112.862 -1.972 . . . . 1.4 110.29 172.594 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -127.39 139.53 52.78 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.949 -2.344 . . . . 1.51 112.046 -176.681 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.6 tp -103.46 127.13 50.91 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 130.695 3.598 . . . . 1.14 109.16 -177.495 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.0 m -135.15 163.95 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 O-C-N 116.351 -3.968 . . . . 1.23 110.557 166.476 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.6 mt -98.07 158.69 15.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 117.024 -1.465 . . . . 2.78 113.278 170.77 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -80.45 142.48 34.25 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 117.125 2.269 . . . . 3.75 117.125 -178.5 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.5 mt -88.4 112.81 23.33 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 104.692 -2.336 . . . . 3.14 104.692 172.95 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -81.46 120.45 25.02 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 114.146 -5.346 . . . . 6.8 110.65 173.827 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.1 -128.72 1.1 Allowed Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 107.131 -2.388 . . . . 3.57 107.131 -173.543 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.778 0 C-N-CA 128.153 2.787 . . . . 3.87 111.496 -178.262 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 CA--C 1.49 -1.36 0 CA-C-O 125.998 2.809 . . . . 1.1 103.709 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -90.28 125.75 35.61 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.969 -3.582 . . . . 1.87 109.432 -179.328 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -127.65 150.49 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 118.926 -1.109 . . . . 0.72 109.092 170.148 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.262 33.3 m-85 -115.03 121.86 44.4 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 124.28 1.99 . . . . 1.4 112.314 -172.027 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -103.12 107.97 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 119.677 -1.889 . . . . 0.58 110.903 178.309 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -85.61 158.66 20.05 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 118.806 -2.434 . . . . 2.09 107.474 177.781 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.3 p -108.43 -167.52 1.24 Allowed 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 106.824 -1.547 . . . . 0.99 106.824 175.3 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.6 mt -88.69 -30.75 18.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 119.865 1.211 . . . . 2.53 109.171 178.592 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.9 p -70.57 -27.65 64.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.055 -2.278 . . . . 2.08 106.542 -179.478 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.34 18.66 6.13 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-O 122.432 1.018 . . . . 1.31 115.592 173.362 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -82.63 117.86 22.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 117.041 -1.457 . . . . 1.4 113.375 -177.463 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.288 89.2 m -85.35 115.41 23.08 Favored 'General case' 0 N--CA 1.431 -1.389 1 CA-C-N 126.202 4.092 . . . . 0.78 114.115 175.396 . . . . . . . . 3 2 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 13' ' ' ILE . 53.2 mt -100.56 107.31 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 1 O-C-N 114.963 -4.836 . . . . 1.55 110.6 178.629 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.7 m -80.68 116.3 20.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.954 -2.341 . . . . 1.08 114.057 175.562 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.9 mt -107.6 127.98 54.12 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.55 -1.969 . . . . 1.55 107.717 178.009 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -96.15 99.83 11.53 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.376 -2.702 . . . . 1.95 104.619 170.69 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.3 m -112.38 164.63 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 105.681 -1.97 . . . . 0.96 105.681 -176.406 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -104.78 163.73 16.61 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 105.618 -1.993 . . . . 2.35 105.618 165.663 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -86.82 -8.93 6.72 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 O-C-N 113.932 -3.773 . . . . 0.95 108.759 -166.402 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.25 4.9 p -90.72 1.14 57.12 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 119.763 -0.775 . . . . 1.45 111.674 177.149 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.27 36.2 m-20 -63.01 148.7 46.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 129.694 3.198 . . . . 1.69 108.737 172.173 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 23.5 p -97.99 163.87 12.59 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 118.846 -2.409 . . . . 0.75 112.632 173.893 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.417 HD12 HD13 ' A' ' 50' ' ' LEU 0.298 24.1 mm -63.41 -34.98 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 120.062 1.301 . . . . 0.73 111.099 -179.581 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -48.77 -39.95 27.04 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 117.948 -2.97 . . . . 1.62 115.243 160.279 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -75.84 -48.65 20.66 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.508 -2.62 . . . . 2.13 107.905 -176.741 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.401 ' CG2' HD11 ' A' ' 56' ' ' LEU . 52.6 t -49.1 -54.25 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.989 2.916 . . . . 0.62 116.334 172.56 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -50.97 -32.75 22.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.427 -1.421 . . . . 1.22 113.876 175.983 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.88 -40.02 91.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.181 3.372 . . . . 0.51 114.068 178.789 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -58.79 -40.94 85.49 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.78 -3.075 . . . . 1.44 112.378 176.245 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.4 mt -70.5 -31.6 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 116.487 -3.883 . . . . 1.32 112.061 176.139 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -69.13 -33.39 73.38 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 119.434 -2.041 . . . . 1.7 111.453 171.929 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.355 17.5 t70 -77.13 -44.3 30.87 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.43 2.011 . . . . 1.55 116.43 167.814 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -65.33 -60.56 2.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.194 -3.441 . . . . 2.62 111.092 -171.099 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -105.13 -37.16 7.02 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 124.283 1.992 . . . . 1.48 109.355 -166.251 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.92 38.39 2.35 Favored Glycine 0 N--CA 1.43 -1.752 0 O-C-N 117.56 -3.213 . . . . 1.12 111.575 168.752 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.5 mt -111.08 122.23 38.48 Favored Pre-proline 0 N--CA 1.43 -1.465 0 O-C-N 118.577 -2.719 . . . . 1.55 106.395 -174.441 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 18.5 Cg_endo -57.76 141.73 95.79 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 O-C-N 115.65 -2.868 . . . . 1.02 116.819 175.448 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 67.6 Cg_exo -64.83 -32.96 54.87 Favored 'Trans proline' 0 N--CA 1.433 -2.03 1 C-N-CA 127.54 5.493 . . . . 1.25 111.797 -174.136 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -51.14 -39.35 56.09 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 129.871 3.268 . . . . 2.25 113.996 168.158 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -82.19 -5.22 58.33 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.11 1.909 . . . . 2.02 112.688 178.248 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -99.6 113.76 26.38 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 116.333 -3.98 . . . . 0.69 108.27 -166.933 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -89.29 123.02 33.11 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 125.31 2.481 . . . . 2.78 104.823 163.017 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.2 mt -109.29 119.67 40.2 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.039 -5.413 . . . . 1.17 105.267 175.385 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.3 mm -108.51 133.16 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 128.306 2.643 . . . . 1.38 113.037 179.57 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -130.93 114.31 15.09 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 129.298 4.124 . . . . 1.5 111.05 174.074 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.01 -92.14 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.162 2.185 . . . . 1.21 113.306 -178.437 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.79 23.0 4.01 Favored Glycine 0 N--CA 1.431 -1.696 0 C-N-CA 127.676 2.56 . . . . 1.3 112.536 174.106 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.9 mmtt -123.33 129.95 52.04 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.09 -1.829 . . . . 2.55 110.212 -179.36 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -87.55 125.13 34.15 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 117.185 -3.447 . . . . 2.48 105.274 172.014 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.417 HD13 HD12 ' A' ' 23' ' ' ILE . 99.3 mt -82.11 126.69 32.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.082 -1.636 . . . . 0.9 111.906 -162.104 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -76.13 147.97 38.16 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.644 -2.535 . . . . 1.94 111.938 168.772 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.276 42.6 m-20 -61.11 -65.65 0.66 Allowed 'General case' 0 N--CA 1.431 -1.419 1 N-CA-C 123.201 4.519 . . . . 1.56 123.201 -171.271 . . . . . . . . 3 2 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.82 32.92 3.36 Favored Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 122.045 3.578 . . . . 0.97 122.045 178.886 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.7 mtt-85 -102.7 153.65 19.93 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 103.697 -2.705 . . . . 2.49 103.697 169.875 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.268 8.1 p -77.43 153.56 33.48 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 131.043 3.737 . . . . 0.76 110.328 171.733 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.401 HD11 ' CG2' ' A' ' 26' ' ' VAL . 1.5 mt -59.74 -42.15 92.52 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.017 -0.992 . . . . 1.05 111.847 172.118 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.6 p -56.81 -36.56 70.06 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.564 2.346 . . . . 1.19 111.725 179.067 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -66.41 -45.7 79.04 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.871 1.669 . . . . 1.9 111.7 -177.197 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -72.19 -9.16 58.08 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 116.966 2.21 . . . . 0.89 116.966 170.62 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 61.46 53.01 3.51 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.496 1.518 . . . . 1.84 112.504 -177.68 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.8 mt -89.05 113.78 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 130.791 3.637 . . . . 0.82 105.038 176.079 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -99.52 -169.9 1.82 Allowed 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.301 1.593 . . . . 2.16 115.301 178.504 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -66.32 141.25 58.06 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.765 1.745 . . . . 2.12 110.791 176.38 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 67.23 24.98 9.01 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 112.437 -2.165 . . . . 1.71 113.272 172.918 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.3 m -75.58 144.6 41.75 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.855 1.312 . . . . 1.04 112.732 -175.874 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 m -97.57 123.46 41.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 118.071 -1.451 . . . . 0.79 108.518 -176.081 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.8 mp -122.26 163.38 19.74 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 104.508 -2.404 . . . . 1.4 104.508 178.195 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.263 43.6 m80 -134.63 112.03 10.49 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.46 2.552 . . . . 1.51 110.822 -172.302 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.05 122.74 22.26 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.695 2.398 . . . . 1.14 111.605 175.397 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.5 t -123.01 136.27 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 102.506 -3.146 . . . . 1.23 102.506 175.202 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.7 tp -98.35 125.68 43.58 Favored 'General case' 0 N--CA 1.429 -1.487 1 O-C-N 114.822 -4.924 . . . . 2.78 111.027 -174.45 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -84.5 117.11 23.48 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.18 1.792 . . . . 3.75 109.225 176.075 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.6 mt -83.07 -166.45 1.35 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.988 1.715 . . . . 3.14 112.223 168.712 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -83.81 176.19 9.11 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.825 1.774 . . . . 6.8 112.506 172.127 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.93 42.77 96.72 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 118.125 2.01 . . . . 3.57 118.125 -167.291 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.83 0 O-C-N 119.908 -1.936 . . . . 3.87 109.24 172.188 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 ptt? . . . . . 0 CA--C 1.491 -1.325 0 N-CA-C 118.225 2.676 . . . . 1.1 118.225 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.257 7.1 tt0 -117.83 123.27 45.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.677 2.791 . . . . 1.87 114.206 -178.498 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.4 pt -127.94 160.47 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 117.774 -3.079 . . . . 0.72 106.922 174.457 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -118.71 132.79 56.16 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.38 3.472 . . . . 1.4 106.231 -173.355 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 t -122.97 125.59 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 123.447 0.699 . . . . 0.58 110.772 170.851 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.344 19.4 mttm -103.05 145.41 29.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.967 2.794 . . . . 2.09 115.067 179.598 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.301 22.9 p -91.45 168.68 11.37 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.722 -4.362 . . . . 0.99 116.291 173.653 . . . . . . . . 3 2 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.342 31.6 tp -59.31 -56.65 19.4 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.673 2.101 . . . . 2.53 116.673 169.603 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 p -61.89 -60.85 3.03 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 114.35 -1.295 . . . . 2.08 112.002 -176.075 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.86 30.53 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 117.964 -2.065 . . . . 1.31 117.214 173.105 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -111.36 146.3 37.35 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.696 -2.061 . . . . 1.4 111.305 -178.509 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.8 m -112.69 104.61 12.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 104.065 -2.568 . . . . 0.78 104.065 167.602 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.2 mt -91.0 123.53 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 122.213 1.006 . . . . 1.55 108.379 -176.447 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 m -94.31 120.89 35.21 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 118.488 -2.632 . . . . 1.08 109.318 -179.957 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.6 mt -113.14 143.51 44.25 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 126.929 3.252 . . . . 1.55 112.215 179.551 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -86.2 112.35 21.26 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 111.805 -2.452 . . . . 1.95 107.004 171.237 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.13 149.86 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.989 1.716 . . . . 0.96 114.922 -177.613 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -108.79 149.54 39.65 Favored Pre-proline 0 N--CA 1.43 -1.438 0 N-CA-C 103.651 -2.722 . . . . 2.35 103.651 172.418 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -63.94 -19.7 67.0 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 123.428 2.752 . . . . 0.95 113.178 -173.84 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.4 p -80.73 -16.77 53.04 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 130.08 3.352 . . . . 1.45 110.683 -177.51 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -60.24 145.63 46.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 116.779 -1.968 . . . . 1.69 113.892 172.428 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.9 p -80.25 162.62 24.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.537 2.113 . . . . 0.75 108.905 176.461 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.491 HG23 HD12 ' A' ' 43' ' ' LEU . 24.3 mm -64.87 -30.5 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 126.833 3.206 . . . . 0.73 112.016 177.125 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.6 -39.17 91.27 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 114.693 -5.004 . . . . 1.62 112.217 167.059 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.253 15.8 m-80 -70.39 -32.73 70.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 119.892 1.224 . . . . 2.13 112.552 171.683 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.35 43.4 t -53.57 -48.67 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 1 O-C-N 114.287 -5.258 . . . . 0.62 112.72 167.825 . . . . . . . . 3 2 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -56.06 -41.25 74.78 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.187 1.921 . . . . 1.22 116.187 174.531 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.3 -31.74 72.96 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.431 1.493 . . . . 0.51 112.637 172.275 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -66.22 -38.59 88.3 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 127.494 3.521 . . . . 1.44 115.673 176.119 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.7 mt -73.07 -36.99 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 117.636 -3.165 . . . . 1.32 107.596 172.911 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.454 ' HG3' ' HD3' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -62.64 -35.2 78.85 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 123.851 3.023 . . . . 1.7 113.844 179.431 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.45 -54.72 24.39 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.461 1.904 . . . . 1.55 109.726 175.188 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.5 mmtt -57.83 -77.64 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.479 3.038 . . . . 2.62 115.638 -179.08 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -101.68 -20.78 14.85 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.166 -3.458 . . . . 1.48 110.142 -161.895 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.77 53.81 2.48 Favored Glycine 0 N--CA 1.431 -1.682 0 O-C-N 120.412 -1.43 . . . . 1.12 115.165 172.524 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.417 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 6.1 mt -108.05 117.04 55.99 Favored Pre-proline 0 N--CA 1.43 -1.436 0 CA-C-O 113.51 -3.138 . . . . 1.55 110.153 -175.773 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.499 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 50.3 Cg_exo -67.32 127.24 16.26 Favored 'Trans proline' 0 C--N 1.299 -2.054 0 CA-C-N 126.241 3.265 . . . . 1.02 117.292 -179.654 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 27.5 Cg_exo -59.49 -31.13 94.15 Favored 'Trans proline' 0 N--CA 1.434 -2.016 1 C-N-CA 127.527 5.485 . . . . 1.25 118.406 -172.402 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -64.9 -24.68 67.6 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.753 2.821 . . . . 2.25 108.445 178.721 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -94.02 12.71 25.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.912 -2.368 . . . . 2.02 116.53 173.733 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.275 9.6 mt-30 -115.29 147.21 40.69 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.217 2.437 . . . . 0.69 110.675 -178.893 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.6 ptt85 -135.02 134.65 40.66 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 112.907 -1.951 . . . . 2.78 106.048 163.853 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.491 HD12 HG23 ' A' ' 23' ' ' ILE . 44.3 mt -103.69 133.48 48.63 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 119.823 1.192 . . . . 1.17 113.203 179.64 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.4 mm -118.64 145.49 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 125.059 2.361 . . . . 1.38 108.553 177.9 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -134.54 108.79 8.29 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.013 -2.93 . . . . 1.5 103.92 172.295 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.519 . . 72.77 -97.33 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 116.666 2.099 . . . . 1.21 116.666 -176.961 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.9 17.52 1.97 Allowed Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 127.603 2.525 . . . . 1.3 108.532 -175.639 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.2 mttm -106.49 144.79 32.66 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.204 -2.35 . . . . 2.55 110.06 170.664 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -107.75 129.29 55.05 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.587 3.089 . . . . 2.48 115.345 169.649 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.7 mt -97.19 122.84 40.66 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.394 -3.941 . . . . 0.9 104.433 -160.342 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -77.09 138.66 39.67 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 117.633 -3.167 . . . . 1.94 111.72 172.397 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -54.91 -41.14 70.6 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 130.489 3.515 . . . . 1.56 115.978 -170.131 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.38 31.24 6.9 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 126.537 2.018 . . . . 0.97 115.051 174.935 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.87 165.28 11.83 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.224 -1.399 . . . . 2.49 107.224 166.426 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 5.4 p -95.62 171.52 8.62 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 119.034 2.976 . . . . 0.76 119.034 169.179 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -59.35 -39.1 82.16 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 121.59 1.995 . . . . 1.05 112.171 169.772 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 t -64.3 -37.86 88.98 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 116.944 2.202 . . . . 1.19 116.944 -179.151 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -61.19 -21.59 63.96 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.657 -1.902 . . . . 1.9 113.851 174.071 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -109.52 12.35 24.48 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.659 2.936 . . . . 0.89 115.685 -178.962 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.401 6.4 t-20 62.6 39.24 11.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.683 2.793 . . . . 1.84 116.71 -177.093 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.7 mt -90.84 105.5 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 112.661 -2.063 . . . . 0.82 112.556 178.046 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -98.9 -171.59 2.13 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 122.23 2.286 . . . . 2.16 107.111 -174.551 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.253 21.8 pttp -61.54 149.01 40.26 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 126.698 1.999 . . . . 2.12 115.604 176.354 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.317 36.1 mt-10 67.19 13.18 9.32 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.804 1.779 . . . . 1.71 115.804 175.123 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.6 m -66.44 148.74 51.45 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.477 -2.014 . . . . 1.04 112.271 -177.835 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.6 m -103.45 97.92 7.9 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.808 1.766 . . . . 0.79 115.494 173.751 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 mp -87.26 152.43 22.31 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.526 -1.984 . . . . 1.4 113.993 -178.924 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.6 m170 -120.79 129.07 53.44 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.158 -1.589 . . . . 1.51 109.87 -173.788 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.4 tp -95.34 128.82 42.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.576 -1.327 . . . . 1.14 114.374 -176.175 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.4 159.0 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 124.163 1.935 . . . . 1.23 113.669 177.371 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 tp -88.55 138.71 31.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.786 -1.196 . . . . 2.78 110.852 -174.439 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -99.21 139.68 34.5 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.854 3.216 . . . . 3.75 106.186 178.407 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.7 mt -131.15 112.75 13.12 Favored 'General case' 0 N--CA 1.43 -1.428 1 N-CA-C 98.629 -4.582 . . . . 3.14 98.629 173.026 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.5 mtm180 -82.46 147.03 28.95 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.786 2.143 . . . . 6.8 116.786 168.771 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.86 -76.79 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 108.384 -1.886 . . . . 3.57 108.384 -168.528 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.761 0 C-N-CA 118.767 -1.682 . . . . 3.87 115.006 177.104 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.2 ttp . . . . . 0 CA--C 1.49 -1.355 0 CA-C-O 116.443 -1.741 . . . . 1.1 109.537 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -96.13 134.29 39.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.114 1.779 . . . . 1.87 109.064 176.69 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 pt -130.22 162.58 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 106.289 -1.745 . . . . 0.72 106.289 163.566 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -115.01 143.32 45.37 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.038 -1.664 . . . . 1.4 113.952 178.088 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.3 t -113.73 120.29 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 118.098 -2.876 . . . . 0.58 104.05 171.106 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -107.78 119.38 39.27 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 126.973 2.109 . . . . 2.09 106.641 177.547 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.3 p -84.13 163.55 19.73 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 121.165 -0.959 . . . . 0.99 111.724 -176.746 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.4 tp -39.56 -43.05 1.24 Allowed 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 118.713 2.857 . . . . 2.53 118.713 172.755 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.5 p -81.2 -24.86 37.16 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.892 1.995 . . . . 2.08 108.419 -176.7 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.44 31.24 3.3 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-O 125.402 2.668 . . . . 1.31 115.245 178.843 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -92.78 124.48 36.81 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.636 -2.685 . . . . 1.4 106.723 178.548 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -109.49 111.73 23.43 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.722 2.677 . . . . 0.78 112.026 175.315 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.262 36.1 pt -100.24 132.57 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 1 CA-C-O 128.847 4.165 . . . . 1.55 106.752 -178.691 . . . . . . . . 3 2 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 95.9 m -90.5 122.11 33.04 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.04 -2.913 . . . . 1.08 110.834 177.584 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.46 142.55 35.94 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.436 2.294 . . . . 1.55 112.675 176.547 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -110.57 118.61 36.68 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.548 2.339 . . . . 1.95 109.667 169.339 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.89 159.92 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 C-N-CA 124.016 0.926 . . . . 0.96 112.006 -178.676 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -92.05 156.26 42.36 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-O 116.424 -1.751 . . . . 2.35 112.693 159.57 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -73.11 -9.13 23.1 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 CA-C-N 126.139 3.228 . . . . 0.95 111.477 -177.285 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.4 m -79.04 -19.15 52.14 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 129.772 3.229 . . . . 1.45 108.545 177.934 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -61.04 137.45 58.23 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.488 2.774 . . . . 1.69 118.488 177.076 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.9 p -86.59 171.42 11.04 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 111.74 0.274 . . . . 0.75 111.74 177.193 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.402 HG13 ' HB3' ' A' ' 50' ' ' LEU . 10.0 mm -68.71 -33.79 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 114.588 1.329 . . . . 0.73 114.588 175.796 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -53.15 -43.44 67.0 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 117.551 2.426 . . . . 1.62 117.551 161.085 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -62.55 -42.53 99.59 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 120.553 1.524 . . . . 2.13 110.615 171.365 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 t -57.02 -48.84 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.449 1.5 . . . . 0.62 111.553 172.915 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -56.7 -34.53 67.52 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 116.953 -3.592 . . . . 1.22 117.627 172.977 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.85 -42.68 81.01 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 125.674 2.654 . . . . 0.51 112.922 176.819 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.27 13.6 mttm -60.02 -34.54 73.5 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 130.382 3.473 . . . . 1.44 115.174 173.584 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.0 mt -74.02 -35.44 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 129.395 3.078 . . . . 1.32 108.13 174.9 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -63.34 -32.03 73.35 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 119.705 3.224 . . . . 1.7 119.705 173.854 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -76.31 -20.41 57.31 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.631 1.973 . . . . 1.55 113.702 169.138 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -84.0 -47.44 10.97 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.657 -2.527 . . . . 2.62 109.942 177.42 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -131.86 -31.69 1.5 Allowed 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 118.453 2.76 . . . . 1.48 118.453 -167.421 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.57 60.99 1.07 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 104.248 -3.541 . . . . 1.12 104.248 169.997 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.1 mt -129.52 115.15 18.25 Favored Pre-proline 0 N--CA 1.43 -1.463 0 N-CA-C 104.699 -2.334 . . . . 1.55 104.699 178.077 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -70.57 160.2 50.27 Favored 'Trans proline' 0 N--CA 1.433 -2.053 1 CA-C-N 129.081 4.279 . . . . 1.02 116.19 -173.347 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.64 -35.13 99.08 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-N 123.682 2.351 . . . . 1.25 116.965 -176.551 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -55.7 -37.0 67.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.986 1.476 . . . . 2.25 114.986 171.635 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -84.32 -12.41 54.64 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 119.56 1.073 . . . . 2.02 111.657 -175.7 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -83.85 115.98 22.52 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.875 -1.528 . . . . 0.69 106.875 -178.561 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -109.2 95.41 5.62 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.525 1.766 . . . . 2.78 107.623 168.266 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.3 mt -87.57 132.53 34.02 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.184 -1.413 . . . . 1.17 107.184 -174.282 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.5 mm -117.19 133.83 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 126.77 2.028 . . . . 1.38 106.166 178.95 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.49 ' HB3' HD21 ' A' ' 50' ' ' LEU . 33.5 t80 -112.34 108.24 17.35 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.977 -1.86 . . . . 1.5 105.977 165.055 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.13 -83.31 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.924 2.89 . . . . 1.21 109.645 -177.474 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.15 -27.3 2.07 Favored Glycine 0 N--CA 1.43 -1.74 0 O-C-N 118.822 -2.424 . . . . 1.3 116.082 -176.019 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -95.59 155.23 16.83 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 126.353 2.978 . . . . 2.55 113.262 -178.572 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -93.91 129.09 40.48 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.77 -3.081 . . . . 2.48 107.764 178.766 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.49 HD21 ' HB3' ' A' ' 45' ' ' PHE . 29.2 mt -80.49 140.57 35.83 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.026 1.393 . . . . 0.9 112.469 -170.373 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -88.54 159.25 18.01 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.282 -4.011 . . . . 1.94 110.703 170.613 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.16 -50.79 15.16 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 127.207 2.203 . . . . 1.56 114.575 -171.264 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.83 62.82 0.78 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 119.058 -2.276 . . . . 0.97 117.14 171.499 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.25 31.4 mmt180 -122.66 153.62 39.12 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.956 -2.239 . . . . 2.49 104.956 164.728 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.1 p -89.62 171.94 9.31 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 119.488 1.04 . . . . 0.76 109.963 174.232 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 29.6 mt -81.18 -29.31 34.67 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.29 -0.881 . . . . 1.05 108.781 175.757 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 t -68.86 -35.76 77.3 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.101 -2.249 . . . . 1.19 112.272 179.053 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.84 -28.27 69.44 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.212 -2.805 . . . . 1.9 112.748 176.385 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -81.59 -13.12 58.4 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.162 -4.086 . . . . 0.89 115.432 179.578 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 77.81 26.75 0.62 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 126.609 2.443 . . . . 1.84 111.152 178.688 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.8 mt -70.0 113.2 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 127.205 3.383 . . . . 0.82 114.79 -179.26 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -95.03 171.97 8.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 114.932 -2.707 . . . . 2.16 110.911 -178.329 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -62.64 145.9 53.43 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.297 -2.752 . . . . 2.12 110.062 176.769 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 58.37 38.53 25.82 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 125.663 2.649 . . . . 1.71 112.379 175.462 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.2 t -98.97 141.79 31.29 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 104.082 -2.562 . . . . 1.04 104.082 179.51 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -96.57 121.11 38.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 127.404 2.282 . . . . 0.79 110.34 178.185 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -101.85 158.89 15.8 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 102.307 -3.22 . . . . 1.4 102.307 174.912 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -114.42 127.79 56.01 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.033 1.733 . . . . 1.51 114.348 -176.19 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.465 ' C ' HD23 ' A' ' 69' ' ' LEU . 4.2 tt -108.48 123.77 49.4 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 106.635 -1.616 . . . . 1.14 106.635 -178.278 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 t -104.37 142.94 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 104.92 -2.252 . . . . 1.23 104.92 173.702 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.49 HD12 ' HA ' ' A' ' 71' ' ' LEU . 7.9 tp -83.46 111.11 18.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.375 -1.774 . . . . 2.78 110.939 174.334 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -76.58 98.86 4.8 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 130.644 3.578 . . . . 3.75 108.26 168.726 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.7 tp -93.18 82.26 4.54 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 127.739 3.637 . . . . 3.14 111.478 170.738 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -75.66 -64.76 1.01 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.312 -2.742 . . . . 6.8 111.328 172.828 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.56 144.27 4.37 Favored Glycine 0 N--CA 1.431 -1.691 0 O-C-N 119.25 -2.156 . . . . 3.57 107.77 -168.123 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.776 0 CA-C-O 117.102 -1.944 . . . . 3.87 113.959 174.52 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 124.2 1.952 . . . . 1.1 108.461 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -104.65 132.13 51.25 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.135 -1.603 . . . . 1.87 108.301 -174.981 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.434 HD12 HD22 ' A' ' 67' ' ' LEU . 8.4 pt -127.38 140.89 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 126.027 2.822 . . . . 0.72 107.526 175.333 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -101.75 131.69 47.89 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.397 -2.064 . . . . 1.4 111.3 -178.939 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.3 t -109.41 111.52 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 116.876 -3.64 . . . . 0.58 108.789 177.965 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.5 mtpt -93.36 139.29 30.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.612 -3.18 . . . . 2.09 106.93 175.912 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p -93.25 164.94 13.04 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 116.918 -1.515 . . . . 0.99 112.301 179.904 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.9 tp -65.87 -30.88 71.56 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.246 3.403 . . . . 2.53 113.379 166.339 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.315 70.2 p -61.61 -38.4 87.46 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.124 -4.11 . . . . 2.08 114.271 -178.815 . . . . . . . . 3 2 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.87 24.42 1.69 Allowed Glycine 0 N--CA 1.43 -1.726 1 C-N-CA 131.031 4.158 . . . . 1.31 114.416 174.191 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -101.6 153.15 20.01 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.054 -1.461 . . . . 1.4 107.054 -177.994 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -108.6 110.47 21.94 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 113.078 -1.874 . . . . 0.78 109.99 168.079 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 mt -92.35 119.91 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 121.129 1.786 . . . . 1.55 115.122 177.362 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.259 8.7 m -89.37 130.06 35.8 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 116.741 -3.725 . . . . 1.08 106.894 179.079 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.0 mt -133.08 156.41 47.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 118.605 -1.238 . . . . 1.55 107.967 177.898 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -112.74 129.37 56.44 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 117.52 -1.228 . . . . 1.95 109.594 165.833 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 m -127.31 177.55 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 126.645 1.978 . . . . 0.96 114.89 177.872 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -120.11 161.64 37.6 Favored Pre-proline 0 N--CA 1.43 -1.432 0 CA-C-O 115.119 -2.372 . . . . 2.35 110.878 164.261 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.256 33.8 Cg_endo -74.81 -12.63 21.95 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 C-N-CA 122.987 2.458 . . . . 0.95 112.649 -176.744 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.255 70.0 m -92.4 9.7 33.09 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.75 2.82 . . . . 1.45 111.724 173.253 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -84.96 139.0 32.14 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 121.67 2.032 . . . . 1.69 109.906 176.864 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.5 p -84.43 156.42 21.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.305 2.955 . . . . 0.75 112.342 176.113 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mm -64.48 -20.71 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 O-C-N 116.372 -3.955 . . . . 0.73 115.086 176.464 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -56.92 -51.87 67.43 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.367 2.508 . . . . 1.62 117.162 163.079 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -60.45 -31.99 70.96 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 111.048 -2.796 . . . . 2.13 116.571 170.535 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.2 t -65.78 -32.89 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 124.098 3.135 . . . . 0.62 112.202 175.804 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -71.71 -27.48 63.05 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.335 1.854 . . . . 1.22 112.082 175.882 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.04 -21.67 58.9 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.803 -2.436 . . . . 0.51 114.82 173.365 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -78.3 -30.5 48.4 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.608 -3.183 . . . . 1.44 108.206 178.584 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.4 mt -68.54 -33.3 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 129.309 3.044 . . . . 1.32 110.189 168.838 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -66.93 -29.47 69.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.712 -3.117 . . . . 1.7 113.885 167.324 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -74.58 -58.22 3.43 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 120.986 1.721 . . . . 1.55 110.464 172.162 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.2 tptt -57.79 -55.86 29.46 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.574 2.435 . . . . 2.62 117.574 -172.915 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -110.84 -36.43 5.69 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.473 2.082 . . . . 1.48 108.756 -164.905 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.85 66.34 1.0 Allowed Glycine 0 N--CA 1.429 -1.788 0 O-C-N 119.576 -1.953 . . . . 1.12 110.583 169.979 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.6 mt -126.93 130.12 23.86 Favored Pre-proline 0 N--CA 1.429 -1.488 0 CA-C-O 114.452 -2.689 . . . . 1.55 105.552 -178.341 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -62.11 150.42 86.68 Favored 'Trans proline' 0 N--CA 1.433 -2.056 0 C-N-CA 124.167 3.245 . . . . 1.02 111.582 178.82 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -87.13 -0.22 7.69 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 CA-C-N 120.853 1.341 . . . . 1.25 110.319 -162.535 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -71.47 -46.83 58.87 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.372 2.269 . . . . 2.25 112.719 170.719 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -69.41 -19.52 63.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.805 2.842 . . . . 2.02 115.599 -175.055 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -86.83 139.43 30.68 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 124.126 1.917 . . . . 0.69 111.053 -168.82 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.9 mtt180 -131.38 134.07 45.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.731 -3.731 . . . . 2.78 104.19 170.556 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.3 mt -114.21 117.03 30.04 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 114.038 -5.414 . . . . 1.17 112.826 175.296 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 mm -99.3 138.28 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 128.489 3.618 . . . . 1.38 114.439 178.684 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -129.5 96.27 4.23 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 120.836 1.653 . . . . 1.5 109.208 170.358 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.26 26.45 2.7 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 111.854 -3.927 . . . . 1.21 117.246 -179.608 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.39 -24.18 23.04 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 122.991 2.632 . . . . 1.3 112.731 -174.408 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -96.56 132.43 42.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.718 -2.636 . . . . 2.55 106.709 175.351 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.79 131.3 35.26 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.893 -2.379 . . . . 2.48 111.784 166.327 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.0 mt -79.01 128.85 33.78 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.033 1.333 . . . . 0.9 108.689 -173.088 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -80.26 138.93 36.86 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 121.564 1.984 . . . . 1.94 111.034 176.437 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.85 -55.38 14.46 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.525 3.157 . . . . 1.56 119.525 -173.254 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.23 39.96 2.12 Favored Glycine 0 N--CA 1.43 -1.733 0 O-C-N 124.662 1.226 . . . . 0.97 115.889 173.059 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.423 HH21 ' CG ' ' A' ' 58' ' ' ASP . 44.1 mmm-85 -117.73 161.07 20.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 124.814 0.949 . . . . 2.49 112.151 158.168 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -96.52 172.38 7.96 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 115.574 1.694 . . . . 0.76 115.574 173.301 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.1 mt -77.26 -25.4 51.44 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.014 1.116 . . . . 1.05 114.014 176.859 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.8 t -78.8 -33.43 46.26 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.106 -1.442 . . . . 1.19 107.106 -179.495 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.423 ' CG ' HH21 ' A' ' 54' ' ' ARG . 38.1 t0 -61.44 -52.82 62.97 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.365 2.666 . . . . 1.9 112.023 178.183 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -74.42 -7.49 53.11 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 126.813 3.197 . . . . 0.89 117.882 177.993 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.3 m120 62.8 46.15 5.29 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.2 -2.812 . . . . 1.84 115.509 179.702 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.4 mt -96.25 124.24 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 103.729 -2.693 . . . . 0.82 103.729 -177.699 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -112.44 -176.2 2.86 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 118.364 -1.334 . . . . 2.16 112.147 -175.055 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -55.06 137.52 46.23 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 126.768 3.175 . . . . 2.12 110.092 174.812 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 57.3 mt-10 76.3 12.98 2.6 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 126.116 2.865 . . . . 1.71 113.534 170.46 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -79.39 133.22 36.57 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 117.593 -3.192 . . . . 1.04 107.475 -170.813 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.1 m -86.07 113.79 22.42 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.85 -3.656 . . . . 0.79 113.848 178.58 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.434 HD22 HD12 ' A' ' 3' ' ' ILE . 9.7 mp -92.46 160.4 15.09 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.625 -1.922 . . . . 1.4 110.895 174.271 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -129.32 123.16 31.1 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.438 2.066 . . . . 1.51 108.351 -175.243 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.5 tp -93.65 125.23 38.15 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 130.892 3.677 . . . . 1.14 108.317 176.59 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.14 159.34 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 104.126 -2.546 . . . . 1.23 104.126 167.201 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.4 mt -115.97 138.89 50.78 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 122.653 1.216 . . . . 2.78 108.042 -179.668 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 ttt-85 -100.2 130.32 46.32 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 104.538 -2.394 . . . . 3.75 104.538 -179.554 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.6 tp -115.13 -54.78 2.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.931 -1.137 . . . . 3.14 107.931 171.723 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -103.66 -42.01 5.77 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 118.495 -2.628 . . . . 6.8 108.353 176.928 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.77 -138.02 3.63 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-O 124.735 2.297 . . . . 3.57 113.266 -173.771 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.763 0 O-C-N 119.192 -2.358 . . . . 3.87 109.041 176.959 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptt? . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 123.259 1.504 . . . . 1.1 109.188 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -101.23 129.44 47.17 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.848 1.659 . . . . 1.87 111.038 -172.304 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.1 pt -125.44 174.48 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.775 -2.453 . . . . 0.72 110.007 176.196 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -119.77 140.91 50.01 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 116.055 1.872 . . . . 1.4 116.055 179.767 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.7 t -124.96 119.63 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 124.196 1.951 . . . . 0.58 105.898 171.606 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -95.44 127.32 41.38 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.627 -3.795 . . . . 2.09 111.68 179.441 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.0 p -73.39 -168.92 0.58 Allowed 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 125.031 2.348 . . . . 0.99 110.953 -176.069 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.536 HD11 ' H ' ' A' ' 71' ' ' LEU . 86.1 mt -86.9 -38.6 16.56 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 111.825 -2.443 . . . . 2.53 111.597 171.492 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.9 p -65.44 -27.35 68.46 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.427 1.891 . . . . 2.08 112.885 -175.9 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.57 22.97 5.25 Favored Glycine 0 N--CA 1.431 -1.669 0 O-C-N 118.151 -2.843 . . . . 1.31 119.108 177.845 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -108.04 138.53 44.14 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 105.602 -1.999 . . . . 1.4 105.602 -175.348 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.0 m -92.91 111.08 22.57 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.595 2.758 . . . . 0.78 108.044 177.149 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -89.85 137.16 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 116.48 -3.888 . . . . 1.55 105.075 -179.268 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.1 m -100.34 129.5 46.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.599 1.959 . . . . 1.08 110.36 -178.653 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.4 mt -129.36 155.38 45.75 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 119.651 1.114 . . . . 1.55 112.673 -175.923 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -116.22 112.25 21.35 Favored 'General case' 0 N--CA 1.429 -1.477 1 O-C-N 115.186 -4.696 . . . . 1.95 105.792 173.253 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.5 m -126.37 155.48 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 110.974 -2.83 . . . . 0.96 112.101 -179.0 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -103.28 159.5 29.1 Favored Pre-proline 0 N--CA 1.431 -1.392 1 O-C-N 114.639 -5.038 . . . . 2.35 109.644 165.485 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -67.66 -20.78 46.34 Favored 'Trans proline' 0 C--N 1.299 -2.039 1 O-C-N 113.297 -4.107 . . . . 0.95 115.455 -170.993 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 p -84.76 4.52 32.48 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.133 2.173 . . . . 1.45 112.121 175.543 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -75.58 138.2 41.3 Favored 'General case' 0 N--CA 1.431 -1.419 1 O-C-N 115.496 -4.502 . . . . 1.69 106.424 170.473 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.563 HG22 HG22 ' A' ' 55' ' ' THR . 64.6 p -87.02 159.76 18.85 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 125.935 2.022 . . . . 0.75 108.074 -179.225 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.7 mm -60.24 -37.02 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 124.168 0.987 . . . . 0.73 109.692 177.415 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.302 25.5 tt0 -47.12 -50.59 19.91 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.664 1.986 . . . . 1.62 113.385 164.465 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -68.86 -32.74 72.64 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 125.934 2.021 . . . . 2.13 109.745 -179.706 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.55 -38.94 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 120.642 1.565 . . . . 0.62 113.315 175.105 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -61.56 -38.67 88.34 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 122.605 1.193 . . . . 1.22 112.83 169.701 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.65 -25.86 57.22 Favored 'General case' 0 N--CA 1.43 -1.428 1 CA-C-O 129.274 4.368 . . . . 0.51 113.694 179.332 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -72.63 -34.05 67.06 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 114.856 -4.903 . . . . 1.44 111.647 171.703 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.253 97.1 mt -64.73 -48.57 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 O-C-N 120.015 -1.678 . . . . 1.32 109.401 171.126 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -56.63 -42.83 79.51 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 116.446 -3.909 . . . . 1.7 113.265 177.145 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -53.95 -47.26 71.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.815 3.197 . . . . 1.55 117.079 166.522 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.265 14.2 tppt? -73.24 -53.49 10.75 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.04 2.352 . . . . 2.62 114.144 -171.844 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -111.42 -30.1 7.53 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.738 -3.101 . . . . 1.48 109.993 -171.431 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.28 38.36 4.56 Favored Glycine 0 N--CA 1.429 -1.787 0 C-N-CA 125.465 1.507 . . . . 1.12 114.056 -179.586 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.4 mt -97.77 130.38 29.13 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-O 114.749 -2.548 . . . . 1.55 112.117 179.509 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo -66.18 154.0 75.86 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 CA-C-N 125.356 2.948 . . . . 1.02 113.487 -173.475 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -65.62 -23.32 56.94 Favored 'Trans proline' 0 N--CA 1.432 -2.094 1 CA-C-N 129.094 4.283 . . . . 1.25 116.373 -177.668 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -69.0 -34.62 75.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.77 -2.456 . . . . 2.25 115.546 178.06 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -73.75 -12.79 60.82 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 124.38 1.05 . . . . 2.02 111.279 179.597 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -98.64 118.06 34.5 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 118.214 -2.804 . . . . 0.69 112.572 -167.951 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -106.51 114.64 28.87 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 126.259 2.224 . . . . 2.78 106.378 170.674 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.1 mt -98.03 109.42 22.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.99 1.853 . . . . 1.17 113.607 175.343 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.3 mt -100.48 112.2 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 128.356 2.662 . . . . 1.38 112.617 180.0 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -105.67 123.76 48.46 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.5 -2.625 . . . . 1.5 107.446 172.008 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.362 . . 69.46 -63.81 0.36 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.128 2.171 . . . . 1.21 110.694 -176.459 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.59 -16.81 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.791 0 N-CA-C 106.122 -2.791 . . . . 1.3 106.122 179.378 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -83.6 125.1 31.46 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.611 3.164 . . . . 2.55 106.848 -172.557 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.3 17.4 tt0 -83.96 115.48 22.33 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.176 1.547 . . . . 2.48 115.176 175.849 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.8 mt -75.58 133.85 40.84 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.173 1.789 . . . . 0.9 112.047 -171.018 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -87.15 151.43 23.21 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 127.859 2.464 . . . . 1.94 115.719 172.743 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -66.24 -44.65 83.12 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 128.364 2.665 . . . . 1.56 113.434 -160.147 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.15 51.25 1.29 Allowed Glycine 0 N--CA 1.43 -1.705 0 O-C-N 118.813 -2.43 . . . . 0.97 110.866 176.332 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -123.56 161.88 24.06 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.889 -1.948 . . . . 2.49 107.377 162.582 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.563 HG22 HG22 ' A' ' 22' ' ' THR . 18.7 p -107.89 172.61 6.73 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.084 -2.26 . . . . 0.76 110.741 179.693 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.407 HD23 HD12 ' A' ' 61' ' ' ILE . 20.8 mt -62.17 -38.41 88.95 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 126.758 2.536 . . . . 1.05 114.077 172.855 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 t -66.52 -30.8 71.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.916 2.486 . . . . 1.19 115.256 174.284 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -71.49 -43.9 65.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.752 -3.093 . . . . 1.9 111.393 171.222 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -91.55 8.26 37.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 124.964 1.415 . . . . 0.89 114.154 -177.877 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 47.23 49.24 15.54 Favored 'General case' 0 N--CA 1.43 -1.438 1 C-N-CA 132.459 4.304 . . . . 1.84 116.613 -179.462 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.567 HG21 HD21 ' A' ' 67' ' ' LEU . 76.8 mt -89.81 115.04 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 114.191 -2.814 . . . . 0.82 105.48 176.912 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -107.22 -166.66 1.18 Allowed 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 126.291 2.244 . . . . 2.16 112.88 -175.754 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -63.27 144.87 56.57 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 125.128 1.517 . . . . 2.12 113.586 -179.682 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.294 32.2 mt-10 67.28 15.13 9.91 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.629 1.971 . . . . 1.71 114.686 -179.766 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 t -90.17 135.94 33.35 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 123.537 1.636 . . . . 1.04 111.07 -173.903 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.2 m -96.09 113.84 25.49 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.821 3.648 . . . . 0.79 112.213 -172.397 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.567 HD21 HG21 ' A' ' 61' ' ' ILE . 10.5 mt -95.98 152.85 18.14 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 115.604 -4.435 . . . . 1.4 108.883 169.762 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -112.2 119.36 38.11 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 115.873 -2.331 . . . . 1.51 109.463 -174.488 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.6 tp -86.45 116.55 24.67 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.346 1.858 . . . . 1.14 111.454 -178.87 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.8 t -111.73 119.87 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 115.167 -2.349 . . . . 1.23 109.402 177.502 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.536 ' H ' HD11 ' A' ' 8' ' ' LEU 0.296 93.3 mt -79.96 137.13 36.79 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 121.211 1.823 . . . . 2.78 108.85 -173.482 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -99.46 79.36 2.28 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.335 1.54 . . . . 3.75 109.364 174.715 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.5 mt -88.99 -103.59 0.09 Allowed 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.305 -1.771 . . . . 3.14 113.006 175.994 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.273 46.5 mtt85 -127.28 145.06 50.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 105.931 -1.877 . . . . 6.8 105.931 170.15 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.41 -91.88 0.15 Allowed Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 108.0 -2.04 . . . . 3.57 108.0 -167.982 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.774 0 N-CA-C 105.146 -3.182 . . . . 3.87 105.146 -178.837 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 CA--C 1.49 -1.327 0 N-CA-C 104.728 -2.323 . . . . 1.1 104.728 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -100.96 128.68 46.88 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.574 -1.954 . . . . 1.87 110.418 -173.675 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.8 pt -137.04 155.75 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 O-C-N 117.315 -3.365 . . . . 0.72 106.709 172.493 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -103.06 140.43 37.32 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.393 1.877 . . . . 1.4 106.716 -175.921 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.8 t -120.73 109.84 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 118.711 -2.493 . . . . 0.58 106.299 171.591 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.7 tttt -96.12 128.75 43.3 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 118.001 2.593 . . . . 2.09 118.001 -178.55 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.7 p -86.12 176.25 8.09 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 115.166 1.543 . . . . 0.99 115.166 174.07 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.8 mt -74.47 -22.85 58.89 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.699 -1.876 . . . . 2.53 115.558 172.76 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 p -67.34 -25.97 66.26 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.808 2.043 . . . . 2.08 113.103 176.602 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.27 28.61 5.74 Favored Glycine 0 N--CA 1.429 -1.803 0 C-N-CA 128.6 3.0 . . . . 1.31 114.29 179.743 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -111.55 141.13 45.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.895 3.712 . . . . 1.4 112.476 -173.014 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.2 m -96.34 116.68 29.43 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 127.891 3.71 . . . . 0.78 116.907 176.084 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mt -96.86 125.35 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 1 O-C-N 114.042 -5.411 . . . . 1.55 110.556 168.299 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.1 m -97.66 118.58 34.51 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 124.903 2.287 . . . . 1.08 106.039 -174.49 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.1 mt -105.48 145.6 30.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.506 -3.871 . . . . 1.55 111.279 -178.163 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -103.79 126.05 50.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.469 1.604 . . . . 1.95 107.219 167.987 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 m -144.43 161.67 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 117.249 -3.407 . . . . 0.96 112.481 -176.006 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -99.33 155.01 37.0 Favored Pre-proline 0 N--CA 1.431 -1.421 0 O-C-N 119.132 -2.23 . . . . 2.35 106.462 157.737 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -72.8 -9.65 24.02 Favored 'Trans proline' 0 N--CA 1.433 -2.064 0 C-N-CA 124.625 3.55 . . . . 0.95 111.755 173.907 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.5 m -87.93 0.71 55.53 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 131.109 3.763 . . . . 1.45 114.584 173.303 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -94.08 143.58 26.24 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 117.729 -3.107 . . . . 1.69 107.809 -179.315 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p -80.58 164.02 23.23 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 128.117 3.818 . . . . 0.75 110.165 176.973 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 mm -59.22 -33.83 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 112.264 -2.244 . . . . 0.73 112.295 175.598 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -59.81 -30.99 69.3 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.585 -1.947 . . . . 1.62 111.627 175.733 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -74.9 -39.12 61.65 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.974 -3.579 . . . . 2.13 111.771 175.9 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.283 57.3 t -57.09 -60.48 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 O-C-N 118.07 -2.894 . . . . 0.62 110.233 172.368 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -53.51 -41.6 66.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 120.579 3.548 . . . . 1.22 120.579 177.318 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.14 -40.71 94.87 Favored 'General case' 0 CA--C 1.489 -1.394 0 O-C-N 119.412 -2.055 . . . . 0.51 111.794 169.932 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -63.95 -32.29 73.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.397 3.11 . . . . 1.44 119.397 170.488 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.2 mt -68.56 -39.04 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 O-C-N 124.871 1.357 . . . . 1.32 108.669 170.585 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -61.31 -43.92 98.07 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.12 2.39 . . . . 1.7 115.881 176.097 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.56 -46.2 91.06 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.122 -2.861 . . . . 1.55 113.933 174.105 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -68.41 -54.84 14.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.873 -3.642 . . . . 2.62 113.738 -179.828 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -104.78 -35.24 7.83 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.928 2.299 . . . . 1.48 116.82 -165.412 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.88 36.66 5.71 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-O 117.236 -1.869 . . . . 1.12 113.236 -179.645 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.8 mt -104.02 119.01 55.69 Favored Pre-proline 0 CA--C 1.489 -1.398 0 CA-C-O 113.78 -3.009 . . . . 1.55 103.585 -176.605 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.25 9.2 Cg_exo -62.81 161.68 28.08 Favored 'Trans proline' 0 N--CA 1.433 -2.031 1 C-N-CA 125.988 4.458 . . . . 1.02 116.611 176.147 . . . . . . . . 3 2 . 1 . 042 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.45 -25.13 11.47 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 CA-C-N 124.941 2.8 . . . . 1.25 117.904 -170.097 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -60.99 -49.13 78.69 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 125.968 2.794 . . . . 2.25 113.098 -179.416 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -62.26 -31.81 72.43 Favored 'General case' 0 N--CA 1.43 -1.45 1 C-N-CA 133.812 4.845 . . . . 2.02 112.727 176.225 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -75.73 130.81 39.26 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 117.736 -3.103 . . . . 0.69 114.413 -174.909 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.421 ' HB3' HG23 ' A' ' 70' ' ' VAL . 29.4 ttt180 -120.57 106.68 12.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.73 -1.211 . . . . 2.78 107.73 175.431 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.4 mt -91.41 129.65 37.37 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.17 2.588 . . . . 1.17 109.838 179.147 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.504 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 13.6 mt -121.79 146.26 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 127.013 2.125 . . . . 1.38 107.939 177.808 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.42 ' HB3' HD21 ' A' ' 50' ' ' LEU . 20.7 t80 -135.7 117.49 15.1 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 105.129 -2.174 . . . . 1.5 105.129 171.615 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.98 -68.88 0.12 Allowed 'General case' 0 N--CA 1.43 -1.464 1 C-N-CA 132.015 4.126 . . . . 1.21 107.612 179.943 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.4 14.11 0.45 Allowed Glycine 0 N--CA 1.43 -1.728 0 O-C-N 117.364 -3.335 . . . . 1.3 113.983 176.967 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -121.53 128.18 51.76 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 123.562 1.649 . . . . 2.55 108.208 -178.686 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -72.0 126.63 30.26 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.399 2.523 . . . . 2.48 109.234 169.47 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 45' ' ' PHE . 31.4 mt -83.27 145.43 29.11 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.261 -1.791 . . . . 0.9 107.464 -171.262 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -106.91 155.82 19.36 Favored 'General case' 0 CA--C 1.489 -1.383 0 CA-C-O 123.985 1.85 . . . . 1.94 113.327 -179.018 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -52.44 -60.28 3.42 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 121.12 3.748 . . . . 1.56 121.12 -168.071 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.9 37.69 2.68 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 129.82 3.581 . . . . 0.97 112.956 174.085 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -120.25 153.54 36.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 116.67 -1.634 . . . . 2.49 107.649 170.759 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.4 p -88.18 168.43 12.76 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 125.364 1.665 . . . . 0.76 113.72 164.918 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.7 mt -74.22 -27.78 60.95 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 116.183 -1.865 . . . . 1.05 109.659 178.031 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.1 p -64.66 -31.65 72.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 126.246 2.216 . . . . 1.19 115.115 174.582 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -55.05 -41.7 71.79 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 127.819 3.676 . . . . 1.9 114.772 171.306 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -84.16 -1.39 54.96 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 117.594 -3.191 . . . . 0.89 116.852 176.946 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.299 7.5 m120 65.85 40.96 4.0 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 125.854 2.74 . . . . 1.84 115.93 -176.927 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.6 mt -92.43 121.36 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 126.701 3.143 . . . . 0.82 111.032 177.969 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -110.64 179.34 4.1 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 111.374 -2.648 . . . . 2.16 108.71 -176.065 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -63.52 156.49 26.22 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 124.767 1.227 . . . . 2.12 113.961 179.22 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.451 65.6 mt-10 79.44 -4.03 2.05 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.323 -2.11 . . . . 1.71 113.485 172.793 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.298 49.7 m -73.14 154.08 40.49 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 117.699 2.481 . . . . 1.04 117.699 -174.578 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.7 m -112.73 124.02 51.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.58 -1.637 . . . . 0.79 106.58 178.247 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.2 mt -103.81 164.25 11.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.869 -1.16 . . . . 1.4 107.869 168.932 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.504 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 44.0 m170 -113.97 129.68 56.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 116.555 -1.688 . . . . 1.51 111.887 -176.902 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.7 tp -117.34 115.6 25.55 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 102.219 -3.252 . . . . 1.14 102.219 -176.125 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 42' ' ' ARG . 24.6 m -115.33 159.76 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 127.33 3.443 . . . . 1.23 102.747 173.909 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.58 144.24 26.2 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 111.015 -7.303 . . . . 2.78 109.562 173.764 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -110.29 137.3 48.21 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 130.301 3.44 . . . . 3.75 113.83 176.445 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.3 mt -104.6 149.67 25.32 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 126.089 2.852 . . . . 3.14 109.464 171.879 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -83.46 161.19 21.37 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.429 -3.919 . . . . 6.8 116.622 169.18 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.0 -64.68 0.84 Allowed Glycine 0 N--CA 1.429 -1.79 0 C-N-CA 124.609 1.099 . . . . 3.57 111.249 -166.582 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.789 0 CA-C-O 123.193 1.44 . . . . 3.87 115.258 177.134 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.253 6.2 ptt? . . . . . 0 CA--C 1.49 -1.342 0 N-CA-C 113.775 1.028 . . . . 1.1 113.775 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.264 34.5 mt-30 -115.18 147.69 39.98 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 116.155 -4.091 . . . . 1.87 110.916 177.08 . . . . . . . . 3 2 . 1 . 043 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.8 pt -134.35 156.67 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 116.904 -3.623 . . . . 0.72 103.436 177.518 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -116.65 139.06 50.95 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.156 -1.59 . . . . 1.4 110.738 178.221 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.0 t -120.43 116.41 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-O 116.98 -1.486 . . . . 0.58 108.553 177.471 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -100.21 139.44 35.87 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 117.081 -1.848 . . . . 2.09 114.707 177.469 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 p -83.49 157.67 22.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.614 2.766 . . . . 0.99 113.234 174.205 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.1 tp -49.12 -41.1 34.79 Favored 'General case' 0 N--CA 1.43 -1.466 2 O-C-N 114.045 -5.41 . . . . 2.53 110.855 166.46 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.1 p -67.83 -28.26 67.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.948 1.832 . . . . 2.08 115.948 179.385 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.11 31.19 3.16 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 125.238 2.577 . . . . 1.31 113.849 173.454 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -109.6 133.39 53.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.743 -3.21 . . . . 1.4 104.181 -176.628 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.4 m -99.51 119.06 37.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.301 -3.374 . . . . 0.78 106.69 175.735 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mt -97.01 98.42 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.823 2.049 . . . . 1.55 106.836 175.997 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.6 m -87.35 125.86 34.51 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 125.401 2.524 . . . . 1.08 107.942 177.851 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.4 mt -116.94 162.59 17.52 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.542 -2.599 . . . . 1.55 107.272 -173.641 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -121.12 112.68 18.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.759 -2.463 . . . . 1.95 110.402 179.718 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -132.45 164.47 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 125.479 1.512 . . . . 0.96 114.356 -176.816 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -111.86 155.68 42.85 Favored Pre-proline 0 N--CA 1.43 -1.438 1 CA-C-O 110.828 -4.415 . . . . 2.35 104.471 164.806 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -69.92 -4.78 14.83 Favored 'Trans proline' 0 C--N 1.3 -2.023 1 CA-C-N 129.049 4.268 . . . . 0.95 114.808 -175.272 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 p -86.09 6.89 26.97 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.662 2.785 . . . . 1.45 111.633 170.714 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.5 133.33 47.56 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.973 -0.751 . . . . 1.69 108.973 169.008 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.7 p -79.96 167.63 20.24 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.731 -2.322 . . . . 0.75 104.731 177.412 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.3 mm -81.5 -21.64 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 117.536 -3.227 . . . . 0.73 109.302 176.849 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -55.1 -49.67 71.11 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 122.02 2.191 . . . . 1.62 109.59 161.348 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -59.14 -59.39 5.54 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 114.578 1.325 . . . . 2.13 114.578 -179.617 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.419 ' H ' HG23 ' A' ' 26' ' ' VAL . 15.2 t -45.1 -43.9 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 127.067 2.147 . . . . 0.62 114.483 172.167 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.454 ' HD2' ' HB2' ' A' ' 41' ' ' GLN 0.349 36.2 mtmt -60.17 -38.95 84.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 118.716 2.858 . . . . 1.22 118.716 171.491 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.57 -19.89 61.41 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.002 2.334 . . . . 0.51 117.024 179.584 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -78.71 -16.33 57.39 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 119.311 -2.118 . . . . 1.44 112.144 171.516 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.332 73.0 mt -78.32 -44.56 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 128.368 3.937 . . . . 1.32 108.751 172.179 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -57.4 -45.24 84.74 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 110.842 -2.89 . . . . 1.7 117.483 172.098 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -45.42 -45.25 12.68 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.872 1.669 . . . . 1.55 114.366 166.761 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -82.38 -68.8 0.67 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.364 -0.834 . . . . 2.62 111.741 -171.33 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -93.99 -20.75 19.69 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 125.789 1.931 . . . . 1.48 113.946 -169.667 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.23 -0.62 64.03 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 118.355 2.102 . . . . 1.12 118.355 175.753 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.9 mt -70.8 122.58 87.23 Favored Pre-proline 0 N--CA 1.429 -1.484 0 CA-C-O 113.955 -2.926 . . . . 1.55 105.303 -178.311 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.37 146.11 61.55 Favored 'Trans proline' 0 N--CA 1.433 -2.033 1 CA-C-O 106.609 -5.663 . . . . 1.02 116.565 177.873 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -55.63 -13.49 8.23 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 128.013 3.898 . . . . 1.25 122.196 -177.847 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -57.04 -41.54 78.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.991 2.517 . . . . 2.25 113.259 176.975 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.281 68.9 mt-30 -84.77 -27.0 27.18 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 126.331 1.852 . . . . 2.02 108.993 -170.437 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.454 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 61.1 mt-30 -71.23 139.92 50.24 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.509 2.781 . . . . 0.69 118.509 -171.496 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -133.83 129.24 36.21 Favored 'General case' 0 N--CA 1.43 -1.435 1 N-CA-C 99.126 -4.398 . . . . 2.78 99.126 172.493 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.46 ' HA ' HD23 ' A' ' 43' ' ' LEU . 23.9 mt -111.24 107.92 17.38 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 112.189 -2.278 . . . . 1.17 106.889 177.426 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 mm -97.26 133.98 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 115.003 -0.999 . . . . 1.38 108.699 176.227 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -122.32 100.6 7.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 101.772 -3.418 . . . . 1.5 101.772 176.794 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 81.65 -100.92 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 105.259 -2.126 . . . . 1.21 105.259 172.61 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.31 -10.16 7.49 Favored Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 107.033 -2.427 . . . . 1.3 107.033 179.284 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -100.94 148.32 25.14 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 119.96 1.88 . . . . 2.55 108.916 -173.478 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -105.4 129.04 53.8 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.795 -2.002 . . . . 2.48 113.661 178.284 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.4 mt -92.72 146.47 23.63 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 116.933 -1.508 . . . . 0.9 109.818 -167.058 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.1 148.94 21.69 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 128.786 3.804 . . . . 1.94 117.667 174.778 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.65 -59.73 4.76 Favored 'General case' 0 CA--C 1.488 -1.41 1 C-N-CA 133.241 4.617 . . . . 1.56 113.295 -169.527 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.66 46.7 3.49 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 119.508 -1.995 . . . . 0.97 116.515 175.458 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -127.75 -179.8 5.13 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 120.553 2.177 . . . . 2.49 112.043 166.805 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.2 p -104.53 172.47 6.77 Favored 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 116.011 -4.181 . . . . 0.76 117.835 178.715 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.5 mt -66.32 -29.63 69.87 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.704 -2.497 . . . . 1.05 111.006 173.105 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -71.69 -29.31 64.44 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 130.019 3.328 . . . . 1.19 117.453 178.367 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.327 23.6 m-20 -63.65 -36.58 84.29 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 119.231 -0.988 . . . . 1.9 112.709 170.118 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -93.42 12.85 23.49 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 117.166 2.284 . . . . 0.89 117.166 -174.996 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 50.08 32.62 6.02 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 118.137 2.643 . . . . 1.84 118.137 -175.304 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.8 mt -89.88 111.59 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 125.11 1.364 . . . . 0.82 110.498 -178.352 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -100.99 -165.68 1.23 Allowed 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 113.868 -1.514 . . . . 2.16 109.286 -173.768 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.5 pttp -68.78 149.81 48.58 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.534 2.111 . . . . 2.12 112.548 179.667 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.281 10.8 mt-10 66.66 30.13 8.39 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 125.619 2.628 . . . . 1.71 116.259 172.71 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.1 m -89.29 135.7 33.43 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.869 -2.394 . . . . 1.04 107.926 -170.697 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.6 m -105.06 106.36 16.81 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.913 -2.367 . . . . 0.79 108.818 -177.006 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -96.61 167.28 11.23 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.448 -2.032 . . . . 1.4 109.586 171.842 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -118.86 121.8 40.84 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 113.662 -1.608 . . . . 1.51 111.138 -170.338 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 51.9 tp -88.31 121.85 31.16 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.816 -1.549 . . . . 1.14 106.816 -177.449 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.6 t -114.26 124.51 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 106.487 -1.671 . . . . 1.23 106.487 179.308 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.0 mt -115.04 -173.86 2.39 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 116.366 -3.959 . . . . 2.78 111.763 179.673 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -95.86 -167.48 1.6 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.952 2.575 . . . . 3.75 117.952 171.263 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.9 mt -81.05 118.29 22.37 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 116.141 -1.885 . . . . 3.14 110.818 174.944 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -75.39 98.15 3.8 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 121.946 2.157 . . . . 6.8 115.845 168.504 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.95 -30.89 0.39 Allowed Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 104.985 -3.246 . . . . 3.57 104.985 -167.19 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.764 0 O-C-N 118.838 -2.566 . . . . 3.87 107.972 -173.927 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptt? . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 121.808 0.813 . . . . 1.1 109.507 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -104.57 120.24 40.84 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 113.129 -3.32 . . . . 1.87 108.717 -175.829 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.265 9.2 pt -116.74 174.01 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 127.007 2.692 . . . . 0.72 114.281 171.365 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -125.68 140.22 52.89 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.897 2.879 . . . . 1.4 106.71 -178.278 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 67' ' ' LEU . 95.8 t -129.07 114.81 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.499 -2.001 . . . . 0.58 107.051 171.405 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -86.23 143.14 28.1 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.678 0.751 . . . . 2.09 111.339 -176.129 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.3 p -88.01 169.36 12.04 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.043 -2.286 . . . . 0.99 111.995 176.408 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.8 mt -56.42 -33.71 66.09 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 114.001 -5.437 . . . . 2.53 113.023 172.609 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.2 p -90.18 -34.9 15.66 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 114.835 1.42 . . . . 2.08 114.835 -172.69 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.71 -17.01 0.4 Allowed Glycine 0 N--CA 1.429 -1.771 0 C-N-CA 116.27 -2.872 . . . . 1.31 112.15 177.46 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -84.84 147.91 26.56 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 124.743 2.211 . . . . 1.4 111.326 -170.743 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.6 m -115.65 128.22 55.76 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.745 -3.722 . . . . 0.78 108.752 178.905 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 mt -95.32 137.92 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 119.662 -1.899 . . . . 1.55 107.02 177.055 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.7 m -95.31 111.43 23.29 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.526 -1.984 . . . . 1.08 112.945 175.623 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.7 mt -115.42 148.87 38.86 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.01 -1.681 . . . . 1.55 111.891 -177.831 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -115.29 109.78 18.45 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 103.449 -2.797 . . . . 1.95 103.449 179.49 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.6 m -120.78 170.2 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 124.993 2.33 . . . . 0.96 105.075 177.36 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -126.75 155.4 75.21 Favored Pre-proline 0 N--CA 1.43 -1.429 0 N-CA-C 104.814 -2.291 . . . . 2.35 104.814 168.818 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.45 -29.34 39.36 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 N-CA-C 120.924 3.394 . . . . 0.95 120.924 -176.679 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 m -76.13 4.37 8.7 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.424 2.379 . . . . 1.45 117.424 177.176 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -85.1 148.74 25.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 125.74 1.9 . . . . 1.69 114.878 177.637 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.3 p -90.1 169.96 10.73 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.35 -2.094 . . . . 0.75 114.225 175.595 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.8 mm -63.64 -41.31 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 1 O-C-N 115.867 -4.27 . . . . 0.73 114.462 176.255 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.382 76.8 tt0 -35.75 -55.73 0.71 Allowed 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 118.624 2.824 . . . . 1.62 118.624 155.583 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -56.83 -28.15 61.13 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.734 -1.854 . . . . 2.13 115.718 176.187 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.2 t -69.98 -42.63 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 117.988 -2.945 . . . . 0.62 108.998 175.208 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -56.29 -39.53 72.84 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.437 -2.039 . . . . 1.22 116.404 171.777 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.0 -49.48 72.3 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.073 -2.892 . . . . 0.51 115.659 174.469 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -52.83 -45.11 67.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.248 1.419 . . . . 1.44 113.131 170.715 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 30' ' ' ILE . 56.4 mt -69.29 -30.9 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 O-C-N 115.722 -4.361 . . . . 1.32 112.169 175.125 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.31 -40.04 71.06 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.119 -1.613 . . . . 1.7 111.041 173.369 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.02 -54.7 44.12 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 123.358 1.551 . . . . 1.55 112.304 170.117 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -72.94 -57.89 3.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 116.55 -3.844 . . . . 2.62 115.628 -174.617 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -94.28 -27.33 16.19 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.364 1.987 . . . . 1.48 116.364 -174.188 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.35 23.67 21.17 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 117.47 1.748 . . . . 1.12 117.47 178.614 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.1 mt -89.77 138.84 27.77 Favored Pre-proline 0 N--CA 1.431 -1.402 0 O-C-N 118.188 -2.948 . . . . 1.55 103.827 -173.194 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.57 151.37 64.38 Favored 'Trans proline' 0 C--N 1.299 -2.052 1 CA-C-N 130.675 4.848 . . . . 1.02 111.712 176.761 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -73.03 -19.0 23.55 Favored 'Trans proline' 0 C--N 1.3 -2.004 3 C-N-CA 126.53 4.82 . . . . 1.25 115.676 -176.729 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.27 -39.03 66.5 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 115.686 1.736 . . . . 2.25 115.686 177.421 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -89.71 -18.61 26.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.342 -1.355 . . . . 2.02 107.342 -173.071 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.454 ' HG2' HD11 ' A' ' 69' ' ' LEU . 67.9 mt-30 -78.35 100.2 6.67 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 117.728 2.492 . . . . 0.69 117.728 -167.639 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -97.85 122.99 41.61 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 119.292 0.951 . . . . 2.78 110.867 171.009 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.1 mt -92.76 105.72 17.81 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.214 2.911 . . . . 1.17 112.896 179.146 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mm -90.66 130.57 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 128.615 2.766 . . . . 1.38 109.783 -177.521 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -138.89 114.8 10.08 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 106.344 -1.724 . . . . 1.5 106.344 176.364 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.458 . . 68.16 24.98 7.45 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.098 -1.626 . . . . 1.21 113.405 173.605 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.24 -24.87 28.33 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 117.827 -1.54 . . . . 1.3 112.151 -173.189 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.5 tttt -106.44 128.99 54.49 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 122.239 3.02 . . . . 2.55 112.618 -179.685 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -78.48 138.22 38.33 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 112.124 -2.307 . . . . 2.48 112.865 168.964 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.1 mt -93.38 137.89 32.24 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 129.305 3.042 . . . . 0.9 108.959 -166.816 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -68.37 144.8 54.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.995 1.85 . . . . 1.94 115.995 173.11 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.15 -38.81 82.53 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 118.751 2.871 . . . . 1.56 118.751 -165.799 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.39 23.47 31.83 Favored Glycine 0 N--CA 1.43 -1.753 0 O-C-N 119.147 -2.221 . . . . 0.97 115.788 173.486 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -99.07 143.82 28.91 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 118.562 1.181 . . . . 2.49 109.104 166.416 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.251 72.1 p -80.9 162.57 23.87 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 126.277 2.235 . . . . 0.76 112.857 -179.76 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.9 -24.26 67.75 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.307 -2.746 . . . . 1.05 110.467 172.622 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.6 t -88.02 -11.08 48.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.936 -1.728 . . . . 1.19 110.431 -176.997 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -75.8 -42.75 49.1 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.659 -1.9 . . . . 1.9 109.526 173.08 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -79.63 -0.05 32.19 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.41 2.374 . . . . 0.89 117.41 176.13 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 64.01 39.76 7.68 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 115.733 1.753 . . . . 1.84 115.733 -179.48 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.1 mm -75.43 118.4 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 O-C-N 119.273 -2.142 . . . . 0.82 110.081 178.085 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -91.84 172.71 8.29 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.322 2.487 . . . . 2.16 114.394 177.373 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -66.98 140.28 57.72 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.451 -3.28 . . . . 2.12 107.607 179.635 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.386 6.3 tt0 85.71 12.7 0.2 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.812 1.645 . . . . 1.71 113.365 177.2 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.8 m -80.15 152.55 29.18 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 116.856 -3.652 . . . . 1.04 112.52 -172.687 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -108.83 115.48 30.17 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.76 2.219 . . . . 0.79 109.599 -178.006 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.451 ' HB2' HG22 ' A' ' 5' ' ' VAL . 10.5 mp -102.52 163.19 12.37 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 114.118 -5.364 . . . . 1.4 104.86 174.183 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -122.67 123.46 41.18 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.866 1.666 . . . . 1.51 109.942 176.496 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.454 HD11 ' HG2' ' A' ' 41' ' ' GLN . 24.1 tp -84.8 122.14 28.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.719 1.608 . . . . 1.14 114.144 179.067 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.1 t -117.82 138.47 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 102.156 -3.276 . . . . 1.23 102.156 177.737 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 71' ' ' LEU . 36.0 mt -104.3 115.17 29.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.057 1.408 . . . . 2.78 108.495 -177.156 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -65.59 148.94 50.9 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 113.083 -1.871 . . . . 3.75 107.828 -177.99 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.379 29.0 tp -91.0 119.44 31.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.647 -1.983 . . . . 3.14 105.647 173.692 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.6 mtp180 -69.48 128.83 37.89 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 119.387 -2.07 . . . . 6.8 112.7 166.263 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.95 108.98 1.86 Allowed Glycine 0 N--CA 1.43 -1.731 0 O-C-N 123.498 0.499 . . . . 3.57 112.427 -158.378 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.733 0 C-N-CA 126.076 1.798 . . . . 3.87 113.234 -175.299 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 3.3 ptt? . . . . . 0 CA--C 1.491 -1.32 0 N-CA-C 116.566 2.061 . . . . 1.1 116.566 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -103.05 112.52 25.41 Favored 'General case' 0 N--CA 1.429 -1.486 1 O-C-N 116.03 -4.169 . . . . 1.87 107.153 -168.571 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.3 pt -117.71 154.07 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 117.333 -1.318 . . . . 0.72 111.425 169.724 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -118.0 134.63 54.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 125.589 1.805 . . . . 1.4 113.815 -179.195 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -104.14 127.16 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 104.509 -2.404 . . . . 0.58 104.509 173.851 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -104.1 147.69 27.13 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.806 -1.553 . . . . 2.09 106.806 176.208 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.337 7.8 p -97.8 154.09 17.85 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 128.228 3.455 . . . . 0.99 113.378 174.119 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.5 mt -55.14 -36.85 66.23 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.87 2.468 . . . . 2.53 113.389 168.044 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.6 p -78.25 -47.31 18.2 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.592 -1.942 . . . . 2.08 112.489 -173.567 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.85 25.6 0.06 OUTLIER Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 117.3 1.68 . . . . 1.31 117.3 167.916 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -103.74 153.24 20.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 116.121 -1.895 . . . . 1.4 111.668 -179.115 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.3 m -116.24 124.59 50.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 106.716 -1.587 . . . . 0.78 106.716 173.67 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.8 mt -99.08 117.65 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 123.413 2.824 . . . . 1.55 104.042 179.768 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.0 m -98.18 112.58 24.5 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.971 -2.956 . . . . 1.08 107.958 -176.107 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.8 mt -96.6 143.98 27.07 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.766 -1.209 . . . . 1.55 109.491 -174.384 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -98.41 119.17 36.64 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 126.284 2.24 . . . . 1.95 106.727 166.211 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.15 172.27 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 CA-C-N 121.231 1.832 . . . . 0.96 110.433 -175.823 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -126.2 152.53 73.67 Favored Pre-proline 0 N--CA 1.429 -1.483 0 C-N-CA 127.873 2.469 . . . . 2.35 107.246 172.409 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -75.69 -26.63 9.67 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 N-CA-C 107.056 -1.94 . . . . 0.95 107.056 -170.626 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.8 p -78.9 -5.76 54.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.672 -2.517 . . . . 1.45 115.557 -179.241 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -70.0 157.87 36.7 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 124.197 0.935 . . . . 1.69 111.852 168.945 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.7 p -88.75 166.72 13.85 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.649 2.092 . . . . 0.75 116.649 175.373 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.5 mm -67.13 -38.88 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.39 -2.069 . . . . 0.73 107.588 175.017 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -49.07 -44.82 42.24 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 118.31 -2.744 . . . . 1.62 114.077 167.676 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -64.71 -22.33 66.96 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.898 2.079 . . . . 2.13 111.8 175.956 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.36 98.5 t -73.67 -39.53 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 124.055 1.883 . . . . 0.62 110.792 176.543 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -70.88 -38.95 73.08 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.91 2.484 . . . . 1.22 110.487 178.449 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.46 -38.16 63.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.692 2.797 . . . . 0.51 114.193 169.853 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 ttmt -77.23 -38.36 51.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.815 -1.803 . . . . 1.44 112.109 177.164 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.1 mt -61.08 -36.55 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 124.451 1.101 . . . . 1.32 111.42 172.219 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -65.51 -38.2 88.99 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 123.743 1.735 . . . . 1.7 110.936 178.777 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.53 -41.1 98.64 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 117.822 -3.049 . . . . 1.55 113.023 176.6 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -81.59 -59.09 2.73 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 116.423 -1.751 . . . . 2.62 112.064 -176.766 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -98.72 -39.17 8.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.989 2.515 . . . . 1.48 114.119 -164.825 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.21 26.59 7.31 Favored Glycine 0 N--CA 1.431 -1.693 0 O-C-N 125.733 1.896 . . . . 1.12 111.753 173.503 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 36' ' ' ILE . 39.2 mt -102.31 128.39 28.44 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 118.712 -2.64 . . . . 1.55 105.923 -176.809 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.305 80.1 Cg_endo -68.54 158.48 57.52 Favored 'Trans proline' 0 C--N 1.299 -2.051 2 C-N-CA 128.958 6.438 . . . . 1.02 112.75 -175.937 . . . . . . . . 3 2 . 1 . 045 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -66.52 -31.68 41.12 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 CA-C-N 124.389 2.603 . . . . 1.25 112.364 -178.514 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -50.14 -47.55 54.13 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.755 2.872 . . . . 2.25 118.755 175.271 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -70.27 -19.77 63.09 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.32 2.341 . . . . 2.02 117.32 176.199 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -96.41 135.97 37.55 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 120.011 1.278 . . . . 0.69 110.398 -173.484 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -128.01 124.23 36.65 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 100.817 -3.771 . . . . 2.78 100.817 173.279 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.8 mt -104.88 129.51 53.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.451 -2.159 . . . . 1.17 110.735 178.21 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.5 mm -108.59 129.21 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 125.588 2.613 . . . . 1.38 110.198 178.473 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -130.15 130.82 45.25 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.939 -2.976 . . . . 1.5 109.502 172.068 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.255 . . 67.51 -75.23 0.06 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.21 1.481 . . . . 1.21 109.089 -173.08 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.428 ' H ' ' H ' ' A' ' 48' ' ' LYS . . . -161.38 -7.9 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 129.912 3.625 . . . . 1.3 112.3 -175.937 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.428 ' H ' ' H ' ' A' ' 47' ' ' GLY . 44.2 mttp -81.3 130.85 35.2 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.569 -1.548 . . . . 2.55 112.427 -177.467 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -91.2 106.87 18.82 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 114.905 -4.872 . . . . 2.48 104.003 169.671 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.4 mt -71.21 133.17 45.93 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 117.316 2.339 . . . . 0.9 117.316 -169.583 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -83.87 141.97 30.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 111.562 -2.563 . . . . 1.94 114.031 -178.795 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.6 -65.68 0.64 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.469 -2.644 . . . . 1.56 117.989 -161.573 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.3 54.26 4.92 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-O 126.339 3.189 . . . . 0.97 117.33 168.701 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -117.14 146.69 43.02 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 111.585 -2.307 . . . . 2.49 108.987 159.657 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.6 p -72.79 152.93 41.33 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.905 1.446 . . . . 0.76 114.905 169.351 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.6 mt -59.72 -36.8 77.31 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.708 2.803 . . . . 1.05 108.161 175.109 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.263 1.7 t -71.38 -26.11 62.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 127.333 2.896 . . . . 1.19 112.836 175.078 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -67.88 -47.57 68.48 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 123.805 3.002 . . . . 1.9 111.183 168.74 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -69.8 -23.15 63.29 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.732 -1.855 . . . . 0.89 114.692 176.963 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.7 t30 73.79 53.11 0.11 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 127.414 2.286 . . . . 1.84 109.668 -171.672 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.8 mt -95.91 119.79 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 103.524 -2.769 . . . . 0.82 103.524 174.163 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -105.18 -178.06 3.54 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.282 -2.136 . . . . 2.16 111.869 -179.038 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.362 14.1 ptmt -49.18 137.42 13.77 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 127.326 2.25 . . . . 2.12 115.668 172.852 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 77.91 11.31 2.0 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.714 1.605 . . . . 1.71 114.421 173.163 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.3 m -82.59 147.19 28.74 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 124.395 1.059 . . . . 1.04 113.188 -175.165 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.5 m -105.19 116.48 32.02 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.732 2.206 . . . . 0.79 110.625 179.635 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.8 mt -88.4 141.46 28.52 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.323 -2.736 . . . . 1.4 110.804 172.15 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -100.69 123.61 45.14 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.714 1.721 . . . . 1.51 107.448 173.75 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.8 tp -85.89 111.99 20.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.916 1.686 . . . . 1.14 113.745 176.86 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.7 t -111.51 134.3 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 2 CA-C-O 129.965 4.698 . . . . 1.23 99.757 178.947 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.6 mt -116.85 133.02 56.53 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.023 -2.923 . . . . 2.78 115.687 -177.549 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -125.51 178.75 5.47 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 117.389 2.366 . . . . 3.75 117.389 178.218 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.3 mt -90.96 -58.38 2.49 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 123.596 2.907 . . . . 3.14 110.578 169.789 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -109.73 -55.36 2.45 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 126.34 2.275 . . . . 6.8 108.394 172.973 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.7 -131.11 1.97 Allowed Glycine 0 N--CA 1.432 -1.633 0 CA-C-O 117.736 -1.591 . . . . 3.57 111.612 -159.354 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.8 0 CA-C-N 118.68 1.24 . . . . 3.87 112.259 -176.346 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 CA--C 1.489 -1.371 0 CA-C-O 117.439 -1.267 . . . . 1.1 111.138 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -94.7 134.57 37.15 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.774 1.75 . . . . 1.87 111.374 -171.633 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -120.61 136.6 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.855 -3.028 . . . . 0.72 106.26 169.037 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -101.66 90.66 4.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 125.312 2.482 . . . . 1.4 111.701 -173.443 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.99 100.08 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.49 1 O-C-N 112.216 -6.553 . . . . 0.58 113.367 177.238 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -96.12 134.89 38.64 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.84 -1.163 . . . . 2.09 110.568 178.452 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.5 p -84.52 -178.78 6.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 131.049 3.74 . . . . 0.99 116.102 174.612 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.3 tp -79.01 -26.58 43.24 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.97 -4.206 . . . . 2.53 116.336 171.395 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.5 p -77.32 -34.01 55.41 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.253 2.93 . . . . 2.08 114.335 -179.167 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.32 4.16 2.6 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 119.27 -2.144 . . . . 1.31 111.455 174.464 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -82.4 122.74 28.39 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.82 -1.988 . . . . 1.4 111.531 -176.174 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 m -99.26 112.23 24.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.394 -2.691 . . . . 0.78 113.362 170.041 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.52 117.63 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 120.021 -1.674 . . . . 1.55 106.59 171.049 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.6 m -99.07 98.04 9.11 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.495 -1.669 . . . . 1.08 106.495 -178.362 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.1 mt -76.51 126.09 30.37 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.436 1.894 . . . . 1.55 111.294 -176.928 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -81.26 104.07 11.47 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.904 -2.997 . . . . 1.95 113.363 166.662 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 m -110.49 171.62 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 123.983 0.913 . . . . 0.96 111.596 -179.739 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -123.32 169.73 9.6 Favored Pre-proline 0 N--CA 1.43 -1.472 0 CA-C-O 116.278 -1.82 . . . . 2.35 107.387 158.22 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -78.66 -16.08 13.3 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 124.127 2.51 . . . . 0.95 112.719 -167.905 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.83 -19.21 65.8 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 114.886 -2.483 . . . . 1.45 113.886 174.537 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -72.18 143.63 48.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 125.189 1.555 . . . . 1.69 113.073 -174.863 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 26' ' ' VAL . 13.5 p -86.89 167.42 14.34 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.568 -1.958 . . . . 0.75 113.361 178.798 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 23' ' ' ILE . 42.4 mm -64.08 -37.16 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.536 -1.353 . . . . 0.73 111.84 172.962 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -53.03 -42.18 65.43 Favored 'General case' 0 N--CA 1.429 -1.492 1 O-C-N 115.458 -4.526 . . . . 1.62 114.866 163.639 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -72.72 -32.94 66.09 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.407 -2.683 . . . . 2.13 111.756 -178.621 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 55.1 t -62.56 -50.38 80.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 119.019 -2.3 . . . . 0.62 109.927 171.724 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -66.82 -18.59 65.45 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.142 1.377 . . . . 1.22 111.168 -179.227 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.0 -35.51 31.86 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 113.292 0.849 . . . . 0.51 113.292 169.816 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 55.1 mttp -63.46 -52.47 61.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.153 -2.217 . . . . 1.44 108.542 171.203 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.8 mt -53.92 -32.54 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 123.96 3.073 . . . . 1.32 117.397 174.83 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -71.1 -40.06 71.73 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.088 -2.883 . . . . 1.7 114.901 173.568 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.64 -56.85 16.16 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.09 -2.881 . . . . 1.55 107.428 168.836 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -71.22 -56.48 5.97 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.485 1.291 . . . . 2.62 114.485 -170.103 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -96.15 -24.79 16.12 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.151 2.58 . . . . 1.48 112.11 -168.972 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.55 37.53 13.99 Favored Glycine 0 N--CA 1.43 -1.751 0 CA-C-O 127.6 3.889 . . . . 1.12 113.71 173.853 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.7 mt -108.86 132.72 21.0 Favored Pre-proline 0 N--CA 1.429 -1.494 1 O-C-N 116.262 -4.081 . . . . 1.55 108.268 -178.539 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -68.51 142.88 55.29 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 C-N-CA 125.05 3.833 . . . . 1.02 120.817 -179.574 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.47 -9.11 21.32 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 123.731 2.954 . . . . 1.25 117.745 -171.376 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.74 -23.39 36.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.906 1.683 . . . . 2.25 112.697 166.85 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -86.15 -41.08 15.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 129.122 2.969 . . . . 2.02 111.123 -177.762 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.257 58.0 mt-30 -70.0 134.54 48.42 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 111.056 -2.793 . . . . 0.69 113.168 179.978 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -133.11 120.13 20.85 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.322 1.601 . . . . 2.78 115.322 175.074 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.6 mt -100.02 117.42 34.25 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 121.223 -0.923 . . . . 1.17 111.167 -177.214 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 44' ' ' ILE . 80.8 mt -110.33 129.19 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 126.964 2.106 . . . . 1.38 108.097 179.472 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -142.83 137.52 29.68 Favored 'General case' 0 N--CA 1.43 -1.463 1 N-CA-C 99.092 -4.41 . . . . 1.5 99.092 173.002 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.16 33.4 23.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 117.078 2.251 . . . . 1.21 117.078 175.695 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.57 9.18 73.53 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 116.198 -2.906 . . . . 1.3 115.459 -174.023 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -121.33 137.9 54.49 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.694 2.187 . . . . 2.55 109.732 -176.459 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -89.37 118.22 28.88 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 127.261 3.41 . . . . 2.48 102.155 179.281 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.1 mt -87.22 152.59 22.18 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.771 -3.706 . . . . 0.9 112.82 -170.715 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -97.4 163.9 12.68 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.104 -3.498 . . . . 1.94 109.535 179.633 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -72.88 -69.04 0.44 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.458 2.303 . . . . 1.56 114.168 -168.314 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.08 59.77 2.25 Favored Glycine 0 N--CA 1.43 -1.728 1 C-N-CA 131.455 4.359 . . . . 0.97 110.76 176.919 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.5 mmt-85 -142.74 148.46 37.28 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.073 -1.825 . . . . 2.49 106.073 169.7 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 72.6 p -86.43 170.24 12.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.217 -3.427 . . . . 0.76 108.617 178.72 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 31.3 mt -65.89 -39.1 90.32 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.794 2.838 . . . . 1.05 110.648 169.078 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.3 t -64.88 -37.03 86.26 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.825 -3.047 . . . . 1.19 114.966 177.726 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -60.48 -40.67 92.14 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 115.925 1.824 . . . . 1.9 115.925 177.486 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -77.25 -9.92 59.1 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.797 2.839 . . . . 0.89 114.246 171.809 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.258 9.6 t30 63.18 48.39 3.73 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 125.787 2.708 . . . . 1.84 113.368 -176.698 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.1 mt -96.47 100.24 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 1 C-N-CA 132.25 4.22 . . . . 0.82 104.843 179.352 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -90.75 -174.45 4.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 121.959 2.163 . . . . 2.16 106.591 -175.955 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -62.37 151.66 36.2 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.58 -1.646 . . . . 2.12 109.76 173.088 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.344 43.7 mt-10 67.4 21.88 9.57 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 128.983 2.913 . . . . 1.71 111.078 171.106 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.1 m -85.59 136.7 33.28 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 115.617 -2.135 . . . . 1.04 112.64 -178.396 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.0 m -90.72 111.13 22.36 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 120.234 1.379 . . . . 0.79 108.623 -178.764 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.3 mt -88.91 137.67 32.11 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.259 -3.4 . . . . 1.4 107.313 173.326 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -94.06 116.65 29.1 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.78 -2.45 . . . . 1.51 106.527 -174.046 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.1 tp -99.63 108.68 21.12 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.749 -1.844 . . . . 1.14 110.005 -176.909 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.3 t -98.52 132.73 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 131.262 3.825 . . . . 1.23 107.691 178.307 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.8 mt -112.86 106.84 15.24 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 127.458 3.504 . . . . 2.78 105.354 177.565 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -63.84 160.69 16.9 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 115.113 -4.742 . . . . 3.75 115.23 -179.38 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.6 mt -113.09 174.36 5.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.732 2.413 . . . . 3.14 106.539 171.419 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -99.98 155.38 17.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.11 -3.494 . . . . 6.8 112.994 171.726 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.38 -91.1 0.56 Allowed Glycine 0 N--CA 1.43 -1.739 0 CA-C-O 117.315 -1.825 . . . . 3.57 112.345 -170.617 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.75 0 CA-C-N 123.804 3.802 . . . . 3.87 107.784 174.578 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ptt? . . . . . 0 CA--C 1.489 -1.392 0 CA-C-O 121.792 0.806 . . . . 1.1 111.739 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -110.81 142.21 43.12 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.645 -1.909 . . . . 1.87 110.301 -169.694 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.2 pt -136.64 146.2 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 129.073 2.949 . . . . 0.72 109.809 178.42 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.422 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 25.3 m-85 -105.29 109.55 21.58 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 113.384 -1.735 . . . . 1.4 112.933 -178.497 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -100.49 103.06 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 117.601 -3.187 . . . . 0.58 108.703 176.227 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -91.76 131.57 37.03 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.73 -1.605 . . . . 2.09 113.049 176.486 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.351 0.0 OUTLIER -98.4 168.83 9.96 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.455 2.302 . . . . 0.99 109.32 -177.976 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.5 mt -67.67 -35.29 78.58 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 126.404 2.315 . . . . 2.53 112.686 -175.611 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.319 17.8 p -71.31 -35.66 71.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.893 1.679 . . . . 2.08 109.197 -176.388 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.29 -12.68 1.83 Allowed Glycine 0 N--CA 1.429 -1.805 0 O-C-N 118.949 -2.344 . . . . 1.31 115.758 178.031 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -80.29 134.45 36.08 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 124.946 2.308 . . . . 1.4 114.064 -175.654 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -99.82 127.3 45.99 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.197 -2.19 . . . . 0.78 109.518 173.813 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 mt -102.48 117.61 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 118.136 -2.853 . . . . 1.55 108.66 174.699 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.1 m -95.92 117.69 31.1 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 119.534 -0.866 . . . . 1.08 109.194 178.629 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.5 mt -119.21 150.27 40.35 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 121.212 -0.93 . . . . 1.55 112.627 177.371 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -101.07 139.91 36.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 127.762 3.164 . . . . 1.95 108.547 167.657 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.9 m -150.93 170.47 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 C-N-CA 129.969 3.307 . . . . 0.96 112.981 -178.383 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -108.47 156.9 37.84 Favored Pre-proline 0 CA--C 1.489 -1.383 0 CA-C-O 114.071 -2.871 . . . . 2.35 110.264 167.054 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -67.84 -21.27 44.51 Favored 'Trans proline' 0 N--CA 1.433 -2.065 0 C-N-CA 124.525 3.483 . . . . 0.95 111.827 -174.643 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.2 p -71.4 -6.64 41.74 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 130.511 3.525 . . . . 1.45 115.944 169.713 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.74 156.19 30.75 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.473 -2.017 . . . . 1.69 112.928 176.021 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.6 p -92.64 169.63 10.36 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.085 1.754 . . . . 0.75 113.128 176.512 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.5 mm -66.93 -30.97 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.806 -2.434 . . . . 0.73 114.975 173.579 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -57.25 -40.44 77.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.883 -3.01 . . . . 1.62 112.176 168.827 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -69.42 -23.65 63.73 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 113.217 0.821 . . . . 2.13 113.217 177.912 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 62.9 t -79.69 -46.54 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 119.647 -1.908 . . . . 0.62 113.48 176.38 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -68.85 -23.6 64.26 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 125.761 2.696 . . . . 1.22 115.017 176.614 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.84 -19.75 57.15 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.24 -3.412 . . . . 0.51 111.105 173.561 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -84.64 -34.85 22.99 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.173 2.416 . . . . 1.44 110.3 -179.838 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.7 mt -75.95 -22.13 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 117.965 -2.96 . . . . 1.32 107.767 175.822 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -70.23 -37.27 74.95 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 117.968 -2.958 . . . . 1.7 110.883 170.818 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.97 -59.33 3.58 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 120.467 -1.396 . . . . 1.55 110.873 172.438 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.256 32.6 tttp -59.18 -58.83 6.93 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.266 2.626 . . . . 2.62 111.25 -172.266 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -92.99 -74.7 0.51 Allowed 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.4 1.88 . . . . 1.48 109.612 -174.065 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 156.6 -14.23 0.35 Allowed Glycine 0 N--CA 1.431 -1.694 0 CA-C-N 125.31 3.687 . . . . 1.12 110.274 177.186 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.6 mt -57.59 119.41 32.61 Favored Pre-proline 0 N--CA 1.43 -1.433 0 C-N-CA 128.929 2.892 . . . . 1.55 113.476 -172.891 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -60.22 147.09 94.85 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 CA-C-N 125.168 2.882 . . . . 1.02 117.534 171.789 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.304 73.6 Cg_endo -72.35 -18.25 26.57 Favored 'Trans proline' 0 N--CA 1.433 -2.031 1 C-N-CA 126.691 4.927 . . . . 1.25 114.615 -172.327 . . . . . . . . 3 2 . 1 . 047 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -73.36 -22.03 60.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 124.176 3.171 . . . . 2.25 109.373 174.799 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -87.4 -18.38 30.13 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.918 -2.364 . . . . 2.02 110.0 -178.724 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -96.12 116.27 28.72 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.726 -1.953 . . . . 0.69 105.726 -172.043 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -103.57 119.79 39.59 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 131.472 3.909 . . . . 2.78 107.851 168.695 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 37.5 mt -109.53 120.82 43.67 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.047 1.403 . . . . 1.17 110.916 179.631 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.414 HD11 HG21 ' A' ' 70' ' ' VAL . 1.4 mt -104.98 126.81 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 O-C-N 119.871 -1.768 . . . . 1.38 109.843 -179.614 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.498 ' CE2' HG12 ' A' ' 61' ' ' ILE . 49.3 t80 -134.12 127.79 32.82 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 116.881 -3.637 . . . . 1.5 112.936 173.762 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 35.39 38.75 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.843 1.657 . . . . 1.21 114.508 -171.51 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.27 -43.12 1.76 Allowed Glycine 0 N--CA 1.431 -1.699 0 O-C-N 118.012 -2.93 . . . . 1.3 113.096 175.752 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -72.46 144.03 48.22 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 119.374 1.587 . . . . 2.55 113.522 176.47 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.445 1.1 mp0 -99.14 112.8 24.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.325 -2.109 . . . . 2.48 112.101 169.742 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.8 mt -78.27 139.28 38.89 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 116.715 -3.741 . . . . 0.9 113.964 -158.393 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -82.05 141.8 32.87 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.747 2.419 . . . . 1.94 109.673 178.262 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.31 -48.46 71.32 Favored 'General case' 0 N--CA 1.43 -1.433 1 N-CA-C 121.91 4.041 . . . . 1.56 121.91 -173.378 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.92 63.25 1.52 Allowed Glycine 0 N--CA 1.431 -1.649 0 O-C-N 118.378 -2.701 . . . . 0.97 114.216 171.228 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -129.65 150.39 50.99 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.371 3.069 . . . . 2.49 105.932 167.62 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.7 p -87.41 170.15 11.63 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 119.071 -1.052 . . . . 0.76 110.048 177.662 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.6 mt -70.67 -30.11 66.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.591 1.956 . . . . 1.05 107.943 173.39 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.3 p -73.03 -43.0 62.56 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 116.241 -4.037 . . . . 1.19 118.036 175.382 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -44.05 -60.45 1.86 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.256 2.222 . . . . 1.9 116.584 167.058 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -73.25 3.78 5.34 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.424 -1.262 . . . . 0.89 112.054 179.61 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.2 t30 52.76 48.76 21.77 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.612 3.165 . . . . 1.84 114.654 -175.308 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.498 HG12 ' CE2' ' A' ' 45' ' ' PHE . 19.5 mt -94.92 124.74 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 116.528 -3.857 . . . . 0.82 108.281 175.785 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -114.33 -162.64 0.82 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 116.794 -3.691 . . . . 2.16 105.809 -165.299 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -67.87 139.59 56.51 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 124.935 2.302 . . . . 2.12 113.371 167.347 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.438 84.5 mt-10 70.81 38.3 1.22 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.912 -2.368 . . . . 1.71 111.191 171.043 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 m -95.53 115.24 27.16 Favored 'General case' 0 N--CA 1.43 -1.453 1 C-N-CA 133.734 4.813 . . . . 1.04 107.779 -170.31 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.422 ' HA ' ' HB2' ' A' ' 4' ' ' PHE 0.256 87.5 m -80.46 102.47 9.7 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.723 -1.236 . . . . 0.79 114.263 175.414 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.308 8.8 mt -89.21 135.61 33.48 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-O 123.904 1.812 . . . . 1.4 107.494 174.033 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -97.39 104.98 17.05 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.084 1.354 . . . . 1.51 107.586 -174.276 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.362 16.6 tp -76.43 115.42 16.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.371 -3.331 . . . . 1.14 114.335 174.906 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.414 HG21 HD11 ' A' ' 44' ' ' ILE . 66.0 t -108.48 128.77 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 115.554 -2.165 . . . . 1.23 106.508 172.212 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.8 mt -96.86 161.05 14.03 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 123.968 3.076 . . . . 2.78 109.019 176.285 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -95.6 98.1 10.24 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 103.089 -2.93 . . . . 3.75 103.089 174.976 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 72.3 mt -97.83 147.72 24.13 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 124.478 2.085 . . . . 3.14 107.881 171.632 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -86.32 123.6 31.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.052 -1.431 . . . . 6.8 109.7 171.557 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.19 -87.97 0.27 Allowed Glycine 0 N--CA 1.43 -1.747 0 CA-C-O 116.238 -2.423 . . . . 3.57 109.11 -173.969 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.74 0 CA-C-O 116.82 -2.1 . . . . 3.87 110.748 178.333 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.458 ' SD ' ' HA ' ' A' ' 63' ' ' LYS . 11.0 ptt? . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 117.878 -1.058 . . . . 1.1 112.834 . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -86.4 129.43 34.86 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 120.878 1.672 . . . . 1.87 112.013 -179.881 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.261 32.5 pt -130.91 150.68 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.129 -3.482 . . . . 0.72 108.642 175.459 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -110.88 142.73 42.55 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 117.897 -3.002 . . . . 1.4 104.819 -178.653 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.4 t -124.1 108.49 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 107.082 -1.451 . . . . 0.58 107.082 172.748 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -98.28 132.1 44.05 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.89 -2.381 . . . . 2.09 110.633 -178.872 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.555 HG22 HD23 ' A' ' 69' ' ' LEU . 2.6 p -86.53 177.48 7.38 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.805 2.241 . . . . 0.99 113.682 178.797 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.317 43.0 mt -83.2 -38.99 21.56 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 119.153 -2.217 . . . . 2.53 109.828 170.073 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 p -63.71 -52.28 61.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.452 3.101 . . . . 2.08 113.963 179.69 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.84 11.31 0.04 OUTLIER Glycine 0 N--CA 1.429 -1.783 0 O-C-N 118.465 -2.647 . . . . 1.31 118.008 -175.136 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -115.59 150.95 35.83 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 105.824 -1.917 . . . . 1.4 105.824 -167.445 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.3 m -122.29 111.23 16.66 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 116.393 -1.765 . . . . 0.78 109.377 166.963 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -91.58 121.79 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 123.605 2.911 . . . . 1.55 109.952 177.622 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 m -87.55 114.18 23.92 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 127.189 3.376 . . . . 1.08 113.286 173.008 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.4 mt -110.8 154.74 23.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.918 -2.989 . . . . 1.55 112.88 -179.712 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -110.09 123.14 49.17 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 124.259 1.981 . . . . 1.95 108.028 166.283 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.96 170.59 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 118.672 -2.517 . . . . 0.96 107.116 -174.528 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -118.91 154.65 53.12 Favored Pre-proline 0 N--CA 1.43 -1.463 0 O-C-N 119.151 -2.218 . . . . 2.35 105.825 165.331 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -68.17 -16.54 44.53 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 O-C-N 114.683 -3.377 . . . . 0.95 114.276 -175.253 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.4 m -91.15 12.03 21.35 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 114.045 -5.409 . . . . 1.45 113.378 175.836 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -88.54 144.86 26.06 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 113.31 -3.356 . . . . 1.69 108.463 179.707 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.278 53.7 p -71.28 153.24 42.55 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.473 1.909 . . . . 0.75 109.758 -179.945 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.6 mm -54.09 -40.58 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 118.403 -2.685 . . . . 0.73 114.598 168.645 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -42.59 -46.29 4.88 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 117.675 2.472 . . . . 1.62 117.675 164.983 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.61 -46.03 84.38 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 111.625 -2.534 . . . . 2.13 112.478 178.151 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.6 t -59.01 -44.32 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 C-N-CA 126.743 2.017 . . . . 0.62 106.155 178.034 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.254 84.2 mttt -60.8 -42.61 97.97 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 116.203 -4.061 . . . . 1.22 114.124 177.473 . . . . . . . . 3 2 . 1 . 048 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.34 -20.68 62.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.448 -3.283 . . . . 0.51 116.379 175.091 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -72.68 -45.24 59.83 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.095 1.758 . . . . 1.44 112.359 170.442 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -48.69 -43.91 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.532 1.533 . . . . 1.32 112.756 163.264 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -66.05 -43.38 87.65 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.855 -3.653 . . . . 1.7 112.622 -179.537 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -53.77 -49.59 67.91 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.323 1.449 . . . . 1.55 110.339 168.26 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -80.97 -54.79 5.27 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.071 -2.893 . . . . 2.62 112.627 -174.815 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -99.62 -26.62 14.02 Favored 'General case' 0 N--CA 1.431 -1.401 1 O-C-N 112.694 -6.254 . . . . 1.48 109.03 -168.309 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.2 17.4 40.23 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 117.918 -2.989 . . . . 1.12 115.158 179.929 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.8 mt -84.83 123.28 74.17 Favored Pre-proline 0 N--CA 1.43 -1.471 0 CA-C-O 113.678 -3.058 . . . . 1.55 107.972 -177.404 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -69.81 144.4 53.61 Favored 'Trans proline' 0 N--CA 1.433 -2.037 1 CA-C-N 129.548 4.446 . . . . 1.02 114.205 -178.142 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_exo -62.08 -20.05 68.42 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 N-CA-C 121.185 3.494 . . . . 1.25 121.185 -165.425 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -66.79 -28.17 68.17 Favored 'General case' 0 N--CA 1.429 -1.49 1 O-C-N 129.998 4.561 . . . . 2.25 111.773 173.542 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -85.62 -24.59 27.05 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 116.296 -1.812 . . . . 2.02 110.457 -176.412 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.251 60.1 mt-30 -79.49 129.8 34.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 127.899 3.249 . . . . 0.69 110.959 -169.107 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -115.1 129.87 56.79 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.457 -2.053 . . . . 2.78 105.457 168.993 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 73.3 mt -114.1 126.96 55.68 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.139 -2.85 . . . . 1.17 111.093 179.647 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 59.8 mt -117.73 124.23 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-O 126.969 3.271 . . . . 1.38 111.245 -175.47 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -135.66 139.3 43.63 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 115.965 -4.21 . . . . 1.5 109.049 172.192 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.362 . . 58.68 25.21 13.05 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 123.779 2.991 . . . . 1.21 115.673 173.469 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.11 2.92 90.7 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 117.077 1.591 . . . . 1.3 117.077 -177.055 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -113.26 157.21 22.05 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.382 2.273 . . . . 2.55 115.61 176.773 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -97.54 139.66 33.12 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.431 -2.668 . . . . 2.48 109.674 173.079 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.3 mt -102.2 120.66 40.82 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.978 -2.951 . . . . 0.9 111.329 -170.362 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -67.28 148.01 52.25 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.191 1.552 . . . . 1.94 115.191 175.283 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.65 -47.11 76.67 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 120.75 3.611 . . . . 1.56 120.75 -174.37 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.39 18.01 21.03 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 115.372 -2.904 . . . . 0.97 118.766 173.684 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -102.79 156.74 17.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.77 2.785 . . . . 2.49 110.974 171.643 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 39.1 p -88.55 169.65 11.55 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 123.329 1.538 . . . . 0.76 115.008 172.817 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.333 77.3 mt -69.22 -23.96 63.95 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 116.011 -4.181 . . . . 1.05 110.809 170.713 . . . . . . . . 3 2 . 1 . 048 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -65.72 -36.4 83.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.8 2.44 . . . . 1.19 115.489 171.806 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -65.41 -38.59 90.38 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.698 1.599 . . . . 1.9 113.911 173.881 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -78.9 -25.28 43.79 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 115.328 -2.272 . . . . 0.89 113.901 175.323 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.279 1.9 m-80 70.8 58.46 0.21 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.107 1.763 . . . . 1.84 109.909 -171.299 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 mt -105.25 117.12 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 105.022 -2.214 . . . . 0.82 105.022 174.034 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -84.83 -175.16 5.65 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 124.837 2.256 . . . . 2.16 111.374 -169.216 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.458 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 59.7 tttt -20.98 -87.87 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.422 1 C-N-CA 134.351 5.06 . . . . 2.12 118.208 169.086 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -103.17 69.3 1.01 Allowed 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 122.408 2.367 . . . . 1.71 116.226 -179.97 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.3 m -91.85 152.38 20.12 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 114.797 -1.092 . . . . 1.04 112.762 -179.99 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.5 m -113.52 115.69 28.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.136 1.374 . . . . 0.79 109.851 174.024 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.3 mt -96.93 156.63 16.27 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.545 1.938 . . . . 1.4 110.83 -179.674 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.405 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 98.2 m-70 -110.9 129.65 55.81 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 100.991 -3.707 . . . . 1.51 100.991 -175.815 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.555 HD23 HG22 ' A' ' 7' ' ' THR . 29.0 tp -102.53 113.89 27.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 125.328 1.643 . . . . 1.14 108.441 178.509 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.6 t -115.96 148.79 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 125.497 2.57 . . . . 1.23 109.464 172.845 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.9 mt -112.62 150.54 31.27 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.728 -4.358 . . . . 2.78 111.985 -177.708 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -78.74 162.55 26.08 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.135 -2.172 . . . . 3.75 105.135 179.533 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.3 mt -78.34 104.53 8.99 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 115.275 -2.57 . . . . 3.14 116.746 172.668 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -85.92 -55.35 3.99 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.997 -1.689 . . . . 6.8 112.333 173.738 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 143.03 -68.98 0.43 Allowed Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 117.79 -1.561 . . . . 3.57 112.593 -175.716 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.733 0 CA-C-N 123.658 3.729 . . . . 3.87 108.563 -178.205 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 ptt? . . . . . 0 CA--C 1.491 -1.316 0 N-CA-C 116.773 2.138 . . . . 1.1 116.773 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -87.62 121.17 29.72 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 122.566 2.439 . . . . 1.87 110.489 178.904 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 pt -108.42 153.09 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 127.699 2.4 . . . . 0.72 108.577 173.777 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -104.18 131.08 51.85 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.868 -1.16 . . . . 1.4 107.868 -179.744 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.5 t -121.01 121.47 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 104.481 -2.414 . . . . 0.58 104.481 168.054 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -100.25 128.18 46.37 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 126.632 1.973 . . . . 2.09 111.727 -176.971 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.353 30.5 p -77.41 -164.07 0.44 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.602 1.668 . . . . 0.99 114.42 179.201 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.308 10.3 mt -90.97 -40.6 11.59 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.704 -1.872 . . . . 2.53 112.911 169.159 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.0 p -64.75 -37.09 86.42 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.548 -2.595 . . . . 2.08 107.616 -176.409 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.35 51.97 0.31 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 128.067 2.746 . . . . 1.31 111.312 175.92 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -114.1 130.27 56.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 101.972 -3.344 . . . . 1.4 101.972 177.425 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.3 m -102.67 103.76 14.05 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 118.016 -2.927 . . . . 0.78 110.399 177.146 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.81 136.51 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 118.755 -2.465 . . . . 1.55 108.418 179.541 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.7 m -103.29 111.93 24.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 118.733 -0.651 . . . . 1.08 109.265 179.602 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.38 142.23 28.01 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 127.992 3.307 . . . . 1.55 109.253 -178.97 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -105.81 116.28 31.67 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 123.395 1.569 . . . . 1.95 113.044 164.407 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.78 179.46 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.039 -1.437 . . . . 0.96 109.635 -178.808 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 89.8 mt-10 -115.89 163.35 21.46 Favored Pre-proline 0 N--CA 1.432 -1.373 0 O-C-N 117.1 -3.5 . . . . 2.35 107.888 164.189 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 56.1 Cg_exo -70.51 -14.46 33.73 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 C-N-CA 122.603 2.202 . . . . 0.95 112.444 -177.688 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.0 p -90.6 -0.99 57.88 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.165 2.186 . . . . 1.45 112.675 179.335 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -75.89 137.51 40.46 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.602 -1.936 . . . . 1.69 112.321 174.284 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 17.2 p -78.87 170.84 16.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.902 1.81 . . . . 0.75 111.625 174.297 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.284 3.5 mp -64.43 -41.07 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.267 -3.396 . . . . 0.73 112.721 168.106 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -43.5 -50.97 6.96 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 117.133 2.271 . . . . 1.62 117.133 163.694 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -67.01 -34.58 78.04 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.234 -2.166 . . . . 2.13 110.743 179.11 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.25 -42.1 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 118.253 2.686 . . . . 0.62 118.253 170.548 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.413 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 40.1 mtmt -71.86 -34.96 69.65 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 117.621 -3.175 . . . . 1.22 117.091 174.337 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.39 -28.38 63.99 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.733 2.413 . . . . 0.51 113.116 179.254 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -71.53 -37.89 71.11 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.689 2.395 . . . . 1.44 110.345 168.616 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.1 mt -68.31 -38.81 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 125.282 1.433 . . . . 1.32 107.996 175.872 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.342 40.3 tt0 -56.44 -41.8 77.04 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 128.788 2.835 . . . . 1.7 114.057 171.035 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -60.51 -41.73 94.95 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 118.236 2.68 . . . . 1.55 118.236 162.013 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -76.28 -52.4 10.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.719 -3.113 . . . . 2.62 116.431 -173.748 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -100.31 -26.77 13.79 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.714 2.406 . . . . 1.48 111.152 -168.585 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.75 13.88 56.04 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 118.12 -2.862 . . . . 1.12 117.289 176.048 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.9 mt -98.7 117.86 63.89 Favored Pre-proline 0 N--CA 1.43 -1.431 0 C-N-CA 127.439 2.295 . . . . 1.55 110.094 -170.799 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.39 152.71 70.94 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 CA-C-N 125.273 2.919 . . . . 1.02 116.932 -178.593 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -81.8 8.73 4.28 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 CA-C-O 113.582 -2.757 . . . . 1.25 107.919 -165.808 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -73.37 -44.13 59.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 125.272 3.669 . . . . 2.25 113.167 168.939 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -72.61 -26.36 61.66 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.783 2.833 . . . . 2.02 107.926 -172.466 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.413 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 73.3 mt-30 -87.25 133.18 33.7 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 123.455 0.702 . . . . 0.69 111.518 -165.932 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -124.6 146.89 48.81 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.182 2.593 . . . . 2.78 105.167 166.01 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 69' ' ' LEU . 32.5 mt -129.33 128.06 42.36 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 129.168 2.987 . . . . 1.17 105.933 -177.709 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -121.01 115.66 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 105.339 -2.097 . . . . 1.38 105.339 -178.165 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.414 ' HB2' HD22 ' A' ' 67' ' ' LEU 0.262 23.8 t80 -101.45 117.37 34.8 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.736 -1.852 . . . . 1.5 106.397 171.127 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.54 -46.31 0.62 Allowed 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.45 2.7 . . . . 1.21 114.806 -177.086 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.04 -32.81 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 126.938 2.209 . . . . 1.3 110.186 -171.712 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.27 52.8 mttm -73.29 125.96 29.01 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 126.657 2.034 . . . . 2.55 114.685 175.272 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -82.79 136.36 34.69 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 128.382 3.944 . . . . 2.48 112.825 172.309 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.4 mt -99.89 132.53 45.19 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.125 -2.86 . . . . 0.9 111.628 -165.171 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -79.17 141.28 37.35 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 122.175 0.988 . . . . 1.94 112.426 174.728 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.82 -57.74 8.45 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 126.031 2.824 . . . . 1.56 116.273 -174.135 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.43 16.43 13.84 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 122.6 3.8 . . . . 0.97 122.6 174.502 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.6 mmt85 -85.41 163.87 18.25 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.8 1.8 . . . . 2.49 111.14 161.17 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.7 p -89.66 169.66 11.13 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 115.365 1.617 . . . . 0.76 115.365 165.287 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.491 ' HA ' HD12 ' A' ' 61' ' ' ILE . 58.5 mt -64.6 -47.8 77.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 129.086 2.954 . . . . 1.05 108.666 172.147 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.7 m -57.65 -37.06 72.72 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.038 -2.289 . . . . 1.19 114.481 175.675 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -62.79 -54.37 39.99 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 129.764 3.226 . . . . 1.9 115.913 175.365 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -64.42 -12.38 42.65 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.564 -2.16 . . . . 0.89 116.294 169.404 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.2 m120 69.67 56.24 0.35 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 126.615 2.447 . . . . 1.84 113.175 -179.583 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 56' ' ' LEU . 65.9 mt -95.66 128.44 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 128.885 2.874 . . . . 0.82 106.433 -176.731 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -75.76 159.42 31.07 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 125.708 1.603 . . . . 2.16 109.875 -171.943 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -52.27 -35.26 49.57 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 120.448 3.499 . . . . 2.12 120.448 167.519 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -128.39 86.44 2.46 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 130.086 4.616 . . . . 1.71 105.011 174.437 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.44 172.76 11.2 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 117.895 -1.05 . . . . 1.04 110.997 -176.697 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.4 m -130.48 125.79 35.27 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 117.807 -1.092 . . . . 0.79 108.727 176.381 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.414 HD22 ' HB2' ' A' ' 45' ' ' PHE . 15.0 mt -104.12 145.64 29.89 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 128.773 2.829 . . . . 1.4 111.671 170.492 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -106.15 122.13 45.56 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.171 -1.58 . . . . 1.51 111.416 -172.277 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 43' ' ' LEU . 57.2 tp -90.22 118.69 29.93 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.208 -1.775 . . . . 1.14 106.208 -173.574 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.5 t -119.29 148.9 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 103.69 -2.707 . . . . 1.23 103.69 173.722 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.9 mt -122.46 151.52 41.2 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 125.933 2.02 . . . . 2.78 108.401 -175.459 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -80.82 179.87 7.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.935 -1.876 . . . . 3.75 105.935 171.028 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.6 mt -69.73 154.88 41.36 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.214 -2.179 . . . . 3.14 110.264 164.534 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 -78.46 123.19 26.77 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.435 2.064 . . . . 6.8 113.303 -179.543 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.42 51.67 50.27 Favored Glycine 0 N--CA 1.431 -1.672 0 O-C-N 118.761 -2.462 . . . . 3.57 111.863 -166.189 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.741 0 CA-C-O 113.716 -3.824 . . . . 3.87 113.288 -178.673 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.368 0 CA-C-O 125.902 2.763 . . . . 1.1 115.991 . . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -82.21 99.19 9.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.174 -3.454 . . . . 1.87 107.851 172.029 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -92.92 134.42 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 120.7 -1.25 . . . . 0.72 113.827 168.944 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -94.77 109.45 21.41 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 129.554 3.142 . . . . 1.4 111.328 -176.497 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 t -90.18 102.54 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 123.747 0.819 . . . . 0.58 111.963 173.352 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -75.87 140.57 42.28 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.137 2.399 . . . . 2.09 108.838 172.869 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 p -108.94 162.39 14.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.809 -1.807 . . . . 0.99 108.424 176.786 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.486 HD11 HG13 ' A' ' 70' ' ' VAL . 5.2 mt -69.63 -32.76 71.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 128.278 3.894 . . . . 2.53 112.531 177.951 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.0 p -70.86 -35.73 72.52 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 130.405 3.482 . . . . 2.08 115.975 -174.707 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.58 15.66 0.95 Allowed Glycine 0 N--CA 1.431 -1.692 0 CA-C-O 116.954 -2.025 . . . . 1.31 117.263 170.468 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -116.87 172.28 7.36 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 120.333 2.066 . . . . 1.4 110.141 -178.26 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.4 m -123.87 106.6 10.58 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 128.134 2.574 . . . . 0.78 113.392 177.259 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -90.58 107.65 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 117.272 -1.347 . . . . 1.55 109.878 178.731 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.3 m -98.63 101.02 12.32 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.852 2.739 . . . . 1.08 106.907 -175.374 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.2 mt -102.15 141.62 34.7 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.284 -1.78 . . . . 1.55 111.658 -179.149 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -89.09 115.96 27.01 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.918 2.192 . . . . 1.95 116.918 163.599 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.407 HG12 ' HE3' ' A' ' 29' ' ' LYS . 15.1 m -127.32 170.26 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 128.79 2.836 . . . . 0.96 110.274 176.959 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -124.17 165.32 24.78 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 127.355 2.262 . . . . 2.35 109.527 167.417 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -69.1 -28.73 28.06 Favored 'Trans proline' 0 N--CA 1.434 -2.012 1 O-C-N 113.487 -4.007 . . . . 0.95 113.468 -168.062 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.7 m -83.93 6.07 23.1 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 114.565 -2.854 . . . . 1.45 111.2 -177.692 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -72.86 142.67 47.96 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.405 2.526 . . . . 1.69 108.168 173.432 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 38.2 p -84.41 164.83 18.65 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.668 -2.52 . . . . 0.75 109.249 -178.619 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.335 1.4 mp -70.25 -29.4 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.192 -2.193 . . . . 0.73 112.128 176.718 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -53.31 -46.68 69.52 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.797 -1.19 . . . . 1.62 113.536 165.649 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -62.05 -38.41 88.66 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 116.875 2.176 . . . . 2.13 116.875 177.496 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.1 -46.73 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 131.163 3.785 . . . . 0.62 111.294 173.028 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -65.63 -35.86 82.02 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.282 1.433 . . . . 1.22 111.127 179.043 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.05 -35.24 74.7 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 115.739 -2.077 . . . . 0.51 113.775 174.446 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.407 ' HE3' HG12 ' A' ' 17' ' ' VAL . 25.7 mttm -72.79 -20.49 61.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.442 2.756 . . . . 1.44 118.442 175.327 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.0 mt -79.57 -34.13 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.98 2.112 . . . . 1.32 111.475 173.44 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -53.79 -41.88 67.71 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.494 -2.629 . . . . 1.7 112.687 175.09 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -67.49 -55.45 13.5 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.164 2.283 . . . . 1.55 117.164 170.028 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -66.46 -71.71 0.19 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.152 -2.218 . . . . 2.62 112.743 -174.461 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -74.19 -38.23 63.7 Favored 'General case' 0 N--CA 1.428 -1.527 0 O-C-N 118.095 -2.878 . . . . 1.48 113.535 -174.734 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.63 32.69 7.13 Favored Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 126.031 3.017 . . . . 1.12 113.267 -179.372 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.4 mt -101.11 125.14 39.1 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-N 111.144 -2.528 . . . . 1.55 107.812 -179.916 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -66.51 163.5 32.34 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 CA-C-O 112.374 -3.261 . . . . 1.02 114.773 -178.735 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -77.7 -16.52 14.7 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 CA-C-N 122.759 2.021 . . . . 1.25 113.444 -177.941 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -68.14 -35.83 78.71 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.77 -2.456 . . . . 2.25 109.935 168.54 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -76.82 -16.79 59.34 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.165 1.386 . . . . 2.02 114.62 -178.214 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -93.31 120.88 34.1 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.635 -3.79 . . . . 0.69 110.161 -173.31 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -103.58 116.27 32.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.503 -2.776 . . . . 2.78 103.503 167.842 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.5 mt -104.98 112.51 25.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 102.159 -3.274 . . . . 1.17 102.159 177.807 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.6 mm -103.23 137.39 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 105.45 -2.055 . . . . 1.38 105.45 177.379 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -129.33 109.34 11.02 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 103.749 -2.686 . . . . 1.5 103.749 176.855 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.402 . . 74.71 -86.58 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.144 -2.223 . . . . 1.21 112.37 177.855 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.28 1.09 1.85 Allowed Glycine 0 N--CA 1.43 -1.765 0 O-C-N 118.929 -2.357 . . . . 1.3 113.914 179.8 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -115.39 141.58 47.85 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 109.468 -0.567 . . . . 2.55 109.468 -178.707 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -86.06 134.25 33.84 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.742 2.417 . . . . 2.48 109.335 173.002 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.7 mt -85.14 121.81 28.43 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.63 2.826 . . . . 0.9 118.63 -179.601 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -81.5 142.19 33.13 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 116.336 1.976 . . . . 1.94 116.336 173.884 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.28 -54.53 19.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.224 1.409 . . . . 1.56 114.579 -167.81 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.0 15.89 2.96 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 120.043 2.777 . . . . 0.97 120.043 172.851 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.498 HH21 ' CG ' ' A' ' 58' ' ' ASP . 79.0 mtp180 -102.83 156.4 17.68 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 121.225 2.512 . . . . 2.49 107.772 165.722 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 16.7 p -82.59 161.73 22.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.321 2.249 . . . . 0.76 114.462 175.874 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -65.48 -28.72 69.41 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.403 2.001 . . . . 1.05 116.403 167.216 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.0 p -74.44 -21.92 59.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 117.08 2.252 . . . . 1.19 117.08 173.052 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.498 ' CG ' HH21 ' A' ' 54' ' ' ARG . 48.6 t0 -67.26 -40.97 86.28 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 118.296 -0.859 . . . . 1.9 110.999 172.346 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -77.53 -17.77 57.62 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 114.911 -2.471 . . . . 0.89 115.17 169.286 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 73.34 34.55 0.99 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.497 2.57 . . . . 1.84 116.367 -179.997 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.5 mt -65.38 124.58 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 116.384 -3.947 . . . . 0.82 115.528 179.618 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -61.43 164.55 5.57 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 119.987 3.328 . . . . 2.16 119.987 -178.082 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -60.08 -61.16 2.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.698 -3.126 . . . . 2.12 110.421 174.178 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -93.35 81.28 4.42 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 116.521 -2.071 . . . . 1.71 113.579 172.784 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.282 19.1 m -108.83 139.72 43.27 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 118.962 2.949 . . . . 1.04 118.962 -178.835 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.2 m -115.08 130.01 56.83 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.164 -1.421 . . . . 0.79 107.164 178.641 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -115.17 168.72 9.69 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 116.513 -1.708 . . . . 1.4 111.245 -179.345 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -122.88 122.84 39.59 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.29 1.436 . . . . 1.51 112.92 -179.22 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 tp -94.77 101.21 13.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.243 -1.536 . . . . 1.14 111.77 177.34 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.486 HG13 HD11 ' A' ' 8' ' ' LEU . 2.8 t -88.45 128.92 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 104.344 -2.465 . . . . 1.23 104.344 173.217 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.8 tp -85.13 129.19 34.85 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 115.585 -2.15 . . . . 2.78 113.074 175.185 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -92.82 143.56 26.15 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.672 -1.603 . . . . 3.75 106.672 174.52 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.7 mt -71.98 175.06 6.21 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.374 -2.704 . . . . 3.14 113.55 -175.84 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -74.36 -39.07 63.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.909 2.766 . . . . 6.8 109.622 168.95 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.47 73.87 0.45 Allowed Glycine 0 N--CA 1.43 -1.756 1 CA-C-O 129.818 5.121 . . . . 3.57 112.017 -168.538 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.825 0 CA-C-O 113.602 -3.888 . . . . 3.87 106.214 -175.915 . . . . . . . . 0 0 . 1 . 051 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 ptt? . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 123.773 1.749 . . . . 1.1 110.914 . . . . . . . . . 0 0 . 1 . 051 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -88.11 107.24 18.66 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 113.773 -5.579 . . . . 1.87 115.316 -178.687 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.3 pt -111.83 164.28 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 117.743 -3.098 . . . . 0.72 109.257 178.564 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -120.39 125.89 49.12 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 116.766 -3.709 . . . . 1.4 112.128 178.703 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 t -109.78 111.4 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 1 O-C-N 113.228 -5.92 . . . . 0.58 109.116 167.686 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -71.68 140.4 49.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.268 2.937 . . . . 2.09 111.124 175.097 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.1 p -87.93 177.75 6.88 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 113.25 -5.906 . . . . 0.99 110.769 169.744 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 tp -79.49 -51.28 9.54 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.334 -1.478 . . . . 2.53 108.422 179.631 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.1 p -65.7 -58.02 6.68 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.758 2.133 . . . . 2.08 116.758 -174.385 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.43 39.99 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.67 0 CA-C-O 115.054 -3.081 . . . . 1.31 110.546 -179.918 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -135.94 156.72 48.34 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 124.192 3.996 . . . . 1.4 110.571 -175.092 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.2 m -127.29 111.51 14.0 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 130.346 3.458 . . . . 0.78 107.514 177.814 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mt -88.28 118.92 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 123.924 3.056 . . . . 1.55 104.566 -177.94 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.9 m -98.73 122.09 41.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.224 -1.398 . . . . 1.08 107.224 178.229 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.8 mt -123.93 154.28 39.98 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 113.534 0.938 . . . . 1.55 113.534 -176.461 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -110.01 111.57 23.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 104.449 -2.426 . . . . 1.95 104.449 171.287 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.25 170.31 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 C-N-CA 127.443 2.297 . . . . 0.96 106.961 -179.91 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -117.97 156.59 49.99 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 105.209 -2.145 . . . . 2.35 105.209 167.035 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.421 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 18.4 Cg_endo -68.49 -16.28 42.77 Favored 'Trans proline' 0 C--N 1.299 -2.069 0 N-CA-C 116.386 1.648 . . . . 0.95 116.386 -177.786 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.2 m -85.02 -11.51 55.24 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-O 115.731 -2.08 . . . . 1.45 110.763 179.699 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.07 139.51 54.83 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 126.262 1.825 . . . . 1.69 109.691 173.379 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.36 35.8 p -71.25 150.89 44.8 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 128.552 2.741 . . . . 0.75 110.021 176.091 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 mt -62.1 -35.1 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 104.869 -2.271 . . . . 0.73 104.869 178.795 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.291 30.1 tt0 -52.95 -46.39 68.15 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 116.262 -4.024 . . . . 1.62 118.548 165.812 . . . . . . . . 3 2 . 1 . 051 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.338 83.9 m-20 -61.77 -35.62 78.67 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.439 1.496 . . . . 2.13 113.95 173.613 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.5 t -68.94 -36.21 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 123.482 1.611 . . . . 0.62 112.01 175.101 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -59.04 -30.44 68.04 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 119.125 -2.234 . . . . 1.22 115.252 163.84 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.21 -38.6 63.54 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 114.634 -5.042 . . . . 0.51 111.591 172.62 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.277 12.4 ttmm -57.32 -39.37 75.69 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.092 -2.88 . . . . 1.44 116.064 166.751 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.0 mt -57.34 -39.96 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 125.132 3.606 . . . . 1.32 114.57 166.945 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 37' ' ' PRO . 21.1 tt0 -66.85 -39.9 87.75 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.898 -1.751 . . . . 1.7 111.315 177.257 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -52.95 -43.51 66.38 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.579 2.066 . . . . 1.55 116.579 172.292 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -87.02 -47.57 8.83 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.664 -1.273 . . . . 2.62 113.289 -175.801 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -99.97 -55.68 2.57 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 116.941 -1.504 . . . . 1.48 107.214 -167.259 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.36 52.26 0.83 Allowed Glycine 0 N--CA 1.431 -1.695 0 CA-C-N 120.719 1.6 . . . . 1.12 112.607 -176.479 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.4 mt -130.74 126.29 21.79 Favored Pre-proline 0 N--CA 1.429 -1.48 0 N-CA-C 101.4 -3.556 . . . . 1.55 101.4 177.817 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HA ' ' OE1' ' A' ' 31' ' ' GLN . 0.5 OUTLIER -60.8 140.75 92.27 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 CA-C-O 111.082 -3.799 . . . . 1.02 111.648 -177.698 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -55.05 -23.8 37.17 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-N 124.925 2.795 . . . . 1.25 117.929 175.416 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -68.89 -23.13 64.16 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.309 1.226 . . . . 2.25 114.309 173.849 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -81.74 -20.96 38.23 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.877 1.323 . . . . 2.02 109.293 176.612 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -97.4 136.7 37.47 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.113 -2.867 . . . . 0.69 118.256 -173.849 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -123.77 108.09 12.14 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.185 -2.28 . . . . 2.78 111.533 173.595 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.406 ' HB3' HD12 ' A' ' 50' ' ' LEU . 16.5 mt -71.5 138.93 49.32 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 123.739 1.733 . . . . 1.17 112.053 176.903 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.316 47.0 mm -127.44 146.85 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 106.252 -1.759 . . . . 1.38 106.252 179.488 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -143.39 133.3 24.06 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.642 -1.911 . . . . 1.5 109.864 177.49 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.69 -83.91 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.412 2.285 . . . . 1.21 111.683 174.544 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -156.03 16.88 0.45 Allowed Glycine 0 N--CA 1.43 -1.759 0 O-C-N 125.647 1.842 . . . . 1.3 109.164 -178.215 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -126.7 167.0 16.33 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 126.077 2.846 . . . . 2.55 109.336 -177.984 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -93.0 162.68 13.95 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 114.607 -5.058 . . . . 2.48 105.874 170.521 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.406 HD12 ' HB3' ' A' ' 43' ' ' LEU . 98.0 mt -109.64 148.06 31.98 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.519 -3.238 . . . . 0.9 109.345 179.011 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -96.68 144.64 26.51 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.511 1.924 . . . . 1.94 110.909 171.681 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -85.88 -40.0 16.42 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 116.153 1.908 . . . . 1.56 116.153 -162.936 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.86 47.22 3.67 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-N 122.823 2.556 . . . . 0.97 113.657 171.505 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -131.84 164.28 26.4 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 104.175 -2.528 . . . . 2.49 104.175 170.353 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.363 20.4 p -90.93 174.74 7.27 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 118.717 -2.489 . . . . 0.76 115.147 -178.777 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 35.2 mt -73.04 -23.98 60.65 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.239 -1.538 . . . . 1.05 110.025 171.874 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -85.57 -41.12 15.55 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.69 1.367 . . . . 1.19 114.69 -177.27 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -53.05 -46.67 68.62 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.875 2.47 . . . . 1.9 111.815 168.881 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -75.06 -9.24 58.35 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 117.64 -3.162 . . . . 0.89 113.769 175.991 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.295 35.2 t-20 59.8 47.91 9.7 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 124.236 1.97 . . . . 1.84 114.896 -177.217 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.5 mm -74.75 130.91 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 128.102 2.561 . . . . 0.82 108.812 178.292 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -69.63 171.07 9.55 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.424 -3.298 . . . . 2.16 115.894 -176.691 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -57.36 -56.12 26.01 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 116.295 -4.003 . . . . 2.12 110.2 172.308 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -103.35 92.55 4.54 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.574 1.15 . . . . 1.71 109.389 171.733 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.3 t -115.14 144.69 43.28 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.644 2.09 . . . . 1.04 116.644 176.397 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.2 m -102.95 102.17 12.21 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.495 1.918 . . . . 0.79 110.875 179.695 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -106.69 172.88 6.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.893 -1.754 . . . . 1.4 109.304 178.292 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -123.7 137.35 54.72 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 118.151 2.648 . . . . 1.51 118.151 178.453 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.5 tp -95.64 118.69 32.8 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 112.744 -2.025 . . . . 1.14 111.282 177.064 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.2 t -122.53 121.67 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 125.862 1.665 . . . . 1.23 112.999 174.854 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.1 mt -83.05 140.95 32.4 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-O 126.974 3.273 . . . . 2.78 115.61 178.792 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -91.66 110.98 22.32 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.9 -3.625 . . . . 3.75 111.071 169.701 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.8 mt -83.28 141.09 32.09 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 105.994 -1.854 . . . . 3.14 105.994 173.252 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -74.08 146.0 43.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.743 2.127 . . . . 6.8 116.743 177.518 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.31 -78.02 0.32 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 128.958 3.17 . . . . 3.57 117.012 -168.564 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.748 0 CA-C-O 116.837 -2.091 . . . . 3.87 108.022 -178.032 . . . . . . . . 0 0 . 1 . 052 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ttp . . . . . 0 CA--C 1.49 -1.335 0 N-CA-C 118.428 2.751 . . . . 1.1 118.428 . . . . . . . . . 0 0 . 1 . 052 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -75.05 124.49 27.08 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 115.078 1.51 . . . . 1.87 115.078 -177.991 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.1 pt -136.14 159.0 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 117.248 -3.408 . . . . 0.72 103.218 175.752 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -116.64 149.5 39.64 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 124.477 1.111 . . . . 1.4 108.607 176.65 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.71 113.31 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-N 111.298 -2.683 . . . . 0.58 107.854 170.458 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -101.68 132.03 47.6 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 103.516 -2.772 . . . . 2.09 103.516 -176.048 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.1 p -86.48 165.86 15.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.986 -3.571 . . . . 0.99 113.508 173.66 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.9 mt -81.95 -29.77 32.04 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.841 -2.412 . . . . 2.53 108.78 174.097 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.9 p -68.1 -48.24 66.03 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 125.185 1.553 . . . . 2.08 111.692 -174.85 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.34 44.63 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.772 0 CA-C-N 119.523 1.056 . . . . 1.31 114.815 168.014 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -143.43 147.17 34.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.684 2.183 . . . . 1.4 110.061 -162.53 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.3 m -112.84 135.04 54.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.48 -2.638 . . . . 0.78 105.038 171.427 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mt -111.57 107.54 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 126.585 1.954 . . . . 1.55 105.916 176.433 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.3 m -89.74 115.94 27.47 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.656 1.693 . . . . 1.08 108.789 -178.16 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.8 mt -115.31 154.99 28.13 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 125.421 2.534 . . . . 1.55 106.974 -170.348 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -112.06 117.68 33.33 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 115.382 -2.247 . . . . 1.95 108.044 166.191 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.413 HG12 ' HE3' ' A' ' 29' ' ' LYS . 23.0 m -129.73 177.47 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 101.859 -3.385 . . . . 0.96 101.859 -178.869 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -111.79 154.23 44.12 Favored Pre-proline 0 N--CA 1.43 -1.462 1 C-N-CA 133.196 4.598 . . . . 2.35 107.603 164.305 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -77.89 -5.46 15.3 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 125.078 3.852 . . . . 0.95 110.733 -172.404 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 m -101.57 3.25 39.83 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 123.529 1.633 . . . . 1.45 108.008 -175.53 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -81.91 149.84 28.04 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.394 1.257 . . . . 1.69 114.394 170.945 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 p -75.66 159.43 31.17 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 123.777 0.831 . . . . 0.75 111.075 -177.835 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.1 mm -67.65 -26.51 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.559 -1.338 . . . . 0.73 108.53 173.454 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -62.03 -34.61 76.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.143 1.792 . . . . 1.62 112.639 168.821 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -65.68 -40.8 92.72 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.748 1.619 . . . . 2.13 108.652 -179.08 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.7 t -64.8 -37.63 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-O 122.382 1.087 . . . . 0.62 113.278 175.947 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -59.97 -40.23 88.37 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 118.395 2.739 . . . . 1.22 118.395 166.292 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.56 -36.86 85.58 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.548 -1.97 . . . . 0.51 113.417 176.16 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.413 ' HE3' HG12 ' A' ' 17' ' ' VAL . 46.2 mttm -59.85 -48.01 83.41 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.577 -1.952 . . . . 1.44 114.805 170.628 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.8 mt -64.91 -32.81 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 119.22 -2.175 . . . . 1.32 112.976 172.029 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -62.98 -38.94 93.15 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.221 -1.55 . . . . 1.7 115.123 169.388 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -62.12 -44.06 97.47 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 123.423 1.582 . . . . 1.55 112.214 172.186 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -66.83 -55.79 13.26 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.572 -2.58 . . . . 2.62 116.002 178.555 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -100.03 -55.84 2.53 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.848 2.859 . . . . 1.48 108.952 -166.713 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.22 -9.56 9.51 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-O 123.443 1.579 . . . . 1.12 113.633 -176.154 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.9 mt -72.44 126.4 90.94 Favored Pre-proline 0 N--CA 1.43 -1.452 0 O-C-N 116.779 -3.777 . . . . 1.55 102.287 -175.635 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 72.6 Cg_endo -70.85 161.38 46.27 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.667 2.245 . . . . 1.02 112.511 175.105 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 20.4 Cg_exo -70.05 -12.17 31.84 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 C-N-CA 121.745 1.63 . . . . 1.25 113.477 -172.593 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -75.67 -27.08 58.17 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.422 2.058 . . . . 2.25 109.63 176.436 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -90.61 -20.07 22.98 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.091 -2.881 . . . . 2.02 108.022 -174.979 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -85.78 124.94 32.85 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.595 3.183 . . . . 0.69 119.595 178.911 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.4 ttm105 -109.31 118.71 37.4 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.467 -2.02 . . . . 2.78 110.538 171.654 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.267 66.9 mt -99.06 105.32 17.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 109.257 -0.645 . . . . 1.17 109.257 -178.944 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.554 HD12 HG21 ' A' ' 70' ' ' VAL . 40.7 mt -93.75 118.81 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-N 113.719 -1.582 . . . . 1.38 108.59 -179.343 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -138.54 138.26 37.83 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.158 -1.589 . . . . 1.5 110.772 173.865 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.16 41.61 26.86 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.053 2.941 . . . . 1.21 113.527 173.417 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.63 -18.01 22.21 Favored Glycine 0 N--CA 1.429 -1.789 1 CA-C-O 112.334 -4.592 . . . . 1.3 113.16 -179.832 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 172.3 7.3 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 123.534 3.667 . . . . 2.55 113.595 -178.544 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -104.57 134.84 47.06 Favored 'General case' 0 N--CA 1.431 -1.401 1 O-C-N 115.353 -4.592 . . . . 2.48 109.03 173.863 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.4 mt -76.3 155.05 34.59 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 123.842 1.782 . . . . 0.9 114.737 -173.661 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -98.85 141.99 30.94 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 124.78 2.229 . . . . 1.94 107.211 178.737 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -75.81 -41.93 51.34 Favored 'General case' 0 N--CA 1.43 -1.454 1 N-CA-C 124.093 4.849 . . . . 1.56 124.093 -167.018 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.04 0.5 89.02 Favored Glycine 0 N--CA 1.431 -1.665 0 O-C-N 116.563 -3.836 . . . . 0.97 110.856 170.232 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -71.55 151.22 44.03 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 122.465 3.132 . . . . 2.49 111.538 169.542 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.7 p -97.83 167.55 10.86 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.101 1.905 . . . . 0.76 111.684 -177.199 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.5 mt -69.37 -25.41 64.16 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.407 -3.308 . . . . 1.05 111.29 178.038 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.2 t -70.81 -39.56 73.01 Favored 'General case' 0 N--CA 1.431 -1.406 1 C-N-CA 132.845 4.458 . . . . 1.19 112.816 175.7 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -57.92 -34.61 70.05 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 124.858 2.266 . . . . 1.9 113.913 172.826 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -94.53 0.09 55.01 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 114.309 -5.244 . . . . 0.89 112.03 -178.208 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.0 m120 58.66 47.52 12.96 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 119.865 3.283 . . . . 1.84 119.865 -175.15 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.0 mt -83.21 105.91 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 126.336 1.854 . . . . 0.82 109.886 171.28 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -121.9 -48.23 2.14 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 124.213 1.958 . . . . 2.16 112.332 -179.246 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.2 mmtt -78.34 -173.95 3.52 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 112.739 -2.028 . . . . 2.12 115.728 176.907 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -71.44 69.79 0.6 Allowed 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 129.964 3.306 . . . . 1.71 112.796 177.267 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -90.59 158.4 16.99 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.511 3.124 . . . . 1.04 111.639 -175.364 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.8 m -118.66 118.36 31.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 104.496 -2.409 . . . . 0.79 104.496 -173.843 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.1 mt -94.57 148.61 22.08 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 103.33 -2.841 . . . . 1.4 103.33 172.105 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -108.63 112.87 25.44 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 126.032 2.825 . . . . 1.51 106.026 -176.489 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.0 tp -89.65 122.26 32.61 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.993 -3.567 . . . . 1.14 113.507 179.264 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.554 HG21 HD12 ' A' ' 44' ' ' ILE 0.33 3.2 t -125.52 145.85 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 114.23 -1.35 . . . . 1.23 108.148 -177.067 . . . . . . . . 3 3 . 1 . 052 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.8 tp -81.24 127.08 32.31 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 130.853 3.661 . . . . 2.78 106.567 -179.954 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -102.5 97.77 7.94 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.274 3.03 . . . . 3.75 112.183 176.107 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.8 mt -113.88 -92.96 0.48 Allowed 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.614 -1.929 . . . . 3.14 108.162 174.749 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.8 mtm-85 -99.22 -121.61 0.15 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.896 1.679 . . . . 6.8 113.588 168.87 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.95 112.69 3.27 Favored Glycine 0 N--CA 1.429 -1.769 1 CA-C-O 128.946 4.636 . . . . 3.57 108.953 -169.164 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.751 0 O-C-N 118.874 -2.545 . . . . 3.87 109.791 -174.128 . . . . . . . . 0 0 . 1 . 053 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ptt? . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 123.816 1.77 . . . . 1.1 107.903 . . . . . . . . . 0 0 . 1 . 053 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -93.44 136.51 33.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 117.067 -3.521 . . . . 1.87 111.523 -179.252 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.2 pt -131.7 161.79 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 117.005 -3.559 . . . . 0.72 104.707 173.771 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -122.04 141.94 50.85 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.767 -1.561 . . . . 1.4 107.888 -170.615 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 t -117.21 120.66 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 103.311 -2.848 . . . . 0.58 103.311 175.748 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -95.81 130.38 42.76 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 119.067 -1.053 . . . . 2.09 108.28 175.409 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.9 p -84.2 -176.13 6.11 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.708 -2.495 . . . . 0.99 115.199 176.788 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mt -68.55 -41.16 80.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 119.805 1.184 . . . . 2.53 109.328 172.086 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -72.59 -13.92 61.5 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 127.972 2.509 . . . . 2.08 107.824 -178.764 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.28 30.53 9.17 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 120.734 1.606 . . . . 1.31 113.577 175.857 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -95.71 134.1 39.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 117.908 -3.113 . . . . 1.4 107.286 -171.412 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.1 m -86.66 90.45 8.27 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 118.537 2.791 . . . . 0.78 118.537 175.449 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.7 mm -79.77 112.01 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 126.977 2.673 . . . . 1.55 109.542 176.204 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.5 m -103.67 113.83 27.65 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 123.279 2.763 . . . . 1.08 109.854 179.788 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -106.63 143.39 34.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.137 -1.602 . . . . 1.55 109.325 -179.511 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -93.3 123.89 36.9 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 104.037 -2.579 . . . . 1.95 104.037 170.246 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 m -133.76 160.44 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-O 115.471 -2.204 . . . . 0.96 108.468 -175.716 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -109.25 160.59 27.03 Favored Pre-proline 0 N--CA 1.43 -1.466 0 N-CA-C 104.899 -2.26 . . . . 2.35 104.899 160.259 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.74 -14.3 24.37 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 C-N-CA 121.788 1.659 . . . . 0.95 113.887 -179.0 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.1 p -75.59 -25.76 57.29 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 114.0 1.111 . . . . 1.45 114.0 173.481 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -62.67 160.53 13.96 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.976 -1.703 . . . . 1.69 114.549 -179.524 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.334 20.4 p -93.67 166.62 12.13 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.939 2.94 . . . . 0.75 118.939 -179.828 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.436 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 32.6 mm -71.3 -34.1 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.311 1.445 . . . . 0.73 111.152 177.386 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -60.04 -34.75 73.82 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.156 2.28 . . . . 1.62 117.156 165.999 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -71.69 -40.42 69.57 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.745 -1.847 . . . . 2.13 113.783 173.67 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.8 t -60.3 -38.81 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 123.709 0.804 . . . . 0.62 111.728 174.228 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -60.74 -40.51 92.69 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.545 -3.222 . . . . 1.22 114.725 164.618 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.75 -33.62 76.29 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.412 1.577 . . . . 0.51 113.634 173.413 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -56.67 -46.89 80.84 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.997 -2.939 . . . . 1.44 117.461 173.22 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.8 mt -67.85 -39.09 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 125.422 2.534 . . . . 1.32 114.333 173.826 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -57.63 -37.93 74.15 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.16 -4.713 . . . . 1.7 111.991 172.256 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -67.05 -35.98 81.04 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.349 2.976 . . . . 1.55 114.045 177.535 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -82.82 -44.49 15.44 Favored 'General case' 0 N--CA 1.429 -1.499 1 O-C-N 115.389 -4.57 . . . . 2.62 108.614 -176.554 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -125.92 -17.13 5.44 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 122.045 2.202 . . . . 1.48 113.186 -166.866 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.05 27.97 7.54 Favored Glycine 0 N--CA 1.43 -1.713 0 CA-C-N 120.861 1.664 . . . . 1.12 113.703 173.171 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.6 mt -99.81 120.4 57.31 Favored Pre-proline 0 N--CA 1.43 -1.467 0 O-C-N 120.014 -1.874 . . . . 1.55 109.104 -172.0 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.74 136.25 61.13 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 C-N-CA 124.899 3.733 . . . . 1.02 112.252 179.624 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -55.94 -15.46 13.58 Favored 'Trans proline' 0 C--N 1.3 -2.008 1 C-N-CA 126.399 4.733 . . . . 1.25 118.219 -177.181 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -76.07 -26.41 56.5 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.735 0.779 . . . . 2.25 111.527 173.748 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -85.2 -30.03 24.23 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.391 2.043 . . . . 2.02 107.63 -177.79 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -74.71 118.18 17.39 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.783 -4.323 . . . . 0.69 112.092 -176.807 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.1 ttm-85 -121.7 116.33 24.33 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.685 -1.969 . . . . 2.78 105.685 170.56 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.5 mt -99.52 130.38 45.77 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.183 -1.043 . . . . 1.17 108.183 -179.772 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.3 mt -113.71 119.54 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 126.818 2.047 . . . . 1.38 112.085 174.715 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.528 ' HB3' HD21 ' A' ' 50' ' ' LEU . 51.6 t80 -114.72 132.11 56.54 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 102.865 -3.013 . . . . 1.5 102.865 174.653 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.39 -94.43 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.417 1 C-N-CA 132.138 4.175 . . . . 1.21 110.079 177.015 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.66 8.61 7.75 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 129.003 3.192 . . . . 1.3 113.059 176.217 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -106.04 137.9 43.16 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 129.5 3.12 . . . . 2.55 111.179 -178.527 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -103.47 113.92 27.79 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 125.543 2.592 . . . . 2.48 106.927 169.863 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.528 HD21 ' HB3' ' A' ' 45' ' ' PHE . 13.6 mt -67.75 126.15 28.48 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.358 -3.338 . . . . 0.9 113.67 -170.707 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -91.06 134.29 34.63 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 114.645 1.35 . . . . 1.94 114.645 174.446 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.436 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 4.6 m-20 -47.1 -52.39 15.42 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 119.893 3.294 . . . . 1.56 119.893 -171.785 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.23 68.78 0.96 Allowed Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 113.962 -3.688 . . . . 0.97 111.668 174.86 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.253 84.1 mmt-85 -139.55 164.74 29.11 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 102.53 -3.137 . . . . 2.49 102.53 167.851 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.9 p -93.54 166.34 12.3 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.188 2.423 . . . . 0.76 108.086 173.828 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.5 mt -59.91 -40.33 88.44 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.444 2.698 . . . . 1.05 108.961 171.079 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.2 t -54.88 -48.61 72.75 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.285 2.234 . . . . 1.19 113.465 176.158 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -50.77 -34.1 25.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 118.595 2.813 . . . . 1.9 118.595 170.791 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -90.48 1.19 56.91 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.151 1.38 . . . . 0.89 110.253 178.203 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.257 4.3 m120 52.08 43.56 30.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.093 2.557 . . . . 1.84 115.157 -174.231 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.4 mt -91.49 115.01 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 127.177 3.37 . . . . 0.82 113.487 177.574 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -95.47 -177.02 3.94 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.213 -2.804 . . . . 2.16 114.805 -176.214 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -62.62 152.45 35.1 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 115.049 -4.782 . . . . 2.12 116.722 169.723 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.331 31.4 mt-10 66.47 18.36 10.81 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.112 -2.243 . . . . 1.71 113.203 174.371 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.3 p -89.96 165.12 14.26 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 127.382 3.468 . . . . 1.04 111.517 -172.87 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.1 m -120.92 108.74 14.26 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 113.337 -5.852 . . . . 0.79 113.177 -177.807 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.0 mt -81.75 137.51 35.34 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 124.905 1.282 . . . . 1.4 113.238 166.794 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -98.33 115.25 28.03 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.904 -0.497 . . . . 1.51 110.323 -177.826 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.9 tp -93.72 112.37 24.23 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 126.197 2.186 . . . . 1.14 106.874 -177.12 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.27 143.42 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 128.468 2.707 . . . . 1.23 104.204 174.972 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.6 mt -103.26 113.57 27.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 121.112 -0.992 . . . . 2.78 108.658 175.367 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -78.49 146.83 34.17 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 117.715 -1.136 . . . . 3.75 109.209 -179.131 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.9 mt -102.64 166.64 10.39 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 119.638 1.108 . . . . 3.14 111.42 173.055 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -92.78 93.36 8.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.02 2.343 . . . . 6.8 113.502 176.142 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.37 -95.28 0.1 Allowed Glycine 0 N--CA 1.43 -1.707 0 O-C-N 117.747 -3.096 . . . . 3.57 109.171 -174.281 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.711 0 C-N-CA 117.66 -2.209 . . . . 3.87 111.634 175.994 . . . . . . . . 0 0 . 1 . 054 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 108.268 -1.012 . . . . 1.1 108.268 . . . . . . . . . 0 0 . 1 . 054 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -100.62 130.13 46.64 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 115.698 -2.096 . . . . 1.87 112.199 179.766 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.3 pt -129.03 159.33 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 120.099 1.318 . . . . 0.72 107.948 171.798 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -106.81 143.35 35.03 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.341 -1.754 . . . . 1.4 110.456 -176.516 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.2 t -119.35 120.04 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 129.43 3.092 . . . . 0.58 108.328 177.715 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.0 mttp -105.28 141.54 36.63 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 116.06 1.874 . . . . 2.09 116.06 169.87 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 p -95.76 177.72 5.69 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.513 2.325 . . . . 0.99 113.195 177.929 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.6 tp -57.74 -45.74 85.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.052 0.941 . . . . 2.53 113.279 178.278 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.2 p -78.01 -14.13 59.62 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.022 2.344 . . . . 2.08 112.879 -175.148 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.15 30.3 4.82 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 117.148 -3.47 . . . . 1.31 114.997 172.882 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -91.91 111.3 22.78 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.049 -1.575 . . . . 1.4 108.782 -176.317 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 m -83.8 115.24 22.14 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.92 -2.988 . . . . 0.78 109.152 177.201 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.44 HG21 HD13 ' A' ' 13' ' ' ILE . 46.9 mt -101.33 126.73 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 106.85 -1.537 . . . . 1.55 106.85 175.297 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.6 m -104.55 125.39 50.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 102.587 -3.116 . . . . 1.08 102.587 -170.338 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.2 mt -128.35 150.73 49.96 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 126.706 2.002 . . . . 1.55 109.239 -173.83 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -115.93 131.5 56.92 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.844 -0.616 . . . . 1.95 112.074 170.245 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.451 HG21 HD13 ' A' ' 56' ' ' LEU . 10.3 m -144.29 165.78 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 125.363 1.665 . . . . 0.96 108.919 -174.433 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -101.07 153.02 37.99 Favored Pre-proline 0 N--CA 1.43 -1.475 0 O-C-N 117.63 -3.169 . . . . 2.35 111.442 165.294 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -67.74 -13.52 38.95 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 CA-C-N 126.932 3.511 . . . . 0.95 115.795 -173.437 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.1 p -84.22 0.86 47.18 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 131.553 3.941 . . . . 1.45 116.059 171.494 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -76.46 136.45 39.4 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 118.892 -2.38 . . . . 1.69 113.407 170.558 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 p -70.13 152.96 43.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.526 -3.233 . . . . 0.75 108.125 179.419 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.6 mm -57.53 -23.1 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 118.039 2.607 . . . . 0.73 118.039 167.858 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -53.74 -43.65 69.3 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.267 -3.396 . . . . 1.62 115.346 159.443 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.4 m-20 -66.54 -28.94 68.94 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.526 2.584 . . . . 2.13 117.746 177.686 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.3 -41.7 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 113.809 -1.541 . . . . 0.62 111.258 171.017 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.68 -33.8 69.14 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 126.512 1.925 . . . . 1.22 112.628 174.615 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.52 -44.25 84.94 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.051 2.14 . . . . 0.51 111.497 170.02 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -61.49 -38.49 87.5 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.692 2.397 . . . . 1.44 110.937 172.222 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.7 mt -70.48 -37.32 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 O-C-N 117.954 -2.966 . . . . 1.32 115.205 170.336 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -52.92 -46.51 68.11 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.632 2.634 . . . . 1.7 110.991 172.388 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -55.03 -59.76 4.3 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 116.181 -4.075 . . . . 1.55 114.713 172.913 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -69.65 -60.23 2.45 Favored 'General case' 0 N--CA 1.43 -1.461 1 CA-C-O 129.579 4.514 . . . . 2.62 110.592 -174.635 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -80.36 -59.93 2.51 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.672 -4.392 . . . . 1.48 114.046 -172.96 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.57 -16.23 6.26 Favored Glycine 0 N--CA 1.431 -1.695 0 CA-C-O 115.427 -2.874 . . . . 1.12 109.105 -179.483 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.9 mt -60.92 122.09 66.64 Favored Pre-proline 0 N--CA 1.431 -1.38 0 C-N-CA 126.877 2.071 . . . . 1.55 112.826 -170.363 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.67 142.98 99.3 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 N-CA-C 119.236 2.744 . . . . 1.02 119.236 -176.33 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -80.49 -9.92 13.46 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 115.82 -2.779 . . . . 1.25 115.072 -166.604 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.55 -14.99 57.75 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.116 2.566 . . . . 2.25 113.469 167.635 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -94.68 -32.31 13.43 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.509 -3.245 . . . . 2.02 110.364 178.522 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -62.93 145.29 55.57 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 113.407 -1.724 . . . . 0.69 113.432 179.521 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.428 ' HB2' HG23 ' A' ' 70' ' ' VAL . 92.5 mtt180 -134.91 130.31 35.69 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.534 -2.604 . . . . 2.78 106.127 164.154 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.4 mt -100.4 131.55 46.26 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.944 2.307 . . . . 1.17 108.21 172.902 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.4 mt -120.24 139.98 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 112.081 -2.327 . . . . 1.38 107.111 176.056 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -135.28 134.43 39.93 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 102.447 -3.168 . . . . 1.5 102.447 168.187 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.83 -68.5 0.22 Allowed 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.196 2.903 . . . . 1.21 113.511 177.171 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.69 -47.26 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.763 0 CA-C-O 127.433 3.796 . . . . 1.3 113.702 -174.692 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -73.85 138.86 44.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 127.59 3.567 . . . . 2.55 113.549 -178.021 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -73.58 124.33 25.7 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.905 -2.997 . . . . 2.48 115.032 166.771 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.6 mt -85.51 161.58 19.3 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.955 -1.716 . . . . 0.9 115.1 -178.016 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.282 27.8 mt-10 -104.77 143.45 33.1 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 120.554 3.538 . . . . 1.94 120.554 174.084 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -67.23 -43.57 81.63 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 116.338 -3.976 . . . . 1.56 116.304 -170.182 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.98 15.91 0.65 Allowed Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 130.437 3.875 . . . . 0.97 114.86 173.947 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -120.71 170.93 8.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.13 1.965 . . . . 2.49 111.738 166.557 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.3 p -107.21 177.51 4.83 Favored 'General case' 0 N--CA 1.429 -1.514 1 CA-C-O 128.554 4.026 . . . . 0.76 111.687 176.374 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.451 HD13 HG21 ' A' ' 17' ' ' VAL . 30.7 mt -70.32 -31.75 69.2 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.444 -2.66 . . . . 1.05 108.329 176.377 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 t -66.7 -41.05 88.63 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.964 -2.335 . . . . 1.19 115.126 -177.823 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -49.61 -45.98 48.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.077 2.151 . . . . 1.9 110.907 173.638 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -85.25 -0.67 55.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.027 2.346 . . . . 0.89 116.272 -178.174 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 56.78 37.42 28.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.04 2.936 . . . . 1.84 115.921 -178.527 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.2 mt -70.39 116.53 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 C-N-CA 128.681 2.792 . . . . 0.82 111.564 173.769 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -89.98 178.01 6.32 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.055 2.142 . . . . 2.16 108.411 174.21 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -67.51 152.89 44.88 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.12 1.914 . . . . 2.12 112.623 177.519 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.268 51.4 mt-10 67.31 27.43 8.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.989 -1.069 . . . . 1.71 113.68 169.434 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.9 m -98.91 144.49 28.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.684 3.194 . . . . 1.04 108.196 -175.253 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.6 m -108.93 120.79 43.56 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.143 -2.848 . . . . 0.79 109.393 -172.29 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -93.07 162.91 13.85 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.416 -1.327 . . . . 1.4 107.416 177.692 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -119.77 132.83 55.73 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.149 1.38 . . . . 1.51 112.968 -179.601 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.0 tp -118.5 116.57 26.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.529 -1.982 . . . . 1.14 109.854 -174.854 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' A' ' 42' ' ' ARG . 3.2 m -117.66 170.36 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 123.351 1.548 . . . . 1.23 110.902 172.516 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 65.1 mt -108.57 151.8 25.62 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.029 1.871 . . . . 2.78 115.072 174.11 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -78.84 140.13 38.22 Favored 'General case' 0 N--CA 1.429 -1.492 1 C-N-CA 131.852 4.061 . . . . 3.75 113.992 176.721 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.0 mt -88.76 141.32 28.61 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 124.675 2.179 . . . . 3.14 111.379 168.571 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -64.78 133.87 52.92 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 114.44 -5.162 . . . . 6.8 113.072 170.656 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 135.07 -43.56 1.25 Allowed Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 125.439 1.495 . . . . 3.57 112.982 -166.169 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.765 0 CA-C-N 119.745 1.772 . . . . 3.87 116.491 -178.307 . . . . . . . . 0 0 . 1 . 055 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.49 -1.361 0 CA-C-O 123.375 1.559 . . . . 1.1 109.497 . . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -104.96 142.32 34.99 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.555 -1.341 . . . . 1.87 109.446 -172.335 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.0 pt -131.81 155.05 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 124.723 1.209 . . . . 0.72 107.997 174.557 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.271 64.2 m-85 -108.33 125.27 51.51 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 112.957 0.725 . . . . 1.4 112.957 177.8 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -105.67 122.77 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 119.03 0.832 . . . . 0.58 109.625 173.257 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -94.61 124.57 38.73 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 128.712 2.805 . . . . 2.09 109.707 175.913 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.8 p -77.56 -173.52 2.99 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 127.627 2.371 . . . . 0.99 105.583 -178.55 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.7 mt -59.86 -48.11 83.0 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 129.802 3.241 . . . . 2.53 117.859 169.564 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.1 p -79.36 -15.43 57.91 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.626 3.571 . . . . 2.08 110.627 -179.202 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.14 44.53 5.62 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 126.914 2.197 . . . . 1.31 114.031 176.067 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -95.4 151.52 19.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 104.697 -2.334 . . . . 1.4 104.697 174.788 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.2 m -101.21 112.36 24.83 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 125.764 1.915 . . . . 0.78 112.08 179.795 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 mm -94.76 124.62 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 103.018 -2.956 . . . . 1.55 103.018 172.032 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.7 m -106.44 115.41 30.16 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.337 -3.352 . . . . 1.08 114.678 -178.999 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.259 34.6 mt -112.71 135.5 53.38 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.87 -2.394 . . . . 1.55 110.895 -175.957 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -75.8 116.39 16.45 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 107.142 -1.429 . . . . 1.95 107.142 161.085 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -127.85 175.74 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.241 1.417 . . . . 0.96 109.76 174.339 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -118.23 156.71 50.4 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-O 124.614 2.15 . . . . 2.35 109.629 167.064 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -71.79 -20.14 26.55 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 O-C-N 113.246 -4.134 . . . . 0.95 111.767 -175.72 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 p -87.36 3.58 46.39 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 130.788 3.635 . . . . 1.45 115.831 175.732 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -83.63 149.21 26.68 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.497 -2.627 . . . . 1.69 106.168 177.36 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 44.2 p -90.8 168.21 11.9 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 118.006 -0.997 . . . . 0.75 108.464 -177.789 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.324 40.9 mm -65.78 -24.61 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 N-CA-C 114.494 1.294 . . . . 0.73 114.494 173.937 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -69.07 -30.41 68.73 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 113.772 -3.013 . . . . 1.62 116.278 163.62 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -76.37 -25.66 54.85 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.207 1.821 . . . . 2.13 108.602 170.687 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.7 -50.25 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 121.879 2.127 . . . . 0.62 114.565 170.822 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -65.72 -34.67 78.73 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 118.454 2.761 . . . . 1.22 118.454 179.75 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.05 -38.87 73.85 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 114.177 -2.821 . . . . 0.51 111.736 168.555 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -66.59 -35.72 80.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 120.709 1.595 . . . . 1.44 114.013 174.28 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 53.8 mt -73.58 -24.28 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 119.777 -1.827 . . . . 1.32 114.803 173.159 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -75.73 -29.98 59.08 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.076 1.762 . . . . 1.7 111.773 172.066 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -72.1 -46.27 57.36 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.468 1.127 . . . . 1.55 112.996 175.831 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -65.17 -75.44 0.09 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 126.176 1.791 . . . . 2.62 111.935 -178.913 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -86.91 -42.31 13.29 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.588 2.355 . . . . 1.48 114.813 -169.532 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.96 31.67 2.22 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 118.277 -1.916 . . . . 1.12 111.948 174.574 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 36' ' ' ILE . 26.8 mt -102.09 124.4 40.11 Favored Pre-proline 0 N--CA 1.43 -1.426 0 CA-C-O 114.6 -2.619 . . . . 1.55 113.436 -175.509 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -60.79 138.7 81.03 Favored 'Trans proline' 0 N--CA 1.433 -2.064 0 CA-C-O 114.05 -2.562 . . . . 1.02 114.38 -176.715 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -62.83 -29.17 76.34 Favored 'Trans proline' 0 N--CA 1.434 -2.009 1 C-N-CA 127.49 5.46 . . . . 1.25 114.273 -171.947 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -62.76 -28.95 70.33 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.849 -2.407 . . . . 2.25 112.056 173.057 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -76.36 -13.18 60.15 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 116.785 2.143 . . . . 2.02 116.785 179.092 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -95.39 117.18 29.89 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.013 -3.555 . . . . 0.69 115.26 -172.361 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -107.27 127.09 53.24 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 127.2 2.2 . . . . 2.78 107.946 169.343 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.284 65.6 mt -109.49 138.69 45.48 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 105.263 -2.125 . . . . 1.17 105.263 -175.788 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.7 mm -122.37 126.23 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 109.74 -3.391 . . . . 1.38 107.325 179.801 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.42 ' HB2' HD11 ' A' ' 50' ' ' LEU . 67.4 t80 -120.46 108.93 14.7 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.652 -1.981 . . . . 1.5 105.652 172.317 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.92 -73.22 0.09 Allowed 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 126.526 1.93 . . . . 1.21 109.106 -179.443 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.41 ' H ' ' H ' ' A' ' 48' ' ' LYS . . . -160.73 7.84 0.11 Allowed Glycine 0 N--CA 1.43 -1.709 0 CA-C-O 124.898 2.388 . . . . 1.3 114.915 -174.039 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.41 ' H ' ' H ' ' A' ' 47' ' ' GLY . 12.4 tppt? -105.78 128.61 53.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 111.585 -2.307 . . . . 2.55 105.842 177.311 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -79.47 138.89 37.72 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.176 -0.952 . . . . 2.48 109.573 170.499 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' A' ' 45' ' ' PHE . 21.3 mt -101.73 126.44 48.59 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 121.649 2.022 . . . . 0.9 111.967 -165.966 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -88.56 156.3 19.14 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.285 -1.746 . . . . 1.94 106.285 178.73 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -76.04 -40.2 53.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 118.748 2.869 . . . . 1.56 118.748 -168.613 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.25 22.85 9.11 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 117.798 -3.064 . . . . 0.97 112.868 177.559 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -108.13 164.37 12.36 Favored 'General case' 0 N--CA 1.431 -1.397 1 O-C-N 116.294 -4.062 . . . . 2.49 106.918 164.786 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 37.0 p -101.1 168.78 9.37 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.989 2.116 . . . . 0.76 111.662 179.129 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -58.5 -42.86 88.59 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 112.119 -2.31 . . . . 1.05 110.275 169.926 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.388 5.6 t -64.03 -33.39 75.64 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.499 1.954 . . . . 1.19 112.973 -179.013 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -61.18 -34.42 75.04 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 119.834 3.272 . . . . 1.9 119.834 175.016 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -90.74 10.72 24.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 111.957 -2.383 . . . . 0.89 114.169 174.934 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.279 46.7 m-80 65.09 21.45 12.21 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 113.379 -5.825 . . . . 1.84 115.263 -178.878 . . . . . . . . 3 2 . 1 . 055 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.0 mt -75.9 106.74 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 124.777 1.231 . . . . 0.82 112.298 -178.326 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -98.45 -164.91 1.18 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.264 2.226 . . . . 2.16 106.465 -169.655 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.264 44.8 mttp -72.25 141.21 48.94 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.641 -2.537 . . . . 2.12 110.867 173.826 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.254 31.9 mt-10 74.32 15.48 3.53 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 125.956 2.035 . . . . 1.71 112.872 172.192 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.32 50.1 m -84.16 145.79 28.2 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.162 -3.461 . . . . 1.04 110.819 -172.165 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.0 m -97.35 118.9 34.86 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.161 2.184 . . . . 0.79 106.14 -175.552 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.3 mp -107.06 145.51 32.31 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.225 2.61 . . . . 1.4 111.854 171.902 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -119.36 139.28 52.23 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.455 -2.054 . . . . 1.51 105.455 -174.989 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tt -107.67 124.48 50.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 113.82 -1.536 . . . . 1.14 107.979 -173.948 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.2 t -116.68 132.53 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 CA-C-O 129.171 4.32 . . . . 1.23 105.035 174.345 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.4 mt -94.08 134.62 36.31 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 116.633 -3.792 . . . . 2.78 108.994 175.746 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.0 tpt180 -110.52 116.28 31.11 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 128.305 3.907 . . . . 3.75 113.097 174.539 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 73' ' ' LEU . 91.5 mt -81.9 100.08 9.43 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.892 -2.38 . . . . 3.14 111.466 163.942 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -71.68 -48.8 45.06 Favored 'General case' 0 N--CA 1.431 -1.41 1 CA-C-O 128.515 4.007 . . . . 6.8 110.764 167.267 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -131.53 -78.62 0.17 Allowed Glycine 0 N--CA 1.431 -1.677 1 O-C-N 116.166 -4.084 . . . . 3.57 106.226 -174.694 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.753 0 CA-C-O 114.552 -3.36 . . . . 3.87 105.87 178.44 . . . . . . . . 0 0 . 1 . 056 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 CA--C 1.49 -1.327 0 CA-C-O 122.367 1.08 . . . . 1.1 110.552 . . . . . . . . . 0 0 . 1 . 056 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -111.65 136.91 50.23 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 117.477 -1.249 . . . . 1.87 109.831 -169.467 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.437 HD12 HD13 ' A' ' 67' ' ' LEU . 5.6 pt -135.56 159.39 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 122.489 2.404 . . . . 0.72 105.806 171.526 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -109.49 145.1 36.81 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.372 2.269 . . . . 1.4 107.781 -173.616 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.3 t -124.64 132.53 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.206 -1.776 . . . . 0.58 106.206 168.613 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 mmtm -97.09 143.59 27.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 104.975 -2.231 . . . . 2.09 104.975 169.472 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.7 p -90.36 -165.04 1.26 Allowed 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 130.272 3.429 . . . . 0.99 111.192 176.128 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.353 0.6 OUTLIER -64.63 -46.98 80.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 130.298 3.439 . . . . 2.53 113.042 175.992 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.3 p -92.84 -37.34 12.35 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 126.381 2.991 . . . . 2.08 115.634 -178.6 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.05 -2.52 1.01 Allowed Glycine 0 N--CA 1.43 -1.721 0 O-C-N 116.301 -3.999 . . . . 1.31 117.701 178.215 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -74.92 120.97 21.19 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 122.7 3.25 . . . . 1.4 105.022 -166.905 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.7 m -71.17 117.23 12.42 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 126.56 2.413 . . . . 0.78 113.91 176.591 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.3 mm -98.84 138.68 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 117.08 -1.848 . . . . 1.55 107.78 173.522 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.4 m -106.3 112.81 25.99 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.702 2.001 . . . . 1.08 111.911 179.692 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.7 mt -108.57 144.26 36.5 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 116.177 -4.077 . . . . 1.55 115.268 175.141 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -90.85 123.71 34.6 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.172 1.789 . . . . 1.95 107.85 166.858 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 m -138.53 154.0 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 121.605 0.717 . . . . 0.96 109.639 -179.165 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -101.55 162.36 20.69 Favored Pre-proline 0 N--CA 1.429 -1.489 0 CA-C-O 115.597 -2.144 . . . . 2.35 109.603 167.365 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -81.7 -8.05 12.43 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 125.846 3.124 . . . . 0.95 112.089 178.694 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 p -81.13 -15.68 55.18 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.613 -0.721 . . . . 1.45 111.902 176.165 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -61.77 143.71 55.85 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 124.964 2.316 . . . . 1.69 115.376 178.933 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 25.0 p -90.58 165.25 13.86 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 115.759 -4.338 . . . . 0.75 108.664 178.5 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.5 mm -71.98 -22.03 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-O 122.76 1.266 . . . . 0.73 109.961 -178.933 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -61.48 -35.36 77.44 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.075 -2.891 . . . . 1.62 118.07 160.681 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -76.53 -30.87 57.33 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 116.83 -3.669 . . . . 2.13 111.697 172.634 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.98 -41.92 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 O-C-N 120.156 -1.59 . . . . 0.62 111.809 179.982 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -61.35 -41.3 96.82 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.118 -2.239 . . . . 1.22 111.783 176.888 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.71 -39.6 81.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 126.538 2.399 . . . . 0.51 111.731 178.871 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.265 51.8 mttm -57.82 -53.94 52.48 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.102 -2.248 . . . . 1.44 110.333 173.465 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.253 64.8 mt -52.15 -41.4 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 130.122 3.369 . . . . 1.32 109.241 178.309 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -66.52 -50.82 61.93 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 130.261 3.424 . . . . 1.7 111.372 174.975 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -49.28 -45.54 45.17 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 124.13 3.15 . . . . 1.55 114.009 169.423 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -75.46 -66.56 0.76 Allowed 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 127.607 2.363 . . . . 2.62 114.137 -177.52 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -96.47 -18.46 19.84 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 117.508 2.41 . . . . 1.48 117.508 -173.042 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.51 46.84 5.36 Favored Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 118.696 2.238 . . . . 1.12 118.696 -177.731 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.8 mt -119.14 129.09 25.58 Favored Pre-proline 0 N--CA 1.43 -1.465 0 CA-C-O 111.704 -3.998 . . . . 1.55 106.376 -174.14 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -64.1 152.14 82.34 Favored 'Trans proline' 0 N--CA 1.433 -2.059 0 CA-C-O 112.132 -3.362 . . . . 1.02 119.896 172.122 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -81.4 -23.53 5.01 Favored 'Trans proline' 0 N--CA 1.433 -2.046 0 CA-C-N 127.253 3.626 . . . . 1.25 112.466 -166.484 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -56.43 -31.67 64.15 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.448 2.699 . . . . 2.25 110.663 175.126 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -93.52 6.97 46.44 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 111.184 -2.735 . . . . 2.02 108.44 -170.09 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -122.11 126.67 48.88 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 122.536 2.426 . . . . 0.69 109.4 -174.285 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -109.47 150.27 28.36 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 116.856 -1.545 . . . . 2.78 110.117 158.975 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.4 mt -125.8 136.06 52.7 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 107.468 -1.308 . . . . 1.17 107.468 176.295 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.9 mm -112.43 124.44 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 128.054 2.541 . . . . 1.38 111.397 -178.787 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -114.31 128.09 56.18 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 122.517 2.417 . . . . 1.5 108.901 168.673 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.66 -85.06 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.56 1.544 . . . . 1.21 110.125 -171.574 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -164.19 43.55 0.31 Allowed Glycine 0 N--CA 1.429 -1.78 0 O-C-N 121.091 -1.006 . . . . 1.3 111.929 178.079 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -135.26 135.83 41.2 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.16 2.184 . . . . 2.55 110.253 -179.768 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -89.32 116.08 27.27 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 114.505 1.298 . . . . 2.48 114.505 175.886 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.5 mt -67.88 160.51 28.3 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.981 2.324 . . . . 0.9 113.308 -168.447 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -103.98 135.11 46.11 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.863 -2.426 . . . . 1.94 109.868 172.519 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.261 2.9 m-20 -56.17 -49.38 74.16 Favored 'General case' 0 N--CA 1.43 -1.439 1 C-N-CA 132.311 4.244 . . . . 1.56 113.528 -172.913 . . . . . . . . 3 2 . 1 . 056 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.2 50.63 2.76 Favored Glycine 0 N--CA 1.43 -1.767 0 N-CA-C 119.689 2.636 . . . . 0.97 119.689 171.226 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -124.03 164.1 20.06 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.233 1.968 . . . . 2.49 106.136 163.062 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 66.6 p -106.12 164.01 12.33 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.211 -2.268 . . . . 0.76 113.859 175.117 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.4 mt -50.08 -37.52 34.13 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.712 -3.742 . . . . 1.05 114.518 168.566 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -64.25 -26.33 68.45 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.257 2.317 . . . . 1.19 117.257 176.703 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -70.15 -51.4 31.62 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.387 1.475 . . . . 1.9 108.036 177.805 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -76.89 2.7 13.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.057 2.143 . . . . 0.89 113.05 179.753 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.508 1.1 m-80 60.42 39.62 18.28 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.334 1.646 . . . . 1.84 114.096 179.778 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.4 mt -90.85 118.87 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 126.054 2.835 . . . . 0.82 113.241 -177.267 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -101.5 -167.37 1.41 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.159 -3.463 . . . . 2.16 113.8 -177.068 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.256 13.7 ptmt -58.5 153.97 14.95 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.851 -2.405 . . . . 2.12 116.329 174.759 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 49.0 42.49 20.87 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 129.745 3.218 . . . . 1.71 113.741 173.149 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.6 m -92.47 142.72 27.1 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 130.749 3.619 . . . . 1.04 105.535 -179.095 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.2 m -104.73 117.41 34.02 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 105.142 -2.17 . . . . 0.79 105.142 -175.012 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.437 HD13 HD12 ' A' ' 3' ' ' ILE . 5.1 mp -98.34 162.91 12.93 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 131.521 3.928 . . . . 1.4 110.045 171.05 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -123.08 126.36 46.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.083 -3.511 . . . . 1.51 111.472 -178.939 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.4 tp -95.9 113.92 25.59 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 107.07 -1.455 . . . . 1.14 107.07 -176.415 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.0 t -104.58 143.66 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 101.197 -3.631 . . . . 1.23 101.197 176.526 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.4 mt -106.88 135.42 48.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 113.181 -3.408 . . . . 2.78 110.927 -179.925 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -102.65 130.47 49.56 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.644 -1.285 . . . . 3.75 108.309 -179.176 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.264 0.7 OUTLIER -70.46 176.5 4.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.098 2.559 . . . . 3.14 117.737 166.24 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -96.49 102.61 14.42 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.02 -2.925 . . . . 6.8 112.499 175.414 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.85 45.17 0.31 Allowed Glycine 0 N--CA 1.429 -1.778 0 O-C-N 118.659 -2.526 . . . . 3.57 111.045 -175.867 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.718 0 N-CA-C 107.673 -2.171 . . . . 3.87 107.673 169.961 . . . . . . . . 0 0 . 1 . 057 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 116.883 -1.532 . . . . 1.1 111.724 . . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -97.17 140.67 31.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 127.273 3.416 . . . . 1.87 109.416 -174.66 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.0 pt -123.44 160.73 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 124.814 2.245 . . . . 0.72 110.996 171.323 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -108.91 143.08 38.62 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.234 -4.041 . . . . 1.4 111.419 -179.265 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.42 HG21 HD11 ' A' ' 30' ' ' ILE . 2.8 t -110.91 123.79 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.243 -3.411 . . . . 0.58 108.043 174.199 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 11' ' ' LYS . 73.9 tttt -119.45 138.89 52.83 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.033 1.397 . . . . 2.09 108.563 -178.618 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.0 p -103.69 168.98 8.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.438 -1.414 . . . . 0.99 108.176 -178.067 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.2 tp -66.34 -42.46 88.11 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.955 1.302 . . . . 2.53 112.285 172.464 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.6 p -76.89 -18.52 58.27 Favored 'General case' 0 N--CA 1.43 -1.463 1 CA-C-O 128.968 4.223 . . . . 2.08 110.064 -171.35 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.15 26.95 1.28 Allowed Glycine 0 N--CA 1.43 -1.727 1 O-C-N 116.004 -4.185 . . . . 1.31 118.002 166.285 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 63.4 tttt -91.98 133.87 35.32 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 117.258 -1.353 . . . . 1.4 110.241 -179.814 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m -122.43 105.94 10.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 125.627 1.83 . . . . 0.78 115.762 168.966 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 pt -114.79 164.92 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 125.92 2.771 . . . . 1.55 105.191 179.778 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.7 m -112.37 135.18 53.37 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.875 -3.015 . . . . 1.08 112.544 -178.37 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.8 mt -115.78 154.74 29.09 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.888 -1.758 . . . . 1.55 109.887 172.393 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -112.73 120.52 41.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.333 -1.48 . . . . 1.95 110.864 167.273 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.4 m -125.28 175.11 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 124.354 2.026 . . . . 0.96 108.427 178.508 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -114.29 171.96 3.98 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 104.7 -2.333 . . . . 2.35 104.7 164.075 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -83.38 -9.51 10.29 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 N-CA-C 107.174 -1.895 . . . . 0.95 107.174 -176.314 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.4 m -95.82 6.35 49.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.608 1.963 . . . . 1.45 115.415 173.48 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -77.09 153.8 33.96 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 104.727 -2.323 . . . . 1.69 104.727 170.296 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.5 p -86.95 162.1 17.87 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 116.158 -4.089 . . . . 0.75 110.218 168.904 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.306 23.1 mm -65.97 -38.89 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 118.159 -2.838 . . . . 0.73 111.31 179.17 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -50.79 -38.12 46.38 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 127.182 3.373 . . . . 1.62 117.597 166.941 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -75.07 -26.38 59.31 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.519 3.128 . . . . 2.13 110.915 172.792 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.38 -34.33 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 123.334 2.788 . . . . 0.62 109.547 170.831 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -70.49 -36.52 73.88 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.528 -1.983 . . . . 1.22 113.838 175.982 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.84 76.91 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 115.724 1.75 . . . . 0.51 115.724 173.278 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -58.26 -37.36 74.8 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.981 2.113 . . . . 1.44 111.964 175.018 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 5' ' ' VAL . 94.3 mt -75.94 -29.12 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 1 O-C-N 115.676 -4.39 . . . . 1.32 110.357 174.717 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -69.05 -42.3 76.46 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 116.797 -3.689 . . . . 1.7 115.155 168.885 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.337 23.2 t70 -55.03 -49.18 72.2 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.238 -2.164 . . . . 1.55 112.396 168.811 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -70.49 -69.04 0.38 Allowed 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.011 -1.681 . . . . 2.62 113.753 -177.388 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -91.44 -48.71 6.73 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 112.287 -2.233 . . . . 1.48 110.187 -167.387 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.1 32.63 3.21 Favored Glycine 0 N--CA 1.429 -1.773 0 CA-C-O 125.183 2.546 . . . . 1.12 114.837 -179.037 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.8 mt -92.65 129.22 41.14 Favored Pre-proline 0 N--CA 1.43 -1.444 0 N-CA-C 102.49 -3.152 . . . . 1.55 102.49 -177.222 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -76.74 139.37 19.86 Favored 'Trans proline' 0 N--CA 1.433 -2.053 0 CA-C-O 114.156 -2.518 . . . . 1.02 112.737 -178.954 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -68.57 0.04 5.31 Favored 'Trans proline' 0 N--CA 1.433 -2.058 1 C-N-CA 125.624 4.216 . . . . 1.25 112.014 -169.501 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -64.92 -42.81 94.4 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.806 1.289 . . . . 2.25 113.097 166.36 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -75.49 -27.07 58.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.132 2.396 . . . . 2.02 111.034 -176.243 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -81.88 122.26 27.51 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 119.995 3.331 . . . . 0.69 119.995 -169.088 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -116.41 136.68 52.78 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 131.242 3.817 . . . . 2.78 108.976 170.453 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.9 mt -120.13 113.58 20.68 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.425 -4.547 . . . . 1.17 113.513 178.392 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.1 mm -102.19 143.01 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 126.889 3.233 . . . . 1.38 105.765 173.425 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.446 ' HB3' HD21 ' A' ' 50' ' ' LEU . 59.1 t80 -132.66 125.3 30.02 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 115.3 -4.625 . . . . 1.5 110.111 162.866 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.63 -95.15 0.05 OUTLIER 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 124.171 1.938 . . . . 1.21 112.615 -172.428 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.74 20.16 3.1 Favored Glycine 0 N--CA 1.43 -1.757 0 O-C-N 119.208 -2.182 . . . . 1.3 111.3 176.352 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -111.85 135.35 52.59 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 128.675 2.79 . . . . 2.55 109.887 175.752 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -86.76 101.01 12.91 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 129.667 3.187 . . . . 2.48 109.591 168.921 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.446 HD21 ' HB3' ' A' ' 45' ' ' PHE . 21.1 mt -72.11 122.08 20.36 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.397 2.679 . . . . 0.9 112.781 -169.194 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -75.11 133.55 41.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 116.414 2.005 . . . . 1.94 116.414 174.786 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -45.52 -55.1 6.59 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 131.252 3.821 . . . . 1.56 116.298 -174.484 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.68 9.61 58.73 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 118.171 2.028 . . . . 0.97 118.171 173.491 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -91.58 165.51 13.3 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 121.836 2.818 . . . . 2.49 109.496 164.712 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.268 30.3 p -94.02 177.64 5.91 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.785 -1.197 . . . . 0.76 113.059 178.411 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mt -75.03 -27.95 60.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.65 2.643 . . . . 1.05 115.289 171.635 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.4 t -68.07 -39.94 82.83 Favored 'General case' 0 N--CA 1.429 -1.481 1 C-N-CA 132.575 4.35 . . . . 1.19 117.13 175.588 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.288 2.5 m-20 -55.52 -46.91 76.96 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.741 2.816 . . . . 1.9 109.567 175.955 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -83.34 -1.07 52.43 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 126.549 1.94 . . . . 0.89 116.105 176.155 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 63.26 47.34 4.09 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 128.877 2.871 . . . . 1.84 112.36 175.503 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.8 mt -85.52 130.25 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 127.676 2.39 . . . . 0.82 110.799 178.762 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -115.84 175.37 5.57 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 116.267 -4.021 . . . . 2.16 112.061 -173.632 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -50.38 146.65 5.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.899 -2.376 . . . . 2.12 114.423 169.116 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 63.43 23.02 13.52 Favored 'General case' 0 N--CA 1.43 -1.461 2 C-N-CA 132.773 4.429 . . . . 1.71 111.757 176.927 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -91.15 155.21 18.79 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 116.927 -3.608 . . . . 1.04 107.034 -178.588 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.4 m -103.41 116.12 31.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 114.123 -1.399 . . . . 0.79 112.062 -177.753 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -97.11 136.15 38.06 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 102.65 -3.093 . . . . 1.4 102.65 172.848 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -101.72 101.82 12.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.521 1.928 . . . . 1.51 110.377 -175.233 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.1 tp -80.18 124.85 29.15 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 125.93 2.019 . . . . 1.14 110.323 -179.242 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.9 t -126.58 124.14 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.183 -1.826 . . . . 1.23 107.249 -169.471 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.3 mt -100.85 133.8 44.79 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 117.943 -1.503 . . . . 2.78 114.709 -177.484 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -82.1 79.38 8.61 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.786 2.434 . . . . 3.75 111.959 175.208 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.7 mt -94.71 -50.34 5.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 114.88 -2.486 . . . . 3.14 111.004 167.733 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.266 21.3 ttt180 -92.42 -86.44 0.24 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 125.796 1.935 . . . . 6.8 108.458 171.543 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.77 80.51 0.85 Allowed Glycine 0 N--CA 1.43 -1.755 0 O-C-N 118.861 -2.399 . . . . 3.57 114.699 -173.101 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.802 0 CA-C-O 114.001 -3.666 . . . . 3.87 107.999 174.108 . . . . . . . . 0 0 . 1 . 058 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 123.649 1.69 . . . . 1.1 110.639 . . . . . . . . . 0 0 . 1 . 058 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -85.19 121.68 28.29 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.05 -2.906 . . . . 1.87 109.691 -176.817 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -118.83 171.59 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 125.392 2.52 . . . . 0.72 107.848 168.272 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -129.42 129.68 45.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 111.706 -2.497 . . . . 1.4 111.808 179.938 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.6 t -110.94 115.96 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 113.254 -1.794 . . . . 0.58 107.113 169.497 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -97.19 140.98 30.87 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 125.125 2.393 . . . . 2.09 107.786 175.464 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.0 p -82.17 178.64 8.16 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.973 -1.704 . . . . 0.99 114.494 179.796 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.2 tp -54.33 -47.0 73.01 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 116.169 -4.082 . . . . 2.53 112.423 167.556 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 p -71.65 -26.89 62.73 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.729 -3.732 . . . . 2.08 111.374 -178.424 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.1 26.93 6.09 Favored Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 126.491 1.996 . . . . 1.31 112.033 -178.02 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -83.19 128.38 34.44 Favored 'General case' 0 N--CA 1.43 -1.474 2 O-C-N 116.287 -4.067 . . . . 1.4 108.386 176.441 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -99.02 113.29 25.4 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 128.333 3.921 . . . . 0.78 109.979 -176.377 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mt -91.95 126.71 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 111.11 -2.768 . . . . 1.55 108.996 176.111 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.6 t -98.89 143.31 29.34 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 119.95 1.25 . . . . 1.08 111.174 172.958 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.9 mt -136.97 158.1 45.24 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.587 2.755 . . . . 1.55 108.592 -177.828 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -111.33 121.1 44.36 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.479 -1.388 . . . . 1.95 107.819 166.057 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.03 159.32 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 126.491 3.043 . . . . 0.96 106.488 -172.724 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -112.01 149.17 40.47 Favored Pre-proline 0 N--CA 1.43 -1.475 1 O-C-N 116.067 -4.145 . . . . 2.35 108.186 165.239 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -72.31 -9.42 24.28 Favored 'Trans proline' 0 C--N 1.299 -2.031 2 O-C-N 112.925 -4.303 . . . . 0.95 115.671 -173.526 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.7 p -89.03 2.98 53.2 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 111.656 -2.52 . . . . 1.45 111.364 177.795 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -78.3 157.95 29.03 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.65 2.092 . . . . 1.69 116.65 172.864 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 67.2 p -95.87 160.12 14.63 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.015 2.816 . . . . 0.75 110.184 169.844 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 mm -54.83 -32.03 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 117.447 -3.283 . . . . 0.73 115.561 166.385 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -51.29 -59.86 3.75 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 116.692 2.108 . . . . 1.62 116.692 160.901 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -54.26 -37.44 64.7 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 117.768 2.507 . . . . 2.13 117.768 174.476 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.4 t -56.54 -42.34 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 126.86 2.064 . . . . 0.62 115.1 167.46 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -68.82 -24.2 64.35 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 115.577 1.695 . . . . 1.22 115.577 174.915 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.34 83.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 116.795 -1.574 . . . . 0.51 112.901 166.349 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -68.23 -35.45 77.96 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 128.726 3.766 . . . . 1.44 115.999 -179.573 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.2 mt -79.98 -32.25 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 C-N-CA 128.634 2.773 . . . . 1.32 113.535 170.931 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -62.96 -51.53 66.53 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 115.781 -4.324 . . . . 1.7 114.058 167.155 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -52.18 -43.85 64.36 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.34 1.978 . . . . 1.55 116.34 169.145 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -84.83 -63.82 1.27 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.066 -1.646 . . . . 2.62 113.944 -177.898 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -96.62 -39.19 9.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.752 2.215 . . . . 1.48 115.86 -174.151 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.61 44.92 2.4 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 116.79 -3.694 . . . . 1.12 113.626 169.604 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.7 mt -103.95 130.84 22.67 Favored Pre-proline 0 N--CA 1.43 -1.451 1 N-CA-C 99.775 -4.157 . . . . 1.55 99.775 -174.489 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -54.16 135.15 63.54 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-O 112.205 -3.331 . . . . 1.02 116.058 -179.571 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.64 -26.12 63.33 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 CA-C-N 127.052 3.554 . . . . 1.25 119.863 -178.988 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -68.67 -37.29 79.5 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.378 -1.283 . . . . 2.25 113.727 177.634 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -73.1 -27.48 61.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.609 -3.182 . . . . 2.02 115.105 178.307 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -68.49 129.49 40.08 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.377 3.473 . . . . 0.69 120.377 177.526 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -127.92 114.99 17.87 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.66 1.984 . . . . 2.78 111.715 168.9 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.565 HD12 HD23 ' A' ' 67' ' ' LEU . 3.8 mm? -86.71 130.16 34.59 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 125.881 1.988 . . . . 1.17 108.248 176.949 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.1 mm -127.41 123.3 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 125.985 2.053 . . . . 1.38 108.131 177.101 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -123.3 124.06 42.14 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.648 1.69 . . . . 1.5 108.945 171.948 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.89 -92.85 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.503 2.721 . . . . 1.21 116.05 -172.886 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.31 -38.18 1.68 Allowed Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 126.462 1.982 . . . . 1.3 113.505 -177.854 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -82.39 146.83 29.13 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 129.897 3.279 . . . . 2.55 116.039 -172.304 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -92.49 141.09 28.89 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 118.966 -2.334 . . . . 2.48 108.953 171.801 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 43' ' ' LEU . 27.7 mt -98.4 128.43 44.78 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 104.418 -2.438 . . . . 0.9 104.418 -168.922 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -83.55 140.63 32.14 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.672 2.389 . . . . 1.94 112.936 173.396 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -56.57 -54.44 45.88 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.34 3.089 . . . . 1.56 119.34 -172.179 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.02 8.44 63.33 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 115.278 -2.957 . . . . 0.97 117.505 175.106 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 22' ' ' THR . 31.0 mmt180 -78.88 158.21 28.14 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 122.732 3.266 . . . . 2.49 115.124 163.041 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.7 p -89.4 156.59 18.58 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 122.758 2.526 . . . . 0.76 113.351 173.141 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.0 mt -53.8 -36.86 62.92 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.104 -0.953 . . . . 1.05 111.675 166.361 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -54.19 -48.05 71.39 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.232 -2.168 . . . . 1.19 113.863 -178.841 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -45.69 -43.93 13.07 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 119.984 3.327 . . . . 1.9 119.984 171.786 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -96.75 3.54 52.29 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.203 2.601 . . . . 0.89 111.176 178.944 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.4 m120 54.88 47.29 22.6 Favored 'General case' 0 N--CA 1.431 -1.384 0 O-C-N 119.32 -2.113 . . . . 1.84 112.862 -176.092 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.3 mt -80.5 117.5 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 122.184 2.265 . . . . 0.82 110.274 177.481 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -110.32 176.86 4.89 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 120.13 1.332 . . . . 2.16 108.423 -168.43 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.377 45.5 pttt -54.27 128.46 31.4 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 131.555 3.942 . . . . 2.12 115.172 174.191 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 64.17 48.18 3.02 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 128.021 2.528 . . . . 1.71 109.269 175.758 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.2 p -92.12 173.45 7.83 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.806 -3.059 . . . . 1.04 113.35 178.117 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.1 m -120.88 114.86 22.18 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.281 -2.137 . . . . 0.79 112.317 173.201 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.565 HD23 HD12 ' A' ' 43' ' ' LEU . 6.3 mp -105.11 155.1 19.32 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.062 1.745 . . . . 1.4 108.522 175.575 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -118.42 130.64 56.09 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 126.543 2.402 . . . . 1.51 105.179 -174.763 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.2 tp -99.38 117.77 34.53 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.411 1.084 . . . . 1.14 112.981 175.524 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.8 t -102.97 129.85 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-O 123.896 1.808 . . . . 1.23 109.134 172.6 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.4 mt -105.6 105.4 15.43 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.939 -2.976 . . . . 2.78 108.522 178.087 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -77.98 127.48 32.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.179 1.392 . . . . 3.75 108.242 172.788 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.1 mt -81.69 145.25 30.63 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.616 -0.678 . . . . 3.14 110.375 170.89 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -117.8 -60.84 1.76 Allowed 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 104.57 -2.381 . . . . 6.8 104.57 175.702 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 142.09 -58.47 0.56 Allowed Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 127.689 2.566 . . . . 3.57 111.791 -162.36 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.742 1 N-CA-C 102.133 -4.387 . . . . 3.87 102.133 179.941 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 CA--C 1.491 -1.319 0 CA-C-O 122.992 1.377 . . . . 1.1 113.882 . . . . . . . . . 0 0 . 1 . 059 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -85.9 135.18 33.79 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.21 1.804 . . . . 1.87 110.175 -174.565 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 pt -135.97 161.01 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 120.003 -1.686 . . . . 0.72 111.815 174.199 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -118.04 141.43 48.47 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.161 -2.212 . . . . 1.4 107.819 -179.268 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 t -116.88 130.11 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 126.064 2.102 . . . . 0.58 107.185 173.566 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -115.06 123.44 49.02 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.133 -3.479 . . . . 2.09 113.722 179.02 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.3 p -68.0 171.22 7.08 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 124.522 2.106 . . . . 0.99 112.038 178.161 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 tp -71.77 -27.37 62.91 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 117.912 -2.993 . . . . 2.53 110.403 174.622 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 p -73.6 -30.32 62.92 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.758 -3.714 . . . . 2.08 106.46 178.546 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.26 -21.22 2.96 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 125.289 3.677 . . . . 1.31 113.041 -179.433 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -57.11 117.41 4.0 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 126.874 2.07 . . . . 1.4 114.185 -177.159 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.8 m -107.64 114.82 29.06 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.169 -1.789 . . . . 0.78 106.169 -179.798 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.516 HD12 ' CE ' ' A' ' 33' ' ' LYS . 26.9 pt -104.61 161.64 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 125.839 1.962 . . . . 1.55 105.883 -178.162 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -117.24 121.13 40.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.711 2.004 . . . . 1.08 108.861 -174.48 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.6 mt -122.99 164.42 18.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 126.289 2.947 . . . . 1.55 110.974 -177.657 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -129.0 132.4 47.52 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 116.406 -3.934 . . . . 1.95 110.884 174.828 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.7 m -137.59 -175.45 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-O 128.377 3.942 . . . . 0.96 112.047 -179.818 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -122.88 147.32 50.83 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-N 112.157 -2.292 . . . . 2.35 110.572 166.084 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -65.6 -20.09 60.07 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 O-C-N 114.036 -3.718 . . . . 0.95 115.276 -178.783 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.6 p -70.64 -21.92 62.57 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 117.45 -3.281 . . . . 1.45 112.154 177.862 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -62.86 146.7 52.16 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.994 2.961 . . . . 1.69 118.994 178.395 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.8 p -85.58 151.64 23.76 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 124.895 1.278 . . . . 0.75 108.191 177.358 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.2 mm -54.0 -41.34 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 129.225 3.01 . . . . 0.73 113.063 -179.884 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -44.56 -53.17 7.36 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 118.612 2.819 . . . . 1.62 118.612 161.777 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -50.8 -32.15 19.15 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 126.537 1.935 . . . . 2.13 113.693 174.096 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.9 t -77.44 -42.7 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 107.243 -1.391 . . . . 0.62 107.243 -177.305 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.496 ' HA ' HD12 ' A' ' 30' ' ' ILE . 40.8 mtmt -60.16 -42.3 94.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 120.393 1.451 . . . . 1.22 112.79 174.744 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.85 -20.53 65.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.594 1.558 . . . . 0.51 110.227 177.915 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -80.11 -40.79 26.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.969 2.319 . . . . 1.44 112.878 174.545 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 27' ' ' LYS . 33.2 mt -51.52 -42.57 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.551 -2.593 . . . . 1.32 113.65 165.68 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -54.17 -47.76 71.64 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.339 2.656 . . . . 1.7 113.613 177.559 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -56.71 -42.51 79.3 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.816 2.046 . . . . 1.55 115.058 170.884 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.516 ' CE ' HD12 ' A' ' 13' ' ' ILE . 52.3 tttp -74.26 -48.56 27.9 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.671 1.988 . . . . 2.62 114.654 -179.213 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -115.85 -15.09 11.3 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 123.911 1.815 . . . . 1.48 114.264 -171.061 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.17 21.67 32.1 Favored Glycine 0 N--CA 1.429 -1.789 1 O-C-N 113.848 -5.533 . . . . 1.12 113.012 171.394 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 mt -98.69 124.02 47.67 Favored Pre-proline 0 N--CA 1.431 -1.42 0 O-C-N 120.626 -1.514 . . . . 1.55 107.009 -175.328 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -67.97 152.54 76.77 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 C-N-CA 124.302 3.335 . . . . 1.02 113.779 178.043 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -82.47 -15.84 8.45 Favored 'Trans proline' 0 N--CA 1.433 -2.052 0 C-N-CA 123.704 2.936 . . . . 1.25 113.321 -163.304 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -72.7 -27.76 62.26 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 129.981 4.551 . . . . 2.25 113.889 175.333 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -82.03 -20.54 38.13 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.046 2.355 . . . . 2.02 112.522 179.132 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.276 76.8 mt-30 -97.11 145.39 26.04 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 127.805 3.669 . . . . 0.69 109.786 -171.867 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -139.18 122.58 17.18 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.101 -2.249 . . . . 2.78 113.903 172.539 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.2 mt -92.44 120.85 33.34 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.414 -1.428 . . . . 1.17 112.866 -176.299 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.5 mt -112.7 130.15 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 129.981 3.313 . . . . 1.38 107.92 -175.537 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -138.3 135.15 35.16 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.744 -1.222 . . . . 1.5 110.206 177.872 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.01 46.96 25.71 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.824 3.202 . . . . 1.21 116.675 179.592 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.17 -44.28 3.35 Favored Glycine 0 N--CA 1.43 -1.717 0 O-C-N 118.617 -2.552 . . . . 1.3 117.479 -177.147 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -86.67 159.5 19.17 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 118.89 1.345 . . . . 2.55 114.498 -176.228 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -83.54 135.01 34.8 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.411 -0.813 . . . . 2.48 109.501 174.497 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 mt -87.7 148.1 24.92 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.759 -1.2 . . . . 0.9 107.759 -179.011 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -99.69 134.54 42.44 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.26 -2.775 . . . . 1.94 110.027 -179.619 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -68.36 -25.86 65.29 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 117.692 2.478 . . . . 1.56 117.692 -167.626 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.05 14.76 64.13 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 115.617 -3.183 . . . . 0.97 117.662 169.091 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -96.84 176.51 5.95 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.991 1.377 . . . . 2.49 108.157 170.005 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.5 p -102.6 -174.72 2.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 116.328 -3.982 . . . . 0.76 117.182 177.648 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.259 60.2 mt -77.33 -38.54 50.17 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.632 -2.542 . . . . 1.05 111.255 174.301 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.1 p -72.28 -15.12 61.9 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 128.369 3.543 . . . . 1.19 118.387 179.012 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -66.09 -29.66 70.02 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.127 -1.608 . . . . 1.9 113.672 168.921 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -102.96 6.46 38.92 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 122.851 1.31 . . . . 0.89 109.83 -177.231 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.8 m120 55.45 35.41 25.01 Favored 'General case' 0 N--CA 1.431 -1.38 1 O-C-N 116.279 -4.013 . . . . 1.84 114.746 -173.507 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.9 mt -68.72 118.03 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.943 1.297 . . . . 0.82 113.475 175.073 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -115.55 -175.85 2.8 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 130.97 3.708 . . . . 2.16 112.859 -178.864 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -67.07 139.12 57.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.247 2.927 . . . . 2.12 110.894 -176.224 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.446 25.3 mt-10 85.38 9.07 0.35 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 111.439 -2.619 . . . . 1.71 116.015 176.652 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.0 m -74.23 133.43 42.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.859 -1.776 . . . . 1.04 114.371 -173.282 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.5 m -99.99 109.99 22.32 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 104.651 -2.351 . . . . 0.79 104.651 -169.595 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.19 151.47 19.44 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.274 2.23 . . . . 1.4 109.134 172.306 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -109.34 108.18 18.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 123.598 1.666 . . . . 1.51 112.228 -179.06 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.4 tp -85.08 120.38 26.52 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.516 2.103 . . . . 1.14 109.412 178.178 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.366 31.3 m -114.67 148.25 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 117.17 -3.456 . . . . 1.23 112.611 171.702 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.286 62.1 mt -109.1 132.8 53.77 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.986 2.803 . . . . 2.78 108.829 -179.076 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -137.29 73.79 1.46 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.242 -2.132 . . . . 3.75 105.242 -179.546 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 pp -84.28 162.03 20.26 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 116.635 2.087 . . . . 3.14 116.635 -178.686 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -105.75 -45.52 4.37 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 115.75 -2.072 . . . . 6.8 108.999 172.755 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.75 -98.69 0.12 Allowed Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 104.761 -3.335 . . . . 3.57 104.761 -168.248 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.751 0 O-C-N 119.459 -2.2 . . . . 3.87 113.235 177.634 . . . . . . . . 0 0 . 1 . 060 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.295 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.359 0 CA-C-O 125.099 2.381 . . . . 1.1 115.096 . . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -87.78 128.5 35.32 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.46 -3.9 . . . . 1.87 111.475 179.317 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.7 pt -126.66 172.96 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 117.07 -3.519 . . . . 0.72 106.603 169.612 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -127.17 135.65 50.99 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 123.519 0.728 . . . . 1.4 110.861 -176.864 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.2 t -117.37 117.94 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 101.342 -3.577 . . . . 0.58 101.342 176.774 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.7 tttp -101.73 148.2 25.56 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.625 -3.797 . . . . 2.09 113.54 174.84 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.4 HG22 HD23 ' A' ' 69' ' ' LEU . 31.1 p -97.28 171.59 8.33 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.542 2.591 . . . . 0.99 108.751 176.946 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.6 mt -83.47 -4.79 58.84 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.811 -2.43 . . . . 2.53 114.205 172.544 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.2 p -88.83 -30.44 18.94 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 115.723 -2.084 . . . . 2.08 105.467 178.947 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.11 -2.17 10.69 Favored Glycine 0 N--CA 1.43 -1.754 1 O-C-N 129.471 4.232 . . . . 1.31 115.89 170.941 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -72.47 140.61 48.36 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.859 -1.163 . . . . 1.4 107.859 -176.421 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.6 m -108.3 124.58 50.55 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.848 -2.649 . . . . 0.78 103.848 177.419 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.3 mm -101.55 116.81 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 119.237 -2.165 . . . . 1.55 109.769 176.209 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.2 m -92.85 120.8 33.57 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 121.351 1.887 . . . . 1.08 107.891 -179.162 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 15' ' ' LEU . 39.4 mt -125.88 127.23 45.7 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.048 2.939 . . . . 1.55 110.261 -173.731 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -86.29 114.26 22.95 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 126.72 2.513 . . . . 1.95 113.075 166.409 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.1 m -129.28 167.11 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 118.044 -2.91 . . . . 0.96 109.103 -179.407 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.271 69.1 mm-40 -110.4 156.08 40.93 Favored Pre-proline 0 N--CA 1.431 -1.408 0 CA-C-O 117.839 -1.077 . . . . 2.35 108.573 164.851 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -71.08 -8.22 23.09 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 CA-C-N 123.217 2.185 . . . . 0.95 113.853 -175.175 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.1 p -81.49 -24.91 36.41 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.049 2.94 . . . . 1.45 113.284 178.535 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -66.74 154.55 40.44 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 117.687 -1.149 . . . . 1.69 111.985 178.97 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 19.0 p -87.13 175.94 7.83 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 106.303 -1.74 . . . . 0.75 106.303 -177.872 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.4 mm -73.31 -33.96 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.54 0 C-N-CA 123.889 0.876 . . . . 0.73 111.792 175.848 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -46.2 -41.14 12.35 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.678 3.191 . . . . 1.62 113.751 167.41 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -73.39 -22.13 60.33 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 115.513 -4.492 . . . . 2.13 114.205 179.275 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -74.51 -47.02 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 113.709 -1.587 . . . . 0.62 109.047 175.589 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -52.69 -27.77 18.89 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 128.419 3.574 . . . . 1.22 119.817 167.116 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.21 -37.38 57.84 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.461 -3.899 . . . . 0.51 110.781 172.54 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -70.22 -39.83 74.88 Favored 'General case' 0 N--CA 1.43 -1.444 2 O-C-N 111.372 -7.08 . . . . 1.44 110.68 177.269 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 53.5 mt -59.28 -42.29 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 1 O-C-N 115.989 -4.194 . . . . 1.32 111.05 173.038 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -65.55 -46.5 79.3 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.215 -3.428 . . . . 1.7 107.671 177.755 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -55.15 -64.99 0.66 Allowed 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.081 -4.762 . . . . 1.55 117.003 169.91 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -61.37 -57.18 13.32 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.226 -2.796 . . . . 2.62 113.215 -176.021 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -100.93 -46.1 5.22 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.957 2.903 . . . . 1.48 111.315 -165.639 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.01 22.75 5.18 Favored Glycine 0 N--CA 1.429 -1.79 0 O-C-N 116.649 -3.782 . . . . 1.12 113.781 170.61 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.9 mt -92.43 128.24 45.44 Favored Pre-proline 0 N--CA 1.432 -1.374 0 N-CA-C 101.666 -3.457 . . . . 1.55 101.666 -173.11 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -71.26 155.78 60.12 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 CA-C-O 112.67 -3.137 . . . . 1.02 114.961 175.681 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -65.61 -24.15 56.05 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 CA-C-N 124.861 2.772 . . . . 1.25 118.274 -179.163 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.83 -33.85 76.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.548 2.055 . . . . 2.25 116.548 172.866 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -83.41 -35.28 25.16 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 126.321 2.962 . . . . 2.02 112.603 -177.916 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -79.05 130.09 35.15 Favored 'General case' 0 N--CA 1.429 -1.482 1 O-C-N 115.575 -4.453 . . . . 0.69 111.816 -176.103 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -123.91 129.73 51.44 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.696 1.599 . . . . 2.78 106.686 166.776 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 mt -96.19 139.42 32.36 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 124.657 1.223 . . . . 1.17 113.595 173.692 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 60.1 mt -114.63 138.5 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.899 -3.0 . . . . 1.38 107.607 174.141 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -147.13 136.74 22.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.797 -3.064 . . . . 1.5 112.062 169.46 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.374 . . 63.53 -2.21 0.51 Allowed 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 116.677 2.103 . . . . 1.21 116.677 -178.426 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.21 -11.28 33.84 Favored Glycine 0 N--CA 1.429 -1.776 0 CA-C-O 126.648 3.36 . . . . 1.3 113.52 -173.862 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -90.23 128.98 36.53 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 117.592 -3.299 . . . . 2.55 108.795 -179.548 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -77.03 126.44 30.97 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.084 -3.51 . . . . 2.48 108.099 171.565 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.289 26.5 mt -79.17 127.96 32.7 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 118.136 2.643 . . . . 0.9 118.136 -170.519 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -83.43 149.49 26.64 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.584 2.068 . . . . 1.94 116.584 174.441 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.76 -36.11 72.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.142 2.577 . . . . 1.56 114.15 -171.782 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.46 10.59 68.81 Favored Glycine 0 N--CA 1.431 -1.694 0 C-N-CA 114.572 -3.68 . . . . 0.97 119.141 171.233 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -80.06 154.3 28.21 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 126.594 1.996 . . . . 2.49 113.225 170.701 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 32.5 p -82.77 164.32 20.7 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 124.886 2.279 . . . . 0.76 111.098 167.902 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 mt -75.43 -29.04 59.59 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 116.791 -3.693 . . . . 1.05 112.481 173.098 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 p -62.92 -40.6 98.1 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.39 -2.069 . . . . 1.19 112.491 173.9 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.278 2.0 t70 -53.62 -40.87 66.11 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 118.535 2.791 . . . . 1.9 118.535 172.833 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -79.66 -9.07 59.58 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 126.009 2.068 . . . . 0.89 116.077 172.184 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.4 m120 70.8 65.82 0.18 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 130.1 3.36 . . . . 1.84 108.557 -177.521 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.5 mt -108.78 124.18 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 O-C-N 117.068 -3.52 . . . . 0.82 111.009 -178.145 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -107.42 -173.83 2.38 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.53 1.532 . . . . 2.16 115.032 -178.045 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -70.87 145.83 49.99 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 119.086 -2.259 . . . . 2.12 113.006 176.709 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.35 31.7 mt-10 78.4 15.05 1.33 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.297 2.639 . . . . 1.71 112.333 165.847 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.5 m -86.61 146.0 26.51 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.314 -2.221 . . . . 1.04 110.265 -169.42 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.7 m -93.79 110.41 22.06 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.547 1.976 . . . . 0.79 116.007 179.406 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -87.29 151.52 23.06 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.497 -2.002 . . . . 1.4 110.184 172.511 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.426 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 39.7 m80 -109.57 100.8 9.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.785 -1.822 . . . . 1.51 114.62 -179.562 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.4 HD23 HG22 ' A' ' 7' ' ' THR 0.259 36.0 tp -84.96 115.73 22.97 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.386 -2.071 . . . . 1.14 108.489 -173.122 . . . . . . . . 3 3 . 1 . 060 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 m -107.74 153.16 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 126.238 1.815 . . . . 1.23 110.792 174.817 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.1 mt -122.21 144.56 48.89 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.802 -2.436 . . . . 2.78 107.788 179.281 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.64 88.56 3.86 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 127.935 3.272 . . . . 3.75 109.068 179.747 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.6 mt -119.17 -91.27 0.56 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.999 1.32 . . . . 3.14 112.127 -177.915 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 -141.24 144.84 34.93 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.39 -1.444 . . . . 6.8 108.224 -178.674 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.17 -114.9 5.1 Favored Glycine 0 N--CA 1.429 -1.771 0 O-C-N 118.352 -2.718 . . . . 3.57 108.654 -169.828 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.754 0 CA-C-O 115.225 -2.986 . . . . 3.87 114.614 -168.994 . . . . . . . . 0 0 . 1 . 061 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 ptt? . . . . . 0 CA--C 1.491 -1.294 0 N-CA-C 115.138 1.533 . . . . 1.1 115.138 . . . . . . . . . 0 0 . 1 . 061 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -87.45 135.12 33.46 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 124.835 1.334 . . . . 1.87 110.435 179.439 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -126.66 138.39 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 105.894 -1.891 . . . . 0.72 105.894 175.073 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -104.19 77.03 1.38 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.791 -1.095 . . . . 1.4 108.91 -176.105 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 t -63.42 105.29 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 116.213 1.931 . . . . 0.58 116.213 168.95 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.257 35.7 tptt -90.46 139.8 30.33 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 124.151 1.929 . . . . 2.09 112.652 179.095 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.3 p -91.17 -179.39 5.42 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.556 -1.965 . . . . 0.99 108.513 179.544 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.4 tp -66.23 -50.88 62.28 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 123.218 1.485 . . . . 2.53 113.903 179.997 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 p -74.69 -22.07 59.06 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.113 1.523 . . . . 2.08 115.113 -172.577 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.05 -2.53 2.96 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 117.679 -2.201 . . . . 1.31 114.817 172.49 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -78.86 131.09 36.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.165 -2.962 . . . . 1.4 112.146 -175.18 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.271 85.8 m -98.83 118.1 34.82 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.147 -2.221 . . . . 0.78 108.97 175.452 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.1 mm -102.39 118.68 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 125.175 1.547 . . . . 1.55 110.201 179.698 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.2 m -81.02 98.33 7.91 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.447 -1.251 . . . . 1.08 110.549 174.862 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.3 tp -100.69 158.08 16.21 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.016 -2.303 . . . . 1.55 110.118 -176.394 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -121.55 118.74 30.03 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.284 -1.006 . . . . 1.95 108.284 174.956 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 m -135.58 176.67 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 107.619 -1.252 . . . . 0.96 107.619 -177.581 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -124.25 166.7 18.2 Favored Pre-proline 0 N--CA 1.429 -1.482 0 O-C-N 118.547 -2.596 . . . . 2.35 109.644 170.275 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.359 14.5 Cg_endo -75.68 -16.27 18.83 Favored 'Trans proline' 0 C--N 1.299 -2.075 0 O-C-N 114.7 -3.368 . . . . 0.95 114.502 -175.99 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.9 p -90.87 2.57 56.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.206 -2.184 . . . . 1.45 107.334 -178.804 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -80.51 142.59 34.04 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.923 -1.736 . . . . 1.69 113.544 179.433 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.6 p -85.71 164.71 17.47 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 117.029 2.233 . . . . 0.75 117.029 177.783 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.5 HD11 HD23 ' A' ' 56' ' ' LEU . 42.9 mm -76.48 -31.06 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 101.738 -3.43 . . . . 0.73 101.738 -172.979 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -49.76 -47.01 51.21 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 115.641 1.719 . . . . 1.62 115.641 167.298 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -76.72 -30.82 56.81 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 115.87 -2.014 . . . . 2.13 112.533 177.328 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.31 -29.7 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 121.592 1.996 . . . . 0.62 114.463 177.551 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -74.55 -35.39 63.08 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 117.607 -1.187 . . . . 1.22 109.213 171.232 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -36.93 83.99 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 123.389 2.813 . . . . 0.51 112.619 171.007 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.6 mttm -63.94 -47.38 80.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 126.842 2.589 . . . . 1.44 114.804 170.364 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.43 HG21 HD13 ' A' ' 30' ' ' ILE . 60.9 mt -61.48 -36.38 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 1 O-C-N 114.462 -5.149 . . . . 1.32 109.756 171.066 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -57.52 -54.27 48.71 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 117.14 -3.475 . . . . 1.7 113.152 172.734 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -52.75 -44.64 66.61 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.767 -1.208 . . . . 1.55 111.98 171.92 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -65.18 -57.41 8.6 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 127.612 2.365 . . . . 2.62 110.464 -173.369 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -105.75 -47.64 3.84 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 118.128 -2.857 . . . . 1.48 115.705 -169.611 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.42 4.63 8.96 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 119.547 -1.971 . . . . 1.12 114.17 -176.445 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.9 mt -83.5 127.37 68.48 Favored Pre-proline 0 N--CA 1.43 -1.462 0 O-C-N 119.026 -2.455 . . . . 1.55 110.478 -176.108 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -73.35 146.57 40.27 Favored 'Trans proline' 0 C--N 1.3 -2.014 2 O-C-N 110.895 -5.371 . . . . 1.02 113.389 179.135 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.06 -5.69 16.4 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 C-N-CA 126.107 4.538 . . . . 1.25 116.672 -176.931 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.53 -37.61 84.38 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.815 2.245 . . . . 2.25 110.782 169.343 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -85.17 -31.9 22.99 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 115.937 -1.982 . . . . 2.02 115.022 -177.411 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.359 46.7 mt-30 -67.58 113.47 5.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.388 2.675 . . . . 0.69 117.698 -172.089 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -122.01 115.47 22.58 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.327 -2.733 . . . . 2.78 109.551 172.765 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.9 mt -96.53 143.11 27.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.51 -1.369 . . . . 1.17 110.256 179.427 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.2 mm -124.6 148.64 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 102.679 -3.082 . . . . 1.38 102.679 175.423 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.407 ' HB3' HD21 ' A' ' 50' ' ' LEU . 69.4 t80 -139.53 112.86 8.27 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 101.156 -3.646 . . . . 1.5 101.156 173.982 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.96 28.76 14.49 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 126.286 2.241 . . . . 1.21 114.119 172.662 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.91 -17.1 56.68 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 124.938 1.256 . . . . 1.3 114.31 -175.168 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.316 34.7 ttmt -87.63 122.51 31.41 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.766 -2.608 . . . . 2.55 115.756 178.417 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -64.46 138.12 58.24 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 118.193 2.664 . . . . 2.48 118.193 171.718 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.407 HD21 ' HB3' ' A' ' 45' ' ' PHE . 39.7 mt -95.9 113.2 24.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.951 -1.022 . . . . 0.9 111.126 -172.326 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -77.5 142.56 39.03 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.873 -1.158 . . . . 1.94 107.873 -178.973 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.472 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 7.0 m-20 -56.96 -65.47 0.61 Allowed 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 119.29 3.071 . . . . 1.56 119.29 -168.723 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.1 25.5 0.15 Allowed Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 119.38 2.512 . . . . 0.97 119.38 171.943 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -105.97 158.0 17.1 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 119.773 1.786 . . . . 2.49 109.926 164.821 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.7 p -84.91 169.1 14.41 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 112.735 -2.03 . . . . 0.76 111.602 170.708 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.5 HD23 HD11 ' A' ' 23' ' ' ILE . 94.0 mt -66.02 -37.16 85.18 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 127.384 2.274 . . . . 1.05 111.739 171.543 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.9 p -69.39 -10.4 57.79 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 129.23 3.012 . . . . 1.19 115.016 173.806 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.99 -48.21 31.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.876 1.67 . . . . 1.9 110.362 169.84 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -85.63 -1.11 56.8 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 130.476 3.51 . . . . 0.89 113.775 -177.924 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.0 m120 57.21 54.32 6.9 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.604 2.361 . . . . 1.84 116.646 179.517 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 88.9 mt -100.27 109.8 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 126.846 2.058 . . . . 0.82 108.797 -179.194 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -93.74 -178.62 4.74 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.052 2.358 . . . . 2.16 110.422 -178.902 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -58.28 140.18 53.77 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.108 -3.495 . . . . 2.12 119.885 175.735 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.327 12.7 mt-10 67.98 40.56 2.26 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 123.778 0.674 . . . . 1.71 110.557 174.913 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 p -96.22 155.43 16.76 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 126.667 1.987 . . . . 1.04 108.547 176.106 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.4 m -104.68 85.75 2.37 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.689 -2.337 . . . . 0.79 104.689 -177.079 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -63.6 159.78 18.15 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 114.539 -5.1 . . . . 1.4 113.884 169.01 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -118.2 129.86 55.75 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.39 2.043 . . . . 1.51 108.584 -178.96 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.6 tp -116.67 131.27 56.99 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 116.065 -4.147 . . . . 1.14 113.242 175.351 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 m -135.1 167.9 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 103.437 -2.801 . . . . 1.23 103.437 175.727 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 66.4 mt -121.83 155.27 35.72 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 126.446 3.022 . . . . 2.78 113.958 179.596 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -110.56 121.19 44.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 130.264 3.426 . . . . 3.75 112.862 -174.193 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.1 mt -128.24 -71.67 0.64 Allowed 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 124.984 1.428 . . . . 3.14 113.26 171.614 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 64.9 ttp85 -72.9 140.87 47.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 117.39 2.367 . . . . 6.8 117.39 173.927 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.56 81.85 1.54 Allowed Glycine 0 N--CA 1.43 -1.702 1 O-C-N 115.975 -4.203 . . . . 3.57 114.573 -171.001 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.755 0 CA-C-O 114.911 -3.16 . . . . 3.87 113.794 -172.658 . . . . . . . . 0 0 . 1 . 062 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.2 ttp . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 117.484 2.401 . . . . 1.1 117.484 . . . . . . . . . 0 0 . 1 . 062 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -100.03 124.01 44.91 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 124.53 1.144 . . . . 1.87 110.852 -176.337 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 17' ' ' VAL . 3.1 pt -129.11 157.89 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 105.571 -2.011 . . . . 0.72 105.571 172.003 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -108.79 134.67 51.17 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.023 1.729 . . . . 1.4 112.117 -174.854 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.491 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 42.1 t -111.85 115.01 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 122.15 0.976 . . . . 0.58 108.852 173.612 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -96.57 149.94 21.2 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.948 -2.345 . . . . 2.09 107.544 176.979 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.6 p -109.78 -149.21 0.44 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 116.275 -1.821 . . . . 0.99 107.462 176.464 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.2 tp -91.77 -58.12 2.52 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-N 122.809 2.55 . . . . 2.53 110.92 167.121 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.4 p -127.19 133.83 50.23 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 113.755 -3.022 . . . . 2.08 117.946 178.877 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.21 -116.97 2.71 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 103.307 -3.917 . . . . 1.31 103.307 173.983 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -119.67 164.62 15.62 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 121.831 -0.805 . . . . 1.4 108.87 -170.17 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.5 m -88.65 120.26 29.88 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 125.853 1.97 . . . . 0.78 109.652 168.958 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 15.6 mt -79.9 122.62 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-N 122.122 2.237 . . . . 1.55 114.983 -179.627 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.8 m -78.83 100.95 7.39 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.767 -1.833 . . . . 1.08 109.973 176.882 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tp -102.8 119.52 38.98 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 113.709 1.003 . . . . 1.55 113.709 -178.302 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -91.71 126.3 36.74 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.396 2.522 . . . . 1.95 112.983 168.574 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.401 HG21 HD13 ' A' ' 3' ' ' ILE . 19.7 m -142.89 171.46 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 1 C-N-CA 131.737 4.015 . . . . 0.96 110.868 -174.331 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 41.5 mt-10 -114.24 169.14 6.9 Favored Pre-proline 0 N--CA 1.43 -1.462 0 C-N-CA 129.163 2.985 . . . . 2.35 106.737 166.428 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 82.1 Cg_exo -73.16 -18.11 24.01 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 N-CA-C 120.11 3.081 . . . . 0.95 120.11 -177.1 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.4 m -84.69 10.15 12.02 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 112.036 -2.347 . . . . 1.45 116.171 174.574 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.69 130.49 35.08 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 116.688 -3.757 . . . . 1.69 106.007 177.464 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 23.9 p -71.05 163.59 27.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.712 2.196 . . . . 0.75 108.493 171.18 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.5 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 49.1 mm -66.41 -34.07 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 113.625 -3.083 . . . . 0.73 105.381 175.951 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -61.65 -40.02 93.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 122.883 2.583 . . . . 1.62 116.207 171.731 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -69.59 -41.02 76.32 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 125.144 1.528 . . . . 2.13 112.476 177.653 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.5 t -49.85 -50.12 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 120.858 -1.151 . . . . 0.62 113.569 169.872 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -58.77 -37.32 76.02 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.152 -1.592 . . . . 1.22 113.735 170.319 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.59 -37.84 85.75 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.648 -2.533 . . . . 0.51 108.908 178.945 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -69.32 -38.29 78.14 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 129.087 2.955 . . . . 1.44 112.813 179.303 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 93.8 mt -69.1 -28.66 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 117.431 -3.293 . . . . 1.32 110.959 170.99 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -66.31 -47.19 74.36 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.519 1.528 . . . . 1.7 110.761 172.235 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -64.3 -28.81 69.97 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 114.519 1.303 . . . . 1.55 114.519 173.058 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -87.89 -46.89 9.01 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.087 -2.258 . . . . 2.62 115.12 -173.839 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -113.58 -29.35 7.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.056 1.742 . . . . 1.48 115.262 -175.486 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.19 4.03 38.42 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 119.305 -2.122 . . . . 1.12 118.165 175.074 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.9 mt -85.06 132.48 45.46 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 119.262 1.531 . . . . 1.55 110.771 -173.934 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -61.32 144.04 98.31 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 C-N-CA 123.464 2.776 . . . . 1.02 116.72 -179.721 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -59.43 -32.52 96.59 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 123.379 2.719 . . . . 1.25 114.141 -178.627 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -63.24 -18.11 63.19 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.928 2.936 . . . . 2.25 118.928 171.59 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -91.89 -23.19 19.71 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 116.295 -1.812 . . . . 2.02 107.1 -177.162 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -89.49 141.09 28.89 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 117.406 2.373 . . . . 0.69 117.406 -172.932 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -123.23 137.72 54.81 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.486 -2.008 . . . . 2.78 110.143 163.496 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.2 mt -112.25 140.0 47.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.882 -1.896 . . . . 1.17 105.882 179.742 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.7 mm -120.92 127.58 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 130.108 3.363 . . . . 1.38 108.668 177.985 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -139.27 126.02 20.77 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 104.721 -2.325 . . . . 1.5 104.721 172.16 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.97 41.27 10.65 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 121.037 3.717 . . . . 1.21 121.037 173.921 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.1 -17.59 58.43 Favored Glycine 0 N--CA 1.43 -1.71 0 O-C-N 117.659 -3.151 . . . . 1.3 113.267 -178.772 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -108.81 135.5 49.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.477 -2.778 . . . . 2.55 115.279 -178.866 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -87.6 127.06 35.27 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.114 0.959 . . . . 2.48 109.248 170.805 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.0 mt -89.41 144.99 25.63 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 126.576 3.084 . . . . 0.9 112.325 -163.638 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -95.09 125.16 39.56 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.428 -3.295 . . . . 1.94 114.806 -179.781 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.5 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 5.9 m-20 -48.05 -49.86 29.96 Favored 'General case' 0 N--CA 1.429 -1.491 1 C-N-CA 132.406 4.282 . . . . 1.56 119.766 -169.006 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.42 46.2 3.18 Favored Glycine 0 N--CA 1.431 -1.673 0 CA-C-O 114.538 -3.368 . . . . 0.97 119.174 168.354 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -125.32 152.72 44.33 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 103.593 -2.743 . . . . 2.49 103.593 165.659 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 55.8 p -94.84 159.75 14.9 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.547 3.654 . . . . 0.76 116.039 176.857 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.6 mt -55.21 -40.49 70.84 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 115.682 1.734 . . . . 1.05 115.682 175.483 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 p -73.43 -9.28 58.53 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.181 -3.449 . . . . 1.19 118.41 179.506 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -93.21 -31.9 14.57 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 114.648 -2.596 . . . . 1.9 107.354 174.585 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -80.0 -5.51 55.87 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 125.892 1.995 . . . . 0.89 106.937 177.049 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 56.18 71.74 0.54 Allowed 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 115.053 -4.78 . . . . 1.84 111.813 -175.38 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.1 mt -115.87 111.9 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 105.001 -2.222 . . . . 0.82 105.001 178.619 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -95.34 -175.08 3.38 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.431 3.015 . . . . 2.16 109.621 -174.232 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -57.73 140.23 51.94 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 111.471 -2.604 . . . . 2.12 112.116 177.162 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.338 51.0 mt-10 69.38 20.85 7.17 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 125.214 1.406 . . . . 1.71 113.309 174.486 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.2 m -85.4 147.72 26.36 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 121.617 -0.677 . . . . 1.04 112.032 -172.459 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.2 m -104.5 111.07 23.6 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.052 -1.655 . . . . 0.79 112.921 -175.509 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -93.8 147.4 23.09 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.45 -1.406 . . . . 1.4 110.9 174.456 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -113.96 128.1 56.25 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.102 -2.874 . . . . 1.51 110.404 -177.367 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.0 tp -102.49 124.48 48.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 124.834 1.334 . . . . 1.14 112.995 -172.059 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.255 6.2 m -138.3 133.37 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.606 2.763 . . . . 1.23 107.662 -175.408 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.4 mt -98.03 159.07 15.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.144 2.402 . . . . 2.78 117.412 -175.995 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -67.76 122.37 17.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 111.962 -2.381 . . . . 3.75 114.976 -175.381 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 tp -141.95 -46.7 0.35 Allowed 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.615 -3.178 . . . . 3.14 113.299 -179.916 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.7 mtt85 -63.53 -69.34 0.28 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 116.172 -2.211 . . . . 6.8 115.503 173.711 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.66 -79.19 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 106.609 -2.596 . . . . 3.57 106.609 -164.906 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.728 0 N-CA-C 105.5 -3.04 . . . . 3.87 105.5 -172.059 . . . . . . . . 0 0 . 1 . 063 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ttp . . . . . 0 CA--C 1.49 -1.347 0 CA-C-O 116.447 -1.74 . . . . 1.1 107.145 . . . . . . . . . 0 0 . 1 . 063 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -116.55 128.91 55.85 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 124.665 1.228 . . . . 1.87 112.323 171.869 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.6 pt -121.06 173.55 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 119.116 -2.24 . . . . 0.72 107.648 169.521 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -128.3 150.93 49.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.98 -2.23 . . . . 1.4 104.98 -179.328 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.6 t -138.8 112.64 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 126.515 3.055 . . . . 0.58 112.627 174.469 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -89.51 153.25 20.95 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 111.072 -2.786 . . . . 2.09 115.509 -176.831 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 t -127.68 -160.55 1.02 Allowed 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 124.483 2.087 . . . . 0.99 107.853 170.864 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.8 mt -81.19 -85.53 0.1 Allowed 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 114.563 -5.086 . . . . 2.53 113.74 175.383 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.1 p -80.71 -41.34 23.8 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 128.764 2.826 . . . . 2.08 117.287 179.239 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.36 -168.31 11.16 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 118.696 -2.503 . . . . 1.31 118.622 176.181 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -60.34 151.31 28.1 Favored 'General case' 0 N--CA 1.43 -1.461 1 C-N-CA 131.735 4.014 . . . . 1.4 114.068 -172.808 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.8 m -98.18 117.23 32.09 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.453 -2.655 . . . . 0.78 104.216 163.659 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 pt -99.86 153.91 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 O-C-N 116.76 -3.713 . . . . 1.55 108.168 179.991 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.7 m -107.55 126.32 52.39 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 104.404 -2.443 . . . . 1.08 104.404 175.852 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.2 mt -117.38 129.04 55.61 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 123.388 1.566 . . . . 1.55 110.519 -179.263 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -96.73 125.99 41.57 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 116.641 -3.787 . . . . 1.95 104.343 174.305 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.25 27.4 m -136.8 170.42 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 129.264 3.025 . . . . 0.96 111.191 -170.871 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -109.7 156.0 40.47 Favored Pre-proline 0 N--CA 1.43 -1.442 0 CA-C-N 124.384 3.266 . . . . 2.35 107.324 166.728 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.86 -16.52 29.46 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 124.991 3.794 . . . . 0.95 114.787 -168.197 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.3 m -107.34 17.5 22.75 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 120.219 1.372 . . . . 1.45 110.21 177.574 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -73.75 151.09 40.74 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.306 -3.371 . . . . 1.69 113.164 171.053 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -91.53 160.07 15.6 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.913 1.816 . . . . 0.75 113.31 -178.525 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.315 26.0 mm -56.51 -37.9 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 116.381 1.993 . . . . 0.73 116.381 176.069 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -52.54 -43.39 65.13 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.844 2.165 . . . . 1.62 116.844 170.206 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -76.93 -42.4 39.51 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.229 -2.794 . . . . 2.13 108.346 -177.949 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.0 t -57.06 -45.62 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 118.177 2.658 . . . . 0.62 118.177 169.619 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -56.25 -40.71 74.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.021 1.328 . . . . 1.22 112.988 170.116 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.55 -33.55 75.27 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.779 2.432 . . . . 0.51 113.346 175.501 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -67.93 -40.19 83.37 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.474 2.709 . . . . 1.44 106.926 170.369 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.5 mt -62.31 -40.89 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 123.448 2.84 . . . . 1.32 113.117 173.092 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -55.64 -48.88 74.23 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.842 2.457 . . . . 1.7 114.503 170.503 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -58.03 -46.55 85.15 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.61 2.078 . . . . 1.55 116.61 170.853 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -76.71 -58.87 3.03 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 117.889 -3.007 . . . . 2.62 114.611 -177.353 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -88.51 -47.15 8.53 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.257 -1.527 . . . . 1.48 110.531 -170.294 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.85 34.84 1.95 Allowed Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 124.006 1.892 . . . . 1.12 113.72 177.367 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 mt -108.75 128.55 25.33 Favored Pre-proline 0 N--CA 1.431 -1.418 0 O-C-N 120.512 -1.581 . . . . 1.55 111.027 -176.935 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -63.36 141.13 80.2 Favored 'Trans proline' 0 N--CA 1.434 -1.98 0 CA-C-N 125.305 2.93 . . . . 1.02 114.111 173.694 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -75.07 -1.8 11.72 Favored 'Trans proline' 0 C--N 1.3 -1.994 1 C-N-CA 127.188 5.259 . . . . 1.25 113.904 -174.868 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -76.13 -34.2 59.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.905 2.482 . . . . 2.25 109.076 171.381 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -82.01 -25.97 34.25 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.056 2.36 . . . . 2.02 110.108 -175.591 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -82.22 125.02 30.44 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.766 2.698 . . . . 0.69 111.038 -171.746 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -114.99 98.07 6.6 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 109.335 -3.575 . . . . 2.78 109.694 167.837 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.3 mt -79.28 125.47 29.53 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 119.244 -2.16 . . . . 1.17 113.114 176.024 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.9 mm -112.92 123.33 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 O-C-N 119.469 -2.019 . . . . 1.38 106.04 176.18 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.439 ' HB2' HD23 ' A' ' 67' ' ' LEU . 10.9 t80 -91.03 -73.76 0.52 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 117.56 -1.656 . . . . 1.5 111.88 168.911 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.72 -69.32 0.65 Allowed 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 128.147 2.579 . . . . 1.21 114.035 179.895 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.47 17.48 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.72 1 O-C-N 112.9 -6.125 . . . . 1.3 115.914 -177.006 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -141.85 162.9 34.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 112.509 -1.845 . . . . 2.55 107.694 178.418 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -64.31 168.34 5.74 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 118.175 2.657 . . . . 2.48 118.175 168.146 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.458 HD22 ' CD2' ' A' ' 59' ' ' TYR . 91.4 mt -123.22 128.18 49.66 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.188 -2.195 . . . . 0.9 107.252 -172.622 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -90.06 152.86 20.96 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.796 1.776 . . . . 1.94 115.796 179.565 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.93 -37.82 79.13 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 129.731 3.212 . . . . 1.56 115.379 -165.375 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.88 43.84 1.8 Allowed Glycine 0 N--CA 1.43 -1.721 1 CA-C-O 113.096 -4.169 . . . . 0.97 109.616 169.913 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -122.12 162.0 22.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.524 3.162 . . . . 2.49 104.758 166.088 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.256 20.7 p -95.79 168.41 10.67 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 113.34 -1.755 . . . . 0.76 113.824 -177.551 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -56.96 -46.98 81.76 Favored 'General case' 0 N--CA 1.43 -1.468 1 C-N-CA 132.298 4.239 . . . . 1.05 115.768 168.666 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 t -60.94 -37.85 83.8 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 117.221 2.304 . . . . 1.19 117.221 173.73 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.276 11.7 t0 -46.19 -60.65 2.17 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 129.624 3.169 . . . . 1.9 111.869 178.171 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.458 ' CD2' HD22 ' A' ' 50' ' ' LEU . 60.6 m-85 -79.68 -1.66 39.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 112.57 -2.105 . . . . 0.89 116.397 -175.368 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.357 33.1 m120 73.89 52.22 0.11 Allowed 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 127.857 2.463 . . . . 1.84 114.176 -178.825 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.1 mt -96.31 117.44 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 103.901 -2.629 . . . . 0.82 103.901 -177.944 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -113.45 178.51 4.25 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 125.058 2.361 . . . . 2.16 111.578 -173.395 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -64.87 129.1 38.48 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 114.918 -4.864 . . . . 2.12 110.844 172.714 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.313 18.1 mt-10 80.03 36.18 0.13 Allowed 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 123.509 1.623 . . . . 1.71 114.558 178.108 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -107.18 125.18 50.78 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.203 2.201 . . . . 1.04 114.808 -176.205 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.9 m -97.32 117.69 32.11 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 121.323 -0.861 . . . . 0.79 111.029 -177.867 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.439 HD23 ' HB2' ' A' ' 45' ' ' PHE . 2.9 mp -101.88 164.7 11.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.479 1.133 . . . . 1.4 109.536 179.361 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -119.69 113.13 20.19 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 116.992 -1.48 . . . . 1.51 111.856 -176.496 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -80.55 131.97 35.6 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 124.654 1.221 . . . . 1.14 108.328 176.197 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.5 t -113.0 129.36 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 105.572 -2.01 . . . . 1.23 105.572 166.274 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.7 tp -97.68 107.19 19.64 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.555 -0.906 . . . . 2.78 108.555 179.644 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.53 -166.22 1.26 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.966 1.841 . . . . 3.75 108.953 179.104 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.9 mt -122.74 166.34 15.1 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 103.545 -2.761 . . . . 3.14 103.545 169.808 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -76.48 109.42 10.19 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.293 -1.504 . . . . 6.8 111.577 178.774 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.14 89.98 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.759 0 CA-C-O 125.031 2.462 . . . . 3.57 117.525 -170.496 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.717 0 CA-C-O 114.32 -3.489 . . . . 3.87 109.929 179.885 . . . . . . . . 0 0 . 1 . 064 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ptt? . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 115.963 1.838 . . . . 1.1 115.963 . . . . . . . . . 0 0 . 1 . 064 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -102.91 127.71 50.01 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 114.923 -2.465 . . . . 1.87 112.592 -175.968 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.4 pt -124.54 176.53 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 123.104 2.683 . . . . 0.72 109.303 176.246 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -120.51 152.72 37.66 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.496 -2.627 . . . . 1.4 111.078 172.992 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.9 t -135.67 124.39 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 105.627 -1.99 . . . . 0.58 105.627 173.72 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -106.69 133.4 51.41 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 114.203 1.186 . . . . 2.09 114.203 175.67 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -95.99 165.39 12.29 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.669 1.588 . . . . 0.99 111.559 -179.588 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.258 43.2 mt -72.28 -28.58 63.19 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 118.037 2.606 . . . . 2.53 118.037 175.939 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 p -76.71 -26.98 55.27 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 126.805 2.042 . . . . 2.08 109.095 -179.362 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.6 46.46 0.48 Allowed Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 129.61 3.481 . . . . 1.31 114.951 167.07 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -109.82 133.83 52.72 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.707 3.203 . . . . 1.4 106.448 177.091 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 m -117.02 106.97 13.97 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 124.192 0.933 . . . . 0.78 109.34 167.521 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mt -85.49 136.95 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.358 1.863 . . . . 1.55 113.919 179.042 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.9 m -95.72 117.37 30.38 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 114.921 -2.466 . . . . 1.08 105.56 176.581 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.3 mt -129.08 137.83 51.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 124.651 3.387 . . . . 1.55 111.175 178.512 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -99.48 128.8 45.62 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 126.739 3.161 . . . . 1.95 110.082 172.379 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.69 172.76 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 101.922 -3.362 . . . . 0.96 101.922 -174.426 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -117.9 155.92 50.53 Favored Pre-proline 0 N--CA 1.43 -1.451 0 N-CA-C 104.276 -2.49 . . . . 2.35 104.276 163.392 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -73.73 -7.22 19.84 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 N-CA-C 115.702 1.385 . . . . 0.95 115.702 -170.414 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 76.1 p -97.57 -0.75 45.27 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 126.199 1.799 . . . . 1.45 109.188 178.179 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -76.89 148.88 36.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.482 -2.636 . . . . 1.69 108.287 173.785 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 72.5 p -85.91 165.13 17.02 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.938 2.495 . . . . 0.75 116.722 176.092 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.9 mm -70.27 -28.74 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 117.435 -3.291 . . . . 0.73 114.776 -178.146 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.25 75.3 tt0 -56.7 -46.56 81.15 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.015 1.388 . . . . 1.62 114.622 167.925 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -67.27 -37.32 83.27 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.362 -2.711 . . . . 2.13 110.798 179.688 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -66.72 -46.66 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 119.77 -1.831 . . . . 0.62 109.109 178.161 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -60.52 -39.22 87.03 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.903 -1.044 . . . . 1.22 112.446 174.724 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.46 -15.16 62.36 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 116.972 2.212 . . . . 0.51 116.972 175.532 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 29' ' ' LYS . 20.2 ttmm -85.3 -33.75 22.04 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.152 1.781 . . . . 1.44 114.316 177.735 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.3 mt -66.99 -47.43 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 1 C-N-CA 131.702 4.001 . . . . 1.32 106.718 166.634 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -47.8 -55.58 9.36 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 121.266 3.802 . . . . 1.7 121.266 173.534 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -34.21 -59.85 0.42 Allowed 'General case' 0 N--CA 1.431 -1.41 1 C-N-CA 131.777 4.031 . . . . 1.55 112.928 164.605 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 mttm -66.39 -57.61 7.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 118.488 2.773 . . . . 2.62 118.488 179.817 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -82.81 -45.64 14.07 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 130.411 3.484 . . . . 1.48 110.874 -171.093 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.18 47.27 1.74 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 107.6 -2.2 . . . . 1.12 107.6 174.178 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.7 mt -120.33 129.15 25.47 Favored Pre-proline 0 N--CA 1.431 -1.413 0 C-N-CA 127.504 2.322 . . . . 1.55 107.825 -169.143 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -72.65 145.69 42.1 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 O-C-N 114.007 -3.733 . . . . 1.02 112.375 175.691 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -65.18 -13.88 42.17 Favored 'Trans proline' 0 N--CA 1.433 -2.062 0 CA-C-N 126.668 3.417 . . . . 1.25 118.463 -177.392 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -56.24 -44.39 79.59 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 124.818 2.246 . . . . 2.25 114.227 175.088 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -90.27 -6.36 55.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 110.535 -3.03 . . . . 2.02 114.09 -177.678 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.415 ' HA ' HD23 ' A' ' 71' ' ' LEU . 66.5 mt-30 -103.77 139.63 38.73 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.353 -2.462 . . . . 0.69 104.353 -177.501 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -130.88 145.48 52.02 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.141 1.924 . . . . 2.78 108.711 167.962 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 mt -107.47 130.34 54.85 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.727 -1.583 . . . . 1.17 106.727 178.931 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 7.1 mm -112.28 140.14 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 105.293 -2.114 . . . . 1.38 105.293 177.925 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -155.07 126.99 7.58 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 125.07 2.367 . . . . 1.5 108.512 175.275 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.358 . . 61.86 34.05 17.27 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 127.747 3.641 . . . . 1.21 118.722 -175.885 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.31 -18.1 11.48 Favored Glycine 0 N--CA 1.429 -1.804 0 O-C-N 118.442 -2.661 . . . . 1.3 114.375 -178.495 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.263 30.0 mtmt -95.77 148.7 22.31 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.607 -3.29 . . . . 2.55 110.278 -177.393 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -88.09 122.1 31.27 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.26 2.225 . . . . 2.48 107.791 172.67 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.2 mt -74.04 162.07 29.4 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 110.06 -3.245 . . . . 0.9 112.433 -176.803 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -109.12 159.18 17.09 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.511 -3.243 . . . . 1.94 106.386 172.869 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.56 -58.56 3.22 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.829 2.852 . . . . 1.56 116.246 -169.93 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.94 43.13 2.59 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 127.356 2.407 . . . . 0.97 113.74 172.999 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -120.87 148.3 44.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.535 -3.332 . . . . 2.49 103.991 164.135 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.9 p -76.69 163.44 26.83 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 118.204 2.668 . . . . 0.76 118.204 170.609 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mt -55.55 -44.53 76.87 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.983 2.913 . . . . 1.05 109.9 170.461 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 p -59.44 -32.11 69.91 Favored 'General case' 0 N--CA 1.431 -1.412 1 O-C-N 129.813 4.446 . . . . 1.19 116.563 174.675 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -69.08 -34.8 75.71 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.609 1.671 . . . . 1.9 112.63 172.62 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -82.97 0.1 46.18 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.898 -3.626 . . . . 0.89 117.684 177.709 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.4 t30 48.96 43.7 22.0 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 131.661 3.984 . . . . 1.84 115.104 -176.535 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.2 mt -82.33 130.46 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 112.845 -1.98 . . . . 0.82 111.959 179.91 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -127.14 178.47 6.0 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 120.089 -1.632 . . . . 2.16 109.798 -173.446 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -57.56 154.72 10.8 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 115.412 1.634 . . . . 2.12 115.412 -178.281 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 61.33 11.02 3.39 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 126.277 1.831 . . . . 1.71 112.461 171.456 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.0 t -89.51 131.07 35.72 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 104.962 -2.236 . . . . 1.04 104.962 -174.069 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.0 m -96.32 114.14 25.79 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 102.761 -3.051 . . . . 0.79 102.761 -174.413 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mt -90.96 161.93 14.95 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.21 -2.806 . . . . 1.4 111.673 167.648 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.419 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 80.6 m80 -112.58 127.03 55.97 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 117.564 -1.208 . . . . 1.51 113.3 -177.54 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.4 tp -93.79 134.63 35.93 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 124.639 1.175 . . . . 1.14 110.635 176.805 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.0 m -129.92 156.47 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 103.823 -2.658 . . . . 1.23 103.823 174.503 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 41' ' ' GLN . 86.1 mt -125.56 125.97 44.06 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 125.059 2.361 . . . . 2.78 113.108 -179.755 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -80.09 -176.73 5.69 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.742 -4.349 . . . . 3.75 112.954 -175.578 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.1 mt -103.26 169.56 8.47 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.116 -3.49 . . . . 3.14 111.942 162.49 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.2 mtt180 -70.3 107.0 3.55 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 124.481 1.113 . . . . 6.8 113.065 168.167 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.91 6.4 54.21 Favored Glycine 0 N--CA 1.43 -1.71 0 CA-C-O 122.58 1.1 . . . . 3.57 112.564 -168.473 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.791 0 CA-C-O 117.267 -1.852 . . . . 3.87 113.171 177.243 . . . . . . . . 0 0 . 1 . 065 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ptt? . . . . . 0 CA--C 1.49 -1.347 0 CA-C-O 123.032 1.396 . . . . 1.1 114.107 . . . . . . . . . 0 0 . 1 . 065 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -94.27 133.52 37.72 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 115.876 1.806 . . . . 1.87 115.876 -174.303 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.9 pt -127.44 153.78 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 120.727 -1.233 . . . . 0.72 109.627 173.993 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.304 58.2 m-85 -112.74 119.1 36.91 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 125.237 1.586 . . . . 1.4 113.099 -179.858 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.442 HG21 HD11 ' A' ' 30' ' ' ILE . 15.5 t -105.53 120.03 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 116.043 -2.263 . . . . 0.58 113.536 177.094 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -88.36 116.99 26.97 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.872 -2.392 . . . . 2.09 114.477 178.318 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.295 19.9 p -72.84 168.2 19.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.001 1.72 . . . . 0.99 112.988 178.774 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.417 HD21 HG12 ' A' ' 70' ' ' VAL 0.291 19.0 mt -66.15 -45.64 80.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.416 1.462 . . . . 2.53 113.862 173.981 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -65.14 -67.24 0.45 Allowed 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 117.379 2.362 . . . . 2.08 117.379 176.555 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.75 22.57 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 117.967 -2.063 . . . . 1.31 115.502 177.893 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -106.37 130.48 54.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.44 -1.319 . . . . 1.4 107.44 -176.831 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.9 m -99.34 107.69 20.02 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 105.722 -1.955 . . . . 0.78 105.722 172.165 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.1 mt -78.57 119.27 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 118.948 -2.345 . . . . 1.55 110.661 -179.967 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.6 m -83.1 117.98 23.24 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.394 -1.442 . . . . 1.08 108.736 174.163 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.2 mt -111.79 164.15 13.38 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 118.841 0.746 . . . . 1.55 111.58 179.136 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -112.75 129.54 56.38 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.351 1.06 . . . . 1.95 109.05 167.539 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.09 161.53 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 104.307 -2.479 . . . . 0.96 104.307 178.046 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -106.71 137.43 19.47 Favored Pre-proline 0 N--CA 1.43 -1.437 0 C-N-CA 128.172 2.589 . . . . 2.35 108.647 163.162 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -68.0 -8.42 22.6 Favored 'Trans proline' 0 N--CA 1.433 -2.04 0 C-N-CA 122.672 2.248 . . . . 0.95 114.586 -174.023 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.6 p -101.35 10.59 40.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.458 2.39 . . . . 1.45 111.697 175.676 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -91.35 165.06 13.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.503 1.62 . . . . 1.69 108.692 -176.7 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -90.4 161.2 15.68 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.777 -4.327 . . . . 0.75 110.093 -178.56 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.3 mt -72.22 -34.29 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.438 -2.663 . . . . 0.73 115.703 -177.156 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -52.47 -45.14 65.97 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.418 2.377 . . . . 1.62 117.418 157.14 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -58.29 -38.73 77.62 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 116.364 -3.96 . . . . 2.13 110.919 175.093 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.74 -49.2 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 122.828 1.299 . . . . 0.62 112.217 170.75 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -55.81 -39.58 71.53 Favored 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 115.786 -4.321 . . . . 1.22 114.658 175.945 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.258 . . -55.86 -31.23 62.59 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.334 2.654 . . . . 0.51 113.2 168.562 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 30.1 mmmt -65.69 -36.25 83.08 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 116.51 -3.868 . . . . 1.44 114.797 173.839 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.442 HD11 HG21 ' A' ' 5' ' ' VAL . 19.0 mt -66.47 -34.41 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 114.932 1.456 . . . . 1.32 114.932 170.266 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -59.86 -38.94 83.58 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 130.106 3.362 . . . . 1.7 109.255 178.148 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -50.42 -46.64 56.56 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 119.452 3.13 . . . . 1.55 119.452 163.837 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -80.54 -45.65 17.08 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 124.884 1.274 . . . . 2.62 111.747 -177.728 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -100.89 -44.29 5.81 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.738 -1.208 . . . . 1.48 107.738 -166.923 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.37 16.99 47.91 Favored Glycine 0 N--CA 1.43 -1.707 0 O-C-N 118.296 -2.752 . . . . 1.12 114.725 177.742 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.1 mt -98.26 127.46 36.4 Favored Pre-proline 0 N--CA 1.43 -1.461 1 C-N-CA 132.235 4.214 . . . . 1.55 104.114 174.583 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.91 151.57 81.97 Favored 'Trans proline' 0 N--CA 1.432 -2.093 1 O-C-N 112.363 -4.599 . . . . 1.02 114.289 -177.928 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.2 -19.29 20.11 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 CA-C-N 124.288 2.567 . . . . 1.25 112.28 -169.633 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -57.84 -30.27 65.63 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 120.615 1.552 . . . . 2.25 114.103 168.033 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.272 10.6 tt0 -77.17 -33.36 56.48 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 118.044 -2.91 . . . . 2.02 112.809 178.799 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -80.57 148.18 30.46 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 117.391 2.367 . . . . 0.69 117.391 -172.97 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -146.64 139.41 25.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.662 -1.607 . . . . 2.78 106.662 173.736 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.1 mt -105.06 145.15 30.89 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.067 -3.521 . . . . 1.17 109.694 -178.634 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.5 mm -119.76 140.67 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 105.456 -2.053 . . . . 1.38 105.456 -178.322 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -147.57 135.04 20.79 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.985 -1.697 . . . . 1.5 110.401 170.919 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.87 8.46 0.16 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 130.213 3.405 . . . . 1.21 116.532 -177.158 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.36 -25.79 9.01 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 129.684 3.516 . . . . 1.3 113.738 -174.498 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -79.61 146.52 32.5 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 121.202 2.501 . . . . 2.55 111.147 179.01 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -89.47 123.46 33.61 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 101.259 -3.608 . . . . 2.48 101.259 172.648 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.7 mt -85.42 145.41 27.46 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 105.709 -1.96 . . . . 0.9 105.709 -172.208 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -79.56 154.88 28.46 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 115.886 1.81 . . . . 1.94 115.886 173.8 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -82.74 -47.36 12.05 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.43 -3.294 . . . . 1.56 117.595 -171.359 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.21 57.34 1.73 Allowed Glycine 0 N--CA 1.43 -1.737 1 O-C-N 116.286 -4.009 . . . . 0.97 111.447 178.432 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.0 ttt85 -138.08 164.37 29.27 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.815 -1.92 . . . . 2.49 105.815 171.822 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.7 p -101.76 153.84 19.44 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 116.495 2.035 . . . . 0.76 116.495 175.366 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.8 mt -53.0 -47.34 68.35 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 126.293 2.949 . . . . 1.05 113.996 177.948 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.4 p -60.86 -24.65 66.07 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.061 -4.15 . . . . 1.19 120.384 174.38 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.28 -30.18 70.55 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 123.147 2.703 . . . . 1.9 114.798 172.946 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -86.87 -12.79 46.76 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.733 2.813 . . . . 0.89 114.646 177.611 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 66.47 45.03 2.21 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.472 -1.695 . . . . 1.84 114.582 -174.311 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.9 mt -98.32 106.71 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 128.327 3.917 . . . . 0.82 110.298 179.01 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -89.45 171.8 9.46 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 110.718 -2.947 . . . . 2.16 116.321 -170.933 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -52.53 137.7 29.55 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.536 1.935 . . . . 2.12 112.403 170.168 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.275 37.0 mt-10 56.4 41.56 28.76 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 119.926 3.306 . . . . 1.71 119.926 178.65 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.8 m -98.62 156.45 16.81 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 127.184 2.193 . . . . 1.04 110.166 -179.592 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.4 m -106.95 106.48 17.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.914 2.769 . . . . 0.79 111.746 -175.329 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -94.82 164.36 12.96 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.351 2.024 . . . . 1.4 109.298 176.343 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -137.5 122.08 18.5 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 126.235 2.921 . . . . 1.51 107.6 -179.386 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.5 tp -87.92 133.8 33.85 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 111.455 -2.611 . . . . 1.14 117.067 178.185 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.417 HG12 HD21 ' A' ' 8' ' ' LEU . 28.6 m -130.02 173.23 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.184 -2.822 . . . . 1.23 106.008 173.487 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.7 mt -134.05 153.79 51.57 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.422 -2.673 . . . . 2.78 108.846 -173.954 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -61.91 113.52 2.84 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 121.693 0.758 . . . . 3.75 112.611 179.027 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.7 mt -91.18 164.68 13.82 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 127.366 3.46 . . . . 3.14 107.688 167.314 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 52.3 mtt85 -91.44 167.5 12.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.91 -2.404 . . . . 6.8 108.881 172.803 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.35 28.63 7.95 Favored Glycine 0 N--CA 1.43 -1.723 0 O-C-N 118.193 -2.817 . . . . 3.57 114.606 -166.633 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.804 1 C-N-CA 133.546 5.355 . . . . 3.87 109.619 175.962 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 CA--C 1.49 -1.361 0 N-CA-C 120.207 3.41 . . . . 1.1 120.207 . . . . . . . . . 0 0 . 1 . 066 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -96.62 140.17 31.62 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 105.82 -1.919 . . . . 1.87 105.82 179.862 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.7 pt -136.43 165.16 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 129.928 3.291 . . . . 0.72 108.868 167.877 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -118.95 132.75 56.09 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.28 -2.138 . . . . 1.4 115.476 -175.812 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.7 t -118.29 121.64 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 1 O-C-N 116.056 -4.152 . . . . 0.58 112.825 176.634 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -91.15 128.11 36.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 118.456 2.762 . . . . 2.09 118.456 178.455 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.491 HG22 HD23 ' A' ' 69' ' ' LEU . 39.4 p -79.53 -177.83 6.01 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.069 2.366 . . . . 0.99 113.232 -177.293 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.3 mt -68.04 -43.6 78.34 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 113.939 -1.482 . . . . 2.53 113.203 166.506 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.6 p -73.89 -21.0 60.24 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 123.005 1.383 . . . . 2.08 108.919 -175.861 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.38 23.68 4.38 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 116.539 -3.851 . . . . 1.31 113.281 171.047 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -82.87 136.25 34.67 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 112.664 -3.541 . . . . 1.4 113.059 -176.932 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.4 m -95.69 118.86 33.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 123.916 3.053 . . . . 0.78 109.343 170.588 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.1 mt -90.74 123.58 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 130.509 3.524 . . . . 1.55 108.119 174.766 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 m -97.6 112.26 24.2 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 116.666 -3.771 . . . . 1.08 107.048 -179.67 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.4 mt -126.75 152.73 46.47 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.425 1.09 . . . . 1.55 113.469 -178.619 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -107.26 146.47 31.42 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.74 -1.207 . . . . 1.95 107.74 172.046 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 m -149.25 178.4 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 102.236 -3.246 . . . . 0.96 102.236 -177.479 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -138.55 157.57 71.95 Favored Pre-proline 0 N--CA 1.43 -1.47 0 CA-C-O 124.076 1.893 . . . . 2.35 106.196 158.996 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 47.6 Cg_exo -52.92 -23.7 22.03 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 124.943 3.762 . . . . 0.95 118.019 -175.221 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.1 m -79.26 -13.15 59.86 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 120.179 1.354 . . . . 1.45 114.107 178.775 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -72.57 153.87 41.07 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 112.73 0.641 . . . . 1.69 112.73 -179.943 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.2 p -87.41 167.42 14.03 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 126.403 3.001 . . . . 0.75 109.906 174.742 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 43' ' ' LEU . 26.7 mm -70.58 -34.19 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 1 O-C-N 116.236 -4.04 . . . . 0.73 109.107 174.202 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.313 29.1 tt0 -51.89 -44.32 63.71 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 116.872 2.175 . . . . 1.62 116.872 168.088 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -71.15 -9.28 57.81 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 119.549 3.166 . . . . 2.13 119.549 179.642 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -87.12 -38.98 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 C-N-CA 126.208 1.803 . . . . 0.62 108.205 167.384 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -75.53 -24.28 56.74 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 117.462 2.393 . . . . 1.22 117.462 177.853 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.07 -45.24 89.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.822 2.449 . . . . 0.51 108.259 165.335 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -57.74 -31.95 66.97 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 118.01 2.596 . . . . 1.44 118.01 164.3 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.447 HD13 HD22 ' A' ' 69' ' ' LEU . 46.8 mt -78.14 -20.79 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 118.816 -2.428 . . . . 1.32 115.859 177.742 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -59.99 -30.13 68.92 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.891 -1.755 . . . . 1.7 112.725 165.606 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -74.06 -51.18 16.57 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.435 -2.041 . . . . 1.55 114.844 168.634 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -56.48 -55.34 34.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.675 -1.148 . . . . 2.62 111.573 -172.474 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -107.65 -57.71 2.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 126.134 2.147 . . . . 1.48 113.468 -173.188 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 133.16 9.5 2.12 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 127.05 2.719 . . . . 1.12 116.135 173.849 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.8 mt -88.96 139.19 29.0 Favored Pre-proline 0 N--CA 1.43 -1.467 1 CA-C-O 111.678 -4.01 . . . . 1.55 111.379 -174.665 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -77.81 151.53 28.11 Favored 'Trans proline' 0 C--N 1.3 -2.0 1 CA-C-N 133.151 5.732 . . . . 1.02 110.936 -171.945 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.45 -17.04 43.9 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 O-C-N 125.453 2.291 . . . . 1.25 112.641 -176.011 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -54.41 -59.95 3.99 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 114.807 -2.52 . . . . 2.25 110.998 167.628 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -70.39 -17.33 63.03 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.394 3.878 . . . . 2.02 117.55 -176.525 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -95.8 147.18 23.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.431 -0.793 . . . . 0.69 111.912 -178.984 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -136.59 139.56 42.21 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.604 -3.185 . . . . 2.78 113.186 170.674 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.402 HD12 HG23 ' A' ' 23' ' ' ILE . 18.8 mt -96.49 143.44 27.5 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.065 -3.522 . . . . 1.17 118.901 174.371 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.8 mt -119.53 139.84 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 102.409 -3.182 . . . . 1.38 102.409 179.317 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -145.58 120.57 10.03 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 101.47 -3.53 . . . . 1.5 101.47 168.673 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.8 52.08 1.71 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 120.05 3.352 . . . . 1.21 120.05 173.874 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 63.75 2.59 6.38 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 129.094 3.235 . . . . 1.3 116.939 177.818 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -120.93 152.9 37.94 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.609 -2.701 . . . . 2.55 109.56 174.873 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -84.96 138.33 32.55 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.337 2.494 . . . . 2.48 109.119 174.629 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.3 mt -94.69 145.21 25.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.239 2.216 . . . . 0.9 109.153 -175.913 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -85.97 142.67 28.63 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.932 -2.355 . . . . 1.94 113.869 170.432 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -59.05 -58.62 7.84 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.821 3.649 . . . . 1.56 112.64 -175.227 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.23 39.39 3.05 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 127.826 2.632 . . . . 0.97 115.301 172.474 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.483 ' HD2' ' HA ' ' A' ' 54' ' ' ARG . 18.7 mmm-85 -110.35 150.62 28.52 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.811 2.719 . . . . 2.49 107.333 155.232 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.1 p -76.28 155.98 33.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.322 -3.361 . . . . 0.76 109.841 172.632 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.519 HD22 HD12 ' A' ' 61' ' ' ILE . 46.8 mt -60.36 -39.4 87.05 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 114.309 1.225 . . . . 1.05 114.309 172.093 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.288 82.7 p -50.62 -42.4 56.03 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.306 -3.371 . . . . 1.19 112.504 175.347 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -56.49 -42.17 77.86 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.537 -3.227 . . . . 1.9 111.804 176.175 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -87.12 -13.57 43.8 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 114.5 -2.667 . . . . 0.89 112.769 177.125 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 70.23 24.71 4.77 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.704 2.669 . . . . 1.84 117.05 -178.971 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.519 HD12 HD22 ' A' ' 56' ' ' LEU . 7.0 mt -70.37 112.54 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 113.064 -1.88 . . . . 0.82 111.531 179.061 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -87.95 179.52 6.42 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.123 -1.611 . . . . 2.16 108.658 178.209 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -55.7 142.25 34.93 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 130.911 3.684 . . . . 2.12 117.796 173.251 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.46 37.6 mt-10 77.21 10.84 2.4 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.499 -2.001 . . . . 1.71 113.769 170.029 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.1 m -75.08 146.13 41.72 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.648 3.179 . . . . 1.04 111.717 177.773 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.2 m -111.02 113.22 25.6 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 125.323 2.487 . . . . 0.79 105.241 -179.294 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.4 mt -96.73 127.19 42.48 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 125.968 1.707 . . . . 1.4 111.39 175.883 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -84.89 136.84 33.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.987 -1.695 . . . . 1.51 109.842 -177.4 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.491 HD23 HG22 ' A' ' 7' ' ' THR . 1.7 tp -104.75 121.01 42.72 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.457 2.348 . . . . 1.14 105.26 178.792 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 m -123.65 163.95 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 119.59 -1.944 . . . . 1.23 106.299 172.847 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.6 mt -85.67 165.88 16.62 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 119.389 -2.07 . . . . 2.78 112.019 176.281 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -76.58 83.81 3.25 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 124.952 1.301 . . . . 3.75 109.559 174.955 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.3 mt -101.6 158.1 16.34 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 111.727 -2.488 . . . . 3.14 107.835 167.333 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -103.22 162.49 12.94 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.111 1.764 . . . . 6.8 110.175 171.161 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.38 -93.57 1.9 Allowed Glycine 0 N--CA 1.43 -1.754 0 C-N-CA 128.549 2.976 . . . . 3.57 114.874 -166.66 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.762 0 O-C-N 118.624 -2.692 . . . . 3.87 115.967 174.791 . . . . . . . . 0 0 . 1 . 067 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 ptt? . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 114.284 1.216 . . . . 1.1 114.284 . . . . . . . . . 0 0 . 1 . 067 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -112.77 122.94 49.14 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 125.828 1.955 . . . . 1.87 112.229 -171.052 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.684 HG22 ' H ' ' A' ' 65' ' ' SER . 5.7 pt -113.07 157.61 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 126.324 2.265 . . . . 0.72 116.175 167.348 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -103.66 125.39 50.13 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.672 1.589 . . . . 1.4 110.165 -174.818 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 t -103.0 125.61 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.109 -2.245 . . . . 0.58 110.974 173.887 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -93.4 118.05 30.83 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.679 2.487 . . . . 2.09 113.009 176.097 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -94.84 171.53 8.72 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.566 -1.959 . . . . 0.99 109.749 -174.421 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.4 mt -83.19 -5.59 59.18 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 117.713 2.486 . . . . 2.53 117.713 171.613 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -88.64 -32.57 17.98 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 104.941 -2.244 . . . . 2.08 104.941 179.88 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.8 37.61 1.04 Allowed Glycine 0 N--CA 1.429 -1.777 0 C-N-CA 126.56 2.028 . . . . 1.31 110.853 -179.952 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -106.7 144.92 32.66 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.764 -1.433 . . . . 1.4 109.798 -179.94 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.5 m -104.84 114.41 28.61 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.564 2.746 . . . . 0.78 108.002 168.462 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.4 mt -109.96 116.66 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 118.55 -2.594 . . . . 1.55 105.062 -168.712 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 m -89.84 97.07 10.98 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.387 1.875 . . . . 1.08 109.944 179.005 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.2 mt -96.5 131.78 42.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 112.531 -2.122 . . . . 1.55 116.383 177.632 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -88.23 111.22 21.4 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.967 2.907 . . . . 1.95 109.787 172.461 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.54 158.26 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 116.565 -3.835 . . . . 0.96 104.447 -172.543 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -103.01 161.23 23.74 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 117.348 -1.311 . . . . 2.35 111.716 169.064 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -75.67 -11.95 20.27 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 CA-C-N 121.008 1.396 . . . . 0.95 113.731 -168.252 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.4 p -85.75 -6.3 59.13 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 125.611 1.819 . . . . 1.45 110.733 175.785 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -76.46 149.69 36.77 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 123.851 1.786 . . . . 1.69 109.138 172.574 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.299 63.3 p -90.17 166.54 13.32 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.881 2.277 . . . . 0.75 108.967 -179.578 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.461 HG23 HD12 ' A' ' 43' ' ' LEU . 19.8 mm -63.79 -36.69 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 111.933 -2.394 . . . . 0.73 110.1 179.956 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -53.14 -42.12 65.76 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 121.509 3.892 . . . . 1.62 121.509 163.142 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 -59.97 -27.51 66.89 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.406 2.373 . . . . 2.13 117.406 173.302 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.9 t -72.23 -47.14 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 C-N-CA 127.112 2.165 . . . . 0.62 114.331 169.302 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 79.5 mttt -60.37 -29.4 68.9 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 113.972 -1.467 . . . . 1.22 112.593 172.5 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.26 -25.58 65.25 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 116.002 -4.186 . . . . 0.51 117.295 -179.556 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -76.77 -35.1 57.93 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 127.156 2.182 . . . . 1.44 109.533 179.471 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.4 mt -71.64 -32.96 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 126.311 1.845 . . . . 1.32 108.88 174.344 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -62.84 -45.42 92.67 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.736 -4.353 . . . . 1.7 111.887 173.376 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -50.73 -60.91 2.56 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 116.206 1.928 . . . . 1.55 116.206 168.063 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -65.14 -62.28 1.64 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.067 2.547 . . . . 2.62 111.45 -174.472 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -105.41 -38.39 6.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.458 -1.401 . . . . 1.48 109.933 -160.596 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.7 -11.2 7.49 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 117.575 -3.203 . . . . 1.12 114.063 168.152 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.0 mt -67.1 124.18 88.21 Favored Pre-proline 0 N--CA 1.429 -1.497 0 O-C-N 119.814 -1.992 . . . . 1.55 108.549 -174.451 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.83 145.05 35.75 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 CA-C-N 120.847 1.338 . . . . 1.02 109.578 172.976 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.03 -0.39 3.99 Favored 'Trans proline' 0 C--N 1.3 -2.009 1 C-N-CA 127.634 5.556 . . . . 1.25 115.975 -169.732 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -91.36 -13.91 31.64 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.117 1.78 . . . . 2.25 113.028 169.99 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -87.94 -45.65 10.06 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 121.47 1.941 . . . . 2.02 111.793 178.815 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -79.33 126.69 31.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.375 2.512 . . . . 0.69 110.963 -176.384 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -113.35 151.15 31.61 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 117.538 -3.226 . . . . 2.78 107.683 171.537 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.461 HD12 HG23 ' A' ' 23' ' ' ILE . 85.1 mt -114.58 120.53 40.49 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 126.223 2.202 . . . . 1.17 111.676 176.817 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.269 82.7 mt -105.49 132.32 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 N-CA-C 115.195 1.554 . . . . 1.38 115.195 175.734 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -148.18 126.36 12.17 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 119.008 -2.308 . . . . 1.5 112.57 173.916 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.17 21.56 7.15 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.874 1.805 . . . . 1.21 115.874 -175.645 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.7 8.48 77.04 Favored Glycine 0 N--CA 1.429 -1.774 1 C-N-CA 131.967 4.603 . . . . 1.3 113.575 -173.451 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -101.38 128.99 47.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.858 -1.534 . . . . 2.55 106.858 179.14 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -74.21 112.03 9.95 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 127.893 2.477 . . . . 2.48 114.02 170.365 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 mt -83.11 124.27 30.32 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 117.741 -1.584 . . . . 0.9 114.725 -163.317 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -75.73 135.36 40.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.344 -3.347 . . . . 1.94 110.849 -178.976 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.413 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -63.05 -45.17 93.5 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 109.144 -3.662 . . . . 1.56 115.941 -168.317 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.18 29.82 1.63 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 118.246 2.058 . . . . 0.97 118.246 166.703 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.5 mtp180 -120.53 158.16 27.89 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 124.21 1.957 . . . . 2.49 111.72 163.452 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.3 p -89.16 168.58 12.18 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 124.216 1.96 . . . . 0.76 114.312 171.585 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.331 8.4 mt -66.7 -38.52 86.9 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 110.845 -2.888 . . . . 1.05 105.25 174.603 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -68.09 -32.53 72.91 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.896 -3.002 . . . . 1.19 111.919 -179.021 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.32 38.0 t0 -63.08 -47.73 81.63 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.484 2.031 . . . . 1.9 116.484 174.219 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -73.86 -9.47 58.68 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.444 -3.91 . . . . 0.89 114.97 168.777 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.4 t30 66.63 58.37 0.64 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.662 2.385 . . . . 1.84 113.804 -178.883 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mt -100.67 120.78 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 126.253 1.821 . . . . 0.82 110.087 -178.15 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.23 174.78 5.98 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.539 1.638 . . . . 2.16 111.792 -174.521 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -53.66 148.51 9.62 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.876 -3.64 . . . . 2.12 114.959 169.199 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.251 86.3 mt-10 67.79 25.18 8.03 Favored 'General case' 0 N--CA 1.431 -1.378 1 C-N-CA 132.699 4.4 . . . . 1.71 110.372 178.495 . . . . . . . . 3 2 . 1 . 067 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.684 ' H ' HG22 ' A' ' 3' ' ' ILE . 69.0 m -75.86 143.9 41.52 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.58 2.61 . . . . 1.04 110.481 -177.496 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.6 m -100.64 97.16 7.86 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.949 -3.594 . . . . 0.79 110.209 -179.519 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.408 HD11 HD12 ' A' ' 3' ' ' ILE . 16.4 mt -91.64 128.76 37.59 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 126.033 2.083 . . . . 1.4 111.54 -178.676 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -89.09 116.12 27.13 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.93 -3.606 . . . . 1.51 113.09 177.34 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 tt -97.54 123.05 41.28 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 104.935 -2.246 . . . . 1.14 104.935 -177.737 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.52 176.41 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 O-C-N 118.686 -2.508 . . . . 1.23 106.135 174.677 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.7 mt -118.08 162.57 17.98 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 125.121 2.391 . . . . 2.78 105.58 173.385 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 -57.13 159.04 4.63 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 115.971 -4.206 . . . . 3.75 114.7 173.598 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.7 mt -111.89 -146.64 0.41 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 103.091 -2.929 . . . . 3.14 103.091 169.862 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -98.38 157.95 15.88 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 129.986 3.314 . . . . 6.8 107.488 175.018 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.83 -123.04 6.01 Favored Glycine 0 N--CA 1.43 -1.738 0 CA-C-N 123.073 2.67 . . . . 3.57 117.726 -164.011 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.786 0 N-CA-C 106.98 -2.448 . . . . 3.87 106.98 -179.429 . . . . . . . . 0 0 . 1 . 068 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 CA--C 1.49 -1.338 0 CA-C-O 118.662 -0.685 . . . . 1.1 112.825 . . . . . . . . . 0 0 . 1 . 068 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -97.96 148.74 23.16 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 120.316 1.416 . . . . 1.87 112.784 -176.492 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.0 pt -130.51 169.05 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.896 -2.377 . . . . 0.72 106.647 171.85 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -112.82 125.93 54.88 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.862 1.43 . . . . 1.4 114.862 179.585 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 t -114.76 116.64 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 126.782 3.182 . . . . 0.58 110.26 173.922 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -92.1 119.03 31.4 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 111.202 -2.726 . . . . 2.09 112.057 179.093 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.1 p -75.1 179.41 5.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.885 2.074 . . . . 0.99 111.488 -178.815 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.4 mt -60.59 -41.15 94.12 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.991 -1.068 . . . . 2.53 113.321 177.384 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.5 p -84.85 -38.21 19.76 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 115.491 -2.195 . . . . 2.08 116.9 178.434 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.92 29.57 0.22 Allowed Glycine 0 N--CA 1.429 -1.826 0 O-C-N 126.991 2.682 . . . . 1.31 111.91 175.571 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -86.76 131.49 34.12 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 119.99 1.895 . . . . 1.4 110.03 175.466 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.5 m -90.93 112.15 23.9 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 117.694 -1.603 . . . . 0.78 109.312 177.188 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.3 mm -95.43 117.21 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 102.666 -3.087 . . . . 1.55 102.666 178.72 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.7 m -100.32 105.13 16.63 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.176 -1.787 . . . . 1.08 106.176 -178.049 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.4 mt -103.12 146.24 28.69 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 118.592 -0.718 . . . . 1.55 109.881 -177.835 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -92.4 139.15 30.89 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 106.407 -1.701 . . . . 1.95 106.407 170.232 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.6 m -142.98 -177.58 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 100.204 -3.999 . . . . 0.96 100.204 -176.831 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -125.94 161.04 53.77 Favored Pre-proline 0 N--CA 1.43 -1.456 0 C-N-CA 128.28 2.632 . . . . 2.35 105.486 169.196 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -62.74 -21.99 73.51 Favored 'Trans proline' 0 C--N 1.3 -2.009 1 C-N-CA 127.832 5.688 . . . . 0.95 111.115 174.792 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 p -83.56 -5.59 59.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 125.898 1.999 . . . . 1.45 113.13 179.936 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -81.29 142.41 33.14 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 120.906 1.685 . . . . 1.69 112.533 179.18 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 61.2 p -87.88 165.28 15.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 128.143 3.402 . . . . 0.75 113.925 175.376 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.2 mm -62.67 -37.19 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 124.697 1.199 . . . . 0.73 111.643 177.957 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -54.94 -42.39 72.22 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 118.656 2.836 . . . . 1.62 118.656 168.515 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -62.88 -36.46 83.37 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 116.873 -3.642 . . . . 2.13 111.774 -178.998 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.3 t -59.83 -48.29 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 C-N-CA 128.84 2.856 . . . . 0.62 114.112 171.229 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -55.85 -43.68 77.31 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 115.242 1.571 . . . . 1.22 115.242 169.689 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.62 -36.69 85.06 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.585 -3.197 . . . . 0.51 115.939 172.467 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.281 41.2 mttm -54.42 -53.87 48.3 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.425 1.89 . . . . 1.44 112.566 167.867 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.9 mt -59.14 -34.79 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 O-C-N 118.198 -2.814 . . . . 1.32 117.751 176.373 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -69.14 -37.25 78.2 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 113.008 -1.906 . . . . 1.7 110.576 178.05 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -65.52 -41.85 92.65 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.988 2.327 . . . . 1.55 115.861 167.661 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -58.97 -82.12 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 125.779 2.704 . . . . 2.62 115.704 -177.73 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -95.56 -23.25 17.16 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.633 2.773 . . . . 1.48 112.939 -171.596 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.14 46.25 3.9 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 117.577 -2.249 . . . . 1.12 113.549 176.165 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.4 mt -105.38 132.09 21.18 Favored Pre-proline 0 N--CA 1.429 -1.475 0 CA-C-O 114.337 -2.744 . . . . 1.55 104.448 178.911 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -67.75 140.55 51.53 Favored 'Trans proline' 0 N--CA 1.434 -1.999 0 CA-C-N 125.439 2.978 . . . . 1.02 117.773 -178.402 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -75.27 -10.59 20.83 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 N-CA-C 120.835 3.359 . . . . 1.25 120.835 -174.173 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -88.7 17.77 5.25 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.35 1.46 . . . . 2.25 108.587 168.507 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -115.24 -31.68 5.91 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.927 -2.983 . . . . 2.02 107.167 -177.686 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -84.09 121.89 28.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 131.457 3.903 . . . . 0.69 117.315 -165.751 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -116.72 122.15 43.66 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.862 1.665 . . . . 2.78 107.545 -179.19 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -95.45 117.7 30.85 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 116.099 -1.905 . . . . 1.17 108.575 -178.427 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.0 mm -101.62 125.11 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 129.308 3.043 . . . . 1.38 111.294 176.888 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -150.9 115.59 5.2 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 127.892 3.71 . . . . 1.5 106.886 174.694 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.35 46.34 0.77 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 109.098 -3.683 . . . . 1.21 113.939 178.872 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.02 -16.29 0.88 Allowed Glycine 0 N--CA 1.43 -1.712 0 CA-C-O 116.558 -2.246 . . . . 1.3 118.398 -171.189 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -101.5 157.13 17.04 Favored 'General case' 0 N--CA 1.43 -1.464 1 CA-C-N 125.797 4.799 . . . . 2.55 103.326 -175.047 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -95.44 141.86 28.49 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.517 2.103 . . . . 2.48 106.3 172.779 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.7 mt -89.84 136.58 32.96 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.65 -2.531 . . . . 0.9 116.658 -169.909 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -65.29 133.05 50.6 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 120.999 3.703 . . . . 1.94 120.999 175.501 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -60.07 -49.67 76.75 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.759 2.695 . . . . 1.56 114.436 -170.567 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.76 45.61 1.41 Allowed Glycine 0 N--CA 1.43 -1.733 0 CA-C-N 111.374 -2.648 . . . . 0.97 116.653 179.303 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.412 ' HD3' ' CE2' ' A' ' 59' ' ' TYR . 62.3 ttt180 -130.54 127.41 39.05 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 128.271 2.983 . . . . 2.49 112.769 169.576 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.375 2.6 p -63.04 167.04 5.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 121.038 3.718 . . . . 0.76 121.038 173.738 . . . . . . . . 3 3 . 1 . 068 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.4 mt -74.0 -43.28 58.59 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.662 -1.899 . . . . 1.05 110.935 176.464 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 t -60.59 -42.26 96.38 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 122.491 1.139 . . . . 1.19 114.035 176.053 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -56.03 -38.21 70.25 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 121.055 3.724 . . . . 1.9 121.055 173.575 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CE2' ' HD3' ' A' ' 54' ' ' ARG . 21.8 m-85 -80.99 -15.87 55.0 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.282 -2.137 . . . . 0.89 111.158 175.242 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.3 m120 77.94 34.63 0.31 Allowed 'General case' 0 N--CA 1.43 -1.462 1 C-N-CA 132.998 4.519 . . . . 1.84 114.067 -177.732 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 mt -89.69 117.48 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 130.295 3.438 . . . . 0.82 114.901 176.61 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -110.34 -178.23 3.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.031 1.872 . . . . 2.16 108.536 -174.869 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -59.11 153.5 17.88 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.4 -3.313 . . . . 2.12 116.251 179.128 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.3 32.2 mt-10 65.11 31.45 10.99 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 125.223 1.409 . . . . 1.71 110.817 175.115 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.2 t -96.67 152.06 19.02 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 104.06 -2.57 . . . . 1.04 104.06 -175.458 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.3 m -109.95 109.53 20.17 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.781 -1.824 . . . . 0.79 113.84 178.515 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.1 mt -106.39 145.33 31.86 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 128.943 2.897 . . . . 1.4 109.384 176.407 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -109.41 127.52 54.44 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 114.239 -2.791 . . . . 1.51 112.72 -175.207 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.3 tp -93.81 120.89 34.67 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 123.444 2.838 . . . . 1.14 113.0 -175.517 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.9 t -110.62 149.42 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 108.101 -1.074 . . . . 1.23 108.101 175.923 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.2 mt -123.95 131.58 53.59 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.161 1.458 . . . . 2.78 114.531 -179.624 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.317 50.5 ptt85 -72.84 161.95 30.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.937 -3.602 . . . . 3.75 113.098 -178.344 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.16 112.73 3.15 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 117.864 2.542 . . . . 3.14 117.864 170.383 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.256 31.2 ptt180 -75.24 144.82 42.39 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 125.773 1.921 . . . . 6.8 114.968 -178.479 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.55 90.17 2.09 Favored Glycine 0 N--CA 1.429 -1.793 0 O-C-N 126.579 2.425 . . . . 3.57 115.604 -161.401 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.731 0 C-N-CA 126.777 2.132 . . . . 3.87 113.419 -174.613 . . . . . . . . 0 0 . 1 . 069 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 CA--C 1.49 -1.331 0 CA-C-O 123.532 1.634 . . . . 1.1 113.204 . . . . . . . . . 0 0 . 1 . 069 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -106.29 125.48 51.05 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.886 -2.384 . . . . 1.87 111.088 -173.702 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.1 pt -120.82 165.58 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 106.266 -1.753 . . . . 0.72 106.266 169.584 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -120.11 139.54 52.43 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.27 -2.769 . . . . 1.4 114.814 -177.02 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.1 t -124.22 125.85 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 118.456 -2.652 . . . . 0.58 108.58 174.029 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -90.6 122.92 33.82 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.798 -4.314 . . . . 2.09 109.695 176.567 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.0 p -91.0 167.32 12.48 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 126.905 2.082 . . . . 0.99 114.828 -179.758 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.521 HD12 HD12 ' A' ' 71' ' ' LEU . 90.3 mt -69.64 -36.8 76.41 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 113.961 1.097 . . . . 2.53 113.961 179.607 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.2 p -74.39 -67.63 0.6 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 130.637 3.575 . . . . 2.08 111.808 -176.881 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.95 62.78 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.638 0 CA-C-O 115.37 -2.906 . . . . 1.31 117.596 171.644 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -150.71 139.16 20.47 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 125.725 2.679 . . . . 1.4 113.818 179.91 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.7 m -102.6 97.42 7.62 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 103.861 -2.644 . . . . 0.78 103.861 174.994 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 13' ' ' ILE . 2.6 mt -65.21 121.57 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 116.763 2.135 . . . . 1.55 116.763 176.184 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.4 m -84.94 105.94 16.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 122.572 2.442 . . . . 1.08 110.119 177.235 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.48 HD23 ' HE3' ' A' ' 33' ' ' LYS . 25.4 mt -101.11 133.77 45.13 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 123.44 1.591 . . . . 1.55 110.193 178.875 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -98.12 110.85 23.36 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 114.652 1.353 . . . . 1.95 114.652 166.909 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.9 m -127.08 176.36 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 128.169 2.588 . . . . 0.96 108.896 -174.8 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.417 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 79.1 mm-40 -116.18 163.76 20.42 Favored Pre-proline 0 N--CA 1.43 -1.455 0 C-N-CA 127.861 2.465 . . . . 2.35 106.56 161.777 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 17.7 Cg_endo -84.58 -6.91 9.82 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 O-C-N 116.569 -2.385 . . . . 0.95 109.751 -166.474 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.4 m -93.23 -6.28 48.0 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.501 2.037 . . . . 1.45 116.501 174.626 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -69.18 147.17 51.71 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 118.801 -1.16 . . . . 1.69 109.639 174.523 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 75.7 p -82.88 175.51 10.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.432 -2.043 . . . . 0.75 112.128 -178.72 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.8 mm -70.24 -42.89 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-O 123.918 1.818 . . . . 0.73 109.316 173.646 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -47.03 -47.77 22.29 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 119.022 2.971 . . . . 1.62 119.022 162.706 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -65.75 -38.18 88.38 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 116.174 -4.079 . . . . 2.13 114.132 174.958 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 56' ' ' LEU . 53.5 t -62.52 -39.31 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 126.758 3.171 . . . . 0.62 111.103 176.012 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -65.99 -33.43 75.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.586 -2.571 . . . . 1.22 114.094 174.131 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.59 -34.1 77.13 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.308 2.255 . . . . 0.51 115.004 173.739 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -74.67 -16.28 60.77 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.309 -2.744 . . . . 1.44 114.811 174.995 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.3 mt -87.0 -36.17 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 127.102 3.334 . . . . 1.32 107.487 171.657 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.97 -38.52 88.77 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.203 -2.811 . . . . 1.7 109.099 -178.274 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -55.93 -48.08 76.36 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.913 -2.992 . . . . 1.55 115.647 170.469 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HE3' HD23 ' A' ' 15' ' ' LEU . 61.9 mttm -79.37 -52.16 8.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.141 -1.6 . . . . 2.62 113.446 -176.243 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -112.44 -8.84 13.87 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.83 1.3 . . . . 1.48 110.386 -161.67 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.98 21.72 60.68 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 118.223 -2.798 . . . . 1.12 113.995 173.601 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mt -83.7 123.38 76.31 Favored Pre-proline 0 N--CA 1.431 -1.386 0 CA-C-O 112.655 -3.545 . . . . 1.55 115.342 -174.555 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -65.81 136.45 45.5 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 CA-C-N 127.199 3.607 . . . . 1.02 116.269 -179.69 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -60.71 -23.0 75.09 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 N-CA-C 117.383 2.032 . . . . 1.25 117.383 -177.286 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.17 -19.5 61.1 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.233 2.213 . . . . 2.25 109.9 177.716 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.418 ' HG2' HD22 ' A' ' 71' ' ' LEU . 17.4 tt0 -92.22 -39.84 11.32 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 130.271 3.428 . . . . 2.02 109.963 -170.654 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -74.45 123.77 25.32 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 113.458 -1.701 . . . . 0.69 113.863 -171.216 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.5 HH12 ' C ' ' A' ' 76' ' ' GLY . 81.4 mtt180 -117.61 123.48 46.28 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 124.379 1.049 . . . . 2.78 109.216 167.792 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.5 mt -105.49 131.34 53.02 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.117 2.389 . . . . 1.17 106.264 -175.965 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.2 mm -116.9 145.57 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 120.349 -1.469 . . . . 1.38 113.49 -178.888 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -161.06 105.07 1.32 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.686 1.736 . . . . 1.5 115.686 174.821 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.468 . . 61.68 32.37 18.41 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 118.003 2.594 . . . . 1.21 118.003 -179.87 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.48 -15.55 45.86 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 119.163 0.892 . . . . 1.3 112.173 -177.497 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -102.46 124.71 48.51 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.732 -2.628 . . . . 2.55 115.277 174.694 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -81.3 145.97 30.63 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 102.714 -3.069 . . . . 2.48 102.714 165.129 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.3 mt -101.75 123.33 45.54 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 114.809 1.411 . . . . 0.9 114.809 -172.954 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.56 157.49 18.59 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 116.489 -2.085 . . . . 1.94 115.174 175.289 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.26 -63.55 1.19 Allowed 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 118.509 2.781 . . . . 1.56 118.509 -165.106 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.68 30.83 4.07 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 116.943 1.537 . . . . 0.97 116.943 176.418 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.7 mmt-85 -99.21 159.0 15.3 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 119.052 -1.059 . . . . 2.49 110.046 162.384 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.8 p -97.19 162.87 13.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.692 -3.755 . . . . 0.76 114.163 178.949 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.483 HD11 HG21 ' A' ' 26' ' ' VAL . 62.5 mt -58.24 -14.82 8.0 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 126.367 2.984 . . . . 1.05 113.864 170.436 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 t -85.12 -42.34 14.87 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.388 -2.695 . . . . 1.19 116.089 172.543 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -63.82 -39.48 94.34 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 127.833 2.453 . . . . 1.9 110.929 175.426 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -80.0 -8.7 59.49 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.784 2.034 . . . . 0.89 110.925 174.923 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.337 57.1 m-80 54.44 45.43 27.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.196 3.406 . . . . 1.84 120.196 -175.979 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.4 mm -78.68 123.99 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 126.132 1.773 . . . . 0.82 113.159 174.65 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -101.89 175.88 5.4 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 114.58 1.326 . . . . 2.16 114.58 -172.333 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -70.45 129.85 40.34 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 126.691 3.139 . . . . 2.12 112.537 -179.603 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.477 7.0 mt-10 67.7 35.99 3.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 125.499 2.571 . . . . 1.71 112.551 -179.858 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.301 4.4 t -94.63 126.94 40.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 109.559 -3.473 . . . . 1.04 110.29 -176.537 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.7 m -96.14 119.55 34.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.948 -1.72 . . . . 0.79 111.061 -169.845 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.5 mt -97.75 148.02 23.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 129.01 2.924 . . . . 1.4 108.745 175.249 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -106.71 137.42 44.76 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.744 -4.348 . . . . 1.51 106.264 178.566 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 47.5 tp -108.73 121.03 44.19 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.754 -3.091 . . . . 1.14 110.526 -178.106 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.0 t -109.85 153.6 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 130.969 3.707 . . . . 1.23 107.707 178.991 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.521 HD12 HD12 ' A' ' 8' ' ' LEU . 96.3 mt -125.23 157.73 35.82 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 119.079 -2.263 . . . . 2.78 115.251 178.427 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -94.16 151.92 19.12 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 115.6 -2.143 . . . . 3.75 110.113 -174.455 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.3 mt -128.28 -87.76 0.55 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.741 1.386 . . . . 3.14 114.741 177.373 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -109.86 -111.41 0.32 Allowed 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.497 2.094 . . . . 6.8 106.487 165.965 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.72 53.76 0.59 Allowed Glycine 0 N--CA 1.432 -1.626 0 O-C-N 117.741 -3.099 . . . . 3.57 108.69 -158.605 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.5 ' C ' HH12 ' A' ' 42' ' ' ARG . . . . . . . . 0 C--O 1.26 1.773 0 C-N-CA 126.948 2.213 . . . . 3.87 114.935 172.441 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 ptt? . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 115.09 1.515 . . . . 1.1 115.09 . . . . . . . . . 0 0 . 1 . 070 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -101.86 133.87 45.93 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.056 -1.652 . . . . 1.87 113.973 -172.652 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -130.77 159.93 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 104.321 -2.474 . . . . 0.72 104.321 174.275 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -119.55 120.87 38.0 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.065 2.946 . . . . 1.4 110.053 -174.111 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.421 HG21 HD11 ' A' ' 30' ' ' ILE . 94.9 t -105.69 115.19 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 119.889 -1.757 . . . . 0.58 110.439 172.979 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -96.37 134.21 39.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 103.639 -2.726 . . . . 2.09 103.639 179.626 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.269 28.0 p -80.86 169.85 17.04 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 118.044 -2.91 . . . . 0.99 112.665 171.813 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.4 mt -54.81 -49.64 70.52 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.961 3.305 . . . . 2.53 116.951 167.916 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.49 -62.26 1.47 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.408 3.004 . . . . 2.08 107.993 -172.029 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.78 12.27 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 116.929 -2.558 . . . . 1.31 116.78 179.618 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -101.01 154.43 18.71 Favored 'General case' 0 N--CA 1.429 -1.504 1 CA-C-N 126.147 4.974 . . . . 1.4 106.895 -169.148 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -113.04 108.91 17.97 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.426 -1.421 . . . . 0.78 108.928 167.063 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.405 ' CD1' HG23 ' A' ' 30' ' ' ILE . 46.9 mt -88.36 124.5 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 105.823 -1.918 . . . . 1.55 105.823 177.999 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.0 m -91.44 130.52 37.27 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 104.721 -2.325 . . . . 1.08 104.721 179.298 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mt -118.56 155.4 30.97 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 112.969 0.729 . . . . 1.55 112.969 179.685 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -113.03 130.14 56.25 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 100.596 -3.853 . . . . 1.95 100.596 167.765 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.1 m -143.95 156.35 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 126.39 1.876 . . . . 0.96 107.506 -176.805 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 36.1 mm-40 -114.21 154.46 46.26 Favored Pre-proline 0 N--CA 1.431 -1.416 0 C-N-CA 126.141 1.776 . . . . 2.35 110.036 168.042 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 53.4 Cg_exo -73.72 -25.7 14.4 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 CA-C-N 125.672 3.062 . . . . 0.95 117.195 -165.355 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -91.24 4.58 51.95 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 122.575 1.179 . . . . 1.45 113.657 177.984 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -64.77 149.43 49.3 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 115.018 -2.673 . . . . 1.69 112.649 165.995 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.319 21.6 p -87.03 169.45 12.41 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 116.049 -2.26 . . . . 0.75 112.743 177.656 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.91 -37.06 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 113.16 0.8 . . . . 0.73 113.16 171.185 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -57.42 -37.57 72.97 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.656 -3.152 . . . . 1.62 110.663 172.059 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -75.42 -28.12 59.27 Favored 'General case' 0 N--CA 1.43 -1.473 1 O-C-N 115.174 -4.704 . . . . 2.13 111.448 -179.217 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.9 t -71.07 -39.51 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.122 1.369 . . . . 0.62 112.474 172.239 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -63.83 -39.91 95.34 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 118.958 0.799 . . . . 1.22 111.97 170.966 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.14 68.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 119.977 3.325 . . . . 0.51 119.977 172.068 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -63.35 -35.44 80.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 115.32 -2.276 . . . . 1.44 112.91 165.856 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.421 HD11 HG21 ' A' ' 5' ' ' VAL . 15.3 mt -73.8 -40.17 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 123.138 2.699 . . . . 1.32 110.608 171.112 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -51.47 -45.89 62.92 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.671 2.788 . . . . 1.7 117.28 176.425 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -60.57 -28.83 68.77 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.433 -2.667 . . . . 1.55 116.279 174.957 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -94.93 -61.83 1.42 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 104.893 -2.262 . . . . 2.62 104.893 -173.139 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -98.87 -8.43 25.71 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 118.894 -2.378 . . . . 1.48 113.486 -169.744 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.76 5.64 89.68 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 118.389 -2.694 . . . . 1.12 113.365 174.695 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.1 mt -88.02 131.75 41.99 Favored Pre-proline 0 N--CA 1.429 -1.505 0 CA-C-N 121.523 2.662 . . . . 1.55 111.742 -175.086 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 74.0 Cg_exo -64.58 146.57 89.29 Favored 'Trans proline' 0 C--N 1.3 -1.993 1 CA-C-N 129.058 4.271 . . . . 1.02 118.274 -177.359 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 34.5 Cg_exo -68.33 -11.86 33.23 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 C-N-CA 123.029 2.486 . . . . 1.25 113.696 -177.581 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -77.87 -24.98 48.32 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.787 -3.696 . . . . 2.25 110.757 170.787 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -83.16 -39.71 20.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 116.352 -2.139 . . . . 2.02 108.49 176.67 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -63.93 125.8 25.6 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 126.611 1.965 . . . . 0.69 113.604 -172.171 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -118.9 118.52 31.75 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.158 -2.839 . . . . 2.78 108.19 170.708 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' A' ' 43' ' ' LEU . 68.6 mt -98.4 128.81 44.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.139 -2.225 . . . . 1.17 112.243 -174.788 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mm -110.05 137.57 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 125.386 1.474 . . . . 1.38 107.543 -179.812 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -146.61 144.59 29.64 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 125.963 1.705 . . . . 1.5 108.392 165.806 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.24 -107.53 0.15 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 123.832 0.707 . . . . 1.21 112.014 172.496 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.2 18.11 4.75 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 108.134 -1.987 . . . . 1.3 108.134 177.333 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.8 mttt -133.45 149.28 51.78 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.606 1.669 . . . . 2.55 114.455 177.114 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -93.67 130.65 39.54 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.238 -4.039 . . . . 2.48 103.831 174.271 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.336 79.4 mt -87.24 138.06 31.81 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.589 -1.944 . . . . 0.9 113.743 -168.485 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -85.8 164.08 17.77 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 117.85 -3.031 . . . . 1.94 111.671 -179.4 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -67.44 -62.89 1.2 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.315 -3.99 . . . . 1.56 118.931 -170.45 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.93 40.17 0.82 Allowed Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 129.495 3.426 . . . . 0.97 114.03 172.04 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -119.51 158.9 25.34 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.484 3.142 . . . . 2.49 105.605 168.179 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 55.4 p -100.09 164.17 12.1 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 125.76 1.912 . . . . 0.76 115.356 176.714 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.18 -43.95 97.68 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 117.851 -3.031 . . . . 1.05 109.947 178.667 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.0 m -53.6 -49.51 67.65 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.424 -3.297 . . . . 1.19 116.405 170.759 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -51.82 -39.29 58.54 Favored 'General case' 0 N--CA 1.429 -1.475 1 O-C-N 116.225 -4.047 . . . . 1.9 114.764 172.317 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -85.87 -13.01 49.24 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.325 1.972 . . . . 0.89 116.325 177.006 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.416 27.9 m120 75.03 23.39 1.65 Allowed 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 124.163 1.935 . . . . 1.84 115.712 -177.772 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.9 mt -77.07 102.06 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 118.34 -2.725 . . . . 0.82 111.77 179.112 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -90.53 -178.99 5.46 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 125.814 2.721 . . . . 2.16 110.398 -176.389 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.4 pttp -66.46 151.69 46.68 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.163 -3.461 . . . . 2.12 113.007 174.396 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.522 90.5 mt-10 90.71 -15.55 0.22 Allowed 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.995 2.918 . . . . 1.71 115.356 -179.102 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.6 m -68.54 137.38 54.3 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.643 2.831 . . . . 1.04 118.643 -171.244 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.5 m -96.6 109.18 21.84 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 119.795 -1.816 . . . . 0.79 113.533 -179.468 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -92.79 163.66 13.64 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.74 3.15 . . . . 1.4 109.92 174.43 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.279 39.1 m80 -124.56 119.82 30.17 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 114.35 -1.295 . . . . 1.51 107.678 -173.347 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.492 HD21 HD21 ' A' ' 71' ' ' LEU 0.263 3.4 tt -91.71 104.67 17.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.496 -3.253 . . . . 1.14 115.567 -177.05 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.2 t -93.44 144.46 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 105.674 -1.973 . . . . 1.23 105.674 177.529 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.492 HD21 HD21 ' A' ' 69' ' ' LEU . 81.3 mt -117.24 145.55 43.85 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.601 2.62 . . . . 2.78 111.766 177.623 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -94.82 149.61 21.06 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 116.04 -4.163 . . . . 3.75 103.956 176.382 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.1 tp -76.56 127.65 33.22 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 130.581 3.553 . . . . 3.14 107.31 179.144 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -68.1 -84.52 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.049 -2.907 . . . . 6.8 116.324 174.466 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.82 -88.31 0.58 Allowed Glycine 0 N--CA 1.43 -1.735 1 N-CA-C 97.972 -6.051 . . . . 3.57 97.972 -173.244 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.748 0 CA-C-O 114.535 -3.369 . . . . 3.87 109.327 177.688 . . . . . . . . 0 0 . 1 . 071 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptt? . . . . . 0 CA--C 1.49 -1.354 0 N-CA-C 107.393 -1.336 . . . . 1.1 107.393 . . . . . . . . . 0 0 . 1 . 071 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -94.23 126.92 39.77 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 114.134 1.161 . . . . 1.87 114.134 178.649 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.5 pt -115.91 163.08 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 107.628 -1.249 . . . . 0.72 107.628 165.886 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -125.05 132.65 53.16 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.984 -1.073 . . . . 1.4 108.111 -178.196 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.5 t -109.45 130.47 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 105.246 -2.131 . . . . 0.58 105.246 174.736 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -118.31 136.1 53.91 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.826 -2.421 . . . . 2.09 108.258 173.581 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.6 p -87.75 174.02 8.64 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 116.393 -3.942 . . . . 0.99 109.554 177.021 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.448 HD11 ' HA ' ' A' ' 70' ' ' VAL . 5.2 mt -73.43 -23.85 60.17 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 127.677 3.608 . . . . 2.53 117.802 172.193 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 p -88.98 -12.91 40.16 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.517 -3.239 . . . . 2.08 107.786 -175.08 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.4 32.53 3.93 Favored Glycine 0 N--CA 1.428 -1.838 0 N-CA-C 115.519 0.968 . . . . 1.31 115.519 167.922 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -113.14 137.9 50.75 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 114.279 -2.968 . . . . 1.4 103.493 -178.228 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.271 32.9 m -109.01 125.2 51.82 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.484 2.088 . . . . 0.78 110.783 -179.129 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.7 mt -109.52 121.97 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.828 -3.045 . . . . 1.55 109.629 179.347 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.3 m -95.84 119.4 34.27 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 114.604 -5.06 . . . . 1.08 110.734 176.966 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.7 mt -126.99 138.97 53.35 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 116.953 -3.592 . . . . 1.55 117.49 -176.27 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -97.83 108.8 21.59 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.709 2.003 . . . . 1.95 109.683 178.781 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -120.11 157.23 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 128.283 2.633 . . . . 0.96 108.908 178.514 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -98.06 148.79 34.98 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-O 115.069 -2.396 . . . . 2.35 113.108 156.522 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.88 -13.77 34.83 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 125.29 3.993 . . . . 0.95 113.112 -172.459 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m -74.08 -25.76 60.0 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.705 1.878 . . . . 1.45 106.1 174.354 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -67.19 140.34 57.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.513 -2.617 . . . . 1.69 116.166 -179.828 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 50.7 p -83.28 161.16 21.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 111.397 -2.638 . . . . 0.75 113.094 -172.398 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.7 mm -59.09 -46.8 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 1 C-N-CA 134.742 5.217 . . . . 0.73 109.505 176.065 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -47.8 -40.08 19.99 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 127.084 2.154 . . . . 1.62 114.283 163.124 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -76.56 -24.64 53.57 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.765 -3.084 . . . . 2.13 116.71 176.304 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.3 t -74.63 -40.43 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 124.151 0.98 . . . . 0.62 111.733 173.996 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -61.38 -29.23 69.79 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.193 1.797 . . . . 1.22 113.249 173.357 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.22 -33.72 76.39 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.513 -1.992 . . . . 0.51 111.095 175.747 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.271 56.2 mttm -61.74 -43.05 99.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.475 -2.641 . . . . 1.44 114.985 176.287 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.0 mt -70.3 -33.87 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 C-N-CA 127.874 2.469 . . . . 1.32 109.364 175.402 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -64.14 -50.59 67.62 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 116.554 -3.841 . . . . 1.7 112.624 179.805 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -54.04 -49.7 68.38 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.293 2.637 . . . . 1.55 111.403 171.668 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -79.63 -61.23 2.06 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.55 2.426 . . . . 2.62 117.55 -178.478 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -87.3 -29.17 21.81 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.056 2.243 . . . . 1.48 117.056 -167.31 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.07 13.8 14.88 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 119.55 -1.309 . . . . 1.12 113.677 171.823 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.9 mt -96.14 119.67 64.08 Favored Pre-proline 0 N--CA 1.43 -1.434 1 CA-C-O 111.533 -4.079 . . . . 1.55 107.001 -171.053 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 67.8 Cg_endo -70.57 159.11 53.89 Favored 'Trans proline' 0 N--CA 1.433 -2.035 1 CA-C-N 129.31 4.361 . . . . 1.02 113.831 172.996 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 52.9 Cg_exo -68.37 -26.37 35.08 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 C-N-CA 122.784 2.323 . . . . 1.25 113.759 -173.131 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -56.47 -33.34 65.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.985 2.514 . . . . 2.25 110.151 174.108 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -98.65 19.79 14.07 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.248 1.944 . . . . 2.02 116.248 175.972 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -127.44 113.15 15.81 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.985 -1.117 . . . . 0.69 107.985 -175.501 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.416 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 14.0 tpp180 -110.28 127.74 55.16 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.797 -0.816 . . . . 2.78 108.797 173.857 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.5 mt -110.3 143.01 41.14 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 112.791 -3.48 . . . . 1.17 114.566 179.419 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.2 mt -128.65 143.24 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 129.031 3.957 . . . . 1.38 105.165 -174.28 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -155.1 136.3 13.95 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.162 -2.211 . . . . 1.5 105.779 168.912 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.251 . . 61.81 26.17 15.84 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 118.556 2.798 . . . . 1.21 118.556 175.837 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.2 -14.13 63.12 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-O 117.557 -1.691 . . . . 1.3 110.604 -173.867 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -97.66 126.95 43.26 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 125.602 1.413 . . . . 2.55 112.794 -171.599 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -80.67 112.31 17.92 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 124.811 2.243 . . . . 2.48 106.448 170.54 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.5 mt -74.67 124.85 27.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.92 2.888 . . . . 0.9 115.664 -176.222 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -87.68 142.11 28.08 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 118.733 2.864 . . . . 1.94 118.733 178.772 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -46.83 -66.77 0.36 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.948 2.499 . . . . 1.56 117.692 -173.072 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.56 35.87 0.84 Allowed Glycine 0 N--CA 1.43 -1.723 0 CA-C-O 125.033 2.463 . . . . 0.97 116.871 171.023 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -115.81 175.64 5.44 Favored 'General case' 0 N--CA 1.429 -1.507 1 O-C-N 113.785 -5.538 . . . . 2.49 107.956 166.299 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 60.0 p -106.95 -174.68 2.59 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.515 -1.99 . . . . 0.76 110.759 175.665 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mt -80.91 -37.01 30.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.877 2.071 . . . . 1.05 108.995 176.449 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.8 t -57.14 -48.4 78.78 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 128.235 3.459 . . . . 1.19 110.884 174.538 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -49.62 -29.7 7.62 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.203 3.038 . . . . 1.9 119.203 175.665 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -111.33 1.55 17.15 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.621 -1.299 . . . . 0.89 109.315 -179.577 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 61.77 40.05 13.36 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.954 2.902 . . . . 1.84 109.324 -178.176 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.9 mt -78.59 114.82 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 124.257 1.98 . . . . 0.82 107.489 172.852 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.473 ' HB3' ' H ' ' A' ' 63' ' ' LYS . 35.5 mt-30 -108.59 -158.58 0.65 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.049 -2.907 . . . . 2.16 115.608 -179.325 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.473 ' H ' ' HB3' ' A' ' 62' ' ' GLN 0.273 25.3 pttt -74.67 138.74 43.04 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.72 -2.487 . . . . 2.12 113.822 -179.235 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 71.87 31.2 2.13 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 124.723 2.201 . . . . 1.71 114.821 178.852 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.3 m -86.59 121.46 29.15 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 113.161 -1.836 . . . . 1.04 115.138 -178.786 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.1 m -92.88 120.48 33.27 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 118.0 -2.937 . . . . 0.79 107.382 176.028 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.1 mt -94.35 147.8 22.86 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.159 -1.837 . . . . 1.4 107.582 171.832 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -92.35 123.6 35.79 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.85 2.46 . . . . 1.51 108.34 176.941 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.47 117.54 31.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 122.257 2.299 . . . . 1.14 107.601 175.244 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.448 ' HA ' HD11 ' A' ' 8' ' ' LEU . 78.0 t -106.61 129.91 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 130.77 3.628 . . . . 1.23 102.672 -176.191 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -86.88 131.99 33.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.446 -2.659 . . . . 2.78 114.129 171.266 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -114.33 167.73 10.46 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.002 -2.311 . . . . 3.75 110.554 -175.949 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.4 mt -115.04 143.97 44.35 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 118.752 -2.467 . . . . 3.14 108.785 172.653 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -60.75 108.94 0.92 Allowed 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.662 -1.899 . . . . 6.8 115.838 173.183 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 131.53 -35.55 2.39 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.281 -1.512 . . . . 3.57 114.367 -166.225 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.796 1 O-C-N 116.348 -4.031 . . . . 3.87 111.807 -173.996 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ptt? . . . . . 0 CA--C 1.491 -1.323 0 N-CA-C 116.767 2.136 . . . . 1.1 116.767 . . . . . . . . . 0 0 . 1 . 072 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.293 19.6 mt-30 -107.47 129.52 54.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 103.941 -2.615 . . . . 1.87 103.941 -176.717 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.9 pt -113.79 153.89 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 117.524 -1.226 . . . . 0.72 110.795 165.623 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -107.02 147.64 29.68 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 122.389 1.09 . . . . 1.4 112.528 174.879 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.2 t -124.05 128.22 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.828 2.051 . . . . 0.58 108.105 176.488 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -107.31 144.93 33.45 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.319 -2.113 . . . . 2.09 106.432 178.822 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 p -89.19 -168.17 2.09 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.291 2.7 . . . . 0.99 118.291 179.796 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 mt -65.87 -52.89 46.35 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.956 1.703 . . . . 2.53 111.721 174.696 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.4 p -70.77 -52.59 19.69 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.081 -2.262 . . . . 2.08 115.428 -178.235 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.27 50.49 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 104.529 -3.428 . . . . 1.31 104.529 171.626 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -107.29 147.88 29.69 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.522 -2.752 . . . . 1.4 107.303 175.598 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.0 m -102.21 136.19 42.48 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 103.131 -2.915 . . . . 0.78 103.131 179.034 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.2 mt -122.75 120.75 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-O 125.371 2.51 . . . . 1.55 108.297 176.659 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.1 m -92.75 125.5 37.4 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.391 -2.693 . . . . 1.08 106.398 177.393 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 29' ' ' LYS . 68.5 mt -116.03 142.4 46.85 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 129.1 4.0 . . . . 1.55 112.657 170.452 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -98.73 123.73 43.13 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 120.656 1.571 . . . . 1.95 109.259 172.026 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.466 HG21 ' CD1' ' A' ' 56' ' ' LEU . 27.8 m -139.67 171.71 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 O-C-N 118.486 -2.634 . . . . 0.96 106.659 -177.788 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -121.47 162.15 37.66 Favored Pre-proline 0 N--CA 1.43 -1.468 0 N-CA-C 103.21 -2.885 . . . . 2.35 103.21 156.773 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -76.39 -3.4 13.77 Favored 'Trans proline' 0 N--CA 1.434 -1.971 0 C-N-CA 124.595 3.53 . . . . 0.95 111.192 -168.819 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.1 m -86.84 -5.25 59.16 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.614 3.102 . . . . 1.45 113.084 178.543 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -78.79 147.36 33.33 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.873 -3.642 . . . . 1.69 116.919 175.996 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 35.1 p -72.46 158.96 34.76 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 118.183 -0.913 . . . . 0.75 112.814 177.701 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.6 mm -67.87 -31.37 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 126.852 2.595 . . . . 0.73 112.813 173.713 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -60.47 -30.98 70.02 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.352 -2.718 . . . . 1.62 114.353 170.966 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -76.74 -35.82 57.52 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.846 -1.784 . . . . 2.13 109.41 176.037 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -69.82 -34.21 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 119.105 -2.247 . . . . 0.62 113.099 178.294 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -69.85 -18.18 63.42 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.114 -2.241 . . . . 1.22 115.869 170.783 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.07 -19.47 43.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.303 1.441 . . . . 0.51 112.474 -179.585 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.513 ' HB3' HD22 ' A' ' 15' ' ' LEU . 43.5 mttm -78.68 -33.4 47.02 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.171 1.788 . . . . 1.44 111.469 172.173 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.3 mt -76.53 -24.08 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 107.603 -1.258 . . . . 1.32 107.603 173.707 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -67.14 -32.08 72.95 Favored 'General case' 0 N--CA 1.429 -1.491 2 O-C-N 114.999 -4.813 . . . . 1.7 115.89 175.042 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -73.59 -31.12 63.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.836 -1.165 . . . . 1.55 112.09 166.795 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -83.66 -72.86 0.44 Allowed 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.45 -2.056 . . . . 2.62 105.45 -170.321 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -93.86 -7.62 42.7 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 115.574 1.694 . . . . 1.48 115.574 -167.309 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.76 16.22 77.98 Favored Glycine 0 N--CA 1.429 -1.782 0 O-C-N 117.679 -3.138 . . . . 1.12 115.74 176.729 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.1 mt -89.03 128.44 51.88 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 116.99 -3.653 . . . . 1.55 104.369 -178.977 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 17.0 Cg_exo -70.15 142.31 45.88 Favored 'Trans proline' 0 N--CA 1.433 -2.044 0 CA-C-N 126.671 3.418 . . . . 1.02 114.565 179.311 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 8.0 Cg_exo -58.1 -17.28 30.94 Favored 'Trans proline' 0 N--CA 1.434 -2.022 1 C-N-CA 126.345 4.696 . . . . 1.25 115.905 -176.942 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -75.82 -18.98 59.28 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.346 2.339 . . . . 2.25 116.33 170.337 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -97.37 2.37 50.44 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 121.272 1.851 . . . . 2.02 115.94 179.885 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -105.79 139.75 39.88 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 111.058 -2.792 . . . . 0.69 111.408 -172.225 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -132.73 122.5 24.67 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.174 2.19 . . . . 2.78 112.536 167.59 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.2 mt -88.11 138.86 31.07 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 106.459 -1.682 . . . . 1.17 106.459 174.082 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mt -119.96 132.68 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 127.424 2.29 . . . . 1.38 105.209 178.344 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -155.16 123.1 5.78 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.165 2.257 . . . . 1.5 110.39 170.54 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.284 . . 75.41 37.01 0.46 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.623 3.569 . . . . 1.21 114.152 176.449 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.05 -24.05 6.43 Favored Glycine 0 N--CA 1.43 -1.749 0 CA-C-O 115.777 -2.679 . . . . 1.3 112.412 -173.929 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -102.94 148.1 26.08 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 120.66 2.23 . . . . 2.55 112.102 -175.834 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -88.15 150.46 23.32 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 122.068 0.937 . . . . 2.48 109.542 171.926 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.1 mt -97.02 133.42 41.72 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.251 1.82 . . . . 0.9 108.715 -169.561 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -80.73 146.09 31.21 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.393 -1.276 . . . . 1.94 109.754 177.166 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -65.39 -59.21 4.26 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.211 -3.43 . . . . 1.56 120.092 -169.542 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.98 32.06 1.51 Allowed Glycine 0 N--CA 1.431 -1.692 0 CA-C-N 111.479 -2.601 . . . . 0.97 119.171 173.079 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -105.12 176.69 5.08 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 104.2 -2.518 . . . . 2.49 104.2 164.676 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 67.3 p -107.26 167.22 10.07 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 112.612 -2.085 . . . . 0.76 112.022 171.462 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.466 ' CD1' HG21 ' A' ' 17' ' ' VAL . 66.9 mt -67.07 -38.31 85.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.058 2.837 . . . . 1.05 113.637 175.678 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.9 t -69.01 -19.2 64.12 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 119.666 3.21 . . . . 1.19 119.666 173.842 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -58.7 -51.99 67.6 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 114.875 -2.488 . . . . 1.9 104.658 172.844 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -81.69 -8.57 59.72 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 129.404 3.081 . . . . 0.89 113.488 -176.053 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 m120 59.98 56.68 3.32 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 116.589 -3.819 . . . . 1.84 117.677 -173.461 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.418 HG21 HD11 ' A' ' 67' ' ' LEU . 62.2 mt -96.54 117.71 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 104.968 -2.234 . . . . 0.82 104.968 -178.284 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -97.71 -176.57 3.51 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.037 -2.289 . . . . 2.16 105.755 -171.85 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.5 pttt -65.85 151.69 46.11 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.644 2.64 . . . . 2.12 116.471 174.521 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 60.98 15.26 5.95 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 131.654 3.981 . . . . 1.71 114.213 176.02 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 t -76.16 150.22 37.19 Favored 'General case' 0 N--CA 1.429 -1.486 1 C-N-CA 132.318 4.247 . . . . 1.04 109.134 -177.541 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.6 m -103.49 105.47 15.74 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.587 -3.196 . . . . 0.79 113.19 -179.417 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.418 HD11 HG21 ' A' ' 61' ' ' ILE . 6.2 mp -82.77 168.38 17.24 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 106.126 -1.805 . . . . 1.4 106.126 170.902 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -121.56 135.57 55.0 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.31 -2.744 . . . . 1.51 108.867 -179.271 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.4 tp -109.16 117.37 33.95 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.08 2.848 . . . . 1.14 111.386 -177.594 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 t -105.96 146.28 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 1 O-C-N 115.932 -4.23 . . . . 1.23 112.22 174.474 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 51.9 mt -108.12 126.28 52.58 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 117.847 2.536 . . . . 2.78 117.847 178.512 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -88.03 156.41 19.31 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.341 -2.099 . . . . 3.75 107.334 176.494 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.9 tp -124.2 -84.09 0.65 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 118.33 -0.843 . . . . 3.14 111.905 178.37 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -95.84 -81.04 0.41 Allowed 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 131.59 3.956 . . . . 6.8 111.878 175.019 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.48 135.35 3.67 Favored Glycine 0 N--CA 1.431 -1.666 1 CA-C-O 111.563 -5.02 . . . . 3.57 108.525 -164.567 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.767 0 O-C-N 127.754 2.679 . . . . 3.87 111.034 179.711 . . . . . . . . 0 0 . 1 . 073 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.269 0.7 OUTLIER . . . . . 0 CA--C 1.491 -1.312 0 N-CA-C 104.38 -2.452 . . . . 1.1 104.38 . . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -89.86 127.73 36.05 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 117.263 -1.351 . . . . 1.87 107.557 -179.114 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.522 HD12 HD22 ' A' ' 67' ' ' LEU . 40.3 pt -115.11 138.83 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 CA-C-N 122.105 2.23 . . . . 0.72 106.658 165.764 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -97.88 118.23 33.98 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.13 0.972 . . . . 1.4 109.794 -178.008 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.5 t -99.56 124.38 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.613 1.965 . . . . 0.58 106.289 174.069 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -117.62 126.92 53.38 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 125.189 1.396 . . . . 2.09 110.155 -175.395 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.289 7.3 p -74.49 176.01 7.23 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 128.485 2.714 . . . . 0.99 117.344 -179.364 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.9 tp -67.99 -56.11 10.19 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.95 1.705 . . . . 2.53 113.219 166.224 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 p -62.52 -53.02 61.01 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 118.462 2.764 . . . . 2.08 118.462 -176.378 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.79 30.09 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 119.122 2.409 . . . . 1.31 119.122 176.87 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.1 tttt -103.58 138.48 40.2 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 119.061 1.43 . . . . 1.4 107.89 176.697 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.1 m -105.09 118.93 37.78 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.194 -2.15 . . . . 0.78 105.194 169.019 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.6 mt -101.49 115.22 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 106.741 -1.577 . . . . 1.55 106.741 176.592 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.9 m -96.52 124.35 40.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 120.804 1.638 . . . . 1.08 112.493 176.004 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.268 84.0 mt -116.03 127.71 55.12 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 127.959 3.743 . . . . 1.55 109.688 -173.217 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -80.02 108.21 13.43 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.1 -3.5 . . . . 1.95 114.68 168.723 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.87 160.87 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 125.373 1.469 . . . . 0.96 111.982 -179.082 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -97.46 161.44 25.96 Favored Pre-proline 0 N--CA 1.431 -1.388 0 C-N-CA 127.794 2.437 . . . . 2.35 107.065 159.852 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -71.14 -15.77 31.98 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 C-N-CA 124.164 3.243 . . . . 0.95 112.29 179.064 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 p -83.38 -2.6 56.16 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.347 1.459 . . . . 1.45 112.503 174.746 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -77.82 140.89 39.44 Favored 'General case' 0 N--CA 1.431 -1.4 1 O-C-N 116.216 -4.053 . . . . 1.69 110.579 169.805 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.361 22.9 p -81.05 176.23 9.99 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 110.759 -2.928 . . . . 0.75 114.892 179.717 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -85.76 -20.77 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 CA-C-N 121.252 1.842 . . . . 0.73 108.526 175.581 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -56.01 -38.27 70.28 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.103 2.561 . . . . 1.62 113.058 165.37 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -71.88 -33.23 68.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.05 2.14 . . . . 2.13 114.961 176.348 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.327 79.1 t -65.33 -48.23 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 C-N-CA 128.065 2.546 . . . . 0.62 110.067 173.841 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -69.96 -26.81 64.28 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.945 -2.347 . . . . 1.22 115.552 174.703 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.75 -37.07 83.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.282 -2.761 . . . . 0.51 113.37 171.445 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.1 mttm -65.37 -51.61 59.26 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.91 -1.744 . . . . 1.44 114.356 176.2 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.7 mt -51.81 -37.43 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 128.064 3.792 . . . . 1.32 113.549 170.723 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -63.24 -44.56 94.86 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 114.748 -4.97 . . . . 1.7 118.308 170.001 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -55.57 -49.55 72.41 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 114.736 1.384 . . . . 1.55 114.736 167.831 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -74.71 -65.58 0.85 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.763 -2.017 . . . . 2.62 107.572 -170.075 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.261 13.8 mm-40 -85.21 -51.75 6.39 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.87 1.804 . . . . 1.48 115.87 -171.119 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.91 9.51 5.2 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 117.628 1.811 . . . . 1.12 117.628 -178.706 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.0 mt -87.82 135.35 33.86 Favored Pre-proline 0 N--CA 1.429 -1.5 0 CA-C-O 113.967 -2.92 . . . . 1.55 112.018 -173.224 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 51.4 Cg_endo -78.32 157.71 29.51 Favored 'Trans proline' 0 N--CA 1.434 -1.991 0 CA-C-N 124.632 2.69 . . . . 1.02 108.71 -178.944 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 29.0 Cg_exo -64.02 -17.09 58.45 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 125.08 3.854 . . . . 1.25 114.257 -178.235 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -67.21 -49.17 65.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 129.879 3.272 . . . . 2.25 111.868 175.768 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -70.95 -31.67 68.32 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.647 -2.533 . . . . 2.02 110.495 -175.951 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -80.01 120.12 23.76 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 130.025 3.33 . . . . 0.69 113.902 -175.095 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -113.63 123.67 50.48 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.221 -2.14 . . . . 2.78 105.221 167.507 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -108.34 126.3 52.69 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 102.984 -2.969 . . . . 1.17 102.984 178.822 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 68' ' ' HIS 0.253 37.8 mm -112.71 154.21 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 131.549 3.94 . . . . 1.38 106.255 177.592 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -114.4 -94.01 0.48 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.535 -3.228 . . . . 1.5 102.744 175.307 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -90.38 -65.78 0.98 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 119.656 -0.818 . . . . 1.21 109.95 177.254 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.63 -13.43 0.73 Allowed Glycine 0 N--CA 1.429 -1.802 0 O-C-N 117.534 -3.229 . . . . 1.3 114.789 -173.705 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -105.95 150.44 25.67 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.828 2.051 . . . . 2.55 110.988 175.789 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -77.16 138.3 39.4 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 130.83 3.652 . . . . 2.48 110.033 178.774 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.4 mt -82.9 160.14 22.18 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.138 -1.601 . . . . 0.9 113.796 -176.478 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -102.99 151.51 22.39 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.981 1.712 . . . . 1.94 109.967 176.755 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.377 30.1 m-20 -75.02 -63.29 1.3 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 112.988 0.736 . . . . 1.56 112.988 -167.294 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.45 55.97 4.72 Favored Glycine 0 N--CA 1.431 -1.665 0 O-C-N 118.631 -2.543 . . . . 0.97 112.3 178.641 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -120.58 161.08 21.94 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 102.62 -3.104 . . . . 2.49 102.62 162.259 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 81.0 p -90.67 164.19 14.25 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.351 2.5 . . . . 0.76 109.23 168.251 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.9 mt -59.03 -34.43 71.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.658 2.783 . . . . 1.05 115.15 167.309 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.8 p -70.99 -21.51 62.3 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 114.606 1.335 . . . . 1.19 114.606 179.221 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -69.99 -34.54 73.47 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.8 2.84 . . . . 1.9 108.969 175.69 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -96.74 15.88 20.67 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.182 2.896 . . . . 0.89 112.964 176.458 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 m120 57.29 25.19 10.84 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 111.298 -2.683 . . . . 1.84 116.97 174.028 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.8 mt -81.63 98.97 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 106.043 -1.836 . . . . 0.82 106.043 178.629 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -112.92 -39.06 4.34 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.795 2.838 . . . . 2.16 104.569 -174.83 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -101.16 171.83 7.38 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.324 1.601 . . . . 2.12 115.324 167.294 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -45.11 103.05 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 129.953 3.301 . . . . 1.71 116.12 168.581 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.6 m -123.13 159.53 28.37 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.469 -4.519 . . . . 1.04 116.75 -175.952 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.2 m -101.88 126.79 48.85 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.843 -1.786 . . . . 0.79 111.822 -175.552 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.522 HD22 HD12 ' A' ' 3' ' ' ILE . 8.5 mp -107.56 142.6 37.22 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.847 3.659 . . . . 1.4 112.327 176.814 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.405 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 49.6 m80 -116.03 117.69 30.8 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.634 -1.917 . . . . 1.51 109.404 -175.469 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.1 tp -87.62 123.43 32.47 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.971 1.367 . . . . 1.14 111.057 -176.894 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.0 t -122.84 136.66 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.181 -2.2 . . . . 1.23 108.488 176.416 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.1 mt -112.31 126.85 55.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.37 -2.706 . . . . 2.78 113.007 -174.165 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.487 ' HE ' ' HA2' ' A' ' 76' ' ' GLY . 49.2 mmt-85 -112.67 -177.38 3.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 119.558 -0.857 . . . . 3.75 109.292 172.248 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.7 mt -85.06 -39.5 17.91 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 125.722 1.609 . . . . 3.14 108.514 172.024 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.9 ttt-85 -148.03 -68.31 0.24 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.685 1.365 . . . . 6.8 114.685 168.208 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.85 -3.86 3.53 Favored Glycine 0 N--CA 1.431 -1.697 0 O-C-N 119.411 -2.055 . . . . 3.57 113.339 -171.19 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.487 ' HA2' ' HE ' ' A' ' 72' ' ' ARG . . . . . . . . 0 C--O 1.26 1.74 0 O-C-N 117.881 -3.129 . . . . 3.87 107.025 174.927 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.351 0 CA-C-O 116.147 -1.882 . . . . 1.1 113.619 . . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -119.22 125.92 50.3 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 120.403 1.456 . . . . 1.87 112.87 -178.028 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.9 pt -121.95 162.75 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 125.89 2.757 . . . . 0.72 107.241 170.582 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -103.89 149.04 25.45 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.5 2.32 . . . . 1.4 110.737 178.064 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.283 49.4 t -119.0 121.97 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 126.792 2.558 . . . . 0.58 106.071 171.067 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.7 tttt -101.9 140.13 36.6 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 126.53 2.394 . . . . 2.09 112.88 177.708 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.9 p -96.97 173.67 7.16 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.327 -2.733 . . . . 0.99 108.092 174.328 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.8 mt -56.61 -57.62 11.6 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.692 -1.88 . . . . 2.53 112.649 167.279 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.1 p -61.46 -30.69 70.75 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 117.66 2.467 . . . . 2.08 117.66 -179.244 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.87 15.91 1.31 Allowed Glycine 0 N--CA 1.429 -1.817 0 CA-C-O 114.784 -3.231 . . . . 1.31 114.715 170.004 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.0 tttt -90.13 115.23 27.22 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 122.768 3.284 . . . . 1.4 106.874 -173.573 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 m -87.16 115.35 24.49 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 113.926 -1.488 . . . . 0.78 113.543 175.454 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mt -103.07 127.46 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 116.533 2.049 . . . . 1.55 116.533 176.302 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.4 m -89.09 105.58 17.88 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 116.687 -3.758 . . . . 1.08 111.456 -174.974 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.9 mt -112.38 127.6 56.06 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 125.186 2.422 . . . . 1.55 110.378 178.537 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -92.74 117.14 29.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.543 3.068 . . . . 1.95 108.422 170.47 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 m -127.1 178.32 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 111.962 -2.381 . . . . 0.96 112.5 -179.444 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -105.38 154.14 39.21 Favored Pre-proline 0 N--CA 1.43 -1.441 0 C-N-CA 126.963 2.105 . . . . 2.35 109.846 165.241 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.11 -14.2 23.45 Favored 'Trans proline' 0 C--N 1.299 -2.028 1 CA-C-N 128.307 4.003 . . . . 0.95 107.157 -177.462 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 m -86.69 -4.88 59.23 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 115.08 1.511 . . . . 1.45 115.08 177.728 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -64.09 146.8 53.56 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.15 -2.219 . . . . 1.69 112.451 174.259 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 15.8 p -89.77 161.86 15.82 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 119.731 -1.855 . . . . 0.75 112.793 172.963 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.7 mm -58.51 -22.64 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.287 -3.383 . . . . 0.73 117.772 174.679 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.09 -59.13 5.54 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 117.857 -3.027 . . . . 1.62 110.985 161.745 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -51.98 -50.24 61.66 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.077 2.151 . . . . 2.13 111.687 176.616 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -61.51 -49.4 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 119.816 -1.802 . . . . 0.62 111.88 -177.9 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -68.53 -19.7 64.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 124.064 3.12 . . . . 1.22 112.238 175.585 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.12 -27.3 63.48 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.394 -2.066 . . . . 0.51 109.293 173.923 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -68.12 -48.18 66.13 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.835 2.054 . . . . 1.44 110.628 171.823 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.4 mt -59.91 -36.06 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 113.794 1.035 . . . . 1.32 113.794 173.033 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -60.22 -43.65 95.84 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.633 -3.167 . . . . 1.7 114.496 175.121 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -47.06 -58.91 3.51 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.635 -3.791 . . . . 1.55 115.758 166.861 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -71.29 -53.56 13.84 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.707 -1.87 . . . . 2.62 113.257 -176.57 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -92.4 -58.89 2.23 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 125.002 1.439 . . . . 1.48 108.385 -167.091 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.53 -0.16 2.74 Favored Glycine 0 N--CA 1.429 -1.782 0 O-C-N 119.698 -1.877 . . . . 1.12 111.72 176.191 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.0 mt -74.46 128.78 85.24 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 114.094 -2.86 . . . . 1.55 113.29 -169.277 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -63.61 151.04 86.92 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 CA-C-N 122.618 1.971 . . . . 1.02 113.856 175.037 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.29 -4.46 15.1 Favored 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 124.188 3.259 . . . . 1.25 118.704 -178.883 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -80.55 -29.53 37.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 126.264 2.228 . . . . 2.25 114.799 170.751 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -79.37 -40.26 30.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.723 2.202 . . . . 2.02 111.784 177.593 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -70.04 95.94 1.01 Allowed 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 114.743 -4.973 . . . . 0.69 115.616 -171.186 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -90.66 132.22 35.9 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 118.526 -2.609 . . . . 2.78 107.589 172.219 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.5 mt -111.06 120.4 42.24 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.813 1.768 . . . . 1.17 110.589 178.449 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.9 mt -102.83 128.64 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 120.476 -1.39 . . . . 1.38 108.919 172.936 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -82.14 -76.85 0.24 Allowed 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.13 2.395 . . . . 1.5 108.673 174.245 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -96.04 -60.07 1.71 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.53 1.532 . . . . 1.21 110.565 -179.004 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.91 -48.01 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.806 0 CA-C-O 122.379 0.989 . . . . 1.3 112.377 -172.522 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -81.09 141.98 33.76 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.246 -1.149 . . . . 2.55 111.037 179.927 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 pm0 -77.38 152.19 34.51 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 117.285 -1.766 . . . . 2.48 111.915 176.761 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.0 mt -98.39 136.96 37.8 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 116.649 -2.02 . . . . 0.9 113.929 -167.047 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.03 144.71 48.71 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.538 2.335 . . . . 1.94 115.499 172.461 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -64.55 -56.19 15.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.805 3.642 . . . . 1.56 114.752 -175.578 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.47 64.37 3.99 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 121.072 3.189 . . . . 0.97 121.072 170.31 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -135.35 158.39 44.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.17 1.788 . . . . 2.49 106.651 161.651 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.259 17.0 p -80.72 164.94 22.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 117.659 2.466 . . . . 0.76 117.659 174.478 . . . . . . . . 3 3 . 1 . 074 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.2 mt -64.56 -33.8 76.76 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.388 -2.07 . . . . 1.05 113.118 175.791 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 t -68.79 -31.37 70.34 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.079 2.152 . . . . 1.19 116.337 177.096 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -57.24 -37.07 71.74 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 120.86 -1.15 . . . . 1.9 111.774 171.369 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -77.59 3.81 12.83 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 118.305 2.706 . . . . 0.89 118.305 174.63 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.66 17.3 m-80 81.76 12.01 0.69 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.034 2.605 . . . . 1.84 118.034 178.686 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.43 HG23 ' HB2' ' A' ' 65' ' ' SER . 9.2 mt -91.51 102.84 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 118.949 -2.344 . . . . 0.82 111.827 178.135 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -106.49 -26.21 11.52 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.739 1.615 . . . . 2.16 108.294 -171.555 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.5 tttp -137.66 -91.99 0.22 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 117.317 2.339 . . . . 2.12 117.317 175.918 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.14 126.09 49.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 121.284 -0.885 . . . . 1.71 111.518 -176.125 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.43 ' HB2' HG23 ' A' ' 61' ' ' ILE . 21.3 t -146.8 145.48 29.92 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.587 -1.188 . . . . 1.04 114.09 -173.714 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.9 m -118.43 109.09 15.83 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.714 -3.116 . . . . 0.79 103.673 179.752 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.6 mt -93.36 154.87 17.72 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.23 -2.137 . . . . 1.4 105.23 173.336 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -118.49 117.05 27.98 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.394 1.092 . . . . 1.51 113.472 -175.258 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.3 tp -79.59 94.62 5.69 Favored 'General case' 0 N--CA 1.43 -1.428 1 C-N-CA 132.904 4.481 . . . . 1.14 107.974 -171.728 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.27 121.44 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 C-N-CA 127.981 2.512 . . . . 1.23 108.613 175.716 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.1 mp -90.09 90.33 8.07 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 116.499 -1.715 . . . . 2.78 111.665 176.61 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -104.92 133.67 49.33 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 126.841 2.588 . . . . 3.75 106.101 177.718 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.3 mt -79.81 150.01 30.85 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 124.761 3.437 . . . . 3.14 112.954 174.685 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -59.45 168.31 1.6 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 130.188 3.395 . . . . 6.8 117.528 171.504 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 150.42 -77.22 0.23 Allowed Glycine 0 N--CA 1.43 -1.718 0 O-C-N 118.031 -2.918 . . . . 3.57 108.696 -170.704 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.774 0 N-CA-C 104.177 -3.569 . . . . 3.87 104.177 -177.214 . . . . . . . . 0 0 . 1 . 075 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.491 -1.311 0 CA-C-O 118.621 -0.704 . . . . 1.1 110.359 . . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -100.56 122.37 43.14 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 119.57 1.077 . . . . 1.87 112.678 177.176 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.258 21.6 pt -106.97 147.57 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 118.188 -2.82 . . . . 0.72 109.551 -179.341 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -105.17 117.94 35.28 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 117.746 -3.096 . . . . 1.4 107.412 -177.683 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.3 t -99.55 96.41 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 120.09 -1.631 . . . . 0.58 108.825 173.219 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -78.99 112.23 15.98 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.762 2.425 . . . . 2.09 107.051 176.409 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.479 HG22 HD23 ' A' ' 69' ' ' LEU . 80.8 p -75.99 166.45 23.48 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 116.315 1.969 . . . . 0.99 116.315 -179.382 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.8 tp -54.54 -39.86 68.1 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 127.393 2.277 . . . . 2.53 110.336 161.753 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.0 p -75.82 -30.17 58.92 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.114 -1.616 . . . . 2.08 111.64 -178.985 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.32 38.78 1.59 Allowed Glycine 0 N--CA 1.43 -1.721 0 CA-C-O 124.385 2.103 . . . . 1.31 113.657 177.571 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -120.53 121.26 38.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 104.671 -2.344 . . . . 1.4 104.671 178.132 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.284 85.6 m -73.0 101.95 3.36 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 112.849 -1.978 . . . . 0.78 112.909 171.16 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 mt -96.62 128.34 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 105.33 -2.1 . . . . 1.55 105.33 -179.08 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.8 m -99.73 119.47 38.19 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.133 -1.062 . . . . 1.08 108.133 175.185 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.8 mt -120.29 128.93 53.75 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 127.837 2.455 . . . . 1.55 109.586 176.207 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -74.48 131.69 41.24 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.713 3.227 . . . . 1.95 119.713 162.939 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.2 m -139.26 176.69 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 120.718 -1.239 . . . . 0.96 113.62 174.193 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -101.84 163.33 18.0 Favored Pre-proline 0 N--CA 1.429 -1.494 0 O-C-N 116.98 -3.575 . . . . 2.35 104.781 160.123 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -77.83 -10.36 16.89 Favored 'Trans proline' 0 N--CA 1.433 -2.043 0 O-C-N 116.802 -2.262 . . . . 0.95 109.325 -179.582 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -79.9 -12.26 59.75 Favored 'General case' 0 N--CA 1.428 -1.531 1 O-C-N 116.002 -4.187 . . . . 1.45 116.882 174.55 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -76.16 151.59 36.91 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.559 1.647 . . . . 1.69 114.3 176.516 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.2 p -80.77 161.25 24.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.908 -1.745 . . . . 0.75 114.13 -177.79 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.0 mt -70.99 -35.99 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 120.428 -1.42 . . . . 0.73 109.374 174.35 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -49.31 -38.81 29.0 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.463 2.705 . . . . 1.62 112.374 162.255 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -70.79 -52.14 22.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.905 -2.997 . . . . 2.13 105.41 179.142 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.284 42.2 t -47.68 -57.56 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-N 121.797 2.09 . . . . 0.62 115.446 166.945 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -60.28 -31.19 70.0 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.103 -3.498 . . . . 1.22 112.307 179.094 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.7 -27.76 58.36 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 124.482 3.31 . . . . 0.51 111.343 -179.404 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.268 35.1 mttm -74.97 -26.84 59.88 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.592 2.757 . . . . 1.44 111.169 173.394 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.2 mt -69.41 -45.53 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 C-N-CA 128.9 2.88 . . . . 1.32 104.911 171.862 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -58.05 -39.35 78.23 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.484 2.313 . . . . 1.7 113.265 176.595 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.53 -56.07 21.44 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 127.203 3.382 . . . . 1.55 111.676 173.265 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -80.81 -58.84 2.91 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.604 -3.81 . . . . 2.62 113.332 -174.038 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -83.62 -50.61 8.04 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.595 -3.191 . . . . 1.48 111.786 -172.535 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.64 73.04 1.27 Allowed Glycine 0 N--CA 1.43 -1.701 0 CA-C-O 125.649 2.805 . . . . 1.12 110.203 179.963 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.9 mt -132.72 128.77 21.0 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-O 113.435 -3.174 . . . . 1.55 103.347 178.341 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -64.54 160.55 39.24 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 125.742 3.087 . . . . 1.02 117.115 179.944 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.01 -26.65 12.82 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 123.058 2.128 . . . . 1.25 111.018 -174.552 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.18 -39.15 81.63 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 117.882 -1.056 . . . . 2.25 112.766 171.203 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -83.78 -1.89 55.2 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 123.011 2.641 . . . . 2.02 112.593 -179.849 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -93.06 122.75 35.74 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 120.938 1.699 . . . . 0.69 108.712 -176.032 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.495 HH22 ' C ' ' A' ' 76' ' ' GLY . 97.0 mtt180 -115.3 114.78 25.63 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 114.347 -1.297 . . . . 2.78 108.035 165.607 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.5 mt -98.63 122.59 42.03 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 123.774 1.749 . . . . 1.17 107.57 -179.264 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.3 mm -106.2 139.24 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 118.614 -2.554 . . . . 1.38 104.708 179.314 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -103.43 -92.67 0.34 Allowed 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 119.61 -1.931 . . . . 1.5 110.234 173.992 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.96 -84.29 0.51 Allowed 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.843 -1.91 . . . . 1.21 105.843 179.844 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.74 7.59 22.05 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 126.809 2.568 . . . . 1.3 112.361 -170.352 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -139.38 155.99 47.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.167 -1.784 . . . . 2.55 110.438 178.28 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -83.23 148.58 27.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.814 -1.178 . . . . 2.48 111.756 166.76 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.1 mt -86.75 131.14 34.21 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 119.26 -2.15 . . . . 0.9 110.806 -176.486 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -84.82 136.88 33.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.417 2.687 . . . . 1.94 110.405 175.016 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.39 -51.56 59.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.366 -3.334 . . . . 1.56 114.398 -167.088 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.61 26.38 2.71 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 123.293 2.769 . . . . 0.97 115.387 171.87 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -105.46 171.69 7.19 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.489 1.138 . . . . 2.49 110.813 165.539 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.6 p -98.82 172.43 7.45 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 127.852 3.691 . . . . 0.76 111.365 167.701 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.6 mt -64.0 -44.45 92.58 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 111.99 -2.368 . . . . 1.05 109.779 171.397 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 t -57.88 -37.45 73.98 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 116.851 2.167 . . . . 1.19 116.851 176.879 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -53.36 -21.66 6.14 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.741 -2.474 . . . . 1.9 113.497 175.687 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -112.27 22.14 15.04 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.5 -2.625 . . . . 0.89 113.206 177.334 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.504 1.0 OUTLIER 61.37 31.95 19.16 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 119.705 3.224 . . . . 1.84 119.705 177.968 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.317 57.4 mt -86.2 125.8 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 118.322 -2.736 . . . . 0.82 105.009 177.968 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -148.77 -51.06 0.16 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.792 -2.442 . . . . 2.16 110.08 -170.831 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.4 tptp -79.47 -173.17 3.6 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 113.633 0.975 . . . . 2.12 113.633 169.352 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -73.05 95.88 2.09 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.123 2.392 . . . . 1.71 116.304 175.84 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.5 m -94.27 160.12 14.82 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 120.922 3.675 . . . . 1.04 120.922 -169.991 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.9 m -106.92 119.19 38.68 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 117.185 -1.388 . . . . 0.79 110.104 177.91 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -105.32 160.95 14.72 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 125.651 1.844 . . . . 1.4 106.61 168.471 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -127.08 124.47 39.31 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.273 -2.142 . . . . 1.51 108.864 -177.946 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.479 HD23 HG22 ' A' ' 7' ' ' THR . 45.4 tp -99.55 112.17 24.42 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.059 1.344 . . . . 1.14 110.63 -174.42 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.1 t -97.6 120.56 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 C-N-CA 130.497 3.519 . . . . 1.23 112.737 174.018 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.4 mt -101.09 123.43 45.24 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 118.21 -1.396 . . . . 2.78 107.758 -177.787 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -140.76 -166.25 2.11 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.725 2.202 . . . . 3.75 110.332 174.533 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 mt -90.68 151.87 21.08 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.372 -3.33 . . . . 3.14 110.4 170.422 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.254 69.5 ttt180 -101.0 138.88 37.46 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 125.506 1.754 . . . . 6.8 112.119 172.134 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.73 37.13 4.56 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 105.179 -3.168 . . . . 3.57 105.179 -166.568 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.495 ' C ' HH22 ' A' ' 42' ' ' ARG . . . . . . . . 0 C--O 1.26 1.776 0 O-C-N 116.632 -3.864 . . . . 3.87 110.057 -178.668 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ttp . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 118.662 2.838 . . . . 1.1 118.662 . . . . . . . . . 0 0 . 1 . 076 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -97.71 112.91 24.61 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.138 1.923 . . . . 1.87 109.623 -178.172 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.463 HG12 HG22 ' A' ' 17' ' ' VAL . 5.0 pt -109.14 146.77 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.038 -2.914 . . . . 0.72 109.368 175.083 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -106.32 124.06 49.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.091 2.956 . . . . 1.4 113.38 175.33 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.412 HG22 ' HB2' ' A' ' 67' ' ' LEU . 85.3 t -105.45 113.58 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 114.76 -1.109 . . . . 0.58 111.375 178.819 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -85.95 135.56 33.62 Favored 'General case' 0 N--CA 1.431 -1.423 2 O-C-N 113.041 -6.037 . . . . 2.09 115.826 179.038 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 p -99.1 173.11 6.97 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.653 -1.28 . . . . 0.99 109.708 178.797 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 tt -56.14 -49.14 74.77 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.22 1.008 . . . . 2.53 111.576 174.686 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -77.29 4.33 10.91 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.04 -2.287 . . . . 2.08 115.261 -177.425 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.16 17.63 46.17 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 119.497 2.559 . . . . 1.31 119.497 177.523 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -99.63 145.55 27.45 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 120.413 2.106 . . . . 1.4 109.939 -177.767 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.3 m -105.43 126.55 52.25 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.755 -1.216 . . . . 0.78 108.019 -173.036 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.9 mt -100.9 107.1 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.814 -3.054 . . . . 1.55 106.265 178.645 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 m -91.19 126.34 36.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.1 1.905 . . . . 1.08 108.021 -175.444 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.0 mt -126.63 160.75 29.81 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.867 2.867 . . . . 1.55 109.241 -178.473 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.342 43.6 mt-10 -122.85 115.62 22.29 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 125.658 2.647 . . . . 1.95 108.922 170.094 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.463 HG22 HG12 ' A' ' 3' ' ' ILE . 27.6 m -123.21 163.6 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 117.242 -3.411 . . . . 0.96 113.619 -178.591 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -98.2 145.45 29.85 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-O 116.634 -1.65 . . . . 2.35 112.816 162.735 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.49 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 21.1 Cg_exo -63.91 -9.87 20.67 Favored 'Trans proline' 0 N--CA 1.434 -1.999 2 CA-C-N 129.993 4.605 . . . . 0.95 114.149 -179.495 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.6 p -84.57 -0.2 52.36 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 127.189 3.376 . . . . 1.45 116.099 173.526 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -80.67 156.01 26.53 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.816 -2.428 . . . . 1.69 106.356 176.0 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 p -104.37 165.77 10.84 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.52 -1.218 . . . . 0.75 113.245 176.292 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -58.43 -41.4 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.183 2.193 . . . . 0.73 112.496 176.695 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -44.17 -60.59 1.82 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.491 3.145 . . . . 1.62 119.491 162.024 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -58.96 -33.31 70.5 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 115.059 1.503 . . . . 2.13 115.059 177.85 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.23 -47.83 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 131.626 3.97 . . . . 0.62 115.406 172.478 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.33 27.1 mtmt -69.45 -32.43 71.37 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 111.561 -2.563 . . . . 1.22 110.944 177.946 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.66 -26.32 65.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.255 1.822 . . . . 0.51 113.537 171.79 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -75.97 -42.71 47.58 Favored 'General case' 0 N--CA 1.431 -1.411 1 C-N-CA 131.972 4.109 . . . . 1.44 108.427 -179.859 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt -61.08 -36.0 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 1 O-C-N 116.207 -4.058 . . . . 1.32 113.524 169.068 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -62.44 -37.54 86.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.052 2.541 . . . . 1.7 111.88 172.54 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.6 -52.18 41.48 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 119.548 3.166 . . . . 1.55 119.548 166.928 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -69.4 -51.5 35.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.662 1.185 . . . . 2.62 112.193 -176.546 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -110.34 -25.38 10.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.161 1.784 . . . . 1.48 112.159 -169.453 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.26 39.94 5.26 Favored Glycine 0 N--CA 1.429 -1.773 0 O-C-N 118.363 -2.711 . . . . 1.12 115.255 175.985 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.5 mt -117.97 126.65 27.14 Favored Pre-proline 0 N--CA 1.429 -1.483 0 CA-C-O 116.836 -1.554 . . . . 1.55 111.775 -174.111 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -63.78 145.39 90.78 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 CA-C-N 127.145 3.588 . . . . 1.02 116.932 178.283 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -66.72 -25.23 46.59 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 CA-C-N 120.686 1.281 . . . . 1.25 113.279 -175.137 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -70.78 -13.8 62.19 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 120.398 3.481 . . . . 2.25 120.398 177.476 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -84.76 -36.88 21.46 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 127.866 3.229 . . . . 2.02 108.165 174.043 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -76.91 108.88 10.27 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.067 2.365 . . . . 0.69 113.422 -173.378 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.425 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 56.2 mtt180 -102.19 114.76 29.18 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 114.611 -5.055 . . . . 2.78 110.756 162.725 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.42 ' HA ' HD23 ' A' ' 43' ' ' LEU . 64.9 mt -100.53 123.43 44.74 Favored 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 116.035 -4.166 . . . . 1.17 111.922 -177.687 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.496 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 33.9 mm -109.4 136.33 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 112.255 -2.248 . . . . 1.38 110.635 -177.654 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -99.42 -88.05 0.35 Allowed 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.742 -1.849 . . . . 1.5 109.571 172.404 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -113.02 -8.63 13.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 126.595 3.093 . . . . 1.21 113.151 -176.186 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.14 -40.04 0.17 Allowed Glycine 0 N--CA 1.429 -1.816 1 N-CA-C 102.958 -4.057 . . . . 1.3 102.958 -178.37 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -75.96 150.57 37.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.47 1.605 . . . . 2.55 114.39 175.424 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -84.25 134.06 34.55 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.858 -3.026 . . . . 2.48 107.532 170.67 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.2 mt -82.38 124.94 30.47 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 129.208 4.068 . . . . 0.9 105.448 -173.715 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -80.25 140.86 36.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.364 3.468 . . . . 1.94 120.364 174.082 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.94 -62.82 1.39 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 116.479 2.029 . . . . 1.56 116.479 -170.723 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.1 56.68 4.97 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 118.512 2.165 . . . . 0.97 118.512 173.056 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.266 50.5 mmt-85 -133.35 151.57 51.86 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 107.623 -1.251 . . . . 2.49 107.623 169.108 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 4.5 p -74.2 169.04 18.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 127.027 3.299 . . . . 0.76 118.141 174.172 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.49 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 94.3 mt -74.4 -34.93 63.42 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.536 -4.477 . . . . 1.05 113.279 173.764 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -66.52 -49.19 67.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.127 -2.76 . . . . 1.19 108.891 178.529 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -42.1 -45.16 3.89 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 120.258 3.429 . . . . 1.9 120.258 173.788 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -82.25 -20.81 36.86 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 115.988 1.847 . . . . 0.89 115.988 179.472 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 80.26 50.16 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 128.001 2.521 . . . . 1.84 111.057 -175.022 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.2 mt -93.2 115.94 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 124.809 1.244 . . . . 0.82 109.519 170.814 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -108.18 -174.86 2.62 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.991 2.116 . . . . 2.16 111.577 -167.197 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -65.58 -34.75 78.96 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.819 1.295 . . . . 2.12 112.821 172.066 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.258 13.5 pt-20 -77.04 -12.14 59.9 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.067 -2.896 . . . . 1.71 115.957 178.455 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.314 19.0 m -82.01 139.86 34.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 114.827 1.417 . . . . 1.04 114.827 -167.437 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.4 m -107.11 124.15 49.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.218 1.807 . . . . 0.79 111.609 -179.495 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.412 ' HB2' HG22 ' A' ' 5' ' ' VAL . 8.6 mp -96.85 149.5 21.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 123.198 2.726 . . . . 1.4 106.269 178.13 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.496 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 57.9 m80 -110.34 131.05 55.4 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.48 1.609 . . . . 1.51 113.413 176.735 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 43' ' ' LEU . 51.8 tp -110.14 135.57 50.72 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 125.527 2.584 . . . . 1.14 105.658 -174.93 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 53.1 t -125.54 123.85 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.082 -2.562 . . . . 1.23 104.082 175.826 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.5 mt -103.87 124.94 49.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.77 -1.206 . . . . 2.78 111.821 177.623 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.9 mmt85 -116.82 145.82 43.29 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.348 1.059 . . . . 3.75 111.514 176.416 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.8 tp -141.97 -78.42 0.25 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 104.945 -2.243 . . . . 3.14 104.945 167.013 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.1 mtm-85 -80.25 106.87 12.59 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 118.888 -2.382 . . . . 6.8 108.932 174.929 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.57 -160.01 31.04 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-O 121.825 0.68 . . . . 3.57 113.485 -167.674 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.777 0 C-N-CA 127.875 2.655 . . . . 3.87 109.619 176.759 . . . . . . . . 0 0 . 1 . 077 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ttp . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 116.743 -1.599 . . . . 1.1 112.034 . . . . . . . . . 0 0 . 1 . 077 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -93.5 111.62 23.33 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 115.316 -2.278 . . . . 1.87 111.185 -177.274 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.7 pt -106.47 167.98 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-O 125.992 2.806 . . . . 0.72 107.824 172.872 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -126.1 114.8 18.87 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.403 2.049 . . . . 1.4 113.129 -176.727 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.0 t -107.6 113.59 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 116.404 -3.935 . . . . 0.58 102.174 -179.002 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -82.74 143.93 30.55 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 116.103 -4.123 . . . . 2.09 116.49 177.166 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.569 HG21 ' HE2' ' A' ' 11' ' ' LYS . 20.2 p -93.85 158.46 15.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.558 1.943 . . . . 0.99 116.126 176.179 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.25 80.1 mt -64.44 -32.53 74.2 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.246 1.818 . . . . 2.53 114.648 175.906 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.7 p -71.61 -44.31 64.64 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.542 -1.349 . . . . 2.08 112.172 178.33 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.79 -33.75 0.44 Allowed Glycine 0 N--CA 1.43 -1.762 0 CA-C-O 125.516 2.731 . . . . 1.31 115.072 172.036 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.569 ' HE2' HG21 ' A' ' 7' ' ' THR 0.362 0.0 OUTLIER -70.9 153.41 42.72 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 110.879 -2.661 . . . . 1.4 115.434 -176.285 . . . . . . . . 4 4 . 1 . 077 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.9 m -103.21 136.38 43.11 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.051 -1.655 . . . . 0.78 110.432 177.642 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 69.7 mt -98.78 115.48 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 116.517 -1.706 . . . . 1.55 108.768 177.597 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 m -92.44 110.83 22.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.242 1.817 . . . . 1.08 111.767 179.95 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.9 mt -112.89 133.85 54.67 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 125.332 2.491 . . . . 1.55 110.803 -174.742 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -91.0 113.15 25.34 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 116.28 -4.012 . . . . 1.95 109.64 168.255 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -123.7 163.14 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 113.502 -1.681 . . . . 0.96 108.688 -177.378 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -104.55 131.0 22.26 Favored Pre-proline 0 N--CA 1.43 -1.434 0 O-C-N 125.792 1.933 . . . . 2.35 106.102 163.449 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.71 -14.04 24.77 Favored 'Trans proline' 0 C--N 1.3 -1.993 1 C-N-CA 127.827 5.684 . . . . 0.95 114.788 -178.542 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -85.96 -17.04 36.46 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.895 2.878 . . . . 1.45 114.858 -179.771 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -68.17 144.46 54.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 116.997 -1.478 . . . . 1.69 113.704 176.007 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.3 p -76.61 164.11 26.23 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 122.959 2.618 . . . . 0.75 110.332 -178.266 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.881 HD13 ' HB3' ' A' ' 50' ' ' LEU . 52.0 mt -67.86 -35.38 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 118.158 -2.838 . . . . 0.73 114.594 176.165 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -47.89 -37.65 14.59 Favored 'General case' 0 N--CA 1.431 -1.409 1 O-C-N 115.665 -4.397 . . . . 1.62 116.873 156.659 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -78.97 -30.22 44.35 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.43 -2.669 . . . . 2.13 111.087 177.094 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.7 t -61.83 -52.98 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 O-C-N 119.554 -1.966 . . . . 0.62 113.305 170.961 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -50.05 -40.73 45.97 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 127.892 3.245 . . . . 1.22 114.771 176.457 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.97 -37.37 68.96 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.839 -1.163 . . . . 0.51 112.432 173.388 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -70.16 -24.92 63.23 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 118.801 2.889 . . . . 1.44 118.801 174.548 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.8 mt -77.33 -42.37 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 129.051 2.94 . . . . 1.32 104.38 179.693 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -61.38 -47.9 83.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.418 -1.426 . . . . 1.7 110.585 179.947 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -41.71 -48.68 4.22 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 118.076 2.621 . . . . 1.55 118.076 170.329 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -79.0 -60.76 2.25 Favored 'General case' 0 N--CA 1.432 -1.372 0 O-C-N 119.192 -2.193 . . . . 2.62 108.607 -174.031 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -101.85 -17.37 16.22 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 119.862 1.21 . . . . 1.48 111.535 -163.922 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.98 46.89 5.77 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 123.844 1.802 . . . . 1.12 116.852 173.444 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.4 mt -129.3 129.1 23.27 Favored Pre-proline 0 N--CA 1.431 -1.395 0 O-C-N 120.211 -1.758 . . . . 1.55 112.162 -174.112 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -62.72 162.16 26.01 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 O-C-N 114.574 -3.435 . . . . 1.02 120.881 -177.278 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.7 -14.92 19.51 Favored 'Trans proline' 0 N--CA 1.433 -2.038 0 CA-C-N 127.825 3.83 . . . . 1.25 112.824 -178.398 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -60.47 -46.21 90.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.919 2.488 . . . . 2.25 109.398 173.41 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -83.77 -27.57 28.77 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 123.503 0.721 . . . . 2.02 112.473 -174.417 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -76.87 108.32 9.83 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.344 2.021 . . . . 0.69 110.731 -177.582 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -93.8 119.13 32.36 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.971 -3.581 . . . . 2.78 104.564 167.542 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.3 mt -98.41 138.38 35.73 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.278 -2.139 . . . . 1.17 108.688 174.277 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.41 134.1 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 101.735 -3.432 . . . . 1.38 101.735 -178.404 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -98.11 -107.23 0.18 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.187 -1.571 . . . . 1.5 109.736 170.171 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.66 -51.38 5.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.079 -2.263 . . . . 1.21 110.752 177.582 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.25 -40.17 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 128.955 3.169 . . . . 1.3 106.343 -171.074 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -74.5 146.77 42.44 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 112.878 0.696 . . . . 2.55 112.878 178.348 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.276 3.6 mp0 -97.92 145.65 26.25 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 100.308 -3.96 . . . . 2.48 100.308 171.879 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.881 ' HB3' HD13 ' A' ' 23' ' ' ILE . 78.8 mt -99.75 121.02 40.65 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 127.733 3.635 . . . . 0.9 108.437 -169.496 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -71.35 129.15 38.12 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.519 -2.613 . . . . 1.94 114.189 170.638 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.41 -48.04 47.46 Favored 'General case' 0 N--CA 1.431 -1.417 1 C-N-CA 131.966 4.106 . . . . 1.56 117.412 -175.071 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.62 -9.58 62.19 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 119.157 2.423 . . . . 0.97 119.157 176.663 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -90.39 177.02 6.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 118.386 1.093 . . . . 2.49 109.247 179.412 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.5 p -108.23 164.36 12.38 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.184 1.393 . . . . 0.76 108.46 173.873 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 67.0 mt -58.4 -33.24 69.42 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.478 1.511 . . . . 1.05 111.421 171.629 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 t -64.27 -34.72 78.78 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 118.788 2.884 . . . . 1.19 118.788 176.728 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.284 64.6 m-20 -67.47 -29.79 69.33 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.42 -2.675 . . . . 1.9 111.785 178.429 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -92.53 -7.16 48.07 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 130.402 3.481 . . . . 0.89 112.088 178.664 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.268 71.6 m-80 61.96 60.82 1.47 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.213 1.482 . . . . 1.84 110.06 176.479 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.282 12.8 mt -83.69 130.43 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 128.054 2.542 . . . . 0.82 109.665 173.431 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -100.7 178.38 4.72 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 117.576 -1.202 . . . . 2.16 114.003 -171.453 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -44.19 -80.86 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.248 2.219 . . . . 2.12 116.684 173.627 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.341 0.8 OUTLIER -93.05 58.29 2.91 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 123.214 1.483 . . . . 1.71 113.622 -177.666 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 p -92.3 139.87 30.17 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.952 2.501 . . . . 1.04 113.514 -175.039 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.4 m -109.79 124.12 50.74 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 104.122 -2.547 . . . . 0.79 104.122 -176.223 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -97.91 170.33 9.03 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 126.531 3.063 . . . . 1.4 104.815 172.361 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -120.76 125.51 47.77 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 118.037 -2.914 . . . . 1.51 105.09 -177.998 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.0 tp -95.17 107.16 19.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.471 2.081 . . . . 1.14 111.608 169.069 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -112.49 150.3 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 118.609 -2.557 . . . . 1.23 107.819 173.964 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.5 mt -112.03 109.88 19.87 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.6 -2.563 . . . . 2.78 111.516 -178.788 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 mmt85 -115.31 171.33 7.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 102.354 -3.202 . . . . 3.75 102.354 178.571 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.9 mt -87.82 -174.74 4.87 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.609 1.707 . . . . 3.14 115.609 174.176 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.3 ttt180 -71.01 123.92 23.18 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 125.582 2.61 . . . . 6.8 113.288 165.968 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.87 37.36 0.29 Allowed Glycine 0 N--CA 1.43 -1.711 1 O-C-N 114.372 -5.205 . . . . 3.57 111.511 -166.862 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.789 0 O-C-N 118.958 -2.495 . . . . 3.87 114.085 -177.637 . . . . . . . . 0 0 . 1 . 078 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tmm? . . . . . 0 CA--C 1.491 -1.32 0 N-CA-C 105.25 -2.13 . . . . 1.1 105.25 . . . . . . . . . 0 0 . 1 . 078 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.83 131.64 36.56 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.095 -3.503 . . . . 1.87 113.372 179.762 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.2 pt -116.48 148.15 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 129.245 3.018 . . . . 0.72 105.305 174.867 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -104.42 131.11 52.14 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.24 -1.538 . . . . 1.4 107.275 -179.546 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.0 t -109.79 118.66 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 105.185 -2.154 . . . . 0.58 105.185 177.083 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -105.08 130.39 53.28 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.475 -1.391 . . . . 2.09 110.066 176.277 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.8 p -69.93 167.02 18.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.549 2.118 . . . . 0.99 113.71 176.883 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.2 tp -56.01 -46.18 78.84 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 112.122 -2.308 . . . . 2.53 114.11 173.427 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 p -81.22 -21.15 39.75 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.299 2.333 . . . . 2.08 117.299 -176.248 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.76 1.69 4.1 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 122.686 3.834 . . . . 1.31 122.686 177.78 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -88.25 131.27 34.84 Favored 'General case' 0 N--CA 1.431 -1.397 1 O-C-N 115.855 -4.321 . . . . 1.4 109.978 -174.306 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.5 m -119.53 112.99 20.04 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 120.171 1.35 . . . . 0.78 113.384 179.626 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.9 pt -101.78 151.94 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 125.691 1.869 . . . . 1.55 107.61 -177.476 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.1 m -116.68 118.68 33.25 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 126.61 2.444 . . . . 1.08 110.012 -175.122 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.7 mt -102.96 149.22 24.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.518 -3.239 . . . . 1.55 107.247 177.977 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -102.48 123.36 46.1 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.225 -1.398 . . . . 1.95 107.225 165.762 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 m -131.77 147.66 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 106.67 -1.604 . . . . 0.96 106.67 -176.558 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -87.01 129.68 51.12 Favored Pre-proline 0 N--CA 1.429 -1.523 1 CA-C-O 111.438 -4.125 . . . . 2.35 110.132 163.875 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.31 -1.94 12.06 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 CA-C-N 127.809 3.825 . . . . 0.95 115.517 -166.246 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.2 m -84.19 2.66 38.72 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 116.301 -3.999 . . . . 1.45 116.513 172.917 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -81.36 163.32 22.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.514 -3.241 . . . . 1.69 113.174 174.952 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 p -90.98 157.95 16.99 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 125.729 2.68 . . . . 0.75 112.73 -178.538 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.44 -37.67 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.004 -2.935 . . . . 0.73 115.814 171.22 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -48.27 -41.21 27.22 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.647 -3.158 . . . . 1.62 117.879 167.811 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -73.8 -33.56 64.26 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.406 1.262 . . . . 2.13 114.406 172.568 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.5 -40.26 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 116.791 -3.693 . . . . 0.62 111.572 174.665 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -66.32 -35.74 81.14 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.288 -2.132 . . . . 1.22 110.115 177.58 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.439 . . -69.62 -27.02 64.72 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.883 2.473 . . . . 0.51 116.148 173.369 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -75.09 -34.84 61.8 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 120.702 -1.249 . . . . 1.44 111.698 172.391 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.1 mt -69.0 -33.73 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 117.425 -1.274 . . . . 1.32 112.666 168.38 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -65.2 -35.21 80.35 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.435 -1.32 . . . . 1.7 107.435 176.53 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.32 -26.9 68.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.041 2.237 . . . . 1.55 117.041 173.892 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -99.37 -69.71 0.76 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.522 1.629 . . . . 2.62 113.332 -172.734 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -84.8 -25.36 28.21 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.058 -2.901 . . . . 1.48 105.475 -169.314 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.88 58.88 2.56 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 107.928 -2.069 . . . . 1.12 107.928 178.948 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.3 mt -115.25 120.31 36.9 Favored Pre-proline 0 N--CA 1.43 -1.443 1 CA-C-O 110.705 -4.474 . . . . 1.55 107.411 -179.25 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -63.56 143.95 88.86 Favored 'Trans proline' 0 N--CA 1.434 -2.028 1 CA-C-N 128.555 4.091 . . . . 1.02 116.801 177.681 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -68.87 -18.37 41.33 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 CA-C-N 125.763 3.094 . . . . 1.25 115.015 -172.925 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.257 11.3 p-10 -77.51 -18.67 56.83 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 127.69 3.614 . . . . 2.25 113.729 178.413 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -90.32 -16.51 29.1 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 114.903 -4.873 . . . . 2.02 110.524 178.831 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -87.46 131.07 34.46 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 126.088 2.852 . . . . 0.69 116.638 -177.614 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -111.85 114.38 27.29 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.171 2.988 . . . . 2.78 111.304 172.361 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 39.5 mt -104.5 126.01 51.2 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 118.455 -2.653 . . . . 1.17 108.253 178.106 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.8 mt -119.72 153.76 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 N-CA-C 101.28 -3.6 . . . . 1.38 101.28 -179.185 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.567 ' HB3' HD21 ' A' ' 50' ' ' LEU 0.429 26.7 t80 -126.03 -73.15 0.63 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 119.052 -1.059 . . . . 1.5 112.738 167.964 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.11 -40.12 8.57 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 114.115 -2.85 . . . . 1.21 115.29 178.768 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.89 -52.69 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 108.452 -1.859 . . . . 1.3 108.452 -175.873 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -89.12 163.46 15.45 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 122.084 2.942 . . . . 2.55 112.787 177.677 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -68.63 147.98 51.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 125.623 1.827 . . . . 2.48 112.053 170.669 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.567 HD21 ' HB3' ' A' ' 45' ' ' PHE . 24.1 mt -84.64 144.73 28.41 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 115.925 -1.988 . . . . 0.9 107.481 -175.436 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -90.97 155.38 18.76 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 125.799 3.908 . . . . 1.94 109.372 178.252 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -65.44 -57.85 7.27 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.87 3.268 . . . . 1.56 112.858 -172.81 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.67 62.62 1.64 Allowed Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 121.385 3.314 . . . . 0.97 121.385 168.506 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 ttm-85 -139.92 163.26 33.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 113.545 -1.328 . . . . 2.49 107.442 164.938 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.254 24.4 p -91.75 172.41 8.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.269 1.985 . . . . 0.76 112.149 -174.93 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.55 -46.0 64.38 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.322 -1.763 . . . . 1.05 111.065 168.594 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.273 1.2 t -63.51 -17.2 62.51 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.127 2.171 . . . . 1.19 114.747 175.733 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -77.73 -36.08 51.23 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 115.596 1.702 . . . . 1.9 115.596 170.268 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -87.22 7.08 29.98 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.289 1.995 . . . . 0.89 112.233 173.08 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 m120 44.06 59.83 3.02 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.887 3.675 . . . . 1.84 115.86 -174.649 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.449 HG12 ' CE2' ' A' ' 45' ' ' PHE . 46.8 mt -87.07 106.98 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 119.411 -2.055 . . . . 0.82 105.811 179.294 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -104.03 -170.31 1.76 Allowed 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 116.269 -0.423 . . . . 2.16 110.364 -179.97 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -27.99 137.46 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 130.16 3.384 . . . . 2.12 118.934 169.124 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 48.42 56.2 7.83 Favored 'General case' 0 N--CA 1.431 -1.385 1 C-N-CA 132.402 4.281 . . . . 1.71 114.948 176.679 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.4 m -116.91 135.45 53.71 Favored 'General case' 0 N--CA 1.432 -1.37 0 O-C-N 119.756 -1.84 . . . . 1.04 113.859 -173.938 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.2 m -102.35 99.87 9.98 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.195 2.998 . . . . 0.79 109.299 -176.471 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.61 135.35 48.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 116.339 -1.791 . . . . 1.4 111.968 169.465 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.6 m170 -91.11 100.37 13.22 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 127.864 2.466 . . . . 1.51 113.15 -176.898 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.2 tp -91.48 135.6 33.73 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 126.9 2.625 . . . . 1.14 114.083 177.681 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.6 t -135.16 120.46 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 129.841 3.256 . . . . 1.23 109.37 170.63 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.0 pp -91.56 149.22 21.77 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 124.366 3.257 . . . . 2.78 107.526 172.264 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -96.88 112.33 24.13 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 122.706 1.241 . . . . 3.75 113.235 -177.563 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 53.6 mt -71.34 172.11 9.99 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.317 1.969 . . . . 3.14 116.317 173.441 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.4 mtt85 -63.34 -80.98 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 115.274 1.583 . . . . 6.8 115.274 177.481 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.06 90.76 0.89 Allowed Glycine 0 N--CA 1.431 -1.65 0 N-CA-C 106.858 -2.497 . . . . 3.57 106.858 -168.704 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.773 0 C-N-CA 127.419 2.437 . . . . 3.87 114.616 -175.293 . . . . . . . . 0 0 . 1 . 079 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ptt? . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 114.363 1.246 . . . . 1.1 114.363 . . . . . . . . . 0 0 . 1 . 079 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -89.05 127.82 35.71 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.281 -2.762 . . . . 1.87 107.456 -175.778 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.8 pt -114.73 162.53 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 115.254 1.575 . . . . 0.72 115.254 171.67 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 64' ' ' GLU . 36.1 m-85 -116.15 121.34 41.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.538 -3.226 . . . . 1.4 110.962 -175.883 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.0 t -103.2 124.45 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 1 O-C-N 116.009 -4.182 . . . . 0.58 110.592 176.49 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.0 tttt -99.62 135.98 40.23 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.38 1.446 . . . . 2.09 109.407 179.744 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.1 p -88.17 -175.49 5.07 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 117.235 -1.364 . . . . 0.99 113.665 176.053 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.3 mt -62.47 -52.52 63.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 124.724 1.265 . . . . 2.53 112.308 170.232 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.5 p -74.53 -12.98 60.61 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 115.591 -2.147 . . . . 2.08 110.472 -178.327 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.54 9.23 25.53 Favored Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 122.14 3.616 . . . . 1.31 122.14 173.291 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.49 140.87 54.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.493 2.092 . . . . 1.4 107.659 -177.006 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.7 m -108.33 104.83 14.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.498 -3.251 . . . . 0.78 112.458 177.128 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.7 mt -98.12 120.57 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 125.046 1.466 . . . . 1.55 107.8 -176.13 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 m -90.99 115.92 28.38 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 127.332 2.895 . . . . 1.08 108.708 178.357 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 mt -123.35 137.45 54.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.26 1.824 . . . . 1.55 107.83 -178.261 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.89 130.93 35.33 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 101.997 -3.335 . . . . 1.95 101.997 170.146 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -138.27 158.78 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 126.022 2.82 . . . . 0.96 108.968 174.472 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -102.6 153.35 38.23 Favored Pre-proline 0 N--CA 1.43 -1.433 1 O-C-N 115.211 -4.681 . . . . 2.35 107.034 161.105 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -76.67 -7.66 17.74 Favored 'Trans proline' 0 N--CA 1.433 -2.037 1 CA-C-N 128.475 4.063 . . . . 0.95 112.567 -167.753 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 p -80.95 -8.92 59.87 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 126.037 1.735 . . . . 1.45 108.776 -179.01 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -66.7 141.17 57.86 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.661 1.984 . . . . 1.69 113.063 171.001 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 82.3 p -82.66 168.01 17.69 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.875 -2.391 . . . . 0.75 114.557 173.435 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.1 mm -64.41 -32.31 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 117.795 -3.065 . . . . 0.73 112.437 173.107 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -58.65 -39.35 80.35 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 115.957 -4.214 . . . . 1.62 115.02 169.539 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -63.48 -43.44 97.28 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 127.837 2.455 . . . . 2.13 111.728 174.874 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.6 t -61.81 -47.05 95.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 126.814 2.046 . . . . 0.62 110.554 175.255 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -62.68 -30.61 71.52 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 119.559 3.17 . . . . 1.22 119.559 170.838 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.76 -28.66 61.79 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 123.075 1.416 . . . . 0.51 112.836 175.819 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.289 18.5 ttmm -80.18 -36.45 34.99 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 129.551 3.14 . . . . 1.44 114.041 173.317 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.443 68.7 mt -62.68 -44.75 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 127.796 2.438 . . . . 1.32 112.368 168.093 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -55.92 -52.19 65.0 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.518 -3.239 . . . . 1.7 114.251 169.872 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -60.58 -42.95 97.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.625 2.083 . . . . 1.55 116.625 175.058 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -86.22 -50.16 7.18 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.776 1.274 . . . . 2.62 110.516 -173.435 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -94.82 -41.97 8.95 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 116.643 -3.786 . . . . 1.48 114.003 -171.691 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.94 22.65 6.81 Favored Glycine 0 N--CA 1.431 -1.699 0 CA-C-O 124.279 2.044 . . . . 1.12 111.836 174.02 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.4 mt -94.89 131.9 29.43 Favored Pre-proline 0 N--CA 1.43 -1.442 0 O-C-N 118.891 -2.535 . . . . 1.55 104.856 -173.168 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -64.72 144.62 84.5 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 C-N-CA 124.685 3.59 . . . . 1.02 119.293 -179.931 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -71.65 -15.46 30.38 Favored 'Trans proline' 0 N--CA 1.433 -2.085 0 C-N-CA 114.745 -3.036 . . . . 1.25 113.757 -172.124 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -65.43 -25.29 67.46 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 118.395 2.739 . . . . 2.25 118.395 175.261 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -96.68 -25.22 15.63 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 116.13 -4.106 . . . . 2.02 105.472 -172.044 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -75.38 103.42 5.51 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.396 -3.94 . . . . 0.69 114.533 -177.382 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -94.77 129.57 41.66 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.425 -2.047 . . . . 2.78 109.203 165.605 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' A' ' 43' ' ' LEU . 42.9 mt -115.08 127.32 55.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.5 -2.0 . . . . 1.17 108.694 -179.494 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 9.5 mm -116.31 155.37 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 127.994 2.518 . . . . 1.38 104.597 173.958 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -104.73 -83.32 0.5 Allowed 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.88 -2.637 . . . . 1.5 103.88 174.218 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.99 -43.69 6.6 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 113.95 -1.477 . . . . 1.21 110.787 179.199 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -173.81 -16.9 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 127.254 2.359 . . . . 1.3 114.23 -179.007 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -82.2 124.73 30.17 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 102.758 -3.053 . . . . 2.55 102.758 178.864 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.04 130.69 45.03 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.349 -2.719 . . . . 2.48 112.166 173.73 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.1 mt -87.41 132.32 34.02 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.108 -2.87 . . . . 0.9 107.432 -175.094 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -94.25 138.18 32.55 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 117.704 -1.141 . . . . 1.94 113.122 177.75 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -50.6 -56.07 13.44 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 130.866 3.666 . . . . 1.56 113.339 -166.813 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.85 52.98 4.48 Favored Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 118.024 1.969 . . . . 0.97 118.024 172.963 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.0 mmt-85 -126.94 159.23 34.65 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 105.942 -1.873 . . . . 2.49 105.942 165.438 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.299 35.6 p -89.7 170.78 10.16 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.566 -2.583 . . . . 0.76 113.277 175.808 . . . . . . . . 3 3 . 1 . 079 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mt -73.3 -32.55 64.69 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 106.416 -1.698 . . . . 1.05 106.416 173.381 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -64.38 -43.56 94.12 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 117.079 -1.439 . . . . 1.19 110.195 177.959 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -46.02 -45.79 16.13 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 122.383 2.356 . . . . 1.9 113.801 173.791 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -82.42 6.68 16.43 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.338 -1.476 . . . . 0.89 114.946 178.45 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.4 m120 61.79 37.96 15.18 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 131.25 3.82 . . . . 1.84 116.684 176.09 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -86.65 128.01 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 127.043 2.137 . . . . 0.82 105.761 -177.57 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -142.94 -47.31 0.31 Allowed 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.243 -1.536 . . . . 2.16 113.333 -172.318 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -88.6 -162.36 0.84 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.333 1.453 . . . . 2.12 114.465 179.917 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.44 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 24.8 mt-10 -84.51 75.45 10.27 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.002 -2.937 . . . . 1.71 111.74 179.598 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 m -82.42 144.09 30.73 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 119.985 3.328 . . . . 1.04 119.985 -175.834 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.3 m -91.7 106.47 18.5 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.2 -1.364 . . . . 0.79 111.44 179.63 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -85.26 154.96 21.59 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 128.317 3.913 . . . . 1.4 105.963 166.126 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.425 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 69.9 m80 -115.17 119.04 35.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 111.791 -2.458 . . . . 1.51 106.637 -176.525 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.5 tp -105.08 99.7 9.31 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 105.118 -2.178 . . . . 1.14 105.118 178.096 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.6 t -86.88 125.39 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 113.478 -1.692 . . . . 1.23 111.017 171.283 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.3 mt -92.5 119.57 32.12 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.191 -2.193 . . . . 2.78 114.635 -179.111 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -76.17 95.54 3.71 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.407 1.099 . . . . 3.75 112.432 178.602 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.0 mt -104.37 -41.38 5.78 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 116.291 -4.005 . . . . 3.14 106.57 176.257 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -77.2 -59.43 2.78 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 120.886 1.676 . . . . 6.8 114.052 173.422 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.47 -82.15 0.12 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 118.487 -2.633 . . . . 3.57 110.059 -169.579 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.699 1 C-N-CA 131.285 4.278 . . . . 3.87 113.374 173.877 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.329 0 CA-C-O 119.556 -0.259 . . . . 1.1 111.252 . . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -114.0 113.26 24.54 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 101.531 -3.507 . . . . 1.87 101.531 -174.581 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.7 pt -92.52 166.66 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 122.601 2.455 . . . . 0.72 111.835 170.611 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -122.61 94.12 4.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.895 1.678 . . . . 1.4 110.831 176.142 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.4 t -77.05 115.11 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 O-C-N 118.035 -2.915 . . . . 0.58 113.557 174.742 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -94.84 128.89 41.91 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 117.083 -1.847 . . . . 2.09 113.74 -178.288 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 p -85.67 173.24 10.26 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 124.463 2.078 . . . . 0.99 109.914 177.126 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.2 mt -79.96 -33.97 39.13 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.242 -2.786 . . . . 2.53 108.406 172.845 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.9 p -71.77 -35.06 69.94 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 123.769 2.986 . . . . 2.08 113.568 179.898 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.81 8.41 0.92 Allowed Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 119.162 2.425 . . . . 1.31 119.162 176.957 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.0 tptt -96.94 144.55 26.75 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.898 -1.519 . . . . 1.4 106.898 -172.309 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.4 m -111.73 108.25 17.62 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.318 -2.845 . . . . 0.78 103.318 174.241 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.9 mt -82.27 111.1 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 113.526 -1.67 . . . . 1.55 108.276 179.472 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.5 m -85.23 106.84 16.95 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.194 1.398 . . . . 1.08 112.665 -178.756 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.4 mt -123.36 133.28 54.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 124.833 1.333 . . . . 1.55 107.871 -172.849 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -94.21 133.59 37.57 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.748 -1.845 . . . . 1.95 110.672 162.902 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.3 m -133.3 173.54 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 125.964 2.792 . . . . 0.96 108.997 176.744 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.267 39.5 mt-10 -123.42 167.08 15.79 Favored Pre-proline 0 N--CA 1.43 -1.451 0 N-CA-C 103.595 -2.743 . . . . 2.35 103.595 162.911 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -69.06 -11.54 32.0 Favored 'Trans proline' 0 N--CA 1.433 -2.065 0 N-CA-C 117.184 1.955 . . . . 0.95 117.184 179.395 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -79.27 -11.73 59.95 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 129.066 2.946 . . . . 1.45 112.07 179.001 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -74.76 141.22 44.42 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.16 -1.588 . . . . 1.69 113.098 175.425 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 57.2 p -84.46 164.35 18.89 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.865 -1.772 . . . . 0.75 107.957 174.875 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.275 1.9 mp -69.95 -27.77 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 119.232 -2.168 . . . . 0.73 113.429 178.86 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -53.34 -46.72 69.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.07 -2.269 . . . . 1.62 114.69 164.436 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -53.3 -40.8 65.04 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.532 -3.23 . . . . 2.13 113.714 172.633 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.06 -42.0 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 O-C-N 121.045 -1.034 . . . . 0.62 111.682 177.546 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -59.56 -36.89 77.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.057 -2.277 . . . . 1.22 115.03 173.634 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.17 73.64 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.052 2.095 . . . . 0.51 115.034 174.883 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -72.81 -37.19 67.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 131.418 3.887 . . . . 1.44 112.748 173.823 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.6 mt -73.6 -28.02 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 117.825 -3.047 . . . . 1.32 109.106 170.596 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -71.2 -35.22 71.47 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.859 -1.776 . . . . 1.7 110.228 176.613 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -69.64 -57.39 5.22 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.098 2.559 . . . . 1.55 109.066 176.41 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.254 22.6 mmtt -57.58 -73.44 0.07 Allowed 'General case' 0 CA--C 1.489 -1.384 0 C-N-CA 131.068 3.747 . . . . 2.62 115.104 178.449 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.276 47.0 mm-40 -88.73 -41.14 12.74 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.727 -2.483 . . . . 1.48 114.52 -168.105 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.62 34.43 2.86 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 126.421 1.962 . . . . 1.12 111.427 173.97 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.8 mm -92.93 135.31 26.15 Favored Pre-proline 0 N--CA 1.429 -1.488 0 CA-C-O 112.456 -3.64 . . . . 1.55 109.52 -177.586 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -75.48 136.02 18.93 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 CA-C-N 127.342 3.658 . . . . 1.02 112.638 176.75 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -60.9 -21.14 69.89 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 C-N-CA 123.574 2.85 . . . . 1.25 116.909 -173.629 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.55 -28.68 68.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 130.094 3.358 . . . . 2.25 113.135 172.814 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -80.98 -34.82 32.77 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 131.066 3.746 . . . . 2.02 113.663 -177.518 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -88.59 115.47 26.14 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 116.266 1.95 . . . . 0.69 116.266 -163.587 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -95.71 120.04 35.27 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.898 -2.376 . . . . 2.78 110.092 173.46 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 43' ' ' LEU 0.264 68.0 mt -97.43 99.17 10.6 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.132 1.787 . . . . 1.17 113.109 175.835 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mm -95.05 130.65 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 128.857 2.863 . . . . 1.38 107.432 -174.788 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -111.7 -80.96 0.59 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 105.326 -2.102 . . . . 1.5 105.326 174.889 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.99 -95.67 0.35 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.777 -2.452 . . . . 1.21 111.016 -179.168 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.58 -4.12 54.91 Favored Glycine 0 N--CA 1.429 -1.772 0 O-C-N 119.551 -1.968 . . . . 1.3 113.634 -178.977 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -133.25 153.87 51.18 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.178 -2.366 . . . . 2.55 113.458 -177.581 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -82.31 141.41 32.91 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.045 -3.535 . . . . 2.48 109.483 162.948 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.8 mt -75.68 141.1 42.81 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.631 -2.543 . . . . 0.9 106.157 -178.909 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -86.42 137.34 32.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.204 -3.435 . . . . 1.94 115.077 176.773 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -53.03 -60.86 2.75 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 120.742 3.608 . . . . 1.56 120.742 -166.372 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.87 25.62 1.18 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 120.81 3.084 . . . . 0.97 120.81 170.128 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -113.87 159.82 19.43 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 127.325 2.427 . . . . 2.49 106.241 173.161 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 29.1 p -87.21 156.84 19.5 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.384 2.364 . . . . 0.76 117.384 -176.462 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.8 mt -53.62 -40.24 65.6 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 118.576 -2.577 . . . . 1.05 114.064 167.824 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.1 t -56.23 -36.69 68.76 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 115.573 1.694 . . . . 1.19 115.573 174.777 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -55.31 -30.49 60.32 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 120.795 3.628 . . . . 1.9 120.795 175.015 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -96.91 -1.24 46.22 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.843 -1.526 . . . . 0.89 109.906 -179.221 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.308 33.8 m-80 64.74 67.86 0.54 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.999 2.92 . . . . 1.84 109.44 -177.978 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.4 mt -124.34 114.02 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 1 C-N-CA 132.614 4.365 . . . . 0.82 101.794 179.851 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.25 57.0 mm-40 -139.77 -25.32 0.82 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 116.448 -1.739 . . . . 2.16 109.083 -176.104 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -107.45 -173.35 2.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 129.555 3.142 . . . . 2.12 110.977 -179.481 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -73.51 77.5 1.44 Allowed 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.938 1.295 . . . . 1.71 113.719 177.597 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.379 54.3 p -80.06 158.56 26.43 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.046 1.339 . . . . 1.04 113.772 -170.386 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.48 HG22 ' CE1' ' A' ' 68' ' ' HIS . 2.9 m -107.96 115.46 30.17 Favored 'General case' 0 N--CA 1.431 -1.424 1 N-CA-C 99.636 -4.209 . . . . 0.79 99.636 179.097 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mp -108.27 168.01 9.61 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 116.66 -3.775 . . . . 1.4 106.292 175.706 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.48 ' CE1' HG22 ' A' ' 66' ' ' THR . 86.3 m-70 -127.33 135.41 50.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.978 -1.701 . . . . 1.51 113.002 -178.554 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.259 42.0 tp -106.08 107.08 17.9 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.655 -2.528 . . . . 1.14 107.393 179.738 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 37.1 t -98.16 143.57 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 103.382 -2.821 . . . . 1.23 103.382 176.543 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.5 mt -110.97 141.74 44.02 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.404 -4.56 . . . . 2.78 112.227 178.022 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.436 HH21 ' C ' ' A' ' 76' ' ' GLY . 76.7 mtp180 -90.06 154.66 19.63 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 124.413 1.085 . . . . 3.75 112.726 174.945 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.9 mt -98.89 161.69 13.5 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 127.137 2.175 . . . . 3.14 107.822 -178.966 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 ptt-85 -69.81 129.85 40.67 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 126.612 2.445 . . . . 6.8 115.709 166.519 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.26 60.47 3.06 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-O 117.157 -1.913 . . . . 3.57 110.819 -159.605 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.436 ' C ' HH21 ' A' ' 72' ' ' ARG . . . . . . . . 0 C--O 1.26 1.724 0 CA-C-N 118.57 1.185 . . . . 3.87 111.147 -177.428 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ptt? . . . . . 0 CA--C 1.489 -1.387 0 CA-C-O 121.672 0.748 . . . . 1.1 112.948 . . . . . . . . . 0 0 . 1 . 081 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -95.54 137.88 33.99 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.939 -2.245 . . . . 1.87 104.939 -179.287 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.444 HD12 HD22 ' A' ' 67' ' ' LEU . 38.2 pt -123.14 155.95 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 124.398 2.047 . . . . 0.72 109.756 161.946 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -115.88 119.07 34.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.469 -3.269 . . . . 1.4 107.433 -172.363 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.495 HG22 ' HB2' ' A' ' 67' ' ' LEU . 40.0 t -110.83 117.89 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 119.032 -2.292 . . . . 0.58 106.028 -179.092 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -108.62 168.77 9.09 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 119.634 -0.827 . . . . 2.09 111.292 177.05 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -103.9 -165.93 1.2 Allowed 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 122.663 1.22 . . . . 0.99 109.743 173.979 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.0 tp -75.29 -49.99 17.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.136 2.174 . . . . 2.53 113.494 173.681 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.8 p -89.43 -37.68 14.64 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.122 -2.236 . . . . 2.08 114.445 -172.548 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.73 28.21 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.713 0 N-CA-C 121.981 3.552 . . . . 1.31 121.981 179.28 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -104.95 95.76 6.08 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 126.478 1.911 . . . . 1.4 114.366 -177.506 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.9 m -89.77 124.19 34.42 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 115.54 -2.464 . . . . 0.78 109.149 178.847 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 pt -119.32 128.57 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 117.688 -3.132 . . . . 1.55 107.5 172.675 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.3 m -95.76 122.94 39.07 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 116.133 -1.889 . . . . 1.08 110.016 -177.565 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.278 76.9 mt -119.89 128.17 53.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 121.925 2.148 . . . . 1.55 111.465 -177.502 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -80.03 122.23 26.49 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 125.487 1.742 . . . . 1.95 108.031 171.608 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 m -136.54 178.72 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 1 C-N-CA 131.797 4.039 . . . . 0.96 111.663 -173.963 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -125.84 162.55 44.65 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 113.046 -3.359 . . . . 2.35 107.303 166.411 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -74.16 -19.46 20.03 Favored 'Trans proline' 0 C--N 1.3 -2.013 1 CA-C-N 130.026 4.616 . . . . 0.95 111.886 -170.622 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.15 10.85 27.65 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 131.056 3.742 . . . . 1.45 110.925 -173.96 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -88.37 148.15 24.39 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.813 -3.679 . . . . 1.69 110.086 176.368 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 p -87.0 162.55 17.58 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.829 1.789 . . . . 0.75 115.829 -177.488 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.442 HD12 HD13 ' A' ' 50' ' ' LEU . 19.6 mm -66.47 -29.39 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 127.817 3.675 . . . . 0.73 114.859 173.389 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -58.51 -51.33 70.35 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 113.574 -5.704 . . . . 1.62 113.358 173.173 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -63.25 -40.02 96.24 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.69 1.596 . . . . 2.13 110.62 176.711 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.6 t -63.38 -33.91 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 117.729 -3.107 . . . . 0.62 116.077 176.455 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.487 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 37.4 mtmt -65.33 -32.18 73.7 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.17 -4.081 . . . . 1.22 111.8 174.386 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.14 -23.35 62.99 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.191 1.796 . . . . 0.51 113.271 172.914 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -76.45 -41.18 48.28 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 126.307 2.955 . . . . 1.44 115.366 170.908 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.9 -35.13 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 118.608 -2.558 . . . . 1.32 109.672 171.139 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -62.81 -54.48 38.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.169 -3.457 . . . . 1.7 110.782 177.343 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -40.17 -52.44 2.59 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 125.619 1.567 . . . . 1.55 113.642 170.362 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -72.15 -67.05 0.57 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 115.958 1.836 . . . . 2.62 115.958 -176.818 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -101.38 -21.19 14.89 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.788 2.709 . . . . 1.48 113.829 -167.08 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.64 7.85 50.24 Favored Glycine 0 N--CA 1.43 -1.715 0 O-C-N 119.138 -2.226 . . . . 1.12 114.426 168.321 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.7 mt -81.46 117.8 69.65 Favored Pre-proline 0 N--CA 1.43 -1.433 0 N-CA-C 103.469 -2.789 . . . . 1.55 103.469 -166.614 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.91 137.28 61.73 Favored 'Trans proline' 0 N--CA 1.433 -2.066 0 C-N-CA 121.871 1.714 . . . . 1.02 114.231 -176.505 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -63.23 -8.82 15.35 Favored 'Trans proline' 0 N--CA 1.434 -1.999 0 N-CA-C 122.05 3.827 . . . . 1.25 122.05 -172.301 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -81.75 -14.35 56.58 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 119.929 -0.709 . . . . 2.25 112.0 168.668 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -90.77 -27.09 19.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.912 2.885 . . . . 2.02 110.38 -175.601 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.487 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 76.2 mt-30 -75.66 128.35 35.02 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 126.294 2.246 . . . . 0.69 114.76 -176.423 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -116.82 100.78 8.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.53 -3.856 . . . . 2.78 101.167 175.176 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 43' ' ' LEU . 94.4 mt -91.11 125.6 35.94 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 103.796 -2.668 . . . . 1.17 103.796 177.822 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 mm -120.76 130.97 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 103.888 -2.634 . . . . 1.38 103.888 178.907 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.667 ' HB2' HD21 ' A' ' 50' ' ' LEU . 1.8 t80 -84.32 -75.44 0.34 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 118.117 -0.945 . . . . 1.5 109.979 170.164 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.0 -77.63 0.59 Allowed 'General case' 0 N--CA 1.43 -1.429 2 O-C-N 115.822 -4.299 . . . . 1.21 104.909 173.589 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.8 -25.26 3.4 Favored Glycine 0 N--CA 1.429 -1.779 0 O-C-N 118.564 -2.585 . . . . 1.3 113.646 -177.971 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -84.43 138.08 33.03 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.835 -2.568 . . . . 2.55 117.503 176.66 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -71.0 142.37 50.96 Favored 'General case' 0 N--CA 1.431 -1.405 1 O-C-N 115.932 -4.23 . . . . 2.48 111.362 174.422 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' A' ' 45' ' ' PHE . 83.8 mt -90.98 141.85 28.4 Favored 'General case' 0 N--CA 1.429 -1.495 1 O-C-N 115.983 -4.198 . . . . 0.9 109.988 -175.835 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -92.66 145.08 24.7 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 125.44 1.713 . . . . 1.94 111.935 -178.069 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.74 -63.36 1.33 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.383 2.04 . . . . 1.56 112.591 -167.619 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.4 39.37 2.49 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 116.745 -3.722 . . . . 0.97 116.106 177.184 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -115.56 159.38 21.33 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 121.511 2.656 . . . . 2.49 107.381 166.399 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.319 33.5 p -84.46 156.45 21.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 126.898 3.237 . . . . 0.76 110.754 176.777 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.1 mt -68.5 -25.94 65.21 Favored 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 111.544 -6.972 . . . . 1.05 115.287 171.776 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -66.65 -32.98 74.65 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.113 -3.492 . . . . 1.19 110.014 172.538 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -64.04 -34.08 77.2 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.075 -1.641 . . . . 1.9 114.47 171.382 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -89.42 -3.44 58.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.146 1.339 . . . . 0.89 111.892 177.025 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.6 m120 55.12 50.0 16.22 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 127.415 2.286 . . . . 1.84 115.948 -174.964 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.9 mt -77.88 126.99 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 113.161 -1.836 . . . . 0.82 108.6 178.474 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -102.46 175.35 5.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.111 1.764 . . . . 2.16 110.825 -176.28 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -72.97 -8.95 58.03 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 119.308 3.077 . . . . 2.12 119.308 177.604 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -106.85 7.48 30.19 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 125.707 1.879 . . . . 1.71 109.739 177.202 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 m -84.36 144.75 28.62 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.872 -1.768 . . . . 1.04 112.766 -171.635 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.3 m -110.32 120.04 41.14 Favored 'General case' 0 N--CA 1.431 -1.384 1 C-N-CA 133.065 4.546 . . . . 0.79 104.516 -177.007 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.495 ' HB2' HG22 ' A' ' 5' ' ' VAL . 7.9 mp -104.77 158.73 16.32 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.374 -2.825 . . . . 1.4 103.374 174.519 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -121.04 124.89 45.92 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.115 1.766 . . . . 1.51 109.413 -176.505 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.1 tp -105.7 99.73 9.32 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.897 1.681 . . . . 1.14 107.058 -177.812 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.7 152.04 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 105.682 -1.97 . . . . 1.23 105.682 171.247 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.2 mt -109.36 127.99 54.77 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.164 -2.21 . . . . 2.78 107.001 176.377 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -84.89 121.14 27.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.029 2.532 . . . . 3.75 109.406 178.113 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.5 mt -66.48 144.26 56.59 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.174 -3.454 . . . . 3.14 113.244 166.309 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -76.23 110.12 10.48 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 126.44 3.019 . . . . 6.8 109.317 169.664 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.94 -51.28 0.18 Allowed Glycine 0 N--CA 1.43 -1.733 0 O-C-N 116.707 -3.746 . . . . 3.57 105.743 -173.96 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.745 0 N-CA-C 106.494 -2.642 . . . . 3.87 106.494 175.534 . . . . . . . . 0 0 . 1 . 082 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.0 ptt? . . . . . 0 CA--C 1.489 -1.37 0 CA-C-O 124.694 2.188 . . . . 1.1 115.184 . . . . . . . . . 0 0 . 1 . 082 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -94.25 125.0 38.62 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.673 -2.517 . . . . 1.87 110.772 -179.715 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.6 pt -124.89 163.79 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 124.902 1.281 . . . . 0.72 112.339 171.696 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -114.42 159.18 20.59 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.137 2.875 . . . . 1.4 107.43 -178.248 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 60.0 t -143.05 134.34 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 102.539 -3.134 . . . . 0.58 102.539 177.283 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -113.73 131.78 56.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.856 1.312 . . . . 2.09 109.324 177.856 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.5 p -87.26 164.77 16.12 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 126.122 2.867 . . . . 0.99 107.801 179.845 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.1 mt -52.36 -56.71 13.09 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 116.173 -4.08 . . . . 2.53 114.696 170.647 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.4 p -69.51 -14.07 62.67 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.202 2.601 . . . . 2.08 114.142 -173.367 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.38 32.18 1.69 Allowed Glycine 0 N--CA 1.43 -1.745 1 N-CA-C 123.26 4.064 . . . . 1.31 123.26 169.246 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -111.6 148.43 33.33 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 115.217 -2.325 . . . . 1.4 114.955 -178.414 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.1 m -98.95 127.0 44.77 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 120.636 1.562 . . . . 0.78 108.067 175.712 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -103.73 123.6 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 125.991 2.805 . . . . 1.55 106.665 175.57 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.9 m -97.86 128.55 44.55 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.494 -3.879 . . . . 1.08 103.971 -178.096 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -125.61 133.08 52.36 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 121.688 2.04 . . . . 1.55 115.897 178.75 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -80.54 104.0 10.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 113.369 0.878 . . . . 1.95 113.369 162.318 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.5 m -114.9 154.1 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 119.211 -2.18 . . . . 0.96 109.583 177.967 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -113.86 151.39 44.7 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 102.923 -2.991 . . . . 2.35 102.923 164.261 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -68.29 -4.17 12.26 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-O 116.907 -1.372 . . . . 0.95 114.911 -173.39 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.2 p -93.11 -5.09 51.07 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.497 3.119 . . . . 1.45 113.065 -179.547 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -79.93 138.39 37.1 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.864 2.066 . . . . 1.69 108.132 174.599 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 39.3 p -76.22 173.78 10.95 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-O 128.392 3.949 . . . . 0.75 108.443 176.803 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.516 HG22 ' HE3' ' A' ' 27' ' ' LYS . 31.0 mm -74.67 -27.45 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 1 O-C-N 113.348 -5.845 . . . . 0.73 106.925 175.037 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -65.6 -33.68 76.46 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 129.268 3.027 . . . . 1.62 111.433 172.079 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -83.96 -33.92 24.52 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.541 1.162 . . . . 2.13 111.825 172.867 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.26 29.0 t -64.62 -39.03 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 1 O-C-N 114.449 -5.157 . . . . 0.62 108.206 178.544 . . . . . . . . 3 2 . 1 . 082 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.516 ' HE3' HG22 ' A' ' 23' ' ' ILE 0.328 91.0 mttt -61.02 -47.87 84.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.23 -3.419 . . . . 1.22 113.528 173.486 . . . . . . . . 3 3 . 1 . 082 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.0 -39.65 63.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.849 -2.407 . . . . 0.51 109.648 170.961 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -61.22 -37.71 84.01 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.662 -4.398 . . . . 1.44 114.224 176.098 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.6 mt -77.7 -33.2 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 127.309 2.244 . . . . 1.32 112.101 171.851 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -60.77 -34.6 74.72 Favored 'General case' 0 N--CA 1.431 -1.384 1 O-C-N 115.647 -4.408 . . . . 1.7 118.452 171.902 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -67.83 -26.03 65.85 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 110.523 -3.035 . . . . 1.55 113.728 168.879 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -96.44 -58.52 2.04 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 104.633 -2.358 . . . . 2.62 104.633 -172.94 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -92.45 -44.38 8.69 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.776 -2.453 . . . . 1.48 115.145 -169.817 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.8 -11.0 10.24 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 119.299 -2.126 . . . . 1.12 111.402 176.718 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.0 mt -68.64 129.12 92.75 Favored Pre-proline 0 N--CA 1.429 -1.49 0 CA-C-O 112.896 -3.43 . . . . 1.55 109.165 -174.627 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -73.87 154.95 48.64 Favored 'Trans proline' 0 N--CA 1.433 -2.049 0 CA-C-N 126.783 3.458 . . . . 1.02 109.959 -174.667 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.39 -11.27 19.05 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 123.942 3.095 . . . . 1.25 111.654 -171.779 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -53.79 -59.14 5.0 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.906 2.482 . . . . 2.25 114.768 165.417 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -66.96 -23.79 65.99 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 118.911 2.93 . . . . 2.02 118.911 -177.871 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -83.97 134.69 34.64 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.415 1.886 . . . . 0.69 113.52 -170.311 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.255 47.8 mtt180 -119.34 114.44 22.36 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.382 -1.449 . . . . 2.78 109.847 172.11 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.0 mt -95.73 137.62 34.53 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.036 -1.839 . . . . 1.17 106.036 178.247 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.4 mt -135.37 136.78 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 128.261 2.625 . . . . 1.38 109.186 179.571 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -139.08 143.93 38.53 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 121.478 -0.764 . . . . 1.5 110.941 168.696 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.344 . . 54.4 27.57 8.35 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.712 -2.493 . . . . 1.21 115.499 176.658 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.88 -7.21 35.98 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-O 119.054 -0.859 . . . . 1.3 112.649 -170.583 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -87.2 139.93 30.06 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 123.032 3.416 . . . . 2.55 111.815 173.537 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -98.09 115.49 28.36 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.493 -2.004 . . . . 2.48 109.03 174.825 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 mt -83.24 159.42 21.97 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.425 -1.261 . . . . 0.9 112.961 -173.532 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -112.47 155.17 24.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 118.486 2.773 . . . . 1.94 118.486 172.471 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.51 -54.03 38.76 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 119.483 3.142 . . . . 1.56 119.483 -167.666 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.78 63.69 4.41 Favored Glycine 0 N--CA 1.431 -1.679 0 O-C-N 119.613 -1.929 . . . . 0.97 116.387 170.952 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -139.48 155.17 47.72 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.006 -2.22 . . . . 2.49 105.006 168.121 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 40.7 p -87.81 171.34 10.46 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.68 2.181 . . . . 0.76 109.481 176.274 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.0 mt -70.46 -37.69 74.34 Favored 'General case' 0 N--CA 1.43 -1.433 1 O-C-N 116.179 -4.076 . . . . 1.05 107.448 172.529 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.8 t -52.61 -45.83 66.74 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 118.5 2.778 . . . . 1.19 118.5 173.802 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -58.34 -53.74 54.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 130.7 3.6 . . . . 1.9 112.184 173.098 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -76.67 -2.1 31.11 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.863 -3.648 . . . . 0.89 115.876 -175.461 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.269 17.6 m120 60.93 55.44 3.14 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.569 1.947 . . . . 1.84 116.036 -178.825 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.0 mt -106.76 128.01 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-O 115.586 -2.149 . . . . 0.82 108.925 174.872 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -107.39 -176.2 3.0 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 114.446 -2.692 . . . . 2.16 111.983 -170.024 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.1 ptmm? -59.14 146.48 38.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 126.706 2.504 . . . . 2.12 114.462 171.717 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.285 50.8 mt-10 69.87 20.5 6.68 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.281 1.515 . . . . 1.71 114.984 174.767 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.8 t -102.77 161.95 13.32 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 114.249 -1.341 . . . . 1.04 110.912 -171.917 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.2 m -121.18 120.12 34.31 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.629 -1.92 . . . . 0.79 114.144 -172.205 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 8.1 mt -92.15 164.06 13.71 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 122.749 1.262 . . . . 1.4 110.381 172.694 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -121.96 112.29 18.11 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.819 -3.051 . . . . 1.51 112.324 -179.234 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.5 tp -87.55 122.29 31.07 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 118.211 -2.806 . . . . 1.14 113.361 179.14 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.94 168.33 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 105.145 -2.169 . . . . 1.23 105.145 175.107 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.1 mt -122.32 169.51 10.86 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 116.24 -4.037 . . . . 2.78 108.782 -176.533 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -87.69 154.51 20.52 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.07 -1.085 . . . . 3.75 108.07 173.394 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 tt -151.88 -48.59 0.11 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 103.86 -2.645 . . . . 3.14 103.86 166.755 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -82.53 -49.44 9.89 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 120.849 1.659 . . . . 6.8 110.114 172.436 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.89 161.01 37.08 Favored Glycine 0 N--CA 1.429 -1.767 0 O-C-N 118.239 -2.788 . . . . 3.57 109.264 -168.809 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.778 0 C-N-CA 127.874 2.654 . . . . 3.87 112.236 170.812 . . . . . . . . 0 0 . 1 . 083 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 CA--C 1.491 -1.312 0 CA-C-O 127.519 3.533 . . . . 1.1 115.955 . . . . . . . . . 0 0 . 1 . 083 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -81.77 140.2 34.38 Favored 'General case' 0 N--CA 1.431 -1.407 1 O-C-N 113.473 -5.767 . . . . 1.87 110.601 -175.387 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.5 pt -131.47 159.47 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 119.818 -1.801 . . . . 0.72 106.606 177.136 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -120.08 100.12 7.01 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.949 1.833 . . . . 1.4 112.048 -175.532 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -91.09 111.99 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 103.968 -2.605 . . . . 0.58 103.968 177.195 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.254 68.2 mmtt -90.68 141.09 29.15 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.232 -2.792 . . . . 2.09 110.85 177.666 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.5 p -93.96 176.29 6.39 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 120.586 3.55 . . . . 0.99 120.586 172.229 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.6 tp -66.11 -43.83 86.07 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 126.35 1.86 . . . . 2.53 110.497 -177.559 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.8 p -78.36 -49.55 13.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.063 3.357 . . . . 2.08 120.063 -171.641 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.9 32.59 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 128.321 2.867 . . . . 1.31 120.073 174.565 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -111.35 149.44 31.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.373 -0.973 . . . . 1.4 108.373 178.482 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -104.59 138.06 41.5 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.667 -2.521 . . . . 0.78 106.752 171.835 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.265 3.2 mt -106.12 92.91 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 122.793 1.282 . . . . 1.55 109.391 175.177 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.8 m -78.81 116.58 19.23 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 119.97 -1.706 . . . . 1.08 109.709 174.812 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.7 mt -125.51 149.26 48.45 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 106.849 -1.537 . . . . 1.55 106.849 -179.773 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -85.2 109.81 18.58 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 127.31 2.881 . . . . 1.95 117.386 165.227 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -121.88 164.07 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 121.879 2.127 . . . . 0.96 110.008 -178.799 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -112.06 157.75 38.85 Favored Pre-proline 0 N--CA 1.43 -1.435 0 C-N-CA 125.529 1.532 . . . . 2.35 109.482 164.858 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -86.48 -0.29 8.15 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 CA-C-N 125.658 3.057 . . . . 0.95 110.902 -170.281 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.1 p -89.82 -14.82 33.62 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 129.657 3.183 . . . . 1.45 111.251 175.205 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -68.03 142.37 55.91 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 127.086 3.327 . . . . 1.69 107.816 173.934 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.2 p -79.69 160.95 26.1 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.795 -2.441 . . . . 0.75 111.429 174.003 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mm -66.58 -27.17 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 1 O-C-N 115.628 -4.42 . . . . 0.73 111.743 171.513 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -56.98 -45.57 82.85 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 129.056 2.942 . . . . 1.62 109.836 167.913 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -65.45 -52.1 55.46 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.146 2.578 . . . . 2.13 111.752 176.626 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.82 -37.36 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 128.866 2.866 . . . . 0.62 109.404 177.046 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.84 -36.42 82.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 121.292 1.86 . . . . 1.22 115.467 174.81 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -24.81 67.78 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.257 1.206 . . . . 0.51 114.257 166.406 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -82.52 -25.57 33.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.756 -3.715 . . . . 1.44 111.618 173.747 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.8 mt -77.53 -29.09 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 117.915 -2.991 . . . . 1.32 111.103 175.093 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -66.61 -43.31 85.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 127.462 2.976 . . . . 1.7 111.567 173.536 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.263 31.6 t70 -49.6 -39.77 36.64 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 116.752 2.13 . . . . 1.55 116.752 168.03 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -86.07 -61.69 1.69 Allowed 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 118.289 2.7 . . . . 2.62 118.289 -178.153 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -95.19 -11.74 27.56 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.088 1.355 . . . . 1.48 113.052 -174.083 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.65 24.77 71.63 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 117.257 -3.402 . . . . 1.12 118.334 179.696 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.5 mt -99.62 132.37 23.21 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 116.852 -3.734 . . . . 1.55 110.218 -169.848 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 11.1 Cg_endo -72.91 152.51 52.11 Favored 'Trans proline' 0 C--N 1.299 -2.038 1 C-N-CA 125.518 4.145 . . . . 1.02 113.536 -175.255 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 64.9 Cg_exo -66.92 -36.61 22.38 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 O-C-N 115.322 -3.041 . . . . 1.25 112.947 -175.046 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.26 -25.74 67.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 124.715 2.198 . . . . 2.25 115.774 178.405 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -91.24 -22.91 20.36 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.29 -1.506 . . . . 2.02 109.811 179.783 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -78.84 135.89 37.17 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.831 -3.043 . . . . 0.69 112.239 -177.517 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.346 38.2 ttt180 -124.25 123.51 40.39 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 116.973 -3.579 . . . . 2.78 109.288 167.948 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mt -105.63 127.17 52.9 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.672 2.177 . . . . 1.17 108.885 179.682 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.3 mm -114.37 143.17 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 131.273 3.829 . . . . 1.38 106.816 -177.683 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -131.07 100.05 5.09 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.723 -3.111 . . . . 1.5 107.973 175.998 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.351 . . 66.76 -61.53 0.32 Allowed 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 129.22 3.008 . . . . 1.21 114.856 -173.031 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.09 -24.31 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 106.538 -2.625 . . . . 1.3 106.538 -176.079 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -90.08 153.41 20.57 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.094 -2.416 . . . . 2.55 110.481 177.237 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -97.73 140.59 31.9 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 102.072 -3.307 . . . . 2.48 102.072 179.184 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.2 mt -116.47 127.08 54.25 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 115.961 -1.971 . . . . 0.9 110.767 -173.023 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -83.31 157.1 22.73 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 118.635 2.828 . . . . 1.94 118.635 -179.419 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -59.87 -63.85 1.16 Allowed 'General case' 0 N--CA 1.43 -1.444 1 N-CA-C 121.829 4.011 . . . . 1.56 121.829 -167.02 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.21 31.79 2.58 Favored Glycine 0 N--CA 1.43 -1.754 0 CA-C-N 113.572 -1.649 . . . . 0.97 117.114 172.05 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.2 mmt180 -98.25 164.77 12.17 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.486 -3.361 . . . . 2.49 109.04 159.616 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.455 11.9 p -95.69 172.83 7.8 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.65 2.38 . . . . 0.76 109.855 172.615 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.6 mp -76.01 -37.96 57.86 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.979 -1.009 . . . . 1.05 109.607 171.098 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -48.97 -50.03 37.62 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 116.588 2.07 . . . . 1.19 116.588 175.433 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -56.28 -35.44 67.49 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.352 2.661 . . . . 1.9 115.367 176.126 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -99.45 6.72 45.89 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.835 1.654 . . . . 0.89 112.849 178.342 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.9 m120 53.87 37.89 27.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.53 2.048 . . . . 1.84 116.53 -178.811 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.2 mm -82.27 114.69 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 126.691 1.996 . . . . 0.82 107.88 -173.896 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -103.61 -177.22 3.31 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.779 -2.451 . . . . 2.16 110.731 -173.61 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -58.45 146.29 35.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 127.143 2.177 . . . . 2.12 113.08 179.425 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.276 72.9 mt-10 64.03 19.42 11.75 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 128.325 3.516 . . . . 1.71 118.119 172.957 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.6 m -88.48 151.33 22.62 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.91 -1.885 . . . . 1.04 105.91 -168.778 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.0 m -90.12 110.38 21.39 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.269 2.228 . . . . 0.79 107.716 -179.364 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -102.34 155.76 18.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 102.214 -3.254 . . . . 1.4 102.214 174.055 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -129.16 128.24 43.01 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.974 -4.204 . . . . 1.51 115.34 -176.781 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.0 tp -108.34 124.21 50.0 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 124.749 1.281 . . . . 1.14 112.28 -174.686 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.431 15.6 m -118.17 -179.3 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 130.481 3.512 . . . . 1.23 108.812 170.202 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.1 mt -131.41 150.92 51.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.398 -3.938 . . . . 2.78 113.099 179.038 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -84.48 160.11 20.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 127.628 3.08 . . . . 3.75 114.076 176.645 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.8 mt -104.19 -179.38 3.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.704 -2.702 . . . . 3.14 103.704 168.499 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.8 mtt85 -79.39 155.12 28.53 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.97 -2.956 . . . . 6.8 112.774 168.825 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.93 -137.05 12.82 Favored Glycine 0 N--CA 1.43 -1.762 0 O-C-N 118.336 -2.727 . . . . 3.57 108.718 -161.746 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.825 0 C-N-CA 117.798 -2.144 . . . . 3.87 108.783 174.075 . . . . . . . . 0 0 . 1 . 084 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 CA--C 1.489 -1.382 0 N-CA-C 115.709 1.744 . . . . 1.1 115.709 . . . . . . . . . 0 0 . 1 . 084 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -74.82 134.64 41.71 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 118.079 -0.962 . . . . 1.87 111.048 -177.683 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.445 HD12 HD12 ' A' ' 67' ' ' LEU . 45.5 pt -131.15 173.38 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-O 127.385 3.469 . . . . 0.72 108.341 174.769 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.439 ' HB2' ' HA ' ' A' ' 66' ' ' THR 0.251 22.9 m-85 -127.41 134.83 49.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.519 -3.238 . . . . 1.4 105.653 -171.465 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -116.69 114.59 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.545 -2.021 . . . . 0.58 105.545 178.554 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -107.98 137.02 46.7 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 116.18 -4.075 . . . . 2.09 109.779 178.367 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.2 p -83.69 166.77 17.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.531 -1.981 . . . . 0.99 115.157 173.167 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.8 mt -39.14 -51.9 1.9 Allowed 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 120.903 3.668 . . . . 2.53 120.903 167.021 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.8 p -82.99 -32.28 27.06 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 116.697 -3.752 . . . . 2.08 110.061 -175.544 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.44 24.66 0.16 Allowed Glycine 0 N--CA 1.43 -1.717 0 O-C-N 119.407 -2.058 . . . . 1.31 116.758 172.066 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -88.41 123.18 32.71 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.207 1.504 . . . . 1.4 112.707 -175.791 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -83.93 115.84 22.49 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 120.726 3.602 . . . . 0.78 120.726 172.939 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.4 mt -108.24 141.08 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 124.911 1.284 . . . . 1.55 111.136 176.352 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.8 m -116.97 137.21 52.37 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.523 -1.986 . . . . 1.08 107.152 178.419 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.8 mt -135.96 144.11 45.23 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.219 1.407 . . . . 1.55 112.007 -179.435 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -93.59 115.83 28.33 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.004 0.82 . . . . 1.95 111.168 169.283 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.53 HG11 HG22 ' A' ' 26' ' ' VAL . 11.5 m -118.57 173.4 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 101.914 -3.365 . . . . 0.96 101.914 178.377 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -118.25 160.24 40.19 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 103.488 -2.782 . . . . 2.35 103.488 167.435 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -64.71 -18.28 62.1 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 C-N-CA 124.558 3.505 . . . . 0.95 117.25 -173.183 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 m -104.08 19.72 19.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 126.622 2.451 . . . . 1.45 107.563 -178.346 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -82.03 140.96 33.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 113.449 0.907 . . . . 1.69 113.449 171.168 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.264 68.2 p -80.02 156.22 27.25 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.563 2.125 . . . . 0.75 113.491 174.99 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.3 mm -58.62 -41.12 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.663 1.585 . . . . 0.73 111.621 175.074 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -46.54 -44.72 18.14 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.701 -1.875 . . . . 1.62 114.992 168.276 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -71.21 -35.58 71.57 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 125.658 1.583 . . . . 2.13 111.276 179.678 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.53 HG22 HG11 ' A' ' 17' ' ' VAL . 5.5 t -58.38 -45.69 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 117.587 -3.196 . . . . 0.62 114.199 167.989 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -65.77 -35.49 80.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 114.169 -2.824 . . . . 1.22 111.353 170.0 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.04 -29.21 68.13 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 123.365 2.802 . . . . 0.51 111.539 175.085 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.6 mttm -65.71 -21.98 66.57 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.571 -1.331 . . . . 1.44 114.049 171.752 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.2 mm -85.94 -23.92 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 127.252 2.221 . . . . 1.32 105.911 170.073 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.426 ' OE1' ' HD3' ' A' ' 38' ' ' PRO . 50.4 tt0 -77.04 -23.03 52.11 Favored 'General case' 0 N--CA 1.429 -1.482 2 O-C-N 114.538 -5.101 . . . . 1.7 111.265 173.717 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -74.51 -40.45 61.77 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 114.716 1.376 . . . . 1.55 114.716 167.571 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -87.35 -66.31 0.92 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 116.592 2.071 . . . . 2.62 116.592 179.093 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -82.52 -32.11 28.85 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 118.057 -1.457 . . . . 1.48 109.625 -172.101 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.75 43.05 3.45 Favored Glycine 0 N--CA 1.429 -1.776 0 O-C-N 116.78 -3.7 . . . . 1.12 114.155 -176.193 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.4 mt -120.38 136.78 25.46 Favored Pre-proline 0 N--CA 1.429 -1.5 1 N-CA-C 99.808 -4.145 . . . . 1.55 99.808 -174.721 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -67.84 152.66 77.08 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 O-C-N 115.767 -2.807 . . . . 1.02 113.845 176.798 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.426 ' HD3' ' OE1' ' A' ' 31' ' ' GLN . 63.1 Cg_endo -78.41 -12.93 15.31 Favored 'Trans proline' 0 N--CA 1.433 -2.079 0 C-N-CA 117.529 -1.181 . . . . 1.25 110.713 -173.277 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -72.6 -38.5 67.82 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.347 -2.095 . . . . 2.25 113.89 170.885 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -69.97 -25.67 63.74 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.327 -2.733 . . . . 2.02 111.085 178.308 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -89.35 143.62 26.69 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.384 2.673 . . . . 0.69 115.873 -171.817 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -132.0 150.38 52.17 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 115.709 -2.091 . . . . 2.78 107.966 167.503 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.9 mt -106.14 138.85 41.6 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 124.553 3.342 . . . . 1.17 110.017 174.355 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 mt -112.67 146.12 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-O 125.03 2.347 . . . . 1.38 106.372 172.251 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.45 ' HB3' HD11 ' A' ' 50' ' ' LEU . 83.8 t80 -165.36 137.08 4.09 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 127.756 3.646 . . . . 1.5 105.166 174.653 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.53 19.51 11.53 Favored 'General case' 0 N--CA 1.431 -1.4 1 O-C-N 116.052 -4.155 . . . . 1.21 113.775 -176.622 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.13 -22.8 32.61 Favored Glycine 0 N--CA 1.431 -1.669 0 O-C-N 119.177 -2.202 . . . . 1.3 113.826 -175.5 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -93.0 157.54 16.26 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 121.539 3.903 . . . . 2.55 121.539 176.403 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -94.45 133.91 37.53 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 116.973 -1.891 . . . . 2.48 111.106 174.226 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 45' ' ' PHE . 19.9 mt -81.13 133.23 35.43 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.106 1.362 . . . . 0.9 113.069 -172.927 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -67.3 142.98 56.67 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.273 1.035 . . . . 1.94 109.725 170.136 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -77.0 -56.43 4.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.154 1.454 . . . . 1.56 110.381 -168.553 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.16 40.87 1.74 Allowed Glycine 0 N--CA 1.43 -1.765 1 O-C-N 116.225 -4.047 . . . . 0.97 118.198 171.33 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -117.73 161.2 20.08 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.626 -3.279 . . . . 2.49 106.555 167.745 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.5 p -86.23 177.19 7.58 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.094 -1.629 . . . . 0.76 114.233 176.11 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.0 mt -70.45 -44.69 67.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.672 -1.893 . . . . 1.05 110.4 176.106 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 t -63.01 -30.54 71.68 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.239 1.57 . . . . 1.19 115.239 -178.811 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -57.26 -46.7 82.81 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.806 2.442 . . . . 1.9 107.269 177.596 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.263 24.2 m-85 -87.15 -1.86 58.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.208 -3.432 . . . . 0.89 116.515 177.121 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 71.88 52.8 0.21 Allowed 'General case' 0 N--CA 1.43 -1.459 1 C-N-CA 133.87 4.868 . . . . 1.84 107.268 178.047 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 mt -96.7 126.27 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.123 -2.236 . . . . 0.82 107.747 -179.455 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.408 31.0 mt-30 -96.76 -167.49 1.56 Allowed 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 121.153 -0.967 . . . . 2.16 110.127 -171.582 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -75.05 151.32 38.7 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.699 1.6 . . . . 2.12 112.79 167.848 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.295 8.8 mt-10 66.6 27.31 9.59 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.579 2.351 . . . . 1.71 114.053 172.856 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.9 t -108.98 134.82 51.12 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 117.183 -3.448 . . . . 1.04 110.648 -172.961 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 97.9 m -82.11 104.21 12.28 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.449 2.547 . . . . 0.79 115.324 -178.346 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.445 HD12 HD12 ' A' ' 3' ' ' ILE . 93.6 mt -91.58 129.23 37.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.142 -2.849 . . . . 1.4 108.922 177.953 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -92.19 115.54 28.17 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.348 -2.72 . . . . 1.51 108.666 -173.22 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.4 tp -86.52 134.2 33.68 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 113.558 -3.115 . . . . 1.14 115.742 179.946 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 m -132.11 -172.63 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 127.892 3.245 . . . . 1.23 108.78 170.427 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.0 mt -114.82 -179.12 3.54 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.317 1.847 . . . . 2.78 110.279 176.315 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.258 12.5 ptt180 -76.47 161.42 28.66 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 125.567 1.792 . . . . 3.75 113.853 179.874 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.1 mt -93.93 166.75 12.02 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 124.744 1.217 . . . . 3.14 110.816 166.733 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.256 26.2 mmt180 -98.69 150.9 21.31 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.071 -1.455 . . . . 6.8 107.071 170.004 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.24 -139.09 6.32 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 127.381 2.419 . . . . 3.57 111.182 -170.374 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.806 0 CA-C-O 125.46 2.7 . . . . 3.87 110.925 177.157 . . . . . . . . 0 0 . 1 . 085 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptt? . . . . . 0 CA--C 1.49 -1.328 0 N-CA-C 107.841 -1.17 . . . . 1.1 107.841 . . . . . . . . . 0 0 . 1 . 085 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -121.55 144.81 48.51 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 119.941 -0.704 . . . . 1.87 111.656 -176.02 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.2 pt -129.06 163.74 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 120.042 -1.661 . . . . 0.72 110.038 175.167 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -111.42 114.31 27.35 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.366 2.508 . . . . 1.4 108.539 -178.647 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 81.4 t -103.76 126.33 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 118.252 -2.78 . . . . 0.58 105.985 169.347 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -107.16 127.49 53.56 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 125.638 1.836 . . . . 2.09 110.385 174.109 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.3 p -81.15 170.31 16.3 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 129.805 3.242 . . . . 0.99 113.154 173.09 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.9 mt -67.2 -30.6 70.58 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.271 -2.143 . . . . 2.53 114.086 174.701 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 p -85.7 -5.42 59.26 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.556 -1.275 . . . . 2.08 107.556 -174.677 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.92 1.49 36.36 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 115.225 0.85 . . . . 1.31 115.225 170.592 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -78.64 114.57 17.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 118.54 1.17 . . . . 1.4 112.518 -178.123 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 m -79.64 130.44 35.37 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 120.708 1.595 . . . . 0.78 110.497 170.052 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 mt -109.19 119.15 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 131.541 3.936 . . . . 1.55 106.554 174.528 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.2 m -92.41 95.66 9.79 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 107.143 -1.429 . . . . 1.08 107.143 178.765 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.3 mt -96.2 139.07 32.89 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 117.937 2.569 . . . . 1.55 117.937 -177.149 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -59.76 114.49 2.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 111.127 -2.761 . . . . 1.95 109.289 163.56 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.298 13.7 m -136.6 166.19 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 126.983 2.113 . . . . 0.96 109.708 173.795 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -125.28 162.42 44.18 Favored Pre-proline 0 N--CA 1.43 -1.473 0 N-CA-C 101.258 -3.608 . . . . 2.35 101.258 171.892 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -81.93 -6.55 12.29 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 O-C-N 117.739 -1.769 . . . . 0.95 107.909 -175.79 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.7 p -99.82 16.98 21.93 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.247 1.573 . . . . 1.45 115.247 176.445 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -78.14 144.29 36.54 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 129.56 3.144 . . . . 1.69 106.123 172.952 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.0 p -83.4 154.53 23.95 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.01 1.724 . . . . 0.75 111.586 175.548 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.0 mm -67.72 -36.3 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 124.897 1.373 . . . . 0.73 110.145 -179.523 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -59.95 -41.97 93.02 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.573 -1.955 . . . . 1.62 111.92 169.977 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.3 28.4 t-20 -61.55 -37.16 82.77 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.75 -3.094 . . . . 2.13 114.738 177.256 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.9 t -53.33 -51.39 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 124.522 1.138 . . . . 0.62 113.329 169.676 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -59.96 -31.86 70.27 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 114.071 1.137 . . . . 1.22 114.071 174.38 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.22 -33.45 73.32 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.168 -2.207 . . . . 0.51 113.376 170.893 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -71.2 -26.04 62.77 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 122.397 2.362 . . . . 1.44 110.247 173.544 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.3 mt -76.99 -26.54 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-N 121.28 1.855 . . . . 1.32 106.585 173.786 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -68.9 -48.51 63.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 121.194 1.816 . . . . 1.7 109.755 176.75 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -51.18 -39.08 55.63 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.071 -2.893 . . . . 1.55 113.616 174.184 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -82.92 -71.11 0.51 Allowed 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.877 2.471 . . . . 2.62 106.221 -174.978 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -100.42 -45.14 5.66 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.051 2.982 . . . . 1.48 119.051 -166.292 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.78 74.25 0.85 Allowed Glycine 0 N--CA 1.431 -1.694 0 CA-C-O 124.748 2.305 . . . . 1.12 115.946 166.37 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.89 127.24 23.94 Favored Pre-proline 0 N--CA 1.43 -1.466 0 CA-C-N 110.804 -2.698 . . . . 1.55 105.54 -178.724 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -58.42 134.92 64.48 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 CA-C-O 112.481 -3.216 . . . . 1.02 118.075 176.851 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -65.44 -14.97 47.68 Favored 'Trans proline' 0 C--N 1.299 -2.046 1 C-N-CA 126.51 4.807 . . . . 1.25 120.528 -174.407 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.85 -20.34 35.79 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.338 -2.101 . . . . 2.25 111.06 167.44 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -87.11 -29.02 22.15 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.517 1.962 . . . . 2.02 114.438 -175.476 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.329 1.5 pt20 -78.95 135.62 37.0 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 115.067 -2.397 . . . . 0.69 110.041 -176.468 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.31 65.9 mtt180 -104.15 136.44 43.77 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 128.482 3.614 . . . . 2.78 110.047 164.834 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.5 mt -108.89 132.83 53.67 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 126.67 3.128 . . . . 1.17 110.072 172.116 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 53.7 mt -119.58 142.06 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 118.822 -2.423 . . . . 1.38 106.51 -178.831 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -157.89 141.15 15.24 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 100.603 -3.851 . . . . 1.5 100.603 171.98 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.56 -44.96 0.61 Allowed 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.385 3.074 . . . . 1.21 116.394 -173.948 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 166.78 -48.42 0.26 Allowed Glycine 0 N--CA 1.43 -1.731 0 CA-C-O 124.646 2.248 . . . . 1.3 109.598 -170.923 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -83.09 -179.97 7.58 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.443 2.016 . . . . 2.55 116.443 178.752 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -96.53 147.7 23.58 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.433 -2.042 . . . . 2.48 111.502 170.87 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.6 mt -94.54 134.11 37.45 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 104.583 -2.377 . . . . 0.9 104.583 -176.105 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -86.09 137.34 32.75 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.717 0.77 . . . . 1.94 111.436 176.478 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.13 -57.99 5.73 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.935 3.694 . . . . 1.56 117.746 -168.95 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.98 44.16 3.28 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 124.639 3.381 . . . . 0.97 120.041 176.318 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 -115.65 173.26 6.63 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.733 2.682 . . . . 2.49 104.479 165.685 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.7 p -108.88 173.8 6.16 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.534 -1.666 . . . . 0.76 112.258 176.406 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.3 mp -71.15 -37.28 72.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 114.856 1.428 . . . . 1.05 114.856 170.062 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -57.51 -42.0 81.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.397 -2.689 . . . . 1.19 113.73 174.539 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -52.21 -41.22 62.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.185 2.661 . . . . 1.9 118.185 173.461 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -88.99 -16.06 32.64 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 128.366 2.667 . . . . 0.89 108.251 178.139 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.419 12.0 m-80 72.83 48.56 0.19 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.776 -1.203 . . . . 1.84 111.395 179.434 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.6 mt -87.92 122.22 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.97 -2.331 . . . . 0.82 107.954 -172.993 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -87.39 -177.12 5.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 117.38 -1.728 . . . . 2.16 114.373 -173.543 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.256 14.8 pttp -63.43 140.37 58.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.952 -3.593 . . . . 2.12 110.969 167.358 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 68.42 30.18 5.47 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 127.937 2.495 . . . . 1.71 111.642 177.908 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.1 m -88.02 145.24 26.08 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 119.097 -2.252 . . . . 1.04 113.278 -172.79 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.3 m -92.27 119.68 32.1 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 118.302 -2.749 . . . . 0.79 112.953 -179.923 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mt -104.95 131.36 52.55 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 119.7 -1.875 . . . . 1.4 107.718 165.3 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -94.92 135.51 36.35 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 103.701 -2.703 . . . . 1.51 103.701 -178.719 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.7 tp -106.96 123.17 47.79 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 127.226 2.211 . . . . 1.14 110.666 -172.18 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.329 0.1 OUTLIER -121.63 167.89 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.578 1.951 . . . . 1.23 112.596 176.499 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.0 mt -127.18 140.15 52.44 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 125.66 1.85 . . . . 2.78 108.697 177.979 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -84.92 168.98 14.52 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.436 2.065 . . . . 3.75 112.505 172.353 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.8 mt -84.35 108.7 17.33 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.412 -3.305 . . . . 3.14 110.516 174.721 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -72.71 -57.62 3.97 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.842 -1.54 . . . . 6.8 106.842 168.137 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.34 88.53 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.752 1 O-C-N 116.287 -4.008 . . . . 3.57 106.265 -172.072 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.802 0 C-N-CA 116.313 -2.851 . . . . 3.87 116.327 -171.412 . . . . . . . . 0 0 . 1 . 086 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 CA--C 1.491 -1.321 0 CA-C-O 116.583 -1.675 . . . . 1.1 114.993 . . . . . . . . . 0 0 . 1 . 086 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -93.35 122.81 36.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 128.69 2.796 . . . . 1.87 106.769 -177.367 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 pt -119.65 170.17 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 124.553 2.121 . . . . 0.72 108.124 169.539 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.263 72.7 m-85 -122.09 144.56 48.85 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.185 -3.447 . . . . 1.4 110.645 -179.652 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.83 128.9 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 120.482 -1.386 . . . . 0.58 108.045 173.327 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -93.28 132.36 37.54 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.753 -3.092 . . . . 2.09 108.573 171.206 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.9 p -74.16 -169.99 0.88 Allowed 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 117.338 2.347 . . . . 0.99 117.338 177.105 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.2 mt -72.69 -62.44 1.45 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.225 2.61 . . . . 2.53 106.377 173.743 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.8 p -56.76 -56.34 22.76 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 120.383 3.475 . . . . 2.08 120.383 -175.178 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.38 43.55 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.764 0 CA-C-O 119.219 -0.767 . . . . 1.31 111.35 177.968 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -126.49 155.56 42.12 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 130.279 3.432 . . . . 1.4 104.334 -179.002 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.9 m -125.32 119.05 27.3 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 104.839 -2.282 . . . . 0.78 104.839 -178.94 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -95.52 148.88 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 103.483 -2.784 . . . . 1.55 103.483 -176.421 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.3 m -117.41 117.85 30.6 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.452 2.548 . . . . 1.08 106.231 177.296 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.2 mt -116.37 138.19 51.54 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.7 -2.5 . . . . 1.55 111.179 -174.517 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.12 106.15 18.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 126.724 2.009 . . . . 1.95 115.143 170.713 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 m -127.87 167.79 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 125.538 2.589 . . . . 0.96 108.549 -172.937 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -110.1 161.78 23.03 Favored Pre-proline 0 N--CA 1.43 -1.453 0 O-C-N 116.584 -3.823 . . . . 2.35 108.257 162.682 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -73.06 -12.12 25.67 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-N 124.72 2.721 . . . . 0.95 113.275 -177.245 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 m -83.7 -9.14 59.05 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 115.124 -2.369 . . . . 1.45 109.339 175.523 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -74.0 155.86 38.15 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 124.391 3.269 . . . . 1.69 111.138 178.251 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.6 p -95.73 164.44 12.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.5 -1.375 . . . . 0.75 110.411 -177.19 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.6 mm -62.47 -31.11 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 124.581 1.153 . . . . 0.73 112.032 175.934 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -58.71 -47.52 84.29 Favored 'General case' 0 N--CA 1.429 -1.499 1 C-N-CA 134.097 4.959 . . . . 1.62 114.611 162.383 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.281 29.4 m120 -66.21 -37.95 86.8 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.483 -3.26 . . . . 2.13 106.93 178.947 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.4 t -71.2 -25.95 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 1 O-C-N 115.045 -4.784 . . . . 0.62 117.875 176.415 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -81.96 -32.92 30.49 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 104.635 -2.357 . . . . 1.22 104.635 178.994 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.4 68.0 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.872 -3.642 . . . . 0.51 111.407 172.715 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -67.15 -28.19 67.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 125.867 1.979 . . . . 1.44 109.921 171.595 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.1 mt -75.39 -18.04 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 116.514 -3.866 . . . . 1.32 113.93 170.138 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -68.35 -27.75 66.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 119.715 1.143 . . . . 1.7 111.694 167.667 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -68.57 -51.74 39.39 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.385 -3.322 . . . . 1.55 112.338 165.638 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -68.81 -74.81 0.12 Allowed 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.926 -2.359 . . . . 2.62 117.256 -175.603 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -90.73 -15.24 30.58 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 124.389 1.055 . . . . 1.48 113.122 -176.6 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.38 48.47 5.94 Favored Glycine 0 N--CA 1.43 -1.723 0 C-N-CA 119.276 -1.44 . . . . 1.12 115.967 168.046 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.4 mt -125.66 140.07 35.62 Favored Pre-proline 0 N--CA 1.429 -1.488 0 C-N-CA 126.781 2.033 . . . . 1.55 107.786 -175.51 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -67.83 149.9 78.4 Favored 'Trans proline' 0 N--CA 1.433 -2.055 2 C-N-CA 125.938 4.425 . . . . 1.02 112.285 -174.381 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.472 58.0 Cg_endo -61.22 -38.35 66.87 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 CA-C-N 127.293 3.64 . . . . 1.25 119.213 -179.972 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -57.44 -36.65 71.67 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 127.003 2.69 . . . . 2.25 114.178 -179.316 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -81.22 -13.11 58.88 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.576 2.065 . . . . 2.02 116.576 -177.021 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -92.19 141.94 28.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.94 -1.725 . . . . 0.69 110.822 -175.445 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -113.52 134.78 54.5 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 125.775 1.922 . . . . 2.78 110.702 167.515 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 69' ' ' LEU . 34.8 mt -116.73 111.96 20.52 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.022 -1.844 . . . . 1.17 106.022 -178.618 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.569 HD13 ' HA ' ' A' ' 49' ' ' GLN . 24.3 mm -102.46 135.58 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 118.626 -2.546 . . . . 1.38 108.063 -173.318 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -154.44 122.89 6.1 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 124.249 1.02 . . . . 1.5 111.166 171.687 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.92 46.64 4.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.801 2.239 . . . . 1.21 116.525 -177.448 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.24 -31.01 4.21 Favored Glycine 0 N--CA 1.43 -1.734 0 CA-C-N 113.875 -1.511 . . . . 1.3 114.505 175.528 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -96.68 156.74 16.22 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 124.867 2.27 . . . . 2.55 114.415 -177.299 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.569 ' HA ' HD13 ' A' ' 44' ' ' ILE . 39.3 tt0 -93.05 121.51 34.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 127.492 3.52 . . . . 2.48 109.867 175.349 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.3 mt -79.07 122.6 26.42 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 113.55 -5.719 . . . . 0.9 114.864 -172.901 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.259 53.4 mt-10 -70.59 139.67 51.49 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 121.171 3.767 . . . . 1.94 121.171 -178.222 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -52.54 -63.09 1.25 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.327 3.051 . . . . 1.56 116.74 -169.323 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.74 43.3 3.06 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 125.784 1.659 . . . . 0.97 113.12 172.296 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.5 mtt-85 -121.91 162.02 21.76 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.642 -2.681 . . . . 2.49 109.543 165.686 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.26 70.2 p -92.63 151.17 20.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.368 2.667 . . . . 0.76 110.372 178.519 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -50.96 -50.59 57.71 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 125.514 2.578 . . . . 1.05 110.9 167.438 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -48.36 -42.69 32.24 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 114.605 -5.059 . . . . 1.19 118.006 174.668 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -71.5 -16.85 62.36 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.938 2.199 . . . . 1.9 116.938 173.538 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -94.15 -2.91 51.92 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 126.167 1.787 . . . . 0.89 106.359 177.096 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.5 m120 66.03 32.3 8.44 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.922 1.689 . . . . 1.84 112.735 176.341 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.7 mt -91.03 121.55 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 126.842 3.211 . . . . 0.82 107.771 -177.537 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -113.1 -170.46 1.68 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.66 -3.15 . . . . 2.16 114.044 178.531 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -61.73 135.63 57.68 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 112.348 -2.206 . . . . 2.12 112.279 -179.689 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.272 12.9 mt-10 83.67 13.58 0.35 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.791 2.036 . . . . 1.71 116.086 173.119 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.8 t -88.11 145.34 25.99 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.843 2.057 . . . . 1.04 105.873 -170.364 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.2 m -108.31 110.16 21.67 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.7 -1.25 . . . . 0.79 110.497 -176.678 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.4 mt -90.34 150.83 21.73 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 127.424 3.488 . . . . 1.4 107.247 172.582 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -111.73 129.39 56.13 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.083 -4.761 . . . . 1.51 110.993 -179.48 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 43' ' ' LEU . 47.3 tp -98.28 133.13 43.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 128.106 3.812 . . . . 1.14 101.559 -171.234 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.55 163.06 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.986 -2.946 . . . . 1.23 106.668 172.516 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 71' ' ' LEU . 33.1 mt -100.96 154.92 18.28 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 125.643 2.64 . . . . 2.78 114.646 176.034 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -65.82 -64.34 0.88 Allowed 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 116.244 -4.035 . . . . 3.75 112.71 -177.428 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.5 tp -121.14 109.9 15.55 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 126.613 1.965 . . . . 3.14 109.145 173.466 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -151.77 -59.95 0.16 Allowed 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 104.704 -2.332 . . . . 6.8 104.704 171.863 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -161.24 -99.65 0.15 Allowed Glycine 0 N--CA 1.43 -1.701 0 O-C-N 117.898 -3.002 . . . . 3.57 107.539 -172.515 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.773 0 C-N-CA 127.491 2.472 . . . . 3.87 109.774 -174.936 . . . . . . . . 0 0 . 1 . 087 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 ptt? . . . . . 0 CA--C 1.491 -1.315 0 N-CA-C 115.303 1.594 . . . . 1.1 115.303 . . . . . . . . . 0 0 . 1 . 087 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.278 4.8 pt20 -127.02 138.93 53.33 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 129.042 3.963 . . . . 1.87 112.984 175.064 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.5 pt -127.2 151.05 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 130.794 3.638 . . . . 0.72 109.989 175.987 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -98.26 136.83 37.89 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 111.898 -2.41 . . . . 1.4 110.438 -179.056 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 89.2 t -112.66 125.84 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 CA-C-O 114.692 -2.575 . . . . 0.58 111.397 171.982 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -105.29 128.43 53.45 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 123.122 2.692 . . . . 2.09 113.611 176.263 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.286 3.5 p -84.56 173.91 10.42 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 120.036 3.347 . . . . 0.99 120.036 177.576 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.77 -38.08 82.93 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 130.548 3.539 . . . . 2.53 111.302 -179.821 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.7 p -74.95 -45.42 42.42 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.485 1.514 . . . . 2.08 109.713 177.408 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.25 42.67 0.31 Allowed Glycine 0 N--CA 1.43 -1.728 0 O-C-N 125.944 2.027 . . . . 1.31 110.603 169.154 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -105.69 157.98 17.04 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.076 2.15 . . . . 1.4 106.279 -173.266 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -111.25 124.53 52.4 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 121.024 1.738 . . . . 0.78 106.33 175.414 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.472 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 20.0 mt -100.04 121.51 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 100.807 -3.775 . . . . 1.55 100.807 173.795 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.0 m -104.89 114.07 28.05 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.176 2.893 . . . . 1.08 105.675 175.087 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.6 mt -101.11 145.16 29.12 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 128.171 2.588 . . . . 1.55 112.772 -177.046 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -97.18 112.69 24.37 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 117.02 -1.467 . . . . 1.95 113.892 173.475 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.8 169.93 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 116.032 1.864 . . . . 0.96 116.032 -179.815 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -114.37 160.74 31.71 Favored Pre-proline 0 N--CA 1.43 -1.449 0 O-C-N 127.968 3.293 . . . . 2.35 109.424 165.954 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.34 -10.66 29.64 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 O-C-N 114.521 -3.463 . . . . 0.95 114.792 -173.687 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.8 p -85.87 -16.18 39.45 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.792 3.808 . . . . 1.45 111.468 177.881 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -70.19 147.8 49.41 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.408 -3.308 . . . . 1.69 114.064 -175.845 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.8 p -95.67 166.24 11.92 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 116.197 -4.064 . . . . 0.75 112.494 -177.299 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.331 29.7 mm -65.42 -31.79 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 116.81 2.152 . . . . 0.73 116.81 179.203 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -46.83 -52.08 15.08 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.19 2.196 . . . . 1.62 116.608 160.965 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -70.72 -35.81 72.9 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.704 2.002 . . . . 2.13 109.11 -177.974 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.9 t -70.04 -49.69 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 119.044 -2.285 . . . . 0.62 111.459 -179.489 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -62.56 -27.7 69.36 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.164 -2.21 . . . . 1.22 115.749 175.984 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.58 -40.53 97.18 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 128.661 2.785 . . . . 0.51 114.422 173.67 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.4 mttm -62.25 -26.93 68.66 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.303 2.241 . . . . 1.44 116.565 171.629 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.9 mt -74.09 -42.89 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 126.997 2.119 . . . . 1.32 111.701 171.913 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -62.68 -34.04 76.31 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.496 -1.229 . . . . 1.7 112.519 178.36 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.24 -47.04 81.2 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.437 -2.039 . . . . 1.55 115.643 171.831 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -78.9 -59.59 2.72 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.27 -1.786 . . . . 2.62 113.725 -177.343 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -101.28 -30.84 11.28 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 128.905 2.882 . . . . 1.48 109.989 -165.258 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.74 19.86 30.56 Favored Glycine 0 N--CA 1.429 -1.77 0 O-C-N 121.098 -1.001 . . . . 1.12 113.993 170.428 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.5 mt -91.3 123.42 64.2 Favored Pre-proline 0 N--CA 1.431 -1.409 0 CA-C-O 114.466 -2.683 . . . . 1.55 110.039 178.219 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -67.66 144.08 64.67 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 124.386 3.391 . . . . 1.02 110.187 -174.009 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.77 -24.41 47.15 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 C-N-CA 125.053 3.836 . . . . 1.25 113.03 -167.831 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -68.01 -26.05 65.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.892 2.477 . . . . 2.25 109.871 178.496 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -89.32 -18.69 26.45 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 125.427 2.537 . . . . 2.02 110.894 -176.275 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -82.18 125.87 31.41 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.621 -2.55 . . . . 0.69 112.059 -177.868 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.573 ' HB2' HG23 ' A' ' 70' ' ' VAL . 94.7 mtt180 -119.54 129.38 54.65 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 104.903 -2.258 . . . . 2.78 104.903 168.759 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.1 mt -103.01 139.48 38.52 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.63 -3.169 . . . . 1.17 111.022 176.69 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.456 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 17.8 mm -121.14 146.97 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 103.154 -2.906 . . . . 1.38 103.154 176.901 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -135.94 105.21 5.99 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 101.365 -3.569 . . . . 1.5 101.365 173.208 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.309 . . 70.65 -75.13 0.08 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.921 2.088 . . . . 1.21 115.054 179.283 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.34 -4.66 0.9 Allowed Glycine 0 N--CA 1.431 -1.651 0 CA-C-N 113.481 -1.691 . . . . 1.3 115.101 -175.385 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.27 65.6 mttm -106.82 143.2 35.26 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.765 -0.828 . . . . 2.55 108.765 -178.85 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -86.44 128.51 34.96 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 117.375 -1.298 . . . . 2.48 108.371 164.775 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 mt -83.66 134.92 34.76 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 116.349 1.981 . . . . 0.9 116.349 -173.815 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -75.86 147.98 38.67 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.576 1.151 . . . . 1.94 111.56 175.182 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -68.53 -38.03 80.51 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 118.559 2.8 . . . . 1.56 118.559 -171.133 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.8 28.25 14.46 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 126.078 1.799 . . . . 0.97 113.49 176.703 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -100.34 163.97 12.15 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 121.234 -1.156 . . . . 2.49 111.671 167.222 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.8 p -96.5 -172.03 2.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.516 -1.99 . . . . 0.76 111.368 175.509 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.3 mt -87.83 -29.25 21.08 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 119.107 -2.245 . . . . 1.05 111.436 172.362 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.282 8.2 t -63.08 -37.49 87.43 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 120.916 3.673 . . . . 1.19 120.916 171.057 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -52.97 -40.38 63.69 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 113.458 -1.701 . . . . 1.9 113.923 170.249 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -93.76 -3.38 52.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.532 2.333 . . . . 0.89 112.485 -177.695 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.286 13.7 m120 66.35 33.05 7.27 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.714 1.721 . . . . 1.84 114.232 -174.046 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.279 33.7 mt -73.59 104.19 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 114.843 -2.503 . . . . 0.82 107.837 172.91 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -92.04 -164.04 1.12 Allowed 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 124.673 1.233 . . . . 2.16 110.101 179.772 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -72.0 156.5 39.16 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.04 1.4 . . . . 2.12 112.094 171.28 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.326 26.9 mt-10 61.26 28.7 18.2 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.033 -2.292 . . . . 1.71 115.628 175.956 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.0 t -101.18 154.89 18.36 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.951 -2.968 . . . . 1.04 109.597 -173.71 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.7 m -110.42 111.81 23.32 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.854 2.74 . . . . 0.79 112.5 -174.783 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.1 mt -93.02 147.52 22.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.308 -3.37 . . . . 1.4 108.008 170.526 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.456 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 5.5 m-70 -102.11 122.89 44.99 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 126.834 2.584 . . . . 1.51 104.721 -175.604 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.8 tp -93.96 137.92 32.65 Favored 'General case' 0 N--CA 1.428 -1.542 0 O-C-N 118.732 -2.48 . . . . 1.14 111.59 178.678 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' A' ' 42' ' ' ARG . 2.7 m -135.93 150.05 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 105.868 -1.901 . . . . 1.23 105.868 168.376 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.8 mt -112.64 158.68 19.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.803 -2.436 . . . . 2.78 112.812 -175.054 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -97.12 177.79 5.47 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.649 2.78 . . . . 3.75 104.381 176.702 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.2 mt -88.16 155.93 19.51 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.242 2.448 . . . . 3.14 107.791 174.171 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -83.39 159.21 21.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 112.96 -1.927 . . . . 6.8 113.953 172.311 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 172.6 -58.09 0.16 Allowed Glycine 0 N--CA 1.43 -1.731 0 CA-C-O 127.079 3.599 . . . . 3.57 116.137 -172.29 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.772 0 N-CA-C 104.144 -3.583 . . . . 3.87 104.144 172.412 . . . . . . . . 0 0 . 1 . 088 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 ptt? . . . . . 0 CA--C 1.49 -1.357 0 CA-C-O 123.049 1.404 . . . . 1.1 114.281 . . . . . . . . . 0 0 . 1 . 088 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -77.89 124.3 27.83 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.224 3.01 . . . . 1.87 114.453 -179.402 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.277 9.8 pt -128.48 153.12 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.301 -2.749 . . . . 0.72 111.139 171.286 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -117.59 130.49 56.43 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.526 1.967 . . . . 1.4 110.666 -178.89 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.51 111.16 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 102.908 -2.997 . . . . 0.58 102.908 -179.749 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -93.13 133.4 36.34 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 124.153 1.93 . . . . 2.09 111.774 -178.231 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.307 3.9 p -102.3 161.48 13.66 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 117.376 2.362 . . . . 0.99 117.376 169.166 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.4 tp -78.78 -35.72 43.99 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 112.22 -2.264 . . . . 2.53 111.449 168.75 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.273 0.8 OUTLIER -63.91 -58.41 6.85 Favored 'General case' 0 N--CA 1.431 -1.412 1 C-N-CA 133.323 4.649 . . . . 2.08 111.716 -169.983 . . . . . . . . 4 3 . 1 . 088 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.85 -79.23 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 129.456 3.407 . . . . 1.31 120.515 176.422 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -77.92 165.4 24.14 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 129.831 3.252 . . . . 1.4 116.197 -170.281 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.8 m -115.66 120.58 39.85 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 103.452 -2.796 . . . . 0.78 103.452 168.315 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.4 mt -89.18 107.03 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.859 2.463 . . . . 1.55 105.93 -176.522 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.7 m -82.54 100.0 9.85 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 124.282 0.989 . . . . 1.08 113.434 178.944 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.1 mt -88.13 154.52 20.39 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.7 2.19 . . . . 1.55 115.911 -179.98 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -104.27 114.78 29.24 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 102.399 -3.186 . . . . 1.95 102.399 163.616 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.8 m -117.36 177.39 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.069 -2.269 . . . . 0.96 109.426 173.081 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -115.57 156.65 45.82 Favored Pre-proline 0 N--CA 1.429 -1.476 0 N-CA-C 104.623 -2.362 . . . . 2.35 104.623 154.913 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -78.53 -9.09 16.12 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 CA-C-N 127.334 3.655 . . . . 0.95 109.197 -171.589 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.1 p -81.45 -9.65 59.67 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.884 -2.385 . . . . 1.45 113.911 174.838 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -66.82 141.85 57.55 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 125.855 1.972 . . . . 1.69 111.83 172.704 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.647 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 52.6 p -81.35 170.34 16.13 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.795 -2.441 . . . . 0.75 112.699 176.852 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.462 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 25.2 mm -66.01 -26.18 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 129.179 2.991 . . . . 0.73 109.37 170.563 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -70.97 -33.85 70.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.164 1.935 . . . . 1.62 115.546 173.999 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.434 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 83.5 m-20 -66.02 -43.38 87.8 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.193 2.597 . . . . 2.13 111.878 169.723 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.25 -45.21 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 115.224 1.564 . . . . 0.62 115.224 174.059 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -67.11 -36.03 81.03 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 117.348 -3.345 . . . . 1.22 113.277 169.769 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.71 -25.02 62.48 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 118.501 -2.624 . . . . 0.51 117.454 172.122 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 25' ' ' ASN 0.356 44.5 mttm -69.63 -55.14 10.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.41 -2.681 . . . . 1.44 117.247 174.537 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.2 mt -52.62 -47.07 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 1 C-N-CA 135.202 5.401 . . . . 1.32 106.419 173.615 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -50.02 -40.82 45.84 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 120.825 3.639 . . . . 1.7 120.825 177.129 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -66.56 -43.4 85.11 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.958 -3.589 . . . . 1.55 114.807 164.444 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -70.19 -49.98 44.83 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 127.656 3.598 . . . . 2.62 110.322 -169.95 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.264 28.7 mm-40 -120.3 4.72 10.76 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 111.286 -2.688 . . . . 1.48 112.726 -165.858 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.6 0.38 47.95 Favored Glycine 0 N--CA 1.431 -1.662 0 C-N-CA 115.678 -3.153 . . . . 1.12 119.222 173.605 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.5 mt -86.42 116.29 65.34 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 103.445 -2.798 . . . . 1.55 103.445 -169.202 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 36.9 Cg_endo -66.1 165.26 24.72 Favored 'Trans proline' 0 C--N 1.3 -2.016 1 C-N-CA 126.54 4.827 . . . . 1.02 115.695 176.389 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.2 Cg_exo -79.38 -17.43 11.51 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 124.524 2.651 . . . . 1.25 112.994 -172.235 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -67.54 -27.49 67.0 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.373 2.035 . . . . 2.25 115.436 175.458 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -104.87 24.02 12.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.813 -2.429 . . . . 2.02 114.308 -178.032 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -123.53 119.0 28.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.987 2.515 . . . . 0.69 113.392 179.66 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.53 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 90.5 mtt-85 -113.94 120.8 41.9 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.806 1.642 . . . . 2.78 108.288 169.466 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.6 mt -104.51 126.62 51.77 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.143 -1.598 . . . . 1.17 111.219 -178.103 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mm -117.61 140.4 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 124.206 3.185 . . . . 1.38 112.755 177.131 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -152.56 132.57 13.4 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 104.752 -2.314 . . . . 1.5 104.752 175.959 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.91 21.92 11.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 115.968 -1.968 . . . . 1.21 115.178 179.64 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.66 -2.34 83.16 Favored Glycine 0 N--CA 1.431 -1.688 1 C-N-CA 132.379 4.8 . . . . 1.3 113.286 -179.38 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 mtmt -101.01 137.57 39.2 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.842 0.829 . . . . 2.55 112.841 -178.983 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -70.68 127.13 31.62 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 117.194 -3.442 . . . . 2.48 115.808 166.627 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.405 ' HB3' HG13 ' A' ' 23' ' ' ILE . 36.9 mt -81.62 136.9 35.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.705 -1.872 . . . . 0.9 113.647 -176.075 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -85.74 144.14 27.94 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 119.031 2.974 . . . . 1.94 119.031 172.467 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.462 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 1.8 m-20 -67.12 -43.26 82.87 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 121.763 3.986 . . . . 1.56 121.763 -168.362 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.23 8.84 50.82 Favored Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 118.123 2.009 . . . . 0.97 118.123 170.446 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -101.59 149.55 24.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.679 1.704 . . . . 2.49 110.233 170.289 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.647 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.283 32.2 p -81.7 170.65 15.52 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.069 -2.894 . . . . 0.76 110.547 -178.211 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.7 mt -67.8 -37.04 81.47 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 127.031 2.132 . . . . 1.05 110.062 167.672 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.382 4.9 t -59.4 -43.64 92.95 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.525 -3.234 . . . . 1.19 114.234 176.72 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -60.82 -44.63 96.64 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.113 2.863 . . . . 1.9 111.042 179.995 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -77.92 -6.76 55.37 Favored 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 114.939 -4.85 . . . . 0.89 115.883 178.416 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.304 13.1 m120 68.95 36.79 2.42 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.605 -2.559 . . . . 1.84 115.412 -178.206 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.2 mt -85.24 113.96 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 125.905 1.682 . . . . 0.82 111.968 177.635 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -103.64 -173.96 2.43 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 118.411 -1.316 . . . . 2.16 108.824 -174.933 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -53.42 147.48 10.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.419 3.009 . . . . 2.12 114.4 171.082 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 56.09 33.51 22.08 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 120.441 3.497 . . . . 1.71 120.441 -178.969 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.7 m -103.51 149.1 25.18 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.777 -1.556 . . . . 1.04 109.96 -177.151 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -103.58 112.06 24.8 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 126.132 1.773 . . . . 0.79 109.106 -170.452 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mt -90.24 140.72 29.41 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.458 -1.312 . . . . 1.4 107.458 174.15 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.375 66.9 m80 -107.28 118.1 35.82 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.665 -1.272 . . . . 1.51 108.116 178.308 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -88.02 121.44 30.43 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 121.378 -0.826 . . . . 1.14 109.761 179.875 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 59.6 t -105.69 135.46 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 104.473 -2.417 . . . . 1.23 104.473 174.242 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.69 157.75 16.01 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.402 -1.332 . . . . 2.78 107.402 -179.5 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -129.95 174.34 9.85 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.34 -1.726 . . . . 3.75 106.34 175.455 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.0 mt -105.82 157.83 17.18 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.796 2.038 . . . . 3.14 106.92 177.054 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -66.39 93.59 0.23 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.161 2.184 . . . . 6.8 110.4 165.96 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.98 100.22 1.61 Allowed Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 127.809 2.623 . . . . 3.57 113.206 -166.652 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.745 0 CA-C-O 113.701 -3.833 . . . . 3.87 116.692 -175.974 . . . . . . . . 0 0 . 1 . 089 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 CA--C 1.49 -1.34 0 N-CA-C 106.721 -1.585 . . . . 1.1 106.721 . . . . . . . . . 0 0 . 1 . 089 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -93.71 126.5 38.93 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.138 1.375 . . . . 1.87 112.692 179.698 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.7 pt -127.25 166.98 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 105.002 -2.222 . . . . 0.72 105.002 167.759 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -123.27 145.05 49.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.076 2.95 . . . . 1.4 110.268 -177.716 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.2 t -124.91 124.18 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 106.691 -1.596 . . . . 0.58 106.691 173.677 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -106.41 128.59 54.16 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.601 2.36 . . . . 2.09 108.406 -178.73 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 p -87.4 179.44 6.58 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.02 2.343 . . . . 0.99 110.03 -179.399 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.331 14.2 tp -65.94 -41.95 90.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.918 2.487 . . . . 2.53 114.61 168.462 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.8 p -75.42 -38.54 59.75 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 120.817 -1.177 . . . . 2.08 108.307 -177.778 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.73 28.32 0.3 Allowed Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 123.652 0.644 . . . . 1.31 113.226 169.783 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -94.48 129.22 41.34 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.082 -2.422 . . . . 1.4 110.863 -177.134 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.8 m -116.36 90.21 3.28 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.937 2.78 . . . . 0.78 107.489 -174.345 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 pt -92.94 136.97 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 112.224 -2.262 . . . . 1.55 106.099 -178.876 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.7 m -94.86 128.37 41.57 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 130.22 3.408 . . . . 1.08 113.287 -178.801 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.9 mt -122.32 151.06 41.53 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.882 1.801 . . . . 1.55 112.88 178.184 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -114.54 112.7 23.36 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.657 1.218 . . . . 1.95 108.689 174.464 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m -118.27 175.11 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 118.715 -2.491 . . . . 0.96 111.548 -176.751 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -108.15 147.93 36.53 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-N 122.186 2.266 . . . . 2.35 106.784 160.498 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.13 -18.88 26.83 Favored 'Trans proline' 0 N--CA 1.433 -2.058 0 C-N-CA 123.718 2.945 . . . . 0.95 112.533 -174.548 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.3 p -90.57 9.92 27.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 121.725 2.057 . . . . 1.45 113.329 178.097 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -89.59 158.42 17.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.331 -3.355 . . . . 1.69 107.333 -179.865 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 69.6 p -80.6 171.11 15.46 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.297 1.221 . . . . 0.75 114.297 178.832 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 18.6 mm -69.77 -39.79 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 125.679 1.592 . . . . 0.73 108.91 175.993 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.26 86.7 tt0 -45.77 -45.75 14.84 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 117.613 2.449 . . . . 1.62 117.613 169.117 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -68.09 -35.66 78.54 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 118.058 2.614 . . . . 2.13 118.058 175.703 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 26' ' ' VAL . 10.8 t -62.96 -31.22 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 112.971 0.73 . . . . 0.62 112.971 170.783 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -71.5 -25.58 62.32 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 118.802 2.89 . . . . 1.22 118.802 167.327 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.87 -20.3 53.26 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 119.582 -1.949 . . . . 0.51 108.476 170.893 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -80.54 -23.51 39.94 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 120.419 1.463 . . . . 1.44 107.993 177.626 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.1 mt -81.85 -28.26 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.784 -2.447 . . . . 1.32 112.802 167.616 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 67.0 tt0 -65.74 -36.75 84.46 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 123.552 2.887 . . . . 1.7 113.362 173.655 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -60.05 -56.79 17.35 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 124.285 1.034 . . . . 1.55 111.781 170.118 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -77.34 -52.75 8.64 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 116.272 1.953 . . . . 2.62 116.272 -172.807 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -99.08 -25.1 14.66 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 119.348 -2.095 . . . . 1.48 108.407 -165.911 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.4 37.33 11.0 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 122.017 2.189 . . . . 1.12 113.161 175.668 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 mt -106.92 126.96 28.96 Favored Pre-proline 0 N--CA 1.43 -1.433 0 C-N-CA 127.671 2.388 . . . . 1.55 107.472 -178.752 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -68.82 150.2 73.49 Favored 'Trans proline' 0 N--CA 1.434 -1.977 0 O-C-N 115.28 -3.063 . . . . 1.02 116.585 -178.653 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -69.39 -14.5 37.37 Favored 'Trans proline' 0 N--CA 1.433 -2.061 0 CA-C-N 124.447 2.624 . . . . 1.25 117.886 -172.557 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -74.86 -34.09 62.22 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.993 1.854 . . . . 2.25 111.069 172.314 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -72.56 -28.41 62.81 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 115.165 -4.709 . . . . 2.02 114.523 -178.895 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -78.99 147.19 33.0 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.353 -1.467 . . . . 0.69 110.419 -173.382 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.277 12.1 tpt180 -133.35 120.12 20.58 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.07 -2.567 . . . . 2.78 104.07 170.773 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.2 mt -96.51 125.85 41.28 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.546 -1.346 . . . . 1.17 108.708 -177.899 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.278 6.2 mt -118.91 115.07 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 116.422 2.008 . . . . 1.38 116.422 -179.865 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -130.54 137.99 49.97 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 117.076 2.25 . . . . 1.5 117.076 164.97 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.291 . . 51.26 45.73 27.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.404 -3.31 . . . . 1.21 118.806 -175.487 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.6 -22.12 1.43 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 125.335 1.445 . . . . 1.3 113.646 -175.471 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -90.22 133.09 35.14 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 118.526 2.787 . . . . 2.55 118.526 -173.828 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -74.19 133.68 42.73 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 116.785 -3.697 . . . . 2.48 104.365 171.016 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.7 mt -91.17 123.69 34.81 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 127.07 3.319 . . . . 0.9 110.869 -175.741 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -85.19 135.5 33.92 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.165 -2.834 . . . . 1.94 116.105 175.966 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.488 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 3.4 m-20 -57.11 -53.04 62.6 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 129.973 3.309 . . . . 1.56 117.38 -160.958 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.09 21.51 1.35 Allowed Glycine 0 N--CA 1.43 -1.737 0 O-C-N 118.952 -2.342 . . . . 0.97 115.88 170.263 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -113.79 166.28 11.72 Favored 'General case' 0 N--CA 1.43 -1.451 1 CA-C-N 124.531 4.165 . . . . 2.49 108.251 168.979 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.8 p -97.78 173.47 7.09 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 123.551 1.644 . . . . 0.76 110.061 -179.173 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.9 mt -67.77 -31.91 72.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 114.317 1.229 . . . . 1.05 114.317 177.065 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.8 t -62.18 -44.73 95.94 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.043 3.337 . . . . 1.19 113.941 178.377 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -52.86 -38.54 61.68 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 125.141 1.526 . . . . 1.9 112.112 175.571 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -91.23 -1.0 57.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.335 1.854 . . . . 0.89 111.984 178.488 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.311 3.4 m120 61.72 31.26 18.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 119.446 3.128 . . . . 1.84 119.446 -179.526 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.4 mt -88.11 110.36 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 128.7 2.8 . . . . 0.82 104.469 -173.41 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -95.82 -169.91 2.03 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 112.373 -2.194 . . . . 2.16 106.288 -174.434 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -57.83 147.9 26.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 130.239 3.416 . . . . 2.12 117.797 172.894 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 55.89 49.33 16.19 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 115.817 1.784 . . . . 1.71 115.817 178.102 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 m -117.53 147.91 42.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 107.774 -1.195 . . . . 1.04 107.774 -174.62 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.4 m -99.2 105.41 17.45 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.355 3.462 . . . . 0.79 111.209 177.394 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.69 132.54 39.32 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.778 1.631 . . . . 1.4 108.505 178.072 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -89.13 124.88 34.74 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.95 -4.219 . . . . 1.51 106.395 -178.734 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.8 tp -95.13 122.09 37.44 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.716 -2.49 . . . . 1.14 105.842 171.214 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.1 t -115.14 151.4 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 127.872 2.469 . . . . 1.23 108.829 168.537 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.0 mt -98.7 126.39 44.29 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.601 -3.187 . . . . 2.78 110.659 174.637 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.9 ttt85 -107.05 84.36 1.97 Allowed 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.362 2.506 . . . . 3.75 110.9 178.818 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.0 mt -87.41 -53.46 4.81 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 116.561 -3.837 . . . . 3.14 109.781 175.024 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.3 ttt-85 -107.51 -58.06 2.01 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.03 2.132 . . . . 6.8 105.555 169.987 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.25 -179.58 24.06 Favored Glycine 0 N--CA 1.429 -1.775 0 O-C-N 119.102 -2.249 . . . . 3.57 108.377 -163.025 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.721 0 C-N-CA 126.713 2.102 . . . . 3.87 109.565 177.579 . . . . . . . . 0 0 . 1 . 090 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 CA--C 1.491 -1.304 0 CA-C-O 121.188 0.518 . . . . 1.1 110.677 . . . . . . . . . 0 0 . 1 . 090 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -110.6 121.31 45.02 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.489 -2.632 . . . . 1.87 111.44 -179.691 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.3 pt -108.73 172.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 114.588 -1.187 . . . . 0.72 111.792 169.621 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -120.4 160.08 23.81 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.76 -0.829 . . . . 1.4 108.76 178.879 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.7 t -139.56 133.46 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 117.381 -3.325 . . . . 0.58 106.815 168.851 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -110.76 137.57 48.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.551 -3.218 . . . . 2.09 109.415 177.323 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.275 11.1 p -81.67 -169.63 2.42 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 114.824 -4.923 . . . . 0.99 115.74 176.858 . . . . . . . . 3 2 . 1 . 090 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.322 13.1 mt -77.46 -37.34 51.69 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 113.656 0.984 . . . . 2.53 113.656 174.963 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.76 -37.72 22.26 Favored 'General case' 0 N--CA 1.429 -1.504 1 C-N-CA 133.61 4.764 . . . . 2.08 110.019 -169.501 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.67 33.66 0.64 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 115.04 -3.089 . . . . 1.31 111.842 173.175 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -97.54 137.48 36.41 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.513 2.156 . . . . 1.4 106.572 -178.953 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 m -108.27 121.42 44.86 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 118.897 -0.573 . . . . 0.78 109.9 176.687 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mt -104.77 106.87 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 125.498 1.749 . . . . 1.55 111.444 179.081 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.9 m -80.78 94.72 6.46 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 130.485 3.514 . . . . 1.08 111.67 178.024 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.8 mt -98.02 130.99 44.82 Favored 'General case' 0 N--CA 1.429 -1.482 1 O-C-N 115.781 -4.324 . . . . 1.55 112.907 -174.898 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -92.08 125.92 36.96 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.182 1.81 . . . . 1.95 107.18 174.836 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.9 m -133.89 174.95 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 107.401 -1.333 . . . . 0.96 107.401 -173.569 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -126.26 159.99 59.83 Favored Pre-proline 0 N--CA 1.43 -1.443 0 O-C-N 120.378 -1.451 . . . . 2.35 108.09 163.694 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -78.02 -10.06 16.66 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 CA-C-N 126.29 3.282 . . . . 0.95 109.919 -172.561 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.9 p -78.34 -22.54 47.85 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 130.369 3.468 . . . . 1.45 113.951 174.598 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -68.08 142.39 55.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.104 2.162 . . . . 1.69 110.655 176.21 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 22.9 p -78.08 164.25 25.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.659 2.171 . . . . 0.75 113.424 175.346 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -59.91 -33.18 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.515 1.926 . . . . 0.73 111.189 173.127 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -63.32 -44.48 94.83 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.582 1.553 . . . . 1.62 113.196 172.141 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -60.83 -26.45 67.35 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 115.517 -2.183 . . . . 2.13 114.083 170.037 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.338 46.6 t -84.43 -25.97 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 CA-C-N 127.243 4.565 . . . . 0.62 109.658 179.146 . . . . . . . . 3 2 . 1 . 090 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -75.74 -30.71 59.32 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.575 -3.203 . . . . 1.22 110.766 173.676 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.74 -40.61 93.06 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.248 -1.532 . . . . 0.51 112.123 174.872 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -58.95 -45.44 90.46 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.436 -3.29 . . . . 1.44 111.074 174.883 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.4 mt -58.48 -33.61 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.292 -3.38 . . . . 1.32 114.652 173.229 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -70.07 -34.85 73.71 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.507 2.41 . . . . 1.7 117.507 -179.673 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -72.82 -47.74 43.75 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 125.016 2.341 . . . . 1.55 116.387 164.506 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -63.86 -65.85 0.62 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.12 -3.488 . . . . 2.62 109.639 -173.673 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -94.23 -51.93 4.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.439 -2.663 . . . . 1.48 110.96 -168.406 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.56 73.19 0.97 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-N 115.489 -0.778 . . . . 1.12 112.276 179.374 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 mt -138.53 117.4 9.46 Favored Pre-proline 0 N--CA 1.429 -1.487 0 N-CA-C 102.427 -3.175 . . . . 1.55 102.427 -174.695 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -57.83 143.13 96.23 Favored 'Trans proline' 0 C--N 1.299 -2.059 0 CA-C-O 112.559 -3.184 . . . . 1.02 114.219 177.838 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -62.21 -15.92 47.52 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 CA-C-N 124.961 2.807 . . . . 1.25 115.926 178.404 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -63.73 -34.99 79.1 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 124.784 2.231 . . . . 2.25 115.907 173.976 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -81.81 -21.87 37.43 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.418 -2.676 . . . . 2.02 109.705 -177.86 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -82.06 104.53 12.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.642 1.686 . . . . 0.69 114.975 -173.767 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.5 tpp85 -100.59 123.37 44.7 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 112.455 -2.157 . . . . 2.78 107.282 162.54 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.0 mt -111.43 137.1 49.65 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.758 2.694 . . . . 1.17 106.531 178.713 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.0 mt -125.36 149.77 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 117.266 -3.396 . . . . 1.38 104.211 -179.654 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.31 84.1 t80 -146.84 135.58 22.17 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 116.564 2.061 . . . . 1.5 116.564 168.541 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.59 -67.3 0.21 Allowed 'General case' 0 N--CA 1.43 -1.45 1 C-N-CA 131.942 4.097 . . . . 1.21 112.317 179.464 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.59 15.42 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.648 0 C-N-CA 128.042 2.734 . . . . 1.3 107.861 174.441 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.1 mttp -123.11 134.14 54.24 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.6 -2.117 . . . . 2.55 107.269 -176.706 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -73.17 140.48 47.05 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 116.857 -1.937 . . . . 2.48 115.237 169.003 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 mt -94.89 133.34 38.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 116.703 -3.748 . . . . 0.9 108.33 -164.558 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -96.67 118.85 34.02 Favored 'General case' 0 N--CA 1.431 -1.393 1 O-C-N 115.46 -4.525 . . . . 1.94 109.46 -176.521 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -39.88 -51.31 2.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 117.797 2.517 . . . . 1.56 117.797 -175.817 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.53 39.54 0.22 Allowed Glycine 0 N--CA 1.429 -1.787 0 C-N-CA 128.04 2.733 . . . . 0.97 114.331 170.411 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -137.1 169.49 17.7 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 119.723 1.762 . . . . 2.49 111.619 164.847 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 44.8 p -98.51 166.36 11.39 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.45 1.9 . . . . 0.76 115.858 175.702 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mt -62.51 -36.47 82.66 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.379 -2.076 . . . . 1.05 112.227 172.167 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -60.64 -44.98 95.75 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.687 1.995 . . . . 1.19 116.336 175.359 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -60.62 -45.82 92.59 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 119.551 1.068 . . . . 1.9 111.8 179.951 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -77.65 -8.86 58.52 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 113.52 0.933 . . . . 0.89 113.52 179.242 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.29 71.4 m-80 62.26 51.29 3.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.048 2.139 . . . . 1.84 116.691 -174.749 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.0 mt -92.7 121.99 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 101.418 -3.549 . . . . 0.82 101.418 178.069 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.6 mm-40 -110.33 -168.49 1.32 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.197 -1.564 . . . . 2.16 112.676 178.923 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -68.74 155.93 39.22 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.586 -3.196 . . . . 2.12 107.83 -179.929 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 64.2 20.59 12.24 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 112.641 -2.072 . . . . 1.71 114.724 178.433 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.278 50.6 m -84.39 148.09 26.8 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-O 114.661 -2.59 . . . . 1.04 114.51 -174.068 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.0 m -109.59 113.62 26.56 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 115.963 -2.295 . . . . 0.79 109.993 176.657 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.6 mt -84.69 155.4 21.96 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.208 -1.558 . . . . 1.4 107.417 175.732 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -107.09 109.95 21.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 118.027 -0.987 . . . . 1.51 111.932 -174.699 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 tt -80.59 112.58 18.08 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.366 1.066 . . . . 1.14 113.065 174.348 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.4 t -109.77 122.06 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 C-N-CA 127.267 2.227 . . . . 1.23 105.382 171.622 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 71' ' ' LEU . 53.9 mt -81.94 122.53 27.88 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 104.142 -2.54 . . . . 2.78 104.142 177.131 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -116.36 145.96 42.82 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 129.735 3.214 . . . . 3.75 107.374 -176.385 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.49 117.45 6.21 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.44 2.696 . . . . 3.14 109.526 173.797 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -59.75 158.65 9.97 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 121.264 3.801 . . . . 6.8 121.264 174.645 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.28 65.3 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.749 0 O-C-N 120.963 -1.086 . . . . 3.57 113.768 -166.953 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.789 0 C-N-CA 126.988 2.232 . . . . 3.87 111.73 -172.424 . . . . . . . . 0 0 . 1 . 091 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptt? . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 117.885 2.55 . . . . 1.1 117.885 . . . . . . . . . 0 0 . 1 . 091 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -89.29 121.35 31.48 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.997 -1.064 . . . . 1.87 111.818 -173.585 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.8 pt -116.46 154.7 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 101.025 -3.695 . . . . 0.72 101.025 173.265 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -113.18 151.94 30.32 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 124.783 1.233 . . . . 1.4 111.623 179.943 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.1 t -134.58 127.64 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 122.745 2.521 . . . . 0.58 105.582 175.456 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -92.86 140.6 29.33 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.716 -1.865 . . . . 2.09 110.743 -179.793 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.0 p -87.13 -177.9 6.12 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 108.365 -0.976 . . . . 0.99 108.365 178.133 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 tp -64.7 -46.52 82.01 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.09 -4.131 . . . . 2.53 115.346 171.126 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -77.23 -21.45 53.76 Favored 'General case' 0 N--CA 1.43 -1.433 1 O-C-N 115.988 -4.195 . . . . 2.08 117.066 178.056 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.59 37.98 0.87 Allowed Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 121.037 3.175 . . . . 1.31 121.037 174.98 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -98.31 127.05 44.06 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 102.006 -3.331 . . . . 1.4 102.006 -177.358 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.0 m -91.68 118.18 30.42 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.134 -1.604 . . . . 0.78 113.871 175.841 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.293 10.4 mt -90.92 126.46 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 103.614 -2.736 . . . . 1.55 103.614 -179.855 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.2 m -98.84 120.16 38.81 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 123.527 2.876 . . . . 1.08 107.127 173.083 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.4 mt -118.38 117.11 28.16 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 125.095 2.379 . . . . 1.55 113.996 177.856 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -79.63 97.37 6.49 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.108 -1.62 . . . . 1.95 113.36 172.258 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -113.84 166.72 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 128.299 2.64 . . . . 0.96 110.915 -175.669 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -107.36 163.71 16.36 Favored Pre-proline 0 N--CA 1.429 -1.5 0 O-C-N 125.017 1.448 . . . . 2.35 111.79 162.02 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.43 -19.67 10.1 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 O-C-N 113.594 -3.951 . . . . 0.95 109.877 -175.172 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 m -81.56 -3.07 52.26 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 116.616 -1.659 . . . . 1.45 114.07 -179.573 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -72.72 142.78 48.19 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.498 1.519 . . . . 1.69 112.576 176.846 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 p -81.82 165.25 21.04 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 124.606 1.191 . . . . 0.75 110.52 176.319 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.422 ' CG2' HD12 ' A' ' 43' ' ' LEU . 4.4 mm -68.79 -24.64 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 1 O-C-N 115.285 -4.634 . . . . 0.73 113.122 178.882 . . . . . . . . 3 3 . 1 . 091 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -51.91 -45.84 64.38 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 129.661 3.185 . . . . 1.62 113.59 164.062 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -62.96 -36.98 85.27 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 115.624 1.713 . . . . 2.13 115.624 174.064 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.75 -48.4 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 127.177 2.191 . . . . 0.62 111.735 175.391 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.5 mttt -55.1 -34.06 63.35 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.339 1.977 . . . . 1.22 116.339 170.033 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.69 -23.79 61.71 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 116.011 1.856 . . . . 0.51 116.011 172.615 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -75.44 -33.49 60.9 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.955 2.902 . . . . 1.44 114.128 168.599 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.4 mt -76.41 -26.68 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 1 O-C-N 113.791 -5.568 . . . . 1.32 110.402 174.861 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -74.01 -25.3 59.82 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.964 -2.335 . . . . 1.7 106.475 178.808 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -86.13 -41.95 14.3 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.172 1.463 . . . . 1.55 114.483 171.122 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.3 mmtt -57.47 -65.7 0.58 Allowed 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 113.999 -5.438 . . . . 2.62 111.36 172.316 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -97.16 -35.53 10.75 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.023 2.529 . . . . 1.48 115.08 -168.067 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.18 44.98 3.65 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 119.896 -1.753 . . . . 1.12 114.093 179.162 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.3 mt -114.18 126.67 27.71 Favored Pre-proline 0 N--CA 1.43 -1.429 1 C-N-CA 134.79 5.236 . . . . 1.55 111.32 -178.76 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.78 156.16 43.97 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 CA-C-N 125.962 3.165 . . . . 1.02 113.442 179.372 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -65.31 -12.11 33.31 Favored 'Trans proline' 0 N--CA 1.433 -2.032 2 CA-C-N 131.235 5.048 . . . . 1.25 118.198 -173.021 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -63.95 -45.14 90.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 127.128 2.768 . . . . 2.25 113.132 175.231 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -84.37 -7.86 59.17 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.9 -3.0 . . . . 2.02 108.465 -175.831 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -92.01 129.74 37.9 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 115.71 -4.368 . . . . 0.69 109.457 -171.684 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -130.64 120.85 24.56 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 129.424 3.09 . . . . 2.78 105.925 172.511 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.422 HD12 ' CG2' ' A' ' 23' ' ' ILE . 82.5 mt -107.01 122.71 46.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.602 3.096 . . . . 1.17 113.474 -176.719 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 29.0 mm -109.9 123.32 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 111.786 -2.461 . . . . 1.38 109.087 177.549 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -101.83 111.41 23.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.53 -2.767 . . . . 1.5 103.53 167.919 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.05 -93.48 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 125.48 1.738 . . . . 1.21 108.905 172.901 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.37 14.04 3.48 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-O 116.208 -2.44 . . . . 1.3 114.15 176.583 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp -107.82 133.63 51.93 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 128.496 3.115 . . . . 2.55 112.858 179.904 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -86.94 115.98 24.7 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 126.018 2.818 . . . . 2.48 114.819 173.681 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.0 mt -73.79 143.88 45.81 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.898 -1.751 . . . . 0.9 112.214 -171.561 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -100.1 138.72 36.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 125.23 2.443 . . . . 1.94 115.568 174.236 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -48.46 -46.86 38.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.422 3.489 . . . . 1.56 119.847 -175.985 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.54 44.91 1.39 Allowed Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 127.105 2.288 . . . . 0.97 116.691 170.928 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.25 20.7 mmt85 -117.25 163.61 16.05 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 117.703 -3.234 . . . . 2.49 103.659 166.332 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.5 p -99.61 163.63 12.41 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.081 -3.512 . . . . 0.76 115.964 169.064 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.7 mt -57.54 -36.17 71.28 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 113.646 -1.615 . . . . 1.05 112.198 174.402 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 t -66.4 -37.75 85.94 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 116.132 1.901 . . . . 1.19 116.132 178.825 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -55.92 -32.15 63.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.37 1.868 . . . . 1.9 114.513 173.065 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -94.86 -8.01 38.54 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 122.951 1.358 . . . . 0.89 110.73 -178.936 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.8 m120 69.0 43.13 1.17 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.356 2.662 . . . . 1.84 114.668 -173.169 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.8 mt -84.9 128.82 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 126.014 2.816 . . . . 0.82 106.379 -179.127 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -109.06 179.99 4.01 Favored 'General case' 0 N--CA 1.431 -1.425 1 O-C-N 115.893 -4.255 . . . . 2.16 108.22 -176.86 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 35.2 ttpt -53.73 138.76 34.57 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 130.943 3.697 . . . . 2.12 115.41 167.005 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 63' ' ' LYS 0.343 9.7 pt-20 77.04 3.2 3.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.598 2.359 . . . . 1.71 117.145 171.828 . . . . . . . . 3 3 . 1 . 091 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.41 164.07 25.37 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 112.818 -1.992 . . . . 1.04 112.849 -176.661 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.3 m -120.0 121.1 38.18 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 124.34 2.019 . . . . 0.79 108.432 175.321 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -103.29 174.18 5.98 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 104.642 -2.355 . . . . 1.4 104.642 175.117 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 31.3 m170 -130.63 141.53 50.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.962 -1.496 . . . . 1.51 106.962 179.232 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.6 tp -112.23 110.78 21.23 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 129.993 3.317 . . . . 1.14 106.849 -174.259 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.1 t -112.83 123.05 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 C-N-CA 125.222 1.409 . . . . 1.23 109.676 176.93 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.7 mt -87.32 152.98 21.82 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.704 1.24 . . . . 2.78 111.63 178.036 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -117.92 142.17 47.63 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 129.275 3.03 . . . . 3.75 109.794 169.88 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.4 mt -96.66 -179.65 4.67 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.492 1.615 . . . . 3.14 111.515 171.894 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.1 ttm-85 -81.24 140.67 34.75 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 117.961 -1.496 . . . . 6.8 110.311 169.006 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.98 -73.26 0.25 Allowed Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 106.303 -2.719 . . . . 3.57 106.303 -174.069 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.842 0 CA-C-N 122.311 3.056 . . . . 3.87 113.829 174.845 . . . . . . . . 0 0 . 1 . 092 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ptt? . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 116.565 2.061 . . . . 1.1 116.565 . . . . . . . . . 0 0 . 1 . 092 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -106.88 123.09 47.66 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.133 -2.854 . . . . 1.87 111.887 -177.31 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.0 pt -127.19 155.61 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 112.028 -2.351 . . . . 0.72 108.535 170.05 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -124.55 137.22 54.42 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.384 1.073 . . . . 1.4 110.282 -176.014 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.1 t -116.6 101.49 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 129.422 3.089 . . . . 0.58 106.371 178.199 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -81.9 139.59 34.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.711 1.243 . . . . 2.09 112.653 178.769 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.2 p -100.43 -175.96 3.07 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 120.191 -1.568 . . . . 0.99 112.61 -179.147 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.2 mt -77.35 -43.19 33.82 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 112.82 -6.175 . . . . 2.53 111.185 178.205 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.8 p -70.05 -17.49 63.25 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.89 2.076 . . . . 2.08 111.526 -168.352 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.52 33.65 3.3 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 126.091 1.805 . . . . 1.31 116.15 170.317 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -108.56 148.44 30.29 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 103.226 -2.879 . . . . 1.4 103.226 -178.557 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 80.5 m -117.38 120.18 37.38 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 126.247 2.217 . . . . 0.78 109.007 -179.212 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.0 mm -98.72 108.7 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 126.48 3.038 . . . . 1.55 112.204 179.904 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.268 47.4 m -85.18 139.49 31.64 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.131 -3.48 . . . . 1.08 106.704 -175.377 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.1 mt -125.47 146.58 49.57 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.688 -2.507 . . . . 1.55 109.497 176.159 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -99.61 104.21 15.97 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 127.651 2.381 . . . . 1.95 110.726 163.95 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.478 HG21 ' CD1' ' A' ' 56' ' ' LEU . 33.7 m -124.8 176.3 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 119.069 -2.269 . . . . 0.96 111.037 177.728 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -115.47 155.65 46.92 Favored Pre-proline 0 N--CA 1.429 -1.508 0 N-CA-C 103.308 -2.849 . . . . 2.35 103.308 162.487 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -74.95 5.73 3.79 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 127.167 3.595 . . . . 0.95 112.026 -174.61 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.7 p -94.97 -8.73 36.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 130.405 3.482 . . . . 1.45 109.434 179.613 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -72.05 134.1 45.65 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.784 -2.448 . . . . 1.69 107.477 175.412 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.6 p -78.62 160.46 27.54 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 111.004 -2.816 . . . . 0.75 110.926 174.154 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -65.57 -31.39 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 117.176 -3.452 . . . . 0.73 116.246 177.692 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -40.16 -53.43 2.47 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.576 -3.828 . . . . 1.62 114.982 159.78 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -58.75 -39.29 80.51 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 125.117 2.389 . . . . 2.13 116.5 173.259 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.29 -42.57 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 129.909 3.284 . . . . 0.62 113.872 -179.346 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.28 39.0 mtmt -70.03 -33.5 72.05 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 126.469 2.355 . . . . 1.22 114.895 174.256 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.27 -34.03 76.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.221 1.563 . . . . 0.51 115.221 169.857 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -58.35 -31.41 67.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 127.986 3.755 . . . . 1.44 118.293 172.046 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 27.2 mt -84.41 -32.42 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 1 CA-C-N 108.299 -4.046 . . . . 1.32 110.151 179.256 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -63.63 -33.97 76.81 Favored 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 116.201 -4.062 . . . . 1.7 114.62 176.863 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -64.34 -47.09 80.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.616 1.566 . . . . 1.55 113.332 168.139 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -75.9 -62.29 1.64 Allowed 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 121.267 1.849 . . . . 2.62 114.101 -178.773 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -89.97 -18.25 26.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.952 1.251 . . . . 1.48 114.035 -171.477 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.62 13.85 46.0 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 120.469 -1.394 . . . . 1.12 111.264 167.534 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.7 mt -98.35 133.46 22.83 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 118.936 -2.508 . . . . 1.55 113.837 -173.93 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 72.3 Cg_exo -64.65 143.61 81.59 Favored 'Trans proline' 0 N--CA 1.433 -2.045 1 N-CA-C 124.499 4.769 . . . . 1.02 124.499 170.563 . . . . . . . . 3 3 . 1 . 092 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 13.4 Cg_exo -62.69 -21.01 72.54 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 124.435 3.423 . . . . 1.25 114.772 179.807 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -63.65 -21.61 66.46 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.517 2.043 . . . . 2.25 116.517 168.381 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -94.94 -38.62 10.61 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 103.994 -2.595 . . . . 2.02 103.994 179.127 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.331 76.5 mt-30 -80.23 132.2 35.82 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 114.255 1.206 . . . . 0.69 114.255 -171.696 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -123.33 151.59 42.31 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.295 2.638 . . . . 2.78 104.822 170.219 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.2 mt -127.84 127.47 43.52 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 124.444 2.069 . . . . 1.17 106.929 176.521 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.6 mt -104.72 137.66 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 101.48 -3.526 . . . . 1.38 101.48 171.107 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.281 2.8 t80 -130.14 103.94 7.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.802 -3.061 . . . . 1.5 103.669 170.401 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.391 . . 80.58 -98.44 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 123.812 1.767 . . . . 1.21 110.844 -178.18 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.6 -5.78 3.95 Favored Glycine 0 N--CA 1.429 -1.79 1 CA-C-O 113.243 -4.087 . . . . 1.3 109.043 -176.995 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -101.77 128.61 48.03 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 122.093 2.947 . . . . 2.55 111.136 177.067 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -88.19 117.84 27.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.638 3.575 . . . . 2.48 111.286 177.803 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 mt -75.9 148.14 38.48 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.289 1.995 . . . . 0.9 113.576 -166.947 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -99.0 153.0 19.19 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 111.586 -2.552 . . . . 1.94 111.436 175.604 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.22 -54.33 8.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.466 1.507 . . . . 1.56 114.832 -168.418 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.06 47.31 3.68 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-O 114.787 -3.229 . . . . 0.97 115.672 176.104 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -130.47 158.15 40.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.756 2.278 . . . . 2.49 110.224 165.82 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.328 27.1 p -84.85 169.11 14.47 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 113.67 -5.644 . . . . 0.76 114.557 179.704 . . . . . . . . 3 2 . 1 . 092 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.478 ' CD1' HG21 ' A' ' 17' ' ' VAL . 36.7 mt -65.73 -34.08 77.36 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 113.326 0.861 . . . . 1.05 113.326 172.251 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.6 t -70.95 -25.42 62.72 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 127.416 2.287 . . . . 1.19 111.231 179.57 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -68.03 -29.31 68.27 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 117.728 -1.13 . . . . 1.9 113.298 169.427 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -96.18 18.2 14.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.578 2.351 . . . . 0.89 105.67 176.158 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.6 m120 45.07 41.19 5.34 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 129.097 2.959 . . . . 1.84 118.727 -179.763 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.9 mt -92.65 131.01 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 118.915 -2.366 . . . . 0.82 105.113 -176.864 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -148.1 -34.91 0.22 Allowed 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.259 2.457 . . . . 2.16 110.022 -175.214 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -95.96 -179.6 4.75 Favored 'General case' 0 N--CA 1.431 -1.379 0 O-C-N 118.934 -2.354 . . . . 2.12 109.526 174.544 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -68.31 97.56 0.75 Allowed 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 124.404 2.05 . . . . 1.71 116.202 175.745 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 98.2 p -91.85 138.97 31.12 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.362 -1.29 . . . . 1.04 109.739 -167.371 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.1 m -89.57 104.07 16.66 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 115.807 -2.357 . . . . 0.79 112.894 175.483 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mp -88.54 158.1 18.41 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.482 -1.386 . . . . 1.4 107.498 176.181 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -122.87 121.94 37.44 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 118.261 -2.774 . . . . 1.51 114.81 176.331 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 tt -82.57 117.99 22.96 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 116.962 -1.895 . . . . 1.14 115.301 -178.793 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.5 t -114.96 133.67 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 CA-C-O 126.368 2.985 . . . . 1.23 112.466 175.321 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.6 mt -92.62 141.31 28.63 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.752 -3.718 . . . . 2.78 107.735 175.87 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -124.35 98.66 5.85 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 112.512 -2.131 . . . . 3.75 105.637 177.139 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.8 mt -91.78 -75.79 0.47 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 129.703 3.201 . . . . 3.14 119.466 176.773 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 53.1 ttm-85 -99.42 -64.16 1.06 Allowed 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 129.313 4.133 . . . . 6.8 106.164 175.317 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.05 111.36 0.3 Allowed Glycine 0 N--CA 1.43 -1.713 0 O-C-N 126.871 2.607 . . . . 3.57 108.602 -175.525 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.791 1 CA-C-O 112.434 -4.536 . . . . 3.87 110.503 -178.435 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 ttp . . . . . 0 CA--C 1.491 -1.318 0 N-CA-C 113.991 1.108 . . . . 1.1 113.991 . . . . . . . . . 0 0 . 1 . 093 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -106.29 95.0 5.46 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.752 -2.467 . . . . 1.87 111.004 -166.316 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.9 pt -90.44 165.58 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 125.762 1.914 . . . . 0.72 111.842 177.855 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -121.41 130.86 53.84 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.393 -1.442 . . . . 1.4 107.338 178.388 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.62 108.45 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 O-C-N 119.816 -1.802 . . . . 0.58 108.44 174.41 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -99.63 133.59 43.74 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.214 1.405 . . . . 2.09 111.059 179.707 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.9 p -101.08 163.58 12.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 115.742 1.756 . . . . 0.99 115.742 -179.31 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 tp -51.58 -49.06 62.85 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.802 3.241 . . . . 2.53 114.303 170.058 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 p -74.86 -40.01 61.23 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.702 1.715 . . . . 2.08 114.201 -165.975 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.37 15.73 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.709 0 O-C-N 118.283 -2.761 . . . . 1.31 114.134 174.323 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.1 tptm -108.03 134.41 50.96 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 126.02 2.819 . . . . 1.4 114.864 -178.367 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.0 m -108.66 107.15 17.51 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 130.02 3.328 . . . . 0.78 105.089 174.059 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -88.4 131.79 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 1 O-C-N 116.066 -4.146 . . . . 1.55 107.318 174.828 . . . . . . . . 3 3 . 1 . 093 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 m -100.1 103.08 14.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 100.416 -3.92 . . . . 1.08 100.416 178.523 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.9 mt -102.97 130.72 50.15 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.055 1.883 . . . . 1.55 112.347 177.398 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -97.17 113.84 25.48 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.411 -2.681 . . . . 1.95 110.689 169.024 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.55 155.76 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 107.273 -1.38 . . . . 0.96 107.273 -177.443 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.325 19.5 mm-40 -86.61 152.8 55.02 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-N 121.644 2.02 . . . . 2.35 107.026 163.669 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -71.25 -16.71 31.45 Favored 'Trans proline' 0 C--N 1.3 -1.996 3 CA-C-N 129.823 4.544 . . . . 0.95 113.537 179.715 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 m -74.95 -6.07 47.26 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 126.042 2.089 . . . . 1.45 113.312 168.652 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -74.3 153.59 39.29 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.64 -2.537 . . . . 1.69 109.276 175.997 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 p -87.28 177.03 7.27 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.196 -2.815 . . . . 0.75 115.283 178.901 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.49 HD12 HD13 ' A' ' 50' ' ' LEU . 47.3 mm -76.79 -32.03 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 124.997 1.319 . . . . 0.73 108.758 174.179 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -53.39 -52.81 58.12 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.89 2.476 . . . . 1.62 113.256 170.488 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -62.58 -38.59 90.71 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 114.79 -2.528 . . . . 2.13 116.234 172.426 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.06 -44.71 92.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 123.265 2.757 . . . . 0.62 111.706 171.587 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -59.9 -32.79 71.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.77 -3.081 . . . . 1.22 112.181 175.482 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.57 -35.2 79.63 Favored 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.731 -4.355 . . . . 0.51 117.727 172.249 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -71.54 -27.03 62.9 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.576 -2.577 . . . . 1.44 114.281 176.053 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.3 mt -75.45 -36.82 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 117.372 -3.33 . . . . 1.32 109.103 173.67 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -63.09 -53.14 58.29 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.21 -1.556 . . . . 1.7 109.963 177.392 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -41.34 -63.5 0.69 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.688 2.847 . . . . 1.55 118.688 166.53 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -81.9 -36.47 28.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 117.08 2.252 . . . . 2.62 117.08 -166.112 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -103.09 -46.97 4.48 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.848 -1.782 . . . . 1.48 111.315 -175.223 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.96 25.36 2.31 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 123.913 0.768 . . . . 1.12 114.668 170.831 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.4 mt -107.09 127.36 28.12 Favored Pre-proline 0 N--CA 1.429 -1.493 0 O-C-N 118.575 -2.72 . . . . 1.55 109.445 -170.465 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -67.78 138.5 45.05 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 C-N-CA 123.286 2.658 . . . . 1.02 115.809 179.344 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.14 -13.63 31.28 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 CA-C-N 121.335 1.512 . . . . 1.25 115.11 -162.025 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -55.93 -27.8 53.97 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 129.509 3.124 . . . . 2.25 113.721 168.517 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -98.08 -0.14 45.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.8 -1.813 . . . . 2.02 111.149 -173.664 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -97.79 135.82 39.01 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.563 2.601 . . . . 0.69 112.646 -175.215 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -125.05 115.45 20.54 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.756 -1.84 . . . . 2.78 107.241 169.175 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mt -94.44 126.07 39.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.681 2.392 . . . . 1.17 113.807 177.888 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.3 mm -111.04 131.7 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 108.736 -0.838 . . . . 1.38 108.736 -175.913 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -123.67 87.46 2.74 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 127.124 2.17 . . . . 1.5 106.853 168.793 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.256 . . 69.18 -98.49 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.378 -2.076 . . . . 1.21 112.176 -178.441 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.06 6.65 13.13 Favored Glycine 0 N--CA 1.431 -1.653 0 O-C-N 118.352 -2.717 . . . . 1.3 111.571 177.762 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -99.36 130.25 45.63 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.91 -1.885 . . . . 2.55 105.91 178.74 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -103.4 107.25 18.01 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 111.156 -2.747 . . . . 2.48 109.597 170.268 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.49 HD13 HD12 ' A' ' 23' ' ' ILE . 53.3 mt -76.1 131.66 39.57 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 121.111 3.745 . . . . 0.9 121.111 -166.059 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -90.5 141.38 28.82 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 119.647 3.203 . . . . 1.94 119.647 176.536 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -42.96 -68.71 0.17 Allowed 'General case' 0 N--CA 1.431 -1.418 1 N-CA-C 122.337 4.199 . . . . 1.56 122.337 -171.752 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.6 25.15 1.15 Allowed Glycine 0 N--CA 1.429 -1.774 0 C-N-CA 129.194 3.283 . . . . 0.97 119.419 171.193 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -105.99 151.95 23.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.178 -3.542 . . . . 2.49 111.845 163.659 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.7 p -76.04 171.37 14.58 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 124.781 2.229 . . . . 0.76 116.412 172.811 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.629 HD23 HD12 ' A' ' 61' ' ' ILE . 47.9 mt -73.02 -27.69 61.91 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.305 -2.122 . . . . 1.05 113.312 167.838 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.9 p -78.49 -28.39 46.35 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-O 118.148 -0.929 . . . . 1.19 110.087 -177.978 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -56.34 -59.74 4.52 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.366 1.066 . . . . 1.9 111.14 171.909 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -62.85 -28.93 70.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 126.743 2.527 . . . . 0.89 114.507 -179.063 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 82.86 51.79 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.412 1 C-N-CA 132.95 4.5 . . . . 1.84 112.048 -178.466 . . . . . . . . 3 3 . 1 . 093 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.629 HD12 HD23 ' A' ' 56' ' ' LEU . 65.5 mt -84.09 114.7 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 108.373 -0.973 . . . . 0.82 108.373 -178.547 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -95.32 159.79 14.84 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 126.256 1.823 . . . . 2.16 114.118 -170.696 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.382 6.5 tmtm? -6.35 -81.31 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 120.233 3.419 . . . . 2.12 120.233 175.165 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -105.39 71.04 0.91 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.948 2.309 . . . . 1.71 110.962 -175.141 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.283 18.7 m -107.55 141.52 38.88 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 124.392 2.044 . . . . 1.04 107.216 -177.49 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.3 m -105.4 119.19 38.47 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.767 -1.833 . . . . 0.79 107.659 174.374 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -96.34 148.92 22.27 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.527 2.331 . . . . 1.4 107.563 174.314 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -126.15 122.33 35.38 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.148 -1.797 . . . . 1.51 106.148 -174.617 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.5 tp -82.29 135.61 35.18 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 125.062 2.363 . . . . 1.14 107.095 -176.143 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.0 t -135.17 150.21 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 1 N-CA-C 99.328 -4.323 . . . . 1.23 99.328 -179.208 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.3 mt -111.56 146.95 36.44 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 115.094 -4.754 . . . . 2.78 107.76 -176.919 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -95.28 130.8 41.9 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 110.403 -3.09 . . . . 3.75 108.709 -179.479 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.345 47.4 mt -111.54 167.52 10.26 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.366 -3.334 . . . . 3.14 109.364 168.374 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -60.99 -57.84 10.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 118.154 -0.926 . . . . 6.8 110.16 169.107 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.73 59.95 4.71 Favored Glycine 0 N--CA 1.43 -1.726 0 CA-C-N 123.62 2.918 . . . . 3.57 110.501 -168.752 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.734 0 O-C-N 120.381 -1.658 . . . . 3.87 113.767 -179.961 . . . . . . . . 0 0 . 1 . 094 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 ttp . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 109.275 -0.639 . . . . 1.1 109.275 . . . . . . . . . 0 0 . 1 . 094 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -102.68 117.6 35.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.811 -3.681 . . . . 1.87 107.85 -178.052 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.0 pt -117.12 149.54 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 125.69 2.662 . . . . 0.72 110.062 174.369 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -95.26 153.76 17.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.984 -2.322 . . . . 1.4 112.223 -177.062 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.9 t -137.37 114.24 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 117.957 -2.964 . . . . 0.58 108.286 172.464 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -86.69 122.51 30.69 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.344 2.257 . . . . 2.09 112.427 179.709 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.301 17.0 p -80.89 174.89 11.17 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.451 -0.795 . . . . 0.99 112.674 -177.378 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.9 tp -78.03 -25.69 48.0 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 119.176 3.028 . . . . 2.53 119.176 171.357 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.9 p -74.82 -46.55 35.89 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.736 -3.102 . . . . 2.08 112.054 -178.001 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.31 6.89 0.12 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 126.629 2.062 . . . . 1.31 110.014 174.137 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -84.0 144.68 28.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 121.415 2.608 . . . . 1.4 114.137 178.371 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.335 31.3 m -102.57 137.63 40.55 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.228 2.211 . . . . 0.78 111.452 167.306 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mt -125.04 129.54 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 1 C-N-CA 132.908 4.483 . . . . 1.55 110.361 177.082 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.6 m -101.06 117.8 35.74 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 125.615 1.822 . . . . 1.08 109.651 177.096 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -111.36 137.82 48.64 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.425 1.89 . . . . 1.55 111.166 173.763 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -90.38 134.28 34.43 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.154 -2.216 . . . . 1.95 106.305 163.711 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.7 m -142.82 161.95 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 C-N-CA 129.427 3.091 . . . . 0.96 111.789 179.503 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -98.06 149.02 35.3 Favored Pre-proline 0 N--CA 1.431 -1.417 0 O-C-N 117.328 -3.358 . . . . 2.35 108.026 165.474 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -69.82 -17.58 37.21 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 CA-C-N 128.182 3.958 . . . . 0.95 112.109 -179.183 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.0 p -77.95 -16.09 58.45 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.048 1.739 . . . . 1.45 112.984 175.784 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -66.86 134.26 51.72 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 114.535 -1.211 . . . . 1.69 113.213 178.757 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -69.03 168.38 13.95 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 115.346 1.61 . . . . 0.75 115.346 174.653 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.276 15.4 mm -76.06 -29.59 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 113.642 -1.617 . . . . 0.73 112.186 176.621 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -46.82 -48.87 20.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.641 3.176 . . . . 1.62 111.703 158.84 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -63.87 -37.22 86.59 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.296 1.438 . . . . 2.13 114.859 176.459 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.3 t -59.99 -43.06 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 118.983 -2.323 . . . . 0.62 116.535 173.593 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HD3' ' HB2' ' A' ' 41' ' ' GLN . 74.4 mttt -71.7 -33.75 69.04 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.241 1.816 . . . . 1.22 114.528 179.741 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.22 -17.76 60.27 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.026 -2.921 . . . . 0.51 109.978 173.412 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -89.93 -12.68 38.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.967 1.841 . . . . 1.44 113.646 173.824 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.8 mt -88.32 -23.52 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 119.918 -1.739 . . . . 1.32 110.671 169.432 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -69.73 -49.42 53.42 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.314 1.845 . . . . 1.7 108.673 172.04 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.306 33.1 t70 -53.7 -62.86 1.38 Allowed 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 123.189 2.722 . . . . 1.55 116.405 164.078 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -63.21 -62.39 1.72 Allowed 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.818 -3.052 . . . . 2.62 113.995 -170.938 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -96.02 -56.46 2.64 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.258 -2.776 . . . . 1.48 113.23 -170.935 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.91 5.49 1.03 Allowed Glycine 0 N--CA 1.431 -1.698 0 O-C-N 124.867 1.354 . . . . 1.12 114.497 170.739 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.5 mt -78.12 135.53 62.3 Favored Pre-proline 0 N--CA 1.43 -1.45 0 CA-C-O 114.611 -2.614 . . . . 1.55 111.969 -174.578 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 3.0 Cg_endo -77.37 153.24 31.03 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 CA-C-N 125.413 2.969 . . . . 1.02 113.469 -178.024 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 85.9 Cg_exo -64.51 -24.66 63.34 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 CA-C-N 127.664 3.773 . . . . 1.25 115.603 -172.106 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -61.24 -33.25 73.21 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.613 -2.555 . . . . 2.25 117.254 173.792 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -76.97 -24.74 52.28 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.376 -3.327 . . . . 2.02 116.746 -178.29 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.484 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 68.0 mt-30 -80.9 107.86 14.08 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.28 2.232 . . . . 0.69 110.513 -172.468 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -103.5 119.67 39.35 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.094 -2.879 . . . . 2.78 106.577 168.713 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.7 mt -102.92 123.86 47.34 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 119.67 3.211 . . . . 1.17 119.67 -178.789 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.0 mm -109.58 157.68 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 115.675 -2.107 . . . . 1.38 109.751 178.356 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -140.63 114.95 9.29 Favored 'General case' 0 N--CA 1.43 -1.453 1 N-CA-C 95.64 -5.689 . . . . 1.5 95.64 173.604 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.259 . . 55.9 -110.23 0.54 Allowed 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.299 -1.501 . . . . 1.21 114.348 -176.815 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.48 -8.71 24.55 Favored Glycine 0 N--CA 1.43 -1.738 0 CA-C-O 123.062 1.368 . . . . 1.3 112.967 -176.601 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -91.61 143.86 26.13 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.388 -3.419 . . . . 2.55 114.468 171.572 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -99.83 129.05 45.89 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.236 1.014 . . . . 2.48 108.634 170.365 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.1 mt -91.36 147.13 23.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.194 1.473 . . . . 0.9 113.234 -167.86 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -91.74 143.23 26.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.719 -1.863 . . . . 1.94 115.581 175.392 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.81 -47.68 77.16 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 118.646 2.832 . . . . 1.56 118.646 -173.504 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.55 26.04 2.75 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 122.934 3.934 . . . . 0.97 122.934 171.885 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.4 mtt-85 -111.46 146.67 36.82 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 118.813 -2.581 . . . . 2.49 110.589 169.84 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.343 43.7 p -70.98 170.9 11.8 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.638 2.637 . . . . 0.76 113.264 176.404 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mt -74.87 -27.96 60.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.318 -2.739 . . . . 1.05 109.779 168.571 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.6 t -65.75 -39.87 91.52 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 127.706 2.402 . . . . 1.19 114.752 178.977 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -51.0 -50.22 58.92 Favored 'General case' 0 N--CA 1.43 -1.452 1 CA-C-O 129.135 4.302 . . . . 1.9 112.505 174.544 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -88.15 -2.1 58.4 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.822 -3.049 . . . . 0.89 114.286 -178.904 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 63.73 55.73 1.63 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.61 1.964 . . . . 1.84 113.183 -176.381 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.1 mm -85.3 118.44 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-O 116.333 -1.794 . . . . 0.82 106.308 179.288 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -82.56 -170.52 3.0 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 128.035 3.334 . . . . 2.16 109.35 -176.69 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.28 92.4 mttt -72.61 -56.3 5.55 Favored 'General case' 0 N--CA 1.429 -1.495 1 N-CA-C 123.84 4.756 . . . . 2.12 123.84 -177.981 . . . . . . . . 3 2 . 1 . 094 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -74.3 27.14 0.08 Allowed 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.783 2.706 . . . . 1.71 115.01 -176.571 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.7 m -73.83 136.41 43.51 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.722 -4.361 . . . . 1.04 116.174 -174.859 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.8 m -112.98 108.97 18.08 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.478 2.085 . . . . 0.79 107.123 178.773 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -75.77 138.97 41.56 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 112.368 -2.197 . . . . 1.4 105.843 174.395 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -106.73 109.41 21.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.744 -3.098 . . . . 1.51 107.225 -170.339 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tp -106.48 126.0 51.7 Favored 'General case' 0 N--CA 1.43 -1.455 1 CA-C-O 128.81 4.148 . . . . 1.14 107.701 -171.69 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -112.85 138.74 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 109.353 -3.567 . . . . 1.23 105.906 -179.151 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -104.41 132.85 50.2 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 116.579 -2.049 . . . . 2.78 108.884 -173.899 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 ptt-85 -121.93 166.39 14.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 113.124 -1.853 . . . . 3.75 112.536 177.128 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.7 mt -89.42 166.56 13.63 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.053 0.93 . . . . 3.14 110.852 171.025 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -85.91 135.56 33.63 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 114.554 1.316 . . . . 6.8 114.554 174.759 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.51 -54.1 0.12 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 118.183 -2.823 . . . . 3.57 113.066 -161.596 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.784 0 CA-C-N 120.267 2.034 . . . . 3.87 114.149 175.628 . . . . . . . . 0 0 . 1 . 095 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ptt? . . . . . 0 CA--C 1.49 -1.356 0 CA-C-O 119.635 -0.221 . . . . 1.1 111.008 . . . . . . . . . 0 0 . 1 . 095 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -111.3 117.67 33.79 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.815 -1.178 . . . . 1.87 108.517 -176.594 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.425 HG12 HG22 ' A' ' 17' ' ' VAL . 16.8 pt -114.13 159.13 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 124.586 1.154 . . . . 0.72 113.054 -178.63 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -112.17 146.61 37.77 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 104.914 -2.254 . . . . 1.4 104.914 174.916 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.8 t -117.3 114.45 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 110.927 -2.851 . . . . 0.58 109.822 174.159 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -91.96 131.5 37.21 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 120.937 1.699 . . . . 2.09 110.329 175.838 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.295 39.4 p -83.12 174.13 11.09 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 126.535 3.064 . . . . 0.99 112.379 174.914 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.3 tp -57.96 -47.32 83.28 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.488 2.566 . . . . 2.53 117.818 172.746 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.3 p -86.4 -8.0 58.0 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.241 2.216 . . . . 2.08 110.103 -173.809 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.4 30.14 5.73 Favored Glycine 0 N--CA 1.431 -1.7 1 C-N-CA 132.932 5.063 . . . . 1.31 118.84 167.613 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -106.15 133.94 50.06 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.258 -2.319 . . . . 1.4 105.54 -176.038 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.7 m -105.05 118.7 37.2 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.239 -0.891 . . . . 0.78 110.155 -173.501 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mt -100.72 129.27 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 124.783 1.233 . . . . 1.55 109.982 -176.12 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 100.0 m -88.86 122.46 32.27 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 126.813 2.571 . . . . 1.08 106.409 177.931 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.2 tp -121.63 134.69 54.99 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.379 -2.076 . . . . 1.55 108.612 -178.616 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -94.02 99.92 12.14 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 129.643 3.177 . . . . 1.95 116.561 173.197 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.425 HG22 HG12 ' A' ' 3' ' ' ILE . 16.2 m -115.29 149.58 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 127.712 2.405 . . . . 0.96 112.681 -175.456 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -103.81 165.84 12.75 Favored Pre-proline 0 N--CA 1.43 -1.448 0 N-CA-C 106.625 -1.62 . . . . 2.35 106.625 168.274 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -79.56 -20.01 9.7 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 123.18 2.587 . . . . 0.95 107.625 -172.597 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.8 p -84.8 0.49 50.59 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.244 -2.16 . . . . 1.45 115.974 177.039 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -70.65 151.65 44.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.816 1.246 . . . . 1.69 110.611 173.913 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 p -84.78 166.64 16.79 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.421 1.488 . . . . 0.75 111.028 171.293 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.4 mm -75.12 -35.87 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 116.645 2.091 . . . . 0.73 116.645 173.335 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -48.31 -49.45 33.93 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.053 2.983 . . . . 1.62 119.053 163.536 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -58.49 -35.73 72.66 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.861 2.064 . . . . 2.13 112.899 173.892 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 t -72.76 -38.9 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 121.09 -1.006 . . . . 0.62 112.797 177.685 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -64.02 -31.26 72.38 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.495 -3.253 . . . . 1.22 111.409 170.514 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.43 -32.04 70.75 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 119.144 0.884 . . . . 0.51 111.695 175.246 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -68.86 -45.16 71.79 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.0 1.481 . . . . 1.44 115.0 171.888 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.5 mt -59.03 -35.41 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 125.621 2.629 . . . . 1.32 113.553 177.428 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.298 26.3 tt0 -69.15 -40.89 77.95 Favored 'General case' 0 N--CA 1.428 -1.535 0 O-C-N 116.331 -3.981 . . . . 1.7 111.475 172.67 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -56.05 -61.79 2.14 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 122.969 2.622 . . . . 1.55 114.362 167.429 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.439 12.0 ptpt -76.77 -50.77 12.75 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 114.8 1.407 . . . . 2.62 114.8 -173.706 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -97.28 -48.44 5.33 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 125.577 2.608 . . . . 1.48 112.98 -170.248 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.93 67.02 0.75 Allowed Glycine 0 N--CA 1.431 -1.683 0 N-CA-C 119.936 2.734 . . . . 1.12 119.936 -179.336 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.3 mt -127.26 135.24 27.12 Favored Pre-proline 0 N--CA 1.43 -1.446 0 N-CA-C 100.563 -3.865 . . . . 1.55 100.563 -177.303 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -85.55 135.17 4.99 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 C-N-CA 115.047 -2.835 . . . . 1.02 111.76 -175.202 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -56.29 -11.68 6.56 Favored 'Trans proline' 0 C--N 1.3 -2.0 1 C-N-CA 126.233 4.622 . . . . 1.25 117.41 -172.91 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -73.83 -23.7 59.69 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.82 1.415 . . . . 2.25 114.82 169.329 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -99.85 -3.06 33.37 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.023 -2.923 . . . . 2.02 113.871 -176.379 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -101.13 97.59 8.11 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.466 -2.021 . . . . 0.69 113.782 -172.706 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.8 ttt-85 -87.82 122.14 31.1 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 115.856 -2.021 . . . . 2.78 110.263 166.737 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.8 mt -111.08 131.5 55.02 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.886 2.18 . . . . 1.17 116.886 -177.717 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.91 136.23 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 105.691 -1.966 . . . . 1.38 105.691 -177.927 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -93.1 -105.42 0.12 Allowed 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.882 -1.508 . . . . 1.5 107.644 168.847 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.83 -69.81 0.79 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 113.934 1.087 . . . . 1.21 113.934 170.174 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.79 -28.57 5.29 Favored Glycine 0 N--CA 1.429 -1.779 0 O-C-N 119.701 -1.874 . . . . 1.3 109.5 -179.275 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -95.25 142.75 27.29 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 120.423 2.112 . . . . 2.55 108.599 -179.404 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -95.3 135.68 36.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 128.634 2.774 . . . . 2.48 104.394 166.851 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.1 mt -86.68 115.85 24.4 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 126.287 2.242 . . . . 0.9 116.777 -168.769 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -84.8 134.4 34.31 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 125.636 2.636 . . . . 1.94 111.776 179.014 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.283 20.0 m-20 -59.75 -40.38 87.92 Favored 'General case' 0 N--CA 1.43 -1.44 2 N-CA-C 127.458 6.095 . . . . 1.56 127.458 -168.547 . . . . . . . . 3 2 . 1 . 095 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.52 56.88 1.98 Allowed Glycine 0 N--CA 1.43 -1.703 0 O-C-N 119.256 -2.153 . . . . 0.97 113.518 167.736 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -131.93 162.25 31.12 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 127.811 2.444 . . . . 2.49 108.733 172.012 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.3 p -95.53 169.71 9.85 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 121.049 1.75 . . . . 0.76 110.134 173.948 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.451 ' HG ' HD12 ' A' ' 61' ' ' ILE 0.262 7.5 mp -59.02 -30.25 67.87 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 119.152 3.019 . . . . 1.05 119.152 161.906 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 p -74.24 -23.62 59.18 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.909 -2.994 . . . . 1.19 109.118 177.614 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -74.63 -40.65 61.37 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 129.759 3.224 . . . . 1.9 112.696 178.784 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.254 46.8 m-85 -91.62 -0.67 57.6 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 113.469 -5.769 . . . . 0.89 109.505 177.553 . . . . . . . . 3 2 . 1 . 095 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.8 m120 63.74 56.78 1.48 Allowed 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 114.233 -2.794 . . . . 1.84 109.278 -179.029 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.451 HD12 ' HG ' ' A' ' 56' ' ' LEU 0.295 65.6 mt -84.66 126.18 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 127.886 2.474 . . . . 0.82 110.659 175.643 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -107.58 170.92 7.68 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 117.925 -1.036 . . . . 2.16 108.277 -173.473 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -71.51 -29.3 64.63 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 115.478 -2.489 . . . . 2.12 113.981 -178.963 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -80.04 10.4 4.37 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 125.603 2.621 . . . . 1.71 113.972 -179.652 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.8 m -78.84 130.94 36.24 Favored 'General case' 0 N--CA 1.431 -1.406 1 O-C-N 116.096 -4.127 . . . . 1.04 116.899 -174.631 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.8 m -106.51 115.71 30.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.937 -1.938 . . . . 0.79 111.879 170.947 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.297 8.8 mp -87.61 157.61 19.08 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.744 -1.116 . . . . 1.4 109.439 177.103 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -128.54 123.93 34.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 103.36 -2.83 . . . . 1.51 103.36 -176.088 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.305 6.8 tt -103.56 115.42 30.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.253 1.021 . . . . 1.14 111.349 179.579 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.388 4.1 m -109.66 166.71 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 118.628 -2.545 . . . . 1.23 112.446 174.283 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.4 tp -75.04 109.84 8.84 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 117.365 2.358 . . . . 2.78 117.365 -178.45 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.36 138.71 38.93 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 120.096 -0.642 . . . . 3.75 110.796 179.731 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 55.4 mt -112.92 166.67 11.18 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 119.767 -1.833 . . . . 3.14 110.704 -176.929 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.0 ttm-85 -79.17 139.26 38.04 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 127.372 3.463 . . . . 6.8 112.173 178.362 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.54 -112.2 0.51 Allowed Glycine 0 N--CA 1.43 -1.736 1 O-C-N 113.652 -5.655 . . . . 3.57 113.661 -165.914 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.772 0 N-CA-C 108.614 -1.795 . . . . 3.87 108.614 -172.657 . . . . . . . . 0 0 . 1 . 096 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 ptt? . . . . . 0 CA--C 1.49 -1.355 0 N-CA-C 113.268 0.84 . . . . 1.1 113.268 . . . . . . . . . 0 0 . 1 . 096 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -101.14 107.11 18.44 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 120.414 1.461 . . . . 1.87 112.021 -178.768 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.1 pt -89.62 155.9 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 C-N-CA 124.76 1.224 . . . . 0.72 111.431 176.763 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -104.88 140.99 37.32 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 123.303 1.525 . . . . 1.4 107.93 -179.894 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.6 t -124.43 114.97 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 103.584 -2.747 . . . . 0.58 103.584 174.298 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -96.59 138.14 34.62 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.828 -1.795 . . . . 2.09 111.481 -178.322 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.65 HG22 HD23 ' A' ' 69' ' ' LEU 0.346 18.3 p -91.73 166.86 12.56 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 116.429 -1.748 . . . . 0.99 110.977 175.204 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.8 mt -68.95 -44.82 72.23 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 125.33 1.644 . . . . 2.53 111.182 171.784 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.1 p -62.17 -81.84 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 128.399 3.952 . . . . 2.08 113.299 -177.432 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.12 40.48 0.11 Allowed Glycine 0 N--CA 1.431 -1.692 1 O-C-N 116.299 -4.001 . . . . 1.31 119.243 174.819 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.2 tttt -122.87 142.39 50.84 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.069 1.435 . . . . 1.4 108.134 -177.206 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.6 m -120.63 118.66 30.72 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.759 2.423 . . . . 0.78 106.289 172.03 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.444 HD13 HG21 ' A' ' 13' ' ' ILE . 2.9 mt -97.59 133.2 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-O 124.978 2.323 . . . . 1.55 105.89 178.61 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 p -107.28 92.63 4.16 Favored 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 132.496 4.318 . . . . 1.08 107.091 -177.402 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.0 mt -101.31 130.36 47.46 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 125.313 1.633 . . . . 1.55 112.353 -179.198 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -74.7 107.49 6.84 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 115.269 -2.301 . . . . 1.95 109.758 171.314 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.1 m -127.57 173.32 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 105.847 -1.908 . . . . 0.96 105.847 -173.349 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -125.77 169.57 11.21 Favored Pre-proline 0 N--CA 1.431 -1.399 0 CA-C-O 112.903 -3.427 . . . . 2.35 106.285 163.849 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -74.87 -17.95 19.48 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 C-N-CA 124.028 3.152 . . . . 0.95 111.356 -175.192 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.6 p -78.17 -8.96 58.94 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.736 2.014 . . . . 1.45 115.656 176.339 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -74.29 137.88 43.19 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.69 -3.131 . . . . 1.69 112.567 176.565 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 29.6 p -76.42 154.84 34.47 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.697 1.999 . . . . 0.75 111.354 176.072 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.0 mm -54.42 -37.08 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 125.679 1.592 . . . . 0.73 112.072 173.96 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -53.32 -45.52 69.07 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.281 2.232 . . . . 1.62 116.783 162.599 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.413 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 5.5 t-20 -55.75 -42.22 75.11 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 119.09 -2.256 . . . . 2.13 115.642 171.692 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.0 t -66.33 -39.34 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 114.284 1.216 . . . . 0.62 114.284 179.204 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -63.27 -27.02 69.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.587 2.069 . . . . 1.22 116.587 168.931 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -64.71 -47.29 78.86 Favored 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 116.291 -4.005 . . . . 0.51 113.773 169.127 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -55.47 -49.95 71.17 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 126.431 3.015 . . . . 1.44 116.672 169.634 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.1 mt -59.11 -40.14 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 O-C-N 116.394 -3.941 . . . . 1.32 114.291 169.921 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -61.09 -39.87 91.56 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.77 -1.831 . . . . 1.7 113.058 173.444 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -62.7 -50.68 70.2 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.511 2.041 . . . . 1.55 116.511 172.711 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -67.6 -61.18 2.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.863 2.465 . . . . 2.62 109.665 -173.583 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -94.93 -56.27 2.81 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.622 -2.549 . . . . 1.48 112.837 -169.719 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.73 -1.1 2.84 Favored Glycine 0 N--CA 1.431 -1.667 0 O-C-N 119.615 -1.928 . . . . 1.12 116.155 176.111 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.1 mt -90.84 134.51 30.27 Favored Pre-proline 0 N--CA 1.429 -1.481 0 O-C-N 119.959 -1.906 . . . . 1.55 107.486 -167.269 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 20.4 Cg_exo -61.08 153.05 67.14 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 O-C-N 115.121 -3.147 . . . . 1.02 114.943 173.5 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 99.0 Cg_exo -73.7 -19.02 21.75 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 122.815 2.041 . . . . 1.25 110.557 -177.644 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.265 3.3 m-20 -63.42 -28.57 70.06 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.12 -2.863 . . . . 2.25 116.897 170.276 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.251 18.6 mt-30 -85.95 -23.91 26.75 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 115.164 -0.925 . . . . 2.02 111.936 -179.552 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -78.43 134.46 37.37 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 120.346 3.461 . . . . 0.69 120.346 -178.456 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -122.57 130.64 53.23 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 105.092 -2.188 . . . . 2.78 105.092 175.465 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.2 mt -114.73 147.11 40.15 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 117.238 -3.414 . . . . 1.17 113.371 175.778 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.0 mt -144.25 136.97 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 C-N-CA 128.268 2.627 . . . . 1.38 104.084 -168.674 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -117.52 123.65 46.79 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 103.289 -2.856 . . . . 1.5 103.289 170.374 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.285 . . 63.3 -89.53 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.476 -2.64 . . . . 1.21 116.75 -176.816 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.9 4.82 3.6 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 105.38 -3.088 . . . . 1.3 105.38 -177.91 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -109.12 130.03 55.48 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.029 -2.454 . . . . 2.55 115.557 -174.538 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -70.32 130.9 43.21 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.836 1.655 . . . . 2.48 110.347 171.171 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.1 mt -99.32 159.15 15.21 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 124.43 3.286 . . . . 0.9 105.094 -168.202 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.491 ' HB3' ' HG3' ' A' ' 54' ' ' ARG . 37.6 tt0 -104.25 130.2 52.05 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 125.65 1.844 . . . . 1.94 114.036 174.5 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -50.25 -50.73 49.17 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.523 3.156 . . . . 1.56 119.523 -168.848 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.6 -9.43 65.15 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 119.832 2.693 . . . . 0.97 119.832 170.68 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.491 ' HG3' ' HB3' ' A' ' 51' ' ' GLU . 37.4 mtt180 -84.92 163.22 19.1 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 115.757 -4.378 . . . . 2.49 115.066 169.687 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 43.0 p -84.02 174.66 10.12 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 118.582 2.808 . . . . 0.76 118.582 171.825 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.83 -31.29 72.41 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 117.922 2.564 . . . . 1.05 117.922 165.892 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.5 t -77.25 -25.2 51.28 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.937 2.095 . . . . 1.19 112.927 178.79 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -65.3 -33.49 76.1 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.316 -2.115 . . . . 1.9 111.898 169.45 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -91.81 4.51 52.69 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.316 -4.615 . . . . 0.89 113.439 170.059 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.663 2.9 m120 63.46 25.83 14.64 Favored 'General case' 0 N--CA 1.43 -1.439 1 N-CA-C 124.288 4.922 . . . . 1.84 124.288 -174.862 . . . . . . . . 3 2 . 1 . 096 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.4 mt -66.84 121.87 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 128.106 2.563 . . . . 0.82 110.541 -177.252 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -89.44 174.73 7.63 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.416 2.531 . . . . 2.16 112.349 -179.518 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -42.06 -56.65 2.75 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 128.023 3.773 . . . . 2.12 118.154 174.791 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -94.61 44.29 1.11 Allowed 'General case' 0 N--CA 1.429 -1.513 1 O-C-N 113.077 -6.015 . . . . 1.71 113.445 -175.269 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.31 38.8 m -92.65 133.73 35.7 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 118.73 -2.481 . . . . 1.04 115.478 -171.716 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.3 m -104.33 105.32 15.41 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 120.694 1.588 . . . . 0.79 107.448 175.004 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 67' ' ' LEU . 5.8 mp -81.74 161.85 23.17 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.299 2.0 . . . . 1.4 109.385 163.67 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.261 98.8 m-70 -118.45 130.7 56.11 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 112.493 -2.139 . . . . 1.51 108.966 -178.199 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.65 HD23 HG22 ' A' ' 7' ' ' THR . 49.8 tp -102.16 111.5 23.81 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 123.351 1.548 . . . . 1.14 110.228 179.295 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.289 40.0 t -109.48 129.79 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 118.218 2.673 . . . . 1.23 118.218 177.848 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.2 tp -115.01 116.44 28.46 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 115.889 -2.324 . . . . 2.78 113.741 -170.287 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.89 179.55 4.09 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 119.023 0.828 . . . . 3.75 109.803 -179.982 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.7 tp -72.4 -83.26 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.274 2.63 . . . . 3.14 114.612 173.035 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -162.37 150.42 14.4 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 101.108 -3.664 . . . . 6.8 101.108 164.313 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.95 143.58 7.78 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 104.967 -3.253 . . . . 3.57 104.967 -167.716 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.757 0 CA-C-N 123.264 3.532 . . . . 3.87 114.712 174.064 . . . . . . . . 0 0 . 1 . 097 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttp . . . . . 0 CA--C 1.491 -1.309 0 N-CA-C 116.139 1.904 . . . . 1.1 116.139 . . . . . . . . . 0 0 . 1 . 097 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -95.98 125.65 40.68 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 116.52 -3.863 . . . . 1.87 110.688 -174.312 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.6 pt -111.98 144.54 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 124.739 2.209 . . . . 0.72 110.12 169.121 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -108.34 112.67 25.24 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.131 -1.85 . . . . 1.4 110.63 -174.661 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.39 116.24 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-O 124.895 2.283 . . . . 0.58 107.262 178.564 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 tppt? -97.38 132.35 43.18 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.389 -3.945 . . . . 2.09 109.197 177.045 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.357 12.5 p -73.56 173.78 9.21 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.08 -2.262 . . . . 0.99 115.106 176.26 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.9 mt -70.92 -15.32 62.6 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 123.628 1.68 . . . . 2.53 114.985 172.962 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.7 p -109.24 -26.17 10.22 Favored 'General case' 0 N--CA 1.431 -1.399 1 O-C-N 116.025 -4.172 . . . . 2.08 107.264 -175.796 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.42 27.22 0.83 Allowed Glycine 0 N--CA 1.431 -1.651 0 O-C-N 118.968 -2.332 . . . . 1.31 117.12 169.383 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -100.66 118.41 36.74 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.808 2.304 . . . . 1.4 109.919 -168.712 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.4 m -81.44 122.48 27.56 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 119.557 -0.857 . . . . 0.78 110.012 178.518 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -111.14 133.77 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 102.729 -3.063 . . . . 1.55 102.729 173.518 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.8 m -111.63 125.73 54.26 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.277 -2.764 . . . . 1.08 108.815 -172.833 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.8 mt -119.01 135.45 54.62 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 120.739 1.609 . . . . 1.55 107.817 -177.369 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -91.43 112.57 24.54 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.143 -1.428 . . . . 1.95 107.143 169.966 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.7 m -127.53 165.85 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 C-N-CA 129.008 2.923 . . . . 0.96 116.02 -178.785 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -109.27 163.32 17.28 Favored Pre-proline 0 N--CA 1.43 -1.462 0 C-N-CA 119.717 -0.793 . . . . 2.35 111.601 163.876 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -82.18 -12.35 10.58 Favored 'Trans proline' 0 C--N 1.299 -2.049 0 O-C-N 114.531 -3.458 . . . . 0.95 113.729 -172.996 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.7 m -82.36 -5.92 58.93 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 124.792 1.307 . . . . 1.45 110.457 176.177 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -85.33 146.5 26.99 Favored 'General case' 0 N--CA 1.429 -1.498 1 O-C-N 114.652 -5.03 . . . . 1.69 109.776 178.783 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 68.9 p -77.55 161.78 27.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 118.289 -2.757 . . . . 0.75 112.159 178.629 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mp -68.81 -31.32 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 119.469 -2.019 . . . . 0.73 108.937 -179.818 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -46.48 -40.51 12.54 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.476 -2.015 . . . . 1.62 114.1 165.65 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -70.77 -29.55 65.8 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 117.514 2.413 . . . . 2.13 117.514 174.752 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.39 -39.61 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-N 113.428 -1.714 . . . . 0.62 109.289 176.809 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.3 84.2 mttt -60.73 -34.37 74.3 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 124.277 0.985 . . . . 1.22 111.974 169.275 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.62 -44.48 96.18 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.524 -2.61 . . . . 0.51 114.676 173.235 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -66.58 -43.55 84.64 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.425 -1.716 . . . . 1.44 115.014 172.397 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.5 mt -58.12 -31.07 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 116.652 -3.78 . . . . 1.32 113.327 170.656 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -60.34 -45.64 92.72 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 116.849 2.166 . . . . 1.7 116.849 170.69 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -63.87 -53.86 43.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.032 2.349 . . . . 1.55 114.151 174.92 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -56.81 -75.96 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 111.502 -2.59 . . . . 2.62 113.551 177.782 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -94.52 -21.38 18.91 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.433 3.123 . . . . 1.48 119.433 -169.068 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.75 43.38 3.63 Favored Glycine 0 N--CA 1.43 -1.755 1 O-C-N 114.802 -4.936 . . . . 1.12 113.471 175.886 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.7 mt -115.72 131.39 23.7 Favored Pre-proline 0 N--CA 1.43 -1.441 0 O-C-N 120.892 -1.357 . . . . 1.55 109.481 179.787 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -63.84 147.07 92.36 Favored 'Trans proline' 0 N--CA 1.433 -2.063 0 O-C-N 116.456 -2.444 . . . . 1.02 113.623 176.069 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.66 -22.89 64.04 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 C-N-CA 124.246 3.297 . . . . 1.25 115.991 -176.606 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.58 -24.47 65.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 128.395 2.678 . . . . 2.25 117.35 177.311 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -86.96 -33.22 19.72 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.014 -1.448 . . . . 2.02 107.257 -177.982 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -85.87 129.78 34.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.081 -1.637 . . . . 0.69 115.118 -168.642 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -115.97 142.24 47.06 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.599 1.959 . . . . 2.78 106.253 163.393 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.8 mt -117.7 125.56 50.9 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 106.306 -1.739 . . . . 1.17 106.306 178.89 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 39.3 mm -102.29 144.65 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 129.959 3.304 . . . . 1.38 107.259 174.222 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.315 17.4 t80 -143.0 114.83 8.18 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 105.235 -2.135 . . . . 1.5 105.235 171.57 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.5 17.73 9.03 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 127.524 3.535 . . . . 1.21 116.826 176.619 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.32 -7.55 54.31 Favored Glycine 0 N--CA 1.43 -1.712 1 O-C-N 114.323 -5.236 . . . . 1.3 111.527 -178.388 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -104.4 133.32 49.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.229 -1.748 . . . . 2.55 108.463 -175.801 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -74.42 125.64 28.97 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 112.901 -1.954 . . . . 2.48 111.372 169.033 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.1 mt -83.76 152.21 24.79 Favored 'General case' 0 N--CA 1.431 -1.383 0 O-C-N 125.078 1.486 . . . . 0.9 108.719 -172.323 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -94.93 135.39 36.51 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 123.28 1.514 . . . . 1.94 111.073 176.074 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -54.59 -53.88 48.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 111.612 -2.54 . . . . 1.56 114.94 -171.801 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.38 63.17 2.72 Favored Glycine 0 N--CA 1.429 -1.803 0 O-C-N 119.297 -2.127 . . . . 0.97 114.554 169.347 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -133.99 158.56 43.2 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 100.794 -3.78 . . . . 2.49 100.794 161.169 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 45.8 p -88.41 171.01 10.44 Favored 'General case' 0 N--CA 1.43 -1.439 1 CA-C-O 129.288 4.375 . . . . 0.76 110.115 176.694 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.32 -36.78 71.71 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 112.07 -6.643 . . . . 1.05 111.467 175.597 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.4 t -51.59 -35.07 39.95 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 129.158 2.983 . . . . 1.19 113.89 179.432 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -62.75 -30.36 71.38 Favored 'General case' 0 N--CA 1.43 -1.455 1 C-N-CA 132.855 4.462 . . . . 1.9 110.384 174.332 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -99.68 167.94 10.25 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.946 -2.346 . . . . 0.89 110.264 179.772 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -89.39 62.81 6.17 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 118.982 -2.324 . . . . 1.84 110.356 -179.829 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.8 mm -80.82 128.61 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 124.454 1.102 . . . . 0.82 108.283 177.858 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -100.17 -119.49 0.16 Allowed 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.49 2.404 . . . . 2.16 117.49 -169.941 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -100.39 -59.55 1.69 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 121.983 0.897 . . . . 2.12 111.192 177.703 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.32 75.23 1.64 Allowed 'General case' 0 N--CA 1.429 -1.523 0 O-C-N 118.321 -2.737 . . . . 1.71 107.684 177.278 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.0 m -91.47 142.6 27.49 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.907 -2.995 . . . . 1.04 109.573 -167.336 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.0 m -98.4 126.95 44.12 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.67 1.7 . . . . 0.79 107.118 178.871 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mp -110.15 166.18 11.16 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.659 -1.901 . . . . 1.4 107.088 176.157 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.549 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 98.4 m-70 -124.07 127.89 48.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.68 -3.762 . . . . 1.51 112.212 -170.109 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.0 tp -103.67 116.91 33.21 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 127.053 2.721 . . . . 1.14 113.022 -178.454 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.7 128.05 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 N-CA-C 105.329 -2.101 . . . . 1.23 105.329 178.351 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.7 mt -97.86 123.0 41.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 124.2 0.937 . . . . 2.78 111.607 174.911 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -89.25 114.01 25.32 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.636 2.375 . . . . 3.75 107.029 175.445 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.6 mt -93.09 137.9 32.03 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.945 -4.222 . . . . 3.14 108.62 171.735 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.269 48.9 mtp85 -73.25 140.83 47.14 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.853 -1.521 . . . . 6.8 110.565 168.051 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.73 -74.14 0.23 Allowed Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 105.711 -2.956 . . . . 3.57 105.711 -168.756 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.794 0 C-N-CA 127.594 2.521 . . . . 3.87 114.799 179.201 . . . . . . . . 0 0 . 1 . 098 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 ttp . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 120.56 0.219 . . . . 1.1 111.2 . . . . . . . . . 0 0 . 1 . 098 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -98.99 114.44 27.09 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.9 -2.259 . . . . 1.87 104.9 -170.069 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 pt -117.83 153.97 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 113.047 -1.888 . . . . 0.72 108.712 -179.722 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -118.88 113.53 21.2 Favored 'General case' 0 N--CA 1.43 -1.44 1 C-N-CA 132.556 4.342 . . . . 1.4 109.521 -175.93 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -104.23 121.49 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 100.812 -3.773 . . . . 0.58 100.812 177.364 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt -99.54 135.77 40.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.353 2.661 . . . . 2.09 110.878 177.511 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.7 p -92.64 -176.62 4.32 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.97 1.708 . . . . 0.99 112.125 173.229 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.5 mt -95.16 -11.72 27.64 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.953 2.101 . . . . 2.53 111.227 168.955 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.3 p -82.92 -46.41 12.99 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.368 2.032 . . . . 2.08 114.534 179.658 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.31 -13.5 0.29 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 117.546 -3.221 . . . . 1.31 111.141 170.976 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -86.82 128.26 35.03 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 119.902 1.851 . . . . 1.4 113.047 -165.654 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -92.52 115.64 28.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.834 -3.041 . . . . 0.78 108.353 175.037 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mt -99.08 117.25 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 1 O-C-N 115.967 -4.208 . . . . 1.55 109.455 -179.342 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.0 m -98.07 124.38 42.56 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.406 2.527 . . . . 1.08 108.459 -178.359 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.4 mt -118.99 138.33 52.89 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.348 1.61 . . . . 1.55 115.348 -179.968 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -103.46 102.37 12.28 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.69 -3.131 . . . . 1.95 109.927 175.219 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.9 m -114.75 170.78 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 128.421 2.688 . . . . 0.96 108.458 -175.296 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -118.18 157.48 48.82 Favored Pre-proline 0 N--CA 1.43 -1.459 0 O-C-N 118.393 -2.692 . . . . 2.35 107.521 163.775 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -62.7 -20.86 72.17 Favored 'Trans proline' 0 C--N 1.299 -2.055 0 C-N-CA 124.044 3.163 . . . . 0.95 115.508 -171.605 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 m -80.91 0.93 33.1 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 118.076 2.621 . . . . 1.45 118.076 173.862 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -87.43 163.91 16.48 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 102.457 -3.164 . . . . 1.69 102.457 175.624 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.2 p -90.8 -175.26 4.32 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.132 2.396 . . . . 0.75 114.006 176.142 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.4 mm -82.63 -36.41 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 O-C-N 116.893 -3.629 . . . . 0.73 106.61 178.917 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -50.97 -45.86 61.07 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.169 2.187 . . . . 1.62 112.478 167.168 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -64.27 -38.73 92.07 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.336 2.654 . . . . 2.13 107.202 175.787 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.8 t -59.27 -48.04 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 124.264 3.211 . . . . 0.62 114.364 176.805 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.262 37.8 mtmt -64.64 -41.73 95.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.46 1.504 . . . . 1.22 112.049 174.162 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.08 -32.38 72.91 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 117.067 2.247 . . . . 0.51 117.067 176.952 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -76.46 -36.54 57.85 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 125.092 1.495 . . . . 1.44 111.694 175.437 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.2 mt -71.9 -31.29 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 116.666 -3.772 . . . . 1.32 110.089 175.557 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -59.28 -59.1 6.0 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 113.579 -3.105 . . . . 1.7 107.74 169.985 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -50.16 -52.51 34.72 Favored 'General case' 0 N--CA 1.43 -1.432 1 CA-C-N 127.925 4.875 . . . . 1.55 111.79 166.418 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -61.66 -48.48 80.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.033 -2.917 . . . . 2.62 117.61 -167.952 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -112.59 -52.04 2.8 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 118.909 -1.116 . . . . 1.48 113.308 -168.317 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.21 36.25 0.43 Allowed Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 126.382 1.944 . . . . 1.12 114.305 178.934 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.8 mt -117.92 116.7 36.02 Favored Pre-proline 0 N--CA 1.429 -1.489 0 O-C-N 118.237 -2.919 . . . . 1.55 105.692 -171.239 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -59.93 154.0 53.51 Favored 'Trans proline' 0 C--N 1.299 -2.051 2 C-N-CA 126.67 4.913 . . . . 1.02 114.877 -179.954 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -73.36 -17.76 23.76 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 C-N-CA 124.566 3.511 . . . . 1.25 113.294 -176.55 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -84.25 -16.55 42.79 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.168 2.587 . . . . 2.25 108.986 -178.814 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.329 14.8 tt0 -97.86 -24.44 15.42 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 126.076 2.11 . . . . 2.02 109.925 -177.017 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -88.07 125.0 34.34 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 113.72 1.007 . . . . 0.69 113.72 -175.761 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -110.07 124.53 51.65 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.055 -0.72 . . . . 2.78 109.055 172.806 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.3 mt -107.84 114.83 29.04 Favored 'General case' 0 N--CA 1.429 -1.516 0 O-C-N 118.933 -2.354 . . . . 1.17 110.748 -173.102 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.7 mm -91.85 124.94 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 114.949 -1.023 . . . . 1.38 109.673 177.107 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -114.15 111.28 21.33 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.072 -1.085 . . . . 1.5 108.072 163.89 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.498 . . 68.01 -44.11 0.49 Allowed 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 127.039 3.305 . . . . 1.21 118.642 174.33 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.67 -47.66 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.738 0 O-C-N 116.798 -3.689 . . . . 1.3 108.246 -172.659 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -75.34 156.59 35.36 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 124.676 2.179 . . . . 2.55 112.319 179.612 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -104.82 135.48 46.11 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.173 -2.204 . . . . 2.48 105.718 169.131 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.418 HD22 ' CE2' ' A' ' 59' ' ' TYR . 12.8 mt -96.1 143.59 27.1 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.748 -1.845 . . . . 0.9 110.395 -169.675 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -83.67 147.44 27.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 113.312 -1.767 . . . . 1.94 115.303 172.449 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.61 -63.83 1.16 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 130.909 3.684 . . . . 1.56 113.216 -165.857 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.81 36.71 2.83 Favored Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 119.785 2.674 . . . . 0.97 119.785 171.637 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -102.73 152.43 21.24 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 120.999 0.428 . . . . 2.49 111.221 161.463 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.1 p -83.67 173.27 11.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 124.781 2.229 . . . . 0.76 109.219 171.677 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -72.7 -38.27 67.58 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.955 -2.966 . . . . 1.05 106.937 172.412 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.34 59.8 p -60.87 -24.76 66.18 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.528 1.931 . . . . 1.19 115.356 178.564 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.386 4.7 t0 -62.18 -38.4 88.91 Favored 'General case' 0 N--CA 1.429 -1.524 1 CA-C-O 129.017 4.246 . . . . 1.9 114.838 172.057 . . . . . . . . 3 2 . 1 . 098 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.418 ' CE2' HD22 ' A' ' 50' ' ' LEU . 76.8 m-85 -97.83 171.12 8.51 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 110.894 -2.867 . . . . 0.89 111.125 -179.367 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -89.68 43.16 1.13 Allowed 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.373 -2.704 . . . . 1.84 116.325 -175.136 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.3 mm -71.59 124.73 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 118.47 2.767 . . . . 0.82 118.47 -179.371 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -85.28 173.76 10.11 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 125.014 2.34 . . . . 2.16 109.125 -177.42 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.47 -48.83 77.91 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.497 -3.252 . . . . 2.12 115.568 173.858 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.06 64.09 0.93 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.445 -3.285 . . . . 1.71 111.964 175.365 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.5 m -87.39 141.65 28.47 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 117.896 2.554 . . . . 1.04 117.896 178.551 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.1 m -102.02 122.47 44.14 Favored 'General case' 0 N--CA 1.431 -1.409 1 CA-C-N 108.097 -4.138 . . . . 0.79 105.032 176.536 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -112.88 154.72 25.89 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 101.84 -3.392 . . . . 1.4 101.84 177.218 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -126.22 117.32 22.84 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.111 -2.243 . . . . 1.51 111.594 -175.534 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.251 3.9 tt -86.38 115.57 23.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 127.252 2.221 . . . . 1.14 108.946 -179.561 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.9 t -101.56 157.41 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 1 C-N-CA 133.523 4.729 . . . . 1.23 105.346 172.087 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.6 mt -121.98 161.82 22.22 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.659 -1.275 . . . . 2.78 108.199 173.676 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -135.63 167.93 20.2 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 115.967 -1.968 . . . . 3.75 107.346 -175.199 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.2 mt -107.78 145.47 33.51 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 121.277 1.853 . . . . 3.14 112.052 175.857 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -84.81 147.14 26.99 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.97 1.841 . . . . 6.8 115.97 174.786 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.82 57.21 0.87 Allowed Glycine 0 N--CA 1.431 -1.698 0 N-CA-C 105.354 -3.098 . . . . 3.57 105.354 -163.815 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.729 0 C-N-CA 128.728 3.061 . . . . 3.87 114.282 177.328 . . . . . . . . 0 0 . 1 . 099 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttp . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 114.076 1.139 . . . . 1.1 114.076 . . . . . . . . . 0 0 . 1 . 099 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -96.95 104.3 16.3 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 114.976 -2.44 . . . . 1.87 109.313 -172.636 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.43 HD12 HD13 ' A' ' 67' ' ' LEU . 13.4 pt -95.47 165.39 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 127.459 2.975 . . . . 0.72 111.977 174.94 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -117.5 136.3 53.33 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.359 1.464 . . . . 1.4 112.742 176.618 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.447 HG21 HD12 ' A' ' 15' ' ' LEU . 18.6 t -116.19 98.58 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 131.246 3.818 . . . . 0.58 111.123 177.21 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -84.53 134.46 34.42 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 119.168 0.895 . . . . 2.09 112.935 179.396 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -83.5 -174.86 5.53 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.809 -1.087 . . . . 0.99 110.95 176.864 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.7 tp -81.75 -41.54 21.08 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.609 1.195 . . . . 2.53 112.758 171.01 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.9 p -74.39 -21.78 59.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.769 2.137 . . . . 2.08 116.769 -177.452 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.45 -0.01 1.03 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 118.415 2.126 . . . . 1.31 118.415 166.62 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.8 tttp -91.24 126.4 36.31 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.132 -1.805 . . . . 1.4 114.303 -172.957 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.5 m -95.37 109.78 21.9 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 121.398 -0.814 . . . . 0.78 110.454 176.197 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.1 mt -89.85 137.29 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 113.162 -3.304 . . . . 1.55 102.324 -174.884 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 m -110.17 129.62 55.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 126.598 2.436 . . . . 1.08 105.397 -174.508 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.447 HD12 HG21 ' A' ' 5' ' ' VAL . 43.2 mt -133.33 125.76 29.91 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.02 -2.3 . . . . 1.55 105.081 -171.596 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -85.74 113.61 22.06 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.433 -3.292 . . . . 1.95 107.875 173.48 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.9 m -123.01 172.34 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 128.031 2.532 . . . . 0.96 111.741 176.447 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -126.01 156.71 71.35 Favored Pre-proline 0 N--CA 1.431 -1.42 0 C-N-CA 124.493 1.117 . . . . 2.35 109.315 164.153 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -64.17 -8.35 16.21 Favored 'Trans proline' 0 N--CA 1.433 -2.038 0 CA-C-N 126.678 3.421 . . . . 0.95 116.551 -174.761 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 p -93.77 -1.93 54.37 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.179 1.809 . . . . 1.45 111.966 178.635 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -73.38 156.0 38.78 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.519 -1.988 . . . . 1.69 110.672 172.569 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 58.3 p -95.63 173.47 7.47 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 114.842 1.423 . . . . 0.75 114.842 176.872 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.9 mm -67.05 -44.79 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 116.307 -1.806 . . . . 0.73 108.479 169.418 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -52.12 -33.54 40.3 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 117.287 2.328 . . . . 1.62 117.287 169.285 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -66.79 -42.72 85.55 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.868 -3.645 . . . . 2.13 113.186 174.463 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 t -53.32 -47.88 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 115.328 1.603 . . . . 0.62 115.328 171.303 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.8 mttt -65.73 -31.16 72.0 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 126.578 2.423 . . . . 1.22 114.734 176.217 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -43.47 98.75 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 120.96 1.709 . . . . 0.51 110.775 176.793 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -57.03 -38.12 72.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.978 1.844 . . . . 1.44 115.978 172.2 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.5 mt -69.75 -34.35 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 113.911 1.078 . . . . 1.32 113.911 168.555 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -69.07 -34.02 74.49 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 130.14 3.376 . . . . 1.7 115.388 174.905 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.351 36.8 t70 -71.19 -41.92 69.68 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 123.977 0.911 . . . . 1.55 113.043 166.509 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -81.12 -44.94 17.19 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 117.527 2.417 . . . . 2.62 117.527 -176.557 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -109.42 -46.84 3.48 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.502 -1.295 . . . . 1.48 107.502 -165.273 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.89 36.13 2.25 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 119.055 2.382 . . . . 1.12 119.055 173.271 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.451 HG21 HD22 ' A' ' 71' ' ' LEU . 9.9 mt -111.18 136.76 20.86 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-O 116.687 -1.625 . . . . 1.55 109.981 -177.575 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -70.85 160.58 48.92 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 CA-C-N 125.08 2.85 . . . . 1.02 112.48 -175.379 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -66.82 -19.84 52.53 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 N-CA-C 118.1 2.308 . . . . 1.25 118.1 178.535 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -62.55 -37.48 86.32 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 119.702 3.223 . . . . 2.25 119.702 171.545 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.34 18.4 mm100 -80.23 -29.76 38.5 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 108.666 -3.879 . . . . 2.02 111.763 -173.21 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -81.8 133.15 35.31 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.064 -1.425 . . . . 0.69 108.484 -175.181 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -123.86 110.92 15.47 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 106.325 -1.731 . . . . 2.78 106.325 175.046 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.8 mt -99.96 118.0 35.43 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.699 2.666 . . . . 1.17 105.556 -179.008 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.8 mm -109.75 116.05 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 104.152 -2.536 . . . . 1.38 104.152 -173.244 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -121.83 110.11 15.49 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.849 -2.278 . . . . 1.5 104.849 176.147 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.27 30.87 4.11 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.627 3.171 . . . . 1.21 110.658 175.951 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.71 -33.74 5.33 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 119.867 1.212 . . . . 1.3 112.396 -175.046 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -78.29 132.94 37.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.232 1.813 . . . . 2.55 108.83 -177.972 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -91.44 122.02 33.66 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.424 2.059 . . . . 2.48 109.409 170.992 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 54.2 mt -70.23 136.08 49.61 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 129.553 3.141 . . . . 0.9 113.691 -174.911 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -77.88 148.42 34.62 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.202 -1.561 . . . . 1.94 114.922 174.973 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -62.95 -63.13 1.3 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.14 -2.225 . . . . 1.56 116.94 -171.943 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.5 42.7 0.24 Allowed Glycine 0 N--CA 1.43 -1.729 1 N-CA-C 123.859 4.303 . . . . 0.97 123.859 167.554 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -117.12 164.43 14.77 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 114.238 -2.791 . . . . 2.49 111.14 168.453 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.0 p -96.39 169.64 9.78 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 122.64 2.473 . . . . 0.76 110.769 169.803 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.2 mt -75.88 -23.47 55.6 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.596 -2.565 . . . . 1.05 112.976 174.916 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.4 t -71.53 -29.59 64.95 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.859 2.17 . . . . 1.19 116.859 178.709 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -58.61 -49.29 78.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 131.434 3.893 . . . . 1.9 110.991 174.236 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -80.44 164.16 23.26 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 125.664 2.65 . . . . 0.89 105.833 -177.961 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -90.92 58.18 3.72 Favored 'General case' 0 N--CA 1.43 -1.473 1 O-C-N 114.139 -5.351 . . . . 1.84 113.484 -175.877 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.4 mm -93.24 143.64 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.521 -1.218 . . . . 0.82 109.702 179.878 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -96.63 -102.65 0.17 Allowed 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.41 1.084 . . . . 2.16 108.846 -174.343 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -131.04 -73.85 0.54 Allowed 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 113.67 0.989 . . . . 2.12 113.67 -179.995 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -98.9 52.09 0.97 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.139 1.447 . . . . 1.71 111.418 177.352 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -83.46 149.3 26.73 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 128.407 2.683 . . . . 1.04 111.388 -169.561 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.7 m -101.56 122.94 44.77 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.532 -1.667 . . . . 0.79 111.79 -174.818 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.43 HD13 HD12 ' A' ' 3' ' ' ILE . 7.0 mp -111.0 156.43 21.26 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 103.749 -2.686 . . . . 1.4 103.749 176.705 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -125.1 129.38 50.08 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 125.656 2.645 . . . . 1.51 108.213 -172.29 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.3 tp -98.62 114.16 26.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.769 -2.457 . . . . 1.14 111.52 179.909 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.2 t -105.71 135.67 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 C-N-CA 127.48 2.312 . . . . 1.23 105.241 174.732 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.451 HD22 HG21 ' A' ' 36' ' ' ILE . 81.5 mt -97.59 140.95 31.24 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.465 -3.272 . . . . 2.78 112.193 175.645 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -77.44 163.73 26.1 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.55 1.94 . . . . 3.75 111.297 176.325 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 46.1 tp -70.06 119.5 14.36 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 117.876 -3.015 . . . . 3.14 110.182 179.711 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -64.6 153.75 38.35 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.748 3.619 . . . . 6.8 114.814 168.172 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.41 -65.43 0.34 Allowed Glycine 0 N--CA 1.43 -1.72 0 O-C-N 120.035 -1.666 . . . . 3.57 111.8 -165.793 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.742 0 C-N-CA 126.273 1.892 . . . . 3.87 112.693 -176.698 . . . . . . . . 0 0 . 1 . 100 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 CA--C 1.49 -1.355 0 N-CA-C 112.965 0.728 . . . . 1.1 112.965 . . . . . . . . . 0 0 . 1 . 100 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.86 134.69 36.92 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 122.793 1.283 . . . . 1.87 108.836 174.576 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.6 pt -125.76 157.51 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 N-CA-C 105.965 -1.865 . . . . 0.72 105.965 164.023 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.424 ' HB3' ' CG2' ' A' ' 12' ' ' THR . 55.9 m-85 -113.72 114.66 26.68 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 125.661 2.648 . . . . 1.4 109.969 -178.612 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.4 t -97.45 106.06 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 113.548 -1.66 . . . . 0.58 111.568 177.303 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.278 85.9 mttt -91.77 122.72 34.58 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 116.92 -3.612 . . . . 2.09 112.044 -177.261 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.1 p -89.81 168.42 12.09 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.036 -2.915 . . . . 0.99 111.641 -179.031 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.8 mt -75.16 -36.55 61.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.957 -2.965 . . . . 2.53 114.3 176.44 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -74.83 -22.98 58.39 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 127.392 2.277 . . . . 2.08 112.416 -177.91 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.46 54.68 0.33 Allowed Glycine 0 N--CA 1.43 -1.757 0 O-C-N 119.528 -1.983 . . . . 1.31 116.191 171.709 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -141.46 140.34 33.55 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.413 -2.227 . . . . 1.4 112.642 169.689 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.424 ' CG2' ' HB3' ' A' ' 4' ' ' PHE . 32.4 m -95.8 105.37 17.37 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 111.767 -2.469 . . . . 0.78 105.294 174.438 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 80.2 mt -89.51 123.2 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.776 -2.453 . . . . 1.55 106.281 -178.025 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -95.44 122.98 38.74 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.191 1.472 . . . . 1.08 110.574 177.095 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.269 62.3 mt -111.86 142.53 44.13 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 128.943 2.897 . . . . 1.55 113.327 -175.074 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -98.75 103.72 15.7 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.163 1.459 . . . . 1.95 108.085 169.426 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.6 172.03 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 117.823 -1.551 . . . . 0.96 111.699 176.354 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -123.2 157.47 60.95 Favored Pre-proline 0 N--CA 1.43 -1.465 0 O-C-N 119.122 -2.236 . . . . 2.35 108.81 165.58 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.75 -7.74 17.7 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 CA-C-N 127.068 3.56 . . . . 0.95 112.998 -171.175 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.5 m -78.58 -25.07 45.2 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 127.303 2.877 . . . . 1.45 108.628 176.91 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -70.3 163.37 26.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.906 2.765 . . . . 1.69 111.528 -175.129 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 38.3 p -98.22 165.04 12.07 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.912 -1.742 . . . . 0.75 109.553 -177.034 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.8 mm -66.59 -32.24 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 126.965 2.106 . . . . 0.73 114.26 172.163 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -52.81 -35.19 56.55 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 130.986 3.714 . . . . 1.62 113.113 163.347 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -80.92 -28.3 35.86 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.555 -1.966 . . . . 2.13 113.522 176.874 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.2 t -67.92 -51.27 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 104.217 -2.512 . . . . 0.62 104.217 178.982 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -64.44 -28.76 69.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 116.66 -3.775 . . . . 1.22 113.215 179.739 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.11 -29.19 66.08 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 121.187 1.812 . . . . 0.51 114.704 175.01 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.06 -30.58 63.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.441 -1.412 . . . . 1.44 114.371 172.313 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.2 mt -65.95 -36.89 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 118.559 -2.588 . . . . 1.32 113.897 167.283 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -58.16 -47.39 83.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.014 2.926 . . . . 1.7 111.457 172.782 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -60.29 -57.14 14.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 118.906 2.928 . . . . 1.55 118.906 165.827 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -66.51 -56.82 9.07 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 128.398 3.952 . . . . 2.62 116.046 -175.912 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -96.17 -44.65 7.19 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.788 -3.695 . . . . 1.48 114.715 -170.378 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.03 32.05 2.31 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 117.44 -1.755 . . . . 1.12 113.824 176.575 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.5 mm -108.55 143.81 28.27 Favored Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 101.824 -3.399 . . . . 1.55 101.824 -174.088 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -73.11 154.47 52.27 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 N-CA-C 116.239 1.592 . . . . 1.02 116.239 174.552 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -78.29 -28.49 4.61 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 CA-C-N 120.644 1.266 . . . . 1.25 112.379 -173.766 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -59.83 -35.29 74.42 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.426 1.891 . . . . 2.25 113.404 173.535 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -81.34 -33.85 32.19 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 116.507 -3.871 . . . . 2.02 111.257 179.349 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.297 71.8 mt-30 -74.66 130.95 40.45 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 116.424 -1.75 . . . . 0.69 111.855 -175.832 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -115.62 125.1 52.49 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 121.703 2.047 . . . . 2.78 110.94 163.47 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.4 mt -99.8 127.36 45.95 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.317 -2.114 . . . . 1.17 110.766 179.169 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.9 mt -118.78 134.08 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 126.981 2.112 . . . . 1.38 108.551 -178.435 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 67' ' ' LEU . 34.4 t80 -128.54 137.79 51.92 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.503 -2.406 . . . . 1.5 104.503 169.091 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 37.32 39.72 0.17 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 118.483 2.771 . . . . 1.21 118.483 -176.078 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.66 -18.0 32.28 Favored Glycine 0 N--CA 1.43 -1.713 0 N-CA-C 119.976 2.75 . . . . 1.3 119.976 -177.921 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -81.32 134.11 35.53 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.756 -2.026 . . . . 2.55 109.45 175.824 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -93.23 106.94 18.84 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 125.957 2.036 . . . . 2.48 108.848 179.182 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.4 mt -66.12 137.03 56.76 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 110.567 -3.015 . . . . 0.9 106.545 -168.542 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -84.36 159.87 20.77 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.645 2.641 . . . . 1.94 109.619 174.18 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -70.38 -55.77 8.28 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 116.383 -3.948 . . . . 1.56 114.086 -167.854 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.65 49.67 4.1 Favored Glycine 0 N--CA 1.431 -1.643 0 C-N-CA 126.348 1.928 . . . . 0.97 110.495 178.182 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 -124.47 158.74 32.12 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.773 -1.936 . . . . 2.49 105.773 164.357 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 21.7 p -89.47 163.02 15.43 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.996 1.48 . . . . 0.76 114.996 175.035 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.8 mt -66.6 -35.49 80.32 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.747 -3.095 . . . . 1.05 105.719 178.571 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 t -58.41 -34.33 70.65 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 118.367 2.729 . . . . 1.19 118.367 173.172 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -74.86 -37.41 62.21 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 113.48 -1.691 . . . . 1.9 110.286 -179.615 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -80.44 5.41 15.14 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.205 -1.56 . . . . 0.89 114.017 172.655 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.275 14.0 m-80 62.48 31.42 17.08 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.632 1.573 . . . . 1.84 113.047 179.755 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.9 mt -78.93 122.22 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 125.351 1.461 . . . . 0.82 112.32 179.904 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -96.06 177.23 5.81 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 110.402 -3.09 . . . . 2.16 114.958 -177.752 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -54.47 130.84 41.07 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 115.746 1.758 . . . . 2.12 115.746 171.229 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.361 77.5 mt-10 62.72 55.46 2.13 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.502 -1.999 . . . . 1.71 116.307 -178.046 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.3 m -104.02 151.46 23.2 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.127 2.394 . . . . 1.04 109.667 -175.173 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.0 m -102.84 113.65 27.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.085 -2.884 . . . . 0.79 105.394 177.946 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.443 HD23 ' CD1' ' A' ' 45' ' ' PHE . 31.9 mt -110.24 165.74 11.52 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 105.858 -1.904 . . . . 1.4 105.858 174.791 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -124.01 126.29 46.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.853 -1.78 . . . . 1.51 111.765 -173.732 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.0 tp -105.27 134.86 47.68 Favored 'General case' 0 N--CA 1.428 -1.526 0 C-N-CA 126.001 1.72 . . . . 1.14 111.759 -176.484 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.1 m -137.29 158.76 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 125.142 2.401 . . . . 1.23 105.007 176.131 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.1 mt -120.56 158.47 27.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.906 -2.996 . . . . 2.78 115.828 -177.207 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -89.27 138.14 31.7 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 123.644 1.688 . . . . 3.75 106.535 177.963 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.9 mt -97.08 -150.43 0.34 Allowed 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 127.687 2.395 . . . . 3.14 113.376 175.566 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -121.28 133.59 55.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 107.458 -1.312 . . . . 6.8 107.458 174.249 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.79 63.28 0.68 Allowed Glycine 0 N--CA 1.431 -1.7 0 O-C-N 120.509 -1.369 . . . . 3.57 110.054 -170.513 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.729 0 O-C-N 119.274 -2.309 . . . . 3.87 112.424 -178.412 . . . . . . . . 0 0 . 1 . 101 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.6 ptt? . . . . . 0 CA--C 1.49 -1.33 0 CA-C-O 119.657 -0.211 . . . . 1.1 110.758 . . . . . . . . . 0 0 . 1 . 101 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -88.44 149.78 23.5 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 117.153 -1.403 . . . . 1.87 110.42 177.222 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.494 HD11 HG11 ' A' ' 17' ' ' VAL . 9.5 pt -140.12 144.6 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.971 -2.233 . . . . 0.72 104.971 175.131 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -103.81 139.17 39.39 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 112.629 -3.628 . . . . 1.4 109.519 177.877 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.492 HG22 ' HB2' ' A' ' 67' ' ' LEU . 12.6 t -113.25 109.67 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 117.983 -2.948 . . . . 0.58 109.526 167.41 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -91.04 137.94 31.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.504 -2.623 . . . . 2.09 111.179 -178.208 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.263 67.8 p -82.34 -175.41 5.68 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 124.787 2.232 . . . . 0.99 115.323 177.707 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.1 mt -50.31 -55.93 13.4 Favored 'General case' 0 N--CA 1.43 -1.461 2 O-C-N 114.521 -5.112 . . . . 2.53 109.426 166.044 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.253 20.4 p -72.19 -31.09 65.57 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.533 -2.604 . . . . 2.08 110.383 -175.834 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.74 25.05 1.62 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 110.773 -0.931 . . . . 1.31 110.773 172.291 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 ttpt -76.53 117.64 18.38 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.041 -3.035 . . . . 1.4 109.328 -179.976 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m -74.39 90.08 2.14 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.017 2.817 . . . . 0.78 113.42 175.694 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mt -83.07 125.73 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 117.249 -3.407 . . . . 1.55 108.456 -179.718 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.3 m -101.33 128.27 47.57 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 119.487 -2.008 . . . . 1.08 113.854 177.55 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.448 HD21 HG13 ' A' ' 30' ' ' ILE . 9.3 mp -128.89 154.67 46.28 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 126.0 2.063 . . . . 1.55 105.557 -175.956 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -100.7 129.29 46.58 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.245 -1.761 . . . . 1.95 106.245 171.883 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.494 HG11 HD11 ' A' ' 3' ' ' ILE . 27.2 m -135.46 155.88 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 O-C-N 127.904 3.252 . . . . 0.96 107.566 179.821 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -106.33 153.67 40.27 Favored Pre-proline 0 N--CA 1.43 -1.474 0 N-CA-C 102.915 -2.995 . . . . 2.35 102.915 161.897 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -70.68 -12.11 30.66 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 O-C-N 115.255 -3.076 . . . . 0.95 116.683 -177.356 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.8 p -90.42 7.08 40.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 117.365 -1.303 . . . . 1.45 109.685 175.039 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -81.31 146.23 30.48 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.927 2.775 . . . . 1.69 109.855 174.189 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.52 159.49 18.61 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.737 -3.102 . . . . 0.75 111.833 -174.289 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.1 mm -59.07 -43.03 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 124.472 1.109 . . . . 0.73 113.067 175.336 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -39.91 -41.66 1.21 Allowed 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.725 3.602 . . . . 1.62 120.725 161.084 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.8 m-20 -79.38 -25.1 42.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 114.721 -2.561 . . . . 2.13 111.716 173.268 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -68.37 -45.92 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 122.856 2.571 . . . . 0.62 110.668 173.417 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -58.73 -38.37 78.24 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.435 1.642 . . . . 1.22 115.435 174.18 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.27 -37.77 72.89 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.301 -2.124 . . . . 0.51 114.598 173.671 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.8 mttm -60.98 -44.77 96.88 Favored 'General case' 0 N--CA 1.431 -1.392 1 C-N-CA 131.884 4.073 . . . . 1.44 111.325 175.463 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.448 HG13 HD21 ' A' ' 15' ' ' LEU . 93.7 mt -66.54 -44.8 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 126.641 3.115 . . . . 1.32 114.602 172.022 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -50.27 -44.41 53.69 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.158 -2.839 . . . . 1.7 114.977 166.899 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -60.61 -59.2 5.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 115.74 -2.076 . . . . 1.55 108.6 175.544 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 tptt -68.01 -47.21 69.09 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 116.607 2.077 . . . . 2.62 116.607 -172.917 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -99.7 -46.36 5.45 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.972 2.509 . . . . 1.48 109.902 -165.58 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.92 22.59 5.9 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 126.484 2.365 . . . . 1.12 114.532 175.014 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mt -97.46 119.82 62.05 Favored Pre-proline 0 N--CA 1.43 -1.44 0 C-N-CA 125.628 1.571 . . . . 1.55 114.355 -174.432 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.74 161.01 30.9 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 116.854 -1.631 . . . . 1.02 113.728 -173.672 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -62.81 -19.68 69.2 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 123.809 3.006 . . . . 1.25 118.546 -171.186 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -67.82 -27.77 67.0 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.078 2.151 . . . . 2.25 114.194 177.338 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -94.34 -38.4 11.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.742 2.017 . . . . 2.02 113.568 -173.062 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -102.17 135.94 42.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.582 2.611 . . . . 0.69 115.156 -170.566 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -121.8 143.53 49.34 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.08 -2.263 . . . . 2.78 111.147 170.813 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -110.62 130.84 55.47 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.21 2.433 . . . . 1.17 112.313 178.72 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.0 mm -109.34 138.66 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 110.581 -3.009 . . . . 1.38 106.537 178.828 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.477 ' HB3' HD21 ' A' ' 50' ' ' LEU . 48.2 t80 -120.77 107.0 12.22 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.995 2.918 . . . . 1.5 109.144 163.558 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.371 . . 69.29 -93.64 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.881 3.229 . . . . 1.21 113.685 179.987 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.61 8.62 6.17 Favored Glycine 0 N--CA 1.43 -1.746 0 O-C-N 116.959 -3.588 . . . . 1.3 111.693 -177.773 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -117.65 138.54 51.9 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 119.61 -2.112 . . . . 2.55 107.462 -177.796 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -76.77 111.16 11.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 112.609 -2.087 . . . . 2.48 113.073 164.812 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.477 HD21 ' HB3' ' A' ' 45' ' ' PHE . 36.5 mt -66.25 113.89 4.92 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 118.423 0.556 . . . . 0.9 111.565 -174.418 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -76.21 129.26 36.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 127.52 3.534 . . . . 1.94 113.03 176.462 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -43.9 -53.43 6.11 Favored 'General case' 0 N--CA 1.43 -1.433 2 N-CA-C 124.061 4.837 . . . . 1.56 124.061 -173.163 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.35 43.97 3.15 Favored Glycine 0 N--CA 1.429 -1.797 0 O-C-N 119.861 -1.774 . . . . 0.97 115.338 175.996 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.311 33.6 mmt180 -118.29 171.79 7.89 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.953 2.311 . . . . 2.49 112.07 159.655 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.7 p -93.37 174.14 7.36 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.497 -2.627 . . . . 0.76 117.748 163.682 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.8 mt -67.16 -33.89 76.39 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 130.231 3.412 . . . . 1.05 114.845 165.057 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 t -65.43 -35.28 80.44 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.86 2.864 . . . . 1.19 114.288 173.315 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -68.41 -44.33 75.26 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 117.673 -1.156 . . . . 1.9 109.899 177.293 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -82.59 3.45 28.66 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 116.196 -1.859 . . . . 0.89 113.311 176.732 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.5 t30 58.27 50.61 9.45 Favored 'General case' 0 N--CA 1.43 -1.434 1 CA-C-O 129.264 4.364 . . . . 1.84 114.564 174.85 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.251 24.6 mt -105.1 115.48 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 C-N-CA 131.87 4.068 . . . . 0.82 108.59 177.641 . . . . . . . . 3 2 . 1 . 101 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -93.46 172.68 8.12 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 130.798 3.639 . . . . 2.16 112.167 -176.507 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -72.04 144.83 48.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 115.546 -2.462 . . . . 2.12 114.175 169.897 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.384 54.3 mt-10 72.06 23.42 3.45 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.759 1.266 . . . . 1.71 114.153 177.275 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.281 17.4 m -88.75 153.46 21.07 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.02 -2.585 . . . . 1.04 104.02 -172.424 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.5 m -103.12 115.05 29.85 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 125.818 2.723 . . . . 0.79 106.788 -178.819 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.492 ' HB2' HG22 ' A' ' 5' ' ' VAL . 8.1 mp -103.38 164.63 11.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 103.027 -2.953 . . . . 1.4 103.027 174.11 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -131.2 138.02 49.21 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.532 -1.355 . . . . 1.51 111.918 177.981 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.1 tp -106.93 117.78 34.96 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 129.221 3.008 . . . . 1.14 108.195 -177.849 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.7 m -115.5 175.06 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 107.119 -1.437 . . . . 1.23 107.119 165.803 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pp -159.18 -179.04 7.64 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.914 -1.116 . . . . 2.78 109.412 -174.197 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -128.37 139.09 52.57 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 129.282 3.033 . . . . 3.75 103.901 173.37 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.5 mt -83.76 148.11 27.23 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 105.777 -1.934 . . . . 3.14 105.777 168.537 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -80.87 133.98 35.68 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.674 -1.891 . . . . 6.8 114.263 178.604 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.46 42.01 1.94 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 127.138 2.304 . . . . 3.57 113.032 -174.327 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.702 0 CA-C-N 120.553 2.176 . . . . 3.87 115.226 -177.782 . . . . . . . . 0 0 . 1 . 102 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.1 ttp . . . . . 0 CA--C 1.491 -1.318 1 CA-C-O 129.664 4.554 . . . . 1.1 110.065 . . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.271 20.5 tt0 -93.81 113.44 25.48 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 114.487 -5.133 . . . . 1.87 110.305 -176.17 . . . . . . . . 3 2 . 1 . 102 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.481 HG12 HG22 ' A' ' 17' ' ' VAL . 15.0 pt -119.93 168.18 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.735 1.731 . . . . 0.72 107.119 170.348 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -131.4 157.61 42.99 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 103.268 -2.864 . . . . 1.4 103.268 -178.838 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.6 t -133.12 128.34 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 101.818 -3.401 . . . . 0.58 101.818 -178.34 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -119.39 119.38 33.77 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 122.591 1.186 . . . . 2.09 108.549 178.98 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.402 HG22 HD23 ' A' ' 69' ' ' LEU . 46.9 p -77.5 174.98 10.26 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 121.654 3.946 . . . . 0.99 121.654 -174.74 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.6 mt -52.02 -52.25 52.04 Favored 'General case' 0 N--CA 1.43 -1.443 1 CA-C-O 129.104 4.288 . . . . 2.53 115.218 169.082 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -72.2 -25.15 61.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.172 -2.83 . . . . 2.08 115.469 -178.066 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.33 19.25 4.29 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 124.778 3.444 . . . . 1.31 111.386 169.303 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -89.57 143.02 27.14 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 104.801 -2.296 . . . . 1.4 104.801 -176.638 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -110.28 119.74 40.22 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.361 1.553 . . . . 0.78 109.942 173.119 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.2 mt -98.8 122.25 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 125.631 2.634 . . . . 1.55 109.812 176.033 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.3 m -91.3 121.69 33.27 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.483 -3.26 . . . . 1.08 108.621 -179.74 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 mt -116.92 163.5 16.11 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.028 -1.842 . . . . 1.55 106.028 -173.527 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -121.44 104.57 9.78 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.334 1.453 . . . . 1.95 107.305 169.983 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.481 HG22 HG12 ' A' ' 3' ' ' ILE . 27.2 m -106.11 -174.13 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 103.912 -2.625 . . . . 0.96 103.912 179.528 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -138.2 155.24 74.32 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 103.004 -2.962 . . . . 2.35 103.004 165.709 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -62.25 -11.88 24.43 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 126.529 3.368 . . . . 0.95 117.382 -173.384 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.9 m -85.22 -0.14 53.69 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.874 1.67 . . . . 1.45 113.025 -175.564 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -84.23 144.04 29.19 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 126.095 2.122 . . . . 1.69 110.735 -179.588 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 67.4 p -83.71 164.1 19.84 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.02 -1.9 . . . . 0.75 110.339 178.159 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.2 mm -68.32 -35.33 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 O-C-N 120.025 -1.672 . . . . 0.73 110.699 -179.912 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -45.8 -49.31 15.25 Favored 'General case' 0 N--CA 1.43 -1.446 1 C-N-CA 133.446 4.699 . . . . 1.62 110.773 163.424 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -73.78 -41.65 62.11 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.153 -2.217 . . . . 2.13 110.746 -176.486 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.1 t -61.56 -37.19 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 116.713 2.116 . . . . 0.62 116.713 170.856 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -56.88 -36.58 70.26 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 118.127 2.64 . . . . 1.22 118.127 170.762 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.56 80.78 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 118.68 -2.512 . . . . 0.51 111.196 166.437 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -68.32 -29.65 68.45 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 115.04 -4.788 . . . . 1.44 115.59 170.323 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.307 56.7 mt -70.09 -30.24 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-O 123.672 1.701 . . . . 1.32 106.816 175.281 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -69.34 -37.52 77.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.245 -1.534 . . . . 1.7 109.173 179.257 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -67.89 -54.63 17.32 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 126.876 2.61 . . . . 1.55 108.735 174.984 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -69.18 -54.63 13.82 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 118.579 -2.576 . . . . 2.62 111.833 -169.652 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -93.26 -59.54 2.0 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.157 -2.214 . . . . 1.48 112.31 -169.978 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.64 45.93 0.37 Allowed Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 107.03 -2.428 . . . . 1.12 107.03 176.444 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.4 mt -118.56 134.61 23.47 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 103.245 -2.872 . . . . 1.55 103.245 -176.662 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 76.4 Cg_exo -75.12 152.05 39.73 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-O 114.939 -2.192 . . . . 1.02 116.354 -177.618 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 81.0 Cg_exo -71.94 -14.3 29.33 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 CA-C-N 121.685 1.638 . . . . 1.25 115.769 -172.938 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.393 2.6 p30 -67.41 -48.64 66.72 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.959 1.704 . . . . 2.25 108.393 172.567 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -68.85 -16.74 63.86 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 116.35 -1.786 . . . . 2.02 113.574 -177.242 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -88.2 110.47 20.73 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 123.366 1.555 . . . . 0.69 108.347 -178.073 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -101.19 112.55 25.07 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.28 -2.118 . . . . 2.78 105.28 170.48 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.5 mt -107.79 128.56 54.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.091 -2.88 . . . . 1.17 111.647 -178.203 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 mt -107.74 136.7 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 1 C-N-CA 135.187 5.395 . . . . 1.38 105.752 -177.892 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.329 73.3 t80 -149.22 114.62 5.54 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 127.753 2.421 . . . . 1.5 105.42 173.624 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.59 30.45 15.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.863 2.465 . . . . 1.21 116.615 -178.839 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.67 -9.08 53.04 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-O 114.689 -3.284 . . . . 1.3 112.266 -176.385 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -92.11 134.3 34.97 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 115.692 -2.403 . . . . 2.55 114.305 167.868 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -86.93 123.58 32.21 Favored 'General case' 0 N--CA 1.429 -1.517 0 O-C-N 118.956 -2.34 . . . . 2.48 109.174 173.473 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.8 mt -78.8 154.85 29.57 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.115 -2.241 . . . . 0.9 111.759 -159.29 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -91.47 150.66 21.13 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.43 -2.044 . . . . 1.94 110.468 173.898 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -71.99 -41.14 67.98 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 121.667 2.031 . . . . 1.56 115.481 -173.086 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.66 45.31 3.42 Favored Glycine 0 N--CA 1.429 -1.812 0 N-CA-C 121.726 3.45 . . . . 0.97 121.726 170.291 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 mmt-85 -122.78 143.99 49.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 128.207 3.86 . . . . 2.49 101.473 168.748 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.312 80.8 p -82.63 167.08 18.62 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.257 -4.027 . . . . 0.76 114.591 168.543 . . . . . . . . 4 3 . 1 . 102 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -57.58 -46.68 83.69 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 126.955 2.102 . . . . 1.05 108.956 172.496 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.255 10.6 t -56.4 -38.61 71.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 130.131 3.372 . . . . 1.19 114.805 178.22 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -63.78 -61.72 2.11 Favored 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.411 -4.556 . . . . 1.9 115.172 172.766 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -64.55 -4.05 3.7 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.707 -1.87 . . . . 0.89 116.009 170.924 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.276 73.9 m-80 66.36 39.31 4.06 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.977 -2.952 . . . . 1.84 112.65 -175.701 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.0 mt -87.05 103.17 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.558 -2.589 . . . . 0.82 104.396 175.266 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -100.15 -172.42 2.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.306 1.842 . . . . 2.16 110.093 -172.454 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -58.99 140.31 55.84 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 127.613 3.578 . . . . 2.12 112.271 177.369 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 65.51 36.8 6.41 Favored 'General case' 0 N--CA 1.43 -1.438 1 C-N-CA 132.124 4.169 . . . . 1.71 112.089 175.75 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 m -88.22 159.64 18.06 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 114.473 -2.679 . . . . 1.04 111.435 -170.969 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.5 m -111.32 113.49 26.0 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 123.921 3.055 . . . . 0.79 108.645 172.887 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.3 mt -88.66 134.48 33.88 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 115.638 -2.425 . . . . 1.4 107.314 167.013 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -101.1 112.84 25.41 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.293 -3.38 . . . . 1.51 108.446 -171.952 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.402 HD23 HG22 ' A' ' 7' ' ' THR . 46.4 tp -92.69 117.87 30.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.894 3.277 . . . . 1.14 119.564 -173.75 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.89 124.65 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 102.384 -3.191 . . . . 1.23 102.384 172.941 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.7 tp -87.71 128.06 35.3 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 116.882 -3.636 . . . . 2.78 109.012 171.51 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -78.81 94.26 5.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.887 -2.383 . . . . 3.75 108.632 174.543 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.55 ' H ' HD23 ' A' ' 73' ' ' LEU . 2.6 pt? -80.04 -176.64 5.62 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 127.219 2.824 . . . . 3.14 107.937 173.397 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -117.1 142.84 46.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.433 2.293 . . . . 6.8 114.998 166.235 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.35 41.86 44.03 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 120.428 -1.42 . . . . 3.57 113.424 -173.633 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.797 0 CA-C-O 113.868 -3.74 . . . . 3.87 108.55 -177.82 . . . . . . . . 0 0 . 1 . 103 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 ptt? . . . . . 0 CA--C 1.491 -1.313 0 N-CA-C 119.601 3.185 . . . . 1.1 119.601 . . . . . . . . . 0 0 . 1 . 103 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -95.98 139.14 32.6 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.096 -2.253 . . . . 1.87 106.889 -174.616 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.0 pt -143.03 150.35 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 122.541 2.428 . . . . 0.72 109.983 169.654 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -108.77 134.02 52.04 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.4 -1.333 . . . . 1.4 107.4 -172.08 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -120.43 122.66 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 116.08 1.882 . . . . 0.58 116.08 166.553 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -94.33 130.1 40.76 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.978 2.511 . . . . 2.09 113.365 -176.013 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.6 p -97.14 153.28 18.07 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.958 -3.589 . . . . 0.99 107.853 -178.57 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.6 mt -61.91 -23.44 66.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 130.978 3.711 . . . . 2.53 112.841 174.095 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.8 p -77.78 -52.4 8.99 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 120.001 1.273 . . . . 2.08 113.754 178.872 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.05 11.51 0.03 OUTLIER Glycine 0 N--CA 1.429 -1.785 0 O-C-N 120.633 -1.292 . . . . 1.31 114.802 169.921 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -107.29 147.83 29.75 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 117.456 -3.379 . . . . 1.4 114.707 -173.276 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.7 m -112.69 116.96 30.96 Favored 'General case' 0 N--CA 1.43 -1.469 1 O-C-N 115.453 -4.529 . . . . 0.78 108.573 173.383 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mt -86.22 128.36 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 128.983 2.913 . . . . 1.55 105.93 -179.279 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.8 m -99.91 99.91 10.76 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.327 -3.358 . . . . 1.08 107.859 174.739 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.9 mt -97.09 145.39 26.03 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 115.973 -4.204 . . . . 1.55 109.721 177.219 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -97.2 132.14 43.26 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 125.32 2.486 . . . . 1.95 114.351 159.407 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -135.48 168.75 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 113.896 -1.502 . . . . 0.96 108.181 -176.148 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -116.08 152.27 47.55 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-O 116.147 -1.882 . . . . 2.35 106.539 166.914 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -76.33 -3.89 14.38 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-N 126.691 3.425 . . . . 0.95 112.999 -172.938 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -88.78 0.34 56.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 123.895 0.878 . . . . 1.45 111.988 173.525 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -82.07 147.33 29.17 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 125.042 1.337 . . . . 1.69 110.921 178.26 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 68.0 p -87.04 160.64 18.54 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.452 1.901 . . . . 0.75 112.349 -179.161 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.0 mm -75.99 -18.66 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 124.888 2.28 . . . . 0.73 114.441 -178.029 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.33 -44.58 94.5 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.37 -3.956 . . . . 1.62 111.298 158.407 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.307 18.3 m120 -50.82 -53.58 30.9 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 123.007 2.639 . . . . 2.13 114.18 169.054 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.501 HG21 HD21 ' A' ' 56' ' ' LEU 0.293 2.4 t -50.46 -43.89 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 119.272 3.064 . . . . 0.62 119.272 171.758 . . . . . . . . 3 3 . 1 . 103 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -74.54 -14.57 60.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.909 3.718 . . . . 1.22 114.515 174.245 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.262 . . -74.16 -34.35 63.8 Favored 'General case' 0 N--CA 1.431 -1.405 1 O-C-N 115.05 -4.781 . . . . 0.51 112.898 169.885 . . . . . . . . 3 2 . 1 . 103 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -64.09 -34.12 77.31 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.223 -1.353 . . . . 1.44 111.937 176.06 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.466 HD13 HD22 ' A' ' 69' ' ' LEU 0.46 36.5 mt -68.86 -38.47 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.877 1.799 . . . . 1.32 110.584 177.158 . . . . . . . . 3 3 . 1 . 103 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -64.81 -40.77 95.76 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.898 -2.376 . . . . 1.7 108.696 178.001 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -60.24 -40.85 91.68 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.684 1.735 . . . . 1.55 115.684 171.715 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -76.42 -67.68 0.67 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.886 -1.134 . . . . 2.62 112.748 -176.909 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -95.95 -45.1 7.07 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 116.645 -1.645 . . . . 1.48 111.027 -172.52 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.09 43.68 0.99 Allowed Glycine 0 N--CA 1.429 -1.78 0 CA-C-O 124.677 2.265 . . . . 1.12 117.237 174.852 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 mt -108.59 134.99 20.08 Favored Pre-proline 0 N--CA 1.43 -1.434 1 CA-C-O 111.536 -4.078 . . . . 1.55 102.736 -177.663 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -63.18 153.86 71.32 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 N-CA-C 120.024 3.048 . . . . 1.02 120.024 174.715 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -73.7 -24.75 15.44 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 CA-C-N 126.677 3.42 . . . . 1.25 113.014 -176.83 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.342 10.2 p-10 -65.86 -32.34 73.8 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 121.986 2.176 . . . . 2.25 111.951 170.528 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -73.84 -24.62 59.79 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.813 -2.429 . . . . 2.02 114.354 -179.174 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -92.11 145.59 24.39 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.929 -2.982 . . . . 0.69 110.225 -173.417 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.4 mtm180 -126.81 135.05 50.5 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 117.282 -1.342 . . . . 2.78 110.843 168.836 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 56.7 mt -103.42 124.99 49.75 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 123.715 2.962 . . . . 1.17 109.122 177.007 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.7 mm -114.88 120.48 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 104.749 -2.315 . . . . 1.38 104.749 177.908 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.457 ' HB3' HD21 ' A' ' 50' ' ' LEU . 35.7 t80 -130.02 136.28 49.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 129.277 3.031 . . . . 1.5 108.843 169.007 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.306 . . 54.6 31.58 15.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.278 1.584 . . . . 1.21 115.278 175.466 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.48 -20.82 6.83 Favored Glycine 0 N--CA 1.429 -1.805 0 O-C-N 119.176 -2.203 . . . . 1.3 115.438 -174.849 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.0 mttt -85.6 136.68 33.29 Favored 'General case' 0 N--CA 1.43 -1.468 2 C-N-CA 133.535 4.734 . . . . 2.55 110.802 -179.211 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -86.57 128.56 34.99 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.095 -1.866 . . . . 2.48 111.345 168.941 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' A' ' 45' ' ' PHE . 17.4 mt -83.76 127.24 33.66 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 104.927 -2.249 . . . . 0.9 104.927 -176.224 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -82.91 137.8 34.1 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.799 -3.063 . . . . 1.94 114.325 175.116 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -37.74 -72.8 0.05 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 131.087 3.755 . . . . 1.56 117.976 -177.676 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.86 51.79 4.6 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 120.696 3.038 . . . . 0.97 120.696 176.566 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.268 10.7 mmt180 -131.34 156.32 45.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.569 -3.313 . . . . 2.49 107.324 172.121 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.253 24.7 p -80.84 169.98 16.87 Favored 'General case' 0 N--CA 1.43 -1.442 2 O-C-N 114.123 -5.361 . . . . 0.76 116.647 176.733 . . . . . . . . 4 3 . 1 . 103 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.501 HD21 HG21 ' A' ' 26' ' ' VAL . 6.8 mt -63.87 -49.47 72.61 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.596 1.958 . . . . 1.05 109.186 171.663 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 t -57.29 -40.33 77.57 Favored 'General case' 0 N--CA 1.432 -1.363 0 O-C-N 118.774 -2.454 . . . . 1.19 111.632 177.137 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.4 -29.97 17.59 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 116.414 2.005 . . . . 1.9 116.414 167.876 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -99.95 7.86 44.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.069 -2.269 . . . . 0.89 115.373 171.846 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.294 7.7 m120 52.17 57.77 6.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 126.576 2.422 . . . . 1.84 117.433 -171.144 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mt -96.57 131.08 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 120.045 -1.659 . . . . 0.82 110.635 -177.876 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -97.68 -171.78 2.25 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 127.023 2.129 . . . . 2.16 114.339 -169.189 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -81.98 143.48 31.57 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.25 -1.531 . . . . 2.12 114.622 175.349 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.254 32.3 mt-10 65.43 21.32 11.86 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.426 2.01 . . . . 1.71 116.426 178.461 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.4 t -85.2 150.22 24.96 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 125.682 1.593 . . . . 1.04 112.741 -174.427 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.311 8.8 m -106.07 115.63 30.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 121.599 1.999 . . . . 0.79 113.648 -176.771 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 mt -101.36 164.15 11.92 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.105 -2.554 . . . . 1.4 104.105 173.759 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.293 74.1 m80 -123.73 135.54 53.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.833 -3.042 . . . . 1.51 107.392 178.431 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.466 HD22 HD13 ' A' ' 30' ' ' ILE . 36.4 tp -97.5 132.41 43.21 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 112.293 -2.231 . . . . 1.14 111.323 178.381 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.9 m -143.65 161.26 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 103.707 -2.701 . . . . 1.23 103.707 176.659 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.6 mt -95.68 166.72 11.69 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.713 2.673 . . . . 2.78 112.846 -174.402 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -71.52 132.07 44.18 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 129.006 2.922 . . . . 3.75 110.853 177.099 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.3 mt -93.52 77.73 4.38 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 127.172 2.189 . . . . 3.14 109.451 171.54 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -91.95 -58.42 2.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.284 -1.376 . . . . 6.8 107.284 174.701 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.74 -91.51 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 127.623 2.535 . . . . 3.57 112.971 -175.193 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.262 1.861 0 C-N-CA 129.774 3.559 . . . . 3.87 112.044 178.529 . . . . . . . . 0 0 . 1 . 104 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 CA--C 1.491 -1.324 0 CA-C-O 117.582 -1.199 . . . . 1.1 111.118 . . . . . . . . . 0 0 . 1 . 104 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -103.51 143.29 32.92 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 120.119 1.327 . . . . 1.87 110.979 179.837 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.9 pt -131.31 168.46 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 116.635 -1.65 . . . . 0.72 109.28 176.657 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -122.17 137.81 54.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 120.927 1.694 . . . . 1.4 113.163 177.283 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.407 HG22 ' HB2' ' A' ' 67' ' ' LEU . 4.3 t -122.22 131.3 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-O 125.842 2.734 . . . . 0.58 118.172 165.706 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -89.21 123.25 33.27 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 112.152 -2.294 . . . . 2.09 108.676 177.932 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.0 p -80.05 177.18 9.12 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.444 1.592 . . . . 0.99 112.758 169.455 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.0 mt -66.0 -46.31 78.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.299 -2.75 . . . . 2.53 113.909 176.165 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 p -65.04 -68.57 0.35 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.08 1.352 . . . . 2.08 108.488 179.379 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.67 -6.24 0.03 OUTLIER Glycine 0 N--CA 1.429 -1.778 0 N-CA-C 117.454 1.742 . . . . 1.31 117.454 -176.203 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -71.62 141.73 49.96 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.304 -1.704 . . . . 1.4 114.664 -175.573 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.3 m -108.27 104.57 13.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 127.915 3.722 . . . . 0.78 111.183 172.435 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -88.59 115.57 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 1 O-C-N 115.874 -4.266 . . . . 1.55 109.743 179.248 . . . . . . . . 4 4 . 1 . 104 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.5 m -91.48 119.22 31.25 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.124 -2.176 . . . . 1.08 105.124 177.719 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 mt -115.42 139.51 49.96 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 125.102 2.382 . . . . 1.55 110.592 -171.378 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -87.97 120.75 29.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.201 -2.187 . . . . 1.95 108.038 174.852 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.9 177.02 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 125.741 1.901 . . . . 0.96 114.095 179.397 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -129.14 148.0 67.26 Favored Pre-proline 0 N--CA 1.43 -1.465 3 CA-C-O 108.292 -5.623 . . . . 2.35 110.668 166.82 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -61.35 -24.39 78.55 Favored 'Trans proline' 0 N--CA 1.434 -2.004 1 CA-C-N 128.843 4.194 . . . . 0.95 115.22 -174.216 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.4 p -69.75 -10.78 59.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.837 2.455 . . . . 1.45 116.072 177.045 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.305 36.4 m-20 -78.75 147.55 33.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 128.044 3.783 . . . . 1.69 108.576 -178.878 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 p -82.82 165.79 19.53 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 114.514 -2.66 . . . . 0.75 115.913 174.55 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.2 mm -66.08 -20.03 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-N 122.071 2.214 . . . . 0.73 111.18 178.289 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -64.68 -39.38 93.58 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 117.522 2.416 . . . . 1.62 117.522 169.51 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -72.74 -33.05 66.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.416 3.008 . . . . 2.13 108.665 179.591 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.6 t -69.09 -48.28 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 112.289 -2.232 . . . . 0.62 112.844 176.86 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.502 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 52.6 mtmt -55.84 -30.82 62.06 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 119.558 3.17 . . . . 1.22 119.558 160.052 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -31.96 72.76 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 124.312 3.233 . . . . 0.51 113.132 172.419 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -70.12 -29.13 66.0 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.544 -3.222 . . . . 1.44 113.342 172.562 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.9 mt -73.09 -39.17 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 120.017 -1.677 . . . . 1.32 112.544 176.255 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -58.21 -35.38 71.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 114.435 -2.698 . . . . 1.7 109.425 171.854 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -66.3 -50.66 62.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 123.355 2.798 . . . . 1.55 117.176 170.797 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -59.75 -61.01 2.94 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 116.949 -3.595 . . . . 2.62 111.616 -172.333 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -101.47 -44.9 5.47 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.449 -1.705 . . . . 1.48 108.893 -168.795 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.01 57.05 1.17 Allowed Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 118.502 -1.808 . . . . 1.12 111.383 178.821 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.0 mt -122.49 125.13 26.57 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 112.381 -3.675 . . . . 1.55 104.637 -177.58 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -57.64 138.42 86.04 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 CA-C-N 129.358 4.378 . . . . 1.02 116.708 177.276 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -54.39 -27.67 50.0 Favored 'Trans proline' 0 C--N 1.299 -2.076 1 C-N-CA 127.208 5.272 . . . . 1.25 117.414 -178.329 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -69.89 -39.41 76.26 Favored 'General case' 0 N--CA 1.431 -1.422 1 CA-C-O 111.334 -4.174 . . . . 2.25 110.086 171.663 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -61.65 -31.33 71.43 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 124.176 3.171 . . . . 2.02 114.326 177.701 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.502 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 63.0 mt-30 -78.13 135.27 37.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 120.354 3.464 . . . . 0.69 120.354 -177.447 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -135.05 146.98 49.48 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 102.512 -3.144 . . . . 2.78 102.512 173.23 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.5 mt -113.0 137.05 52.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.76 -2.462 . . . . 1.17 110.173 179.17 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.7 mm -117.47 133.9 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 124.994 2.33 . . . . 1.38 108.209 -178.551 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.444 ' HB3' HD21 ' A' ' 50' ' ' LEU . 7.7 t80 -147.47 138.02 23.32 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.29 -3.381 . . . . 1.5 112.338 169.787 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.76 43.27 30.33 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.412 3.085 . . . . 1.21 115.166 -178.525 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.55 -23.66 15.2 Favored Glycine 0 N--CA 1.429 -1.781 0 O-C-N 118.06 -2.9 . . . . 1.3 116.801 -176.373 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -119.03 166.81 12.42 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.056 -3.026 . . . . 2.55 112.841 -171.791 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.345 33.3 tt0 -98.78 153.41 18.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.126 -0.943 . . . . 2.48 112.435 178.192 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 45' ' ' PHE . 8.1 mt -110.56 126.58 54.57 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.675 1.59 . . . . 0.9 110.353 -173.302 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.493 ' HB2' ' HG3' ' A' ' 54' ' ' ARG . 28.2 mt-10 -73.73 141.63 46.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 128.19 2.596 . . . . 1.94 113.725 -178.1 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -46.98 -54.44 10.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 118.476 2.769 . . . . 1.56 118.476 -177.254 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.94 5.76 61.25 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 127.265 2.853 . . . . 0.97 120.088 172.893 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.493 ' HG3' ' HB2' ' A' ' 51' ' ' GLU . 6.3 mtt180 -87.92 154.33 20.6 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 120.092 1.946 . . . . 2.49 106.54 171.903 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.0 p -97.79 162.09 13.43 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.094 1.902 . . . . 0.76 115.79 172.038 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.38 -20.2 65.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.901 -2.999 . . . . 1.05 114.15 174.748 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.0 p -80.28 -31.86 38.26 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.541 3.137 . . . . 1.19 110.805 178.856 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.68 -46.22 39.26 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 112.834 -3.46 . . . . 1.9 111.799 175.483 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -76.52 -18.82 58.51 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 127.117 2.76 . . . . 0.89 110.654 178.095 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.7 t30 65.96 53.88 1.07 Allowed 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 127.073 2.149 . . . . 1.84 109.599 -176.264 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 mt -84.39 106.67 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 101.192 -3.633 . . . . 0.82 101.192 172.186 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -89.26 -174.43 4.4 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 122.248 2.295 . . . . 2.16 112.017 -178.713 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -60.53 137.55 58.15 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 123.638 1.685 . . . . 2.12 114.35 174.584 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 74.42 26.75 1.49 Allowed 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 131.492 3.917 . . . . 1.71 114.476 169.627 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.89 151.93 20.31 Favored 'General case' 0 N--CA 1.429 -1.491 1 C-N-CA 131.892 4.077 . . . . 1.04 105.613 -177.22 . . . . . . . . 3 3 . 1 . 104 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.4 m -107.3 126.25 52.21 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.57 -1.956 . . . . 0.79 112.411 178.364 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.407 ' HB2' HG22 ' A' ' 5' ' ' VAL . 66.4 mt -100.07 151.9 20.85 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 126.259 2.933 . . . . 1.4 106.532 169.561 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -113.35 116.58 29.92 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 116.035 -4.166 . . . . 1.51 112.584 179.083 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.7 tp -92.58 125.93 37.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 126.314 2.959 . . . . 1.14 107.826 -176.906 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.7 t -118.81 147.97 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 C-N-CA 127.216 2.206 . . . . 1.23 106.255 176.64 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.9 mt -114.2 156.11 24.87 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.797 -3.064 . . . . 2.78 114.205 175.404 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -80.25 141.11 35.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.681 -3.137 . . . . 3.75 112.09 177.857 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.579 ' H ' HD23 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -75.02 155.06 37.7 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.319 -2.113 . . . . 3.14 113.673 177.043 . . . . . . . . 3 3 . 1 . 104 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.7 mtm-85 -76.14 134.43 39.96 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.373 1.99 . . . . 6.8 116.373 174.871 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.58 -144.9 4.53 Favored Glycine 0 N--CA 1.431 -1.667 0 CA-C-N 123.311 2.778 . . . . 3.57 108.438 -170.013 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.827 0 N-CA-C 108.174 -1.97 . . . . 3.87 108.174 -176.329 . . . . . . . . 0 0 . 1 . 105 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 ptt? . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 117.633 -1.175 . . . . 1.1 113.744 . . . . . . . . . 0 0 . 1 . 105 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -90.03 140.3 29.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 123.054 2.661 . . . . 1.87 112.907 175.357 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.2 pt -130.72 161.97 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 108.066 -1.087 . . . . 0.72 108.066 166.062 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -119.62 130.13 54.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.315 3.046 . . . . 1.4 111.245 172.656 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.0 t -109.56 121.4 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 111.677 -2.511 . . . . 0.58 108.554 172.954 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -97.24 123.36 41.0 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 117.784 -3.073 . . . . 2.09 112.595 174.637 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.6 p -78.78 174.53 11.36 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.148 3.356 . . . . 0.99 115.214 170.062 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.12 -43.18 74.93 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 116.416 -3.927 . . . . 2.53 115.935 178.412 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.9 p -73.36 -41.22 63.69 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.119 2.568 . . . . 2.08 110.957 -177.334 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.57 8.18 0.42 Allowed Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 115.514 -3.231 . . . . 1.31 116.178 170.766 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -93.23 133.96 35.91 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 104.583 -2.377 . . . . 1.4 104.583 -176.137 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.6 m -98.73 123.39 42.92 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.301 -1.5 . . . . 0.78 107.156 171.274 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -100.59 95.41 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 124.437 2.065 . . . . 1.55 109.871 175.676 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.4 m -76.53 115.42 16.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 105.256 -2.127 . . . . 1.08 105.256 177.923 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.5 mt -120.24 171.69 8.32 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.001 2.12 . . . . 1.55 112.215 -176.712 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -127.61 132.39 49.79 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 105.304 -2.11 . . . . 1.95 105.304 169.505 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.8 m -140.25 169.49 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 128.286 2.634 . . . . 0.96 108.549 -178.471 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -104.81 159.93 27.69 Favored Pre-proline 0 N--CA 1.43 -1.433 0 O-C-N 119.269 -2.144 . . . . 2.35 108.774 162.897 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -70.23 -19.06 34.37 Favored 'Trans proline' 0 N--CA 1.434 -2.01 1 O-C-N 112.146 -4.713 . . . . 0.95 106.999 -174.911 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 m -91.57 9.01 33.91 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.474 2.398 . . . . 1.45 117.474 -176.481 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -85.66 150.19 24.79 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 113.082 0.771 . . . . 1.69 113.082 173.098 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.8 p -78.35 160.14 27.99 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 123.395 1.569 . . . . 0.75 113.176 173.559 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -60.59 -33.86 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 126.615 1.966 . . . . 0.73 109.92 169.884 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.303 3.4 tt0 -47.03 -46.56 22.16 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.526 2.047 . . . . 1.62 116.526 158.766 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -75.53 -35.73 60.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 116.83 2.159 . . . . 2.13 116.83 -178.021 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.4 t -57.92 -47.18 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 111.683 -2.508 . . . . 0.62 111.374 173.417 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.286 37.6 mtmt -57.91 -29.83 65.42 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 121.692 3.96 . . . . 1.22 121.692 170.628 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.38 -33.06 62.95 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.892 -2.38 . . . . 0.51 112.872 169.645 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -61.5 -17.17 53.43 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.706 1.602 . . . . 1.44 113.735 167.677 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.9 mt -98.61 -36.15 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 125.636 2.636 . . . . 1.32 108.945 178.777 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.307 24.7 tt0 -45.18 -50.01 11.74 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 117.815 -3.053 . . . . 1.7 113.825 173.752 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.397 0.6 OUTLIER -62.01 -26.4 68.21 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.92 2.933 . . . . 1.55 118.92 174.879 . . . . . . . . 3 3 . 1 . 105 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -86.17 -78.7 0.27 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.182 2.593 . . . . 2.62 109.212 -178.61 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -89.21 -12.36 41.04 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 119.03 2.974 . . . . 1.48 119.03 -172.529 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.66 24.08 26.71 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 120.92 -1.112 . . . . 1.12 115.419 172.962 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.4 mt -104.28 133.88 19.98 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-O 112.594 -3.574 . . . . 1.55 107.765 -169.549 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 41.2 Cg_endo -77.51 158.95 32.49 Favored 'Trans proline' 0 N--CA 1.434 -1.974 0 CA-C-N 125.037 2.835 . . . . 1.02 115.397 -179.377 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 14.7 Cg_exo -61.92 -26.73 79.21 Favored 'Trans proline' 0 C--N 1.299 -2.03 1 C-N-CA 127.002 5.135 . . . . 1.25 117.358 -178.329 . . . . . . . . 3 3 . 1 . 105 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.342 0.2 OUTLIER -61.02 -51.2 70.2 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 130.275 3.43 . . . . 2.25 110.259 179.303 . . . . . . . . 3 3 . 1 . 105 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -74.71 -43.65 54.01 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.597 -1.26 . . . . 2.02 107.597 178.284 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -60.21 137.8 58.05 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 116.792 2.145 . . . . 0.69 116.792 -174.35 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -138.17 128.68 26.37 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 125.875 1.67 . . . . 2.78 109.955 175.351 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.261 85.2 mt -95.64 135.67 37.03 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.648 1.69 . . . . 1.17 110.488 174.608 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.251 37.2 mm -123.17 120.23 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-N 109.565 -3.47 . . . . 1.38 106.501 173.748 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -134.62 131.81 38.26 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.615 2.626 . . . . 1.5 108.886 171.127 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.58 45.52 24.17 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.405 2.743 . . . . 1.21 118.405 179.848 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.54 -45.98 1.99 Allowed Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 120.574 -0.822 . . . . 1.3 114.895 179.456 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -82.73 149.04 27.51 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.083 2.553 . . . . 2.55 116.252 179.372 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -81.27 125.71 30.66 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 129.041 2.936 . . . . 2.48 107.988 172.464 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 mt -88.09 146.53 25.39 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.74 1.257 . . . . 0.9 109.702 -173.437 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -98.07 146.54 25.44 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 126.087 2.851 . . . . 1.94 107.41 177.207 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.7 -61.49 2.57 Favored 'General case' 0 N--CA 1.43 -1.473 1 C-N-CA 133.675 4.79 . . . . 1.56 117.042 -168.753 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.41 12.63 1.8 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 120.088 2.795 . . . . 0.97 120.088 172.985 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -106.15 159.35 16.15 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.702 1.715 . . . . 2.49 113.274 178.06 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -95.48 162.98 13.42 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.878 -4.264 . . . . 0.76 110.945 -179.639 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.3 mt -64.28 -43.21 95.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.957 3.303 . . . . 1.05 108.242 178.538 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 p -60.8 -34.23 74.2 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 114.479 1.288 . . . . 1.19 114.479 -179.992 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -64.09 -37.24 86.72 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 129.774 3.23 . . . . 1.9 113.807 173.04 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -92.9 7.82 42.29 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.947 -2.971 . . . . 0.89 110.97 177.639 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.2 m120 55.5 39.15 31.02 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 130.917 3.687 . . . . 1.84 114.459 -175.897 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.427 HG21 HD21 ' A' ' 67' ' ' LEU . 33.2 mt -82.56 115.99 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 103.999 -2.593 . . . . 0.82 103.999 179.064 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -100.99 -179.94 4.19 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.917 2.294 . . . . 2.16 110.54 -176.655 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.284 32.7 pttt -54.41 137.07 43.14 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.674 -3.141 . . . . 2.12 119.085 169.232 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.292 59.3 mt-10 71.31 24.28 3.79 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.061 1.744 . . . . 1.71 113.748 171.919 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.7 p -91.23 159.32 16.11 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.256 2.622 . . . . 1.04 115.431 -174.827 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.1 m -105.97 100.32 9.87 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.201 3.0 . . . . 0.79 114.321 176.952 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.427 HD21 HG21 ' A' ' 61' ' ' ILE . 3.9 mp -97.9 146.84 25.05 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 103.31 -2.848 . . . . 1.4 103.31 170.893 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -109.31 145.65 35.64 Favored 'General case' 0 CA--C 1.489 -1.37 0 CA-C-O 114.498 -2.668 . . . . 1.51 110.299 -179.009 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.2 tp -111.7 119.88 40.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 127.347 2.904 . . . . 1.14 110.592 -173.582 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 m -113.31 151.58 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 118.968 -2.332 . . . . 1.23 111.326 172.959 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.2 mt -110.86 124.75 52.67 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 116.966 -1.894 . . . . 2.78 108.846 -179.624 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -60.81 142.06 56.44 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 126.817 2.573 . . . . 3.75 113.892 -176.606 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.5 mt -114.17 139.28 49.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 103.898 -2.63 . . . . 3.14 103.898 174.576 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -80.46 143.41 33.4 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.161 2.184 . . . . 6.8 108.184 175.485 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.34 -71.29 0.43 Allowed Glycine 0 N--CA 1.429 -1.784 0 CA-C-O 124.698 2.277 . . . . 3.57 108.604 -162.706 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.756 0 O-C-N 119.156 -2.379 . . . . 3.87 113.689 176.078 . . . . . . . . 0 0 . 1 . 106 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.37 15.3 ptt? . . . . . 0 CA--C 1.489 -1.382 0 N-CA-C 115.006 1.484 . . . . 1.1 115.006 . . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -97.74 130.07 44.73 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 117.168 -1.813 . . . . 1.87 111.79 179.799 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.2 pt -121.15 169.06 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 103.247 -2.872 . . . . 0.72 103.247 175.953 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -128.4 126.39 40.53 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.691 -1.226 . . . . 1.4 107.691 -171.442 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.42 HG23 HD23 ' A' ' 15' ' ' LEU . 76.0 t -107.91 121.96 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 114.494 -1.23 . . . . 0.58 108.406 172.462 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -99.04 126.88 44.86 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.313 1.445 . . . . 2.09 108.902 175.903 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 p -69.69 -178.63 1.53 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.643 2.09 . . . . 0.99 116.643 175.024 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.7 tp -74.73 -38.55 62.25 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.943 -1.098 . . . . 2.53 112.126 173.529 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.2 p -79.33 -53.25 7.11 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.987 2.588 . . . . 2.08 117.987 176.697 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.99 7.89 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.778 0 CA-C-N 125.772 3.897 . . . . 1.31 115.096 179.988 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -99.77 139.6 35.19 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 115.198 -2.601 . . . . 1.4 113.695 -175.603 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.4 m -103.28 128.19 50.39 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 116.53 -2.068 . . . . 0.78 105.534 174.787 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.4 mt -116.32 123.98 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.661 2.784 . . . . 1.55 111.265 -177.72 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.8 m -96.64 126.41 41.79 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 105.847 -1.908 . . . . 1.08 105.847 -174.891 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.42 HD23 HG23 ' A' ' 5' ' ' VAL . 1.9 mm? -121.35 120.31 34.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.399 2.28 . . . . 1.55 111.222 -178.056 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -82.48 111.65 18.69 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.114 1.765 . . . . 1.95 108.16 172.667 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.263 23.8 m -134.97 -178.43 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 O-C-N 120.163 -1.586 . . . . 0.96 107.25 177.579 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -117.31 174.68 2.38 Favored Pre-proline 0 N--CA 1.43 -1.451 0 O-C-N 117.237 -3.414 . . . . 2.35 108.304 163.817 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -77.56 -19.04 13.28 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 117.377 -1.96 . . . . 0.95 113.215 -175.124 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.333 4.5 m -82.94 3.95 27.79 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 122.755 2.525 . . . . 1.45 115.387 176.816 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.269 2.8 m-20 -72.59 153.74 41.12 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 115.917 1.821 . . . . 1.69 115.917 172.114 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.5 p -89.85 153.86 20.32 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 117.481 -3.262 . . . . 0.75 111.424 -179.61 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.5 mm -47.63 -49.01 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 118.832 -2.417 . . . . 0.73 116.497 172.354 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -45.31 -35.71 3.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 117.101 2.26 . . . . 1.62 117.101 167.828 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -65.48 -32.42 74.01 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 122.02 2.191 . . . . 2.13 114.515 174.836 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.9 t -75.75 -40.19 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 120.112 -1.618 . . . . 0.62 109.772 -174.93 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -59.37 -32.07 69.8 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 113.251 -1.795 . . . . 1.22 114.957 167.556 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.17 84.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 114.98 -2.438 . . . . 0.51 112.905 171.748 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -70.2 -22.16 62.96 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 127.635 3.084 . . . . 1.44 115.023 -179.648 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.1 mm -79.38 -35.66 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 127.262 2.225 . . . . 1.32 109.513 175.446 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.35 8.7 tt0 -58.39 -48.78 79.54 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 126.539 2.399 . . . . 1.7 113.459 172.867 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -54.05 -53.04 58.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 111.647 -2.524 . . . . 1.55 113.145 168.949 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -87.53 -49.21 7.34 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.488 -3.258 . . . . 2.62 114.102 -167.522 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -96.36 -44.45 7.22 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 113.472 -1.695 . . . . 1.48 113.832 -172.202 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.74 -28.28 3.98 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 117.226 1.65 . . . . 1.12 117.226 169.56 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.494 HD12 ' H ' ' A' ' 36' ' ' ILE . 2.8 mp -57.45 138.17 81.43 Favored Pre-proline 0 N--CA 1.429 -1.496 0 N-CA-C 115.754 1.761 . . . . 1.55 115.754 -174.57 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -59.92 134.39 56.49 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 C-N-CA 123.872 3.048 . . . . 1.02 114.445 174.772 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -73.95 -16.75 22.93 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-O 112.004 -3.415 . . . . 1.25 112.74 -169.72 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.03 -38.33 90.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.596 2.617 . . . . 2.25 111.616 171.584 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -78.4 -18.29 55.23 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.765 -2.459 . . . . 2.02 114.739 178.521 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -88.66 138.64 31.24 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.781 2.229 . . . . 0.69 116.09 177.766 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -121.77 158.04 29.68 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.908 -3.62 . . . . 2.78 110.976 165.408 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.276 12.8 mt -119.26 125.16 48.47 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 126.285 1.834 . . . . 1.17 111.387 179.324 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.1 mt -113.08 136.88 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 106.932 -1.507 . . . . 1.38 106.932 -174.149 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -142.04 129.59 21.4 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.588 -1.32 . . . . 1.5 111.106 173.214 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.43 18.3 6.72 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 130.322 3.449 . . . . 1.21 116.334 -179.288 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.54 -3.76 57.89 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 126.561 2.029 . . . . 1.3 115.049 -175.624 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -108.0 133.3 52.51 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 126.421 3.01 . . . . 2.55 113.785 177.215 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -77.41 127.62 32.85 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.251 -4.031 . . . . 2.48 104.735 172.564 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.5 mt -89.61 147.33 23.98 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.283 -2.136 . . . . 0.9 116.73 -173.927 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -82.83 132.87 35.15 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.366 2.031 . . . . 1.94 112.572 171.435 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -60.9 -51.45 69.23 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 111.008 -2.814 . . . . 1.56 115.213 -172.671 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.19 46.95 3.62 Favored Glycine 0 N--CA 1.43 -1.747 0 CA-C-O 118.347 -1.252 . . . . 0.97 114.293 173.726 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -128.21 155.6 44.26 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.085 2.154 . . . . 2.49 113.152 168.8 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.342 70.1 p -82.04 164.01 21.7 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 121.692 2.042 . . . . 0.76 111.116 173.951 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mt -70.41 -26.98 63.93 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 111.302 -2.681 . . . . 1.05 111.698 170.314 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.254 23.2 t -65.74 -46.28 79.45 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 115.572 -2.156 . . . . 1.19 111.681 171.515 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -52.27 -28.36 18.56 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 117.999 2.592 . . . . 1.9 117.999 176.397 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -93.39 -11.46 32.19 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 117.593 -3.192 . . . . 0.89 111.31 -179.693 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.1 m120 67.23 50.5 0.98 Allowed 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 128.728 2.811 . . . . 1.84 113.308 -175.087 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.8 mt -95.46 110.54 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 1 CA-C-O 128.857 4.17 . . . . 0.82 107.674 177.366 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -89.84 -173.15 3.8 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 114.081 -5.387 . . . . 2.16 112.563 -179.589 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -61.73 166.48 4.3 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.118 -2.239 . . . . 2.12 111.329 175.1 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 49.79 28.82 2.9 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 118.471 2.767 . . . . 1.71 118.471 172.703 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.9 p -90.88 147.33 23.23 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.074 2.55 . . . . 1.04 113.054 -174.848 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.9 m -107.98 98.6 8.15 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 115.305 1.594 . . . . 0.79 115.305 -179.205 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.297 2.7 mp -84.01 156.22 22.38 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 129.176 2.99 . . . . 1.4 107.945 175.123 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -126.05 120.23 29.69 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 118.281 -1.368 . . . . 1.51 109.873 -176.614 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.9 tp -84.58 130.81 34.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.903 -2.373 . . . . 1.14 107.636 -179.879 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.5 m -125.04 140.47 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 126.388 2.994 . . . . 1.23 113.066 166.065 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.335 4.9 mt -80.32 125.98 30.58 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.023 -2.923 . . . . 2.78 112.553 176.919 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -96.88 97.68 9.48 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.616 -1.302 . . . . 3.75 111.591 176.017 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -92.46 -68.43 0.8 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 124.884 1.274 . . . . 3.14 111.075 178.032 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.9 ptt-85 -65.6 147.36 53.53 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 126.22 2.914 . . . . 6.8 106.916 -179.652 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.69 80.42 0.64 Allowed Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 116.782 -2.628 . . . . 3.57 113.001 -171.31 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.761 0 N-CA-C 107.952 -2.059 . . . . 3.87 107.952 -169.16 . . . . . . . . 0 0 . 1 . 107 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptt? . . . . . 0 CA--C 1.491 -1.319 0 CA-C-O 117.99 -1.005 . . . . 1.1 111.215 . . . . . . . . . 0 0 . 1 . 107 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -115.42 135.05 54.51 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 127.476 2.985 . . . . 1.87 109.275 175.997 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt -117.25 163.54 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 106.832 -1.544 . . . . 0.72 106.832 171.25 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -109.53 136.08 49.49 Favored 'General case' 0 N--CA 1.431 -1.409 1 C-N-CA 132.429 4.292 . . . . 1.4 109.703 174.998 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.9 t -130.01 123.46 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 O-C-N 118.099 -2.876 . . . . 0.58 104.861 178.769 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -98.03 139.49 33.77 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.299 -3.376 . . . . 2.09 112.391 176.531 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.323 32.7 p -82.59 -171.67 3.62 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.831 -1.168 . . . . 0.99 111.676 176.319 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 71' ' ' LEU . 83.9 mt -61.71 -47.77 83.78 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.389 -1.444 . . . . 2.53 112.544 172.14 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.3 p -81.02 -22.84 39.06 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.969 -1.707 . . . . 2.08 109.1 -178.672 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.93 23.89 4.46 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 118.969 2.347 . . . . 1.31 118.969 172.375 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -77.73 134.4 38.1 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 120.054 1.927 . . . . 1.4 108.276 179.039 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.9 m -91.66 110.75 22.08 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.409 -2.057 . . . . 0.78 109.31 -173.272 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.0 mt -100.86 125.91 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 125.742 1.617 . . . . 1.55 106.723 178.153 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.0 m -103.79 121.42 42.99 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.781 2.032 . . . . 1.08 108.207 179.613 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.5 mt -120.45 125.01 46.85 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.774 -2.454 . . . . 1.55 117.268 -178.621 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -70.69 117.56 12.36 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 124.774 1.296 . . . . 1.95 110.235 170.461 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.0 m -142.84 171.97 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 126.2 2.905 . . . . 0.96 109.064 178.231 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -118.58 158.62 46.7 Favored Pre-proline 0 N--CA 1.43 -1.428 1 O-C-N 114.087 -5.383 . . . . 2.35 106.484 163.509 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.08 -14.1 26.06 Favored 'Trans proline' 0 C--N 1.299 -2.048 1 C-N-CA 125.581 4.188 . . . . 0.95 110.235 -171.379 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.2 m -90.25 8.21 34.33 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 122.125 2.239 . . . . 1.45 110.24 177.773 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.35 147.03 28.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.593 -2.567 . . . . 1.69 110.285 171.388 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 47.0 p -86.71 161.35 18.47 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.663 -1.606 . . . . 0.75 106.663 -177.395 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.439 HD13 ' HA ' ' A' ' 23' ' ' ILE 0.3 26.1 mm -64.98 -29.32 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 O-C-N 116.205 -4.06 . . . . 0.73 110.991 -178.374 . . . . . . . . 4 3 . 1 . 107 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -52.98 -47.49 68.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 129.009 2.924 . . . . 1.62 111.773 167.963 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.258 26.3 t30 -71.31 -32.85 69.1 Favored 'General case' 0 N--CA 1.431 -1.41 1 O-C-N 116.229 -4.044 . . . . 2.13 112.997 177.789 . . . . . . . . 3 2 . 1 . 107 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.0 t -63.15 -45.09 99.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 1 O-C-N 113.509 -5.744 . . . . 0.62 113.931 174.482 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.5 mttt -60.37 -38.71 84.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 128.006 3.316 . . . . 1.22 117.267 167.859 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.51 -41.6 85.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 123.901 1.81 . . . . 0.51 113.335 172.442 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttm -68.33 -29.46 68.21 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.545 -3.222 . . . . 1.44 117.156 171.107 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.8 mt -71.98 -43.92 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-N 120.898 1.681 . . . . 1.32 110.602 172.487 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -49.34 -45.84 46.13 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.575 2.35 . . . . 1.7 115.375 170.951 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -51.58 -46.53 63.53 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.751 2.215 . . . . 1.55 115.023 175.342 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 tttp -85.03 -57.73 2.98 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.681 -3.137 . . . . 2.62 113.008 -174.767 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -89.12 -46.81 8.54 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 129.824 3.25 . . . . 1.48 114.636 -168.274 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.88 27.08 3.35 Favored Glycine 0 N--CA 1.429 -1.798 1 O-C-N 114.637 -5.04 . . . . 1.12 110.455 169.981 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.0 mt -104.97 124.24 37.31 Favored Pre-proline 0 N--CA 1.429 -1.484 0 CA-C-O 113.883 -2.96 . . . . 1.55 107.087 -178.256 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -64.39 164.51 22.95 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 CA-C-N 127.969 3.882 . . . . 1.02 118.413 174.677 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -65.33 -26.65 55.91 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 123.815 3.01 . . . . 1.25 118.593 -176.847 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -55.96 -43.34 77.44 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 127.344 2.902 . . . . 2.25 113.062 173.774 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -85.38 -1.51 57.09 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 113.147 -1.842 . . . . 2.02 114.321 -170.317 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -107.6 103.62 12.97 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.146 1.378 . . . . 0.69 112.451 -171.946 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.257 72.6 mtt180 -96.39 116.74 29.53 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.286 -2.759 . . . . 2.78 107.849 167.74 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.1 mt -99.46 126.86 45.46 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.583 -3.198 . . . . 1.17 105.089 177.559 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.7 mt -114.31 143.36 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 125.298 2.475 . . . . 1.38 107.966 176.481 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.515 ' C ' ' H ' ' A' ' 47' ' ' GLY . 34.9 t80 -141.2 127.37 19.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.346 -3.971 . . . . 1.5 108.888 171.964 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 75.93 -27.39 0.18 Allowed 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 127.953 2.501 . . . . 1.21 109.624 174.155 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 143.48 -13.02 2.25 Favored Glycine 0 N--CA 1.431 -1.694 0 CA-C-O 125.162 2.535 . . . . 1.3 113.55 -175.887 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -86.22 137.1 32.89 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 111.806 -2.197 . . . . 2.55 109.473 178.781 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -77.59 109.66 11.75 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.796 3.638 . . . . 2.48 110.508 169.092 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.8 mt -68.46 130.97 44.44 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 114.858 1.429 . . . . 0.9 114.858 -177.393 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -89.8 144.52 25.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.654 1.582 . . . . 1.94 113.285 177.891 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -60.87 -54.87 39.81 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.718 -3.114 . . . . 1.56 115.862 -171.933 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -73.42 28.86 0.85 Allowed Glycine 0 N--CA 1.43 -1.763 1 N-CA-C 123.754 4.262 . . . . 0.97 123.754 171.357 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -127.87 160.01 33.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.548 -1.56 . . . . 2.49 112.139 173.01 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.26 44.2 p -89.15 167.07 13.41 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.356 1.551 . . . . 0.76 109.974 -177.703 . . . . . . . . 3 3 . 1 . 107 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mt -64.81 -34.73 79.06 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 113.892 -1.503 . . . . 1.05 109.854 169.938 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.9 t -61.16 -41.81 97.43 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 122.598 1.189 . . . . 1.19 109.613 179.397 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -55.23 -41.87 72.63 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.569 -2.582 . . . . 1.9 117.56 176.309 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -84.9 -6.69 59.34 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 117.75 2.5 . . . . 0.89 117.75 -179.441 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.318 35.9 m120 68.62 50.57 0.67 Allowed 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 119.399 1.0 . . . . 1.84 111.999 -176.204 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.6 mt -103.44 108.73 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 121.704 0.764 . . . . 0.82 111.451 172.838 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -93.78 -175.8 3.85 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.297 2.639 . . . . 2.16 107.627 177.886 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -68.59 149.35 49.28 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 125.932 2.777 . . . . 2.12 113.747 171.275 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.429 75.3 mt-10 64.97 22.39 12.44 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 109.99 -3.277 . . . . 1.71 115.375 174.687 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.5 m -92.23 156.42 17.31 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.776 -3.077 . . . . 1.04 110.812 -176.883 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.2 m -106.89 110.19 22.28 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 126.521 2.388 . . . . 0.79 108.211 -173.005 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -93.22 141.33 28.54 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.59 1.556 . . . . 1.4 106.869 172.31 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -101.9 117.99 35.99 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.015 -2.928 . . . . 1.51 106.773 -177.902 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.8 tp -93.1 121.4 34.42 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.697 -2.502 . . . . 1.14 111.163 173.868 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.1 t -111.36 140.77 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 O-C-N 117.8 -3.062 . . . . 1.23 108.084 177.561 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.413 ' HB3' HD11 ' A' ' 8' ' ' LEU . 10.5 tp -85.87 126.17 33.86 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 116.39 1.996 . . . . 2.78 116.39 174.567 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -91.72 115.98 28.5 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 124.631 1.172 . . . . 3.75 108.106 -174.105 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.7 mt -111.43 -146.46 0.41 Allowed 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.539 1.136 . . . . 3.14 109.884 175.017 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -109.75 123.76 50.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 115.6 1.704 . . . . 6.8 115.6 177.581 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.31 100.09 0.86 Allowed Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 122.691 3.836 . . . . 3.57 122.691 -163.297 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.765 0 CA-C-O 117.563 -1.687 . . . . 3.87 110.366 175.625 . . . . . . . . 0 0 . 1 . 108 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ptt? . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 106.733 -1.58 . . . . 1.1 106.733 . . . . . . . . . 0 0 . 1 . 108 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.1 pm0 -107.15 131.6 53.96 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 114.28 1.215 . . . . 1.87 114.28 -178.863 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 pt -121.32 152.7 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 105.867 -1.901 . . . . 0.72 105.867 169.67 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.252 75.0 m-85 -113.89 135.34 54.08 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.035 -1.439 . . . . 1.4 108.88 -176.58 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.0 t -118.07 107.47 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 123.191 1.472 . . . . 0.58 111.405 178.709 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -89.02 138.23 31.59 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 118.239 -2.788 . . . . 2.09 118.278 174.686 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.329 27.8 p -94.81 154.35 17.3 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 110.725 -2.943 . . . . 0.99 110.013 178.309 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.282 43.1 mt -65.6 -41.64 92.57 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 131.012 3.725 . . . . 2.53 107.611 178.367 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 p -67.57 -46.17 73.45 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.138 1.375 . . . . 2.08 114.001 -176.7 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.05 50.57 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.757 0 C-N-CA 125.406 1.479 . . . . 1.31 114.953 166.417 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -127.87 137.94 52.51 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.505 2.574 . . . . 1.4 107.652 -179.798 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.0 m -103.07 110.89 22.99 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 120.192 -1.567 . . . . 0.78 111.634 167.492 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.9 mm -97.54 112.72 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 104.545 -2.391 . . . . 1.55 104.545 -179.475 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.7 m -87.58 104.0 16.09 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.795 -1.191 . . . . 1.08 110.067 176.922 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.422 HD11 HG12 ' A' ' 30' ' ' ILE . 24.0 mt -101.54 134.76 44.16 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 105.598 -2.001 . . . . 1.55 105.598 -170.646 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -81.72 99.37 8.9 Favored 'General case' 0 N--CA 1.429 -1.492 1 O-C-N 116.116 -4.115 . . . . 1.95 116.395 165.233 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.5 m -109.22 -177.66 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.457 1 O-C-N 116.295 -4.003 . . . . 0.96 109.964 -179.693 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -124.11 158.5 60.42 Favored Pre-proline 0 N--CA 1.431 -1.417 0 CA-C-O 114.885 -2.483 . . . . 2.35 105.823 161.55 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -79.03 -6.82 15.18 Favored 'Trans proline' 0 N--CA 1.434 -2.019 1 CA-C-N 129.825 4.544 . . . . 0.95 111.894 -173.347 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.275 1.0 OUTLIER -82.79 2.2 35.22 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 116.448 2.018 . . . . 1.45 116.448 172.01 . . . . . . . . 3 3 . 1 . 108 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -78.02 134.63 37.76 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 116.566 2.062 . . . . 1.69 116.566 172.552 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.7 p -73.63 157.93 35.71 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.139 2.4 . . . . 0.75 110.134 174.569 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.266 35.4 mm -68.64 -37.31 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 112.392 -2.186 . . . . 0.73 110.075 -177.545 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -44.67 -46.53 10.3 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 128.329 2.652 . . . . 1.62 112.463 162.762 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -74.51 -38.63 62.79 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.748 2.69 . . . . 2.13 117.015 -179.679 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.7 t -65.11 -37.86 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 O-C-N 115.188 -4.695 . . . . 0.62 110.196 175.2 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -60.89 -29.72 69.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.838 -2.414 . . . . 1.22 115.334 172.34 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.48 -32.86 66.56 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.097 1.359 . . . . 0.51 112.162 174.325 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.28 0.4 OUTLIER -64.82 -32.95 74.89 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 130.371 3.469 . . . . 1.44 112.822 171.724 . . . . . . . . 3 3 . 1 . 108 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.422 HG12 HD11 ' A' ' 15' ' ' LEU . 15.3 mt -70.82 -41.15 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.579 2.351 . . . . 1.32 108.761 167.495 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.369 13.6 tt0 -57.83 -45.5 86.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 127.754 3.645 . . . . 1.7 117.259 170.065 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -52.45 -56.88 12.05 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.41 -3.306 . . . . 1.55 116.004 170.772 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -78.17 -51.12 10.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.92 -2.362 . . . . 2.62 113.074 -177.992 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -93.91 -62.19 1.4 Allowed 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.982 -2.949 . . . . 1.48 110.386 -170.973 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.15 53.68 0.35 Allowed Glycine 0 N--CA 1.431 -1.663 1 O-C-N 114.13 -5.356 . . . . 1.12 114.829 -179.489 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.9 mt -123.11 127.97 25.48 Favored Pre-proline 0 N--CA 1.43 -1.432 1 N-CA-C 99.661 -4.2 . . . . 1.55 99.661 -177.172 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.02 135.18 39.73 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 C-N-CA 123.022 2.482 . . . . 1.02 112.022 -179.319 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER -46.47 -21.51 1.33 Allowed 'Trans proline' 0 N--CA 1.434 -1.999 1 C-N-CA 128.968 6.445 . . . . 1.25 121.96 179.612 . . . . . . . . 3 3 . 1 . 108 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -72.87 -50.41 24.06 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.881 2.472 . . . . 2.25 110.334 177.416 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -77.66 -7.22 56.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.551 3.072 . . . . 2.02 108.51 -172.977 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -91.72 124.02 35.55 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.387 -3.321 . . . . 0.69 113.424 -178.705 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -121.18 147.93 44.92 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.565 2.126 . . . . 2.78 105.467 169.008 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.262 29.5 mt -127.07 133.95 50.36 Favored 'General case' 0 N--CA 1.429 -1.517 0 C-N-CA 117.912 -1.515 . . . . 1.17 107.013 178.587 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.5 mt -106.39 147.98 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 127.948 3.28 . . . . 1.38 107.569 171.57 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -128.59 107.3 9.59 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.416 -2.068 . . . . 1.5 105.416 177.164 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.43 -42.13 0.49 Allowed 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 132.225 4.21 . . . . 1.21 113.216 177.38 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -172.23 -25.44 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 127.747 2.594 . . . . 1.3 109.435 -176.811 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm -104.43 147.77 27.18 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.278 1.539 . . . . 2.55 113.48 -175.489 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -81.59 140.63 34.35 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.012 -1.449 . . . . 2.48 113.232 172.266 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.5 mt -98.44 144.76 27.45 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.378 1.561 . . . . 0.9 113.482 -177.883 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -99.04 144.82 27.75 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.601 -2.562 . . . . 1.94 108.277 170.501 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.92 -43.93 94.45 Favored 'General case' 0 CA--C 1.489 -1.391 1 C-N-CA 137.864 6.465 . . . . 1.56 114.513 -167.668 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.31 22.87 13.54 Favored Glycine 0 N--CA 1.43 -1.74 0 C-N-CA 129.14 3.257 . . . . 0.97 111.847 168.605 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -98.57 168.34 10.23 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.812 2.244 . . . . 2.49 109.25 161.234 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.3 p -102.68 173.09 6.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.586 -2.571 . . . . 0.76 111.27 170.741 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.321 16.7 mt -76.68 -31.51 57.31 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 119.442 -2.036 . . . . 1.05 106.579 176.951 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 t -64.05 -41.77 97.27 Favored 'General case' 0 CA--C 1.489 -1.39 0 C-N-CA 124.796 1.238 . . . . 1.19 111.093 179.703 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -56.14 -41.01 74.7 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.843 2.164 . . . . 1.9 116.843 174.552 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -87.67 7.36 30.35 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.004 2.122 . . . . 0.89 112.781 179.456 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.277 35.0 m120 56.67 40.49 29.23 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.721 -2.487 . . . . 1.84 115.455 -179.855 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.2 mt -79.03 108.18 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 124.082 1.896 . . . . 0.82 112.116 171.916 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -95.01 -175.27 3.48 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.927 -1.733 . . . . 2.16 113.009 179.131 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -69.02 146.36 52.76 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 115.858 -2.02 . . . . 2.12 114.901 170.774 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 69.57 42.94 1.06 Allowed 'General case' 0 N--CA 1.431 -1.409 1 CA-C-O 130.943 5.163 . . . . 1.71 108.193 177.372 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.256 37.9 m -107.11 129.48 54.82 Favored 'General case' 0 N--CA 1.431 -1.411 1 O-C-N 113.693 -5.629 . . . . 1.04 115.809 176.943 . . . . . . . . 3 2 . 1 . 108 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.3 m -88.33 126.12 35.03 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 125.686 1.866 . . . . 0.79 111.815 177.53 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -112.57 151.7 29.75 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.67 2.788 . . . . 1.4 108.271 173.607 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -110.26 113.45 26.13 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.224 1.935 . . . . 1.51 116.224 -174.967 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.3 tp -82.21 112.97 19.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.203 -2.811 . . . . 1.14 113.39 -178.64 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.39 112.56 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 125.04 2.352 . . . . 1.23 112.593 179.408 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.7 tp -86.52 122.6 30.69 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.935 -2.353 . . . . 2.78 107.644 -175.301 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.63 161.87 28.64 Favored 'General case' 0 N--CA 1.428 -1.532 0 O-C-N 127.951 3.282 . . . . 3.75 113.902 -178.679 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.2 mt -120.72 167.16 12.76 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 104.62 -2.363 . . . . 3.14 104.62 170.45 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.1 mtt-85 -71.25 141.8 50.57 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.58 3.152 . . . . 6.8 115.402 168.155 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 140.54 -71.13 0.43 Allowed Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 128.254 2.835 . . . . 3.57 109.366 -168.876 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.748 0 C-N-CA 114.686 -3.626 . . . . 3.87 104.368 -178.986 . . . . . . . . 0 0 . 1 . 109 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.324 0 N-CA-C 107.442 -1.318 . . . . 1.1 107.442 . . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -99.16 144.45 28.28 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.288 1.994 . . . . 1.87 108.857 -173.913 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 pt -118.7 145.52 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 120.201 -1.562 . . . . 0.72 110.818 169.946 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -100.86 104.13 15.34 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.714 -0.676 . . . . 1.4 110.965 -179.567 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.8 t -88.29 117.62 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.446 -2.034 . . . . 0.58 107.299 174.651 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -101.88 145.12 29.66 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 125.288 1.618 . . . . 2.09 107.264 -179.529 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -103.9 -166.54 1.26 Allowed 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.582 2.134 . . . . 0.99 112.186 178.532 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.5 tp -61.14 -51.29 69.68 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.539 -4.476 . . . . 2.53 114.15 176.233 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 p -72.24 -24.69 61.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.443 -3.286 . . . . 2.08 110.458 178.523 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.25 38.1 2.73 Favored Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 115.043 -3.087 . . . . 1.31 112.167 179.261 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -95.67 130.06 42.67 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 121.492 2.646 . . . . 1.4 110.956 -178.74 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.1 m -80.0 120.74 24.6 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.091 2.956 . . . . 0.78 112.786 178.972 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mt -107.8 118.1 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 101.786 -3.413 . . . . 1.55 101.786 171.523 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.6 m -102.0 113.33 26.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 123.723 2.965 . . . . 1.08 107.462 -172.23 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.8 mt -108.58 137.05 47.17 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.231 -0.918 . . . . 1.55 110.924 177.543 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -80.94 112.86 18.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.872 1.269 . . . . 1.95 110.635 165.516 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -121.48 171.86 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 116.648 2.092 . . . . 0.96 116.648 174.866 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -106.14 158.05 33.44 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 104.115 -2.55 . . . . 2.35 104.115 164.712 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -82.51 4.61 6.95 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 O-C-N 114.656 -3.391 . . . . 0.95 109.095 179.926 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.6 p -92.66 -13.61 29.25 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.329 1.452 . . . . 1.45 114.561 175.661 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -66.67 135.88 54.72 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 126.109 2.861 . . . . 1.69 109.041 -179.416 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.263 23.8 p -68.96 158.33 34.91 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 116.451 -3.906 . . . . 0.75 113.534 177.881 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.401 7.9 mm -55.85 -41.77 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 124.623 2.154 . . . . 0.73 116.416 171.953 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -56.53 -39.65 73.72 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 119.546 3.165 . . . . 1.62 119.546 167.933 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -29.21 64.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.552 2.056 . . . . 2.13 116.552 172.321 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.44 -37.09 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 130.373 3.469 . . . . 0.62 109.635 168.732 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -81.44 -18.74 44.29 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 122.538 1.161 . . . . 1.22 109.793 -179.427 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.38 -17.34 58.28 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.651 -1.906 . . . . 0.51 111.532 168.242 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -83.64 -30.61 26.74 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 119.831 -1.793 . . . . 1.44 111.522 173.22 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.258 13.6 mt -73.01 -26.56 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 117.167 -3.458 . . . . 1.32 113.213 171.561 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -70.65 -51.36 28.46 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.492 3.517 . . . . 1.7 109.446 174.305 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -50.28 -45.16 54.22 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.608 2.763 . . . . 1.55 117.005 165.708 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -81.59 -60.15 2.36 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 113.869 1.063 . . . . 2.62 113.869 -179.646 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -95.13 -48.35 5.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.041 1.497 . . . . 1.48 115.041 -171.396 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.07 -2.0 6.25 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-O 124.222 2.012 . . . . 1.12 114.614 169.922 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.7 mt -74.03 117.61 62.76 Favored Pre-proline 0 N--CA 1.431 -1.409 0 C-N-CA 127.899 2.48 . . . . 1.55 105.039 -174.732 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -69.14 166.88 25.29 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 CA-C-O 111.815 -3.494 . . . . 1.02 117.074 178.03 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -66.19 -32.72 41.98 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 N-CA-C 120.133 3.09 . . . . 1.25 120.133 -174.64 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.379 38.0 m-20 -47.95 -36.63 12.83 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.974 2.109 . . . . 2.25 113.173 169.102 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -98.59 -4.74 33.35 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.964 -0.46 . . . . 2.02 111.802 -172.172 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -97.58 126.17 42.73 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.459 -2.025 . . . . 0.69 110.839 -179.685 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -106.83 116.82 32.59 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.08 2.152 . . . . 2.78 108.826 168.691 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.5 mt -104.84 115.73 30.79 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.8 -1.188 . . . . 1.17 112.037 -179.086 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.9 mm -110.65 126.17 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 127.129 2.172 . . . . 1.38 116.589 -179.779 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -127.92 104.0 7.56 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 104.792 -2.299 . . . . 1.5 104.792 174.97 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.284 . . 61.88 -117.03 0.62 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 110.641 -2.982 . . . . 1.21 110.976 -179.655 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.08 -27.12 29.28 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 119.876 -1.765 . . . . 1.3 110.634 -168.513 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -96.28 139.55 32.26 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 126.86 2.153 . . . . 2.55 115.36 -179.224 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -90.46 127.73 36.3 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 111.919 -2.4 . . . . 2.48 105.836 173.408 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.4 mt -83.85 117.17 23.13 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.363 -1.461 . . . . 0.9 112.445 -171.424 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -68.7 139.7 55.4 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 119.936 3.31 . . . . 1.94 119.936 172.381 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.52 -59.43 4.84 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 118.566 2.802 . . . . 1.56 118.566 -174.611 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.76 60.19 4.83 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-N 113.118 -1.855 . . . . 0.97 114.805 172.362 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -136.8 178.48 7.04 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.418 2.532 . . . . 2.49 106.038 164.521 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.6 p -110.38 176.6 4.98 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 116.604 -3.81 . . . . 0.76 106.961 170.241 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.6 mt -75.2 -33.92 61.46 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.32 -2.737 . . . . 1.05 109.024 177.302 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.6 t -56.01 -44.24 78.47 Favored 'General case' 0 N--CA 1.43 -1.436 1 C-N-CA 134.34 5.056 . . . . 1.19 109.685 176.84 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.251 33.6 m-20 -57.27 -39.79 76.36 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.542 -3.849 . . . . 1.9 118.25 175.653 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -96.67 -2.25 45.02 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 127.469 2.308 . . . . 0.89 112.76 179.476 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.9 m120 58.21 42.53 21.84 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.916 2.886 . . . . 1.84 118.713 -179.165 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.1 mt -94.36 114.38 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 119.439 -2.038 . . . . 0.82 108.596 -179.695 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -101.13 -172.77 2.23 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.742 2.417 . . . . 2.16 112.776 -179.85 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -45.56 151.55 0.39 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.492 -3.88 . . . . 2.12 120.577 174.056 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 50.96 34.93 11.45 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.694 1.368 . . . . 1.71 114.694 174.548 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.0 m -91.84 137.38 32.41 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.697 -1.592 . . . . 1.04 109.294 -176.257 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.2 m -86.7 111.45 20.69 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 124.981 1.425 . . . . 0.79 110.831 177.003 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -92.13 163.97 13.75 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 117.461 -3.274 . . . . 1.4 107.428 171.405 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -128.95 116.28 19.13 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 124.232 1.968 . . . . 1.51 110.031 179.93 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.7 tp -82.36 110.26 17.35 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 119.677 3.214 . . . . 1.14 119.677 174.548 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.6 t -113.19 142.8 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.686 -1.227 . . . . 1.23 107.686 -178.919 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.9 tp -91.31 128.07 37.0 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 122.919 2.6 . . . . 2.78 108.851 178.37 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -96.29 135.33 38.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.426 2.69 . . . . 3.75 108.242 -178.391 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.26 0.0 OUTLIER -115.44 164.01 14.9 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 108.996 -3.729 . . . . 3.14 113.779 173.272 . . . . . . . . 3 3 . 1 . 109 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -66.11 64.59 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.043 -1.661 . . . . 6.8 114.716 163.703 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.75 90.84 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 129.751 3.548 . . . . 3.57 115.582 -161.553 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.723 1 C-N-CA 132.544 4.878 . . . . 3.87 118.103 170.884 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 114.307 1.225 . . . . 1.1 114.307 . . . . . . . . . 0 0 . 1 . 110 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -93.31 130.16 39.16 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.646 -2.534 . . . . 1.87 112.898 -175.967 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.5 pt -129.85 149.64 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 128.561 3.663 . . . . 0.72 110.614 176.149 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -109.0 130.69 55.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 113.052 -1.886 . . . . 1.4 107.854 -176.106 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.48 130.58 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 103.076 -2.935 . . . . 0.58 103.076 173.589 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -110.24 146.13 36.14 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 116.21 -4.056 . . . . 2.09 115.691 174.137 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.482 HG22 HD23 ' A' ' 69' ' ' LEU 0.251 2.9 p -104.34 171.63 7.23 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 119.727 1.149 . . . . 0.99 108.4 173.704 . . . . . . . . 3 3 . 1 . 110 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.9 mt -73.41 -40.26 64.42 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 117.242 -3.411 . . . . 2.53 114.962 174.592 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.0 p -80.72 -37.29 30.86 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.62 2.452 . . . . 2.08 117.62 -175.549 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.57 -55.14 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 116.252 -2.88 . . . . 1.31 119.801 174.973 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -54.18 129.62 35.52 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 121.102 3.742 . . . . 1.4 121.102 -178.311 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.7 m -112.6 115.23 28.27 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 104.498 -2.408 . . . . 0.78 104.498 168.261 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mt -95.03 129.06 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 107.474 -1.306 . . . . 1.55 107.474 -173.005 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.9 m -89.23 111.09 21.8 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.879 2.276 . . . . 1.08 106.634 172.832 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.8 mt -111.44 141.48 44.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 117.408 2.373 . . . . 1.55 117.408 174.527 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -103.37 115.94 31.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 130.64 3.576 . . . . 1.95 109.283 168.251 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.0 m -131.45 155.89 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.223 1.809 . . . . 0.96 112.994 -176.938 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -97.02 142.58 24.75 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-O 112.675 -3.536 . . . . 2.35 117.07 164.356 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' A' ' 56' ' ' LEU 0.267 18.8 Cg_endo -70.7 -24.68 25.11 Favored 'Trans proline' 0 C--N 1.299 -2.055 2 C-N-CA 127.502 5.468 . . . . 0.95 111.705 -170.373 . . . . . . . . 4 3 . 1 . 110 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.329 25.5 m -84.56 8.13 17.73 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 114.216 1.191 . . . . 1.45 114.216 173.916 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -78.13 149.0 33.89 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.992 2.517 . . . . 1.69 104.859 174.637 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.2 p -74.36 163.83 27.33 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.516 2.413 . . . . 0.75 117.516 169.907 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.2 mm -66.26 -36.22 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 121.673 2.033 . . . . 0.73 110.264 171.027 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -52.27 -43.55 64.47 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.391 -2.693 . . . . 1.62 116.709 171.839 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -57.44 -46.49 83.54 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.323 -2.11 . . . . 2.13 113.006 171.765 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.63 -39.23 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 120.408 1.458 . . . . 0.62 113.18 177.106 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.03 -33.0 74.75 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.113 1.153 . . . . 1.22 114.113 173.295 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.25 -27.8 66.66 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.476 1.11 . . . . 0.51 112.548 175.001 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -81.61 -26.34 34.95 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.699 -2.5 . . . . 1.44 109.221 176.913 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.4 mt -75.02 -30.44 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 122.213 2.278 . . . . 1.32 109.485 174.918 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -57.13 -48.81 77.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 130.17 3.388 . . . . 1.7 108.74 169.44 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.29 4.4 t70 -52.29 -58.63 6.05 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.015 1.726 . . . . 1.55 111.478 171.227 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -75.93 -62.47 1.58 Allowed 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 116.02 -4.175 . . . . 2.62 113.296 -172.553 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -96.37 -20.27 18.59 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 116.513 2.042 . . . . 1.48 116.513 -170.221 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.68 20.73 21.07 Favored Glycine 0 N--CA 1.429 -1.803 0 CA-C-O 125.24 2.578 . . . . 1.12 114.736 169.91 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.95 127.46 36.96 Favored Pre-proline 0 N--CA 1.43 -1.445 1 O-C-N 115.801 -4.353 . . . . 1.55 107.707 -174.385 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 52.7 Cg_exo -64.61 147.76 90.21 Favored 'Trans proline' 0 C--N 1.3 -2.016 1 CA-C-N 129.276 4.349 . . . . 1.02 115.017 -178.966 . . . . . . . . 3 3 . 1 . 110 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.1 Cg_exo -62.07 -12.43 26.38 Favored 'Trans proline' 0 N--CA 1.433 -2.049 0 C-N-CA 124.386 3.391 . . . . 1.25 111.672 -178.778 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -73.68 -30.4 62.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 124.629 3.377 . . . . 2.25 115.253 172.382 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -78.66 -32.49 47.2 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 119.181 -2.2 . . . . 2.02 115.498 -176.47 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -71.2 124.52 24.68 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 124.499 1.124 . . . . 0.69 111.326 -172.129 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -120.93 109.78 15.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 114.785 -1.098 . . . . 2.78 109.82 167.537 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.8 mt -90.3 124.43 34.89 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 106.224 -1.769 . . . . 1.17 106.224 -175.997 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.0 mm -102.6 121.1 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 129.685 3.194 . . . . 1.38 113.582 172.107 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -136.49 136.13 39.16 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.902 -1.749 . . . . 1.5 108.773 171.756 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.12 27.01 7.12 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 120.101 3.371 . . . . 1.21 120.101 -178.963 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.73 5.53 84.0 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 119.025 -1.56 . . . . 1.3 116.713 -175.05 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -114.48 143.03 45.6 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.246 1.819 . . . . 2.55 113.818 -178.609 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -97.45 116.18 29.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.674 -1.232 . . . . 2.48 107.674 176.898 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.49 120.91 25.1 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.679 -2.513 . . . . 0.9 108.498 -164.491 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -66.69 157.61 32.2 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 113.849 1.055 . . . . 1.94 113.849 173.659 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -69.72 -55.53 9.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 114.398 1.258 . . . . 1.56 114.398 -176.305 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.27 46.8 2.81 Favored Glycine 0 N--CA 1.43 -1.766 0 CA-C-N 120.202 1.365 . . . . 0.97 115.075 173.538 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -112.88 156.39 23.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 119.913 -1.934 . . . . 2.49 108.212 162.778 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.2 p -99.13 168.78 9.85 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 115.428 -4.545 . . . . 0.76 113.185 169.32 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.403 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 6.6 mt -63.81 -37.58 87.92 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 125.273 1.608 . . . . 1.05 112.367 173.291 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.6 t -71.89 -36.43 70.04 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 122.229 1.014 . . . . 1.19 113.355 -179.943 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -54.6 -36.73 64.77 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.5 3.519 . . . . 1.9 120.5 168.284 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -92.02 9.52 32.91 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.087 -1.449 . . . . 0.89 107.087 -179.964 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 46.42 44.03 12.49 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 117.068 2.247 . . . . 1.84 117.068 -169.65 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.4 mt -86.4 121.04 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 106.5 -1.667 . . . . 0.82 106.5 175.988 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -104.71 179.31 4.31 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 123.296 1.522 . . . . 2.16 107.67 179.632 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -48.84 155.01 0.63 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 117.584 2.439 . . . . 2.12 117.584 173.064 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.305 20.0 mt-10 62.46 25.47 15.18 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 119.068 2.988 . . . . 1.71 119.068 172.075 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -93.25 145.64 24.29 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.721 1.608 . . . . 1.04 113.213 -173.178 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.253 3.2 m -94.02 104.29 16.34 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.3 -4.0 . . . . 0.79 113.666 176.229 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -89.25 142.69 27.43 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 124.394 1.059 . . . . 1.4 109.638 172.645 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -105.05 119.66 39.58 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 116.448 -3.908 . . . . 1.51 108.607 -178.89 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.482 HD23 HG22 ' A' ' 7' ' ' THR . 44.7 tp -91.54 129.86 37.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.951 -3.593 . . . . 1.14 106.374 177.359 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.14 148.45 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 128.125 2.57 . . . . 1.23 106.376 174.297 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 71.2 mt -119.72 170.35 9.29 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.913 -4.242 . . . . 2.78 110.442 175.651 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.6 ptt85 -90.83 111.64 23.12 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.943 -1.132 . . . . 3.75 107.943 169.57 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.5 tp -105.49 -81.08 0.54 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.913 -1.884 . . . . 3.14 105.913 166.184 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -77.21 168.58 19.81 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 127.171 2.188 . . . . 6.8 110.993 170.906 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.15 71.49 0.63 Allowed Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 107.584 -2.206 . . . . 3.57 107.584 -178.43 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.729 0 N-CA-C 107.802 -2.119 . . . . 3.87 107.802 -178.925 . . . . . . . . 0 0 . 1 . 111 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ptt? . . . . . 0 CA--C 1.49 -1.338 0 N-CA-C 109.758 -0.46 . . . . 1.1 109.758 . . . . . . . . . 0 0 . 1 . 111 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -99.43 126.55 45.36 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.49 2.716 . . . . 1.87 111.005 -177.007 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.4 pt -116.85 142.19 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 118.386 -2.696 . . . . 0.72 106.245 168.648 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -100.3 106.33 17.96 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.444 2.698 . . . . 1.4 109.205 -178.16 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.0 t -101.66 112.14 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 O-C-N 117.403 -3.311 . . . . 0.58 106.986 173.354 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.5 mttm -89.98 146.93 24.01 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.89 -3.006 . . . . 2.09 113.375 177.964 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.493 HG22 HD23 ' A' ' 69' ' ' LEU . 82.2 p -98.69 172.05 7.72 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.472 3.034 . . . . 0.99 108.097 172.651 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.6 mt -73.39 -26.47 61.0 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.666 -2.061 . . . . 2.53 113.67 166.181 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.9 p -71.94 -69.95 0.36 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.069 2.248 . . . . 2.08 117.069 -175.67 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.02 12.67 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.809 0 CA-C-O 115.619 -2.767 . . . . 1.31 111.859 176.738 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -108.09 126.91 53.3 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 120.461 2.131 . . . . 1.4 113.225 -177.423 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.2 m -103.78 103.44 13.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.927 -2.249 . . . . 0.78 104.927 173.219 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -82.85 113.93 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 O-C-N 117.129 -3.482 . . . . 1.55 110.912 177.446 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.5 m -79.76 116.25 19.82 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.902 -2.374 . . . . 1.08 105.545 172.647 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.5 mt -114.2 134.43 54.92 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.169 -1.419 . . . . 1.55 107.169 176.185 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -86.75 106.99 18.05 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.174 2.99 . . . . 1.95 114.07 167.719 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.74 165.42 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 112.981 -1.918 . . . . 0.96 109.571 -177.552 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -109.53 155.18 41.73 Favored Pre-proline 0 N--CA 1.429 -1.485 0 N-CA-C 109.38 -0.6 . . . . 2.35 109.38 162.421 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -73.56 -11.87 24.5 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 O-C-N 117.134 -2.087 . . . . 0.95 111.326 -173.01 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.6 p -89.13 0.21 56.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.943 2.897 . . . . 1.45 113.475 178.353 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -76.22 150.12 37.12 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 126.121 2.867 . . . . 1.69 114.456 170.361 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.3 p -85.11 153.12 22.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.232 -2.167 . . . . 0.75 112.567 176.081 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.2 mm -65.45 -36.15 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 120.512 1.506 . . . . 0.73 114.071 -178.954 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -58.28 -39.98 80.69 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.069 -2.269 . . . . 1.62 116.923 173.669 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.323 70.1 m-80 -66.03 -26.04 67.33 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 116.1 1.889 . . . . 2.13 116.1 170.524 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -72.04 -33.3 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-N 120.135 1.334 . . . . 0.62 111.854 170.838 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -83.14 -20.34 34.95 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.381 -2.699 . . . . 1.22 111.175 177.842 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.67 67.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 121.197 1.817 . . . . 0.51 114.012 171.476 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -72.32 -48.86 38.83 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 125.452 1.72 . . . . 1.44 111.261 175.277 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.5 mt -60.79 -33.25 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 125.695 1.598 . . . . 1.32 111.258 176.284 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -64.66 -60.04 3.58 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.644 1.212 . . . . 1.7 110.659 177.624 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -42.43 -56.67 2.93 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 115.368 1.618 . . . . 1.55 115.368 174.698 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -67.69 -59.91 2.95 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 113.977 1.103 . . . . 2.62 113.977 177.359 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -92.37 -58.52 2.35 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.354 -1.466 . . . . 1.48 111.66 -166.414 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.16 16.69 0.64 Allowed Glycine 0 N--CA 1.43 -1.746 0 O-C-N 119.814 -1.804 . . . . 1.12 115.579 175.049 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.415 HG21 HD22 ' A' ' 71' ' ' LEU . 2.4 mp -96.59 133.76 24.21 Favored Pre-proline 0 N--CA 1.43 -1.464 0 C-N-CA 119.291 -0.964 . . . . 1.55 110.903 -175.31 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.39 149.16 91.9 Favored 'Trans proline' 0 N--CA 1.435 -1.965 0 CA-C-N 125.036 2.834 . . . . 1.02 112.933 176.004 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -80.08 -11.25 13.62 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-O 115.702 -1.874 . . . . 1.25 108.9 -168.653 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -77.99 -24.49 48.0 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.871 2.123 . . . . 2.25 114.999 166.914 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -84.35 -34.28 23.68 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 124.244 1.973 . . . . 2.02 109.952 -177.773 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -72.38 100.06 2.58 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.437 -3.29 . . . . 0.69 112.069 179.797 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -86.65 135.37 33.43 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 121.558 1.981 . . . . 2.78 108.05 166.393 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 43' ' ' LEU 0.274 80.0 mt -104.17 125.82 50.78 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.631 3.586 . . . . 1.17 108.226 175.572 . . . . . . . . 3 3 . 1 . 111 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 29.8 mm -103.13 140.93 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 118.976 -2.327 . . . . 1.38 110.358 171.699 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -130.14 107.98 9.72 Favored 'General case' 0 N--CA 1.429 -1.479 1 N-CA-C 98.835 -4.505 . . . . 1.5 98.835 170.506 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.07 -84.89 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.246 1.818 . . . . 1.21 115.14 179.87 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.01 13.25 0.74 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 130.473 3.892 . . . . 1.3 111.338 -175.583 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -109.6 151.36 26.93 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 121.189 2.495 . . . . 2.55 104.439 168.268 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -94.42 132.81 38.67 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 130.031 3.332 . . . . 2.48 102.726 171.071 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.9 mt -91.38 133.2 35.65 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.481 -2.012 . . . . 0.9 107.011 -170.387 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -71.88 151.73 43.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.19 -3.443 . . . . 1.94 108.605 171.572 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.25 -40.81 36.06 Favored 'General case' 0 N--CA 1.429 -1.523 0 O-C-N 116.865 -3.647 . . . . 1.56 110.137 -168.81 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.04 45.45 3.42 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 118.193 -2.817 . . . . 0.97 117.149 172.265 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -116.25 167.5 10.96 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 118.417 -0.802 . . . . 2.49 109.778 163.007 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.6 p -96.9 175.84 6.19 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 127.398 3.475 . . . . 0.76 108.286 167.941 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.8 mt -72.45 -43.75 63.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.742 -3.099 . . . . 1.05 108.607 176.514 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.2 p -72.9 1.41 8.77 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 119.969 3.322 . . . . 1.19 119.969 179.301 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -82.45 -40.59 20.95 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.47 -2.644 . . . . 1.9 112.27 169.593 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -77.87 -7.3 56.51 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.072 2.549 . . . . 0.89 110.621 172.161 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.312 42.8 m-80 68.46 33.32 4.11 Favored 'General case' 0 N--CA 1.428 -1.539 0 O-C-N 116.669 -3.769 . . . . 1.84 115.829 -177.273 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.6 mt -81.31 125.29 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 CA-C-N 114.011 -1.45 . . . . 0.82 111.657 -179.573 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -108.1 -164.11 0.94 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 121.28 3.808 . . . . 2.16 121.28 -176.535 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -74.4 146.63 42.78 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 120.438 -1.414 . . . . 2.12 112.853 171.946 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.261 43.4 mt-10 68.59 18.17 8.89 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 126.901 2.08 . . . . 1.71 115.436 178.182 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -77.04 124.66 28.12 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.413 2.685 . . . . 1.04 113.482 -174.749 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.29 3.8 m -80.97 105.16 11.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 127.418 2.287 . . . . 0.79 115.143 175.845 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.9 mp -103.52 166.76 10.23 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 125.58 2.61 . . . . 1.4 106.044 175.249 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.42 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 73.6 m80 -128.72 133.1 48.05 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.829 -4.295 . . . . 1.51 110.108 -172.12 . . . . . . . . 3 3 . 1 . 111 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.493 HD23 HG22 ' A' ' 7' ' ' THR . 36.6 tp -99.29 129.72 45.53 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.217 -0.927 . . . . 1.14 112.551 -176.368 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -131.05 123.4 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 122.074 2.216 . . . . 1.23 112.26 175.743 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.415 HD22 HG21 ' A' ' 36' ' ' ILE . 18.7 mt -90.42 110.47 21.57 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.65 2.463 . . . . 2.78 117.65 -178.397 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -123.52 -152.74 0.52 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.667 1.987 . . . . 3.75 106.778 -179.325 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.9 mt -122.78 165.7 16.17 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.238 2.215 . . . . 3.14 109.884 170.237 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -57.21 155.42 8.74 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.29 2.329 . . . . 6.8 117.29 -178.661 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.65 -20.25 0.6 Allowed Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 116.583 -2.722 . . . . 3.57 119.307 -160.732 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.76 1 N-CA-C 101.977 -4.449 . . . . 3.87 101.977 -176.736 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 113.311 0.856 . . . . 1.1 113.311 . . . . . . . . . 0 0 . 1 . 112 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.408 HE21 ' HB2' ' A' ' 2' ' ' GLN . 12.0 mt-30 -91.7 142.7 27.33 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.826 -1.916 . . . . 1.87 105.826 -178.046 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.0 pt -132.01 176.69 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 105.166 -2.161 . . . . 0.72 105.166 167.701 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -127.13 130.14 49.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.402 1.573 . . . . 1.4 109.079 176.299 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 t -109.49 110.09 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 126.231 2.919 . . . . 0.58 104.481 175.158 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 12' ' ' THR 0.27 23.7 ttmm -103.98 142.55 34.24 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 114.843 -4.911 . . . . 2.09 109.656 -178.422 . . . . . . . . 4 3 . 1 . 112 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.7 p -91.76 142.52 27.5 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 114.284 -2.77 . . . . 0.99 111.885 179.668 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.3 tp -59.97 -37.78 80.61 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.605 2.362 . . . . 2.53 109.532 165.711 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.9 -27.01 57.51 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-N 122.754 2.525 . . . . 2.08 110.192 -178.357 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.07 -77.38 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.739 1 N-CA-C 123.187 4.035 . . . . 1.31 123.187 176.297 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -72.59 157.51 37.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 129.266 3.568 . . . . 1.4 117.881 -174.694 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 3.3 m -105.11 133.88 49.15 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.944 2.497 . . . . 0.78 107.713 162.499 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 pt -113.18 143.88 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 101.584 -3.487 . . . . 1.55 101.584 176.319 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.3 m -99.85 128.65 45.93 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 114.753 -4.967 . . . . 1.08 104.159 174.397 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.7 mt -114.87 148.86 38.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.145 -3.472 . . . . 1.55 102.892 178.542 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -109.44 122.07 46.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 105.635 -1.987 . . . . 1.95 105.635 171.164 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.79 175.16 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-O 121.862 0.839 . . . . 0.96 111.136 -176.984 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.268 81.3 mt-10 -112.77 167.04 9.8 Favored Pre-proline 0 N--CA 1.431 -1.403 0 O-C-N 117.614 -3.178 . . . . 2.35 110.268 168.222 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -88.43 -8.75 5.27 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 CA-C-N 124.692 2.711 . . . . 0.95 110.513 -169.739 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 p -81.63 1.16 35.26 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 128.146 2.578 . . . . 1.45 115.897 172.958 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -77.52 137.74 38.79 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 115.058 -0.974 . . . . 1.69 108.507 175.25 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.3 p -79.29 156.36 28.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 128.198 2.599 . . . . 0.75 108.873 172.69 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.352 8.0 mm -61.64 -45.44 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 128.062 2.545 . . . . 0.73 114.764 -177.856 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.299 31.8 tt0 -48.83 -39.55 25.99 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 116.313 1.968 . . . . 1.62 116.313 167.292 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -73.55 -28.26 61.77 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 124.326 1.05 . . . . 2.13 111.575 179.793 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.2 t -69.06 -46.42 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 125.502 1.521 . . . . 0.62 109.262 171.297 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -62.21 -16.07 50.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 117.984 2.587 . . . . 1.22 117.984 176.878 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.82 -35.63 38.06 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 127.582 2.353 . . . . 0.51 109.574 171.465 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -70.02 -33.4 71.95 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.413 -1.429 . . . . 1.44 110.28 172.653 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.25 42.4 mt -63.63 -37.3 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 116.465 -3.897 . . . . 1.32 115.541 168.903 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.447 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 50.2 tt0 -69.62 -31.59 69.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 117.315 -1.326 . . . . 1.7 114.444 170.806 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.52 -45.48 65.47 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.393 1.451 . . . . 1.55 109.551 172.241 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -78.02 -64.78 1.08 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.049 -2.282 . . . . 2.62 114.41 -171.007 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.287 21.7 mm-40 -93.54 -45.78 7.59 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.716 1.246 . . . . 1.48 109.851 -172.745 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.88 64.15 0.34 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 106.067 -2.813 . . . . 1.12 106.067 167.069 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.447 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 8.8 mt -120.37 127.9 26.08 Favored Pre-proline 0 N--CA 1.43 -1.433 0 O-C-N 126.837 2.14 . . . . 1.55 111.448 -177.977 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -63.0 129.64 26.53 Favored 'Trans proline' 0 C--N 1.3 -2.023 1 CA-C-O 110.002 -4.249 . . . . 1.02 121.654 179.797 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -33.16 87.19 Favored 'Trans proline' 0 N--CA 1.434 -2.006 1 CA-C-N 129.243 4.337 . . . . 1.25 121.947 -175.142 . . . . . . . . 3 3 . 1 . 112 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -60.77 -37.81 83.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 125.243 3.656 . . . . 2.25 114.21 174.099 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -71.62 -28.05 63.52 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 107.107 -1.442 . . . . 2.02 107.107 -172.862 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -79.96 119.48 22.86 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.401 1.91 . . . . 0.69 115.382 -170.092 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.483 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 92.6 mtt180 -103.81 112.14 24.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 114.171 1.174 . . . . 2.78 114.171 166.821 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.6 mt -94.5 119.14 32.74 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.635 -3.166 . . . . 1.17 110.863 177.165 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.21 130.91 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 122.074 2.216 . . . . 1.38 108.152 174.484 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -118.3 114.94 23.72 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 102.953 -2.98 . . . . 1.5 102.953 171.445 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.383 . . 77.62 -63.9 0.32 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 125.961 2.791 . . . . 1.21 116.296 179.409 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.3 -60.66 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 127.213 2.339 . . . . 1.3 117.263 -172.55 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -68.26 125.41 26.31 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.971 2.908 . . . . 2.55 111.687 172.964 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -71.88 143.17 49.47 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 112.82 -1.991 . . . . 2.48 109.728 173.882 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.2 mt -80.05 128.57 33.65 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.875 1.67 . . . . 0.9 110.79 -178.04 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -86.07 148.31 25.77 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.445 -0.785 . . . . 1.94 109.107 176.002 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -59.41 -47.68 84.54 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 127.481 3.515 . . . . 1.56 117.16 -171.431 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.18 39.47 2.88 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 117.717 -3.114 . . . . 0.97 120.34 170.39 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.353 14.5 mmt180 -116.47 173.39 6.64 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 119.395 -0.922 . . . . 2.49 109.86 163.541 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.5 p -96.84 165.96 11.86 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 115.587 1.699 . . . . 0.76 115.587 168.754 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.0 mt -67.78 -32.55 73.2 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 123.04 1.4 . . . . 1.05 111.901 171.2 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.3 p -67.21 -16.19 64.15 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.256 -2.777 . . . . 1.19 112.895 174.909 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -69.81 -41.25 75.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 122.014 2.188 . . . . 1.9 115.236 177.467 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -90.35 -9.62 47.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.762 2.425 . . . . 0.89 109.724 -179.497 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.287 41.8 m-80 58.76 50.47 8.7 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 117.441 2.386 . . . . 1.84 117.441 -176.461 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.43 HG21 HD11 ' A' ' 67' ' ' LEU . 71.9 mt -86.42 118.2 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 126.409 3.004 . . . . 0.82 113.145 170.085 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -98.92 -178.16 3.86 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.638 -2.539 . . . . 2.16 111.277 -179.011 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -54.32 144.4 20.6 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 118.584 -2.573 . . . . 2.12 117.385 173.596 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.314 22.5 mt-10 66.66 27.39 9.44 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.737 -2.477 . . . . 1.71 117.068 174.825 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -101.09 153.46 19.55 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.232 -1.349 . . . . 1.04 108.877 -174.52 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.6 m -111.17 117.17 32.5 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.681 -3.137 . . . . 0.79 106.605 -175.125 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.43 HD11 HG21 ' A' ' 61' ' ' ILE . 7.7 mp -100.73 135.6 41.91 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.225 2.21 . . . . 1.4 106.047 176.798 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -99.57 117.44 33.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.403 -2.061 . . . . 1.51 110.178 -176.707 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.8 tp -86.96 119.44 27.17 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.465 3.506 . . . . 1.14 111.4 176.952 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 44.7 t -107.63 151.33 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 115.208 -2.33 . . . . 1.23 106.623 174.718 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.0 tp -123.75 131.66 53.64 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 115.26 -2.576 . . . . 2.78 107.465 179.667 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -93.33 136.69 33.36 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 114.965 -4.835 . . . . 3.75 103.855 178.753 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.3 mt -70.24 143.19 52.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.022 2.82 . . . . 3.14 110.69 173.7 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -101.08 -44.68 5.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 112.187 -2.279 . . . . 6.8 109.84 167.884 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.69 64.8 0.7 Allowed Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 115.945 1.138 . . . . 3.57 115.945 -170.97 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.763 1 C-N-CA 132.228 4.728 . . . . 3.87 113.337 174.164 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 ttp . . . . . 0 CA--C 1.491 -1.318 0 CA-C-O 115.598 -2.144 . . . . 1.1 110.758 . . . . . . . . . 0 0 . 1 . 113 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.415 HE21 HG21 ' A' ' 14' ' ' THR . 29.0 mt-30 -90.9 132.36 35.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.766 2.53 . . . . 1.87 112.547 -178.36 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.1 pt -111.68 149.18 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 122.077 2.217 . . . . 0.72 110.543 172.282 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -108.95 115.52 30.24 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.919 -1.882 . . . . 1.4 105.919 178.694 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.427 HG21 HD11 ' A' ' 30' ' ' ILE . 77.5 t -100.34 120.0 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 115.179 -2.343 . . . . 0.58 105.017 175.885 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.251 89.1 mttt -101.79 130.59 48.26 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 116.893 -1.527 . . . . 2.09 106.892 176.489 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.2 p -82.57 170.62 14.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 120.418 1.463 . . . . 0.99 111.621 176.039 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.2 tp -79.62 -28.02 40.97 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 125.712 2.673 . . . . 2.53 111.535 170.277 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.296 38.9 p -75.5 -50.1 16.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.339 -3.35 . . . . 2.08 113.38 -177.195 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.15 32.2 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 122.75 3.86 . . . . 1.31 122.75 167.182 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -135.71 147.45 48.49 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 121.405 2.603 . . . . 1.4 112.043 -175.059 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.8 m -97.09 122.8 40.5 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.882 -1.508 . . . . 0.78 107.956 173.265 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.9 mt -117.28 115.93 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 103.939 -2.615 . . . . 1.55 103.939 -175.155 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.415 HG21 HE21 ' A' ' 2' ' ' GLN . 47.4 m -94.72 104.6 16.52 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.961 1.362 . . . . 1.08 114.226 179.52 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.6 mt -97.27 140.43 31.75 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 119.113 -2.242 . . . . 1.55 111.116 -176.425 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -91.3 115.43 28.02 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 115.538 -4.476 . . . . 1.95 113.236 165.118 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -133.3 152.61 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 126.773 2.546 . . . . 0.96 107.762 -179.189 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -90.71 153.67 45.62 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 115.859 -2.02 . . . . 2.35 110.843 163.452 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -84.07 0.91 9.07 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 CA-C-N 126.07 3.204 . . . . 0.95 116.473 -171.749 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.8 p -85.94 -14.79 43.66 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.614 3.166 . . . . 1.45 111.051 174.612 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.284 18.7 m-20 -82.34 156.02 24.46 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.102 2.161 . . . . 1.69 112.359 177.823 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 60.0 p -78.07 171.15 15.45 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 127.284 3.421 . . . . 0.75 116.759 175.35 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.443 HD13 ' HG ' ' A' ' 56' ' ' LEU . 14.4 mm -74.76 -27.75 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 1 O-C-N 114.968 -4.833 . . . . 0.73 111.524 174.415 . . . . . . . . 3 3 . 1 . 113 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -54.43 -41.34 69.25 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 125.652 1.581 . . . . 1.62 108.964 165.536 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.263 18.1 t-20 -60.71 -44.3 96.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 124.483 2.087 . . . . 2.13 113.423 175.539 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.08 -50.13 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 113.143 -1.844 . . . . 0.62 111.53 174.194 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.404 ' HD2' ' OD2' ' A' ' 52' ' ' ASP . 94.0 mttt -64.64 -41.57 96.05 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.332 2.345 . . . . 1.22 117.332 174.588 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.99 -45.15 41.84 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.158 2.183 . . . . 0.51 115.431 168.375 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -62.72 -39.61 94.61 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 116.182 1.919 . . . . 1.44 116.182 170.652 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.427 HD11 HG21 ' A' ' 5' ' ' VAL 0.257 21.2 mt -63.51 -25.82 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 C-N-CA 125.296 1.438 . . . . 1.32 112.57 173.155 . . . . . . . . 3 3 . 1 . 113 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -77.61 -35.55 52.64 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.561 -0.745 . . . . 1.7 112.58 174.307 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.36 -44.14 95.85 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.139 1.447 . . . . 1.55 113.378 167.975 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -73.29 -66.65 0.66 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 119.783 3.253 . . . . 2.62 119.783 -176.821 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -95.14 -48.6 5.87 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 128.377 2.671 . . . . 1.48 110.348 -174.725 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.91 -10.82 6.64 Favored Glycine 0 N--CA 1.43 -1.757 0 O-C-N 127.049 2.718 . . . . 1.12 117.104 173.362 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mm -71.68 132.19 85.48 Favored Pre-proline 0 N--CA 1.43 -1.428 0 O-C-N 119.367 -2.255 . . . . 1.55 109.178 -173.271 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 43.2 Cg_endo -68.36 151.61 76.04 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 O-C-N 117.343 -1.978 . . . . 1.02 115.117 178.802 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -62.79 -25.49 74.74 Favored 'Trans proline' 0 N--CA 1.433 -2.035 1 C-N-CA 126.68 4.92 . . . . 1.25 112.703 -173.525 . . . . . . . . 4 4 . 1 . 113 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.85 -42.54 98.01 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 129.446 3.098 . . . . 2.25 108.38 -179.296 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -78.97 -22.72 45.21 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 117.469 2.396 . . . . 2.02 117.469 -177.998 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -85.89 129.0 34.96 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.205 1.479 . . . . 0.69 110.221 -169.567 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.43 ' HB2' HG23 ' A' ' 70' ' ' VAL . 92.2 mtt180 -116.29 117.33 29.71 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 125.156 2.407 . . . . 2.78 110.103 173.289 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.6 mt -96.27 128.16 42.93 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 114.336 -5.227 . . . . 1.17 105.936 179.098 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.447 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 15.3 mm -107.26 141.36 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 103.095 -2.928 . . . . 1.38 103.095 178.649 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.452 ' HB3' HD21 ' A' ' 50' ' ' LEU 0.296 26.1 t80 -140.58 109.46 6.04 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.53 1.932 . . . . 1.5 108.137 176.894 . . . . . . . . 3 3 . 1 . 113 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.371 . . 64.8 -75.46 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.51 2.324 . . . . 1.21 112.079 -172.101 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -137.44 -34.97 0.19 Allowed Glycine 0 N--CA 1.429 -1.824 0 O-C-N 123.999 0.812 . . . . 1.3 114.686 178.847 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -89.44 150.78 22.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.221 1.934 . . . . 2.55 116.221 -176.077 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -84.71 127.34 34.05 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 111.903 -2.408 . . . . 2.48 112.183 174.552 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 45' ' ' PHE . 39.1 mt -81.91 148.44 28.75 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 121.057 1.753 . . . . 0.9 112.492 -168.548 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -98.27 148.67 23.39 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 118.605 -1.238 . . . . 1.94 113.697 179.765 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' OD2' ' HD2' ' A' ' 27' ' ' LYS . 4.6 m-20 -60.69 -66.62 0.5 Allowed 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 116.197 -4.064 . . . . 1.56 117.288 -170.962 . . . . . . . . 3 3 . 1 . 113 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.27 32.25 0.32 Allowed Glycine 0 N--CA 1.432 -1.632 0 N-CA-C 122.607 3.803 . . . . 0.97 122.607 172.977 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -115.24 161.97 17.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.469 -2.049 . . . . 2.49 105.469 166.026 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 26.7 p -81.23 158.65 24.77 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.707 -1.871 . . . . 0.76 113.767 175.279 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.443 ' HG ' HD13 ' A' ' 23' ' ' ILE . 5.1 mt -65.78 -24.8 67.01 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.277 2.231 . . . . 1.05 114.591 175.757 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.4 p -83.46 -11.28 57.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.9 2.48 . . . . 1.19 111.467 178.667 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -61.85 -55.83 25.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.483 3.113 . . . . 1.9 108.089 167.26 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -76.81 -13.59 60.0 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 130.13 4.643 . . . . 0.89 113.713 -176.236 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 57.23 64.67 1.55 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 116.678 2.103 . . . . 1.84 116.678 -176.059 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.8 mm -78.54 104.53 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 105.549 -2.019 . . . . 0.82 105.549 174.892 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -73.32 169.94 16.07 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.056 1.342 . . . . 2.16 112.64 175.418 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -55.66 136.3 50.68 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.188 -3.445 . . . . 2.12 112.822 163.115 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 70.3 38.83 1.35 Allowed 'General case' 0 N--CA 1.429 -1.49 1 C-N-CA 135.946 5.698 . . . . 1.71 112.686 175.65 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.6 m -90.73 142.26 27.94 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 116.657 2.095 . . . . 1.04 116.657 -172.595 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.7 m -100.25 116.61 32.65 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 126.169 2.168 . . . . 0.79 107.224 -178.399 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -100.62 152.67 20.16 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 123.352 1.549 . . . . 1.4 111.362 168.875 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.447 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 33.8 m80 -120.93 130.53 53.9 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.086 -2.259 . . . . 1.51 107.511 -174.218 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 tp -112.14 118.2 34.7 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 116.574 2.064 . . . . 1.14 116.574 177.924 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.43 HG23 ' HB2' ' A' ' 42' ' ' ARG . 6.6 m -112.77 172.08 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 103.325 -2.843 . . . . 1.23 103.325 173.1 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.255 10.8 mt -127.83 150.21 49.94 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 113.857 -1.52 . . . . 2.78 112.428 178.111 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -98.39 111.23 23.64 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 125.185 1.394 . . . . 3.75 107.408 178.842 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.5 mp -79.03 159.41 27.61 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 104.622 -2.362 . . . . 3.14 104.622 176.812 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.0 mtm-85 -71.59 -50.76 27.91 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.762 -1.108 . . . . 6.8 111.855 178.412 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.41 70.28 1.7 Allowed Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 108.743 -1.743 . . . . 3.57 108.743 -173.062 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.775 0 C-N-CA 116.994 -2.527 . . . . 3.87 113.759 -175.764 . . . . . . . . 0 0 . 1 . 114 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 ptt? . . . . . 0 CA--C 1.489 -1.372 0 CA-C-O 116.273 -1.822 . . . . 1.1 111.64 . . . . . . . . . 0 0 . 1 . 114 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -99.6 138.85 36.11 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 125.214 1.571 . . . . 1.87 109.824 -173.49 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.5 pt -123.28 160.81 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 128.37 3.938 . . . . 0.72 108.281 173.641 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -119.07 133.22 55.93 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 115.195 -4.69 . . . . 1.4 106.61 -176.556 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.97 119.48 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 106.204 -1.776 . . . . 0.58 106.204 175.973 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -106.34 133.94 50.25 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 115.79 -4.318 . . . . 2.09 111.354 178.568 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.1 p -89.19 178.99 6.22 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.452 -2.03 . . . . 0.99 115.599 -174.144 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.404 HD11 ' H ' ' A' ' 71' ' ' LEU . 5.8 mt -78.11 -22.42 48.94 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 121.727 2.058 . . . . 2.53 109.985 173.379 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.3 p -80.54 -36.27 33.3 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.357 -2.714 . . . . 2.08 109.666 -178.921 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.67 53.82 0.66 Allowed Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 130.088 3.709 . . . . 1.31 119.824 175.957 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -122.74 137.24 54.98 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.102 3.361 . . . . 1.4 105.005 -176.696 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.8 m -105.68 121.54 44.21 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-O 124.42 2.057 . . . . 0.78 108.46 179.823 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.5 mt -99.32 140.5 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.357 -2.714 . . . . 1.55 107.882 174.852 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.8 m -106.75 98.61 8.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.096 -2.252 . . . . 1.08 110.835 -178.606 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.7 mt -95.18 140.84 29.53 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 121.521 1.964 . . . . 1.55 112.933 179.942 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -97.29 134.41 40.62 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.989 -2.319 . . . . 1.95 109.16 169.772 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 m -138.87 156.66 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 127.042 2.137 . . . . 0.96 107.063 -174.141 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -106.37 160.75 25.11 Favored Pre-proline 0 N--CA 1.43 -1.446 0 O-C-N 118.197 -2.815 . . . . 2.35 107.317 162.671 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -71.25 -7.85 22.19 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 CA-C-N 124.394 2.605 . . . . 0.95 112.235 -172.136 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.3 p -93.89 -14.37 26.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.037 2.135 . . . . 1.45 111.894 -174.141 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -65.39 149.29 50.26 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 130.16 3.384 . . . . 1.69 105.635 174.246 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.509 HG22 HG22 ' A' ' 55' ' ' THR . 68.6 p -96.44 170.93 8.89 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 117.235 -1.364 . . . . 0.75 111.097 178.568 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.404 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 32.7 mm -62.16 -32.6 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.413 0 C-N-CA 126.658 1.983 . . . . 0.73 111.366 170.508 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.295 35.5 tt0 -54.15 -51.35 64.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.581 3.552 . . . . 1.62 108.86 169.453 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -57.22 -37.69 72.63 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.557 -2.59 . . . . 2.13 114.918 174.354 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 88.3 t -62.79 -44.82 99.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 114.803 1.408 . . . . 0.62 114.803 175.091 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -65.86 -30.2 70.78 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 129.539 3.136 . . . . 1.22 113.465 173.451 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.19 83.18 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.864 -3.648 . . . . 0.51 111.101 179.738 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -61.96 -42.37 99.04 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.529 -3.232 . . . . 1.44 115.203 174.0 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.1 mt -72.95 -23.75 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 123.439 1.59 . . . . 1.32 110.513 175.995 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -70.12 -35.01 73.8 Favored 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 114.517 -5.114 . . . . 1.7 112.623 169.559 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.69 -48.7 78.16 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.783 2.706 . . . . 1.55 112.558 175.412 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -82.55 -63.04 1.45 Allowed 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 114.406 -5.184 . . . . 2.62 114.88 -178.975 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -85.49 -15.4 42.95 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.948 -3.595 . . . . 1.48 116.918 -168.658 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.37 31.45 54.61 Favored Glycine 0 N--CA 1.429 -1.776 0 O-C-N 119.725 -1.859 . . . . 1.12 114.617 176.543 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mt -101.25 135.43 19.89 Favored Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 108.452 -0.944 . . . . 1.55 108.452 -173.702 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -68.1 151.26 77.44 Favored 'Trans proline' 0 N--CA 1.433 -2.03 0 CA-C-N 123.884 2.423 . . . . 1.02 111.608 179.901 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -73.17 -20.63 21.27 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-N 126.515 3.362 . . . . 1.25 111.242 -173.478 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -65.7 -29.99 70.61 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 126.191 2.9 . . . . 2.25 112.805 174.463 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -81.74 -25.7 35.15 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 114.667 -5.021 . . . . 2.02 107.944 -177.566 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -82.92 119.3 24.24 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.839 -2.413 . . . . 0.69 110.991 -169.775 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.358 80.2 mtp180 -108.18 124.98 51.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.519 -1.219 . . . . 2.78 110.229 163.942 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -107.2 116.73 32.44 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.431 2.539 . . . . 1.17 104.554 -177.771 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.3 mt -111.44 137.28 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 O-C-N 119.939 -1.726 . . . . 1.38 112.982 176.552 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -148.98 132.67 16.87 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 124.15 0.98 . . . . 1.5 111.089 174.249 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.354 . . 49.38 25.03 1.18 Allowed 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 120.256 3.428 . . . . 1.21 120.256 171.199 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.11 7.55 26.73 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 121.477 -0.765 . . . . 1.3 114.591 -177.881 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -149.0 153.53 38.06 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.442 -2.799 . . . . 2.55 110.632 -176.813 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -96.64 128.34 43.48 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 113.912 -1.495 . . . . 2.48 111.662 171.224 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.2 mt -81.49 121.21 25.99 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.648 2.468 . . . . 0.9 115.691 -174.593 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -73.72 137.32 43.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.094 2.627 . . . . 1.94 118.094 177.098 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -40.27 -64.49 0.5 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 131.431 3.892 . . . . 1.56 117.397 -171.319 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.31 16.64 12.5 Favored Glycine 0 N--CA 1.429 -1.798 1 CA-C-O 112.011 -4.772 . . . . 0.97 118.745 175.275 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.0 mtt180 -95.46 161.56 14.02 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 121.155 2.478 . . . . 2.49 110.163 171.632 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.509 HG22 HG22 ' A' ' 22' ' ' THR . 19.3 p -97.56 170.63 8.9 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 117.179 -1.809 . . . . 0.76 114.596 172.94 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.85 -39.79 82.36 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.274 -2.239 . . . . 1.05 111.828 176.506 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.3 t -61.75 -44.24 97.29 Favored 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 130.118 3.367 . . . . 1.19 113.56 175.067 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -59.57 -24.83 64.08 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 115.224 1.565 . . . . 1.9 115.224 174.201 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -106.36 9.45 31.85 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.069 -2.895 . . . . 0.89 112.601 175.08 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.6 m120 44.68 62.77 1.93 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 128.163 2.585 . . . . 1.84 114.155 -177.579 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.7 mt -108.35 127.55 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 129.398 3.079 . . . . 0.82 107.183 176.511 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -106.71 -174.11 2.46 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.541 2.336 . . . . 2.16 110.979 -172.978 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.2 ptmm? -61.2 148.16 41.81 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 114.73 1.382 . . . . 2.12 114.73 174.811 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 62.75 37.89 12.21 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 126.51 3.053 . . . . 1.71 112.921 169.957 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.7 m -84.03 133.06 34.68 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.924 2.297 . . . . 1.04 110.665 178.079 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.7 m -93.39 104.82 16.95 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.202 -2.186 . . . . 0.79 109.3 176.344 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.6 mt -88.1 147.38 24.97 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 123.184 0.593 . . . . 1.4 110.066 174.296 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -97.68 121.52 39.69 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 116.917 -1.516 . . . . 1.51 113.815 173.622 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.9 tp -91.01 111.97 23.66 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.591 2.756 . . . . 1.14 108.491 175.942 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.7 t -112.11 141.83 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 114.579 -1.192 . . . . 1.23 109.151 172.156 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.404 ' H ' HD11 ' A' ' 8' ' ' LEU . 64.4 mt -110.89 132.99 53.74 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 119.61 3.189 . . . . 2.78 119.61 179.639 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -85.39 153.65 22.38 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.391 1.476 . . . . 3.75 109.185 -178.29 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.1 tp -116.7 109.58 17.34 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.512 -1.676 . . . . 3.14 115.436 179.529 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -82.14 -53.99 5.64 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 124.873 1.269 . . . . 6.8 108.03 173.785 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 131.2 -65.82 0.59 Allowed Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 105.62 -2.992 . . . . 3.57 105.62 -166.448 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.704 0 CA-C-O 115.875 -2.625 . . . . 3.87 114.065 -179.362 . . . . . . . . 0 0 . 1 . 115 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ptt? . . . . . 0 CA--C 1.489 -1.371 0 N-CA-C 112.624 0.601 . . . . 1.1 112.624 . . . . . . . . . 0 0 . 1 . 115 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.338 0.0 OUTLIER -97.83 133.72 41.95 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.129 -1.607 . . . . 1.87 111.446 179.286 . . . . . . . . 3 3 . 1 . 115 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.3 pt -115.74 158.88 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 103.637 -2.727 . . . . 0.72 103.637 169.74 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -112.34 137.89 49.85 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.452 2.701 . . . . 1.4 107.302 178.92 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.9 t -118.15 123.15 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 102.226 -3.25 . . . . 0.58 102.226 174.291 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.7 tppt? -100.36 126.96 46.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 126.144 2.878 . . . . 2.09 105.33 175.687 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 p -78.3 -162.91 0.39 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 120.253 3.427 . . . . 0.99 120.253 173.463 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 mt -88.31 -34.73 17.56 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 117.294 -1.336 . . . . 2.53 112.831 173.66 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 p -68.38 -32.74 73.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 127.536 2.334 . . . . 2.08 106.999 173.266 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.67 35.29 2.26 Favored Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 127.592 2.52 . . . . 1.31 107.744 168.367 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -80.57 134.36 35.91 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.258 -2.867 . . . . 1.4 103.258 178.876 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.9 m -95.02 91.49 6.39 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.855 -1.521 . . . . 0.78 114.341 175.042 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.4 mt -88.38 119.13 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 123.848 1.785 . . . . 1.55 106.714 -175.449 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.1 m -90.44 126.88 36.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.062 -2.273 . . . . 1.08 110.37 -177.268 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.5 mt -128.18 134.12 49.0 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.221 -3.424 . . . . 1.55 106.246 -175.238 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -98.15 132.24 43.84 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.615 -1.624 . . . . 1.95 106.615 171.87 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.4 m -140.61 164.79 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 126.962 2.105 . . . . 0.96 109.621 -173.938 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -109.58 151.92 42.5 Favored Pre-proline 0 N--CA 1.43 -1.454 0 CA-C-O 114.486 -2.673 . . . . 2.35 112.651 160.373 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 96.4 Cg_endo -70.52 -14.93 34.14 Favored 'Trans proline' 0 N--CA 1.433 -2.058 0 C-N-CA 125.09 3.86 . . . . 0.95 109.715 -165.29 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.1 m -82.93 -9.95 59.05 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 122.346 2.339 . . . . 1.45 108.974 176.919 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -66.74 142.5 57.37 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.443 3.497 . . . . 1.69 112.43 172.732 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 p -83.19 171.58 13.51 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 113.121 -5.987 . . . . 0.75 110.142 -174.632 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.1 mm -75.57 -30.55 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 122.949 1.357 . . . . 0.73 109.783 179.098 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.253 38.2 tt0 -45.34 -42.85 10.38 Favored 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 117.977 -2.952 . . . . 1.62 117.49 157.925 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -68.35 -38.52 81.55 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 125.336 1.648 . . . . 2.13 110.968 176.49 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.1 t -62.67 -35.28 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 125.156 2.408 . . . . 0.62 115.094 177.844 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HD3' ' HB2' ' A' ' 41' ' ' GLN . 90.1 mttt -68.31 -38.42 81.58 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.163 -1.586 . . . . 1.22 115.093 166.269 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.68 -22.42 66.63 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 118.465 2.765 . . . . 0.51 118.465 169.796 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -84.45 -29.48 26.06 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.675 -1.891 . . . . 1.44 111.901 173.947 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.8 mt -70.49 -38.06 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 124.164 1.935 . . . . 1.32 114.752 170.662 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.45 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 10.8 tt0 -65.51 -42.53 91.96 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 128.208 2.603 . . . . 1.7 109.66 171.926 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -58.09 -52.48 65.35 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.348 -3.345 . . . . 1.55 113.116 172.469 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.2 mmtt -64.09 -66.32 0.56 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.618 3.58 . . . . 2.62 111.818 -176.179 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -89.84 -44.59 9.84 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 110.654 -2.976 . . . . 1.48 112.956 -172.119 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 113.42 0.69 24.89 Favored Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 117.649 1.82 . . . . 1.12 117.649 -177.899 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 mt -68.49 121.26 80.08 Favored Pre-proline 0 N--CA 1.429 -1.488 0 O-C-N 118.77 -2.606 . . . . 1.55 107.003 -176.549 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -67.88 164.68 30.7 Favored 'Trans proline' 0 N--CA 1.434 -1.989 1 C-N-CA 125.739 4.293 . . . . 1.02 112.126 -176.459 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -67.45 -34.16 27.2 Favored 'Trans proline' 0 N--CA 1.433 -2.05 1 C-N-CA 125.758 4.305 . . . . 1.25 113.173 -175.223 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -44.17 -48.94 9.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 126.604 3.097 . . . . 2.25 114.211 173.762 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -83.98 -17.0 41.99 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.146 -2.846 . . . . 2.02 115.951 -170.93 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.407 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 79.1 mt-30 -85.49 134.29 34.05 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.439 1.896 . . . . 0.69 111.218 -168.875 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -121.14 114.64 21.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 130.388 3.475 . . . . 2.78 108.606 167.467 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.4 mt -88.9 116.97 27.57 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.627 -1.921 . . . . 1.17 112.578 173.866 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.6 mm -106.4 141.1 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 102.652 -3.092 . . . . 1.38 102.652 -178.431 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -132.24 97.58 4.16 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 100.378 -3.934 . . . . 1.5 100.378 174.976 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.36 . . 79.5 -86.62 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.096 2.159 . . . . 1.21 106.858 -179.309 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.57 -6.55 1.8 Allowed Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 128.668 3.032 . . . . 1.3 111.179 -178.017 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -92.87 131.1 38.2 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 128.403 2.681 . . . . 2.55 109.135 -177.114 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -81.66 114.59 20.44 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 112.364 -2.198 . . . . 2.48 110.776 175.234 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.8 mt -83.23 148.62 27.3 Favored 'General case' 0 N--CA 1.431 -1.407 1 O-C-N 115.198 -4.689 . . . . 0.9 112.267 -174.521 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -100.3 149.36 23.68 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.499 1.919 . . . . 1.94 113.291 172.852 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -61.67 -61.15 2.72 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 130.49 3.516 . . . . 1.56 112.222 -169.525 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.82 20.52 0.2 Allowed Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 122.285 3.674 . . . . 0.97 122.285 171.705 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -107.67 154.13 21.92 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.135 -1.803 . . . . 2.49 113.042 167.02 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.3 p -94.21 168.45 10.91 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.805 2.891 . . . . 0.76 118.805 177.999 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 56.4 mt -62.77 -43.05 99.82 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.887 -1.758 . . . . 1.05 109.916 174.316 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 t -55.36 -43.66 75.27 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 120.342 3.46 . . . . 1.19 120.342 174.719 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -54.45 -42.2 70.34 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 128.287 2.635 . . . . 1.9 110.87 177.687 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -95.03 11.39 32.2 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 115.289 1.589 . . . . 0.89 115.289 -178.65 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 52.45 50.0 19.22 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 129.038 2.935 . . . . 1.84 110.98 -177.798 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.0 mt -91.94 114.19 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 N-CA-C 106.621 -1.622 . . . . 0.82 106.621 -179.068 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -94.16 -170.67 2.35 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 125.197 2.427 . . . . 2.16 109.494 -177.153 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.321 17.8 pttp -67.39 150.82 48.44 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 111.695 -2.502 . . . . 2.12 117.416 168.769 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.343 17.2 mt-10 68.38 9.52 7.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.942 2.201 . . . . 1.71 116.942 170.156 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.3 t -94.36 138.76 31.94 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 131.034 3.734 . . . . 1.04 107.855 -175.82 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.2 m -85.99 122.95 30.74 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 115.969 1.84 . . . . 0.79 115.969 179.225 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mp -99.78 157.45 16.49 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 101.472 -3.529 . . . . 1.4 101.472 169.674 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -121.04 117.27 26.81 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 113.995 1.109 . . . . 1.51 113.995 179.956 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.7 tp -88.85 110.37 21.0 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.413 2.054 . . . . 1.14 113.185 -178.713 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.7 t -107.04 147.82 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 117.981 -2.949 . . . . 1.23 106.124 171.605 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.0 mt -109.0 154.37 22.28 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.159 -2.213 . . . . 2.78 109.437 -179.532 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -115.33 131.04 57.05 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.47 -2.018 . . . . 3.75 108.737 179.302 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.19 142.92 27.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.109 -3.495 . . . . 3.14 108.452 178.784 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -62.4 92.42 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 118.151 2.649 . . . . 6.8 118.151 174.101 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.75 59.73 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.706 0 O-C-N 119.46 -2.025 . . . . 3.57 108.831 -163.857 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.792 0 N-CA-C 119.267 2.467 . . . . 3.87 119.267 -177.378 . . . . . . . . 0 0 . 1 . 116 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 119.322 -0.37 . . . . 1.1 110.208 . . . . . . . . . 0 0 . 1 . 116 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -102.7 132.42 48.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.66 -2.525 . . . . 1.87 106.83 -179.249 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.0 pt -132.42 167.02 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-O 116.376 -1.773 . . . . 0.72 108.001 173.923 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -124.1 149.08 46.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 122.349 2.34 . . . . 1.4 115.282 176.75 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 t -128.42 119.48 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 102.858 -3.016 . . . . 0.58 102.858 171.024 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -109.82 129.1 55.67 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 111.329 -2.669 . . . . 2.09 109.595 176.258 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 p -89.89 -173.87 4.05 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 126.546 3.069 . . . . 0.99 109.205 178.555 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.6 mt -91.48 3.66 54.43 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.678 -3.764 . . . . 2.53 117.739 169.51 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.2 p -76.6 -31.14 57.27 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.861 2.465 . . . . 2.08 108.578 177.899 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.22 -29.35 3.69 Favored Glycine 0 N--CA 1.43 -1.739 1 N-CA-C 102.78 -4.128 . . . . 1.31 102.78 179.904 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -63.58 131.21 47.33 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.406 2.002 . . . . 1.4 116.406 -170.898 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.9 m -102.1 117.48 34.89 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.345 -1.298 . . . . 0.78 108.895 169.112 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.283 7.7 mt -103.83 109.69 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 129.047 2.939 . . . . 1.55 106.243 -177.2 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.6 m -83.36 131.6 35.05 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.479 1.133 . . . . 1.08 110.21 177.559 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.3 mt -134.06 140.56 46.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.037 -2.289 . . . . 1.55 108.61 -175.759 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -84.3 124.14 30.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.487 2.715 . . . . 1.95 108.583 174.175 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.344 4.1 m -134.42 149.3 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 O-C-N 118.353 -2.717 . . . . 0.96 113.258 -176.423 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -95.73 141.72 23.57 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 115.233 -2.318 . . . . 2.35 105.331 165.291 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -81.98 -15.54 9.22 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 CA-C-N 126.484 3.351 . . . . 0.95 111.512 -167.899 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.8 m -71.56 -11.78 61.03 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 120.734 -1.229 . . . . 1.45 114.08 174.948 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -67.49 159.04 30.47 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.471 2.082 . . . . 1.69 112.235 177.455 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.6 p -87.12 177.37 7.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.323 -2.736 . . . . 0.75 109.1 -177.699 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.1 mt -84.12 -24.0 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 1 O-C-N 114.307 -5.246 . . . . 0.73 114.899 171.671 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.08 -28.39 69.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.153 1.908 . . . . 1.62 116.153 163.049 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -73.29 -36.27 66.26 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 121.221 1.828 . . . . 2.13 111.888 173.889 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.8 t -63.01 -48.8 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 C-N-CA 128.504 2.722 . . . . 0.62 114.243 176.421 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -57.91 -33.96 69.32 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.633 2.086 . . . . 1.22 116.633 176.353 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.21 -24.16 67.75 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.227 1.936 . . . . 0.51 116.227 169.827 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -72.86 -31.66 64.89 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 126.397 2.999 . . . . 1.44 116.355 172.947 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.5 mm -68.37 -27.95 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 O-C-N 117.678 -3.139 . . . . 1.32 106.702 169.758 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.424 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 41.6 tt0 -71.49 -39.0 71.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.924 -2.36 . . . . 1.7 112.277 172.283 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -63.04 -41.43 99.51 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 118.227 2.677 . . . . 1.55 118.227 171.603 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -83.96 -58.16 2.9 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.824 2.05 . . . . 2.62 111.941 -174.878 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -97.99 -42.64 7.42 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.491 1.516 . . . . 1.48 109.698 -173.905 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 94.62 57.33 1.27 Allowed Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 128.142 2.782 . . . . 1.12 111.899 179.387 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.1 mt -115.23 122.31 33.47 Favored Pre-proline 0 N--CA 1.431 -1.423 0 N-CA-C 101.927 -3.36 . . . . 1.55 101.927 -177.957 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -66.94 149.29 82.99 Favored 'Trans proline' 0 C--N 1.3 -2.024 1 CA-C-O 108.871 -4.72 . . . . 1.02 108.283 -174.134 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -66.48 -8.54 21.13 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 CA-C-N 127.15 3.589 . . . . 1.25 116.496 -174.645 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.95 -35.16 62.14 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.234 1.969 . . . . 2.25 115.134 175.771 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -81.11 -15.68 55.24 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.214 -3.429 . . . . 2.02 111.753 -177.573 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -70.65 116.49 11.02 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.649 1.98 . . . . 0.69 112.875 -175.202 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.456 HH12 ' C ' ' A' ' 76' ' ' GLY . 64.2 mtt180 -106.35 124.84 50.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.885 -3.009 . . . . 2.78 105.537 175.561 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.0 tp -112.46 125.58 54.38 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 123.987 1.851 . . . . 1.17 107.085 -175.674 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.1 mm -114.74 125.99 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 O-C-N 120.283 -1.511 . . . . 1.38 110.01 -175.733 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -138.22 118.73 13.86 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.987 -1.857 . . . . 1.5 105.987 171.512 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.6 35.99 1.75 Allowed 'General case' 0 N--CA 1.431 -1.421 1 CA-C-O 129.417 4.437 . . . . 1.21 115.946 175.195 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.29 -21.47 28.28 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 110.423 -3.081 . . . . 1.3 115.052 -175.925 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -100.43 148.38 24.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.138 2.273 . . . . 2.55 117.138 -178.524 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -76.49 119.33 20.19 Favored 'General case' 0 N--CA 1.428 -1.53 0 C-N-CA 129.901 3.281 . . . . 2.48 109.43 169.819 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.514 HD22 ' CG ' ' A' ' 59' ' ' TYR . 20.5 mt -85.92 147.04 26.43 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.675 2.179 . . . . 0.9 116.85 -177.073 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -92.21 136.65 33.02 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 117.382 -3.324 . . . . 1.94 115.087 176.297 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -66.1 -42.54 89.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.884 -3.01 . . . . 1.56 116.258 -173.19 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.88 -13.95 62.39 Favored Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 125.32 1.438 . . . . 0.97 116.673 169.317 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -77.99 160.55 28.1 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 121.027 2.414 . . . . 2.49 112.306 174.115 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.261 60.8 p -91.15 159.5 16.05 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 116.41 -3.931 . . . . 0.76 110.805 177.331 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mt -70.05 -26.25 63.94 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.285 -1.78 . . . . 1.05 110.095 179.852 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.5 p -77.07 -30.85 55.66 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.079 2.552 . . . . 1.19 111.799 176.527 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.284 3.5 t70 -60.89 -43.18 98.83 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.051 -3.53 . . . . 1.9 114.31 172.35 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.514 ' CG ' HD22 ' A' ' 50' ' ' LEU . 35.6 m-85 -85.27 -6.0 59.28 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 116.743 -1.599 . . . . 0.89 113.293 170.734 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.37 55.6 t30 68.9 50.54 0.61 Allowed 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 123.455 2.843 . . . . 1.84 113.11 175.79 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.46 HD13 HD21 ' A' ' 67' ' ' LEU . 68.2 mt -100.42 124.11 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 105.605 -1.998 . . . . 0.82 105.605 176.169 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -110.82 -173.1 2.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 129.337 3.055 . . . . 2.16 113.504 -177.832 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.314 26.2 tttm -46.4 124.05 5.43 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.961 2.505 . . . . 2.12 112.726 174.568 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.399 44.1 mt-10 61.9 43.16 9.53 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.235 3.014 . . . . 1.71 117.522 174.203 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 t -99.36 153.41 19.0 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.527 2.108 . . . . 1.04 109.876 -175.424 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.287 11.8 m -97.25 107.41 19.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.721 -1.862 . . . . 0.79 113.81 178.465 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.46 HD21 HD13 ' A' ' 61' ' ' ILE . 50.8 mt -88.34 139.8 30.12 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.414 -1.328 . . . . 1.4 107.414 170.196 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -107.38 133.55 51.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 124.628 1.205 . . . . 1.51 109.069 -177.972 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.329 36.9 tp -111.33 121.1 44.36 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 127.161 2.788 . . . . 1.14 109.473 -178.802 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.409 HG23 ' HB2' ' A' ' 42' ' ' ARG . 9.9 m -117.78 164.99 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 116.923 -1.513 . . . . 1.23 111.03 168.787 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.6 mt -105.02 159.66 15.65 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 122.223 2.283 . . . . 2.78 113.972 176.19 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -73.68 136.12 43.77 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 119.8 -1.813 . . . . 3.75 114.804 -174.646 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.5 mt -112.8 154.03 26.89 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.288 2.635 . . . . 3.14 110.512 166.959 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -81.48 150.45 28.28 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 126.051 2.834 . . . . 6.8 114.716 167.734 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.75 -87.54 1.08 Allowed Glycine 0 N--CA 1.431 -1.688 0 O-C-N 118.286 -2.758 . . . . 3.57 115.539 -164.73 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.456 ' C ' HH12 ' A' ' 42' ' ' ARG . . . . . . . . 0 N--CA 1.43 -1.731 0 O-C-N 117.583 -3.304 . . . . 3.87 113.69 -179.822 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 114.926 1.454 . . . . 1.1 114.926 . . . . . . . . . 0 0 . 1 . 117 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -101.39 112.77 25.39 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.226 1.81 . . . . 1.87 107.537 -179.504 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -100.42 174.43 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 127.168 2.187 . . . . 0.72 114.183 166.908 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -123.83 141.37 52.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.969 -2.332 . . . . 1.4 110.869 -175.0 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.0 t -106.03 119.37 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 118.026 -2.921 . . . . 0.58 112.372 166.676 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -98.37 119.14 36.54 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 116.468 -3.895 . . . . 2.09 108.716 176.723 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p -73.57 173.26 9.96 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.601 -3.187 . . . . 0.99 119.599 174.036 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.2 mt -53.41 -54.06 42.28 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 118.157 2.651 . . . . 2.53 118.157 170.401 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.4 p -69.23 -24.59 64.03 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 126.393 2.308 . . . . 2.08 111.015 -177.748 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.21 38.07 0.97 Allowed Glycine 0 N--CA 1.43 -1.712 0 O-C-N 119.526 -1.984 . . . . 1.31 112.707 170.25 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -109.98 131.07 55.39 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.867 -3.137 . . . . 1.4 107.023 -173.149 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -89.68 106.62 18.58 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.857 2.063 . . . . 0.78 114.316 177.841 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.4 mt -104.99 120.37 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 103.502 -2.777 . . . . 1.55 103.502 -178.128 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.3 m -86.33 132.95 33.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.761 -1.109 . . . . 1.08 111.978 178.971 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.3 mt -136.53 132.9 35.87 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 115.208 -2.33 . . . . 1.55 114.893 -175.698 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -84.39 114.32 21.81 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 131.258 3.823 . . . . 1.95 111.48 173.974 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.5 m -140.77 167.1 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-O 125.097 2.38 . . . . 0.96 106.131 178.763 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -121.07 158.28 53.08 Favored Pre-proline 0 N--CA 1.431 -1.425 0 O-C-N 118.518 -2.613 . . . . 2.35 111.571 168.26 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -59.14 -16.53 33.95 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 O-C-N 111.538 -5.032 . . . . 0.95 116.41 -176.45 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.7 p -79.14 -5.29 53.82 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.086 1.513 . . . . 1.45 115.086 171.691 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.27 46.5 m-20 -76.93 142.62 40.0 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.779 -1.201 . . . . 1.69 109.743 -178.395 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.3 p -86.35 161.08 18.89 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.073 -1.084 . . . . 0.75 108.073 179.761 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.447 HG23 HD12 ' A' ' 43' ' ' LEU . 27.8 mm -58.03 -42.24 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 122.324 1.059 . . . . 0.73 110.727 176.291 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -37.66 -54.01 1.21 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 119.142 3.015 . . . . 1.62 119.142 160.864 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -55.77 -41.9 74.72 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.591 2.756 . . . . 2.13 113.315 176.905 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.6 t -61.66 -50.96 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 126.282 1.833 . . . . 0.62 111.742 173.55 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.4 mttt -61.47 -27.9 68.9 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.458 -3.276 . . . . 1.22 118.237 175.248 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.53 -27.57 64.27 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.56 2.124 . . . . 0.51 113.943 178.0 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -76.47 -36.51 57.82 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.803 -2.436 . . . . 1.44 112.479 176.044 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.56 -30.05 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.908 -1.496 . . . . 1.32 114.808 161.574 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -68.6 -33.36 73.91 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.448 1.476 . . . . 1.7 113.627 179.003 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -78.3 -53.85 6.85 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 117.235 -1.786 . . . . 1.55 115.092 166.354 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -59.19 -43.51 92.19 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 115.153 -2.356 . . . . 2.62 117.309 -174.925 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -108.14 -26.65 10.51 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 126.702 2.501 . . . . 1.48 110.524 -172.713 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.52 48.89 3.83 Favored Glycine 0 N--CA 1.43 -1.767 0 O-C-N 119.987 -1.695 . . . . 1.12 111.914 171.212 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.4 mt -128.57 125.37 23.11 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-O 115.622 -2.133 . . . . 1.55 109.822 -177.876 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 75.5 Cg_exo -66.85 148.76 82.92 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-N 125.484 2.994 . . . . 1.02 114.094 178.16 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 52.1 Cg_exo -69.33 -14.1 36.85 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 N-CA-C 116.63 1.742 . . . . 1.25 116.63 -170.933 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.56 -29.67 70.75 Favored 'General case' 0 N--CA 1.43 -1.449 1 C-N-CA 132.514 4.326 . . . . 2.25 109.029 169.788 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -90.87 -31.1 16.56 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.482 1.66 . . . . 2.02 115.482 -178.697 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.281 77.4 mt-30 -81.08 134.3 35.63 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.856 -1.164 . . . . 0.69 107.856 -175.012 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -121.15 133.4 55.2 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.914 -2.991 . . . . 2.78 105.98 168.898 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 43' ' ' LEU . 98.2 mt -98.01 126.49 43.46 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 105.781 -1.933 . . . . 1.17 105.781 -177.905 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 mm -110.84 138.86 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 CA-C-N 122.466 2.393 . . . . 1.38 104.616 -178.407 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -144.48 130.15 19.11 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 106.376 -1.713 . . . . 1.5 106.376 163.49 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.05 24.78 14.86 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 120.381 3.474 . . . . 1.21 120.381 177.771 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.86 -18.51 57.39 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 115.72 -2.711 . . . . 1.3 108.439 -179.785 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.0 pttt -101.22 156.72 17.27 Favored 'General case' 0 N--CA 1.431 -1.422 1 CA-C-N 124.847 4.323 . . . . 2.55 111.028 177.382 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.291 39.9 tt0 -96.74 144.57 26.61 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.858 2.742 . . . . 2.48 107.95 175.185 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.6 mt -92.45 148.09 22.38 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.472 -3.268 . . . . 0.9 109.129 -178.727 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -92.93 144.45 25.25 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 130.611 3.564 . . . . 1.94 112.813 -179.522 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -63.64 -54.91 28.34 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.284 -3.385 . . . . 1.56 115.665 -167.479 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.86 42.36 3.05 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-O 123.299 1.5 . . . . 0.97 115.51 173.036 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -110.43 152.95 25.69 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.362 -2.257 . . . . 2.49 105.253 165.281 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.7 p -103.1 158.82 16.04 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.86 2.064 . . . . 0.76 108.256 -177.99 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.0 mt -65.44 -28.31 69.14 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 128.484 2.714 . . . . 1.05 108.378 176.042 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 p -64.59 -40.99 96.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.285 2.634 . . . . 1.19 115.461 171.874 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -65.24 -35.24 80.43 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 124.235 0.959 . . . . 1.9 113.411 176.623 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -85.43 3.1 41.67 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.336 1.606 . . . . 0.89 115.336 179.595 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.0 m120 56.02 32.27 19.62 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 110.698 -2.956 . . . . 1.84 117.895 -174.232 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.6 mm -72.17 130.02 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 1 O-C-N 115.325 -4.609 . . . . 0.82 116.582 176.594 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -117.61 174.81 5.95 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 128.115 2.566 . . . . 2.16 107.049 -168.106 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -54.32 152.8 5.96 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.058 1.503 . . . . 2.12 115.058 172.858 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.37 35.0 mt-10 73.55 14.03 4.37 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 125.554 2.597 . . . . 1.71 115.282 172.112 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.327 27.3 m -78.51 124.39 28.1 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 116.303 1.964 . . . . 1.04 116.303 -175.019 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.6 m -89.59 99.87 12.78 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 118.134 2.642 . . . . 0.79 118.134 177.913 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.5 mt -86.52 139.06 31.23 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.302 -2.481 . . . . 1.4 104.302 176.547 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -97.29 141.5 30.32 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.747 -3.096 . . . . 1.51 108.832 174.685 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.0 tp -106.62 125.62 51.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.11 1.909 . . . . 1.14 111.382 179.954 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.12 163.89 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 N-CA-C 105.063 -2.199 . . . . 1.23 105.063 174.695 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.9 mt -127.61 129.57 47.49 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 101.799 -3.408 . . . . 2.78 101.799 -176.672 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.1 ptt85 -81.23 166.89 20.18 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.976 -2.952 . . . . 3.75 108.372 173.603 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.7 mt -84.39 157.52 21.4 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 116.336 -3.978 . . . . 3.14 107.752 170.473 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -114.79 -120.87 0.3 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.559 -1.655 . . . . 6.8 110.009 -177.605 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.91 -22.69 6.02 Favored Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 106.264 -2.735 . . . . 3.57 106.264 -161.492 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.792 0 N-CA-C 107.929 -2.068 . . . . 3.87 107.929 -179.16 . . . . . . . . 0 0 . 1 . 118 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 ttp . . . . . 0 CA--C 1.491 -1.326 0 CA-C-O 118.61 -0.709 . . . . 1.1 112.597 . . . . . . . . . 0 0 . 1 . 118 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -94.31 133.54 37.75 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.562 -2.586 . . . . 1.87 111.716 178.576 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -123.37 159.34 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.269 2.628 . . . . 0.72 106.859 175.278 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.297 44.3 m-85 -128.96 121.71 28.6 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 123.887 1.803 . . . . 1.4 110.679 -177.604 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -100.52 105.01 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 125.851 2.739 . . . . 0.58 110.757 175.308 . . . . . . . . 3 3 . 1 . 118 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -88.13 138.59 31.31 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.547 -3.221 . . . . 2.09 110.066 176.241 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.9 p -90.52 -177.67 5.11 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 127.989 3.306 . . . . 0.99 116.18 -174.405 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.7 mt -82.74 -26.18 32.16 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.564 -1.96 . . . . 2.53 113.169 163.674 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.1 p -64.35 -62.58 1.52 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.507 1.923 . . . . 2.08 114.758 -174.262 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.49 31.61 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.757 0 N-CA-C 105.234 -3.147 . . . . 1.31 105.234 174.826 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -117.61 128.42 54.92 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 123.618 1.675 . . . . 1.4 109.025 -172.493 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.6 m -107.08 102.32 11.67 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 104.526 -2.398 . . . . 0.78 104.526 176.412 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.8 pt -91.27 133.06 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 120.778 1.626 . . . . 1.55 109.998 176.924 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.9 m -91.53 151.19 20.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 121.183 -0.948 . . . . 1.08 108.565 175.544 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.1 mt -144.31 139.39 28.52 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.106 -1.813 . . . . 1.55 106.106 176.48 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -78.0 116.19 18.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.101 1.519 . . . . 1.95 115.101 165.085 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.277 11.3 m -127.75 151.22 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 127.672 2.389 . . . . 0.96 106.839 178.49 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -94.87 161.96 26.8 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 118.107 -2.871 . . . . 2.35 112.622 157.828 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -73.45 -20.95 20.21 Favored 'Trans proline' 0 N--CA 1.433 -2.072 0 CA-C-N 126.69 3.425 . . . . 0.95 115.743 -174.895 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.6 p -72.59 5.32 3.14 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.488 3.915 . . . . 1.45 114.039 169.011 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -95.82 135.16 37.9 Favored 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 117.775 -3.078 . . . . 1.69 112.909 -179.604 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 26.6 p -67.79 173.98 3.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.21 -2.268 . . . . 0.75 114.225 177.414 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.6 mm -84.88 -29.7 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 118.143 -2.848 . . . . 0.73 105.156 176.861 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -48.95 -48.34 43.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.228 -2.795 . . . . 1.62 116.55 163.622 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -51.87 -50.27 61.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.861 -2.399 . . . . 2.13 115.148 167.369 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.2 t -55.97 -42.75 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 114.73 -2.557 . . . . 0.62 115.246 177.409 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -64.15 -41.11 97.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 125.101 2.382 . . . . 1.22 116.337 174.896 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.85 -43.73 81.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.51 3.124 . . . . 0.51 115.893 166.983 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.41 ' HB2' ' HE2' ' A' ' 29' ' ' LYS . 2.3 ttmm -58.86 -33.29 70.29 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 116.248 -4.033 . . . . 1.44 113.835 170.616 . . . . . . . . 3 3 . 1 . 118 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.9 mt -78.79 -31.09 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 112.907 -1.951 . . . . 1.32 108.969 176.521 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -71.15 -40.35 71.4 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 115.53 1.678 . . . . 1.7 115.53 177.868 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -58.01 -52.11 66.88 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.932 1.456 . . . . 1.55 114.932 168.001 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.2 tttp -70.23 -71.66 0.23 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.579 2.751 . . . . 2.62 113.361 -172.374 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -90.58 -34.24 15.57 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.048 -1.658 . . . . 1.48 111.616 -162.798 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.47 5.55 22.59 Favored Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 105.089 -3.204 . . . . 1.12 105.089 175.593 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 30.9 mt -80.17 122.37 82.86 Favored Pre-proline 0 N--CA 1.431 -1.41 0 CA-C-N 119.087 1.443 . . . . 1.55 108.475 -175.799 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 24.3 Cg_exo -68.31 150.75 76.52 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 C-N-CA 124.58 3.52 . . . . 1.02 110.653 -175.883 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.263 39.0 Cg_endo -62.91 -43.8 18.61 Favored 'Trans proline' 0 N--CA 1.433 -2.039 1 C-N-CA 126.963 5.109 . . . . 1.25 116.469 -168.904 . . . . . . . . 3 2 . 1 . 118 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -55.86 -26.56 47.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 121.792 3.997 . . . . 2.25 121.792 171.945 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -71.17 -34.89 71.36 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.585 1.954 . . . . 2.02 110.691 -179.322 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -70.62 97.71 1.38 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.165 2.283 . . . . 0.69 117.165 -175.299 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -87.44 126.14 34.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 118.341 -0.838 . . . . 2.78 108.96 161.957 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.0 mt -117.8 119.54 35.2 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 121.478 1.945 . . . . 1.17 108.431 -178.639 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 27.4 mt -108.3 128.94 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 128.53 2.732 . . . . 1.38 113.818 -172.426 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.429 ' CE2' HG12 ' A' ' 61' ' ' ILE 0.288 72.1 t80 -144.95 110.92 5.46 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 105.581 -2.007 . . . . 1.5 105.581 178.648 . . . . . . . . 3 3 . 1 . 118 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.82 45.25 7.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.867 1.802 . . . . 1.21 115.867 178.974 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.02 -4.85 36.25 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 120.681 3.032 . . . . 1.3 120.681 -171.534 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -96.3 119.72 35.31 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 130.155 4.091 . . . . 2.55 115.642 177.441 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -79.76 110.29 14.97 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 114.922 -4.861 . . . . 2.48 109.593 168.899 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.2 mt -82.12 146.35 29.66 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.041 -2.287 . . . . 0.9 110.827 -163.765 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -85.3 145.22 27.63 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.836 2.055 . . . . 1.94 114.004 173.536 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.39 -59.07 4.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.594 2.072 . . . . 1.56 116.594 -168.703 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.64 49.82 3.7 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-O 123.943 1.857 . . . . 0.97 116.905 173.744 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -118.25 156.48 28.75 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 101.489 -3.522 . . . . 2.49 101.489 165.443 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 16.9 p -100.07 162.48 12.95 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.686 -3.133 . . . . 0.76 112.784 174.005 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.4 mt -54.87 -48.27 73.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.777 2.831 . . . . 1.05 109.2 174.813 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 p -60.72 -37.92 83.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.07 2.148 . . . . 1.19 113.856 179.085 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -61.31 -33.93 74.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 122.637 2.471 . . . . 1.9 113.375 174.276 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -85.96 -14.34 44.94 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 127.002 2.121 . . . . 0.89 114.055 178.836 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.6 m120 66.84 50.34 1.11 Allowed 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 124.242 1.972 . . . . 1.84 111.739 -177.661 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.429 HG12 ' CE2' ' A' ' 45' ' ' PHE . 70.8 mt -95.78 128.71 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 119.951 -1.718 . . . . 0.82 108.457 174.629 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -100.1 175.98 5.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 112.159 -2.291 . . . . 2.16 111.07 -174.171 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -46.37 137.43 6.43 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.819 -3.05 . . . . 2.12 117.639 166.811 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.253 73.8 mt-10 69.57 14.04 8.27 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.287 -2.758 . . . . 1.71 117.682 175.455 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 m -76.1 148.95 37.53 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 120.438 -1.414 . . . . 1.04 112.826 -175.364 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.1 m -97.28 119.0 34.98 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 126.177 2.173 . . . . 0.79 111.258 -179.365 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.449 ' HB2' HG13 ' A' ' 5' ' ' VAL . 33.3 mt -103.8 136.68 43.03 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.053 -1.655 . . . . 1.4 107.851 170.235 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.431 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 63.5 m80 -91.64 107.5 19.25 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.298 2.332 . . . . 1.51 117.298 174.181 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.449 ' HB2' HG12 ' A' ' 5' ' ' VAL . 15.2 tp -88.09 117.04 26.7 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 124.835 1.254 . . . . 1.14 110.184 -179.334 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.2 t -120.84 143.25 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 126.493 3.044 . . . . 1.23 103.723 178.431 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.9 mt -118.12 110.51 17.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.149 -2.845 . . . . 2.78 109.126 -175.422 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -136.66 158.77 43.68 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 105.767 -1.938 . . . . 3.75 105.767 178.745 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -64.53 137.1 57.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 125.421 1.701 . . . . 3.14 115.374 167.969 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -69.33 123.94 22.53 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.713 -0.676 . . . . 6.8 111.394 172.058 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.32 94.29 0.1 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 117.622 -1.655 . . . . 3.57 114.083 -176.857 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.79 0 CA-C-O 115.938 -2.59 . . . . 3.87 112.213 168.345 . . . . . . . . 0 0 . 1 . 119 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.27 0.2 OUTLIER . . . . . 0 CA--C 1.491 -1.321 0 N-CA-C 107.138 -1.43 . . . . 1.1 107.138 . . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -115.38 119.96 38.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.765 2.026 . . . . 1.87 109.359 -178.41 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 pt -120.74 158.44 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 122.031 0.919 . . . . 0.72 112.716 -179.905 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -114.37 148.14 38.1 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.878 -2.389 . . . . 1.4 106.299 176.028 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.4 t -124.16 121.86 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 129.385 3.074 . . . . 0.58 105.51 173.118 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -107.16 137.69 44.75 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.305 2.642 . . . . 2.09 112.342 177.004 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.6 p -95.65 -176.83 3.86 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 123.376 1.56 . . . . 0.99 114.329 179.935 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.374 66.4 tp -57.54 -45.81 84.62 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 116.01 -4.181 . . . . 2.53 113.11 172.222 . . . . . . . . 3 2 . 1 . 119 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.5 p -80.11 -35.56 36.65 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 121.579 1.99 . . . . 2.08 111.844 -175.555 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.07 7.16 1.36 Allowed Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 119.524 1.057 . . . . 1.31 113.498 178.14 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.3 mtpt -76.6 130.65 38.15 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.676 -2.661 . . . . 1.4 111.65 -176.555 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 98.0 m -97.96 113.57 25.44 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 125.22 2.438 . . . . 0.78 113.203 -179.184 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.0 mt -92.4 95.15 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 119.101 -2.249 . . . . 1.55 110.369 178.327 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.6 m -81.48 118.82 23.03 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 120.473 1.488 . . . . 1.08 110.432 175.324 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.4 mt -119.85 153.64 35.51 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.567 -2.382 . . . . 1.55 104.567 178.275 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -110.44 120.17 41.57 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 111.558 -2.565 . . . . 1.95 107.493 174.25 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.87 -176.76 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.457 -2.652 . . . . 0.96 106.287 175.2 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -105.48 163.06 17.88 Favored Pre-proline 0 N--CA 1.431 -1.408 0 O-C-N 116.631 -3.793 . . . . 2.35 104.64 169.693 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -71.1 -14.74 32.03 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 124.012 2.468 . . . . 0.95 112.82 179.055 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.263 18.9 m -92.76 5.82 49.77 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 123.766 2.985 . . . . 1.45 111.572 -179.64 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -82.4 151.09 26.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 127.892 3.71 . . . . 1.69 108.706 176.445 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 68.7 p -79.49 170.57 16.38 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 113.586 -5.696 . . . . 0.75 113.596 179.322 . . . . . . . . 3 3 . 1 . 119 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.41 -30.57 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-N 113.561 -1.654 . . . . 0.73 110.873 178.572 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -54.82 -41.55 70.81 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.922 2.089 . . . . 1.62 113.724 169.36 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -61.9 -45.5 93.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.248 1.944 . . . . 2.13 116.248 171.252 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 56.4 t -51.51 -48.85 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 128.583 2.753 . . . . 0.62 107.896 175.445 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -67.42 -36.12 80.61 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 122.402 2.365 . . . . 1.22 117.384 175.197 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.02 -32.48 73.85 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 116.037 -4.164 . . . . 0.51 118.402 169.008 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -67.19 -31.05 71.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 112.483 -2.144 . . . . 1.44 114.839 170.142 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.293 57.3 mt -68.31 -25.43 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 CA-C-O 125.969 2.795 . . . . 1.32 113.683 172.339 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -85.47 -27.51 25.63 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.84 -4.287 . . . . 1.7 106.835 -174.32 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -78.09 -38.14 44.88 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 114.095 -3.042 . . . . 1.55 111.032 168.92 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -65.08 -61.46 2.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 112.986 0.736 . . . . 2.62 112.986 -172.243 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -106.09 -52.64 2.77 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.209 3.004 . . . . 1.48 108.969 -167.403 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.93 -15.8 5.86 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 119.096 2.398 . . . . 1.12 119.096 176.491 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mt -65.1 131.83 95.24 Favored Pre-proline 0 N--CA 1.43 -1.469 0 CA-C-O 116.499 -1.715 . . . . 1.55 110.337 -175.156 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.407 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 93.6 Cg_endo -74.93 155.36 43.25 Favored 'Trans proline' 0 N--CA 1.433 -2.038 0 C-N-CA 125.219 3.946 . . . . 1.02 112.814 -177.136 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.9 Cg_exo -63.84 -27.41 67.4 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 123.663 2.909 . . . . 1.25 119.056 -174.364 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.272 2.6 m-20 -62.08 -32.46 73.01 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.072 1.415 . . . . 2.25 113.39 177.268 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -87.81 -16.91 32.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.159 1.457 . . . . 2.02 114.085 -171.436 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -87.31 127.17 35.19 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 117.148 -1.406 . . . . 0.69 109.698 -174.909 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -118.44 128.18 54.37 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.441 -1.689 . . . . 2.78 106.441 170.421 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.2 mt -95.05 136.76 34.98 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.103 -2.873 . . . . 1.17 112.678 174.565 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 73.0 mt -125.38 117.92 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-O 124.415 2.055 . . . . 1.38 110.775 178.401 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -109.0 107.82 18.32 Favored 'General case' 0 N--CA 1.43 -1.439 1 N-CA-C 99.77 -4.159 . . . . 1.5 99.77 -178.534 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.88 -74.32 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.477 2.311 . . . . 1.21 113.716 -172.555 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.92 6.11 1.13 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 105.709 -2.956 . . . . 1.3 105.709 178.095 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -94.98 119.04 32.82 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.327 -3.455 . . . . 2.55 110.17 177.747 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -89.08 121.64 31.61 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.862 -2.399 . . . . 2.48 108.642 175.599 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.0 mt -80.08 164.67 23.19 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 114.158 -1.383 . . . . 0.9 111.599 -164.131 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -115.66 137.05 52.46 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 127.012 3.291 . . . . 1.94 111.396 174.552 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.28 -40.77 97.35 Favored 'General case' 0 N--CA 1.429 -1.483 1 N-CA-C 122.274 4.175 . . . . 1.56 122.274 -166.842 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.42 30.44 5.25 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 118.079 1.991 . . . . 0.97 118.079 171.385 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -105.86 162.61 13.41 Favored 'General case' 0 N--CA 1.43 -1.439 1 CA-C-O 130.099 4.762 . . . . 2.49 107.959 163.073 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 63.0 p -84.25 163.82 19.44 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 113.02 -6.05 . . . . 0.76 109.648 172.279 . . . . . . . . 3 3 . 1 . 119 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.2 mt -64.76 -42.7 94.92 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 121.0 -1.063 . . . . 1.05 109.086 172.432 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.3 p -66.32 -21.56 66.26 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.406 -3.309 . . . . 1.19 115.092 -179.22 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -59.34 -17.69 31.82 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 118.123 2.638 . . . . 1.9 118.123 167.017 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -115.79 11.22 15.56 Favored 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 114.561 -5.087 . . . . 0.89 109.189 178.835 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.334 1.3 t-20 67.01 33.97 5.42 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.568 1.947 . . . . 1.84 114.111 179.044 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.4 mt -92.03 126.37 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 104.759 -2.311 . . . . 0.82 104.759 -174.688 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -125.17 -171.46 2.37 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 119.488 1.04 . . . . 2.16 109.458 -169.25 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -52.68 141.7 20.26 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 118.452 -2.655 . . . . 2.12 112.842 165.722 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.316 4.2 mt-10 60.71 36.46 19.44 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.298 2.873 . . . . 1.71 115.926 175.066 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.4 t -109.49 140.82 42.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 111.562 -2.563 . . . . 1.04 106.74 -167.107 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.3 m -114.18 120.37 40.27 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.782 -1.192 . . . . 0.79 107.782 -167.759 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.7 mt -100.52 161.58 13.51 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.518 2.727 . . . . 1.4 111.186 173.795 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -123.79 109.65 13.92 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.122 2.169 . . . . 1.51 111.196 -177.616 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.9 tp -92.12 122.87 35.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 111.812 -2.449 . . . . 1.14 108.073 -175.008 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.327 4.7 m -118.4 141.03 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 118.802 -2.436 . . . . 1.23 110.953 175.63 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.9 mt -104.37 135.09 46.47 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.926 -2.984 . . . . 2.78 110.145 177.226 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.411 HH21 ' C ' ' A' ' 76' ' ' GLY . 9.8 ttt180 -150.13 150.13 31.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 101.095 -3.669 . . . . 3.75 101.095 -177.099 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.0 mt -68.59 132.83 47.59 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.045 -2.285 . . . . 3.14 112.015 171.767 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -65.31 123.43 19.57 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.114 0.959 . . . . 6.8 111.825 169.837 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.13 -63.94 0.31 Allowed Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 103.158 -3.977 . . . . 3.57 103.158 -171.207 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.411 ' C ' HH21 ' A' ' 72' ' ' ARG . . . . . . . . 0 N--CA 1.429 -1.796 0 O-C-N 120.472 -1.605 . . . . 3.87 109.622 178.942 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 ptt? . . . . . 0 CA--C 1.491 -1.301 0 CA-C-O 120.957 0.408 . . . . 1.1 110.23 . . . . . . . . . 0 0 . 1 . 120 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -107.65 147.38 30.77 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.537 -0.727 . . . . 1.87 112.3 -176.681 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.3 pt -134.09 152.41 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 124.174 1.94 . . . . 0.72 106.385 172.935 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -109.7 134.37 52.05 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 127.019 2.128 . . . . 1.4 114.298 178.619 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.7 t -114.14 109.57 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 118.015 -2.928 . . . . 0.58 106.062 178.338 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 6' ' ' LYS . 17.9 tptm -93.61 131.38 38.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.219 -1.551 . . . . 2.09 111.83 178.673 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.1 p -89.07 -178.67 5.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.211 -2.806 . . . . 0.99 113.782 -178.428 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.263 35.4 tp -85.31 -33.47 22.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 119.292 -2.13 . . . . 2.53 108.198 171.85 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.259 59.9 p -68.33 -34.32 75.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.678 -1.889 . . . . 2.08 109.015 -174.095 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.0 44.54 0.44 Allowed Glycine 0 N--CA 1.431 -1.673 0 CA-C-O 115.376 -2.902 . . . . 1.31 113.513 178.378 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -127.55 148.69 50.34 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 114.076 -2.868 . . . . 1.4 110.853 -177.838 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.8 m -122.89 121.76 36.97 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 124.69 3.405 . . . . 0.78 103.626 177.126 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mt -98.13 124.54 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 1 O-C-N 115.971 -4.206 . . . . 1.55 104.355 179.1 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.0 m -101.29 118.2 36.51 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.261 -2.15 . . . . 1.08 107.876 179.912 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.7 mt -117.46 162.3 18.18 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.5 -2.625 . . . . 1.55 109.683 178.3 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -101.26 136.11 41.64 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 127.144 2.777 . . . . 1.95 112.656 166.545 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -142.36 171.26 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 128.085 2.554 . . . . 0.96 107.48 -176.236 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -118.53 148.22 43.65 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 101.904 -3.369 . . . . 2.35 101.904 163.139 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.97 -6.12 17.39 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 O-C-N 115.809 -2.785 . . . . 0.95 118.35 178.07 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.8 p -80.57 -5.77 57.28 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.475 2.71 . . . . 1.45 112.401 169.131 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -70.01 143.17 52.65 Favored 'General case' 0 N--CA 1.431 -1.413 1 CA-C-O 128.515 4.007 . . . . 1.69 111.706 171.129 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.395 53.6 p -75.09 157.05 35.38 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.02 -2.925 . . . . 0.75 112.848 176.493 . . . . . . . . 3 3 . 1 . 120 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.9 mm -71.53 -29.97 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 122.95 1.357 . . . . 0.73 109.634 179.131 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -46.57 -57.9 4.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.561 3.077 . . . . 1.62 115.538 164.661 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -54.48 -34.24 61.22 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 119.849 3.277 . . . . 2.13 119.849 178.017 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 68.9 t -71.05 -35.73 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 112.185 -2.28 . . . . 0.62 111.208 176.109 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -72.96 -34.11 66.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.011 -2.931 . . . . 1.22 113.456 171.76 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.98 -32.63 74.22 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 117.992 -2.943 . . . . 0.51 113.067 174.335 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt -72.42 -33.55 67.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 123.35 1.547 . . . . 1.44 114.853 174.279 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 30' ' ' ILE . 47.2 mt -72.39 -29.99 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 120.399 -1.438 . . . . 1.32 108.309 176.26 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.494 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 7.7 tt0 -64.0 -51.28 64.99 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.809 1.644 . . . . 1.7 112.549 171.803 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -60.75 -39.47 88.85 Favored 'General case' 0 N--CA 1.432 -1.368 0 O-C-N 120.121 -1.612 . . . . 1.55 113.509 175.549 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.6 tptt -67.83 -56.44 9.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.427 -1.421 . . . . 2.62 114.781 -173.818 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.307 71.4 mm-40 -113.71 -15.23 12.49 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 115.755 1.761 . . . . 1.48 115.755 -171.995 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.21 64.31 1.6 Allowed Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 125.169 1.366 . . . . 1.12 110.338 171.303 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.494 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 16.9 mt -141.53 117.07 7.13 Favored Pre-proline 0 N--CA 1.429 -1.485 0 N-CA-C 101.947 -3.353 . . . . 1.55 101.947 -176.436 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.472 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 57.3 Cg_exo -58.01 153.64 43.79 Favored 'Trans proline' 0 C--N 1.3 -2.002 1 C-N-CA 128.218 5.945 . . . . 1.02 111.93 178.149 . . . . . . . . 3 3 . 1 . 120 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 95.2 Cg_exo -71.73 -27.75 17.84 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 CA-C-N 125.454 2.984 . . . . 1.25 115.37 -171.825 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -61.36 -31.62 71.5 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.354 3.062 . . . . 2.25 113.912 178.007 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -92.57 -10.36 37.84 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 116.462 -3.899 . . . . 2.02 105.546 -172.332 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -92.87 132.47 36.98 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 124.062 3.119 . . . . 0.69 109.818 -172.041 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -103.52 125.56 50.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.762 -1.837 . . . . 2.78 109.369 163.811 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.6 mt -113.81 118.51 34.47 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.64 -2.537 . . . . 1.17 109.388 179.16 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mt -110.83 125.36 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 126.824 2.049 . . . . 1.38 109.794 -177.446 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -125.23 130.78 52.76 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.17 -1.789 . . . . 1.5 106.17 168.403 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.78 -76.44 0.07 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.804 1.242 . . . . 1.21 112.0 179.259 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -177.4 33.8 0.08 OUTLIER Glycine 0 N--CA 1.431 -1.649 0 O-C-N 117.258 -3.401 . . . . 1.3 104.809 -175.482 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.32 122.29 16.69 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.644 1.978 . . . . 2.55 107.277 179.444 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -70.85 143.14 51.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.425 -2.672 . . . . 2.48 107.228 166.186 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.1 mt -99.97 139.99 34.83 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 125.268 1.605 . . . . 0.9 110.183 -173.107 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -83.05 161.64 21.63 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 117.767 -1.111 . . . . 1.94 108.886 176.44 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -73.49 -57.15 4.2 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 129.03 2.932 . . . . 1.56 117.131 -169.237 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.04 54.47 3.64 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 126.607 3.337 . . . . 0.97 120.048 172.631 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.253 79.2 mmt-85 -122.58 169.18 11.29 Favored 'General case' 0 N--CA 1.43 -1.444 1 C-N-CA 132.122 4.169 . . . . 2.49 103.306 169.257 . . . . . . . . 3 2 . 1 . 120 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 62.5 p -109.29 -179.72 3.92 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.409 -3.932 . . . . 0.76 108.464 170.561 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 79.8 mt -72.64 -33.67 66.77 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 130.825 3.65 . . . . 1.05 109.738 172.295 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.4 t -73.9 -37.74 64.57 Favored 'General case' 0 N--CA 1.43 -1.468 1 C-N-CA 131.976 4.111 . . . . 1.19 110.688 -176.214 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -64.08 -38.14 89.98 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 113.209 -1.814 . . . . 1.9 113.956 173.509 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -84.0 -2.83 57.37 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 113.945 -2.931 . . . . 0.89 112.47 170.463 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.417 8.1 t-20 56.9 46.34 19.8 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 121.24 1.836 . . . . 1.84 114.245 -177.043 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.2 mt -88.18 107.31 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 130.713 3.605 . . . . 0.82 108.212 176.621 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -79.33 -175.88 4.92 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.567 -2.583 . . . . 2.16 111.556 -177.131 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -72.88 149.1 43.78 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 118.382 -2.699 . . . . 2.12 108.305 172.98 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 71.51 18.32 5.46 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 126.615 3.102 . . . . 1.71 116.88 174.915 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -83.33 151.64 25.46 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.289 -3.382 . . . . 1.04 117.223 178.951 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.6 m -108.89 110.29 21.58 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.753 -1.203 . . . . 0.79 107.753 -173.604 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.7 mt -87.94 147.58 24.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 102.162 -3.273 . . . . 1.4 102.162 170.878 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -108.41 112.87 25.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.382 -1.34 . . . . 1.51 107.382 -175.761 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.7 tp -87.68 112.0 21.89 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.898 -2.376 . . . . 1.14 110.226 -178.81 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.7 t -111.13 120.23 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 103.055 -2.943 . . . . 1.23 103.055 178.368 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.5 mt -109.98 141.15 43.17 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.732 1.73 . . . . 2.78 114.435 -178.312 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -91.55 130.02 37.44 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.894 2.553 . . . . 3.75 117.894 -176.091 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.4 mt -83.98 153.49 23.85 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.077 -3.514 . . . . 3.14 114.399 168.85 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -93.82 160.79 14.59 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 104.244 -2.502 . . . . 6.8 104.244 179.543 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.29 -50.04 1.6 Allowed Glycine 0 N--CA 1.431 -1.689 0 CA-C-O 115.099 -3.056 . . . . 3.57 113.929 -171.321 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.737 0 CA-C-N 120.942 2.371 . . . . 3.87 114.714 178.837 . . . . . . . . 0 0 . 1 . 121 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 CA--C 1.49 -1.329 0 CA-C-O 125.53 2.586 . . . . 1.1 113.826 . . . . . . . . . 0 0 . 1 . 121 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -115.59 108.82 16.92 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.881 -2.387 . . . . 1.87 106.272 -173.861 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.3 pt -114.08 164.49 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 105.733 -1.951 . . . . 0.72 105.733 171.942 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -124.35 151.68 44.05 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.573 -2.01 . . . . 1.4 105.573 -172.09 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 t -134.1 118.52 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 102.86 -3.015 . . . . 0.58 102.86 174.545 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.6 mmtm -90.83 141.4 28.85 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.434 -1.321 . . . . 2.09 107.434 171.055 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.2 p -91.49 -162.46 0.92 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.803 2.841 . . . . 0.99 111.45 -178.715 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.5 mt -83.2 -30.89 27.39 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 126.138 2.875 . . . . 2.53 110.132 178.493 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.8 p -82.09 -60.73 2.12 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 113.977 -5.452 . . . . 2.08 110.01 -171.615 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.93 31.41 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 125.03 1.3 . . . . 1.31 111.101 175.101 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -103.76 134.81 46.45 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.949 -4.265 . . . . 1.4 104.676 -174.609 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 m -80.98 119.63 23.75 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 112.779 -2.01 . . . . 0.78 109.908 167.675 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 mt -94.84 117.51 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 104.168 -2.531 . . . . 1.55 104.168 172.468 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.266 99.3 m -86.42 122.0 29.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 124.98 1.312 . . . . 1.08 109.683 179.227 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.492 HD11 HG13 ' A' ' 30' ' ' ILE . 89.3 mt -129.3 112.66 14.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 126.554 3.073 . . . . 1.55 109.146 -174.026 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -79.63 120.79 24.45 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 110.668 -2.969 . . . . 1.95 113.393 174.561 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.1 162.43 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 113.427 -1.715 . . . . 0.96 108.487 -175.235 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -118.54 170.53 6.32 Favored Pre-proline 0 N--CA 1.43 -1.435 0 O-C-N 116.836 -3.665 . . . . 2.35 108.85 168.13 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -62.9 -18.86 66.98 Favored 'Trans proline' 0 C--N 1.3 -1.982 1 C-N-CA 125.42 4.08 . . . . 0.95 120.813 -173.109 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.7 m -95.49 16.19 17.69 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 118.448 2.759 . . . . 1.45 118.448 171.049 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -77.25 148.45 35.77 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 124.746 2.212 . . . . 1.69 106.966 167.421 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.418 ' HB ' ' H ' ' A' ' 23' ' ' ILE . 71.4 p -97.73 -168.26 1.65 Allowed 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.028 -4.795 . . . . 0.75 114.109 175.791 . . . . . . . . 3 3 . 1 . 121 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.418 ' H ' ' HB ' ' A' ' 22' ' ' THR . 33.3 mm -89.1 -30.3 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 119.631 -1.918 . . . . 0.73 110.488 175.114 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -59.41 -32.19 69.95 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 128.0 2.52 . . . . 1.62 114.038 167.118 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.265 71.1 m-20 -64.23 -44.41 91.95 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 130.411 3.484 . . . . 2.13 115.348 161.709 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.9 t -65.91 -33.37 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 C-N-CA 114.268 -2.973 . . . . 0.62 117.683 175.305 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.275 53.1 mtmt -73.11 -36.55 66.78 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.261 2.625 . . . . 1.22 109.227 -176.73 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.11 -32.84 71.06 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.631 -2.543 . . . . 0.51 111.197 174.569 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -74.95 -25.35 58.81 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 116.367 -3.958 . . . . 1.44 115.747 176.206 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.492 HG13 HD11 ' A' ' 15' ' ' LEU . 18.4 mt -80.83 -27.53 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 C-N-CA 117.181 -1.808 . . . . 1.32 113.88 172.933 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -64.09 -36.4 83.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.625 1.97 . . . . 1.7 114.351 169.997 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -60.54 -65.07 0.75 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 128.978 3.924 . . . . 1.55 109.786 167.859 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -67.6 -54.07 22.81 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 115.384 1.624 . . . . 2.62 115.384 -172.343 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -113.08 -25.1 9.1 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.951 -2.343 . . . . 1.48 115.001 -164.646 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.69 50.27 2.75 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 118.06 -2.019 . . . . 1.12 116.115 168.651 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.5 mt -120.72 128.4 25.8 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 130.389 3.476 . . . . 1.55 105.021 -178.623 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -63.98 146.73 91.6 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 124.403 3.402 . . . . 1.02 115.839 177.183 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -73.71 -9.05 22.25 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 C-N-CA 124.356 3.37 . . . . 1.25 113.315 -171.268 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -87.86 -17.43 31.47 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 115.948 -2.301 . . . . 2.25 112.522 170.404 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -78.97 -25.21 43.48 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 120.179 1.354 . . . . 2.02 114.39 178.587 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -82.22 103.19 11.64 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.37 1.468 . . . . 0.69 113.131 -170.469 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 70' ' ' VAL . 93.9 mtt180 -90.89 118.33 30.2 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.934 -2.354 . . . . 2.78 112.677 170.553 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.409 HD12 HG23 ' A' ' 23' ' ' ILE . 76.9 mt -103.06 114.07 28.05 Favored 'General case' 0 N--CA 1.431 -1.392 1 CA-C-N 126.431 4.196 . . . . 1.17 113.698 -178.151 . . . . . . . . 3 3 . 1 . 121 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.8 mm -97.32 138.71 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 117.062 -1.447 . . . . 1.38 109.622 -177.13 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -157.35 129.46 7.2 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.596 -1.631 . . . . 1.5 106.596 176.251 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.06 9.12 2.91 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.181 1.792 . . . . 1.21 114.187 -174.483 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.57 -28.66 9.3 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 117.641 -1.644 . . . . 1.3 116.865 -176.092 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -96.47 153.8 17.63 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.417 2.377 . . . . 2.55 117.417 179.405 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -82.77 103.72 12.47 Favored 'General case' 0 N--CA 1.43 -1.433 1 C-N-CA 134.336 5.054 . . . . 2.48 112.911 178.017 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.9 mt -69.9 141.89 53.07 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.736 3.16 . . . . 0.9 115.219 -174.979 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.259 34.7 mt-10 -80.41 141.82 34.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.191 2.596 . . . . 1.94 114.381 176.831 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -53.03 -65.15 0.61 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 120.771 3.619 . . . . 1.56 120.771 -177.524 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.25 49.22 3.48 Favored Glycine 0 N--CA 1.43 -1.751 0 O-C-N 127.293 2.871 . . . . 0.97 111.807 178.799 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -118.86 147.63 43.75 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.544 -2.739 . . . . 2.49 104.825 168.873 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -79.66 173.4 12.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 117.125 -1.83 . . . . 0.76 115.16 175.74 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.2 mt -73.29 -20.5 60.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.612 -2.555 . . . . 1.05 111.89 172.048 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 t -70.04 -49.03 55.38 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.207 -2.808 . . . . 1.19 110.952 177.6 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -57.04 -36.38 70.42 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.764 1.626 . . . . 1.9 114.02 175.824 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -92.83 5.73 50.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.097 2.159 . . . . 0.89 115.336 177.671 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.447 26.4 m120 44.82 43.25 6.79 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.247 2.619 . . . . 1.84 117.842 -176.796 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.8 mt -81.71 128.27 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 104.914 -2.254 . . . . 0.82 104.914 -176.339 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.268 10.2 mt-30 -105.85 179.94 4.12 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 127.774 3.171 . . . . 2.16 111.505 -174.155 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.1 pttp -69.02 129.02 38.73 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 124.807 1.243 . . . . 2.12 112.42 170.168 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 87.24 10.02 0.16 Allowed 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 126.837 2.055 . . . . 1.71 111.611 177.4 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.6 t -85.07 134.83 34.19 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 114.534 -5.104 . . . . 1.04 111.601 -173.542 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.8 m -99.97 120.93 40.57 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 123.697 1.713 . . . . 0.79 110.615 -177.811 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.0 mt -95.84 169.5 9.96 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.619 -1.628 . . . . 1.4 111.354 172.175 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -126.52 110.71 13.56 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.567 -1.958 . . . . 1.51 113.634 -173.281 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.7 tp -87.37 112.23 21.91 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.203 -1.56 . . . . 1.14 108.783 -175.824 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 42' ' ' ARG . 49.4 t -107.46 131.36 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 129.519 3.128 . . . . 1.23 112.068 170.881 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.6 mt -109.09 176.06 5.23 Favored 'General case' 0 N--CA 1.431 -1.381 0 O-C-N 120.056 -1.653 . . . . 2.78 111.289 -176.886 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -140.2 176.99 8.3 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.433 -2.062 . . . . 3.75 105.433 -177.518 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.3 mt -103.86 159.87 15.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.764 -1.835 . . . . 3.14 113.523 167.069 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.274 25.9 ptt180 -92.93 148.05 22.33 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.18 -3.45 . . . . 6.8 114.673 176.512 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.47 -108.8 0.22 Allowed Glycine 0 N--CA 1.431 -1.639 0 C-N-CA 118.16 -1.971 . . . . 3.57 111.701 -169.008 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.75 0 O-C-N 120.044 -1.857 . . . . 3.87 109.273 175.184 . . . . . . . . 0 0 . 1 . 122 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 CA--C 1.491 -1.315 0 CA-C-O 118.85 -0.595 . . . . 1.1 110.761 . . . . . . . . . 0 0 . 1 . 122 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -97.25 118.96 34.86 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 113.633 0.975 . . . . 1.87 113.633 -169.553 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.8 pt -125.59 169.62 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 120.504 1.502 . . . . 0.72 112.725 172.404 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -120.87 154.02 36.39 Favored 'General case' 0 N--CA 1.431 -1.407 1 O-C-N 114.913 -4.867 . . . . 1.4 110.628 -178.211 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.3 t -125.39 135.25 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 103.237 -2.875 . . . . 0.58 103.237 172.901 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -114.22 143.38 44.92 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.837 -3.039 . . . . 2.09 107.579 176.803 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -96.75 170.08 9.43 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.414 1.486 . . . . 0.99 114.566 176.552 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.3 mt -55.7 -45.53 77.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.554 -2.591 . . . . 2.53 110.246 174.355 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 p -73.64 -57.46 3.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 116.66 -1.638 . . . . 2.08 111.936 -177.001 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.11 19.25 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.7 0 CA-C-O 125.549 2.75 . . . . 1.31 117.485 179.156 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -102.99 122.33 44.39 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 111.659 -2.27 . . . . 1.4 109.004 -168.707 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.0 m -95.6 124.62 39.71 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.395 2.521 . . . . 0.78 110.96 177.305 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 mm -100.44 129.7 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 115.034 -2.412 . . . . 1.55 106.824 -179.097 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.4 m -89.72 104.84 17.36 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 124.133 3.152 . . . . 1.08 108.319 179.49 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.4 mt -108.73 146.52 33.39 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 125.455 3.752 . . . . 1.55 120.975 -178.845 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -98.33 131.83 44.31 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 114.245 -1.343 . . . . 1.95 109.44 169.682 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.7 m -144.5 162.47 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 1 C-N-CA 132.127 4.171 . . . . 0.96 108.214 177.831 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -114.13 150.8 44.22 Favored Pre-proline 0 N--CA 1.429 -1.477 0 C-N-CA 126.487 1.915 . . . . 2.35 108.452 166.428 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -62.47 -21.92 73.38 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-O 125.182 2.076 . . . . 0.95 114.59 -168.104 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.8 p -83.26 0.1 47.1 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.273 3.429 . . . . 1.45 111.193 178.923 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -79.99 151.97 29.71 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 115.974 -4.204 . . . . 1.69 105.473 172.525 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 35.0 p -93.57 173.48 7.67 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 112.721 -2.036 . . . . 0.75 113.372 177.865 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 42.2 mm -72.05 -33.13 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 O-C-N 120.542 -1.349 . . . . 0.73 108.276 -179.076 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -55.45 -44.96 76.85 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 125.516 2.579 . . . . 1.62 115.806 167.004 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 -60.09 -42.47 94.69 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 116.075 -4.141 . . . . 2.13 112.595 176.488 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.9 t -69.78 -42.04 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 C-N-CA 129.485 3.114 . . . . 0.62 109.737 172.152 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -64.85 -37.44 87.65 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 125.825 3.92 . . . . 1.22 112.267 -178.668 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.5 -31.59 56.29 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 119.926 3.306 . . . . 0.51 119.926 169.739 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.265 15.9 tppt? -80.15 -35.04 37.16 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 121.543 0.687 . . . . 1.44 111.977 174.087 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.8 mt -60.81 -42.49 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.371 -1.455 . . . . 1.32 114.289 171.215 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -56.11 -39.5 72.27 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.878 2.871 . . . . 1.7 111.622 173.845 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -70.57 -45.47 65.35 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 124.71 1.256 . . . . 1.55 113.718 176.698 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -70.67 -51.69 26.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 115.04 1.496 . . . . 2.62 115.04 -176.643 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -104.48 -14.14 15.8 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.682 1.993 . . . . 1.48 113.903 -168.66 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.21 49.23 34.22 Favored Glycine 0 N--CA 1.431 -1.648 0 O-C-N 118.238 -2.789 . . . . 1.12 112.987 175.438 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.407 ' CD1' HD21 ' A' ' 69' ' ' LEU . 56.9 mt -125.25 126.38 25.14 Favored Pre-proline 0 N--CA 1.429 -1.478 0 N-CA-C 105.047 -2.205 . . . . 1.55 105.047 178.735 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -66.84 150.29 83.24 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 125.237 3.958 . . . . 1.02 111.79 179.983 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -60.08 -31.51 93.47 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 C-N-CA 125.169 3.913 . . . . 1.25 114.721 -173.689 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -56.96 -41.4 78.27 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 130.33 3.452 . . . . 2.25 110.096 176.285 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -89.19 2.72 53.8 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.601 -1.312 . . . . 2.02 113.714 -178.307 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -90.01 116.51 28.1 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.429 2.692 . . . . 0.69 116.678 -173.697 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -111.96 109.03 18.58 Favored 'General case' 0 N--CA 1.429 -1.5 1 O-C-N 115.623 -4.423 . . . . 2.78 111.777 169.2 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 43' ' ' LEU . 51.8 mt -89.4 122.04 32.23 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.943 -1.723 . . . . 1.17 108.537 -178.879 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.3 mm -111.47 123.43 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 126.941 3.258 . . . . 1.38 111.474 177.316 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.276 69.6 t80 -132.31 134.7 45.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 116.531 -3.856 . . . . 1.5 104.533 173.104 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.99 28.22 0.59 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 119.77 3.248 . . . . 1.21 119.77 -177.62 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.8 -12.1 69.83 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 126.033 1.778 . . . . 1.3 111.598 -177.757 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -86.59 145.04 26.91 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.621 -1.517 . . . . 2.55 114.396 -179.347 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -87.09 109.76 19.64 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.033 -2.292 . . . . 2.48 109.615 171.893 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.7 mt -71.16 133.14 45.96 Favored 'General case' 0 N--CA 1.431 -1.423 1 CA-C-O 128.778 4.132 . . . . 0.9 109.303 -170.017 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -89.94 135.69 33.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.363 -3.961 . . . . 1.94 118.123 -179.791 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.407 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 9.0 m-20 -55.05 -54.22 45.83 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 116.864 -3.648 . . . . 1.56 119.332 -168.492 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.55 23.27 16.74 Favored Glycine 0 N--CA 1.429 -1.785 0 CA-C-O 118.424 -1.209 . . . . 0.97 112.026 177.298 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.4 mtt-85 -104.27 161.56 13.94 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 121.679 2.74 . . . . 2.49 108.624 165.981 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.1 p -97.89 156.63 16.51 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.557 2.743 . . . . 0.76 112.993 178.005 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.3 mt -58.86 -32.48 69.48 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.243 2.449 . . . . 1.05 114.878 179.712 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.5 p -69.03 -26.65 65.1 Favored 'General case' 0 N--CA 1.429 -1.52 0 O-C-N 116.627 -3.795 . . . . 1.19 117.558 176.376 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -68.61 -37.18 79.58 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.53 -1.981 . . . . 1.9 110.628 174.974 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -82.0 -13.57 57.21 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 115.262 -2.304 . . . . 0.89 106.779 -178.403 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.3 m120 65.82 56.44 0.89 Allowed 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 126.295 2.247 . . . . 1.84 108.437 -177.174 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.8 mt -99.32 136.17 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 103.922 -2.622 . . . . 0.82 103.922 179.545 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -109.69 178.16 4.51 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 126.318 2.961 . . . . 2.16 109.932 -178.799 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -60.8 152.32 27.38 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 112.4 -2.182 . . . . 2.12 116.212 167.778 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.277 53.4 mt-10 67.04 11.99 8.71 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 114.937 1.458 . . . . 1.71 114.937 -177.899 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -89.16 150.0 22.89 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.067 2.365 . . . . 1.04 109.485 -175.883 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.1 m -104.38 120.28 40.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.175 -1.578 . . . . 0.79 111.757 -176.918 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.3 mt -89.51 135.7 33.45 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.695 -1.878 . . . . 1.4 112.399 172.988 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -105.53 122.5 46.13 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.581 -2.574 . . . . 1.51 104.998 -174.792 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.407 HD21 ' CD1' ' A' ' 36' ' ' ILE . 60.0 tp -93.63 108.51 20.22 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.445 2.298 . . . . 1.14 110.803 -177.084 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.278 28.8 t -98.88 140.29 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 128.179 3.847 . . . . 1.23 105.07 173.216 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.0 mt -87.72 134.23 33.7 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 118.621 -2.55 . . . . 2.78 106.756 170.643 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -90.41 117.07 28.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.369 1.868 . . . . 3.75 110.692 178.347 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.0 mt -95.17 112.2 23.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 127.059 2.725 . . . . 3.14 107.855 173.769 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.319 13.7 ptm180 -63.89 161.27 15.88 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 117.568 2.432 . . . . 6.8 117.568 177.023 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -143.29 35.28 1.67 Allowed Glycine 0 N--CA 1.43 -1.731 0 CA-C-O 118.156 -1.358 . . . . 3.57 110.508 -170.482 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.754 0 CA-C-O 123.966 1.87 . . . . 3.87 111.868 -175.09 . . . . . . . . 0 0 . 1 . 123 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.4 ttp . . . . . 0 CA--C 1.489 -1.388 0 CA-C-O 117.375 -1.298 . . . . 1.1 109.681 . . . . . . . . . 0 0 . 1 . 123 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -87.8 133.05 33.95 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 120.314 1.415 . . . . 1.87 114.681 -178.704 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pt -138.98 164.54 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 118.582 -2.574 . . . . 0.72 109.332 174.443 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -113.21 146.71 38.84 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 127.053 2.141 . . . . 1.4 110.852 -177.397 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.1 t -126.98 105.61 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 105.886 -1.894 . . . . 0.58 105.886 175.076 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -84.03 120.96 26.76 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 131.631 3.972 . . . . 2.09 115.293 173.761 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.2 p -104.41 -121.96 0.21 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.677 1.362 . . . . 0.99 114.677 -174.163 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.0 tp -159.98 -63.53 0.07 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 103.284 -2.858 . . . . 2.53 103.284 173.585 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.5 p -97.14 93.94 6.84 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 120.418 1.463 . . . . 2.08 111.901 -178.215 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.49 -146.93 17.63 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 127.842 2.639 . . . . 1.31 110.415 176.96 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -90.88 168.33 11.78 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 122.545 1.164 . . . . 1.4 112.154 -174.853 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -102.61 116.91 33.54 Favored 'General case' 0 N--CA 1.431 -1.383 1 N-CA-C 99.382 -4.303 . . . . 0.78 99.382 175.65 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.28 16.4 pt -84.33 152.17 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 128.097 2.559 . . . . 1.55 112.578 178.159 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 m -116.77 128.67 55.52 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 128.345 2.658 . . . . 1.08 106.263 176.617 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.6 mt -122.06 157.43 31.43 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.393 -2.692 . . . . 1.55 108.447 179.663 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -107.65 120.88 43.45 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.019 -2.301 . . . . 1.95 104.983 170.996 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.1 m -131.03 172.55 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 125.435 1.494 . . . . 0.96 109.806 -175.263 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -112.94 152.7 45.1 Favored Pre-proline 0 N--CA 1.43 -1.441 0 CA-C-O 116.304 -1.808 . . . . 2.35 111.136 164.911 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.76 -22.32 32.26 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 126.335 3.298 . . . . 0.95 114.118 -176.345 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.0 m -72.45 -12.88 61.28 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 116.137 -1.887 . . . . 1.45 110.251 176.073 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -66.08 135.54 54.76 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 123.4 2.818 . . . . 1.69 117.842 177.276 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.5 p -69.83 160.91 30.89 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 117.547 -3.221 . . . . 0.75 112.873 176.795 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 mm -66.58 -42.28 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 128.025 2.53 . . . . 0.73 108.279 175.366 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -45.93 -49.62 15.52 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.084 2.624 . . . . 1.62 118.084 161.275 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -68.31 -45.53 72.72 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 127.547 3.029 . . . . 2.13 111.447 178.997 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.453 HG21 HD11 ' A' ' 56' ' ' LEU . 58.5 t -59.02 -30.1 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 115.209 1.559 . . . . 0.62 115.209 173.936 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -68.38 -35.56 77.88 Favored 'General case' 0 N--CA 1.43 -1.475 1 O-C-N 113.871 -5.518 . . . . 1.22 111.671 169.657 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.2 -46.76 82.6 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 124.106 1.908 . . . . 0.51 115.506 169.6 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -47.98 -49.84 29.41 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 127.0 2.12 . . . . 1.44 109.046 169.727 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.2 mt -62.63 -30.34 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 123.653 2.933 . . . . 1.32 116.856 175.462 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -68.48 -34.64 76.29 Favored 'General case' 0 N--CA 1.431 -1.414 1 CA-C-O 128.821 4.153 . . . . 1.7 114.52 -174.181 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -61.74 -41.41 97.62 Favored 'General case' 0 N--CA 1.432 -1.369 2 O-C-N 115.043 -4.786 . . . . 1.55 112.178 172.286 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -91.74 -65.65 0.99 Allowed 'General case' 0 N--CA 1.429 -1.495 1 O-C-N 115.556 -4.465 . . . . 2.62 107.467 -172.801 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -88.36 -17.77 29.85 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 126.111 2.862 . . . . 1.48 116.158 -165.241 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.75 34.31 28.12 Favored Glycine 0 N--CA 1.43 -1.747 0 O-C-N 117.648 -3.158 . . . . 1.12 116.248 176.629 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.8 mt -107.85 121.92 42.49 Favored Pre-proline 0 N--CA 1.429 -1.492 0 N-CA-C 107.011 -1.477 . . . . 1.55 107.011 -178.354 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.288 52.8 Cg_exo -51.36 146.8 23.54 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-O 113.875 -2.635 . . . . 1.02 116.357 175.78 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -68.67 -23.1 36.68 Favored 'Trans proline' 0 C--N 1.299 -2.058 1 C-N-CA 125.761 4.307 . . . . 1.25 110.249 -175.623 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -84.44 -18.48 35.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.555 2.428 . . . . 2.25 117.555 176.573 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -88.34 -24.15 23.21 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 115.465 1.654 . . . . 2.02 115.465 -177.59 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -100.57 139.25 36.52 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.568 1.547 . . . . 0.69 112.528 -177.201 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -118.4 133.14 56.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 107.89 -1.152 . . . . 2.78 107.89 175.172 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.6 mt -99.5 127.0 45.54 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.733 1.606 . . . . 1.17 114.762 -179.441 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.0 mm -107.86 138.41 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 1 O-C-N 130.357 4.786 . . . . 1.38 107.121 -177.09 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -145.72 140.05 26.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.441 -3.912 . . . . 1.5 102.274 171.552 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.301 . . 62.5 -96.13 0.05 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.604 1.561 . . . . 1.21 109.079 -174.66 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.61 24.59 1.2 Allowed Glycine 0 N--CA 1.429 -1.817 0 O-C-N 127.744 3.153 . . . . 1.3 110.217 -179.291 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -121.34 147.87 45.11 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.2 1.8 . . . . 2.55 107.793 -177.37 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -95.98 130.97 42.82 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.897 -1.956 . . . . 2.48 107.58 173.306 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mt -96.15 124.79 40.29 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.805 3.261 . . . . 0.9 119.805 -172.813 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -66.14 132.75 49.2 Favored 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 132.549 4.34 . . . . 1.94 114.024 177.429 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -63.64 -32.87 74.48 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.297 -3.377 . . . . 1.56 114.737 -169.239 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.84 25.71 7.28 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 116.374 -3.953 . . . . 0.97 115.362 173.662 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -121.47 168.28 11.88 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 120.766 2.283 . . . . 2.49 111.134 173.614 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.7 p -104.83 154.6 19.83 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.185 1.469 . . . . 0.76 111.262 -178.39 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.453 HD11 HG21 ' A' ' 26' ' ' VAL . 24.8 mt -51.48 -37.96 51.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.046 1.879 . . . . 1.05 113.268 173.444 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -59.16 -50.1 75.33 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.48 -3.263 . . . . 1.19 117.057 171.391 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -43.04 -47.72 5.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.986 -3.571 . . . . 1.9 113.882 168.046 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -77.97 -13.61 59.82 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 117.762 2.504 . . . . 0.89 117.762 177.415 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.5 m120 69.08 63.9 0.29 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.631 1.972 . . . . 1.84 112.723 178.523 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.4 mt -98.33 137.1 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 117.43 -3.293 . . . . 0.82 106.837 176.22 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -117.58 -179.47 3.74 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 106.32 -1.733 . . . . 2.16 106.32 -174.659 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -71.3 140.45 50.31 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 126.77 2.544 . . . . 2.12 115.363 176.712 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 22.9 mt-10 70.83 46.53 0.49 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 126.133 2.873 . . . . 1.71 114.099 177.308 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.3 m -109.42 135.46 50.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 112.076 -2.329 . . . . 1.04 113.298 -173.643 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.3 m -92.47 99.81 12.48 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.788 -3.07 . . . . 0.79 112.392 -173.985 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mp -81.95 146.35 29.82 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.168 -1.79 . . . . 1.4 106.168 176.344 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -107.91 138.44 44.16 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.934 -1.506 . . . . 1.51 106.934 -175.363 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 tt -106.56 122.07 45.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 119.983 1.265 . . . . 1.14 111.435 -177.606 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.6 m -107.84 122.45 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 104.922 -2.251 . . . . 1.23 104.922 175.5 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.8 tp -100.42 127.15 46.84 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.707 2.803 . . . . 2.78 116.863 -173.385 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -82.19 118.45 23.1 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.596 -2.565 . . . . 3.75 110.925 -179.564 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.1 mt -105.84 -51.3 3.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 126.328 2.267 . . . . 3.14 105.392 178.974 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.6 mtt85 -106.74 -72.8 0.71 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.275 -2.861 . . . . 6.8 103.275 173.782 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.85 151.9 5.58 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-O 125.577 2.765 . . . . 3.57 111.048 -169.324 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.815 0 O-C-N 117.356 -3.438 . . . . 3.87 109.423 -177.444 . . . . . . . . 0 0 . 1 . 124 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.3 ttp . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 117.391 2.367 . . . . 1.1 117.391 . . . . . . . . . 0 0 . 1 . 124 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -109.58 113.48 26.3 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.492 1.293 . . . . 1.87 114.492 -173.499 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.51 HD12 HD13 ' A' ' 67' ' ' LEU . 20.3 pt -111.41 171.15 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 119.597 -1.94 . . . . 0.72 110.062 174.246 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -124.65 122.67 38.17 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.869 2.068 . . . . 1.4 108.07 -176.617 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.507 HG22 ' HB2' ' A' ' 67' ' ' LEU . 45.6 t -104.41 114.17 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 118.549 -2.594 . . . . 0.58 110.091 171.169 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -93.37 158.22 15.84 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.06 -3.525 . . . . 2.09 108.909 178.063 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.9 p -119.27 172.91 7.27 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.533 -3.23 . . . . 0.99 114.369 -178.945 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.2 tp -72.55 -47.3 49.3 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.572 1.653 . . . . 2.53 110.97 178.647 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.9 p -73.65 -30.67 63.07 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.479 -1.388 . . . . 2.08 113.271 -176.398 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.07 2.07 0.65 Allowed Glycine 0 N--CA 1.43 -1.724 0 O-C-N 117.021 -3.55 . . . . 1.31 117.203 176.995 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -91.28 149.84 21.58 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 122.667 3.234 . . . . 1.4 108.57 -179.664 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.2 m -134.95 112.8 10.92 Favored 'General case' 0 N--CA 1.431 -1.398 1 N-CA-C 100.138 -4.023 . . . . 0.78 100.138 -179.806 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 mt -106.31 113.35 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 129.741 3.217 . . . . 1.55 114.231 -171.682 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.6 m -74.75 114.98 13.81 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.662 -2.524 . . . . 1.08 115.542 173.445 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.1 mt -113.66 129.11 56.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.515 1.507 . . . . 1.55 109.088 -176.791 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -97.72 113.86 25.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.618 -1.301 . . . . 1.95 111.714 174.704 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -116.5 166.62 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 126.395 2.309 . . . . 0.96 110.569 -170.599 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -112.19 155.34 43.66 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 113.252 -3.261 . . . . 2.35 105.69 164.641 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.9 -21.73 63.81 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 CA-C-N 124.207 2.538 . . . . 0.95 117.433 -175.957 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.5 p -73.89 -17.31 61.06 Favored 'General case' 0 N--CA 1.431 -1.41 1 C-N-CA 134.307 5.043 . . . . 1.45 118.927 173.024 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -69.14 143.47 54.11 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 125.475 2.56 . . . . 1.69 109.301 174.083 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 3.3 p -94.74 164.12 13.07 Favored 'General case' 0 N--CA 1.431 -1.408 1 O-C-N 116.197 -4.064 . . . . 0.75 105.154 -177.43 . . . . . . . . 3 3 . 1 . 124 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.1 mm -56.27 -42.91 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 126.666 2.479 . . . . 0.73 111.605 176.651 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -46.77 -50.55 18.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 116.213 1.931 . . . . 1.62 116.213 164.559 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -74.02 -24.97 59.63 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 121.919 2.145 . . . . 2.13 111.166 178.45 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.2 t -74.06 -33.27 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 116.867 -3.646 . . . . 0.62 111.322 176.44 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -71.16 -28.84 64.55 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.347 -3.971 . . . . 1.22 109.231 172.366 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.57 -28.13 69.66 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 115.914 -4.241 . . . . 0.51 117.377 168.192 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -74.16 -30.87 62.47 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 122.593 2.452 . . . . 1.44 109.021 -178.134 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.0 mt -67.69 -35.71 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 O-C-N 127.216 2.822 . . . . 1.32 114.813 172.284 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -73.33 -15.8 61.38 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 118.993 2.96 . . . . 1.7 118.993 178.157 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -69.07 -43.0 75.48 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.436 1.273 . . . . 1.55 114.436 162.721 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -73.06 -61.07 1.94 Allowed 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 126.893 3.235 . . . . 2.62 112.348 -175.405 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -100.15 -30.34 11.99 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.133 -2.854 . . . . 1.48 110.16 -164.564 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.43 33.11 7.75 Favored Glycine 0 N--CA 1.431 -1.674 0 O-C-N 128.116 3.385 . . . . 1.12 115.729 173.239 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.3 mt -106.05 129.21 24.93 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 116.566 -1.683 . . . . 1.55 107.291 -177.975 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -62.82 142.65 89.57 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 124.405 3.404 . . . . 1.02 119.747 175.98 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.28 -17.65 35.07 Favored 'Trans proline' 0 C--N 1.299 -2.057 0 N-CA-C 118.445 2.441 . . . . 1.25 118.445 -178.111 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -68.15 -24.87 65.04 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.72 -1.237 . . . . 2.25 113.728 173.144 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -93.69 -18.11 22.48 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.746 1.736 . . . . 2.02 111.184 -179.493 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -95.02 154.15 17.3 Favored 'General case' 0 N--CA 1.431 -1.378 0 O-C-N 118.419 -2.676 . . . . 0.69 110.82 -176.264 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -141.32 151.35 43.53 Favored 'General case' 0 N--CA 1.43 -1.465 1 C-N-CA 133.284 4.633 . . . . 2.78 113.257 171.136 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.5 mt -115.99 132.61 56.6 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.211 -2.806 . . . . 1.17 111.035 177.404 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.1 mt -109.73 123.1 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.354 -1.35 . . . . 1.38 107.354 -178.529 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -145.72 140.92 27.57 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.382 -2.699 . . . . 1.5 103.976 175.712 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.85 14.21 7.99 Favored 'General case' 0 N--CA 1.43 -1.434 1 C-N-CA 131.717 4.007 . . . . 1.21 114.53 -176.555 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.95 -30.39 10.52 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 125.74 1.638 . . . . 1.3 115.441 -171.796 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -101.25 156.16 17.6 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 120.73 2.265 . . . . 2.55 115.422 -177.974 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -72.29 135.62 46.02 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 116.897 -1.525 . . . . 2.48 113.416 167.797 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.6 mt -89.05 145.57 25.39 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.102 2.228 . . . . 0.9 112.716 -176.119 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -72.55 139.24 47.4 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.203 -2.186 . . . . 1.94 111.549 173.418 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -66.99 -56.25 10.96 Favored 'General case' 0 N--CA 1.431 -1.409 1 C-N-CA 131.826 4.05 . . . . 1.56 119.49 -168.519 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.6 37.14 2.78 Favored Glycine 0 N--CA 1.43 -1.757 0 O-C-N 117.936 -2.977 . . . . 0.97 116.775 175.564 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -114.13 160.49 18.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.866 -2.549 . . . . 2.49 108.576 171.266 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 22' ' ' THR 0.452 54.7 p -87.49 146.27 25.89 Favored 'General case' 0 N--CA 1.43 -1.47 1 C-N-CA 132.103 4.161 . . . . 0.76 111.571 179.711 . . . . . . . . 4 3 . 1 . 124 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mt -55.46 -34.87 64.9 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 114.694 1.368 . . . . 1.05 114.694 172.026 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 p -64.11 -33.81 76.62 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.238 3.015 . . . . 1.19 112.975 178.567 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -66.62 -37.12 84.19 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 125.047 1.339 . . . . 1.9 113.74 178.226 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -85.92 -5.13 59.28 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.06 1.344 . . . . 0.89 110.038 175.152 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.4 t30 60.74 38.45 18.25 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 127.053 3.311 . . . . 1.84 116.257 179.139 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.0 mt -74.82 125.24 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 O-C-N 116.892 -3.63 . . . . 0.82 109.611 -177.405 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -99.19 -175.84 3.14 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.217 -2.802 . . . . 2.16 111.854 -176.982 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -70.68 160.67 32.18 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 124.116 1.912 . . . . 2.12 111.233 177.165 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.384 16.4 mt-10 44.83 48.54 9.1 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 118.133 2.642 . . . . 1.71 118.133 179.626 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.6 m -107.28 144.05 34.66 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 127.34 2.9 . . . . 1.04 106.028 -175.941 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.6 m -108.75 103.81 12.96 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.586 -1.188 . . . . 0.79 108.118 -178.205 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.51 HD13 HD12 ' A' ' 3' ' ' ILE . 4.1 mp -87.62 158.51 18.85 Favored 'General case' 0 N--CA 1.429 -1.475 1 C-N-CA 132.52 4.328 . . . . 1.4 106.377 173.339 . . . . . . . . 3 3 . 1 . 124 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -121.28 142.89 49.51 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 102.079 -3.304 . . . . 1.51 102.079 -174.085 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.5 tp -97.99 129.35 44.87 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 114.669 -2.586 . . . . 1.14 108.975 -179.784 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 m -129.72 168.05 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 121.642 2.019 . . . . 1.23 106.632 171.092 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.9 mt -112.49 143.9 42.85 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.384 -2.073 . . . . 2.78 106.772 -177.147 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -102.96 94.82 5.77 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.489 -0.778 . . . . 3.75 109.666 177.175 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.56 -176.83 3.19 Favored 'General case' 0 N--CA 1.43 -1.437 1 C-N-CA 134.083 4.953 . . . . 3.14 110.438 174.071 . . . . . . . . 3 3 . 1 . 124 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.8 mtm105 -81.02 132.63 35.38 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.596 2.617 . . . . 6.8 110.375 166.345 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.53 -133.72 11.46 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 119.287 -2.133 . . . . 3.57 115.036 -161.391 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.743 1 CA-C-O 112.132 -4.705 . . . . 3.87 113.841 -174.715 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptt? . . . . . 0 CA--C 1.489 -1.389 0 N-CA-C 108.363 -0.977 . . . . 1.1 108.363 . . . . . . . . . 0 0 . 1 . 125 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -102.39 131.58 48.94 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.009 2.124 . . . . 1.87 112.365 -172.147 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.1 pt -139.07 157.17 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-O 125.606 2.622 . . . . 0.72 106.625 176.651 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -109.01 121.7 45.69 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.834 -2.416 . . . . 1.4 112.764 -176.954 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.1 t -96.85 103.42 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 116.854 -3.654 . . . . 0.58 107.166 175.073 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -76.43 136.43 39.44 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 118.567 2.803 . . . . 2.09 118.567 168.272 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -83.33 169.96 15.08 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 116.065 -4.147 . . . . 0.99 109.847 177.622 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.512 HD11 HG13 ' A' ' 70' ' ' VAL . 19.2 mt -60.71 -42.64 97.64 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.419 -2.676 . . . . 2.53 115.455 170.324 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -75.44 -51.2 13.61 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 127.145 2.778 . . . . 2.08 116.148 -176.706 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.21 -44.84 0.19 Allowed Glycine 0 N--CA 1.431 -1.695 0 CA-C-O 113.956 -3.691 . . . . 1.31 114.161 -177.845 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -53.51 136.18 38.7 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 122.62 3.21 . . . . 1.4 118.625 -177.445 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.266 88.5 m -107.72 98.7 8.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.79 1.757 . . . . 0.78 107.818 178.4 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -80.72 98.64 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 125.695 2.664 . . . . 1.55 110.195 177.231 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.5 m -82.12 122.85 28.38 Favored 'General case' 0 N--CA 1.429 -1.498 1 O-C-N 115.153 -4.717 . . . . 1.08 110.722 178.269 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.5 mt -122.28 144.32 49.07 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.175 1.917 . . . . 1.55 116.175 -178.494 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -103.86 124.83 49.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 116.42 -2.112 . . . . 1.95 108.749 174.905 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.8 m -140.98 165.08 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.041 -1.662 . . . . 0.96 108.094 -171.122 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.293 4.6 mm-40 -102.75 150.19 37.49 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-O 114.538 -2.649 . . . . 2.35 110.518 163.578 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.41 ' HB2' ' HB2' ' A' ' 57' ' ' SER . 33.3 Cg_endo -75.96 -14.9 18.95 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 125.877 3.135 . . . . 0.95 109.12 -171.963 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.1 p -81.18 -1.31 44.16 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 123.836 1.779 . . . . 1.45 114.129 174.202 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -75.02 147.92 40.31 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 118.315 -2.74 . . . . 1.69 113.021 172.309 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.649 ' O ' HG23 ' A' ' 26' ' ' VAL . 41.0 p -85.82 176.42 8.12 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 124.287 1.994 . . . . 0.75 112.894 -175.349 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.252 20.8 mm -76.85 -37.23 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 116.345 -3.972 . . . . 0.73 106.278 177.832 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -53.33 -36.36 61.2 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.282 -3.386 . . . . 1.62 112.027 169.027 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -74.83 -46.08 38.96 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 120.629 1.559 . . . . 2.13 112.281 177.365 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 22' ' ' THR . 26.1 t -57.3 -43.26 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 C-N-CA 128.829 2.852 . . . . 0.62 112.02 175.538 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -70.26 -34.26 72.6 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.661 2.467 . . . . 1.22 117.661 171.509 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.94 89.29 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.598 -1.939 . . . . 0.51 106.855 178.057 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -57.97 -41.52 83.1 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 119.292 3.071 . . . . 1.44 119.292 167.567 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.268 65.3 mt -63.22 -35.91 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.242 -2.786 . . . . 1.32 113.66 170.635 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -61.37 -41.26 96.81 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 130.747 3.619 . . . . 1.7 109.389 172.074 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -58.15 -57.53 12.45 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 114.45 1.278 . . . . 1.55 114.45 177.195 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -73.13 -63.59 1.15 Allowed 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 117.731 2.493 . . . . 2.62 117.731 -174.284 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -101.35 -19.06 15.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.071 -1.643 . . . . 1.48 111.566 -168.529 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.76 30.3 6.88 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 118.215 2.046 . . . . 1.12 118.215 173.696 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.9 mt -106.15 119.2 52.86 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-N 121.35 2.575 . . . . 1.55 109.104 -176.018 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -56.28 145.89 75.19 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 CA-C-N 127.263 3.629 . . . . 1.02 114.363 174.946 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -82.72 -5.31 11.56 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 124.499 3.466 . . . . 1.25 108.493 -166.214 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -80.93 -23.74 38.67 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.516 1.507 . . . . 2.25 111.384 176.389 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -90.07 -12.75 37.56 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.051 -2.281 . . . . 2.02 111.657 -178.192 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -87.21 123.49 32.28 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 130.167 3.387 . . . . 0.69 111.647 -174.682 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -123.47 114.13 19.69 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-O 125.107 2.384 . . . . 2.78 109.472 161.777 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.9 mt -87.18 138.6 31.35 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 124.346 2.022 . . . . 1.17 106.486 -178.553 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.6 mt -135.37 128.54 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 128.006 2.523 . . . . 1.38 110.209 -178.54 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -127.17 115.32 18.92 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 115.291 -4.631 . . . . 1.5 104.603 177.931 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 73.15 -58.52 0.6 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.729 2.812 . . . . 1.21 110.605 177.082 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.412 ' H ' ' H ' ' A' ' 48' ' ' LYS . . . -162.66 -13.73 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 O-C-N 120.502 -1.374 . . . . 1.3 111.849 -178.365 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.412 ' H ' ' H ' ' A' ' 47' ' ' GLY . 48.4 mttt -98.62 134.0 42.17 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.127 -1.536 . . . . 2.55 109.502 -177.163 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -73.27 140.61 46.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.838 2.055 . . . . 2.48 108.856 166.828 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.0 mt -97.56 123.28 41.39 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.204 -1.776 . . . . 0.9 106.204 -170.853 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -91.46 145.68 24.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.747 -2.471 . . . . 1.94 110.26 178.955 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -43.26 -57.59 2.92 Favored 'General case' 0 N--CA 1.43 -1.439 1 C-N-CA 131.993 4.117 . . . . 1.56 119.818 -175.757 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.15 7.29 8.13 Favored Glycine 0 N--CA 1.43 -1.728 1 N-CA-C 123.149 4.02 . . . . 0.97 123.149 168.524 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -98.23 167.07 11.09 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 120.656 2.228 . . . . 2.49 112.158 167.738 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.341 18.6 p -109.81 166.61 10.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.828 2.159 . . . . 0.76 116.828 -179.137 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.6 mt -61.98 -35.36 78.28 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.029 2.347 . . . . 1.05 111.62 172.21 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 5.8 t -75.84 -33.03 60.02 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.601 -2.562 . . . . 1.19 113.477 -179.997 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -56.42 -46.4 80.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.834 2.054 . . . . 1.9 114.116 166.248 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -84.77 -9.22 58.4 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 121.817 2.099 . . . . 0.89 112.756 -179.617 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.522 12.8 m120 81.68 46.52 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 125.867 1.667 . . . . 1.84 113.591 175.403 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.1 mt -96.8 118.81 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 113.495 -1.684 . . . . 0.82 114.012 179.931 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -115.1 -179.02 3.51 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 106.319 -1.734 . . . . 2.16 106.319 -174.964 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -62.05 151.87 34.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 127.801 2.441 . . . . 2.12 114.405 -178.675 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 66.2 29.55 9.66 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.797 2.237 . . . . 1.71 110.746 177.495 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.6 p -106.71 150.95 25.75 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 113.982 -5.449 . . . . 1.04 109.298 -176.158 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.4 m -103.14 122.18 44.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.329 2.49 . . . . 0.79 109.668 179.713 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -110.57 145.21 38.22 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 118.615 -2.553 . . . . 1.4 105.539 176.559 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -100.67 136.12 41.03 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 118.58 -2.575 . . . . 1.51 107.189 179.859 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.5 tp -113.96 123.96 50.99 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.961 -1.712 . . . . 1.14 108.21 174.691 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.512 HG13 HD11 ' A' ' 8' ' ' LEU . 48.8 t -105.85 134.51 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 103.083 -2.932 . . . . 1.23 103.083 176.04 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.8 tp -96.05 143.17 27.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.339 2.495 . . . . 2.78 111.985 174.825 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -117.05 148.7 41.27 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.348 -3.345 . . . . 3.75 105.781 174.839 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.463 4.6 mt -77.38 127.72 33.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 121.095 -0.242 . . . . 3.14 110.68 173.548 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.407 30.1 ttm180 -129.87 -73.93 0.56 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 123.169 0.587 . . . . 6.8 111.602 163.442 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.95 20.75 1.43 Allowed Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 120.208 2.843 . . . . 3.57 120.208 -166.305 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.728 1 O-C-N 116.176 -4.132 . . . . 3.87 108.317 177.04 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.4 ttp . . . . . 0 CA--C 1.49 -1.335 0 CA-C-O 117.396 -1.288 . . . . 1.1 110.935 . . . . . . . . . 0 0 . 1 . 126 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -81.34 133.1 35.37 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 120.405 1.457 . . . . 1.87 111.21 -179.136 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 pt -140.25 162.73 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 123.981 1.848 . . . . 0.72 108.072 173.565 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -120.66 133.31 55.37 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 102.226 -3.25 . . . . 1.4 102.226 -177.148 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.0 t -109.48 123.83 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 127.994 2.517 . . . . 0.58 104.831 167.829 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -101.06 124.16 46.34 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.787 -1.821 . . . . 2.09 111.43 176.74 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.423 HG22 HD23 ' A' ' 69' ' ' LEU . 1.3 p -85.84 151.81 23.5 Favored 'General case' 0 N--CA 1.431 -1.41 1 O-C-N 115.448 -4.533 . . . . 0.99 114.041 175.032 . . . . . . . . 3 3 . 1 . 126 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.5 tp -34.56 -54.1 0.54 Allowed 'General case' 0 N--CA 1.43 -1.434 1 C-N-CA 133.018 4.527 . . . . 2.53 115.404 169.83 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.4 p -81.88 -31.78 31.32 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 125.872 1.982 . . . . 2.08 110.644 -170.93 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.78 17.28 0.11 Allowed Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 118.444 -1.836 . . . . 1.31 117.048 178.862 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -114.79 141.91 47.23 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 115.68 -4.423 . . . . 1.4 105.404 -177.685 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.5 m -105.77 124.79 50.13 Favored 'General case' 0 N--CA 1.429 -1.522 0 O-C-N 123.358 0.411 . . . . 0.78 109.944 173.473 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.402 HD13 HG23 ' A' ' 30' ' ' ILE . 2.4 mt -93.46 116.09 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 125.577 2.608 . . . . 1.55 105.933 179.889 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.2 m -92.26 102.45 14.95 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 115.507 -4.495 . . . . 1.08 107.323 174.72 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.5 mt -90.96 160.21 15.77 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.526 -1.359 . . . . 1.55 110.54 178.616 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -125.3 114.06 18.41 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 119.854 -1.779 . . . . 1.95 108.008 165.715 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.01 -176.2 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 119.205 -2.185 . . . . 0.96 110.382 -173.318 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -107.08 149.12 38.22 Favored Pre-proline 0 N--CA 1.43 -1.432 0 CA-C-O 114.096 -2.859 . . . . 2.35 109.622 167.145 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.39 -24.15 19.68 Favored 'Trans proline' 0 N--CA 1.433 -2.054 1 CA-C-N 128.661 4.129 . . . . 0.95 111.807 -171.561 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.8 m -102.03 16.29 26.47 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 126.318 2.261 . . . . 1.45 116.873 -179.352 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.83 157.56 25.68 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.306 1.527 . . . . 1.69 112.446 173.227 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 1.8 p -86.68 162.58 17.84 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.51 3.052 . . . . 0.75 116.204 -176.903 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mm -70.45 -38.96 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 1 O-C-N 115.124 -4.735 . . . . 0.73 107.512 -179.289 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -47.58 -54.11 12.7 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.346 3.058 . . . . 1.62 111.592 167.937 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -62.22 -36.98 83.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.945 2.898 . . . . 2.13 118.178 171.375 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.372 4.2 t -63.3 -39.31 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 116.57 -3.831 . . . . 0.62 112.52 174.847 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -65.91 -32.39 73.87 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.844 2.165 . . . . 1.22 116.844 172.089 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.82 -31.62 72.36 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.636 -1.915 . . . . 0.51 114.1 170.472 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -68.24 -26.88 65.91 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.276 1.988 . . . . 1.44 115.217 170.199 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.402 HG23 HD13 ' A' ' 13' ' ' ILE . 84.4 mt -75.2 -28.25 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 117.385 -3.322 . . . . 1.32 114.174 170.489 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -70.81 -38.39 73.29 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.352 2.501 . . . . 1.7 115.062 170.3 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.83 -36.84 85.23 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 116.748 -3.72 . . . . 1.55 111.917 172.513 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -85.35 -53.39 5.25 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.478 1.609 . . . . 2.62 110.919 -176.69 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -100.73 -43.98 5.96 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.882 -3.011 . . . . 1.48 117.141 -174.069 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.66 -0.73 18.03 Favored Glycine 0 N--CA 1.429 -1.806 0 CA-C-O 117.01 -1.994 . . . . 1.12 111.599 178.194 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.0 mt -70.22 130.72 89.23 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-N 121.099 2.45 . . . . 1.55 112.733 -178.805 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -76.32 154.3 36.29 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 O-C-N 115.556 -2.918 . . . . 1.02 116.023 174.788 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -71.8 -6.81 19.89 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 124.009 3.139 . . . . 1.25 113.039 -169.13 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -67.58 -35.03 78.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.345 3.058 . . . . 2.25 109.132 175.116 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -85.28 -22.32 28.64 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.384 -1.448 . . . . 2.02 113.396 178.708 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -83.19 119.16 24.19 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.028 -2.92 . . . . 0.69 117.622 -168.654 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.425 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 51.4 ttt180 -107.83 118.78 37.63 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 105.297 -2.112 . . . . 2.78 105.297 172.758 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.5 mt -113.73 122.51 47.33 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 116.375 -1.774 . . . . 1.17 108.671 -177.092 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.3 mt -120.19 136.2 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 124.574 2.13 . . . . 1.38 107.702 177.483 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.447 ' HB3' HD21 ' A' ' 50' ' ' LEU . 84.9 t80 -130.4 112.2 13.03 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.056 1.884 . . . . 1.5 109.496 171.45 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.65 -72.58 0.09 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.468 2.307 . . . . 1.21 114.021 177.968 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.7 -62.18 0.19 Allowed Glycine 0 N--CA 1.43 -1.751 0 O-C-N 120.835 -1.165 . . . . 1.3 112.675 -178.28 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -79.85 153.51 29.04 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 115.085 1.513 . . . . 2.55 115.085 -173.455 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -82.95 137.66 34.11 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.321 -2.737 . . . . 2.48 111.052 171.503 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.447 HD21 ' HB3' ' A' ' 45' ' ' PHE . 11.8 mt -84.87 121.57 27.92 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.488 -2.007 . . . . 0.9 114.835 -169.217 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.316 10.7 pt-20 -78.63 173.25 12.62 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 118.463 -2.648 . . . . 1.94 115.669 175.152 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -68.08 -58.68 4.09 Favored 'General case' 0 N--CA 1.429 -1.478 1 N-CA-C 125.054 5.205 . . . . 1.56 125.054 -177.023 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.65 56.59 1.37 Allowed Glycine 0 N--CA 1.43 -1.711 0 O-C-N 118.502 -2.624 . . . . 0.97 111.143 170.81 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -123.24 168.65 12.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.224 -2.139 . . . . 2.49 105.224 160.722 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.0 p -101.65 169.29 8.93 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.469 -1.394 . . . . 0.76 112.279 179.494 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mt -54.61 -44.9 73.51 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 114.717 1.377 . . . . 1.05 114.717 166.98 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.262 41.7 p -67.88 -24.38 65.22 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.258 2.623 . . . . 1.19 115.078 -176.651 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -70.59 -25.18 62.94 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.124 2.869 . . . . 1.9 115.793 176.195 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -95.81 -6.71 38.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.123 -2.308 . . . . 0.89 114.18 175.157 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.26 7.6 t30 76.53 43.16 0.15 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.864 -2.397 . . . . 1.84 110.166 179.56 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 61' ' ' ILE . 77.7 mt -91.91 107.3 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.733 -1.229 . . . . 0.82 108.261 177.325 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -101.08 -170.82 1.89 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 126.184 2.897 . . . . 2.16 107.749 -174.304 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -63.69 141.91 58.59 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 111.318 -2.674 . . . . 2.12 110.693 171.822 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 69.05 20.84 7.59 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 110.734 -2.939 . . . . 1.71 116.877 177.008 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.6 m -88.88 159.37 17.72 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 116.165 1.913 . . . . 1.04 116.165 -170.899 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.2 m -101.32 115.79 31.3 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 117.007 -3.558 . . . . 0.79 110.49 -178.97 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -105.37 146.82 28.92 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.674 -1.232 . . . . 1.4 107.674 171.181 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -101.58 130.63 47.94 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 116.132 -1.89 . . . . 1.51 110.736 177.05 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.423 HD23 HG22 ' A' ' 7' ' ' THR . 25.1 tp -115.12 108.29 16.44 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.205 1.366 . . . . 1.14 107.551 177.172 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 74.6 t -96.2 130.19 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 119.131 -2.23 . . . . 1.23 105.784 171.801 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.9 mt -92.76 130.69 38.3 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 120.275 1.398 . . . . 2.78 111.087 178.896 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -115.29 -166.27 1.11 Allowed 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 120.141 -1.6 . . . . 3.75 110.06 174.773 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mp -117.79 -59.01 1.96 Allowed 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.751 2.215 . . . . 3.14 107.592 -179.966 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -99.6 -74.55 0.59 Allowed 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.01 -4.806 . . . . 6.8 106.115 172.128 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 177.81 172.05 41.88 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 126.437 3.243 . . . . 3.57 111.849 -162.215 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.749 0 C-N-CA 128.444 2.926 . . . . 3.87 109.087 -170.418 . . . . . . . . 0 0 . 1 . 127 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 ptt? . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 104.575 -2.379 . . . . 1.1 104.575 . . . . . . . . . 0 0 . 1 . 127 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -119.08 154.54 33.02 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 124.53 3.332 . . . . 1.87 106.291 175.994 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -136.37 167.36 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 105.425 -2.065 . . . . 0.72 105.425 167.491 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -120.96 125.84 48.44 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.046 2.138 . . . . 1.4 108.129 -176.835 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.6 t -104.45 130.72 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.708 -3.12 . . . . 0.58 105.283 170.751 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.287 12.4 ttpt -127.03 122.08 33.39 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 129.715 4.384 . . . . 2.09 119.645 -177.12 . . . . . . . . 3 2 . 1 . 127 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 p -70.89 161.73 30.53 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 112.671 -2.059 . . . . 0.99 115.106 177.963 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.7 tp -54.31 -48.34 71.44 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.783 2.433 . . . . 2.53 115.465 174.058 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.31 -31.95 70.76 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.522 2.729 . . . . 2.08 115.582 -177.728 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.94 27.68 0.7 Allowed Glycine 0 N--CA 1.429 -1.775 0 CA-C-O 117.641 -1.644 . . . . 1.31 109.817 176.1 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -97.46 122.98 41.15 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.449 3.125 . . . . 1.4 108.318 -178.093 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.4 m -96.45 117.48 30.97 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 127.309 3.433 . . . . 0.78 107.156 172.661 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.8 mt -93.6 122.05 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 117.668 -3.145 . . . . 1.55 102.529 174.944 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -108.91 106.5 16.5 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 123.657 1.694 . . . . 1.08 109.943 174.256 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.4 mt -102.6 152.58 21.01 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 116.475 -3.89 . . . . 1.55 109.445 -178.033 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.68 130.44 42.58 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.382 -1.449 . . . . 1.95 110.869 169.299 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.66 163.01 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 114.196 -1.365 . . . . 0.96 110.232 -173.969 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -104.06 151.25 38.94 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 117.963 -2.961 . . . . 2.35 112.427 158.476 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -75.99 -7.29 18.16 Favored 'Trans proline' 0 N--CA 1.434 -1.998 1 CA-C-N 129.621 4.472 . . . . 0.95 117.359 -176.262 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.3 m -82.34 -9.95 59.27 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 128.36 2.664 . . . . 1.45 113.515 173.565 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -76.27 158.2 31.81 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 116.195 -2.202 . . . . 1.69 109.774 177.918 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.2 p -87.36 158.46 19.02 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 116.304 1.964 . . . . 0.75 116.304 177.307 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.0 mp -55.13 -46.02 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 118.402 -0.808 . . . . 0.73 111.428 172.187 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.264 42.9 tt0 -41.39 -44.41 2.81 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 120.11 3.374 . . . . 1.62 120.11 163.586 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -83.36 -34.26 25.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.346 -3.346 . . . . 2.13 110.524 -177.077 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.0 t -62.44 -37.82 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 O-C-N 117.016 -3.553 . . . . 0.62 108.076 170.727 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -67.17 -24.63 65.89 Favored 'General case' 0 N--CA 1.431 -1.412 1 CA-C-O 128.715 4.102 . . . . 1.22 119.518 175.64 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.6 -16.39 62.62 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 117.974 -2.954 . . . . 0.51 113.403 169.105 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -87.48 -30.94 20.27 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 116.008 -4.182 . . . . 1.44 112.429 179.01 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.287 51.3 mt -66.16 -19.01 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 CA-C-O 124.519 2.104 . . . . 1.32 108.518 173.155 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -75.05 -43.97 50.35 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.681 -2.512 . . . . 1.7 112.295 178.458 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -65.81 -53.8 35.29 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.668 1.187 . . . . 1.55 110.143 168.948 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -59.89 -69.71 0.2 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.209 1.48 . . . . 2.62 112.64 -173.179 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -90.13 -40.82 12.0 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 128.672 2.789 . . . . 1.48 113.517 -166.848 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.22 31.6 3.75 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 116.244 -2.884 . . . . 1.12 111.849 172.53 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.1 mt -113.17 119.11 43.04 Favored Pre-proline 0 N--CA 1.429 -1.48 0 C-N-CA 126.939 2.096 . . . . 1.55 109.816 -177.001 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -63.1 156.24 56.26 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 125.276 3.984 . . . . 1.02 116.48 175.754 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -74.88 -21.05 16.55 Favored 'Trans proline' 0 N--CA 1.433 -2.072 0 CA-C-N 128.114 3.934 . . . . 1.25 115.945 -170.171 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.17 -34.08 69.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.777 2.431 . . . . 2.25 115.691 167.369 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -84.8 -1.9 56.99 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 125.743 2.687 . . . . 2.02 112.974 177.952 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -114.87 129.05 56.63 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 115.342 -4.599 . . . . 0.69 111.26 -171.895 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -129.04 134.81 48.27 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 104.638 -2.356 . . . . 2.78 104.638 171.562 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.3 mt -107.38 129.04 54.96 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 128.14 2.576 . . . . 1.17 108.39 -177.77 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.7 mm -105.99 125.44 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 131.282 3.833 . . . . 1.38 102.915 -174.433 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.405 ' HB3' HD21 ' A' ' 50' ' ' LEU . 41.8 t80 -116.56 110.79 19.02 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 120.651 1.569 . . . . 1.5 107.069 170.53 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.36 -101.61 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 104.826 -2.287 . . . . 1.21 104.826 177.467 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.63 2.98 15.4 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 125.881 1.988 . . . . 1.3 113.831 -179.578 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -115.45 157.07 24.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.214 1.483 . . . . 2.55 109.274 -179.096 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -94.02 144.42 25.48 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.766 -2.679 . . . . 2.48 103.766 179.512 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.405 HD21 ' HB3' ' A' ' 45' ' ' PHE . 27.8 mt -97.12 140.4 31.69 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.769 -3.082 . . . . 0.9 109.983 -175.441 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -79.39 149.02 31.77 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.294 -1.504 . . . . 1.94 113.184 172.923 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -76.81 -37.12 56.33 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 115.655 1.724 . . . . 1.56 115.655 -173.231 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.43 44.71 2.6 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-O 116.655 -2.192 . . . . 0.97 108.0 179.55 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -126.93 160.05 32.2 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 121.315 2.558 . . . . 2.49 106.07 168.343 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 p -84.19 175.62 9.33 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 126.553 3.073 . . . . 0.76 112.506 169.448 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.7 mt -71.54 -42.42 67.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.929 -3.607 . . . . 1.05 110.064 171.381 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 m -60.19 -38.85 84.52 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 128.823 2.849 . . . . 1.19 114.094 171.875 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -52.59 -36.6 56.45 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.973 2.953 . . . . 1.9 118.973 171.425 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -90.53 3.05 55.1 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 116.505 2.039 . . . . 0.89 116.505 176.442 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 64.31 27.33 13.77 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.751 2.42 . . . . 1.84 114.64 -173.944 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.257 75.7 mt -69.82 140.8 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 118.943 -2.348 . . . . 0.82 108.185 178.027 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -111.41 175.6 5.36 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.475 -2.016 . . . . 2.16 111.777 -174.441 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -64.0 148.28 50.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.411 -1.431 . . . . 2.12 111.713 166.15 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.338 35.9 mt-10 77.13 21.24 1.12 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.425 -2.047 . . . . 1.71 113.41 169.175 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.95 140.91 30.02 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.982 3.313 . . . . 1.04 112.949 -173.622 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.8 m -89.62 114.83 26.49 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.911 2.884 . . . . 0.79 111.746 -178.856 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -113.52 151.8 31.06 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.851 -3.031 . . . . 1.4 104.789 175.246 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -107.57 123.75 48.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 123.505 1.621 . . . . 1.51 109.854 -169.748 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.5 tp -90.96 110.63 21.88 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.148 -2.845 . . . . 1.14 113.275 -178.034 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.9 t -105.08 128.9 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 1 N-CA-C 99.468 -4.271 . . . . 1.23 99.468 176.67 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.0 tp -97.89 127.49 43.87 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 113.357 -1.747 . . . . 2.78 109.337 177.147 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -89.75 109.62 20.59 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.495 -1.684 . . . . 3.75 111.398 174.805 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.1 tp -127.45 -41.45 1.72 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 120.794 1.634 . . . . 3.14 109.708 173.103 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.9 ttp-105 -76.09 -52.66 9.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.466 -1.396 . . . . 6.8 111.783 171.127 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.48 -56.18 0.11 Allowed Glycine 0 N--CA 1.429 -1.77 1 CA-C-O 113.144 -4.142 . . . . 3.57 112.148 -172.964 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.769 0 N-CA-C 107.576 -2.21 . . . . 3.87 107.576 -179.844 . . . . . . . . 0 0 . 1 . 128 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 CA--C 1.489 -1.37 0 CA-C-O 122.74 1.257 . . . . 1.1 113.344 . . . . . . . . . 0 0 . 1 . 128 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -114.58 130.03 56.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 115.738 1.755 . . . . 1.87 115.738 -171.508 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.7 pt -120.46 151.67 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-O 115.244 -2.313 . . . . 0.72 111.686 177.693 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -110.66 118.83 37.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.674 -1.973 . . . . 1.4 105.674 -174.298 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.35 116.04 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 O-C-N 118.926 -2.359 . . . . 0.58 111.052 171.983 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.314 42.1 mtpt -104.32 136.3 44.17 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 127.997 3.76 . . . . 2.09 117.599 178.325 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 p -89.82 156.15 18.69 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.522 -2.611 . . . . 0.99 111.07 172.857 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.5 mt -63.6 -44.5 93.82 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.266 -3.396 . . . . 2.53 112.267 168.141 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.337 69.4 p -65.22 -38.47 90.5 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 116.453 -1.737 . . . . 2.08 114.009 -169.7 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.13 1.88 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 123.358 2.799 . . . . 1.31 116.009 167.802 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -98.68 144.82 27.53 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.304 3.052 . . . . 1.4 111.064 -179.587 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -131.07 139.69 49.93 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 118.028 -2.92 . . . . 0.78 106.51 168.084 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.465 HG21 HD13 ' A' ' 13' ' ' ILE . 28.4 pt -130.4 150.99 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 130.098 3.359 . . . . 1.55 106.558 179.165 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.4 m -107.05 127.15 53.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.946 -1.479 . . . . 1.08 108.022 175.247 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.3 mt -106.8 137.0 45.66 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 125.088 2.375 . . . . 1.55 109.81 169.754 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -89.99 126.47 35.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 128.414 3.959 . . . . 1.95 107.831 162.035 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -132.09 152.33 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 109.585 -3.461 . . . . 0.96 113.358 -173.186 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -99.99 146.18 31.47 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-O 114.776 -2.535 . . . . 2.35 106.459 168.083 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -80.42 -4.8 13.21 Favored 'Trans proline' 0 C--N 1.299 -2.052 0 CA-C-N 128.087 3.924 . . . . 0.95 106.661 -171.302 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.4 p -85.56 -17.63 35.75 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 120.0 -1.687 . . . . 1.45 111.851 175.659 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -61.44 136.26 57.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.826 -2.421 . . . . 1.69 111.733 174.992 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.7 p -78.26 162.23 26.69 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.588 -3.195 . . . . 0.75 112.473 178.655 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.4 mm -64.35 -44.23 97.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-N 113.09 -1.868 . . . . 0.73 112.093 172.283 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.434 76.2 tt0 -35.26 -58.66 0.55 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.349 -3.344 . . . . 1.62 117.1 158.914 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -68.75 -34.27 75.32 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.018 -3.551 . . . . 2.13 116.253 -177.967 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.7 t -55.3 -44.6 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 O-C-N 118.143 -2.848 . . . . 0.62 116.907 164.518 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 43.3 mtmt -54.18 -49.82 68.44 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.045 3.338 . . . . 1.22 110.018 175.704 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.95 -26.67 67.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.875 -3.016 . . . . 0.51 112.898 178.706 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -67.83 -35.34 78.42 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.218 -2.801 . . . . 1.44 111.604 173.115 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.7 mt -71.36 -26.7 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 117.851 -1.54 . . . . 1.32 112.246 172.934 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -68.15 -37.96 81.6 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 118.854 -0.593 . . . . 1.7 110.889 -179.646 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -58.29 -44.62 88.58 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 123.45 1.595 . . . . 1.55 111.463 175.819 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -84.49 -80.55 0.2 Allowed 'General case' 0 N--CA 1.43 -1.446 1 C-N-CA 132.043 4.137 . . . . 2.62 114.302 -171.197 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -78.4 -27.13 46.69 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 123.742 1.734 . . . . 1.48 110.295 -171.965 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.23 28.63 16.89 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 118.73 -2.481 . . . . 1.12 108.262 170.395 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.9 mt -94.66 123.98 56.38 Favored Pre-proline 0 N--CA 1.431 -1.421 0 N-CA-C 103.98 -2.6 . . . . 1.55 103.98 179.961 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 9.3 Cg_exo -62.13 145.64 96.33 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 C-N-CA 116.272 -2.018 . . . . 1.02 114.249 175.685 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 88.4 Cg_exo -66.32 -22.36 53.09 Favored 'Trans proline' 0 N--CA 1.433 -2.038 1 C-N-CA 126.201 4.6 . . . . 1.25 112.751 -175.653 . . . . . . . . 3 3 . 1 . 128 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -60.3 -31.98 70.77 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 131.544 3.938 . . . . 2.25 111.375 171.264 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -97.31 1.81 49.94 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 112.76 -2.018 . . . . 2.02 112.245 -178.617 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -100.56 100.14 10.83 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.659 -2.526 . . . . 0.69 111.793 -177.331 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.491 ' HG3' ' HB2' ' A' ' 72' ' ' ARG . 10.8 mtp180 -96.2 95.19 7.96 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.808 -1.807 . . . . 2.78 110.371 168.489 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.1 mt -72.73 127.34 32.26 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.448 1.499 . . . . 1.17 112.891 179.358 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.9 mm -118.36 135.51 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 123.483 2.856 . . . . 1.38 109.598 175.636 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -122.42 101.23 7.38 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.958 -2.339 . . . . 1.5 107.148 175.95 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.3 . . 78.04 -91.72 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.906 1.282 . . . . 1.21 109.935 179.027 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.18 21.09 2.63 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 104.595 -3.402 . . . . 1.3 104.595 -177.567 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -112.08 120.74 42.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.051 -1.852 . . . . 2.55 111.666 178.562 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -76.22 113.7 14.07 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.637 2.375 . . . . 2.48 108.563 166.416 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.6 mt -90.82 146.06 24.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.154 2.407 . . . . 0.9 109.329 -164.04 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -83.98 164.68 19.19 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.258 1.823 . . . . 1.94 112.284 175.281 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -89.32 -53.02 4.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 116.391 -3.943 . . . . 1.56 114.048 -167.691 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.84 18.58 4.81 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 120.118 2.807 . . . . 0.97 120.118 176.046 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.285 0.0 OUTLIER -79.43 152.3 30.39 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.731 1.752 . . . . 2.49 115.731 168.596 . . . . . . . . 3 3 . 1 . 128 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.9 p -89.37 170.48 10.52 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.558 -1.201 . . . . 0.76 111.513 168.523 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.8 mt -75.6 -32.09 60.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.457 -2.027 . . . . 1.05 109.138 177.374 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.294 1.1 t -62.89 -49.4 74.99 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.728 1.611 . . . . 1.19 109.619 -179.199 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -47.2 -50.59 20.54 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.511 2.324 . . . . 1.9 111.776 172.225 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -76.71 -6.53 52.55 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 119.637 3.199 . . . . 0.89 119.637 176.118 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 65.41 41.17 4.37 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.521 2.045 . . . . 1.84 116.521 -179.693 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.406 HG23 ' HB2' ' A' ' 65' ' ' SER . 55.8 mt -95.05 114.89 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 101.71 -3.441 . . . . 0.82 101.71 179.146 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -102.26 -175.6 2.88 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.345 -1.298 . . . . 2.16 107.878 -178.072 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -61.03 142.91 56.26 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 117.448 2.388 . . . . 2.12 117.448 169.711 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.379 13.8 mt-10 75.17 19.71 2.22 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 129.965 4.541 . . . . 1.71 118.411 177.569 . . . . . . . . 3 2 . 1 . 128 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.406 ' HB2' HG23 ' A' ' 61' ' ' ILE . 19.2 m -92.74 153.52 18.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.538 2.399 . . . . 1.04 105.669 -173.445 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.8 m -106.09 103.52 13.02 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 131.207 3.803 . . . . 0.79 111.101 -176.358 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -94.47 168.52 10.82 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 105.045 -2.206 . . . . 1.4 105.045 174.405 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.97 162.84 32.17 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 105.499 -2.037 . . . . 1.51 105.499 -174.258 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.265 0.5 OUTLIER -144.77 121.91 11.47 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.983 -1.858 . . . . 1.14 105.983 -172.805 . . . . . . . . 3 3 . 1 . 128 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -115.69 125.65 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 129.416 3.086 . . . . 1.23 106.85 178.713 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.1 mt -80.43 125.09 29.5 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 119.594 -1.941 . . . . 2.78 114.783 -175.649 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.491 ' HB2' ' HG3' ' A' ' 42' ' ' ARG . 53.7 ttt180 -96.12 80.84 3.3 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.886 -1.052 . . . . 3.75 109.126 176.171 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.0 mt -98.3 -151.86 0.39 Allowed 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.265 -1.522 . . . . 3.14 109.487 169.97 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.4 mtm-85 -106.99 -62.73 1.37 Allowed 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 100.507 -3.886 . . . . 6.8 100.507 174.633 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.13 81.46 0.78 Allowed Glycine 0 N--CA 1.43 -1.755 0 CA-C-O 115.179 -3.012 . . . . 3.57 112.739 -171.788 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.769 0 CA-C-O 115.303 -2.943 . . . . 3.87 117.811 179.031 . . . . . . . . 0 0 . 1 . 129 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.7 ttp . . . . . 0 CA--C 1.491 -1.318 0 N-CA-C 118.974 2.953 . . . . 1.1 118.974 . . . . . . . . . 0 0 . 1 . 129 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.11 127.12 35.41 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 119.417 -2.052 . . . . 1.87 115.091 174.045 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 pt -122.06 163.92 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.612 2.365 . . . . 0.72 114.598 166.534 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -112.0 123.62 50.65 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 116.108 -4.12 . . . . 1.4 113.835 176.169 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.8 t -110.41 113.15 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 118.622 -2.549 . . . . 0.58 108.502 171.052 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -86.37 139.92 30.51 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 113.894 -1.503 . . . . 2.09 110.503 -178.719 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.6 p -100.25 175.37 5.74 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.453 2.073 . . . . 0.99 110.412 174.815 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.6 mt -80.56 -25.19 38.74 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 114.876 -4.89 . . . . 2.53 108.892 171.599 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 p -65.88 -46.09 79.67 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.275 -3.39 . . . . 2.08 113.717 -176.092 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.2 6.56 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 112.134 -2.303 . . . . 1.31 117.345 173.765 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -98.85 150.62 21.7 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 128.157 3.837 . . . . 1.4 114.187 -173.199 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.2 m -114.98 90.93 3.46 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.722 -3.111 . . . . 0.78 105.578 169.822 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mt -80.9 111.15 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 O-C-N 120.805 -1.184 . . . . 1.55 109.36 -179.807 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.4 m -77.17 107.22 9.4 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.144 -2.223 . . . . 1.08 109.584 170.936 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.6 mt -103.64 148.6 25.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 126.764 3.173 . . . . 1.55 104.912 173.828 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -120.44 129.35 53.85 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.172 2.189 . . . . 1.95 113.1 166.703 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.0 m -143.02 174.07 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.486 -2.413 . . . . 0.96 104.486 -178.937 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -96.82 154.03 38.46 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 104.699 -2.334 . . . . 2.35 104.699 165.06 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -73.79 -15.56 23.92 Favored 'Trans proline' 0 C--N 1.3 -2.003 1 C-N-CA 125.871 4.381 . . . . 0.95 112.239 -176.252 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.1 p -94.34 5.57 51.37 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.758 -3.089 . . . . 1.45 115.236 172.225 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -71.39 154.91 41.21 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.85 -1.157 . . . . 1.69 110.426 168.112 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 65.7 p -92.12 159.5 15.64 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.185 -1.043 . . . . 0.75 108.185 176.752 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -63.53 -16.49 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.463 1.905 . . . . 0.73 113.27 -179.543 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -62.93 -32.58 73.91 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.316 1.846 . . . . 1.62 115.781 166.68 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -72.78 -35.99 67.52 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.887 2.075 . . . . 2.13 111.788 168.765 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.9 t -57.53 -51.53 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 118.945 -2.347 . . . . 0.62 114.381 169.66 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -65.38 -35.99 82.64 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 129.152 2.981 . . . . 1.22 111.339 176.363 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.37 -45.54 69.26 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 116.045 1.868 . . . . 0.51 116.045 174.021 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -74.58 -28.56 60.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.599 1.559 . . . . 1.44 110.256 -179.837 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.6 mt -78.82 -29.17 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 1 O-C-N 115.457 -4.527 . . . . 1.32 114.083 172.669 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -67.31 -32.29 73.17 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.523 -3.236 . . . . 1.7 113.061 170.022 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -61.0 -49.11 78.77 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.247 2.314 . . . . 1.55 117.247 169.666 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -89.23 -43.99 10.6 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.123 2.268 . . . . 2.62 117.123 -176.897 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -99.66 -36.87 9.35 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.434 -2.666 . . . . 1.48 113.182 -172.289 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.83 68.09 1.3 Allowed Glycine 0 N--CA 1.43 -1.704 0 CA-C-N 110.81 -2.905 . . . . 1.12 111.775 172.144 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 mt -126.85 119.2 22.49 Favored Pre-proline 0 N--CA 1.429 -1.508 0 O-C-N 126.637 2.022 . . . . 1.55 108.343 174.32 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 9.1 Cg_exo -55.87 145.48 72.83 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-O 113.104 -2.956 . . . . 1.02 117.637 176.174 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 27.6 Cg_exo -58.66 -22.52 61.12 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 123.418 2.746 . . . . 1.25 115.142 -175.025 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.02 -43.15 99.46 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 131.109 3.764 . . . . 2.25 109.357 173.887 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -83.79 -14.79 50.57 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 117.152 2.279 . . . . 2.02 117.152 -176.962 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -85.45 104.57 15.36 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 118.871 -2.393 . . . . 0.69 113.131 -175.726 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -96.23 101.04 12.63 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 106.327 -1.731 . . . . 2.78 106.327 175.16 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.4 mt -87.16 125.43 34.16 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.965 -2.334 . . . . 1.17 116.554 173.387 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.5 mm -108.57 106.36 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 118.853 -2.404 . . . . 1.38 109.114 178.226 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -92.99 91.97 7.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 118.977 -1.089 . . . . 1.5 110.578 171.149 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.49 -65.93 0.25 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.719 2.408 . . . . 1.21 112.811 -172.657 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.91 -14.82 0.4 Allowed Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 126.718 2.104 . . . . 1.3 112.923 -178.954 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -90.59 129.03 36.76 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 115.299 -2.56 . . . . 2.55 109.926 -176.83 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -83.17 117.24 22.77 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 119.302 -2.124 . . . . 2.48 112.309 165.934 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.7 mt -79.05 163.53 25.08 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 120.925 -1.109 . . . . 0.9 109.586 -166.181 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -125.64 128.53 47.99 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.329 1.852 . . . . 1.94 108.793 176.354 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.345 30.4 m-20 -45.62 -50.61 13.15 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.079 2.952 . . . . 1.56 115.489 -174.795 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.15 20.59 15.7 Favored Glycine 0 N--CA 1.43 -1.765 1 O-C-N 115.535 -4.478 . . . . 0.97 114.343 175.675 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -107.22 142.89 36.24 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 116.147 -4.149 . . . . 2.49 105.723 168.692 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 17.5 p -70.09 168.51 15.42 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.949 -1.023 . . . . 0.76 113.136 175.803 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.455 ' HG ' HD12 ' A' ' 61' ' ' ILE . 6.3 mp -67.09 -42.32 84.84 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.683 1.993 . . . . 1.05 112.984 173.73 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.2 p -52.79 -26.57 14.75 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 131.515 3.926 . . . . 1.19 112.216 179.455 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -75.77 -51.45 12.62 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-O 126.571 3.081 . . . . 1.9 116.922 175.697 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.272 35.3 m-85 -83.31 9.32 11.12 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.831 -3.043 . . . . 0.89 114.691 174.119 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.7 t30 47.31 59.18 4.24 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 118.801 2.889 . . . . 1.84 118.801 -176.379 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.455 HD12 ' HG ' ' A' ' 56' ' ' LEU . 78.8 mt -93.95 122.3 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 104.489 -2.411 . . . . 0.82 104.489 179.523 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -121.35 -160.99 0.88 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 122.217 2.28 . . . . 2.16 111.742 -173.12 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -59.44 136.06 57.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 119.173 3.027 . . . . 2.12 119.173 175.649 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.295 42.8 mt-10 64.04 25.65 13.86 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.206 -2.184 . . . . 1.71 114.738 172.914 . . . . . . . . 2 2 . 1 . 129 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.7 m -75.18 137.55 41.37 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 128.005 2.522 . . . . 1.04 114.817 179.862 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.2 m -91.66 104.79 17.22 Favored 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 127.105 2.753 . . . . 0.79 114.62 -176.632 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -92.62 128.6 38.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 116.785 -1.579 . . . . 1.4 111.588 171.551 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -96.47 114.73 26.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 104.407 -2.442 . . . . 1.51 104.407 -177.803 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.4 tp -92.38 120.55 33.01 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.584 -3.197 . . . . 1.14 106.91 -177.424 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.84 153.74 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 126.251 2.22 . . . . 1.23 106.159 174.956 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.9 tp -96.21 134.08 39.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 116.056 -2.258 . . . . 2.78 105.586 175.978 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -86.9 124.12 32.76 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.328 1.851 . . . . 3.75 110.925 179.946 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.8 mt -96.98 -173.83 2.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.307 1.443 . . . . 3.14 110.061 170.293 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 65.6 mtt85 -93.21 102.53 14.82 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 118.504 -2.623 . . . . 6.8 112.034 169.455 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.68 153.19 29.47 Favored Glycine 0 N--CA 1.43 -1.742 0 CA-C-O 126.183 3.102 . . . . 3.57 110.848 -165.886 . . . . . . . . 1 1 . 1 . 129 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.768 1 O-C-N 116.323 -4.045 . . . . 3.87 114.184 174.829 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.418 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 5.5 ttt . . . . . 0 CA--C 1.49 -1.35 0 CA-C-O 117.206 -1.378 . . . . 1.1 109.387 . . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -86.33 135.17 33.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 115.895 -2.002 . . . . 1.87 113.301 -171.833 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.7 pt -129.91 153.06 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 122.105 2.23 . . . . 0.72 107.238 170.577 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.331 11.6 m-85 -115.82 122.62 45.94 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 116.876 -1.93 . . . . 1.4 110.974 177.298 . . . . . . . . 2 2 . 1 . 130 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.05 108.48 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 117.749 -3.094 . . . . 0.58 111.548 177.463 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -87.79 120.43 29.1 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.931 1.825 . . . . 2.09 108.537 -173.487 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.2 p -79.4 169.37 18.18 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 115.484 -4.51 . . . . 0.99 113.165 174.686 . . . . . . . . 2 2 . 1 . 130 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.3 mt -73.79 -26.35 60.58 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.004 -3.56 . . . . 2.53 112.222 164.851 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.5 p -75.25 -34.16 61.38 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 124.216 1.006 . . . . 2.08 111.824 -171.197 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.97 -8.0 2.44 Favored Glycine 0 N--CA 1.431 -1.678 0 CA-C-O 115.829 -2.651 . . . . 1.31 116.635 177.384 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -97.89 136.29 38.4 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 126.318 1.834 . . . . 1.4 109.983 -174.122 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -111.94 96.14 5.88 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.433 1.111 . . . . 0.78 109.363 169.759 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.7 pt -91.85 125.31 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 113.852 -1.522 . . . . 1.55 113.366 -175.149 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.8 m -91.22 109.6 20.87 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.424 -2.673 . . . . 1.08 105.443 -171.734 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.7 mt -93.34 153.16 18.7 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.371 -2.705 . . . . 1.55 108.306 176.826 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -92.78 121.56 34.28 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.524 1.929 . . . . 1.95 113.219 165.396 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 1' ' ' MET . 28.9 m -137.26 173.21 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 123.634 1.683 . . . . 0.96 108.082 176.741 . . . . . . . . 2 2 . 1 . 130 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -121.8 154.97 60.77 Favored Pre-proline 0 N--CA 1.43 -1.439 0 O-C-N 117.999 -2.938 . . . . 2.35 108.529 162.869 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.287 40.1 Cg_endo -64.4 -18.6 63.63 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 C-N-CA 123.133 2.555 . . . . 0.95 117.493 -172.611 . . . . . . . . 2 2 . 1 . 130 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.2 m -89.31 7.78 33.85 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.397 2.046 . . . . 1.45 115.596 178.58 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -81.05 146.68 30.51 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 130.037 3.335 . . . . 1.69 108.238 173.984 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.308 30.3 p -75.39 164.83 26.0 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 118.324 -1.351 . . . . 0.75 113.073 172.986 . . . . . . . . 2 2 . 1 . 130 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.5 mt -78.97 -35.7 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 108.063 -1.088 . . . . 0.73 108.063 178.859 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -47.07 -41.68 17.43 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.918 2.192 . . . . 1.62 116.918 162.796 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -64.95 -38.31 90.53 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.671 -4.393 . . . . 2.13 112.235 175.41 . . . . . . . . 2 2 . 1 . 130 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.413 HG22 HG11 ' A' ' 17' ' ' VAL . 68.3 t -69.49 -28.21 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 114.703 1.372 . . . . 0.62 114.703 174.489 . . . . . . . . 2 2 . 1 . 130 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -69.8 -30.24 67.72 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.712 -2.492 . . . . 1.22 112.117 169.247 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.47 -27.23 65.05 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.56 -1.963 . . . . 0.51 110.909 174.418 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? -72.61 -35.86 67.95 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 120.748 1.613 . . . . 1.44 111.399 172.745 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.9 mt -60.54 -46.22 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 O-C-N 116.381 -3.949 . . . . 1.32 112.486 167.515 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -57.26 -45.73 83.73 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 117.968 -2.957 . . . . 1.7 116.449 175.016 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -45.31 -40.87 8.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 125.455 2.55 . . . . 1.55 114.804 166.907 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -87.5 -59.24 2.3 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.691 -3.13 . . . . 2.62 114.824 -173.966 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -97.4 -25.59 15.16 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.954 1.835 . . . . 1.48 109.009 -165.921 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.29 52.77 4.11 Favored Glycine 0 N--CA 1.429 -1.809 1 O-C-N 115.136 -4.727 . . . . 1.12 116.287 -178.175 . . . . . . . . 2 2 . 1 . 130 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.2 mt -130.57 109.81 16.07 Favored Pre-proline 0 N--CA 1.429 -1.505 0 CA-C-N 112.223 -1.988 . . . . 1.55 109.738 -176.81 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -60.59 139.09 84.12 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 N-CA-C 120.948 3.403 . . . . 1.02 120.948 -179.919 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -51.85 -27.92 29.16 Favored 'Trans proline' 0 C--N 1.299 -2.06 0 C-N-CA 124.948 3.765 . . . . 1.25 117.088 -176.197 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.58 -34.63 72.95 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 123.211 2.732 . . . . 2.25 115.954 171.488 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -80.0 4.32 17.36 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 113.639 -3.077 . . . . 2.02 108.899 -175.057 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -141.98 150.6 41.59 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 125.118 3.599 . . . . 0.69 108.897 -176.832 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -130.46 149.91 51.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.195 -2.816 . . . . 2.78 105.317 168.601 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.3 mt -106.47 149.74 26.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.951 2.159 . . . . 1.17 112.657 174.859 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.5 mt -128.52 132.79 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 108.452 -0.944 . . . . 1.38 108.452 178.911 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.264 50.4 t80 -117.07 121.05 40.21 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.537 1.637 . . . . 1.5 106.705 178.358 . . . . . . . . 2 2 . 1 . 130 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.52 -82.27 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.001 -3.562 . . . . 1.21 113.479 174.826 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.77 -26.02 1.47 Allowed Glycine 0 N--CA 1.43 -1.731 0 CA-C-N 122.356 2.344 . . . . 1.3 113.459 176.181 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -100.49 150.2 22.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.991 3.757 . . . . 2.55 117.466 178.875 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -74.48 133.51 42.34 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.982 -2.949 . . . . 2.48 112.718 172.601 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.0 mt -84.4 126.07 32.9 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.939 -2.975 . . . . 0.9 115.27 -171.856 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -64.18 125.57 24.94 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 125.953 2.787 . . . . 1.94 109.18 173.919 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -63.59 -45.7 89.2 Favored 'General case' 0 N--CA 1.429 -1.491 1 O-C-N 114.466 -5.146 . . . . 1.56 116.957 -172.81 . . . . . . . . 2 2 . 1 . 130 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.22 33.57 3.37 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-O 124.799 2.333 . . . . 0.97 118.504 177.226 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -110.83 167.14 10.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.878 -2.542 . . . . 2.49 112.134 167.071 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.9 p -87.4 176.83 7.32 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.802 2.841 . . . . 0.76 111.898 170.761 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.5 mt -82.25 -41.39 20.27 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 127.135 2.174 . . . . 1.05 108.645 -178.72 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.0 p -59.35 -41.56 89.51 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 129.205 3.002 . . . . 1.19 111.353 176.189 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -48.72 -52.01 25.81 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 128.704 2.802 . . . . 1.9 112.626 172.725 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -86.81 -3.69 59.09 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 115.606 1.706 . . . . 0.89 115.606 179.584 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.6 m120 73.47 37.87 0.68 Allowed 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.696 -1.138 . . . . 1.84 112.167 177.036 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.3 mt -84.97 129.08 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 119.713 -1.867 . . . . 0.82 113.17 173.614 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -116.53 -175.83 2.84 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.996 2.808 . . . . 2.16 113.2 -176.361 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -40.66 121.63 1.5 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 112.214 -2.266 . . . . 2.12 116.06 172.949 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 59.89 50.86 6.44 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 119.261 3.06 . . . . 1.71 119.261 179.06 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.1 m -89.79 133.92 34.46 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 116.479 -1.724 . . . . 1.04 112.207 -178.721 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.4 m -81.48 109.08 15.61 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 126.986 2.678 . . . . 0.79 110.538 179.087 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.58 169.71 8.36 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.465 1.939 . . . . 1.4 110.247 176.652 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -125.3 146.64 49.47 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.217 1.007 . . . . 1.51 108.887 -176.372 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.99 132.11 56.1 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 115.008 -2.425 . . . . 1.14 107.723 172.916 . . . . . . . . 2 2 . 1 . 130 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.6 m -121.26 164.24 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 121.889 2.131 . . . . 1.23 114.797 171.526 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.2 tp -75.2 139.85 42.9 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.076 -2.89 . . . . 2.78 110.899 -179.484 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.1 ttt-85 -134.41 138.25 44.68 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 127.328 2.251 . . . . 3.75 113.036 177.618 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.3 mt -88.23 143.47 27.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.909 2.483 . . . . 3.14 110.473 170.658 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -76.59 139.21 40.58 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 117.824 -3.047 . . . . 6.8 115.372 172.881 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.41 86.86 1.95 Allowed Glycine 0 N--CA 1.431 -1.676 0 CA-C-N 111.73 -2.487 . . . . 3.57 113.371 -174.248 . . . . . . . . 1 1 . 1 . 130 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.756 0 O-C-N 120.137 -1.801 . . . . 3.87 111.46 -177.224 . . . . . . . . 0 0 . 1 . 131 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.6 ttp . . . . . 0 CA--C 1.49 -1.354 0 CA-C-O 125.828 2.728 . . . . 1.1 109.936 . . . . . . . . . 0 0 . 1 . 131 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -69.56 127.98 34.88 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 115.409 -2.234 . . . . 1.87 112.559 178.167 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.318 7.4 pt -133.27 150.03 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 107.151 -1.426 . . . . 0.72 107.151 172.511 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -118.74 118.7 32.31 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.798 2.237 . . . . 1.4 112.942 -176.099 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -102.7 112.21 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.786 -3.071 . . . . 0.58 108.489 -179.993 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.506 ' HE3' HG21 ' A' ' 66' ' ' THR . 75.9 mttt -96.1 138.31 33.9 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.021 -3.549 . . . . 2.09 111.334 177.699 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 p -89.25 -176.4 5.09 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 122.789 1.28 . . . . 0.99 112.602 178.551 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.4 tp -86.03 -34.59 20.72 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.2 -2.188 . . . . 2.53 110.311 170.4 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.7 p -56.6 -57.28 13.07 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.145 2.578 . . . . 2.08 113.327 -178.753 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.36 24.32 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.701 0 O-C-N 117.816 -3.052 . . . . 1.31 114.254 171.745 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -106.92 146.43 31.02 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.729 2.411 . . . . 1.4 105.705 -178.001 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.7 m -116.98 97.38 5.92 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.537 3.135 . . . . 0.78 103.054 171.154 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -80.41 116.77 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 106.44 -1.689 . . . . 1.55 106.44 -176.785 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 m -88.07 114.76 25.0 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.597 -4.439 . . . . 1.08 109.613 175.21 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.8 mt -113.75 161.43 17.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 128.128 3.392 . . . . 1.55 108.829 178.127 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -118.01 112.66 20.56 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.386 2.993 . . . . 1.95 108.256 170.313 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.6 m -107.48 160.14 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.191 -2.818 . . . . 0.96 112.954 176.529 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -105.2 143.32 26.51 Favored Pre-proline 0 N--CA 1.43 -1.43 0 O-C-N 118.925 -2.359 . . . . 2.35 107.923 164.705 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -76.51 -13.53 18.33 Favored 'Trans proline' 0 C--N 1.299 -2.044 1 C-N-CA 127.476 5.45 . . . . 0.95 116.079 -166.118 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.0 m -85.79 -2.16 57.95 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 121.413 1.915 . . . . 1.45 109.175 176.889 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -73.73 159.72 32.57 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 120.344 3.461 . . . . 1.69 120.344 169.68 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 30.3 p -79.75 163.53 24.4 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.869 -1.77 . . . . 0.75 114.988 177.521 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.7 mm -73.04 -25.23 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 118.344 -1.343 . . . . 0.73 111.421 177.307 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -50.93 -36.67 39.76 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.752 -2.467 . . . . 1.62 116.566 162.818 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -69.05 -24.67 64.2 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.671 2.789 . . . . 2.13 109.104 -177.825 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.34 -59.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 104.539 -2.393 . . . . 0.62 104.539 175.699 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -49.76 -38.57 34.52 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.123 2.569 . . . . 1.22 113.512 173.441 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.89 -30.93 71.22 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 123.097 2.68 . . . . 0.51 114.893 178.78 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -71.75 -29.12 64.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.865 -1.147 . . . . 1.44 112.477 175.202 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.5 mt -73.06 -33.28 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-O 125.912 2.768 . . . . 1.32 111.685 171.157 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -73.81 -41.93 61.65 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.113 -3.492 . . . . 1.7 105.927 177.04 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -61.64 -36.51 80.99 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.649 -2.532 . . . . 1.55 115.923 174.645 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -84.18 -51.22 7.21 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.04 -3.538 . . . . 2.62 113.085 -175.082 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -104.68 -36.83 7.31 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.271 -2.143 . . . . 1.48 114.574 -169.994 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.05 16.83 17.8 Favored Glycine 0 N--CA 1.429 -1.81 0 C-N-CA 115.381 -3.295 . . . . 1.12 110.249 175.263 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.9 mt -95.92 134.84 23.34 Favored Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 102.44 -3.17 . . . . 1.55 102.44 -175.073 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.428 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 17.2 Cg_exo -67.05 156.9 64.3 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 125.924 3.152 . . . . 1.02 114.904 174.558 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -85.9 -14.96 4.99 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 CA-C-N 124.728 2.724 . . . . 1.25 115.586 -174.16 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -67.25 -29.96 69.72 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 114.808 -2.52 . . . . 2.25 108.954 169.044 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -83.05 -19.9 35.99 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 123.238 2.745 . . . . 2.02 113.183 -176.856 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 37' ' ' PRO . 77.7 mt-30 -87.8 107.59 18.73 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 126.7 2.0 . . . . 0.69 110.264 -170.709 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -99.08 122.84 42.85 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.446 -1.687 . . . . 2.78 106.446 171.525 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.4 mt -104.0 127.31 51.55 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 124.846 1.341 . . . . 1.17 110.568 176.417 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.1 mt -115.16 115.4 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 119.388 -2.07 . . . . 1.38 108.314 179.847 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -104.07 102.76 12.5 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 113.456 -1.702 . . . . 1.5 107.477 175.002 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.02 -94.05 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.189 1.796 . . . . 1.21 110.353 -178.478 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.4 -19.08 6.35 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 128.25 2.833 . . . . 1.3 114.406 -177.443 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -98.55 137.08 37.72 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 125.946 2.784 . . . . 2.55 105.304 -175.876 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.4 113.97 26.26 Favored 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 119.224 -2.173 . . . . 2.48 107.168 172.972 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.4 mt -77.36 144.43 37.98 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 121.524 1.966 . . . . 0.9 115.195 -163.134 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -90.24 150.39 21.98 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.878 2.471 . . . . 1.94 113.812 173.018 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -70.47 -59.77 2.66 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.755 2.422 . . . . 1.56 115.543 -168.086 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.92 22.55 0.9 Allowed Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 122.155 3.622 . . . . 0.97 122.155 169.987 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -97.91 162.72 13.1 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.137 -2.978 . . . . 2.49 109.06 168.633 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 44.6 p -100.12 176.79 5.28 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 124.007 3.094 . . . . 0.76 112.712 178.094 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.5 mt -65.75 -34.47 78.25 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.34 -2.1 . . . . 1.05 109.133 172.961 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -57.82 -42.78 84.99 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.814 1.783 . . . . 1.19 115.814 174.318 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -71.64 -30.32 65.62 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.609 -3.182 . . . . 1.9 115.129 -177.272 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -93.11 2.62 56.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 119.132 0.878 . . . . 0.89 113.063 176.017 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.9 m120 51.17 70.76 0.5 Allowed 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 130.705 3.602 . . . . 1.84 113.06 -176.009 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.6 mt -104.84 120.48 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 118.715 -2.491 . . . . 0.82 111.654 -179.344 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -110.85 176.53 4.99 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 111.053 -2.794 . . . . 2.16 115.743 -176.618 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -51.79 118.43 3.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 120.028 3.344 . . . . 2.12 120.028 173.74 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.386 26.2 mt-10 84.56 35.75 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.302 2.001 . . . . 1.71 111.657 171.109 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.8 m -89.64 146.62 24.42 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.618 -2.552 . . . . 1.04 114.145 -174.633 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.506 HG21 ' HE3' ' A' ' 6' ' ' LYS . 5.3 m -108.1 107.96 18.84 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.672 -1.268 . . . . 0.79 112.341 -177.637 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -103.39 143.6 32.47 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 103.466 -2.79 . . . . 1.4 103.466 178.964 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.294 62.3 m80 -104.5 131.64 51.65 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 104.754 -2.313 . . . . 1.51 104.754 -177.095 . . . . . . . . 2 2 . 1 . 131 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.5 tp -95.83 110.56 22.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.943 2.306 . . . . 1.14 108.112 178.899 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 t -110.74 131.91 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 119.108 -2.245 . . . . 1.23 107.855 172.345 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.0 mt -97.74 138.0 35.78 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.153 -0.93 . . . . 2.78 112.329 176.035 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -149.9 126.25 10.79 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.137 -3.477 . . . . 3.75 105.751 -175.936 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.2 mt -72.55 159.21 34.29 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.366 1.866 . . . . 3.14 108.904 178.8 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -88.68 122.83 32.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.108 -2.87 . . . . 6.8 109.702 177.675 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.97 47.15 6.33 Favored Glycine 0 N--CA 1.428 -1.839 0 C-N-CA 120.217 -0.992 . . . . 3.57 113.779 -164.49 . . . . . . . . 1 1 . 1 . 131 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.792 0 CA-C-O 116.256 -2.413 . . . . 3.87 118.772 178.645 . . . . . . . . 0 0 . 1 . 132 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 ptt? . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 111.909 0.337 . . . . 1.1 111.909 . . . . . . . . . 0 0 . 1 . 132 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -98.59 144.16 28.19 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 126.569 3.08 . . . . 1.87 106.144 -178.518 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.7 pt -130.62 152.91 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 1 N-CA-C 99.206 -4.368 . . . . 0.72 99.206 178.136 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -109.79 126.29 53.62 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.532 -2.605 . . . . 1.4 110.496 179.666 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.4 t -96.26 115.7 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 120.599 -1.313 . . . . 0.58 108.147 168.952 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -91.77 137.95 31.95 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 106.044 -1.836 . . . . 2.09 106.044 177.162 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -87.82 -164.59 1.13 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.68 -1.263 . . . . 0.99 113.348 178.627 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.9 mt -82.09 -39.03 23.98 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 124.344 1.027 . . . . 2.53 110.359 176.216 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.289 44.9 p -75.41 -10.96 59.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.701 2.4 . . . . 2.08 108.946 -177.329 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.28 39.42 5.69 Favored Glycine 0 N--CA 1.431 -1.664 1 C-N-CA 135.1 6.095 . . . . 1.31 114.094 172.473 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -90.05 132.4 35.41 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.099 1.95 . . . . 1.4 106.788 -171.309 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.8 m -88.87 111.43 22.06 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.18 -2.2 . . . . 0.78 108.357 -174.627 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.8 mt -104.47 115.49 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 115.569 1.692 . . . . 1.55 115.569 176.429 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 m -81.66 115.85 21.12 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 120.719 -1.238 . . . . 1.08 110.585 -179.129 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.0 mt -121.67 147.89 45.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 115.249 -2.31 . . . . 1.55 111.902 177.625 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -99.69 119.31 37.91 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 120.877 1.671 . . . . 1.95 115.48 171.63 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.82 167.75 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 C-N-CA 130.403 3.481 . . . . 0.96 108.779 -177.598 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -118.62 167.44 11.63 Favored Pre-proline 0 N--CA 1.43 -1.47 0 O-C-N 118.477 -2.639 . . . . 2.35 106.953 162.41 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -67.54 -16.54 47.37 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 CA-C-N 125.248 2.91 . . . . 0.95 115.532 -170.654 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.7 p -74.86 -15.59 60.71 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 131.265 3.826 . . . . 1.45 117.905 174.41 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -69.66 138.34 52.93 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.061 -2.275 . . . . 1.69 115.09 171.024 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 26' ' ' VAL . 36.1 p -79.16 179.52 7.32 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.187 -1.824 . . . . 0.75 114.76 -175.842 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -78.42 -33.75 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 118.934 -2.354 . . . . 0.73 110.799 176.513 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -49.9 -41.96 46.96 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.74 -3.1 . . . . 1.62 116.856 159.182 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.263 40.6 m-20 -76.48 -32.77 58.55 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 112.9 -3.429 . . . . 2.13 113.212 177.677 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 22' ' ' THR . 1.9 t -66.44 -50.5 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 126.954 2.659 . . . . 0.62 113.363 167.855 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.6 mtmt -60.01 -31.17 69.69 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.078 -2.889 . . . . 1.22 116.601 169.109 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.78 -45.38 78.2 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.781 2.141 . . . . 0.51 116.781 170.307 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -65.71 -41.25 92.52 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.383 -3.948 . . . . 1.44 115.374 179.481 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.6 mm -56.83 -40.51 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.147 1.779 . . . . 1.32 113.685 166.773 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -59.81 -55.5 33.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.577 1.951 . . . . 1.7 115.168 171.693 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -46.82 -57.37 4.97 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 130.271 3.428 . . . . 1.55 112.528 175.26 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -85.89 -62.14 1.59 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.371 1.868 . . . . 2.62 112.525 -166.847 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -76.68 -23.01 53.2 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.406 2.002 . . . . 1.48 116.406 -175.459 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.59 20.11 38.72 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 118.556 2.182 . . . . 1.12 118.556 172.876 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.1 mt -101.51 134.79 20.04 Favored Pre-proline 0 N--CA 1.43 -1.465 0 CA-C-O 113.491 -3.147 . . . . 1.55 116.75 -174.564 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -64.52 132.56 33.7 Favored 'Trans proline' 0 C--N 1.3 -2.009 1 C-N-CA 126.319 4.679 . . . . 1.02 116.819 -179.046 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -63.36 -14.71 43.83 Favored 'Trans proline' 0 C--N 1.299 -2.05 0 CA-C-N 127.792 3.819 . . . . 1.25 116.467 -179.026 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -60.31 -27.91 67.69 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 117.758 2.503 . . . . 2.25 117.758 168.615 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -93.12 -29.52 15.72 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.599 -1.313 . . . . 2.02 108.669 -176.951 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -72.77 126.33 29.65 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 126.341 2.972 . . . . 0.69 112.972 -171.759 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -126.78 146.94 50.05 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 111.52 -2.582 . . . . 2.78 109.478 167.328 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 mt -117.28 127.64 54.28 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 114.158 1.17 . . . . 1.17 114.158 175.429 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mm -119.52 126.72 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 118.848 -2.407 . . . . 1.38 106.151 -175.999 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.496 ' CD2' HG12 ' A' ' 61' ' ' ILE . 49.0 t80 -137.79 121.17 17.06 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.865 -3.022 . . . . 1.5 103.328 176.038 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.25 . . 43.51 62.54 1.85 Allowed 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.216 3.006 . . . . 1.21 113.35 179.942 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.72 -31.96 2.7 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 120.346 2.898 . . . . 1.3 120.346 177.863 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -89.79 127.02 35.9 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 126.568 1.947 . . . . 2.55 114.261 -178.31 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -73.68 116.38 14.2 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 115.708 -2.091 . . . . 2.48 108.521 173.156 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 mt -76.96 136.43 38.76 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 116.761 2.134 . . . . 0.9 116.761 -168.648 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -87.73 139.35 30.62 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 121.376 3.843 . . . . 1.94 121.376 179.826 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -47.01 -55.33 8.37 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 121.25 3.796 . . . . 1.56 121.25 -166.403 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.05 35.5 4.74 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 125.94 1.733 . . . . 0.97 116.902 179.433 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.3 mtt-85 -114.47 172.6 6.92 Favored 'General case' 0 N--CA 1.429 -1.482 1 O-C-N 116.0 -4.235 . . . . 2.49 100.864 168.496 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.6 p -104.73 170.0 8.13 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.061 3.344 . . . . 0.76 114.282 179.07 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.8 mt -60.75 -41.62 95.77 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.813 1.412 . . . . 1.05 114.813 169.247 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.0 t -64.41 -28.26 69.56 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.575 2.131 . . . . 1.19 116.259 -178.46 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -59.17 -37.51 77.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.772 -3.705 . . . . 1.9 110.741 173.563 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -94.51 1.2 55.72 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.678 -1.264 . . . . 0.89 109.873 -179.301 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.303 32.8 m120 53.82 51.3 15.14 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 126.946 2.098 . . . . 1.84 111.032 -177.716 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.496 HG12 ' CD2' ' A' ' 45' ' ' PHE . 76.8 mt -94.36 107.96 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 104.906 -2.257 . . . . 0.82 104.906 179.985 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -81.79 -171.72 3.5 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-O 125.864 2.745 . . . . 2.16 111.773 -179.69 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -70.04 165.53 21.66 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 113.437 -5.789 . . . . 2.12 111.319 168.298 . . . . . . . . 2 2 . 1 . 132 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 63.57 22.96 13.41 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.239 1.971 . . . . 1.71 110.801 177.127 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -98.86 125.57 44.29 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 125.434 1.494 . . . . 1.04 107.285 -170.693 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 47.1 m -93.55 113.95 26.19 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 122.165 0.983 . . . . 0.79 111.029 -178.121 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -101.71 129.5 47.89 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 129.327 3.051 . . . . 1.4 113.06 -179.633 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -86.82 111.44 20.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 127.331 3.443 . . . . 1.51 111.652 -171.352 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.9 tp -87.68 111.39 21.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 116.874 -3.641 . . . . 1.14 108.564 -177.918 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 37.7 t -106.16 120.66 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 128.209 2.604 . . . . 1.23 109.098 -177.191 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.9 mt -108.94 105.33 14.82 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.823 1.649 . . . . 2.78 106.82 -179.523 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -99.33 123.07 43.31 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 124.683 2.182 . . . . 3.75 110.745 -177.601 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.8 mt -80.29 144.47 32.8 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.341 -3.975 . . . . 3.14 111.68 177.832 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -141.16 -82.64 0.22 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.041 -2.912 . . . . 6.8 109.083 179.048 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.29 -76.47 1.14 Allowed Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 110.78 -0.928 . . . . 3.57 110.78 -164.67 . . . . . . . . 1 1 . 1 . 132 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.775 1 CA-C-O 112.897 -4.279 . . . . 3.87 106.938 -179.55 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ptt? . . . . . 0 CA--C 1.49 -1.352 0 CA-C-O 122.833 1.301 . . . . 1.1 114.384 . . . . . . . . . 0 0 . 1 . 133 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -108.86 130.31 55.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.54 -3.85 . . . . 1.87 107.148 -168.644 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -128.7 163.84 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 127.396 2.278 . . . . 0.72 110.711 173.728 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -123.33 129.26 51.07 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 112.714 -2.039 . . . . 1.4 113.717 179.91 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -111.96 118.61 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 118.917 -1.113 . . . . 0.58 108.607 172.191 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -89.28 134.25 34.13 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.073 -2.267 . . . . 2.09 113.74 171.089 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.403 HG22 HD23 ' A' ' 69' ' ' LEU . 81.4 p -85.82 167.73 14.92 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.833 2.16 . . . . 0.99 116.833 177.916 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.2 mt -69.07 -40.41 78.5 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 127.145 3.355 . . . . 2.53 109.793 175.348 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.274 17.2 p -57.1 -60.68 3.24 Favored 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 114.878 -4.889 . . . . 2.08 119.021 174.85 . . . . . . . . 3 2 . 1 . 133 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.67 6.33 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.768 0 CA-C-N 119.879 1.218 . . . . 1.31 112.642 177.811 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.2 ttpt -95.63 142.63 27.72 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 121.55 2.675 . . . . 1.4 109.769 -174.937 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.0 m -112.3 120.91 43.35 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.616 -1.624 . . . . 0.78 106.616 174.496 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 mt -102.09 123.91 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 116.494 -1.717 . . . . 1.55 106.933 -177.676 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.1 m -90.37 119.6 30.8 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 124.763 1.29 . . . . 1.08 111.002 175.726 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.0 mt -111.76 137.22 49.98 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 115.358 1.614 . . . . 1.55 115.358 178.713 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -91.49 119.63 31.61 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 117.95 2.574 . . . . 1.95 117.95 165.586 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.8 m -139.3 -178.25 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.414 1 N-CA-C 99.64 -4.207 . . . . 0.96 99.64 -175.303 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -123.29 159.81 53.02 Favored Pre-proline 0 N--CA 1.43 -1.43 1 O-C-N 115.779 -4.326 . . . . 2.35 104.456 163.234 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 48.3 Cg_endo -69.47 -7.96 22.34 Favored 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 125.026 3.817 . . . . 0.95 112.802 -173.273 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.2 p -80.52 -7.1 59.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.541 2.736 . . . . 1.45 114.528 171.405 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -83.4 145.04 29.22 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.965 -2.334 . . . . 1.69 109.997 175.875 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.35 41.4 p -75.17 154.75 37.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 118.282 2.697 . . . . 0.75 118.282 176.143 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.6 mm -58.36 -29.78 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 127.07 2.148 . . . . 0.73 113.765 171.486 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.62 -32.87 74.68 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.197 2.599 . . . . 1.62 110.815 167.465 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -72.53 -28.66 62.99 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 126.078 1.751 . . . . 2.13 111.541 179.758 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.42 -50.23 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 131.39 3.876 . . . . 0.62 110.605 168.496 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -69.18 -27.64 65.69 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 115.361 1.615 . . . . 1.22 115.361 173.045 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.25 . . -72.79 -39.36 66.77 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.411 -1.431 . . . . 0.51 109.328 -178.945 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -66.49 -39.61 88.82 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.326 3.05 . . . . 1.44 112.62 169.445 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.63 -30.85 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 117.674 -3.141 . . . . 1.32 114.796 169.478 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -65.09 -60.86 2.56 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.814 -1.804 . . . . 1.7 109.444 174.053 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -45.7 -39.57 8.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.929 2.937 . . . . 1.55 118.929 172.02 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -91.81 -63.2 1.28 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.582 2.753 . . . . 2.62 107.481 -172.282 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -93.11 -17.79 23.37 Favored 'General case' 0 N--CA 1.429 -1.521 0 O-C-N 117.272 -3.393 . . . . 1.48 115.541 -169.233 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.55 -4.84 62.06 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 108.712 -1.755 . . . . 1.12 108.712 170.793 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.2 mt -75.06 133.84 75.09 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 125.077 1.351 . . . . 1.55 112.785 -176.879 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -75.9 138.29 20.77 Favored 'Trans proline' 0 N--CA 1.433 -2.043 0 CA-C-O 114.122 -2.532 . . . . 1.02 115.766 -178.597 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -64.67 -24.66 62.23 Favored 'Trans proline' 0 N--CA 1.433 -2.031 1 C-N-CA 125.996 4.464 . . . . 1.25 118.572 -172.176 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -55.76 -36.05 66.88 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.212 3.445 . . . . 2.25 116.176 173.299 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -79.9 -11.89 59.78 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.025 1.73 . . . . 2.02 109.928 -178.842 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -86.58 121.21 28.8 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 118.737 2.865 . . . . 0.69 118.737 -169.172 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -110.44 110.55 21.34 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.211 1.368 . . . . 2.78 111.678 172.458 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.2 mt -97.93 119.43 36.53 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 123.675 2.943 . . . . 1.17 109.7 -176.001 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.6 mm -108.45 137.8 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 119.175 -2.203 . . . . 1.38 110.96 178.301 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -130.06 121.67 26.87 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 104.604 -2.369 . . . . 1.5 104.604 173.121 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.26 -100.47 0.06 Allowed 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 120.909 -1.12 . . . . 1.21 110.129 -178.793 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.69 10.39 6.75 Favored Glycine 0 N--CA 1.429 -1.817 0 C-N-CA 126.176 1.846 . . . . 1.3 115.348 174.186 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -110.38 137.66 47.8 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.729 -1.235 . . . . 2.55 112.72 -173.857 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -95.24 129.13 42.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 126.643 2.464 . . . . 2.48 109.421 176.826 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.2 mt -100.35 136.86 39.59 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 117.263 2.32 . . . . 0.9 117.263 -166.804 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -79.54 138.74 37.6 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.79 -2.444 . . . . 1.94 116.614 -178.164 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.97 -47.18 87.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.367 -2.708 . . . . 1.56 114.78 -168.869 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.76 35.86 3.45 Favored Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 119.677 2.631 . . . . 0.97 119.677 173.058 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -114.97 160.51 19.48 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 123.102 1.429 . . . . 2.49 108.463 163.152 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.4 p -100.58 171.4 7.75 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.006 -3.559 . . . . 0.76 117.235 177.953 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 3.2 mt -64.71 -23.61 67.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.712 1.72 . . . . 1.05 113.088 172.25 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.271 19.2 t -60.4 -59.59 5.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.266 3.426 . . . . 1.19 116.111 174.993 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -39.29 -41.27 0.87 Allowed 'General case' 0 N--CA 1.43 -1.458 1 C-N-CA 132.928 4.491 . . . . 1.9 118.74 165.632 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -97.57 9.84 41.42 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 112.508 -3.615 . . . . 0.89 116.436 175.214 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.1 t30 52.84 51.22 16.36 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 131.213 5.321 . . . . 1.84 115.44 -175.486 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.0 mt -101.79 116.94 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 125.574 2.607 . . . . 0.82 111.011 177.394 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -100.86 -153.59 0.45 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.15 -1.594 . . . . 2.16 109.824 -173.277 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -74.31 142.5 45.18 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 128.157 2.583 . . . . 2.12 116.422 175.74 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.252 49.0 mt-10 68.89 33.88 3.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.937 2.095 . . . . 1.71 108.072 176.782 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.0 m -91.67 137.03 32.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 130.004 3.322 . . . . 1.04 113.969 -175.465 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.1 m -107.94 117.26 33.65 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 126.673 1.989 . . . . 0.79 114.962 -174.125 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.64 156.86 17.47 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 125.629 1.571 . . . . 1.4 108.332 177.08 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -117.37 123.14 45.74 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-O 125.546 2.594 . . . . 1.51 108.13 -178.661 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.403 HD23 HG22 ' A' ' 7' ' ' THR . 60.2 tp -97.13 93.4 6.54 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.633 -2.542 . . . . 1.14 112.433 -179.916 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.5 t -91.46 136.27 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 127.831 2.452 . . . . 1.23 106.154 174.569 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.5 mt -109.47 164.04 12.87 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 124.506 2.098 . . . . 2.78 111.198 178.582 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -88.61 154.24 20.48 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 130.569 3.548 . . . . 3.75 108.309 168.528 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.2 mt -64.79 130.6 44.1 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 128.158 2.583 . . . . 3.14 113.198 171.965 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -79.66 115.76 19.46 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 116.668 2.099 . . . . 6.8 116.668 174.082 . . . . . . . . 1 1 . 1 . 133 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.65 -58.72 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.722 1 N-CA-C 101.887 -4.485 . . . . 3.57 101.887 -169.894 . . . . . . . . 2 2 . 1 . 133 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.782 0 N-CA-C 103.158 -3.977 . . . . 3.87 103.158 -178.022 . . . . . . . . 0 0 . 1 . 134 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.263 16.0 ptt? . . . . . 0 CA--C 1.49 -1.333 0 N-CA-C 114.366 1.247 . . . . 1.1 114.366 . . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -106.78 135.35 48.46 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 116.088 1.884 . . . . 1.87 116.088 -177.109 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.1 pt -120.42 165.11 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 N-CA-C 101.514 -3.514 . . . . 0.72 101.514 176.657 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -116.83 147.53 42.04 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 121.989 0.9 . . . . 1.4 111.74 -179.732 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.347 65.0 t -123.34 113.79 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-O 123.703 1.716 . . . . 0.58 107.802 174.856 . . . . . . . . 2 2 . 1 . 134 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -99.2 130.48 45.5 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.737 -2.477 . . . . 2.09 108.545 -178.618 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.7 p -98.65 175.82 5.86 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.93 -1.731 . . . . 0.99 111.847 176.502 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.7 tp -77.32 -31.71 54.78 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 118.211 -1.396 . . . . 2.53 111.097 169.798 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.8 p -59.62 -27.31 66.21 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 131.62 3.968 . . . . 2.08 115.679 -177.425 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.01 56.6 0.62 Allowed Glycine 0 N--CA 1.43 -1.766 1 C-N-CA 135.417 6.246 . . . . 1.31 104.909 165.608 . . . . . . . . 2 2 . 1 . 134 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -125.73 141.96 51.75 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 118.306 -2.879 . . . . 1.4 107.807 177.642 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 100.0 m -120.53 112.69 19.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.556 -1.276 . . . . 0.78 107.556 175.921 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 13' ' ' ILE . 15.3 mt -93.97 141.07 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 118.212 -2.805 . . . . 1.55 106.838 -178.634 . . . . . . . . 2 2 . 1 . 134 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -104.42 117.74 34.9 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 124.551 2.12 . . . . 1.08 107.868 177.585 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.9 mt -116.06 128.7 55.9 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 111.75 -2.477 . . . . 1.55 107.735 -178.878 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -87.47 117.01 25.97 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 104.598 -2.371 . . . . 1.95 104.598 175.763 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.26 159.34 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 125.213 1.57 . . . . 0.96 107.591 -174.766 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 26.1 mt-10 -106.34 165.04 13.68 Favored Pre-proline 0 N--CA 1.429 -1.484 0 C-N-CA 125.502 1.521 . . . . 2.35 108.208 165.226 . . . . . . . . 2 2 . 1 . 134 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 95.7 Cg_exo -72.76 -22.38 20.44 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 125.073 3.849 . . . . 0.95 115.381 -173.18 . . . . . . . . 2 2 . 1 . 134 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.8 m -88.88 -1.33 58.04 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.796 -0.638 . . . . 1.45 112.32 -179.833 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -74.32 140.7 45.05 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.023 -2.923 . . . . 1.69 112.935 -179.318 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.0 p -76.5 162.39 27.85 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.772 -4.33 . . . . 0.75 113.499 177.873 . . . . . . . . 2 2 . 1 . 134 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mm -64.86 -29.05 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.29 -2.756 . . . . 0.73 114.325 175.48 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -61.28 -31.75 71.58 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 116.943 2.201 . . . . 1.62 116.943 164.921 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -75.43 -39.85 58.4 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.915 -1.116 . . . . 2.13 109.212 -179.344 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.0 t -63.67 -39.89 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 117.398 2.37 . . . . 0.62 117.398 171.535 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.257 66.4 mttt -61.22 -40.45 94.04 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 124.649 2.166 . . . . 1.22 114.934 172.529 . . . . . . . . 2 2 . 1 . 134 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.37 -39.77 67.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.974 -3.579 . . . . 0.51 113.6 172.506 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -68.76 -28.66 66.99 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 120.75 1.614 . . . . 1.44 109.855 172.519 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.1 mt -70.87 -24.8 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 116.95 -3.594 . . . . 1.32 115.402 174.381 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -62.11 -30.15 70.81 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.035 -2.916 . . . . 1.7 112.392 173.254 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -71.83 -20.04 61.89 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.896 -2.378 . . . . 1.55 113.205 175.801 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -103.11 -59.43 1.71 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.506 -1.664 . . . . 2.62 106.506 -173.907 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -105.57 -10.2 16.99 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.249 -1.341 . . . . 1.48 111.401 -164.45 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 56.3 54.0 38.97 Favored Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 125.757 1.646 . . . . 1.12 112.801 175.906 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.0 mt -118.49 127.55 26.5 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 127.236 2.214 . . . . 1.55 105.433 178.586 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 37.2 Cg_endo -75.6 163.91 33.19 Favored 'Trans proline' 0 N--CA 1.432 -2.124 2 O-C-N 112.669 -4.438 . . . . 1.02 115.553 179.499 . . . . . . . . 3 3 . 1 . 134 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 71.3 Cg_exo -70.63 -12.23 30.93 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 CA-C-N 123.622 2.329 . . . . 1.25 117.053 -177.238 . . . . . . . . 2 2 . 1 . 134 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -75.2 -16.25 60.5 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 115.603 -4.436 . . . . 2.25 112.533 172.642 . . . . . . . . 2 2 . 1 . 134 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -90.26 -10.68 43.34 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 119.668 1.122 . . . . 2.02 109.773 -177.071 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -103.32 132.04 49.9 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 123.931 1.824 . . . . 0.69 106.1 -160.301 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -121.41 111.25 17.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 114.207 -1.361 . . . . 2.78 112.428 168.506 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.3 mt -90.13 132.37 35.48 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.552 -1.967 . . . . 1.17 115.751 179.362 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 mm -123.73 124.82 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-O 126.316 2.96 . . . . 1.38 112.331 -179.587 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -124.48 108.16 11.84 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 127.612 2.365 . . . . 1.5 108.529 177.15 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.53 -74.3 0.09 Allowed 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 110.592 -3.003 . . . . 1.21 114.066 -178.056 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -147.67 -10.98 0.17 Allowed Glycine 0 N--CA 1.431 -1.679 1 C-N-CA 131.178 4.228 . . . . 1.3 114.631 -177.886 . . . . . . . . 2 2 . 1 . 134 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -94.93 122.43 37.56 Favored 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 118.515 -2.756 . . . . 2.55 113.909 -173.032 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -73.26 117.96 15.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.751 1.62 . . . . 2.48 111.273 168.76 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.8 mt -92.17 128.68 38.1 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 123.429 2.831 . . . . 0.9 113.186 -171.842 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -73.8 146.64 44.07 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.415 1.579 . . . . 1.94 112.963 178.956 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -66.1 -50.1 65.22 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.817 -2.427 . . . . 1.56 115.554 -170.288 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.92 52.85 1.93 Allowed Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 117.234 -2.412 . . . . 0.97 118.082 168.527 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -114.55 161.64 17.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.848 -1.908 . . . . 2.49 105.848 161.553 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.3 p -108.05 175.6 5.42 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 116.749 2.129 . . . . 0.76 116.749 178.11 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.3 mt -65.49 -31.62 72.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.158 2.885 . . . . 1.05 114.563 172.301 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 t -63.06 -44.41 95.89 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.879 -3.638 . . . . 1.19 118.011 171.511 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -64.74 -37.2 86.81 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 129.602 3.161 . . . . 1.9 110.269 -175.597 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -98.4 -10.16 24.13 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.788 2.835 . . . . 0.89 110.085 -174.305 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.1 m120 60.66 54.89 3.5 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 128.487 3.994 . . . . 1.84 113.003 178.715 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.9 mt -106.59 101.35 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-N 108.768 -3.833 . . . . 0.82 106.644 179.607 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -104.01 174.49 5.85 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 129.988 3.315 . . . . 2.16 111.583 -167.012 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -55.67 138.81 46.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.815 -3.053 . . . . 2.12 114.486 179.813 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 67.71 39.07 2.8 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 129.837 3.255 . . . . 1.71 112.783 -178.89 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.3 t -109.9 137.28 47.9 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 106.22 -1.77 . . . . 1.04 106.22 -169.494 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.6 m -96.81 110.0 22.57 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 129.148 2.979 . . . . 0.79 114.114 -176.031 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.1 mt -95.06 147.28 23.59 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 127.647 2.379 . . . . 1.4 107.742 169.342 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -109.31 123.43 49.28 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 103.735 -2.691 . . . . 1.51 103.735 -173.207 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.6 tp -81.9 107.23 14.45 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.246 -2.784 . . . . 1.14 109.011 173.706 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.4 t -98.37 144.69 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 127.923 3.264 . . . . 1.23 104.692 167.809 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.9 mt -109.19 137.08 47.63 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 117.841 -3.037 . . . . 2.78 110.593 178.755 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -85.11 -174.65 5.36 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 129.389 3.076 . . . . 3.75 112.151 177.486 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.0 mt -124.52 173.66 8.32 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 102.701 -3.074 . . . . 3.14 102.701 172.362 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.1 ttp180 -93.11 150.84 20.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.054 2.835 . . . . 6.8 118.267 175.045 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 134.6 -90.22 0.24 Allowed Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 112.548 -2.114 . . . . 3.57 112.472 -165.387 . . . . . . . . 1 1 . 1 . 134 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.727 0 N-CA-C 106.235 -2.746 . . . . 3.87 106.235 175.836 . . . . . . . . 0 0 . 1 . 135 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 ptt? . . . . . 0 CA--C 1.489 -1.381 0 N-CA-C 112.017 0.377 . . . . 1.1 112.017 . . . . . . . . . 0 0 . 1 . 135 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -92.0 136.16 33.38 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.191 -2.193 . . . . 1.87 115.964 173.659 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.373 27.5 pt -116.61 161.66 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 CA-C-O 114.541 -2.647 . . . . 0.72 112.378 165.839 . . . . . . . . 2 2 . 1 . 135 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -120.13 143.52 48.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 121.383 1.901 . . . . 1.4 110.91 177.226 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.83 127.55 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 112.33 -2.213 . . . . 0.58 108.198 175.654 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -97.4 138.83 34.26 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.343 -1.725 . . . . 2.09 106.343 177.256 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 p -97.57 -179.45 4.47 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 127.609 3.576 . . . . 0.99 110.867 173.027 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.8 mt -77.79 -51.33 10.68 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.208 -4.683 . . . . 2.53 112.624 175.315 . . . . . . . . 2 2 . 1 . 135 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.0 p -56.83 -43.87 81.48 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.464 2.024 . . . . 2.08 116.464 177.602 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.08 61.08 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 127.106 2.289 . . . . 1.31 111.118 177.978 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.38 156.48 48.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 103.1 -2.926 . . . . 1.4 103.1 178.38 . . . . . . . . 2 2 . 1 . 135 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.9 m -133.04 121.81 23.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.715 2.674 . . . . 0.78 110.805 -176.95 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mt -102.23 115.27 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 118.627 -2.546 . . . . 1.55 106.896 -175.998 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.2 m -93.19 115.73 28.34 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.163 -1.586 . . . . 1.08 106.784 174.867 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.3 mt -117.63 147.87 42.47 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 125.726 2.679 . . . . 1.55 112.022 -178.787 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -90.61 121.13 32.26 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.378 1.871 . . . . 1.95 110.525 177.346 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.6 m -140.99 167.38 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 116.534 -1.698 . . . . 0.96 111.829 -176.735 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -118.86 173.46 3.4 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-N 122.739 2.518 . . . . 2.35 114.182 156.96 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -75.7 -11.31 20.24 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 115.224 -2.717 . . . . 0.95 118.861 -179.479 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.6 m -79.57 -3.02 45.06 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.359 1.064 . . . . 1.45 112.062 170.493 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -81.33 151.57 27.95 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.517 -1.99 . . . . 1.69 107.884 178.781 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.269 17.3 p -92.52 164.03 13.6 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 115.088 1.514 . . . . 0.75 115.088 178.796 . . . . . . . . 2 2 . 1 . 135 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.9 mm -63.33 -22.38 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 116.267 1.951 . . . . 0.73 116.267 171.999 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -66.72 -45.34 79.01 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.149 3.379 . . . . 1.62 111.764 166.114 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -56.89 -38.16 72.39 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.343 -2.098 . . . . 2.13 114.504 178.133 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.1 t -66.26 -36.03 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 127.914 2.485 . . . . 0.62 114.245 174.979 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -67.4 -39.56 85.58 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.97 2.952 . . . . 1.22 118.97 173.582 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.28 -36.55 66.25 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 116.847 2.166 . . . . 0.51 116.847 170.547 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -60.42 -40.25 90.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.913 1.285 . . . . 1.44 114.224 170.048 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.3 mt -76.4 -31.42 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.438 1.495 . . . . 1.32 108.654 179.367 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -67.26 -43.55 81.59 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.171 -2.205 . . . . 1.7 113.904 174.851 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -58.13 -65.57 0.62 Allowed 'General case' 0 N--CA 1.429 -1.518 0 C-N-CA 130.386 3.474 . . . . 1.55 110.805 168.783 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -56.63 -53.55 56.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.926 3.306 . . . . 2.62 119.926 -175.252 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -120.87 -3.63 9.68 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.681 -1.6 . . . . 1.48 112.826 -164.845 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.83 -6.34 81.95 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 118.493 2.157 . . . . 1.12 118.493 169.527 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.7 mp -73.97 113.63 25.1 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 118.288 -2.889 . . . . 1.55 115.451 -170.665 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 14.5 Cg_exo -60.23 146.44 96.39 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 124.974 3.783 . . . . 1.02 114.009 179.718 . . . . . . . . 2 2 . 1 . 135 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -58.18 -24.91 69.26 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 C-N-CA 123.437 2.758 . . . . 1.25 117.224 -177.534 . . . . . . . . 3 3 . 1 . 135 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -70.8 -26.2 63.21 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 130.176 4.672 . . . . 2.25 112.702 179.296 . . . . . . . . 2 2 . 1 . 135 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -89.89 -16.26 30.4 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.21 -3.431 . . . . 2.02 112.492 -174.974 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -87.25 126.87 35.09 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 117.313 2.338 . . . . 0.69 117.313 -177.759 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -120.74 126.27 49.73 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.127 2.571 . . . . 2.78 108.099 164.883 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.9 mt -109.51 115.03 29.17 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.774 -3.079 . . . . 1.17 109.391 -174.993 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.3 mm -101.18 134.72 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 125.943 1.697 . . . . 1.38 108.581 -177.028 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -154.42 126.54 7.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.565 -2.383 . . . . 1.5 104.565 174.976 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.52 45.12 16.85 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 125.958 2.789 . . . . 1.21 113.788 -177.264 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.49 2.27 20.08 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 111.97 -2.377 . . . . 1.3 118.737 -173.506 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -103.88 125.9 50.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.283 -3.481 . . . . 2.55 107.19 -175.523 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -74.0 122.01 21.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.083 -2.261 . . . . 2.48 107.258 163.707 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.9 mt -78.24 127.02 31.64 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 130.459 3.504 . . . . 0.9 116.855 -177.396 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -89.29 130.55 35.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 116.421 2.008 . . . . 1.94 116.421 173.871 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.53 -61.41 1.7 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 130.275 3.43 . . . . 1.56 115.898 -170.269 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.68 23.8 3.45 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 123.066 3.986 . . . . 0.97 123.066 173.199 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -99.73 165.44 11.59 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.363 1.465 . . . . 2.49 107.347 163.862 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.391 18.6 p -92.6 171.19 9.17 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 117.09 2.256 . . . . 0.76 117.09 177.097 . . . . . . . . 2 2 . 1 . 135 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.72 -33.79 64.52 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-O 114.897 -2.478 . . . . 1.05 107.374 170.987 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -73.46 -35.68 65.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.42 1.888 . . . . 1.19 107.94 -175.256 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.39 3.0 t0 -63.32 -53.98 44.25 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.941 1.353 . . . . 1.9 111.859 171.005 . . . . . . . . 2 2 . 1 . 135 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -73.19 -7.98 53.79 Favored 'General case' 0 N--CA 1.43 -1.454 2 O-C-N 115.318 -4.613 . . . . 0.89 122.295 177.112 . . . . . . . . 2 2 . 1 . 135 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.0 m120 70.2 56.42 0.29 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.568 1.692 . . . . 1.84 115.568 179.137 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.1 mt -104.71 108.29 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 128.097 3.373 . . . . 0.82 109.008 177.485 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -87.95 -175.39 5.09 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 125.265 2.46 . . . . 2.16 109.49 177.807 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -63.2 131.0 47.0 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 115.276 -4.64 . . . . 2.12 115.62 174.522 . . . . . . . . 2 2 . 1 . 135 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.662 17.9 mt-10 97.69 -5.31 0.05 Allowed 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 124.622 1.201 . . . . 1.71 112.284 174.315 . . . . . . . . 2 2 . 1 . 135 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -66.71 122.69 18.2 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.807 2.043 . . . . 1.04 115.455 -176.265 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.5 m -91.2 115.59 28.14 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 103.803 -2.666 . . . . 0.79 103.803 -178.682 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.4 mt -79.34 139.74 37.7 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.079 2.952 . . . . 1.4 112.245 165.343 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -108.7 117.08 33.25 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.95 -2.969 . . . . 1.51 114.702 -179.059 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.9 tp -83.17 115.14 21.79 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 128.577 2.751 . . . . 1.14 111.746 -174.916 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.2 t -104.25 133.27 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 105.354 -2.091 . . . . 1.23 105.354 174.498 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.8 mt -114.57 165.74 12.45 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 125.345 1.653 . . . . 2.78 110.036 -178.231 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -106.19 140.19 39.53 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 102.121 -3.289 . . . . 3.75 102.121 176.981 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.5 mt -86.26 170.71 11.85 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 116.288 -1.815 . . . . 3.14 112.298 178.89 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -79.06 85.0 5.01 Favored 'General case' 0 N--CA 1.431 -1.418 1 O-C-N 129.586 4.304 . . . . 6.8 115.443 171.567 . . . . . . . . 2 2 . 1 . 135 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.22 -94.58 0.1 OUTLIER Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 117.173 1.629 . . . . 3.57 117.173 -169.902 . . . . . . . . 1 1 . 1 . 135 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.725 0 CA-C-N 121.324 2.562 . . . . 3.87 112.447 179.053 . . . . . . . . 0 0 . 1 . 136 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 ptt? . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 122.104 0.954 . . . . 1.1 109.965 . . . . . . . . . 0 0 . 1 . 136 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -103.08 144.02 31.83 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.336 -1.302 . . . . 1.87 107.966 -177.381 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.2 pt -132.35 159.68 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 C-N-CA 127.341 2.256 . . . . 0.72 107.182 175.71 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -103.39 153.09 20.85 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 128.581 2.753 . . . . 1.4 111.574 178.752 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.5 t -137.7 104.68 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 106.636 -1.616 . . . . 0.58 106.636 177.546 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -90.59 117.62 29.4 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 127.062 3.315 . . . . 2.09 111.13 -179.791 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.1 p -80.22 174.5 11.53 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.137 -3.477 . . . . 0.99 115.567 179.303 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.2 mt -61.47 -52.74 63.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 124.875 1.359 . . . . 2.53 111.573 170.235 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.276 72.6 p -66.5 -38.17 86.65 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 119.465 -2.022 . . . . 2.08 115.625 -173.189 . . . . . . . . 2 2 . 1 . 136 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.75 52.12 0.17 Allowed Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 125.542 1.544 . . . . 1.31 116.49 173.578 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -119.3 149.27 42.06 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 103.475 -2.787 . . . . 1.4 103.475 174.773 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.3 m -119.28 115.05 23.36 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 125.497 1.748 . . . . 0.78 106.636 174.633 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 mt -95.69 135.63 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.189 -2.195 . . . . 1.55 105.33 179.744 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.8 m -96.14 129.52 43.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.961 -2.977 . . . . 1.08 102.961 172.122 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.0 mt -124.29 133.89 53.36 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 106.104 -1.813 . . . . 1.55 106.104 -179.102 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -92.3 107.24 19.07 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.07 -2.268 . . . . 1.95 111.098 169.413 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 m -113.67 179.04 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 C-N-CA 127.734 2.414 . . . . 0.96 114.113 174.669 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -125.73 154.75 73.2 Favored Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 103.84 -2.652 . . . . 2.35 103.84 166.317 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.294 25.6 Cg_endo -66.74 -30.73 41.04 Favored 'Trans proline' 0 N--CA 1.434 -2.001 1 C-N-CA 125.577 4.185 . . . . 0.95 110.234 -172.031 . . . . . . . . 3 2 . 1 . 136 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.2 p -64.51 -16.94 63.39 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.552 3.141 . . . . 1.45 116.646 173.549 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -70.07 142.47 52.66 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.376 -2.077 . . . . 1.69 109.39 177.137 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.0 p -78.26 164.56 24.79 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 126.247 2.217 . . . . 0.75 112.941 174.237 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.4 mm -65.2 -32.6 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 117.142 2.275 . . . . 0.73 117.142 174.114 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -50.03 -49.88 49.44 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 126.386 2.993 . . . . 1.62 109.688 164.533 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -65.36 -37.21 86.35 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.407 -2.683 . . . . 2.13 116.295 -178.127 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.4 t -67.53 -27.89 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 121.254 1.843 . . . . 0.62 108.221 174.812 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -75.0 -27.32 60.09 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 121.005 1.729 . . . . 1.22 112.526 178.343 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.18 -31.74 69.35 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 117.3 -1.333 . . . . 0.51 111.457 173.844 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -69.05 -35.64 76.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.515 2.726 . . . . 1.44 109.914 175.033 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.8 mt -69.03 -43.66 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-N 113.789 -1.55 . . . . 1.32 111.359 171.134 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -62.68 -38.07 88.92 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.103 -2.248 . . . . 1.7 113.389 179.206 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -49.67 -49.5 47.2 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 130.272 3.429 . . . . 1.55 114.474 168.943 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -87.96 -58.45 2.56 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.106 -3.496 . . . . 2.62 117.002 -179.557 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -81.88 -43.97 17.47 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.695 1.712 . . . . 1.48 112.546 -166.086 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.1 63.35 1.14 Allowed Glycine 0 N--CA 1.431 -1.689 0 CA-C-N 111.946 -2.388 . . . . 1.12 112.586 176.001 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.2 mt -129.81 117.9 18.52 Favored Pre-proline 0 N--CA 1.429 -1.505 0 CA-C-O 115.789 -2.053 . . . . 1.55 106.074 -177.599 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -67.4 140.63 53.35 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 CA-C-N 127.493 3.712 . . . . 1.02 112.114 -179.904 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -51.9 -20.17 9.57 Favored 'Trans proline' 0 N--CA 1.433 -2.073 1 N-CA-C 122.719 4.084 . . . . 1.25 122.719 -175.958 . . . . . . . . 3 3 . 1 . 136 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -70.96 -39.55 72.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.805 2.842 . . . . 2.25 111.02 172.523 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -75.75 -36.0 60.01 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 116.706 -3.746 . . . . 2.02 111.496 179.878 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -93.52 142.45 27.33 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 119.951 -1.718 . . . . 0.69 107.036 -166.136 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -124.13 151.54 43.82 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.993 -1.692 . . . . 2.78 106.535 166.599 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.6 mt -121.64 123.9 43.02 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.084 1.421 . . . . 1.17 108.868 -179.559 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.4 mt -105.53 128.43 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 129.719 3.208 . . . . 1.38 110.664 -176.101 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.416 ' C ' ' H ' ' A' ' 47' ' ' GLY . 2.4 t80 -139.13 133.11 31.04 Favored 'General case' 0 N--CA 1.43 -1.473 1 N-CA-C 99.256 -4.35 . . . . 1.5 99.256 179.835 . . . . . . . . 3 3 . 1 . 136 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.57 -36.01 0.18 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 131.418 3.887 . . . . 1.21 113.557 179.504 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 45' ' ' PHE . . . 164.91 -26.06 0.18 Allowed Glycine 0 N--CA 1.429 -1.781 0 O-C-N 116.964 -3.585 . . . . 1.3 111.245 178.297 . . . . . . . . 2 2 . 1 . 136 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -83.22 137.67 33.92 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.703 2.668 . . . . 2.55 111.611 -178.974 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 pm0 -92.4 126.99 37.72 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.26 -2.15 . . . . 2.48 109.514 177.019 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.293 34.8 mt -81.87 122.84 28.24 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.378 2.513 . . . . 0.9 109.899 -161.683 . . . . . . . . 2 2 . 1 . 136 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -77.99 130.64 36.75 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 116.801 -3.687 . . . . 1.94 108.119 178.601 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -46.57 -48.18 19.58 Favored 'General case' 0 N--CA 1.43 -1.472 1 C-N-CA 132.34 4.256 . . . . 1.56 115.028 -173.34 . . . . . . . . 2 2 . 1 . 136 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.65 49.61 3.89 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 128.425 2.917 . . . . 0.97 116.077 172.983 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -135.78 172.86 12.39 Favored 'General case' 0 N--CA 1.43 -1.464 1 N-CA-C 97.606 -4.961 . . . . 2.49 97.606 169.47 . . . . . . . . 2 2 . 1 . 136 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.5 p -99.14 169.21 9.56 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.232 -1.804 . . . . 0.76 114.56 170.3 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.5 mt -76.02 -21.68 56.59 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 112.324 -2.216 . . . . 1.05 109.161 176.907 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 t -73.86 -39.78 63.73 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.893 -0.594 . . . . 1.19 109.798 176.862 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -54.84 -40.8 69.98 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 120.442 3.497 . . . . 1.9 120.442 174.508 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -78.84 -15.03 58.89 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 128.121 2.568 . . . . 0.89 116.992 175.966 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 m120 68.74 51.54 0.59 Allowed 'General case' 0 N--CA 1.43 -1.445 1 C-N-CA 132.932 4.493 . . . . 1.84 113.88 -178.311 . . . . . . . . 2 2 . 1 . 136 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mp -82.15 116.86 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 117.39 -3.318 . . . . 0.82 108.976 175.516 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -95.95 165.07 12.44 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 111.884 -2.417 . . . . 2.16 115.531 177.309 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -53.49 135.23 40.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.359 -1.291 . . . . 2.12 113.576 176.269 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 63.84 34.29 11.96 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 118.674 2.842 . . . . 1.71 118.674 178.241 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.7 m -92.12 154.46 18.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.1 2.16 . . . . 1.04 114.277 -177.314 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.0 m -102.36 114.14 28.07 Favored 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 117.516 -3.24 . . . . 0.79 116.348 -179.957 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.7 mt -87.15 147.7 25.51 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.651 -0.656 . . . . 1.4 109.855 165.806 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -114.92 120.77 41.06 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 123.797 0.839 . . . . 1.51 109.137 -178.692 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.4 tp -97.69 129.16 44.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.932 -2.355 . . . . 1.14 109.472 -175.565 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.6 m -124.83 164.52 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 129.887 3.275 . . . . 1.23 105.555 177.796 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.7 mt -119.08 175.73 5.64 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 116.794 -3.691 . . . . 2.78 109.364 179.553 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -106.75 177.65 4.79 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.845 -1.07 . . . . 3.75 111.994 172.505 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.297 92.9 mt -83.65 114.69 21.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.071 1.878 . . . . 3.14 116.071 169.57 . . . . . . . . 2 2 . 1 . 136 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -75.7 120.16 20.72 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.043 2.537 . . . . 6.8 117.147 179.308 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.93 -13.12 1.92 Allowed Glycine 0 N--CA 1.43 -1.759 0 CA-C-N 112.384 -2.189 . . . . 3.57 116.433 -175.031 . . . . . . . . 1 1 . 1 . 136 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.79 0 CA-C-N 119.724 1.762 . . . . 3.87 112.845 175.41 . . . . . . . . 0 0 . 1 . 137 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 ptt? . . . . . 0 CA--C 1.49 -1.339 0 CA-C-O 115.847 -2.025 . . . . 1.1 116.247 . . . . . . . . . 0 0 . 1 . 137 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.62 138.13 34.66 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 122.809 2.55 . . . . 1.87 109.978 -179.096 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.8 pt -124.33 170.85 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 104.232 -2.507 . . . . 0.72 104.232 167.991 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.463 ' HB3' HG23 ' A' ' 12' ' ' THR . 22.2 m-85 -119.1 147.25 44.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.811 3.245 . . . . 1.4 107.051 -176.586 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.5 t -133.93 138.08 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 102.832 -3.025 . . . . 0.58 102.832 170.755 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -110.6 130.31 55.6 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.082 2.153 . . . . 2.09 107.328 177.768 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -81.8 -176.73 6.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 123.898 0.749 . . . . 0.99 111.966 174.977 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.7 mt -58.49 -47.51 83.84 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.171 2.988 . . . . 2.53 112.331 179.494 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.0 p -89.04 -35.73 16.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.161 -2.837 . . . . 2.08 106.529 -172.338 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.74 5.54 0.25 Allowed Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 119.938 2.735 . . . . 1.31 119.938 -178.497 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.1 ttpt -85.17 126.03 33.31 Favored 'General case' 0 N--CA 1.43 -1.443 2 O-C-N 113.803 -5.528 . . . . 1.4 108.895 -174.482 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.463 HG23 ' HB3' ' A' ' 4' ' ' PHE 0.293 66.0 m -83.77 114.9 21.94 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.058 2.361 . . . . 0.78 109.362 173.966 . . . . . . . . 3 3 . 1 . 137 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mt -98.25 116.7 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 124.553 2.121 . . . . 1.55 105.654 177.051 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.6 m -86.59 105.89 17.18 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.812 -3.055 . . . . 1.08 116.436 173.371 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.0 mt -113.41 115.99 28.93 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 117.199 -1.381 . . . . 1.55 113.319 -179.495 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.368 0.8 OUTLIER -67.94 111.71 4.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.811 1.291 . . . . 1.95 111.211 171.081 . . . . . . . . 3 3 . 1 . 137 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 m -117.0 169.81 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 117.039 -3.538 . . . . 0.96 112.678 179.334 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -112.82 165.57 12.83 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-N 121.512 1.96 . . . . 2.35 108.382 160.25 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -66.47 -28.31 46.01 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 CA-C-N 124.27 2.561 . . . . 0.95 114.313 -172.587 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.293 24.0 p -77.65 1.01 21.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 130.953 3.701 . . . . 1.45 119.475 177.143 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -80.78 143.49 32.83 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.254 -1.529 . . . . 1.69 107.654 175.377 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.3 p -75.56 167.79 21.24 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.439 -0.578 . . . . 0.75 109.439 179.174 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -68.4 -37.18 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.672 -1.893 . . . . 0.73 115.158 175.849 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -49.74 -43.68 48.07 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 112.164 -2.289 . . . . 1.62 114.141 162.817 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -72.42 -28.42 62.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.852 -1.155 . . . . 2.13 113.868 176.104 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.7 t -71.56 -35.42 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 117.366 -3.334 . . . . 0.62 112.042 170.556 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -68.91 -35.66 77.1 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 124.45 1.094 . . . . 1.22 109.146 172.704 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.27 -40.65 96.94 Favored 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 118.78 -2.45 . . . . 0.51 112.97 172.485 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -61.09 -42.35 98.35 Favored 'General case' 0 N--CA 1.429 -1.506 0 O-C-N 119.031 -2.293 . . . . 1.44 115.542 171.003 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.0 mt -58.89 -36.29 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 119.077 -2.264 . . . . 1.32 112.796 167.583 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -61.44 -40.21 93.65 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.49 -1.381 . . . . 1.7 113.501 176.44 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.45 -40.37 94.23 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 119.697 3.221 . . . . 1.55 119.697 162.931 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt -78.68 -68.2 0.67 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.167 2.187 . . . . 2.62 107.935 -176.88 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -101.44 -19.19 15.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 116.857 -1.937 . . . . 1.48 111.238 -169.364 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.57 9.84 45.71 Favored Glycine 0 N--CA 1.431 -1.679 0 CA-C-O 114.748 -3.251 . . . . 1.12 115.877 176.156 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.581 HG22 ' HG3' ' A' ' 41' ' ' GLN . 19.1 mt -85.97 128.39 58.33 Favored Pre-proline 0 N--CA 1.429 -1.49 1 CA-C-O 110.901 -4.38 . . . . 1.55 106.797 -178.953 . . . . . . . . 3 3 . 1 . 137 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -80.65 153.12 20.11 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 CA-C-N 127.561 3.736 . . . . 1.02 110.671 -179.03 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.64 -19.95 41.24 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 124.829 3.686 . . . . 1.25 111.84 -165.768 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -68.16 -39.52 82.56 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 124.283 1.992 . . . . 2.25 116.276 173.009 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -73.04 -43.62 61.77 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 131.221 3.808 . . . . 2.02 115.119 174.091 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.581 ' HG3' HG22 ' A' ' 36' ' ' ILE . 55.7 mt-30 -60.75 137.22 58.22 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.584 -2.573 . . . . 0.69 111.094 -174.591 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -116.51 142.78 46.43 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 125.021 3.555 . . . . 2.78 107.402 167.294 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.483 HD13 HD13 ' A' ' 67' ' ' LEU . 74.9 mt -127.52 119.67 26.56 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.251 -2.129 . . . . 1.17 105.251 178.297 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.5 HD12 HG21 ' A' ' 70' ' ' VAL . 21.3 mt -111.55 132.9 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 129.093 2.957 . . . . 1.38 110.672 -179.995 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -139.23 141.04 37.89 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.394 -2.076 . . . . 1.5 105.394 170.413 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.43 20.71 0.32 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.123 -2.861 . . . . 1.21 117.712 177.667 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.59 6.19 80.78 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 116.807 -3.683 . . . . 1.3 113.287 179.677 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -98.09 121.71 40.35 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 115.382 -2.247 . . . . 2.55 110.841 174.795 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -77.68 125.13 28.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.506 2.323 . . . . 2.48 105.897 171.945 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.288 22.2 mt -79.99 136.41 36.6 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.908 1.814 . . . . 0.9 112.402 -167.684 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.32 46.1 mt-10 -81.19 129.65 34.68 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.113 -3.492 . . . . 1.94 113.574 173.039 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -59.83 -46.05 90.46 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.807 2.521 . . . . 1.56 117.807 -172.211 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.9 49.02 2.25 Favored Glycine 0 N--CA 1.43 -1.704 1 O-C-N 113.098 -6.001 . . . . 0.97 110.149 173.14 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -119.5 176.25 5.45 Favored 'General case' 0 N--CA 1.429 -1.477 1 O-C-N 116.232 -4.099 . . . . 2.49 105.388 161.561 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.3 p -104.29 -175.54 2.82 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 117.904 -1.518 . . . . 0.76 114.245 175.385 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.0 mt -77.97 -29.27 49.65 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.783 -1.198 . . . . 1.05 110.818 173.888 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.9 t -73.58 -29.47 62.43 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.576 -1.328 . . . . 1.19 113.261 176.584 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -58.88 -28.91 66.6 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.833 2.901 . . . . 1.9 118.833 172.252 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.356 26.6 m-85 -100.18 8.96 43.47 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 115.671 1.73 . . . . 0.89 115.671 173.022 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.7 m120 46.69 64.14 1.64 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.553 2.341 . . . . 1.84 113.019 -173.514 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.4 mt -104.5 121.87 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 103.213 -2.884 . . . . 0.82 103.213 177.218 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -96.84 -172.66 2.52 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.994 2.118 . . . . 2.16 106.494 -168.681 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.17 153.61 40.64 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 116.49 -2.084 . . . . 2.12 110.685 173.131 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.301 41.5 mt-10 59.53 46.65 11.86 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 115.117 1.525 . . . . 1.71 115.117 177.729 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -104.17 142.94 33.63 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 131.469 3.908 . . . . 1.04 106.305 178.75 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.4 m -108.77 118.02 35.71 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.176 1.941 . . . . 0.79 106.76 -179.832 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.483 HD13 HD13 ' A' ' 43' ' ' LEU . 74.4 mt -92.44 146.53 23.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 113.202 -1.817 . . . . 1.4 110.242 167.381 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -105.33 115.45 30.27 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.691 2.186 . . . . 1.51 107.036 -179.771 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 tt -88.22 116.3 26.32 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 111.863 -2.426 . . . . 1.14 110.844 -179.625 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.5 HG21 HD12 ' A' ' 44' ' ' ILE . 1.9 t -119.75 -178.51 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 105.259 -2.126 . . . . 1.23 105.259 176.795 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.0 mt -126.97 146.38 50.35 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.173 -3.454 . . . . 2.78 113.354 177.889 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -75.03 144.37 43.08 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 130.139 4.649 . . . . 3.75 115.821 -175.638 . . . . . . . . 2 2 . 1 . 137 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.7 tp -103.59 148.47 25.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 101.78 -3.415 . . . . 3.14 101.78 174.605 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -130.85 147.02 52.45 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.849 -1.523 . . . . 6.8 112.676 174.102 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.82 -50.97 0.78 Allowed Glycine 0 N--CA 1.43 -1.743 0 O-C-N 119.404 -2.06 . . . . 3.57 112.899 -169.251 . . . . . . . . 1 1 . 1 . 137 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.81 0 C-N-CA 125.088 1.328 . . . . 3.87 110.892 179.344 . . . . . . . . 0 0 . 1 . 138 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ptt? . . . . . 0 CA--C 1.49 -1.344 0 N-CA-C 115.568 1.692 . . . . 1.1 115.568 . . . . . . . . . 0 0 . 1 . 138 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -99.16 142.45 30.63 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.173 -2.158 . . . . 1.87 105.173 179.508 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.431 HG13 ' HB2' ' A' ' 15' ' ' LEU . 3.1 pt -117.6 165.08 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 106.569 -1.641 . . . . 0.72 106.569 169.282 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -118.35 121.14 39.66 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.559 -1.338 . . . . 1.4 108.49 179.053 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.3 t -103.37 138.76 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 104.685 -2.339 . . . . 0.58 104.685 171.369 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -111.94 143.58 42.68 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 113.427 -3.178 . . . . 2.09 112.248 173.228 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.5 p -88.61 -172.41 3.73 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.452 3.595 . . . . 0.99 112.915 179.243 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.1 mt -54.14 -38.83 65.91 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 127.028 3.299 . . . . 2.53 116.169 167.282 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -88.81 -35.58 16.53 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 114.297 -5.252 . . . . 2.08 113.002 179.842 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.92 27.37 0.94 Allowed Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 117.745 -1.586 . . . . 1.31 114.541 -179.804 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.8 124.9 29.04 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 120.73 2.265 . . . . 1.4 109.784 -173.929 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.528 1.7 m -78.64 118.63 20.93 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 113.835 -5.54 . . . . 0.78 118.25 176.98 . . . . . . . . 3 2 . 1 . 138 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mt -106.04 121.36 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 125.736 1.615 . . . . 1.55 110.099 172.873 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.251 6.4 m -92.51 108.93 20.34 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 116.854 2.168 . . . . 1.08 116.854 179.55 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.431 ' HB2' HG13 ' A' ' 3' ' ' ILE . 21.5 mt -113.9 130.64 56.48 Favored 'General case' 0 N--CA 1.431 -1.409 1 O-C-N 115.141 -4.724 . . . . 1.55 110.651 -173.627 . . . . . . . . 3 3 . 1 . 138 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -84.81 101.06 11.97 Favored 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 116.688 -3.757 . . . . 1.95 111.184 169.61 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.0 m -114.18 164.26 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 121.154 -0.967 . . . . 0.96 110.089 -179.064 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.403 ' O ' HD12 ' A' ' 56' ' ' LEU . 32.9 mt-10 -102.14 161.4 23.51 Favored Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 127.395 2.278 . . . . 2.35 104.941 159.058 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -77.16 -7.65 17.25 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 CA-C-N 122.655 1.984 . . . . 0.95 107.523 -179.616 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 m -79.31 -14.92 58.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.692 1.597 . . . . 1.45 111.825 177.174 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -65.99 144.8 56.52 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.923 2.297 . . . . 1.69 105.948 -179.888 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.4 p -89.34 158.28 17.85 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.415 -1.72 . . . . 0.75 112.937 176.972 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.332 2.8 mp -53.53 -43.74 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 116.323 -3.985 . . . . 0.73 115.305 169.8 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -41.18 -59.96 1.37 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.189 2.196 . . . . 1.62 114.941 165.888 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -72.24 -24.54 61.39 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 120.322 3.453 . . . . 2.13 120.322 -175.624 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -61.18 -32.22 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 120.361 -1.462 . . . . 0.62 113.198 168.777 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.2 mttt -60.06 -43.46 95.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 117.68 -1.152 . . . . 1.22 110.987 177.602 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.78 -27.06 63.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 125.008 1.443 . . . . 0.51 109.027 177.895 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -66.46 -30.8 71.22 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 118.273 -2.767 . . . . 1.44 110.64 173.535 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.6 mt -65.87 -31.42 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 129.686 3.194 . . . . 1.32 109.732 169.494 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.328 52.9 tt0 -69.33 -33.63 73.42 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.024 -2.922 . . . . 1.7 116.91 175.694 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.261 11.9 m-20 -67.81 -36.87 81.17 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.422 2.289 . . . . 1.55 112.196 168.918 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -76.49 -77.28 0.14 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.831 1.252 . . . . 2.62 110.995 -178.494 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -88.17 -66.92 0.87 Allowed 'General case' 0 N--CA 1.429 -1.487 1 C-N-CA 133.316 4.646 . . . . 1.48 114.743 -166.561 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.76 29.66 0.74 Allowed Glycine 0 N--CA 1.43 -1.714 0 O-C-N 126.973 2.671 . . . . 1.12 110.599 166.932 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.6 mt -89.44 126.12 59.35 Favored Pre-proline 0 N--CA 1.43 -1.459 1 O-C-N 115.738 -4.39 . . . . 1.55 109.192 -179.448 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -54.37 129.28 33.86 Favored 'Trans proline' 0 C--N 1.299 -2.035 1 C-N-CA 125.611 4.207 . . . . 1.02 116.274 175.674 . . . . . . . . 3 3 . 1 . 138 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -59.96 -14.24 26.87 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 CA-C-N 124.324 2.58 . . . . 1.25 116.511 -173.38 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -65.28 -21.92 66.79 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 128.826 2.851 . . . . 2.25 118.581 170.608 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -102.41 -9.4 20.32 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-O 116.406 -1.759 . . . . 2.02 108.715 -172.712 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -89.38 133.49 34.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.742 2.417 . . . . 0.69 114.993 -170.39 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.5 ' HB2' HG23 ' A' ' 70' ' ' VAL . 64.3 mtt180 -132.96 145.09 50.58 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.435 2.064 . . . . 2.78 106.906 169.621 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.5 mt -122.15 143.45 49.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.414 -2.054 . . . . 1.17 114.616 -177.992 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.5 mt -118.83 129.5 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 130.166 3.386 . . . . 1.38 108.887 -179.699 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -130.28 127.3 39.25 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.199 1.8 . . . . 1.5 109.816 167.641 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.85 12.8 0.93 Allowed 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.212 2.301 . . . . 1.21 117.212 -178.379 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.49 0.19 29.35 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 118.136 -2.852 . . . . 1.3 116.837 -174.388 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.307 64.5 mttt -114.62 137.18 52.2 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.748 1.737 . . . . 2.55 114.622 179.671 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -86.01 138.5 31.92 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 117.188 -1.805 . . . . 2.48 107.845 174.192 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.7 mt -88.98 138.74 31.13 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.151 2.278 . . . . 0.9 117.151 -171.654 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -73.11 147.71 44.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 124.107 0.879 . . . . 1.94 113.356 169.932 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.72 -53.96 13.61 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.473 -2.017 . . . . 1.56 111.731 -168.532 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.87 44.1 2.93 Favored Glycine 0 N--CA 1.431 -1.666 0 O-C-N 126.702 2.501 . . . . 0.97 115.372 172.121 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -116.91 165.37 13.41 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 125.43 2.538 . . . . 2.49 104.447 163.616 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.9 p -96.66 163.76 12.88 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 112.89 -1.959 . . . . 0.76 110.605 172.873 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 18' ' ' GLU . 96.2 mt -57.39 -40.43 78.2 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 127.345 2.258 . . . . 1.05 111.161 170.518 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.9 t -64.92 -40.94 95.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 126.646 2.466 . . . . 1.19 114.374 -179.174 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -56.0 -40.83 73.93 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.124 -3.485 . . . . 1.9 119.409 176.822 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -84.91 3.82 36.36 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 112.882 -1.963 . . . . 0.89 110.938 170.851 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.421 26.4 m120 62.49 38.64 12.5 Favored 'General case' 0 N--CA 1.43 -1.454 1 N-CA-C 121.957 4.058 . . . . 1.84 121.957 -174.382 . . . . . . . . 3 2 . 1 . 138 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.1 mt -93.65 123.65 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 117.281 -3.387 . . . . 0.82 109.107 -175.044 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 -107.69 -172.48 2.08 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.178 1.353 . . . . 2.16 111.009 -172.577 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -56.16 144.35 29.91 Favored 'General case' 0 N--CA 1.428 -1.526 0 O-C-N 126.65 2.469 . . . . 2.12 113.658 168.315 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.294 35.5 mt-10 57.23 32.34 21.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.525 3.13 . . . . 1.71 117.052 173.226 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 t -96.14 133.86 39.91 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.719 3.208 . . . . 1.04 109.996 -174.237 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.15 116.57 21.12 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 118.119 2.637 . . . . 0.79 118.119 177.344 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.263 54.3 mt -101.46 140.24 36.03 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.847 -3.033 . . . . 1.4 106.291 173.542 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -104.14 121.22 42.78 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-O 116.081 -1.914 . . . . 1.51 110.934 -174.556 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.3 tp -89.89 128.52 36.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.869 1.795 . . . . 1.14 115.365 178.48 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.5 HG23 ' HB2' ' A' ' 42' ' ' ARG . 35.4 m -127.09 151.71 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 1 CA-C-O 128.827 4.156 . . . . 1.23 104.86 176.778 . . . . . . . . 3 3 . 1 . 138 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.8 mt -115.51 141.88 47.46 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 116.188 -4.07 . . . . 2.78 111.481 -167.571 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -77.27 168.0 20.77 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 115.359 -4.588 . . . . 3.75 118.022 174.012 . . . . . . . . 2 2 . 1 . 138 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.8 mt -97.6 -175.03 3.07 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 118.637 -2.539 . . . . 3.14 106.818 167.006 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -70.81 -55.45 8.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 114.971 -2.442 . . . . 6.8 114.058 -179.545 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.72 88.58 0.2 Allowed Glycine 0 N--CA 1.429 -1.779 0 O-C-N 126.702 2.501 . . . . 3.57 108.835 -172.493 . . . . . . . . 1 1 . 1 . 138 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.782 0 C-N-CA 130.456 3.884 . . . . 3.87 111.456 179.979 . . . . . . . . 0 0 . 1 . 139 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.294 45.1 ttp . . . . . 0 CA--C 1.491 -1.327 0 N-CA-C 113.749 1.018 . . . . 1.1 113.749 . . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -100.73 123.47 44.98 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 119.491 -0.883 . . . . 1.87 111.541 -177.499 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.451 HG12 HG22 ' A' ' 17' ' ' VAL . 6.6 pt -120.93 163.65 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.311 -0.996 . . . . 0.72 108.311 174.258 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -119.95 143.03 48.22 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 130.937 3.695 . . . . 1.4 109.738 -177.924 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.298 43.5 t -116.84 115.07 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 116.915 -3.616 . . . . 0.58 113.651 171.734 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -95.53 143.8 26.54 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 115.949 -1.977 . . . . 2.09 108.374 -176.54 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.7 p -101.37 179.75 4.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 126.748 3.166 . . . . 0.99 112.213 173.058 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.3 mt -79.77 -10.42 59.78 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 111.607 -6.933 . . . . 2.53 115.062 173.218 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.257 28.8 p -86.51 -51.64 6.06 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 126.321 2.962 . . . . 2.08 110.914 178.002 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.7 -2.19 0.45 Allowed Glycine 0 N--CA 1.43 -1.705 0 O-C-N 118.198 -2.814 . . . . 1.31 112.343 177.891 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -78.19 142.58 37.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 123.078 3.439 . . . . 1.4 110.672 -179.627 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.6 m -107.95 132.88 53.03 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 123.863 1.792 . . . . 0.78 107.503 171.797 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -109.93 149.16 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 102.454 -3.165 . . . . 1.55 102.454 177.212 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.3 m -123.4 125.11 44.37 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.487 -3.883 . . . . 1.08 100.645 -177.256 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -126.51 159.11 34.35 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.357 2.263 . . . . 1.55 106.011 176.244 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -120.92 125.91 48.65 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.939 3.295 . . . . 1.95 108.576 169.839 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.451 HG22 HG12 ' A' ' 3' ' ' ILE . 3.4 m -132.28 158.41 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 129.843 3.257 . . . . 0.96 105.315 -173.059 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -114.38 141.13 26.03 Favored Pre-proline 0 N--CA 1.429 -1.476 0 N-CA-C 102.409 -3.182 . . . . 2.35 102.409 167.365 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -61.96 -7.52 9.83 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 C-N-CA 124.511 3.474 . . . . 0.95 116.169 -171.295 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 p -73.36 -14.71 61.33 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.161 2.984 . . . . 1.45 112.104 172.977 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -75.34 145.36 41.79 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 117.354 -3.341 . . . . 1.69 111.652 179.538 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 60.9 p -89.83 179.19 6.05 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.875 -1.141 . . . . 0.75 113.477 178.31 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 23' ' ' ILE . 23.3 mm -79.67 -22.59 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 121.289 1.859 . . . . 0.73 107.162 175.453 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -70.83 -31.4 68.12 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.052 2.141 . . . . 1.62 110.499 170.233 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -77.18 -35.42 55.84 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.65 2.38 . . . . 2.13 111.788 173.493 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.0 t -55.44 -55.11 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-N 123.819 3.009 . . . . 0.62 112.32 167.043 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -50.44 -39.2 47.03 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 126.298 2.249 . . . . 1.22 116.078 173.939 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.83 -35.82 80.94 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.075 1.75 . . . . 0.51 111.139 173.499 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -74.54 -22.8 58.83 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 115.825 -2.35 . . . . 1.44 111.429 174.062 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.287 55.5 mt -70.96 -30.48 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.389 -2.07 . . . . 1.32 111.931 171.572 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -65.4 -38.09 88.91 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 113.768 -1.56 . . . . 1.7 110.306 175.481 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.57 -59.9 2.8 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 115.22 -4.675 . . . . 1.55 112.497 168.951 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -60.75 -58.4 8.61 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.767 1.627 . . . . 2.62 112.367 -172.737 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -95.34 -56.21 2.79 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.917 -2.364 . . . . 1.48 109.611 -170.542 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.94 4.48 7.22 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 105.146 -3.182 . . . . 1.12 105.146 176.779 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mt -74.16 129.51 84.35 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 114.32 -2.753 . . . . 1.55 105.826 -173.878 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -70.58 154.23 64.62 Favored 'Trans proline' 0 N--CA 1.434 -2.009 0 C-N-CA 115.388 -2.608 . . . . 1.02 116.888 178.006 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.59 -4.88 13.83 Favored 'Trans proline' 0 C--N 1.3 -2.015 1 C-N-CA 125.544 4.162 . . . . 1.25 108.068 -172.647 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -77.45 -40.09 44.46 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 125.669 3.849 . . . . 2.25 111.55 169.334 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -60.07 -28.62 67.95 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.668 2.47 . . . . 2.02 117.668 -178.981 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -89.47 151.77 21.82 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.182 1.944 . . . . 0.69 115.396 -178.223 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.28 83.9 mtt180 -135.8 139.8 43.77 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 101.258 -3.608 . . . . 2.78 101.258 170.104 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 39.0 mt -122.14 128.6 51.46 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 124.67 3.396 . . . . 1.17 105.793 -178.682 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 mm -119.06 139.02 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 114.704 -2.57 . . . . 1.38 107.57 -178.888 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -131.53 126.51 35.09 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 115.921 -1.99 . . . . 1.5 106.358 171.964 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 82.23 -71.95 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 126.874 2.609 . . . . 1.21 106.188 -177.83 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.18 -26.57 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.659 0 C-N-CA 126.112 1.815 . . . . 1.3 114.206 -171.491 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -85.55 160.35 19.68 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.241 1.941 . . . . 2.55 116.241 172.809 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.277 49.2 tt0 -90.76 137.43 32.36 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.24 3.052 . . . . 2.48 119.24 170.324 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.0 mt -94.45 127.73 40.55 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.082 -3.511 . . . . 0.9 109.274 -169.472 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -75.9 158.81 31.61 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 118.225 2.676 . . . . 1.94 118.225 179.885 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -63.44 -59.82 4.16 Favored 'General case' 0 N--CA 1.43 -1.473 1 N-CA-C 122.879 4.4 . . . . 1.56 122.879 -168.018 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.44 23.51 8.44 Favored Glycine 0 N--CA 1.429 -1.795 0 CA-C-O 116.094 -2.503 . . . . 0.97 113.836 178.75 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -98.22 154.19 17.95 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 122.787 3.294 . . . . 2.49 109.106 168.35 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 31.1 p -85.7 177.3 7.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.873 -2.392 . . . . 0.76 115.591 171.356 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.27 -40.89 90.41 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 111.667 -2.515 . . . . 1.05 111.297 173.225 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.4 m -70.9 -25.79 62.94 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.567 3.547 . . . . 1.19 112.307 178.435 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -66.69 -55.6 14.43 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 120.762 1.619 . . . . 1.9 113.182 170.773 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -75.42 3.69 8.72 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 120.544 3.535 . . . . 0.89 120.544 173.685 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 54.43 46.78 24.3 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.023 -2.298 . . . . 1.84 117.011 178.704 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.4 mt -97.06 103.92 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 104.867 -2.271 . . . . 0.82 104.867 -179.556 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -104.67 -172.79 2.16 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 125.4 2.524 . . . . 2.16 109.296 -172.862 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -53.5 139.82 30.0 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.127 -2.858 . . . . 2.12 112.958 -179.863 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.374 30.7 mt-10 59.77 21.9 10.74 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 130.945 3.698 . . . . 1.71 113.871 -179.057 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.11 143.32 27.14 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.152 1.908 . . . . 1.04 116.152 -176.989 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.7 m -106.67 121.08 43.64 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 123.769 0.668 . . . . 0.79 112.552 -171.441 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.2 mt -95.41 164.64 12.73 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 106.694 -1.595 . . . . 1.4 106.694 173.063 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -115.48 116.64 28.54 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.486 1.915 . . . . 1.51 110.733 -179.58 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.5 tp -92.76 125.6 37.45 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.682 1.706 . . . . 1.14 112.889 179.683 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.1 t -120.08 126.08 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 101.89 -3.374 . . . . 1.23 101.89 178.252 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.8 mt -101.85 153.85 19.46 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 126.229 2.918 . . . . 2.78 113.709 178.394 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -91.75 125.06 36.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.183 -2.198 . . . . 3.75 108.217 177.421 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.2 tp -120.01 -37.94 3.02 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 129.174 4.046 . . . . 3.14 111.246 170.205 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.313 24.1 mtm-85 -107.43 -97.98 0.36 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.697 -1.223 . . . . 6.8 107.697 171.283 . . . . . . . . 2 2 . 1 . 139 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.2 123.69 0.78 Allowed Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 104.785 -3.326 . . . . 3.57 104.785 -161.392 . . . . . . . . 1 1 . 1 . 139 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.793 0 N-CA-C 105.098 -3.201 . . . . 3.87 105.098 -179.081 . . . . . . . . 0 0 . 1 . 140 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptt? . . . . . 0 CA--C 1.49 -1.355 0 N-CA-C 118.619 2.822 . . . . 1.1 118.619 . . . . . . . . . 0 0 . 1 . 140 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -85.78 146.83 26.6 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 117.823 -1.551 . . . . 1.87 110.191 179.722 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.2 pt -140.76 158.41 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 101.07 -3.678 . . . . 0.72 101.07 175.722 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -112.15 115.89 29.58 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 113.619 -1.628 . . . . 1.4 111.047 -176.816 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -85.84 113.69 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 118.942 -2.349 . . . . 0.58 107.749 171.594 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -104.06 122.23 44.85 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.13 -3.481 . . . . 2.09 111.868 177.688 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.2 p -83.47 158.05 22.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 123.481 1.61 . . . . 0.99 112.902 174.767 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.6 mt -88.52 -23.92 23.06 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 115.606 -4.434 . . . . 2.53 109.173 176.36 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.0 p -61.37 -37.89 85.0 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.199 -3.438 . . . . 2.08 110.699 174.415 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.23 -58.09 0.38 Allowed Glycine 0 N--CA 1.43 -1.76 0 O-C-N 121.75 -0.594 . . . . 1.31 112.896 176.272 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.261 19.3 ptmt -61.69 150.34 36.93 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.567 -3.314 . . . . 1.4 116.312 -170.675 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.3 m -114.66 123.55 49.57 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.488 1.515 . . . . 0.78 108.237 169.811 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.2 mt -114.41 126.97 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.211 -3.43 . . . . 1.55 110.821 179.766 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.6 m -89.49 109.81 20.71 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.611 -2.556 . . . . 1.08 108.514 -177.256 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.7 mt -107.12 157.51 17.8 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.92 -1.881 . . . . 1.55 105.92 179.629 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -106.68 133.6 51.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.069 1.748 . . . . 1.95 108.296 171.199 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.462 HG21 HD13 ' A' ' 56' ' ' LEU . 30.1 m -145.23 160.81 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 117.274 -1.346 . . . . 0.96 107.881 -178.484 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -95.98 155.59 38.12 Favored Pre-proline 0 N--CA 1.43 -1.462 0 N-CA-C 106.225 -1.768 . . . . 2.35 106.225 168.308 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.265 39.7 Cg_exo -66.28 -13.99 42.27 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 123.129 2.552 . . . . 0.95 115.456 -176.371 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -111.2 25.59 11.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 122.658 1.218 . . . . 1.45 108.538 -179.751 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -84.17 137.14 33.67 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 116.841 -3.662 . . . . 1.69 104.613 174.388 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.335 80.4 p -67.05 165.21 16.2 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 117.773 2.509 . . . . 0.75 117.773 176.627 . . . . . . . . 3 3 . 1 . 140 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.2 mm -67.95 -38.05 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 116.966 -3.584 . . . . 0.73 109.517 175.269 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -46.87 -42.21 17.04 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 128.651 2.781 . . . . 1.62 113.688 168.596 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -80.08 -29.13 39.05 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.449 -2.657 . . . . 2.13 110.771 -178.268 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.5 HG21 HD21 ' A' ' 56' ' ' LEU 0.274 12.0 t -67.81 -41.15 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 119.764 -1.835 . . . . 0.62 113.239 167.606 . . . . . . . . 3 3 . 1 . 140 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -65.04 -26.5 68.29 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.552 -2.593 . . . . 1.22 116.463 170.771 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.23 -31.2 68.51 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.429 -3.294 . . . . 0.51 112.51 172.184 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -73.45 -37.31 65.86 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 123.686 0.616 . . . . 1.44 111.651 174.584 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.5 mt -65.3 -35.09 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-O 124.442 2.068 . . . . 1.32 112.064 175.322 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -61.45 -41.82 97.8 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.045 3.738 . . . . 1.7 112.493 -178.783 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -68.47 -32.74 72.96 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 126.759 2.537 . . . . 1.55 115.347 167.943 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -79.13 -60.09 2.51 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 119.17 0.896 . . . . 2.62 112.497 -179.415 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -102.71 -20.84 14.22 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 118.246 -2.784 . . . . 1.48 112.545 -167.388 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.2 30.49 10.9 Favored Glycine 0 N--CA 1.43 -1.738 0 C-N-CA 117.59 -2.243 . . . . 1.12 112.643 178.73 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.8 mt -109.56 111.49 59.34 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 116.544 -1.694 . . . . 1.55 108.435 -178.589 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -61.77 153.1 70.04 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 122.973 2.449 . . . . 1.02 113.362 179.816 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -70.96 -15.14 32.63 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-N 126.631 3.404 . . . . 1.25 118.961 -177.005 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -51.83 -46.0 64.17 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 126.301 2.251 . . . . 2.25 113.784 170.48 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -76.97 -5.43 48.58 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 116.988 -1.482 . . . . 2.02 111.424 -177.701 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -99.26 126.42 45.09 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 120.013 1.279 . . . . 0.69 109.842 -172.374 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -116.8 130.84 56.96 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 128.626 2.77 . . . . 2.78 104.443 164.508 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -107.54 132.43 53.26 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.309 -2.744 . . . . 1.17 111.669 173.74 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.4 mm -109.63 141.96 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 119.881 -1.762 . . . . 1.38 108.74 179.556 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -140.7 117.66 11.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.575 -1.268 . . . . 1.5 107.575 170.636 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.377 . . 72.98 -44.19 0.59 Allowed 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 129.594 3.157 . . . . 1.21 112.048 -175.827 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 173.38 -42.45 0.15 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 128.039 2.733 . . . . 1.3 115.253 -171.947 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -74.13 157.5 35.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 118.584 -1.246 . . . . 2.55 110.262 178.663 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -87.58 143.59 27.12 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 126.319 1.848 . . . . 2.48 110.283 176.273 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.3 mt -93.64 151.79 19.43 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 116.288 -4.008 . . . . 0.9 112.216 -176.655 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -93.49 147.66 22.77 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 104.403 -2.443 . . . . 1.94 104.403 174.05 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -66.37 -52.68 44.39 Favored 'General case' 0 N--CA 1.43 -1.426 1 CA-C-O 128.599 4.047 . . . . 1.56 116.194 -170.938 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.61 48.34 3.66 Favored Glycine 0 N--CA 1.43 -1.743 1 O-C-N 114.511 -5.118 . . . . 0.97 111.838 173.962 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -130.67 161.84 30.74 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.547 -2.737 . . . . 2.49 105.742 162.071 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 14.0 p -95.7 179.72 5.02 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 117.036 -1.866 . . . . 0.76 110.076 -173.174 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.5 HD21 HG21 ' A' ' 26' ' ' VAL . 2.9 mt -72.24 -41.68 66.54 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 116.783 -1.579 . . . . 1.05 113.082 172.378 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 t -68.34 -11.96 60.34 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 121.769 2.077 . . . . 1.19 114.869 172.617 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -79.92 -29.44 39.77 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 125.445 3.748 . . . . 1.9 110.405 177.826 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -90.68 -6.04 55.02 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.056 -3.528 . . . . 0.89 112.304 174.258 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 75.7 34.19 0.59 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.684 3.74 . . . . 1.84 113.174 175.889 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.705 HD13 HD21 ' A' ' 67' ' ' LEU . 37.7 mt -74.7 107.66 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 127.476 2.31 . . . . 0.82 111.917 175.685 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -84.74 178.51 7.62 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 126.728 2.517 . . . . 2.16 110.509 177.624 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -62.05 146.94 48.82 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 115.031 1.493 . . . . 2.12 115.031 172.451 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 64.29 39.41 7.32 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 122.827 1.299 . . . . 1.71 111.477 173.144 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 t -113.94 147.56 38.34 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.806 -1.543 . . . . 1.04 112.949 -173.806 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.2 m -93.96 130.14 40.18 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.726 -1.858 . . . . 0.79 113.777 178.446 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.705 HD21 HD13 ' A' ' 61' ' ' ILE . 96.7 mt -115.01 132.92 56.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.918 -1.882 . . . . 1.4 105.918 173.808 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -94.05 125.34 38.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.756 3.169 . . . . 1.51 111.278 -174.469 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 tp -92.94 116.1 28.73 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 113.345 -5.847 . . . . 1.14 110.57 176.735 . . . . . . . . 2 2 . 1 . 140 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.0 t -111.77 126.03 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 128.474 2.709 . . . . 1.23 106.332 179.23 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mp -93.39 139.24 30.9 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.216 -2.802 . . . . 2.78 107.015 178.948 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -59.67 133.59 56.23 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 128.255 2.622 . . . . 3.75 116.549 -171.066 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 41.8 mt -102.88 160.08 14.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.032 -1.668 . . . . 3.14 106.836 168.125 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -124.36 140.7 52.71 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.173 -1.579 . . . . 6.8 111.798 168.07 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.86 40.81 1.05 Allowed Glycine 0 N--CA 1.429 -1.777 0 CA-C-O 114.372 -3.46 . . . . 3.57 107.386 -165.662 . . . . . . . . 1 1 . 1 . 140 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.812 0 C-N-CA 129.209 3.29 . . . . 3.87 115.133 -176.256 . . . . . . . . 0 0 . 1 . 141 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 ttp . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 123.405 1.574 . . . . 1.1 109.537 . . . . . . . . . 0 0 . 1 . 141 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -91.53 144.43 25.56 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.235 -4.666 . . . . 1.87 106.781 178.357 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.3 pt -140.12 175.35 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 124.195 1.95 . . . . 0.72 106.974 169.008 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -116.29 143.54 45.4 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 104.736 -2.32 . . . . 1.4 104.736 176.557 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.92 117.74 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 1 O-C-N 129.425 4.203 . . . . 0.58 103.805 167.315 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -105.75 141.3 37.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.411 -2.68 . . . . 2.09 114.13 173.582 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.1 p -84.25 171.34 12.83 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.35 -1.468 . . . . 0.99 112.658 177.058 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.258 13.1 tp -57.53 -44.09 84.84 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.754 2.822 . . . . 2.53 114.854 168.142 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 p -75.83 -65.58 0.89 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.752 1.621 . . . . 2.08 112.844 -173.72 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.09 53.28 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.696 0 CA-C-O 117.574 -1.681 . . . . 1.31 116.585 175.599 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -128.6 124.52 36.07 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.29 -1.744 . . . . 1.4 106.29 -179.374 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.9 m -104.14 133.86 48.36 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 102.906 -2.998 . . . . 0.78 102.906 -178.778 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.8 mt -106.85 135.01 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 103.182 -2.896 . . . . 1.55 103.182 178.703 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.9 m -97.35 122.71 40.7 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.158 -2.214 . . . . 1.08 106.821 178.351 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.8 tp -129.02 124.18 34.28 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 117.217 2.303 . . . . 1.55 117.217 -175.379 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -79.86 124.63 28.82 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 117.166 -1.397 . . . . 1.95 107.443 174.47 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.0 m -134.77 177.57 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 128.668 2.787 . . . . 0.96 106.655 178.95 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.4 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 44.4 mt-10 -123.36 166.57 17.81 Favored Pre-proline 0 N--CA 1.43 -1.448 0 C-N-CA 127.187 2.195 . . . . 2.35 106.735 163.092 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 58.2 Cg_endo -82.2 -17.31 7.95 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 122.915 2.41 . . . . 0.95 109.681 -174.37 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.3 m -90.35 5.19 48.4 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.255 -2.153 . . . . 1.45 110.318 178.156 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -84.2 158.55 21.26 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.112 -1.81 . . . . 1.69 106.112 177.324 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -92.78 163.94 13.54 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 123.579 1.657 . . . . 0.75 110.202 178.767 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mp -68.08 -34.82 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 127.272 3.415 . . . . 0.73 116.363 174.548 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -53.36 -44.07 68.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.724 -2.485 . . . . 1.62 117.59 161.699 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -66.37 -31.97 73.07 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.583 1.953 . . . . 2.13 109.801 175.847 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.51 -47.98 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 117.848 -3.032 . . . . 0.62 113.497 175.899 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.302 95.8 mttt -49.63 -40.82 40.64 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 130.275 3.43 . . . . 1.22 115.229 167.664 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.89 -39.66 87.54 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.941 1.696 . . . . 0.51 113.494 177.923 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -66.03 -29.78 70.2 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 118.346 2.721 . . . . 1.44 118.346 167.929 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.1 mt -76.02 -33.65 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 118.496 -2.627 . . . . 1.32 114.827 171.841 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -69.6 -33.4 72.64 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.268 -1.333 . . . . 1.7 109.951 172.931 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.3 -59.54 4.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.078 1.751 . . . . 1.55 110.069 170.37 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -65.62 -60.52 2.83 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 130.463 3.505 . . . . 2.62 112.029 -168.478 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -102.85 -53.15 2.91 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.623 -3.173 . . . . 1.48 111.885 -175.521 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.05 38.02 0.4 Allowed Glycine 0 N--CA 1.43 -1.721 0 O-C-N 120.466 -1.396 . . . . 1.12 115.309 172.325 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.7 mt -110.24 126.43 28.95 Favored Pre-proline 0 N--CA 1.43 -1.435 0 C-N-CA 126.26 1.824 . . . . 1.55 108.695 -174.974 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.47 143.54 97.45 Favored 'Trans proline' 0 N--CA 1.434 -2.006 1 O-C-N 112.743 -4.398 . . . . 1.02 115.701 -178.411 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -67.61 -14.15 41.17 Favored 'Trans proline' 0 N--CA 1.434 -2.029 0 N-CA-C 118.897 2.614 . . . . 1.25 118.897 -173.179 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -79.78 -36.71 36.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 125.37 1.669 . . . . 2.25 107.951 179.364 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -74.98 -30.2 61.12 Favored 'General case' 0 N--CA 1.431 -1.402 1 C-N-CA 133.634 4.773 . . . . 2.02 111.363 -169.035 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -87.92 134.14 33.77 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.566 -2.584 . . . . 0.69 112.519 -173.41 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.617 ' HB2' HG23 ' A' ' 70' ' ' VAL . 84.5 mtt180 -112.71 142.84 44.86 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 116.74 -3.725 . . . . 2.78 107.012 168.408 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.3 mt -119.86 116.49 25.95 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 118.896 -2.378 . . . . 1.17 113.393 174.958 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.3 mt -88.87 137.01 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 127.875 2.47 . . . . 1.38 110.967 -178.901 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -154.9 131.18 10.36 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.685 2.184 . . . . 1.5 105.439 173.286 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.74 -64.75 0.1 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 119.395 3.109 . . . . 1.21 119.395 178.998 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -158.34 11.47 0.22 Allowed Glycine 0 N--CA 1.43 -1.703 0 CA-C-O 122.776 1.209 . . . . 1.3 112.914 177.835 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.5 pttt -144.94 177.23 8.9 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 111.964 -2.118 . . . . 2.55 111.486 -174.411 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -110.39 157.3 19.69 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.533 1.933 . . . . 2.48 108.707 171.982 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.6 mt -102.86 137.7 40.71 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 117.953 -1.022 . . . . 0.9 113.02 -173.837 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.472 ' HB2' ' HG2' ' A' ' 54' ' ' ARG . 49.8 mt-10 -75.44 141.82 43.09 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.89 2.876 . . . . 1.94 111.003 177.512 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -69.21 -53.07 21.84 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 123.3 2.773 . . . . 1.56 116.005 -162.977 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.95 42.04 3.12 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 119.078 -2.264 . . . . 0.97 114.714 175.121 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.472 ' HG2' ' HB2' ' A' ' 51' ' ' GLU . 28.6 mmt180 -112.14 161.31 16.67 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 121.415 2.607 . . . . 2.49 104.142 166.766 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.1 p -90.9 162.26 14.86 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 116.807 -3.683 . . . . 0.76 111.546 178.879 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.2 mt -63.86 -33.13 75.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.488 2.315 . . . . 1.05 110.573 169.566 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.5 p -63.57 -53.6 49.21 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.369 -2.707 . . . . 1.19 114.978 179.339 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -56.16 -34.19 65.92 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.424 -1.262 . . . . 1.9 114.385 173.875 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -82.01 -4.17 56.14 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.906 -1.121 . . . . 0.89 112.571 -176.896 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.261 19.4 m-80 58.42 41.89 22.13 Favored 'General case' 0 N--CA 1.431 -1.415 1 C-N-CA 133.043 4.537 . . . . 1.84 115.861 -174.418 . . . . . . . . 3 2 . 1 . 141 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.1 mt -85.32 122.51 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 117.607 -3.183 . . . . 0.82 112.576 178.188 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -97.54 -174.04 2.81 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 125.404 2.526 . . . . 2.16 113.251 -175.141 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -59.52 131.82 52.11 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 127.348 3.452 . . . . 2.12 116.702 170.82 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.308 13.6 mt-10 73.02 31.46 1.48 Allowed 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 127.04 3.305 . . . . 1.71 114.127 173.797 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.5 m -88.84 160.98 16.97 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 118.523 -2.611 . . . . 1.04 108.68 -173.48 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.253 4.3 m -114.38 114.16 25.51 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 116.41 -3.931 . . . . 0.79 112.307 -178.424 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.9 mt -93.87 128.24 40.05 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 129.909 3.284 . . . . 1.4 108.158 170.337 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -111.51 116.81 31.49 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 126.128 2.871 . . . . 1.51 115.184 -175.85 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.9 tp -84.53 116.98 23.42 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.852 -2.405 . . . . 1.14 113.852 -173.622 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.617 HG23 ' HB2' ' A' ' 42' ' ' ARG . 31.4 m -122.0 161.24 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 114.415 -1.266 . . . . 1.23 111.082 168.7 . . . . . . . . 2 2 . 1 . 141 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.4 mt -92.14 170.09 10.1 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.055 -1.653 . . . . 2.78 107.598 178.981 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -119.51 144.87 46.79 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 101.061 -3.681 . . . . 3.75 101.061 -171.698 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.6 mt -104.34 171.51 7.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.414 -0.804 . . . . 3.14 109.186 176.993 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -83.21 117.72 23.12 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.101 -2.25 . . . . 6.8 116.228 177.236 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.55 80.99 0.17 Allowed Glycine 0 N--CA 1.429 -1.792 0 CA-C-O 116.454 -2.303 . . . . 3.57 113.278 -166.747 . . . . . . . . 1 1 . 1 . 141 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.789 0 CA-C-N 119.958 1.879 . . . . 3.87 112.402 174.861 . . . . . . . . 0 0 . 1 . 142 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 ptt? . . . . . 0 CA--C 1.489 -1.373 0 N-CA-C 113.809 1.04 . . . . 1.1 113.809 . . . . . . . . . 0 0 . 1 . 142 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -88.52 127.92 35.54 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.466 -1.396 . . . . 1.87 109.379 -176.449 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.424 HD12 HD13 ' A' ' 67' ' ' LEU . 8.8 pt -121.97 161.07 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 104.891 -2.262 . . . . 0.72 104.891 164.798 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -120.69 137.01 54.69 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.182 2.193 . . . . 1.4 106.865 176.449 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -119.07 125.31 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 128.281 2.632 . . . . 0.58 110.253 173.402 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -99.48 141.9 31.66 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.515 -1.991 . . . . 2.09 113.894 -178.215 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 p -102.19 175.63 5.46 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 121.165 1.802 . . . . 0.99 109.908 179.136 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.2 tp -44.6 -47.76 10.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.461 1.652 . . . . 2.53 115.461 167.996 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.8 p -80.55 -0.56 38.23 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 123.547 0.739 . . . . 2.08 112.401 -178.662 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.8 25.57 57.95 Favored Glycine 0 N--CA 1.43 -1.76 1 C-N-CA 134.18 5.657 . . . . 1.31 112.533 178.651 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -71.01 127.1 31.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.862 -1.533 . . . . 1.4 106.862 -173.145 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.1 m -84.79 122.23 28.83 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 113.076 -3.45 . . . . 0.78 114.55 173.957 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.0 mt -98.99 119.64 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 105.323 -2.103 . . . . 1.55 105.323 173.086 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.5 m -90.63 111.47 22.81 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.312 2.258 . . . . 1.08 113.148 -178.986 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.0 mt -116.28 155.1 28.98 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 120.254 1.388 . . . . 1.55 111.45 -174.882 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -107.34 114.58 28.7 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 128.396 2.678 . . . . 1.95 105.134 172.377 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -124.68 164.12 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 118.185 -2.822 . . . . 0.96 106.831 179.117 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -102.84 147.84 34.68 Favored Pre-proline 0 N--CA 1.43 -1.453 1 C-N-CA 133.06 4.544 . . . . 2.35 114.308 159.792 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -77.58 -12.67 16.72 Favored 'Trans proline' 0 C--N 1.3 -2.008 1 CA-C-N 129.347 4.374 . . . . 0.95 110.929 -166.521 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 p -88.88 -0.51 57.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 115.311 -2.281 . . . . 1.45 113.295 178.342 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -74.31 149.67 40.54 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 125.276 1.61 . . . . 1.69 114.6 177.233 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.259 57.8 p -85.04 157.33 20.77 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 125.632 2.634 . . . . 0.75 110.153 -178.505 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.3 mm -67.72 -32.03 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 118.492 -2.63 . . . . 0.73 109.783 175.665 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -61.89 -32.72 73.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.224 2.21 . . . . 1.62 116.096 165.086 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -81.17 -29.47 34.66 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 122.428 2.376 . . . . 2.13 113.162 176.023 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.8 -32.2 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.401 -1.333 . . . . 0.62 107.401 174.488 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.319 48.8 mttt -51.69 -41.29 61.33 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 118.889 2.922 . . . . 1.22 118.889 172.95 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.1 -40.73 59.11 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 117.512 2.412 . . . . 0.51 117.512 166.179 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -68.7 -48.99 62.47 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.405 2.526 . . . . 1.44 114.228 -178.933 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 30' ' ' ILE . 4.2 mt -54.74 -39.67 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 O-C-N 118.144 -2.848 . . . . 1.32 117.714 166.621 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -68.52 -32.11 71.84 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.032 -2.917 . . . . 1.7 112.152 -179.801 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -59.93 -38.17 81.6 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.167 -2.833 . . . . 1.55 114.76 168.411 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -75.13 -66.24 0.78 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 127.586 2.354 . . . . 2.62 109.676 -178.761 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -106.41 -20.88 13.24 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 128.403 2.681 . . . . 1.48 111.824 -159.988 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.31 -2.27 70.89 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 121.773 3.469 . . . . 1.12 121.773 177.901 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.8 mt -68.93 129.37 92.34 Favored Pre-proline 0 N--CA 1.431 -1.41 0 C-N-CA 127.473 2.309 . . . . 1.55 113.561 -179.584 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.251 0.3 OUTLIER -72.52 143.74 38.97 Favored 'Trans proline' 0 C--N 1.299 -2.042 1 C-N-CA 125.496 4.131 . . . . 1.02 112.995 -173.285 . . . . . . . . 4 3 . 1 . 142 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.53 -11.95 33.79 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 121.813 1.683 . . . . 1.25 114.151 -178.53 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.48 -31.86 67.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.832 -1.168 . . . . 2.25 112.054 173.99 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -96.88 -22.19 17.04 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 125.227 1.58 . . . . 2.02 113.903 -173.373 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -75.86 122.65 24.43 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 123.674 1.702 . . . . 0.69 111.921 178.705 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -121.99 143.76 49.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 117.721 -3.112 . . . . 2.78 106.134 168.653 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.45 150.53 29.73 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.181 -3.449 . . . . 1.17 110.999 178.972 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mt -129.69 140.04 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 N-CA-C 97.291 -5.077 . . . . 1.38 97.291 -179.583 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -154.98 137.78 15.33 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.793 2.437 . . . . 1.5 105.448 169.492 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.406 . . 74.46 -49.52 0.67 Allowed 'General case' 0 N--CA 1.431 -1.385 1 C-N-CA 134.917 5.287 . . . . 1.21 115.425 178.999 . . . . . . . . 3 2 . 1 . 142 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -173.43 -23.92 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 106.095 -2.802 . . . . 1.3 106.095 -177.497 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -118.53 158.3 25.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.626 2.631 . . . . 2.55 113.281 -170.819 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -71.66 126.29 29.3 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.7 -1.963 . . . . 2.48 105.7 169.715 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.1 mt -82.97 141.66 31.96 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.861 2.464 . . . . 0.9 108.887 -175.962 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -81.42 152.69 27.3 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.491 -4.506 . . . . 1.94 106.589 171.889 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -77.59 -57.22 3.93 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.287 -1.779 . . . . 1.56 111.654 -167.843 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.34 17.59 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.752 0 CA-C-O 114.002 -3.666 . . . . 0.97 120.37 168.689 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -110.21 175.15 5.54 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 123.609 3.704 . . . . 2.49 105.122 176.307 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.0 p -102.41 171.9 7.19 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 128.242 3.877 . . . . 0.76 117.012 171.003 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.2 mt -65.32 -33.18 75.37 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 112.241 -2.254 . . . . 1.05 112.923 173.848 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 m -64.23 -36.25 83.47 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.142 2.645 . . . . 1.19 118.142 177.099 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -56.88 -42.89 80.62 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.493 2.717 . . . . 1.9 109.045 173.097 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -93.4 3.81 54.99 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.175 -3.453 . . . . 0.89 116.981 -177.905 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.321 69.9 m-80 71.48 29.96 2.58 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 125.936 2.779 . . . . 1.84 112.162 171.313 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.3 mt -80.97 119.71 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 111.842 -2.436 . . . . 0.82 110.408 -178.071 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -115.59 -176.58 2.96 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.324 -3.36 . . . . 2.16 107.322 -173.386 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -64.2 153.49 37.79 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 117.728 -3.108 . . . . 2.12 117.433 177.322 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 64.0 20.27 12.12 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 130.506 3.522 . . . . 1.71 113.157 168.578 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.2 m -88.79 160.28 17.35 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 115.356 -2.259 . . . . 1.04 113.69 -172.286 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.0 m -101.92 95.93 6.71 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 115.573 -2.156 . . . . 0.79 111.163 -172.389 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.424 HD13 HD12 ' A' ' 3' ' ' ILE . 5.3 mp -91.4 163.38 14.21 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 124.355 3.252 . . . . 1.4 106.819 179.373 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -123.04 152.31 41.1 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 124.584 2.135 . . . . 1.51 113.465 -178.173 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.6 tp -127.93 136.96 52.06 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.888 -1.758 . . . . 1.14 108.393 -176.694 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.4 m -135.14 156.76 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 104.003 -2.592 . . . . 1.23 104.003 178.94 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.3 mt -100.95 108.95 20.82 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.928 1.347 . . . . 2.78 113.71 179.357 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.97 88.17 6.85 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.226 2.21 . . . . 3.75 106.935 -179.247 . . . . . . . . 2 2 . 1 . 142 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.3 mt -105.04 -83.8 0.5 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.59 -1.633 . . . . 3.14 106.59 176.143 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 50.8 ttm-85 -145.28 -61.2 0.35 Allowed 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 125.928 1.691 . . . . 6.8 111.181 176.459 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.67 90.69 1.11 Allowed Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.268 -1.933 . . . . 3.57 108.268 -167.443 . . . . . . . . 1 1 . 1 . 142 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.757 0 CA-C-N 120.949 2.375 . . . . 3.87 107.809 -176.995 . . . . . . . . 0 0 . 1 . 143 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.368 0 N-CA-C 112.64 0.608 . . . . 1.1 112.64 . . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.04 146.72 23.51 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.8 -1.813 . . . . 1.87 110.467 179.078 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 pt -127.99 170.03 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 103.997 -2.594 . . . . 0.72 103.997 168.147 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -124.28 142.22 51.43 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.505 -3.247 . . . . 1.4 106.327 -178.809 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.1 t -130.79 118.98 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-O 116.953 -1.499 . . . . 0.58 107.211 179.741 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -97.29 133.3 42.1 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 125.957 2.036 . . . . 2.09 112.782 176.859 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.4 ' HB ' ' H ' ' A' ' 8' ' ' LEU . 46.9 p -74.29 -161.78 0.13 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.527 -2.608 . . . . 0.99 117.697 171.665 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.4 ' H ' ' HB ' ' A' ' 7' ' ' THR . 84.5 mt -71.0 -63.95 1.0 Allowed 'General case' 0 N--CA 1.429 -1.492 2 C-N-CA 134.428 5.091 . . . . 2.53 113.111 174.606 . . . . . . . . 3 3 . 1 . 143 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.5 p -69.09 -47.18 65.88 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 118.921 -2.362 . . . . 2.08 116.31 -176.405 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.06 1.22 0.04 OUTLIER Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 121.594 3.398 . . . . 1.31 121.594 177.458 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -86.47 126.21 34.26 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 118.51 -2.759 . . . . 1.4 111.103 -173.494 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.259 80.1 m -102.89 116.84 33.33 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 105.101 -2.185 . . . . 0.78 105.101 174.947 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.5 pt -99.68 148.94 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 122.543 1.163 . . . . 1.55 111.101 173.102 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.251 37.5 m -106.66 101.97 11.38 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 127.05 2.14 . . . . 1.08 109.161 178.147 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.6 mt -96.98 140.26 31.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 113.809 1.04 . . . . 1.55 113.809 179.376 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -104.13 130.92 51.87 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 126.247 2.927 . . . . 1.95 110.96 172.643 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.6 m -135.24 158.92 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 118.292 -2.755 . . . . 0.96 110.096 -169.49 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -103.93 147.0 33.61 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 106.337 -1.727 . . . . 2.35 106.337 160.397 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.364 43.9 Cg_endo -72.07 -0.89 9.21 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 124.937 2.799 . . . . 0.95 117.548 -176.554 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.6 p -108.59 2.06 21.8 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.792 2.437 . . . . 1.45 106.146 -176.2 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.76 139.96 43.71 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 119.815 1.189 . . . . 1.69 113.514 171.393 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 5.8 p -79.11 167.36 21.15 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.227 2.441 . . . . 0.75 106.74 -179.046 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.2 mm -66.68 -33.6 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 115.358 -2.258 . . . . 0.73 111.104 176.624 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -54.46 -46.43 73.32 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 126.01 2.069 . . . . 1.62 111.79 171.593 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -70.24 -42.11 72.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 112.877 -3.44 . . . . 2.13 115.278 174.825 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.1 t -52.47 -32.76 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 122.266 2.303 . . . . 0.62 112.894 168.71 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 27.6 mttt -73.11 -31.49 64.36 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.407 -3.308 . . . . 1.22 113.447 178.454 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.27 -33.81 75.34 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.282 1.433 . . . . 0.51 110.683 167.432 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -73.23 -34.8 66.1 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.119 -4.113 . . . . 1.44 113.55 176.563 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 99.6 mt -67.75 -31.02 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 127.777 2.431 . . . . 1.32 106.252 172.638 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -39.36 80.02 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 120.468 1.485 . . . . 1.7 114.014 174.214 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -69.79 -47.12 64.06 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 116.77 -1.586 . . . . 1.55 108.846 175.633 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -75.82 -56.38 4.73 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 125.827 1.651 . . . . 2.62 114.237 -174.442 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -103.3 -25.09 13.45 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 117.428 -3.295 . . . . 1.48 110.603 -165.045 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.41 32.95 8.98 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 115.769 -2.684 . . . . 1.12 111.796 -179.893 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mt -110.44 123.1 36.67 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 113.016 -3.373 . . . . 1.55 105.881 -176.403 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -62.16 144.82 96.23 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 124.072 3.181 . . . . 1.02 117.805 177.196 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 94.0 Cg_endo -72.75 -2.04 11.29 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 123.821 3.014 . . . . 1.25 116.134 -170.193 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -73.06 -43.64 61.67 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.686 2.394 . . . . 2.25 109.276 169.076 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.292 31.1 mt-30 -66.35 -55.57 15.29 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.179 -1.576 . . . . 2.02 110.915 -172.667 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.408 70.7 mt-30 -63.89 130.18 43.08 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 128.919 2.888 . . . . 0.69 112.595 -175.874 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -120.31 115.63 23.95 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 103.25 -2.87 . . . . 2.78 103.25 174.026 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.2 mt -97.91 142.52 29.54 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.317 -1.734 . . . . 1.17 106.317 179.557 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.7 mt -136.85 144.88 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 100.597 -3.853 . . . . 1.38 100.597 177.291 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -127.9 104.8 8.01 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 124.389 2.042 . . . . 1.5 106.944 173.736 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.3 . . 71.27 -75.28 0.08 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 112.454 -2.157 . . . . 1.21 113.747 -179.694 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.75 -17.48 1.06 Allowed Glycine 0 N--CA 1.43 -1.71 0 CA-C-O 114.351 -3.472 . . . . 1.3 113.844 174.787 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -96.64 131.3 43.44 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 105.914 -1.884 . . . . 2.55 105.914 -174.378 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -83.28 132.51 35.03 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 131.369 3.867 . . . . 2.48 105.226 172.56 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.286 56.1 mt -85.93 146.37 26.73 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 115.585 -2.15 . . . . 0.9 105.782 -170.556 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -109.15 165.29 11.72 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 125.631 3.832 . . . . 1.94 104.433 169.919 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -76.77 -44.3 33.49 Favored 'General case' 0 N--CA 1.43 -1.434 2 C-N-CA 133.1 4.56 . . . . 1.56 122.423 -171.444 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.68 43.13 2.76 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 126.428 1.966 . . . . 0.97 113.487 169.404 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -122.18 152.91 39.46 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.444 2.297 . . . . 2.49 111.231 170.491 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 77.6 p -95.91 168.68 10.49 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 127.899 3.249 . . . . 0.76 112.221 177.934 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.3 mt -69.95 -33.12 71.69 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 116.735 -3.728 . . . . 1.05 109.837 176.952 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.2 t -68.86 -36.59 78.32 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.435 -3.29 . . . . 1.19 112.213 178.753 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -51.59 -49.5 62.0 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.233 -2.792 . . . . 1.9 112.504 176.391 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -87.53 -4.95 58.97 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 115.785 -4.322 . . . . 0.89 111.087 -179.163 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.3 t30 54.26 53.45 10.93 Favored 'General case' 0 N--CA 1.43 -1.467 1 C-N-CA 132.597 4.359 . . . . 1.84 117.392 176.754 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.0 mt -73.42 126.18 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 126.783 3.182 . . . . 0.82 112.559 -175.617 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -92.66 171.34 9.07 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 114.884 -4.885 . . . . 2.16 114.182 -176.603 . . . . . . . . 2 2 . 1 . 143 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -64.09 143.26 58.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 118.27 -2.769 . . . . 2.12 109.048 174.727 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 55.92 19.2 3.44 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 118.389 2.737 . . . . 1.71 118.389 -178.593 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -74.96 147.32 40.97 Favored 'General case' 0 N--CA 1.428 -1.54 0 O-C-N 120.028 -1.67 . . . . 1.04 106.941 -173.947 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.7 m -93.41 113.28 25.39 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.628 -1.92 . . . . 0.79 106.425 -176.981 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 mp -110.59 156.69 20.59 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 123.125 2.693 . . . . 1.4 104.041 175.558 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -106.35 144.14 33.46 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.136 -2.852 . . . . 1.51 110.155 -179.622 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.6 tp -128.01 115.9 19.21 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 102.947 -2.983 . . . . 1.14 102.947 179.369 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.89 138.22 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 119.18 -2.2 . . . . 1.23 106.218 177.334 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.4 mt -128.47 127.38 42.36 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.814 1.768 . . . . 2.78 113.51 -175.474 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.4 ttt85 -96.66 137.01 36.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 131.133 3.773 . . . . 3.75 103.301 178.236 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.0 mt -98.32 157.13 16.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 112.039 -2.346 . . . . 3.14 112.28 173.651 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.5 mtm180 -96.2 -37.24 10.64 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.196 -2.815 . . . . 6.8 108.596 173.725 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.96 -96.31 0.14 Allowed Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 119.226 -1.464 . . . . 3.57 110.282 -164.994 . . . . . . . . 1 1 . 1 . 143 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.748 0 C-N-CA 129.904 3.621 . . . . 3.87 112.081 -179.064 . . . . . . . . 0 0 . 1 . 144 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 CA--C 1.489 -1.375 0 CA-C-O 123.218 1.485 . . . . 1.1 110.811 . . . . . . . . . 0 0 . 1 . 144 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -100.93 94.17 5.89 Favored 'General case' 0 N--CA 1.431 -1.402 1 O-C-N 115.028 -4.795 . . . . 1.87 106.864 -173.984 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.266 18.9 pt -85.35 149.84 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 1 O-C-N 129.244 4.09 . . . . 0.72 114.227 172.913 . . . . . . . . 3 2 . 1 . 144 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -107.75 108.13 19.21 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.09 2.556 . . . . 1.4 114.707 -179.358 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -94.55 116.27 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-N 119.91 1.232 . . . . 0.58 110.073 176.232 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -95.74 129.86 42.83 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 124.941 2.305 . . . . 2.09 110.232 176.357 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 58.0 p -74.03 -173.78 1.7 Allowed 'General case' 0 N--CA 1.431 -1.393 1 O-C-N 114.808 -4.932 . . . . 0.99 112.829 166.486 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.1 mt -81.12 -49.53 10.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 125.959 2.037 . . . . 2.53 116.421 170.271 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 p -63.56 -56.02 19.21 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.858 -4.276 . . . . 2.08 111.87 -173.392 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.22 53.7 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 116.778 -2.63 . . . . 1.31 111.745 173.098 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -136.7 125.16 23.48 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 121.491 2.646 . . . . 1.4 104.566 -174.193 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.8 m -107.04 113.35 26.77 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 118.668 -2.52 . . . . 0.78 114.431 175.876 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.419 ' CG2' ' HG2' ' A' ' 33' ' ' LYS . 15.6 mt -96.49 125.71 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 122.784 1.278 . . . . 1.55 111.96 -176.043 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.0 m -89.84 119.03 29.87 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.05 -2.906 . . . . 1.08 111.244 177.768 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.8 mt -116.53 153.07 32.85 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 120.309 -1.494 . . . . 1.55 109.013 -179.324 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -109.29 130.7 55.49 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.262 -3.399 . . . . 1.95 107.561 172.198 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -144.42 173.61 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 123.31 1.529 . . . . 0.96 109.685 179.709 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.434 ' O ' HD12 ' A' ' 56' ' ' LEU . 18.9 mm-40 -106.44 159.68 28.91 Favored Pre-proline 0 N--CA 1.431 -1.42 0 N-CA-C 105.244 -2.132 . . . . 2.35 105.244 167.164 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -84.5 -11.33 8.27 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 O-C-N 113.87 -3.805 . . . . 0.95 106.486 -173.71 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.9 p -93.32 -3.37 53.59 Favored 'General case' 0 N--CA 1.43 -1.439 1 C-N-CA 131.769 4.028 . . . . 1.45 110.818 -174.154 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -73.76 152.05 40.45 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.253 2.221 . . . . 1.69 107.22 177.269 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.6 p -86.35 156.5 20.19 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 116.906 -3.621 . . . . 0.75 106.73 175.09 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 mm -44.23 -48.55 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 1 C-N-CA 131.764 4.026 . . . . 0.73 112.12 174.842 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -35.46 -57.72 0.61 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 119.019 2.97 . . . . 1.62 119.019 166.831 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -71.16 -27.77 63.78 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 113.367 -1.742 . . . . 2.13 113.848 179.461 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.37 -48.54 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 125.862 2.744 . . . . 0.62 114.085 170.868 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -60.22 -37.36 80.06 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.904 -3.623 . . . . 1.22 115.239 175.879 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.45 -14.35 61.23 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.304 -2.747 . . . . 0.51 112.694 179.509 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.442 ' O ' ' HB3' ' A' ' 32' ' ' ASP . 10.5 ttmt -74.18 -41.61 61.18 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.097 -1.627 . . . . 1.44 114.233 170.261 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.3 mt -58.51 -46.29 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 123.234 1.492 . . . . 1.32 111.439 166.741 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -49.03 -42.83 39.6 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 125.194 2.426 . . . . 1.7 112.856 171.738 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 29' ' ' LYS . 34.0 t70 -60.53 -58.91 6.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.869 -3.644 . . . . 1.55 113.787 168.827 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.419 ' HG2' ' CG2' ' A' ' 13' ' ' ILE . 33.9 tptt -68.82 -62.04 1.55 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.541 2.336 . . . . 2.62 113.429 -170.079 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -87.22 -45.2 10.85 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 128.061 2.545 . . . . 1.48 113.142 -168.57 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.11 39.89 3.91 Favored Glycine 0 N--CA 1.43 -1.751 0 CA-C-N 112.659 -2.064 . . . . 1.12 114.92 177.691 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.3 mt -106.7 134.16 19.95 Favored Pre-proline 0 N--CA 1.43 -1.466 0 C-N-CA 126.374 1.87 . . . . 1.55 107.01 -178.043 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.69 143.44 99.41 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-O 113.684 -2.715 . . . . 1.02 117.513 175.692 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -80.84 -2.31 11.75 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 126.497 3.356 . . . . 1.25 112.012 -168.331 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.74 -26.21 32.13 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 124.829 2.252 . . . . 2.25 111.66 170.393 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -84.86 -20.26 31.09 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.235 -2.791 . . . . 2.02 114.773 -176.065 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -85.85 117.93 25.02 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 114.944 -1.025 . . . . 0.69 111.266 -176.221 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.404 ' HB2' HG23 ' A' ' 70' ' ' VAL . 13.8 mtt-85 -113.22 116.01 29.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.669 -1.269 . . . . 2.78 108.706 169.772 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.5 mt -88.41 136.84 32.79 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.858 -1.151 . . . . 1.17 112.559 176.181 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -113.49 117.63 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 O-C-N 117.682 -3.136 . . . . 1.38 104.886 179.904 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.417 ' HB3' HD21 ' A' ' 50' ' ' LEU . 50.0 t80 -107.21 123.13 47.84 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 116.675 -3.766 . . . . 1.5 108.05 165.916 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.305 . . 64.29 -82.84 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 131.314 3.846 . . . . 1.21 114.215 -173.991 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.66 3.06 2.03 Favored Glycine 0 N--CA 1.43 -1.719 0 O-C-N 116.65 -3.781 . . . . 1.3 105.466 -176.919 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -127.0 141.72 51.72 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 115.658 -4.436 . . . . 2.55 113.913 178.454 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -65.38 142.98 58.03 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.246 2.219 . . . . 2.48 113.589 171.439 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.417 HD21 ' HB3' ' A' ' 45' ' ' PHE . 34.6 mt -96.36 123.46 40.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.765 -3.084 . . . . 0.9 113.493 -176.519 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -81.47 144.26 31.49 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 130.012 3.325 . . . . 1.94 112.959 -178.54 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.6 150.72 28.0 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 128.453 2.701 . . . . 1.56 107.385 -169.113 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.97 -4.44 78.28 Favored Glycine 0 N--CA 1.429 -1.77 0 O-C-N 119.454 -2.029 . . . . 0.97 109.409 174.194 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -97.34 172.34 7.84 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.087 2.286 . . . . 2.49 110.392 171.433 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.6 p -110.83 174.32 5.91 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.504 -1.372 . . . . 0.76 112.57 173.282 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 18' ' ' GLU . 67.1 mt -52.16 -34.67 46.0 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.844 2.458 . . . . 1.05 112.427 170.185 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.1 m -75.11 -34.56 61.72 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.701 2.501 . . . . 1.19 114.179 -172.579 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -51.31 -34.68 34.4 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 119.985 3.328 . . . . 1.9 119.985 170.442 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -92.56 -5.91 50.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 109.712 -3.404 . . . . 0.89 114.195 178.892 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.25 8.9 m120 64.92 50.3 1.96 Allowed 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.057 -2.902 . . . . 1.84 113.516 179.583 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.8 mt -92.64 107.84 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 126.004 2.811 . . . . 0.82 110.903 178.409 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -89.49 172.61 8.86 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.207 -2.269 . . . . 2.16 106.231 -171.288 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -14.42 -89.35 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.007 3.323 . . . . 2.12 119.613 167.473 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -91.44 74.95 6.01 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.537 -4.477 . . . . 1.71 114.309 179.028 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -94.41 144.85 25.21 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 115.89 -4.256 . . . . 1.04 119.657 177.024 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.1 m -101.13 110.11 22.09 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.284 3.434 . . . . 0.79 106.472 -177.026 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -108.81 152.37 24.98 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.695 -1.965 . . . . 1.4 105.695 -177.672 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -116.53 133.24 56.25 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.618 -4.426 . . . . 1.51 110.0 -179.788 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.0 tp -107.75 115.42 30.11 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 115.183 -2.341 . . . . 1.14 110.905 -174.173 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 42' ' ' ARG . 15.7 m -111.75 146.93 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 126.059 2.837 . . . . 1.23 106.373 173.967 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.417 HD21 HD21 ' A' ' 73' ' ' LEU . 9.0 tp -93.72 120.54 34.11 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.935 -1.728 . . . . 2.78 111.877 -174.124 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.81 114.4 28.32 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.86 -1.163 . . . . 3.75 107.86 -177.365 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.417 HD21 HD21 ' A' ' 71' ' ' LEU . 77.2 mt -103.51 -66.69 0.93 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 104.247 -2.501 . . . . 3.14 104.247 174.401 . . . . . . . . 2 2 . 1 . 144 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -120.96 -147.09 0.38 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 116.73 -1.988 . . . . 6.8 107.367 164.649 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.39 -90.5 1.33 Allowed Glycine 0 N--CA 1.43 -1.725 0 CA-C-O 119.369 -0.684 . . . . 3.57 112.273 -163.254 . . . . . . . . 1 1 . 1 . 144 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.745 0 CA-C-N 119.839 1.82 . . . . 3.87 111.7 -172.036 . . . . . . . . 0 0 . 1 stop_ save_